data_2k7p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k7p _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 121.301 0.572 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -67.85 128.69 93.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.055 0.942 . . . . 0.0 110.578 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.0 167.69 25.6 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.522 2.815 . . . . 0.0 112.822 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -104.88 121.39 43.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 108.621 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -146.73 126.01 13.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.676 1.19 . . . . 0.0 110.299 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.26 159.63 41.84 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.433 1.893 . . . . 0.0 110.09 -170.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -133.11 139.49 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.116 1.366 . . . . 0.0 110.315 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.6 mt -133.48 135.2 24.77 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 109.118 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.96 109.67 2.74 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.364 2.709 . . . . 0.0 109.765 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 47.1 t80 -175.7 151.93 1.22 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.344 2.258 . . . . 0.0 108.956 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 41.5 m -134.67 125.89 28.0 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 110.576 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 37.5 mt -82.97 134.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.862 1.265 . . . . 0.0 109.389 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -131.77 -60.22 0.93 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 0.0 111.564 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.4 tptt -152.27 127.5 9.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.552 1.541 . . . . 0.0 110.388 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.95 -149.95 17.82 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.288 1.423 . . . . 0.0 111.648 -167.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.09 146.14 18.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.565 1.146 . . . . 0.0 111.089 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.5 tt -126.89 136.04 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.776 1.631 . . . . 0.0 111.043 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.9 p -148.58 173.16 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.398 1.879 . . . . 0.0 110.252 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.82 -170.69 24.71 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.65 137.96 15.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.593 1.557 . . . . 0.0 109.716 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 20.9 t -113.6 135.01 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 108.195 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -119.41 132.42 55.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.632 1.173 . . . . 0.0 111.457 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.08 142.52 25.21 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.842 1.657 . . . . 0.0 111.694 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.23 -32.96 82.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.149 3.232 . . . . 0.0 114.407 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -72.32 2.83 5.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.908 1.283 . . . . 0.0 114.34 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.35 4.75 65.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.634 1.588 . . . . 0.0 114.599 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.7 164.29 16.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.225 1.41 . . . . 0.0 111.91 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.4 m -137.91 152.83 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.603 1.561 . . . . 0.0 110.889 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.01 163.21 36.6 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.319 1.448 . . . . 0.0 111.624 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -105.97 139.17 19.98 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.169 0.988 . . . . 0.0 111.128 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.63 170.1 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.227 3.284 . . . . 0.0 111.771 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.7 m -109.5 135.71 50.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.41 1.484 . . . . 0.0 108.964 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.62 135.66 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.975 1.31 . . . . 0.0 109.252 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 53.0 m -137.98 127.3 24.63 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.323 1.449 . . . . 0.0 109.971 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -80.27 129.98 34.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.001 0.92 . . . . 0.0 111.154 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.7 -8.77 58.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 37.3 mtmm 63.97 14.3 8.33 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.532 2.333 . . . . 0.0 113.805 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.46 8.38 21.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.221 2.209 . . . . 0.0 112.503 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 12.52 57.07 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.22 1.39 . . . . 0.0 114.4 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.0 p -131.32 155.42 47.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.035 1.734 . . . . 0.0 111.202 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.3 m -112.99 139.47 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.058 0.943 . . . . 0.0 109.869 163.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 49.5 m -96.62 139.5 32.61 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.002 1.321 . . . . 0.0 108.523 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.6 t -124.92 134.82 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.475 1.51 . . . . 0.0 109.241 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -136.17 153.58 51.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 112.504 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.92 136.56 16.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.787 1.635 . . . . 0.0 111.576 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.63 123.46 70.86 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.643 1.177 . . . . 0.0 110.724 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.81 160.2 18.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.942 3.095 . . . . 0.0 112.574 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.9 p -152.34 -9.56 0.19 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.73 149.47 45.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.852 1.661 . . . . 0.0 110.075 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -91.6 166.25 12.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.176 0.991 . . . . 0.0 111.969 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.76 -171.06 13.8 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.148 1.356 . . . . 0.0 113.795 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.54 121.41 30.89 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.723 1.209 . . . . 0.0 109.825 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 70.2 m80 -119.85 165.32 14.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.134 1.774 . . . . 0.0 111.833 -172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.78 154.11 37.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.965 0.906 . . . . 0.0 111.975 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.3 ttm -134.94 127.4 30.52 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.904 2.082 . . . . 0.0 109.986 -168.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -97.4 135.6 39.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.617 1.567 . . . . 0.0 109.975 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.5 mm -132.95 130.55 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.932 1.293 . . . . 0.0 109.769 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.04 138.72 32.0 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.2 t80 -101.85 119.36 38.66 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 109.323 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.17 32.75 11.1 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.916 1.286 . . . . 0.0 112.903 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.5 m-80 74.95 7.22 4.28 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.957 2.503 . . . . 0.0 115.266 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.1 tpp -100.01 129.48 46.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.585 1.154 . . . . 0.0 110.573 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.79 136.7 56.97 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.373 -0.829 . . . . 0.0 113.067 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.7 pt -75.63 155.65 85.24 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.555 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -58.97 129.48 32.14 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.059 1.839 . . . . 0.0 109.485 169.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.06 62.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.499 1.047 . . . . 0.0 114.124 -174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -82.27 143.81 49.2 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.722 1.761 . . . . 0.0 111.209 171.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.0 155.68 91.58 Favored 'Cis proline' 0 C--N 1.351 0.684 0 CA-C-N 119.944 1.016 . . . . 0.0 112.117 -5.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.91 153.43 18.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.553 1.141 . . . . 0.0 110.548 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -150.0 135.07 17.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.693 1.197 . . . . 0.0 109.789 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.17 169.92 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.735 1.214 . . . . 0.0 112.324 -170.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 29.6 t80 -104.19 147.61 27.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.272 -0.892 . . . . 0.0 112.309 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 85.3 t -117.69 133.58 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.295 1.838 . . . . 0.0 108.893 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -151.1 163.04 39.71 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -169.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -80.0 87.63 5.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.226 1.411 . . . . 0.0 111.105 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 10.7 p -54.53 -27.59 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.242 1.417 . . . . 0.0 114.506 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -77.82 -16.99 57.91 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -75.9 161.97 28.52 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.749 1.219 . . . . 0.0 112.438 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.44 -9.82 78.39 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.9 1.238 . . . . 0.0 115.778 -169.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -66.63 147.72 52.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.169 1.485 . . . . 0.0 113.165 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 p -64.47 134.58 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.774 -0.579 . . . . 0.0 109.709 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.1 t -156.2 160.9 40.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.508 1.123 . . . . 0.0 111.057 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.93 142.92 33.04 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.06 161.05 19.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.526 1.531 . . . . 0.0 112.922 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 136.87 175.03 13.57 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.392 1.472 . . . . 0.0 113.046 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.31 -36.95 8.49 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.723 2.282 . . . . 0.0 112.944 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.18 -34.64 90.17 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.439 1.018 . . . . 0.0 114.608 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.59 -6.18 54.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.653 1.227 . . . . 0.0 113.561 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.0 m -104.7 -43.78 5.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.403 1.881 . . . . 0.0 111.166 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -147.31 142.76 27.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.582 1.953 . . . . 0.0 111.916 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -134.21 173.66 21.26 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.349 0.976 . . . . 0.0 113.052 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 28.0 t -138.69 133.3 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.348 1.059 . . . . 0.0 108.575 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.5 m -57.15 133.77 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.165 0.586 . . . . 0.0 112.442 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 23.1 m120 69.61 0.16 2.86 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.872 2.069 . . . . 0.0 114.192 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -103.14 138.66 19.61 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.212 1.405 . . . . 0.0 110.541 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.24 112.64 3.48 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.604 2.203 . . . . 0.0 109.866 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -96.39 133.1 41.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.132 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.7 p -127.04 153.63 45.7 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.4 p90 -162.83 176.23 10.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.989 1.716 . . . . 0.0 111.415 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.7 m -126.82 142.63 51.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.24 1.416 . . . . 0.0 110.493 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.8 t -114.31 126.58 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 107.801 167.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -93.55 120.18 33.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.923 0.889 . . . . 0.0 110.378 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 20.2 p -119.76 15.45 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.97 2.108 . . . . 0.0 112.096 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -58.45 -30.97 67.36 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.029 1.732 . . . . 0.0 114.726 -164.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -131.69 20.28 4.66 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.993 1.717 . . . . 0.0 112.101 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -81.06 -9.5 59.82 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 90.98 -125.56 8.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.39 0.995 . . . . 0.0 112.623 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -154.03 151.5 29.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.335 1.454 . . . . 0.0 111.26 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 154.55 -156.21 26.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.821 1.677 . . . . 0.0 112.521 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.2 107.81 3.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.091 0.853 . . . . 0.0 111.218 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.54 126.53 32.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.884 1.274 . . . . 0.0 108.502 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -130.66 158.1 40.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.905 1.282 . . . . 0.0 112.607 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.6 tp -157.49 135.43 10.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.407 1.883 . . . . 0.0 108.728 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.63 161.39 39.9 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.949 0.9 . . . . 0.0 112.203 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.3 mt -134.87 135.65 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.589 1.156 . . . . 0.0 109.563 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.83 113.51 20.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.037 1.335 . . . . 0.0 109.316 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -129.44 -173.91 13.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.99 1.281 . . . . 0.0 113.912 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.97 -18.57 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.003 3.135 . . . . 0.0 112.32 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -142.57 157.32 44.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.772 1.629 . . . . 0.0 109.339 165.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1907 ' ' LYS . . . . . 0.4 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 1.0 OUTLIER -73.3 107.84 5.84 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.111 -0.993 . . . . 0.0 111.729 -175.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.49 145.81 48.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.867 0.867 . . . . 0.0 111.165 167.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.48 145.8 24.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.484 0.713 . . . . 0.0 110.457 168.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.0 mt -134.9 140.8 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.934 1.293 . . . . 0.0 110.316 -165.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 59.6 m -133.42 155.93 48.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.818 1.647 . . . . 0.0 110.713 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.4 p -153.23 153.97 33.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.482 1.113 . . . . 0.0 112.125 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.4 m -143.76 126.32 15.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.831 1.252 . . . . 0.0 110.748 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.66 131.17 39.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.968 1.307 . . . . 0.0 111.396 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -103.97 151.8 22.76 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.668 1.587 . . . . 0.0 111.852 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -68.18 -16.21 63.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.887 0.875 . . . . 0.0 113.184 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.22 -12.45 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 113.518 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.72 19.2 35.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.676 1.132 . . . . 0.0 114.139 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 80.4 p -114.2 165.36 12.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.958 1.703 . . . . 0.0 110.749 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.8 m -115.26 129.0 56.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.169 1.387 . . . . 0.0 109.916 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.1 t -87.0 151.7 23.04 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.842 0.857 . . . . 0.0 110.65 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.6 t -132.21 144.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.136 1.774 . . . . 0.0 110.026 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.6 t -141.81 141.69 33.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.641 1.577 . . . . 0.0 110.924 171.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.2 p90 -147.19 155.0 41.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.1 mt -119.72 104.31 44.9 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.569 1.547 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.01 167.46 18.08 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.632 2.888 . . . . 0.0 110.36 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.4 p -132.29 -18.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -170.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.51 150.18 50.14 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.61 1.164 . . . . 0.0 110.404 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.29 142.57 27.17 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 111.552 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 158.61 -167.55 34.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.66 1.124 . . . . 0.0 113.331 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.33 126.8 40.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.215 1.406 . . . . 0.0 112.111 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -120.62 124.28 44.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.801 1.64 . . . . 0.0 109.922 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.9 m -87.64 121.08 29.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.116 -0.99 . . . . 0.0 110.851 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.51 127.88 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 108.522 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.46 130.54 55.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 38.2 t -133.22 130.56 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.289 1.036 . . . . 0.0 109.804 172.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.83 144.45 24.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 -167.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.08 124.76 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.892 1.277 . . . . 0.0 110.165 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 56.02 53.49 9.08 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.867 1.267 . . . . 0.0 111.676 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.94 3.42 0.32 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.988 2.915 . . . . 0.0 116.75 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -107.49 126.55 52.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.758 1.223 . . . . 0.0 110.718 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -63.89 147.29 52.28 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.238 -0.914 . . . . 0.0 111.949 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 9.9 m -68.85 152.84 96.57 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.672 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.99 130.29 30.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.165 1.91 . . . . 0.0 110.527 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.94 -15.93 61.63 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.005 1.288 . . . . 0.0 114.919 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.8 t -77.67 140.85 63.97 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 119.282 1.541 . . . . 0.0 111.465 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.72 137.87 52.75 Favored 'Cis proline' 0 C--N 1.352 0.727 0 CA-C-N 119.337 0.799 . . . . 0.0 112.077 -3.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -89.63 169.86 10.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.203 1.801 . . . . 0.0 110.555 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.6 m -129.12 115.95 18.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.698 0.799 . . . . 0.0 110.781 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.27 144.93 25.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.872 1.269 . . . . 0.0 110.656 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 17.8 ttt85 -108.82 121.52 45.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.832 0.853 . . . . 0.0 110.035 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.1 t -102.44 134.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.179 1.392 . . . . 0.0 110.648 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 48.4 p -114.88 169.64 8.93 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.252 1.421 . . . . 0.0 112.939 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.3 140.16 22.58 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.027 1.298 . . . . 0.0 112.612 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 124.38 1.072 . . . . 0.0 112.855 174.414 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 120.987 0.422 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -58.39 118.1 25.27 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.97 1.308 . . . . 0.0 110.991 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.08 152.68 45.99 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.024 2.483 . . . . 0.0 111.037 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.26 113.94 27.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.804 0.842 . . . . 0.0 109.71 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -146.81 125.23 12.34 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 109.99 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.16 153.48 50.45 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.482 1.913 . . . . 0.0 109.891 -173.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.8 p -129.2 136.77 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.029 1.332 . . . . 0.0 110.351 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.01 138.72 33.03 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.001 1.72 . . . . 0.0 109.074 -175.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.87 67.7 7.93 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 124.353 3.369 . . . . 0.0 111.698 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -113.82 150.73 33.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.146 1.778 . . . . 0.0 110.231 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 77.7 m -119.08 125.41 49.24 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.596 1.158 . . . . 0.0 109.751 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 81.1 mt -91.46 132.08 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.755 1.222 . . . . 0.0 109.876 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -114.35 -100.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.18 1.392 . . . . 0.0 110.746 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.4 mttp -133.69 139.35 46.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 111.089 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.4 -139.81 11.2 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.719 1.628 . . . . 0.0 110.801 -165.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.53 141.61 16.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.118 0.967 . . . . 0.0 111.36 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.68 135.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 0.0 110.711 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.3 p -145.77 174.58 11.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.112 1.765 . . . . 0.0 110.206 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.44 -170.96 24.64 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.3 140.14 16.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.843 1.657 . . . . 0.0 109.305 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.1 t -117.72 130.74 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.546 1.539 . . . . 0.0 108.343 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -117.99 128.36 54.71 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.001 1.32 . . . . 0.0 110.389 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 32.4 mtt -99.76 153.32 37.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.198 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -17.87 31.83 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.431 2.754 . . . . 0.0 112.831 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 35.3 p -72.76 -8.06 53.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.0 113.973 170.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.51 83.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.721 1.629 . . . . 0.0 113.777 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -72.52 159.54 33.76 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.599 1.16 . . . . 0.0 112.536 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 46.9 t -139.34 142.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.517 1.527 . . . . 0.0 110.169 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.88 171.15 16.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.885 1.674 . . . . 0.0 111.772 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -106.61 140.39 21.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.34 1.056 . . . . 0.0 111.264 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -86.65 174.0 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.549 3.499 . . . . 0.0 111.94 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 60.3 m -113.46 131.76 55.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.394 1.478 . . . . 0.0 108.982 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.01 133.31 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.839 1.256 . . . . 0.0 109.154 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 92.9 m -123.51 129.04 50.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.152 1.781 . . . . 0.0 109.789 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 59.5 t0 -81.78 118.61 23.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.309 1.044 . . . . 0.0 110.127 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -83.01 -10.54 58.71 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.8 mmmt 73.5 -10.44 1.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.269 2.628 . . . . 0.0 114.331 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -92.75 5.61 50.52 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.495 1.918 . . . . 0.0 113.691 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.89 15.82 53.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.802 1.191 . . . . 0.0 113.716 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 67.3 p -128.26 159.29 35.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.364 1.866 . . . . 0.0 110.286 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -121.79 143.01 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.494 1.118 . . . . 0.0 109.875 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 31.8 m -104.09 137.23 42.34 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.396 1.078 . . . . 0.0 108.618 170.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.3 t -124.92 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.184 1.394 . . . . 0.0 109.042 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -133.76 156.45 47.97 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.138 1.375 . . . . 0.0 112.826 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 22.9 t80 -155.61 135.76 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.828 1.651 . . . . 0.0 111.427 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.37 120.05 71.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.411 1.084 . . . . 0.0 110.776 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.33 139.99 21.49 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.349 2.699 . . . . 0.0 112.01 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.2 m -132.92 0.3 3.48 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -161.4 150.46 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.296 1.838 . . . . 0.0 109.686 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -86.09 173.06 10.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.857 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.09 -172.68 21.73 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.262 1.41 . . . . 0.0 114.098 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -78.0 125.84 29.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.618 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 51.2 m80 -123.09 163.05 21.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.075 1.75 . . . . 0.0 111.372 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.22 153.1 34.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.157 0.983 . . . . 0.0 111.862 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 28.0 ttm -137.36 135.25 36.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.956 1.702 . . . . 0.0 110.771 -167.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.11 134.3 51.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.443 1.897 . . . . 0.0 109.848 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.6 mm -133.97 130.59 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.171 1.388 . . . . 0.0 109.53 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 136.5 23.4 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -173.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.67 122.68 43.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.641 1.976 . . . . 0.0 109.784 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 51.82 31.28 8.03 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.876 1.27 . . . . 0.0 112.881 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 18.1 t30 77.62 5.09 3.01 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.279 2.631 . . . . 0.0 115.108 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 95.9 mtp -100.07 129.36 46.11 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.31 1.444 . . . . 0.0 110.772 170.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -56.77 137.15 55.05 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.6 pt -74.55 151.14 87.18 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.861 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.04 132.34 44.11 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.672 2.248 . . . . 0.0 110.243 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.91 -17.15 59.83 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.733 1.159 . . . . 0.0 113.905 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.9 t -85.53 147.77 47.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 119.164 1.482 . . . . 0.0 110.905 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.44 157.43 99.47 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.666 1.274 . . . . 0.0 113.251 -0.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 80.1 mt -101.38 157.87 16.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.67 1.588 . . . . 0.0 110.884 173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -151.93 135.26 15.96 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.839 1.256 . . . . 0.0 110.154 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.2 p90 -165.51 167.2 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 111.98 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -108.52 141.09 40.93 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.126 -0.984 . . . . 0.0 112.928 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.9 t -111.56 139.93 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.815 1.646 . . . . 0.0 109.679 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -161.42 151.77 17.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.9 1.28 . . . . 0.0 112.22 -170.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -67.53 134.15 50.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.932 1.293 . . . . 0.0 112.152 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -68.41 -27.37 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.113 -0.992 . . . . 0.0 113.289 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.89 -21.33 44.11 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -170.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.6 t -67.22 147.03 53.57 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.484 -0.76 . . . . 0.0 112.964 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.9 -6.77 82.0 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.145 1.355 . . . . 0.0 115.103 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.29 166.85 11.36 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.09 1.445 . . . . 0.0 114.0 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.8 t -73.19 144.73 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.978 0.911 . . . . 0.0 108.832 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.0 t -159.74 148.25 17.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.03 1.332 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.61 144.83 50.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.62 1.168 . . . . 0.0 111.658 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.7 p90 -166.73 161.65 15.73 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.615 1.566 . . . . 0.0 112.745 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.02 175.36 13.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.324 1.44 . . . . 0.0 112.897 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 -36.48 9.66 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.721 2.28 . . . . 0.0 112.832 -171.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.96 90.75 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.378 0.99 . . . . 0.0 114.406 -171.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -78.77 -5.64 53.84 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.829 1.314 . . . . 0.0 113.615 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 32.3 m -104.89 -42.1 5.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.409 1.884 . . . . 0.0 111.25 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -151.14 143.39 24.11 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.772 2.029 . . . . 0.0 112.054 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -136.09 177.56 19.45 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.822 1.201 . . . . 0.0 113.212 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 25.5 t -142.96 135.19 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.905 1.282 . . . . 0.0 108.378 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.94 135.33 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 66.34 2.81 2.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.604 1.962 . . . . 0.0 114.382 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -100.01 142.3 24.36 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.907 1.283 . . . . 0.0 110.807 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.37 109.13 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.777 2.318 . . . . 0.0 109.853 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -93.6 133.0 37.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.003 1.321 . . . . 0.0 110.134 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.8 p -127.35 149.01 50.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -159.51 174.79 14.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.754 1.621 . . . . 0.0 111.664 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.8 m -126.51 145.14 50.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.347 1.459 . . . . 0.0 110.721 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 29.9 t -114.76 130.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.476 1.511 . . . . 0.0 108.128 167.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.02 132.77 36.29 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.226 1.011 . . . . 0.0 111.051 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.5 p -131.91 13.67 4.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.787 2.035 . . . . 0.0 112.449 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -50.61 -36.2 33.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.258 2.223 . . . . 0.0 115.268 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.27 24.83 3.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.647 1.579 . . . . 0.0 111.858 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.05 69.03 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.461 1.105 . . . . 0.0 113.619 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.66 150.74 5.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.827 1.203 . . . . 0.0 112.337 -169.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -73.82 149.27 41.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.744 0.783 . . . . 0.0 112.024 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.74 14.42 0.02 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.881 1.705 . . . . 0.0 114.905 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 92.85 100.63 1.46 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.535 1.541 . . . . 0.0 112.806 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.49 130.7 35.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.366 1.466 . . . . 0.0 109.415 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.3 m -126.96 158.4 36.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.64 1.576 . . . . 0.0 112.123 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.7 tp -160.72 135.45 7.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.788 1.635 . . . . 0.0 109.23 -169.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 161.57 38.1 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.043 0.937 . . . . 0.0 112.321 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -135.53 134.58 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.762 1.225 . . . . 0.0 109.547 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -116.73 115.7 26.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.001 1.32 . . . . 0.0 109.326 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -128.37 -177.64 14.97 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.978 1.275 . . . . 0.0 113.873 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.54 -22.65 44.32 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.001 3.134 . . . . 0.0 112.128 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -140.28 158.06 44.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.57 . . . . 0.0 109.069 161.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 118.51 11.98 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.093 -1.005 . . . . 0.0 111.915 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.09 142.63 33.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.207 1.003 . . . . 0.0 110.824 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.05 142.0 28.24 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.322 0.649 . . . . 0.0 110.082 171.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.8 mt -132.06 139.21 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.822 1.249 . . . . 0.0 110.471 -167.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.8 m -128.38 155.56 44.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.861 1.664 . . . . 0.0 110.393 167.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -151.46 156.23 40.19 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.156 0.982 . . . . 0.0 112.237 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.7 m -140.49 118.62 11.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.341 1.456 . . . . 0.0 109.697 -171.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.31 123.71 25.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.169 0.988 . . . . 0.0 110.779 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.55 -17.91 26.18 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 15.0 mm100 71.27 -10.34 0.8 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.344 2.658 . . . . 0.0 114.495 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.69 -14.04 61.48 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.313 1.445 . . . . 0.0 113.104 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 116.81 22.03 4.43 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.509 1.528 . . . . 0.0 114.17 -170.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.0 p -142.38 158.5 43.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.676 1.59 . . . . 0.0 111.111 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -126.23 135.45 51.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.632 1.973 . . . . 0.0 109.068 166.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 16.4 t -94.83 153.29 17.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.459 1.104 . . . . 0.0 111.343 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -132.11 145.03 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.316 1.846 . . . . 0.0 110.0 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.2 t -140.63 138.85 34.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.694 1.598 . . . . 0.0 110.752 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.99 154.5 42.62 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 26.4 mt -118.07 102.62 50.75 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.097 1.759 . . . . 0.0 110.415 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.68 160.67 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.546 2.83 . . . . 0.0 110.139 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.9 m -127.15 -7.77 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.72 151.18 22.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.176 1.39 . . . . 0.0 110.402 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.07 140.77 25.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.796 2.331 . . . . 0.0 111.691 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 157.8 -169.86 34.66 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.86 1.219 . . . . 0.0 113.087 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.82 135.3 35.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.889 1.276 . . . . 0.0 112.135 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.56 128.69 46.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.288 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.0 m -90.51 122.58 33.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.18 -0.95 . . . . 0.0 110.963 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.53 125.69 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.356 1.462 . . . . 0.0 108.621 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.09 130.42 55.48 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.424 1.49 . . . . 0.0 109.71 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 39.2 t -133.25 129.96 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.349 1.06 . . . . 0.0 109.753 172.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.48 142.26 22.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.145 1.378 . . . . 0.0 111.511 -168.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.5 122.17 19.75 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.817 1.247 . . . . 0.0 109.523 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.5 57.89 5.71 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.038 1.335 . . . . 0.0 112.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 8.2 pt-20 59.7 2.42 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.965 2.906 . . . . 0.0 116.819 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -107.5 123.54 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.567 1.147 . . . . 0.0 110.998 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.88 145.41 55.87 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.306 -0.871 . . . . 0.0 111.984 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.4 m -73.39 157.37 88.08 Favored Pre-proline 0 N--CA 1.48 1.065 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.64 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.04 125.82 20.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.63 2.887 . . . . 0.0 111.785 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.24 -11.36 67.84 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.705 1.145 . . . . 0.0 115.469 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.3 t -76.44 139.73 67.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.356 1.578 . . . . 0.0 111.579 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.07 136.84 47.06 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 CA-C-N 119.382 0.815 . . . . 0.0 111.969 -3.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -87.07 170.25 11.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.134 1.774 . . . . 0.0 110.662 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.1 m -128.92 117.76 21.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.748 0.819 . . . . 0.0 110.771 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.1 160.31 15.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.455 1.502 . . . . 0.0 110.954 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -127.62 126.22 41.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.553 1.141 . . . . 0.0 110.207 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.5 t -107.23 134.44 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 0.0 110.866 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 41.8 p -107.2 157.61 17.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.075 1.35 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -94.27 116.76 5.35 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.104 1.335 . . . . 0.0 112.349 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.73 1.212 . . . . 0.0 112.935 173.318 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.373 0.606 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -55.17 114.0 6.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.046 1.739 . . . . 0.0 111.302 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.3 142.54 50.26 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.566 2.177 . . . . 0.0 109.71 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 39.6 t80 -120.14 123.36 43.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.531 0.732 . . . . 0.0 111.457 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.3 135.88 13.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.92 1.688 . . . . 0.0 110.572 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.0 151.63 45.63 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.214 1.805 . . . . 0.0 110.317 -171.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.5 p -117.6 140.23 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.233 1.413 . . . . 0.0 110.318 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.7 mt -133.21 134.93 24.72 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.407 1.883 . . . . 0.0 108.367 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.37 38.75 0.75 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 124.33 3.353 . . . . 0.0 113.354 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.0 t80 -87.26 152.78 22.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.005 1.322 . . . . 0.0 111.415 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 94.2 m -122.94 127.46 48.93 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.419 1.488 . . . . 0.0 109.708 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.6 mt -75.61 136.24 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.457 1.103 . . . . 0.0 111.216 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.1 pttt -112.74 -148.97 0.44 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.497 1.919 . . . . 0.0 112.036 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -87.16 131.91 34.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.557 1.143 . . . . 0.0 111.102 167.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.52 -139.54 11.03 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.311 1.434 . . . . 0.0 111.884 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -156.68 145.01 19.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.567 1.147 . . . . 0.0 111.74 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.6 tt -117.81 137.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.987 1.715 . . . . 0.0 111.057 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 26.1 p -146.27 161.16 40.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.689 1.596 . . . . 0.0 110.799 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.86 20.05 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.0 138.98 18.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.7 1.6 . . . . 0.0 109.798 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 19.6 t -111.56 136.62 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.337 1.855 . . . . 0.0 108.053 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -121.11 125.02 46.18 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 110.882 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.05 148.25 34.12 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.84 1.656 . . . . 0.0 111.319 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.53 -20.2 31.49 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.481 2.787 . . . . 0.0 113.929 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.6 t -77.03 -4.08 42.38 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.91 51.06 2.53 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.596 1.093 . . . . 0.0 113.035 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.81 166.96 25.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.678 1.591 . . . . 0.0 111.849 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.9 m -139.41 159.49 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.671 1.188 . . . . 0.0 113.071 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.05 171.83 18.47 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.142 2.177 . . . . 0.0 110.545 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -107.26 137.98 19.76 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.822 0.849 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.97 168.11 13.91 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.939 3.092 . . . . 0.0 110.972 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.5 m -104.63 126.23 51.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.005 1.322 . . . . 0.0 108.83 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.31 137.67 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.962 1.305 . . . . 0.0 108.846 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 24.4 m -146.71 127.25 14.13 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 109.393 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.56 143.64 40.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 112.648 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -88.76 -3.09 58.85 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? 65.94 18.49 11.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.343 1.857 . . . . 0.0 112.978 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -128.2 15.53 6.72 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.529 1.932 . . . . 0.0 112.684 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 85.11 15.91 66.03 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.575 1.083 . . . . 0.0 114.094 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 30.2 p -135.19 158.14 45.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.281 1.833 . . . . 0.0 110.32 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -123.81 144.66 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.613 1.165 . . . . 0.0 110.497 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.1 m -103.71 140.16 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.118 1.367 . . . . 0.0 108.862 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 34.0 t -122.62 133.78 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.486 1.514 . . . . 0.0 108.833 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.45 153.77 50.54 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.574 1.55 . . . . 0.0 111.983 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 26.6 t80 -157.0 133.31 9.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.207 1.403 . . . . 0.0 111.826 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.43 119.04 71.23 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.374 1.07 . . . . 0.0 110.513 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.59 144.31 31.68 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.524 2.816 . . . . 0.0 112.114 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.7 p -129.07 -7.6 4.88 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -159.88 150.97 19.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.74 1.616 . . . . 0.0 110.698 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.31 170.8 14.22 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.649 1.18 . . . . 0.0 113.308 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.15 -171.09 13.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.099 1.809 . . . . 0.0 113.919 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.3 tp -85.21 133.72 34.17 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.753 1.221 . . . . 0.0 110.035 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -130.47 166.47 20.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.028 1.731 . . . . 0.0 111.37 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.67 157.32 45.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.447 1.099 . . . . 0.0 110.691 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.2 tmm? -146.56 135.02 21.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.013 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.31 137.71 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.832 2.053 . . . . 0.0 110.03 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.0 mm -135.03 132.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.133 1.373 . . . . 0.0 110.137 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 141.21 32.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.4 t80 -103.27 120.49 40.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.541 1.936 . . . . 0.0 109.965 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.26 32.39 8.15 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.716 1.206 . . . . 0.0 112.889 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.8 t30 81.47 0.69 1.6 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.728 2.811 . . . . 0.0 115.08 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 57.4 ttm -98.83 128.5 45.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.343 1.457 . . . . 0.0 110.957 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.27 137.42 52.26 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.38 154.17 81.84 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.26 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.51 129.58 33.21 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.514 2.143 . . . . 0.0 109.988 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.79 -16.92 59.65 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.812 1.196 . . . . 0.0 114.065 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.6 t -86.66 145.51 39.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 119.699 1.75 . . . . 0.0 111.244 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -82.8 165.31 70.91 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.076 1.063 . . . . 0.0 112.73 -4.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.63 156.88 25.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.286 1.834 . . . . 0.0 111.423 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -137.05 137.88 39.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.522 1.529 . . . . 0.0 109.71 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 27.0 p90 -158.5 155.89 29.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.284 1.034 . . . . 0.0 112.315 -169.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.0 t80 -106.01 148.17 28.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.878 0.871 . . . . 0.0 112.341 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 55.0 t -126.11 137.45 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.523 1.529 . . . . 0.0 108.979 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -150.35 158.43 44.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.599 1.16 . . . . 0.0 113.115 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.8 118.46 20.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.941 0.896 . . . . 0.0 111.748 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.6 p -62.9 -34.29 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.743 1.217 . . . . 0.0 114.017 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -88.24 -7.44 56.8 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 39.7 t -67.35 -34.04 76.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.292 1.037 . . . . 0.0 113.065 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 82.67 2.6 90.65 Favored Glycine 0 N--CA 1.476 1.319 0 C-N-CA 124.901 1.239 . . . . 0.0 115.325 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -64.03 163.26 12.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.622 1.569 . . . . 0.0 113.698 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.3 t -70.16 132.76 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.0 t -165.27 164.24 19.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.784 1.233 . . . . 0.0 110.963 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.32 143.9 44.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.433 1.493 . . . . 0.0 111.251 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.5 p90 -162.93 162.84 26.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.278 1.431 . . . . 0.0 112.782 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 125.89 173.59 13.66 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.443 1.497 . . . . 0.0 112.797 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.01 -34.99 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.793 2.329 . . . . 0.0 112.947 -170.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.82 -32.95 82.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.51 1.05 . . . . 0.0 114.786 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.33 -6.08 55.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.877 1.338 . . . . 0.0 113.526 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.2 m -105.0 -45.28 4.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.497 1.919 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -146.44 150.52 35.78 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.679 1.992 . . . . 0.0 112.132 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 179.86 22.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.293 0.949 . . . . 0.0 113.493 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 31.5 t -142.45 133.2 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 0.0 108.522 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.5 m -55.54 137.44 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.3 m-80 68.98 -4.92 1.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.072 2.149 . . . . 0.0 114.814 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -104.39 138.58 19.56 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.012 1.325 . . . . 0.0 110.771 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.93 127.13 12.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.368 2.045 . . . . 0.0 110.334 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.21 145.18 32.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.595 1.558 . . . . 0.0 110.368 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.6 p -135.11 151.07 50.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.909 0.884 . . . . 0.0 113.245 -167.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.5 p90 -162.01 176.26 10.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.945 1.698 . . . . 0.0 111.441 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 67.8 m -129.93 143.03 50.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.226 1.411 . . . . 0.0 110.275 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 49.0 t -115.4 135.15 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.689 1.596 . . . . 0.0 108.137 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.7 133.67 42.7 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.364 1.066 . . . . 0.0 111.136 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.7 p -134.61 14.57 3.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.778 1.631 . . . . 0.0 112.519 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.12 -34.78 70.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.645 1.578 . . . . 0.0 114.992 -163.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -129.39 21.51 5.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.691 1.596 . . . . 0.0 111.868 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.59 -39.14 70.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.482 1.113 . . . . 0.0 113.841 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.41 146.76 4.61 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.783 1.183 . . . . 0.0 112.01 -168.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.13 165.86 22.66 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 113.391 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.75 16.47 0.25 Allowed Glycine 0 N--CA 1.477 1.394 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.61 97.22 1.86 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.302 1.429 . . . . 0.0 113.126 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -80.14 127.22 32.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 108.952 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -120.08 159.49 24.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.775 1.63 . . . . 0.0 112.547 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -159.65 137.46 10.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.048 1.739 . . . . 0.0 109.437 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.13 159.51 36.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.442 1.097 . . . . 0.0 111.839 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.13 133.66 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.448 1.099 . . . . 0.0 109.813 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.52 132.68 53.98 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.182 1.393 . . . . 0.0 109.752 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.82 -165.6 15.11 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 119.089 -0.839 . . . . 0.0 114.412 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.31 -29.44 79.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.917 3.078 . . . . 0.0 111.996 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.2 t -129.83 150.43 51.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.851 1.26 . . . . 0.0 108.972 158.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -70.68 125.69 27.51 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.306 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.87 152.8 35.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.68 133.14 34.04 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 162.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.4 mt -133.07 143.13 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.823 1.249 . . . . 0.0 109.994 -166.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.7 t -143.42 158.99 43.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.931 1.293 . . . . 0.0 110.834 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -158.07 154.44 27.57 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.463 1.105 . . . . 0.0 112.436 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.7 m -135.84 120.06 17.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.302 1.441 . . . . 0.0 109.954 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.61 132.03 40.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.901 1.28 . . . . 0.0 110.913 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -109.82 138.77 45.72 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.156 1.382 . . . . 0.0 111.084 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -65.66 -17.85 64.9 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.863 0.865 . . . . 0.0 112.226 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.49 -12.44 57.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.048 1.739 . . . . 0.0 114.346 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.04 33.42 5.5 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.876 1.227 . . . . 0.0 114.486 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.8 p -140.55 164.24 30.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.596 1.558 . . . . 0.0 110.794 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.6 m -119.34 130.45 55.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 163.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -91.49 148.51 22.25 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 110.398 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.9 t -131.38 141.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.412 1.485 . . . . 0.0 110.606 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 49.8 m -133.43 143.46 48.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.947 1.699 . . . . 0.0 111.084 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.8 p90 -150.46 155.2 39.08 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.2 109.24 44.72 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.017 1.727 . . . . 0.0 110.67 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.86 174.68 10.03 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.712 2.941 . . . . 0.0 110.178 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -152.22 -31.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.32 146.17 31.96 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 119.319 0.963 . . . . 0.0 110.48 167.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.89 155.76 53.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.772 2.315 . . . . 0.0 110.703 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.02 -152.71 21.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.49 1.043 . . . . 0.0 112.926 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -114.37 129.75 56.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.634 1.173 . . . . 0.0 111.614 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.26 130.53 56.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 110.28 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.651 1.18 . . . . 0.0 110.798 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.34 124.3 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.416 1.886 . . . . 0.0 108.62 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.03 132.2 51.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.653 1.581 . . . . 0.0 109.58 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.3 t -133.36 131.87 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.417 1.487 . . . . 0.0 108.316 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.6 144.81 18.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.763 1.225 . . . . 0.0 110.714 -166.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.72 121.24 15.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.531 1.132 . . . . 0.0 109.591 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.2 t-20 52.64 57.72 6.11 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.059 1.344 . . . . 0.0 112.334 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.296 7.9 pt-20 59.36 11.72 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.302 2.641 . . . . 0.0 116.35 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.2 124.6 48.31 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.541 1.137 . . . . 0.0 111.218 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -61.1 154.58 22.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.058 0.943 . . . . 0.0 112.663 170.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.51 153.86 71.11 Favored Pre-proline 0 N--CA 1.479 0.984 0 O-C-N 121.845 -0.534 . . . . 0.0 110.269 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -57.15 123.14 13.13 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 110.457 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 97.33 -16.19 61.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.178 1.371 . . . . 0.0 115.956 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 89.8 p -79.56 152.98 75.94 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 120.321 2.06 . . . . 0.0 112.942 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.22 156.28 99.77 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 119.31 0.789 . . . . 0.0 112.675 -4.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -111.13 140.82 45.36 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.573 1.549 . . . . 0.0 111.001 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 43.8 m -95.25 115.43 27.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.509 0.724 . . . . 0.0 110.997 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.08 127.99 42.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.994 1.318 . . . . 0.0 110.664 169.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -96.0 125.21 40.39 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.187 0.595 . . . . 0.0 110.634 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.4 t -110.7 129.77 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.33 1.452 . . . . 0.0 110.897 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.7 p -97.73 148.77 23.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.702 1.201 . . . . 0.0 112.778 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.75 59.62 2.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.35 1.928 . . . . 0.0 112.782 -175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.328 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 120.94 0.4 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -63.35 122.34 75.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.808 1.243 . . . . 0.0 110.357 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.27 140.2 52.53 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.932 2.421 . . . . 0.0 110.485 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.0 t80 -94.63 123.13 37.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.215 0.606 . . . . 0.0 110.255 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -147.42 136.12 21.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.191 1.396 . . . . 0.0 110.504 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.47 149.48 37.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.202 1.801 . . . . 0.0 109.533 -173.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.89 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.056 1.342 . . . . 0.0 110.164 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.83 136.12 27.17 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.774 1.629 . . . . 0.0 109.231 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.93 107.04 2.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.475 2.783 . . . . 0.0 109.693 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -172.95 152.3 2.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.758 2.423 . . . . 0.0 108.464 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.7 m -132.59 126.99 34.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.359 1.064 . . . . 0.0 109.783 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.85 117.63 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.229 1.011 . . . . 0.0 109.749 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 36.9 tptt -100.44 -146.06 0.34 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.214 1.406 . . . . 0.0 110.414 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.2 tttt -78.3 125.28 29.13 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.466 -1.396 . . . . 0.0 111.021 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 139.51 -150.4 21.34 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 125.462 1.506 . . . . 0.0 112.117 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -159.09 147.01 17.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.489 1.116 . . . . 0.0 111.412 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.33 136.78 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.876 1.67 . . . . 0.0 111.07 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.25 167.32 24.52 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.809 1.644 . . . . 0.0 111.004 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.74 -173.63 30.63 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.22 132.55 11.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.96 1.704 . . . . 0.0 109.648 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 86.2 t -103.33 134.43 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.708 1.603 . . . . 0.0 108.326 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.44 131.51 54.2 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.069 1.347 . . . . 0.0 110.972 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.8 mtt -106.23 149.24 37.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.634 1.574 . . . . 0.0 111.617 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -56.0 -28.18 67.79 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.073 3.182 . . . . 0.0 115.183 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 34.8 p -74.45 -6.15 46.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.542 1.537 . . . . 0.0 114.388 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.49 -5.5 82.52 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.535 1.54 . . . . 0.0 113.718 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -70.04 157.11 38.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.589 1.155 . . . . 0.0 112.128 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -142.06 155.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.275 1.43 . . . . 0.0 111.645 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.24 177.43 11.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.953 2.101 . . . . 0.0 110.149 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.43 143.17 33.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 120.974 -1.078 . . . . 0.0 112.254 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -83.97 169.18 11.81 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.417 3.411 . . . . 0.0 111.666 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.4 m -111.01 130.23 55.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.486 1.514 . . . . 0.0 109.03 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.35 137.32 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.945 1.298 . . . . 0.0 109.666 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -138.98 129.21 25.46 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.265 1.426 . . . . 0.0 110.002 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.11 129.04 34.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.949 0.899 . . . . 0.0 110.776 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -84.31 -9.14 58.72 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 66.3 mttm 65.71 10.24 6.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.469 2.308 . . . . 0.0 113.897 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.9 6.93 31.9 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.208 2.203 . . . . 0.0 112.632 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.95 11.82 58.45 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.314 1.435 . . . . 0.0 114.162 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.31 155.64 45.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.207 1.803 . . . . 0.0 111.044 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.5 m -111.14 142.12 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.986 0.914 . . . . 0.0 109.701 162.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 33.7 m -102.06 138.57 38.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.816 1.246 . . . . 0.0 108.465 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.8 t -123.6 134.41 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.196 1.398 . . . . 0.0 109.019 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.19 156.36 46.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.223 1.409 . . . . 0.0 112.715 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 32.6 t80 -155.35 135.41 12.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.718 1.607 . . . . 0.0 111.786 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.03 116.25 65.41 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.536 1.135 . . . . 0.0 110.59 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.46 148.01 29.31 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.47 2.78 . . . . 0.0 112.348 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 7.6 t -140.56 -2.59 1.37 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.166 0.987 . . . . 0.0 113.639 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -144.7 148.29 34.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.366 1.866 . . . . 0.0 109.501 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.15 168.31 12.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.02 0.928 . . . . 0.0 112.076 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.04 -172.48 18.96 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.686 1.136 . . . . 0.0 114.59 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.1 tp -79.86 110.74 15.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.564 1.546 . . . . 0.0 110.912 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 49.1 m80 -107.18 164.05 12.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.191 1.797 . . . . 0.0 112.214 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 142.46 42.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.217 1.407 . . . . 0.0 109.95 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.5 ttm -122.72 126.32 47.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.925 1.29 . . . . 0.0 111.196 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 t70 -87.77 133.86 33.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.801 1.641 . . . . 0.0 110.091 166.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 16.9 mm -134.15 139.63 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.309 1.443 . . . . 0.0 109.874 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.4 142.22 23.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.116 0.966 . . . . 0.0 113.585 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.0 t80 -98.52 118.79 36.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 109.505 172.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.46 34.36 12.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.999 1.32 . . . . 0.0 112.919 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 74.38 10.69 4.22 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.784 2.434 . . . . 0.0 115.073 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 6.0 tmm? -107.39 126.48 52.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.618 1.567 . . . . 0.0 110.197 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m170 -54.87 131.98 45.47 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.044 -1.035 . . . . 0.0 113.711 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.6 pt -71.43 154.41 93.48 Favored Pre-proline 0 N--CA 1.481 1.088 0 O-C-N 121.247 -0.908 . . . . 0.0 111.464 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.53 122.04 10.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.431 2.087 . . . . 0.0 109.627 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.39 43.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.692 1.139 . . . . 0.0 114.563 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.8 t -80.95 147.68 62.4 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.326 1.563 . . . . 0.0 112.173 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.64 164.02 82.65 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.286 1.138 . . . . 0.0 112.258 -7.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 50.8 mt -97.26 156.69 16.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.047 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -153.26 134.35 14.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.395 1.078 . . . . 0.0 110.012 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -167.02 160.59 14.23 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.164 0.986 . . . . 0.0 112.852 -170.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 58.4 t80 -96.44 134.42 39.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.945 0.898 . . . . 0.0 112.74 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.7 t -98.03 128.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.944 1.297 . . . . 0.0 109.966 173.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -132.61 173.51 11.25 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.373 2.269 . . . . 0.0 111.581 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -74.4 141.44 45.08 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.018 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 6.0 p -63.17 -27.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.343 1.057 . . . . 0.0 113.334 -170.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -132.45 134.95 45.71 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.292 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 26.5 p -169.71 164.05 10.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.011 1.724 . . . . 0.0 112.172 -174.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.31 -22.99 20.76 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.721 1.153 . . . . 0.0 114.38 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -73.16 158.54 35.08 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.378 1.089 . . . . 0.0 113.497 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.3 t -70.44 128.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.81 0.844 . . . . 0.0 108.956 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.9 t -147.01 158.15 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.983 1.313 . . . . 0.0 110.45 -175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.13 142.57 36.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.055 1.342 . . . . 0.0 111.513 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.5 p90 -165.69 160.69 17.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.529 1.532 . . . . 0.0 112.532 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.38 174.24 13.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.113 1.339 . . . . 0.0 113.294 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.52 -33.12 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.943 2.429 . . . . 0.0 113.088 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.63 70.62 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.481 1.037 . . . . 0.0 114.501 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.99 -6.64 57.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.028 1.414 . . . . 0.0 113.191 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 49.6 m -102.41 -40.29 6.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.532 1.933 . . . . 0.0 111.794 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.581 1.952 . . . . 0.0 112.338 -167.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -158.59 -175.3 29.36 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.708 0.671 . . . . 0.0 113.822 168.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.5 p -152.46 137.2 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.24 1.416 . . . . 0.0 108.67 174.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 30.1 m -56.74 140.95 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.3 m-80 72.04 -3.03 2.34 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.518 2.327 . . . . 0.0 114.86 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 41.4 mttm -103.59 143.6 26.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.507 1.123 . . . . 0.0 111.133 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.7 123.2 8.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.61 147.25 26.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.384 1.473 . . . . 0.0 110.273 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 70.0 p -137.05 150.85 48.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -168.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -161.38 175.53 12.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.794 1.638 . . . . 0.0 111.592 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.6 m -126.97 142.31 51.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.959 1.304 . . . . 0.0 110.752 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.9 t -117.58 130.22 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.695 1.598 . . . . 0.0 108.27 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -93.75 129.28 40.15 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.231 1.012 . . . . 0.0 111.158 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 56.8 p -136.0 0.52 2.64 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.039 1.336 . . . . 0.0 113.997 -166.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.12 -38.2 67.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.402 1.481 . . . . 0.0 114.727 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.84 9.15 17.53 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.763 1.625 . . . . 0.0 112.935 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.79 -38.42 67.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.9 145.29 5.03 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.93 1.253 . . . . 0.0 112.34 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.1 140.73 49.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.962 0.905 . . . . 0.0 112.014 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 176.1 19.35 0.02 OUTLIER Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.959 1.144 . . . . 0.0 115.959 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 88.62 97.45 0.99 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.191 1.377 . . . . 0.0 112.58 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.51 129.23 34.97 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.328 1.451 . . . . 0.0 109.017 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -124.03 159.66 29.38 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.666 1.586 . . . . 0.0 112.286 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.7 tp -160.34 136.09 8.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.052 1.741 . . . . 0.0 109.09 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.48 157.46 35.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.866 . . . . 0.0 112.331 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.9 mt -137.01 140.74 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.015 1.326 . . . . 0.0 110.006 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.8 159.09 36.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.23 1.812 . . . . 0.0 109.745 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.28 -160.34 28.03 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.862 -0.966 . . . . 0.0 114.595 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.45 -24.61 63.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.123 3.215 . . . . 0.0 112.649 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.1 t -146.81 160.39 42.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.365 1.466 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.01 118.5 16.05 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.986 -1.071 . . . . 0.0 111.59 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.0 149.98 40.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.01 0.924 . . . . 0.0 111.953 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.72 141.01 29.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.799 0.84 . . . . 0.0 109.572 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.4 140.65 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.68 1.192 . . . . 0.0 110.585 -166.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 58.6 m -134.84 157.39 46.93 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.719 1.608 . . . . 0.0 111.124 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 42.3 t -154.14 143.42 21.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.358 1.063 . . . . 0.0 111.778 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.4 m -137.27 126.25 24.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.669 1.587 . . . . 0.0 110.514 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.02 135.89 36.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.176 1.39 . . . . 0.0 111.664 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -113.65 148.26 36.62 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.654 1.581 . . . . 0.0 111.642 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -64.72 -18.62 65.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.331 1.053 . . . . 0.0 112.479 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.73 -8.36 34.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.046 1.738 . . . . 0.0 114.271 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.05 30.01 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.54 1.067 . . . . 0.0 114.032 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 41.6 p -138.4 143.79 39.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.939 1.295 . . . . 0.0 111.399 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.4 m -92.51 123.86 36.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.38 1.072 . . . . 0.0 109.035 161.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.79 139.93 30.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 109.902 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.6 t -117.25 144.44 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.966 1.707 . . . . 0.0 109.933 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 62.8 p -136.79 145.31 44.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.407 1.083 . . . . 0.0 111.77 165.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.3 p90 -151.44 152.94 33.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 12.4 mt -116.57 105.82 49.48 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.042 1.737 . . . . 0.0 110.755 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.74 162.23 16.39 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.79 2.993 . . . . 0.0 110.447 167.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.0 m -134.99 -20.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.62 149.04 47.31 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 110.371 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.31 154.55 51.29 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 111.107 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 135.08 -164.01 24.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.842 1.21 . . . . 0.0 113.592 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -92.18 130.53 37.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 112.368 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -117.3 132.35 56.63 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.601 1.561 . . . . 0.0 110.513 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.3 m -90.71 125.88 35.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.545 1.138 . . . . 0.0 110.551 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.88 127.12 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.535 1.534 . . . . 0.0 108.583 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.88 132.56 54.05 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.496 1.519 . . . . 0.0 109.75 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 67.2 t -132.79 130.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.684 1.594 . . . . 0.0 108.203 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.98 142.63 19.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.616 1.166 . . . . 0.0 111.08 -168.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.01 121.56 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.786 1.234 . . . . 0.0 109.641 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 53.87 56.1 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.103 1.361 . . . . 0.0 112.468 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.2 pt-20 58.25 13.67 2.46 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 128.085 2.554 . . . . 0.0 116.159 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -119.73 127.71 53.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.555 1.142 . . . . 0.0 111.262 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -63.62 159.94 17.85 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 113.006 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -83.3 159.09 62.71 Favored Pre-proline 0 N--CA 1.48 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.065 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.41 -27.44 49.09 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 115.931 -171.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -104.69 -6.04 41.2 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.311 1.284 . . . . 0.0 116.311 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 81.0 p -84.24 153.61 62.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 119.953 1.876 . . . . 0.0 113.416 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.73 148.0 90.76 Favored 'Cis proline' 0 C--N 1.354 0.827 0 CA-C-N 118.829 0.618 . . . . 0.0 112.112 -5.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.67 169.99 9.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.82 1.648 . . . . 0.0 110.724 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 60.9 m -133.22 121.35 22.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.671 0.788 . . . . 0.0 110.877 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.56 139.6 34.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.538 1.535 . . . . 0.0 111.082 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.97 110.88 23.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.677 0.791 . . . . 0.0 109.811 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.9 t -95.7 145.42 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.307 1.443 . . . . 0.0 109.884 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.6 t -128.51 175.11 8.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.262 1.025 . . . . 0.0 113.038 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.68 139.9 18.34 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.624 1.583 . . . . 0.0 112.692 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 124.693 1.197 . . . . 0.0 112.721 174.573 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 121.202 0.525 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.23 117.87 25.49 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 110.634 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.35 157.01 50.23 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.321 2.68 . . . . 0.0 111.532 -173.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 19.6 t80 -110.47 125.12 52.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.701 0.801 . . . . 0.0 110.958 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -154.07 133.54 12.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.238 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.83 146.02 33.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.842 1.657 . . . . 0.0 109.794 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.3 p -111.52 139.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.063 1.345 . . . . 0.0 110.204 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.3 mt -131.06 134.84 26.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.953 1.701 . . . . 0.0 108.843 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.05 92.81 1.03 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.715 2.944 . . . . 0.0 109.759 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 68.8 t80 -151.89 154.28 35.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.16 1.784 . . . . 0.0 109.801 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 68.0 m -126.51 123.82 38.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.705 1.202 . . . . 0.0 109.65 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 91.6 mt -87.68 118.88 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.337 1.055 . . . . 0.0 109.147 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 99.6 mttt -98.08 -77.01 0.51 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.502 1.121 . . . . 0.0 113.232 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.35 -4.61 0.16 Allowed 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.23 -129.1 2.73 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.294 1.902 . . . . 0.0 111.938 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.39 148.61 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.829 1.252 . . . . 0.0 110.824 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -141.09 129.87 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.344 1.458 . . . . 0.0 111.722 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.46 168.4 22.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.007 1.723 . . . . 0.0 110.701 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -153.84 -171.45 20.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.18 138.18 18.16 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.74 1.616 . . . . 0.0 109.63 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.6 t -108.36 136.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.134 1.774 . . . . 0.0 107.892 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.23 121.27 35.47 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.111 1.364 . . . . 0.0 110.541 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 12.7 mtm -87.75 151.55 50.21 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.863 1.665 . . . . 0.0 111.028 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.46 -18.26 38.51 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.442 2.761 . . . . 0.0 113.207 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 36.0 p -73.06 -6.72 47.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.011 1.724 . . . . 0.0 114.22 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.76 -4.85 79.35 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.83 1.681 . . . . 0.0 113.898 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -69.93 158.55 35.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.596 1.159 . . . . 0.0 112.234 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.4 m -137.61 156.79 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 0.0 112.23 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.9 171.94 18.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.665 1.986 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.78 137.5 19.35 Favored Pre-proline 0 CA--C 1.546 0.813 0 O-C-N 121.288 -0.882 . . . . 0.0 111.051 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.52 163.31 19.18 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.837 3.025 . . . . 0.0 110.938 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 67.9 m -101.99 120.31 40.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.9 1.28 . . . . 0.0 108.578 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.04 131.41 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.351 1.06 . . . . 0.0 108.631 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -127.76 124.96 38.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 109.652 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.85 122.72 24.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.235 1.014 . . . . 0.0 110.83 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.7 -15.36 45.5 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 58.0 tttt 71.67 4.01 4.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.308 2.243 . . . . 0.0 114.241 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -113.83 15.29 18.66 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.88 2.072 . . . . 0.0 112.805 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.16 12.15 52.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.105 1.336 . . . . 0.0 114.636 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -131.39 160.57 34.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.018 1.727 . . . . 0.0 110.705 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.9 m -123.93 147.44 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.594 1.158 . . . . 0.0 109.566 164.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.2 m -107.38 136.48 47.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.144 0.978 . . . . 0.0 108.643 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 35.8 t -120.42 131.9 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.126 1.37 . . . . 0.0 109.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -133.1 155.63 48.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.435 1.494 . . . . 0.0 112.662 -169.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -158.29 136.86 11.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.338 1.455 . . . . 0.0 112.338 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.27 120.09 69.74 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.776 1.23 . . . . 0.0 110.996 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.72 159.77 28.08 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.713 2.942 . . . . 0.0 112.233 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 5.5 t -147.59 -11.77 0.4 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.37 149.02 20.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.819 1.648 . . . . 0.0 110.98 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.04 171.0 15.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.656 1.182 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.31 -175.14 15.56 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.535 1.541 . . . . 0.0 114.409 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.93 124.67 31.92 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 110.097 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 46.7 m80 -118.93 152.88 35.53 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.547 1.539 . . . . 0.0 112.193 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -117.3 148.14 41.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.091 1.756 . . . . 0.0 108.899 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.1 tmm? -143.89 130.19 19.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 111.407 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -118.13 139.7 50.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.45 1.9 . . . . 0.0 110.924 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -137.27 133.19 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.185 1.394 . . . . 0.0 110.57 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 140.69 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -103.05 119.85 39.59 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.589 1.956 . . . . 0.0 109.489 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.79 34.61 13.51 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.762 1.225 . . . . 0.0 112.835 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.7 m-80 72.76 9.16 5.57 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.698 2.399 . . . . 0.0 115.147 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.1 mtm -103.35 128.48 50.42 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.352 1.461 . . . . 0.0 110.158 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -57.37 136.61 56.6 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.247 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.9 pt -75.56 154.26 85.6 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.218 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -59.56 128.45 27.19 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.216 1.944 . . . . 0.0 109.791 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.09 -15.9 59.96 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.838 1.209 . . . . 0.0 114.014 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.2 t -84.89 143.48 40.34 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.687 1.744 . . . . 0.0 111.105 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.1 159.2 83.47 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.025 1.044 . . . . 0.0 112.664 -4.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 87.6 mt -107.21 161.51 14.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.427 1.891 . . . . 0.0 111.183 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.17 139.91 18.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.821 1.249 . . . . 0.0 110.03 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -166.31 174.78 8.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.58 1.152 . . . . 0.0 112.413 -170.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -122.79 131.73 53.9 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.223 1.009 . . . . 0.0 112.718 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 99.3 t -96.92 135.12 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.589 1.556 . . . . 0.0 109.059 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 19.8 t0 -154.98 166.76 32.58 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.943 1.297 . . . . 0.0 111.111 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -82.81 137.45 34.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.81 1.244 . . . . 0.0 112.064 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 7.7 p -67.61 -24.84 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.473 0.709 . . . . 0.0 112.331 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -88.9 25.54 1.77 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.01 1.724 . . . . 0.0 112.773 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.2 p -56.68 151.02 14.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.422 1.489 . . . . 0.0 114.212 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.94 28.52 11.97 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.14 1.829 . . . . 0.0 112.324 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -162.38 163.17 27.94 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.866 1.666 . . . . 0.0 112.556 -163.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 18.3 t -70.18 137.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.29 1.036 . . . . 0.0 109.82 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -147.26 158.7 44.05 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.756 1.222 . . . . 0.0 110.622 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.73 144.08 37.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.101 1.36 . . . . 0.0 111.52 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.3 p90 -168.34 164.83 12.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.403 1.481 . . . . 0.0 113.214 -173.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 126.16 170.75 13.03 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.614 1.578 . . . . 0.0 112.29 -175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -34.89 9.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.778 2.319 . . . . 0.0 113.222 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.08 76.41 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 119.348 0.976 . . . . 0.0 114.968 -169.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.01 -1.62 40.53 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.906 1.353 . . . . 0.0 113.813 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 51.6 m -118.05 -46.51 2.62 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.669 1.988 . . . . 0.0 111.726 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -138.01 148.2 44.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.503 1.521 . . . . 0.0 112.437 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -147.46 178.73 24.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.24 0.924 . . . . 0.0 113.52 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 19.1 t -139.53 136.97 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.914 1.286 . . . . 0.0 108.314 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -55.46 138.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 70.88 -3.29 2.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.547 2.339 . . . . 0.0 114.656 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.5 mttm -98.52 140.54 21.89 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.581 1.153 . . . . 0.0 111.144 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.89 109.77 2.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.647 2.232 . . . . 0.0 109.677 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -89.07 139.14 30.76 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.926 1.29 . . . . 0.0 110.168 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.0 p -130.83 151.25 51.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -166.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.28 175.95 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.276 1.83 . . . . 0.0 111.357 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.5 m -130.69 144.61 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.501 1.52 . . . . 0.0 110.898 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 31.1 t -117.59 135.77 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.584 1.554 . . . . 0.0 108.555 168.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.42 117.64 35.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.575 1.15 . . . . 0.0 110.632 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.8 p -117.05 14.4 14.97 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.289 1.836 . . . . 0.0 112.236 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 60.2 tttp -60.27 -28.39 68.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.421 1.488 . . . . 0.0 114.264 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -118.08 16.59 14.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.996 1.718 . . . . 0.0 112.754 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.71 -12.61 61.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.13 -103.34 2.48 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.718 1.151 . . . . 0.0 110.828 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.02 147.8 24.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.322 1.449 . . . . 0.0 110.432 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 164.36 -105.87 0.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.044 1.307 . . . . 0.0 111.061 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 167.27 144.36 4.1 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 124.773 1.177 . . . . 0.0 112.701 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 25.5 tp -92.39 137.97 31.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.666 1.186 . . . . 0.0 111.277 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.3 m -120.56 157.44 29.46 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.408 1.883 . . . . 0.0 110.74 169.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 53.4 tp -157.07 134.9 10.89 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.202 1.401 . . . . 0.0 109.721 -168.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.17 158.4 36.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.106 0.962 . . . . 0.0 112.324 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.1 mt -137.32 139.17 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.736 1.214 . . . . 0.0 109.986 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.17 131.34 47.13 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.439 1.496 . . . . 0.0 109.872 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -157.7 -162.7 11.89 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.891 -0.95 . . . . 0.0 114.625 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.79 -23.65 68.92 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.253 3.302 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.1 t -144.84 159.6 42.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.24 1.416 . . . . 0.0 109.433 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.11 111.54 5.84 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.095 -1.003 . . . . 0.0 111.019 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.65 148.31 50.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.863 0.865 . . . . 0.0 111.617 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.97 138.43 31.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.194 0.597 . . . . 0.0 109.416 166.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.2 mt -129.53 143.88 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.084 1.353 . . . . 0.0 109.906 -168.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.03 162.8 34.52 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 111.137 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.89 154.83 30.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.697 1.199 . . . . 0.0 112.485 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.3 m -136.94 123.36 20.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.61 1.564 . . . . 0.0 110.09 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.68 130.84 36.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.984 1.314 . . . . 0.0 111.239 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.91 149.14 27.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.463 1.505 . . . . 0.0 111.603 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -65.11 -20.0 66.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.539 1.136 . . . . 0.0 112.882 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.93 -7.87 53.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.203 1.401 . . . . 0.0 113.923 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.67 12.37 47.6 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.925 1.25 . . . . 0.0 114.869 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.0 p -108.61 154.88 21.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.099 1.359 . . . . 0.0 111.289 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 90.0 m -110.63 123.23 49.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 108.822 163.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -86.5 147.45 25.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.46 0.704 . . . . 0.0 110.161 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 90.3 t -128.36 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.977 1.711 . . . . 0.0 109.9 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.72 147.27 44.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 111.81 168.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -151.02 151.18 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -112.41 101.79 53.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.778 1.631 . . . . 0.0 110.575 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.27 161.13 29.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.303 2.669 . . . . 0.0 109.946 166.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.9 m -135.96 -21.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 89.9 mt -118.4 147.52 42.0 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.953 1.301 . . . . 0.0 110.21 170.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.08 154.12 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.734 2.29 . . . . 0.0 110.648 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 137.97 -158.54 24.75 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.706 1.146 . . . . 0.0 112.881 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -106.03 133.78 50.2 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.358 1.063 . . . . 0.0 111.727 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -121.0 125.27 46.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.98 1.712 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -87.6 127.17 35.27 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.965 -1.084 . . . . 0.0 110.848 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.43 120.74 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.545 1.538 . . . . 0.0 108.528 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -103.71 127.53 51.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -130.14 129.17 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.159 1.384 . . . . 0.0 109.036 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.37 136.56 22.43 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.353 -170.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 39.6 t80 -132.22 133.58 44.32 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.991 1.316 . . . . 0.0 110.933 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 48.99 53.73 12.08 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 112.547 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 8.4 pt-20 58.55 16.01 3.98 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 128.037 2.535 . . . . 0.0 116.413 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -125.15 130.33 51.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 111.292 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.3 m170 -62.15 141.35 58.21 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.481 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 8.3 m -71.25 150.86 94.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.35 -0.834 . . . . 0.0 109.872 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.83 130.37 39.5 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.38 2.72 . . . . 0.0 111.742 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.84 -15.14 58.4 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.279 1.419 . . . . 0.0 115.034 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 3.5 t -83.17 143.21 45.01 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 118.935 1.367 . . . . 0.0 111.488 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.9 138.11 51.94 Favored 'Cis proline' 0 C--N 1.357 0.996 0 CA-C-N 119.832 0.976 . . . . 0.0 112.72 0.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.0 173.8 8.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.809 1.643 . . . . 0.0 110.232 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.4 m -135.3 119.74 18.0 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.575 -0.703 . . . . 0.0 110.887 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.93 148.76 21.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 110.973 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -113.46 125.16 53.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.065 0.946 . . . . 0.0 110.21 172.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 83.9 t -111.5 132.46 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.297 1.439 . . . . 0.0 110.593 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 43.9 p -107.39 168.29 9.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.276 1.431 . . . . 0.0 112.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.64 149.57 33.52 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.049 1.309 . . . . 0.0 112.521 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 CA--C 1.548 0.894 0 C-N-CA 124.629 1.172 . . . . 0.0 113.147 176.055 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.332 0.587 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -56.81 116.02 11.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.06 1.744 . . . . 0.0 111.107 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.95 155.4 48.1 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.113 2.542 . . . . 0.0 110.947 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -105.28 124.38 49.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.345 0.658 . . . . 0.0 110.232 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -153.88 130.83 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 110.692 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.92 150.49 43.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.538 1.935 . . . . 0.0 109.565 -175.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -124.93 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.034 1.334 . . . . 0.0 110.31 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.49 138.57 27.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.117 1.767 . . . . 0.0 108.926 -172.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 47.41 2.37 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.655 3.57 . . . . 0.0 113.156 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 61.3 t80 -93.8 159.17 15.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.333 1.453 . . . . 0.0 110.559 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 49.2 m -135.16 127.29 29.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.919 1.288 . . . . 0.0 109.796 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 49.3 mt -75.56 131.46 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.244 1.018 . . . . 0.0 110.419 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -120.62 -145.48 0.36 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.426 1.49 . . . . 0.0 110.683 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -77.17 122.49 25.09 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.548 -1.345 . . . . 0.0 110.749 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.41 -146.01 16.89 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.455 1.503 . . . . 0.0 112.07 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -158.87 145.35 17.0 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.758 1.223 . . . . 0.0 111.084 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.6 137.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.645 1.578 . . . . 0.0 111.122 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.5 p -148.4 168.56 22.3 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.937 1.695 . . . . 0.0 110.654 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.69 -176.47 26.98 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.73 134.71 13.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.293 1.437 . . . . 0.0 110.183 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 5.8 t -99.9 136.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.662 1.985 . . . . 0.0 108.024 171.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -121.53 126.3 48.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.828 1.251 . . . . 0.0 110.755 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -105.73 142.15 24.17 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.325 1.45 . . . . 0.0 112.09 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.61 -26.66 73.48 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.118 3.212 . . . . 0.0 115.022 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 23.3 p -73.84 1.19 11.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.257 1.423 . . . . 0.0 114.506 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.73 37.41 7.4 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.593 1.092 . . . . 0.0 113.46 173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.21 169.32 17.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.408 1.483 . . . . 0.0 112.543 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.7 m -140.39 160.6 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.106 1.362 . . . . 0.0 112.43 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.32 169.19 24.78 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.494 1.918 . . . . 0.0 110.794 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -108.13 136.89 19.75 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.33 167.25 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.063 3.176 . . . . 0.0 111.406 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.9 m -105.13 130.85 53.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.566 1.546 . . . . 0.0 109.069 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 131.27 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.767 1.227 . . . . 0.0 108.976 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.9 m -133.22 122.21 23.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.251 1.42 . . . . 0.0 109.732 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.06 127.73 32.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.363 0.665 . . . . 0.0 110.407 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -82.31 -11.46 58.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 71.68 2.01 4.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 128.276 2.63 . . . . 0.0 114.055 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -94.38 3.57 55.01 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.564 1.946 . . . . 0.0 113.047 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.21 17.99 41.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.87 1.224 . . . . 0.0 113.93 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -131.06 155.63 46.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.47 1.908 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -112.51 143.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 109.532 163.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.8 m -104.23 135.17 46.2 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.624 1.17 . . . . 0.0 107.908 165.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.7 t -122.37 132.64 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.325 . . . . 0.0 108.838 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -135.02 160.54 38.0 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.086 1.354 . . . . 0.0 112.842 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.2 t80 -159.01 137.71 10.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.519 1.528 . . . . 0.0 111.936 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.41 119.08 71.26 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.665 1.186 . . . . 0.0 110.904 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.97 158.16 46.33 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.06 3.173 . . . . 0.0 112.432 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 8.4 t -135.86 -22.79 1.4 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -161.12 155.8 23.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.769 1.628 . . . . 0.0 109.952 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -72.05 166.43 22.26 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 126.1 178.38 15.28 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 125.906 1.717 . . . . 0.0 113.952 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -80.77 119.01 22.8 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.749 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 23.4 m80 -113.87 159.86 19.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.462 1.505 . . . . 0.0 110.892 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.46 155.72 40.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 111.517 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 3.2 tmm? -148.16 134.81 19.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.77 1.228 . . . . 0.0 111.303 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -103.04 138.45 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.85 1.66 . . . . 0.0 110.426 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.2 mm -127.63 136.56 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.339 1.456 . . . . 0.0 109.796 171.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.94 137.95 23.94 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -102.92 124.93 49.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 0.0 109.902 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.22 32.08 10.18 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.734 1.213 . . . . 0.0 112.462 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.1 t30 75.82 6.52 3.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 128.2 2.6 . . . . 0.0 115.17 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.17 131.13 53.04 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.769 1.628 . . . . 0.0 110.903 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.59 134.03 56.38 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.244 -0.91 . . . . 0.0 113.077 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.17 156.89 85.61 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 123.127 0.571 . . . . 0.0 112.046 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.25 126.37 21.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.274 1.983 . . . . 0.0 109.626 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.74 -16.57 57.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.666 1.127 . . . . 0.0 114.463 -172.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 21.2 t -86.03 148.37 47.74 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.37 1.585 . . . . 0.0 111.961 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -83.19 171.61 50.76 Favored 'Cis proline' 0 CA--C 1.54 0.783 0 CA-C-N 120.246 1.124 . . . . 0.0 112.485 -6.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.28 154.92 22.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.976 1.71 . . . . 0.0 111.662 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -145.36 140.92 28.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.441 1.497 . . . . 0.0 110.041 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -163.42 160.01 22.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.98 1.312 . . . . 0.0 112.04 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.8 t80 -100.15 135.21 41.93 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.058 -1.026 . . . . 0.0 112.396 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.1 t -103.99 141.05 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.961 1.704 . . . . 0.0 109.28 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 12.8 t0 -154.71 162.9 40.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.611 1.164 . . . . 0.0 111.683 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -81.77 148.06 29.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.57 1.148 . . . . 0.0 112.707 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 30.4 m -69.93 -17.65 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.9 p30 -80.51 -10.54 59.74 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.4 m -70.32 133.02 46.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.147 0.979 . . . . 0.0 112.584 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -101.75 -13.43 32.17 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 125.141 1.353 . . . . 0.0 114.773 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -68.59 164.45 21.38 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -63.46 138.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.355 1.062 . . . . 0.0 109.705 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.9 t -165.2 153.41 11.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.273 1.429 . . . . 0.0 110.022 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -129.8 145.16 51.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.34 . . . . 0.0 111.844 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -168.15 167.86 12.1 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.964 1.706 . . . . 0.0 112.864 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.07 169.37 13.28 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.508 1.528 . . . . 0.0 112.08 -172.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.04 -30.79 20.41 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.63 -33.98 77.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 119.255 0.934 . . . . 0.0 114.605 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.74 -4.33 45.72 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.169 1.485 . . . . 0.0 113.484 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.0 m -108.97 -41.25 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 111.973 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -149.48 152.37 35.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.131 1.772 . . . . 0.0 112.314 -172.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -152.01 177.14 30.02 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.847 0.737 . . . . 0.0 113.665 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 58.5 t -137.9 134.78 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.972 1.309 . . . . 0.0 108.192 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.6 m -55.58 137.51 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 55.5 m-80 68.92 2.21 3.46 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.011 2.124 . . . . 0.0 114.415 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.0 mttt -108.06 140.91 22.13 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.149 1.38 . . . . 0.0 111.087 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.04 124.22 9.9 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.462 2.108 . . . . 0.0 110.205 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.5 144.24 31.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.33 1.452 . . . . 0.0 110.291 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.6 p -133.87 149.59 51.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -166.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -160.18 178.28 9.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.812 1.645 . . . . 0.0 111.496 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 27.5 m -134.14 143.06 47.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.145 1.378 . . . . 0.0 110.565 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 22.7 t -115.14 130.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 108.137 168.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.83 129.83 36.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 111.08 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 69.6 p -137.1 1.01 2.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.103 1.361 . . . . 0.0 113.841 -166.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 82.4 tttt -55.89 -38.95 70.87 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.466 1.506 . . . . 0.0 114.992 -166.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -115.73 10.23 15.38 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.671 1.589 . . . . 0.0 112.667 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.4 67.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.15 151.37 8.07 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.672 1.13 . . . . 0.0 112.281 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.74 166.12 22.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 0.0 113.298 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 145.23 9.61 0.31 Allowed Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 102.0 96.95 2.32 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.484 1.516 . . . . 0.0 113.157 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.98 132.83 36.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.347 1.459 . . . . 0.0 109.251 169.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.5 t -134.98 165.78 24.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.366 1.467 . . . . 0.0 112.45 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 36.1 tp -166.86 137.36 3.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.738 2.015 . . . . 0.0 109.272 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.45 34.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.162 0.985 . . . . 0.0 112.16 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.6 mt -136.42 139.93 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.792 1.237 . . . . 0.0 110.264 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.58 145.74 51.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.717 1.607 . . . . 0.0 109.652 170.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.28 -165.48 25.74 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 119.091 -0.838 . . . . 0.0 114.841 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.47 -26.01 70.35 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.316 3.344 . . . . 0.0 112.657 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.3 t -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.962 1.305 . . . . 0.0 109.144 159.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.72 116.49 12.15 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.978 -1.076 . . . . 0.0 111.4 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -72.81 147.55 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.795 0.838 . . . . 0.0 111.903 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.17 143.66 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.677 0.791 . . . . 0.0 109.76 167.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.76 145.88 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.164 1.385 . . . . 0.0 110.826 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -142.74 164.72 29.34 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.045 162.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.5 p -161.78 155.72 21.82 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.939 1.296 . . . . 0.0 112.616 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 79.3 m -143.85 124.89 14.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.544 1.537 . . . . 0.0 110.437 -171.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.53 130.96 36.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.54 1.136 . . . . 0.0 111.216 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.43 147.87 32.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.471 1.508 . . . . 0.0 112.017 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.3 -15.47 63.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.0 0.92 . . . . 0.0 113.437 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -74.92 -6.58 49.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.103 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.62 33.08 7.68 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.476 1.036 . . . . 0.0 113.951 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.0 p -138.43 157.26 46.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.961 1.304 . . . . 0.0 111.268 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 39.2 t -105.24 124.13 49.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.572 1.149 . . . . 0.0 108.734 158.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -90.34 146.61 24.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.922 0.889 . . . . 0.0 110.282 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -129.38 143.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 95.3 p -136.31 149.68 48.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.811 1.244 . . . . 0.0 112.155 168.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.4 p90 -151.52 152.79 33.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.47 104.97 52.82 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.864 1.666 . . . . 0.0 110.649 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.25 164.98 14.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.839 3.026 . . . . 0.0 110.374 167.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -137.15 -20.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.7 mt -118.38 149.31 45.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.013 1.325 . . . . 0.0 110.327 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.57 155.67 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.966 2.444 . . . . 0.0 110.883 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.83 -162.38 23.82 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.738 1.161 . . . . 0.0 113.691 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -92.11 129.02 38.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.487 1.515 . . . . 0.0 112.671 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 130.05 55.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.485 1.514 . . . . 0.0 110.207 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -90.91 119.03 30.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.616 1.167 . . . . 0.0 110.52 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.42 123.22 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.304 1.842 . . . . 0.0 108.501 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -104.45 134.3 47.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.516 1.526 . . . . 0.0 109.391 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 83.8 t -133.95 133.47 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.312 1.445 . . . . 0.0 108.454 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.74 141.73 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.906 1.283 . . . . 0.0 111.071 -169.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.31 120.25 14.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.695 1.198 . . . . 0.0 109.974 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 52.48 58.42 5.41 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.445 1.498 . . . . 0.0 112.067 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 60.64 2.8 0.53 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.911 2.885 . . . . 0.0 116.684 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -107.27 127.1 53.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.473 1.109 . . . . 0.0 111.177 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -62.93 157.67 21.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.816 0.846 . . . . 0.0 112.392 167.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 32.6 m -87.73 155.75 53.16 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 0.0 110.498 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.53 121.59 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.834 2.356 . . . . 0.0 110.353 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.53 -13.73 66.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.373 1.464 . . . . 0.0 116.037 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.3 p -79.79 151.53 73.92 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 120.434 2.117 . . . . 0.0 113.028 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.35 149.75 94.62 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 119.107 0.717 . . . . 0.0 112.295 -4.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -102.44 156.1 17.82 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.84 1.656 . . . . 0.0 110.888 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 63.4 m -111.29 118.45 35.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.692 0.797 . . . . 0.0 111.047 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.18 133.17 37.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.036 1.334 . . . . 0.0 110.921 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.66 106.36 18.45 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.964 0.905 . . . . 0.0 109.738 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 90.4 t -90.98 145.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 0.0 109.875 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.7 t -137.25 174.26 10.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.049 0.939 . . . . 0.0 113.031 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.72 140.5 18.04 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.741 1.639 . . . . 0.0 112.914 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 124.048 0.939 . . . . 0.0 112.813 173.056 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 47.8 tp . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -47.62 111.06 1.53 Allowed Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.925 1.69 . . . . 0.0 112.326 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.44 155.28 45.72 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.021 2.48 . . . . 0.0 110.655 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.77 125.45 51.43 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.611 0.764 . . . . 0.0 110.514 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -151.46 128.33 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.782 1.633 . . . . 0.0 109.53 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.75 125.95 13.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 109.973 -167.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 96.7 t -93.23 137.92 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.911 1.284 . . . . 0.0 109.863 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.9 mt -131.25 136.2 28.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.651 1.58 . . . . 0.0 108.752 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.28 58.17 6.87 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.273 3.315 . . . . 0.0 111.896 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -107.45 158.56 17.09 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.878 1.671 . . . . 0.0 111.197 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.6 m -125.45 123.08 38.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.819 1.248 . . . . 0.0 109.576 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.45 128.37 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.758 1.223 . . . . 0.0 109.73 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.38 -143.12 0.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.065 1.346 . . . . 0.0 110.718 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -75.53 -10.63 59.62 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.43 168.99 50.68 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.354 1.454 . . . . 0.0 113.704 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 147.6 23.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.329 1.451 . . . . 0.0 111.699 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.49 131.52 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.292 1.437 . . . . 0.0 111.056 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 57.5 p -147.44 -168.82 3.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.546 1.938 . . . . 0.0 109.807 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.49 -155.76 9.12 Favored Glycine 0 N--CA 1.467 0.765 0 O-C-N 121.357 -0.839 . . . . 0.0 114.957 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.91 137.0 9.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.45 1.9 . . . . 0.0 108.964 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 6.7 t -108.5 135.22 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.949 1.699 . . . . 0.0 108.629 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -117.37 123.42 46.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.121 1.368 . . . . 0.0 110.554 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.0 mtm -96.85 147.56 33.1 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.827 1.651 . . . . 0.0 111.349 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.49 -18.79 25.62 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.643 2.895 . . . . 0.0 113.576 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -77.28 2.27 16.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.071 1.348 . . . . 0.0 114.338 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.17 48.29 3.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.678 1.133 . . . . 0.0 113.218 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -156.12 166.39 33.59 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.793 1.637 . . . . 0.0 111.872 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.38 161.48 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.446 1.098 . . . . 0.0 113.194 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.1 178.24 10.51 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.733 2.013 . . . . 0.0 111.006 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.91 140.72 25.14 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.385 1.074 . . . . 0.0 110.872 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.63 160.34 22.0 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.605 2.87 . . . . 0.0 111.003 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.8 m -104.39 120.73 41.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 108.692 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.62 131.35 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.194 0.998 . . . . 0.0 108.706 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.7 m -132.14 128.14 37.45 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.303 1.441 . . . . 0.0 109.221 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.43 134.37 42.37 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.275 0.63 . . . . 0.0 111.564 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -82.69 -13.52 56.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.0 ttpt 67.25 18.86 10.33 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.954 2.102 . . . . 0.0 113.356 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.43 17.38 8.95 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.824 2.049 . . . . 0.0 112.499 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.6 13.12 68.14 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.824 1.202 . . . . 0.0 114.014 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 62.7 p -136.9 164.65 27.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.911 2.085 . . . . 0.0 110.027 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.5 m -127.74 163.38 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.861 1.264 . . . . 0.0 110.115 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.1 t -120.69 147.19 45.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 110.098 164.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 39.0 t -120.01 128.09 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.523 1.529 . . . . 0.0 108.424 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.94 156.55 43.56 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.667 1.587 . . . . 0.0 111.829 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -163.93 133.4 3.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.069 1.348 . . . . 0.0 111.97 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -83.62 123.17 76.7 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.539 1.136 . . . . 0.0 110.483 175.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.24 174.49 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.632 2.888 . . . . 0.0 111.823 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -149.66 -40.24 0.14 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -137.55 154.89 49.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.315 1.446 . . . . 0.0 110.509 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.18 171.0 14.93 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.329 1.052 . . . . 0.0 113.624 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 118.08 -173.03 14.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.048 1.785 . . . . 0.0 113.943 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -85.19 131.78 34.38 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.977 1.311 . . . . 0.0 110.57 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 53.0 m80 -125.69 156.41 39.37 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.743 1.617 . . . . 0.0 111.47 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -134.31 146.49 50.03 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.352 1.461 . . . . 0.0 109.486 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 17.3 tmm? -151.1 132.41 14.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.627 0.771 . . . . 0.0 112.252 -168.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -106.03 148.52 27.65 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.873 1.669 . . . . 0.0 111.65 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 31.4 mm -133.63 135.42 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.406 1.082 . . . . 0.0 110.9 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.36 128.19 19.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.037 1.335 . . . . 0.0 113.085 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.37 126.58 45.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.873 2.069 . . . . 0.0 109.689 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.79 33.27 13.79 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.877 1.271 . . . . 0.0 112.539 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.4 t30 75.5 2.75 3.86 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.334 2.654 . . . . 0.0 114.795 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.26 132.77 50.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.177 1.391 . . . . 0.0 110.843 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -56.55 134.95 54.66 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.01 155.9 88.19 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.592 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.02 -19.67 69.65 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.503 2.136 . . . . 0.0 113.853 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -80.45 -3.5 89.99 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.32 0.964 . . . . 0.0 114.686 172.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 7.7 t -93.02 154.18 41.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 119.203 1.502 . . . . 0.0 111.887 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -82.36 163.01 75.8 Favored 'Cis proline' 0 C--N 1.352 0.726 0 CA-C-N 119.795 0.962 . . . . 0.0 111.591 -13.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 72.1 mt -111.52 156.63 21.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.634 1.574 . . . . 0.0 111.376 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -147.27 139.29 24.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.149 1.38 . . . . 0.0 109.416 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.2 p90 -162.68 162.19 26.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.889 0.876 . . . . 0.0 112.5 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 62.9 t80 -109.72 145.22 36.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.446 1.098 . . . . 0.0 113.004 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 69.4 t -121.95 141.02 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.311 1.844 . . . . 0.0 109.302 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -155.18 144.58 21.16 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.251 1.42 . . . . 0.0 112.989 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -70.06 145.32 51.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 111.551 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 28.2 m -66.52 -19.4 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -91.11 0.56 57.51 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.342 1.457 . . . . 0.0 114.859 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 96.3 m -62.8 132.94 53.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.307 0.958 . . . . 0.0 112.247 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.87 -25.14 18.31 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.704 1.145 . . . . 0.0 113.887 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -68.5 159.71 31.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.22 1.008 . . . . 0.0 113.201 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.4 p -64.37 131.4 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.096 0.959 . . . . 0.0 111.272 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 53.4 p -136.36 164.78 27.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.166 1.786 . . . . 0.0 110.106 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -143.7 144.52 31.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.284 1.034 . . . . 0.0 111.671 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 38.9 p90 -166.49 167.27 15.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.684 1.593 . . . . 0.0 112.861 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.8 170.9 12.86 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.508 1.528 . . . . 0.0 112.454 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.74 -33.82 12.29 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.701 2.267 . . . . 0.0 113.142 -169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.5 -32.89 83.04 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.358 0.981 . . . . 0.0 114.609 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.82 -3.12 39.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.03 1.415 . . . . 0.0 113.771 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 77.5 m -113.31 -47.16 3.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.583 1.953 . . . . 0.0 111.863 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -138.58 143.38 39.35 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.684 1.594 . . . . 0.0 112.448 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.83 175.74 22.39 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.056 1.313 . . . . 0.0 113.026 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -139.62 134.67 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.452 1.101 . . . . 0.0 108.778 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.8 m -56.54 132.32 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 24.7 m120 69.35 1.65 3.37 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.112 2.165 . . . . 0.0 114.401 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -105.27 137.56 19.29 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.285 1.434 . . . . 0.0 110.433 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.47 121.94 7.88 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.417 2.078 . . . . 0.0 110.364 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 145.22 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.457 1.503 . . . . 0.0 110.393 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.5 p -136.22 149.17 48.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.6 p90 -160.74 176.29 11.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.96 1.704 . . . . 0.0 111.47 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.7 m -133.35 141.52 47.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.068 1.347 . . . . 0.0 110.851 -170.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.77 136.36 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.786 1.634 . . . . 0.0 108.014 168.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -104.13 123.0 46.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.421 1.089 . . . . 0.0 110.284 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.9 p -127.04 3.81 6.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.785 1.634 . . . . 0.0 113.636 -166.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.49 -36.92 36.02 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.856 2.062 . . . . 0.0 115.64 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -129.3 17.54 6.0 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.426 1.49 . . . . 0.0 112.423 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.7 -30.07 59.18 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.2 142.36 5.99 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.385 1.469 . . . . 0.0 113.156 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -72.9 152.95 41.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.668 1.187 . . . . 0.0 112.087 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.37 13.12 0.05 OUTLIER Glycine 0 N--CA 1.476 1.36 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 107.96 89.77 2.09 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-N 118.776 1.288 . . . . 0.0 112.728 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.14 126.62 31.08 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.802 1.241 . . . . 0.0 109.367 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -121.54 157.95 29.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.196 1.798 . . . . 0.0 112.166 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.3 tp -160.19 134.99 7.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.915 1.686 . . . . 0.0 109.343 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.82 158.1 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.384 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.55 138.03 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.859 1.263 . . . . 0.0 109.964 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.6 164.24 20.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.266 1.826 . . . . 0.0 109.731 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 169.96 -155.84 26.05 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.673 -1.071 . . . . 0.0 114.224 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.36 -21.92 60.53 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.866 3.044 . . . . 0.0 112.784 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 14.5 t -152.05 164.53 37.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.616 1.566 . . . . 0.0 109.708 166.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -72.45 112.58 8.63 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.991 -1.068 . . . . 0.0 111.153 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.43 148.17 48.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.762 0.825 . . . . 0.0 111.088 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.19 144.1 25.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.045 0.538 . . . . 0.0 110.27 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.7 mt -134.27 144.93 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.056 1.342 . . . . 0.0 110.074 -163.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.5 t -142.45 162.28 35.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.766 1.226 . . . . 0.0 110.922 166.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -159.32 158.83 33.09 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.645 1.178 . . . . 0.0 112.622 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 55.7 m -142.55 123.93 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.273 1.429 . . . . 0.0 110.162 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.09 132.4 37.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.887 1.275 . . . . 0.0 111.152 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -112.71 148.18 35.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.215 1.406 . . . . 0.0 111.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -70.54 -14.03 62.34 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.111 0.964 . . . . 0.0 112.877 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.45 -6.44 50.12 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.707 1.603 . . . . 0.0 114.125 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 35.81 6.21 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.555 1.074 . . . . 0.0 113.519 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.3 p -141.16 161.21 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.307 1.443 . . . . 0.0 111.172 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 66.0 m -115.39 128.3 55.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.032 1.333 . . . . 0.0 108.785 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -89.01 147.63 24.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.65 0.78 . . . . 0.0 110.296 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -129.38 143.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 110.127 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 77.6 p -136.82 148.02 46.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.916 1.286 . . . . 0.0 111.755 167.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 12.8 p90 -152.75 157.02 40.22 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.66 105.93 35.23 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.857 1.663 . . . . 0.0 110.081 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.92 167.26 20.41 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.543 2.829 . . . . 0.0 110.31 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 30.7 m -136.17 -25.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.3 mt -118.26 147.99 42.84 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.042 1.337 . . . . 0.0 110.395 170.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.36 156.11 45.98 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.924 2.416 . . . . 0.0 110.952 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.53 -149.1 20.55 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.55 1.072 . . . . 0.0 112.997 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -113.7 128.27 56.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.041 1.336 . . . . 0.0 111.24 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -112.31 139.74 47.61 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.371 1.468 . . . . 0.0 110.929 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.6 m -97.79 122.28 40.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.642 1.177 . . . . 0.0 110.496 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.34 127.91 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.482 1.513 . . . . 0.0 108.543 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.88 133.02 53.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.778 1.631 . . . . 0.0 109.861 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.4 t -133.9 132.41 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.504 1.521 . . . . 0.0 108.123 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -156.67 144.49 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.852 1.261 . . . . 0.0 110.786 -167.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.7 118.69 12.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 51.57 59.57 4.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.446 1.498 . . . . 0.0 112.179 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 59.39 12.05 2.5 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.036 2.534 . . . . 0.0 116.424 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -119.57 125.43 48.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.389 1.076 . . . . 0.0 111.133 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -60.63 155.45 18.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.099 0.96 . . . . 0.0 112.774 171.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.5 m -74.51 152.19 87.51 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 169.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.05 -12.33 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.506 2.138 . . . . 0.0 114.897 -167.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -102.22 -11.6 36.07 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 174.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 80.5 p -84.5 156.07 62.38 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 120.055 1.927 . . . . 0.0 113.6 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.49 151.21 96.77 Favored 'Cis proline' 0 C--N 1.352 0.763 0 CA-C-N 118.982 0.672 . . . . 0.0 112.472 -4.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -102.42 160.05 14.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.43 1.492 . . . . 0.0 110.825 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 44.3 m -119.71 116.62 26.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.747 0.819 . . . . 0.0 110.57 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.73 126.43 43.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.529 1.132 . . . . 0.0 111.222 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.34 114.41 21.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.163 0.985 . . . . 0.0 108.926 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.7 t -103.34 136.2 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.065 0.946 . . . . 0.0 110.402 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 34.0 p -121.83 171.59 8.79 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 112.589 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.95 145.66 30.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.936 1.255 . . . . 0.0 112.686 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 124.156 0.982 . . . . 0.0 112.863 174.125 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 22.0 tp . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.727 0.298 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.3 120.28 46.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.311 1.044 . . . . 0.0 111.303 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.24 156.64 58.83 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.459 2.773 . . . . 0.0 110.922 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.1 t80 -108.12 127.72 54.06 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.656 0.782 . . . . 0.0 111.096 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.52 135.74 14.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.655 1.582 . . . . 0.0 110.785 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.39 152.48 41.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.518 1.927 . . . . 0.0 109.862 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.0 p -123.31 139.16 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.023 1.329 . . . . 0.0 110.469 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.24 137.49 29.42 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.271 1.828 . . . . 0.0 108.486 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -79.06 45.95 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.555 3.503 . . . . 0.0 112.999 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 29.2 t80 -91.15 153.49 20.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.135 1.374 . . . . 0.0 111.137 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.4 m -125.28 126.36 45.0 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.946 1.298 . . . . 0.0 109.746 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 95.2 mt -91.18 138.06 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.059 1.344 . . . . 0.0 109.917 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -149.74 95.96 2.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.501 1.12 . . . . 0.0 111.521 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 72.59 -31.74 0.23 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 128.539 2.736 . . . . 0.0 115.179 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.1 175.74 54.68 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.626 1.584 . . . . 0.0 113.443 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -111.45 141.68 44.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.235 1.414 . . . . 0.0 111.289 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -125.31 134.29 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.548 1.539 . . . . 0.0 110.602 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.18 170.64 17.97 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.183 1.793 . . . . 0.0 110.324 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -158.89 -167.48 19.67 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 115.884 1.114 . . . . 0.0 115.884 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.48 134.85 15.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.702 1.601 . . . . 0.0 109.264 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.0 t -104.53 131.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.694 1.598 . . . . 0.0 107.443 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -116.38 129.05 56.04 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.833 1.253 . . . . 0.0 110.657 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -97.02 150.68 37.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.71 1.604 . . . . 0.0 111.468 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.4 -20.56 27.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.507 2.804 . . . . 0.0 113.051 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -79.68 -0.54 34.44 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.945 1.698 . . . . 0.0 114.561 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.41 54.08 2.48 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.56 1.076 . . . . 0.0 113.161 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -155.62 167.04 31.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.064 1.746 . . . . 0.0 111.676 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.8 m -140.43 158.09 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.849 1.26 . . . . 0.0 112.58 -172.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.89 166.87 32.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.507 1.923 . . . . 0.0 110.892 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.01 137.73 20.16 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.2 -0.937 . . . . 0.0 111.588 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.77 163.96 20.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.958 3.105 . . . . 0.0 110.993 168.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.7 m -107.87 117.82 35.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.088 1.355 . . . . 0.0 108.852 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -97.64 133.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.43 1.092 . . . . 0.0 109.007 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -125.85 130.64 51.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.111 1.764 . . . . 0.0 109.901 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 17.5 t0 -75.52 122.23 23.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.169 0.988 . . . . 0.0 110.775 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -84.46 -15.4 46.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.7 tttt 71.39 0.22 3.37 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.614 2.366 . . . . 0.0 114.017 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.83 7.87 45.67 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.07 2.148 . . . . 0.0 113.023 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.83 15.12 55.39 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.983 1.278 . . . . 0.0 113.835 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.9 p -132.38 161.78 32.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.419 1.888 . . . . 0.0 110.3 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -125.4 145.24 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.787 1.235 . . . . 0.0 109.831 167.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.2 m -104.71 139.25 39.8 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.291 1.037 . . . . 0.0 108.564 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.7 t -124.14 129.49 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.912 1.285 . . . . 0.0 109.108 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -129.37 161.86 29.33 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -159.64 135.91 8.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 111.828 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.35 114.39 60.88 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.801 1.241 . . . . 0.0 110.602 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -83.97 165.82 13.21 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.723 2.949 . . . . 0.0 112.221 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.3 t -144.35 -1.5 0.92 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.92 152.02 3.49 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.509 1.924 . . . . 0.0 111.27 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.55 175.37 7.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.309 1.443 . . . . 0.0 114.49 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.86 -171.02 13.61 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 126.138 1.827 . . . . 0.0 113.985 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 59.3 tp -79.69 127.41 32.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.623 1.169 . . . . 0.0 110.454 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 55.0 m80 -125.69 168.99 12.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.809 1.644 . . . . 0.0 111.394 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -147.35 153.52 39.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.04 0.936 . . . . 0.0 111.77 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 22.1 ttm -124.34 133.71 53.37 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.117 1.767 . . . . 0.0 110.095 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -111.14 136.12 50.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.236 1.814 . . . . 0.0 109.829 169.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.1 mm -135.59 134.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.028 1.331 . . . . 0.0 110.451 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.03 140.42 36.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.366 1.066 . . . . 0.0 113.588 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.4 t80 -103.6 118.09 35.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.058 2.143 . . . . 0.0 109.256 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.81 31.92 11.41 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.826 1.25 . . . . 0.0 112.945 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.13 5.0 4.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.143 2.577 . . . . 0.0 115.171 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.8 ttp -95.4 127.94 41.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.595 1.158 . . . . 0.0 110.079 165.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.79 137.55 57.65 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.254 -0.904 . . . . 0.0 112.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -71.82 154.43 92.81 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.432 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.55 -17.86 61.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.582 2.188 . . . . 0.0 113.912 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -88.64 2.54 84.67 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.814 1.197 . . . . 0.0 114.88 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 31.5 t -101.94 142.62 24.97 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 119.822 1.811 . . . . 0.0 111.953 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.61 170.33 57.41 Favored 'Cis proline' 0 C--N 1.352 0.76 0 CA-C-N 119.816 0.97 . . . . 0.0 112.477 -3.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.2 mt -120.91 151.42 39.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.118 1.767 . . . . 0.0 110.38 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -132.67 144.73 50.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.73 1.212 . . . . 0.0 110.505 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 6.0 p90 -165.79 154.65 11.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.362 1.065 . . . . 0.0 112.304 -172.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 37.2 t80 -101.66 143.23 31.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 112.429 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 91.8 t -116.09 137.57 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.21 1.804 . . . . 0.0 109.413 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.0 t0 -159.6 147.64 17.3 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.857 1.263 . . . . 0.0 112.267 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -74.47 149.11 40.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 0.0 112.784 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 3.4 p -70.59 -22.33 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.507 -0.745 . . . . 0.0 112.83 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -82.67 -13.24 56.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.107 1.363 . . . . 0.0 114.174 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 82.9 m -58.98 134.49 57.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.535 1.134 . . . . 0.0 113.935 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.15 70.08 1.08 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.702 1.62 . . . . 0.0 111.772 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -162.6 168.58 21.55 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.652 1.581 . . . . 0.0 113.072 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.8 p -68.59 143.79 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.634 0.774 . . . . 0.0 110.074 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -163.52 159.51 22.08 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.692 1.597 . . . . 0.0 110.025 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -138.33 144.76 40.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.335 1.054 . . . . 0.0 112.358 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 45.0 p90 -167.67 165.44 14.32 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.683 1.593 . . . . 0.0 113.239 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.58 175.5 13.96 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.253 1.406 . . . . 0.0 112.977 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.56 -37.0 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.764 -171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.06 91.34 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.538 1.063 . . . . 0.0 114.507 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.02 -6.51 52.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.704 1.252 . . . . 0.0 113.327 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 38.7 m -100.98 -54.73 2.73 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.222 1.809 . . . . 0.0 110.18 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -137.26 139.8 41.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.601 1.961 . . . . 0.0 112.375 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -129.97 172.84 20.01 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.058 1.313 . . . . 0.0 113.242 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 60.9 t -136.85 134.11 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.627 1.171 . . . . 0.0 108.948 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -56.95 139.23 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.0 m-80 66.16 2.24 2.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.86 2.064 . . . . 0.0 114.809 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.35 142.22 29.09 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.908 1.683 . . . . 0.0 111.096 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.79 119.21 5.95 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.637 2.224 . . . . 0.0 110.415 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -94.82 145.7 24.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.218 1.407 . . . . 0.0 109.996 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 76.0 p -136.18 151.57 49.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -168.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.7 p90 -162.87 176.16 10.49 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.461 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.9 m -134.05 138.34 45.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.707 1.203 . . . . 0.0 110.983 -169.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.4 t -102.09 134.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.186 1.394 . . . . 0.0 107.701 165.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -96.43 128.08 43.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.071 0.948 . . . . 0.0 109.824 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.1 p -129.39 7.46 5.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.379 1.872 . . . . 0.0 112.861 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -55.65 -32.17 62.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.91 1.684 . . . . 0.0 114.464 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.65 11.85 13.83 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.541 1.536 . . . . 0.0 113.063 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.03 -15.64 56.78 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.75 -128.75 8.62 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.344 0.973 . . . . 0.0 112.162 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -155.65 150.3 26.19 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.443 1.497 . . . . 0.0 110.723 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.3 -85.0 0.08 OUTLIER Glycine 0 N--CA 1.469 0.851 0 C-N-CA 125.482 1.515 . . . . 0.0 111.003 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -168.77 118.08 0.76 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.575 1.083 . . . . 0.0 112.222 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.14 138.2 32.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.439 1.096 . . . . 0.0 110.063 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.4 m -131.32 158.52 40.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.677 1.591 . . . . 0.0 111.547 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 43.2 tp -156.75 135.93 12.01 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.783 1.633 . . . . 0.0 108.893 -171.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.65 158.93 39.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.77 0.828 . . . . 0.0 112.346 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.0 mt -134.39 137.51 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 109.445 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.15 122.34 38.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.082 1.353 . . . . 0.0 109.379 172.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -139.1 -175.75 14.24 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.724 1.154 . . . . 0.0 114.08 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.5 -23.84 43.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.045 3.164 . . . . 0.0 112.112 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.3 t -136.59 152.23 50.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.506 1.522 . . . . 0.0 108.578 160.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.5 tptt -71.91 120.05 16.96 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.033 -1.042 . . . . 0.0 111.976 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.36 147.97 41.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.933 0.893 . . . . 0.0 111.681 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -89.81 142.85 27.3 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.505 0.722 . . . . 0.0 109.741 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.7 mt -135.11 143.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.587 1.155 . . . . 0.0 110.334 -167.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.2 t -143.19 158.22 43.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 110.838 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -158.74 157.31 31.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.442 1.097 . . . . 0.0 112.988 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 67.3 m -140.89 115.2 9.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.447 1.499 . . . . 0.0 109.868 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.85 136.92 36.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.026 1.331 . . . . 0.0 111.338 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -117.88 146.22 44.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.843 1.657 . . . . 0.0 111.986 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.86 -15.16 63.49 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.759 1.224 . . . . 0.0 112.496 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -70.87 -9.32 57.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.937 1.695 . . . . 0.0 114.159 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.88 33.73 7.22 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.266 0.936 . . . . 0.0 113.553 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.9 p -139.14 163.54 32.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.345 1.458 . . . . 0.0 110.931 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -130.88 125.64 34.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.453 1.501 . . . . 0.0 108.642 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -92.41 144.52 25.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.198 0.999 . . . . 0.0 110.589 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.9 t -126.62 141.7 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.542 1.537 . . . . 0.0 110.802 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 63.2 m -132.92 141.01 48.14 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.985 1.714 . . . . 0.0 110.795 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 10.6 p90 -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.56 104.56 49.45 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.375 1.87 . . . . 0.0 110.524 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.8 165.13 15.68 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.694 2.93 . . . . 0.0 110.199 166.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.0 p -127.77 -19.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.3 pp -146.84 152.06 43.48 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.188 0.995 . . . . 0.0 111.594 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -67.46 147.77 77.83 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.041 2.494 . . . . 0.0 112.838 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.21 -171.09 30.18 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.53 1.062 . . . . 0.0 113.708 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.92 134.64 34.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.956 1.302 . . . . 0.0 112.104 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.66 126.37 41.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.586 1.554 . . . . 0.0 109.842 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 62.6 m -88.37 124.33 33.82 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.987 -1.07 . . . . 0.0 110.708 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.0 128.31 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.512 1.525 . . . . 0.0 108.304 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.1 tt -112.31 130.34 55.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.426 1.49 . . . . 0.0 109.385 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 24.0 t -132.18 131.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.144 0.978 . . . . 0.0 109.577 173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.98 147.48 27.92 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.122 1.369 . . . . 0.0 111.683 -168.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.57 120.25 11.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 109.8 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.12 56.24 5.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.6 1.56 . . . . 0.0 111.824 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.4 pt-20 57.24 13.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.415 2.686 . . . . 0.0 116.322 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -120.23 127.09 52.11 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.732 1.213 . . . . 0.0 110.641 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -63.69 147.08 52.54 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.324 -0.86 . . . . 0.0 112.079 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -70.77 153.73 94.69 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.758 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.43 129.64 30.49 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.632 2.221 . . . . 0.0 110.887 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 91.95 -14.76 63.5 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.103 1.335 . . . . 0.0 114.949 -175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.8 t -78.42 142.63 62.84 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 119.433 1.617 . . . . 0.0 111.734 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.41 140.79 69.24 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.317 0.792 . . . . 0.0 111.989 -4.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -93.52 166.29 12.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.312 1.845 . . . . 0.0 110.689 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 51.3 m -124.44 113.99 18.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.816 0.847 . . . . 0.0 110.395 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.9 156.97 19.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.679 1.192 . . . . 0.0 110.953 167.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -120.9 126.55 50.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.184 0.993 . . . . 0.0 109.949 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.2 t -103.18 131.81 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.38 1.472 . . . . 0.0 109.793 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.2 p -108.99 162.1 14.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.73 1.212 . . . . 0.0 112.62 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.49 142.69 28.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.91 1.243 . . . . 0.0 112.089 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 CA--C 1.549 0.926 0 C-N-CA 124.602 1.161 . . . . 0.0 113.52 -178.717 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 61.5 mt . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.03 0.443 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.22 115.34 10.3 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.551 1.54 . . . . 0.0 111.377 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.79 129.43 18.63 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.32 2.013 . . . . 0.0 108.852 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -114.83 128.88 56.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.616 0.766 . . . . 0.0 111.722 -171.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -157.67 142.72 16.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.817 1.647 . . . . 0.0 111.092 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.97 156.16 49.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.595 1.958 . . . . 0.0 110.141 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.5 p -122.35 137.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.904 1.282 . . . . 0.0 109.959 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 57.9 mt -131.64 133.48 24.31 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.999 1.72 . . . . 0.0 109.035 -172.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.94 112.1 3.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.266 2.644 . . . . 0.0 109.81 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.0 t80 -175.54 148.58 0.93 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.107 2.163 . . . . 0.0 109.177 -171.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.3 m -130.75 124.01 30.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.518 1.127 . . . . 0.0 109.234 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.7 mt -74.47 125.52 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.195 0.598 . . . . 0.0 110.265 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.6 mttp -110.42 -143.0 0.39 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.694 1.597 . . . . 0.0 110.513 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.46 120.29 19.82 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.651 -1.281 . . . . 0.0 110.883 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.98 -152.14 20.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.589 1.566 . . . . 0.0 112.303 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -160.31 147.47 16.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.956 1.302 . . . . 0.0 110.978 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.29 136.73 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.402 1.481 . . . . 0.0 111.207 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 25.2 p -149.58 174.31 12.67 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.573 1.949 . . . . 0.0 110.235 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -157.82 -166.33 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -152.34 142.3 22.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.234 1.813 . . . . 0.0 109.42 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.7 t -119.93 133.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.948 1.699 . . . . 0.0 108.673 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -109.97 132.89 53.75 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.665 1.186 . . . . 0.0 111.794 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -104.34 143.43 26.66 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.674 1.589 . . . . 0.0 111.219 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.08 -29.15 64.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.211 3.274 . . . . 0.0 114.994 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 6.1 m -69.94 -0.77 7.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.3 42.04 6.35 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.6 1.095 . . . . 0.0 112.839 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.59 162.65 39.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.809 1.644 . . . . 0.0 111.99 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.5 m -141.18 158.15 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.988 1.315 . . . . 0.0 112.204 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -151.53 179.1 8.66 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.018 2.127 . . . . 0.0 109.974 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.54 143.8 38.77 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 121.107 -0.996 . . . . 0.0 111.718 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -83.73 166.34 13.47 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.089 3.192 . . . . 0.0 111.405 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 77.5 m -107.21 130.58 54.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.4 1.48 . . . . 0.0 108.651 171.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.52 136.7 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.518 1.127 . . . . 0.0 109.443 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 63.0 m -133.26 124.26 27.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.659 1.584 . . . . 0.0 109.648 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.02 127.26 31.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.292 1.037 . . . . 0.0 111.076 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -87.52 -4.26 58.98 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -170.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 35.9 mmtm 71.57 -5.91 1.53 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.638 2.375 . . . . 0.0 114.538 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -98.21 2.79 48.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.715 2.006 . . . . 0.0 113.218 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.13 16.8 31.62 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.026 1.298 . . . . 0.0 114.457 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 65.1 p -128.75 157.39 41.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.016 1.726 . . . . 0.0 110.677 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -115.31 139.61 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.051 0.94 . . . . 0.0 109.633 163.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.1 m -96.7 138.05 34.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.659 1.184 . . . . 0.0 108.495 169.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 24.8 t -119.11 135.05 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.483 1.513 . . . . 0.0 109.052 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.1 152.77 51.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.558 1.543 . . . . 0.0 111.785 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -153.47 132.44 12.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.349 1.46 . . . . 0.0 110.914 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.43 117.89 70.0 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.236 1.014 . . . . 0.0 110.5 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.56 130.69 12.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.132 2.554 . . . . 0.0 111.823 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 78.2 p -118.7 -15.18 9.51 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -141.54 157.54 44.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.909 1.684 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -90.99 166.28 13.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.27 1.028 . . . . 0.0 112.004 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.24 -166.71 12.17 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.693 1.616 . . . . 0.0 114.079 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -91.77 122.28 34.18 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.338 1.455 . . . . 0.0 110.494 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.5 m80 -119.1 169.57 9.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 111.26 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.51 152.72 42.95 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 171.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 5.7 ttm -125.55 119.45 28.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.886 2.074 . . . . 0.0 109.928 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -95.86 138.4 33.57 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 109.967 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.6 mm -135.96 135.43 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.745 1.218 . . . . 0.0 110.577 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 141.1 32.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 113.329 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 20.6 t80 -103.14 120.26 40.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.153 1.781 . . . . 0.0 109.788 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.73 34.07 15.36 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.673 1.189 . . . . 0.0 112.701 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 73.29 5.35 5.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.92 2.488 . . . . 0.0 115.066 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -97.06 124.6 41.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.079 1.351 . . . . 0.0 109.921 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -57.51 136.11 56.68 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.265 -0.897 . . . . 0.0 112.938 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.3 pt -68.96 152.41 96.82 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.602 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.28 120.11 7.69 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.326 2.018 . . . . 0.0 109.748 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 90.86 7.57 66.11 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.664 -1.075 . . . . 0.0 115.5 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.2 t -74.16 142.11 78.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 120.283 2.041 . . . . 0.0 110.746 162.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -86.59 171.54 38.47 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 120.388 1.174 . . . . 0.0 113.205 -2.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.63 159.34 16.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.131 1.772 . . . . 0.0 110.62 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -133.47 138.86 46.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.614 1.166 . . . . 0.0 110.434 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -156.94 153.32 27.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.07 0.948 . . . . 0.0 112.863 -167.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 43.6 t80 -104.28 148.79 25.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.983 0.913 . . . . 0.0 112.916 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 32.2 t -132.41 139.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.613 1.565 . . . . 0.0 109.22 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.09 153.5 32.95 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.817 1.247 . . . . 0.0 113.023 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -75.69 125.99 30.14 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 111.35 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.0 p -68.72 -24.72 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.572 -0.705 . . . . 0.0 112.428 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.97 -26.02 63.9 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.996 1.318 . . . . 0.0 114.05 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 85.2 m -73.02 -24.61 60.75 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 74.44 7.19 78.14 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.697 1.141 . . . . 0.0 115.504 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -67.91 161.81 25.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.59 1.556 . . . . 0.0 113.629 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -68.26 127.43 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.7 t -156.21 162.78 40.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.41 1.084 . . . . 0.0 111.161 -167.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.4 147.01 31.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.082 1.353 . . . . 0.0 111.804 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.2 p90 -166.54 162.4 16.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.676 1.591 . . . . 0.0 112.355 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.97 173.34 13.26 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.3 1.428 . . . . 0.0 112.991 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.36 -32.56 15.84 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.989 2.46 . . . . 0.0 112.766 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.4 77.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.347 0.976 . . . . 0.0 114.498 -171.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.4 -2.93 44.01 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.865 1.332 . . . . 0.0 113.508 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -106.4 -40.41 5.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.709 2.003 . . . . 0.0 111.558 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -152.47 141.96 21.69 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.356 1.862 . . . . 0.0 111.92 -164.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.9 -179.91 23.35 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.032 1.301 . . . . 0.0 113.118 168.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 62.1 t -142.04 138.28 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.859 1.663 . . . . 0.0 107.831 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -54.91 134.52 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.3 m-80 69.18 -4.48 1.27 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.185 2.194 . . . . 0.0 114.644 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -95.51 137.25 22.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.598 1.159 . . . . 0.0 110.812 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.03 121.77 7.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.486 2.124 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.51 146.51 28.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.377 1.471 . . . . 0.0 110.319 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 73.2 p -138.92 151.2 46.73 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.09 174.43 13.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.0 1.72 . . . . 0.0 111.527 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.0 m -126.85 143.5 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.279 1.432 . . . . 0.0 110.769 -172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.4 t -117.12 134.69 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.017 1.727 . . . . 0.0 108.287 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.13 133.67 36.07 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.033 0.933 . . . . 0.0 111.811 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -134.8 0.87 2.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.433 1.493 . . . . 0.0 113.801 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -54.03 -40.14 66.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.313 1.845 . . . . 0.0 114.804 -167.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -119.92 12.07 11.95 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.708 1.603 . . . . 0.0 112.587 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.99 -35.94 69.61 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 82.37 145.11 5.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.947 1.261 . . . . 0.0 112.496 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.97 148.26 46.14 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.337 1.055 . . . . 0.0 112.142 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.69 -30.54 0.09 OUTLIER Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.51 1.052 . . . . 0.0 114.688 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 145.18 103.28 0.39 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.435 1.493 . . . . 0.0 112.662 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.38 131.49 35.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.232 1.413 . . . . 0.0 109.256 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 9.2 t -135.06 162.99 30.9 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.593 1.557 . . . . 0.0 112.211 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.9 tp -165.63 135.9 3.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.554 1.941 . . . . 0.0 109.205 -163.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.88 159.52 35.1 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.417 1.087 . . . . 0.0 111.956 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.45 135.83 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.523 1.129 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.3 136.23 53.96 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.108 1.363 . . . . 0.0 110.026 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -162.92 -165.02 19.29 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.509 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.98 -26.56 74.07 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.077 3.185 . . . . 0.0 112.514 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -135.87 156.53 48.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.735 1.214 . . . . 0.0 109.464 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -72.95 111.13 7.79 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.076 -1.015 . . . . 0.0 110.288 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.58 147.0 52.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.083 0.953 . . . . 0.0 111.96 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -84.94 135.07 34.21 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.5 mt -130.6 144.68 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 110.418 -166.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.7 t -145.18 165.02 29.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.824 1.25 . . . . 0.0 111.187 167.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -159.26 154.73 25.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.749 1.22 . . . . 0.0 112.528 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.6 m -138.97 125.09 20.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.524 1.53 . . . . 0.0 110.285 -172.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.11 128.79 35.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.715 1.206 . . . . 0.0 111.12 171.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -104.0 148.48 26.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.46 1.504 . . . . 0.0 111.686 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -68.18 -18.26 64.55 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.179 0.992 . . . . 0.0 113.556 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.02 -22.81 60.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.205 1.002 . . . . 0.0 113.695 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 104.52 45.62 1.41 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.287 0.946 . . . . 0.0 113.19 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -140.89 158.07 44.47 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.296 1.438 . . . . 0.0 110.005 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.5 m -107.92 127.36 53.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.638 1.175 . . . . 0.0 109.263 162.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -86.71 147.08 26.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.419 0.688 . . . . 0.0 109.955 166.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -127.98 144.2 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.67 1.588 . . . . 0.0 109.762 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.08 147.93 46.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.873 1.269 . . . . 0.0 111.98 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.9 p90 -151.88 154.25 35.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.15 107.69 43.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.231 1.812 . . . . 0.0 110.383 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -82.81 176.41 7.74 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.901 3.067 . . . . 0.0 110.333 167.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.2 p -151.45 -28.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 85.9 mt -107.58 147.03 34.54 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.53 1.059 . . . . 0.0 110.525 167.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.91 154.98 48.42 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.863 2.376 . . . . 0.0 110.824 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.89 -165.45 24.59 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.96 137.31 32.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.065 1.346 . . . . 0.0 112.506 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -125.36 125.87 44.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.849 1.66 . . . . 0.0 110.079 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 65.3 m -88.19 122.29 31.58 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.646 1.178 . . . . 0.0 110.643 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.69 123.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.437 1.495 . . . . 0.0 108.626 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.45 136.21 44.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.408 1.483 . . . . 0.0 109.318 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 98.4 t -140.32 127.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.173 1.389 . . . . 0.0 108.912 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.96 140.8 20.99 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.567 1.147 . . . . 0.0 111.331 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.4 121.04 14.28 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.465 1.106 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 49.8 t30 57.47 57.27 4.46 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.219 1.408 . . . . 0.0 111.581 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.0 pt-20 58.51 13.96 2.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.438 2.695 . . . . 0.0 116.372 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -124.83 125.9 44.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.382 1.073 . . . . 0.0 111.329 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -65.04 157.05 29.48 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.942 0.897 . . . . 0.0 112.547 169.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.1 m -75.81 152.65 84.93 Favored Pre-proline 0 N--CA 1.483 1.18 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.392 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.3 -13.01 37.97 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.08 1.853 . . . . 0.0 114.462 -166.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -100.24 -10.31 45.52 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.1 p -87.64 153.63 52.95 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 119.779 1.789 . . . . 0.0 113.148 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.11 141.09 68.21 Favored 'Cis proline' 0 C--N 1.352 0.732 0 CA-C-N 119.063 0.701 . . . . 0.0 112.107 -3.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -90.26 167.17 12.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.094 1.357 . . . . 0.0 110.281 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.2 m -128.35 112.15 14.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 110.048 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.76 150.23 23.71 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.383 1.073 . . . . 0.0 110.574 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -110.68 124.76 52.54 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.246 1.018 . . . . 0.0 109.78 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.4 t -107.5 135.05 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.922 1.289 . . . . 0.0 110.834 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.0 p -113.37 164.93 12.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.31 1.444 . . . . 0.0 112.561 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.93 143.15 29.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.007 1.289 . . . . 0.0 112.183 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 124.429 1.091 . . . . 0.0 113.362 -179.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 21.6 tp . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.326 0.584 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.0 ttm-85 -59.06 120.04 43.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.931 1.692 . . . . 0.0 111.908 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.37 159.26 47.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.523 2.816 . . . . 0.0 112.02 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.8 t80 -112.16 123.03 49.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.777 1.231 . . . . 0.0 110.098 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.2 134.26 15.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.064 1.346 . . . . 0.0 110.514 170.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.9 140.81 31.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.686 1.594 . . . . 0.0 109.9 -170.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.1 p -107.67 138.93 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.715 1.206 . . . . 0.0 110.855 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.8 mt -134.08 134.99 23.52 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.348 1.859 . . . . 0.0 108.812 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.04 109.22 2.78 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.411 2.74 . . . . 0.0 110.1 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 48.4 t80 -175.2 151.62 1.31 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.999 2.12 . . . . 0.0 109.821 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 29.1 m -135.06 130.93 36.36 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.615 1.166 . . . . 0.0 110.057 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.98 122.35 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 109.437 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.64 -69.91 0.84 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.45 1.1 . . . . 0.0 112.322 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -158.79 127.14 5.24 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.782 1.633 . . . . 0.0 110.952 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.39 -139.54 11.04 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.51 1.528 . . . . 0.0 111.158 -166.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.09 142.29 17.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.366 1.066 . . . . 0.0 111.385 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.7 tt -121.65 135.49 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.785 1.634 . . . . 0.0 111.032 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.4 p -149.28 169.08 21.6 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.182 1.793 . . . . 0.0 110.596 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -162.07 -175.6 33.27 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 115.711 1.045 . . . . 0.0 115.711 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -153.21 143.35 22.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.654 1.582 . . . . 0.0 109.839 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.8 t -115.67 132.49 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.931 1.692 . . . . 0.0 108.101 171.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -119.03 137.47 53.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 110.898 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.8 mtt -110.56 146.67 34.83 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.463 1.505 . . . . 0.0 111.591 -169.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.63 -28.9 77.24 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.919 3.079 . . . . 0.0 114.944 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.5 p -74.51 0.58 14.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.046 1.738 . . . . 0.0 114.37 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.77 83.18 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.692 1.615 . . . . 0.0 113.947 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -72.96 159.11 34.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.742 1.617 . . . . 0.0 112.182 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.4 m -145.72 155.93 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.641 1.576 . . . . 0.0 111.074 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.68 166.5 26.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.442 1.497 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -100.06 137.63 20.13 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.175 0.99 . . . . 0.0 111.506 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.69 169.29 12.15 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.195 3.263 . . . . 0.0 111.827 171.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 86.9 m -110.24 119.75 40.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.667 1.587 . . . . 0.0 109.002 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.75 129.93 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.279 1.032 . . . . 0.0 109.026 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 35.0 m -125.99 116.13 20.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.861 1.664 . . . . 0.0 109.001 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.01 124.0 27.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.616 -0.678 . . . . 0.0 110.045 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.09 -10.24 59.75 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 72.97 -3.37 2.44 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.023 2.529 . . . . 0.0 113.864 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -93.86 1.19 56.45 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.665 1.986 . . . . 0.0 113.33 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.74 14.16 38.21 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.102 1.334 . . . . 0.0 114.472 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 76.1 p -128.37 157.12 41.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.407 1.883 . . . . 0.0 110.348 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -113.61 137.9 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.513 0.725 . . . . 0.0 109.59 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.5 m -102.29 128.88 48.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.649 1.179 . . . . 0.0 107.993 168.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.4 t -113.74 128.98 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.944 1.298 . . . . 0.0 108.95 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -126.53 154.4 43.88 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.231 1.812 . . . . 0.0 111.619 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.4 t80 -158.99 134.98 8.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.76 1.224 . . . . 0.0 112.275 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.91 119.96 70.66 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.562 1.145 . . . . 0.0 110.648 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.36 150.68 15.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.526 2.817 . . . . 0.0 111.798 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.4 m -132.2 -8.07 3.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -166.98 145.98 5.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.583 1.553 . . . . 0.0 110.325 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.56 170.66 16.17 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 0.0 113.523 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.84 178.77 17.88 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.484 1.516 . . . . 0.0 114.405 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 51.6 tp -75.98 103.21 5.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.191 1.397 . . . . 0.0 110.426 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -96.73 159.46 14.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 111.251 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.64 149.87 36.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 111.627 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 25.3 ttm -134.27 135.67 43.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.387 1.875 . . . . 0.0 110.645 -163.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -118.26 126.36 52.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.904 1.682 . . . . 0.0 109.763 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -127.94 130.13 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.818 1.247 . . . . 0.0 109.727 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 141.1 33.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.4 t80 -103.23 120.3 40.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.257 1.823 . . . . 0.0 109.5 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.15 32.6 10.8 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.766 1.226 . . . . 0.0 112.953 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 75.07 7.32 4.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.052 2.541 . . . . 0.0 115.195 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.4 mtp -99.19 128.03 45.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.921 1.288 . . . . 0.0 110.315 166.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -55.41 136.18 49.72 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.32 -0.862 . . . . 0.0 113.03 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.6 pt -73.12 150.63 90.05 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.883 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.39 131.62 39.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.532 2.155 . . . . 0.0 110.398 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.36 63.43 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.764 1.173 . . . . 0.0 114.51 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.33 150.24 44.35 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.59 1.695 . . . . 0.0 110.922 172.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.98 164.34 88.1 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 120.715 1.291 . . . . 0.0 113.317 -1.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.71 161.32 21.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.937 1.695 . . . . 0.0 111.322 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -157.86 148.99 21.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.391 1.077 . . . . 0.0 112.125 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -168.28 157.8 9.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.302 1.441 . . . . 0.0 111.885 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.4 t80 -95.04 128.69 42.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.056 -1.028 . . . . 0.0 112.685 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.4 t -93.13 135.13 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.501 1.52 . . . . 0.0 108.777 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.79 148.12 20.63 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.324 1.05 . . . . 0.0 112.717 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.34 144.47 51.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.105 1.362 . . . . 0.0 113.295 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.8 p -76.21 -28.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.208 1.003 . . . . 0.0 113.59 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -85.05 -19.48 31.87 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 73.1 m -67.27 149.16 50.76 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.325 1.05 . . . . 0.0 113.401 -173.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.53 -13.52 63.08 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.826 1.203 . . . . 0.0 114.831 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -64.23 153.39 38.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 118.713 1.257 . . . . 0.0 113.296 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.9 p -64.79 135.72 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.727 0.811 . . . . 0.0 110.001 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 9.6 t -154.64 157.27 37.91 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.729 1.212 . . . . 0.0 110.836 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.1 145.59 39.67 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.495 1.118 . . . . 0.0 111.975 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.5 p90 -165.91 165.16 18.35 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.91 1.684 . . . . 0.0 112.236 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.84 175.28 14.0 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.178 1.371 . . . . 0.0 113.123 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 -34.29 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.704 2.269 . . . . 0.0 113.057 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.65 -34.25 86.91 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.578 1.081 . . . . 0.0 114.444 -171.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.95 -4.67 48.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.797 1.299 . . . . 0.0 113.41 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.5 m -106.07 -47.74 3.77 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.446 1.898 . . . . 0.0 110.989 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -143.66 149.14 36.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.46 1.904 . . . . 0.0 112.341 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -145.43 178.27 23.29 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.451 1.024 . . . . 0.0 113.721 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 50.3 t -139.25 135.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 108.451 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.6 m -57.26 136.41 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.29 -0.72 2.07 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.168 2.187 . . . . 0.0 114.442 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -104.17 140.47 21.1 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.408 1.483 . . . . 0.0 110.881 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.54 120.19 6.57 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.613 2.209 . . . . 0.0 110.326 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.74 135.23 42.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.251 1.42 . . . . 0.0 110.155 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.6 p -129.41 147.24 51.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -165.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.46 175.8 13.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.628 1.571 . . . . 0.0 111.636 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.3 m -130.33 142.82 50.51 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.995 1.318 . . . . 0.0 110.839 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -113.04 132.82 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.862 1.665 . . . . 0.0 108.135 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.73 129.86 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.214 1.006 . . . . 0.0 110.393 173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.7 p -132.92 2.29 3.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.42 1.488 . . . . 0.0 113.859 -166.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -50.22 -38.16 38.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.484 1.913 . . . . 0.0 115.346 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -128.88 20.47 5.96 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.439 1.496 . . . . 0.0 112.387 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.58 64.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.16 146.7 7.63 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.171 1.367 . . . . 0.0 113.039 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -75.88 148.06 38.58 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.423 1.089 . . . . 0.0 111.968 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.24 -30.1 0.17 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.692 1.139 . . . . 0.0 114.531 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.41 112.66 0.87 Allowed Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.511 1.529 . . . . 0.0 112.82 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.08 128.9 34.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.369 1.468 . . . . 0.0 109.209 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 37.2 m -126.95 156.04 42.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.996 1.718 . . . . 0.0 111.781 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.8 134.94 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.656 1.582 . . . . 0.0 109.103 -169.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.14 35.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.015 0.926 . . . . 0.0 112.275 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.24 139.31 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.874 1.27 . . . . 0.0 109.934 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.86 129.47 38.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.294 1.438 . . . . 0.0 110.095 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.52 -159.77 9.54 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.83 -0.984 . . . . 0.0 114.342 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.41 -23.08 71.56 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.101 3.201 . . . . 0.0 112.757 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.9 t -146.29 161.34 40.51 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.266 1.426 . . . . 0.0 109.542 163.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.74 113.63 8.02 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.002 -1.061 . . . . 0.0 111.078 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.15 147.9 49.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.73 0.812 . . . . 0.0 111.389 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.44 139.16 30.8 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.297 0.639 . . . . 0.0 109.532 168.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 28.7 mt -130.98 138.55 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.565 1.146 . . . . 0.0 110.325 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.5 m -129.79 152.65 49.05 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.737 1.615 . . . . 0.0 110.473 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -151.88 151.39 31.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.079 0.951 . . . . 0.0 112.332 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.5 m -140.9 116.44 10.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.205 1.402 . . . . 0.0 110.114 -169.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -72.26 135.63 46.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.161 0.985 . . . . 0.0 111.04 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -112.34 150.65 30.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.476 1.51 . . . . 0.0 111.863 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -72.75 -12.01 60.84 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.68 1.28 52.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.209 1.403 . . . . 0.0 114.553 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.53 30.9 8.68 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.523 1.059 . . . . 0.0 114.218 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 40.7 p -133.76 170.92 14.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.854 1.262 . . . . 0.0 111.703 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 53.5 t -130.57 130.85 44.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.496 1.919 . . . . 0.0 108.724 165.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.0 t -94.1 147.78 22.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.284 1.034 . . . . 0.0 110.935 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -126.97 143.57 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.81 1.644 . . . . 0.0 109.981 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -139.89 139.19 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.515 1.526 . . . . 0.0 110.603 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -144.91 151.74 39.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.7 mt -113.8 101.99 54.37 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.033 1.733 . . . . 0.0 110.288 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.46 164.8 23.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.442 2.762 . . . . 0.0 110.058 166.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.6 m -136.41 -22.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 92.1 mt -117.98 147.86 42.21 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.033 1.333 . . . . 0.0 110.234 170.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.96 155.39 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.656 2.238 . . . . 0.0 110.759 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.97 -165.65 23.41 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.684 1.135 . . . . 0.0 113.295 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.6 137.59 32.25 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.806 1.242 . . . . 0.0 112.973 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.74 124.8 40.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.797 1.639 . . . . 0.0 109.93 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -84.18 129.43 34.89 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.994 -1.066 . . . . 0.0 110.714 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.92 130.47 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.625 1.57 . . . . 0.0 108.127 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.8 tt -111.66 132.19 54.77 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.438 1.495 . . . . 0.0 109.613 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -134.46 128.12 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 172.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.5 141.09 23.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 111.433 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.09 121.75 15.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.43 1.092 . . . . 0.0 110.062 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.8 57.76 3.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.322 1.449 . . . . 0.0 111.496 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.1 pt-20 56.34 19.92 4.33 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.305 2.642 . . . . 0.0 116.172 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.48 128.65 37.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.719 1.207 . . . . 0.0 110.989 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.32 150.85 42.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.741 0.816 . . . . 0.0 112.237 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 7.9 m -67.12 154.19 93.13 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.039 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -52.68 -31.69 51.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.984 3.123 . . . . 0.0 116.29 -170.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.36 -4.6 59.53 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -84.33 143.29 41.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.153 1.477 . . . . 0.0 112.33 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.75 140.98 70.34 Favored 'Cis proline' 0 C--N 1.352 0.719 0 CA-C-N 119.106 0.717 . . . . 0.0 112.169 -4.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.35 172.86 8.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.193 1.797 . . . . 0.0 110.491 173.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.7 m -136.7 119.04 15.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.712 0.805 . . . . 0.0 110.567 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.91 158.57 16.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.214 1.406 . . . . 0.0 111.082 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -120.84 127.88 52.32 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.198 0.999 . . . . 0.0 110.287 169.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.8 t -107.17 132.74 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.759 -172.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 56.7 m -101.21 155.32 18.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.311 1.844 . . . . 0.0 111.612 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.55 138.35 23.05 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.709 1.147 . . . . 0.0 112.119 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.62 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -59.86 116.63 17.83 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.446 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.31 154.81 32.36 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.736 2.291 . . . . 0.0 111.025 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.3 t80 -100.9 128.97 46.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.236 0.541 . . . . 0.0 110.411 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -156.25 148.28 23.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.819 1.648 . . . . 0.0 110.836 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.09 152.89 17.57 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.126 1.37 . . . . 0.0 110.632 -174.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.3 p -125.8 133.15 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.201 1.4 . . . . 0.0 109.483 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 73.7 mt -132.15 135.33 26.31 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.901 1.68 . . . . 0.0 109.163 -167.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.57 112.74 3.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.995 2.463 . . . . 0.0 109.868 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.0 t80 -177.2 150.28 0.72 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.175 2.19 . . . . 0.0 109.435 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.4 m -132.1 128.72 38.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.381 1.072 . . . . 0.0 109.77 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.23 118.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.811 0.844 . . . . 0.0 109.834 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.0 pttt -90.95 -146.13 0.19 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.772 1.629 . . . . 0.0 112.393 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -72.84 -12.62 61.05 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.09 -149.04 19.67 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.86 1.695 . . . . 0.0 113.032 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.94 156.17 44.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 111.345 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.52 138.28 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 111.381 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.7 p -149.19 163.73 36.79 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.114 1.766 . . . . 0.0 110.76 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.56 -174.43 15.83 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.72 136.87 14.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.256 1.823 . . . . 0.0 108.915 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.01 134.19 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.748 1.619 . . . . 0.0 107.94 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -118.61 130.68 56.01 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.187 0.995 . . . . 0.0 111.207 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -96.52 152.23 38.49 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.069 1.748 . . . . 0.0 111.665 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.31 -21.89 26.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.378 2.719 . . . . 0.0 113.014 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.5 p -80.51 2.18 26.42 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.712 1.605 . . . . 0.0 114.5 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.36 54.15 2.62 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.515 1.055 . . . . 0.0 113.233 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -156.4 166.97 31.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.052 1.741 . . . . 0.0 111.681 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.6 159.25 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.587 1.155 . . . . 0.0 113.068 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.04 -178.65 7.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.802 2.441 . . . . 0.0 109.757 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.55 145.5 53.35 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 120.612 -1.305 . . . . 0.0 112.562 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.64 173.4 6.28 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.551 3.501 . . . . 0.0 111.696 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.0 m -108.75 136.18 48.75 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.524 1.53 . . . . 0.0 108.835 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.08 134.44 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.092 1.357 . . . . 0.0 109.187 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -136.11 121.83 19.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.539 1.535 . . . . 0.0 109.743 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.14 128.0 33.64 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.601 0.76 . . . . 0.0 110.617 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.63 -7.56 59.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 39.5 tttm 74.36 -5.24 2.13 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.437 2.695 . . . . 0.0 113.723 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -94.57 1.41 55.64 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.944 2.098 . . . . 0.0 113.329 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.2 16.37 32.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.108 1.337 . . . . 0.0 114.379 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.08 155.27 45.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.041 1.737 . . . . 0.0 110.608 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -113.6 135.95 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.98 0.912 . . . . 0.0 109.979 165.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.5 m -92.06 138.08 31.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.445 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.6 t -127.34 136.03 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.201 1.4 . . . . 0.0 109.026 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -141.58 155.02 45.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.811 1.244 . . . . 0.0 112.692 -174.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 31.6 t80 -154.41 133.17 12.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.522 1.529 . . . . 0.0 111.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -81.88 127.55 71.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.408 1.083 . . . . 0.0 111.214 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.09 175.03 10.79 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.835 3.024 . . . . 0.0 112.231 -173.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 19.0 t -162.89 -38.09 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.16 0.984 . . . . 0.0 113.227 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -135.0 150.78 50.39 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.828 1.651 . . . . 0.0 110.331 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -85.64 172.28 11.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 0.0 113.524 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.99 -170.49 13.34 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 126.121 1.819 . . . . 0.0 113.72 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.4 tp -81.32 131.02 35.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 110.43 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 59.5 m80 -128.69 163.5 24.97 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.065 1.746 . . . . 0.0 111.101 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -142.43 157.54 44.66 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.162 0.985 . . . . 0.0 111.266 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 67.0 ttp -141.16 123.87 16.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.388 1.075 . . . . 0.0 111.845 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -85.91 139.75 30.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.335 1.854 . . . . 0.0 110.373 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.17 128.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.295 1.438 . . . . 0.0 108.199 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 138.05 30.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -104.03 123.91 48.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.914 2.086 . . . . 0.0 110.336 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.91 34.34 13.38 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.47 1.108 . . . . 0.0 112.586 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 36.2 t30 78.66 2.3 2.56 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 128.519 2.727 . . . . 0.0 114.942 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.5 129.81 54.39 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.723 1.609 . . . . 0.0 111.035 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.06 139.09 35.91 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.85 147.43 97.86 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.925 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.62 120.25 7.59 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.532 2.155 . . . . 0.0 111.722 -165.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -8.96 72.37 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.338 1.447 . . . . 0.0 115.157 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 12.8 m -74.58 157.79 85.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 120.047 1.923 . . . . 0.0 112.359 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.87 161.48 91.45 Favored 'Cis proline' 0 C--N 1.355 0.881 0 CA-C-N 119.844 0.98 . . . . 0.0 113.999 5.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.47 162.11 13.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.885 1.674 . . . . 0.0 110.905 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -142.3 138.98 31.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.729 1.211 . . . . 0.0 110.503 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.47 167.74 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.751 1.221 . . . . 0.0 112.146 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 18.5 t80 -110.29 141.57 43.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.996 0.918 . . . . 0.0 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.4 t -112.04 138.08 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.946 1.698 . . . . 0.0 108.469 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t0 -156.4 151.62 26.51 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -75.61 95.89 3.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.283 1.433 . . . . 0.0 111.522 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 16.3 m -58.47 -23.1 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.293 1.437 . . . . 0.0 114.447 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.69 -13.68 44.74 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 97.9 m -75.92 156.67 34.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.211 1.004 . . . . 0.0 113.25 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.19 77.82 2.06 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.227 1.394 . . . . 0.0 112.35 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -163.9 154.71 15.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.099 1.759 . . . . 0.0 112.356 173.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.7 p -73.35 135.3 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.283 1.033 . . . . 0.0 110.434 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 5.9 t -152.78 171.37 18.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.572 1.149 . . . . 0.0 111.682 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -153.68 150.39 28.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.531 1.133 . . . . 0.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.68 164.81 6.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.052 1.741 . . . . 0.0 112.93 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.55 173.16 12.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.34 1.448 . . . . 0.0 113.167 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.55 -34.75 18.99 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.082 2.521 . . . . 0.0 112.762 -172.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.18 -33.5 85.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.895 0.77 . . . . 0.0 114.373 -172.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.22 0.13 38.03 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.744 1.272 . . . . 0.0 113.878 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.7 m -107.04 -38.85 5.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.414 1.886 . . . . 0.0 111.536 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -157.76 146.58 19.43 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.127 1.371 . . . . 0.0 112.993 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 -173.89 21.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.874 1.702 . . . . 0.0 112.852 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.7 p -150.89 138.61 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.981 1.312 . . . . 0.0 109.245 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.9 m -57.64 141.36 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 27.5 m120 69.53 -5.29 1.19 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.131 2.173 . . . . 0.0 114.728 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -102.18 144.29 28.3 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.338 1.455 . . . . 0.0 111.045 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.24 130.56 15.37 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.566 2.178 . . . . 0.0 110.625 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.91 147.05 32.78 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.548 . . . . 0.0 110.437 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.7 p -136.84 147.3 46.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -160.03 176.05 12.28 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.291 1.836 . . . . 0.0 110.936 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 82.8 m -134.01 136.75 44.28 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.152 0.981 . . . . 0.0 111.097 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 20.5 t -98.08 132.22 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.55 . . . . 0.0 107.752 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -98.66 116.74 31.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 109.753 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -121.3 8.69 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.685 1.994 . . . . 0.0 113.007 -166.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -52.75 -38.35 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.73 1.612 . . . . 0.0 113.786 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -92.39 -12.47 32.15 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.109 1.364 . . . . 0.0 113.637 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.23 68.32 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.168 0.987 . . . . 0.0 112.975 -172.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 76.76 -76.26 1.59 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.229 1.395 . . . . 0.0 113.848 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -163.46 150.15 12.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.395 1.878 . . . . 0.0 110.078 -171.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 133.39 -2.48 4.61 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.965 1.269 . . . . 0.0 115.085 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 99.81 117.66 4.04 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.73 1.634 . . . . 0.0 113.48 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 129.22 34.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.809 1.644 . . . . 0.0 109.247 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -121.4 153.05 38.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.411 1.485 . . . . 0.0 111.575 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.9 tp -159.83 134.8 7.96 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.356 1.462 . . . . 0.0 109.464 -170.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.29 161.3 37.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.338 1.055 . . . . 0.0 112.08 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.6 mt -137.4 132.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.622 1.169 . . . . 0.0 109.433 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -121.72 112.66 18.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.238 1.415 . . . . 0.0 109.684 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.26 12.92 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.23 -22.12 54.03 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.936 . . . . 0.0 111.998 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.4 t -135.29 157.86 45.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.237 1.415 . . . . 0.0 109.132 157.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -75.62 119.28 19.45 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.914 -1.116 . . . . 0.0 111.38 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.07 148.79 43.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.232 1.013 . . . . 0.0 111.7 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.67 139.91 32.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.235 0.614 . . . . 0.0 109.587 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.35 143.35 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.443 1.097 . . . . 0.0 110.362 -168.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.0 t -143.43 160.78 39.94 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.031 1.332 . . . . 0.0 110.846 167.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -157.42 155.28 30.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.334 1.054 . . . . 0.0 112.979 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -138.65 117.01 11.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.6 1.56 . . . . 0.0 110.198 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -74.83 136.37 41.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.077 1.351 . . . . 0.0 111.471 172.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -117.47 146.83 43.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.539 1.536 . . . . 0.0 112.016 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -68.16 -13.22 62.06 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.09 -5.1 45.01 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.652 1.581 . . . . 0.0 113.982 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.32 30.11 8.97 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.754 1.169 . . . . 0.0 113.858 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.2 p -137.44 165.0 27.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.299 1.44 . . . . 0.0 111.484 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -127.68 122.57 33.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.663 1.585 . . . . 0.0 108.796 164.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -87.51 145.87 26.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.959 0.903 . . . . 0.0 110.592 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.4 t -125.85 141.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.578 1.551 . . . . 0.0 110.321 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 67.3 m -130.96 140.71 50.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.884 1.673 . . . . 0.0 110.632 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -146.24 151.73 38.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.72 105.62 40.68 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.686 1.994 . . . . 0.0 110.494 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -86.62 160.3 9.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.043 3.162 . . . . 0.0 110.7 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -119.98 -21.82 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -169.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.52 149.32 36.83 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.857 1.263 . . . . 0.0 110.587 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.97 153.64 37.42 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.88 2.387 . . . . 0.0 112.432 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.67 -167.72 27.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.095 1.331 . . . . 0.0 113.393 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -91.08 128.56 36.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.013 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -118.77 127.35 53.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.678 1.591 . . . . 0.0 109.805 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.11 121.31 30.37 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.86 0.864 . . . . 0.0 110.448 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.27 127.21 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.19 1.396 . . . . 0.0 108.111 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.91 130.37 55.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.278 1.431 . . . . 0.0 109.5 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.1 t -132.99 129.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.276 1.03 . . . . 0.0 109.457 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 147.51 26.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 111.418 -166.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 2.2 t80 -140.9 126.14 18.55 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.794 1.238 . . . . 0.0 110.279 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.1 t-20 45.07 58.9 3.76 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.117 1.367 . . . . 0.0 113.245 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.311 7.9 pt-20 60.02 13.8 3.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.107 2.563 . . . . 0.0 116.596 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -125.65 128.46 47.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.48 1.112 . . . . 0.0 111.352 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.84 151.55 45.19 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.055 -1.028 . . . . 0.0 112.716 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 29.1 m -65.48 152.05 93.12 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.65 163.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.37 -20.04 66.03 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.476 2.117 . . . . 0.0 114.84 -167.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -94.46 -6.58 61.05 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -86.64 143.83 36.49 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 119.049 1.424 . . . . 0.0 112.33 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.74 141.29 71.33 Favored 'Cis proline' 0 C--N 1.354 0.819 0 CA-C-N 119.117 0.72 . . . . 0.0 112.064 -4.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -92.68 166.8 12.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.966 1.706 . . . . 0.0 110.041 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.7 m -131.75 119.71 21.68 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.536 0.734 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -103.16 137.53 41.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.949 1.3 . . . . 0.0 111.737 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -86.05 117.29 24.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.5 t -92.42 130.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.101 0.96 . . . . 0.0 109.207 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.1 m -105.13 159.92 15.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.756 1.623 . . . . 0.0 110.644 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.9 138.22 23.38 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.119 0.866 . . . . 0.0 111.969 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 125.221 1.408 . . . . 0.0 113.584 -174.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 30.0 tp . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -60.27 118.27 31.84 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.119 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.42 159.5 46.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.277 2.651 . . . . 0.0 111.318 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.01 123.23 36.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.429 0.692 . . . . 0.0 109.225 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.17 130.46 16.57 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.331 1.453 . . . . 0.0 109.956 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.39 141.53 27.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.266 1.426 . . . . 0.0 109.931 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -118.79 137.76 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.96 137.49 25.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.331 1.853 . . . . 0.0 108.738 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.48 37.99 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.386 3.39 . . . . 0.0 113.526 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.38 161.32 17.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.54 1.536 . . . . 0.0 110.499 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 87.6 m -133.42 130.2 38.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.019 1.327 . . . . 0.0 109.688 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 115.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.362 1.065 . . . . 0.0 110.304 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -92.94 -163.27 1.02 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.218 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.0 pttp -71.91 132.52 44.47 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.806 -1.184 . . . . 0.0 112.052 169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.53 -141.7 12.29 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.319 1.438 . . . . 0.0 111.631 -167.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.31 143.74 18.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.853 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.6 tt -134.68 136.48 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.292 1.837 . . . . 0.0 110.367 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 33.4 p -145.6 165.27 29.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.603 1.561 . . . . 0.0 110.849 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.65 176.46 29.22 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -151.94 138.17 18.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.128 1.771 . . . . 0.0 109.644 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.2 t -111.79 134.46 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.241 1.816 . . . . 0.0 108.651 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -113.7 123.16 49.23 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.862 1.665 . . . . 0.0 110.209 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.8 mtm -98.05 146.64 31.84 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.703 1.601 . . . . 0.0 111.466 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.28 -16.21 28.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.799 2.999 . . . . 0.0 113.144 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.7 p -74.42 0.28 15.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.806 1.642 . . . . 0.0 114.197 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.39 42.38 5.53 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.722 1.153 . . . . 0.0 113.538 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -152.66 169.26 23.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.392 1.477 . . . . 0.0 112.525 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.0 m -139.22 159.25 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.899 1.28 . . . . 0.0 112.848 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.8 171.26 19.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.078 2.151 . . . . 0.0 110.257 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -110.55 142.36 25.92 Favored Pre-proline 0 CA--C 1.547 0.831 0 O-C-N 121.103 -0.998 . . . . 0.0 112.344 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.22 175.87 3.91 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.57 3.513 . . . . 0.0 112.385 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.1 m -108.02 130.24 55.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.444 1.498 . . . . 0.0 108.963 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.84 131.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.149 1.379 . . . . 0.0 108.676 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.4 m -132.94 130.36 39.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.373 1.469 . . . . 0.0 110.05 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -82.45 126.46 32.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.164 0.586 . . . . 0.0 110.106 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -80.59 -7.6 59.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.2 mttp 71.77 7.4 5.9 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.592 2.357 . . . . 0.0 113.606 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.07 7.59 23.62 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.345 2.258 . . . . 0.0 112.597 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 19.35 35.55 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.974 1.274 . . . . 0.0 114.317 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.8 p -134.23 158.19 44.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.105 1.762 . . . . 0.0 110.267 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 27.2 m -116.13 148.1 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.568 1.147 . . . . 0.0 110.13 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 50.6 m -113.99 136.48 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 41.7 t -119.91 134.8 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.202 1.401 . . . . 0.0 108.925 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.21 154.96 50.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.896 1.279 . . . . 0.0 113.16 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.5 t80 -153.77 136.89 15.57 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.565 1.546 . . . . 0.0 111.927 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.2 117.26 67.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.023 1.329 . . . . 0.0 110.804 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.36 156.02 16.69 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.96 3.106 . . . . 0.0 112.656 -172.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.4 m -118.29 -18.39 9.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -163.66 155.12 16.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.665 1.586 . . . . 0.0 110.572 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -69.07 168.49 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.576 1.15 . . . . 0.0 113.531 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.06 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.598 1.571 . . . . 0.0 114.138 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.5 tp -79.09 129.61 34.64 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.744 1.218 . . . . 0.0 110.677 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.8 m80 -130.27 162.0 29.96 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.587 1.555 . . . . 0.0 111.373 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.71 156.15 41.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 111.786 172.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -138.92 126.85 22.31 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.112 1.765 . . . . 0.0 109.956 -168.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.46 122.4 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.335 1.454 . . . . 0.0 109.389 175.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 42.8 mm -120.89 135.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.129 1.372 . . . . 0.0 109.805 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.78 137.72 20.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.6 t80 -99.3 123.27 43.45 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.823 2.049 . . . . 0.0 109.857 175.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.15 33.42 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.785 1.234 . . . . 0.0 112.729 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 22.6 t30 75.77 5.94 3.89 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 128.123 2.569 . . . . 0.0 115.109 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.36 131.62 51.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.806 1.643 . . . . 0.0 110.884 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m170 -56.8 134.09 54.83 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.057 -1.027 . . . . 0.0 113.213 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.33 155.86 89.49 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.402 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.85 125.87 19.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.367 2.045 . . . . 0.0 109.761 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.69 53.54 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.725 1.155 . . . . 0.0 114.344 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.7 t -84.6 148.06 50.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.054 1.427 . . . . 0.0 111.919 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.38 159.99 94.35 Favored 'Cis proline' 0 C--N 1.352 0.72 0 CA-C-N 119.936 1.013 . . . . 0.0 112.062 -7.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.36 152.19 20.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.401 1.48 . . . . 0.0 110.523 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -151.43 134.41 15.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.469 1.108 . . . . 0.0 110.259 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.91 165.05 18.43 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.373 1.069 . . . . 0.0 112.504 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 44.2 t80 -103.19 139.76 38.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.168 0.987 . . . . 0.0 112.154 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 78.1 t -105.34 140.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.195 1.798 . . . . 0.0 109.24 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.4 t0 -156.41 149.12 23.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.087 1.355 . . . . 0.0 111.455 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.99 147.18 51.99 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.462 -0.774 . . . . 0.0 112.44 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 95.0 t -72.0 -29.04 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.071 0.948 . . . . 0.0 111.383 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -80.73 -7.7 59.44 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.6 m -58.52 137.44 57.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.481 1.113 . . . . 0.0 113.386 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.2 -19.87 40.8 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.951 1.263 . . . . 0.0 114.086 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.68 158.91 31.15 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.267 1.033 . . . . 0.0 113.457 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.9 p -62.49 138.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 110.176 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.0 t -159.67 156.68 28.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.17 1.388 . . . . 0.0 110.653 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.25 145.7 47.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.581 1.152 . . . . 0.0 112.65 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.3 p90 -168.17 157.1 9.18 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.881 1.673 . . . . 0.0 113.233 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 147.62 173.65 18.86 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.092 1.329 . . . . 0.0 113.985 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.82 -38.84 12.61 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.27 2.647 . . . . 0.0 112.468 -173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.19 -18.46 74.91 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.017 0.826 . . . . 0.0 114.099 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 15.7 tp -82.25 -11.21 58.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.562 1.145 . . . . 0.0 112.55 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.1 m -116.59 -40.06 3.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.415 1.886 . . . . 0.0 111.776 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -136.25 169.84 16.99 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.956 2.502 . . . . 0.0 111.489 -172.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -168.29 173.2 43.06 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 121.046 -1.034 . . . . 0.0 113.215 164.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 64.7 t -136.9 130.65 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.728 1.211 . . . . 0.0 108.622 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.7 m -57.16 142.61 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.0 m-80 67.12 2.07 2.62 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.804 2.042 . . . . 0.0 114.606 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 93.7 mttt -118.79 141.6 30.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.791 1.636 . . . . 0.0 111.017 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.95 136.63 30.29 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.659 2.24 . . . . 0.0 110.853 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.74 146.48 42.77 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.1 p -135.58 150.37 49.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.124 0.97 . . . . 0.0 113.462 -164.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.5 p90 -160.69 176.9 11.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.672 1.589 . . . . 0.0 111.661 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 39.7 m -130.19 143.89 51.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.232 1.413 . . . . 0.0 110.552 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.8 t -116.81 126.16 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 108.088 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.01 126.7 34.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.106 0.962 . . . . 0.0 110.696 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.3 p -134.32 4.49 3.44 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.092 1.357 . . . . 0.0 113.769 -167.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.2 tttp -54.96 -36.52 65.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.791 1.636 . . . . 0.0 114.789 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.19 14.17 10.49 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.815 1.646 . . . . 0.0 112.516 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -78.66 -11.53 59.98 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.93 -130.86 10.06 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.514 1.054 . . . . 0.0 112.267 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -160.95 161.55 31.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.037 1.735 . . . . 0.0 110.238 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 147.38 -14.28 1.43 Allowed Glycine 0 N--CA 1.475 1.29 0 C-N-CA 125.104 1.335 . . . . 0.0 115.284 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.45 105.73 0.92 Allowed Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.836 1.684 . . . . 0.0 112.482 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.02 125.98 32.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.11 1.364 . . . . 0.0 108.874 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.9 m -124.13 159.69 29.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.879 1.671 . . . . 0.0 112.118 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.7 tp -159.07 137.4 10.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.794 1.637 . . . . 0.0 109.404 -170.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.81 156.37 34.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.372 1.069 . . . . 0.0 111.935 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.75 135.52 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.534 1.134 . . . . 0.0 109.795 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.12 127.67 43.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.419 1.488 . . . . 0.0 109.787 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -153.15 -165.12 13.12 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.132 -0.816 . . . . 0.0 114.499 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.09 -24.15 66.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.087 3.191 . . . . 0.0 112.664 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.7 t -140.27 153.25 46.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.007 1.323 . . . . 0.0 109.739 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -72.56 117.17 13.91 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.167 -0.958 . . . . 0.0 111.049 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.81 153.16 37.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.481 1.112 . . . . 0.0 112.133 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.27 141.65 28.51 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 161.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.5 mt -138.37 138.54 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.758 1.223 . . . . 0.0 110.011 -163.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 65.1 m -137.98 158.1 45.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.515 1.526 . . . . 0.0 111.147 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.1 p -154.33 155.03 34.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 75.6 m -143.67 122.69 12.82 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.179 1.392 . . . . 0.0 110.66 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.94 113.61 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 165.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 27.6 p30 -83.53 -7.46 59.52 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 71.5 0.36 3.44 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -88.22 -11.09 47.66 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.326 1.45 . . . . 0.0 113.137 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 132.79 1.74 4.07 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.452 1.501 . . . . 0.0 115.661 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 64.4 p -137.27 156.66 48.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.231 1.516 . . . . 0.0 112.143 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 79.7 m -104.21 128.14 51.9 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.344 1.458 . . . . 0.0 109.115 165.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.8 t -91.48 151.89 20.59 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.126 0.97 . . . . 0.0 110.763 172.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.1 t -132.33 144.54 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.765 1.626 . . . . 0.0 110.041 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 76.0 p -140.98 148.08 39.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.809 1.243 . . . . 0.0 112.236 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.9 p90 -152.51 156.72 39.95 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.16 -0.963 . . . . 0.0 113.212 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.15 106.18 43.53 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.117 1.367 . . . . 0.0 110.871 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -82.6 174.45 9.67 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.976 3.117 . . . . 0.0 110.884 168.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -150.24 -30.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.1 mt -105.99 146.96 33.93 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.502 1.046 . . . . 0.0 110.393 166.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.22 157.37 41.89 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.874 2.383 . . . . 0.0 110.946 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.85 -162.39 24.18 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.778 1.18 . . . . 0.0 113.621 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.49 125.92 35.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.187 1.395 . . . . 0.0 112.303 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -113.84 126.38 55.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.374 1.47 . . . . 0.0 109.203 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.2 m -89.45 127.7 35.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.147 0.979 . . . . 0.0 110.734 175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.9 128.11 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.841 1.257 . . . . 0.0 108.943 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.71 129.93 53.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.661 1.584 . . . . 0.0 109.361 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.0 t -130.19 132.44 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.536 1.134 . . . . 0.0 109.221 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.95 140.7 20.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.326 1.45 . . . . 0.0 111.357 -168.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 117.8 15.32 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.441 1.096 . . . . 0.0 110.017 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 50.7 t-20 56.61 63.6 1.91 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.686 1.594 . . . . 0.0 111.774 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.281 9.2 pt-20 55.63 18.68 2.91 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.234 2.613 . . . . 0.0 116.423 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -132.81 129.04 38.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.782 1.233 . . . . 0.0 110.922 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.4 m170 -64.17 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.917 0.887 . . . . 0.0 112.354 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.7 m -70.87 152.81 95.02 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.437 169.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.28 133.62 41.41 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.643 2.228 . . . . 0.0 111.224 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.58 63.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.899 1.237 . . . . 0.0 114.928 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.3 t -81.08 144.33 54.47 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.009 1.405 . . . . 0.0 111.68 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.43 140.34 64.32 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.014 1.041 . . . . 0.0 112.682 -1.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -95.05 175.81 6.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.595 1.958 . . . . 0.0 110.958 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -135.26 127.01 29.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.103 0.961 . . . . 0.0 110.687 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -106.69 140.55 39.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.684 . . . . 0.0 110.981 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.16 108.46 21.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.115 0.966 . . . . 0.0 110.178 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 87.8 t -90.84 143.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.917 1.287 . . . . 0.0 110.135 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.5 t -131.1 172.26 12.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.487 1.115 . . . . 0.0 112.767 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.42 142.8 26.39 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.746 1.641 . . . . 0.0 112.739 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 124.435 1.094 . . . . 0.0 113.198 177.674 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 120.935 0.398 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 121.64 68.6 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.852 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.27 156.18 51.04 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.144 2.563 . . . . 0.0 111.002 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1791 ' ' PHE . . . . . 0.478 ' CE2' ' HE1' ' A' 1842 ' ' MET . 1.4 t80 -116.05 122.13 44.28 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.389 0.676 . . . . 0.0 110.966 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -148.69 151.87 35.67 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.743 1.617 . . . . 0.0 110.618 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 151.84 24.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.575 1.55 . . . . 0.0 109.949 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -125.95 133.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.927 1.291 . . . . 0.0 109.43 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.81 137.17 30.19 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.037 1.735 . . . . 0.0 108.673 -171.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.94 49.48 3.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.658 3.572 . . . . 0.0 112.827 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.3 t80 -93.91 153.0 18.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.463 1.505 . . . . 0.0 110.625 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 127.31 47.19 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.92 1.288 . . . . 0.0 110.217 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.6 mt -92.61 136.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.042 1.337 . . . . 0.0 109.203 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.9 tptt -129.04 -60.22 1.09 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.151 0.98 . . . . 0.0 112.49 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -159.15 131.06 6.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.316 1.846 . . . . 0.0 110.388 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.65 -146.82 16.54 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.292 1.425 . . . . 0.0 111.384 -166.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -157.7 144.84 18.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.577 1.151 . . . . 0.0 110.914 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.85 136.15 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.57 1.548 . . . . 0.0 110.864 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.8 p -148.0 174.4 11.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.165 1.786 . . . . 0.0 110.525 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.64 -171.31 27.53 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.83 146.07 23.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.571 1.949 . . . . 0.0 109.603 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 21.5 t -123.25 138.43 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.331 1.852 . . . . 0.0 108.351 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 68.7 mtm-85 -127.61 142.19 51.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.897 0.879 . . . . 0.0 112.037 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 5.3 mpp? -118.6 148.66 44.68 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.596 1.558 . . . . 0.0 111.936 -173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.01 -29.57 89.6 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.121 3.214 . . . . 0.0 114.886 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 12.5 m -72.93 3.32 5.44 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.88 42.14 6.47 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.556 1.074 . . . . 0.0 112.833 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -148.16 158.26 43.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.842 1.657 . . . . 0.0 111.854 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.9 m -143.21 162.52 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.108 1.363 . . . . 0.0 112.035 -171.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.58 -179.44 8.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.706 2.003 . . . . 0.0 110.923 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -128.96 147.73 65.99 Favored Pre-proline 0 CA--C 1.544 0.74 0 O-C-N 121.185 -0.947 . . . . 0.0 111.601 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -86.94 173.89 5.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.229 3.286 . . . . 0.0 112.191 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.0 m -110.39 135.47 51.05 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.458 1.503 . . . . 0.0 108.75 170.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.6 131.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.954 1.302 . . . . 0.0 108.693 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 89.4 m -132.66 126.85 33.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.475 1.51 . . . . 0.0 109.306 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.8 136.11 40.24 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.021 0.528 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -88.21 -12.69 43.06 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 56.7 tttt 70.63 6.07 5.67 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.219 2.208 . . . . 0.0 113.708 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -105.87 11.15 32.14 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.208 2.203 . . . . 0.0 112.751 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.78 16.15 52.56 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.889 1.233 . . . . 0.0 113.964 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 40.1 p -134.41 158.93 42.61 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 110.622 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.0 m -122.87 143.47 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.794 1.238 . . . . 0.0 110.084 168.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 35.0 m -98.47 138.09 36.2 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.351 1.46 . . . . 0.0 108.831 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 46.1 t -125.13 134.97 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.741 1.617 . . . . 0.0 108.824 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -140.8 156.58 46.12 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.894 1.277 . . . . 0.0 112.594 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 23.2 t80 -153.77 133.11 12.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.732 1.613 . . . . 0.0 111.216 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.19 119.83 73.78 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.4 1.08 . . . . 0.0 110.493 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.67 134.64 15.31 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.238 2.625 . . . . 0.0 111.691 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.2 m -131.73 8.06 4.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.558 1.143 . . . . 0.0 113.12 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -160.18 155.84 25.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.047 1.739 . . . . 0.0 109.912 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.63 175.95 6.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.315 1.046 . . . . 0.0 112.563 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 98.14 -170.4 24.79 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.297 1.427 . . . . 0.0 114.199 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 44.8 tp -76.87 121.85 24.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.924 1.289 . . . . 0.0 110.243 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 12.8 m80 -111.96 164.35 13.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.78 1.632 . . . . 0.0 110.863 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.56 149.79 35.22 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.669 -0.645 . . . . 0.0 111.954 162.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1842 ' ' MET . . . . . 0.478 ' HE1' ' CE2' ' A' 1791 ' ' PHE . 42.4 ttm -121.36 139.82 52.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.614 1.966 . . . . 0.0 110.121 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.73 134.55 52.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.318 1.447 . . . . 0.0 109.808 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.39 136.42 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.811 1.644 . . . . 0.0 109.433 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 141.07 28.36 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.094 0.958 . . . . 0.0 113.53 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.4 t80 -107.3 122.5 46.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.389 2.276 . . . . 0.0 109.65 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 31.71 10.12 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.56 1.144 . . . . 0.0 112.432 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.0 t30 76.05 5.17 3.79 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.333 2.653 . . . . 0.0 115.071 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.6 mtm -102.44 132.27 48.57 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.526 1.531 . . . . 0.0 110.83 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 12.0 m170 -57.37 136.67 56.61 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 113.142 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 25.5 pt -77.45 153.06 81.52 Favored Pre-proline 0 N--CA 1.48 1.03 0 O-C-N 121.76 -0.588 . . . . 0.0 111.294 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.28 134.15 50.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.158 1.906 . . . . 0.0 109.671 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.4 -13.69 64.14 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.343 0.973 . . . . 0.0 113.973 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.15 146.7 31.77 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 119.11 1.455 . . . . 0.0 111.179 173.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.23 160.67 95.4 Favored 'Cis proline' 0 C--N 1.353 0.802 0 CA-C-N 120.688 1.282 . . . . 0.0 113.455 2.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 75.8 mt -112.06 133.68 54.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.786 2.034 . . . . 0.0 109.054 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -130.16 134.4 47.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.261 1.024 . . . . 0.0 110.575 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -163.12 162.67 25.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.05 0.94 . . . . 0.0 112.817 -175.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.6 t80 -106.57 144.58 33.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.267 1.027 . . . . 0.0 112.88 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 56.2 t -118.95 138.23 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.34 1.456 . . . . 0.0 110.124 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -155.54 147.95 23.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.361 1.064 . . . . 0.0 112.766 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -63.17 142.63 58.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.34 1.456 . . . . 0.0 112.94 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.7 p -67.27 -23.97 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.5 p30 -75.42 -17.06 60.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.7 m -68.21 143.35 55.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.919 0.888 . . . . 0.0 113.357 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -89.99 -17.14 54.73 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.865 1.221 . . . . 0.0 114.36 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -67.25 163.88 19.52 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.466 1.133 . . . . 0.0 113.283 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 4.5 t -66.53 136.94 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.535 1.134 . . . . 0.0 109.52 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 56.7 p -132.65 162.16 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.456 1.102 . . . . 0.0 110.682 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.55 142.21 28.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.358 1.063 . . . . 0.0 110.969 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.9 p90 -166.01 159.94 16.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.616 1.566 . . . . 0.0 112.362 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.74 170.84 12.69 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.329 1.443 . . . . 0.0 113.159 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.05 -32.77 33.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.29 2.66 . . . . 0.0 112.849 -171.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.75 -13.93 72.31 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.936 -0.924 . . . . 0.0 114.791 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.99 -12.64 60.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.128 1.464 . . . . 0.0 112.966 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 15.5 m -119.38 -38.42 3.02 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.684 1.593 . . . . 0.0 112.431 -165.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -156.11 155.03 31.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.61 -173.75 25.5 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.469 1.033 . . . . 0.0 113.033 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.9 p -150.74 136.45 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.647 1.179 . . . . 0.0 109.286 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.7 m -56.57 140.82 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.59 -4.45 1.65 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.396 2.278 . . . . 0.0 114.924 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.65 143.31 26.43 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.965 1.306 . . . . 0.0 110.867 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.54 127.59 11.89 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.461 2.107 . . . . 0.0 110.723 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.48 148.7 26.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.431 1.492 . . . . 0.0 110.361 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.6 p -137.25 155.07 49.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.1 0.96 . . . . 0.0 113.507 -167.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -164.48 172.84 12.8 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.562 1.945 . . . . 0.0 111.404 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.1 m -128.01 144.23 51.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.691 1.596 . . . . 0.0 110.731 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 46.9 t -120.11 130.52 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.123 1.769 . . . . 0.0 108.454 171.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m120 -87.37 127.82 35.2 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.372 -0.83 . . . . 0.0 111.162 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 50.9 p -131.49 3.35 4.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.352 1.461 . . . . 0.0 113.36 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -55.93 -40.03 72.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.781 1.632 . . . . 0.0 114.328 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.34 4.64 22.8 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.523 1.529 . . . . 0.0 112.896 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.05 -25.92 59.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.349 1.06 . . . . 0.0 113.329 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 -92.47 1.46 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.766 1.174 . . . . 0.0 112.664 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -166.6 179.03 5.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.013 1.725 . . . . 0.0 111.863 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 116.52 5.76 15.96 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.998 1.285 . . . . 0.0 115.477 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.99 105.6 2.16 Favored Glycine 0 N--CA 1.47 0.961 0 C-N-CA 125.503 1.525 . . . . 0.0 113.079 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.23 132.1 34.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 109.179 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -128.26 161.02 30.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.69 1.596 . . . . 0.0 112.142 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.2 tp -159.08 136.55 10.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.699 1.599 . . . . 0.0 109.646 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.67 162.3 37.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.713 1.205 . . . . 0.0 111.776 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 41.2 mt -139.03 132.83 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.404 1.082 . . . . 0.0 109.935 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.29 163.76 14.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.769 1.627 . . . . 0.0 110.083 168.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 167.56 -158.49 31.39 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.179 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.72 -22.2 50.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.686 2.924 . . . . 0.0 112.435 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.3 t -147.11 158.54 43.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 109.499 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.63 112.05 9.35 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.977 -1.077 . . . . 0.0 110.595 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -66.47 150.72 48.53 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.119 0.968 . . . . 0.0 111.739 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.51 137.51 32.27 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.409 0.684 . . . . 0.0 109.315 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 35.1 mt -132.2 143.83 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.443 1.097 . . . . 0.0 110.428 -165.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.41 163.0 35.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 111.301 168.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -157.7 156.76 32.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 112.777 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -138.22 125.26 21.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.907 1.683 . . . . 0.0 110.069 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.34 128.92 33.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 110.862 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -107.98 151.94 25.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.292 1.437 . . . . 0.0 112.434 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -68.87 -16.81 63.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.05 0.94 . . . . 0.0 112.719 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.45 -6.39 48.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.724 1.61 . . . . 0.0 113.968 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.73 33.12 8.61 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.499 1.047 . . . . 0.0 113.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.8 p -136.74 156.77 48.07 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.815 1.246 . . . . 0.0 111.15 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.7 m -102.71 127.6 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.956 0.902 . . . . 0.0 108.903 157.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.8 t -92.21 145.83 24.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.746 0.818 . . . . 0.0 109.796 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.8 t -130.38 143.69 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.129 1.372 . . . . 0.0 109.976 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.1 p -134.08 149.45 51.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.05 1.34 . . . . 0.0 111.919 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.89 152.82 33.07 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 18.8 mt -115.64 105.69 51.43 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.394 1.878 . . . . 0.0 110.207 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.71 170.63 15.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.573 2.849 . . . . 0.0 110.332 167.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -144.99 -28.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -172.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.93 147.89 36.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 110.394 166.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.97 156.22 52.38 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.83 2.353 . . . . 0.0 110.775 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.3 -167.84 23.65 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.98 1.276 . . . . 0.0 113.382 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.6 128.37 39.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.784 1.234 . . . . 0.0 112.262 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -112.47 140.5 47.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.46 1.904 . . . . 0.0 110.496 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.3 m -105.03 111.94 24.89 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.992 1.317 . . . . 0.0 110.229 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.03 122.27 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.023 1.329 . . . . 0.0 108.383 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.25 125.8 47.92 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.572 1.549 . . . . 0.0 109.231 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.1 t -126.71 129.38 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.27 1.028 . . . . 0.0 109.442 171.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.68 142.83 24.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.921 1.288 . . . . 0.0 111.943 -167.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.12 123.67 22.22 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 109.701 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.5 t-20 52.56 57.13 6.72 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.559 1.543 . . . . 0.0 112.541 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.1 pt-20 58.42 12.17 1.94 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.295 2.638 . . . . 0.0 116.286 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.97 125.28 49.04 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.629 1.172 . . . . 0.0 110.779 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.43 143.38 57.15 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.47 -0.769 . . . . 0.0 111.591 172.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.5 m -72.22 152.01 92.37 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.058 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -56.02 125.44 19.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.148 2.566 . . . . 0.0 111.115 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.73 64.33 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.458 1.504 . . . . 0.0 115.316 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 141.56 68.89 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.264 1.532 . . . . 0.0 111.804 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.69 145.54 79.63 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.587 0.888 . . . . 0.0 112.275 -3.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -96.55 139.4 32.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.585 1.554 . . . . 0.0 110.763 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -100.66 107.47 19.11 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.328 0.651 . . . . 0.0 110.63 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.51 125.17 45.22 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.652 1.181 . . . . 0.0 111.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -95.78 116.69 29.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.518 0.727 . . . . 0.0 110.685 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -99.43 133.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.045 1.738 . . . . 0.0 110.678 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 60.2 p -104.12 169.25 8.6 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.296 1.438 . . . . 0.0 112.959 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.83 142.03 25.07 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.946 1.26 . . . . 0.0 111.691 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 . . . . . 0 CA--C 1.549 0.935 0 C-N-CA 124.49 1.116 . . . . 0.0 113.781 -176.838 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 23.3 tp . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -66.42 119.06 59.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.918 -168.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.46 154.59 60.5 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.315 2.676 . . . . 0.0 111.715 -171.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.7 123.25 42.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.786 0.834 . . . . 0.0 110.194 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -153.18 130.2 11.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.446 1.498 . . . . 0.0 110.344 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.71 143.46 30.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.854 1.662 . . . . 0.0 109.83 -172.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.1 p -112.45 138.59 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.057 1.343 . . . . 0.0 110.571 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 70.8 mt -131.53 136.6 28.81 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.412 1.885 . . . . 0.0 108.71 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.66 45.47 1.96 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.503 3.469 . . . . 0.0 112.926 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 75.1 t80 -91.53 155.12 18.62 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.254 1.422 . . . . 0.0 111.462 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 95.7 m -125.43 125.86 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.549 1.54 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.7 134.25 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.346 1.058 . . . . 0.0 110.641 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -113.18 -141.78 0.38 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.845 1.658 . . . . 0.0 110.656 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.2 135.66 33.63 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.91 -1.119 . . . . 0.0 110.956 166.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 132.98 -145.26 17.29 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.511 1.529 . . . . 0.0 111.555 -167.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -158.6 151.47 22.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.464 1.106 . . . . 0.0 111.536 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.0 tt -124.64 135.23 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.763 1.625 . . . . 0.0 111.936 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.08 164.07 34.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.72 1.608 . . . . 0.0 110.978 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.72 -175.75 23.0 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.42 140.59 16.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.556 1.543 . . . . 0.0 110.02 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 16.3 t -111.47 132.91 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.814 1.646 . . . . 0.0 108.171 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.4 mtm105 -119.49 119.3 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.682 1.193 . . . . 0.0 110.226 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 11.3 mtt -95.53 149.24 35.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.781 1.632 . . . . 0.0 111.376 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.17 -20.59 28.2 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.4 2.733 . . . . 0.0 113.672 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.7 p -80.61 4.29 19.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.206 1.402 . . . . 0.0 114.387 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.06 45.11 4.88 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 124.485 1.04 . . . . 0.0 113.367 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.54 166.18 31.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.76 1.624 . . . . 0.0 112.021 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.59 161.37 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.224 1.01 . . . . 0.0 113.217 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.04 -179.26 7.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.063 2.145 . . . . 0.0 110.533 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -120.52 141.74 32.71 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 121.189 -0.944 . . . . 0.0 111.333 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.18 166.88 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.322 3.348 . . . . 0.0 111.343 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.8 m -106.91 128.02 53.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 108.915 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.9 130.43 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.611 1.165 . . . . 0.0 109.075 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 77.1 m -135.07 120.98 19.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.163 1.385 . . . . 0.0 109.321 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.58 141.77 41.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 112.218 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.63 -5.61 48.34 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.19 6.33 4.73 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.34 2.256 . . . . 0.0 113.515 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -107.2 9.51 30.2 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.805 2.042 . . . . 0.0 112.991 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.11 17.12 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.719 1.152 . . . . 0.0 113.608 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 34.9 p -134.86 159.77 40.34 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.316 1.846 . . . . 0.0 110.413 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.9 m -125.34 143.4 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.584 1.154 . . . . 0.0 110.076 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 96.3 m -104.56 135.92 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.432 1.093 . . . . 0.0 108.668 171.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 40.0 t -120.11 132.99 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.208 1.403 . . . . 0.0 108.744 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -133.14 159.17 40.91 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.035 1.334 . . . . 0.0 112.706 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.7 t80 -160.5 136.48 8.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.688 1.595 . . . . 0.0 111.66 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.12 112.03 51.67 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.749 1.219 . . . . 0.0 110.185 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.24 151.36 26.52 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.216 2.611 . . . . 0.0 112.209 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -116.16 -12.71 11.19 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -163.44 150.34 12.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.59 1.556 . . . . 0.0 110.884 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.79 172.48 12.1 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.7 1.2 . . . . 0.0 113.497 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.87 -178.58 17.63 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 125.542 1.544 . . . . 0.0 114.435 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.43 123.22 25.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.924 1.29 . . . . 0.0 110.088 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.7 m80 -117.7 157.07 27.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.314 1.446 . . . . 0.0 111.818 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -133.46 142.42 48.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.076 1.35 . . . . 0.0 109.317 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.7 tmm? -143.04 132.45 23.47 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.082 0.953 . . . . 0.0 111.753 -168.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -108.72 139.88 42.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.951 2.1 . . . . 0.0 111.455 -173.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.5 mm -139.32 131.05 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.187 1.395 . . . . 0.0 109.304 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.27 139.71 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.18 123.34 46.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.537 1.935 . . . . 0.0 109.912 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.91 30.95 7.78 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.719 1.208 . . . . 0.0 112.827 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.0 t30 80.59 6.16 1.54 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.53 2.732 . . . . 0.0 115.28 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 90.3 mtp -109.05 133.17 53.35 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.054 1.342 . . . . 0.0 111.119 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.24 138.05 55.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -72.84 153.7 91.15 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.273 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.26 123.89 14.89 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.036 2.491 . . . . 0.0 110.37 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.21 -11.22 61.89 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.376 -1.235 . . . . 0.0 114.903 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.3 m -102.2 154.59 37.28 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-N 119.999 1.9 . . . . 0.0 112.673 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.58 163.83 89.48 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.558 0.878 . . . . 0.0 113.272 0.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.22 151.91 24.8 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.82 1.648 . . . . 0.0 111.504 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.87 141.7 47.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.288 1.435 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.2 p90 -166.56 158.28 13.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.372 1.069 . . . . 0.0 112.072 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 38.2 t80 -96.36 130.19 43.53 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.433 0.693 . . . . 0.0 111.755 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 71.4 t -91.86 132.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.998 1.319 . . . . 0.0 108.681 172.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.1 t0 -146.51 163.7 34.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.498 1.519 . . . . 0.0 110.628 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.76 148.82 44.23 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.992 0.917 . . . . 0.0 112.543 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 89.7 t -67.05 -45.02 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.138 0.975 . . . . 0.0 110.631 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 6.4 p30 -93.64 141.66 28.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.924 0.89 . . . . 0.0 111.125 168.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.4 p -173.85 156.79 2.89 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.051 1.741 . . . . 0.0 112.235 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.42 -23.47 11.13 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.854 1.216 . . . . 0.0 113.595 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -73.59 156.9 37.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.424 1.089 . . . . 0.0 113.736 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.4 t -66.95 138.13 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.173 0.989 . . . . 0.0 108.473 170.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.0 t -153.49 166.77 31.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.038 0.935 . . . . 0.0 111.349 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.01 145.46 29.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.134 1.374 . . . . 0.0 111.665 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 47.2 p90 -166.15 162.4 17.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.629 1.572 . . . . 0.0 112.467 -175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.77 173.47 13.22 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.283 1.421 . . . . 0.0 113.014 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.72 -35.04 13.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.879 2.386 . . . . 0.0 112.751 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.38 -32.12 78.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.463 -171.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.34 -3.47 49.64 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.233 1.516 . . . . 0.0 113.478 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.6 m -108.17 -41.24 4.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.473 1.909 . . . . 0.0 111.676 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -151.09 152.55 33.58 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.244 1.818 . . . . 0.0 112.332 -170.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -153.19 -175.41 24.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.406 1.003 . . . . 0.0 113.393 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.8 p -153.6 137.36 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.07 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.8 m -58.57 142.12 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.0 m-80 68.28 7.33 5.86 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.558 1.943 . . . . 0.0 114.582 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -114.7 143.57 30.25 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.167 1.387 . . . . 0.0 110.924 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.48 127.94 13.06 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.604 2.202 . . . . 0.0 110.316 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.13 145.83 32.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.624 1.57 . . . . 0.0 110.273 173.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.2 p -135.69 152.23 50.97 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -167.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.9 173.83 13.97 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.985 1.714 . . . . 0.0 111.385 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 76.0 m -125.73 142.43 51.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.316 1.446 . . . . 0.0 110.464 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 48.1 t -115.9 128.16 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.837 1.655 . . . . 0.0 107.875 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.32 123.92 35.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.021 0.928 . . . . 0.0 110.932 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 54.5 p -125.99 10.25 7.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.408 1.883 . . . . 0.0 112.608 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.16 -40.06 76.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.52 1.528 . . . . 0.0 114.372 -165.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.39 5.42 21.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.648 1.579 . . . . 0.0 112.738 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.71 58.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.575 1.15 . . . . 0.0 113.693 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.33 -86.71 1.38 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.872 1.225 . . . . 0.0 112.772 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.6 -177.88 3.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.27 1.828 . . . . 0.0 111.627 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 119.38 9.52 8.54 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.815 1.198 . . . . 0.0 115.618 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.33 103.52 1.63 Allowed Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.533 1.54 . . . . 0.0 112.834 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 39.2 tp -84.66 141.35 30.67 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.319 1.447 . . . . 0.0 110.158 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.7 m -135.46 159.41 41.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.592 1.557 . . . . 0.0 112.155 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.5 tp -160.71 136.44 8.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.024 1.73 . . . . 0.0 109.338 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.36 159.17 35.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.74 137.24 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.884 1.274 . . . . 0.0 109.837 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.26 134.39 48.96 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.31 1.444 . . . . 0.0 109.979 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.5 -164.55 16.61 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.667 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.32 -24.48 64.81 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.18 3.253 . . . . 0.0 112.836 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.8 t -139.3 159.75 41.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.914 1.285 . . . . 0.0 109.6 162.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.25 110.57 5.98 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.088 -1.008 . . . . 0.0 110.704 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 145.18 54.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 0.0 111.144 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.46 137.13 32.79 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 36.5 mt -129.36 143.73 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.746 1.218 . . . . 0.0 110.131 -168.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.63 162.68 35.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 110.966 166.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -158.14 155.41 29.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.646 1.178 . . . . 0.0 112.228 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -142.38 125.18 16.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.385 1.474 . . . . 0.0 109.79 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.36 129.56 36.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.946 169.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.18 151.58 20.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.362 1.465 . . . . 0.0 111.808 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -71.14 -16.48 62.55 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.888 0.875 . . . . 0.0 113.281 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.06 -6.96 59.56 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.31 33.89 6.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.815 1.198 . . . . 0.0 114.445 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -127.94 174.09 9.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.331 1.452 . . . . 0.0 110.572 169.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.1 m -124.16 130.96 53.42 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.105 1.362 . . . . 0.0 109.963 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.6 t -93.88 149.13 21.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.277 1.031 . . . . 0.0 110.745 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.1 t -128.17 143.79 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.102 1.761 . . . . 0.0 109.742 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.1 p -136.14 148.1 48.04 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.78 168.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.28 153.78 36.74 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.5 107.33 43.12 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 110.375 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -85.79 173.07 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.114 3.209 . . . . 0.0 110.834 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.1 p -147.34 -28.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -173.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.06 148.67 37.92 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.249 1.019 . . . . 0.0 110.718 167.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.59 157.71 48.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.98 2.453 . . . . 0.0 110.845 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.16 -168.1 22.17 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.164 1.364 . . . . 0.0 113.484 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.66 132.77 34.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.956 1.302 . . . . 0.0 112.568 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 126.64 49.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.275 1.83 . . . . 0.0 109.816 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.1 m -86.8 124.33 32.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.529 1.132 . . . . 0.0 110.482 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.48 124.31 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.605 1.562 . . . . 0.0 108.402 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.6 tt -106.14 131.04 53.87 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.319 1.447 . . . . 0.0 109.831 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.8 t -133.07 127.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.552 1.141 . . . . 0.0 109.607 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.42 143.42 24.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.969 1.308 . . . . 0.0 111.547 -168.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.63 122.31 15.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.957 1.303 . . . . 0.0 109.641 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.68 56.26 6.96 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.199 1.399 . . . . 0.0 112.095 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.3 pt-20 59.42 3.74 0.43 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.85 2.86 . . . . 0.0 116.644 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -108.98 125.05 51.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.678 1.191 . . . . 0.0 110.87 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.62 145.87 54.86 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.279 -0.888 . . . . 0.0 111.809 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 16.3 m -70.39 152.7 95.45 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.091 170.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.42 128.32 27.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.007 2.471 . . . . 0.0 110.57 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.42 62.8 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.052 1.31 . . . . 0.0 115.082 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.3 t -77.61 139.99 63.5 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.392 1.596 . . . . 0.0 111.482 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.36 135.92 42.56 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.358 0.806 . . . . 0.0 111.857 -3.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -86.01 170.3 12.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.794 1.637 . . . . 0.0 110.378 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 45.7 m -131.45 117.38 18.75 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.549 0.74 . . . . 0.0 110.718 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.35 143.41 26.42 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.669 1.188 . . . . 0.0 110.722 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -104.22 119.37 38.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.931 0.492 . . . . 0.0 110.771 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.3 t -97.28 144.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.944 1.698 . . . . 0.0 109.237 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.5 t -132.82 175.65 9.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.038 0.935 . . . . 0.0 112.854 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.33 137.47 19.78 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.644 1.593 . . . . 0.0 112.367 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 124.336 1.054 . . . . 0.0 113.402 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.5 tp . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -44.5 110.07 0.97 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.5 1.52 . . . . 0.0 112.513 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.03 120.64 7.51 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.474 2.116 . . . . 0.0 108.297 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 53.6 t80 -101.01 130.33 46.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.617 0.723 . . . . 0.0 111.677 -172.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 2.1 p30 -160.38 150.11 17.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.769 1.628 . . . . 0.0 111.69 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.4 150.27 40.43 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.456 1.902 . . . . 0.0 110.044 -171.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 139.47 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.773 1.629 . . . . 0.0 110.316 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.3 139.04 30.36 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.886 1.675 . . . . 0.0 108.732 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.13 46.25 2.04 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.707 3.605 . . . . 0.0 112.934 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.15 160.78 14.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.917 1.687 . . . . 0.0 110.532 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 58.1 m -132.47 130.33 40.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.717 1.207 . . . . 0.0 109.41 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.7 mt -92.78 119.49 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.772 1.229 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 -161.98 0.86 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.442 1.497 . . . . 0.0 110.915 170.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -63.58 120.52 11.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.719 -1.238 . . . . 0.0 111.727 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.33 170.63 12.11 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.783 1.659 . . . . 0.0 112.868 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -98.3 143.83 28.36 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.35 1.06 . . . . 0.0 112.528 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 9.8 tt -146.84 129.36 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.807 1.643 . . . . 0.0 110.335 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 76.8 p -146.61 -177.85 5.86 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.174 1.79 . . . . 0.0 110.337 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -165.38 -171.38 31.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.26 141.12 21.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 109.783 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 92.7 t -111.02 136.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.202 1.801 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -118.06 129.49 55.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.943 1.297 . . . . 0.0 110.634 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 17.7 mtm -99.91 151.66 37.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.76 1.624 . . . . 0.0 111.52 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.81 -18.88 36.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.477 2.785 . . . . 0.0 113.021 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 25.8 p -74.85 -4.13 36.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.705 1.602 . . . . 0.0 114.177 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.53 79.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.757 1.646 . . . . 0.0 114.206 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -68.44 160.01 30.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.925 1.29 . . . . 0.0 112.616 173.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -137.49 156.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.207 1.403 . . . . 0.0 111.586 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.36 178.65 9.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.944 2.097 . . . . 0.0 110.095 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.31 142.13 31.86 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.039 -1.038 . . . . 0.0 111.788 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.91 166.98 12.98 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.059 3.173 . . . . 0.0 111.566 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.5 m -102.31 120.39 40.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.484 1.514 . . . . 0.0 108.883 174.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.6 137.97 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.993 1.317 . . . . 0.0 109.158 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 19.0 m -144.37 131.76 20.86 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.334 1.453 . . . . 0.0 110.082 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.43 129.3 34.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.782 0.833 . . . . 0.0 110.218 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -80.85 -4.63 55.43 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.7 mmmt 69.84 13.27 8.02 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.525 2.33 . . . . 0.0 113.365 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -126.59 13.88 7.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.699 2.0 . . . . 0.0 112.755 -173.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.5 13.54 59.71 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.828 1.204 . . . . 0.0 114.56 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 58.4 p -132.33 157.56 44.14 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.208 1.803 . . . . 0.0 110.28 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -114.51 148.1 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.509 1.123 . . . . 0.0 109.769 165.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.8 m -114.57 137.02 52.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.737 1.215 . . . . 0.0 108.256 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.15 130.48 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.875 1.27 . . . . 0.0 108.812 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -125.89 160.92 28.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.012 1.325 . . . . 0.0 112.546 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 16.5 t80 -157.08 134.22 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.104 1.362 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.56 117.27 68.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.664 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -80.99 162.98 20.57 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.592 2.861 . . . . 0.0 112.382 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.9 p -135.69 -20.14 1.57 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.27 155.26 44.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.0 110.987 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.93 174.12 11.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.516 1.126 . . . . 0.0 112.655 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 110.67 -170.86 14.2 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.838 1.685 . . . . 0.0 113.843 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.17 132.19 34.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.753 1.221 . . . . 0.0 110.766 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.0 m80 -129.84 170.72 13.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.687 1.995 . . . . 0.0 111.055 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.0 154.06 41.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.445 1.098 . . . . 0.0 111.424 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 2.3 ttm -138.66 123.73 19.03 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.352 1.461 . . . . 0.0 110.82 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -96.87 135.83 38.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.081 1.753 . . . . 0.0 110.305 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.85 137.44 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.208 1.403 . . . . 0.0 109.997 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.68 135.25 18.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -173.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -102.98 124.17 47.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.634 1.973 . . . . 0.0 109.558 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.34 40.38 22.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.902 1.281 . . . . 0.0 112.467 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.5 m120 76.36 -3.6 2.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.292 2.637 . . . . 0.0 114.845 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.8 mtm -103.45 134.18 47.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.472 1.509 . . . . 0.0 111.462 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.26 135.63 53.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.8 pt -73.9 157.48 87.13 Favored Pre-proline 0 N--CA 1.482 1.146 0 CA-C-O 118.698 -0.667 . . . . 0.0 111.505 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -57.97 125.81 19.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.635 2.224 . . . . 0.0 110.988 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.35 -9.94 71.62 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.991 1.281 . . . . 0.0 114.69 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.1 t -82.78 147.31 54.77 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.36 1.58 . . . . 0.0 111.667 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.4 164.76 69.02 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 120.126 1.081 . . . . 0.0 112.451 -4.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.37 156.64 17.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.703 1.601 . . . . 0.0 111.998 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -136.71 136.36 38.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 109.191 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.9 150.07 25.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 57.8 t80 -105.2 142.31 35.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.182 0.993 . . . . 0.0 112.199 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -124.83 138.33 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.692 1.597 . . . . 0.0 109.056 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 37.2 t0 -162.22 157.32 22.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.372 1.469 . . . . 0.0 111.581 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -82.73 146.19 29.16 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.963 -1.085 . . . . 0.0 113.188 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.1 t -62.63 -30.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.102 1.361 . . . . 0.0 112.281 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.22 -11.34 59.74 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.6 m -57.96 136.34 57.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.85 61.9 1.95 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.809 1.671 . . . . 0.0 112.575 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -158.56 166.67 31.56 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.228 1.411 . . . . 0.0 113.269 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 10.6 p -70.15 139.76 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.876 0.871 . . . . 0.0 110.089 166.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -156.41 167.64 29.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.23 145.98 31.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.39 1.076 . . . . 0.0 112.257 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.9 p90 -167.86 166.08 13.64 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.691 . . . . 0.0 112.882 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.03 172.02 13.03 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.7 1.619 . . . . 0.0 112.362 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.3 -34.84 12.08 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.859 2.372 . . . . 0.0 113.191 -169.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.14 -29.13 73.21 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.844 -0.976 . . . . 0.0 114.625 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.85 -0.13 42.1 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.21 1.505 . . . . 0.0 113.659 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 19.6 m -116.22 -42.21 3.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.051 2.141 . . . . 0.0 111.999 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -140.6 153.05 45.92 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.823 1.649 . . . . 0.0 112.604 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -155.09 -176.13 26.93 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.112 0.863 . . . . 0.0 113.436 167.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.8 p -151.6 137.98 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.92 1.288 . . . . 0.0 108.982 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -58.29 143.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 69.56 5.76 5.35 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.607 1.963 . . . . 0.0 114.776 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.6 mttm -117.41 147.49 40.74 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 111.194 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.25 138.65 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.62 2.214 . . . . 0.0 110.806 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -118.81 147.52 43.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.928 1.691 . . . . 0.0 110.3 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.6 p -135.52 152.45 51.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.088 0.955 . . . . 0.0 113.573 -166.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.67 176.53 10.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.093 1.757 . . . . 0.0 111.325 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 81.8 m -132.3 138.53 47.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.88 1.272 . . . . 0.0 110.68 -171.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.2 t -104.0 130.29 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.135 1.374 . . . . 0.0 107.6 167.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -97.3 123.8 41.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.561 1.144 . . . . 0.0 110.187 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 52.8 p -127.97 5.97 5.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.793 1.637 . . . . 0.0 113.397 -167.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -54.54 -33.92 60.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.629 1.572 . . . . 0.0 114.647 -171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.0 t70 -113.9 7.02 16.83 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.537 1.535 . . . . 0.0 113.259 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.41 -14.86 59.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.04 -97.98 2.19 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.493 1.044 . . . . 0.0 112.761 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.67 171.38 16.95 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.381 1.473 . . . . 0.0 112.515 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 125.46 -160.62 20.0 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.005 1.764 . . . . 0.0 112.771 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.98 115.25 4.73 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.257 0.932 . . . . 0.0 111.371 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.7 128.4 34.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.199 1.4 . . . . 0.0 108.88 171.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 34.4 m -129.9 158.54 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.508 1.523 . . . . 0.0 112.289 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -160.18 135.55 8.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.239 1.816 . . . . 0.0 108.909 -169.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.41 157.91 34.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.666 0.786 . . . . 0.0 112.497 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -136.29 140.39 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.132 1.373 . . . . 0.0 109.763 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.22 136.11 45.42 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.431 1.492 . . . . 0.0 109.38 171.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.29 -164.55 16.39 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.833 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.86 -27.19 67.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.077 3.185 . . . . 0.0 112.417 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.3 t -135.4 159.86 40.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.868 1.267 . . . . 0.0 109.352 159.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -75.76 109.51 9.42 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.042 -1.036 . . . . 0.0 110.871 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 147.27 52.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.724 0.809 . . . . 0.0 111.768 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.94 145.5 27.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.387 0.675 . . . . 0.0 110.083 166.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.94 140.21 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 110.203 -167.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 57.9 m -135.35 157.01 47.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.587 1.555 . . . . 0.0 110.776 167.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -156.16 156.7 34.66 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.094 0.957 . . . . 0.0 112.458 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.1 m -141.91 122.13 13.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.035 1.334 . . . . 0.0 110.406 -172.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.47 132.05 41.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.97 1.308 . . . . 0.0 111.065 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -112.76 146.4 38.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 111.75 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.45 -13.3 61.91 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.986 0.914 . . . . 0.0 113.312 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.77 -4.88 40.28 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.242 1.817 . . . . 0.0 114.219 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.25 31.55 9.61 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.58 1.086 . . . . 0.0 113.804 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.0 p -141.06 161.35 38.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.351 1.46 . . . . 0.0 111.357 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 78.9 m -112.85 128.23 56.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.719 1.207 . . . . 0.0 109.004 158.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.1 t -87.4 148.02 25.18 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 110.462 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -129.39 142.83 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.672 1.589 . . . . 0.0 110.214 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 69.6 p -136.45 145.75 45.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.922 1.289 . . . . 0.0 111.591 165.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.4 p90 -148.44 156.9 43.07 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.018 -1.051 . . . . 0.0 112.693 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.06 104.84 25.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.264 1.026 . . . . 0.0 110.666 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.17 172.13 9.8 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 124.226 3.284 . . . . 0.0 111.219 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.6 p -147.36 -29.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -172.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.28 147.91 36.11 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 119.515 1.052 . . . . 0.0 110.776 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.49 156.49 49.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.911 2.408 . . . . 0.0 110.696 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.96 -162.53 24.74 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.104 1.335 . . . . 0.0 113.003 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -104.03 125.85 50.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.344 1.058 . . . . 0.0 111.242 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -109.97 129.47 55.66 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.881 1.672 . . . . 0.0 110.023 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -88.23 127.19 35.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 110.611 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -106.64 127.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.63 1.572 . . . . 0.0 108.657 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.31 134.78 51.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 109.756 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.6 t -136.29 131.27 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.249 1.419 . . . . 0.0 108.546 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.12 143.22 22.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.865 1.266 . . . . 0.0 111.332 -170.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.77 124.67 15.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.849 1.259 . . . . 0.0 109.941 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 57.85 51.82 8.7 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 9.0 pt-20 55.57 17.24 2.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.149 2.579 . . . . 0.0 115.84 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -122.02 128.82 51.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.858 1.263 . . . . 0.0 110.725 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -65.18 156.24 32.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.132 0.973 . . . . 0.0 112.829 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.7 m -72.82 152.48 91.17 Favored Pre-proline 0 N--CA 1.48 1.029 0 O-C-N 121.545 -0.722 . . . . 0.0 109.247 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.94 -11.15 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.965 1.777 . . . . 0.0 114.657 -166.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -105.0 -7.48 38.22 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 85.1 p -85.89 156.4 58.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.143 1.971 . . . . 0.0 113.722 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.19 144.53 79.75 Favored 'Cis proline' 0 C--N 1.354 0.844 0 CA-C-N 118.968 0.667 . . . . 0.0 112.136 -5.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -95.71 167.93 10.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.362 1.465 . . . . 0.0 110.668 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 29.6 m -130.54 118.09 20.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.909 0.884 . . . . 0.0 110.23 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.72 127.29 44.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.354 . . . . 0.0 110.684 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -92.13 117.12 29.54 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.664 0.386 . . . . 0.0 110.353 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -102.81 140.82 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.087 1.755 . . . . 0.0 109.45 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.9 t -128.57 173.46 10.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 0.0 112.76 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.92 140.69 21.07 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.806 1.669 . . . . 0.0 112.193 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 CA--C 1.549 0.93 0 C-N-CA 124.112 0.965 . . . . 0.0 113.464 177.982 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.272 0.558 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -60.12 117.49 24.28 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 110.837 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.29 152.74 44.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.821 2.347 . . . . 0.0 111.052 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -94.26 116.25 28.62 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 169.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -145.49 125.29 13.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.771 1.228 . . . . 0.0 110.184 168.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.92 147.02 39.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.304 1.842 . . . . 0.0 109.55 -174.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -122.32 136.94 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.967 1.307 . . . . 0.0 110.453 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.4 mt -135.15 136.15 24.16 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.893 1.677 . . . . 0.0 109.287 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.12 117.67 5.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.401 2.734 . . . . 0.0 110.167 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.6 t80 178.02 149.6 0.2 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.356 . . . . 0.0 109.315 -168.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 23.9 m -130.75 125.69 34.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.136 0.974 . . . . 0.0 110.336 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 31.8 mt -83.16 119.33 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.744 1.218 . . . . 0.0 108.954 171.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -122.68 -53.21 1.89 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.913 0.885 . . . . 0.0 113.189 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -160.18 121.74 3.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.313 1.445 . . . . 0.0 111.398 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.68 -146.7 18.61 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 125.735 1.636 . . . . 0.0 111.716 -169.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.6 146.94 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.711 1.204 . . . . 0.0 110.959 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 10.8 tt -130.58 136.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.523 1.529 . . . . 0.0 111.571 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 41.4 p -147.23 -177.99 5.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.611 1.964 . . . . 0.0 110.158 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.67 -166.99 34.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 115.324 0.889 . . . . 0.0 115.324 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.86 131.84 9.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.497 1.519 . . . . 0.0 110.306 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 18.3 t -101.6 136.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.367 1.467 . . . . 0.0 108.648 170.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -120.32 131.11 54.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.719 1.207 . . . . 0.0 111.222 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -105.78 148.33 36.27 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.798 1.639 . . . . 0.0 112.104 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.55 -39.79 55.21 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.8 3.667 . . . . 0.0 115.784 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 7.1 t -73.64 -1.4 18.74 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.44 60.8 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.707 1.622 . . . . 0.0 114.366 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -69.49 160.71 30.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.246 1.418 . . . . 0.0 112.169 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.5 m -139.41 155.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.334 1.454 . . . . 0.0 111.609 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.62 163.29 40.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.79 1.636 . . . . 0.0 111.37 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.63 137.02 21.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.567 0.747 . . . . 0.0 111.577 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.11 169.18 11.62 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.59 3.527 . . . . 0.0 111.924 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -110.55 139.08 46.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 108.995 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.24 132.24 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.668 1.187 . . . . 0.0 109.283 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -134.29 127.09 31.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.416 1.487 . . . . 0.0 109.74 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.08 127.17 31.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.458 0.703 . . . . 0.0 110.279 170.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -79.01 -3.49 45.35 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.2 mmtm 71.24 13.12 6.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.76 2.424 . . . . 0.0 113.13 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -126.63 11.09 7.27 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.825 2.05 . . . . 0.0 113.001 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.48 12.78 57.98 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.855 1.217 . . . . 0.0 114.821 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -128.38 154.32 46.12 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.064 1.746 . . . . 0.0 110.396 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.2 m -111.62 141.42 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.903 0.881 . . . . 0.0 109.894 165.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.0 m -103.43 133.61 48.2 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.604 1.162 . . . . 0.0 108.412 168.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 59.9 t -116.99 134.4 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.125 1.77 . . . . 0.0 108.649 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -139.2 159.2 42.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.636 1.174 . . . . 0.0 113.47 -172.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.2 t80 -158.47 135.84 10.11 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.019 1.727 . . . . 0.0 111.483 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.93 120.0 73.23 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 124.726 1.21 . . . . 0.0 110.846 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.33 148.03 23.5 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.706 2.937 . . . . 0.0 112.607 -170.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.0 p -142.25 5.41 1.66 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.664 1.186 . . . . 0.0 114.009 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -160.18 144.52 14.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.895 1.678 . . . . 0.0 110.056 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.86 163.51 13.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 0.0 112.196 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 114.45 -168.76 12.65 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 125.247 1.403 . . . . 0.0 113.665 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -86.21 122.26 29.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.9 m80 -118.61 161.58 19.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.966 1.707 . . . . 0.0 111.822 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.16 155.96 46.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 40.9 ttm -140.77 118.37 11.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.253 1.421 . . . . 0.0 111.156 -172.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -81.56 134.98 35.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.255 2.222 . . . . 0.0 109.832 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 19.9 mm -141.09 136.32 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.349 1.459 . . . . 0.0 108.714 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 136.84 16.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.9 t80 -97.21 121.98 39.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.741 2.016 . . . . 0.0 109.795 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.94 35.51 16.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.876 1.27 . . . . 0.0 112.775 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 76.69 4.22 3.47 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 127.983 2.513 . . . . 0.0 114.506 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.6 mtm -107.53 132.6 53.07 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.68 1.592 . . . . 0.0 110.952 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.24 139.07 55.75 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 39.9 pt -74.71 155.21 87.19 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.456 0.702 . . . . 0.0 110.902 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.58 119.78 7.21 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.932 2.421 . . . . 0.0 111.942 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.9 69.83 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.52 1.533 . . . . 0.0 115.128 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 38.8 m -80.79 154.69 73.3 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.758 1.779 . . . . 0.0 112.025 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.97 155.01 99.73 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.422 0.829 . . . . 0.0 112.538 -0.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.92 159.56 15.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.097 1.359 . . . . 0.0 110.86 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -159.08 133.9 8.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.315 1.046 . . . . 0.0 110.478 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.92 -179.48 5.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.032 1.333 . . . . 0.0 112.697 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -118.31 137.29 53.17 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.219 1.008 . . . . 0.0 113.353 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.0 t -108.95 138.04 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.25 1.82 . . . . 0.0 110.021 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.6 t0 -149.1 178.9 8.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.334 1.853 . . . . 0.0 109.509 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -77.85 143.07 38.11 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.693 -1.254 . . . . 0.0 111.304 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.9 m -65.47 -17.71 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -166.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -148.81 41.41 0.93 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.978 0.911 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 2.6 t -66.68 -28.58 68.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 106.09 -25.36 23.93 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.113 1.815 . . . . 0.0 115.019 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -72.42 160.49 32.25 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.909 1.354 . . . . 0.0 113.445 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.5 t -64.36 134.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.603 1.161 . . . . 0.0 109.678 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -161.47 150.09 15.79 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.59 1.156 . . . . 0.0 110.874 -173.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -118.96 147.05 44.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.836 1.254 . . . . 0.0 111.978 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.4 p90 -166.8 158.02 12.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.082 1.753 . . . . 0.0 112.818 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 141.19 170.3 12.16 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.309 1.433 . . . . 0.0 113.258 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 -33.19 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.942 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.92 82.04 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.263 0.938 . . . . 0.0 114.047 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.85 -5.99 54.94 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 118.645 1.222 . . . . 0.0 112.658 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.6 m -99.09 -45.56 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.073 1.749 . . . . 0.0 111.406 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -147.57 142.38 26.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.531 1.932 . . . . 0.0 111.987 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -137.31 170.4 23.61 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.373 0.987 . . . . 0.0 113.376 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 59.9 t -134.92 135.58 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.144 1.378 . . . . 0.0 107.963 173.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -55.85 133.84 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.199 0.6 . . . . 0.0 112.493 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.08 -0.19 2.19 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.094 2.158 . . . . 0.0 114.54 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.59 140.06 21.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.084 1.354 . . . . 0.0 110.973 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.45 120.96 7.06 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.636 2.224 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.61 133.89 48.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.331 1.452 . . . . 0.0 110.141 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.1 p -128.5 149.46 50.58 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.49 178.65 8.91 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.74 1.616 . . . . 0.0 111.728 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -130.79 145.14 51.89 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.129 1.372 . . . . 0.0 110.793 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.0 t -116.55 132.65 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.644 1.578 . . . . 0.0 108.288 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -94.25 128.67 40.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.31 1.044 . . . . 0.0 111.009 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 48.7 p -136.46 3.51 2.81 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.47 1.508 . . . . 0.0 113.792 -167.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -53.73 -40.23 65.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.422 1.489 . . . . 0.0 114.668 -169.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -107.43 5.87 27.69 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.505 1.522 . . . . 0.0 113.123 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.28 -19.11 61.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.07 -89.98 1.63 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.724 1.154 . . . . 0.0 112.497 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -165.04 173.06 11.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.286 1.434 . . . . 0.0 112.648 -169.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 121.09 -167.52 14.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.199 1.857 . . . . 0.0 112.73 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.64 106.55 3.2 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.935 0.779 . . . . 0.0 111.791 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.6 124.6 28.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.509 1.124 . . . . 0.0 108.586 168.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 46.1 m -124.07 158.04 33.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.782 1.633 . . . . 0.0 112.24 -173.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.46 137.22 10.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.857 1.663 . . . . 0.0 109.515 -172.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 160.57 37.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.354 1.061 . . . . 0.0 111.909 175.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.8 mt -135.53 132.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.499 1.12 . . . . 0.0 109.6 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.88 108.06 15.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.413 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -117.53 -178.16 17.5 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.124 1.345 . . . . 0.0 113.743 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.79 -26.1 52.83 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.797 2.998 . . . . 0.0 111.652 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 151.48 51.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.234 1.414 . . . . 0.0 108.646 155.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.18 122.25 20.72 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.957 -1.089 . . . . 0.0 112.0 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.88 154.27 41.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 112.12 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.88 139.62 30.27 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.354 0.662 . . . . 0.0 109.397 166.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 34.4 mt -133.85 143.61 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -166.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 10.8 t -142.58 161.64 37.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.31 1.444 . . . . 0.0 111.065 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -160.09 155.11 24.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.92 1.288 . . . . 0.0 112.687 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.0 m -141.65 127.32 19.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.375 1.47 . . . . 0.0 110.455 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.91 131.63 37.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.814 1.246 . . . . 0.0 111.264 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -111.13 151.06 28.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.129 1.371 . . . . 0.0 112.442 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -67.69 -19.68 65.19 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.49 1.116 . . . . 0.0 112.461 173.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.23 -5.71 37.76 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.811 1.644 . . . . 0.0 114.421 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.22 33.96 8.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.46 1.029 . . . . 0.0 113.235 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -141.28 161.37 38.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.518 1.527 . . . . 0.0 111.143 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.5 m -108.6 131.68 54.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.859 1.263 . . . . 0.0 108.913 158.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -91.09 149.89 21.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.939 0.895 . . . . 0.0 110.486 168.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 95.1 t -130.2 144.8 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.046 1.739 . . . . 0.0 109.973 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.1 t -140.35 141.05 35.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.486 1.514 . . . . 0.0 110.932 170.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -147.03 153.99 40.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.51 103.32 49.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.483 1.913 . . . . 0.0 110.256 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.12 161.99 17.94 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.647 2.898 . . . . 0.0 110.306 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.5 m -126.39 -10.06 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.48 151.63 22.82 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.207 1.403 . . . . 0.0 110.419 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.24 142.99 27.81 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.762 2.308 . . . . 0.0 111.649 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 155.4 -167.59 32.99 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.779 1.181 . . . . 0.0 113.299 -174.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -101.08 128.54 47.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.573 1.149 . . . . 0.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -120.15 123.23 42.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.65 1.58 . . . . 0.0 110.121 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 48.8 m -86.45 125.78 33.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.039 -1.038 . . . . 0.0 111.22 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 128.55 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.531 1.533 . . . . 0.0 108.614 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.23 129.95 55.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.301 1.44 . . . . 0.0 109.655 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.5 t -132.59 128.93 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.435 1.094 . . . . 0.0 109.757 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.39 143.68 24.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.269 1.428 . . . . 0.0 111.046 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.88 121.74 11.99 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.535 1.134 . . . . 0.0 109.721 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.77 55.28 5.56 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.034 1.333 . . . . 0.0 111.544 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.2 pt-20 58.26 13.19 2.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.396 2.678 . . . . 0.0 116.267 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.18 126.2 49.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.647 1.179 . . . . 0.0 110.909 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.57 146.15 54.28 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.803 170.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.5 m -71.19 152.76 94.51 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.152 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.96 129.59 35.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.005 2.47 . . . . 0.0 110.895 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.7 -17.69 57.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.169 1.366 . . . . 0.0 114.89 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 35.6 t -77.77 140.13 62.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.26 1.53 . . . . 0.0 111.542 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.0 135.42 40.07 Favored 'Cis proline' 0 C--N 1.352 0.735 0 CA-C-N 119.377 0.813 . . . . 0.0 111.717 -4.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.67 176.85 6.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.223 1.809 . . . . 0.0 110.492 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 95.4 m -137.35 123.25 20.13 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.94 0.896 . . . . 0.0 111.096 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.12 160.07 15.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.127 1.771 . . . . 0.0 110.711 167.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -122.13 126.31 48.09 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.788 0.835 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.5 t -106.19 141.01 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.21 1.804 . . . . 0.0 109.881 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -130.33 171.11 13.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 112.978 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.91 144.34 31.06 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.382 1.468 . . . . 0.0 112.557 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 124.231 1.012 . . . . 0.0 113.2 177.69 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.469 0.476 0 CA-C-O 121.049 0.452 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -66.01 119.98 65.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 110.608 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.71 137.74 43.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.93 2.42 . . . . 0.0 110.197 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 27.4 t80 -105.63 129.91 53.77 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.535 0.734 . . . . 0.0 111.663 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -157.61 142.8 16.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.505 1.522 . . . . 0.0 111.2 171.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.42 151.02 45.93 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.164 1.786 . . . . 0.0 109.954 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.4 p -115.59 138.07 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 109.938 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.34 134.49 26.14 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.002 1.721 . . . . 0.0 108.713 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.51 100.02 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.385 2.724 . . . . 0.0 109.572 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -161.82 148.79 14.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.496 1.918 . . . . 0.0 109.164 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.5 m -124.28 125.93 45.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.122 . . . . 0.0 109.357 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 80.1 mt -86.01 126.0 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 0.0 109.933 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.29 -161.25 0.75 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.946 1.698 . . . . 0.0 111.658 172.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.97 126.46 29.55 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.897 -1.127 . . . . 0.0 111.509 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.39 -144.6 12.98 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.952 1.739 . . . . 0.0 111.476 -170.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.74 141.95 16.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.146 0.978 . . . . 0.0 111.752 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.4 tt -133.5 134.04 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.052 1.741 . . . . 0.0 110.607 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.25 166.5 27.78 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.85 1.66 . . . . 0.0 111.06 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.73 -175.34 24.13 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.99 140.68 18.99 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.683 1.993 . . . . 0.0 109.333 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.2 t -117.92 131.71 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.716 1.606 . . . . 0.0 108.19 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -113.92 125.34 53.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.479 1.112 . . . . 0.0 110.633 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 37.6 mtm -104.25 138.67 19.59 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.354 1.461 . . . . 0.0 111.473 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -56.42 -29.48 77.75 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.513 3.476 . . . . 0.0 116.098 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 9.0 p -77.67 8.13 4.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.152 1.381 . . . . 0.0 114.666 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.44 46.41 4.06 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.69 1.138 . . . . 0.0 113.168 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.54 162.42 41.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.646 1.578 . . . . 0.0 112.014 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.7 m -140.26 157.76 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.819 1.247 . . . . 0.0 112.396 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -149.32 178.16 9.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.1 2.16 . . . . 0.0 109.999 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.83 142.19 30.37 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.114 -0.991 . . . . 0.0 111.75 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -83.64 167.22 13.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.214 3.276 . . . . 0.0 111.547 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 64.3 m -104.3 116.48 32.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.314 1.446 . . . . 0.0 108.982 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.24 130.03 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.328 1.051 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -121.2 125.63 47.62 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.374 1.87 . . . . 0.0 109.491 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 63.2 t0 -82.47 116.93 22.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.26 1.024 . . . . 0.0 110.154 172.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.2 -14.0 54.24 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 67.47 4.0 3.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.022 2.129 . . . . 0.0 114.204 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -102.55 6.78 40.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.792 2.037 . . . . 0.0 113.146 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.69 9.16 63.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.087 1.327 . . . . 0.0 113.912 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.2 p -127.17 161.44 28.49 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.524 1.929 . . . . 0.0 110.558 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -120.69 144.48 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.961 0.904 . . . . 0.0 109.656 163.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.9 m -105.47 138.15 42.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.398 1.079 . . . . 0.0 108.144 170.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -125.52 127.58 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.162 0.985 . . . . 0.0 109.21 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -123.81 158.0 32.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.298 1.439 . . . . 0.0 112.229 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 15.3 t80 -157.35 134.36 10.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.147 1.379 . . . . 0.0 111.812 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.77 117.11 68.03 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 0.0 110.515 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.22 145.15 27.13 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.234 2.623 . . . . 0.0 112.258 -173.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.6 t -138.73 -10.96 1.35 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -139.49 153.21 47.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.404 1.882 . . . . 0.0 109.654 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -99.63 166.51 11.09 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.545 1.138 . . . . 0.0 112.556 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.01 -168.15 13.26 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.24 1.4 . . . . 0.0 114.217 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.1 tp -83.33 110.75 18.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.838 1.255 . . . . 0.0 110.91 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -105.73 170.96 7.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.341 1.856 . . . . 0.0 112.304 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.29 152.4 41.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.491 1.117 . . . . 0.0 111.49 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 13.6 ttm -122.21 127.67 50.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.034 1.734 . . . . 0.0 110.08 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.69 131.58 49.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.25 2.22 . . . . 0.0 109.2 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.2 mm -138.32 135.1 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.78 1.232 . . . . 0.0 109.193 174.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.49 140.0 27.21 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.864 0.866 . . . . 0.0 113.324 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -99.44 119.96 38.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.121 1.768 . . . . 0.0 109.179 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.22 34.83 12.08 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.927 1.291 . . . . 0.0 113.057 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.0 m-80 72.79 10.21 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.573 2.349 . . . . 0.0 115.133 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.7 mtt -104.65 130.36 52.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.133 1.373 . . . . 0.0 110.391 167.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.29 137.65 55.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.243 -0.911 . . . . 0.0 113.35 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.7 pt -74.17 153.88 88.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.986 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.29 126.5 20.25 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.565 2.177 . . . . 0.0 110.632 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.23 -18.2 54.52 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.14 1.353 . . . . 0.0 114.302 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 62.0 m -87.64 154.91 53.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.848 1.824 . . . . 0.0 112.564 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.22 158.11 98.95 Favored 'Cis proline' 0 C--N 1.354 0.838 0 CA-C-N 119.258 0.771 . . . . 0.0 112.241 -4.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.0 mt -103.53 157.71 16.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.985 1.314 . . . . 0.0 111.244 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -141.22 138.89 33.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 109.606 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.5 p90 -166.64 159.39 14.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.507 1.123 . . . . 0.0 111.977 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 35.3 t80 -101.24 139.56 36.75 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.145 -0.972 . . . . 0.0 112.656 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 50.5 t -107.83 132.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.154 1.381 . . . . 0.0 109.688 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -147.79 175.18 11.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.991 2.117 . . . . 0.0 111.454 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -84.71 145.02 28.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 0.0 112.792 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 17.1 m -69.49 -25.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.544 -0.722 . . . . 0.0 112.221 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -99.65 34.31 2.28 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.277 1.831 . . . . 0.0 111.691 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 14.9 p -53.36 141.99 22.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.982 1.713 . . . . 0.0 114.208 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.5 37.02 3.76 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 126.16 1.838 . . . . 0.0 112.255 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -166.93 156.52 10.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.619 1.568 . . . . 0.0 112.857 -167.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.1 p -61.1 141.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 110.126 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 163.18 36.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.91 0.884 . . . . 0.0 111.604 -173.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.43 145.18 31.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.379 1.472 . . . . 0.0 111.936 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.7 p90 -166.31 157.73 13.33 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.796 1.638 . . . . 0.0 112.722 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 146.2 175.77 19.5 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.485 1.04 . . . . 0.0 114.483 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.54 -43.49 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.203 2.602 . . . . 0.0 112.259 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.56 73.77 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.085 0.857 . . . . 0.0 113.641 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.57 -19.17 63.68 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.3 m -110.4 -49.73 3.03 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.06 1.744 . . . . 0.0 111.327 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -135.27 133.69 39.19 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.19 1.796 . . . . 0.0 112.035 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -119.38 167.37 13.31 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.593 1.092 . . . . 0.0 113.314 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.04 130.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 109.218 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 139.46 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.836 0.854 . . . . 0.0 111.966 -175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.83 6.12 4.4 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.674 1.99 . . . . 0.0 114.216 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 63.9 mttp -125.15 145.46 50.59 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.856 1.662 . . . . 0.0 111.06 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.01 133.58 21.78 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.606 2.204 . . . . 0.0 111.05 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -115.65 147.49 40.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.758 1.623 . . . . 0.0 110.179 173.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -166.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -160.76 176.17 11.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.769 1.628 . . . . 0.0 111.662 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.5 m -131.65 144.21 50.86 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.301 1.441 . . . . 0.0 110.789 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 36.3 t -113.92 138.19 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.075 1.75 . . . . 0.0 108.017 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -104.8 127.44 52.6 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.47 1.108 . . . . 0.0 110.037 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -125.07 3.22 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.648 1.979 . . . . 0.0 113.323 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.1 tttt -50.33 -36.71 33.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.317 1.847 . . . . 0.0 114.674 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -115.41 10.95 15.91 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.585 1.554 . . . . 0.0 113.132 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.57 -40.05 50.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.78 154.71 9.4 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.63 1.11 . . . . 0.0 112.323 -168.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.63 171.94 14.41 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.455 1.102 . . . . 0.0 112.957 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 134.72 14.87 1.12 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.861 1.219 . . . . 0.0 115.81 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 103.51 103.68 2.82 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.595 1.569 . . . . 0.0 113.204 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.57 143.29 31.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.216 1.407 . . . . 0.0 110.52 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.6 m -136.07 156.8 48.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 111.938 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.4 tp -157.96 133.58 9.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.206 1.803 . . . . 0.0 108.756 -173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 159.78 38.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.738 0.815 . . . . 0.0 112.427 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.0 mt -134.58 131.2 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.565 1.146 . . . . 0.0 109.481 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.59 107.4 14.2 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.28 1.432 . . . . 0.0 109.309 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -120.52 -173.74 15.01 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.122 1.344 . . . . 0.0 113.992 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.57 -21.66 45.67 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.78 2.987 . . . . 0.0 111.904 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.0 t -137.94 157.9 45.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.629 1.572 . . . . 0.0 109.096 158.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -71.95 117.47 13.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.987 -1.071 . . . . 0.0 111.638 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.05 149.05 43.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.79 140.5 29.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.194 0.598 . . . . 0.0 109.536 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 43.8 mt -131.84 143.53 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 110.111 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.8 t -140.34 163.08 33.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.806 1.242 . . . . 0.0 110.829 166.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -161.51 155.33 21.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.524 1.13 . . . . 0.0 112.658 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 81.5 m -137.19 114.72 11.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.61 1.564 . . . . 0.0 109.283 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.2 144.92 27.21 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.82 1.248 . . . . 0.0 112.226 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -123.07 147.76 46.37 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.411 1.484 . . . . 0.0 111.75 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -71.98 -12.59 61.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.714 0.806 . . . . 0.0 112.514 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.2 -7.0 49.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.861 1.664 . . . . 0.0 114.027 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.94 32.57 7.07 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.576 1.084 . . . . 0.0 113.99 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.3 p -141.08 161.31 38.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 111.292 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 30.0 m -132.3 133.14 43.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.343 1.457 . . . . 0.0 109.366 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -94.1 147.97 22.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.187 0.995 . . . . 0.0 110.459 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.0 t -130.72 142.84 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.736 1.614 . . . . 0.0 110.118 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 90.5 p -135.18 149.24 49.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.091 1.356 . . . . 0.0 111.783 167.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -151.51 155.26 38.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 4.6 mt -121.08 104.19 41.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.284 1.834 . . . . 0.0 110.344 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.52 164.09 16.6 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.731 2.954 . . . . 0.0 110.274 166.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -127.18 -20.51 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.4 153.25 32.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.797 1.239 . . . . 0.0 110.984 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.14 151.88 39.46 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.878 2.385 . . . . 0.0 112.63 -168.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.46 -151.67 23.67 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.471 1.51 . . . . 0.0 112.68 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.98 128.81 51.9 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.089 1.356 . . . . 0.0 110.672 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.14 127.4 55.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.339 1.856 . . . . 0.0 109.653 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 57.1 m -89.31 125.23 35.03 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.777 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.67 126.88 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.895 1.278 . . . . 0.0 108.977 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.38 129.35 55.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 109.594 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -130.66 129.92 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.685 1.194 . . . . 0.0 109.025 171.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.85 144.59 23.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.91 1.284 . . . . 0.0 111.845 -167.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.47 123.66 15.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.005 1.322 . . . . 0.0 109.933 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 52.55 56.91 6.99 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.623 1.569 . . . . 0.0 112.172 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 7.5 pt-20 59.35 8.47 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.62 2.768 . . . . 0.0 116.544 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -115.75 124.84 51.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.454 1.102 . . . . 0.0 110.899 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -61.84 145.89 51.31 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.431 -0.793 . . . . 0.0 111.704 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.2 m -68.8 149.94 97.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.254 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.37 131.33 40.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.073 2.515 . . . . 0.0 111.576 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.59 -14.57 61.03 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.223 1.392 . . . . 0.0 114.943 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.6 t -80.1 144.17 58.3 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 119.011 1.405 . . . . 0.0 111.411 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.08 140.64 67.05 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 120.01 1.039 . . . . 0.0 112.576 -0.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.36 175.57 6.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 110.541 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 27.8 m -135.3 125.73 26.68 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 110.739 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.49 132.16 48.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.023 1.329 . . . . 0.0 109.973 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.9 ttt85 -92.47 136.9 32.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 61.5 t -132.75 131.81 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.514 1.126 . . . . 0.0 110.759 -163.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 7.3 t -173.55 164.66 4.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.346 1.858 . . . . 0.0 111.217 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 143.18 -163.15 27.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.539 1.543 . . . . 0.0 113.682 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 N--CA 1.48 1.063 0 C-N-CA 127.197 2.199 . . . . 0.0 114.114 176.279 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -55.91 115.97 11.03 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.744 1.218 . . . . 0.0 110.975 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.94 151.54 50.66 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.822 2.348 . . . . 0.0 110.501 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.51 118.41 35.68 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.286 0.634 . . . . 0.0 110.195 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -150.63 122.34 8.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.687 1.595 . . . . 0.0 109.832 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.81 149.12 47.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.159 1.784 . . . . 0.0 110.088 -171.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.7 p -118.87 138.12 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.011 1.324 . . . . 0.0 109.689 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 51.1 mt -134.43 135.53 24.01 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.198 1.799 . . . . 0.0 108.42 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.91 31.21 0.44 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.488 3.458 . . . . 0.0 113.628 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.0 t80 -83.03 157.55 22.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.276 1.431 . . . . 0.0 110.833 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 90.5 m -129.62 126.35 38.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.314 1.446 . . . . 0.0 109.574 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 93.9 mt -87.58 134.53 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 110.389 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1800 ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' 1801 ' ' LYS . 29.0 ttpt -119.81 -147.48 0.4 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.77 1.628 . . . . 0.0 110.851 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1801 ' ' LYS . . . . . 0.427 ' H ' ' HG2' ' A' 1800 ' ' LYS . 8.0 tmtm? -73.5 123.11 23.28 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.573 -1.33 . . . . 0.0 110.201 171.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.2 -148.98 20.08 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.241 1.4 . . . . 0.0 112.16 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -156.97 145.79 19.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 110.772 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -129.03 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.596 1.558 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 44.6 p -144.75 -177.1 5.34 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.345 1.858 . . . . 0.0 109.998 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.84 37.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -154.49 133.15 12.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.319 1.447 . . . . 0.0 110.258 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.1 t -102.22 130.73 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.906 1.682 . . . . 0.0 108.458 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -106.14 125.53 51.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.404 1.481 . . . . 0.0 110.748 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 19.2 mtm -92.76 146.59 32.48 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.381 1.472 . . . . 0.0 110.447 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.68 -16.62 30.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.269 2.646 . . . . 0.0 113.488 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 51.7 p -73.96 -5.53 41.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.179 1.391 . . . . 0.0 113.929 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 98.48 -5.32 60.46 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.979 1.752 . . . . 0.0 114.177 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -73.81 159.55 32.74 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.5 1.12 . . . . 0.0 112.207 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.4 m -141.55 154.76 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.145 1.378 . . . . 0.0 111.771 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.19 166.65 32.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.351 1.86 . . . . 0.0 111.255 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -101.76 138.6 19.87 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 121.304 -0.873 . . . . 0.0 111.815 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -83.85 169.5 11.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.361 3.374 . . . . 0.0 111.672 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.3 m -108.62 131.69 54.63 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.611 1.564 . . . . 0.0 109.12 172.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.82 132.82 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.207 1.403 . . . . 0.0 109.126 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 84.8 m -135.39 127.87 30.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.49 1.516 . . . . 0.0 110.081 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.2 129.32 34.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.395 0.678 . . . . 0.0 110.861 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -82.52 -5.43 58.73 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 27.0 mmmt 73.24 3.86 4.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.145 2.578 . . . . 0.0 113.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -109.33 8.19 25.45 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.995 2.118 . . . . 0.0 112.967 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.2 20.42 42.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.72 1.152 . . . . 0.0 113.876 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 41.8 p -133.94 158.28 43.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.273 1.829 . . . . 0.0 109.966 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.97 146.73 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.472 1.109 . . . . 0.0 110.059 167.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.6 m -104.2 138.63 40.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.797 1.239 . . . . 0.0 108.449 167.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 27.3 t -126.47 134.81 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.991 1.317 . . . . 0.0 109.373 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -136.67 158.13 45.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.856 1.262 . . . . 0.0 113.277 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 10.3 t80 -156.42 135.42 11.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.314 1.846 . . . . 0.0 111.36 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.27 119.32 72.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.338 1.055 . . . . 0.0 110.579 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.97 145.39 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.53 2.82 . . . . 0.0 112.155 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.9 t -136.73 -14.52 1.64 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.81 152.35 45.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.995 1.718 . . . . 0.0 109.962 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.79 168.85 12.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.034 0.934 . . . . 0.0 112.116 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 105.15 -168.5 15.71 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.648 1.594 . . . . 0.0 113.916 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 39.7 tp -78.74 132.25 36.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.73 1.212 . . . . 0.0 110.613 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 47.5 m80 -127.17 166.37 17.82 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.796 1.638 . . . . 0.0 111.093 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -145.81 153.16 40.6 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.732 0.813 . . . . 0.0 111.356 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 65.4 ttp -128.28 117.21 21.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.568 1.547 . . . . 0.0 110.314 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.82 129.19 35.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.465 2.306 . . . . 0.0 109.411 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.5 mm -130.85 132.11 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 109.913 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 136.22 21.3 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -99.56 119.27 37.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.745 2.418 . . . . 0.0 109.699 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.16 36.14 15.01 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.808 1.243 . . . . 0.0 112.795 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.7 2.93 3.0 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.623 2.369 . . . . 0.0 113.93 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 68.8 mtm -104.37 131.65 51.49 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.617 1.567 . . . . 0.0 110.739 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -55.33 138.22 46.0 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.4 pt -72.47 154.01 91.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 166.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.56 129.33 30.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.237 1.958 . . . . 0.0 110.4 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.57 1.56 87.58 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.652 1.12 . . . . 0.0 115.453 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.1 t -76.03 145.89 78.02 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 119.771 1.785 . . . . 0.0 111.652 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.54 159.85 88.59 Favored 'Cis proline' 0 C--N 1.353 0.816 0 CA-C-N 119.845 0.98 . . . . 0.0 112.076 -6.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.92 148.47 22.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.874 1.27 . . . . 0.0 110.288 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -121.17 144.33 48.64 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.484 1.114 . . . . 0.0 110.586 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.6 p90 -163.54 164.78 24.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.152 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.5 t80 -110.7 143.99 40.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.045 0.938 . . . . 0.0 112.705 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.9 t -117.09 141.89 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.422 1.489 . . . . 0.0 109.32 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.7 t0 -157.22 165.36 36.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 0.0 111.463 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.19 148.43 47.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.581 1.152 . . . . 0.0 112.861 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.1 m -86.52 -16.47 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -109.58 -5.91 15.54 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -168.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 84.9 m -82.66 153.94 25.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.493 1.117 . . . . 0.0 112.878 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.62 -9.64 62.65 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.973 1.273 . . . . 0.0 115.238 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -65.38 159.27 24.48 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.69 1.245 . . . . 0.0 113.675 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.5 t -65.96 136.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.038 0.935 . . . . 0.0 109.083 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.4 t -156.49 145.53 20.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.53 1.132 . . . . 0.0 110.379 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.97 141.51 44.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.822 1.249 . . . . 0.0 111.86 -170.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.8 p90 -169.16 163.72 11.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 112.756 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.0 172.18 12.8 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.4 1.476 . . . . 0.0 112.784 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.94 -33.35 16.06 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.833 2.355 . . . . 0.0 112.681 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.3 -37.07 92.54 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.549 1.068 . . . . 0.0 114.321 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.85 -6.23 53.51 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.784 1.292 . . . . 0.0 113.272 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 53.9 m -97.35 -43.73 7.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.899 1.68 . . . . 0.0 110.777 170.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -152.86 124.54 7.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.041 1.737 . . . . 0.0 112.3 -164.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -127.65 -179.54 15.89 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.448 1.975 . . . . 0.0 112.315 166.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.9 t -142.59 139.77 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.821 1.649 . . . . 0.0 107.792 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.62 134.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 118.288 0.494 . . . . 0.0 112.125 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.4 m-80 67.93 -1.39 1.74 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.964 2.106 . . . . 0.0 114.752 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.45 137.17 19.56 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.949 1.3 . . . . 0.0 110.957 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.16 122.58 8.16 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.609 2.206 . . . . 0.0 110.299 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.15 144.03 34.47 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.4 1.48 . . . . 0.0 110.484 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.11 148.45 49.8 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.56 175.95 12.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.898 1.679 . . . . 0.0 112.011 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -132.36 145.55 51.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.095 1.358 . . . . 0.0 110.921 -171.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 28.6 t -117.47 138.0 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.13 1.772 . . . . 0.0 108.436 168.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -94.97 134.1 38.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.351 1.061 . . . . 0.0 111.423 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 72.3 p -131.13 3.67 4.36 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.164 1.785 . . . . 0.0 113.11 -171.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -55.99 -34.46 65.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.617 1.967 . . . . 0.0 115.615 -164.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.04 19.42 5.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.548 1.539 . . . . 0.0 112.357 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.69 -34.26 60.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.79 148.45 9.68 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.874 1.226 . . . . 0.0 112.737 -171.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.19 148.23 39.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.527 1.131 . . . . 0.0 112.165 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 172.01 -24.1 0.08 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.51 1.052 . . . . 0.0 115.121 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.81 110.14 1.15 Allowed Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.497 1.523 . . . . 0.0 112.643 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.44 126.76 32.58 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.609 1.564 . . . . 0.0 109.037 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 44.3 m -122.79 155.64 36.14 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.869 1.668 . . . . 0.0 111.875 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.6 tp -158.44 135.16 9.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.614 1.566 . . . . 0.0 109.131 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.57 159.0 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.995 0.918 . . . . 0.0 112.175 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -136.07 141.32 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.846 1.258 . . . . 0.0 109.661 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.24 161.7 28.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 109.882 170.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.87 31.47 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 118.875 -0.958 . . . . 0.0 114.317 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.57 -24.84 62.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.048 3.165 . . . . 0.0 112.717 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.1 t -143.42 160.87 39.77 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.311 1.444 . . . . 0.0 109.628 164.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.2 tptt -74.34 116.99 15.64 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.071 -1.018 . . . . 0.0 110.989 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.59 149.07 46.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.73 0.812 . . . . 0.0 111.738 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -85.79 140.82 30.14 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.644 0.778 . . . . 0.0 109.171 166.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.3 143.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.439 1.096 . . . . 0.0 110.402 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -140.63 164.97 28.74 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.871 1.268 . . . . 0.0 110.906 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.3 p -161.55 158.88 27.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.758 1.223 . . . . 0.0 112.555 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 50.4 m -144.42 119.14 9.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.989 1.316 . . . . 0.0 110.126 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.57 130.37 36.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.565 1.146 . . . . 0.0 110.938 171.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -109.77 145.57 36.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.883 1.673 . . . . 0.0 111.73 -176.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.02 -18.17 65.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.966 1.307 . . . . 0.0 113.237 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -69.62 -22.43 63.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.558 1.143 . . . . 0.0 113.636 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 103.41 43.54 1.84 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.271 0.939 . . . . 0.0 113.223 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 57.6 p -139.09 159.36 42.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.177 1.391 . . . . 0.0 110.398 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 36.4 t -115.38 125.63 53.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.174 1.39 . . . . 0.0 108.588 161.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.2 t -87.21 151.4 23.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.853 0.861 . . . . 0.0 110.293 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -133.03 143.12 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.827 1.651 . . . . 0.0 110.085 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.5 p -135.6 148.05 48.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.949 1.3 . . . . 0.0 111.694 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.2 p90 -150.39 153.17 35.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.9 mt -120.55 105.62 41.09 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.559 1.943 . . . . 0.0 109.869 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -82.67 176.87 7.39 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.847 3.031 . . . . 0.0 110.321 167.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -148.85 -30.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 69.3 mt -107.58 147.63 35.69 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 119.725 1.148 . . . . 0.0 110.767 167.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.6 155.17 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.128 2.552 . . . . 0.0 111.041 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.65 -159.09 25.8 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.442 1.496 . . . . 0.0 113.134 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.01 135.26 41.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.065 1.346 . . . . 0.0 111.929 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -118.87 142.49 47.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.718 1.607 . . . . 0.0 110.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -101.65 122.0 43.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.82 1.248 . . . . 0.0 110.356 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.91 120.89 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.775 1.63 . . . . 0.0 108.466 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.1 tt -103.69 131.36 50.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.478 1.511 . . . . 0.0 109.744 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 131.32 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.454 1.502 . . . . 0.0 108.098 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -152.99 142.9 22.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.104 1.362 . . . . 0.0 110.325 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.93 123.75 11.26 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.213 -0.93 . . . . 0.0 110.534 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 43.8 t-20 57.5 54.25 6.67 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.973 1.309 . . . . 0.0 111.443 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 9.4 pt-20 56.2 22.7 6.35 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.21 2.604 . . . . 0.0 115.975 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.4 129.78 39.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.558 1.143 . . . . 0.0 111.328 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.42 156.89 18.08 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.187 0.995 . . . . 0.0 112.482 169.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.7 m -87.83 156.68 52.52 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.272 0.629 . . . . 0.0 110.489 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.52 119.1 5.86 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.885 2.39 . . . . 0.0 110.203 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.94 -13.2 65.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.297 1.427 . . . . 0.0 116.564 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.5 p -81.5 151.36 68.59 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 119.921 1.861 . . . . 0.0 113.214 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 146.56 86.88 Favored 'Cis proline' 0 C--N 1.355 0.885 0 CA-C-N 119.076 0.706 . . . . 0.0 112.051 -6.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.64 159.31 15.05 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 110.955 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 48.4 m -114.71 121.17 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.817 0.847 . . . . 0.0 110.654 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -104.02 141.35 36.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.421 1.488 . . . . 0.0 111.623 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.56 141.02 41.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.548 1.139 . . . . 0.0 109.912 164.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.1 t -133.24 138.74 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.655 1.182 . . . . 0.0 109.562 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 11.8 p -132.7 169.99 15.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.677 1.191 . . . . 0.0 112.469 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.48 140.99 27.05 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.603 1.573 . . . . 0.0 113.129 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 124.5 1.12 . . . . 0.0 113.047 175.542 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 120.608 0.242 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.19 121.19 67.86 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.17 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.5 148.1 47.43 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.664 2.243 . . . . 0.0 110.424 173.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.36 135.66 33.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.468 0.651 . . . . 0.0 110.733 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -157.33 144.28 18.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.021 1.728 . . . . 0.0 110.531 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.36 149.87 21.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.455 1.502 . . . . 0.0 109.73 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -123.17 132.74 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.166 1.386 . . . . 0.0 109.489 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 74.0 mt -129.37 136.27 28.88 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.325 1.85 . . . . 0.0 108.735 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.0 72.24 6.27 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.256 3.304 . . . . 0.0 111.419 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 34.6 t80 -124.41 152.5 43.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.589 1.956 . . . . 0.0 109.338 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 34.6 m -127.25 125.62 41.28 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.424 1.09 . . . . 0.0 109.624 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.2 mt -75.08 135.6 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 110.378 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 21.4 pttp -128.84 -147.85 0.36 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.248 1.819 . . . . 0.0 110.923 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.11 126.74 29.02 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.537 -1.352 . . . . 0.0 110.418 165.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 124.65 -154.03 17.93 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.52 1.533 . . . . 0.0 112.183 -170.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -161.39 151.95 17.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 111.214 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.48 134.89 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.51 1.524 . . . . 0.0 111.847 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -147.52 158.85 44.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.561 1.544 . . . . 0.0 110.917 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -137.44 -175.85 14.08 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -153.39 143.71 22.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.341 1.856 . . . . 0.0 109.065 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 98.3 t -119.45 129.31 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.719 1.608 . . . . 0.0 108.008 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -113.5 130.08 56.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.356 1.462 . . . . 0.0 110.479 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 34.8 mtm -108.67 139.92 21.32 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.413 1.485 . . . . 0.0 111.875 -171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.37 -27.48 75.89 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 124.258 3.305 . . . . 0.0 115.54 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.8 p -75.08 4.87 6.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.353 1.461 . . . . 0.0 114.563 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.83 44.54 5.12 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 124.665 1.126 . . . . 0.0 113.088 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -153.24 165.07 36.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.522 1.529 . . . . 0.0 112.107 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.6 m -141.25 159.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.67 1.188 . . . . 0.0 112.632 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.05 175.55 13.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.063 2.145 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -121.91 143.9 39.75 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.123 -0.985 . . . . 0.0 112.204 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -86.25 171.74 7.56 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 111.877 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.2 m -106.91 130.56 54.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 109.031 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.88 132.88 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.163 1.385 . . . . 0.0 108.951 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -136.55 124.04 22.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.36 1.464 . . . . 0.0 109.975 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.1 126.41 30.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.54 0.736 . . . . 0.0 110.753 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.02 -6.33 57.39 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 73.68 1.09 3.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 113.537 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -102.85 4.6 37.9 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.086 2.155 . . . . 0.0 112.979 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.08 15.89 40.27 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.069 1.319 . . . . 0.0 114.341 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.0 p -130.69 155.94 45.76 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.163 1.785 . . . . 0.0 110.615 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -112.64 137.34 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.71 165.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.5 m -93.74 137.91 32.5 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.583 1.153 . . . . 0.0 108.424 167.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.2 t -125.5 133.43 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.469 1.508 . . . . 0.0 108.855 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -139.84 155.79 47.05 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 0.0 112.656 -176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.3 t80 -151.05 134.55 16.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 111.547 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.86 122.72 74.45 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.575 1.15 . . . . 0.0 111.105 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.23 161.15 20.27 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.784 2.99 . . . . 0.0 111.938 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -149.81 -21.81 0.27 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -141.4 149.54 41.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.46 1.904 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.91 167.76 19.5 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.039 0.936 . . . . 0.0 112.98 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 122.58 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.59 1.567 . . . . 0.0 114.085 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tt -83.68 118.7 24.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.436 1.094 . . . . 0.0 109.417 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 28.3 m80 -111.38 158.43 19.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.524 1.53 . . . . 0.0 111.054 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -143.73 150.99 39.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.482 0.658 . . . . 0.0 112.337 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.8 ttm -132.14 139.2 48.35 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.782 2.033 . . . . 0.0 110.712 -164.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -112.19 137.37 50.37 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 109.635 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.3 mm -133.93 129.39 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.646 1.178 . . . . 0.0 109.683 174.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.87 137.66 36.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 19.9 t80 -103.83 124.91 49.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.499 1.92 . . . . 0.0 109.672 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 27.3 t70 48.29 46.51 20.11 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.779 1.232 . . . . 0.0 112.293 -177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.306 0.3 OUTLIER 62.78 13.35 6.4 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 128.005 2.522 . . . . 0.0 116.543 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 58.9 ttm -114.74 130.41 56.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.529 1.532 . . . . 0.0 110.926 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -56.06 135.9 52.53 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.285 -0.885 . . . . 0.0 113.053 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.87 154.32 89.02 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.328 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.04 128.2 25.78 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.992 1.794 . . . . 0.0 109.403 170.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.35 -16.05 58.34 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.702 1.144 . . . . 0.0 114.098 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.1 t -82.41 146.98 55.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-N 119.803 1.802 . . . . 0.0 110.876 170.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.68 163.85 82.86 Favored 'Cis proline' 0 C--N 1.353 0.804 0 CA-C-N 120.333 1.155 . . . . 0.0 112.413 -6.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.5 159.26 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.17 1.788 . . . . 0.0 111.047 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -155.4 148.72 24.89 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 112.819 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 7.8 p90 -167.2 -179.4 4.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.968 1.707 . . . . 0.0 111.264 -167.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -120.48 142.39 49.32 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.779 -1.201 . . . . 0.0 113.405 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.1 t -111.73 134.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.144 1.778 . . . . 0.0 108.966 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -161.29 158.31 26.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.96 1.304 . . . . 0.0 112.923 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -75.48 122.15 23.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 112.124 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 32.7 m -79.79 -15.77 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 p30 -85.07 -14.69 46.45 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.719 1.208 . . . . 0.0 114.181 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.7 m -77.81 -17.22 57.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 85.16 -3.44 87.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 0.0 115.676 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -64.84 156.0 32.22 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 119.201 1.501 . . . . 0.0 112.962 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.5 t -68.19 131.82 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.2 t -152.92 161.1 42.97 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.507 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.84 142.8 36.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.358 1.463 . . . . 0.0 111.235 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 20.6 p90 -163.58 161.11 23.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.572 1.549 . . . . 0.0 112.161 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.67 176.97 15.63 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.863 1.22 . . . . 0.0 113.293 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.12 -37.94 5.49 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.045 2.496 . . . . 0.0 112.594 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.91 -32.54 73.69 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.588 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.23 -3.84 41.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.769 1.284 . . . . 0.0 113.426 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.7 m -110.35 -48.48 3.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.327 1.851 . . . . 0.0 111.109 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -138.54 145.96 41.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.101 1.76 . . . . 0.0 112.235 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.91 -179.27 21.15 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.574 1.083 . . . . 0.0 113.624 173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.0 t -143.57 136.04 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.108 1.363 . . . . 0.0 108.598 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.3 m -56.46 137.34 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.2 m-80 68.06 -2.88 1.36 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.756 2.022 . . . . 0.0 114.663 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -100.9 136.99 19.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.039 1.336 . . . . 0.0 110.725 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.25 127.95 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.377 2.051 . . . . 0.0 110.124 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.12 146.55 36.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.613 1.565 . . . . 0.0 110.523 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.4 p -136.43 153.98 50.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -164.16 172.49 13.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.26 1.824 . . . . 0.0 111.351 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.7 m -122.75 142.42 50.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.161 1.384 . . . . 0.0 110.694 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.9 t -115.85 133.71 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.474 1.509 . . . . 0.0 108.417 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.73 132.85 36.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.381 1.072 . . . . 0.0 111.585 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 45.8 p -136.64 0.87 2.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.189 1.395 . . . . 0.0 114.108 -169.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -53.46 -37.86 63.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 115.119 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -117.01 9.92 13.82 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.396 1.479 . . . . 0.0 112.538 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.13 56.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.446 1.099 . . . . 0.0 113.504 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.36 -106.77 2.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.609 1.1 . . . . 0.0 112.247 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -161.45 155.12 21.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.523 1.929 . . . . 0.0 109.942 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 148.08 9.21 0.19 Allowed Glycine 0 N--CA 1.473 1.118 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.03 103.84 2.05 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 126.078 1.799 . . . . 0.0 112.479 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.72 132.85 33.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.984 1.713 . . . . 0.0 109.603 171.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.3 m -129.86 157.99 40.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.6 1.56 . . . . 0.0 112.134 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.1 tp -159.02 136.06 9.69 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.029 1.732 . . . . 0.0 109.184 -170.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.45 158.93 36.73 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 112.424 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.3 mt -137.51 139.04 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.89 1.276 . . . . 0.0 109.98 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.83 129.16 40.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.369 1.468 . . . . 0.0 109.944 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.35 -162.16 11.24 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 119.04 -0.866 . . . . 0.0 114.386 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.7 -24.72 69.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.042 3.162 . . . . 0.0 112.56 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.6 t -138.97 160.45 39.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.978 1.311 . . . . 0.0 109.627 162.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -71.75 112.34 7.77 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.134 -0.979 . . . . 0.0 110.689 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.64 148.77 50.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.694 0.798 . . . . 0.0 111.688 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.44 140.71 29.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.09 143.89 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.665 1.186 . . . . 0.0 110.259 -167.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.9 t -141.67 156.5 45.64 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.13 1.372 . . . . 0.0 111.144 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 48.9 t -145.35 136.97 25.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.211 1.405 . . . . 0.0 110.66 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 93.5 m -132.3 129.33 39.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.272 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.99 131.5 43.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 110.779 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.17 -131.23 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.85 0.86 . . . . 0.0 110.222 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -84.1 38.04 0.64 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.461 -1.399 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 20.7 t70 71.37 -20.44 0.23 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.813 2.845 . . . . 0.0 114.588 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . -76.77 -21.27 74.89 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.758 1.17 . . . . 0.0 114.194 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 31.8 p -147.5 157.61 43.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.788 1.635 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 74.2 m -115.54 136.7 52.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.115 1.766 . . . . 0.0 109.205 162.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -98.57 136.89 38.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.466 1.106 . . . . 0.0 110.493 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.5 t -111.43 142.48 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.93 1.692 . . . . 0.0 109.782 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 51.9 m -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.145 1.378 . . . . 0.0 110.833 168.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 9.6 p90 -148.38 154.29 39.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 8.8 mt -120.62 107.66 38.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.893 1.677 . . . . 0.0 110.763 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.64 175.03 9.18 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.036 3.157 . . . . 0.0 110.46 166.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.3 p -151.07 -30.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.4 mt -105.6 146.33 32.61 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.586 1.085 . . . . 0.0 110.533 167.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.86 154.53 48.46 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.911 2.407 . . . . 0.0 110.949 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.13 -158.6 24.0 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.796 1.188 . . . . 0.0 113.247 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -100.82 133.31 45.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.09 1.356 . . . . 0.0 112.492 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.83 126.07 50.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.999 1.72 . . . . 0.0 109.956 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 71.2 m -84.32 126.62 33.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.108 0.963 . . . . 0.0 110.582 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.73 124.99 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.6 1.56 . . . . 0.0 108.283 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -108.86 130.49 55.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.29 1.436 . . . . 0.0 109.811 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -132.58 128.79 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.417 1.087 . . . . 0.0 109.879 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.99 142.2 24.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.058 1.343 . . . . 0.0 111.718 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.65 121.36 16.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.809 1.244 . . . . 0.0 109.448 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.41 57.37 4.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.472 1.509 . . . . 0.0 112.159 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.285 8.5 pt-20 57.21 12.12 1.26 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.498 2.719 . . . . 0.0 116.329 -177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -119.26 125.31 48.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.704 1.202 . . . . 0.0 110.671 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -64.72 147.39 53.17 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.457 -0.777 . . . . 0.0 111.894 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 21.8 m -69.11 152.47 96.71 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.044 168.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.99 128.69 23.66 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.254 1.969 . . . . 0.0 110.063 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.52 -14.74 64.74 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.989 1.28 . . . . 0.0 115.007 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.8 t -78.16 139.94 61.08 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.258 1.529 . . . . 0.0 111.295 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.41 135.55 40.83 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.383 0.816 . . . . 0.0 111.905 -3.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.3 170.9 12.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.0 1.72 . . . . 0.0 110.399 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 52.4 m -132.73 121.27 22.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.35 140.33 30.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.312 1.445 . . . . 0.0 110.872 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -100.89 122.52 43.6 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.732 0.813 . . . . 0.0 109.968 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.7 t -109.26 129.89 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.589 1.555 . . . . 0.0 110.373 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.5 p -100.68 155.96 17.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.676 1.19 . . . . 0.0 112.752 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.7 121.98 6.85 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.404 1.478 . . . . 0.0 111.183 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 CA--C 1.551 1.009 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.38 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.38 117.49 16.88 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.605 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.67 112.54 3.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.546 2.164 . . . . 0.0 108.809 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.71 135.48 42.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.718 0.807 . . . . 0.0 111.686 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.75 166.07 27.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.508 1.923 . . . . 0.0 111.411 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 156.47 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.427 1.491 . . . . 0.0 111.038 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -121.67 135.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.326 1.45 . . . . 0.0 109.364 167.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 65.2 mt -132.02 136.94 29.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.368 1.867 . . . . 0.0 108.367 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.76 42.45 1.26 Allowed 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.46 3.44 . . . . 0.0 113.124 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -89.01 159.16 17.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.303 1.441 . . . . 0.0 111.546 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.5 m -127.04 128.1 45.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.396 1.478 . . . . 0.0 110.282 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 26.4 mt -93.8 130.67 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.617 1.167 . . . . 0.0 109.376 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -113.24 -75.23 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.635 1.174 . . . . 0.0 111.791 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.8 tttm -160.07 133.73 7.08 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.998 1.719 . . . . 0.0 110.951 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.6 -137.73 9.76 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.533 1.54 . . . . 0.0 110.945 -166.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -155.88 140.11 16.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.026 0.931 . . . . 0.0 111.727 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.9 tt -116.74 138.08 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.847 1.659 . . . . 0.0 110.696 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.0 p -144.1 177.96 8.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.19 1.796 . . . . 0.0 110.392 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.18 -172.27 37.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -156.41 143.83 19.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.62 1.568 . . . . 0.0 109.919 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 91.0 t -118.17 132.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.566 1.546 . . . . 0.0 108.674 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -108.76 137.14 47.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 112.166 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 8.3 mtm -103.0 142.5 24.68 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.059 1.743 . . . . 0.0 111.135 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.33 -27.21 66.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.052 3.168 . . . . 0.0 115.278 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.8 p -73.81 0.69 12.42 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.407 1.483 . . . . 0.0 114.37 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.71 69.22 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.892 1.71 . . . . 0.0 114.3 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -73.69 156.81 37.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.057 1.343 . . . . 0.0 112.153 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.0 m -139.95 152.59 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.594 1.557 . . . . 0.0 110.795 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.29 170.04 22.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.721 1.608 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -101.74 138.62 19.88 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.704 0.802 . . . . 0.0 111.556 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.36 162.53 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.946 3.098 . . . . 0.0 111.073 169.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 91.4 m -109.82 119.39 39.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.332 1.453 . . . . 0.0 108.997 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.73 132.01 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.957 1.303 . . . . 0.0 109.239 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.5 m -134.13 120.14 19.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.565 1.546 . . . . 0.0 109.376 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.37 131.64 37.05 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.718 0.807 . . . . 0.0 112.094 172.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.96 -3.55 58.96 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt 73.06 0.78 3.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.575 2.35 . . . . 0.0 113.875 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -109.78 8.44 24.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.802 2.041 . . . . 0.0 113.112 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.31 15.75 49.68 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.866 1.222 . . . . 0.0 114.352 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 45.1 p -131.14 161.03 33.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.216 1.806 . . . . 0.0 110.415 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 17.9 m -122.75 140.77 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 110.212 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 46.7 m -98.29 140.66 32.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.993 1.317 . . . . 0.0 108.432 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.4 t -127.56 134.84 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.546 1.139 . . . . 0.0 109.522 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -132.18 162.87 29.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.651 1.581 . . . . 0.0 111.984 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.1 t80 -157.14 140.4 15.55 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.513 1.525 . . . . 0.0 111.796 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.98 114.86 63.87 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.705 1.202 . . . . 0.0 110.807 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.68 158.33 28.29 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.593 2.862 . . . . 0.0 112.075 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 95.9 p -143.45 0.37 1.14 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -169.59 157.25 7.02 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.415 1.886 . . . . 0.0 110.554 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.87 170.94 15.62 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.324 1.05 . . . . 0.0 113.085 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.7 -177.79 16.39 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 125.884 1.707 . . . . 0.0 114.391 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.0 tp -86.93 112.38 21.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 110.155 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 45.2 m80 -105.71 171.69 7.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.002 1.721 . . . . 0.0 111.444 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.34 151.17 37.07 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.948 0.899 . . . . 0.0 111.339 172.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 31.4 ttm -119.19 129.98 55.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.059 1.744 . . . . 0.0 110.685 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.77 134.3 40.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.082 2.553 . . . . 0.0 109.392 165.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.0 mm -138.47 135.98 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.928 1.291 . . . . 0.0 108.703 168.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.71 142.15 24.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.993 0.917 . . . . 0.0 113.384 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.63 118.73 36.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.405 1.882 . . . . 0.0 109.611 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.14 34.23 10.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.62 1.168 . . . . 0.0 112.727 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 73.05 8.05 5.39 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.827 2.451 . . . . 0.0 115.11 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.98 128.68 46.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.375 1.47 . . . . 0.0 110.459 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 139.27 55.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.6 pt -73.66 150.29 88.71 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.88 169.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.21 -20.12 66.67 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.837 2.358 . . . . 0.0 113.959 -172.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.42 1.01 88.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.099 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.1 m -119.84 156.46 54.08 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 120.031 1.916 . . . . 0.0 113.347 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.35 169.29 74.4 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 119.098 0.714 . . . . 0.0 113.212 0.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 74.3 mt -129.71 150.12 51.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.375 1.87 . . . . 0.0 110.563 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.8 136.84 47.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.936 1.294 . . . . 0.0 110.164 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.4 p90 -154.17 149.26 26.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.386 1.074 . . . . 0.0 112.213 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.5 t80 -99.87 145.27 27.96 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.179 -0.951 . . . . 0.0 112.748 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.0 t -124.43 143.39 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.786 1.634 . . . . 0.0 109.233 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.9 t0 -151.64 167.8 26.98 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.966 1.306 . . . . 0.0 110.96 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.67 164.72 24.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.02 1.328 . . . . 0.0 112.787 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 34.1 m -73.52 -20.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.962 167.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -86.89 -6.74 58.69 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.849 1.259 . . . . 0.0 114.138 -171.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 29.4 p -64.14 145.57 55.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.267 1.027 . . . . 0.0 113.615 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -108.19 -21.15 7.85 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.156 1.36 . . . . 0.0 113.932 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -70.12 159.85 33.15 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.65 1.18 . . . . 0.0 113.999 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.3 t -64.59 135.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 109.061 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.9 t -156.71 163.12 39.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.773 1.229 . . . . 0.0 110.877 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.59 147.33 31.94 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.875 1.27 . . . . 0.0 112.38 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -169.08 160.34 9.79 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.758 1.623 . . . . 0.0 112.968 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 145.22 175.82 18.67 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.201 1.381 . . . . 0.0 113.576 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.46 -37.55 12.98 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.045 2.497 . . . . 0.0 112.218 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.9 75.88 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.215 0.912 . . . . 0.0 114.099 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.26 -11.09 60.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.576 1.15 . . . . 0.0 113.213 171.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.8 m -120.67 -43.52 2.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.718 1.607 . . . . 0.0 111.912 -170.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -142.84 154.56 44.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.715 2.006 . . . . 0.0 112.139 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.05 174.4 26.0 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.476 1.036 . . . . 0.0 113.699 172.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 38.4 t -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.919 1.288 . . . . 0.0 108.571 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.8 m -56.39 135.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.153 0.581 . . . . 0.0 112.52 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.7 m-80 66.45 3.5 2.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.938 2.095 . . . . 0.0 114.73 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 54.7 mttm -110.0 142.9 26.85 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.391 1.476 . . . . 0.0 110.948 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.33 119.87 6.22 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.576 2.184 . . . . 0.0 110.577 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -99.55 143.1 30.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.082 1.353 . . . . 0.0 110.082 172.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.9 p -133.49 152.99 51.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -165.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -164.04 174.63 11.13 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.741 1.616 . . . . 0.0 112.175 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 80.7 m -126.69 142.83 51.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.579 1.552 . . . . 0.0 110.964 -170.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.8 t -116.48 133.15 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.963 1.705 . . . . 0.0 108.265 167.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.03 127.47 35.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.053 0.941 . . . . 0.0 111.222 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 51.5 p -133.13 0.44 3.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.076 1.35 . . . . 0.0 114.011 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.1 tptp -52.5 -39.12 60.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.699 1.6 . . . . 0.0 114.459 -173.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.37 6.66 20.54 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.385 1.474 . . . . 0.0 113.046 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.23 60.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.231 1.012 . . . . 0.0 113.622 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 77.72 -102.49 1.77 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.624 1.107 . . . . 0.0 112.164 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.92 157.28 23.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.247 1.819 . . . . 0.0 110.18 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.79 4.21 0.75 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.572 1.558 . . . . 0.0 115.146 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.01 103.67 1.89 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.544 1.545 . . . . 0.0 113.224 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.06 135.58 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.655 1.582 . . . . 0.0 109.266 168.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -138.76 165.3 27.34 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.079 1.352 . . . . 0.0 112.319 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -165.05 136.8 4.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.207 1.803 . . . . 0.0 109.699 -161.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.92 166.24 32.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.519 1.128 . . . . 0.0 112.004 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.66 131.76 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.651 1.18 . . . . 0.0 109.55 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.87 113.38 25.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 109.454 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.08 -174.95 13.93 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.128 1.347 . . . . 0.0 113.802 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.84 -23.81 47.36 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.853 3.035 . . . . 0.0 111.942 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -142.06 159.53 42.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 160.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.06 130.62 43.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.933 -1.105 . . . . 0.0 112.52 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.37 152.44 27.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.103 0.961 . . . . 0.0 110.981 164.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.21 139.3 30.63 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 165.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -132.8 138.76 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.558 1.143 . . . . 0.0 110.392 -167.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 68.6 m -134.74 158.27 44.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 111.008 170.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -152.87 153.61 33.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.387 1.075 . . . . 0.0 112.544 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.9 m -143.09 122.2 12.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.461 1.504 . . . . 0.0 110.373 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.68 129.51 36.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.415 1.086 . . . . 0.0 111.132 171.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -104.62 158.74 16.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.424 1.489 . . . . 0.0 112.602 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -70.92 -15.59 62.62 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.83 0.852 . . . . 0.0 112.114 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.47 -3.62 34.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.267 1.827 . . . . 0.0 114.551 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 86.99 27.3 29.0 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.207 0.908 . . . . 0.0 113.775 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.3 p -137.85 158.74 43.71 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 110.943 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 34.5 t -103.6 127.97 50.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.333 1.053 . . . . 0.0 108.819 159.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -88.15 152.36 22.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.681 0.793 . . . . 0.0 110.226 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 91.9 t -133.63 143.86 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.628 1.571 . . . . 0.0 109.567 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -135.97 147.64 48.12 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.019 1.328 . . . . 0.0 111.793 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -149.81 152.12 34.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.9 mt -117.54 102.0 52.16 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.693 1.997 . . . . 0.0 110.262 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.79 162.12 18.73 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.763 2.976 . . . . 0.0 110.412 170.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.9 m -124.25 -10.56 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -167.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -156.01 151.79 22.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.363 1.465 . . . . 0.0 110.347 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.33 140.69 24.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.665 2.244 . . . . 0.0 111.462 -173.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.63 -167.91 33.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.507 1.051 . . . . 0.0 113.591 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -96.0 124.3 39.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.331 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.67 121.33 38.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.75 1.62 . . . . 0.0 110.176 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.4 m -92.4 109.8 21.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.267 1.027 . . . . 0.0 110.989 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -81.49 131.99 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.765 1.626 . . . . 0.0 108.677 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.88 128.88 55.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.951 1.7 . . . . 0.0 108.987 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 48.9 t -128.28 130.02 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.19 0.996 . . . . 0.0 109.839 172.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.61 141.36 22.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.842 1.257 . . . . 0.0 111.961 -167.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.46 123.46 21.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.041 1.336 . . . . 0.0 109.457 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.79 57.72 5.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.347 1.459 . . . . 0.0 112.617 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.1 pt-20 57.84 11.02 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 128.134 2.574 . . . . 0.0 116.296 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -117.45 124.66 49.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.655 1.182 . . . . 0.0 110.597 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.73 143.6 57.27 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.463 -0.773 . . . . 0.0 111.29 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.8 m -70.11 151.83 95.92 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.718 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.54 132.8 45.14 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.535 2.157 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.44 -17.42 57.47 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.103 1.335 . . . . 0.0 114.751 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 32.7 t -75.68 141.29 72.21 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.289 1.544 . . . . 0.0 111.663 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.23 148.87 88.54 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.551 0.875 . . . . 0.0 112.339 -4.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -110.66 132.66 54.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 110.161 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 87.9 m -95.44 114.3 26.06 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.055 0.843 . . . . 0.0 111.251 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.3 138.31 33.17 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.037 1.335 . . . . 0.0 111.033 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -97.04 117.9 32.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.421 0.689 . . . . 0.0 110.887 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.8 t -93.34 137.5 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.399 1.48 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.0 p -115.58 155.84 26.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.564 1.546 . . . . 0.0 112.871 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.23 136.16 14.16 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.962 1.268 . . . . 0.0 112.119 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.3 t70 . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 124.648 1.179 . . . . 0.0 113.464 178.473 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.476 0.655 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -64.41 115.84 23.28 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.443 1.897 . . . . 0.0 110.073 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 151.46 64.59 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -171.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.82 122.89 41.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.199 0.6 . . . . 0.0 110.078 176.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -150.14 132.8 15.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.764 1.226 . . . . 0.0 110.966 174.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.01 157.73 45.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.33 2.252 . . . . 0.0 109.41 -175.303 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.9 p -135.3 134.14 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.654 1.182 . . . . 0.0 109.438 172.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.73 136.41 28.37 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.544 1.537 . . . . 0.0 109.284 -169.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.78 85.56 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.892 3.061 . . . . 0.0 110.319 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.4 t80 -139.98 152.53 46.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.697 1.999 . . . . 0.0 109.429 177.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -126.42 134.51 50.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.822 1.249 . . . . 0.0 109.471 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.5 mt -91.49 128.81 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.522 1.129 . . . . 0.0 109.345 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -99.52 -131.08 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.544 1.138 . . . . 0.0 109.821 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -83.01 -4.21 58.07 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.91 -152.65 17.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.801 1.667 . . . . 0.0 113.291 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.24 149.62 26.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.203 1.401 . . . . 0.0 110.631 -173.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.3 tt -128.8 136.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.542 1.537 . . . . 0.0 111.446 -175.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.1 p -149.25 167.64 25.48 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.169 1.788 . . . . 0.0 110.857 -175.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.39 -170.1 19.87 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -175.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.57 132.94 9.96 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.084 1.754 . . . . 0.0 109.589 177.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 40.2 t -112.33 138.99 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.61 1.564 . . . . 0.0 108.634 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.18 132.71 48.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.832 0.853 . . . . 0.0 111.153 -174.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.4 mtm -106.38 141.66 23.26 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.838 1.655 . . . . 0.0 111.95 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.12 -23.57 36.71 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.63 3.554 . . . . 0.0 115.757 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.0 t -68.92 -8.33 43.29 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.56 48.71 3.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.95 1.262 . . . . 0.0 112.429 177.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -156.87 163.36 39.27 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.131 1.773 . . . . 0.0 111.43 -171.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -139.0 161.71 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.541 1.136 . . . . 0.0 112.734 -171.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.08 169.48 24.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.695 1.998 . . . . 0.0 111.435 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.7 140.79 21.42 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.122 0.969 . . . . 0.0 111.308 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.38 175.24 7.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.209 3.273 . . . . 0.0 111.966 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -114.11 138.01 50.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.534 1.534 . . . . 0.0 109.008 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.76 131.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.783 1.233 . . . . 0.0 108.682 173.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.3 m -133.22 115.44 15.0 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.418 1.487 . . . . 0.0 109.092 -178.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.84 135.27 43.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 112.089 174.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.66 -13.5 34.12 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.3 mttp 66.49 7.04 4.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.326 2.25 . . . . 0.0 114.048 -177.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 9.47 43.25 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.082 2.153 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.84 11.9 57.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.356 1.455 . . . . 0.0 114.025 -174.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -130.13 157.31 42.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.062 1.745 . . . . 0.0 111.385 178.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -119.99 140.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.349 1.06 . . . . 0.0 109.949 164.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 51.7 m -94.16 138.5 32.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 170.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.6 t -126.72 133.04 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.688 1.595 . . . . 0.0 108.612 -175.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.07 157.23 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.553 1.141 . . . . 0.0 113.346 -170.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.0 t80 -158.31 137.83 11.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.874 1.669 . . . . 0.0 111.917 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.0 112.67 56.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.997 1.319 . . . . 0.0 110.785 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.11 149.04 28.09 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.685 2.923 . . . . 0.0 112.921 -174.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.1 p -139.21 -2.99 1.59 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 174.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -141.64 145.89 35.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.241 1.816 . . . . 0.0 109.484 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.74 169.53 15.15 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.976 0.911 . . . . 0.0 112.978 176.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 107.14 -173.19 18.77 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 124.992 1.282 . . . . 0.0 114.712 173.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 60.8 tp -77.71 128.16 33.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.96 1.304 . . . . 0.0 110.893 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -126.41 166.86 16.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.952 1.701 . . . . 0.0 111.175 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.49 153.54 51.71 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 112.312 156.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 43.7 ttm -112.54 121.8 45.86 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 109.875 169.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.77 136.22 38.99 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.106 1.363 . . . . 0.0 110.133 164.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.8 mm -133.88 135.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.709 1.203 . . . . 0.0 109.78 167.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.41 138.65 31.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.665 1.186 . . . . 0.0 112.966 175.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 46.4 t80 -102.87 123.81 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.53 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.08 45.75 22.86 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.766 1.227 . . . . 0.0 112.055 -176.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.28 4.6 p30 67.44 -2.05 1.39 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.864 2.866 . . . . 0.0 116.584 -177.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.2 mtt -100.67 134.27 43.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.069 1.347 . . . . 0.0 111.454 176.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 10.6 m170 -56.08 134.72 52.85 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.318 -0.864 . . . . 0.0 112.551 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.1 154.82 86.52 Favored Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 121.734 -0.603 . . . . 0.0 111.272 173.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -60.37 126.57 20.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.675 1.583 . . . . 0.0 108.587 165.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.98 45.53 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.565 1.078 . . . . 0.0 114.366 -173.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 20.7 t -82.09 142.15 47.56 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.181 1.491 . . . . 0.0 112.143 176.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.05 152.95 77.1 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.988 1.032 . . . . 0.0 111.864 -7.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.59 111.2 22.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.021 1.328 . . . . 0.0 109.109 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -102.27 139.4 37.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.331 1.052 . . . . 0.0 111.531 -176.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.5 p90 -164.35 160.11 20.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.174 0.989 . . . . 0.0 112.801 -176.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -102.75 130.98 49.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.338 1.055 . . . . 0.0 111.998 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.3 t -92.12 134.37 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.919 1.288 . . . . 0.0 109.726 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 21.0 t0 -144.1 162.35 36.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.579 1.952 . . . . 0.0 110.805 -169.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.83 154.02 26.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.387 1.075 . . . . 0.0 112.584 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -65.6 -29.21 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.309 -0.869 . . . . 0.0 112.054 168.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -92.24 -163.06 0.99 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.752 1.621 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.9 m 79.04 155.61 0.15 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.43 2.692 . . . . 0.0 113.352 173.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.35 -8.35 53.07 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 124.912 1.244 . . . . 0.0 115.521 -173.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.96 152.95 41.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 118.911 1.355 . . . . 0.0 113.871 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.2 t -64.88 143.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.181 0.992 . . . . 0.0 108.792 172.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -156.67 158.52 37.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.248 1.019 . . . . 0.0 110.795 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.92 141.81 33.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.194 1.398 . . . . 0.0 111.003 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.3 p90 -166.43 165.99 16.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.229 1.412 . . . . 0.0 112.796 -172.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 122.47 171.84 13.92 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.408 1.48 . . . . 0.0 112.466 -174.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.09 -33.68 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.914 2.409 . . . . 0.0 113.27 -168.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.61 86.68 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.144 0.884 . . . . 0.0 114.513 -169.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.65 -6.92 55.5 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.728 1.264 . . . . 0.0 113.785 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 -40.37 5.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.025 2.13 . . . . 0.0 111.723 176.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -153.43 142.44 21.26 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.039 1.336 . . . . 0.0 112.568 -171.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.57 -176.11 15.61 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.923 1.249 . . . . 0.0 112.672 174.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.0 p -153.38 136.14 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.734 1.214 . . . . 0.0 109.281 176.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.0 m -60.11 147.01 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -171.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 67.42 5.02 4.04 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.432 1.893 . . . . 0.0 114.574 173.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.9 mttp -120.61 149.72 50.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.179 1.792 . . . . 0.0 110.884 170.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.57 135.16 21.56 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.678 2.252 . . . . 0.0 110.848 175.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.29 146.92 36.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.798 1.639 . . . . 0.0 110.105 171.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.1 p -135.53 148.74 49.26 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -164.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -159.56 179.23 9.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.034 1.733 . . . . 0.0 111.265 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 52.6 m -132.87 144.87 50.48 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.316 1.446 . . . . 0.0 110.516 -170.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.6 t -122.53 127.75 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.876 1.67 . . . . 0.0 108.448 172.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -95.05 114.31 26.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.272 1.029 . . . . 0.0 110.554 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 25.2 p -120.54 -1.79 10.06 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.072 2.149 . . . . 0.0 113.423 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.64 -45.12 77.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.922 1.689 . . . . 0.0 114.562 -165.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.45 -15.85 38.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 113.534 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -82.46 -67.12 0.81 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.599 1.16 . . . . 0.0 111.058 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 64.99 16.02 61.28 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 165.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.5 146.58 22.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.585 1.693 . . . . 0.0 111.655 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 90.53 -170.96 35.9 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.58 1.562 . . . . 0.0 112.862 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -92.88 115.63 4.92 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 124.244 0.926 . . . . 0.0 111.525 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -77.74 123.24 26.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.346 1.059 . . . . 0.0 108.608 170.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 47.4 m -120.52 154.09 35.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.433 1.493 . . . . 0.0 112.104 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -157.66 133.83 9.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.865 1.666 . . . . 0.0 108.964 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 160.62 39.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.876 0.871 . . . . 0.0 112.147 177.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -135.04 134.34 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.794 1.238 . . . . 0.0 109.333 172.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.13 120.51 37.95 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.143 1.377 . . . . 0.0 109.051 171.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -132.57 179.93 16.82 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.659 1.124 . . . . 0.0 114.226 -176.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.05 -24.85 38.54 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.038 3.159 . . . . 0.0 111.923 174.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.5 t -134.73 157.81 45.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 108.683 156.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.99 120.64 19.85 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.843 -1.161 . . . . 0.0 112.132 -174.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.56 145.73 34.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.049 0.94 . . . . 0.0 111.202 168.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.62 148.84 25.3 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.336 0.654 . . . . 0.0 110.393 167.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -137.59 144.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.808 1.243 . . . . 0.0 110.235 -166.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 166.86 24.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.891 1.276 . . . . 0.0 111.259 167.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.0 p -155.97 153.46 29.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.939 1.295 . . . . 0.0 112.404 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 70.3 m -140.14 131.38 26.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.436 1.494 . . . . 0.0 110.331 -169.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.63 128.12 34.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.134 174.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -91.84 152.18 20.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.708 1.203 . . . . 0.0 111.657 176.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.51 -17.58 64.2 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.494 0.717 . . . . 0.0 112.322 173.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.8 -9.76 58.78 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.576 1.55 . . . . 0.0 113.702 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 9.66 57.94 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.16 1.362 . . . . 0.0 115.203 176.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.9 p -108.23 161.23 15.19 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.948 1.699 . . . . 0.0 111.524 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 83.5 m -102.65 124.86 48.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.954 1.302 . . . . 0.0 110.278 170.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.3 t -88.69 151.98 22.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.807 0.843 . . . . 0.0 110.582 166.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.3 t -130.94 144.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.174 1.79 . . . . 0.0 109.984 -177.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.5 p -135.65 147.66 48.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.615 1.166 . . . . 0.0 111.729 166.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -148.92 154.95 40.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.31 -0.869 . . . . 0.0 113.005 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.75 102.62 25.22 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.79 1.236 . . . . 0.0 110.456 -173.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.78 163.91 9.07 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.033 3.155 . . . . 0.0 111.3 175.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -127.12 -21.45 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.77 150.51 60.16 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.487 1.115 . . . . 0.0 110.755 173.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.9 145.73 32.2 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.849 2.366 . . . . 0.0 111.99 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.39 -167.54 32.46 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.837 1.208 . . . . 0.0 113.654 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.04 124.57 38.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.392 1.477 . . . . 0.0 112.098 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -116.51 128.21 55.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.855 1.662 . . . . 0.0 110.009 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.9 m -89.99 116.29 27.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.105 0.962 . . . . 0.0 110.705 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.59 124.67 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.698 1.599 . . . . 0.0 108.326 177.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.7 tt -108.53 127.48 53.97 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.455 1.502 . . . . 0.0 109.261 176.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -130.29 127.71 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.315 1.046 . . . . 0.0 109.497 173.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.75 144.6 24.41 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.066 1.347 . . . . 0.0 111.398 -167.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.29 125.98 13.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.509 1.123 . . . . 0.0 110.131 -177.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.1 52.37 11.84 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.576 1.15 . . . . 0.0 112.041 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 7.8 pt-20 58.84 12.68 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.322 2.649 . . . . 0.0 116.39 -177.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -119.49 127.35 52.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.453 1.101 . . . . 0.0 110.997 177.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -62.43 143.32 57.21 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.466 -0.772 . . . . 0.0 111.417 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.4 m -71.38 151.99 94.15 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.03 173.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -55.36 126.55 22.88 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.249 2.633 . . . . 0.0 111.19 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.92 62.17 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.367 1.46 . . . . 0.0 115.085 -175.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 36.4 t -78.06 141.69 63.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 119.356 1.578 . . . . 0.0 111.701 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 141.78 72.16 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.421 0.829 . . . . 0.0 112.27 -4.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -93.95 161.92 14.11 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.171 1.788 . . . . 0.0 110.617 176.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.7 m -119.97 116.0 24.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.675 0.79 . . . . 0.0 110.745 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.33 133.23 39.48 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.702 1.201 . . . . 0.0 111.084 172.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 111.75 23.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.898 0.879 . . . . 0.0 109.553 174.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.2 t -94.6 133.01 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.924 1.29 . . . . 0.0 110.05 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 78.7 p -108.37 165.69 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.915 1.286 . . . . 0.0 113.094 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.96 136.96 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.77 1.176 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 124.78 1.232 . . . . 0.0 113.768 -175.456 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -45.65 110.75 1.21 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.392 1.877 . . . . 0.0 111.349 175.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 133.32 29.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.271 1.98 . . . . 0.0 108.801 172.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.99 123.67 45.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.587 0.755 . . . . 0.0 111.047 -174.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -157.2 141.78 16.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 110.928 177.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.72 147.6 51.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.267 1.827 . . . . 0.0 110.266 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -109.8 138.43 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.785 1.234 . . . . 0.0 109.963 172.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.8 mt -132.47 133.86 24.13 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.048 1.739 . . . . 0.0 108.686 -174.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.13 66.82 8.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.199 3.266 . . . . 0.0 111.211 177.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.8 t80 -115.68 153.81 30.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.895 1.678 . . . . 0.0 111.16 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 59.2 m -121.91 119.72 32.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.264 1.426 . . . . 0.0 109.429 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.46 127.01 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 109.295 174.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.17 -139.59 0.36 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.701 1.2 . . . . 0.0 110.67 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -75.27 -6.68 51.09 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.9 -148.42 8.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.781 1.658 . . . . 0.0 113.017 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -154.88 148.05 24.86 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 110.517 -173.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.49 136.03 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.286 1.434 . . . . 0.0 111.184 -178.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 54.9 p -146.14 -175.33 4.72 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.457 1.903 . . . . 0.0 109.894 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.88 -162.18 20.55 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 -177.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.37 144.75 17.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.289 1.836 . . . . 0.0 109.664 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 90.8 t -123.07 135.89 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.015 1.726 . . . . 0.0 108.223 173.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -120.72 139.59 52.85 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 112.056 -174.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.5 148.11 36.59 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.717 1.607 . . . . 0.0 111.481 -176.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.71 -28.75 67.96 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.115 3.21 . . . . 0.0 114.927 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.1 p -73.56 -2.78 24.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 114.496 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.35 -5.77 83.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.562 1.554 . . . . 0.0 113.9 -178.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -68.77 157.56 36.12 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.144 1.377 . . . . 0.0 112.052 173.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.9 m -140.76 156.36 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.165 1.386 . . . . 0.0 111.655 177.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.28 179.83 8.86 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.92 2.088 . . . . 0.0 110.267 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -127.36 144.76 51.92 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 121.146 -0.971 . . . . 0.0 111.915 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.83 166.14 13.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.146 3.231 . . . . 0.0 111.399 176.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.0 m -111.54 125.59 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.052 1.341 . . . . 0.0 108.96 173.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.14 132.47 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.788 1.235 . . . . 0.0 109.142 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 67.2 m -135.13 126.15 27.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.375 1.47 . . . . 0.0 109.744 178.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.84 139.01 41.49 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.954 0.901 . . . . 0.0 112.607 173.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -93.47 -4.96 50.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 71.14 -3.69 1.99 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.816 2.446 . . . . 0.0 114.225 -176.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.4 5.73 49.33 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.658 1.983 . . . . 0.0 113.264 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.43 14.75 55.17 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.964 1.269 . . . . 0.0 113.891 -174.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 63.7 p -129.69 161.59 30.28 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.293 1.837 . . . . 0.0 110.611 177.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 18.7 m -121.31 146.79 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.595 1.158 . . . . 0.0 109.689 166.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 80.8 m -105.77 135.69 46.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.402 1.081 . . . . 0.0 108.467 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 20.5 t -115.05 133.57 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.569 1.548 . . . . 0.0 108.95 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.55 154.07 47.41 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.55 1.54 . . . . 0.0 112.1 -174.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -153.9 136.19 14.9 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.714 1.606 . . . . 0.0 111.513 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.12 118.12 68.88 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.52 1.128 . . . . 0.0 110.88 177.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.46 144.98 23.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.508 2.805 . . . . 0.0 111.77 -176.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.4 p -135.02 -7.42 2.34 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 178.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -163.49 143.81 8.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.818 1.647 . . . . 0.0 110.218 -175.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -81.6 165.41 21.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.44 1.096 . . . . 0.0 113.239 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.68 -168.24 15.88 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.782 1.658 . . . . 0.0 114.377 178.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.0 130.19 37.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.197 1.799 . . . . 0.0 109.58 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 76.9 m80 -134.25 169.88 16.53 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.251 1.421 . . . . 0.0 112.007 -170.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.76 152.39 38.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 168.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.1 ttm -121.22 118.07 28.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.894 2.478 . . . . 0.0 109.837 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.34 137.75 32.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.428 1.491 . . . . 0.0 109.944 169.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.0 mm -135.65 135.17 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.573 1.149 . . . . 0.0 110.649 175.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.12 20.72 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.73 1.212 . . . . 0.0 113.131 -175.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -99.61 125.31 45.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.743 2.017 . . . . 0.0 109.901 174.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.4 34.05 14.3 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.734 1.214 . . . . 0.0 112.448 -174.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.1 t30 75.15 2.65 3.97 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.397 2.679 . . . . 0.0 114.746 -178.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.0 mtm -102.64 130.61 49.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 0.0 110.638 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -58.7 137.71 57.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.1 pt -71.45 152.46 94.01 Favored Pre-proline 0 N--CA 1.48 1.033 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.599 173.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.17 125.68 17.58 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.363 2.042 . . . . 0.0 110.936 -176.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.92 -8.63 76.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.144 1.354 . . . . 0.0 115.233 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.8 t -63.93 141.26 98.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 120.07 1.935 . . . . 0.0 111.941 175.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.59 161.45 76.15 Favored 'Cis proline' 0 C--N 1.354 0.837 0 CA-C-N 119.998 1.035 . . . . 0.0 113.492 0.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.1 mt -96.4 136.21 37.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.68 1.592 . . . . 0.0 110.004 172.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -109.25 141.96 40.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.372 1.069 . . . . 0.0 110.959 -177.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 34.0 p90 -153.85 174.13 14.99 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 113.212 -173.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.9 t80 -128.49 147.75 50.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 112.421 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 49.3 t -127.6 139.27 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.091 1.756 . . . . 0.0 109.16 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -153.38 160.41 42.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.459 1.504 . . . . 0.0 110.756 -174.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -76.38 139.79 41.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 111.485 177.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -66.04 -23.61 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 121.442 -0.786 . . . . 0.0 112.842 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 55.4 p30 -85.8 -3.66 58.96 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.469 1.508 . . . . 0.0 114.809 -176.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.1 m -64.48 137.48 57.89 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.04 0.936 . . . . 0.0 112.536 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.02 -12.95 54.63 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.939 1.257 . . . . 0.0 114.514 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -69.18 166.91 17.32 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 t -68.01 137.83 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 157.93 31.01 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.04 1.336 . . . . 0.0 110.335 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.07 143.35 44.6 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 111.823 -174.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.44 164.99 15.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.62 1.568 . . . . 0.0 112.813 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.57 173.8 13.42 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.229 1.395 . . . . 0.0 113.19 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.95 -32.99 12.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.666 -171.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.23 -38.32 91.74 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.641 1.109 . . . . 0.0 114.094 -172.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.75 -8.68 57.14 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.712 1.256 . . . . 0.0 113.35 176.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.8 m -96.96 -42.93 7.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.45 1.9 . . . . 0.0 110.881 174.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -155.55 127.42 7.49 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.34 1.856 . . . . 0.0 112.025 -164.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.58 -177.79 15.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.693 2.092 . . . . 0.0 112.165 168.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 87.2 t -145.6 142.71 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.833 2.053 . . . . 0.0 107.476 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.2 m -56.14 138.47 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 65.86 1.91 2.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.802 2.041 . . . . 0.0 114.887 175.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -106.74 139.43 20.36 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.411 1.484 . . . . 0.0 111.057 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.38 119.57 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.705 2.27 . . . . 0.0 110.314 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -101.96 134.54 45.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.179 1.392 . . . . 0.0 110.055 175.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 38.6 p -127.52 145.98 50.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -165.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -157.26 177.05 11.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 178.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.9 m -128.47 142.1 51.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 -169.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.08 131.66 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.679 1.591 . . . . 0.0 108.422 168.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -91.75 129.53 37.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.42 1.088 . . . . 0.0 111.024 -177.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -135.65 8.15 3.31 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.049 1.34 . . . . 0.0 113.606 -168.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.6 tptm -54.23 -37.0 64.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.307 1.843 . . . . 0.0 114.772 -168.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.12 20.13 5.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.695 1.598 . . . . 0.0 112.268 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.77 78.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.377 1.071 . . . . 0.0 113.854 -174.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.27 149.14 4.85 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.883 1.23 . . . . 0.0 112.365 -171.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.18 139.84 52.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.468 0.707 . . . . 0.0 111.815 -178.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.09 10.84 0.02 OUTLIER Glycine 0 CA--C 1.535 1.304 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.88 97.99 1.55 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.163 1.363 . . . . 0.0 112.819 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.47 127.25 31.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.817 1.247 . . . . 0.0 108.748 166.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 49.1 m -117.03 154.69 30.5 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 0.0 111.731 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 54.9 tp -159.57 132.49 6.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.605 1.562 . . . . 0.0 109.096 -172.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.92 159.65 36.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.062 0.945 . . . . 0.0 112.311 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.43 127.42 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.59 1.156 . . . . 0.0 109.9 175.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -105.6 168.01 9.38 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.897 1.679 . . . . 0.0 109.879 167.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 166.11 -161.16 34.79 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.008 -1.057 . . . . 0.0 113.717 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.1 -13.5 26.01 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.569 2.846 . . . . 0.0 112.435 176.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 9.5 t -155.08 168.25 27.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.396 1.879 . . . . 0.0 109.627 168.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -77.97 116.02 18.14 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.898 -1.126 . . . . 0.0 111.363 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -79.7 143.73 34.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.993 0.917 . . . . 0.0 110.802 166.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.64 146.73 23.54 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.236 0.615 . . . . 0.0 110.854 171.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.87 140.32 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.679 1.192 . . . . 0.0 110.856 -163.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -131.31 158.75 39.84 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.116 1.766 . . . . 0.0 110.628 167.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.9 p -151.55 153.65 34.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.165 0.986 . . . . 0.0 112.404 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.2 m -147.0 131.13 17.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.287 1.435 . . . . 0.0 110.812 -166.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 9.5 t0 -71.04 123.02 21.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.199 1.0 . . . . 0.0 110.986 169.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -80.96 -9.78 59.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 113.356 177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 tt0 79.2 -25.12 0.19 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 129.005 2.922 . . . . 0.0 112.696 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.61 1.9 13.23 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.447 1.899 . . . . 0.0 114.15 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.86 21.17 19.32 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 125.216 1.389 . . . . 0.0 114.081 -177.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -133.78 150.4 51.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.095 1.358 . . . . 0.0 110.411 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 82.3 m -106.66 126.1 51.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.451 1.5 . . . . 0.0 109.339 170.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -84.33 150.71 25.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.819 0.848 . . . . 0.0 110.536 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.2 t -126.85 144.87 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.844 2.058 . . . . 0.0 108.828 177.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.1 t -137.35 136.59 38.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.38 1.472 . . . . 0.0 110.277 171.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -142.89 153.74 43.42 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 177.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.5 mt -120.13 104.72 43.31 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.953 1.701 . . . . 0.0 110.073 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.55 155.49 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.481 2.787 . . . . 0.0 110.021 169.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.2 m -116.73 -13.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.28 156.04 26.93 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.835 1.654 . . . . 0.0 110.458 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 153.52 49.32 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.005 2.47 . . . . 0.0 112.72 -170.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.64 -151.4 23.67 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.94 1.257 . . . . 0.0 113.47 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -120.91 125.37 47.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.339 1.456 . . . . 0.0 110.718 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -110.77 149.34 30.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.93 1.692 . . . . 0.0 110.778 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 66.6 m -113.27 114.25 26.43 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.556 1.142 . . . . 0.0 110.963 -177.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.44 123.41 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.288 1.835 . . . . 0.0 108.882 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.53 131.88 52.38 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.549 1.54 . . . . 0.0 109.479 173.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 50.6 t -133.46 131.9 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.394 1.478 . . . . 0.0 108.289 172.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.21 142.96 17.57 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.852 1.261 . . . . 0.0 110.765 -167.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.66 123.58 22.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.548 1.139 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 51.43 56.96 7.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.129 1.372 . . . . 0.0 112.492 176.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.307 8.0 pt-20 59.62 12.95 3.1 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.189 2.596 . . . . 0.0 116.321 -177.215 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -118.96 124.62 47.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.451 1.101 . . . . 0.0 111.188 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -61.59 155.52 22.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.149 0.98 . . . . 0.0 112.785 170.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.92 155.94 70.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 O-C-N 121.787 -0.571 . . . . 0.0 110.427 175.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -55.4 121.19 9.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.795 2.33 . . . . 0.0 110.448 172.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -13.04 67.22 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.177 1.37 . . . . 0.0 116.316 178.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 98.7 p -80.08 153.83 74.82 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 120.552 2.176 . . . . 0.0 113.212 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.95 158.34 99.05 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.222 0.758 . . . . 0.0 112.596 -4.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -112.96 138.21 50.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.335 1.454 . . . . 0.0 111.345 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 21.2 m -89.9 117.42 28.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.876 0.871 . . . . 0.0 110.712 177.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.76 127.5 44.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.281 1.432 . . . . 0.0 111.392 173.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.62 138.22 46.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.534 1.533 . . . . 0.0 110.608 172.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.1 t -138.15 138.8 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.646 1.178 . . . . 0.0 110.818 172.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 81.1 p -130.57 165.19 23.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.535 1.134 . . . . 0.0 112.672 174.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.64 144.19 22.05 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.941 1.734 . . . . 0.0 112.909 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 CA--C 1.552 1.046 0 C-N-CA 125.239 1.416 . . . . 0.0 112.707 178.984 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 20.9 tp . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 110.866 -0.049 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -53.13 110.91 2.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.689 1.196 . . . . 0.0 113.5 -168.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.02 135.79 28.23 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.19 1.927 . . . . 0.0 108.937 172.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1791 ' ' PHE . . . . . 0.407 ' CE2' ' HE1' ' A' 1842 ' ' MET . 2.0 t80 -102.43 121.31 42.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.205 0.602 . . . . 0.0 109.839 -179.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.67 124.53 9.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.828 1.251 . . . . 0.0 110.89 175.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -131.72 149.18 52.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.804 2.042 . . . . 0.0 109.558 -176.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 15.0 p -123.67 135.71 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.894 1.278 . . . . 0.0 110.069 176.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.94 138.18 31.27 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 125.885 1.674 . . . . 0.0 108.979 -174.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.48 59.56 7.2 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.582 3.521 . . . . 0.0 112.216 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 40.1 t80 -100.71 151.7 21.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.529 1.532 . . . . 0.0 111.017 174.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.1 m -124.53 126.79 46.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.149 1.379 . . . . 0.0 109.535 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.41 128.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.792 1.237 . . . . 0.0 110.691 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 41.0 tttm -99.08 -140.17 0.32 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.945 1.698 . . . . 0.0 111.707 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -82.51 -10.63 58.93 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -175.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.42 -143.01 6.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.056 1.789 . . . . 0.0 112.628 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.46 147.44 24.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.732 1.213 . . . . 0.0 110.924 -175.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.7 tt -118.54 133.76 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.684 1.593 . . . . 0.0 111.148 -178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 29.1 p -150.31 170.84 18.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.197 1.799 . . . . 0.0 110.647 -174.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.47 -169.05 24.23 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 -176.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.77 141.86 21.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.395 1.878 . . . . 0.0 109.661 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.3 t -117.31 136.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.64 1.976 . . . . 0.0 108.12 173.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.57 132.2 56.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.252 1.021 . . . . 0.0 111.577 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -100.54 145.48 30.38 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.634 1.574 . . . . 0.0 111.235 -176.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.63 -16.89 23.74 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.673 2.916 . . . . 0.0 112.936 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 30.6 p -76.0 -2.06 28.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.369 1.467 . . . . 0.0 114.301 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.45 45.64 3.98 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.638 1.114 . . . . 0.0 113.63 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.48 170.09 18.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.282 1.433 . . . . 0.0 112.426 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.8 m -138.81 157.84 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.296 1.439 . . . . 0.0 112.159 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.6 177.6 11.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.899 2.08 . . . . 0.0 110.296 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -123.56 145.62 47.57 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 121.222 -0.924 . . . . 0.0 111.896 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -82.93 167.9 14.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.209 3.273 . . . . 0.0 111.342 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.84 126.62 53.24 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.125 1.37 . . . . 0.0 108.547 170.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.72 130.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.317 1.047 . . . . 0.0 108.848 175.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -121.12 128.39 52.5 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.799 1.64 . . . . 0.0 109.639 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.83 121.3 25.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.422 1.089 . . . . 0.0 110.346 173.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.11 -12.75 54.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 65.79 9.84 6.34 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.997 2.119 . . . . 0.0 114.149 -178.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -108.59 10.07 27.15 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.835 2.054 . . . . 0.0 112.808 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.8 15.06 62.0 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.79 1.186 . . . . 0.0 113.601 -172.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 64.2 p -132.78 160.26 37.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.544 1.938 . . . . 0.0 110.472 177.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.3 m -125.0 144.85 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.739 1.215 . . . . 0.0 109.636 166.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 85.9 m -106.96 135.55 48.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.208 1.003 . . . . 0.0 108.691 171.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.5 t -119.97 131.05 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.406 1.483 . . . . 0.0 108.846 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -130.9 156.44 45.05 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.404 . . . . 0.0 112.768 -174.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 9.1 t80 -153.93 137.19 15.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.667 1.587 . . . . 0.0 111.675 176.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.36 120.84 69.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.805 1.242 . . . . 0.0 111.023 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.02 155.88 26.32 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.757 2.971 . . . . 0.0 112.694 -172.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.1 p -140.66 -11.88 1.01 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -160.66 151.29 18.38 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.611 1.565 . . . . 0.0 110.55 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.02 170.44 16.68 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.893 1.277 . . . . 0.0 113.299 179.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.28 -172.11 14.07 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.428 1.49 . . . . 0.0 114.148 177.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.0 tp -82.32 134.56 35.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.636 1.175 . . . . 0.0 110.458 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 66.1 m80 -134.56 165.19 25.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 111.628 -172.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.15 153.49 37.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.438 1.095 . . . . 0.0 111.621 175.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1842 ' ' MET . . . . . 0.407 ' HE1' ' CE2' ' A' 1791 ' ' PHE . 36.3 ttm -130.74 140.31 50.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.567 1.547 . . . . 0.0 110.889 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -107.73 131.1 54.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.425 1.49 . . . . 0.0 110.042 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.58 137.92 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.562 1.145 . . . . 0.0 109.852 167.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.41 144.01 37.91 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.638 1.175 . . . . 0.0 113.027 176.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -103.5 117.28 34.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.439 1.896 . . . . 0.0 109.679 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.56 30.97 9.24 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.663 1.185 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 65.8 m-80 79.09 4.56 2.32 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.662 2.785 . . . . 0.0 115.12 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.6 ttp -96.12 126.42 41.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.696 1.198 . . . . 0.0 110.206 166.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -59.11 139.12 57.21 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.172 -0.955 . . . . 0.0 113.086 -178.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.4 pt -73.76 149.85 88.26 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.375 173.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.34 -20.33 61.75 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 114.067 -171.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.77 -7.84 86.78 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 114.809 174.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.5 m -94.89 155.75 38.83 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.281 1.54 . . . . 0.0 113.078 177.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.22 161.48 94.61 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 118.707 0.574 . . . . 0.0 112.554 -1.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 85.0 mt -104.74 154.03 20.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.592 1.557 . . . . 0.0 110.129 172.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -145.99 139.38 26.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.663 1.185 . . . . 0.0 110.052 -177.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -163.4 166.13 23.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -177.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.9 t80 -110.16 141.52 42.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.025 0.93 . . . . 0.0 111.914 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 97.6 t -110.84 129.91 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.861 1.664 . . . . 0.0 109.085 -178.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.2 t0 -160.42 146.57 15.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.005 1.322 . . . . 0.0 111.841 -173.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 150.36 48.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 113.436 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.3 t -62.06 -44.38 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.289 1.036 . . . . 0.0 111.564 177.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.07 22.98 4.56 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.759 1.224 . . . . 0.0 113.407 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 31.4 p -62.39 -26.57 68.54 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 79.77 -46.81 3.18 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.997 1.761 . . . . 0.0 113.812 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -62.5 165.03 6.65 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.2 t -67.55 134.85 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.762 0.825 . . . . 0.0 109.308 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -160.33 167.7 26.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.953 1.301 . . . . 0.0 110.876 -174.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -148.03 146.31 28.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.879 1.271 . . . . 0.0 111.793 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.5 p90 -166.73 160.65 15.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.49 1.516 . . . . 0.0 113.041 -174.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.4 172.92 13.21 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.622 1.582 . . . . 0.0 112.747 -175.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.16 -32.34 6.87 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.189 2.593 . . . . 0.0 113.443 -170.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.06 77.07 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 0.0 114.287 -170.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.22 -2.32 37.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.678 1.239 . . . . 0.0 113.654 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.5 m -112.97 -41.47 3.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.841 2.056 . . . . 0.0 112.033 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -149.26 146.0 27.37 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.817 1.247 . . . . 0.0 112.843 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.72 179.2 21.3 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.116 1.341 . . . . 0.0 113.096 173.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.7 t -138.8 137.2 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.572 1.149 . . . . 0.0 108.661 174.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -55.7 141.6 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 66.2 m-80 65.9 4.95 3.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.698 1.999 . . . . 0.0 114.716 174.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -123.44 141.78 37.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.632 1.573 . . . . 0.0 110.766 176.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.15 135.9 25.91 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.554 2.17 . . . . 0.0 111.382 -174.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.28 147.14 39.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 110.262 173.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.0 p -136.72 150.85 48.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -165.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 56.0 p90 -162.29 -179.94 7.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.289 1.835 . . . . 0.0 111.507 176.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -129.69 143.64 50.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.37 1.468 . . . . 0.0 110.714 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 60.1 t -116.53 133.36 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.663 1.585 . . . . 0.0 108.393 170.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.33 132.92 37.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.483 1.113 . . . . 0.0 111.421 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.3 p -130.18 6.02 4.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.188 1.795 . . . . 0.0 112.89 -176.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -59.37 -20.65 56.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -165.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.63 31.83 1.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.197 1.399 . . . . 0.0 111.442 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.47 -37.34 65.81 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -175.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.63 153.22 9.04 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.513 1.054 . . . . 0.0 112.236 -168.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -76.78 165.01 25.31 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 160.01 -77.87 0.18 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.367 1.461 . . . . 0.0 111.457 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -176.07 114.67 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.496 1.046 . . . . 0.0 112.625 171.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.44 130.31 34.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.147 1.379 . . . . 0.0 109.32 174.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.9 m -128.27 155.91 43.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.516 1.526 . . . . 0.0 112.159 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 38.2 tp -155.11 135.45 13.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.41 1.884 . . . . 0.0 108.614 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.51 160.26 40.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.992 0.917 . . . . 0.0 112.097 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.9 mt -135.14 133.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.578 1.151 . . . . 0.0 109.614 174.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.82 110.11 13.9 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.301 1.44 . . . . 0.0 109.347 175.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.14 -169.73 12.75 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.918 1.247 . . . . 0.0 113.896 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.31 -18.76 38.97 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.657 2.905 . . . . 0.0 111.987 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.8 t -137.06 159.63 41.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.613 1.565 . . . . 0.0 109.211 159.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -76.86 114.52 15.72 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.85 -1.156 . . . . 0.0 111.216 -178.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -77.13 141.96 39.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.285 1.034 . . . . 0.0 111.547 174.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.51 146.68 26.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.004 0.521 . . . . 0.0 110.597 170.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.9 145.33 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.345 1.458 . . . . 0.0 110.277 -165.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 17.3 t -145.02 142.75 30.03 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.071 0.948 . . . . 0.0 110.695 164.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -140.44 153.86 46.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.34 1.056 . . . . 0.0 112.142 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 92.5 m -136.42 119.78 16.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.434 1.493 . . . . 0.0 109.875 -172.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -71.67 116.65 12.28 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.84 0.856 . . . . 0.0 109.774 166.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -81.24 -13.25 58.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.905 0.882 . . . . 0.0 112.844 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 70.86 -3.95 1.85 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.367 2.667 . . . . 0.0 114.072 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -87.71 2.0 52.28 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.986 1.714 . . . . 0.0 113.718 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 106.61 10.12 29.55 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.499 1.523 . . . . 0.0 114.754 -172.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 50.7 p -133.84 153.35 51.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.85 1.325 . . . . 0.0 112.375 173.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -112.46 129.69 56.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.885 1.674 . . . . 0.0 109.06 162.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.7 t -86.78 148.41 25.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 110.526 170.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.3 t -130.26 141.67 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.626 1.571 . . . . 0.0 110.074 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 98.2 p -136.36 148.88 48.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.57 1.548 . . . . 0.0 111.671 169.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.3 p90 -151.37 156.1 40.03 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 5.5 mt -122.0 107.4 35.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.742 1.617 . . . . 0.0 110.684 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.82 169.87 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.907 3.072 . . . . 0.0 110.452 167.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 10.8 p -135.01 -23.91 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.29 151.0 57.14 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.916 1.287 . . . . 0.0 110.495 175.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.19 153.91 41.24 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -168.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.23 -163.83 28.06 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.371 1.462 . . . . 0.0 112.534 -174.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.08 125.33 52.02 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.438 1.095 . . . . 0.0 111.338 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.26 129.68 55.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.787 2.035 . . . . 0.0 109.941 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.2 m -88.38 126.36 35.17 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.977 -1.077 . . . . 0.0 111.053 177.252 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.98 124.97 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 108.365 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -109.21 129.18 55.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.302 1.441 . . . . 0.0 109.708 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.0 t -131.94 129.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.434 1.094 . . . . 0.0 109.692 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.44 143.42 23.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.894 1.278 . . . . 0.0 111.721 -167.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.87 122.69 18.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.76 1.224 . . . . 0.0 109.587 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.2 t-20 55.04 56.94 6.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.197 1.399 . . . . 0.0 111.876 176.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 7.7 pt-20 58.82 8.43 0.95 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.653 2.781 . . . . 0.0 116.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.98 123.55 50.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.426 1.09 . . . . 0.0 110.884 177.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -63.34 145.24 55.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.549 -0.72 . . . . 0.0 111.742 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 11.3 m -72.5 157.67 88.66 Favored Pre-proline 0 N--CA 1.479 1.008 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.608 172.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -54.39 126.89 23.75 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 0.0 111.932 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.24 63.73 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.817 1.198 . . . . 0.0 115.375 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.7 t -75.59 140.14 71.44 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.437 1.618 . . . . 0.0 111.404 176.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.09 137.28 49.36 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 119.459 0.843 . . . . 0.0 112.101 -3.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -86.91 175.21 8.28 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.143 1.777 . . . . 0.0 110.725 174.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -136.78 119.66 16.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.765 0.826 . . . . 0.0 110.824 178.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.59 129.06 49.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.377 1.471 . . . . 0.0 110.806 174.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -91.13 125.03 35.79 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.955 -0.466 . . . . 0.0 110.557 173.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.6 t -107.09 129.2 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.525 1.53 . . . . 0.0 109.896 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.2 p -106.55 165.8 11.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.848 1.259 . . . . 0.0 112.538 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.37 144.09 29.04 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.751 1.167 . . . . 0.0 112.271 176.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 124.572 1.149 . . . . 0.0 113.018 176.544 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.314 0.578 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -60.51 117.81 28.24 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.627 1.571 . . . . 0.0 110.672 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.19 144.38 56.87 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.765 2.31 . . . . 0.0 109.746 178.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 34.0 t80 -109.92 129.32 55.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.444 0.697 . . . . 0.0 111.424 -174.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -155.79 145.61 21.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.462 1.505 . . . . 0.0 111.2 174.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.16 144.33 30.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.973 1.709 . . . . 0.0 110.008 -171.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.7 p -113.94 137.11 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 0.0 110.103 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.6 mt -133.71 135.41 24.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.924 1.689 . . . . 0.0 109.172 -172.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.39 96.13 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.731 2.954 . . . . 0.0 109.927 173.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 58.0 t80 -159.4 152.74 22.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.209 2.204 . . . . 0.0 108.523 -178.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.62 126.9 37.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.323 1.049 . . . . 0.0 109.868 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.6 mt -78.98 116.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.025 0.93 . . . . 0.0 109.71 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -98.68 -152.66 0.41 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.473 1.509 . . . . 0.0 110.882 172.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -70.93 122.23 19.58 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.635 -1.29 . . . . 0.0 111.03 171.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.0 -150.37 21.45 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.613 1.578 . . . . 0.0 111.986 -170.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -159.54 145.92 16.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 111.168 -175.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.7 tt -123.74 138.78 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.633 1.573 . . . . 0.0 110.965 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.3 p -146.51 170.77 16.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.95 1.7 . . . . 0.0 110.534 -177.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.51 -171.43 27.54 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -177.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -154.42 144.93 22.24 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.427 1.891 . . . . 0.0 109.637 176.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 74.3 t -120.3 132.58 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.929 1.692 . . . . 0.0 108.777 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -105.27 134.8 47.77 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.824 1.25 . . . . 0.0 111.713 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 9.4 mtm -101.82 140.11 20.92 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.697 1.599 . . . . 0.0 110.846 174.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -56.09 -30.13 77.54 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.084 3.189 . . . . 0.0 115.017 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.8 p -74.67 2.37 10.07 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.022 1.729 . . . . 0.0 114.375 178.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.28 62.94 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.716 1.627 . . . . 0.0 114.837 172.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -73.82 159.0 33.51 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.498 1.119 . . . . 0.0 111.898 175.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 19.3 m -139.65 150.83 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.491 1.516 . . . . 0.0 110.837 172.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.15 172.55 18.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.394 1.877 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -115.63 141.58 27.6 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.208 -0.933 . . . . 0.0 112.152 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.18 167.65 15.68 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.11 3.207 . . . . 0.0 111.317 174.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.04 130.32 55.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.044 1.338 . . . . 0.0 108.923 172.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.79 133.55 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.823 1.249 . . . . 0.0 109.437 177.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.8 m -133.41 127.63 33.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.605 1.562 . . . . 0.0 109.756 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.42 128.6 33.55 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.751 0.821 . . . . 0.0 110.625 172.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.48 -9.33 59.47 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.1 mttt 72.23 0.95 3.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.193 2.597 . . . . 0.0 114.088 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -97.41 3.7 50.87 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.682 1.993 . . . . 0.0 113.143 174.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.12 16.17 39.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.983 1.278 . . . . 0.0 114.426 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.7 p -127.96 156.65 42.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.206 1.802 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.5 m -112.74 144.94 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.809 0.844 . . . . 0.0 109.816 164.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 61.6 m -104.94 134.82 47.41 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.53 1.132 . . . . 0.0 108.435 166.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.6 t -114.04 135.78 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.561 1.544 . . . . 0.0 108.704 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -132.49 151.8 51.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 112.128 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 57.6 t80 -155.45 137.17 14.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.299 1.44 . . . . 0.0 112.306 -178.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -93.74 120.49 66.01 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.635 1.174 . . . . 0.0 111.109 177.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.65 150.52 24.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.664 2.909 . . . . 0.0 111.99 -178.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 87.6 p -122.95 -13.32 7.85 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -166.71 148.87 6.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.013 1.725 . . . . 0.0 110.206 -171.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.98 165.5 25.17 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.079 0.952 . . . . 0.0 113.348 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 128.62 179.5 15.95 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 125.484 1.516 . . . . 0.0 114.505 176.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.1 tp -85.9 107.65 17.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 110.402 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 25.8 m80 -100.48 169.79 8.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.686 1.594 . . . . 0.0 111.665 -176.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -141.59 149.13 40.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.897 0.879 . . . . 0.0 111.208 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.1 ttm -118.19 128.73 54.99 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.63 1.972 . . . . 0.0 110.018 -178.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.64 131.39 53.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.165 2.186 . . . . 0.0 109.385 173.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.9 mm -135.05 135.81 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.505 1.122 . . . . 0.0 110.466 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.04 139.73 26.29 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.21 123.97 47.73 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.89 2.076 . . . . 0.0 109.93 176.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 52.16 32.17 10.17 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.745 1.218 . . . . 0.0 112.535 -173.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.5 t30 75.56 6.15 4.0 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.076 2.55 . . . . 0.0 115.108 -178.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.8 mtm -104.41 132.66 50.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.739 1.616 . . . . 0.0 110.943 173.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.3 135.77 44.19 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.3 pt -75.82 154.54 85.13 Favored Pre-proline 0 N--CA 1.478 0.956 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.004 170.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.19 127.5 23.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.069 1.846 . . . . 0.0 109.302 170.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.58 -14.13 57.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.418 -175.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.8 t -82.78 143.2 46.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 119.812 1.806 . . . . 0.0 111.533 172.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.57 163.63 80.76 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.719 0.935 . . . . 0.0 112.28 -8.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.2 mt -113.27 156.6 23.04 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.157 1.783 . . . . 0.0 110.881 175.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -128.08 142.54 51.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.952 1.301 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 31.7 p90 -158.51 150.56 21.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.63 1.172 . . . . 0.0 112.056 -174.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 41.6 t80 -103.76 131.53 50.86 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.193 -0.942 . . . . 0.0 112.678 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.1 t -102.26 137.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.586 1.554 . . . . 0.0 108.852 176.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.63 160.68 31.94 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.638 1.175 . . . . 0.0 111.628 -169.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -75.45 117.43 17.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.007 0.923 . . . . 0.0 111.028 177.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.2 p -81.5 -23.63 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.025 0.93 . . . . 0.0 113.193 -168.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -83.36 -14.31 53.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.441 1.096 . . . . 0.0 113.547 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.4 m -72.77 156.66 38.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.72 1.208 . . . . 0.0 112.663 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.21 -14.77 68.23 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.467 1.032 . . . . 0.0 115.134 -173.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -64.51 154.63 35.37 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.793 1.296 . . . . 0.0 113.438 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 22.0 t -68.57 132.5 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.096 0.958 . . . . 0.0 109.38 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.8 t -154.1 146.72 24.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.461 1.105 . . . . 0.0 110.42 -176.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.44 141.96 51.77 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.746 1.219 . . . . 0.0 111.898 -172.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.0 p90 -168.07 164.8 13.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.314 1.446 . . . . 0.0 113.61 -175.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.07 172.18 12.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.653 1.597 . . . . 0.0 112.27 -176.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.4 -38.92 13.74 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.753 2.302 . . . . 0.0 112.422 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.57 89.62 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.799 -1.001 . . . . 0.0 115.14 -170.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -78.0 -3.59 42.82 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.444 1.622 . . . . 0.0 113.776 175.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.5 m -105.89 -61.46 1.5 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.172 1.789 . . . . 0.0 110.144 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -127.7 133.19 49.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.619 1.967 . . . . 0.0 111.502 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.02 177.02 16.83 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.166 1.365 . . . . 0.0 112.041 171.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 7.5 p -153.52 138.18 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.137 0.975 . . . . 0.0 109.451 176.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 29.3 m -60.68 152.93 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -170.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 34.1 m120 70.27 11.53 7.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.826 2.05 . . . . 0.0 114.738 166.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -147.03 156.97 47.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.524 1.529 . . . . 0.0 111.36 176.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.94 132.48 16.97 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.413 2.075 . . . . 0.0 111.586 -177.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.83 146.85 28.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.074 1.75 . . . . 0.0 109.784 167.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 40.1 p -132.19 149.13 52.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -164.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.23 177.24 11.26 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.84 1.656 . . . . 0.0 111.486 175.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -134.27 145.58 49.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.501 1.52 . . . . 0.0 110.336 -170.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.9 t -116.49 128.11 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.209 1.404 . . . . 0.0 108.221 168.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.33 131.41 35.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.719 177.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 53.7 p -134.01 12.11 3.94 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 112.812 -169.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.5 tptt -53.76 -40.41 66.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.21 1.804 . . . . 0.0 115.267 -162.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -110.54 1.88 18.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.076 1.35 . . . . 0.0 113.364 -178.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.8 -65.43 0.97 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.155 0.982 . . . . 0.0 111.127 178.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 69.97 0.99 30.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.795 1.878 . . . . 0.0 117.795 162.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -160.32 143.22 13.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.883 1.842 . . . . 0.0 111.731 -172.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 102.8 -173.7 22.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.868 1.699 . . . . 0.0 113.02 -177.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -94.83 114.66 4.89 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 124.231 0.92 . . . . 0.0 111.813 177.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.48 133.2 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.013 1.325 . . . . 0.0 108.751 168.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -140.2 161.53 37.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.46 1.504 . . . . 0.0 112.034 -168.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -166.35 139.34 3.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.617 1.567 . . . . 0.0 110.027 -162.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.85 163.26 34.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.902 1.281 . . . . 0.0 111.625 173.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 59.0 mt -136.43 134.0 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.298 1.039 . . . . 0.0 109.677 173.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.06 117.42 31.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.589 1.156 . . . . 0.0 109.519 170.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.58 179.26 16.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.928 1.251 . . . . 0.0 114.066 -177.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.27 -26.67 41.63 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.062 3.175 . . . . 0.0 111.753 172.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -137.51 154.87 49.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.57 1.548 . . . . 0.0 108.506 158.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.3 tttt -69.84 121.73 17.87 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.877 -1.139 . . . . 0.0 112.069 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.91 149.31 36.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 111.216 167.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -86.12 144.45 27.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.281 0.633 . . . . 0.0 109.647 166.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -133.69 139.49 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.797 1.239 . . . . 0.0 110.309 -167.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 72.8 m -135.17 157.21 47.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.689 1.596 . . . . 0.0 110.838 169.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -154.82 157.18 37.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.35 1.06 . . . . 0.0 112.484 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -143.48 125.72 15.55 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.125 1.37 . . . . 0.0 110.61 -171.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.77 131.6 40.93 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.944 1.297 . . . . 0.0 110.732 171.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -109.06 142.92 39.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.627 1.171 . . . . 0.0 111.723 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.43 -14.81 63.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.45 -11.69 60.78 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 113.905 177.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.78 36.08 5.66 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.914 1.245 . . . . 0.0 113.674 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.4 p -140.75 166.49 24.62 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.91 1.684 . . . . 0.0 110.424 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 76.3 m -120.53 129.79 53.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.685 1.594 . . . . 0.0 108.966 165.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.4 t -91.74 150.54 21.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.975 0.91 . . . . 0.0 110.808 172.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 77.6 t -134.97 141.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.686 1.594 . . . . 0.0 110.273 -176.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 53.0 m -132.67 140.37 48.12 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 110.552 172.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -145.18 148.23 33.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.134 -0.979 . . . . 0.0 113.19 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.2 tt -118.67 99.81 51.25 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.789 1.236 . . . . 0.0 110.006 -173.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -83.15 153.54 14.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.753 2.969 . . . . 0.0 111.279 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.0 m -116.54 -11.45 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -167.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.05 151.2 22.47 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.374 1.469 . . . . 0.0 110.537 177.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 142.99 28.29 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.918 2.412 . . . . 0.0 111.713 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.29 -165.0 32.7 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.518 1.056 . . . . 0.0 113.493 -176.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -99.44 124.43 44.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 112.327 -179.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -120.18 127.42 52.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.828 1.651 . . . . 0.0 110.431 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.8 m -92.06 114.46 27.01 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.951 -1.093 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.05 121.35 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.97 1.708 . . . . 0.0 108.777 177.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.91 134.92 45.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.778 1.631 . . . . 0.0 109.107 176.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 61.5 t -139.43 131.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.723 1.209 . . . . 0.0 109.126 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.2 tmmt? -154.73 143.39 20.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.911 1.285 . . . . 0.0 110.946 -165.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.82 121.06 10.86 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.552 1.141 . . . . 0.0 109.498 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.42 55.81 4.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.243 1.417 . . . . 0.0 111.599 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.0 pt-20 55.8 18.23 2.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.084 2.554 . . . . 0.0 115.94 -177.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -125.35 125.28 43.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.079 1.352 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.667 0.787 . . . . 0.0 112.499 171.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.7 m -74.39 155.53 87.67 Favored Pre-proline 0 N--CA 1.479 1.023 0 O-C-N 121.669 -0.644 . . . . 0.0 110.863 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -55.79 123.74 14.57 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.625 2.217 . . . . 0.0 110.343 172.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -15.42 63.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 178.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.1 p -79.52 151.76 74.9 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.177 1.988 . . . . 0.0 112.753 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.17 153.43 98.9 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.274 0.776 . . . . 0.0 112.9 -1.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -107.72 132.99 52.77 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.208 1.403 . . . . 0.0 110.49 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 58.6 m -88.86 108.93 19.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.374 0.67 . . . . 0.0 110.541 178.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.53 132.23 34.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.773 170.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.34 115.28 27.48 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 0.0 109.263 174.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -93.73 134.4 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.75 1.22 . . . . 0.0 109.894 177.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.6 p -111.01 166.89 10.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.165 1.386 . . . . 0.0 112.964 177.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.47 141.37 22.85 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.103 1.335 . . . . 0.0 112.137 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 CA--C 1.546 0.809 0 C-N-CA 124.627 1.171 . . . . 0.0 113.225 179.876 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 26.5 tp . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -52.13 115.92 7.55 Favored Pre-proline 0 N--CA 1.479 0.993 0 CA-C-O 118.25 -0.881 . . . . 0.0 112.82 -165.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.28 138.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.373 2.049 . . . . 0.0 108.824 174.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 56.7 t80 -130.74 125.37 33.67 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 111.575 -171.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -157.43 139.42 14.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.771 1.629 . . . . 0.0 110.795 176.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.1 mm? -130.9 157.24 43.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.981 2.112 . . . . 0.0 110.0 -175.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.07 136.81 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.916 1.286 . . . . 0.0 109.901 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.1 mt -133.01 134.41 24.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.749 1.62 . . . . 0.0 109.038 -169.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.65 114.08 3.84 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.221 2.614 . . . . 0.0 109.795 173.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.7 t80 -175.24 148.45 0.97 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.389 1.876 . . . . 0.0 110.23 -171.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.2 m -128.6 128.29 43.93 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.72 1.208 . . . . 0.0 110.103 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.7 mt -89.76 135.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.672 1.189 . . . . 0.0 109.12 172.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.4 tptt -132.15 -58.36 0.95 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.105 0.962 . . . . 0.0 112.574 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.6 tttp -157.37 131.01 8.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.985 1.714 . . . . 0.0 110.55 179.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 121.14 -148.45 17.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 125.286 1.422 . . . . 0.0 111.485 -166.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.06 144.88 17.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -175.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.2 tt -121.52 136.2 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.779 1.632 . . . . 0.0 111.081 177.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 39.4 p -146.56 178.71 8.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.365 1.866 . . . . 0.0 110.259 -177.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.49 -168.46 30.6 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.319 0.887 . . . . 0.0 115.319 -179.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.96 146.39 23.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.87 1.668 . . . . 0.0 109.927 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 95.1 t -125.74 131.13 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.729 1.612 . . . . 0.0 108.327 173.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.7 mtm105 -119.66 138.33 53.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.651 1.18 . . . . 0.0 111.669 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 23.5 mtt -111.8 151.32 43.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.775 1.63 . . . . 0.0 111.764 -169.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -53.84 -38.76 85.81 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.093 3.195 . . . . 0.0 115.052 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -77.25 4.01 11.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -176.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.92 80.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.302 1.43 . . . . 0.0 114.155 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 152.01 44.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.15 1.38 . . . . 0.0 111.512 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.2 t -142.68 143.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.172 1.389 . . . . 0.0 109.981 -174.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.03 179.21 7.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.262 1.825 . . . . 0.0 110.984 177.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.66 143.98 43.24 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.928 0.891 . . . . 0.0 111.241 175.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.63 165.17 16.03 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.149 3.232 . . . . 0.0 111.41 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 89.9 m -106.41 124.09 49.06 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.222 1.409 . . . . 0.0 108.685 172.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.93 134.22 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.548 1.139 . . . . 0.0 109.213 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.1 m -135.41 122.63 21.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.495 1.518 . . . . 0.0 109.382 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.76 133.76 41.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.101 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.9 -12.08 45.8 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.5 mttm 69.79 6.91 5.96 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.333 2.253 . . . . 0.0 113.821 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.57 8.3 35.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.163 2.185 . . . . 0.0 112.804 179.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 94.22 14.42 51.35 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.169 1.366 . . . . 0.0 114.156 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.5 p -130.9 156.71 44.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.085 1.754 . . . . 0.0 110.774 176.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 30.0 m -119.22 138.87 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.291 1.036 . . . . 0.0 109.797 166.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 47.6 m -97.09 141.97 29.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.93 1.292 . . . . 0.0 108.604 171.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.1 t -126.59 132.19 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.045 1.338 . . . . 0.0 109.269 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.27 152.96 48.26 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.713 1.605 . . . . 0.0 111.693 -172.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 13.6 t80 -153.51 129.63 10.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.249 1.419 . . . . 0.0 111.327 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -79.76 121.43 82.35 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.102 0.961 . . . . 0.0 110.098 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.0 130.05 12.91 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 0.0 111.768 -170.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 74.2 m -126.0 -0.33 7.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -161.67 152.68 18.15 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.304 1.442 . . . . 0.0 111.021 -178.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -93.79 164.84 12.97 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.479 1.112 . . . . 0.0 112.683 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 102.28 -164.18 16.83 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.315 1.436 . . . . 0.0 113.9 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 26.4 tp -84.55 121.94 28.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.944 1.297 . . . . 0.0 110.95 -178.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 52.7 m80 -118.17 167.74 11.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.585 1.954 . . . . 0.0 111.316 -175.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -146.47 150.71 36.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.509 0.671 . . . . 0.0 112.571 167.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 10.6 ttm -119.91 131.89 55.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.655 2.382 . . . . 0.0 110.008 -174.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -102.05 139.3 37.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.812 1.645 . . . . 0.0 110.037 168.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -138.15 133.77 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.961 1.305 . . . . 0.0 109.268 173.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.64 138.55 23.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -102.41 119.35 38.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.025 2.13 . . . . 0.0 109.462 176.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 50.92 35.85 13.48 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.72 1.208 . . . . 0.0 112.829 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 6.7 t-20 82.71 -7.73 1.23 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.896 2.878 . . . . 0.0 114.69 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.0 mtp -94.11 129.49 40.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.831 1.252 . . . . 0.0 111.466 176.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.05 137.69 56.65 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.263 -0.898 . . . . 0.0 113.289 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.88 154.04 83.03 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.366 0.666 . . . . 0.0 111.501 176.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.63 135.53 57.24 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.479 2.119 . . . . 0.0 110.615 175.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 91.98 -13.95 65.61 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.646 1.117 . . . . 0.0 114.716 -175.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.1 m -96.52 158.7 33.31 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.463 1.631 . . . . 0.0 112.092 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.82 167.81 78.33 Favored 'Cis proline' 0 C--N 1.354 0.848 0 CA-C-N 119.827 0.974 . . . . 0.0 112.842 -2.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 98.8 mt -120.97 143.16 49.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.502 1.521 . . . . 0.0 110.994 -174.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -125.68 137.87 53.87 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.921 1.288 . . . . 0.0 110.374 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.99 152.04 24.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.565 1.146 . . . . 0.0 112.545 -166.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -103.91 148.28 26.35 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.291 -0.88 . . . . 0.0 112.945 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 25.5 t -129.73 137.42 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.311 1.444 . . . . 0.0 110.206 -177.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -165.81 145.21 6.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.746 1.618 . . . . 0.0 112.14 -163.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -71.22 133.97 46.53 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.433 -1.417 . . . . 0.0 113.237 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.8 p -63.74 -29.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -175.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.75 0.12 57.51 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.667 1.187 . . . . 0.0 113.775 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -66.69 140.15 57.88 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.216 -0.928 . . . . 0.0 111.919 -177.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.32 78.14 2.04 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.952 1.263 . . . . 0.0 112.334 -173.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -163.26 168.74 20.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.511 1.524 . . . . 0.0 113.795 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.4 p -67.37 146.2 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.749 0.819 . . . . 0.0 109.34 157.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.0 t -164.24 165.97 21.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.375 1.47 . . . . 0.0 110.637 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.69 147.78 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.54 1.136 . . . . 0.0 112.444 -176.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.6 p90 -166.02 160.11 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 112.623 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.65 170.49 12.1 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.347 1.451 . . . . 0.0 113.189 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.95 -30.86 32.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.241 2.628 . . . . 0.0 112.854 -170.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.9 -16.15 72.24 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 119.318 0.963 . . . . 0.0 114.703 -178.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.04 -13.75 59.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.939 1.369 . . . . 0.0 112.92 170.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 62.1 m -117.16 -38.97 3.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.43 1.892 . . . . 0.0 111.905 -166.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -147.35 159.64 43.45 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.903 2.081 . . . . 0.0 111.823 -171.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.2 175.92 33.77 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.313 0.959 . . . . 0.0 112.908 169.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 24.2 t -139.61 135.92 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 108.758 173.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.3 m -57.12 139.04 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 66.08 3.98 2.89 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.96 2.104 . . . . 0.0 114.926 173.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -119.43 144.63 36.98 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.697 1.599 . . . . 0.0 110.923 176.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.72 125.07 10.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 111.094 -174.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.95 146.73 27.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.298 1.439 . . . . 0.0 110.137 170.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 62.9 p -136.19 154.46 50.94 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -164.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -164.09 172.07 14.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.229 1.812 . . . . 0.0 111.595 177.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.5 m -125.04 141.53 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.453 1.501 . . . . 0.0 110.565 -174.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.19 128.7 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.801 168.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -90.64 122.01 33.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 0.0 109.871 172.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 44.9 p -122.36 2.82 9.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.456 1.902 . . . . 0.0 113.251 -171.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 62.2 tttp -51.74 -37.37 50.85 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.861 1.664 . . . . 0.0 114.116 -176.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 1.52 31.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.308 1.443 . . . . 0.0 113.632 179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.22 -23.44 61.24 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.87 -91.64 1.42 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.712 1.149 . . . . 0.0 112.553 175.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.36 171.66 17.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.717 1.607 . . . . 0.0 112.231 -173.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 113.53 -166.89 12.19 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.929 1.728 . . . . 0.0 111.976 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -90.54 118.0 5.23 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 124.269 0.937 . . . . 0.0 112.262 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.45 128.67 34.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 108.484 164.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.9 m -127.78 157.98 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.372 1.469 . . . . 0.0 111.822 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.6 tp -159.6 133.73 7.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.598 1.559 . . . . 0.0 109.12 -169.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.91 162.52 38.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.293 1.037 . . . . 0.0 112.017 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.61 134.13 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.523 1.129 . . . . 0.0 109.751 175.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -114.67 159.19 20.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.634 1.573 . . . . 0.0 109.918 168.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.64 -163.39 35.99 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.416 -0.802 . . . . 0.0 113.572 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.29 -16.11 28.14 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.543 2.829 . . . . 0.0 112.716 177.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -152.49 160.15 43.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.064 1.746 . . . . 0.0 109.418 168.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -75.63 114.73 14.54 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.894 -1.129 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.18 148.04 44.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.902 0.881 . . . . 0.0 111.259 168.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.38 144.63 25.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.642 0.777 . . . . 0.0 109.967 170.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.48 144.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 110.719 -166.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.7 t -142.37 157.64 44.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.02 1.328 . . . . 0.0 110.713 166.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.8 p -155.65 154.92 32.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 112.764 -176.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.5 m -140.74 123.41 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.352 1.461 . . . . 0.0 110.246 -171.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -72.42 120.51 18.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 110.077 166.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.02 -10.31 57.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.769 0.827 . . . . 0.0 112.933 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 76.08 -28.37 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.583 2.753 . . . . 0.0 112.581 178.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -73.83 10.68 1.06 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.293 2.237 . . . . 0.0 114.68 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.51 16.99 32.51 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.234 1.397 . . . . 0.0 114.198 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 77.7 p -138.7 154.14 48.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.301 1.44 . . . . 0.0 111.325 175.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.0 m -119.49 134.28 55.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.001 1.721 . . . . 0.0 109.309 166.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.1 t -94.87 150.4 20.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 110.837 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 66.7 t -132.22 143.05 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.363 1.465 . . . . 0.0 110.405 -179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 58.9 m -131.89 141.76 49.46 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.143 1.777 . . . . 0.0 110.748 171.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.7 p90 -147.01 152.36 38.47 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.81 102.82 49.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.852 2.061 . . . . 0.0 110.422 -178.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.77 160.08 16.29 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.683 2.922 . . . . 0.0 110.303 168.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 33.4 m -121.55 -10.12 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -168.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.77 152.72 24.66 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.267 1.427 . . . . 0.0 110.412 178.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.98 143.79 23.37 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.891 2.394 . . . . 0.0 111.729 -172.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 153.64 -172.09 32.43 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.07 1.319 . . . . 0.0 113.252 -174.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.83 129.3 37.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.006 1.322 . . . . 0.0 112.288 176.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -121.52 140.82 51.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.033 1.733 . . . . 0.0 110.341 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 72.2 m -106.49 113.39 26.87 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.997 1.319 . . . . 0.0 110.45 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -92.74 121.75 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.135 1.374 . . . . 0.0 108.514 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.2 tt -100.28 128.18 46.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.484 1.514 . . . . 0.0 109.362 175.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -129.71 130.61 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.232 1.013 . . . . 0.0 109.671 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.57 143.14 23.59 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.954 1.302 . . . . 0.0 112.087 -167.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.51 124.79 24.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 0.0 109.787 176.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 53.84 56.32 7.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.122 1.369 . . . . 0.0 112.033 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.301 8.2 pt-20 58.91 3.32 0.31 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 128.957 2.903 . . . . 0.0 116.809 -176.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -109.27 126.07 52.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.0 110.661 178.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m170 -62.0 144.13 55.56 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.221 -0.924 . . . . 0.0 111.716 172.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.3 m -70.32 152.11 95.64 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.445 172.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.49 127.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.665 2.243 . . . . 0.0 110.696 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.44 -13.07 67.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.147 1.356 . . . . 0.0 115.316 -176.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.1 t -75.1 141.36 74.38 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.335 1.567 . . . . 0.0 111.713 176.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.86 146.59 81.79 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 119.613 0.898 . . . . 0.0 112.385 -3.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -99.74 139.87 34.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.686 1.594 . . . . 0.0 111.155 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 5.9 m -98.91 108.0 20.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.894 0.878 . . . . 0.0 111.048 -176.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.64 126.13 45.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.29 175.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -93.21 115.13 27.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.304 0.641 . . . . 0.0 110.425 176.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.7 t -91.5 136.57 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.803 1.641 . . . . 0.0 110.461 -177.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 8.7 m -113.53 153.77 28.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.057 1.743 . . . . 0.0 111.094 -171.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.23 137.53 23.02 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.928 0.775 . . . . 0.0 111.802 172.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 39.1 t70 . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 124.087 0.955 . . . . 0.0 113.315 -178.474 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 120.876 0.37 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -67.2 122.95 85.09 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.736 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.01 150.52 60.75 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.006 2.471 . . . . 0.0 110.86 179.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 20.4 t80 -107.0 128.51 54.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.381 0.672 . . . . 0.0 111.103 178.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -151.76 136.37 17.01 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.328 1.451 . . . . 0.0 110.723 173.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.57 153.85 46.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.604 1.962 . . . . 0.0 109.724 -173.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -129.29 137.48 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.987 1.315 . . . . 0.0 110.363 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.47 137.55 29.26 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.166 1.787 . . . . 0.0 108.586 -173.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 52.39 4.28 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.417 3.411 . . . . 0.0 112.775 -178.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 44.2 t80 -95.68 150.05 20.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.262 1.425 . . . . 0.0 111.212 174.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 93.1 m -119.79 124.0 45.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.793 1.237 . . . . 0.0 109.897 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.3 mt -91.12 139.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.276 1.43 . . . . 0.0 109.74 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -148.69 -43.99 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -177.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 tttm -164.23 123.77 1.98 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.246 1.418 . . . . 0.0 111.601 178.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 123.74 -157.2 18.13 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.868 1.699 . . . . 0.0 111.764 -168.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -141.4 150.09 41.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.819 1.247 . . . . 0.0 111.457 -176.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.3 tt -127.68 135.24 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.718 1.607 . . . . 0.0 111.099 176.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.8 p -146.7 176.4 9.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.014 1.726 . . . . 0.0 109.953 176.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -164.99 -170.72 30.32 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 178.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -155.98 145.9 21.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.841 1.656 . . . . 0.0 110.194 -176.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 61.8 t -126.53 137.2 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.472 1.909 . . . . 0.0 108.944 178.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -116.63 131.36 56.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.666 1.586 . . . . 0.0 111.879 -173.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -102.42 148.25 35.19 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.804 1.641 . . . . 0.0 111.698 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.87 -28.6 68.69 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.283 3.322 . . . . 0.0 114.922 174.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 37.9 p -72.8 -5.95 41.52 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.492 1.517 . . . . 0.0 114.359 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.1 -5.09 81.59 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.473 1.511 . . . . 0.0 113.67 -175.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.68 159.18 32.64 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.347 1.073 . . . . 0.0 111.888 174.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.9 m -138.33 154.43 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.245 1.418 . . . . 0.0 111.384 174.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.55 171.6 19.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.396 1.879 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -117.19 141.44 28.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.651 0.781 . . . . 0.0 111.421 178.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -86.34 172.15 7.24 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.269 3.313 . . . . 0.0 111.93 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.5 m -103.01 130.69 50.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.925 1.29 . . . . 0.0 108.793 170.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.1 132.71 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 0.0 108.819 172.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.6 m -124.54 128.25 48.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.195 1.798 . . . . 0.0 109.746 -178.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.1 t0 -80.45 119.32 22.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.15 0.98 . . . . 0.0 110.276 171.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -81.73 -11.18 59.14 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.5 mmmt 72.48 -3.84 2.22 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 128.046 2.538 . . . . 0.0 114.007 -178.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -97.35 6.12 48.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.672 1.989 . . . . 0.0 113.41 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 89.52 16.02 57.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.722 1.153 . . . . 0.0 113.491 -172.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 48.5 p -130.86 159.55 37.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.611 1.965 . . . . 0.0 110.154 175.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -123.18 143.75 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.621 1.168 . . . . 0.0 109.928 168.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 24.1 m -104.74 139.86 38.92 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.729 1.212 . . . . 0.0 108.796 172.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 29.3 t -121.57 134.59 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.453 1.501 . . . . 0.0 108.664 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.78 149.22 50.38 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.078 1.351 . . . . 0.0 112.433 -173.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 29.8 t80 -150.83 131.1 13.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.418 1.487 . . . . 0.0 111.812 178.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.7 120.73 73.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.632 1.173 . . . . 0.0 110.825 176.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.06 146.17 20.02 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.71 2.94 . . . . 0.0 112.427 -170.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 84.3 p -128.4 -11.71 5.09 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 174.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -147.63 152.3 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.28 1.832 . . . . 0.0 110.487 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.45 168.17 12.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.368 1.067 . . . . 0.0 111.926 169.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.71 -173.45 14.74 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.463 1.506 . . . . 0.0 114.15 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.3 tp -82.06 114.83 20.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.695 1.198 . . . . 0.0 110.249 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 48.1 m80 -110.55 165.62 11.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 111.429 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.61 154.44 45.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.198 0.999 . . . . 0.0 111.103 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.5 ttm -138.35 137.78 37.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.846 1.658 . . . . 0.0 110.439 -171.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -121.21 121.1 37.05 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.509 1.924 . . . . 0.0 109.386 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -125.9 132.59 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.578 1.151 . . . . 0.0 110.158 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.41 136.55 26.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -172.034 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 11.6 t80 -106.13 125.16 50.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.455 1.902 . . . . 0.0 110.004 175.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 51.48 37.0 18.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.776 1.23 . . . . 0.0 112.569 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 57.0 t30 82.99 -9.42 1.09 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 129.081 2.952 . . . . 0.0 114.768 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 26.5 mmt -101.94 136.19 42.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.917 1.287 . . . . 0.0 111.819 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.22 136.42 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.59 152.65 91.67 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.178 175.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -57.41 124.34 15.9 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.085 2.523 . . . . 0.0 111.092 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 96.92 -11.28 66.12 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.933 1.254 . . . . 0.0 114.836 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.16 149.4 39.8 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 120.029 1.915 . . . . 0.0 111.099 173.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.15 162.1 92.74 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.778 1.314 . . . . 0.0 113.311 1.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.7 mt -113.42 157.15 22.28 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.179 1.792 . . . . 0.0 111.349 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.62 140.11 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.099 1.36 . . . . 0.0 109.458 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.55 163.46 17.01 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.389 1.075 . . . . 0.0 112.112 -169.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -104.29 135.11 46.37 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.188 -0.945 . . . . 0.0 113.028 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.1 t -103.17 139.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.335 1.454 . . . . 0.0 108.426 171.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.9 t0 -150.87 165.89 32.23 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.344 1.058 . . . . 0.0 111.875 -172.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -78.05 138.51 38.81 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.843 0.857 . . . . 0.0 111.536 174.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 94.8 t -72.24 -37.81 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.872 0.869 . . . . 0.0 112.643 -171.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -124.76 17.57 8.69 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -166.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 12.7 t -68.63 -26.73 65.49 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.0 -1.063 . . . . 0.0 113.125 178.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 101.39 -14.23 58.12 Favored Glycine 0 N--CA 1.476 1.34 0 C-N-CA 125.7 1.619 . . . . 0.0 115.782 166.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -66.47 158.57 29.2 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.001 1.4 . . . . 0.0 113.587 175.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 p -60.84 139.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.572 0.749 . . . . 0.0 110.137 169.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -161.54 172.23 16.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.243 1.417 . . . . 0.0 110.519 -178.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.72 144.58 24.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.542 1.137 . . . . 0.0 111.859 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.66 163.63 12.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.389 1.476 . . . . 0.0 113.156 -175.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.37 173.53 13.42 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.398 1.475 . . . . 0.0 112.717 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.66 -33.86 26.84 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.874 2.383 . . . . 0.0 112.418 -173.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.91 72.1 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.718 -1.046 . . . . 0.0 114.849 -173.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.83 -0.39 43.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.343 1.572 . . . . 0.0 113.854 174.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 55.4 m -108.64 -47.85 3.41 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 178.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -142.44 152.31 42.64 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.804 2.042 . . . . 0.0 112.255 -172.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -154.53 -176.07 26.4 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.474 1.035 . . . . 0.0 113.635 169.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.4 p -153.3 136.85 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.124 1.37 . . . . 0.0 108.889 177.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -58.8 145.23 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -170.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.6 m-80 68.79 1.57 3.14 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.734 2.014 . . . . 0.0 114.656 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -115.44 141.59 27.48 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.586 1.555 . . . . 0.0 110.597 176.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.1 136.81 30.3 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.661 2.24 . . . . 0.0 110.86 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.87 139.02 51.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.887 1.675 . . . . 0.0 110.182 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.2 p -131.84 147.69 52.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -165.13 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -157.68 174.98 14.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.635 1.574 . . . . 0.0 111.364 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.2 m -129.49 136.97 50.53 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.809 1.243 . . . . 0.0 110.812 -172.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.1 t -100.35 132.14 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.36 1.464 . . . . 0.0 107.811 167.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.53 130.46 49.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.789 1.236 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.0 p -135.28 11.27 3.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.293 1.837 . . . . 0.0 112.941 -170.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 58.5 tttp -52.37 -34.96 50.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.336 1.854 . . . . 0.0 115.546 -165.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.69 23.88 4.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.315 1.446 . . . . 0.0 111.934 175.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.66 -8.87 59.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.907 1.283 . . . . 0.0 114.433 -177.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 87.95 -122.16 6.18 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.669 1.128 . . . . 0.0 112.439 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.0 167.77 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.471 1.508 . . . . 0.0 112.254 -174.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 139.81 -162.69 26.27 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.625 1.583 . . . . 0.0 113.21 -178.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -84.58 109.6 3.27 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 124.082 0.848 . . . . 0.0 111.488 175.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 44.7 tp -85.15 134.46 34.17 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.612 1.165 . . . . 0.0 109.645 171.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.9 m -132.83 158.64 41.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.283 1.433 . . . . 0.0 112.338 -175.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.2 tp -161.08 134.87 6.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.393 1.877 . . . . 0.0 108.783 -169.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.08 157.3 34.31 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.978 0.911 . . . . 0.0 112.104 176.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -137.42 140.27 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.847 1.259 . . . . 0.0 109.625 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.02 143.56 50.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.639 1.576 . . . . 0.0 109.516 172.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.75 -162.99 23.03 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.99 -0.895 . . . . 0.0 114.982 -174.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -64.26 -26.86 64.05 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.126 3.217 . . . . 0.0 112.602 178.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -138.22 158.85 43.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.008 1.323 . . . . 0.0 109.253 161.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -74.6 112.78 11.13 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.895 -1.128 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.76 149.42 49.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.923 0.889 . . . . 0.0 112.123 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.3 139.89 30.09 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.523 0.729 . . . . 0.0 109.258 165.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.46 138.12 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.668 1.187 . . . . 0.0 110.469 -167.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -134.78 155.75 50.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 110.783 171.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.74 154.49 32.93 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.089 0.956 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 90.7 m -143.31 120.03 11.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.82 1.648 . . . . 0.0 109.906 -172.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -72.61 124.96 26.32 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.341 0.656 . . . . 0.0 110.109 170.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -86.28 -11.33 52.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -174.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 69.31 -3.3 1.61 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.27 2.628 . . . . 0.0 113.759 -175.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.49 8.29 39.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.446 1.898 . . . . 0.0 113.236 -177.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.43 18.28 36.44 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.097 1.332 . . . . 0.0 113.637 -172.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 54.1 p -142.64 157.03 45.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.673 1.589 . . . . 0.0 111.652 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 52.7 t -127.19 124.81 39.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.616 1.967 . . . . 0.0 109.009 169.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 146.64 25.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.235 1.014 . . . . 0.0 110.904 177.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.3 t -128.44 143.48 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.063 1.745 . . . . 0.0 109.778 -178.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.4 t -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.469 1.508 . . . . 0.0 110.728 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.0 p90 -144.95 153.58 41.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.185 -0.947 . . . . 0.0 113.491 175.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 3.2 mt -114.37 106.38 52.75 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.976 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.64 170.04 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.887 3.058 . . . . 0.0 110.703 167.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.5 p -148.52 -28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -173.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.05 146.18 33.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.541 1.064 . . . . 0.0 110.928 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 163.55 34.7 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.255 2.636 . . . . 0.0 111.159 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.93 -134.94 7.89 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 125.269 1.414 . . . . 0.0 111.02 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 2.2 p30 -143.91 145.36 32.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.009 0.909 . . . . 0.0 112.829 176.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -121.26 135.68 55.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.789 2.035 . . . . 0.0 109.872 -171.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -89.78 127.14 35.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.305 1.042 . . . . 0.0 110.509 174.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.4 120.67 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.66 1.584 . . . . 0.0 108.593 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -102.37 134.5 45.57 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 109.942 174.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.7 t -136.66 133.12 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.355 1.462 . . . . 0.0 108.384 171.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.39 141.69 19.57 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.015 1.326 . . . . 0.0 111.026 -170.302 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.37 125.38 18.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.662 1.185 . . . . 0.0 110.43 -178.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.76 54.3 10.09 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.056 1.343 . . . . 0.0 111.909 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.303 8.5 pt-20 57.97 15.72 3.3 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.233 2.613 . . . . 0.0 116.236 -177.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -121.99 129.81 52.77 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.577 1.151 . . . . 0.0 111.282 177.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -61.97 155.71 22.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.092 0.957 . . . . 0.0 112.722 170.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.2 m -83.14 156.4 66.7 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.272 0.629 . . . . 0.0 110.126 175.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.58 122.77 12.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.455 2.104 . . . . 0.0 110.276 176.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.39 -13.07 68.0 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.293 -1.281 . . . . 0.0 116.079 -179.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.4 p -80.92 152.02 71.26 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 120.262 2.031 . . . . 0.0 112.91 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.46 141.93 71.53 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.152 0.733 . . . . 0.0 111.948 -4.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.85 169.64 11.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.431 1.493 . . . . 0.0 110.669 176.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 37.4 m -132.81 117.43 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.647 0.779 . . . . 0.0 110.741 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.63 128.47 45.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.803 1.241 . . . . 0.0 110.94 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -88.85 131.67 35.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.195 0.452 . . . . 0.0 110.749 174.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -121.22 138.25 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.676 1.59 . . . . 0.0 109.788 -173.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -126.01 177.16 6.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.24 1.016 . . . . 0.0 112.801 -176.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.82 138.66 21.14 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.825 1.678 . . . . 0.0 112.51 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 CA--C 1.546 0.797 0 C-N-CA 124.578 1.151 . . . . 0.0 113.558 -178.7 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.1 tp . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -61.8 121.9 67.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.949 0.9 . . . . 0.0 112.098 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.299 2.666 . . . . 0.0 111.506 -177.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.1 t80 -101.39 122.14 43.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.115 0.966 . . . . 0.0 109.635 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -148.63 131.29 15.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 110.581 171.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.23 153.84 43.23 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.381 1.872 . . . . 0.0 109.653 -170.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.62 137.81 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.825 1.25 . . . . 0.0 110.353 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.2 mt -131.7 136.32 28.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.303 1.841 . . . . 0.0 108.734 -172.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -77.75 69.58 7.3 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.558 3.505 . . . . 0.0 111.019 177.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -123.33 162.43 22.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.583 1.953 . . . . 0.0 110.307 175.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.8 m -139.28 130.0 26.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.906 1.282 . . . . 0.0 109.926 178.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 57.9 mt -82.17 118.2 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.18 0.992 . . . . 0.0 108.688 170.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -24.99 11.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -174.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -170.43 -24.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 178.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.79 -147.67 13.45 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.766 1.65 . . . . 0.0 113.087 -177.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.82 145.05 29.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 109.894 -176.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.74 132.61 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.279 1.432 . . . . 0.0 110.985 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -149.62 170.58 18.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.981 1.713 . . . . 0.0 110.465 -173.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.69 -167.29 20.1 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 116.301 1.281 . . . . 0.0 116.301 -175.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.52 142.59 22.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.13 1.772 . . . . 0.0 109.164 174.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.3 t -115.33 127.87 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.206 1.402 . . . . 0.0 108.379 172.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -109.69 122.53 47.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.915 1.686 . . . . 0.0 109.48 -175.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.3 mtt -93.77 150.8 39.26 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.278 1.431 . . . . 0.0 111.214 -173.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.24 -21.71 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.445 2.763 . . . . 0.0 112.774 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 14.0 m -72.84 -0.05 12.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.106 1.362 . . . . 0.0 114.47 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.15 42.96 6.45 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.698 1.142 . . . . 0.0 113.252 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -153.73 166.02 34.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.616 . . . . 0.0 111.931 -173.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 24.1 m -141.83 159.38 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.435 1.094 . . . . 0.0 113.144 -167.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.41 175.53 12.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.012 2.125 . . . . 0.0 110.617 174.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -112.39 143.45 28.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.113 -0.992 . . . . 0.0 112.31 -175.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.45 170.95 7.69 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.418 3.412 . . . . 0.0 111.767 173.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.3 m -115.27 128.49 56.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.564 1.546 . . . . 0.0 108.911 174.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.03 135.57 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.78 1.232 . . . . 0.0 109.395 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.1 m -134.29 126.79 30.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.532 1.533 . . . . 0.0 109.723 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.12 125.67 29.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.737 0.815 . . . . 0.0 110.651 172.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -82.19 -8.14 59.64 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.032 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 70.9 1.57 3.83 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.677 2.391 . . . . 0.0 113.674 -176.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.57 4.86 41.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.999 2.119 . . . . 0.0 113.039 -177.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.05 13.38 52.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.089 1.328 . . . . 0.0 114.112 -174.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 68.0 p -132.17 158.49 41.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.321 1.848 . . . . 0.0 110.999 178.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 22.3 m -115.31 141.07 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.253 1.021 . . . . 0.0 109.378 163.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 22.4 m -100.0 139.17 36.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.66 1.184 . . . . 0.0 108.444 169.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.99 133.82 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.38 1.472 . . . . 0.0 108.903 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -132.74 156.4 47.12 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.075 1.35 . . . . 0.0 112.267 -177.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.9 t80 -157.73 135.4 10.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.565 1.546 . . . . 0.0 111.625 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.86 124.53 76.87 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.188 0.995 . . . . 0.0 110.674 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -78.61 172.9 14.46 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.697 2.931 . . . . 0.0 111.73 -176.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -158.14 -39.3 0.07 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.779 0.832 . . . . 0.0 113.064 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -127.68 158.18 38.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.596 1.558 . . . . 0.0 110.767 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.23 174.99 10.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.238 1.015 . . . . 0.0 112.254 172.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.14 -177.66 22.47 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.156 1.36 . . . . 0.0 114.134 176.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 53.6 tp -73.93 117.69 16.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.327 1.051 . . . . 0.0 110.467 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 32.9 m80 -110.52 161.1 16.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.996 1.719 . . . . 0.0 110.71 178.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.2 150.09 33.11 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.7 -0.625 . . . . 0.0 112.401 175.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 30.8 ttm -128.82 139.26 52.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.139 1.776 . . . . 0.0 111.139 -168.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -108.7 137.14 47.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.194 1.798 . . . . 0.0 110.073 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.97 134.56 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.768 1.227 . . . . 0.0 110.43 175.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.92 138.94 36.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.586 1.154 . . . . 0.0 113.482 178.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 62.0 t80 -101.75 121.36 41.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.437 1.895 . . . . 0.0 109.334 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.38 32.33 13.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.836 1.254 . . . . 0.0 112.759 -175.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.5 m-80 73.87 7.28 4.9 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.798 2.439 . . . . 0.0 115.081 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.0 ttm -100.23 128.58 46.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.885 1.274 . . . . 0.0 110.269 166.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.17 136.59 57.28 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.46 -0.775 . . . . 0.0 112.762 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -74.81 156.74 86.32 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.76 174.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.08 -17.78 61.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.641 2.227 . . . . 0.0 113.204 175.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.92 7.61 65.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.643 1.116 . . . . 0.0 114.571 170.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 18.1 t -111.29 146.1 33.88 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 119.683 1.742 . . . . 0.0 111.678 178.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.37 169.45 72.81 Favored 'Cis proline' 0 C--N 1.351 0.668 0 CA-C-N 119.816 0.97 . . . . 0.0 111.76 -9.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.66 158.31 24.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.918 1.687 . . . . 0.0 110.654 171.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -148.41 152.18 36.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.334 -0.854 . . . . 0.0 111.894 171.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -165.97 154.28 10.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.914 1.286 . . . . 0.0 111.244 -175.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.3 t80 -94.67 129.39 41.57 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.483 -0.76 . . . . 0.0 112.301 177.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.6 t -95.1 134.25 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.989 1.316 . . . . 0.0 109.214 174.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -149.77 158.29 44.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.514 1.525 . . . . 0.0 110.146 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -67.65 160.49 27.84 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 63.4 t -65.09 -39.49 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.557 0.743 . . . . 0.0 111.046 179.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 p30 -90.46 155.73 18.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.238 1.015 . . . . 0.0 111.57 165.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 25.1 p -161.79 156.17 22.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.763 1.225 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -112.72 30.27 7.6 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 126.182 1.848 . . . . 0.0 113.094 178.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -165.19 162.84 20.25 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.342 1.457 . . . . 0.0 113.091 -165.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.3 p -66.75 140.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 0.0 110.015 167.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -156.58 162.48 39.89 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.874 1.27 . . . . 0.0 111.022 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.14 144.76 36.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.744 1.218 . . . . 0.0 112.042 -177.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 44.7 p90 -165.24 161.24 19.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.785 1.634 . . . . 0.0 112.527 -176.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.7 174.42 13.54 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.302 1.429 . . . . 0.0 113.369 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.17 -33.12 9.78 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.107 2.538 . . . . 0.0 113.447 -171.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.62 -36.69 88.43 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 119.523 1.056 . . . . 0.0 114.175 -171.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.16 -9.1 58.24 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.916 1.358 . . . . 0.0 113.215 176.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 29.1 m -98.45 -49.85 4.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.348 1.859 . . . . 0.0 111.089 177.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -143.11 146.03 33.39 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.511 1.924 . . . . 0.0 112.881 -174.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.16 178.61 21.28 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.485 1.517 . . . . 0.0 113.32 171.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.3 p -149.63 136.29 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.778 1.231 . . . . 0.0 109.37 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -58.21 144.01 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.1 m-80 67.8 7.44 5.73 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.737 2.015 . . . . 0.0 114.773 174.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 95.1 mttt -125.99 146.47 55.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.679 1.592 . . . . 0.0 110.877 174.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 135.68 25.72 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.78 2.32 . . . . 0.0 111.188 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.16 137.83 51.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 109.99 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.0 p -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -165.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -161.56 177.69 9.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.393 1.877 . . . . 0.0 111.26 178.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 45.6 m -130.82 142.01 50.37 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.669 1.187 . . . . 0.0 110.761 -170.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.3 t -112.82 128.46 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.194 1.398 . . . . 0.0 107.976 169.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -94.27 126.07 39.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.664 1.186 . . . . 0.0 110.084 176.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.8 p -127.88 0.19 5.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.053 1.741 . . . . 0.0 113.57 -167.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 63.0 tttp -51.07 -38.69 53.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.134 1.774 . . . . 0.0 114.729 -171.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.47 9.58 18.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.517 1.527 . . . . 0.0 113.183 -178.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.33 62.79 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -172.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.73 147.23 5.88 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.908 1.242 . . . . 0.0 112.525 -172.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.84 148.29 36.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.252 1.021 . . . . 0.0 112.397 -177.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 177.22 -45.34 0.1 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.991 1.281 . . . . 0.0 113.715 175.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 165.03 106.45 0.19 Allowed Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.919 1.247 . . . . 0.0 112.729 171.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.92 130.32 34.91 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.076 1.35 . . . . 0.0 109.423 175.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.9 m -127.87 156.37 42.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.547 1.539 . . . . 0.0 112.159 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 38.5 tp -155.81 135.22 12.37 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.476 1.91 . . . . 0.0 108.663 -175.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -154.36 155.31 34.82 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.146 0.978 . . . . 0.0 112.031 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.6 mt -137.04 133.18 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.489 1.116 . . . . 0.0 110.374 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -115.85 160.85 19.62 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.261 1.824 . . . . 0.0 109.657 170.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.57 -163.35 34.62 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.047 -1.033 . . . . 0.0 114.695 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.73 -24.49 61.96 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.886 3.057 . . . . 0.0 112.278 175.109 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -140.79 159.65 41.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.431 1.492 . . . . 0.0 108.939 164.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 tptt -74.06 113.61 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.846 -1.158 . . . . 0.0 110.6 176.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.31 145.86 52.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 0.0 111.411 174.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.2 143.55 28.7 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 109.808 169.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 99.7 mt -128.78 144.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 110.887 -167.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 14.5 t -139.38 156.16 47.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 164.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 26.7 p -157.56 150.46 23.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.603 1.161 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.8 m -140.55 118.43 11.79 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 110.018 -169.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 14.0 t0 -67.43 118.38 10.69 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.785 0.834 . . . . 0.0 109.785 166.152 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -80.79 -13.37 59.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.69 0.796 . . . . 0.0 112.775 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 73.68 -7.96 1.48 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 128.5 2.72 . . . . 0.0 113.455 -179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -88.6 8.43 28.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.478 1.911 . . . . 0.0 113.372 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.25 18.33 39.68 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.058 1.313 . . . . 0.0 113.694 -171.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.8 p -139.54 155.4 47.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.545 1.538 . . . . 0.0 111.181 176.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 43.5 t -124.33 128.9 49.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.532 1.933 . . . . 0.0 109.244 170.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.6 t -89.62 145.76 25.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.306 1.043 . . . . 0.0 110.643 174.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.1 t -126.83 143.3 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.933 1.693 . . . . 0.0 109.709 -177.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.8 t -138.3 141.32 39.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.603 1.561 . . . . 0.0 110.685 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -144.21 153.2 41.83 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.152 -0.967 . . . . 0.0 113.586 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 57.5 tp -119.35 103.09 47.51 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.705 1.602 . . . . 0.0 110.085 -176.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.71 172.72 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.85 3.034 . . . . 0.0 110.88 170.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.1 p -146.76 -30.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.8 mt -107.59 146.86 34.21 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.331 1.052 . . . . 0.0 110.902 167.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.78 160.69 43.17 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.142 2.561 . . . . 0.0 110.9 173.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 138.19 -132.61 5.91 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.444 1.021 . . . . 0.0 112.309 -175.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.84 135.94 30.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.133 1.373 . . . . 0.0 111.562 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.66 134.55 54.98 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.872 1.669 . . . . 0.0 110.423 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 31.9 m -91.54 121.32 33.13 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.22 126.04 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.93 1.692 . . . . 0.0 108.356 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.22 130.17 55.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.353 1.461 . . . . 0.0 109.298 175.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.9 t -132.11 130.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.33 1.052 . . . . 0.0 109.534 173.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.57 142.72 22.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.957 1.303 . . . . 0.0 111.804 -167.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.18 120.66 18.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.809 1.243 . . . . 0.0 109.733 178.302 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 54.57 58.18 5.11 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.358 1.463 . . . . 0.0 112.133 177.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 58.62 9.33 1.09 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.571 2.748 . . . . 0.0 116.542 -177.245 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -115.88 124.97 51.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.487 1.115 . . . . 0.0 110.801 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.87 145.69 54.52 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.379 -0.825 . . . . 0.0 111.984 172.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.6 m -72.26 156.87 90.13 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.142 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.64 125.75 18.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.697 2.932 . . . . 0.0 112.475 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.51 -12.42 63.13 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.919 1.247 . . . . 0.0 115.664 -179.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.6 t -74.67 142.02 76.72 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-N 119.449 1.625 . . . . 0.0 111.641 177.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.88 142.94 75.33 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.297 0.785 . . . . 0.0 112.24 -3.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -97.15 168.87 10.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.577 1.951 . . . . 0.0 110.803 175.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 90.0 m -126.51 122.03 34.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.962 0.905 . . . . 0.0 111.251 172.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.49 132.68 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.044 1.338 . . . . 0.0 110.874 173.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -84.53 124.43 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.307 0.643 . . . . 0.0 109.435 173.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.89 133.62 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.757 0.823 . . . . 0.0 110.304 -178.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.0 p -110.76 161.6 15.61 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.427 1.491 . . . . 0.0 112.686 -174.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.24 136.41 16.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.537 1.065 . . . . 0.0 110.95 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.386 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.69 121.61 76.3 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.497 1.119 . . . . 0.0 110.676 -178.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.61 151.24 64.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.287 2.658 . . . . 0.0 111.632 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.4 t80 -106.79 121.97 45.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.896 0.878 . . . . 0.0 110.87 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.89 133.19 14.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.335 1.454 . . . . 0.0 110.367 170.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.75 134.74 25.46 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.379 1.471 . . . . 0.0 109.993 -167.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 11.2 p -103.72 139.94 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.931 1.292 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -134.89 137.9 28.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.584 1.953 . . . . 0.0 108.333 -177.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.02 23.76 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.236 3.291 . . . . 0.0 114.199 -178.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.1 t80 -72.75 153.15 41.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.563 1.145 . . . . 0.0 111.405 174.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 96.2 m -123.82 126.88 47.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.351 1.46 . . . . 0.0 110.225 -177.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.48 131.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.397 1.079 . . . . 0.0 109.642 172.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.46 -64.03 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.317 1.047 . . . . 0.0 112.71 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.97 124.62 4.35 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.543 1.537 . . . . 0.0 110.888 179.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.38 -144.6 16.58 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.567 1.556 . . . . 0.0 111.308 -166.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.09 143.8 17.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.515 1.126 . . . . 0.0 110.949 -176.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.4 tt -119.09 138.41 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.3 1.44 . . . . 0.0 111.257 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.16 166.01 30.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.884 1.674 . . . . 0.0 110.736 -178.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.17 -172.47 19.54 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 -177.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -151.18 138.76 19.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.231 1.812 . . . . 0.0 109.31 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 4.7 t -110.7 137.88 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.094 1.758 . . . . 0.0 108.218 174.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 53.1 mtp85 -129.18 118.62 22.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.769 1.627 . . . . 0.0 110.094 -171.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.8 mpp? -91.78 153.31 43.72 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.571 1.548 . . . . 0.0 111.265 -175.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.9 -19.2 46.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.385 2.723 . . . . 0.0 113.4 178.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 44.8 p -73.96 -8.49 56.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.381 1.473 . . . . 0.0 114.134 171.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.2 -4.95 81.25 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.512 1.53 . . . . 0.0 113.979 -174.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -68.48 160.02 30.58 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.531 1.166 . . . . 0.0 111.885 173.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.9 m -140.29 156.7 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.634 1.173 . . . . 0.0 112.427 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.54 -173.03 4.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.418 2.287 . . . . 0.0 110.059 178.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -130.79 143.86 51.09 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.843 -1.161 . . . . 0.0 111.395 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -84.74 167.07 11.54 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.945 3.097 . . . . 0.0 111.507 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.1 m -104.44 133.07 49.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.355 1.462 . . . . 0.0 108.726 170.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.13 135.19 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.157 0.983 . . . . 0.0 109.642 176.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -130.82 127.52 38.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.775 1.63 . . . . 0.0 109.389 178.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.31 127.96 33.74 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.261 0.624 . . . . 0.0 110.314 170.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -82.81 -5.58 59.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 69.91 4.62 4.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.59 2.356 . . . . 0.0 114.044 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.66 7.54 30.63 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.004 2.122 . . . . 0.0 112.795 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.56 20.18 41.88 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.853 1.216 . . . . 0.0 113.945 -175.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 36.9 p -135.77 160.13 39.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.231 1.812 . . . . 0.0 110.301 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.4 m -120.37 148.02 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.515 1.126 . . . . 0.0 110.17 168.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.2 m -111.36 133.72 53.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.523 1.129 . . . . 0.0 108.897 169.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.2 t -110.17 134.15 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.846 1.658 . . . . 0.0 108.587 176.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -134.19 152.24 51.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.265 1.426 . . . . 0.0 112.367 -169.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.7 t80 -159.52 133.92 7.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.448 1.499 . . . . 0.0 112.125 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.84 119.4 71.15 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.53 1.132 . . . . 0.0 110.563 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.03 139.81 19.55 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.501 2.801 . . . . 0.0 112.686 -170.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 52.2 m -123.02 -7.51 8.35 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 174.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -140.37 157.62 45.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.828 1.651 . . . . 0.0 110.68 -177.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.3 170.57 9.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.73 1.212 . . . . 0.0 111.688 168.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.66 -170.42 19.16 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.214 1.388 . . . . 0.0 113.781 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -83.53 119.29 24.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.432 1.093 . . . . 0.0 110.117 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 24.2 m80 -107.57 156.3 19.17 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.115 1.766 . . . . 0.0 111.759 -177.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -124.27 149.71 46.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.069 1.748 . . . . 0.0 109.059 175.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 15.7 tmm? -153.12 136.01 15.44 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 111.901 -175.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.5 1.92 . . . . 0.0 111.702 -172.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.4 mm -136.66 135.38 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.444 1.498 . . . . 0.0 110.803 175.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 142.83 30.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.211 1.004 . . . . 0.0 113.622 178.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.3 t80 -107.39 122.41 46.54 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.952 2.101 . . . . 0.0 110.208 177.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 52.12 32.17 10.07 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.528 1.131 . . . . 0.0 112.485 -172.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 20.3 t30 77.14 3.9 3.26 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.426 2.69 . . . . 0.0 115.149 -178.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.35 128.84 47.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.659 1.583 . . . . 0.0 110.809 174.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -59.14 137.3 58.01 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 113.582 -177.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.25 155.45 87.98 Favored Pre-proline 0 N--CA 1.48 1.034 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.459 172.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.42 -13.64 40.76 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.485 2.124 . . . . 0.0 113.762 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -89.45 9.32 77.45 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.008 1.29 . . . . 0.0 114.672 170.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 29.5 t -116.32 148.22 41.19 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.533 1.667 . . . . 0.0 111.698 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.02 165.87 77.93 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 119.931 1.011 . . . . 0.0 112.135 -6.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 65.5 mt -113.97 158.8 20.67 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.319 1.848 . . . . 0.0 110.92 172.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.79 146.97 19.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.766 1.226 . . . . 0.0 110.954 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 3.8 p90 -170.96 163.52 7.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.914 1.285 . . . . 0.0 111.784 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -98.45 138.61 35.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.246 -0.909 . . . . 0.0 112.967 177.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 45.0 t -111.75 135.54 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.701 1.6 . . . . 0.0 109.451 174.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -146.38 164.1 33.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.307 1.843 . . . . 0.0 111.715 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -80.71 155.32 26.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.633 0.773 . . . . 0.0 112.862 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 25.1 m -66.17 -16.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.344 -0.847 . . . . 0.0 112.309 165.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -74.49 -19.7 60.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.909 1.684 . . . . 0.0 114.194 178.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 92.6 m -62.41 130.61 46.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.859 1.264 . . . . 0.0 113.551 -170.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.31 -18.17 22.37 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.2 1.381 . . . . 0.0 114.12 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -68.45 160.3 30.0 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.294 1.047 . . . . 0.0 113.51 176.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 40.0 t -63.75 128.5 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 157.1 44.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.691 1.196 . . . . 0.0 110.596 -172.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.69 144.3 37.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 -176.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -166.83 172.24 10.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 0.0 112.375 -173.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 118.27 172.29 15.58 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.266 1.412 . . . . 0.0 112.622 -177.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.71 -35.01 17.42 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.789 2.326 . . . . 0.0 112.704 -170.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -64.14 -38.6 96.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.398 0.999 . . . . 0.0 114.668 -171.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -77.01 -7.16 55.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.055 1.428 . . . . 0.0 113.761 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.3 m -100.91 -40.27 7.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.385 1.874 . . . . 0.0 111.071 176.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -153.73 141.08 19.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.38 1.872 . . . . 0.0 112.189 -167.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -135.5 177.0 19.77 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.529 1.538 . . . . 0.0 112.17 173.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.0 t -141.86 135.67 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.132 0.973 . . . . 0.0 108.85 174.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.9 m -55.97 135.85 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.302 0.641 . . . . 0.0 112.576 -177.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 58.3 m-80 67.71 1.17 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.95 2.1 . . . . 0.0 114.89 174.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -121.22 143.46 37.37 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 125.468 1.507 . . . . 0.0 111.038 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.53 133.04 19.9 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.523 2.149 . . . . 0.0 111.309 -173.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -113.08 146.42 39.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.66 1.584 . . . . 0.0 110.116 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.7 p -137.12 145.33 43.72 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -154.46 175.38 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.266 1.426 . . . . 0.0 111.948 177.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 29.9 m -130.94 144.27 51.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.25 1.42 . . . . 0.0 110.759 -169.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.2 t -121.36 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.674 1.59 . . . . 0.0 108.704 170.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.54 124.38 43.26 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.56 1.144 . . . . 0.0 111.307 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 34.5 p -124.99 12.28 8.36 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.808 2.043 . . . . 0.0 112.318 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.29 -36.43 66.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.615 1.566 . . . . 0.0 114.564 -170.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.74 12.62 19.67 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.729 1.612 . . . . 0.0 112.741 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.95 60.83 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 -84.45 1.57 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.052 1.311 . . . . 0.0 111.91 178.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -159.56 148.4 17.86 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.434 1.493 . . . . 0.0 110.634 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 156.19 -152.46 23.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.392 1.473 . . . . 0.0 111.661 -174.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -147.68 144.97 13.1 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.81 1.195 . . . . 0.0 112.377 176.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.33 141.35 28.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.198 1.399 . . . . 0.0 111.12 176.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 12.3 t -125.69 160.13 30.5 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.961 1.705 . . . . 0.0 110.816 166.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.3 tp -163.06 136.23 5.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.928 1.691 . . . . 0.0 109.491 -162.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.41 160.84 35.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.36 1.064 . . . . 0.0 111.954 175.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.4 mt -132.87 137.83 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.723 1.209 . . . . 0.0 109.518 173.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -129.12 119.48 24.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.171 1.388 . . . . 0.0 109.517 174.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -136.88 -173.26 12.83 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.92 1.248 . . . . 0.0 113.911 -177.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.04 -21.07 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.958 3.105 . . . . 0.0 112.257 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -136.22 157.1 47.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.344 1.458 . . . . 0.0 109.0 158.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.0 tptt -76.03 122.48 24.28 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.796 -1.19 . . . . 0.0 111.862 -176.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.94 150.08 35.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.037 0.935 . . . . 0.0 112.082 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -86.19 142.81 28.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.798 0.839 . . . . 0.0 109.314 166.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.87 144.16 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.441 1.096 . . . . 0.0 110.626 -167.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.3 t -146.81 168.13 22.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.036 1.334 . . . . 0.0 111.461 168.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -161.32 158.48 27.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 112.965 -177.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.9 m -143.8 129.02 18.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.8 1.64 . . . . 0.0 110.446 -172.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.63 128.69 34.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.82 1.248 . . . . 0.0 111.09 170.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -98.72 149.73 22.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 111.732 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -67.48 -16.37 64.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.766 0.826 . . . . 0.0 112.661 174.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.13 -7.72 52.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.435 1.494 . . . . 0.0 113.85 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.17 27.06 19.68 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.783 1.182 . . . . 0.0 114.464 176.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.5 p -130.82 156.46 44.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.777 1.631 . . . . 0.0 110.589 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.1 m -106.89 128.0 53.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.626 1.171 . . . . 0.0 109.921 171.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.7 t -94.72 149.57 21.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.147 0.979 . . . . 0.0 110.375 169.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.4 t -131.36 144.56 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.097 1.759 . . . . 0.0 109.63 -176.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.7 p -135.51 149.95 49.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.893 1.277 . . . . 0.0 111.987 170.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.72 155.7 37.73 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 176.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.9 mt -122.72 106.65 34.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.641 1.976 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.09 170.17 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 124.065 3.177 . . . . 0.0 110.488 167.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -131.4 -20.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -170.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.93 151.28 48.72 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.701 1.201 . . . . 0.0 110.769 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.5 152.29 38.34 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.826 2.351 . . . . 0.0 112.366 -170.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.3 -152.46 24.34 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.502 1.049 . . . . 0.0 112.883 -177.199 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.32 130.33 56.67 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.829 1.652 . . . . 0.0 111.627 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -122.35 129.41 52.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.715 1.606 . . . . 0.0 110.015 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -86.7 127.76 34.98 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.09 -1.006 . . . . 0.0 111.159 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.15 121.8 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 108.666 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -98.1 134.79 40.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.107 1.363 . . . . 0.0 109.979 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 91.4 t -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.442 1.497 . . . . 0.0 108.416 171.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -151.6 133.98 15.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.818 1.247 . . . . 0.0 110.93 -172.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -133.42 133.63 42.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.825 1.25 . . . . 0.0 111.151 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.8 t-20 49.16 53.36 12.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.77 1.228 . . . . 0.0 112.406 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.31 8.8 pt-20 58.49 18.18 5.48 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.016 2.526 . . . . 0.0 116.305 -177.178 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -127.78 131.53 49.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.618 1.167 . . . . 0.0 111.88 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -63.02 157.03 23.0 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.268 -0.895 . . . . 0.0 112.486 168.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.8 m -88.52 155.13 51.2 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.499 0.72 . . . . 0.0 110.314 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.6 123.1 12.61 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.237 1.958 . . . . 0.0 110.051 175.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.48 -13.48 65.47 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.141 1.353 . . . . 0.0 115.633 -177.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 87.0 p -82.56 150.68 63.66 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.343 2.071 . . . . 0.0 112.87 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.91 140.96 67.21 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.218 0.757 . . . . 0.0 111.791 -4.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -86.84 170.17 11.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 110.406 175.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 35.0 m -132.65 117.92 18.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 176.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.7 134.25 38.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 111.641 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -86.75 113.86 22.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.271 1.028 . . . . 0.0 109.944 174.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.6 t -92.17 124.56 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.581 0.752 . . . . 0.0 110.173 178.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 82.9 m -92.44 142.83 27.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.657 1.983 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.61 17.26 11.13 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.046 1.308 . . . . 0.0 115.347 -176.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 CA--C 1.553 1.092 0 C-N-CA 127.559 2.344 . . . . 0.0 113.659 -178.028 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 121.393 0.616 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.6 ttm180 -57.32 116.08 12.63 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.852 1.661 . . . . 0.0 110.829 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.47 137.22 32.91 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.705 2.27 . . . . 0.0 109.334 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.8 t80 -102.81 121.61 42.83 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.506 0.669 . . . . 0.0 111.047 -176.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.66 138.72 21.19 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.657 1.583 . . . . 0.0 110.104 171.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.56 140.52 30.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.208 1.403 . . . . 0.0 109.83 -172.263 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 86.0 t -102.88 134.76 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 109.331 176.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.72 135.73 27.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.64 109.48 2.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.32 2.68 . . . . 0.0 109.876 173.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -174.51 149.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.275 2.23 . . . . 0.0 109.098 -172.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.0 m -126.96 124.43 39.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.16 0.984 . . . . 0.0 109.927 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.1 mt -87.01 120.94 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.692 1.197 . . . . 0.0 109.144 174.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.81 -101.86 0.4 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.825 1.25 . . . . 0.0 110.492 176.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 68.0 mttm -119.63 132.17 55.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.082 1.353 . . . . 0.0 111.249 174.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.04 -144.83 16.21 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.922 1.725 . . . . 0.0 111.186 -167.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -159.6 151.02 19.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.469 1.107 . . . . 0.0 111.082 -177.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.7 tt -141.25 130.98 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.098 1.359 . . . . 0.0 111.477 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 82.7 p -144.45 178.64 7.8 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.771 1.628 . . . . 0.0 110.382 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.53 -164.83 22.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -154.66 145.22 22.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.564 1.546 . . . . 0.0 110.113 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.4 t -128.66 134.24 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.954 1.701 . . . . 0.0 108.574 174.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -118.74 141.86 48.22 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.278 1.031 . . . . 0.0 112.158 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 1.5 mtm -103.04 147.36 34.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.036 1.734 . . . . 0.0 111.317 178.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.66 -26.88 67.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.007 3.138 . . . . 0.0 115.008 175.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.6 p -73.34 -3.6 28.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.983 1.713 . . . . 0.0 114.524 178.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.73 -4.36 75.63 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.508 1.528 . . . . 0.0 114.058 -179.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -69.04 152.58 45.04 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.732 1.213 . . . . 0.0 111.964 171.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 47.9 t -142.49 141.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.829 1.652 . . . . 0.0 109.673 -176.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -153.06 -179.7 7.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.077 1.751 . . . . 0.0 110.955 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -123.8 144.63 45.25 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.875 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.5 167.09 13.6 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.276 3.317 . . . . 0.0 111.513 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.3 m -110.86 127.13 55.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.482 1.513 . . . . 0.0 108.981 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -108.6 133.5 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 109.345 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 69.8 m -136.09 137.77 41.39 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.736 1.614 . . . . 0.0 109.494 177.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.6 129.47 34.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.287 0.635 . . . . 0.0 110.896 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -76.75 -8.11 56.67 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 71.49 13.01 6.51 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.895 2.478 . . . . 0.0 113.334 -179.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.62 9.88 10.92 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.074 2.15 . . . . 0.0 112.783 -176.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.63 12.7 59.17 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.043 1.306 . . . . 0.0 114.367 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.1 p -131.02 158.39 40.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.616 1.967 . . . . 0.0 109.991 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.9 m -111.99 151.7 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.939 0.896 . . . . 0.0 110.292 168.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 139.14 38.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 163.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.0 t -120.6 127.51 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.121 1.368 . . . . 0.0 108.466 173.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -130.49 153.35 48.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.504 1.521 . . . . 0.0 111.815 -166.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 43.5 t80 -159.67 137.0 9.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.748 1.219 . . . . 0.0 112.219 -174.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.13 119.85 69.25 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.532 1.133 . . . . 0.0 110.808 176.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.67 154.06 26.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.522 2.814 . . . . 0.0 111.608 -179.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 86.6 p -133.16 -9.78 2.96 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -168.88 145.52 3.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.479 1.512 . . . . 0.0 110.39 -168.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -76.41 167.63 21.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.286 1.034 . . . . 0.0 113.379 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 124.86 -178.25 16.58 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.537 1.541 . . . . 0.0 114.266 176.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.4 tp -82.17 127.17 32.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.008 1.323 . . . . 0.0 109.986 177.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.6 m80 -124.67 153.22 42.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.094 1.358 . . . . 0.0 111.655 -172.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.68 139.95 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.407 1.483 . . . . 0.0 109.882 178.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 20.3 ttm -118.51 133.37 55.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.353 1.861 . . . . 0.0 110.645 178.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -107.42 134.69 50.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.927 2.091 . . . . 0.0 109.753 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.1 mm -134.89 139.31 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.877 1.271 . . . . 0.0 110.996 176.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.8 135.07 20.55 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 113.518 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.9 t80 -99.62 123.12 43.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.061 1.744 . . . . 0.0 109.933 173.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 50.87 36.19 14.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.356 1.462 . . . . 0.0 112.829 -176.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.2 t30 79.3 0.05 2.29 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 128.305 2.642 . . . . 0.0 114.74 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -103.41 134.44 46.78 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.27 1.428 . . . . 0.0 111.007 175.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.7 m170 -54.14 136.95 41.61 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -76.33 154.46 84.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.989 166.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.57 -23.39 70.47 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.389 2.059 . . . . 0.0 113.28 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -81.07 3.85 74.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.39 0.995 . . . . 0.0 114.686 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.1 t -99.82 147.12 32.99 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.616 1.708 . . . . 0.0 111.8 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.14 170.12 71.17 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 CA-C-N 119.785 0.959 . . . . 0.0 111.498 -11.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.59 158.27 24.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.106 1.363 . . . . 0.0 110.846 169.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -148.03 139.94 24.0 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.589 1.156 . . . . 0.0 110.366 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -164.49 173.4 12.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 0.0 111.796 -173.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -114.67 135.78 53.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.985 0.914 . . . . 0.0 113.248 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 57.9 t -102.36 138.56 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.867 1.667 . . . . 0.0 108.973 174.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.5 t0 -160.99 166.5 28.17 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.915 1.286 . . . . 0.0 111.091 178.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.12 123.62 23.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.716 0.807 . . . . 0.0 111.267 174.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -70.98 -25.58 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.166 0.986 . . . . 0.0 113.361 -167.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -95.7 -2.79 47.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.198 1.399 . . . . 0.0 113.639 -177.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 4.3 t -69.81 150.36 46.94 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.184 -0.948 . . . . 0.0 113.501 -170.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -87.09 74.84 2.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.48 1.514 . . . . 0.0 113.278 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -169.96 166.87 9.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.007 2.123 . . . . 0.0 112.335 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -71.47 132.65 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.801 1.241 . . . . 0.0 109.605 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 81.9 p -138.69 164.12 30.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.939 1.296 . . . . 0.0 110.991 176.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.88 143.76 36.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.497 1.119 . . . . 0.0 111.274 171.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.7 p90 -169.36 164.6 10.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.773 1.629 . . . . 0.0 112.736 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.54 175.1 13.72 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.329 1.442 . . . . 0.0 112.695 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.94 -37.94 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.648 2.232 . . . . 0.0 112.374 -172.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.15 -36.95 93.54 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 119.534 1.061 . . . . 0.0 114.556 -171.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.59 -4.38 45.55 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.929 1.364 . . . . 0.0 113.648 176.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.3 m -104.9 -49.59 3.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.038 1.735 . . . . 0.0 110.506 176.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -142.49 131.86 23.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.5 1.92 . . . . 0.0 112.724 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -125.19 177.78 16.8 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.218 1.866 . . . . 0.0 112.431 171.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 46.3 t -142.05 134.6 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.654 1.182 . . . . 0.0 108.826 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.7 m -58.21 138.99 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 62.91 9.8 3.94 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.046 1.738 . . . . 0.0 114.635 176.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -120.89 141.3 32.32 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.79 129.37 15.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.578 2.185 . . . . 0.0 110.616 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.78 144.22 36.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.634 1.574 . . . . 0.0 110.185 174.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.0 p -135.6 147.33 48.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -166.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.69 178.06 10.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.632 1.573 . . . . 0.0 111.488 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.8 m -128.9 144.03 51.06 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.407 1.483 . . . . 0.0 110.768 -170.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 50.8 t -117.73 132.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.852 1.661 . . . . 0.0 108.158 169.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.48 129.57 38.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.932 0.893 . . . . 0.0 111.184 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -127.95 0.9 5.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.021 1.728 . . . . 0.0 113.349 -172.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.84 -41.78 62.06 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.042 1.737 . . . . 0.0 114.022 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.83 -3.89 34.44 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.27 1.428 . . . . 0.0 113.38 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.49 65.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.151 0.98 . . . . 0.0 113.611 -173.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.42 -88.62 1.11 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.744 1.164 . . . . 0.0 112.369 177.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.76 149.07 19.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.572 1.549 . . . . 0.0 110.954 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 163.54 -151.49 21.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.06 1.791 . . . . 0.0 111.519 -177.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -111.27 107.58 2.2 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.422 1.01 . . . . 0.0 111.402 172.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 55.6 tp -81.33 136.47 35.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.411 1.084 . . . . 0.0 109.864 172.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.2 m -136.67 156.18 48.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 0.0 111.768 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.0 tp -159.91 131.89 6.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 108.8 -168.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.23 34.59 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.786 0.834 . . . . 0.0 112.4 -179.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.39 137.43 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.016 1.326 . . . . 0.0 109.871 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -125.06 157.5 36.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.385 1.874 . . . . 0.0 109.807 171.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.71 -161.73 29.83 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.658 -178.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.4 -25.23 63.7 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.009 3.14 . . . . 0.0 112.68 177.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.4 t -140.45 159.95 41.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.041 1.336 . . . . 0.0 109.444 162.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.9 tptt -76.94 107.05 9.0 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.983 -1.073 . . . . 0.0 111.233 -178.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.81 147.01 53.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.024 0.93 . . . . 0.0 111.723 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.83 148.42 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.627 0.771 . . . . 0.0 110.674 168.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.0 mt -137.62 145.38 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.074 1.35 . . . . 0.0 110.181 -164.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -143.08 167.17 22.71 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.054 1.342 . . . . 0.0 111.016 166.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.8 156.03 28.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 0.0 112.594 -178.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 89.1 m -143.08 124.99 15.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.676 1.59 . . . . 0.0 109.922 -171.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 20.3 t0 -74.3 120.95 20.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.916 0.886 . . . . 0.0 109.839 170.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -83.48 -7.32 59.56 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.151 0.98 . . . . 0.0 113.455 -176.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 74.72 -17.51 0.48 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.07 2.948 . . . . 0.0 113.908 178.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -81.36 -3.88 54.05 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.853 1.661 . . . . 0.0 113.913 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 105.21 22.5 8.21 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.446 1.498 . . . . 0.0 114.07 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.9 p -138.94 154.63 48.34 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.613 172.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 93.9 m -115.04 131.56 56.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.858 1.663 . . . . 0.0 109.137 165.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -86.38 149.24 25.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.823 0.849 . . . . 0.0 110.304 168.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.5 t -127.01 142.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.426 1.89 . . . . 0.0 109.076 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 81.6 p -131.86 146.14 51.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.724 1.21 . . . . 0.0 111.442 167.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.44 157.05 42.96 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.077 -1.014 . . . . 0.0 113.118 175.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 43.4 tp -126.41 102.2 26.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.839 1.255 . . . . 0.0 110.492 -174.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.87 174.29 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.746 2.964 . . . . 0.0 110.61 170.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -148.44 -30.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.48 145.34 31.07 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.657 1.117 . . . . 0.0 110.776 167.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.56 164.81 31.67 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.273 2.649 . . . . 0.0 111.339 177.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.24 -124.48 3.93 Favored Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.909 1.242 . . . . 0.0 111.86 -175.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -147.76 144.78 28.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.359 1.464 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.18 143.22 51.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.445 1.898 . . . . 0.0 110.863 -172.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 60.4 m -96.1 123.7 39.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.717 1.207 . . . . 0.0 110.429 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.27 124.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.609 1.564 . . . . 0.0 108.464 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.98 131.87 54.65 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 109.908 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 42.6 t -133.58 127.85 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.465 1.106 . . . . 0.0 109.74 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.3 142.68 26.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.16 1.384 . . . . 0.0 111.397 -169.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.92 121.34 12.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.54 1.136 . . . . 0.0 110.025 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 59.59 56.08 3.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.584 1.554 . . . . 0.0 111.55 178.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.286 10.5 pt-20 54.19 23.59 4.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.796 2.438 . . . . 0.0 115.645 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -133.29 128.67 36.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.115 1.366 . . . . 0.0 110.432 177.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -65.01 148.04 52.38 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.448 -0.783 . . . . 0.0 112.022 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 15.2 m -70.21 152.43 95.68 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.879 168.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.22 128.01 24.94 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.683 2.255 . . . . 0.0 110.402 177.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.96 62.28 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.175 1.369 . . . . 0.0 115.045 -174.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.7 t -78.49 140.71 60.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.281 1.54 . . . . 0.0 111.5 175.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.71 137.39 49.97 Favored 'Cis proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.401 0.822 . . . . 0.0 111.963 -4.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -87.71 165.69 15.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.107 1.763 . . . . 0.0 110.66 175.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 88.7 m -123.84 119.22 29.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.885 0.874 . . . . 0.0 110.255 174.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.61 135.56 39.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.809 1.243 . . . . 0.0 110.921 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.6 tpt85 -80.2 141.41 35.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.818 0.847 . . . . 0.0 109.259 167.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.8 t -129.41 132.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.78 1.173 . . . . 0.0 110.926 176.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 27.6 p -111.49 159.55 17.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.251 1.42 . . . . 0.0 112.843 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.04 128.72 9.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.703 1.621 . . . . 0.0 112.57 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.222 1.409 . . . . 0.0 113.42 176.645 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -52.0 112.96 3.67 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.787 1.235 . . . . 0.0 112.313 -172.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.63 148.76 33.33 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.693 2.262 . . . . 0.0 110.811 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.48 122.49 32.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.182 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -148.45 147.13 28.8 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.904 1.282 . . . . 0.0 111.057 168.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.93 154.8 20.28 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.38 1.472 . . . . 0.0 110.503 -175.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 10.6 p -127.4 134.42 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.627 1.571 . . . . 0.0 109.615 172.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.0 mt -132.58 137.63 30.25 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.789 1.636 . . . . 0.0 109.334 -171.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.4 84.73 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.895 3.063 . . . . 0.0 110.883 177.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -134.16 151.16 51.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.509 1.923 . . . . 0.0 109.625 173.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 80.7 m -126.37 123.86 38.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 109.488 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.88 129.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.704 1.201 . . . . 0.0 109.904 178.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -105.69 -139.12 0.37 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.961 1.304 . . . . 0.0 110.643 175.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -75.94 -6.21 49.84 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -178.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.93 -149.18 10.58 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.922 1.725 . . . . 0.0 113.038 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.49 151.1 27.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.934 1.294 . . . . 0.0 111.033 -174.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.0 tt -127.35 135.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.59 1.556 . . . . 0.0 112.015 -175.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.3 p -147.92 162.66 38.85 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.814 1.645 . . . . 0.0 110.875 -176.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -147.19 -176.16 20.67 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 116.046 1.178 . . . . 0.0 116.046 -177.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -153.92 143.31 21.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.566 1.946 . . . . 0.0 109.119 173.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 24.9 t -117.61 133.2 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.727 1.611 . . . . 0.0 108.195 174.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -117.4 129.35 55.8 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.288 1.035 . . . . 0.0 110.813 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.9 mpp? -97.3 148.22 34.1 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.576 1.55 . . . . 0.0 111.506 -173.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 -21.01 29.91 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.462 2.774 . . . . 0.0 113.145 -179.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.2 p -79.22 1.02 26.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.379 1.471 . . . . 0.0 114.431 176.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.04 54.63 2.27 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.665 1.126 . . . . 0.0 113.296 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -156.61 166.33 33.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.961 1.704 . . . . 0.0 111.864 -177.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.8 m -141.63 158.13 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.798 1.239 . . . . 0.0 112.652 -173.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.88 173.46 16.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.474 2.31 . . . . 0.0 110.045 177.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -114.75 144.93 32.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 121.13 -0.981 . . . . 0.0 112.769 -179.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -86.56 174.8 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.837 3.691 . . . . 0.0 112.034 177.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 71.7 m -110.05 133.5 53.14 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.809 1.644 . . . . 0.0 108.806 171.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.83 140.75 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.989 1.316 . . . . 0.0 108.604 173.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 14.5 t -148.0 139.42 23.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.731 1.212 . . . . 0.0 111.005 177.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.01 138.38 32.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.651 1.18 . . . . 0.0 112.638 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -96.56 -9.54 29.23 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.064 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.76 -1.69 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.693 2.397 . . . . 0.0 115.02 173.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.79 3.33 55.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.602 1.961 . . . . 0.0 113.549 175.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 102.29 12.28 34.01 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.365 1.46 . . . . 0.0 114.399 -174.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 26.3 p -125.86 161.62 27.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.141 1.377 . . . . 0.0 111.824 174.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -121.79 144.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.734 1.214 . . . . 0.0 109.946 165.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 17.1 m -97.33 139.81 32.72 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.331 1.452 . . . . 0.0 109.037 170.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.1 t -127.23 136.84 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.69 1.596 . . . . 0.0 108.934 178.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -142.35 157.7 44.52 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.07 1.348 . . . . 0.0 112.684 -174.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -154.92 135.27 13.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.254 1.421 . . . . 0.0 111.88 172.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.16 120.58 72.5 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.9 1.28 . . . . 0.0 110.923 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.87 167.55 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.906 3.07 . . . . 0.0 112.281 -172.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 89.4 p -147.22 -26.32 0.39 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.92 150.09 45.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.175 1.79 . . . . 0.0 110.393 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.73 168.67 18.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.492 1.117 . . . . 0.0 113.135 178.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 121.44 -173.15 15.56 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 125.425 1.488 . . . . 0.0 114.071 178.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.8 tt -87.8 127.47 35.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.809 1.244 . . . . 0.0 109.747 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 65.3 m80 -127.66 164.16 22.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.943 1.697 . . . . 0.0 111.585 -172.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -146.35 154.15 41.33 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.777 0.799 . . . . 0.0 112.554 166.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.9 ttm -127.33 133.7 50.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.85 2.46 . . . . 0.0 109.763 -173.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -103.83 131.93 50.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.304 1.842 . . . . 0.0 109.354 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 27.8 mm -130.51 128.26 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.358 1.063 . . . . 0.0 109.783 175.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.52 137.39 37.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 48.2 t80 -103.9 124.07 48.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.836 2.054 . . . . 0.0 109.358 174.066 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.01 46.09 22.57 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.692 1.197 . . . . 0.0 112.344 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.301 0.2 OUTLIER 63.34 9.99 4.44 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.034 2.533 . . . . 0.0 116.56 -177.222 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.7 mtp -110.88 131.24 55.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.231 1.412 . . . . 0.0 110.931 173.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -55.91 134.11 51.86 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.433 -0.792 . . . . 0.0 112.813 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.8 pt -73.89 155.59 88.6 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.701 178.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -59.44 122.44 11.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.711 1.607 . . . . 0.0 108.395 163.288 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 113.78 -25.01 11.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.996 1.284 . . . . 0.0 113.021 -171.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.4 t -83.79 148.3 54.01 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 118.91 1.355 . . . . 0.0 111.341 174.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.06 155.85 97.27 Favored 'Cis proline' 0 C--N 1.351 0.698 0 CA-C-N 119.79 0.961 . . . . 0.0 111.674 -10.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.51 133.75 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 109.227 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -137.92 134.74 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 110.975 -170.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.5 178.85 7.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.309 1.043 . . . . 0.0 113.109 -171.062 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -116.8 143.53 45.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.517 1.127 . . . . 0.0 112.555 176.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 94.2 t -112.86 132.69 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.293 1.837 . . . . 0.0 109.416 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 29.3 t0 -159.46 152.0 21.39 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.07 134.86 39.94 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.18 -0.95 . . . . 0.0 112.622 -176.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.1 p -70.58 -19.95 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.4 0.68 . . . . 0.0 112.589 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -73.39 -20.61 60.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.889 1.276 . . . . 0.0 114.014 -178.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.0 m -73.92 148.61 42.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.384 1.073 . . . . 0.0 113.146 -173.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -92.46 -14.03 56.22 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.95 1.262 . . . . 0.0 114.703 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -65.03 160.78 20.16 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.553 1.176 . . . . 0.0 113.427 177.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.5 t -69.47 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.731 0.812 . . . . 0.0 109.363 177.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -161.22 161.53 30.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.301 1.441 . . . . 0.0 110.543 -175.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.73 147.83 32.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.511 1.124 . . . . 0.0 112.291 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.51 161.55 13.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.752 1.621 . . . . 0.0 112.941 -176.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.25 171.86 12.33 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.506 1.527 . . . . 0.0 113.09 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.29 -34.84 26.09 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.12 2.546 . . . . 0.0 112.616 -173.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.82 -21.99 73.5 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 119.036 0.835 . . . . 0.0 114.662 -177.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.89 -14.9 60.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.39 1.095 . . . . 0.0 113.168 172.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 16.9 m -117.15 -36.16 3.87 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.777 1.631 . . . . 0.0 111.926 -168.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -150.6 155.63 39.78 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.489 1.916 . . . . 0.0 111.963 -174.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -149.31 173.51 29.13 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 123.978 0.799 . . . . 0.0 113.176 171.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 54.6 t -135.32 132.01 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.654 1.182 . . . . 0.0 108.353 176.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -57.73 138.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.11 2.28 2.24 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.997 2.119 . . . . 0.0 114.62 176.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -117.64 141.28 28.7 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.026 1.73 . . . . 0.0 110.93 177.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.13 130.29 16.3 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.672 2.248 . . . . 0.0 111.099 -173.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.7 139.54 44.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.415 1.486 . . . . 0.0 110.06 173.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -131.02 152.61 50.15 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.1 175.12 12.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.541 1.536 . . . . 0.0 112.189 177.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 47.5 m -125.62 143.45 51.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.963 1.705 . . . . 0.0 110.625 -171.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.3 t -121.45 131.45 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.215 1.806 . . . . 0.0 108.362 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -89.13 132.31 34.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.391 1.077 . . . . 0.0 111.754 -178.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.6 p -130.74 1.31 4.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.754 . . . . 0.0 113.222 -176.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -52.0 -38.8 58.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.02 2.128 . . . . 0.0 115.445 -168.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -131.81 21.05 4.59 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.523 1.529 . . . . 0.0 111.926 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.95 69.43 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.729 1.212 . . . . 0.0 113.885 -174.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.51 149.88 6.37 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.685 1.136 . . . . 0.0 112.301 -169.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.67 163.96 27.28 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.08 0.952 . . . . 0.0 113.531 -177.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 161.85 -30.49 0.31 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.538 1.066 . . . . 0.0 114.705 175.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.73 101.15 0.35 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.579 1.562 . . . . 0.0 112.748 173.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.72 144.63 37.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.989 1.316 . . . . 0.0 110.457 175.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -147.44 158.34 43.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.974 1.31 . . . . 0.0 112.049 -173.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.7 tp -166.6 135.87 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.928 1.691 . . . . 0.0 109.495 -164.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.86 159.13 36.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.359 1.064 . . . . 0.0 111.923 175.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.35 128.67 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.662 1.185 . . . . 0.0 109.67 175.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -115.69 163.65 15.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.107 1.763 . . . . 0.0 110.039 171.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 178.91 -166.88 36.81 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.269 -0.894 . . . . 0.0 113.852 -179.309 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.75 -19.18 36.48 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.625 2.883 . . . . 0.0 112.268 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.0 t -142.88 158.16 43.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.831 1.653 . . . . 0.0 108.867 161.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 23.2 tptp -74.84 120.69 20.72 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.832 -1.167 . . . . 0.0 111.96 -175.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.2 147.33 34.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.002 0.921 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.01 147.68 23.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.057 0.943 . . . . 0.0 110.777 169.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 13.6 mt -137.08 145.98 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.882 1.273 . . . . 0.0 110.524 -161.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 78.5 p -143.79 161.98 37.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.1 1.36 . . . . 0.0 111.388 165.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.02 158.64 35.24 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.384 1.074 . . . . 0.0 112.738 -175.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.9 m -147.54 119.47 8.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.462 1.505 . . . . 0.0 110.097 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.69 129.7 35.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.658 1.183 . . . . 0.0 111.303 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -108.9 152.74 24.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.827 1.251 . . . . 0.0 112.127 -177.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -64.54 -26.31 68.36 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.855 1.262 . . . . 0.0 113.482 -174.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -83.13 8.08 14.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.241 1.416 . . . . 0.0 114.767 -178.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.53 27.73 8.94 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 168.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 23.4 p -139.88 135.14 32.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.324 1.05 . . . . 0.0 111.583 175.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 41.3 t -90.64 128.84 36.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 109.819 163.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -92.55 149.45 21.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.14 0.976 . . . . 0.0 110.212 169.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 61.9 t -132.43 144.09 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.761 1.624 . . . . 0.0 109.663 -178.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 19.7 t -138.19 142.38 40.02 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.601 1.561 . . . . 0.0 110.916 172.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.5 p90 -148.54 156.46 42.47 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.2 mt -121.31 107.25 37.25 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.828 1.651 . . . . 0.0 110.541 -179.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.35 164.27 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.7 2.933 . . . . 0.0 110.284 166.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.6 p -125.63 -21.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -170.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.9 pp -146.0 151.48 45.28 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.949 1.3 . . . . 0.0 110.31 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.48 153.28 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 112.534 -169.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.67 -165.51 28.38 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.8 1.19 . . . . 0.0 113.431 -177.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -93.13 124.87 37.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.159 1.384 . . . . 0.0 111.853 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -114.1 138.32 50.56 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.385 1.474 . . . . 0.0 110.627 178.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -102.64 114.7 29.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.483 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.51 125.46 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.196 1.398 . . . . 0.0 108.665 -179.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -104.63 132.26 51.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.578 1.551 . . . . 0.0 109.545 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.7 t -133.45 129.28 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.341 1.056 . . . . 0.0 109.565 172.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -154.54 144.45 21.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.98 1.312 . . . . 0.0 111.689 -165.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.92 122.15 11.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.833 1.253 . . . . 0.0 109.618 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.3 t-20 54.92 56.62 6.44 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.352 1.461 . . . . 0.0 111.635 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 60.62 1.46 0.41 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 129.149 2.98 . . . . 0.0 116.701 -177.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -106.46 125.92 51.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.532 1.133 . . . . 0.0 111.015 178.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.21 145.16 56.44 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 169.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 6.8 m -75.37 157.69 84.44 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.774 173.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.76 125.22 17.94 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.616 2.878 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.42 77.09 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.716 1.15 . . . . 0.0 115.544 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 33.0 t -77.03 139.91 65.97 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.349 1.575 . . . . 0.0 111.728 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.84 141.8 71.86 Favored 'Cis proline' 0 CA--C 1.539 0.773 0 CA-C-N 119.5 0.857 . . . . 0.0 111.953 -4.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 154.08 17.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 110.95 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 62.2 m -112.73 114.44 27.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.636 0.774 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.5 133.76 42.42 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 111.407 174.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -94.62 105.84 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.678 1.191 . . . . 0.0 109.863 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.4 t -91.09 137.68 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.245 1.018 . . . . 0.0 110.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 68.6 p -115.81 158.95 22.14 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.434 1.494 . . . . 0.0 112.942 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.53 137.66 19.24 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.896 1.236 . . . . 0.0 111.531 174.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 CA--C 1.548 0.866 0 C-N-CA 124.391 1.076 . . . . 0.0 113.373 -179.015 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.29 0.567 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -68.88 121.58 81.98 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.239 1.415 . . . . 0.0 110.51 -175.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.66 151.98 69.73 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.297 2.665 . . . . 0.0 111.723 -171.075 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.7 t80 -98.48 124.63 43.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.588 0.755 . . . . 0.0 110.306 176.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -153.16 133.35 13.44 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 110.913 173.389 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.11 156.37 44.32 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.456 1.902 . . . . 0.0 109.873 -170.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -130.98 138.57 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.083 1.353 . . . . 0.0 110.53 -178.451 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.86 136.41 27.67 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.243 1.817 . . . . 0.0 109.094 -174.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.18 114.38 3.97 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.168 2.579 . . . . 0.0 110.053 172.528 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 42.2 t80 -178.2 152.56 0.71 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.182 2.193 . . . . 0.0 109.333 -170.215 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 36.8 m -133.49 129.57 37.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.455 1.102 . . . . 0.0 110.218 178.719 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.0 mt -79.62 109.98 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.189 0.995 . . . . 0.0 109.056 171.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.73 -58.8 2.08 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -176.708 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -158.88 -12.32 0.07 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.482 2.031 . . . . 0.0 116.482 -167.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.02 -136.89 5.94 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.134 1.826 . . . . 0.0 112.226 176.089 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -154.31 145.64 22.98 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.147 1.379 . . . . 0.0 110.421 -176.053 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.8 tt -128.45 137.93 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.414 1.486 . . . . 0.0 111.438 -178.193 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.2 p -147.31 164.78 32.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.965 1.706 . . . . 0.0 110.587 -178.283 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -149.65 177.78 27.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 -177.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -150.62 137.3 18.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.993 1.717 . . . . 0.0 109.614 175.036 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.9 t -111.32 137.99 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.332 1.853 . . . . 0.0 108.506 174.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.88 133.67 54.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.969 1.308 . . . . 0.0 111.551 -173.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.02 149.61 38.79 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.837 1.655 . . . . 0.0 111.971 -173.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -54.66 -32.28 74.66 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.174 3.249 . . . . 0.0 114.668 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 38.1 m -71.42 -1.27 12.54 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.451 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.65 -1.53 83.84 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.545 1.545 . . . . 0.0 113.935 -176.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -74.83 161.61 29.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.596 1.558 . . . . 0.0 112.001 177.582 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.9 m -139.21 157.33 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.186 1.394 . . . . 0.0 111.831 176.438 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.6 170.42 21.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.41 1.884 . . . . 0.0 111.017 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -114.13 138.75 23.05 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.026 0.931 . . . . 0.0 111.391 178.591 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.62 175.55 2.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.497 3.465 . . . . 0.0 112.45 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.9 m -109.33 133.08 53.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.47 1.508 . . . . 0.0 109.373 173.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.93 134.47 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.051 1.34 . . . . 0.0 109.263 175.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -135.69 126.29 27.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.627 1.571 . . . . 0.0 109.999 179.243 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.69 129.52 34.55 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.744 0.818 . . . . 0.0 110.558 171.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.76 -5.0 59.09 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 65.37 22.46 11.99 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.331 1.853 . . . . 0.0 112.53 -175.878 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -134.77 15.44 3.62 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.383 1.873 . . . . 0.0 112.71 -171.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.37 11.11 72.72 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.768 1.175 . . . . 0.0 114.451 -179.058 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.1 p -130.86 154.06 48.45 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 110.958 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.1 m -113.76 138.21 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.313 1.045 . . . . 0.0 109.697 164.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.1 m -99.0 139.47 34.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.051 1.341 . . . . 0.0 108.531 170.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 36.2 t -126.08 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.288 1.435 . . . . 0.0 108.962 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -135.32 154.09 51.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.757 1.223 . . . . 0.0 112.823 -172.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 42.2 t80 -155.02 136.33 14.05 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.747 1.619 . . . . 0.0 112.054 177.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.55 117.39 67.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.799 1.239 . . . . 0.0 110.817 176.789 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.38 146.99 22.46 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.658 2.905 . . . . 0.0 112.704 -174.242 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 68.4 m -122.84 -2.75 8.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.68 1.192 . . . . 0.0 113.634 175.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 154.58 19.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.225 1.81 . . . . 0.0 111.166 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.62 172.02 12.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.519 1.128 . . . . 0.0 112.664 176.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.71 -175.92 16.8 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.047 1.308 . . . . 0.0 113.996 177.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -84.98 118.19 24.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.354 1.062 . . . . 0.0 110.186 -178.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 39.4 m80 -114.01 165.1 12.97 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.223 1.809 . . . . 0.0 111.779 -174.565 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.83 155.96 44.3 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.325 1.05 . . . . 0.0 111.551 173.134 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 29.2 ttm -142.28 124.16 15.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.583 1.553 . . . . 0.0 110.203 -171.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.93 126.34 46.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 109.841 176.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 41.0 mm -123.42 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.262 1.425 . . . . 0.0 110.285 176.395 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.32 139.77 23.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.422 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.8 t80 -106.18 124.95 50.38 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.337 2.255 . . . . 0.0 110.102 177.574 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 53.32 29.0 7.95 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.775 1.23 . . . . 0.0 112.461 -173.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 25.2 t30 77.41 4.87 3.13 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.573 2.749 . . . . 0.0 115.185 -178.224 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 59.8 ttm -103.32 134.04 47.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.346 1.458 . . . . 0.0 111.063 172.313 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.3 m170 -57.31 134.34 55.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.293 -0.879 . . . . 0.0 113.001 -178.549 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 42.0 pt -74.94 155.01 86.84 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.65 . . . . 0.0 111.568 176.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.12 125.86 19.33 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.374 2.049 . . . . 0.0 109.779 172.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.07 -16.7 56.99 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.618 1.104 . . . . 0.0 114.326 -173.243 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.5 t -81.76 146.65 56.82 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 119.043 1.422 . . . . 0.0 111.73 176.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.76 162.64 84.7 Favored 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 120.09 1.068 . . . . 0.0 112.302 -6.174 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.4 mt -95.64 155.3 16.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.038 1.335 . . . . 0.0 110.834 172.38 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -156.74 132.96 9.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.714 1.205 . . . . 0.0 109.977 -175.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.9 p90 -167.39 172.95 9.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.426 1.09 . . . . 0.0 112.526 -168.162 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 46.3 t80 -108.74 134.04 51.99 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.178 0.991 . . . . 0.0 113.035 176.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.3 t -96.31 133.38 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 109.494 172.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 45.5 t0 -143.97 173.89 11.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.811 2.045 . . . . 0.0 109.918 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -79.12 151.25 31.47 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.724 -1.235 . . . . 0.0 113.459 178.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 69.4 t -66.3 -47.64 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.229 1.411 . . . . 0.0 110.4 174.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -95.52 128.22 42.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 110.621 175.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 23.6 p -171.77 153.17 3.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.979 1.712 . . . . 0.0 112.192 -175.323 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -103.59 -19.33 12.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.114 1.34 . . . . 0.0 113.772 173.471 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -71.61 155.98 39.91 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.337 1.068 . . . . 0.0 113.379 177.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -68.39 137.58 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.095 0.958 . . . . 0.0 108.567 172.653 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.6 t -156.0 168.15 28.17 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.72 1.208 . . . . 0.0 110.972 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.22 147.36 30.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.823 1.249 . . . . 0.0 112.155 -177.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.7 p90 -167.21 164.41 15.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.052 1.741 . . . . 0.0 112.391 -175.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.39 173.72 13.44 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.201 1.381 . . . . 0.0 113.315 -179.203 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.37 -32.69 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.935 2.424 . . . . 0.0 113.194 -170.624 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.43 76.52 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 119.402 1.001 . . . . 0.0 114.333 -172.593 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.0 pp -78.09 -3.38 42.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.965 1.383 . . . . 0.0 113.374 174.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.2 m -107.01 -39.91 5.61 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.595 1.958 . . . . 0.0 111.891 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -149.94 150.51 31.96 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.501 1.92 . . . . 0.0 112.495 -169.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 177.07 28.92 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.015 0.817 . . . . 0.0 113.472 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 35.3 t -139.98 134.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.941 1.296 . . . . 0.0 107.901 174.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.2 m -56.31 134.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 122.901 0.48 . . . . 0.0 112.253 -177.821 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.9 m-80 69.48 -5.51 1.14 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.142 2.177 . . . . 0.0 114.616 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -97.87 138.45 21.0 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.865 1.266 . . . . 0.0 110.646 175.205 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.99 126.17 11.01 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.475 2.117 . . . . 0.0 110.289 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.58 144.11 36.72 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.463 1.505 . . . . 0.0 110.371 175.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 60.3 p -135.38 149.16 49.6 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -166.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.0 p90 -160.26 175.51 12.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.443 1.497 . . . . 0.0 111.682 177.234 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 30.5 m -129.68 139.48 51.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.04 1.336 . . . . 0.0 110.805 -169.024 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -110.44 133.94 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.024 1.73 . . . . 0.0 107.877 168.137 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.88 126.99 37.17 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.137 0.975 . . . . 0.0 111.02 178.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 78.6 p -127.09 3.13 6.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.065 1.746 . . . . 0.0 113.072 -172.777 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -52.99 -27.33 18.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.473 2.309 . . . . 0.0 116.382 -171.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.56 15.2 5.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.471 1.508 . . . . 0.0 112.191 176.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -79.23 -25.03 42.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.633 1.173 . . . . 0.0 113.494 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.09 -107.0 2.38 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.638 1.113 . . . . 0.0 112.101 178.649 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.94 152.99 23.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.234 1.813 . . . . 0.0 110.066 -174.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.55 8.26 0.11 Allowed Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 90.87 106.45 1.36 Allowed Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.463 1.506 . . . . 0.0 112.885 177.133 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 139.19 30.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.066 1.347 . . . . 0.0 109.762 170.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.0 m -130.77 159.35 37.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.569 1.548 . . . . 0.0 111.826 178.108 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.9 135.25 8.19 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.531 1.532 . . . . 0.0 109.409 -167.418 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 158.57 35.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.189 0.996 . . . . 0.0 112.194 178.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -138.24 136.04 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.758 1.223 . . . . 0.0 109.827 177.159 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -129.23 130.13 45.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.215 1.406 . . . . 0.0 110.21 176.075 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.84 -162.49 11.41 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.094 -176.259 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -62.33 -25.71 76.62 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.932 3.088 . . . . 0.0 112.388 174.324 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 21.1 t -137.2 153.8 50.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 109.112 161.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -74.07 119.54 18.42 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.876 -1.14 . . . . 0.0 110.837 177.006 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.33 151.7 44.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.002 0.921 . . . . 0.0 112.332 178.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.11 137.76 32.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 164.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.3 mt -132.99 138.9 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.479 1.112 . . . . 0.0 110.501 -169.307 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 74.1 m -132.03 157.53 43.89 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.848 1.659 . . . . 0.0 110.635 167.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -153.41 155.76 36.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.059 0.944 . . . . 0.0 112.766 177.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.6 m -143.54 119.22 10.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.33 1.452 . . . . 0.0 110.382 -170.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.11 134.47 38.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.633 1.173 . . . . 0.0 111.396 173.251 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -114.3 148.44 37.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.626 1.571 . . . . 0.0 111.913 -177.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.51 -12.81 61.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.838 0.855 . . . . 0.0 112.718 174.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.35 -5.77 44.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.791 1.637 . . . . 0.0 114.031 177.115 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 32.83 7.63 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.646 1.117 . . . . 0.0 113.723 -179.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.7 p -139.84 160.17 40.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.968 1.307 . . . . 0.0 111.363 176.797 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 46.5 t -114.66 127.22 55.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.246 1.419 . . . . 0.0 108.434 160.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.7 t -92.52 147.93 22.5 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.144 0.977 . . . . 0.0 110.759 174.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.6 t -124.83 142.11 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.883 1.673 . . . . 0.0 109.927 -178.176 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.4 m -131.06 140.43 50.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.523 1.529 . . . . 0.0 110.424 167.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 14.4 p90 -146.85 154.11 40.94 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 174.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.17 106.74 42.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.085 1.754 . . . . 0.0 110.514 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.31 176.41 7.36 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.926 3.084 . . . . 0.0 110.523 167.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.7 p -149.83 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.572 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.77 147.29 35.5 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.422 1.089 . . . . 0.0 110.434 166.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.21 156.07 46.66 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.897 2.398 . . . . 0.0 110.925 175.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.62 -161.19 23.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.77 1.176 . . . . 0.0 113.647 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.24 131.96 36.43 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.154 1.382 . . . . 0.0 112.682 -178.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.57 122.41 38.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.602 1.561 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.6 m -84.23 127.22 33.82 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.192 -0.942 . . . . 0.0 110.832 175.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.38 124.88 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.953 1.701 . . . . 0.0 108.33 178.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -105.01 130.68 53.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.401 1.48 . . . . 0.0 109.699 174.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.4 t -131.7 128.36 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.409 1.084 . . . . 0.0 109.779 172.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.9 147.08 29.35 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.233 1.413 . . . . 0.0 111.615 -170.358 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.47 121.93 11.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.94 1.296 . . . . 0.0 109.461 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 54.08 56.79 6.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.425 1.49 . . . . 0.0 112.123 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 8.4 pt-20 59.38 4.13 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.965 2.906 . . . . 0.0 116.711 -176.478 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.67 126.12 53.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.659 1.184 . . . . 0.0 111.022 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -65.02 146.9 54.41 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.234 -0.916 . . . . 0.0 111.787 169.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.2 m -72.09 153.47 92.61 Favored Pre-proline 0 N--CA 1.482 1.152 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.378 170.75 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -57.99 130.42 38.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.116 2.544 . . . . 0.0 110.65 175.223 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 90.71 -15.75 59.74 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.95 1.262 . . . . 0.0 114.929 -175.516 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.0 t -77.87 139.95 62.34 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.457 1.628 . . . . 0.0 111.457 175.629 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.45 135.92 42.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.373 0.812 . . . . 0.0 111.977 -3.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.44 172.92 10.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.825 1.65 . . . . 0.0 110.186 172.808 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 84.9 m -137.21 121.61 18.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 174.092 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.25 147.46 23.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.985 1.714 . . . . 0.0 111.571 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.47 113.0 25.7 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.343 1.057 . . . . 0.0 109.759 173.831 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.0 t -95.37 142.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.976 1.31 . . . . 0.0 110.115 177.29 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.4 t -128.3 170.61 12.86 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.305 1.042 . . . . 0.0 113.167 178.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -82.45 137.83 17.47 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.788 1.661 . . . . 0.0 113.091 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 125.067 1.347 . . . . 0.0 112.803 174.987 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 121.021 0.438 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -55.03 118.85 18.97 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.251 1.42 . . . . 0.0 111.615 -174.316 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.19 126.64 13.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.443 2.095 . . . . 0.0 108.756 177.425 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 64.7 t80 -116.24 125.07 51.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.7 0.762 . . . . 0.0 111.833 -171.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.62 142.34 16.56 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.017 1.727 . . . . 0.0 110.524 174.124 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.39 148.36 47.78 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.867 1.667 . . . . 0.0 110.418 -173.209 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.1 p -112.54 137.59 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.105 1.362 . . . . 0.0 109.923 173.034 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.0 mt -134.68 135.58 23.77 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.93 1.692 . . . . 0.0 108.798 -173.348 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.77 113.84 3.88 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.273 2.649 . . . . 0.0 109.979 175.964 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.4 t80 -172.72 146.07 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.485 1.914 . . . . 0.0 109.689 -172.766 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.7 m -118.71 122.31 42.19 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.496 1.119 . . . . 0.0 109.269 176.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.77 116.42 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.73 0.812 . . . . 0.0 109.372 175.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.3 mttt -96.56 -143.23 0.28 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.37 1.468 . . . . 0.0 111.607 178.174 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -78.07 -9.79 59.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.82 -142.56 5.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.335 1.921 . . . . 0.0 113.086 177.178 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.94 150.05 25.47 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.015 1.326 . . . . 0.0 111.229 -172.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.14 136.88 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.791 1.636 . . . . 0.0 111.389 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.7 p -146.07 -178.08 5.94 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.207 1.803 . . . . 0.0 110.138 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.0 -165.07 31.81 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -179.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -147.87 149.29 31.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.773 2.029 . . . . 0.0 109.934 -179.881 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 62.0 t -122.23 132.25 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.689 1.595 . . . . 0.0 107.92 167.659 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -115.38 130.97 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.808 1.243 . . . . 0.0 111.133 -174.505 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -102.84 149.9 37.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.717 1.607 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.65 -32.95 85.65 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.349 3.366 . . . . 0.0 115.315 176.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.0 t -77.59 -1.68 31.99 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.2 -1.06 72.89 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.386 1.469 . . . . 0.0 114.079 -177.684 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -66.03 155.95 35.16 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 111.763 171.152 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.7 m -139.7 152.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.019 1.328 . . . . 0.0 111.334 175.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.97 175.02 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.556 1.942 . . . . 0.0 110.222 179.684 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -120.03 141.02 30.74 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 121.482 -0.761 . . . . 0.0 111.358 178.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.94 165.65 13.33 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.957 3.105 . . . . 0.0 111.341 177.236 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.7 m -104.82 125.5 50.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.009 1.324 . . . . 0.0 108.679 172.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.0 135.12 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 109.236 175.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 83.9 m -128.25 132.1 48.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.049 1.74 . . . . 0.0 109.935 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 18.0 t0 -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.241 1.016 . . . . 0.0 111.019 171.596 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.9 -14.74 43.93 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 62.8 tttt 72.71 -2.88 2.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 127.668 2.387 . . . . 0.0 113.967 178.267 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -96.98 5.34 50.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.005 2.122 . . . . 0.0 113.29 -178.138 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.12 12.78 54.52 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.144 1.354 . . . . 0.0 113.962 -174.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.6 p -127.46 159.32 34.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.173 1.789 . . . . 0.0 110.477 173.764 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.79 146.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.59 1.156 . . . . 0.0 109.623 166.275 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 27.0 m -105.04 137.06 43.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.111 0.965 . . . . 0.0 108.736 170.597 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.5 t -119.56 133.83 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.148 1.379 . . . . 0.0 109.167 178.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.76 150.76 51.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.628 1.571 . . . . 0.0 111.841 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.6 t80 -155.62 132.59 10.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.429 1.491 . . . . 0.0 111.384 178.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.36 120.7 74.75 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.246 1.019 . . . . 0.0 110.498 176.821 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.9 139.36 27.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.301 2.667 . . . . 0.0 112.138 -172.04 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -138.82 10.58 2.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.338 1.055 . . . . 0.0 113.815 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -161.83 154.26 19.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.226 1.81 . . . . 0.0 110.012 -178.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -101.27 160.18 14.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.612 1.165 . . . . 0.0 112.257 174.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.24 -163.39 12.25 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.555 1.55 . . . . 0.0 113.991 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -92.86 113.46 25.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.052 1.341 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.2 m80 -105.59 173.72 6.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.233 2.213 . . . . 0.0 111.933 -174.441 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.3 146.83 35.48 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.644 0.778 . . . . 0.0 112.071 171.364 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.2 ttm -116.7 134.97 54.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.051 2.14 . . . . 0.0 109.457 -179.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -126.62 119.7 27.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.712 2.005 . . . . 0.0 109.136 -174.273 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -131.45 136.77 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.051 0.941 . . . . 0.0 111.393 -171.39 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 134.86 21.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.486 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 27.3 t80 -101.49 125.1 48.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 110.185 176.366 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.8 36.38 14.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.858 1.263 . . . . 0.0 112.641 -176.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 45.0 m-80 83.02 -8.54 1.14 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.358 3.063 . . . . 0.0 114.658 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 62.3 mtt -100.95 134.71 43.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.22 1.408 . . . . 0.0 111.999 -178.469 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -54.0 135.85 42.28 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.189 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -76.89 155.23 83.01 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.272 173.109 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.09 131.96 41.93 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.153 1.902 . . . . 0.0 109.945 172.146 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.13 -9.17 76.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.432 -174.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.1 t -84.03 144.29 44.24 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 120.042 1.921 . . . . 0.0 111.422 170.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -79.38 164.1 83.25 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.816 0.97 . . . . 0.0 112.244 -7.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.6 mt -113.3 156.95 22.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.965 1.706 . . . . 0.0 110.697 174.512 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.59 143.46 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.711 1.204 . . . . 0.0 110.404 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -159.12 150.17 20.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.952 0.901 . . . . 0.0 112.489 -170.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -100.55 143.74 30.37 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.294 -0.879 . . . . 0.0 112.599 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 38.4 t -126.16 137.5 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.355 1.462 . . . . 0.0 109.438 178.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -161.48 158.54 26.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.81 -167.697 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -75.48 146.35 40.69 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.855 -1.153 . . . . 0.0 113.357 -173.443 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 18.0 m -70.6 -18.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.988 -1.07 . . . . 0.0 112.796 171.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 31.9 p30 -90.83 4.75 50.89 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.353 1.461 . . . . 0.0 114.244 178.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.1 p -62.66 151.41 38.27 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -166.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.91 40.73 2.42 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.382 1.944 . . . . 0.0 113.166 -177.424 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -153.89 167.33 30.06 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.24 1.416 . . . . 0.0 113.081 -176.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.2 t -73.05 134.76 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.113 0.965 . . . . 0.0 108.801 171.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.4 t -148.93 165.64 30.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.825 1.25 . . . . 0.0 110.905 -175.183 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.2 147.44 27.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.727 1.211 . . . . 0.0 111.861 -177.487 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 48.1 p90 -168.63 163.46 12.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.754 1.622 . . . . 0.0 112.597 -173.367 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.04 174.33 13.27 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.278 1.418 . . . . 0.0 113.032 -178.42 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.51 -35.12 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.908 2.405 . . . . 0.0 112.799 -172.308 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.73 -31.04 72.77 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.368 0.986 . . . . 0.0 114.537 -171.152 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.52 -3.99 49.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.814 1.307 . . . . 0.0 113.351 174.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -104.85 -51.74 3.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 110.69 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -141.56 145.12 34.71 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.093 1.757 . . . . 0.0 112.553 -176.864 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -140.4 178.38 19.99 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 124.767 1.175 . . . . 0.0 113.217 172.632 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 15.3 t -139.66 135.97 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.043 . . . . 0.0 108.884 175.941 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -55.57 139.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.3 m-80 67.96 -1.17 1.81 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.943 2.097 . . . . 0.0 115.039 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -116.39 141.99 28.77 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.226 1.41 . . . . 0.0 111.166 177.32 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.0 134.05 20.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.52 2.147 . . . . 0.0 111.126 -174.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -112.82 147.18 37.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.707 1.603 . . . . 0.0 110.306 173.653 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.3 p -136.52 152.28 50.34 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.114 0.966 . . . . 0.0 113.604 -167.188 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.9 p90 -161.86 176.56 10.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.097 1.759 . . . . 0.0 111.485 176.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 32.2 m -130.79 140.82 50.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.03 1.332 . . . . 0.0 110.862 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -109.96 132.51 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.723 1.609 . . . . 0.0 107.92 168.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.93 123.33 38.34 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.131 0.973 . . . . 0.0 110.634 179.516 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.5 p -126.63 1.58 6.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.445 1.498 . . . . 0.0 113.735 -168.236 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -52.91 -38.12 61.49 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.919 1.687 . . . . 0.0 113.777 -177.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -99.86 -1.22 37.99 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.643 1.577 . . . . 0.0 113.472 -179.272 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.55 -22.57 50.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -171.417 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.44 -105.53 2.39 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.218 0.913 . . . . 0.0 111.624 -177.057 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -158.37 148.91 20.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.825 -175.691 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.59 31.64 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.469 1.509 . . . . 0.0 112.667 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.73 103.26 2.89 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 124.063 0.84 . . . . 0.0 111.614 176.416 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.65 129.6 34.76 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.996 1.318 . . . . 0.0 108.935 170.442 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 26.9 m -133.55 158.84 42.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.266 1.426 . . . . 0.0 112.399 -175.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.8 tp -161.08 136.19 7.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.97 1.708 . . . . 0.0 109.123 -168.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.49 36.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.065 0.946 . . . . 0.0 112.299 177.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 48.8 mt -138.3 137.36 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.989 1.316 . . . . 0.0 109.675 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -127.37 143.06 51.28 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.42 1.488 . . . . 0.0 109.907 174.188 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -173.13 -162.13 24.65 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.895 -175.28 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.38 -22.81 59.35 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.223 3.282 . . . . 0.0 113.161 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.4 t -144.36 164.45 30.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.008 1.323 . . . . 0.0 109.829 165.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -68.7 107.63 3.07 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.845 178.053 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.478 0.711 . . . . 0.0 110.414 169.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -102.7 133.84 47.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.479 0.711 . . . . 0.0 109.717 176.605 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -128.15 144.86 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.709 1.204 . . . . 0.0 110.477 -159.137 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -141.57 164.07 31.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.773 1.229 . . . . 0.0 111.093 166.144 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -160.13 156.85 27.43 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.951 1.3 . . . . 0.0 112.206 -178.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 62.1 m -145.49 125.07 13.21 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 109.935 -172.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.15 134.72 38.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.09 0.956 . . . . 0.0 111.489 170.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -108.54 154.62 21.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.298 1.439 . . . . 0.0 112.342 -174.066 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -67.72 -22.02 65.27 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.568 1.147 . . . . 0.0 112.441 175.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.6 -4.83 50.8 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.716 1.606 . . . . 0.0 114.734 -176.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.98 35.46 6.74 Favored Glycine 0 N--CA 1.476 1.303 0 C-N-CA 124.23 0.919 . . . . 0.0 113.77 -179.414 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 72.9 p -139.46 165.38 27.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.746 1.618 . . . . 0.0 110.539 176.027 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.7 m -116.01 130.4 56.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.904 1.282 . . . . 0.0 109.14 161.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.7 t -89.53 149.57 22.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.968 0.907 . . . . 0.0 110.52 170.956 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 96.1 t -129.66 143.35 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.883 1.673 . . . . 0.0 109.842 -178.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.2 p -136.39 147.81 47.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.013 1.325 . . . . 0.0 111.84 167.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -151.92 152.79 33.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 175.668 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.2 mt -113.54 110.09 50.32 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.257 1.823 . . . . 0.0 110.427 176.401 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -83.1 175.86 8.05 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.918 3.079 . . . . 0.0 110.257 164.162 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -150.04 -31.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -173.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.94 147.19 34.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 119.481 1.037 . . . . 0.0 110.728 167.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.25 159.67 43.48 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.992 2.462 . . . . 0.0 111.088 175.475 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 127.77 -168.17 19.85 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.173 1.368 . . . . 0.0 112.822 -174.515 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.65 142.89 27.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.387 1.075 . . . . 0.0 113.101 178.167 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -127.13 135.14 50.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.007 1.723 . . . . 0.0 110.26 178.148 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -91.41 126.84 36.63 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.087 -1.008 . . . . 0.0 110.543 174.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.18 128.34 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.74 1.616 . . . . 0.0 108.229 178.757 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -111.8 131.82 55.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.383 1.473 . . . . 0.0 109.856 177.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.8 t -133.44 127.31 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.663 1.185 . . . . 0.0 109.893 174.192 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.15 144.32 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.148 1.379 . . . . 0.0 111.889 -169.518 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.62 121.21 11.79 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.916 1.286 . . . . 0.0 110.011 -179.226 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 56.38 55.96 6.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.33 1.452 . . . . 0.0 111.814 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.7 pt-20 56.9 14.65 1.95 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.333 2.653 . . . . 0.0 116.234 -177.84 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -123.81 129.03 50.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.661 1.184 . . . . 0.0 110.746 177.414 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -66.68 151.01 48.23 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.326 -0.859 . . . . 0.0 112.111 173.235 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 25.9 m -65.85 150.5 96.35 Favored Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.271 162.425 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.0 -16.69 45.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.269 1.98 . . . . 0.0 114.654 -164.213 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.77 -7.45 61.44 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.137 0.875 . . . . 0.0 115.253 172.525 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -84.69 143.07 40.26 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 118.88 1.34 . . . . 0.0 112.104 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.27 139.85 63.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 CA-C-N 119.2 0.75 . . . . 0.0 111.961 -4.016 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -91.38 165.2 13.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.992 1.717 . . . . 0.0 110.401 174.186 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.5 m -125.35 117.09 22.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.791 0.836 . . . . 0.0 110.223 174.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.57 158.7 15.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.735 1.214 . . . . 0.0 110.774 168.195 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -123.98 132.03 53.65 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.775 0.83 . . . . 0.0 110.483 169.363 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.6 t -113.35 131.28 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.437 1.495 . . . . 0.0 110.45 -171.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 32.1 p -106.45 167.41 9.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.098 1.359 . . . . 0.0 112.688 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.69 143.2 25.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.103 1.335 . . . . 0.0 112.058 174.247 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 124.156 0.982 . . . . 0.0 113.177 176.442 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 51.5 mt . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 121.683 0.754 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -56.95 118.15 21.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.445 1.898 . . . . 0.0 111.007 175.063 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.35 146.2 55.9 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.611 2.207 . . . . 0.0 109.46 172.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -131.14 133.24 45.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.74 0.781 . . . . 0.0 111.68 -175.333 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.51 146.98 10.33 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.593 1.957 . . . . 0.0 110.875 178.313 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.56 154.04 50.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.18 1.792 . . . . 0.0 110.546 -175.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.6 p -114.58 138.45 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.215 1.406 . . . . 0.0 109.624 170.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 46.5 mt -131.45 135.31 26.78 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.166 1.787 . . . . 0.0 108.395 -172.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.89 36.48 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.453 3.435 . . . . 0.0 112.909 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.17 152.11 27.9 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.846 1.258 . . . . 0.0 111.456 177.478 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -116.49 121.28 41.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.229 1.412 . . . . 0.0 109.925 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 78.8 mt -87.91 134.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.871 1.268 . . . . 0.0 110.013 175.84 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -117.91 -141.89 0.36 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.496 1.519 . . . . 0.0 110.542 174.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.75 127.18 32.67 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.707 -1.245 . . . . 0.0 110.904 171.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.11 -147.99 19.53 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 125.402 1.477 . . . . 0.0 111.723 -171.188 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.44 146.27 18.22 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.67 1.188 . . . . 0.0 111.242 -175.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -121.48 135.89 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.714 1.606 . . . . 0.0 111.217 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 47.0 p -146.85 177.69 8.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.399 1.88 . . . . 0.0 110.28 -177.827 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -163.18 -167.31 23.42 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.97 144.24 22.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.521 1.929 . . . . 0.0 109.549 175.689 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 96.2 t -121.72 134.98 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.897 1.679 . . . . 0.0 108.572 173.597 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -112.98 135.1 54.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.596 1.158 . . . . 0.0 111.832 -175.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.7 mpp? -108.04 142.89 26.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.707 1.603 . . . . 0.0 111.748 -175.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.46 -27.25 58.0 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.48 3.454 . . . . 0.0 115.819 174.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.3 t -71.93 -4.09 26.35 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.071 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.38 48.93 3.6 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.755 1.169 . . . . 0.0 112.383 177.8 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -153.31 163.67 39.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.084 1.754 . . . . 0.0 111.711 -172.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.37 157.84 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.87 1.268 . . . . 0.0 112.384 -173.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.07 176.47 12.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.265 2.226 . . . . 0.0 109.888 178.005 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -119.15 143.35 33.91 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 121.216 -0.928 . . . . 0.0 112.186 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -82.73 166.26 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.118 3.212 . . . . 0.0 111.388 174.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.8 m -110.58 122.52 47.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.05 1.34 . . . . 0.0 108.911 173.794 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.54 133.41 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.733 1.213 . . . . 0.0 109.351 177.422 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 52.4 m -120.93 130.24 53.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.557 1.943 . . . . 0.0 109.512 176.813 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.2 t0 -79.75 117.21 20.43 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.108 0.963 . . . . 0.0 110.15 170.583 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.52 -12.56 58.78 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.601 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 69.07 3.19 3.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.211 2.204 . . . . 0.0 114.21 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.78 9.2 35.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.823 2.049 . . . . 0.0 113.025 -175.563 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.08 11.97 60.74 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.931 1.253 . . . . 0.0 113.816 -173.295 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 56.3 p -131.73 164.69 25.42 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.462 1.905 . . . . 0.0 110.541 177.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.3 m -128.38 146.38 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.152 1.381 . . . . 0.0 109.821 168.224 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 32.6 m -105.84 139.37 40.51 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.315 1.046 . . . . 0.0 108.926 173.159 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.7 t -123.44 130.96 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.864 1.266 . . . . 0.0 109.249 179.135 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -128.08 157.49 40.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.329 1.451 . . . . 0.0 112.042 -176.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.5 t80 -155.15 138.2 15.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.498 1.519 . . . . 0.0 111.521 179.777 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.33 119.74 70.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.415 1.086 . . . . 0.0 110.762 177.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.6 135.08 14.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.172 2.581 . . . . 0.0 111.777 -173.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 80.9 p -127.09 -12.28 5.81 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 176.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -141.52 158.8 43.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.1 166.79 11.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.639 1.175 . . . . 0.0 112.059 169.593 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.97 -168.0 12.6 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.727 1.632 . . . . 0.0 113.992 179.489 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.9 tp -86.83 122.27 30.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.04 1.336 . . . . 0.0 110.299 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.0 m80 -117.78 168.86 10.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.07 1.748 . . . . 0.0 111.292 -174.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.8 148.52 33.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.894 . . . . 0.0 111.856 173.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.9 ttm -121.88 123.33 41.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.832 2.053 . . . . 0.0 110.125 -175.433 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -97.45 135.9 38.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.988 1.715 . . . . 0.0 109.809 169.605 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.1 mm -134.99 134.3 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.906 1.282 . . . . 0.0 109.95 176.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.7 139.09 27.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.361 1.065 . . . . 0.0 113.491 -176.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.3 t80 -102.53 122.16 43.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.809 2.044 . . . . 0.0 109.914 175.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 52.4 30.5 8.28 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.896 1.278 . . . . 0.0 112.739 -173.688 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 19.1 t30 79.46 2.63 2.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.658 2.783 . . . . 0.0 115.169 -179.263 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -99.74 130.61 45.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.167 1.387 . . . . 0.0 110.86 171.189 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -55.5 138.31 46.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -177.534 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.24 152.26 90.25 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.379 171.358 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.16 134.08 53.8 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.471 2.114 . . . . 0.0 110.952 -178.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.68 -7.63 75.92 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.966 1.27 . . . . 0.0 115.161 -178.146 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.2 t -76.55 144.86 74.47 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.77 1.785 . . . . 0.0 111.362 173.767 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.24 162.76 86.05 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.558 1.235 . . . . 0.0 114.107 1.69 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 84.4 mt -102.68 157.03 17.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.979 1.711 . . . . 0.0 110.632 171.174 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.68 141.47 49.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.069 1.347 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.54 155.69 28.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.66 1.184 . . . . 0.0 112.285 -171.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -112.13 135.94 52.15 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.11 -0.993 . . . . 0.0 113.191 179.533 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -118.43 142.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.529 1.532 . . . . 0.0 109.215 -178.196 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.25 165.8 35.32 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.6 1.16 . . . . 0.0 111.611 -175.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -77.02 128.15 33.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.427 1.091 . . . . 0.0 110.574 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 75.3 t -67.64 -31.89 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.604 -0.685 . . . . 0.0 112.248 -171.361 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -80.5 -14.19 58.46 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -178.001 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.0 t -70.33 139.24 51.99 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.239 -0.913 . . . . 0.0 112.758 -172.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.7 88.06 1.2 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.114 1.34 . . . . 0.0 113.129 -171.93 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -168.91 169.66 9.59 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.807 2.043 . . . . 0.0 112.533 174.177 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.5 p -66.57 142.95 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.875 0.87 . . . . 0.0 110.966 170.375 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -166.73 150.44 7.02 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.392 1.477 . . . . 0.0 110.711 178.972 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -123.71 145.89 48.66 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.228 1.411 . . . . 0.0 112.171 -176.308 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.6 p90 -167.6 163.87 14.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.82 1.648 . . . . 0.0 113.444 -179.962 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.8 172.59 13.05 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.461 1.505 . . . . 0.0 112.704 -178.359 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.82 -33.81 12.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.832 2.355 . . . . 0.0 112.693 -171.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.08 93.54 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.688 -1.062 . . . . 0.0 114.323 -171.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.09 -6.72 51.01 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.896 1.348 . . . . 0.0 113.381 176.552 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.9 m -99.77 -42.3 6.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.309 1.843 . . . . 0.0 110.943 173.504 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -155.4 126.38 7.07 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.026 1.73 . . . . 0.0 112.34 -165.239 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -130.63 -178.91 15.69 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.55 2.024 . . . . 0.0 112.794 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.4 t -141.19 139.52 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.864 1.666 . . . . 0.0 108.201 177.394 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -56.47 134.76 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 68.22 -0.91 1.98 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.349 2.26 . . . . 0.0 114.541 178.306 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.09 139.14 19.82 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.28 1.432 . . . . 0.0 110.951 176.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.37 123.93 9.06 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.519 2.146 . . . . 0.0 110.395 -178.513 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 142.7 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.509 1.524 . . . . 0.0 110.28 174.613 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 57.0 p -134.11 149.34 51.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -166.562 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.94 177.19 10.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.629 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 73.5 m -132.11 145.28 51.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.221 1.408 . . . . 0.0 110.497 -171.513 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 122.59 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 0.0 107.876 167.099 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -84.29 126.87 33.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.342 0.657 . . . . 0.0 109.924 173.542 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 4.1 p -133.77 12.11 4.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.418 1.887 . . . . 0.0 112.626 -172.038 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 65.3 mttt -61.87 -35.48 78.44 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.442 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.56 11.36 12.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.258 1.823 . . . . 0.0 112.57 -176.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.1 -4.9 54.72 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 93.62 -127.84 9.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.736 1.16 . . . . 0.0 112.624 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -153.42 150.71 29.1 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.146 1.379 . . . . 0.0 110.901 -172.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 149.2 -158.55 27.7 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.763 1.649 . . . . 0.0 112.473 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.43 113.15 4.02 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.88 0.752 . . . . 0.0 111.315 174.097 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.39 125.18 32.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.887 1.275 . . . . 0.0 108.225 169.553 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 42.1 m -125.04 158.1 34.59 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.527 1.531 . . . . 0.0 112.397 -174.337 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -158.5 134.62 9.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.253 1.821 . . . . 0.0 108.979 -171.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.79 158.25 36.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.033 0.933 . . . . 0.0 112.145 177.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.68 134.55 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.561 1.144 . . . . 0.0 109.942 177.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -120.81 164.53 16.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.887 1.675 . . . . 0.0 109.94 168.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.01 29.7 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.251 -178.061 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.97 -22.82 62.27 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.894 3.062 . . . . 0.0 112.694 176.012 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.0 t -148.57 164.43 34.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.674 1.589 . . . . 0.0 109.517 164.663 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -73.17 113.63 10.45 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.926 -1.109 . . . . 0.0 111.081 177.55 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.01 149.51 48.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.796 0.838 . . . . 0.0 111.461 170.832 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.65 142.07 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.357 0.663 . . . . 0.0 109.648 168.751 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.2 mt -132.97 143.14 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.443 1.097 . . . . 0.0 110.456 -167.304 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.5 t -140.84 160.37 40.2 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.134 1.373 . . . . 0.0 110.62 167.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -158.5 156.47 30.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.594 1.158 . . . . 0.0 112.466 -177.217 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -140.24 123.7 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 110.385 -172.173 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.29 126.16 30.43 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.615 1.166 . . . . 0.0 110.417 168.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -100.61 151.33 21.74 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.078 1.351 . . . . 0.0 112.116 -178.45 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -67.47 -21.87 65.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.941 0.896 . . . . 0.0 112.703 179.008 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.33 -9.12 58.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.589 1.156 . . . . 0.0 113.557 172.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 98.28 10.5 51.14 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.176 1.369 . . . . 0.0 115.18 174.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.3 p -100.88 161.91 13.27 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.132 1.466 . . . . 0.0 111.565 174.882 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.4 m -111.64 123.98 51.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.046 1.338 . . . . 0.0 109.685 166.755 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -92.39 151.07 20.44 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.014 0.926 . . . . 0.0 110.773 170.259 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.5 t -132.57 141.71 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.788 1.635 . . . . 0.0 110.652 -176.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.6 m -132.52 142.94 49.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.876 1.67 . . . . 0.0 110.854 168.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.15 152.37 37.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 174.326 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.4 mt -119.27 102.88 47.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.48 167.09 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.677 2.918 . . . . 0.0 110.251 168.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.4 m -136.54 -24.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.314 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 76.2 mt -116.91 149.63 44.44 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.772 1.229 . . . . 0.0 110.703 171.272 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 154.54 49.91 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.006 2.471 . . . . 0.0 110.922 174.832 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 140.45 -152.72 23.1 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.271 1.415 . . . . 0.0 113.031 -177.236 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -113.1 131.11 55.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.005 1.322 . . . . 0.0 111.082 178.73 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -113.47 144.96 41.93 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.787 1.635 . . . . 0.0 110.951 179.734 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.4 m -105.77 116.15 31.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.971 1.309 . . . . 0.0 110.257 178.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.53 120.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.872 1.669 . . . . 0.0 108.374 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -103.53 133.57 48.34 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.362 1.465 . . . . 0.0 109.55 174.593 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.6 t -135.57 133.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.301 1.44 . . . . 0.0 108.058 172.28 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.67 144.39 20.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.741 1.216 . . . . 0.0 111.037 -168.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 123.6 14.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.513 1.125 . . . . 0.0 110.363 -178.574 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.7 53.01 10.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.923 1.289 . . . . 0.0 111.767 178.294 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.19 13.08 2.14 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.392 2.677 . . . . 0.0 116.283 -176.554 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -117.39 128.26 54.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 0.0 110.922 176.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.26 152.28 25.31 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.704 0.802 . . . . 0.0 112.417 170.214 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 17.3 m -79.26 156.94 76.05 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.064 176.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.49 119.2 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.656 2.237 . . . . 0.0 110.776 174.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.43 65.38 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.312 1.434 . . . . 0.0 116.472 178.486 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.7 p -79.59 153.89 76.08 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 120.329 2.064 . . . . 0.0 113.238 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.77 153.36 99.12 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 119.154 0.733 . . . . 0.0 112.397 -5.076 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -106.37 143.51 34.39 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.44 1.496 . . . . 0.0 111.197 -177.505 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 54.0 m -95.09 117.34 30.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -100.9 132.87 46.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.055 1.342 . . . . 0.0 111.212 173.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 141.16 51.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.959 0.903 . . . . 0.0 110.065 166.12 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.4 138.9 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.484 1.113 . . . . 0.0 109.672 163.19 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 16.5 p -134.83 174.12 10.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.183 . . . . 0.0 112.124 178.145 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -68.27 152.87 52.73 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.404 1.478 . . . . 0.0 113.139 178.934 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 124.63 1.172 . . . . 0.0 113.363 178.022 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 120.752 0.31 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.26 114.61 6.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.519 1.127 . . . . 0.0 110.828 179.557 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.02 131.98 21.97 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.153 2.569 . . . . 0.0 110.56 -175.46 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.2 t80 -99.36 117.1 33.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.536 0.735 . . . . 0.0 111.079 -176.883 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -151.35 136.81 17.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 111.226 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.96 159.71 41.29 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.294 2.238 . . . . 0.0 110.115 -170.039 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -131.09 138.71 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.894 1.278 . . . . 0.0 110.271 177.742 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 53.8 mt -132.42 135.48 26.37 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.04 1.736 . . . . 0.0 108.832 -172.995 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.6 64.96 8.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.208 3.272 . . . . 0.0 111.813 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.51 147.34 35.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.706 1.602 . . . . 0.0 111.048 175.581 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 92.0 m -115.58 123.21 47.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.183 1.393 . . . . 0.0 109.61 178.164 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 74.5 mt -81.25 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.505 1.122 . . . . 0.0 110.326 177.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.2 -141.71 0.37 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.7 1.6 . . . . 0.0 110.8 178.282 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -80.11 123.79 28.19 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.752 -1.217 . . . . 0.0 110.871 170.673 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.96 -149.24 19.84 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.309 1.433 . . . . 0.0 112.199 -171.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -159.15 148.6 18.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.907 1.283 . . . . 0.0 111.132 -174.917 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.6 tt -120.92 136.12 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.59 1.556 . . . . 0.0 111.585 -179.436 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.7 p -148.46 -174.03 4.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.661 1.984 . . . . 0.0 110.197 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -178.09 -164.58 31.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.545 0.978 . . . . 0.0 115.545 -179.658 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -152.87 144.15 23.21 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.768 1.627 . . . . 0.0 110.24 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 85.8 t -121.0 137.15 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.504 1.921 . . . . 0.0 108.481 173.26 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -119.57 137.91 53.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.464 1.106 . . . . 0.0 112.448 -176.331 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.4 mtm -108.86 149.49 39.62 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.409 1.884 . . . . 0.0 111.999 -176.098 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.61 -40.0 55.62 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.965 3.776 . . . . 0.0 116.598 -177.601 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.7 t -74.61 0.85 13.67 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 95.83 -1.19 63.25 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.802 1.668 . . . . 0.0 114.064 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -67.99 153.36 43.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.971 1.308 . . . . 0.0 111.597 173.016 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.3 m -137.5 157.32 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.018 1.327 . . . . 0.0 111.551 -179.753 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.39 169.93 23.6 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.972 1.709 . . . . 0.0 111.263 -178.077 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -108.29 138.6 20.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.134 0.973 . . . . 0.0 111.068 178.206 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.95 165.09 17.58 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.187 3.258 . . . . 0.0 111.332 172.408 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.5 m -109.23 125.27 52.08 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.868 1.267 . . . . 0.0 108.972 173.804 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.31 138.43 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.792 1.237 . . . . 0.0 109.428 177.33 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 65.6 m -131.55 131.96 43.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.986 1.714 . . . . 0.0 110.322 -178.694 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -77.79 121.74 24.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 172.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -85.01 -13.3 50.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 73.87 -5.64 1.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.989 2.516 . . . . 0.0 114.075 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -91.79 3.49 55.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.229 1.812 . . . . 0.0 113.712 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.97 17.5 57.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.442 1.02 . . . . 0.0 113.368 -171.561 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.6 p -129.46 161.52 30.21 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.725 2.01 . . . . 0.0 109.88 176.051 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -123.21 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.203 1.001 . . . . 0.0 110.109 168.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 18.2 m -96.43 142.81 28.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.377 1.071 . . . . 0.0 108.598 170.576 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 12.7 t -127.87 134.47 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 109.301 178.487 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -132.38 154.89 49.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 -173.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.7 t80 -156.72 136.49 12.48 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.956 1.703 . . . . 0.0 111.722 178.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.02 118.02 69.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 110.812 176.496 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.93 135.49 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.401 2.734 . . . . 0.0 112.076 -174.167 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 69.6 m -131.83 4.42 4.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.344 1.058 . . . . 0.0 113.78 -178.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -162.35 144.75 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 110.156 -174.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.75 162.01 13.94 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.547 1.139 . . . . 0.0 112.45 177.034 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.1 -167.93 12.45 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.88 1.705 . . . . 0.0 113.633 -178.755 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 27.8 tp -78.76 126.35 30.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.672 1.189 . . . . 0.0 110.619 179.003 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.55 165.78 17.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.987 1.715 . . . . 0.0 111.257 -175.57 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.21 153.85 39.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.116 0.967 . . . . 0.0 111.817 176.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.9 ttm -131.67 131.99 43.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.125 -176.152 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -105.64 135.01 47.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.996 1.719 . . . . 0.0 109.546 169.108 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.2 133.58 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.437 1.095 . . . . 0.0 110.109 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 137.74 25.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.556 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.1 t80 -100.63 121.88 42.37 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.692 1.997 . . . . 0.0 109.861 175.171 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.9 34.71 14.07 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.542 1.137 . . . . 0.0 112.69 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.67 4.53 2.52 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.779 2.431 . . . . 0.0 114.083 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.9 mtm -107.1 129.82 54.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.615 1.566 . . . . 0.0 111.011 176.272 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -57.51 137.2 56.54 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -175.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.1 pt -79.49 156.08 75.97 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.721 175.61 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.88 131.15 38.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.251 1.967 . . . . 0.0 109.732 168.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.24 67.38 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.536 1.065 . . . . 0.0 114.138 -172.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.5 t -84.61 146.6 47.21 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 119.561 1.68 . . . . 0.0 110.952 168.658 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.35 158.8 82.57 Favored 'Cis proline' 0 C--N 1.351 0.694 0 CA-C-N 120.055 1.055 . . . . 0.0 112.032 -8.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.0 mt -103.61 153.56 20.47 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.79 1.236 . . . . 0.0 110.9 172.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -143.44 139.89 30.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.931 1.292 . . . . 0.0 109.525 -178.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 4.6 p90 -167.16 167.55 14.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.293 1.037 . . . . 0.0 112.223 -169.758 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.8 t80 -107.72 140.63 40.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.905 0.882 . . . . 0.0 112.564 178.495 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.4 t -109.7 139.41 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.616 1.566 . . . . 0.0 108.583 172.414 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.7 t0 -156.12 161.06 40.41 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.944 0.878 . . . . 0.0 113.074 -174.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -79.92 103.87 10.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.572 1.549 . . . . 0.0 110.783 177.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 29.9 m -65.02 -16.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.456 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -84.36 -14.58 49.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.664 1.186 . . . . 0.0 114.172 -178.307 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.5 m -73.72 157.32 36.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.241 1.016 . . . . 0.0 112.749 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.85 -14.9 68.85 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.499 1.047 . . . . 0.0 115.154 -173.274 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -67.84 155.22 39.84 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 118.679 1.24 . . . . 0.0 113.213 176.75 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 t -72.32 132.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.844 0.858 . . . . 0.0 109.089 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 6.3 t -150.5 162.67 40.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.773 1.229 . . . . 0.0 110.945 -175.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.65 147.99 32.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.535 1.134 . . . . 0.0 112.24 -174.449 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -168.14 163.22 13.3 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.787 1.635 . . . . 0.0 112.979 -174.843 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.92 175.05 13.62 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.264 1.411 . . . . 0.0 113.046 -179.557 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.02 -35.54 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.734 2.29 . . . . 0.0 112.88 -172.414 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.23 -34.09 87.08 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 119.478 1.035 . . . . 0.0 114.533 -171.384 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.13 -5.24 53.68 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.661 1.23 . . . . 0.0 113.51 175.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 48.4 m -103.8 -49.39 3.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.372 1.869 . . . . 0.0 110.884 177.61 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -139.6 142.88 37.07 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.484 1.914 . . . . 0.0 112.07 -178.36 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.9 171.28 21.79 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.707 1.146 . . . . 0.0 112.963 172.243 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.9 t -136.65 132.7 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 25.3 m -59.98 144.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.044 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.4 m-20 68.74 -3.91 1.31 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.597 1.959 . . . . 0.0 114.313 178.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.49 142.36 28.04 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.819 1.648 . . . . 0.0 111.269 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.5 125.84 11.02 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.704 2.27 . . . . 0.0 110.572 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -106.29 136.27 46.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.444 1.497 . . . . 0.0 110.167 175.0 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.3 p -129.53 148.77 51.46 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.84 177.68 10.56 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.686 1.594 . . . . 0.0 111.72 176.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.6 m -130.5 142.7 50.48 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.208 1.403 . . . . 0.0 111.028 -169.936 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.7 t -114.34 133.9 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.928 1.691 . . . . 0.0 108.208 169.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.15 127.07 40.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.452 1.101 . . . . 0.0 111.03 -179.505 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 57.8 p -131.53 7.04 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.587 1.555 . . . . 0.0 113.312 -170.501 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -54.54 -35.86 63.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.043 1.737 . . . . 0.0 114.788 -169.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -121.99 15.98 10.83 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.774 1.63 . . . . 0.0 112.572 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.29 -15.42 60.97 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.08 -125.01 6.66 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.377 0.989 . . . . 0.0 111.41 -176.156 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.51 151.52 30.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.006 1.322 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.39 -129.41 1.77 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.072 1.796 . . . . 0.0 110.57 -175.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -125.09 109.14 1.17 Allowed Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.372 0.986 . . . . 0.0 111.797 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.12 132.27 39.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.522 1.129 . . . . 0.0 108.875 170.738 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.7 t -140.06 158.91 43.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 0.0 111.847 -169.766 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 50.0 tp -166.99 136.28 2.85 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 109.472 -161.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.75 160.46 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.155 0.982 . . . . 0.0 112.226 176.625 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.99 137.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.945 1.298 . . . . 0.0 109.512 174.362 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.8 159.14 28.71 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.837 1.655 . . . . 0.0 109.727 170.726 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.44 -163.22 34.54 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.147 -0.971 . . . . 0.0 114.014 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.24 -11.7 23.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.638 2.892 . . . . 0.0 112.9 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 10.6 t -152.72 160.64 43.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.804 1.642 . . . . 0.0 109.938 169.595 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1907 ' ' LYS . . . . . 0.401 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 0.9 OUTLIER -76.75 109.07 10.23 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.958 -1.089 . . . . 0.0 111.616 -177.72 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.35 147.76 44.09 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.954 0.902 . . . . 0.0 111.51 169.153 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.035 0.934 . . . . 0.0 110.072 170.431 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.61 139.83 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.678 1.191 . . . . 0.0 110.668 -166.742 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -133.64 156.98 46.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.925 1.69 . . . . 0.0 110.828 169.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -152.72 155.56 37.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.29 1.036 . . . . 0.0 112.398 176.42 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.1 m -140.47 124.65 17.58 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.605 1.562 . . . . 0.0 110.353 -172.244 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.7 131.42 39.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 111.187 170.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -107.68 146.9 31.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.315 1.446 . . . . 0.0 111.822 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.0 tm0? -65.68 -21.68 66.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.471 1.108 . . . . 0.0 112.471 175.292 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -73.76 -5.32 40.04 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.705 1.602 . . . . 0.0 114.684 -179.973 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 33.25 6.65 Favored Glycine 0 N--CA 1.476 1.3 0 C-N-CA 124.474 1.035 . . . . 0.0 114.171 177.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.5 p -140.32 162.68 34.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.476 1.51 . . . . 0.0 110.902 176.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 98.3 m -111.81 130.47 55.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.828 1.251 . . . . 0.0 109.272 161.202 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -89.44 150.0 22.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.831 0.853 . . . . 0.0 110.471 169.258 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.7 t -130.25 144.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.134 1.774 . . . . 0.0 109.797 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.3 t -140.44 140.32 35.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.552 1.541 . . . . 0.0 110.78 172.113 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -146.77 154.16 41.06 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.2 mt -118.96 104.02 47.21 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.061 1.744 . . . . 0.0 110.629 -178.673 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.22 162.69 17.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.603 2.869 . . . . 0.0 110.336 166.326 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.0 p -127.59 -19.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.939 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.96 149.23 41.71 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.522 1.129 . . . . 0.0 110.614 174.567 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.28 153.03 40.16 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.887 2.391 . . . . 0.0 112.183 -169.524 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 151.1 -154.88 25.84 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.907 1.242 . . . . 0.0 112.598 -174.311 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -115.41 129.77 56.68 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.613 1.165 . . . . 0.0 110.682 178.351 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.45 134.52 55.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.889 1.675 . . . . 0.0 110.596 -176.805 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.1 m -93.2 125.96 38.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 110.85 178.916 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.58 129.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.4 1.48 . . . . 0.0 108.381 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.69 131.76 55.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.476 1.51 . . . . 0.0 109.65 176.633 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.9 t -133.89 130.87 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.108 174.59 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.6 tmmt? -153.69 144.75 22.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.212 1.405 . . . . 0.0 111.392 -165.321 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.16 119.98 11.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.762 1.225 . . . . 0.0 109.611 177.729 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 57.69 57.82 4.04 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 111.773 177.823 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.289 8.6 pt-20 58.16 15.16 3.12 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.179 2.592 . . . . 0.0 116.175 -179.236 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.54 131.56 52.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.679 1.192 . . . . 0.0 110.89 177.162 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -69.08 152.75 44.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.874 0.87 . . . . 0.0 112.456 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.1 m -67.9 152.36 96.44 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.707 163.386 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.23 -20.17 56.03 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.413 2.075 . . . . 0.0 114.846 -165.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.55 -7.11 62.01 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.124 0.869 . . . . 0.0 115.186 174.203 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 42.1 t -84.74 143.64 41.04 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 119.002 1.401 . . . . 0.0 112.193 -176.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.1 142.26 74.12 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 CA-C-N 119.158 0.735 . . . . 0.0 112.192 -3.856 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.07 170.48 9.5 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.318 1.847 . . . . 0.0 110.525 173.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 85.1 m -132.36 121.89 24.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.95 0.9 . . . . 0.0 110.63 173.02 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.65 138.01 36.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.561 1.545 . . . . 0.0 111.022 172.693 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 34.1 ttt85 -96.88 127.6 43.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.605 0.762 . . . . 0.0 110.032 173.545 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 96.1 t -114.86 130.22 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.863 1.265 . . . . 0.0 110.703 -171.02 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 39.5 p -110.08 163.44 13.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.123 1.369 . . . . 0.0 113.022 -179.197 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.16 141.21 22.97 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.445 1.498 . . . . 0.0 112.535 178.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 176.96 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 36.1 tp . . . . . 0 CA--C 1.541 0.627 0 CA-C-O 119.685 -0.198 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A 1789 ' ' ARG . . . . . 0.434 ' HB2' ' H ' ' A' 1861 ' ' ASP . 0.9 OUTLIER -41.66 108.57 0.6 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.239 1.816 . . . . 0.0 113.381 -168.666 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.56 100.03 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.635 2.224 . . . . 0.0 109.022 -178.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 37.4 t80 -89.42 130.89 35.7 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.752 0.787 . . . . 0.0 111.956 -174.753 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -158.04 160.62 37.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.24 1.816 . . . . 0.0 110.768 172.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.95 132.81 13.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.273 1.029 . . . . 0.0 110.572 -177.896 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 95.6 t -93.87 127.7 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.052 1.341 . . . . 0.0 109.023 169.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.93 135.37 26.96 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.171 1.788 . . . . 0.0 109.069 -173.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.66 110.69 2.95 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.543 2.829 . . . . 0.0 110.233 176.084 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 31.6 t80 -177.61 152.85 0.83 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.333 2.253 . . . . 0.0 109.291 -171.198 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 43.5 m -135.04 129.63 34.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.405 1.082 . . . . 0.0 110.052 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.1 mt -84.51 113.29 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 0.0 109.343 175.049 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -89.13 -66.96 0.87 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.738 0.815 . . . . 0.0 112.936 -179.536 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -157.03 -8.05 0.09 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.494 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.22 -138.4 4.39 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.751 1.644 . . . . 0.0 111.857 175.452 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -152.63 143.85 23.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.652 1.181 . . . . 0.0 110.665 -177.75 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.8 tt -126.25 134.91 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.649 1.58 . . . . 0.0 110.736 179.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 70.0 p -146.61 -179.66 6.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.894 1.678 . . . . 0.0 109.933 179.802 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.23 -166.21 33.16 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.549 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.93 137.77 18.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.512 1.525 . . . . 0.0 109.826 -179.734 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.2 t -107.54 133.96 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.892 1.677 . . . . 0.0 108.027 171.532 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -120.75 125.4 47.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.225 1.41 . . . . 0.0 110.468 -169.136 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.54 153.24 41.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.831 1.653 . . . . 0.0 111.373 -176.19 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.14 -23.48 29.0 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.177 2.585 . . . . 0.0 112.411 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.3 m -74.57 -1.16 20.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.681 1.592 . . . . 0.0 114.805 -178.416 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 85.87 49.49 4.28 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.518 1.056 . . . . 0.0 113.003 178.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.25 164.92 37.22 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.038 1.735 . . . . 0.0 111.743 -175.074 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.4 m -141.48 158.98 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.73 1.212 . . . . 0.0 112.97 -171.069 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.46 166.0 34.87 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.679 1.992 . . . . 0.0 111.219 178.451 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -100.31 137.65 20.04 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.781 0.833 . . . . 0.0 111.709 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.16 169.97 11.11 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.276 3.317 . . . . 0.0 111.646 170.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 72.3 m -113.48 129.74 56.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.292 1.437 . . . . 0.0 108.852 173.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.63 136.38 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.683 1.193 . . . . 0.0 109.36 176.545 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 61.7 m -139.18 132.81 30.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.142 1.377 . . . . 0.0 109.846 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.67 128.64 33.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.767 0.827 . . . . 0.0 110.824 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -82.91 -6.59 59.53 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.67 11.94 7.17 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.286 2.235 . . . . 0.0 113.882 -173.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.41 8.34 21.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.817 2.047 . . . . 0.0 112.872 -176.347 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.9 11.09 68.41 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.947 1.261 . . . . 0.0 113.711 -172.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 72.8 p -130.37 157.58 42.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.728 2.011 . . . . 0.0 110.362 178.477 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -109.72 153.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.086 0.954 . . . . 0.0 109.212 163.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.2 t -105.54 142.94 34.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.672 0.789 . . . . 0.0 109.449 162.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.6 t -119.56 132.44 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.401 1.48 . . . . 0.0 108.297 173.428 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -131.35 154.35 48.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.002 1.721 . . . . 0.0 111.497 -172.808 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.6 t80 -154.07 135.04 13.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.349 1.459 . . . . 0.0 111.814 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.79 115.82 65.29 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.684 1.194 . . . . 0.0 110.483 175.571 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.54 148.89 16.36 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.474 2.783 . . . . 0.0 112.258 -172.136 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 50.8 m -119.39 -21.6 7.39 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -167.08 156.65 10.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.95 1.7 . . . . 0.0 111.812 -175.151 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.78 169.6 17.38 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.83 1.252 . . . . 0.0 114.022 -174.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.74 -170.29 14.41 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.175 1.845 . . . . 0.0 114.036 177.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 32.6 tp -87.33 130.56 34.58 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.717 1.207 . . . . 0.0 110.612 177.382 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.5 m80 -128.71 167.61 16.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.034 1.734 . . . . 0.0 111.45 -173.164 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -144.67 159.01 43.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.977 0.911 . . . . 0.0 111.432 172.433 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 35.3 ttm -139.43 130.15 26.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.84 1.656 . . . . 0.0 110.023 -171.68 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.92 118.77 33.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.905 1.682 . . . . 0.0 109.197 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 38.4 mm -120.03 138.61 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.132 1.373 . . . . 0.0 110.637 -179.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 136.94 22.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.463 1.105 . . . . 0.0 113.625 -175.174 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.733 2.013 . . . . 0.0 110.014 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.36 36.2 15.81 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.834 1.254 . . . . 0.0 112.696 -177.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.6 t30 81.7 -1.0 1.59 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.706 2.802 . . . . 0.0 114.842 178.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 86.1 mtp -111.12 137.06 49.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.979 1.312 . . . . 0.0 111.697 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.6 m170 -57.97 136.85 57.15 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.042 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.19 155.85 86.01 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.588 175.434 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.71 129.08 29.23 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.094 1.863 . . . . 0.0 109.787 171.348 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.88 62.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.74 1.162 . . . . 0.0 113.981 -173.648 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.0 t -84.13 144.86 44.85 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 119.46 1.63 . . . . 0.0 111.31 173.349 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.19 164.17 80.76 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.24 1.121 . . . . 0.0 112.486 -5.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 81.0 mt -116.13 153.53 31.62 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.642 1.977 . . . . 0.0 110.788 -176.35 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.75 136.43 38.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.586 1.154 . . . . 0.0 110.66 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 30.1 p90 -155.95 151.37 26.9 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.064 0.945 . . . . 0.0 112.171 -169.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.8 t80 -102.79 149.44 24.48 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 0.0 112.049 175.4 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.2 t -125.95 135.87 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.604 1.562 . . . . 0.0 109.021 -178.566 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1861 ' ' ASP . . . . . 0.434 ' H ' ' HB2' ' A' 1789 ' ' ARG . 3.5 p30 -157.86 152.24 24.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.177 1.791 . . . . 0.0 111.878 -174.794 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.75 138.75 58.15 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.38 -173.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 71.8 t -69.01 -33.07 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 121.308 -0.87 . . . . 0.0 112.101 -169.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -95.95 14.2 24.36 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.078 1.351 . . . . 0.0 113.785 -175.534 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 18.2 p -65.37 162.55 17.42 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -175.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.46 -20.94 25.77 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.784 1.183 . . . . 0.0 114.164 174.561 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -74.04 161.25 30.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.628 1.214 . . . . 0.0 113.726 179.474 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 19.1 t -75.38 125.12 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.923 1.289 . . . . 0.0 109.107 179.266 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 21.0 p -108.46 172.02 7.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.681 1.192 . . . . 0.0 111.711 -175.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.36 133.71 15.36 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.251 1.02 . . . . 0.0 110.195 160.222 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.5 p90 -161.89 161.97 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.238 1.415 . . . . 0.0 112.556 -177.148 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 127.25 173.84 13.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.393 1.473 . . . . 0.0 112.424 -174.195 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.73 -36.33 6.51 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.997 2.465 . . . . 0.0 113.205 -169.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.66 -32.12 80.49 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 118.741 0.7 . . . . 0.0 114.724 -168.131 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.93 -2.92 39.23 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.702 1.251 . . . . 0.0 113.818 178.213 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 70.7 m -118.49 -36.97 3.39 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.497 1.919 . . . . 0.0 112.238 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -142.73 146.14 34.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.382 1.473 . . . . 0.0 112.703 177.105 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 -179.16 22.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.514 1.054 . . . . 0.0 113.283 171.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.1 t -142.27 136.72 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.811 1.244 . . . . 0.0 108.491 175.403 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -55.82 135.62 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 122.799 0.44 . . . . 0.0 112.112 179.662 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.1 m-80 69.02 -4.33 1.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 114.97 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.71 139.14 20.61 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.512 1.125 . . . . 0.0 111.089 174.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.96 124.33 9.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.514 2.143 . . . . 0.0 110.229 178.418 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.24 146.44 34.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.332 1.453 . . . . 0.0 110.546 175.542 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 49.9 p -135.8 154.38 51.23 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -166.205 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -164.54 175.02 10.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.313 1.845 . . . . 0.0 111.772 177.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 91.9 m -130.68 144.85 51.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.639 1.576 . . . . 0.0 111.0 -169.233 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 72.6 t -124.61 126.48 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.951 2.1 . . . . 0.0 107.891 176.585 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.5 132.94 34.8 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.972 1.26 . . . . 0.0 111.406 177.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -128.34 -0.56 5.68 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.098 1.759 . . . . 0.0 113.494 -173.322 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -52.88 -39.6 62.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.927 1.691 . . . . 0.0 115.078 -169.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -114.61 11.15 16.91 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.537 1.535 . . . . 0.0 112.94 -179.02 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -173.39 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 151.9 8.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.739 1.161 . . . . 0.0 112.103 -168.417 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.34 143.27 50.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.557 0.743 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 179.93 -152.38 10.84 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.278 1.894 . . . . 0.0 111.813 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -93.8 101.28 2.73 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 123.955 0.788 . . . . 0.0 111.407 174.277 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.89 127.26 32.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.545 1.138 . . . . 0.0 108.84 170.686 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.1 m -129.25 156.25 44.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.239 1.416 . . . . 0.0 112.229 -176.71 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.0 tp -158.91 133.41 7.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.073 1.749 . . . . 0.0 108.517 -171.353 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.69 156.34 34.77 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.777 0.831 . . . . 0.0 112.065 179.082 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.7 mt -138.81 130.69 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.606 1.162 . . . . 0.0 109.682 177.728 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -116.73 162.56 17.49 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.171 1.788 . . . . 0.0 109.817 172.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.2 -160.52 32.83 Favored Glycine 0 CA--C 1.538 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 114.705 -179.163 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.95 -24.56 60.36 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.049 3.166 . . . . 0.0 112.415 176.279 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.3 t -140.25 159.99 40.96 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.291 1.437 . . . . 0.0 109.455 164.423 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 19.7 tptp -77.22 114.05 15.62 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.979 -1.075 . . . . 0.0 110.816 179.63 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.69 150.77 46.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.657 0.783 . . . . 0.0 112.15 178.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.16 139.38 30.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.766 0.826 . . . . 0.0 109.338 168.237 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -134.77 144.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.485 1.114 . . . . 0.0 110.54 -165.717 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -142.46 165.6 26.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.983 1.313 . . . . 0.0 111.156 166.625 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -160.16 157.48 28.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.78 1.232 . . . . 0.0 112.606 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.9 m -139.9 123.67 17.42 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.553 1.541 . . . . 0.0 110.053 -173.212 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -78.27 133.48 37.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.802 1.241 . . . . 0.0 111.2 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -114.12 145.55 41.48 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 111.694 -179.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -69.86 -13.09 62.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.83 0.852 . . . . 0.0 112.695 174.14 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.96 -3.18 24.31 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.811 1.645 . . . . 0.0 113.816 174.015 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.09 31.91 9.39 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.675 1.131 . . . . 0.0 113.877 176.962 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 61.7 p -138.95 158.62 43.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.047 1.339 . . . . 0.0 111.409 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 88.0 m -105.35 132.59 51.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.607 1.163 . . . . 0.0 109.021 155.818 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.8 148.44 22.12 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.054 0.942 . . . . 0.0 110.002 166.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 98.3 t -127.06 144.37 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.871 1.668 . . . . 0.0 110.122 -176.154 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -136.16 147.76 47.85 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 111.868 166.5 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.23 154.99 36.86 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 177.405 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 23.4 mt -120.73 107.55 38.19 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.662 1.985 . . . . 0.0 110.318 179.76 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.06 175.86 8.09 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.809 3.006 . . . . 0.0 110.337 166.179 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.4 p -148.98 -29.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -173.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.2 mt -107.56 146.71 33.89 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.723 1.147 . . . . 0.0 110.503 166.096 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.48 156.2 45.39 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.838 2.359 . . . . 0.0 110.96 176.075 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.98 -163.61 24.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.976 1.274 . . . . 0.0 113.358 -177.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.51 130.07 41.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.873 1.269 . . . . 0.0 112.413 178.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -115.03 139.45 49.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.7 m -99.27 119.94 38.73 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.699 1.2 . . . . 0.0 110.335 178.036 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.75 126.94 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.382 1.473 . . . . 0.0 108.401 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -110.74 131.93 54.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.623 1.569 . . . . 0.0 109.838 177.339 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.0 t -133.51 128.15 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.352 1.061 . . . . 0.0 109.762 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.4 143.16 23.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.108 1.363 . . . . 0.0 111.662 -168.102 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.7 119.26 11.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.514 1.126 . . . . 0.0 110.224 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 57.84 58.92 3.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.614 1.565 . . . . 0.0 111.762 179.036 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.283 10.1 pt-20 54.52 21.97 3.65 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.891 2.476 . . . . 0.0 115.764 -178.833 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -132.8 127.69 35.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.037 1.335 . . . . 0.0 110.439 177.167 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -66.16 152.34 45.0 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.784 0.834 . . . . 0.0 112.518 175.09 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.8 m -65.87 150.75 96.11 Favored Pre-proline 0 N--CA 1.485 1.302 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.132 162.818 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.74 -18.04 52.86 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.41 2.073 . . . . 0.0 114.893 -163.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.3 -6.58 58.71 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 173.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -82.03 143.33 49.26 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.038 1.419 . . . . 0.0 112.045 -176.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 145.51 82.31 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 119.183 0.744 . . . . 0.0 112.561 -3.231 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.62 166.13 11.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.385 1.874 . . . . 0.0 110.924 176.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 46.5 m -124.47 119.29 28.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.858 0.863 . . . . 0.0 110.766 177.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -101.46 135.29 43.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.868 1.267 . . . . 0.0 110.848 171.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -97.37 119.53 36.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.22 0.608 . . . . 0.0 110.059 173.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 78.5 t -104.5 131.03 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.37 1.468 . . . . 0.0 110.282 -175.611 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.6 p -103.27 163.57 12.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.933 1.293 . . . . 0.0 112.838 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.3 142.49 21.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.12 1.343 . . . . 0.0 112.475 177.289 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 CA--C 1.548 0.89 0 C-N-CA 124.871 1.268 . . . . 0.0 112.904 175.573 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -61.55 120.48 56.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.902 0.881 . . . . 0.0 111.389 -169.703 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 156.27 57.74 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.33 2.686 . . . . 0.0 111.612 -173.766 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -96.38 125.39 40.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.554 0.742 . . . . 0.0 109.943 176.603 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.13 131.37 13.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.172 1.389 . . . . 0.0 110.663 173.25 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.41 34.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.539 1.936 . . . . 0.0 109.471 -173.276 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -123.59 136.4 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.835 1.254 . . . . 0.0 110.42 179.486 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.4 mt -135.72 138.8 29.03 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 125.879 1.672 . . . . 0.0 109.092 -174.543 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.61 43.88 1.43 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.728 3.619 . . . . 0.0 113.134 177.706 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 88.5 t80 -87.09 157.51 19.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.316 1.446 . . . . 0.0 110.897 171.244 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 85.2 m -124.62 127.71 47.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.405 1.482 . . . . 0.0 110.128 -177.181 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.9 mt -88.17 128.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.503 1.121 . . . . 0.0 110.171 174.682 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -111.37 -146.96 0.41 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.926 1.691 . . . . 0.0 110.757 176.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -78.5 127.78 32.63 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.818 -1.176 . . . . 0.0 110.898 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 135.81 -148.33 19.6 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.443 1.497 . . . . 0.0 112.103 -170.804 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.71 148.58 19.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.677 1.191 . . . . 0.0 111.428 -174.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 11.8 tt -121.44 138.32 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.718 1.607 . . . . 0.0 111.398 179.214 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 45.2 p -144.54 -174.74 4.4 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.381 1.872 . . . . 0.0 110.317 -176.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.39 -169.31 38.34 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -152.92 136.76 16.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.894 1.677 . . . . 0.0 109.8 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 26.9 t -108.62 134.8 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.756 1.622 . . . . 0.0 108.343 171.656 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -119.93 138.87 53.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.43 1.092 . . . . 0.0 111.594 -172.196 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -109.32 144.14 29.17 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.825 1.65 . . . . 0.0 111.173 -176.157 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.37 -30.11 61.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.125 3.216 . . . . 0.0 114.836 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.7 m -69.49 -2.27 10.81 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.192 1.397 . . . . 0.0 114.402 178.535 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.22 -1.62 77.27 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.889 1.709 . . . . 0.0 113.829 -177.016 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -79.2 160.67 26.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.652 1.581 . . . . 0.0 111.963 179.732 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 36.0 m -141.55 157.51 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.152 1.381 . . . . 0.0 111.82 178.217 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.65 166.93 32.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.244 1.817 . . . . 0.0 111.415 -179.572 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.52 140.09 20.8 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 -179.836 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.47 174.98 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.625 3.55 . . . . 0.0 112.094 175.267 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.4 m -116.59 141.6 47.98 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 109.052 170.855 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.3 135.64 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.714 1.206 . . . . 0.0 109.272 174.541 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 54.5 m -140.06 128.08 22.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.277 1.431 . . . . 0.0 109.72 -178.691 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.17 137.52 40.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.908 0.883 . . . . 0.0 112.288 172.448 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -89.91 -8.73 51.15 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 69.43 3.1 4.01 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.636 2.374 . . . . 0.0 114.15 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.97 7.51 46.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.896 2.078 . . . . 0.0 112.821 178.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.43 16.81 51.96 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.942 1.258 . . . . 0.0 113.703 -173.36 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 37.7 p -132.68 159.69 38.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 178.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 31.5 m -121.51 147.26 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.674 1.19 . . . . 0.0 110.226 167.099 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 97.3 m -105.33 135.03 47.45 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.827 1.251 . . . . 0.0 108.752 169.131 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 65.1 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.413 1.885 . . . . 0.0 108.467 177.974 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -138.53 159.06 43.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.001 1.32 . . . . 0.0 113.131 -172.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.8 t80 -159.35 137.17 10.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.86 1.664 . . . . 0.0 111.883 174.94 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.35 115.91 65.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.09 1.356 . . . . 0.0 110.736 177.311 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.81 156.81 13.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.78 2.987 . . . . 0.0 112.769 -172.011 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 49.9 m -124.88 -24.6 4.06 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.682 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -145.77 148.61 33.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.421 1.489 . . . . 0.0 110.915 -177.351 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.82 162.89 27.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.547 1.139 . . . . 0.0 113.197 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 133.56 -177.37 19.08 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 125.282 1.42 . . . . 0.0 114.15 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.2 tt -88.26 123.55 32.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 109.115 175.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.45 159.05 32.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.219 1.407 . . . . 0.0 111.673 -172.235 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.18 154.79 50.31 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 111.649 172.291 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -137.69 123.96 20.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.222 1.809 . . . . 0.0 109.81 -172.312 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -95.16 129.52 42.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.748 2.019 . . . . 0.0 109.429 174.118 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.8 mm -127.64 136.82 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.739 1.216 . . . . 0.0 109.87 174.362 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -179.832 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -96.6 121.09 38.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.492 1.917 . . . . 0.0 109.886 173.634 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.47 35.03 10.24 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.965 1.306 . . . . 0.0 112.858 -174.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 47.9 t30 78.55 1.93 2.6 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.334 2.654 . . . . 0.0 114.787 -179.66 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -102.38 133.56 47.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.525 1.53 . . . . 0.0 111.435 174.188 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m170 -52.92 137.2 33.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.615 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.58 156.79 70.54 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.375 0.67 . . . . 0.0 111.204 169.425 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.53 130.87 35.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.034 1.823 . . . . 0.0 109.29 166.067 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.58 -2.27 67.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.245 0.926 . . . . 0.0 113.937 -172.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.4 t -93.24 145.12 29.45 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 118.939 1.369 . . . . 0.0 111.527 170.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.76 165.31 85.43 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.86 0.986 . . . . 0.0 111.606 -10.494 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.12 154.54 20.03 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.367 1.867 . . . . 0.0 110.068 173.725 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -158.23 135.12 9.81 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.177 0.991 . . . . 0.0 111.07 -174.575 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.1 p90 -167.23 173.43 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.746 1.218 . . . . 0.0 112.815 -167.551 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.8 t80 -107.13 141.69 37.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.945 0.898 . . . . 0.0 113.149 173.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 91.0 t -110.11 131.79 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.807 2.043 . . . . 0.0 109.157 179.046 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -152.02 151.2 30.84 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.355 1.462 . . . . 0.0 112.792 -172.833 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -69.99 149.23 47.94 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.235 -0.916 . . . . 0.0 112.751 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.9 m -71.54 -14.66 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -171.058 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.28 -126.1 0.18 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.463 1.505 . . . . 0.0 111.334 178.704 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 75.9 m 75.1 160.7 0.23 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.232 2.613 . . . . 0.0 114.398 171.848 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -102.27 -17.32 20.45 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.051 1.31 . . . . 0.0 114.652 178.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -71.82 155.62 40.21 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.685 1.242 . . . . 0.0 113.833 -179.509 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.7 t -68.01 143.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.604 1.162 . . . . 0.0 108.842 172.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.02 167.22 29.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.507 1.123 . . . . 0.0 110.984 -175.486 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -152.46 148.17 27.11 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.529 1.532 . . . . 0.0 111.441 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -165.51 161.14 18.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 112.392 -173.43 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.17 169.96 12.55 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.105 1.336 . . . . 0.0 113.56 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.08 -30.59 38.34 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.227 2.618 . . . . 0.0 113.092 -170.407 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.3 -17.38 72.23 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.429 1.013 . . . . 0.0 114.586 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 63.8 mt -76.04 -15.76 60.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.749 169.299 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 5.7 m -115.64 -39.46 3.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.029 1.732 . . . . 0.0 112.043 -165.711 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -151.4 150.36 30.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.086 1.754 . . . . 0.0 112.392 -172.434 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.83 176.87 29.19 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.235 1.398 . . . . 0.0 112.712 172.781 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.2 t -140.04 136.29 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.559 1.144 . . . . 0.0 108.342 175.442 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -57.12 137.12 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.272 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 65.32 3.79 2.42 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.833 2.053 . . . . 0.0 114.658 176.879 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -118.03 138.49 25.52 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.895 1.678 . . . . 0.0 110.401 177.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.08 131.97 17.48 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.363 2.042 . . . . 0.0 111.407 -171.077 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.2 148.24 33.22 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.479 1.512 . . . . 0.0 110.355 172.282 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 33.2 p -137.57 149.87 47.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -165.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.28 172.89 16.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.593 1.557 . . . . 0.0 111.85 176.59 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.9 m -123.35 141.39 52.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.738 1.615 . . . . 0.0 110.482 -173.657 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 59.2 t -113.71 139.6 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.272 1.829 . . . . 0.0 107.897 168.215 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.48 133.17 45.31 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.228 1.011 . . . . 0.0 111.738 177.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 68.3 p -125.58 1.02 7.57 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.469 1.907 . . . . 0.0 113.039 -177.317 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -49.97 -28.63 7.12 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.76 2.424 . . . . 0.0 117.122 -169.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -139.21 20.38 2.6 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.1 1.36 . . . . 0.0 112.031 176.678 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.46 44.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 113.474 -174.845 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.36 146.11 4.29 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.007 1.289 . . . . 0.0 112.297 -171.179 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.13 147.16 38.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.832 0.853 . . . . 0.0 112.005 -179.378 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . -175.79 -42.43 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.002 1.287 . . . . 0.0 113.543 176.513 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 162.03 102.17 0.17 Allowed Glycine 0 N--CA 1.47 0.943 0 C-N-CA 125.065 1.316 . . . . 0.0 112.594 170.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 33.2 tp -81.65 136.88 35.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.305 1.042 . . . . 0.0 110.117 176.577 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -129.97 157.44 42.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.346 1.458 . . . . 0.0 111.553 177.555 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 55.6 tp -160.68 132.35 5.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.457 1.503 . . . . 0.0 108.977 -169.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.43 162.72 37.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.877 0.871 . . . . 0.0 112.132 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.6 mt -136.59 132.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.872 1.269 . . . . 0.0 109.074 172.54 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -115.02 157.71 23.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.704 1.602 . . . . 0.0 109.744 169.219 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.6 -165.15 35.24 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.192 -0.943 . . . . 0.0 113.748 -177.714 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.62 -15.12 27.41 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.633 2.889 . . . . 0.0 112.422 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -147.1 160.38 42.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.997 1.719 . . . . 0.0 109.255 163.488 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 52.1 tptt -83.24 113.02 20.39 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.868 -1.145 . . . . 0.0 111.857 -174.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.94 150.27 44.29 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.182 0.993 . . . . 0.0 111.857 173.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.52 145.65 26.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.888 0.875 . . . . 0.0 110.691 169.611 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 20.1 mt -137.4 140.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.813 1.245 . . . . 0.0 110.505 -163.631 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.9 m -133.3 157.27 45.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.772 1.629 . . . . 0.0 110.675 168.442 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 31.8 p -156.46 156.89 34.54 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.233 -0.917 . . . . 0.0 113.104 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -144.14 124.82 14.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.704 1.602 . . . . 0.0 110.078 -171.032 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.24 144.92 32.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.569 1.147 . . . . 0.0 112.535 173.951 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -121.74 152.0 39.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.586 1.554 . . . . 0.0 112.062 -176.16 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -68.23 -18.41 64.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.818 1.247 . . . . 0.0 112.788 176.43 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -76.55 -2.79 34.18 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.86 1.664 . . . . 0.0 114.247 -178.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 89.77 33.92 8.76 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.385 0.993 . . . . 0.0 113.399 -178.563 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.2 p -139.88 163.63 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.354 1.461 . . . . 0.0 111.215 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.0 m -121.08 132.89 55.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.717 1.607 . . . . 0.0 108.841 161.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -92.02 147.51 22.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.857 0.863 . . . . 0.0 110.261 170.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 91.0 t -128.95 142.97 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.561 1.544 . . . . 0.0 109.83 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 86.2 p -132.99 147.5 52.28 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.227 1.411 . . . . 0.0 111.589 167.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -151.22 157.8 43.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 24.6 mt -124.93 108.4 28.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.903 1.681 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.02 168.95 15.05 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.781 2.987 . . . . 0.0 110.25 166.116 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.3 p -131.64 -20.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.434 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.7 150.73 51.44 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.556 1.142 . . . . 0.0 110.575 173.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.65 154.39 39.47 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.929 2.419 . . . . 0.0 112.573 -168.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.34 -144.68 12.19 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.683 1.135 . . . . 0.0 112.964 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -123.31 133.37 54.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.49 177.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -123.55 134.08 53.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 0.0 110.769 -174.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 74.7 m -100.06 110.32 22.62 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.996 1.318 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.35 126.77 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.419 1.488 . . . . 0.0 108.546 176.156 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -105.33 130.98 53.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.626 . . . . 0.0 109.665 174.378 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -131.11 128.55 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.433 1.093 . . . . 0.0 109.7 172.072 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.37 141.37 21.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.174 1.39 . . . . 0.0 111.502 -168.505 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.49 121.32 17.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.935 1.294 . . . . 0.0 109.968 -178.768 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 52.65 59.07 4.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.541 1.536 . . . . 0.0 112.0 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 7.7 pt-20 60.86 0.78 0.39 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 129.035 2.934 . . . . 0.0 116.867 -177.198 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -107.52 123.63 48.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.111 179.293 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.18 144.78 54.99 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.35 -0.844 . . . . 0.0 111.703 169.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.5 m -73.44 151.08 89.56 Favored Pre-proline 0 N--CA 1.48 1.041 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.038 171.976 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.52 129.67 35.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.129 2.553 . . . . 0.0 110.762 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.13 -15.24 63.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.04 1.305 . . . . 0.0 115.027 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 34.5 t -77.09 139.36 65.19 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.223 1.511 . . . . 0.0 111.346 176.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.79 147.55 81.3 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.648 0.91 . . . . 0.0 112.585 -3.098 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.24 133.77 45.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.837 1.655 . . . . 0.0 110.59 -178.887 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 24.6 m -97.67 108.66 21.43 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.552 0.741 . . . . 0.0 110.847 -177.08 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.34 132.84 37.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.014 1.326 . . . . 0.0 111.886 176.328 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 22.0 tpt85 -88.15 113.29 23.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.482 178.771 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.0 t -103.49 129.56 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.048 0.939 . . . . 0.0 110.758 -176.422 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 69.6 p -110.11 162.47 14.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.019 1.327 . . . . 0.0 112.977 -179.683 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.57 135.44 13.6 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.938 1.256 . . . . 0.0 112.345 178.003 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 CA--C 1.548 0.87 0 C-N-CA 124.577 1.151 . . . . 0.0 112.937 175.684 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 31.6 mt . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 47.4 ttm-85 -67.28 117.9 51.04 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.817 1.647 . . . . 0.0 110.215 -175.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.2 151.11 60.48 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.212 2.608 . . . . 0.0 111.572 -171.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.4 t80 -101.16 119.5 38.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.938 0.895 . . . . 0.0 109.689 176.339 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -147.81 131.13 16.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.136 1.374 . . . . 0.0 110.398 172.38 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.78 148.31 35.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 109.756 -171.054 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -119.94 139.56 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.043 1.337 . . . . 0.0 110.56 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.3 mt -133.92 137.49 28.57 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.164 1.786 . . . . 0.0 108.465 -176.107 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.36 46.7 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.332 3.354 . . . . 0.0 112.861 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.2 t80 -91.41 155.05 18.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.362 1.465 . . . . 0.0 111.072 174.81 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.3 m -125.25 126.35 45.02 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.882 1.273 . . . . 0.0 109.831 177.866 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.3 mt -95.69 115.23 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 109.077 177.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.79 -55.52 4.05 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.627 0.771 . . . . 0.0 112.992 179.656 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -161.82 -35.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.852 1.261 . . . . 0.0 114.002 -171.536 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -72.53 164.9 54.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.226 1.393 . . . . 0.0 113.801 179.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -86.42 142.71 28.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.871 1.269 . . . . 0.0 112.212 -174.515 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.86 134.39 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.58 1.552 . . . . 0.0 110.459 174.591 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.1 p -145.68 173.03 12.43 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.998 1.719 . . . . 0.0 110.738 -175.082 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.72 -176.62 25.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 -177.658 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -151.43 137.72 18.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.938 1.695 . . . . 0.0 109.057 171.026 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.3 t -111.69 133.29 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.054 1.742 . . . . 0.0 108.131 174.179 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -109.28 129.96 55.5 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.237 1.415 . . . . 0.0 110.626 -176.625 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -96.21 151.79 38.4 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.621 1.568 . . . . 0.0 111.411 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.99 -24.85 45.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.294 2.663 . . . . 0.0 113.213 -179.093 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 20.3 m -73.91 -1.09 18.21 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.84 70.41 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.736 1.636 . . . . 0.0 114.624 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -71.75 163.76 27.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.221 1.408 . . . . 0.0 112.301 176.263 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.74 153.39 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.219 1.408 . . . . 0.0 111.873 175.647 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.43 166.55 31.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.852 2.061 . . . . 0.0 110.41 179.096 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.06 141.57 23.01 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.188 -0.945 . . . . 0.0 112.444 -177.823 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.24 172.64 8.29 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.67 3.58 . . . . 0.0 111.658 173.332 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.9 m -109.34 125.58 52.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.322 1.449 . . . . 0.0 108.899 172.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.02 129.46 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.407 1.083 . . . . 0.0 108.42 173.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.5 m -118.77 128.33 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.149 1.78 . . . . 0.0 109.674 -178.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.42 119.92 22.43 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.246 1.018 . . . . 0.0 110.465 170.615 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -84.67 -14.43 48.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.3 mttt 71.5 -3.36 2.15 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.788 2.435 . . . . 0.0 114.514 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -92.8 5.57 50.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.297 1.839 . . . . 0.0 113.319 178.515 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.63 19.02 46.03 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.694 1.14 . . . . 0.0 113.53 -172.504 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -131.98 162.0 31.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 109.966 175.216 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.1 m -126.1 147.13 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.226 . . . . 0.0 109.978 168.413 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 52.1 m -108.75 135.22 50.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.376 1.071 . . . . 0.0 108.568 171.328 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -117.63 131.49 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.309 1.444 . . . . 0.0 108.797 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.08 151.27 51.86 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.012 1.325 . . . . 0.0 112.504 -173.261 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.05 136.08 17.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.38 1.472 . . . . 0.0 111.764 176.825 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.86 115.62 64.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.764 1.225 . . . . 0.0 110.827 177.792 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.03 140.43 25.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.826 3.018 . . . . 0.0 112.918 -172.117 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.2 p -116.78 -8.45 11.37 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.705 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.29 157.48 22.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.044 1.738 . . . . 0.0 111.579 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.78 172.62 12.02 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.458 1.103 . . . . 0.0 112.377 174.058 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.95 -172.17 15.57 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.527 1.537 . . . . 0.0 113.62 178.778 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.83 130.9 35.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.502 1.121 . . . . 0.0 110.233 -178.581 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.5 m80 -128.89 162.08 28.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.913 1.685 . . . . 0.0 111.612 -173.786 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -141.98 159.5 42.11 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.28 1.032 . . . . 0.0 111.696 172.943 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.1 ttm -139.44 134.52 32.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 110.607 -171.8 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -110.24 136.16 49.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 109.922 172.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.0 mm -133.1 132.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.146 1.378 . . . . 0.0 109.951 178.118 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 138.19 28.32 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.8 t80 -102.47 121.03 41.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.478 2.311 . . . . 0.0 109.586 176.32 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.07 38.4 20.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.832 1.253 . . . . 0.0 112.551 -174.844 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 78.89 -9.0 1.57 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 128.906 2.883 . . . . 0.0 115.174 -178.392 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 67.7 mtm -95.53 129.82 42.58 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.208 1.403 . . . . 0.0 111.187 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -59.12 138.33 57.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.208 -0.933 . . . . 0.0 113.438 -177.309 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 33.4 pt -71.81 153.05 93.26 Favored Pre-proline 0 N--CA 1.48 1.044 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.044 169.645 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.65 -18.37 58.65 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.407 2.071 . . . . 0.0 113.9 -174.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.83 0.52 87.9 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.771 1.177 . . . . 0.0 114.685 171.485 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -97.2 142.6 24.78 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.652 1.726 . . . . 0.0 111.539 176.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.53 165.7 74.06 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.842 0.979 . . . . 0.0 112.854 -1.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 86.2 mt -112.93 159.54 18.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.22 1.808 . . . . 0.0 110.665 170.282 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -155.49 139.6 16.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.638 1.175 . . . . 0.0 110.137 -173.381 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.33 -175.69 3.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.906 1.282 . . . . 0.0 112.382 -170.429 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.4 t80 -124.02 141.58 51.92 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.89 1.276 . . . . 0.0 112.679 178.23 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 54.7 t -110.9 142.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.099 1.76 . . . . 0.0 109.434 176.724 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.03 169.39 21.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.801 2.04 . . . . 0.0 109.954 -171.607 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -77.32 143.57 38.71 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.513 -1.367 . . . . 0.0 111.187 170.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.7 m -61.94 -26.87 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -175.152 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.75 134.18 48.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.307 1.443 . . . . 0.0 110.045 166.814 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 7.6 t -164.66 156.56 15.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.934 1.694 . . . . 0.0 110.724 178.274 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.6 58.23 4.99 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.172 1.367 . . . . 0.0 113.525 -173.857 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -155.5 167.79 29.23 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.3 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.0 p -71.49 147.26 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.382 1.073 . . . . 0.0 109.582 159.436 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.5 t -160.02 167.96 26.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.087 1.355 . . . . 0.0 110.487 178.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.68 145.48 25.86 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 -179.119 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.6 p90 -168.74 166.77 11.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.786 1.634 . . . . 0.0 112.578 -173.757 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.89 174.63 13.7 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.3 1.428 . . . . 0.0 112.542 -177.279 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.17 -36.1 13.06 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.257 . . . . 0.0 112.87 -170.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.41 87.65 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.45 1.023 . . . . 0.0 114.589 -170.738 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.13 -2.08 39.08 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.912 1.356 . . . . 0.0 113.498 175.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.3 m -108.17 -51.39 2.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.28 1.832 . . . . 0.0 110.926 177.529 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -138.4 144.71 40.34 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.537 1.935 . . . . 0.0 112.522 -176.731 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.22 178.27 20.4 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.985 1.278 . . . . 0.0 112.912 171.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -141.67 138.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.852 1.261 . . . . 0.0 108.259 174.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -59.96 149.17 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.062 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 77.6 m-20 67.2 14.76 9.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.425 1.89 . . . . 0.0 114.382 169.838 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -145.56 152.84 50.34 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.874 1.67 . . . . 0.0 111.236 174.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.74 145.66 32.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.497 2.131 . . . . 0.0 112.145 -174.616 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -121.46 150.83 40.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.409 1.884 . . . . 0.0 110.043 170.621 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.8 p -137.71 149.97 46.93 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -165.487 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.07 175.96 12.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.78 1.632 . . . . 0.0 111.457 175.341 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.6 m -129.71 140.42 51.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.944 1.298 . . . . 0.0 110.727 -172.045 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.2 t -105.2 133.27 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.443 1.497 . . . . 0.0 107.906 168.217 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.43 126.69 46.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.703 1.201 . . . . 0.0 110.446 174.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.1 p -126.51 5.4 6.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.849 2.06 . . . . 0.0 113.066 -171.604 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.74 -37.5 51.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.241 1.817 . . . . 0.0 115.104 -170.241 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -116.36 9.73 14.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.403 1.481 . . . . 0.0 113.014 178.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.62 -10.94 59.71 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -171.097 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 86.37 -125.68 7.5 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.453 1.025 . . . . 0.0 112.446 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.02 149.5 28.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.387 1.475 . . . . 0.0 110.878 -173.901 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.84 -155.78 26.74 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.585 1.564 . . . . 0.0 112.736 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.1 108.14 3.38 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.127 0.87 . . . . 0.0 111.504 174.416 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.74 128.17 34.33 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 108.722 171.84 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.6 m -133.74 160.24 38.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.032 1.333 . . . . 0.0 112.854 -173.299 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 37.3 tp -158.46 138.53 12.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.491 1.916 . . . . 0.0 108.951 -171.569 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.15 157.19 35.54 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.071 0.948 . . . . 0.0 111.944 174.85 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.7 mt -138.35 140.29 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.875 1.27 . . . . 0.0 109.741 177.05 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.22 144.04 51.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.652 1.581 . . . . 0.0 109.877 173.723 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.34 -166.0 26.67 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.958 -175.242 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.58 -26.33 69.5 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.477 3.451 . . . . 0.0 112.843 178.436 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -141.72 156.26 45.61 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.986 1.314 . . . . 0.0 109.093 161.039 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -72.31 110.72 6.93 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.193 -0.942 . . . . 0.0 111.258 -177.739 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.88 148.38 51.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.0 111.372 172.229 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.33 146.34 27.77 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.818 0.447 . . . . 0.0 110.159 165.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.24 143.97 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.029 1.332 . . . . 0.0 109.856 -165.182 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.58 163.24 35.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.693 1.197 . . . . 0.0 111.418 168.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -161.34 152.43 18.5 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.991 1.317 . . . . 0.0 112.305 -178.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 95.1 m -137.96 121.92 17.79 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.637 1.575 . . . . 0.0 109.692 -175.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.55 119.3 15.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.452 0.701 . . . . 0.0 109.966 165.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.66 -16.79 50.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 112.656 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 10.3 tt0 72.71 -8.8 1.18 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 128.08 2.552 . . . . 0.0 113.072 -176.286 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.36 11.61 8.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.972 2.109 . . . . 0.0 113.494 -177.368 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.84 15.34 54.73 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.187 1.375 . . . . 0.0 113.605 -171.869 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 65.9 p -141.66 154.17 45.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.651 1.58 . . . . 0.0 111.754 177.419 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 35.3 m -120.87 131.24 54.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.662 1.585 . . . . 0.0 108.988 164.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.5 t -88.17 149.4 23.91 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.923 0.889 . . . . 0.0 110.838 173.125 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -132.58 143.14 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.632 1.573 . . . . 0.0 110.121 -177.229 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 92.8 p -137.28 150.32 47.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.876 1.27 . . . . 0.0 112.252 168.852 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -152.24 155.05 36.98 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.138 -0.976 . . . . 0.0 112.462 173.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.38 99.98 29.88 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.398 1.079 . . . . 0.0 109.998 -174.461 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -83.21 162.21 15.32 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.069 3.179 . . . . 0.0 111.083 176.41 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -133.77 -20.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -172.441 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.6 mt -118.65 147.32 41.86 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 124.849 1.259 . . . . 0.0 110.261 170.21 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 158.76 43.61 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.883 2.388 . . . . 0.0 111.019 176.385 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 128.08 -163.79 21.58 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.967 1.27 . . . . 0.0 113.213 -177.048 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.81 136.9 32.77 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 112.921 -178.957 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -124.78 129.98 51.51 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.743 1.617 . . . . 0.0 110.031 176.429 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.81 126.19 35.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 110.436 174.838 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.71 126.23 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.465 1.506 . . . . 0.0 108.047 178.643 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -108.94 131.84 54.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.474 1.509 . . . . 0.0 109.442 175.651 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.85 129.09 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.392 1.077 . . . . 0.0 109.383 172.739 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.78 143.39 26.34 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.225 1.41 . . . . 0.0 111.59 -168.36 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.83 122.18 12.34 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.597 1.159 . . . . 0.0 110.341 179.748 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 57.67 56.24 5.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.315 1.446 . . . . 0.0 111.732 -179.406 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 10.0 pt-20 54.78 22.34 4.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.903 2.481 . . . . 0.0 115.898 -179.113 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -132.84 131.39 40.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.071 1.348 . . . . 0.0 110.542 176.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.58 150.32 47.12 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.796 0.838 . . . . 0.0 112.299 174.788 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -67.69 156.29 89.37 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.103 167.833 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -52.28 -33.67 56.39 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.042 3.161 . . . . 0.0 116.378 -169.388 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.98 -3.21 59.17 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.6 t -84.12 143.02 41.87 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.983 1.392 . . . . 0.0 112.355 -177.316 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.26 138.14 54.17 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.062 0.701 . . . . 0.0 111.812 -4.449 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.48 168.3 12.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.862 1.665 . . . . 0.0 110.292 172.843 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 25.0 m -131.76 116.86 17.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 110.069 172.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -91.46 152.93 20.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.746 1.219 . . . . 0.0 110.785 170.113 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -108.87 129.08 55.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.516 0.726 . . . . 0.0 110.19 166.521 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.8 t -105.06 129.22 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.318 1.447 . . . . 0.0 110.135 179.242 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 86.9 m -95.99 152.56 18.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.0 1.72 . . . . 0.0 111.495 -178.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.27 133.35 12.18 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.871 1.224 . . . . 0.0 112.079 175.289 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 CA--C 1.546 0.799 0 C-N-CA 124.751 1.22 . . . . 0.0 113.484 -177.157 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -56.27 115.54 10.19 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.287 1.435 . . . . 0.0 110.362 177.445 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 133.41 27.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.117 1.878 . . . . 0.0 108.682 174.122 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.02 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 109.947 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.93 150.51 25.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.351 1.461 . . . . 0.0 111.652 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -159.62 151.57 20.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.856 1.662 . . . . 0.0 109.893 -177.123 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -123.81 134.5 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.005 1.322 . . . . 0.0 109.655 170.845 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.77 135.98 27.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.919 1.688 . . . . 0.0 109.215 -172.692 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.02 112.77 3.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.209 2.606 . . . . 0.0 110.208 173.873 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 46.8 t80 -174.94 147.6 0.98 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.026 2.13 . . . . 0.0 109.278 -171.683 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 52.5 m -125.63 127.0 45.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.574 1.15 . . . . 0.0 109.803 -178.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.82 113.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.731 0.812 . . . . 0.0 109.436 174.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -98.33 -158.53 0.68 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.213 1.405 . . . . 0.0 111.006 172.006 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tptt -68.5 120.36 14.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.603 -1.311 . . . . 0.0 111.091 173.104 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.64 -147.61 18.63 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.676 1.608 . . . . 0.0 111.867 -171.066 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.78 143.46 15.89 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.3 1.04 . . . . 0.0 111.496 -175.118 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.9 tt -128.95 136.44 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.731 1.612 . . . . 0.0 110.946 177.076 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.9 p -147.64 -178.37 6.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.337 1.855 . . . . 0.0 110.372 -176.765 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.52 -170.55 31.57 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 179.027 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -149.72 139.81 22.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.317 1.847 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 45.1 t -113.67 135.53 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.3 1.84 . . . . 0.0 108.178 170.647 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -119.02 138.15 53.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.166 1.387 . . . . 0.0 111.947 -178.386 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.5 mpp? -114.05 141.57 26.51 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.831 1.652 . . . . 0.0 111.399 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -25.13 78.77 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.126 3.217 . . . . 0.0 115.017 177.144 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.3 p -74.71 4.35 6.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.861 1.664 . . . . 0.0 114.655 -177.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.84 41.15 6.04 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 124.606 1.098 . . . . 0.0 113.293 172.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -148.67 163.89 35.94 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.63 1.572 . . . . 0.0 111.938 -175.058 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.5 161.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.011 1.324 . . . . 0.0 112.231 -174.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.02 -178.25 6.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.088 2.155 . . . . 0.0 110.22 178.051 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -127.04 146.23 56.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.065 -1.022 . . . . 0.0 111.419 176.581 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.33 166.18 14.23 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.207 3.271 . . . . 0.0 111.49 177.857 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.8 m -101.98 134.21 45.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 108.585 170.131 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.17 132.91 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.799 1.239 . . . . 0.0 109.013 175.019 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.7 m -138.6 122.32 17.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.243 1.417 . . . . 0.0 109.465 178.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -76.63 131.8 39.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.865 0.866 . . . . 0.0 111.73 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -83.44 1.68 40.44 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.041 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 69.51 16.86 8.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.624 1.97 . . . . 0.0 112.991 179.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -138.66 16.82 2.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.18 1.792 . . . . 0.0 113.015 -169.545 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.74 13.27 63.03 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.596 1.093 . . . . 0.0 115.132 177.184 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.9 p -129.44 155.94 44.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.835 1.654 . . . . 0.0 110.41 174.843 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.0 m -115.42 138.37 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.886 0.875 . . . . 0.0 110.202 167.192 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.4 m -96.03 136.43 36.49 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.731 1.212 . . . . 0.0 108.429 167.964 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 52.9 t -121.78 135.85 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.791 1.636 . . . . 0.0 108.399 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -140.63 159.33 42.44 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.562 1.145 . . . . 0.0 113.139 -175.839 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.0 t80 -154.59 134.25 12.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.942 1.697 . . . . 0.0 111.538 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.46 121.75 75.08 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.381 1.072 . . . . 0.0 111.205 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.44 156.68 32.65 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.741 2.96 . . . . 0.0 111.857 -176.558 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.1 t -140.75 -13.76 0.96 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.516 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -165.38 151.54 9.8 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 110.657 -176.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.02 168.45 20.07 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.427 1.091 . . . . 0.0 113.444 -177.602 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 125.04 -179.97 15.94 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.346 1.45 . . . . 0.0 114.157 176.723 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.0 tt -86.66 122.37 30.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.758 1.223 . . . . 0.0 109.821 179.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 26.2 m80 -116.99 160.82 20.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.698 1.599 . . . . 0.0 111.619 -173.113 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -142.78 144.21 32.5 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.978 1.311 . . . . 0.0 110.304 -178.557 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.5 ttm -135.39 141.02 45.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.827 1.251 . . . . 0.0 112.613 -176.386 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.09 139.57 35.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.737 1.615 . . . . 0.0 110.405 163.667 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.4 mm -127.84 131.61 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 109.272 163.63 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.31 134.69 23.06 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.106 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 13.7 t80 -98.03 122.83 41.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.573 1.949 . . . . 0.0 109.632 174.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.83 36.43 14.59 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.723 1.209 . . . . 0.0 112.824 -175.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 77.78 3.18 2.97 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 128.107 2.563 . . . . 0.0 114.614 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.0 mtm -105.64 130.21 53.72 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.583 1.553 . . . . 0.0 111.079 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.28 137.22 41.93 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.773 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 24.6 pt -77.05 156.18 82.25 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.228 171.024 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -59.82 128.53 27.14 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.111 1.874 . . . . 0.0 109.718 169.977 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.92 -16.9 57.99 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.784 1.183 . . . . 0.0 114.072 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.4 t -83.22 144.75 47.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 119.347 1.574 . . . . 0.0 110.664 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.43 160.24 93.94 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 120.209 1.11 . . . . 0.0 113.048 -2.638 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.97 154.07 22.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.661 1.984 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -156.4 134.41 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.039 0.936 . . . . 0.0 110.96 -173.025 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.08 -177.53 5.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 112.779 -172.486 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.4 t80 -122.4 137.44 54.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 177.253 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 90.4 t -100.75 134.59 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.644 1.577 . . . . 0.0 109.573 174.481 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 18.6 t0 -156.51 169.25 25.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.242 1.817 . . . . 0.0 110.301 -179.519 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -69.45 142.78 53.73 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.073 -1.017 . . . . 0.0 112.7 176.622 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 53.6 t -67.02 -36.14 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.207 1.003 . . . . 0.0 112.556 -172.245 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -121.61 20.04 11.1 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.533 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 28.5 p -61.4 158.93 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.922 1.289 . . . . 0.0 114.413 -176.203 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -82.42 -29.65 35.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.331 0.967 . . . . 0.0 113.661 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -71.55 153.7 41.98 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.253 1.027 . . . . 0.0 112.583 173.472 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.8 t -70.17 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 3.3 t -155.0 164.11 39.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.591 1.157 . . . . 0.0 111.249 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.17 149.22 42.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 -175.966 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 4.2 p90 -161.93 158.62 25.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.643 1.577 . . . . 0.0 113.004 179.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.04 168.3 11.29 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.258 1.409 . . . . 0.0 113.572 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.48 -30.14 36.35 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.429 2.753 . . . . 0.0 113.153 -171.46 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.45 -13.58 71.12 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.078 0.847 . . . . 0.0 114.527 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 66.6 mt -79.03 -11.94 60.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.935 1.367 . . . . 0.0 112.807 168.603 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 10.3 m -120.6 -38.53 2.86 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.839 1.656 . . . . 0.0 112.466 -165.605 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -154.83 156.99 37.21 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.74 1.616 . . . . 0.0 112.366 -172.009 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.14 -176.84 28.71 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.108 0.861 . . . . 0.0 114.074 172.068 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.5 t -141.22 133.3 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.172 1.389 . . . . 0.0 108.255 177.741 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.9 m -56.63 137.44 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.876 0.47 . . . . 0.0 111.958 179.634 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.03 -2.18 1.86 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.691 1.996 . . . . 0.0 114.713 178.076 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -106.81 142.06 24.19 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.451 1.5 . . . . 0.0 110.791 175.793 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.4 126.53 11.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.382 2.054 . . . . 0.0 110.81 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -103.23 145.37 30.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.345 1.458 . . . . 0.0 110.282 172.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.4 p -135.9 153.51 51.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -165.626 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -165.6 173.45 10.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.226 1.81 . . . . 0.0 111.629 177.476 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 38.2 m -128.96 140.63 51.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.508 1.523 . . . . 0.0 110.781 -171.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.5 t -110.52 136.32 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.908 1.683 . . . . 0.0 108.335 168.198 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.39 126.0 38.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.681 1.193 . . . . 0.0 110.769 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 74.7 p -133.45 -1.31 3.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.909 1.283 . . . . 0.0 114.148 -167.53 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -54.59 -38.74 67.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.225 1.41 . . . . 0.0 114.684 -169.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -114.33 9.7 16.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.733 1.613 . . . . 0.0 112.759 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.83 67.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.329 1.052 . . . . 0.0 113.479 -175.116 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.13 153.11 6.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.833 1.206 . . . . 0.0 112.291 -169.554 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -70.13 160.94 31.14 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.655 0.782 . . . . 0.0 112.913 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.38 15.86 0.07 OUTLIER Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -176.419 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.44 96.0 1.5 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.531 1.539 . . . . 0.0 112.574 177.899 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.59 125.49 29.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.786 1.235 . . . . 0.0 108.527 167.543 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -116.34 154.96 29.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.98 1.712 . . . . 0.0 111.853 -179.465 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 59.7 tp -162.16 133.37 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 109.698 -170.034 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.84 161.68 34.52 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.655 1.182 . . . . 0.0 111.912 -179.523 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -137.99 132.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.612 1.165 . . . . 0.0 110.114 175.756 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -112.07 134.04 53.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.844 1.657 . . . . 0.0 109.323 170.458 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -164.96 -168.52 27.24 Favored Glycine 0 CA--C 1.537 1.435 0 O-C-N 121.353 -0.842 . . . . 0.0 114.909 -175.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.77 -23.35 55.82 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.929 3.086 . . . . 0.0 112.467 176.155 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -141.03 157.75 44.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.433 1.493 . . . . 0.0 109.441 165.377 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -69.29 111.36 5.15 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.042 -1.036 . . . . 0.0 110.424 174.454 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.06 146.18 51.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.553 0.741 . . . . 0.0 111.299 172.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.62 136.51 32.96 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.341 0.656 . . . . 0.0 109.368 169.394 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.9 mt -131.0 138.83 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.572 1.149 . . . . 0.0 110.456 -167.368 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.8 m -133.75 152.89 52.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.442 1.497 . . . . 0.0 110.661 169.75 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.6 p -150.88 153.18 34.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.829 0.852 . . . . 0.0 112.96 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 84.8 m -139.84 120.37 14.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.649 1.58 . . . . 0.0 110.107 -171.22 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.5 133.21 37.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.664 1.186 . . . . 0.0 111.332 172.189 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -110.75 145.89 37.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.697 1.599 . . . . 0.0 111.635 -178.685 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -69.25 -14.22 62.84 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.766 0.826 . . . . 0.0 112.736 174.524 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.78 -8.26 54.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.597 1.559 . . . . 0.0 113.913 174.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.98 31.68 7.19 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.466 1.031 . . . . 0.0 114.288 177.573 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.4 p -137.19 159.59 41.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.16 1.384 . . . . 0.0 110.966 175.665 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 49.6 t -112.86 126.21 55.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 108.667 160.697 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -93.23 145.39 24.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.921 0.889 . . . . 0.0 110.307 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 78.9 t -127.33 143.72 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.171 1.388 . . . . 0.0 110.138 -177.657 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.6 p -134.58 146.45 49.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.007 1.323 . . . . 0.0 111.552 167.096 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 26.1 p90 -148.21 151.38 35.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.576 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.8 mt -112.73 106.77 55.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.037 1.735 . . . . 0.0 110.512 179.021 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.64 174.44 10.41 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.795 2.997 . . . . 0.0 110.224 165.022 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -149.57 -31.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.214 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.44 148.69 35.82 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.33 0.968 . . . . 0.0 110.628 167.042 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.47 157.42 56.41 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 110.761 171.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.0 -159.7 23.1 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.667 1.127 . . . . 0.0 112.604 -175.667 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.35 129.86 56.15 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.187 0.995 . . . . 0.0 111.94 -174.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -116.88 127.69 54.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.528 1.931 . . . . 0.0 110.099 -177.588 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.5 m -97.23 114.42 26.15 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.635 1.174 . . . . 0.0 110.961 178.686 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -88.61 125.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.251 1.82 . . . . 0.0 108.776 178.355 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -101.16 131.37 47.15 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.357 1.463 . . . . 0.0 109.721 173.231 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 49.1 t -130.64 128.76 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 110.037 172.069 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -153.88 141.52 19.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.476 1.51 . . . . 0.0 111.071 -169.137 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.83 121.26 18.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.551 1.14 . . . . 0.0 109.545 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.84 59.57 4.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.24 1.416 . . . . 0.0 112.294 178.191 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.9 pt-20 59.14 11.97 2.28 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.279 2.632 . . . . 0.0 116.43 -178.431 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.41 123.35 41.88 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.48 1.112 . . . . 0.0 111.172 178.142 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -64.21 146.88 53.55 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.393 -0.817 . . . . 0.0 112.114 172.243 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 12.2 m -77.63 156.02 80.78 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.828 172.804 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -54.67 130.76 42.02 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.427 2.751 . . . . 0.0 112.086 177.397 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 85.75 -10.8 63.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.571 1.081 . . . . 0.0 115.554 -179.736 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -72.81 139.32 80.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 119.439 1.62 . . . . 0.0 111.344 176.717 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.89 149.06 80.23 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 CA-C-N 119.676 0.92 . . . . 0.0 112.768 -2.291 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -104.68 126.63 51.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 110.702 -177.199 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.8 m -94.73 110.95 22.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.599 0.759 . . . . 0.0 111.295 -175.791 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.86 129.55 45.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.917 1.687 . . . . 0.0 111.692 177.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -94.72 117.53 30.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.417 0.687 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 79.8 t -98.56 133.86 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.148 1.779 . . . . 0.0 110.643 -174.652 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 57.4 p -99.08 145.95 26.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.17 39.25 3.12 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.065 1.793 . . . . 0.0 113.831 -175.162 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.2 t70 . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -168.133 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 46.6 mt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.223 0.535 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -64.36 118.54 48.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.871 1.268 . . . . 0.0 111.504 -179.627 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.0 152.55 57.31 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.115 2.543 . . . . 0.0 110.865 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 16.2 t80 -107.8 125.66 51.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.937 0.895 . . . . 0.0 110.302 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.56 130.06 13.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.531 1.532 . . . . 0.0 110.001 173.568 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 131.18 21.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.236 1.414 . . . . 0.0 110.054 -169.577 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 58.0 t -95.73 138.05 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.105 1.362 . . . . 0.0 109.598 -179.773 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.75 135.01 26.69 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.652 1.581 . . . . 0.0 108.784 -179.002 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -79.8 37.76 0.69 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.22 3.28 . . . . 0.0 113.141 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -85.79 152.38 23.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.221 1.408 . . . . 0.0 111.458 178.196 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.9 m -116.23 119.25 35.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.846 1.258 . . . . 0.0 109.733 177.184 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.29 127.69 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.211 1.004 . . . . 0.0 109.953 175.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -112.99 -154.92 0.55 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.569 1.547 . . . . 0.0 110.622 172.74 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -70.07 124.46 24.13 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.594 -1.316 . . . . 0.0 111.353 172.569 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.85 -148.76 20.5 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.789 1.661 . . . . 0.0 111.772 -170.514 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.18 146.27 18.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.307 1.043 . . . . 0.0 111.68 -175.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.18 135.74 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.97 1.708 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 32.7 p -146.23 177.08 9.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.154 1.781 . . . . 0.0 110.572 -175.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.76 -172.63 29.39 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.21 138.79 19.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.441 1.496 . . . . 0.0 109.762 173.71 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 13.3 t -108.51 132.59 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.14 1.776 . . . . 0.0 108.088 172.768 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -117.77 122.89 44.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.9 1.28 . . . . 0.0 110.124 -177.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.4 mtt -95.92 152.3 38.9 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.66 1.584 . . . . 0.0 111.461 -172.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.83 -20.7 34.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.28 2.654 . . . . 0.0 113.601 -177.259 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 58.4 p -78.44 -4.63 49.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 114.171 174.193 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.32 -3.82 64.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.575 1.56 . . . . 0.0 114.56 -178.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.47 159.54 33.08 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 118.506 1.153 . . . . 0.0 112.199 173.994 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.6 m -136.89 154.71 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.156 1.382 . . . . 0.0 111.519 175.077 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.17 172.63 17.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.234 1.813 . . . . 0.0 111.121 -179.193 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -109.7 139.47 21.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.981 0.913 . . . . 0.0 111.172 178.37 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -82.18 165.6 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.861 3.041 . . . . 0.0 110.82 170.34 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 97.4 m -107.86 123.36 48.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.102 1.361 . . . . 0.0 108.659 172.511 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.85 130.58 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.297 1.039 . . . . 0.0 108.677 175.485 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 97.4 m -128.27 130.53 48.02 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.495 1.518 . . . . 0.0 109.816 -177.901 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -76.16 130.77 38.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.823 1.249 . . . . 0.0 112.05 174.619 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -87.91 -15.74 35.82 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.345 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.4 mttt 70.07 4.19 4.71 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.736 2.414 . . . . 0.0 114.391 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -100.86 12.17 38.12 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.622 1.969 . . . . 0.0 112.849 -179.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.55 16.82 61.32 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.731 1.158 . . . . 0.0 113.38 -171.413 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -136.87 166.47 23.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.851 2.06 . . . . 0.0 110.178 179.993 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.0 m -131.37 164.97 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.222 1.409 . . . . 0.0 110.326 172.031 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.9 t -123.15 148.94 45.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.351 1.06 . . . . 0.0 110.073 166.478 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 32.4 t -123.42 128.51 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.502 1.521 . . . . 0.0 108.737 178.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -129.12 155.41 45.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.747 1.619 . . . . 0.0 111.836 -170.637 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.2 t80 -159.88 135.81 8.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.833 1.253 . . . . 0.0 112.297 -177.606 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.58 117.37 68.56 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.82 1.248 . . . . 0.0 110.694 175.771 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.03 145.76 22.39 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.482 2.788 . . . . 0.0 111.694 -174.87 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.8 p -131.17 -4.83 3.88 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 172.554 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -141.75 153.98 44.95 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.109 1.764 . . . . 0.0 110.316 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.23 173.32 8.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 111.757 166.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 104.6 -171.49 19.32 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.23 1.395 . . . . 0.0 114.002 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.33 124.27 30.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.971 1.308 . . . . 0.0 110.112 -177.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.9 m80 -120.57 163.13 18.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.427 1.891 . . . . 0.0 111.382 -176.051 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.25 155.56 39.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.126 0.971 . . . . 0.0 111.169 173.354 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.8 tmm? -148.85 132.68 17.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.166 0.986 . . . . 0.0 111.547 -160.686 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -111.08 141.96 43.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.738 2.015 . . . . 0.0 111.295 -174.831 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -133.86 134.33 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.858 1.263 . . . . 0.0 111.004 175.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.3 139.0 37.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.498 1.119 . . . . 0.0 113.331 176.629 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -99.7 120.94 40.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.362 1.865 . . . . 0.0 109.527 172.506 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 49.26 39.88 16.83 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.936 1.294 . . . . 0.0 112.853 -176.083 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 7.8 t-20 82.27 -13.65 0.83 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.03 2.932 . . . . 0.0 114.696 179.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.3 tpp -90.98 128.61 36.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.522 1.129 . . . . 0.0 111.561 177.029 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -57.68 136.22 56.82 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.38 -0.825 . . . . 0.0 113.164 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.3 pt -76.82 153.91 83.14 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.594 178.019 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -61.5 124.53 14.84 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.885 1.723 . . . . 0.0 108.617 166.121 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.4 -11.22 47.15 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.572 1.082 . . . . 0.0 114.681 -172.873 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.9 t -85.94 143.79 38.17 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.351 1.575 . . . . 0.0 111.319 169.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -82.85 171.83 51.23 Favored 'Cis proline' 0 C--N 1.352 0.738 0 CA-C-N 120.075 1.062 . . . . 0.0 112.505 -6.32 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.2 mt -113.99 160.82 18.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.459 1.904 . . . . 0.0 111.159 171.346 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -150.4 138.73 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.189 1.396 . . . . 0.0 109.99 -171.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 15.9 p90 -164.46 167.25 19.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.444 1.097 . . . . 0.0 112.398 -165.264 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.5 t80 -122.55 136.09 54.8 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.129 -0.982 . . . . 0.0 112.129 176.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 42.2 t -111.84 142.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.398 1.479 . . . . 0.0 109.675 -178.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 28.5 t0 -151.59 163.01 40.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.898 1.279 . . . . 0.0 111.52 -177.553 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -74.96 125.6 29.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.227 . . . . 0.0 111.152 178.319 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 31.4 m -78.92 -18.55 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -167.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -89.35 -4.63 58.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.792 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.7 m -72.73 150.51 42.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.962 0.905 . . . . 0.0 112.498 176.576 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.73 -14.62 60.96 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.604 1.097 . . . . 0.0 115.118 -174.369 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -66.56 158.14 30.52 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.7 1.25 . . . . 0.0 113.93 179.131 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 141.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.454 1.102 . . . . 0.0 110.888 173.422 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -158.1 152.89 25.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.358 1.463 . . . . 0.0 110.273 178.655 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.81 142.83 51.32 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.999 1.319 . . . . 0.0 111.754 -177.706 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.3 p90 -167.08 160.88 14.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.582 1.553 . . . . 0.0 113.519 -175.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.83 170.27 12.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.408 1.48 . . . . 0.0 112.539 -177.54 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.08 -33.29 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 113.324 -168.651 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.81 -33.78 86.83 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.455 1.025 . . . . 0.0 114.506 -171.567 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 1.5 pp -78.43 -0.61 29.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.832 1.316 . . . . 0.0 113.631 177.45 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.5 m -113.63 -46.09 3.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.698 1.999 . . . . 0.0 111.366 176.696 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1877 ' ' HIS . . . . . 0.496 ' CE1' HH22 ' A' 1951 ' ' ARG . 3.7 t-80 -137.88 122.37 18.42 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.314 1.845 . . . . 0.0 111.426 -174.075 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.5 170.94 16.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.28 1.419 . . . . 0.0 112.786 170.655 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 98.2 t -138.8 137.14 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.899 1.28 . . . . 0.0 108.239 174.203 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.7 m -55.3 136.54 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 61.0 m-80 67.32 0.31 2.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.969 2.108 . . . . 0.0 114.685 177.509 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -104.87 139.91 20.56 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.019 1.328 . . . . 0.0 110.977 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.9 118.66 5.74 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.59 2.193 . . . . 0.0 110.167 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.03 134.8 42.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.29 1.436 . . . . 0.0 110.205 176.544 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -128.31 148.16 50.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -164.729 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.63 -179.85 7.97 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.948 1.699 . . . . 0.0 111.673 176.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 60.2 m -135.03 146.65 49.19 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.228 1.411 . . . . 0.0 110.936 -168.096 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -116.86 129.89 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.687 1.595 . . . . 0.0 108.262 168.456 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.51 126.43 38.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.963 . . . . 0.0 110.325 176.079 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 40.6 p -132.06 4.15 4.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.708 1.603 . . . . 0.0 113.634 -167.147 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 52.2 tttp -55.22 -32.45 62.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.051 1.74 . . . . 0.0 115.61 -164.464 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.33 17.53 6.52 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.603 1.561 . . . . 0.0 112.42 178.407 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.28 58.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -176.557 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 151.44 12.21 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.186 1.374 . . . . 0.0 112.861 -175.643 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -72.94 145.65 46.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.159 0.983 . . . . 0.0 112.307 -177.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.7 -158.66 26.89 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.689 1.614 . . . . 0.0 112.501 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -82.98 98.39 2.04 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 175.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.17 126.55 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.707 1.203 . . . . 0.0 108.853 171.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.4 m -129.68 155.27 46.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.012 1.325 . . . . 0.0 112.133 -177.806 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.0 tp -158.95 132.61 7.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.162 1.785 . . . . 0.0 108.583 -171.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.64 160.41 39.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.853 0.861 . . . . 0.0 112.238 -179.313 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 58.4 mt -135.08 132.34 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.519 1.128 . . . . 0.0 109.645 174.379 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -114.76 105.98 13.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.013 1.325 . . . . 0.0 109.052 172.655 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -116.9 -178.84 17.85 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.024 1.297 . . . . 0.0 113.92 -178.639 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.2 -20.42 37.48 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.909 3.073 . . . . 0.0 111.811 170.744 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.2 t -137.43 157.77 45.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.877 1.671 . . . . 0.0 109.055 161.253 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.59 119.0 13.17 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.993 -1.067 . . . . 0.0 111.773 -176.866 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -80.13 144.33 33.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.166 170.14 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.86 140.92 29.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.479 0.712 . . . . 0.0 109.656 168.363 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.2 mt -132.91 139.24 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.79 1.236 . . . . 0.0 110.467 -167.67 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -130.32 155.96 45.48 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.652 168.544 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -152.65 154.07 34.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.102 0.961 . . . . 0.0 112.373 175.604 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.8 m -142.25 125.57 16.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.599 1.56 . . . . 0.0 109.985 -172.528 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.91 141.35 37.68 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 112.244 172.758 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -117.24 152.0 35.74 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.703 1.601 . . . . 0.0 112.031 -175.803 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -69.43 -18.54 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.926 1.29 . . . . 0.0 112.96 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.68 -13.44 60.62 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.128 1.371 . . . . 0.0 114.083 -179.503 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.74 34.73 4.84 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.786 1.184 . . . . 0.0 113.674 -175.773 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.7 p -138.34 164.3 29.65 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.266 1.426 . . . . 0.0 110.841 177.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 80.6 m -120.09 131.18 54.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.717 1.607 . . . . 0.0 109.033 164.369 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.6 t -90.18 150.15 22.12 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.161 0.984 . . . . 0.0 110.686 171.112 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 93.6 t -129.43 144.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.521 1.928 . . . . 0.0 109.592 -178.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 139.12 35.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.411 1.484 . . . . 0.0 110.707 171.074 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -144.63 153.24 41.55 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.7 mt -115.51 105.79 51.53 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.802 1.641 . . . . 0.0 110.816 179.636 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.0 169.71 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.645 2.897 . . . . 0.0 110.235 165.456 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -136.99 -20.13 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.39 152.06 59.57 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.632 1.173 . . . . 0.0 110.675 174.007 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.18 147.74 38.24 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.893 2.395 . . . . 0.0 111.904 -172.871 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.03 -155.68 26.33 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.675 1.131 . . . . 0.0 113.059 -174.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.26 126.41 53.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.07 1.348 . . . . 0.0 111.149 179.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.8 125.71 53.06 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.311 1.844 . . . . 0.0 109.93 -176.624 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 54.6 m -88.0 122.08 31.18 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.975 -1.078 . . . . 0.0 110.933 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.22 128.23 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.292 1.437 . . . . 0.0 108.626 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -112.23 131.07 55.7 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.367 1.467 . . . . 0.0 109.542 175.965 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.55 130.11 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.304 1.042 . . . . 0.0 109.67 172.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.93 144.02 23.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.061 1.344 . . . . 0.0 111.721 -168.552 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.11 122.64 14.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.697 1.199 . . . . 0.0 110.555 -177.882 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 57.0 44.62 22.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.134 1.374 . . . . 0.0 112.199 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.261 0.6 OUTLIER 77.98 -12.87 1.02 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.177 2.991 . . . . 0.0 114.736 -179.107 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -98.43 125.6 43.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.75 1.22 . . . . 0.0 111.384 -176.814 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -63.07 143.76 57.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.384 -0.823 . . . . 0.0 111.912 171.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.5 m -68.0 152.35 96.49 Favored Pre-proline 0 N--CA 1.48 1.036 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.57 171.417 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 126.96 22.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.781 2.321 . . . . 0.0 110.595 179.387 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.58 -15.01 64.23 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.193 1.378 . . . . 0.0 115.323 -176.118 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.5 t -76.62 140.98 68.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.304 1.552 . . . . 0.0 111.628 176.552 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.53 140.29 65.88 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.418 0.828 . . . . 0.0 112.161 -3.723 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.05 173.23 7.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.615 1.966 . . . . 0.0 110.779 175.51 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -131.02 122.32 26.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.845 0.858 . . . . 0.0 110.933 174.159 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.05 137.99 34.32 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.57 1.548 . . . . 0.0 110.535 169.429 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1951 ' ' ARG . . . . . 0.496 HH22 ' CE1' ' A' 1877 ' ' HIS . 0.0 OUTLIER -93.81 138.5 31.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.596 0.759 . . . . 0.0 109.474 169.756 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 139.59 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.456 1.502 . . . . 0.0 110.861 -178.402 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 1.1 p -124.04 163.2 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.931 1.693 . . . . 0.0 112.433 179.521 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.87 148.55 33.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.107 1.337 . . . . 0.0 112.249 172.269 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 123.949 0.9 . . . . 0.0 112.898 174.323 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -58.72 119.52 37.76 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.233 1.013 . . . . 0.0 111.041 177.671 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.42 159.76 48.48 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.158 2.572 . . . . 0.0 110.431 176.496 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.46 134.26 17.83 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.642 0.734 . . . . 0.0 112.324 -172.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -163.98 145.81 9.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.817 2.047 . . . . 0.0 110.724 178.055 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 161.28 36.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.599 1.959 . . . . 0.0 110.831 -170.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -134.07 139.37 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.184 1.393 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 43.8 mt -136.59 138.2 25.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.314 1.846 . . . . 0.0 108.302 -170.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.11 31.93 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.505 3.47 . . . . 0.0 113.993 -177.052 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 27.6 t80 -79.65 155.03 28.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.47 1.108 . . . . 0.0 111.027 173.113 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.85 126.17 35.52 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.048 1.339 . . . . 0.0 109.534 176.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.5 mt -76.42 126.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.572 0.749 . . . . 0.0 110.49 177.24 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 67.1 mttm -116.48 -139.7 0.37 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.724 1.61 . . . . 0.0 110.516 172.71 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.76 124.44 27.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.657 -1.277 . . . . 0.0 111.188 171.689 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.4 -151.31 19.68 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.862 1.696 . . . . 0.0 111.805 -169.872 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.84 150.48 17.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.913 1.285 . . . . 0.0 111.178 -176.448 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.0 tt -122.51 133.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.353 1.461 . . . . 0.0 111.888 179.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 77.3 p -149.22 -178.05 6.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.082 1.753 . . . . 0.0 110.38 177.704 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.48 -164.4 27.9 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.341 0.897 . . . . 0.0 115.341 -179.323 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -157.47 139.49 14.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.616 1.566 . . . . 0.0 109.954 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 43.7 t -105.87 133.63 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.771 1.628 . . . . 0.0 108.266 171.435 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -121.44 135.46 55.05 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.847 1.659 . . . . 0.0 111.052 -174.677 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.2 mpp? -112.9 157.39 40.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.754 1.622 . . . . 0.0 112.562 -172.412 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -55.0 -37.15 93.9 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.243 3.295 . . . . 0.0 114.538 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.0 m -71.86 -5.22 32.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.14 1.376 . . . . 0.0 114.463 -176.098 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -2.2 84.83 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.343 1.449 . . . . 0.0 113.711 -170.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -64.96 152.38 43.41 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.265 1.426 . . . . 0.0 111.719 172.175 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.7 155.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.24 1.416 . . . . 0.0 111.537 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.47 164.46 37.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.791 1.636 . . . . 0.0 111.336 -179.841 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -102.36 134.2 20.12 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.675 0.79 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.98 161.21 20.91 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.721 2.948 . . . . 0.0 110.88 169.912 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.0 m -108.81 125.75 52.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.071 1.348 . . . . 0.0 108.986 174.13 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.7 137.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.905 1.282 . . . . 0.0 109.679 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 56.5 m -139.3 126.57 21.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.197 1.399 . . . . 0.0 110.049 176.477 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.9 126.83 31.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 172.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.2 -6.37 57.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.527 1.131 . . . . 0.0 114.032 -174.331 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.3 mmtm 77.99 -7.95 1.74 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.917 2.887 . . . . 0.0 113.831 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -92.58 2.53 56.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.406 1.882 . . . . 0.0 113.295 175.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.5 25.79 13.14 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.757 1.17 . . . . 0.0 114.141 -177.921 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 61.8 p -134.16 155.93 49.22 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.17 1.788 . . . . 0.0 109.706 174.179 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -115.17 138.67 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.196 0.998 . . . . 0.0 110.056 167.397 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 40.5 m -98.29 141.83 30.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.008 1.323 . . . . 0.0 108.588 168.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.3 t -125.66 134.41 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.4 1.48 . . . . 0.0 109.462 179.6 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -131.96 153.94 49.81 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 112.289 -174.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.65 134.34 10.9 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.857 1.663 . . . . 0.0 111.674 -177.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.69 123.67 68.87 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.343 1.057 . . . . 0.0 110.442 175.303 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.47 131.4 12.6 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.076 2.517 . . . . 0.0 111.6 -173.534 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -132.03 15.73 4.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.738 1.215 . . . . 0.0 112.406 179.22 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.93 162.26 20.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.569 1.948 . . . . 0.0 109.958 -175.224 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -111.79 170.93 7.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.924 1.29 . . . . 0.0 112.6 174.329 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 93.66 -161.79 25.11 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.182 1.372 . . . . 0.0 113.547 179.281 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.7 tp -81.58 114.93 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.591 1.156 . . . . 0.0 110.759 -177.816 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 6.4 m80 -103.3 168.34 9.23 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.077 1.751 . . . . 0.0 110.903 177.478 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.16 148.97 29.59 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.491 -0.756 . . . . 0.0 112.02 168.033 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 16.3 ttm -120.99 132.82 55.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.034 2.134 . . . . 0.0 110.264 -173.821 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -100.07 137.9 37.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.637 1.575 . . . . 0.0 109.893 166.891 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -133.95 133.95 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.907 1.283 . . . . 0.0 109.733 171.814 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 138.07 31.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.548 1.139 . . . . 0.0 112.681 -174.069 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.9 t80 -107.74 123.8 49.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.305 1.842 . . . . 0.0 110.063 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.19 35.35 16.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.551 1.14 . . . . 0.0 112.531 -176.128 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.8 t30 80.12 -0.68 2.03 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.671 2.788 . . . . 0.0 114.827 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.33 130.69 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.289 1.436 . . . . 0.0 110.907 178.319 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -56.23 135.13 53.52 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.258 -0.901 . . . . 0.0 113.111 -179.5 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.4 pt -71.6 155.2 92.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.254 172.755 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.6 -25.43 79.23 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.304 2.003 . . . . 0.0 113.648 -176.006 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -79.32 -3.66 88.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.17 0.891 . . . . 0.0 114.72 173.731 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 25.6 t -97.39 144.17 27.45 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.467 1.633 . . . . 0.0 111.824 178.773 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.21 161.01 85.33 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.677 0.92 . . . . 0.0 112.198 -4.563 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.33 144.67 37.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 109.85 170.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -126.48 137.2 53.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 109.682 179.152 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.01 146.2 21.52 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.678 0.791 . . . . 0.0 112.438 -169.299 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.1 t80 -99.62 139.43 35.28 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.397 -0.814 . . . . 0.0 112.433 179.694 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 41.1 t -122.83 142.51 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.852 1.661 . . . . 0.0 108.948 179.158 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 9.8 t0 -151.59 173.01 15.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.433 1.093 . . . . 0.0 111.679 -173.52 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -87.44 123.42 32.34 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.918 1.287 . . . . 0.0 111.288 178.2 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 35.4 m -72.09 -21.8 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -170.585 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.0 p30 -90.95 -8.76 48.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.75 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 87.6 m -78.75 -24.35 44.83 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -172.501 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 81.25 -7.29 60.96 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.175 1.369 . . . . 0.0 116.442 168.109 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -67.48 163.75 20.31 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.108 1.454 . . . . 0.0 113.484 176.282 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.4 t -64.88 133.26 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.704 0.801 . . . . 0.0 110.002 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -163.61 154.12 15.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.214 1.406 . . . . 0.0 109.855 -168.241 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.11 145.24 37.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.545 1.138 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.9 p90 -169.64 169.4 8.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.559 1.543 . . . . 0.0 113.092 -173.006 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.75 172.39 13.72 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.6 1.572 . . . . 0.0 112.175 -174.124 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.26 -32.63 12.52 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.774 2.316 . . . . 0.0 113.216 -170.308 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.03 -31.15 74.63 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 119.373 0.988 . . . . 0.0 114.873 -170.601 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.32 -0.37 36.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.925 1.362 . . . . 0.0 113.208 175.36 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 89.7 m -113.52 -48.4 2.94 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.657 1.983 . . . . 0.0 110.82 -178.933 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -137.76 149.07 46.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.089 1.756 . . . . 0.0 112.36 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.38 177.24 23.1 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 124.359 0.98 . . . . 0.0 113.116 170.123 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.6 t -139.1 133.42 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.454 1.102 . . . . 0.0 108.437 176.016 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -56.41 135.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 118.021 0.373 . . . . 0.0 111.986 -178.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.5 m-80 70.26 -8.92 0.8 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.381 2.273 . . . . 0.0 114.859 179.384 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.4 mttm -96.47 141.88 23.74 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.485 1.114 . . . . 0.0 111.078 174.011 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.22 123.64 8.92 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.509 2.14 . . . . 0.0 110.353 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.77 144.6 30.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.443 1.497 . . . . 0.0 110.472 174.525 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.1 p -135.49 145.52 47.21 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -166.364 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.36 178.99 9.68 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.735 1.614 . . . . 0.0 111.306 175.719 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 26.7 m -134.99 144.05 47.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 110.644 -169.658 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.8 t -116.53 131.32 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.571 1.548 . . . . 0.0 108.179 169.726 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.77 131.41 39.16 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.159 0.984 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.8 p -137.79 4.03 2.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.348 1.459 . . . . 0.0 113.765 -166.551 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 84.0 tttt -55.06 -33.66 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.77 1.628 . . . . 0.0 115.04 -168.361 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.87 16.63 9.38 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.741 1.617 . . . . 0.0 112.564 178.972 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.55 -39.57 70.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.368 1.067 . . . . 0.0 113.842 -174.062 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.71 145.22 4.85 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.908 1.242 . . . . 0.0 112.352 -171.084 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.94 148.98 45.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 112.185 -178.019 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 173.93 -27.36 0.08 OUTLIER Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.471 1.034 . . . . 0.0 114.973 176.667 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 142.56 102.05 0.43 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.884 1.707 . . . . 0.0 112.988 172.067 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.44 130.79 35.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.0 109.568 175.071 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.5 m -129.79 160.59 32.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.756 1.622 . . . . 0.0 112.273 -178.129 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.4 tp -160.48 136.68 8.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.762 1.625 . . . . 0.0 109.522 -169.264 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.33 156.9 33.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.392 1.077 . . . . 0.0 112.023 176.251 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 37.2 mt -139.64 134.78 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.96 143.25 51.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.485 1.514 . . . . 0.0 110.223 176.381 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.63 -161.83 20.77 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-O 118.81 -0.994 . . . . 0.0 114.694 -175.561 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -62.26 -26.16 77.19 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.044 3.163 . . . . 0.0 112.646 176.44 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -140.21 153.2 46.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.75 1.22 . . . . 0.0 109.618 161.352 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -71.68 123.37 22.4 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.995 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.7 152.99 37.4 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.313 1.045 . . . . 0.0 112.905 -178.054 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.16 134.1 33.56 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 163.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.9 mt -134.39 138.92 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.577 1.151 . . . . 0.0 110.231 -166.466 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 64.7 m -139.0 162.01 35.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.584 1.553 . . . . 0.0 111.247 172.592 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -155.27 156.47 35.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.378 1.071 . . . . 0.0 112.71 178.502 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.5 m -139.45 129.83 25.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.907 1.683 . . . . 0.0 110.248 -172.282 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -80.73 132.42 35.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.356 1.062 . . . . 0.0 111.264 174.141 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -110.13 148.62 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.077 1.351 . . . . 0.0 112.08 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -68.32 -21.3 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.507 1.123 . . . . 0.0 112.735 178.103 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.14 -6.83 48.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.556 1.543 . . . . 0.0 114.342 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.6 39.87 4.87 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.538 1.065 . . . . 0.0 113.266 -179.255 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.0 p -141.13 158.68 43.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.011 1.324 . . . . 0.0 111.304 177.23 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 63.9 m -107.22 125.19 50.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.391 1.476 . . . . 0.0 108.434 161.455 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.8 t -86.52 149.03 25.25 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.484 0.714 . . . . 0.0 110.393 167.704 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.4 t -130.31 142.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.842 1.657 . . . . 0.0 109.736 -177.54 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 84.1 p -136.12 147.22 47.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.849 1.26 . . . . 0.0 111.802 168.192 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.86 153.89 35.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.495 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.78 105.87 50.89 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.084 1.754 . . . . 0.0 110.282 179.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.83 173.79 11.7 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.618 2.879 . . . . 0.0 110.131 165.003 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.8 p -149.69 -29.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -172.814 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.54 144.83 30.32 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.402 1.001 . . . . 0.0 110.213 166.806 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.63 157.64 44.15 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.92 2.413 . . . . 0.0 111.013 177.303 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.32 -162.9 23.68 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.987 1.28 . . . . 0.0 113.204 -176.283 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.79 139.97 30.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.728 1.211 . . . . 0.0 112.844 179.739 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.49 131.67 50.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.757 1.623 . . . . 0.0 110.322 178.008 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.7 m -90.47 125.76 35.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.209 1.004 . . . . 0.0 110.684 174.757 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.99 120.91 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.735 1.614 . . . . 0.0 108.482 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -104.93 128.85 53.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.535 1.534 . . . . 0.0 109.808 178.709 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 58.2 t -130.92 128.52 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.574 1.15 . . . . 0.0 109.848 173.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.1 142.3 24.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.109 1.364 . . . . 0.0 111.666 -168.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.12 120.21 14.6 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.8 1.24 . . . . 0.0 109.679 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.1 t-20 54.93 58.98 4.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.602 1.561 . . . . 0.0 111.979 179.174 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 9.0 pt-20 57.11 13.56 1.65 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.418 2.687 . . . . 0.0 116.422 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -119.59 122.41 41.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.896 1.279 . . . . 0.0 110.671 177.655 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -63.94 142.69 58.31 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.618 0.767 . . . . 0.0 111.488 170.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.0 m -72.62 156.85 89.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.764 175.025 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.81 129.6 35.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.301 2.667 . . . . 0.0 111.963 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 86.27 -13.02 58.96 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.697 1.141 . . . . 0.0 115.142 -177.397 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.7 t -76.0 140.27 70.06 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.527 1.663 . . . . 0.0 111.491 176.121 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.48 136.02 43.04 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 -3.568 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -83.92 169.98 14.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.778 1.631 . . . . 0.0 110.532 173.889 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 28.4 m -131.12 116.73 18.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.552 0.741 . . . . 0.0 110.694 177.264 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.02 155.02 18.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.736 1.214 . . . . 0.0 111.082 169.279 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -116.48 125.64 52.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.291 1.037 . . . . 0.0 110.062 170.297 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 92.2 t -107.65 130.99 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.41 . . . . 0.0 110.526 -174.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.1 p -108.06 171.24 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.288 1.435 . . . . 0.0 112.739 178.921 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.59 154.62 44.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.372 1.463 . . . . 0.0 113.67 -178.576 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 125.02 1.328 . . . . 0.0 113.241 179.035 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.02 -22.94 59.38 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -166.03 169.95 14.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.43 1.892 . . . . 0.0 112.011 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -64.88 153.08 89.24 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.435 1.094 . . . . 0.0 112.295 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.5 171.59 16.8 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.538 2.826 . . . . 0.0 111.741 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.6 37.3 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.686 1.594 . . . . 0.0 113.102 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -149.24 48.63 0.6 Allowed Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 126.741 2.016 . . . . 0.0 113.313 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.55 158.71 55.12 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.269 2.646 . . . . 0.0 111.915 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 57.1 tp -159.17 141.36 13.73 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.352 1.461 . . . . 0.0 110.33 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 82.1 t -110.9 135.3 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.504 1.522 . . . . 0.0 109.262 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -148.49 157.55 27.34 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.153 1.358 . . . . 0.0 112.971 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 96.9 t -98.44 124.37 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.001 1.32 . . . . 0.0 109.592 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -95.49 -15.61 22.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.442 1.097 . . . . 0.0 113.699 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -81.85 160.55 41.15 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.011 1.291 . . . . 0.0 113.185 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.0 163.46 13.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.747 1.219 . . . . 0.0 111.623 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 2.2 t0 -155.17 -176.05 5.74 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.071 1.348 . . . . 0.0 111.072 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 7.3 p -58.13 -20.35 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.576 1.55 . . . . 0.0 114.061 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.9 t -76.58 -27.51 55.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.134 1.373 . . . . 0.0 113.03 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 21.7 p -118.82 -14.8 9.46 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 6.1 mt -118.53 151.9 36.99 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.691 1.596 . . . . 0.0 111.948 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -67.85 128.69 93.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.055 0.942 . . . . 0.0 110.578 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.0 167.69 25.6 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.522 2.815 . . . . 0.0 112.822 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -104.88 121.39 43.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 108.621 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -146.73 126.01 13.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.676 1.19 . . . . 0.0 110.299 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.26 159.63 41.84 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.433 1.893 . . . . 0.0 110.09 -170.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -133.11 139.49 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.116 1.366 . . . . 0.0 110.315 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.6 mt -133.48 135.2 24.77 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 109.118 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.96 109.67 2.74 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.364 2.709 . . . . 0.0 109.765 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 47.1 t80 -175.7 151.93 1.22 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.344 2.258 . . . . 0.0 108.956 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 41.5 m -134.67 125.89 28.0 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 110.576 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 37.5 mt -82.97 134.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.862 1.265 . . . . 0.0 109.389 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -131.77 -60.22 0.93 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 0.0 111.564 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.4 tptt -152.27 127.5 9.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.552 1.541 . . . . 0.0 110.388 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.95 -149.95 17.82 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.288 1.423 . . . . 0.0 111.648 -167.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.09 146.14 18.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.565 1.146 . . . . 0.0 111.089 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.5 tt -126.89 136.04 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.776 1.631 . . . . 0.0 111.043 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.9 p -148.58 173.16 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.398 1.879 . . . . 0.0 110.252 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.82 -170.69 24.71 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.65 137.96 15.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.593 1.557 . . . . 0.0 109.716 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 20.9 t -113.6 135.01 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 108.195 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -119.41 132.42 55.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.632 1.173 . . . . 0.0 111.457 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.08 142.52 25.21 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.842 1.657 . . . . 0.0 111.694 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.23 -32.96 82.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.149 3.232 . . . . 0.0 114.407 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -72.32 2.83 5.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.908 1.283 . . . . 0.0 114.34 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.35 4.75 65.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.634 1.588 . . . . 0.0 114.599 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.7 164.29 16.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.225 1.41 . . . . 0.0 111.91 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.4 m -137.91 152.83 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.603 1.561 . . . . 0.0 110.889 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.01 163.21 36.6 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.319 1.448 . . . . 0.0 111.624 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -105.97 139.17 19.98 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.169 0.988 . . . . 0.0 111.128 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.63 170.1 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.227 3.284 . . . . 0.0 111.771 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.7 m -109.5 135.71 50.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.41 1.484 . . . . 0.0 108.964 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.62 135.66 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.975 1.31 . . . . 0.0 109.252 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 53.0 m -137.98 127.3 24.63 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.323 1.449 . . . . 0.0 109.971 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -80.27 129.98 34.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.001 0.92 . . . . 0.0 111.154 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.7 -8.77 58.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 37.3 mtmm 63.97 14.3 8.33 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.532 2.333 . . . . 0.0 113.805 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.46 8.38 21.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.221 2.209 . . . . 0.0 112.503 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 12.52 57.07 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.22 1.39 . . . . 0.0 114.4 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.0 p -131.32 155.42 47.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.035 1.734 . . . . 0.0 111.202 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.3 m -112.99 139.47 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.058 0.943 . . . . 0.0 109.869 163.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 49.5 m -96.62 139.5 32.61 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.002 1.321 . . . . 0.0 108.523 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.6 t -124.92 134.82 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.475 1.51 . . . . 0.0 109.241 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -136.17 153.58 51.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 112.504 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.92 136.56 16.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.787 1.635 . . . . 0.0 111.576 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.63 123.46 70.86 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.643 1.177 . . . . 0.0 110.724 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.81 160.2 18.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.942 3.095 . . . . 0.0 112.574 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.9 p -152.34 -9.56 0.19 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.73 149.47 45.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.852 1.661 . . . . 0.0 110.075 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -91.6 166.25 12.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.176 0.991 . . . . 0.0 111.969 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.76 -171.06 13.8 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.148 1.356 . . . . 0.0 113.795 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.54 121.41 30.89 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.723 1.209 . . . . 0.0 109.825 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 70.2 m80 -119.85 165.32 14.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.134 1.774 . . . . 0.0 111.833 -172.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.78 154.11 37.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.965 0.906 . . . . 0.0 111.975 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.3 ttm -134.94 127.4 30.52 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.904 2.082 . . . . 0.0 109.986 -168.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -97.4 135.6 39.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.617 1.567 . . . . 0.0 109.975 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.5 mm -132.95 130.55 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.932 1.293 . . . . 0.0 109.769 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.04 138.72 32.0 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.2 t80 -101.85 119.36 38.66 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 109.323 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.17 32.75 11.1 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.916 1.286 . . . . 0.0 112.903 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.5 m-80 74.95 7.22 4.28 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.957 2.503 . . . . 0.0 115.266 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.1 tpp -100.01 129.48 46.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.585 1.154 . . . . 0.0 110.573 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.79 136.7 56.97 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.373 -0.829 . . . . 0.0 113.067 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.7 pt -75.63 155.65 85.24 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.555 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -58.97 129.48 32.14 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.059 1.839 . . . . 0.0 109.485 169.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.06 62.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.499 1.047 . . . . 0.0 114.124 -174.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -82.27 143.81 49.2 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.722 1.761 . . . . 0.0 111.209 171.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.0 155.68 91.58 Favored 'Cis proline' 0 C--N 1.351 0.684 0 CA-C-N 119.944 1.016 . . . . 0.0 112.117 -5.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.91 153.43 18.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.553 1.141 . . . . 0.0 110.548 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -150.0 135.07 17.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.693 1.197 . . . . 0.0 109.789 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.17 169.92 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.735 1.214 . . . . 0.0 112.324 -170.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 29.6 t80 -104.19 147.61 27.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.272 -0.892 . . . . 0.0 112.309 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 85.3 t -117.69 133.58 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.295 1.838 . . . . 0.0 108.893 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -151.1 163.04 39.71 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -169.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -80.0 87.63 5.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.226 1.411 . . . . 0.0 111.105 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 10.7 p -54.53 -27.59 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.242 1.417 . . . . 0.0 114.506 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -77.82 -16.99 57.91 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -75.9 161.97 28.52 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.749 1.219 . . . . 0.0 112.438 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.44 -9.82 78.39 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.9 1.238 . . . . 0.0 115.778 -169.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -66.63 147.72 52.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.169 1.485 . . . . 0.0 113.165 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 p -64.47 134.58 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.774 -0.579 . . . . 0.0 109.709 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.1 t -156.2 160.9 40.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.508 1.123 . . . . 0.0 111.057 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.93 142.92 33.04 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.06 161.05 19.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.526 1.531 . . . . 0.0 112.922 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 136.87 175.03 13.57 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.392 1.472 . . . . 0.0 113.046 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.31 -36.95 8.49 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.723 2.282 . . . . 0.0 112.944 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.18 -34.64 90.17 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.439 1.018 . . . . 0.0 114.608 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.59 -6.18 54.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.653 1.227 . . . . 0.0 113.561 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.0 m -104.7 -43.78 5.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.403 1.881 . . . . 0.0 111.166 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -147.31 142.76 27.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.582 1.953 . . . . 0.0 111.916 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -134.21 173.66 21.26 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.349 0.976 . . . . 0.0 113.052 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 28.0 t -138.69 133.3 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.348 1.059 . . . . 0.0 108.575 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.5 m -57.15 133.77 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.165 0.586 . . . . 0.0 112.442 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 23.1 m120 69.61 0.16 2.86 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.872 2.069 . . . . 0.0 114.192 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -103.14 138.66 19.61 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.212 1.405 . . . . 0.0 110.541 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.24 112.64 3.48 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.604 2.203 . . . . 0.0 109.866 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -96.39 133.1 41.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.132 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.7 p -127.04 153.63 45.7 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.4 p90 -162.83 176.23 10.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.989 1.716 . . . . 0.0 111.415 176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.7 m -126.82 142.63 51.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.24 1.416 . . . . 0.0 110.493 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.8 t -114.31 126.58 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 107.801 167.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -93.55 120.18 33.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.923 0.889 . . . . 0.0 110.378 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 20.2 p -119.76 15.45 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.97 2.108 . . . . 0.0 112.096 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -58.45 -30.97 67.36 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.029 1.732 . . . . 0.0 114.726 -164.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -131.69 20.28 4.66 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.993 1.717 . . . . 0.0 112.101 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -81.06 -9.5 59.82 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 90.98 -125.56 8.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.39 0.995 . . . . 0.0 112.623 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -154.03 151.5 29.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.335 1.454 . . . . 0.0 111.26 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 154.55 -156.21 26.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.821 1.677 . . . . 0.0 112.521 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.2 107.81 3.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.091 0.853 . . . . 0.0 111.218 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.54 126.53 32.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.884 1.274 . . . . 0.0 108.502 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -130.66 158.1 40.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.905 1.282 . . . . 0.0 112.607 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.6 tp -157.49 135.43 10.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.407 1.883 . . . . 0.0 108.728 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.63 161.39 39.9 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.949 0.9 . . . . 0.0 112.203 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.3 mt -134.87 135.65 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.589 1.156 . . . . 0.0 109.563 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.83 113.51 20.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.037 1.335 . . . . 0.0 109.316 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -129.44 -173.91 13.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.99 1.281 . . . . 0.0 113.912 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.97 -18.57 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.003 3.135 . . . . 0.0 112.32 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -142.57 157.32 44.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.772 1.629 . . . . 0.0 109.339 165.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1907 ' ' LYS . . . . . 0.4 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 1.0 OUTLIER -73.3 107.84 5.84 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.111 -0.993 . . . . 0.0 111.729 -175.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.49 145.81 48.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.867 0.867 . . . . 0.0 111.165 167.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.48 145.8 24.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.484 0.713 . . . . 0.0 110.457 168.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.0 mt -134.9 140.8 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.934 1.293 . . . . 0.0 110.316 -165.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 59.6 m -133.42 155.93 48.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.818 1.647 . . . . 0.0 110.713 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.4 p -153.23 153.97 33.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.482 1.113 . . . . 0.0 112.125 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.4 m -143.76 126.32 15.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.831 1.252 . . . . 0.0 110.748 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.66 131.17 39.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.968 1.307 . . . . 0.0 111.396 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -103.97 151.8 22.76 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.668 1.587 . . . . 0.0 111.852 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -68.18 -16.21 63.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.887 0.875 . . . . 0.0 113.184 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.22 -12.45 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 113.518 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.72 19.2 35.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.676 1.132 . . . . 0.0 114.139 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 80.4 p -114.2 165.36 12.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.958 1.703 . . . . 0.0 110.749 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.8 m -115.26 129.0 56.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.169 1.387 . . . . 0.0 109.916 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.1 t -87.0 151.7 23.04 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.842 0.857 . . . . 0.0 110.65 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.6 t -132.21 144.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.136 1.774 . . . . 0.0 110.026 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.6 t -141.81 141.69 33.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.641 1.577 . . . . 0.0 110.924 171.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.2 p90 -147.19 155.0 41.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.1 mt -119.72 104.31 44.9 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.569 1.547 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.01 167.46 18.08 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.632 2.888 . . . . 0.0 110.36 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.4 p -132.29 -18.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -170.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.51 150.18 50.14 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.61 1.164 . . . . 0.0 110.404 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.29 142.57 27.17 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 111.552 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 158.61 -167.55 34.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.66 1.124 . . . . 0.0 113.331 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.33 126.8 40.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.215 1.406 . . . . 0.0 112.111 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -120.62 124.28 44.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.801 1.64 . . . . 0.0 109.922 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.9 m -87.64 121.08 29.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.116 -0.99 . . . . 0.0 110.851 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.51 127.88 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 108.522 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.46 130.54 55.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 38.2 t -133.22 130.56 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.289 1.036 . . . . 0.0 109.804 172.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.83 144.45 24.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 -167.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.08 124.76 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.892 1.277 . . . . 0.0 110.165 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 56.02 53.49 9.08 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.867 1.267 . . . . 0.0 111.676 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.94 3.42 0.32 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.988 2.915 . . . . 0.0 116.75 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -107.49 126.55 52.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.758 1.223 . . . . 0.0 110.718 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -63.89 147.29 52.28 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.238 -0.914 . . . . 0.0 111.949 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 9.9 m -68.85 152.84 96.57 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.672 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.99 130.29 30.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.165 1.91 . . . . 0.0 110.527 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.94 -15.93 61.63 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.005 1.288 . . . . 0.0 114.919 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.8 t -77.67 140.85 63.97 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 119.282 1.541 . . . . 0.0 111.465 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.72 137.87 52.75 Favored 'Cis proline' 0 C--N 1.352 0.727 0 CA-C-N 119.337 0.799 . . . . 0.0 112.077 -3.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -89.63 169.86 10.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.203 1.801 . . . . 0.0 110.555 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.6 m -129.12 115.95 18.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.698 0.799 . . . . 0.0 110.781 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.27 144.93 25.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.872 1.269 . . . . 0.0 110.656 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 17.8 ttt85 -108.82 121.52 45.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.832 0.853 . . . . 0.0 110.035 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.1 t -102.44 134.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.179 1.392 . . . . 0.0 110.648 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 48.4 p -114.88 169.64 8.93 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.252 1.421 . . . . 0.0 112.939 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.3 140.16 22.58 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.027 1.298 . . . . 0.0 112.612 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.76 -23.81 41.98 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.38 1.072 . . . . 0.0 112.855 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.801 2.04 . . . . 0.0 112.54 -175.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.35 -22.66 61.87 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -142.19 9.9 1.9 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.928 1.291 . . . . 0.0 114.483 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -158.06 149.18 16.47 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.287 1.435 . . . . 0.0 112.038 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.63 171.58 16.5 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.137 3.224 . . . . 0.0 112.18 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -163.1 164.17 25.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.239 1.816 . . . . 0.0 110.86 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -64.33 140.09 97.87 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.747 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.99 174.99 11.83 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.738 2.959 . . . . 0.0 111.785 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 87.5 mt -76.84 67.66 2.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.176 1.391 . . . . 0.0 111.762 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 35.2 m -69.37 -10.68 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.681 1.592 . . . . 0.0 114.255 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 91.24 -145.43 17.77 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.866 1.222 . . . . 0.0 112.432 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 90.2 t -128.57 138.87 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.635 1.574 . . . . 0.0 109.578 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 53.6 t30 -139.38 38.42 2.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.611 1.564 . . . . 0.0 111.285 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 85.6 -149.2 23.32 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.996 1.284 . . . . 0.0 111.077 -166.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.83 144.97 52.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.511 0.724 . . . . 0.0 111.076 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -72.51 -19.66 61.49 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.158 0.983 . . . . 0.0 113.196 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 18.1 m -142.61 153.45 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.178 2.191 . . . . 0.0 109.848 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 13.0 t -164.15 -45.01 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.913 1.285 . . . . 0.0 111.827 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 90.8 p -165.0 150.57 9.71 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.46 158.95 16.8 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.072 1.749 . . . . 0.0 110.004 161.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -58.39 118.1 25.27 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.97 1.308 . . . . 0.0 110.991 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.08 152.68 45.99 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.024 2.483 . . . . 0.0 111.037 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.26 113.94 27.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.804 0.842 . . . . 0.0 109.71 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -146.81 125.23 12.34 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 109.99 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.16 153.48 50.45 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.482 1.913 . . . . 0.0 109.891 -173.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.8 p -129.2 136.77 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.029 1.332 . . . . 0.0 110.351 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.01 138.72 33.03 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.001 1.72 . . . . 0.0 109.074 -175.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.87 67.7 7.93 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 124.353 3.369 . . . . 0.0 111.698 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -113.82 150.73 33.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.146 1.778 . . . . 0.0 110.231 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 77.7 m -119.08 125.41 49.24 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.596 1.158 . . . . 0.0 109.751 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 81.1 mt -91.46 132.08 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.755 1.222 . . . . 0.0 109.876 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -114.35 -100.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.18 1.392 . . . . 0.0 110.746 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.4 mttp -133.69 139.35 46.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 111.089 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.4 -139.81 11.2 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.719 1.628 . . . . 0.0 110.801 -165.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.53 141.61 16.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.118 0.967 . . . . 0.0 111.36 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.68 135.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 0.0 110.711 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.3 p -145.77 174.58 11.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.112 1.765 . . . . 0.0 110.206 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.44 -170.96 24.64 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.3 140.14 16.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.843 1.657 . . . . 0.0 109.305 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.1 t -117.72 130.74 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.546 1.539 . . . . 0.0 108.343 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -117.99 128.36 54.71 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.001 1.32 . . . . 0.0 110.389 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 32.4 mtt -99.76 153.32 37.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.198 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -17.87 31.83 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.431 2.754 . . . . 0.0 112.831 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 35.3 p -72.76 -8.06 53.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.0 113.973 170.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.51 83.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.721 1.629 . . . . 0.0 113.777 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -72.52 159.54 33.76 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.599 1.16 . . . . 0.0 112.536 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 46.9 t -139.34 142.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.517 1.527 . . . . 0.0 110.169 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.88 171.15 16.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.885 1.674 . . . . 0.0 111.772 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -106.61 140.39 21.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.34 1.056 . . . . 0.0 111.264 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -86.65 174.0 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.549 3.499 . . . . 0.0 111.94 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 60.3 m -113.46 131.76 55.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.394 1.478 . . . . 0.0 108.982 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.01 133.31 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.839 1.256 . . . . 0.0 109.154 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 92.9 m -123.51 129.04 50.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.152 1.781 . . . . 0.0 109.789 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 59.5 t0 -81.78 118.61 23.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.309 1.044 . . . . 0.0 110.127 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -83.01 -10.54 58.71 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.8 mmmt 73.5 -10.44 1.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.269 2.628 . . . . 0.0 114.331 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -92.75 5.61 50.52 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.495 1.918 . . . . 0.0 113.691 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.89 15.82 53.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.802 1.191 . . . . 0.0 113.716 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 67.3 p -128.26 159.29 35.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.364 1.866 . . . . 0.0 110.286 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -121.79 143.01 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.494 1.118 . . . . 0.0 109.875 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 31.8 m -104.09 137.23 42.34 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.396 1.078 . . . . 0.0 108.618 170.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.3 t -124.92 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.184 1.394 . . . . 0.0 109.042 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -133.76 156.45 47.97 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.138 1.375 . . . . 0.0 112.826 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 22.9 t80 -155.61 135.76 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.828 1.651 . . . . 0.0 111.427 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.37 120.05 71.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.411 1.084 . . . . 0.0 110.776 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.33 139.99 21.49 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.349 2.699 . . . . 0.0 112.01 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.2 m -132.92 0.3 3.48 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -161.4 150.46 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.296 1.838 . . . . 0.0 109.686 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -86.09 173.06 10.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.857 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.09 -172.68 21.73 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.262 1.41 . . . . 0.0 114.098 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -78.0 125.84 29.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.618 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 51.2 m80 -123.09 163.05 21.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.075 1.75 . . . . 0.0 111.372 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.22 153.1 34.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.157 0.983 . . . . 0.0 111.862 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 28.0 ttm -137.36 135.25 36.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.956 1.702 . . . . 0.0 110.771 -167.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.11 134.3 51.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.443 1.897 . . . . 0.0 109.848 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.6 mm -133.97 130.59 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.171 1.388 . . . . 0.0 109.53 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 136.5 23.4 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -173.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.67 122.68 43.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.641 1.976 . . . . 0.0 109.784 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 51.82 31.28 8.03 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.876 1.27 . . . . 0.0 112.881 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 18.1 t30 77.62 5.09 3.01 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.279 2.631 . . . . 0.0 115.108 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 95.9 mtp -100.07 129.36 46.11 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.31 1.444 . . . . 0.0 110.772 170.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -56.77 137.15 55.05 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.6 pt -74.55 151.14 87.18 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.861 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.04 132.34 44.11 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.672 2.248 . . . . 0.0 110.243 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.91 -17.15 59.83 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.733 1.159 . . . . 0.0 113.905 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.9 t -85.53 147.77 47.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 119.164 1.482 . . . . 0.0 110.905 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.44 157.43 99.47 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.666 1.274 . . . . 0.0 113.251 -0.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 80.1 mt -101.38 157.87 16.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.67 1.588 . . . . 0.0 110.884 173.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -151.93 135.26 15.96 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.839 1.256 . . . . 0.0 110.154 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.2 p90 -165.51 167.2 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 111.98 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -108.52 141.09 40.93 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.126 -0.984 . . . . 0.0 112.928 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.9 t -111.56 139.93 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.815 1.646 . . . . 0.0 109.679 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -161.42 151.77 17.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.9 1.28 . . . . 0.0 112.22 -170.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -67.53 134.15 50.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.932 1.293 . . . . 0.0 112.152 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -68.41 -27.37 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.113 -0.992 . . . . 0.0 113.289 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.89 -21.33 44.11 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -170.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.6 t -67.22 147.03 53.57 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.484 -0.76 . . . . 0.0 112.964 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.9 -6.77 82.0 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.145 1.355 . . . . 0.0 115.103 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.29 166.85 11.36 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.09 1.445 . . . . 0.0 114.0 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.8 t -73.19 144.73 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.978 0.911 . . . . 0.0 108.832 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.0 t -159.74 148.25 17.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.03 1.332 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.61 144.83 50.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.62 1.168 . . . . 0.0 111.658 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.7 p90 -166.73 161.65 15.73 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.615 1.566 . . . . 0.0 112.745 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.02 175.36 13.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.324 1.44 . . . . 0.0 112.897 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 -36.48 9.66 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.721 2.28 . . . . 0.0 112.832 -171.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.96 90.75 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.378 0.99 . . . . 0.0 114.406 -171.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -78.77 -5.64 53.84 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.829 1.314 . . . . 0.0 113.615 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 32.3 m -104.89 -42.1 5.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.409 1.884 . . . . 0.0 111.25 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -151.14 143.39 24.11 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.772 2.029 . . . . 0.0 112.054 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -136.09 177.56 19.45 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.822 1.201 . . . . 0.0 113.212 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 25.5 t -142.96 135.19 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.905 1.282 . . . . 0.0 108.378 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.94 135.33 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 66.34 2.81 2.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.604 1.962 . . . . 0.0 114.382 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -100.01 142.3 24.36 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.907 1.283 . . . . 0.0 110.807 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.37 109.13 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.777 2.318 . . . . 0.0 109.853 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -93.6 133.0 37.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.003 1.321 . . . . 0.0 110.134 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.8 p -127.35 149.01 50.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -159.51 174.79 14.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.754 1.621 . . . . 0.0 111.664 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.8 m -126.51 145.14 50.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.347 1.459 . . . . 0.0 110.721 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 29.9 t -114.76 130.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.476 1.511 . . . . 0.0 108.128 167.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.02 132.77 36.29 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.226 1.011 . . . . 0.0 111.051 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.5 p -131.91 13.67 4.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.787 2.035 . . . . 0.0 112.449 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -50.61 -36.2 33.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.258 2.223 . . . . 0.0 115.268 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.27 24.83 3.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.647 1.579 . . . . 0.0 111.858 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.05 69.03 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.461 1.105 . . . . 0.0 113.619 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.66 150.74 5.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.827 1.203 . . . . 0.0 112.337 -169.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -73.82 149.27 41.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.744 0.783 . . . . 0.0 112.024 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.74 14.42 0.02 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.881 1.705 . . . . 0.0 114.905 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 92.85 100.63 1.46 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.535 1.541 . . . . 0.0 112.806 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.49 130.7 35.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.366 1.466 . . . . 0.0 109.415 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.3 m -126.96 158.4 36.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.64 1.576 . . . . 0.0 112.123 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.7 tp -160.72 135.45 7.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.788 1.635 . . . . 0.0 109.23 -169.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 161.57 38.1 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.043 0.937 . . . . 0.0 112.321 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -135.53 134.58 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.762 1.225 . . . . 0.0 109.547 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -116.73 115.7 26.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.001 1.32 . . . . 0.0 109.326 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -128.37 -177.64 14.97 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.978 1.275 . . . . 0.0 113.873 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.54 -22.65 44.32 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.001 3.134 . . . . 0.0 112.128 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -140.28 158.06 44.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.57 . . . . 0.0 109.069 161.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 118.51 11.98 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.093 -1.005 . . . . 0.0 111.915 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.09 142.63 33.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.207 1.003 . . . . 0.0 110.824 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.05 142.0 28.24 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.322 0.649 . . . . 0.0 110.082 171.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.8 mt -132.06 139.21 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.822 1.249 . . . . 0.0 110.471 -167.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.8 m -128.38 155.56 44.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.861 1.664 . . . . 0.0 110.393 167.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -151.46 156.23 40.19 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.156 0.982 . . . . 0.0 112.237 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.7 m -140.49 118.62 11.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.341 1.456 . . . . 0.0 109.697 -171.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.31 123.71 25.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.169 0.988 . . . . 0.0 110.779 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.55 -17.91 26.18 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 15.0 mm100 71.27 -10.34 0.8 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.344 2.658 . . . . 0.0 114.495 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.69 -14.04 61.48 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.313 1.445 . . . . 0.0 113.104 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 116.81 22.03 4.43 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.509 1.528 . . . . 0.0 114.17 -170.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.0 p -142.38 158.5 43.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.676 1.59 . . . . 0.0 111.111 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -126.23 135.45 51.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.632 1.973 . . . . 0.0 109.068 166.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 16.4 t -94.83 153.29 17.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.459 1.104 . . . . 0.0 111.343 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -132.11 145.03 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.316 1.846 . . . . 0.0 110.0 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.2 t -140.63 138.85 34.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.694 1.598 . . . . 0.0 110.752 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.99 154.5 42.62 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 26.4 mt -118.07 102.62 50.75 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.097 1.759 . . . . 0.0 110.415 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.68 160.67 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.546 2.83 . . . . 0.0 110.139 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.9 m -127.15 -7.77 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.72 151.18 22.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.176 1.39 . . . . 0.0 110.402 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.07 140.77 25.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.796 2.331 . . . . 0.0 111.691 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 157.8 -169.86 34.66 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.86 1.219 . . . . 0.0 113.087 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.82 135.3 35.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.889 1.276 . . . . 0.0 112.135 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.56 128.69 46.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.288 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.0 m -90.51 122.58 33.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.18 -0.95 . . . . 0.0 110.963 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.53 125.69 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.356 1.462 . . . . 0.0 108.621 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.09 130.42 55.48 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.424 1.49 . . . . 0.0 109.71 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 39.2 t -133.25 129.96 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.349 1.06 . . . . 0.0 109.753 172.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.48 142.26 22.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.145 1.378 . . . . 0.0 111.511 -168.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.5 122.17 19.75 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.817 1.247 . . . . 0.0 109.523 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.5 57.89 5.71 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.038 1.335 . . . . 0.0 112.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 8.2 pt-20 59.7 2.42 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.965 2.906 . . . . 0.0 116.819 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -107.5 123.54 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.567 1.147 . . . . 0.0 110.998 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.88 145.41 55.87 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.306 -0.871 . . . . 0.0 111.984 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.4 m -73.39 157.37 88.08 Favored Pre-proline 0 N--CA 1.48 1.065 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.64 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.04 125.82 20.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.63 2.887 . . . . 0.0 111.785 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.24 -11.36 67.84 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.705 1.145 . . . . 0.0 115.469 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.3 t -76.44 139.73 67.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.356 1.578 . . . . 0.0 111.579 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.07 136.84 47.06 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 CA-C-N 119.382 0.815 . . . . 0.0 111.969 -3.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -87.07 170.25 11.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.134 1.774 . . . . 0.0 110.662 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.1 m -128.92 117.76 21.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.748 0.819 . . . . 0.0 110.771 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.1 160.31 15.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.455 1.502 . . . . 0.0 110.954 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -127.62 126.22 41.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.553 1.141 . . . . 0.0 110.207 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.5 t -107.23 134.44 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 0.0 110.866 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 41.8 p -107.2 157.61 17.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.075 1.35 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -94.27 116.76 5.35 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.104 1.335 . . . . 0.0 112.349 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 -94.96 -30.05 14.33 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.73 1.212 . . . . 0.0 112.935 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 125.526 1.531 . . . . 0.0 113.305 179.661 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.96 -28.01 0.18 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 128.588 2.755 . . . . 0.0 115.248 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.19 176.72 12.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.375 2.27 . . . . 0.0 111.007 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -132.26 148.57 70.26 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.988 1.315 . . . . 0.0 111.706 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.0 -178.31 4.52 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.16 3.24 . . . . 0.0 111.79 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -145.89 164.56 31.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.389 1.475 . . . . 0.0 111.475 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -58.59 123.69 68.49 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.557 1.143 . . . . 0.0 111.586 -175.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.32 174.85 12.15 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.681 2.921 . . . . 0.0 111.741 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.93 8.39 0.54 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -173.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 34.5 m -58.82 -11.12 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.131 1.772 . . . . 0.0 114.761 -174.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -74.87 -7.72 81.35 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.979 1.276 . . . . 0.0 114.97 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 28.4 m -62.56 153.67 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 119.732 1.766 . . . . 0.0 112.249 172.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -63.51 144.76 56.73 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.347 1.059 . . . . 0.0 112.959 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 131.74 -179.61 16.98 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.831 1.681 . . . . 0.0 113.159 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.7 142.3 46.37 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.223 1.009 . . . . 0.0 111.868 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.13 -171.87 3.97 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.969 1.708 . . . . 0.0 110.376 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 34.2 m -62.12 -24.95 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 120.643 -1.285 . . . . 0.0 113.446 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.5 t -73.26 -22.46 60.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.993 1.317 . . . . 0.0 112.82 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 3.7 m -83.4 -6.28 59.41 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.1 1.36 . . . . 0.0 113.425 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 86.7 mt -84.53 149.81 25.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.284 1.033 . . . . 0.0 111.903 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -55.17 114.0 6.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.046 1.739 . . . . 0.0 111.302 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.3 142.54 50.26 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.566 2.177 . . . . 0.0 109.71 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 39.6 t80 -120.14 123.36 43.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.531 0.732 . . . . 0.0 111.457 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.3 135.88 13.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.92 1.688 . . . . 0.0 110.572 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.0 151.63 45.63 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.214 1.805 . . . . 0.0 110.317 -171.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.5 p -117.6 140.23 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.233 1.413 . . . . 0.0 110.318 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.7 mt -133.21 134.93 24.72 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.407 1.883 . . . . 0.0 108.367 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.37 38.75 0.75 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 124.33 3.353 . . . . 0.0 113.354 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.0 t80 -87.26 152.78 22.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.005 1.322 . . . . 0.0 111.415 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 94.2 m -122.94 127.46 48.93 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.419 1.488 . . . . 0.0 109.708 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.6 mt -75.61 136.24 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.457 1.103 . . . . 0.0 111.216 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.1 pttt -112.74 -148.97 0.44 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.497 1.919 . . . . 0.0 112.036 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -87.16 131.91 34.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.557 1.143 . . . . 0.0 111.102 167.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.52 -139.54 11.03 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.311 1.434 . . . . 0.0 111.884 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -156.68 145.01 19.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.567 1.147 . . . . 0.0 111.74 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.6 tt -117.81 137.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.987 1.715 . . . . 0.0 111.057 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 26.1 p -146.27 161.16 40.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.689 1.596 . . . . 0.0 110.799 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.86 20.05 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.0 138.98 18.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.7 1.6 . . . . 0.0 109.798 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 19.6 t -111.56 136.62 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.337 1.855 . . . . 0.0 108.053 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -121.11 125.02 46.18 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 110.882 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.05 148.25 34.12 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.84 1.656 . . . . 0.0 111.319 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.53 -20.2 31.49 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.481 2.787 . . . . 0.0 113.929 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.6 t -77.03 -4.08 42.38 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.91 51.06 2.53 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.596 1.093 . . . . 0.0 113.035 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.81 166.96 25.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.678 1.591 . . . . 0.0 111.849 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.9 m -139.41 159.49 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.671 1.188 . . . . 0.0 113.071 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.05 171.83 18.47 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.142 2.177 . . . . 0.0 110.545 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -107.26 137.98 19.76 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.822 0.849 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.97 168.11 13.91 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.939 3.092 . . . . 0.0 110.972 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.5 m -104.63 126.23 51.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.005 1.322 . . . . 0.0 108.83 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.31 137.67 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.962 1.305 . . . . 0.0 108.846 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 24.4 m -146.71 127.25 14.13 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 109.393 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.56 143.64 40.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 112.648 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -88.76 -3.09 58.85 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? 65.94 18.49 11.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.343 1.857 . . . . 0.0 112.978 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -128.2 15.53 6.72 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.529 1.932 . . . . 0.0 112.684 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 85.11 15.91 66.03 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.575 1.083 . . . . 0.0 114.094 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 30.2 p -135.19 158.14 45.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.281 1.833 . . . . 0.0 110.32 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -123.81 144.66 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.613 1.165 . . . . 0.0 110.497 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.1 m -103.71 140.16 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.118 1.367 . . . . 0.0 108.862 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 34.0 t -122.62 133.78 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.486 1.514 . . . . 0.0 108.833 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.45 153.77 50.54 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.574 1.55 . . . . 0.0 111.983 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 26.6 t80 -157.0 133.31 9.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.207 1.403 . . . . 0.0 111.826 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.43 119.04 71.23 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.374 1.07 . . . . 0.0 110.513 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.59 144.31 31.68 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.524 2.816 . . . . 0.0 112.114 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.7 p -129.07 -7.6 4.88 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -159.88 150.97 19.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.74 1.616 . . . . 0.0 110.698 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.31 170.8 14.22 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.649 1.18 . . . . 0.0 113.308 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.15 -171.09 13.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.099 1.809 . . . . 0.0 113.919 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.3 tp -85.21 133.72 34.17 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.753 1.221 . . . . 0.0 110.035 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -130.47 166.47 20.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.028 1.731 . . . . 0.0 111.37 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.67 157.32 45.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.447 1.099 . . . . 0.0 110.691 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.2 tmm? -146.56 135.02 21.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.013 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.31 137.71 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.832 2.053 . . . . 0.0 110.03 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.0 mm -135.03 132.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.133 1.373 . . . . 0.0 110.137 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 141.21 32.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.4 t80 -103.27 120.49 40.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.541 1.936 . . . . 0.0 109.965 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.26 32.39 8.15 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.716 1.206 . . . . 0.0 112.889 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.8 t30 81.47 0.69 1.6 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.728 2.811 . . . . 0.0 115.08 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 57.4 ttm -98.83 128.5 45.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.343 1.457 . . . . 0.0 110.957 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.27 137.42 52.26 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.38 154.17 81.84 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.26 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.51 129.58 33.21 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.514 2.143 . . . . 0.0 109.988 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.79 -16.92 59.65 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.812 1.196 . . . . 0.0 114.065 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.6 t -86.66 145.51 39.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 119.699 1.75 . . . . 0.0 111.244 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -82.8 165.31 70.91 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.076 1.063 . . . . 0.0 112.73 -4.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.63 156.88 25.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.286 1.834 . . . . 0.0 111.423 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -137.05 137.88 39.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.522 1.529 . . . . 0.0 109.71 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 27.0 p90 -158.5 155.89 29.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.284 1.034 . . . . 0.0 112.315 -169.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.0 t80 -106.01 148.17 28.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.878 0.871 . . . . 0.0 112.341 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 55.0 t -126.11 137.45 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.523 1.529 . . . . 0.0 108.979 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -150.35 158.43 44.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.599 1.16 . . . . 0.0 113.115 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.8 118.46 20.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.941 0.896 . . . . 0.0 111.748 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.6 p -62.9 -34.29 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.743 1.217 . . . . 0.0 114.017 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -88.24 -7.44 56.8 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 39.7 t -67.35 -34.04 76.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.292 1.037 . . . . 0.0 113.065 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 82.67 2.6 90.65 Favored Glycine 0 N--CA 1.476 1.319 0 C-N-CA 124.901 1.239 . . . . 0.0 115.325 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -64.03 163.26 12.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.622 1.569 . . . . 0.0 113.698 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.3 t -70.16 132.76 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.0 t -165.27 164.24 19.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.784 1.233 . . . . 0.0 110.963 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.32 143.9 44.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.433 1.493 . . . . 0.0 111.251 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.5 p90 -162.93 162.84 26.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.278 1.431 . . . . 0.0 112.782 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 125.89 173.59 13.66 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.443 1.497 . . . . 0.0 112.797 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.01 -34.99 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.793 2.329 . . . . 0.0 112.947 -170.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.82 -32.95 82.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.51 1.05 . . . . 0.0 114.786 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.33 -6.08 55.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.877 1.338 . . . . 0.0 113.526 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.2 m -105.0 -45.28 4.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.497 1.919 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -146.44 150.52 35.78 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.679 1.992 . . . . 0.0 112.132 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 179.86 22.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.293 0.949 . . . . 0.0 113.493 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 31.5 t -142.45 133.2 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 0.0 108.522 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.5 m -55.54 137.44 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.3 m-80 68.98 -4.92 1.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.072 2.149 . . . . 0.0 114.814 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -104.39 138.58 19.56 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.012 1.325 . . . . 0.0 110.771 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.93 127.13 12.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.368 2.045 . . . . 0.0 110.334 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.21 145.18 32.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.595 1.558 . . . . 0.0 110.368 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.6 p -135.11 151.07 50.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.909 0.884 . . . . 0.0 113.245 -167.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.5 p90 -162.01 176.26 10.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.945 1.698 . . . . 0.0 111.441 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 67.8 m -129.93 143.03 50.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.226 1.411 . . . . 0.0 110.275 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 49.0 t -115.4 135.15 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.689 1.596 . . . . 0.0 108.137 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.7 133.67 42.7 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.364 1.066 . . . . 0.0 111.136 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.7 p -134.61 14.57 3.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.778 1.631 . . . . 0.0 112.519 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.12 -34.78 70.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.645 1.578 . . . . 0.0 114.992 -163.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -129.39 21.51 5.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.691 1.596 . . . . 0.0 111.868 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.59 -39.14 70.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.482 1.113 . . . . 0.0 113.841 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.41 146.76 4.61 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.783 1.183 . . . . 0.0 112.01 -168.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.13 165.86 22.66 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 113.391 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.75 16.47 0.25 Allowed Glycine 0 N--CA 1.477 1.394 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.61 97.22 1.86 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.302 1.429 . . . . 0.0 113.126 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -80.14 127.22 32.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 108.952 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -120.08 159.49 24.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.775 1.63 . . . . 0.0 112.547 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -159.65 137.46 10.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.048 1.739 . . . . 0.0 109.437 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.13 159.51 36.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.442 1.097 . . . . 0.0 111.839 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.13 133.66 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.448 1.099 . . . . 0.0 109.813 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.52 132.68 53.98 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.182 1.393 . . . . 0.0 109.752 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.82 -165.6 15.11 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 119.089 -0.839 . . . . 0.0 114.412 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.31 -29.44 79.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.917 3.078 . . . . 0.0 111.996 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.2 t -129.83 150.43 51.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.851 1.26 . . . . 0.0 108.972 158.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -70.68 125.69 27.51 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.306 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.87 152.8 35.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.68 133.14 34.04 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 162.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.4 mt -133.07 143.13 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.823 1.249 . . . . 0.0 109.994 -166.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.7 t -143.42 158.99 43.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.931 1.293 . . . . 0.0 110.834 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -158.07 154.44 27.57 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.463 1.105 . . . . 0.0 112.436 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.7 m -135.84 120.06 17.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.302 1.441 . . . . 0.0 109.954 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.61 132.03 40.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.901 1.28 . . . . 0.0 110.913 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -109.82 138.77 45.72 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.156 1.382 . . . . 0.0 111.084 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -65.66 -17.85 64.9 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.863 0.865 . . . . 0.0 112.226 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.49 -12.44 57.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.048 1.739 . . . . 0.0 114.346 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.04 33.42 5.5 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.876 1.227 . . . . 0.0 114.486 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.8 p -140.55 164.24 30.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.596 1.558 . . . . 0.0 110.794 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.6 m -119.34 130.45 55.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 163.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -91.49 148.51 22.25 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 110.398 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.9 t -131.38 141.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.412 1.485 . . . . 0.0 110.606 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 49.8 m -133.43 143.46 48.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.947 1.699 . . . . 0.0 111.084 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.8 p90 -150.46 155.2 39.08 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.2 109.24 44.72 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.017 1.727 . . . . 0.0 110.67 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.86 174.68 10.03 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.712 2.941 . . . . 0.0 110.178 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -152.22 -31.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.32 146.17 31.96 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 119.319 0.963 . . . . 0.0 110.48 167.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.89 155.76 53.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.772 2.315 . . . . 0.0 110.703 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.02 -152.71 21.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.49 1.043 . . . . 0.0 112.926 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -114.37 129.75 56.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.634 1.173 . . . . 0.0 111.614 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.26 130.53 56.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 110.28 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.651 1.18 . . . . 0.0 110.798 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.34 124.3 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.416 1.886 . . . . 0.0 108.62 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.03 132.2 51.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.653 1.581 . . . . 0.0 109.58 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.3 t -133.36 131.87 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.417 1.487 . . . . 0.0 108.316 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.6 144.81 18.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.763 1.225 . . . . 0.0 110.714 -166.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.72 121.24 15.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.531 1.132 . . . . 0.0 109.591 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.2 t-20 52.64 57.72 6.11 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.059 1.344 . . . . 0.0 112.334 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.296 7.9 pt-20 59.36 11.72 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.302 2.641 . . . . 0.0 116.35 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.2 124.6 48.31 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.541 1.137 . . . . 0.0 111.218 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -61.1 154.58 22.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.058 0.943 . . . . 0.0 112.663 170.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.51 153.86 71.11 Favored Pre-proline 0 N--CA 1.479 0.984 0 O-C-N 121.845 -0.534 . . . . 0.0 110.269 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -57.15 123.14 13.13 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 110.457 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 97.33 -16.19 61.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.178 1.371 . . . . 0.0 115.956 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 89.8 p -79.56 152.98 75.94 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 120.321 2.06 . . . . 0.0 112.942 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.22 156.28 99.77 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 119.31 0.789 . . . . 0.0 112.675 -4.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -111.13 140.82 45.36 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.573 1.549 . . . . 0.0 111.001 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 43.8 m -95.25 115.43 27.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.509 0.724 . . . . 0.0 110.997 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.08 127.99 42.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.994 1.318 . . . . 0.0 110.664 169.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -96.0 125.21 40.39 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.187 0.595 . . . . 0.0 110.634 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.4 t -110.7 129.77 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.33 1.452 . . . . 0.0 110.897 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.7 p -97.73 148.77 23.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.702 1.201 . . . . 0.0 112.778 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.75 59.62 2.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.35 1.928 . . . . 0.0 112.782 -175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.6 t70 -70.41 -26.64 63.78 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 124.768 1.227 . . . . 0.0 113.48 177.372 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.61 164.26 26.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.444 1.098 . . . . 0.0 112.844 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 77.5 mtm -68.96 139.6 55.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.13 0.972 . . . . 0.0 111.633 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -165.06 156.59 13.09 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.822 1.649 . . . . 0.0 111.661 -174.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.19 173.1 13.52 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.699 2.932 . . . . 0.0 111.521 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.39 149.11 48.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.804 1.241 . . . . 0.0 111.945 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -79.0 146.24 67.46 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.302 1.041 . . . . 0.0 112.118 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.19 167.89 25.88 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.667 2.911 . . . . 0.0 111.194 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.63 145.07 19.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.03 1.332 . . . . 0.0 111.842 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 10.7 p -175.81 144.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 127.299 2.24 . . . . 0.0 109.557 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 71.21 28.88 69.32 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 123.47 0.557 . . . . 0.0 113.945 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 35.1 m -62.24 152.57 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.241 1.416 . . . . 0.0 113.03 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 48.2 t30 -73.86 -11.39 60.35 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.674 1.19 . . . . 0.0 114.123 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -74.97 179.98 44.09 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.128 1.347 . . . . 0.0 114.075 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.86 164.97 25.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.934 1.294 . . . . 0.0 112.709 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 34.7 t70 -154.44 -51.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.614 1.565 . . . . 0.0 111.149 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 20.3 m -134.14 149.13 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.531 1.532 . . . . 0.0 109.963 163.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.7 t -173.15 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.559 1.944 . . . . 0.0 111.808 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 47.4 m -75.97 90.31 2.99 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.411 1.084 . . . . 0.0 112.169 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.67 140.18 55.45 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.815 0.846 . . . . 0.0 110.312 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -63.35 122.34 75.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.808 1.243 . . . . 0.0 110.357 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.27 140.2 52.53 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.932 2.421 . . . . 0.0 110.485 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.0 t80 -94.63 123.13 37.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.215 0.606 . . . . 0.0 110.255 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -147.42 136.12 21.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.191 1.396 . . . . 0.0 110.504 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.47 149.48 37.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.202 1.801 . . . . 0.0 109.533 -173.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.89 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.056 1.342 . . . . 0.0 110.164 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.83 136.12 27.17 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.774 1.629 . . . . 0.0 109.231 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.93 107.04 2.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.475 2.783 . . . . 0.0 109.693 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -172.95 152.3 2.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.758 2.423 . . . . 0.0 108.464 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.7 m -132.59 126.99 34.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.359 1.064 . . . . 0.0 109.783 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.85 117.63 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.229 1.011 . . . . 0.0 109.749 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 36.9 tptt -100.44 -146.06 0.34 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.214 1.406 . . . . 0.0 110.414 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.2 tttt -78.3 125.28 29.13 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.466 -1.396 . . . . 0.0 111.021 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 139.51 -150.4 21.34 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 125.462 1.506 . . . . 0.0 112.117 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -159.09 147.01 17.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.489 1.116 . . . . 0.0 111.412 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.33 136.78 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.876 1.67 . . . . 0.0 111.07 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.25 167.32 24.52 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.809 1.644 . . . . 0.0 111.004 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.74 -173.63 30.63 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.22 132.55 11.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.96 1.704 . . . . 0.0 109.648 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 86.2 t -103.33 134.43 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.708 1.603 . . . . 0.0 108.326 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.44 131.51 54.2 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.069 1.347 . . . . 0.0 110.972 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.8 mtt -106.23 149.24 37.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.634 1.574 . . . . 0.0 111.617 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -56.0 -28.18 67.79 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.073 3.182 . . . . 0.0 115.183 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 34.8 p -74.45 -6.15 46.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.542 1.537 . . . . 0.0 114.388 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.49 -5.5 82.52 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.535 1.54 . . . . 0.0 113.718 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -70.04 157.11 38.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.589 1.155 . . . . 0.0 112.128 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -142.06 155.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.275 1.43 . . . . 0.0 111.645 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.24 177.43 11.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.953 2.101 . . . . 0.0 110.149 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.43 143.17 33.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 120.974 -1.078 . . . . 0.0 112.254 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -83.97 169.18 11.81 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.417 3.411 . . . . 0.0 111.666 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.4 m -111.01 130.23 55.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.486 1.514 . . . . 0.0 109.03 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.35 137.32 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.945 1.298 . . . . 0.0 109.666 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -138.98 129.21 25.46 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.265 1.426 . . . . 0.0 110.002 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.11 129.04 34.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.949 0.899 . . . . 0.0 110.776 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -84.31 -9.14 58.72 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 66.3 mttm 65.71 10.24 6.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.469 2.308 . . . . 0.0 113.897 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.9 6.93 31.9 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.208 2.203 . . . . 0.0 112.632 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.95 11.82 58.45 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.314 1.435 . . . . 0.0 114.162 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.31 155.64 45.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.207 1.803 . . . . 0.0 111.044 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.5 m -111.14 142.12 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.986 0.914 . . . . 0.0 109.701 162.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 33.7 m -102.06 138.57 38.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.816 1.246 . . . . 0.0 108.465 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.8 t -123.6 134.41 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.196 1.398 . . . . 0.0 109.019 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.19 156.36 46.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.223 1.409 . . . . 0.0 112.715 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 32.6 t80 -155.35 135.41 12.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.718 1.607 . . . . 0.0 111.786 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.03 116.25 65.41 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.536 1.135 . . . . 0.0 110.59 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.46 148.01 29.31 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.47 2.78 . . . . 0.0 112.348 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 7.6 t -140.56 -2.59 1.37 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.166 0.987 . . . . 0.0 113.639 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -144.7 148.29 34.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.366 1.866 . . . . 0.0 109.501 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.15 168.31 12.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.02 0.928 . . . . 0.0 112.076 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.04 -172.48 18.96 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.686 1.136 . . . . 0.0 114.59 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.1 tp -79.86 110.74 15.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.564 1.546 . . . . 0.0 110.912 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 49.1 m80 -107.18 164.05 12.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.191 1.797 . . . . 0.0 112.214 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 142.46 42.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.217 1.407 . . . . 0.0 109.95 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.5 ttm -122.72 126.32 47.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.925 1.29 . . . . 0.0 111.196 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 t70 -87.77 133.86 33.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.801 1.641 . . . . 0.0 110.091 166.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 16.9 mm -134.15 139.63 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.309 1.443 . . . . 0.0 109.874 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.4 142.22 23.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.116 0.966 . . . . 0.0 113.585 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.0 t80 -98.52 118.79 36.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 109.505 172.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.46 34.36 12.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.999 1.32 . . . . 0.0 112.919 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 74.38 10.69 4.22 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.784 2.434 . . . . 0.0 115.073 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 6.0 tmm? -107.39 126.48 52.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.618 1.567 . . . . 0.0 110.197 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m170 -54.87 131.98 45.47 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.044 -1.035 . . . . 0.0 113.711 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.6 pt -71.43 154.41 93.48 Favored Pre-proline 0 N--CA 1.481 1.088 0 O-C-N 121.247 -0.908 . . . . 0.0 111.464 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.53 122.04 10.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.431 2.087 . . . . 0.0 109.627 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.39 43.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.692 1.139 . . . . 0.0 114.563 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.8 t -80.95 147.68 62.4 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.326 1.563 . . . . 0.0 112.173 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.64 164.02 82.65 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.286 1.138 . . . . 0.0 112.258 -7.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 50.8 mt -97.26 156.69 16.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.047 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -153.26 134.35 14.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.395 1.078 . . . . 0.0 110.012 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -167.02 160.59 14.23 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.164 0.986 . . . . 0.0 112.852 -170.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 58.4 t80 -96.44 134.42 39.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.945 0.898 . . . . 0.0 112.74 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.7 t -98.03 128.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.944 1.297 . . . . 0.0 109.966 173.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -132.61 173.51 11.25 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.373 2.269 . . . . 0.0 111.581 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -74.4 141.44 45.08 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.018 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 6.0 p -63.17 -27.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.343 1.057 . . . . 0.0 113.334 -170.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -132.45 134.95 45.71 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.292 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 26.5 p -169.71 164.05 10.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.011 1.724 . . . . 0.0 112.172 -174.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.31 -22.99 20.76 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.721 1.153 . . . . 0.0 114.38 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -73.16 158.54 35.08 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.378 1.089 . . . . 0.0 113.497 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.3 t -70.44 128.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.81 0.844 . . . . 0.0 108.956 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.9 t -147.01 158.15 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.983 1.313 . . . . 0.0 110.45 -175.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.13 142.57 36.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.055 1.342 . . . . 0.0 111.513 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.5 p90 -165.69 160.69 17.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.529 1.532 . . . . 0.0 112.532 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.38 174.24 13.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.113 1.339 . . . . 0.0 113.294 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.52 -33.12 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.943 2.429 . . . . 0.0 113.088 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.63 70.62 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.481 1.037 . . . . 0.0 114.501 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.99 -6.64 57.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.028 1.414 . . . . 0.0 113.191 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 49.6 m -102.41 -40.29 6.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.532 1.933 . . . . 0.0 111.794 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.581 1.952 . . . . 0.0 112.338 -167.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -158.59 -175.3 29.36 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.708 0.671 . . . . 0.0 113.822 168.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.5 p -152.46 137.2 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.24 1.416 . . . . 0.0 108.67 174.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 30.1 m -56.74 140.95 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.3 m-80 72.04 -3.03 2.34 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.518 2.327 . . . . 0.0 114.86 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 41.4 mttm -103.59 143.6 26.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.507 1.123 . . . . 0.0 111.133 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.7 123.2 8.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.61 147.25 26.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.384 1.473 . . . . 0.0 110.273 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 70.0 p -137.05 150.85 48.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -168.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -161.38 175.53 12.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.794 1.638 . . . . 0.0 111.592 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.6 m -126.97 142.31 51.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.959 1.304 . . . . 0.0 110.752 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.9 t -117.58 130.22 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.695 1.598 . . . . 0.0 108.27 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -93.75 129.28 40.15 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.231 1.012 . . . . 0.0 111.158 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 56.8 p -136.0 0.52 2.64 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.039 1.336 . . . . 0.0 113.997 -166.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.12 -38.2 67.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.402 1.481 . . . . 0.0 114.727 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.84 9.15 17.53 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.763 1.625 . . . . 0.0 112.935 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.79 -38.42 67.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.9 145.29 5.03 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.93 1.253 . . . . 0.0 112.34 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.1 140.73 49.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.962 0.905 . . . . 0.0 112.014 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 176.1 19.35 0.02 OUTLIER Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.959 1.144 . . . . 0.0 115.959 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 88.62 97.45 0.99 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.191 1.377 . . . . 0.0 112.58 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.51 129.23 34.97 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.328 1.451 . . . . 0.0 109.017 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -124.03 159.66 29.38 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.666 1.586 . . . . 0.0 112.286 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.7 tp -160.34 136.09 8.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.052 1.741 . . . . 0.0 109.09 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.48 157.46 35.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.866 . . . . 0.0 112.331 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.9 mt -137.01 140.74 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.015 1.326 . . . . 0.0 110.006 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.8 159.09 36.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.23 1.812 . . . . 0.0 109.745 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.28 -160.34 28.03 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.862 -0.966 . . . . 0.0 114.595 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.45 -24.61 63.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.123 3.215 . . . . 0.0 112.649 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.1 t -146.81 160.39 42.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.365 1.466 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.01 118.5 16.05 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.986 -1.071 . . . . 0.0 111.59 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.0 149.98 40.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.01 0.924 . . . . 0.0 111.953 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.72 141.01 29.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.799 0.84 . . . . 0.0 109.572 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.4 140.65 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.68 1.192 . . . . 0.0 110.585 -166.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 58.6 m -134.84 157.39 46.93 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.719 1.608 . . . . 0.0 111.124 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 42.3 t -154.14 143.42 21.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.358 1.063 . . . . 0.0 111.778 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.4 m -137.27 126.25 24.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.669 1.587 . . . . 0.0 110.514 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.02 135.89 36.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.176 1.39 . . . . 0.0 111.664 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -113.65 148.26 36.62 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.654 1.581 . . . . 0.0 111.642 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -64.72 -18.62 65.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.331 1.053 . . . . 0.0 112.479 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.73 -8.36 34.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.046 1.738 . . . . 0.0 114.271 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.05 30.01 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.54 1.067 . . . . 0.0 114.032 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 41.6 p -138.4 143.79 39.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.939 1.295 . . . . 0.0 111.399 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.4 m -92.51 123.86 36.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.38 1.072 . . . . 0.0 109.035 161.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.79 139.93 30.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 109.902 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.6 t -117.25 144.44 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.966 1.707 . . . . 0.0 109.933 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 62.8 p -136.79 145.31 44.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.407 1.083 . . . . 0.0 111.77 165.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.3 p90 -151.44 152.94 33.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 12.4 mt -116.57 105.82 49.48 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.042 1.737 . . . . 0.0 110.755 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.74 162.23 16.39 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.79 2.993 . . . . 0.0 110.447 167.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.0 m -134.99 -20.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.62 149.04 47.31 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 110.371 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.31 154.55 51.29 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 111.107 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 135.08 -164.01 24.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.842 1.21 . . . . 0.0 113.592 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -92.18 130.53 37.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 112.368 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -117.3 132.35 56.63 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.601 1.561 . . . . 0.0 110.513 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.3 m -90.71 125.88 35.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.545 1.138 . . . . 0.0 110.551 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.88 127.12 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.535 1.534 . . . . 0.0 108.583 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.88 132.56 54.05 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.496 1.519 . . . . 0.0 109.75 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 67.2 t -132.79 130.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.684 1.594 . . . . 0.0 108.203 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.98 142.63 19.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.616 1.166 . . . . 0.0 111.08 -168.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.01 121.56 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.786 1.234 . . . . 0.0 109.641 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 53.87 56.1 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.103 1.361 . . . . 0.0 112.468 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.2 pt-20 58.25 13.67 2.46 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 128.085 2.554 . . . . 0.0 116.159 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -119.73 127.71 53.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.555 1.142 . . . . 0.0 111.262 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -63.62 159.94 17.85 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 113.006 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -83.3 159.09 62.71 Favored Pre-proline 0 N--CA 1.48 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.065 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.41 -27.44 49.09 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 115.931 -171.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -104.69 -6.04 41.2 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.311 1.284 . . . . 0.0 116.311 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 81.0 p -84.24 153.61 62.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 119.953 1.876 . . . . 0.0 113.416 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.73 148.0 90.76 Favored 'Cis proline' 0 C--N 1.354 0.827 0 CA-C-N 118.829 0.618 . . . . 0.0 112.112 -5.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.67 169.99 9.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.82 1.648 . . . . 0.0 110.724 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 60.9 m -133.22 121.35 22.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.671 0.788 . . . . 0.0 110.877 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.56 139.6 34.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.538 1.535 . . . . 0.0 111.082 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.97 110.88 23.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.677 0.791 . . . . 0.0 109.811 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.9 t -95.7 145.42 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.307 1.443 . . . . 0.0 109.884 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.6 t -128.51 175.11 8.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.262 1.025 . . . . 0.0 113.038 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.68 139.9 18.34 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.624 1.583 . . . . 0.0 112.692 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.02 -29.45 35.11 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.693 1.197 . . . . 0.0 112.721 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 C--O 1.256 1.402 0 C-N-CA 125.736 1.614 . . . . 0.0 113.491 179.586 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.488 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.57 160.3 31.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.461 1.104 . . . . 0.0 112.937 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 15.4 tpt -158.36 139.03 12.81 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.812 1.645 . . . . 0.0 110.695 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -166.58 153.38 8.45 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 126.133 1.773 . . . . 0.0 111.514 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.6 159.62 45.64 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.666 2.91 . . . . 0.0 111.521 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -107.41 128.96 54.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.74 1.216 . . . . 0.0 110.933 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -74.66 130.67 81.09 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.33 1.052 . . . . 0.0 111.02 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.79 151.84 36.51 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.273 2.649 . . . . 0.0 111.236 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.18 10.62 23.84 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.423 1.089 . . . . 0.0 113.527 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.3 p -160.23 148.01 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.467 1.907 . . . . 0.0 110.65 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -87.38 -156.87 30.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.998 1.285 . . . . 0.0 113.329 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 27.0 m -68.57 149.61 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.309 1.043 . . . . 0.0 112.017 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 64.0 t30 -161.48 148.42 14.56 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.199 1.4 . . . . 0.0 111.813 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -86.78 175.56 47.1 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.207 1.384 . . . . 0.0 113.807 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 86.4 mt -101.68 153.14 20.04 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.39 1.476 . . . . 0.0 111.38 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.71 -30.02 51.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.935 0.894 . . . . 0.0 113.369 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 31.1 m -68.59 -15.13 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 1.8 t -75.03 -16.51 60.59 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.716 1.206 . . . . 0.0 113.11 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 50.4 m -75.73 1.65 14.16 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.38 156.38 22.66 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.484 1.114 . . . . 0.0 112.218 169.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.23 117.87 25.49 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 110.634 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.35 157.01 50.23 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.321 2.68 . . . . 0.0 111.532 -173.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 19.6 t80 -110.47 125.12 52.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.701 0.801 . . . . 0.0 110.958 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -154.07 133.54 12.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.238 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.83 146.02 33.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.842 1.657 . . . . 0.0 109.794 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.3 p -111.52 139.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.063 1.345 . . . . 0.0 110.204 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.3 mt -131.06 134.84 26.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.953 1.701 . . . . 0.0 108.843 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.05 92.81 1.03 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.715 2.944 . . . . 0.0 109.759 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 68.8 t80 -151.89 154.28 35.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.16 1.784 . . . . 0.0 109.801 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 68.0 m -126.51 123.82 38.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.705 1.202 . . . . 0.0 109.65 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 91.6 mt -87.68 118.88 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.337 1.055 . . . . 0.0 109.147 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 99.6 mttt -98.08 -77.01 0.51 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.502 1.121 . . . . 0.0 113.232 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.35 -4.61 0.16 Allowed 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.23 -129.1 2.73 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.294 1.902 . . . . 0.0 111.938 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.39 148.61 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.829 1.252 . . . . 0.0 110.824 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -141.09 129.87 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.344 1.458 . . . . 0.0 111.722 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.46 168.4 22.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.007 1.723 . . . . 0.0 110.701 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -153.84 -171.45 20.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.18 138.18 18.16 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.74 1.616 . . . . 0.0 109.63 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.6 t -108.36 136.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.134 1.774 . . . . 0.0 107.892 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.23 121.27 35.47 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.111 1.364 . . . . 0.0 110.541 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 12.7 mtm -87.75 151.55 50.21 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.863 1.665 . . . . 0.0 111.028 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.46 -18.26 38.51 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.442 2.761 . . . . 0.0 113.207 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 36.0 p -73.06 -6.72 47.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.011 1.724 . . . . 0.0 114.22 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.76 -4.85 79.35 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.83 1.681 . . . . 0.0 113.898 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -69.93 158.55 35.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.596 1.159 . . . . 0.0 112.234 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.4 m -137.61 156.79 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 0.0 112.23 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.9 171.94 18.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.665 1.986 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.78 137.5 19.35 Favored Pre-proline 0 CA--C 1.546 0.813 0 O-C-N 121.288 -0.882 . . . . 0.0 111.051 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.52 163.31 19.18 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.837 3.025 . . . . 0.0 110.938 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 67.9 m -101.99 120.31 40.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.9 1.28 . . . . 0.0 108.578 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.04 131.41 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.351 1.06 . . . . 0.0 108.631 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -127.76 124.96 38.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 109.652 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.85 122.72 24.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.235 1.014 . . . . 0.0 110.83 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.7 -15.36 45.5 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 58.0 tttt 71.67 4.01 4.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.308 2.243 . . . . 0.0 114.241 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -113.83 15.29 18.66 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.88 2.072 . . . . 0.0 112.805 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.16 12.15 52.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.105 1.336 . . . . 0.0 114.636 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -131.39 160.57 34.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.018 1.727 . . . . 0.0 110.705 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.9 m -123.93 147.44 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.594 1.158 . . . . 0.0 109.566 164.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.2 m -107.38 136.48 47.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.144 0.978 . . . . 0.0 108.643 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 35.8 t -120.42 131.9 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.126 1.37 . . . . 0.0 109.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -133.1 155.63 48.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.435 1.494 . . . . 0.0 112.662 -169.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -158.29 136.86 11.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.338 1.455 . . . . 0.0 112.338 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.27 120.09 69.74 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.776 1.23 . . . . 0.0 110.996 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.72 159.77 28.08 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.713 2.942 . . . . 0.0 112.233 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 5.5 t -147.59 -11.77 0.4 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.37 149.02 20.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.819 1.648 . . . . 0.0 110.98 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.04 171.0 15.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.656 1.182 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.31 -175.14 15.56 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.535 1.541 . . . . 0.0 114.409 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.93 124.67 31.92 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 110.097 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 46.7 m80 -118.93 152.88 35.53 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.547 1.539 . . . . 0.0 112.193 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -117.3 148.14 41.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.091 1.756 . . . . 0.0 108.899 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.1 tmm? -143.89 130.19 19.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 111.407 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -118.13 139.7 50.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.45 1.9 . . . . 0.0 110.924 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -137.27 133.19 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.185 1.394 . . . . 0.0 110.57 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 140.69 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -103.05 119.85 39.59 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.589 1.956 . . . . 0.0 109.489 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.79 34.61 13.51 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.762 1.225 . . . . 0.0 112.835 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.7 m-80 72.76 9.16 5.57 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.698 2.399 . . . . 0.0 115.147 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.1 mtm -103.35 128.48 50.42 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.352 1.461 . . . . 0.0 110.158 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -57.37 136.61 56.6 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.247 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.9 pt -75.56 154.26 85.6 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.218 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -59.56 128.45 27.19 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.216 1.944 . . . . 0.0 109.791 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.09 -15.9 59.96 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.838 1.209 . . . . 0.0 114.014 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.2 t -84.89 143.48 40.34 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.687 1.744 . . . . 0.0 111.105 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.1 159.2 83.47 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.025 1.044 . . . . 0.0 112.664 -4.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 87.6 mt -107.21 161.51 14.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.427 1.891 . . . . 0.0 111.183 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.17 139.91 18.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.821 1.249 . . . . 0.0 110.03 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -166.31 174.78 8.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.58 1.152 . . . . 0.0 112.413 -170.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -122.79 131.73 53.9 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.223 1.009 . . . . 0.0 112.718 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 99.3 t -96.92 135.12 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.589 1.556 . . . . 0.0 109.059 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 19.8 t0 -154.98 166.76 32.58 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.943 1.297 . . . . 0.0 111.111 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -82.81 137.45 34.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.81 1.244 . . . . 0.0 112.064 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 7.7 p -67.61 -24.84 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.473 0.709 . . . . 0.0 112.331 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -88.9 25.54 1.77 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.01 1.724 . . . . 0.0 112.773 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.2 p -56.68 151.02 14.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.422 1.489 . . . . 0.0 114.212 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.94 28.52 11.97 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.14 1.829 . . . . 0.0 112.324 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -162.38 163.17 27.94 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.866 1.666 . . . . 0.0 112.556 -163.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 18.3 t -70.18 137.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.29 1.036 . . . . 0.0 109.82 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -147.26 158.7 44.05 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.756 1.222 . . . . 0.0 110.622 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.73 144.08 37.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.101 1.36 . . . . 0.0 111.52 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.3 p90 -168.34 164.83 12.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.403 1.481 . . . . 0.0 113.214 -173.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 126.16 170.75 13.03 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.614 1.578 . . . . 0.0 112.29 -175.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -34.89 9.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.778 2.319 . . . . 0.0 113.222 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.08 76.41 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 119.348 0.976 . . . . 0.0 114.968 -169.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.01 -1.62 40.53 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.906 1.353 . . . . 0.0 113.813 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 51.6 m -118.05 -46.51 2.62 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.669 1.988 . . . . 0.0 111.726 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -138.01 148.2 44.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.503 1.521 . . . . 0.0 112.437 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -147.46 178.73 24.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.24 0.924 . . . . 0.0 113.52 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 19.1 t -139.53 136.97 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.914 1.286 . . . . 0.0 108.314 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -55.46 138.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 70.88 -3.29 2.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.547 2.339 . . . . 0.0 114.656 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.5 mttm -98.52 140.54 21.89 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.581 1.153 . . . . 0.0 111.144 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.89 109.77 2.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.647 2.232 . . . . 0.0 109.677 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -89.07 139.14 30.76 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.926 1.29 . . . . 0.0 110.168 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.0 p -130.83 151.25 51.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -166.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.28 175.95 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.276 1.83 . . . . 0.0 111.357 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.5 m -130.69 144.61 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.501 1.52 . . . . 0.0 110.898 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 31.1 t -117.59 135.77 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.584 1.554 . . . . 0.0 108.555 168.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.42 117.64 35.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.575 1.15 . . . . 0.0 110.632 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.8 p -117.05 14.4 14.97 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.289 1.836 . . . . 0.0 112.236 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 60.2 tttp -60.27 -28.39 68.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.421 1.488 . . . . 0.0 114.264 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -118.08 16.59 14.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.996 1.718 . . . . 0.0 112.754 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.71 -12.61 61.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.13 -103.34 2.48 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.718 1.151 . . . . 0.0 110.828 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.02 147.8 24.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.322 1.449 . . . . 0.0 110.432 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 164.36 -105.87 0.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.044 1.307 . . . . 0.0 111.061 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 167.27 144.36 4.1 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 124.773 1.177 . . . . 0.0 112.701 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 25.5 tp -92.39 137.97 31.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.666 1.186 . . . . 0.0 111.277 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.3 m -120.56 157.44 29.46 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.408 1.883 . . . . 0.0 110.74 169.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 53.4 tp -157.07 134.9 10.89 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.202 1.401 . . . . 0.0 109.721 -168.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.17 158.4 36.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.106 0.962 . . . . 0.0 112.324 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.1 mt -137.32 139.17 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.736 1.214 . . . . 0.0 109.986 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.17 131.34 47.13 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.439 1.496 . . . . 0.0 109.872 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -157.7 -162.7 11.89 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.891 -0.95 . . . . 0.0 114.625 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.79 -23.65 68.92 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.253 3.302 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.1 t -144.84 159.6 42.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.24 1.416 . . . . 0.0 109.433 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.11 111.54 5.84 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.095 -1.003 . . . . 0.0 111.019 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.65 148.31 50.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.863 0.865 . . . . 0.0 111.617 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.97 138.43 31.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.194 0.597 . . . . 0.0 109.416 166.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.2 mt -129.53 143.88 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.084 1.353 . . . . 0.0 109.906 -168.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.03 162.8 34.52 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 111.137 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.89 154.83 30.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.697 1.199 . . . . 0.0 112.485 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.3 m -136.94 123.36 20.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.61 1.564 . . . . 0.0 110.09 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.68 130.84 36.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.984 1.314 . . . . 0.0 111.239 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.91 149.14 27.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.463 1.505 . . . . 0.0 111.603 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -65.11 -20.0 66.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.539 1.136 . . . . 0.0 112.882 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.93 -7.87 53.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.203 1.401 . . . . 0.0 113.923 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.67 12.37 47.6 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.925 1.25 . . . . 0.0 114.869 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.0 p -108.61 154.88 21.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.099 1.359 . . . . 0.0 111.289 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 90.0 m -110.63 123.23 49.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 108.822 163.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -86.5 147.45 25.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.46 0.704 . . . . 0.0 110.161 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 90.3 t -128.36 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.977 1.711 . . . . 0.0 109.9 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.72 147.27 44.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 111.81 168.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -151.02 151.18 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -112.41 101.79 53.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.778 1.631 . . . . 0.0 110.575 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.27 161.13 29.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.303 2.669 . . . . 0.0 109.946 166.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.9 m -135.96 -21.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 89.9 mt -118.4 147.52 42.0 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.953 1.301 . . . . 0.0 110.21 170.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.08 154.12 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.734 2.29 . . . . 0.0 110.648 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 137.97 -158.54 24.75 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.706 1.146 . . . . 0.0 112.881 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -106.03 133.78 50.2 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.358 1.063 . . . . 0.0 111.727 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -121.0 125.27 46.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.98 1.712 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -87.6 127.17 35.27 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.965 -1.084 . . . . 0.0 110.848 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.43 120.74 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.545 1.538 . . . . 0.0 108.528 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -103.71 127.53 51.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -130.14 129.17 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.159 1.384 . . . . 0.0 109.036 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.37 136.56 22.43 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.353 -170.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 39.6 t80 -132.22 133.58 44.32 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.991 1.316 . . . . 0.0 110.933 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 48.99 53.73 12.08 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 112.547 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 8.4 pt-20 58.55 16.01 3.98 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 128.037 2.535 . . . . 0.0 116.413 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -125.15 130.33 51.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 111.292 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.3 m170 -62.15 141.35 58.21 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.481 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 8.3 m -71.25 150.86 94.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.35 -0.834 . . . . 0.0 109.872 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.83 130.37 39.5 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.38 2.72 . . . . 0.0 111.742 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.84 -15.14 58.4 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.279 1.419 . . . . 0.0 115.034 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 3.5 t -83.17 143.21 45.01 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 118.935 1.367 . . . . 0.0 111.488 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.9 138.11 51.94 Favored 'Cis proline' 0 C--N 1.357 0.996 0 CA-C-N 119.832 0.976 . . . . 0.0 112.72 0.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.0 173.8 8.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.809 1.643 . . . . 0.0 110.232 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.4 m -135.3 119.74 18.0 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.575 -0.703 . . . . 0.0 110.887 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.93 148.76 21.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 110.973 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -113.46 125.16 53.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.065 0.946 . . . . 0.0 110.21 172.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 83.9 t -111.5 132.46 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.297 1.439 . . . . 0.0 110.593 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 43.9 p -107.39 168.29 9.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.276 1.431 . . . . 0.0 112.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.64 149.57 33.52 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.049 1.309 . . . . 0.0 112.521 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.1 t70 -75.8 -18.99 59.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.629 1.172 . . . . 0.0 113.147 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 126.639 1.976 . . . . 0.0 112.673 -178.251 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.371 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.84 -36.17 67.4 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -77.69 -32.4 53.01 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.564 1.145 . . . . 0.0 112.915 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -166.88 152.55 7.53 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.563 1.945 . . . . 0.0 111.182 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -75.71 160.96 37.31 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.455 2.77 . . . . 0.0 111.708 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -67.52 -16.65 64.31 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.726 1.21 . . . . 0.0 112.837 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -59.94 122.27 64.6 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.372 1.469 . . . . 0.0 110.275 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.49 157.38 36.54 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.714 2.943 . . . . 0.0 113.088 -169.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 30.2 tp -80.87 67.42 6.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.95 1.3 . . . . 0.0 111.119 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.6 p -160.17 150.1 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.391 1.876 . . . . 0.0 110.406 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 92.27 -147.25 18.6 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.855 1.217 . . . . 0.0 112.337 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 27.8 m -135.78 150.6 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.521 1.528 . . . . 0.0 111.199 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 11.5 p30 -93.5 162.42 13.97 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.861 1.264 . . . . 0.0 113.233 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 90.62 131.24 4.76 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.59 1.567 . . . . 0.0 113.303 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 94.8 mt -144.37 161.25 39.45 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.375 2.27 . . . . 0.0 109.764 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 33.5 t0 -158.16 165.54 34.68 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.493 1.117 . . . . 0.0 112.28 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 22.7 m -73.52 6.04 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.826 1.65 . . . . 0.0 114.255 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.3 t -67.89 -11.93 59.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.838 1.655 . . . . 0.0 112.853 168.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 7.9 t -61.77 153.82 27.44 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.8 mt -112.49 151.92 29.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.595 1.958 . . . . 0.0 111.456 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -56.81 116.02 11.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.06 1.744 . . . . 0.0 111.107 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.95 155.4 48.1 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.113 2.542 . . . . 0.0 110.947 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -105.28 124.38 49.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.345 0.658 . . . . 0.0 110.232 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -153.88 130.83 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 110.692 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.92 150.49 43.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.538 1.935 . . . . 0.0 109.565 -175.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -124.93 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.034 1.334 . . . . 0.0 110.31 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.49 138.57 27.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.117 1.767 . . . . 0.0 108.926 -172.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 47.41 2.37 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.655 3.57 . . . . 0.0 113.156 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 61.3 t80 -93.8 159.17 15.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.333 1.453 . . . . 0.0 110.559 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 49.2 m -135.16 127.29 29.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.919 1.288 . . . . 0.0 109.796 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 49.3 mt -75.56 131.46 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.244 1.018 . . . . 0.0 110.419 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -120.62 -145.48 0.36 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.426 1.49 . . . . 0.0 110.683 174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -77.17 122.49 25.09 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.548 -1.345 . . . . 0.0 110.749 173.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.41 -146.01 16.89 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.455 1.503 . . . . 0.0 112.07 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -158.87 145.35 17.0 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.758 1.223 . . . . 0.0 111.084 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.6 137.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.645 1.578 . . . . 0.0 111.122 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.5 p -148.4 168.56 22.3 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.937 1.695 . . . . 0.0 110.654 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.69 -176.47 26.98 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.73 134.71 13.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.293 1.437 . . . . 0.0 110.183 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 5.8 t -99.9 136.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.662 1.985 . . . . 0.0 108.024 171.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -121.53 126.3 48.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.828 1.251 . . . . 0.0 110.755 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -105.73 142.15 24.17 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.325 1.45 . . . . 0.0 112.09 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.61 -26.66 73.48 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.118 3.212 . . . . 0.0 115.022 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 23.3 p -73.84 1.19 11.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.257 1.423 . . . . 0.0 114.506 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.73 37.41 7.4 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.593 1.092 . . . . 0.0 113.46 173.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.21 169.32 17.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.408 1.483 . . . . 0.0 112.543 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.7 m -140.39 160.6 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.106 1.362 . . . . 0.0 112.43 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.32 169.19 24.78 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.494 1.918 . . . . 0.0 110.794 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -108.13 136.89 19.75 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.33 167.25 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.063 3.176 . . . . 0.0 111.406 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.9 m -105.13 130.85 53.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.566 1.546 . . . . 0.0 109.069 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 131.27 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.767 1.227 . . . . 0.0 108.976 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.9 m -133.22 122.21 23.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.251 1.42 . . . . 0.0 109.732 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.06 127.73 32.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.363 0.665 . . . . 0.0 110.407 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -82.31 -11.46 58.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 71.68 2.01 4.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 128.276 2.63 . . . . 0.0 114.055 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -94.38 3.57 55.01 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.564 1.946 . . . . 0.0 113.047 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.21 17.99 41.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.87 1.224 . . . . 0.0 113.93 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -131.06 155.63 46.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.47 1.908 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -112.51 143.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 109.532 163.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.8 m -104.23 135.17 46.2 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.624 1.17 . . . . 0.0 107.908 165.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.7 t -122.37 132.64 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.325 . . . . 0.0 108.838 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -135.02 160.54 38.0 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.086 1.354 . . . . 0.0 112.842 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.2 t80 -159.01 137.71 10.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.519 1.528 . . . . 0.0 111.936 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.41 119.08 71.26 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.665 1.186 . . . . 0.0 110.904 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.97 158.16 46.33 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.06 3.173 . . . . 0.0 112.432 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 8.4 t -135.86 -22.79 1.4 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -161.12 155.8 23.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.769 1.628 . . . . 0.0 109.952 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -72.05 166.43 22.26 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 126.1 178.38 15.28 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 125.906 1.717 . . . . 0.0 113.952 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -80.77 119.01 22.8 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.749 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 23.4 m80 -113.87 159.86 19.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.462 1.505 . . . . 0.0 110.892 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.46 155.72 40.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 111.517 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 3.2 tmm? -148.16 134.81 19.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.77 1.228 . . . . 0.0 111.303 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -103.04 138.45 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.85 1.66 . . . . 0.0 110.426 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.2 mm -127.63 136.56 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.339 1.456 . . . . 0.0 109.796 171.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.94 137.95 23.94 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -102.92 124.93 49.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 0.0 109.902 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.22 32.08 10.18 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.734 1.213 . . . . 0.0 112.462 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.1 t30 75.82 6.52 3.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 128.2 2.6 . . . . 0.0 115.17 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.17 131.13 53.04 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.769 1.628 . . . . 0.0 110.903 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.59 134.03 56.38 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.244 -0.91 . . . . 0.0 113.077 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.17 156.89 85.61 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 123.127 0.571 . . . . 0.0 112.046 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.25 126.37 21.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.274 1.983 . . . . 0.0 109.626 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.74 -16.57 57.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.666 1.127 . . . . 0.0 114.463 -172.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 21.2 t -86.03 148.37 47.74 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.37 1.585 . . . . 0.0 111.961 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -83.19 171.61 50.76 Favored 'Cis proline' 0 CA--C 1.54 0.783 0 CA-C-N 120.246 1.124 . . . . 0.0 112.485 -6.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.28 154.92 22.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.976 1.71 . . . . 0.0 111.662 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -145.36 140.92 28.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.441 1.497 . . . . 0.0 110.041 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -163.42 160.01 22.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.98 1.312 . . . . 0.0 112.04 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.8 t80 -100.15 135.21 41.93 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.058 -1.026 . . . . 0.0 112.396 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.1 t -103.99 141.05 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.961 1.704 . . . . 0.0 109.28 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 12.8 t0 -154.71 162.9 40.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.611 1.164 . . . . 0.0 111.683 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -81.77 148.06 29.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.57 1.148 . . . . 0.0 112.707 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 30.4 m -69.93 -17.65 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.9 p30 -80.51 -10.54 59.74 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.4 m -70.32 133.02 46.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.147 0.979 . . . . 0.0 112.584 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -101.75 -13.43 32.17 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 125.141 1.353 . . . . 0.0 114.773 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -68.59 164.45 21.38 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -63.46 138.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.355 1.062 . . . . 0.0 109.705 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.9 t -165.2 153.41 11.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.273 1.429 . . . . 0.0 110.022 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -129.8 145.16 51.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.34 . . . . 0.0 111.844 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -168.15 167.86 12.1 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.964 1.706 . . . . 0.0 112.864 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.07 169.37 13.28 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.508 1.528 . . . . 0.0 112.08 -172.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.04 -30.79 20.41 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.63 -33.98 77.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 119.255 0.934 . . . . 0.0 114.605 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.74 -4.33 45.72 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.169 1.485 . . . . 0.0 113.484 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.0 m -108.97 -41.25 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 111.973 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -149.48 152.37 35.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.131 1.772 . . . . 0.0 112.314 -172.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -152.01 177.14 30.02 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.847 0.737 . . . . 0.0 113.665 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 58.5 t -137.9 134.78 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.972 1.309 . . . . 0.0 108.192 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.6 m -55.58 137.51 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 55.5 m-80 68.92 2.21 3.46 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.011 2.124 . . . . 0.0 114.415 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.0 mttt -108.06 140.91 22.13 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.149 1.38 . . . . 0.0 111.087 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.04 124.22 9.9 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.462 2.108 . . . . 0.0 110.205 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.5 144.24 31.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.33 1.452 . . . . 0.0 110.291 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.6 p -133.87 149.59 51.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -166.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -160.18 178.28 9.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.812 1.645 . . . . 0.0 111.496 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 27.5 m -134.14 143.06 47.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.145 1.378 . . . . 0.0 110.565 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 22.7 t -115.14 130.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 108.137 168.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.83 129.83 36.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 111.08 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 69.6 p -137.1 1.01 2.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.103 1.361 . . . . 0.0 113.841 -166.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 82.4 tttt -55.89 -38.95 70.87 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.466 1.506 . . . . 0.0 114.992 -166.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -115.73 10.23 15.38 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.671 1.589 . . . . 0.0 112.667 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.4 67.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.15 151.37 8.07 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.672 1.13 . . . . 0.0 112.281 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.74 166.12 22.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 0.0 113.298 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 145.23 9.61 0.31 Allowed Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 102.0 96.95 2.32 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.484 1.516 . . . . 0.0 113.157 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.98 132.83 36.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.347 1.459 . . . . 0.0 109.251 169.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.5 t -134.98 165.78 24.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.366 1.467 . . . . 0.0 112.45 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 36.1 tp -166.86 137.36 3.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.738 2.015 . . . . 0.0 109.272 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.45 34.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.162 0.985 . . . . 0.0 112.16 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.6 mt -136.42 139.93 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.792 1.237 . . . . 0.0 110.264 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.58 145.74 51.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.717 1.607 . . . . 0.0 109.652 170.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.28 -165.48 25.74 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 119.091 -0.838 . . . . 0.0 114.841 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.47 -26.01 70.35 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.316 3.344 . . . . 0.0 112.657 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.3 t -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.962 1.305 . . . . 0.0 109.144 159.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.72 116.49 12.15 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.978 -1.076 . . . . 0.0 111.4 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -72.81 147.55 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.795 0.838 . . . . 0.0 111.903 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.17 143.66 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.677 0.791 . . . . 0.0 109.76 167.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.76 145.88 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.164 1.385 . . . . 0.0 110.826 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -142.74 164.72 29.34 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.045 162.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.5 p -161.78 155.72 21.82 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.939 1.296 . . . . 0.0 112.616 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 79.3 m -143.85 124.89 14.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.544 1.537 . . . . 0.0 110.437 -171.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.53 130.96 36.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.54 1.136 . . . . 0.0 111.216 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.43 147.87 32.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.471 1.508 . . . . 0.0 112.017 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.3 -15.47 63.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.0 0.92 . . . . 0.0 113.437 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -74.92 -6.58 49.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.103 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.62 33.08 7.68 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.476 1.036 . . . . 0.0 113.951 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.0 p -138.43 157.26 46.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.961 1.304 . . . . 0.0 111.268 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 39.2 t -105.24 124.13 49.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.572 1.149 . . . . 0.0 108.734 158.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -90.34 146.61 24.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.922 0.889 . . . . 0.0 110.282 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -129.38 143.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 95.3 p -136.31 149.68 48.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.811 1.244 . . . . 0.0 112.155 168.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.4 p90 -151.52 152.79 33.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.47 104.97 52.82 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.864 1.666 . . . . 0.0 110.649 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.25 164.98 14.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.839 3.026 . . . . 0.0 110.374 167.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -137.15 -20.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.7 mt -118.38 149.31 45.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.013 1.325 . . . . 0.0 110.327 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.57 155.67 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.966 2.444 . . . . 0.0 110.883 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.83 -162.38 23.82 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.738 1.161 . . . . 0.0 113.691 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -92.11 129.02 38.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.487 1.515 . . . . 0.0 112.671 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 130.05 55.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.485 1.514 . . . . 0.0 110.207 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -90.91 119.03 30.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.616 1.167 . . . . 0.0 110.52 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.42 123.22 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.304 1.842 . . . . 0.0 108.501 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -104.45 134.3 47.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.516 1.526 . . . . 0.0 109.391 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 83.8 t -133.95 133.47 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.312 1.445 . . . . 0.0 108.454 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.74 141.73 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.906 1.283 . . . . 0.0 111.071 -169.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.31 120.25 14.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.695 1.198 . . . . 0.0 109.974 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 52.48 58.42 5.41 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.445 1.498 . . . . 0.0 112.067 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 60.64 2.8 0.53 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.911 2.885 . . . . 0.0 116.684 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -107.27 127.1 53.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.473 1.109 . . . . 0.0 111.177 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -62.93 157.67 21.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.816 0.846 . . . . 0.0 112.392 167.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 32.6 m -87.73 155.75 53.16 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 0.0 110.498 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.53 121.59 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.834 2.356 . . . . 0.0 110.353 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.53 -13.73 66.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.373 1.464 . . . . 0.0 116.037 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.3 p -79.79 151.53 73.92 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 120.434 2.117 . . . . 0.0 113.028 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.35 149.75 94.62 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 119.107 0.717 . . . . 0.0 112.295 -4.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -102.44 156.1 17.82 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.84 1.656 . . . . 0.0 110.888 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 63.4 m -111.29 118.45 35.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.692 0.797 . . . . 0.0 111.047 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.18 133.17 37.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.036 1.334 . . . . 0.0 110.921 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.66 106.36 18.45 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.964 0.905 . . . . 0.0 109.738 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 90.4 t -90.98 145.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 0.0 109.875 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.7 t -137.25 174.26 10.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.049 0.939 . . . . 0.0 113.031 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.72 140.5 18.04 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.741 1.639 . . . . 0.0 112.914 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.64 -33.81 31.17 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.048 0.939 . . . . 0.0 112.813 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.831 1.652 . . . . 0.0 113.458 -177.735 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.33 162.91 28.8 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.43 1.092 . . . . 0.0 112.913 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -68.15 -19.72 64.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -160.0 153.92 19.55 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 126.716 2.007 . . . . 0.0 110.833 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.62 164.77 34.05 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.452 2.768 . . . . 0.0 111.297 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.71 -20.74 66.5 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.557 1.143 . . . . 0.0 113.553 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -126.51 76.68 73.7 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.077 1.751 . . . . 0.0 109.971 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -82.51 168.52 14.48 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.829 3.02 . . . . 0.0 111.832 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 78.2 mt -83.11 19.98 1.33 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.109 1.364 . . . . 0.0 113.626 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 84.3 t -60.92 136.42 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.77 1.628 . . . . 0.0 110.492 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 115.26 -146.0 18.77 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.389 1.471 . . . . 0.0 111.784 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 9.4 p -65.47 -25.42 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.27 1.028 . . . . 0.0 113.754 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.66 -54.73 7.46 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.357 0.663 . . . . 0.0 112.314 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 76.25 168.3 26.5 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.964 1.268 . . . . 0.0 113.19 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.2 mt -80.23 137.91 36.73 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.177 0.991 . . . . 0.0 110.694 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -164.22 161.23 21.95 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.902 1.681 . . . . 0.0 111.286 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 75.3 t -96.68 127.59 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.598 1.559 . . . . 0.0 109.767 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.8 t -154.63 13.73 0.42 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.122 1.369 . . . . 0.0 113.099 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 61.1 m -81.2 114.76 20.23 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.56 -1.337 . . . . 0.0 111.997 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 47.8 tp -148.78 139.07 22.41 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.493 1.517 . . . . 0.0 110.193 -159.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -47.62 111.06 1.53 Allowed Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.925 1.69 . . . . 0.0 112.326 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.44 155.28 45.72 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.021 2.48 . . . . 0.0 110.655 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.77 125.45 51.43 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.611 0.764 . . . . 0.0 110.514 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -151.46 128.33 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.782 1.633 . . . . 0.0 109.53 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.75 125.95 13.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 109.973 -167.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 96.7 t -93.23 137.92 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.911 1.284 . . . . 0.0 109.863 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.9 mt -131.25 136.2 28.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.651 1.58 . . . . 0.0 108.752 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.28 58.17 6.87 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.273 3.315 . . . . 0.0 111.896 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -107.45 158.56 17.09 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.878 1.671 . . . . 0.0 111.197 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.6 m -125.45 123.08 38.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.819 1.248 . . . . 0.0 109.576 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.45 128.37 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.758 1.223 . . . . 0.0 109.73 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.38 -143.12 0.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.065 1.346 . . . . 0.0 110.718 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -75.53 -10.63 59.62 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.43 168.99 50.68 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.354 1.454 . . . . 0.0 113.704 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 147.6 23.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.329 1.451 . . . . 0.0 111.699 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.49 131.52 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.292 1.437 . . . . 0.0 111.056 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 57.5 p -147.44 -168.82 3.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.546 1.938 . . . . 0.0 109.807 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.49 -155.76 9.12 Favored Glycine 0 N--CA 1.467 0.765 0 O-C-N 121.357 -0.839 . . . . 0.0 114.957 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.91 137.0 9.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.45 1.9 . . . . 0.0 108.964 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 6.7 t -108.5 135.22 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.949 1.699 . . . . 0.0 108.629 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -117.37 123.42 46.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.121 1.368 . . . . 0.0 110.554 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.0 mtm -96.85 147.56 33.1 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.827 1.651 . . . . 0.0 111.349 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.49 -18.79 25.62 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.643 2.895 . . . . 0.0 113.576 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -77.28 2.27 16.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.071 1.348 . . . . 0.0 114.338 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.17 48.29 3.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.678 1.133 . . . . 0.0 113.218 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -156.12 166.39 33.59 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.793 1.637 . . . . 0.0 111.872 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.38 161.48 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.446 1.098 . . . . 0.0 113.194 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.1 178.24 10.51 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.733 2.013 . . . . 0.0 111.006 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.91 140.72 25.14 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.385 1.074 . . . . 0.0 110.872 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.63 160.34 22.0 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.605 2.87 . . . . 0.0 111.003 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.8 m -104.39 120.73 41.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 108.692 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.62 131.35 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.194 0.998 . . . . 0.0 108.706 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.7 m -132.14 128.14 37.45 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.303 1.441 . . . . 0.0 109.221 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.43 134.37 42.37 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.275 0.63 . . . . 0.0 111.564 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -82.69 -13.52 56.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.0 ttpt 67.25 18.86 10.33 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.954 2.102 . . . . 0.0 113.356 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.43 17.38 8.95 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.824 2.049 . . . . 0.0 112.499 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.6 13.12 68.14 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.824 1.202 . . . . 0.0 114.014 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 62.7 p -136.9 164.65 27.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.911 2.085 . . . . 0.0 110.027 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.5 m -127.74 163.38 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.861 1.264 . . . . 0.0 110.115 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.1 t -120.69 147.19 45.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 110.098 164.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 39.0 t -120.01 128.09 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.523 1.529 . . . . 0.0 108.424 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.94 156.55 43.56 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.667 1.587 . . . . 0.0 111.829 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -163.93 133.4 3.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.069 1.348 . . . . 0.0 111.97 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -83.62 123.17 76.7 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.539 1.136 . . . . 0.0 110.483 175.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.24 174.49 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.632 2.888 . . . . 0.0 111.823 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -149.66 -40.24 0.14 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -137.55 154.89 49.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.315 1.446 . . . . 0.0 110.509 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.18 171.0 14.93 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.329 1.052 . . . . 0.0 113.624 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 118.08 -173.03 14.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.048 1.785 . . . . 0.0 113.943 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -85.19 131.78 34.38 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.977 1.311 . . . . 0.0 110.57 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 53.0 m80 -125.69 156.41 39.37 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.743 1.617 . . . . 0.0 111.47 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -134.31 146.49 50.03 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.352 1.461 . . . . 0.0 109.486 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 17.3 tmm? -151.1 132.41 14.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.627 0.771 . . . . 0.0 112.252 -168.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -106.03 148.52 27.65 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.873 1.669 . . . . 0.0 111.65 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 31.4 mm -133.63 135.42 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.406 1.082 . . . . 0.0 110.9 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.36 128.19 19.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.037 1.335 . . . . 0.0 113.085 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.37 126.58 45.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.873 2.069 . . . . 0.0 109.689 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.79 33.27 13.79 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.877 1.271 . . . . 0.0 112.539 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.4 t30 75.5 2.75 3.86 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.334 2.654 . . . . 0.0 114.795 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.26 132.77 50.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.177 1.391 . . . . 0.0 110.843 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -56.55 134.95 54.66 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.01 155.9 88.19 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.592 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.02 -19.67 69.65 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.503 2.136 . . . . 0.0 113.853 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -80.45 -3.5 89.99 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.32 0.964 . . . . 0.0 114.686 172.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 7.7 t -93.02 154.18 41.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 119.203 1.502 . . . . 0.0 111.887 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -82.36 163.01 75.8 Favored 'Cis proline' 0 C--N 1.352 0.726 0 CA-C-N 119.795 0.962 . . . . 0.0 111.591 -13.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 72.1 mt -111.52 156.63 21.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.634 1.574 . . . . 0.0 111.376 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -147.27 139.29 24.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.149 1.38 . . . . 0.0 109.416 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.2 p90 -162.68 162.19 26.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.889 0.876 . . . . 0.0 112.5 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 62.9 t80 -109.72 145.22 36.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.446 1.098 . . . . 0.0 113.004 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 69.4 t -121.95 141.02 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.311 1.844 . . . . 0.0 109.302 -178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -155.18 144.58 21.16 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.251 1.42 . . . . 0.0 112.989 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -70.06 145.32 51.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 111.551 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 28.2 m -66.52 -19.4 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -91.11 0.56 57.51 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.342 1.457 . . . . 0.0 114.859 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 96.3 m -62.8 132.94 53.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.307 0.958 . . . . 0.0 112.247 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.87 -25.14 18.31 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.704 1.145 . . . . 0.0 113.887 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -68.5 159.71 31.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.22 1.008 . . . . 0.0 113.201 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.4 p -64.37 131.4 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.096 0.959 . . . . 0.0 111.272 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 53.4 p -136.36 164.78 27.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.166 1.786 . . . . 0.0 110.106 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -143.7 144.52 31.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.284 1.034 . . . . 0.0 111.671 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 38.9 p90 -166.49 167.27 15.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.684 1.593 . . . . 0.0 112.861 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.8 170.9 12.86 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.508 1.528 . . . . 0.0 112.454 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.74 -33.82 12.29 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.701 2.267 . . . . 0.0 113.142 -169.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.5 -32.89 83.04 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.358 0.981 . . . . 0.0 114.609 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.82 -3.12 39.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.03 1.415 . . . . 0.0 113.771 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 77.5 m -113.31 -47.16 3.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.583 1.953 . . . . 0.0 111.863 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -138.58 143.38 39.35 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.684 1.594 . . . . 0.0 112.448 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.83 175.74 22.39 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.056 1.313 . . . . 0.0 113.026 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -139.62 134.67 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.452 1.101 . . . . 0.0 108.778 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.8 m -56.54 132.32 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 24.7 m120 69.35 1.65 3.37 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.112 2.165 . . . . 0.0 114.401 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -105.27 137.56 19.29 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.285 1.434 . . . . 0.0 110.433 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.47 121.94 7.88 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.417 2.078 . . . . 0.0 110.364 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 145.22 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.457 1.503 . . . . 0.0 110.393 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.5 p -136.22 149.17 48.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.6 p90 -160.74 176.29 11.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.96 1.704 . . . . 0.0 111.47 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.7 m -133.35 141.52 47.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.068 1.347 . . . . 0.0 110.851 -170.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.77 136.36 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.786 1.634 . . . . 0.0 108.014 168.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -104.13 123.0 46.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.421 1.089 . . . . 0.0 110.284 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.9 p -127.04 3.81 6.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.785 1.634 . . . . 0.0 113.636 -166.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.49 -36.92 36.02 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.856 2.062 . . . . 0.0 115.64 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -129.3 17.54 6.0 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.426 1.49 . . . . 0.0 112.423 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.7 -30.07 59.18 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.2 142.36 5.99 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.385 1.469 . . . . 0.0 113.156 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -72.9 152.95 41.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.668 1.187 . . . . 0.0 112.087 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.37 13.12 0.05 OUTLIER Glycine 0 N--CA 1.476 1.36 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 107.96 89.77 2.09 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-N 118.776 1.288 . . . . 0.0 112.728 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.14 126.62 31.08 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.802 1.241 . . . . 0.0 109.367 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -121.54 157.95 29.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.196 1.798 . . . . 0.0 112.166 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.3 tp -160.19 134.99 7.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.915 1.686 . . . . 0.0 109.343 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.82 158.1 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.384 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.55 138.03 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.859 1.263 . . . . 0.0 109.964 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.6 164.24 20.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.266 1.826 . . . . 0.0 109.731 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 169.96 -155.84 26.05 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.673 -1.071 . . . . 0.0 114.224 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.36 -21.92 60.53 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.866 3.044 . . . . 0.0 112.784 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 14.5 t -152.05 164.53 37.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.616 1.566 . . . . 0.0 109.708 166.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -72.45 112.58 8.63 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.991 -1.068 . . . . 0.0 111.153 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.43 148.17 48.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.762 0.825 . . . . 0.0 111.088 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.19 144.1 25.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.045 0.538 . . . . 0.0 110.27 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.7 mt -134.27 144.93 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.056 1.342 . . . . 0.0 110.074 -163.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.5 t -142.45 162.28 35.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.766 1.226 . . . . 0.0 110.922 166.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -159.32 158.83 33.09 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.645 1.178 . . . . 0.0 112.622 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 55.7 m -142.55 123.93 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.273 1.429 . . . . 0.0 110.162 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.09 132.4 37.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.887 1.275 . . . . 0.0 111.152 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -112.71 148.18 35.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.215 1.406 . . . . 0.0 111.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -70.54 -14.03 62.34 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.111 0.964 . . . . 0.0 112.877 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.45 -6.44 50.12 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.707 1.603 . . . . 0.0 114.125 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 35.81 6.21 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.555 1.074 . . . . 0.0 113.519 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.3 p -141.16 161.21 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.307 1.443 . . . . 0.0 111.172 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 66.0 m -115.39 128.3 55.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.032 1.333 . . . . 0.0 108.785 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -89.01 147.63 24.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.65 0.78 . . . . 0.0 110.296 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -129.38 143.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 110.127 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 77.6 p -136.82 148.02 46.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.916 1.286 . . . . 0.0 111.755 167.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 12.8 p90 -152.75 157.02 40.22 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.66 105.93 35.23 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.857 1.663 . . . . 0.0 110.081 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.92 167.26 20.41 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.543 2.829 . . . . 0.0 110.31 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 30.7 m -136.17 -25.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -173.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.3 mt -118.26 147.99 42.84 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.042 1.337 . . . . 0.0 110.395 170.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.36 156.11 45.98 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.924 2.416 . . . . 0.0 110.952 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.53 -149.1 20.55 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.55 1.072 . . . . 0.0 112.997 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -113.7 128.27 56.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.041 1.336 . . . . 0.0 111.24 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -112.31 139.74 47.61 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.371 1.468 . . . . 0.0 110.929 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.6 m -97.79 122.28 40.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.642 1.177 . . . . 0.0 110.496 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.34 127.91 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.482 1.513 . . . . 0.0 108.543 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.88 133.02 53.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.778 1.631 . . . . 0.0 109.861 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.4 t -133.9 132.41 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.504 1.521 . . . . 0.0 108.123 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -156.67 144.49 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.852 1.261 . . . . 0.0 110.786 -167.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.7 118.69 12.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 51.57 59.57 4.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.446 1.498 . . . . 0.0 112.179 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 59.39 12.05 2.5 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.036 2.534 . . . . 0.0 116.424 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -119.57 125.43 48.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.389 1.076 . . . . 0.0 111.133 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -60.63 155.45 18.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.099 0.96 . . . . 0.0 112.774 171.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.5 m -74.51 152.19 87.51 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 169.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.05 -12.33 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.506 2.138 . . . . 0.0 114.897 -167.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -102.22 -11.6 36.07 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 174.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 80.5 p -84.5 156.07 62.38 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 120.055 1.927 . . . . 0.0 113.6 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.49 151.21 96.77 Favored 'Cis proline' 0 C--N 1.352 0.763 0 CA-C-N 118.982 0.672 . . . . 0.0 112.472 -4.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -102.42 160.05 14.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.43 1.492 . . . . 0.0 110.825 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 44.3 m -119.71 116.62 26.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.747 0.819 . . . . 0.0 110.57 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.73 126.43 43.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.529 1.132 . . . . 0.0 111.222 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.34 114.41 21.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.163 0.985 . . . . 0.0 108.926 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.7 t -103.34 136.2 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.065 0.946 . . . . 0.0 110.402 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 34.0 p -121.83 171.59 8.79 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 112.589 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.95 145.66 30.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.936 1.255 . . . . 0.0 112.686 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.57 -21.16 45.44 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.156 0.982 . . . . 0.0 112.863 174.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.867 1.667 . . . . 0.0 114.03 179.336 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.67 162.33 28.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.34 1.056 . . . . 0.0 113.03 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -69.29 157.75 36.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.032 1.333 . . . . 0.0 112.655 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . 49.34 58.1 17.9 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 126.04 1.736 . . . . 0.0 113.759 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.59 161.99 44.1 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.793 2.995 . . . . 0.0 112.483 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.35 154.56 38.03 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.421 1.489 . . . . 0.0 110.522 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.05 147.03 57.17 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.228 1.411 . . . . 0.0 112.622 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.84 154.02 38.31 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.463 2.775 . . . . 0.0 111.458 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 83.1 mt -105.92 26.21 9.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.39 1.476 . . . . 0.0 111.959 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 13.1 p -161.0 150.16 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.885 2.074 . . . . 0.0 110.318 -171.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 86.37 -152.16 25.13 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.582 1.087 . . . . 0.0 112.445 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 14.7 p -158.05 135.36 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.095 1.358 . . . . 0.0 110.802 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -97.17 -7.27 32.89 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.987 1.315 . . . . 0.0 113.87 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -66.12 156.76 49.78 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.98 1.276 . . . . 0.0 113.537 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.9 166.23 34.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.783 1.633 . . . . 0.0 111.517 -174.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 31.0 t70 68.79 -43.81 0.51 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.563 2.745 . . . . 0.0 113.929 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.7 p -61.27 -24.26 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.775 1.63 . . . . 0.0 112.89 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.7 t -81.59 -16.47 51.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.66 1.584 . . . . 0.0 112.929 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.62 38.71 0.76 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.816 1.647 . . . . 0.0 111.725 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 22.0 tp -98.46 134.4 41.5 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.434 1.894 . . . . 0.0 111.241 -171.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.3 120.28 46.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.311 1.044 . . . . 0.0 111.303 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.24 156.64 58.83 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.459 2.773 . . . . 0.0 110.922 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.1 t80 -108.12 127.72 54.06 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.656 0.782 . . . . 0.0 111.096 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.52 135.74 14.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.655 1.582 . . . . 0.0 110.785 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.39 152.48 41.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.518 1.927 . . . . 0.0 109.862 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.0 p -123.31 139.16 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.023 1.329 . . . . 0.0 110.469 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.24 137.49 29.42 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.271 1.828 . . . . 0.0 108.486 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -79.06 45.95 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.555 3.503 . . . . 0.0 112.999 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 29.2 t80 -91.15 153.49 20.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.135 1.374 . . . . 0.0 111.137 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.4 m -125.28 126.36 45.0 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.946 1.298 . . . . 0.0 109.746 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 95.2 mt -91.18 138.06 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.059 1.344 . . . . 0.0 109.917 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -149.74 95.96 2.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.501 1.12 . . . . 0.0 111.521 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 72.59 -31.74 0.23 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 128.539 2.736 . . . . 0.0 115.179 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.1 175.74 54.68 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.626 1.584 . . . . 0.0 113.443 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -111.45 141.68 44.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.235 1.414 . . . . 0.0 111.289 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -125.31 134.29 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.548 1.539 . . . . 0.0 110.602 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.18 170.64 17.97 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.183 1.793 . . . . 0.0 110.324 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -158.89 -167.48 19.67 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 115.884 1.114 . . . . 0.0 115.884 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.48 134.85 15.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.702 1.601 . . . . 0.0 109.264 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.0 t -104.53 131.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.694 1.598 . . . . 0.0 107.443 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -116.38 129.05 56.04 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.833 1.253 . . . . 0.0 110.657 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -97.02 150.68 37.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.71 1.604 . . . . 0.0 111.468 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.4 -20.56 27.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.507 2.804 . . . . 0.0 113.051 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -79.68 -0.54 34.44 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.945 1.698 . . . . 0.0 114.561 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.41 54.08 2.48 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.56 1.076 . . . . 0.0 113.161 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -155.62 167.04 31.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.064 1.746 . . . . 0.0 111.676 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.8 m -140.43 158.09 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.849 1.26 . . . . 0.0 112.58 -172.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.89 166.87 32.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.507 1.923 . . . . 0.0 110.892 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.01 137.73 20.16 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.2 -0.937 . . . . 0.0 111.588 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.77 163.96 20.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.958 3.105 . . . . 0.0 110.993 168.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.7 m -107.87 117.82 35.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.088 1.355 . . . . 0.0 108.852 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -97.64 133.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.43 1.092 . . . . 0.0 109.007 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -125.85 130.64 51.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.111 1.764 . . . . 0.0 109.901 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 17.5 t0 -75.52 122.23 23.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.169 0.988 . . . . 0.0 110.775 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -84.46 -15.4 46.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.7 tttt 71.39 0.22 3.37 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.614 2.366 . . . . 0.0 114.017 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.83 7.87 45.67 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.07 2.148 . . . . 0.0 113.023 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.83 15.12 55.39 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.983 1.278 . . . . 0.0 113.835 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.9 p -132.38 161.78 32.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.419 1.888 . . . . 0.0 110.3 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -125.4 145.24 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.787 1.235 . . . . 0.0 109.831 167.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.2 m -104.71 139.25 39.8 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.291 1.037 . . . . 0.0 108.564 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.7 t -124.14 129.49 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.912 1.285 . . . . 0.0 109.108 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -129.37 161.86 29.33 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -159.64 135.91 8.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 111.828 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.35 114.39 60.88 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.801 1.241 . . . . 0.0 110.602 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -83.97 165.82 13.21 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.723 2.949 . . . . 0.0 112.221 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.3 t -144.35 -1.5 0.92 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.92 152.02 3.49 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.509 1.924 . . . . 0.0 111.27 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.55 175.37 7.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.309 1.443 . . . . 0.0 114.49 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.86 -171.02 13.61 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 126.138 1.827 . . . . 0.0 113.985 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 59.3 tp -79.69 127.41 32.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.623 1.169 . . . . 0.0 110.454 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 55.0 m80 -125.69 168.99 12.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.809 1.644 . . . . 0.0 111.394 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -147.35 153.52 39.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.04 0.936 . . . . 0.0 111.77 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 22.1 ttm -124.34 133.71 53.37 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.117 1.767 . . . . 0.0 110.095 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -111.14 136.12 50.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.236 1.814 . . . . 0.0 109.829 169.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.1 mm -135.59 134.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.028 1.331 . . . . 0.0 110.451 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.03 140.42 36.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.366 1.066 . . . . 0.0 113.588 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.4 t80 -103.6 118.09 35.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.058 2.143 . . . . 0.0 109.256 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.81 31.92 11.41 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.826 1.25 . . . . 0.0 112.945 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.13 5.0 4.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.143 2.577 . . . . 0.0 115.171 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.8 ttp -95.4 127.94 41.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.595 1.158 . . . . 0.0 110.079 165.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.79 137.55 57.65 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.254 -0.904 . . . . 0.0 112.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -71.82 154.43 92.81 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.432 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.55 -17.86 61.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.582 2.188 . . . . 0.0 113.912 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -88.64 2.54 84.67 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.814 1.197 . . . . 0.0 114.88 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 31.5 t -101.94 142.62 24.97 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 119.822 1.811 . . . . 0.0 111.953 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.61 170.33 57.41 Favored 'Cis proline' 0 C--N 1.352 0.76 0 CA-C-N 119.816 0.97 . . . . 0.0 112.477 -3.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.2 mt -120.91 151.42 39.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.118 1.767 . . . . 0.0 110.38 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -132.67 144.73 50.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.73 1.212 . . . . 0.0 110.505 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 6.0 p90 -165.79 154.65 11.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.362 1.065 . . . . 0.0 112.304 -172.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 37.2 t80 -101.66 143.23 31.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 112.429 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 91.8 t -116.09 137.57 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.21 1.804 . . . . 0.0 109.413 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.0 t0 -159.6 147.64 17.3 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.857 1.263 . . . . 0.0 112.267 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -74.47 149.11 40.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 0.0 112.784 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 3.4 p -70.59 -22.33 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.507 -0.745 . . . . 0.0 112.83 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -82.67 -13.24 56.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.107 1.363 . . . . 0.0 114.174 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 82.9 m -58.98 134.49 57.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.535 1.134 . . . . 0.0 113.935 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.15 70.08 1.08 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.702 1.62 . . . . 0.0 111.772 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -162.6 168.58 21.55 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.652 1.581 . . . . 0.0 113.072 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.8 p -68.59 143.79 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.634 0.774 . . . . 0.0 110.074 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -163.52 159.51 22.08 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.692 1.597 . . . . 0.0 110.025 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -138.33 144.76 40.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.335 1.054 . . . . 0.0 112.358 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 45.0 p90 -167.67 165.44 14.32 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.683 1.593 . . . . 0.0 113.239 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.58 175.5 13.96 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.253 1.406 . . . . 0.0 112.977 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.56 -37.0 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.764 -171.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.06 91.34 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.538 1.063 . . . . 0.0 114.507 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.02 -6.51 52.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.704 1.252 . . . . 0.0 113.327 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 38.7 m -100.98 -54.73 2.73 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.222 1.809 . . . . 0.0 110.18 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -137.26 139.8 41.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.601 1.961 . . . . 0.0 112.375 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -129.97 172.84 20.01 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.058 1.313 . . . . 0.0 113.242 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 60.9 t -136.85 134.11 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.627 1.171 . . . . 0.0 108.948 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -56.95 139.23 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.0 m-80 66.16 2.24 2.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.86 2.064 . . . . 0.0 114.809 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.35 142.22 29.09 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.908 1.683 . . . . 0.0 111.096 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.79 119.21 5.95 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.637 2.224 . . . . 0.0 110.415 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -94.82 145.7 24.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.218 1.407 . . . . 0.0 109.996 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 76.0 p -136.18 151.57 49.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -168.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.7 p90 -162.87 176.16 10.49 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.461 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.9 m -134.05 138.34 45.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.707 1.203 . . . . 0.0 110.983 -169.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.4 t -102.09 134.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.186 1.394 . . . . 0.0 107.701 165.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -96.43 128.08 43.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.071 0.948 . . . . 0.0 109.824 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.1 p -129.39 7.46 5.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.379 1.872 . . . . 0.0 112.861 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -55.65 -32.17 62.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.91 1.684 . . . . 0.0 114.464 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.65 11.85 13.83 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.541 1.536 . . . . 0.0 113.063 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.03 -15.64 56.78 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.75 -128.75 8.62 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.344 0.973 . . . . 0.0 112.162 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -155.65 150.3 26.19 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.443 1.497 . . . . 0.0 110.723 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.3 -85.0 0.08 OUTLIER Glycine 0 N--CA 1.469 0.851 0 C-N-CA 125.482 1.515 . . . . 0.0 111.003 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -168.77 118.08 0.76 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.575 1.083 . . . . 0.0 112.222 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.14 138.2 32.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.439 1.096 . . . . 0.0 110.063 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.4 m -131.32 158.52 40.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.677 1.591 . . . . 0.0 111.547 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 43.2 tp -156.75 135.93 12.01 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.783 1.633 . . . . 0.0 108.893 -171.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.65 158.93 39.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.77 0.828 . . . . 0.0 112.346 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.0 mt -134.39 137.51 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 109.445 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.15 122.34 38.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.082 1.353 . . . . 0.0 109.379 172.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -139.1 -175.75 14.24 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.724 1.154 . . . . 0.0 114.08 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.5 -23.84 43.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.045 3.164 . . . . 0.0 112.112 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.3 t -136.59 152.23 50.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.506 1.522 . . . . 0.0 108.578 160.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.5 tptt -71.91 120.05 16.96 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.033 -1.042 . . . . 0.0 111.976 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.36 147.97 41.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.933 0.893 . . . . 0.0 111.681 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -89.81 142.85 27.3 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.505 0.722 . . . . 0.0 109.741 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.7 mt -135.11 143.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.587 1.155 . . . . 0.0 110.334 -167.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.2 t -143.19 158.22 43.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 110.838 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -158.74 157.31 31.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.442 1.097 . . . . 0.0 112.988 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 67.3 m -140.89 115.2 9.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.447 1.499 . . . . 0.0 109.868 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.85 136.92 36.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.026 1.331 . . . . 0.0 111.338 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -117.88 146.22 44.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.843 1.657 . . . . 0.0 111.986 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.86 -15.16 63.49 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.759 1.224 . . . . 0.0 112.496 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -70.87 -9.32 57.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.937 1.695 . . . . 0.0 114.159 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.88 33.73 7.22 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.266 0.936 . . . . 0.0 113.553 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.9 p -139.14 163.54 32.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.345 1.458 . . . . 0.0 110.931 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -130.88 125.64 34.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.453 1.501 . . . . 0.0 108.642 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -92.41 144.52 25.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.198 0.999 . . . . 0.0 110.589 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.9 t -126.62 141.7 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.542 1.537 . . . . 0.0 110.802 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 63.2 m -132.92 141.01 48.14 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.985 1.714 . . . . 0.0 110.795 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 10.6 p90 -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.56 104.56 49.45 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.375 1.87 . . . . 0.0 110.524 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.8 165.13 15.68 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.694 2.93 . . . . 0.0 110.199 166.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.0 p -127.77 -19.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.3 pp -146.84 152.06 43.48 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.188 0.995 . . . . 0.0 111.594 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -67.46 147.77 77.83 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.041 2.494 . . . . 0.0 112.838 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.21 -171.09 30.18 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.53 1.062 . . . . 0.0 113.708 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.92 134.64 34.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.956 1.302 . . . . 0.0 112.104 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.66 126.37 41.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.586 1.554 . . . . 0.0 109.842 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 62.6 m -88.37 124.33 33.82 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.987 -1.07 . . . . 0.0 110.708 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.0 128.31 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.512 1.525 . . . . 0.0 108.304 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.1 tt -112.31 130.34 55.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.426 1.49 . . . . 0.0 109.385 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 24.0 t -132.18 131.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.144 0.978 . . . . 0.0 109.577 173.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.98 147.48 27.92 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.122 1.369 . . . . 0.0 111.683 -168.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.57 120.25 11.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 109.8 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.12 56.24 5.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.6 1.56 . . . . 0.0 111.824 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.4 pt-20 57.24 13.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.415 2.686 . . . . 0.0 116.322 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -120.23 127.09 52.11 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.732 1.213 . . . . 0.0 110.641 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -63.69 147.08 52.54 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.324 -0.86 . . . . 0.0 112.079 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -70.77 153.73 94.69 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.758 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.43 129.64 30.49 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.632 2.221 . . . . 0.0 110.887 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 91.95 -14.76 63.5 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.103 1.335 . . . . 0.0 114.949 -175.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.8 t -78.42 142.63 62.84 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 119.433 1.617 . . . . 0.0 111.734 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.41 140.79 69.24 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.317 0.792 . . . . 0.0 111.989 -4.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -93.52 166.29 12.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.312 1.845 . . . . 0.0 110.689 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 51.3 m -124.44 113.99 18.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.816 0.847 . . . . 0.0 110.395 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.9 156.97 19.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.679 1.192 . . . . 0.0 110.953 167.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -120.9 126.55 50.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.184 0.993 . . . . 0.0 109.949 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.2 t -103.18 131.81 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.38 1.472 . . . . 0.0 109.793 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.2 p -108.99 162.1 14.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.73 1.212 . . . . 0.0 112.62 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.49 142.69 28.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.91 1.243 . . . . 0.0 112.089 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.3 t70 -87.16 -10.71 52.01 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.602 1.161 . . . . 0.0 113.52 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.617 1.967 . . . . 0.0 112.557 -177.564 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -75.92 -28.38 58.0 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.2 mtt -84.15 156.15 22.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.855 1.262 . . . . 0.0 112.107 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -67.26 150.0 98.13 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.304 1.042 . . . . 0.0 112.627 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.65 170.56 20.04 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.8 3.0 . . . . 0.0 112.014 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.41 154.17 42.43 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.135 0.974 . . . . 0.0 112.168 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -58.64 132.47 85.85 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.476 1.11 . . . . 0.0 111.49 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -72.89 164.74 34.72 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.464 2.776 . . . . 0.0 112.201 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -70.76 20.52 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.875 2.07 . . . . 0.0 115.622 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 14.3 p -159.32 147.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.341 1.856 . . . . 0.0 110.848 -170.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -154.62 172.96 33.1 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.32 1.438 . . . . 0.0 113.293 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 85.0 t -76.56 128.82 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.494 1.118 . . . . 0.0 110.046 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -78.4 -14.04 59.57 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 88.66 31.45 12.98 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.874 1.226 . . . . 0.0 113.704 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.27 144.83 56.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.821 1.249 . . . . 0.0 112.201 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 27.4 t70 -137.06 22.75 3.04 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.293 1.437 . . . . 0.0 111.921 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 17.8 m -71.34 145.04 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.19 1.396 . . . . 0.0 111.765 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 9.5 t 179.42 -43.31 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.744 2.418 . . . . 0.0 110.503 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 74.9 m -80.73 86.05 6.0 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.394 1.077 . . . . 0.0 112.131 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 61.5 mt -72.34 153.32 41.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.115 1.366 . . . . 0.0 110.968 165.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.22 115.34 10.3 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.551 1.54 . . . . 0.0 111.377 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.79 129.43 18.63 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.32 2.013 . . . . 0.0 108.852 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -114.83 128.88 56.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.616 0.766 . . . . 0.0 111.722 -171.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -157.67 142.72 16.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.817 1.647 . . . . 0.0 111.092 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.97 156.16 49.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.595 1.958 . . . . 0.0 110.141 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.5 p -122.35 137.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.904 1.282 . . . . 0.0 109.959 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 57.9 mt -131.64 133.48 24.31 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.999 1.72 . . . . 0.0 109.035 -172.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.94 112.1 3.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.266 2.644 . . . . 0.0 109.81 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.0 t80 -175.54 148.58 0.93 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.107 2.163 . . . . 0.0 109.177 -171.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.3 m -130.75 124.01 30.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.518 1.127 . . . . 0.0 109.234 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.7 mt -74.47 125.52 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.195 0.598 . . . . 0.0 110.265 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.6 mttp -110.42 -143.0 0.39 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.694 1.597 . . . . 0.0 110.513 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.46 120.29 19.82 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.651 -1.281 . . . . 0.0 110.883 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.98 -152.14 20.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.589 1.566 . . . . 0.0 112.303 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -160.31 147.47 16.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.956 1.302 . . . . 0.0 110.978 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.29 136.73 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.402 1.481 . . . . 0.0 111.207 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 25.2 p -149.58 174.31 12.67 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.573 1.949 . . . . 0.0 110.235 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -157.82 -166.33 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -152.34 142.3 22.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.234 1.813 . . . . 0.0 109.42 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.7 t -119.93 133.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.948 1.699 . . . . 0.0 108.673 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -109.97 132.89 53.75 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.665 1.186 . . . . 0.0 111.794 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -104.34 143.43 26.66 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.674 1.589 . . . . 0.0 111.219 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.08 -29.15 64.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.211 3.274 . . . . 0.0 114.994 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 6.1 m -69.94 -0.77 7.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.3 42.04 6.35 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.6 1.095 . . . . 0.0 112.839 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.59 162.65 39.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.809 1.644 . . . . 0.0 111.99 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.5 m -141.18 158.15 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.988 1.315 . . . . 0.0 112.204 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -151.53 179.1 8.66 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.018 2.127 . . . . 0.0 109.974 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.54 143.8 38.77 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 121.107 -0.996 . . . . 0.0 111.718 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -83.73 166.34 13.47 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.089 3.192 . . . . 0.0 111.405 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 77.5 m -107.21 130.58 54.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.4 1.48 . . . . 0.0 108.651 171.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.52 136.7 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.518 1.127 . . . . 0.0 109.443 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 63.0 m -133.26 124.26 27.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.659 1.584 . . . . 0.0 109.648 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.02 127.26 31.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.292 1.037 . . . . 0.0 111.076 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -87.52 -4.26 58.98 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -170.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 35.9 mmtm 71.57 -5.91 1.53 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.638 2.375 . . . . 0.0 114.538 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -98.21 2.79 48.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.715 2.006 . . . . 0.0 113.218 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.13 16.8 31.62 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.026 1.298 . . . . 0.0 114.457 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 65.1 p -128.75 157.39 41.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.016 1.726 . . . . 0.0 110.677 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -115.31 139.61 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.051 0.94 . . . . 0.0 109.633 163.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.1 m -96.7 138.05 34.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.659 1.184 . . . . 0.0 108.495 169.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 24.8 t -119.11 135.05 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.483 1.513 . . . . 0.0 109.052 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.1 152.77 51.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.558 1.543 . . . . 0.0 111.785 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -153.47 132.44 12.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.349 1.46 . . . . 0.0 110.914 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.43 117.89 70.0 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.236 1.014 . . . . 0.0 110.5 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.56 130.69 12.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.132 2.554 . . . . 0.0 111.823 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 78.2 p -118.7 -15.18 9.51 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -141.54 157.54 44.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.909 1.684 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -90.99 166.28 13.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.27 1.028 . . . . 0.0 112.004 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.24 -166.71 12.17 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.693 1.616 . . . . 0.0 114.079 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -91.77 122.28 34.18 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.338 1.455 . . . . 0.0 110.494 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.5 m80 -119.1 169.57 9.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 111.26 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.51 152.72 42.95 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 171.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 5.7 ttm -125.55 119.45 28.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.886 2.074 . . . . 0.0 109.928 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -95.86 138.4 33.57 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 109.967 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.6 mm -135.96 135.43 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.745 1.218 . . . . 0.0 110.577 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 141.1 32.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 113.329 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 20.6 t80 -103.14 120.26 40.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.153 1.781 . . . . 0.0 109.788 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.73 34.07 15.36 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.673 1.189 . . . . 0.0 112.701 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 73.29 5.35 5.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.92 2.488 . . . . 0.0 115.066 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -97.06 124.6 41.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.079 1.351 . . . . 0.0 109.921 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -57.51 136.11 56.68 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.265 -0.897 . . . . 0.0 112.938 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.3 pt -68.96 152.41 96.82 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.602 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.28 120.11 7.69 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.326 2.018 . . . . 0.0 109.748 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 90.86 7.57 66.11 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.664 -1.075 . . . . 0.0 115.5 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.2 t -74.16 142.11 78.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 120.283 2.041 . . . . 0.0 110.746 162.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -86.59 171.54 38.47 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 120.388 1.174 . . . . 0.0 113.205 -2.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.63 159.34 16.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.131 1.772 . . . . 0.0 110.62 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -133.47 138.86 46.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.614 1.166 . . . . 0.0 110.434 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -156.94 153.32 27.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.07 0.948 . . . . 0.0 112.863 -167.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 43.6 t80 -104.28 148.79 25.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.983 0.913 . . . . 0.0 112.916 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 32.2 t -132.41 139.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.613 1.565 . . . . 0.0 109.22 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.09 153.5 32.95 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.817 1.247 . . . . 0.0 113.023 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -75.69 125.99 30.14 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 111.35 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.0 p -68.72 -24.72 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.572 -0.705 . . . . 0.0 112.428 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.97 -26.02 63.9 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.996 1.318 . . . . 0.0 114.05 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 85.2 m -73.02 -24.61 60.75 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 74.44 7.19 78.14 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.697 1.141 . . . . 0.0 115.504 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -67.91 161.81 25.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.59 1.556 . . . . 0.0 113.629 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -68.26 127.43 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.7 t -156.21 162.78 40.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.41 1.084 . . . . 0.0 111.161 -167.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.4 147.01 31.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.082 1.353 . . . . 0.0 111.804 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.2 p90 -166.54 162.4 16.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.676 1.591 . . . . 0.0 112.355 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.97 173.34 13.26 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.3 1.428 . . . . 0.0 112.991 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.36 -32.56 15.84 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.989 2.46 . . . . 0.0 112.766 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.4 77.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.347 0.976 . . . . 0.0 114.498 -171.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.4 -2.93 44.01 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.865 1.332 . . . . 0.0 113.508 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -106.4 -40.41 5.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.709 2.003 . . . . 0.0 111.558 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -152.47 141.96 21.69 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.356 1.862 . . . . 0.0 111.92 -164.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.9 -179.91 23.35 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.032 1.301 . . . . 0.0 113.118 168.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 62.1 t -142.04 138.28 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.859 1.663 . . . . 0.0 107.831 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -54.91 134.52 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.3 m-80 69.18 -4.48 1.27 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.185 2.194 . . . . 0.0 114.644 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -95.51 137.25 22.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.598 1.159 . . . . 0.0 110.812 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.03 121.77 7.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.486 2.124 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.51 146.51 28.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.377 1.471 . . . . 0.0 110.319 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 73.2 p -138.92 151.2 46.73 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.09 174.43 13.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.0 1.72 . . . . 0.0 111.527 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.0 m -126.85 143.5 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.279 1.432 . . . . 0.0 110.769 -172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.4 t -117.12 134.69 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.017 1.727 . . . . 0.0 108.287 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.13 133.67 36.07 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.033 0.933 . . . . 0.0 111.811 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -134.8 0.87 2.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.433 1.493 . . . . 0.0 113.801 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -54.03 -40.14 66.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.313 1.845 . . . . 0.0 114.804 -167.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -119.92 12.07 11.95 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.708 1.603 . . . . 0.0 112.587 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.99 -35.94 69.61 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 82.37 145.11 5.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.947 1.261 . . . . 0.0 112.496 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.97 148.26 46.14 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.337 1.055 . . . . 0.0 112.142 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.69 -30.54 0.09 OUTLIER Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.51 1.052 . . . . 0.0 114.688 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 145.18 103.28 0.39 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.435 1.493 . . . . 0.0 112.662 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.38 131.49 35.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.232 1.413 . . . . 0.0 109.256 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 9.2 t -135.06 162.99 30.9 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.593 1.557 . . . . 0.0 112.211 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.9 tp -165.63 135.9 3.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.554 1.941 . . . . 0.0 109.205 -163.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.88 159.52 35.1 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.417 1.087 . . . . 0.0 111.956 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.45 135.83 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.523 1.129 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.3 136.23 53.96 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.108 1.363 . . . . 0.0 110.026 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -162.92 -165.02 19.29 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.509 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.98 -26.56 74.07 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.077 3.185 . . . . 0.0 112.514 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -135.87 156.53 48.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.735 1.214 . . . . 0.0 109.464 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -72.95 111.13 7.79 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.076 -1.015 . . . . 0.0 110.288 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.58 147.0 52.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.083 0.953 . . . . 0.0 111.96 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -84.94 135.07 34.21 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.5 mt -130.6 144.68 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 110.418 -166.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.7 t -145.18 165.02 29.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.824 1.25 . . . . 0.0 111.187 167.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -159.26 154.73 25.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.749 1.22 . . . . 0.0 112.528 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.6 m -138.97 125.09 20.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.524 1.53 . . . . 0.0 110.285 -172.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.11 128.79 35.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.715 1.206 . . . . 0.0 111.12 171.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -104.0 148.48 26.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.46 1.504 . . . . 0.0 111.686 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -68.18 -18.26 64.55 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.179 0.992 . . . . 0.0 113.556 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.02 -22.81 60.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.205 1.002 . . . . 0.0 113.695 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 104.52 45.62 1.41 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.287 0.946 . . . . 0.0 113.19 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -140.89 158.07 44.47 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.296 1.438 . . . . 0.0 110.005 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.5 m -107.92 127.36 53.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.638 1.175 . . . . 0.0 109.263 162.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -86.71 147.08 26.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.419 0.688 . . . . 0.0 109.955 166.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -127.98 144.2 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.67 1.588 . . . . 0.0 109.762 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.08 147.93 46.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.873 1.269 . . . . 0.0 111.98 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.9 p90 -151.88 154.25 35.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.15 107.69 43.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.231 1.812 . . . . 0.0 110.383 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -82.81 176.41 7.74 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.901 3.067 . . . . 0.0 110.333 167.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.2 p -151.45 -28.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 85.9 mt -107.58 147.03 34.54 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.53 1.059 . . . . 0.0 110.525 167.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.91 154.98 48.42 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.863 2.376 . . . . 0.0 110.824 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.89 -165.45 24.59 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.96 137.31 32.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.065 1.346 . . . . 0.0 112.506 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -125.36 125.87 44.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.849 1.66 . . . . 0.0 110.079 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 65.3 m -88.19 122.29 31.58 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.646 1.178 . . . . 0.0 110.643 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.69 123.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.437 1.495 . . . . 0.0 108.626 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.45 136.21 44.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.408 1.483 . . . . 0.0 109.318 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 98.4 t -140.32 127.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.173 1.389 . . . . 0.0 108.912 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.96 140.8 20.99 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.567 1.147 . . . . 0.0 111.331 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.4 121.04 14.28 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.465 1.106 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 49.8 t30 57.47 57.27 4.46 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.219 1.408 . . . . 0.0 111.581 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.0 pt-20 58.51 13.96 2.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.438 2.695 . . . . 0.0 116.372 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -124.83 125.9 44.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.382 1.073 . . . . 0.0 111.329 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -65.04 157.05 29.48 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.942 0.897 . . . . 0.0 112.547 169.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.1 m -75.81 152.65 84.93 Favored Pre-proline 0 N--CA 1.483 1.18 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.392 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.3 -13.01 37.97 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.08 1.853 . . . . 0.0 114.462 -166.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -100.24 -10.31 45.52 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.1 p -87.64 153.63 52.95 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 119.779 1.789 . . . . 0.0 113.148 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.11 141.09 68.21 Favored 'Cis proline' 0 C--N 1.352 0.732 0 CA-C-N 119.063 0.701 . . . . 0.0 112.107 -3.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -90.26 167.17 12.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.094 1.357 . . . . 0.0 110.281 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.2 m -128.35 112.15 14.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 110.048 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.76 150.23 23.71 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.383 1.073 . . . . 0.0 110.574 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -110.68 124.76 52.54 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.246 1.018 . . . . 0.0 109.78 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.4 t -107.5 135.05 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.922 1.289 . . . . 0.0 110.834 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.0 p -113.37 164.93 12.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.31 1.444 . . . . 0.0 112.561 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.93 143.15 29.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.007 1.289 . . . . 0.0 112.183 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.47 -14.93 47.78 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.429 1.091 . . . . 0.0 113.362 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.596 1.958 . . . . 0.0 112.524 -177.45 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.489 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.25 163.47 28.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.462 1.105 . . . . 0.0 112.876 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? -74.98 -15.23 60.68 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -70.02 151.6 96.07 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.881 1.272 . . . . 0.0 112.67 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.87 160.64 47.28 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.675 2.917 . . . . 0.0 111.78 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.8 128.71 36.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.025 0.93 . . . . 0.0 111.737 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -104.14 137.93 19.37 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.606 1.562 . . . . 0.0 110.049 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.64 151.55 74.89 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.085 2.523 . . . . 0.0 111.598 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 82.4 mt -80.48 50.27 1.27 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.294 1.437 . . . . 0.0 112.358 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 9.1 p -169.6 -40.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.124 2.17 . . . . 0.0 111.635 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -79.19 147.49 30.29 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.853 0.74 . . . . 0.0 111.608 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 27.2 m -141.54 140.03 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.812 1.245 . . . . 0.0 111.254 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -91.24 -10.67 40.73 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.802 1.241 . . . . 0.0 113.119 173.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -83.39 84.82 1.54 Allowed Glycine 0 C--N 1.342 0.902 0 C-N-CA 125.355 1.455 . . . . 0.0 110.812 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.63 163.18 26.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.282 1.833 . . . . 0.0 110.805 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -155.65 160.91 40.79 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.246 1.418 . . . . 0.0 112.431 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 21.4 m -133.51 14.97 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.466 1.506 . . . . 0.0 113.361 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.0 t -75.97 -27.82 57.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.159 0.984 . . . . 0.0 113.401 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 30.2 m -79.18 35.24 0.26 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.633 1.573 . . . . 0.0 113.52 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 21.6 tp -73.13 141.57 47.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.478 1.511 . . . . 0.0 111.927 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.0 ttm-85 -59.06 120.04 43.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.931 1.692 . . . . 0.0 111.908 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.37 159.26 47.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.523 2.816 . . . . 0.0 112.02 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.8 t80 -112.16 123.03 49.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.777 1.231 . . . . 0.0 110.098 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.2 134.26 15.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.064 1.346 . . . . 0.0 110.514 170.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.9 140.81 31.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.686 1.594 . . . . 0.0 109.9 -170.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.1 p -107.67 138.93 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.715 1.206 . . . . 0.0 110.855 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.8 mt -134.08 134.99 23.52 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.348 1.859 . . . . 0.0 108.812 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.04 109.22 2.78 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.411 2.74 . . . . 0.0 110.1 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 48.4 t80 -175.2 151.62 1.31 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.999 2.12 . . . . 0.0 109.821 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 29.1 m -135.06 130.93 36.36 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.615 1.166 . . . . 0.0 110.057 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.98 122.35 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 109.437 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.64 -69.91 0.84 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.45 1.1 . . . . 0.0 112.322 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -158.79 127.14 5.24 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.782 1.633 . . . . 0.0 110.952 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.39 -139.54 11.04 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.51 1.528 . . . . 0.0 111.158 -166.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.09 142.29 17.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.366 1.066 . . . . 0.0 111.385 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.7 tt -121.65 135.49 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.785 1.634 . . . . 0.0 111.032 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.4 p -149.28 169.08 21.6 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.182 1.793 . . . . 0.0 110.596 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -162.07 -175.6 33.27 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 115.711 1.045 . . . . 0.0 115.711 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -153.21 143.35 22.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.654 1.582 . . . . 0.0 109.839 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.8 t -115.67 132.49 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.931 1.692 . . . . 0.0 108.101 171.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -119.03 137.47 53.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 110.898 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.8 mtt -110.56 146.67 34.83 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.463 1.505 . . . . 0.0 111.591 -169.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.63 -28.9 77.24 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.919 3.079 . . . . 0.0 114.944 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.5 p -74.51 0.58 14.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.046 1.738 . . . . 0.0 114.37 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.77 83.18 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.692 1.615 . . . . 0.0 113.947 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -72.96 159.11 34.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.742 1.617 . . . . 0.0 112.182 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.4 m -145.72 155.93 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.641 1.576 . . . . 0.0 111.074 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.68 166.5 26.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.442 1.497 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -100.06 137.63 20.13 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.175 0.99 . . . . 0.0 111.506 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.69 169.29 12.15 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.195 3.263 . . . . 0.0 111.827 171.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 86.9 m -110.24 119.75 40.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.667 1.587 . . . . 0.0 109.002 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.75 129.93 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.279 1.032 . . . . 0.0 109.026 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 35.0 m -125.99 116.13 20.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.861 1.664 . . . . 0.0 109.001 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.01 124.0 27.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.616 -0.678 . . . . 0.0 110.045 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.09 -10.24 59.75 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 72.97 -3.37 2.44 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.023 2.529 . . . . 0.0 113.864 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -93.86 1.19 56.45 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.665 1.986 . . . . 0.0 113.33 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.74 14.16 38.21 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.102 1.334 . . . . 0.0 114.472 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 76.1 p -128.37 157.12 41.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.407 1.883 . . . . 0.0 110.348 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -113.61 137.9 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.513 0.725 . . . . 0.0 109.59 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.5 m -102.29 128.88 48.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.649 1.179 . . . . 0.0 107.993 168.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.4 t -113.74 128.98 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.944 1.298 . . . . 0.0 108.95 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -126.53 154.4 43.88 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.231 1.812 . . . . 0.0 111.619 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.4 t80 -158.99 134.98 8.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.76 1.224 . . . . 0.0 112.275 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.91 119.96 70.66 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.562 1.145 . . . . 0.0 110.648 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.36 150.68 15.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.526 2.817 . . . . 0.0 111.798 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.4 m -132.2 -8.07 3.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -166.98 145.98 5.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.583 1.553 . . . . 0.0 110.325 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.56 170.66 16.17 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 0.0 113.523 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.84 178.77 17.88 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.484 1.516 . . . . 0.0 114.405 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 51.6 tp -75.98 103.21 5.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.191 1.397 . . . . 0.0 110.426 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -96.73 159.46 14.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 111.251 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.64 149.87 36.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 111.627 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 25.3 ttm -134.27 135.67 43.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.387 1.875 . . . . 0.0 110.645 -163.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -118.26 126.36 52.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.904 1.682 . . . . 0.0 109.763 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -127.94 130.13 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.818 1.247 . . . . 0.0 109.727 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 141.1 33.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.4 t80 -103.23 120.3 40.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.257 1.823 . . . . 0.0 109.5 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.15 32.6 10.8 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.766 1.226 . . . . 0.0 112.953 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 75.07 7.32 4.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.052 2.541 . . . . 0.0 115.195 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.4 mtp -99.19 128.03 45.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.921 1.288 . . . . 0.0 110.315 166.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -55.41 136.18 49.72 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.32 -0.862 . . . . 0.0 113.03 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.6 pt -73.12 150.63 90.05 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.883 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.39 131.62 39.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.532 2.155 . . . . 0.0 110.398 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.36 63.43 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.764 1.173 . . . . 0.0 114.51 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.33 150.24 44.35 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.59 1.695 . . . . 0.0 110.922 172.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.98 164.34 88.1 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 120.715 1.291 . . . . 0.0 113.317 -1.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.71 161.32 21.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.937 1.695 . . . . 0.0 111.322 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -157.86 148.99 21.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.391 1.077 . . . . 0.0 112.125 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -168.28 157.8 9.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.302 1.441 . . . . 0.0 111.885 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.4 t80 -95.04 128.69 42.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.056 -1.028 . . . . 0.0 112.685 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.4 t -93.13 135.13 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.501 1.52 . . . . 0.0 108.777 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.79 148.12 20.63 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.324 1.05 . . . . 0.0 112.717 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.34 144.47 51.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.105 1.362 . . . . 0.0 113.295 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.8 p -76.21 -28.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.208 1.003 . . . . 0.0 113.59 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -85.05 -19.48 31.87 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 73.1 m -67.27 149.16 50.76 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.325 1.05 . . . . 0.0 113.401 -173.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.53 -13.52 63.08 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.826 1.203 . . . . 0.0 114.831 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -64.23 153.39 38.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 118.713 1.257 . . . . 0.0 113.296 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.9 p -64.79 135.72 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.727 0.811 . . . . 0.0 110.001 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 9.6 t -154.64 157.27 37.91 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.729 1.212 . . . . 0.0 110.836 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.1 145.59 39.67 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.495 1.118 . . . . 0.0 111.975 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.5 p90 -165.91 165.16 18.35 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.91 1.684 . . . . 0.0 112.236 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.84 175.28 14.0 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.178 1.371 . . . . 0.0 113.123 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 -34.29 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.704 2.269 . . . . 0.0 113.057 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.65 -34.25 86.91 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.578 1.081 . . . . 0.0 114.444 -171.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.95 -4.67 48.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.797 1.299 . . . . 0.0 113.41 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.5 m -106.07 -47.74 3.77 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.446 1.898 . . . . 0.0 110.989 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -143.66 149.14 36.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.46 1.904 . . . . 0.0 112.341 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -145.43 178.27 23.29 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.451 1.024 . . . . 0.0 113.721 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 50.3 t -139.25 135.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 108.451 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.6 m -57.26 136.41 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.29 -0.72 2.07 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.168 2.187 . . . . 0.0 114.442 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -104.17 140.47 21.1 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.408 1.483 . . . . 0.0 110.881 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.54 120.19 6.57 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.613 2.209 . . . . 0.0 110.326 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.74 135.23 42.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.251 1.42 . . . . 0.0 110.155 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.6 p -129.41 147.24 51.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -165.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.46 175.8 13.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.628 1.571 . . . . 0.0 111.636 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.3 m -130.33 142.82 50.51 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.995 1.318 . . . . 0.0 110.839 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -113.04 132.82 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.862 1.665 . . . . 0.0 108.135 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.73 129.86 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.214 1.006 . . . . 0.0 110.393 173.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.7 p -132.92 2.29 3.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.42 1.488 . . . . 0.0 113.859 -166.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -50.22 -38.16 38.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.484 1.913 . . . . 0.0 115.346 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -128.88 20.47 5.96 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.439 1.496 . . . . 0.0 112.387 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.58 64.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.16 146.7 7.63 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.171 1.367 . . . . 0.0 113.039 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -75.88 148.06 38.58 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.423 1.089 . . . . 0.0 111.968 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.24 -30.1 0.17 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.692 1.139 . . . . 0.0 114.531 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.41 112.66 0.87 Allowed Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.511 1.529 . . . . 0.0 112.82 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.08 128.9 34.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.369 1.468 . . . . 0.0 109.209 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 37.2 m -126.95 156.04 42.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.996 1.718 . . . . 0.0 111.781 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.8 134.94 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.656 1.582 . . . . 0.0 109.103 -169.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.14 35.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.015 0.926 . . . . 0.0 112.275 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.24 139.31 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.874 1.27 . . . . 0.0 109.934 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.86 129.47 38.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.294 1.438 . . . . 0.0 110.095 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.52 -159.77 9.54 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.83 -0.984 . . . . 0.0 114.342 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.41 -23.08 71.56 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.101 3.201 . . . . 0.0 112.757 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.9 t -146.29 161.34 40.51 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.266 1.426 . . . . 0.0 109.542 163.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.74 113.63 8.02 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.002 -1.061 . . . . 0.0 111.078 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.15 147.9 49.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.73 0.812 . . . . 0.0 111.389 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.44 139.16 30.8 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.297 0.639 . . . . 0.0 109.532 168.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 28.7 mt -130.98 138.55 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.565 1.146 . . . . 0.0 110.325 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.5 m -129.79 152.65 49.05 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.737 1.615 . . . . 0.0 110.473 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -151.88 151.39 31.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.079 0.951 . . . . 0.0 112.332 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.5 m -140.9 116.44 10.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.205 1.402 . . . . 0.0 110.114 -169.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -72.26 135.63 46.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.161 0.985 . . . . 0.0 111.04 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -112.34 150.65 30.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.476 1.51 . . . . 0.0 111.863 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -72.75 -12.01 60.84 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.68 1.28 52.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.209 1.403 . . . . 0.0 114.553 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.53 30.9 8.68 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.523 1.059 . . . . 0.0 114.218 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 40.7 p -133.76 170.92 14.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.854 1.262 . . . . 0.0 111.703 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 53.5 t -130.57 130.85 44.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.496 1.919 . . . . 0.0 108.724 165.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.0 t -94.1 147.78 22.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.284 1.034 . . . . 0.0 110.935 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -126.97 143.57 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.81 1.644 . . . . 0.0 109.981 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -139.89 139.19 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.515 1.526 . . . . 0.0 110.603 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -144.91 151.74 39.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.7 mt -113.8 101.99 54.37 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.033 1.733 . . . . 0.0 110.288 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.46 164.8 23.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.442 2.762 . . . . 0.0 110.058 166.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.6 m -136.41 -22.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 92.1 mt -117.98 147.86 42.21 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.033 1.333 . . . . 0.0 110.234 170.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.96 155.39 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.656 2.238 . . . . 0.0 110.759 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.97 -165.65 23.41 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.684 1.135 . . . . 0.0 113.295 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.6 137.59 32.25 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.806 1.242 . . . . 0.0 112.973 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.74 124.8 40.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.797 1.639 . . . . 0.0 109.93 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -84.18 129.43 34.89 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.994 -1.066 . . . . 0.0 110.714 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.92 130.47 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.625 1.57 . . . . 0.0 108.127 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.8 tt -111.66 132.19 54.77 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.438 1.495 . . . . 0.0 109.613 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -134.46 128.12 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 172.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.5 141.09 23.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 111.433 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.09 121.75 15.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.43 1.092 . . . . 0.0 110.062 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.8 57.76 3.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.322 1.449 . . . . 0.0 111.496 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.1 pt-20 56.34 19.92 4.33 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.305 2.642 . . . . 0.0 116.172 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.48 128.65 37.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.719 1.207 . . . . 0.0 110.989 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.32 150.85 42.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.741 0.816 . . . . 0.0 112.237 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 7.9 m -67.12 154.19 93.13 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.039 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -52.68 -31.69 51.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.984 3.123 . . . . 0.0 116.29 -170.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.36 -4.6 59.53 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -84.33 143.29 41.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.153 1.477 . . . . 0.0 112.33 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.75 140.98 70.34 Favored 'Cis proline' 0 C--N 1.352 0.719 0 CA-C-N 119.106 0.717 . . . . 0.0 112.169 -4.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.35 172.86 8.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.193 1.797 . . . . 0.0 110.491 173.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.7 m -136.7 119.04 15.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.712 0.805 . . . . 0.0 110.567 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.91 158.57 16.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.214 1.406 . . . . 0.0 111.082 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -120.84 127.88 52.32 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.198 0.999 . . . . 0.0 110.287 169.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.8 t -107.17 132.74 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.759 -172.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 56.7 m -101.21 155.32 18.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.311 1.844 . . . . 0.0 111.612 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.55 138.35 23.05 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.709 1.147 . . . . 0.0 112.119 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 -82.65 -18.43 41.1 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 125.565 1.546 . . . . 0.0 113.773 178.82 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -63.39 -19.04 64.33 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -173.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -82.9 -13.37 56.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.796 1.238 . . . . 0.0 113.797 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -69.87 -48.58 21.72 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 117.218 -1.373 . . . . 0.0 114.602 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.86 154.64 43.35 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.525 2.15 . . . . 0.0 111.829 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.03 150.2 25.05 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.421 1.088 . . . . 0.0 111.539 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -156.89 135.88 7.94 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.933 1.293 . . . . 0.0 111.375 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.02 175.84 10.88 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.951 3.101 . . . . 0.0 112.069 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.73 10.79 1.0 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.791 1.636 . . . . 0.0 115.372 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 83.3 t -60.79 139.18 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.811 1.645 . . . . 0.0 110.732 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 112.69 -5.73 26.08 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.969 1.271 . . . . 0.0 114.884 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 16.3 m -61.68 142.64 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 118.647 1.224 . . . . 0.0 111.508 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 30.9 m120 -77.01 150.4 35.82 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.146 0.978 . . . . 0.0 113.257 -173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 76.39 -174.41 53.62 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.979 1.276 . . . . 0.0 114.257 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.36 147.81 45.2 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.88 1.672 . . . . 0.0 110.393 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 41.0 t0 -81.4 158.36 24.66 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.178 0.991 . . . . 0.0 112.368 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 16.0 m -144.04 144.85 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.244 1.818 . . . . 0.0 110.507 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 12.9 t -177.57 -33.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.769 2.027 . . . . 0.0 111.96 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 15.3 m -58.77 142.99 48.56 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.968 1.307 . . . . 0.0 114.196 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 1.7 mt -161.04 166.41 28.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.161 2.184 . . . . 0.0 109.159 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -59.86 116.63 17.83 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.446 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.31 154.81 32.36 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.736 2.291 . . . . 0.0 111.025 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.3 t80 -100.9 128.97 46.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.236 0.541 . . . . 0.0 110.411 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -156.25 148.28 23.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.819 1.648 . . . . 0.0 110.836 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.09 152.89 17.57 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.126 1.37 . . . . 0.0 110.632 -174.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.3 p -125.8 133.15 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.201 1.4 . . . . 0.0 109.483 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 73.7 mt -132.15 135.33 26.31 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.901 1.68 . . . . 0.0 109.163 -167.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.57 112.74 3.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.995 2.463 . . . . 0.0 109.868 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.0 t80 -177.2 150.28 0.72 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.175 2.19 . . . . 0.0 109.435 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.4 m -132.1 128.72 38.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.381 1.072 . . . . 0.0 109.77 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.23 118.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.811 0.844 . . . . 0.0 109.834 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.0 pttt -90.95 -146.13 0.19 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.772 1.629 . . . . 0.0 112.393 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -72.84 -12.62 61.05 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.09 -149.04 19.67 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.86 1.695 . . . . 0.0 113.032 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.94 156.17 44.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 111.345 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.52 138.28 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 111.381 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.7 p -149.19 163.73 36.79 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.114 1.766 . . . . 0.0 110.76 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.56 -174.43 15.83 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.72 136.87 14.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.256 1.823 . . . . 0.0 108.915 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.01 134.19 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.748 1.619 . . . . 0.0 107.94 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -118.61 130.68 56.01 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.187 0.995 . . . . 0.0 111.207 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -96.52 152.23 38.49 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.069 1.748 . . . . 0.0 111.665 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.31 -21.89 26.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.378 2.719 . . . . 0.0 113.014 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.5 p -80.51 2.18 26.42 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.712 1.605 . . . . 0.0 114.5 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.36 54.15 2.62 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.515 1.055 . . . . 0.0 113.233 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -156.4 166.97 31.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.052 1.741 . . . . 0.0 111.681 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.6 159.25 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.587 1.155 . . . . 0.0 113.068 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.04 -178.65 7.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.802 2.441 . . . . 0.0 109.757 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.55 145.5 53.35 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 120.612 -1.305 . . . . 0.0 112.562 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.64 173.4 6.28 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.551 3.501 . . . . 0.0 111.696 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.0 m -108.75 136.18 48.75 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.524 1.53 . . . . 0.0 108.835 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.08 134.44 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.092 1.357 . . . . 0.0 109.187 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -136.11 121.83 19.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.539 1.535 . . . . 0.0 109.743 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.14 128.0 33.64 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.601 0.76 . . . . 0.0 110.617 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.63 -7.56 59.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 39.5 tttm 74.36 -5.24 2.13 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.437 2.695 . . . . 0.0 113.723 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -94.57 1.41 55.64 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.944 2.098 . . . . 0.0 113.329 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.2 16.37 32.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.108 1.337 . . . . 0.0 114.379 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.08 155.27 45.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.041 1.737 . . . . 0.0 110.608 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -113.6 135.95 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.98 0.912 . . . . 0.0 109.979 165.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.5 m -92.06 138.08 31.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.445 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.6 t -127.34 136.03 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.201 1.4 . . . . 0.0 109.026 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -141.58 155.02 45.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.811 1.244 . . . . 0.0 112.692 -174.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 31.6 t80 -154.41 133.17 12.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.522 1.529 . . . . 0.0 111.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -81.88 127.55 71.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.408 1.083 . . . . 0.0 111.214 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.09 175.03 10.79 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.835 3.024 . . . . 0.0 112.231 -173.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 19.0 t -162.89 -38.09 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.16 0.984 . . . . 0.0 113.227 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -135.0 150.78 50.39 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.828 1.651 . . . . 0.0 110.331 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -85.64 172.28 11.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 0.0 113.524 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.99 -170.49 13.34 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 126.121 1.819 . . . . 0.0 113.72 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.4 tp -81.32 131.02 35.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 110.43 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 59.5 m80 -128.69 163.5 24.97 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.065 1.746 . . . . 0.0 111.101 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -142.43 157.54 44.66 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.162 0.985 . . . . 0.0 111.266 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 67.0 ttp -141.16 123.87 16.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.388 1.075 . . . . 0.0 111.845 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -85.91 139.75 30.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.335 1.854 . . . . 0.0 110.373 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.17 128.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.295 1.438 . . . . 0.0 108.199 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 138.05 30.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -104.03 123.91 48.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.914 2.086 . . . . 0.0 110.336 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.91 34.34 13.38 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.47 1.108 . . . . 0.0 112.586 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 36.2 t30 78.66 2.3 2.56 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 128.519 2.727 . . . . 0.0 114.942 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.5 129.81 54.39 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.723 1.609 . . . . 0.0 111.035 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.06 139.09 35.91 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.85 147.43 97.86 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.925 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.62 120.25 7.59 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.532 2.155 . . . . 0.0 111.722 -165.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -8.96 72.37 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.338 1.447 . . . . 0.0 115.157 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 12.8 m -74.58 157.79 85.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 120.047 1.923 . . . . 0.0 112.359 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.87 161.48 91.45 Favored 'Cis proline' 0 C--N 1.355 0.881 0 CA-C-N 119.844 0.98 . . . . 0.0 113.999 5.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.47 162.11 13.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.885 1.674 . . . . 0.0 110.905 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -142.3 138.98 31.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.729 1.211 . . . . 0.0 110.503 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.47 167.74 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.751 1.221 . . . . 0.0 112.146 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 18.5 t80 -110.29 141.57 43.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.996 0.918 . . . . 0.0 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.4 t -112.04 138.08 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.946 1.698 . . . . 0.0 108.469 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t0 -156.4 151.62 26.51 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -75.61 95.89 3.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.283 1.433 . . . . 0.0 111.522 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 16.3 m -58.47 -23.1 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.293 1.437 . . . . 0.0 114.447 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.69 -13.68 44.74 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 97.9 m -75.92 156.67 34.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.211 1.004 . . . . 0.0 113.25 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.19 77.82 2.06 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.227 1.394 . . . . 0.0 112.35 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -163.9 154.71 15.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.099 1.759 . . . . 0.0 112.356 173.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.7 p -73.35 135.3 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.283 1.033 . . . . 0.0 110.434 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 5.9 t -152.78 171.37 18.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.572 1.149 . . . . 0.0 111.682 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -153.68 150.39 28.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.531 1.133 . . . . 0.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.68 164.81 6.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.052 1.741 . . . . 0.0 112.93 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.55 173.16 12.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.34 1.448 . . . . 0.0 113.167 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.55 -34.75 18.99 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.082 2.521 . . . . 0.0 112.762 -172.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.18 -33.5 85.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.895 0.77 . . . . 0.0 114.373 -172.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.22 0.13 38.03 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.744 1.272 . . . . 0.0 113.878 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.7 m -107.04 -38.85 5.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.414 1.886 . . . . 0.0 111.536 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -157.76 146.58 19.43 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.127 1.371 . . . . 0.0 112.993 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 -173.89 21.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.874 1.702 . . . . 0.0 112.852 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.7 p -150.89 138.61 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.981 1.312 . . . . 0.0 109.245 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.9 m -57.64 141.36 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 27.5 m120 69.53 -5.29 1.19 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.131 2.173 . . . . 0.0 114.728 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -102.18 144.29 28.3 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.338 1.455 . . . . 0.0 111.045 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.24 130.56 15.37 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.566 2.178 . . . . 0.0 110.625 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.91 147.05 32.78 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.548 . . . . 0.0 110.437 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.7 p -136.84 147.3 46.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -160.03 176.05 12.28 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.291 1.836 . . . . 0.0 110.936 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 82.8 m -134.01 136.75 44.28 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.152 0.981 . . . . 0.0 111.097 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 20.5 t -98.08 132.22 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.55 . . . . 0.0 107.752 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -98.66 116.74 31.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 109.753 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -121.3 8.69 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.685 1.994 . . . . 0.0 113.007 -166.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -52.75 -38.35 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.73 1.612 . . . . 0.0 113.786 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -92.39 -12.47 32.15 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.109 1.364 . . . . 0.0 113.637 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.23 68.32 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.168 0.987 . . . . 0.0 112.975 -172.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 76.76 -76.26 1.59 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.229 1.395 . . . . 0.0 113.848 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -163.46 150.15 12.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.395 1.878 . . . . 0.0 110.078 -171.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 133.39 -2.48 4.61 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.965 1.269 . . . . 0.0 115.085 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 99.81 117.66 4.04 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.73 1.634 . . . . 0.0 113.48 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 129.22 34.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.809 1.644 . . . . 0.0 109.247 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -121.4 153.05 38.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.411 1.485 . . . . 0.0 111.575 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.9 tp -159.83 134.8 7.96 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.356 1.462 . . . . 0.0 109.464 -170.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.29 161.3 37.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.338 1.055 . . . . 0.0 112.08 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.6 mt -137.4 132.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.622 1.169 . . . . 0.0 109.433 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -121.72 112.66 18.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.238 1.415 . . . . 0.0 109.684 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.26 12.92 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.23 -22.12 54.03 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.936 . . . . 0.0 111.998 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.4 t -135.29 157.86 45.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.237 1.415 . . . . 0.0 109.132 157.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -75.62 119.28 19.45 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.914 -1.116 . . . . 0.0 111.38 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.07 148.79 43.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.232 1.013 . . . . 0.0 111.7 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.67 139.91 32.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.235 0.614 . . . . 0.0 109.587 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.35 143.35 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.443 1.097 . . . . 0.0 110.362 -168.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.0 t -143.43 160.78 39.94 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.031 1.332 . . . . 0.0 110.846 167.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -157.42 155.28 30.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.334 1.054 . . . . 0.0 112.979 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -138.65 117.01 11.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.6 1.56 . . . . 0.0 110.198 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -74.83 136.37 41.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.077 1.351 . . . . 0.0 111.471 172.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -117.47 146.83 43.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.539 1.536 . . . . 0.0 112.016 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -68.16 -13.22 62.06 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.09 -5.1 45.01 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.652 1.581 . . . . 0.0 113.982 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.32 30.11 8.97 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.754 1.169 . . . . 0.0 113.858 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.2 p -137.44 165.0 27.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.299 1.44 . . . . 0.0 111.484 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -127.68 122.57 33.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.663 1.585 . . . . 0.0 108.796 164.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -87.51 145.87 26.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.959 0.903 . . . . 0.0 110.592 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.4 t -125.85 141.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.578 1.551 . . . . 0.0 110.321 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 67.3 m -130.96 140.71 50.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.884 1.673 . . . . 0.0 110.632 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -146.24 151.73 38.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.72 105.62 40.68 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.686 1.994 . . . . 0.0 110.494 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -86.62 160.3 9.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.043 3.162 . . . . 0.0 110.7 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -119.98 -21.82 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -169.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.52 149.32 36.83 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.857 1.263 . . . . 0.0 110.587 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.97 153.64 37.42 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.88 2.387 . . . . 0.0 112.432 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.67 -167.72 27.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.095 1.331 . . . . 0.0 113.393 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -91.08 128.56 36.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.013 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -118.77 127.35 53.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.678 1.591 . . . . 0.0 109.805 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.11 121.31 30.37 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.86 0.864 . . . . 0.0 110.448 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.27 127.21 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.19 1.396 . . . . 0.0 108.111 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.91 130.37 55.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.278 1.431 . . . . 0.0 109.5 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.1 t -132.99 129.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.276 1.03 . . . . 0.0 109.457 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 147.51 26.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 111.418 -166.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 2.2 t80 -140.9 126.14 18.55 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.794 1.238 . . . . 0.0 110.279 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.1 t-20 45.07 58.9 3.76 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.117 1.367 . . . . 0.0 113.245 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.311 7.9 pt-20 60.02 13.8 3.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.107 2.563 . . . . 0.0 116.596 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -125.65 128.46 47.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.48 1.112 . . . . 0.0 111.352 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.84 151.55 45.19 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.055 -1.028 . . . . 0.0 112.716 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 29.1 m -65.48 152.05 93.12 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.65 163.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.37 -20.04 66.03 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.476 2.117 . . . . 0.0 114.84 -167.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -94.46 -6.58 61.05 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -86.64 143.83 36.49 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 119.049 1.424 . . . . 0.0 112.33 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.74 141.29 71.33 Favored 'Cis proline' 0 C--N 1.354 0.819 0 CA-C-N 119.117 0.72 . . . . 0.0 112.064 -4.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -92.68 166.8 12.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.966 1.706 . . . . 0.0 110.041 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.7 m -131.75 119.71 21.68 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.536 0.734 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -103.16 137.53 41.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.949 1.3 . . . . 0.0 111.737 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -86.05 117.29 24.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.5 t -92.42 130.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.101 0.96 . . . . 0.0 109.207 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.1 m -105.13 159.92 15.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.756 1.623 . . . . 0.0 110.644 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.9 138.22 23.38 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.119 0.866 . . . . 0.0 111.969 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -89.39 -18.65 26.42 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.221 1.408 . . . . 0.0 113.584 -174.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 126.61 1.964 . . . . 0.0 112.703 -175.657 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.541 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.16 155.68 39.39 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.268 1.027 . . . . 0.0 112.758 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.7 mmm -85.43 -12.38 52.13 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.505 1.122 . . . . 0.0 113.913 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -68.89 144.72 96.13 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 124.345 1.058 . . . . 0.0 112.637 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.29 163.13 32.95 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.76 2.973 . . . . 0.0 111.96 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -156.65 144.4 19.28 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.423 1.489 . . . . 0.0 110.139 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -135.72 145.27 52.38 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.502 1.521 . . . . 0.0 110.235 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.24 146.0 27.93 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.354 2.703 . . . . 0.0 111.639 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 29.0 tp -83.0 65.46 8.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.792 1.237 . . . . 0.0 110.974 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 7.2 p -160.26 148.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.632 1.573 . . . . 0.0 111.138 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -144.7 -174.36 16.89 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.495 1.521 . . . . 0.0 113.32 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 99.7 t -62.23 134.69 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.505 1.122 . . . . 0.0 110.365 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 8.7 p30 -156.81 162.38 39.72 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.104 1.362 . . . . 0.0 112.551 -174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -172.75 -174.72 40.15 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.981 1.277 . . . . 0.0 113.835 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.96 150.44 39.04 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.643 1.177 . . . . 0.0 111.998 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.01 -24.94 59.65 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.356 1.062 . . . . 0.0 112.895 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.1 p -159.46 145.48 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.989 2.116 . . . . 0.0 109.407 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 12.3 t -169.2 -34.63 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.994 1.718 . . . . 0.0 111.902 -175.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 31.6 m -64.53 103.9 0.73 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.568 1.147 . . . . 0.0 111.841 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 30.0 tp -112.86 128.53 56.48 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.617 1.567 . . . . 0.0 109.745 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -60.27 118.27 31.84 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.119 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.42 159.5 46.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.277 2.651 . . . . 0.0 111.318 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.01 123.23 36.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.429 0.692 . . . . 0.0 109.225 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.17 130.46 16.57 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.331 1.453 . . . . 0.0 109.956 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.39 141.53 27.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.266 1.426 . . . . 0.0 109.931 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -118.79 137.76 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.96 137.49 25.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.331 1.853 . . . . 0.0 108.738 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.48 37.99 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.386 3.39 . . . . 0.0 113.526 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.38 161.32 17.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.54 1.536 . . . . 0.0 110.499 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 87.6 m -133.42 130.2 38.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.019 1.327 . . . . 0.0 109.688 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 115.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.362 1.065 . . . . 0.0 110.304 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -92.94 -163.27 1.02 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.218 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.0 pttp -71.91 132.52 44.47 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.806 -1.184 . . . . 0.0 112.052 169.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.53 -141.7 12.29 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.319 1.438 . . . . 0.0 111.631 -167.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.31 143.74 18.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.853 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.6 tt -134.68 136.48 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.292 1.837 . . . . 0.0 110.367 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 33.4 p -145.6 165.27 29.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.603 1.561 . . . . 0.0 110.849 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.65 176.46 29.22 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -151.94 138.17 18.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.128 1.771 . . . . 0.0 109.644 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.2 t -111.79 134.46 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.241 1.816 . . . . 0.0 108.651 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -113.7 123.16 49.23 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.862 1.665 . . . . 0.0 110.209 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.8 mtm -98.05 146.64 31.84 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.703 1.601 . . . . 0.0 111.466 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.28 -16.21 28.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.799 2.999 . . . . 0.0 113.144 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.7 p -74.42 0.28 15.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.806 1.642 . . . . 0.0 114.197 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.39 42.38 5.53 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.722 1.153 . . . . 0.0 113.538 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -152.66 169.26 23.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.392 1.477 . . . . 0.0 112.525 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.0 m -139.22 159.25 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.899 1.28 . . . . 0.0 112.848 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.8 171.26 19.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.078 2.151 . . . . 0.0 110.257 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -110.55 142.36 25.92 Favored Pre-proline 0 CA--C 1.547 0.831 0 O-C-N 121.103 -0.998 . . . . 0.0 112.344 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.22 175.87 3.91 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.57 3.513 . . . . 0.0 112.385 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.1 m -108.02 130.24 55.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.444 1.498 . . . . 0.0 108.963 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.84 131.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.149 1.379 . . . . 0.0 108.676 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.4 m -132.94 130.36 39.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.373 1.469 . . . . 0.0 110.05 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -82.45 126.46 32.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.164 0.586 . . . . 0.0 110.106 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -80.59 -7.6 59.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.2 mttp 71.77 7.4 5.9 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.592 2.357 . . . . 0.0 113.606 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.07 7.59 23.62 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.345 2.258 . . . . 0.0 112.597 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 19.35 35.55 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.974 1.274 . . . . 0.0 114.317 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.8 p -134.23 158.19 44.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.105 1.762 . . . . 0.0 110.267 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 27.2 m -116.13 148.1 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.568 1.147 . . . . 0.0 110.13 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 50.6 m -113.99 136.48 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 41.7 t -119.91 134.8 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.202 1.401 . . . . 0.0 108.925 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.21 154.96 50.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.896 1.279 . . . . 0.0 113.16 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.5 t80 -153.77 136.89 15.57 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.565 1.546 . . . . 0.0 111.927 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.2 117.26 67.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.023 1.329 . . . . 0.0 110.804 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.36 156.02 16.69 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.96 3.106 . . . . 0.0 112.656 -172.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.4 m -118.29 -18.39 9.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -163.66 155.12 16.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.665 1.586 . . . . 0.0 110.572 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -69.07 168.49 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.576 1.15 . . . . 0.0 113.531 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.06 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.598 1.571 . . . . 0.0 114.138 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.5 tp -79.09 129.61 34.64 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.744 1.218 . . . . 0.0 110.677 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.8 m80 -130.27 162.0 29.96 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.587 1.555 . . . . 0.0 111.373 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.71 156.15 41.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 111.786 172.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -138.92 126.85 22.31 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.112 1.765 . . . . 0.0 109.956 -168.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.46 122.4 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.335 1.454 . . . . 0.0 109.389 175.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 42.8 mm -120.89 135.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.129 1.372 . . . . 0.0 109.805 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.78 137.72 20.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.6 t80 -99.3 123.27 43.45 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.823 2.049 . . . . 0.0 109.857 175.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.15 33.42 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.785 1.234 . . . . 0.0 112.729 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 22.6 t30 75.77 5.94 3.89 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 128.123 2.569 . . . . 0.0 115.109 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.36 131.62 51.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.806 1.643 . . . . 0.0 110.884 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m170 -56.8 134.09 54.83 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.057 -1.027 . . . . 0.0 113.213 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.33 155.86 89.49 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.402 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.85 125.87 19.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.367 2.045 . . . . 0.0 109.761 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.69 53.54 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.725 1.155 . . . . 0.0 114.344 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.7 t -84.6 148.06 50.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.054 1.427 . . . . 0.0 111.919 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.38 159.99 94.35 Favored 'Cis proline' 0 C--N 1.352 0.72 0 CA-C-N 119.936 1.013 . . . . 0.0 112.062 -7.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.36 152.19 20.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.401 1.48 . . . . 0.0 110.523 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -151.43 134.41 15.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.469 1.108 . . . . 0.0 110.259 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.91 165.05 18.43 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.373 1.069 . . . . 0.0 112.504 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 44.2 t80 -103.19 139.76 38.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.168 0.987 . . . . 0.0 112.154 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 78.1 t -105.34 140.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.195 1.798 . . . . 0.0 109.24 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.4 t0 -156.41 149.12 23.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.087 1.355 . . . . 0.0 111.455 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.99 147.18 51.99 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.462 -0.774 . . . . 0.0 112.44 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 95.0 t -72.0 -29.04 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.071 0.948 . . . . 0.0 111.383 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -80.73 -7.7 59.44 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.6 m -58.52 137.44 57.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.481 1.113 . . . . 0.0 113.386 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.2 -19.87 40.8 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.951 1.263 . . . . 0.0 114.086 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.68 158.91 31.15 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.267 1.033 . . . . 0.0 113.457 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.9 p -62.49 138.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 110.176 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.0 t -159.67 156.68 28.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.17 1.388 . . . . 0.0 110.653 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.25 145.7 47.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.581 1.152 . . . . 0.0 112.65 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.3 p90 -168.17 157.1 9.18 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.881 1.673 . . . . 0.0 113.233 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 147.62 173.65 18.86 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.092 1.329 . . . . 0.0 113.985 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.82 -38.84 12.61 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.27 2.647 . . . . 0.0 112.468 -173.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.19 -18.46 74.91 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.017 0.826 . . . . 0.0 114.099 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 15.7 tp -82.25 -11.21 58.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.562 1.145 . . . . 0.0 112.55 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.1 m -116.59 -40.06 3.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.415 1.886 . . . . 0.0 111.776 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -136.25 169.84 16.99 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.956 2.502 . . . . 0.0 111.489 -172.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -168.29 173.2 43.06 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 121.046 -1.034 . . . . 0.0 113.215 164.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 64.7 t -136.9 130.65 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.728 1.211 . . . . 0.0 108.622 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.7 m -57.16 142.61 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.0 m-80 67.12 2.07 2.62 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.804 2.042 . . . . 0.0 114.606 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 93.7 mttt -118.79 141.6 30.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.791 1.636 . . . . 0.0 111.017 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.95 136.63 30.29 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.659 2.24 . . . . 0.0 110.853 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.74 146.48 42.77 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.1 p -135.58 150.37 49.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.124 0.97 . . . . 0.0 113.462 -164.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.5 p90 -160.69 176.9 11.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.672 1.589 . . . . 0.0 111.661 175.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 39.7 m -130.19 143.89 51.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.232 1.413 . . . . 0.0 110.552 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.8 t -116.81 126.16 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 108.088 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.01 126.7 34.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.106 0.962 . . . . 0.0 110.696 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.3 p -134.32 4.49 3.44 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.092 1.357 . . . . 0.0 113.769 -167.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.2 tttp -54.96 -36.52 65.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.791 1.636 . . . . 0.0 114.789 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.19 14.17 10.49 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.815 1.646 . . . . 0.0 112.516 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -78.66 -11.53 59.98 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.93 -130.86 10.06 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.514 1.054 . . . . 0.0 112.267 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -160.95 161.55 31.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.037 1.735 . . . . 0.0 110.238 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 147.38 -14.28 1.43 Allowed Glycine 0 N--CA 1.475 1.29 0 C-N-CA 125.104 1.335 . . . . 0.0 115.284 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.45 105.73 0.92 Allowed Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.836 1.684 . . . . 0.0 112.482 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.02 125.98 32.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.11 1.364 . . . . 0.0 108.874 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.9 m -124.13 159.69 29.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.879 1.671 . . . . 0.0 112.118 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.7 tp -159.07 137.4 10.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.794 1.637 . . . . 0.0 109.404 -170.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.81 156.37 34.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.372 1.069 . . . . 0.0 111.935 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.75 135.52 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.534 1.134 . . . . 0.0 109.795 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.12 127.67 43.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.419 1.488 . . . . 0.0 109.787 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -153.15 -165.12 13.12 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.132 -0.816 . . . . 0.0 114.499 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.09 -24.15 66.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.087 3.191 . . . . 0.0 112.664 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.7 t -140.27 153.25 46.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.007 1.323 . . . . 0.0 109.739 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -72.56 117.17 13.91 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.167 -0.958 . . . . 0.0 111.049 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.81 153.16 37.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.481 1.112 . . . . 0.0 112.133 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.27 141.65 28.51 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 161.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.5 mt -138.37 138.54 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.758 1.223 . . . . 0.0 110.011 -163.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 65.1 m -137.98 158.1 45.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.515 1.526 . . . . 0.0 111.147 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.1 p -154.33 155.03 34.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 75.6 m -143.67 122.69 12.82 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.179 1.392 . . . . 0.0 110.66 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.94 113.61 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 165.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 27.6 p30 -83.53 -7.46 59.52 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 71.5 0.36 3.44 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -88.22 -11.09 47.66 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.326 1.45 . . . . 0.0 113.137 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 132.79 1.74 4.07 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.452 1.501 . . . . 0.0 115.661 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 64.4 p -137.27 156.66 48.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.231 1.516 . . . . 0.0 112.143 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 79.7 m -104.21 128.14 51.9 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.344 1.458 . . . . 0.0 109.115 165.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.8 t -91.48 151.89 20.59 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.126 0.97 . . . . 0.0 110.763 172.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.1 t -132.33 144.54 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.765 1.626 . . . . 0.0 110.041 -176.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 76.0 p -140.98 148.08 39.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.809 1.243 . . . . 0.0 112.236 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.9 p90 -152.51 156.72 39.95 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.16 -0.963 . . . . 0.0 113.212 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.15 106.18 43.53 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.117 1.367 . . . . 0.0 110.871 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -82.6 174.45 9.67 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.976 3.117 . . . . 0.0 110.884 168.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -150.24 -30.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.1 mt -105.99 146.96 33.93 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.502 1.046 . . . . 0.0 110.393 166.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.22 157.37 41.89 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.874 2.383 . . . . 0.0 110.946 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.85 -162.39 24.18 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.778 1.18 . . . . 0.0 113.621 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.49 125.92 35.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.187 1.395 . . . . 0.0 112.303 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -113.84 126.38 55.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.374 1.47 . . . . 0.0 109.203 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.2 m -89.45 127.7 35.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.147 0.979 . . . . 0.0 110.734 175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.9 128.11 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.841 1.257 . . . . 0.0 108.943 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.71 129.93 53.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.661 1.584 . . . . 0.0 109.361 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.0 t -130.19 132.44 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.536 1.134 . . . . 0.0 109.221 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.95 140.7 20.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.326 1.45 . . . . 0.0 111.357 -168.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 117.8 15.32 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.441 1.096 . . . . 0.0 110.017 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 50.7 t-20 56.61 63.6 1.91 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.686 1.594 . . . . 0.0 111.774 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.281 9.2 pt-20 55.63 18.68 2.91 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.234 2.613 . . . . 0.0 116.423 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -132.81 129.04 38.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.782 1.233 . . . . 0.0 110.922 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.4 m170 -64.17 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.917 0.887 . . . . 0.0 112.354 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.7 m -70.87 152.81 95.02 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.437 169.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.28 133.62 41.41 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.643 2.228 . . . . 0.0 111.224 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.58 63.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.899 1.237 . . . . 0.0 114.928 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.3 t -81.08 144.33 54.47 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.009 1.405 . . . . 0.0 111.68 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.43 140.34 64.32 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.014 1.041 . . . . 0.0 112.682 -1.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -95.05 175.81 6.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.595 1.958 . . . . 0.0 110.958 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -135.26 127.01 29.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.103 0.961 . . . . 0.0 110.687 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -106.69 140.55 39.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.684 . . . . 0.0 110.981 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.16 108.46 21.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.115 0.966 . . . . 0.0 110.178 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 87.8 t -90.84 143.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.917 1.287 . . . . 0.0 110.135 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.5 t -131.1 172.26 12.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.487 1.115 . . . . 0.0 112.767 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.42 142.8 26.39 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.746 1.641 . . . . 0.0 112.739 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.0 t70 -88.84 -17.67 29.23 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.435 1.094 . . . . 0.0 113.198 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.017 1.727 . . . . 0.0 114.386 -179.553 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 55.91 -117.9 1.17 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.404 1.481 . . . . 0.0 111.566 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -79.79 -15.76 56.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.625 1.17 . . . . 0.0 113.88 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -81.14 153.21 71.88 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.167 0.987 . . . . 0.0 111.896 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.95 -10.6 23.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.665 2.91 . . . . 0.0 113.983 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.41 78.48 3.93 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.71 1.204 . . . . 0.0 110.703 176.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -78.35 135.74 61.18 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.088 1.355 . . . . 0.0 111.026 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.37 162.68 14.03 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.757 2.971 . . . . 0.0 113.056 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 84.1 mt -79.68 54.22 1.76 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.317 1.447 . . . . 0.0 112.743 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 32.7 m -76.55 -6.54 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.432 1.493 . . . . 0.0 114.35 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 89.16 -164.16 32.05 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.797 1.189 . . . . 0.0 113.432 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 20.6 m -145.19 156.87 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.667 1.587 . . . . 0.0 111.169 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 9.0 p30 -162.16 157.91 23.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.7 1.6 . . . . 0.0 112.439 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -89.96 -162.65 38.53 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.371 1.462 . . . . 0.0 114.204 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.04 157.45 36.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.778 1.231 . . . . 0.0 112.174 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 45.1 t0 -100.55 162.76 12.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.202 1.401 . . . . 0.0 111.165 175.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 34.0 m -59.82 -23.49 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.7 t -75.64 -18.05 59.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.451 1.5 . . . . 0.0 113.459 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 49.6 m -67.12 128.15 35.3 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.174 -0.954 . . . . 0.0 113.196 -172.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 76.3 mt -89.04 159.57 17.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.868 1.667 . . . . 0.0 111.038 171.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 121.64 68.6 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.852 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.27 156.18 51.04 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.144 2.563 . . . . 0.0 111.002 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1791 ' ' PHE . . . . . 0.478 ' CE2' ' HE1' ' A' 1842 ' ' MET . 1.4 t80 -116.05 122.13 44.28 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.389 0.676 . . . . 0.0 110.966 174.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -148.69 151.87 35.67 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.743 1.617 . . . . 0.0 110.618 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 151.84 24.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.575 1.55 . . . . 0.0 109.949 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -125.95 133.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.927 1.291 . . . . 0.0 109.43 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.81 137.17 30.19 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.037 1.735 . . . . 0.0 108.673 -171.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.94 49.48 3.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.658 3.572 . . . . 0.0 112.827 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.3 t80 -93.91 153.0 18.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.463 1.505 . . . . 0.0 110.625 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 127.31 47.19 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.92 1.288 . . . . 0.0 110.217 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.6 mt -92.61 136.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.042 1.337 . . . . 0.0 109.203 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.9 tptt -129.04 -60.22 1.09 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.151 0.98 . . . . 0.0 112.49 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -159.15 131.06 6.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.316 1.846 . . . . 0.0 110.388 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.65 -146.82 16.54 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.292 1.425 . . . . 0.0 111.384 -166.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -157.7 144.84 18.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.577 1.151 . . . . 0.0 110.914 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.85 136.15 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.57 1.548 . . . . 0.0 110.864 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.8 p -148.0 174.4 11.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.165 1.786 . . . . 0.0 110.525 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.64 -171.31 27.53 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.83 146.07 23.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.571 1.949 . . . . 0.0 109.603 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 21.5 t -123.25 138.43 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.331 1.852 . . . . 0.0 108.351 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 68.7 mtm-85 -127.61 142.19 51.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.897 0.879 . . . . 0.0 112.037 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 5.3 mpp? -118.6 148.66 44.68 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.596 1.558 . . . . 0.0 111.936 -173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.01 -29.57 89.6 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.121 3.214 . . . . 0.0 114.886 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 12.5 m -72.93 3.32 5.44 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.88 42.14 6.47 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.556 1.074 . . . . 0.0 112.833 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -148.16 158.26 43.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.842 1.657 . . . . 0.0 111.854 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.9 m -143.21 162.52 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.108 1.363 . . . . 0.0 112.035 -171.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.58 -179.44 8.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.706 2.003 . . . . 0.0 110.923 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -128.96 147.73 65.99 Favored Pre-proline 0 CA--C 1.544 0.74 0 O-C-N 121.185 -0.947 . . . . 0.0 111.601 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -86.94 173.89 5.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.229 3.286 . . . . 0.0 112.191 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.0 m -110.39 135.47 51.05 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.458 1.503 . . . . 0.0 108.75 170.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.6 131.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.954 1.302 . . . . 0.0 108.693 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 89.4 m -132.66 126.85 33.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.475 1.51 . . . . 0.0 109.306 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.8 136.11 40.24 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.021 0.528 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -88.21 -12.69 43.06 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 56.7 tttt 70.63 6.07 5.67 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.219 2.208 . . . . 0.0 113.708 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -105.87 11.15 32.14 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.208 2.203 . . . . 0.0 112.751 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.78 16.15 52.56 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.889 1.233 . . . . 0.0 113.964 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 40.1 p -134.41 158.93 42.61 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 110.622 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.0 m -122.87 143.47 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.794 1.238 . . . . 0.0 110.084 168.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 35.0 m -98.47 138.09 36.2 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.351 1.46 . . . . 0.0 108.831 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 46.1 t -125.13 134.97 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.741 1.617 . . . . 0.0 108.824 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -140.8 156.58 46.12 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.894 1.277 . . . . 0.0 112.594 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 23.2 t80 -153.77 133.11 12.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.732 1.613 . . . . 0.0 111.216 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.19 119.83 73.78 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.4 1.08 . . . . 0.0 110.493 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.67 134.64 15.31 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.238 2.625 . . . . 0.0 111.691 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.2 m -131.73 8.06 4.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.558 1.143 . . . . 0.0 113.12 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -160.18 155.84 25.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.047 1.739 . . . . 0.0 109.912 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.63 175.95 6.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.315 1.046 . . . . 0.0 112.563 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 98.14 -170.4 24.79 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.297 1.427 . . . . 0.0 114.199 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 44.8 tp -76.87 121.85 24.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.924 1.289 . . . . 0.0 110.243 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 12.8 m80 -111.96 164.35 13.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.78 1.632 . . . . 0.0 110.863 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.56 149.79 35.22 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.669 -0.645 . . . . 0.0 111.954 162.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1842 ' ' MET . . . . . 0.478 ' HE1' ' CE2' ' A' 1791 ' ' PHE . 42.4 ttm -121.36 139.82 52.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.614 1.966 . . . . 0.0 110.121 178.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.73 134.55 52.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.318 1.447 . . . . 0.0 109.808 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.39 136.42 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.811 1.644 . . . . 0.0 109.433 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 141.07 28.36 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.094 0.958 . . . . 0.0 113.53 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.4 t80 -107.3 122.5 46.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.389 2.276 . . . . 0.0 109.65 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 31.71 10.12 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.56 1.144 . . . . 0.0 112.432 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.0 t30 76.05 5.17 3.79 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.333 2.653 . . . . 0.0 115.071 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.6 mtm -102.44 132.27 48.57 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.526 1.531 . . . . 0.0 110.83 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 12.0 m170 -57.37 136.67 56.61 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 113.142 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 25.5 pt -77.45 153.06 81.52 Favored Pre-proline 0 N--CA 1.48 1.03 0 O-C-N 121.76 -0.588 . . . . 0.0 111.294 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.28 134.15 50.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.158 1.906 . . . . 0.0 109.671 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.4 -13.69 64.14 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.343 0.973 . . . . 0.0 113.973 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.15 146.7 31.77 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 119.11 1.455 . . . . 0.0 111.179 173.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.23 160.67 95.4 Favored 'Cis proline' 0 C--N 1.353 0.802 0 CA-C-N 120.688 1.282 . . . . 0.0 113.455 2.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 75.8 mt -112.06 133.68 54.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.786 2.034 . . . . 0.0 109.054 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -130.16 134.4 47.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.261 1.024 . . . . 0.0 110.575 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -163.12 162.67 25.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.05 0.94 . . . . 0.0 112.817 -175.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.6 t80 -106.57 144.58 33.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.267 1.027 . . . . 0.0 112.88 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 56.2 t -118.95 138.23 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.34 1.456 . . . . 0.0 110.124 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -155.54 147.95 23.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.361 1.064 . . . . 0.0 112.766 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -63.17 142.63 58.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.34 1.456 . . . . 0.0 112.94 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.7 p -67.27 -23.97 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.5 p30 -75.42 -17.06 60.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.7 m -68.21 143.35 55.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.919 0.888 . . . . 0.0 113.357 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -89.99 -17.14 54.73 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.865 1.221 . . . . 0.0 114.36 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -67.25 163.88 19.52 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.466 1.133 . . . . 0.0 113.283 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 4.5 t -66.53 136.94 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.535 1.134 . . . . 0.0 109.52 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 56.7 p -132.65 162.16 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.456 1.102 . . . . 0.0 110.682 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.55 142.21 28.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.358 1.063 . . . . 0.0 110.969 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.9 p90 -166.01 159.94 16.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.616 1.566 . . . . 0.0 112.362 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.74 170.84 12.69 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.329 1.443 . . . . 0.0 113.159 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.05 -32.77 33.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.29 2.66 . . . . 0.0 112.849 -171.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.75 -13.93 72.31 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.936 -0.924 . . . . 0.0 114.791 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.99 -12.64 60.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.128 1.464 . . . . 0.0 112.966 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 15.5 m -119.38 -38.42 3.02 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.684 1.593 . . . . 0.0 112.431 -165.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -156.11 155.03 31.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.61 -173.75 25.5 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.469 1.033 . . . . 0.0 113.033 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.9 p -150.74 136.45 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.647 1.179 . . . . 0.0 109.286 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.7 m -56.57 140.82 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.59 -4.45 1.65 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.396 2.278 . . . . 0.0 114.924 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.65 143.31 26.43 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.965 1.306 . . . . 0.0 110.867 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.54 127.59 11.89 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.461 2.107 . . . . 0.0 110.723 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.48 148.7 26.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.431 1.492 . . . . 0.0 110.361 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.6 p -137.25 155.07 49.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.1 0.96 . . . . 0.0 113.507 -167.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -164.48 172.84 12.8 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.562 1.945 . . . . 0.0 111.404 177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.1 m -128.01 144.23 51.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.691 1.596 . . . . 0.0 110.731 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 46.9 t -120.11 130.52 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.123 1.769 . . . . 0.0 108.454 171.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m120 -87.37 127.82 35.2 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.372 -0.83 . . . . 0.0 111.162 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 50.9 p -131.49 3.35 4.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.352 1.461 . . . . 0.0 113.36 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -55.93 -40.03 72.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.781 1.632 . . . . 0.0 114.328 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.34 4.64 22.8 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.523 1.529 . . . . 0.0 112.896 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.05 -25.92 59.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.349 1.06 . . . . 0.0 113.329 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 -92.47 1.46 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.766 1.174 . . . . 0.0 112.664 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -166.6 179.03 5.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.013 1.725 . . . . 0.0 111.863 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 116.52 5.76 15.96 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.998 1.285 . . . . 0.0 115.477 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.99 105.6 2.16 Favored Glycine 0 N--CA 1.47 0.961 0 C-N-CA 125.503 1.525 . . . . 0.0 113.079 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.23 132.1 34.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 109.179 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -128.26 161.02 30.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.69 1.596 . . . . 0.0 112.142 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.2 tp -159.08 136.55 10.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.699 1.599 . . . . 0.0 109.646 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.67 162.3 37.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.713 1.205 . . . . 0.0 111.776 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 41.2 mt -139.03 132.83 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.404 1.082 . . . . 0.0 109.935 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.29 163.76 14.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.769 1.627 . . . . 0.0 110.083 168.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 167.56 -158.49 31.39 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.179 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.72 -22.2 50.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.686 2.924 . . . . 0.0 112.435 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.3 t -147.11 158.54 43.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 109.499 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.63 112.05 9.35 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.977 -1.077 . . . . 0.0 110.595 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -66.47 150.72 48.53 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.119 0.968 . . . . 0.0 111.739 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.51 137.51 32.27 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.409 0.684 . . . . 0.0 109.315 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 35.1 mt -132.2 143.83 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.443 1.097 . . . . 0.0 110.428 -165.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.41 163.0 35.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 111.301 168.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -157.7 156.76 32.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 112.777 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -138.22 125.26 21.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.907 1.683 . . . . 0.0 110.069 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.34 128.92 33.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 110.862 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -107.98 151.94 25.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.292 1.437 . . . . 0.0 112.434 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -68.87 -16.81 63.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.05 0.94 . . . . 0.0 112.719 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.45 -6.39 48.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.724 1.61 . . . . 0.0 113.968 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.73 33.12 8.61 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.499 1.047 . . . . 0.0 113.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.8 p -136.74 156.77 48.07 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.815 1.246 . . . . 0.0 111.15 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.7 m -102.71 127.6 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.956 0.902 . . . . 0.0 108.903 157.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.8 t -92.21 145.83 24.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.746 0.818 . . . . 0.0 109.796 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.8 t -130.38 143.69 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.129 1.372 . . . . 0.0 109.976 -175.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.1 p -134.08 149.45 51.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.05 1.34 . . . . 0.0 111.919 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.89 152.82 33.07 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 18.8 mt -115.64 105.69 51.43 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.394 1.878 . . . . 0.0 110.207 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.71 170.63 15.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.573 2.849 . . . . 0.0 110.332 167.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -144.99 -28.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -172.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.93 147.89 36.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 110.394 166.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.97 156.22 52.38 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.83 2.353 . . . . 0.0 110.775 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.3 -167.84 23.65 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.98 1.276 . . . . 0.0 113.382 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.6 128.37 39.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.784 1.234 . . . . 0.0 112.262 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -112.47 140.5 47.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.46 1.904 . . . . 0.0 110.496 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.3 m -105.03 111.94 24.89 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.992 1.317 . . . . 0.0 110.229 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.03 122.27 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.023 1.329 . . . . 0.0 108.383 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.25 125.8 47.92 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.572 1.549 . . . . 0.0 109.231 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.1 t -126.71 129.38 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.27 1.028 . . . . 0.0 109.442 171.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.68 142.83 24.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.921 1.288 . . . . 0.0 111.943 -167.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.12 123.67 22.22 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 109.701 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.5 t-20 52.56 57.13 6.72 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.559 1.543 . . . . 0.0 112.541 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.1 pt-20 58.42 12.17 1.94 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.295 2.638 . . . . 0.0 116.286 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.97 125.28 49.04 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.629 1.172 . . . . 0.0 110.779 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.43 143.38 57.15 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.47 -0.769 . . . . 0.0 111.591 172.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.5 m -72.22 152.01 92.37 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.058 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -56.02 125.44 19.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.148 2.566 . . . . 0.0 111.115 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.73 64.33 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.458 1.504 . . . . 0.0 115.316 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 141.56 68.89 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.264 1.532 . . . . 0.0 111.804 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.69 145.54 79.63 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.587 0.888 . . . . 0.0 112.275 -3.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -96.55 139.4 32.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.585 1.554 . . . . 0.0 110.763 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -100.66 107.47 19.11 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.328 0.651 . . . . 0.0 110.63 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.51 125.17 45.22 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.652 1.181 . . . . 0.0 111.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -95.78 116.69 29.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.518 0.727 . . . . 0.0 110.685 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -99.43 133.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.045 1.738 . . . . 0.0 110.678 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 60.2 p -104.12 169.25 8.6 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.296 1.438 . . . . 0.0 112.959 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.83 142.03 25.07 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.946 1.26 . . . . 0.0 111.691 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.48 -11.51 59.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.49 1.116 . . . . 0.0 113.781 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 126.662 1.985 . . . . 0.0 112.577 -179.81 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.27 163.8 27.59 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.479 1.112 . . . . 0.0 112.862 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.8 ttt -72.42 -31.3 65.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 0.0 112.502 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -72.28 150.24 91.87 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.61 1.164 . . . . 0.0 112.128 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.28 171.58 17.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.638 2.892 . . . . 0.0 111.509 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -71.57 123.22 21.98 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.462 0.705 . . . . 0.0 110.57 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -79.91 145.95 62.8 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.063 0.945 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.99 162.04 37.81 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.657 2.904 . . . . 0.0 111.845 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 68.0 tp -115.52 131.16 57.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.181 1.392 . . . . 0.0 109.792 172.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 96.2 t -105.19 128.6 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.149 1.38 . . . . 0.0 108.396 170.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 74.03 -149.67 41.41 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 123.844 0.735 . . . . 0.0 112.357 -174.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 49.1 t -136.6 138.24 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.712 1.605 . . . . 0.0 108.842 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -64.99 -28.61 69.63 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 87.97 -3.03 85.94 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.426 1.489 . . . . 0.0 115.189 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.21 144.47 37.27 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.222 1.409 . . . . 0.0 111.115 176.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 39.3 t0 -160.22 149.36 17.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.211 1.804 . . . . 0.0 110.149 172.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . 0.276 1.1 p 50.7 15.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 128.244 2.618 . . . . 0.0 115.461 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.7 t -75.26 -12.02 60.19 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.884 1.674 . . . . 0.0 113.675 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 74.0 p -73.98 75.31 1.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.114 1.366 . . . . 0.0 111.619 173.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 23.3 tp -91.09 129.43 37.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.499 1.519 . . . . 0.0 109.764 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -66.42 119.06 59.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.918 -168.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.46 154.59 60.5 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.315 2.676 . . . . 0.0 111.715 -171.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.7 123.25 42.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.786 0.834 . . . . 0.0 110.194 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -153.18 130.2 11.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.446 1.498 . . . . 0.0 110.344 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.71 143.46 30.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.854 1.662 . . . . 0.0 109.83 -172.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.1 p -112.45 138.59 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.057 1.343 . . . . 0.0 110.571 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 70.8 mt -131.53 136.6 28.81 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.412 1.885 . . . . 0.0 108.71 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.66 45.47 1.96 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.503 3.469 . . . . 0.0 112.926 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 75.1 t80 -91.53 155.12 18.62 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.254 1.422 . . . . 0.0 111.462 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 95.7 m -125.43 125.86 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.549 1.54 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.7 134.25 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.346 1.058 . . . . 0.0 110.641 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -113.18 -141.78 0.38 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.845 1.658 . . . . 0.0 110.656 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.2 135.66 33.63 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.91 -1.119 . . . . 0.0 110.956 166.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 132.98 -145.26 17.29 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.511 1.529 . . . . 0.0 111.555 -167.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -158.6 151.47 22.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.464 1.106 . . . . 0.0 111.536 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.0 tt -124.64 135.23 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.763 1.625 . . . . 0.0 111.936 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.08 164.07 34.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.72 1.608 . . . . 0.0 110.978 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.72 -175.75 23.0 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.42 140.59 16.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.556 1.543 . . . . 0.0 110.02 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 16.3 t -111.47 132.91 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.814 1.646 . . . . 0.0 108.171 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.4 mtm105 -119.49 119.3 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.682 1.193 . . . . 0.0 110.226 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 11.3 mtt -95.53 149.24 35.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.781 1.632 . . . . 0.0 111.376 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.17 -20.59 28.2 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.4 2.733 . . . . 0.0 113.672 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.7 p -80.61 4.29 19.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.206 1.402 . . . . 0.0 114.387 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.06 45.11 4.88 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 124.485 1.04 . . . . 0.0 113.367 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.54 166.18 31.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.76 1.624 . . . . 0.0 112.021 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.59 161.37 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.224 1.01 . . . . 0.0 113.217 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.04 -179.26 7.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.063 2.145 . . . . 0.0 110.533 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -120.52 141.74 32.71 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 121.189 -0.944 . . . . 0.0 111.333 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.18 166.88 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.322 3.348 . . . . 0.0 111.343 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.8 m -106.91 128.02 53.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 108.915 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.9 130.43 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.611 1.165 . . . . 0.0 109.075 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 77.1 m -135.07 120.98 19.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.163 1.385 . . . . 0.0 109.321 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.58 141.77 41.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 112.218 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.63 -5.61 48.34 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.19 6.33 4.73 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.34 2.256 . . . . 0.0 113.515 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -107.2 9.51 30.2 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.805 2.042 . . . . 0.0 112.991 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.11 17.12 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.719 1.152 . . . . 0.0 113.608 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 34.9 p -134.86 159.77 40.34 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.316 1.846 . . . . 0.0 110.413 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.9 m -125.34 143.4 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.584 1.154 . . . . 0.0 110.076 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 96.3 m -104.56 135.92 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.432 1.093 . . . . 0.0 108.668 171.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 40.0 t -120.11 132.99 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.208 1.403 . . . . 0.0 108.744 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -133.14 159.17 40.91 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.035 1.334 . . . . 0.0 112.706 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.7 t80 -160.5 136.48 8.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.688 1.595 . . . . 0.0 111.66 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.12 112.03 51.67 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.749 1.219 . . . . 0.0 110.185 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.24 151.36 26.52 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.216 2.611 . . . . 0.0 112.209 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -116.16 -12.71 11.19 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -163.44 150.34 12.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.59 1.556 . . . . 0.0 110.884 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.79 172.48 12.1 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.7 1.2 . . . . 0.0 113.497 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.87 -178.58 17.63 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 125.542 1.544 . . . . 0.0 114.435 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.43 123.22 25.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.924 1.29 . . . . 0.0 110.088 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.7 m80 -117.7 157.07 27.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.314 1.446 . . . . 0.0 111.818 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -133.46 142.42 48.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.076 1.35 . . . . 0.0 109.317 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.7 tmm? -143.04 132.45 23.47 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.082 0.953 . . . . 0.0 111.753 -168.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -108.72 139.88 42.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.951 2.1 . . . . 0.0 111.455 -173.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.5 mm -139.32 131.05 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.187 1.395 . . . . 0.0 109.304 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.27 139.71 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.18 123.34 46.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.537 1.935 . . . . 0.0 109.912 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.91 30.95 7.78 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.719 1.208 . . . . 0.0 112.827 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.0 t30 80.59 6.16 1.54 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.53 2.732 . . . . 0.0 115.28 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 90.3 mtp -109.05 133.17 53.35 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.054 1.342 . . . . 0.0 111.119 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.24 138.05 55.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -72.84 153.7 91.15 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.273 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.26 123.89 14.89 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.036 2.491 . . . . 0.0 110.37 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.21 -11.22 61.89 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.376 -1.235 . . . . 0.0 114.903 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.3 m -102.2 154.59 37.28 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-N 119.999 1.9 . . . . 0.0 112.673 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.58 163.83 89.48 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.558 0.878 . . . . 0.0 113.272 0.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.22 151.91 24.8 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.82 1.648 . . . . 0.0 111.504 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.87 141.7 47.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.288 1.435 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.2 p90 -166.56 158.28 13.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.372 1.069 . . . . 0.0 112.072 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 38.2 t80 -96.36 130.19 43.53 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.433 0.693 . . . . 0.0 111.755 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 71.4 t -91.86 132.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.998 1.319 . . . . 0.0 108.681 172.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.1 t0 -146.51 163.7 34.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.498 1.519 . . . . 0.0 110.628 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.76 148.82 44.23 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.992 0.917 . . . . 0.0 112.543 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 89.7 t -67.05 -45.02 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.138 0.975 . . . . 0.0 110.631 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 6.4 p30 -93.64 141.66 28.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.924 0.89 . . . . 0.0 111.125 168.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.4 p -173.85 156.79 2.89 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.051 1.741 . . . . 0.0 112.235 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.42 -23.47 11.13 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.854 1.216 . . . . 0.0 113.595 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -73.59 156.9 37.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.424 1.089 . . . . 0.0 113.736 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.4 t -66.95 138.13 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.173 0.989 . . . . 0.0 108.473 170.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.0 t -153.49 166.77 31.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.038 0.935 . . . . 0.0 111.349 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.01 145.46 29.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.134 1.374 . . . . 0.0 111.665 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 47.2 p90 -166.15 162.4 17.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.629 1.572 . . . . 0.0 112.467 -175.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.77 173.47 13.22 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.283 1.421 . . . . 0.0 113.014 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.72 -35.04 13.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.879 2.386 . . . . 0.0 112.751 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.38 -32.12 78.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.463 -171.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.34 -3.47 49.64 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.233 1.516 . . . . 0.0 113.478 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.6 m -108.17 -41.24 4.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.473 1.909 . . . . 0.0 111.676 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -151.09 152.55 33.58 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.244 1.818 . . . . 0.0 112.332 -170.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -153.19 -175.41 24.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.406 1.003 . . . . 0.0 113.393 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.8 p -153.6 137.36 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.07 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.8 m -58.57 142.12 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.0 m-80 68.28 7.33 5.86 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.558 1.943 . . . . 0.0 114.582 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -114.7 143.57 30.25 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.167 1.387 . . . . 0.0 110.924 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.48 127.94 13.06 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.604 2.202 . . . . 0.0 110.316 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.13 145.83 32.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.624 1.57 . . . . 0.0 110.273 173.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.2 p -135.69 152.23 50.97 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -167.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.9 173.83 13.97 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.985 1.714 . . . . 0.0 111.385 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 76.0 m -125.73 142.43 51.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.316 1.446 . . . . 0.0 110.464 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 48.1 t -115.9 128.16 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.837 1.655 . . . . 0.0 107.875 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.32 123.92 35.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.021 0.928 . . . . 0.0 110.932 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 54.5 p -125.99 10.25 7.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.408 1.883 . . . . 0.0 112.608 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.16 -40.06 76.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.52 1.528 . . . . 0.0 114.372 -165.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.39 5.42 21.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.648 1.579 . . . . 0.0 112.738 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.71 58.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.575 1.15 . . . . 0.0 113.693 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.33 -86.71 1.38 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.872 1.225 . . . . 0.0 112.772 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.6 -177.88 3.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.27 1.828 . . . . 0.0 111.627 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 119.38 9.52 8.54 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.815 1.198 . . . . 0.0 115.618 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.33 103.52 1.63 Allowed Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.533 1.54 . . . . 0.0 112.834 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 39.2 tp -84.66 141.35 30.67 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.319 1.447 . . . . 0.0 110.158 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.7 m -135.46 159.41 41.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.592 1.557 . . . . 0.0 112.155 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.5 tp -160.71 136.44 8.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.024 1.73 . . . . 0.0 109.338 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.36 159.17 35.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.74 137.24 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.884 1.274 . . . . 0.0 109.837 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.26 134.39 48.96 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.31 1.444 . . . . 0.0 109.979 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.5 -164.55 16.61 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.667 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.32 -24.48 64.81 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.18 3.253 . . . . 0.0 112.836 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.8 t -139.3 159.75 41.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.914 1.285 . . . . 0.0 109.6 162.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.25 110.57 5.98 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.088 -1.008 . . . . 0.0 110.704 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 145.18 54.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 0.0 111.144 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.46 137.13 32.79 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 36.5 mt -129.36 143.73 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.746 1.218 . . . . 0.0 110.131 -168.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.63 162.68 35.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 110.966 166.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -158.14 155.41 29.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.646 1.178 . . . . 0.0 112.228 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -142.38 125.18 16.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.385 1.474 . . . . 0.0 109.79 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.36 129.56 36.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.946 169.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.18 151.58 20.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.362 1.465 . . . . 0.0 111.808 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -71.14 -16.48 62.55 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.888 0.875 . . . . 0.0 113.281 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.06 -6.96 59.56 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.31 33.89 6.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.815 1.198 . . . . 0.0 114.445 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -127.94 174.09 9.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.331 1.452 . . . . 0.0 110.572 169.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.1 m -124.16 130.96 53.42 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.105 1.362 . . . . 0.0 109.963 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.6 t -93.88 149.13 21.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.277 1.031 . . . . 0.0 110.745 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.1 t -128.17 143.79 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.102 1.761 . . . . 0.0 109.742 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.1 p -136.14 148.1 48.04 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.78 168.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.28 153.78 36.74 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.5 107.33 43.12 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 110.375 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -85.79 173.07 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.114 3.209 . . . . 0.0 110.834 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.1 p -147.34 -28.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -173.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.06 148.67 37.92 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.249 1.019 . . . . 0.0 110.718 167.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.59 157.71 48.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.98 2.453 . . . . 0.0 110.845 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.16 -168.1 22.17 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.164 1.364 . . . . 0.0 113.484 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.66 132.77 34.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.956 1.302 . . . . 0.0 112.568 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 126.64 49.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.275 1.83 . . . . 0.0 109.816 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.1 m -86.8 124.33 32.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.529 1.132 . . . . 0.0 110.482 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.48 124.31 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.605 1.562 . . . . 0.0 108.402 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.6 tt -106.14 131.04 53.87 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.319 1.447 . . . . 0.0 109.831 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.8 t -133.07 127.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.552 1.141 . . . . 0.0 109.607 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.42 143.42 24.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.969 1.308 . . . . 0.0 111.547 -168.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.63 122.31 15.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.957 1.303 . . . . 0.0 109.641 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.68 56.26 6.96 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.199 1.399 . . . . 0.0 112.095 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.3 pt-20 59.42 3.74 0.43 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.85 2.86 . . . . 0.0 116.644 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -108.98 125.05 51.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.678 1.191 . . . . 0.0 110.87 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.62 145.87 54.86 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.279 -0.888 . . . . 0.0 111.809 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 16.3 m -70.39 152.7 95.45 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.091 170.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.42 128.32 27.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.007 2.471 . . . . 0.0 110.57 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.42 62.8 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.052 1.31 . . . . 0.0 115.082 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.3 t -77.61 139.99 63.5 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.392 1.596 . . . . 0.0 111.482 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.36 135.92 42.56 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.358 0.806 . . . . 0.0 111.857 -3.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -86.01 170.3 12.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.794 1.637 . . . . 0.0 110.378 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 45.7 m -131.45 117.38 18.75 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.549 0.74 . . . . 0.0 110.718 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.35 143.41 26.42 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.669 1.188 . . . . 0.0 110.722 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -104.22 119.37 38.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.931 0.492 . . . . 0.0 110.771 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.3 t -97.28 144.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.944 1.698 . . . . 0.0 109.237 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.5 t -132.82 175.65 9.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.038 0.935 . . . . 0.0 112.854 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.33 137.47 19.78 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.644 1.593 . . . . 0.0 112.367 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.0 t70 -83.08 -23.77 32.99 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.336 1.054 . . . . 0.0 113.402 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.833 2.053 . . . . 0.0 112.456 -176.032 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -80.46 -8.65 59.63 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -62.5 147.18 49.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.807 1.643 . . . . 0.0 112.853 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -70.22 150.67 95.98 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.275 1.03 . . . . 0.0 112.652 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.85 173.63 14.17 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.88 3.053 . . . . 0.0 111.854 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.62 6.43 5.91 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.049 1.34 . . . . 0.0 113.829 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.31 145.76 85.46 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.43 1.492 . . . . 0.0 112.45 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.85 153.36 68.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.563 2.842 . . . . 0.0 111.489 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.48 29.24 0.3 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.421 1.488 . . . . 0.0 113.139 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.6 p -169.25 153.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.598 2.359 . . . . 0.0 109.613 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -68.42 145.17 43.71 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.657 0.646 . . . . 0.0 112.27 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 22.2 m -142.55 154.67 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.776 1.63 . . . . 0.0 111.234 -176.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 18.9 t-20 75.69 133.14 0.05 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 128.48 2.712 . . . . 0.0 113.014 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -82.81 121.2 5.37 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.351 0.976 . . . . 0.0 111.618 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 83.5 mt -83.01 152.59 25.34 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.567 1.147 . . . . 0.0 111.44 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 39.5 t0 -76.09 152.47 36.8 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.86 0.864 . . . . 0.0 112.087 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 9.3 p -172.64 139.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.915 2.086 . . . . 0.0 110.354 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 13.1 t -155.28 30.78 0.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.308 1.443 . . . . 0.0 112.381 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 16.3 m -63.7 149.22 47.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.323 1.049 . . . . 0.0 112.79 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.5 tp -84.29 136.93 33.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.857 1.263 . . . . 0.0 109.368 169.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -44.5 110.07 0.97 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.5 1.52 . . . . 0.0 112.513 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.03 120.64 7.51 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.474 2.116 . . . . 0.0 108.297 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 53.6 t80 -101.01 130.33 46.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.617 0.723 . . . . 0.0 111.677 -172.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 2.1 p30 -160.38 150.11 17.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.769 1.628 . . . . 0.0 111.69 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.4 150.27 40.43 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.456 1.902 . . . . 0.0 110.044 -171.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 139.47 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.773 1.629 . . . . 0.0 110.316 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.3 139.04 30.36 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.886 1.675 . . . . 0.0 108.732 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.13 46.25 2.04 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.707 3.605 . . . . 0.0 112.934 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.15 160.78 14.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.917 1.687 . . . . 0.0 110.532 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 58.1 m -132.47 130.33 40.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.717 1.207 . . . . 0.0 109.41 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.7 mt -92.78 119.49 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.772 1.229 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 -161.98 0.86 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.442 1.497 . . . . 0.0 110.915 170.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -63.58 120.52 11.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.719 -1.238 . . . . 0.0 111.727 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.33 170.63 12.11 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.783 1.659 . . . . 0.0 112.868 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -98.3 143.83 28.36 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.35 1.06 . . . . 0.0 112.528 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 9.8 tt -146.84 129.36 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.807 1.643 . . . . 0.0 110.335 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 76.8 p -146.61 -177.85 5.86 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.174 1.79 . . . . 0.0 110.337 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -165.38 -171.38 31.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.26 141.12 21.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 109.783 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 92.7 t -111.02 136.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.202 1.801 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -118.06 129.49 55.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.943 1.297 . . . . 0.0 110.634 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 17.7 mtm -99.91 151.66 37.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.76 1.624 . . . . 0.0 111.52 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.81 -18.88 36.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.477 2.785 . . . . 0.0 113.021 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 25.8 p -74.85 -4.13 36.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.705 1.602 . . . . 0.0 114.177 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.53 79.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.757 1.646 . . . . 0.0 114.206 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -68.44 160.01 30.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.925 1.29 . . . . 0.0 112.616 173.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -137.49 156.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.207 1.403 . . . . 0.0 111.586 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.36 178.65 9.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.944 2.097 . . . . 0.0 110.095 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.31 142.13 31.86 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.039 -1.038 . . . . 0.0 111.788 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.91 166.98 12.98 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.059 3.173 . . . . 0.0 111.566 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.5 m -102.31 120.39 40.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.484 1.514 . . . . 0.0 108.883 174.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.6 137.97 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.993 1.317 . . . . 0.0 109.158 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 19.0 m -144.37 131.76 20.86 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.334 1.453 . . . . 0.0 110.082 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.43 129.3 34.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.782 0.833 . . . . 0.0 110.218 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -80.85 -4.63 55.43 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.7 mmmt 69.84 13.27 8.02 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.525 2.33 . . . . 0.0 113.365 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -126.59 13.88 7.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.699 2.0 . . . . 0.0 112.755 -173.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.5 13.54 59.71 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.828 1.204 . . . . 0.0 114.56 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 58.4 p -132.33 157.56 44.14 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.208 1.803 . . . . 0.0 110.28 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -114.51 148.1 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.509 1.123 . . . . 0.0 109.769 165.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.8 m -114.57 137.02 52.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.737 1.215 . . . . 0.0 108.256 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.15 130.48 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.875 1.27 . . . . 0.0 108.812 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -125.89 160.92 28.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.012 1.325 . . . . 0.0 112.546 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 16.5 t80 -157.08 134.22 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.104 1.362 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.56 117.27 68.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.664 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -80.99 162.98 20.57 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.592 2.861 . . . . 0.0 112.382 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.9 p -135.69 -20.14 1.57 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.27 155.26 44.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.0 110.987 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.93 174.12 11.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.516 1.126 . . . . 0.0 112.655 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 110.67 -170.86 14.2 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.838 1.685 . . . . 0.0 113.843 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.17 132.19 34.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.753 1.221 . . . . 0.0 110.766 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.0 m80 -129.84 170.72 13.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.687 1.995 . . . . 0.0 111.055 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.0 154.06 41.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.445 1.098 . . . . 0.0 111.424 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 2.3 ttm -138.66 123.73 19.03 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.352 1.461 . . . . 0.0 110.82 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -96.87 135.83 38.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.081 1.753 . . . . 0.0 110.305 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.85 137.44 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.208 1.403 . . . . 0.0 109.997 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.68 135.25 18.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -173.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -102.98 124.17 47.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.634 1.973 . . . . 0.0 109.558 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.34 40.38 22.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.902 1.281 . . . . 0.0 112.467 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.5 m120 76.36 -3.6 2.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.292 2.637 . . . . 0.0 114.845 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.8 mtm -103.45 134.18 47.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.472 1.509 . . . . 0.0 111.462 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.26 135.63 53.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.8 pt -73.9 157.48 87.13 Favored Pre-proline 0 N--CA 1.482 1.146 0 CA-C-O 118.698 -0.667 . . . . 0.0 111.505 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -57.97 125.81 19.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.635 2.224 . . . . 0.0 110.988 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.35 -9.94 71.62 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.991 1.281 . . . . 0.0 114.69 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.1 t -82.78 147.31 54.77 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.36 1.58 . . . . 0.0 111.667 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.4 164.76 69.02 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 120.126 1.081 . . . . 0.0 112.451 -4.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.37 156.64 17.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.703 1.601 . . . . 0.0 111.998 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -136.71 136.36 38.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 109.191 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.9 150.07 25.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 57.8 t80 -105.2 142.31 35.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.182 0.993 . . . . 0.0 112.199 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -124.83 138.33 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.692 1.597 . . . . 0.0 109.056 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 37.2 t0 -162.22 157.32 22.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.372 1.469 . . . . 0.0 111.581 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -82.73 146.19 29.16 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.963 -1.085 . . . . 0.0 113.188 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.1 t -62.63 -30.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.102 1.361 . . . . 0.0 112.281 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.22 -11.34 59.74 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.6 m -57.96 136.34 57.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.85 61.9 1.95 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.809 1.671 . . . . 0.0 112.575 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -158.56 166.67 31.56 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.228 1.411 . . . . 0.0 113.269 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 10.6 p -70.15 139.76 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.876 0.871 . . . . 0.0 110.089 166.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -156.41 167.64 29.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.23 145.98 31.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.39 1.076 . . . . 0.0 112.257 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.9 p90 -167.86 166.08 13.64 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.691 . . . . 0.0 112.882 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.03 172.02 13.03 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.7 1.619 . . . . 0.0 112.362 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.3 -34.84 12.08 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.859 2.372 . . . . 0.0 113.191 -169.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.14 -29.13 73.21 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.844 -0.976 . . . . 0.0 114.625 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.85 -0.13 42.1 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.21 1.505 . . . . 0.0 113.659 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 19.6 m -116.22 -42.21 3.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.051 2.141 . . . . 0.0 111.999 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -140.6 153.05 45.92 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.823 1.649 . . . . 0.0 112.604 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -155.09 -176.13 26.93 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.112 0.863 . . . . 0.0 113.436 167.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.8 p -151.6 137.98 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.92 1.288 . . . . 0.0 108.982 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -58.29 143.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 69.56 5.76 5.35 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.607 1.963 . . . . 0.0 114.776 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.6 mttm -117.41 147.49 40.74 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 111.194 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.25 138.65 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.62 2.214 . . . . 0.0 110.806 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -118.81 147.52 43.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.928 1.691 . . . . 0.0 110.3 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.6 p -135.52 152.45 51.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.088 0.955 . . . . 0.0 113.573 -166.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.67 176.53 10.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.093 1.757 . . . . 0.0 111.325 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 81.8 m -132.3 138.53 47.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.88 1.272 . . . . 0.0 110.68 -171.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.2 t -104.0 130.29 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.135 1.374 . . . . 0.0 107.6 167.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -97.3 123.8 41.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.561 1.144 . . . . 0.0 110.187 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 52.8 p -127.97 5.97 5.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.793 1.637 . . . . 0.0 113.397 -167.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -54.54 -33.92 60.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.629 1.572 . . . . 0.0 114.647 -171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.0 t70 -113.9 7.02 16.83 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.537 1.535 . . . . 0.0 113.259 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.41 -14.86 59.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.04 -97.98 2.19 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.493 1.044 . . . . 0.0 112.761 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.67 171.38 16.95 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.381 1.473 . . . . 0.0 112.515 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 125.46 -160.62 20.0 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.005 1.764 . . . . 0.0 112.771 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.98 115.25 4.73 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.257 0.932 . . . . 0.0 111.371 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.7 128.4 34.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.199 1.4 . . . . 0.0 108.88 171.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 34.4 m -129.9 158.54 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.508 1.523 . . . . 0.0 112.289 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -160.18 135.55 8.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.239 1.816 . . . . 0.0 108.909 -169.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.41 157.91 34.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.666 0.786 . . . . 0.0 112.497 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -136.29 140.39 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.132 1.373 . . . . 0.0 109.763 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.22 136.11 45.42 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.431 1.492 . . . . 0.0 109.38 171.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.29 -164.55 16.39 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.833 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.86 -27.19 67.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.077 3.185 . . . . 0.0 112.417 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.3 t -135.4 159.86 40.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.868 1.267 . . . . 0.0 109.352 159.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -75.76 109.51 9.42 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.042 -1.036 . . . . 0.0 110.871 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 147.27 52.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.724 0.809 . . . . 0.0 111.768 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.94 145.5 27.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.387 0.675 . . . . 0.0 110.083 166.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.94 140.21 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 110.203 -167.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 57.9 m -135.35 157.01 47.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.587 1.555 . . . . 0.0 110.776 167.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -156.16 156.7 34.66 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.094 0.957 . . . . 0.0 112.458 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.1 m -141.91 122.13 13.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.035 1.334 . . . . 0.0 110.406 -172.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.47 132.05 41.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.97 1.308 . . . . 0.0 111.065 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -112.76 146.4 38.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 111.75 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.45 -13.3 61.91 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.986 0.914 . . . . 0.0 113.312 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.77 -4.88 40.28 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.242 1.817 . . . . 0.0 114.219 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.25 31.55 9.61 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.58 1.086 . . . . 0.0 113.804 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.0 p -141.06 161.35 38.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.351 1.46 . . . . 0.0 111.357 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 78.9 m -112.85 128.23 56.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.719 1.207 . . . . 0.0 109.004 158.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.1 t -87.4 148.02 25.18 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 110.462 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -129.39 142.83 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.672 1.589 . . . . 0.0 110.214 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 69.6 p -136.45 145.75 45.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.922 1.289 . . . . 0.0 111.591 165.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.4 p90 -148.44 156.9 43.07 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.018 -1.051 . . . . 0.0 112.693 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.06 104.84 25.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.264 1.026 . . . . 0.0 110.666 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.17 172.13 9.8 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 124.226 3.284 . . . . 0.0 111.219 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.6 p -147.36 -29.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -172.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.28 147.91 36.11 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 119.515 1.052 . . . . 0.0 110.776 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.49 156.49 49.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.911 2.408 . . . . 0.0 110.696 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.96 -162.53 24.74 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.104 1.335 . . . . 0.0 113.003 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -104.03 125.85 50.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.344 1.058 . . . . 0.0 111.242 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -109.97 129.47 55.66 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.881 1.672 . . . . 0.0 110.023 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -88.23 127.19 35.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 110.611 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -106.64 127.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.63 1.572 . . . . 0.0 108.657 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.31 134.78 51.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 109.756 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.6 t -136.29 131.27 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.249 1.419 . . . . 0.0 108.546 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.12 143.22 22.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.865 1.266 . . . . 0.0 111.332 -170.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.77 124.67 15.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.849 1.259 . . . . 0.0 109.941 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 57.85 51.82 8.7 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 9.0 pt-20 55.57 17.24 2.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.149 2.579 . . . . 0.0 115.84 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -122.02 128.82 51.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.858 1.263 . . . . 0.0 110.725 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -65.18 156.24 32.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.132 0.973 . . . . 0.0 112.829 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.7 m -72.82 152.48 91.17 Favored Pre-proline 0 N--CA 1.48 1.029 0 O-C-N 121.545 -0.722 . . . . 0.0 109.247 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.94 -11.15 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.965 1.777 . . . . 0.0 114.657 -166.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -105.0 -7.48 38.22 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 85.1 p -85.89 156.4 58.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.143 1.971 . . . . 0.0 113.722 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.19 144.53 79.75 Favored 'Cis proline' 0 C--N 1.354 0.844 0 CA-C-N 118.968 0.667 . . . . 0.0 112.136 -5.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -95.71 167.93 10.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.362 1.465 . . . . 0.0 110.668 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 29.6 m -130.54 118.09 20.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.909 0.884 . . . . 0.0 110.23 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.72 127.29 44.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.354 . . . . 0.0 110.684 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -92.13 117.12 29.54 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.664 0.386 . . . . 0.0 110.353 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -102.81 140.82 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.087 1.755 . . . . 0.0 109.45 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.9 t -128.57 173.46 10.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 0.0 112.76 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.92 140.69 21.07 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.806 1.669 . . . . 0.0 112.193 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -85.42 -8.74 58.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.112 0.965 . . . . 0.0 113.464 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 126.732 2.013 . . . . 0.0 113.118 -177.825 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.373 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.29 -43.67 69.93 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.806 0.803 . . . . 0.0 110.949 169.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -79.8 168.07 19.76 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.15 1.78 . . . . 0.0 111.404 161.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -57.73 -50.36 88.58 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-O 117.24 -1.362 . . . . 0.0 114.518 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.7 172.57 15.52 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.82 2.347 . . . . 0.0 111.706 173.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -80.89 -13.45 58.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.612 0.765 . . . . 0.0 112.586 170.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -79.93 137.49 53.8 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.281 1.433 . . . . 0.0 111.66 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.35 157.44 49.65 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.554 2.836 . . . . 0.0 111.473 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 90.7 mt -116.06 12.63 15.66 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.909 1.284 . . . . 0.0 113.387 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 78.0 t -121.44 132.9 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.126 1.771 . . . . 0.0 110.203 -174.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -105.04 166.44 14.63 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.6 1.571 . . . . 0.0 113.7 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 9.9 p -74.64 147.15 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.889 1.276 . . . . 0.0 111.855 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -79.56 -9.24 59.59 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 84.42 7.92 84.05 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.339 1.447 . . . . 0.0 115.348 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.29 158.44 24.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.534 1.534 . . . . 0.0 111.473 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.04 175.54 13.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.222 1.409 . . . . 0.0 110.778 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 23.7 m -60.94 -20.63 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.554 1.142 . . . . 0.0 113.775 -175.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.8 t -80.82 -15.3 56.76 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.276 1.83 . . . . 0.0 113.454 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 40.8 m -66.05 144.21 56.86 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.179 -0.951 . . . . 0.0 112.838 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 48.3 mt -82.97 147.92 27.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.225 1.01 . . . . 0.0 111.172 171.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -60.12 117.49 24.28 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 110.837 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.29 152.74 44.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.821 2.347 . . . . 0.0 111.052 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -94.26 116.25 28.62 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 169.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -145.49 125.29 13.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.771 1.228 . . . . 0.0 110.184 168.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.92 147.02 39.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.304 1.842 . . . . 0.0 109.55 -174.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -122.32 136.94 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.967 1.307 . . . . 0.0 110.453 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.4 mt -135.15 136.15 24.16 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.893 1.677 . . . . 0.0 109.287 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.12 117.67 5.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.401 2.734 . . . . 0.0 110.167 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.6 t80 178.02 149.6 0.2 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.356 . . . . 0.0 109.315 -168.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 23.9 m -130.75 125.69 34.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.136 0.974 . . . . 0.0 110.336 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 31.8 mt -83.16 119.33 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.744 1.218 . . . . 0.0 108.954 171.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -122.68 -53.21 1.89 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.913 0.885 . . . . 0.0 113.189 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -160.18 121.74 3.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.313 1.445 . . . . 0.0 111.398 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.68 -146.7 18.61 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 125.735 1.636 . . . . 0.0 111.716 -169.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.6 146.94 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.711 1.204 . . . . 0.0 110.959 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 10.8 tt -130.58 136.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.523 1.529 . . . . 0.0 111.571 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 41.4 p -147.23 -177.99 5.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.611 1.964 . . . . 0.0 110.158 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.67 -166.99 34.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 115.324 0.889 . . . . 0.0 115.324 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.86 131.84 9.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.497 1.519 . . . . 0.0 110.306 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 18.3 t -101.6 136.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.367 1.467 . . . . 0.0 108.648 170.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -120.32 131.11 54.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.719 1.207 . . . . 0.0 111.222 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -105.78 148.33 36.27 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.798 1.639 . . . . 0.0 112.104 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.55 -39.79 55.21 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.8 3.667 . . . . 0.0 115.784 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 7.1 t -73.64 -1.4 18.74 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.44 60.8 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.707 1.622 . . . . 0.0 114.366 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -69.49 160.71 30.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.246 1.418 . . . . 0.0 112.169 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.5 m -139.41 155.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.334 1.454 . . . . 0.0 111.609 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.62 163.29 40.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.79 1.636 . . . . 0.0 111.37 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.63 137.02 21.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.567 0.747 . . . . 0.0 111.577 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.11 169.18 11.62 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.59 3.527 . . . . 0.0 111.924 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -110.55 139.08 46.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 108.995 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.24 132.24 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.668 1.187 . . . . 0.0 109.283 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -134.29 127.09 31.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.416 1.487 . . . . 0.0 109.74 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.08 127.17 31.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.458 0.703 . . . . 0.0 110.279 170.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -79.01 -3.49 45.35 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.2 mmtm 71.24 13.12 6.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.76 2.424 . . . . 0.0 113.13 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -126.63 11.09 7.27 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.825 2.05 . . . . 0.0 113.001 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.48 12.78 57.98 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.855 1.217 . . . . 0.0 114.821 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -128.38 154.32 46.12 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.064 1.746 . . . . 0.0 110.396 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.2 m -111.62 141.42 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.903 0.881 . . . . 0.0 109.894 165.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.0 m -103.43 133.61 48.2 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.604 1.162 . . . . 0.0 108.412 168.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 59.9 t -116.99 134.4 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.125 1.77 . . . . 0.0 108.649 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -139.2 159.2 42.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.636 1.174 . . . . 0.0 113.47 -172.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.2 t80 -158.47 135.84 10.11 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.019 1.727 . . . . 0.0 111.483 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.93 120.0 73.23 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 124.726 1.21 . . . . 0.0 110.846 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.33 148.03 23.5 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.706 2.937 . . . . 0.0 112.607 -170.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.0 p -142.25 5.41 1.66 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.664 1.186 . . . . 0.0 114.009 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -160.18 144.52 14.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.895 1.678 . . . . 0.0 110.056 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.86 163.51 13.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 0.0 112.196 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 114.45 -168.76 12.65 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 125.247 1.403 . . . . 0.0 113.665 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -86.21 122.26 29.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.9 m80 -118.61 161.58 19.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.966 1.707 . . . . 0.0 111.822 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.16 155.96 46.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 40.9 ttm -140.77 118.37 11.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.253 1.421 . . . . 0.0 111.156 -172.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -81.56 134.98 35.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.255 2.222 . . . . 0.0 109.832 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 19.9 mm -141.09 136.32 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.349 1.459 . . . . 0.0 108.714 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 136.84 16.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.9 t80 -97.21 121.98 39.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.741 2.016 . . . . 0.0 109.795 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.94 35.51 16.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.876 1.27 . . . . 0.0 112.775 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 76.69 4.22 3.47 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 127.983 2.513 . . . . 0.0 114.506 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.6 mtm -107.53 132.6 53.07 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.68 1.592 . . . . 0.0 110.952 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.24 139.07 55.75 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 39.9 pt -74.71 155.21 87.19 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.456 0.702 . . . . 0.0 110.902 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.58 119.78 7.21 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.932 2.421 . . . . 0.0 111.942 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.9 69.83 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.52 1.533 . . . . 0.0 115.128 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 38.8 m -80.79 154.69 73.3 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.758 1.779 . . . . 0.0 112.025 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.97 155.01 99.73 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.422 0.829 . . . . 0.0 112.538 -0.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.92 159.56 15.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.097 1.359 . . . . 0.0 110.86 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -159.08 133.9 8.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.315 1.046 . . . . 0.0 110.478 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.92 -179.48 5.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.032 1.333 . . . . 0.0 112.697 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -118.31 137.29 53.17 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.219 1.008 . . . . 0.0 113.353 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.0 t -108.95 138.04 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.25 1.82 . . . . 0.0 110.021 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.6 t0 -149.1 178.9 8.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.334 1.853 . . . . 0.0 109.509 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -77.85 143.07 38.11 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.693 -1.254 . . . . 0.0 111.304 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.9 m -65.47 -17.71 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -166.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -148.81 41.41 0.93 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.978 0.911 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 2.6 t -66.68 -28.58 68.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 106.09 -25.36 23.93 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.113 1.815 . . . . 0.0 115.019 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -72.42 160.49 32.25 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.909 1.354 . . . . 0.0 113.445 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.5 t -64.36 134.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.603 1.161 . . . . 0.0 109.678 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -161.47 150.09 15.79 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.59 1.156 . . . . 0.0 110.874 -173.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -118.96 147.05 44.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.836 1.254 . . . . 0.0 111.978 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.4 p90 -166.8 158.02 12.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.082 1.753 . . . . 0.0 112.818 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 141.19 170.3 12.16 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.309 1.433 . . . . 0.0 113.258 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 -33.19 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.942 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.92 82.04 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.263 0.938 . . . . 0.0 114.047 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.85 -5.99 54.94 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 118.645 1.222 . . . . 0.0 112.658 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.6 m -99.09 -45.56 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.073 1.749 . . . . 0.0 111.406 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -147.57 142.38 26.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.531 1.932 . . . . 0.0 111.987 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -137.31 170.4 23.61 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.373 0.987 . . . . 0.0 113.376 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 59.9 t -134.92 135.58 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.144 1.378 . . . . 0.0 107.963 173.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -55.85 133.84 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.199 0.6 . . . . 0.0 112.493 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.08 -0.19 2.19 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.094 2.158 . . . . 0.0 114.54 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.59 140.06 21.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.084 1.354 . . . . 0.0 110.973 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.45 120.96 7.06 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.636 2.224 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.61 133.89 48.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.331 1.452 . . . . 0.0 110.141 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.1 p -128.5 149.46 50.58 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.49 178.65 8.91 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.74 1.616 . . . . 0.0 111.728 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -130.79 145.14 51.89 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.129 1.372 . . . . 0.0 110.793 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.0 t -116.55 132.65 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.644 1.578 . . . . 0.0 108.288 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -94.25 128.67 40.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.31 1.044 . . . . 0.0 111.009 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 48.7 p -136.46 3.51 2.81 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.47 1.508 . . . . 0.0 113.792 -167.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -53.73 -40.23 65.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.422 1.489 . . . . 0.0 114.668 -169.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -107.43 5.87 27.69 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.505 1.522 . . . . 0.0 113.123 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.28 -19.11 61.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.07 -89.98 1.63 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.724 1.154 . . . . 0.0 112.497 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -165.04 173.06 11.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.286 1.434 . . . . 0.0 112.648 -169.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 121.09 -167.52 14.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.199 1.857 . . . . 0.0 112.73 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.64 106.55 3.2 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.935 0.779 . . . . 0.0 111.791 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.6 124.6 28.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.509 1.124 . . . . 0.0 108.586 168.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 46.1 m -124.07 158.04 33.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.782 1.633 . . . . 0.0 112.24 -173.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.46 137.22 10.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.857 1.663 . . . . 0.0 109.515 -172.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 160.57 37.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.354 1.061 . . . . 0.0 111.909 175.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.8 mt -135.53 132.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.499 1.12 . . . . 0.0 109.6 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.88 108.06 15.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.413 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -117.53 -178.16 17.5 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.124 1.345 . . . . 0.0 113.743 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.79 -26.1 52.83 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.797 2.998 . . . . 0.0 111.652 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 151.48 51.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.234 1.414 . . . . 0.0 108.646 155.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.18 122.25 20.72 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.957 -1.089 . . . . 0.0 112.0 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.88 154.27 41.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 112.12 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.88 139.62 30.27 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.354 0.662 . . . . 0.0 109.397 166.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 34.4 mt -133.85 143.61 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -166.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 10.8 t -142.58 161.64 37.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.31 1.444 . . . . 0.0 111.065 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -160.09 155.11 24.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.92 1.288 . . . . 0.0 112.687 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.0 m -141.65 127.32 19.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.375 1.47 . . . . 0.0 110.455 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.91 131.63 37.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.814 1.246 . . . . 0.0 111.264 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -111.13 151.06 28.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.129 1.371 . . . . 0.0 112.442 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -67.69 -19.68 65.19 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.49 1.116 . . . . 0.0 112.461 173.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.23 -5.71 37.76 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.811 1.644 . . . . 0.0 114.421 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.22 33.96 8.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.46 1.029 . . . . 0.0 113.235 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -141.28 161.37 38.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.518 1.527 . . . . 0.0 111.143 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.5 m -108.6 131.68 54.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.859 1.263 . . . . 0.0 108.913 158.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -91.09 149.89 21.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.939 0.895 . . . . 0.0 110.486 168.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 95.1 t -130.2 144.8 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.046 1.739 . . . . 0.0 109.973 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.1 t -140.35 141.05 35.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.486 1.514 . . . . 0.0 110.932 170.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -147.03 153.99 40.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.51 103.32 49.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.483 1.913 . . . . 0.0 110.256 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.12 161.99 17.94 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.647 2.898 . . . . 0.0 110.306 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.5 m -126.39 -10.06 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.48 151.63 22.82 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.207 1.403 . . . . 0.0 110.419 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.24 142.99 27.81 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.762 2.308 . . . . 0.0 111.649 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 155.4 -167.59 32.99 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.779 1.181 . . . . 0.0 113.299 -174.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -101.08 128.54 47.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.573 1.149 . . . . 0.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -120.15 123.23 42.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.65 1.58 . . . . 0.0 110.121 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 48.8 m -86.45 125.78 33.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.039 -1.038 . . . . 0.0 111.22 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 128.55 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.531 1.533 . . . . 0.0 108.614 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.23 129.95 55.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.301 1.44 . . . . 0.0 109.655 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.5 t -132.59 128.93 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.435 1.094 . . . . 0.0 109.757 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.39 143.68 24.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.269 1.428 . . . . 0.0 111.046 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.88 121.74 11.99 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.535 1.134 . . . . 0.0 109.721 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.77 55.28 5.56 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.034 1.333 . . . . 0.0 111.544 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.2 pt-20 58.26 13.19 2.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.396 2.678 . . . . 0.0 116.267 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.18 126.2 49.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.647 1.179 . . . . 0.0 110.909 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.57 146.15 54.28 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.803 170.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.5 m -71.19 152.76 94.51 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.152 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.96 129.59 35.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.005 2.47 . . . . 0.0 110.895 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.7 -17.69 57.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.169 1.366 . . . . 0.0 114.89 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 35.6 t -77.77 140.13 62.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.26 1.53 . . . . 0.0 111.542 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.0 135.42 40.07 Favored 'Cis proline' 0 C--N 1.352 0.735 0 CA-C-N 119.377 0.813 . . . . 0.0 111.717 -4.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.67 176.85 6.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.223 1.809 . . . . 0.0 110.492 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 95.4 m -137.35 123.25 20.13 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.94 0.896 . . . . 0.0 111.096 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.12 160.07 15.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.127 1.771 . . . . 0.0 110.711 167.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -122.13 126.31 48.09 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.788 0.835 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.5 t -106.19 141.01 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.21 1.804 . . . . 0.0 109.881 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -130.33 171.11 13.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 112.978 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.91 144.34 31.06 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.382 1.468 . . . . 0.0 112.557 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.88 -17.29 55.84 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.231 1.012 . . . . 0.0 113.2 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.786 2.035 . . . . 0.0 112.518 -179.086 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.63 162.98 28.6 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.396 1.078 . . . . 0.0 112.842 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.8 mtp -71.54 149.93 45.26 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.327 1.051 . . . . 0.0 112.218 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -70.44 152.7 95.41 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.404 1.082 . . . . 0.0 112.291 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.07 168.27 24.46 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.758 2.972 . . . . 0.0 111.997 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.86 -179.43 7.13 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.356 1.462 . . . . 0.0 112.196 -176.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 6.3 tpp85 -156.69 136.29 8.35 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.009 1.324 . . . . 0.0 110.71 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.98 153.07 63.47 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.841 2.361 . . . . 0.0 111.058 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 9.9 mp 65.55 9.92 6.24 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.506 1.922 . . . . 0.0 113.949 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 9.8 p -64.98 -20.4 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.237 1.415 . . . . 0.0 113.629 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 120.33 -171.76 14.73 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.751 1.644 . . . . 0.0 113.683 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 96.9 t -124.66 137.17 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.029 1.732 . . . . 0.0 109.177 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 30.0 m120 -69.96 127.76 33.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.823 0.849 . . . . 0.0 111.728 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 81.18 165.55 34.49 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.762 1.172 . . . . 0.0 113.516 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.17 172.75 6.81 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.635 1.574 . . . . 0.0 111.551 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 45.3 t0 -150.65 161.73 42.03 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.876 1.67 . . . . 0.0 111.285 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 14.1 p -164.15 139.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.059 1.744 . . . . 0.0 110.928 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.5 t -158.21 26.72 0.25 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.554 1.542 . . . . 0.0 111.949 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 18.6 m -80.68 149.15 29.88 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.699 -1.25 . . . . 0.0 113.635 -171.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.58 141.25 53.81 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.51 -0.744 . . . . 0.0 109.853 161.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -66.01 119.98 65.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 110.608 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.71 137.74 43.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.93 2.42 . . . . 0.0 110.197 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 27.4 t80 -105.63 129.91 53.77 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.535 0.734 . . . . 0.0 111.663 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -157.61 142.8 16.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.505 1.522 . . . . 0.0 111.2 171.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.42 151.02 45.93 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.164 1.786 . . . . 0.0 109.954 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.4 p -115.59 138.07 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 109.938 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.34 134.49 26.14 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.002 1.721 . . . . 0.0 108.713 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.51 100.02 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.385 2.724 . . . . 0.0 109.572 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -161.82 148.79 14.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.496 1.918 . . . . 0.0 109.164 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.5 m -124.28 125.93 45.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.122 . . . . 0.0 109.357 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 80.1 mt -86.01 126.0 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 0.0 109.933 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.29 -161.25 0.75 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.946 1.698 . . . . 0.0 111.658 172.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.97 126.46 29.55 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.897 -1.127 . . . . 0.0 111.509 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.39 -144.6 12.98 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.952 1.739 . . . . 0.0 111.476 -170.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.74 141.95 16.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.146 0.978 . . . . 0.0 111.752 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.4 tt -133.5 134.04 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.052 1.741 . . . . 0.0 110.607 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.25 166.5 27.78 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.85 1.66 . . . . 0.0 111.06 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.73 -175.34 24.13 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.99 140.68 18.99 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.683 1.993 . . . . 0.0 109.333 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.2 t -117.92 131.71 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.716 1.606 . . . . 0.0 108.19 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -113.92 125.34 53.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.479 1.112 . . . . 0.0 110.633 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 37.6 mtm -104.25 138.67 19.59 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.354 1.461 . . . . 0.0 111.473 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -56.42 -29.48 77.75 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.513 3.476 . . . . 0.0 116.098 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 9.0 p -77.67 8.13 4.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.152 1.381 . . . . 0.0 114.666 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.44 46.41 4.06 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.69 1.138 . . . . 0.0 113.168 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.54 162.42 41.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.646 1.578 . . . . 0.0 112.014 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.7 m -140.26 157.76 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.819 1.247 . . . . 0.0 112.396 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -149.32 178.16 9.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.1 2.16 . . . . 0.0 109.999 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.83 142.19 30.37 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.114 -0.991 . . . . 0.0 111.75 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -83.64 167.22 13.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.214 3.276 . . . . 0.0 111.547 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 64.3 m -104.3 116.48 32.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.314 1.446 . . . . 0.0 108.982 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.24 130.03 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.328 1.051 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -121.2 125.63 47.62 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.374 1.87 . . . . 0.0 109.491 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 63.2 t0 -82.47 116.93 22.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.26 1.024 . . . . 0.0 110.154 172.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.2 -14.0 54.24 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 67.47 4.0 3.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.022 2.129 . . . . 0.0 114.204 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -102.55 6.78 40.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.792 2.037 . . . . 0.0 113.146 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.69 9.16 63.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.087 1.327 . . . . 0.0 113.912 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.2 p -127.17 161.44 28.49 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.524 1.929 . . . . 0.0 110.558 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -120.69 144.48 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.961 0.904 . . . . 0.0 109.656 163.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.9 m -105.47 138.15 42.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.398 1.079 . . . . 0.0 108.144 170.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -125.52 127.58 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.162 0.985 . . . . 0.0 109.21 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -123.81 158.0 32.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.298 1.439 . . . . 0.0 112.229 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 15.3 t80 -157.35 134.36 10.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.147 1.379 . . . . 0.0 111.812 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.77 117.11 68.03 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 0.0 110.515 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.22 145.15 27.13 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.234 2.623 . . . . 0.0 112.258 -173.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.6 t -138.73 -10.96 1.35 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -139.49 153.21 47.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.404 1.882 . . . . 0.0 109.654 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -99.63 166.51 11.09 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.545 1.138 . . . . 0.0 112.556 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.01 -168.15 13.26 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.24 1.4 . . . . 0.0 114.217 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.1 tp -83.33 110.75 18.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.838 1.255 . . . . 0.0 110.91 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -105.73 170.96 7.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.341 1.856 . . . . 0.0 112.304 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.29 152.4 41.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.491 1.117 . . . . 0.0 111.49 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 13.6 ttm -122.21 127.67 50.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.034 1.734 . . . . 0.0 110.08 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.69 131.58 49.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.25 2.22 . . . . 0.0 109.2 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.2 mm -138.32 135.1 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.78 1.232 . . . . 0.0 109.193 174.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.49 140.0 27.21 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.864 0.866 . . . . 0.0 113.324 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -99.44 119.96 38.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.121 1.768 . . . . 0.0 109.179 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.22 34.83 12.08 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.927 1.291 . . . . 0.0 113.057 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.0 m-80 72.79 10.21 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.573 2.349 . . . . 0.0 115.133 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.7 mtt -104.65 130.36 52.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.133 1.373 . . . . 0.0 110.391 167.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.29 137.65 55.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.243 -0.911 . . . . 0.0 113.35 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.7 pt -74.17 153.88 88.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.986 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.29 126.5 20.25 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.565 2.177 . . . . 0.0 110.632 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.23 -18.2 54.52 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.14 1.353 . . . . 0.0 114.302 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 62.0 m -87.64 154.91 53.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.848 1.824 . . . . 0.0 112.564 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.22 158.11 98.95 Favored 'Cis proline' 0 C--N 1.354 0.838 0 CA-C-N 119.258 0.771 . . . . 0.0 112.241 -4.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.0 mt -103.53 157.71 16.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.985 1.314 . . . . 0.0 111.244 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -141.22 138.89 33.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 109.606 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.5 p90 -166.64 159.39 14.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.507 1.123 . . . . 0.0 111.977 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 35.3 t80 -101.24 139.56 36.75 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.145 -0.972 . . . . 0.0 112.656 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 50.5 t -107.83 132.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.154 1.381 . . . . 0.0 109.688 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -147.79 175.18 11.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.991 2.117 . . . . 0.0 111.454 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -84.71 145.02 28.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 0.0 112.792 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 17.1 m -69.49 -25.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.544 -0.722 . . . . 0.0 112.221 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -99.65 34.31 2.28 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.277 1.831 . . . . 0.0 111.691 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 14.9 p -53.36 141.99 22.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.982 1.713 . . . . 0.0 114.208 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.5 37.02 3.76 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 126.16 1.838 . . . . 0.0 112.255 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -166.93 156.52 10.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.619 1.568 . . . . 0.0 112.857 -167.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.1 p -61.1 141.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 110.126 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 163.18 36.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.91 0.884 . . . . 0.0 111.604 -173.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.43 145.18 31.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.379 1.472 . . . . 0.0 111.936 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.7 p90 -166.31 157.73 13.33 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.796 1.638 . . . . 0.0 112.722 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 146.2 175.77 19.5 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.485 1.04 . . . . 0.0 114.483 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.54 -43.49 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.203 2.602 . . . . 0.0 112.259 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.56 73.77 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.085 0.857 . . . . 0.0 113.641 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.57 -19.17 63.68 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.3 m -110.4 -49.73 3.03 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.06 1.744 . . . . 0.0 111.327 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -135.27 133.69 39.19 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.19 1.796 . . . . 0.0 112.035 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -119.38 167.37 13.31 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.593 1.092 . . . . 0.0 113.314 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.04 130.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 109.218 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 139.46 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.836 0.854 . . . . 0.0 111.966 -175.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.83 6.12 4.4 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.674 1.99 . . . . 0.0 114.216 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 63.9 mttp -125.15 145.46 50.59 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.856 1.662 . . . . 0.0 111.06 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.01 133.58 21.78 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.606 2.204 . . . . 0.0 111.05 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -115.65 147.49 40.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.758 1.623 . . . . 0.0 110.179 173.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -166.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -160.76 176.17 11.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.769 1.628 . . . . 0.0 111.662 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.5 m -131.65 144.21 50.86 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.301 1.441 . . . . 0.0 110.789 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 36.3 t -113.92 138.19 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.075 1.75 . . . . 0.0 108.017 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -104.8 127.44 52.6 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.47 1.108 . . . . 0.0 110.037 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -125.07 3.22 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.648 1.979 . . . . 0.0 113.323 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.1 tttt -50.33 -36.71 33.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.317 1.847 . . . . 0.0 114.674 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -115.41 10.95 15.91 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.585 1.554 . . . . 0.0 113.132 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.57 -40.05 50.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.78 154.71 9.4 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.63 1.11 . . . . 0.0 112.323 -168.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.63 171.94 14.41 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.455 1.102 . . . . 0.0 112.957 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 134.72 14.87 1.12 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.861 1.219 . . . . 0.0 115.81 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 103.51 103.68 2.82 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.595 1.569 . . . . 0.0 113.204 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.57 143.29 31.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.216 1.407 . . . . 0.0 110.52 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.6 m -136.07 156.8 48.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 111.938 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.4 tp -157.96 133.58 9.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.206 1.803 . . . . 0.0 108.756 -173.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 159.78 38.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.738 0.815 . . . . 0.0 112.427 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.0 mt -134.58 131.2 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.565 1.146 . . . . 0.0 109.481 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.59 107.4 14.2 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.28 1.432 . . . . 0.0 109.309 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -120.52 -173.74 15.01 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.122 1.344 . . . . 0.0 113.992 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.57 -21.66 45.67 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.78 2.987 . . . . 0.0 111.904 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.0 t -137.94 157.9 45.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.629 1.572 . . . . 0.0 109.096 158.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -71.95 117.47 13.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.987 -1.071 . . . . 0.0 111.638 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.05 149.05 43.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.79 140.5 29.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.194 0.598 . . . . 0.0 109.536 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 43.8 mt -131.84 143.53 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 110.111 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.8 t -140.34 163.08 33.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.806 1.242 . . . . 0.0 110.829 166.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -161.51 155.33 21.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.524 1.13 . . . . 0.0 112.658 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 81.5 m -137.19 114.72 11.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.61 1.564 . . . . 0.0 109.283 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.2 144.92 27.21 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.82 1.248 . . . . 0.0 112.226 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -123.07 147.76 46.37 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.411 1.484 . . . . 0.0 111.75 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -71.98 -12.59 61.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.714 0.806 . . . . 0.0 112.514 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.2 -7.0 49.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.861 1.664 . . . . 0.0 114.027 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.94 32.57 7.07 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.576 1.084 . . . . 0.0 113.99 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.3 p -141.08 161.31 38.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 111.292 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 30.0 m -132.3 133.14 43.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.343 1.457 . . . . 0.0 109.366 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -94.1 147.97 22.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.187 0.995 . . . . 0.0 110.459 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.0 t -130.72 142.84 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.736 1.614 . . . . 0.0 110.118 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 90.5 p -135.18 149.24 49.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.091 1.356 . . . . 0.0 111.783 167.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -151.51 155.26 38.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 4.6 mt -121.08 104.19 41.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.284 1.834 . . . . 0.0 110.344 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.52 164.09 16.6 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.731 2.954 . . . . 0.0 110.274 166.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -127.18 -20.51 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.4 153.25 32.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.797 1.239 . . . . 0.0 110.984 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.14 151.88 39.46 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.878 2.385 . . . . 0.0 112.63 -168.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.46 -151.67 23.67 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.471 1.51 . . . . 0.0 112.68 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.98 128.81 51.9 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.089 1.356 . . . . 0.0 110.672 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.14 127.4 55.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.339 1.856 . . . . 0.0 109.653 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 57.1 m -89.31 125.23 35.03 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.777 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.67 126.88 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.895 1.278 . . . . 0.0 108.977 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.38 129.35 55.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 109.594 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -130.66 129.92 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.685 1.194 . . . . 0.0 109.025 171.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.85 144.59 23.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.91 1.284 . . . . 0.0 111.845 -167.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.47 123.66 15.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.005 1.322 . . . . 0.0 109.933 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 52.55 56.91 6.99 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.623 1.569 . . . . 0.0 112.172 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 7.5 pt-20 59.35 8.47 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.62 2.768 . . . . 0.0 116.544 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -115.75 124.84 51.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.454 1.102 . . . . 0.0 110.899 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -61.84 145.89 51.31 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.431 -0.793 . . . . 0.0 111.704 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.2 m -68.8 149.94 97.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.254 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.37 131.33 40.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.073 2.515 . . . . 0.0 111.576 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.59 -14.57 61.03 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.223 1.392 . . . . 0.0 114.943 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.6 t -80.1 144.17 58.3 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 119.011 1.405 . . . . 0.0 111.411 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.08 140.64 67.05 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 120.01 1.039 . . . . 0.0 112.576 -0.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.36 175.57 6.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 110.541 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 27.8 m -135.3 125.73 26.68 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 110.739 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.49 132.16 48.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.023 1.329 . . . . 0.0 109.973 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.9 ttt85 -92.47 136.9 32.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 61.5 t -132.75 131.81 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.514 1.126 . . . . 0.0 110.759 -163.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 7.3 t -173.55 164.66 4.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.346 1.858 . . . . 0.0 111.217 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 143.18 -163.15 27.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.539 1.543 . . . . 0.0 113.682 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 15.7 t70 72.31 7.04 5.64 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 127.197 2.199 . . . . 0.0 114.114 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.32 1.848 . . . . 0.0 113.916 177.4 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.5 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.34 163.61 27.84 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.469 1.108 . . . . 0.0 112.878 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 44.6 tpp -155.06 143.25 20.24 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.245 1.418 . . . . 0.0 111.432 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -98.75 156.46 35.57 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.541 1.537 . . . . 0.0 112.29 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.85 173.09 14.07 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.617 2.878 . . . . 0.0 111.553 172.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.54 3.32 9.64 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.07 1.348 . . . . 0.0 114.234 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 -60.71 148.24 82.54 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.075 1.35 . . . . 0.0 112.085 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.07 155.91 63.79 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.548 2.832 . . . . 0.0 112.277 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.74 7.66 3.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.866 1.666 . . . . 0.0 115.255 -176.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 13.6 p -151.62 143.73 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.322 1.849 . . . . 0.0 110.318 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -81.76 151.42 30.61 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.533 1.063 . . . . 0.0 113.391 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 24.0 m -146.16 160.7 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.789 2.036 . . . . 0.0 110.191 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -64.61 -39.82 94.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.996 0.518 . . . . 0.0 112.331 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 76.52 -44.36 1.96 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 126.439 1.971 . . . . 0.0 115.529 169.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 98.2 mt -79.7 129.21 34.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.379 1.472 . . . . 0.0 111.763 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -79.5 -26.18 41.64 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.633 1.173 . . . . 0.0 112.78 174.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 30.2 m -65.16 -7.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.366 1.466 . . . . 0.0 113.99 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 3.7 t -64.55 -26.53 68.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.96 0.904 . . . . 0.0 112.328 168.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 2.3 t 90.02 161.57 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.057 2.543 . . . . 0.0 115.186 165.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 62.1 mt -131.44 164.16 26.35 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.962 2.505 . . . . 0.0 109.792 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -55.91 115.97 11.03 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.744 1.218 . . . . 0.0 110.975 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.94 151.54 50.66 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.822 2.348 . . . . 0.0 110.501 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.51 118.41 35.68 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.286 0.634 . . . . 0.0 110.195 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -150.63 122.34 8.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.687 1.595 . . . . 0.0 109.832 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.81 149.12 47.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.159 1.784 . . . . 0.0 110.088 -171.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.7 p -118.87 138.12 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.011 1.324 . . . . 0.0 109.689 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 51.1 mt -134.43 135.53 24.01 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.198 1.799 . . . . 0.0 108.42 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.91 31.21 0.44 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.488 3.458 . . . . 0.0 113.628 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.0 t80 -83.03 157.55 22.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.276 1.431 . . . . 0.0 110.833 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 90.5 m -129.62 126.35 38.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.314 1.446 . . . . 0.0 109.574 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 93.9 mt -87.58 134.53 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 110.389 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1800 ' ' LYS . . . . . 0.427 ' HG2' ' H ' ' A' 1801 ' ' LYS . 29.0 ttpt -119.81 -147.48 0.4 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.77 1.628 . . . . 0.0 110.851 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1801 ' ' LYS . . . . . 0.427 ' H ' ' HG2' ' A' 1800 ' ' LYS . 8.0 tmtm? -73.5 123.11 23.28 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.573 -1.33 . . . . 0.0 110.201 171.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.2 -148.98 20.08 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.241 1.4 . . . . 0.0 112.16 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -156.97 145.79 19.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 110.772 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -129.03 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.596 1.558 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 44.6 p -144.75 -177.1 5.34 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.345 1.858 . . . . 0.0 109.998 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.84 37.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -154.49 133.15 12.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.319 1.447 . . . . 0.0 110.258 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.1 t -102.22 130.73 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.906 1.682 . . . . 0.0 108.458 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -106.14 125.53 51.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.404 1.481 . . . . 0.0 110.748 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 19.2 mtm -92.76 146.59 32.48 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.381 1.472 . . . . 0.0 110.447 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.68 -16.62 30.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.269 2.646 . . . . 0.0 113.488 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 51.7 p -73.96 -5.53 41.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.179 1.391 . . . . 0.0 113.929 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 98.48 -5.32 60.46 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.979 1.752 . . . . 0.0 114.177 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -73.81 159.55 32.74 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.5 1.12 . . . . 0.0 112.207 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.4 m -141.55 154.76 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.145 1.378 . . . . 0.0 111.771 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.19 166.65 32.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.351 1.86 . . . . 0.0 111.255 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -101.76 138.6 19.87 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 121.304 -0.873 . . . . 0.0 111.815 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -83.85 169.5 11.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.361 3.374 . . . . 0.0 111.672 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.3 m -108.62 131.69 54.63 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.611 1.564 . . . . 0.0 109.12 172.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.82 132.82 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.207 1.403 . . . . 0.0 109.126 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 84.8 m -135.39 127.87 30.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.49 1.516 . . . . 0.0 110.081 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.2 129.32 34.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.395 0.678 . . . . 0.0 110.861 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -82.52 -5.43 58.73 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 27.0 mmmt 73.24 3.86 4.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.145 2.578 . . . . 0.0 113.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -109.33 8.19 25.45 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.995 2.118 . . . . 0.0 112.967 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.2 20.42 42.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.72 1.152 . . . . 0.0 113.876 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 41.8 p -133.94 158.28 43.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.273 1.829 . . . . 0.0 109.966 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.97 146.73 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.472 1.109 . . . . 0.0 110.059 167.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.6 m -104.2 138.63 40.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.797 1.239 . . . . 0.0 108.449 167.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 27.3 t -126.47 134.81 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.991 1.317 . . . . 0.0 109.373 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -136.67 158.13 45.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.856 1.262 . . . . 0.0 113.277 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 10.3 t80 -156.42 135.42 11.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.314 1.846 . . . . 0.0 111.36 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.27 119.32 72.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.338 1.055 . . . . 0.0 110.579 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.97 145.39 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.53 2.82 . . . . 0.0 112.155 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.9 t -136.73 -14.52 1.64 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.81 152.35 45.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.995 1.718 . . . . 0.0 109.962 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.79 168.85 12.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.034 0.934 . . . . 0.0 112.116 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 105.15 -168.5 15.71 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.648 1.594 . . . . 0.0 113.916 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 39.7 tp -78.74 132.25 36.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.73 1.212 . . . . 0.0 110.613 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 47.5 m80 -127.17 166.37 17.82 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.796 1.638 . . . . 0.0 111.093 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -145.81 153.16 40.6 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.732 0.813 . . . . 0.0 111.356 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 65.4 ttp -128.28 117.21 21.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.568 1.547 . . . . 0.0 110.314 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.82 129.19 35.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.465 2.306 . . . . 0.0 109.411 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.5 mm -130.85 132.11 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 109.913 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 136.22 21.3 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -99.56 119.27 37.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.745 2.418 . . . . 0.0 109.699 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.16 36.14 15.01 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.808 1.243 . . . . 0.0 112.795 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.7 2.93 3.0 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.623 2.369 . . . . 0.0 113.93 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 68.8 mtm -104.37 131.65 51.49 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.617 1.567 . . . . 0.0 110.739 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -55.33 138.22 46.0 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.4 pt -72.47 154.01 91.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 166.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.56 129.33 30.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.237 1.958 . . . . 0.0 110.4 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.57 1.56 87.58 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.652 1.12 . . . . 0.0 115.453 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.1 t -76.03 145.89 78.02 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 119.771 1.785 . . . . 0.0 111.652 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.54 159.85 88.59 Favored 'Cis proline' 0 C--N 1.353 0.816 0 CA-C-N 119.845 0.98 . . . . 0.0 112.076 -6.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.92 148.47 22.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.874 1.27 . . . . 0.0 110.288 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -121.17 144.33 48.64 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.484 1.114 . . . . 0.0 110.586 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.6 p90 -163.54 164.78 24.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.152 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.5 t80 -110.7 143.99 40.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.045 0.938 . . . . 0.0 112.705 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.9 t -117.09 141.89 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.422 1.489 . . . . 0.0 109.32 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.7 t0 -157.22 165.36 36.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 0.0 111.463 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.19 148.43 47.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.581 1.152 . . . . 0.0 112.861 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.1 m -86.52 -16.47 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -109.58 -5.91 15.54 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -168.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 84.9 m -82.66 153.94 25.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.493 1.117 . . . . 0.0 112.878 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.62 -9.64 62.65 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.973 1.273 . . . . 0.0 115.238 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -65.38 159.27 24.48 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.69 1.245 . . . . 0.0 113.675 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.5 t -65.96 136.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.038 0.935 . . . . 0.0 109.083 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.4 t -156.49 145.53 20.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.53 1.132 . . . . 0.0 110.379 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.97 141.51 44.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.822 1.249 . . . . 0.0 111.86 -170.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.8 p90 -169.16 163.72 11.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 112.756 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.0 172.18 12.8 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.4 1.476 . . . . 0.0 112.784 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.94 -33.35 16.06 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.833 2.355 . . . . 0.0 112.681 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.3 -37.07 92.54 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.549 1.068 . . . . 0.0 114.321 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.85 -6.23 53.51 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.784 1.292 . . . . 0.0 113.272 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 53.9 m -97.35 -43.73 7.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.899 1.68 . . . . 0.0 110.777 170.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -152.86 124.54 7.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.041 1.737 . . . . 0.0 112.3 -164.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -127.65 -179.54 15.89 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.448 1.975 . . . . 0.0 112.315 166.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.9 t -142.59 139.77 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.821 1.649 . . . . 0.0 107.792 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.62 134.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 118.288 0.494 . . . . 0.0 112.125 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.4 m-80 67.93 -1.39 1.74 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.964 2.106 . . . . 0.0 114.752 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.45 137.17 19.56 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.949 1.3 . . . . 0.0 110.957 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.16 122.58 8.16 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.609 2.206 . . . . 0.0 110.299 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.15 144.03 34.47 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.4 1.48 . . . . 0.0 110.484 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.11 148.45 49.8 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.56 175.95 12.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.898 1.679 . . . . 0.0 112.011 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -132.36 145.55 51.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.095 1.358 . . . . 0.0 110.921 -171.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 28.6 t -117.47 138.0 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.13 1.772 . . . . 0.0 108.436 168.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -94.97 134.1 38.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.351 1.061 . . . . 0.0 111.423 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 72.3 p -131.13 3.67 4.36 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.164 1.785 . . . . 0.0 113.11 -171.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -55.99 -34.46 65.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.617 1.967 . . . . 0.0 115.615 -164.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.04 19.42 5.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.548 1.539 . . . . 0.0 112.357 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.69 -34.26 60.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -171.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.79 148.45 9.68 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.874 1.226 . . . . 0.0 112.737 -171.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.19 148.23 39.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.527 1.131 . . . . 0.0 112.165 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 172.01 -24.1 0.08 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.51 1.052 . . . . 0.0 115.121 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.81 110.14 1.15 Allowed Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.497 1.523 . . . . 0.0 112.643 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.44 126.76 32.58 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.609 1.564 . . . . 0.0 109.037 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 44.3 m -122.79 155.64 36.14 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.869 1.668 . . . . 0.0 111.875 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.6 tp -158.44 135.16 9.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.614 1.566 . . . . 0.0 109.131 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.57 159.0 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.995 0.918 . . . . 0.0 112.175 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -136.07 141.32 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.846 1.258 . . . . 0.0 109.661 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.24 161.7 28.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 109.882 170.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.87 31.47 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 118.875 -0.958 . . . . 0.0 114.317 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.57 -24.84 62.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.048 3.165 . . . . 0.0 112.717 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.1 t -143.42 160.87 39.77 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.311 1.444 . . . . 0.0 109.628 164.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.2 tptt -74.34 116.99 15.64 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.071 -1.018 . . . . 0.0 110.989 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.59 149.07 46.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.73 0.812 . . . . 0.0 111.738 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -85.79 140.82 30.14 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.644 0.778 . . . . 0.0 109.171 166.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.3 143.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.439 1.096 . . . . 0.0 110.402 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -140.63 164.97 28.74 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.871 1.268 . . . . 0.0 110.906 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.3 p -161.55 158.88 27.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.758 1.223 . . . . 0.0 112.555 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 50.4 m -144.42 119.14 9.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.989 1.316 . . . . 0.0 110.126 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.57 130.37 36.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.565 1.146 . . . . 0.0 110.938 171.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -109.77 145.57 36.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.883 1.673 . . . . 0.0 111.73 -176.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.02 -18.17 65.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.966 1.307 . . . . 0.0 113.237 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -69.62 -22.43 63.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.558 1.143 . . . . 0.0 113.636 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 103.41 43.54 1.84 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.271 0.939 . . . . 0.0 113.223 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 57.6 p -139.09 159.36 42.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.177 1.391 . . . . 0.0 110.398 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 36.4 t -115.38 125.63 53.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.174 1.39 . . . . 0.0 108.588 161.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.2 t -87.21 151.4 23.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.853 0.861 . . . . 0.0 110.293 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -133.03 143.12 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.827 1.651 . . . . 0.0 110.085 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.5 p -135.6 148.05 48.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.949 1.3 . . . . 0.0 111.694 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.2 p90 -150.39 153.17 35.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.9 mt -120.55 105.62 41.09 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.559 1.943 . . . . 0.0 109.869 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -82.67 176.87 7.39 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.847 3.031 . . . . 0.0 110.321 167.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -148.85 -30.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 69.3 mt -107.58 147.63 35.69 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 119.725 1.148 . . . . 0.0 110.767 167.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.6 155.17 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.128 2.552 . . . . 0.0 111.041 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.65 -159.09 25.8 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.442 1.496 . . . . 0.0 113.134 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.01 135.26 41.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.065 1.346 . . . . 0.0 111.929 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -118.87 142.49 47.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.718 1.607 . . . . 0.0 110.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -101.65 122.0 43.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.82 1.248 . . . . 0.0 110.356 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.91 120.89 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.775 1.63 . . . . 0.0 108.466 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.1 tt -103.69 131.36 50.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.478 1.511 . . . . 0.0 109.744 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 131.32 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.454 1.502 . . . . 0.0 108.098 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -152.99 142.9 22.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.104 1.362 . . . . 0.0 110.325 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.93 123.75 11.26 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.213 -0.93 . . . . 0.0 110.534 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 43.8 t-20 57.5 54.25 6.67 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.973 1.309 . . . . 0.0 111.443 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 9.4 pt-20 56.2 22.7 6.35 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.21 2.604 . . . . 0.0 115.975 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.4 129.78 39.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.558 1.143 . . . . 0.0 111.328 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.42 156.89 18.08 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.187 0.995 . . . . 0.0 112.482 169.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.7 m -87.83 156.68 52.52 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.272 0.629 . . . . 0.0 110.489 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.52 119.1 5.86 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.885 2.39 . . . . 0.0 110.203 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.94 -13.2 65.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.297 1.427 . . . . 0.0 116.564 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.5 p -81.5 151.36 68.59 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 119.921 1.861 . . . . 0.0 113.214 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 146.56 86.88 Favored 'Cis proline' 0 C--N 1.355 0.885 0 CA-C-N 119.076 0.706 . . . . 0.0 112.051 -6.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.64 159.31 15.05 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 110.955 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 48.4 m -114.71 121.17 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.817 0.847 . . . . 0.0 110.654 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -104.02 141.35 36.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.421 1.488 . . . . 0.0 111.623 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.56 141.02 41.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.548 1.139 . . . . 0.0 109.912 164.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.1 t -133.24 138.74 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.655 1.182 . . . . 0.0 109.562 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 11.8 p -132.7 169.99 15.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.677 1.191 . . . . 0.0 112.469 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.48 140.99 27.05 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.603 1.573 . . . . 0.0 113.129 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.7 t70 -86.69 -25.77 24.62 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.5 1.12 . . . . 0.0 113.047 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.949 1.699 . . . . 0.0 113.519 -179.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 112.196 -0.362 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.88 155.83 39.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.53 1.132 . . . . 0.0 112.813 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 96.7 mtp -85.52 146.24 27.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.211 1.405 . . . . 0.0 110.669 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . 72.43 153.19 0.15 Allowed Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 127.853 2.461 . . . . 0.0 112.316 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.34 161.77 44.59 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.072 2.515 . . . . 0.0 113.183 -170.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.21 6.19 4.63 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.503 1.521 . . . . 0.0 114.807 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -52.98 138.91 44.56 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 125.371 1.468 . . . . 0.0 110.728 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.24 130.73 21.31 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.393 2.729 . . . . 0.0 112.799 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 7.0 mp 74.46 -2.02 2.93 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 127.946 2.499 . . . . 0.0 113.752 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 17.2 t -108.33 148.85 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.118 1.767 . . . . 0.0 109.866 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 119.73 138.09 5.62 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.441 1.496 . . . . 0.0 112.309 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 10.1 p -153.33 147.9 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.669 1.188 . . . . 0.0 111.841 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -137.1 150.48 48.03 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.32 1.448 . . . . 0.0 112.27 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 117.08 159.03 11.35 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.818 1.675 . . . . 0.0 113.796 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 81.6 mt -88.89 -179.51 5.97 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.479 1.512 . . . . 0.0 111.966 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 46.5 t0 -147.3 164.45 33.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.861 1.664 . . . . 0.0 111.014 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.7 p -61.24 -21.57 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.116 1.366 . . . . 0.0 113.788 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.0 t -77.81 -8.62 58.28 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.544 1.538 . . . . 0.0 114.204 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 69.1 m -72.72 84.98 1.2 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.452 1.024 . . . . 0.0 113.695 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.3 147.69 39.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.475 1.51 . . . . 0.0 110.51 160.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.19 121.19 67.86 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.17 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.5 148.1 47.43 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.664 2.243 . . . . 0.0 110.424 173.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.36 135.66 33.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.468 0.651 . . . . 0.0 110.733 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -157.33 144.28 18.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.021 1.728 . . . . 0.0 110.531 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.36 149.87 21.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.455 1.502 . . . . 0.0 109.73 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -123.17 132.74 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.166 1.386 . . . . 0.0 109.489 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 74.0 mt -129.37 136.27 28.88 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.325 1.85 . . . . 0.0 108.735 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.0 72.24 6.27 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.256 3.304 . . . . 0.0 111.419 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 34.6 t80 -124.41 152.5 43.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.589 1.956 . . . . 0.0 109.338 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 34.6 m -127.25 125.62 41.28 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.424 1.09 . . . . 0.0 109.624 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.2 mt -75.08 135.6 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 110.378 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 21.4 pttp -128.84 -147.85 0.36 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.248 1.819 . . . . 0.0 110.923 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.11 126.74 29.02 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.537 -1.352 . . . . 0.0 110.418 165.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 124.65 -154.03 17.93 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.52 1.533 . . . . 0.0 112.183 -170.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -161.39 151.95 17.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 111.214 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.48 134.89 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.51 1.524 . . . . 0.0 111.847 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -147.52 158.85 44.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.561 1.544 . . . . 0.0 110.917 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -137.44 -175.85 14.08 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -153.39 143.71 22.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.341 1.856 . . . . 0.0 109.065 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 98.3 t -119.45 129.31 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.719 1.608 . . . . 0.0 108.008 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -113.5 130.08 56.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.356 1.462 . . . . 0.0 110.479 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 34.8 mtm -108.67 139.92 21.32 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.413 1.485 . . . . 0.0 111.875 -171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.37 -27.48 75.89 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 124.258 3.305 . . . . 0.0 115.54 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.8 p -75.08 4.87 6.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.353 1.461 . . . . 0.0 114.563 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.83 44.54 5.12 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 124.665 1.126 . . . . 0.0 113.088 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -153.24 165.07 36.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.522 1.529 . . . . 0.0 112.107 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.6 m -141.25 159.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.67 1.188 . . . . 0.0 112.632 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.05 175.55 13.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.063 2.145 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -121.91 143.9 39.75 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.123 -0.985 . . . . 0.0 112.204 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -86.25 171.74 7.56 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 111.877 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.2 m -106.91 130.56 54.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 109.031 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.88 132.88 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.163 1.385 . . . . 0.0 108.951 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -136.55 124.04 22.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.36 1.464 . . . . 0.0 109.975 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.1 126.41 30.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.54 0.736 . . . . 0.0 110.753 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.02 -6.33 57.39 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 73.68 1.09 3.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 113.537 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -102.85 4.6 37.9 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.086 2.155 . . . . 0.0 112.979 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.08 15.89 40.27 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.069 1.319 . . . . 0.0 114.341 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.0 p -130.69 155.94 45.76 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.163 1.785 . . . . 0.0 110.615 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -112.64 137.34 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.71 165.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.5 m -93.74 137.91 32.5 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.583 1.153 . . . . 0.0 108.424 167.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.2 t -125.5 133.43 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.469 1.508 . . . . 0.0 108.855 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -139.84 155.79 47.05 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 0.0 112.656 -176.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.3 t80 -151.05 134.55 16.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 111.547 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.86 122.72 74.45 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.575 1.15 . . . . 0.0 111.105 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.23 161.15 20.27 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.784 2.99 . . . . 0.0 111.938 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -149.81 -21.81 0.27 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -141.4 149.54 41.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.46 1.904 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.91 167.76 19.5 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.039 0.936 . . . . 0.0 112.98 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 122.58 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.59 1.567 . . . . 0.0 114.085 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tt -83.68 118.7 24.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.436 1.094 . . . . 0.0 109.417 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 28.3 m80 -111.38 158.43 19.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.524 1.53 . . . . 0.0 111.054 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -143.73 150.99 39.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.482 0.658 . . . . 0.0 112.337 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.8 ttm -132.14 139.2 48.35 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.782 2.033 . . . . 0.0 110.712 -164.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -112.19 137.37 50.37 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 109.635 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.3 mm -133.93 129.39 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.646 1.178 . . . . 0.0 109.683 174.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.87 137.66 36.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 19.9 t80 -103.83 124.91 49.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.499 1.92 . . . . 0.0 109.672 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 27.3 t70 48.29 46.51 20.11 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.779 1.232 . . . . 0.0 112.293 -177.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.306 0.3 OUTLIER 62.78 13.35 6.4 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 128.005 2.522 . . . . 0.0 116.543 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 58.9 ttm -114.74 130.41 56.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.529 1.532 . . . . 0.0 110.926 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -56.06 135.9 52.53 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.285 -0.885 . . . . 0.0 113.053 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.87 154.32 89.02 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.328 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.04 128.2 25.78 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.992 1.794 . . . . 0.0 109.403 170.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.35 -16.05 58.34 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.702 1.144 . . . . 0.0 114.098 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.1 t -82.41 146.98 55.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-N 119.803 1.802 . . . . 0.0 110.876 170.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.68 163.85 82.86 Favored 'Cis proline' 0 C--N 1.353 0.804 0 CA-C-N 120.333 1.155 . . . . 0.0 112.413 -6.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.5 159.26 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.17 1.788 . . . . 0.0 111.047 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -155.4 148.72 24.89 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 112.819 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 7.8 p90 -167.2 -179.4 4.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.968 1.707 . . . . 0.0 111.264 -167.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -120.48 142.39 49.32 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.779 -1.201 . . . . 0.0 113.405 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.1 t -111.73 134.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.144 1.778 . . . . 0.0 108.966 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -161.29 158.31 26.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.96 1.304 . . . . 0.0 112.923 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -75.48 122.15 23.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 112.124 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 32.7 m -79.79 -15.77 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 p30 -85.07 -14.69 46.45 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.719 1.208 . . . . 0.0 114.181 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.7 m -77.81 -17.22 57.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 85.16 -3.44 87.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 0.0 115.676 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -64.84 156.0 32.22 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 119.201 1.501 . . . . 0.0 112.962 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.5 t -68.19 131.82 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.2 t -152.92 161.1 42.97 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.507 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.84 142.8 36.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.358 1.463 . . . . 0.0 111.235 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 20.6 p90 -163.58 161.11 23.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.572 1.549 . . . . 0.0 112.161 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.67 176.97 15.63 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.863 1.22 . . . . 0.0 113.293 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.12 -37.94 5.49 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.045 2.496 . . . . 0.0 112.594 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.91 -32.54 73.69 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.588 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.23 -3.84 41.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.769 1.284 . . . . 0.0 113.426 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.7 m -110.35 -48.48 3.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.327 1.851 . . . . 0.0 111.109 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -138.54 145.96 41.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.101 1.76 . . . . 0.0 112.235 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.91 -179.27 21.15 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.574 1.083 . . . . 0.0 113.624 173.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.0 t -143.57 136.04 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.108 1.363 . . . . 0.0 108.598 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.3 m -56.46 137.34 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.2 m-80 68.06 -2.88 1.36 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.756 2.022 . . . . 0.0 114.663 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -100.9 136.99 19.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.039 1.336 . . . . 0.0 110.725 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.25 127.95 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.377 2.051 . . . . 0.0 110.124 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.12 146.55 36.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.613 1.565 . . . . 0.0 110.523 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.4 p -136.43 153.98 50.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -164.16 172.49 13.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.26 1.824 . . . . 0.0 111.351 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.7 m -122.75 142.42 50.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.161 1.384 . . . . 0.0 110.694 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.9 t -115.85 133.71 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.474 1.509 . . . . 0.0 108.417 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.73 132.85 36.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.381 1.072 . . . . 0.0 111.585 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 45.8 p -136.64 0.87 2.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.189 1.395 . . . . 0.0 114.108 -169.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -53.46 -37.86 63.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 115.119 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -117.01 9.92 13.82 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.396 1.479 . . . . 0.0 112.538 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.13 56.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.446 1.099 . . . . 0.0 113.504 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.36 -106.77 2.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.609 1.1 . . . . 0.0 112.247 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -161.45 155.12 21.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.523 1.929 . . . . 0.0 109.942 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 148.08 9.21 0.19 Allowed Glycine 0 N--CA 1.473 1.118 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.03 103.84 2.05 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 126.078 1.799 . . . . 0.0 112.479 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.72 132.85 33.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.984 1.713 . . . . 0.0 109.603 171.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.3 m -129.86 157.99 40.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.6 1.56 . . . . 0.0 112.134 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.1 tp -159.02 136.06 9.69 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.029 1.732 . . . . 0.0 109.184 -170.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.45 158.93 36.73 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 112.424 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.3 mt -137.51 139.04 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.89 1.276 . . . . 0.0 109.98 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.83 129.16 40.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.369 1.468 . . . . 0.0 109.944 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.35 -162.16 11.24 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 119.04 -0.866 . . . . 0.0 114.386 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.7 -24.72 69.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.042 3.162 . . . . 0.0 112.56 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.6 t -138.97 160.45 39.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.978 1.311 . . . . 0.0 109.627 162.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -71.75 112.34 7.77 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.134 -0.979 . . . . 0.0 110.689 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.64 148.77 50.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.694 0.798 . . . . 0.0 111.688 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.44 140.71 29.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.09 143.89 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.665 1.186 . . . . 0.0 110.259 -167.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.9 t -141.67 156.5 45.64 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.13 1.372 . . . . 0.0 111.144 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 48.9 t -145.35 136.97 25.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.211 1.405 . . . . 0.0 110.66 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 93.5 m -132.3 129.33 39.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.272 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.99 131.5 43.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 110.779 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.17 -131.23 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.85 0.86 . . . . 0.0 110.222 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -84.1 38.04 0.64 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.461 -1.399 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 20.7 t70 71.37 -20.44 0.23 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.813 2.845 . . . . 0.0 114.588 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . -76.77 -21.27 74.89 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.758 1.17 . . . . 0.0 114.194 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 31.8 p -147.5 157.61 43.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.788 1.635 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 74.2 m -115.54 136.7 52.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.115 1.766 . . . . 0.0 109.205 162.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -98.57 136.89 38.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.466 1.106 . . . . 0.0 110.493 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.5 t -111.43 142.48 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.93 1.692 . . . . 0.0 109.782 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 51.9 m -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.145 1.378 . . . . 0.0 110.833 168.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 9.6 p90 -148.38 154.29 39.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 8.8 mt -120.62 107.66 38.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.893 1.677 . . . . 0.0 110.763 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.64 175.03 9.18 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.036 3.157 . . . . 0.0 110.46 166.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.3 p -151.07 -30.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.4 mt -105.6 146.33 32.61 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.586 1.085 . . . . 0.0 110.533 167.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.86 154.53 48.46 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.911 2.407 . . . . 0.0 110.949 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.13 -158.6 24.0 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.796 1.188 . . . . 0.0 113.247 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -100.82 133.31 45.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.09 1.356 . . . . 0.0 112.492 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.83 126.07 50.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.999 1.72 . . . . 0.0 109.956 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 71.2 m -84.32 126.62 33.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.108 0.963 . . . . 0.0 110.582 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.73 124.99 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.6 1.56 . . . . 0.0 108.283 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -108.86 130.49 55.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.29 1.436 . . . . 0.0 109.811 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -132.58 128.79 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.417 1.087 . . . . 0.0 109.879 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.99 142.2 24.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.058 1.343 . . . . 0.0 111.718 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.65 121.36 16.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.809 1.244 . . . . 0.0 109.448 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.41 57.37 4.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.472 1.509 . . . . 0.0 112.159 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.285 8.5 pt-20 57.21 12.12 1.26 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.498 2.719 . . . . 0.0 116.329 -177.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -119.26 125.31 48.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.704 1.202 . . . . 0.0 110.671 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -64.72 147.39 53.17 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.457 -0.777 . . . . 0.0 111.894 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 21.8 m -69.11 152.47 96.71 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.044 168.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.99 128.69 23.66 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.254 1.969 . . . . 0.0 110.063 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.52 -14.74 64.74 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.989 1.28 . . . . 0.0 115.007 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.8 t -78.16 139.94 61.08 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.258 1.529 . . . . 0.0 111.295 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.41 135.55 40.83 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.383 0.816 . . . . 0.0 111.905 -3.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.3 170.9 12.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.0 1.72 . . . . 0.0 110.399 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 52.4 m -132.73 121.27 22.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.35 140.33 30.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.312 1.445 . . . . 0.0 110.872 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -100.89 122.52 43.6 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.732 0.813 . . . . 0.0 109.968 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.7 t -109.26 129.89 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.589 1.555 . . . . 0.0 110.373 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.5 p -100.68 155.96 17.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.676 1.19 . . . . 0.0 112.752 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.7 121.98 6.85 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.404 1.478 . . . . 0.0 111.183 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -151.86 4.23 0.41 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.823 1.249 . . . . 0.0 113.636 178.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.79 -26.0 64.07 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 54.4 mtm -139.73 161.68 36.96 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.685 1.594 . . . . 0.0 111.093 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -65.04 -44.17 69.99 Favored Pre-proline 0 CA--C 1.556 1.181 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.15 172.33 16.27 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.661 2.241 . . . . 0.0 112.297 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -67.17 1.64 1.98 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.354 1.862 . . . . 0.0 114.681 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -117.21 56.48 1.81 Allowed Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 126.831 2.052 . . . . 0.0 113.276 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.97 166.11 30.15 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.43 2.753 . . . . 0.0 111.786 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.63 33.66 0.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.686 1.594 . . . . 0.0 113.413 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 60.2 t -142.58 135.28 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 127.025 2.13 . . . . 0.0 109.082 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 166.78 174.76 36.35 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.657 1.123 . . . . 0.0 114.046 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 12.9 p -165.09 145.43 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 126.293 1.837 . . . . 0.0 110.21 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -68.5 128.2 35.76 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.826 0.851 . . . . 0.0 111.869 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -86.18 -15.83 63.92 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.722 1.154 . . . . 0.0 114.416 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.4 mt -91.17 153.79 19.79 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.685 1.194 . . . . 0.0 111.618 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 44.0 t0 -106.04 157.57 17.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.636 1.574 . . . . 0.0 111.052 167.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 58.3 t -141.38 132.49 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.74 1.616 . . . . 0.0 109.406 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 8.8 t -172.87 -38.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.894 2.078 . . . . 0.0 110.854 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 72.5 m -118.83 139.08 52.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.367 1.067 . . . . 0.0 111.982 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 5.7 mt -125.91 161.42 27.5 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.627 2.371 . . . . 0.0 110.149 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.38 117.49 16.88 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.605 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.67 112.54 3.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.546 2.164 . . . . 0.0 108.809 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.71 135.48 42.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.718 0.807 . . . . 0.0 111.686 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.75 166.07 27.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.508 1.923 . . . . 0.0 111.411 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 156.47 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.427 1.491 . . . . 0.0 111.038 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -121.67 135.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.326 1.45 . . . . 0.0 109.364 167.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 65.2 mt -132.02 136.94 29.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.368 1.867 . . . . 0.0 108.367 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.76 42.45 1.26 Allowed 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.46 3.44 . . . . 0.0 113.124 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -89.01 159.16 17.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.303 1.441 . . . . 0.0 111.546 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.5 m -127.04 128.1 45.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.396 1.478 . . . . 0.0 110.282 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 26.4 mt -93.8 130.67 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.617 1.167 . . . . 0.0 109.376 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -113.24 -75.23 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.635 1.174 . . . . 0.0 111.791 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.8 tttm -160.07 133.73 7.08 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.998 1.719 . . . . 0.0 110.951 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.6 -137.73 9.76 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.533 1.54 . . . . 0.0 110.945 -166.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -155.88 140.11 16.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.026 0.931 . . . . 0.0 111.727 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.9 tt -116.74 138.08 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.847 1.659 . . . . 0.0 110.696 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.0 p -144.1 177.96 8.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.19 1.796 . . . . 0.0 110.392 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.18 -172.27 37.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -156.41 143.83 19.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.62 1.568 . . . . 0.0 109.919 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 91.0 t -118.17 132.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.566 1.546 . . . . 0.0 108.674 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -108.76 137.14 47.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 112.166 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 8.3 mtm -103.0 142.5 24.68 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.059 1.743 . . . . 0.0 111.135 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.33 -27.21 66.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.052 3.168 . . . . 0.0 115.278 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.8 p -73.81 0.69 12.42 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.407 1.483 . . . . 0.0 114.37 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.71 69.22 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.892 1.71 . . . . 0.0 114.3 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -73.69 156.81 37.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.057 1.343 . . . . 0.0 112.153 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.0 m -139.95 152.59 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.594 1.557 . . . . 0.0 110.795 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.29 170.04 22.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.721 1.608 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -101.74 138.62 19.88 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.704 0.802 . . . . 0.0 111.556 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.36 162.53 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.946 3.098 . . . . 0.0 111.073 169.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 91.4 m -109.82 119.39 39.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.332 1.453 . . . . 0.0 108.997 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.73 132.01 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.957 1.303 . . . . 0.0 109.239 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.5 m -134.13 120.14 19.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.565 1.546 . . . . 0.0 109.376 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.37 131.64 37.05 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.718 0.807 . . . . 0.0 112.094 172.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.96 -3.55 58.96 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt 73.06 0.78 3.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.575 2.35 . . . . 0.0 113.875 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -109.78 8.44 24.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.802 2.041 . . . . 0.0 113.112 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.31 15.75 49.68 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.866 1.222 . . . . 0.0 114.352 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 45.1 p -131.14 161.03 33.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.216 1.806 . . . . 0.0 110.415 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 17.9 m -122.75 140.77 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 110.212 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 46.7 m -98.29 140.66 32.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.993 1.317 . . . . 0.0 108.432 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.4 t -127.56 134.84 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.546 1.139 . . . . 0.0 109.522 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -132.18 162.87 29.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.651 1.581 . . . . 0.0 111.984 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.1 t80 -157.14 140.4 15.55 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.513 1.525 . . . . 0.0 111.796 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.98 114.86 63.87 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.705 1.202 . . . . 0.0 110.807 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.68 158.33 28.29 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.593 2.862 . . . . 0.0 112.075 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 95.9 p -143.45 0.37 1.14 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -169.59 157.25 7.02 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.415 1.886 . . . . 0.0 110.554 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.87 170.94 15.62 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.324 1.05 . . . . 0.0 113.085 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.7 -177.79 16.39 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 125.884 1.707 . . . . 0.0 114.391 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.0 tp -86.93 112.38 21.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 110.155 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 45.2 m80 -105.71 171.69 7.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.002 1.721 . . . . 0.0 111.444 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.34 151.17 37.07 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.948 0.899 . . . . 0.0 111.339 172.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 31.4 ttm -119.19 129.98 55.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.059 1.744 . . . . 0.0 110.685 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.77 134.3 40.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.082 2.553 . . . . 0.0 109.392 165.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.0 mm -138.47 135.98 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.928 1.291 . . . . 0.0 108.703 168.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.71 142.15 24.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.993 0.917 . . . . 0.0 113.384 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.63 118.73 36.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.405 1.882 . . . . 0.0 109.611 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.14 34.23 10.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.62 1.168 . . . . 0.0 112.727 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 73.05 8.05 5.39 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.827 2.451 . . . . 0.0 115.11 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.98 128.68 46.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.375 1.47 . . . . 0.0 110.459 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 139.27 55.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.6 pt -73.66 150.29 88.71 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.88 169.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.21 -20.12 66.67 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.837 2.358 . . . . 0.0 113.959 -172.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.42 1.01 88.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.099 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.1 m -119.84 156.46 54.08 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 120.031 1.916 . . . . 0.0 113.347 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.35 169.29 74.4 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 119.098 0.714 . . . . 0.0 113.212 0.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 74.3 mt -129.71 150.12 51.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.375 1.87 . . . . 0.0 110.563 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.8 136.84 47.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.936 1.294 . . . . 0.0 110.164 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.4 p90 -154.17 149.26 26.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.386 1.074 . . . . 0.0 112.213 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.5 t80 -99.87 145.27 27.96 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.179 -0.951 . . . . 0.0 112.748 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.0 t -124.43 143.39 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.786 1.634 . . . . 0.0 109.233 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.9 t0 -151.64 167.8 26.98 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.966 1.306 . . . . 0.0 110.96 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.67 164.72 24.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.02 1.328 . . . . 0.0 112.787 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 34.1 m -73.52 -20.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.962 167.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -86.89 -6.74 58.69 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.849 1.259 . . . . 0.0 114.138 -171.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 29.4 p -64.14 145.57 55.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.267 1.027 . . . . 0.0 113.615 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -108.19 -21.15 7.85 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.156 1.36 . . . . 0.0 113.932 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -70.12 159.85 33.15 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.65 1.18 . . . . 0.0 113.999 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.3 t -64.59 135.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 109.061 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.9 t -156.71 163.12 39.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.773 1.229 . . . . 0.0 110.877 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.59 147.33 31.94 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.875 1.27 . . . . 0.0 112.38 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -169.08 160.34 9.79 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.758 1.623 . . . . 0.0 112.968 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 145.22 175.82 18.67 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.201 1.381 . . . . 0.0 113.576 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.46 -37.55 12.98 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.045 2.497 . . . . 0.0 112.218 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.9 75.88 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.215 0.912 . . . . 0.0 114.099 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.26 -11.09 60.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.576 1.15 . . . . 0.0 113.213 171.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.8 m -120.67 -43.52 2.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.718 1.607 . . . . 0.0 111.912 -170.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -142.84 154.56 44.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.715 2.006 . . . . 0.0 112.139 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.05 174.4 26.0 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.476 1.036 . . . . 0.0 113.699 172.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 38.4 t -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.919 1.288 . . . . 0.0 108.571 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.8 m -56.39 135.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.153 0.581 . . . . 0.0 112.52 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.7 m-80 66.45 3.5 2.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.938 2.095 . . . . 0.0 114.73 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 54.7 mttm -110.0 142.9 26.85 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.391 1.476 . . . . 0.0 110.948 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.33 119.87 6.22 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.576 2.184 . . . . 0.0 110.577 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -99.55 143.1 30.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.082 1.353 . . . . 0.0 110.082 172.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.9 p -133.49 152.99 51.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -165.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -164.04 174.63 11.13 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.741 1.616 . . . . 0.0 112.175 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 80.7 m -126.69 142.83 51.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.579 1.552 . . . . 0.0 110.964 -170.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.8 t -116.48 133.15 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.963 1.705 . . . . 0.0 108.265 167.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.03 127.47 35.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.053 0.941 . . . . 0.0 111.222 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 51.5 p -133.13 0.44 3.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.076 1.35 . . . . 0.0 114.011 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.1 tptp -52.5 -39.12 60.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.699 1.6 . . . . 0.0 114.459 -173.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.37 6.66 20.54 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.385 1.474 . . . . 0.0 113.046 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.23 60.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.231 1.012 . . . . 0.0 113.622 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 77.72 -102.49 1.77 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.624 1.107 . . . . 0.0 112.164 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.92 157.28 23.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.247 1.819 . . . . 0.0 110.18 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.79 4.21 0.75 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.572 1.558 . . . . 0.0 115.146 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.01 103.67 1.89 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.544 1.545 . . . . 0.0 113.224 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.06 135.58 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.655 1.582 . . . . 0.0 109.266 168.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -138.76 165.3 27.34 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.079 1.352 . . . . 0.0 112.319 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -165.05 136.8 4.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.207 1.803 . . . . 0.0 109.699 -161.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.92 166.24 32.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.519 1.128 . . . . 0.0 112.004 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.66 131.76 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.651 1.18 . . . . 0.0 109.55 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.87 113.38 25.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 109.454 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.08 -174.95 13.93 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.128 1.347 . . . . 0.0 113.802 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.84 -23.81 47.36 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.853 3.035 . . . . 0.0 111.942 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -142.06 159.53 42.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 160.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.06 130.62 43.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.933 -1.105 . . . . 0.0 112.52 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.37 152.44 27.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.103 0.961 . . . . 0.0 110.981 164.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.21 139.3 30.63 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 165.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -132.8 138.76 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.558 1.143 . . . . 0.0 110.392 -167.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 68.6 m -134.74 158.27 44.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 111.008 170.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -152.87 153.61 33.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.387 1.075 . . . . 0.0 112.544 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.9 m -143.09 122.2 12.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.461 1.504 . . . . 0.0 110.373 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.68 129.51 36.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.415 1.086 . . . . 0.0 111.132 171.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -104.62 158.74 16.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.424 1.489 . . . . 0.0 112.602 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -70.92 -15.59 62.62 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.83 0.852 . . . . 0.0 112.114 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.47 -3.62 34.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.267 1.827 . . . . 0.0 114.551 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 86.99 27.3 29.0 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.207 0.908 . . . . 0.0 113.775 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.3 p -137.85 158.74 43.71 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 110.943 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 34.5 t -103.6 127.97 50.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.333 1.053 . . . . 0.0 108.819 159.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -88.15 152.36 22.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.681 0.793 . . . . 0.0 110.226 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 91.9 t -133.63 143.86 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.628 1.571 . . . . 0.0 109.567 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -135.97 147.64 48.12 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.019 1.328 . . . . 0.0 111.793 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -149.81 152.12 34.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.9 mt -117.54 102.0 52.16 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.693 1.997 . . . . 0.0 110.262 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.79 162.12 18.73 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.763 2.976 . . . . 0.0 110.412 170.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.9 m -124.25 -10.56 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -167.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -156.01 151.79 22.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.363 1.465 . . . . 0.0 110.347 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.33 140.69 24.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.665 2.244 . . . . 0.0 111.462 -173.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.63 -167.91 33.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.507 1.051 . . . . 0.0 113.591 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -96.0 124.3 39.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.331 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.67 121.33 38.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.75 1.62 . . . . 0.0 110.176 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.4 m -92.4 109.8 21.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.267 1.027 . . . . 0.0 110.989 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -81.49 131.99 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.765 1.626 . . . . 0.0 108.677 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.88 128.88 55.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.951 1.7 . . . . 0.0 108.987 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 48.9 t -128.28 130.02 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.19 0.996 . . . . 0.0 109.839 172.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.61 141.36 22.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.842 1.257 . . . . 0.0 111.961 -167.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.46 123.46 21.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.041 1.336 . . . . 0.0 109.457 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.79 57.72 5.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.347 1.459 . . . . 0.0 112.617 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.1 pt-20 57.84 11.02 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 128.134 2.574 . . . . 0.0 116.296 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -117.45 124.66 49.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.655 1.182 . . . . 0.0 110.597 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.73 143.6 57.27 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.463 -0.773 . . . . 0.0 111.29 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.8 m -70.11 151.83 95.92 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.718 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.54 132.8 45.14 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.535 2.157 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.44 -17.42 57.47 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.103 1.335 . . . . 0.0 114.751 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 32.7 t -75.68 141.29 72.21 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.289 1.544 . . . . 0.0 111.663 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.23 148.87 88.54 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.551 0.875 . . . . 0.0 112.339 -4.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -110.66 132.66 54.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 110.161 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 87.9 m -95.44 114.3 26.06 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.055 0.843 . . . . 0.0 111.251 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.3 138.31 33.17 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.037 1.335 . . . . 0.0 111.033 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -97.04 117.9 32.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.421 0.689 . . . . 0.0 110.887 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.8 t -93.34 137.5 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.399 1.48 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.0 p -115.58 155.84 26.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.564 1.546 . . . . 0.0 112.871 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.23 136.16 14.16 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.962 1.268 . . . . 0.0 112.119 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -90.53 -10.88 41.9 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.648 1.179 . . . . 0.0 113.464 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.714 2.005 . . . . 0.0 112.543 -177.434 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.05 -8.46 53.5 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -176.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -66.79 -15.61 63.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.117 1.767 . . . . 0.0 114.409 -176.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -141.75 152.81 63.71 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.691 1.597 . . . . 0.0 111.853 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.85 164.69 31.38 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.858 3.039 . . . . 0.0 112.105 178.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -74.0 146.39 43.83 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.171 0.988 . . . . 0.0 112.201 178.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -141.08 150.34 58.66 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.939 1.696 . . . . 0.0 110.752 178.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.02 149.87 59.6 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.461 2.774 . . . . 0.0 112.091 -175.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 97.8 mt -141.35 158.27 44.1 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.235 1.814 . . . . 0.0 110.427 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 84.8 t -101.45 136.03 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.124 1.37 . . . . 0.0 109.486 176.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 87.22 0.98 84.63 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.681 1.134 . . . . 0.0 115.317 175.37 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 35.6 m -86.69 153.08 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.987 1.315 . . . . 0.0 111.575 176.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 13.0 p30 -76.95 165.25 24.92 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.244 1.018 . . . . 0.0 113.559 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -163.12 171.57 38.91 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.491 1.519 . . . . 0.0 113.485 176.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.24 153.6 51.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.904 1.682 . . . . 0.0 111.325 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -162.82 171.08 17.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.714 2.005 . . . . 0.0 109.797 176.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 7.4 p -57.35 -21.36 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.321 1.448 . . . . 0.0 114.006 -176.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.0 t -62.64 -25.2 68.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.858 1.263 . . . . 0.0 112.923 173.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 41.5 m -75.58 109.56 9.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.009 0.924 . . . . 0.0 111.668 178.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 90.7 mt -85.68 146.05 27.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.66 1.184 . . . . 0.0 110.585 169.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -64.41 115.84 23.28 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.443 1.897 . . . . 0.0 110.073 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 151.46 64.59 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -171.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.82 122.89 41.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.199 0.6 . . . . 0.0 110.078 176.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -150.14 132.8 15.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.764 1.226 . . . . 0.0 110.966 174.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.01 157.73 45.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.33 2.252 . . . . 0.0 109.41 -175.303 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.9 p -135.3 134.14 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.654 1.182 . . . . 0.0 109.438 172.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.73 136.41 28.37 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.544 1.537 . . . . 0.0 109.284 -169.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.78 85.56 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.892 3.061 . . . . 0.0 110.319 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.4 t80 -139.98 152.53 46.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.697 1.999 . . . . 0.0 109.429 177.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -126.42 134.51 50.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.822 1.249 . . . . 0.0 109.471 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.5 mt -91.49 128.81 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.522 1.129 . . . . 0.0 109.345 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -99.52 -131.08 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.544 1.138 . . . . 0.0 109.821 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -83.01 -4.21 58.07 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.91 -152.65 17.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.801 1.667 . . . . 0.0 113.291 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.24 149.62 26.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.203 1.401 . . . . 0.0 110.631 -173.111 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.3 tt -128.8 136.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.542 1.537 . . . . 0.0 111.446 -175.296 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.1 p -149.25 167.64 25.48 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.169 1.788 . . . . 0.0 110.857 -175.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.39 -170.1 19.87 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -175.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.57 132.94 9.96 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.084 1.754 . . . . 0.0 109.589 177.401 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 40.2 t -112.33 138.99 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.61 1.564 . . . . 0.0 108.634 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.18 132.71 48.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.832 0.853 . . . . 0.0 111.153 -174.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.4 mtm -106.38 141.66 23.26 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.838 1.655 . . . . 0.0 111.95 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.12 -23.57 36.71 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.63 3.554 . . . . 0.0 115.757 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.0 t -68.92 -8.33 43.29 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.56 48.71 3.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.95 1.262 . . . . 0.0 112.429 177.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -156.87 163.36 39.27 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.131 1.773 . . . . 0.0 111.43 -171.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -139.0 161.71 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.541 1.136 . . . . 0.0 112.734 -171.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.08 169.48 24.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.695 1.998 . . . . 0.0 111.435 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.7 140.79 21.42 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.122 0.969 . . . . 0.0 111.308 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.38 175.24 7.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.209 3.273 . . . . 0.0 111.966 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -114.11 138.01 50.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.534 1.534 . . . . 0.0 109.008 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.76 131.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.783 1.233 . . . . 0.0 108.682 173.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.3 m -133.22 115.44 15.0 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.418 1.487 . . . . 0.0 109.092 -178.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.84 135.27 43.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 112.089 174.124 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.66 -13.5 34.12 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.3 mttp 66.49 7.04 4.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.326 2.25 . . . . 0.0 114.048 -177.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 9.47 43.25 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.082 2.153 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.84 11.9 57.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.356 1.455 . . . . 0.0 114.025 -174.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -130.13 157.31 42.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.062 1.745 . . . . 0.0 111.385 178.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -119.99 140.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.349 1.06 . . . . 0.0 109.949 164.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 51.7 m -94.16 138.5 32.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 170.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.6 t -126.72 133.04 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.688 1.595 . . . . 0.0 108.612 -175.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.07 157.23 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.553 1.141 . . . . 0.0 113.346 -170.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.0 t80 -158.31 137.83 11.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.874 1.669 . . . . 0.0 111.917 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.0 112.67 56.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.997 1.319 . . . . 0.0 110.785 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.11 149.04 28.09 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.685 2.923 . . . . 0.0 112.921 -174.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.1 p -139.21 -2.99 1.59 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 174.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -141.64 145.89 35.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.241 1.816 . . . . 0.0 109.484 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.74 169.53 15.15 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.976 0.911 . . . . 0.0 112.978 176.963 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 107.14 -173.19 18.77 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 124.992 1.282 . . . . 0.0 114.712 173.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 60.8 tp -77.71 128.16 33.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.96 1.304 . . . . 0.0 110.893 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -126.41 166.86 16.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.952 1.701 . . . . 0.0 111.175 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.49 153.54 51.71 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 112.312 156.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 43.7 ttm -112.54 121.8 45.86 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 109.875 169.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.77 136.22 38.99 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.106 1.363 . . . . 0.0 110.133 164.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.8 mm -133.88 135.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.709 1.203 . . . . 0.0 109.78 167.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.41 138.65 31.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.665 1.186 . . . . 0.0 112.966 175.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 46.4 t80 -102.87 123.81 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.53 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.08 45.75 22.86 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.766 1.227 . . . . 0.0 112.055 -176.048 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.28 4.6 p30 67.44 -2.05 1.39 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.864 2.866 . . . . 0.0 116.584 -177.065 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.2 mtt -100.67 134.27 43.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.069 1.347 . . . . 0.0 111.454 176.594 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 10.6 m170 -56.08 134.72 52.85 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.318 -0.864 . . . . 0.0 112.551 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.1 154.82 86.52 Favored Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 121.734 -0.603 . . . . 0.0 111.272 173.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -60.37 126.57 20.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.675 1.583 . . . . 0.0 108.587 165.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.98 45.53 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.565 1.078 . . . . 0.0 114.366 -173.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 20.7 t -82.09 142.15 47.56 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.181 1.491 . . . . 0.0 112.143 176.399 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.05 152.95 77.1 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.988 1.032 . . . . 0.0 111.864 -7.021 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.59 111.2 22.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.021 1.328 . . . . 0.0 109.109 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -102.27 139.4 37.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.331 1.052 . . . . 0.0 111.531 -176.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.5 p90 -164.35 160.11 20.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.174 0.989 . . . . 0.0 112.801 -176.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -102.75 130.98 49.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.338 1.055 . . . . 0.0 111.998 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.3 t -92.12 134.37 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.919 1.288 . . . . 0.0 109.726 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 21.0 t0 -144.1 162.35 36.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.579 1.952 . . . . 0.0 110.805 -169.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.83 154.02 26.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.387 1.075 . . . . 0.0 112.584 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -65.6 -29.21 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.309 -0.869 . . . . 0.0 112.054 168.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -92.24 -163.06 0.99 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.752 1.621 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.9 m 79.04 155.61 0.15 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.43 2.692 . . . . 0.0 113.352 173.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.35 -8.35 53.07 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 124.912 1.244 . . . . 0.0 115.521 -173.184 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.96 152.95 41.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 118.911 1.355 . . . . 0.0 113.871 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.2 t -64.88 143.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.181 0.992 . . . . 0.0 108.792 172.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -156.67 158.52 37.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.248 1.019 . . . . 0.0 110.795 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.92 141.81 33.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.194 1.398 . . . . 0.0 111.003 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.3 p90 -166.43 165.99 16.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.229 1.412 . . . . 0.0 112.796 -172.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 122.47 171.84 13.92 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.408 1.48 . . . . 0.0 112.466 -174.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.09 -33.68 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.914 2.409 . . . . 0.0 113.27 -168.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.61 86.68 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.144 0.884 . . . . 0.0 114.513 -169.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.65 -6.92 55.5 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.728 1.264 . . . . 0.0 113.785 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 -40.37 5.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.025 2.13 . . . . 0.0 111.723 176.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -153.43 142.44 21.26 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.039 1.336 . . . . 0.0 112.568 -171.058 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.57 -176.11 15.61 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.923 1.249 . . . . 0.0 112.672 174.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.0 p -153.38 136.14 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.734 1.214 . . . . 0.0 109.281 176.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.0 m -60.11 147.01 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -171.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 67.42 5.02 4.04 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.432 1.893 . . . . 0.0 114.574 173.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.9 mttp -120.61 149.72 50.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.179 1.792 . . . . 0.0 110.884 170.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.57 135.16 21.56 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.678 2.252 . . . . 0.0 110.848 175.189 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.29 146.92 36.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.798 1.639 . . . . 0.0 110.105 171.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.1 p -135.53 148.74 49.26 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -164.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -159.56 179.23 9.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.034 1.733 . . . . 0.0 111.265 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 52.6 m -132.87 144.87 50.48 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.316 1.446 . . . . 0.0 110.516 -170.46 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.6 t -122.53 127.75 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.876 1.67 . . . . 0.0 108.448 172.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -95.05 114.31 26.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.272 1.029 . . . . 0.0 110.554 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 25.2 p -120.54 -1.79 10.06 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.072 2.149 . . . . 0.0 113.423 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.64 -45.12 77.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.922 1.689 . . . . 0.0 114.562 -165.519 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.45 -15.85 38.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 113.534 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -82.46 -67.12 0.81 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.599 1.16 . . . . 0.0 111.058 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 64.99 16.02 61.28 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 165.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.5 146.58 22.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.585 1.693 . . . . 0.0 111.655 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 90.53 -170.96 35.9 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.58 1.562 . . . . 0.0 112.862 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -92.88 115.63 4.92 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 124.244 0.926 . . . . 0.0 111.525 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -77.74 123.24 26.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.346 1.059 . . . . 0.0 108.608 170.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 47.4 m -120.52 154.09 35.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.433 1.493 . . . . 0.0 112.104 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -157.66 133.83 9.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.865 1.666 . . . . 0.0 108.964 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 160.62 39.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.876 0.871 . . . . 0.0 112.147 177.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -135.04 134.34 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.794 1.238 . . . . 0.0 109.333 172.7 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.13 120.51 37.95 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.143 1.377 . . . . 0.0 109.051 171.412 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -132.57 179.93 16.82 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.659 1.124 . . . . 0.0 114.226 -176.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.05 -24.85 38.54 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.038 3.159 . . . . 0.0 111.923 174.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.5 t -134.73 157.81 45.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 108.683 156.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.99 120.64 19.85 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.843 -1.161 . . . . 0.0 112.132 -174.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.56 145.73 34.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.049 0.94 . . . . 0.0 111.202 168.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.62 148.84 25.3 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.336 0.654 . . . . 0.0 110.393 167.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -137.59 144.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.808 1.243 . . . . 0.0 110.235 -166.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 166.86 24.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.891 1.276 . . . . 0.0 111.259 167.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.0 p -155.97 153.46 29.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.939 1.295 . . . . 0.0 112.404 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 70.3 m -140.14 131.38 26.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.436 1.494 . . . . 0.0 110.331 -169.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.63 128.12 34.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.134 174.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -91.84 152.18 20.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.708 1.203 . . . . 0.0 111.657 176.065 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.51 -17.58 64.2 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.494 0.717 . . . . 0.0 112.322 173.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.8 -9.76 58.78 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.576 1.55 . . . . 0.0 113.702 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 9.66 57.94 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.16 1.362 . . . . 0.0 115.203 176.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.9 p -108.23 161.23 15.19 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.948 1.699 . . . . 0.0 111.524 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 83.5 m -102.65 124.86 48.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.954 1.302 . . . . 0.0 110.278 170.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.3 t -88.69 151.98 22.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.807 0.843 . . . . 0.0 110.582 166.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.3 t -130.94 144.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.174 1.79 . . . . 0.0 109.984 -177.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.5 p -135.65 147.66 48.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.615 1.166 . . . . 0.0 111.729 166.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -148.92 154.95 40.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.31 -0.869 . . . . 0.0 113.005 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.75 102.62 25.22 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.79 1.236 . . . . 0.0 110.456 -173.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.78 163.91 9.07 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.033 3.155 . . . . 0.0 111.3 175.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -127.12 -21.45 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.223 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.77 150.51 60.16 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.487 1.115 . . . . 0.0 110.755 173.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.9 145.73 32.2 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.849 2.366 . . . . 0.0 111.99 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.39 -167.54 32.46 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.837 1.208 . . . . 0.0 113.654 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.04 124.57 38.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.392 1.477 . . . . 0.0 112.098 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -116.51 128.21 55.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.855 1.662 . . . . 0.0 110.009 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.9 m -89.99 116.29 27.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.105 0.962 . . . . 0.0 110.705 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.59 124.67 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.698 1.599 . . . . 0.0 108.326 177.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.7 tt -108.53 127.48 53.97 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.455 1.502 . . . . 0.0 109.261 176.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -130.29 127.71 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.315 1.046 . . . . 0.0 109.497 173.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.75 144.6 24.41 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.066 1.347 . . . . 0.0 111.398 -167.522 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.29 125.98 13.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.509 1.123 . . . . 0.0 110.131 -177.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.1 52.37 11.84 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.576 1.15 . . . . 0.0 112.041 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 7.8 pt-20 58.84 12.68 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.322 2.649 . . . . 0.0 116.39 -177.45 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -119.49 127.35 52.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.453 1.101 . . . . 0.0 110.997 177.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -62.43 143.32 57.21 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.466 -0.772 . . . . 0.0 111.417 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.4 m -71.38 151.99 94.15 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.03 173.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -55.36 126.55 22.88 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.249 2.633 . . . . 0.0 111.19 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.92 62.17 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.367 1.46 . . . . 0.0 115.085 -175.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 36.4 t -78.06 141.69 63.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 119.356 1.578 . . . . 0.0 111.701 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 141.78 72.16 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.421 0.829 . . . . 0.0 112.27 -4.156 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -93.95 161.92 14.11 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.171 1.788 . . . . 0.0 110.617 176.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.7 m -119.97 116.0 24.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.675 0.79 . . . . 0.0 110.745 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.33 133.23 39.48 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.702 1.201 . . . . 0.0 111.084 172.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 111.75 23.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.898 0.879 . . . . 0.0 109.553 174.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.2 t -94.6 133.01 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.924 1.29 . . . . 0.0 110.05 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 78.7 p -108.37 165.69 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.915 1.286 . . . . 0.0 113.094 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.96 136.96 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.77 1.176 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -88.82 -18.31 27.93 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.78 1.232 . . . . 0.0 113.768 -175.456 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 24.9 t0 . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.652 2.381 . . . . 0.0 114.277 179.135 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.34 159.22 37.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.549 1.54 . . . . 0.0 112.121 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -75.25 163.75 27.17 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.322 1.449 . . . . 0.0 112.352 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -63.67 151.22 89.01 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.265 1.026 . . . . 0.0 112.282 174.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.04 -10.47 19.57 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.734 2.956 . . . . 0.0 113.81 -178.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.83 153.25 30.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.607 1.563 . . . . 0.0 110.191 -178.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.78 147.89 88.4 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.689 1.195 . . . . 0.0 112.419 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.61 154.11 72.16 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.697 2.931 . . . . 0.0 111.763 177.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 24.0 tp -79.89 59.26 3.11 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.308 1.443 . . . . 0.0 111.92 -174.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 84.7 t -75.99 131.25 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.284 1.433 . . . . 0.0 109.876 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 170.23 -178.96 42.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.856 1.217 . . . . 0.0 113.657 -179.438 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 21.4 m -143.53 154.16 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.851 1.661 . . . . 0.0 111.377 -179.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 63.6 t30 -164.29 162.15 22.27 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.295 1.838 . . . . 0.0 110.82 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -67.5 128.65 27.44 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.007 0.813 . . . . 0.0 111.111 173.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.96 145.85 26.61 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.57 1.148 . . . . 0.0 111.859 -174.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 37.5 t0 70.2 164.04 0.26 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.618 2.367 . . . . 0.0 112.692 -177.041 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 66.6 t -134.27 138.89 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.615 1.566 . . . . 0.0 109.726 -178.347 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.6 t -156.35 -40.45 0.08 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.405 1.482 . . . . 0.0 111.464 175.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 6.6 t -162.46 147.45 12.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.238 1.015 . . . . 0.0 112.245 168.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 54.1 mt -97.21 153.52 17.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.571 1.548 . . . . 0.0 110.144 168.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -45.65 110.75 1.21 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.392 1.877 . . . . 0.0 111.349 175.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 133.32 29.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.271 1.98 . . . . 0.0 108.801 172.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.99 123.67 45.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.587 0.755 . . . . 0.0 111.047 -174.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -157.2 141.78 16.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 110.928 177.103 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.72 147.6 51.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.267 1.827 . . . . 0.0 110.266 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -109.8 138.43 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.785 1.234 . . . . 0.0 109.963 172.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.8 mt -132.47 133.86 24.13 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.048 1.739 . . . . 0.0 108.686 -174.285 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.13 66.82 8.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.199 3.266 . . . . 0.0 111.211 177.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.8 t80 -115.68 153.81 30.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.895 1.678 . . . . 0.0 111.16 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 59.2 m -121.91 119.72 32.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.264 1.426 . . . . 0.0 109.429 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.46 127.01 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 109.295 174.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.17 -139.59 0.36 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.701 1.2 . . . . 0.0 110.67 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -75.27 -6.68 51.09 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.9 -148.42 8.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.781 1.658 . . . . 0.0 113.017 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -154.88 148.05 24.86 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 110.517 -173.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.49 136.03 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.286 1.434 . . . . 0.0 111.184 -178.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 54.9 p -146.14 -175.33 4.72 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.457 1.903 . . . . 0.0 109.894 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.88 -162.18 20.55 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 -177.491 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.37 144.75 17.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.289 1.836 . . . . 0.0 109.664 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 90.8 t -123.07 135.89 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.015 1.726 . . . . 0.0 108.223 173.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -120.72 139.59 52.85 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 112.056 -174.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.5 148.11 36.59 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.717 1.607 . . . . 0.0 111.481 -176.008 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.71 -28.75 67.96 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.115 3.21 . . . . 0.0 114.927 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.1 p -73.56 -2.78 24.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 114.496 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.35 -5.77 83.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.562 1.554 . . . . 0.0 113.9 -178.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -68.77 157.56 36.12 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.144 1.377 . . . . 0.0 112.052 173.1 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.9 m -140.76 156.36 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.165 1.386 . . . . 0.0 111.655 177.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.28 179.83 8.86 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.92 2.088 . . . . 0.0 110.267 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -127.36 144.76 51.92 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 121.146 -0.971 . . . . 0.0 111.915 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.83 166.14 13.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.146 3.231 . . . . 0.0 111.399 176.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.0 m -111.54 125.59 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.052 1.341 . . . . 0.0 108.96 173.479 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.14 132.47 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.788 1.235 . . . . 0.0 109.142 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 67.2 m -135.13 126.15 27.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.375 1.47 . . . . 0.0 109.744 178.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.84 139.01 41.49 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.954 0.901 . . . . 0.0 112.607 173.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -93.47 -4.96 50.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 71.14 -3.69 1.99 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.816 2.446 . . . . 0.0 114.225 -176.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.4 5.73 49.33 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.658 1.983 . . . . 0.0 113.264 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.43 14.75 55.17 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.964 1.269 . . . . 0.0 113.891 -174.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 63.7 p -129.69 161.59 30.28 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.293 1.837 . . . . 0.0 110.611 177.071 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 18.7 m -121.31 146.79 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.595 1.158 . . . . 0.0 109.689 166.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 80.8 m -105.77 135.69 46.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.402 1.081 . . . . 0.0 108.467 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 20.5 t -115.05 133.57 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.569 1.548 . . . . 0.0 108.95 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.55 154.07 47.41 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.55 1.54 . . . . 0.0 112.1 -174.66 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -153.9 136.19 14.9 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.714 1.606 . . . . 0.0 111.513 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.12 118.12 68.88 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.52 1.128 . . . . 0.0 110.88 177.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.46 144.98 23.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.508 2.805 . . . . 0.0 111.77 -176.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.4 p -135.02 -7.42 2.34 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 178.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -163.49 143.81 8.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.818 1.647 . . . . 0.0 110.218 -175.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -81.6 165.41 21.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.44 1.096 . . . . 0.0 113.239 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.68 -168.24 15.88 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.782 1.658 . . . . 0.0 114.377 178.011 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.0 130.19 37.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.197 1.799 . . . . 0.0 109.58 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 76.9 m80 -134.25 169.88 16.53 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.251 1.421 . . . . 0.0 112.007 -170.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.76 152.39 38.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 168.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.1 ttm -121.22 118.07 28.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.894 2.478 . . . . 0.0 109.837 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.34 137.75 32.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.428 1.491 . . . . 0.0 109.944 169.864 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.0 mm -135.65 135.17 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.573 1.149 . . . . 0.0 110.649 175.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.12 20.72 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.73 1.212 . . . . 0.0 113.131 -175.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -99.61 125.31 45.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.743 2.017 . . . . 0.0 109.901 174.126 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.4 34.05 14.3 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.734 1.214 . . . . 0.0 112.448 -174.587 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.1 t30 75.15 2.65 3.97 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.397 2.679 . . . . 0.0 114.746 -178.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.0 mtm -102.64 130.61 49.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 0.0 110.638 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -58.7 137.71 57.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.1 pt -71.45 152.46 94.01 Favored Pre-proline 0 N--CA 1.48 1.033 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.599 173.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.17 125.68 17.58 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.363 2.042 . . . . 0.0 110.936 -176.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.92 -8.63 76.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.144 1.354 . . . . 0.0 115.233 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.8 t -63.93 141.26 98.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 120.07 1.935 . . . . 0.0 111.941 175.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.59 161.45 76.15 Favored 'Cis proline' 0 C--N 1.354 0.837 0 CA-C-N 119.998 1.035 . . . . 0.0 113.492 0.016 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.1 mt -96.4 136.21 37.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.68 1.592 . . . . 0.0 110.004 172.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -109.25 141.96 40.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.372 1.069 . . . . 0.0 110.959 -177.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 34.0 p90 -153.85 174.13 14.99 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 113.212 -173.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.9 t80 -128.49 147.75 50.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 112.421 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 49.3 t -127.6 139.27 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.091 1.756 . . . . 0.0 109.16 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -153.38 160.41 42.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.459 1.504 . . . . 0.0 110.756 -174.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -76.38 139.79 41.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 111.485 177.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -66.04 -23.61 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 121.442 -0.786 . . . . 0.0 112.842 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 55.4 p30 -85.8 -3.66 58.96 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.469 1.508 . . . . 0.0 114.809 -176.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.1 m -64.48 137.48 57.89 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.04 0.936 . . . . 0.0 112.536 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.02 -12.95 54.63 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.939 1.257 . . . . 0.0 114.514 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -69.18 166.91 17.32 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 t -68.01 137.83 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 157.93 31.01 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.04 1.336 . . . . 0.0 110.335 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.07 143.35 44.6 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 111.823 -174.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.44 164.99 15.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.62 1.568 . . . . 0.0 112.813 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.57 173.8 13.42 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.229 1.395 . . . . 0.0 113.19 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.95 -32.99 12.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.666 -171.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.23 -38.32 91.74 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.641 1.109 . . . . 0.0 114.094 -172.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.75 -8.68 57.14 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.712 1.256 . . . . 0.0 113.35 176.069 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.8 m -96.96 -42.93 7.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.45 1.9 . . . . 0.0 110.881 174.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -155.55 127.42 7.49 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.34 1.856 . . . . 0.0 112.025 -164.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.58 -177.79 15.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.693 2.092 . . . . 0.0 112.165 168.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 87.2 t -145.6 142.71 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.833 2.053 . . . . 0.0 107.476 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.2 m -56.14 138.47 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 65.86 1.91 2.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.802 2.041 . . . . 0.0 114.887 175.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -106.74 139.43 20.36 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.411 1.484 . . . . 0.0 111.057 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.38 119.57 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.705 2.27 . . . . 0.0 110.314 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -101.96 134.54 45.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.179 1.392 . . . . 0.0 110.055 175.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 38.6 p -127.52 145.98 50.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -165.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -157.26 177.05 11.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 178.051 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.9 m -128.47 142.1 51.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 -169.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.08 131.66 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.679 1.591 . . . . 0.0 108.422 168.274 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -91.75 129.53 37.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.42 1.088 . . . . 0.0 111.024 -177.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -135.65 8.15 3.31 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.049 1.34 . . . . 0.0 113.606 -168.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.6 tptm -54.23 -37.0 64.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.307 1.843 . . . . 0.0 114.772 -168.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.12 20.13 5.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.695 1.598 . . . . 0.0 112.268 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.77 78.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.377 1.071 . . . . 0.0 113.854 -174.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.27 149.14 4.85 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.883 1.23 . . . . 0.0 112.365 -171.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.18 139.84 52.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.468 0.707 . . . . 0.0 111.815 -178.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.09 10.84 0.02 OUTLIER Glycine 0 CA--C 1.535 1.304 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.88 97.99 1.55 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.163 1.363 . . . . 0.0 112.819 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.47 127.25 31.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.817 1.247 . . . . 0.0 108.748 166.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 49.1 m -117.03 154.69 30.5 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 0.0 111.731 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 54.9 tp -159.57 132.49 6.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.605 1.562 . . . . 0.0 109.096 -172.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.92 159.65 36.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.062 0.945 . . . . 0.0 112.311 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.43 127.42 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.59 1.156 . . . . 0.0 109.9 175.363 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -105.6 168.01 9.38 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.897 1.679 . . . . 0.0 109.879 167.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 166.11 -161.16 34.79 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.008 -1.057 . . . . 0.0 113.717 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.1 -13.5 26.01 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.569 2.846 . . . . 0.0 112.435 176.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 9.5 t -155.08 168.25 27.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.396 1.879 . . . . 0.0 109.627 168.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -77.97 116.02 18.14 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.898 -1.126 . . . . 0.0 111.363 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -79.7 143.73 34.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.993 0.917 . . . . 0.0 110.802 166.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.64 146.73 23.54 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.236 0.615 . . . . 0.0 110.854 171.513 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.87 140.32 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.679 1.192 . . . . 0.0 110.856 -163.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -131.31 158.75 39.84 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.116 1.766 . . . . 0.0 110.628 167.31 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.9 p -151.55 153.65 34.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.165 0.986 . . . . 0.0 112.404 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.2 m -147.0 131.13 17.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.287 1.435 . . . . 0.0 110.812 -166.284 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 9.5 t0 -71.04 123.02 21.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.199 1.0 . . . . 0.0 110.986 169.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -80.96 -9.78 59.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 113.356 177.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 tt0 79.2 -25.12 0.19 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 129.005 2.922 . . . . 0.0 112.696 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.61 1.9 13.23 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.447 1.899 . . . . 0.0 114.15 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.86 21.17 19.32 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 125.216 1.389 . . . . 0.0 114.081 -177.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -133.78 150.4 51.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.095 1.358 . . . . 0.0 110.411 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 82.3 m -106.66 126.1 51.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.451 1.5 . . . . 0.0 109.339 170.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -84.33 150.71 25.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.819 0.848 . . . . 0.0 110.536 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.2 t -126.85 144.87 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.844 2.058 . . . . 0.0 108.828 177.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.1 t -137.35 136.59 38.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.38 1.472 . . . . 0.0 110.277 171.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -142.89 153.74 43.42 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 177.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.5 mt -120.13 104.72 43.31 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.953 1.701 . . . . 0.0 110.073 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.55 155.49 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.481 2.787 . . . . 0.0 110.021 169.361 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.2 m -116.73 -13.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.28 156.04 26.93 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.835 1.654 . . . . 0.0 110.458 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 153.52 49.32 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.005 2.47 . . . . 0.0 112.72 -170.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.64 -151.4 23.67 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.94 1.257 . . . . 0.0 113.47 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -120.91 125.37 47.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.339 1.456 . . . . 0.0 110.718 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -110.77 149.34 30.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.93 1.692 . . . . 0.0 110.778 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 66.6 m -113.27 114.25 26.43 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.556 1.142 . . . . 0.0 110.963 -177.574 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.44 123.41 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.288 1.835 . . . . 0.0 108.882 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.53 131.88 52.38 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.549 1.54 . . . . 0.0 109.479 173.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 50.6 t -133.46 131.9 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.394 1.478 . . . . 0.0 108.289 172.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.21 142.96 17.57 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.852 1.261 . . . . 0.0 110.765 -167.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.66 123.58 22.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.548 1.139 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 51.43 56.96 7.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.129 1.372 . . . . 0.0 112.492 176.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.307 8.0 pt-20 59.62 12.95 3.1 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.189 2.596 . . . . 0.0 116.321 -177.215 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -118.96 124.62 47.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.451 1.101 . . . . 0.0 111.188 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -61.59 155.52 22.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.149 0.98 . . . . 0.0 112.785 170.787 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.92 155.94 70.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 O-C-N 121.787 -0.571 . . . . 0.0 110.427 175.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -55.4 121.19 9.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.795 2.33 . . . . 0.0 110.448 172.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -13.04 67.22 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.177 1.37 . . . . 0.0 116.316 178.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 98.7 p -80.08 153.83 74.82 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 120.552 2.176 . . . . 0.0 113.212 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.95 158.34 99.05 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.222 0.758 . . . . 0.0 112.596 -4.697 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -112.96 138.21 50.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.335 1.454 . . . . 0.0 111.345 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 21.2 m -89.9 117.42 28.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.876 0.871 . . . . 0.0 110.712 177.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.76 127.5 44.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.281 1.432 . . . . 0.0 111.392 173.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.62 138.22 46.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.534 1.533 . . . . 0.0 110.608 172.083 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.1 t -138.15 138.8 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.646 1.178 . . . . 0.0 110.818 172.632 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 81.1 p -130.57 165.19 23.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.535 1.134 . . . . 0.0 112.672 174.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.64 144.19 22.05 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.941 1.734 . . . . 0.0 112.909 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.11 17.46 0.42 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.239 1.416 . . . . 0.0 112.707 178.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.239 1.815 . . . . 0.0 112.655 -176.887 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.97 164.27 36.98 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.698 1.599 . . . . 0.0 111.76 -179.085 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 77.1 mtm -73.28 148.08 43.92 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.23 1.012 . . . . 0.0 111.855 176.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -158.57 149.52 16.24 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 125.41 1.484 . . . . 0.0 111.708 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.26 170.78 18.06 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.832 3.021 . . . . 0.0 111.854 177.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -152.98 139.75 18.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.186 1.394 . . . . 0.0 109.934 173.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -75.11 150.3 85.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.825 0.85 . . . . 0.0 112.958 -174.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.63 171.19 18.66 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.435 2.756 . . . . 0.0 111.074 171.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -11.81 60.35 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 60.6 t -82.85 134.12 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.804 1.641 . . . . 0.0 110.021 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 79.83 -122.35 5.75 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.146 0.879 . . . . 0.0 112.25 175.38 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 96.5 t -59.58 135.63 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.66 1.184 . . . . 0.0 110.508 -179.077 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 8.0 p30 -156.93 153.35 27.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.186 1.394 . . . . 0.0 112.088 -176.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -83.43 166.23 43.57 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.706 1.146 . . . . 0.0 113.263 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.9 mt -69.69 155.58 40.3 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.181 0.993 . . . . 0.0 111.87 176.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.96 -14.83 61.53 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.757 1.223 . . . . 0.0 113.163 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 6.8 m -138.22 148.56 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.832 2.053 . . . . 0.0 111.287 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 8.9 t 174.84 -39.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 128.902 2.881 . . . . 0.0 110.482 -178.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 40.8 m -76.62 73.07 3.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.322 1.449 . . . . 0.0 111.694 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 20.9 tp -91.66 149.13 21.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.47 1.908 . . . . 0.0 110.866 177.138 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -53.13 110.91 2.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.689 1.196 . . . . 0.0 113.5 -168.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.02 135.79 28.23 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.19 1.927 . . . . 0.0 108.937 172.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1791 ' ' PHE . . . . . 0.407 ' CE2' ' HE1' ' A' 1842 ' ' MET . 2.0 t80 -102.43 121.31 42.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.205 0.602 . . . . 0.0 109.839 -179.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.67 124.53 9.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.828 1.251 . . . . 0.0 110.89 175.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -131.72 149.18 52.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.804 2.042 . . . . 0.0 109.558 -176.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 15.0 p -123.67 135.71 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.894 1.278 . . . . 0.0 110.069 176.21 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.94 138.18 31.27 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 125.885 1.674 . . . . 0.0 108.979 -174.389 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.48 59.56 7.2 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.582 3.521 . . . . 0.0 112.216 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 40.1 t80 -100.71 151.7 21.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.529 1.532 . . . . 0.0 111.017 174.426 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.1 m -124.53 126.79 46.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.149 1.379 . . . . 0.0 109.535 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.41 128.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.792 1.237 . . . . 0.0 110.691 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 41.0 tttm -99.08 -140.17 0.32 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.945 1.698 . . . . 0.0 111.707 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -82.51 -10.63 58.93 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -175.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.42 -143.01 6.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.056 1.789 . . . . 0.0 112.628 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.46 147.44 24.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.732 1.213 . . . . 0.0 110.924 -175.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.7 tt -118.54 133.76 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.684 1.593 . . . . 0.0 111.148 -178.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 29.1 p -150.31 170.84 18.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.197 1.799 . . . . 0.0 110.647 -174.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.47 -169.05 24.23 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 -176.356 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.77 141.86 21.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.395 1.878 . . . . 0.0 109.661 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.3 t -117.31 136.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.64 1.976 . . . . 0.0 108.12 173.324 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.57 132.2 56.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.252 1.021 . . . . 0.0 111.577 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -100.54 145.48 30.38 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.634 1.574 . . . . 0.0 111.235 -176.354 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.63 -16.89 23.74 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.673 2.916 . . . . 0.0 112.936 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 30.6 p -76.0 -2.06 28.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.369 1.467 . . . . 0.0 114.301 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.45 45.64 3.98 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.638 1.114 . . . . 0.0 113.63 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.48 170.09 18.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.282 1.433 . . . . 0.0 112.426 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.8 m -138.81 157.84 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.296 1.439 . . . . 0.0 112.159 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.6 177.6 11.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.899 2.08 . . . . 0.0 110.296 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -123.56 145.62 47.57 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 121.222 -0.924 . . . . 0.0 111.896 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -82.93 167.9 14.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.209 3.273 . . . . 0.0 111.342 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.84 126.62 53.24 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.125 1.37 . . . . 0.0 108.547 170.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.72 130.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.317 1.047 . . . . 0.0 108.848 175.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -121.12 128.39 52.5 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.799 1.64 . . . . 0.0 109.639 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.83 121.3 25.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.422 1.089 . . . . 0.0 110.346 173.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.11 -12.75 54.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 65.79 9.84 6.34 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.997 2.119 . . . . 0.0 114.149 -178.717 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -108.59 10.07 27.15 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.835 2.054 . . . . 0.0 112.808 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.8 15.06 62.0 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.79 1.186 . . . . 0.0 113.601 -172.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 64.2 p -132.78 160.26 37.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.544 1.938 . . . . 0.0 110.472 177.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.3 m -125.0 144.85 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.739 1.215 . . . . 0.0 109.636 166.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 85.9 m -106.96 135.55 48.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.208 1.003 . . . . 0.0 108.691 171.732 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.5 t -119.97 131.05 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.406 1.483 . . . . 0.0 108.846 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -130.9 156.44 45.05 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.404 . . . . 0.0 112.768 -174.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 9.1 t80 -153.93 137.19 15.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.667 1.587 . . . . 0.0 111.675 176.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.36 120.84 69.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.805 1.242 . . . . 0.0 111.023 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.02 155.88 26.32 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.757 2.971 . . . . 0.0 112.694 -172.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.1 p -140.66 -11.88 1.01 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -160.66 151.29 18.38 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.611 1.565 . . . . 0.0 110.55 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.02 170.44 16.68 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.893 1.277 . . . . 0.0 113.299 179.161 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.28 -172.11 14.07 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.428 1.49 . . . . 0.0 114.148 177.395 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.0 tp -82.32 134.56 35.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.636 1.175 . . . . 0.0 110.458 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 66.1 m80 -134.56 165.19 25.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 111.628 -172.653 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.15 153.49 37.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.438 1.095 . . . . 0.0 111.621 175.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1842 ' ' MET . . . . . 0.407 ' HE1' ' CE2' ' A' 1791 ' ' PHE . 36.3 ttm -130.74 140.31 50.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.567 1.547 . . . . 0.0 110.889 179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -107.73 131.1 54.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.425 1.49 . . . . 0.0 110.042 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.58 137.92 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.562 1.145 . . . . 0.0 109.852 167.574 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.41 144.01 37.91 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.638 1.175 . . . . 0.0 113.027 176.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -103.5 117.28 34.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.439 1.896 . . . . 0.0 109.679 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.56 30.97 9.24 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.663 1.185 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 65.8 m-80 79.09 4.56 2.32 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.662 2.785 . . . . 0.0 115.12 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.6 ttp -96.12 126.42 41.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.696 1.198 . . . . 0.0 110.206 166.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -59.11 139.12 57.21 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.172 -0.955 . . . . 0.0 113.086 -178.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.4 pt -73.76 149.85 88.26 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.375 173.802 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.34 -20.33 61.75 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 114.067 -171.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.77 -7.84 86.78 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 114.809 174.183 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.5 m -94.89 155.75 38.83 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.281 1.54 . . . . 0.0 113.078 177.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.22 161.48 94.61 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 118.707 0.574 . . . . 0.0 112.554 -1.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 85.0 mt -104.74 154.03 20.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.592 1.557 . . . . 0.0 110.129 172.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -145.99 139.38 26.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.663 1.185 . . . . 0.0 110.052 -177.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -163.4 166.13 23.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -177.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.9 t80 -110.16 141.52 42.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.025 0.93 . . . . 0.0 111.914 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 97.6 t -110.84 129.91 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.861 1.664 . . . . 0.0 109.085 -178.454 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.2 t0 -160.42 146.57 15.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.005 1.322 . . . . 0.0 111.841 -173.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 150.36 48.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 113.436 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.3 t -62.06 -44.38 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.289 1.036 . . . . 0.0 111.564 177.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.07 22.98 4.56 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.759 1.224 . . . . 0.0 113.407 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 31.4 p -62.39 -26.57 68.54 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 79.77 -46.81 3.18 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.997 1.761 . . . . 0.0 113.812 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -62.5 165.03 6.65 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.2 t -67.55 134.85 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.762 0.825 . . . . 0.0 109.308 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -160.33 167.7 26.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.953 1.301 . . . . 0.0 110.876 -174.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -148.03 146.31 28.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.879 1.271 . . . . 0.0 111.793 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.5 p90 -166.73 160.65 15.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.49 1.516 . . . . 0.0 113.041 -174.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.4 172.92 13.21 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.622 1.582 . . . . 0.0 112.747 -175.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.16 -32.34 6.87 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.189 2.593 . . . . 0.0 113.443 -170.591 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.06 77.07 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 0.0 114.287 -170.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.22 -2.32 37.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.678 1.239 . . . . 0.0 113.654 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.5 m -112.97 -41.47 3.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.841 2.056 . . . . 0.0 112.033 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -149.26 146.0 27.37 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.817 1.247 . . . . 0.0 112.843 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.72 179.2 21.3 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.116 1.341 . . . . 0.0 113.096 173.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.7 t -138.8 137.2 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.572 1.149 . . . . 0.0 108.661 174.404 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -55.7 141.6 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 66.2 m-80 65.9 4.95 3.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.698 1.999 . . . . 0.0 114.716 174.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -123.44 141.78 37.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.632 1.573 . . . . 0.0 110.766 176.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.15 135.9 25.91 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.554 2.17 . . . . 0.0 111.382 -174.029 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.28 147.14 39.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 110.262 173.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.0 p -136.72 150.85 48.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -165.22 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 56.0 p90 -162.29 -179.94 7.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.289 1.835 . . . . 0.0 111.507 176.528 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -129.69 143.64 50.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.37 1.468 . . . . 0.0 110.714 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 60.1 t -116.53 133.36 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.663 1.585 . . . . 0.0 108.393 170.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.33 132.92 37.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.483 1.113 . . . . 0.0 111.421 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.3 p -130.18 6.02 4.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.188 1.795 . . . . 0.0 112.89 -176.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -59.37 -20.65 56.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -165.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.63 31.83 1.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.197 1.399 . . . . 0.0 111.442 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.47 -37.34 65.81 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -175.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.63 153.22 9.04 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.513 1.054 . . . . 0.0 112.236 -168.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -76.78 165.01 25.31 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 160.01 -77.87 0.18 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.367 1.461 . . . . 0.0 111.457 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -176.07 114.67 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.496 1.046 . . . . 0.0 112.625 171.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.44 130.31 34.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.147 1.379 . . . . 0.0 109.32 174.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.9 m -128.27 155.91 43.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.516 1.526 . . . . 0.0 112.159 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 38.2 tp -155.11 135.45 13.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.41 1.884 . . . . 0.0 108.614 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.51 160.26 40.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.992 0.917 . . . . 0.0 112.097 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.9 mt -135.14 133.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.578 1.151 . . . . 0.0 109.614 174.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.82 110.11 13.9 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.301 1.44 . . . . 0.0 109.347 175.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.14 -169.73 12.75 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.918 1.247 . . . . 0.0 113.896 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.31 -18.76 38.97 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.657 2.905 . . . . 0.0 111.987 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.8 t -137.06 159.63 41.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.613 1.565 . . . . 0.0 109.211 159.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -76.86 114.52 15.72 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.85 -1.156 . . . . 0.0 111.216 -178.598 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -77.13 141.96 39.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.285 1.034 . . . . 0.0 111.547 174.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.51 146.68 26.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.004 0.521 . . . . 0.0 110.597 170.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.9 145.33 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.345 1.458 . . . . 0.0 110.277 -165.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 17.3 t -145.02 142.75 30.03 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.071 0.948 . . . . 0.0 110.695 164.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -140.44 153.86 46.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.34 1.056 . . . . 0.0 112.142 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 92.5 m -136.42 119.78 16.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.434 1.493 . . . . 0.0 109.875 -172.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -71.67 116.65 12.28 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.84 0.856 . . . . 0.0 109.774 166.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -81.24 -13.25 58.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.905 0.882 . . . . 0.0 112.844 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 70.86 -3.95 1.85 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.367 2.667 . . . . 0.0 114.072 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -87.71 2.0 52.28 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.986 1.714 . . . . 0.0 113.718 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 106.61 10.12 29.55 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.499 1.523 . . . . 0.0 114.754 -172.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 50.7 p -133.84 153.35 51.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.85 1.325 . . . . 0.0 112.375 173.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -112.46 129.69 56.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.885 1.674 . . . . 0.0 109.06 162.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.7 t -86.78 148.41 25.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 110.526 170.083 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.3 t -130.26 141.67 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.626 1.571 . . . . 0.0 110.074 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 98.2 p -136.36 148.88 48.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.57 1.548 . . . . 0.0 111.671 169.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.3 p90 -151.37 156.1 40.03 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 5.5 mt -122.0 107.4 35.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.742 1.617 . . . . 0.0 110.684 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.82 169.87 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.907 3.072 . . . . 0.0 110.452 167.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 10.8 p -135.01 -23.91 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.29 151.0 57.14 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.916 1.287 . . . . 0.0 110.495 175.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.19 153.91 41.24 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -168.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.23 -163.83 28.06 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.371 1.462 . . . . 0.0 112.534 -174.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.08 125.33 52.02 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.438 1.095 . . . . 0.0 111.338 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.26 129.68 55.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.787 2.035 . . . . 0.0 109.941 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.2 m -88.38 126.36 35.17 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.977 -1.077 . . . . 0.0 111.053 177.252 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.98 124.97 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 108.365 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -109.21 129.18 55.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.302 1.441 . . . . 0.0 109.708 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.0 t -131.94 129.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.434 1.094 . . . . 0.0 109.692 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.44 143.42 23.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.894 1.278 . . . . 0.0 111.721 -167.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.87 122.69 18.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.76 1.224 . . . . 0.0 109.587 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.2 t-20 55.04 56.94 6.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.197 1.399 . . . . 0.0 111.876 176.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 7.7 pt-20 58.82 8.43 0.95 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.653 2.781 . . . . 0.0 116.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.98 123.55 50.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.426 1.09 . . . . 0.0 110.884 177.522 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -63.34 145.24 55.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.549 -0.72 . . . . 0.0 111.742 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 11.3 m -72.5 157.67 88.66 Favored Pre-proline 0 N--CA 1.479 1.008 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.608 172.691 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -54.39 126.89 23.75 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 0.0 111.932 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.24 63.73 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.817 1.198 . . . . 0.0 115.375 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.7 t -75.59 140.14 71.44 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.437 1.618 . . . . 0.0 111.404 176.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.09 137.28 49.36 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 119.459 0.843 . . . . 0.0 112.101 -3.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -86.91 175.21 8.28 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.143 1.777 . . . . 0.0 110.725 174.176 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -136.78 119.66 16.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.765 0.826 . . . . 0.0 110.824 178.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.59 129.06 49.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.377 1.471 . . . . 0.0 110.806 174.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -91.13 125.03 35.79 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.955 -0.466 . . . . 0.0 110.557 173.87 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.6 t -107.09 129.2 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.525 1.53 . . . . 0.0 109.896 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.2 p -106.55 165.8 11.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.848 1.259 . . . . 0.0 112.538 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.37 144.09 29.04 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.751 1.167 . . . . 0.0 112.271 176.373 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.14 -13.62 59.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.572 1.149 . . . . 0.0 113.018 176.544 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.833 2.053 . . . . 0.0 112.473 -178.975 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -63.76 -18.11 63.73 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -173.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 49.0 ttp -72.4 -18.12 61.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.023 1.329 . . . . 0.0 113.367 176.438 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -64.37 140.93 98.08 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.883 0.873 . . . . 0.0 112.686 -177.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.43 163.34 29.92 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.786 2.99 . . . . 0.0 112.269 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -160.52 141.59 11.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.701 1.6 . . . . 0.0 109.921 177.308 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -157.82 131.53 4.85 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.081 1.352 . . . . 0.0 110.741 -179.453 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.19 157.38 29.96 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.454 2.769 . . . . 0.0 111.906 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 60.6 tp -161.55 136.26 7.19 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.69 1.596 . . . . 0.0 109.928 176.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 93.1 t -99.0 126.44 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.771 1.229 . . . . 0.0 109.411 175.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -96.27 148.75 19.1 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.947 1.261 . . . . 0.0 112.207 174.054 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 23.4 m -143.5 152.84 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.657 1.583 . . . . 0.0 110.972 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 10.3 p30 -107.17 165.96 10.98 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.296 1.438 . . . . 0.0 112.686 177.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -85.3 -112.13 0.72 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.496 1.522 . . . . 0.0 111.7 177.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.05 156.55 38.65 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.083 0.953 . . . . 0.0 111.516 174.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -74.18 65.97 1.21 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.294 1.438 . . . . 0.0 111.328 175.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 12.3 p -58.39 -32.71 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.526 1.531 . . . . 0.0 113.448 -172.384 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 1.7 t 60.22 -21.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 130.506 3.522 . . . . 0.0 117.49 171.31 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 50.1 m -79.07 72.15 5.59 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.178 1.391 . . . . 0.0 112.828 -173.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.71 136.26 55.25 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.284 -0.885 . . . . 0.0 110.39 167.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -60.51 117.81 28.24 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.627 1.571 . . . . 0.0 110.672 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.19 144.38 56.87 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.765 2.31 . . . . 0.0 109.746 178.371 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 34.0 t80 -109.92 129.32 55.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.444 0.697 . . . . 0.0 111.424 -174.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -155.79 145.61 21.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.462 1.505 . . . . 0.0 111.2 174.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.16 144.33 30.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.973 1.709 . . . . 0.0 110.008 -171.474 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.7 p -113.94 137.11 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 0.0 110.103 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.6 mt -133.71 135.41 24.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.924 1.689 . . . . 0.0 109.172 -172.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.39 96.13 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.731 2.954 . . . . 0.0 109.927 173.546 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 58.0 t80 -159.4 152.74 22.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.209 2.204 . . . . 0.0 108.523 -178.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.62 126.9 37.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.323 1.049 . . . . 0.0 109.868 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.6 mt -78.98 116.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.025 0.93 . . . . 0.0 109.71 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -98.68 -152.66 0.41 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.473 1.509 . . . . 0.0 110.882 172.697 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -70.93 122.23 19.58 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.635 -1.29 . . . . 0.0 111.03 171.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.0 -150.37 21.45 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.613 1.578 . . . . 0.0 111.986 -170.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -159.54 145.92 16.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 111.168 -175.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.7 tt -123.74 138.78 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.633 1.573 . . . . 0.0 110.965 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.3 p -146.51 170.77 16.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.95 1.7 . . . . 0.0 110.534 -177.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.51 -171.43 27.54 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -177.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -154.42 144.93 22.24 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.427 1.891 . . . . 0.0 109.637 176.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 74.3 t -120.3 132.58 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.929 1.692 . . . . 0.0 108.777 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -105.27 134.8 47.77 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.824 1.25 . . . . 0.0 111.713 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 9.4 mtm -101.82 140.11 20.92 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.697 1.599 . . . . 0.0 110.846 174.487 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -56.09 -30.13 77.54 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.084 3.189 . . . . 0.0 115.017 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.8 p -74.67 2.37 10.07 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.022 1.729 . . . . 0.0 114.375 178.224 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.28 62.94 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.716 1.627 . . . . 0.0 114.837 172.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -73.82 159.0 33.51 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.498 1.119 . . . . 0.0 111.898 175.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 19.3 m -139.65 150.83 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.491 1.516 . . . . 0.0 110.837 172.64 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.15 172.55 18.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.394 1.877 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -115.63 141.58 27.6 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.208 -0.933 . . . . 0.0 112.152 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.18 167.65 15.68 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.11 3.207 . . . . 0.0 111.317 174.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.04 130.32 55.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.044 1.338 . . . . 0.0 108.923 172.594 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.79 133.55 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.823 1.249 . . . . 0.0 109.437 177.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.8 m -133.41 127.63 33.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.605 1.562 . . . . 0.0 109.756 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.42 128.6 33.55 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.751 0.821 . . . . 0.0 110.625 172.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.48 -9.33 59.47 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.038 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.1 mttt 72.23 0.95 3.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.193 2.597 . . . . 0.0 114.088 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -97.41 3.7 50.87 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.682 1.993 . . . . 0.0 113.143 174.289 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.12 16.17 39.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.983 1.278 . . . . 0.0 114.426 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.7 p -127.96 156.65 42.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.206 1.802 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.5 m -112.74 144.94 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.809 0.844 . . . . 0.0 109.816 164.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 61.6 m -104.94 134.82 47.41 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.53 1.132 . . . . 0.0 108.435 166.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.6 t -114.04 135.78 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.561 1.544 . . . . 0.0 108.704 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -132.49 151.8 51.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 112.128 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 57.6 t80 -155.45 137.17 14.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.299 1.44 . . . . 0.0 112.306 -178.452 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -93.74 120.49 66.01 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.635 1.174 . . . . 0.0 111.109 177.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.65 150.52 24.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.664 2.909 . . . . 0.0 111.99 -178.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 87.6 p -122.95 -13.32 7.85 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -166.71 148.87 6.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.013 1.725 . . . . 0.0 110.206 -171.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.98 165.5 25.17 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.079 0.952 . . . . 0.0 113.348 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 128.62 179.5 15.95 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 125.484 1.516 . . . . 0.0 114.505 176.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.1 tp -85.9 107.65 17.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 110.402 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 25.8 m80 -100.48 169.79 8.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.686 1.594 . . . . 0.0 111.665 -176.601 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -141.59 149.13 40.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.897 0.879 . . . . 0.0 111.208 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.1 ttm -118.19 128.73 54.99 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.63 1.972 . . . . 0.0 110.018 -178.297 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.64 131.39 53.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.165 2.186 . . . . 0.0 109.385 173.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.9 mm -135.05 135.81 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.505 1.122 . . . . 0.0 110.466 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.04 139.73 26.29 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.21 123.97 47.73 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.89 2.076 . . . . 0.0 109.93 176.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 52.16 32.17 10.17 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.745 1.218 . . . . 0.0 112.535 -173.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.5 t30 75.56 6.15 4.0 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.076 2.55 . . . . 0.0 115.108 -178.427 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.8 mtm -104.41 132.66 50.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.739 1.616 . . . . 0.0 110.943 173.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.3 135.77 44.19 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.3 pt -75.82 154.54 85.13 Favored Pre-proline 0 N--CA 1.478 0.956 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.004 170.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.19 127.5 23.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.069 1.846 . . . . 0.0 109.302 170.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.58 -14.13 57.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.418 -175.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.8 t -82.78 143.2 46.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 119.812 1.806 . . . . 0.0 111.533 172.492 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.57 163.63 80.76 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.719 0.935 . . . . 0.0 112.28 -8.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.2 mt -113.27 156.6 23.04 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.157 1.783 . . . . 0.0 110.881 175.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -128.08 142.54 51.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.952 1.301 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 31.7 p90 -158.51 150.56 21.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.63 1.172 . . . . 0.0 112.056 -174.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 41.6 t80 -103.76 131.53 50.86 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.193 -0.942 . . . . 0.0 112.678 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.1 t -102.26 137.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.586 1.554 . . . . 0.0 108.852 176.741 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.63 160.68 31.94 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.638 1.175 . . . . 0.0 111.628 -169.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -75.45 117.43 17.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.007 0.923 . . . . 0.0 111.028 177.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.2 p -81.5 -23.63 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.025 0.93 . . . . 0.0 113.193 -168.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -83.36 -14.31 53.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.441 1.096 . . . . 0.0 113.547 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.4 m -72.77 156.66 38.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.72 1.208 . . . . 0.0 112.663 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.21 -14.77 68.23 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.467 1.032 . . . . 0.0 115.134 -173.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -64.51 154.63 35.37 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.793 1.296 . . . . 0.0 113.438 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 22.0 t -68.57 132.5 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.096 0.958 . . . . 0.0 109.38 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.8 t -154.1 146.72 24.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.461 1.105 . . . . 0.0 110.42 -176.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.44 141.96 51.77 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.746 1.219 . . . . 0.0 111.898 -172.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.0 p90 -168.07 164.8 13.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.314 1.446 . . . . 0.0 113.61 -175.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.07 172.18 12.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.653 1.597 . . . . 0.0 112.27 -176.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.4 -38.92 13.74 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.753 2.302 . . . . 0.0 112.422 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.57 89.62 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.799 -1.001 . . . . 0.0 115.14 -170.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -78.0 -3.59 42.82 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.444 1.622 . . . . 0.0 113.776 175.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.5 m -105.89 -61.46 1.5 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.172 1.789 . . . . 0.0 110.144 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -127.7 133.19 49.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.619 1.967 . . . . 0.0 111.502 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.02 177.02 16.83 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.166 1.365 . . . . 0.0 112.041 171.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 7.5 p -153.52 138.18 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.137 0.975 . . . . 0.0 109.451 176.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 29.3 m -60.68 152.93 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -170.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 34.1 m120 70.27 11.53 7.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.826 2.05 . . . . 0.0 114.738 166.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -147.03 156.97 47.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.524 1.529 . . . . 0.0 111.36 176.14 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.94 132.48 16.97 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.413 2.075 . . . . 0.0 111.586 -177.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.83 146.85 28.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.074 1.75 . . . . 0.0 109.784 167.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 40.1 p -132.19 149.13 52.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -164.181 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.23 177.24 11.26 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.84 1.656 . . . . 0.0 111.486 175.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -134.27 145.58 49.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.501 1.52 . . . . 0.0 110.336 -170.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.9 t -116.49 128.11 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.209 1.404 . . . . 0.0 108.221 168.848 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.33 131.41 35.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.719 177.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 53.7 p -134.01 12.11 3.94 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 112.812 -169.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.5 tptt -53.76 -40.41 66.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.21 1.804 . . . . 0.0 115.267 -162.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -110.54 1.88 18.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.076 1.35 . . . . 0.0 113.364 -178.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.8 -65.43 0.97 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.155 0.982 . . . . 0.0 111.127 178.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 69.97 0.99 30.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.795 1.878 . . . . 0.0 117.795 162.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -160.32 143.22 13.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.883 1.842 . . . . 0.0 111.731 -172.463 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 102.8 -173.7 22.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.868 1.699 . . . . 0.0 113.02 -177.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -94.83 114.66 4.89 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 124.231 0.92 . . . . 0.0 111.813 177.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.48 133.2 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.013 1.325 . . . . 0.0 108.751 168.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -140.2 161.53 37.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.46 1.504 . . . . 0.0 112.034 -168.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -166.35 139.34 3.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.617 1.567 . . . . 0.0 110.027 -162.37 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.85 163.26 34.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.902 1.281 . . . . 0.0 111.625 173.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 59.0 mt -136.43 134.0 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.298 1.039 . . . . 0.0 109.677 173.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.06 117.42 31.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.589 1.156 . . . . 0.0 109.519 170.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.58 179.26 16.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.928 1.251 . . . . 0.0 114.066 -177.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.27 -26.67 41.63 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.062 3.175 . . . . 0.0 111.753 172.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -137.51 154.87 49.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.57 1.548 . . . . 0.0 108.506 158.246 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.3 tttt -69.84 121.73 17.87 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.877 -1.139 . . . . 0.0 112.069 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.91 149.31 36.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 111.216 167.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -86.12 144.45 27.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.281 0.633 . . . . 0.0 109.647 166.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -133.69 139.49 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.797 1.239 . . . . 0.0 110.309 -167.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 72.8 m -135.17 157.21 47.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.689 1.596 . . . . 0.0 110.838 169.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -154.82 157.18 37.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.35 1.06 . . . . 0.0 112.484 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -143.48 125.72 15.55 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.125 1.37 . . . . 0.0 110.61 -171.317 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.77 131.6 40.93 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.944 1.297 . . . . 0.0 110.732 171.372 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -109.06 142.92 39.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.627 1.171 . . . . 0.0 111.723 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.43 -14.81 63.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.45 -11.69 60.78 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 113.905 177.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.78 36.08 5.66 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.914 1.245 . . . . 0.0 113.674 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.4 p -140.75 166.49 24.62 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.91 1.684 . . . . 0.0 110.424 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 76.3 m -120.53 129.79 53.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.685 1.594 . . . . 0.0 108.966 165.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.4 t -91.74 150.54 21.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.975 0.91 . . . . 0.0 110.808 172.257 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 77.6 t -134.97 141.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.686 1.594 . . . . 0.0 110.273 -176.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 53.0 m -132.67 140.37 48.12 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 110.552 172.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -145.18 148.23 33.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.134 -0.979 . . . . 0.0 113.19 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.2 tt -118.67 99.81 51.25 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.789 1.236 . . . . 0.0 110.006 -173.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -83.15 153.54 14.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.753 2.969 . . . . 0.0 111.279 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.0 m -116.54 -11.45 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -167.55 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.05 151.2 22.47 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.374 1.469 . . . . 0.0 110.537 177.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 142.99 28.29 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.918 2.412 . . . . 0.0 111.713 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.29 -165.0 32.7 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.518 1.056 . . . . 0.0 113.493 -176.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -99.44 124.43 44.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 112.327 -179.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -120.18 127.42 52.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.828 1.651 . . . . 0.0 110.431 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.8 m -92.06 114.46 27.01 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.951 -1.093 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.05 121.35 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.97 1.708 . . . . 0.0 108.777 177.349 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.91 134.92 45.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.778 1.631 . . . . 0.0 109.107 176.009 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 61.5 t -139.43 131.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.723 1.209 . . . . 0.0 109.126 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.2 tmmt? -154.73 143.39 20.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.911 1.285 . . . . 0.0 110.946 -165.684 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.82 121.06 10.86 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.552 1.141 . . . . 0.0 109.498 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.42 55.81 4.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.243 1.417 . . . . 0.0 111.599 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.0 pt-20 55.8 18.23 2.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.084 2.554 . . . . 0.0 115.94 -177.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -125.35 125.28 43.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.079 1.352 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.667 0.787 . . . . 0.0 112.499 171.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.7 m -74.39 155.53 87.67 Favored Pre-proline 0 N--CA 1.479 1.023 0 O-C-N 121.669 -0.644 . . . . 0.0 110.863 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -55.79 123.74 14.57 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.625 2.217 . . . . 0.0 110.343 172.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -15.42 63.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 178.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.1 p -79.52 151.76 74.9 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.177 1.988 . . . . 0.0 112.753 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.17 153.43 98.9 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.274 0.776 . . . . 0.0 112.9 -1.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -107.72 132.99 52.77 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.208 1.403 . . . . 0.0 110.49 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 58.6 m -88.86 108.93 19.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.374 0.67 . . . . 0.0 110.541 178.514 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.53 132.23 34.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.773 170.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.34 115.28 27.48 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 0.0 109.263 174.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -93.73 134.4 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.75 1.22 . . . . 0.0 109.894 177.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.6 p -111.01 166.89 10.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.165 1.386 . . . . 0.0 112.964 177.688 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.47 141.37 22.85 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.103 1.335 . . . . 0.0 112.137 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.28 -27.8 27.6 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.627 1.171 . . . . 0.0 113.225 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.571 1.548 . . . . 0.0 113.648 -179.55 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.523 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 60.95 -156.33 0.35 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.404 1.882 . . . . 0.0 112.866 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 24.6 ttt 74.22 -54.77 0.67 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 128.747 2.819 . . . . 0.0 112.833 177.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -89.44 148.77 41.19 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.224 1.41 . . . . 0.0 111.751 174.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.29 161.84 34.5 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.692 2.928 . . . . 0.0 111.716 176.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.68 136.04 40.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.805 0.842 . . . . 0.0 110.642 172.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -63.66 132.0 95.06 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.776 0.83 . . . . 0.0 111.741 -176.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.07 161.78 15.24 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.854 3.036 . . . . 0.0 113.189 169.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 96.2 mt -123.48 117.61 25.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.015 1.326 . . . . 0.0 109.168 172.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 41.2 t -144.13 -64.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.087 1.355 . . . . 0.0 110.007 -177.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 74.29 -165.66 54.77 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.282 0.944 . . . . 0.0 113.739 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 14.1 p -163.5 138.34 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.932 1.693 . . . . 0.0 110.389 177.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -89.51 135.51 33.56 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.529 1.132 . . . . 0.0 112.061 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -83.37 121.82 5.59 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.268 0.937 . . . . 0.0 111.33 175.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 86.4 mt -85.12 151.85 23.82 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.563 1.145 . . . . 0.0 111.726 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -79.57 130.27 35.23 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.127 0.971 . . . . 0.0 111.802 177.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 15.4 m -147.4 147.51 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.264 1.826 . . . . 0.0 110.177 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.2 t -176.87 -32.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.607 1.963 . . . . 0.0 112.129 -175.391 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 1.7 m -75.79 29.85 0.11 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.726 2.01 . . . . 0.0 115.387 -171.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 26.5 tp -75.28 148.06 39.71 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.275 2.23 . . . . 0.0 110.038 170.377 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -52.13 115.92 7.55 Favored Pre-proline 0 N--CA 1.479 0.993 0 CA-C-O 118.25 -0.881 . . . . 0.0 112.82 -165.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.28 138.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.373 2.049 . . . . 0.0 108.824 174.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 56.7 t80 -130.74 125.37 33.67 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 111.575 -171.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -157.43 139.42 14.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.771 1.629 . . . . 0.0 110.795 176.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.1 mm? -130.9 157.24 43.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.981 2.112 . . . . 0.0 110.0 -175.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.07 136.81 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.916 1.286 . . . . 0.0 109.901 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.1 mt -133.01 134.41 24.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.749 1.62 . . . . 0.0 109.038 -169.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.65 114.08 3.84 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.221 2.614 . . . . 0.0 109.795 173.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.7 t80 -175.24 148.45 0.97 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.389 1.876 . . . . 0.0 110.23 -171.008 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.2 m -128.6 128.29 43.93 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.72 1.208 . . . . 0.0 110.103 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.7 mt -89.76 135.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.672 1.189 . . . . 0.0 109.12 172.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.4 tptt -132.15 -58.36 0.95 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.105 0.962 . . . . 0.0 112.574 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.6 tttp -157.37 131.01 8.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.985 1.714 . . . . 0.0 110.55 179.347 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 121.14 -148.45 17.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 125.286 1.422 . . . . 0.0 111.485 -166.332 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.06 144.88 17.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -175.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.2 tt -121.52 136.2 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.779 1.632 . . . . 0.0 111.081 177.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 39.4 p -146.56 178.71 8.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.365 1.866 . . . . 0.0 110.259 -177.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.49 -168.46 30.6 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.319 0.887 . . . . 0.0 115.319 -179.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.96 146.39 23.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.87 1.668 . . . . 0.0 109.927 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 95.1 t -125.74 131.13 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.729 1.612 . . . . 0.0 108.327 173.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.7 mtm105 -119.66 138.33 53.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.651 1.18 . . . . 0.0 111.669 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 23.5 mtt -111.8 151.32 43.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.775 1.63 . . . . 0.0 111.764 -169.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -53.84 -38.76 85.81 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.093 3.195 . . . . 0.0 115.052 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -77.25 4.01 11.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -176.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.92 80.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.302 1.43 . . . . 0.0 114.155 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 152.01 44.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.15 1.38 . . . . 0.0 111.512 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.2 t -142.68 143.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.172 1.389 . . . . 0.0 109.981 -174.256 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.03 179.21 7.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.262 1.825 . . . . 0.0 110.984 177.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.66 143.98 43.24 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.928 0.891 . . . . 0.0 111.241 175.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.63 165.17 16.03 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.149 3.232 . . . . 0.0 111.41 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 89.9 m -106.41 124.09 49.06 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.222 1.409 . . . . 0.0 108.685 172.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.93 134.22 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.548 1.139 . . . . 0.0 109.213 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.1 m -135.41 122.63 21.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.495 1.518 . . . . 0.0 109.382 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.76 133.76 41.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.101 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.9 -12.08 45.8 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.5 mttm 69.79 6.91 5.96 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.333 2.253 . . . . 0.0 113.821 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.57 8.3 35.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.163 2.185 . . . . 0.0 112.804 179.319 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 94.22 14.42 51.35 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.169 1.366 . . . . 0.0 114.156 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.5 p -130.9 156.71 44.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.085 1.754 . . . . 0.0 110.774 176.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 30.0 m -119.22 138.87 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.291 1.036 . . . . 0.0 109.797 166.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 47.6 m -97.09 141.97 29.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.93 1.292 . . . . 0.0 108.604 171.027 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.1 t -126.59 132.19 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.045 1.338 . . . . 0.0 109.269 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.27 152.96 48.26 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.713 1.605 . . . . 0.0 111.693 -172.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 13.6 t80 -153.51 129.63 10.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.249 1.419 . . . . 0.0 111.327 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -79.76 121.43 82.35 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.102 0.961 . . . . 0.0 110.098 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.0 130.05 12.91 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 0.0 111.768 -170.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 74.2 m -126.0 -0.33 7.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -161.67 152.68 18.15 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.304 1.442 . . . . 0.0 111.021 -178.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -93.79 164.84 12.97 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.479 1.112 . . . . 0.0 112.683 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 102.28 -164.18 16.83 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.315 1.436 . . . . 0.0 113.9 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 26.4 tp -84.55 121.94 28.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.944 1.297 . . . . 0.0 110.95 -178.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 52.7 m80 -118.17 167.74 11.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.585 1.954 . . . . 0.0 111.316 -175.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -146.47 150.71 36.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.509 0.671 . . . . 0.0 112.571 167.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 10.6 ttm -119.91 131.89 55.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.655 2.382 . . . . 0.0 110.008 -174.616 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -102.05 139.3 37.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.812 1.645 . . . . 0.0 110.037 168.216 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -138.15 133.77 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.961 1.305 . . . . 0.0 109.268 173.519 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.64 138.55 23.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -102.41 119.35 38.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.025 2.13 . . . . 0.0 109.462 176.513 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 50.92 35.85 13.48 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.72 1.208 . . . . 0.0 112.829 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 6.7 t-20 82.71 -7.73 1.23 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.896 2.878 . . . . 0.0 114.69 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.0 mtp -94.11 129.49 40.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.831 1.252 . . . . 0.0 111.466 176.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.05 137.69 56.65 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.263 -0.898 . . . . 0.0 113.289 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.88 154.04 83.03 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.366 0.666 . . . . 0.0 111.501 176.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.63 135.53 57.24 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.479 2.119 . . . . 0.0 110.615 175.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 91.98 -13.95 65.61 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.646 1.117 . . . . 0.0 114.716 -175.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.1 m -96.52 158.7 33.31 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.463 1.631 . . . . 0.0 112.092 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.82 167.81 78.33 Favored 'Cis proline' 0 C--N 1.354 0.848 0 CA-C-N 119.827 0.974 . . . . 0.0 112.842 -2.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 98.8 mt -120.97 143.16 49.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.502 1.521 . . . . 0.0 110.994 -174.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -125.68 137.87 53.87 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.921 1.288 . . . . 0.0 110.374 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.99 152.04 24.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.565 1.146 . . . . 0.0 112.545 -166.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -103.91 148.28 26.35 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.291 -0.88 . . . . 0.0 112.945 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 25.5 t -129.73 137.42 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.311 1.444 . . . . 0.0 110.206 -177.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -165.81 145.21 6.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.746 1.618 . . . . 0.0 112.14 -163.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -71.22 133.97 46.53 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.433 -1.417 . . . . 0.0 113.237 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.8 p -63.74 -29.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -175.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.75 0.12 57.51 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.667 1.187 . . . . 0.0 113.775 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -66.69 140.15 57.88 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.216 -0.928 . . . . 0.0 111.919 -177.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.32 78.14 2.04 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.952 1.263 . . . . 0.0 112.334 -173.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -163.26 168.74 20.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.511 1.524 . . . . 0.0 113.795 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.4 p -67.37 146.2 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.749 0.819 . . . . 0.0 109.34 157.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.0 t -164.24 165.97 21.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.375 1.47 . . . . 0.0 110.637 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.69 147.78 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.54 1.136 . . . . 0.0 112.444 -176.096 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.6 p90 -166.02 160.11 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 112.623 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.65 170.49 12.1 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.347 1.451 . . . . 0.0 113.189 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.95 -30.86 32.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.241 2.628 . . . . 0.0 112.854 -170.754 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.9 -16.15 72.24 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 119.318 0.963 . . . . 0.0 114.703 -178.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.04 -13.75 59.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.939 1.369 . . . . 0.0 112.92 170.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 62.1 m -117.16 -38.97 3.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.43 1.892 . . . . 0.0 111.905 -166.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -147.35 159.64 43.45 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.903 2.081 . . . . 0.0 111.823 -171.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.2 175.92 33.77 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.313 0.959 . . . . 0.0 112.908 169.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 24.2 t -139.61 135.92 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 108.758 173.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.3 m -57.12 139.04 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 66.08 3.98 2.89 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.96 2.104 . . . . 0.0 114.926 173.139 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -119.43 144.63 36.98 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.697 1.599 . . . . 0.0 110.923 176.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.72 125.07 10.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 111.094 -174.268 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.95 146.73 27.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.298 1.439 . . . . 0.0 110.137 170.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 62.9 p -136.19 154.46 50.94 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -164.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -164.09 172.07 14.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.229 1.812 . . . . 0.0 111.595 177.333 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.5 m -125.04 141.53 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.453 1.501 . . . . 0.0 110.565 -174.17 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.19 128.7 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.801 168.291 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -90.64 122.01 33.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 0.0 109.871 172.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 44.9 p -122.36 2.82 9.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.456 1.902 . . . . 0.0 113.251 -171.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 62.2 tttp -51.74 -37.37 50.85 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.861 1.664 . . . . 0.0 114.116 -176.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 1.52 31.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.308 1.443 . . . . 0.0 113.632 179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.22 -23.44 61.24 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.87 -91.64 1.42 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.712 1.149 . . . . 0.0 112.553 175.464 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.36 171.66 17.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.717 1.607 . . . . 0.0 112.231 -173.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 113.53 -166.89 12.19 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.929 1.728 . . . . 0.0 111.976 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -90.54 118.0 5.23 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 124.269 0.937 . . . . 0.0 112.262 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.45 128.67 34.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 108.484 164.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.9 m -127.78 157.98 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.372 1.469 . . . . 0.0 111.822 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.6 tp -159.6 133.73 7.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.598 1.559 . . . . 0.0 109.12 -169.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.91 162.52 38.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.293 1.037 . . . . 0.0 112.017 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.61 134.13 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.523 1.129 . . . . 0.0 109.751 175.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -114.67 159.19 20.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.634 1.573 . . . . 0.0 109.918 168.151 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.64 -163.39 35.99 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.416 -0.802 . . . . 0.0 113.572 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.29 -16.11 28.14 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.543 2.829 . . . . 0.0 112.716 177.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -152.49 160.15 43.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.064 1.746 . . . . 0.0 109.418 168.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -75.63 114.73 14.54 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.894 -1.129 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.18 148.04 44.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.902 0.881 . . . . 0.0 111.259 168.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.38 144.63 25.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.642 0.777 . . . . 0.0 109.967 170.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.48 144.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 110.719 -166.702 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.7 t -142.37 157.64 44.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.02 1.328 . . . . 0.0 110.713 166.848 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.8 p -155.65 154.92 32.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 112.764 -176.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.5 m -140.74 123.41 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.352 1.461 . . . . 0.0 110.246 -171.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -72.42 120.51 18.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 110.077 166.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.02 -10.31 57.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.769 0.827 . . . . 0.0 112.933 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 76.08 -28.37 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.583 2.753 . . . . 0.0 112.581 178.18 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -73.83 10.68 1.06 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.293 2.237 . . . . 0.0 114.68 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.51 16.99 32.51 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.234 1.397 . . . . 0.0 114.198 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 77.7 p -138.7 154.14 48.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.301 1.44 . . . . 0.0 111.325 175.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.0 m -119.49 134.28 55.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.001 1.721 . . . . 0.0 109.309 166.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.1 t -94.87 150.4 20.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 110.837 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 66.7 t -132.22 143.05 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.363 1.465 . . . . 0.0 110.405 -179.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 58.9 m -131.89 141.76 49.46 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.143 1.777 . . . . 0.0 110.748 171.315 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.7 p90 -147.01 152.36 38.47 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.81 102.82 49.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.852 2.061 . . . . 0.0 110.422 -178.055 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.77 160.08 16.29 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.683 2.922 . . . . 0.0 110.303 168.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 33.4 m -121.55 -10.12 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -168.49 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.77 152.72 24.66 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.267 1.427 . . . . 0.0 110.412 178.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.98 143.79 23.37 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.891 2.394 . . . . 0.0 111.729 -172.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 153.64 -172.09 32.43 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.07 1.319 . . . . 0.0 113.252 -174.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.83 129.3 37.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.006 1.322 . . . . 0.0 112.288 176.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -121.52 140.82 51.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.033 1.733 . . . . 0.0 110.341 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 72.2 m -106.49 113.39 26.87 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.997 1.319 . . . . 0.0 110.45 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -92.74 121.75 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.135 1.374 . . . . 0.0 108.514 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.2 tt -100.28 128.18 46.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.484 1.514 . . . . 0.0 109.362 175.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -129.71 130.61 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.232 1.013 . . . . 0.0 109.671 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.57 143.14 23.59 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.954 1.302 . . . . 0.0 112.087 -167.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.51 124.79 24.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 0.0 109.787 176.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 53.84 56.32 7.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.122 1.369 . . . . 0.0 112.033 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.301 8.2 pt-20 58.91 3.32 0.31 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 128.957 2.903 . . . . 0.0 116.809 -176.101 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -109.27 126.07 52.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.0 110.661 178.329 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m170 -62.0 144.13 55.56 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.221 -0.924 . . . . 0.0 111.716 172.424 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.3 m -70.32 152.11 95.64 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.445 172.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.49 127.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.665 2.243 . . . . 0.0 110.696 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.44 -13.07 67.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.147 1.356 . . . . 0.0 115.316 -176.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.1 t -75.1 141.36 74.38 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.335 1.567 . . . . 0.0 111.713 176.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.86 146.59 81.79 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 119.613 0.898 . . . . 0.0 112.385 -3.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -99.74 139.87 34.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.686 1.594 . . . . 0.0 111.155 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 5.9 m -98.91 108.0 20.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.894 0.878 . . . . 0.0 111.048 -176.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.64 126.13 45.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.29 175.12 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -93.21 115.13 27.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.304 0.641 . . . . 0.0 110.425 176.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.7 t -91.5 136.57 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.803 1.641 . . . . 0.0 110.461 -177.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 8.7 m -113.53 153.77 28.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.057 1.743 . . . . 0.0 111.094 -171.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.23 137.53 23.02 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.928 0.775 . . . . 0.0 111.802 172.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 39.1 t70 -76.99 -28.13 54.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.087 0.955 . . . . 0.0 113.315 -178.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.255 1.346 0 C-N-CA 126.436 1.894 . . . . 0.0 112.62 -176.815 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.52 -29.29 66.87 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.972 0.909 . . . . 0.0 113.145 178.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.2 ttt -104.55 148.26 26.7 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.893 1.677 . . . . 0.0 110.903 173.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -67.09 154.0 93.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.788 1.235 . . . . 0.0 112.612 175.199 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.28 167.35 26.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.708 2.938 . . . . 0.0 112.06 177.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.13 146.8 27.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.288 1.435 . . . . 0.0 110.4 -177.436 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -161.77 151.3 13.63 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.378 1.471 . . . . 0.0 112.287 -173.032 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.57 152.56 65.21 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.429 2.753 . . . . 0.0 111.702 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 15.7 tp -120.55 24.92 10.08 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.428 1.491 . . . . 0.0 111.909 -174.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 80.9 t -68.99 121.41 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.004 1.321 . . . . 0.0 110.542 -175.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -105.49 -142.47 11.19 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.676 1.608 . . . . 0.0 112.175 176.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 94.2 t -68.04 130.93 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.017 0.927 . . . . 0.0 109.481 173.664 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 33.2 m120 -79.94 -0.29 34.47 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -170.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 99.66 -176.69 28.85 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.759 1.647 . . . . 0.0 113.109 -176.456 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.1 mt -76.08 140.8 42.04 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.081 0.953 . . . . 0.0 112.039 -176.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 18.1 t0 -162.21 134.62 5.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.706 2.002 . . . . 0.0 109.218 178.528 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . 0.302 10.0 p 44.09 31.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.558 1.943 . . . . 0.0 114.465 -173.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.6 t -67.75 -32.26 72.74 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.876 1.27 . . . . 0.0 112.307 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 33.6 t -164.75 125.78 2.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.554 1.542 . . . . 0.0 110.026 172.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.72 137.06 32.75 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.956 1.302 . . . . 0.0 110.27 174.057 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -67.2 122.95 85.09 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.736 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.01 150.52 60.75 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.006 2.471 . . . . 0.0 110.86 179.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 20.4 t80 -107.0 128.51 54.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.381 0.672 . . . . 0.0 111.103 178.108 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -151.76 136.37 17.01 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.328 1.451 . . . . 0.0 110.723 173.046 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.57 153.85 46.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.604 1.962 . . . . 0.0 109.724 -173.42 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -129.29 137.48 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.987 1.315 . . . . 0.0 110.363 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.47 137.55 29.26 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.166 1.787 . . . . 0.0 108.586 -173.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 52.39 4.28 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.417 3.411 . . . . 0.0 112.775 -178.117 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 44.2 t80 -95.68 150.05 20.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.262 1.425 . . . . 0.0 111.212 174.075 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 93.1 m -119.79 124.0 45.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.793 1.237 . . . . 0.0 109.897 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.3 mt -91.12 139.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.276 1.43 . . . . 0.0 109.74 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -148.69 -43.99 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -177.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 tttm -164.23 123.77 1.98 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.246 1.418 . . . . 0.0 111.601 178.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 123.74 -157.2 18.13 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.868 1.699 . . . . 0.0 111.764 -168.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -141.4 150.09 41.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.819 1.247 . . . . 0.0 111.457 -176.449 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.3 tt -127.68 135.24 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.718 1.607 . . . . 0.0 111.099 176.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.8 p -146.7 176.4 9.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.014 1.726 . . . . 0.0 109.953 176.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -164.99 -170.72 30.32 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 178.678 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -155.98 145.9 21.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.841 1.656 . . . . 0.0 110.194 -176.266 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 61.8 t -126.53 137.2 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.472 1.909 . . . . 0.0 108.944 178.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -116.63 131.36 56.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.666 1.586 . . . . 0.0 111.879 -173.277 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -102.42 148.25 35.19 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.804 1.641 . . . . 0.0 111.698 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.87 -28.6 68.69 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.283 3.322 . . . . 0.0 114.922 174.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 37.9 p -72.8 -5.95 41.52 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.492 1.517 . . . . 0.0 114.359 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.1 -5.09 81.59 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.473 1.511 . . . . 0.0 113.67 -175.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.68 159.18 32.64 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.347 1.073 . . . . 0.0 111.888 174.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.9 m -138.33 154.43 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.245 1.418 . . . . 0.0 111.384 174.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.55 171.6 19.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.396 1.879 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -117.19 141.44 28.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.651 0.781 . . . . 0.0 111.421 178.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -86.34 172.15 7.24 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.269 3.313 . . . . 0.0 111.93 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.5 m -103.01 130.69 50.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.925 1.29 . . . . 0.0 108.793 170.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.1 132.71 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 0.0 108.819 172.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.6 m -124.54 128.25 48.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.195 1.798 . . . . 0.0 109.746 -178.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.1 t0 -80.45 119.32 22.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.15 0.98 . . . . 0.0 110.276 171.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -81.73 -11.18 59.14 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.5 mmmt 72.48 -3.84 2.22 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 128.046 2.538 . . . . 0.0 114.007 -178.408 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -97.35 6.12 48.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.672 1.989 . . . . 0.0 113.41 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 89.52 16.02 57.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.722 1.153 . . . . 0.0 113.491 -172.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 48.5 p -130.86 159.55 37.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.611 1.965 . . . . 0.0 110.154 175.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -123.18 143.75 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.621 1.168 . . . . 0.0 109.928 168.107 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 24.1 m -104.74 139.86 38.92 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.729 1.212 . . . . 0.0 108.796 172.442 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 29.3 t -121.57 134.59 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.453 1.501 . . . . 0.0 108.664 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.78 149.22 50.38 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.078 1.351 . . . . 0.0 112.433 -173.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 29.8 t80 -150.83 131.1 13.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.418 1.487 . . . . 0.0 111.812 178.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.7 120.73 73.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.632 1.173 . . . . 0.0 110.825 176.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.06 146.17 20.02 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.71 2.94 . . . . 0.0 112.427 -170.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 84.3 p -128.4 -11.71 5.09 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 174.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -147.63 152.3 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.28 1.832 . . . . 0.0 110.487 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.45 168.17 12.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.368 1.067 . . . . 0.0 111.926 169.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.71 -173.45 14.74 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.463 1.506 . . . . 0.0 114.15 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.3 tp -82.06 114.83 20.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.695 1.198 . . . . 0.0 110.249 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 48.1 m80 -110.55 165.62 11.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 111.429 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.61 154.44 45.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.198 0.999 . . . . 0.0 111.103 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.5 ttm -138.35 137.78 37.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.846 1.658 . . . . 0.0 110.439 -171.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -121.21 121.1 37.05 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.509 1.924 . . . . 0.0 109.386 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -125.9 132.59 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.578 1.151 . . . . 0.0 110.158 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.41 136.55 26.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -172.034 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 11.6 t80 -106.13 125.16 50.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.455 1.902 . . . . 0.0 110.004 175.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 51.48 37.0 18.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.776 1.23 . . . . 0.0 112.569 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 57.0 t30 82.99 -9.42 1.09 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 129.081 2.952 . . . . 0.0 114.768 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 26.5 mmt -101.94 136.19 42.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.917 1.287 . . . . 0.0 111.819 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.22 136.42 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.59 152.65 91.67 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.178 175.484 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -57.41 124.34 15.9 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.085 2.523 . . . . 0.0 111.092 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 96.92 -11.28 66.12 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.933 1.254 . . . . 0.0 114.836 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.16 149.4 39.8 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 120.029 1.915 . . . . 0.0 111.099 173.268 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.15 162.1 92.74 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.778 1.314 . . . . 0.0 113.311 1.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.7 mt -113.42 157.15 22.28 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.179 1.792 . . . . 0.0 111.349 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.62 140.11 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.099 1.36 . . . . 0.0 109.458 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.55 163.46 17.01 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.389 1.075 . . . . 0.0 112.112 -169.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -104.29 135.11 46.37 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.188 -0.945 . . . . 0.0 113.028 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.1 t -103.17 139.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.335 1.454 . . . . 0.0 108.426 171.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.9 t0 -150.87 165.89 32.23 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.344 1.058 . . . . 0.0 111.875 -172.886 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -78.05 138.51 38.81 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.843 0.857 . . . . 0.0 111.536 174.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 94.8 t -72.24 -37.81 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.872 0.869 . . . . 0.0 112.643 -171.213 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -124.76 17.57 8.69 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -166.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 12.7 t -68.63 -26.73 65.49 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.0 -1.063 . . . . 0.0 113.125 178.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 101.39 -14.23 58.12 Favored Glycine 0 N--CA 1.476 1.34 0 C-N-CA 125.7 1.619 . . . . 0.0 115.782 166.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -66.47 158.57 29.2 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.001 1.4 . . . . 0.0 113.587 175.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 p -60.84 139.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.572 0.749 . . . . 0.0 110.137 169.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -161.54 172.23 16.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.243 1.417 . . . . 0.0 110.519 -178.215 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.72 144.58 24.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.542 1.137 . . . . 0.0 111.859 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.66 163.63 12.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.389 1.476 . . . . 0.0 113.156 -175.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.37 173.53 13.42 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.398 1.475 . . . . 0.0 112.717 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.66 -33.86 26.84 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.874 2.383 . . . . 0.0 112.418 -173.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.91 72.1 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.718 -1.046 . . . . 0.0 114.849 -173.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.83 -0.39 43.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.343 1.572 . . . . 0.0 113.854 174.076 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 55.4 m -108.64 -47.85 3.41 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 178.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -142.44 152.31 42.64 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.804 2.042 . . . . 0.0 112.255 -172.654 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -154.53 -176.07 26.4 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.474 1.035 . . . . 0.0 113.635 169.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.4 p -153.3 136.85 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.124 1.37 . . . . 0.0 108.889 177.053 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -58.8 145.23 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -170.881 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.6 m-80 68.79 1.57 3.14 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.734 2.014 . . . . 0.0 114.656 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -115.44 141.59 27.48 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.586 1.555 . . . . 0.0 110.597 176.101 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.1 136.81 30.3 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.661 2.24 . . . . 0.0 110.86 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.87 139.02 51.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.887 1.675 . . . . 0.0 110.182 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.2 p -131.84 147.69 52.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -165.13 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -157.68 174.98 14.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.635 1.574 . . . . 0.0 111.364 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.2 m -129.49 136.97 50.53 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.809 1.243 . . . . 0.0 110.812 -172.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.1 t -100.35 132.14 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.36 1.464 . . . . 0.0 107.811 167.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.53 130.46 49.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.789 1.236 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.0 p -135.28 11.27 3.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.293 1.837 . . . . 0.0 112.941 -170.063 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 58.5 tttp -52.37 -34.96 50.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.336 1.854 . . . . 0.0 115.546 -165.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.69 23.88 4.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.315 1.446 . . . . 0.0 111.934 175.006 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.66 -8.87 59.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.907 1.283 . . . . 0.0 114.433 -177.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 87.95 -122.16 6.18 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.669 1.128 . . . . 0.0 112.439 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.0 167.77 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.471 1.508 . . . . 0.0 112.254 -174.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 139.81 -162.69 26.27 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.625 1.583 . . . . 0.0 113.21 -178.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -84.58 109.6 3.27 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 124.082 0.848 . . . . 0.0 111.488 175.54 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 44.7 tp -85.15 134.46 34.17 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.612 1.165 . . . . 0.0 109.645 171.555 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.9 m -132.83 158.64 41.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.283 1.433 . . . . 0.0 112.338 -175.365 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.2 tp -161.08 134.87 6.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.393 1.877 . . . . 0.0 108.783 -169.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.08 157.3 34.31 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.978 0.911 . . . . 0.0 112.104 176.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -137.42 140.27 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.847 1.259 . . . . 0.0 109.625 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.02 143.56 50.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.639 1.576 . . . . 0.0 109.516 172.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.75 -162.99 23.03 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.99 -0.895 . . . . 0.0 114.982 -174.327 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -64.26 -26.86 64.05 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.126 3.217 . . . . 0.0 112.602 178.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -138.22 158.85 43.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.008 1.323 . . . . 0.0 109.253 161.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -74.6 112.78 11.13 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.895 -1.128 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.76 149.42 49.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.923 0.889 . . . . 0.0 112.123 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.3 139.89 30.09 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.523 0.729 . . . . 0.0 109.258 165.818 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.46 138.12 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.668 1.187 . . . . 0.0 110.469 -167.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -134.78 155.75 50.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 110.783 171.084 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.74 154.49 32.93 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.089 0.956 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 90.7 m -143.31 120.03 11.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.82 1.648 . . . . 0.0 109.906 -172.723 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -72.61 124.96 26.32 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.341 0.656 . . . . 0.0 110.109 170.188 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -86.28 -11.33 52.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -174.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 69.31 -3.3 1.61 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.27 2.628 . . . . 0.0 113.759 -175.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.49 8.29 39.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.446 1.898 . . . . 0.0 113.236 -177.437 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.43 18.28 36.44 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.097 1.332 . . . . 0.0 113.637 -172.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 54.1 p -142.64 157.03 45.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.673 1.589 . . . . 0.0 111.652 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 52.7 t -127.19 124.81 39.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.616 1.967 . . . . 0.0 109.009 169.585 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 146.64 25.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.235 1.014 . . . . 0.0 110.904 177.034 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.3 t -128.44 143.48 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.063 1.745 . . . . 0.0 109.778 -178.129 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.4 t -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.469 1.508 . . . . 0.0 110.728 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.0 p90 -144.95 153.58 41.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.185 -0.947 . . . . 0.0 113.491 175.255 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 3.2 mt -114.37 106.38 52.75 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.976 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.64 170.04 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.887 3.058 . . . . 0.0 110.703 167.152 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.5 p -148.52 -28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -173.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.05 146.18 33.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.541 1.064 . . . . 0.0 110.928 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 163.55 34.7 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.255 2.636 . . . . 0.0 111.159 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.93 -134.94 7.89 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 125.269 1.414 . . . . 0.0 111.02 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 2.2 p30 -143.91 145.36 32.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.009 0.909 . . . . 0.0 112.829 176.306 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -121.26 135.68 55.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.789 2.035 . . . . 0.0 109.872 -171.802 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -89.78 127.14 35.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.305 1.042 . . . . 0.0 110.509 174.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.4 120.67 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.66 1.584 . . . . 0.0 108.593 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -102.37 134.5 45.57 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 109.942 174.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.7 t -136.66 133.12 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.355 1.462 . . . . 0.0 108.384 171.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.39 141.69 19.57 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.015 1.326 . . . . 0.0 111.026 -170.302 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.37 125.38 18.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.662 1.185 . . . . 0.0 110.43 -178.557 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.76 54.3 10.09 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.056 1.343 . . . . 0.0 111.909 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.303 8.5 pt-20 57.97 15.72 3.3 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.233 2.613 . . . . 0.0 116.236 -177.933 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -121.99 129.81 52.77 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.577 1.151 . . . . 0.0 111.282 177.242 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -61.97 155.71 22.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.092 0.957 . . . . 0.0 112.722 170.556 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.2 m -83.14 156.4 66.7 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.272 0.629 . . . . 0.0 110.126 175.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.58 122.77 12.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.455 2.104 . . . . 0.0 110.276 176.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.39 -13.07 68.0 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.293 -1.281 . . . . 0.0 116.079 -179.135 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.4 p -80.92 152.02 71.26 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 120.262 2.031 . . . . 0.0 112.91 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.46 141.93 71.53 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.152 0.733 . . . . 0.0 111.948 -4.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.85 169.64 11.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.431 1.493 . . . . 0.0 110.669 176.221 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 37.4 m -132.81 117.43 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.647 0.779 . . . . 0.0 110.741 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.63 128.47 45.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.803 1.241 . . . . 0.0 110.94 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -88.85 131.67 35.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.195 0.452 . . . . 0.0 110.749 174.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -121.22 138.25 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.676 1.59 . . . . 0.0 109.788 -173.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -126.01 177.16 6.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.24 1.016 . . . . 0.0 112.801 -176.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.82 138.66 21.14 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.825 1.678 . . . . 0.0 112.51 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.94 -18.34 34.91 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.578 1.151 . . . . 0.0 113.558 -178.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.771 2.028 . . . . 0.0 112.544 -176.751 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.38 152.4 42.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.23 1.012 . . . . 0.0 112.628 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 28.4 ptm -77.7 -22.26 50.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -83.18 150.65 61.48 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.876 1.27 . . . . 0.0 112.41 -179.44 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.6 158.74 50.28 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.644 2.896 . . . . 0.0 111.58 175.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.17 -6.72 52.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.262 1.025 . . . . 0.0 113.489 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -134.43 133.99 22.08 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.368 1.867 . . . . 0.0 110.169 178.306 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.74 152.81 47.98 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.313 2.675 . . . . 0.0 111.711 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.43 11.96 19.98 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.007 1.323 . . . . 0.0 113.147 -178.64 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 10.9 p -57.15 143.49 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.445 1.898 . . . . 0.0 112.959 -175.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 100.84 -8.46 57.92 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.166 1.365 . . . . 0.0 115.366 173.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 33.0 m -77.0 145.22 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.873 1.337 . . . . 0.0 111.524 174.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -86.55 156.85 19.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.338 1.055 . . . . 0.0 113.214 177.09 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -90.76 -176.26 44.17 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.956 1.265 . . . . 0.0 112.335 167.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.4 mt -122.91 147.35 46.69 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.199 1.4 . . . . 0.0 110.824 175.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -93.53 8.5 40.49 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.285 1.434 . . . . 0.0 113.378 -174.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.8 p -57.43 -23.77 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.579 1.952 . . . . 0.0 115.213 -166.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.7 t -63.9 -33.91 76.77 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.29 1.036 . . . . 0.0 112.365 173.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 2.7 t 79.44 160.65 0.18 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.107 2.563 . . . . 0.0 114.436 174.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.1 tp -107.06 138.2 43.69 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.029 1.731 . . . . 0.0 109.121 173.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -61.8 121.9 67.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.949 0.9 . . . . 0.0 112.098 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.299 2.666 . . . . 0.0 111.506 -177.468 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.1 t80 -101.39 122.14 43.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.115 0.966 . . . . 0.0 109.635 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -148.63 131.29 15.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 110.581 171.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.23 153.84 43.23 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.381 1.872 . . . . 0.0 109.653 -170.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.62 137.81 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.825 1.25 . . . . 0.0 110.353 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.2 mt -131.7 136.32 28.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.303 1.841 . . . . 0.0 108.734 -172.609 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -77.75 69.58 7.3 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.558 3.505 . . . . 0.0 111.019 177.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -123.33 162.43 22.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.583 1.953 . . . . 0.0 110.307 175.156 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.8 m -139.28 130.0 26.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.906 1.282 . . . . 0.0 109.926 178.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 57.9 mt -82.17 118.2 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.18 0.992 . . . . 0.0 108.688 170.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -24.99 11.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -174.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -170.43 -24.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 178.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.79 -147.67 13.45 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.766 1.65 . . . . 0.0 113.087 -177.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.82 145.05 29.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 109.894 -176.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.74 132.61 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.279 1.432 . . . . 0.0 110.985 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -149.62 170.58 18.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.981 1.713 . . . . 0.0 110.465 -173.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.69 -167.29 20.1 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 116.301 1.281 . . . . 0.0 116.301 -175.448 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.52 142.59 22.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.13 1.772 . . . . 0.0 109.164 174.142 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.3 t -115.33 127.87 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.206 1.402 . . . . 0.0 108.379 172.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -109.69 122.53 47.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.915 1.686 . . . . 0.0 109.48 -175.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.3 mtt -93.77 150.8 39.26 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.278 1.431 . . . . 0.0 111.214 -173.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.24 -21.71 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.445 2.763 . . . . 0.0 112.774 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 14.0 m -72.84 -0.05 12.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.106 1.362 . . . . 0.0 114.47 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.15 42.96 6.45 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.698 1.142 . . . . 0.0 113.252 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -153.73 166.02 34.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.616 . . . . 0.0 111.931 -173.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 24.1 m -141.83 159.38 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.435 1.094 . . . . 0.0 113.144 -167.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.41 175.53 12.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.012 2.125 . . . . 0.0 110.617 174.168 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -112.39 143.45 28.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.113 -0.992 . . . . 0.0 112.31 -175.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.45 170.95 7.69 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.418 3.412 . . . . 0.0 111.767 173.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.3 m -115.27 128.49 56.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.564 1.546 . . . . 0.0 108.911 174.046 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.03 135.57 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.78 1.232 . . . . 0.0 109.395 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.1 m -134.29 126.79 30.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.532 1.533 . . . . 0.0 109.723 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.12 125.67 29.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.737 0.815 . . . . 0.0 110.651 172.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -82.19 -8.14 59.64 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.032 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 70.9 1.57 3.83 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.677 2.391 . . . . 0.0 113.674 -176.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.57 4.86 41.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.999 2.119 . . . . 0.0 113.039 -177.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.05 13.38 52.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.089 1.328 . . . . 0.0 114.112 -174.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 68.0 p -132.17 158.49 41.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.321 1.848 . . . . 0.0 110.999 178.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 22.3 m -115.31 141.07 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.253 1.021 . . . . 0.0 109.378 163.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 22.4 m -100.0 139.17 36.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.66 1.184 . . . . 0.0 108.444 169.92 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.99 133.82 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.38 1.472 . . . . 0.0 108.903 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -132.74 156.4 47.12 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.075 1.35 . . . . 0.0 112.267 -177.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.9 t80 -157.73 135.4 10.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.565 1.546 . . . . 0.0 111.625 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.86 124.53 76.87 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.188 0.995 . . . . 0.0 110.674 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -78.61 172.9 14.46 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.697 2.931 . . . . 0.0 111.73 -176.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -158.14 -39.3 0.07 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.779 0.832 . . . . 0.0 113.064 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -127.68 158.18 38.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.596 1.558 . . . . 0.0 110.767 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.23 174.99 10.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.238 1.015 . . . . 0.0 112.254 172.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.14 -177.66 22.47 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.156 1.36 . . . . 0.0 114.134 176.396 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 53.6 tp -73.93 117.69 16.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.327 1.051 . . . . 0.0 110.467 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 32.9 m80 -110.52 161.1 16.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.996 1.719 . . . . 0.0 110.71 178.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.2 150.09 33.11 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.7 -0.625 . . . . 0.0 112.401 175.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 30.8 ttm -128.82 139.26 52.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.139 1.776 . . . . 0.0 111.139 -168.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -108.7 137.14 47.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.194 1.798 . . . . 0.0 110.073 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.97 134.56 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.768 1.227 . . . . 0.0 110.43 175.934 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.92 138.94 36.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.586 1.154 . . . . 0.0 113.482 178.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 62.0 t80 -101.75 121.36 41.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.437 1.895 . . . . 0.0 109.334 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.38 32.33 13.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.836 1.254 . . . . 0.0 112.759 -175.297 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.5 m-80 73.87 7.28 4.9 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.798 2.439 . . . . 0.0 115.081 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.0 ttm -100.23 128.58 46.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.885 1.274 . . . . 0.0 110.269 166.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.17 136.59 57.28 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.46 -0.775 . . . . 0.0 112.762 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -74.81 156.74 86.32 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.76 174.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.08 -17.78 61.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.641 2.227 . . . . 0.0 113.204 175.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.92 7.61 65.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.643 1.116 . . . . 0.0 114.571 170.26 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 18.1 t -111.29 146.1 33.88 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 119.683 1.742 . . . . 0.0 111.678 178.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.37 169.45 72.81 Favored 'Cis proline' 0 C--N 1.351 0.668 0 CA-C-N 119.816 0.97 . . . . 0.0 111.76 -9.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.66 158.31 24.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.918 1.687 . . . . 0.0 110.654 171.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -148.41 152.18 36.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.334 -0.854 . . . . 0.0 111.894 171.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -165.97 154.28 10.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.914 1.286 . . . . 0.0 111.244 -175.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.3 t80 -94.67 129.39 41.57 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.483 -0.76 . . . . 0.0 112.301 177.568 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.6 t -95.1 134.25 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.989 1.316 . . . . 0.0 109.214 174.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -149.77 158.29 44.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.514 1.525 . . . . 0.0 110.146 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -67.65 160.49 27.84 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 63.4 t -65.09 -39.49 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.557 0.743 . . . . 0.0 111.046 179.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 p30 -90.46 155.73 18.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.238 1.015 . . . . 0.0 111.57 165.248 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 25.1 p -161.79 156.17 22.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.763 1.225 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -112.72 30.27 7.6 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 126.182 1.848 . . . . 0.0 113.094 178.502 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -165.19 162.84 20.25 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.342 1.457 . . . . 0.0 113.091 -165.361 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.3 p -66.75 140.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 0.0 110.015 167.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -156.58 162.48 39.89 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.874 1.27 . . . . 0.0 111.022 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.14 144.76 36.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.744 1.218 . . . . 0.0 112.042 -177.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 44.7 p90 -165.24 161.24 19.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.785 1.634 . . . . 0.0 112.527 -176.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.7 174.42 13.54 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.302 1.429 . . . . 0.0 113.369 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.17 -33.12 9.78 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.107 2.538 . . . . 0.0 113.447 -171.077 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.62 -36.69 88.43 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 119.523 1.056 . . . . 0.0 114.175 -171.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.16 -9.1 58.24 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.916 1.358 . . . . 0.0 113.215 176.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 29.1 m -98.45 -49.85 4.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.348 1.859 . . . . 0.0 111.089 177.211 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -143.11 146.03 33.39 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.511 1.924 . . . . 0.0 112.881 -174.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.16 178.61 21.28 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.485 1.517 . . . . 0.0 113.32 171.652 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.3 p -149.63 136.29 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.778 1.231 . . . . 0.0 109.37 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -58.21 144.01 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.1 m-80 67.8 7.44 5.73 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.737 2.015 . . . . 0.0 114.773 174.258 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 95.1 mttt -125.99 146.47 55.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.679 1.592 . . . . 0.0 110.877 174.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 135.68 25.72 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.78 2.32 . . . . 0.0 111.188 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.16 137.83 51.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 109.99 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.0 p -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -165.305 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -161.56 177.69 9.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.393 1.877 . . . . 0.0 111.26 178.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 45.6 m -130.82 142.01 50.37 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.669 1.187 . . . . 0.0 110.761 -170.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.3 t -112.82 128.46 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.194 1.398 . . . . 0.0 107.976 169.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -94.27 126.07 39.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.664 1.186 . . . . 0.0 110.084 176.273 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.8 p -127.88 0.19 5.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.053 1.741 . . . . 0.0 113.57 -167.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 63.0 tttp -51.07 -38.69 53.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.134 1.774 . . . . 0.0 114.729 -171.592 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.47 9.58 18.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.517 1.527 . . . . 0.0 113.183 -178.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.33 62.79 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -172.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.73 147.23 5.88 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.908 1.242 . . . . 0.0 112.525 -172.055 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.84 148.29 36.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.252 1.021 . . . . 0.0 112.397 -177.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 177.22 -45.34 0.1 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.991 1.281 . . . . 0.0 113.715 175.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 165.03 106.45 0.19 Allowed Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.919 1.247 . . . . 0.0 112.729 171.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.92 130.32 34.91 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.076 1.35 . . . . 0.0 109.423 175.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.9 m -127.87 156.37 42.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.547 1.539 . . . . 0.0 112.159 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 38.5 tp -155.81 135.22 12.37 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.476 1.91 . . . . 0.0 108.663 -175.383 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -154.36 155.31 34.82 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.146 0.978 . . . . 0.0 112.031 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.6 mt -137.04 133.18 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.489 1.116 . . . . 0.0 110.374 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -115.85 160.85 19.62 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.261 1.824 . . . . 0.0 109.657 170.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.57 -163.35 34.62 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.047 -1.033 . . . . 0.0 114.695 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.73 -24.49 61.96 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.886 3.057 . . . . 0.0 112.278 175.109 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -140.79 159.65 41.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.431 1.492 . . . . 0.0 108.939 164.036 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 tptt -74.06 113.61 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.846 -1.158 . . . . 0.0 110.6 176.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.31 145.86 52.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 0.0 111.411 174.324 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.2 143.55 28.7 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 109.808 169.25 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 99.7 mt -128.78 144.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 110.887 -167.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 14.5 t -139.38 156.16 47.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 164.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 26.7 p -157.56 150.46 23.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.603 1.161 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.8 m -140.55 118.43 11.79 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 110.018 -169.63 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 14.0 t0 -67.43 118.38 10.69 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.785 0.834 . . . . 0.0 109.785 166.152 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -80.79 -13.37 59.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.69 0.796 . . . . 0.0 112.775 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 73.68 -7.96 1.48 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 128.5 2.72 . . . . 0.0 113.455 -179.272 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -88.6 8.43 28.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.478 1.911 . . . . 0.0 113.372 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.25 18.33 39.68 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.058 1.313 . . . . 0.0 113.694 -171.98 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.8 p -139.54 155.4 47.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.545 1.538 . . . . 0.0 111.181 176.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 43.5 t -124.33 128.9 49.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.532 1.933 . . . . 0.0 109.244 170.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.6 t -89.62 145.76 25.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.306 1.043 . . . . 0.0 110.643 174.453 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.1 t -126.83 143.3 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.933 1.693 . . . . 0.0 109.709 -177.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.8 t -138.3 141.32 39.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.603 1.561 . . . . 0.0 110.685 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -144.21 153.2 41.83 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.152 -0.967 . . . . 0.0 113.586 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 57.5 tp -119.35 103.09 47.51 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.705 1.602 . . . . 0.0 110.085 -176.207 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.71 172.72 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.85 3.034 . . . . 0.0 110.88 170.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.1 p -146.76 -30.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.8 mt -107.59 146.86 34.21 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.331 1.052 . . . . 0.0 110.902 167.633 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.78 160.69 43.17 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.142 2.561 . . . . 0.0 110.9 173.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 138.19 -132.61 5.91 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.444 1.021 . . . . 0.0 112.309 -175.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.84 135.94 30.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.133 1.373 . . . . 0.0 111.562 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.66 134.55 54.98 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.872 1.669 . . . . 0.0 110.423 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 31.9 m -91.54 121.32 33.13 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.22 126.04 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.93 1.692 . . . . 0.0 108.356 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.22 130.17 55.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.353 1.461 . . . . 0.0 109.298 175.346 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.9 t -132.11 130.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.33 1.052 . . . . 0.0 109.534 173.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.57 142.72 22.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.957 1.303 . . . . 0.0 111.804 -167.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.18 120.66 18.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.809 1.243 . . . . 0.0 109.733 178.302 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 54.57 58.18 5.11 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.358 1.463 . . . . 0.0 112.133 177.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 58.62 9.33 1.09 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.571 2.748 . . . . 0.0 116.542 -177.245 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -115.88 124.97 51.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.487 1.115 . . . . 0.0 110.801 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.87 145.69 54.52 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.379 -0.825 . . . . 0.0 111.984 172.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.6 m -72.26 156.87 90.13 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.142 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.64 125.75 18.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.697 2.932 . . . . 0.0 112.475 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.51 -12.42 63.13 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.919 1.247 . . . . 0.0 115.664 -179.061 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.6 t -74.67 142.02 76.72 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-N 119.449 1.625 . . . . 0.0 111.641 177.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.88 142.94 75.33 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.297 0.785 . . . . 0.0 112.24 -3.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -97.15 168.87 10.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.577 1.951 . . . . 0.0 110.803 175.801 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 90.0 m -126.51 122.03 34.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.962 0.905 . . . . 0.0 111.251 172.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.49 132.68 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.044 1.338 . . . . 0.0 110.874 173.004 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -84.53 124.43 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.307 0.643 . . . . 0.0 109.435 173.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.89 133.62 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.757 0.823 . . . . 0.0 110.304 -178.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.0 p -110.76 161.6 15.61 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.427 1.491 . . . . 0.0 112.686 -174.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.24 136.41 16.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.537 1.065 . . . . 0.0 110.95 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.52 -16.92 53.08 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.386 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.898 2.079 . . . . 0.0 112.488 -178.784 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 71.36 170.33 0.32 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.88 2.472 . . . . 0.0 113.761 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 28.7 ptm -78.9 -9.88 59.63 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -134.92 150.51 73.44 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.832 1.653 . . . . 0.0 111.632 -178.043 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.73 166.47 28.24 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.804 3.003 . . . . 0.0 112.362 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -157.37 157.13 33.49 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.761 1.624 . . . . 0.0 110.404 177.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -58.5 147.46 69.15 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.657 1.983 . . . . 0.0 112.999 -176.053 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.88 167.53 26.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.786 2.99 . . . . 0.0 111.357 173.315 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.3 36.84 0.19 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.667 1.587 . . . . 0.0 113.5 -175.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 92.2 t -83.07 138.07 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.377 1.871 . . . . 0.0 109.628 177.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -72.09 141.93 32.26 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.181 0.896 . . . . 0.0 113.308 -176.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 34.2 m -88.74 8.4 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 125.291 1.436 . . . . 0.0 113.675 -176.569 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 22.0 t30 -63.19 -26.12 68.66 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.971 1.308 . . . . 0.0 114.145 -177.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 85.37 -176.96 50.25 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.976 1.274 . . . . 0.0 113.374 -178.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.6 mt -72.18 128.01 34.35 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.611 1.164 . . . . 0.0 111.364 -177.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -87.79 -33.61 18.58 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 34.5 m -91.39 -8.47 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -169.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.7 t -86.12 -17.74 34.21 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 22.6 m -66.84 141.71 57.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -165.202 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 60.3 mt -81.66 144.67 31.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.662 1.185 . . . . 0.0 109.98 161.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.69 121.61 76.3 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.497 1.119 . . . . 0.0 110.676 -178.56 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.61 151.24 64.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.287 2.658 . . . . 0.0 111.632 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.4 t80 -106.79 121.97 45.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.896 0.878 . . . . 0.0 110.87 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.89 133.19 14.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.335 1.454 . . . . 0.0 110.367 170.724 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.75 134.74 25.46 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.379 1.471 . . . . 0.0 109.993 -167.702 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 11.2 p -103.72 139.94 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.931 1.292 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -134.89 137.9 28.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.584 1.953 . . . . 0.0 108.333 -177.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.02 23.76 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.236 3.291 . . . . 0.0 114.199 -178.339 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.1 t80 -72.75 153.15 41.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.563 1.145 . . . . 0.0 111.405 174.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 96.2 m -123.82 126.88 47.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.351 1.46 . . . . 0.0 110.225 -177.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.48 131.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.397 1.079 . . . . 0.0 109.642 172.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.46 -64.03 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.317 1.047 . . . . 0.0 112.71 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.97 124.62 4.35 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.543 1.537 . . . . 0.0 110.888 179.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.38 -144.6 16.58 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.567 1.556 . . . . 0.0 111.308 -166.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.09 143.8 17.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.515 1.126 . . . . 0.0 110.949 -176.469 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.4 tt -119.09 138.41 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.3 1.44 . . . . 0.0 111.257 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.16 166.01 30.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.884 1.674 . . . . 0.0 110.736 -178.818 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.17 -172.47 19.54 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 -177.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -151.18 138.76 19.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.231 1.812 . . . . 0.0 109.31 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 4.7 t -110.7 137.88 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.094 1.758 . . . . 0.0 108.218 174.578 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 53.1 mtp85 -129.18 118.62 22.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.769 1.627 . . . . 0.0 110.094 -171.837 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.8 mpp? -91.78 153.31 43.72 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.571 1.548 . . . . 0.0 111.265 -175.407 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.9 -19.2 46.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.385 2.723 . . . . 0.0 113.4 178.394 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 44.8 p -73.96 -8.49 56.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.381 1.473 . . . . 0.0 114.134 171.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.2 -4.95 81.25 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.512 1.53 . . . . 0.0 113.979 -174.573 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -68.48 160.02 30.58 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.531 1.166 . . . . 0.0 111.885 173.447 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.9 m -140.29 156.7 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.634 1.173 . . . . 0.0 112.427 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.54 -173.03 4.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.418 2.287 . . . . 0.0 110.059 178.494 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -130.79 143.86 51.09 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.843 -1.161 . . . . 0.0 111.395 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -84.74 167.07 11.54 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.945 3.097 . . . . 0.0 111.507 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.1 m -104.44 133.07 49.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.355 1.462 . . . . 0.0 108.726 170.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.13 135.19 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.157 0.983 . . . . 0.0 109.642 176.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -130.82 127.52 38.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.775 1.63 . . . . 0.0 109.389 178.016 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.31 127.96 33.74 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.261 0.624 . . . . 0.0 110.314 170.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -82.81 -5.58 59.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.177 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 69.91 4.62 4.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.59 2.356 . . . . 0.0 114.044 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.66 7.54 30.63 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.004 2.122 . . . . 0.0 112.795 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.56 20.18 41.88 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.853 1.216 . . . . 0.0 113.945 -175.822 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 36.9 p -135.77 160.13 39.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.231 1.812 . . . . 0.0 110.301 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.4 m -120.37 148.02 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.515 1.126 . . . . 0.0 110.17 168.881 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.2 m -111.36 133.72 53.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.523 1.129 . . . . 0.0 108.897 169.115 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.2 t -110.17 134.15 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.846 1.658 . . . . 0.0 108.587 176.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -134.19 152.24 51.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.265 1.426 . . . . 0.0 112.367 -169.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.7 t80 -159.52 133.92 7.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.448 1.499 . . . . 0.0 112.125 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.84 119.4 71.15 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.53 1.132 . . . . 0.0 110.563 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.03 139.81 19.55 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.501 2.801 . . . . 0.0 112.686 -170.358 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 52.2 m -123.02 -7.51 8.35 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 174.962 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -140.37 157.62 45.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.828 1.651 . . . . 0.0 110.68 -177.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.3 170.57 9.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.73 1.212 . . . . 0.0 111.688 168.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.66 -170.42 19.16 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.214 1.388 . . . . 0.0 113.781 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -83.53 119.29 24.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.432 1.093 . . . . 0.0 110.117 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 24.2 m80 -107.57 156.3 19.17 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.115 1.766 . . . . 0.0 111.759 -177.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -124.27 149.71 46.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.069 1.748 . . . . 0.0 109.059 175.062 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 15.7 tmm? -153.12 136.01 15.44 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 111.901 -175.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.5 1.92 . . . . 0.0 111.702 -172.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.4 mm -136.66 135.38 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.444 1.498 . . . . 0.0 110.803 175.235 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 142.83 30.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.211 1.004 . . . . 0.0 113.622 178.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.3 t80 -107.39 122.41 46.54 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.952 2.101 . . . . 0.0 110.208 177.812 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 52.12 32.17 10.07 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.528 1.131 . . . . 0.0 112.485 -172.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 20.3 t30 77.14 3.9 3.26 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.426 2.69 . . . . 0.0 115.149 -178.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.35 128.84 47.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.659 1.583 . . . . 0.0 110.809 174.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -59.14 137.3 58.01 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 113.582 -177.342 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.25 155.45 87.98 Favored Pre-proline 0 N--CA 1.48 1.034 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.459 172.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.42 -13.64 40.76 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.485 2.124 . . . . 0.0 113.762 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -89.45 9.32 77.45 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.008 1.29 . . . . 0.0 114.672 170.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 29.5 t -116.32 148.22 41.19 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.533 1.667 . . . . 0.0 111.698 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.02 165.87 77.93 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 119.931 1.011 . . . . 0.0 112.135 -6.333 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 65.5 mt -113.97 158.8 20.67 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.319 1.848 . . . . 0.0 110.92 172.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.79 146.97 19.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.766 1.226 . . . . 0.0 110.954 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 3.8 p90 -170.96 163.52 7.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.914 1.285 . . . . 0.0 111.784 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -98.45 138.61 35.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.246 -0.909 . . . . 0.0 112.967 177.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 45.0 t -111.75 135.54 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.701 1.6 . . . . 0.0 109.451 174.811 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -146.38 164.1 33.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.307 1.843 . . . . 0.0 111.715 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -80.71 155.32 26.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.633 0.773 . . . . 0.0 112.862 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 25.1 m -66.17 -16.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.344 -0.847 . . . . 0.0 112.309 165.535 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -74.49 -19.7 60.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.909 1.684 . . . . 0.0 114.194 178.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 92.6 m -62.41 130.61 46.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.859 1.264 . . . . 0.0 113.551 -170.123 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.31 -18.17 22.37 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.2 1.381 . . . . 0.0 114.12 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -68.45 160.3 30.0 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.294 1.047 . . . . 0.0 113.51 176.336 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 40.0 t -63.75 128.5 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.55 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 157.1 44.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.691 1.196 . . . . 0.0 110.596 -172.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.69 144.3 37.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 -176.77 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -166.83 172.24 10.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 0.0 112.375 -173.715 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 118.27 172.29 15.58 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.266 1.412 . . . . 0.0 112.622 -177.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.71 -35.01 17.42 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.789 2.326 . . . . 0.0 112.704 -170.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -64.14 -38.6 96.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.398 0.999 . . . . 0.0 114.668 -171.379 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -77.01 -7.16 55.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.055 1.428 . . . . 0.0 113.761 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.3 m -100.91 -40.27 7.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.385 1.874 . . . . 0.0 111.071 176.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -153.73 141.08 19.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.38 1.872 . . . . 0.0 112.189 -167.491 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -135.5 177.0 19.77 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.529 1.538 . . . . 0.0 112.17 173.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.0 t -141.86 135.67 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.132 0.973 . . . . 0.0 108.85 174.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.9 m -55.97 135.85 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.302 0.641 . . . . 0.0 112.576 -177.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 58.3 m-80 67.71 1.17 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.95 2.1 . . . . 0.0 114.89 174.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -121.22 143.46 37.37 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 125.468 1.507 . . . . 0.0 111.038 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.53 133.04 19.9 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.523 2.149 . . . . 0.0 111.309 -173.389 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -113.08 146.42 39.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.66 1.584 . . . . 0.0 110.116 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.7 p -137.12 145.33 43.72 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.385 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -154.46 175.38 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.266 1.426 . . . . 0.0 111.948 177.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 29.9 m -130.94 144.27 51.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.25 1.42 . . . . 0.0 110.759 -169.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.2 t -121.36 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.674 1.59 . . . . 0.0 108.704 170.105 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.54 124.38 43.26 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.56 1.144 . . . . 0.0 111.307 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 34.5 p -124.99 12.28 8.36 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.808 2.043 . . . . 0.0 112.318 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.29 -36.43 66.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.615 1.566 . . . . 0.0 114.564 -170.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.74 12.62 19.67 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.729 1.612 . . . . 0.0 112.741 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.95 60.83 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.507 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 -84.45 1.57 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.052 1.311 . . . . 0.0 111.91 178.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -159.56 148.4 17.86 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.434 1.493 . . . . 0.0 110.634 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 156.19 -152.46 23.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.392 1.473 . . . . 0.0 111.661 -174.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -147.68 144.97 13.1 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.81 1.195 . . . . 0.0 112.377 176.267 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.33 141.35 28.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.198 1.399 . . . . 0.0 111.12 176.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 12.3 t -125.69 160.13 30.5 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.961 1.705 . . . . 0.0 110.816 166.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.3 tp -163.06 136.23 5.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.928 1.691 . . . . 0.0 109.491 -162.708 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.41 160.84 35.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.36 1.064 . . . . 0.0 111.954 175.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.4 mt -132.87 137.83 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.723 1.209 . . . . 0.0 109.518 173.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -129.12 119.48 24.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.171 1.388 . . . . 0.0 109.517 174.034 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -136.88 -173.26 12.83 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.92 1.248 . . . . 0.0 113.911 -177.729 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.04 -21.07 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.958 3.105 . . . . 0.0 112.257 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -136.22 157.1 47.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.344 1.458 . . . . 0.0 109.0 158.716 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.0 tptt -76.03 122.48 24.28 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.796 -1.19 . . . . 0.0 111.862 -176.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.94 150.08 35.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.037 0.935 . . . . 0.0 112.082 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -86.19 142.81 28.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.798 0.839 . . . . 0.0 109.314 166.335 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.87 144.16 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.441 1.096 . . . . 0.0 110.626 -167.623 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.3 t -146.81 168.13 22.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.036 1.334 . . . . 0.0 111.461 168.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -161.32 158.48 27.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 112.965 -177.887 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.9 m -143.8 129.02 18.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.8 1.64 . . . . 0.0 110.446 -172.508 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.63 128.69 34.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.82 1.248 . . . . 0.0 111.09 170.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -98.72 149.73 22.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 111.732 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -67.48 -16.37 64.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.766 0.826 . . . . 0.0 112.661 174.293 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.13 -7.72 52.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.435 1.494 . . . . 0.0 113.85 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.17 27.06 19.68 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.783 1.182 . . . . 0.0 114.464 176.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.5 p -130.82 156.46 44.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.777 1.631 . . . . 0.0 110.589 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.1 m -106.89 128.0 53.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.626 1.171 . . . . 0.0 109.921 171.188 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.7 t -94.72 149.57 21.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.147 0.979 . . . . 0.0 110.375 169.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.4 t -131.36 144.56 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.097 1.759 . . . . 0.0 109.63 -176.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.7 p -135.51 149.95 49.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.893 1.277 . . . . 0.0 111.987 170.161 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.72 155.7 37.73 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 176.57 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.9 mt -122.72 106.65 34.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.641 1.976 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.09 170.17 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 124.065 3.177 . . . . 0.0 110.488 167.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -131.4 -20.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -170.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.93 151.28 48.72 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.701 1.201 . . . . 0.0 110.769 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.5 152.29 38.34 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.826 2.351 . . . . 0.0 112.366 -170.51 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.3 -152.46 24.34 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.502 1.049 . . . . 0.0 112.883 -177.199 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.32 130.33 56.67 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.829 1.652 . . . . 0.0 111.627 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -122.35 129.41 52.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.715 1.606 . . . . 0.0 110.015 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -86.7 127.76 34.98 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.09 -1.006 . . . . 0.0 111.159 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.15 121.8 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 108.666 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -98.1 134.79 40.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.107 1.363 . . . . 0.0 109.979 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 91.4 t -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.442 1.497 . . . . 0.0 108.416 171.808 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -151.6 133.98 15.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.818 1.247 . . . . 0.0 110.93 -172.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -133.42 133.63 42.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.825 1.25 . . . . 0.0 111.151 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.8 t-20 49.16 53.36 12.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.77 1.228 . . . . 0.0 112.406 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.31 8.8 pt-20 58.49 18.18 5.48 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.016 2.526 . . . . 0.0 116.305 -177.178 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -127.78 131.53 49.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.618 1.167 . . . . 0.0 111.88 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -63.02 157.03 23.0 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.268 -0.895 . . . . 0.0 112.486 168.169 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.8 m -88.52 155.13 51.2 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.499 0.72 . . . . 0.0 110.314 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.6 123.1 12.61 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.237 1.958 . . . . 0.0 110.051 175.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.48 -13.48 65.47 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.141 1.353 . . . . 0.0 115.633 -177.319 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 87.0 p -82.56 150.68 63.66 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.343 2.071 . . . . 0.0 112.87 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.91 140.96 67.21 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.218 0.757 . . . . 0.0 111.791 -4.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -86.84 170.17 11.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 110.406 175.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 35.0 m -132.65 117.92 18.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 176.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.7 134.25 38.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 111.641 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -86.75 113.86 22.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.271 1.028 . . . . 0.0 109.944 174.209 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.6 t -92.17 124.56 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.581 0.752 . . . . 0.0 110.173 178.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 82.9 m -92.44 142.83 27.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.657 1.983 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.61 17.26 11.13 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.046 1.308 . . . . 0.0 115.347 -176.32 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.5 t70 66.4 10.21 7.08 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.559 2.344 . . . . 0.0 113.659 -178.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.345 1.858 . . . . 0.0 114.1 -177.865 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.582 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -79.56 -18.46 51.7 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -177.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -74.81 166.79 23.04 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.604 1.561 . . . . 0.0 113.366 178.148 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -141.77 151.05 58.88 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.573 1.549 . . . . 0.0 111.361 178.054 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.95 157.03 43.24 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.708 2.939 . . . . 0.0 111.998 -179.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -83.43 121.42 27.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.941 0.897 . . . . 0.0 110.361 175.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -70.72 -44.46 16.34 Favored Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -176.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.44 151.78 33.57 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.121 1.88 . . . . 0.0 111.967 -173.09 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.35 36.43 0.3 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.718 1.607 . . . . 0.0 112.683 -176.143 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.6 p -75.14 140.11 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.117 1.367 . . . . 0.0 111.358 -176.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 84.88 3.65 87.77 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 172.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 28.2 m -72.68 159.71 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 118.841 1.32 . . . . 0.0 112.163 177.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 60.4 t30 -154.27 143.75 21.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.751 1.221 . . . . 0.0 111.761 179.232 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -91.29 -159.03 35.22 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.411 1.481 . . . . 0.0 113.126 177.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 91.2 mt -73.9 157.31 36.53 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.38 1.072 . . . . 0.0 111.758 176.015 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.09 -11.37 58.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.906 1.282 . . . . 0.0 114.458 -175.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 17.8 m -67.71 127.89 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.355 1.062 . . . . 0.0 111.837 -178.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.1 t -163.21 19.84 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.551 1.54 . . . . 0.0 112.612 -174.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 9.8 m -76.94 30.4 0.13 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.861 1.664 . . . . 0.0 114.537 -170.208 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.88 141.66 56.34 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.133 1.373 . . . . 0.0 111.466 176.796 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.6 ttm180 -57.32 116.08 12.63 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.852 1.661 . . . . 0.0 110.829 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.47 137.22 32.91 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.705 2.27 . . . . 0.0 109.334 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.8 t80 -102.81 121.61 42.83 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.506 0.669 . . . . 0.0 111.047 -176.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.66 138.72 21.19 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.657 1.583 . . . . 0.0 110.104 171.379 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.56 140.52 30.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.208 1.403 . . . . 0.0 109.83 -172.263 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 86.0 t -102.88 134.76 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 109.331 176.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.72 135.73 27.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.64 109.48 2.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.32 2.68 . . . . 0.0 109.876 173.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -174.51 149.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.275 2.23 . . . . 0.0 109.098 -172.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.0 m -126.96 124.43 39.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.16 0.984 . . . . 0.0 109.927 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.1 mt -87.01 120.94 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.692 1.197 . . . . 0.0 109.144 174.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.81 -101.86 0.4 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.825 1.25 . . . . 0.0 110.492 176.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 68.0 mttm -119.63 132.17 55.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.082 1.353 . . . . 0.0 111.249 174.233 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.04 -144.83 16.21 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.922 1.725 . . . . 0.0 111.186 -167.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -159.6 151.02 19.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.469 1.107 . . . . 0.0 111.082 -177.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.7 tt -141.25 130.98 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.098 1.359 . . . . 0.0 111.477 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 82.7 p -144.45 178.64 7.8 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.771 1.628 . . . . 0.0 110.382 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.53 -164.83 22.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -154.66 145.22 22.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.564 1.546 . . . . 0.0 110.113 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.4 t -128.66 134.24 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.954 1.701 . . . . 0.0 108.574 174.53 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -118.74 141.86 48.22 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.278 1.031 . . . . 0.0 112.158 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 1.5 mtm -103.04 147.36 34.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.036 1.734 . . . . 0.0 111.317 178.643 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.66 -26.88 67.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.007 3.138 . . . . 0.0 115.008 175.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.6 p -73.34 -3.6 28.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.983 1.713 . . . . 0.0 114.524 178.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.73 -4.36 75.63 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.508 1.528 . . . . 0.0 114.058 -179.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -69.04 152.58 45.04 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.732 1.213 . . . . 0.0 111.964 171.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 47.9 t -142.49 141.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.829 1.652 . . . . 0.0 109.673 -176.102 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -153.06 -179.7 7.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.077 1.751 . . . . 0.0 110.955 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -123.8 144.63 45.25 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.875 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.5 167.09 13.6 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.276 3.317 . . . . 0.0 111.513 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.3 m -110.86 127.13 55.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.482 1.513 . . . . 0.0 108.981 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -108.6 133.5 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 109.345 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 69.8 m -136.09 137.77 41.39 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.736 1.614 . . . . 0.0 109.494 177.366 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.6 129.47 34.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.287 0.635 . . . . 0.0 110.896 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -76.75 -8.11 56.67 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 71.49 13.01 6.51 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.895 2.478 . . . . 0.0 113.334 -179.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.62 9.88 10.92 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.074 2.15 . . . . 0.0 112.783 -176.763 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.63 12.7 59.17 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.043 1.306 . . . . 0.0 114.367 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.1 p -131.02 158.39 40.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.616 1.967 . . . . 0.0 109.991 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.9 m -111.99 151.7 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.939 0.896 . . . . 0.0 110.292 168.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 139.14 38.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 163.017 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.0 t -120.6 127.51 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.121 1.368 . . . . 0.0 108.466 173.921 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -130.49 153.35 48.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.504 1.521 . . . . 0.0 111.815 -166.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 43.5 t80 -159.67 137.0 9.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.748 1.219 . . . . 0.0 112.219 -174.428 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.13 119.85 69.25 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.532 1.133 . . . . 0.0 110.808 176.565 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.67 154.06 26.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.522 2.814 . . . . 0.0 111.608 -179.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 86.6 p -133.16 -9.78 2.96 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -168.88 145.52 3.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.479 1.512 . . . . 0.0 110.39 -168.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -76.41 167.63 21.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.286 1.034 . . . . 0.0 113.379 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 124.86 -178.25 16.58 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.537 1.541 . . . . 0.0 114.266 176.839 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.4 tp -82.17 127.17 32.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.008 1.323 . . . . 0.0 109.986 177.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.6 m80 -124.67 153.22 42.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.094 1.358 . . . . 0.0 111.655 -172.712 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.68 139.95 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.407 1.483 . . . . 0.0 109.882 178.363 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 20.3 ttm -118.51 133.37 55.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.353 1.861 . . . . 0.0 110.645 178.277 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -107.42 134.69 50.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.927 2.091 . . . . 0.0 109.753 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.1 mm -134.89 139.31 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.877 1.271 . . . . 0.0 110.996 176.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.8 135.07 20.55 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 113.518 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.9 t80 -99.62 123.12 43.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.061 1.744 . . . . 0.0 109.933 173.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 50.87 36.19 14.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.356 1.462 . . . . 0.0 112.829 -176.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.2 t30 79.3 0.05 2.29 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 128.305 2.642 . . . . 0.0 114.74 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -103.41 134.44 46.78 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.27 1.428 . . . . 0.0 111.007 175.594 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.7 m170 -54.14 136.95 41.61 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -76.33 154.46 84.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.989 166.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.57 -23.39 70.47 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.389 2.059 . . . . 0.0 113.28 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -81.07 3.85 74.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.39 0.995 . . . . 0.0 114.686 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.1 t -99.82 147.12 32.99 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.616 1.708 . . . . 0.0 111.8 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.14 170.12 71.17 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 CA-C-N 119.785 0.959 . . . . 0.0 111.498 -11.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.59 158.27 24.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.106 1.363 . . . . 0.0 110.846 169.809 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -148.03 139.94 24.0 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.589 1.156 . . . . 0.0 110.366 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -164.49 173.4 12.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 0.0 111.796 -173.38 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -114.67 135.78 53.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.985 0.914 . . . . 0.0 113.248 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 57.9 t -102.36 138.56 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.867 1.667 . . . . 0.0 108.973 174.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.5 t0 -160.99 166.5 28.17 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.915 1.286 . . . . 0.0 111.091 178.507 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.12 123.62 23.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.716 0.807 . . . . 0.0 111.267 174.048 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -70.98 -25.58 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.166 0.986 . . . . 0.0 113.361 -167.663 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -95.7 -2.79 47.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.198 1.399 . . . . 0.0 113.639 -177.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 4.3 t -69.81 150.36 46.94 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.184 -0.948 . . . . 0.0 113.501 -170.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -87.09 74.84 2.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.48 1.514 . . . . 0.0 113.278 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -169.96 166.87 9.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.007 2.123 . . . . 0.0 112.335 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -71.47 132.65 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.801 1.241 . . . . 0.0 109.605 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 81.9 p -138.69 164.12 30.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.939 1.296 . . . . 0.0 110.991 176.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.88 143.76 36.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.497 1.119 . . . . 0.0 111.274 171.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.7 p90 -169.36 164.6 10.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.773 1.629 . . . . 0.0 112.736 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.54 175.1 13.72 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.329 1.442 . . . . 0.0 112.695 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.94 -37.94 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.648 2.232 . . . . 0.0 112.374 -172.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.15 -36.95 93.54 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 119.534 1.061 . . . . 0.0 114.556 -171.106 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.59 -4.38 45.55 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.929 1.364 . . . . 0.0 113.648 176.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.3 m -104.9 -49.59 3.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.038 1.735 . . . . 0.0 110.506 176.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -142.49 131.86 23.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.5 1.92 . . . . 0.0 112.724 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -125.19 177.78 16.8 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.218 1.866 . . . . 0.0 112.431 171.117 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 46.3 t -142.05 134.6 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.654 1.182 . . . . 0.0 108.826 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.7 m -58.21 138.99 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 62.91 9.8 3.94 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.046 1.738 . . . . 0.0 114.635 176.915 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -120.89 141.3 32.32 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.79 129.37 15.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.578 2.185 . . . . 0.0 110.616 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.78 144.22 36.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.634 1.574 . . . . 0.0 110.185 174.229 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.0 p -135.6 147.33 48.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -166.774 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.69 178.06 10.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.632 1.573 . . . . 0.0 111.488 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.8 m -128.9 144.03 51.06 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.407 1.483 . . . . 0.0 110.768 -170.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 50.8 t -117.73 132.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.852 1.661 . . . . 0.0 108.158 169.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.48 129.57 38.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.932 0.893 . . . . 0.0 111.184 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -127.95 0.9 5.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.021 1.728 . . . . 0.0 113.349 -172.493 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.84 -41.78 62.06 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.042 1.737 . . . . 0.0 114.022 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.83 -3.89 34.44 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.27 1.428 . . . . 0.0 113.38 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.49 65.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.151 0.98 . . . . 0.0 113.611 -173.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.42 -88.62 1.11 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.744 1.164 . . . . 0.0 112.369 177.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.76 149.07 19.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.572 1.549 . . . . 0.0 110.954 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 163.54 -151.49 21.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.06 1.791 . . . . 0.0 111.519 -177.648 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -111.27 107.58 2.2 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.422 1.01 . . . . 0.0 111.402 172.378 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 55.6 tp -81.33 136.47 35.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.411 1.084 . . . . 0.0 109.864 172.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.2 m -136.67 156.18 48.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 0.0 111.768 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.0 tp -159.91 131.89 6.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 108.8 -168.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.23 34.59 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.786 0.834 . . . . 0.0 112.4 -179.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.39 137.43 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.016 1.326 . . . . 0.0 109.871 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -125.06 157.5 36.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.385 1.874 . . . . 0.0 109.807 171.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.71 -161.73 29.83 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.658 -178.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.4 -25.23 63.7 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.009 3.14 . . . . 0.0 112.68 177.646 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.4 t -140.45 159.95 41.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.041 1.336 . . . . 0.0 109.444 162.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.9 tptt -76.94 107.05 9.0 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.983 -1.073 . . . . 0.0 111.233 -178.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.81 147.01 53.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.024 0.93 . . . . 0.0 111.723 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.83 148.42 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.627 0.771 . . . . 0.0 110.674 168.881 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.0 mt -137.62 145.38 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.074 1.35 . . . . 0.0 110.181 -164.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -143.08 167.17 22.71 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.054 1.342 . . . . 0.0 111.016 166.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.8 156.03 28.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 0.0 112.594 -178.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 89.1 m -143.08 124.99 15.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.676 1.59 . . . . 0.0 109.922 -171.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 20.3 t0 -74.3 120.95 20.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.916 0.886 . . . . 0.0 109.839 170.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -83.48 -7.32 59.56 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.151 0.98 . . . . 0.0 113.455 -176.077 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 74.72 -17.51 0.48 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.07 2.948 . . . . 0.0 113.908 178.003 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -81.36 -3.88 54.05 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.853 1.661 . . . . 0.0 113.913 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 105.21 22.5 8.21 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.446 1.498 . . . . 0.0 114.07 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.9 p -138.94 154.63 48.34 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.613 172.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 93.9 m -115.04 131.56 56.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.858 1.663 . . . . 0.0 109.137 165.83 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -86.38 149.24 25.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.823 0.849 . . . . 0.0 110.304 168.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.5 t -127.01 142.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.426 1.89 . . . . 0.0 109.076 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 81.6 p -131.86 146.14 51.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.724 1.21 . . . . 0.0 111.442 167.334 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.44 157.05 42.96 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.077 -1.014 . . . . 0.0 113.118 175.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 43.4 tp -126.41 102.2 26.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.839 1.255 . . . . 0.0 110.492 -174.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.87 174.29 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.746 2.964 . . . . 0.0 110.61 170.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -148.44 -30.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.028 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.48 145.34 31.07 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.657 1.117 . . . . 0.0 110.776 167.764 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.56 164.81 31.67 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.273 2.649 . . . . 0.0 111.339 177.052 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.24 -124.48 3.93 Favored Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.909 1.242 . . . . 0.0 111.86 -175.784 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -147.76 144.78 28.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.359 1.464 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.18 143.22 51.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.445 1.898 . . . . 0.0 110.863 -172.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 60.4 m -96.1 123.7 39.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.717 1.207 . . . . 0.0 110.429 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.27 124.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.609 1.564 . . . . 0.0 108.464 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.98 131.87 54.65 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 109.908 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 42.6 t -133.58 127.85 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.465 1.106 . . . . 0.0 109.74 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.3 142.68 26.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.16 1.384 . . . . 0.0 111.397 -169.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.92 121.34 12.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.54 1.136 . . . . 0.0 110.025 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 59.59 56.08 3.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.584 1.554 . . . . 0.0 111.55 178.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.286 10.5 pt-20 54.19 23.59 4.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.796 2.438 . . . . 0.0 115.645 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -133.29 128.67 36.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.115 1.366 . . . . 0.0 110.432 177.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -65.01 148.04 52.38 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.448 -0.783 . . . . 0.0 112.022 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 15.2 m -70.21 152.43 95.68 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.879 168.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.22 128.01 24.94 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.683 2.255 . . . . 0.0 110.402 177.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.96 62.28 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.175 1.369 . . . . 0.0 115.045 -174.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.7 t -78.49 140.71 60.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.281 1.54 . . . . 0.0 111.5 175.411 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.71 137.39 49.97 Favored 'Cis proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.401 0.822 . . . . 0.0 111.963 -4.163 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -87.71 165.69 15.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.107 1.763 . . . . 0.0 110.66 175.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 88.7 m -123.84 119.22 29.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.885 0.874 . . . . 0.0 110.255 174.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.61 135.56 39.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.809 1.243 . . . . 0.0 110.921 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.6 tpt85 -80.2 141.41 35.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.818 0.847 . . . . 0.0 109.259 167.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.8 t -129.41 132.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.78 1.173 . . . . 0.0 110.926 176.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 27.6 p -111.49 159.55 17.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.251 1.42 . . . . 0.0 112.843 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.04 128.72 9.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.703 1.621 . . . . 0.0 112.57 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -102.09 -18.57 15.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.222 1.409 . . . . 0.0 113.42 176.645 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.331 1.852 . . . . 0.0 112.719 -173.609 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.69 150.59 45.8 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.277 1.031 . . . . 0.0 112.553 178.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -96.62 140.28 31.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.767 1.227 . . . . 0.0 111.628 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -87.15 147.28 42.2 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.413 1.085 . . . . 0.0 111.947 176.088 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.99 162.78 31.7 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.668 2.912 . . . . 0.0 111.716 176.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.53 166.14 17.47 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.779 1.232 . . . . 0.0 112.091 170.67 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -60.39 133.28 90.91 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.66 174.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.18 169.27 21.05 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.134 2.556 . . . . 0.0 111.357 173.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.76 12.69 1.98 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.689 1.196 . . . . 0.0 113.493 -176.276 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.0 p -51.46 126.61 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.949 1.3 . . . . 0.0 111.235 177.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 86.81 -14.09 57.28 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.084 1.326 . . . . 0.0 114.805 -173.252 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 36.4 t -101.7 -55.13 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.336 1.455 . . . . 0.0 109.75 175.129 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -94.48 -10.89 30.89 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 174.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -86.55 127.8 8.56 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.168 1.366 . . . . 0.0 111.651 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.6 mt -142.62 171.05 14.59 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.653 1.981 . . . . 0.0 110.722 -177.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 49.8 t0 -146.5 151.24 37.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.203 1.401 . . . . 0.0 111.412 174.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 31.3 m -148.43 13.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.853 2.061 . . . . 0.0 113.421 -168.022 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 1.7 t -87.3 -2.67 58.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.068 1.347 . . . . 0.0 114.236 -172.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 37.0 p -70.08 151.21 45.76 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -161.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.0 tp -91.29 135.41 33.82 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.533 1.933 . . . . 0.0 109.57 174.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -52.0 112.96 3.67 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.787 1.235 . . . . 0.0 112.313 -172.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.63 148.76 33.33 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.693 2.262 . . . . 0.0 110.811 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.48 122.49 32.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.182 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -148.45 147.13 28.8 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.904 1.282 . . . . 0.0 111.057 168.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.93 154.8 20.28 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.38 1.472 . . . . 0.0 110.503 -175.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 10.6 p -127.4 134.42 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.627 1.571 . . . . 0.0 109.615 172.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.0 mt -132.58 137.63 30.25 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.789 1.636 . . . . 0.0 109.334 -171.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.4 84.73 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.895 3.063 . . . . 0.0 110.883 177.343 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -134.16 151.16 51.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.509 1.923 . . . . 0.0 109.625 173.91 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 80.7 m -126.37 123.86 38.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 109.488 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.88 129.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.704 1.201 . . . . 0.0 109.904 178.573 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -105.69 -139.12 0.37 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.961 1.304 . . . . 0.0 110.643 175.797 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -75.94 -6.21 49.84 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -178.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.93 -149.18 10.58 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.922 1.725 . . . . 0.0 113.038 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.49 151.1 27.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.934 1.294 . . . . 0.0 111.033 -174.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.0 tt -127.35 135.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.59 1.556 . . . . 0.0 112.015 -175.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.3 p -147.92 162.66 38.85 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.814 1.645 . . . . 0.0 110.875 -176.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -147.19 -176.16 20.67 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 116.046 1.178 . . . . 0.0 116.046 -177.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -153.92 143.31 21.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.566 1.946 . . . . 0.0 109.119 173.327 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 24.9 t -117.61 133.2 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.727 1.611 . . . . 0.0 108.195 174.38 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -117.4 129.35 55.8 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.288 1.035 . . . . 0.0 110.813 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.9 mpp? -97.3 148.22 34.1 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.576 1.55 . . . . 0.0 111.506 -173.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 -21.01 29.91 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.462 2.774 . . . . 0.0 113.145 -179.161 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.2 p -79.22 1.02 26.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.379 1.471 . . . . 0.0 114.431 176.76 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.04 54.63 2.27 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.665 1.126 . . . . 0.0 113.296 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -156.61 166.33 33.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.961 1.704 . . . . 0.0 111.864 -177.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.8 m -141.63 158.13 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.798 1.239 . . . . 0.0 112.652 -173.326 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.88 173.46 16.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.474 2.31 . . . . 0.0 110.045 177.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -114.75 144.93 32.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 121.13 -0.981 . . . . 0.0 112.769 -179.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -86.56 174.8 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.837 3.691 . . . . 0.0 112.034 177.695 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 71.7 m -110.05 133.5 53.14 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.809 1.644 . . . . 0.0 108.806 171.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.83 140.75 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.989 1.316 . . . . 0.0 108.604 173.592 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 14.5 t -148.0 139.42 23.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.731 1.212 . . . . 0.0 111.005 177.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.01 138.38 32.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.651 1.18 . . . . 0.0 112.638 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -96.56 -9.54 29.23 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.064 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.76 -1.69 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.693 2.397 . . . . 0.0 115.02 173.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.79 3.33 55.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.602 1.961 . . . . 0.0 113.549 175.359 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 102.29 12.28 34.01 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.365 1.46 . . . . 0.0 114.399 -174.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 26.3 p -125.86 161.62 27.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.141 1.377 . . . . 0.0 111.824 174.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -121.79 144.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.734 1.214 . . . . 0.0 109.946 165.524 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 17.1 m -97.33 139.81 32.72 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.331 1.452 . . . . 0.0 109.037 170.788 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.1 t -127.23 136.84 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.69 1.596 . . . . 0.0 108.934 178.748 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -142.35 157.7 44.52 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.07 1.348 . . . . 0.0 112.684 -174.629 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -154.92 135.27 13.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.254 1.421 . . . . 0.0 111.88 172.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.16 120.58 72.5 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.9 1.28 . . . . 0.0 110.923 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.87 167.55 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.906 3.07 . . . . 0.0 112.281 -172.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 89.4 p -147.22 -26.32 0.39 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.877 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.92 150.09 45.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.175 1.79 . . . . 0.0 110.393 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.73 168.67 18.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.492 1.117 . . . . 0.0 113.135 178.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 121.44 -173.15 15.56 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 125.425 1.488 . . . . 0.0 114.071 178.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.8 tt -87.8 127.47 35.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.809 1.244 . . . . 0.0 109.747 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 65.3 m80 -127.66 164.16 22.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.943 1.697 . . . . 0.0 111.585 -172.29 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -146.35 154.15 41.33 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.777 0.799 . . . . 0.0 112.554 166.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.9 ttm -127.33 133.7 50.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.85 2.46 . . . . 0.0 109.763 -173.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -103.83 131.93 50.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.304 1.842 . . . . 0.0 109.354 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 27.8 mm -130.51 128.26 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.358 1.063 . . . . 0.0 109.783 175.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.52 137.39 37.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.926 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 48.2 t80 -103.9 124.07 48.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.836 2.054 . . . . 0.0 109.358 174.066 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.01 46.09 22.57 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.692 1.197 . . . . 0.0 112.344 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.301 0.2 OUTLIER 63.34 9.99 4.44 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.034 2.533 . . . . 0.0 116.56 -177.222 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.7 mtp -110.88 131.24 55.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.231 1.412 . . . . 0.0 110.931 173.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -55.91 134.11 51.86 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.433 -0.792 . . . . 0.0 112.813 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.8 pt -73.89 155.59 88.6 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.701 178.197 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -59.44 122.44 11.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.711 1.607 . . . . 0.0 108.395 163.288 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 113.78 -25.01 11.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.996 1.284 . . . . 0.0 113.021 -171.52 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.4 t -83.79 148.3 54.01 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 118.91 1.355 . . . . 0.0 111.341 174.794 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.06 155.85 97.27 Favored 'Cis proline' 0 C--N 1.351 0.698 0 CA-C-N 119.79 0.961 . . . . 0.0 111.674 -10.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.51 133.75 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 109.227 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -137.92 134.74 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 110.975 -170.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.5 178.85 7.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.309 1.043 . . . . 0.0 113.109 -171.062 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -116.8 143.53 45.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.517 1.127 . . . . 0.0 112.555 176.173 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 94.2 t -112.86 132.69 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.293 1.837 . . . . 0.0 109.416 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 29.3 t0 -159.46 152.0 21.39 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.235 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.07 134.86 39.94 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.18 -0.95 . . . . 0.0 112.622 -176.636 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.1 p -70.58 -19.95 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.4 0.68 . . . . 0.0 112.589 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -73.39 -20.61 60.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.889 1.276 . . . . 0.0 114.014 -178.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.0 m -73.92 148.61 42.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.384 1.073 . . . . 0.0 113.146 -173.731 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -92.46 -14.03 56.22 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.95 1.262 . . . . 0.0 114.703 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -65.03 160.78 20.16 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.553 1.176 . . . . 0.0 113.427 177.111 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.5 t -69.47 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.731 0.812 . . . . 0.0 109.363 177.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -161.22 161.53 30.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.301 1.441 . . . . 0.0 110.543 -175.661 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.73 147.83 32.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.511 1.124 . . . . 0.0 112.291 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.51 161.55 13.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.752 1.621 . . . . 0.0 112.941 -176.345 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.25 171.86 12.33 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.506 1.527 . . . . 0.0 113.09 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.29 -34.84 26.09 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.12 2.546 . . . . 0.0 112.616 -173.139 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.82 -21.99 73.5 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 119.036 0.835 . . . . 0.0 114.662 -177.431 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.89 -14.9 60.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.39 1.095 . . . . 0.0 113.168 172.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 16.9 m -117.15 -36.16 3.87 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.777 1.631 . . . . 0.0 111.926 -168.55 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -150.6 155.63 39.78 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.489 1.916 . . . . 0.0 111.963 -174.468 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -149.31 173.51 29.13 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 123.978 0.799 . . . . 0.0 113.176 171.351 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 54.6 t -135.32 132.01 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.654 1.182 . . . . 0.0 108.353 176.051 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -57.73 138.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.11 2.28 2.24 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.997 2.119 . . . . 0.0 114.62 176.651 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -117.64 141.28 28.7 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.026 1.73 . . . . 0.0 110.93 177.171 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.13 130.29 16.3 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.672 2.248 . . . . 0.0 111.099 -173.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.7 139.54 44.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.415 1.486 . . . . 0.0 110.06 173.34 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -131.02 152.61 50.15 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.1 175.12 12.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.541 1.536 . . . . 0.0 112.189 177.31 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 47.5 m -125.62 143.45 51.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.963 1.705 . . . . 0.0 110.625 -171.9 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.3 t -121.45 131.45 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.215 1.806 . . . . 0.0 108.362 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -89.13 132.31 34.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.391 1.077 . . . . 0.0 111.754 -178.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.6 p -130.74 1.31 4.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.754 . . . . 0.0 113.222 -176.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -52.0 -38.8 58.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.02 2.128 . . . . 0.0 115.445 -168.213 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -131.81 21.05 4.59 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.523 1.529 . . . . 0.0 111.926 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.95 69.43 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.729 1.212 . . . . 0.0 113.885 -174.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.51 149.88 6.37 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.685 1.136 . . . . 0.0 112.301 -169.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.67 163.96 27.28 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.08 0.952 . . . . 0.0 113.531 -177.766 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 161.85 -30.49 0.31 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.538 1.066 . . . . 0.0 114.705 175.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.73 101.15 0.35 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.579 1.562 . . . . 0.0 112.748 173.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.72 144.63 37.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.989 1.316 . . . . 0.0 110.457 175.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -147.44 158.34 43.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.974 1.31 . . . . 0.0 112.049 -173.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.7 tp -166.6 135.87 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.928 1.691 . . . . 0.0 109.495 -164.605 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.86 159.13 36.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.359 1.064 . . . . 0.0 111.923 175.312 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.35 128.67 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.662 1.185 . . . . 0.0 109.67 175.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -115.69 163.65 15.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.107 1.763 . . . . 0.0 110.039 171.771 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 178.91 -166.88 36.81 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.269 -0.894 . . . . 0.0 113.852 -179.309 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.75 -19.18 36.48 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.625 2.883 . . . . 0.0 112.268 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.0 t -142.88 158.16 43.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.831 1.653 . . . . 0.0 108.867 161.308 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 23.2 tptp -74.84 120.69 20.72 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.832 -1.167 . . . . 0.0 111.96 -175.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.2 147.33 34.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.002 0.921 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.01 147.68 23.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.057 0.943 . . . . 0.0 110.777 169.567 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 13.6 mt -137.08 145.98 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.882 1.273 . . . . 0.0 110.524 -161.466 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 78.5 p -143.79 161.98 37.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.1 1.36 . . . . 0.0 111.388 165.246 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.02 158.64 35.24 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.384 1.074 . . . . 0.0 112.738 -175.878 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.9 m -147.54 119.47 8.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.462 1.505 . . . . 0.0 110.097 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.69 129.7 35.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.658 1.183 . . . . 0.0 111.303 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -108.9 152.74 24.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.827 1.251 . . . . 0.0 112.127 -177.853 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -64.54 -26.31 68.36 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.855 1.262 . . . . 0.0 113.482 -174.21 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -83.13 8.08 14.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.241 1.416 . . . . 0.0 114.767 -178.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.53 27.73 8.94 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 168.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 23.4 p -139.88 135.14 32.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.324 1.05 . . . . 0.0 111.583 175.717 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 41.3 t -90.64 128.84 36.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 109.819 163.535 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -92.55 149.45 21.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.14 0.976 . . . . 0.0 110.212 169.77 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 61.9 t -132.43 144.09 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.761 1.624 . . . . 0.0 109.663 -178.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 19.7 t -138.19 142.38 40.02 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.601 1.561 . . . . 0.0 110.916 172.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.5 p90 -148.54 156.46 42.47 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.2 mt -121.31 107.25 37.25 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.828 1.651 . . . . 0.0 110.541 -179.314 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.35 164.27 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.7 2.933 . . . . 0.0 110.284 166.186 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.6 p -125.63 -21.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -170.854 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.9 pp -146.0 151.48 45.28 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.949 1.3 . . . . 0.0 110.31 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.48 153.28 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 112.534 -169.634 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.67 -165.51 28.38 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.8 1.19 . . . . 0.0 113.431 -177.59 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -93.13 124.87 37.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.159 1.384 . . . . 0.0 111.853 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -114.1 138.32 50.56 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.385 1.474 . . . . 0.0 110.627 178.272 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -102.64 114.7 29.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.483 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.51 125.46 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.196 1.398 . . . . 0.0 108.665 -179.275 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -104.63 132.26 51.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.578 1.551 . . . . 0.0 109.545 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.7 t -133.45 129.28 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.341 1.056 . . . . 0.0 109.565 172.391 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -154.54 144.45 21.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.98 1.312 . . . . 0.0 111.689 -165.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.92 122.15 11.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.833 1.253 . . . . 0.0 109.618 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.3 t-20 54.92 56.62 6.44 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.352 1.461 . . . . 0.0 111.635 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 60.62 1.46 0.41 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 129.149 2.98 . . . . 0.0 116.701 -177.522 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -106.46 125.92 51.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.532 1.133 . . . . 0.0 111.015 178.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.21 145.16 56.44 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 169.1 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 6.8 m -75.37 157.69 84.44 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.774 173.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.76 125.22 17.94 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.616 2.878 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.42 77.09 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.716 1.15 . . . . 0.0 115.544 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 33.0 t -77.03 139.91 65.97 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.349 1.575 . . . . 0.0 111.728 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.84 141.8 71.86 Favored 'Cis proline' 0 CA--C 1.539 0.773 0 CA-C-N 119.5 0.857 . . . . 0.0 111.953 -4.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 154.08 17.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 110.95 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 62.2 m -112.73 114.44 27.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.636 0.774 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.5 133.76 42.42 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 111.407 174.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -94.62 105.84 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.678 1.191 . . . . 0.0 109.863 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.4 t -91.09 137.68 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.245 1.018 . . . . 0.0 110.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 68.6 p -115.81 158.95 22.14 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.434 1.494 . . . . 0.0 112.942 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.53 137.66 19.24 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.896 1.236 . . . . 0.0 111.531 174.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.5 t70 -83.16 -16.86 45.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.391 1.076 . . . . 0.0 113.373 -179.015 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.872 2.069 . . . . 0.0 112.439 -178.076 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -63.37 -16.14 59.59 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -172.551 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.5 mtp -69.72 -17.27 63.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.715 1.206 . . . . 0.0 113.511 174.523 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -118.76 153.5 52.41 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.557 1.543 . . . . 0.0 112.329 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.75 172.68 15.83 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.769 2.979 . . . . 0.0 111.477 173.146 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.64 156.17 37.48 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.652 0.781 . . . . 0.0 112.663 173.326 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -56.52 120.65 37.92 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.852 1.261 . . . . 0.0 111.484 -178.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.81 151.41 28.01 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.36 2.707 . . . . 0.0 111.433 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 11.2 mp -86.78 -6.89 58.69 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.441 1.096 . . . . 0.0 113.094 -179.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 59.6 t -112.39 136.88 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.666 1.987 . . . . 0.0 109.752 -177.124 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -82.71 170.34 49.94 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.853 1.216 . . . . 0.0 114.503 -177.104 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 91.5 t -85.24 138.74 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.185 1.394 . . . . 0.0 110.535 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -119.33 143.55 47.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.609 1.564 . . . . 0.0 111.766 176.452 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 162.38 -175.69 38.8 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.117 1.341 . . . . 0.0 113.992 179.097 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.6 mt -73.65 151.61 40.74 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.353 1.061 . . . . 0.0 111.661 175.58 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 43.1 t0 -88.65 161.28 16.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.63 1.172 . . . . 0.0 111.344 170.597 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 33.8 m -65.07 -19.0 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.5 t -70.15 -17.59 63.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.109 1.364 . . . . 0.0 112.926 174.137 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 49.3 m -78.96 9.02 4.67 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.613 1.165 . . . . 0.0 114.101 179.45 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 82.1 mt -72.52 135.81 45.73 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.035 -1.041 . . . . 0.0 110.598 166.736 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -68.88 121.58 81.98 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.239 1.415 . . . . 0.0 110.51 -175.339 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.66 151.98 69.73 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.297 2.665 . . . . 0.0 111.723 -171.075 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.7 t80 -98.48 124.63 43.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.588 0.755 . . . . 0.0 110.306 176.869 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -153.16 133.35 13.44 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 110.913 173.389 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.11 156.37 44.32 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.456 1.902 . . . . 0.0 109.873 -170.783 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -130.98 138.57 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.083 1.353 . . . . 0.0 110.53 -178.451 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.86 136.41 27.67 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.243 1.817 . . . . 0.0 109.094 -174.953 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.18 114.38 3.97 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.168 2.579 . . . . 0.0 110.053 172.528 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 42.2 t80 -178.2 152.56 0.71 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.182 2.193 . . . . 0.0 109.333 -170.215 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 36.8 m -133.49 129.57 37.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.455 1.102 . . . . 0.0 110.218 178.719 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.0 mt -79.62 109.98 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.189 0.995 . . . . 0.0 109.056 171.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.73 -58.8 2.08 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -176.708 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -158.88 -12.32 0.07 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.482 2.031 . . . . 0.0 116.482 -167.1 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.02 -136.89 5.94 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.134 1.826 . . . . 0.0 112.226 176.089 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -154.31 145.64 22.98 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.147 1.379 . . . . 0.0 110.421 -176.053 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.8 tt -128.45 137.93 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.414 1.486 . . . . 0.0 111.438 -178.193 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.2 p -147.31 164.78 32.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.965 1.706 . . . . 0.0 110.587 -178.283 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -149.65 177.78 27.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 -177.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -150.62 137.3 18.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.993 1.717 . . . . 0.0 109.614 175.036 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.9 t -111.32 137.99 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.332 1.853 . . . . 0.0 108.506 174.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.88 133.67 54.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.969 1.308 . . . . 0.0 111.551 -173.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.02 149.61 38.79 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.837 1.655 . . . . 0.0 111.971 -173.946 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -54.66 -32.28 74.66 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.174 3.249 . . . . 0.0 114.668 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 38.1 m -71.42 -1.27 12.54 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.451 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.65 -1.53 83.84 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.545 1.545 . . . . 0.0 113.935 -176.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -74.83 161.61 29.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.596 1.558 . . . . 0.0 112.001 177.582 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.9 m -139.21 157.33 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.186 1.394 . . . . 0.0 111.831 176.438 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.6 170.42 21.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.41 1.884 . . . . 0.0 111.017 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -114.13 138.75 23.05 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.026 0.931 . . . . 0.0 111.391 178.591 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.62 175.55 2.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.497 3.465 . . . . 0.0 112.45 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.9 m -109.33 133.08 53.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.47 1.508 . . . . 0.0 109.373 173.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.93 134.47 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.051 1.34 . . . . 0.0 109.263 175.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -135.69 126.29 27.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.627 1.571 . . . . 0.0 109.999 179.243 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.69 129.52 34.55 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.744 0.818 . . . . 0.0 110.558 171.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.76 -5.0 59.09 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.997 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 65.37 22.46 11.99 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.331 1.853 . . . . 0.0 112.53 -175.878 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -134.77 15.44 3.62 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.383 1.873 . . . . 0.0 112.71 -171.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.37 11.11 72.72 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.768 1.175 . . . . 0.0 114.451 -179.058 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.1 p -130.86 154.06 48.45 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 110.958 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.1 m -113.76 138.21 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.313 1.045 . . . . 0.0 109.697 164.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.1 m -99.0 139.47 34.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.051 1.341 . . . . 0.0 108.531 170.093 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 36.2 t -126.08 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.288 1.435 . . . . 0.0 108.962 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -135.32 154.09 51.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.757 1.223 . . . . 0.0 112.823 -172.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 42.2 t80 -155.02 136.33 14.05 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.747 1.619 . . . . 0.0 112.054 177.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.55 117.39 67.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.799 1.239 . . . . 0.0 110.817 176.789 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.38 146.99 22.46 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.658 2.905 . . . . 0.0 112.704 -174.242 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 68.4 m -122.84 -2.75 8.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.68 1.192 . . . . 0.0 113.634 175.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 154.58 19.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.225 1.81 . . . . 0.0 111.166 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.62 172.02 12.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.519 1.128 . . . . 0.0 112.664 176.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.71 -175.92 16.8 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.047 1.308 . . . . 0.0 113.996 177.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -84.98 118.19 24.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.354 1.062 . . . . 0.0 110.186 -178.656 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 39.4 m80 -114.01 165.1 12.97 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.223 1.809 . . . . 0.0 111.779 -174.565 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.83 155.96 44.3 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.325 1.05 . . . . 0.0 111.551 173.134 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 29.2 ttm -142.28 124.16 15.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.583 1.553 . . . . 0.0 110.203 -171.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.93 126.34 46.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 109.841 176.253 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 41.0 mm -123.42 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.262 1.425 . . . . 0.0 110.285 176.395 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.32 139.77 23.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.422 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.8 t80 -106.18 124.95 50.38 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.337 2.255 . . . . 0.0 110.102 177.574 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 53.32 29.0 7.95 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.775 1.23 . . . . 0.0 112.461 -173.09 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 25.2 t30 77.41 4.87 3.13 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.573 2.749 . . . . 0.0 115.185 -178.224 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 59.8 ttm -103.32 134.04 47.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.346 1.458 . . . . 0.0 111.063 172.313 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.3 m170 -57.31 134.34 55.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.293 -0.879 . . . . 0.0 113.001 -178.549 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 42.0 pt -74.94 155.01 86.84 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.65 . . . . 0.0 111.568 176.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.12 125.86 19.33 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.374 2.049 . . . . 0.0 109.779 172.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.07 -16.7 56.99 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.618 1.104 . . . . 0.0 114.326 -173.243 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.5 t -81.76 146.65 56.82 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 119.043 1.422 . . . . 0.0 111.73 176.783 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.76 162.64 84.7 Favored 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 120.09 1.068 . . . . 0.0 112.302 -6.174 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.4 mt -95.64 155.3 16.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.038 1.335 . . . . 0.0 110.834 172.38 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -156.74 132.96 9.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.714 1.205 . . . . 0.0 109.977 -175.268 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.9 p90 -167.39 172.95 9.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.426 1.09 . . . . 0.0 112.526 -168.162 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 46.3 t80 -108.74 134.04 51.99 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.178 0.991 . . . . 0.0 113.035 176.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.3 t -96.31 133.38 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 109.494 172.938 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 45.5 t0 -143.97 173.89 11.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.811 2.045 . . . . 0.0 109.918 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -79.12 151.25 31.47 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.724 -1.235 . . . . 0.0 113.459 178.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 69.4 t -66.3 -47.64 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.229 1.411 . . . . 0.0 110.4 174.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -95.52 128.22 42.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 110.621 175.047 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 23.6 p -171.77 153.17 3.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.979 1.712 . . . . 0.0 112.192 -175.323 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -103.59 -19.33 12.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.114 1.34 . . . . 0.0 113.772 173.471 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -71.61 155.98 39.91 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.337 1.068 . . . . 0.0 113.379 177.782 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -68.39 137.58 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.095 0.958 . . . . 0.0 108.567 172.653 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.6 t -156.0 168.15 28.17 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.72 1.208 . . . . 0.0 110.972 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.22 147.36 30.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.823 1.249 . . . . 0.0 112.155 -177.603 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.7 p90 -167.21 164.41 15.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.052 1.741 . . . . 0.0 112.391 -175.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.39 173.72 13.44 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.201 1.381 . . . . 0.0 113.315 -179.203 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.37 -32.69 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.935 2.424 . . . . 0.0 113.194 -170.624 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.43 76.52 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 119.402 1.001 . . . . 0.0 114.333 -172.593 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.0 pp -78.09 -3.38 42.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.965 1.383 . . . . 0.0 113.374 174.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.2 m -107.01 -39.91 5.61 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.595 1.958 . . . . 0.0 111.891 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -149.94 150.51 31.96 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.501 1.92 . . . . 0.0 112.495 -169.817 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 177.07 28.92 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.015 0.817 . . . . 0.0 113.472 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 35.3 t -139.98 134.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.941 1.296 . . . . 0.0 107.901 174.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.2 m -56.31 134.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 122.901 0.48 . . . . 0.0 112.253 -177.821 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.9 m-80 69.48 -5.51 1.14 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.142 2.177 . . . . 0.0 114.616 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -97.87 138.45 21.0 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.865 1.266 . . . . 0.0 110.646 175.205 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.99 126.17 11.01 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.475 2.117 . . . . 0.0 110.289 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.58 144.11 36.72 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.463 1.505 . . . . 0.0 110.371 175.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 60.3 p -135.38 149.16 49.6 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -166.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.0 p90 -160.26 175.51 12.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.443 1.497 . . . . 0.0 111.682 177.234 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 30.5 m -129.68 139.48 51.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.04 1.336 . . . . 0.0 110.805 -169.024 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -110.44 133.94 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.024 1.73 . . . . 0.0 107.877 168.137 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.88 126.99 37.17 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.137 0.975 . . . . 0.0 111.02 178.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 78.6 p -127.09 3.13 6.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.065 1.746 . . . . 0.0 113.072 -172.777 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -52.99 -27.33 18.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.473 2.309 . . . . 0.0 116.382 -171.781 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.56 15.2 5.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.471 1.508 . . . . 0.0 112.191 176.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -79.23 -25.03 42.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.633 1.173 . . . . 0.0 113.494 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.09 -107.0 2.38 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.638 1.113 . . . . 0.0 112.101 178.649 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.94 152.99 23.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.234 1.813 . . . . 0.0 110.066 -174.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.55 8.26 0.11 Allowed Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 90.87 106.45 1.36 Allowed Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.463 1.506 . . . . 0.0 112.885 177.133 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 139.19 30.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.066 1.347 . . . . 0.0 109.762 170.396 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.0 m -130.77 159.35 37.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.569 1.548 . . . . 0.0 111.826 178.108 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.9 135.25 8.19 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.531 1.532 . . . . 0.0 109.409 -167.418 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 158.57 35.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.189 0.996 . . . . 0.0 112.194 178.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -138.24 136.04 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.758 1.223 . . . . 0.0 109.827 177.159 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -129.23 130.13 45.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.215 1.406 . . . . 0.0 110.21 176.075 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.84 -162.49 11.41 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.094 -176.259 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -62.33 -25.71 76.62 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.932 3.088 . . . . 0.0 112.388 174.324 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 21.1 t -137.2 153.8 50.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 109.112 161.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -74.07 119.54 18.42 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.876 -1.14 . . . . 0.0 110.837 177.006 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.33 151.7 44.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.002 0.921 . . . . 0.0 112.332 178.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.11 137.76 32.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 164.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.3 mt -132.99 138.9 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.479 1.112 . . . . 0.0 110.501 -169.307 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 74.1 m -132.03 157.53 43.89 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.848 1.659 . . . . 0.0 110.635 167.662 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -153.41 155.76 36.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.059 0.944 . . . . 0.0 112.766 177.617 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.6 m -143.54 119.22 10.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.33 1.452 . . . . 0.0 110.382 -170.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.11 134.47 38.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.633 1.173 . . . . 0.0 111.396 173.251 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -114.3 148.44 37.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.626 1.571 . . . . 0.0 111.913 -177.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.51 -12.81 61.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.838 0.855 . . . . 0.0 112.718 174.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.35 -5.77 44.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.791 1.637 . . . . 0.0 114.031 177.115 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 32.83 7.63 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.646 1.117 . . . . 0.0 113.723 -179.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.7 p -139.84 160.17 40.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.968 1.307 . . . . 0.0 111.363 176.797 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 46.5 t -114.66 127.22 55.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.246 1.419 . . . . 0.0 108.434 160.187 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.7 t -92.52 147.93 22.5 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.144 0.977 . . . . 0.0 110.759 174.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.6 t -124.83 142.11 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.883 1.673 . . . . 0.0 109.927 -178.176 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.4 m -131.06 140.43 50.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.523 1.529 . . . . 0.0 110.424 167.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 14.4 p90 -146.85 154.11 40.94 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 174.718 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.17 106.74 42.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.085 1.754 . . . . 0.0 110.514 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.31 176.41 7.36 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.926 3.084 . . . . 0.0 110.523 167.413 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.7 p -149.83 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.572 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.77 147.29 35.5 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.422 1.089 . . . . 0.0 110.434 166.693 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.21 156.07 46.66 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.897 2.398 . . . . 0.0 110.925 175.069 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.62 -161.19 23.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.77 1.176 . . . . 0.0 113.647 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.24 131.96 36.43 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.154 1.382 . . . . 0.0 112.682 -178.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.57 122.41 38.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.602 1.561 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.6 m -84.23 127.22 33.82 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.192 -0.942 . . . . 0.0 110.832 175.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.38 124.88 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.953 1.701 . . . . 0.0 108.33 178.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -105.01 130.68 53.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.401 1.48 . . . . 0.0 109.699 174.926 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.4 t -131.7 128.36 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.409 1.084 . . . . 0.0 109.779 172.284 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.9 147.08 29.35 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.233 1.413 . . . . 0.0 111.615 -170.358 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.47 121.93 11.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.94 1.296 . . . . 0.0 109.461 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 54.08 56.79 6.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.425 1.49 . . . . 0.0 112.123 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 8.4 pt-20 59.38 4.13 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.965 2.906 . . . . 0.0 116.711 -176.478 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.67 126.12 53.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.659 1.184 . . . . 0.0 111.022 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -65.02 146.9 54.41 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.234 -0.916 . . . . 0.0 111.787 169.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.2 m -72.09 153.47 92.61 Favored Pre-proline 0 N--CA 1.482 1.152 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.378 170.75 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -57.99 130.42 38.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.116 2.544 . . . . 0.0 110.65 175.223 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 90.71 -15.75 59.74 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.95 1.262 . . . . 0.0 114.929 -175.516 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.0 t -77.87 139.95 62.34 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.457 1.628 . . . . 0.0 111.457 175.629 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.45 135.92 42.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.373 0.812 . . . . 0.0 111.977 -3.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.44 172.92 10.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.825 1.65 . . . . 0.0 110.186 172.808 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 84.9 m -137.21 121.61 18.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 174.092 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.25 147.46 23.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.985 1.714 . . . . 0.0 111.571 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.47 113.0 25.7 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.343 1.057 . . . . 0.0 109.759 173.831 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.0 t -95.37 142.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.976 1.31 . . . . 0.0 110.115 177.29 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.4 t -128.3 170.61 12.86 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.305 1.042 . . . . 0.0 113.167 178.732 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -82.45 137.83 17.47 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.788 1.661 . . . . 0.0 113.091 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.06 -22.57 21.77 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.067 1.347 . . . . 0.0 112.803 174.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.255 1.347 0 C-N-CA 127.002 2.121 . . . . 0.0 112.425 -174.381 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.94 156.28 39.01 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.271 1.029 . . . . 0.0 112.813 178.843 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 54.1 ttm -73.71 -22.83 59.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.559 1.143 . . . . 0.0 113.161 179.316 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -149.03 154.64 39.79 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.998 1.719 . . . . 0.0 111.312 -178.444 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.34 160.1 47.79 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.577 2.851 . . . . 0.0 112.035 179.467 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.06 151.68 33.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.224 1.009 . . . . 0.0 112.39 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.27 148.52 97.89 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.437 1.095 . . . . 0.0 111.974 176.161 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.69 163.96 37.16 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.411 2.741 . . . . 0.0 110.903 170.569 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.39 37.94 0.35 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.347 1.459 . . . . 0.0 112.722 -173.806 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 12.0 p -168.78 143.11 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.69 2.396 . . . . 0.0 109.598 -174.744 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 72.64 20.11 79.45 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 123.597 0.617 . . . . 0.0 114.461 177.354 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 99.4 t -67.23 125.59 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.422 1.489 . . . . 0.0 110.437 -175.123 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.24 -18.93 58.79 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -174.892 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 86.98 -158.85 30.84 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.284 1.421 . . . . 0.0 112.901 -177.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.07 165.82 22.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.582 1.153 . . . . 0.0 112.061 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.33 -9.61 58.77 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.361 1.464 . . . . 0.0 114.845 -174.002 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.3 p -77.8 53.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.567 1.947 . . . . 0.0 112.408 -177.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.3 t -152.39 10.48 0.51 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.929 1.691 . . . . 0.0 113.353 -177.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 50.6 p -78.24 169.82 17.63 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.588 1.555 . . . . 0.0 114.407 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 74.9 mt -81.13 159.05 24.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.112 1.365 . . . . 0.0 111.036 165.399 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 8.7 tpp180 -55.03 118.85 18.97 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.251 1.42 . . . . 0.0 111.615 -174.316 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.19 126.64 13.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.443 2.095 . . . . 0.0 108.756 177.425 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 64.7 t80 -116.24 125.07 51.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.7 0.762 . . . . 0.0 111.833 -171.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.62 142.34 16.56 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.017 1.727 . . . . 0.0 110.524 174.124 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.39 148.36 47.78 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.867 1.667 . . . . 0.0 110.418 -173.209 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.1 p -112.54 137.59 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.105 1.362 . . . . 0.0 109.923 173.034 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.0 mt -134.68 135.58 23.77 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.93 1.692 . . . . 0.0 108.798 -173.348 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.77 113.84 3.88 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.273 2.649 . . . . 0.0 109.979 175.964 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.4 t80 -172.72 146.07 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.485 1.914 . . . . 0.0 109.689 -172.766 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.7 m -118.71 122.31 42.19 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.496 1.119 . . . . 0.0 109.269 176.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.77 116.42 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.73 0.812 . . . . 0.0 109.372 175.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.3 mttt -96.56 -143.23 0.28 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.37 1.468 . . . . 0.0 111.607 178.174 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -78.07 -9.79 59.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.82 -142.56 5.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.335 1.921 . . . . 0.0 113.086 177.178 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.94 150.05 25.47 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.015 1.326 . . . . 0.0 111.229 -172.484 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.14 136.88 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.791 1.636 . . . . 0.0 111.389 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.7 p -146.07 -178.08 5.94 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.207 1.803 . . . . 0.0 110.138 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.0 -165.07 31.81 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -179.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -147.87 149.29 31.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.773 2.029 . . . . 0.0 109.934 -179.881 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 62.0 t -122.23 132.25 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.689 1.595 . . . . 0.0 107.92 167.659 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -115.38 130.97 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.808 1.243 . . . . 0.0 111.133 -174.505 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -102.84 149.9 37.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.717 1.607 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.65 -32.95 85.65 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.349 3.366 . . . . 0.0 115.315 176.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.0 t -77.59 -1.68 31.99 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.2 -1.06 72.89 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.386 1.469 . . . . 0.0 114.079 -177.684 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -66.03 155.95 35.16 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 111.763 171.152 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.7 m -139.7 152.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.019 1.328 . . . . 0.0 111.334 175.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.97 175.02 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.556 1.942 . . . . 0.0 110.222 179.684 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -120.03 141.02 30.74 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 121.482 -0.761 . . . . 0.0 111.358 178.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.94 165.65 13.33 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.957 3.105 . . . . 0.0 111.341 177.236 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.7 m -104.82 125.5 50.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.009 1.324 . . . . 0.0 108.679 172.098 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.0 135.12 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 109.236 175.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 83.9 m -128.25 132.1 48.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.049 1.74 . . . . 0.0 109.935 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 18.0 t0 -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.241 1.016 . . . . 0.0 111.019 171.596 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.9 -14.74 43.93 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.088 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 62.8 tttt 72.71 -2.88 2.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 127.668 2.387 . . . . 0.0 113.967 178.267 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -96.98 5.34 50.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.005 2.122 . . . . 0.0 113.29 -178.138 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.12 12.78 54.52 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.144 1.354 . . . . 0.0 113.962 -174.19 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.6 p -127.46 159.32 34.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.173 1.789 . . . . 0.0 110.477 173.764 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.79 146.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.59 1.156 . . . . 0.0 109.623 166.275 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 27.0 m -105.04 137.06 43.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.111 0.965 . . . . 0.0 108.736 170.597 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.5 t -119.56 133.83 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.148 1.379 . . . . 0.0 109.167 178.619 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.76 150.76 51.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.628 1.571 . . . . 0.0 111.841 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.6 t80 -155.62 132.59 10.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.429 1.491 . . . . 0.0 111.384 178.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.36 120.7 74.75 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.246 1.019 . . . . 0.0 110.498 176.821 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.9 139.36 27.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.301 2.667 . . . . 0.0 112.138 -172.04 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -138.82 10.58 2.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.338 1.055 . . . . 0.0 113.815 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -161.83 154.26 19.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.226 1.81 . . . . 0.0 110.012 -178.269 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -101.27 160.18 14.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.612 1.165 . . . . 0.0 112.257 174.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.24 -163.39 12.25 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.555 1.55 . . . . 0.0 113.991 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -92.86 113.46 25.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.052 1.341 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.2 m80 -105.59 173.72 6.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.233 2.213 . . . . 0.0 111.933 -174.441 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.3 146.83 35.48 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.644 0.778 . . . . 0.0 112.071 171.364 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.2 ttm -116.7 134.97 54.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.051 2.14 . . . . 0.0 109.457 -179.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -126.62 119.7 27.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.712 2.005 . . . . 0.0 109.136 -174.273 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -131.45 136.77 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.051 0.941 . . . . 0.0 111.393 -171.39 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 134.86 21.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.486 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 27.3 t80 -101.49 125.1 48.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 110.185 176.366 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.8 36.38 14.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.858 1.263 . . . . 0.0 112.641 -176.229 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 45.0 m-80 83.02 -8.54 1.14 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.358 3.063 . . . . 0.0 114.658 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 62.3 mtt -100.95 134.71 43.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.22 1.408 . . . . 0.0 111.999 -178.469 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -54.0 135.85 42.28 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.189 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -76.89 155.23 83.01 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.272 173.109 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.09 131.96 41.93 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.153 1.902 . . . . 0.0 109.945 172.146 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.13 -9.17 76.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.432 -174.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.1 t -84.03 144.29 44.24 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 120.042 1.921 . . . . 0.0 111.422 170.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -79.38 164.1 83.25 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.816 0.97 . . . . 0.0 112.244 -7.439 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.6 mt -113.3 156.95 22.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.965 1.706 . . . . 0.0 110.697 174.512 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.59 143.46 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.711 1.204 . . . . 0.0 110.404 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -159.12 150.17 20.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.952 0.901 . . . . 0.0 112.489 -170.315 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -100.55 143.74 30.37 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.294 -0.879 . . . . 0.0 112.599 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 38.4 t -126.16 137.5 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.355 1.462 . . . . 0.0 109.438 178.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -161.48 158.54 26.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.81 -167.697 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -75.48 146.35 40.69 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.855 -1.153 . . . . 0.0 113.357 -173.443 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 18.0 m -70.6 -18.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.988 -1.07 . . . . 0.0 112.796 171.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 31.9 p30 -90.83 4.75 50.89 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.353 1.461 . . . . 0.0 114.244 178.97 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.1 p -62.66 151.41 38.27 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -166.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.91 40.73 2.42 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.382 1.944 . . . . 0.0 113.166 -177.424 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -153.89 167.33 30.06 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.24 1.416 . . . . 0.0 113.081 -176.21 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.2 t -73.05 134.76 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.113 0.965 . . . . 0.0 108.801 171.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.4 t -148.93 165.64 30.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.825 1.25 . . . . 0.0 110.905 -175.183 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.2 147.44 27.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.727 1.211 . . . . 0.0 111.861 -177.487 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 48.1 p90 -168.63 163.46 12.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.754 1.622 . . . . 0.0 112.597 -173.367 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.04 174.33 13.27 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.278 1.418 . . . . 0.0 113.032 -178.42 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.51 -35.12 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.908 2.405 . . . . 0.0 112.799 -172.308 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.73 -31.04 72.77 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.368 0.986 . . . . 0.0 114.537 -171.152 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.52 -3.99 49.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.814 1.307 . . . . 0.0 113.351 174.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -104.85 -51.74 3.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 110.69 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -141.56 145.12 34.71 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.093 1.757 . . . . 0.0 112.553 -176.864 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -140.4 178.38 19.99 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 124.767 1.175 . . . . 0.0 113.217 172.632 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 15.3 t -139.66 135.97 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.043 . . . . 0.0 108.884 175.941 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -55.57 139.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.3 m-80 67.96 -1.17 1.81 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.943 2.097 . . . . 0.0 115.039 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -116.39 141.99 28.77 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.226 1.41 . . . . 0.0 111.166 177.32 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.0 134.05 20.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.52 2.147 . . . . 0.0 111.126 -174.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -112.82 147.18 37.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.707 1.603 . . . . 0.0 110.306 173.653 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.3 p -136.52 152.28 50.34 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.114 0.966 . . . . 0.0 113.604 -167.188 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.9 p90 -161.86 176.56 10.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.097 1.759 . . . . 0.0 111.485 176.623 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 32.2 m -130.79 140.82 50.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.03 1.332 . . . . 0.0 110.862 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -109.96 132.51 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.723 1.609 . . . . 0.0 107.92 168.705 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.93 123.33 38.34 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.131 0.973 . . . . 0.0 110.634 179.516 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.5 p -126.63 1.58 6.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.445 1.498 . . . . 0.0 113.735 -168.236 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -52.91 -38.12 61.49 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.919 1.687 . . . . 0.0 113.777 -177.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -99.86 -1.22 37.99 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.643 1.577 . . . . 0.0 113.472 -179.272 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.55 -22.57 50.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -171.417 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.44 -105.53 2.39 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.218 0.913 . . . . 0.0 111.624 -177.057 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -158.37 148.91 20.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.825 -175.691 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.59 31.64 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.469 1.509 . . . . 0.0 112.667 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.73 103.26 2.89 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 124.063 0.84 . . . . 0.0 111.614 176.416 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.65 129.6 34.76 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.996 1.318 . . . . 0.0 108.935 170.442 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 26.9 m -133.55 158.84 42.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.266 1.426 . . . . 0.0 112.399 -175.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.8 tp -161.08 136.19 7.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.97 1.708 . . . . 0.0 109.123 -168.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.49 36.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.065 0.946 . . . . 0.0 112.299 177.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 48.8 mt -138.3 137.36 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.989 1.316 . . . . 0.0 109.675 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -127.37 143.06 51.28 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.42 1.488 . . . . 0.0 109.907 174.188 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -173.13 -162.13 24.65 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.895 -175.28 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.38 -22.81 59.35 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.223 3.282 . . . . 0.0 113.161 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.4 t -144.36 164.45 30.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.008 1.323 . . . . 0.0 109.829 165.647 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -68.7 107.63 3.07 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.845 178.053 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.478 0.711 . . . . 0.0 110.414 169.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -102.7 133.84 47.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.479 0.711 . . . . 0.0 109.717 176.605 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -128.15 144.86 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.709 1.204 . . . . 0.0 110.477 -159.137 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -141.57 164.07 31.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.773 1.229 . . . . 0.0 111.093 166.144 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -160.13 156.85 27.43 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.951 1.3 . . . . 0.0 112.206 -178.59 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 62.1 m -145.49 125.07 13.21 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 109.935 -172.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.15 134.72 38.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.09 0.956 . . . . 0.0 111.489 170.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -108.54 154.62 21.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.298 1.439 . . . . 0.0 112.342 -174.066 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -67.72 -22.02 65.27 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.568 1.147 . . . . 0.0 112.441 175.858 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.6 -4.83 50.8 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.716 1.606 . . . . 0.0 114.734 -176.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.98 35.46 6.74 Favored Glycine 0 N--CA 1.476 1.303 0 C-N-CA 124.23 0.919 . . . . 0.0 113.77 -179.414 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 72.9 p -139.46 165.38 27.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.746 1.618 . . . . 0.0 110.539 176.027 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.7 m -116.01 130.4 56.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.904 1.282 . . . . 0.0 109.14 161.529 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.7 t -89.53 149.57 22.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.968 0.907 . . . . 0.0 110.52 170.956 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 96.1 t -129.66 143.35 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.883 1.673 . . . . 0.0 109.842 -178.894 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.2 p -136.39 147.81 47.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.013 1.325 . . . . 0.0 111.84 167.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -151.92 152.79 33.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 175.668 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.2 mt -113.54 110.09 50.32 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.257 1.823 . . . . 0.0 110.427 176.401 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -83.1 175.86 8.05 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.918 3.079 . . . . 0.0 110.257 164.162 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -150.04 -31.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -173.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.94 147.19 34.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 119.481 1.037 . . . . 0.0 110.728 167.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.25 159.67 43.48 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.992 2.462 . . . . 0.0 111.088 175.475 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 127.77 -168.17 19.85 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.173 1.368 . . . . 0.0 112.822 -174.515 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.65 142.89 27.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.387 1.075 . . . . 0.0 113.101 178.167 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -127.13 135.14 50.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.007 1.723 . . . . 0.0 110.26 178.148 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -91.41 126.84 36.63 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.087 -1.008 . . . . 0.0 110.543 174.35 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.18 128.34 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.74 1.616 . . . . 0.0 108.229 178.757 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -111.8 131.82 55.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.383 1.473 . . . . 0.0 109.856 177.128 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.8 t -133.44 127.31 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.663 1.185 . . . . 0.0 109.893 174.192 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.15 144.32 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.148 1.379 . . . . 0.0 111.889 -169.518 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.62 121.21 11.79 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.916 1.286 . . . . 0.0 110.011 -179.226 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 56.38 55.96 6.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.33 1.452 . . . . 0.0 111.814 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.7 pt-20 56.9 14.65 1.95 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.333 2.653 . . . . 0.0 116.234 -177.84 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -123.81 129.03 50.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.661 1.184 . . . . 0.0 110.746 177.414 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -66.68 151.01 48.23 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.326 -0.859 . . . . 0.0 112.111 173.235 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 25.9 m -65.85 150.5 96.35 Favored Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.271 162.425 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.0 -16.69 45.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.269 1.98 . . . . 0.0 114.654 -164.213 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.77 -7.45 61.44 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.137 0.875 . . . . 0.0 115.253 172.525 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -84.69 143.07 40.26 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 118.88 1.34 . . . . 0.0 112.104 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.27 139.85 63.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 CA-C-N 119.2 0.75 . . . . 0.0 111.961 -4.016 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -91.38 165.2 13.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.992 1.717 . . . . 0.0 110.401 174.186 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.5 m -125.35 117.09 22.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.791 0.836 . . . . 0.0 110.223 174.639 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.57 158.7 15.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.735 1.214 . . . . 0.0 110.774 168.195 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -123.98 132.03 53.65 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.775 0.83 . . . . 0.0 110.483 169.363 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.6 t -113.35 131.28 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.437 1.495 . . . . 0.0 110.45 -171.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 32.1 p -106.45 167.41 9.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.098 1.359 . . . . 0.0 112.688 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.69 143.2 25.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.103 1.335 . . . . 0.0 112.058 174.247 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.81 -14.17 58.3 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.156 0.982 . . . . 0.0 113.177 176.442 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 25.6 m-20 . . . . . 0 C--O 1.255 1.353 0 C-N-CA 126.846 2.059 . . . . 0.0 112.269 176.832 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.0 160.58 31.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.407 1.083 . . . . 0.0 113.025 178.566 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -68.14 154.14 42.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.192 1.397 . . . . 0.0 112.228 178.851 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -152.77 153.78 30.55 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.375 1.47 . . . . 0.0 111.855 -179.29 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.52 -4.91 13.89 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.94 3.093 . . . . 0.0 113.889 -179.715 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.66 150.08 29.85 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.264 1.426 . . . . 0.0 111.654 -177.115 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -96.73 138.17 21.4 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.836 1.254 . . . . 0.0 111.133 -179.119 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.89 161.12 47.19 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.148 2.565 . . . . 0.0 111.709 170.618 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 68.5 tp -149.57 118.2 6.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.124 1.37 . . . . 0.0 110.226 -177.624 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 59.2 t -145.06 126.64 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.672 1.589 . . . . 0.0 108.895 176.756 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 76.71 -62.3 3.2 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.439 1.495 . . . . 0.0 113.623 175.799 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 23.3 m -144.37 157.5 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.104 2.162 . . . . 0.0 110.57 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -70.58 154.02 42.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.874 0.87 . . . . 0.0 113.017 175.621 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -126.13 170.98 17.93 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.389 1.471 . . . . 0.0 113.442 177.142 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.44 -159.97 0.77 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.464 1.506 . . . . 0.0 111.616 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 2.5 t0 -153.87 -178.24 6.93 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.035 1.734 . . . . 0.0 111.097 -177.107 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 6.3 p -62.0 -11.89 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.559 1.944 . . . . 0.0 114.685 -173.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.4 t -67.96 -12.2 60.27 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.622 1.969 . . . . 0.0 114.576 -179.38 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 5.2 t -71.59 -166.58 0.2 Allowed 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -171.511 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 51.5 mt -67.75 147.96 51.91 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.977 1.311 . . . . 0.0 111.711 170.72 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -56.95 118.15 21.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.445 1.898 . . . . 0.0 111.007 175.063 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.35 146.2 55.9 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.611 2.207 . . . . 0.0 109.46 172.596 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -131.14 133.24 45.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.74 0.781 . . . . 0.0 111.68 -175.333 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.51 146.98 10.33 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.593 1.957 . . . . 0.0 110.875 178.313 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.56 154.04 50.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.18 1.792 . . . . 0.0 110.546 -175.648 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.6 p -114.58 138.45 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.215 1.406 . . . . 0.0 109.624 170.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 46.5 mt -131.45 135.31 26.78 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.166 1.787 . . . . 0.0 108.395 -172.809 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.89 36.48 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.453 3.435 . . . . 0.0 112.909 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.17 152.11 27.9 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.846 1.258 . . . . 0.0 111.456 177.478 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -116.49 121.28 41.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.229 1.412 . . . . 0.0 109.925 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 78.8 mt -87.91 134.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.871 1.268 . . . . 0.0 110.013 175.84 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -117.91 -141.89 0.36 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.496 1.519 . . . . 0.0 110.542 174.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.75 127.18 32.67 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.707 -1.245 . . . . 0.0 110.904 171.412 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.11 -147.99 19.53 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 125.402 1.477 . . . . 0.0 111.723 -171.188 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.44 146.27 18.22 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.67 1.188 . . . . 0.0 111.242 -175.85 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -121.48 135.89 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.714 1.606 . . . . 0.0 111.217 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 47.0 p -146.85 177.69 8.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.399 1.88 . . . . 0.0 110.28 -177.827 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -163.18 -167.31 23.42 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.778 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.97 144.24 22.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.521 1.929 . . . . 0.0 109.549 175.689 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 96.2 t -121.72 134.98 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.897 1.679 . . . . 0.0 108.572 173.597 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -112.98 135.1 54.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.596 1.158 . . . . 0.0 111.832 -175.269 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.7 mpp? -108.04 142.89 26.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.707 1.603 . . . . 0.0 111.748 -175.736 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.46 -27.25 58.0 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.48 3.454 . . . . 0.0 115.819 174.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.3 t -71.93 -4.09 26.35 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.071 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.38 48.93 3.6 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.755 1.169 . . . . 0.0 112.383 177.8 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -153.31 163.67 39.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.084 1.754 . . . . 0.0 111.711 -172.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.37 157.84 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.87 1.268 . . . . 0.0 112.384 -173.425 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.07 176.47 12.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.265 2.226 . . . . 0.0 109.888 178.005 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -119.15 143.35 33.91 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 121.216 -0.928 . . . . 0.0 112.186 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -82.73 166.26 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.118 3.212 . . . . 0.0 111.388 174.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.8 m -110.58 122.52 47.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.05 1.34 . . . . 0.0 108.911 173.794 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.54 133.41 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.733 1.213 . . . . 0.0 109.351 177.422 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 52.4 m -120.93 130.24 53.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.557 1.943 . . . . 0.0 109.512 176.813 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.2 t0 -79.75 117.21 20.43 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.108 0.963 . . . . 0.0 110.15 170.583 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.52 -12.56 58.78 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.601 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 69.07 3.19 3.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.211 2.204 . . . . 0.0 114.21 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.78 9.2 35.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.823 2.049 . . . . 0.0 113.025 -175.563 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.08 11.97 60.74 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.931 1.253 . . . . 0.0 113.816 -173.295 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 56.3 p -131.73 164.69 25.42 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.462 1.905 . . . . 0.0 110.541 177.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.3 m -128.38 146.38 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.152 1.381 . . . . 0.0 109.821 168.224 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 32.6 m -105.84 139.37 40.51 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.315 1.046 . . . . 0.0 108.926 173.159 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.7 t -123.44 130.96 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.864 1.266 . . . . 0.0 109.249 179.135 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -128.08 157.49 40.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.329 1.451 . . . . 0.0 112.042 -176.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.5 t80 -155.15 138.2 15.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.498 1.519 . . . . 0.0 111.521 179.777 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.33 119.74 70.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.415 1.086 . . . . 0.0 110.762 177.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.6 135.08 14.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.172 2.581 . . . . 0.0 111.777 -173.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 80.9 p -127.09 -12.28 5.81 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 176.371 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -141.52 158.8 43.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.1 166.79 11.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.639 1.175 . . . . 0.0 112.059 169.593 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.97 -168.0 12.6 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.727 1.632 . . . . 0.0 113.992 179.489 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.9 tp -86.83 122.27 30.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.04 1.336 . . . . 0.0 110.299 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.0 m80 -117.78 168.86 10.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.07 1.748 . . . . 0.0 111.292 -174.949 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.8 148.52 33.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.894 . . . . 0.0 111.856 173.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.9 ttm -121.88 123.33 41.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.832 2.053 . . . . 0.0 110.125 -175.433 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -97.45 135.9 38.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.988 1.715 . . . . 0.0 109.809 169.605 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.1 mm -134.99 134.3 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.906 1.282 . . . . 0.0 109.95 176.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.7 139.09 27.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.361 1.065 . . . . 0.0 113.491 -176.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.3 t80 -102.53 122.16 43.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.809 2.044 . . . . 0.0 109.914 175.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 52.4 30.5 8.28 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.896 1.278 . . . . 0.0 112.739 -173.688 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 19.1 t30 79.46 2.63 2.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.658 2.783 . . . . 0.0 115.169 -179.263 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -99.74 130.61 45.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.167 1.387 . . . . 0.0 110.86 171.189 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -55.5 138.31 46.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -177.534 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.24 152.26 90.25 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.379 171.358 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.16 134.08 53.8 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.471 2.114 . . . . 0.0 110.952 -178.678 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.68 -7.63 75.92 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.966 1.27 . . . . 0.0 115.161 -178.146 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.2 t -76.55 144.86 74.47 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.77 1.785 . . . . 0.0 111.362 173.767 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.24 162.76 86.05 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.558 1.235 . . . . 0.0 114.107 1.69 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 84.4 mt -102.68 157.03 17.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.979 1.711 . . . . 0.0 110.632 171.174 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.68 141.47 49.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.069 1.347 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.54 155.69 28.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.66 1.184 . . . . 0.0 112.285 -171.463 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -112.13 135.94 52.15 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.11 -0.993 . . . . 0.0 113.191 179.533 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -118.43 142.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.529 1.532 . . . . 0.0 109.215 -178.196 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.25 165.8 35.32 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.6 1.16 . . . . 0.0 111.611 -175.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -77.02 128.15 33.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.427 1.091 . . . . 0.0 110.574 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 75.3 t -67.64 -31.89 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.604 -0.685 . . . . 0.0 112.248 -171.361 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -80.5 -14.19 58.46 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -178.001 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.0 t -70.33 139.24 51.99 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.239 -0.913 . . . . 0.0 112.758 -172.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.7 88.06 1.2 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.114 1.34 . . . . 0.0 113.129 -171.93 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -168.91 169.66 9.59 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.807 2.043 . . . . 0.0 112.533 174.177 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.5 p -66.57 142.95 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.875 0.87 . . . . 0.0 110.966 170.375 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -166.73 150.44 7.02 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.392 1.477 . . . . 0.0 110.711 178.972 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -123.71 145.89 48.66 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.228 1.411 . . . . 0.0 112.171 -176.308 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.6 p90 -167.6 163.87 14.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.82 1.648 . . . . 0.0 113.444 -179.962 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.8 172.59 13.05 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.461 1.505 . . . . 0.0 112.704 -178.359 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.82 -33.81 12.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.832 2.355 . . . . 0.0 112.693 -171.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.08 93.54 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.688 -1.062 . . . . 0.0 114.323 -171.342 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.09 -6.72 51.01 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.896 1.348 . . . . 0.0 113.381 176.552 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.9 m -99.77 -42.3 6.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.309 1.843 . . . . 0.0 110.943 173.504 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -155.4 126.38 7.07 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.026 1.73 . . . . 0.0 112.34 -165.239 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -130.63 -178.91 15.69 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.55 2.024 . . . . 0.0 112.794 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.4 t -141.19 139.52 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.864 1.666 . . . . 0.0 108.201 177.394 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -56.47 134.76 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 68.22 -0.91 1.98 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.349 2.26 . . . . 0.0 114.541 178.306 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.09 139.14 19.82 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.28 1.432 . . . . 0.0 110.951 176.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.37 123.93 9.06 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.519 2.146 . . . . 0.0 110.395 -178.513 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 142.7 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.509 1.524 . . . . 0.0 110.28 174.613 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 57.0 p -134.11 149.34 51.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -166.562 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.94 177.19 10.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.629 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 73.5 m -132.11 145.28 51.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.221 1.408 . . . . 0.0 110.497 -171.513 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 122.59 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 0.0 107.876 167.099 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -84.29 126.87 33.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.342 0.657 . . . . 0.0 109.924 173.542 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 4.1 p -133.77 12.11 4.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.418 1.887 . . . . 0.0 112.626 -172.038 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 65.3 mttt -61.87 -35.48 78.44 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.442 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.56 11.36 12.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.258 1.823 . . . . 0.0 112.57 -176.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.1 -4.9 54.72 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.854 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 93.62 -127.84 9.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.736 1.16 . . . . 0.0 112.624 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -153.42 150.71 29.1 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.146 1.379 . . . . 0.0 110.901 -172.806 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 149.2 -158.55 27.7 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.763 1.649 . . . . 0.0 112.473 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.43 113.15 4.02 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.88 0.752 . . . . 0.0 111.315 174.097 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.39 125.18 32.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.887 1.275 . . . . 0.0 108.225 169.553 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 42.1 m -125.04 158.1 34.59 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.527 1.531 . . . . 0.0 112.397 -174.337 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -158.5 134.62 9.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.253 1.821 . . . . 0.0 108.979 -171.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.79 158.25 36.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.033 0.933 . . . . 0.0 112.145 177.899 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.68 134.55 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.561 1.144 . . . . 0.0 109.942 177.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -120.81 164.53 16.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.887 1.675 . . . . 0.0 109.94 168.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.01 29.7 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.251 -178.061 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.97 -22.82 62.27 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.894 3.062 . . . . 0.0 112.694 176.012 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.0 t -148.57 164.43 34.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.674 1.589 . . . . 0.0 109.517 164.663 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -73.17 113.63 10.45 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.926 -1.109 . . . . 0.0 111.081 177.55 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.01 149.51 48.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.796 0.838 . . . . 0.0 111.461 170.832 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.65 142.07 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.357 0.663 . . . . 0.0 109.648 168.751 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.2 mt -132.97 143.14 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.443 1.097 . . . . 0.0 110.456 -167.304 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.5 t -140.84 160.37 40.2 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.134 1.373 . . . . 0.0 110.62 167.376 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -158.5 156.47 30.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.594 1.158 . . . . 0.0 112.466 -177.217 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -140.24 123.7 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 110.385 -172.173 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.29 126.16 30.43 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.615 1.166 . . . . 0.0 110.417 168.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -100.61 151.33 21.74 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.078 1.351 . . . . 0.0 112.116 -178.45 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -67.47 -21.87 65.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.941 0.896 . . . . 0.0 112.703 179.008 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.33 -9.12 58.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.589 1.156 . . . . 0.0 113.557 172.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 98.28 10.5 51.14 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.176 1.369 . . . . 0.0 115.18 174.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.3 p -100.88 161.91 13.27 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.132 1.466 . . . . 0.0 111.565 174.882 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.4 m -111.64 123.98 51.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.046 1.338 . . . . 0.0 109.685 166.755 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -92.39 151.07 20.44 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.014 0.926 . . . . 0.0 110.773 170.259 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.5 t -132.57 141.71 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.788 1.635 . . . . 0.0 110.652 -176.112 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.6 m -132.52 142.94 49.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.876 1.67 . . . . 0.0 110.854 168.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.15 152.37 37.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 174.326 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.4 mt -119.27 102.88 47.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.48 167.09 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.677 2.918 . . . . 0.0 110.251 168.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.4 m -136.54 -24.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.314 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 76.2 mt -116.91 149.63 44.44 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.772 1.229 . . . . 0.0 110.703 171.272 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 154.54 49.91 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.006 2.471 . . . . 0.0 110.922 174.832 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 140.45 -152.72 23.1 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.271 1.415 . . . . 0.0 113.031 -177.236 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -113.1 131.11 55.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.005 1.322 . . . . 0.0 111.082 178.73 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -113.47 144.96 41.93 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.787 1.635 . . . . 0.0 110.951 179.734 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.4 m -105.77 116.15 31.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.971 1.309 . . . . 0.0 110.257 178.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.53 120.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.872 1.669 . . . . 0.0 108.374 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -103.53 133.57 48.34 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.362 1.465 . . . . 0.0 109.55 174.593 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.6 t -135.57 133.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.301 1.44 . . . . 0.0 108.058 172.28 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.67 144.39 20.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.741 1.216 . . . . 0.0 111.037 -168.888 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 123.6 14.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.513 1.125 . . . . 0.0 110.363 -178.574 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.7 53.01 10.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.923 1.289 . . . . 0.0 111.767 178.294 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.19 13.08 2.14 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.392 2.677 . . . . 0.0 116.283 -176.554 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -117.39 128.26 54.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 0.0 110.922 176.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.26 152.28 25.31 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.704 0.802 . . . . 0.0 112.417 170.214 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 17.3 m -79.26 156.94 76.05 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.064 176.577 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.49 119.2 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.656 2.237 . . . . 0.0 110.776 174.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.43 65.38 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.312 1.434 . . . . 0.0 116.472 178.486 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.7 p -79.59 153.89 76.08 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 120.329 2.064 . . . . 0.0 113.238 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.77 153.36 99.12 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 119.154 0.733 . . . . 0.0 112.397 -5.076 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -106.37 143.51 34.39 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.44 1.496 . . . . 0.0 111.197 -177.505 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 54.0 m -95.09 117.34 30.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -100.9 132.87 46.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.055 1.342 . . . . 0.0 111.212 173.256 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 141.16 51.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.959 0.903 . . . . 0.0 110.065 166.12 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.4 138.9 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.484 1.113 . . . . 0.0 109.672 163.19 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 16.5 p -134.83 174.12 10.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.183 . . . . 0.0 112.124 178.145 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -68.27 152.87 52.73 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.404 1.478 . . . . 0.0 113.139 178.934 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.64 -9.08 59.25 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.63 1.172 . . . . 0.0 113.363 178.022 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.827 2.051 . . . . 0.0 113.093 178.713 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.67 158.32 35.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.313 1.045 . . . . 0.0 112.74 177.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 96.3 mtp -136.37 150.91 49.04 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.546 1.538 . . . . 0.0 111.412 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -73.15 152.66 90.52 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.22 1.008 . . . . 0.0 112.154 175.222 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.2 173.4 14.57 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.736 2.957 . . . . 0.0 111.624 175.577 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -78.09 -3.62 43.24 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.356 1.063 . . . . 0.0 113.281 175.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -148.62 55.42 2.09 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.637 1.575 . . . . 0.0 113.607 -173.147 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.68 148.64 53.4 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.264 2.643 . . . . 0.0 111.288 -178.715 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 82.1 mt -93.44 2.04 56.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.457 1.103 . . . . 0.0 113.486 -178.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 47.7 t -133.83 139.95 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.789 2.035 . . . . 0.0 109.205 -177.288 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -85.12 -147.18 8.89 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.112 1.339 . . . . 0.0 113.418 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 24.6 m -134.82 149.3 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.69 1.596 . . . . 0.0 111.061 178.468 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 31.2 m120 -148.39 169.63 19.75 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.791 1.637 . . . . 0.0 111.976 -174.051 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 100.82 162.63 27.87 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.412 1.482 . . . . 0.0 113.769 177.118 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.6 mt -137.03 165.66 25.49 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.786 2.034 . . . . 0.0 110.702 -178.816 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 45.1 t0 -70.15 151.77 45.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.453 0.701 . . . . 0.0 111.93 173.706 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 33.6 m 48.48 19.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 128.303 2.641 . . . . 0.0 115.933 -178.109 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.3 t -72.91 -13.79 61.34 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.433 1.493 . . . . 0.0 114.872 -170.143 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 18.7 p -71.7 161.47 30.93 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -174.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 34.2 mt -65.85 158.05 28.88 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.375 1.07 . . . . 0.0 111.288 166.558 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.26 114.61 6.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.519 1.127 . . . . 0.0 110.828 179.557 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.02 131.98 21.97 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.153 2.569 . . . . 0.0 110.56 -175.46 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.2 t80 -99.36 117.1 33.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.536 0.735 . . . . 0.0 111.079 -176.883 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -151.35 136.81 17.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 111.226 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.96 159.71 41.29 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.294 2.238 . . . . 0.0 110.115 -170.039 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -131.09 138.71 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.894 1.278 . . . . 0.0 110.271 177.742 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 53.8 mt -132.42 135.48 26.37 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.04 1.736 . . . . 0.0 108.832 -172.995 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.6 64.96 8.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.208 3.272 . . . . 0.0 111.813 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.51 147.34 35.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.706 1.602 . . . . 0.0 111.048 175.581 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 92.0 m -115.58 123.21 47.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.183 1.393 . . . . 0.0 109.61 178.164 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 74.5 mt -81.25 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.505 1.122 . . . . 0.0 110.326 177.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.2 -141.71 0.37 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.7 1.6 . . . . 0.0 110.8 178.282 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -80.11 123.79 28.19 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.752 -1.217 . . . . 0.0 110.871 170.673 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.96 -149.24 19.84 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.309 1.433 . . . . 0.0 112.199 -171.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -159.15 148.6 18.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.907 1.283 . . . . 0.0 111.132 -174.917 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.6 tt -120.92 136.12 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.59 1.556 . . . . 0.0 111.585 -179.436 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.7 p -148.46 -174.03 4.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.661 1.984 . . . . 0.0 110.197 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -178.09 -164.58 31.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.545 0.978 . . . . 0.0 115.545 -179.658 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -152.87 144.15 23.21 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.768 1.627 . . . . 0.0 110.24 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 85.8 t -121.0 137.15 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.504 1.921 . . . . 0.0 108.481 173.26 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -119.57 137.91 53.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.464 1.106 . . . . 0.0 112.448 -176.331 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.4 mtm -108.86 149.49 39.62 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.409 1.884 . . . . 0.0 111.999 -176.098 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.61 -40.0 55.62 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.965 3.776 . . . . 0.0 116.598 -177.601 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.7 t -74.61 0.85 13.67 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.957 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 95.83 -1.19 63.25 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.802 1.668 . . . . 0.0 114.064 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -67.99 153.36 43.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.971 1.308 . . . . 0.0 111.597 173.016 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.3 m -137.5 157.32 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.018 1.327 . . . . 0.0 111.551 -179.753 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.39 169.93 23.6 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.972 1.709 . . . . 0.0 111.263 -178.077 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -108.29 138.6 20.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.134 0.973 . . . . 0.0 111.068 178.206 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.95 165.09 17.58 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.187 3.258 . . . . 0.0 111.332 172.408 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.5 m -109.23 125.27 52.08 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.868 1.267 . . . . 0.0 108.972 173.804 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.31 138.43 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.792 1.237 . . . . 0.0 109.428 177.33 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 65.6 m -131.55 131.96 43.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.986 1.714 . . . . 0.0 110.322 -178.694 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -77.79 121.74 24.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 172.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -85.01 -13.3 50.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.608 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 73.87 -5.64 1.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.989 2.516 . . . . 0.0 114.075 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -91.79 3.49 55.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.229 1.812 . . . . 0.0 113.712 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.97 17.5 57.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.442 1.02 . . . . 0.0 113.368 -171.561 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.6 p -129.46 161.52 30.21 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.725 2.01 . . . . 0.0 109.88 176.051 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -123.21 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.203 1.001 . . . . 0.0 110.109 168.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 18.2 m -96.43 142.81 28.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.377 1.071 . . . . 0.0 108.598 170.576 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 12.7 t -127.87 134.47 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 109.301 178.487 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -132.38 154.89 49.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 -173.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.7 t80 -156.72 136.49 12.48 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.956 1.703 . . . . 0.0 111.722 178.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.02 118.02 69.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 110.812 176.496 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.93 135.49 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.401 2.734 . . . . 0.0 112.076 -174.167 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 69.6 m -131.83 4.42 4.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.344 1.058 . . . . 0.0 113.78 -178.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -162.35 144.75 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 110.156 -174.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.75 162.01 13.94 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.547 1.139 . . . . 0.0 112.45 177.034 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.1 -167.93 12.45 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.88 1.705 . . . . 0.0 113.633 -178.755 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 27.8 tp -78.76 126.35 30.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.672 1.189 . . . . 0.0 110.619 179.003 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.55 165.78 17.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.987 1.715 . . . . 0.0 111.257 -175.57 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.21 153.85 39.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.116 0.967 . . . . 0.0 111.817 176.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.9 ttm -131.67 131.99 43.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.125 -176.152 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -105.64 135.01 47.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.996 1.719 . . . . 0.0 109.546 169.108 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.2 133.58 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.437 1.095 . . . . 0.0 110.109 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 137.74 25.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.556 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.1 t80 -100.63 121.88 42.37 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.692 1.997 . . . . 0.0 109.861 175.171 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.9 34.71 14.07 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.542 1.137 . . . . 0.0 112.69 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.67 4.53 2.52 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.779 2.431 . . . . 0.0 114.083 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.9 mtm -107.1 129.82 54.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.615 1.566 . . . . 0.0 111.011 176.272 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -57.51 137.2 56.54 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -175.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.1 pt -79.49 156.08 75.97 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.721 175.61 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.88 131.15 38.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.251 1.967 . . . . 0.0 109.732 168.71 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.24 67.38 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.536 1.065 . . . . 0.0 114.138 -172.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.5 t -84.61 146.6 47.21 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 119.561 1.68 . . . . 0.0 110.952 168.658 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.35 158.8 82.57 Favored 'Cis proline' 0 C--N 1.351 0.694 0 CA-C-N 120.055 1.055 . . . . 0.0 112.032 -8.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.0 mt -103.61 153.56 20.47 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.79 1.236 . . . . 0.0 110.9 172.876 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -143.44 139.89 30.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.931 1.292 . . . . 0.0 109.525 -178.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 4.6 p90 -167.16 167.55 14.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.293 1.037 . . . . 0.0 112.223 -169.758 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.8 t80 -107.72 140.63 40.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.905 0.882 . . . . 0.0 112.564 178.495 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.4 t -109.7 139.41 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.616 1.566 . . . . 0.0 108.583 172.414 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.7 t0 -156.12 161.06 40.41 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.944 0.878 . . . . 0.0 113.074 -174.398 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -79.92 103.87 10.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.572 1.549 . . . . 0.0 110.783 177.91 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 29.9 m -65.02 -16.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.456 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -84.36 -14.58 49.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.664 1.186 . . . . 0.0 114.172 -178.307 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.5 m -73.72 157.32 36.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.241 1.016 . . . . 0.0 112.749 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.85 -14.9 68.85 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.499 1.047 . . . . 0.0 115.154 -173.274 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -67.84 155.22 39.84 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 118.679 1.24 . . . . 0.0 113.213 176.75 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 t -72.32 132.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.844 0.858 . . . . 0.0 109.089 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 6.3 t -150.5 162.67 40.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.773 1.229 . . . . 0.0 110.945 -175.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.65 147.99 32.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.535 1.134 . . . . 0.0 112.24 -174.449 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -168.14 163.22 13.3 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.787 1.635 . . . . 0.0 112.979 -174.843 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.92 175.05 13.62 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.264 1.411 . . . . 0.0 113.046 -179.557 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.02 -35.54 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.734 2.29 . . . . 0.0 112.88 -172.414 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.23 -34.09 87.08 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 119.478 1.035 . . . . 0.0 114.533 -171.384 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.13 -5.24 53.68 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.661 1.23 . . . . 0.0 113.51 175.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 48.4 m -103.8 -49.39 3.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.372 1.869 . . . . 0.0 110.884 177.61 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -139.6 142.88 37.07 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.484 1.914 . . . . 0.0 112.07 -178.36 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.9 171.28 21.79 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.707 1.146 . . . . 0.0 112.963 172.243 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.9 t -136.65 132.7 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 25.3 m -59.98 144.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.044 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.4 m-20 68.74 -3.91 1.31 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.597 1.959 . . . . 0.0 114.313 178.737 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.49 142.36 28.04 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.819 1.648 . . . . 0.0 111.269 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.5 125.84 11.02 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.704 2.27 . . . . 0.0 110.572 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -106.29 136.27 46.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.444 1.497 . . . . 0.0 110.167 175.0 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.3 p -129.53 148.77 51.46 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.84 177.68 10.56 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.686 1.594 . . . . 0.0 111.72 176.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.6 m -130.5 142.7 50.48 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.208 1.403 . . . . 0.0 111.028 -169.936 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.7 t -114.34 133.9 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.928 1.691 . . . . 0.0 108.208 169.265 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.15 127.07 40.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.452 1.101 . . . . 0.0 111.03 -179.505 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 57.8 p -131.53 7.04 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.587 1.555 . . . . 0.0 113.312 -170.501 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -54.54 -35.86 63.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.043 1.737 . . . . 0.0 114.788 -169.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -121.99 15.98 10.83 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.774 1.63 . . . . 0.0 112.572 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.29 -15.42 60.97 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.08 -125.01 6.66 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.377 0.989 . . . . 0.0 111.41 -176.156 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.51 151.52 30.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.006 1.322 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.39 -129.41 1.77 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.072 1.796 . . . . 0.0 110.57 -175.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -125.09 109.14 1.17 Allowed Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.372 0.986 . . . . 0.0 111.797 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.12 132.27 39.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.522 1.129 . . . . 0.0 108.875 170.738 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.7 t -140.06 158.91 43.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 0.0 111.847 -169.766 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 50.0 tp -166.99 136.28 2.85 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 109.472 -161.867 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.75 160.46 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.155 0.982 . . . . 0.0 112.226 176.625 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.99 137.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.945 1.298 . . . . 0.0 109.512 174.362 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.8 159.14 28.71 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.837 1.655 . . . . 0.0 109.727 170.726 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.44 -163.22 34.54 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.147 -0.971 . . . . 0.0 114.014 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.24 -11.7 23.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.638 2.892 . . . . 0.0 112.9 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 10.6 t -152.72 160.64 43.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.804 1.642 . . . . 0.0 109.938 169.595 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1907 ' ' LYS . . . . . 0.401 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 0.9 OUTLIER -76.75 109.07 10.23 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.958 -1.089 . . . . 0.0 111.616 -177.72 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.35 147.76 44.09 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.954 0.902 . . . . 0.0 111.51 169.153 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.035 0.934 . . . . 0.0 110.072 170.431 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.61 139.83 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.678 1.191 . . . . 0.0 110.668 -166.742 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -133.64 156.98 46.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.925 1.69 . . . . 0.0 110.828 169.042 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -152.72 155.56 37.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.29 1.036 . . . . 0.0 112.398 176.42 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.1 m -140.47 124.65 17.58 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.605 1.562 . . . . 0.0 110.353 -172.244 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.7 131.42 39.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 111.187 170.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -107.68 146.9 31.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.315 1.446 . . . . 0.0 111.822 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.0 tm0? -65.68 -21.68 66.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.471 1.108 . . . . 0.0 112.471 175.292 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -73.76 -5.32 40.04 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.705 1.602 . . . . 0.0 114.684 -179.973 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 33.25 6.65 Favored Glycine 0 N--CA 1.476 1.3 0 C-N-CA 124.474 1.035 . . . . 0.0 114.171 177.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.5 p -140.32 162.68 34.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.476 1.51 . . . . 0.0 110.902 176.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 98.3 m -111.81 130.47 55.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.828 1.251 . . . . 0.0 109.272 161.202 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -89.44 150.0 22.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.831 0.853 . . . . 0.0 110.471 169.258 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.7 t -130.25 144.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.134 1.774 . . . . 0.0 109.797 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.3 t -140.44 140.32 35.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.552 1.541 . . . . 0.0 110.78 172.113 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -146.77 154.16 41.06 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.2 mt -118.96 104.02 47.21 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.061 1.744 . . . . 0.0 110.629 -178.673 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.22 162.69 17.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.603 2.869 . . . . 0.0 110.336 166.326 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.0 p -127.59 -19.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.939 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.96 149.23 41.71 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.522 1.129 . . . . 0.0 110.614 174.567 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.28 153.03 40.16 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.887 2.391 . . . . 0.0 112.183 -169.524 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 151.1 -154.88 25.84 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.907 1.242 . . . . 0.0 112.598 -174.311 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -115.41 129.77 56.68 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.613 1.165 . . . . 0.0 110.682 178.351 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.45 134.52 55.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.889 1.675 . . . . 0.0 110.596 -176.805 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.1 m -93.2 125.96 38.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 110.85 178.916 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.58 129.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.4 1.48 . . . . 0.0 108.381 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.69 131.76 55.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.476 1.51 . . . . 0.0 109.65 176.633 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.9 t -133.89 130.87 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.108 174.59 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.6 tmmt? -153.69 144.75 22.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.212 1.405 . . . . 0.0 111.392 -165.321 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.16 119.98 11.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.762 1.225 . . . . 0.0 109.611 177.729 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 57.69 57.82 4.04 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 111.773 177.823 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.289 8.6 pt-20 58.16 15.16 3.12 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.179 2.592 . . . . 0.0 116.175 -179.236 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.54 131.56 52.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.679 1.192 . . . . 0.0 110.89 177.162 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -69.08 152.75 44.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.874 0.87 . . . . 0.0 112.456 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.1 m -67.9 152.36 96.44 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.707 163.386 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.23 -20.17 56.03 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.413 2.075 . . . . 0.0 114.846 -165.236 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.55 -7.11 62.01 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.124 0.869 . . . . 0.0 115.186 174.203 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 42.1 t -84.74 143.64 41.04 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 119.002 1.401 . . . . 0.0 112.193 -176.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.1 142.26 74.12 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 CA-C-N 119.158 0.735 . . . . 0.0 112.192 -3.856 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.07 170.48 9.5 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.318 1.847 . . . . 0.0 110.525 173.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 85.1 m -132.36 121.89 24.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.95 0.9 . . . . 0.0 110.63 173.02 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.65 138.01 36.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.561 1.545 . . . . 0.0 111.022 172.693 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 34.1 ttt85 -96.88 127.6 43.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.605 0.762 . . . . 0.0 110.032 173.545 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 96.1 t -114.86 130.22 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.863 1.265 . . . . 0.0 110.703 -171.02 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 39.5 p -110.08 163.44 13.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.123 1.369 . . . . 0.0 113.022 -179.197 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.16 141.21 22.97 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.445 1.498 . . . . 0.0 112.535 178.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -88.77 -10.94 46.44 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 176.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.255 1.371 0 C-N-CA 126.766 2.026 . . . . 0.0 112.639 -177.317 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.504 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.63 161.98 29.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.484 1.114 . . . . 0.0 112.992 178.192 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.11 164.14 30.9 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.177 1.791 . . . . 0.0 111.766 -179.584 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -81.88 137.05 47.11 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 123.887 0.875 . . . . 0.0 111.953 -179.828 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.72 173.19 14.92 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.778 2.986 . . . . 0.0 111.652 175.67 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -54.3 142.78 25.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.479 1.112 . . . . 0.0 113.134 -179.538 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -104.66 154.26 38.63 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.219 1.408 . . . . 0.0 112.709 -170.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.25 -167.25 0.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.997 3.131 . . . . 0.0 110.868 172.725 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 37.0 tp -71.49 76.13 0.78 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.088 1.355 . . . . 0.0 111.374 179.695 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 9.9 p -162.62 152.61 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.021 2.128 . . . . 0.0 109.998 -176.716 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -77.59 48.83 2.97 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.427 1.489 . . . . 0.0 114.044 -178.387 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 25.3 t 71.15 102.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 128.724 2.81 . . . . 0.0 110.447 -176.592 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 51.4 t30 -165.71 171.9 12.43 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.973 1.709 . . . . 0.0 110.704 -176.266 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -76.73 -177.15 44.24 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.346 0.974 . . . . 0.0 112.468 166.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 91.3 mt -70.84 155.61 40.58 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.731 0.812 . . . . 0.0 111.722 175.87 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 21.9 t0 -142.57 115.17 8.57 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.271 1.429 . . . . 0.0 109.798 175.506 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.0 p -175.35 152.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.309 1.844 . . . . 0.0 110.073 -166.085 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.9 t -154.59 -36.21 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.052 1.341 . . . . 0.0 112.595 177.655 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 74.1 p -157.16 162.67 39.36 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.46 1.104 . . . . 0.0 112.531 176.384 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 36.1 tp -129.38 148.37 51.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.945 1.698 . . . . 0.0 110.827 -166.14 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1789 ' ' ARG . . . . . 0.434 ' HB2' ' H ' ' A' 1861 ' ' ASP . 0.9 OUTLIER -41.66 108.57 0.6 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.239 1.816 . . . . 0.0 113.381 -168.666 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.56 100.03 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.635 2.224 . . . . 0.0 109.022 -178.964 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 37.4 t80 -89.42 130.89 35.7 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.752 0.787 . . . . 0.0 111.956 -174.753 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -158.04 160.62 37.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.24 1.816 . . . . 0.0 110.768 172.682 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.95 132.81 13.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.273 1.029 . . . . 0.0 110.572 -177.896 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 95.6 t -93.87 127.7 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.052 1.341 . . . . 0.0 109.023 169.51 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.93 135.37 26.96 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.171 1.788 . . . . 0.0 109.069 -173.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.66 110.69 2.95 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.543 2.829 . . . . 0.0 110.233 176.084 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 31.6 t80 -177.61 152.85 0.83 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.333 2.253 . . . . 0.0 109.291 -171.198 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 43.5 m -135.04 129.63 34.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.405 1.082 . . . . 0.0 110.052 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.1 mt -84.51 113.29 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 0.0 109.343 175.049 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -89.13 -66.96 0.87 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.738 0.815 . . . . 0.0 112.936 -179.536 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -157.03 -8.05 0.09 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.494 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.22 -138.4 4.39 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.751 1.644 . . . . 0.0 111.857 175.452 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -152.63 143.85 23.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.652 1.181 . . . . 0.0 110.665 -177.75 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.8 tt -126.25 134.91 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.649 1.58 . . . . 0.0 110.736 179.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 70.0 p -146.61 -179.66 6.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.894 1.678 . . . . 0.0 109.933 179.802 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.23 -166.21 33.16 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.549 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.93 137.77 18.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.512 1.525 . . . . 0.0 109.826 -179.734 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.2 t -107.54 133.96 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.892 1.677 . . . . 0.0 108.027 171.532 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -120.75 125.4 47.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.225 1.41 . . . . 0.0 110.468 -169.136 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.54 153.24 41.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.831 1.653 . . . . 0.0 111.373 -176.19 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.14 -23.48 29.0 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.177 2.585 . . . . 0.0 112.411 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.3 m -74.57 -1.16 20.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.681 1.592 . . . . 0.0 114.805 -178.416 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 85.87 49.49 4.28 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.518 1.056 . . . . 0.0 113.003 178.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.25 164.92 37.22 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.038 1.735 . . . . 0.0 111.743 -175.074 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.4 m -141.48 158.98 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.73 1.212 . . . . 0.0 112.97 -171.069 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.46 166.0 34.87 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.679 1.992 . . . . 0.0 111.219 178.451 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -100.31 137.65 20.04 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.781 0.833 . . . . 0.0 111.709 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.16 169.97 11.11 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.276 3.317 . . . . 0.0 111.646 170.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 72.3 m -113.48 129.74 56.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.292 1.437 . . . . 0.0 108.852 173.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.63 136.38 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.683 1.193 . . . . 0.0 109.36 176.545 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 61.7 m -139.18 132.81 30.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.142 1.377 . . . . 0.0 109.846 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.67 128.64 33.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.767 0.827 . . . . 0.0 110.824 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -82.91 -6.59 59.53 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.667 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.67 11.94 7.17 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.286 2.235 . . . . 0.0 113.882 -173.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.41 8.34 21.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.817 2.047 . . . . 0.0 112.872 -176.347 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.9 11.09 68.41 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.947 1.261 . . . . 0.0 113.711 -172.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 72.8 p -130.37 157.58 42.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.728 2.011 . . . . 0.0 110.362 178.477 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -109.72 153.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.086 0.954 . . . . 0.0 109.212 163.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.2 t -105.54 142.94 34.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.672 0.789 . . . . 0.0 109.449 162.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.6 t -119.56 132.44 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.401 1.48 . . . . 0.0 108.297 173.428 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -131.35 154.35 48.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.002 1.721 . . . . 0.0 111.497 -172.808 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.6 t80 -154.07 135.04 13.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.349 1.459 . . . . 0.0 111.814 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.79 115.82 65.29 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.684 1.194 . . . . 0.0 110.483 175.571 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.54 148.89 16.36 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.474 2.783 . . . . 0.0 112.258 -172.136 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 50.8 m -119.39 -21.6 7.39 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -167.08 156.65 10.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.95 1.7 . . . . 0.0 111.812 -175.151 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.78 169.6 17.38 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.83 1.252 . . . . 0.0 114.022 -174.888 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.74 -170.29 14.41 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.175 1.845 . . . . 0.0 114.036 177.927 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 32.6 tp -87.33 130.56 34.58 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.717 1.207 . . . . 0.0 110.612 177.382 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.5 m80 -128.71 167.61 16.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.034 1.734 . . . . 0.0 111.45 -173.164 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -144.67 159.01 43.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.977 0.911 . . . . 0.0 111.432 172.433 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 35.3 ttm -139.43 130.15 26.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.84 1.656 . . . . 0.0 110.023 -171.68 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.92 118.77 33.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.905 1.682 . . . . 0.0 109.197 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 38.4 mm -120.03 138.61 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.132 1.373 . . . . 0.0 110.637 -179.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 136.94 22.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.463 1.105 . . . . 0.0 113.625 -175.174 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.733 2.013 . . . . 0.0 110.014 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.36 36.2 15.81 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.834 1.254 . . . . 0.0 112.696 -177.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.6 t30 81.7 -1.0 1.59 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.706 2.802 . . . . 0.0 114.842 178.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 86.1 mtp -111.12 137.06 49.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.979 1.312 . . . . 0.0 111.697 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.6 m170 -57.97 136.85 57.15 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.042 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.19 155.85 86.01 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.588 175.434 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.71 129.08 29.23 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.094 1.863 . . . . 0.0 109.787 171.348 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.88 62.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.74 1.162 . . . . 0.0 113.981 -173.648 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.0 t -84.13 144.86 44.85 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 119.46 1.63 . . . . 0.0 111.31 173.349 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.19 164.17 80.76 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.24 1.121 . . . . 0.0 112.486 -5.795 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 81.0 mt -116.13 153.53 31.62 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.642 1.977 . . . . 0.0 110.788 -176.35 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.75 136.43 38.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.586 1.154 . . . . 0.0 110.66 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 30.1 p90 -155.95 151.37 26.9 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.064 0.945 . . . . 0.0 112.171 -169.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.8 t80 -102.79 149.44 24.48 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 0.0 112.049 175.4 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.2 t -125.95 135.87 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.604 1.562 . . . . 0.0 109.021 -178.566 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1861 ' ' ASP . . . . . 0.434 ' H ' ' HB2' ' A' 1789 ' ' ARG . 3.5 p30 -157.86 152.24 24.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.177 1.791 . . . . 0.0 111.878 -174.794 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.75 138.75 58.15 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.38 -173.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 71.8 t -69.01 -33.07 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 121.308 -0.87 . . . . 0.0 112.101 -169.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -95.95 14.2 24.36 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.078 1.351 . . . . 0.0 113.785 -175.534 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 18.2 p -65.37 162.55 17.42 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -175.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.46 -20.94 25.77 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.784 1.183 . . . . 0.0 114.164 174.561 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -74.04 161.25 30.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.628 1.214 . . . . 0.0 113.726 179.474 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 19.1 t -75.38 125.12 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.923 1.289 . . . . 0.0 109.107 179.266 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 21.0 p -108.46 172.02 7.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.681 1.192 . . . . 0.0 111.711 -175.484 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.36 133.71 15.36 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.251 1.02 . . . . 0.0 110.195 160.222 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.5 p90 -161.89 161.97 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.238 1.415 . . . . 0.0 112.556 -177.148 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 127.25 173.84 13.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.393 1.473 . . . . 0.0 112.424 -174.195 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.73 -36.33 6.51 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.997 2.465 . . . . 0.0 113.205 -169.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.66 -32.12 80.49 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 118.741 0.7 . . . . 0.0 114.724 -168.131 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.93 -2.92 39.23 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.702 1.251 . . . . 0.0 113.818 178.213 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 70.7 m -118.49 -36.97 3.39 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.497 1.919 . . . . 0.0 112.238 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -142.73 146.14 34.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.382 1.473 . . . . 0.0 112.703 177.105 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 -179.16 22.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.514 1.054 . . . . 0.0 113.283 171.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.1 t -142.27 136.72 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.811 1.244 . . . . 0.0 108.491 175.403 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -55.82 135.62 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 122.799 0.44 . . . . 0.0 112.112 179.662 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.1 m-80 69.02 -4.33 1.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 114.97 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.71 139.14 20.61 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.512 1.125 . . . . 0.0 111.089 174.712 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.96 124.33 9.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.514 2.143 . . . . 0.0 110.229 178.418 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.24 146.44 34.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.332 1.453 . . . . 0.0 110.546 175.542 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 49.9 p -135.8 154.38 51.23 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -166.205 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -164.54 175.02 10.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.313 1.845 . . . . 0.0 111.772 177.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 91.9 m -130.68 144.85 51.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.639 1.576 . . . . 0.0 111.0 -169.233 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 72.6 t -124.61 126.48 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.951 2.1 . . . . 0.0 107.891 176.585 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.5 132.94 34.8 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.972 1.26 . . . . 0.0 111.406 177.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -128.34 -0.56 5.68 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.098 1.759 . . . . 0.0 113.494 -173.322 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -52.88 -39.6 62.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.927 1.691 . . . . 0.0 115.078 -169.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -114.61 11.15 16.91 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.537 1.535 . . . . 0.0 112.94 -179.02 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -173.39 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 151.9 8.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.739 1.161 . . . . 0.0 112.103 -168.417 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.34 143.27 50.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.557 0.743 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 179.93 -152.38 10.84 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.278 1.894 . . . . 0.0 111.813 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -93.8 101.28 2.73 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 123.955 0.788 . . . . 0.0 111.407 174.277 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.89 127.26 32.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.545 1.138 . . . . 0.0 108.84 170.686 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.1 m -129.25 156.25 44.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.239 1.416 . . . . 0.0 112.229 -176.71 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.0 tp -158.91 133.41 7.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.073 1.749 . . . . 0.0 108.517 -171.353 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.69 156.34 34.77 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.777 0.831 . . . . 0.0 112.065 179.082 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.7 mt -138.81 130.69 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.606 1.162 . . . . 0.0 109.682 177.728 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -116.73 162.56 17.49 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.171 1.788 . . . . 0.0 109.817 172.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.2 -160.52 32.83 Favored Glycine 0 CA--C 1.538 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 114.705 -179.163 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.95 -24.56 60.36 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.049 3.166 . . . . 0.0 112.415 176.279 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.3 t -140.25 159.99 40.96 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.291 1.437 . . . . 0.0 109.455 164.423 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 19.7 tptp -77.22 114.05 15.62 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.979 -1.075 . . . . 0.0 110.816 179.63 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.69 150.77 46.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.657 0.783 . . . . 0.0 112.15 178.599 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.16 139.38 30.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.766 0.826 . . . . 0.0 109.338 168.237 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -134.77 144.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.485 1.114 . . . . 0.0 110.54 -165.717 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -142.46 165.6 26.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.983 1.313 . . . . 0.0 111.156 166.625 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -160.16 157.48 28.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.78 1.232 . . . . 0.0 112.606 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.9 m -139.9 123.67 17.42 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.553 1.541 . . . . 0.0 110.053 -173.212 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -78.27 133.48 37.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.802 1.241 . . . . 0.0 111.2 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -114.12 145.55 41.48 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 111.694 -179.645 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -69.86 -13.09 62.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.83 0.852 . . . . 0.0 112.695 174.14 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.96 -3.18 24.31 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.811 1.645 . . . . 0.0 113.816 174.015 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.09 31.91 9.39 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.675 1.131 . . . . 0.0 113.877 176.962 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 61.7 p -138.95 158.62 43.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.047 1.339 . . . . 0.0 111.409 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 88.0 m -105.35 132.59 51.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.607 1.163 . . . . 0.0 109.021 155.818 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.8 148.44 22.12 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.054 0.942 . . . . 0.0 110.002 166.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 98.3 t -127.06 144.37 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.871 1.668 . . . . 0.0 110.122 -176.154 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -136.16 147.76 47.85 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 111.868 166.5 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.23 154.99 36.86 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 177.405 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 23.4 mt -120.73 107.55 38.19 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.662 1.985 . . . . 0.0 110.318 179.76 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.06 175.86 8.09 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.809 3.006 . . . . 0.0 110.337 166.179 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.4 p -148.98 -29.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -173.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.2 mt -107.56 146.71 33.89 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.723 1.147 . . . . 0.0 110.503 166.096 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.48 156.2 45.39 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.838 2.359 . . . . 0.0 110.96 176.075 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.98 -163.61 24.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.976 1.274 . . . . 0.0 113.358 -177.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.51 130.07 41.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.873 1.269 . . . . 0.0 112.413 178.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -115.03 139.45 49.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.7 m -99.27 119.94 38.73 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.699 1.2 . . . . 0.0 110.335 178.036 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.75 126.94 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.382 1.473 . . . . 0.0 108.401 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -110.74 131.93 54.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.623 1.569 . . . . 0.0 109.838 177.339 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.0 t -133.51 128.15 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.352 1.061 . . . . 0.0 109.762 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.4 143.16 23.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.108 1.363 . . . . 0.0 111.662 -168.102 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.7 119.26 11.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.514 1.126 . . . . 0.0 110.224 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 57.84 58.92 3.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.614 1.565 . . . . 0.0 111.762 179.036 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.283 10.1 pt-20 54.52 21.97 3.65 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.891 2.476 . . . . 0.0 115.764 -178.833 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -132.8 127.69 35.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.037 1.335 . . . . 0.0 110.439 177.167 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -66.16 152.34 45.0 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.784 0.834 . . . . 0.0 112.518 175.09 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.8 m -65.87 150.75 96.11 Favored Pre-proline 0 N--CA 1.485 1.302 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.132 162.818 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.74 -18.04 52.86 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.41 2.073 . . . . 0.0 114.893 -163.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.3 -6.58 58.71 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 173.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -82.03 143.33 49.26 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.038 1.419 . . . . 0.0 112.045 -176.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 145.51 82.31 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 119.183 0.744 . . . . 0.0 112.561 -3.231 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.62 166.13 11.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.385 1.874 . . . . 0.0 110.924 176.246 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 46.5 m -124.47 119.29 28.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.858 0.863 . . . . 0.0 110.766 177.762 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -101.46 135.29 43.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.868 1.267 . . . . 0.0 110.848 171.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -97.37 119.53 36.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.22 0.608 . . . . 0.0 110.059 173.184 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 78.5 t -104.5 131.03 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.37 1.468 . . . . 0.0 110.282 -175.611 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.6 p -103.27 163.57 12.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.933 1.293 . . . . 0.0 112.838 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.3 142.49 21.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.12 1.343 . . . . 0.0 112.475 177.289 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.0 t70 -81.27 -21.6 39.26 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.871 1.268 . . . . 0.0 112.904 175.573 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.584 1.954 . . . . 0.0 112.598 -176.705 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.444 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.1 151.59 44.32 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.203 1.001 . . . . 0.0 112.683 178.865 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 24.3 mmt -107.1 138.43 43.3 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.358 1.463 . . . . 0.0 111.615 178.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -88.29 150.73 47.57 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.618 1.167 . . . . 0.0 112.142 177.233 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.06 -13.91 17.07 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.78 2.987 . . . . 0.0 113.392 176.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -143.21 141.44 31.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.84 1.656 . . . . 0.0 109.42 178.434 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -118.05 153.47 51.25 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.284 1.434 . . . . 0.0 111.932 -170.549 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.57 165.04 30.64 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.725 2.95 . . . . 0.0 112.338 178.694 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -70.63 27.84 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.2 2.2 . . . . 0.0 116.224 -170.406 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 96.3 t -54.63 120.56 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.036 1.334 . . . . 0.0 109.974 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 101.07 -13.21 58.9 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.419 1.485 . . . . 0.0 114.753 -173.98 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 47.3 t -87.68 138.09 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.22 1.51 . . . . 0.0 109.309 172.13 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 64.1 t30 -153.19 153.05 31.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.871 1.269 . . . . 0.0 111.797 -178.289 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -80.37 -179.93 53.0 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.109 1.338 . . . . 0.0 113.751 178.582 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 88.0 mt -78.92 168.63 19.42 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.847 1.259 . . . . 0.0 112.413 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 47.3 t0 -153.85 168.52 26.05 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.378 1.871 . . . . 0.0 110.958 -178.107 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.6 p -156.93 143.33 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.328 1.451 . . . . 0.0 111.716 -172.535 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.5 t -153.75 -10.97 0.15 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -173.296 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 15.4 m -75.76 26.27 0.11 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.598 1.559 . . . . 0.0 114.072 177.799 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 25.4 tp -104.93 128.97 53.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.367 2.267 . . . . 0.0 110.03 -173.04 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -61.55 120.48 56.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.902 0.881 . . . . 0.0 111.389 -169.703 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 156.27 57.74 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.33 2.686 . . . . 0.0 111.612 -173.766 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -96.38 125.39 40.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.554 0.742 . . . . 0.0 109.943 176.603 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.13 131.37 13.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.172 1.389 . . . . 0.0 110.663 173.25 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.41 34.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.539 1.936 . . . . 0.0 109.471 -173.276 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -123.59 136.4 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.835 1.254 . . . . 0.0 110.42 179.486 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.4 mt -135.72 138.8 29.03 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 125.879 1.672 . . . . 0.0 109.092 -174.543 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.61 43.88 1.43 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.728 3.619 . . . . 0.0 113.134 177.706 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 88.5 t80 -87.09 157.51 19.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.316 1.446 . . . . 0.0 110.897 171.244 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 85.2 m -124.62 127.71 47.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.405 1.482 . . . . 0.0 110.128 -177.181 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.9 mt -88.17 128.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.503 1.121 . . . . 0.0 110.171 174.682 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -111.37 -146.96 0.41 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.926 1.691 . . . . 0.0 110.757 176.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -78.5 127.78 32.63 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.818 -1.176 . . . . 0.0 110.898 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 135.81 -148.33 19.6 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.443 1.497 . . . . 0.0 112.103 -170.804 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.71 148.58 19.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.677 1.191 . . . . 0.0 111.428 -174.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 11.8 tt -121.44 138.32 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.718 1.607 . . . . 0.0 111.398 179.214 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 45.2 p -144.54 -174.74 4.4 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.381 1.872 . . . . 0.0 110.317 -176.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.39 -169.31 38.34 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -152.92 136.76 16.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.894 1.677 . . . . 0.0 109.8 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 26.9 t -108.62 134.8 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.756 1.622 . . . . 0.0 108.343 171.656 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -119.93 138.87 53.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.43 1.092 . . . . 0.0 111.594 -172.196 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -109.32 144.14 29.17 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.825 1.65 . . . . 0.0 111.173 -176.157 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.37 -30.11 61.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.125 3.216 . . . . 0.0 114.836 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.7 m -69.49 -2.27 10.81 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.192 1.397 . . . . 0.0 114.402 178.535 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.22 -1.62 77.27 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.889 1.709 . . . . 0.0 113.829 -177.016 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -79.2 160.67 26.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.652 1.581 . . . . 0.0 111.963 179.732 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 36.0 m -141.55 157.51 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.152 1.381 . . . . 0.0 111.82 178.217 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.65 166.93 32.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.244 1.817 . . . . 0.0 111.415 -179.572 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.52 140.09 20.8 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 -179.836 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.47 174.98 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.625 3.55 . . . . 0.0 112.094 175.267 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.4 m -116.59 141.6 47.98 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 109.052 170.855 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.3 135.64 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.714 1.206 . . . . 0.0 109.272 174.541 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 54.5 m -140.06 128.08 22.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.277 1.431 . . . . 0.0 109.72 -178.691 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.17 137.52 40.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.908 0.883 . . . . 0.0 112.288 172.448 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -89.91 -8.73 51.15 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 69.43 3.1 4.01 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.636 2.374 . . . . 0.0 114.15 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.97 7.51 46.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.896 2.078 . . . . 0.0 112.821 178.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.43 16.81 51.96 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.942 1.258 . . . . 0.0 113.703 -173.36 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 37.7 p -132.68 159.69 38.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 178.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 31.5 m -121.51 147.26 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.674 1.19 . . . . 0.0 110.226 167.099 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 97.3 m -105.33 135.03 47.45 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.827 1.251 . . . . 0.0 108.752 169.131 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 65.1 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.413 1.885 . . . . 0.0 108.467 177.974 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -138.53 159.06 43.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.001 1.32 . . . . 0.0 113.131 -172.838 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.8 t80 -159.35 137.17 10.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.86 1.664 . . . . 0.0 111.883 174.94 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.35 115.91 65.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.09 1.356 . . . . 0.0 110.736 177.311 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.81 156.81 13.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.78 2.987 . . . . 0.0 112.769 -172.011 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 49.9 m -124.88 -24.6 4.06 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.682 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -145.77 148.61 33.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.421 1.489 . . . . 0.0 110.915 -177.351 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.82 162.89 27.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.547 1.139 . . . . 0.0 113.197 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 133.56 -177.37 19.08 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 125.282 1.42 . . . . 0.0 114.15 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.2 tt -88.26 123.55 32.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 109.115 175.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.45 159.05 32.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.219 1.407 . . . . 0.0 111.673 -172.235 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.18 154.79 50.31 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 111.649 172.291 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -137.69 123.96 20.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.222 1.809 . . . . 0.0 109.81 -172.312 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -95.16 129.52 42.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.748 2.019 . . . . 0.0 109.429 174.118 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.8 mm -127.64 136.82 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.739 1.216 . . . . 0.0 109.87 174.362 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -179.832 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -96.6 121.09 38.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.492 1.917 . . . . 0.0 109.886 173.634 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.47 35.03 10.24 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.965 1.306 . . . . 0.0 112.858 -174.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 47.9 t30 78.55 1.93 2.6 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.334 2.654 . . . . 0.0 114.787 -179.66 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -102.38 133.56 47.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.525 1.53 . . . . 0.0 111.435 174.188 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m170 -52.92 137.2 33.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.615 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.58 156.79 70.54 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.375 0.67 . . . . 0.0 111.204 169.425 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.53 130.87 35.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.034 1.823 . . . . 0.0 109.29 166.067 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.58 -2.27 67.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.245 0.926 . . . . 0.0 113.937 -172.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.4 t -93.24 145.12 29.45 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 118.939 1.369 . . . . 0.0 111.527 170.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.76 165.31 85.43 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.86 0.986 . . . . 0.0 111.606 -10.494 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.12 154.54 20.03 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.367 1.867 . . . . 0.0 110.068 173.725 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -158.23 135.12 9.81 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.177 0.991 . . . . 0.0 111.07 -174.575 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.1 p90 -167.23 173.43 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.746 1.218 . . . . 0.0 112.815 -167.551 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.8 t80 -107.13 141.69 37.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.945 0.898 . . . . 0.0 113.149 173.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 91.0 t -110.11 131.79 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.807 2.043 . . . . 0.0 109.157 179.046 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -152.02 151.2 30.84 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.355 1.462 . . . . 0.0 112.792 -172.833 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -69.99 149.23 47.94 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.235 -0.916 . . . . 0.0 112.751 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.9 m -71.54 -14.66 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -171.058 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.28 -126.1 0.18 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.463 1.505 . . . . 0.0 111.334 178.704 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 75.9 m 75.1 160.7 0.23 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.232 2.613 . . . . 0.0 114.398 171.848 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -102.27 -17.32 20.45 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.051 1.31 . . . . 0.0 114.652 178.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -71.82 155.62 40.21 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.685 1.242 . . . . 0.0 113.833 -179.509 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.7 t -68.01 143.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.604 1.162 . . . . 0.0 108.842 172.663 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.02 167.22 29.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.507 1.123 . . . . 0.0 110.984 -175.486 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -152.46 148.17 27.11 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.529 1.532 . . . . 0.0 111.441 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -165.51 161.14 18.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 112.392 -173.43 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.17 169.96 12.55 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.105 1.336 . . . . 0.0 113.56 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.08 -30.59 38.34 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.227 2.618 . . . . 0.0 113.092 -170.407 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.3 -17.38 72.23 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.429 1.013 . . . . 0.0 114.586 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 63.8 mt -76.04 -15.76 60.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.749 169.299 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 5.7 m -115.64 -39.46 3.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.029 1.732 . . . . 0.0 112.043 -165.711 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -151.4 150.36 30.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.086 1.754 . . . . 0.0 112.392 -172.434 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.83 176.87 29.19 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.235 1.398 . . . . 0.0 112.712 172.781 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.2 t -140.04 136.29 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.559 1.144 . . . . 0.0 108.342 175.442 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -57.12 137.12 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.272 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 65.32 3.79 2.42 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.833 2.053 . . . . 0.0 114.658 176.879 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -118.03 138.49 25.52 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.895 1.678 . . . . 0.0 110.401 177.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.08 131.97 17.48 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.363 2.042 . . . . 0.0 111.407 -171.077 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.2 148.24 33.22 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.479 1.512 . . . . 0.0 110.355 172.282 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 33.2 p -137.57 149.87 47.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -165.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.28 172.89 16.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.593 1.557 . . . . 0.0 111.85 176.59 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.9 m -123.35 141.39 52.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.738 1.615 . . . . 0.0 110.482 -173.657 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 59.2 t -113.71 139.6 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.272 1.829 . . . . 0.0 107.897 168.215 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.48 133.17 45.31 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.228 1.011 . . . . 0.0 111.738 177.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 68.3 p -125.58 1.02 7.57 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.469 1.907 . . . . 0.0 113.039 -177.317 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -49.97 -28.63 7.12 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.76 2.424 . . . . 0.0 117.122 -169.86 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -139.21 20.38 2.6 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.1 1.36 . . . . 0.0 112.031 176.678 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.46 44.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 113.474 -174.845 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.36 146.11 4.29 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.007 1.289 . . . . 0.0 112.297 -171.179 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.13 147.16 38.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.832 0.853 . . . . 0.0 112.005 -179.378 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . -175.79 -42.43 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.002 1.287 . . . . 0.0 113.543 176.513 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 162.03 102.17 0.17 Allowed Glycine 0 N--CA 1.47 0.943 0 C-N-CA 125.065 1.316 . . . . 0.0 112.594 170.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 33.2 tp -81.65 136.88 35.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.305 1.042 . . . . 0.0 110.117 176.577 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -129.97 157.44 42.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.346 1.458 . . . . 0.0 111.553 177.555 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 55.6 tp -160.68 132.35 5.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.457 1.503 . . . . 0.0 108.977 -169.589 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.43 162.72 37.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.877 0.871 . . . . 0.0 112.132 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.6 mt -136.59 132.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.872 1.269 . . . . 0.0 109.074 172.54 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -115.02 157.71 23.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.704 1.602 . . . . 0.0 109.744 169.219 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.6 -165.15 35.24 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.192 -0.943 . . . . 0.0 113.748 -177.714 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.62 -15.12 27.41 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.633 2.889 . . . . 0.0 112.422 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -147.1 160.38 42.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.997 1.719 . . . . 0.0 109.255 163.488 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 52.1 tptt -83.24 113.02 20.39 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.868 -1.145 . . . . 0.0 111.857 -174.973 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.94 150.27 44.29 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.182 0.993 . . . . 0.0 111.857 173.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.52 145.65 26.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.888 0.875 . . . . 0.0 110.691 169.611 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 20.1 mt -137.4 140.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.813 1.245 . . . . 0.0 110.505 -163.631 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.9 m -133.3 157.27 45.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.772 1.629 . . . . 0.0 110.675 168.442 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 31.8 p -156.46 156.89 34.54 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.233 -0.917 . . . . 0.0 113.104 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -144.14 124.82 14.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.704 1.602 . . . . 0.0 110.078 -171.032 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.24 144.92 32.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.569 1.147 . . . . 0.0 112.535 173.951 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -121.74 152.0 39.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.586 1.554 . . . . 0.0 112.062 -176.16 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -68.23 -18.41 64.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.818 1.247 . . . . 0.0 112.788 176.43 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -76.55 -2.79 34.18 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.86 1.664 . . . . 0.0 114.247 -178.427 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 89.77 33.92 8.76 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.385 0.993 . . . . 0.0 113.399 -178.563 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.2 p -139.88 163.63 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.354 1.461 . . . . 0.0 111.215 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.0 m -121.08 132.89 55.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.717 1.607 . . . . 0.0 108.841 161.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -92.02 147.51 22.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.857 0.863 . . . . 0.0 110.261 170.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 91.0 t -128.95 142.97 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.561 1.544 . . . . 0.0 109.83 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 86.2 p -132.99 147.5 52.28 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.227 1.411 . . . . 0.0 111.589 167.758 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -151.22 157.8 43.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 24.6 mt -124.93 108.4 28.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.903 1.681 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.02 168.95 15.05 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.781 2.987 . . . . 0.0 110.25 166.116 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.3 p -131.64 -20.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.434 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.7 150.73 51.44 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.556 1.142 . . . . 0.0 110.575 173.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.65 154.39 39.47 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.929 2.419 . . . . 0.0 112.573 -168.839 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.34 -144.68 12.19 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.683 1.135 . . . . 0.0 112.964 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -123.31 133.37 54.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.49 177.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -123.55 134.08 53.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 0.0 110.769 -174.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 74.7 m -100.06 110.32 22.62 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.996 1.318 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.35 126.77 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.419 1.488 . . . . 0.0 108.546 176.156 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -105.33 130.98 53.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.626 . . . . 0.0 109.665 174.378 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -131.11 128.55 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.433 1.093 . . . . 0.0 109.7 172.072 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.37 141.37 21.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.174 1.39 . . . . 0.0 111.502 -168.505 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.49 121.32 17.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.935 1.294 . . . . 0.0 109.968 -178.768 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 52.65 59.07 4.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.541 1.536 . . . . 0.0 112.0 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 7.7 pt-20 60.86 0.78 0.39 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 129.035 2.934 . . . . 0.0 116.867 -177.198 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -107.52 123.63 48.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.111 179.293 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.18 144.78 54.99 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.35 -0.844 . . . . 0.0 111.703 169.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.5 m -73.44 151.08 89.56 Favored Pre-proline 0 N--CA 1.48 1.041 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.038 171.976 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.52 129.67 35.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.129 2.553 . . . . 0.0 110.762 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.13 -15.24 63.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.04 1.305 . . . . 0.0 115.027 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 34.5 t -77.09 139.36 65.19 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.223 1.511 . . . . 0.0 111.346 176.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.79 147.55 81.3 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.648 0.91 . . . . 0.0 112.585 -3.098 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.24 133.77 45.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.837 1.655 . . . . 0.0 110.59 -178.887 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 24.6 m -97.67 108.66 21.43 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.552 0.741 . . . . 0.0 110.847 -177.08 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.34 132.84 37.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.014 1.326 . . . . 0.0 111.886 176.328 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 22.0 tpt85 -88.15 113.29 23.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.482 178.771 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.0 t -103.49 129.56 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.048 0.939 . . . . 0.0 110.758 -176.422 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 69.6 p -110.11 162.47 14.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.019 1.327 . . . . 0.0 112.977 -179.683 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.57 135.44 13.6 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.938 1.256 . . . . 0.0 112.345 178.003 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 -85.84 -23.53 27.1 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.577 1.151 . . . . 0.0 112.937 175.684 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.789 1.635 . . . . 0.0 113.796 -179.535 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.01 -28.81 64.68 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.209 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 15.2 tpt -162.1 138.51 7.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.001 1.721 . . . . 0.0 110.998 178.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -167.69 149.53 5.2 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.873 2.069 . . . . 0.0 110.748 177.419 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.18 140.12 30.44 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.269 2.646 . . . . 0.0 110.893 176.347 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -166.96 148.13 5.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.78 1.632 . . . . 0.0 110.28 -177.17 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -63.29 154.78 77.21 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.914 0.886 . . . . 0.0 113.144 177.656 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.36 145.39 53.57 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.991 2.461 . . . . 0.0 110.655 168.617 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 90.5 mt -116.7 15.48 15.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.287 1.435 . . . . 0.0 112.548 -177.376 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 59.2 t -68.2 135.97 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.538 1.535 . . . . 0.0 110.811 -176.588 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -171.4 -169.25 34.09 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.068 1.318 . . . . 0.0 113.639 178.728 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 26.1 t 81.27 134.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 128.515 2.726 . . . . 0.0 111.115 177.941 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 50.0 t30 -156.14 145.46 20.73 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.399 1.48 . . . . 0.0 111.396 179.525 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -79.04 137.65 19.57 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.583 1.087 . . . . 0.0 112.588 -179.669 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.9 mt -142.22 167.05 23.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.712 2.005 . . . . 0.0 110.535 -179.565 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 46.3 t0 -154.4 159.52 41.15 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.204 1.402 . . . . 0.0 111.874 179.084 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 61.7 t -91.8 133.46 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.788 1.635 . . . . 0.0 109.597 179.365 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 9.0 t -172.88 -35.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.56 1.544 . . . . 0.0 113.069 -175.437 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 14.8 m -67.85 139.91 56.55 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -162.046 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.24 144.27 40.49 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.254 1.022 . . . . 0.0 109.549 157.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 47.4 ttm-85 -67.28 117.9 51.04 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.817 1.647 . . . . 0.0 110.215 -175.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.2 151.11 60.48 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.212 2.608 . . . . 0.0 111.572 -171.463 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.4 t80 -101.16 119.5 38.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.938 0.895 . . . . 0.0 109.689 176.339 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -147.81 131.13 16.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.136 1.374 . . . . 0.0 110.398 172.38 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.78 148.31 35.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 109.756 -171.054 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -119.94 139.56 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.043 1.337 . . . . 0.0 110.56 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.3 mt -133.92 137.49 28.57 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.164 1.786 . . . . 0.0 108.465 -176.107 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.36 46.7 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.332 3.354 . . . . 0.0 112.861 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.2 t80 -91.41 155.05 18.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.362 1.465 . . . . 0.0 111.072 174.81 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.3 m -125.25 126.35 45.02 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.882 1.273 . . . . 0.0 109.831 177.866 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.3 mt -95.69 115.23 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 109.077 177.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.79 -55.52 4.05 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.627 0.771 . . . . 0.0 112.992 179.656 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -161.82 -35.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.852 1.261 . . . . 0.0 114.002 -171.536 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -72.53 164.9 54.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.226 1.393 . . . . 0.0 113.801 179.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -86.42 142.71 28.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.871 1.269 . . . . 0.0 112.212 -174.515 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.86 134.39 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.58 1.552 . . . . 0.0 110.459 174.591 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.1 p -145.68 173.03 12.43 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.998 1.719 . . . . 0.0 110.738 -175.082 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.72 -176.62 25.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 -177.658 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -151.43 137.72 18.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.938 1.695 . . . . 0.0 109.057 171.026 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.3 t -111.69 133.29 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.054 1.742 . . . . 0.0 108.131 174.179 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -109.28 129.96 55.5 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.237 1.415 . . . . 0.0 110.626 -176.625 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -96.21 151.79 38.4 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.621 1.568 . . . . 0.0 111.411 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.99 -24.85 45.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.294 2.663 . . . . 0.0 113.213 -179.093 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 20.3 m -73.91 -1.09 18.21 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.84 70.41 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.736 1.636 . . . . 0.0 114.624 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -71.75 163.76 27.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.221 1.408 . . . . 0.0 112.301 176.263 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.74 153.39 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.219 1.408 . . . . 0.0 111.873 175.647 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.43 166.55 31.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.852 2.061 . . . . 0.0 110.41 179.096 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.06 141.57 23.01 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.188 -0.945 . . . . 0.0 112.444 -177.823 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.24 172.64 8.29 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.67 3.58 . . . . 0.0 111.658 173.332 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.9 m -109.34 125.58 52.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.322 1.449 . . . . 0.0 108.899 172.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.02 129.46 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.407 1.083 . . . . 0.0 108.42 173.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.5 m -118.77 128.33 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.149 1.78 . . . . 0.0 109.674 -178.43 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.42 119.92 22.43 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.246 1.018 . . . . 0.0 110.465 170.615 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -84.67 -14.43 48.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.3 mttt 71.5 -3.36 2.15 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.788 2.435 . . . . 0.0 114.514 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -92.8 5.57 50.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.297 1.839 . . . . 0.0 113.319 178.515 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.63 19.02 46.03 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.694 1.14 . . . . 0.0 113.53 -172.504 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -131.98 162.0 31.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 109.966 175.216 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.1 m -126.1 147.13 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.226 . . . . 0.0 109.978 168.413 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 52.1 m -108.75 135.22 50.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.376 1.071 . . . . 0.0 108.568 171.328 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -117.63 131.49 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.309 1.444 . . . . 0.0 108.797 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.08 151.27 51.86 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.012 1.325 . . . . 0.0 112.504 -173.261 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.05 136.08 17.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.38 1.472 . . . . 0.0 111.764 176.825 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.86 115.62 64.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.764 1.225 . . . . 0.0 110.827 177.792 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.03 140.43 25.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.826 3.018 . . . . 0.0 112.918 -172.117 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.2 p -116.78 -8.45 11.37 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.705 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.29 157.48 22.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.044 1.738 . . . . 0.0 111.579 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.78 172.62 12.02 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.458 1.103 . . . . 0.0 112.377 174.058 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.95 -172.17 15.57 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.527 1.537 . . . . 0.0 113.62 178.778 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.83 130.9 35.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.502 1.121 . . . . 0.0 110.233 -178.581 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.5 m80 -128.89 162.08 28.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.913 1.685 . . . . 0.0 111.612 -173.786 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -141.98 159.5 42.11 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.28 1.032 . . . . 0.0 111.696 172.943 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.1 ttm -139.44 134.52 32.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 110.607 -171.8 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -110.24 136.16 49.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 109.922 172.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.0 mm -133.1 132.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.146 1.378 . . . . 0.0 109.951 178.118 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 138.19 28.32 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.972 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.8 t80 -102.47 121.03 41.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.478 2.311 . . . . 0.0 109.586 176.32 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.07 38.4 20.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.832 1.253 . . . . 0.0 112.551 -174.844 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 78.89 -9.0 1.57 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 128.906 2.883 . . . . 0.0 115.174 -178.392 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 67.7 mtm -95.53 129.82 42.58 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.208 1.403 . . . . 0.0 111.187 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -59.12 138.33 57.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.208 -0.933 . . . . 0.0 113.438 -177.309 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 33.4 pt -71.81 153.05 93.26 Favored Pre-proline 0 N--CA 1.48 1.044 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.044 169.645 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.65 -18.37 58.65 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.407 2.071 . . . . 0.0 113.9 -174.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.83 0.52 87.9 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.771 1.177 . . . . 0.0 114.685 171.485 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -97.2 142.6 24.78 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.652 1.726 . . . . 0.0 111.539 176.533 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.53 165.7 74.06 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.842 0.979 . . . . 0.0 112.854 -1.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 86.2 mt -112.93 159.54 18.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.22 1.808 . . . . 0.0 110.665 170.282 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -155.49 139.6 16.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.638 1.175 . . . . 0.0 110.137 -173.381 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.33 -175.69 3.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.906 1.282 . . . . 0.0 112.382 -170.429 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.4 t80 -124.02 141.58 51.92 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.89 1.276 . . . . 0.0 112.679 178.23 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 54.7 t -110.9 142.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.099 1.76 . . . . 0.0 109.434 176.724 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.03 169.39 21.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.801 2.04 . . . . 0.0 109.954 -171.607 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -77.32 143.57 38.71 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.513 -1.367 . . . . 0.0 111.187 170.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.7 m -61.94 -26.87 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -175.152 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.75 134.18 48.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.307 1.443 . . . . 0.0 110.045 166.814 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 7.6 t -164.66 156.56 15.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.934 1.694 . . . . 0.0 110.724 178.274 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.6 58.23 4.99 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.172 1.367 . . . . 0.0 113.525 -173.857 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -155.5 167.79 29.23 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.3 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.0 p -71.49 147.26 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.382 1.073 . . . . 0.0 109.582 159.436 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.5 t -160.02 167.96 26.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.087 1.355 . . . . 0.0 110.487 178.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.68 145.48 25.86 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 -179.119 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.6 p90 -168.74 166.77 11.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.786 1.634 . . . . 0.0 112.578 -173.757 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.89 174.63 13.7 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.3 1.428 . . . . 0.0 112.542 -177.279 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.17 -36.1 13.06 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.257 . . . . 0.0 112.87 -170.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.41 87.65 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.45 1.023 . . . . 0.0 114.589 -170.738 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.13 -2.08 39.08 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.912 1.356 . . . . 0.0 113.498 175.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.3 m -108.17 -51.39 2.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.28 1.832 . . . . 0.0 110.926 177.529 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -138.4 144.71 40.34 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.537 1.935 . . . . 0.0 112.522 -176.731 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.22 178.27 20.4 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.985 1.278 . . . . 0.0 112.912 171.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -141.67 138.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.852 1.261 . . . . 0.0 108.259 174.501 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -59.96 149.17 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.062 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 77.6 m-20 67.2 14.76 9.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.425 1.89 . . . . 0.0 114.382 169.838 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -145.56 152.84 50.34 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.874 1.67 . . . . 0.0 111.236 174.211 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.74 145.66 32.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.497 2.131 . . . . 0.0 112.145 -174.616 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -121.46 150.83 40.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.409 1.884 . . . . 0.0 110.043 170.621 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.8 p -137.71 149.97 46.93 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -165.487 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.07 175.96 12.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.78 1.632 . . . . 0.0 111.457 175.341 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.6 m -129.71 140.42 51.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.944 1.298 . . . . 0.0 110.727 -172.045 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.2 t -105.2 133.27 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.443 1.497 . . . . 0.0 107.906 168.217 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.43 126.69 46.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.703 1.201 . . . . 0.0 110.446 174.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.1 p -126.51 5.4 6.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.849 2.06 . . . . 0.0 113.066 -171.604 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.74 -37.5 51.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.241 1.817 . . . . 0.0 115.104 -170.241 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -116.36 9.73 14.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.403 1.481 . . . . 0.0 113.014 178.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.62 -10.94 59.71 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -171.097 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 86.37 -125.68 7.5 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.453 1.025 . . . . 0.0 112.446 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.02 149.5 28.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.387 1.475 . . . . 0.0 110.878 -173.901 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.84 -155.78 26.74 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.585 1.564 . . . . 0.0 112.736 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.1 108.14 3.38 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.127 0.87 . . . . 0.0 111.504 174.416 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.74 128.17 34.33 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 108.722 171.84 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.6 m -133.74 160.24 38.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.032 1.333 . . . . 0.0 112.854 -173.299 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 37.3 tp -158.46 138.53 12.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.491 1.916 . . . . 0.0 108.951 -171.569 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.15 157.19 35.54 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.071 0.948 . . . . 0.0 111.944 174.85 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.7 mt -138.35 140.29 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.875 1.27 . . . . 0.0 109.741 177.05 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.22 144.04 51.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.652 1.581 . . . . 0.0 109.877 173.723 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.34 -166.0 26.67 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.958 -175.242 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.58 -26.33 69.5 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.477 3.451 . . . . 0.0 112.843 178.436 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -141.72 156.26 45.61 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.986 1.314 . . . . 0.0 109.093 161.039 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -72.31 110.72 6.93 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.193 -0.942 . . . . 0.0 111.258 -177.739 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.88 148.38 51.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.0 111.372 172.229 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.33 146.34 27.77 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.818 0.447 . . . . 0.0 110.159 165.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.24 143.97 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.029 1.332 . . . . 0.0 109.856 -165.182 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.58 163.24 35.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.693 1.197 . . . . 0.0 111.418 168.946 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -161.34 152.43 18.5 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.991 1.317 . . . . 0.0 112.305 -178.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 95.1 m -137.96 121.92 17.79 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.637 1.575 . . . . 0.0 109.692 -175.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.55 119.3 15.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.452 0.701 . . . . 0.0 109.966 165.872 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.66 -16.79 50.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 112.656 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 10.3 tt0 72.71 -8.8 1.18 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 128.08 2.552 . . . . 0.0 113.072 -176.286 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.36 11.61 8.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.972 2.109 . . . . 0.0 113.494 -177.368 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.84 15.34 54.73 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.187 1.375 . . . . 0.0 113.605 -171.869 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 65.9 p -141.66 154.17 45.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.651 1.58 . . . . 0.0 111.754 177.419 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 35.3 m -120.87 131.24 54.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.662 1.585 . . . . 0.0 108.988 164.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.5 t -88.17 149.4 23.91 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.923 0.889 . . . . 0.0 110.838 173.125 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -132.58 143.14 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.632 1.573 . . . . 0.0 110.121 -177.229 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 92.8 p -137.28 150.32 47.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.876 1.27 . . . . 0.0 112.252 168.852 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -152.24 155.05 36.98 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.138 -0.976 . . . . 0.0 112.462 173.974 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.38 99.98 29.88 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.398 1.079 . . . . 0.0 109.998 -174.461 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -83.21 162.21 15.32 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.069 3.179 . . . . 0.0 111.083 176.41 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -133.77 -20.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -172.441 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.6 mt -118.65 147.32 41.86 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 124.849 1.259 . . . . 0.0 110.261 170.21 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 158.76 43.61 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.883 2.388 . . . . 0.0 111.019 176.385 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 128.08 -163.79 21.58 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.967 1.27 . . . . 0.0 113.213 -177.048 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.81 136.9 32.77 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 112.921 -178.957 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -124.78 129.98 51.51 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.743 1.617 . . . . 0.0 110.031 176.429 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.81 126.19 35.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 110.436 174.838 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.71 126.23 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.465 1.506 . . . . 0.0 108.047 178.643 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -108.94 131.84 54.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.474 1.509 . . . . 0.0 109.442 175.651 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.85 129.09 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.392 1.077 . . . . 0.0 109.383 172.739 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.78 143.39 26.34 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.225 1.41 . . . . 0.0 111.59 -168.36 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.83 122.18 12.34 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.597 1.159 . . . . 0.0 110.341 179.748 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 57.67 56.24 5.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.315 1.446 . . . . 0.0 111.732 -179.406 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 10.0 pt-20 54.78 22.34 4.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.903 2.481 . . . . 0.0 115.898 -179.113 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -132.84 131.39 40.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.071 1.348 . . . . 0.0 110.542 176.804 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.58 150.32 47.12 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.796 0.838 . . . . 0.0 112.299 174.788 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -67.69 156.29 89.37 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.103 167.833 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -52.28 -33.67 56.39 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.042 3.161 . . . . 0.0 116.378 -169.388 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.98 -3.21 59.17 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.6 t -84.12 143.02 41.87 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.983 1.392 . . . . 0.0 112.355 -177.316 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.26 138.14 54.17 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.062 0.701 . . . . 0.0 111.812 -4.449 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.48 168.3 12.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.862 1.665 . . . . 0.0 110.292 172.843 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 25.0 m -131.76 116.86 17.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 110.069 172.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -91.46 152.93 20.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.746 1.219 . . . . 0.0 110.785 170.113 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -108.87 129.08 55.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.516 0.726 . . . . 0.0 110.19 166.521 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.8 t -105.06 129.22 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.318 1.447 . . . . 0.0 110.135 179.242 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 86.9 m -95.99 152.56 18.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.0 1.72 . . . . 0.0 111.495 -178.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.27 133.35 12.18 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.871 1.224 . . . . 0.0 112.079 175.289 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.32 -25.6 39.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.751 1.22 . . . . 0.0 113.484 -177.157 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.48 1.912 . . . . 0.0 112.675 -176.206 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.94 157.64 37.03 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.289 1.036 . . . . 0.0 112.744 177.849 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.0 mmt -79.04 -22.76 44.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.111 0.964 . . . . 0.0 113.53 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -75.65 135.28 71.76 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.23 1.012 . . . . 0.0 112.241 -177.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.35 172.04 14.14 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.948 3.099 . . . . 0.0 111.707 176.017 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.03 149.38 21.31 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.46 1.504 . . . . 0.0 111.026 173.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -137.77 148.39 60.71 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 125.812 1.645 . . . . 0.0 111.486 -179.244 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.25 170.02 20.3 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.931 3.087 . . . . 0.0 111.734 175.436 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 61.7 tp -146.86 126.47 13.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.281 1.433 . . . . 0.0 109.101 172.672 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.5 p -168.3 154.9 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.176 1.39 . . . . 0.0 111.035 -169.424 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 86.31 -68.77 3.26 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.029 1.299 . . . . 0.0 113.154 171.054 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 13.1 p -165.16 146.25 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.212 1.405 . . . . 0.0 111.588 -173.596 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 3.9 p30 -161.69 159.38 27.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.658 1.983 . . . . 0.0 111.03 173.198 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -72.24 114.68 5.08 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 123.951 0.786 . . . . 0.0 112.554 -172.966 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.0 mt -143.46 151.07 39.9 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.331 1.852 . . . . 0.0 110.546 -176.967 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 32.0 t70 70.93 -52.79 0.68 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.354 2.662 . . . . 0.0 113.718 170.688 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1785 ' ' VAL . . . . . 0.501 ' HA ' HD22 ' A' 1864 ' ' ASN . 9.8 p -61.95 -24.59 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.591 1.556 . . . . 0.0 112.998 176.672 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 8.4 t -90.97 -11.69 38.21 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.176 1.79 . . . . 0.0 113.062 178.612 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 49.5 m -80.1 116.07 20.01 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.012 -1.055 . . . . 0.0 113.753 -166.037 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.01 149.77 35.85 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.324 1.05 . . . . 0.0 110.145 159.187 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -56.27 115.54 10.19 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.287 1.435 . . . . 0.0 110.362 177.445 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 133.41 27.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.117 1.878 . . . . 0.0 108.682 174.122 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.02 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 109.947 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.93 150.51 25.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.351 1.461 . . . . 0.0 111.652 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -159.62 151.57 20.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.856 1.662 . . . . 0.0 109.893 -177.123 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -123.81 134.5 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.005 1.322 . . . . 0.0 109.655 170.845 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.77 135.98 27.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.919 1.688 . . . . 0.0 109.215 -172.692 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.02 112.77 3.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.209 2.606 . . . . 0.0 110.208 173.873 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 46.8 t80 -174.94 147.6 0.98 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.026 2.13 . . . . 0.0 109.278 -171.683 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 52.5 m -125.63 127.0 45.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.574 1.15 . . . . 0.0 109.803 -178.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.82 113.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.731 0.812 . . . . 0.0 109.436 174.883 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -98.33 -158.53 0.68 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.213 1.405 . . . . 0.0 111.006 172.006 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tptt -68.5 120.36 14.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.603 -1.311 . . . . 0.0 111.091 173.104 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.64 -147.61 18.63 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.676 1.608 . . . . 0.0 111.867 -171.066 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.78 143.46 15.89 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.3 1.04 . . . . 0.0 111.496 -175.118 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.9 tt -128.95 136.44 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.731 1.612 . . . . 0.0 110.946 177.076 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.9 p -147.64 -178.37 6.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.337 1.855 . . . . 0.0 110.372 -176.765 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.52 -170.55 31.57 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 179.027 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -149.72 139.81 22.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.317 1.847 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 45.1 t -113.67 135.53 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.3 1.84 . . . . 0.0 108.178 170.647 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -119.02 138.15 53.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.166 1.387 . . . . 0.0 111.947 -178.386 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.5 mpp? -114.05 141.57 26.51 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.831 1.652 . . . . 0.0 111.399 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -25.13 78.77 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.126 3.217 . . . . 0.0 115.017 177.144 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.3 p -74.71 4.35 6.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.861 1.664 . . . . 0.0 114.655 -177.831 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.84 41.15 6.04 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 124.606 1.098 . . . . 0.0 113.293 172.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -148.67 163.89 35.94 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.63 1.572 . . . . 0.0 111.938 -175.058 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.5 161.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.011 1.324 . . . . 0.0 112.231 -174.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.02 -178.25 6.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.088 2.155 . . . . 0.0 110.22 178.051 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -127.04 146.23 56.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.065 -1.022 . . . . 0.0 111.419 176.581 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.33 166.18 14.23 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.207 3.271 . . . . 0.0 111.49 177.857 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.8 m -101.98 134.21 45.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 108.585 170.131 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.17 132.91 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.799 1.239 . . . . 0.0 109.013 175.019 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.7 m -138.6 122.32 17.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.243 1.417 . . . . 0.0 109.465 178.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -76.63 131.8 39.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.865 0.866 . . . . 0.0 111.73 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -83.44 1.68 40.44 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.041 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 69.51 16.86 8.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.624 1.97 . . . . 0.0 112.991 179.639 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -138.66 16.82 2.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.18 1.792 . . . . 0.0 113.015 -169.545 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.74 13.27 63.03 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.596 1.093 . . . . 0.0 115.132 177.184 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.9 p -129.44 155.94 44.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.835 1.654 . . . . 0.0 110.41 174.843 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.0 m -115.42 138.37 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.886 0.875 . . . . 0.0 110.202 167.192 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.4 m -96.03 136.43 36.49 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.731 1.212 . . . . 0.0 108.429 167.964 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 52.9 t -121.78 135.85 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.791 1.636 . . . . 0.0 108.399 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -140.63 159.33 42.44 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.562 1.145 . . . . 0.0 113.139 -175.839 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.0 t80 -154.59 134.25 12.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.942 1.697 . . . . 0.0 111.538 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.46 121.75 75.08 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.381 1.072 . . . . 0.0 111.205 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.44 156.68 32.65 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.741 2.96 . . . . 0.0 111.857 -176.558 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.1 t -140.75 -13.76 0.96 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.516 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -165.38 151.54 9.8 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 110.657 -176.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.02 168.45 20.07 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.427 1.091 . . . . 0.0 113.444 -177.602 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 125.04 -179.97 15.94 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.346 1.45 . . . . 0.0 114.157 176.723 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.0 tt -86.66 122.37 30.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.758 1.223 . . . . 0.0 109.821 179.771 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 26.2 m80 -116.99 160.82 20.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.698 1.599 . . . . 0.0 111.619 -173.113 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -142.78 144.21 32.5 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.978 1.311 . . . . 0.0 110.304 -178.557 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.5 ttm -135.39 141.02 45.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.827 1.251 . . . . 0.0 112.613 -176.386 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.09 139.57 35.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.737 1.615 . . . . 0.0 110.405 163.667 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.4 mm -127.84 131.61 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 109.272 163.63 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.31 134.69 23.06 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.106 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 13.7 t80 -98.03 122.83 41.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.573 1.949 . . . . 0.0 109.632 174.655 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.83 36.43 14.59 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.723 1.209 . . . . 0.0 112.824 -175.462 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 77.78 3.18 2.97 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 128.107 2.563 . . . . 0.0 114.614 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.0 mtm -105.64 130.21 53.72 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.583 1.553 . . . . 0.0 111.079 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.28 137.22 41.93 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.773 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 24.6 pt -77.05 156.18 82.25 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.228 171.024 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -59.82 128.53 27.14 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.111 1.874 . . . . 0.0 109.718 169.977 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.92 -16.9 57.99 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.784 1.183 . . . . 0.0 114.072 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.4 t -83.22 144.75 47.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 119.347 1.574 . . . . 0.0 110.664 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.43 160.24 93.94 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 120.209 1.11 . . . . 0.0 113.048 -2.638 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.97 154.07 22.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.661 1.984 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -156.4 134.41 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.039 0.936 . . . . 0.0 110.96 -173.025 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.08 -177.53 5.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 112.779 -172.486 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.4 t80 -122.4 137.44 54.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 177.253 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 90.4 t -100.75 134.59 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.644 1.577 . . . . 0.0 109.573 174.481 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 18.6 t0 -156.51 169.25 25.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.242 1.817 . . . . 0.0 110.301 -179.519 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -69.45 142.78 53.73 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.073 -1.017 . . . . 0.0 112.7 176.622 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 53.6 t -67.02 -36.14 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.207 1.003 . . . . 0.0 112.556 -172.245 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1864 ' ' ASN . . . . . 0.501 HD22 ' HA ' ' A' 1785 ' ' VAL . 45.8 p-10 -121.61 20.04 11.1 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.533 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 28.5 p -61.4 158.93 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.922 1.289 . . . . 0.0 114.413 -176.203 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -82.42 -29.65 35.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.331 0.967 . . . . 0.0 113.661 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -71.55 153.7 41.98 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.253 1.027 . . . . 0.0 112.583 173.472 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.8 t -70.17 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 3.3 t -155.0 164.11 39.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.591 1.157 . . . . 0.0 111.249 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.17 149.22 42.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 -175.966 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 4.2 p90 -161.93 158.62 25.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.643 1.577 . . . . 0.0 113.004 179.66 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.04 168.3 11.29 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.258 1.409 . . . . 0.0 113.572 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.48 -30.14 36.35 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.429 2.753 . . . . 0.0 113.153 -171.46 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.45 -13.58 71.12 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.078 0.847 . . . . 0.0 114.527 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 66.6 mt -79.03 -11.94 60.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.935 1.367 . . . . 0.0 112.807 168.603 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 10.3 m -120.6 -38.53 2.86 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.839 1.656 . . . . 0.0 112.466 -165.605 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -154.83 156.99 37.21 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.74 1.616 . . . . 0.0 112.366 -172.009 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.14 -176.84 28.71 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.108 0.861 . . . . 0.0 114.074 172.068 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.5 t -141.22 133.3 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.172 1.389 . . . . 0.0 108.255 177.741 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.9 m -56.63 137.44 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.876 0.47 . . . . 0.0 111.958 179.634 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.03 -2.18 1.86 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.691 1.996 . . . . 0.0 114.713 178.076 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -106.81 142.06 24.19 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.451 1.5 . . . . 0.0 110.791 175.793 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.4 126.53 11.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.382 2.054 . . . . 0.0 110.81 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -103.23 145.37 30.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.345 1.458 . . . . 0.0 110.282 172.422 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.4 p -135.9 153.51 51.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -165.626 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -165.6 173.45 10.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.226 1.81 . . . . 0.0 111.629 177.476 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 38.2 m -128.96 140.63 51.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.508 1.523 . . . . 0.0 110.781 -171.733 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.5 t -110.52 136.32 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.908 1.683 . . . . 0.0 108.335 168.198 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.39 126.0 38.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.681 1.193 . . . . 0.0 110.769 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 74.7 p -133.45 -1.31 3.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.909 1.283 . . . . 0.0 114.148 -167.53 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -54.59 -38.74 67.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.225 1.41 . . . . 0.0 114.684 -169.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -114.33 9.7 16.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.733 1.613 . . . . 0.0 112.759 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.83 67.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.329 1.052 . . . . 0.0 113.479 -175.116 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.13 153.11 6.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.833 1.206 . . . . 0.0 112.291 -169.554 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -70.13 160.94 31.14 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.655 0.782 . . . . 0.0 112.913 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.38 15.86 0.07 OUTLIER Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -176.419 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.44 96.0 1.5 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.531 1.539 . . . . 0.0 112.574 177.899 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.59 125.49 29.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.786 1.235 . . . . 0.0 108.527 167.543 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -116.34 154.96 29.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.98 1.712 . . . . 0.0 111.853 -179.465 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 59.7 tp -162.16 133.37 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 109.698 -170.034 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.84 161.68 34.52 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.655 1.182 . . . . 0.0 111.912 -179.523 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -137.99 132.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.612 1.165 . . . . 0.0 110.114 175.756 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -112.07 134.04 53.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.844 1.657 . . . . 0.0 109.323 170.458 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -164.96 -168.52 27.24 Favored Glycine 0 CA--C 1.537 1.435 0 O-C-N 121.353 -0.842 . . . . 0.0 114.909 -175.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.77 -23.35 55.82 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.929 3.086 . . . . 0.0 112.467 176.155 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -141.03 157.75 44.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.433 1.493 . . . . 0.0 109.441 165.377 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -69.29 111.36 5.15 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.042 -1.036 . . . . 0.0 110.424 174.454 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.06 146.18 51.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.553 0.741 . . . . 0.0 111.299 172.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.62 136.51 32.96 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.341 0.656 . . . . 0.0 109.368 169.394 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.9 mt -131.0 138.83 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.572 1.149 . . . . 0.0 110.456 -167.368 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.8 m -133.75 152.89 52.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.442 1.497 . . . . 0.0 110.661 169.75 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.6 p -150.88 153.18 34.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.829 0.852 . . . . 0.0 112.96 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 84.8 m -139.84 120.37 14.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.649 1.58 . . . . 0.0 110.107 -171.22 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.5 133.21 37.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.664 1.186 . . . . 0.0 111.332 172.189 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -110.75 145.89 37.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.697 1.599 . . . . 0.0 111.635 -178.685 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -69.25 -14.22 62.84 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.766 0.826 . . . . 0.0 112.736 174.524 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.78 -8.26 54.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.597 1.559 . . . . 0.0 113.913 174.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.98 31.68 7.19 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.466 1.031 . . . . 0.0 114.288 177.573 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.4 p -137.19 159.59 41.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.16 1.384 . . . . 0.0 110.966 175.665 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 49.6 t -112.86 126.21 55.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 108.667 160.697 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -93.23 145.39 24.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.921 0.889 . . . . 0.0 110.307 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 78.9 t -127.33 143.72 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.171 1.388 . . . . 0.0 110.138 -177.657 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.6 p -134.58 146.45 49.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.007 1.323 . . . . 0.0 111.552 167.096 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 26.1 p90 -148.21 151.38 35.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.576 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.8 mt -112.73 106.77 55.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.037 1.735 . . . . 0.0 110.512 179.021 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.64 174.44 10.41 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.795 2.997 . . . . 0.0 110.224 165.022 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -149.57 -31.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.214 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.44 148.69 35.82 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.33 0.968 . . . . 0.0 110.628 167.042 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.47 157.42 56.41 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 110.761 171.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.0 -159.7 23.1 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.667 1.127 . . . . 0.0 112.604 -175.667 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.35 129.86 56.15 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.187 0.995 . . . . 0.0 111.94 -174.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -116.88 127.69 54.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.528 1.931 . . . . 0.0 110.099 -177.588 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.5 m -97.23 114.42 26.15 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.635 1.174 . . . . 0.0 110.961 178.686 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -88.61 125.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.251 1.82 . . . . 0.0 108.776 178.355 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -101.16 131.37 47.15 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.357 1.463 . . . . 0.0 109.721 173.231 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 49.1 t -130.64 128.76 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 110.037 172.069 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -153.88 141.52 19.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.476 1.51 . . . . 0.0 111.071 -169.137 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.83 121.26 18.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.551 1.14 . . . . 0.0 109.545 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.84 59.57 4.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.24 1.416 . . . . 0.0 112.294 178.191 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.9 pt-20 59.14 11.97 2.28 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.279 2.632 . . . . 0.0 116.43 -178.431 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.41 123.35 41.88 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.48 1.112 . . . . 0.0 111.172 178.142 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -64.21 146.88 53.55 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.393 -0.817 . . . . 0.0 112.114 172.243 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 12.2 m -77.63 156.02 80.78 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.828 172.804 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -54.67 130.76 42.02 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.427 2.751 . . . . 0.0 112.086 177.397 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 85.75 -10.8 63.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.571 1.081 . . . . 0.0 115.554 -179.736 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -72.81 139.32 80.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 119.439 1.62 . . . . 0.0 111.344 176.717 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.89 149.06 80.23 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 CA-C-N 119.676 0.92 . . . . 0.0 112.768 -2.291 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -104.68 126.63 51.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 110.702 -177.199 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.8 m -94.73 110.95 22.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.599 0.759 . . . . 0.0 111.295 -175.791 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.86 129.55 45.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.917 1.687 . . . . 0.0 111.692 177.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -94.72 117.53 30.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.417 0.687 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 79.8 t -98.56 133.86 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.148 1.779 . . . . 0.0 110.643 -174.652 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 57.4 p -99.08 145.95 26.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.17 39.25 3.12 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.065 1.793 . . . . 0.0 113.831 -175.162 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -70.3 -28.4 65.16 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -168.133 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.253 1.238 0 C-N-CA 125.035 1.334 . . . . 0.0 113.659 -178.993 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.525 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.3 159.96 32.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.469 1.107 . . . . 0.0 112.921 178.248 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 14.8 tpt -70.88 145.62 50.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.38 1.072 . . . . 0.0 111.91 176.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -69.42 147.49 96.95 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.426 1.09 . . . . 0.0 112.639 179.317 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.15 162.88 33.63 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.771 2.981 . . . . 0.0 111.982 178.293 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.18 88.72 6.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.163 0.985 . . . . 0.0 110.223 175.369 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -72.68 147.37 89.25 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.26 1.024 . . . . 0.0 112.293 -177.859 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.69 173.58 14.25 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.019 3.146 . . . . 0.0 111.786 176.762 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -70.34 22.75 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.487 1.915 . . . . 0.0 114.899 175.853 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 86.3 t -133.78 144.44 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.918 2.487 . . . . 0.0 108.521 -174.879 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -66.37 107.94 2.19 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.198 0.904 . . . . 0.0 112.658 -175.457 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 99.1 t -68.32 137.16 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.859 1.264 . . . . 0.0 110.06 179.219 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -155.37 171.85 19.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.308 1.443 . . . . 0.0 112.337 -171.2 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 97.09 -111.16 4.19 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 124.731 1.158 . . . . 0.0 111.037 -175.604 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 67.7 mt -68.4 159.41 31.61 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.221 1.008 . . . . 0.0 112.038 177.549 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 37.4 t0 -154.93 159.7 40.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.083 1.353 . . . . 0.0 112.11 -176.373 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 32.7 m -68.93 -8.44 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.421 1.488 . . . . 0.0 114.575 -170.696 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 11.5 t -63.51 -32.22 73.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.148 1.379 . . . . 0.0 112.827 174.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 6.6 t 77.41 124.1 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.518 2.327 . . . . 0.0 114.62 164.068 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 46.6 mt -104.04 148.62 26.02 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.137 1.775 . . . . 0.0 111.482 176.512 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -64.36 118.54 48.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.871 1.268 . . . . 0.0 111.504 -179.627 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.0 152.55 57.31 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.115 2.543 . . . . 0.0 110.865 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 16.2 t80 -107.8 125.66 51.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.937 0.895 . . . . 0.0 110.302 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.56 130.06 13.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.531 1.532 . . . . 0.0 110.001 173.568 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 131.18 21.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.236 1.414 . . . . 0.0 110.054 -169.577 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 58.0 t -95.73 138.05 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.105 1.362 . . . . 0.0 109.598 -179.773 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.75 135.01 26.69 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.652 1.581 . . . . 0.0 108.784 -179.002 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -79.8 37.76 0.69 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.22 3.28 . . . . 0.0 113.141 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -85.79 152.38 23.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.221 1.408 . . . . 0.0 111.458 178.196 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.9 m -116.23 119.25 35.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.846 1.258 . . . . 0.0 109.733 177.184 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.29 127.69 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.211 1.004 . . . . 0.0 109.953 175.29 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -112.99 -154.92 0.55 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.569 1.547 . . . . 0.0 110.622 172.74 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -70.07 124.46 24.13 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.594 -1.316 . . . . 0.0 111.353 172.569 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.85 -148.76 20.5 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.789 1.661 . . . . 0.0 111.772 -170.514 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.18 146.27 18.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.307 1.043 . . . . 0.0 111.68 -175.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.18 135.74 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.97 1.708 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 32.7 p -146.23 177.08 9.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.154 1.781 . . . . 0.0 110.572 -175.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.76 -172.63 29.39 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.21 138.79 19.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.441 1.496 . . . . 0.0 109.762 173.71 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 13.3 t -108.51 132.59 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.14 1.776 . . . . 0.0 108.088 172.768 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -117.77 122.89 44.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.9 1.28 . . . . 0.0 110.124 -177.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.4 mtt -95.92 152.3 38.9 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.66 1.584 . . . . 0.0 111.461 -172.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.83 -20.7 34.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.28 2.654 . . . . 0.0 113.601 -177.259 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 58.4 p -78.44 -4.63 49.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 114.171 174.193 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.32 -3.82 64.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.575 1.56 . . . . 0.0 114.56 -178.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.47 159.54 33.08 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 118.506 1.153 . . . . 0.0 112.199 173.994 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.6 m -136.89 154.71 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.156 1.382 . . . . 0.0 111.519 175.077 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.17 172.63 17.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.234 1.813 . . . . 0.0 111.121 -179.193 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -109.7 139.47 21.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.981 0.913 . . . . 0.0 111.172 178.37 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -82.18 165.6 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.861 3.041 . . . . 0.0 110.82 170.34 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 97.4 m -107.86 123.36 48.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.102 1.361 . . . . 0.0 108.659 172.511 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.85 130.58 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.297 1.039 . . . . 0.0 108.677 175.485 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 97.4 m -128.27 130.53 48.02 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.495 1.518 . . . . 0.0 109.816 -177.901 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -76.16 130.77 38.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.823 1.249 . . . . 0.0 112.05 174.619 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -87.91 -15.74 35.82 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.345 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.4 mttt 70.07 4.19 4.71 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.736 2.414 . . . . 0.0 114.391 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -100.86 12.17 38.12 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.622 1.969 . . . . 0.0 112.849 -179.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.55 16.82 61.32 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.731 1.158 . . . . 0.0 113.38 -171.413 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -136.87 166.47 23.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.851 2.06 . . . . 0.0 110.178 179.993 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.0 m -131.37 164.97 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.222 1.409 . . . . 0.0 110.326 172.031 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.9 t -123.15 148.94 45.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.351 1.06 . . . . 0.0 110.073 166.478 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 32.4 t -123.42 128.51 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.502 1.521 . . . . 0.0 108.737 178.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -129.12 155.41 45.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.747 1.619 . . . . 0.0 111.836 -170.637 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.2 t80 -159.88 135.81 8.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.833 1.253 . . . . 0.0 112.297 -177.606 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.58 117.37 68.56 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.82 1.248 . . . . 0.0 110.694 175.771 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.03 145.76 22.39 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.482 2.788 . . . . 0.0 111.694 -174.87 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.8 p -131.17 -4.83 3.88 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 172.554 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -141.75 153.98 44.95 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.109 1.764 . . . . 0.0 110.316 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.23 173.32 8.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 111.757 166.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 104.6 -171.49 19.32 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.23 1.395 . . . . 0.0 114.002 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.33 124.27 30.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.971 1.308 . . . . 0.0 110.112 -177.882 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.9 m80 -120.57 163.13 18.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.427 1.891 . . . . 0.0 111.382 -176.051 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.25 155.56 39.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.126 0.971 . . . . 0.0 111.169 173.354 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.8 tmm? -148.85 132.68 17.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.166 0.986 . . . . 0.0 111.547 -160.686 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -111.08 141.96 43.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.738 2.015 . . . . 0.0 111.295 -174.831 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -133.86 134.33 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.858 1.263 . . . . 0.0 111.004 175.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.3 139.0 37.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.498 1.119 . . . . 0.0 113.331 176.629 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -99.7 120.94 40.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.362 1.865 . . . . 0.0 109.527 172.506 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 49.26 39.88 16.83 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.936 1.294 . . . . 0.0 112.853 -176.083 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 7.8 t-20 82.27 -13.65 0.83 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.03 2.932 . . . . 0.0 114.696 179.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.3 tpp -90.98 128.61 36.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.522 1.129 . . . . 0.0 111.561 177.029 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -57.68 136.22 56.82 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.38 -0.825 . . . . 0.0 113.164 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.3 pt -76.82 153.91 83.14 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.594 178.019 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -61.5 124.53 14.84 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.885 1.723 . . . . 0.0 108.617 166.121 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.4 -11.22 47.15 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.572 1.082 . . . . 0.0 114.681 -172.873 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.9 t -85.94 143.79 38.17 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.351 1.575 . . . . 0.0 111.319 169.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -82.85 171.83 51.23 Favored 'Cis proline' 0 C--N 1.352 0.738 0 CA-C-N 120.075 1.062 . . . . 0.0 112.505 -6.32 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.2 mt -113.99 160.82 18.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.459 1.904 . . . . 0.0 111.159 171.346 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -150.4 138.73 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.189 1.396 . . . . 0.0 109.99 -171.687 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 15.9 p90 -164.46 167.25 19.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.444 1.097 . . . . 0.0 112.398 -165.264 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.5 t80 -122.55 136.09 54.8 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.129 -0.982 . . . . 0.0 112.129 176.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 42.2 t -111.84 142.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.398 1.479 . . . . 0.0 109.675 -178.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 28.5 t0 -151.59 163.01 40.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.898 1.279 . . . . 0.0 111.52 -177.553 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -74.96 125.6 29.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.227 . . . . 0.0 111.152 178.319 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 31.4 m -78.92 -18.55 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -167.545 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -89.35 -4.63 58.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.792 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.7 m -72.73 150.51 42.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.962 0.905 . . . . 0.0 112.498 176.576 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.73 -14.62 60.96 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.604 1.097 . . . . 0.0 115.118 -174.369 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -66.56 158.14 30.52 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.7 1.25 . . . . 0.0 113.93 179.131 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 141.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.454 1.102 . . . . 0.0 110.888 173.422 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -158.1 152.89 25.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.358 1.463 . . . . 0.0 110.273 178.655 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.81 142.83 51.32 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.999 1.319 . . . . 0.0 111.754 -177.706 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.3 p90 -167.08 160.88 14.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.582 1.553 . . . . 0.0 113.519 -175.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.83 170.27 12.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.408 1.48 . . . . 0.0 112.539 -177.54 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.08 -33.29 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 113.324 -168.651 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.81 -33.78 86.83 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.455 1.025 . . . . 0.0 114.506 -171.567 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 1.5 pp -78.43 -0.61 29.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.832 1.316 . . . . 0.0 113.631 177.45 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.5 m -113.63 -46.09 3.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.698 1.999 . . . . 0.0 111.366 176.696 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1877 ' ' HIS . . . . . 0.496 ' CE1' HH22 ' A' 1951 ' ' ARG . 3.7 t-80 -137.88 122.37 18.42 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.314 1.845 . . . . 0.0 111.426 -174.075 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.5 170.94 16.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.28 1.419 . . . . 0.0 112.786 170.655 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 98.2 t -138.8 137.14 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.899 1.28 . . . . 0.0 108.239 174.203 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.7 m -55.3 136.54 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 61.0 m-80 67.32 0.31 2.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.969 2.108 . . . . 0.0 114.685 177.509 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -104.87 139.91 20.56 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.019 1.328 . . . . 0.0 110.977 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.9 118.66 5.74 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.59 2.193 . . . . 0.0 110.167 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.03 134.8 42.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.29 1.436 . . . . 0.0 110.205 176.544 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -128.31 148.16 50.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -164.729 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.63 -179.85 7.97 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.948 1.699 . . . . 0.0 111.673 176.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 60.2 m -135.03 146.65 49.19 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.228 1.411 . . . . 0.0 110.936 -168.096 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -116.86 129.89 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.687 1.595 . . . . 0.0 108.262 168.456 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.51 126.43 38.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.963 . . . . 0.0 110.325 176.079 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 40.6 p -132.06 4.15 4.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.708 1.603 . . . . 0.0 113.634 -167.147 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 52.2 tttp -55.22 -32.45 62.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.051 1.74 . . . . 0.0 115.61 -164.464 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.33 17.53 6.52 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.603 1.561 . . . . 0.0 112.42 178.407 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.28 58.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -176.557 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 151.44 12.21 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.186 1.374 . . . . 0.0 112.861 -175.643 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -72.94 145.65 46.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.159 0.983 . . . . 0.0 112.307 -177.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.7 -158.66 26.89 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.689 1.614 . . . . 0.0 112.501 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -82.98 98.39 2.04 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 175.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.17 126.55 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.707 1.203 . . . . 0.0 108.853 171.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.4 m -129.68 155.27 46.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.012 1.325 . . . . 0.0 112.133 -177.806 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.0 tp -158.95 132.61 7.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.162 1.785 . . . . 0.0 108.583 -171.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.64 160.41 39.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.853 0.861 . . . . 0.0 112.238 -179.313 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 58.4 mt -135.08 132.34 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.519 1.128 . . . . 0.0 109.645 174.379 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -114.76 105.98 13.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.013 1.325 . . . . 0.0 109.052 172.655 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -116.9 -178.84 17.85 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.024 1.297 . . . . 0.0 113.92 -178.639 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.2 -20.42 37.48 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.909 3.073 . . . . 0.0 111.811 170.744 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.2 t -137.43 157.77 45.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.877 1.671 . . . . 0.0 109.055 161.253 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.59 119.0 13.17 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.993 -1.067 . . . . 0.0 111.773 -176.866 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -80.13 144.33 33.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.166 170.14 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.86 140.92 29.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.479 0.712 . . . . 0.0 109.656 168.363 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.2 mt -132.91 139.24 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.79 1.236 . . . . 0.0 110.467 -167.67 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -130.32 155.96 45.48 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.652 168.544 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -152.65 154.07 34.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.102 0.961 . . . . 0.0 112.373 175.604 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.8 m -142.25 125.57 16.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.599 1.56 . . . . 0.0 109.985 -172.528 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.91 141.35 37.68 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 112.244 172.758 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -117.24 152.0 35.74 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.703 1.601 . . . . 0.0 112.031 -175.803 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -69.43 -18.54 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.926 1.29 . . . . 0.0 112.96 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.68 -13.44 60.62 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.128 1.371 . . . . 0.0 114.083 -179.503 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.74 34.73 4.84 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.786 1.184 . . . . 0.0 113.674 -175.773 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.7 p -138.34 164.3 29.65 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.266 1.426 . . . . 0.0 110.841 177.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 80.6 m -120.09 131.18 54.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.717 1.607 . . . . 0.0 109.033 164.369 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.6 t -90.18 150.15 22.12 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.161 0.984 . . . . 0.0 110.686 171.112 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 93.6 t -129.43 144.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.521 1.928 . . . . 0.0 109.592 -178.43 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 139.12 35.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.411 1.484 . . . . 0.0 110.707 171.074 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -144.63 153.24 41.55 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.587 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.7 mt -115.51 105.79 51.53 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.802 1.641 . . . . 0.0 110.816 179.636 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.0 169.71 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.645 2.897 . . . . 0.0 110.235 165.456 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -136.99 -20.13 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.39 152.06 59.57 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.632 1.173 . . . . 0.0 110.675 174.007 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.18 147.74 38.24 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.893 2.395 . . . . 0.0 111.904 -172.871 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.03 -155.68 26.33 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.675 1.131 . . . . 0.0 113.059 -174.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.26 126.41 53.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.07 1.348 . . . . 0.0 111.149 179.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.8 125.71 53.06 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.311 1.844 . . . . 0.0 109.93 -176.624 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 54.6 m -88.0 122.08 31.18 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.975 -1.078 . . . . 0.0 110.933 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.22 128.23 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.292 1.437 . . . . 0.0 108.626 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -112.23 131.07 55.7 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.367 1.467 . . . . 0.0 109.542 175.965 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.55 130.11 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.304 1.042 . . . . 0.0 109.67 172.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.93 144.02 23.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.061 1.344 . . . . 0.0 111.721 -168.552 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.11 122.64 14.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.697 1.199 . . . . 0.0 110.555 -177.882 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 57.0 44.62 22.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.134 1.374 . . . . 0.0 112.199 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.261 0.6 OUTLIER 77.98 -12.87 1.02 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.177 2.991 . . . . 0.0 114.736 -179.107 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -98.43 125.6 43.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.75 1.22 . . . . 0.0 111.384 -176.814 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -63.07 143.76 57.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.384 -0.823 . . . . 0.0 111.912 171.585 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.5 m -68.0 152.35 96.49 Favored Pre-proline 0 N--CA 1.48 1.036 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.57 171.417 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 126.96 22.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.781 2.321 . . . . 0.0 110.595 179.387 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.58 -15.01 64.23 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.193 1.378 . . . . 0.0 115.323 -176.118 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.5 t -76.62 140.98 68.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.304 1.552 . . . . 0.0 111.628 176.552 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.53 140.29 65.88 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.418 0.828 . . . . 0.0 112.161 -3.723 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.05 173.23 7.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.615 1.966 . . . . 0.0 110.779 175.51 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -131.02 122.32 26.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.845 0.858 . . . . 0.0 110.933 174.159 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.05 137.99 34.32 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.57 1.548 . . . . 0.0 110.535 169.429 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1951 ' ' ARG . . . . . 0.496 HH22 ' CE1' ' A' 1877 ' ' HIS . 0.0 OUTLIER -93.81 138.5 31.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.596 0.759 . . . . 0.0 109.474 169.756 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 139.59 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.456 1.502 . . . . 0.0 110.861 -178.402 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 1.1 p -124.04 163.2 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.931 1.693 . . . . 0.0 112.433 179.521 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.87 148.55 33.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.107 1.337 . . . . 0.0 112.249 172.269 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.17 -23.73 57.79 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.949 0.9 . . . . 0.0 112.898 174.323 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.477 1.911 . . . . 0.0 112.864 178.321 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.706 -0.557 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -156.73 163.84 38.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.724 1.609 . . . . 0.0 111.76 -179.068 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 77.4 mtm -74.2 -21.43 59.82 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.315 1.046 . . . . 0.0 113.619 -179.536 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -160.75 160.04 25.36 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 126.36 1.864 . . . . 0.0 111.341 -179.457 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.92 153.8 48.64 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.9 3.067 . . . . 0.0 113.308 174.455 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.19 -7.71 55.06 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.27 1.428 . . . . 0.0 113.209 174.762 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -62.66 137.75 96.61 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.441 1.096 . . . . 0.0 111.83 -179.433 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.52 165.08 32.5 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.821 3.014 . . . . 0.0 111.736 174.792 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -70.24 -5.07 24.98 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -173.21 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 5.2 p -67.86 -16.99 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 125.359 1.464 . . . . 0.0 113.694 -176.504 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -77.12 52.65 3.36 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.905 1.717 . . . . 0.0 114.451 -175.477 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 33.3 m -69.06 150.69 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.218 1.407 . . . . 0.0 111.99 177.482 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -77.14 -16.06 59.3 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.734 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -173.24 169.51 42.63 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.559 1.552 . . . . 0.0 113.244 178.645 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.8 149.66 36.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.035 0.934 . . . . 0.0 111.684 178.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 35.7 t70 -75.07 -21.02 59.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.255 1.022 . . . . 0.0 112.74 174.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.0 p -163.22 150.25 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.657 1.983 . . . . 0.0 110.602 -175.016 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 12.8 t -167.65 -35.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.66 1.984 . . . . 0.0 111.067 -178.503 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 24.2 p -73.24 146.38 45.5 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.605 1.162 . . . . 0.0 113.044 169.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 11.3 mt -137.08 153.68 50.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.531 1.932 . . . . 0.0 109.891 178.094 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 18.1 ttm-85 -58.72 119.52 37.76 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.233 1.013 . . . . 0.0 111.041 177.671 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.42 159.76 48.48 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.158 2.572 . . . . 0.0 110.431 176.496 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.46 134.26 17.83 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.642 0.734 . . . . 0.0 112.324 -172.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -163.98 145.81 9.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.817 2.047 . . . . 0.0 110.724 178.055 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 161.28 36.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.599 1.959 . . . . 0.0 110.831 -170.609 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -134.07 139.37 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.184 1.393 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 43.8 mt -136.59 138.2 25.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.314 1.846 . . . . 0.0 108.302 -170.801 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.11 31.93 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.505 3.47 . . . . 0.0 113.993 -177.052 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 27.6 t80 -79.65 155.03 28.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.47 1.108 . . . . 0.0 111.027 173.113 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.85 126.17 35.52 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.048 1.339 . . . . 0.0 109.534 176.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.5 mt -76.42 126.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.572 0.749 . . . . 0.0 110.49 177.24 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 67.1 mttm -116.48 -139.7 0.37 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.724 1.61 . . . . 0.0 110.516 172.71 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.76 124.44 27.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.657 -1.277 . . . . 0.0 111.188 171.689 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.4 -151.31 19.68 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.862 1.696 . . . . 0.0 111.805 -169.872 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.84 150.48 17.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.913 1.285 . . . . 0.0 111.178 -176.448 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.0 tt -122.51 133.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.353 1.461 . . . . 0.0 111.888 179.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 77.3 p -149.22 -178.05 6.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.082 1.753 . . . . 0.0 110.38 177.704 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.48 -164.4 27.9 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.341 0.897 . . . . 0.0 115.341 -179.323 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -157.47 139.49 14.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.616 1.566 . . . . 0.0 109.954 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 43.7 t -105.87 133.63 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.771 1.628 . . . . 0.0 108.266 171.435 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -121.44 135.46 55.05 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.847 1.659 . . . . 0.0 111.052 -174.677 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.2 mpp? -112.9 157.39 40.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.754 1.622 . . . . 0.0 112.562 -172.412 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -55.0 -37.15 93.9 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.243 3.295 . . . . 0.0 114.538 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.0 m -71.86 -5.22 32.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.14 1.376 . . . . 0.0 114.463 -176.098 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -2.2 84.83 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.343 1.449 . . . . 0.0 113.711 -170.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -64.96 152.38 43.41 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.265 1.426 . . . . 0.0 111.719 172.175 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.7 155.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.24 1.416 . . . . 0.0 111.537 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.47 164.46 37.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.791 1.636 . . . . 0.0 111.336 -179.841 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -102.36 134.2 20.12 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.675 0.79 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.98 161.21 20.91 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.721 2.948 . . . . 0.0 110.88 169.912 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.0 m -108.81 125.75 52.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.071 1.348 . . . . 0.0 108.986 174.13 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.7 137.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.905 1.282 . . . . 0.0 109.679 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 56.5 m -139.3 126.57 21.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.197 1.399 . . . . 0.0 110.049 176.477 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.9 126.83 31.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 172.533 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.2 -6.37 57.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.527 1.131 . . . . 0.0 114.032 -174.331 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.3 mmtm 77.99 -7.95 1.74 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.917 2.887 . . . . 0.0 113.831 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -92.58 2.53 56.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.406 1.882 . . . . 0.0 113.295 175.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.5 25.79 13.14 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.757 1.17 . . . . 0.0 114.141 -177.921 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 61.8 p -134.16 155.93 49.22 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.17 1.788 . . . . 0.0 109.706 174.179 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -115.17 138.67 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.196 0.998 . . . . 0.0 110.056 167.397 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 40.5 m -98.29 141.83 30.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.008 1.323 . . . . 0.0 108.588 168.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.3 t -125.66 134.41 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.4 1.48 . . . . 0.0 109.462 179.6 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -131.96 153.94 49.81 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 112.289 -174.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.65 134.34 10.9 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.857 1.663 . . . . 0.0 111.674 -177.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.69 123.67 68.87 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.343 1.057 . . . . 0.0 110.442 175.303 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.47 131.4 12.6 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.076 2.517 . . . . 0.0 111.6 -173.534 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -132.03 15.73 4.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.738 1.215 . . . . 0.0 112.406 179.22 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.93 162.26 20.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.569 1.948 . . . . 0.0 109.958 -175.224 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -111.79 170.93 7.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.924 1.29 . . . . 0.0 112.6 174.329 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 93.66 -161.79 25.11 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.182 1.372 . . . . 0.0 113.547 179.281 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.7 tp -81.58 114.93 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.591 1.156 . . . . 0.0 110.759 -177.816 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 6.4 m80 -103.3 168.34 9.23 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.077 1.751 . . . . 0.0 110.903 177.478 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.16 148.97 29.59 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.491 -0.756 . . . . 0.0 112.02 168.033 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 16.3 ttm -120.99 132.82 55.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.034 2.134 . . . . 0.0 110.264 -173.821 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -100.07 137.9 37.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.637 1.575 . . . . 0.0 109.893 166.891 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -133.95 133.95 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.907 1.283 . . . . 0.0 109.733 171.814 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 138.07 31.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.548 1.139 . . . . 0.0 112.681 -174.069 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.9 t80 -107.74 123.8 49.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.305 1.842 . . . . 0.0 110.063 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.19 35.35 16.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.551 1.14 . . . . 0.0 112.531 -176.128 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.8 t30 80.12 -0.68 2.03 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.671 2.788 . . . . 0.0 114.827 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.33 130.69 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.289 1.436 . . . . 0.0 110.907 178.319 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -56.23 135.13 53.52 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.258 -0.901 . . . . 0.0 113.111 -179.5 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.4 pt -71.6 155.2 92.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.254 172.755 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.6 -25.43 79.23 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.304 2.003 . . . . 0.0 113.648 -176.006 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -79.32 -3.66 88.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.17 0.891 . . . . 0.0 114.72 173.731 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 25.6 t -97.39 144.17 27.45 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.467 1.633 . . . . 0.0 111.824 178.773 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.21 161.01 85.33 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.677 0.92 . . . . 0.0 112.198 -4.563 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.33 144.67 37.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 109.85 170.959 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -126.48 137.2 53.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 109.682 179.152 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.01 146.2 21.52 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.678 0.791 . . . . 0.0 112.438 -169.299 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.1 t80 -99.62 139.43 35.28 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.397 -0.814 . . . . 0.0 112.433 179.694 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 41.1 t -122.83 142.51 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.852 1.661 . . . . 0.0 108.948 179.158 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 9.8 t0 -151.59 173.01 15.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.433 1.093 . . . . 0.0 111.679 -173.52 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -87.44 123.42 32.34 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.918 1.287 . . . . 0.0 111.288 178.2 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 35.4 m -72.09 -21.8 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -170.585 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.0 p30 -90.95 -8.76 48.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.75 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 87.6 m -78.75 -24.35 44.83 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -172.501 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 81.25 -7.29 60.96 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.175 1.369 . . . . 0.0 116.442 168.109 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -67.48 163.75 20.31 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.108 1.454 . . . . 0.0 113.484 176.282 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.4 t -64.88 133.26 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.704 0.801 . . . . 0.0 110.002 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -163.61 154.12 15.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.214 1.406 . . . . 0.0 109.855 -168.241 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.11 145.24 37.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.545 1.138 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.9 p90 -169.64 169.4 8.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.559 1.543 . . . . 0.0 113.092 -173.006 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.75 172.39 13.72 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.6 1.572 . . . . 0.0 112.175 -174.124 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.26 -32.63 12.52 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.774 2.316 . . . . 0.0 113.216 -170.308 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.03 -31.15 74.63 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 119.373 0.988 . . . . 0.0 114.873 -170.601 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.32 -0.37 36.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.925 1.362 . . . . 0.0 113.208 175.36 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 89.7 m -113.52 -48.4 2.94 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.657 1.983 . . . . 0.0 110.82 -178.933 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -137.76 149.07 46.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.089 1.756 . . . . 0.0 112.36 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.38 177.24 23.1 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 124.359 0.98 . . . . 0.0 113.116 170.123 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.6 t -139.1 133.42 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.454 1.102 . . . . 0.0 108.437 176.016 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -56.41 135.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 118.021 0.373 . . . . 0.0 111.986 -178.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.5 m-80 70.26 -8.92 0.8 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.381 2.273 . . . . 0.0 114.859 179.384 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.4 mttm -96.47 141.88 23.74 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.485 1.114 . . . . 0.0 111.078 174.011 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.22 123.64 8.92 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.509 2.14 . . . . 0.0 110.353 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.77 144.6 30.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.443 1.497 . . . . 0.0 110.472 174.525 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.1 p -135.49 145.52 47.21 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -166.364 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.36 178.99 9.68 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.735 1.614 . . . . 0.0 111.306 175.719 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 26.7 m -134.99 144.05 47.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 110.644 -169.658 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.8 t -116.53 131.32 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.571 1.548 . . . . 0.0 108.179 169.726 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.77 131.41 39.16 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.159 0.984 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.8 p -137.79 4.03 2.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.348 1.459 . . . . 0.0 113.765 -166.551 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 84.0 tttt -55.06 -33.66 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.77 1.628 . . . . 0.0 115.04 -168.361 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.87 16.63 9.38 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.741 1.617 . . . . 0.0 112.564 178.972 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.55 -39.57 70.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.368 1.067 . . . . 0.0 113.842 -174.062 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.71 145.22 4.85 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.908 1.242 . . . . 0.0 112.352 -171.084 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.94 148.98 45.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 112.185 -178.019 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 173.93 -27.36 0.08 OUTLIER Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.471 1.034 . . . . 0.0 114.973 176.667 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 142.56 102.05 0.43 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.884 1.707 . . . . 0.0 112.988 172.067 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.44 130.79 35.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.0 109.568 175.071 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.5 m -129.79 160.59 32.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.756 1.622 . . . . 0.0 112.273 -178.129 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.4 tp -160.48 136.68 8.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.762 1.625 . . . . 0.0 109.522 -169.264 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.33 156.9 33.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.392 1.077 . . . . 0.0 112.023 176.251 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 37.2 mt -139.64 134.78 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.96 143.25 51.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.485 1.514 . . . . 0.0 110.223 176.381 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.63 -161.83 20.77 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-O 118.81 -0.994 . . . . 0.0 114.694 -175.561 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -62.26 -26.16 77.19 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.044 3.163 . . . . 0.0 112.646 176.44 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -140.21 153.2 46.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.75 1.22 . . . . 0.0 109.618 161.352 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -71.68 123.37 22.4 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.995 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.7 152.99 37.4 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.313 1.045 . . . . 0.0 112.905 -178.054 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.16 134.1 33.56 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 163.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.9 mt -134.39 138.92 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.577 1.151 . . . . 0.0 110.231 -166.466 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 64.7 m -139.0 162.01 35.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.584 1.553 . . . . 0.0 111.247 172.592 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -155.27 156.47 35.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.378 1.071 . . . . 0.0 112.71 178.502 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.5 m -139.45 129.83 25.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.907 1.683 . . . . 0.0 110.248 -172.282 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -80.73 132.42 35.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.356 1.062 . . . . 0.0 111.264 174.141 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -110.13 148.62 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.077 1.351 . . . . 0.0 112.08 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -68.32 -21.3 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.507 1.123 . . . . 0.0 112.735 178.103 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.14 -6.83 48.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.556 1.543 . . . . 0.0 114.342 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.6 39.87 4.87 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.538 1.065 . . . . 0.0 113.266 -179.255 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.0 p -141.13 158.68 43.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.011 1.324 . . . . 0.0 111.304 177.23 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 63.9 m -107.22 125.19 50.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.391 1.476 . . . . 0.0 108.434 161.455 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.8 t -86.52 149.03 25.25 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.484 0.714 . . . . 0.0 110.393 167.704 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.4 t -130.31 142.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.842 1.657 . . . . 0.0 109.736 -177.54 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 84.1 p -136.12 147.22 47.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.849 1.26 . . . . 0.0 111.802 168.192 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.86 153.89 35.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.495 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.78 105.87 50.89 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.084 1.754 . . . . 0.0 110.282 179.333 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.83 173.79 11.7 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.618 2.879 . . . . 0.0 110.131 165.003 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.8 p -149.69 -29.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -172.814 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.54 144.83 30.32 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.402 1.001 . . . . 0.0 110.213 166.806 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.63 157.64 44.15 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.92 2.413 . . . . 0.0 111.013 177.303 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.32 -162.9 23.68 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.987 1.28 . . . . 0.0 113.204 -176.283 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.79 139.97 30.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.728 1.211 . . . . 0.0 112.844 179.739 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.49 131.67 50.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.757 1.623 . . . . 0.0 110.322 178.008 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.7 m -90.47 125.76 35.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.209 1.004 . . . . 0.0 110.684 174.757 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.99 120.91 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.735 1.614 . . . . 0.0 108.482 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -104.93 128.85 53.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.535 1.534 . . . . 0.0 109.808 178.709 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 58.2 t -130.92 128.52 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.574 1.15 . . . . 0.0 109.848 173.695 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.1 142.3 24.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.109 1.364 . . . . 0.0 111.666 -168.975 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.12 120.21 14.6 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.8 1.24 . . . . 0.0 109.679 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.1 t-20 54.93 58.98 4.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.602 1.561 . . . . 0.0 111.979 179.174 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 9.0 pt-20 57.11 13.56 1.65 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.418 2.687 . . . . 0.0 116.422 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -119.59 122.41 41.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.896 1.279 . . . . 0.0 110.671 177.655 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -63.94 142.69 58.31 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.618 0.767 . . . . 0.0 111.488 170.752 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.0 m -72.62 156.85 89.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.764 175.025 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.81 129.6 35.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.301 2.667 . . . . 0.0 111.963 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 86.27 -13.02 58.96 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.697 1.141 . . . . 0.0 115.142 -177.397 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.7 t -76.0 140.27 70.06 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.527 1.663 . . . . 0.0 111.491 176.121 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.48 136.02 43.04 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 -3.568 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -83.92 169.98 14.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.778 1.631 . . . . 0.0 110.532 173.889 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 28.4 m -131.12 116.73 18.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.552 0.741 . . . . 0.0 110.694 177.264 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.02 155.02 18.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.736 1.214 . . . . 0.0 111.082 169.279 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -116.48 125.64 52.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.291 1.037 . . . . 0.0 110.062 170.297 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 92.2 t -107.65 130.99 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.41 . . . . 0.0 110.526 -174.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.1 p -108.06 171.24 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.288 1.435 . . . . 0.0 112.739 178.921 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.59 154.62 44.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.372 1.463 . . . . 0.0 113.67 -178.576 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.28 -23.86 54.41 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.02 1.328 . . . . 0.0 113.241 179.035 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 125.809 1.644 . . . . 0.0 114.095 -179.678 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 121.301 0.572 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -67.85 128.69 93.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.055 0.942 . . . . 0.0 110.578 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.0 167.69 25.6 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.522 2.815 . . . . 0.0 112.822 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -104.88 121.39 43.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 108.621 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -146.73 126.01 13.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.676 1.19 . . . . 0.0 110.299 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.26 159.63 41.84 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.433 1.893 . . . . 0.0 110.09 -170.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -133.11 139.49 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.116 1.366 . . . . 0.0 110.315 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.6 mt -133.48 135.2 24.77 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 109.118 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.96 109.67 2.74 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.364 2.709 . . . . 0.0 109.765 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 47.1 t80 -175.7 151.93 1.22 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.344 2.258 . . . . 0.0 108.956 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 41.5 m -134.67 125.89 28.0 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 110.576 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 37.5 mt -82.97 134.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.862 1.265 . . . . 0.0 109.389 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -131.77 -60.22 0.93 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 0.0 111.564 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.4 tptt -152.27 127.5 9.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.552 1.541 . . . . 0.0 110.388 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.95 -149.95 17.82 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.288 1.423 . . . . 0.0 111.648 -167.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.09 146.14 18.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.565 1.146 . . . . 0.0 111.089 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.5 tt -126.89 136.04 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.776 1.631 . . . . 0.0 111.043 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.9 p -148.58 173.16 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.398 1.879 . . . . 0.0 110.252 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.82 -170.69 24.71 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.65 137.96 15.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.593 1.557 . . . . 0.0 109.716 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 20.9 t -113.6 135.01 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 108.195 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -119.41 132.42 55.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.632 1.173 . . . . 0.0 111.457 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.08 142.52 25.21 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.842 1.657 . . . . 0.0 111.694 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.23 -32.96 82.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.149 3.232 . . . . 0.0 114.407 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -72.32 2.83 5.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.908 1.283 . . . . 0.0 114.34 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.35 4.75 65.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.634 1.588 . . . . 0.0 114.599 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.7 164.29 16.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.225 1.41 . . . . 0.0 111.91 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.4 m -137.91 152.83 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.603 1.561 . . . . 0.0 110.889 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.01 163.21 36.6 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.319 1.448 . . . . 0.0 111.624 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -105.97 139.17 19.98 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.169 0.988 . . . . 0.0 111.128 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.63 170.1 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.227 3.284 . . . . 0.0 111.771 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.7 m -109.5 135.71 50.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.41 1.484 . . . . 0.0 108.964 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.62 135.66 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.975 1.31 . . . . 0.0 109.252 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 53.0 m -137.98 127.3 24.63 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.323 1.449 . . . . 0.0 109.971 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -80.27 129.98 34.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.001 0.92 . . . . 0.0 111.154 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.7 -8.77 58.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 37.3 mtmm 63.97 14.3 8.33 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.532 2.333 . . . . 0.0 113.805 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.46 8.38 21.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.221 2.209 . . . . 0.0 112.503 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 12.52 57.07 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.22 1.39 . . . . 0.0 114.4 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.0 p -131.32 155.42 47.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.035 1.734 . . . . 0.0 111.202 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.3 m -112.99 139.47 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.058 0.943 . . . . 0.0 109.869 163.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 49.5 m -96.62 139.5 32.61 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.002 1.321 . . . . 0.0 108.523 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.6 t -124.92 134.82 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.475 1.51 . . . . 0.0 109.241 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -136.17 153.58 51.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 112.504 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.92 136.56 16.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.787 1.635 . . . . 0.0 111.576 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.63 123.46 70.86 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.643 1.177 . . . . 0.0 110.724 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.81 160.2 18.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.942 3.095 . . . . 0.0 112.574 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.9 p -152.34 -9.56 0.19 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.73 149.47 45.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.852 1.661 . . . . 0.0 110.075 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -91.6 166.25 12.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.176 0.991 . . . . 0.0 111.969 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.76 -171.06 13.8 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.148 1.356 . . . . 0.0 113.795 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.54 121.41 30.89 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.723 1.209 . . . . 0.0 109.825 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 70.2 m80 -119.85 165.32 14.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.134 1.774 . . . . 0.0 111.833 -172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.78 154.11 37.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.965 0.906 . . . . 0.0 111.975 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.3 ttm -134.94 127.4 30.52 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.904 2.082 . . . . 0.0 109.986 -168.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -97.4 135.6 39.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.617 1.567 . . . . 0.0 109.975 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.5 mm -132.95 130.55 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.932 1.293 . . . . 0.0 109.769 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.04 138.72 32.0 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.2 t80 -101.85 119.36 38.66 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 109.323 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.17 32.75 11.1 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.916 1.286 . . . . 0.0 112.903 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.5 m-80 74.95 7.22 4.28 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.957 2.503 . . . . 0.0 115.266 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.1 tpp -100.01 129.48 46.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.585 1.154 . . . . 0.0 110.573 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.79 136.7 56.97 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.373 -0.829 . . . . 0.0 113.067 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.7 pt -75.63 155.65 85.24 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.555 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -58.97 129.48 32.14 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.059 1.839 . . . . 0.0 109.485 169.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.06 62.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.499 1.047 . . . . 0.0 114.124 -174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -82.27 143.81 49.2 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.722 1.761 . . . . 0.0 111.209 171.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.0 155.68 91.58 Favored 'Cis proline' 0 C--N 1.351 0.684 0 CA-C-N 119.944 1.016 . . . . 0.0 112.117 -5.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.91 153.43 18.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.553 1.141 . . . . 0.0 110.548 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -150.0 135.07 17.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.693 1.197 . . . . 0.0 109.789 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.17 169.92 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.735 1.214 . . . . 0.0 112.324 -170.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 29.6 t80 -104.19 147.61 27.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.272 -0.892 . . . . 0.0 112.309 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 85.3 t -117.69 133.58 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.295 1.838 . . . . 0.0 108.893 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -151.1 163.04 39.71 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -169.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -80.0 87.63 5.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.226 1.411 . . . . 0.0 111.105 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 10.7 p -54.53 -27.59 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.242 1.417 . . . . 0.0 114.506 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -77.82 -16.99 57.91 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -75.9 161.97 28.52 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.749 1.219 . . . . 0.0 112.438 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.44 -9.82 78.39 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.9 1.238 . . . . 0.0 115.778 -169.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -66.63 147.72 52.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.169 1.485 . . . . 0.0 113.165 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 p -64.47 134.58 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.774 -0.579 . . . . 0.0 109.709 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.1 t -156.2 160.9 40.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.508 1.123 . . . . 0.0 111.057 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.93 142.92 33.04 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.06 161.05 19.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.526 1.531 . . . . 0.0 112.922 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 136.87 175.03 13.57 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.392 1.472 . . . . 0.0 113.046 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.31 -36.95 8.49 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.723 2.282 . . . . 0.0 112.944 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.18 -34.64 90.17 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.439 1.018 . . . . 0.0 114.608 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.59 -6.18 54.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.653 1.227 . . . . 0.0 113.561 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.0 m -104.7 -43.78 5.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.403 1.881 . . . . 0.0 111.166 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -147.31 142.76 27.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.582 1.953 . . . . 0.0 111.916 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -134.21 173.66 21.26 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.349 0.976 . . . . 0.0 113.052 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 28.0 t -138.69 133.3 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.348 1.059 . . . . 0.0 108.575 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.5 m -57.15 133.77 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.165 0.586 . . . . 0.0 112.442 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 23.1 m120 69.61 0.16 2.86 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.872 2.069 . . . . 0.0 114.192 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -103.14 138.66 19.61 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.212 1.405 . . . . 0.0 110.541 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.24 112.64 3.48 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.604 2.203 . . . . 0.0 109.866 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -96.39 133.1 41.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.132 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.7 p -127.04 153.63 45.7 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1886 ' ' PHE . . . . . 0.405 ' CZ ' HG11 ' A' 1922 ' ' VAL . 54.4 p90 -162.83 176.23 10.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.989 1.716 . . . . 0.0 111.415 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.7 m -126.82 142.63 51.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.24 1.416 . . . . 0.0 110.493 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.8 t -114.31 126.58 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 107.801 167.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -93.55 120.18 33.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.923 0.889 . . . . 0.0 110.378 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 20.2 p -119.76 15.45 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.97 2.108 . . . . 0.0 112.096 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -58.45 -30.97 67.36 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.029 1.732 . . . . 0.0 114.726 -164.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -131.69 20.28 4.66 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.993 1.717 . . . . 0.0 112.101 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -81.06 -9.5 59.82 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 90.98 -125.56 8.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.39 0.995 . . . . 0.0 112.623 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -154.03 151.5 29.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.335 1.454 . . . . 0.0 111.26 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 154.55 -156.21 26.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.821 1.677 . . . . 0.0 112.521 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.2 107.81 3.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.091 0.853 . . . . 0.0 111.218 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.54 126.53 32.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.884 1.274 . . . . 0.0 108.502 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -130.66 158.1 40.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.905 1.282 . . . . 0.0 112.607 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.6 tp -157.49 135.43 10.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.407 1.883 . . . . 0.0 108.728 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.63 161.39 39.9 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.949 0.9 . . . . 0.0 112.203 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.3 mt -134.87 135.65 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.589 1.156 . . . . 0.0 109.563 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.83 113.51 20.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.037 1.335 . . . . 0.0 109.316 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -129.44 -173.91 13.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.99 1.281 . . . . 0.0 113.912 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.97 -18.57 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.003 3.135 . . . . 0.0 112.32 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -142.57 157.32 44.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.772 1.629 . . . . 0.0 109.339 165.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1907 ' ' LYS . . . . . 0.432 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 1.0 OUTLIER -73.3 107.84 5.84 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.111 -0.993 . . . . 0.0 111.729 -175.502 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.49 145.81 48.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.867 0.867 . . . . 0.0 111.165 167.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.48 145.8 24.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.484 0.713 . . . . 0.0 110.457 168.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.0 mt -134.9 140.8 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.934 1.293 . . . . 0.0 110.316 -165.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 59.6 m -133.42 155.93 48.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.818 1.647 . . . . 0.0 110.713 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.4 p -153.23 153.97 33.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.482 1.113 . . . . 0.0 112.125 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.4 m -143.76 126.32 15.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.831 1.252 . . . . 0.0 110.748 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.66 131.17 39.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.968 1.307 . . . . 0.0 111.396 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -103.97 151.8 22.76 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.668 1.587 . . . . 0.0 111.852 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -68.18 -16.21 63.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.887 0.875 . . . . 0.0 113.184 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.22 -12.45 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 113.518 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.72 19.2 35.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.676 1.132 . . . . 0.0 114.139 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 80.4 p -114.2 165.36 12.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.958 1.703 . . . . 0.0 110.749 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.8 m -115.26 129.0 56.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.169 1.387 . . . . 0.0 109.916 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.1 t -87.0 151.7 23.04 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.842 0.857 . . . . 0.0 110.65 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1922 ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' 1886 ' ' PHE . 89.6 t -132.21 144.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.136 1.774 . . . . 0.0 110.026 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.6 t -141.81 141.69 33.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.641 1.577 . . . . 0.0 110.924 171.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.2 p90 -147.19 155.0 41.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.1 mt -119.72 104.31 44.9 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.569 1.547 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.01 167.46 18.08 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.632 2.888 . . . . 0.0 110.36 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.4 p -132.29 -18.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -170.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.51 150.18 50.14 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.61 1.164 . . . . 0.0 110.404 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.29 142.57 27.17 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 111.552 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 158.61 -167.55 34.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.66 1.124 . . . . 0.0 113.331 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.33 126.8 40.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.215 1.406 . . . . 0.0 112.111 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -120.62 124.28 44.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.801 1.64 . . . . 0.0 109.922 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.9 m -87.64 121.08 29.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.116 -0.99 . . . . 0.0 110.851 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.51 127.88 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 108.522 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.46 130.54 55.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 38.2 t -133.22 130.56 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.289 1.036 . . . . 0.0 109.804 172.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.83 144.45 24.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 -167.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.08 124.76 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.892 1.277 . . . . 0.0 110.165 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 56.02 53.49 9.08 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.867 1.267 . . . . 0.0 111.676 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.94 3.42 0.32 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.988 2.915 . . . . 0.0 116.75 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -107.49 126.55 52.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.758 1.223 . . . . 0.0 110.718 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -63.89 147.29 52.28 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.238 -0.914 . . . . 0.0 111.949 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 9.9 m -68.85 152.84 96.57 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.672 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.99 130.29 30.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.165 1.91 . . . . 0.0 110.527 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.94 -15.93 61.63 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.005 1.288 . . . . 0.0 114.919 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.8 t -77.67 140.85 63.97 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 119.282 1.541 . . . . 0.0 111.465 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.72 137.87 52.75 Favored 'Cis proline' 0 C--N 1.352 0.727 0 CA-C-N 119.337 0.799 . . . . 0.0 112.077 -3.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -89.63 169.86 10.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.203 1.801 . . . . 0.0 110.555 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.6 m -129.12 115.95 18.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.698 0.799 . . . . 0.0 110.781 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.27 144.93 25.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.872 1.269 . . . . 0.0 110.656 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 17.8 ttt85 -108.82 121.52 45.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.832 0.853 . . . . 0.0 110.035 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.1 t -102.44 134.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.179 1.392 . . . . 0.0 110.648 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 48.4 p -114.88 169.64 8.93 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.252 1.421 . . . . 0.0 112.939 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.3 140.16 22.58 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.027 1.298 . . . . 0.0 112.612 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 124.38 1.072 . . . . 0.0 112.855 174.414 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 120.987 0.422 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -58.39 118.1 25.27 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.97 1.308 . . . . 0.0 110.991 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.08 152.68 45.99 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.024 2.483 . . . . 0.0 111.037 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.26 113.94 27.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.804 0.842 . . . . 0.0 109.71 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -146.81 125.23 12.34 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 109.99 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.16 153.48 50.45 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.482 1.913 . . . . 0.0 109.891 -173.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.8 p -129.2 136.77 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.029 1.332 . . . . 0.0 110.351 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.01 138.72 33.03 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.001 1.72 . . . . 0.0 109.074 -175.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.87 67.7 7.93 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 124.353 3.369 . . . . 0.0 111.698 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -113.82 150.73 33.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.146 1.778 . . . . 0.0 110.231 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 77.7 m -119.08 125.41 49.24 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.596 1.158 . . . . 0.0 109.751 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 81.1 mt -91.46 132.08 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.755 1.222 . . . . 0.0 109.876 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -114.35 -100.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.18 1.392 . . . . 0.0 110.746 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.4 mttp -133.69 139.35 46.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 111.089 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.4 -139.81 11.2 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.719 1.628 . . . . 0.0 110.801 -165.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.53 141.61 16.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.118 0.967 . . . . 0.0 111.36 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.68 135.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 0.0 110.711 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.3 p -145.77 174.58 11.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.112 1.765 . . . . 0.0 110.206 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.44 -170.96 24.64 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.3 140.14 16.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.843 1.657 . . . . 0.0 109.305 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.1 t -117.72 130.74 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.546 1.539 . . . . 0.0 108.343 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -117.99 128.36 54.71 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.001 1.32 . . . . 0.0 110.389 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 32.4 mtt -99.76 153.32 37.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.198 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -17.87 31.83 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.431 2.754 . . . . 0.0 112.831 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 35.3 p -72.76 -8.06 53.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.0 113.973 170.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.51 83.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.721 1.629 . . . . 0.0 113.777 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -72.52 159.54 33.76 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.599 1.16 . . . . 0.0 112.536 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 46.9 t -139.34 142.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.517 1.527 . . . . 0.0 110.169 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.88 171.15 16.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.885 1.674 . . . . 0.0 111.772 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -106.61 140.39 21.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.34 1.056 . . . . 0.0 111.264 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -86.65 174.0 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.549 3.499 . . . . 0.0 111.94 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 60.3 m -113.46 131.76 55.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.394 1.478 . . . . 0.0 108.982 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.01 133.31 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.839 1.256 . . . . 0.0 109.154 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 92.9 m -123.51 129.04 50.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.152 1.781 . . . . 0.0 109.789 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 59.5 t0 -81.78 118.61 23.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.309 1.044 . . . . 0.0 110.127 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -83.01 -10.54 58.71 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.8 mmmt 73.5 -10.44 1.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.269 2.628 . . . . 0.0 114.331 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -92.75 5.61 50.52 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.495 1.918 . . . . 0.0 113.691 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.89 15.82 53.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.802 1.191 . . . . 0.0 113.716 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 67.3 p -128.26 159.29 35.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.364 1.866 . . . . 0.0 110.286 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -121.79 143.01 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.494 1.118 . . . . 0.0 109.875 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 31.8 m -104.09 137.23 42.34 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.396 1.078 . . . . 0.0 108.618 170.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.3 t -124.92 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.184 1.394 . . . . 0.0 109.042 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -133.76 156.45 47.97 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.138 1.375 . . . . 0.0 112.826 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 22.9 t80 -155.61 135.76 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.828 1.651 . . . . 0.0 111.427 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.37 120.05 71.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.411 1.084 . . . . 0.0 110.776 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.33 139.99 21.49 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.349 2.699 . . . . 0.0 112.01 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.2 m -132.92 0.3 3.48 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -161.4 150.46 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.296 1.838 . . . . 0.0 109.686 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -86.09 173.06 10.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.857 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.09 -172.68 21.73 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.262 1.41 . . . . 0.0 114.098 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -78.0 125.84 29.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.618 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 51.2 m80 -123.09 163.05 21.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.075 1.75 . . . . 0.0 111.372 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.22 153.1 34.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.157 0.983 . . . . 0.0 111.862 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 28.0 ttm -137.36 135.25 36.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.956 1.702 . . . . 0.0 110.771 -167.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.11 134.3 51.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.443 1.897 . . . . 0.0 109.848 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.6 mm -133.97 130.59 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.171 1.388 . . . . 0.0 109.53 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 136.5 23.4 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -173.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.67 122.68 43.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.641 1.976 . . . . 0.0 109.784 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 51.82 31.28 8.03 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.876 1.27 . . . . 0.0 112.881 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 18.1 t30 77.62 5.09 3.01 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.279 2.631 . . . . 0.0 115.108 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 95.9 mtp -100.07 129.36 46.11 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.31 1.444 . . . . 0.0 110.772 170.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -56.77 137.15 55.05 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.6 pt -74.55 151.14 87.18 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.861 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.04 132.34 44.11 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.672 2.248 . . . . 0.0 110.243 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.91 -17.15 59.83 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.733 1.159 . . . . 0.0 113.905 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.9 t -85.53 147.77 47.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 119.164 1.482 . . . . 0.0 110.905 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.44 157.43 99.47 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.666 1.274 . . . . 0.0 113.251 -0.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 80.1 mt -101.38 157.87 16.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.67 1.588 . . . . 0.0 110.884 173.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -151.93 135.26 15.96 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.839 1.256 . . . . 0.0 110.154 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.2 p90 -165.51 167.2 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 111.98 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -108.52 141.09 40.93 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.126 -0.984 . . . . 0.0 112.928 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.9 t -111.56 139.93 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.815 1.646 . . . . 0.0 109.679 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -161.42 151.77 17.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.9 1.28 . . . . 0.0 112.22 -170.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -67.53 134.15 50.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.932 1.293 . . . . 0.0 112.152 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -68.41 -27.37 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.113 -0.992 . . . . 0.0 113.289 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.89 -21.33 44.11 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -170.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.6 t -67.22 147.03 53.57 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.484 -0.76 . . . . 0.0 112.964 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.9 -6.77 82.0 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.145 1.355 . . . . 0.0 115.103 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.29 166.85 11.36 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.09 1.445 . . . . 0.0 114.0 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.8 t -73.19 144.73 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.978 0.911 . . . . 0.0 108.832 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.0 t -159.74 148.25 17.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.03 1.332 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.61 144.83 50.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.62 1.168 . . . . 0.0 111.658 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.7 p90 -166.73 161.65 15.73 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.615 1.566 . . . . 0.0 112.745 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.02 175.36 13.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.324 1.44 . . . . 0.0 112.897 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 -36.48 9.66 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.721 2.28 . . . . 0.0 112.832 -171.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.96 90.75 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.378 0.99 . . . . 0.0 114.406 -171.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -78.77 -5.64 53.84 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.829 1.314 . . . . 0.0 113.615 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 32.3 m -104.89 -42.1 5.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.409 1.884 . . . . 0.0 111.25 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -151.14 143.39 24.11 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.772 2.029 . . . . 0.0 112.054 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -136.09 177.56 19.45 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.822 1.201 . . . . 0.0 113.212 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 25.5 t -142.96 135.19 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.905 1.282 . . . . 0.0 108.378 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.94 135.33 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 66.34 2.81 2.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.604 1.962 . . . . 0.0 114.382 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -100.01 142.3 24.36 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.907 1.283 . . . . 0.0 110.807 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.37 109.13 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.777 2.318 . . . . 0.0 109.853 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -93.6 133.0 37.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.003 1.321 . . . . 0.0 110.134 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.8 p -127.35 149.01 50.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -159.51 174.79 14.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.754 1.621 . . . . 0.0 111.664 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.8 m -126.51 145.14 50.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.347 1.459 . . . . 0.0 110.721 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 29.9 t -114.76 130.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.476 1.511 . . . . 0.0 108.128 167.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.02 132.77 36.29 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.226 1.011 . . . . 0.0 111.051 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.5 p -131.91 13.67 4.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.787 2.035 . . . . 0.0 112.449 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -50.61 -36.2 33.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.258 2.223 . . . . 0.0 115.268 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.27 24.83 3.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.647 1.579 . . . . 0.0 111.858 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.05 69.03 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.461 1.105 . . . . 0.0 113.619 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.66 150.74 5.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.827 1.203 . . . . 0.0 112.337 -169.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -73.82 149.27 41.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.744 0.783 . . . . 0.0 112.024 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.74 14.42 0.02 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.881 1.705 . . . . 0.0 114.905 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 92.85 100.63 1.46 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.535 1.541 . . . . 0.0 112.806 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.49 130.7 35.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.366 1.466 . . . . 0.0 109.415 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.3 m -126.96 158.4 36.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.64 1.576 . . . . 0.0 112.123 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.7 tp -160.72 135.45 7.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.788 1.635 . . . . 0.0 109.23 -169.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 161.57 38.1 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.043 0.937 . . . . 0.0 112.321 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -135.53 134.58 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.762 1.225 . . . . 0.0 109.547 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -116.73 115.7 26.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.001 1.32 . . . . 0.0 109.326 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -128.37 -177.64 14.97 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.978 1.275 . . . . 0.0 113.873 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.54 -22.65 44.32 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.001 3.134 . . . . 0.0 112.128 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -140.28 158.06 44.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.57 . . . . 0.0 109.069 161.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 118.51 11.98 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.093 -1.005 . . . . 0.0 111.915 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.09 142.63 33.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.207 1.003 . . . . 0.0 110.824 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.05 142.0 28.24 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.322 0.649 . . . . 0.0 110.082 171.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.8 mt -132.06 139.21 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.822 1.249 . . . . 0.0 110.471 -167.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.8 m -128.38 155.56 44.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.861 1.664 . . . . 0.0 110.393 167.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -151.46 156.23 40.19 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.156 0.982 . . . . 0.0 112.237 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.7 m -140.49 118.62 11.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.341 1.456 . . . . 0.0 109.697 -171.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.31 123.71 25.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.169 0.988 . . . . 0.0 110.779 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.55 -17.91 26.18 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 15.0 mm100 71.27 -10.34 0.8 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.344 2.658 . . . . 0.0 114.495 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.69 -14.04 61.48 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.313 1.445 . . . . 0.0 113.104 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 116.81 22.03 4.43 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.509 1.528 . . . . 0.0 114.17 -170.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.0 p -142.38 158.5 43.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.676 1.59 . . . . 0.0 111.111 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -126.23 135.45 51.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.632 1.973 . . . . 0.0 109.068 166.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 16.4 t -94.83 153.29 17.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.459 1.104 . . . . 0.0 111.343 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -132.11 145.03 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.316 1.846 . . . . 0.0 110.0 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.2 t -140.63 138.85 34.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.694 1.598 . . . . 0.0 110.752 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.99 154.5 42.62 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 26.4 mt -118.07 102.62 50.75 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.097 1.759 . . . . 0.0 110.415 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.68 160.67 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.546 2.83 . . . . 0.0 110.139 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.9 m -127.15 -7.77 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.72 151.18 22.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.176 1.39 . . . . 0.0 110.402 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.07 140.77 25.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.796 2.331 . . . . 0.0 111.691 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 157.8 -169.86 34.66 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.86 1.219 . . . . 0.0 113.087 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.82 135.3 35.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.889 1.276 . . . . 0.0 112.135 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.56 128.69 46.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.288 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.0 m -90.51 122.58 33.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.18 -0.95 . . . . 0.0 110.963 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.53 125.69 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.356 1.462 . . . . 0.0 108.621 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.09 130.42 55.48 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.424 1.49 . . . . 0.0 109.71 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 39.2 t -133.25 129.96 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.349 1.06 . . . . 0.0 109.753 172.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.48 142.26 22.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.145 1.378 . . . . 0.0 111.511 -168.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.5 122.17 19.75 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.817 1.247 . . . . 0.0 109.523 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.5 57.89 5.71 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.038 1.335 . . . . 0.0 112.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 8.2 pt-20 59.7 2.42 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.965 2.906 . . . . 0.0 116.819 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -107.5 123.54 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.567 1.147 . . . . 0.0 110.998 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.88 145.41 55.87 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.306 -0.871 . . . . 0.0 111.984 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.4 m -73.39 157.37 88.08 Favored Pre-proline 0 N--CA 1.48 1.065 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.64 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.04 125.82 20.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.63 2.887 . . . . 0.0 111.785 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.24 -11.36 67.84 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.705 1.145 . . . . 0.0 115.469 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.3 t -76.44 139.73 67.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.356 1.578 . . . . 0.0 111.579 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.07 136.84 47.06 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 CA-C-N 119.382 0.815 . . . . 0.0 111.969 -3.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -87.07 170.25 11.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.134 1.774 . . . . 0.0 110.662 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.1 m -128.92 117.76 21.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.748 0.819 . . . . 0.0 110.771 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.1 160.31 15.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.455 1.502 . . . . 0.0 110.954 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -127.62 126.22 41.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.553 1.141 . . . . 0.0 110.207 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.5 t -107.23 134.44 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 0.0 110.866 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 41.8 p -107.2 157.61 17.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.075 1.35 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -94.27 116.76 5.35 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.104 1.335 . . . . 0.0 112.349 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.73 1.212 . . . . 0.0 112.935 173.318 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.373 0.606 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -55.17 114.0 6.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.046 1.739 . . . . 0.0 111.302 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.3 142.54 50.26 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.566 2.177 . . . . 0.0 109.71 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 39.6 t80 -120.14 123.36 43.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.531 0.732 . . . . 0.0 111.457 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.3 135.88 13.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.92 1.688 . . . . 0.0 110.572 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.0 151.63 45.63 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.214 1.805 . . . . 0.0 110.317 -171.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.5 p -117.6 140.23 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.233 1.413 . . . . 0.0 110.318 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.7 mt -133.21 134.93 24.72 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.407 1.883 . . . . 0.0 108.367 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.37 38.75 0.75 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 124.33 3.353 . . . . 0.0 113.354 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.0 t80 -87.26 152.78 22.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.005 1.322 . . . . 0.0 111.415 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 94.2 m -122.94 127.46 48.93 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.419 1.488 . . . . 0.0 109.708 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.6 mt -75.61 136.24 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.457 1.103 . . . . 0.0 111.216 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.1 pttt -112.74 -148.97 0.44 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.497 1.919 . . . . 0.0 112.036 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -87.16 131.91 34.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.557 1.143 . . . . 0.0 111.102 167.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.52 -139.54 11.03 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.311 1.434 . . . . 0.0 111.884 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -156.68 145.01 19.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.567 1.147 . . . . 0.0 111.74 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.6 tt -117.81 137.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.987 1.715 . . . . 0.0 111.057 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 26.1 p -146.27 161.16 40.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.689 1.596 . . . . 0.0 110.799 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.86 20.05 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.0 138.98 18.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.7 1.6 . . . . 0.0 109.798 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 19.6 t -111.56 136.62 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.337 1.855 . . . . 0.0 108.053 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -121.11 125.02 46.18 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 110.882 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.05 148.25 34.12 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.84 1.656 . . . . 0.0 111.319 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.53 -20.2 31.49 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.481 2.787 . . . . 0.0 113.929 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.6 t -77.03 -4.08 42.38 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.91 51.06 2.53 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.596 1.093 . . . . 0.0 113.035 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.81 166.96 25.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.678 1.591 . . . . 0.0 111.849 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.9 m -139.41 159.49 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.671 1.188 . . . . 0.0 113.071 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.05 171.83 18.47 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.142 2.177 . . . . 0.0 110.545 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -107.26 137.98 19.76 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.822 0.849 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.97 168.11 13.91 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.939 3.092 . . . . 0.0 110.972 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.5 m -104.63 126.23 51.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.005 1.322 . . . . 0.0 108.83 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.31 137.67 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.962 1.305 . . . . 0.0 108.846 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 24.4 m -146.71 127.25 14.13 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 109.393 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.56 143.64 40.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 112.648 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -88.76 -3.09 58.85 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? 65.94 18.49 11.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.343 1.857 . . . . 0.0 112.978 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -128.2 15.53 6.72 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.529 1.932 . . . . 0.0 112.684 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 85.11 15.91 66.03 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.575 1.083 . . . . 0.0 114.094 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 30.2 p -135.19 158.14 45.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.281 1.833 . . . . 0.0 110.32 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -123.81 144.66 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.613 1.165 . . . . 0.0 110.497 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.1 m -103.71 140.16 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.118 1.367 . . . . 0.0 108.862 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 34.0 t -122.62 133.78 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.486 1.514 . . . . 0.0 108.833 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.45 153.77 50.54 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.574 1.55 . . . . 0.0 111.983 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 26.6 t80 -157.0 133.31 9.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.207 1.403 . . . . 0.0 111.826 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.43 119.04 71.23 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.374 1.07 . . . . 0.0 110.513 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.59 144.31 31.68 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.524 2.816 . . . . 0.0 112.114 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.7 p -129.07 -7.6 4.88 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -159.88 150.97 19.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.74 1.616 . . . . 0.0 110.698 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.31 170.8 14.22 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.649 1.18 . . . . 0.0 113.308 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.15 -171.09 13.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.099 1.809 . . . . 0.0 113.919 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.3 tp -85.21 133.72 34.17 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.753 1.221 . . . . 0.0 110.035 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -130.47 166.47 20.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.028 1.731 . . . . 0.0 111.37 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.67 157.32 45.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.447 1.099 . . . . 0.0 110.691 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.2 tmm? -146.56 135.02 21.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.013 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.31 137.71 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.832 2.053 . . . . 0.0 110.03 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.0 mm -135.03 132.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.133 1.373 . . . . 0.0 110.137 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 141.21 32.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.4 t80 -103.27 120.49 40.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.541 1.936 . . . . 0.0 109.965 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.26 32.39 8.15 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.716 1.206 . . . . 0.0 112.889 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.8 t30 81.47 0.69 1.6 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.728 2.811 . . . . 0.0 115.08 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 57.4 ttm -98.83 128.5 45.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.343 1.457 . . . . 0.0 110.957 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.27 137.42 52.26 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.38 154.17 81.84 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.26 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.51 129.58 33.21 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.514 2.143 . . . . 0.0 109.988 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.79 -16.92 59.65 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.812 1.196 . . . . 0.0 114.065 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.6 t -86.66 145.51 39.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 119.699 1.75 . . . . 0.0 111.244 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -82.8 165.31 70.91 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.076 1.063 . . . . 0.0 112.73 -4.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.63 156.88 25.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.286 1.834 . . . . 0.0 111.423 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -137.05 137.88 39.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.522 1.529 . . . . 0.0 109.71 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 27.0 p90 -158.5 155.89 29.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.284 1.034 . . . . 0.0 112.315 -169.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.0 t80 -106.01 148.17 28.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.878 0.871 . . . . 0.0 112.341 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 55.0 t -126.11 137.45 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.523 1.529 . . . . 0.0 108.979 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -150.35 158.43 44.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.599 1.16 . . . . 0.0 113.115 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.8 118.46 20.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.941 0.896 . . . . 0.0 111.748 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.6 p -62.9 -34.29 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.743 1.217 . . . . 0.0 114.017 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -88.24 -7.44 56.8 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 39.7 t -67.35 -34.04 76.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.292 1.037 . . . . 0.0 113.065 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 82.67 2.6 90.65 Favored Glycine 0 N--CA 1.476 1.319 0 C-N-CA 124.901 1.239 . . . . 0.0 115.325 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -64.03 163.26 12.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.622 1.569 . . . . 0.0 113.698 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.3 t -70.16 132.76 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.0 t -165.27 164.24 19.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.784 1.233 . . . . 0.0 110.963 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.32 143.9 44.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.433 1.493 . . . . 0.0 111.251 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.5 p90 -162.93 162.84 26.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.278 1.431 . . . . 0.0 112.782 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 125.89 173.59 13.66 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.443 1.497 . . . . 0.0 112.797 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.01 -34.99 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.793 2.329 . . . . 0.0 112.947 -170.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.82 -32.95 82.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.51 1.05 . . . . 0.0 114.786 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.33 -6.08 55.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.877 1.338 . . . . 0.0 113.526 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.2 m -105.0 -45.28 4.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.497 1.919 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -146.44 150.52 35.78 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.679 1.992 . . . . 0.0 112.132 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 179.86 22.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.293 0.949 . . . . 0.0 113.493 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 31.5 t -142.45 133.2 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 0.0 108.522 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.5 m -55.54 137.44 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.3 m-80 68.98 -4.92 1.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.072 2.149 . . . . 0.0 114.814 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -104.39 138.58 19.56 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.012 1.325 . . . . 0.0 110.771 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.93 127.13 12.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.368 2.045 . . . . 0.0 110.334 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.21 145.18 32.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.595 1.558 . . . . 0.0 110.368 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.6 p -135.11 151.07 50.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.909 0.884 . . . . 0.0 113.245 -167.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.5 p90 -162.01 176.26 10.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.945 1.698 . . . . 0.0 111.441 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 67.8 m -129.93 143.03 50.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.226 1.411 . . . . 0.0 110.275 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 49.0 t -115.4 135.15 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.689 1.596 . . . . 0.0 108.137 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -98.7 133.67 42.7 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.364 1.066 . . . . 0.0 111.136 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.7 p -134.61 14.57 3.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.778 1.631 . . . . 0.0 112.519 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.12 -34.78 70.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.645 1.578 . . . . 0.0 114.992 -163.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -129.39 21.51 5.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.691 1.596 . . . . 0.0 111.868 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.59 -39.14 70.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.482 1.113 . . . . 0.0 113.841 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.41 146.76 4.61 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.783 1.183 . . . . 0.0 112.01 -168.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.13 165.86 22.66 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 113.391 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.75 16.47 0.25 Allowed Glycine 0 N--CA 1.477 1.394 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.61 97.22 1.86 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.302 1.429 . . . . 0.0 113.126 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -80.14 127.22 32.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 108.952 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -120.08 159.49 24.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.775 1.63 . . . . 0.0 112.547 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -159.65 137.46 10.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.048 1.739 . . . . 0.0 109.437 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.13 159.51 36.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.442 1.097 . . . . 0.0 111.839 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.13 133.66 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.448 1.099 . . . . 0.0 109.813 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.52 132.68 53.98 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.182 1.393 . . . . 0.0 109.752 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.82 -165.6 15.11 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 119.089 -0.839 . . . . 0.0 114.412 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.31 -29.44 79.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.917 3.078 . . . . 0.0 111.996 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.2 t -129.83 150.43 51.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.851 1.26 . . . . 0.0 108.972 158.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -70.68 125.69 27.51 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.306 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.87 152.8 35.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.68 133.14 34.04 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 162.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.4 mt -133.07 143.13 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.823 1.249 . . . . 0.0 109.994 -166.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.7 t -143.42 158.99 43.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.931 1.293 . . . . 0.0 110.834 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -158.07 154.44 27.57 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.463 1.105 . . . . 0.0 112.436 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.7 m -135.84 120.06 17.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.302 1.441 . . . . 0.0 109.954 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.61 132.03 40.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.901 1.28 . . . . 0.0 110.913 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -109.82 138.77 45.72 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.156 1.382 . . . . 0.0 111.084 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -65.66 -17.85 64.9 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.863 0.865 . . . . 0.0 112.226 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.49 -12.44 57.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.048 1.739 . . . . 0.0 114.346 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.04 33.42 5.5 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.876 1.227 . . . . 0.0 114.486 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.8 p -140.55 164.24 30.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.596 1.558 . . . . 0.0 110.794 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.6 m -119.34 130.45 55.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 163.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -91.49 148.51 22.25 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 110.398 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.9 t -131.38 141.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.412 1.485 . . . . 0.0 110.606 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 49.8 m -133.43 143.46 48.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.947 1.699 . . . . 0.0 111.084 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.8 p90 -150.46 155.2 39.08 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.2 109.24 44.72 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.017 1.727 . . . . 0.0 110.67 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.86 174.68 10.03 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.712 2.941 . . . . 0.0 110.178 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -152.22 -31.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.32 146.17 31.96 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 119.319 0.963 . . . . 0.0 110.48 167.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.89 155.76 53.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.772 2.315 . . . . 0.0 110.703 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.02 -152.71 21.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.49 1.043 . . . . 0.0 112.926 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -114.37 129.75 56.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.634 1.173 . . . . 0.0 111.614 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.26 130.53 56.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 110.28 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.651 1.18 . . . . 0.0 110.798 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.34 124.3 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.416 1.886 . . . . 0.0 108.62 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.03 132.2 51.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.653 1.581 . . . . 0.0 109.58 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.3 t -133.36 131.87 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.417 1.487 . . . . 0.0 108.316 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.6 144.81 18.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.763 1.225 . . . . 0.0 110.714 -166.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.72 121.24 15.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.531 1.132 . . . . 0.0 109.591 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.2 t-20 52.64 57.72 6.11 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.059 1.344 . . . . 0.0 112.334 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.296 7.9 pt-20 59.36 11.72 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.302 2.641 . . . . 0.0 116.35 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.2 124.6 48.31 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.541 1.137 . . . . 0.0 111.218 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -61.1 154.58 22.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.058 0.943 . . . . 0.0 112.663 170.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.51 153.86 71.11 Favored Pre-proline 0 N--CA 1.479 0.984 0 O-C-N 121.845 -0.534 . . . . 0.0 110.269 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -57.15 123.14 13.13 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 110.457 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 97.33 -16.19 61.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.178 1.371 . . . . 0.0 115.956 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 89.8 p -79.56 152.98 75.94 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 120.321 2.06 . . . . 0.0 112.942 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.22 156.28 99.77 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 119.31 0.789 . . . . 0.0 112.675 -4.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -111.13 140.82 45.36 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.573 1.549 . . . . 0.0 111.001 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 43.8 m -95.25 115.43 27.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.509 0.724 . . . . 0.0 110.997 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.08 127.99 42.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.994 1.318 . . . . 0.0 110.664 169.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -96.0 125.21 40.39 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.187 0.595 . . . . 0.0 110.634 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.4 t -110.7 129.77 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.33 1.452 . . . . 0.0 110.897 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.7 p -97.73 148.77 23.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.702 1.201 . . . . 0.0 112.778 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.75 59.62 2.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.35 1.928 . . . . 0.0 112.782 -175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.328 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 120.94 0.4 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -63.35 122.34 75.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.808 1.243 . . . . 0.0 110.357 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.27 140.2 52.53 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.932 2.421 . . . . 0.0 110.485 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.0 t80 -94.63 123.13 37.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.215 0.606 . . . . 0.0 110.255 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -147.42 136.12 21.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.191 1.396 . . . . 0.0 110.504 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.47 149.48 37.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.202 1.801 . . . . 0.0 109.533 -173.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.89 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.056 1.342 . . . . 0.0 110.164 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.83 136.12 27.17 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.774 1.629 . . . . 0.0 109.231 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.93 107.04 2.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.475 2.783 . . . . 0.0 109.693 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -172.95 152.3 2.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.758 2.423 . . . . 0.0 108.464 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.7 m -132.59 126.99 34.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.359 1.064 . . . . 0.0 109.783 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.85 117.63 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.229 1.011 . . . . 0.0 109.749 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 36.9 tptt -100.44 -146.06 0.34 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.214 1.406 . . . . 0.0 110.414 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.2 tttt -78.3 125.28 29.13 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.466 -1.396 . . . . 0.0 111.021 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 139.51 -150.4 21.34 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 125.462 1.506 . . . . 0.0 112.117 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -159.09 147.01 17.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.489 1.116 . . . . 0.0 111.412 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.33 136.78 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.876 1.67 . . . . 0.0 111.07 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.25 167.32 24.52 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.809 1.644 . . . . 0.0 111.004 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.74 -173.63 30.63 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.22 132.55 11.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.96 1.704 . . . . 0.0 109.648 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 86.2 t -103.33 134.43 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.708 1.603 . . . . 0.0 108.326 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.44 131.51 54.2 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.069 1.347 . . . . 0.0 110.972 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.8 mtt -106.23 149.24 37.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.634 1.574 . . . . 0.0 111.617 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -56.0 -28.18 67.79 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.073 3.182 . . . . 0.0 115.183 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 34.8 p -74.45 -6.15 46.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.542 1.537 . . . . 0.0 114.388 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.49 -5.5 82.52 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.535 1.54 . . . . 0.0 113.718 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -70.04 157.11 38.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.589 1.155 . . . . 0.0 112.128 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -142.06 155.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.275 1.43 . . . . 0.0 111.645 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.24 177.43 11.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.953 2.101 . . . . 0.0 110.149 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.43 143.17 33.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 120.974 -1.078 . . . . 0.0 112.254 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -83.97 169.18 11.81 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.417 3.411 . . . . 0.0 111.666 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.4 m -111.01 130.23 55.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.486 1.514 . . . . 0.0 109.03 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.35 137.32 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.945 1.298 . . . . 0.0 109.666 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -138.98 129.21 25.46 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.265 1.426 . . . . 0.0 110.002 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.11 129.04 34.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.949 0.899 . . . . 0.0 110.776 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -84.31 -9.14 58.72 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 66.3 mttm 65.71 10.24 6.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.469 2.308 . . . . 0.0 113.897 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.9 6.93 31.9 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.208 2.203 . . . . 0.0 112.632 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.95 11.82 58.45 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.314 1.435 . . . . 0.0 114.162 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.31 155.64 45.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.207 1.803 . . . . 0.0 111.044 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.5 m -111.14 142.12 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.986 0.914 . . . . 0.0 109.701 162.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 33.7 m -102.06 138.57 38.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.816 1.246 . . . . 0.0 108.465 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.8 t -123.6 134.41 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.196 1.398 . . . . 0.0 109.019 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.19 156.36 46.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.223 1.409 . . . . 0.0 112.715 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 32.6 t80 -155.35 135.41 12.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.718 1.607 . . . . 0.0 111.786 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.03 116.25 65.41 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.536 1.135 . . . . 0.0 110.59 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.46 148.01 29.31 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.47 2.78 . . . . 0.0 112.348 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 7.6 t -140.56 -2.59 1.37 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.166 0.987 . . . . 0.0 113.639 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -144.7 148.29 34.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.366 1.866 . . . . 0.0 109.501 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.15 168.31 12.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.02 0.928 . . . . 0.0 112.076 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.04 -172.48 18.96 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.686 1.136 . . . . 0.0 114.59 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.1 tp -79.86 110.74 15.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.564 1.546 . . . . 0.0 110.912 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 49.1 m80 -107.18 164.05 12.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.191 1.797 . . . . 0.0 112.214 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 142.46 42.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.217 1.407 . . . . 0.0 109.95 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.5 ttm -122.72 126.32 47.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.925 1.29 . . . . 0.0 111.196 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 t70 -87.77 133.86 33.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.801 1.641 . . . . 0.0 110.091 166.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 16.9 mm -134.15 139.63 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.309 1.443 . . . . 0.0 109.874 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.4 142.22 23.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.116 0.966 . . . . 0.0 113.585 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.0 t80 -98.52 118.79 36.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 109.505 172.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.46 34.36 12.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.999 1.32 . . . . 0.0 112.919 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 74.38 10.69 4.22 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.784 2.434 . . . . 0.0 115.073 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 6.0 tmm? -107.39 126.48 52.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.618 1.567 . . . . 0.0 110.197 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m170 -54.87 131.98 45.47 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.044 -1.035 . . . . 0.0 113.711 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.6 pt -71.43 154.41 93.48 Favored Pre-proline 0 N--CA 1.481 1.088 0 O-C-N 121.247 -0.908 . . . . 0.0 111.464 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.53 122.04 10.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.431 2.087 . . . . 0.0 109.627 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.39 43.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.692 1.139 . . . . 0.0 114.563 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.8 t -80.95 147.68 62.4 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.326 1.563 . . . . 0.0 112.173 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.64 164.02 82.65 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.286 1.138 . . . . 0.0 112.258 -7.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 50.8 mt -97.26 156.69 16.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.047 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -153.26 134.35 14.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.395 1.078 . . . . 0.0 110.012 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -167.02 160.59 14.23 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.164 0.986 . . . . 0.0 112.852 -170.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 58.4 t80 -96.44 134.42 39.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.945 0.898 . . . . 0.0 112.74 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.7 t -98.03 128.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.944 1.297 . . . . 0.0 109.966 173.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -132.61 173.51 11.25 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.373 2.269 . . . . 0.0 111.581 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -74.4 141.44 45.08 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.018 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 6.0 p -63.17 -27.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.343 1.057 . . . . 0.0 113.334 -170.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -132.45 134.95 45.71 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.292 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 26.5 p -169.71 164.05 10.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.011 1.724 . . . . 0.0 112.172 -174.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.31 -22.99 20.76 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.721 1.153 . . . . 0.0 114.38 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -73.16 158.54 35.08 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.378 1.089 . . . . 0.0 113.497 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.3 t -70.44 128.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.81 0.844 . . . . 0.0 108.956 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.9 t -147.01 158.15 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.983 1.313 . . . . 0.0 110.45 -175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.13 142.57 36.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.055 1.342 . . . . 0.0 111.513 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.5 p90 -165.69 160.69 17.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.529 1.532 . . . . 0.0 112.532 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.38 174.24 13.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.113 1.339 . . . . 0.0 113.294 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.52 -33.12 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.943 2.429 . . . . 0.0 113.088 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.63 70.62 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.481 1.037 . . . . 0.0 114.501 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.99 -6.64 57.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.028 1.414 . . . . 0.0 113.191 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 49.6 m -102.41 -40.29 6.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.532 1.933 . . . . 0.0 111.794 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.581 1.952 . . . . 0.0 112.338 -167.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -158.59 -175.3 29.36 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.708 0.671 . . . . 0.0 113.822 168.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.5 p -152.46 137.2 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.24 1.416 . . . . 0.0 108.67 174.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 30.1 m -56.74 140.95 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.3 m-80 72.04 -3.03 2.34 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.518 2.327 . . . . 0.0 114.86 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 41.4 mttm -103.59 143.6 26.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.507 1.123 . . . . 0.0 111.133 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.7 123.2 8.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.61 147.25 26.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.384 1.473 . . . . 0.0 110.273 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 70.0 p -137.05 150.85 48.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -168.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -161.38 175.53 12.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.794 1.638 . . . . 0.0 111.592 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.6 m -126.97 142.31 51.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.959 1.304 . . . . 0.0 110.752 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.9 t -117.58 130.22 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.695 1.598 . . . . 0.0 108.27 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.3 m120 -93.75 129.28 40.15 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.231 1.012 . . . . 0.0 111.158 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 56.8 p -136.0 0.52 2.64 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.039 1.336 . . . . 0.0 113.997 -166.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.12 -38.2 67.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.402 1.481 . . . . 0.0 114.727 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.84 9.15 17.53 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.763 1.625 . . . . 0.0 112.935 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.79 -38.42 67.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.9 145.29 5.03 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.93 1.253 . . . . 0.0 112.34 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.1 140.73 49.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.962 0.905 . . . . 0.0 112.014 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 176.1 19.35 0.02 OUTLIER Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.959 1.144 . . . . 0.0 115.959 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 88.62 97.45 0.99 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.191 1.377 . . . . 0.0 112.58 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.51 129.23 34.97 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.328 1.451 . . . . 0.0 109.017 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -124.03 159.66 29.38 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.666 1.586 . . . . 0.0 112.286 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.7 tp -160.34 136.09 8.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.052 1.741 . . . . 0.0 109.09 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.48 157.46 35.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.866 . . . . 0.0 112.331 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.9 mt -137.01 140.74 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.015 1.326 . . . . 0.0 110.006 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.8 159.09 36.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.23 1.812 . . . . 0.0 109.745 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.28 -160.34 28.03 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.862 -0.966 . . . . 0.0 114.595 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.45 -24.61 63.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.123 3.215 . . . . 0.0 112.649 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.1 t -146.81 160.39 42.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.365 1.466 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.01 118.5 16.05 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.986 -1.071 . . . . 0.0 111.59 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.0 149.98 40.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.01 0.924 . . . . 0.0 111.953 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.72 141.01 29.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.799 0.84 . . . . 0.0 109.572 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.4 140.65 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.68 1.192 . . . . 0.0 110.585 -166.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 58.6 m -134.84 157.39 46.93 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.719 1.608 . . . . 0.0 111.124 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 42.3 t -154.14 143.42 21.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.358 1.063 . . . . 0.0 111.778 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.4 m -137.27 126.25 24.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.669 1.587 . . . . 0.0 110.514 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.02 135.89 36.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.176 1.39 . . . . 0.0 111.664 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -113.65 148.26 36.62 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.654 1.581 . . . . 0.0 111.642 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -64.72 -18.62 65.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.331 1.053 . . . . 0.0 112.479 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.73 -8.36 34.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.046 1.738 . . . . 0.0 114.271 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.05 30.01 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.54 1.067 . . . . 0.0 114.032 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 41.6 p -138.4 143.79 39.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.939 1.295 . . . . 0.0 111.399 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.4 m -92.51 123.86 36.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.38 1.072 . . . . 0.0 109.035 161.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.79 139.93 30.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 109.902 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.6 t -117.25 144.44 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.966 1.707 . . . . 0.0 109.933 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 62.8 p -136.79 145.31 44.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.407 1.083 . . . . 0.0 111.77 165.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.3 p90 -151.44 152.94 33.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 12.4 mt -116.57 105.82 49.48 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.042 1.737 . . . . 0.0 110.755 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.74 162.23 16.39 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.79 2.993 . . . . 0.0 110.447 167.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.0 m -134.99 -20.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.62 149.04 47.31 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 110.371 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.31 154.55 51.29 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 111.107 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 135.08 -164.01 24.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.842 1.21 . . . . 0.0 113.592 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -92.18 130.53 37.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 112.368 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -117.3 132.35 56.63 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.601 1.561 . . . . 0.0 110.513 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.3 m -90.71 125.88 35.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.545 1.138 . . . . 0.0 110.551 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.88 127.12 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.535 1.534 . . . . 0.0 108.583 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.88 132.56 54.05 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.496 1.519 . . . . 0.0 109.75 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 67.2 t -132.79 130.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.684 1.594 . . . . 0.0 108.203 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.98 142.63 19.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.616 1.166 . . . . 0.0 111.08 -168.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.01 121.56 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.786 1.234 . . . . 0.0 109.641 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 53.87 56.1 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.103 1.361 . . . . 0.0 112.468 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.2 pt-20 58.25 13.67 2.46 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 128.085 2.554 . . . . 0.0 116.159 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -119.73 127.71 53.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.555 1.142 . . . . 0.0 111.262 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -63.62 159.94 17.85 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 113.006 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -83.3 159.09 62.71 Favored Pre-proline 0 N--CA 1.48 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.065 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.41 -27.44 49.09 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 115.931 -171.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -104.69 -6.04 41.2 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.311 1.284 . . . . 0.0 116.311 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 81.0 p -84.24 153.61 62.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 119.953 1.876 . . . . 0.0 113.416 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.73 148.0 90.76 Favored 'Cis proline' 0 C--N 1.354 0.827 0 CA-C-N 118.829 0.618 . . . . 0.0 112.112 -5.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.67 169.99 9.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.82 1.648 . . . . 0.0 110.724 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 60.9 m -133.22 121.35 22.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.671 0.788 . . . . 0.0 110.877 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.56 139.6 34.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.538 1.535 . . . . 0.0 111.082 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.97 110.88 23.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.677 0.791 . . . . 0.0 109.811 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.9 t -95.7 145.42 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.307 1.443 . . . . 0.0 109.884 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.6 t -128.51 175.11 8.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.262 1.025 . . . . 0.0 113.038 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.68 139.9 18.34 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.624 1.583 . . . . 0.0 112.692 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 124.693 1.197 . . . . 0.0 112.721 174.573 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 121.202 0.525 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.23 117.87 25.49 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 110.634 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.35 157.01 50.23 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.321 2.68 . . . . 0.0 111.532 -173.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 19.6 t80 -110.47 125.12 52.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.701 0.801 . . . . 0.0 110.958 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -154.07 133.54 12.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.238 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.83 146.02 33.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.842 1.657 . . . . 0.0 109.794 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.3 p -111.52 139.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.063 1.345 . . . . 0.0 110.204 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.3 mt -131.06 134.84 26.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.953 1.701 . . . . 0.0 108.843 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.05 92.81 1.03 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.715 2.944 . . . . 0.0 109.759 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 68.8 t80 -151.89 154.28 35.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.16 1.784 . . . . 0.0 109.801 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 68.0 m -126.51 123.82 38.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.705 1.202 . . . . 0.0 109.65 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 91.6 mt -87.68 118.88 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.337 1.055 . . . . 0.0 109.147 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 99.6 mttt -98.08 -77.01 0.51 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.502 1.121 . . . . 0.0 113.232 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.35 -4.61 0.16 Allowed 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.23 -129.1 2.73 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.294 1.902 . . . . 0.0 111.938 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.39 148.61 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.829 1.252 . . . . 0.0 110.824 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -141.09 129.87 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.344 1.458 . . . . 0.0 111.722 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.46 168.4 22.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.007 1.723 . . . . 0.0 110.701 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -153.84 -171.45 20.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.18 138.18 18.16 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.74 1.616 . . . . 0.0 109.63 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.6 t -108.36 136.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.134 1.774 . . . . 0.0 107.892 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.23 121.27 35.47 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.111 1.364 . . . . 0.0 110.541 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 12.7 mtm -87.75 151.55 50.21 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.863 1.665 . . . . 0.0 111.028 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.46 -18.26 38.51 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.442 2.761 . . . . 0.0 113.207 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 36.0 p -73.06 -6.72 47.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.011 1.724 . . . . 0.0 114.22 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.76 -4.85 79.35 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.83 1.681 . . . . 0.0 113.898 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -69.93 158.55 35.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.596 1.159 . . . . 0.0 112.234 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.4 m -137.61 156.79 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 0.0 112.23 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.9 171.94 18.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.665 1.986 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.78 137.5 19.35 Favored Pre-proline 0 CA--C 1.546 0.813 0 O-C-N 121.288 -0.882 . . . . 0.0 111.051 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.52 163.31 19.18 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.837 3.025 . . . . 0.0 110.938 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 67.9 m -101.99 120.31 40.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.9 1.28 . . . . 0.0 108.578 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.04 131.41 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.351 1.06 . . . . 0.0 108.631 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -127.76 124.96 38.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 109.652 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.85 122.72 24.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.235 1.014 . . . . 0.0 110.83 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.7 -15.36 45.5 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 58.0 tttt 71.67 4.01 4.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.308 2.243 . . . . 0.0 114.241 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -113.83 15.29 18.66 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.88 2.072 . . . . 0.0 112.805 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.16 12.15 52.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.105 1.336 . . . . 0.0 114.636 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -131.39 160.57 34.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.018 1.727 . . . . 0.0 110.705 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.9 m -123.93 147.44 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.594 1.158 . . . . 0.0 109.566 164.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.2 m -107.38 136.48 47.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.144 0.978 . . . . 0.0 108.643 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 35.8 t -120.42 131.9 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.126 1.37 . . . . 0.0 109.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -133.1 155.63 48.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.435 1.494 . . . . 0.0 112.662 -169.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -158.29 136.86 11.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.338 1.455 . . . . 0.0 112.338 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.27 120.09 69.74 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.776 1.23 . . . . 0.0 110.996 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.72 159.77 28.08 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.713 2.942 . . . . 0.0 112.233 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 5.5 t -147.59 -11.77 0.4 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.37 149.02 20.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.819 1.648 . . . . 0.0 110.98 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.04 171.0 15.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.656 1.182 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.31 -175.14 15.56 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.535 1.541 . . . . 0.0 114.409 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.93 124.67 31.92 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 110.097 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 46.7 m80 -118.93 152.88 35.53 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.547 1.539 . . . . 0.0 112.193 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -117.3 148.14 41.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.091 1.756 . . . . 0.0 108.899 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.1 tmm? -143.89 130.19 19.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 111.407 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -118.13 139.7 50.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.45 1.9 . . . . 0.0 110.924 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -137.27 133.19 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.185 1.394 . . . . 0.0 110.57 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 140.69 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -103.05 119.85 39.59 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.589 1.956 . . . . 0.0 109.489 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.79 34.61 13.51 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.762 1.225 . . . . 0.0 112.835 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.7 m-80 72.76 9.16 5.57 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.698 2.399 . . . . 0.0 115.147 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.1 mtm -103.35 128.48 50.42 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.352 1.461 . . . . 0.0 110.158 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -57.37 136.61 56.6 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.247 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.9 pt -75.56 154.26 85.6 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.218 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -59.56 128.45 27.19 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.216 1.944 . . . . 0.0 109.791 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.09 -15.9 59.96 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.838 1.209 . . . . 0.0 114.014 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.2 t -84.89 143.48 40.34 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.687 1.744 . . . . 0.0 111.105 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.1 159.2 83.47 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.025 1.044 . . . . 0.0 112.664 -4.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 87.6 mt -107.21 161.51 14.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.427 1.891 . . . . 0.0 111.183 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.17 139.91 18.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.821 1.249 . . . . 0.0 110.03 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -166.31 174.78 8.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.58 1.152 . . . . 0.0 112.413 -170.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -122.79 131.73 53.9 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.223 1.009 . . . . 0.0 112.718 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 99.3 t -96.92 135.12 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.589 1.556 . . . . 0.0 109.059 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 19.8 t0 -154.98 166.76 32.58 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.943 1.297 . . . . 0.0 111.111 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -82.81 137.45 34.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.81 1.244 . . . . 0.0 112.064 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 7.7 p -67.61 -24.84 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.473 0.709 . . . . 0.0 112.331 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -88.9 25.54 1.77 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.01 1.724 . . . . 0.0 112.773 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.2 p -56.68 151.02 14.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.422 1.489 . . . . 0.0 114.212 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.94 28.52 11.97 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.14 1.829 . . . . 0.0 112.324 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -162.38 163.17 27.94 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.866 1.666 . . . . 0.0 112.556 -163.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 18.3 t -70.18 137.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.29 1.036 . . . . 0.0 109.82 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -147.26 158.7 44.05 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.756 1.222 . . . . 0.0 110.622 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.73 144.08 37.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.101 1.36 . . . . 0.0 111.52 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.3 p90 -168.34 164.83 12.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.403 1.481 . . . . 0.0 113.214 -173.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 126.16 170.75 13.03 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.614 1.578 . . . . 0.0 112.29 -175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -34.89 9.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.778 2.319 . . . . 0.0 113.222 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.08 76.41 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 119.348 0.976 . . . . 0.0 114.968 -169.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.01 -1.62 40.53 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.906 1.353 . . . . 0.0 113.813 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 51.6 m -118.05 -46.51 2.62 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.669 1.988 . . . . 0.0 111.726 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -138.01 148.2 44.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.503 1.521 . . . . 0.0 112.437 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -147.46 178.73 24.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.24 0.924 . . . . 0.0 113.52 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 19.1 t -139.53 136.97 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.914 1.286 . . . . 0.0 108.314 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -55.46 138.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 70.88 -3.29 2.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.547 2.339 . . . . 0.0 114.656 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.5 mttm -98.52 140.54 21.89 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.581 1.153 . . . . 0.0 111.144 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.89 109.77 2.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.647 2.232 . . . . 0.0 109.677 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -89.07 139.14 30.76 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.926 1.29 . . . . 0.0 110.168 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.0 p -130.83 151.25 51.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -166.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.28 175.95 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.276 1.83 . . . . 0.0 111.357 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.5 m -130.69 144.61 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.501 1.52 . . . . 0.0 110.898 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 31.1 t -117.59 135.77 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.584 1.554 . . . . 0.0 108.555 168.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.42 117.64 35.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.575 1.15 . . . . 0.0 110.632 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.8 p -117.05 14.4 14.97 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.289 1.836 . . . . 0.0 112.236 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 60.2 tttp -60.27 -28.39 68.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.421 1.488 . . . . 0.0 114.264 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -118.08 16.59 14.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.996 1.718 . . . . 0.0 112.754 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.71 -12.61 61.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.13 -103.34 2.48 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.718 1.151 . . . . 0.0 110.828 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.02 147.8 24.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.322 1.449 . . . . 0.0 110.432 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 164.36 -105.87 0.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.044 1.307 . . . . 0.0 111.061 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 167.27 144.36 4.1 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 124.773 1.177 . . . . 0.0 112.701 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 25.5 tp -92.39 137.97 31.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.666 1.186 . . . . 0.0 111.277 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.3 m -120.56 157.44 29.46 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.408 1.883 . . . . 0.0 110.74 169.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 53.4 tp -157.07 134.9 10.89 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.202 1.401 . . . . 0.0 109.721 -168.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.17 158.4 36.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.106 0.962 . . . . 0.0 112.324 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.1 mt -137.32 139.17 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.736 1.214 . . . . 0.0 109.986 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.17 131.34 47.13 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.439 1.496 . . . . 0.0 109.872 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -157.7 -162.7 11.89 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.891 -0.95 . . . . 0.0 114.625 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.79 -23.65 68.92 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.253 3.302 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.1 t -144.84 159.6 42.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.24 1.416 . . . . 0.0 109.433 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.11 111.54 5.84 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.095 -1.003 . . . . 0.0 111.019 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.65 148.31 50.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.863 0.865 . . . . 0.0 111.617 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.97 138.43 31.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.194 0.597 . . . . 0.0 109.416 166.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.2 mt -129.53 143.88 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.084 1.353 . . . . 0.0 109.906 -168.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.03 162.8 34.52 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 111.137 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.89 154.83 30.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.697 1.199 . . . . 0.0 112.485 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.3 m -136.94 123.36 20.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.61 1.564 . . . . 0.0 110.09 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.68 130.84 36.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.984 1.314 . . . . 0.0 111.239 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.91 149.14 27.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.463 1.505 . . . . 0.0 111.603 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -65.11 -20.0 66.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.539 1.136 . . . . 0.0 112.882 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.93 -7.87 53.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.203 1.401 . . . . 0.0 113.923 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.67 12.37 47.6 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.925 1.25 . . . . 0.0 114.869 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.0 p -108.61 154.88 21.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.099 1.359 . . . . 0.0 111.289 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 90.0 m -110.63 123.23 49.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 108.822 163.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -86.5 147.45 25.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.46 0.704 . . . . 0.0 110.161 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 90.3 t -128.36 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.977 1.711 . . . . 0.0 109.9 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.72 147.27 44.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 111.81 168.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -151.02 151.18 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -112.41 101.79 53.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.778 1.631 . . . . 0.0 110.575 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.27 161.13 29.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.303 2.669 . . . . 0.0 109.946 166.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.9 m -135.96 -21.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 89.9 mt -118.4 147.52 42.0 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.953 1.301 . . . . 0.0 110.21 170.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.08 154.12 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.734 2.29 . . . . 0.0 110.648 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 137.97 -158.54 24.75 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.706 1.146 . . . . 0.0 112.881 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -106.03 133.78 50.2 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.358 1.063 . . . . 0.0 111.727 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -121.0 125.27 46.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.98 1.712 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -87.6 127.17 35.27 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.965 -1.084 . . . . 0.0 110.848 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.43 120.74 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.545 1.538 . . . . 0.0 108.528 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -103.71 127.53 51.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -130.14 129.17 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.159 1.384 . . . . 0.0 109.036 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.37 136.56 22.43 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.353 -170.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 39.6 t80 -132.22 133.58 44.32 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.991 1.316 . . . . 0.0 110.933 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 48.99 53.73 12.08 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 112.547 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 8.4 pt-20 58.55 16.01 3.98 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 128.037 2.535 . . . . 0.0 116.413 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -125.15 130.33 51.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 111.292 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.3 m170 -62.15 141.35 58.21 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.481 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 8.3 m -71.25 150.86 94.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.35 -0.834 . . . . 0.0 109.872 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.83 130.37 39.5 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.38 2.72 . . . . 0.0 111.742 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.84 -15.14 58.4 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.279 1.419 . . . . 0.0 115.034 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 3.5 t -83.17 143.21 45.01 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 118.935 1.367 . . . . 0.0 111.488 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.9 138.11 51.94 Favored 'Cis proline' 0 C--N 1.357 0.996 0 CA-C-N 119.832 0.976 . . . . 0.0 112.72 0.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.0 173.8 8.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.809 1.643 . . . . 0.0 110.232 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.4 m -135.3 119.74 18.0 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.575 -0.703 . . . . 0.0 110.887 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.93 148.76 21.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 110.973 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -113.46 125.16 53.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.065 0.946 . . . . 0.0 110.21 172.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 83.9 t -111.5 132.46 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.297 1.439 . . . . 0.0 110.593 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 43.9 p -107.39 168.29 9.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.276 1.431 . . . . 0.0 112.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.64 149.57 33.52 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.049 1.309 . . . . 0.0 112.521 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 CA--C 1.548 0.894 0 C-N-CA 124.629 1.172 . . . . 0.0 113.147 176.055 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.332 0.587 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -56.81 116.02 11.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.06 1.744 . . . . 0.0 111.107 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.95 155.4 48.1 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.113 2.542 . . . . 0.0 110.947 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -105.28 124.38 49.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.345 0.658 . . . . 0.0 110.232 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -153.88 130.83 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 110.692 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.92 150.49 43.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.538 1.935 . . . . 0.0 109.565 -175.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -124.93 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.034 1.334 . . . . 0.0 110.31 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.49 138.57 27.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.117 1.767 . . . . 0.0 108.926 -172.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 47.41 2.37 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.655 3.57 . . . . 0.0 113.156 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 61.3 t80 -93.8 159.17 15.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.333 1.453 . . . . 0.0 110.559 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 49.2 m -135.16 127.29 29.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.919 1.288 . . . . 0.0 109.796 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 49.3 mt -75.56 131.46 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.244 1.018 . . . . 0.0 110.419 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1800 ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' 1801 ' ' LYS . 9.3 tppt? -120.62 -145.48 0.36 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.426 1.49 . . . . 0.0 110.683 174.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1801 ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' 1800 ' ' LYS . 1.5 tmtp? -77.17 122.49 25.09 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.548 -1.345 . . . . 0.0 110.749 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.41 -146.01 16.89 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.455 1.503 . . . . 0.0 112.07 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -158.87 145.35 17.0 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.758 1.223 . . . . 0.0 111.084 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.6 137.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.645 1.578 . . . . 0.0 111.122 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.5 p -148.4 168.56 22.3 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.937 1.695 . . . . 0.0 110.654 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.69 -176.47 26.98 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.73 134.71 13.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.293 1.437 . . . . 0.0 110.183 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 5.8 t -99.9 136.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.662 1.985 . . . . 0.0 108.024 171.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -121.53 126.3 48.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.828 1.251 . . . . 0.0 110.755 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -105.73 142.15 24.17 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.325 1.45 . . . . 0.0 112.09 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.61 -26.66 73.48 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.118 3.212 . . . . 0.0 115.022 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 23.3 p -73.84 1.19 11.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.257 1.423 . . . . 0.0 114.506 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.73 37.41 7.4 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.593 1.092 . . . . 0.0 113.46 173.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.21 169.32 17.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.408 1.483 . . . . 0.0 112.543 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.7 m -140.39 160.6 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.106 1.362 . . . . 0.0 112.43 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.32 169.19 24.78 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.494 1.918 . . . . 0.0 110.794 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -108.13 136.89 19.75 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.33 167.25 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.063 3.176 . . . . 0.0 111.406 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.9 m -105.13 130.85 53.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.566 1.546 . . . . 0.0 109.069 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 131.27 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.767 1.227 . . . . 0.0 108.976 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.9 m -133.22 122.21 23.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.251 1.42 . . . . 0.0 109.732 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.06 127.73 32.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.363 0.665 . . . . 0.0 110.407 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -82.31 -11.46 58.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 71.68 2.01 4.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 128.276 2.63 . . . . 0.0 114.055 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -94.38 3.57 55.01 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.564 1.946 . . . . 0.0 113.047 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.21 17.99 41.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.87 1.224 . . . . 0.0 113.93 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -131.06 155.63 46.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.47 1.908 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -112.51 143.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 109.532 163.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.8 m -104.23 135.17 46.2 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.624 1.17 . . . . 0.0 107.908 165.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.7 t -122.37 132.64 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.325 . . . . 0.0 108.838 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -135.02 160.54 38.0 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.086 1.354 . . . . 0.0 112.842 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.2 t80 -159.01 137.71 10.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.519 1.528 . . . . 0.0 111.936 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.41 119.08 71.26 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.665 1.186 . . . . 0.0 110.904 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.97 158.16 46.33 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.06 3.173 . . . . 0.0 112.432 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 8.4 t -135.86 -22.79 1.4 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -161.12 155.8 23.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.769 1.628 . . . . 0.0 109.952 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -72.05 166.43 22.26 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 126.1 178.38 15.28 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 125.906 1.717 . . . . 0.0 113.952 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -80.77 119.01 22.8 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.749 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 23.4 m80 -113.87 159.86 19.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.462 1.505 . . . . 0.0 110.892 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.46 155.72 40.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 111.517 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 3.2 tmm? -148.16 134.81 19.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.77 1.228 . . . . 0.0 111.303 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -103.04 138.45 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.85 1.66 . . . . 0.0 110.426 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.2 mm -127.63 136.56 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.339 1.456 . . . . 0.0 109.796 171.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.94 137.95 23.94 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -102.92 124.93 49.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 0.0 109.902 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.22 32.08 10.18 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.734 1.213 . . . . 0.0 112.462 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.1 t30 75.82 6.52 3.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 128.2 2.6 . . . . 0.0 115.17 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.17 131.13 53.04 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.769 1.628 . . . . 0.0 110.903 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.59 134.03 56.38 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.244 -0.91 . . . . 0.0 113.077 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.17 156.89 85.61 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 123.127 0.571 . . . . 0.0 112.046 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.25 126.37 21.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.274 1.983 . . . . 0.0 109.626 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.74 -16.57 57.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.666 1.127 . . . . 0.0 114.463 -172.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 21.2 t -86.03 148.37 47.74 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.37 1.585 . . . . 0.0 111.961 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -83.19 171.61 50.76 Favored 'Cis proline' 0 CA--C 1.54 0.783 0 CA-C-N 120.246 1.124 . . . . 0.0 112.485 -6.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.28 154.92 22.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.976 1.71 . . . . 0.0 111.662 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -145.36 140.92 28.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.441 1.497 . . . . 0.0 110.041 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -163.42 160.01 22.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.98 1.312 . . . . 0.0 112.04 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.8 t80 -100.15 135.21 41.93 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.058 -1.026 . . . . 0.0 112.396 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.1 t -103.99 141.05 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.961 1.704 . . . . 0.0 109.28 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 12.8 t0 -154.71 162.9 40.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.611 1.164 . . . . 0.0 111.683 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -81.77 148.06 29.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.57 1.148 . . . . 0.0 112.707 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 30.4 m -69.93 -17.65 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.9 p30 -80.51 -10.54 59.74 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.4 m -70.32 133.02 46.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.147 0.979 . . . . 0.0 112.584 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -101.75 -13.43 32.17 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 125.141 1.353 . . . . 0.0 114.773 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -68.59 164.45 21.38 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -63.46 138.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.355 1.062 . . . . 0.0 109.705 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.9 t -165.2 153.41 11.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.273 1.429 . . . . 0.0 110.022 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -129.8 145.16 51.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.34 . . . . 0.0 111.844 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -168.15 167.86 12.1 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.964 1.706 . . . . 0.0 112.864 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.07 169.37 13.28 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.508 1.528 . . . . 0.0 112.08 -172.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.04 -30.79 20.41 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.63 -33.98 77.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 119.255 0.934 . . . . 0.0 114.605 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.74 -4.33 45.72 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.169 1.485 . . . . 0.0 113.484 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.0 m -108.97 -41.25 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 111.973 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -149.48 152.37 35.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.131 1.772 . . . . 0.0 112.314 -172.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -152.01 177.14 30.02 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.847 0.737 . . . . 0.0 113.665 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 58.5 t -137.9 134.78 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.972 1.309 . . . . 0.0 108.192 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.6 m -55.58 137.51 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 55.5 m-80 68.92 2.21 3.46 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.011 2.124 . . . . 0.0 114.415 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.0 mttt -108.06 140.91 22.13 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.149 1.38 . . . . 0.0 111.087 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.04 124.22 9.9 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.462 2.108 . . . . 0.0 110.205 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.5 144.24 31.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.33 1.452 . . . . 0.0 110.291 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.6 p -133.87 149.59 51.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -166.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -160.18 178.28 9.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.812 1.645 . . . . 0.0 111.496 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 27.5 m -134.14 143.06 47.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.145 1.378 . . . . 0.0 110.565 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 22.7 t -115.14 130.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 108.137 168.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.83 129.83 36.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 111.08 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 69.6 p -137.1 1.01 2.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.103 1.361 . . . . 0.0 113.841 -166.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 82.4 tttt -55.89 -38.95 70.87 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.466 1.506 . . . . 0.0 114.992 -166.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -115.73 10.23 15.38 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.671 1.589 . . . . 0.0 112.667 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.4 67.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.15 151.37 8.07 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.672 1.13 . . . . 0.0 112.281 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.74 166.12 22.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 0.0 113.298 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 145.23 9.61 0.31 Allowed Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 102.0 96.95 2.32 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.484 1.516 . . . . 0.0 113.157 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.98 132.83 36.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.347 1.459 . . . . 0.0 109.251 169.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.5 t -134.98 165.78 24.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.366 1.467 . . . . 0.0 112.45 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 36.1 tp -166.86 137.36 3.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.738 2.015 . . . . 0.0 109.272 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.45 34.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.162 0.985 . . . . 0.0 112.16 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.6 mt -136.42 139.93 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.792 1.237 . . . . 0.0 110.264 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.58 145.74 51.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.717 1.607 . . . . 0.0 109.652 170.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.28 -165.48 25.74 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 119.091 -0.838 . . . . 0.0 114.841 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.47 -26.01 70.35 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.316 3.344 . . . . 0.0 112.657 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.3 t -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.962 1.305 . . . . 0.0 109.144 159.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.72 116.49 12.15 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.978 -1.076 . . . . 0.0 111.4 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -72.81 147.55 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.795 0.838 . . . . 0.0 111.903 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.17 143.66 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.677 0.791 . . . . 0.0 109.76 167.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.76 145.88 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.164 1.385 . . . . 0.0 110.826 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -142.74 164.72 29.34 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.045 162.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.5 p -161.78 155.72 21.82 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.939 1.296 . . . . 0.0 112.616 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 79.3 m -143.85 124.89 14.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.544 1.537 . . . . 0.0 110.437 -171.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.53 130.96 36.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.54 1.136 . . . . 0.0 111.216 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.43 147.87 32.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.471 1.508 . . . . 0.0 112.017 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.3 -15.47 63.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.0 0.92 . . . . 0.0 113.437 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -74.92 -6.58 49.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.103 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.62 33.08 7.68 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.476 1.036 . . . . 0.0 113.951 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.0 p -138.43 157.26 46.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.961 1.304 . . . . 0.0 111.268 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 39.2 t -105.24 124.13 49.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.572 1.149 . . . . 0.0 108.734 158.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -90.34 146.61 24.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.922 0.889 . . . . 0.0 110.282 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -129.38 143.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 95.3 p -136.31 149.68 48.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.811 1.244 . . . . 0.0 112.155 168.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.4 p90 -151.52 152.79 33.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.47 104.97 52.82 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.864 1.666 . . . . 0.0 110.649 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.25 164.98 14.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.839 3.026 . . . . 0.0 110.374 167.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -137.15 -20.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.7 mt -118.38 149.31 45.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.013 1.325 . . . . 0.0 110.327 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.57 155.67 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.966 2.444 . . . . 0.0 110.883 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.83 -162.38 23.82 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.738 1.161 . . . . 0.0 113.691 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -92.11 129.02 38.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.487 1.515 . . . . 0.0 112.671 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 130.05 55.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.485 1.514 . . . . 0.0 110.207 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -90.91 119.03 30.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.616 1.167 . . . . 0.0 110.52 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.42 123.22 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.304 1.842 . . . . 0.0 108.501 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -104.45 134.3 47.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.516 1.526 . . . . 0.0 109.391 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 83.8 t -133.95 133.47 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.312 1.445 . . . . 0.0 108.454 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.74 141.73 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.906 1.283 . . . . 0.0 111.071 -169.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.31 120.25 14.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.695 1.198 . . . . 0.0 109.974 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 52.48 58.42 5.41 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.445 1.498 . . . . 0.0 112.067 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 60.64 2.8 0.53 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.911 2.885 . . . . 0.0 116.684 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -107.27 127.1 53.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.473 1.109 . . . . 0.0 111.177 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -62.93 157.67 21.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.816 0.846 . . . . 0.0 112.392 167.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 32.6 m -87.73 155.75 53.16 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 0.0 110.498 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.53 121.59 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.834 2.356 . . . . 0.0 110.353 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.53 -13.73 66.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.373 1.464 . . . . 0.0 116.037 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.3 p -79.79 151.53 73.92 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 120.434 2.117 . . . . 0.0 113.028 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.35 149.75 94.62 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 119.107 0.717 . . . . 0.0 112.295 -4.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -102.44 156.1 17.82 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.84 1.656 . . . . 0.0 110.888 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 63.4 m -111.29 118.45 35.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.692 0.797 . . . . 0.0 111.047 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.18 133.17 37.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.036 1.334 . . . . 0.0 110.921 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.66 106.36 18.45 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.964 0.905 . . . . 0.0 109.738 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 90.4 t -90.98 145.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 0.0 109.875 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.7 t -137.25 174.26 10.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.049 0.939 . . . . 0.0 113.031 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.72 140.5 18.04 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.741 1.639 . . . . 0.0 112.914 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 124.048 0.939 . . . . 0.0 112.813 173.056 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A 1788 ' ' LEU . . . . . 0.494 HD11 HG12 ' A' 1860 ' ' VAL . 47.8 tp . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -47.62 111.06 1.53 Allowed Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.925 1.69 . . . . 0.0 112.326 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.44 155.28 45.72 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.021 2.48 . . . . 0.0 110.655 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.77 125.45 51.43 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.611 0.764 . . . . 0.0 110.514 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -151.46 128.33 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.782 1.633 . . . . 0.0 109.53 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.75 125.95 13.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 109.973 -167.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 96.7 t -93.23 137.92 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.911 1.284 . . . . 0.0 109.863 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.9 mt -131.25 136.2 28.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.651 1.58 . . . . 0.0 108.752 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.28 58.17 6.87 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.273 3.315 . . . . 0.0 111.896 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -107.45 158.56 17.09 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.878 1.671 . . . . 0.0 111.197 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.6 m -125.45 123.08 38.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.819 1.248 . . . . 0.0 109.576 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.45 128.37 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.758 1.223 . . . . 0.0 109.73 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.38 -143.12 0.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.065 1.346 . . . . 0.0 110.718 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -75.53 -10.63 59.62 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.43 168.99 50.68 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.354 1.454 . . . . 0.0 113.704 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 147.6 23.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.329 1.451 . . . . 0.0 111.699 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.49 131.52 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.292 1.437 . . . . 0.0 111.056 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 57.5 p -147.44 -168.82 3.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.546 1.938 . . . . 0.0 109.807 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.49 -155.76 9.12 Favored Glycine 0 N--CA 1.467 0.765 0 O-C-N 121.357 -0.839 . . . . 0.0 114.957 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.91 137.0 9.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.45 1.9 . . . . 0.0 108.964 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 6.7 t -108.5 135.22 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.949 1.699 . . . . 0.0 108.629 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -117.37 123.42 46.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.121 1.368 . . . . 0.0 110.554 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.0 mtm -96.85 147.56 33.1 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.827 1.651 . . . . 0.0 111.349 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.49 -18.79 25.62 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.643 2.895 . . . . 0.0 113.576 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -77.28 2.27 16.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.071 1.348 . . . . 0.0 114.338 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.17 48.29 3.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.678 1.133 . . . . 0.0 113.218 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -156.12 166.39 33.59 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.793 1.637 . . . . 0.0 111.872 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.38 161.48 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.446 1.098 . . . . 0.0 113.194 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.1 178.24 10.51 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.733 2.013 . . . . 0.0 111.006 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.91 140.72 25.14 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.385 1.074 . . . . 0.0 110.872 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.63 160.34 22.0 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.605 2.87 . . . . 0.0 111.003 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.8 m -104.39 120.73 41.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 108.692 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.62 131.35 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.194 0.998 . . . . 0.0 108.706 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.7 m -132.14 128.14 37.45 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.303 1.441 . . . . 0.0 109.221 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.43 134.37 42.37 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.275 0.63 . . . . 0.0 111.564 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -82.69 -13.52 56.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.0 ttpt 67.25 18.86 10.33 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.954 2.102 . . . . 0.0 113.356 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.43 17.38 8.95 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.824 2.049 . . . . 0.0 112.499 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.6 13.12 68.14 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.824 1.202 . . . . 0.0 114.014 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 62.7 p -136.9 164.65 27.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.911 2.085 . . . . 0.0 110.027 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.5 m -127.74 163.38 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.861 1.264 . . . . 0.0 110.115 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.1 t -120.69 147.19 45.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 110.098 164.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 39.0 t -120.01 128.09 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.523 1.529 . . . . 0.0 108.424 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.94 156.55 43.56 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.667 1.587 . . . . 0.0 111.829 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -163.93 133.4 3.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.069 1.348 . . . . 0.0 111.97 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -83.62 123.17 76.7 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.539 1.136 . . . . 0.0 110.483 175.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.24 174.49 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.632 2.888 . . . . 0.0 111.823 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -149.66 -40.24 0.14 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -137.55 154.89 49.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.315 1.446 . . . . 0.0 110.509 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.18 171.0 14.93 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.329 1.052 . . . . 0.0 113.624 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 118.08 -173.03 14.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.048 1.785 . . . . 0.0 113.943 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -85.19 131.78 34.38 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.977 1.311 . . . . 0.0 110.57 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 53.0 m80 -125.69 156.41 39.37 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.743 1.617 . . . . 0.0 111.47 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -134.31 146.49 50.03 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.352 1.461 . . . . 0.0 109.486 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 17.3 tmm? -151.1 132.41 14.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.627 0.771 . . . . 0.0 112.252 -168.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -106.03 148.52 27.65 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.873 1.669 . . . . 0.0 111.65 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 31.4 mm -133.63 135.42 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.406 1.082 . . . . 0.0 110.9 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.36 128.19 19.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.037 1.335 . . . . 0.0 113.085 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.37 126.58 45.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.873 2.069 . . . . 0.0 109.689 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.79 33.27 13.79 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.877 1.271 . . . . 0.0 112.539 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.4 t30 75.5 2.75 3.86 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.334 2.654 . . . . 0.0 114.795 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.26 132.77 50.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.177 1.391 . . . . 0.0 110.843 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -56.55 134.95 54.66 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.01 155.9 88.19 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.592 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.02 -19.67 69.65 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.503 2.136 . . . . 0.0 113.853 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -80.45 -3.5 89.99 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.32 0.964 . . . . 0.0 114.686 172.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 7.7 t -93.02 154.18 41.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 119.203 1.502 . . . . 0.0 111.887 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -82.36 163.01 75.8 Favored 'Cis proline' 0 C--N 1.352 0.726 0 CA-C-N 119.795 0.962 . . . . 0.0 111.591 -13.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 72.1 mt -111.52 156.63 21.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.634 1.574 . . . . 0.0 111.376 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -147.27 139.29 24.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.149 1.38 . . . . 0.0 109.416 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.2 p90 -162.68 162.19 26.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.889 0.876 . . . . 0.0 112.5 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 62.9 t80 -109.72 145.22 36.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.446 1.098 . . . . 0.0 113.004 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1860 ' ' VAL . . . . . 0.494 HG12 HD11 ' A' 1788 ' ' LEU . 69.4 t -121.95 141.02 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.311 1.844 . . . . 0.0 109.302 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -155.18 144.58 21.16 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.251 1.42 . . . . 0.0 112.989 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1862 ' ' TYR . . . . . 0.408 ' CD1' HD13 ' A' 1788 ' ' LEU . 49.9 m-85 -70.06 145.32 51.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 111.551 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 28.2 m -66.52 -19.4 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -91.11 0.56 57.51 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.342 1.457 . . . . 0.0 114.859 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 96.3 m -62.8 132.94 53.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.307 0.958 . . . . 0.0 112.247 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.87 -25.14 18.31 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.704 1.145 . . . . 0.0 113.887 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -68.5 159.71 31.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.22 1.008 . . . . 0.0 113.201 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.4 p -64.37 131.4 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.096 0.959 . . . . 0.0 111.272 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 53.4 p -136.36 164.78 27.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.166 1.786 . . . . 0.0 110.106 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -143.7 144.52 31.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.284 1.034 . . . . 0.0 111.671 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 38.9 p90 -166.49 167.27 15.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.684 1.593 . . . . 0.0 112.861 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.8 170.9 12.86 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.508 1.528 . . . . 0.0 112.454 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.74 -33.82 12.29 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.701 2.267 . . . . 0.0 113.142 -169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.5 -32.89 83.04 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.358 0.981 . . . . 0.0 114.609 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.82 -3.12 39.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.03 1.415 . . . . 0.0 113.771 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 77.5 m -113.31 -47.16 3.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.583 1.953 . . . . 0.0 111.863 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -138.58 143.38 39.35 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.684 1.594 . . . . 0.0 112.448 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.83 175.74 22.39 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.056 1.313 . . . . 0.0 113.026 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -139.62 134.67 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.452 1.101 . . . . 0.0 108.778 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.8 m -56.54 132.32 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 24.7 m120 69.35 1.65 3.37 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.112 2.165 . . . . 0.0 114.401 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -105.27 137.56 19.29 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.285 1.434 . . . . 0.0 110.433 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.47 121.94 7.88 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.417 2.078 . . . . 0.0 110.364 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 145.22 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.457 1.503 . . . . 0.0 110.393 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.5 p -136.22 149.17 48.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.6 p90 -160.74 176.29 11.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.96 1.704 . . . . 0.0 111.47 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.7 m -133.35 141.52 47.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.068 1.347 . . . . 0.0 110.851 -170.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.77 136.36 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.786 1.634 . . . . 0.0 108.014 168.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -104.13 123.0 46.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.421 1.089 . . . . 0.0 110.284 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.9 p -127.04 3.81 6.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.785 1.634 . . . . 0.0 113.636 -166.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.49 -36.92 36.02 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.856 2.062 . . . . 0.0 115.64 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -129.3 17.54 6.0 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.426 1.49 . . . . 0.0 112.423 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.7 -30.07 59.18 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.2 142.36 5.99 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.385 1.469 . . . . 0.0 113.156 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -72.9 152.95 41.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.668 1.187 . . . . 0.0 112.087 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.37 13.12 0.05 OUTLIER Glycine 0 N--CA 1.476 1.36 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 107.96 89.77 2.09 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-N 118.776 1.288 . . . . 0.0 112.728 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.14 126.62 31.08 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.802 1.241 . . . . 0.0 109.367 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -121.54 157.95 29.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.196 1.798 . . . . 0.0 112.166 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.3 tp -160.19 134.99 7.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.915 1.686 . . . . 0.0 109.343 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.82 158.1 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.384 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.55 138.03 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.859 1.263 . . . . 0.0 109.964 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.6 164.24 20.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.266 1.826 . . . . 0.0 109.731 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 169.96 -155.84 26.05 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.673 -1.071 . . . . 0.0 114.224 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.36 -21.92 60.53 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.866 3.044 . . . . 0.0 112.784 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 14.5 t -152.05 164.53 37.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.616 1.566 . . . . 0.0 109.708 166.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -72.45 112.58 8.63 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.991 -1.068 . . . . 0.0 111.153 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.43 148.17 48.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.762 0.825 . . . . 0.0 111.088 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.19 144.1 25.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.045 0.538 . . . . 0.0 110.27 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.7 mt -134.27 144.93 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.056 1.342 . . . . 0.0 110.074 -163.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.5 t -142.45 162.28 35.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.766 1.226 . . . . 0.0 110.922 166.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -159.32 158.83 33.09 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.645 1.178 . . . . 0.0 112.622 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 55.7 m -142.55 123.93 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.273 1.429 . . . . 0.0 110.162 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.09 132.4 37.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.887 1.275 . . . . 0.0 111.152 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -112.71 148.18 35.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.215 1.406 . . . . 0.0 111.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -70.54 -14.03 62.34 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.111 0.964 . . . . 0.0 112.877 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.45 -6.44 50.12 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.707 1.603 . . . . 0.0 114.125 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 35.81 6.21 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.555 1.074 . . . . 0.0 113.519 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.3 p -141.16 161.21 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.307 1.443 . . . . 0.0 111.172 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 66.0 m -115.39 128.3 55.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.032 1.333 . . . . 0.0 108.785 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -89.01 147.63 24.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.65 0.78 . . . . 0.0 110.296 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -129.38 143.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 110.127 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 77.6 p -136.82 148.02 46.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.916 1.286 . . . . 0.0 111.755 167.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 12.8 p90 -152.75 157.02 40.22 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.66 105.93 35.23 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.857 1.663 . . . . 0.0 110.081 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.92 167.26 20.41 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.543 2.829 . . . . 0.0 110.31 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 30.7 m -136.17 -25.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.3 mt -118.26 147.99 42.84 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.042 1.337 . . . . 0.0 110.395 170.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.36 156.11 45.98 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.924 2.416 . . . . 0.0 110.952 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.53 -149.1 20.55 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.55 1.072 . . . . 0.0 112.997 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -113.7 128.27 56.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.041 1.336 . . . . 0.0 111.24 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -112.31 139.74 47.61 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.371 1.468 . . . . 0.0 110.929 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.6 m -97.79 122.28 40.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.642 1.177 . . . . 0.0 110.496 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.34 127.91 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.482 1.513 . . . . 0.0 108.543 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.88 133.02 53.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.778 1.631 . . . . 0.0 109.861 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.4 t -133.9 132.41 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.504 1.521 . . . . 0.0 108.123 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -156.67 144.49 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.852 1.261 . . . . 0.0 110.786 -167.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.7 118.69 12.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 51.57 59.57 4.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.446 1.498 . . . . 0.0 112.179 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 59.39 12.05 2.5 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.036 2.534 . . . . 0.0 116.424 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -119.57 125.43 48.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.389 1.076 . . . . 0.0 111.133 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -60.63 155.45 18.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.099 0.96 . . . . 0.0 112.774 171.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.5 m -74.51 152.19 87.51 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 169.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.05 -12.33 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.506 2.138 . . . . 0.0 114.897 -167.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -102.22 -11.6 36.07 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 174.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 80.5 p -84.5 156.07 62.38 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 120.055 1.927 . . . . 0.0 113.6 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.49 151.21 96.77 Favored 'Cis proline' 0 C--N 1.352 0.763 0 CA-C-N 118.982 0.672 . . . . 0.0 112.472 -4.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -102.42 160.05 14.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.43 1.492 . . . . 0.0 110.825 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 44.3 m -119.71 116.62 26.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.747 0.819 . . . . 0.0 110.57 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.73 126.43 43.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.529 1.132 . . . . 0.0 111.222 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.34 114.41 21.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.163 0.985 . . . . 0.0 108.926 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.7 t -103.34 136.2 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.065 0.946 . . . . 0.0 110.402 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 34.0 p -121.83 171.59 8.79 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 112.589 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.95 145.66 30.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.936 1.255 . . . . 0.0 112.686 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 124.156 0.982 . . . . 0.0 112.863 174.125 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 1788 ' ' LEU . . . . . 0.63 HD11 HG12 ' A' 1860 ' ' VAL . 22.0 tp . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.727 0.298 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.3 120.28 46.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.311 1.044 . . . . 0.0 111.303 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.24 156.64 58.83 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.459 2.773 . . . . 0.0 110.922 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.1 t80 -108.12 127.72 54.06 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.656 0.782 . . . . 0.0 111.096 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.52 135.74 14.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.655 1.582 . . . . 0.0 110.785 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.39 152.48 41.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.518 1.927 . . . . 0.0 109.862 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.0 p -123.31 139.16 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.023 1.329 . . . . 0.0 110.469 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.24 137.49 29.42 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.271 1.828 . . . . 0.0 108.486 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -79.06 45.95 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.555 3.503 . . . . 0.0 112.999 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 29.2 t80 -91.15 153.49 20.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.135 1.374 . . . . 0.0 111.137 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.4 m -125.28 126.36 45.0 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.946 1.298 . . . . 0.0 109.746 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 95.2 mt -91.18 138.06 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.059 1.344 . . . . 0.0 109.917 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -149.74 95.96 2.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.501 1.12 . . . . 0.0 111.521 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 72.59 -31.74 0.23 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 128.539 2.736 . . . . 0.0 115.179 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.1 175.74 54.68 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.626 1.584 . . . . 0.0 113.443 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -111.45 141.68 44.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.235 1.414 . . . . 0.0 111.289 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -125.31 134.29 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.548 1.539 . . . . 0.0 110.602 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.18 170.64 17.97 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.183 1.793 . . . . 0.0 110.324 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -158.89 -167.48 19.67 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 115.884 1.114 . . . . 0.0 115.884 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.48 134.85 15.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.702 1.601 . . . . 0.0 109.264 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.0 t -104.53 131.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.694 1.598 . . . . 0.0 107.443 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -116.38 129.05 56.04 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.833 1.253 . . . . 0.0 110.657 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -97.02 150.68 37.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.71 1.604 . . . . 0.0 111.468 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.4 -20.56 27.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.507 2.804 . . . . 0.0 113.051 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -79.68 -0.54 34.44 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.945 1.698 . . . . 0.0 114.561 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.41 54.08 2.48 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.56 1.076 . . . . 0.0 113.161 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -155.62 167.04 31.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.064 1.746 . . . . 0.0 111.676 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.8 m -140.43 158.09 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.849 1.26 . . . . 0.0 112.58 -172.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.89 166.87 32.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.507 1.923 . . . . 0.0 110.892 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.01 137.73 20.16 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.2 -0.937 . . . . 0.0 111.588 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.77 163.96 20.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.958 3.105 . . . . 0.0 110.993 168.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.7 m -107.87 117.82 35.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.088 1.355 . . . . 0.0 108.852 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -97.64 133.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.43 1.092 . . . . 0.0 109.007 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -125.85 130.64 51.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.111 1.764 . . . . 0.0 109.901 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 17.5 t0 -75.52 122.23 23.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.169 0.988 . . . . 0.0 110.775 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -84.46 -15.4 46.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.7 tttt 71.39 0.22 3.37 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.614 2.366 . . . . 0.0 114.017 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.83 7.87 45.67 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.07 2.148 . . . . 0.0 113.023 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.83 15.12 55.39 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.983 1.278 . . . . 0.0 113.835 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.9 p -132.38 161.78 32.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.419 1.888 . . . . 0.0 110.3 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -125.4 145.24 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.787 1.235 . . . . 0.0 109.831 167.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.2 m -104.71 139.25 39.8 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.291 1.037 . . . . 0.0 108.564 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.7 t -124.14 129.49 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.912 1.285 . . . . 0.0 109.108 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -129.37 161.86 29.33 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -159.64 135.91 8.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 111.828 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.35 114.39 60.88 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.801 1.241 . . . . 0.0 110.602 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -83.97 165.82 13.21 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.723 2.949 . . . . 0.0 112.221 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.3 t -144.35 -1.5 0.92 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.92 152.02 3.49 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.509 1.924 . . . . 0.0 111.27 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.55 175.37 7.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.309 1.443 . . . . 0.0 114.49 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.86 -171.02 13.61 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 126.138 1.827 . . . . 0.0 113.985 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 59.3 tp -79.69 127.41 32.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.623 1.169 . . . . 0.0 110.454 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 55.0 m80 -125.69 168.99 12.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.809 1.644 . . . . 0.0 111.394 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -147.35 153.52 39.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.04 0.936 . . . . 0.0 111.77 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 22.1 ttm -124.34 133.71 53.37 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.117 1.767 . . . . 0.0 110.095 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -111.14 136.12 50.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.236 1.814 . . . . 0.0 109.829 169.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.1 mm -135.59 134.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.028 1.331 . . . . 0.0 110.451 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.03 140.42 36.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.366 1.066 . . . . 0.0 113.588 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.4 t80 -103.6 118.09 35.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.058 2.143 . . . . 0.0 109.256 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.81 31.92 11.41 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.826 1.25 . . . . 0.0 112.945 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.13 5.0 4.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.143 2.577 . . . . 0.0 115.171 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.8 ttp -95.4 127.94 41.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.595 1.158 . . . . 0.0 110.079 165.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.79 137.55 57.65 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.254 -0.904 . . . . 0.0 112.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -71.82 154.43 92.81 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.432 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.55 -17.86 61.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.582 2.188 . . . . 0.0 113.912 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -88.64 2.54 84.67 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.814 1.197 . . . . 0.0 114.88 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 31.5 t -101.94 142.62 24.97 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 119.822 1.811 . . . . 0.0 111.953 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.61 170.33 57.41 Favored 'Cis proline' 0 C--N 1.352 0.76 0 CA-C-N 119.816 0.97 . . . . 0.0 112.477 -3.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.2 mt -120.91 151.42 39.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.118 1.767 . . . . 0.0 110.38 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -132.67 144.73 50.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.73 1.212 . . . . 0.0 110.505 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 6.0 p90 -165.79 154.65 11.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.362 1.065 . . . . 0.0 112.304 -172.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 37.2 t80 -101.66 143.23 31.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 112.429 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1860 ' ' VAL . . . . . 0.63 HG12 HD11 ' A' 1788 ' ' LEU . 91.8 t -116.09 137.57 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.21 1.804 . . . . 0.0 109.413 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.0 t0 -159.6 147.64 17.3 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.857 1.263 . . . . 0.0 112.267 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -74.47 149.11 40.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 0.0 112.784 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 3.4 p -70.59 -22.33 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.507 -0.745 . . . . 0.0 112.83 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -82.67 -13.24 56.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.107 1.363 . . . . 0.0 114.174 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 82.9 m -58.98 134.49 57.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.535 1.134 . . . . 0.0 113.935 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.15 70.08 1.08 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.702 1.62 . . . . 0.0 111.772 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -162.6 168.58 21.55 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.652 1.581 . . . . 0.0 113.072 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.8 p -68.59 143.79 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.634 0.774 . . . . 0.0 110.074 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -163.52 159.51 22.08 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.692 1.597 . . . . 0.0 110.025 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -138.33 144.76 40.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.335 1.054 . . . . 0.0 112.358 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 45.0 p90 -167.67 165.44 14.32 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.683 1.593 . . . . 0.0 113.239 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.58 175.5 13.96 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.253 1.406 . . . . 0.0 112.977 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.56 -37.0 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.764 -171.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.06 91.34 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.538 1.063 . . . . 0.0 114.507 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.02 -6.51 52.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.704 1.252 . . . . 0.0 113.327 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 38.7 m -100.98 -54.73 2.73 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.222 1.809 . . . . 0.0 110.18 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -137.26 139.8 41.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.601 1.961 . . . . 0.0 112.375 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -129.97 172.84 20.01 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.058 1.313 . . . . 0.0 113.242 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 60.9 t -136.85 134.11 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.627 1.171 . . . . 0.0 108.948 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -56.95 139.23 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.0 m-80 66.16 2.24 2.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.86 2.064 . . . . 0.0 114.809 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.35 142.22 29.09 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.908 1.683 . . . . 0.0 111.096 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.79 119.21 5.95 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.637 2.224 . . . . 0.0 110.415 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -94.82 145.7 24.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.218 1.407 . . . . 0.0 109.996 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 76.0 p -136.18 151.57 49.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -168.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.7 p90 -162.87 176.16 10.49 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.461 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.9 m -134.05 138.34 45.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.707 1.203 . . . . 0.0 110.983 -169.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.4 t -102.09 134.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.186 1.394 . . . . 0.0 107.701 165.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -96.43 128.08 43.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.071 0.948 . . . . 0.0 109.824 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.1 p -129.39 7.46 5.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.379 1.872 . . . . 0.0 112.861 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -55.65 -32.17 62.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.91 1.684 . . . . 0.0 114.464 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.65 11.85 13.83 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.541 1.536 . . . . 0.0 113.063 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.03 -15.64 56.78 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.75 -128.75 8.62 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.344 0.973 . . . . 0.0 112.162 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -155.65 150.3 26.19 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.443 1.497 . . . . 0.0 110.723 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.3 -85.0 0.08 OUTLIER Glycine 0 N--CA 1.469 0.851 0 C-N-CA 125.482 1.515 . . . . 0.0 111.003 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -168.77 118.08 0.76 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.575 1.083 . . . . 0.0 112.222 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.14 138.2 32.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.439 1.096 . . . . 0.0 110.063 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.4 m -131.32 158.52 40.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.677 1.591 . . . . 0.0 111.547 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 43.2 tp -156.75 135.93 12.01 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.783 1.633 . . . . 0.0 108.893 -171.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.65 158.93 39.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.77 0.828 . . . . 0.0 112.346 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.0 mt -134.39 137.51 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 109.445 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.15 122.34 38.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.082 1.353 . . . . 0.0 109.379 172.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -139.1 -175.75 14.24 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.724 1.154 . . . . 0.0 114.08 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.5 -23.84 43.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.045 3.164 . . . . 0.0 112.112 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.3 t -136.59 152.23 50.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.506 1.522 . . . . 0.0 108.578 160.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.5 tptt -71.91 120.05 16.96 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.033 -1.042 . . . . 0.0 111.976 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.36 147.97 41.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.933 0.893 . . . . 0.0 111.681 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -89.81 142.85 27.3 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.505 0.722 . . . . 0.0 109.741 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.7 mt -135.11 143.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.587 1.155 . . . . 0.0 110.334 -167.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.2 t -143.19 158.22 43.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 110.838 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -158.74 157.31 31.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.442 1.097 . . . . 0.0 112.988 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 67.3 m -140.89 115.2 9.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.447 1.499 . . . . 0.0 109.868 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.85 136.92 36.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.026 1.331 . . . . 0.0 111.338 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -117.88 146.22 44.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.843 1.657 . . . . 0.0 111.986 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.86 -15.16 63.49 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.759 1.224 . . . . 0.0 112.496 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -70.87 -9.32 57.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.937 1.695 . . . . 0.0 114.159 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.88 33.73 7.22 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.266 0.936 . . . . 0.0 113.553 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.9 p -139.14 163.54 32.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.345 1.458 . . . . 0.0 110.931 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -130.88 125.64 34.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.453 1.501 . . . . 0.0 108.642 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -92.41 144.52 25.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.198 0.999 . . . . 0.0 110.589 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.9 t -126.62 141.7 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.542 1.537 . . . . 0.0 110.802 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 63.2 m -132.92 141.01 48.14 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.985 1.714 . . . . 0.0 110.795 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 10.6 p90 -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.56 104.56 49.45 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.375 1.87 . . . . 0.0 110.524 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.8 165.13 15.68 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.694 2.93 . . . . 0.0 110.199 166.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.0 p -127.77 -19.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.3 pp -146.84 152.06 43.48 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.188 0.995 . . . . 0.0 111.594 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -67.46 147.77 77.83 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.041 2.494 . . . . 0.0 112.838 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.21 -171.09 30.18 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.53 1.062 . . . . 0.0 113.708 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.92 134.64 34.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.956 1.302 . . . . 0.0 112.104 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.66 126.37 41.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.586 1.554 . . . . 0.0 109.842 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 62.6 m -88.37 124.33 33.82 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.987 -1.07 . . . . 0.0 110.708 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.0 128.31 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.512 1.525 . . . . 0.0 108.304 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.1 tt -112.31 130.34 55.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.426 1.49 . . . . 0.0 109.385 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 24.0 t -132.18 131.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.144 0.978 . . . . 0.0 109.577 173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.98 147.48 27.92 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.122 1.369 . . . . 0.0 111.683 -168.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.57 120.25 11.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 109.8 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.12 56.24 5.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.6 1.56 . . . . 0.0 111.824 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.4 pt-20 57.24 13.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.415 2.686 . . . . 0.0 116.322 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -120.23 127.09 52.11 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.732 1.213 . . . . 0.0 110.641 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -63.69 147.08 52.54 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.324 -0.86 . . . . 0.0 112.079 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -70.77 153.73 94.69 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.758 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.43 129.64 30.49 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.632 2.221 . . . . 0.0 110.887 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 91.95 -14.76 63.5 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.103 1.335 . . . . 0.0 114.949 -175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.8 t -78.42 142.63 62.84 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 119.433 1.617 . . . . 0.0 111.734 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.41 140.79 69.24 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.317 0.792 . . . . 0.0 111.989 -4.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -93.52 166.29 12.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.312 1.845 . . . . 0.0 110.689 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 51.3 m -124.44 113.99 18.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.816 0.847 . . . . 0.0 110.395 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.9 156.97 19.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.679 1.192 . . . . 0.0 110.953 167.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -120.9 126.55 50.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.184 0.993 . . . . 0.0 109.949 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.2 t -103.18 131.81 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.38 1.472 . . . . 0.0 109.793 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.2 p -108.99 162.1 14.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.73 1.212 . . . . 0.0 112.62 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.49 142.69 28.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.91 1.243 . . . . 0.0 112.089 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 CA--C 1.549 0.926 0 C-N-CA 124.602 1.161 . . . . 0.0 113.52 -178.717 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 61.5 mt . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.03 0.443 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.22 115.34 10.3 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.551 1.54 . . . . 0.0 111.377 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.79 129.43 18.63 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.32 2.013 . . . . 0.0 108.852 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -114.83 128.88 56.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.616 0.766 . . . . 0.0 111.722 -171.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -157.67 142.72 16.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.817 1.647 . . . . 0.0 111.092 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.97 156.16 49.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.595 1.958 . . . . 0.0 110.141 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.5 p -122.35 137.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.904 1.282 . . . . 0.0 109.959 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 57.9 mt -131.64 133.48 24.31 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.999 1.72 . . . . 0.0 109.035 -172.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.94 112.1 3.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.266 2.644 . . . . 0.0 109.81 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.0 t80 -175.54 148.58 0.93 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.107 2.163 . . . . 0.0 109.177 -171.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.3 m -130.75 124.01 30.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.518 1.127 . . . . 0.0 109.234 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.7 mt -74.47 125.52 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.195 0.598 . . . . 0.0 110.265 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.6 mttp -110.42 -143.0 0.39 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.694 1.597 . . . . 0.0 110.513 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.46 120.29 19.82 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.651 -1.281 . . . . 0.0 110.883 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.98 -152.14 20.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.589 1.566 . . . . 0.0 112.303 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -160.31 147.47 16.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.956 1.302 . . . . 0.0 110.978 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.29 136.73 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.402 1.481 . . . . 0.0 111.207 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 25.2 p -149.58 174.31 12.67 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.573 1.949 . . . . 0.0 110.235 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -157.82 -166.33 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -152.34 142.3 22.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.234 1.813 . . . . 0.0 109.42 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.7 t -119.93 133.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.948 1.699 . . . . 0.0 108.673 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -109.97 132.89 53.75 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.665 1.186 . . . . 0.0 111.794 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -104.34 143.43 26.66 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.674 1.589 . . . . 0.0 111.219 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.08 -29.15 64.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.211 3.274 . . . . 0.0 114.994 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 6.1 m -69.94 -0.77 7.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.3 42.04 6.35 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.6 1.095 . . . . 0.0 112.839 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.59 162.65 39.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.809 1.644 . . . . 0.0 111.99 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.5 m -141.18 158.15 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.988 1.315 . . . . 0.0 112.204 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -151.53 179.1 8.66 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.018 2.127 . . . . 0.0 109.974 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.54 143.8 38.77 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 121.107 -0.996 . . . . 0.0 111.718 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -83.73 166.34 13.47 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.089 3.192 . . . . 0.0 111.405 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 77.5 m -107.21 130.58 54.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.4 1.48 . . . . 0.0 108.651 171.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.52 136.7 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.518 1.127 . . . . 0.0 109.443 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 63.0 m -133.26 124.26 27.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.659 1.584 . . . . 0.0 109.648 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.02 127.26 31.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.292 1.037 . . . . 0.0 111.076 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -87.52 -4.26 58.98 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -170.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 35.9 mmtm 71.57 -5.91 1.53 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.638 2.375 . . . . 0.0 114.538 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -98.21 2.79 48.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.715 2.006 . . . . 0.0 113.218 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.13 16.8 31.62 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.026 1.298 . . . . 0.0 114.457 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 65.1 p -128.75 157.39 41.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.016 1.726 . . . . 0.0 110.677 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -115.31 139.61 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.051 0.94 . . . . 0.0 109.633 163.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.1 m -96.7 138.05 34.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.659 1.184 . . . . 0.0 108.495 169.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 24.8 t -119.11 135.05 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.483 1.513 . . . . 0.0 109.052 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.1 152.77 51.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.558 1.543 . . . . 0.0 111.785 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -153.47 132.44 12.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.349 1.46 . . . . 0.0 110.914 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.43 117.89 70.0 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.236 1.014 . . . . 0.0 110.5 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.56 130.69 12.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.132 2.554 . . . . 0.0 111.823 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 78.2 p -118.7 -15.18 9.51 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -141.54 157.54 44.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.909 1.684 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -90.99 166.28 13.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.27 1.028 . . . . 0.0 112.004 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.24 -166.71 12.17 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.693 1.616 . . . . 0.0 114.079 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -91.77 122.28 34.18 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.338 1.455 . . . . 0.0 110.494 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.5 m80 -119.1 169.57 9.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 111.26 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.51 152.72 42.95 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 171.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 5.7 ttm -125.55 119.45 28.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.886 2.074 . . . . 0.0 109.928 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -95.86 138.4 33.57 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 109.967 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.6 mm -135.96 135.43 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.745 1.218 . . . . 0.0 110.577 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 141.1 32.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 113.329 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 20.6 t80 -103.14 120.26 40.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.153 1.781 . . . . 0.0 109.788 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.73 34.07 15.36 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.673 1.189 . . . . 0.0 112.701 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 73.29 5.35 5.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.92 2.488 . . . . 0.0 115.066 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -97.06 124.6 41.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.079 1.351 . . . . 0.0 109.921 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -57.51 136.11 56.68 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.265 -0.897 . . . . 0.0 112.938 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.3 pt -68.96 152.41 96.82 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.602 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.28 120.11 7.69 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.326 2.018 . . . . 0.0 109.748 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 90.86 7.57 66.11 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.664 -1.075 . . . . 0.0 115.5 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.2 t -74.16 142.11 78.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 120.283 2.041 . . . . 0.0 110.746 162.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -86.59 171.54 38.47 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 120.388 1.174 . . . . 0.0 113.205 -2.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.63 159.34 16.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.131 1.772 . . . . 0.0 110.62 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -133.47 138.86 46.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.614 1.166 . . . . 0.0 110.434 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -156.94 153.32 27.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.07 0.948 . . . . 0.0 112.863 -167.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 43.6 t80 -104.28 148.79 25.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.983 0.913 . . . . 0.0 112.916 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 32.2 t -132.41 139.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.613 1.565 . . . . 0.0 109.22 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.09 153.5 32.95 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.817 1.247 . . . . 0.0 113.023 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -75.69 125.99 30.14 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 111.35 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.0 p -68.72 -24.72 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.572 -0.705 . . . . 0.0 112.428 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.97 -26.02 63.9 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.996 1.318 . . . . 0.0 114.05 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 85.2 m -73.02 -24.61 60.75 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 74.44 7.19 78.14 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.697 1.141 . . . . 0.0 115.504 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -67.91 161.81 25.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.59 1.556 . . . . 0.0 113.629 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -68.26 127.43 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.7 t -156.21 162.78 40.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.41 1.084 . . . . 0.0 111.161 -167.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.4 147.01 31.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.082 1.353 . . . . 0.0 111.804 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.2 p90 -166.54 162.4 16.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.676 1.591 . . . . 0.0 112.355 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.97 173.34 13.26 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.3 1.428 . . . . 0.0 112.991 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.36 -32.56 15.84 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.989 2.46 . . . . 0.0 112.766 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.4 77.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.347 0.976 . . . . 0.0 114.498 -171.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.4 -2.93 44.01 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.865 1.332 . . . . 0.0 113.508 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -106.4 -40.41 5.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.709 2.003 . . . . 0.0 111.558 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -152.47 141.96 21.69 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.356 1.862 . . . . 0.0 111.92 -164.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.9 -179.91 23.35 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.032 1.301 . . . . 0.0 113.118 168.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 62.1 t -142.04 138.28 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.859 1.663 . . . . 0.0 107.831 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -54.91 134.52 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.3 m-80 69.18 -4.48 1.27 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.185 2.194 . . . . 0.0 114.644 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -95.51 137.25 22.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.598 1.159 . . . . 0.0 110.812 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.03 121.77 7.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.486 2.124 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.51 146.51 28.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.377 1.471 . . . . 0.0 110.319 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 73.2 p -138.92 151.2 46.73 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.09 174.43 13.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.0 1.72 . . . . 0.0 111.527 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.0 m -126.85 143.5 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.279 1.432 . . . . 0.0 110.769 -172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.4 t -117.12 134.69 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.017 1.727 . . . . 0.0 108.287 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.13 133.67 36.07 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.033 0.933 . . . . 0.0 111.811 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -134.8 0.87 2.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.433 1.493 . . . . 0.0 113.801 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -54.03 -40.14 66.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.313 1.845 . . . . 0.0 114.804 -167.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -119.92 12.07 11.95 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.708 1.603 . . . . 0.0 112.587 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.99 -35.94 69.61 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 82.37 145.11 5.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.947 1.261 . . . . 0.0 112.496 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.97 148.26 46.14 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.337 1.055 . . . . 0.0 112.142 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.69 -30.54 0.09 OUTLIER Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.51 1.052 . . . . 0.0 114.688 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 145.18 103.28 0.39 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.435 1.493 . . . . 0.0 112.662 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.38 131.49 35.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.232 1.413 . . . . 0.0 109.256 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 9.2 t -135.06 162.99 30.9 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.593 1.557 . . . . 0.0 112.211 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.9 tp -165.63 135.9 3.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.554 1.941 . . . . 0.0 109.205 -163.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.88 159.52 35.1 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.417 1.087 . . . . 0.0 111.956 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.45 135.83 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.523 1.129 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.3 136.23 53.96 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.108 1.363 . . . . 0.0 110.026 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -162.92 -165.02 19.29 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.509 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.98 -26.56 74.07 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.077 3.185 . . . . 0.0 112.514 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -135.87 156.53 48.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.735 1.214 . . . . 0.0 109.464 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -72.95 111.13 7.79 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.076 -1.015 . . . . 0.0 110.288 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.58 147.0 52.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.083 0.953 . . . . 0.0 111.96 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -84.94 135.07 34.21 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.5 mt -130.6 144.68 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 110.418 -166.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.7 t -145.18 165.02 29.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.824 1.25 . . . . 0.0 111.187 167.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -159.26 154.73 25.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.749 1.22 . . . . 0.0 112.528 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.6 m -138.97 125.09 20.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.524 1.53 . . . . 0.0 110.285 -172.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.11 128.79 35.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.715 1.206 . . . . 0.0 111.12 171.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -104.0 148.48 26.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.46 1.504 . . . . 0.0 111.686 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -68.18 -18.26 64.55 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.179 0.992 . . . . 0.0 113.556 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.02 -22.81 60.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.205 1.002 . . . . 0.0 113.695 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 104.52 45.62 1.41 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.287 0.946 . . . . 0.0 113.19 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -140.89 158.07 44.47 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.296 1.438 . . . . 0.0 110.005 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.5 m -107.92 127.36 53.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.638 1.175 . . . . 0.0 109.263 162.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -86.71 147.08 26.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.419 0.688 . . . . 0.0 109.955 166.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -127.98 144.2 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.67 1.588 . . . . 0.0 109.762 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.08 147.93 46.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.873 1.269 . . . . 0.0 111.98 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.9 p90 -151.88 154.25 35.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.15 107.69 43.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.231 1.812 . . . . 0.0 110.383 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -82.81 176.41 7.74 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.901 3.067 . . . . 0.0 110.333 167.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.2 p -151.45 -28.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 85.9 mt -107.58 147.03 34.54 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.53 1.059 . . . . 0.0 110.525 167.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.91 154.98 48.42 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.863 2.376 . . . . 0.0 110.824 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.89 -165.45 24.59 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.96 137.31 32.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.065 1.346 . . . . 0.0 112.506 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -125.36 125.87 44.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.849 1.66 . . . . 0.0 110.079 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 65.3 m -88.19 122.29 31.58 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.646 1.178 . . . . 0.0 110.643 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.69 123.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.437 1.495 . . . . 0.0 108.626 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.45 136.21 44.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.408 1.483 . . . . 0.0 109.318 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 98.4 t -140.32 127.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.173 1.389 . . . . 0.0 108.912 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.96 140.8 20.99 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.567 1.147 . . . . 0.0 111.331 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.4 121.04 14.28 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.465 1.106 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 49.8 t30 57.47 57.27 4.46 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.219 1.408 . . . . 0.0 111.581 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.0 pt-20 58.51 13.96 2.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.438 2.695 . . . . 0.0 116.372 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -124.83 125.9 44.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.382 1.073 . . . . 0.0 111.329 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -65.04 157.05 29.48 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.942 0.897 . . . . 0.0 112.547 169.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.1 m -75.81 152.65 84.93 Favored Pre-proline 0 N--CA 1.483 1.18 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.392 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.3 -13.01 37.97 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.08 1.853 . . . . 0.0 114.462 -166.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -100.24 -10.31 45.52 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.1 p -87.64 153.63 52.95 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 119.779 1.789 . . . . 0.0 113.148 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.11 141.09 68.21 Favored 'Cis proline' 0 C--N 1.352 0.732 0 CA-C-N 119.063 0.701 . . . . 0.0 112.107 -3.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -90.26 167.17 12.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.094 1.357 . . . . 0.0 110.281 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.2 m -128.35 112.15 14.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 110.048 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.76 150.23 23.71 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.383 1.073 . . . . 0.0 110.574 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -110.68 124.76 52.54 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.246 1.018 . . . . 0.0 109.78 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.4 t -107.5 135.05 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.922 1.289 . . . . 0.0 110.834 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.0 p -113.37 164.93 12.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.31 1.444 . . . . 0.0 112.561 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.93 143.15 29.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.007 1.289 . . . . 0.0 112.183 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 124.429 1.091 . . . . 0.0 113.362 -179.941 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 21.6 tp . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.326 0.584 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.0 ttm-85 -59.06 120.04 43.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.931 1.692 . . . . 0.0 111.908 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.37 159.26 47.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.523 2.816 . . . . 0.0 112.02 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.8 t80 -112.16 123.03 49.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.777 1.231 . . . . 0.0 110.098 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.2 134.26 15.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.064 1.346 . . . . 0.0 110.514 170.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.9 140.81 31.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.686 1.594 . . . . 0.0 109.9 -170.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.1 p -107.67 138.93 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.715 1.206 . . . . 0.0 110.855 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.8 mt -134.08 134.99 23.52 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.348 1.859 . . . . 0.0 108.812 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.04 109.22 2.78 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.411 2.74 . . . . 0.0 110.1 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 48.4 t80 -175.2 151.62 1.31 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.999 2.12 . . . . 0.0 109.821 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 29.1 m -135.06 130.93 36.36 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.615 1.166 . . . . 0.0 110.057 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.98 122.35 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 109.437 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.64 -69.91 0.84 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.45 1.1 . . . . 0.0 112.322 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -158.79 127.14 5.24 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.782 1.633 . . . . 0.0 110.952 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.39 -139.54 11.04 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.51 1.528 . . . . 0.0 111.158 -166.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.09 142.29 17.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.366 1.066 . . . . 0.0 111.385 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.7 tt -121.65 135.49 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.785 1.634 . . . . 0.0 111.032 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.4 p -149.28 169.08 21.6 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.182 1.793 . . . . 0.0 110.596 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -162.07 -175.6 33.27 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 115.711 1.045 . . . . 0.0 115.711 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -153.21 143.35 22.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.654 1.582 . . . . 0.0 109.839 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.8 t -115.67 132.49 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.931 1.692 . . . . 0.0 108.101 171.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -119.03 137.47 53.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 110.898 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.8 mtt -110.56 146.67 34.83 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.463 1.505 . . . . 0.0 111.591 -169.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.63 -28.9 77.24 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.919 3.079 . . . . 0.0 114.944 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.5 p -74.51 0.58 14.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.046 1.738 . . . . 0.0 114.37 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.77 83.18 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.692 1.615 . . . . 0.0 113.947 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -72.96 159.11 34.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.742 1.617 . . . . 0.0 112.182 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.4 m -145.72 155.93 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.641 1.576 . . . . 0.0 111.074 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.68 166.5 26.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.442 1.497 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -100.06 137.63 20.13 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.175 0.99 . . . . 0.0 111.506 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.69 169.29 12.15 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.195 3.263 . . . . 0.0 111.827 171.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 86.9 m -110.24 119.75 40.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.667 1.587 . . . . 0.0 109.002 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.75 129.93 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.279 1.032 . . . . 0.0 109.026 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 35.0 m -125.99 116.13 20.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.861 1.664 . . . . 0.0 109.001 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.01 124.0 27.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.616 -0.678 . . . . 0.0 110.045 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.09 -10.24 59.75 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 72.97 -3.37 2.44 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.023 2.529 . . . . 0.0 113.864 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -93.86 1.19 56.45 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.665 1.986 . . . . 0.0 113.33 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.74 14.16 38.21 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.102 1.334 . . . . 0.0 114.472 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 76.1 p -128.37 157.12 41.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.407 1.883 . . . . 0.0 110.348 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -113.61 137.9 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.513 0.725 . . . . 0.0 109.59 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.5 m -102.29 128.88 48.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.649 1.179 . . . . 0.0 107.993 168.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.4 t -113.74 128.98 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.944 1.298 . . . . 0.0 108.95 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -126.53 154.4 43.88 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.231 1.812 . . . . 0.0 111.619 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.4 t80 -158.99 134.98 8.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.76 1.224 . . . . 0.0 112.275 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.91 119.96 70.66 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.562 1.145 . . . . 0.0 110.648 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.36 150.68 15.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.526 2.817 . . . . 0.0 111.798 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.4 m -132.2 -8.07 3.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -166.98 145.98 5.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.583 1.553 . . . . 0.0 110.325 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.56 170.66 16.17 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 0.0 113.523 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.84 178.77 17.88 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.484 1.516 . . . . 0.0 114.405 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 51.6 tp -75.98 103.21 5.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.191 1.397 . . . . 0.0 110.426 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -96.73 159.46 14.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 111.251 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.64 149.87 36.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 111.627 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 25.3 ttm -134.27 135.67 43.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.387 1.875 . . . . 0.0 110.645 -163.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -118.26 126.36 52.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.904 1.682 . . . . 0.0 109.763 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -127.94 130.13 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.818 1.247 . . . . 0.0 109.727 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 141.1 33.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.4 t80 -103.23 120.3 40.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.257 1.823 . . . . 0.0 109.5 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.15 32.6 10.8 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.766 1.226 . . . . 0.0 112.953 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 75.07 7.32 4.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.052 2.541 . . . . 0.0 115.195 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.4 mtp -99.19 128.03 45.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.921 1.288 . . . . 0.0 110.315 166.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -55.41 136.18 49.72 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.32 -0.862 . . . . 0.0 113.03 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.6 pt -73.12 150.63 90.05 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.883 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.39 131.62 39.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.532 2.155 . . . . 0.0 110.398 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.36 63.43 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.764 1.173 . . . . 0.0 114.51 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.33 150.24 44.35 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.59 1.695 . . . . 0.0 110.922 172.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.98 164.34 88.1 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 120.715 1.291 . . . . 0.0 113.317 -1.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.71 161.32 21.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.937 1.695 . . . . 0.0 111.322 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -157.86 148.99 21.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.391 1.077 . . . . 0.0 112.125 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -168.28 157.8 9.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.302 1.441 . . . . 0.0 111.885 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.4 t80 -95.04 128.69 42.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.056 -1.028 . . . . 0.0 112.685 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.4 t -93.13 135.13 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.501 1.52 . . . . 0.0 108.777 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.79 148.12 20.63 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.324 1.05 . . . . 0.0 112.717 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.34 144.47 51.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.105 1.362 . . . . 0.0 113.295 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.8 p -76.21 -28.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.208 1.003 . . . . 0.0 113.59 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -85.05 -19.48 31.87 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 73.1 m -67.27 149.16 50.76 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.325 1.05 . . . . 0.0 113.401 -173.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.53 -13.52 63.08 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.826 1.203 . . . . 0.0 114.831 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -64.23 153.39 38.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 118.713 1.257 . . . . 0.0 113.296 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.9 p -64.79 135.72 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.727 0.811 . . . . 0.0 110.001 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 9.6 t -154.64 157.27 37.91 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.729 1.212 . . . . 0.0 110.836 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.1 145.59 39.67 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.495 1.118 . . . . 0.0 111.975 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.5 p90 -165.91 165.16 18.35 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.91 1.684 . . . . 0.0 112.236 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.84 175.28 14.0 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.178 1.371 . . . . 0.0 113.123 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 -34.29 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.704 2.269 . . . . 0.0 113.057 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.65 -34.25 86.91 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.578 1.081 . . . . 0.0 114.444 -171.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.95 -4.67 48.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.797 1.299 . . . . 0.0 113.41 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.5 m -106.07 -47.74 3.77 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.446 1.898 . . . . 0.0 110.989 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -143.66 149.14 36.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.46 1.904 . . . . 0.0 112.341 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -145.43 178.27 23.29 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.451 1.024 . . . . 0.0 113.721 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 50.3 t -139.25 135.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 108.451 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.6 m -57.26 136.41 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.29 -0.72 2.07 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.168 2.187 . . . . 0.0 114.442 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -104.17 140.47 21.1 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.408 1.483 . . . . 0.0 110.881 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.54 120.19 6.57 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.613 2.209 . . . . 0.0 110.326 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.74 135.23 42.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.251 1.42 . . . . 0.0 110.155 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.6 p -129.41 147.24 51.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -165.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.46 175.8 13.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.628 1.571 . . . . 0.0 111.636 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.3 m -130.33 142.82 50.51 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.995 1.318 . . . . 0.0 110.839 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -113.04 132.82 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.862 1.665 . . . . 0.0 108.135 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.3 m120 -94.73 129.86 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.214 1.006 . . . . 0.0 110.393 173.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.7 p -132.92 2.29 3.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.42 1.488 . . . . 0.0 113.859 -166.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -50.22 -38.16 38.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.484 1.913 . . . . 0.0 115.346 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -128.88 20.47 5.96 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.439 1.496 . . . . 0.0 112.387 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.58 64.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.16 146.7 7.63 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.171 1.367 . . . . 0.0 113.039 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -75.88 148.06 38.58 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.423 1.089 . . . . 0.0 111.968 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.24 -30.1 0.17 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.692 1.139 . . . . 0.0 114.531 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.41 112.66 0.87 Allowed Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.511 1.529 . . . . 0.0 112.82 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.08 128.9 34.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.369 1.468 . . . . 0.0 109.209 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 37.2 m -126.95 156.04 42.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.996 1.718 . . . . 0.0 111.781 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.8 134.94 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.656 1.582 . . . . 0.0 109.103 -169.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.14 35.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.015 0.926 . . . . 0.0 112.275 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.24 139.31 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.874 1.27 . . . . 0.0 109.934 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.86 129.47 38.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.294 1.438 . . . . 0.0 110.095 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.52 -159.77 9.54 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.83 -0.984 . . . . 0.0 114.342 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.41 -23.08 71.56 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.101 3.201 . . . . 0.0 112.757 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.9 t -146.29 161.34 40.51 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.266 1.426 . . . . 0.0 109.542 163.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.74 113.63 8.02 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.002 -1.061 . . . . 0.0 111.078 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.15 147.9 49.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.73 0.812 . . . . 0.0 111.389 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.44 139.16 30.8 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.297 0.639 . . . . 0.0 109.532 168.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 28.7 mt -130.98 138.55 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.565 1.146 . . . . 0.0 110.325 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.5 m -129.79 152.65 49.05 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.737 1.615 . . . . 0.0 110.473 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -151.88 151.39 31.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.079 0.951 . . . . 0.0 112.332 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.5 m -140.9 116.44 10.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.205 1.402 . . . . 0.0 110.114 -169.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -72.26 135.63 46.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.161 0.985 . . . . 0.0 111.04 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -112.34 150.65 30.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.476 1.51 . . . . 0.0 111.863 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -72.75 -12.01 60.84 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.68 1.28 52.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.209 1.403 . . . . 0.0 114.553 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.53 30.9 8.68 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.523 1.059 . . . . 0.0 114.218 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 40.7 p -133.76 170.92 14.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.854 1.262 . . . . 0.0 111.703 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 53.5 t -130.57 130.85 44.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.496 1.919 . . . . 0.0 108.724 165.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.0 t -94.1 147.78 22.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.284 1.034 . . . . 0.0 110.935 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -126.97 143.57 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.81 1.644 . . . . 0.0 109.981 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -139.89 139.19 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.515 1.526 . . . . 0.0 110.603 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -144.91 151.74 39.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.7 mt -113.8 101.99 54.37 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.033 1.733 . . . . 0.0 110.288 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.46 164.8 23.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.442 2.762 . . . . 0.0 110.058 166.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.6 m -136.41 -22.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 92.1 mt -117.98 147.86 42.21 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.033 1.333 . . . . 0.0 110.234 170.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.96 155.39 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.656 2.238 . . . . 0.0 110.759 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.97 -165.65 23.41 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.684 1.135 . . . . 0.0 113.295 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.6 137.59 32.25 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.806 1.242 . . . . 0.0 112.973 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.74 124.8 40.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.797 1.639 . . . . 0.0 109.93 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -84.18 129.43 34.89 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.994 -1.066 . . . . 0.0 110.714 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.92 130.47 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.625 1.57 . . . . 0.0 108.127 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.8 tt -111.66 132.19 54.77 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.438 1.495 . . . . 0.0 109.613 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -134.46 128.12 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 172.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.5 141.09 23.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 111.433 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.09 121.75 15.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.43 1.092 . . . . 0.0 110.062 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.8 57.76 3.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.322 1.449 . . . . 0.0 111.496 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.1 pt-20 56.34 19.92 4.33 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.305 2.642 . . . . 0.0 116.172 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.48 128.65 37.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.719 1.207 . . . . 0.0 110.989 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.32 150.85 42.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.741 0.816 . . . . 0.0 112.237 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 7.9 m -67.12 154.19 93.13 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.039 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -52.68 -31.69 51.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.984 3.123 . . . . 0.0 116.29 -170.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.36 -4.6 59.53 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -84.33 143.29 41.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.153 1.477 . . . . 0.0 112.33 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.75 140.98 70.34 Favored 'Cis proline' 0 C--N 1.352 0.719 0 CA-C-N 119.106 0.717 . . . . 0.0 112.169 -4.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.35 172.86 8.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.193 1.797 . . . . 0.0 110.491 173.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.7 m -136.7 119.04 15.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.712 0.805 . . . . 0.0 110.567 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.91 158.57 16.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.214 1.406 . . . . 0.0 111.082 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -120.84 127.88 52.32 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.198 0.999 . . . . 0.0 110.287 169.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.8 t -107.17 132.74 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.759 -172.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 56.7 m -101.21 155.32 18.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.311 1.844 . . . . 0.0 111.612 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.55 138.35 23.05 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.709 1.147 . . . . 0.0 112.119 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.62 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -59.86 116.63 17.83 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.446 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.31 154.81 32.36 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.736 2.291 . . . . 0.0 111.025 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.3 t80 -100.9 128.97 46.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.236 0.541 . . . . 0.0 110.411 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -156.25 148.28 23.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.819 1.648 . . . . 0.0 110.836 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.09 152.89 17.57 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.126 1.37 . . . . 0.0 110.632 -174.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.3 p -125.8 133.15 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.201 1.4 . . . . 0.0 109.483 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 73.7 mt -132.15 135.33 26.31 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.901 1.68 . . . . 0.0 109.163 -167.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.57 112.74 3.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.995 2.463 . . . . 0.0 109.868 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.0 t80 -177.2 150.28 0.72 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.175 2.19 . . . . 0.0 109.435 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.4 m -132.1 128.72 38.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.381 1.072 . . . . 0.0 109.77 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.23 118.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.811 0.844 . . . . 0.0 109.834 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.0 pttt -90.95 -146.13 0.19 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.772 1.629 . . . . 0.0 112.393 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -72.84 -12.62 61.05 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.09 -149.04 19.67 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.86 1.695 . . . . 0.0 113.032 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.94 156.17 44.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 111.345 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.52 138.28 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 111.381 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.7 p -149.19 163.73 36.79 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.114 1.766 . . . . 0.0 110.76 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.56 -174.43 15.83 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.72 136.87 14.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.256 1.823 . . . . 0.0 108.915 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.01 134.19 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.748 1.619 . . . . 0.0 107.94 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -118.61 130.68 56.01 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.187 0.995 . . . . 0.0 111.207 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -96.52 152.23 38.49 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.069 1.748 . . . . 0.0 111.665 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.31 -21.89 26.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.378 2.719 . . . . 0.0 113.014 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.5 p -80.51 2.18 26.42 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.712 1.605 . . . . 0.0 114.5 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.36 54.15 2.62 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.515 1.055 . . . . 0.0 113.233 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -156.4 166.97 31.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.052 1.741 . . . . 0.0 111.681 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.6 159.25 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.587 1.155 . . . . 0.0 113.068 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.04 -178.65 7.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.802 2.441 . . . . 0.0 109.757 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.55 145.5 53.35 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 120.612 -1.305 . . . . 0.0 112.562 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.64 173.4 6.28 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.551 3.501 . . . . 0.0 111.696 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.0 m -108.75 136.18 48.75 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.524 1.53 . . . . 0.0 108.835 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.08 134.44 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.092 1.357 . . . . 0.0 109.187 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -136.11 121.83 19.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.539 1.535 . . . . 0.0 109.743 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.14 128.0 33.64 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.601 0.76 . . . . 0.0 110.617 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.63 -7.56 59.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 39.5 tttm 74.36 -5.24 2.13 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.437 2.695 . . . . 0.0 113.723 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -94.57 1.41 55.64 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.944 2.098 . . . . 0.0 113.329 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.2 16.37 32.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.108 1.337 . . . . 0.0 114.379 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.08 155.27 45.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.041 1.737 . . . . 0.0 110.608 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -113.6 135.95 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.98 0.912 . . . . 0.0 109.979 165.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.5 m -92.06 138.08 31.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.445 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.6 t -127.34 136.03 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.201 1.4 . . . . 0.0 109.026 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -141.58 155.02 45.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.811 1.244 . . . . 0.0 112.692 -174.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 31.6 t80 -154.41 133.17 12.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.522 1.529 . . . . 0.0 111.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -81.88 127.55 71.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.408 1.083 . . . . 0.0 111.214 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.09 175.03 10.79 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.835 3.024 . . . . 0.0 112.231 -173.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 19.0 t -162.89 -38.09 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.16 0.984 . . . . 0.0 113.227 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -135.0 150.78 50.39 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.828 1.651 . . . . 0.0 110.331 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -85.64 172.28 11.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 0.0 113.524 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.99 -170.49 13.34 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 126.121 1.819 . . . . 0.0 113.72 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.4 tp -81.32 131.02 35.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 110.43 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 59.5 m80 -128.69 163.5 24.97 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.065 1.746 . . . . 0.0 111.101 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -142.43 157.54 44.66 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.162 0.985 . . . . 0.0 111.266 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 67.0 ttp -141.16 123.87 16.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.388 1.075 . . . . 0.0 111.845 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -85.91 139.75 30.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.335 1.854 . . . . 0.0 110.373 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.17 128.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.295 1.438 . . . . 0.0 108.199 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 138.05 30.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -104.03 123.91 48.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.914 2.086 . . . . 0.0 110.336 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.91 34.34 13.38 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.47 1.108 . . . . 0.0 112.586 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 36.2 t30 78.66 2.3 2.56 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 128.519 2.727 . . . . 0.0 114.942 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.5 129.81 54.39 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.723 1.609 . . . . 0.0 111.035 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.06 139.09 35.91 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.85 147.43 97.86 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.925 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.62 120.25 7.59 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.532 2.155 . . . . 0.0 111.722 -165.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -8.96 72.37 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.338 1.447 . . . . 0.0 115.157 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 12.8 m -74.58 157.79 85.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 120.047 1.923 . . . . 0.0 112.359 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.87 161.48 91.45 Favored 'Cis proline' 0 C--N 1.355 0.881 0 CA-C-N 119.844 0.98 . . . . 0.0 113.999 5.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.47 162.11 13.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.885 1.674 . . . . 0.0 110.905 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -142.3 138.98 31.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.729 1.211 . . . . 0.0 110.503 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.47 167.74 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.751 1.221 . . . . 0.0 112.146 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 18.5 t80 -110.29 141.57 43.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.996 0.918 . . . . 0.0 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.4 t -112.04 138.08 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.946 1.698 . . . . 0.0 108.469 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t0 -156.4 151.62 26.51 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -75.61 95.89 3.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.283 1.433 . . . . 0.0 111.522 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 16.3 m -58.47 -23.1 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.293 1.437 . . . . 0.0 114.447 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.69 -13.68 44.74 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 97.9 m -75.92 156.67 34.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.211 1.004 . . . . 0.0 113.25 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.19 77.82 2.06 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.227 1.394 . . . . 0.0 112.35 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -163.9 154.71 15.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.099 1.759 . . . . 0.0 112.356 173.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.7 p -73.35 135.3 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.283 1.033 . . . . 0.0 110.434 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 5.9 t -152.78 171.37 18.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.572 1.149 . . . . 0.0 111.682 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -153.68 150.39 28.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.531 1.133 . . . . 0.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.68 164.81 6.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.052 1.741 . . . . 0.0 112.93 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.55 173.16 12.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.34 1.448 . . . . 0.0 113.167 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.55 -34.75 18.99 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.082 2.521 . . . . 0.0 112.762 -172.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.18 -33.5 85.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.895 0.77 . . . . 0.0 114.373 -172.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.22 0.13 38.03 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.744 1.272 . . . . 0.0 113.878 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.7 m -107.04 -38.85 5.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.414 1.886 . . . . 0.0 111.536 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -157.76 146.58 19.43 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.127 1.371 . . . . 0.0 112.993 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 -173.89 21.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.874 1.702 . . . . 0.0 112.852 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.7 p -150.89 138.61 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.981 1.312 . . . . 0.0 109.245 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.9 m -57.64 141.36 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 27.5 m120 69.53 -5.29 1.19 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.131 2.173 . . . . 0.0 114.728 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -102.18 144.29 28.3 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.338 1.455 . . . . 0.0 111.045 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.24 130.56 15.37 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.566 2.178 . . . . 0.0 110.625 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.91 147.05 32.78 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.548 . . . . 0.0 110.437 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.7 p -136.84 147.3 46.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -160.03 176.05 12.28 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.291 1.836 . . . . 0.0 110.936 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 82.8 m -134.01 136.75 44.28 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.152 0.981 . . . . 0.0 111.097 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 20.5 t -98.08 132.22 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.55 . . . . 0.0 107.752 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -98.66 116.74 31.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 109.753 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -121.3 8.69 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.685 1.994 . . . . 0.0 113.007 -166.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -52.75 -38.35 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.73 1.612 . . . . 0.0 113.786 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -92.39 -12.47 32.15 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.109 1.364 . . . . 0.0 113.637 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.23 68.32 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.168 0.987 . . . . 0.0 112.975 -172.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 76.76 -76.26 1.59 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.229 1.395 . . . . 0.0 113.848 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -163.46 150.15 12.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.395 1.878 . . . . 0.0 110.078 -171.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 133.39 -2.48 4.61 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.965 1.269 . . . . 0.0 115.085 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 99.81 117.66 4.04 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.73 1.634 . . . . 0.0 113.48 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 129.22 34.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.809 1.644 . . . . 0.0 109.247 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -121.4 153.05 38.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.411 1.485 . . . . 0.0 111.575 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.9 tp -159.83 134.8 7.96 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.356 1.462 . . . . 0.0 109.464 -170.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.29 161.3 37.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.338 1.055 . . . . 0.0 112.08 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.6 mt -137.4 132.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.622 1.169 . . . . 0.0 109.433 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -121.72 112.66 18.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.238 1.415 . . . . 0.0 109.684 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.26 12.92 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.23 -22.12 54.03 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.936 . . . . 0.0 111.998 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.4 t -135.29 157.86 45.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.237 1.415 . . . . 0.0 109.132 157.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -75.62 119.28 19.45 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.914 -1.116 . . . . 0.0 111.38 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.07 148.79 43.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.232 1.013 . . . . 0.0 111.7 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.67 139.91 32.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.235 0.614 . . . . 0.0 109.587 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.35 143.35 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.443 1.097 . . . . 0.0 110.362 -168.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.0 t -143.43 160.78 39.94 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.031 1.332 . . . . 0.0 110.846 167.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -157.42 155.28 30.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.334 1.054 . . . . 0.0 112.979 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -138.65 117.01 11.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.6 1.56 . . . . 0.0 110.198 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -74.83 136.37 41.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.077 1.351 . . . . 0.0 111.471 172.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -117.47 146.83 43.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.539 1.536 . . . . 0.0 112.016 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -68.16 -13.22 62.06 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.09 -5.1 45.01 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.652 1.581 . . . . 0.0 113.982 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.32 30.11 8.97 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.754 1.169 . . . . 0.0 113.858 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.2 p -137.44 165.0 27.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.299 1.44 . . . . 0.0 111.484 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -127.68 122.57 33.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.663 1.585 . . . . 0.0 108.796 164.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -87.51 145.87 26.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.959 0.903 . . . . 0.0 110.592 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.4 t -125.85 141.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.578 1.551 . . . . 0.0 110.321 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 67.3 m -130.96 140.71 50.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.884 1.673 . . . . 0.0 110.632 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -146.24 151.73 38.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.72 105.62 40.68 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.686 1.994 . . . . 0.0 110.494 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -86.62 160.3 9.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.043 3.162 . . . . 0.0 110.7 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -119.98 -21.82 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -169.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.52 149.32 36.83 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.857 1.263 . . . . 0.0 110.587 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.97 153.64 37.42 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.88 2.387 . . . . 0.0 112.432 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.67 -167.72 27.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.095 1.331 . . . . 0.0 113.393 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -91.08 128.56 36.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.013 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -118.77 127.35 53.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.678 1.591 . . . . 0.0 109.805 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.11 121.31 30.37 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.86 0.864 . . . . 0.0 110.448 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.27 127.21 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.19 1.396 . . . . 0.0 108.111 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.91 130.37 55.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.278 1.431 . . . . 0.0 109.5 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.1 t -132.99 129.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.276 1.03 . . . . 0.0 109.457 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 147.51 26.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 111.418 -166.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 2.2 t80 -140.9 126.14 18.55 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.794 1.238 . . . . 0.0 110.279 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.1 t-20 45.07 58.9 3.76 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.117 1.367 . . . . 0.0 113.245 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.311 7.9 pt-20 60.02 13.8 3.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.107 2.563 . . . . 0.0 116.596 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -125.65 128.46 47.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.48 1.112 . . . . 0.0 111.352 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.84 151.55 45.19 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.055 -1.028 . . . . 0.0 112.716 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 29.1 m -65.48 152.05 93.12 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.65 163.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.37 -20.04 66.03 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.476 2.117 . . . . 0.0 114.84 -167.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -94.46 -6.58 61.05 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -86.64 143.83 36.49 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 119.049 1.424 . . . . 0.0 112.33 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.74 141.29 71.33 Favored 'Cis proline' 0 C--N 1.354 0.819 0 CA-C-N 119.117 0.72 . . . . 0.0 112.064 -4.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -92.68 166.8 12.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.966 1.706 . . . . 0.0 110.041 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.7 m -131.75 119.71 21.68 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.536 0.734 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -103.16 137.53 41.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.949 1.3 . . . . 0.0 111.737 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -86.05 117.29 24.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.5 t -92.42 130.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.101 0.96 . . . . 0.0 109.207 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.1 m -105.13 159.92 15.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.756 1.623 . . . . 0.0 110.644 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.9 138.22 23.38 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.119 0.866 . . . . 0.0 111.969 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 125.221 1.408 . . . . 0.0 113.584 -174.965 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 30.0 tp . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -60.27 118.27 31.84 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.119 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.42 159.5 46.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.277 2.651 . . . . 0.0 111.318 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.01 123.23 36.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.429 0.692 . . . . 0.0 109.225 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.17 130.46 16.57 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.331 1.453 . . . . 0.0 109.956 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.39 141.53 27.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.266 1.426 . . . . 0.0 109.931 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -118.79 137.76 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.96 137.49 25.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.331 1.853 . . . . 0.0 108.738 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.48 37.99 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.386 3.39 . . . . 0.0 113.526 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.38 161.32 17.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.54 1.536 . . . . 0.0 110.499 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 87.6 m -133.42 130.2 38.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.019 1.327 . . . . 0.0 109.688 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 115.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.362 1.065 . . . . 0.0 110.304 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -92.94 -163.27 1.02 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.218 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.0 pttp -71.91 132.52 44.47 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.806 -1.184 . . . . 0.0 112.052 169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.53 -141.7 12.29 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.319 1.438 . . . . 0.0 111.631 -167.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.31 143.74 18.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.853 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.6 tt -134.68 136.48 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.292 1.837 . . . . 0.0 110.367 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 33.4 p -145.6 165.27 29.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.603 1.561 . . . . 0.0 110.849 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.65 176.46 29.22 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -151.94 138.17 18.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.128 1.771 . . . . 0.0 109.644 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.2 t -111.79 134.46 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.241 1.816 . . . . 0.0 108.651 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -113.7 123.16 49.23 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.862 1.665 . . . . 0.0 110.209 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.8 mtm -98.05 146.64 31.84 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.703 1.601 . . . . 0.0 111.466 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.28 -16.21 28.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.799 2.999 . . . . 0.0 113.144 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.7 p -74.42 0.28 15.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.806 1.642 . . . . 0.0 114.197 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.39 42.38 5.53 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.722 1.153 . . . . 0.0 113.538 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -152.66 169.26 23.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.392 1.477 . . . . 0.0 112.525 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.0 m -139.22 159.25 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.899 1.28 . . . . 0.0 112.848 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.8 171.26 19.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.078 2.151 . . . . 0.0 110.257 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -110.55 142.36 25.92 Favored Pre-proline 0 CA--C 1.547 0.831 0 O-C-N 121.103 -0.998 . . . . 0.0 112.344 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.22 175.87 3.91 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.57 3.513 . . . . 0.0 112.385 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.1 m -108.02 130.24 55.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.444 1.498 . . . . 0.0 108.963 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.84 131.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.149 1.379 . . . . 0.0 108.676 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.4 m -132.94 130.36 39.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.373 1.469 . . . . 0.0 110.05 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -82.45 126.46 32.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.164 0.586 . . . . 0.0 110.106 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -80.59 -7.6 59.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.2 mttp 71.77 7.4 5.9 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.592 2.357 . . . . 0.0 113.606 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.07 7.59 23.62 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.345 2.258 . . . . 0.0 112.597 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 19.35 35.55 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.974 1.274 . . . . 0.0 114.317 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.8 p -134.23 158.19 44.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.105 1.762 . . . . 0.0 110.267 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 27.2 m -116.13 148.1 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.568 1.147 . . . . 0.0 110.13 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 50.6 m -113.99 136.48 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 41.7 t -119.91 134.8 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.202 1.401 . . . . 0.0 108.925 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.21 154.96 50.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.896 1.279 . . . . 0.0 113.16 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.5 t80 -153.77 136.89 15.57 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.565 1.546 . . . . 0.0 111.927 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.2 117.26 67.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.023 1.329 . . . . 0.0 110.804 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.36 156.02 16.69 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.96 3.106 . . . . 0.0 112.656 -172.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.4 m -118.29 -18.39 9.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -163.66 155.12 16.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.665 1.586 . . . . 0.0 110.572 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -69.07 168.49 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.576 1.15 . . . . 0.0 113.531 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.06 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.598 1.571 . . . . 0.0 114.138 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.5 tp -79.09 129.61 34.64 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.744 1.218 . . . . 0.0 110.677 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.8 m80 -130.27 162.0 29.96 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.587 1.555 . . . . 0.0 111.373 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.71 156.15 41.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 111.786 172.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -138.92 126.85 22.31 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.112 1.765 . . . . 0.0 109.956 -168.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.46 122.4 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.335 1.454 . . . . 0.0 109.389 175.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 42.8 mm -120.89 135.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.129 1.372 . . . . 0.0 109.805 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.78 137.72 20.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.6 t80 -99.3 123.27 43.45 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.823 2.049 . . . . 0.0 109.857 175.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.15 33.42 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.785 1.234 . . . . 0.0 112.729 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 22.6 t30 75.77 5.94 3.89 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 128.123 2.569 . . . . 0.0 115.109 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.36 131.62 51.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.806 1.643 . . . . 0.0 110.884 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m170 -56.8 134.09 54.83 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.057 -1.027 . . . . 0.0 113.213 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.33 155.86 89.49 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.402 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.85 125.87 19.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.367 2.045 . . . . 0.0 109.761 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.69 53.54 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.725 1.155 . . . . 0.0 114.344 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.7 t -84.6 148.06 50.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.054 1.427 . . . . 0.0 111.919 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.38 159.99 94.35 Favored 'Cis proline' 0 C--N 1.352 0.72 0 CA-C-N 119.936 1.013 . . . . 0.0 112.062 -7.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.36 152.19 20.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.401 1.48 . . . . 0.0 110.523 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -151.43 134.41 15.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.469 1.108 . . . . 0.0 110.259 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.91 165.05 18.43 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.373 1.069 . . . . 0.0 112.504 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 44.2 t80 -103.19 139.76 38.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.168 0.987 . . . . 0.0 112.154 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 78.1 t -105.34 140.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.195 1.798 . . . . 0.0 109.24 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.4 t0 -156.41 149.12 23.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.087 1.355 . . . . 0.0 111.455 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.99 147.18 51.99 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.462 -0.774 . . . . 0.0 112.44 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 95.0 t -72.0 -29.04 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.071 0.948 . . . . 0.0 111.383 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -80.73 -7.7 59.44 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.6 m -58.52 137.44 57.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.481 1.113 . . . . 0.0 113.386 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.2 -19.87 40.8 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.951 1.263 . . . . 0.0 114.086 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.68 158.91 31.15 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.267 1.033 . . . . 0.0 113.457 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.9 p -62.49 138.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 110.176 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.0 t -159.67 156.68 28.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.17 1.388 . . . . 0.0 110.653 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.25 145.7 47.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.581 1.152 . . . . 0.0 112.65 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.3 p90 -168.17 157.1 9.18 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.881 1.673 . . . . 0.0 113.233 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 147.62 173.65 18.86 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.092 1.329 . . . . 0.0 113.985 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.82 -38.84 12.61 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.27 2.647 . . . . 0.0 112.468 -173.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.19 -18.46 74.91 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.017 0.826 . . . . 0.0 114.099 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 15.7 tp -82.25 -11.21 58.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.562 1.145 . . . . 0.0 112.55 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.1 m -116.59 -40.06 3.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.415 1.886 . . . . 0.0 111.776 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -136.25 169.84 16.99 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.956 2.502 . . . . 0.0 111.489 -172.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -168.29 173.2 43.06 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 121.046 -1.034 . . . . 0.0 113.215 164.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 64.7 t -136.9 130.65 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.728 1.211 . . . . 0.0 108.622 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.7 m -57.16 142.61 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.0 m-80 67.12 2.07 2.62 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.804 2.042 . . . . 0.0 114.606 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 93.7 mttt -118.79 141.6 30.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.791 1.636 . . . . 0.0 111.017 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.95 136.63 30.29 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.659 2.24 . . . . 0.0 110.853 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.74 146.48 42.77 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.1 p -135.58 150.37 49.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.124 0.97 . . . . 0.0 113.462 -164.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1886 ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' 1922 ' ' VAL . 52.5 p90 -160.69 176.9 11.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.672 1.589 . . . . 0.0 111.661 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 39.7 m -130.19 143.89 51.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.232 1.413 . . . . 0.0 110.552 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.8 t -116.81 126.16 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 108.088 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.01 126.7 34.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.106 0.962 . . . . 0.0 110.696 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.3 p -134.32 4.49 3.44 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.092 1.357 . . . . 0.0 113.769 -167.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.2 tttp -54.96 -36.52 65.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.791 1.636 . . . . 0.0 114.789 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.19 14.17 10.49 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.815 1.646 . . . . 0.0 112.516 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -78.66 -11.53 59.98 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.93 -130.86 10.06 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.514 1.054 . . . . 0.0 112.267 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -160.95 161.55 31.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.037 1.735 . . . . 0.0 110.238 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 147.38 -14.28 1.43 Allowed Glycine 0 N--CA 1.475 1.29 0 C-N-CA 125.104 1.335 . . . . 0.0 115.284 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.45 105.73 0.92 Allowed Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.836 1.684 . . . . 0.0 112.482 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.02 125.98 32.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.11 1.364 . . . . 0.0 108.874 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.9 m -124.13 159.69 29.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.879 1.671 . . . . 0.0 112.118 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.7 tp -159.07 137.4 10.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.794 1.637 . . . . 0.0 109.404 -170.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.81 156.37 34.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.372 1.069 . . . . 0.0 111.935 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.75 135.52 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.534 1.134 . . . . 0.0 109.795 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.12 127.67 43.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.419 1.488 . . . . 0.0 109.787 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -153.15 -165.12 13.12 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.132 -0.816 . . . . 0.0 114.499 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.09 -24.15 66.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.087 3.191 . . . . 0.0 112.664 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.7 t -140.27 153.25 46.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.007 1.323 . . . . 0.0 109.739 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -72.56 117.17 13.91 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.167 -0.958 . . . . 0.0 111.049 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.81 153.16 37.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.481 1.112 . . . . 0.0 112.133 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.27 141.65 28.51 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 161.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.5 mt -138.37 138.54 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.758 1.223 . . . . 0.0 110.011 -163.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 65.1 m -137.98 158.1 45.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.515 1.526 . . . . 0.0 111.147 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.1 p -154.33 155.03 34.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 75.6 m -143.67 122.69 12.82 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.179 1.392 . . . . 0.0 110.66 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.94 113.61 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 165.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 27.6 p30 -83.53 -7.46 59.52 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 71.5 0.36 3.44 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -88.22 -11.09 47.66 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.326 1.45 . . . . 0.0 113.137 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 132.79 1.74 4.07 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.452 1.501 . . . . 0.0 115.661 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 64.4 p -137.27 156.66 48.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.231 1.516 . . . . 0.0 112.143 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 79.7 m -104.21 128.14 51.9 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.344 1.458 . . . . 0.0 109.115 165.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.8 t -91.48 151.89 20.59 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.126 0.97 . . . . 0.0 110.763 172.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1922 ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' 1886 ' ' PHE . 84.1 t -132.33 144.54 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.765 1.626 . . . . 0.0 110.041 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 76.0 p -140.98 148.08 39.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.809 1.243 . . . . 0.0 112.236 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.9 p90 -152.51 156.72 39.95 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.16 -0.963 . . . . 0.0 113.212 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.15 106.18 43.53 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.117 1.367 . . . . 0.0 110.871 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -82.6 174.45 9.67 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.976 3.117 . . . . 0.0 110.884 168.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -150.24 -30.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.1 mt -105.99 146.96 33.93 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.502 1.046 . . . . 0.0 110.393 166.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.22 157.37 41.89 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.874 2.383 . . . . 0.0 110.946 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.85 -162.39 24.18 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.778 1.18 . . . . 0.0 113.621 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.49 125.92 35.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.187 1.395 . . . . 0.0 112.303 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -113.84 126.38 55.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.374 1.47 . . . . 0.0 109.203 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.2 m -89.45 127.7 35.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.147 0.979 . . . . 0.0 110.734 175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.9 128.11 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.841 1.257 . . . . 0.0 108.943 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.71 129.93 53.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.661 1.584 . . . . 0.0 109.361 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.0 t -130.19 132.44 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.536 1.134 . . . . 0.0 109.221 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.95 140.7 20.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.326 1.45 . . . . 0.0 111.357 -168.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 117.8 15.32 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.441 1.096 . . . . 0.0 110.017 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 50.7 t-20 56.61 63.6 1.91 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.686 1.594 . . . . 0.0 111.774 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.281 9.2 pt-20 55.63 18.68 2.91 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.234 2.613 . . . . 0.0 116.423 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -132.81 129.04 38.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.782 1.233 . . . . 0.0 110.922 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.4 m170 -64.17 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.917 0.887 . . . . 0.0 112.354 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.7 m -70.87 152.81 95.02 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.437 169.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.28 133.62 41.41 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.643 2.228 . . . . 0.0 111.224 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.58 63.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.899 1.237 . . . . 0.0 114.928 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.3 t -81.08 144.33 54.47 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.009 1.405 . . . . 0.0 111.68 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.43 140.34 64.32 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.014 1.041 . . . . 0.0 112.682 -1.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -95.05 175.81 6.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.595 1.958 . . . . 0.0 110.958 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -135.26 127.01 29.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.103 0.961 . . . . 0.0 110.687 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -106.69 140.55 39.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.684 . . . . 0.0 110.981 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.16 108.46 21.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.115 0.966 . . . . 0.0 110.178 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 87.8 t -90.84 143.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.917 1.287 . . . . 0.0 110.135 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.5 t -131.1 172.26 12.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.487 1.115 . . . . 0.0 112.767 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.42 142.8 26.39 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.746 1.641 . . . . 0.0 112.739 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 124.435 1.094 . . . . 0.0 113.198 177.674 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 120.935 0.398 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 121.64 68.6 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.852 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.27 156.18 51.04 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.144 2.563 . . . . 0.0 111.002 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.4 t80 -116.05 122.13 44.28 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.389 0.676 . . . . 0.0 110.966 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -148.69 151.87 35.67 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.743 1.617 . . . . 0.0 110.618 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 151.84 24.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.575 1.55 . . . . 0.0 109.949 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -125.95 133.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.927 1.291 . . . . 0.0 109.43 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.81 137.17 30.19 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.037 1.735 . . . . 0.0 108.673 -171.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.94 49.48 3.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.658 3.572 . . . . 0.0 112.827 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.3 t80 -93.91 153.0 18.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.463 1.505 . . . . 0.0 110.625 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 127.31 47.19 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.92 1.288 . . . . 0.0 110.217 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.6 mt -92.61 136.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.042 1.337 . . . . 0.0 109.203 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.9 tptt -129.04 -60.22 1.09 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.151 0.98 . . . . 0.0 112.49 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -159.15 131.06 6.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.316 1.846 . . . . 0.0 110.388 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.65 -146.82 16.54 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.292 1.425 . . . . 0.0 111.384 -166.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -157.7 144.84 18.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.577 1.151 . . . . 0.0 110.914 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.85 136.15 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.57 1.548 . . . . 0.0 110.864 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.8 p -148.0 174.4 11.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.165 1.786 . . . . 0.0 110.525 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.64 -171.31 27.53 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.83 146.07 23.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.571 1.949 . . . . 0.0 109.603 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 21.5 t -123.25 138.43 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.331 1.852 . . . . 0.0 108.351 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 68.7 mtm-85 -127.61 142.19 51.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.897 0.879 . . . . 0.0 112.037 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 5.3 mpp? -118.6 148.66 44.68 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.596 1.558 . . . . 0.0 111.936 -173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.01 -29.57 89.6 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.121 3.214 . . . . 0.0 114.886 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 12.5 m -72.93 3.32 5.44 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.88 42.14 6.47 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.556 1.074 . . . . 0.0 112.833 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -148.16 158.26 43.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.842 1.657 . . . . 0.0 111.854 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.9 m -143.21 162.52 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.108 1.363 . . . . 0.0 112.035 -171.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.58 -179.44 8.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.706 2.003 . . . . 0.0 110.923 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -128.96 147.73 65.99 Favored Pre-proline 0 CA--C 1.544 0.74 0 O-C-N 121.185 -0.947 . . . . 0.0 111.601 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -86.94 173.89 5.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.229 3.286 . . . . 0.0 112.191 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.0 m -110.39 135.47 51.05 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.458 1.503 . . . . 0.0 108.75 170.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.6 131.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.954 1.302 . . . . 0.0 108.693 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 89.4 m -132.66 126.85 33.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.475 1.51 . . . . 0.0 109.306 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.8 136.11 40.24 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.021 0.528 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -88.21 -12.69 43.06 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 56.7 tttt 70.63 6.07 5.67 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.219 2.208 . . . . 0.0 113.708 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -105.87 11.15 32.14 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.208 2.203 . . . . 0.0 112.751 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.78 16.15 52.56 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.889 1.233 . . . . 0.0 113.964 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 40.1 p -134.41 158.93 42.61 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 110.622 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.0 m -122.87 143.47 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.794 1.238 . . . . 0.0 110.084 168.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 35.0 m -98.47 138.09 36.2 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.351 1.46 . . . . 0.0 108.831 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 46.1 t -125.13 134.97 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.741 1.617 . . . . 0.0 108.824 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -140.8 156.58 46.12 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.894 1.277 . . . . 0.0 112.594 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 23.2 t80 -153.77 133.11 12.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.732 1.613 . . . . 0.0 111.216 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.19 119.83 73.78 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.4 1.08 . . . . 0.0 110.493 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.67 134.64 15.31 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.238 2.625 . . . . 0.0 111.691 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.2 m -131.73 8.06 4.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.558 1.143 . . . . 0.0 113.12 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -160.18 155.84 25.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.047 1.739 . . . . 0.0 109.912 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.63 175.95 6.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.315 1.046 . . . . 0.0 112.563 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 98.14 -170.4 24.79 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.297 1.427 . . . . 0.0 114.199 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 44.8 tp -76.87 121.85 24.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.924 1.289 . . . . 0.0 110.243 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 12.8 m80 -111.96 164.35 13.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.78 1.632 . . . . 0.0 110.863 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.56 149.79 35.22 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.669 -0.645 . . . . 0.0 111.954 162.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 42.4 ttm -121.36 139.82 52.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.614 1.966 . . . . 0.0 110.121 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.73 134.55 52.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.318 1.447 . . . . 0.0 109.808 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.39 136.42 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.811 1.644 . . . . 0.0 109.433 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 141.07 28.36 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.094 0.958 . . . . 0.0 113.53 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.4 t80 -107.3 122.5 46.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.389 2.276 . . . . 0.0 109.65 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 31.71 10.12 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.56 1.144 . . . . 0.0 112.432 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.0 t30 76.05 5.17 3.79 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.333 2.653 . . . . 0.0 115.071 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.6 mtm -102.44 132.27 48.57 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.526 1.531 . . . . 0.0 110.83 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 12.0 m170 -57.37 136.67 56.61 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 113.142 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 25.5 pt -77.45 153.06 81.52 Favored Pre-proline 0 N--CA 1.48 1.03 0 O-C-N 121.76 -0.588 . . . . 0.0 111.294 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.28 134.15 50.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.158 1.906 . . . . 0.0 109.671 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.4 -13.69 64.14 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.343 0.973 . . . . 0.0 113.973 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.15 146.7 31.77 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 119.11 1.455 . . . . 0.0 111.179 173.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.23 160.67 95.4 Favored 'Cis proline' 0 C--N 1.353 0.802 0 CA-C-N 120.688 1.282 . . . . 0.0 113.455 2.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 75.8 mt -112.06 133.68 54.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.786 2.034 . . . . 0.0 109.054 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -130.16 134.4 47.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.261 1.024 . . . . 0.0 110.575 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -163.12 162.67 25.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.05 0.94 . . . . 0.0 112.817 -175.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.6 t80 -106.57 144.58 33.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.267 1.027 . . . . 0.0 112.88 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 56.2 t -118.95 138.23 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.34 1.456 . . . . 0.0 110.124 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -155.54 147.95 23.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.361 1.064 . . . . 0.0 112.766 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -63.17 142.63 58.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.34 1.456 . . . . 0.0 112.94 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.7 p -67.27 -23.97 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.5 p30 -75.42 -17.06 60.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.7 m -68.21 143.35 55.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.919 0.888 . . . . 0.0 113.357 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -89.99 -17.14 54.73 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.865 1.221 . . . . 0.0 114.36 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -67.25 163.88 19.52 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.466 1.133 . . . . 0.0 113.283 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 4.5 t -66.53 136.94 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.535 1.134 . . . . 0.0 109.52 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 56.7 p -132.65 162.16 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.456 1.102 . . . . 0.0 110.682 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.55 142.21 28.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.358 1.063 . . . . 0.0 110.969 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.9 p90 -166.01 159.94 16.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.616 1.566 . . . . 0.0 112.362 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.74 170.84 12.69 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.329 1.443 . . . . 0.0 113.159 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.05 -32.77 33.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.29 2.66 . . . . 0.0 112.849 -171.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.75 -13.93 72.31 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.936 -0.924 . . . . 0.0 114.791 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.99 -12.64 60.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.128 1.464 . . . . 0.0 112.966 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 15.5 m -119.38 -38.42 3.02 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.684 1.593 . . . . 0.0 112.431 -165.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -156.11 155.03 31.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.61 -173.75 25.5 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.469 1.033 . . . . 0.0 113.033 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.9 p -150.74 136.45 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.647 1.179 . . . . 0.0 109.286 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.7 m -56.57 140.82 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.59 -4.45 1.65 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.396 2.278 . . . . 0.0 114.924 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.65 143.31 26.43 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.965 1.306 . . . . 0.0 110.867 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.54 127.59 11.89 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.461 2.107 . . . . 0.0 110.723 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.48 148.7 26.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.431 1.492 . . . . 0.0 110.361 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.6 p -137.25 155.07 49.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.1 0.96 . . . . 0.0 113.507 -167.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1886 ' ' PHE . . . . . 0.424 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.3 p90 -164.48 172.84 12.8 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.562 1.945 . . . . 0.0 111.404 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.1 m -128.01 144.23 51.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.691 1.596 . . . . 0.0 110.731 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 46.9 t -120.11 130.52 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.123 1.769 . . . . 0.0 108.454 171.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m120 -87.37 127.82 35.2 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.372 -0.83 . . . . 0.0 111.162 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 50.9 p -131.49 3.35 4.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.352 1.461 . . . . 0.0 113.36 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -55.93 -40.03 72.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.781 1.632 . . . . 0.0 114.328 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.34 4.64 22.8 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.523 1.529 . . . . 0.0 112.896 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.05 -25.92 59.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.349 1.06 . . . . 0.0 113.329 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 -92.47 1.46 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.766 1.174 . . . . 0.0 112.664 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -166.6 179.03 5.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.013 1.725 . . . . 0.0 111.863 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 116.52 5.76 15.96 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.998 1.285 . . . . 0.0 115.477 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.99 105.6 2.16 Favored Glycine 0 N--CA 1.47 0.961 0 C-N-CA 125.503 1.525 . . . . 0.0 113.079 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.23 132.1 34.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 109.179 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -128.26 161.02 30.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.69 1.596 . . . . 0.0 112.142 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.2 tp -159.08 136.55 10.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.699 1.599 . . . . 0.0 109.646 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.67 162.3 37.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.713 1.205 . . . . 0.0 111.776 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 41.2 mt -139.03 132.83 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.404 1.082 . . . . 0.0 109.935 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.29 163.76 14.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.769 1.627 . . . . 0.0 110.083 168.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 167.56 -158.49 31.39 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.179 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.72 -22.2 50.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.686 2.924 . . . . 0.0 112.435 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.3 t -147.11 158.54 43.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 109.499 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.63 112.05 9.35 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.977 -1.077 . . . . 0.0 110.595 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -66.47 150.72 48.53 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.119 0.968 . . . . 0.0 111.739 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.51 137.51 32.27 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.409 0.684 . . . . 0.0 109.315 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 35.1 mt -132.2 143.83 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.443 1.097 . . . . 0.0 110.428 -165.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.41 163.0 35.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 111.301 168.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -157.7 156.76 32.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 112.777 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -138.22 125.26 21.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.907 1.683 . . . . 0.0 110.069 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.34 128.92 33.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 110.862 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -107.98 151.94 25.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.292 1.437 . . . . 0.0 112.434 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -68.87 -16.81 63.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.05 0.94 . . . . 0.0 112.719 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.45 -6.39 48.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.724 1.61 . . . . 0.0 113.968 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.73 33.12 8.61 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.499 1.047 . . . . 0.0 113.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.8 p -136.74 156.77 48.07 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.815 1.246 . . . . 0.0 111.15 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.7 m -102.71 127.6 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.956 0.902 . . . . 0.0 108.903 157.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.8 t -92.21 145.83 24.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.746 0.818 . . . . 0.0 109.796 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1922 ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' 1886 ' ' PHE . 86.8 t -130.38 143.69 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.129 1.372 . . . . 0.0 109.976 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.1 p -134.08 149.45 51.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.05 1.34 . . . . 0.0 111.919 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.89 152.82 33.07 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 18.8 mt -115.64 105.69 51.43 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.394 1.878 . . . . 0.0 110.207 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.71 170.63 15.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.573 2.849 . . . . 0.0 110.332 167.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -144.99 -28.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -172.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.93 147.89 36.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 110.394 166.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.97 156.22 52.38 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.83 2.353 . . . . 0.0 110.775 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.3 -167.84 23.65 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.98 1.276 . . . . 0.0 113.382 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.6 128.37 39.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.784 1.234 . . . . 0.0 112.262 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -112.47 140.5 47.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.46 1.904 . . . . 0.0 110.496 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.3 m -105.03 111.94 24.89 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.992 1.317 . . . . 0.0 110.229 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.03 122.27 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.023 1.329 . . . . 0.0 108.383 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.25 125.8 47.92 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.572 1.549 . . . . 0.0 109.231 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.1 t -126.71 129.38 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.27 1.028 . . . . 0.0 109.442 171.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.68 142.83 24.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.921 1.288 . . . . 0.0 111.943 -167.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.12 123.67 22.22 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 109.701 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.5 t-20 52.56 57.13 6.72 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.559 1.543 . . . . 0.0 112.541 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.1 pt-20 58.42 12.17 1.94 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.295 2.638 . . . . 0.0 116.286 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.97 125.28 49.04 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.629 1.172 . . . . 0.0 110.779 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.43 143.38 57.15 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.47 -0.769 . . . . 0.0 111.591 172.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.5 m -72.22 152.01 92.37 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.058 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -56.02 125.44 19.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.148 2.566 . . . . 0.0 111.115 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.73 64.33 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.458 1.504 . . . . 0.0 115.316 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 141.56 68.89 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.264 1.532 . . . . 0.0 111.804 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.69 145.54 79.63 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.587 0.888 . . . . 0.0 112.275 -3.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -96.55 139.4 32.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.585 1.554 . . . . 0.0 110.763 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -100.66 107.47 19.11 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.328 0.651 . . . . 0.0 110.63 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.51 125.17 45.22 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.652 1.181 . . . . 0.0 111.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -95.78 116.69 29.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.518 0.727 . . . . 0.0 110.685 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -99.43 133.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.045 1.738 . . . . 0.0 110.678 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 60.2 p -104.12 169.25 8.6 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.296 1.438 . . . . 0.0 112.959 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.83 142.03 25.07 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.946 1.26 . . . . 0.0 111.691 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 . . . . . 0 CA--C 1.549 0.935 0 C-N-CA 124.49 1.116 . . . . 0.0 113.781 -176.838 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 23.3 tp . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -66.42 119.06 59.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.918 -168.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.46 154.59 60.5 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.315 2.676 . . . . 0.0 111.715 -171.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.7 123.25 42.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.786 0.834 . . . . 0.0 110.194 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -153.18 130.2 11.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.446 1.498 . . . . 0.0 110.344 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.71 143.46 30.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.854 1.662 . . . . 0.0 109.83 -172.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.1 p -112.45 138.59 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.057 1.343 . . . . 0.0 110.571 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 70.8 mt -131.53 136.6 28.81 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.412 1.885 . . . . 0.0 108.71 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.66 45.47 1.96 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.503 3.469 . . . . 0.0 112.926 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 75.1 t80 -91.53 155.12 18.62 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.254 1.422 . . . . 0.0 111.462 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 95.7 m -125.43 125.86 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.549 1.54 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.7 134.25 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.346 1.058 . . . . 0.0 110.641 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -113.18 -141.78 0.38 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.845 1.658 . . . . 0.0 110.656 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.2 135.66 33.63 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.91 -1.119 . . . . 0.0 110.956 166.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 132.98 -145.26 17.29 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.511 1.529 . . . . 0.0 111.555 -167.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -158.6 151.47 22.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.464 1.106 . . . . 0.0 111.536 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.0 tt -124.64 135.23 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.763 1.625 . . . . 0.0 111.936 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.08 164.07 34.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.72 1.608 . . . . 0.0 110.978 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.72 -175.75 23.0 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.42 140.59 16.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.556 1.543 . . . . 0.0 110.02 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 16.3 t -111.47 132.91 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.814 1.646 . . . . 0.0 108.171 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.4 mtm105 -119.49 119.3 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.682 1.193 . . . . 0.0 110.226 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 11.3 mtt -95.53 149.24 35.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.781 1.632 . . . . 0.0 111.376 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.17 -20.59 28.2 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.4 2.733 . . . . 0.0 113.672 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.7 p -80.61 4.29 19.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.206 1.402 . . . . 0.0 114.387 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.06 45.11 4.88 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 124.485 1.04 . . . . 0.0 113.367 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.54 166.18 31.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.76 1.624 . . . . 0.0 112.021 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.59 161.37 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.224 1.01 . . . . 0.0 113.217 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.04 -179.26 7.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.063 2.145 . . . . 0.0 110.533 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -120.52 141.74 32.71 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 121.189 -0.944 . . . . 0.0 111.333 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.18 166.88 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.322 3.348 . . . . 0.0 111.343 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.8 m -106.91 128.02 53.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 108.915 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.9 130.43 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.611 1.165 . . . . 0.0 109.075 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 77.1 m -135.07 120.98 19.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.163 1.385 . . . . 0.0 109.321 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.58 141.77 41.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 112.218 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.63 -5.61 48.34 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.19 6.33 4.73 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.34 2.256 . . . . 0.0 113.515 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -107.2 9.51 30.2 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.805 2.042 . . . . 0.0 112.991 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.11 17.12 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.719 1.152 . . . . 0.0 113.608 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 34.9 p -134.86 159.77 40.34 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.316 1.846 . . . . 0.0 110.413 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.9 m -125.34 143.4 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.584 1.154 . . . . 0.0 110.076 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 96.3 m -104.56 135.92 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.432 1.093 . . . . 0.0 108.668 171.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 40.0 t -120.11 132.99 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.208 1.403 . . . . 0.0 108.744 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -133.14 159.17 40.91 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.035 1.334 . . . . 0.0 112.706 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.7 t80 -160.5 136.48 8.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.688 1.595 . . . . 0.0 111.66 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.12 112.03 51.67 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.749 1.219 . . . . 0.0 110.185 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.24 151.36 26.52 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.216 2.611 . . . . 0.0 112.209 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -116.16 -12.71 11.19 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -163.44 150.34 12.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.59 1.556 . . . . 0.0 110.884 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.79 172.48 12.1 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.7 1.2 . . . . 0.0 113.497 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.87 -178.58 17.63 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 125.542 1.544 . . . . 0.0 114.435 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.43 123.22 25.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.924 1.29 . . . . 0.0 110.088 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.7 m80 -117.7 157.07 27.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.314 1.446 . . . . 0.0 111.818 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -133.46 142.42 48.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.076 1.35 . . . . 0.0 109.317 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.7 tmm? -143.04 132.45 23.47 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.082 0.953 . . . . 0.0 111.753 -168.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -108.72 139.88 42.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.951 2.1 . . . . 0.0 111.455 -173.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.5 mm -139.32 131.05 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.187 1.395 . . . . 0.0 109.304 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.27 139.71 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.18 123.34 46.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.537 1.935 . . . . 0.0 109.912 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.91 30.95 7.78 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.719 1.208 . . . . 0.0 112.827 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.0 t30 80.59 6.16 1.54 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.53 2.732 . . . . 0.0 115.28 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 90.3 mtp -109.05 133.17 53.35 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.054 1.342 . . . . 0.0 111.119 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.24 138.05 55.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -72.84 153.7 91.15 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.273 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.26 123.89 14.89 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.036 2.491 . . . . 0.0 110.37 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.21 -11.22 61.89 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.376 -1.235 . . . . 0.0 114.903 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.3 m -102.2 154.59 37.28 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-N 119.999 1.9 . . . . 0.0 112.673 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.58 163.83 89.48 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.558 0.878 . . . . 0.0 113.272 0.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.22 151.91 24.8 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.82 1.648 . . . . 0.0 111.504 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.87 141.7 47.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.288 1.435 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.2 p90 -166.56 158.28 13.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.372 1.069 . . . . 0.0 112.072 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 38.2 t80 -96.36 130.19 43.53 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.433 0.693 . . . . 0.0 111.755 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 71.4 t -91.86 132.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.998 1.319 . . . . 0.0 108.681 172.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.1 t0 -146.51 163.7 34.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.498 1.519 . . . . 0.0 110.628 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.76 148.82 44.23 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.992 0.917 . . . . 0.0 112.543 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 89.7 t -67.05 -45.02 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.138 0.975 . . . . 0.0 110.631 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 6.4 p30 -93.64 141.66 28.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.924 0.89 . . . . 0.0 111.125 168.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.4 p -173.85 156.79 2.89 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.051 1.741 . . . . 0.0 112.235 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.42 -23.47 11.13 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.854 1.216 . . . . 0.0 113.595 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -73.59 156.9 37.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.424 1.089 . . . . 0.0 113.736 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.4 t -66.95 138.13 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.173 0.989 . . . . 0.0 108.473 170.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.0 t -153.49 166.77 31.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.038 0.935 . . . . 0.0 111.349 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.01 145.46 29.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.134 1.374 . . . . 0.0 111.665 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 47.2 p90 -166.15 162.4 17.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.629 1.572 . . . . 0.0 112.467 -175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.77 173.47 13.22 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.283 1.421 . . . . 0.0 113.014 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.72 -35.04 13.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.879 2.386 . . . . 0.0 112.751 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.38 -32.12 78.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.463 -171.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.34 -3.47 49.64 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.233 1.516 . . . . 0.0 113.478 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.6 m -108.17 -41.24 4.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.473 1.909 . . . . 0.0 111.676 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -151.09 152.55 33.58 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.244 1.818 . . . . 0.0 112.332 -170.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -153.19 -175.41 24.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.406 1.003 . . . . 0.0 113.393 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.8 p -153.6 137.36 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.07 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.8 m -58.57 142.12 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.0 m-80 68.28 7.33 5.86 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.558 1.943 . . . . 0.0 114.582 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -114.7 143.57 30.25 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.167 1.387 . . . . 0.0 110.924 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.48 127.94 13.06 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.604 2.202 . . . . 0.0 110.316 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.13 145.83 32.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.624 1.57 . . . . 0.0 110.273 173.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.2 p -135.69 152.23 50.97 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -167.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.9 173.83 13.97 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.985 1.714 . . . . 0.0 111.385 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 76.0 m -125.73 142.43 51.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.316 1.446 . . . . 0.0 110.464 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 48.1 t -115.9 128.16 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.837 1.655 . . . . 0.0 107.875 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.32 123.92 35.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.021 0.928 . . . . 0.0 110.932 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 54.5 p -125.99 10.25 7.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.408 1.883 . . . . 0.0 112.608 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.16 -40.06 76.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.52 1.528 . . . . 0.0 114.372 -165.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.39 5.42 21.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.648 1.579 . . . . 0.0 112.738 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.71 58.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.575 1.15 . . . . 0.0 113.693 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.33 -86.71 1.38 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.872 1.225 . . . . 0.0 112.772 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.6 -177.88 3.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.27 1.828 . . . . 0.0 111.627 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 119.38 9.52 8.54 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.815 1.198 . . . . 0.0 115.618 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.33 103.52 1.63 Allowed Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.533 1.54 . . . . 0.0 112.834 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 39.2 tp -84.66 141.35 30.67 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.319 1.447 . . . . 0.0 110.158 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.7 m -135.46 159.41 41.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.592 1.557 . . . . 0.0 112.155 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.5 tp -160.71 136.44 8.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.024 1.73 . . . . 0.0 109.338 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.36 159.17 35.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.74 137.24 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.884 1.274 . . . . 0.0 109.837 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.26 134.39 48.96 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.31 1.444 . . . . 0.0 109.979 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.5 -164.55 16.61 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.667 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.32 -24.48 64.81 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.18 3.253 . . . . 0.0 112.836 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.8 t -139.3 159.75 41.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.914 1.285 . . . . 0.0 109.6 162.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.25 110.57 5.98 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.088 -1.008 . . . . 0.0 110.704 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 145.18 54.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 0.0 111.144 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.46 137.13 32.79 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 36.5 mt -129.36 143.73 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.746 1.218 . . . . 0.0 110.131 -168.233 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.63 162.68 35.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 110.966 166.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -158.14 155.41 29.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.646 1.178 . . . . 0.0 112.228 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -142.38 125.18 16.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.385 1.474 . . . . 0.0 109.79 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.36 129.56 36.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.946 169.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.18 151.58 20.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.362 1.465 . . . . 0.0 111.808 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -71.14 -16.48 62.55 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.888 0.875 . . . . 0.0 113.281 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.06 -6.96 59.56 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.31 33.89 6.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.815 1.198 . . . . 0.0 114.445 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -127.94 174.09 9.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.331 1.452 . . . . 0.0 110.572 169.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.1 m -124.16 130.96 53.42 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.105 1.362 . . . . 0.0 109.963 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.6 t -93.88 149.13 21.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.277 1.031 . . . . 0.0 110.745 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.1 t -128.17 143.79 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.102 1.761 . . . . 0.0 109.742 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.1 p -136.14 148.1 48.04 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.78 168.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.28 153.78 36.74 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.5 107.33 43.12 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 110.375 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -85.79 173.07 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.114 3.209 . . . . 0.0 110.834 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.1 p -147.34 -28.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -173.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.06 148.67 37.92 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.249 1.019 . . . . 0.0 110.718 167.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.59 157.71 48.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.98 2.453 . . . . 0.0 110.845 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.16 -168.1 22.17 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.164 1.364 . . . . 0.0 113.484 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.66 132.77 34.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.956 1.302 . . . . 0.0 112.568 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 126.64 49.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.275 1.83 . . . . 0.0 109.816 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.1 m -86.8 124.33 32.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.529 1.132 . . . . 0.0 110.482 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.48 124.31 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.605 1.562 . . . . 0.0 108.402 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.6 tt -106.14 131.04 53.87 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.319 1.447 . . . . 0.0 109.831 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.8 t -133.07 127.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.552 1.141 . . . . 0.0 109.607 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.42 143.42 24.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.969 1.308 . . . . 0.0 111.547 -168.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.63 122.31 15.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.957 1.303 . . . . 0.0 109.641 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.68 56.26 6.96 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.199 1.399 . . . . 0.0 112.095 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.3 pt-20 59.42 3.74 0.43 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.85 2.86 . . . . 0.0 116.644 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -108.98 125.05 51.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.678 1.191 . . . . 0.0 110.87 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.62 145.87 54.86 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.279 -0.888 . . . . 0.0 111.809 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 16.3 m -70.39 152.7 95.45 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.091 170.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.42 128.32 27.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.007 2.471 . . . . 0.0 110.57 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.42 62.8 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.052 1.31 . . . . 0.0 115.082 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.3 t -77.61 139.99 63.5 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.392 1.596 . . . . 0.0 111.482 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.36 135.92 42.56 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.358 0.806 . . . . 0.0 111.857 -3.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -86.01 170.3 12.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.794 1.637 . . . . 0.0 110.378 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 45.7 m -131.45 117.38 18.75 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.549 0.74 . . . . 0.0 110.718 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.35 143.41 26.42 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.669 1.188 . . . . 0.0 110.722 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -104.22 119.37 38.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.931 0.492 . . . . 0.0 110.771 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.3 t -97.28 144.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.944 1.698 . . . . 0.0 109.237 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.5 t -132.82 175.65 9.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.038 0.935 . . . . 0.0 112.854 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.33 137.47 19.78 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.644 1.593 . . . . 0.0 112.367 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 124.336 1.054 . . . . 0.0 113.402 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.5 tp . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -44.5 110.07 0.97 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.5 1.52 . . . . 0.0 112.513 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.03 120.64 7.51 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.474 2.116 . . . . 0.0 108.297 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 53.6 t80 -101.01 130.33 46.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.617 0.723 . . . . 0.0 111.677 -172.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 2.1 p30 -160.38 150.11 17.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.769 1.628 . . . . 0.0 111.69 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.4 150.27 40.43 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.456 1.902 . . . . 0.0 110.044 -171.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 139.47 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.773 1.629 . . . . 0.0 110.316 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.3 139.04 30.36 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.886 1.675 . . . . 0.0 108.732 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.13 46.25 2.04 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.707 3.605 . . . . 0.0 112.934 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.15 160.78 14.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.917 1.687 . . . . 0.0 110.532 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 58.1 m -132.47 130.33 40.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.717 1.207 . . . . 0.0 109.41 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.7 mt -92.78 119.49 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.772 1.229 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 -161.98 0.86 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.442 1.497 . . . . 0.0 110.915 170.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -63.58 120.52 11.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.719 -1.238 . . . . 0.0 111.727 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.33 170.63 12.11 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.783 1.659 . . . . 0.0 112.868 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -98.3 143.83 28.36 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.35 1.06 . . . . 0.0 112.528 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 9.8 tt -146.84 129.36 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.807 1.643 . . . . 0.0 110.335 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 76.8 p -146.61 -177.85 5.86 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.174 1.79 . . . . 0.0 110.337 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -165.38 -171.38 31.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.26 141.12 21.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 109.783 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 92.7 t -111.02 136.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.202 1.801 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -118.06 129.49 55.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.943 1.297 . . . . 0.0 110.634 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 17.7 mtm -99.91 151.66 37.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.76 1.624 . . . . 0.0 111.52 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.81 -18.88 36.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.477 2.785 . . . . 0.0 113.021 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 25.8 p -74.85 -4.13 36.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.705 1.602 . . . . 0.0 114.177 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.53 79.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.757 1.646 . . . . 0.0 114.206 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -68.44 160.01 30.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.925 1.29 . . . . 0.0 112.616 173.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -137.49 156.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.207 1.403 . . . . 0.0 111.586 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.36 178.65 9.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.944 2.097 . . . . 0.0 110.095 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.31 142.13 31.86 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.039 -1.038 . . . . 0.0 111.788 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.91 166.98 12.98 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.059 3.173 . . . . 0.0 111.566 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.5 m -102.31 120.39 40.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.484 1.514 . . . . 0.0 108.883 174.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.6 137.97 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.993 1.317 . . . . 0.0 109.158 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 19.0 m -144.37 131.76 20.86 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.334 1.453 . . . . 0.0 110.082 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.43 129.3 34.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.782 0.833 . . . . 0.0 110.218 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -80.85 -4.63 55.43 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.7 mmmt 69.84 13.27 8.02 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.525 2.33 . . . . 0.0 113.365 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -126.59 13.88 7.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.699 2.0 . . . . 0.0 112.755 -173.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.5 13.54 59.71 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.828 1.204 . . . . 0.0 114.56 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 58.4 p -132.33 157.56 44.14 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.208 1.803 . . . . 0.0 110.28 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -114.51 148.1 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.509 1.123 . . . . 0.0 109.769 165.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.8 m -114.57 137.02 52.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.737 1.215 . . . . 0.0 108.256 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.15 130.48 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.875 1.27 . . . . 0.0 108.812 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -125.89 160.92 28.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.012 1.325 . . . . 0.0 112.546 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 16.5 t80 -157.08 134.22 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.104 1.362 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.56 117.27 68.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.664 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -80.99 162.98 20.57 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.592 2.861 . . . . 0.0 112.382 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.9 p -135.69 -20.14 1.57 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.27 155.26 44.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.0 110.987 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.93 174.12 11.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.516 1.126 . . . . 0.0 112.655 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 110.67 -170.86 14.2 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.838 1.685 . . . . 0.0 113.843 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.17 132.19 34.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.753 1.221 . . . . 0.0 110.766 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.0 m80 -129.84 170.72 13.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.687 1.995 . . . . 0.0 111.055 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.0 154.06 41.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.445 1.098 . . . . 0.0 111.424 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 2.3 ttm -138.66 123.73 19.03 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.352 1.461 . . . . 0.0 110.82 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -96.87 135.83 38.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.081 1.753 . . . . 0.0 110.305 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.85 137.44 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.208 1.403 . . . . 0.0 109.997 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.68 135.25 18.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -173.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -102.98 124.17 47.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.634 1.973 . . . . 0.0 109.558 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.34 40.38 22.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.902 1.281 . . . . 0.0 112.467 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.5 m120 76.36 -3.6 2.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.292 2.637 . . . . 0.0 114.845 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.8 mtm -103.45 134.18 47.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.472 1.509 . . . . 0.0 111.462 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.26 135.63 53.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.8 pt -73.9 157.48 87.13 Favored Pre-proline 0 N--CA 1.482 1.146 0 CA-C-O 118.698 -0.667 . . . . 0.0 111.505 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -57.97 125.81 19.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.635 2.224 . . . . 0.0 110.988 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.35 -9.94 71.62 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.991 1.281 . . . . 0.0 114.69 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.1 t -82.78 147.31 54.77 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.36 1.58 . . . . 0.0 111.667 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.4 164.76 69.02 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 120.126 1.081 . . . . 0.0 112.451 -4.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.37 156.64 17.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.703 1.601 . . . . 0.0 111.998 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -136.71 136.36 38.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 109.191 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.9 150.07 25.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 57.8 t80 -105.2 142.31 35.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.182 0.993 . . . . 0.0 112.199 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -124.83 138.33 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.692 1.597 . . . . 0.0 109.056 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 37.2 t0 -162.22 157.32 22.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.372 1.469 . . . . 0.0 111.581 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -82.73 146.19 29.16 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.963 -1.085 . . . . 0.0 113.188 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.1 t -62.63 -30.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.102 1.361 . . . . 0.0 112.281 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.22 -11.34 59.74 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.6 m -57.96 136.34 57.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.85 61.9 1.95 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.809 1.671 . . . . 0.0 112.575 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -158.56 166.67 31.56 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.228 1.411 . . . . 0.0 113.269 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 10.6 p -70.15 139.76 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.876 0.871 . . . . 0.0 110.089 166.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -156.41 167.64 29.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.23 145.98 31.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.39 1.076 . . . . 0.0 112.257 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.9 p90 -167.86 166.08 13.64 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.691 . . . . 0.0 112.882 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.03 172.02 13.03 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.7 1.619 . . . . 0.0 112.362 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.3 -34.84 12.08 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.859 2.372 . . . . 0.0 113.191 -169.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.14 -29.13 73.21 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.844 -0.976 . . . . 0.0 114.625 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.85 -0.13 42.1 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.21 1.505 . . . . 0.0 113.659 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 19.6 m -116.22 -42.21 3.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.051 2.141 . . . . 0.0 111.999 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -140.6 153.05 45.92 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.823 1.649 . . . . 0.0 112.604 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -155.09 -176.13 26.93 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.112 0.863 . . . . 0.0 113.436 167.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.8 p -151.6 137.98 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.92 1.288 . . . . 0.0 108.982 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -58.29 143.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 69.56 5.76 5.35 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.607 1.963 . . . . 0.0 114.776 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.6 mttm -117.41 147.49 40.74 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 111.194 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.25 138.65 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.62 2.214 . . . . 0.0 110.806 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -118.81 147.52 43.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.928 1.691 . . . . 0.0 110.3 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.6 p -135.52 152.45 51.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.088 0.955 . . . . 0.0 113.573 -166.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.67 176.53 10.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.093 1.757 . . . . 0.0 111.325 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 81.8 m -132.3 138.53 47.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.88 1.272 . . . . 0.0 110.68 -171.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.2 t -104.0 130.29 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.135 1.374 . . . . 0.0 107.6 167.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -97.3 123.8 41.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.561 1.144 . . . . 0.0 110.187 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 52.8 p -127.97 5.97 5.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.793 1.637 . . . . 0.0 113.397 -167.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -54.54 -33.92 60.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.629 1.572 . . . . 0.0 114.647 -171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.0 t70 -113.9 7.02 16.83 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.537 1.535 . . . . 0.0 113.259 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.41 -14.86 59.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.04 -97.98 2.19 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.493 1.044 . . . . 0.0 112.761 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.67 171.38 16.95 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.381 1.473 . . . . 0.0 112.515 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 125.46 -160.62 20.0 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.005 1.764 . . . . 0.0 112.771 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.98 115.25 4.73 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.257 0.932 . . . . 0.0 111.371 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.7 128.4 34.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.199 1.4 . . . . 0.0 108.88 171.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 34.4 m -129.9 158.54 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.508 1.523 . . . . 0.0 112.289 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -160.18 135.55 8.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.239 1.816 . . . . 0.0 108.909 -169.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.41 157.91 34.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.666 0.786 . . . . 0.0 112.497 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -136.29 140.39 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.132 1.373 . . . . 0.0 109.763 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.22 136.11 45.42 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.431 1.492 . . . . 0.0 109.38 171.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.29 -164.55 16.39 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.833 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.86 -27.19 67.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.077 3.185 . . . . 0.0 112.417 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.3 t -135.4 159.86 40.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.868 1.267 . . . . 0.0 109.352 159.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -75.76 109.51 9.42 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.042 -1.036 . . . . 0.0 110.871 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 147.27 52.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.724 0.809 . . . . 0.0 111.768 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.94 145.5 27.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.387 0.675 . . . . 0.0 110.083 166.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.94 140.21 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 110.203 -167.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 57.9 m -135.35 157.01 47.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.587 1.555 . . . . 0.0 110.776 167.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -156.16 156.7 34.66 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.094 0.957 . . . . 0.0 112.458 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.1 m -141.91 122.13 13.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.035 1.334 . . . . 0.0 110.406 -172.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.47 132.05 41.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.97 1.308 . . . . 0.0 111.065 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -112.76 146.4 38.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 111.75 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.45 -13.3 61.91 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.986 0.914 . . . . 0.0 113.312 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.77 -4.88 40.28 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.242 1.817 . . . . 0.0 114.219 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.25 31.55 9.61 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.58 1.086 . . . . 0.0 113.804 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.0 p -141.06 161.35 38.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.351 1.46 . . . . 0.0 111.357 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 78.9 m -112.85 128.23 56.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.719 1.207 . . . . 0.0 109.004 158.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.1 t -87.4 148.02 25.18 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 110.462 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -129.39 142.83 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.672 1.589 . . . . 0.0 110.214 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 69.6 p -136.45 145.75 45.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.922 1.289 . . . . 0.0 111.591 165.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.4 p90 -148.44 156.9 43.07 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.018 -1.051 . . . . 0.0 112.693 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.06 104.84 25.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.264 1.026 . . . . 0.0 110.666 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.17 172.13 9.8 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 124.226 3.284 . . . . 0.0 111.219 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.6 p -147.36 -29.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.28 147.91 36.11 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 119.515 1.052 . . . . 0.0 110.776 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.49 156.49 49.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.911 2.408 . . . . 0.0 110.696 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.96 -162.53 24.74 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.104 1.335 . . . . 0.0 113.003 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -104.03 125.85 50.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.344 1.058 . . . . 0.0 111.242 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -109.97 129.47 55.66 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.881 1.672 . . . . 0.0 110.023 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -88.23 127.19 35.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 110.611 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -106.64 127.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.63 1.572 . . . . 0.0 108.657 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.31 134.78 51.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 109.756 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.6 t -136.29 131.27 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.249 1.419 . . . . 0.0 108.546 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.12 143.22 22.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.865 1.266 . . . . 0.0 111.332 -170.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.77 124.67 15.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.849 1.259 . . . . 0.0 109.941 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 57.85 51.82 8.7 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 9.0 pt-20 55.57 17.24 2.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.149 2.579 . . . . 0.0 115.84 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -122.02 128.82 51.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.858 1.263 . . . . 0.0 110.725 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -65.18 156.24 32.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.132 0.973 . . . . 0.0 112.829 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.7 m -72.82 152.48 91.17 Favored Pre-proline 0 N--CA 1.48 1.029 0 O-C-N 121.545 -0.722 . . . . 0.0 109.247 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.94 -11.15 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.965 1.777 . . . . 0.0 114.657 -166.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -105.0 -7.48 38.22 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 85.1 p -85.89 156.4 58.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.143 1.971 . . . . 0.0 113.722 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.19 144.53 79.75 Favored 'Cis proline' 0 C--N 1.354 0.844 0 CA-C-N 118.968 0.667 . . . . 0.0 112.136 -5.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -95.71 167.93 10.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.362 1.465 . . . . 0.0 110.668 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 29.6 m -130.54 118.09 20.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.909 0.884 . . . . 0.0 110.23 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.72 127.29 44.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.354 . . . . 0.0 110.684 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -92.13 117.12 29.54 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.664 0.386 . . . . 0.0 110.353 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -102.81 140.82 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.087 1.755 . . . . 0.0 109.45 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.9 t -128.57 173.46 10.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 0.0 112.76 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.92 140.69 21.07 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.806 1.669 . . . . 0.0 112.193 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 CA--C 1.549 0.93 0 C-N-CA 124.112 0.965 . . . . 0.0 113.464 177.982 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.272 0.558 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -60.12 117.49 24.28 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 110.837 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.29 152.74 44.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.821 2.347 . . . . 0.0 111.052 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -94.26 116.25 28.62 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 169.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -145.49 125.29 13.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.771 1.228 . . . . 0.0 110.184 168.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.92 147.02 39.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.304 1.842 . . . . 0.0 109.55 -174.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -122.32 136.94 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.967 1.307 . . . . 0.0 110.453 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.4 mt -135.15 136.15 24.16 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.893 1.677 . . . . 0.0 109.287 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.12 117.67 5.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.401 2.734 . . . . 0.0 110.167 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.6 t80 178.02 149.6 0.2 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.356 . . . . 0.0 109.315 -168.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 23.9 m -130.75 125.69 34.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.136 0.974 . . . . 0.0 110.336 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 31.8 mt -83.16 119.33 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.744 1.218 . . . . 0.0 108.954 171.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -122.68 -53.21 1.89 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.913 0.885 . . . . 0.0 113.189 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -160.18 121.74 3.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.313 1.445 . . . . 0.0 111.398 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.68 -146.7 18.61 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 125.735 1.636 . . . . 0.0 111.716 -169.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.6 146.94 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.711 1.204 . . . . 0.0 110.959 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 10.8 tt -130.58 136.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.523 1.529 . . . . 0.0 111.571 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 41.4 p -147.23 -177.99 5.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.611 1.964 . . . . 0.0 110.158 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.67 -166.99 34.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 115.324 0.889 . . . . 0.0 115.324 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.86 131.84 9.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.497 1.519 . . . . 0.0 110.306 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 18.3 t -101.6 136.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.367 1.467 . . . . 0.0 108.648 170.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -120.32 131.11 54.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.719 1.207 . . . . 0.0 111.222 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -105.78 148.33 36.27 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.798 1.639 . . . . 0.0 112.104 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.55 -39.79 55.21 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.8 3.667 . . . . 0.0 115.784 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 7.1 t -73.64 -1.4 18.74 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.44 60.8 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.707 1.622 . . . . 0.0 114.366 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -69.49 160.71 30.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.246 1.418 . . . . 0.0 112.169 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.5 m -139.41 155.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.334 1.454 . . . . 0.0 111.609 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.62 163.29 40.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.79 1.636 . . . . 0.0 111.37 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.63 137.02 21.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.567 0.747 . . . . 0.0 111.577 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.11 169.18 11.62 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.59 3.527 . . . . 0.0 111.924 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -110.55 139.08 46.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 108.995 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.24 132.24 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.668 1.187 . . . . 0.0 109.283 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -134.29 127.09 31.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.416 1.487 . . . . 0.0 109.74 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.08 127.17 31.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.458 0.703 . . . . 0.0 110.279 170.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -79.01 -3.49 45.35 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.2 mmtm 71.24 13.12 6.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.76 2.424 . . . . 0.0 113.13 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -126.63 11.09 7.27 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.825 2.05 . . . . 0.0 113.001 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.48 12.78 57.98 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.855 1.217 . . . . 0.0 114.821 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -128.38 154.32 46.12 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.064 1.746 . . . . 0.0 110.396 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.2 m -111.62 141.42 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.903 0.881 . . . . 0.0 109.894 165.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.0 m -103.43 133.61 48.2 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.604 1.162 . . . . 0.0 108.412 168.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 59.9 t -116.99 134.4 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.125 1.77 . . . . 0.0 108.649 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -139.2 159.2 42.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.636 1.174 . . . . 0.0 113.47 -172.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.2 t80 -158.47 135.84 10.11 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.019 1.727 . . . . 0.0 111.483 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.93 120.0 73.23 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 124.726 1.21 . . . . 0.0 110.846 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.33 148.03 23.5 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.706 2.937 . . . . 0.0 112.607 -170.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.0 p -142.25 5.41 1.66 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.664 1.186 . . . . 0.0 114.009 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -160.18 144.52 14.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.895 1.678 . . . . 0.0 110.056 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.86 163.51 13.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 0.0 112.196 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 114.45 -168.76 12.65 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 125.247 1.403 . . . . 0.0 113.665 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -86.21 122.26 29.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.9 m80 -118.61 161.58 19.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.966 1.707 . . . . 0.0 111.822 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.16 155.96 46.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 40.9 ttm -140.77 118.37 11.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.253 1.421 . . . . 0.0 111.156 -172.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -81.56 134.98 35.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.255 2.222 . . . . 0.0 109.832 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 19.9 mm -141.09 136.32 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.349 1.459 . . . . 0.0 108.714 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 136.84 16.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.9 t80 -97.21 121.98 39.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.741 2.016 . . . . 0.0 109.795 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.94 35.51 16.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.876 1.27 . . . . 0.0 112.775 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 76.69 4.22 3.47 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 127.983 2.513 . . . . 0.0 114.506 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.6 mtm -107.53 132.6 53.07 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.68 1.592 . . . . 0.0 110.952 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.24 139.07 55.75 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 39.9 pt -74.71 155.21 87.19 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.456 0.702 . . . . 0.0 110.902 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.58 119.78 7.21 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.932 2.421 . . . . 0.0 111.942 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.9 69.83 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.52 1.533 . . . . 0.0 115.128 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 38.8 m -80.79 154.69 73.3 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.758 1.779 . . . . 0.0 112.025 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.97 155.01 99.73 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.422 0.829 . . . . 0.0 112.538 -0.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.92 159.56 15.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.097 1.359 . . . . 0.0 110.86 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -159.08 133.9 8.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.315 1.046 . . . . 0.0 110.478 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.92 -179.48 5.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.032 1.333 . . . . 0.0 112.697 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -118.31 137.29 53.17 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.219 1.008 . . . . 0.0 113.353 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.0 t -108.95 138.04 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.25 1.82 . . . . 0.0 110.021 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.6 t0 -149.1 178.9 8.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.334 1.853 . . . . 0.0 109.509 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -77.85 143.07 38.11 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.693 -1.254 . . . . 0.0 111.304 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.9 m -65.47 -17.71 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -166.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -148.81 41.41 0.93 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.978 0.911 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 2.6 t -66.68 -28.58 68.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 106.09 -25.36 23.93 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.113 1.815 . . . . 0.0 115.019 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -72.42 160.49 32.25 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.909 1.354 . . . . 0.0 113.445 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.5 t -64.36 134.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.603 1.161 . . . . 0.0 109.678 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -161.47 150.09 15.79 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.59 1.156 . . . . 0.0 110.874 -173.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -118.96 147.05 44.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.836 1.254 . . . . 0.0 111.978 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.4 p90 -166.8 158.02 12.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.082 1.753 . . . . 0.0 112.818 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 141.19 170.3 12.16 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.309 1.433 . . . . 0.0 113.258 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 -33.19 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.942 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.92 82.04 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.263 0.938 . . . . 0.0 114.047 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.85 -5.99 54.94 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 118.645 1.222 . . . . 0.0 112.658 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.6 m -99.09 -45.56 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.073 1.749 . . . . 0.0 111.406 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -147.57 142.38 26.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.531 1.932 . . . . 0.0 111.987 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -137.31 170.4 23.61 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.373 0.987 . . . . 0.0 113.376 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 59.9 t -134.92 135.58 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.144 1.378 . . . . 0.0 107.963 173.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -55.85 133.84 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.199 0.6 . . . . 0.0 112.493 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.08 -0.19 2.19 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.094 2.158 . . . . 0.0 114.54 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.59 140.06 21.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.084 1.354 . . . . 0.0 110.973 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.45 120.96 7.06 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.636 2.224 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.61 133.89 48.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.331 1.452 . . . . 0.0 110.141 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.1 p -128.5 149.46 50.58 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.49 178.65 8.91 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.74 1.616 . . . . 0.0 111.728 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -130.79 145.14 51.89 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.129 1.372 . . . . 0.0 110.793 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.0 t -116.55 132.65 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.644 1.578 . . . . 0.0 108.288 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -94.25 128.67 40.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.31 1.044 . . . . 0.0 111.009 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 48.7 p -136.46 3.51 2.81 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.47 1.508 . . . . 0.0 113.792 -167.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -53.73 -40.23 65.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.422 1.489 . . . . 0.0 114.668 -169.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -107.43 5.87 27.69 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.505 1.522 . . . . 0.0 113.123 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.28 -19.11 61.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.07 -89.98 1.63 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.724 1.154 . . . . 0.0 112.497 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -165.04 173.06 11.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.286 1.434 . . . . 0.0 112.648 -169.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 121.09 -167.52 14.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.199 1.857 . . . . 0.0 112.73 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.64 106.55 3.2 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.935 0.779 . . . . 0.0 111.791 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.6 124.6 28.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.509 1.124 . . . . 0.0 108.586 168.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 46.1 m -124.07 158.04 33.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.782 1.633 . . . . 0.0 112.24 -173.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.46 137.22 10.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.857 1.663 . . . . 0.0 109.515 -172.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 160.57 37.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.354 1.061 . . . . 0.0 111.909 175.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.8 mt -135.53 132.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.499 1.12 . . . . 0.0 109.6 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.88 108.06 15.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.413 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -117.53 -178.16 17.5 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.124 1.345 . . . . 0.0 113.743 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.79 -26.1 52.83 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.797 2.998 . . . . 0.0 111.652 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 151.48 51.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.234 1.414 . . . . 0.0 108.646 155.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.18 122.25 20.72 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.957 -1.089 . . . . 0.0 112.0 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.88 154.27 41.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 112.12 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.88 139.62 30.27 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.354 0.662 . . . . 0.0 109.397 166.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 34.4 mt -133.85 143.61 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -166.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 10.8 t -142.58 161.64 37.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.31 1.444 . . . . 0.0 111.065 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -160.09 155.11 24.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.92 1.288 . . . . 0.0 112.687 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.0 m -141.65 127.32 19.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.375 1.47 . . . . 0.0 110.455 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.91 131.63 37.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.814 1.246 . . . . 0.0 111.264 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -111.13 151.06 28.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.129 1.371 . . . . 0.0 112.442 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -67.69 -19.68 65.19 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.49 1.116 . . . . 0.0 112.461 173.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.23 -5.71 37.76 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.811 1.644 . . . . 0.0 114.421 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.22 33.96 8.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.46 1.029 . . . . 0.0 113.235 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -141.28 161.37 38.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.518 1.527 . . . . 0.0 111.143 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.5 m -108.6 131.68 54.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.859 1.263 . . . . 0.0 108.913 158.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -91.09 149.89 21.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.939 0.895 . . . . 0.0 110.486 168.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 95.1 t -130.2 144.8 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.046 1.739 . . . . 0.0 109.973 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.1 t -140.35 141.05 35.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.486 1.514 . . . . 0.0 110.932 170.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -147.03 153.99 40.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.51 103.32 49.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.483 1.913 . . . . 0.0 110.256 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.12 161.99 17.94 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.647 2.898 . . . . 0.0 110.306 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.5 m -126.39 -10.06 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.48 151.63 22.82 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.207 1.403 . . . . 0.0 110.419 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.24 142.99 27.81 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.762 2.308 . . . . 0.0 111.649 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 155.4 -167.59 32.99 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.779 1.181 . . . . 0.0 113.299 -174.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -101.08 128.54 47.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.573 1.149 . . . . 0.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -120.15 123.23 42.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.65 1.58 . . . . 0.0 110.121 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 48.8 m -86.45 125.78 33.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.039 -1.038 . . . . 0.0 111.22 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 128.55 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.531 1.533 . . . . 0.0 108.614 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.23 129.95 55.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.301 1.44 . . . . 0.0 109.655 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.5 t -132.59 128.93 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.435 1.094 . . . . 0.0 109.757 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.39 143.68 24.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.269 1.428 . . . . 0.0 111.046 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.88 121.74 11.99 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.535 1.134 . . . . 0.0 109.721 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.77 55.28 5.56 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.034 1.333 . . . . 0.0 111.544 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.2 pt-20 58.26 13.19 2.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.396 2.678 . . . . 0.0 116.267 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.18 126.2 49.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.647 1.179 . . . . 0.0 110.909 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.57 146.15 54.28 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.803 170.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.5 m -71.19 152.76 94.51 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.152 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.96 129.59 35.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.005 2.47 . . . . 0.0 110.895 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.7 -17.69 57.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.169 1.366 . . . . 0.0 114.89 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 35.6 t -77.77 140.13 62.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.26 1.53 . . . . 0.0 111.542 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.0 135.42 40.07 Favored 'Cis proline' 0 C--N 1.352 0.735 0 CA-C-N 119.377 0.813 . . . . 0.0 111.717 -4.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.67 176.85 6.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.223 1.809 . . . . 0.0 110.492 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 95.4 m -137.35 123.25 20.13 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.94 0.896 . . . . 0.0 111.096 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.12 160.07 15.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.127 1.771 . . . . 0.0 110.711 167.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -122.13 126.31 48.09 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.788 0.835 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.5 t -106.19 141.01 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.21 1.804 . . . . 0.0 109.881 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -130.33 171.11 13.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 112.978 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.91 144.34 31.06 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.382 1.468 . . . . 0.0 112.557 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 124.231 1.012 . . . . 0.0 113.2 177.69 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.469 0.476 0 CA-C-O 121.049 0.452 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -66.01 119.98 65.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 110.608 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.71 137.74 43.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.93 2.42 . . . . 0.0 110.197 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 27.4 t80 -105.63 129.91 53.77 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.535 0.734 . . . . 0.0 111.663 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -157.61 142.8 16.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.505 1.522 . . . . 0.0 111.2 171.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.42 151.02 45.93 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.164 1.786 . . . . 0.0 109.954 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.4 p -115.59 138.07 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 109.938 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.34 134.49 26.14 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.002 1.721 . . . . 0.0 108.713 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.51 100.02 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.385 2.724 . . . . 0.0 109.572 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -161.82 148.79 14.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.496 1.918 . . . . 0.0 109.164 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.5 m -124.28 125.93 45.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.122 . . . . 0.0 109.357 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 80.1 mt -86.01 126.0 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 0.0 109.933 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.29 -161.25 0.75 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.946 1.698 . . . . 0.0 111.658 172.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.97 126.46 29.55 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.897 -1.127 . . . . 0.0 111.509 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.39 -144.6 12.98 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.952 1.739 . . . . 0.0 111.476 -170.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.74 141.95 16.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.146 0.978 . . . . 0.0 111.752 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.4 tt -133.5 134.04 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.052 1.741 . . . . 0.0 110.607 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.25 166.5 27.78 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.85 1.66 . . . . 0.0 111.06 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.73 -175.34 24.13 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.99 140.68 18.99 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.683 1.993 . . . . 0.0 109.333 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.2 t -117.92 131.71 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.716 1.606 . . . . 0.0 108.19 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -113.92 125.34 53.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.479 1.112 . . . . 0.0 110.633 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 37.6 mtm -104.25 138.67 19.59 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.354 1.461 . . . . 0.0 111.473 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -56.42 -29.48 77.75 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.513 3.476 . . . . 0.0 116.098 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 9.0 p -77.67 8.13 4.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.152 1.381 . . . . 0.0 114.666 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.44 46.41 4.06 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.69 1.138 . . . . 0.0 113.168 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.54 162.42 41.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.646 1.578 . . . . 0.0 112.014 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.7 m -140.26 157.76 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.819 1.247 . . . . 0.0 112.396 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -149.32 178.16 9.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.1 2.16 . . . . 0.0 109.999 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.83 142.19 30.37 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.114 -0.991 . . . . 0.0 111.75 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -83.64 167.22 13.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.214 3.276 . . . . 0.0 111.547 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 64.3 m -104.3 116.48 32.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.314 1.446 . . . . 0.0 108.982 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.24 130.03 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.328 1.051 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -121.2 125.63 47.62 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.374 1.87 . . . . 0.0 109.491 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 63.2 t0 -82.47 116.93 22.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.26 1.024 . . . . 0.0 110.154 172.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.2 -14.0 54.24 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 67.47 4.0 3.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.022 2.129 . . . . 0.0 114.204 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -102.55 6.78 40.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.792 2.037 . . . . 0.0 113.146 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.69 9.16 63.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.087 1.327 . . . . 0.0 113.912 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.2 p -127.17 161.44 28.49 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.524 1.929 . . . . 0.0 110.558 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -120.69 144.48 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.961 0.904 . . . . 0.0 109.656 163.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.9 m -105.47 138.15 42.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.398 1.079 . . . . 0.0 108.144 170.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -125.52 127.58 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.162 0.985 . . . . 0.0 109.21 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -123.81 158.0 32.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.298 1.439 . . . . 0.0 112.229 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 15.3 t80 -157.35 134.36 10.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.147 1.379 . . . . 0.0 111.812 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.77 117.11 68.03 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 0.0 110.515 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.22 145.15 27.13 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.234 2.623 . . . . 0.0 112.258 -173.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.6 t -138.73 -10.96 1.35 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -139.49 153.21 47.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.404 1.882 . . . . 0.0 109.654 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -99.63 166.51 11.09 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.545 1.138 . . . . 0.0 112.556 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.01 -168.15 13.26 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.24 1.4 . . . . 0.0 114.217 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.1 tp -83.33 110.75 18.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.838 1.255 . . . . 0.0 110.91 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -105.73 170.96 7.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.341 1.856 . . . . 0.0 112.304 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.29 152.4 41.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.491 1.117 . . . . 0.0 111.49 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 13.6 ttm -122.21 127.67 50.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.034 1.734 . . . . 0.0 110.08 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.69 131.58 49.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.25 2.22 . . . . 0.0 109.2 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.2 mm -138.32 135.1 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.78 1.232 . . . . 0.0 109.193 174.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.49 140.0 27.21 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.864 0.866 . . . . 0.0 113.324 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -99.44 119.96 38.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.121 1.768 . . . . 0.0 109.179 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.22 34.83 12.08 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.927 1.291 . . . . 0.0 113.057 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.0 m-80 72.79 10.21 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.573 2.349 . . . . 0.0 115.133 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.7 mtt -104.65 130.36 52.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.133 1.373 . . . . 0.0 110.391 167.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.29 137.65 55.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.243 -0.911 . . . . 0.0 113.35 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.7 pt -74.17 153.88 88.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.986 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.29 126.5 20.25 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.565 2.177 . . . . 0.0 110.632 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.23 -18.2 54.52 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.14 1.353 . . . . 0.0 114.302 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 62.0 m -87.64 154.91 53.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.848 1.824 . . . . 0.0 112.564 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.22 158.11 98.95 Favored 'Cis proline' 0 C--N 1.354 0.838 0 CA-C-N 119.258 0.771 . . . . 0.0 112.241 -4.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.0 mt -103.53 157.71 16.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.985 1.314 . . . . 0.0 111.244 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -141.22 138.89 33.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 109.606 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.5 p90 -166.64 159.39 14.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.507 1.123 . . . . 0.0 111.977 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 35.3 t80 -101.24 139.56 36.75 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.145 -0.972 . . . . 0.0 112.656 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 50.5 t -107.83 132.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.154 1.381 . . . . 0.0 109.688 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -147.79 175.18 11.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.991 2.117 . . . . 0.0 111.454 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -84.71 145.02 28.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 0.0 112.792 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 17.1 m -69.49 -25.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.544 -0.722 . . . . 0.0 112.221 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -99.65 34.31 2.28 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.277 1.831 . . . . 0.0 111.691 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 14.9 p -53.36 141.99 22.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.982 1.713 . . . . 0.0 114.208 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.5 37.02 3.76 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 126.16 1.838 . . . . 0.0 112.255 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -166.93 156.52 10.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.619 1.568 . . . . 0.0 112.857 -167.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.1 p -61.1 141.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 110.126 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 163.18 36.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.91 0.884 . . . . 0.0 111.604 -173.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.43 145.18 31.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.379 1.472 . . . . 0.0 111.936 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.7 p90 -166.31 157.73 13.33 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.796 1.638 . . . . 0.0 112.722 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 146.2 175.77 19.5 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.485 1.04 . . . . 0.0 114.483 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.54 -43.49 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.203 2.602 . . . . 0.0 112.259 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.56 73.77 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.085 0.857 . . . . 0.0 113.641 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.57 -19.17 63.68 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.3 m -110.4 -49.73 3.03 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.06 1.744 . . . . 0.0 111.327 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -135.27 133.69 39.19 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.19 1.796 . . . . 0.0 112.035 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -119.38 167.37 13.31 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.593 1.092 . . . . 0.0 113.314 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.04 130.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 109.218 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 139.46 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.836 0.854 . . . . 0.0 111.966 -175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.83 6.12 4.4 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.674 1.99 . . . . 0.0 114.216 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 63.9 mttp -125.15 145.46 50.59 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.856 1.662 . . . . 0.0 111.06 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.01 133.58 21.78 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.606 2.204 . . . . 0.0 111.05 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -115.65 147.49 40.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.758 1.623 . . . . 0.0 110.179 173.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -166.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -160.76 176.17 11.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.769 1.628 . . . . 0.0 111.662 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.5 m -131.65 144.21 50.86 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.301 1.441 . . . . 0.0 110.789 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 36.3 t -113.92 138.19 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.075 1.75 . . . . 0.0 108.017 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.0 m120 -104.8 127.44 52.6 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.47 1.108 . . . . 0.0 110.037 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -125.07 3.22 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.648 1.979 . . . . 0.0 113.323 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.1 tttt -50.33 -36.71 33.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.317 1.847 . . . . 0.0 114.674 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -115.41 10.95 15.91 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.585 1.554 . . . . 0.0 113.132 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.57 -40.05 50.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.78 154.71 9.4 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.63 1.11 . . . . 0.0 112.323 -168.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.63 171.94 14.41 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.455 1.102 . . . . 0.0 112.957 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 134.72 14.87 1.12 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.861 1.219 . . . . 0.0 115.81 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 103.51 103.68 2.82 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.595 1.569 . . . . 0.0 113.204 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.57 143.29 31.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.216 1.407 . . . . 0.0 110.52 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.6 m -136.07 156.8 48.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 111.938 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.4 tp -157.96 133.58 9.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.206 1.803 . . . . 0.0 108.756 -173.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 159.78 38.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.738 0.815 . . . . 0.0 112.427 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.0 mt -134.58 131.2 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.565 1.146 . . . . 0.0 109.481 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.59 107.4 14.2 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.28 1.432 . . . . 0.0 109.309 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -120.52 -173.74 15.01 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.122 1.344 . . . . 0.0 113.992 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.57 -21.66 45.67 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.78 2.987 . . . . 0.0 111.904 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.0 t -137.94 157.9 45.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.629 1.572 . . . . 0.0 109.096 158.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -71.95 117.47 13.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.987 -1.071 . . . . 0.0 111.638 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.05 149.05 43.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.79 140.5 29.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.194 0.598 . . . . 0.0 109.536 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 43.8 mt -131.84 143.53 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 110.111 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.8 t -140.34 163.08 33.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.806 1.242 . . . . 0.0 110.829 166.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -161.51 155.33 21.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.524 1.13 . . . . 0.0 112.658 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 81.5 m -137.19 114.72 11.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.61 1.564 . . . . 0.0 109.283 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.2 144.92 27.21 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.82 1.248 . . . . 0.0 112.226 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -123.07 147.76 46.37 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.411 1.484 . . . . 0.0 111.75 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -71.98 -12.59 61.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.714 0.806 . . . . 0.0 112.514 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.2 -7.0 49.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.861 1.664 . . . . 0.0 114.027 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.94 32.57 7.07 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.576 1.084 . . . . 0.0 113.99 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.3 p -141.08 161.31 38.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 111.292 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 30.0 m -132.3 133.14 43.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.343 1.457 . . . . 0.0 109.366 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -94.1 147.97 22.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.187 0.995 . . . . 0.0 110.459 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.0 t -130.72 142.84 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.736 1.614 . . . . 0.0 110.118 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 90.5 p -135.18 149.24 49.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.091 1.356 . . . . 0.0 111.783 167.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -151.51 155.26 38.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 4.6 mt -121.08 104.19 41.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.284 1.834 . . . . 0.0 110.344 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.52 164.09 16.6 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.731 2.954 . . . . 0.0 110.274 166.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -127.18 -20.51 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.4 153.25 32.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.797 1.239 . . . . 0.0 110.984 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.14 151.88 39.46 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.878 2.385 . . . . 0.0 112.63 -168.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.46 -151.67 23.67 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.471 1.51 . . . . 0.0 112.68 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.98 128.81 51.9 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.089 1.356 . . . . 0.0 110.672 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.14 127.4 55.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.339 1.856 . . . . 0.0 109.653 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 57.1 m -89.31 125.23 35.03 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.777 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.67 126.88 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.895 1.278 . . . . 0.0 108.977 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.38 129.35 55.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 109.594 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -130.66 129.92 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.685 1.194 . . . . 0.0 109.025 171.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.85 144.59 23.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.91 1.284 . . . . 0.0 111.845 -167.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.47 123.66 15.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.005 1.322 . . . . 0.0 109.933 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 52.55 56.91 6.99 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.623 1.569 . . . . 0.0 112.172 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 7.5 pt-20 59.35 8.47 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.62 2.768 . . . . 0.0 116.544 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -115.75 124.84 51.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.454 1.102 . . . . 0.0 110.899 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -61.84 145.89 51.31 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.431 -0.793 . . . . 0.0 111.704 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.2 m -68.8 149.94 97.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.254 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.37 131.33 40.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.073 2.515 . . . . 0.0 111.576 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.59 -14.57 61.03 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.223 1.392 . . . . 0.0 114.943 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.6 t -80.1 144.17 58.3 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 119.011 1.405 . . . . 0.0 111.411 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.08 140.64 67.05 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 120.01 1.039 . . . . 0.0 112.576 -0.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.36 175.57 6.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 110.541 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 27.8 m -135.3 125.73 26.68 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 110.739 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.49 132.16 48.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.023 1.329 . . . . 0.0 109.973 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.9 ttt85 -92.47 136.9 32.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 61.5 t -132.75 131.81 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.514 1.126 . . . . 0.0 110.759 -163.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 7.3 t -173.55 164.66 4.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.346 1.858 . . . . 0.0 111.217 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 143.18 -163.15 27.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.539 1.543 . . . . 0.0 113.682 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 N--CA 1.48 1.063 0 C-N-CA 127.197 2.199 . . . . 0.0 114.114 176.279 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -55.91 115.97 11.03 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.744 1.218 . . . . 0.0 110.975 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.94 151.54 50.66 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.822 2.348 . . . . 0.0 110.501 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.51 118.41 35.68 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.286 0.634 . . . . 0.0 110.195 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -150.63 122.34 8.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.687 1.595 . . . . 0.0 109.832 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.81 149.12 47.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.159 1.784 . . . . 0.0 110.088 -171.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.7 p -118.87 138.12 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.011 1.324 . . . . 0.0 109.689 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 51.1 mt -134.43 135.53 24.01 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.198 1.799 . . . . 0.0 108.42 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.91 31.21 0.44 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.488 3.458 . . . . 0.0 113.628 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.0 t80 -83.03 157.55 22.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.276 1.431 . . . . 0.0 110.833 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 90.5 m -129.62 126.35 38.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.314 1.446 . . . . 0.0 109.574 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 93.9 mt -87.58 134.53 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 110.389 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1800 ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' 1801 ' ' LYS . 29.0 ttpt -119.81 -147.48 0.4 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.77 1.628 . . . . 0.0 110.851 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1801 ' ' LYS . . . . . 0.443 ' H ' ' HG2' ' A' 1800 ' ' LYS . 8.0 tmtm? -73.5 123.11 23.28 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.573 -1.33 . . . . 0.0 110.201 171.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.2 -148.98 20.08 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.241 1.4 . . . . 0.0 112.16 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -156.97 145.79 19.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 110.772 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -129.03 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.596 1.558 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 44.6 p -144.75 -177.1 5.34 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.345 1.858 . . . . 0.0 109.998 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.84 37.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -154.49 133.15 12.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.319 1.447 . . . . 0.0 110.258 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.1 t -102.22 130.73 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.906 1.682 . . . . 0.0 108.458 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -106.14 125.53 51.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.404 1.481 . . . . 0.0 110.748 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 19.2 mtm -92.76 146.59 32.48 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.381 1.472 . . . . 0.0 110.447 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.68 -16.62 30.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.269 2.646 . . . . 0.0 113.488 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 51.7 p -73.96 -5.53 41.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.179 1.391 . . . . 0.0 113.929 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 98.48 -5.32 60.46 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.979 1.752 . . . . 0.0 114.177 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -73.81 159.55 32.74 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.5 1.12 . . . . 0.0 112.207 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.4 m -141.55 154.76 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.145 1.378 . . . . 0.0 111.771 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.19 166.65 32.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.351 1.86 . . . . 0.0 111.255 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -101.76 138.6 19.87 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 121.304 -0.873 . . . . 0.0 111.815 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -83.85 169.5 11.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.361 3.374 . . . . 0.0 111.672 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.3 m -108.62 131.69 54.63 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.611 1.564 . . . . 0.0 109.12 172.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.82 132.82 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.207 1.403 . . . . 0.0 109.126 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 84.8 m -135.39 127.87 30.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.49 1.516 . . . . 0.0 110.081 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.2 129.32 34.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.395 0.678 . . . . 0.0 110.861 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -82.52 -5.43 58.73 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 27.0 mmmt 73.24 3.86 4.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.145 2.578 . . . . 0.0 113.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -109.33 8.19 25.45 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.995 2.118 . . . . 0.0 112.967 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.2 20.42 42.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.72 1.152 . . . . 0.0 113.876 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 41.8 p -133.94 158.28 43.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.273 1.829 . . . . 0.0 109.966 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.97 146.73 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.472 1.109 . . . . 0.0 110.059 167.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.6 m -104.2 138.63 40.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.797 1.239 . . . . 0.0 108.449 167.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 27.3 t -126.47 134.81 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.991 1.317 . . . . 0.0 109.373 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -136.67 158.13 45.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.856 1.262 . . . . 0.0 113.277 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 10.3 t80 -156.42 135.42 11.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.314 1.846 . . . . 0.0 111.36 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.27 119.32 72.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.338 1.055 . . . . 0.0 110.579 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.97 145.39 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.53 2.82 . . . . 0.0 112.155 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.9 t -136.73 -14.52 1.64 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.81 152.35 45.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.995 1.718 . . . . 0.0 109.962 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.79 168.85 12.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.034 0.934 . . . . 0.0 112.116 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 105.15 -168.5 15.71 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.648 1.594 . . . . 0.0 113.916 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 39.7 tp -78.74 132.25 36.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.73 1.212 . . . . 0.0 110.613 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 47.5 m80 -127.17 166.37 17.82 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.796 1.638 . . . . 0.0 111.093 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -145.81 153.16 40.6 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.732 0.813 . . . . 0.0 111.356 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 65.4 ttp -128.28 117.21 21.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.568 1.547 . . . . 0.0 110.314 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.82 129.19 35.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.465 2.306 . . . . 0.0 109.411 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.5 mm -130.85 132.11 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 109.913 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 136.22 21.3 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -99.56 119.27 37.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.745 2.418 . . . . 0.0 109.699 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.16 36.14 15.01 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.808 1.243 . . . . 0.0 112.795 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.7 2.93 3.0 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.623 2.369 . . . . 0.0 113.93 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 68.8 mtm -104.37 131.65 51.49 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.617 1.567 . . . . 0.0 110.739 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -55.33 138.22 46.0 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.4 pt -72.47 154.01 91.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 166.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.56 129.33 30.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.237 1.958 . . . . 0.0 110.4 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.57 1.56 87.58 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.652 1.12 . . . . 0.0 115.453 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.1 t -76.03 145.89 78.02 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 119.771 1.785 . . . . 0.0 111.652 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.54 159.85 88.59 Favored 'Cis proline' 0 C--N 1.353 0.816 0 CA-C-N 119.845 0.98 . . . . 0.0 112.076 -6.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.92 148.47 22.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.874 1.27 . . . . 0.0 110.288 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -121.17 144.33 48.64 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.484 1.114 . . . . 0.0 110.586 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.6 p90 -163.54 164.78 24.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.152 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.5 t80 -110.7 143.99 40.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.045 0.938 . . . . 0.0 112.705 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.9 t -117.09 141.89 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.422 1.489 . . . . 0.0 109.32 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.7 t0 -157.22 165.36 36.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 0.0 111.463 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.19 148.43 47.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.581 1.152 . . . . 0.0 112.861 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.1 m -86.52 -16.47 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -109.58 -5.91 15.54 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -168.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 84.9 m -82.66 153.94 25.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.493 1.117 . . . . 0.0 112.878 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.62 -9.64 62.65 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.973 1.273 . . . . 0.0 115.238 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -65.38 159.27 24.48 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.69 1.245 . . . . 0.0 113.675 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.5 t -65.96 136.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.038 0.935 . . . . 0.0 109.083 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.4 t -156.49 145.53 20.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.53 1.132 . . . . 0.0 110.379 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.97 141.51 44.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.822 1.249 . . . . 0.0 111.86 -170.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.8 p90 -169.16 163.72 11.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 112.756 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.0 172.18 12.8 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.4 1.476 . . . . 0.0 112.784 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.94 -33.35 16.06 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.833 2.355 . . . . 0.0 112.681 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.3 -37.07 92.54 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.549 1.068 . . . . 0.0 114.321 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.85 -6.23 53.51 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.784 1.292 . . . . 0.0 113.272 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 53.9 m -97.35 -43.73 7.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.899 1.68 . . . . 0.0 110.777 170.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -152.86 124.54 7.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.041 1.737 . . . . 0.0 112.3 -164.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -127.65 -179.54 15.89 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.448 1.975 . . . . 0.0 112.315 166.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.9 t -142.59 139.77 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.821 1.649 . . . . 0.0 107.792 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.62 134.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 118.288 0.494 . . . . 0.0 112.125 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.4 m-80 67.93 -1.39 1.74 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.964 2.106 . . . . 0.0 114.752 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.45 137.17 19.56 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.949 1.3 . . . . 0.0 110.957 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.16 122.58 8.16 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.609 2.206 . . . . 0.0 110.299 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.15 144.03 34.47 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.4 1.48 . . . . 0.0 110.484 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.11 148.45 49.8 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.56 175.95 12.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.898 1.679 . . . . 0.0 112.011 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -132.36 145.55 51.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.095 1.358 . . . . 0.0 110.921 -171.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 28.6 t -117.47 138.0 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.13 1.772 . . . . 0.0 108.436 168.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -94.97 134.1 38.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.351 1.061 . . . . 0.0 111.423 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 72.3 p -131.13 3.67 4.36 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.164 1.785 . . . . 0.0 113.11 -171.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -55.99 -34.46 65.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.617 1.967 . . . . 0.0 115.615 -164.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.04 19.42 5.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.548 1.539 . . . . 0.0 112.357 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.69 -34.26 60.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.79 148.45 9.68 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.874 1.226 . . . . 0.0 112.737 -171.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.19 148.23 39.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.527 1.131 . . . . 0.0 112.165 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 172.01 -24.1 0.08 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.51 1.052 . . . . 0.0 115.121 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.81 110.14 1.15 Allowed Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.497 1.523 . . . . 0.0 112.643 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.44 126.76 32.58 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.609 1.564 . . . . 0.0 109.037 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 44.3 m -122.79 155.64 36.14 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.869 1.668 . . . . 0.0 111.875 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.6 tp -158.44 135.16 9.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.614 1.566 . . . . 0.0 109.131 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.57 159.0 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.995 0.918 . . . . 0.0 112.175 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -136.07 141.32 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.846 1.258 . . . . 0.0 109.661 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.24 161.7 28.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 109.882 170.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.87 31.47 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 118.875 -0.958 . . . . 0.0 114.317 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.57 -24.84 62.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.048 3.165 . . . . 0.0 112.717 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.1 t -143.42 160.87 39.77 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.311 1.444 . . . . 0.0 109.628 164.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.2 tptt -74.34 116.99 15.64 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.071 -1.018 . . . . 0.0 110.989 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.59 149.07 46.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.73 0.812 . . . . 0.0 111.738 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -85.79 140.82 30.14 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.644 0.778 . . . . 0.0 109.171 166.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.3 143.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.439 1.096 . . . . 0.0 110.402 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -140.63 164.97 28.74 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.871 1.268 . . . . 0.0 110.906 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.3 p -161.55 158.88 27.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.758 1.223 . . . . 0.0 112.555 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 50.4 m -144.42 119.14 9.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.989 1.316 . . . . 0.0 110.126 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.57 130.37 36.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.565 1.146 . . . . 0.0 110.938 171.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -109.77 145.57 36.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.883 1.673 . . . . 0.0 111.73 -176.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.02 -18.17 65.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.966 1.307 . . . . 0.0 113.237 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -69.62 -22.43 63.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.558 1.143 . . . . 0.0 113.636 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 103.41 43.54 1.84 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.271 0.939 . . . . 0.0 113.223 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 57.6 p -139.09 159.36 42.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.177 1.391 . . . . 0.0 110.398 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 36.4 t -115.38 125.63 53.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.174 1.39 . . . . 0.0 108.588 161.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.2 t -87.21 151.4 23.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.853 0.861 . . . . 0.0 110.293 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -133.03 143.12 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.827 1.651 . . . . 0.0 110.085 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.5 p -135.6 148.05 48.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.949 1.3 . . . . 0.0 111.694 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.2 p90 -150.39 153.17 35.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.9 mt -120.55 105.62 41.09 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.559 1.943 . . . . 0.0 109.869 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -82.67 176.87 7.39 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.847 3.031 . . . . 0.0 110.321 167.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -148.85 -30.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 69.3 mt -107.58 147.63 35.69 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 119.725 1.148 . . . . 0.0 110.767 167.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.6 155.17 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.128 2.552 . . . . 0.0 111.041 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.65 -159.09 25.8 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.442 1.496 . . . . 0.0 113.134 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.01 135.26 41.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.065 1.346 . . . . 0.0 111.929 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -118.87 142.49 47.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.718 1.607 . . . . 0.0 110.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -101.65 122.0 43.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.82 1.248 . . . . 0.0 110.356 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.91 120.89 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.775 1.63 . . . . 0.0 108.466 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.1 tt -103.69 131.36 50.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.478 1.511 . . . . 0.0 109.744 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 131.32 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.454 1.502 . . . . 0.0 108.098 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -152.99 142.9 22.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.104 1.362 . . . . 0.0 110.325 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.93 123.75 11.26 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.213 -0.93 . . . . 0.0 110.534 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 43.8 t-20 57.5 54.25 6.67 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.973 1.309 . . . . 0.0 111.443 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 9.4 pt-20 56.2 22.7 6.35 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.21 2.604 . . . . 0.0 115.975 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.4 129.78 39.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.558 1.143 . . . . 0.0 111.328 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.42 156.89 18.08 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.187 0.995 . . . . 0.0 112.482 169.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.7 m -87.83 156.68 52.52 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.272 0.629 . . . . 0.0 110.489 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.52 119.1 5.86 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.885 2.39 . . . . 0.0 110.203 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.94 -13.2 65.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.297 1.427 . . . . 0.0 116.564 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.5 p -81.5 151.36 68.59 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 119.921 1.861 . . . . 0.0 113.214 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 146.56 86.88 Favored 'Cis proline' 0 C--N 1.355 0.885 0 CA-C-N 119.076 0.706 . . . . 0.0 112.051 -6.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.64 159.31 15.05 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 110.955 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 48.4 m -114.71 121.17 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.817 0.847 . . . . 0.0 110.654 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -104.02 141.35 36.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.421 1.488 . . . . 0.0 111.623 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.56 141.02 41.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.548 1.139 . . . . 0.0 109.912 164.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.1 t -133.24 138.74 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.655 1.182 . . . . 0.0 109.562 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 11.8 p -132.7 169.99 15.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.677 1.191 . . . . 0.0 112.469 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.48 140.99 27.05 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.603 1.573 . . . . 0.0 113.129 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 124.5 1.12 . . . . 0.0 113.047 175.542 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 120.608 0.242 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.19 121.19 67.86 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.17 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.5 148.1 47.43 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.664 2.243 . . . . 0.0 110.424 173.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.36 135.66 33.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.468 0.651 . . . . 0.0 110.733 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -157.33 144.28 18.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.021 1.728 . . . . 0.0 110.531 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.36 149.87 21.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.455 1.502 . . . . 0.0 109.73 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -123.17 132.74 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.166 1.386 . . . . 0.0 109.489 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 74.0 mt -129.37 136.27 28.88 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.325 1.85 . . . . 0.0 108.735 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.0 72.24 6.27 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.256 3.304 . . . . 0.0 111.419 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 34.6 t80 -124.41 152.5 43.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.589 1.956 . . . . 0.0 109.338 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 34.6 m -127.25 125.62 41.28 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.424 1.09 . . . . 0.0 109.624 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.2 mt -75.08 135.6 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 110.378 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 21.4 pttp -128.84 -147.85 0.36 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.248 1.819 . . . . 0.0 110.923 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.11 126.74 29.02 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.537 -1.352 . . . . 0.0 110.418 165.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 124.65 -154.03 17.93 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.52 1.533 . . . . 0.0 112.183 -170.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -161.39 151.95 17.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 111.214 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.48 134.89 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.51 1.524 . . . . 0.0 111.847 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -147.52 158.85 44.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.561 1.544 . . . . 0.0 110.917 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -137.44 -175.85 14.08 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -153.39 143.71 22.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.341 1.856 . . . . 0.0 109.065 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 98.3 t -119.45 129.31 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.719 1.608 . . . . 0.0 108.008 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -113.5 130.08 56.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.356 1.462 . . . . 0.0 110.479 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 34.8 mtm -108.67 139.92 21.32 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.413 1.485 . . . . 0.0 111.875 -171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.37 -27.48 75.89 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 124.258 3.305 . . . . 0.0 115.54 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.8 p -75.08 4.87 6.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.353 1.461 . . . . 0.0 114.563 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.83 44.54 5.12 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 124.665 1.126 . . . . 0.0 113.088 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -153.24 165.07 36.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.522 1.529 . . . . 0.0 112.107 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.6 m -141.25 159.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.67 1.188 . . . . 0.0 112.632 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.05 175.55 13.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.063 2.145 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -121.91 143.9 39.75 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.123 -0.985 . . . . 0.0 112.204 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -86.25 171.74 7.56 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 111.877 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.2 m -106.91 130.56 54.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 109.031 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.88 132.88 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.163 1.385 . . . . 0.0 108.951 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -136.55 124.04 22.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.36 1.464 . . . . 0.0 109.975 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.1 126.41 30.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.54 0.736 . . . . 0.0 110.753 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.02 -6.33 57.39 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 73.68 1.09 3.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 113.537 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -102.85 4.6 37.9 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.086 2.155 . . . . 0.0 112.979 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.08 15.89 40.27 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.069 1.319 . . . . 0.0 114.341 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.0 p -130.69 155.94 45.76 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.163 1.785 . . . . 0.0 110.615 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -112.64 137.34 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.71 165.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.5 m -93.74 137.91 32.5 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.583 1.153 . . . . 0.0 108.424 167.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.2 t -125.5 133.43 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.469 1.508 . . . . 0.0 108.855 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -139.84 155.79 47.05 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 0.0 112.656 -176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.3 t80 -151.05 134.55 16.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 111.547 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.86 122.72 74.45 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.575 1.15 . . . . 0.0 111.105 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.23 161.15 20.27 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.784 2.99 . . . . 0.0 111.938 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -149.81 -21.81 0.27 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -141.4 149.54 41.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.46 1.904 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.91 167.76 19.5 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.039 0.936 . . . . 0.0 112.98 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 122.58 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.59 1.567 . . . . 0.0 114.085 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tt -83.68 118.7 24.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.436 1.094 . . . . 0.0 109.417 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 28.3 m80 -111.38 158.43 19.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.524 1.53 . . . . 0.0 111.054 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -143.73 150.99 39.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.482 0.658 . . . . 0.0 112.337 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.8 ttm -132.14 139.2 48.35 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.782 2.033 . . . . 0.0 110.712 -164.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -112.19 137.37 50.37 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 109.635 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.3 mm -133.93 129.39 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.646 1.178 . . . . 0.0 109.683 174.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.87 137.66 36.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 19.9 t80 -103.83 124.91 49.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.499 1.92 . . . . 0.0 109.672 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 27.3 t70 48.29 46.51 20.11 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.779 1.232 . . . . 0.0 112.293 -177.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.306 0.3 OUTLIER 62.78 13.35 6.4 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 128.005 2.522 . . . . 0.0 116.543 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 58.9 ttm -114.74 130.41 56.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.529 1.532 . . . . 0.0 110.926 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -56.06 135.9 52.53 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.285 -0.885 . . . . 0.0 113.053 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.87 154.32 89.02 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.328 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.04 128.2 25.78 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.992 1.794 . . . . 0.0 109.403 170.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.35 -16.05 58.34 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.702 1.144 . . . . 0.0 114.098 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.1 t -82.41 146.98 55.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-N 119.803 1.802 . . . . 0.0 110.876 170.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.68 163.85 82.86 Favored 'Cis proline' 0 C--N 1.353 0.804 0 CA-C-N 120.333 1.155 . . . . 0.0 112.413 -6.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.5 159.26 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.17 1.788 . . . . 0.0 111.047 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -155.4 148.72 24.89 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 112.819 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 7.8 p90 -167.2 -179.4 4.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.968 1.707 . . . . 0.0 111.264 -167.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -120.48 142.39 49.32 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.779 -1.201 . . . . 0.0 113.405 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.1 t -111.73 134.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.144 1.778 . . . . 0.0 108.966 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -161.29 158.31 26.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.96 1.304 . . . . 0.0 112.923 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -75.48 122.15 23.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 112.124 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 32.7 m -79.79 -15.77 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 p30 -85.07 -14.69 46.45 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.719 1.208 . . . . 0.0 114.181 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.7 m -77.81 -17.22 57.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 85.16 -3.44 87.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 0.0 115.676 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -64.84 156.0 32.22 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 119.201 1.501 . . . . 0.0 112.962 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.5 t -68.19 131.82 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.2 t -152.92 161.1 42.97 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.507 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.84 142.8 36.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.358 1.463 . . . . 0.0 111.235 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 20.6 p90 -163.58 161.11 23.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.572 1.549 . . . . 0.0 112.161 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.67 176.97 15.63 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.863 1.22 . . . . 0.0 113.293 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.12 -37.94 5.49 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.045 2.496 . . . . 0.0 112.594 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.91 -32.54 73.69 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.588 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.23 -3.84 41.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.769 1.284 . . . . 0.0 113.426 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.7 m -110.35 -48.48 3.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.327 1.851 . . . . 0.0 111.109 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -138.54 145.96 41.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.101 1.76 . . . . 0.0 112.235 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.91 -179.27 21.15 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.574 1.083 . . . . 0.0 113.624 173.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.0 t -143.57 136.04 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.108 1.363 . . . . 0.0 108.598 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.3 m -56.46 137.34 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.2 m-80 68.06 -2.88 1.36 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.756 2.022 . . . . 0.0 114.663 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -100.9 136.99 19.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.039 1.336 . . . . 0.0 110.725 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.25 127.95 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.377 2.051 . . . . 0.0 110.124 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.12 146.55 36.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.613 1.565 . . . . 0.0 110.523 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.4 p -136.43 153.98 50.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -164.16 172.49 13.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.26 1.824 . . . . 0.0 111.351 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.7 m -122.75 142.42 50.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.161 1.384 . . . . 0.0 110.694 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.9 t -115.85 133.71 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.474 1.509 . . . . 0.0 108.417 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.73 132.85 36.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.381 1.072 . . . . 0.0 111.585 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 45.8 p -136.64 0.87 2.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.189 1.395 . . . . 0.0 114.108 -169.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -53.46 -37.86 63.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 115.119 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -117.01 9.92 13.82 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.396 1.479 . . . . 0.0 112.538 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.13 56.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.446 1.099 . . . . 0.0 113.504 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.36 -106.77 2.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.609 1.1 . . . . 0.0 112.247 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -161.45 155.12 21.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.523 1.929 . . . . 0.0 109.942 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 148.08 9.21 0.19 Allowed Glycine 0 N--CA 1.473 1.118 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.03 103.84 2.05 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 126.078 1.799 . . . . 0.0 112.479 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.72 132.85 33.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.984 1.713 . . . . 0.0 109.603 171.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.3 m -129.86 157.99 40.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.6 1.56 . . . . 0.0 112.134 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.1 tp -159.02 136.06 9.69 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.029 1.732 . . . . 0.0 109.184 -170.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.45 158.93 36.73 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 112.424 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.3 mt -137.51 139.04 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.89 1.276 . . . . 0.0 109.98 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.83 129.16 40.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.369 1.468 . . . . 0.0 109.944 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.35 -162.16 11.24 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 119.04 -0.866 . . . . 0.0 114.386 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.7 -24.72 69.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.042 3.162 . . . . 0.0 112.56 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.6 t -138.97 160.45 39.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.978 1.311 . . . . 0.0 109.627 162.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -71.75 112.34 7.77 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.134 -0.979 . . . . 0.0 110.689 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.64 148.77 50.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.694 0.798 . . . . 0.0 111.688 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.44 140.71 29.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.09 143.89 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.665 1.186 . . . . 0.0 110.259 -167.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.9 t -141.67 156.5 45.64 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.13 1.372 . . . . 0.0 111.144 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 48.9 t -145.35 136.97 25.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.211 1.405 . . . . 0.0 110.66 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 93.5 m -132.3 129.33 39.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.272 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.99 131.5 43.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 110.779 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.17 -131.23 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.85 0.86 . . . . 0.0 110.222 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -84.1 38.04 0.64 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.461 -1.399 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 20.7 t70 71.37 -20.44 0.23 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.813 2.845 . . . . 0.0 114.588 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . -76.77 -21.27 74.89 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.758 1.17 . . . . 0.0 114.194 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 31.8 p -147.5 157.61 43.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.788 1.635 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 74.2 m -115.54 136.7 52.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.115 1.766 . . . . 0.0 109.205 162.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -98.57 136.89 38.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.466 1.106 . . . . 0.0 110.493 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.5 t -111.43 142.48 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.93 1.692 . . . . 0.0 109.782 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 51.9 m -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.145 1.378 . . . . 0.0 110.833 168.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 9.6 p90 -148.38 154.29 39.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 8.8 mt -120.62 107.66 38.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.893 1.677 . . . . 0.0 110.763 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.64 175.03 9.18 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.036 3.157 . . . . 0.0 110.46 166.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.3 p -151.07 -30.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.4 mt -105.6 146.33 32.61 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.586 1.085 . . . . 0.0 110.533 167.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.86 154.53 48.46 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.911 2.407 . . . . 0.0 110.949 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.13 -158.6 24.0 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.796 1.188 . . . . 0.0 113.247 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -100.82 133.31 45.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.09 1.356 . . . . 0.0 112.492 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.83 126.07 50.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.999 1.72 . . . . 0.0 109.956 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 71.2 m -84.32 126.62 33.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.108 0.963 . . . . 0.0 110.582 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.73 124.99 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.6 1.56 . . . . 0.0 108.283 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -108.86 130.49 55.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.29 1.436 . . . . 0.0 109.811 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -132.58 128.79 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.417 1.087 . . . . 0.0 109.879 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.99 142.2 24.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.058 1.343 . . . . 0.0 111.718 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.65 121.36 16.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.809 1.244 . . . . 0.0 109.448 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.41 57.37 4.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.472 1.509 . . . . 0.0 112.159 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.285 8.5 pt-20 57.21 12.12 1.26 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.498 2.719 . . . . 0.0 116.329 -177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -119.26 125.31 48.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.704 1.202 . . . . 0.0 110.671 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -64.72 147.39 53.17 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.457 -0.777 . . . . 0.0 111.894 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 21.8 m -69.11 152.47 96.71 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.044 168.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.99 128.69 23.66 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.254 1.969 . . . . 0.0 110.063 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.52 -14.74 64.74 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.989 1.28 . . . . 0.0 115.007 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.8 t -78.16 139.94 61.08 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.258 1.529 . . . . 0.0 111.295 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.41 135.55 40.83 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.383 0.816 . . . . 0.0 111.905 -3.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.3 170.9 12.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.0 1.72 . . . . 0.0 110.399 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 52.4 m -132.73 121.27 22.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.35 140.33 30.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.312 1.445 . . . . 0.0 110.872 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -100.89 122.52 43.6 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.732 0.813 . . . . 0.0 109.968 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.7 t -109.26 129.89 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.589 1.555 . . . . 0.0 110.373 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.5 p -100.68 155.96 17.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.676 1.19 . . . . 0.0 112.752 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.7 121.98 6.85 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.404 1.478 . . . . 0.0 111.183 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 CA--C 1.551 1.009 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.38 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.38 117.49 16.88 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.605 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.67 112.54 3.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.546 2.164 . . . . 0.0 108.809 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.71 135.48 42.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.718 0.807 . . . . 0.0 111.686 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.75 166.07 27.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.508 1.923 . . . . 0.0 111.411 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 156.47 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.427 1.491 . . . . 0.0 111.038 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -121.67 135.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.326 1.45 . . . . 0.0 109.364 167.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 65.2 mt -132.02 136.94 29.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.368 1.867 . . . . 0.0 108.367 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.76 42.45 1.26 Allowed 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.46 3.44 . . . . 0.0 113.124 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -89.01 159.16 17.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.303 1.441 . . . . 0.0 111.546 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.5 m -127.04 128.1 45.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.396 1.478 . . . . 0.0 110.282 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 26.4 mt -93.8 130.67 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.617 1.167 . . . . 0.0 109.376 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -113.24 -75.23 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.635 1.174 . . . . 0.0 111.791 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.8 tttm -160.07 133.73 7.08 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.998 1.719 . . . . 0.0 110.951 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.6 -137.73 9.76 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.533 1.54 . . . . 0.0 110.945 -166.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -155.88 140.11 16.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.026 0.931 . . . . 0.0 111.727 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.9 tt -116.74 138.08 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.847 1.659 . . . . 0.0 110.696 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.0 p -144.1 177.96 8.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.19 1.796 . . . . 0.0 110.392 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.18 -172.27 37.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -156.41 143.83 19.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.62 1.568 . . . . 0.0 109.919 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 91.0 t -118.17 132.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.566 1.546 . . . . 0.0 108.674 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -108.76 137.14 47.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 112.166 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 8.3 mtm -103.0 142.5 24.68 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.059 1.743 . . . . 0.0 111.135 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.33 -27.21 66.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.052 3.168 . . . . 0.0 115.278 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.8 p -73.81 0.69 12.42 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.407 1.483 . . . . 0.0 114.37 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.71 69.22 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.892 1.71 . . . . 0.0 114.3 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -73.69 156.81 37.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.057 1.343 . . . . 0.0 112.153 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.0 m -139.95 152.59 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.594 1.557 . . . . 0.0 110.795 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.29 170.04 22.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.721 1.608 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -101.74 138.62 19.88 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.704 0.802 . . . . 0.0 111.556 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.36 162.53 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.946 3.098 . . . . 0.0 111.073 169.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 91.4 m -109.82 119.39 39.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.332 1.453 . . . . 0.0 108.997 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.73 132.01 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.957 1.303 . . . . 0.0 109.239 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.5 m -134.13 120.14 19.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.565 1.546 . . . . 0.0 109.376 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.37 131.64 37.05 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.718 0.807 . . . . 0.0 112.094 172.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.96 -3.55 58.96 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt 73.06 0.78 3.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.575 2.35 . . . . 0.0 113.875 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -109.78 8.44 24.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.802 2.041 . . . . 0.0 113.112 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.31 15.75 49.68 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.866 1.222 . . . . 0.0 114.352 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 45.1 p -131.14 161.03 33.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.216 1.806 . . . . 0.0 110.415 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 17.9 m -122.75 140.77 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 110.212 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 46.7 m -98.29 140.66 32.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.993 1.317 . . . . 0.0 108.432 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.4 t -127.56 134.84 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.546 1.139 . . . . 0.0 109.522 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -132.18 162.87 29.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.651 1.581 . . . . 0.0 111.984 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.1 t80 -157.14 140.4 15.55 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.513 1.525 . . . . 0.0 111.796 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.98 114.86 63.87 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.705 1.202 . . . . 0.0 110.807 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.68 158.33 28.29 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.593 2.862 . . . . 0.0 112.075 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 95.9 p -143.45 0.37 1.14 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -169.59 157.25 7.02 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.415 1.886 . . . . 0.0 110.554 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.87 170.94 15.62 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.324 1.05 . . . . 0.0 113.085 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.7 -177.79 16.39 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 125.884 1.707 . . . . 0.0 114.391 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.0 tp -86.93 112.38 21.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 110.155 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 45.2 m80 -105.71 171.69 7.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.002 1.721 . . . . 0.0 111.444 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.34 151.17 37.07 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.948 0.899 . . . . 0.0 111.339 172.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 31.4 ttm -119.19 129.98 55.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.059 1.744 . . . . 0.0 110.685 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.77 134.3 40.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.082 2.553 . . . . 0.0 109.392 165.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.0 mm -138.47 135.98 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.928 1.291 . . . . 0.0 108.703 168.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.71 142.15 24.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.993 0.917 . . . . 0.0 113.384 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.63 118.73 36.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.405 1.882 . . . . 0.0 109.611 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.14 34.23 10.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.62 1.168 . . . . 0.0 112.727 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 73.05 8.05 5.39 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.827 2.451 . . . . 0.0 115.11 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.98 128.68 46.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.375 1.47 . . . . 0.0 110.459 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 139.27 55.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.6 pt -73.66 150.29 88.71 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.88 169.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.21 -20.12 66.67 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.837 2.358 . . . . 0.0 113.959 -172.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.42 1.01 88.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.099 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.1 m -119.84 156.46 54.08 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 120.031 1.916 . . . . 0.0 113.347 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.35 169.29 74.4 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 119.098 0.714 . . . . 0.0 113.212 0.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 74.3 mt -129.71 150.12 51.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.375 1.87 . . . . 0.0 110.563 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.8 136.84 47.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.936 1.294 . . . . 0.0 110.164 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.4 p90 -154.17 149.26 26.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.386 1.074 . . . . 0.0 112.213 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.5 t80 -99.87 145.27 27.96 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.179 -0.951 . . . . 0.0 112.748 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.0 t -124.43 143.39 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.786 1.634 . . . . 0.0 109.233 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.9 t0 -151.64 167.8 26.98 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.966 1.306 . . . . 0.0 110.96 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.67 164.72 24.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.02 1.328 . . . . 0.0 112.787 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 34.1 m -73.52 -20.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.962 167.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -86.89 -6.74 58.69 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.849 1.259 . . . . 0.0 114.138 -171.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 29.4 p -64.14 145.57 55.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.267 1.027 . . . . 0.0 113.615 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -108.19 -21.15 7.85 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.156 1.36 . . . . 0.0 113.932 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -70.12 159.85 33.15 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.65 1.18 . . . . 0.0 113.999 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.3 t -64.59 135.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 109.061 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.9 t -156.71 163.12 39.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.773 1.229 . . . . 0.0 110.877 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.59 147.33 31.94 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.875 1.27 . . . . 0.0 112.38 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -169.08 160.34 9.79 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.758 1.623 . . . . 0.0 112.968 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 145.22 175.82 18.67 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.201 1.381 . . . . 0.0 113.576 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.46 -37.55 12.98 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.045 2.497 . . . . 0.0 112.218 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.9 75.88 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.215 0.912 . . . . 0.0 114.099 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.26 -11.09 60.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.576 1.15 . . . . 0.0 113.213 171.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.8 m -120.67 -43.52 2.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.718 1.607 . . . . 0.0 111.912 -170.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -142.84 154.56 44.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.715 2.006 . . . . 0.0 112.139 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.05 174.4 26.0 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.476 1.036 . . . . 0.0 113.699 172.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 38.4 t -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.919 1.288 . . . . 0.0 108.571 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.8 m -56.39 135.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.153 0.581 . . . . 0.0 112.52 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.7 m-80 66.45 3.5 2.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.938 2.095 . . . . 0.0 114.73 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 54.7 mttm -110.0 142.9 26.85 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.391 1.476 . . . . 0.0 110.948 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.33 119.87 6.22 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.576 2.184 . . . . 0.0 110.577 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -99.55 143.1 30.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.082 1.353 . . . . 0.0 110.082 172.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.9 p -133.49 152.99 51.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -165.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1886 ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.4 p90 -164.04 174.63 11.13 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.741 1.616 . . . . 0.0 112.175 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 80.7 m -126.69 142.83 51.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.579 1.552 . . . . 0.0 110.964 -170.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.8 t -116.48 133.15 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.963 1.705 . . . . 0.0 108.265 167.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.03 127.47 35.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.053 0.941 . . . . 0.0 111.222 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 51.5 p -133.13 0.44 3.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.076 1.35 . . . . 0.0 114.011 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.1 tptp -52.5 -39.12 60.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.699 1.6 . . . . 0.0 114.459 -173.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.37 6.66 20.54 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.385 1.474 . . . . 0.0 113.046 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.23 60.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.231 1.012 . . . . 0.0 113.622 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 77.72 -102.49 1.77 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.624 1.107 . . . . 0.0 112.164 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.92 157.28 23.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.247 1.819 . . . . 0.0 110.18 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.79 4.21 0.75 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.572 1.558 . . . . 0.0 115.146 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.01 103.67 1.89 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.544 1.545 . . . . 0.0 113.224 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.06 135.58 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.655 1.582 . . . . 0.0 109.266 168.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -138.76 165.3 27.34 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.079 1.352 . . . . 0.0 112.319 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -165.05 136.8 4.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.207 1.803 . . . . 0.0 109.699 -161.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.92 166.24 32.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.519 1.128 . . . . 0.0 112.004 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.66 131.76 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.651 1.18 . . . . 0.0 109.55 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.87 113.38 25.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 109.454 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.08 -174.95 13.93 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.128 1.347 . . . . 0.0 113.802 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.84 -23.81 47.36 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.853 3.035 . . . . 0.0 111.942 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -142.06 159.53 42.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 160.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.06 130.62 43.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.933 -1.105 . . . . 0.0 112.52 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.37 152.44 27.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.103 0.961 . . . . 0.0 110.981 164.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.21 139.3 30.63 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 165.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -132.8 138.76 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.558 1.143 . . . . 0.0 110.392 -167.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 68.6 m -134.74 158.27 44.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 111.008 170.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -152.87 153.61 33.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.387 1.075 . . . . 0.0 112.544 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.9 m -143.09 122.2 12.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.461 1.504 . . . . 0.0 110.373 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.68 129.51 36.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.415 1.086 . . . . 0.0 111.132 171.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -104.62 158.74 16.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.424 1.489 . . . . 0.0 112.602 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -70.92 -15.59 62.62 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.83 0.852 . . . . 0.0 112.114 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.47 -3.62 34.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.267 1.827 . . . . 0.0 114.551 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 86.99 27.3 29.0 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.207 0.908 . . . . 0.0 113.775 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.3 p -137.85 158.74 43.71 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 110.943 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 34.5 t -103.6 127.97 50.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.333 1.053 . . . . 0.0 108.819 159.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -88.15 152.36 22.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.681 0.793 . . . . 0.0 110.226 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1922 ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' 1886 ' ' PHE . 91.9 t -133.63 143.86 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.628 1.571 . . . . 0.0 109.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -135.97 147.64 48.12 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.019 1.328 . . . . 0.0 111.793 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -149.81 152.12 34.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.9 mt -117.54 102.0 52.16 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.693 1.997 . . . . 0.0 110.262 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.79 162.12 18.73 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.763 2.976 . . . . 0.0 110.412 170.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.9 m -124.25 -10.56 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -167.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -156.01 151.79 22.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.363 1.465 . . . . 0.0 110.347 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.33 140.69 24.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.665 2.244 . . . . 0.0 111.462 -173.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.63 -167.91 33.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.507 1.051 . . . . 0.0 113.591 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -96.0 124.3 39.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.331 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.67 121.33 38.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.75 1.62 . . . . 0.0 110.176 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.4 m -92.4 109.8 21.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.267 1.027 . . . . 0.0 110.989 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -81.49 131.99 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.765 1.626 . . . . 0.0 108.677 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.88 128.88 55.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.951 1.7 . . . . 0.0 108.987 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 48.9 t -128.28 130.02 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.19 0.996 . . . . 0.0 109.839 172.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.61 141.36 22.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.842 1.257 . . . . 0.0 111.961 -167.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.46 123.46 21.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.041 1.336 . . . . 0.0 109.457 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.79 57.72 5.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.347 1.459 . . . . 0.0 112.617 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.1 pt-20 57.84 11.02 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 128.134 2.574 . . . . 0.0 116.296 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -117.45 124.66 49.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.655 1.182 . . . . 0.0 110.597 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.73 143.6 57.27 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.463 -0.773 . . . . 0.0 111.29 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.8 m -70.11 151.83 95.92 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.718 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.54 132.8 45.14 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.535 2.157 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.44 -17.42 57.47 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.103 1.335 . . . . 0.0 114.751 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 32.7 t -75.68 141.29 72.21 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.289 1.544 . . . . 0.0 111.663 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.23 148.87 88.54 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.551 0.875 . . . . 0.0 112.339 -4.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -110.66 132.66 54.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 110.161 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 87.9 m -95.44 114.3 26.06 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.055 0.843 . . . . 0.0 111.251 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.3 138.31 33.17 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.037 1.335 . . . . 0.0 111.033 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -97.04 117.9 32.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.421 0.689 . . . . 0.0 110.887 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.8 t -93.34 137.5 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.399 1.48 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.0 p -115.58 155.84 26.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.564 1.546 . . . . 0.0 112.871 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.23 136.16 14.16 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.962 1.268 . . . . 0.0 112.119 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.3 t70 . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 124.648 1.179 . . . . 0.0 113.464 178.473 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.476 0.655 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -64.41 115.84 23.28 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.443 1.897 . . . . 0.0 110.073 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 151.46 64.59 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -171.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.82 122.89 41.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.199 0.6 . . . . 0.0 110.078 176.686 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -150.14 132.8 15.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.764 1.226 . . . . 0.0 110.966 174.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.01 157.73 45.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.33 2.252 . . . . 0.0 109.41 -175.303 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.9 p -135.3 134.14 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.654 1.182 . . . . 0.0 109.438 172.482 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.73 136.41 28.37 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.544 1.537 . . . . 0.0 109.284 -169.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.78 85.56 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.892 3.061 . . . . 0.0 110.319 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.4 t80 -139.98 152.53 46.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.697 1.999 . . . . 0.0 109.429 177.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -126.42 134.51 50.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.822 1.249 . . . . 0.0 109.471 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.5 mt -91.49 128.81 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.522 1.129 . . . . 0.0 109.345 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -99.52 -131.08 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.544 1.138 . . . . 0.0 109.821 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -83.01 -4.21 58.07 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.91 -152.65 17.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.801 1.667 . . . . 0.0 113.291 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.24 149.62 26.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.203 1.401 . . . . 0.0 110.631 -173.111 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.3 tt -128.8 136.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.542 1.537 . . . . 0.0 111.446 -175.296 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.1 p -149.25 167.64 25.48 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.169 1.788 . . . . 0.0 110.857 -175.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.39 -170.1 19.87 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -175.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.57 132.94 9.96 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.084 1.754 . . . . 0.0 109.589 177.401 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 40.2 t -112.33 138.99 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.61 1.564 . . . . 0.0 108.634 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.18 132.71 48.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.832 0.853 . . . . 0.0 111.153 -174.336 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.4 mtm -106.38 141.66 23.26 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.838 1.655 . . . . 0.0 111.95 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.12 -23.57 36.71 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.63 3.554 . . . . 0.0 115.757 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.0 t -68.92 -8.33 43.29 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.56 48.71 3.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.95 1.262 . . . . 0.0 112.429 177.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -156.87 163.36 39.27 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.131 1.773 . . . . 0.0 111.43 -171.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -139.0 161.71 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.541 1.136 . . . . 0.0 112.734 -171.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.08 169.48 24.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.695 1.998 . . . . 0.0 111.435 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.7 140.79 21.42 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.122 0.969 . . . . 0.0 111.308 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.38 175.24 7.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.209 3.273 . . . . 0.0 111.966 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -114.11 138.01 50.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.534 1.534 . . . . 0.0 109.008 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.76 131.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.783 1.233 . . . . 0.0 108.682 173.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.3 m -133.22 115.44 15.0 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.418 1.487 . . . . 0.0 109.092 -178.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.84 135.27 43.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 112.089 174.124 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.66 -13.5 34.12 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.3 mttp 66.49 7.04 4.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.326 2.25 . . . . 0.0 114.048 -177.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 9.47 43.25 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.082 2.153 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.84 11.9 57.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.356 1.455 . . . . 0.0 114.025 -174.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -130.13 157.31 42.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.062 1.745 . . . . 0.0 111.385 178.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -119.99 140.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.349 1.06 . . . . 0.0 109.949 164.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 51.7 m -94.16 138.5 32.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 170.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.6 t -126.72 133.04 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.688 1.595 . . . . 0.0 108.612 -175.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.07 157.23 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.553 1.141 . . . . 0.0 113.346 -170.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.0 t80 -158.31 137.83 11.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.874 1.669 . . . . 0.0 111.917 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.0 112.67 56.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.997 1.319 . . . . 0.0 110.785 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.11 149.04 28.09 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.685 2.923 . . . . 0.0 112.921 -174.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.1 p -139.21 -2.99 1.59 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 174.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -141.64 145.89 35.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.241 1.816 . . . . 0.0 109.484 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.74 169.53 15.15 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.976 0.911 . . . . 0.0 112.978 176.963 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 107.14 -173.19 18.77 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 124.992 1.282 . . . . 0.0 114.712 173.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 60.8 tp -77.71 128.16 33.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.96 1.304 . . . . 0.0 110.893 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -126.41 166.86 16.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.952 1.701 . . . . 0.0 111.175 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.49 153.54 51.71 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 112.312 156.537 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 43.7 ttm -112.54 121.8 45.86 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 109.875 169.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.77 136.22 38.99 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.106 1.363 . . . . 0.0 110.133 164.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.8 mm -133.88 135.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.709 1.203 . . . . 0.0 109.78 167.085 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.41 138.65 31.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.665 1.186 . . . . 0.0 112.966 175.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 46.4 t80 -102.87 123.81 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.53 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.08 45.75 22.86 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.766 1.227 . . . . 0.0 112.055 -176.048 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.28 4.6 p30 67.44 -2.05 1.39 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.864 2.866 . . . . 0.0 116.584 -177.065 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.2 mtt -100.67 134.27 43.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.069 1.347 . . . . 0.0 111.454 176.594 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 10.6 m170 -56.08 134.72 52.85 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.318 -0.864 . . . . 0.0 112.551 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.1 154.82 86.52 Favored Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 121.734 -0.603 . . . . 0.0 111.272 173.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -60.37 126.57 20.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.675 1.583 . . . . 0.0 108.587 165.231 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.98 45.53 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.565 1.078 . . . . 0.0 114.366 -173.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 20.7 t -82.09 142.15 47.56 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.181 1.491 . . . . 0.0 112.143 176.399 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.05 152.95 77.1 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.988 1.032 . . . . 0.0 111.864 -7.021 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.59 111.2 22.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.021 1.328 . . . . 0.0 109.109 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -102.27 139.4 37.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.331 1.052 . . . . 0.0 111.531 -176.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.5 p90 -164.35 160.11 20.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.174 0.989 . . . . 0.0 112.801 -176.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -102.75 130.98 49.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.338 1.055 . . . . 0.0 111.998 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.3 t -92.12 134.37 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.919 1.288 . . . . 0.0 109.726 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 21.0 t0 -144.1 162.35 36.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.579 1.952 . . . . 0.0 110.805 -169.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.83 154.02 26.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.387 1.075 . . . . 0.0 112.584 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -65.6 -29.21 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.309 -0.869 . . . . 0.0 112.054 168.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -92.24 -163.06 0.99 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.752 1.621 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.9 m 79.04 155.61 0.15 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.43 2.692 . . . . 0.0 113.352 173.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.35 -8.35 53.07 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 124.912 1.244 . . . . 0.0 115.521 -173.184 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.96 152.95 41.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 118.911 1.355 . . . . 0.0 113.871 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.2 t -64.88 143.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.181 0.992 . . . . 0.0 108.792 172.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -156.67 158.52 37.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.248 1.019 . . . . 0.0 110.795 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.92 141.81 33.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.194 1.398 . . . . 0.0 111.003 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.3 p90 -166.43 165.99 16.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.229 1.412 . . . . 0.0 112.796 -172.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 122.47 171.84 13.92 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.408 1.48 . . . . 0.0 112.466 -174.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.09 -33.68 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.914 2.409 . . . . 0.0 113.27 -168.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.61 86.68 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.144 0.884 . . . . 0.0 114.513 -169.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.65 -6.92 55.5 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.728 1.264 . . . . 0.0 113.785 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 -40.37 5.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.025 2.13 . . . . 0.0 111.723 176.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -153.43 142.44 21.26 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.039 1.336 . . . . 0.0 112.568 -171.058 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.57 -176.11 15.61 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.923 1.249 . . . . 0.0 112.672 174.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.0 p -153.38 136.14 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.734 1.214 . . . . 0.0 109.281 176.361 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.0 m -60.11 147.01 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -171.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 67.42 5.02 4.04 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.432 1.893 . . . . 0.0 114.574 173.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.9 mttp -120.61 149.72 50.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.179 1.792 . . . . 0.0 110.884 170.535 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.57 135.16 21.56 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.678 2.252 . . . . 0.0 110.848 175.189 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.29 146.92 36.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.798 1.639 . . . . 0.0 110.105 171.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.1 p -135.53 148.74 49.26 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -164.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -159.56 179.23 9.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.034 1.733 . . . . 0.0 111.265 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 52.6 m -132.87 144.87 50.48 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.316 1.446 . . . . 0.0 110.516 -170.46 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.6 t -122.53 127.75 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.876 1.67 . . . . 0.0 108.448 172.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -95.05 114.31 26.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.272 1.029 . . . . 0.0 110.554 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 25.2 p -120.54 -1.79 10.06 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.072 2.149 . . . . 0.0 113.423 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.64 -45.12 77.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.922 1.689 . . . . 0.0 114.562 -165.519 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.45 -15.85 38.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 113.534 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -82.46 -67.12 0.81 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.599 1.16 . . . . 0.0 111.058 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 64.99 16.02 61.28 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 165.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.5 146.58 22.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.585 1.693 . . . . 0.0 111.655 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 90.53 -170.96 35.9 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.58 1.562 . . . . 0.0 112.862 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -92.88 115.63 4.92 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 124.244 0.926 . . . . 0.0 111.525 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -77.74 123.24 26.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.346 1.059 . . . . 0.0 108.608 170.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 47.4 m -120.52 154.09 35.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.433 1.493 . . . . 0.0 112.104 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -157.66 133.83 9.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.865 1.666 . . . . 0.0 108.964 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 160.62 39.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.876 0.871 . . . . 0.0 112.147 177.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -135.04 134.34 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.794 1.238 . . . . 0.0 109.333 172.7 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.13 120.51 37.95 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.143 1.377 . . . . 0.0 109.051 171.412 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -132.57 179.93 16.82 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.659 1.124 . . . . 0.0 114.226 -176.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.05 -24.85 38.54 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.038 3.159 . . . . 0.0 111.923 174.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.5 t -134.73 157.81 45.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 108.683 156.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.99 120.64 19.85 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.843 -1.161 . . . . 0.0 112.132 -174.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.56 145.73 34.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.049 0.94 . . . . 0.0 111.202 168.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.62 148.84 25.3 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.336 0.654 . . . . 0.0 110.393 167.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -137.59 144.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.808 1.243 . . . . 0.0 110.235 -166.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 166.86 24.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.891 1.276 . . . . 0.0 111.259 167.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.0 p -155.97 153.46 29.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.939 1.295 . . . . 0.0 112.404 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 70.3 m -140.14 131.38 26.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.436 1.494 . . . . 0.0 110.331 -169.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.63 128.12 34.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.134 174.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -91.84 152.18 20.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.708 1.203 . . . . 0.0 111.657 176.065 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.51 -17.58 64.2 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.494 0.717 . . . . 0.0 112.322 173.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.8 -9.76 58.78 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.576 1.55 . . . . 0.0 113.702 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 9.66 57.94 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.16 1.362 . . . . 0.0 115.203 176.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.9 p -108.23 161.23 15.19 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.948 1.699 . . . . 0.0 111.524 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 83.5 m -102.65 124.86 48.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.954 1.302 . . . . 0.0 110.278 170.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.3 t -88.69 151.98 22.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.807 0.843 . . . . 0.0 110.582 166.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.3 t -130.94 144.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.174 1.79 . . . . 0.0 109.984 -177.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.5 p -135.65 147.66 48.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.615 1.166 . . . . 0.0 111.729 166.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -148.92 154.95 40.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.31 -0.869 . . . . 0.0 113.005 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.75 102.62 25.22 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.79 1.236 . . . . 0.0 110.456 -173.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.78 163.91 9.07 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.033 3.155 . . . . 0.0 111.3 175.464 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -127.12 -21.45 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.223 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.77 150.51 60.16 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.487 1.115 . . . . 0.0 110.755 173.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.9 145.73 32.2 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.849 2.366 . . . . 0.0 111.99 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.39 -167.54 32.46 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.837 1.208 . . . . 0.0 113.654 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.04 124.57 38.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.392 1.477 . . . . 0.0 112.098 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -116.51 128.21 55.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.855 1.662 . . . . 0.0 110.009 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.9 m -89.99 116.29 27.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.105 0.962 . . . . 0.0 110.705 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.59 124.67 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.698 1.599 . . . . 0.0 108.326 177.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.7 tt -108.53 127.48 53.97 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.455 1.502 . . . . 0.0 109.261 176.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -130.29 127.71 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.315 1.046 . . . . 0.0 109.497 173.358 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.75 144.6 24.41 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.066 1.347 . . . . 0.0 111.398 -167.522 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.29 125.98 13.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.509 1.123 . . . . 0.0 110.131 -177.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.1 52.37 11.84 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.576 1.15 . . . . 0.0 112.041 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 7.8 pt-20 58.84 12.68 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.322 2.649 . . . . 0.0 116.39 -177.45 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -119.49 127.35 52.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.453 1.101 . . . . 0.0 110.997 177.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -62.43 143.32 57.21 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.466 -0.772 . . . . 0.0 111.417 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.4 m -71.38 151.99 94.15 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.03 173.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -55.36 126.55 22.88 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.249 2.633 . . . . 0.0 111.19 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.92 62.17 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.367 1.46 . . . . 0.0 115.085 -175.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 36.4 t -78.06 141.69 63.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 119.356 1.578 . . . . 0.0 111.701 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 141.78 72.16 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.421 0.829 . . . . 0.0 112.27 -4.156 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -93.95 161.92 14.11 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.171 1.788 . . . . 0.0 110.617 176.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.7 m -119.97 116.0 24.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.675 0.79 . . . . 0.0 110.745 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.33 133.23 39.48 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.702 1.201 . . . . 0.0 111.084 172.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 111.75 23.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.898 0.879 . . . . 0.0 109.553 174.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.2 t -94.6 133.01 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.924 1.29 . . . . 0.0 110.05 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 78.7 p -108.37 165.69 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.915 1.286 . . . . 0.0 113.094 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.96 136.96 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.77 1.176 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 124.78 1.232 . . . . 0.0 113.768 -175.456 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -45.65 110.75 1.21 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.392 1.877 . . . . 0.0 111.349 175.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 133.32 29.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.271 1.98 . . . . 0.0 108.801 172.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.99 123.67 45.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.587 0.755 . . . . 0.0 111.047 -174.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -157.2 141.78 16.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 110.928 177.103 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.72 147.6 51.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.267 1.827 . . . . 0.0 110.266 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -109.8 138.43 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.785 1.234 . . . . 0.0 109.963 172.084 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.8 mt -132.47 133.86 24.13 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.048 1.739 . . . . 0.0 108.686 -174.285 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.13 66.82 8.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.199 3.266 . . . . 0.0 111.211 177.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.8 t80 -115.68 153.81 30.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.895 1.678 . . . . 0.0 111.16 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 59.2 m -121.91 119.72 32.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.264 1.426 . . . . 0.0 109.429 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.46 127.01 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 109.295 174.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.17 -139.59 0.36 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.701 1.2 . . . . 0.0 110.67 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -75.27 -6.68 51.09 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.9 -148.42 8.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.781 1.658 . . . . 0.0 113.017 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -154.88 148.05 24.86 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 110.517 -173.683 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.49 136.03 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.286 1.434 . . . . 0.0 111.184 -178.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 54.9 p -146.14 -175.33 4.72 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.457 1.903 . . . . 0.0 109.894 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.88 -162.18 20.55 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 -177.491 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.37 144.75 17.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.289 1.836 . . . . 0.0 109.664 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 90.8 t -123.07 135.89 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.015 1.726 . . . . 0.0 108.223 173.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -120.72 139.59 52.85 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 112.056 -174.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.5 148.11 36.59 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.717 1.607 . . . . 0.0 111.481 -176.008 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.71 -28.75 67.96 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.115 3.21 . . . . 0.0 114.927 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.1 p -73.56 -2.78 24.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 114.496 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.35 -5.77 83.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.562 1.554 . . . . 0.0 113.9 -178.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -68.77 157.56 36.12 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.144 1.377 . . . . 0.0 112.052 173.1 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.9 m -140.76 156.36 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.165 1.386 . . . . 0.0 111.655 177.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.28 179.83 8.86 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.92 2.088 . . . . 0.0 110.267 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -127.36 144.76 51.92 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 121.146 -0.971 . . . . 0.0 111.915 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.83 166.14 13.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.146 3.231 . . . . 0.0 111.399 176.475 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.0 m -111.54 125.59 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.052 1.341 . . . . 0.0 108.96 173.479 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.14 132.47 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.788 1.235 . . . . 0.0 109.142 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 67.2 m -135.13 126.15 27.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.375 1.47 . . . . 0.0 109.744 178.15 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.84 139.01 41.49 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.954 0.901 . . . . 0.0 112.607 173.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -93.47 -4.96 50.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 71.14 -3.69 1.99 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.816 2.446 . . . . 0.0 114.225 -176.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.4 5.73 49.33 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.658 1.983 . . . . 0.0 113.264 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.43 14.75 55.17 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.964 1.269 . . . . 0.0 113.891 -174.455 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 63.7 p -129.69 161.59 30.28 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.293 1.837 . . . . 0.0 110.611 177.071 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 18.7 m -121.31 146.79 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.595 1.158 . . . . 0.0 109.689 166.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 80.8 m -105.77 135.69 46.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.402 1.081 . . . . 0.0 108.467 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 20.5 t -115.05 133.57 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.569 1.548 . . . . 0.0 108.95 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.55 154.07 47.41 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.55 1.54 . . . . 0.0 112.1 -174.66 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -153.9 136.19 14.9 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.714 1.606 . . . . 0.0 111.513 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.12 118.12 68.88 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.52 1.128 . . . . 0.0 110.88 177.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.46 144.98 23.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.508 2.805 . . . . 0.0 111.77 -176.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.4 p -135.02 -7.42 2.34 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 178.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -163.49 143.81 8.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.818 1.647 . . . . 0.0 110.218 -175.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -81.6 165.41 21.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.44 1.096 . . . . 0.0 113.239 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.68 -168.24 15.88 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.782 1.658 . . . . 0.0 114.377 178.011 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.0 130.19 37.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.197 1.799 . . . . 0.0 109.58 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 76.9 m80 -134.25 169.88 16.53 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.251 1.421 . . . . 0.0 112.007 -170.21 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.76 152.39 38.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 168.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.1 ttm -121.22 118.07 28.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.894 2.478 . . . . 0.0 109.837 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.34 137.75 32.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.428 1.491 . . . . 0.0 109.944 169.864 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.0 mm -135.65 135.17 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.573 1.149 . . . . 0.0 110.649 175.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.12 20.72 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.73 1.212 . . . . 0.0 113.131 -175.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -99.61 125.31 45.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.743 2.017 . . . . 0.0 109.901 174.126 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.4 34.05 14.3 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.734 1.214 . . . . 0.0 112.448 -174.587 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.1 t30 75.15 2.65 3.97 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.397 2.679 . . . . 0.0 114.746 -178.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.0 mtm -102.64 130.61 49.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 0.0 110.638 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -58.7 137.71 57.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.1 pt -71.45 152.46 94.01 Favored Pre-proline 0 N--CA 1.48 1.033 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.599 173.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.17 125.68 17.58 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.363 2.042 . . . . 0.0 110.936 -176.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.92 -8.63 76.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.144 1.354 . . . . 0.0 115.233 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.8 t -63.93 141.26 98.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 120.07 1.935 . . . . 0.0 111.941 175.427 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.59 161.45 76.15 Favored 'Cis proline' 0 C--N 1.354 0.837 0 CA-C-N 119.998 1.035 . . . . 0.0 113.492 0.016 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.1 mt -96.4 136.21 37.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.68 1.592 . . . . 0.0 110.004 172.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -109.25 141.96 40.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.372 1.069 . . . . 0.0 110.959 -177.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 34.0 p90 -153.85 174.13 14.99 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 113.212 -173.634 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.9 t80 -128.49 147.75 50.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 112.421 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 49.3 t -127.6 139.27 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.091 1.756 . . . . 0.0 109.16 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -153.38 160.41 42.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.459 1.504 . . . . 0.0 110.756 -174.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -76.38 139.79 41.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 111.485 177.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -66.04 -23.61 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 121.442 -0.786 . . . . 0.0 112.842 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 55.4 p30 -85.8 -3.66 58.96 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.469 1.508 . . . . 0.0 114.809 -176.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.1 m -64.48 137.48 57.89 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.04 0.936 . . . . 0.0 112.536 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.02 -12.95 54.63 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.939 1.257 . . . . 0.0 114.514 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -69.18 166.91 17.32 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 t -68.01 137.83 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 157.93 31.01 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.04 1.336 . . . . 0.0 110.335 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.07 143.35 44.6 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 111.823 -174.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.44 164.99 15.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.62 1.568 . . . . 0.0 112.813 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.57 173.8 13.42 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.229 1.395 . . . . 0.0 113.19 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.95 -32.99 12.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.666 -171.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.23 -38.32 91.74 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.641 1.109 . . . . 0.0 114.094 -172.806 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.75 -8.68 57.14 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.712 1.256 . . . . 0.0 113.35 176.069 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.8 m -96.96 -42.93 7.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.45 1.9 . . . . 0.0 110.881 174.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -155.55 127.42 7.49 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.34 1.856 . . . . 0.0 112.025 -164.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.58 -177.79 15.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.693 2.092 . . . . 0.0 112.165 168.393 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 87.2 t -145.6 142.71 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.833 2.053 . . . . 0.0 107.476 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.2 m -56.14 138.47 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 65.86 1.91 2.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.802 2.041 . . . . 0.0 114.887 175.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -106.74 139.43 20.36 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.411 1.484 . . . . 0.0 111.057 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.38 119.57 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.705 2.27 . . . . 0.0 110.314 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -101.96 134.54 45.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.179 1.392 . . . . 0.0 110.055 175.715 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 38.6 p -127.52 145.98 50.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -165.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -157.26 177.05 11.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 178.051 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.9 m -128.47 142.1 51.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 -169.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.08 131.66 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.679 1.591 . . . . 0.0 108.422 168.274 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -91.75 129.53 37.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.42 1.088 . . . . 0.0 111.024 -177.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -135.65 8.15 3.31 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.049 1.34 . . . . 0.0 113.606 -168.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.6 tptm -54.23 -37.0 64.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.307 1.843 . . . . 0.0 114.772 -168.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.12 20.13 5.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.695 1.598 . . . . 0.0 112.268 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.77 78.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.377 1.071 . . . . 0.0 113.854 -174.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.27 149.14 4.85 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.883 1.23 . . . . 0.0 112.365 -171.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.18 139.84 52.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.468 0.707 . . . . 0.0 111.815 -178.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.09 10.84 0.02 OUTLIER Glycine 0 CA--C 1.535 1.304 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.88 97.99 1.55 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.163 1.363 . . . . 0.0 112.819 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.47 127.25 31.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.817 1.247 . . . . 0.0 108.748 166.19 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 49.1 m -117.03 154.69 30.5 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 0.0 111.731 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 54.9 tp -159.57 132.49 6.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.605 1.562 . . . . 0.0 109.096 -172.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.92 159.65 36.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.062 0.945 . . . . 0.0 112.311 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.43 127.42 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.59 1.156 . . . . 0.0 109.9 175.363 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -105.6 168.01 9.38 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.897 1.679 . . . . 0.0 109.879 167.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 166.11 -161.16 34.79 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.008 -1.057 . . . . 0.0 113.717 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.1 -13.5 26.01 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.569 2.846 . . . . 0.0 112.435 176.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 9.5 t -155.08 168.25 27.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.396 1.879 . . . . 0.0 109.627 168.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -77.97 116.02 18.14 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.898 -1.126 . . . . 0.0 111.363 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -79.7 143.73 34.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.993 0.917 . . . . 0.0 110.802 166.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.64 146.73 23.54 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.236 0.615 . . . . 0.0 110.854 171.513 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.87 140.32 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.679 1.192 . . . . 0.0 110.856 -163.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -131.31 158.75 39.84 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.116 1.766 . . . . 0.0 110.628 167.31 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.9 p -151.55 153.65 34.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.165 0.986 . . . . 0.0 112.404 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.2 m -147.0 131.13 17.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.287 1.435 . . . . 0.0 110.812 -166.284 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 9.5 t0 -71.04 123.02 21.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.199 1.0 . . . . 0.0 110.986 169.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -80.96 -9.78 59.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 113.356 177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 tt0 79.2 -25.12 0.19 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 129.005 2.922 . . . . 0.0 112.696 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.61 1.9 13.23 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.447 1.899 . . . . 0.0 114.15 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.86 21.17 19.32 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 125.216 1.389 . . . . 0.0 114.081 -177.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -133.78 150.4 51.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.095 1.358 . . . . 0.0 110.411 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 82.3 m -106.66 126.1 51.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.451 1.5 . . . . 0.0 109.339 170.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -84.33 150.71 25.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.819 0.848 . . . . 0.0 110.536 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.2 t -126.85 144.87 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.844 2.058 . . . . 0.0 108.828 177.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.1 t -137.35 136.59 38.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.38 1.472 . . . . 0.0 110.277 171.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -142.89 153.74 43.42 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 177.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.5 mt -120.13 104.72 43.31 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.953 1.701 . . . . 0.0 110.073 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.55 155.49 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.481 2.787 . . . . 0.0 110.021 169.361 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.2 m -116.73 -13.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.28 156.04 26.93 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.835 1.654 . . . . 0.0 110.458 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 153.52 49.32 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.005 2.47 . . . . 0.0 112.72 -170.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.64 -151.4 23.67 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.94 1.257 . . . . 0.0 113.47 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -120.91 125.37 47.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.339 1.456 . . . . 0.0 110.718 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -110.77 149.34 30.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.93 1.692 . . . . 0.0 110.778 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 66.6 m -113.27 114.25 26.43 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.556 1.142 . . . . 0.0 110.963 -177.574 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.44 123.41 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.288 1.835 . . . . 0.0 108.882 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.53 131.88 52.38 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.549 1.54 . . . . 0.0 109.479 173.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 50.6 t -133.46 131.9 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.394 1.478 . . . . 0.0 108.289 172.418 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.21 142.96 17.57 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.852 1.261 . . . . 0.0 110.765 -167.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.66 123.58 22.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.548 1.139 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 51.43 56.96 7.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.129 1.372 . . . . 0.0 112.492 176.995 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.307 8.0 pt-20 59.62 12.95 3.1 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.189 2.596 . . . . 0.0 116.321 -177.215 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -118.96 124.62 47.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.451 1.101 . . . . 0.0 111.188 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -61.59 155.52 22.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.149 0.98 . . . . 0.0 112.785 170.787 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.92 155.94 70.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 O-C-N 121.787 -0.571 . . . . 0.0 110.427 175.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -55.4 121.19 9.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.795 2.33 . . . . 0.0 110.448 172.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -13.04 67.22 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.177 1.37 . . . . 0.0 116.316 178.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 98.7 p -80.08 153.83 74.82 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 120.552 2.176 . . . . 0.0 113.212 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.95 158.34 99.05 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.222 0.758 . . . . 0.0 112.596 -4.697 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -112.96 138.21 50.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.335 1.454 . . . . 0.0 111.345 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 21.2 m -89.9 117.42 28.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.876 0.871 . . . . 0.0 110.712 177.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.76 127.5 44.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.281 1.432 . . . . 0.0 111.392 173.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.62 138.22 46.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.534 1.533 . . . . 0.0 110.608 172.083 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.1 t -138.15 138.8 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.646 1.178 . . . . 0.0 110.818 172.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 81.1 p -130.57 165.19 23.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.535 1.134 . . . . 0.0 112.672 174.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.64 144.19 22.05 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.941 1.734 . . . . 0.0 112.909 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 CA--C 1.552 1.046 0 C-N-CA 125.239 1.416 . . . . 0.0 112.707 178.984 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A 1788 ' ' LEU . . . . . 0.482 HD11 HG12 ' A' 1860 ' ' VAL . 20.9 tp . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 110.866 -0.049 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -53.13 110.91 2.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.689 1.196 . . . . 0.0 113.5 -168.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.02 135.79 28.23 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.19 1.927 . . . . 0.0 108.937 172.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -102.43 121.31 42.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.205 0.602 . . . . 0.0 109.839 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.67 124.53 9.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.828 1.251 . . . . 0.0 110.89 175.071 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -131.72 149.18 52.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.804 2.042 . . . . 0.0 109.558 -176.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 15.0 p -123.67 135.71 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.894 1.278 . . . . 0.0 110.069 176.21 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.94 138.18 31.27 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 125.885 1.674 . . . . 0.0 108.979 -174.389 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.48 59.56 7.2 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.582 3.521 . . . . 0.0 112.216 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 40.1 t80 -100.71 151.7 21.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.529 1.532 . . . . 0.0 111.017 174.426 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.1 m -124.53 126.79 46.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.149 1.379 . . . . 0.0 109.535 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.41 128.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.792 1.237 . . . . 0.0 110.691 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 41.0 tttm -99.08 -140.17 0.32 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.945 1.698 . . . . 0.0 111.707 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -82.51 -10.63 58.93 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -175.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.42 -143.01 6.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.056 1.789 . . . . 0.0 112.628 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.46 147.44 24.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.732 1.213 . . . . 0.0 110.924 -175.325 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.7 tt -118.54 133.76 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.684 1.593 . . . . 0.0 111.148 -178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 29.1 p -150.31 170.84 18.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.197 1.799 . . . . 0.0 110.647 -174.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.47 -169.05 24.23 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 -176.356 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.77 141.86 21.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.395 1.878 . . . . 0.0 109.661 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.3 t -117.31 136.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.64 1.976 . . . . 0.0 108.12 173.324 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.57 132.2 56.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.252 1.021 . . . . 0.0 111.577 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -100.54 145.48 30.38 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.634 1.574 . . . . 0.0 111.235 -176.354 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.63 -16.89 23.74 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.673 2.916 . . . . 0.0 112.936 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 30.6 p -76.0 -2.06 28.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.369 1.467 . . . . 0.0 114.301 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.45 45.64 3.98 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.638 1.114 . . . . 0.0 113.63 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.48 170.09 18.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.282 1.433 . . . . 0.0 112.426 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.8 m -138.81 157.84 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.296 1.439 . . . . 0.0 112.159 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.6 177.6 11.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.899 2.08 . . . . 0.0 110.296 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -123.56 145.62 47.57 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 121.222 -0.924 . . . . 0.0 111.896 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -82.93 167.9 14.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.209 3.273 . . . . 0.0 111.342 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.84 126.62 53.24 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.125 1.37 . . . . 0.0 108.547 170.52 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.72 130.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.317 1.047 . . . . 0.0 108.848 175.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -121.12 128.39 52.5 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.799 1.64 . . . . 0.0 109.639 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.83 121.3 25.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.422 1.089 . . . . 0.0 110.346 173.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.11 -12.75 54.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 65.79 9.84 6.34 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.997 2.119 . . . . 0.0 114.149 -178.717 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -108.59 10.07 27.15 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.835 2.054 . . . . 0.0 112.808 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.8 15.06 62.0 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.79 1.186 . . . . 0.0 113.601 -172.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 64.2 p -132.78 160.26 37.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.544 1.938 . . . . 0.0 110.472 177.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.3 m -125.0 144.85 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.739 1.215 . . . . 0.0 109.636 166.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 85.9 m -106.96 135.55 48.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.208 1.003 . . . . 0.0 108.691 171.732 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.5 t -119.97 131.05 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.406 1.483 . . . . 0.0 108.846 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -130.9 156.44 45.05 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.404 . . . . 0.0 112.768 -174.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 9.1 t80 -153.93 137.19 15.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.667 1.587 . . . . 0.0 111.675 176.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.36 120.84 69.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.805 1.242 . . . . 0.0 111.023 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.02 155.88 26.32 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.757 2.971 . . . . 0.0 112.694 -172.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.1 p -140.66 -11.88 1.01 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -160.66 151.29 18.38 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.611 1.565 . . . . 0.0 110.55 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.02 170.44 16.68 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.893 1.277 . . . . 0.0 113.299 179.161 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.28 -172.11 14.07 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.428 1.49 . . . . 0.0 114.148 177.395 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.0 tp -82.32 134.56 35.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.636 1.175 . . . . 0.0 110.458 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 66.1 m80 -134.56 165.19 25.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 111.628 -172.653 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.15 153.49 37.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.438 1.095 . . . . 0.0 111.621 175.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.3 ttm -130.74 140.31 50.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.567 1.547 . . . . 0.0 110.889 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -107.73 131.1 54.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.425 1.49 . . . . 0.0 110.042 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.58 137.92 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.562 1.145 . . . . 0.0 109.852 167.574 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.41 144.01 37.91 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.638 1.175 . . . . 0.0 113.027 176.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -103.5 117.28 34.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.439 1.896 . . . . 0.0 109.679 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.56 30.97 9.24 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.663 1.185 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 65.8 m-80 79.09 4.56 2.32 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.662 2.785 . . . . 0.0 115.12 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.6 ttp -96.12 126.42 41.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.696 1.198 . . . . 0.0 110.206 166.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -59.11 139.12 57.21 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.172 -0.955 . . . . 0.0 113.086 -178.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.4 pt -73.76 149.85 88.26 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.375 173.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.34 -20.33 61.75 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 114.067 -171.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.77 -7.84 86.78 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 114.809 174.183 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.5 m -94.89 155.75 38.83 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.281 1.54 . . . . 0.0 113.078 177.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.22 161.48 94.61 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 118.707 0.574 . . . . 0.0 112.554 -1.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 85.0 mt -104.74 154.03 20.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.592 1.557 . . . . 0.0 110.129 172.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -145.99 139.38 26.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.663 1.185 . . . . 0.0 110.052 -177.956 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -163.4 166.13 23.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -177.344 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.9 t80 -110.16 141.52 42.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.025 0.93 . . . . 0.0 111.914 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1860 ' ' VAL . . . . . 0.482 HG12 HD11 ' A' 1788 ' ' LEU . 97.6 t -110.84 129.91 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.861 1.664 . . . . 0.0 109.085 -178.454 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.2 t0 -160.42 146.57 15.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.005 1.322 . . . . 0.0 111.841 -173.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 150.36 48.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 113.436 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.3 t -62.06 -44.38 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.289 1.036 . . . . 0.0 111.564 177.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.07 22.98 4.56 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.759 1.224 . . . . 0.0 113.407 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 31.4 p -62.39 -26.57 68.54 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 79.77 -46.81 3.18 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.997 1.761 . . . . 0.0 113.812 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -62.5 165.03 6.65 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.2 t -67.55 134.85 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.762 0.825 . . . . 0.0 109.308 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -160.33 167.7 26.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.953 1.301 . . . . 0.0 110.876 -174.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -148.03 146.31 28.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.879 1.271 . . . . 0.0 111.793 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.5 p90 -166.73 160.65 15.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.49 1.516 . . . . 0.0 113.041 -174.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.4 172.92 13.21 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.622 1.582 . . . . 0.0 112.747 -175.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.16 -32.34 6.87 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.189 2.593 . . . . 0.0 113.443 -170.591 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.06 77.07 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 0.0 114.287 -170.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.22 -2.32 37.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.678 1.239 . . . . 0.0 113.654 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.5 m -112.97 -41.47 3.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.841 2.056 . . . . 0.0 112.033 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -149.26 146.0 27.37 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.817 1.247 . . . . 0.0 112.843 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.72 179.2 21.3 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.116 1.341 . . . . 0.0 113.096 173.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.7 t -138.8 137.2 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.572 1.149 . . . . 0.0 108.661 174.404 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -55.7 141.6 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 66.2 m-80 65.9 4.95 3.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.698 1.999 . . . . 0.0 114.716 174.35 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -123.44 141.78 37.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.632 1.573 . . . . 0.0 110.766 176.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.15 135.9 25.91 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.554 2.17 . . . . 0.0 111.382 -174.029 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.28 147.14 39.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 110.262 173.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.0 p -136.72 150.85 48.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -165.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 56.0 p90 -162.29 -179.94 7.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.289 1.835 . . . . 0.0 111.507 176.528 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -129.69 143.64 50.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.37 1.468 . . . . 0.0 110.714 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 60.1 t -116.53 133.36 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.663 1.585 . . . . 0.0 108.393 170.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.33 132.92 37.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.483 1.113 . . . . 0.0 111.421 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.3 p -130.18 6.02 4.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.188 1.795 . . . . 0.0 112.89 -176.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -59.37 -20.65 56.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -165.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.63 31.83 1.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.197 1.399 . . . . 0.0 111.442 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.47 -37.34 65.81 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -175.017 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.63 153.22 9.04 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.513 1.054 . . . . 0.0 112.236 -168.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -76.78 165.01 25.31 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.745 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 160.01 -77.87 0.18 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.367 1.461 . . . . 0.0 111.457 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -176.07 114.67 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.496 1.046 . . . . 0.0 112.625 171.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.44 130.31 34.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.147 1.379 . . . . 0.0 109.32 174.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.9 m -128.27 155.91 43.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.516 1.526 . . . . 0.0 112.159 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 38.2 tp -155.11 135.45 13.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.41 1.884 . . . . 0.0 108.614 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.51 160.26 40.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.992 0.917 . . . . 0.0 112.097 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.9 mt -135.14 133.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.578 1.151 . . . . 0.0 109.614 174.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.82 110.11 13.9 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.301 1.44 . . . . 0.0 109.347 175.217 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.14 -169.73 12.75 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.918 1.247 . . . . 0.0 113.896 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.31 -18.76 38.97 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.657 2.905 . . . . 0.0 111.987 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.8 t -137.06 159.63 41.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.613 1.565 . . . . 0.0 109.211 159.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -76.86 114.52 15.72 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.85 -1.156 . . . . 0.0 111.216 -178.598 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -77.13 141.96 39.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.285 1.034 . . . . 0.0 111.547 174.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.51 146.68 26.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.004 0.521 . . . . 0.0 110.597 170.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.9 145.33 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.345 1.458 . . . . 0.0 110.277 -165.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 17.3 t -145.02 142.75 30.03 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.071 0.948 . . . . 0.0 110.695 164.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -140.44 153.86 46.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.34 1.056 . . . . 0.0 112.142 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 92.5 m -136.42 119.78 16.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.434 1.493 . . . . 0.0 109.875 -172.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -71.67 116.65 12.28 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.84 0.856 . . . . 0.0 109.774 166.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -81.24 -13.25 58.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.905 0.882 . . . . 0.0 112.844 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 70.86 -3.95 1.85 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.367 2.667 . . . . 0.0 114.072 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -87.71 2.0 52.28 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.986 1.714 . . . . 0.0 113.718 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 106.61 10.12 29.55 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.499 1.523 . . . . 0.0 114.754 -172.715 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 50.7 p -133.84 153.35 51.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.85 1.325 . . . . 0.0 112.375 173.279 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -112.46 129.69 56.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.885 1.674 . . . . 0.0 109.06 162.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.7 t -86.78 148.41 25.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 110.526 170.083 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.3 t -130.26 141.67 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.626 1.571 . . . . 0.0 110.074 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 98.2 p -136.36 148.88 48.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.57 1.548 . . . . 0.0 111.671 169.076 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.3 p90 -151.37 156.1 40.03 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 5.5 mt -122.0 107.4 35.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.742 1.617 . . . . 0.0 110.684 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.82 169.87 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.907 3.072 . . . . 0.0 110.452 167.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 10.8 p -135.01 -23.91 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.29 151.0 57.14 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.916 1.287 . . . . 0.0 110.495 175.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.19 153.91 41.24 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -168.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.23 -163.83 28.06 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.371 1.462 . . . . 0.0 112.534 -174.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.08 125.33 52.02 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.438 1.095 . . . . 0.0 111.338 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.26 129.68 55.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.787 2.035 . . . . 0.0 109.941 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.2 m -88.38 126.36 35.17 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.977 -1.077 . . . . 0.0 111.053 177.252 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.98 124.97 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 108.365 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -109.21 129.18 55.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.302 1.441 . . . . 0.0 109.708 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.0 t -131.94 129.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.434 1.094 . . . . 0.0 109.692 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.44 143.42 23.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.894 1.278 . . . . 0.0 111.721 -167.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.87 122.69 18.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.76 1.224 . . . . 0.0 109.587 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.2 t-20 55.04 56.94 6.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.197 1.399 . . . . 0.0 111.876 176.826 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 7.7 pt-20 58.82 8.43 0.95 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.653 2.781 . . . . 0.0 116.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.98 123.55 50.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.426 1.09 . . . . 0.0 110.884 177.522 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -63.34 145.24 55.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.549 -0.72 . . . . 0.0 111.742 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 11.3 m -72.5 157.67 88.66 Favored Pre-proline 0 N--CA 1.479 1.008 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.608 172.691 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -54.39 126.89 23.75 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 0.0 111.932 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.24 63.73 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.817 1.198 . . . . 0.0 115.375 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.7 t -75.59 140.14 71.44 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.437 1.618 . . . . 0.0 111.404 176.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.09 137.28 49.36 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 119.459 0.843 . . . . 0.0 112.101 -3.342 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -86.91 175.21 8.28 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.143 1.777 . . . . 0.0 110.725 174.176 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -136.78 119.66 16.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.765 0.826 . . . . 0.0 110.824 178.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.59 129.06 49.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.377 1.471 . . . . 0.0 110.806 174.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -91.13 125.03 35.79 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.955 -0.466 . . . . 0.0 110.557 173.87 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.6 t -107.09 129.2 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.525 1.53 . . . . 0.0 109.896 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.2 p -106.55 165.8 11.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.848 1.259 . . . . 0.0 112.538 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.37 144.09 29.04 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.751 1.167 . . . . 0.0 112.271 176.373 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 124.572 1.149 . . . . 0.0 113.018 176.544 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.314 0.578 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -60.51 117.81 28.24 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.627 1.571 . . . . 0.0 110.672 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.19 144.38 56.87 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.765 2.31 . . . . 0.0 109.746 178.371 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 34.0 t80 -109.92 129.32 55.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.444 0.697 . . . . 0.0 111.424 -174.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -155.79 145.61 21.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.462 1.505 . . . . 0.0 111.2 174.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.16 144.33 30.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.973 1.709 . . . . 0.0 110.008 -171.474 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.7 p -113.94 137.11 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 0.0 110.103 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.6 mt -133.71 135.41 24.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.924 1.689 . . . . 0.0 109.172 -172.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.39 96.13 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.731 2.954 . . . . 0.0 109.927 173.546 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 58.0 t80 -159.4 152.74 22.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.209 2.204 . . . . 0.0 108.523 -178.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.62 126.9 37.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.323 1.049 . . . . 0.0 109.868 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.6 mt -78.98 116.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.025 0.93 . . . . 0.0 109.71 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -98.68 -152.66 0.41 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.473 1.509 . . . . 0.0 110.882 172.697 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -70.93 122.23 19.58 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.635 -1.29 . . . . 0.0 111.03 171.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.0 -150.37 21.45 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.613 1.578 . . . . 0.0 111.986 -170.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -159.54 145.92 16.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 111.168 -175.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.7 tt -123.74 138.78 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.633 1.573 . . . . 0.0 110.965 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.3 p -146.51 170.77 16.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.95 1.7 . . . . 0.0 110.534 -177.789 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.51 -171.43 27.54 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -177.529 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -154.42 144.93 22.24 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.427 1.891 . . . . 0.0 109.637 176.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 74.3 t -120.3 132.58 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.929 1.692 . . . . 0.0 108.777 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -105.27 134.8 47.77 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.824 1.25 . . . . 0.0 111.713 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 9.4 mtm -101.82 140.11 20.92 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.697 1.599 . . . . 0.0 110.846 174.487 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -56.09 -30.13 77.54 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.084 3.189 . . . . 0.0 115.017 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.8 p -74.67 2.37 10.07 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.022 1.729 . . . . 0.0 114.375 178.224 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.28 62.94 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.716 1.627 . . . . 0.0 114.837 172.05 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -73.82 159.0 33.51 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.498 1.119 . . . . 0.0 111.898 175.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 19.3 m -139.65 150.83 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.491 1.516 . . . . 0.0 110.837 172.64 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.15 172.55 18.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.394 1.877 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -115.63 141.58 27.6 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.208 -0.933 . . . . 0.0 112.152 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.18 167.65 15.68 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.11 3.207 . . . . 0.0 111.317 174.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.04 130.32 55.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.044 1.338 . . . . 0.0 108.923 172.594 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.79 133.55 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.823 1.249 . . . . 0.0 109.437 177.109 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.8 m -133.41 127.63 33.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.605 1.562 . . . . 0.0 109.756 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.42 128.6 33.55 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.751 0.821 . . . . 0.0 110.625 172.008 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.48 -9.33 59.47 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.038 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.1 mttt 72.23 0.95 3.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.193 2.597 . . . . 0.0 114.088 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -97.41 3.7 50.87 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.682 1.993 . . . . 0.0 113.143 174.289 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.12 16.17 39.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.983 1.278 . . . . 0.0 114.426 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.7 p -127.96 156.65 42.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.206 1.802 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.5 m -112.74 144.94 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.809 0.844 . . . . 0.0 109.816 164.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 61.6 m -104.94 134.82 47.41 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.53 1.132 . . . . 0.0 108.435 166.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.6 t -114.04 135.78 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.561 1.544 . . . . 0.0 108.704 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -132.49 151.8 51.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 112.128 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 57.6 t80 -155.45 137.17 14.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.299 1.44 . . . . 0.0 112.306 -178.452 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -93.74 120.49 66.01 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.635 1.174 . . . . 0.0 111.109 177.024 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.65 150.52 24.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.664 2.909 . . . . 0.0 111.99 -178.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 87.6 p -122.95 -13.32 7.85 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -166.71 148.87 6.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.013 1.725 . . . . 0.0 110.206 -171.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.98 165.5 25.17 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.079 0.952 . . . . 0.0 113.348 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 128.62 179.5 15.95 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 125.484 1.516 . . . . 0.0 114.505 176.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.1 tp -85.9 107.65 17.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 110.402 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 25.8 m80 -100.48 169.79 8.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.686 1.594 . . . . 0.0 111.665 -176.601 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -141.59 149.13 40.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.897 0.879 . . . . 0.0 111.208 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.1 ttm -118.19 128.73 54.99 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.63 1.972 . . . . 0.0 110.018 -178.297 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.64 131.39 53.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.165 2.186 . . . . 0.0 109.385 173.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.9 mm -135.05 135.81 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.505 1.122 . . . . 0.0 110.466 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.04 139.73 26.29 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.21 123.97 47.73 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.89 2.076 . . . . 0.0 109.93 176.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 52.16 32.17 10.17 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.745 1.218 . . . . 0.0 112.535 -173.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.5 t30 75.56 6.15 4.0 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.076 2.55 . . . . 0.0 115.108 -178.427 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.8 mtm -104.41 132.66 50.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.739 1.616 . . . . 0.0 110.943 173.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.3 135.77 44.19 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.3 pt -75.82 154.54 85.13 Favored Pre-proline 0 N--CA 1.478 0.956 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.004 170.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.19 127.5 23.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.069 1.846 . . . . 0.0 109.302 170.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.58 -14.13 57.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.418 -175.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.8 t -82.78 143.2 46.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 119.812 1.806 . . . . 0.0 111.533 172.492 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.57 163.63 80.76 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.719 0.935 . . . . 0.0 112.28 -8.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.2 mt -113.27 156.6 23.04 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.157 1.783 . . . . 0.0 110.881 175.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -128.08 142.54 51.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.952 1.301 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 31.7 p90 -158.51 150.56 21.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.63 1.172 . . . . 0.0 112.056 -174.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 41.6 t80 -103.76 131.53 50.86 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.193 -0.942 . . . . 0.0 112.678 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.1 t -102.26 137.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.586 1.554 . . . . 0.0 108.852 176.741 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.63 160.68 31.94 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.638 1.175 . . . . 0.0 111.628 -169.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -75.45 117.43 17.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.007 0.923 . . . . 0.0 111.028 177.316 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.2 p -81.5 -23.63 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.025 0.93 . . . . 0.0 113.193 -168.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -83.36 -14.31 53.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.441 1.096 . . . . 0.0 113.547 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.4 m -72.77 156.66 38.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.72 1.208 . . . . 0.0 112.663 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.21 -14.77 68.23 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.467 1.032 . . . . 0.0 115.134 -173.982 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -64.51 154.63 35.37 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.793 1.296 . . . . 0.0 113.438 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 22.0 t -68.57 132.5 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.096 0.958 . . . . 0.0 109.38 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.8 t -154.1 146.72 24.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.461 1.105 . . . . 0.0 110.42 -176.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.44 141.96 51.77 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.746 1.219 . . . . 0.0 111.898 -172.488 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.0 p90 -168.07 164.8 13.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.314 1.446 . . . . 0.0 113.61 -175.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.07 172.18 12.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.653 1.597 . . . . 0.0 112.27 -176.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.4 -38.92 13.74 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.753 2.302 . . . . 0.0 112.422 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.57 89.62 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.799 -1.001 . . . . 0.0 115.14 -170.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -78.0 -3.59 42.82 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.444 1.622 . . . . 0.0 113.776 175.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.5 m -105.89 -61.46 1.5 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.172 1.789 . . . . 0.0 110.144 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -127.7 133.19 49.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.619 1.967 . . . . 0.0 111.502 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.02 177.02 16.83 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.166 1.365 . . . . 0.0 112.041 171.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 7.5 p -153.52 138.18 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.137 0.975 . . . . 0.0 109.451 176.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 29.3 m -60.68 152.93 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -170.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 34.1 m120 70.27 11.53 7.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.826 2.05 . . . . 0.0 114.738 166.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -147.03 156.97 47.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.524 1.529 . . . . 0.0 111.36 176.14 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.94 132.48 16.97 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.413 2.075 . . . . 0.0 111.586 -177.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.83 146.85 28.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.074 1.75 . . . . 0.0 109.784 167.707 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 40.1 p -132.19 149.13 52.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -164.181 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.23 177.24 11.26 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.84 1.656 . . . . 0.0 111.486 175.086 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -134.27 145.58 49.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.501 1.52 . . . . 0.0 110.336 -170.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.9 t -116.49 128.11 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.209 1.404 . . . . 0.0 108.221 168.848 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.33 131.41 35.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.719 177.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 53.7 p -134.01 12.11 3.94 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 112.812 -169.196 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.5 tptt -53.76 -40.41 66.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.21 1.804 . . . . 0.0 115.267 -162.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -110.54 1.88 18.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.076 1.35 . . . . 0.0 113.364 -178.255 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.8 -65.43 0.97 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.155 0.982 . . . . 0.0 111.127 178.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 69.97 0.99 30.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.795 1.878 . . . . 0.0 117.795 162.961 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -160.32 143.22 13.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.883 1.842 . . . . 0.0 111.731 -172.463 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 102.8 -173.7 22.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.868 1.699 . . . . 0.0 113.02 -177.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -94.83 114.66 4.89 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 124.231 0.92 . . . . 0.0 111.813 177.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.48 133.2 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.013 1.325 . . . . 0.0 108.751 168.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -140.2 161.53 37.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.46 1.504 . . . . 0.0 112.034 -168.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -166.35 139.34 3.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.617 1.567 . . . . 0.0 110.027 -162.37 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.85 163.26 34.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.902 1.281 . . . . 0.0 111.625 173.537 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 59.0 mt -136.43 134.0 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.298 1.039 . . . . 0.0 109.677 173.207 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.06 117.42 31.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.589 1.156 . . . . 0.0 109.519 170.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.58 179.26 16.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.928 1.251 . . . . 0.0 114.066 -177.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.27 -26.67 41.63 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.062 3.175 . . . . 0.0 111.753 172.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -137.51 154.87 49.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.57 1.548 . . . . 0.0 108.506 158.246 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.3 tttt -69.84 121.73 17.87 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.877 -1.139 . . . . 0.0 112.069 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.91 149.31 36.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 111.216 167.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -86.12 144.45 27.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.281 0.633 . . . . 0.0 109.647 166.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -133.69 139.49 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.797 1.239 . . . . 0.0 110.309 -167.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 72.8 m -135.17 157.21 47.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.689 1.596 . . . . 0.0 110.838 169.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -154.82 157.18 37.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.35 1.06 . . . . 0.0 112.484 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -143.48 125.72 15.55 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.125 1.37 . . . . 0.0 110.61 -171.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.77 131.6 40.93 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.944 1.297 . . . . 0.0 110.732 171.372 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -109.06 142.92 39.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.627 1.171 . . . . 0.0 111.723 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.43 -14.81 63.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.45 -11.69 60.78 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 113.905 177.058 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.78 36.08 5.66 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.914 1.245 . . . . 0.0 113.674 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.4 p -140.75 166.49 24.62 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.91 1.684 . . . . 0.0 110.424 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 76.3 m -120.53 129.79 53.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.685 1.594 . . . . 0.0 108.966 165.818 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.4 t -91.74 150.54 21.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.975 0.91 . . . . 0.0 110.808 172.257 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 77.6 t -134.97 141.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.686 1.594 . . . . 0.0 110.273 -176.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 53.0 m -132.67 140.37 48.12 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 110.552 172.028 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -145.18 148.23 33.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.134 -0.979 . . . . 0.0 113.19 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.2 tt -118.67 99.81 51.25 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.789 1.236 . . . . 0.0 110.006 -173.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -83.15 153.54 14.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.753 2.969 . . . . 0.0 111.279 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.0 m -116.54 -11.45 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -167.55 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.05 151.2 22.47 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.374 1.469 . . . . 0.0 110.537 177.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 142.99 28.29 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.918 2.412 . . . . 0.0 111.713 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.29 -165.0 32.7 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.518 1.056 . . . . 0.0 113.493 -176.133 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -99.44 124.43 44.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 112.327 -179.206 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -120.18 127.42 52.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.828 1.651 . . . . 0.0 110.431 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.8 m -92.06 114.46 27.01 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.951 -1.093 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.05 121.35 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.97 1.708 . . . . 0.0 108.777 177.349 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.91 134.92 45.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.778 1.631 . . . . 0.0 109.107 176.009 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 61.5 t -139.43 131.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.723 1.209 . . . . 0.0 109.126 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.2 tmmt? -154.73 143.39 20.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.911 1.285 . . . . 0.0 110.946 -165.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.82 121.06 10.86 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.552 1.141 . . . . 0.0 109.498 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.42 55.81 4.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.243 1.417 . . . . 0.0 111.599 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.0 pt-20 55.8 18.23 2.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.084 2.554 . . . . 0.0 115.94 -177.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -125.35 125.28 43.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.079 1.352 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.667 0.787 . . . . 0.0 112.499 171.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.7 m -74.39 155.53 87.67 Favored Pre-proline 0 N--CA 1.479 1.023 0 O-C-N 121.669 -0.644 . . . . 0.0 110.863 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -55.79 123.74 14.57 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.625 2.217 . . . . 0.0 110.343 172.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -15.42 63.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 178.142 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.1 p -79.52 151.76 74.9 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.177 1.988 . . . . 0.0 112.753 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.17 153.43 98.9 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.274 0.776 . . . . 0.0 112.9 -1.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -107.72 132.99 52.77 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.208 1.403 . . . . 0.0 110.49 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 58.6 m -88.86 108.93 19.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.374 0.67 . . . . 0.0 110.541 178.514 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.53 132.23 34.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.773 170.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.34 115.28 27.48 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 0.0 109.263 174.69 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -93.73 134.4 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.75 1.22 . . . . 0.0 109.894 177.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.6 p -111.01 166.89 10.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.165 1.386 . . . . 0.0 112.964 177.688 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.47 141.37 22.85 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.103 1.335 . . . . 0.0 112.137 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 CA--C 1.546 0.809 0 C-N-CA 124.627 1.171 . . . . 0.0 113.225 179.876 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 26.5 tp . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -52.13 115.92 7.55 Favored Pre-proline 0 N--CA 1.479 0.993 0 CA-C-O 118.25 -0.881 . . . . 0.0 112.82 -165.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.28 138.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.373 2.049 . . . . 0.0 108.824 174.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 56.7 t80 -130.74 125.37 33.67 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 111.575 -171.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -157.43 139.42 14.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.771 1.629 . . . . 0.0 110.795 176.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.1 mm? -130.9 157.24 43.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.981 2.112 . . . . 0.0 110.0 -175.088 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.07 136.81 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.916 1.286 . . . . 0.0 109.901 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.1 mt -133.01 134.41 24.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.749 1.62 . . . . 0.0 109.038 -169.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.65 114.08 3.84 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.221 2.614 . . . . 0.0 109.795 173.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.7 t80 -175.24 148.45 0.97 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.389 1.876 . . . . 0.0 110.23 -171.008 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.2 m -128.6 128.29 43.93 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.72 1.208 . . . . 0.0 110.103 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.7 mt -89.76 135.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.672 1.189 . . . . 0.0 109.12 172.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.4 tptt -132.15 -58.36 0.95 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.105 0.962 . . . . 0.0 112.574 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.6 tttp -157.37 131.01 8.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.985 1.714 . . . . 0.0 110.55 179.347 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 121.14 -148.45 17.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 125.286 1.422 . . . . 0.0 111.485 -166.332 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.06 144.88 17.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -175.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.2 tt -121.52 136.2 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.779 1.632 . . . . 0.0 111.081 177.561 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 39.4 p -146.56 178.71 8.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.365 1.866 . . . . 0.0 110.259 -177.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.49 -168.46 30.6 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.319 0.887 . . . . 0.0 115.319 -179.179 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.96 146.39 23.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.87 1.668 . . . . 0.0 109.927 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 95.1 t -125.74 131.13 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.729 1.612 . . . . 0.0 108.327 173.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.7 mtm105 -119.66 138.33 53.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.651 1.18 . . . . 0.0 111.669 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 23.5 mtt -111.8 151.32 43.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.775 1.63 . . . . 0.0 111.764 -169.608 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -53.84 -38.76 85.81 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.093 3.195 . . . . 0.0 115.052 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -77.25 4.01 11.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -176.376 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.92 80.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.302 1.43 . . . . 0.0 114.155 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 152.01 44.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.15 1.38 . . . . 0.0 111.512 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.2 t -142.68 143.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.172 1.389 . . . . 0.0 109.981 -174.256 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.03 179.21 7.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.262 1.825 . . . . 0.0 110.984 177.246 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.66 143.98 43.24 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.928 0.891 . . . . 0.0 111.241 175.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.63 165.17 16.03 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.149 3.232 . . . . 0.0 111.41 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 89.9 m -106.41 124.09 49.06 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.222 1.409 . . . . 0.0 108.685 172.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.93 134.22 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.548 1.139 . . . . 0.0 109.213 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.1 m -135.41 122.63 21.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.495 1.518 . . . . 0.0 109.382 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.76 133.76 41.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.101 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.9 -12.08 45.8 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.5 mttm 69.79 6.91 5.96 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.333 2.253 . . . . 0.0 113.821 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.57 8.3 35.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.163 2.185 . . . . 0.0 112.804 179.319 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 94.22 14.42 51.35 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.169 1.366 . . . . 0.0 114.156 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.5 p -130.9 156.71 44.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.085 1.754 . . . . 0.0 110.774 176.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 30.0 m -119.22 138.87 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.291 1.036 . . . . 0.0 109.797 166.571 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 47.6 m -97.09 141.97 29.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.93 1.292 . . . . 0.0 108.604 171.027 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.1 t -126.59 132.19 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.045 1.338 . . . . 0.0 109.269 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.27 152.96 48.26 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.713 1.605 . . . . 0.0 111.693 -172.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 13.6 t80 -153.51 129.63 10.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.249 1.419 . . . . 0.0 111.327 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -79.76 121.43 82.35 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.102 0.961 . . . . 0.0 110.098 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.0 130.05 12.91 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 0.0 111.768 -170.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 74.2 m -126.0 -0.33 7.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.615 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -161.67 152.68 18.15 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.304 1.442 . . . . 0.0 111.021 -178.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -93.79 164.84 12.97 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.479 1.112 . . . . 0.0 112.683 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 102.28 -164.18 16.83 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.315 1.436 . . . . 0.0 113.9 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 26.4 tp -84.55 121.94 28.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.944 1.297 . . . . 0.0 110.95 -178.099 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 52.7 m80 -118.17 167.74 11.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.585 1.954 . . . . 0.0 111.316 -175.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -146.47 150.71 36.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.509 0.671 . . . . 0.0 112.571 167.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 10.6 ttm -119.91 131.89 55.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.655 2.382 . . . . 0.0 110.008 -174.616 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -102.05 139.3 37.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.812 1.645 . . . . 0.0 110.037 168.216 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -138.15 133.77 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.961 1.305 . . . . 0.0 109.268 173.519 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.64 138.55 23.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -102.41 119.35 38.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.025 2.13 . . . . 0.0 109.462 176.513 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 50.92 35.85 13.48 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.72 1.208 . . . . 0.0 112.829 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 6.7 t-20 82.71 -7.73 1.23 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.896 2.878 . . . . 0.0 114.69 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.0 mtp -94.11 129.49 40.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.831 1.252 . . . . 0.0 111.466 176.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.05 137.69 56.65 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.263 -0.898 . . . . 0.0 113.289 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.88 154.04 83.03 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.366 0.666 . . . . 0.0 111.501 176.412 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.63 135.53 57.24 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.479 2.119 . . . . 0.0 110.615 175.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 91.98 -13.95 65.61 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.646 1.117 . . . . 0.0 114.716 -175.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.1 m -96.52 158.7 33.31 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.463 1.631 . . . . 0.0 112.092 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.82 167.81 78.33 Favored 'Cis proline' 0 C--N 1.354 0.848 0 CA-C-N 119.827 0.974 . . . . 0.0 112.842 -2.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 98.8 mt -120.97 143.16 49.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.502 1.521 . . . . 0.0 110.994 -174.901 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -125.68 137.87 53.87 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.921 1.288 . . . . 0.0 110.374 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.99 152.04 24.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.565 1.146 . . . . 0.0 112.545 -166.079 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -103.91 148.28 26.35 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.291 -0.88 . . . . 0.0 112.945 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 25.5 t -129.73 137.42 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.311 1.444 . . . . 0.0 110.206 -177.054 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -165.81 145.21 6.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.746 1.618 . . . . 0.0 112.14 -163.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -71.22 133.97 46.53 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.433 -1.417 . . . . 0.0 113.237 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.8 p -63.74 -29.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -175.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.75 0.12 57.51 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.667 1.187 . . . . 0.0 113.775 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -66.69 140.15 57.88 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.216 -0.928 . . . . 0.0 111.919 -177.412 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.32 78.14 2.04 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.952 1.263 . . . . 0.0 112.334 -173.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -163.26 168.74 20.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.511 1.524 . . . . 0.0 113.795 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.4 p -67.37 146.2 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.749 0.819 . . . . 0.0 109.34 157.226 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.0 t -164.24 165.97 21.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.375 1.47 . . . . 0.0 110.637 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.69 147.78 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.54 1.136 . . . . 0.0 112.444 -176.096 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.6 p90 -166.02 160.11 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 112.623 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.65 170.49 12.1 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.347 1.451 . . . . 0.0 113.189 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.95 -30.86 32.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.241 2.628 . . . . 0.0 112.854 -170.754 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.9 -16.15 72.24 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 119.318 0.963 . . . . 0.0 114.703 -178.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.04 -13.75 59.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.939 1.369 . . . . 0.0 112.92 170.197 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 62.1 m -117.16 -38.97 3.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.43 1.892 . . . . 0.0 111.905 -166.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -147.35 159.64 43.45 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.903 2.081 . . . . 0.0 111.823 -171.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.2 175.92 33.77 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.313 0.959 . . . . 0.0 112.908 169.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 24.2 t -139.61 135.92 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 108.758 173.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.3 m -57.12 139.04 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 66.08 3.98 2.89 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.96 2.104 . . . . 0.0 114.926 173.139 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -119.43 144.63 36.98 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.697 1.599 . . . . 0.0 110.923 176.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.72 125.07 10.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 111.094 -174.268 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.95 146.73 27.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.298 1.439 . . . . 0.0 110.137 170.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 62.9 p -136.19 154.46 50.94 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -164.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1886 ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.3 p90 -164.09 172.07 14.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.229 1.812 . . . . 0.0 111.595 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.5 m -125.04 141.53 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.453 1.501 . . . . 0.0 110.565 -174.17 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.19 128.7 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.801 168.291 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -90.64 122.01 33.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 0.0 109.871 172.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 44.9 p -122.36 2.82 9.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.456 1.902 . . . . 0.0 113.251 -171.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 62.2 tttp -51.74 -37.37 50.85 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.861 1.664 . . . . 0.0 114.116 -176.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 1.52 31.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.308 1.443 . . . . 0.0 113.632 179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.22 -23.44 61.24 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.87 -91.64 1.42 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.712 1.149 . . . . 0.0 112.553 175.464 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.36 171.66 17.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.717 1.607 . . . . 0.0 112.231 -173.993 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 113.53 -166.89 12.19 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.929 1.728 . . . . 0.0 111.976 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -90.54 118.0 5.23 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 124.269 0.937 . . . . 0.0 112.262 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.45 128.67 34.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 108.484 164.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.9 m -127.78 157.98 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.372 1.469 . . . . 0.0 111.822 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.6 tp -159.6 133.73 7.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.598 1.559 . . . . 0.0 109.12 -169.22 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.91 162.52 38.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.293 1.037 . . . . 0.0 112.017 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.61 134.13 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.523 1.129 . . . . 0.0 109.751 175.075 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -114.67 159.19 20.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.634 1.573 . . . . 0.0 109.918 168.151 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.64 -163.39 35.99 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.416 -0.802 . . . . 0.0 113.572 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.29 -16.11 28.14 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.543 2.829 . . . . 0.0 112.716 177.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -152.49 160.15 43.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.064 1.746 . . . . 0.0 109.418 168.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -75.63 114.73 14.54 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.894 -1.129 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.18 148.04 44.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.902 0.881 . . . . 0.0 111.259 168.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.38 144.63 25.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.642 0.777 . . . . 0.0 109.967 170.677 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.48 144.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 110.719 -166.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.7 t -142.37 157.64 44.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.02 1.328 . . . . 0.0 110.713 166.848 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.8 p -155.65 154.92 32.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 112.764 -176.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.5 m -140.74 123.41 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.352 1.461 . . . . 0.0 110.246 -171.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -72.42 120.51 18.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 110.077 166.572 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.02 -10.31 57.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.769 0.827 . . . . 0.0 112.933 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 76.08 -28.37 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.583 2.753 . . . . 0.0 112.581 178.18 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -73.83 10.68 1.06 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.293 2.237 . . . . 0.0 114.68 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.51 16.99 32.51 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.234 1.397 . . . . 0.0 114.198 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 77.7 p -138.7 154.14 48.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.301 1.44 . . . . 0.0 111.325 175.651 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.0 m -119.49 134.28 55.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.001 1.721 . . . . 0.0 109.309 166.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.1 t -94.87 150.4 20.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 110.837 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1922 ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' A' 1886 ' ' PHE . 66.7 t -132.22 143.05 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.363 1.465 . . . . 0.0 110.405 -179.165 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 58.9 m -131.89 141.76 49.46 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.143 1.777 . . . . 0.0 110.748 171.315 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.7 p90 -147.01 152.36 38.47 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.81 102.82 49.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.852 2.061 . . . . 0.0 110.422 -178.055 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.77 160.08 16.29 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.683 2.922 . . . . 0.0 110.303 168.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 33.4 m -121.55 -10.12 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -168.49 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.77 152.72 24.66 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.267 1.427 . . . . 0.0 110.412 178.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.98 143.79 23.37 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.891 2.394 . . . . 0.0 111.729 -172.97 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 153.64 -172.09 32.43 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.07 1.319 . . . . 0.0 113.252 -174.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.83 129.3 37.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.006 1.322 . . . . 0.0 112.288 176.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -121.52 140.82 51.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.033 1.733 . . . . 0.0 110.341 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 72.2 m -106.49 113.39 26.87 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.997 1.319 . . . . 0.0 110.45 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -92.74 121.75 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.135 1.374 . . . . 0.0 108.514 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.2 tt -100.28 128.18 46.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.484 1.514 . . . . 0.0 109.362 175.777 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -129.71 130.61 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.232 1.013 . . . . 0.0 109.671 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.57 143.14 23.59 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.954 1.302 . . . . 0.0 112.087 -167.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.51 124.79 24.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 0.0 109.787 176.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 53.84 56.32 7.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.122 1.369 . . . . 0.0 112.033 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.301 8.2 pt-20 58.91 3.32 0.31 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 128.957 2.903 . . . . 0.0 116.809 -176.101 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -109.27 126.07 52.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.0 110.661 178.329 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m170 -62.0 144.13 55.56 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.221 -0.924 . . . . 0.0 111.716 172.424 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.3 m -70.32 152.11 95.64 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.445 172.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.49 127.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.665 2.243 . . . . 0.0 110.696 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.44 -13.07 67.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.147 1.356 . . . . 0.0 115.316 -176.301 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.1 t -75.1 141.36 74.38 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.335 1.567 . . . . 0.0 111.713 176.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.86 146.59 81.79 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 119.613 0.898 . . . . 0.0 112.385 -3.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -99.74 139.87 34.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.686 1.594 . . . . 0.0 111.155 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 5.9 m -98.91 108.0 20.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.894 0.878 . . . . 0.0 111.048 -176.26 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.64 126.13 45.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.29 175.12 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -93.21 115.13 27.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.304 0.641 . . . . 0.0 110.425 176.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.7 t -91.5 136.57 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.803 1.641 . . . . 0.0 110.461 -177.078 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 8.7 m -113.53 153.77 28.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.057 1.743 . . . . 0.0 111.094 -171.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.23 137.53 23.02 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.928 0.775 . . . . 0.0 111.802 172.056 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 39.1 t70 . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 124.087 0.955 . . . . 0.0 113.315 -178.474 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 120.876 0.37 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -67.2 122.95 85.09 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.736 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.01 150.52 60.75 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.006 2.471 . . . . 0.0 110.86 179.526 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1791 ' ' PHE . . . . . 0.4 ' CE1' HD23 ' A' 1793 ' ' LEU . 20.4 t80 -107.0 128.51 54.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.381 0.672 . . . . 0.0 111.103 178.108 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -151.76 136.37 17.01 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.328 1.451 . . . . 0.0 110.723 173.046 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1793 ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' 1791 ' ' PHE . 0.4 OUTLIER -140.57 153.85 46.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.604 1.962 . . . . 0.0 109.724 -173.42 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -129.29 137.48 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.987 1.315 . . . . 0.0 110.363 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.47 137.55 29.26 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.166 1.787 . . . . 0.0 108.586 -173.207 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 52.39 4.28 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.417 3.411 . . . . 0.0 112.775 -178.117 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 44.2 t80 -95.68 150.05 20.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.262 1.425 . . . . 0.0 111.212 174.075 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 93.1 m -119.79 124.0 45.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.793 1.237 . . . . 0.0 109.897 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.3 mt -91.12 139.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.276 1.43 . . . . 0.0 109.74 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -148.69 -43.99 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -177.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 tttm -164.23 123.77 1.98 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.246 1.418 . . . . 0.0 111.601 178.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 123.74 -157.2 18.13 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.868 1.699 . . . . 0.0 111.764 -168.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -141.4 150.09 41.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.819 1.247 . . . . 0.0 111.457 -176.449 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.3 tt -127.68 135.24 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.718 1.607 . . . . 0.0 111.099 176.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.8 p -146.7 176.4 9.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.014 1.726 . . . . 0.0 109.953 176.783 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -164.99 -170.72 30.32 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 178.678 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -155.98 145.9 21.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.841 1.656 . . . . 0.0 110.194 -176.266 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 61.8 t -126.53 137.2 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.472 1.909 . . . . 0.0 108.944 178.672 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -116.63 131.36 56.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.666 1.586 . . . . 0.0 111.879 -173.277 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -102.42 148.25 35.19 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.804 1.641 . . . . 0.0 111.698 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.87 -28.6 68.69 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.283 3.322 . . . . 0.0 114.922 174.154 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 37.9 p -72.8 -5.95 41.52 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.492 1.517 . . . . 0.0 114.359 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.1 -5.09 81.59 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.473 1.511 . . . . 0.0 113.67 -175.561 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.68 159.18 32.64 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.347 1.073 . . . . 0.0 111.888 174.388 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.9 m -138.33 154.43 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.245 1.418 . . . . 0.0 111.384 174.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.55 171.6 19.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.396 1.879 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -117.19 141.44 28.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.651 0.781 . . . . 0.0 111.421 178.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -86.34 172.15 7.24 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.269 3.313 . . . . 0.0 111.93 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.5 m -103.01 130.69 50.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.925 1.29 . . . . 0.0 108.793 170.665 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.1 132.71 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 0.0 108.819 172.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.6 m -124.54 128.25 48.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.195 1.798 . . . . 0.0 109.746 -178.135 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.1 t0 -80.45 119.32 22.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.15 0.98 . . . . 0.0 110.276 171.514 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -81.73 -11.18 59.14 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.202 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.5 mmmt 72.48 -3.84 2.22 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 128.046 2.538 . . . . 0.0 114.007 -178.408 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -97.35 6.12 48.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.672 1.989 . . . . 0.0 113.41 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 89.52 16.02 57.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.722 1.153 . . . . 0.0 113.491 -172.101 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 48.5 p -130.86 159.55 37.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.611 1.965 . . . . 0.0 110.154 175.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -123.18 143.75 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.621 1.168 . . . . 0.0 109.928 168.107 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 24.1 m -104.74 139.86 38.92 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.729 1.212 . . . . 0.0 108.796 172.442 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 29.3 t -121.57 134.59 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.453 1.501 . . . . 0.0 108.664 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.78 149.22 50.38 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.078 1.351 . . . . 0.0 112.433 -173.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 29.8 t80 -150.83 131.1 13.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.418 1.487 . . . . 0.0 111.812 178.347 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.7 120.73 73.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.632 1.173 . . . . 0.0 110.825 176.774 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.06 146.17 20.02 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.71 2.94 . . . . 0.0 112.427 -170.354 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 84.3 p -128.4 -11.71 5.09 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 174.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -147.63 152.3 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.28 1.832 . . . . 0.0 110.487 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.45 168.17 12.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.368 1.067 . . . . 0.0 111.926 169.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.71 -173.45 14.74 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.463 1.506 . . . . 0.0 114.15 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.3 tp -82.06 114.83 20.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.695 1.198 . . . . 0.0 110.249 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 48.1 m80 -110.55 165.62 11.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 111.429 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.61 154.44 45.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.198 0.999 . . . . 0.0 111.103 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.5 ttm -138.35 137.78 37.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.846 1.658 . . . . 0.0 110.439 -171.018 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -121.21 121.1 37.05 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.509 1.924 . . . . 0.0 109.386 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -125.9 132.59 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.578 1.151 . . . . 0.0 110.158 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.41 136.55 26.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -172.034 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 11.6 t80 -106.13 125.16 50.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.455 1.902 . . . . 0.0 110.004 175.414 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 51.48 37.0 18.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.776 1.23 . . . . 0.0 112.569 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 57.0 t30 82.99 -9.42 1.09 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 129.081 2.952 . . . . 0.0 114.768 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 26.5 mmt -101.94 136.19 42.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.917 1.287 . . . . 0.0 111.819 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.22 136.42 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.218 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.59 152.65 91.67 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.178 175.484 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -57.41 124.34 15.9 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.085 2.523 . . . . 0.0 111.092 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 96.92 -11.28 66.12 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.933 1.254 . . . . 0.0 114.836 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.16 149.4 39.8 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 120.029 1.915 . . . . 0.0 111.099 173.268 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.15 162.1 92.74 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.778 1.314 . . . . 0.0 113.311 1.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.7 mt -113.42 157.15 22.28 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.179 1.792 . . . . 0.0 111.349 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.62 140.11 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.099 1.36 . . . . 0.0 109.458 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.55 163.46 17.01 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.389 1.075 . . . . 0.0 112.112 -169.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -104.29 135.11 46.37 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.188 -0.945 . . . . 0.0 113.028 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.1 t -103.17 139.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.335 1.454 . . . . 0.0 108.426 171.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.9 t0 -150.87 165.89 32.23 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.344 1.058 . . . . 0.0 111.875 -172.886 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -78.05 138.51 38.81 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.843 0.857 . . . . 0.0 111.536 174.275 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 94.8 t -72.24 -37.81 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.872 0.869 . . . . 0.0 112.643 -171.213 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -124.76 17.57 8.69 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -166.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 12.7 t -68.63 -26.73 65.49 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.0 -1.063 . . . . 0.0 113.125 178.116 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 101.39 -14.23 58.12 Favored Glycine 0 N--CA 1.476 1.34 0 C-N-CA 125.7 1.619 . . . . 0.0 115.782 166.25 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -66.47 158.57 29.2 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.001 1.4 . . . . 0.0 113.587 175.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 p -60.84 139.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.572 0.749 . . . . 0.0 110.137 169.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -161.54 172.23 16.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.243 1.417 . . . . 0.0 110.519 -178.215 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.72 144.58 24.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.542 1.137 . . . . 0.0 111.859 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.66 163.63 12.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.389 1.476 . . . . 0.0 113.156 -175.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.37 173.53 13.42 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.398 1.475 . . . . 0.0 112.717 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.66 -33.86 26.84 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.874 2.383 . . . . 0.0 112.418 -173.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.91 72.1 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.718 -1.046 . . . . 0.0 114.849 -173.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.83 -0.39 43.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.343 1.572 . . . . 0.0 113.854 174.076 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 55.4 m -108.64 -47.85 3.41 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 178.638 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -142.44 152.31 42.64 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.804 2.042 . . . . 0.0 112.255 -172.654 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -154.53 -176.07 26.4 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.474 1.035 . . . . 0.0 113.635 169.273 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.4 p -153.3 136.85 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.124 1.37 . . . . 0.0 108.889 177.053 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -58.8 145.23 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -170.881 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.6 m-80 68.79 1.57 3.14 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.734 2.014 . . . . 0.0 114.656 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -115.44 141.59 27.48 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.586 1.555 . . . . 0.0 110.597 176.101 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.1 136.81 30.3 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.661 2.24 . . . . 0.0 110.86 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.87 139.02 51.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.887 1.675 . . . . 0.0 110.182 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.2 p -131.84 147.69 52.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -165.13 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -157.68 174.98 14.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.635 1.574 . . . . 0.0 111.364 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.2 m -129.49 136.97 50.53 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.809 1.243 . . . . 0.0 110.812 -172.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.1 t -100.35 132.14 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.36 1.464 . . . . 0.0 107.811 167.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.53 130.46 49.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.789 1.236 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.0 p -135.28 11.27 3.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.293 1.837 . . . . 0.0 112.941 -170.063 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 58.5 tttp -52.37 -34.96 50.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.336 1.854 . . . . 0.0 115.546 -165.924 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.69 23.88 4.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.315 1.446 . . . . 0.0 111.934 175.006 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.66 -8.87 59.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.907 1.283 . . . . 0.0 114.433 -177.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 87.95 -122.16 6.18 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.669 1.128 . . . . 0.0 112.439 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.0 167.77 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.471 1.508 . . . . 0.0 112.254 -174.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 139.81 -162.69 26.27 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.625 1.583 . . . . 0.0 113.21 -178.671 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -84.58 109.6 3.27 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 124.082 0.848 . . . . 0.0 111.488 175.54 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 44.7 tp -85.15 134.46 34.17 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.612 1.165 . . . . 0.0 109.645 171.555 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.9 m -132.83 158.64 41.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.283 1.433 . . . . 0.0 112.338 -175.365 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.2 tp -161.08 134.87 6.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.393 1.877 . . . . 0.0 108.783 -169.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.08 157.3 34.31 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.978 0.911 . . . . 0.0 112.104 176.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -137.42 140.27 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.847 1.259 . . . . 0.0 109.625 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.02 143.56 50.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.639 1.576 . . . . 0.0 109.516 172.672 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.75 -162.99 23.03 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.99 -0.895 . . . . 0.0 114.982 -174.327 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -64.26 -26.86 64.05 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.126 3.217 . . . . 0.0 112.602 178.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -138.22 158.85 43.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.008 1.323 . . . . 0.0 109.253 161.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -74.6 112.78 11.13 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.895 -1.128 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.76 149.42 49.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.923 0.889 . . . . 0.0 112.123 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.3 139.89 30.09 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.523 0.729 . . . . 0.0 109.258 165.818 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.46 138.12 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.668 1.187 . . . . 0.0 110.469 -167.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -134.78 155.75 50.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 110.783 171.084 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.74 154.49 32.93 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.089 0.956 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 90.7 m -143.31 120.03 11.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.82 1.648 . . . . 0.0 109.906 -172.723 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -72.61 124.96 26.32 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.341 0.656 . . . . 0.0 110.109 170.188 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -86.28 -11.33 52.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -174.011 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 69.31 -3.3 1.61 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.27 2.628 . . . . 0.0 113.759 -175.254 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.49 8.29 39.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.446 1.898 . . . . 0.0 113.236 -177.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.43 18.28 36.44 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.097 1.332 . . . . 0.0 113.637 -172.19 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 54.1 p -142.64 157.03 45.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.673 1.589 . . . . 0.0 111.652 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 52.7 t -127.19 124.81 39.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.616 1.967 . . . . 0.0 109.009 169.585 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 146.64 25.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.235 1.014 . . . . 0.0 110.904 177.034 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.3 t -128.44 143.48 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.063 1.745 . . . . 0.0 109.778 -178.129 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.4 t -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.469 1.508 . . . . 0.0 110.728 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.0 p90 -144.95 153.58 41.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.185 -0.947 . . . . 0.0 113.491 175.255 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 3.2 mt -114.37 106.38 52.75 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.976 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.64 170.04 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.887 3.058 . . . . 0.0 110.703 167.152 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.5 p -148.52 -28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -173.636 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.05 146.18 33.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.541 1.064 . . . . 0.0 110.928 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 163.55 34.7 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.255 2.636 . . . . 0.0 111.159 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.93 -134.94 7.89 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 125.269 1.414 . . . . 0.0 111.02 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 2.2 p30 -143.91 145.36 32.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.009 0.909 . . . . 0.0 112.829 176.306 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -121.26 135.68 55.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.789 2.035 . . . . 0.0 109.872 -171.802 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -89.78 127.14 35.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.305 1.042 . . . . 0.0 110.509 174.364 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.4 120.67 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.66 1.584 . . . . 0.0 108.593 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -102.37 134.5 45.57 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 109.942 174.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.7 t -136.66 133.12 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.355 1.462 . . . . 0.0 108.384 171.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.39 141.69 19.57 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.015 1.326 . . . . 0.0 111.026 -170.302 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.37 125.38 18.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.662 1.185 . . . . 0.0 110.43 -178.557 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.76 54.3 10.09 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.056 1.343 . . . . 0.0 111.909 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.303 8.5 pt-20 57.97 15.72 3.3 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.233 2.613 . . . . 0.0 116.236 -177.933 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -121.99 129.81 52.77 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.577 1.151 . . . . 0.0 111.282 177.242 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -61.97 155.71 22.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.092 0.957 . . . . 0.0 112.722 170.556 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.2 m -83.14 156.4 66.7 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.272 0.629 . . . . 0.0 110.126 175.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.58 122.77 12.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.455 2.104 . . . . 0.0 110.276 176.237 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.39 -13.07 68.0 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.293 -1.281 . . . . 0.0 116.079 -179.135 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.4 p -80.92 152.02 71.26 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 120.262 2.031 . . . . 0.0 112.91 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.46 141.93 71.53 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.152 0.733 . . . . 0.0 111.948 -4.524 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.85 169.64 11.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.431 1.493 . . . . 0.0 110.669 176.221 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 37.4 m -132.81 117.43 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.647 0.779 . . . . 0.0 110.741 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.63 128.47 45.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.803 1.241 . . . . 0.0 110.94 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -88.85 131.67 35.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.195 0.452 . . . . 0.0 110.749 174.009 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -121.22 138.25 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.676 1.59 . . . . 0.0 109.788 -173.668 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -126.01 177.16 6.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.24 1.016 . . . . 0.0 112.801 -176.297 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.82 138.66 21.14 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.825 1.678 . . . . 0.0 112.51 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 CA--C 1.546 0.797 0 C-N-CA 124.578 1.151 . . . . 0.0 113.558 -178.7 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.1 tp . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -61.8 121.9 67.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.949 0.9 . . . . 0.0 112.098 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.299 2.666 . . . . 0.0 111.506 -177.468 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.1 t80 -101.39 122.14 43.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.115 0.966 . . . . 0.0 109.635 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -148.63 131.29 15.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 110.581 171.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.23 153.84 43.23 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.381 1.872 . . . . 0.0 109.653 -170.592 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.62 137.81 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.825 1.25 . . . . 0.0 110.353 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.2 mt -131.7 136.32 28.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.303 1.841 . . . . 0.0 108.734 -172.609 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -77.75 69.58 7.3 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.558 3.505 . . . . 0.0 111.019 177.374 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -123.33 162.43 22.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.583 1.953 . . . . 0.0 110.307 175.156 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.8 m -139.28 130.0 26.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.906 1.282 . . . . 0.0 109.926 178.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 57.9 mt -82.17 118.2 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.18 0.992 . . . . 0.0 108.688 170.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -24.99 11.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -174.057 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -170.43 -24.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 178.264 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.79 -147.67 13.45 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.766 1.65 . . . . 0.0 113.087 -177.323 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.82 145.05 29.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 109.894 -176.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.74 132.61 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.279 1.432 . . . . 0.0 110.985 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -149.62 170.58 18.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.981 1.713 . . . . 0.0 110.465 -173.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.69 -167.29 20.1 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 116.301 1.281 . . . . 0.0 116.301 -175.448 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.52 142.59 22.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.13 1.772 . . . . 0.0 109.164 174.142 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.3 t -115.33 127.87 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.206 1.402 . . . . 0.0 108.379 172.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -109.69 122.53 47.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.915 1.686 . . . . 0.0 109.48 -175.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.3 mtt -93.77 150.8 39.26 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.278 1.431 . . . . 0.0 111.214 -173.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.24 -21.71 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.445 2.763 . . . . 0.0 112.774 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 14.0 m -72.84 -0.05 12.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.106 1.362 . . . . 0.0 114.47 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.15 42.96 6.45 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.698 1.142 . . . . 0.0 113.252 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -153.73 166.02 34.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.616 . . . . 0.0 111.931 -173.386 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 24.1 m -141.83 159.38 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.435 1.094 . . . . 0.0 113.144 -167.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.41 175.53 12.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.012 2.125 . . . . 0.0 110.617 174.168 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -112.39 143.45 28.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.113 -0.992 . . . . 0.0 112.31 -175.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.45 170.95 7.69 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.418 3.412 . . . . 0.0 111.767 173.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.3 m -115.27 128.49 56.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.564 1.546 . . . . 0.0 108.911 174.046 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.03 135.57 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.78 1.232 . . . . 0.0 109.395 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.1 m -134.29 126.79 30.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.532 1.533 . . . . 0.0 109.723 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.12 125.67 29.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.737 0.815 . . . . 0.0 110.651 172.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -82.19 -8.14 59.64 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.032 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 70.9 1.57 3.83 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.677 2.391 . . . . 0.0 113.674 -176.527 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.57 4.86 41.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.999 2.119 . . . . 0.0 113.039 -177.039 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.05 13.38 52.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.089 1.328 . . . . 0.0 114.112 -174.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 68.0 p -132.17 158.49 41.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.321 1.848 . . . . 0.0 110.999 178.302 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 22.3 m -115.31 141.07 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.253 1.021 . . . . 0.0 109.378 163.374 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 22.4 m -100.0 139.17 36.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.66 1.184 . . . . 0.0 108.444 169.92 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.99 133.82 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.38 1.472 . . . . 0.0 108.903 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -132.74 156.4 47.12 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.075 1.35 . . . . 0.0 112.267 -177.169 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.9 t80 -157.73 135.4 10.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.565 1.546 . . . . 0.0 111.625 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.86 124.53 76.87 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.188 0.995 . . . . 0.0 110.674 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -78.61 172.9 14.46 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.697 2.931 . . . . 0.0 111.73 -176.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -158.14 -39.3 0.07 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.779 0.832 . . . . 0.0 113.064 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -127.68 158.18 38.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.596 1.558 . . . . 0.0 110.767 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.23 174.99 10.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.238 1.015 . . . . 0.0 112.254 172.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.14 -177.66 22.47 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.156 1.36 . . . . 0.0 114.134 176.396 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 53.6 tp -73.93 117.69 16.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.327 1.051 . . . . 0.0 110.467 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 32.9 m80 -110.52 161.1 16.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.996 1.719 . . . . 0.0 110.71 178.013 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.2 150.09 33.11 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.7 -0.625 . . . . 0.0 112.401 175.372 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 30.8 ttm -128.82 139.26 52.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.139 1.776 . . . . 0.0 111.139 -168.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -108.7 137.14 47.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.194 1.798 . . . . 0.0 110.073 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.97 134.56 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.768 1.227 . . . . 0.0 110.43 175.934 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.92 138.94 36.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.586 1.154 . . . . 0.0 113.482 178.635 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 62.0 t80 -101.75 121.36 41.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.437 1.895 . . . . 0.0 109.334 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.38 32.33 13.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.836 1.254 . . . . 0.0 112.759 -175.297 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.5 m-80 73.87 7.28 4.9 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.798 2.439 . . . . 0.0 115.081 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.0 ttm -100.23 128.58 46.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.885 1.274 . . . . 0.0 110.269 166.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.17 136.59 57.28 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.46 -0.775 . . . . 0.0 112.762 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -74.81 156.74 86.32 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.76 174.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.08 -17.78 61.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.641 2.227 . . . . 0.0 113.204 175.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.92 7.61 65.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.643 1.116 . . . . 0.0 114.571 170.26 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 18.1 t -111.29 146.1 33.88 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 119.683 1.742 . . . . 0.0 111.678 178.111 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.37 169.45 72.81 Favored 'Cis proline' 0 C--N 1.351 0.668 0 CA-C-N 119.816 0.97 . . . . 0.0 111.76 -9.0 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.66 158.31 24.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.918 1.687 . . . . 0.0 110.654 171.004 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -148.41 152.18 36.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.334 -0.854 . . . . 0.0 111.894 171.332 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -165.97 154.28 10.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.914 1.286 . . . . 0.0 111.244 -175.313 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.3 t80 -94.67 129.39 41.57 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.483 -0.76 . . . . 0.0 112.301 177.568 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.6 t -95.1 134.25 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.989 1.316 . . . . 0.0 109.214 174.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -149.77 158.29 44.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.514 1.525 . . . . 0.0 110.146 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -67.65 160.49 27.84 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 63.4 t -65.09 -39.49 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.557 0.743 . . . . 0.0 111.046 179.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 p30 -90.46 155.73 18.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.238 1.015 . . . . 0.0 111.57 165.248 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 25.1 p -161.79 156.17 22.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.763 1.225 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -112.72 30.27 7.6 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 126.182 1.848 . . . . 0.0 113.094 178.502 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -165.19 162.84 20.25 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.342 1.457 . . . . 0.0 113.091 -165.361 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.3 p -66.75 140.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 0.0 110.015 167.282 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -156.58 162.48 39.89 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.874 1.27 . . . . 0.0 111.022 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.14 144.76 36.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.744 1.218 . . . . 0.0 112.042 -177.057 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 44.7 p90 -165.24 161.24 19.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.785 1.634 . . . . 0.0 112.527 -176.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.7 174.42 13.54 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.302 1.429 . . . . 0.0 113.369 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.17 -33.12 9.78 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.107 2.538 . . . . 0.0 113.447 -171.077 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.62 -36.69 88.43 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 119.523 1.056 . . . . 0.0 114.175 -171.211 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.16 -9.1 58.24 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.916 1.358 . . . . 0.0 113.215 176.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 29.1 m -98.45 -49.85 4.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.348 1.859 . . . . 0.0 111.089 177.211 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -143.11 146.03 33.39 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.511 1.924 . . . . 0.0 112.881 -174.557 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.16 178.61 21.28 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.485 1.517 . . . . 0.0 113.32 171.652 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.3 p -149.63 136.29 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.778 1.231 . . . . 0.0 109.37 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -58.21 144.01 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.1 m-80 67.8 7.44 5.73 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.737 2.015 . . . . 0.0 114.773 174.258 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 95.1 mttt -125.99 146.47 55.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.679 1.592 . . . . 0.0 110.877 174.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 135.68 25.72 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.78 2.32 . . . . 0.0 111.188 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.16 137.83 51.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 109.99 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.0 p -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -165.305 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -161.56 177.69 9.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.393 1.877 . . . . 0.0 111.26 178.25 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 45.6 m -130.82 142.01 50.37 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.669 1.187 . . . . 0.0 110.761 -170.625 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.3 t -112.82 128.46 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.194 1.398 . . . . 0.0 107.976 169.74 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -94.27 126.07 39.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.664 1.186 . . . . 0.0 110.084 176.273 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.8 p -127.88 0.19 5.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.053 1.741 . . . . 0.0 113.57 -167.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 63.0 tttp -51.07 -38.69 53.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.134 1.774 . . . . 0.0 114.729 -171.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.47 9.58 18.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.517 1.527 . . . . 0.0 113.183 -178.68 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.33 62.79 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -172.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.73 147.23 5.88 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.908 1.242 . . . . 0.0 112.525 -172.055 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.84 148.29 36.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.252 1.021 . . . . 0.0 112.397 -177.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 177.22 -45.34 0.1 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.991 1.281 . . . . 0.0 113.715 175.214 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 165.03 106.45 0.19 Allowed Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.919 1.247 . . . . 0.0 112.729 171.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.92 130.32 34.91 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.076 1.35 . . . . 0.0 109.423 175.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.9 m -127.87 156.37 42.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.547 1.539 . . . . 0.0 112.159 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1900 ' ' LEU . . . . . 0.411 HD21 HG13 ' A' 1922 ' ' VAL . 38.5 tp -155.81 135.22 12.37 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.476 1.91 . . . . 0.0 108.663 -175.383 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -154.36 155.31 34.82 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.146 0.978 . . . . 0.0 112.031 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.6 mt -137.04 133.18 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.489 1.116 . . . . 0.0 110.374 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -115.85 160.85 19.62 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.261 1.824 . . . . 0.0 109.657 170.382 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.57 -163.35 34.62 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.047 -1.033 . . . . 0.0 114.695 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.73 -24.49 61.96 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.886 3.057 . . . . 0.0 112.278 175.109 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -140.79 159.65 41.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.431 1.492 . . . . 0.0 108.939 164.036 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 tptt -74.06 113.61 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.846 -1.158 . . . . 0.0 110.6 176.564 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.31 145.86 52.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 0.0 111.411 174.324 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.2 143.55 28.7 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 109.808 169.25 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 99.7 mt -128.78 144.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 110.887 -167.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 14.5 t -139.38 156.16 47.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 164.604 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 26.7 p -157.56 150.46 23.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.603 1.161 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.8 m -140.55 118.43 11.79 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 110.018 -169.63 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 14.0 t0 -67.43 118.38 10.69 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.785 0.834 . . . . 0.0 109.785 166.152 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -80.79 -13.37 59.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.69 0.796 . . . . 0.0 112.775 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 73.68 -7.96 1.48 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 128.5 2.72 . . . . 0.0 113.455 -179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -88.6 8.43 28.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.478 1.911 . . . . 0.0 113.372 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.25 18.33 39.68 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.058 1.313 . . . . 0.0 113.694 -171.98 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.8 p -139.54 155.4 47.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.545 1.538 . . . . 0.0 111.181 176.821 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 43.5 t -124.33 128.9 49.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.532 1.933 . . . . 0.0 109.244 170.903 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.6 t -89.62 145.76 25.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.306 1.043 . . . . 0.0 110.643 174.453 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1922 ' ' VAL . . . . . 0.411 HG13 HD21 ' A' 1900 ' ' LEU . 84.1 t -126.83 143.3 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.933 1.693 . . . . 0.0 109.709 -177.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.8 t -138.3 141.32 39.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.603 1.561 . . . . 0.0 110.685 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -144.21 153.2 41.83 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.152 -0.967 . . . . 0.0 113.586 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 57.5 tp -119.35 103.09 47.51 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.705 1.602 . . . . 0.0 110.085 -176.207 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.71 172.72 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.85 3.034 . . . . 0.0 110.88 170.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.1 p -146.76 -30.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.8 mt -107.59 146.86 34.21 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.331 1.052 . . . . 0.0 110.902 167.633 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.78 160.69 43.17 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.142 2.561 . . . . 0.0 110.9 173.302 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 138.19 -132.61 5.91 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.444 1.021 . . . . 0.0 112.309 -175.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.84 135.94 30.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.133 1.373 . . . . 0.0 111.562 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.66 134.55 54.98 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.872 1.669 . . . . 0.0 110.423 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 31.9 m -91.54 121.32 33.13 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.22 126.04 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.93 1.692 . . . . 0.0 108.356 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.22 130.17 55.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.353 1.461 . . . . 0.0 109.298 175.346 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.9 t -132.11 130.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.33 1.052 . . . . 0.0 109.534 173.081 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.57 142.72 22.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.957 1.303 . . . . 0.0 111.804 -167.634 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.18 120.66 18.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.809 1.243 . . . . 0.0 109.733 178.302 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 54.57 58.18 5.11 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.358 1.463 . . . . 0.0 112.133 177.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 58.62 9.33 1.09 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.571 2.748 . . . . 0.0 116.542 -177.245 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -115.88 124.97 51.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.487 1.115 . . . . 0.0 110.801 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.87 145.69 54.52 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.379 -0.825 . . . . 0.0 111.984 172.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.6 m -72.26 156.87 90.13 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.142 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.64 125.75 18.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.697 2.932 . . . . 0.0 112.475 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.51 -12.42 63.13 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.919 1.247 . . . . 0.0 115.664 -179.061 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.6 t -74.67 142.02 76.72 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-N 119.449 1.625 . . . . 0.0 111.641 177.313 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.88 142.94 75.33 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.297 0.785 . . . . 0.0 112.24 -3.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -97.15 168.87 10.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.577 1.951 . . . . 0.0 110.803 175.801 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 90.0 m -126.51 122.03 34.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.962 0.905 . . . . 0.0 111.251 172.479 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.49 132.68 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.044 1.338 . . . . 0.0 110.874 173.004 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -84.53 124.43 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.307 0.643 . . . . 0.0 109.435 173.285 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.89 133.62 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.757 0.823 . . . . 0.0 110.304 -178.617 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.0 p -110.76 161.6 15.61 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.427 1.491 . . . . 0.0 112.686 -174.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.24 136.41 16.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.537 1.065 . . . . 0.0 110.95 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.386 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.69 121.61 76.3 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.497 1.119 . . . . 0.0 110.676 -178.56 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.61 151.24 64.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.287 2.658 . . . . 0.0 111.632 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.4 t80 -106.79 121.97 45.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.896 0.878 . . . . 0.0 110.87 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.89 133.19 14.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.335 1.454 . . . . 0.0 110.367 170.724 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.75 134.74 25.46 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.379 1.471 . . . . 0.0 109.993 -167.702 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 11.2 p -103.72 139.94 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.931 1.292 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -134.89 137.9 28.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.584 1.953 . . . . 0.0 108.333 -177.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.02 23.76 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.236 3.291 . . . . 0.0 114.199 -178.339 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.1 t80 -72.75 153.15 41.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.563 1.145 . . . . 0.0 111.405 174.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 96.2 m -123.82 126.88 47.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.351 1.46 . . . . 0.0 110.225 -177.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.48 131.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.397 1.079 . . . . 0.0 109.642 172.483 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.46 -64.03 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.317 1.047 . . . . 0.0 112.71 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.97 124.62 4.35 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.543 1.537 . . . . 0.0 110.888 179.412 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.38 -144.6 16.58 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.567 1.556 . . . . 0.0 111.308 -166.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.09 143.8 17.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.515 1.126 . . . . 0.0 110.949 -176.469 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.4 tt -119.09 138.41 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.3 1.44 . . . . 0.0 111.257 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.16 166.01 30.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.884 1.674 . . . . 0.0 110.736 -178.818 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.17 -172.47 19.54 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 -177.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -151.18 138.76 19.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.231 1.812 . . . . 0.0 109.31 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 4.7 t -110.7 137.88 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.094 1.758 . . . . 0.0 108.218 174.578 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 53.1 mtp85 -129.18 118.62 22.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.769 1.627 . . . . 0.0 110.094 -171.837 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.8 mpp? -91.78 153.31 43.72 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.571 1.548 . . . . 0.0 111.265 -175.407 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.9 -19.2 46.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.385 2.723 . . . . 0.0 113.4 178.394 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 44.8 p -73.96 -8.49 56.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.381 1.473 . . . . 0.0 114.134 171.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.2 -4.95 81.25 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.512 1.53 . . . . 0.0 113.979 -174.573 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -68.48 160.02 30.58 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.531 1.166 . . . . 0.0 111.885 173.447 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.9 m -140.29 156.7 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.634 1.173 . . . . 0.0 112.427 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.54 -173.03 4.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.418 2.287 . . . . 0.0 110.059 178.494 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -130.79 143.86 51.09 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.843 -1.161 . . . . 0.0 111.395 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -84.74 167.07 11.54 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.945 3.097 . . . . 0.0 111.507 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.1 m -104.44 133.07 49.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.355 1.462 . . . . 0.0 108.726 170.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.13 135.19 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.157 0.983 . . . . 0.0 109.642 176.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -130.82 127.52 38.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.775 1.63 . . . . 0.0 109.389 178.016 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.31 127.96 33.74 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.261 0.624 . . . . 0.0 110.314 170.75 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -82.81 -5.58 59.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.177 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 69.91 4.62 4.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.59 2.356 . . . . 0.0 114.044 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.66 7.54 30.63 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.004 2.122 . . . . 0.0 112.795 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.56 20.18 41.88 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.853 1.216 . . . . 0.0 113.945 -175.822 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 36.9 p -135.77 160.13 39.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.231 1.812 . . . . 0.0 110.301 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.4 m -120.37 148.02 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.515 1.126 . . . . 0.0 110.17 168.881 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.2 m -111.36 133.72 53.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.523 1.129 . . . . 0.0 108.897 169.115 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.2 t -110.17 134.15 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.846 1.658 . . . . 0.0 108.587 176.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -134.19 152.24 51.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.265 1.426 . . . . 0.0 112.367 -169.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.7 t80 -159.52 133.92 7.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.448 1.499 . . . . 0.0 112.125 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.84 119.4 71.15 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.53 1.132 . . . . 0.0 110.563 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.03 139.81 19.55 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.501 2.801 . . . . 0.0 112.686 -170.358 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 52.2 m -123.02 -7.51 8.35 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 174.962 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -140.37 157.62 45.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.828 1.651 . . . . 0.0 110.68 -177.333 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.3 170.57 9.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.73 1.212 . . . . 0.0 111.688 168.445 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.66 -170.42 19.16 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.214 1.388 . . . . 0.0 113.781 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -83.53 119.29 24.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.432 1.093 . . . . 0.0 110.117 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 24.2 m80 -107.57 156.3 19.17 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.115 1.766 . . . . 0.0 111.759 -177.609 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -124.27 149.71 46.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.069 1.748 . . . . 0.0 109.059 175.062 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 15.7 tmm? -153.12 136.01 15.44 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 111.901 -175.026 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.5 1.92 . . . . 0.0 111.702 -172.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.4 mm -136.66 135.38 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.444 1.498 . . . . 0.0 110.803 175.235 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 142.83 30.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.211 1.004 . . . . 0.0 113.622 178.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.3 t80 -107.39 122.41 46.54 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.952 2.101 . . . . 0.0 110.208 177.812 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 52.12 32.17 10.07 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.528 1.131 . . . . 0.0 112.485 -172.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 20.3 t30 77.14 3.9 3.26 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.426 2.69 . . . . 0.0 115.149 -178.32 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.35 128.84 47.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.659 1.583 . . . . 0.0 110.809 174.11 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -59.14 137.3 58.01 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 113.582 -177.342 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.25 155.45 87.98 Favored Pre-proline 0 N--CA 1.48 1.034 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.459 172.429 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.42 -13.64 40.76 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.485 2.124 . . . . 0.0 113.762 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -89.45 9.32 77.45 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.008 1.29 . . . . 0.0 114.672 170.019 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 29.5 t -116.32 148.22 41.19 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.533 1.667 . . . . 0.0 111.698 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.02 165.87 77.93 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 119.931 1.011 . . . . 0.0 112.135 -6.333 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 65.5 mt -113.97 158.8 20.67 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.319 1.848 . . . . 0.0 110.92 172.198 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.79 146.97 19.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.766 1.226 . . . . 0.0 110.954 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 3.8 p90 -170.96 163.52 7.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.914 1.285 . . . . 0.0 111.784 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -98.45 138.61 35.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.246 -0.909 . . . . 0.0 112.967 177.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 45.0 t -111.75 135.54 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.701 1.6 . . . . 0.0 109.451 174.811 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -146.38 164.1 33.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.307 1.843 . . . . 0.0 111.715 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -80.71 155.32 26.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.633 0.773 . . . . 0.0 112.862 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 25.1 m -66.17 -16.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.344 -0.847 . . . . 0.0 112.309 165.535 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -74.49 -19.7 60.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.909 1.684 . . . . 0.0 114.194 178.298 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 92.6 m -62.41 130.61 46.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.859 1.264 . . . . 0.0 113.551 -170.123 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.31 -18.17 22.37 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.2 1.381 . . . . 0.0 114.12 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -68.45 160.3 30.0 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.294 1.047 . . . . 0.0 113.51 176.336 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 40.0 t -63.75 128.5 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.55 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 157.1 44.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.691 1.196 . . . . 0.0 110.596 -172.802 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.69 144.3 37.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 -176.77 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -166.83 172.24 10.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 0.0 112.375 -173.715 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 118.27 172.29 15.58 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.266 1.412 . . . . 0.0 112.622 -177.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.71 -35.01 17.42 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.789 2.326 . . . . 0.0 112.704 -170.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -64.14 -38.6 96.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.398 0.999 . . . . 0.0 114.668 -171.379 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -77.01 -7.16 55.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.055 1.428 . . . . 0.0 113.761 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.3 m -100.91 -40.27 7.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.385 1.874 . . . . 0.0 111.071 176.401 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -153.73 141.08 19.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.38 1.872 . . . . 0.0 112.189 -167.491 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -135.5 177.0 19.77 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.529 1.538 . . . . 0.0 112.17 173.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.0 t -141.86 135.67 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.132 0.973 . . . . 0.0 108.85 174.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.9 m -55.97 135.85 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.302 0.641 . . . . 0.0 112.576 -177.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 58.3 m-80 67.71 1.17 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.95 2.1 . . . . 0.0 114.89 174.537 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -121.22 143.46 37.37 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 125.468 1.507 . . . . 0.0 111.038 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.53 133.04 19.9 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.523 2.149 . . . . 0.0 111.309 -173.389 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -113.08 146.42 39.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.66 1.584 . . . . 0.0 110.116 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.7 p -137.12 145.33 43.72 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.385 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -154.46 175.38 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.266 1.426 . . . . 0.0 111.948 177.059 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 29.9 m -130.94 144.27 51.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.25 1.42 . . . . 0.0 110.759 -169.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.2 t -121.36 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.674 1.59 . . . . 0.0 108.704 170.105 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.54 124.38 43.26 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.56 1.144 . . . . 0.0 111.307 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 34.5 p -124.99 12.28 8.36 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.808 2.043 . . . . 0.0 112.318 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.29 -36.43 66.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.615 1.566 . . . . 0.0 114.564 -170.121 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.74 12.62 19.67 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.729 1.612 . . . . 0.0 112.741 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.95 60.83 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.507 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 -84.45 1.57 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.052 1.311 . . . . 0.0 111.91 178.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -159.56 148.4 17.86 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.434 1.493 . . . . 0.0 110.634 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 156.19 -152.46 23.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.392 1.473 . . . . 0.0 111.661 -174.203 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -147.68 144.97 13.1 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.81 1.195 . . . . 0.0 112.377 176.267 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.33 141.35 28.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.198 1.399 . . . . 0.0 111.12 176.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 12.3 t -125.69 160.13 30.5 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.961 1.705 . . . . 0.0 110.816 166.94 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.3 tp -163.06 136.23 5.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.928 1.691 . . . . 0.0 109.491 -162.708 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.41 160.84 35.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.36 1.064 . . . . 0.0 111.954 175.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.4 mt -132.87 137.83 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.723 1.209 . . . . 0.0 109.518 173.035 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -129.12 119.48 24.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.171 1.388 . . . . 0.0 109.517 174.034 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -136.88 -173.26 12.83 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.92 1.248 . . . . 0.0 113.911 -177.729 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.04 -21.07 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.958 3.105 . . . . 0.0 112.257 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -136.22 157.1 47.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.344 1.458 . . . . 0.0 109.0 158.716 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.0 tptt -76.03 122.48 24.28 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.796 -1.19 . . . . 0.0 111.862 -176.53 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.94 150.08 35.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.037 0.935 . . . . 0.0 112.082 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -86.19 142.81 28.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.798 0.839 . . . . 0.0 109.314 166.335 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.87 144.16 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.441 1.096 . . . . 0.0 110.626 -167.623 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.3 t -146.81 168.13 22.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.036 1.334 . . . . 0.0 111.461 168.011 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -161.32 158.48 27.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 112.965 -177.887 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.9 m -143.8 129.02 18.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.8 1.64 . . . . 0.0 110.446 -172.508 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.63 128.69 34.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.82 1.248 . . . . 0.0 111.09 170.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -98.72 149.73 22.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 111.732 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -67.48 -16.37 64.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.766 0.826 . . . . 0.0 112.661 174.293 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.13 -7.72 52.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.435 1.494 . . . . 0.0 113.85 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.17 27.06 19.68 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.783 1.182 . . . . 0.0 114.464 176.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.5 p -130.82 156.46 44.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.777 1.631 . . . . 0.0 110.589 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.1 m -106.89 128.0 53.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.626 1.171 . . . . 0.0 109.921 171.188 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.7 t -94.72 149.57 21.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.147 0.979 . . . . 0.0 110.375 169.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.4 t -131.36 144.56 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.097 1.759 . . . . 0.0 109.63 -176.496 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.7 p -135.51 149.95 49.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.893 1.277 . . . . 0.0 111.987 170.161 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.72 155.7 37.73 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 176.57 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.9 mt -122.72 106.65 34.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.641 1.976 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.09 170.17 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 124.065 3.177 . . . . 0.0 110.488 167.633 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -131.4 -20.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -170.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.93 151.28 48.72 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.701 1.201 . . . . 0.0 110.769 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.5 152.29 38.34 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.826 2.351 . . . . 0.0 112.366 -170.51 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.3 -152.46 24.34 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.502 1.049 . . . . 0.0 112.883 -177.199 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.32 130.33 56.67 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.829 1.652 . . . . 0.0 111.627 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -122.35 129.41 52.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.715 1.606 . . . . 0.0 110.015 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -86.7 127.76 34.98 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.09 -1.006 . . . . 0.0 111.159 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.15 121.8 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 108.666 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -98.1 134.79 40.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.107 1.363 . . . . 0.0 109.979 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 91.4 t -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.442 1.497 . . . . 0.0 108.416 171.808 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -151.6 133.98 15.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.818 1.247 . . . . 0.0 110.93 -172.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -133.42 133.63 42.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.825 1.25 . . . . 0.0 111.151 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.8 t-20 49.16 53.36 12.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.77 1.228 . . . . 0.0 112.406 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.31 8.8 pt-20 58.49 18.18 5.48 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.016 2.526 . . . . 0.0 116.305 -177.178 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -127.78 131.53 49.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.618 1.167 . . . . 0.0 111.88 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -63.02 157.03 23.0 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.268 -0.895 . . . . 0.0 112.486 168.169 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.8 m -88.52 155.13 51.2 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.499 0.72 . . . . 0.0 110.314 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.6 123.1 12.61 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.237 1.958 . . . . 0.0 110.051 175.251 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.48 -13.48 65.47 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.141 1.353 . . . . 0.0 115.633 -177.319 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 87.0 p -82.56 150.68 63.66 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.343 2.071 . . . . 0.0 112.87 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.91 140.96 67.21 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.218 0.757 . . . . 0.0 111.791 -4.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -86.84 170.17 11.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 110.406 175.593 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 35.0 m -132.65 117.92 18.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 176.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.7 134.25 38.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 111.641 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -86.75 113.86 22.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.271 1.028 . . . . 0.0 109.944 174.209 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.6 t -92.17 124.56 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.581 0.752 . . . . 0.0 110.173 178.064 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 82.9 m -92.44 142.83 27.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.657 1.983 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.61 17.26 11.13 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.046 1.308 . . . . 0.0 115.347 -176.32 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 CA--C 1.553 1.092 0 C-N-CA 127.559 2.344 . . . . 0.0 113.659 -178.028 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 121.393 0.616 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.6 ttm180 -57.32 116.08 12.63 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.852 1.661 . . . . 0.0 110.829 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.47 137.22 32.91 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.705 2.27 . . . . 0.0 109.334 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.8 t80 -102.81 121.61 42.83 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.506 0.669 . . . . 0.0 111.047 -176.648 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.66 138.72 21.19 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.657 1.583 . . . . 0.0 110.104 171.379 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.56 140.52 30.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.208 1.403 . . . . 0.0 109.83 -172.263 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 86.0 t -102.88 134.76 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 109.331 176.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.72 135.73 27.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.64 109.48 2.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.32 2.68 . . . . 0.0 109.876 173.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -174.51 149.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.275 2.23 . . . . 0.0 109.098 -172.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.0 m -126.96 124.43 39.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.16 0.984 . . . . 0.0 109.927 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.1 mt -87.01 120.94 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.692 1.197 . . . . 0.0 109.144 174.327 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.81 -101.86 0.4 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.825 1.25 . . . . 0.0 110.492 176.428 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 68.0 mttm -119.63 132.17 55.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.082 1.353 . . . . 0.0 111.249 174.233 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.04 -144.83 16.21 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.922 1.725 . . . . 0.0 111.186 -167.141 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -159.6 151.02 19.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.469 1.107 . . . . 0.0 111.082 -177.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.7 tt -141.25 130.98 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.098 1.359 . . . . 0.0 111.477 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 82.7 p -144.45 178.64 7.8 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.771 1.628 . . . . 0.0 110.382 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.53 -164.83 22.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -154.66 145.22 22.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.564 1.546 . . . . 0.0 110.113 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.4 t -128.66 134.24 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.954 1.701 . . . . 0.0 108.574 174.53 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -118.74 141.86 48.22 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.278 1.031 . . . . 0.0 112.158 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 1.5 mtm -103.04 147.36 34.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.036 1.734 . . . . 0.0 111.317 178.643 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.66 -26.88 67.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.007 3.138 . . . . 0.0 115.008 175.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.6 p -73.34 -3.6 28.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.983 1.713 . . . . 0.0 114.524 178.128 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.73 -4.36 75.63 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.508 1.528 . . . . 0.0 114.058 -179.64 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -69.04 152.58 45.04 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.732 1.213 . . . . 0.0 111.964 171.799 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 47.9 t -142.49 141.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.829 1.652 . . . . 0.0 109.673 -176.102 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -153.06 -179.7 7.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.077 1.751 . . . . 0.0 110.955 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -123.8 144.63 45.25 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.875 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.5 167.09 13.6 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.276 3.317 . . . . 0.0 111.513 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.3 m -110.86 127.13 55.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.482 1.513 . . . . 0.0 108.981 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -108.6 133.5 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 109.345 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 69.8 m -136.09 137.77 41.39 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.736 1.614 . . . . 0.0 109.494 177.366 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.6 129.47 34.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.287 0.635 . . . . 0.0 110.896 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -76.75 -8.11 56.67 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 71.49 13.01 6.51 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.895 2.478 . . . . 0.0 113.334 -179.686 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.62 9.88 10.92 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.074 2.15 . . . . 0.0 112.783 -176.763 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.63 12.7 59.17 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.043 1.306 . . . . 0.0 114.367 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.1 p -131.02 158.39 40.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.616 1.967 . . . . 0.0 109.991 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.9 m -111.99 151.7 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.939 0.896 . . . . 0.0 110.292 168.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 139.14 38.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 163.017 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.0 t -120.6 127.51 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.121 1.368 . . . . 0.0 108.466 173.921 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -130.49 153.35 48.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.504 1.521 . . . . 0.0 111.815 -166.979 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 43.5 t80 -159.67 137.0 9.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.748 1.219 . . . . 0.0 112.219 -174.428 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.13 119.85 69.25 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.532 1.133 . . . . 0.0 110.808 176.565 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.67 154.06 26.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.522 2.814 . . . . 0.0 111.608 -179.168 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 86.6 p -133.16 -9.78 2.96 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -168.88 145.52 3.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.479 1.512 . . . . 0.0 110.39 -168.22 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -76.41 167.63 21.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.286 1.034 . . . . 0.0 113.379 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 124.86 -178.25 16.58 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.537 1.541 . . . . 0.0 114.266 176.839 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.4 tp -82.17 127.17 32.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.008 1.323 . . . . 0.0 109.986 177.272 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.6 m80 -124.67 153.22 42.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.094 1.358 . . . . 0.0 111.655 -172.712 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.68 139.95 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.407 1.483 . . . . 0.0 109.882 178.363 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 20.3 ttm -118.51 133.37 55.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.353 1.861 . . . . 0.0 110.645 178.277 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -107.42 134.69 50.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.927 2.091 . . . . 0.0 109.753 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.1 mm -134.89 139.31 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.877 1.271 . . . . 0.0 110.996 176.002 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.8 135.07 20.55 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 113.518 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.9 t80 -99.62 123.12 43.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.061 1.744 . . . . 0.0 109.933 173.274 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 50.87 36.19 14.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.356 1.462 . . . . 0.0 112.829 -176.984 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.2 t30 79.3 0.05 2.29 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 128.305 2.642 . . . . 0.0 114.74 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -103.41 134.44 46.78 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.27 1.428 . . . . 0.0 111.007 175.594 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.7 m170 -54.14 136.95 41.61 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -76.33 154.46 84.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.989 166.297 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.57 -23.39 70.47 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.389 2.059 . . . . 0.0 113.28 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -81.07 3.85 74.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.39 0.995 . . . . 0.0 114.686 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.1 t -99.82 147.12 32.99 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.616 1.708 . . . . 0.0 111.8 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.14 170.12 71.17 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 CA-C-N 119.785 0.959 . . . . 0.0 111.498 -11.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.59 158.27 24.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.106 1.363 . . . . 0.0 110.846 169.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -148.03 139.94 24.0 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.589 1.156 . . . . 0.0 110.366 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -164.49 173.4 12.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 0.0 111.796 -173.38 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -114.67 135.78 53.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.985 0.914 . . . . 0.0 113.248 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 57.9 t -102.36 138.56 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.867 1.667 . . . . 0.0 108.973 174.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.5 t0 -160.99 166.5 28.17 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.915 1.286 . . . . 0.0 111.091 178.507 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.12 123.62 23.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.716 0.807 . . . . 0.0 111.267 174.048 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -70.98 -25.58 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.166 0.986 . . . . 0.0 113.361 -167.663 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -95.7 -2.79 47.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.198 1.399 . . . . 0.0 113.639 -177.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 4.3 t -69.81 150.36 46.94 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.184 -0.948 . . . . 0.0 113.501 -170.398 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -87.09 74.84 2.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.48 1.514 . . . . 0.0 113.278 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -169.96 166.87 9.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.007 2.123 . . . . 0.0 112.335 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -71.47 132.65 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.801 1.241 . . . . 0.0 109.605 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 81.9 p -138.69 164.12 30.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.939 1.296 . . . . 0.0 110.991 176.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.88 143.76 36.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.497 1.119 . . . . 0.0 111.274 171.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.7 p90 -169.36 164.6 10.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.773 1.629 . . . . 0.0 112.736 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.54 175.1 13.72 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.329 1.442 . . . . 0.0 112.695 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.94 -37.94 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.648 2.232 . . . . 0.0 112.374 -172.445 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.15 -36.95 93.54 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 119.534 1.061 . . . . 0.0 114.556 -171.106 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.59 -4.38 45.55 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.929 1.364 . . . . 0.0 113.648 176.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.3 m -104.9 -49.59 3.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.038 1.735 . . . . 0.0 110.506 176.5 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -142.49 131.86 23.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.5 1.92 . . . . 0.0 112.724 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -125.19 177.78 16.8 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.218 1.866 . . . . 0.0 112.431 171.117 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 46.3 t -142.05 134.6 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.654 1.182 . . . . 0.0 108.826 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.7 m -58.21 138.99 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 62.91 9.8 3.94 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.046 1.738 . . . . 0.0 114.635 176.915 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -120.89 141.3 32.32 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.79 129.37 15.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.578 2.185 . . . . 0.0 110.616 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.78 144.22 36.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.634 1.574 . . . . 0.0 110.185 174.229 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.0 p -135.6 147.33 48.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -166.774 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.69 178.06 10.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.632 1.573 . . . . 0.0 111.488 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.8 m -128.9 144.03 51.06 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.407 1.483 . . . . 0.0 110.768 -170.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 50.8 t -117.73 132.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.852 1.661 . . . . 0.0 108.158 169.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.48 129.57 38.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.932 0.893 . . . . 0.0 111.184 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -127.95 0.9 5.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.021 1.728 . . . . 0.0 113.349 -172.493 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.84 -41.78 62.06 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.042 1.737 . . . . 0.0 114.022 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.83 -3.89 34.44 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.27 1.428 . . . . 0.0 113.38 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.49 65.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.151 0.98 . . . . 0.0 113.611 -173.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.42 -88.62 1.11 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.744 1.164 . . . . 0.0 112.369 177.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.76 149.07 19.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.572 1.549 . . . . 0.0 110.954 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 163.54 -151.49 21.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.06 1.791 . . . . 0.0 111.519 -177.648 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -111.27 107.58 2.2 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.422 1.01 . . . . 0.0 111.402 172.378 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 55.6 tp -81.33 136.47 35.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.411 1.084 . . . . 0.0 109.864 172.077 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.2 m -136.67 156.18 48.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 0.0 111.768 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.0 tp -159.91 131.89 6.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 108.8 -168.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.23 34.59 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.786 0.834 . . . . 0.0 112.4 -179.287 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.39 137.43 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.016 1.326 . . . . 0.0 109.871 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -125.06 157.5 36.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.385 1.874 . . . . 0.0 109.807 171.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.71 -161.73 29.83 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.658 -178.057 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.4 -25.23 63.7 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.009 3.14 . . . . 0.0 112.68 177.646 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.4 t -140.45 159.95 41.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.041 1.336 . . . . 0.0 109.444 162.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.9 tptt -76.94 107.05 9.0 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.983 -1.073 . . . . 0.0 111.233 -178.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.81 147.01 53.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.024 0.93 . . . . 0.0 111.723 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.83 148.42 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.627 0.771 . . . . 0.0 110.674 168.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.0 mt -137.62 145.38 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.074 1.35 . . . . 0.0 110.181 -164.389 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -143.08 167.17 22.71 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.054 1.342 . . . . 0.0 111.016 166.447 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.8 156.03 28.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 0.0 112.594 -178.125 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 89.1 m -143.08 124.99 15.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.676 1.59 . . . . 0.0 109.922 -171.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 20.3 t0 -74.3 120.95 20.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.916 0.886 . . . . 0.0 109.839 170.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -83.48 -7.32 59.56 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.151 0.98 . . . . 0.0 113.455 -176.077 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 74.72 -17.51 0.48 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.07 2.948 . . . . 0.0 113.908 178.003 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -81.36 -3.88 54.05 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.853 1.661 . . . . 0.0 113.913 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 105.21 22.5 8.21 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.446 1.498 . . . . 0.0 114.07 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.9 p -138.94 154.63 48.34 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.613 172.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 93.9 m -115.04 131.56 56.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.858 1.663 . . . . 0.0 109.137 165.83 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -86.38 149.24 25.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.823 0.849 . . . . 0.0 110.304 168.42 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.5 t -127.01 142.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.426 1.89 . . . . 0.0 109.076 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 81.6 p -131.86 146.14 51.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.724 1.21 . . . . 0.0 111.442 167.334 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.44 157.05 42.96 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.077 -1.014 . . . . 0.0 113.118 175.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 43.4 tp -126.41 102.2 26.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.839 1.255 . . . . 0.0 110.492 -174.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.87 174.29 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.746 2.964 . . . . 0.0 110.61 170.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -148.44 -30.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.028 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.48 145.34 31.07 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.657 1.117 . . . . 0.0 110.776 167.764 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.56 164.81 31.67 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.273 2.649 . . . . 0.0 111.339 177.052 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.24 -124.48 3.93 Favored Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.909 1.242 . . . . 0.0 111.86 -175.784 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -147.76 144.78 28.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.359 1.464 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.18 143.22 51.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.445 1.898 . . . . 0.0 110.863 -172.497 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 60.4 m -96.1 123.7 39.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.717 1.207 . . . . 0.0 110.429 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.27 124.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.609 1.564 . . . . 0.0 108.464 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.98 131.87 54.65 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 109.908 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 42.6 t -133.58 127.85 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.465 1.106 . . . . 0.0 109.74 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.3 142.68 26.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.16 1.384 . . . . 0.0 111.397 -169.6 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.92 121.34 12.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.54 1.136 . . . . 0.0 110.025 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 59.59 56.08 3.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.584 1.554 . . . . 0.0 111.55 178.727 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.286 10.5 pt-20 54.19 23.59 4.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.796 2.438 . . . . 0.0 115.645 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -133.29 128.67 36.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.115 1.366 . . . . 0.0 110.432 177.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -65.01 148.04 52.38 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.448 -0.783 . . . . 0.0 112.022 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 15.2 m -70.21 152.43 95.68 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.879 168.973 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.22 128.01 24.94 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.683 2.255 . . . . 0.0 110.402 177.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.96 62.28 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.175 1.369 . . . . 0.0 115.045 -174.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.7 t -78.49 140.71 60.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.281 1.54 . . . . 0.0 111.5 175.411 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.71 137.39 49.97 Favored 'Cis proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.401 0.822 . . . . 0.0 111.963 -4.163 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -87.71 165.69 15.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.107 1.763 . . . . 0.0 110.66 175.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 88.7 m -123.84 119.22 29.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.885 0.874 . . . . 0.0 110.255 174.343 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.61 135.56 39.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.809 1.243 . . . . 0.0 110.921 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.6 tpt85 -80.2 141.41 35.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.818 0.847 . . . . 0.0 109.259 167.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.8 t -129.41 132.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.78 1.173 . . . . 0.0 110.926 176.306 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 27.6 p -111.49 159.55 17.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.251 1.42 . . . . 0.0 112.843 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.04 128.72 9.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.703 1.621 . . . . 0.0 112.57 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.222 1.409 . . . . 0.0 113.42 176.645 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -52.0 112.96 3.67 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.787 1.235 . . . . 0.0 112.313 -172.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.63 148.76 33.33 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.693 2.262 . . . . 0.0 110.811 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.48 122.49 32.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.182 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -148.45 147.13 28.8 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.904 1.282 . . . . 0.0 111.057 168.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.93 154.8 20.28 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.38 1.472 . . . . 0.0 110.503 -175.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 10.6 p -127.4 134.42 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.627 1.571 . . . . 0.0 109.615 172.533 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.0 mt -132.58 137.63 30.25 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.789 1.636 . . . . 0.0 109.334 -171.766 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.4 84.73 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.895 3.063 . . . . 0.0 110.883 177.343 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -134.16 151.16 51.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.509 1.923 . . . . 0.0 109.625 173.91 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 80.7 m -126.37 123.86 38.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 109.488 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.88 129.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.704 1.201 . . . . 0.0 109.904 178.573 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -105.69 -139.12 0.37 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.961 1.304 . . . . 0.0 110.643 175.797 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -75.94 -6.21 49.84 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -178.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.93 -149.18 10.58 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.922 1.725 . . . . 0.0 113.038 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.49 151.1 27.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.934 1.294 . . . . 0.0 111.033 -174.618 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.0 tt -127.35 135.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.59 1.556 . . . . 0.0 112.015 -175.794 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.3 p -147.92 162.66 38.85 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.814 1.645 . . . . 0.0 110.875 -176.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -147.19 -176.16 20.67 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 116.046 1.178 . . . . 0.0 116.046 -177.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -153.92 143.31 21.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.566 1.946 . . . . 0.0 109.119 173.327 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 24.9 t -117.61 133.2 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.727 1.611 . . . . 0.0 108.195 174.38 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -117.4 129.35 55.8 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.288 1.035 . . . . 0.0 110.813 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.9 mpp? -97.3 148.22 34.1 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.576 1.55 . . . . 0.0 111.506 -173.291 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 -21.01 29.91 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.462 2.774 . . . . 0.0 113.145 -179.161 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.2 p -79.22 1.02 26.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.379 1.471 . . . . 0.0 114.431 176.76 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.04 54.63 2.27 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.665 1.126 . . . . 0.0 113.296 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -156.61 166.33 33.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.961 1.704 . . . . 0.0 111.864 -177.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.8 m -141.63 158.13 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.798 1.239 . . . . 0.0 112.652 -173.326 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.88 173.46 16.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.474 2.31 . . . . 0.0 110.045 177.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -114.75 144.93 32.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 121.13 -0.981 . . . . 0.0 112.769 -179.225 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -86.56 174.8 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.837 3.691 . . . . 0.0 112.034 177.695 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 71.7 m -110.05 133.5 53.14 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.809 1.644 . . . . 0.0 108.806 171.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.83 140.75 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.989 1.316 . . . . 0.0 108.604 173.592 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 14.5 t -148.0 139.42 23.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.731 1.212 . . . . 0.0 111.005 177.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.01 138.38 32.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.651 1.18 . . . . 0.0 112.638 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -96.56 -9.54 29.23 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.064 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.76 -1.69 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.693 2.397 . . . . 0.0 115.02 173.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.79 3.33 55.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.602 1.961 . . . . 0.0 113.549 175.359 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 102.29 12.28 34.01 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.365 1.46 . . . . 0.0 114.399 -174.128 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 26.3 p -125.86 161.62 27.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.141 1.377 . . . . 0.0 111.824 174.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -121.79 144.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.734 1.214 . . . . 0.0 109.946 165.524 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 17.1 m -97.33 139.81 32.72 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.331 1.452 . . . . 0.0 109.037 170.788 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.1 t -127.23 136.84 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.69 1.596 . . . . 0.0 108.934 178.748 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -142.35 157.7 44.52 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.07 1.348 . . . . 0.0 112.684 -174.629 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -154.92 135.27 13.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.254 1.421 . . . . 0.0 111.88 172.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.16 120.58 72.5 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.9 1.28 . . . . 0.0 110.923 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.87 167.55 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.906 3.07 . . . . 0.0 112.281 -172.645 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 89.4 p -147.22 -26.32 0.39 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.877 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.92 150.09 45.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.175 1.79 . . . . 0.0 110.393 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.73 168.67 18.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.492 1.117 . . . . 0.0 113.135 178.477 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 121.44 -173.15 15.56 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 125.425 1.488 . . . . 0.0 114.071 178.09 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.8 tt -87.8 127.47 35.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.809 1.244 . . . . 0.0 109.747 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 65.3 m80 -127.66 164.16 22.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.943 1.697 . . . . 0.0 111.585 -172.29 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -146.35 154.15 41.33 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.777 0.799 . . . . 0.0 112.554 166.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.9 ttm -127.33 133.7 50.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.85 2.46 . . . . 0.0 109.763 -173.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -103.83 131.93 50.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.304 1.842 . . . . 0.0 109.354 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 27.8 mm -130.51 128.26 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.358 1.063 . . . . 0.0 109.783 175.84 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.52 137.39 37.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.926 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 48.2 t80 -103.9 124.07 48.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.836 2.054 . . . . 0.0 109.358 174.066 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.01 46.09 22.57 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.692 1.197 . . . . 0.0 112.344 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.301 0.2 OUTLIER 63.34 9.99 4.44 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.034 2.533 . . . . 0.0 116.56 -177.222 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.7 mtp -110.88 131.24 55.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.231 1.412 . . . . 0.0 110.931 173.349 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -55.91 134.11 51.86 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.433 -0.792 . . . . 0.0 112.813 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.8 pt -73.89 155.59 88.6 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.701 178.197 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -59.44 122.44 11.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.711 1.607 . . . . 0.0 108.395 163.288 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 113.78 -25.01 11.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.996 1.284 . . . . 0.0 113.021 -171.52 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.4 t -83.79 148.3 54.01 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 118.91 1.355 . . . . 0.0 111.341 174.794 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.06 155.85 97.27 Favored 'Cis proline' 0 C--N 1.351 0.698 0 CA-C-N 119.79 0.961 . . . . 0.0 111.674 -10.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.51 133.75 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 109.227 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -137.92 134.74 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 110.975 -170.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.5 178.85 7.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.309 1.043 . . . . 0.0 113.109 -171.062 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -116.8 143.53 45.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.517 1.127 . . . . 0.0 112.555 176.173 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 94.2 t -112.86 132.69 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.293 1.837 . . . . 0.0 109.416 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 29.3 t0 -159.46 152.0 21.39 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.235 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.07 134.86 39.94 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.18 -0.95 . . . . 0.0 112.622 -176.636 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.1 p -70.58 -19.95 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.4 0.68 . . . . 0.0 112.589 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -73.39 -20.61 60.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.889 1.276 . . . . 0.0 114.014 -178.186 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.0 m -73.92 148.61 42.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.384 1.073 . . . . 0.0 113.146 -173.731 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -92.46 -14.03 56.22 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.95 1.262 . . . . 0.0 114.703 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -65.03 160.78 20.16 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.553 1.176 . . . . 0.0 113.427 177.111 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.5 t -69.47 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.731 0.812 . . . . 0.0 109.363 177.044 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -161.22 161.53 30.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.301 1.441 . . . . 0.0 110.543 -175.661 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.73 147.83 32.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.511 1.124 . . . . 0.0 112.291 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.51 161.55 13.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.752 1.621 . . . . 0.0 112.941 -176.345 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.25 171.86 12.33 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.506 1.527 . . . . 0.0 113.09 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.29 -34.84 26.09 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.12 2.546 . . . . 0.0 112.616 -173.139 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.82 -21.99 73.5 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 119.036 0.835 . . . . 0.0 114.662 -177.431 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.89 -14.9 60.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.39 1.095 . . . . 0.0 113.168 172.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 16.9 m -117.15 -36.16 3.87 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.777 1.631 . . . . 0.0 111.926 -168.55 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -150.6 155.63 39.78 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.489 1.916 . . . . 0.0 111.963 -174.468 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -149.31 173.51 29.13 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 123.978 0.799 . . . . 0.0 113.176 171.351 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 54.6 t -135.32 132.01 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.654 1.182 . . . . 0.0 108.353 176.051 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -57.73 138.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.11 2.28 2.24 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.997 2.119 . . . . 0.0 114.62 176.651 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -117.64 141.28 28.7 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.026 1.73 . . . . 0.0 110.93 177.171 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.13 130.29 16.3 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.672 2.248 . . . . 0.0 111.099 -173.292 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.7 139.54 44.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.415 1.486 . . . . 0.0 110.06 173.34 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -131.02 152.61 50.15 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.5 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.1 175.12 12.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.541 1.536 . . . . 0.0 112.189 177.31 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 47.5 m -125.62 143.45 51.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.963 1.705 . . . . 0.0 110.625 -171.9 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.3 t -121.45 131.45 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.215 1.806 . . . . 0.0 108.362 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -89.13 132.31 34.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.391 1.077 . . . . 0.0 111.754 -178.332 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.6 p -130.74 1.31 4.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.754 . . . . 0.0 113.222 -176.372 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -52.0 -38.8 58.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.02 2.128 . . . . 0.0 115.445 -168.213 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -131.81 21.05 4.59 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.523 1.529 . . . . 0.0 111.926 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.95 69.43 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.729 1.212 . . . . 0.0 113.885 -174.587 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.51 149.88 6.37 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.685 1.136 . . . . 0.0 112.301 -169.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.67 163.96 27.28 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.08 0.952 . . . . 0.0 113.531 -177.766 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 161.85 -30.49 0.31 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.538 1.066 . . . . 0.0 114.705 175.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.73 101.15 0.35 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.579 1.562 . . . . 0.0 112.748 173.179 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.72 144.63 37.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.989 1.316 . . . . 0.0 110.457 175.421 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -147.44 158.34 43.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.974 1.31 . . . . 0.0 112.049 -173.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.7 tp -166.6 135.87 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.928 1.691 . . . . 0.0 109.495 -164.605 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.86 159.13 36.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.359 1.064 . . . . 0.0 111.923 175.312 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.35 128.67 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.662 1.185 . . . . 0.0 109.67 175.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -115.69 163.65 15.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.107 1.763 . . . . 0.0 110.039 171.771 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 178.91 -166.88 36.81 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.269 -0.894 . . . . 0.0 113.852 -179.309 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.75 -19.18 36.48 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.625 2.883 . . . . 0.0 112.268 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.0 t -142.88 158.16 43.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.831 1.653 . . . . 0.0 108.867 161.308 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 23.2 tptp -74.84 120.69 20.72 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.832 -1.167 . . . . 0.0 111.96 -175.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.2 147.33 34.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.002 0.921 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.01 147.68 23.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.057 0.943 . . . . 0.0 110.777 169.567 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 13.6 mt -137.08 145.98 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.882 1.273 . . . . 0.0 110.524 -161.466 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 78.5 p -143.79 161.98 37.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.1 1.36 . . . . 0.0 111.388 165.246 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.02 158.64 35.24 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.384 1.074 . . . . 0.0 112.738 -175.878 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.9 m -147.54 119.47 8.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.462 1.505 . . . . 0.0 110.097 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.69 129.7 35.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.658 1.183 . . . . 0.0 111.303 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -108.9 152.74 24.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.827 1.251 . . . . 0.0 112.127 -177.853 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -64.54 -26.31 68.36 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.855 1.262 . . . . 0.0 113.482 -174.21 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -83.13 8.08 14.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.241 1.416 . . . . 0.0 114.767 -178.562 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.53 27.73 8.94 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 168.436 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 23.4 p -139.88 135.14 32.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.324 1.05 . . . . 0.0 111.583 175.717 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 41.3 t -90.64 128.84 36.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 109.819 163.535 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -92.55 149.45 21.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.14 0.976 . . . . 0.0 110.212 169.77 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 61.9 t -132.43 144.09 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.761 1.624 . . . . 0.0 109.663 -178.098 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 19.7 t -138.19 142.38 40.02 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.601 1.561 . . . . 0.0 110.916 172.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.5 p90 -148.54 156.46 42.47 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.2 mt -121.31 107.25 37.25 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.828 1.651 . . . . 0.0 110.541 -179.314 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.35 164.27 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.7 2.933 . . . . 0.0 110.284 166.186 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.6 p -125.63 -21.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -170.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.9 pp -146.0 151.48 45.28 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.949 1.3 . . . . 0.0 110.31 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.48 153.28 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 112.534 -169.634 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.67 -165.51 28.38 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.8 1.19 . . . . 0.0 113.431 -177.59 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -93.13 124.87 37.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.159 1.384 . . . . 0.0 111.853 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -114.1 138.32 50.56 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.385 1.474 . . . . 0.0 110.627 178.272 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -102.64 114.7 29.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.483 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.51 125.46 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.196 1.398 . . . . 0.0 108.665 -179.275 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -104.63 132.26 51.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.578 1.551 . . . . 0.0 109.545 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.7 t -133.45 129.28 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.341 1.056 . . . . 0.0 109.565 172.391 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -154.54 144.45 21.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.98 1.312 . . . . 0.0 111.689 -165.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.92 122.15 11.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.833 1.253 . . . . 0.0 109.618 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.3 t-20 54.92 56.62 6.44 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.352 1.461 . . . . 0.0 111.635 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 60.62 1.46 0.41 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 129.149 2.98 . . . . 0.0 116.701 -177.522 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -106.46 125.92 51.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.532 1.133 . . . . 0.0 111.015 178.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.21 145.16 56.44 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 169.1 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 6.8 m -75.37 157.69 84.44 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.774 173.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.76 125.22 17.94 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.616 2.878 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.42 77.09 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.716 1.15 . . . . 0.0 115.544 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 33.0 t -77.03 139.91 65.97 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.349 1.575 . . . . 0.0 111.728 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.84 141.8 71.86 Favored 'Cis proline' 0 CA--C 1.539 0.773 0 CA-C-N 119.5 0.857 . . . . 0.0 111.953 -4.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 154.08 17.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 110.95 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 62.2 m -112.73 114.44 27.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.636 0.774 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.5 133.76 42.42 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 111.407 174.192 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -94.62 105.84 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.678 1.191 . . . . 0.0 109.863 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.4 t -91.09 137.68 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.245 1.018 . . . . 0.0 110.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 68.6 p -115.81 158.95 22.14 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.434 1.494 . . . . 0.0 112.942 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.53 137.66 19.24 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.896 1.236 . . . . 0.0 111.531 174.683 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 CA--C 1.548 0.866 0 C-N-CA 124.391 1.076 . . . . 0.0 113.373 -179.015 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.29 0.567 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -68.88 121.58 81.98 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.239 1.415 . . . . 0.0 110.51 -175.339 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.66 151.98 69.73 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.297 2.665 . . . . 0.0 111.723 -171.075 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.7 t80 -98.48 124.63 43.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.588 0.755 . . . . 0.0 110.306 176.869 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -153.16 133.35 13.44 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 110.913 173.389 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.11 156.37 44.32 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.456 1.902 . . . . 0.0 109.873 -170.783 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -130.98 138.57 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.083 1.353 . . . . 0.0 110.53 -178.451 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.86 136.41 27.67 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.243 1.817 . . . . 0.0 109.094 -174.953 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.18 114.38 3.97 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.168 2.579 . . . . 0.0 110.053 172.528 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 42.2 t80 -178.2 152.56 0.71 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.182 2.193 . . . . 0.0 109.333 -170.215 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 36.8 m -133.49 129.57 37.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.455 1.102 . . . . 0.0 110.218 178.719 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.0 mt -79.62 109.98 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.189 0.995 . . . . 0.0 109.056 171.761 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.73 -58.8 2.08 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -176.708 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -158.88 -12.32 0.07 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.482 2.031 . . . . 0.0 116.482 -167.1 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.02 -136.89 5.94 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.134 1.826 . . . . 0.0 112.226 176.089 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -154.31 145.64 22.98 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.147 1.379 . . . . 0.0 110.421 -176.053 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.8 tt -128.45 137.93 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.414 1.486 . . . . 0.0 111.438 -178.193 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.2 p -147.31 164.78 32.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.965 1.706 . . . . 0.0 110.587 -178.283 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -149.65 177.78 27.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 -177.069 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -150.62 137.3 18.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.993 1.717 . . . . 0.0 109.614 175.036 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.9 t -111.32 137.99 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.332 1.853 . . . . 0.0 108.506 174.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.88 133.67 54.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.969 1.308 . . . . 0.0 111.551 -173.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.02 149.61 38.79 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.837 1.655 . . . . 0.0 111.971 -173.946 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -54.66 -32.28 74.66 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.174 3.249 . . . . 0.0 114.668 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 38.1 m -71.42 -1.27 12.54 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.451 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.65 -1.53 83.84 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.545 1.545 . . . . 0.0 113.935 -176.976 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -74.83 161.61 29.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.596 1.558 . . . . 0.0 112.001 177.582 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.9 m -139.21 157.33 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.186 1.394 . . . . 0.0 111.831 176.438 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.6 170.42 21.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.41 1.884 . . . . 0.0 111.017 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -114.13 138.75 23.05 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.026 0.931 . . . . 0.0 111.391 178.591 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.62 175.55 2.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.497 3.465 . . . . 0.0 112.45 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.9 m -109.33 133.08 53.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.47 1.508 . . . . 0.0 109.373 173.813 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.93 134.47 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.051 1.34 . . . . 0.0 109.263 175.899 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -135.69 126.29 27.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.627 1.571 . . . . 0.0 109.999 179.243 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.69 129.52 34.55 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.744 0.818 . . . . 0.0 110.558 171.22 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.76 -5.0 59.09 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.997 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 65.37 22.46 11.99 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.331 1.853 . . . . 0.0 112.53 -175.878 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -134.77 15.44 3.62 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.383 1.873 . . . . 0.0 112.71 -171.437 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.37 11.11 72.72 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.768 1.175 . . . . 0.0 114.451 -179.058 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.1 p -130.86 154.06 48.45 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 110.958 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.1 m -113.76 138.21 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.313 1.045 . . . . 0.0 109.697 164.482 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.1 m -99.0 139.47 34.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.051 1.341 . . . . 0.0 108.531 170.093 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 36.2 t -126.08 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.288 1.435 . . . . 0.0 108.962 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -135.32 154.09 51.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.757 1.223 . . . . 0.0 112.823 -172.413 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 42.2 t80 -155.02 136.33 14.05 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.747 1.619 . . . . 0.0 112.054 177.707 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.55 117.39 67.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.799 1.239 . . . . 0.0 110.817 176.789 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.38 146.99 22.46 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.658 2.905 . . . . 0.0 112.704 -174.242 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 68.4 m -122.84 -2.75 8.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.68 1.192 . . . . 0.0 113.634 175.766 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 154.58 19.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.225 1.81 . . . . 0.0 111.166 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.62 172.02 12.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.519 1.128 . . . . 0.0 112.664 176.826 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.71 -175.92 16.8 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.047 1.308 . . . . 0.0 113.996 177.284 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -84.98 118.19 24.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.354 1.062 . . . . 0.0 110.186 -178.656 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 39.4 m80 -114.01 165.1 12.97 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.223 1.809 . . . . 0.0 111.779 -174.565 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.83 155.96 44.3 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.325 1.05 . . . . 0.0 111.551 173.134 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 29.2 ttm -142.28 124.16 15.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.583 1.553 . . . . 0.0 110.203 -171.931 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.93 126.34 46.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 109.841 176.253 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 41.0 mm -123.42 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.262 1.425 . . . . 0.0 110.285 176.395 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.32 139.77 23.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.422 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.8 t80 -106.18 124.95 50.38 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.337 2.255 . . . . 0.0 110.102 177.574 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 53.32 29.0 7.95 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.775 1.23 . . . . 0.0 112.461 -173.09 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 25.2 t30 77.41 4.87 3.13 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.573 2.749 . . . . 0.0 115.185 -178.224 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 59.8 ttm -103.32 134.04 47.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.346 1.458 . . . . 0.0 111.063 172.313 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.3 m170 -57.31 134.34 55.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.293 -0.879 . . . . 0.0 113.001 -178.549 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 42.0 pt -74.94 155.01 86.84 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.65 . . . . 0.0 111.568 176.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.12 125.86 19.33 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.374 2.049 . . . . 0.0 109.779 172.731 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.07 -16.7 56.99 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.618 1.104 . . . . 0.0 114.326 -173.243 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.5 t -81.76 146.65 56.82 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 119.043 1.422 . . . . 0.0 111.73 176.783 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.76 162.64 84.7 Favored 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 120.09 1.068 . . . . 0.0 112.302 -6.174 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.4 mt -95.64 155.3 16.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.038 1.335 . . . . 0.0 110.834 172.38 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -156.74 132.96 9.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.714 1.205 . . . . 0.0 109.977 -175.268 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.9 p90 -167.39 172.95 9.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.426 1.09 . . . . 0.0 112.526 -168.162 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 46.3 t80 -108.74 134.04 51.99 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.178 0.991 . . . . 0.0 113.035 176.308 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.3 t -96.31 133.38 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 109.494 172.938 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 45.5 t0 -143.97 173.89 11.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.811 2.045 . . . . 0.0 109.918 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -79.12 151.25 31.47 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.724 -1.235 . . . . 0.0 113.459 178.368 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 69.4 t -66.3 -47.64 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.229 1.411 . . . . 0.0 110.4 174.922 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -95.52 128.22 42.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 110.621 175.047 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 23.6 p -171.77 153.17 3.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.979 1.712 . . . . 0.0 112.192 -175.323 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -103.59 -19.33 12.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.114 1.34 . . . . 0.0 113.772 173.471 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -71.61 155.98 39.91 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.337 1.068 . . . . 0.0 113.379 177.782 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -68.39 137.58 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.095 0.958 . . . . 0.0 108.567 172.653 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.6 t -156.0 168.15 28.17 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.72 1.208 . . . . 0.0 110.972 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.22 147.36 30.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.823 1.249 . . . . 0.0 112.155 -177.603 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.7 p90 -167.21 164.41 15.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.052 1.741 . . . . 0.0 112.391 -175.842 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.39 173.72 13.44 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.201 1.381 . . . . 0.0 113.315 -179.203 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.37 -32.69 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.935 2.424 . . . . 0.0 113.194 -170.624 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.43 76.52 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 119.402 1.001 . . . . 0.0 114.333 -172.593 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.0 pp -78.09 -3.38 42.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.965 1.383 . . . . 0.0 113.374 174.818 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.2 m -107.01 -39.91 5.61 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.595 1.958 . . . . 0.0 111.891 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -149.94 150.51 31.96 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.501 1.92 . . . . 0.0 112.495 -169.817 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 177.07 28.92 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.015 0.817 . . . . 0.0 113.472 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 35.3 t -139.98 134.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.941 1.296 . . . . 0.0 107.901 174.787 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.2 m -56.31 134.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 122.901 0.48 . . . . 0.0 112.253 -177.821 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.9 m-80 69.48 -5.51 1.14 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.142 2.177 . . . . 0.0 114.616 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -97.87 138.45 21.0 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.865 1.266 . . . . 0.0 110.646 175.205 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.99 126.17 11.01 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.475 2.117 . . . . 0.0 110.289 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.58 144.11 36.72 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.463 1.505 . . . . 0.0 110.371 175.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 60.3 p -135.38 149.16 49.6 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -166.57 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.0 p90 -160.26 175.51 12.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.443 1.497 . . . . 0.0 111.682 177.234 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 30.5 m -129.68 139.48 51.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.04 1.336 . . . . 0.0 110.805 -169.024 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -110.44 133.94 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.024 1.73 . . . . 0.0 107.877 168.137 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.88 126.99 37.17 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.137 0.975 . . . . 0.0 111.02 178.931 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 78.6 p -127.09 3.13 6.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.065 1.746 . . . . 0.0 113.072 -172.777 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -52.99 -27.33 18.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.473 2.309 . . . . 0.0 116.382 -171.781 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.56 15.2 5.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.471 1.508 . . . . 0.0 112.191 176.483 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -79.23 -25.03 42.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.633 1.173 . . . . 0.0 113.494 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.09 -107.0 2.38 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.638 1.113 . . . . 0.0 112.101 178.649 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.94 152.99 23.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.234 1.813 . . . . 0.0 110.066 -174.998 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.55 8.26 0.11 Allowed Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 90.87 106.45 1.36 Allowed Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.463 1.506 . . . . 0.0 112.885 177.133 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 139.19 30.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.066 1.347 . . . . 0.0 109.762 170.396 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.0 m -130.77 159.35 37.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.569 1.548 . . . . 0.0 111.826 178.108 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.9 135.25 8.19 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.531 1.532 . . . . 0.0 109.409 -167.418 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 158.57 35.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.189 0.996 . . . . 0.0 112.194 178.664 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -138.24 136.04 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.758 1.223 . . . . 0.0 109.827 177.159 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -129.23 130.13 45.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.215 1.406 . . . . 0.0 110.21 176.075 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.84 -162.49 11.41 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.094 -176.259 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -62.33 -25.71 76.62 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.932 3.088 . . . . 0.0 112.388 174.324 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 21.1 t -137.2 153.8 50.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 109.112 161.202 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -74.07 119.54 18.42 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.876 -1.14 . . . . 0.0 110.837 177.006 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.33 151.7 44.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.002 0.921 . . . . 0.0 112.332 178.413 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.11 137.76 32.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 164.974 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.3 mt -132.99 138.9 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.479 1.112 . . . . 0.0 110.501 -169.307 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 74.1 m -132.03 157.53 43.89 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.848 1.659 . . . . 0.0 110.635 167.662 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -153.41 155.76 36.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.059 0.944 . . . . 0.0 112.766 177.617 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.6 m -143.54 119.22 10.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.33 1.452 . . . . 0.0 110.382 -170.902 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.11 134.47 38.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.633 1.173 . . . . 0.0 111.396 173.251 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -114.3 148.44 37.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.626 1.571 . . . . 0.0 111.913 -177.959 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.51 -12.81 61.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.838 0.855 . . . . 0.0 112.718 174.842 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.35 -5.77 44.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.791 1.637 . . . . 0.0 114.031 177.115 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 32.83 7.63 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.646 1.117 . . . . 0.0 113.723 -179.717 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.7 p -139.84 160.17 40.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.968 1.307 . . . . 0.0 111.363 176.797 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 46.5 t -114.66 127.22 55.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.246 1.419 . . . . 0.0 108.434 160.187 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.7 t -92.52 147.93 22.5 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.144 0.977 . . . . 0.0 110.759 174.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.6 t -124.83 142.11 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.883 1.673 . . . . 0.0 109.927 -178.176 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.4 m -131.06 140.43 50.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.523 1.529 . . . . 0.0 110.424 167.521 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 14.4 p90 -146.85 154.11 40.94 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 174.718 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.17 106.74 42.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.085 1.754 . . . . 0.0 110.514 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.31 176.41 7.36 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.926 3.084 . . . . 0.0 110.523 167.413 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.7 p -149.83 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.572 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.77 147.29 35.5 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.422 1.089 . . . . 0.0 110.434 166.693 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.21 156.07 46.66 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.897 2.398 . . . . 0.0 110.925 175.069 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.62 -161.19 23.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.77 1.176 . . . . 0.0 113.647 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.24 131.96 36.43 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.154 1.382 . . . . 0.0 112.682 -178.967 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.57 122.41 38.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.602 1.561 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.6 m -84.23 127.22 33.82 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.192 -0.942 . . . . 0.0 110.832 175.99 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.38 124.88 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.953 1.701 . . . . 0.0 108.33 178.881 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -105.01 130.68 53.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.401 1.48 . . . . 0.0 109.699 174.926 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.4 t -131.7 128.36 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.409 1.084 . . . . 0.0 109.779 172.284 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.9 147.08 29.35 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.233 1.413 . . . . 0.0 111.615 -170.358 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.47 121.93 11.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.94 1.296 . . . . 0.0 109.461 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 54.08 56.79 6.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.425 1.49 . . . . 0.0 112.123 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 8.4 pt-20 59.38 4.13 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.965 2.906 . . . . 0.0 116.711 -176.478 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.67 126.12 53.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.659 1.184 . . . . 0.0 111.022 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -65.02 146.9 54.41 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.234 -0.916 . . . . 0.0 111.787 169.907 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.2 m -72.09 153.47 92.61 Favored Pre-proline 0 N--CA 1.482 1.152 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.378 170.75 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -57.99 130.42 38.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.116 2.544 . . . . 0.0 110.65 175.223 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 90.71 -15.75 59.74 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.95 1.262 . . . . 0.0 114.929 -175.516 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.0 t -77.87 139.95 62.34 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.457 1.628 . . . . 0.0 111.457 175.629 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.45 135.92 42.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.373 0.812 . . . . 0.0 111.977 -3.807 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.44 172.92 10.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.825 1.65 . . . . 0.0 110.186 172.808 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 84.9 m -137.21 121.61 18.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 174.092 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.25 147.46 23.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.985 1.714 . . . . 0.0 111.571 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.47 113.0 25.7 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.343 1.057 . . . . 0.0 109.759 173.831 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.0 t -95.37 142.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.976 1.31 . . . . 0.0 110.115 177.29 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.4 t -128.3 170.61 12.86 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.305 1.042 . . . . 0.0 113.167 178.732 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -82.45 137.83 17.47 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.788 1.661 . . . . 0.0 113.091 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 125.067 1.347 . . . . 0.0 112.803 174.987 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 121.021 0.438 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A 1789 ' ' ARG . . . . . 0.421 HH12 ' HA ' ' A' 1863 ' ' VAL . 8.7 tpp180 -55.03 118.85 18.97 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.251 1.42 . . . . 0.0 111.615 -174.316 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.19 126.64 13.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.443 2.095 . . . . 0.0 108.756 177.425 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 64.7 t80 -116.24 125.07 51.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.7 0.762 . . . . 0.0 111.833 -171.718 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.62 142.34 16.56 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.017 1.727 . . . . 0.0 110.524 174.124 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.39 148.36 47.78 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.867 1.667 . . . . 0.0 110.418 -173.209 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.1 p -112.54 137.59 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.105 1.362 . . . . 0.0 109.923 173.034 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.0 mt -134.68 135.58 23.77 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.93 1.692 . . . . 0.0 108.798 -173.348 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.77 113.84 3.88 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.273 2.649 . . . . 0.0 109.979 175.964 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.4 t80 -172.72 146.07 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.485 1.914 . . . . 0.0 109.689 -172.766 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.7 m -118.71 122.31 42.19 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.496 1.119 . . . . 0.0 109.269 176.19 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.77 116.42 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.73 0.812 . . . . 0.0 109.372 175.969 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.3 mttt -96.56 -143.23 0.28 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.37 1.468 . . . . 0.0 111.607 178.174 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -78.07 -9.79 59.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.59 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.82 -142.56 5.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.335 1.921 . . . . 0.0 113.086 177.178 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.94 150.05 25.47 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.015 1.326 . . . . 0.0 111.229 -172.484 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.14 136.88 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.791 1.636 . . . . 0.0 111.389 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.7 p -146.07 -178.08 5.94 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.207 1.803 . . . . 0.0 110.138 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.0 -165.07 31.81 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -179.437 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -147.87 149.29 31.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.773 2.029 . . . . 0.0 109.934 -179.881 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 62.0 t -122.23 132.25 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.689 1.595 . . . . 0.0 107.92 167.659 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -115.38 130.97 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.808 1.243 . . . . 0.0 111.133 -174.505 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -102.84 149.9 37.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.717 1.607 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.65 -32.95 85.65 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.349 3.366 . . . . 0.0 115.315 176.969 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.0 t -77.59 -1.68 31.99 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.2 -1.06 72.89 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.386 1.469 . . . . 0.0 114.079 -177.684 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -66.03 155.95 35.16 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 111.763 171.152 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.7 m -139.7 152.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.019 1.328 . . . . 0.0 111.334 175.874 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.97 175.02 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.556 1.942 . . . . 0.0 110.222 179.684 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -120.03 141.02 30.74 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 121.482 -0.761 . . . . 0.0 111.358 178.713 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.94 165.65 13.33 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.957 3.105 . . . . 0.0 111.341 177.236 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.7 m -104.82 125.5 50.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.009 1.324 . . . . 0.0 108.679 172.098 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.0 135.12 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 109.236 175.485 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 83.9 m -128.25 132.1 48.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.049 1.74 . . . . 0.0 109.935 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 18.0 t0 -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.241 1.016 . . . . 0.0 111.019 171.596 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.9 -14.74 43.93 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.088 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 62.8 tttt 72.71 -2.88 2.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 127.668 2.387 . . . . 0.0 113.967 178.267 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -96.98 5.34 50.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.005 2.122 . . . . 0.0 113.29 -178.138 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.12 12.78 54.52 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.144 1.354 . . . . 0.0 113.962 -174.19 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.6 p -127.46 159.32 34.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.173 1.789 . . . . 0.0 110.477 173.764 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.79 146.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.59 1.156 . . . . 0.0 109.623 166.275 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 27.0 m -105.04 137.06 43.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.111 0.965 . . . . 0.0 108.736 170.597 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.5 t -119.56 133.83 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.148 1.379 . . . . 0.0 109.167 178.619 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.76 150.76 51.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.628 1.571 . . . . 0.0 111.841 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.6 t80 -155.62 132.59 10.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.429 1.491 . . . . 0.0 111.384 178.431 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.36 120.7 74.75 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.246 1.019 . . . . 0.0 110.498 176.821 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.9 139.36 27.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.301 2.667 . . . . 0.0 112.138 -172.04 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -138.82 10.58 2.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.338 1.055 . . . . 0.0 113.815 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -161.83 154.26 19.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.226 1.81 . . . . 0.0 110.012 -178.269 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -101.27 160.18 14.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.612 1.165 . . . . 0.0 112.257 174.921 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.24 -163.39 12.25 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.555 1.55 . . . . 0.0 113.991 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -92.86 113.46 25.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.052 1.341 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.2 m80 -105.59 173.72 6.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.233 2.213 . . . . 0.0 111.933 -174.441 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.3 146.83 35.48 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.644 0.778 . . . . 0.0 112.071 171.364 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.2 ttm -116.7 134.97 54.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.051 2.14 . . . . 0.0 109.457 -179.899 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -126.62 119.7 27.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.712 2.005 . . . . 0.0 109.136 -174.273 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -131.45 136.77 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.051 0.941 . . . . 0.0 111.393 -171.39 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 134.86 21.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.486 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 27.3 t80 -101.49 125.1 48.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 110.185 176.366 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.8 36.38 14.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.858 1.263 . . . . 0.0 112.641 -176.229 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 45.0 m-80 83.02 -8.54 1.14 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.358 3.063 . . . . 0.0 114.658 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 62.3 mtt -100.95 134.71 43.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.22 1.408 . . . . 0.0 111.999 -178.469 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -54.0 135.85 42.28 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.189 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -76.89 155.23 83.01 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.272 173.109 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.09 131.96 41.93 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.153 1.902 . . . . 0.0 109.945 172.146 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.13 -9.17 76.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.432 -174.967 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.1 t -84.03 144.29 44.24 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 120.042 1.921 . . . . 0.0 111.422 170.721 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -79.38 164.1 83.25 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.816 0.97 . . . . 0.0 112.244 -7.439 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.6 mt -113.3 156.95 22.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.965 1.706 . . . . 0.0 110.697 174.512 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.59 143.46 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.711 1.204 . . . . 0.0 110.404 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -159.12 150.17 20.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.952 0.901 . . . . 0.0 112.489 -170.315 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -100.55 143.74 30.37 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.294 -0.879 . . . . 0.0 112.599 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 38.4 t -126.16 137.5 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.355 1.462 . . . . 0.0 109.438 178.98 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -161.48 158.54 26.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.81 -167.697 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -75.48 146.35 40.69 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.855 -1.153 . . . . 0.0 113.357 -173.443 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1863 ' ' VAL . . . . . 0.421 ' HA ' HH12 ' A' 1789 ' ' ARG . 18.0 m -70.6 -18.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.988 -1.07 . . . . 0.0 112.796 171.585 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 31.9 p30 -90.83 4.75 50.89 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.353 1.461 . . . . 0.0 114.244 178.97 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.1 p -62.66 151.41 38.27 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -166.342 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.91 40.73 2.42 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.382 1.944 . . . . 0.0 113.166 -177.424 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -153.89 167.33 30.06 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.24 1.416 . . . . 0.0 113.081 -176.21 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.2 t -73.05 134.76 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.113 0.965 . . . . 0.0 108.801 171.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.4 t -148.93 165.64 30.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.825 1.25 . . . . 0.0 110.905 -175.183 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.2 147.44 27.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.727 1.211 . . . . 0.0 111.861 -177.487 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 48.1 p90 -168.63 163.46 12.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.754 1.622 . . . . 0.0 112.597 -173.367 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.04 174.33 13.27 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.278 1.418 . . . . 0.0 113.032 -178.42 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.51 -35.12 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.908 2.405 . . . . 0.0 112.799 -172.308 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.73 -31.04 72.77 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.368 0.986 . . . . 0.0 114.537 -171.152 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.52 -3.99 49.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.814 1.307 . . . . 0.0 113.351 174.342 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -104.85 -51.74 3.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 110.69 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -141.56 145.12 34.71 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.093 1.757 . . . . 0.0 112.553 -176.864 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -140.4 178.38 19.99 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 124.767 1.175 . . . . 0.0 113.217 172.632 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 15.3 t -139.66 135.97 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.043 . . . . 0.0 108.884 175.941 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -55.57 139.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.3 m-80 67.96 -1.17 1.81 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.943 2.097 . . . . 0.0 115.039 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -116.39 141.99 28.77 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.226 1.41 . . . . 0.0 111.166 177.32 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.0 134.05 20.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.52 2.147 . . . . 0.0 111.126 -174.824 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -112.82 147.18 37.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.707 1.603 . . . . 0.0 110.306 173.653 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.3 p -136.52 152.28 50.34 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.114 0.966 . . . . 0.0 113.604 -167.188 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.9 p90 -161.86 176.56 10.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.097 1.759 . . . . 0.0 111.485 176.623 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 32.2 m -130.79 140.82 50.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.03 1.332 . . . . 0.0 110.862 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -109.96 132.51 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.723 1.609 . . . . 0.0 107.92 168.705 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.93 123.33 38.34 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.131 0.973 . . . . 0.0 110.634 179.516 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.5 p -126.63 1.58 6.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.445 1.498 . . . . 0.0 113.735 -168.236 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -52.91 -38.12 61.49 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.919 1.687 . . . . 0.0 113.777 -177.585 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -99.86 -1.22 37.99 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.643 1.577 . . . . 0.0 113.472 -179.272 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.55 -22.57 50.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -171.417 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.44 -105.53 2.39 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.218 0.913 . . . . 0.0 111.624 -177.057 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -158.37 148.91 20.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.825 -175.691 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.59 31.64 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.469 1.509 . . . . 0.0 112.667 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.73 103.26 2.89 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 124.063 0.84 . . . . 0.0 111.614 176.416 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.65 129.6 34.76 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.996 1.318 . . . . 0.0 108.935 170.442 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 26.9 m -133.55 158.84 42.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.266 1.426 . . . . 0.0 112.399 -175.99 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.8 tp -161.08 136.19 7.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.97 1.708 . . . . 0.0 109.123 -168.727 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.49 36.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.065 0.946 . . . . 0.0 112.299 177.615 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 48.8 mt -138.3 137.36 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.989 1.316 . . . . 0.0 109.675 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -127.37 143.06 51.28 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.42 1.488 . . . . 0.0 109.907 174.188 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -173.13 -162.13 24.65 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.895 -175.28 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.38 -22.81 59.35 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.223 3.282 . . . . 0.0 113.161 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.4 t -144.36 164.45 30.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.008 1.323 . . . . 0.0 109.829 165.647 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -68.7 107.63 3.07 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.845 178.053 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.478 0.711 . . . . 0.0 110.414 169.305 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -102.7 133.84 47.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.479 0.711 . . . . 0.0 109.717 176.605 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -128.15 144.86 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.709 1.204 . . . . 0.0 110.477 -159.137 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -141.57 164.07 31.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.773 1.229 . . . . 0.0 111.093 166.144 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -160.13 156.85 27.43 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.951 1.3 . . . . 0.0 112.206 -178.59 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 62.1 m -145.49 125.07 13.21 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 109.935 -172.465 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.15 134.72 38.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.09 0.956 . . . . 0.0 111.489 170.711 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -108.54 154.62 21.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.298 1.439 . . . . 0.0 112.342 -174.066 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -67.72 -22.02 65.27 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.568 1.147 . . . . 0.0 112.441 175.858 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.6 -4.83 50.8 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.716 1.606 . . . . 0.0 114.734 -176.884 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.98 35.46 6.74 Favored Glycine 0 N--CA 1.476 1.303 0 C-N-CA 124.23 0.919 . . . . 0.0 113.77 -179.414 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 72.9 p -139.46 165.38 27.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.746 1.618 . . . . 0.0 110.539 176.027 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.7 m -116.01 130.4 56.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.904 1.282 . . . . 0.0 109.14 161.529 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.7 t -89.53 149.57 22.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.968 0.907 . . . . 0.0 110.52 170.956 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 96.1 t -129.66 143.35 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.883 1.673 . . . . 0.0 109.842 -178.894 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.2 p -136.39 147.81 47.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.013 1.325 . . . . 0.0 111.84 167.957 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -151.92 152.79 33.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 175.668 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.2 mt -113.54 110.09 50.32 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.257 1.823 . . . . 0.0 110.427 176.401 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -83.1 175.86 8.05 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.918 3.079 . . . . 0.0 110.257 164.162 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -150.04 -31.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -173.932 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.94 147.19 34.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 119.481 1.037 . . . . 0.0 110.728 167.678 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.25 159.67 43.48 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.992 2.462 . . . . 0.0 111.088 175.475 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 127.77 -168.17 19.85 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.173 1.368 . . . . 0.0 112.822 -174.515 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.65 142.89 27.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.387 1.075 . . . . 0.0 113.101 178.167 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -127.13 135.14 50.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.007 1.723 . . . . 0.0 110.26 178.148 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -91.41 126.84 36.63 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.087 -1.008 . . . . 0.0 110.543 174.35 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.18 128.34 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.74 1.616 . . . . 0.0 108.229 178.757 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -111.8 131.82 55.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.383 1.473 . . . . 0.0 109.856 177.128 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.8 t -133.44 127.31 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.663 1.185 . . . . 0.0 109.893 174.192 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.15 144.32 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.148 1.379 . . . . 0.0 111.889 -169.518 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.62 121.21 11.79 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.916 1.286 . . . . 0.0 110.011 -179.226 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 56.38 55.96 6.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.33 1.452 . . . . 0.0 111.814 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.7 pt-20 56.9 14.65 1.95 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.333 2.653 . . . . 0.0 116.234 -177.84 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -123.81 129.03 50.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.661 1.184 . . . . 0.0 110.746 177.414 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -66.68 151.01 48.23 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.326 -0.859 . . . . 0.0 112.111 173.235 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 25.9 m -65.85 150.5 96.35 Favored Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.271 162.425 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.0 -16.69 45.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.269 1.98 . . . . 0.0 114.654 -164.213 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.77 -7.45 61.44 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.137 0.875 . . . . 0.0 115.253 172.525 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -84.69 143.07 40.26 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 118.88 1.34 . . . . 0.0 112.104 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.27 139.85 63.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 CA-C-N 119.2 0.75 . . . . 0.0 111.961 -4.016 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -91.38 165.2 13.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.992 1.717 . . . . 0.0 110.401 174.186 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.5 m -125.35 117.09 22.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.791 0.836 . . . . 0.0 110.223 174.639 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.57 158.7 15.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.735 1.214 . . . . 0.0 110.774 168.195 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -123.98 132.03 53.65 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.775 0.83 . . . . 0.0 110.483 169.363 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.6 t -113.35 131.28 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.437 1.495 . . . . 0.0 110.45 -171.875 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 32.1 p -106.45 167.41 9.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.098 1.359 . . . . 0.0 112.688 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.69 143.2 25.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.103 1.335 . . . . 0.0 112.058 174.247 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 124.156 0.982 . . . . 0.0 113.177 176.442 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 51.5 mt . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 121.683 0.754 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -56.95 118.15 21.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.445 1.898 . . . . 0.0 111.007 175.063 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.35 146.2 55.9 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.611 2.207 . . . . 0.0 109.46 172.596 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -131.14 133.24 45.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.74 0.781 . . . . 0.0 111.68 -175.333 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.51 146.98 10.33 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.593 1.957 . . . . 0.0 110.875 178.313 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.56 154.04 50.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.18 1.792 . . . . 0.0 110.546 -175.648 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.6 p -114.58 138.45 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.215 1.406 . . . . 0.0 109.624 170.993 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 46.5 mt -131.45 135.31 26.78 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.166 1.787 . . . . 0.0 108.395 -172.809 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.89 36.48 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.453 3.435 . . . . 0.0 112.909 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.17 152.11 27.9 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.846 1.258 . . . . 0.0 111.456 177.478 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -116.49 121.28 41.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.229 1.412 . . . . 0.0 109.925 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 78.8 mt -87.91 134.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.871 1.268 . . . . 0.0 110.013 175.84 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -117.91 -141.89 0.36 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.496 1.519 . . . . 0.0 110.542 174.713 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.75 127.18 32.67 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.707 -1.245 . . . . 0.0 110.904 171.412 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.11 -147.99 19.53 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 125.402 1.477 . . . . 0.0 111.723 -171.188 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.44 146.27 18.22 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.67 1.188 . . . . 0.0 111.242 -175.85 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -121.48 135.89 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.714 1.606 . . . . 0.0 111.217 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 47.0 p -146.85 177.69 8.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.399 1.88 . . . . 0.0 110.28 -177.827 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -163.18 -167.31 23.42 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.778 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.97 144.24 22.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.521 1.929 . . . . 0.0 109.549 175.689 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 96.2 t -121.72 134.98 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.897 1.679 . . . . 0.0 108.572 173.597 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -112.98 135.1 54.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.596 1.158 . . . . 0.0 111.832 -175.269 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.7 mpp? -108.04 142.89 26.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.707 1.603 . . . . 0.0 111.748 -175.736 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.46 -27.25 58.0 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.48 3.454 . . . . 0.0 115.819 174.941 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.3 t -71.93 -4.09 26.35 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.071 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.38 48.93 3.6 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.755 1.169 . . . . 0.0 112.383 177.8 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -153.31 163.67 39.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.084 1.754 . . . . 0.0 111.711 -172.979 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.37 157.84 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.87 1.268 . . . . 0.0 112.384 -173.425 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.07 176.47 12.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.265 2.226 . . . . 0.0 109.888 178.005 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -119.15 143.35 33.91 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 121.216 -0.928 . . . . 0.0 112.186 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -82.73 166.26 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.118 3.212 . . . . 0.0 111.388 174.872 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.8 m -110.58 122.52 47.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.05 1.34 . . . . 0.0 108.911 173.794 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.54 133.41 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.733 1.213 . . . . 0.0 109.351 177.422 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 52.4 m -120.93 130.24 53.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.557 1.943 . . . . 0.0 109.512 176.813 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.2 t0 -79.75 117.21 20.43 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.108 0.963 . . . . 0.0 110.15 170.583 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.52 -12.56 58.78 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.601 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 69.07 3.19 3.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.211 2.204 . . . . 0.0 114.21 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.78 9.2 35.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.823 2.049 . . . . 0.0 113.025 -175.563 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.08 11.97 60.74 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.931 1.253 . . . . 0.0 113.816 -173.295 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 56.3 p -131.73 164.69 25.42 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.462 1.905 . . . . 0.0 110.541 177.371 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.3 m -128.38 146.38 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.152 1.381 . . . . 0.0 109.821 168.224 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 32.6 m -105.84 139.37 40.51 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.315 1.046 . . . . 0.0 108.926 173.159 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.7 t -123.44 130.96 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.864 1.266 . . . . 0.0 109.249 179.135 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -128.08 157.49 40.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.329 1.451 . . . . 0.0 112.042 -176.08 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.5 t80 -155.15 138.2 15.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.498 1.519 . . . . 0.0 111.521 179.777 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.33 119.74 70.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.415 1.086 . . . . 0.0 110.762 177.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.6 135.08 14.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.172 2.581 . . . . 0.0 111.777 -173.956 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 80.9 p -127.09 -12.28 5.81 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 176.371 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -141.52 158.8 43.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.1 166.79 11.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.639 1.175 . . . . 0.0 112.059 169.593 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.97 -168.0 12.6 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.727 1.632 . . . . 0.0 113.992 179.489 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.9 tp -86.83 122.27 30.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.04 1.336 . . . . 0.0 110.299 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.0 m80 -117.78 168.86 10.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.07 1.748 . . . . 0.0 111.292 -174.949 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.8 148.52 33.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.894 . . . . 0.0 111.856 173.856 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.9 ttm -121.88 123.33 41.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.832 2.053 . . . . 0.0 110.125 -175.433 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -97.45 135.9 38.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.988 1.715 . . . . 0.0 109.809 169.605 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.1 mm -134.99 134.3 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.906 1.282 . . . . 0.0 109.95 176.393 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.7 139.09 27.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.361 1.065 . . . . 0.0 113.491 -176.976 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.3 t80 -102.53 122.16 43.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.809 2.044 . . . . 0.0 109.914 175.917 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 52.4 30.5 8.28 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.896 1.278 . . . . 0.0 112.739 -173.688 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 19.1 t30 79.46 2.63 2.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.658 2.783 . . . . 0.0 115.169 -179.263 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -99.74 130.61 45.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.167 1.387 . . . . 0.0 110.86 171.189 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -55.5 138.31 46.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -177.534 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.24 152.26 90.25 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.379 171.358 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.16 134.08 53.8 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.471 2.114 . . . . 0.0 110.952 -178.678 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.68 -7.63 75.92 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.966 1.27 . . . . 0.0 115.161 -178.146 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.2 t -76.55 144.86 74.47 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.77 1.785 . . . . 0.0 111.362 173.767 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.24 162.76 86.05 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.558 1.235 . . . . 0.0 114.107 1.69 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 84.4 mt -102.68 157.03 17.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.979 1.711 . . . . 0.0 110.632 171.174 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.68 141.47 49.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.069 1.347 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.54 155.69 28.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.66 1.184 . . . . 0.0 112.285 -171.463 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -112.13 135.94 52.15 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.11 -0.993 . . . . 0.0 113.191 179.533 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -118.43 142.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.529 1.532 . . . . 0.0 109.215 -178.196 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.25 165.8 35.32 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.6 1.16 . . . . 0.0 111.611 -175.768 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -77.02 128.15 33.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.427 1.091 . . . . 0.0 110.574 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 75.3 t -67.64 -31.89 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.604 -0.685 . . . . 0.0 112.248 -171.361 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -80.5 -14.19 58.46 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -178.001 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.0 t -70.33 139.24 51.99 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.239 -0.913 . . . . 0.0 112.758 -172.034 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.7 88.06 1.2 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.114 1.34 . . . . 0.0 113.129 -171.93 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -168.91 169.66 9.59 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.807 2.043 . . . . 0.0 112.533 174.177 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.5 p -66.57 142.95 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.875 0.87 . . . . 0.0 110.966 170.375 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -166.73 150.44 7.02 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.392 1.477 . . . . 0.0 110.711 178.972 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -123.71 145.89 48.66 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.228 1.411 . . . . 0.0 112.171 -176.308 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.6 p90 -167.6 163.87 14.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.82 1.648 . . . . 0.0 113.444 -179.962 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.8 172.59 13.05 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.461 1.505 . . . . 0.0 112.704 -178.359 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.82 -33.81 12.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.832 2.355 . . . . 0.0 112.693 -171.944 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.08 93.54 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.688 -1.062 . . . . 0.0 114.323 -171.342 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.09 -6.72 51.01 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.896 1.348 . . . . 0.0 113.381 176.552 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.9 m -99.77 -42.3 6.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.309 1.843 . . . . 0.0 110.943 173.504 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -155.4 126.38 7.07 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.026 1.73 . . . . 0.0 112.34 -165.239 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -130.63 -178.91 15.69 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.55 2.024 . . . . 0.0 112.794 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.4 t -141.19 139.52 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.864 1.666 . . . . 0.0 108.201 177.394 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -56.47 134.76 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.639 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 68.22 -0.91 1.98 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.349 2.26 . . . . 0.0 114.541 178.306 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.09 139.14 19.82 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.28 1.432 . . . . 0.0 110.951 176.502 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.37 123.93 9.06 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.519 2.146 . . . . 0.0 110.395 -178.513 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 142.7 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.509 1.524 . . . . 0.0 110.28 174.613 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 57.0 p -134.11 149.34 51.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -166.562 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.94 177.19 10.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.629 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 73.5 m -132.11 145.28 51.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.221 1.408 . . . . 0.0 110.497 -171.513 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 122.59 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 0.0 107.876 167.099 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -84.29 126.87 33.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.342 0.657 . . . . 0.0 109.924 173.542 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 4.1 p -133.77 12.11 4.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.418 1.887 . . . . 0.0 112.626 -172.038 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1891 ' ' LYS . . . . . 0.417 ' HE2' HG23 ' A' 1919 ' ' THR . 65.3 mttt -61.87 -35.48 78.44 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.442 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.56 11.36 12.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.258 1.823 . . . . 0.0 112.57 -176.854 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.1 -4.9 54.72 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.854 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 93.62 -127.84 9.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.736 1.16 . . . . 0.0 112.624 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -153.42 150.71 29.1 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.146 1.379 . . . . 0.0 110.901 -172.806 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 149.2 -158.55 27.7 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.763 1.649 . . . . 0.0 112.473 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.43 113.15 4.02 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.88 0.752 . . . . 0.0 111.315 174.097 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.39 125.18 32.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.887 1.275 . . . . 0.0 108.225 169.553 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 42.1 m -125.04 158.1 34.59 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.527 1.531 . . . . 0.0 112.397 -174.337 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -158.5 134.62 9.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.253 1.821 . . . . 0.0 108.979 -171.808 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.79 158.25 36.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.033 0.933 . . . . 0.0 112.145 177.899 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.68 134.55 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.561 1.144 . . . . 0.0 109.942 177.971 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -120.81 164.53 16.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.887 1.675 . . . . 0.0 109.94 168.942 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.01 29.7 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.251 -178.061 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.97 -22.82 62.27 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.894 3.062 . . . . 0.0 112.694 176.012 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.0 t -148.57 164.43 34.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.674 1.589 . . . . 0.0 109.517 164.663 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -73.17 113.63 10.45 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.926 -1.109 . . . . 0.0 111.081 177.55 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.01 149.51 48.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.796 0.838 . . . . 0.0 111.461 170.832 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.65 142.07 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.357 0.663 . . . . 0.0 109.648 168.751 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.2 mt -132.97 143.14 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.443 1.097 . . . . 0.0 110.456 -167.304 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.5 t -140.84 160.37 40.2 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.134 1.373 . . . . 0.0 110.62 167.376 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -158.5 156.47 30.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.594 1.158 . . . . 0.0 112.466 -177.217 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -140.24 123.7 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 110.385 -172.173 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.29 126.16 30.43 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.615 1.166 . . . . 0.0 110.417 168.812 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -100.61 151.33 21.74 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.078 1.351 . . . . 0.0 112.116 -178.45 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -67.47 -21.87 65.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.941 0.896 . . . . 0.0 112.703 179.008 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.33 -9.12 58.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.589 1.156 . . . . 0.0 113.557 172.629 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 98.28 10.5 51.14 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.176 1.369 . . . . 0.0 115.18 174.839 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1919 ' ' THR . . . . . 0.417 HG23 ' HE2' ' A' 1891 ' ' LYS . 82.3 p -100.88 161.91 13.27 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.132 1.466 . . . . 0.0 111.565 174.882 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.4 m -111.64 123.98 51.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.046 1.338 . . . . 0.0 109.685 166.755 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -92.39 151.07 20.44 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.014 0.926 . . . . 0.0 110.773 170.259 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.5 t -132.57 141.71 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.788 1.635 . . . . 0.0 110.652 -176.112 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.6 m -132.52 142.94 49.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.876 1.67 . . . . 0.0 110.854 168.654 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.15 152.37 37.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 174.326 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.4 mt -119.27 102.88 47.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.48 167.09 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.677 2.918 . . . . 0.0 110.251 168.498 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.4 m -136.54 -24.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.314 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 76.2 mt -116.91 149.63 44.44 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.772 1.229 . . . . 0.0 110.703 171.272 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 154.54 49.91 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.006 2.471 . . . . 0.0 110.922 174.832 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 140.45 -152.72 23.1 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.271 1.415 . . . . 0.0 113.031 -177.236 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -113.1 131.11 55.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.005 1.322 . . . . 0.0 111.082 178.73 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -113.47 144.96 41.93 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.787 1.635 . . . . 0.0 110.951 179.734 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.4 m -105.77 116.15 31.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.971 1.309 . . . . 0.0 110.257 178.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.53 120.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.872 1.669 . . . . 0.0 108.374 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -103.53 133.57 48.34 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.362 1.465 . . . . 0.0 109.55 174.593 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.6 t -135.57 133.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.301 1.44 . . . . 0.0 108.058 172.28 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.67 144.39 20.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.741 1.216 . . . . 0.0 111.037 -168.888 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 123.6 14.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.513 1.125 . . . . 0.0 110.363 -178.574 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.7 53.01 10.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.923 1.289 . . . . 0.0 111.767 178.294 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.19 13.08 2.14 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.392 2.677 . . . . 0.0 116.283 -176.554 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -117.39 128.26 54.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 0.0 110.922 176.952 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.26 152.28 25.31 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.704 0.802 . . . . 0.0 112.417 170.214 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 17.3 m -79.26 156.94 76.05 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.064 176.577 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.49 119.2 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.656 2.237 . . . . 0.0 110.776 174.981 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.43 65.38 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.312 1.434 . . . . 0.0 116.472 178.486 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.7 p -79.59 153.89 76.08 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 120.329 2.064 . . . . 0.0 113.238 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.77 153.36 99.12 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 119.154 0.733 . . . . 0.0 112.397 -5.076 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -106.37 143.51 34.39 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.44 1.496 . . . . 0.0 111.197 -177.505 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 54.0 m -95.09 117.34 30.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -100.9 132.87 46.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.055 1.342 . . . . 0.0 111.212 173.256 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 141.16 51.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.959 0.903 . . . . 0.0 110.065 166.12 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.4 138.9 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.484 1.113 . . . . 0.0 109.672 163.19 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 16.5 p -134.83 174.12 10.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.183 . . . . 0.0 112.124 178.145 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -68.27 152.87 52.73 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.404 1.478 . . . . 0.0 113.139 178.934 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 124.63 1.172 . . . . 0.0 113.363 178.022 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 120.752 0.31 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.26 114.61 6.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.519 1.127 . . . . 0.0 110.828 179.557 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.02 131.98 21.97 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.153 2.569 . . . . 0.0 110.56 -175.46 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.2 t80 -99.36 117.1 33.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.536 0.735 . . . . 0.0 111.079 -176.883 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -151.35 136.81 17.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 111.226 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.96 159.71 41.29 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.294 2.238 . . . . 0.0 110.115 -170.039 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -131.09 138.71 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.894 1.278 . . . . 0.0 110.271 177.742 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 53.8 mt -132.42 135.48 26.37 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.04 1.736 . . . . 0.0 108.832 -172.995 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.6 64.96 8.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.208 3.272 . . . . 0.0 111.813 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.51 147.34 35.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.706 1.602 . . . . 0.0 111.048 175.581 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 92.0 m -115.58 123.21 47.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.183 1.393 . . . . 0.0 109.61 178.164 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 74.5 mt -81.25 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.505 1.122 . . . . 0.0 110.326 177.863 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.2 -141.71 0.37 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.7 1.6 . . . . 0.0 110.8 178.282 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -80.11 123.79 28.19 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.752 -1.217 . . . . 0.0 110.871 170.673 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.96 -149.24 19.84 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.309 1.433 . . . . 0.0 112.199 -171.967 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -159.15 148.6 18.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.907 1.283 . . . . 0.0 111.132 -174.917 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.6 tt -120.92 136.12 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.59 1.556 . . . . 0.0 111.585 -179.436 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.7 p -148.46 -174.03 4.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.661 1.984 . . . . 0.0 110.197 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -178.09 -164.58 31.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.545 0.978 . . . . 0.0 115.545 -179.658 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -152.87 144.15 23.21 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.768 1.627 . . . . 0.0 110.24 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 85.8 t -121.0 137.15 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.504 1.921 . . . . 0.0 108.481 173.26 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -119.57 137.91 53.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.464 1.106 . . . . 0.0 112.448 -176.331 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.4 mtm -108.86 149.49 39.62 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.409 1.884 . . . . 0.0 111.999 -176.098 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.61 -40.0 55.62 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.965 3.776 . . . . 0.0 116.598 -177.601 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.7 t -74.61 0.85 13.67 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.957 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 95.83 -1.19 63.25 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.802 1.668 . . . . 0.0 114.064 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -67.99 153.36 43.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.971 1.308 . . . . 0.0 111.597 173.016 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.3 m -137.5 157.32 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.018 1.327 . . . . 0.0 111.551 -179.753 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.39 169.93 23.6 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.972 1.709 . . . . 0.0 111.263 -178.077 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -108.29 138.6 20.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.134 0.973 . . . . 0.0 111.068 178.206 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.95 165.09 17.58 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.187 3.258 . . . . 0.0 111.332 172.408 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.5 m -109.23 125.27 52.08 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.868 1.267 . . . . 0.0 108.972 173.804 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.31 138.43 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.792 1.237 . . . . 0.0 109.428 177.33 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 65.6 m -131.55 131.96 43.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.986 1.714 . . . . 0.0 110.322 -178.694 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -77.79 121.74 24.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 172.942 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -85.01 -13.3 50.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.608 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 73.87 -5.64 1.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.989 2.516 . . . . 0.0 114.075 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -91.79 3.49 55.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.229 1.812 . . . . 0.0 113.712 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.97 17.5 57.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.442 1.02 . . . . 0.0 113.368 -171.561 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.6 p -129.46 161.52 30.21 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.725 2.01 . . . . 0.0 109.88 176.051 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -123.21 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.203 1.001 . . . . 0.0 110.109 168.78 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 18.2 m -96.43 142.81 28.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.377 1.071 . . . . 0.0 108.598 170.576 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 12.7 t -127.87 134.47 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 109.301 178.487 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -132.38 154.89 49.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 -173.131 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.7 t80 -156.72 136.49 12.48 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.956 1.703 . . . . 0.0 111.722 178.465 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.02 118.02 69.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 110.812 176.496 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.93 135.49 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.401 2.734 . . . . 0.0 112.076 -174.167 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 69.6 m -131.83 4.42 4.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.344 1.058 . . . . 0.0 113.78 -178.861 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -162.35 144.75 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 110.156 -174.911 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.75 162.01 13.94 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.547 1.139 . . . . 0.0 112.45 177.034 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.1 -167.93 12.45 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.88 1.705 . . . . 0.0 113.633 -178.755 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 27.8 tp -78.76 126.35 30.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.672 1.189 . . . . 0.0 110.619 179.003 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.55 165.78 17.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.987 1.715 . . . . 0.0 111.257 -175.57 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.21 153.85 39.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.116 0.967 . . . . 0.0 111.817 176.927 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.9 ttm -131.67 131.99 43.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.125 -176.152 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -105.64 135.01 47.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.996 1.719 . . . . 0.0 109.546 169.108 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.2 133.58 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.437 1.095 . . . . 0.0 110.109 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 137.74 25.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.556 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.1 t80 -100.63 121.88 42.37 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.692 1.997 . . . . 0.0 109.861 175.171 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.9 34.71 14.07 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.542 1.137 . . . . 0.0 112.69 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.67 4.53 2.52 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.779 2.431 . . . . 0.0 114.083 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.9 mtm -107.1 129.82 54.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.615 1.566 . . . . 0.0 111.011 176.272 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -57.51 137.2 56.54 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -175.948 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.1 pt -79.49 156.08 75.97 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.721 175.61 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.88 131.15 38.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.251 1.967 . . . . 0.0 109.732 168.71 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.24 67.38 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.536 1.065 . . . . 0.0 114.138 -172.956 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.5 t -84.61 146.6 47.21 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 119.561 1.68 . . . . 0.0 110.952 168.658 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.35 158.8 82.57 Favored 'Cis proline' 0 C--N 1.351 0.694 0 CA-C-N 120.055 1.055 . . . . 0.0 112.032 -8.398 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.0 mt -103.61 153.56 20.47 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.79 1.236 . . . . 0.0 110.9 172.876 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -143.44 139.89 30.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.931 1.292 . . . . 0.0 109.525 -178.737 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 4.6 p90 -167.16 167.55 14.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.293 1.037 . . . . 0.0 112.223 -169.758 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.8 t80 -107.72 140.63 40.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.905 0.882 . . . . 0.0 112.564 178.495 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.4 t -109.7 139.41 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.616 1.566 . . . . 0.0 108.583 172.414 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.7 t0 -156.12 161.06 40.41 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.944 0.878 . . . . 0.0 113.074 -174.398 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -79.92 103.87 10.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.572 1.549 . . . . 0.0 110.783 177.91 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 29.9 m -65.02 -16.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.456 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -84.36 -14.58 49.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.664 1.186 . . . . 0.0 114.172 -178.307 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.5 m -73.72 157.32 36.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.241 1.016 . . . . 0.0 112.749 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.85 -14.9 68.85 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.499 1.047 . . . . 0.0 115.154 -173.274 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -67.84 155.22 39.84 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 118.679 1.24 . . . . 0.0 113.213 176.75 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 t -72.32 132.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.844 0.858 . . . . 0.0 109.089 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 6.3 t -150.5 162.67 40.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.773 1.229 . . . . 0.0 110.945 -175.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.65 147.99 32.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.535 1.134 . . . . 0.0 112.24 -174.449 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -168.14 163.22 13.3 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.787 1.635 . . . . 0.0 112.979 -174.843 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.92 175.05 13.62 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.264 1.411 . . . . 0.0 113.046 -179.557 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.02 -35.54 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.734 2.29 . . . . 0.0 112.88 -172.414 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.23 -34.09 87.08 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 119.478 1.035 . . . . 0.0 114.533 -171.384 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.13 -5.24 53.68 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.661 1.23 . . . . 0.0 113.51 175.999 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 48.4 m -103.8 -49.39 3.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.372 1.869 . . . . 0.0 110.884 177.61 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -139.6 142.88 37.07 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.484 1.914 . . . . 0.0 112.07 -178.36 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.9 171.28 21.79 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.707 1.146 . . . . 0.0 112.963 172.243 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.9 t -136.65 132.7 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.892 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 25.3 m -59.98 144.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.044 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.4 m-20 68.74 -3.91 1.31 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.597 1.959 . . . . 0.0 114.313 178.737 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.49 142.36 28.04 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.819 1.648 . . . . 0.0 111.269 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.5 125.84 11.02 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.704 2.27 . . . . 0.0 110.572 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -106.29 136.27 46.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.444 1.497 . . . . 0.0 110.167 175.0 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.3 p -129.53 148.77 51.46 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.922 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.84 177.68 10.56 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.686 1.594 . . . . 0.0 111.72 176.861 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.6 m -130.5 142.7 50.48 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.208 1.403 . . . . 0.0 111.028 -169.936 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.7 t -114.34 133.9 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.928 1.691 . . . . 0.0 108.208 169.265 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.15 127.07 40.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.452 1.101 . . . . 0.0 111.03 -179.505 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 57.8 p -131.53 7.04 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.587 1.555 . . . . 0.0 113.312 -170.501 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -54.54 -35.86 63.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.043 1.737 . . . . 0.0 114.788 -169.23 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -121.99 15.98 10.83 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.774 1.63 . . . . 0.0 112.572 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.29 -15.42 60.97 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.135 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.08 -125.01 6.66 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.377 0.989 . . . . 0.0 111.41 -176.156 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.51 151.52 30.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.006 1.322 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.39 -129.41 1.77 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.072 1.796 . . . . 0.0 110.57 -175.617 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -125.09 109.14 1.17 Allowed Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.372 0.986 . . . . 0.0 111.797 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.12 132.27 39.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.522 1.129 . . . . 0.0 108.875 170.738 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.7 t -140.06 158.91 43.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 0.0 111.847 -169.766 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 50.0 tp -166.99 136.28 2.85 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 109.472 -161.867 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.75 160.46 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.155 0.982 . . . . 0.0 112.226 176.625 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.99 137.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.945 1.298 . . . . 0.0 109.512 174.362 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.8 159.14 28.71 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.837 1.655 . . . . 0.0 109.727 170.726 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.44 -163.22 34.54 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.147 -0.971 . . . . 0.0 114.014 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.24 -11.7 23.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.638 2.892 . . . . 0.0 112.9 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 10.6 t -152.72 160.64 43.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.804 1.642 . . . . 0.0 109.938 169.595 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1907 ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 0.9 OUTLIER -76.75 109.07 10.23 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.958 -1.089 . . . . 0.0 111.616 -177.72 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.35 147.76 44.09 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.954 0.902 . . . . 0.0 111.51 169.153 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.035 0.934 . . . . 0.0 110.072 170.431 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.61 139.83 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.678 1.191 . . . . 0.0 110.668 -166.742 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -133.64 156.98 46.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.925 1.69 . . . . 0.0 110.828 169.042 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -152.72 155.56 37.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.29 1.036 . . . . 0.0 112.398 176.42 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.1 m -140.47 124.65 17.58 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.605 1.562 . . . . 0.0 110.353 -172.244 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.7 131.42 39.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 111.187 170.88 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -107.68 146.9 31.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.315 1.446 . . . . 0.0 111.822 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.0 tm0? -65.68 -21.68 66.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.471 1.108 . . . . 0.0 112.471 175.292 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -73.76 -5.32 40.04 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.705 1.602 . . . . 0.0 114.684 -179.973 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 33.25 6.65 Favored Glycine 0 N--CA 1.476 1.3 0 C-N-CA 124.474 1.035 . . . . 0.0 114.171 177.89 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.5 p -140.32 162.68 34.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.476 1.51 . . . . 0.0 110.902 176.748 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 98.3 m -111.81 130.47 55.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.828 1.251 . . . . 0.0 109.272 161.202 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -89.44 150.0 22.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.831 0.853 . . . . 0.0 110.471 169.258 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.7 t -130.25 144.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.134 1.774 . . . . 0.0 109.797 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.3 t -140.44 140.32 35.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.552 1.541 . . . . 0.0 110.78 172.113 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -146.77 154.16 41.06 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.2 mt -118.96 104.02 47.21 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.061 1.744 . . . . 0.0 110.629 -178.673 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.22 162.69 17.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.603 2.869 . . . . 0.0 110.336 166.326 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.0 p -127.59 -19.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.939 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.96 149.23 41.71 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.522 1.129 . . . . 0.0 110.614 174.567 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.28 153.03 40.16 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.887 2.391 . . . . 0.0 112.183 -169.524 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 151.1 -154.88 25.84 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.907 1.242 . . . . 0.0 112.598 -174.311 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -115.41 129.77 56.68 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.613 1.165 . . . . 0.0 110.682 178.351 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.45 134.52 55.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.889 1.675 . . . . 0.0 110.596 -176.805 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.1 m -93.2 125.96 38.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 110.85 178.916 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.58 129.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.4 1.48 . . . . 0.0 108.381 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.69 131.76 55.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.476 1.51 . . . . 0.0 109.65 176.633 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.9 t -133.89 130.87 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.108 174.59 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.6 tmmt? -153.69 144.75 22.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.212 1.405 . . . . 0.0 111.392 -165.321 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.16 119.98 11.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.762 1.225 . . . . 0.0 109.611 177.729 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 57.69 57.82 4.04 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 111.773 177.823 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.289 8.6 pt-20 58.16 15.16 3.12 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.179 2.592 . . . . 0.0 116.175 -179.236 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.54 131.56 52.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.679 1.192 . . . . 0.0 110.89 177.162 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -69.08 152.75 44.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.874 0.87 . . . . 0.0 112.456 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.1 m -67.9 152.36 96.44 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.707 163.386 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.23 -20.17 56.03 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.413 2.075 . . . . 0.0 114.846 -165.236 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.55 -7.11 62.01 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.124 0.869 . . . . 0.0 115.186 174.203 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 42.1 t -84.74 143.64 41.04 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 119.002 1.401 . . . . 0.0 112.193 -176.845 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.1 142.26 74.12 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 CA-C-N 119.158 0.735 . . . . 0.0 112.192 -3.856 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.07 170.48 9.5 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.318 1.847 . . . . 0.0 110.525 173.929 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 85.1 m -132.36 121.89 24.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.95 0.9 . . . . 0.0 110.63 173.02 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.65 138.01 36.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.561 1.545 . . . . 0.0 111.022 172.693 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 34.1 ttt85 -96.88 127.6 43.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.605 0.762 . . . . 0.0 110.032 173.545 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 96.1 t -114.86 130.22 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.863 1.265 . . . . 0.0 110.703 -171.02 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 39.5 p -110.08 163.44 13.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.123 1.369 . . . . 0.0 113.022 -179.197 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.16 141.21 22.97 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.445 1.498 . . . . 0.0 112.535 178.976 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 176.96 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 36.1 tp . . . . . 0 CA--C 1.541 0.627 0 CA-C-O 119.685 -0.198 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A 1789 ' ' ARG . . . . . 0.451 ' HB2' ' H ' ' A' 1861 ' ' ASP . 0.9 OUTLIER -41.66 108.57 0.6 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.239 1.816 . . . . 0.0 113.381 -168.666 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.56 100.03 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.635 2.224 . . . . 0.0 109.022 -178.964 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 37.4 t80 -89.42 130.89 35.7 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.752 0.787 . . . . 0.0 111.956 -174.753 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -158.04 160.62 37.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.24 1.816 . . . . 0.0 110.768 172.682 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.95 132.81 13.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.273 1.029 . . . . 0.0 110.572 -177.896 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 95.6 t -93.87 127.7 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.052 1.341 . . . . 0.0 109.023 169.51 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.93 135.37 26.96 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.171 1.788 . . . . 0.0 109.069 -173.944 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.66 110.69 2.95 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.543 2.829 . . . . 0.0 110.233 176.084 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 31.6 t80 -177.61 152.85 0.83 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.333 2.253 . . . . 0.0 109.291 -171.198 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 43.5 m -135.04 129.63 34.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.405 1.082 . . . . 0.0 110.052 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.1 mt -84.51 113.29 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 0.0 109.343 175.049 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -89.13 -66.96 0.87 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.738 0.815 . . . . 0.0 112.936 -179.536 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -157.03 -8.05 0.09 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.494 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.22 -138.4 4.39 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.751 1.644 . . . . 0.0 111.857 175.452 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -152.63 143.85 23.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.652 1.181 . . . . 0.0 110.665 -177.75 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.8 tt -126.25 134.91 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.649 1.58 . . . . 0.0 110.736 179.759 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 70.0 p -146.61 -179.66 6.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.894 1.678 . . . . 0.0 109.933 179.802 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.23 -166.21 33.16 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.549 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.93 137.77 18.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.512 1.525 . . . . 0.0 109.826 -179.734 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.2 t -107.54 133.96 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.892 1.677 . . . . 0.0 108.027 171.532 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -120.75 125.4 47.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.225 1.41 . . . . 0.0 110.468 -169.136 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.54 153.24 41.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.831 1.653 . . . . 0.0 111.373 -176.19 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.14 -23.48 29.0 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.177 2.585 . . . . 0.0 112.411 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.3 m -74.57 -1.16 20.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.681 1.592 . . . . 0.0 114.805 -178.416 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 85.87 49.49 4.28 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.518 1.056 . . . . 0.0 113.003 178.883 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.25 164.92 37.22 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.038 1.735 . . . . 0.0 111.743 -175.074 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.4 m -141.48 158.98 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.73 1.212 . . . . 0.0 112.97 -171.069 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.46 166.0 34.87 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.679 1.992 . . . . 0.0 111.219 178.451 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -100.31 137.65 20.04 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.781 0.833 . . . . 0.0 111.709 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.16 169.97 11.11 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.276 3.317 . . . . 0.0 111.646 170.57 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 72.3 m -113.48 129.74 56.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.292 1.437 . . . . 0.0 108.852 173.177 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.63 136.38 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.683 1.193 . . . . 0.0 109.36 176.545 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 61.7 m -139.18 132.81 30.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.142 1.377 . . . . 0.0 109.846 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.67 128.64 33.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.767 0.827 . . . . 0.0 110.824 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -82.91 -6.59 59.53 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.667 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.67 11.94 7.17 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.286 2.235 . . . . 0.0 113.882 -173.927 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.41 8.34 21.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.817 2.047 . . . . 0.0 112.872 -176.347 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.9 11.09 68.41 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.947 1.261 . . . . 0.0 113.711 -172.72 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 72.8 p -130.37 157.58 42.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.728 2.011 . . . . 0.0 110.362 178.477 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -109.72 153.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.086 0.954 . . . . 0.0 109.212 163.475 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.2 t -105.54 142.94 34.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.672 0.789 . . . . 0.0 109.449 162.981 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.6 t -119.56 132.44 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.401 1.48 . . . . 0.0 108.297 173.428 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -131.35 154.35 48.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.002 1.721 . . . . 0.0 111.497 -172.808 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.6 t80 -154.07 135.04 13.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.349 1.459 . . . . 0.0 111.814 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.79 115.82 65.29 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.684 1.194 . . . . 0.0 110.483 175.571 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.54 148.89 16.36 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.474 2.783 . . . . 0.0 112.258 -172.136 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 50.8 m -119.39 -21.6 7.39 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -167.08 156.65 10.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.95 1.7 . . . . 0.0 111.812 -175.151 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.78 169.6 17.38 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.83 1.252 . . . . 0.0 114.022 -174.888 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.74 -170.29 14.41 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.175 1.845 . . . . 0.0 114.036 177.927 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 32.6 tp -87.33 130.56 34.58 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.717 1.207 . . . . 0.0 110.612 177.382 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.5 m80 -128.71 167.61 16.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.034 1.734 . . . . 0.0 111.45 -173.164 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -144.67 159.01 43.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.977 0.911 . . . . 0.0 111.432 172.433 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 35.3 ttm -139.43 130.15 26.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.84 1.656 . . . . 0.0 110.023 -171.68 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.92 118.77 33.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.905 1.682 . . . . 0.0 109.197 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 38.4 mm -120.03 138.61 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.132 1.373 . . . . 0.0 110.637 -179.666 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 136.94 22.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.463 1.105 . . . . 0.0 113.625 -175.174 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.733 2.013 . . . . 0.0 110.014 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.36 36.2 15.81 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.834 1.254 . . . . 0.0 112.696 -177.438 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.6 t30 81.7 -1.0 1.59 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.706 2.802 . . . . 0.0 114.842 178.928 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 86.1 mtp -111.12 137.06 49.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.979 1.312 . . . . 0.0 111.697 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.6 m170 -57.97 136.85 57.15 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.042 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.19 155.85 86.01 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.588 175.434 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.71 129.08 29.23 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.094 1.863 . . . . 0.0 109.787 171.348 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.88 62.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.74 1.162 . . . . 0.0 113.981 -173.648 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.0 t -84.13 144.86 44.85 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 119.46 1.63 . . . . 0.0 111.31 173.349 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.19 164.17 80.76 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.24 1.121 . . . . 0.0 112.486 -5.795 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 81.0 mt -116.13 153.53 31.62 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.642 1.977 . . . . 0.0 110.788 -176.35 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.75 136.43 38.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.586 1.154 . . . . 0.0 110.66 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 30.1 p90 -155.95 151.37 26.9 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.064 0.945 . . . . 0.0 112.171 -169.972 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.8 t80 -102.79 149.44 24.48 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 0.0 112.049 175.4 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.2 t -125.95 135.87 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.604 1.562 . . . . 0.0 109.021 -178.566 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1861 ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' 1789 ' ' ARG . 3.5 p30 -157.86 152.24 24.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.177 1.791 . . . . 0.0 111.878 -174.794 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.75 138.75 58.15 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.38 -173.639 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 71.8 t -69.01 -33.07 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 121.308 -0.87 . . . . 0.0 112.101 -169.955 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -95.95 14.2 24.36 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.078 1.351 . . . . 0.0 113.785 -175.534 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 18.2 p -65.37 162.55 17.42 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -175.981 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.46 -20.94 25.77 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.784 1.183 . . . . 0.0 114.164 174.561 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -74.04 161.25 30.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.628 1.214 . . . . 0.0 113.726 179.474 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 19.1 t -75.38 125.12 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.923 1.289 . . . . 0.0 109.107 179.266 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 21.0 p -108.46 172.02 7.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.681 1.192 . . . . 0.0 111.711 -175.484 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.36 133.71 15.36 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.251 1.02 . . . . 0.0 110.195 160.222 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.5 p90 -161.89 161.97 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.238 1.415 . . . . 0.0 112.556 -177.148 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 127.25 173.84 13.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.393 1.473 . . . . 0.0 112.424 -174.195 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.73 -36.33 6.51 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.997 2.465 . . . . 0.0 113.205 -169.712 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.66 -32.12 80.49 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 118.741 0.7 . . . . 0.0 114.724 -168.131 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.93 -2.92 39.23 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.702 1.251 . . . . 0.0 113.818 178.213 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 70.7 m -118.49 -36.97 3.39 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.497 1.919 . . . . 0.0 112.238 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -142.73 146.14 34.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.382 1.473 . . . . 0.0 112.703 177.105 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 -179.16 22.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.514 1.054 . . . . 0.0 113.283 171.933 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.1 t -142.27 136.72 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.811 1.244 . . . . 0.0 108.491 175.403 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -55.82 135.62 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 122.799 0.44 . . . . 0.0 112.112 179.662 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.1 m-80 69.02 -4.33 1.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 114.97 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.71 139.14 20.61 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.512 1.125 . . . . 0.0 111.089 174.712 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.96 124.33 9.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.514 2.143 . . . . 0.0 110.229 178.418 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.24 146.44 34.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.332 1.453 . . . . 0.0 110.546 175.542 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 49.9 p -135.8 154.38 51.23 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -166.205 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -164.54 175.02 10.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.313 1.845 . . . . 0.0 111.772 177.243 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 91.9 m -130.68 144.85 51.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.639 1.576 . . . . 0.0 111.0 -169.233 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 72.6 t -124.61 126.48 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.951 2.1 . . . . 0.0 107.891 176.585 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.5 132.94 34.8 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.972 1.26 . . . . 0.0 111.406 177.976 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -128.34 -0.56 5.68 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.098 1.759 . . . . 0.0 113.494 -173.322 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -52.88 -39.6 62.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.927 1.691 . . . . 0.0 115.078 -169.446 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -114.61 11.15 16.91 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.537 1.535 . . . . 0.0 112.94 -179.02 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -173.39 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 151.9 8.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.739 1.161 . . . . 0.0 112.103 -168.417 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.34 143.27 50.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.557 0.743 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 179.93 -152.38 10.84 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.278 1.894 . . . . 0.0 111.813 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -93.8 101.28 2.73 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 123.955 0.788 . . . . 0.0 111.407 174.277 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.89 127.26 32.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.545 1.138 . . . . 0.0 108.84 170.686 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.1 m -129.25 156.25 44.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.239 1.416 . . . . 0.0 112.229 -176.71 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.0 tp -158.91 133.41 7.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.073 1.749 . . . . 0.0 108.517 -171.353 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.69 156.34 34.77 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.777 0.831 . . . . 0.0 112.065 179.082 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.7 mt -138.81 130.69 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.606 1.162 . . . . 0.0 109.682 177.728 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -116.73 162.56 17.49 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.171 1.788 . . . . 0.0 109.817 172.986 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.2 -160.52 32.83 Favored Glycine 0 CA--C 1.538 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 114.705 -179.163 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.95 -24.56 60.36 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.049 3.166 . . . . 0.0 112.415 176.279 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.3 t -140.25 159.99 40.96 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.291 1.437 . . . . 0.0 109.455 164.423 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 19.7 tptp -77.22 114.05 15.62 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.979 -1.075 . . . . 0.0 110.816 179.63 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.69 150.77 46.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.657 0.783 . . . . 0.0 112.15 178.599 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.16 139.38 30.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.766 0.826 . . . . 0.0 109.338 168.237 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -134.77 144.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.485 1.114 . . . . 0.0 110.54 -165.717 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -142.46 165.6 26.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.983 1.313 . . . . 0.0 111.156 166.625 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -160.16 157.48 28.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.78 1.232 . . . . 0.0 112.606 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.9 m -139.9 123.67 17.42 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.553 1.541 . . . . 0.0 110.053 -173.212 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -78.27 133.48 37.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.802 1.241 . . . . 0.0 111.2 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -114.12 145.55 41.48 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 111.694 -179.645 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -69.86 -13.09 62.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.83 0.852 . . . . 0.0 112.695 174.14 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.96 -3.18 24.31 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.811 1.645 . . . . 0.0 113.816 174.015 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.09 31.91 9.39 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.675 1.131 . . . . 0.0 113.877 176.962 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 61.7 p -138.95 158.62 43.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.047 1.339 . . . . 0.0 111.409 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 88.0 m -105.35 132.59 51.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.607 1.163 . . . . 0.0 109.021 155.818 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.8 148.44 22.12 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.054 0.942 . . . . 0.0 110.002 166.938 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 98.3 t -127.06 144.37 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.871 1.668 . . . . 0.0 110.122 -176.154 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -136.16 147.76 47.85 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 111.868 166.5 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.23 154.99 36.86 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 177.405 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 23.4 mt -120.73 107.55 38.19 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.662 1.985 . . . . 0.0 110.318 179.76 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.06 175.86 8.09 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.809 3.006 . . . . 0.0 110.337 166.179 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.4 p -148.98 -29.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -173.242 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.2 mt -107.56 146.71 33.89 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.723 1.147 . . . . 0.0 110.503 166.096 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.48 156.2 45.39 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.838 2.359 . . . . 0.0 110.96 176.075 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.98 -163.61 24.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.976 1.274 . . . . 0.0 113.358 -177.246 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.51 130.07 41.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.873 1.269 . . . . 0.0 112.413 178.946 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -115.03 139.45 49.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.7 m -99.27 119.94 38.73 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.699 1.2 . . . . 0.0 110.335 178.036 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.75 126.94 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.382 1.473 . . . . 0.0 108.401 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -110.74 131.93 54.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.623 1.569 . . . . 0.0 109.838 177.339 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.0 t -133.51 128.15 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.352 1.061 . . . . 0.0 109.762 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.4 143.16 23.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.108 1.363 . . . . 0.0 111.662 -168.102 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.7 119.26 11.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.514 1.126 . . . . 0.0 110.224 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 57.84 58.92 3.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.614 1.565 . . . . 0.0 111.762 179.036 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.283 10.1 pt-20 54.52 21.97 3.65 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.891 2.476 . . . . 0.0 115.764 -178.833 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -132.8 127.69 35.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.037 1.335 . . . . 0.0 110.439 177.167 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -66.16 152.34 45.0 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.784 0.834 . . . . 0.0 112.518 175.09 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.8 m -65.87 150.75 96.11 Favored Pre-proline 0 N--CA 1.485 1.302 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.132 162.818 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.74 -18.04 52.86 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.41 2.073 . . . . 0.0 114.893 -163.446 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.3 -6.58 58.71 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 173.937 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -82.03 143.33 49.26 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.038 1.419 . . . . 0.0 112.045 -176.647 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 145.51 82.31 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 119.183 0.744 . . . . 0.0 112.561 -3.231 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.62 166.13 11.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.385 1.874 . . . . 0.0 110.924 176.246 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 46.5 m -124.47 119.29 28.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.858 0.863 . . . . 0.0 110.766 177.762 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -101.46 135.29 43.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.868 1.267 . . . . 0.0 110.848 171.94 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -97.37 119.53 36.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.22 0.608 . . . . 0.0 110.059 173.184 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 78.5 t -104.5 131.03 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.37 1.468 . . . . 0.0 110.282 -175.611 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.6 p -103.27 163.57 12.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.933 1.293 . . . . 0.0 112.838 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.3 142.49 21.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.12 1.343 . . . . 0.0 112.475 177.289 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 CA--C 1.548 0.89 0 C-N-CA 124.871 1.268 . . . . 0.0 112.904 175.573 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -61.55 120.48 56.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.902 0.881 . . . . 0.0 111.389 -169.703 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 156.27 57.74 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.33 2.686 . . . . 0.0 111.612 -173.766 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -96.38 125.39 40.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.554 0.742 . . . . 0.0 109.943 176.603 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.13 131.37 13.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.172 1.389 . . . . 0.0 110.663 173.25 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.41 34.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.539 1.936 . . . . 0.0 109.471 -173.276 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -123.59 136.4 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.835 1.254 . . . . 0.0 110.42 179.486 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.4 mt -135.72 138.8 29.03 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 125.879 1.672 . . . . 0.0 109.092 -174.543 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.61 43.88 1.43 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.728 3.619 . . . . 0.0 113.134 177.706 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 88.5 t80 -87.09 157.51 19.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.316 1.446 . . . . 0.0 110.897 171.244 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 85.2 m -124.62 127.71 47.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.405 1.482 . . . . 0.0 110.128 -177.181 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.9 mt -88.17 128.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.503 1.121 . . . . 0.0 110.171 174.682 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -111.37 -146.96 0.41 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.926 1.691 . . . . 0.0 110.757 176.738 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -78.5 127.78 32.63 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.818 -1.176 . . . . 0.0 110.898 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 135.81 -148.33 19.6 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.443 1.497 . . . . 0.0 112.103 -170.804 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.71 148.58 19.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.677 1.191 . . . . 0.0 111.428 -174.994 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 11.8 tt -121.44 138.32 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.718 1.607 . . . . 0.0 111.398 179.214 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 45.2 p -144.54 -174.74 4.4 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.381 1.872 . . . . 0.0 110.317 -176.663 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.39 -169.31 38.34 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -152.92 136.76 16.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.894 1.677 . . . . 0.0 109.8 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 26.9 t -108.62 134.8 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.756 1.622 . . . . 0.0 108.343 171.656 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -119.93 138.87 53.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.43 1.092 . . . . 0.0 111.594 -172.196 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -109.32 144.14 29.17 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.825 1.65 . . . . 0.0 111.173 -176.157 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.37 -30.11 61.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.125 3.216 . . . . 0.0 114.836 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.7 m -69.49 -2.27 10.81 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.192 1.397 . . . . 0.0 114.402 178.535 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.22 -1.62 77.27 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.889 1.709 . . . . 0.0 113.829 -177.016 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -79.2 160.67 26.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.652 1.581 . . . . 0.0 111.963 179.732 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 36.0 m -141.55 157.51 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.152 1.381 . . . . 0.0 111.82 178.217 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.65 166.93 32.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.244 1.817 . . . . 0.0 111.415 -179.572 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.52 140.09 20.8 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 -179.836 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.47 174.98 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.625 3.55 . . . . 0.0 112.094 175.267 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.4 m -116.59 141.6 47.98 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 109.052 170.855 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.3 135.64 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.714 1.206 . . . . 0.0 109.272 174.541 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 54.5 m -140.06 128.08 22.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.277 1.431 . . . . 0.0 109.72 -178.691 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.17 137.52 40.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.908 0.883 . . . . 0.0 112.288 172.448 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -89.91 -8.73 51.15 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 69.43 3.1 4.01 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.636 2.374 . . . . 0.0 114.15 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.97 7.51 46.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.896 2.078 . . . . 0.0 112.821 178.849 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.43 16.81 51.96 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.942 1.258 . . . . 0.0 113.703 -173.36 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 37.7 p -132.68 159.69 38.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 178.859 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 31.5 m -121.51 147.26 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.674 1.19 . . . . 0.0 110.226 167.099 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 97.3 m -105.33 135.03 47.45 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.827 1.251 . . . . 0.0 108.752 169.131 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 65.1 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.413 1.885 . . . . 0.0 108.467 177.974 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -138.53 159.06 43.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.001 1.32 . . . . 0.0 113.131 -172.838 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.8 t80 -159.35 137.17 10.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.86 1.664 . . . . 0.0 111.883 174.94 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.35 115.91 65.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.09 1.356 . . . . 0.0 110.736 177.311 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.81 156.81 13.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.78 2.987 . . . . 0.0 112.769 -172.011 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 49.9 m -124.88 -24.6 4.06 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.682 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -145.77 148.61 33.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.421 1.489 . . . . 0.0 110.915 -177.351 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.82 162.89 27.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.547 1.139 . . . . 0.0 113.197 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 133.56 -177.37 19.08 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 125.282 1.42 . . . . 0.0 114.15 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.2 tt -88.26 123.55 32.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 109.115 175.588 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.45 159.05 32.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.219 1.407 . . . . 0.0 111.673 -172.235 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.18 154.79 50.31 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 111.649 172.291 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -137.69 123.96 20.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.222 1.809 . . . . 0.0 109.81 -172.312 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -95.16 129.52 42.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.748 2.019 . . . . 0.0 109.429 174.118 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.8 mm -127.64 136.82 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.739 1.216 . . . . 0.0 109.87 174.362 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -179.832 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -96.6 121.09 38.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.492 1.917 . . . . 0.0 109.886 173.634 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.47 35.03 10.24 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.965 1.306 . . . . 0.0 112.858 -174.969 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 47.9 t30 78.55 1.93 2.6 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.334 2.654 . . . . 0.0 114.787 -179.66 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -102.38 133.56 47.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.525 1.53 . . . . 0.0 111.435 174.188 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m170 -52.92 137.2 33.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.615 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.58 156.79 70.54 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.375 0.67 . . . . 0.0 111.204 169.425 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.53 130.87 35.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.034 1.823 . . . . 0.0 109.29 166.067 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.58 -2.27 67.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.245 0.926 . . . . 0.0 113.937 -172.963 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.4 t -93.24 145.12 29.45 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 118.939 1.369 . . . . 0.0 111.527 170.432 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.76 165.31 85.43 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.86 0.986 . . . . 0.0 111.606 -10.494 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.12 154.54 20.03 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.367 1.867 . . . . 0.0 110.068 173.725 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -158.23 135.12 9.81 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.177 0.991 . . . . 0.0 111.07 -174.575 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.1 p90 -167.23 173.43 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.746 1.218 . . . . 0.0 112.815 -167.551 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.8 t80 -107.13 141.69 37.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.945 0.898 . . . . 0.0 113.149 173.993 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 91.0 t -110.11 131.79 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.807 2.043 . . . . 0.0 109.157 179.046 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -152.02 151.2 30.84 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.355 1.462 . . . . 0.0 112.792 -172.833 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -69.99 149.23 47.94 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.235 -0.916 . . . . 0.0 112.751 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.9 m -71.54 -14.66 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -171.058 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.28 -126.1 0.18 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.463 1.505 . . . . 0.0 111.334 178.704 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 75.9 m 75.1 160.7 0.23 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.232 2.613 . . . . 0.0 114.398 171.848 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -102.27 -17.32 20.45 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.051 1.31 . . . . 0.0 114.652 178.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -71.82 155.62 40.21 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.685 1.242 . . . . 0.0 113.833 -179.509 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.7 t -68.01 143.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.604 1.162 . . . . 0.0 108.842 172.663 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.02 167.22 29.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.507 1.123 . . . . 0.0 110.984 -175.486 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -152.46 148.17 27.11 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.529 1.532 . . . . 0.0 111.441 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -165.51 161.14 18.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 112.392 -173.43 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.17 169.96 12.55 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.105 1.336 . . . . 0.0 113.56 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.08 -30.59 38.34 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.227 2.618 . . . . 0.0 113.092 -170.407 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.3 -17.38 72.23 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.429 1.013 . . . . 0.0 114.586 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 63.8 mt -76.04 -15.76 60.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.749 169.299 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 5.7 m -115.64 -39.46 3.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.029 1.732 . . . . 0.0 112.043 -165.711 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -151.4 150.36 30.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.086 1.754 . . . . 0.0 112.392 -172.434 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.83 176.87 29.19 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.235 1.398 . . . . 0.0 112.712 172.781 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.2 t -140.04 136.29 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.559 1.144 . . . . 0.0 108.342 175.442 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -57.12 137.12 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.272 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 65.32 3.79 2.42 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.833 2.053 . . . . 0.0 114.658 176.879 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -118.03 138.49 25.52 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.895 1.678 . . . . 0.0 110.401 177.919 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.08 131.97 17.48 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.363 2.042 . . . . 0.0 111.407 -171.077 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.2 148.24 33.22 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.479 1.512 . . . . 0.0 110.355 172.282 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 33.2 p -137.57 149.87 47.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -165.849 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.28 172.89 16.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.593 1.557 . . . . 0.0 111.85 176.59 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.9 m -123.35 141.39 52.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.738 1.615 . . . . 0.0 110.482 -173.657 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 59.2 t -113.71 139.6 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.272 1.829 . . . . 0.0 107.897 168.215 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.48 133.17 45.31 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.228 1.011 . . . . 0.0 111.738 177.947 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 68.3 p -125.58 1.02 7.57 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.469 1.907 . . . . 0.0 113.039 -177.317 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -49.97 -28.63 7.12 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.76 2.424 . . . . 0.0 117.122 -169.86 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -139.21 20.38 2.6 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.1 1.36 . . . . 0.0 112.031 176.678 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.46 44.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 113.474 -174.845 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.36 146.11 4.29 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.007 1.289 . . . . 0.0 112.297 -171.179 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.13 147.16 38.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.832 0.853 . . . . 0.0 112.005 -179.378 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . -175.79 -42.43 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.002 1.287 . . . . 0.0 113.543 176.513 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 162.03 102.17 0.17 Allowed Glycine 0 N--CA 1.47 0.943 0 C-N-CA 125.065 1.316 . . . . 0.0 112.594 170.996 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 33.2 tp -81.65 136.88 35.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.305 1.042 . . . . 0.0 110.117 176.577 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -129.97 157.44 42.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.346 1.458 . . . . 0.0 111.553 177.555 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 55.6 tp -160.68 132.35 5.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.457 1.503 . . . . 0.0 108.977 -169.589 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.43 162.72 37.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.877 0.871 . . . . 0.0 112.132 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.6 mt -136.59 132.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.872 1.269 . . . . 0.0 109.074 172.54 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -115.02 157.71 23.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.704 1.602 . . . . 0.0 109.744 169.219 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.6 -165.15 35.24 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.192 -0.943 . . . . 0.0 113.748 -177.714 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.62 -15.12 27.41 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.633 2.889 . . . . 0.0 112.422 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -147.1 160.38 42.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.997 1.719 . . . . 0.0 109.255 163.488 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 52.1 tptt -83.24 113.02 20.39 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.868 -1.145 . . . . 0.0 111.857 -174.973 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.94 150.27 44.29 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.182 0.993 . . . . 0.0 111.857 173.911 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.52 145.65 26.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.888 0.875 . . . . 0.0 110.691 169.611 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 20.1 mt -137.4 140.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.813 1.245 . . . . 0.0 110.505 -163.631 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.9 m -133.3 157.27 45.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.772 1.629 . . . . 0.0 110.675 168.442 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 31.8 p -156.46 156.89 34.54 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.233 -0.917 . . . . 0.0 113.104 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -144.14 124.82 14.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.704 1.602 . . . . 0.0 110.078 -171.032 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.24 144.92 32.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.569 1.147 . . . . 0.0 112.535 173.951 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -121.74 152.0 39.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.586 1.554 . . . . 0.0 112.062 -176.16 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -68.23 -18.41 64.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.818 1.247 . . . . 0.0 112.788 176.43 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -76.55 -2.79 34.18 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.86 1.664 . . . . 0.0 114.247 -178.427 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 89.77 33.92 8.76 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.385 0.993 . . . . 0.0 113.399 -178.563 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.2 p -139.88 163.63 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.354 1.461 . . . . 0.0 111.215 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.0 m -121.08 132.89 55.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.717 1.607 . . . . 0.0 108.841 161.933 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -92.02 147.51 22.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.857 0.863 . . . . 0.0 110.261 170.588 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 91.0 t -128.95 142.97 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.561 1.544 . . . . 0.0 109.83 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 86.2 p -132.99 147.5 52.28 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.227 1.411 . . . . 0.0 111.589 167.758 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -151.22 157.8 43.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 24.6 mt -124.93 108.4 28.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.903 1.681 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.02 168.95 15.05 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.781 2.987 . . . . 0.0 110.25 166.116 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.3 p -131.64 -20.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.434 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.7 150.73 51.44 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.556 1.142 . . . . 0.0 110.575 173.846 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.65 154.39 39.47 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.929 2.419 . . . . 0.0 112.573 -168.839 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.34 -144.68 12.19 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.683 1.135 . . . . 0.0 112.964 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -123.31 133.37 54.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.49 177.365 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -123.55 134.08 53.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 0.0 110.769 -174.911 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 74.7 m -100.06 110.32 22.62 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.996 1.318 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.35 126.77 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.419 1.488 . . . . 0.0 108.546 176.156 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -105.33 130.98 53.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.626 . . . . 0.0 109.665 174.378 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -131.11 128.55 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.433 1.093 . . . . 0.0 109.7 172.072 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.37 141.37 21.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.174 1.39 . . . . 0.0 111.502 -168.505 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.49 121.32 17.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.935 1.294 . . . . 0.0 109.968 -178.768 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 52.65 59.07 4.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.541 1.536 . . . . 0.0 112.0 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 7.7 pt-20 60.86 0.78 0.39 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 129.035 2.934 . . . . 0.0 116.867 -177.198 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -107.52 123.63 48.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.111 179.293 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.18 144.78 54.99 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.35 -0.844 . . . . 0.0 111.703 169.982 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.5 m -73.44 151.08 89.56 Favored Pre-proline 0 N--CA 1.48 1.041 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.038 171.976 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.52 129.67 35.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.129 2.553 . . . . 0.0 110.762 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.13 -15.24 63.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.04 1.305 . . . . 0.0 115.027 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 34.5 t -77.09 139.36 65.19 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.223 1.511 . . . . 0.0 111.346 176.148 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.79 147.55 81.3 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.648 0.91 . . . . 0.0 112.585 -3.098 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.24 133.77 45.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.837 1.655 . . . . 0.0 110.59 -178.887 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 24.6 m -97.67 108.66 21.43 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.552 0.741 . . . . 0.0 110.847 -177.08 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.34 132.84 37.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.014 1.326 . . . . 0.0 111.886 176.328 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 22.0 tpt85 -88.15 113.29 23.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.482 178.771 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.0 t -103.49 129.56 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.048 0.939 . . . . 0.0 110.758 -176.422 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 69.6 p -110.11 162.47 14.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.019 1.327 . . . . 0.0 112.977 -179.683 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.57 135.44 13.6 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.938 1.256 . . . . 0.0 112.345 178.003 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 CA--C 1.548 0.87 0 C-N-CA 124.577 1.151 . . . . 0.0 112.937 175.684 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 31.6 mt . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 47.4 ttm-85 -67.28 117.9 51.04 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.817 1.647 . . . . 0.0 110.215 -175.993 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.2 151.11 60.48 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.212 2.608 . . . . 0.0 111.572 -171.463 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.4 t80 -101.16 119.5 38.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.938 0.895 . . . . 0.0 109.689 176.339 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -147.81 131.13 16.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.136 1.374 . . . . 0.0 110.398 172.38 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.78 148.31 35.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 109.756 -171.054 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -119.94 139.56 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.043 1.337 . . . . 0.0 110.56 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.3 mt -133.92 137.49 28.57 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.164 1.786 . . . . 0.0 108.465 -176.107 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.36 46.7 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.332 3.354 . . . . 0.0 112.861 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.2 t80 -91.41 155.05 18.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.362 1.465 . . . . 0.0 111.072 174.81 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.3 m -125.25 126.35 45.02 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.882 1.273 . . . . 0.0 109.831 177.866 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.3 mt -95.69 115.23 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 109.077 177.477 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.79 -55.52 4.05 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.627 0.771 . . . . 0.0 112.992 179.656 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -161.82 -35.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.852 1.261 . . . . 0.0 114.002 -171.536 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -72.53 164.9 54.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.226 1.393 . . . . 0.0 113.801 179.106 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -86.42 142.71 28.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.871 1.269 . . . . 0.0 112.212 -174.515 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.86 134.39 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.58 1.552 . . . . 0.0 110.459 174.591 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.1 p -145.68 173.03 12.43 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.998 1.719 . . . . 0.0 110.738 -175.082 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.72 -176.62 25.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 -177.658 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -151.43 137.72 18.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.938 1.695 . . . . 0.0 109.057 171.026 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.3 t -111.69 133.29 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.054 1.742 . . . . 0.0 108.131 174.179 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -109.28 129.96 55.5 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.237 1.415 . . . . 0.0 110.626 -176.625 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -96.21 151.79 38.4 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.621 1.568 . . . . 0.0 111.411 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.99 -24.85 45.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.294 2.663 . . . . 0.0 113.213 -179.093 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 20.3 m -73.91 -1.09 18.21 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.036 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.84 70.41 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.736 1.636 . . . . 0.0 114.624 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -71.75 163.76 27.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.221 1.408 . . . . 0.0 112.301 176.263 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.74 153.39 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.219 1.408 . . . . 0.0 111.873 175.647 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.43 166.55 31.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.852 2.061 . . . . 0.0 110.41 179.096 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.06 141.57 23.01 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.188 -0.945 . . . . 0.0 112.444 -177.823 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.24 172.64 8.29 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.67 3.58 . . . . 0.0 111.658 173.332 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.9 m -109.34 125.58 52.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.322 1.449 . . . . 0.0 108.899 172.942 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.02 129.46 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.407 1.083 . . . . 0.0 108.42 173.442 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.5 m -118.77 128.33 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.149 1.78 . . . . 0.0 109.674 -178.43 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.42 119.92 22.43 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.246 1.018 . . . . 0.0 110.465 170.615 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -84.67 -14.43 48.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.3 mttt 71.5 -3.36 2.15 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.788 2.435 . . . . 0.0 114.514 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -92.8 5.57 50.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.297 1.839 . . . . 0.0 113.319 178.515 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.63 19.02 46.03 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.694 1.14 . . . . 0.0 113.53 -172.504 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -131.98 162.0 31.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 109.966 175.216 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.1 m -126.1 147.13 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.226 . . . . 0.0 109.978 168.413 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 52.1 m -108.75 135.22 50.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.376 1.071 . . . . 0.0 108.568 171.328 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -117.63 131.49 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.309 1.444 . . . . 0.0 108.797 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.08 151.27 51.86 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.012 1.325 . . . . 0.0 112.504 -173.261 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.05 136.08 17.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.38 1.472 . . . . 0.0 111.764 176.825 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.86 115.62 64.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.764 1.225 . . . . 0.0 110.827 177.792 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.03 140.43 25.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.826 3.018 . . . . 0.0 112.918 -172.117 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.2 p -116.78 -8.45 11.37 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.705 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.29 157.48 22.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.044 1.738 . . . . 0.0 111.579 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.78 172.62 12.02 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.458 1.103 . . . . 0.0 112.377 174.058 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.95 -172.17 15.57 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.527 1.537 . . . . 0.0 113.62 178.778 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.83 130.9 35.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.502 1.121 . . . . 0.0 110.233 -178.581 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.5 m80 -128.89 162.08 28.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.913 1.685 . . . . 0.0 111.612 -173.786 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -141.98 159.5 42.11 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.28 1.032 . . . . 0.0 111.696 172.943 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.1 ttm -139.44 134.52 32.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 110.607 -171.8 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -110.24 136.16 49.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 109.922 172.691 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.0 mm -133.1 132.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.146 1.378 . . . . 0.0 109.951 178.118 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 138.19 28.32 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.972 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.8 t80 -102.47 121.03 41.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.478 2.311 . . . . 0.0 109.586 176.32 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.07 38.4 20.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.832 1.253 . . . . 0.0 112.551 -174.844 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 78.89 -9.0 1.57 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 128.906 2.883 . . . . 0.0 115.174 -178.392 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 67.7 mtm -95.53 129.82 42.58 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.208 1.403 . . . . 0.0 111.187 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -59.12 138.33 57.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.208 -0.933 . . . . 0.0 113.438 -177.309 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 33.4 pt -71.81 153.05 93.26 Favored Pre-proline 0 N--CA 1.48 1.044 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.044 169.645 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.65 -18.37 58.65 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.407 2.071 . . . . 0.0 113.9 -174.442 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.83 0.52 87.9 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.771 1.177 . . . . 0.0 114.685 171.485 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -97.2 142.6 24.78 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.652 1.726 . . . . 0.0 111.539 176.533 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.53 165.7 74.06 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.842 0.979 . . . . 0.0 112.854 -1.67 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 86.2 mt -112.93 159.54 18.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.22 1.808 . . . . 0.0 110.665 170.282 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -155.49 139.6 16.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.638 1.175 . . . . 0.0 110.137 -173.381 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.33 -175.69 3.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.906 1.282 . . . . 0.0 112.382 -170.429 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.4 t80 -124.02 141.58 51.92 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.89 1.276 . . . . 0.0 112.679 178.23 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 54.7 t -110.9 142.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.099 1.76 . . . . 0.0 109.434 176.724 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.03 169.39 21.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.801 2.04 . . . . 0.0 109.954 -171.607 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -77.32 143.57 38.71 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.513 -1.367 . . . . 0.0 111.187 170.981 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.7 m -61.94 -26.87 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -175.152 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.75 134.18 48.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.307 1.443 . . . . 0.0 110.045 166.814 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 7.6 t -164.66 156.56 15.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.934 1.694 . . . . 0.0 110.724 178.274 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.6 58.23 4.99 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.172 1.367 . . . . 0.0 113.525 -173.857 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -155.5 167.79 29.23 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.3 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.0 p -71.49 147.26 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.382 1.073 . . . . 0.0 109.582 159.436 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.5 t -160.02 167.96 26.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.087 1.355 . . . . 0.0 110.487 178.355 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.68 145.48 25.86 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 -179.119 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.6 p90 -168.74 166.77 11.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.786 1.634 . . . . 0.0 112.578 -173.757 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.89 174.63 13.7 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.3 1.428 . . . . 0.0 112.542 -177.279 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.17 -36.1 13.06 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.257 . . . . 0.0 112.87 -170.973 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.41 87.65 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.45 1.023 . . . . 0.0 114.589 -170.738 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.13 -2.08 39.08 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.912 1.356 . . . . 0.0 113.498 175.934 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.3 m -108.17 -51.39 2.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.28 1.832 . . . . 0.0 110.926 177.529 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -138.4 144.71 40.34 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.537 1.935 . . . . 0.0 112.522 -176.731 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.22 178.27 20.4 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.985 1.278 . . . . 0.0 112.912 171.718 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -141.67 138.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.852 1.261 . . . . 0.0 108.259 174.501 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -59.96 149.17 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.062 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 77.6 m-20 67.2 14.76 9.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.425 1.89 . . . . 0.0 114.382 169.838 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -145.56 152.84 50.34 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.874 1.67 . . . . 0.0 111.236 174.211 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.74 145.66 32.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.497 2.131 . . . . 0.0 112.145 -174.616 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -121.46 150.83 40.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.409 1.884 . . . . 0.0 110.043 170.621 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.8 p -137.71 149.97 46.93 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -165.487 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.07 175.96 12.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.78 1.632 . . . . 0.0 111.457 175.341 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.6 m -129.71 140.42 51.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.944 1.298 . . . . 0.0 110.727 -172.045 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.2 t -105.2 133.27 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.443 1.497 . . . . 0.0 107.906 168.217 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.43 126.69 46.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.703 1.201 . . . . 0.0 110.446 174.762 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.1 p -126.51 5.4 6.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.849 2.06 . . . . 0.0 113.066 -171.604 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.74 -37.5 51.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.241 1.817 . . . . 0.0 115.104 -170.241 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -116.36 9.73 14.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.403 1.481 . . . . 0.0 113.014 178.67 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.62 -10.94 59.71 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -171.097 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 86.37 -125.68 7.5 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.453 1.025 . . . . 0.0 112.446 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.02 149.5 28.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.387 1.475 . . . . 0.0 110.878 -173.901 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.84 -155.78 26.74 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.585 1.564 . . . . 0.0 112.736 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.1 108.14 3.38 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.127 0.87 . . . . 0.0 111.504 174.416 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.74 128.17 34.33 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 108.722 171.84 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.6 m -133.74 160.24 38.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.032 1.333 . . . . 0.0 112.854 -173.299 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 37.3 tp -158.46 138.53 12.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.491 1.916 . . . . 0.0 108.951 -171.569 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.15 157.19 35.54 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.071 0.948 . . . . 0.0 111.944 174.85 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.7 mt -138.35 140.29 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.875 1.27 . . . . 0.0 109.741 177.05 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.22 144.04 51.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.652 1.581 . . . . 0.0 109.877 173.723 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.34 -166.0 26.67 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.958 -175.242 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.58 -26.33 69.5 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.477 3.451 . . . . 0.0 112.843 178.436 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -141.72 156.26 45.61 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.986 1.314 . . . . 0.0 109.093 161.039 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -72.31 110.72 6.93 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.193 -0.942 . . . . 0.0 111.258 -177.739 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.88 148.38 51.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.0 111.372 172.229 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.33 146.34 27.77 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.818 0.447 . . . . 0.0 110.159 165.762 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.24 143.97 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.029 1.332 . . . . 0.0 109.856 -165.182 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.58 163.24 35.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.693 1.197 . . . . 0.0 111.418 168.946 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -161.34 152.43 18.5 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.991 1.317 . . . . 0.0 112.305 -178.606 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 95.1 m -137.96 121.92 17.79 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.637 1.575 . . . . 0.0 109.692 -175.914 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.55 119.3 15.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.452 0.701 . . . . 0.0 109.966 165.872 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.66 -16.79 50.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 112.656 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 10.3 tt0 72.71 -8.8 1.18 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 128.08 2.552 . . . . 0.0 113.072 -176.286 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.36 11.61 8.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.972 2.109 . . . . 0.0 113.494 -177.368 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.84 15.34 54.73 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.187 1.375 . . . . 0.0 113.605 -171.869 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 65.9 p -141.66 154.17 45.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.651 1.58 . . . . 0.0 111.754 177.419 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 35.3 m -120.87 131.24 54.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.662 1.585 . . . . 0.0 108.988 164.986 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.5 t -88.17 149.4 23.91 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.923 0.889 . . . . 0.0 110.838 173.125 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -132.58 143.14 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.632 1.573 . . . . 0.0 110.121 -177.229 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 92.8 p -137.28 150.32 47.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.876 1.27 . . . . 0.0 112.252 168.852 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -152.24 155.05 36.98 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.138 -0.976 . . . . 0.0 112.462 173.974 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.38 99.98 29.88 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.398 1.079 . . . . 0.0 109.998 -174.461 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -83.21 162.21 15.32 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.069 3.179 . . . . 0.0 111.083 176.41 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -133.77 -20.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -172.441 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.6 mt -118.65 147.32 41.86 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 124.849 1.259 . . . . 0.0 110.261 170.21 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 158.76 43.61 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.883 2.388 . . . . 0.0 111.019 176.385 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 128.08 -163.79 21.58 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.967 1.27 . . . . 0.0 113.213 -177.048 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.81 136.9 32.77 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 112.921 -178.957 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -124.78 129.98 51.51 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.743 1.617 . . . . 0.0 110.031 176.429 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.81 126.19 35.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 110.436 174.838 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.71 126.23 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.465 1.506 . . . . 0.0 108.047 178.643 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -108.94 131.84 54.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.474 1.509 . . . . 0.0 109.442 175.651 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.85 129.09 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.392 1.077 . . . . 0.0 109.383 172.739 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.78 143.39 26.34 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.225 1.41 . . . . 0.0 111.59 -168.36 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.83 122.18 12.34 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.597 1.159 . . . . 0.0 110.341 179.748 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 57.67 56.24 5.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.315 1.446 . . . . 0.0 111.732 -179.406 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 10.0 pt-20 54.78 22.34 4.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.903 2.481 . . . . 0.0 115.898 -179.113 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -132.84 131.39 40.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.071 1.348 . . . . 0.0 110.542 176.804 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.58 150.32 47.12 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.796 0.838 . . . . 0.0 112.299 174.788 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -67.69 156.29 89.37 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.103 167.833 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -52.28 -33.67 56.39 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.042 3.161 . . . . 0.0 116.378 -169.388 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.98 -3.21 59.17 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.6 t -84.12 143.02 41.87 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.983 1.392 . . . . 0.0 112.355 -177.316 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.26 138.14 54.17 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.062 0.701 . . . . 0.0 111.812 -4.449 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.48 168.3 12.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.862 1.665 . . . . 0.0 110.292 172.843 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 25.0 m -131.76 116.86 17.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 110.069 172.992 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -91.46 152.93 20.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.746 1.219 . . . . 0.0 110.785 170.113 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -108.87 129.08 55.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.516 0.726 . . . . 0.0 110.19 166.521 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.8 t -105.06 129.22 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.318 1.447 . . . . 0.0 110.135 179.242 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 86.9 m -95.99 152.56 18.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.0 1.72 . . . . 0.0 111.495 -178.897 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.27 133.35 12.18 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.871 1.224 . . . . 0.0 112.079 175.289 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 CA--C 1.546 0.799 0 C-N-CA 124.751 1.22 . . . . 0.0 113.484 -177.157 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -56.27 115.54 10.19 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.287 1.435 . . . . 0.0 110.362 177.445 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 133.41 27.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.117 1.878 . . . . 0.0 108.682 174.122 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.02 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 109.947 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.93 150.51 25.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.351 1.461 . . . . 0.0 111.652 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -159.62 151.57 20.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.856 1.662 . . . . 0.0 109.893 -177.123 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -123.81 134.5 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.005 1.322 . . . . 0.0 109.655 170.845 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.77 135.98 27.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.919 1.688 . . . . 0.0 109.215 -172.692 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.02 112.77 3.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.209 2.606 . . . . 0.0 110.208 173.873 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 46.8 t80 -174.94 147.6 0.98 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.026 2.13 . . . . 0.0 109.278 -171.683 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 52.5 m -125.63 127.0 45.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.574 1.15 . . . . 0.0 109.803 -178.993 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.82 113.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.731 0.812 . . . . 0.0 109.436 174.883 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -98.33 -158.53 0.68 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.213 1.405 . . . . 0.0 111.006 172.006 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tptt -68.5 120.36 14.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.603 -1.311 . . . . 0.0 111.091 173.104 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.64 -147.61 18.63 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.676 1.608 . . . . 0.0 111.867 -171.066 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.78 143.46 15.89 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.3 1.04 . . . . 0.0 111.496 -175.118 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.9 tt -128.95 136.44 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.731 1.612 . . . . 0.0 110.946 177.076 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.9 p -147.64 -178.37 6.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.337 1.855 . . . . 0.0 110.372 -176.765 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.52 -170.55 31.57 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 179.027 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -149.72 139.81 22.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.317 1.847 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 45.1 t -113.67 135.53 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.3 1.84 . . . . 0.0 108.178 170.647 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -119.02 138.15 53.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.166 1.387 . . . . 0.0 111.947 -178.386 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.5 mpp? -114.05 141.57 26.51 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.831 1.652 . . . . 0.0 111.399 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -25.13 78.77 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.126 3.217 . . . . 0.0 115.017 177.144 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.3 p -74.71 4.35 6.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.861 1.664 . . . . 0.0 114.655 -177.831 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.84 41.15 6.04 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 124.606 1.098 . . . . 0.0 113.293 172.961 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -148.67 163.89 35.94 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.63 1.572 . . . . 0.0 111.938 -175.058 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.5 161.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.011 1.324 . . . . 0.0 112.231 -174.207 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.02 -178.25 6.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.088 2.155 . . . . 0.0 110.22 178.051 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -127.04 146.23 56.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.065 -1.022 . . . . 0.0 111.419 176.581 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.33 166.18 14.23 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.207 3.271 . . . . 0.0 111.49 177.857 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.8 m -101.98 134.21 45.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 108.585 170.131 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.17 132.91 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.799 1.239 . . . . 0.0 109.013 175.019 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.7 m -138.6 122.32 17.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.243 1.417 . . . . 0.0 109.465 178.864 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -76.63 131.8 39.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.865 0.866 . . . . 0.0 111.73 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -83.44 1.68 40.44 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.041 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 69.51 16.86 8.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.624 1.97 . . . . 0.0 112.991 179.639 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -138.66 16.82 2.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.18 1.792 . . . . 0.0 113.015 -169.545 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.74 13.27 63.03 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.596 1.093 . . . . 0.0 115.132 177.184 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.9 p -129.44 155.94 44.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.835 1.654 . . . . 0.0 110.41 174.843 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.0 m -115.42 138.37 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.886 0.875 . . . . 0.0 110.202 167.192 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.4 m -96.03 136.43 36.49 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.731 1.212 . . . . 0.0 108.429 167.964 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 52.9 t -121.78 135.85 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.791 1.636 . . . . 0.0 108.399 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -140.63 159.33 42.44 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.562 1.145 . . . . 0.0 113.139 -175.839 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.0 t80 -154.59 134.25 12.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.942 1.697 . . . . 0.0 111.538 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.46 121.75 75.08 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.381 1.072 . . . . 0.0 111.205 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.44 156.68 32.65 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.741 2.96 . . . . 0.0 111.857 -176.558 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.1 t -140.75 -13.76 0.96 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.516 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -165.38 151.54 9.8 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 110.657 -176.531 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.02 168.45 20.07 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.427 1.091 . . . . 0.0 113.444 -177.602 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 125.04 -179.97 15.94 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.346 1.45 . . . . 0.0 114.157 176.723 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.0 tt -86.66 122.37 30.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.758 1.223 . . . . 0.0 109.821 179.771 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 26.2 m80 -116.99 160.82 20.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.698 1.599 . . . . 0.0 111.619 -173.113 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -142.78 144.21 32.5 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.978 1.311 . . . . 0.0 110.304 -178.557 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.5 ttm -135.39 141.02 45.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.827 1.251 . . . . 0.0 112.613 -176.386 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.09 139.57 35.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.737 1.615 . . . . 0.0 110.405 163.667 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.4 mm -127.84 131.61 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 109.272 163.63 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.31 134.69 23.06 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.106 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 13.7 t80 -98.03 122.83 41.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.573 1.949 . . . . 0.0 109.632 174.655 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.83 36.43 14.59 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.723 1.209 . . . . 0.0 112.824 -175.462 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 77.78 3.18 2.97 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 128.107 2.563 . . . . 0.0 114.614 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.0 mtm -105.64 130.21 53.72 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.583 1.553 . . . . 0.0 111.079 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.28 137.22 41.93 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.773 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 24.6 pt -77.05 156.18 82.25 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.228 171.024 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -59.82 128.53 27.14 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.111 1.874 . . . . 0.0 109.718 169.977 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.92 -16.9 57.99 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.784 1.183 . . . . 0.0 114.072 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.4 t -83.22 144.75 47.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 119.347 1.574 . . . . 0.0 110.664 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.43 160.24 93.94 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 120.209 1.11 . . . . 0.0 113.048 -2.638 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.97 154.07 22.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.661 1.984 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -156.4 134.41 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.039 0.936 . . . . 0.0 110.96 -173.025 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.08 -177.53 5.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 112.779 -172.486 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.4 t80 -122.4 137.44 54.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 177.253 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 90.4 t -100.75 134.59 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.644 1.577 . . . . 0.0 109.573 174.481 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 18.6 t0 -156.51 169.25 25.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.242 1.817 . . . . 0.0 110.301 -179.519 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -69.45 142.78 53.73 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.073 -1.017 . . . . 0.0 112.7 176.622 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 53.6 t -67.02 -36.14 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.207 1.003 . . . . 0.0 112.556 -172.245 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -121.61 20.04 11.1 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.533 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 28.5 p -61.4 158.93 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.922 1.289 . . . . 0.0 114.413 -176.203 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -82.42 -29.65 35.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.331 0.967 . . . . 0.0 113.661 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -71.55 153.7 41.98 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.253 1.027 . . . . 0.0 112.583 173.472 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.8 t -70.17 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 3.3 t -155.0 164.11 39.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.591 1.157 . . . . 0.0 111.249 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.17 149.22 42.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 -175.966 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 4.2 p90 -161.93 158.62 25.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.643 1.577 . . . . 0.0 113.004 179.66 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.04 168.3 11.29 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.258 1.409 . . . . 0.0 113.572 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.48 -30.14 36.35 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.429 2.753 . . . . 0.0 113.153 -171.46 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.45 -13.58 71.12 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.078 0.847 . . . . 0.0 114.527 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 66.6 mt -79.03 -11.94 60.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.935 1.367 . . . . 0.0 112.807 168.603 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 10.3 m -120.6 -38.53 2.86 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.839 1.656 . . . . 0.0 112.466 -165.605 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -154.83 156.99 37.21 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.74 1.616 . . . . 0.0 112.366 -172.009 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.14 -176.84 28.71 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.108 0.861 . . . . 0.0 114.074 172.068 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.5 t -141.22 133.3 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.172 1.389 . . . . 0.0 108.255 177.741 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.9 m -56.63 137.44 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.876 0.47 . . . . 0.0 111.958 179.634 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.03 -2.18 1.86 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.691 1.996 . . . . 0.0 114.713 178.076 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -106.81 142.06 24.19 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.451 1.5 . . . . 0.0 110.791 175.793 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.4 126.53 11.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.382 2.054 . . . . 0.0 110.81 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -103.23 145.37 30.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.345 1.458 . . . . 0.0 110.282 172.422 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.4 p -135.9 153.51 51.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -165.626 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -165.6 173.45 10.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.226 1.81 . . . . 0.0 111.629 177.476 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 38.2 m -128.96 140.63 51.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.508 1.523 . . . . 0.0 110.781 -171.733 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.5 t -110.52 136.32 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.908 1.683 . . . . 0.0 108.335 168.198 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.39 126.0 38.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.681 1.193 . . . . 0.0 110.769 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 74.7 p -133.45 -1.31 3.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.909 1.283 . . . . 0.0 114.148 -167.53 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -54.59 -38.74 67.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.225 1.41 . . . . 0.0 114.684 -169.437 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -114.33 9.7 16.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.733 1.613 . . . . 0.0 112.759 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.83 67.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.329 1.052 . . . . 0.0 113.479 -175.116 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.13 153.11 6.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.833 1.206 . . . . 0.0 112.291 -169.554 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -70.13 160.94 31.14 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.655 0.782 . . . . 0.0 112.913 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.38 15.86 0.07 OUTLIER Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -176.419 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.44 96.0 1.5 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.531 1.539 . . . . 0.0 112.574 177.899 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.59 125.49 29.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.786 1.235 . . . . 0.0 108.527 167.543 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -116.34 154.96 29.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.98 1.712 . . . . 0.0 111.853 -179.465 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 59.7 tp -162.16 133.37 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 109.698 -170.034 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.84 161.68 34.52 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.655 1.182 . . . . 0.0 111.912 -179.523 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -137.99 132.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.612 1.165 . . . . 0.0 110.114 175.756 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -112.07 134.04 53.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.844 1.657 . . . . 0.0 109.323 170.458 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -164.96 -168.52 27.24 Favored Glycine 0 CA--C 1.537 1.435 0 O-C-N 121.353 -0.842 . . . . 0.0 114.909 -175.973 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.77 -23.35 55.82 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.929 3.086 . . . . 0.0 112.467 176.155 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -141.03 157.75 44.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.433 1.493 . . . . 0.0 109.441 165.377 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -69.29 111.36 5.15 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.042 -1.036 . . . . 0.0 110.424 174.454 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.06 146.18 51.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.553 0.741 . . . . 0.0 111.299 172.972 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.62 136.51 32.96 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.341 0.656 . . . . 0.0 109.368 169.394 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.9 mt -131.0 138.83 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.572 1.149 . . . . 0.0 110.456 -167.368 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.8 m -133.75 152.89 52.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.442 1.497 . . . . 0.0 110.661 169.75 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.6 p -150.88 153.18 34.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.829 0.852 . . . . 0.0 112.96 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 84.8 m -139.84 120.37 14.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.649 1.58 . . . . 0.0 110.107 -171.22 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.5 133.21 37.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.664 1.186 . . . . 0.0 111.332 172.189 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -110.75 145.89 37.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.697 1.599 . . . . 0.0 111.635 -178.685 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -69.25 -14.22 62.84 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.766 0.826 . . . . 0.0 112.736 174.524 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.78 -8.26 54.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.597 1.559 . . . . 0.0 113.913 174.999 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.98 31.68 7.19 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.466 1.031 . . . . 0.0 114.288 177.573 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.4 p -137.19 159.59 41.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.16 1.384 . . . . 0.0 110.966 175.665 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 49.6 t -112.86 126.21 55.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 108.667 160.697 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -93.23 145.39 24.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.921 0.889 . . . . 0.0 110.307 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 78.9 t -127.33 143.72 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.171 1.388 . . . . 0.0 110.138 -177.657 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.6 p -134.58 146.45 49.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.007 1.323 . . . . 0.0 111.552 167.096 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 26.1 p90 -148.21 151.38 35.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.576 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.8 mt -112.73 106.77 55.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.037 1.735 . . . . 0.0 110.512 179.021 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.64 174.44 10.41 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.795 2.997 . . . . 0.0 110.224 165.022 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -149.57 -31.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.214 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.44 148.69 35.82 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.33 0.968 . . . . 0.0 110.628 167.042 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.47 157.42 56.41 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 110.761 171.668 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.0 -159.7 23.1 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.667 1.127 . . . . 0.0 112.604 -175.667 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.35 129.86 56.15 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.187 0.995 . . . . 0.0 111.94 -174.805 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -116.88 127.69 54.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.528 1.931 . . . . 0.0 110.099 -177.588 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.5 m -97.23 114.42 26.15 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.635 1.174 . . . . 0.0 110.961 178.686 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -88.61 125.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.251 1.82 . . . . 0.0 108.776 178.355 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -101.16 131.37 47.15 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.357 1.463 . . . . 0.0 109.721 173.231 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 49.1 t -130.64 128.76 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 110.037 172.069 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -153.88 141.52 19.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.476 1.51 . . . . 0.0 111.071 -169.137 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.83 121.26 18.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.551 1.14 . . . . 0.0 109.545 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.84 59.57 4.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.24 1.416 . . . . 0.0 112.294 178.191 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.9 pt-20 59.14 11.97 2.28 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.279 2.632 . . . . 0.0 116.43 -178.431 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.41 123.35 41.88 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.48 1.112 . . . . 0.0 111.172 178.142 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -64.21 146.88 53.55 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.393 -0.817 . . . . 0.0 112.114 172.243 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 12.2 m -77.63 156.02 80.78 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.828 172.804 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -54.67 130.76 42.02 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.427 2.751 . . . . 0.0 112.086 177.397 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 85.75 -10.8 63.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.571 1.081 . . . . 0.0 115.554 -179.736 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -72.81 139.32 80.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 119.439 1.62 . . . . 0.0 111.344 176.717 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.89 149.06 80.23 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 CA-C-N 119.676 0.92 . . . . 0.0 112.768 -2.291 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -104.68 126.63 51.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 110.702 -177.199 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.8 m -94.73 110.95 22.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.599 0.759 . . . . 0.0 111.295 -175.791 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.86 129.55 45.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.917 1.687 . . . . 0.0 111.692 177.985 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -94.72 117.53 30.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.417 0.687 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 79.8 t -98.56 133.86 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.148 1.779 . . . . 0.0 110.643 -174.652 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 57.4 p -99.08 145.95 26.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.17 39.25 3.12 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.065 1.793 . . . . 0.0 113.831 -175.162 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.2 t70 . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -168.133 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 46.6 mt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.223 0.535 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -64.36 118.54 48.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.871 1.268 . . . . 0.0 111.504 -179.627 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.0 152.55 57.31 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.115 2.543 . . . . 0.0 110.865 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 16.2 t80 -107.8 125.66 51.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.937 0.895 . . . . 0.0 110.302 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.56 130.06 13.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.531 1.532 . . . . 0.0 110.001 173.568 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 131.18 21.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.236 1.414 . . . . 0.0 110.054 -169.577 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 58.0 t -95.73 138.05 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.105 1.362 . . . . 0.0 109.598 -179.773 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.75 135.01 26.69 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.652 1.581 . . . . 0.0 108.784 -179.002 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -79.8 37.76 0.69 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.22 3.28 . . . . 0.0 113.141 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -85.79 152.38 23.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.221 1.408 . . . . 0.0 111.458 178.196 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.9 m -116.23 119.25 35.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.846 1.258 . . . . 0.0 109.733 177.184 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.29 127.69 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.211 1.004 . . . . 0.0 109.953 175.29 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -112.99 -154.92 0.55 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.569 1.547 . . . . 0.0 110.622 172.74 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -70.07 124.46 24.13 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.594 -1.316 . . . . 0.0 111.353 172.569 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.85 -148.76 20.5 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.789 1.661 . . . . 0.0 111.772 -170.514 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.18 146.27 18.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.307 1.043 . . . . 0.0 111.68 -175.944 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.18 135.74 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.97 1.708 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 32.7 p -146.23 177.08 9.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.154 1.781 . . . . 0.0 110.572 -175.218 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.76 -172.63 29.39 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.779 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.21 138.79 19.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.441 1.496 . . . . 0.0 109.762 173.71 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 13.3 t -108.51 132.59 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.14 1.776 . . . . 0.0 108.088 172.768 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -117.77 122.89 44.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.9 1.28 . . . . 0.0 110.124 -177.943 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.4 mtt -95.92 152.3 38.9 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.66 1.584 . . . . 0.0 111.461 -172.915 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.83 -20.7 34.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.28 2.654 . . . . 0.0 113.601 -177.259 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 58.4 p -78.44 -4.63 49.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 114.171 174.193 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.32 -3.82 64.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.575 1.56 . . . . 0.0 114.56 -178.946 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.47 159.54 33.08 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 118.506 1.153 . . . . 0.0 112.199 173.994 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.6 m -136.89 154.71 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.156 1.382 . . . . 0.0 111.519 175.077 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.17 172.63 17.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.234 1.813 . . . . 0.0 111.121 -179.193 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -109.7 139.47 21.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.981 0.913 . . . . 0.0 111.172 178.37 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -82.18 165.6 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.861 3.041 . . . . 0.0 110.82 170.34 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 97.4 m -107.86 123.36 48.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.102 1.361 . . . . 0.0 108.659 172.511 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.85 130.58 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.297 1.039 . . . . 0.0 108.677 175.485 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 97.4 m -128.27 130.53 48.02 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.495 1.518 . . . . 0.0 109.816 -177.901 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -76.16 130.77 38.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.823 1.249 . . . . 0.0 112.05 174.619 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -87.91 -15.74 35.82 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.345 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.4 mttt 70.07 4.19 4.71 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.736 2.414 . . . . 0.0 114.391 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -100.86 12.17 38.12 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.622 1.969 . . . . 0.0 112.849 -179.291 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.55 16.82 61.32 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.731 1.158 . . . . 0.0 113.38 -171.413 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -136.87 166.47 23.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.851 2.06 . . . . 0.0 110.178 179.993 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.0 m -131.37 164.97 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.222 1.409 . . . . 0.0 110.326 172.031 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.9 t -123.15 148.94 45.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.351 1.06 . . . . 0.0 110.073 166.478 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 32.4 t -123.42 128.51 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.502 1.521 . . . . 0.0 108.737 178.666 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -129.12 155.41 45.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.747 1.619 . . . . 0.0 111.836 -170.637 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.2 t80 -159.88 135.81 8.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.833 1.253 . . . . 0.0 112.297 -177.606 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.58 117.37 68.56 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.82 1.248 . . . . 0.0 110.694 175.771 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.03 145.76 22.39 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.482 2.788 . . . . 0.0 111.694 -174.87 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.8 p -131.17 -4.83 3.88 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 172.554 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -141.75 153.98 44.95 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.109 1.764 . . . . 0.0 110.316 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.23 173.32 8.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 111.757 166.43 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 104.6 -171.49 19.32 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.23 1.395 . . . . 0.0 114.002 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.33 124.27 30.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.971 1.308 . . . . 0.0 110.112 -177.882 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.9 m80 -120.57 163.13 18.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.427 1.891 . . . . 0.0 111.382 -176.051 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.25 155.56 39.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.126 0.971 . . . . 0.0 111.169 173.354 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.8 tmm? -148.85 132.68 17.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.166 0.986 . . . . 0.0 111.547 -160.686 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -111.08 141.96 43.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.738 2.015 . . . . 0.0 111.295 -174.831 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -133.86 134.33 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.858 1.263 . . . . 0.0 111.004 175.921 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.3 139.0 37.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.498 1.119 . . . . 0.0 113.331 176.629 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -99.7 120.94 40.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.362 1.865 . . . . 0.0 109.527 172.506 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 49.26 39.88 16.83 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.936 1.294 . . . . 0.0 112.853 -176.083 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 7.8 t-20 82.27 -13.65 0.83 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.03 2.932 . . . . 0.0 114.696 179.43 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.3 tpp -90.98 128.61 36.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.522 1.129 . . . . 0.0 111.561 177.029 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -57.68 136.22 56.82 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.38 -0.825 . . . . 0.0 113.164 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.3 pt -76.82 153.91 83.14 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.594 178.019 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -61.5 124.53 14.84 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.885 1.723 . . . . 0.0 108.617 166.121 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.4 -11.22 47.15 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.572 1.082 . . . . 0.0 114.681 -172.873 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.9 t -85.94 143.79 38.17 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.351 1.575 . . . . 0.0 111.319 169.587 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -82.85 171.83 51.23 Favored 'Cis proline' 0 C--N 1.352 0.738 0 CA-C-N 120.075 1.062 . . . . 0.0 112.505 -6.32 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.2 mt -113.99 160.82 18.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.459 1.904 . . . . 0.0 111.159 171.346 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -150.4 138.73 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.189 1.396 . . . . 0.0 109.99 -171.687 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 15.9 p90 -164.46 167.25 19.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.444 1.097 . . . . 0.0 112.398 -165.264 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.5 t80 -122.55 136.09 54.8 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.129 -0.982 . . . . 0.0 112.129 176.947 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 42.2 t -111.84 142.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.398 1.479 . . . . 0.0 109.675 -178.934 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 28.5 t0 -151.59 163.01 40.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.898 1.279 . . . . 0.0 111.52 -177.553 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -74.96 125.6 29.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.227 . . . . 0.0 111.152 178.319 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 31.4 m -78.92 -18.55 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -167.545 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -89.35 -4.63 58.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.792 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.7 m -72.73 150.51 42.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.962 0.905 . . . . 0.0 112.498 176.576 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.73 -14.62 60.96 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.604 1.097 . . . . 0.0 115.118 -174.369 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -66.56 158.14 30.52 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.7 1.25 . . . . 0.0 113.93 179.131 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 141.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.454 1.102 . . . . 0.0 110.888 173.422 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -158.1 152.89 25.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.358 1.463 . . . . 0.0 110.273 178.655 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.81 142.83 51.32 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.999 1.319 . . . . 0.0 111.754 -177.706 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.3 p90 -167.08 160.88 14.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.582 1.553 . . . . 0.0 113.519 -175.937 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.83 170.27 12.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.408 1.48 . . . . 0.0 112.539 -177.54 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.08 -33.29 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 113.324 -168.651 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.81 -33.78 86.83 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.455 1.025 . . . . 0.0 114.506 -171.567 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 1.5 pp -78.43 -0.61 29.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.832 1.316 . . . . 0.0 113.631 177.45 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.5 m -113.63 -46.09 3.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.698 1.999 . . . . 0.0 111.366 176.696 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1877 ' ' HIS . . . . . 0.555 ' CE1' HH22 ' A' 1951 ' ' ARG . 3.7 t-80 -137.88 122.37 18.42 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.314 1.845 . . . . 0.0 111.426 -174.075 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.5 170.94 16.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.28 1.419 . . . . 0.0 112.786 170.655 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 98.2 t -138.8 137.14 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.899 1.28 . . . . 0.0 108.239 174.203 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.7 m -55.3 136.54 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.585 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 61.0 m-80 67.32 0.31 2.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.969 2.108 . . . . 0.0 114.685 177.509 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -104.87 139.91 20.56 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.019 1.328 . . . . 0.0 110.977 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.9 118.66 5.74 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.59 2.193 . . . . 0.0 110.167 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.03 134.8 42.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.29 1.436 . . . . 0.0 110.205 176.544 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -128.31 148.16 50.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -164.729 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.63 -179.85 7.97 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.948 1.699 . . . . 0.0 111.673 176.704 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 60.2 m -135.03 146.65 49.19 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.228 1.411 . . . . 0.0 110.936 -168.096 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -116.86 129.89 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.687 1.595 . . . . 0.0 108.262 168.456 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.51 126.43 38.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.963 . . . . 0.0 110.325 176.079 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 40.6 p -132.06 4.15 4.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.708 1.603 . . . . 0.0 113.634 -167.147 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 52.2 tttp -55.22 -32.45 62.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.051 1.74 . . . . 0.0 115.61 -164.464 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.33 17.53 6.52 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.603 1.561 . . . . 0.0 112.42 178.407 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.28 58.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -176.557 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 151.44 12.21 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.186 1.374 . . . . 0.0 112.861 -175.643 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -72.94 145.65 46.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.159 0.983 . . . . 0.0 112.307 -177.218 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.7 -158.66 26.89 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.689 1.614 . . . . 0.0 112.501 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -82.98 98.39 2.04 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 175.43 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.17 126.55 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.707 1.203 . . . . 0.0 108.853 171.928 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.4 m -129.68 155.27 46.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.012 1.325 . . . . 0.0 112.133 -177.806 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.0 tp -158.95 132.61 7.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.162 1.785 . . . . 0.0 108.583 -171.108 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.64 160.41 39.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.853 0.861 . . . . 0.0 112.238 -179.313 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 58.4 mt -135.08 132.34 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.519 1.128 . . . . 0.0 109.645 174.379 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -114.76 105.98 13.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.013 1.325 . . . . 0.0 109.052 172.655 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -116.9 -178.84 17.85 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.024 1.297 . . . . 0.0 113.92 -178.639 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.2 -20.42 37.48 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.909 3.073 . . . . 0.0 111.811 170.744 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.2 t -137.43 157.77 45.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.877 1.671 . . . . 0.0 109.055 161.253 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.59 119.0 13.17 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.993 -1.067 . . . . 0.0 111.773 -176.866 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -80.13 144.33 33.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.166 170.14 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.86 140.92 29.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.479 0.712 . . . . 0.0 109.656 168.363 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.2 mt -132.91 139.24 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.79 1.236 . . . . 0.0 110.467 -167.67 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -130.32 155.96 45.48 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.652 168.544 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -152.65 154.07 34.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.102 0.961 . . . . 0.0 112.373 175.604 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.8 m -142.25 125.57 16.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.599 1.56 . . . . 0.0 109.985 -172.528 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.91 141.35 37.68 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 112.244 172.758 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -117.24 152.0 35.74 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.703 1.601 . . . . 0.0 112.031 -175.803 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -69.43 -18.54 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.926 1.29 . . . . 0.0 112.96 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.68 -13.44 60.62 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.128 1.371 . . . . 0.0 114.083 -179.503 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.74 34.73 4.84 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.786 1.184 . . . . 0.0 113.674 -175.773 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.7 p -138.34 164.3 29.65 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.266 1.426 . . . . 0.0 110.841 177.968 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 80.6 m -120.09 131.18 54.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.717 1.607 . . . . 0.0 109.033 164.369 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.6 t -90.18 150.15 22.12 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.161 0.984 . . . . 0.0 110.686 171.112 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 93.6 t -129.43 144.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.521 1.928 . . . . 0.0 109.592 -178.43 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 139.12 35.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.411 1.484 . . . . 0.0 110.707 171.074 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -144.63 153.24 41.55 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.587 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.7 mt -115.51 105.79 51.53 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.802 1.641 . . . . 0.0 110.816 179.636 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.0 169.71 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.645 2.897 . . . . 0.0 110.235 165.456 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -136.99 -20.13 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.81 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.39 152.06 59.57 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.632 1.173 . . . . 0.0 110.675 174.007 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.18 147.74 38.24 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.893 2.395 . . . . 0.0 111.904 -172.871 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.03 -155.68 26.33 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.675 1.131 . . . . 0.0 113.059 -174.896 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.26 126.41 53.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.07 1.348 . . . . 0.0 111.149 179.612 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.8 125.71 53.06 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.311 1.844 . . . . 0.0 109.93 -176.624 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 54.6 m -88.0 122.08 31.18 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.975 -1.078 . . . . 0.0 110.933 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.22 128.23 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.292 1.437 . . . . 0.0 108.626 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -112.23 131.07 55.7 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.367 1.467 . . . . 0.0 109.542 175.965 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.55 130.11 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.304 1.042 . . . . 0.0 109.67 172.898 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.93 144.02 23.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.061 1.344 . . . . 0.0 111.721 -168.552 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.11 122.64 14.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.697 1.199 . . . . 0.0 110.555 -177.882 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 57.0 44.62 22.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.134 1.374 . . . . 0.0 112.199 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.261 0.6 OUTLIER 77.98 -12.87 1.02 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.177 2.991 . . . . 0.0 114.736 -179.107 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -98.43 125.6 43.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.75 1.22 . . . . 0.0 111.384 -176.814 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -63.07 143.76 57.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.384 -0.823 . . . . 0.0 111.912 171.585 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.5 m -68.0 152.35 96.49 Favored Pre-proline 0 N--CA 1.48 1.036 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.57 171.417 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 126.96 22.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.781 2.321 . . . . 0.0 110.595 179.387 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.58 -15.01 64.23 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.193 1.378 . . . . 0.0 115.323 -176.118 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.5 t -76.62 140.98 68.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.304 1.552 . . . . 0.0 111.628 176.552 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.53 140.29 65.88 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.418 0.828 . . . . 0.0 112.161 -3.723 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.05 173.23 7.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.615 1.966 . . . . 0.0 110.779 175.51 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -131.02 122.32 26.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.845 0.858 . . . . 0.0 110.933 174.159 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.05 137.99 34.32 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.57 1.548 . . . . 0.0 110.535 169.429 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1951 ' ' ARG . . . . . 0.555 HH22 ' CE1' ' A' 1877 ' ' HIS . 0.0 OUTLIER -93.81 138.5 31.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.596 0.759 . . . . 0.0 109.474 169.756 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 139.59 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.456 1.502 . . . . 0.0 110.861 -178.402 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 1.1 p -124.04 163.2 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.931 1.693 . . . . 0.0 112.433 179.521 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.87 148.55 33.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.107 1.337 . . . . 0.0 112.249 172.269 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 123.949 0.9 . . . . 0.0 112.898 174.323 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A 1789 ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' 1789 ' ' ARG . 18.1 ttm-85 -58.72 119.52 37.76 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.233 1.013 . . . . 0.0 111.041 177.671 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.42 159.76 48.48 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.158 2.572 . . . . 0.0 110.431 176.496 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.46 134.26 17.83 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.642 0.734 . . . . 0.0 112.324 -172.533 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -163.98 145.81 9.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.817 2.047 . . . . 0.0 110.724 178.055 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 161.28 36.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.599 1.959 . . . . 0.0 110.831 -170.609 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -134.07 139.37 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.184 1.393 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 43.8 mt -136.59 138.2 25.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.314 1.846 . . . . 0.0 108.302 -170.801 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.11 31.93 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.505 3.47 . . . . 0.0 113.993 -177.052 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 27.6 t80 -79.65 155.03 28.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.47 1.108 . . . . 0.0 111.027 173.113 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.85 126.17 35.52 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.048 1.339 . . . . 0.0 109.534 176.76 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.5 mt -76.42 126.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.572 0.749 . . . . 0.0 110.49 177.24 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 67.1 mttm -116.48 -139.7 0.37 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.724 1.61 . . . . 0.0 110.516 172.71 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.76 124.44 27.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.657 -1.277 . . . . 0.0 111.188 171.689 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.4 -151.31 19.68 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.862 1.696 . . . . 0.0 111.805 -169.872 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.84 150.48 17.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.913 1.285 . . . . 0.0 111.178 -176.448 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.0 tt -122.51 133.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.353 1.461 . . . . 0.0 111.888 179.77 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 77.3 p -149.22 -178.05 6.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.082 1.753 . . . . 0.0 110.38 177.704 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.48 -164.4 27.9 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.341 0.897 . . . . 0.0 115.341 -179.323 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -157.47 139.49 14.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.616 1.566 . . . . 0.0 109.954 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 43.7 t -105.87 133.63 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.771 1.628 . . . . 0.0 108.266 171.435 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -121.44 135.46 55.05 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.847 1.659 . . . . 0.0 111.052 -174.677 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.2 mpp? -112.9 157.39 40.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.754 1.622 . . . . 0.0 112.562 -172.412 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -55.0 -37.15 93.9 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.243 3.295 . . . . 0.0 114.538 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.0 m -71.86 -5.22 32.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.14 1.376 . . . . 0.0 114.463 -176.098 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -2.2 84.83 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.343 1.449 . . . . 0.0 113.711 -170.951 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -64.96 152.38 43.41 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.265 1.426 . . . . 0.0 111.719 172.175 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.7 155.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.24 1.416 . . . . 0.0 111.537 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.47 164.46 37.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.791 1.636 . . . . 0.0 111.336 -179.841 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -102.36 134.2 20.12 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.675 0.79 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.98 161.21 20.91 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.721 2.948 . . . . 0.0 110.88 169.912 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.0 m -108.81 125.75 52.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.071 1.348 . . . . 0.0 108.986 174.13 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.7 137.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.905 1.282 . . . . 0.0 109.679 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 56.5 m -139.3 126.57 21.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.197 1.399 . . . . 0.0 110.049 176.477 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.9 126.83 31.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 172.533 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.2 -6.37 57.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.527 1.131 . . . . 0.0 114.032 -174.331 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.3 mmtm 77.99 -7.95 1.74 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.917 2.887 . . . . 0.0 113.831 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -92.58 2.53 56.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.406 1.882 . . . . 0.0 113.295 175.866 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.5 25.79 13.14 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.757 1.17 . . . . 0.0 114.141 -177.921 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 61.8 p -134.16 155.93 49.22 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.17 1.788 . . . . 0.0 109.706 174.179 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -115.17 138.67 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.196 0.998 . . . . 0.0 110.056 167.397 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 40.5 m -98.29 141.83 30.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.008 1.323 . . . . 0.0 108.588 168.867 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.3 t -125.66 134.41 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.4 1.48 . . . . 0.0 109.462 179.6 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -131.96 153.94 49.81 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 112.289 -174.787 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.65 134.34 10.9 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.857 1.663 . . . . 0.0 111.674 -177.957 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.69 123.67 68.87 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.343 1.057 . . . . 0.0 110.442 175.303 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.47 131.4 12.6 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.076 2.517 . . . . 0.0 111.6 -173.534 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -132.03 15.73 4.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.738 1.215 . . . . 0.0 112.406 179.22 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.93 162.26 20.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.569 1.948 . . . . 0.0 109.958 -175.224 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -111.79 170.93 7.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.924 1.29 . . . . 0.0 112.6 174.329 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 93.66 -161.79 25.11 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.182 1.372 . . . . 0.0 113.547 179.281 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.7 tp -81.58 114.93 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.591 1.156 . . . . 0.0 110.759 -177.816 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 6.4 m80 -103.3 168.34 9.23 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.077 1.751 . . . . 0.0 110.903 177.478 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.16 148.97 29.59 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.491 -0.756 . . . . 0.0 112.02 168.033 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 16.3 ttm -120.99 132.82 55.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.034 2.134 . . . . 0.0 110.264 -173.821 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -100.07 137.9 37.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.637 1.575 . . . . 0.0 109.893 166.891 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -133.95 133.95 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.907 1.283 . . . . 0.0 109.733 171.814 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 138.07 31.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.548 1.139 . . . . 0.0 112.681 -174.069 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.9 t80 -107.74 123.8 49.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.305 1.842 . . . . 0.0 110.063 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.19 35.35 16.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.551 1.14 . . . . 0.0 112.531 -176.128 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.8 t30 80.12 -0.68 2.03 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.671 2.788 . . . . 0.0 114.827 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.33 130.69 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.289 1.436 . . . . 0.0 110.907 178.319 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -56.23 135.13 53.52 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.258 -0.901 . . . . 0.0 113.111 -179.5 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.4 pt -71.6 155.2 92.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.254 172.755 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.6 -25.43 79.23 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.304 2.003 . . . . 0.0 113.648 -176.006 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -79.32 -3.66 88.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.17 0.891 . . . . 0.0 114.72 173.731 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 25.6 t -97.39 144.17 27.45 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.467 1.633 . . . . 0.0 111.824 178.773 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.21 161.01 85.33 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.677 0.92 . . . . 0.0 112.198 -4.563 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.33 144.67 37.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 109.85 170.959 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -126.48 137.2 53.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 109.682 179.152 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.01 146.2 21.52 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.678 0.791 . . . . 0.0 112.438 -169.299 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.1 t80 -99.62 139.43 35.28 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.397 -0.814 . . . . 0.0 112.433 179.694 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 41.1 t -122.83 142.51 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.852 1.661 . . . . 0.0 108.948 179.158 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 9.8 t0 -151.59 173.01 15.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.433 1.093 . . . . 0.0 111.679 -173.52 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -87.44 123.42 32.34 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.918 1.287 . . . . 0.0 111.288 178.2 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 35.4 m -72.09 -21.8 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -170.585 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.0 p30 -90.95 -8.76 48.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.75 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 87.6 m -78.75 -24.35 44.83 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -172.501 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 81.25 -7.29 60.96 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.175 1.369 . . . . 0.0 116.442 168.109 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -67.48 163.75 20.31 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.108 1.454 . . . . 0.0 113.484 176.282 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.4 t -64.88 133.26 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.704 0.801 . . . . 0.0 110.002 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -163.61 154.12 15.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.214 1.406 . . . . 0.0 109.855 -168.241 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.11 145.24 37.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.545 1.138 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.9 p90 -169.64 169.4 8.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.559 1.543 . . . . 0.0 113.092 -173.006 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.75 172.39 13.72 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.6 1.572 . . . . 0.0 112.175 -174.124 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.26 -32.63 12.52 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.774 2.316 . . . . 0.0 113.216 -170.308 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.03 -31.15 74.63 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 119.373 0.988 . . . . 0.0 114.873 -170.601 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.32 -0.37 36.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.925 1.362 . . . . 0.0 113.208 175.36 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 89.7 m -113.52 -48.4 2.94 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.657 1.983 . . . . 0.0 110.82 -178.933 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -137.76 149.07 46.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.089 1.756 . . . . 0.0 112.36 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.38 177.24 23.1 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 124.359 0.98 . . . . 0.0 113.116 170.123 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.6 t -139.1 133.42 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.454 1.102 . . . . 0.0 108.437 176.016 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -56.41 135.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 118.021 0.373 . . . . 0.0 111.986 -178.979 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.5 m-80 70.26 -8.92 0.8 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.381 2.273 . . . . 0.0 114.859 179.384 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.4 mttm -96.47 141.88 23.74 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.485 1.114 . . . . 0.0 111.078 174.011 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.22 123.64 8.92 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.509 2.14 . . . . 0.0 110.353 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.77 144.6 30.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.443 1.497 . . . . 0.0 110.472 174.525 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.1 p -135.49 145.52 47.21 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -166.364 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.36 178.99 9.68 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.735 1.614 . . . . 0.0 111.306 175.719 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 26.7 m -134.99 144.05 47.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 110.644 -169.658 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.8 t -116.53 131.32 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.571 1.548 . . . . 0.0 108.179 169.726 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.0 m120 -93.77 131.41 39.16 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.159 0.984 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.8 p -137.79 4.03 2.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.348 1.459 . . . . 0.0 113.765 -166.551 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 84.0 tttt -55.06 -33.66 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.77 1.628 . . . . 0.0 115.04 -168.361 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.87 16.63 9.38 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.741 1.617 . . . . 0.0 112.564 178.972 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.55 -39.57 70.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.368 1.067 . . . . 0.0 113.842 -174.062 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.71 145.22 4.85 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.908 1.242 . . . . 0.0 112.352 -171.084 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.94 148.98 45.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 112.185 -178.019 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 173.93 -27.36 0.08 OUTLIER Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.471 1.034 . . . . 0.0 114.973 176.667 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 142.56 102.05 0.43 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.884 1.707 . . . . 0.0 112.988 172.067 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.44 130.79 35.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.0 109.568 175.071 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.5 m -129.79 160.59 32.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.756 1.622 . . . . 0.0 112.273 -178.129 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.4 tp -160.48 136.68 8.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.762 1.625 . . . . 0.0 109.522 -169.264 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.33 156.9 33.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.392 1.077 . . . . 0.0 112.023 176.251 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 37.2 mt -139.64 134.78 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.96 143.25 51.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.485 1.514 . . . . 0.0 110.223 176.381 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.63 -161.83 20.77 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-O 118.81 -0.994 . . . . 0.0 114.694 -175.561 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -62.26 -26.16 77.19 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.044 3.163 . . . . 0.0 112.646 176.44 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -140.21 153.2 46.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.75 1.22 . . . . 0.0 109.618 161.352 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -71.68 123.37 22.4 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.995 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.7 152.99 37.4 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.313 1.045 . . . . 0.0 112.905 -178.054 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.16 134.1 33.56 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 163.829 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.9 mt -134.39 138.92 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.577 1.151 . . . . 0.0 110.231 -166.466 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 64.7 m -139.0 162.01 35.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.584 1.553 . . . . 0.0 111.247 172.592 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -155.27 156.47 35.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.378 1.071 . . . . 0.0 112.71 178.502 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.5 m -139.45 129.83 25.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.907 1.683 . . . . 0.0 110.248 -172.282 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -80.73 132.42 35.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.356 1.062 . . . . 0.0 111.264 174.141 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -110.13 148.62 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.077 1.351 . . . . 0.0 112.08 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -68.32 -21.3 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.507 1.123 . . . . 0.0 112.735 178.103 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.14 -6.83 48.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.556 1.543 . . . . 0.0 114.342 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.6 39.87 4.87 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.538 1.065 . . . . 0.0 113.266 -179.255 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.0 p -141.13 158.68 43.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.011 1.324 . . . . 0.0 111.304 177.23 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 63.9 m -107.22 125.19 50.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.391 1.476 . . . . 0.0 108.434 161.455 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.8 t -86.52 149.03 25.25 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.484 0.714 . . . . 0.0 110.393 167.704 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.4 t -130.31 142.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.842 1.657 . . . . 0.0 109.736 -177.54 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 84.1 p -136.12 147.22 47.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.849 1.26 . . . . 0.0 111.802 168.192 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.86 153.89 35.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.495 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.78 105.87 50.89 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.084 1.754 . . . . 0.0 110.282 179.333 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.83 173.79 11.7 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.618 2.879 . . . . 0.0 110.131 165.003 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.8 p -149.69 -29.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -172.814 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.54 144.83 30.32 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.402 1.001 . . . . 0.0 110.213 166.806 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.63 157.64 44.15 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.92 2.413 . . . . 0.0 111.013 177.303 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.32 -162.9 23.68 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.987 1.28 . . . . 0.0 113.204 -176.283 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.79 139.97 30.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.728 1.211 . . . . 0.0 112.844 179.739 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.49 131.67 50.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.757 1.623 . . . . 0.0 110.322 178.008 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.7 m -90.47 125.76 35.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.209 1.004 . . . . 0.0 110.684 174.757 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.99 120.91 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.735 1.614 . . . . 0.0 108.482 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -104.93 128.85 53.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.535 1.534 . . . . 0.0 109.808 178.709 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 58.2 t -130.92 128.52 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.574 1.15 . . . . 0.0 109.848 173.695 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.1 142.3 24.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.109 1.364 . . . . 0.0 111.666 -168.975 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.12 120.21 14.6 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.8 1.24 . . . . 0.0 109.679 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.1 t-20 54.93 58.98 4.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.602 1.561 . . . . 0.0 111.979 179.174 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 9.0 pt-20 57.11 13.56 1.65 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.418 2.687 . . . . 0.0 116.422 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -119.59 122.41 41.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.896 1.279 . . . . 0.0 110.671 177.655 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -63.94 142.69 58.31 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.618 0.767 . . . . 0.0 111.488 170.752 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.0 m -72.62 156.85 89.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.764 175.025 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.81 129.6 35.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.301 2.667 . . . . 0.0 111.963 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 86.27 -13.02 58.96 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.697 1.141 . . . . 0.0 115.142 -177.397 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.7 t -76.0 140.27 70.06 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.527 1.663 . . . . 0.0 111.491 176.121 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.48 136.02 43.04 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 -3.568 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -83.92 169.98 14.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.778 1.631 . . . . 0.0 110.532 173.889 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 28.4 m -131.12 116.73 18.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.552 0.741 . . . . 0.0 110.694 177.264 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.02 155.02 18.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.736 1.214 . . . . 0.0 111.082 169.279 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -116.48 125.64 52.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.291 1.037 . . . . 0.0 110.062 170.297 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 92.2 t -107.65 130.99 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.41 . . . . 0.0 110.526 -174.616 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.1 p -108.06 171.24 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.288 1.435 . . . . 0.0 112.739 178.921 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.59 154.62 44.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.372 1.463 . . . . 0.0 113.67 -178.576 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 125.02 1.328 . . . . 0.0 113.241 179.035 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.02 -22.94 59.38 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -166.03 169.95 14.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.43 1.892 . . . . 0.0 112.011 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -64.88 153.08 89.24 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.435 1.094 . . . . 0.0 112.295 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.5 171.59 16.8 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.538 2.826 . . . . 0.0 111.741 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.6 37.3 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.686 1.594 . . . . 0.0 113.102 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -149.24 48.63 0.6 Allowed Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 126.741 2.016 . . . . 0.0 113.313 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.55 158.71 55.12 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.269 2.646 . . . . 0.0 111.915 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 57.1 tp -159.17 141.36 13.73 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.352 1.461 . . . . 0.0 110.33 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 82.1 t -110.9 135.3 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.504 1.522 . . . . 0.0 109.262 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -148.49 157.55 27.34 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.153 1.358 . . . . 0.0 112.971 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 96.9 t -98.44 124.37 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.001 1.32 . . . . 0.0 109.592 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -95.49 -15.61 22.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.442 1.097 . . . . 0.0 113.699 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -81.85 160.55 41.15 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.011 1.291 . . . . 0.0 113.185 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.0 163.46 13.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.747 1.219 . . . . 0.0 111.623 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 2.2 t0 -155.17 -176.05 5.74 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.071 1.348 . . . . 0.0 111.072 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 7.3 p -58.13 -20.35 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.576 1.55 . . . . 0.0 114.061 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.9 t -76.58 -27.51 55.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.134 1.373 . . . . 0.0 113.03 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 21.7 p -118.82 -14.8 9.46 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 6.1 mt -118.53 151.9 36.99 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.691 1.596 . . . . 0.0 111.948 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -67.85 128.69 93.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.055 0.942 . . . . 0.0 110.578 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.0 167.69 25.6 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.522 2.815 . . . . 0.0 112.822 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -104.88 121.39 43.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 108.621 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -146.73 126.01 13.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.676 1.19 . . . . 0.0 110.299 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.26 159.63 41.84 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.433 1.893 . . . . 0.0 110.09 -170.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -133.11 139.49 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.116 1.366 . . . . 0.0 110.315 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.6 mt -133.48 135.2 24.77 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 109.118 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.96 109.67 2.74 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.364 2.709 . . . . 0.0 109.765 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 47.1 t80 -175.7 151.93 1.22 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.344 2.258 . . . . 0.0 108.956 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 41.5 m -134.67 125.89 28.0 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 110.576 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 37.5 mt -82.97 134.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.862 1.265 . . . . 0.0 109.389 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -131.77 -60.22 0.93 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 0.0 111.564 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.4 tptt -152.27 127.5 9.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.552 1.541 . . . . 0.0 110.388 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.95 -149.95 17.82 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.288 1.423 . . . . 0.0 111.648 -167.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.09 146.14 18.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.565 1.146 . . . . 0.0 111.089 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.5 tt -126.89 136.04 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.776 1.631 . . . . 0.0 111.043 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.9 p -148.58 173.16 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.398 1.879 . . . . 0.0 110.252 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.82 -170.69 24.71 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.65 137.96 15.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.593 1.557 . . . . 0.0 109.716 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 20.9 t -113.6 135.01 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 108.195 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -119.41 132.42 55.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.632 1.173 . . . . 0.0 111.457 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.08 142.52 25.21 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.842 1.657 . . . . 0.0 111.694 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.23 -32.96 82.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.149 3.232 . . . . 0.0 114.407 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -72.32 2.83 5.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.908 1.283 . . . . 0.0 114.34 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.35 4.75 65.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.634 1.588 . . . . 0.0 114.599 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.7 164.29 16.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.225 1.41 . . . . 0.0 111.91 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.4 m -137.91 152.83 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.603 1.561 . . . . 0.0 110.889 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.01 163.21 36.6 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.319 1.448 . . . . 0.0 111.624 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -105.97 139.17 19.98 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.169 0.988 . . . . 0.0 111.128 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.63 170.1 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.227 3.284 . . . . 0.0 111.771 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.7 m -109.5 135.71 50.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.41 1.484 . . . . 0.0 108.964 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.62 135.66 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.975 1.31 . . . . 0.0 109.252 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 53.0 m -137.98 127.3 24.63 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.323 1.449 . . . . 0.0 109.971 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -80.27 129.98 34.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.001 0.92 . . . . 0.0 111.154 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.7 -8.77 58.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 37.3 mtmm 63.97 14.3 8.33 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.532 2.333 . . . . 0.0 113.805 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.46 8.38 21.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.221 2.209 . . . . 0.0 112.503 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 12.52 57.07 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.22 1.39 . . . . 0.0 114.4 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.0 p -131.32 155.42 47.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.035 1.734 . . . . 0.0 111.202 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.3 m -112.99 139.47 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.058 0.943 . . . . 0.0 109.869 163.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 49.5 m -96.62 139.5 32.61 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.002 1.321 . . . . 0.0 108.523 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.6 t -124.92 134.82 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.475 1.51 . . . . 0.0 109.241 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -136.17 153.58 51.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 112.504 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.92 136.56 16.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.787 1.635 . . . . 0.0 111.576 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.63 123.46 70.86 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.643 1.177 . . . . 0.0 110.724 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.81 160.2 18.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.942 3.095 . . . . 0.0 112.574 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.9 p -152.34 -9.56 0.19 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.73 149.47 45.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.852 1.661 . . . . 0.0 110.075 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -91.6 166.25 12.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.176 0.991 . . . . 0.0 111.969 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.76 -171.06 13.8 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.148 1.356 . . . . 0.0 113.795 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.54 121.41 30.89 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.723 1.209 . . . . 0.0 109.825 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 70.2 m80 -119.85 165.32 14.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.134 1.774 . . . . 0.0 111.833 -172.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.78 154.11 37.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.965 0.906 . . . . 0.0 111.975 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.3 ttm -134.94 127.4 30.52 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.904 2.082 . . . . 0.0 109.986 -168.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -97.4 135.6 39.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.617 1.567 . . . . 0.0 109.975 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.5 mm -132.95 130.55 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.932 1.293 . . . . 0.0 109.769 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.04 138.72 32.0 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.2 t80 -101.85 119.36 38.66 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 109.323 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.17 32.75 11.1 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.916 1.286 . . . . 0.0 112.903 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.5 m-80 74.95 7.22 4.28 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.957 2.503 . . . . 0.0 115.266 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.1 tpp -100.01 129.48 46.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.585 1.154 . . . . 0.0 110.573 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.79 136.7 56.97 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.373 -0.829 . . . . 0.0 113.067 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.7 pt -75.63 155.65 85.24 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.555 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -58.97 129.48 32.14 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.059 1.839 . . . . 0.0 109.485 169.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.06 62.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.499 1.047 . . . . 0.0 114.124 -174.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -82.27 143.81 49.2 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.722 1.761 . . . . 0.0 111.209 171.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.0 155.68 91.58 Favored 'Cis proline' 0 C--N 1.351 0.684 0 CA-C-N 119.944 1.016 . . . . 0.0 112.117 -5.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.91 153.43 18.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.553 1.141 . . . . 0.0 110.548 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -150.0 135.07 17.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.693 1.197 . . . . 0.0 109.789 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.17 169.92 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.735 1.214 . . . . 0.0 112.324 -170.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 29.6 t80 -104.19 147.61 27.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.272 -0.892 . . . . 0.0 112.309 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 85.3 t -117.69 133.58 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.295 1.838 . . . . 0.0 108.893 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -151.1 163.04 39.71 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -169.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -80.0 87.63 5.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.226 1.411 . . . . 0.0 111.105 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 10.7 p -54.53 -27.59 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.242 1.417 . . . . 0.0 114.506 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -77.82 -16.99 57.91 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -75.9 161.97 28.52 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.749 1.219 . . . . 0.0 112.438 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.44 -9.82 78.39 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.9 1.238 . . . . 0.0 115.778 -169.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -66.63 147.72 52.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.169 1.485 . . . . 0.0 113.165 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 p -64.47 134.58 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.774 -0.579 . . . . 0.0 109.709 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.1 t -156.2 160.9 40.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.508 1.123 . . . . 0.0 111.057 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.93 142.92 33.04 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.06 161.05 19.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.526 1.531 . . . . 0.0 112.922 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 136.87 175.03 13.57 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.392 1.472 . . . . 0.0 113.046 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.31 -36.95 8.49 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.723 2.282 . . . . 0.0 112.944 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.18 -34.64 90.17 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.439 1.018 . . . . 0.0 114.608 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.59 -6.18 54.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.653 1.227 . . . . 0.0 113.561 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.0 m -104.7 -43.78 5.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.403 1.881 . . . . 0.0 111.166 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -147.31 142.76 27.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.582 1.953 . . . . 0.0 111.916 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -134.21 173.66 21.26 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.349 0.976 . . . . 0.0 113.052 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 28.0 t -138.69 133.3 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.348 1.059 . . . . 0.0 108.575 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.5 m -57.15 133.77 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.165 0.586 . . . . 0.0 112.442 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 23.1 m120 69.61 0.16 2.86 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.872 2.069 . . . . 0.0 114.192 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -103.14 138.66 19.61 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.212 1.405 . . . . 0.0 110.541 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.24 112.64 3.48 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.604 2.203 . . . . 0.0 109.866 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -96.39 133.1 41.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.132 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.7 p -127.04 153.63 45.7 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1886 ' ' PHE . . . . . 0.405 ' CZ ' HG11 ' A' 1922 ' ' VAL . 54.4 p90 -162.83 176.23 10.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.989 1.716 . . . . 0.0 111.415 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.7 m -126.82 142.63 51.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.24 1.416 . . . . 0.0 110.493 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.8 t -114.31 126.58 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 107.801 167.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -93.55 120.18 33.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.923 0.889 . . . . 0.0 110.378 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 20.2 p -119.76 15.45 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.97 2.108 . . . . 0.0 112.096 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -58.45 -30.97 67.36 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.029 1.732 . . . . 0.0 114.726 -164.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -131.69 20.28 4.66 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.993 1.717 . . . . 0.0 112.101 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -81.06 -9.5 59.82 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 90.98 -125.56 8.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.39 0.995 . . . . 0.0 112.623 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -154.03 151.5 29.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.335 1.454 . . . . 0.0 111.26 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 154.55 -156.21 26.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.821 1.677 . . . . 0.0 112.521 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.2 107.81 3.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.091 0.853 . . . . 0.0 111.218 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.54 126.53 32.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.884 1.274 . . . . 0.0 108.502 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -130.66 158.1 40.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.905 1.282 . . . . 0.0 112.607 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.6 tp -157.49 135.43 10.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.407 1.883 . . . . 0.0 108.728 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.63 161.39 39.9 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.949 0.9 . . . . 0.0 112.203 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.3 mt -134.87 135.65 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.589 1.156 . . . . 0.0 109.563 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.83 113.51 20.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.037 1.335 . . . . 0.0 109.316 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -129.44 -173.91 13.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.99 1.281 . . . . 0.0 113.912 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.97 -18.57 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.003 3.135 . . . . 0.0 112.32 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -142.57 157.32 44.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.772 1.629 . . . . 0.0 109.339 165.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1907 ' ' LYS . . . . . 0.432 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 1.0 OUTLIER -73.3 107.84 5.84 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.111 -0.993 . . . . 0.0 111.729 -175.502 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.49 145.81 48.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.867 0.867 . . . . 0.0 111.165 167.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.48 145.8 24.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.484 0.713 . . . . 0.0 110.457 168.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.0 mt -134.9 140.8 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.934 1.293 . . . . 0.0 110.316 -165.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 59.6 m -133.42 155.93 48.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.818 1.647 . . . . 0.0 110.713 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.4 p -153.23 153.97 33.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.482 1.113 . . . . 0.0 112.125 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.4 m -143.76 126.32 15.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.831 1.252 . . . . 0.0 110.748 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.66 131.17 39.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.968 1.307 . . . . 0.0 111.396 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -103.97 151.8 22.76 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.668 1.587 . . . . 0.0 111.852 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -68.18 -16.21 63.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.887 0.875 . . . . 0.0 113.184 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.22 -12.45 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 113.518 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.72 19.2 35.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.676 1.132 . . . . 0.0 114.139 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 80.4 p -114.2 165.36 12.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.958 1.703 . . . . 0.0 110.749 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.8 m -115.26 129.0 56.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.169 1.387 . . . . 0.0 109.916 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.1 t -87.0 151.7 23.04 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.842 0.857 . . . . 0.0 110.65 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1922 ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' 1886 ' ' PHE . 89.6 t -132.21 144.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.136 1.774 . . . . 0.0 110.026 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.6 t -141.81 141.69 33.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.641 1.577 . . . . 0.0 110.924 171.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.2 p90 -147.19 155.0 41.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.1 mt -119.72 104.31 44.9 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.569 1.547 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.01 167.46 18.08 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.632 2.888 . . . . 0.0 110.36 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.4 p -132.29 -18.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -170.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.51 150.18 50.14 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.61 1.164 . . . . 0.0 110.404 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.29 142.57 27.17 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 111.552 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 158.61 -167.55 34.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.66 1.124 . . . . 0.0 113.331 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.33 126.8 40.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.215 1.406 . . . . 0.0 112.111 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -120.62 124.28 44.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.801 1.64 . . . . 0.0 109.922 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.9 m -87.64 121.08 29.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.116 -0.99 . . . . 0.0 110.851 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.51 127.88 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 108.522 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.46 130.54 55.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 38.2 t -133.22 130.56 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.289 1.036 . . . . 0.0 109.804 172.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.83 144.45 24.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 -167.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.08 124.76 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.892 1.277 . . . . 0.0 110.165 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 56.02 53.49 9.08 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.867 1.267 . . . . 0.0 111.676 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.94 3.42 0.32 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.988 2.915 . . . . 0.0 116.75 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -107.49 126.55 52.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.758 1.223 . . . . 0.0 110.718 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -63.89 147.29 52.28 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.238 -0.914 . . . . 0.0 111.949 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 9.9 m -68.85 152.84 96.57 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.672 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.99 130.29 30.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.165 1.91 . . . . 0.0 110.527 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.94 -15.93 61.63 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.005 1.288 . . . . 0.0 114.919 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.8 t -77.67 140.85 63.97 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 119.282 1.541 . . . . 0.0 111.465 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.72 137.87 52.75 Favored 'Cis proline' 0 C--N 1.352 0.727 0 CA-C-N 119.337 0.799 . . . . 0.0 112.077 -3.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -89.63 169.86 10.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.203 1.801 . . . . 0.0 110.555 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.6 m -129.12 115.95 18.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.698 0.799 . . . . 0.0 110.781 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.27 144.93 25.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.872 1.269 . . . . 0.0 110.656 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 17.8 ttt85 -108.82 121.52 45.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.832 0.853 . . . . 0.0 110.035 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.1 t -102.44 134.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.179 1.392 . . . . 0.0 110.648 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 48.4 p -114.88 169.64 8.93 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.252 1.421 . . . . 0.0 112.939 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.3 140.16 22.58 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.027 1.298 . . . . 0.0 112.612 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.76 -23.81 41.98 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.38 1.072 . . . . 0.0 112.855 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.801 2.04 . . . . 0.0 112.54 -175.911 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.35 -22.66 61.87 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -142.19 9.9 1.9 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.928 1.291 . . . . 0.0 114.483 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -158.06 149.18 16.47 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.287 1.435 . . . . 0.0 112.038 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.63 171.58 16.5 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.137 3.224 . . . . 0.0 112.18 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -163.1 164.17 25.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.239 1.816 . . . . 0.0 110.86 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -64.33 140.09 97.87 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.747 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.99 174.99 11.83 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.738 2.959 . . . . 0.0 111.785 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 87.5 mt -76.84 67.66 2.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.176 1.391 . . . . 0.0 111.762 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 35.2 m -69.37 -10.68 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.681 1.592 . . . . 0.0 114.255 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 91.24 -145.43 17.77 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.866 1.222 . . . . 0.0 112.432 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 90.2 t -128.57 138.87 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.635 1.574 . . . . 0.0 109.578 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 53.6 t30 -139.38 38.42 2.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.611 1.564 . . . . 0.0 111.285 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 85.6 -149.2 23.32 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.996 1.284 . . . . 0.0 111.077 -166.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.83 144.97 52.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.511 0.724 . . . . 0.0 111.076 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -72.51 -19.66 61.49 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.158 0.983 . . . . 0.0 113.196 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 18.1 m -142.61 153.45 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.178 2.191 . . . . 0.0 109.848 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 13.0 t -164.15 -45.01 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.913 1.285 . . . . 0.0 111.827 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 90.8 p -165.0 150.57 9.71 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.46 158.95 16.8 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.072 1.749 . . . . 0.0 110.004 161.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -58.39 118.1 25.27 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.97 1.308 . . . . 0.0 110.991 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.08 152.68 45.99 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.024 2.483 . . . . 0.0 111.037 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.26 113.94 27.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.804 0.842 . . . . 0.0 109.71 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -146.81 125.23 12.34 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 109.99 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.16 153.48 50.45 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.482 1.913 . . . . 0.0 109.891 -173.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.8 p -129.2 136.77 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.029 1.332 . . . . 0.0 110.351 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.01 138.72 33.03 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.001 1.72 . . . . 0.0 109.074 -175.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.87 67.7 7.93 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 124.353 3.369 . . . . 0.0 111.698 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -113.82 150.73 33.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.146 1.778 . . . . 0.0 110.231 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 77.7 m -119.08 125.41 49.24 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.596 1.158 . . . . 0.0 109.751 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 81.1 mt -91.46 132.08 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.755 1.222 . . . . 0.0 109.876 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -114.35 -100.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.18 1.392 . . . . 0.0 110.746 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.4 mttp -133.69 139.35 46.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 111.089 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.4 -139.81 11.2 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.719 1.628 . . . . 0.0 110.801 -165.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.53 141.61 16.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.118 0.967 . . . . 0.0 111.36 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.68 135.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 0.0 110.711 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.3 p -145.77 174.58 11.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.112 1.765 . . . . 0.0 110.206 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.44 -170.96 24.64 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.3 140.14 16.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.843 1.657 . . . . 0.0 109.305 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.1 t -117.72 130.74 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.546 1.539 . . . . 0.0 108.343 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -117.99 128.36 54.71 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.001 1.32 . . . . 0.0 110.389 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 32.4 mtt -99.76 153.32 37.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.198 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -17.87 31.83 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.431 2.754 . . . . 0.0 112.831 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 35.3 p -72.76 -8.06 53.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.0 113.973 170.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.51 83.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.721 1.629 . . . . 0.0 113.777 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -72.52 159.54 33.76 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.599 1.16 . . . . 0.0 112.536 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 46.9 t -139.34 142.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.517 1.527 . . . . 0.0 110.169 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.88 171.15 16.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.885 1.674 . . . . 0.0 111.772 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -106.61 140.39 21.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.34 1.056 . . . . 0.0 111.264 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -86.65 174.0 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.549 3.499 . . . . 0.0 111.94 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 60.3 m -113.46 131.76 55.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.394 1.478 . . . . 0.0 108.982 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.01 133.31 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.839 1.256 . . . . 0.0 109.154 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 92.9 m -123.51 129.04 50.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.152 1.781 . . . . 0.0 109.789 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 59.5 t0 -81.78 118.61 23.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.309 1.044 . . . . 0.0 110.127 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -83.01 -10.54 58.71 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.8 mmmt 73.5 -10.44 1.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.269 2.628 . . . . 0.0 114.331 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -92.75 5.61 50.52 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.495 1.918 . . . . 0.0 113.691 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.89 15.82 53.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.802 1.191 . . . . 0.0 113.716 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 67.3 p -128.26 159.29 35.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.364 1.866 . . . . 0.0 110.286 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -121.79 143.01 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.494 1.118 . . . . 0.0 109.875 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 31.8 m -104.09 137.23 42.34 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.396 1.078 . . . . 0.0 108.618 170.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.3 t -124.92 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.184 1.394 . . . . 0.0 109.042 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -133.76 156.45 47.97 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.138 1.375 . . . . 0.0 112.826 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 22.9 t80 -155.61 135.76 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.828 1.651 . . . . 0.0 111.427 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.37 120.05 71.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.411 1.084 . . . . 0.0 110.776 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.33 139.99 21.49 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.349 2.699 . . . . 0.0 112.01 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.2 m -132.92 0.3 3.48 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -161.4 150.46 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.296 1.838 . . . . 0.0 109.686 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -86.09 173.06 10.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.857 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.09 -172.68 21.73 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.262 1.41 . . . . 0.0 114.098 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -78.0 125.84 29.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.618 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 51.2 m80 -123.09 163.05 21.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.075 1.75 . . . . 0.0 111.372 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.22 153.1 34.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.157 0.983 . . . . 0.0 111.862 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 28.0 ttm -137.36 135.25 36.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.956 1.702 . . . . 0.0 110.771 -167.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.11 134.3 51.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.443 1.897 . . . . 0.0 109.848 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.6 mm -133.97 130.59 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.171 1.388 . . . . 0.0 109.53 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 136.5 23.4 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -173.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.67 122.68 43.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.641 1.976 . . . . 0.0 109.784 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 51.82 31.28 8.03 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.876 1.27 . . . . 0.0 112.881 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 18.1 t30 77.62 5.09 3.01 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.279 2.631 . . . . 0.0 115.108 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 95.9 mtp -100.07 129.36 46.11 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.31 1.444 . . . . 0.0 110.772 170.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -56.77 137.15 55.05 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.6 pt -74.55 151.14 87.18 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.861 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.04 132.34 44.11 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.672 2.248 . . . . 0.0 110.243 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.91 -17.15 59.83 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.733 1.159 . . . . 0.0 113.905 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.9 t -85.53 147.77 47.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 119.164 1.482 . . . . 0.0 110.905 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.44 157.43 99.47 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.666 1.274 . . . . 0.0 113.251 -0.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 80.1 mt -101.38 157.87 16.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.67 1.588 . . . . 0.0 110.884 173.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -151.93 135.26 15.96 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.839 1.256 . . . . 0.0 110.154 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.2 p90 -165.51 167.2 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 111.98 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -108.52 141.09 40.93 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.126 -0.984 . . . . 0.0 112.928 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.9 t -111.56 139.93 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.815 1.646 . . . . 0.0 109.679 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -161.42 151.77 17.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.9 1.28 . . . . 0.0 112.22 -170.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -67.53 134.15 50.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.932 1.293 . . . . 0.0 112.152 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -68.41 -27.37 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.113 -0.992 . . . . 0.0 113.289 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.89 -21.33 44.11 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -170.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.6 t -67.22 147.03 53.57 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.484 -0.76 . . . . 0.0 112.964 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.9 -6.77 82.0 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.145 1.355 . . . . 0.0 115.103 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.29 166.85 11.36 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.09 1.445 . . . . 0.0 114.0 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.8 t -73.19 144.73 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.978 0.911 . . . . 0.0 108.832 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.0 t -159.74 148.25 17.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.03 1.332 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.61 144.83 50.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.62 1.168 . . . . 0.0 111.658 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.7 p90 -166.73 161.65 15.73 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.615 1.566 . . . . 0.0 112.745 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.02 175.36 13.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.324 1.44 . . . . 0.0 112.897 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 -36.48 9.66 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.721 2.28 . . . . 0.0 112.832 -171.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.96 90.75 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.378 0.99 . . . . 0.0 114.406 -171.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -78.77 -5.64 53.84 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.829 1.314 . . . . 0.0 113.615 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 32.3 m -104.89 -42.1 5.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.409 1.884 . . . . 0.0 111.25 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -151.14 143.39 24.11 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.772 2.029 . . . . 0.0 112.054 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -136.09 177.56 19.45 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.822 1.201 . . . . 0.0 113.212 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 25.5 t -142.96 135.19 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.905 1.282 . . . . 0.0 108.378 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.94 135.33 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 66.34 2.81 2.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.604 1.962 . . . . 0.0 114.382 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -100.01 142.3 24.36 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.907 1.283 . . . . 0.0 110.807 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.37 109.13 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.777 2.318 . . . . 0.0 109.853 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -93.6 133.0 37.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.003 1.321 . . . . 0.0 110.134 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.8 p -127.35 149.01 50.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -159.51 174.79 14.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.754 1.621 . . . . 0.0 111.664 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.8 m -126.51 145.14 50.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.347 1.459 . . . . 0.0 110.721 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 29.9 t -114.76 130.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.476 1.511 . . . . 0.0 108.128 167.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.02 132.77 36.29 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.226 1.011 . . . . 0.0 111.051 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.5 p -131.91 13.67 4.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.787 2.035 . . . . 0.0 112.449 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -50.61 -36.2 33.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.258 2.223 . . . . 0.0 115.268 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.27 24.83 3.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.647 1.579 . . . . 0.0 111.858 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.05 69.03 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.461 1.105 . . . . 0.0 113.619 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.66 150.74 5.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.827 1.203 . . . . 0.0 112.337 -169.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -73.82 149.27 41.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.744 0.783 . . . . 0.0 112.024 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.74 14.42 0.02 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.881 1.705 . . . . 0.0 114.905 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 92.85 100.63 1.46 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.535 1.541 . . . . 0.0 112.806 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.49 130.7 35.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.366 1.466 . . . . 0.0 109.415 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.3 m -126.96 158.4 36.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.64 1.576 . . . . 0.0 112.123 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.7 tp -160.72 135.45 7.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.788 1.635 . . . . 0.0 109.23 -169.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 161.57 38.1 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.043 0.937 . . . . 0.0 112.321 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -135.53 134.58 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.762 1.225 . . . . 0.0 109.547 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -116.73 115.7 26.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.001 1.32 . . . . 0.0 109.326 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -128.37 -177.64 14.97 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.978 1.275 . . . . 0.0 113.873 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.54 -22.65 44.32 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.001 3.134 . . . . 0.0 112.128 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -140.28 158.06 44.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.57 . . . . 0.0 109.069 161.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 118.51 11.98 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.093 -1.005 . . . . 0.0 111.915 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.09 142.63 33.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.207 1.003 . . . . 0.0 110.824 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.05 142.0 28.24 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.322 0.649 . . . . 0.0 110.082 171.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.8 mt -132.06 139.21 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.822 1.249 . . . . 0.0 110.471 -167.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.8 m -128.38 155.56 44.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.861 1.664 . . . . 0.0 110.393 167.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -151.46 156.23 40.19 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.156 0.982 . . . . 0.0 112.237 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.7 m -140.49 118.62 11.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.341 1.456 . . . . 0.0 109.697 -171.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.31 123.71 25.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.169 0.988 . . . . 0.0 110.779 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.55 -17.91 26.18 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 15.0 mm100 71.27 -10.34 0.8 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.344 2.658 . . . . 0.0 114.495 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.69 -14.04 61.48 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.313 1.445 . . . . 0.0 113.104 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 116.81 22.03 4.43 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.509 1.528 . . . . 0.0 114.17 -170.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.0 p -142.38 158.5 43.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.676 1.59 . . . . 0.0 111.111 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -126.23 135.45 51.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.632 1.973 . . . . 0.0 109.068 166.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 16.4 t -94.83 153.29 17.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.459 1.104 . . . . 0.0 111.343 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -132.11 145.03 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.316 1.846 . . . . 0.0 110.0 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.2 t -140.63 138.85 34.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.694 1.598 . . . . 0.0 110.752 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.99 154.5 42.62 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 26.4 mt -118.07 102.62 50.75 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.097 1.759 . . . . 0.0 110.415 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.68 160.67 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.546 2.83 . . . . 0.0 110.139 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.9 m -127.15 -7.77 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.72 151.18 22.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.176 1.39 . . . . 0.0 110.402 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.07 140.77 25.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.796 2.331 . . . . 0.0 111.691 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 157.8 -169.86 34.66 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.86 1.219 . . . . 0.0 113.087 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.82 135.3 35.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.889 1.276 . . . . 0.0 112.135 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.56 128.69 46.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.288 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.0 m -90.51 122.58 33.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.18 -0.95 . . . . 0.0 110.963 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.53 125.69 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.356 1.462 . . . . 0.0 108.621 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.09 130.42 55.48 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.424 1.49 . . . . 0.0 109.71 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 39.2 t -133.25 129.96 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.349 1.06 . . . . 0.0 109.753 172.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.48 142.26 22.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.145 1.378 . . . . 0.0 111.511 -168.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.5 122.17 19.75 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.817 1.247 . . . . 0.0 109.523 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.5 57.89 5.71 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.038 1.335 . . . . 0.0 112.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 8.2 pt-20 59.7 2.42 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.965 2.906 . . . . 0.0 116.819 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -107.5 123.54 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.567 1.147 . . . . 0.0 110.998 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.88 145.41 55.87 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.306 -0.871 . . . . 0.0 111.984 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.4 m -73.39 157.37 88.08 Favored Pre-proline 0 N--CA 1.48 1.065 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.64 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.04 125.82 20.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.63 2.887 . . . . 0.0 111.785 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.24 -11.36 67.84 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.705 1.145 . . . . 0.0 115.469 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.3 t -76.44 139.73 67.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.356 1.578 . . . . 0.0 111.579 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.07 136.84 47.06 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 CA-C-N 119.382 0.815 . . . . 0.0 111.969 -3.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -87.07 170.25 11.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.134 1.774 . . . . 0.0 110.662 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.1 m -128.92 117.76 21.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.748 0.819 . . . . 0.0 110.771 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.1 160.31 15.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.455 1.502 . . . . 0.0 110.954 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -127.62 126.22 41.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.553 1.141 . . . . 0.0 110.207 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.5 t -107.23 134.44 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 0.0 110.866 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 41.8 p -107.2 157.61 17.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.075 1.35 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -94.27 116.76 5.35 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.104 1.335 . . . . 0.0 112.349 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 -94.96 -30.05 14.33 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.73 1.212 . . . . 0.0 112.935 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 125.526 1.531 . . . . 0.0 113.305 179.661 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.96 -28.01 0.18 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 128.588 2.755 . . . . 0.0 115.248 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.19 176.72 12.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.375 2.27 . . . . 0.0 111.007 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -132.26 148.57 70.26 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.988 1.315 . . . . 0.0 111.706 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.0 -178.31 4.52 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.16 3.24 . . . . 0.0 111.79 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -145.89 164.56 31.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.389 1.475 . . . . 0.0 111.475 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -58.59 123.69 68.49 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.557 1.143 . . . . 0.0 111.586 -175.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.32 174.85 12.15 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.681 2.921 . . . . 0.0 111.741 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.93 8.39 0.54 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -173.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 34.5 m -58.82 -11.12 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.131 1.772 . . . . 0.0 114.761 -174.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -74.87 -7.72 81.35 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.979 1.276 . . . . 0.0 114.97 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 28.4 m -62.56 153.67 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 119.732 1.766 . . . . 0.0 112.249 172.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -63.51 144.76 56.73 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.347 1.059 . . . . 0.0 112.959 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 131.74 -179.61 16.98 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.831 1.681 . . . . 0.0 113.159 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.7 142.3 46.37 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.223 1.009 . . . . 0.0 111.868 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.13 -171.87 3.97 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.969 1.708 . . . . 0.0 110.376 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 34.2 m -62.12 -24.95 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 120.643 -1.285 . . . . 0.0 113.446 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.5 t -73.26 -22.46 60.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.993 1.317 . . . . 0.0 112.82 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 3.7 m -83.4 -6.28 59.41 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.1 1.36 . . . . 0.0 113.425 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 86.7 mt -84.53 149.81 25.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.284 1.033 . . . . 0.0 111.903 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -55.17 114.0 6.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.046 1.739 . . . . 0.0 111.302 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.3 142.54 50.26 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.566 2.177 . . . . 0.0 109.71 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 39.6 t80 -120.14 123.36 43.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.531 0.732 . . . . 0.0 111.457 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.3 135.88 13.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.92 1.688 . . . . 0.0 110.572 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.0 151.63 45.63 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.214 1.805 . . . . 0.0 110.317 -171.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.5 p -117.6 140.23 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.233 1.413 . . . . 0.0 110.318 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.7 mt -133.21 134.93 24.72 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.407 1.883 . . . . 0.0 108.367 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.37 38.75 0.75 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 124.33 3.353 . . . . 0.0 113.354 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.0 t80 -87.26 152.78 22.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.005 1.322 . . . . 0.0 111.415 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 94.2 m -122.94 127.46 48.93 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.419 1.488 . . . . 0.0 109.708 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.6 mt -75.61 136.24 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.457 1.103 . . . . 0.0 111.216 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.1 pttt -112.74 -148.97 0.44 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.497 1.919 . . . . 0.0 112.036 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -87.16 131.91 34.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.557 1.143 . . . . 0.0 111.102 167.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.52 -139.54 11.03 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.311 1.434 . . . . 0.0 111.884 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -156.68 145.01 19.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.567 1.147 . . . . 0.0 111.74 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.6 tt -117.81 137.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.987 1.715 . . . . 0.0 111.057 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 26.1 p -146.27 161.16 40.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.689 1.596 . . . . 0.0 110.799 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.86 20.05 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.0 138.98 18.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.7 1.6 . . . . 0.0 109.798 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 19.6 t -111.56 136.62 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.337 1.855 . . . . 0.0 108.053 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -121.11 125.02 46.18 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 110.882 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.05 148.25 34.12 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.84 1.656 . . . . 0.0 111.319 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.53 -20.2 31.49 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.481 2.787 . . . . 0.0 113.929 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.6 t -77.03 -4.08 42.38 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.91 51.06 2.53 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.596 1.093 . . . . 0.0 113.035 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.81 166.96 25.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.678 1.591 . . . . 0.0 111.849 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.9 m -139.41 159.49 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.671 1.188 . . . . 0.0 113.071 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.05 171.83 18.47 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.142 2.177 . . . . 0.0 110.545 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -107.26 137.98 19.76 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.822 0.849 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.97 168.11 13.91 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.939 3.092 . . . . 0.0 110.972 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.5 m -104.63 126.23 51.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.005 1.322 . . . . 0.0 108.83 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.31 137.67 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.962 1.305 . . . . 0.0 108.846 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 24.4 m -146.71 127.25 14.13 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 109.393 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.56 143.64 40.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 112.648 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -88.76 -3.09 58.85 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? 65.94 18.49 11.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.343 1.857 . . . . 0.0 112.978 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -128.2 15.53 6.72 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.529 1.932 . . . . 0.0 112.684 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 85.11 15.91 66.03 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.575 1.083 . . . . 0.0 114.094 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 30.2 p -135.19 158.14 45.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.281 1.833 . . . . 0.0 110.32 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -123.81 144.66 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.613 1.165 . . . . 0.0 110.497 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.1 m -103.71 140.16 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.118 1.367 . . . . 0.0 108.862 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 34.0 t -122.62 133.78 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.486 1.514 . . . . 0.0 108.833 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.45 153.77 50.54 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.574 1.55 . . . . 0.0 111.983 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 26.6 t80 -157.0 133.31 9.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.207 1.403 . . . . 0.0 111.826 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.43 119.04 71.23 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.374 1.07 . . . . 0.0 110.513 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.59 144.31 31.68 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.524 2.816 . . . . 0.0 112.114 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.7 p -129.07 -7.6 4.88 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -159.88 150.97 19.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.74 1.616 . . . . 0.0 110.698 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.31 170.8 14.22 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.649 1.18 . . . . 0.0 113.308 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.15 -171.09 13.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.099 1.809 . . . . 0.0 113.919 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.3 tp -85.21 133.72 34.17 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.753 1.221 . . . . 0.0 110.035 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -130.47 166.47 20.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.028 1.731 . . . . 0.0 111.37 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.67 157.32 45.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.447 1.099 . . . . 0.0 110.691 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.2 tmm? -146.56 135.02 21.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.013 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.31 137.71 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.832 2.053 . . . . 0.0 110.03 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.0 mm -135.03 132.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.133 1.373 . . . . 0.0 110.137 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 141.21 32.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.4 t80 -103.27 120.49 40.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.541 1.936 . . . . 0.0 109.965 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.26 32.39 8.15 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.716 1.206 . . . . 0.0 112.889 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.8 t30 81.47 0.69 1.6 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.728 2.811 . . . . 0.0 115.08 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 57.4 ttm -98.83 128.5 45.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.343 1.457 . . . . 0.0 110.957 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.27 137.42 52.26 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.38 154.17 81.84 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.26 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.51 129.58 33.21 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.514 2.143 . . . . 0.0 109.988 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.79 -16.92 59.65 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.812 1.196 . . . . 0.0 114.065 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.6 t -86.66 145.51 39.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 119.699 1.75 . . . . 0.0 111.244 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -82.8 165.31 70.91 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.076 1.063 . . . . 0.0 112.73 -4.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.63 156.88 25.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.286 1.834 . . . . 0.0 111.423 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -137.05 137.88 39.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.522 1.529 . . . . 0.0 109.71 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 27.0 p90 -158.5 155.89 29.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.284 1.034 . . . . 0.0 112.315 -169.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.0 t80 -106.01 148.17 28.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.878 0.871 . . . . 0.0 112.341 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 55.0 t -126.11 137.45 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.523 1.529 . . . . 0.0 108.979 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -150.35 158.43 44.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.599 1.16 . . . . 0.0 113.115 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.8 118.46 20.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.941 0.896 . . . . 0.0 111.748 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.6 p -62.9 -34.29 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.743 1.217 . . . . 0.0 114.017 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -88.24 -7.44 56.8 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 39.7 t -67.35 -34.04 76.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.292 1.037 . . . . 0.0 113.065 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 82.67 2.6 90.65 Favored Glycine 0 N--CA 1.476 1.319 0 C-N-CA 124.901 1.239 . . . . 0.0 115.325 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -64.03 163.26 12.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.622 1.569 . . . . 0.0 113.698 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.3 t -70.16 132.76 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.0 t -165.27 164.24 19.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.784 1.233 . . . . 0.0 110.963 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.32 143.9 44.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.433 1.493 . . . . 0.0 111.251 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.5 p90 -162.93 162.84 26.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.278 1.431 . . . . 0.0 112.782 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 125.89 173.59 13.66 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.443 1.497 . . . . 0.0 112.797 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.01 -34.99 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.793 2.329 . . . . 0.0 112.947 -170.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.82 -32.95 82.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.51 1.05 . . . . 0.0 114.786 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.33 -6.08 55.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.877 1.338 . . . . 0.0 113.526 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.2 m -105.0 -45.28 4.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.497 1.919 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -146.44 150.52 35.78 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.679 1.992 . . . . 0.0 112.132 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 179.86 22.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.293 0.949 . . . . 0.0 113.493 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 31.5 t -142.45 133.2 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 0.0 108.522 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.5 m -55.54 137.44 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.3 m-80 68.98 -4.92 1.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.072 2.149 . . . . 0.0 114.814 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -104.39 138.58 19.56 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.012 1.325 . . . . 0.0 110.771 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.93 127.13 12.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.368 2.045 . . . . 0.0 110.334 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.21 145.18 32.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.595 1.558 . . . . 0.0 110.368 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.6 p -135.11 151.07 50.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.909 0.884 . . . . 0.0 113.245 -167.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.5 p90 -162.01 176.26 10.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.945 1.698 . . . . 0.0 111.441 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 67.8 m -129.93 143.03 50.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.226 1.411 . . . . 0.0 110.275 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 49.0 t -115.4 135.15 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.689 1.596 . . . . 0.0 108.137 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -98.7 133.67 42.7 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.364 1.066 . . . . 0.0 111.136 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.7 p -134.61 14.57 3.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.778 1.631 . . . . 0.0 112.519 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.12 -34.78 70.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.645 1.578 . . . . 0.0 114.992 -163.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -129.39 21.51 5.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.691 1.596 . . . . 0.0 111.868 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.59 -39.14 70.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.482 1.113 . . . . 0.0 113.841 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.41 146.76 4.61 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.783 1.183 . . . . 0.0 112.01 -168.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.13 165.86 22.66 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 113.391 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.75 16.47 0.25 Allowed Glycine 0 N--CA 1.477 1.394 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.61 97.22 1.86 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.302 1.429 . . . . 0.0 113.126 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -80.14 127.22 32.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 108.952 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -120.08 159.49 24.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.775 1.63 . . . . 0.0 112.547 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -159.65 137.46 10.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.048 1.739 . . . . 0.0 109.437 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.13 159.51 36.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.442 1.097 . . . . 0.0 111.839 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.13 133.66 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.448 1.099 . . . . 0.0 109.813 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.52 132.68 53.98 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.182 1.393 . . . . 0.0 109.752 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.82 -165.6 15.11 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 119.089 -0.839 . . . . 0.0 114.412 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.31 -29.44 79.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.917 3.078 . . . . 0.0 111.996 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.2 t -129.83 150.43 51.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.851 1.26 . . . . 0.0 108.972 158.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -70.68 125.69 27.51 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.306 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.87 152.8 35.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.68 133.14 34.04 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 162.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.4 mt -133.07 143.13 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.823 1.249 . . . . 0.0 109.994 -166.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.7 t -143.42 158.99 43.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.931 1.293 . . . . 0.0 110.834 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -158.07 154.44 27.57 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.463 1.105 . . . . 0.0 112.436 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.7 m -135.84 120.06 17.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.302 1.441 . . . . 0.0 109.954 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.61 132.03 40.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.901 1.28 . . . . 0.0 110.913 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -109.82 138.77 45.72 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.156 1.382 . . . . 0.0 111.084 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -65.66 -17.85 64.9 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.863 0.865 . . . . 0.0 112.226 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.49 -12.44 57.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.048 1.739 . . . . 0.0 114.346 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.04 33.42 5.5 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.876 1.227 . . . . 0.0 114.486 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.8 p -140.55 164.24 30.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.596 1.558 . . . . 0.0 110.794 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.6 m -119.34 130.45 55.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 163.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -91.49 148.51 22.25 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 110.398 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.9 t -131.38 141.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.412 1.485 . . . . 0.0 110.606 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 49.8 m -133.43 143.46 48.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.947 1.699 . . . . 0.0 111.084 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.8 p90 -150.46 155.2 39.08 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.2 109.24 44.72 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.017 1.727 . . . . 0.0 110.67 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.86 174.68 10.03 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.712 2.941 . . . . 0.0 110.178 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -152.22 -31.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.32 146.17 31.96 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 119.319 0.963 . . . . 0.0 110.48 167.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.89 155.76 53.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.772 2.315 . . . . 0.0 110.703 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.02 -152.71 21.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.49 1.043 . . . . 0.0 112.926 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -114.37 129.75 56.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.634 1.173 . . . . 0.0 111.614 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.26 130.53 56.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 110.28 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.651 1.18 . . . . 0.0 110.798 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.34 124.3 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.416 1.886 . . . . 0.0 108.62 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.03 132.2 51.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.653 1.581 . . . . 0.0 109.58 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.3 t -133.36 131.87 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.417 1.487 . . . . 0.0 108.316 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.6 144.81 18.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.763 1.225 . . . . 0.0 110.714 -166.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.72 121.24 15.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.531 1.132 . . . . 0.0 109.591 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.2 t-20 52.64 57.72 6.11 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.059 1.344 . . . . 0.0 112.334 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.296 7.9 pt-20 59.36 11.72 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.302 2.641 . . . . 0.0 116.35 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.2 124.6 48.31 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.541 1.137 . . . . 0.0 111.218 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -61.1 154.58 22.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.058 0.943 . . . . 0.0 112.663 170.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.51 153.86 71.11 Favored Pre-proline 0 N--CA 1.479 0.984 0 O-C-N 121.845 -0.534 . . . . 0.0 110.269 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -57.15 123.14 13.13 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 110.457 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 97.33 -16.19 61.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.178 1.371 . . . . 0.0 115.956 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 89.8 p -79.56 152.98 75.94 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 120.321 2.06 . . . . 0.0 112.942 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.22 156.28 99.77 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 119.31 0.789 . . . . 0.0 112.675 -4.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -111.13 140.82 45.36 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.573 1.549 . . . . 0.0 111.001 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 43.8 m -95.25 115.43 27.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.509 0.724 . . . . 0.0 110.997 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.08 127.99 42.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.994 1.318 . . . . 0.0 110.664 169.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -96.0 125.21 40.39 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.187 0.595 . . . . 0.0 110.634 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.4 t -110.7 129.77 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.33 1.452 . . . . 0.0 110.897 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.7 p -97.73 148.77 23.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.702 1.201 . . . . 0.0 112.778 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.75 59.62 2.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.35 1.928 . . . . 0.0 112.782 -175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.6 t70 -70.41 -26.64 63.78 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 124.768 1.227 . . . . 0.0 113.48 177.372 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.61 164.26 26.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.444 1.098 . . . . 0.0 112.844 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 77.5 mtm -68.96 139.6 55.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.13 0.972 . . . . 0.0 111.633 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -165.06 156.59 13.09 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.822 1.649 . . . . 0.0 111.661 -174.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.19 173.1 13.52 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.699 2.932 . . . . 0.0 111.521 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.39 149.11 48.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.804 1.241 . . . . 0.0 111.945 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -79.0 146.24 67.46 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.302 1.041 . . . . 0.0 112.118 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.19 167.89 25.88 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.667 2.911 . . . . 0.0 111.194 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.63 145.07 19.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.03 1.332 . . . . 0.0 111.842 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 10.7 p -175.81 144.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 127.299 2.24 . . . . 0.0 109.557 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 71.21 28.88 69.32 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 123.47 0.557 . . . . 0.0 113.945 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 35.1 m -62.24 152.57 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.241 1.416 . . . . 0.0 113.03 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 48.2 t30 -73.86 -11.39 60.35 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.674 1.19 . . . . 0.0 114.123 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -74.97 179.98 44.09 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.128 1.347 . . . . 0.0 114.075 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.86 164.97 25.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.934 1.294 . . . . 0.0 112.709 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 34.7 t70 -154.44 -51.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.614 1.565 . . . . 0.0 111.149 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 20.3 m -134.14 149.13 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.531 1.532 . . . . 0.0 109.963 163.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.7 t -173.15 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.559 1.944 . . . . 0.0 111.808 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 47.4 m -75.97 90.31 2.99 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.411 1.084 . . . . 0.0 112.169 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.67 140.18 55.45 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.815 0.846 . . . . 0.0 110.312 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -63.35 122.34 75.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.808 1.243 . . . . 0.0 110.357 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.27 140.2 52.53 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.932 2.421 . . . . 0.0 110.485 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.0 t80 -94.63 123.13 37.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.215 0.606 . . . . 0.0 110.255 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -147.42 136.12 21.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.191 1.396 . . . . 0.0 110.504 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.47 149.48 37.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.202 1.801 . . . . 0.0 109.533 -173.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.89 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.056 1.342 . . . . 0.0 110.164 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.83 136.12 27.17 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.774 1.629 . . . . 0.0 109.231 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.93 107.04 2.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.475 2.783 . . . . 0.0 109.693 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -172.95 152.3 2.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.758 2.423 . . . . 0.0 108.464 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.7 m -132.59 126.99 34.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.359 1.064 . . . . 0.0 109.783 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.85 117.63 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.229 1.011 . . . . 0.0 109.749 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 36.9 tptt -100.44 -146.06 0.34 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.214 1.406 . . . . 0.0 110.414 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.2 tttt -78.3 125.28 29.13 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.466 -1.396 . . . . 0.0 111.021 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 139.51 -150.4 21.34 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 125.462 1.506 . . . . 0.0 112.117 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -159.09 147.01 17.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.489 1.116 . . . . 0.0 111.412 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.33 136.78 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.876 1.67 . . . . 0.0 111.07 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.25 167.32 24.52 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.809 1.644 . . . . 0.0 111.004 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.74 -173.63 30.63 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.22 132.55 11.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.96 1.704 . . . . 0.0 109.648 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 86.2 t -103.33 134.43 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.708 1.603 . . . . 0.0 108.326 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.44 131.51 54.2 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.069 1.347 . . . . 0.0 110.972 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.8 mtt -106.23 149.24 37.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.634 1.574 . . . . 0.0 111.617 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -56.0 -28.18 67.79 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.073 3.182 . . . . 0.0 115.183 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 34.8 p -74.45 -6.15 46.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.542 1.537 . . . . 0.0 114.388 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.49 -5.5 82.52 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.535 1.54 . . . . 0.0 113.718 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -70.04 157.11 38.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.589 1.155 . . . . 0.0 112.128 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -142.06 155.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.275 1.43 . . . . 0.0 111.645 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.24 177.43 11.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.953 2.101 . . . . 0.0 110.149 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.43 143.17 33.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 120.974 -1.078 . . . . 0.0 112.254 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -83.97 169.18 11.81 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.417 3.411 . . . . 0.0 111.666 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.4 m -111.01 130.23 55.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.486 1.514 . . . . 0.0 109.03 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.35 137.32 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.945 1.298 . . . . 0.0 109.666 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -138.98 129.21 25.46 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.265 1.426 . . . . 0.0 110.002 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.11 129.04 34.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.949 0.899 . . . . 0.0 110.776 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -84.31 -9.14 58.72 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 66.3 mttm 65.71 10.24 6.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.469 2.308 . . . . 0.0 113.897 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.9 6.93 31.9 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.208 2.203 . . . . 0.0 112.632 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.95 11.82 58.45 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.314 1.435 . . . . 0.0 114.162 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.31 155.64 45.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.207 1.803 . . . . 0.0 111.044 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.5 m -111.14 142.12 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.986 0.914 . . . . 0.0 109.701 162.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 33.7 m -102.06 138.57 38.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.816 1.246 . . . . 0.0 108.465 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.8 t -123.6 134.41 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.196 1.398 . . . . 0.0 109.019 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.19 156.36 46.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.223 1.409 . . . . 0.0 112.715 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 32.6 t80 -155.35 135.41 12.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.718 1.607 . . . . 0.0 111.786 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.03 116.25 65.41 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.536 1.135 . . . . 0.0 110.59 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.46 148.01 29.31 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.47 2.78 . . . . 0.0 112.348 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 7.6 t -140.56 -2.59 1.37 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.166 0.987 . . . . 0.0 113.639 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -144.7 148.29 34.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.366 1.866 . . . . 0.0 109.501 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.15 168.31 12.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.02 0.928 . . . . 0.0 112.076 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.04 -172.48 18.96 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.686 1.136 . . . . 0.0 114.59 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.1 tp -79.86 110.74 15.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.564 1.546 . . . . 0.0 110.912 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 49.1 m80 -107.18 164.05 12.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.191 1.797 . . . . 0.0 112.214 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 142.46 42.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.217 1.407 . . . . 0.0 109.95 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.5 ttm -122.72 126.32 47.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.925 1.29 . . . . 0.0 111.196 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 t70 -87.77 133.86 33.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.801 1.641 . . . . 0.0 110.091 166.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 16.9 mm -134.15 139.63 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.309 1.443 . . . . 0.0 109.874 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.4 142.22 23.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.116 0.966 . . . . 0.0 113.585 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.0 t80 -98.52 118.79 36.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 109.505 172.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.46 34.36 12.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.999 1.32 . . . . 0.0 112.919 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 74.38 10.69 4.22 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.784 2.434 . . . . 0.0 115.073 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 6.0 tmm? -107.39 126.48 52.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.618 1.567 . . . . 0.0 110.197 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m170 -54.87 131.98 45.47 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.044 -1.035 . . . . 0.0 113.711 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.6 pt -71.43 154.41 93.48 Favored Pre-proline 0 N--CA 1.481 1.088 0 O-C-N 121.247 -0.908 . . . . 0.0 111.464 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.53 122.04 10.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.431 2.087 . . . . 0.0 109.627 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.39 43.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.692 1.139 . . . . 0.0 114.563 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.8 t -80.95 147.68 62.4 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.326 1.563 . . . . 0.0 112.173 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.64 164.02 82.65 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.286 1.138 . . . . 0.0 112.258 -7.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 50.8 mt -97.26 156.69 16.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.047 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -153.26 134.35 14.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.395 1.078 . . . . 0.0 110.012 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -167.02 160.59 14.23 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.164 0.986 . . . . 0.0 112.852 -170.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 58.4 t80 -96.44 134.42 39.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.945 0.898 . . . . 0.0 112.74 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.7 t -98.03 128.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.944 1.297 . . . . 0.0 109.966 173.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -132.61 173.51 11.25 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.373 2.269 . . . . 0.0 111.581 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -74.4 141.44 45.08 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.018 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 6.0 p -63.17 -27.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.343 1.057 . . . . 0.0 113.334 -170.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -132.45 134.95 45.71 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.292 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 26.5 p -169.71 164.05 10.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.011 1.724 . . . . 0.0 112.172 -174.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.31 -22.99 20.76 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.721 1.153 . . . . 0.0 114.38 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -73.16 158.54 35.08 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.378 1.089 . . . . 0.0 113.497 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.3 t -70.44 128.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.81 0.844 . . . . 0.0 108.956 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.9 t -147.01 158.15 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.983 1.313 . . . . 0.0 110.45 -175.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.13 142.57 36.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.055 1.342 . . . . 0.0 111.513 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.5 p90 -165.69 160.69 17.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.529 1.532 . . . . 0.0 112.532 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.38 174.24 13.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.113 1.339 . . . . 0.0 113.294 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.52 -33.12 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.943 2.429 . . . . 0.0 113.088 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.63 70.62 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.481 1.037 . . . . 0.0 114.501 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.99 -6.64 57.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.028 1.414 . . . . 0.0 113.191 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 49.6 m -102.41 -40.29 6.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.532 1.933 . . . . 0.0 111.794 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.581 1.952 . . . . 0.0 112.338 -167.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -158.59 -175.3 29.36 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.708 0.671 . . . . 0.0 113.822 168.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.5 p -152.46 137.2 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.24 1.416 . . . . 0.0 108.67 174.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 30.1 m -56.74 140.95 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.3 m-80 72.04 -3.03 2.34 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.518 2.327 . . . . 0.0 114.86 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 41.4 mttm -103.59 143.6 26.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.507 1.123 . . . . 0.0 111.133 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.7 123.2 8.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.61 147.25 26.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.384 1.473 . . . . 0.0 110.273 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 70.0 p -137.05 150.85 48.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -168.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -161.38 175.53 12.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.794 1.638 . . . . 0.0 111.592 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.6 m -126.97 142.31 51.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.959 1.304 . . . . 0.0 110.752 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.9 t -117.58 130.22 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.695 1.598 . . . . 0.0 108.27 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.3 m120 -93.75 129.28 40.15 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.231 1.012 . . . . 0.0 111.158 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 56.8 p -136.0 0.52 2.64 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.039 1.336 . . . . 0.0 113.997 -166.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.12 -38.2 67.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.402 1.481 . . . . 0.0 114.727 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.84 9.15 17.53 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.763 1.625 . . . . 0.0 112.935 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.79 -38.42 67.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.9 145.29 5.03 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.93 1.253 . . . . 0.0 112.34 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.1 140.73 49.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.962 0.905 . . . . 0.0 112.014 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 176.1 19.35 0.02 OUTLIER Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.959 1.144 . . . . 0.0 115.959 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 88.62 97.45 0.99 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.191 1.377 . . . . 0.0 112.58 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.51 129.23 34.97 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.328 1.451 . . . . 0.0 109.017 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -124.03 159.66 29.38 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.666 1.586 . . . . 0.0 112.286 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.7 tp -160.34 136.09 8.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.052 1.741 . . . . 0.0 109.09 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.48 157.46 35.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.866 . . . . 0.0 112.331 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.9 mt -137.01 140.74 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.015 1.326 . . . . 0.0 110.006 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.8 159.09 36.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.23 1.812 . . . . 0.0 109.745 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.28 -160.34 28.03 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.862 -0.966 . . . . 0.0 114.595 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.45 -24.61 63.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.123 3.215 . . . . 0.0 112.649 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.1 t -146.81 160.39 42.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.365 1.466 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.01 118.5 16.05 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.986 -1.071 . . . . 0.0 111.59 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.0 149.98 40.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.01 0.924 . . . . 0.0 111.953 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.72 141.01 29.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.799 0.84 . . . . 0.0 109.572 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.4 140.65 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.68 1.192 . . . . 0.0 110.585 -166.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 58.6 m -134.84 157.39 46.93 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.719 1.608 . . . . 0.0 111.124 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 42.3 t -154.14 143.42 21.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.358 1.063 . . . . 0.0 111.778 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.4 m -137.27 126.25 24.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.669 1.587 . . . . 0.0 110.514 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.02 135.89 36.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.176 1.39 . . . . 0.0 111.664 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -113.65 148.26 36.62 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.654 1.581 . . . . 0.0 111.642 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -64.72 -18.62 65.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.331 1.053 . . . . 0.0 112.479 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.73 -8.36 34.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.046 1.738 . . . . 0.0 114.271 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.05 30.01 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.54 1.067 . . . . 0.0 114.032 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 41.6 p -138.4 143.79 39.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.939 1.295 . . . . 0.0 111.399 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.4 m -92.51 123.86 36.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.38 1.072 . . . . 0.0 109.035 161.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.79 139.93 30.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 109.902 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.6 t -117.25 144.44 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.966 1.707 . . . . 0.0 109.933 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 62.8 p -136.79 145.31 44.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.407 1.083 . . . . 0.0 111.77 165.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.3 p90 -151.44 152.94 33.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 12.4 mt -116.57 105.82 49.48 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.042 1.737 . . . . 0.0 110.755 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.74 162.23 16.39 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.79 2.993 . . . . 0.0 110.447 167.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.0 m -134.99 -20.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.62 149.04 47.31 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 110.371 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.31 154.55 51.29 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 111.107 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 135.08 -164.01 24.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.842 1.21 . . . . 0.0 113.592 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -92.18 130.53 37.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 112.368 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -117.3 132.35 56.63 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.601 1.561 . . . . 0.0 110.513 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.3 m -90.71 125.88 35.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.545 1.138 . . . . 0.0 110.551 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.88 127.12 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.535 1.534 . . . . 0.0 108.583 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.88 132.56 54.05 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.496 1.519 . . . . 0.0 109.75 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 67.2 t -132.79 130.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.684 1.594 . . . . 0.0 108.203 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.98 142.63 19.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.616 1.166 . . . . 0.0 111.08 -168.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.01 121.56 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.786 1.234 . . . . 0.0 109.641 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 53.87 56.1 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.103 1.361 . . . . 0.0 112.468 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.2 pt-20 58.25 13.67 2.46 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 128.085 2.554 . . . . 0.0 116.159 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -119.73 127.71 53.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.555 1.142 . . . . 0.0 111.262 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -63.62 159.94 17.85 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 113.006 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -83.3 159.09 62.71 Favored Pre-proline 0 N--CA 1.48 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.065 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.41 -27.44 49.09 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 115.931 -171.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -104.69 -6.04 41.2 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.311 1.284 . . . . 0.0 116.311 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 81.0 p -84.24 153.61 62.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 119.953 1.876 . . . . 0.0 113.416 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.73 148.0 90.76 Favored 'Cis proline' 0 C--N 1.354 0.827 0 CA-C-N 118.829 0.618 . . . . 0.0 112.112 -5.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.67 169.99 9.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.82 1.648 . . . . 0.0 110.724 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 60.9 m -133.22 121.35 22.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.671 0.788 . . . . 0.0 110.877 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.56 139.6 34.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.538 1.535 . . . . 0.0 111.082 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.97 110.88 23.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.677 0.791 . . . . 0.0 109.811 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.9 t -95.7 145.42 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.307 1.443 . . . . 0.0 109.884 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.6 t -128.51 175.11 8.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.262 1.025 . . . . 0.0 113.038 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.68 139.9 18.34 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.624 1.583 . . . . 0.0 112.692 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.02 -29.45 35.11 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.693 1.197 . . . . 0.0 112.721 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 C--O 1.256 1.402 0 C-N-CA 125.736 1.614 . . . . 0.0 113.491 179.586 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.488 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.57 160.3 31.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.461 1.104 . . . . 0.0 112.937 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 15.4 tpt -158.36 139.03 12.81 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.812 1.645 . . . . 0.0 110.695 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -166.58 153.38 8.45 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 126.133 1.773 . . . . 0.0 111.514 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.6 159.62 45.64 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.666 2.91 . . . . 0.0 111.521 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -107.41 128.96 54.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.74 1.216 . . . . 0.0 110.933 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -74.66 130.67 81.09 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.33 1.052 . . . . 0.0 111.02 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.79 151.84 36.51 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.273 2.649 . . . . 0.0 111.236 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.18 10.62 23.84 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.423 1.089 . . . . 0.0 113.527 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.3 p -160.23 148.01 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.467 1.907 . . . . 0.0 110.65 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -87.38 -156.87 30.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.998 1.285 . . . . 0.0 113.329 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 27.0 m -68.57 149.61 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.309 1.043 . . . . 0.0 112.017 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 64.0 t30 -161.48 148.42 14.56 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.199 1.4 . . . . 0.0 111.813 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -86.78 175.56 47.1 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.207 1.384 . . . . 0.0 113.807 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 86.4 mt -101.68 153.14 20.04 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.39 1.476 . . . . 0.0 111.38 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.71 -30.02 51.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.935 0.894 . . . . 0.0 113.369 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 31.1 m -68.59 -15.13 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 1.8 t -75.03 -16.51 60.59 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.716 1.206 . . . . 0.0 113.11 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 50.4 m -75.73 1.65 14.16 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.38 156.38 22.66 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.484 1.114 . . . . 0.0 112.218 169.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.23 117.87 25.49 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 110.634 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.35 157.01 50.23 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.321 2.68 . . . . 0.0 111.532 -173.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 19.6 t80 -110.47 125.12 52.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.701 0.801 . . . . 0.0 110.958 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -154.07 133.54 12.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.238 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.83 146.02 33.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.842 1.657 . . . . 0.0 109.794 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.3 p -111.52 139.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.063 1.345 . . . . 0.0 110.204 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.3 mt -131.06 134.84 26.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.953 1.701 . . . . 0.0 108.843 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.05 92.81 1.03 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.715 2.944 . . . . 0.0 109.759 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 68.8 t80 -151.89 154.28 35.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.16 1.784 . . . . 0.0 109.801 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 68.0 m -126.51 123.82 38.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.705 1.202 . . . . 0.0 109.65 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 91.6 mt -87.68 118.88 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.337 1.055 . . . . 0.0 109.147 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 99.6 mttt -98.08 -77.01 0.51 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.502 1.121 . . . . 0.0 113.232 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.35 -4.61 0.16 Allowed 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.23 -129.1 2.73 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.294 1.902 . . . . 0.0 111.938 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.39 148.61 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.829 1.252 . . . . 0.0 110.824 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -141.09 129.87 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.344 1.458 . . . . 0.0 111.722 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.46 168.4 22.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.007 1.723 . . . . 0.0 110.701 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -153.84 -171.45 20.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.18 138.18 18.16 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.74 1.616 . . . . 0.0 109.63 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.6 t -108.36 136.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.134 1.774 . . . . 0.0 107.892 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.23 121.27 35.47 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.111 1.364 . . . . 0.0 110.541 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 12.7 mtm -87.75 151.55 50.21 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.863 1.665 . . . . 0.0 111.028 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.46 -18.26 38.51 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.442 2.761 . . . . 0.0 113.207 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 36.0 p -73.06 -6.72 47.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.011 1.724 . . . . 0.0 114.22 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.76 -4.85 79.35 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.83 1.681 . . . . 0.0 113.898 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -69.93 158.55 35.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.596 1.159 . . . . 0.0 112.234 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.4 m -137.61 156.79 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 0.0 112.23 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.9 171.94 18.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.665 1.986 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.78 137.5 19.35 Favored Pre-proline 0 CA--C 1.546 0.813 0 O-C-N 121.288 -0.882 . . . . 0.0 111.051 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.52 163.31 19.18 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.837 3.025 . . . . 0.0 110.938 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 67.9 m -101.99 120.31 40.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.9 1.28 . . . . 0.0 108.578 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.04 131.41 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.351 1.06 . . . . 0.0 108.631 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -127.76 124.96 38.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 109.652 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.85 122.72 24.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.235 1.014 . . . . 0.0 110.83 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.7 -15.36 45.5 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 58.0 tttt 71.67 4.01 4.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.308 2.243 . . . . 0.0 114.241 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -113.83 15.29 18.66 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.88 2.072 . . . . 0.0 112.805 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.16 12.15 52.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.105 1.336 . . . . 0.0 114.636 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -131.39 160.57 34.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.018 1.727 . . . . 0.0 110.705 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.9 m -123.93 147.44 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.594 1.158 . . . . 0.0 109.566 164.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.2 m -107.38 136.48 47.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.144 0.978 . . . . 0.0 108.643 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 35.8 t -120.42 131.9 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.126 1.37 . . . . 0.0 109.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -133.1 155.63 48.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.435 1.494 . . . . 0.0 112.662 -169.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -158.29 136.86 11.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.338 1.455 . . . . 0.0 112.338 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.27 120.09 69.74 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.776 1.23 . . . . 0.0 110.996 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.72 159.77 28.08 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.713 2.942 . . . . 0.0 112.233 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 5.5 t -147.59 -11.77 0.4 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.37 149.02 20.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.819 1.648 . . . . 0.0 110.98 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.04 171.0 15.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.656 1.182 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.31 -175.14 15.56 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.535 1.541 . . . . 0.0 114.409 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.93 124.67 31.92 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 110.097 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 46.7 m80 -118.93 152.88 35.53 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.547 1.539 . . . . 0.0 112.193 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -117.3 148.14 41.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.091 1.756 . . . . 0.0 108.899 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.1 tmm? -143.89 130.19 19.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 111.407 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -118.13 139.7 50.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.45 1.9 . . . . 0.0 110.924 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -137.27 133.19 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.185 1.394 . . . . 0.0 110.57 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 140.69 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -103.05 119.85 39.59 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.589 1.956 . . . . 0.0 109.489 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.79 34.61 13.51 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.762 1.225 . . . . 0.0 112.835 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.7 m-80 72.76 9.16 5.57 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.698 2.399 . . . . 0.0 115.147 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.1 mtm -103.35 128.48 50.42 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.352 1.461 . . . . 0.0 110.158 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -57.37 136.61 56.6 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.247 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.9 pt -75.56 154.26 85.6 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.218 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -59.56 128.45 27.19 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.216 1.944 . . . . 0.0 109.791 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.09 -15.9 59.96 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.838 1.209 . . . . 0.0 114.014 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.2 t -84.89 143.48 40.34 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.687 1.744 . . . . 0.0 111.105 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.1 159.2 83.47 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.025 1.044 . . . . 0.0 112.664 -4.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 87.6 mt -107.21 161.51 14.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.427 1.891 . . . . 0.0 111.183 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.17 139.91 18.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.821 1.249 . . . . 0.0 110.03 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -166.31 174.78 8.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.58 1.152 . . . . 0.0 112.413 -170.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -122.79 131.73 53.9 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.223 1.009 . . . . 0.0 112.718 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 99.3 t -96.92 135.12 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.589 1.556 . . . . 0.0 109.059 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 19.8 t0 -154.98 166.76 32.58 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.943 1.297 . . . . 0.0 111.111 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -82.81 137.45 34.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.81 1.244 . . . . 0.0 112.064 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 7.7 p -67.61 -24.84 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.473 0.709 . . . . 0.0 112.331 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -88.9 25.54 1.77 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.01 1.724 . . . . 0.0 112.773 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.2 p -56.68 151.02 14.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.422 1.489 . . . . 0.0 114.212 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.94 28.52 11.97 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.14 1.829 . . . . 0.0 112.324 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -162.38 163.17 27.94 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.866 1.666 . . . . 0.0 112.556 -163.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 18.3 t -70.18 137.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.29 1.036 . . . . 0.0 109.82 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -147.26 158.7 44.05 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.756 1.222 . . . . 0.0 110.622 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.73 144.08 37.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.101 1.36 . . . . 0.0 111.52 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.3 p90 -168.34 164.83 12.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.403 1.481 . . . . 0.0 113.214 -173.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 126.16 170.75 13.03 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.614 1.578 . . . . 0.0 112.29 -175.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -34.89 9.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.778 2.319 . . . . 0.0 113.222 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.08 76.41 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 119.348 0.976 . . . . 0.0 114.968 -169.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.01 -1.62 40.53 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.906 1.353 . . . . 0.0 113.813 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 51.6 m -118.05 -46.51 2.62 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.669 1.988 . . . . 0.0 111.726 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -138.01 148.2 44.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.503 1.521 . . . . 0.0 112.437 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -147.46 178.73 24.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.24 0.924 . . . . 0.0 113.52 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 19.1 t -139.53 136.97 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.914 1.286 . . . . 0.0 108.314 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -55.46 138.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 70.88 -3.29 2.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.547 2.339 . . . . 0.0 114.656 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.5 mttm -98.52 140.54 21.89 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.581 1.153 . . . . 0.0 111.144 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.89 109.77 2.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.647 2.232 . . . . 0.0 109.677 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -89.07 139.14 30.76 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.926 1.29 . . . . 0.0 110.168 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.0 p -130.83 151.25 51.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -166.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.28 175.95 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.276 1.83 . . . . 0.0 111.357 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.5 m -130.69 144.61 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.501 1.52 . . . . 0.0 110.898 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 31.1 t -117.59 135.77 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.584 1.554 . . . . 0.0 108.555 168.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.42 117.64 35.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.575 1.15 . . . . 0.0 110.632 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.8 p -117.05 14.4 14.97 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.289 1.836 . . . . 0.0 112.236 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 60.2 tttp -60.27 -28.39 68.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.421 1.488 . . . . 0.0 114.264 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -118.08 16.59 14.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.996 1.718 . . . . 0.0 112.754 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.71 -12.61 61.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.13 -103.34 2.48 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.718 1.151 . . . . 0.0 110.828 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.02 147.8 24.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.322 1.449 . . . . 0.0 110.432 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 164.36 -105.87 0.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.044 1.307 . . . . 0.0 111.061 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 167.27 144.36 4.1 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 124.773 1.177 . . . . 0.0 112.701 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 25.5 tp -92.39 137.97 31.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.666 1.186 . . . . 0.0 111.277 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.3 m -120.56 157.44 29.46 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.408 1.883 . . . . 0.0 110.74 169.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 53.4 tp -157.07 134.9 10.89 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.202 1.401 . . . . 0.0 109.721 -168.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.17 158.4 36.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.106 0.962 . . . . 0.0 112.324 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.1 mt -137.32 139.17 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.736 1.214 . . . . 0.0 109.986 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.17 131.34 47.13 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.439 1.496 . . . . 0.0 109.872 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -157.7 -162.7 11.89 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.891 -0.95 . . . . 0.0 114.625 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.79 -23.65 68.92 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.253 3.302 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.1 t -144.84 159.6 42.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.24 1.416 . . . . 0.0 109.433 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.11 111.54 5.84 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.095 -1.003 . . . . 0.0 111.019 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.65 148.31 50.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.863 0.865 . . . . 0.0 111.617 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.97 138.43 31.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.194 0.597 . . . . 0.0 109.416 166.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.2 mt -129.53 143.88 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.084 1.353 . . . . 0.0 109.906 -168.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.03 162.8 34.52 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 111.137 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.89 154.83 30.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.697 1.199 . . . . 0.0 112.485 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.3 m -136.94 123.36 20.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.61 1.564 . . . . 0.0 110.09 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.68 130.84 36.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.984 1.314 . . . . 0.0 111.239 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.91 149.14 27.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.463 1.505 . . . . 0.0 111.603 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -65.11 -20.0 66.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.539 1.136 . . . . 0.0 112.882 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.93 -7.87 53.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.203 1.401 . . . . 0.0 113.923 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.67 12.37 47.6 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.925 1.25 . . . . 0.0 114.869 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.0 p -108.61 154.88 21.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.099 1.359 . . . . 0.0 111.289 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 90.0 m -110.63 123.23 49.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 108.822 163.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -86.5 147.45 25.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.46 0.704 . . . . 0.0 110.161 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 90.3 t -128.36 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.977 1.711 . . . . 0.0 109.9 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.72 147.27 44.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 111.81 168.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -151.02 151.18 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -112.41 101.79 53.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.778 1.631 . . . . 0.0 110.575 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.27 161.13 29.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.303 2.669 . . . . 0.0 109.946 166.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.9 m -135.96 -21.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 89.9 mt -118.4 147.52 42.0 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.953 1.301 . . . . 0.0 110.21 170.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.08 154.12 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.734 2.29 . . . . 0.0 110.648 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 137.97 -158.54 24.75 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.706 1.146 . . . . 0.0 112.881 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -106.03 133.78 50.2 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.358 1.063 . . . . 0.0 111.727 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -121.0 125.27 46.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.98 1.712 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -87.6 127.17 35.27 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.965 -1.084 . . . . 0.0 110.848 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.43 120.74 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.545 1.538 . . . . 0.0 108.528 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -103.71 127.53 51.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -130.14 129.17 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.159 1.384 . . . . 0.0 109.036 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.37 136.56 22.43 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.353 -170.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 39.6 t80 -132.22 133.58 44.32 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.991 1.316 . . . . 0.0 110.933 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 48.99 53.73 12.08 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 112.547 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 8.4 pt-20 58.55 16.01 3.98 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 128.037 2.535 . . . . 0.0 116.413 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -125.15 130.33 51.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 111.292 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.3 m170 -62.15 141.35 58.21 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.481 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 8.3 m -71.25 150.86 94.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.35 -0.834 . . . . 0.0 109.872 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.83 130.37 39.5 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.38 2.72 . . . . 0.0 111.742 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.84 -15.14 58.4 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.279 1.419 . . . . 0.0 115.034 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 3.5 t -83.17 143.21 45.01 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 118.935 1.367 . . . . 0.0 111.488 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.9 138.11 51.94 Favored 'Cis proline' 0 C--N 1.357 0.996 0 CA-C-N 119.832 0.976 . . . . 0.0 112.72 0.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.0 173.8 8.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.809 1.643 . . . . 0.0 110.232 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.4 m -135.3 119.74 18.0 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.575 -0.703 . . . . 0.0 110.887 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.93 148.76 21.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 110.973 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -113.46 125.16 53.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.065 0.946 . . . . 0.0 110.21 172.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 83.9 t -111.5 132.46 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.297 1.439 . . . . 0.0 110.593 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 43.9 p -107.39 168.29 9.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.276 1.431 . . . . 0.0 112.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.64 149.57 33.52 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.049 1.309 . . . . 0.0 112.521 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.1 t70 -75.8 -18.99 59.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.629 1.172 . . . . 0.0 113.147 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 126.639 1.976 . . . . 0.0 112.673 -178.251 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.371 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.84 -36.17 67.4 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -77.69 -32.4 53.01 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.564 1.145 . . . . 0.0 112.915 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -166.88 152.55 7.53 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.563 1.945 . . . . 0.0 111.182 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -75.71 160.96 37.31 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.455 2.77 . . . . 0.0 111.708 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -67.52 -16.65 64.31 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.726 1.21 . . . . 0.0 112.837 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -59.94 122.27 64.6 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.372 1.469 . . . . 0.0 110.275 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.49 157.38 36.54 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.714 2.943 . . . . 0.0 113.088 -169.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 30.2 tp -80.87 67.42 6.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.95 1.3 . . . . 0.0 111.119 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.6 p -160.17 150.1 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.391 1.876 . . . . 0.0 110.406 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 92.27 -147.25 18.6 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.855 1.217 . . . . 0.0 112.337 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 27.8 m -135.78 150.6 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.521 1.528 . . . . 0.0 111.199 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 11.5 p30 -93.5 162.42 13.97 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.861 1.264 . . . . 0.0 113.233 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 90.62 131.24 4.76 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.59 1.567 . . . . 0.0 113.303 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 94.8 mt -144.37 161.25 39.45 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.375 2.27 . . . . 0.0 109.764 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 33.5 t0 -158.16 165.54 34.68 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.493 1.117 . . . . 0.0 112.28 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 22.7 m -73.52 6.04 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.826 1.65 . . . . 0.0 114.255 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.3 t -67.89 -11.93 59.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.838 1.655 . . . . 0.0 112.853 168.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 7.9 t -61.77 153.82 27.44 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.8 mt -112.49 151.92 29.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.595 1.958 . . . . 0.0 111.456 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -56.81 116.02 11.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.06 1.744 . . . . 0.0 111.107 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.95 155.4 48.1 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.113 2.542 . . . . 0.0 110.947 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -105.28 124.38 49.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.345 0.658 . . . . 0.0 110.232 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -153.88 130.83 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 110.692 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.92 150.49 43.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.538 1.935 . . . . 0.0 109.565 -175.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -124.93 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.034 1.334 . . . . 0.0 110.31 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.49 138.57 27.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.117 1.767 . . . . 0.0 108.926 -172.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 47.41 2.37 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.655 3.57 . . . . 0.0 113.156 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 61.3 t80 -93.8 159.17 15.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.333 1.453 . . . . 0.0 110.559 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 49.2 m -135.16 127.29 29.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.919 1.288 . . . . 0.0 109.796 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 49.3 mt -75.56 131.46 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.244 1.018 . . . . 0.0 110.419 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1800 ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' 1801 ' ' LYS . 9.3 tppt? -120.62 -145.48 0.36 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.426 1.49 . . . . 0.0 110.683 174.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1801 ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' 1800 ' ' LYS . 1.5 tmtp? -77.17 122.49 25.09 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.548 -1.345 . . . . 0.0 110.749 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.41 -146.01 16.89 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.455 1.503 . . . . 0.0 112.07 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -158.87 145.35 17.0 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.758 1.223 . . . . 0.0 111.084 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.6 137.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.645 1.578 . . . . 0.0 111.122 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.5 p -148.4 168.56 22.3 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.937 1.695 . . . . 0.0 110.654 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.69 -176.47 26.98 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.73 134.71 13.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.293 1.437 . . . . 0.0 110.183 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 5.8 t -99.9 136.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.662 1.985 . . . . 0.0 108.024 171.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -121.53 126.3 48.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.828 1.251 . . . . 0.0 110.755 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -105.73 142.15 24.17 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.325 1.45 . . . . 0.0 112.09 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.61 -26.66 73.48 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.118 3.212 . . . . 0.0 115.022 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 23.3 p -73.84 1.19 11.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.257 1.423 . . . . 0.0 114.506 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.73 37.41 7.4 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.593 1.092 . . . . 0.0 113.46 173.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.21 169.32 17.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.408 1.483 . . . . 0.0 112.543 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.7 m -140.39 160.6 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.106 1.362 . . . . 0.0 112.43 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.32 169.19 24.78 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.494 1.918 . . . . 0.0 110.794 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -108.13 136.89 19.75 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.33 167.25 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.063 3.176 . . . . 0.0 111.406 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.9 m -105.13 130.85 53.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.566 1.546 . . . . 0.0 109.069 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 131.27 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.767 1.227 . . . . 0.0 108.976 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.9 m -133.22 122.21 23.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.251 1.42 . . . . 0.0 109.732 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.06 127.73 32.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.363 0.665 . . . . 0.0 110.407 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -82.31 -11.46 58.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 71.68 2.01 4.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 128.276 2.63 . . . . 0.0 114.055 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -94.38 3.57 55.01 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.564 1.946 . . . . 0.0 113.047 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.21 17.99 41.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.87 1.224 . . . . 0.0 113.93 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -131.06 155.63 46.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.47 1.908 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -112.51 143.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 109.532 163.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.8 m -104.23 135.17 46.2 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.624 1.17 . . . . 0.0 107.908 165.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.7 t -122.37 132.64 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.325 . . . . 0.0 108.838 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -135.02 160.54 38.0 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.086 1.354 . . . . 0.0 112.842 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.2 t80 -159.01 137.71 10.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.519 1.528 . . . . 0.0 111.936 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.41 119.08 71.26 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.665 1.186 . . . . 0.0 110.904 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.97 158.16 46.33 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.06 3.173 . . . . 0.0 112.432 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 8.4 t -135.86 -22.79 1.4 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -161.12 155.8 23.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.769 1.628 . . . . 0.0 109.952 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -72.05 166.43 22.26 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 126.1 178.38 15.28 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 125.906 1.717 . . . . 0.0 113.952 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -80.77 119.01 22.8 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.749 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 23.4 m80 -113.87 159.86 19.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.462 1.505 . . . . 0.0 110.892 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.46 155.72 40.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 111.517 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 3.2 tmm? -148.16 134.81 19.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.77 1.228 . . . . 0.0 111.303 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -103.04 138.45 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.85 1.66 . . . . 0.0 110.426 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.2 mm -127.63 136.56 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.339 1.456 . . . . 0.0 109.796 171.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.94 137.95 23.94 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -102.92 124.93 49.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 0.0 109.902 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.22 32.08 10.18 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.734 1.213 . . . . 0.0 112.462 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.1 t30 75.82 6.52 3.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 128.2 2.6 . . . . 0.0 115.17 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.17 131.13 53.04 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.769 1.628 . . . . 0.0 110.903 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.59 134.03 56.38 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.244 -0.91 . . . . 0.0 113.077 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.17 156.89 85.61 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 123.127 0.571 . . . . 0.0 112.046 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.25 126.37 21.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.274 1.983 . . . . 0.0 109.626 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.74 -16.57 57.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.666 1.127 . . . . 0.0 114.463 -172.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 21.2 t -86.03 148.37 47.74 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.37 1.585 . . . . 0.0 111.961 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -83.19 171.61 50.76 Favored 'Cis proline' 0 CA--C 1.54 0.783 0 CA-C-N 120.246 1.124 . . . . 0.0 112.485 -6.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.28 154.92 22.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.976 1.71 . . . . 0.0 111.662 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -145.36 140.92 28.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.441 1.497 . . . . 0.0 110.041 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -163.42 160.01 22.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.98 1.312 . . . . 0.0 112.04 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.8 t80 -100.15 135.21 41.93 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.058 -1.026 . . . . 0.0 112.396 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.1 t -103.99 141.05 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.961 1.704 . . . . 0.0 109.28 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 12.8 t0 -154.71 162.9 40.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.611 1.164 . . . . 0.0 111.683 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -81.77 148.06 29.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.57 1.148 . . . . 0.0 112.707 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 30.4 m -69.93 -17.65 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.9 p30 -80.51 -10.54 59.74 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.4 m -70.32 133.02 46.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.147 0.979 . . . . 0.0 112.584 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -101.75 -13.43 32.17 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 125.141 1.353 . . . . 0.0 114.773 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -68.59 164.45 21.38 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -63.46 138.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.355 1.062 . . . . 0.0 109.705 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.9 t -165.2 153.41 11.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.273 1.429 . . . . 0.0 110.022 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -129.8 145.16 51.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.34 . . . . 0.0 111.844 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -168.15 167.86 12.1 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.964 1.706 . . . . 0.0 112.864 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.07 169.37 13.28 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.508 1.528 . . . . 0.0 112.08 -172.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.04 -30.79 20.41 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.63 -33.98 77.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 119.255 0.934 . . . . 0.0 114.605 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.74 -4.33 45.72 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.169 1.485 . . . . 0.0 113.484 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.0 m -108.97 -41.25 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 111.973 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -149.48 152.37 35.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.131 1.772 . . . . 0.0 112.314 -172.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -152.01 177.14 30.02 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.847 0.737 . . . . 0.0 113.665 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 58.5 t -137.9 134.78 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.972 1.309 . . . . 0.0 108.192 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.6 m -55.58 137.51 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 55.5 m-80 68.92 2.21 3.46 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.011 2.124 . . . . 0.0 114.415 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.0 mttt -108.06 140.91 22.13 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.149 1.38 . . . . 0.0 111.087 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.04 124.22 9.9 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.462 2.108 . . . . 0.0 110.205 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.5 144.24 31.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.33 1.452 . . . . 0.0 110.291 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.6 p -133.87 149.59 51.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -166.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -160.18 178.28 9.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.812 1.645 . . . . 0.0 111.496 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 27.5 m -134.14 143.06 47.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.145 1.378 . . . . 0.0 110.565 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 22.7 t -115.14 130.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 108.137 168.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.83 129.83 36.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 111.08 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 69.6 p -137.1 1.01 2.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.103 1.361 . . . . 0.0 113.841 -166.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 82.4 tttt -55.89 -38.95 70.87 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.466 1.506 . . . . 0.0 114.992 -166.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -115.73 10.23 15.38 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.671 1.589 . . . . 0.0 112.667 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.4 67.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.15 151.37 8.07 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.672 1.13 . . . . 0.0 112.281 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.74 166.12 22.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 0.0 113.298 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 145.23 9.61 0.31 Allowed Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 102.0 96.95 2.32 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.484 1.516 . . . . 0.0 113.157 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.98 132.83 36.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.347 1.459 . . . . 0.0 109.251 169.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.5 t -134.98 165.78 24.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.366 1.467 . . . . 0.0 112.45 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 36.1 tp -166.86 137.36 3.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.738 2.015 . . . . 0.0 109.272 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.45 34.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.162 0.985 . . . . 0.0 112.16 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.6 mt -136.42 139.93 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.792 1.237 . . . . 0.0 110.264 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.58 145.74 51.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.717 1.607 . . . . 0.0 109.652 170.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.28 -165.48 25.74 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 119.091 -0.838 . . . . 0.0 114.841 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.47 -26.01 70.35 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.316 3.344 . . . . 0.0 112.657 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.3 t -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.962 1.305 . . . . 0.0 109.144 159.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.72 116.49 12.15 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.978 -1.076 . . . . 0.0 111.4 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -72.81 147.55 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.795 0.838 . . . . 0.0 111.903 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.17 143.66 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.677 0.791 . . . . 0.0 109.76 167.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.76 145.88 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.164 1.385 . . . . 0.0 110.826 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -142.74 164.72 29.34 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.045 162.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.5 p -161.78 155.72 21.82 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.939 1.296 . . . . 0.0 112.616 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 79.3 m -143.85 124.89 14.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.544 1.537 . . . . 0.0 110.437 -171.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.53 130.96 36.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.54 1.136 . . . . 0.0 111.216 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.43 147.87 32.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.471 1.508 . . . . 0.0 112.017 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.3 -15.47 63.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.0 0.92 . . . . 0.0 113.437 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -74.92 -6.58 49.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.103 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.62 33.08 7.68 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.476 1.036 . . . . 0.0 113.951 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.0 p -138.43 157.26 46.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.961 1.304 . . . . 0.0 111.268 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 39.2 t -105.24 124.13 49.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.572 1.149 . . . . 0.0 108.734 158.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -90.34 146.61 24.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.922 0.889 . . . . 0.0 110.282 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -129.38 143.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 95.3 p -136.31 149.68 48.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.811 1.244 . . . . 0.0 112.155 168.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.4 p90 -151.52 152.79 33.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.47 104.97 52.82 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.864 1.666 . . . . 0.0 110.649 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.25 164.98 14.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.839 3.026 . . . . 0.0 110.374 167.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -137.15 -20.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.7 mt -118.38 149.31 45.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.013 1.325 . . . . 0.0 110.327 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.57 155.67 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.966 2.444 . . . . 0.0 110.883 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.83 -162.38 23.82 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.738 1.161 . . . . 0.0 113.691 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -92.11 129.02 38.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.487 1.515 . . . . 0.0 112.671 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 130.05 55.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.485 1.514 . . . . 0.0 110.207 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -90.91 119.03 30.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.616 1.167 . . . . 0.0 110.52 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.42 123.22 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.304 1.842 . . . . 0.0 108.501 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -104.45 134.3 47.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.516 1.526 . . . . 0.0 109.391 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 83.8 t -133.95 133.47 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.312 1.445 . . . . 0.0 108.454 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.74 141.73 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.906 1.283 . . . . 0.0 111.071 -169.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.31 120.25 14.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.695 1.198 . . . . 0.0 109.974 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 52.48 58.42 5.41 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.445 1.498 . . . . 0.0 112.067 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 60.64 2.8 0.53 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.911 2.885 . . . . 0.0 116.684 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -107.27 127.1 53.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.473 1.109 . . . . 0.0 111.177 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -62.93 157.67 21.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.816 0.846 . . . . 0.0 112.392 167.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 32.6 m -87.73 155.75 53.16 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 0.0 110.498 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.53 121.59 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.834 2.356 . . . . 0.0 110.353 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.53 -13.73 66.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.373 1.464 . . . . 0.0 116.037 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.3 p -79.79 151.53 73.92 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 120.434 2.117 . . . . 0.0 113.028 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.35 149.75 94.62 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 119.107 0.717 . . . . 0.0 112.295 -4.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -102.44 156.1 17.82 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.84 1.656 . . . . 0.0 110.888 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 63.4 m -111.29 118.45 35.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.692 0.797 . . . . 0.0 111.047 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.18 133.17 37.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.036 1.334 . . . . 0.0 110.921 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.66 106.36 18.45 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.964 0.905 . . . . 0.0 109.738 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 90.4 t -90.98 145.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 0.0 109.875 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.7 t -137.25 174.26 10.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.049 0.939 . . . . 0.0 113.031 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.72 140.5 18.04 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.741 1.639 . . . . 0.0 112.914 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.64 -33.81 31.17 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.048 0.939 . . . . 0.0 112.813 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.831 1.652 . . . . 0.0 113.458 -177.735 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.33 162.91 28.8 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.43 1.092 . . . . 0.0 112.913 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -68.15 -19.72 64.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -160.0 153.92 19.55 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 126.716 2.007 . . . . 0.0 110.833 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.62 164.77 34.05 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.452 2.768 . . . . 0.0 111.297 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.71 -20.74 66.5 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.557 1.143 . . . . 0.0 113.553 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -126.51 76.68 73.7 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.077 1.751 . . . . 0.0 109.971 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -82.51 168.52 14.48 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.829 3.02 . . . . 0.0 111.832 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 78.2 mt -83.11 19.98 1.33 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.109 1.364 . . . . 0.0 113.626 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 84.3 t -60.92 136.42 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.77 1.628 . . . . 0.0 110.492 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 115.26 -146.0 18.77 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.389 1.471 . . . . 0.0 111.784 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 9.4 p -65.47 -25.42 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.27 1.028 . . . . 0.0 113.754 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.66 -54.73 7.46 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.357 0.663 . . . . 0.0 112.314 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 76.25 168.3 26.5 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.964 1.268 . . . . 0.0 113.19 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.2 mt -80.23 137.91 36.73 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.177 0.991 . . . . 0.0 110.694 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -164.22 161.23 21.95 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.902 1.681 . . . . 0.0 111.286 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 75.3 t -96.68 127.59 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.598 1.559 . . . . 0.0 109.767 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.8 t -154.63 13.73 0.42 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.122 1.369 . . . . 0.0 113.099 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 61.1 m -81.2 114.76 20.23 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.56 -1.337 . . . . 0.0 111.997 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1788 ' ' LEU . . . . . 0.494 HD11 HG12 ' A' 1860 ' ' VAL . 47.8 tp -148.78 139.07 22.41 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.493 1.517 . . . . 0.0 110.193 -159.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -47.62 111.06 1.53 Allowed Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.925 1.69 . . . . 0.0 112.326 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.44 155.28 45.72 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.021 2.48 . . . . 0.0 110.655 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.77 125.45 51.43 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.611 0.764 . . . . 0.0 110.514 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -151.46 128.33 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.782 1.633 . . . . 0.0 109.53 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.75 125.95 13.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 109.973 -167.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 96.7 t -93.23 137.92 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.911 1.284 . . . . 0.0 109.863 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.9 mt -131.25 136.2 28.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.651 1.58 . . . . 0.0 108.752 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.28 58.17 6.87 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.273 3.315 . . . . 0.0 111.896 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -107.45 158.56 17.09 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.878 1.671 . . . . 0.0 111.197 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.6 m -125.45 123.08 38.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.819 1.248 . . . . 0.0 109.576 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.45 128.37 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.758 1.223 . . . . 0.0 109.73 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.38 -143.12 0.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.065 1.346 . . . . 0.0 110.718 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -75.53 -10.63 59.62 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.43 168.99 50.68 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.354 1.454 . . . . 0.0 113.704 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 147.6 23.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.329 1.451 . . . . 0.0 111.699 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.49 131.52 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.292 1.437 . . . . 0.0 111.056 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 57.5 p -147.44 -168.82 3.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.546 1.938 . . . . 0.0 109.807 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.49 -155.76 9.12 Favored Glycine 0 N--CA 1.467 0.765 0 O-C-N 121.357 -0.839 . . . . 0.0 114.957 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.91 137.0 9.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.45 1.9 . . . . 0.0 108.964 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 6.7 t -108.5 135.22 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.949 1.699 . . . . 0.0 108.629 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -117.37 123.42 46.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.121 1.368 . . . . 0.0 110.554 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.0 mtm -96.85 147.56 33.1 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.827 1.651 . . . . 0.0 111.349 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.49 -18.79 25.62 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.643 2.895 . . . . 0.0 113.576 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -77.28 2.27 16.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.071 1.348 . . . . 0.0 114.338 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.17 48.29 3.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.678 1.133 . . . . 0.0 113.218 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -156.12 166.39 33.59 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.793 1.637 . . . . 0.0 111.872 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.38 161.48 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.446 1.098 . . . . 0.0 113.194 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.1 178.24 10.51 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.733 2.013 . . . . 0.0 111.006 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.91 140.72 25.14 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.385 1.074 . . . . 0.0 110.872 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.63 160.34 22.0 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.605 2.87 . . . . 0.0 111.003 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.8 m -104.39 120.73 41.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 108.692 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.62 131.35 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.194 0.998 . . . . 0.0 108.706 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.7 m -132.14 128.14 37.45 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.303 1.441 . . . . 0.0 109.221 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.43 134.37 42.37 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.275 0.63 . . . . 0.0 111.564 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -82.69 -13.52 56.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.0 ttpt 67.25 18.86 10.33 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.954 2.102 . . . . 0.0 113.356 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.43 17.38 8.95 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.824 2.049 . . . . 0.0 112.499 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.6 13.12 68.14 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.824 1.202 . . . . 0.0 114.014 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 62.7 p -136.9 164.65 27.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.911 2.085 . . . . 0.0 110.027 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.5 m -127.74 163.38 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.861 1.264 . . . . 0.0 110.115 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.1 t -120.69 147.19 45.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 110.098 164.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 39.0 t -120.01 128.09 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.523 1.529 . . . . 0.0 108.424 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.94 156.55 43.56 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.667 1.587 . . . . 0.0 111.829 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -163.93 133.4 3.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.069 1.348 . . . . 0.0 111.97 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -83.62 123.17 76.7 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.539 1.136 . . . . 0.0 110.483 175.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.24 174.49 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.632 2.888 . . . . 0.0 111.823 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -149.66 -40.24 0.14 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -137.55 154.89 49.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.315 1.446 . . . . 0.0 110.509 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.18 171.0 14.93 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.329 1.052 . . . . 0.0 113.624 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 118.08 -173.03 14.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.048 1.785 . . . . 0.0 113.943 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -85.19 131.78 34.38 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.977 1.311 . . . . 0.0 110.57 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 53.0 m80 -125.69 156.41 39.37 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.743 1.617 . . . . 0.0 111.47 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -134.31 146.49 50.03 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.352 1.461 . . . . 0.0 109.486 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 17.3 tmm? -151.1 132.41 14.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.627 0.771 . . . . 0.0 112.252 -168.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -106.03 148.52 27.65 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.873 1.669 . . . . 0.0 111.65 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 31.4 mm -133.63 135.42 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.406 1.082 . . . . 0.0 110.9 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.36 128.19 19.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.037 1.335 . . . . 0.0 113.085 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.37 126.58 45.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.873 2.069 . . . . 0.0 109.689 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.79 33.27 13.79 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.877 1.271 . . . . 0.0 112.539 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.4 t30 75.5 2.75 3.86 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.334 2.654 . . . . 0.0 114.795 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.26 132.77 50.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.177 1.391 . . . . 0.0 110.843 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -56.55 134.95 54.66 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.01 155.9 88.19 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.592 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.02 -19.67 69.65 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.503 2.136 . . . . 0.0 113.853 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -80.45 -3.5 89.99 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.32 0.964 . . . . 0.0 114.686 172.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 7.7 t -93.02 154.18 41.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 119.203 1.502 . . . . 0.0 111.887 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -82.36 163.01 75.8 Favored 'Cis proline' 0 C--N 1.352 0.726 0 CA-C-N 119.795 0.962 . . . . 0.0 111.591 -13.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 72.1 mt -111.52 156.63 21.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.634 1.574 . . . . 0.0 111.376 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -147.27 139.29 24.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.149 1.38 . . . . 0.0 109.416 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.2 p90 -162.68 162.19 26.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.889 0.876 . . . . 0.0 112.5 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 62.9 t80 -109.72 145.22 36.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.446 1.098 . . . . 0.0 113.004 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1860 ' ' VAL . . . . . 0.494 HG12 HD11 ' A' 1788 ' ' LEU . 69.4 t -121.95 141.02 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.311 1.844 . . . . 0.0 109.302 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -155.18 144.58 21.16 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.251 1.42 . . . . 0.0 112.989 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1862 ' ' TYR . . . . . 0.408 ' CD1' HD13 ' A' 1788 ' ' LEU . 49.9 m-85 -70.06 145.32 51.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 111.551 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 28.2 m -66.52 -19.4 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -91.11 0.56 57.51 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.342 1.457 . . . . 0.0 114.859 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 96.3 m -62.8 132.94 53.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.307 0.958 . . . . 0.0 112.247 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.87 -25.14 18.31 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.704 1.145 . . . . 0.0 113.887 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -68.5 159.71 31.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.22 1.008 . . . . 0.0 113.201 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.4 p -64.37 131.4 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.096 0.959 . . . . 0.0 111.272 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 53.4 p -136.36 164.78 27.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.166 1.786 . . . . 0.0 110.106 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -143.7 144.52 31.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.284 1.034 . . . . 0.0 111.671 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 38.9 p90 -166.49 167.27 15.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.684 1.593 . . . . 0.0 112.861 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.8 170.9 12.86 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.508 1.528 . . . . 0.0 112.454 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.74 -33.82 12.29 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.701 2.267 . . . . 0.0 113.142 -169.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.5 -32.89 83.04 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.358 0.981 . . . . 0.0 114.609 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.82 -3.12 39.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.03 1.415 . . . . 0.0 113.771 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 77.5 m -113.31 -47.16 3.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.583 1.953 . . . . 0.0 111.863 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -138.58 143.38 39.35 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.684 1.594 . . . . 0.0 112.448 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.83 175.74 22.39 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.056 1.313 . . . . 0.0 113.026 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -139.62 134.67 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.452 1.101 . . . . 0.0 108.778 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.8 m -56.54 132.32 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 24.7 m120 69.35 1.65 3.37 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.112 2.165 . . . . 0.0 114.401 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -105.27 137.56 19.29 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.285 1.434 . . . . 0.0 110.433 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.47 121.94 7.88 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.417 2.078 . . . . 0.0 110.364 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 145.22 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.457 1.503 . . . . 0.0 110.393 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.5 p -136.22 149.17 48.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.6 p90 -160.74 176.29 11.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.96 1.704 . . . . 0.0 111.47 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.7 m -133.35 141.52 47.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.068 1.347 . . . . 0.0 110.851 -170.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.77 136.36 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.786 1.634 . . . . 0.0 108.014 168.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -104.13 123.0 46.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.421 1.089 . . . . 0.0 110.284 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.9 p -127.04 3.81 6.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.785 1.634 . . . . 0.0 113.636 -166.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.49 -36.92 36.02 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.856 2.062 . . . . 0.0 115.64 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -129.3 17.54 6.0 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.426 1.49 . . . . 0.0 112.423 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.7 -30.07 59.18 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.2 142.36 5.99 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.385 1.469 . . . . 0.0 113.156 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -72.9 152.95 41.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.668 1.187 . . . . 0.0 112.087 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.37 13.12 0.05 OUTLIER Glycine 0 N--CA 1.476 1.36 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 107.96 89.77 2.09 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-N 118.776 1.288 . . . . 0.0 112.728 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.14 126.62 31.08 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.802 1.241 . . . . 0.0 109.367 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -121.54 157.95 29.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.196 1.798 . . . . 0.0 112.166 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.3 tp -160.19 134.99 7.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.915 1.686 . . . . 0.0 109.343 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.82 158.1 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.384 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.55 138.03 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.859 1.263 . . . . 0.0 109.964 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.6 164.24 20.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.266 1.826 . . . . 0.0 109.731 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 169.96 -155.84 26.05 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.673 -1.071 . . . . 0.0 114.224 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.36 -21.92 60.53 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.866 3.044 . . . . 0.0 112.784 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 14.5 t -152.05 164.53 37.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.616 1.566 . . . . 0.0 109.708 166.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -72.45 112.58 8.63 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.991 -1.068 . . . . 0.0 111.153 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.43 148.17 48.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.762 0.825 . . . . 0.0 111.088 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.19 144.1 25.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.045 0.538 . . . . 0.0 110.27 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.7 mt -134.27 144.93 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.056 1.342 . . . . 0.0 110.074 -163.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.5 t -142.45 162.28 35.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.766 1.226 . . . . 0.0 110.922 166.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -159.32 158.83 33.09 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.645 1.178 . . . . 0.0 112.622 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 55.7 m -142.55 123.93 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.273 1.429 . . . . 0.0 110.162 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.09 132.4 37.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.887 1.275 . . . . 0.0 111.152 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -112.71 148.18 35.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.215 1.406 . . . . 0.0 111.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -70.54 -14.03 62.34 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.111 0.964 . . . . 0.0 112.877 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.45 -6.44 50.12 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.707 1.603 . . . . 0.0 114.125 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 35.81 6.21 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.555 1.074 . . . . 0.0 113.519 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.3 p -141.16 161.21 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.307 1.443 . . . . 0.0 111.172 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 66.0 m -115.39 128.3 55.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.032 1.333 . . . . 0.0 108.785 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -89.01 147.63 24.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.65 0.78 . . . . 0.0 110.296 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -129.38 143.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 110.127 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 77.6 p -136.82 148.02 46.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.916 1.286 . . . . 0.0 111.755 167.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 12.8 p90 -152.75 157.02 40.22 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.66 105.93 35.23 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.857 1.663 . . . . 0.0 110.081 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.92 167.26 20.41 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.543 2.829 . . . . 0.0 110.31 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 30.7 m -136.17 -25.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -173.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.3 mt -118.26 147.99 42.84 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.042 1.337 . . . . 0.0 110.395 170.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.36 156.11 45.98 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.924 2.416 . . . . 0.0 110.952 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.53 -149.1 20.55 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.55 1.072 . . . . 0.0 112.997 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -113.7 128.27 56.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.041 1.336 . . . . 0.0 111.24 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -112.31 139.74 47.61 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.371 1.468 . . . . 0.0 110.929 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.6 m -97.79 122.28 40.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.642 1.177 . . . . 0.0 110.496 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.34 127.91 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.482 1.513 . . . . 0.0 108.543 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.88 133.02 53.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.778 1.631 . . . . 0.0 109.861 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.4 t -133.9 132.41 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.504 1.521 . . . . 0.0 108.123 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -156.67 144.49 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.852 1.261 . . . . 0.0 110.786 -167.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.7 118.69 12.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 51.57 59.57 4.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.446 1.498 . . . . 0.0 112.179 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 59.39 12.05 2.5 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.036 2.534 . . . . 0.0 116.424 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -119.57 125.43 48.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.389 1.076 . . . . 0.0 111.133 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -60.63 155.45 18.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.099 0.96 . . . . 0.0 112.774 171.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.5 m -74.51 152.19 87.51 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 169.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.05 -12.33 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.506 2.138 . . . . 0.0 114.897 -167.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -102.22 -11.6 36.07 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 174.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 80.5 p -84.5 156.07 62.38 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 120.055 1.927 . . . . 0.0 113.6 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.49 151.21 96.77 Favored 'Cis proline' 0 C--N 1.352 0.763 0 CA-C-N 118.982 0.672 . . . . 0.0 112.472 -4.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -102.42 160.05 14.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.43 1.492 . . . . 0.0 110.825 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 44.3 m -119.71 116.62 26.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.747 0.819 . . . . 0.0 110.57 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.73 126.43 43.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.529 1.132 . . . . 0.0 111.222 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.34 114.41 21.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.163 0.985 . . . . 0.0 108.926 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.7 t -103.34 136.2 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.065 0.946 . . . . 0.0 110.402 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 34.0 p -121.83 171.59 8.79 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 112.589 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.95 145.66 30.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.936 1.255 . . . . 0.0 112.686 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.57 -21.16 45.44 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.156 0.982 . . . . 0.0 112.863 174.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.867 1.667 . . . . 0.0 114.03 179.336 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.67 162.33 28.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.34 1.056 . . . . 0.0 113.03 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -69.29 157.75 36.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.032 1.333 . . . . 0.0 112.655 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . 49.34 58.1 17.9 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 126.04 1.736 . . . . 0.0 113.759 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.59 161.99 44.1 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.793 2.995 . . . . 0.0 112.483 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.35 154.56 38.03 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.421 1.489 . . . . 0.0 110.522 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.05 147.03 57.17 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.228 1.411 . . . . 0.0 112.622 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.84 154.02 38.31 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.463 2.775 . . . . 0.0 111.458 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 83.1 mt -105.92 26.21 9.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.39 1.476 . . . . 0.0 111.959 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 13.1 p -161.0 150.16 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.885 2.074 . . . . 0.0 110.318 -171.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 86.37 -152.16 25.13 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.582 1.087 . . . . 0.0 112.445 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 14.7 p -158.05 135.36 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.095 1.358 . . . . 0.0 110.802 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -97.17 -7.27 32.89 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.987 1.315 . . . . 0.0 113.87 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -66.12 156.76 49.78 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.98 1.276 . . . . 0.0 113.537 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.9 166.23 34.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.783 1.633 . . . . 0.0 111.517 -174.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 31.0 t70 68.79 -43.81 0.51 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.563 2.745 . . . . 0.0 113.929 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.7 p -61.27 -24.26 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.775 1.63 . . . . 0.0 112.89 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.7 t -81.59 -16.47 51.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.66 1.584 . . . . 0.0 112.929 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.62 38.71 0.76 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.816 1.647 . . . . 0.0 111.725 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1788 ' ' LEU . . . . . 0.63 HD11 HG12 ' A' 1860 ' ' VAL . 22.0 tp -98.46 134.4 41.5 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.434 1.894 . . . . 0.0 111.241 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.3 120.28 46.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.311 1.044 . . . . 0.0 111.303 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.24 156.64 58.83 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.459 2.773 . . . . 0.0 110.922 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.1 t80 -108.12 127.72 54.06 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.656 0.782 . . . . 0.0 111.096 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.52 135.74 14.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.655 1.582 . . . . 0.0 110.785 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.39 152.48 41.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.518 1.927 . . . . 0.0 109.862 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.0 p -123.31 139.16 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.023 1.329 . . . . 0.0 110.469 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.24 137.49 29.42 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.271 1.828 . . . . 0.0 108.486 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -79.06 45.95 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.555 3.503 . . . . 0.0 112.999 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 29.2 t80 -91.15 153.49 20.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.135 1.374 . . . . 0.0 111.137 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.4 m -125.28 126.36 45.0 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.946 1.298 . . . . 0.0 109.746 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 95.2 mt -91.18 138.06 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.059 1.344 . . . . 0.0 109.917 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -149.74 95.96 2.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.501 1.12 . . . . 0.0 111.521 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 72.59 -31.74 0.23 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 128.539 2.736 . . . . 0.0 115.179 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.1 175.74 54.68 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.626 1.584 . . . . 0.0 113.443 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -111.45 141.68 44.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.235 1.414 . . . . 0.0 111.289 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -125.31 134.29 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.548 1.539 . . . . 0.0 110.602 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.18 170.64 17.97 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.183 1.793 . . . . 0.0 110.324 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -158.89 -167.48 19.67 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 115.884 1.114 . . . . 0.0 115.884 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.48 134.85 15.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.702 1.601 . . . . 0.0 109.264 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.0 t -104.53 131.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.694 1.598 . . . . 0.0 107.443 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -116.38 129.05 56.04 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.833 1.253 . . . . 0.0 110.657 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -97.02 150.68 37.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.71 1.604 . . . . 0.0 111.468 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.4 -20.56 27.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.507 2.804 . . . . 0.0 113.051 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -79.68 -0.54 34.44 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.945 1.698 . . . . 0.0 114.561 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.41 54.08 2.48 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.56 1.076 . . . . 0.0 113.161 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -155.62 167.04 31.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.064 1.746 . . . . 0.0 111.676 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.8 m -140.43 158.09 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.849 1.26 . . . . 0.0 112.58 -172.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.89 166.87 32.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.507 1.923 . . . . 0.0 110.892 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.01 137.73 20.16 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.2 -0.937 . . . . 0.0 111.588 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.77 163.96 20.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.958 3.105 . . . . 0.0 110.993 168.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.7 m -107.87 117.82 35.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.088 1.355 . . . . 0.0 108.852 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -97.64 133.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.43 1.092 . . . . 0.0 109.007 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -125.85 130.64 51.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.111 1.764 . . . . 0.0 109.901 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 17.5 t0 -75.52 122.23 23.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.169 0.988 . . . . 0.0 110.775 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -84.46 -15.4 46.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.7 tttt 71.39 0.22 3.37 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.614 2.366 . . . . 0.0 114.017 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.83 7.87 45.67 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.07 2.148 . . . . 0.0 113.023 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.83 15.12 55.39 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.983 1.278 . . . . 0.0 113.835 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.9 p -132.38 161.78 32.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.419 1.888 . . . . 0.0 110.3 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -125.4 145.24 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.787 1.235 . . . . 0.0 109.831 167.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.2 m -104.71 139.25 39.8 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.291 1.037 . . . . 0.0 108.564 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.7 t -124.14 129.49 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.912 1.285 . . . . 0.0 109.108 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -129.37 161.86 29.33 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -159.64 135.91 8.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 111.828 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.35 114.39 60.88 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.801 1.241 . . . . 0.0 110.602 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -83.97 165.82 13.21 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.723 2.949 . . . . 0.0 112.221 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.3 t -144.35 -1.5 0.92 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.92 152.02 3.49 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.509 1.924 . . . . 0.0 111.27 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.55 175.37 7.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.309 1.443 . . . . 0.0 114.49 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.86 -171.02 13.61 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 126.138 1.827 . . . . 0.0 113.985 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 59.3 tp -79.69 127.41 32.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.623 1.169 . . . . 0.0 110.454 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 55.0 m80 -125.69 168.99 12.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.809 1.644 . . . . 0.0 111.394 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -147.35 153.52 39.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.04 0.936 . . . . 0.0 111.77 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 22.1 ttm -124.34 133.71 53.37 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.117 1.767 . . . . 0.0 110.095 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -111.14 136.12 50.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.236 1.814 . . . . 0.0 109.829 169.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.1 mm -135.59 134.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.028 1.331 . . . . 0.0 110.451 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.03 140.42 36.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.366 1.066 . . . . 0.0 113.588 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.4 t80 -103.6 118.09 35.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.058 2.143 . . . . 0.0 109.256 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.81 31.92 11.41 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.826 1.25 . . . . 0.0 112.945 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.13 5.0 4.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.143 2.577 . . . . 0.0 115.171 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.8 ttp -95.4 127.94 41.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.595 1.158 . . . . 0.0 110.079 165.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.79 137.55 57.65 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.254 -0.904 . . . . 0.0 112.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -71.82 154.43 92.81 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.432 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.55 -17.86 61.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.582 2.188 . . . . 0.0 113.912 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -88.64 2.54 84.67 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.814 1.197 . . . . 0.0 114.88 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 31.5 t -101.94 142.62 24.97 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 119.822 1.811 . . . . 0.0 111.953 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.61 170.33 57.41 Favored 'Cis proline' 0 C--N 1.352 0.76 0 CA-C-N 119.816 0.97 . . . . 0.0 112.477 -3.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.2 mt -120.91 151.42 39.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.118 1.767 . . . . 0.0 110.38 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -132.67 144.73 50.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.73 1.212 . . . . 0.0 110.505 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 6.0 p90 -165.79 154.65 11.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.362 1.065 . . . . 0.0 112.304 -172.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 37.2 t80 -101.66 143.23 31.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 112.429 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1860 ' ' VAL . . . . . 0.63 HG12 HD11 ' A' 1788 ' ' LEU . 91.8 t -116.09 137.57 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.21 1.804 . . . . 0.0 109.413 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.0 t0 -159.6 147.64 17.3 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.857 1.263 . . . . 0.0 112.267 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -74.47 149.11 40.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 0.0 112.784 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 3.4 p -70.59 -22.33 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.507 -0.745 . . . . 0.0 112.83 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -82.67 -13.24 56.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.107 1.363 . . . . 0.0 114.174 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 82.9 m -58.98 134.49 57.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.535 1.134 . . . . 0.0 113.935 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.15 70.08 1.08 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.702 1.62 . . . . 0.0 111.772 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -162.6 168.58 21.55 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.652 1.581 . . . . 0.0 113.072 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.8 p -68.59 143.79 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.634 0.774 . . . . 0.0 110.074 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -163.52 159.51 22.08 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.692 1.597 . . . . 0.0 110.025 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -138.33 144.76 40.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.335 1.054 . . . . 0.0 112.358 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 45.0 p90 -167.67 165.44 14.32 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.683 1.593 . . . . 0.0 113.239 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.58 175.5 13.96 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.253 1.406 . . . . 0.0 112.977 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.56 -37.0 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.764 -171.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.06 91.34 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.538 1.063 . . . . 0.0 114.507 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.02 -6.51 52.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.704 1.252 . . . . 0.0 113.327 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 38.7 m -100.98 -54.73 2.73 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.222 1.809 . . . . 0.0 110.18 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -137.26 139.8 41.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.601 1.961 . . . . 0.0 112.375 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -129.97 172.84 20.01 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.058 1.313 . . . . 0.0 113.242 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 60.9 t -136.85 134.11 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.627 1.171 . . . . 0.0 108.948 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -56.95 139.23 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.0 m-80 66.16 2.24 2.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.86 2.064 . . . . 0.0 114.809 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.35 142.22 29.09 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.908 1.683 . . . . 0.0 111.096 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.79 119.21 5.95 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.637 2.224 . . . . 0.0 110.415 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -94.82 145.7 24.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.218 1.407 . . . . 0.0 109.996 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 76.0 p -136.18 151.57 49.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -168.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.7 p90 -162.87 176.16 10.49 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.461 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.9 m -134.05 138.34 45.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.707 1.203 . . . . 0.0 110.983 -169.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.4 t -102.09 134.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.186 1.394 . . . . 0.0 107.701 165.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -96.43 128.08 43.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.071 0.948 . . . . 0.0 109.824 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.1 p -129.39 7.46 5.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.379 1.872 . . . . 0.0 112.861 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -55.65 -32.17 62.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.91 1.684 . . . . 0.0 114.464 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.65 11.85 13.83 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.541 1.536 . . . . 0.0 113.063 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.03 -15.64 56.78 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.75 -128.75 8.62 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.344 0.973 . . . . 0.0 112.162 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -155.65 150.3 26.19 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.443 1.497 . . . . 0.0 110.723 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.3 -85.0 0.08 OUTLIER Glycine 0 N--CA 1.469 0.851 0 C-N-CA 125.482 1.515 . . . . 0.0 111.003 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -168.77 118.08 0.76 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.575 1.083 . . . . 0.0 112.222 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.14 138.2 32.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.439 1.096 . . . . 0.0 110.063 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.4 m -131.32 158.52 40.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.677 1.591 . . . . 0.0 111.547 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 43.2 tp -156.75 135.93 12.01 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.783 1.633 . . . . 0.0 108.893 -171.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.65 158.93 39.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.77 0.828 . . . . 0.0 112.346 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.0 mt -134.39 137.51 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 109.445 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.15 122.34 38.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.082 1.353 . . . . 0.0 109.379 172.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -139.1 -175.75 14.24 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.724 1.154 . . . . 0.0 114.08 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.5 -23.84 43.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.045 3.164 . . . . 0.0 112.112 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.3 t -136.59 152.23 50.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.506 1.522 . . . . 0.0 108.578 160.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.5 tptt -71.91 120.05 16.96 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.033 -1.042 . . . . 0.0 111.976 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.36 147.97 41.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.933 0.893 . . . . 0.0 111.681 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -89.81 142.85 27.3 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.505 0.722 . . . . 0.0 109.741 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.7 mt -135.11 143.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.587 1.155 . . . . 0.0 110.334 -167.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.2 t -143.19 158.22 43.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 110.838 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -158.74 157.31 31.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.442 1.097 . . . . 0.0 112.988 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 67.3 m -140.89 115.2 9.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.447 1.499 . . . . 0.0 109.868 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.85 136.92 36.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.026 1.331 . . . . 0.0 111.338 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -117.88 146.22 44.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.843 1.657 . . . . 0.0 111.986 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.86 -15.16 63.49 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.759 1.224 . . . . 0.0 112.496 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -70.87 -9.32 57.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.937 1.695 . . . . 0.0 114.159 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.88 33.73 7.22 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.266 0.936 . . . . 0.0 113.553 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.9 p -139.14 163.54 32.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.345 1.458 . . . . 0.0 110.931 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -130.88 125.64 34.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.453 1.501 . . . . 0.0 108.642 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -92.41 144.52 25.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.198 0.999 . . . . 0.0 110.589 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.9 t -126.62 141.7 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.542 1.537 . . . . 0.0 110.802 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 63.2 m -132.92 141.01 48.14 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.985 1.714 . . . . 0.0 110.795 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 10.6 p90 -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.56 104.56 49.45 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.375 1.87 . . . . 0.0 110.524 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.8 165.13 15.68 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.694 2.93 . . . . 0.0 110.199 166.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.0 p -127.77 -19.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.3 pp -146.84 152.06 43.48 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.188 0.995 . . . . 0.0 111.594 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -67.46 147.77 77.83 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.041 2.494 . . . . 0.0 112.838 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.21 -171.09 30.18 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.53 1.062 . . . . 0.0 113.708 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.92 134.64 34.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.956 1.302 . . . . 0.0 112.104 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.66 126.37 41.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.586 1.554 . . . . 0.0 109.842 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 62.6 m -88.37 124.33 33.82 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.987 -1.07 . . . . 0.0 110.708 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.0 128.31 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.512 1.525 . . . . 0.0 108.304 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.1 tt -112.31 130.34 55.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.426 1.49 . . . . 0.0 109.385 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 24.0 t -132.18 131.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.144 0.978 . . . . 0.0 109.577 173.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.98 147.48 27.92 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.122 1.369 . . . . 0.0 111.683 -168.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.57 120.25 11.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 109.8 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.12 56.24 5.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.6 1.56 . . . . 0.0 111.824 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.4 pt-20 57.24 13.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.415 2.686 . . . . 0.0 116.322 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -120.23 127.09 52.11 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.732 1.213 . . . . 0.0 110.641 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -63.69 147.08 52.54 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.324 -0.86 . . . . 0.0 112.079 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -70.77 153.73 94.69 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.758 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.43 129.64 30.49 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.632 2.221 . . . . 0.0 110.887 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 91.95 -14.76 63.5 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.103 1.335 . . . . 0.0 114.949 -175.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.8 t -78.42 142.63 62.84 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 119.433 1.617 . . . . 0.0 111.734 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.41 140.79 69.24 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.317 0.792 . . . . 0.0 111.989 -4.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -93.52 166.29 12.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.312 1.845 . . . . 0.0 110.689 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 51.3 m -124.44 113.99 18.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.816 0.847 . . . . 0.0 110.395 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.9 156.97 19.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.679 1.192 . . . . 0.0 110.953 167.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -120.9 126.55 50.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.184 0.993 . . . . 0.0 109.949 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.2 t -103.18 131.81 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.38 1.472 . . . . 0.0 109.793 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.2 p -108.99 162.1 14.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.73 1.212 . . . . 0.0 112.62 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.49 142.69 28.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.91 1.243 . . . . 0.0 112.089 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.3 t70 -87.16 -10.71 52.01 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.602 1.161 . . . . 0.0 113.52 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.617 1.967 . . . . 0.0 112.557 -177.564 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -75.92 -28.38 58.0 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.2 mtt -84.15 156.15 22.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.855 1.262 . . . . 0.0 112.107 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -67.26 150.0 98.13 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.304 1.042 . . . . 0.0 112.627 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.65 170.56 20.04 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.8 3.0 . . . . 0.0 112.014 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.41 154.17 42.43 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.135 0.974 . . . . 0.0 112.168 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -58.64 132.47 85.85 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.476 1.11 . . . . 0.0 111.49 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -72.89 164.74 34.72 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.464 2.776 . . . . 0.0 112.201 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -70.76 20.52 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.875 2.07 . . . . 0.0 115.622 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 14.3 p -159.32 147.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.341 1.856 . . . . 0.0 110.848 -170.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -154.62 172.96 33.1 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.32 1.438 . . . . 0.0 113.293 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 85.0 t -76.56 128.82 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.494 1.118 . . . . 0.0 110.046 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -78.4 -14.04 59.57 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 88.66 31.45 12.98 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.874 1.226 . . . . 0.0 113.704 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.27 144.83 56.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.821 1.249 . . . . 0.0 112.201 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 27.4 t70 -137.06 22.75 3.04 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.293 1.437 . . . . 0.0 111.921 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 17.8 m -71.34 145.04 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.19 1.396 . . . . 0.0 111.765 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 9.5 t 179.42 -43.31 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.744 2.418 . . . . 0.0 110.503 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 74.9 m -80.73 86.05 6.0 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.394 1.077 . . . . 0.0 112.131 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 61.5 mt -72.34 153.32 41.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.115 1.366 . . . . 0.0 110.968 165.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.22 115.34 10.3 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.551 1.54 . . . . 0.0 111.377 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.79 129.43 18.63 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.32 2.013 . . . . 0.0 108.852 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -114.83 128.88 56.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.616 0.766 . . . . 0.0 111.722 -171.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -157.67 142.72 16.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.817 1.647 . . . . 0.0 111.092 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.97 156.16 49.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.595 1.958 . . . . 0.0 110.141 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.5 p -122.35 137.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.904 1.282 . . . . 0.0 109.959 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 57.9 mt -131.64 133.48 24.31 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.999 1.72 . . . . 0.0 109.035 -172.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.94 112.1 3.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.266 2.644 . . . . 0.0 109.81 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.0 t80 -175.54 148.58 0.93 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.107 2.163 . . . . 0.0 109.177 -171.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.3 m -130.75 124.01 30.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.518 1.127 . . . . 0.0 109.234 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.7 mt -74.47 125.52 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.195 0.598 . . . . 0.0 110.265 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.6 mttp -110.42 -143.0 0.39 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.694 1.597 . . . . 0.0 110.513 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.46 120.29 19.82 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.651 -1.281 . . . . 0.0 110.883 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.98 -152.14 20.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.589 1.566 . . . . 0.0 112.303 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -160.31 147.47 16.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.956 1.302 . . . . 0.0 110.978 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.29 136.73 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.402 1.481 . . . . 0.0 111.207 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 25.2 p -149.58 174.31 12.67 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.573 1.949 . . . . 0.0 110.235 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -157.82 -166.33 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -152.34 142.3 22.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.234 1.813 . . . . 0.0 109.42 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.7 t -119.93 133.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.948 1.699 . . . . 0.0 108.673 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -109.97 132.89 53.75 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.665 1.186 . . . . 0.0 111.794 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -104.34 143.43 26.66 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.674 1.589 . . . . 0.0 111.219 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.08 -29.15 64.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.211 3.274 . . . . 0.0 114.994 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 6.1 m -69.94 -0.77 7.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.3 42.04 6.35 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.6 1.095 . . . . 0.0 112.839 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.59 162.65 39.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.809 1.644 . . . . 0.0 111.99 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.5 m -141.18 158.15 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.988 1.315 . . . . 0.0 112.204 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -151.53 179.1 8.66 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.018 2.127 . . . . 0.0 109.974 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.54 143.8 38.77 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 121.107 -0.996 . . . . 0.0 111.718 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -83.73 166.34 13.47 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.089 3.192 . . . . 0.0 111.405 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 77.5 m -107.21 130.58 54.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.4 1.48 . . . . 0.0 108.651 171.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.52 136.7 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.518 1.127 . . . . 0.0 109.443 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 63.0 m -133.26 124.26 27.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.659 1.584 . . . . 0.0 109.648 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.02 127.26 31.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.292 1.037 . . . . 0.0 111.076 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -87.52 -4.26 58.98 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -170.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 35.9 mmtm 71.57 -5.91 1.53 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.638 2.375 . . . . 0.0 114.538 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -98.21 2.79 48.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.715 2.006 . . . . 0.0 113.218 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.13 16.8 31.62 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.026 1.298 . . . . 0.0 114.457 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 65.1 p -128.75 157.39 41.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.016 1.726 . . . . 0.0 110.677 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -115.31 139.61 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.051 0.94 . . . . 0.0 109.633 163.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.1 m -96.7 138.05 34.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.659 1.184 . . . . 0.0 108.495 169.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 24.8 t -119.11 135.05 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.483 1.513 . . . . 0.0 109.052 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.1 152.77 51.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.558 1.543 . . . . 0.0 111.785 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -153.47 132.44 12.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.349 1.46 . . . . 0.0 110.914 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.43 117.89 70.0 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.236 1.014 . . . . 0.0 110.5 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.56 130.69 12.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.132 2.554 . . . . 0.0 111.823 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 78.2 p -118.7 -15.18 9.51 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -141.54 157.54 44.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.909 1.684 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -90.99 166.28 13.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.27 1.028 . . . . 0.0 112.004 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.24 -166.71 12.17 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.693 1.616 . . . . 0.0 114.079 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -91.77 122.28 34.18 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.338 1.455 . . . . 0.0 110.494 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.5 m80 -119.1 169.57 9.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 111.26 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.51 152.72 42.95 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 171.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 5.7 ttm -125.55 119.45 28.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.886 2.074 . . . . 0.0 109.928 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -95.86 138.4 33.57 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 109.967 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.6 mm -135.96 135.43 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.745 1.218 . . . . 0.0 110.577 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 141.1 32.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 113.329 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 20.6 t80 -103.14 120.26 40.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.153 1.781 . . . . 0.0 109.788 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.73 34.07 15.36 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.673 1.189 . . . . 0.0 112.701 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 73.29 5.35 5.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.92 2.488 . . . . 0.0 115.066 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -97.06 124.6 41.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.079 1.351 . . . . 0.0 109.921 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -57.51 136.11 56.68 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.265 -0.897 . . . . 0.0 112.938 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.3 pt -68.96 152.41 96.82 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.602 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.28 120.11 7.69 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.326 2.018 . . . . 0.0 109.748 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 90.86 7.57 66.11 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.664 -1.075 . . . . 0.0 115.5 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.2 t -74.16 142.11 78.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 120.283 2.041 . . . . 0.0 110.746 162.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -86.59 171.54 38.47 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 120.388 1.174 . . . . 0.0 113.205 -2.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.63 159.34 16.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.131 1.772 . . . . 0.0 110.62 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -133.47 138.86 46.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.614 1.166 . . . . 0.0 110.434 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -156.94 153.32 27.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.07 0.948 . . . . 0.0 112.863 -167.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 43.6 t80 -104.28 148.79 25.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.983 0.913 . . . . 0.0 112.916 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 32.2 t -132.41 139.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.613 1.565 . . . . 0.0 109.22 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.09 153.5 32.95 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.817 1.247 . . . . 0.0 113.023 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -75.69 125.99 30.14 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 111.35 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.0 p -68.72 -24.72 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.572 -0.705 . . . . 0.0 112.428 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.97 -26.02 63.9 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.996 1.318 . . . . 0.0 114.05 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 85.2 m -73.02 -24.61 60.75 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 74.44 7.19 78.14 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.697 1.141 . . . . 0.0 115.504 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -67.91 161.81 25.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.59 1.556 . . . . 0.0 113.629 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -68.26 127.43 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.7 t -156.21 162.78 40.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.41 1.084 . . . . 0.0 111.161 -167.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.4 147.01 31.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.082 1.353 . . . . 0.0 111.804 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.2 p90 -166.54 162.4 16.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.676 1.591 . . . . 0.0 112.355 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.97 173.34 13.26 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.3 1.428 . . . . 0.0 112.991 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.36 -32.56 15.84 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.989 2.46 . . . . 0.0 112.766 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.4 77.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.347 0.976 . . . . 0.0 114.498 -171.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.4 -2.93 44.01 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.865 1.332 . . . . 0.0 113.508 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -106.4 -40.41 5.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.709 2.003 . . . . 0.0 111.558 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -152.47 141.96 21.69 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.356 1.862 . . . . 0.0 111.92 -164.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.9 -179.91 23.35 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.032 1.301 . . . . 0.0 113.118 168.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 62.1 t -142.04 138.28 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.859 1.663 . . . . 0.0 107.831 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -54.91 134.52 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.3 m-80 69.18 -4.48 1.27 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.185 2.194 . . . . 0.0 114.644 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -95.51 137.25 22.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.598 1.159 . . . . 0.0 110.812 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.03 121.77 7.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.486 2.124 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.51 146.51 28.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.377 1.471 . . . . 0.0 110.319 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 73.2 p -138.92 151.2 46.73 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.09 174.43 13.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.0 1.72 . . . . 0.0 111.527 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.0 m -126.85 143.5 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.279 1.432 . . . . 0.0 110.769 -172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.4 t -117.12 134.69 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.017 1.727 . . . . 0.0 108.287 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.13 133.67 36.07 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.033 0.933 . . . . 0.0 111.811 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -134.8 0.87 2.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.433 1.493 . . . . 0.0 113.801 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -54.03 -40.14 66.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.313 1.845 . . . . 0.0 114.804 -167.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -119.92 12.07 11.95 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.708 1.603 . . . . 0.0 112.587 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.99 -35.94 69.61 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 82.37 145.11 5.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.947 1.261 . . . . 0.0 112.496 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.97 148.26 46.14 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.337 1.055 . . . . 0.0 112.142 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.69 -30.54 0.09 OUTLIER Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.51 1.052 . . . . 0.0 114.688 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 145.18 103.28 0.39 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.435 1.493 . . . . 0.0 112.662 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.38 131.49 35.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.232 1.413 . . . . 0.0 109.256 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 9.2 t -135.06 162.99 30.9 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.593 1.557 . . . . 0.0 112.211 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.9 tp -165.63 135.9 3.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.554 1.941 . . . . 0.0 109.205 -163.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.88 159.52 35.1 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.417 1.087 . . . . 0.0 111.956 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.45 135.83 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.523 1.129 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.3 136.23 53.96 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.108 1.363 . . . . 0.0 110.026 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -162.92 -165.02 19.29 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.509 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.98 -26.56 74.07 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.077 3.185 . . . . 0.0 112.514 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -135.87 156.53 48.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.735 1.214 . . . . 0.0 109.464 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -72.95 111.13 7.79 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.076 -1.015 . . . . 0.0 110.288 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.58 147.0 52.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.083 0.953 . . . . 0.0 111.96 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -84.94 135.07 34.21 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.5 mt -130.6 144.68 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 110.418 -166.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.7 t -145.18 165.02 29.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.824 1.25 . . . . 0.0 111.187 167.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -159.26 154.73 25.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.749 1.22 . . . . 0.0 112.528 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.6 m -138.97 125.09 20.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.524 1.53 . . . . 0.0 110.285 -172.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.11 128.79 35.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.715 1.206 . . . . 0.0 111.12 171.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -104.0 148.48 26.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.46 1.504 . . . . 0.0 111.686 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -68.18 -18.26 64.55 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.179 0.992 . . . . 0.0 113.556 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.02 -22.81 60.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.205 1.002 . . . . 0.0 113.695 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 104.52 45.62 1.41 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.287 0.946 . . . . 0.0 113.19 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -140.89 158.07 44.47 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.296 1.438 . . . . 0.0 110.005 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.5 m -107.92 127.36 53.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.638 1.175 . . . . 0.0 109.263 162.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -86.71 147.08 26.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.419 0.688 . . . . 0.0 109.955 166.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -127.98 144.2 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.67 1.588 . . . . 0.0 109.762 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.08 147.93 46.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.873 1.269 . . . . 0.0 111.98 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.9 p90 -151.88 154.25 35.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.15 107.69 43.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.231 1.812 . . . . 0.0 110.383 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -82.81 176.41 7.74 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.901 3.067 . . . . 0.0 110.333 167.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.2 p -151.45 -28.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 85.9 mt -107.58 147.03 34.54 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.53 1.059 . . . . 0.0 110.525 167.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.91 154.98 48.42 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.863 2.376 . . . . 0.0 110.824 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.89 -165.45 24.59 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.96 137.31 32.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.065 1.346 . . . . 0.0 112.506 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -125.36 125.87 44.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.849 1.66 . . . . 0.0 110.079 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 65.3 m -88.19 122.29 31.58 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.646 1.178 . . . . 0.0 110.643 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.69 123.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.437 1.495 . . . . 0.0 108.626 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.45 136.21 44.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.408 1.483 . . . . 0.0 109.318 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 98.4 t -140.32 127.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.173 1.389 . . . . 0.0 108.912 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.96 140.8 20.99 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.567 1.147 . . . . 0.0 111.331 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.4 121.04 14.28 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.465 1.106 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 49.8 t30 57.47 57.27 4.46 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.219 1.408 . . . . 0.0 111.581 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.0 pt-20 58.51 13.96 2.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.438 2.695 . . . . 0.0 116.372 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -124.83 125.9 44.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.382 1.073 . . . . 0.0 111.329 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -65.04 157.05 29.48 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.942 0.897 . . . . 0.0 112.547 169.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.1 m -75.81 152.65 84.93 Favored Pre-proline 0 N--CA 1.483 1.18 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.392 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.3 -13.01 37.97 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.08 1.853 . . . . 0.0 114.462 -166.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -100.24 -10.31 45.52 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.1 p -87.64 153.63 52.95 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 119.779 1.789 . . . . 0.0 113.148 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.11 141.09 68.21 Favored 'Cis proline' 0 C--N 1.352 0.732 0 CA-C-N 119.063 0.701 . . . . 0.0 112.107 -3.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -90.26 167.17 12.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.094 1.357 . . . . 0.0 110.281 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.2 m -128.35 112.15 14.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 110.048 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.76 150.23 23.71 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.383 1.073 . . . . 0.0 110.574 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -110.68 124.76 52.54 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.246 1.018 . . . . 0.0 109.78 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.4 t -107.5 135.05 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.922 1.289 . . . . 0.0 110.834 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.0 p -113.37 164.93 12.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.31 1.444 . . . . 0.0 112.561 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.93 143.15 29.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.007 1.289 . . . . 0.0 112.183 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.47 -14.93 47.78 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.429 1.091 . . . . 0.0 113.362 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.596 1.958 . . . . 0.0 112.524 -177.45 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.489 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.25 163.47 28.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.462 1.105 . . . . 0.0 112.876 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? -74.98 -15.23 60.68 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -70.02 151.6 96.07 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.881 1.272 . . . . 0.0 112.67 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.87 160.64 47.28 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.675 2.917 . . . . 0.0 111.78 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.8 128.71 36.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.025 0.93 . . . . 0.0 111.737 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -104.14 137.93 19.37 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.606 1.562 . . . . 0.0 110.049 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.64 151.55 74.89 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.085 2.523 . . . . 0.0 111.598 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 82.4 mt -80.48 50.27 1.27 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.294 1.437 . . . . 0.0 112.358 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 9.1 p -169.6 -40.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.124 2.17 . . . . 0.0 111.635 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -79.19 147.49 30.29 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.853 0.74 . . . . 0.0 111.608 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 27.2 m -141.54 140.03 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.812 1.245 . . . . 0.0 111.254 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -91.24 -10.67 40.73 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.802 1.241 . . . . 0.0 113.119 173.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -83.39 84.82 1.54 Allowed Glycine 0 C--N 1.342 0.902 0 C-N-CA 125.355 1.455 . . . . 0.0 110.812 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.63 163.18 26.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.282 1.833 . . . . 0.0 110.805 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -155.65 160.91 40.79 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.246 1.418 . . . . 0.0 112.431 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 21.4 m -133.51 14.97 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.466 1.506 . . . . 0.0 113.361 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.0 t -75.97 -27.82 57.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.159 0.984 . . . . 0.0 113.401 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 30.2 m -79.18 35.24 0.26 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.633 1.573 . . . . 0.0 113.52 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 21.6 tp -73.13 141.57 47.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.478 1.511 . . . . 0.0 111.927 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.0 ttm-85 -59.06 120.04 43.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.931 1.692 . . . . 0.0 111.908 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.37 159.26 47.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.523 2.816 . . . . 0.0 112.02 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.8 t80 -112.16 123.03 49.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.777 1.231 . . . . 0.0 110.098 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.2 134.26 15.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.064 1.346 . . . . 0.0 110.514 170.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.9 140.81 31.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.686 1.594 . . . . 0.0 109.9 -170.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.1 p -107.67 138.93 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.715 1.206 . . . . 0.0 110.855 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.8 mt -134.08 134.99 23.52 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.348 1.859 . . . . 0.0 108.812 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.04 109.22 2.78 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.411 2.74 . . . . 0.0 110.1 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 48.4 t80 -175.2 151.62 1.31 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.999 2.12 . . . . 0.0 109.821 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 29.1 m -135.06 130.93 36.36 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.615 1.166 . . . . 0.0 110.057 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.98 122.35 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 109.437 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.64 -69.91 0.84 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.45 1.1 . . . . 0.0 112.322 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -158.79 127.14 5.24 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.782 1.633 . . . . 0.0 110.952 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.39 -139.54 11.04 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.51 1.528 . . . . 0.0 111.158 -166.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.09 142.29 17.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.366 1.066 . . . . 0.0 111.385 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.7 tt -121.65 135.49 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.785 1.634 . . . . 0.0 111.032 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.4 p -149.28 169.08 21.6 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.182 1.793 . . . . 0.0 110.596 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -162.07 -175.6 33.27 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 115.711 1.045 . . . . 0.0 115.711 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -153.21 143.35 22.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.654 1.582 . . . . 0.0 109.839 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.8 t -115.67 132.49 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.931 1.692 . . . . 0.0 108.101 171.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -119.03 137.47 53.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 110.898 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.8 mtt -110.56 146.67 34.83 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.463 1.505 . . . . 0.0 111.591 -169.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.63 -28.9 77.24 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.919 3.079 . . . . 0.0 114.944 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.5 p -74.51 0.58 14.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.046 1.738 . . . . 0.0 114.37 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.77 83.18 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.692 1.615 . . . . 0.0 113.947 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -72.96 159.11 34.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.742 1.617 . . . . 0.0 112.182 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.4 m -145.72 155.93 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.641 1.576 . . . . 0.0 111.074 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.68 166.5 26.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.442 1.497 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -100.06 137.63 20.13 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.175 0.99 . . . . 0.0 111.506 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.69 169.29 12.15 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.195 3.263 . . . . 0.0 111.827 171.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 86.9 m -110.24 119.75 40.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.667 1.587 . . . . 0.0 109.002 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.75 129.93 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.279 1.032 . . . . 0.0 109.026 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 35.0 m -125.99 116.13 20.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.861 1.664 . . . . 0.0 109.001 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.01 124.0 27.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.616 -0.678 . . . . 0.0 110.045 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.09 -10.24 59.75 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 72.97 -3.37 2.44 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.023 2.529 . . . . 0.0 113.864 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -93.86 1.19 56.45 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.665 1.986 . . . . 0.0 113.33 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.74 14.16 38.21 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.102 1.334 . . . . 0.0 114.472 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 76.1 p -128.37 157.12 41.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.407 1.883 . . . . 0.0 110.348 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -113.61 137.9 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.513 0.725 . . . . 0.0 109.59 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.5 m -102.29 128.88 48.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.649 1.179 . . . . 0.0 107.993 168.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.4 t -113.74 128.98 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.944 1.298 . . . . 0.0 108.95 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -126.53 154.4 43.88 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.231 1.812 . . . . 0.0 111.619 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.4 t80 -158.99 134.98 8.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.76 1.224 . . . . 0.0 112.275 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.91 119.96 70.66 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.562 1.145 . . . . 0.0 110.648 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.36 150.68 15.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.526 2.817 . . . . 0.0 111.798 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.4 m -132.2 -8.07 3.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -166.98 145.98 5.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.583 1.553 . . . . 0.0 110.325 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.56 170.66 16.17 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 0.0 113.523 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.84 178.77 17.88 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.484 1.516 . . . . 0.0 114.405 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 51.6 tp -75.98 103.21 5.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.191 1.397 . . . . 0.0 110.426 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -96.73 159.46 14.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 111.251 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.64 149.87 36.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 111.627 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 25.3 ttm -134.27 135.67 43.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.387 1.875 . . . . 0.0 110.645 -163.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -118.26 126.36 52.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.904 1.682 . . . . 0.0 109.763 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -127.94 130.13 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.818 1.247 . . . . 0.0 109.727 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 141.1 33.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.4 t80 -103.23 120.3 40.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.257 1.823 . . . . 0.0 109.5 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.15 32.6 10.8 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.766 1.226 . . . . 0.0 112.953 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 75.07 7.32 4.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.052 2.541 . . . . 0.0 115.195 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.4 mtp -99.19 128.03 45.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.921 1.288 . . . . 0.0 110.315 166.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -55.41 136.18 49.72 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.32 -0.862 . . . . 0.0 113.03 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.6 pt -73.12 150.63 90.05 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.883 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.39 131.62 39.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.532 2.155 . . . . 0.0 110.398 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.36 63.43 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.764 1.173 . . . . 0.0 114.51 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.33 150.24 44.35 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.59 1.695 . . . . 0.0 110.922 172.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.98 164.34 88.1 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 120.715 1.291 . . . . 0.0 113.317 -1.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.71 161.32 21.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.937 1.695 . . . . 0.0 111.322 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -157.86 148.99 21.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.391 1.077 . . . . 0.0 112.125 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -168.28 157.8 9.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.302 1.441 . . . . 0.0 111.885 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.4 t80 -95.04 128.69 42.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.056 -1.028 . . . . 0.0 112.685 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.4 t -93.13 135.13 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.501 1.52 . . . . 0.0 108.777 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.79 148.12 20.63 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.324 1.05 . . . . 0.0 112.717 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.34 144.47 51.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.105 1.362 . . . . 0.0 113.295 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.8 p -76.21 -28.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.208 1.003 . . . . 0.0 113.59 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -85.05 -19.48 31.87 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 73.1 m -67.27 149.16 50.76 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.325 1.05 . . . . 0.0 113.401 -173.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.53 -13.52 63.08 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.826 1.203 . . . . 0.0 114.831 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -64.23 153.39 38.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 118.713 1.257 . . . . 0.0 113.296 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.9 p -64.79 135.72 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.727 0.811 . . . . 0.0 110.001 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 9.6 t -154.64 157.27 37.91 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.729 1.212 . . . . 0.0 110.836 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.1 145.59 39.67 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.495 1.118 . . . . 0.0 111.975 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.5 p90 -165.91 165.16 18.35 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.91 1.684 . . . . 0.0 112.236 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.84 175.28 14.0 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.178 1.371 . . . . 0.0 113.123 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 -34.29 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.704 2.269 . . . . 0.0 113.057 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.65 -34.25 86.91 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.578 1.081 . . . . 0.0 114.444 -171.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.95 -4.67 48.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.797 1.299 . . . . 0.0 113.41 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.5 m -106.07 -47.74 3.77 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.446 1.898 . . . . 0.0 110.989 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -143.66 149.14 36.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.46 1.904 . . . . 0.0 112.341 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -145.43 178.27 23.29 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.451 1.024 . . . . 0.0 113.721 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 50.3 t -139.25 135.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 108.451 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.6 m -57.26 136.41 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.29 -0.72 2.07 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.168 2.187 . . . . 0.0 114.442 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -104.17 140.47 21.1 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.408 1.483 . . . . 0.0 110.881 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.54 120.19 6.57 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.613 2.209 . . . . 0.0 110.326 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.74 135.23 42.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.251 1.42 . . . . 0.0 110.155 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.6 p -129.41 147.24 51.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -165.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.46 175.8 13.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.628 1.571 . . . . 0.0 111.636 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.3 m -130.33 142.82 50.51 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.995 1.318 . . . . 0.0 110.839 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -113.04 132.82 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.862 1.665 . . . . 0.0 108.135 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.3 m120 -94.73 129.86 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.214 1.006 . . . . 0.0 110.393 173.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.7 p -132.92 2.29 3.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.42 1.488 . . . . 0.0 113.859 -166.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -50.22 -38.16 38.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.484 1.913 . . . . 0.0 115.346 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -128.88 20.47 5.96 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.439 1.496 . . . . 0.0 112.387 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.58 64.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.16 146.7 7.63 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.171 1.367 . . . . 0.0 113.039 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -75.88 148.06 38.58 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.423 1.089 . . . . 0.0 111.968 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.24 -30.1 0.17 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.692 1.139 . . . . 0.0 114.531 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.41 112.66 0.87 Allowed Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.511 1.529 . . . . 0.0 112.82 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.08 128.9 34.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.369 1.468 . . . . 0.0 109.209 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 37.2 m -126.95 156.04 42.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.996 1.718 . . . . 0.0 111.781 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.8 134.94 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.656 1.582 . . . . 0.0 109.103 -169.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.14 35.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.015 0.926 . . . . 0.0 112.275 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.24 139.31 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.874 1.27 . . . . 0.0 109.934 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.86 129.47 38.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.294 1.438 . . . . 0.0 110.095 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.52 -159.77 9.54 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.83 -0.984 . . . . 0.0 114.342 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.41 -23.08 71.56 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.101 3.201 . . . . 0.0 112.757 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.9 t -146.29 161.34 40.51 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.266 1.426 . . . . 0.0 109.542 163.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.74 113.63 8.02 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.002 -1.061 . . . . 0.0 111.078 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.15 147.9 49.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.73 0.812 . . . . 0.0 111.389 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.44 139.16 30.8 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.297 0.639 . . . . 0.0 109.532 168.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 28.7 mt -130.98 138.55 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.565 1.146 . . . . 0.0 110.325 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.5 m -129.79 152.65 49.05 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.737 1.615 . . . . 0.0 110.473 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -151.88 151.39 31.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.079 0.951 . . . . 0.0 112.332 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.5 m -140.9 116.44 10.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.205 1.402 . . . . 0.0 110.114 -169.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -72.26 135.63 46.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.161 0.985 . . . . 0.0 111.04 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -112.34 150.65 30.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.476 1.51 . . . . 0.0 111.863 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -72.75 -12.01 60.84 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.68 1.28 52.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.209 1.403 . . . . 0.0 114.553 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.53 30.9 8.68 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.523 1.059 . . . . 0.0 114.218 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 40.7 p -133.76 170.92 14.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.854 1.262 . . . . 0.0 111.703 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 53.5 t -130.57 130.85 44.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.496 1.919 . . . . 0.0 108.724 165.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.0 t -94.1 147.78 22.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.284 1.034 . . . . 0.0 110.935 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -126.97 143.57 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.81 1.644 . . . . 0.0 109.981 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -139.89 139.19 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.515 1.526 . . . . 0.0 110.603 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -144.91 151.74 39.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.7 mt -113.8 101.99 54.37 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.033 1.733 . . . . 0.0 110.288 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.46 164.8 23.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.442 2.762 . . . . 0.0 110.058 166.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.6 m -136.41 -22.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 92.1 mt -117.98 147.86 42.21 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.033 1.333 . . . . 0.0 110.234 170.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.96 155.39 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.656 2.238 . . . . 0.0 110.759 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.97 -165.65 23.41 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.684 1.135 . . . . 0.0 113.295 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.6 137.59 32.25 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.806 1.242 . . . . 0.0 112.973 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.74 124.8 40.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.797 1.639 . . . . 0.0 109.93 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -84.18 129.43 34.89 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.994 -1.066 . . . . 0.0 110.714 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.92 130.47 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.625 1.57 . . . . 0.0 108.127 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.8 tt -111.66 132.19 54.77 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.438 1.495 . . . . 0.0 109.613 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -134.46 128.12 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 172.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.5 141.09 23.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 111.433 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.09 121.75 15.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.43 1.092 . . . . 0.0 110.062 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.8 57.76 3.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.322 1.449 . . . . 0.0 111.496 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.1 pt-20 56.34 19.92 4.33 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.305 2.642 . . . . 0.0 116.172 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.48 128.65 37.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.719 1.207 . . . . 0.0 110.989 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.32 150.85 42.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.741 0.816 . . . . 0.0 112.237 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 7.9 m -67.12 154.19 93.13 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.039 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -52.68 -31.69 51.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.984 3.123 . . . . 0.0 116.29 -170.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.36 -4.6 59.53 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -84.33 143.29 41.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.153 1.477 . . . . 0.0 112.33 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.75 140.98 70.34 Favored 'Cis proline' 0 C--N 1.352 0.719 0 CA-C-N 119.106 0.717 . . . . 0.0 112.169 -4.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.35 172.86 8.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.193 1.797 . . . . 0.0 110.491 173.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.7 m -136.7 119.04 15.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.712 0.805 . . . . 0.0 110.567 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.91 158.57 16.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.214 1.406 . . . . 0.0 111.082 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -120.84 127.88 52.32 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.198 0.999 . . . . 0.0 110.287 169.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.8 t -107.17 132.74 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.759 -172.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 56.7 m -101.21 155.32 18.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.311 1.844 . . . . 0.0 111.612 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.55 138.35 23.05 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.709 1.147 . . . . 0.0 112.119 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 -82.65 -18.43 41.1 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 125.565 1.546 . . . . 0.0 113.773 178.82 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -63.39 -19.04 64.33 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -173.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -82.9 -13.37 56.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.796 1.238 . . . . 0.0 113.797 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -69.87 -48.58 21.72 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 117.218 -1.373 . . . . 0.0 114.602 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.86 154.64 43.35 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.525 2.15 . . . . 0.0 111.829 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.03 150.2 25.05 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.421 1.088 . . . . 0.0 111.539 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -156.89 135.88 7.94 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.933 1.293 . . . . 0.0 111.375 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.02 175.84 10.88 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.951 3.101 . . . . 0.0 112.069 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.73 10.79 1.0 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.791 1.636 . . . . 0.0 115.372 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 83.3 t -60.79 139.18 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.811 1.645 . . . . 0.0 110.732 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 112.69 -5.73 26.08 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.969 1.271 . . . . 0.0 114.884 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 16.3 m -61.68 142.64 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 118.647 1.224 . . . . 0.0 111.508 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 30.9 m120 -77.01 150.4 35.82 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.146 0.978 . . . . 0.0 113.257 -173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 76.39 -174.41 53.62 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.979 1.276 . . . . 0.0 114.257 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.36 147.81 45.2 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.88 1.672 . . . . 0.0 110.393 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 41.0 t0 -81.4 158.36 24.66 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.178 0.991 . . . . 0.0 112.368 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 16.0 m -144.04 144.85 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.244 1.818 . . . . 0.0 110.507 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 12.9 t -177.57 -33.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.769 2.027 . . . . 0.0 111.96 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 15.3 m -58.77 142.99 48.56 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.968 1.307 . . . . 0.0 114.196 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 1.7 mt -161.04 166.41 28.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.161 2.184 . . . . 0.0 109.159 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -59.86 116.63 17.83 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.446 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.31 154.81 32.36 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.736 2.291 . . . . 0.0 111.025 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.3 t80 -100.9 128.97 46.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.236 0.541 . . . . 0.0 110.411 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -156.25 148.28 23.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.819 1.648 . . . . 0.0 110.836 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.09 152.89 17.57 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.126 1.37 . . . . 0.0 110.632 -174.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.3 p -125.8 133.15 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.201 1.4 . . . . 0.0 109.483 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 73.7 mt -132.15 135.33 26.31 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.901 1.68 . . . . 0.0 109.163 -167.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.57 112.74 3.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.995 2.463 . . . . 0.0 109.868 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.0 t80 -177.2 150.28 0.72 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.175 2.19 . . . . 0.0 109.435 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.4 m -132.1 128.72 38.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.381 1.072 . . . . 0.0 109.77 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.23 118.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.811 0.844 . . . . 0.0 109.834 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.0 pttt -90.95 -146.13 0.19 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.772 1.629 . . . . 0.0 112.393 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -72.84 -12.62 61.05 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.09 -149.04 19.67 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.86 1.695 . . . . 0.0 113.032 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.94 156.17 44.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 111.345 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.52 138.28 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 111.381 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.7 p -149.19 163.73 36.79 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.114 1.766 . . . . 0.0 110.76 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.56 -174.43 15.83 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.72 136.87 14.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.256 1.823 . . . . 0.0 108.915 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.01 134.19 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.748 1.619 . . . . 0.0 107.94 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -118.61 130.68 56.01 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.187 0.995 . . . . 0.0 111.207 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -96.52 152.23 38.49 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.069 1.748 . . . . 0.0 111.665 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.31 -21.89 26.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.378 2.719 . . . . 0.0 113.014 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.5 p -80.51 2.18 26.42 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.712 1.605 . . . . 0.0 114.5 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.36 54.15 2.62 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.515 1.055 . . . . 0.0 113.233 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -156.4 166.97 31.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.052 1.741 . . . . 0.0 111.681 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.6 159.25 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.587 1.155 . . . . 0.0 113.068 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.04 -178.65 7.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.802 2.441 . . . . 0.0 109.757 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.55 145.5 53.35 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 120.612 -1.305 . . . . 0.0 112.562 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.64 173.4 6.28 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.551 3.501 . . . . 0.0 111.696 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.0 m -108.75 136.18 48.75 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.524 1.53 . . . . 0.0 108.835 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.08 134.44 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.092 1.357 . . . . 0.0 109.187 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -136.11 121.83 19.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.539 1.535 . . . . 0.0 109.743 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.14 128.0 33.64 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.601 0.76 . . . . 0.0 110.617 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.63 -7.56 59.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 39.5 tttm 74.36 -5.24 2.13 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.437 2.695 . . . . 0.0 113.723 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -94.57 1.41 55.64 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.944 2.098 . . . . 0.0 113.329 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.2 16.37 32.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.108 1.337 . . . . 0.0 114.379 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.08 155.27 45.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.041 1.737 . . . . 0.0 110.608 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -113.6 135.95 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.98 0.912 . . . . 0.0 109.979 165.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.5 m -92.06 138.08 31.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.445 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.6 t -127.34 136.03 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.201 1.4 . . . . 0.0 109.026 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -141.58 155.02 45.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.811 1.244 . . . . 0.0 112.692 -174.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 31.6 t80 -154.41 133.17 12.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.522 1.529 . . . . 0.0 111.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -81.88 127.55 71.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.408 1.083 . . . . 0.0 111.214 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.09 175.03 10.79 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.835 3.024 . . . . 0.0 112.231 -173.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 19.0 t -162.89 -38.09 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.16 0.984 . . . . 0.0 113.227 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -135.0 150.78 50.39 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.828 1.651 . . . . 0.0 110.331 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -85.64 172.28 11.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 0.0 113.524 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.99 -170.49 13.34 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 126.121 1.819 . . . . 0.0 113.72 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.4 tp -81.32 131.02 35.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 110.43 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 59.5 m80 -128.69 163.5 24.97 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.065 1.746 . . . . 0.0 111.101 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -142.43 157.54 44.66 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.162 0.985 . . . . 0.0 111.266 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 67.0 ttp -141.16 123.87 16.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.388 1.075 . . . . 0.0 111.845 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -85.91 139.75 30.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.335 1.854 . . . . 0.0 110.373 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.17 128.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.295 1.438 . . . . 0.0 108.199 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 138.05 30.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -104.03 123.91 48.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.914 2.086 . . . . 0.0 110.336 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.91 34.34 13.38 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.47 1.108 . . . . 0.0 112.586 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 36.2 t30 78.66 2.3 2.56 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 128.519 2.727 . . . . 0.0 114.942 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.5 129.81 54.39 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.723 1.609 . . . . 0.0 111.035 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.06 139.09 35.91 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.85 147.43 97.86 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.925 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.62 120.25 7.59 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.532 2.155 . . . . 0.0 111.722 -165.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -8.96 72.37 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.338 1.447 . . . . 0.0 115.157 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 12.8 m -74.58 157.79 85.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 120.047 1.923 . . . . 0.0 112.359 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.87 161.48 91.45 Favored 'Cis proline' 0 C--N 1.355 0.881 0 CA-C-N 119.844 0.98 . . . . 0.0 113.999 5.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.47 162.11 13.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.885 1.674 . . . . 0.0 110.905 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -142.3 138.98 31.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.729 1.211 . . . . 0.0 110.503 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.47 167.74 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.751 1.221 . . . . 0.0 112.146 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 18.5 t80 -110.29 141.57 43.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.996 0.918 . . . . 0.0 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.4 t -112.04 138.08 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.946 1.698 . . . . 0.0 108.469 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t0 -156.4 151.62 26.51 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -75.61 95.89 3.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.283 1.433 . . . . 0.0 111.522 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 16.3 m -58.47 -23.1 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.293 1.437 . . . . 0.0 114.447 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.69 -13.68 44.74 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 97.9 m -75.92 156.67 34.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.211 1.004 . . . . 0.0 113.25 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.19 77.82 2.06 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.227 1.394 . . . . 0.0 112.35 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -163.9 154.71 15.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.099 1.759 . . . . 0.0 112.356 173.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.7 p -73.35 135.3 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.283 1.033 . . . . 0.0 110.434 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 5.9 t -152.78 171.37 18.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.572 1.149 . . . . 0.0 111.682 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -153.68 150.39 28.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.531 1.133 . . . . 0.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.68 164.81 6.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.052 1.741 . . . . 0.0 112.93 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.55 173.16 12.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.34 1.448 . . . . 0.0 113.167 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.55 -34.75 18.99 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.082 2.521 . . . . 0.0 112.762 -172.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.18 -33.5 85.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.895 0.77 . . . . 0.0 114.373 -172.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.22 0.13 38.03 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.744 1.272 . . . . 0.0 113.878 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.7 m -107.04 -38.85 5.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.414 1.886 . . . . 0.0 111.536 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -157.76 146.58 19.43 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.127 1.371 . . . . 0.0 112.993 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 -173.89 21.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.874 1.702 . . . . 0.0 112.852 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.7 p -150.89 138.61 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.981 1.312 . . . . 0.0 109.245 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.9 m -57.64 141.36 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 27.5 m120 69.53 -5.29 1.19 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.131 2.173 . . . . 0.0 114.728 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -102.18 144.29 28.3 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.338 1.455 . . . . 0.0 111.045 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.24 130.56 15.37 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.566 2.178 . . . . 0.0 110.625 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.91 147.05 32.78 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.548 . . . . 0.0 110.437 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.7 p -136.84 147.3 46.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -160.03 176.05 12.28 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.291 1.836 . . . . 0.0 110.936 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 82.8 m -134.01 136.75 44.28 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.152 0.981 . . . . 0.0 111.097 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 20.5 t -98.08 132.22 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.55 . . . . 0.0 107.752 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -98.66 116.74 31.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 109.753 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -121.3 8.69 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.685 1.994 . . . . 0.0 113.007 -166.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -52.75 -38.35 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.73 1.612 . . . . 0.0 113.786 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -92.39 -12.47 32.15 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.109 1.364 . . . . 0.0 113.637 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.23 68.32 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.168 0.987 . . . . 0.0 112.975 -172.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 76.76 -76.26 1.59 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.229 1.395 . . . . 0.0 113.848 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -163.46 150.15 12.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.395 1.878 . . . . 0.0 110.078 -171.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 133.39 -2.48 4.61 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.965 1.269 . . . . 0.0 115.085 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 99.81 117.66 4.04 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.73 1.634 . . . . 0.0 113.48 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 129.22 34.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.809 1.644 . . . . 0.0 109.247 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -121.4 153.05 38.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.411 1.485 . . . . 0.0 111.575 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.9 tp -159.83 134.8 7.96 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.356 1.462 . . . . 0.0 109.464 -170.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.29 161.3 37.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.338 1.055 . . . . 0.0 112.08 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.6 mt -137.4 132.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.622 1.169 . . . . 0.0 109.433 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -121.72 112.66 18.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.238 1.415 . . . . 0.0 109.684 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.26 12.92 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.23 -22.12 54.03 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.936 . . . . 0.0 111.998 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.4 t -135.29 157.86 45.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.237 1.415 . . . . 0.0 109.132 157.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -75.62 119.28 19.45 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.914 -1.116 . . . . 0.0 111.38 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.07 148.79 43.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.232 1.013 . . . . 0.0 111.7 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.67 139.91 32.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.235 0.614 . . . . 0.0 109.587 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.35 143.35 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.443 1.097 . . . . 0.0 110.362 -168.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.0 t -143.43 160.78 39.94 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.031 1.332 . . . . 0.0 110.846 167.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -157.42 155.28 30.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.334 1.054 . . . . 0.0 112.979 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -138.65 117.01 11.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.6 1.56 . . . . 0.0 110.198 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -74.83 136.37 41.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.077 1.351 . . . . 0.0 111.471 172.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -117.47 146.83 43.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.539 1.536 . . . . 0.0 112.016 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -68.16 -13.22 62.06 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.09 -5.1 45.01 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.652 1.581 . . . . 0.0 113.982 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.32 30.11 8.97 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.754 1.169 . . . . 0.0 113.858 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.2 p -137.44 165.0 27.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.299 1.44 . . . . 0.0 111.484 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -127.68 122.57 33.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.663 1.585 . . . . 0.0 108.796 164.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -87.51 145.87 26.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.959 0.903 . . . . 0.0 110.592 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.4 t -125.85 141.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.578 1.551 . . . . 0.0 110.321 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 67.3 m -130.96 140.71 50.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.884 1.673 . . . . 0.0 110.632 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -146.24 151.73 38.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.72 105.62 40.68 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.686 1.994 . . . . 0.0 110.494 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -86.62 160.3 9.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.043 3.162 . . . . 0.0 110.7 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -119.98 -21.82 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -169.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.52 149.32 36.83 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.857 1.263 . . . . 0.0 110.587 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.97 153.64 37.42 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.88 2.387 . . . . 0.0 112.432 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.67 -167.72 27.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.095 1.331 . . . . 0.0 113.393 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -91.08 128.56 36.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.013 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -118.77 127.35 53.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.678 1.591 . . . . 0.0 109.805 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.11 121.31 30.37 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.86 0.864 . . . . 0.0 110.448 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.27 127.21 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.19 1.396 . . . . 0.0 108.111 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.91 130.37 55.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.278 1.431 . . . . 0.0 109.5 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.1 t -132.99 129.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.276 1.03 . . . . 0.0 109.457 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 147.51 26.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 111.418 -166.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 2.2 t80 -140.9 126.14 18.55 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.794 1.238 . . . . 0.0 110.279 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.1 t-20 45.07 58.9 3.76 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.117 1.367 . . . . 0.0 113.245 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.311 7.9 pt-20 60.02 13.8 3.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.107 2.563 . . . . 0.0 116.596 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -125.65 128.46 47.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.48 1.112 . . . . 0.0 111.352 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.84 151.55 45.19 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.055 -1.028 . . . . 0.0 112.716 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 29.1 m -65.48 152.05 93.12 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.65 163.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.37 -20.04 66.03 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.476 2.117 . . . . 0.0 114.84 -167.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -94.46 -6.58 61.05 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -86.64 143.83 36.49 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 119.049 1.424 . . . . 0.0 112.33 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.74 141.29 71.33 Favored 'Cis proline' 0 C--N 1.354 0.819 0 CA-C-N 119.117 0.72 . . . . 0.0 112.064 -4.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -92.68 166.8 12.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.966 1.706 . . . . 0.0 110.041 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.7 m -131.75 119.71 21.68 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.536 0.734 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -103.16 137.53 41.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.949 1.3 . . . . 0.0 111.737 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -86.05 117.29 24.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.5 t -92.42 130.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.101 0.96 . . . . 0.0 109.207 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.1 m -105.13 159.92 15.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.756 1.623 . . . . 0.0 110.644 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.9 138.22 23.38 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.119 0.866 . . . . 0.0 111.969 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -89.39 -18.65 26.42 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.221 1.408 . . . . 0.0 113.584 -174.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 126.61 1.964 . . . . 0.0 112.703 -175.657 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.541 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.16 155.68 39.39 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.268 1.027 . . . . 0.0 112.758 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.7 mmm -85.43 -12.38 52.13 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.505 1.122 . . . . 0.0 113.913 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -68.89 144.72 96.13 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 124.345 1.058 . . . . 0.0 112.637 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.29 163.13 32.95 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.76 2.973 . . . . 0.0 111.96 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -156.65 144.4 19.28 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.423 1.489 . . . . 0.0 110.139 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -135.72 145.27 52.38 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.502 1.521 . . . . 0.0 110.235 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.24 146.0 27.93 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.354 2.703 . . . . 0.0 111.639 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 29.0 tp -83.0 65.46 8.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.792 1.237 . . . . 0.0 110.974 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 7.2 p -160.26 148.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.632 1.573 . . . . 0.0 111.138 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -144.7 -174.36 16.89 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.495 1.521 . . . . 0.0 113.32 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 99.7 t -62.23 134.69 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.505 1.122 . . . . 0.0 110.365 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 8.7 p30 -156.81 162.38 39.72 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.104 1.362 . . . . 0.0 112.551 -174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -172.75 -174.72 40.15 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.981 1.277 . . . . 0.0 113.835 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.96 150.44 39.04 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.643 1.177 . . . . 0.0 111.998 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.01 -24.94 59.65 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.356 1.062 . . . . 0.0 112.895 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.1 p -159.46 145.48 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.989 2.116 . . . . 0.0 109.407 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 12.3 t -169.2 -34.63 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.994 1.718 . . . . 0.0 111.902 -175.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 31.6 m -64.53 103.9 0.73 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.568 1.147 . . . . 0.0 111.841 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 30.0 tp -112.86 128.53 56.48 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.617 1.567 . . . . 0.0 109.745 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -60.27 118.27 31.84 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.119 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.42 159.5 46.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.277 2.651 . . . . 0.0 111.318 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.01 123.23 36.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.429 0.692 . . . . 0.0 109.225 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.17 130.46 16.57 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.331 1.453 . . . . 0.0 109.956 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.39 141.53 27.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.266 1.426 . . . . 0.0 109.931 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -118.79 137.76 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.96 137.49 25.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.331 1.853 . . . . 0.0 108.738 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.48 37.99 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.386 3.39 . . . . 0.0 113.526 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.38 161.32 17.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.54 1.536 . . . . 0.0 110.499 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 87.6 m -133.42 130.2 38.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.019 1.327 . . . . 0.0 109.688 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 115.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.362 1.065 . . . . 0.0 110.304 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -92.94 -163.27 1.02 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.218 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.0 pttp -71.91 132.52 44.47 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.806 -1.184 . . . . 0.0 112.052 169.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.53 -141.7 12.29 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.319 1.438 . . . . 0.0 111.631 -167.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.31 143.74 18.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.853 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.6 tt -134.68 136.48 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.292 1.837 . . . . 0.0 110.367 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 33.4 p -145.6 165.27 29.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.603 1.561 . . . . 0.0 110.849 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.65 176.46 29.22 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -151.94 138.17 18.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.128 1.771 . . . . 0.0 109.644 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.2 t -111.79 134.46 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.241 1.816 . . . . 0.0 108.651 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -113.7 123.16 49.23 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.862 1.665 . . . . 0.0 110.209 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.8 mtm -98.05 146.64 31.84 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.703 1.601 . . . . 0.0 111.466 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.28 -16.21 28.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.799 2.999 . . . . 0.0 113.144 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.7 p -74.42 0.28 15.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.806 1.642 . . . . 0.0 114.197 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.39 42.38 5.53 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.722 1.153 . . . . 0.0 113.538 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -152.66 169.26 23.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.392 1.477 . . . . 0.0 112.525 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.0 m -139.22 159.25 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.899 1.28 . . . . 0.0 112.848 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.8 171.26 19.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.078 2.151 . . . . 0.0 110.257 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -110.55 142.36 25.92 Favored Pre-proline 0 CA--C 1.547 0.831 0 O-C-N 121.103 -0.998 . . . . 0.0 112.344 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.22 175.87 3.91 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.57 3.513 . . . . 0.0 112.385 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.1 m -108.02 130.24 55.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.444 1.498 . . . . 0.0 108.963 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.84 131.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.149 1.379 . . . . 0.0 108.676 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.4 m -132.94 130.36 39.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.373 1.469 . . . . 0.0 110.05 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -82.45 126.46 32.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.164 0.586 . . . . 0.0 110.106 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -80.59 -7.6 59.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.2 mttp 71.77 7.4 5.9 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.592 2.357 . . . . 0.0 113.606 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.07 7.59 23.62 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.345 2.258 . . . . 0.0 112.597 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 19.35 35.55 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.974 1.274 . . . . 0.0 114.317 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.8 p -134.23 158.19 44.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.105 1.762 . . . . 0.0 110.267 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 27.2 m -116.13 148.1 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.568 1.147 . . . . 0.0 110.13 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 50.6 m -113.99 136.48 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 41.7 t -119.91 134.8 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.202 1.401 . . . . 0.0 108.925 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.21 154.96 50.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.896 1.279 . . . . 0.0 113.16 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.5 t80 -153.77 136.89 15.57 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.565 1.546 . . . . 0.0 111.927 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.2 117.26 67.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.023 1.329 . . . . 0.0 110.804 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.36 156.02 16.69 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.96 3.106 . . . . 0.0 112.656 -172.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.4 m -118.29 -18.39 9.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -163.66 155.12 16.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.665 1.586 . . . . 0.0 110.572 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -69.07 168.49 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.576 1.15 . . . . 0.0 113.531 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.06 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.598 1.571 . . . . 0.0 114.138 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.5 tp -79.09 129.61 34.64 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.744 1.218 . . . . 0.0 110.677 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.8 m80 -130.27 162.0 29.96 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.587 1.555 . . . . 0.0 111.373 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.71 156.15 41.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 111.786 172.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -138.92 126.85 22.31 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.112 1.765 . . . . 0.0 109.956 -168.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.46 122.4 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.335 1.454 . . . . 0.0 109.389 175.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 42.8 mm -120.89 135.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.129 1.372 . . . . 0.0 109.805 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.78 137.72 20.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.6 t80 -99.3 123.27 43.45 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.823 2.049 . . . . 0.0 109.857 175.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.15 33.42 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.785 1.234 . . . . 0.0 112.729 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 22.6 t30 75.77 5.94 3.89 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 128.123 2.569 . . . . 0.0 115.109 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.36 131.62 51.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.806 1.643 . . . . 0.0 110.884 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m170 -56.8 134.09 54.83 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.057 -1.027 . . . . 0.0 113.213 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.33 155.86 89.49 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.402 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.85 125.87 19.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.367 2.045 . . . . 0.0 109.761 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.69 53.54 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.725 1.155 . . . . 0.0 114.344 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.7 t -84.6 148.06 50.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.054 1.427 . . . . 0.0 111.919 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.38 159.99 94.35 Favored 'Cis proline' 0 C--N 1.352 0.72 0 CA-C-N 119.936 1.013 . . . . 0.0 112.062 -7.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.36 152.19 20.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.401 1.48 . . . . 0.0 110.523 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -151.43 134.41 15.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.469 1.108 . . . . 0.0 110.259 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.91 165.05 18.43 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.373 1.069 . . . . 0.0 112.504 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 44.2 t80 -103.19 139.76 38.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.168 0.987 . . . . 0.0 112.154 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 78.1 t -105.34 140.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.195 1.798 . . . . 0.0 109.24 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.4 t0 -156.41 149.12 23.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.087 1.355 . . . . 0.0 111.455 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.99 147.18 51.99 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.462 -0.774 . . . . 0.0 112.44 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 95.0 t -72.0 -29.04 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.071 0.948 . . . . 0.0 111.383 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -80.73 -7.7 59.44 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.6 m -58.52 137.44 57.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.481 1.113 . . . . 0.0 113.386 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.2 -19.87 40.8 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.951 1.263 . . . . 0.0 114.086 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.68 158.91 31.15 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.267 1.033 . . . . 0.0 113.457 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.9 p -62.49 138.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 110.176 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.0 t -159.67 156.68 28.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.17 1.388 . . . . 0.0 110.653 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.25 145.7 47.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.581 1.152 . . . . 0.0 112.65 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.3 p90 -168.17 157.1 9.18 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.881 1.673 . . . . 0.0 113.233 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 147.62 173.65 18.86 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.092 1.329 . . . . 0.0 113.985 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.82 -38.84 12.61 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.27 2.647 . . . . 0.0 112.468 -173.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.19 -18.46 74.91 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.017 0.826 . . . . 0.0 114.099 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 15.7 tp -82.25 -11.21 58.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.562 1.145 . . . . 0.0 112.55 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.1 m -116.59 -40.06 3.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.415 1.886 . . . . 0.0 111.776 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -136.25 169.84 16.99 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.956 2.502 . . . . 0.0 111.489 -172.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -168.29 173.2 43.06 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 121.046 -1.034 . . . . 0.0 113.215 164.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 64.7 t -136.9 130.65 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.728 1.211 . . . . 0.0 108.622 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.7 m -57.16 142.61 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.0 m-80 67.12 2.07 2.62 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.804 2.042 . . . . 0.0 114.606 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 93.7 mttt -118.79 141.6 30.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.791 1.636 . . . . 0.0 111.017 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.95 136.63 30.29 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.659 2.24 . . . . 0.0 110.853 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.74 146.48 42.77 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.1 p -135.58 150.37 49.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.124 0.97 . . . . 0.0 113.462 -164.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1886 ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' 1922 ' ' VAL . 52.5 p90 -160.69 176.9 11.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.672 1.589 . . . . 0.0 111.661 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 39.7 m -130.19 143.89 51.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.232 1.413 . . . . 0.0 110.552 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.8 t -116.81 126.16 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 108.088 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.01 126.7 34.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.106 0.962 . . . . 0.0 110.696 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.3 p -134.32 4.49 3.44 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.092 1.357 . . . . 0.0 113.769 -167.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.2 tttp -54.96 -36.52 65.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.791 1.636 . . . . 0.0 114.789 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.19 14.17 10.49 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.815 1.646 . . . . 0.0 112.516 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -78.66 -11.53 59.98 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.93 -130.86 10.06 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.514 1.054 . . . . 0.0 112.267 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -160.95 161.55 31.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.037 1.735 . . . . 0.0 110.238 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 147.38 -14.28 1.43 Allowed Glycine 0 N--CA 1.475 1.29 0 C-N-CA 125.104 1.335 . . . . 0.0 115.284 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.45 105.73 0.92 Allowed Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.836 1.684 . . . . 0.0 112.482 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.02 125.98 32.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.11 1.364 . . . . 0.0 108.874 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.9 m -124.13 159.69 29.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.879 1.671 . . . . 0.0 112.118 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.7 tp -159.07 137.4 10.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.794 1.637 . . . . 0.0 109.404 -170.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.81 156.37 34.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.372 1.069 . . . . 0.0 111.935 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.75 135.52 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.534 1.134 . . . . 0.0 109.795 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.12 127.67 43.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.419 1.488 . . . . 0.0 109.787 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -153.15 -165.12 13.12 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.132 -0.816 . . . . 0.0 114.499 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.09 -24.15 66.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.087 3.191 . . . . 0.0 112.664 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.7 t -140.27 153.25 46.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.007 1.323 . . . . 0.0 109.739 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -72.56 117.17 13.91 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.167 -0.958 . . . . 0.0 111.049 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.81 153.16 37.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.481 1.112 . . . . 0.0 112.133 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.27 141.65 28.51 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 161.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.5 mt -138.37 138.54 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.758 1.223 . . . . 0.0 110.011 -163.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 65.1 m -137.98 158.1 45.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.515 1.526 . . . . 0.0 111.147 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.1 p -154.33 155.03 34.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 75.6 m -143.67 122.69 12.82 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.179 1.392 . . . . 0.0 110.66 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.94 113.61 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 165.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 27.6 p30 -83.53 -7.46 59.52 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 71.5 0.36 3.44 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -88.22 -11.09 47.66 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.326 1.45 . . . . 0.0 113.137 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 132.79 1.74 4.07 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.452 1.501 . . . . 0.0 115.661 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 64.4 p -137.27 156.66 48.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.231 1.516 . . . . 0.0 112.143 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 79.7 m -104.21 128.14 51.9 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.344 1.458 . . . . 0.0 109.115 165.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.8 t -91.48 151.89 20.59 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.126 0.97 . . . . 0.0 110.763 172.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1922 ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' 1886 ' ' PHE . 84.1 t -132.33 144.54 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.765 1.626 . . . . 0.0 110.041 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 76.0 p -140.98 148.08 39.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.809 1.243 . . . . 0.0 112.236 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.9 p90 -152.51 156.72 39.95 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.16 -0.963 . . . . 0.0 113.212 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.15 106.18 43.53 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.117 1.367 . . . . 0.0 110.871 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -82.6 174.45 9.67 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.976 3.117 . . . . 0.0 110.884 168.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -150.24 -30.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.1 mt -105.99 146.96 33.93 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.502 1.046 . . . . 0.0 110.393 166.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.22 157.37 41.89 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.874 2.383 . . . . 0.0 110.946 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.85 -162.39 24.18 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.778 1.18 . . . . 0.0 113.621 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.49 125.92 35.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.187 1.395 . . . . 0.0 112.303 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -113.84 126.38 55.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.374 1.47 . . . . 0.0 109.203 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.2 m -89.45 127.7 35.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.147 0.979 . . . . 0.0 110.734 175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.9 128.11 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.841 1.257 . . . . 0.0 108.943 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.71 129.93 53.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.661 1.584 . . . . 0.0 109.361 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.0 t -130.19 132.44 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.536 1.134 . . . . 0.0 109.221 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.95 140.7 20.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.326 1.45 . . . . 0.0 111.357 -168.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 117.8 15.32 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.441 1.096 . . . . 0.0 110.017 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 50.7 t-20 56.61 63.6 1.91 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.686 1.594 . . . . 0.0 111.774 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.281 9.2 pt-20 55.63 18.68 2.91 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.234 2.613 . . . . 0.0 116.423 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -132.81 129.04 38.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.782 1.233 . . . . 0.0 110.922 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.4 m170 -64.17 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.917 0.887 . . . . 0.0 112.354 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.7 m -70.87 152.81 95.02 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.437 169.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.28 133.62 41.41 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.643 2.228 . . . . 0.0 111.224 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.58 63.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.899 1.237 . . . . 0.0 114.928 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.3 t -81.08 144.33 54.47 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.009 1.405 . . . . 0.0 111.68 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.43 140.34 64.32 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.014 1.041 . . . . 0.0 112.682 -1.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -95.05 175.81 6.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.595 1.958 . . . . 0.0 110.958 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -135.26 127.01 29.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.103 0.961 . . . . 0.0 110.687 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -106.69 140.55 39.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.684 . . . . 0.0 110.981 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.16 108.46 21.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.115 0.966 . . . . 0.0 110.178 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 87.8 t -90.84 143.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.917 1.287 . . . . 0.0 110.135 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.5 t -131.1 172.26 12.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.487 1.115 . . . . 0.0 112.767 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.42 142.8 26.39 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.746 1.641 . . . . 0.0 112.739 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.0 t70 -88.84 -17.67 29.23 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.435 1.094 . . . . 0.0 113.198 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.017 1.727 . . . . 0.0 114.386 -179.553 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 55.91 -117.9 1.17 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.404 1.481 . . . . 0.0 111.566 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -79.79 -15.76 56.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.625 1.17 . . . . 0.0 113.88 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -81.14 153.21 71.88 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.167 0.987 . . . . 0.0 111.896 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.95 -10.6 23.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.665 2.91 . . . . 0.0 113.983 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.41 78.48 3.93 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.71 1.204 . . . . 0.0 110.703 176.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -78.35 135.74 61.18 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.088 1.355 . . . . 0.0 111.026 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.37 162.68 14.03 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.757 2.971 . . . . 0.0 113.056 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 84.1 mt -79.68 54.22 1.76 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.317 1.447 . . . . 0.0 112.743 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 32.7 m -76.55 -6.54 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.432 1.493 . . . . 0.0 114.35 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 89.16 -164.16 32.05 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.797 1.189 . . . . 0.0 113.432 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 20.6 m -145.19 156.87 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.667 1.587 . . . . 0.0 111.169 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 9.0 p30 -162.16 157.91 23.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.7 1.6 . . . . 0.0 112.439 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -89.96 -162.65 38.53 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.371 1.462 . . . . 0.0 114.204 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.04 157.45 36.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.778 1.231 . . . . 0.0 112.174 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 45.1 t0 -100.55 162.76 12.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.202 1.401 . . . . 0.0 111.165 175.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 34.0 m -59.82 -23.49 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.7 t -75.64 -18.05 59.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.451 1.5 . . . . 0.0 113.459 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 49.6 m -67.12 128.15 35.3 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.174 -0.954 . . . . 0.0 113.196 -172.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 76.3 mt -89.04 159.57 17.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.868 1.667 . . . . 0.0 111.038 171.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 121.64 68.6 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.852 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.27 156.18 51.04 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.144 2.563 . . . . 0.0 111.002 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.4 t80 -116.05 122.13 44.28 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.389 0.676 . . . . 0.0 110.966 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -148.69 151.87 35.67 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.743 1.617 . . . . 0.0 110.618 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 151.84 24.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.575 1.55 . . . . 0.0 109.949 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -125.95 133.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.927 1.291 . . . . 0.0 109.43 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.81 137.17 30.19 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.037 1.735 . . . . 0.0 108.673 -171.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.94 49.48 3.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.658 3.572 . . . . 0.0 112.827 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.3 t80 -93.91 153.0 18.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.463 1.505 . . . . 0.0 110.625 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 127.31 47.19 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.92 1.288 . . . . 0.0 110.217 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.6 mt -92.61 136.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.042 1.337 . . . . 0.0 109.203 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.9 tptt -129.04 -60.22 1.09 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.151 0.98 . . . . 0.0 112.49 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -159.15 131.06 6.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.316 1.846 . . . . 0.0 110.388 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.65 -146.82 16.54 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.292 1.425 . . . . 0.0 111.384 -166.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -157.7 144.84 18.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.577 1.151 . . . . 0.0 110.914 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.85 136.15 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.57 1.548 . . . . 0.0 110.864 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.8 p -148.0 174.4 11.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.165 1.786 . . . . 0.0 110.525 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.64 -171.31 27.53 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.83 146.07 23.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.571 1.949 . . . . 0.0 109.603 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 21.5 t -123.25 138.43 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.331 1.852 . . . . 0.0 108.351 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 68.7 mtm-85 -127.61 142.19 51.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.897 0.879 . . . . 0.0 112.037 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 5.3 mpp? -118.6 148.66 44.68 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.596 1.558 . . . . 0.0 111.936 -173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.01 -29.57 89.6 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.121 3.214 . . . . 0.0 114.886 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 12.5 m -72.93 3.32 5.44 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.88 42.14 6.47 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.556 1.074 . . . . 0.0 112.833 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -148.16 158.26 43.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.842 1.657 . . . . 0.0 111.854 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.9 m -143.21 162.52 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.108 1.363 . . . . 0.0 112.035 -171.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.58 -179.44 8.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.706 2.003 . . . . 0.0 110.923 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -128.96 147.73 65.99 Favored Pre-proline 0 CA--C 1.544 0.74 0 O-C-N 121.185 -0.947 . . . . 0.0 111.601 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -86.94 173.89 5.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.229 3.286 . . . . 0.0 112.191 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.0 m -110.39 135.47 51.05 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.458 1.503 . . . . 0.0 108.75 170.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.6 131.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.954 1.302 . . . . 0.0 108.693 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 89.4 m -132.66 126.85 33.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.475 1.51 . . . . 0.0 109.306 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.8 136.11 40.24 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.021 0.528 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -88.21 -12.69 43.06 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 56.7 tttt 70.63 6.07 5.67 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.219 2.208 . . . . 0.0 113.708 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -105.87 11.15 32.14 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.208 2.203 . . . . 0.0 112.751 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.78 16.15 52.56 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.889 1.233 . . . . 0.0 113.964 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 40.1 p -134.41 158.93 42.61 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 110.622 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.0 m -122.87 143.47 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.794 1.238 . . . . 0.0 110.084 168.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 35.0 m -98.47 138.09 36.2 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.351 1.46 . . . . 0.0 108.831 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 46.1 t -125.13 134.97 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.741 1.617 . . . . 0.0 108.824 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -140.8 156.58 46.12 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.894 1.277 . . . . 0.0 112.594 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 23.2 t80 -153.77 133.11 12.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.732 1.613 . . . . 0.0 111.216 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.19 119.83 73.78 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.4 1.08 . . . . 0.0 110.493 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.67 134.64 15.31 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.238 2.625 . . . . 0.0 111.691 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.2 m -131.73 8.06 4.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.558 1.143 . . . . 0.0 113.12 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -160.18 155.84 25.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.047 1.739 . . . . 0.0 109.912 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.63 175.95 6.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.315 1.046 . . . . 0.0 112.563 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 98.14 -170.4 24.79 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.297 1.427 . . . . 0.0 114.199 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 44.8 tp -76.87 121.85 24.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.924 1.289 . . . . 0.0 110.243 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 12.8 m80 -111.96 164.35 13.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.78 1.632 . . . . 0.0 110.863 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.56 149.79 35.22 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.669 -0.645 . . . . 0.0 111.954 162.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 42.4 ttm -121.36 139.82 52.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.614 1.966 . . . . 0.0 110.121 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.73 134.55 52.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.318 1.447 . . . . 0.0 109.808 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.39 136.42 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.811 1.644 . . . . 0.0 109.433 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 141.07 28.36 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.094 0.958 . . . . 0.0 113.53 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.4 t80 -107.3 122.5 46.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.389 2.276 . . . . 0.0 109.65 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 31.71 10.12 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.56 1.144 . . . . 0.0 112.432 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.0 t30 76.05 5.17 3.79 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.333 2.653 . . . . 0.0 115.071 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.6 mtm -102.44 132.27 48.57 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.526 1.531 . . . . 0.0 110.83 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 12.0 m170 -57.37 136.67 56.61 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 113.142 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 25.5 pt -77.45 153.06 81.52 Favored Pre-proline 0 N--CA 1.48 1.03 0 O-C-N 121.76 -0.588 . . . . 0.0 111.294 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.28 134.15 50.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.158 1.906 . . . . 0.0 109.671 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.4 -13.69 64.14 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.343 0.973 . . . . 0.0 113.973 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.15 146.7 31.77 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 119.11 1.455 . . . . 0.0 111.179 173.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.23 160.67 95.4 Favored 'Cis proline' 0 C--N 1.353 0.802 0 CA-C-N 120.688 1.282 . . . . 0.0 113.455 2.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 75.8 mt -112.06 133.68 54.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.786 2.034 . . . . 0.0 109.054 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -130.16 134.4 47.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.261 1.024 . . . . 0.0 110.575 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -163.12 162.67 25.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.05 0.94 . . . . 0.0 112.817 -175.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.6 t80 -106.57 144.58 33.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.267 1.027 . . . . 0.0 112.88 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 56.2 t -118.95 138.23 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.34 1.456 . . . . 0.0 110.124 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -155.54 147.95 23.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.361 1.064 . . . . 0.0 112.766 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -63.17 142.63 58.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.34 1.456 . . . . 0.0 112.94 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.7 p -67.27 -23.97 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.5 p30 -75.42 -17.06 60.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.7 m -68.21 143.35 55.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.919 0.888 . . . . 0.0 113.357 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -89.99 -17.14 54.73 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.865 1.221 . . . . 0.0 114.36 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -67.25 163.88 19.52 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.466 1.133 . . . . 0.0 113.283 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 4.5 t -66.53 136.94 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.535 1.134 . . . . 0.0 109.52 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 56.7 p -132.65 162.16 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.456 1.102 . . . . 0.0 110.682 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.55 142.21 28.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.358 1.063 . . . . 0.0 110.969 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.9 p90 -166.01 159.94 16.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.616 1.566 . . . . 0.0 112.362 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.74 170.84 12.69 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.329 1.443 . . . . 0.0 113.159 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.05 -32.77 33.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.29 2.66 . . . . 0.0 112.849 -171.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.75 -13.93 72.31 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.936 -0.924 . . . . 0.0 114.791 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.99 -12.64 60.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.128 1.464 . . . . 0.0 112.966 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 15.5 m -119.38 -38.42 3.02 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.684 1.593 . . . . 0.0 112.431 -165.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -156.11 155.03 31.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.61 -173.75 25.5 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.469 1.033 . . . . 0.0 113.033 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.9 p -150.74 136.45 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.647 1.179 . . . . 0.0 109.286 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.7 m -56.57 140.82 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.59 -4.45 1.65 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.396 2.278 . . . . 0.0 114.924 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.65 143.31 26.43 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.965 1.306 . . . . 0.0 110.867 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.54 127.59 11.89 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.461 2.107 . . . . 0.0 110.723 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.48 148.7 26.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.431 1.492 . . . . 0.0 110.361 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.6 p -137.25 155.07 49.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.1 0.96 . . . . 0.0 113.507 -167.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1886 ' ' PHE . . . . . 0.424 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.3 p90 -164.48 172.84 12.8 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.562 1.945 . . . . 0.0 111.404 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.1 m -128.01 144.23 51.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.691 1.596 . . . . 0.0 110.731 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 46.9 t -120.11 130.52 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.123 1.769 . . . . 0.0 108.454 171.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m120 -87.37 127.82 35.2 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.372 -0.83 . . . . 0.0 111.162 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 50.9 p -131.49 3.35 4.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.352 1.461 . . . . 0.0 113.36 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -55.93 -40.03 72.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.781 1.632 . . . . 0.0 114.328 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.34 4.64 22.8 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.523 1.529 . . . . 0.0 112.896 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.05 -25.92 59.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.349 1.06 . . . . 0.0 113.329 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 -92.47 1.46 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.766 1.174 . . . . 0.0 112.664 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -166.6 179.03 5.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.013 1.725 . . . . 0.0 111.863 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 116.52 5.76 15.96 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.998 1.285 . . . . 0.0 115.477 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.99 105.6 2.16 Favored Glycine 0 N--CA 1.47 0.961 0 C-N-CA 125.503 1.525 . . . . 0.0 113.079 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.23 132.1 34.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 109.179 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -128.26 161.02 30.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.69 1.596 . . . . 0.0 112.142 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.2 tp -159.08 136.55 10.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.699 1.599 . . . . 0.0 109.646 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.67 162.3 37.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.713 1.205 . . . . 0.0 111.776 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 41.2 mt -139.03 132.83 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.404 1.082 . . . . 0.0 109.935 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.29 163.76 14.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.769 1.627 . . . . 0.0 110.083 168.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 167.56 -158.49 31.39 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.179 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.72 -22.2 50.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.686 2.924 . . . . 0.0 112.435 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.3 t -147.11 158.54 43.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 109.499 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.63 112.05 9.35 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.977 -1.077 . . . . 0.0 110.595 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -66.47 150.72 48.53 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.119 0.968 . . . . 0.0 111.739 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.51 137.51 32.27 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.409 0.684 . . . . 0.0 109.315 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 35.1 mt -132.2 143.83 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.443 1.097 . . . . 0.0 110.428 -165.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.41 163.0 35.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 111.301 168.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -157.7 156.76 32.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 112.777 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -138.22 125.26 21.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.907 1.683 . . . . 0.0 110.069 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.34 128.92 33.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 110.862 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -107.98 151.94 25.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.292 1.437 . . . . 0.0 112.434 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -68.87 -16.81 63.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.05 0.94 . . . . 0.0 112.719 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.45 -6.39 48.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.724 1.61 . . . . 0.0 113.968 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.73 33.12 8.61 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.499 1.047 . . . . 0.0 113.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.8 p -136.74 156.77 48.07 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.815 1.246 . . . . 0.0 111.15 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.7 m -102.71 127.6 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.956 0.902 . . . . 0.0 108.903 157.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.8 t -92.21 145.83 24.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.746 0.818 . . . . 0.0 109.796 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1922 ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' 1886 ' ' PHE . 86.8 t -130.38 143.69 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.129 1.372 . . . . 0.0 109.976 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.1 p -134.08 149.45 51.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.05 1.34 . . . . 0.0 111.919 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.89 152.82 33.07 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 18.8 mt -115.64 105.69 51.43 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.394 1.878 . . . . 0.0 110.207 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.71 170.63 15.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.573 2.849 . . . . 0.0 110.332 167.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -144.99 -28.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -172.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.93 147.89 36.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 110.394 166.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.97 156.22 52.38 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.83 2.353 . . . . 0.0 110.775 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.3 -167.84 23.65 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.98 1.276 . . . . 0.0 113.382 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.6 128.37 39.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.784 1.234 . . . . 0.0 112.262 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -112.47 140.5 47.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.46 1.904 . . . . 0.0 110.496 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.3 m -105.03 111.94 24.89 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.992 1.317 . . . . 0.0 110.229 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.03 122.27 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.023 1.329 . . . . 0.0 108.383 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.25 125.8 47.92 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.572 1.549 . . . . 0.0 109.231 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.1 t -126.71 129.38 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.27 1.028 . . . . 0.0 109.442 171.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.68 142.83 24.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.921 1.288 . . . . 0.0 111.943 -167.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.12 123.67 22.22 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 109.701 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.5 t-20 52.56 57.13 6.72 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.559 1.543 . . . . 0.0 112.541 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.1 pt-20 58.42 12.17 1.94 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.295 2.638 . . . . 0.0 116.286 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.97 125.28 49.04 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.629 1.172 . . . . 0.0 110.779 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.43 143.38 57.15 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.47 -0.769 . . . . 0.0 111.591 172.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.5 m -72.22 152.01 92.37 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.058 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -56.02 125.44 19.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.148 2.566 . . . . 0.0 111.115 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.73 64.33 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.458 1.504 . . . . 0.0 115.316 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 141.56 68.89 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.264 1.532 . . . . 0.0 111.804 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.69 145.54 79.63 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.587 0.888 . . . . 0.0 112.275 -3.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -96.55 139.4 32.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.585 1.554 . . . . 0.0 110.763 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -100.66 107.47 19.11 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.328 0.651 . . . . 0.0 110.63 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.51 125.17 45.22 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.652 1.181 . . . . 0.0 111.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -95.78 116.69 29.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.518 0.727 . . . . 0.0 110.685 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -99.43 133.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.045 1.738 . . . . 0.0 110.678 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 60.2 p -104.12 169.25 8.6 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.296 1.438 . . . . 0.0 112.959 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.83 142.03 25.07 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.946 1.26 . . . . 0.0 111.691 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.48 -11.51 59.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.49 1.116 . . . . 0.0 113.781 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 126.662 1.985 . . . . 0.0 112.577 -179.81 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.27 163.8 27.59 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.479 1.112 . . . . 0.0 112.862 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.8 ttt -72.42 -31.3 65.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 0.0 112.502 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -72.28 150.24 91.87 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.61 1.164 . . . . 0.0 112.128 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.28 171.58 17.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.638 2.892 . . . . 0.0 111.509 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -71.57 123.22 21.98 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.462 0.705 . . . . 0.0 110.57 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -79.91 145.95 62.8 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.063 0.945 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.99 162.04 37.81 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.657 2.904 . . . . 0.0 111.845 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 68.0 tp -115.52 131.16 57.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.181 1.392 . . . . 0.0 109.792 172.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 96.2 t -105.19 128.6 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.149 1.38 . . . . 0.0 108.396 170.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 74.03 -149.67 41.41 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 123.844 0.735 . . . . 0.0 112.357 -174.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 49.1 t -136.6 138.24 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.712 1.605 . . . . 0.0 108.842 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -64.99 -28.61 69.63 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 87.97 -3.03 85.94 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.426 1.489 . . . . 0.0 115.189 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.21 144.47 37.27 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.222 1.409 . . . . 0.0 111.115 176.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 39.3 t0 -160.22 149.36 17.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.211 1.804 . . . . 0.0 110.149 172.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . 0.276 1.1 p 50.7 15.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 128.244 2.618 . . . . 0.0 115.461 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.7 t -75.26 -12.02 60.19 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.884 1.674 . . . . 0.0 113.675 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 74.0 p -73.98 75.31 1.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.114 1.366 . . . . 0.0 111.619 173.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 23.3 tp -91.09 129.43 37.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.499 1.519 . . . . 0.0 109.764 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -66.42 119.06 59.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.918 -168.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.46 154.59 60.5 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.315 2.676 . . . . 0.0 111.715 -171.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.7 123.25 42.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.786 0.834 . . . . 0.0 110.194 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -153.18 130.2 11.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.446 1.498 . . . . 0.0 110.344 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.71 143.46 30.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.854 1.662 . . . . 0.0 109.83 -172.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.1 p -112.45 138.59 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.057 1.343 . . . . 0.0 110.571 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 70.8 mt -131.53 136.6 28.81 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.412 1.885 . . . . 0.0 108.71 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.66 45.47 1.96 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.503 3.469 . . . . 0.0 112.926 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 75.1 t80 -91.53 155.12 18.62 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.254 1.422 . . . . 0.0 111.462 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 95.7 m -125.43 125.86 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.549 1.54 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.7 134.25 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.346 1.058 . . . . 0.0 110.641 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -113.18 -141.78 0.38 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.845 1.658 . . . . 0.0 110.656 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.2 135.66 33.63 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.91 -1.119 . . . . 0.0 110.956 166.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 132.98 -145.26 17.29 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.511 1.529 . . . . 0.0 111.555 -167.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -158.6 151.47 22.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.464 1.106 . . . . 0.0 111.536 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.0 tt -124.64 135.23 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.763 1.625 . . . . 0.0 111.936 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.08 164.07 34.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.72 1.608 . . . . 0.0 110.978 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.72 -175.75 23.0 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.42 140.59 16.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.556 1.543 . . . . 0.0 110.02 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 16.3 t -111.47 132.91 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.814 1.646 . . . . 0.0 108.171 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.4 mtm105 -119.49 119.3 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.682 1.193 . . . . 0.0 110.226 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 11.3 mtt -95.53 149.24 35.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.781 1.632 . . . . 0.0 111.376 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.17 -20.59 28.2 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.4 2.733 . . . . 0.0 113.672 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.7 p -80.61 4.29 19.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.206 1.402 . . . . 0.0 114.387 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.06 45.11 4.88 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 124.485 1.04 . . . . 0.0 113.367 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.54 166.18 31.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.76 1.624 . . . . 0.0 112.021 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.59 161.37 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.224 1.01 . . . . 0.0 113.217 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.04 -179.26 7.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.063 2.145 . . . . 0.0 110.533 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -120.52 141.74 32.71 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 121.189 -0.944 . . . . 0.0 111.333 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.18 166.88 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.322 3.348 . . . . 0.0 111.343 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.8 m -106.91 128.02 53.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 108.915 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.9 130.43 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.611 1.165 . . . . 0.0 109.075 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 77.1 m -135.07 120.98 19.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.163 1.385 . . . . 0.0 109.321 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.58 141.77 41.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 112.218 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.63 -5.61 48.34 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.19 6.33 4.73 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.34 2.256 . . . . 0.0 113.515 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -107.2 9.51 30.2 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.805 2.042 . . . . 0.0 112.991 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.11 17.12 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.719 1.152 . . . . 0.0 113.608 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 34.9 p -134.86 159.77 40.34 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.316 1.846 . . . . 0.0 110.413 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.9 m -125.34 143.4 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.584 1.154 . . . . 0.0 110.076 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 96.3 m -104.56 135.92 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.432 1.093 . . . . 0.0 108.668 171.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 40.0 t -120.11 132.99 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.208 1.403 . . . . 0.0 108.744 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -133.14 159.17 40.91 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.035 1.334 . . . . 0.0 112.706 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.7 t80 -160.5 136.48 8.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.688 1.595 . . . . 0.0 111.66 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.12 112.03 51.67 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.749 1.219 . . . . 0.0 110.185 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.24 151.36 26.52 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.216 2.611 . . . . 0.0 112.209 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -116.16 -12.71 11.19 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -163.44 150.34 12.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.59 1.556 . . . . 0.0 110.884 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.79 172.48 12.1 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.7 1.2 . . . . 0.0 113.497 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.87 -178.58 17.63 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 125.542 1.544 . . . . 0.0 114.435 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.43 123.22 25.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.924 1.29 . . . . 0.0 110.088 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.7 m80 -117.7 157.07 27.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.314 1.446 . . . . 0.0 111.818 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -133.46 142.42 48.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.076 1.35 . . . . 0.0 109.317 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.7 tmm? -143.04 132.45 23.47 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.082 0.953 . . . . 0.0 111.753 -168.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -108.72 139.88 42.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.951 2.1 . . . . 0.0 111.455 -173.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.5 mm -139.32 131.05 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.187 1.395 . . . . 0.0 109.304 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.27 139.71 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.18 123.34 46.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.537 1.935 . . . . 0.0 109.912 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.91 30.95 7.78 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.719 1.208 . . . . 0.0 112.827 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.0 t30 80.59 6.16 1.54 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.53 2.732 . . . . 0.0 115.28 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 90.3 mtp -109.05 133.17 53.35 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.054 1.342 . . . . 0.0 111.119 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.24 138.05 55.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -72.84 153.7 91.15 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.273 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.26 123.89 14.89 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.036 2.491 . . . . 0.0 110.37 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.21 -11.22 61.89 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.376 -1.235 . . . . 0.0 114.903 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.3 m -102.2 154.59 37.28 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-N 119.999 1.9 . . . . 0.0 112.673 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.58 163.83 89.48 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.558 0.878 . . . . 0.0 113.272 0.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.22 151.91 24.8 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.82 1.648 . . . . 0.0 111.504 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.87 141.7 47.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.288 1.435 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.2 p90 -166.56 158.28 13.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.372 1.069 . . . . 0.0 112.072 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 38.2 t80 -96.36 130.19 43.53 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.433 0.693 . . . . 0.0 111.755 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 71.4 t -91.86 132.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.998 1.319 . . . . 0.0 108.681 172.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.1 t0 -146.51 163.7 34.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.498 1.519 . . . . 0.0 110.628 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.76 148.82 44.23 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.992 0.917 . . . . 0.0 112.543 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 89.7 t -67.05 -45.02 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.138 0.975 . . . . 0.0 110.631 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 6.4 p30 -93.64 141.66 28.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.924 0.89 . . . . 0.0 111.125 168.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.4 p -173.85 156.79 2.89 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.051 1.741 . . . . 0.0 112.235 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.42 -23.47 11.13 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.854 1.216 . . . . 0.0 113.595 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -73.59 156.9 37.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.424 1.089 . . . . 0.0 113.736 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.4 t -66.95 138.13 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.173 0.989 . . . . 0.0 108.473 170.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.0 t -153.49 166.77 31.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.038 0.935 . . . . 0.0 111.349 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.01 145.46 29.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.134 1.374 . . . . 0.0 111.665 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 47.2 p90 -166.15 162.4 17.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.629 1.572 . . . . 0.0 112.467 -175.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.77 173.47 13.22 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.283 1.421 . . . . 0.0 113.014 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.72 -35.04 13.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.879 2.386 . . . . 0.0 112.751 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.38 -32.12 78.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.463 -171.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.34 -3.47 49.64 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.233 1.516 . . . . 0.0 113.478 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.6 m -108.17 -41.24 4.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.473 1.909 . . . . 0.0 111.676 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -151.09 152.55 33.58 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.244 1.818 . . . . 0.0 112.332 -170.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -153.19 -175.41 24.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.406 1.003 . . . . 0.0 113.393 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.8 p -153.6 137.36 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.07 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.8 m -58.57 142.12 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.0 m-80 68.28 7.33 5.86 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.558 1.943 . . . . 0.0 114.582 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -114.7 143.57 30.25 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.167 1.387 . . . . 0.0 110.924 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.48 127.94 13.06 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.604 2.202 . . . . 0.0 110.316 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.13 145.83 32.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.624 1.57 . . . . 0.0 110.273 173.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.2 p -135.69 152.23 50.97 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -167.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.9 173.83 13.97 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.985 1.714 . . . . 0.0 111.385 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 76.0 m -125.73 142.43 51.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.316 1.446 . . . . 0.0 110.464 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 48.1 t -115.9 128.16 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.837 1.655 . . . . 0.0 107.875 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.32 123.92 35.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.021 0.928 . . . . 0.0 110.932 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 54.5 p -125.99 10.25 7.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.408 1.883 . . . . 0.0 112.608 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.16 -40.06 76.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.52 1.528 . . . . 0.0 114.372 -165.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.39 5.42 21.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.648 1.579 . . . . 0.0 112.738 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.71 58.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.575 1.15 . . . . 0.0 113.693 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.33 -86.71 1.38 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.872 1.225 . . . . 0.0 112.772 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.6 -177.88 3.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.27 1.828 . . . . 0.0 111.627 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 119.38 9.52 8.54 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.815 1.198 . . . . 0.0 115.618 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.33 103.52 1.63 Allowed Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.533 1.54 . . . . 0.0 112.834 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 39.2 tp -84.66 141.35 30.67 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.319 1.447 . . . . 0.0 110.158 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.7 m -135.46 159.41 41.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.592 1.557 . . . . 0.0 112.155 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.5 tp -160.71 136.44 8.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.024 1.73 . . . . 0.0 109.338 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.36 159.17 35.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.74 137.24 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.884 1.274 . . . . 0.0 109.837 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.26 134.39 48.96 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.31 1.444 . . . . 0.0 109.979 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.5 -164.55 16.61 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.667 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.32 -24.48 64.81 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.18 3.253 . . . . 0.0 112.836 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.8 t -139.3 159.75 41.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.914 1.285 . . . . 0.0 109.6 162.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.25 110.57 5.98 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.088 -1.008 . . . . 0.0 110.704 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 145.18 54.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 0.0 111.144 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.46 137.13 32.79 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 36.5 mt -129.36 143.73 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.746 1.218 . . . . 0.0 110.131 -168.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.63 162.68 35.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 110.966 166.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -158.14 155.41 29.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.646 1.178 . . . . 0.0 112.228 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -142.38 125.18 16.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.385 1.474 . . . . 0.0 109.79 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.36 129.56 36.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.946 169.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.18 151.58 20.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.362 1.465 . . . . 0.0 111.808 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -71.14 -16.48 62.55 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.888 0.875 . . . . 0.0 113.281 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.06 -6.96 59.56 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.31 33.89 6.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.815 1.198 . . . . 0.0 114.445 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -127.94 174.09 9.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.331 1.452 . . . . 0.0 110.572 169.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.1 m -124.16 130.96 53.42 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.105 1.362 . . . . 0.0 109.963 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.6 t -93.88 149.13 21.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.277 1.031 . . . . 0.0 110.745 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.1 t -128.17 143.79 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.102 1.761 . . . . 0.0 109.742 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.1 p -136.14 148.1 48.04 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.78 168.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.28 153.78 36.74 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.5 107.33 43.12 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 110.375 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -85.79 173.07 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.114 3.209 . . . . 0.0 110.834 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.1 p -147.34 -28.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -173.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.06 148.67 37.92 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.249 1.019 . . . . 0.0 110.718 167.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.59 157.71 48.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.98 2.453 . . . . 0.0 110.845 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.16 -168.1 22.17 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.164 1.364 . . . . 0.0 113.484 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.66 132.77 34.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.956 1.302 . . . . 0.0 112.568 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 126.64 49.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.275 1.83 . . . . 0.0 109.816 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.1 m -86.8 124.33 32.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.529 1.132 . . . . 0.0 110.482 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.48 124.31 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.605 1.562 . . . . 0.0 108.402 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.6 tt -106.14 131.04 53.87 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.319 1.447 . . . . 0.0 109.831 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.8 t -133.07 127.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.552 1.141 . . . . 0.0 109.607 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.42 143.42 24.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.969 1.308 . . . . 0.0 111.547 -168.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.63 122.31 15.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.957 1.303 . . . . 0.0 109.641 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.68 56.26 6.96 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.199 1.399 . . . . 0.0 112.095 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.3 pt-20 59.42 3.74 0.43 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.85 2.86 . . . . 0.0 116.644 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -108.98 125.05 51.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.678 1.191 . . . . 0.0 110.87 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.62 145.87 54.86 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.279 -0.888 . . . . 0.0 111.809 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 16.3 m -70.39 152.7 95.45 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.091 170.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.42 128.32 27.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.007 2.471 . . . . 0.0 110.57 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.42 62.8 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.052 1.31 . . . . 0.0 115.082 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.3 t -77.61 139.99 63.5 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.392 1.596 . . . . 0.0 111.482 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.36 135.92 42.56 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.358 0.806 . . . . 0.0 111.857 -3.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -86.01 170.3 12.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.794 1.637 . . . . 0.0 110.378 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 45.7 m -131.45 117.38 18.75 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.549 0.74 . . . . 0.0 110.718 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.35 143.41 26.42 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.669 1.188 . . . . 0.0 110.722 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -104.22 119.37 38.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.931 0.492 . . . . 0.0 110.771 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.3 t -97.28 144.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.944 1.698 . . . . 0.0 109.237 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.5 t -132.82 175.65 9.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.038 0.935 . . . . 0.0 112.854 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.33 137.47 19.78 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.644 1.593 . . . . 0.0 112.367 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.0 t70 -83.08 -23.77 32.99 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.336 1.054 . . . . 0.0 113.402 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.833 2.053 . . . . 0.0 112.456 -176.032 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -80.46 -8.65 59.63 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -62.5 147.18 49.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.807 1.643 . . . . 0.0 112.853 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -70.22 150.67 95.98 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.275 1.03 . . . . 0.0 112.652 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.85 173.63 14.17 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.88 3.053 . . . . 0.0 111.854 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.62 6.43 5.91 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.049 1.34 . . . . 0.0 113.829 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.31 145.76 85.46 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.43 1.492 . . . . 0.0 112.45 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.85 153.36 68.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.563 2.842 . . . . 0.0 111.489 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.48 29.24 0.3 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.421 1.488 . . . . 0.0 113.139 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.6 p -169.25 153.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.598 2.359 . . . . 0.0 109.613 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -68.42 145.17 43.71 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.657 0.646 . . . . 0.0 112.27 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 22.2 m -142.55 154.67 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.776 1.63 . . . . 0.0 111.234 -176.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 18.9 t-20 75.69 133.14 0.05 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 128.48 2.712 . . . . 0.0 113.014 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -82.81 121.2 5.37 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.351 0.976 . . . . 0.0 111.618 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 83.5 mt -83.01 152.59 25.34 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.567 1.147 . . . . 0.0 111.44 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 39.5 t0 -76.09 152.47 36.8 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.86 0.864 . . . . 0.0 112.087 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 9.3 p -172.64 139.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.915 2.086 . . . . 0.0 110.354 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 13.1 t -155.28 30.78 0.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.308 1.443 . . . . 0.0 112.381 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 16.3 m -63.7 149.22 47.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.323 1.049 . . . . 0.0 112.79 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.5 tp -84.29 136.93 33.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.857 1.263 . . . . 0.0 109.368 169.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -44.5 110.07 0.97 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.5 1.52 . . . . 0.0 112.513 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.03 120.64 7.51 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.474 2.116 . . . . 0.0 108.297 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 53.6 t80 -101.01 130.33 46.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.617 0.723 . . . . 0.0 111.677 -172.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 2.1 p30 -160.38 150.11 17.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.769 1.628 . . . . 0.0 111.69 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.4 150.27 40.43 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.456 1.902 . . . . 0.0 110.044 -171.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 139.47 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.773 1.629 . . . . 0.0 110.316 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.3 139.04 30.36 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.886 1.675 . . . . 0.0 108.732 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.13 46.25 2.04 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.707 3.605 . . . . 0.0 112.934 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.15 160.78 14.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.917 1.687 . . . . 0.0 110.532 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 58.1 m -132.47 130.33 40.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.717 1.207 . . . . 0.0 109.41 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.7 mt -92.78 119.49 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.772 1.229 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 -161.98 0.86 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.442 1.497 . . . . 0.0 110.915 170.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -63.58 120.52 11.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.719 -1.238 . . . . 0.0 111.727 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.33 170.63 12.11 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.783 1.659 . . . . 0.0 112.868 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -98.3 143.83 28.36 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.35 1.06 . . . . 0.0 112.528 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 9.8 tt -146.84 129.36 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.807 1.643 . . . . 0.0 110.335 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 76.8 p -146.61 -177.85 5.86 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.174 1.79 . . . . 0.0 110.337 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -165.38 -171.38 31.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.26 141.12 21.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 109.783 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 92.7 t -111.02 136.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.202 1.801 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -118.06 129.49 55.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.943 1.297 . . . . 0.0 110.634 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 17.7 mtm -99.91 151.66 37.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.76 1.624 . . . . 0.0 111.52 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.81 -18.88 36.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.477 2.785 . . . . 0.0 113.021 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 25.8 p -74.85 -4.13 36.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.705 1.602 . . . . 0.0 114.177 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.53 79.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.757 1.646 . . . . 0.0 114.206 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -68.44 160.01 30.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.925 1.29 . . . . 0.0 112.616 173.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -137.49 156.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.207 1.403 . . . . 0.0 111.586 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.36 178.65 9.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.944 2.097 . . . . 0.0 110.095 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.31 142.13 31.86 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.039 -1.038 . . . . 0.0 111.788 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.91 166.98 12.98 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.059 3.173 . . . . 0.0 111.566 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.5 m -102.31 120.39 40.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.484 1.514 . . . . 0.0 108.883 174.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.6 137.97 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.993 1.317 . . . . 0.0 109.158 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 19.0 m -144.37 131.76 20.86 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.334 1.453 . . . . 0.0 110.082 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.43 129.3 34.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.782 0.833 . . . . 0.0 110.218 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -80.85 -4.63 55.43 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.7 mmmt 69.84 13.27 8.02 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.525 2.33 . . . . 0.0 113.365 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -126.59 13.88 7.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.699 2.0 . . . . 0.0 112.755 -173.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.5 13.54 59.71 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.828 1.204 . . . . 0.0 114.56 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 58.4 p -132.33 157.56 44.14 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.208 1.803 . . . . 0.0 110.28 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -114.51 148.1 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.509 1.123 . . . . 0.0 109.769 165.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.8 m -114.57 137.02 52.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.737 1.215 . . . . 0.0 108.256 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.15 130.48 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.875 1.27 . . . . 0.0 108.812 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -125.89 160.92 28.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.012 1.325 . . . . 0.0 112.546 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 16.5 t80 -157.08 134.22 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.104 1.362 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.56 117.27 68.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.664 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -80.99 162.98 20.57 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.592 2.861 . . . . 0.0 112.382 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.9 p -135.69 -20.14 1.57 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.27 155.26 44.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.0 110.987 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.93 174.12 11.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.516 1.126 . . . . 0.0 112.655 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 110.67 -170.86 14.2 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.838 1.685 . . . . 0.0 113.843 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.17 132.19 34.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.753 1.221 . . . . 0.0 110.766 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.0 m80 -129.84 170.72 13.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.687 1.995 . . . . 0.0 111.055 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.0 154.06 41.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.445 1.098 . . . . 0.0 111.424 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 2.3 ttm -138.66 123.73 19.03 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.352 1.461 . . . . 0.0 110.82 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -96.87 135.83 38.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.081 1.753 . . . . 0.0 110.305 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.85 137.44 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.208 1.403 . . . . 0.0 109.997 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.68 135.25 18.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -173.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -102.98 124.17 47.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.634 1.973 . . . . 0.0 109.558 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.34 40.38 22.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.902 1.281 . . . . 0.0 112.467 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.5 m120 76.36 -3.6 2.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.292 2.637 . . . . 0.0 114.845 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.8 mtm -103.45 134.18 47.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.472 1.509 . . . . 0.0 111.462 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.26 135.63 53.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.8 pt -73.9 157.48 87.13 Favored Pre-proline 0 N--CA 1.482 1.146 0 CA-C-O 118.698 -0.667 . . . . 0.0 111.505 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -57.97 125.81 19.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.635 2.224 . . . . 0.0 110.988 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.35 -9.94 71.62 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.991 1.281 . . . . 0.0 114.69 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.1 t -82.78 147.31 54.77 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.36 1.58 . . . . 0.0 111.667 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.4 164.76 69.02 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 120.126 1.081 . . . . 0.0 112.451 -4.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.37 156.64 17.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.703 1.601 . . . . 0.0 111.998 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -136.71 136.36 38.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 109.191 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.9 150.07 25.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 57.8 t80 -105.2 142.31 35.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.182 0.993 . . . . 0.0 112.199 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -124.83 138.33 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.692 1.597 . . . . 0.0 109.056 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 37.2 t0 -162.22 157.32 22.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.372 1.469 . . . . 0.0 111.581 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -82.73 146.19 29.16 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.963 -1.085 . . . . 0.0 113.188 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.1 t -62.63 -30.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.102 1.361 . . . . 0.0 112.281 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.22 -11.34 59.74 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.6 m -57.96 136.34 57.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.85 61.9 1.95 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.809 1.671 . . . . 0.0 112.575 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -158.56 166.67 31.56 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.228 1.411 . . . . 0.0 113.269 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 10.6 p -70.15 139.76 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.876 0.871 . . . . 0.0 110.089 166.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -156.41 167.64 29.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.23 145.98 31.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.39 1.076 . . . . 0.0 112.257 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.9 p90 -167.86 166.08 13.64 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.691 . . . . 0.0 112.882 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.03 172.02 13.03 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.7 1.619 . . . . 0.0 112.362 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.3 -34.84 12.08 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.859 2.372 . . . . 0.0 113.191 -169.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.14 -29.13 73.21 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.844 -0.976 . . . . 0.0 114.625 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.85 -0.13 42.1 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.21 1.505 . . . . 0.0 113.659 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 19.6 m -116.22 -42.21 3.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.051 2.141 . . . . 0.0 111.999 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -140.6 153.05 45.92 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.823 1.649 . . . . 0.0 112.604 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -155.09 -176.13 26.93 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.112 0.863 . . . . 0.0 113.436 167.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.8 p -151.6 137.98 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.92 1.288 . . . . 0.0 108.982 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -58.29 143.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 69.56 5.76 5.35 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.607 1.963 . . . . 0.0 114.776 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.6 mttm -117.41 147.49 40.74 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 111.194 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.25 138.65 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.62 2.214 . . . . 0.0 110.806 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -118.81 147.52 43.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.928 1.691 . . . . 0.0 110.3 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.6 p -135.52 152.45 51.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.088 0.955 . . . . 0.0 113.573 -166.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.67 176.53 10.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.093 1.757 . . . . 0.0 111.325 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 81.8 m -132.3 138.53 47.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.88 1.272 . . . . 0.0 110.68 -171.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.2 t -104.0 130.29 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.135 1.374 . . . . 0.0 107.6 167.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -97.3 123.8 41.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.561 1.144 . . . . 0.0 110.187 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 52.8 p -127.97 5.97 5.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.793 1.637 . . . . 0.0 113.397 -167.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -54.54 -33.92 60.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.629 1.572 . . . . 0.0 114.647 -171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.0 t70 -113.9 7.02 16.83 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.537 1.535 . . . . 0.0 113.259 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.41 -14.86 59.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.04 -97.98 2.19 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.493 1.044 . . . . 0.0 112.761 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.67 171.38 16.95 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.381 1.473 . . . . 0.0 112.515 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 125.46 -160.62 20.0 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.005 1.764 . . . . 0.0 112.771 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.98 115.25 4.73 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.257 0.932 . . . . 0.0 111.371 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.7 128.4 34.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.199 1.4 . . . . 0.0 108.88 171.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 34.4 m -129.9 158.54 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.508 1.523 . . . . 0.0 112.289 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -160.18 135.55 8.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.239 1.816 . . . . 0.0 108.909 -169.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.41 157.91 34.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.666 0.786 . . . . 0.0 112.497 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -136.29 140.39 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.132 1.373 . . . . 0.0 109.763 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.22 136.11 45.42 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.431 1.492 . . . . 0.0 109.38 171.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.29 -164.55 16.39 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.833 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.86 -27.19 67.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.077 3.185 . . . . 0.0 112.417 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.3 t -135.4 159.86 40.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.868 1.267 . . . . 0.0 109.352 159.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -75.76 109.51 9.42 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.042 -1.036 . . . . 0.0 110.871 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 147.27 52.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.724 0.809 . . . . 0.0 111.768 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.94 145.5 27.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.387 0.675 . . . . 0.0 110.083 166.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.94 140.21 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 110.203 -167.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 57.9 m -135.35 157.01 47.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.587 1.555 . . . . 0.0 110.776 167.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -156.16 156.7 34.66 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.094 0.957 . . . . 0.0 112.458 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.1 m -141.91 122.13 13.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.035 1.334 . . . . 0.0 110.406 -172.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.47 132.05 41.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.97 1.308 . . . . 0.0 111.065 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -112.76 146.4 38.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 111.75 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.45 -13.3 61.91 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.986 0.914 . . . . 0.0 113.312 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.77 -4.88 40.28 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.242 1.817 . . . . 0.0 114.219 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.25 31.55 9.61 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.58 1.086 . . . . 0.0 113.804 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.0 p -141.06 161.35 38.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.351 1.46 . . . . 0.0 111.357 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 78.9 m -112.85 128.23 56.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.719 1.207 . . . . 0.0 109.004 158.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.1 t -87.4 148.02 25.18 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 110.462 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -129.39 142.83 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.672 1.589 . . . . 0.0 110.214 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 69.6 p -136.45 145.75 45.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.922 1.289 . . . . 0.0 111.591 165.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.4 p90 -148.44 156.9 43.07 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.018 -1.051 . . . . 0.0 112.693 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.06 104.84 25.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.264 1.026 . . . . 0.0 110.666 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.17 172.13 9.8 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 124.226 3.284 . . . . 0.0 111.219 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.6 p -147.36 -29.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -172.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.28 147.91 36.11 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 119.515 1.052 . . . . 0.0 110.776 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.49 156.49 49.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.911 2.408 . . . . 0.0 110.696 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.96 -162.53 24.74 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.104 1.335 . . . . 0.0 113.003 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -104.03 125.85 50.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.344 1.058 . . . . 0.0 111.242 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -109.97 129.47 55.66 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.881 1.672 . . . . 0.0 110.023 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -88.23 127.19 35.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 110.611 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -106.64 127.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.63 1.572 . . . . 0.0 108.657 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.31 134.78 51.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 109.756 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.6 t -136.29 131.27 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.249 1.419 . . . . 0.0 108.546 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.12 143.22 22.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.865 1.266 . . . . 0.0 111.332 -170.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.77 124.67 15.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.849 1.259 . . . . 0.0 109.941 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 57.85 51.82 8.7 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 9.0 pt-20 55.57 17.24 2.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.149 2.579 . . . . 0.0 115.84 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -122.02 128.82 51.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.858 1.263 . . . . 0.0 110.725 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -65.18 156.24 32.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.132 0.973 . . . . 0.0 112.829 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.7 m -72.82 152.48 91.17 Favored Pre-proline 0 N--CA 1.48 1.029 0 O-C-N 121.545 -0.722 . . . . 0.0 109.247 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.94 -11.15 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.965 1.777 . . . . 0.0 114.657 -166.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -105.0 -7.48 38.22 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 85.1 p -85.89 156.4 58.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.143 1.971 . . . . 0.0 113.722 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.19 144.53 79.75 Favored 'Cis proline' 0 C--N 1.354 0.844 0 CA-C-N 118.968 0.667 . . . . 0.0 112.136 -5.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -95.71 167.93 10.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.362 1.465 . . . . 0.0 110.668 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 29.6 m -130.54 118.09 20.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.909 0.884 . . . . 0.0 110.23 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.72 127.29 44.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.354 . . . . 0.0 110.684 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -92.13 117.12 29.54 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.664 0.386 . . . . 0.0 110.353 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -102.81 140.82 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.087 1.755 . . . . 0.0 109.45 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.9 t -128.57 173.46 10.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 0.0 112.76 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.92 140.69 21.07 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.806 1.669 . . . . 0.0 112.193 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -85.42 -8.74 58.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.112 0.965 . . . . 0.0 113.464 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 126.732 2.013 . . . . 0.0 113.118 -177.825 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.373 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.29 -43.67 69.93 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.806 0.803 . . . . 0.0 110.949 169.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -79.8 168.07 19.76 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.15 1.78 . . . . 0.0 111.404 161.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -57.73 -50.36 88.58 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-O 117.24 -1.362 . . . . 0.0 114.518 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.7 172.57 15.52 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.82 2.347 . . . . 0.0 111.706 173.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -80.89 -13.45 58.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.612 0.765 . . . . 0.0 112.586 170.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -79.93 137.49 53.8 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.281 1.433 . . . . 0.0 111.66 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.35 157.44 49.65 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.554 2.836 . . . . 0.0 111.473 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 90.7 mt -116.06 12.63 15.66 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.909 1.284 . . . . 0.0 113.387 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 78.0 t -121.44 132.9 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.126 1.771 . . . . 0.0 110.203 -174.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -105.04 166.44 14.63 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.6 1.571 . . . . 0.0 113.7 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 9.9 p -74.64 147.15 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.889 1.276 . . . . 0.0 111.855 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -79.56 -9.24 59.59 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 84.42 7.92 84.05 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.339 1.447 . . . . 0.0 115.348 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.29 158.44 24.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.534 1.534 . . . . 0.0 111.473 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.04 175.54 13.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.222 1.409 . . . . 0.0 110.778 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 23.7 m -60.94 -20.63 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.554 1.142 . . . . 0.0 113.775 -175.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.8 t -80.82 -15.3 56.76 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.276 1.83 . . . . 0.0 113.454 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 40.8 m -66.05 144.21 56.86 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.179 -0.951 . . . . 0.0 112.838 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 48.3 mt -82.97 147.92 27.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.225 1.01 . . . . 0.0 111.172 171.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -60.12 117.49 24.28 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 110.837 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.29 152.74 44.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.821 2.347 . . . . 0.0 111.052 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -94.26 116.25 28.62 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 169.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -145.49 125.29 13.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.771 1.228 . . . . 0.0 110.184 168.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.92 147.02 39.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.304 1.842 . . . . 0.0 109.55 -174.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -122.32 136.94 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.967 1.307 . . . . 0.0 110.453 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.4 mt -135.15 136.15 24.16 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.893 1.677 . . . . 0.0 109.287 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.12 117.67 5.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.401 2.734 . . . . 0.0 110.167 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.6 t80 178.02 149.6 0.2 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.356 . . . . 0.0 109.315 -168.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 23.9 m -130.75 125.69 34.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.136 0.974 . . . . 0.0 110.336 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 31.8 mt -83.16 119.33 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.744 1.218 . . . . 0.0 108.954 171.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -122.68 -53.21 1.89 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.913 0.885 . . . . 0.0 113.189 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -160.18 121.74 3.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.313 1.445 . . . . 0.0 111.398 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.68 -146.7 18.61 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 125.735 1.636 . . . . 0.0 111.716 -169.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.6 146.94 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.711 1.204 . . . . 0.0 110.959 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 10.8 tt -130.58 136.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.523 1.529 . . . . 0.0 111.571 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 41.4 p -147.23 -177.99 5.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.611 1.964 . . . . 0.0 110.158 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.67 -166.99 34.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 115.324 0.889 . . . . 0.0 115.324 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.86 131.84 9.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.497 1.519 . . . . 0.0 110.306 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 18.3 t -101.6 136.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.367 1.467 . . . . 0.0 108.648 170.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -120.32 131.11 54.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.719 1.207 . . . . 0.0 111.222 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -105.78 148.33 36.27 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.798 1.639 . . . . 0.0 112.104 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.55 -39.79 55.21 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.8 3.667 . . . . 0.0 115.784 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 7.1 t -73.64 -1.4 18.74 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.44 60.8 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.707 1.622 . . . . 0.0 114.366 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -69.49 160.71 30.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.246 1.418 . . . . 0.0 112.169 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.5 m -139.41 155.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.334 1.454 . . . . 0.0 111.609 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.62 163.29 40.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.79 1.636 . . . . 0.0 111.37 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.63 137.02 21.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.567 0.747 . . . . 0.0 111.577 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.11 169.18 11.62 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.59 3.527 . . . . 0.0 111.924 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -110.55 139.08 46.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 108.995 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.24 132.24 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.668 1.187 . . . . 0.0 109.283 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -134.29 127.09 31.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.416 1.487 . . . . 0.0 109.74 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.08 127.17 31.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.458 0.703 . . . . 0.0 110.279 170.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -79.01 -3.49 45.35 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.2 mmtm 71.24 13.12 6.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.76 2.424 . . . . 0.0 113.13 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -126.63 11.09 7.27 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.825 2.05 . . . . 0.0 113.001 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.48 12.78 57.98 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.855 1.217 . . . . 0.0 114.821 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -128.38 154.32 46.12 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.064 1.746 . . . . 0.0 110.396 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.2 m -111.62 141.42 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.903 0.881 . . . . 0.0 109.894 165.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.0 m -103.43 133.61 48.2 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.604 1.162 . . . . 0.0 108.412 168.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 59.9 t -116.99 134.4 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.125 1.77 . . . . 0.0 108.649 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -139.2 159.2 42.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.636 1.174 . . . . 0.0 113.47 -172.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.2 t80 -158.47 135.84 10.11 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.019 1.727 . . . . 0.0 111.483 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.93 120.0 73.23 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 124.726 1.21 . . . . 0.0 110.846 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.33 148.03 23.5 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.706 2.937 . . . . 0.0 112.607 -170.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.0 p -142.25 5.41 1.66 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.664 1.186 . . . . 0.0 114.009 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -160.18 144.52 14.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.895 1.678 . . . . 0.0 110.056 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.86 163.51 13.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 0.0 112.196 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 114.45 -168.76 12.65 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 125.247 1.403 . . . . 0.0 113.665 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -86.21 122.26 29.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.9 m80 -118.61 161.58 19.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.966 1.707 . . . . 0.0 111.822 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.16 155.96 46.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 40.9 ttm -140.77 118.37 11.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.253 1.421 . . . . 0.0 111.156 -172.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -81.56 134.98 35.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.255 2.222 . . . . 0.0 109.832 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 19.9 mm -141.09 136.32 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.349 1.459 . . . . 0.0 108.714 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 136.84 16.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.9 t80 -97.21 121.98 39.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.741 2.016 . . . . 0.0 109.795 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.94 35.51 16.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.876 1.27 . . . . 0.0 112.775 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 76.69 4.22 3.47 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 127.983 2.513 . . . . 0.0 114.506 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.6 mtm -107.53 132.6 53.07 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.68 1.592 . . . . 0.0 110.952 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.24 139.07 55.75 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 39.9 pt -74.71 155.21 87.19 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.456 0.702 . . . . 0.0 110.902 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.58 119.78 7.21 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.932 2.421 . . . . 0.0 111.942 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.9 69.83 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.52 1.533 . . . . 0.0 115.128 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 38.8 m -80.79 154.69 73.3 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.758 1.779 . . . . 0.0 112.025 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.97 155.01 99.73 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.422 0.829 . . . . 0.0 112.538 -0.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.92 159.56 15.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.097 1.359 . . . . 0.0 110.86 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -159.08 133.9 8.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.315 1.046 . . . . 0.0 110.478 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.92 -179.48 5.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.032 1.333 . . . . 0.0 112.697 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -118.31 137.29 53.17 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.219 1.008 . . . . 0.0 113.353 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.0 t -108.95 138.04 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.25 1.82 . . . . 0.0 110.021 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.6 t0 -149.1 178.9 8.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.334 1.853 . . . . 0.0 109.509 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -77.85 143.07 38.11 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.693 -1.254 . . . . 0.0 111.304 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.9 m -65.47 -17.71 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -166.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -148.81 41.41 0.93 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.978 0.911 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 2.6 t -66.68 -28.58 68.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 106.09 -25.36 23.93 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.113 1.815 . . . . 0.0 115.019 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -72.42 160.49 32.25 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.909 1.354 . . . . 0.0 113.445 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.5 t -64.36 134.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.603 1.161 . . . . 0.0 109.678 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -161.47 150.09 15.79 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.59 1.156 . . . . 0.0 110.874 -173.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -118.96 147.05 44.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.836 1.254 . . . . 0.0 111.978 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.4 p90 -166.8 158.02 12.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.082 1.753 . . . . 0.0 112.818 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 141.19 170.3 12.16 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.309 1.433 . . . . 0.0 113.258 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 -33.19 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.942 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.92 82.04 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.263 0.938 . . . . 0.0 114.047 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.85 -5.99 54.94 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 118.645 1.222 . . . . 0.0 112.658 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.6 m -99.09 -45.56 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.073 1.749 . . . . 0.0 111.406 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -147.57 142.38 26.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.531 1.932 . . . . 0.0 111.987 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -137.31 170.4 23.61 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.373 0.987 . . . . 0.0 113.376 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 59.9 t -134.92 135.58 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.144 1.378 . . . . 0.0 107.963 173.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -55.85 133.84 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.199 0.6 . . . . 0.0 112.493 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.08 -0.19 2.19 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.094 2.158 . . . . 0.0 114.54 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.59 140.06 21.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.084 1.354 . . . . 0.0 110.973 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.45 120.96 7.06 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.636 2.224 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.61 133.89 48.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.331 1.452 . . . . 0.0 110.141 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.1 p -128.5 149.46 50.58 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.49 178.65 8.91 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.74 1.616 . . . . 0.0 111.728 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -130.79 145.14 51.89 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.129 1.372 . . . . 0.0 110.793 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.0 t -116.55 132.65 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.644 1.578 . . . . 0.0 108.288 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -94.25 128.67 40.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.31 1.044 . . . . 0.0 111.009 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 48.7 p -136.46 3.51 2.81 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.47 1.508 . . . . 0.0 113.792 -167.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -53.73 -40.23 65.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.422 1.489 . . . . 0.0 114.668 -169.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -107.43 5.87 27.69 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.505 1.522 . . . . 0.0 113.123 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.28 -19.11 61.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.07 -89.98 1.63 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.724 1.154 . . . . 0.0 112.497 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -165.04 173.06 11.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.286 1.434 . . . . 0.0 112.648 -169.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 121.09 -167.52 14.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.199 1.857 . . . . 0.0 112.73 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.64 106.55 3.2 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.935 0.779 . . . . 0.0 111.791 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.6 124.6 28.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.509 1.124 . . . . 0.0 108.586 168.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 46.1 m -124.07 158.04 33.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.782 1.633 . . . . 0.0 112.24 -173.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.46 137.22 10.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.857 1.663 . . . . 0.0 109.515 -172.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 160.57 37.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.354 1.061 . . . . 0.0 111.909 175.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.8 mt -135.53 132.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.499 1.12 . . . . 0.0 109.6 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.88 108.06 15.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.413 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -117.53 -178.16 17.5 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.124 1.345 . . . . 0.0 113.743 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.79 -26.1 52.83 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.797 2.998 . . . . 0.0 111.652 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 151.48 51.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.234 1.414 . . . . 0.0 108.646 155.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.18 122.25 20.72 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.957 -1.089 . . . . 0.0 112.0 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.88 154.27 41.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 112.12 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.88 139.62 30.27 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.354 0.662 . . . . 0.0 109.397 166.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 34.4 mt -133.85 143.61 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -166.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 10.8 t -142.58 161.64 37.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.31 1.444 . . . . 0.0 111.065 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -160.09 155.11 24.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.92 1.288 . . . . 0.0 112.687 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.0 m -141.65 127.32 19.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.375 1.47 . . . . 0.0 110.455 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.91 131.63 37.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.814 1.246 . . . . 0.0 111.264 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -111.13 151.06 28.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.129 1.371 . . . . 0.0 112.442 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -67.69 -19.68 65.19 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.49 1.116 . . . . 0.0 112.461 173.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.23 -5.71 37.76 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.811 1.644 . . . . 0.0 114.421 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.22 33.96 8.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.46 1.029 . . . . 0.0 113.235 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -141.28 161.37 38.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.518 1.527 . . . . 0.0 111.143 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.5 m -108.6 131.68 54.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.859 1.263 . . . . 0.0 108.913 158.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -91.09 149.89 21.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.939 0.895 . . . . 0.0 110.486 168.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 95.1 t -130.2 144.8 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.046 1.739 . . . . 0.0 109.973 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.1 t -140.35 141.05 35.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.486 1.514 . . . . 0.0 110.932 170.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -147.03 153.99 40.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.51 103.32 49.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.483 1.913 . . . . 0.0 110.256 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.12 161.99 17.94 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.647 2.898 . . . . 0.0 110.306 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.5 m -126.39 -10.06 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.48 151.63 22.82 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.207 1.403 . . . . 0.0 110.419 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.24 142.99 27.81 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.762 2.308 . . . . 0.0 111.649 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 155.4 -167.59 32.99 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.779 1.181 . . . . 0.0 113.299 -174.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -101.08 128.54 47.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.573 1.149 . . . . 0.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -120.15 123.23 42.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.65 1.58 . . . . 0.0 110.121 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 48.8 m -86.45 125.78 33.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.039 -1.038 . . . . 0.0 111.22 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 128.55 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.531 1.533 . . . . 0.0 108.614 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.23 129.95 55.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.301 1.44 . . . . 0.0 109.655 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.5 t -132.59 128.93 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.435 1.094 . . . . 0.0 109.757 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.39 143.68 24.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.269 1.428 . . . . 0.0 111.046 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.88 121.74 11.99 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.535 1.134 . . . . 0.0 109.721 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.77 55.28 5.56 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.034 1.333 . . . . 0.0 111.544 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.2 pt-20 58.26 13.19 2.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.396 2.678 . . . . 0.0 116.267 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.18 126.2 49.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.647 1.179 . . . . 0.0 110.909 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.57 146.15 54.28 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.803 170.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.5 m -71.19 152.76 94.51 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.152 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.96 129.59 35.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.005 2.47 . . . . 0.0 110.895 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.7 -17.69 57.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.169 1.366 . . . . 0.0 114.89 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 35.6 t -77.77 140.13 62.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.26 1.53 . . . . 0.0 111.542 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.0 135.42 40.07 Favored 'Cis proline' 0 C--N 1.352 0.735 0 CA-C-N 119.377 0.813 . . . . 0.0 111.717 -4.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.67 176.85 6.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.223 1.809 . . . . 0.0 110.492 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 95.4 m -137.35 123.25 20.13 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.94 0.896 . . . . 0.0 111.096 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.12 160.07 15.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.127 1.771 . . . . 0.0 110.711 167.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -122.13 126.31 48.09 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.788 0.835 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.5 t -106.19 141.01 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.21 1.804 . . . . 0.0 109.881 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -130.33 171.11 13.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 112.978 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.91 144.34 31.06 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.382 1.468 . . . . 0.0 112.557 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.88 -17.29 55.84 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.231 1.012 . . . . 0.0 113.2 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.786 2.035 . . . . 0.0 112.518 -179.086 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.63 162.98 28.6 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.396 1.078 . . . . 0.0 112.842 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.8 mtp -71.54 149.93 45.26 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.327 1.051 . . . . 0.0 112.218 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -70.44 152.7 95.41 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.404 1.082 . . . . 0.0 112.291 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.07 168.27 24.46 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.758 2.972 . . . . 0.0 111.997 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.86 -179.43 7.13 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.356 1.462 . . . . 0.0 112.196 -176.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 6.3 tpp85 -156.69 136.29 8.35 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.009 1.324 . . . . 0.0 110.71 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.98 153.07 63.47 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.841 2.361 . . . . 0.0 111.058 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 9.9 mp 65.55 9.92 6.24 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.506 1.922 . . . . 0.0 113.949 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 9.8 p -64.98 -20.4 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.237 1.415 . . . . 0.0 113.629 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 120.33 -171.76 14.73 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.751 1.644 . . . . 0.0 113.683 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 96.9 t -124.66 137.17 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.029 1.732 . . . . 0.0 109.177 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 30.0 m120 -69.96 127.76 33.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.823 0.849 . . . . 0.0 111.728 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 81.18 165.55 34.49 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.762 1.172 . . . . 0.0 113.516 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.17 172.75 6.81 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.635 1.574 . . . . 0.0 111.551 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 45.3 t0 -150.65 161.73 42.03 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.876 1.67 . . . . 0.0 111.285 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 14.1 p -164.15 139.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.059 1.744 . . . . 0.0 110.928 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.5 t -158.21 26.72 0.25 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.554 1.542 . . . . 0.0 111.949 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 18.6 m -80.68 149.15 29.88 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.699 -1.25 . . . . 0.0 113.635 -171.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.58 141.25 53.81 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.51 -0.744 . . . . 0.0 109.853 161.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -66.01 119.98 65.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 110.608 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.71 137.74 43.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.93 2.42 . . . . 0.0 110.197 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 27.4 t80 -105.63 129.91 53.77 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.535 0.734 . . . . 0.0 111.663 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -157.61 142.8 16.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.505 1.522 . . . . 0.0 111.2 171.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.42 151.02 45.93 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.164 1.786 . . . . 0.0 109.954 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.4 p -115.59 138.07 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 109.938 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.34 134.49 26.14 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.002 1.721 . . . . 0.0 108.713 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.51 100.02 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.385 2.724 . . . . 0.0 109.572 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -161.82 148.79 14.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.496 1.918 . . . . 0.0 109.164 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.5 m -124.28 125.93 45.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.122 . . . . 0.0 109.357 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 80.1 mt -86.01 126.0 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 0.0 109.933 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.29 -161.25 0.75 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.946 1.698 . . . . 0.0 111.658 172.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.97 126.46 29.55 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.897 -1.127 . . . . 0.0 111.509 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.39 -144.6 12.98 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.952 1.739 . . . . 0.0 111.476 -170.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.74 141.95 16.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.146 0.978 . . . . 0.0 111.752 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.4 tt -133.5 134.04 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.052 1.741 . . . . 0.0 110.607 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.25 166.5 27.78 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.85 1.66 . . . . 0.0 111.06 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.73 -175.34 24.13 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.99 140.68 18.99 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.683 1.993 . . . . 0.0 109.333 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.2 t -117.92 131.71 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.716 1.606 . . . . 0.0 108.19 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -113.92 125.34 53.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.479 1.112 . . . . 0.0 110.633 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 37.6 mtm -104.25 138.67 19.59 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.354 1.461 . . . . 0.0 111.473 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -56.42 -29.48 77.75 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.513 3.476 . . . . 0.0 116.098 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 9.0 p -77.67 8.13 4.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.152 1.381 . . . . 0.0 114.666 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.44 46.41 4.06 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.69 1.138 . . . . 0.0 113.168 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.54 162.42 41.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.646 1.578 . . . . 0.0 112.014 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.7 m -140.26 157.76 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.819 1.247 . . . . 0.0 112.396 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -149.32 178.16 9.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.1 2.16 . . . . 0.0 109.999 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.83 142.19 30.37 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.114 -0.991 . . . . 0.0 111.75 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -83.64 167.22 13.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.214 3.276 . . . . 0.0 111.547 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 64.3 m -104.3 116.48 32.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.314 1.446 . . . . 0.0 108.982 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.24 130.03 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.328 1.051 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -121.2 125.63 47.62 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.374 1.87 . . . . 0.0 109.491 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 63.2 t0 -82.47 116.93 22.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.26 1.024 . . . . 0.0 110.154 172.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.2 -14.0 54.24 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 67.47 4.0 3.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.022 2.129 . . . . 0.0 114.204 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -102.55 6.78 40.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.792 2.037 . . . . 0.0 113.146 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.69 9.16 63.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.087 1.327 . . . . 0.0 113.912 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.2 p -127.17 161.44 28.49 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.524 1.929 . . . . 0.0 110.558 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -120.69 144.48 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.961 0.904 . . . . 0.0 109.656 163.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.9 m -105.47 138.15 42.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.398 1.079 . . . . 0.0 108.144 170.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -125.52 127.58 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.162 0.985 . . . . 0.0 109.21 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -123.81 158.0 32.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.298 1.439 . . . . 0.0 112.229 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 15.3 t80 -157.35 134.36 10.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.147 1.379 . . . . 0.0 111.812 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.77 117.11 68.03 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 0.0 110.515 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.22 145.15 27.13 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.234 2.623 . . . . 0.0 112.258 -173.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.6 t -138.73 -10.96 1.35 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -139.49 153.21 47.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.404 1.882 . . . . 0.0 109.654 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -99.63 166.51 11.09 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.545 1.138 . . . . 0.0 112.556 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.01 -168.15 13.26 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.24 1.4 . . . . 0.0 114.217 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.1 tp -83.33 110.75 18.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.838 1.255 . . . . 0.0 110.91 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -105.73 170.96 7.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.341 1.856 . . . . 0.0 112.304 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.29 152.4 41.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.491 1.117 . . . . 0.0 111.49 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 13.6 ttm -122.21 127.67 50.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.034 1.734 . . . . 0.0 110.08 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.69 131.58 49.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.25 2.22 . . . . 0.0 109.2 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.2 mm -138.32 135.1 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.78 1.232 . . . . 0.0 109.193 174.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.49 140.0 27.21 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.864 0.866 . . . . 0.0 113.324 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -99.44 119.96 38.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.121 1.768 . . . . 0.0 109.179 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.22 34.83 12.08 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.927 1.291 . . . . 0.0 113.057 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.0 m-80 72.79 10.21 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.573 2.349 . . . . 0.0 115.133 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.7 mtt -104.65 130.36 52.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.133 1.373 . . . . 0.0 110.391 167.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.29 137.65 55.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.243 -0.911 . . . . 0.0 113.35 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.7 pt -74.17 153.88 88.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.986 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.29 126.5 20.25 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.565 2.177 . . . . 0.0 110.632 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.23 -18.2 54.52 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.14 1.353 . . . . 0.0 114.302 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 62.0 m -87.64 154.91 53.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.848 1.824 . . . . 0.0 112.564 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.22 158.11 98.95 Favored 'Cis proline' 0 C--N 1.354 0.838 0 CA-C-N 119.258 0.771 . . . . 0.0 112.241 -4.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.0 mt -103.53 157.71 16.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.985 1.314 . . . . 0.0 111.244 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -141.22 138.89 33.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 109.606 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.5 p90 -166.64 159.39 14.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.507 1.123 . . . . 0.0 111.977 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 35.3 t80 -101.24 139.56 36.75 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.145 -0.972 . . . . 0.0 112.656 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 50.5 t -107.83 132.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.154 1.381 . . . . 0.0 109.688 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -147.79 175.18 11.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.991 2.117 . . . . 0.0 111.454 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -84.71 145.02 28.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 0.0 112.792 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 17.1 m -69.49 -25.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.544 -0.722 . . . . 0.0 112.221 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -99.65 34.31 2.28 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.277 1.831 . . . . 0.0 111.691 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 14.9 p -53.36 141.99 22.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.982 1.713 . . . . 0.0 114.208 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.5 37.02 3.76 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 126.16 1.838 . . . . 0.0 112.255 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -166.93 156.52 10.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.619 1.568 . . . . 0.0 112.857 -167.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.1 p -61.1 141.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 110.126 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 163.18 36.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.91 0.884 . . . . 0.0 111.604 -173.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.43 145.18 31.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.379 1.472 . . . . 0.0 111.936 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.7 p90 -166.31 157.73 13.33 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.796 1.638 . . . . 0.0 112.722 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 146.2 175.77 19.5 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.485 1.04 . . . . 0.0 114.483 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.54 -43.49 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.203 2.602 . . . . 0.0 112.259 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.56 73.77 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.085 0.857 . . . . 0.0 113.641 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.57 -19.17 63.68 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.3 m -110.4 -49.73 3.03 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.06 1.744 . . . . 0.0 111.327 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -135.27 133.69 39.19 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.19 1.796 . . . . 0.0 112.035 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -119.38 167.37 13.31 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.593 1.092 . . . . 0.0 113.314 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.04 130.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 109.218 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 139.46 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.836 0.854 . . . . 0.0 111.966 -175.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.83 6.12 4.4 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.674 1.99 . . . . 0.0 114.216 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 63.9 mttp -125.15 145.46 50.59 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.856 1.662 . . . . 0.0 111.06 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.01 133.58 21.78 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.606 2.204 . . . . 0.0 111.05 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -115.65 147.49 40.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.758 1.623 . . . . 0.0 110.179 173.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -166.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -160.76 176.17 11.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.769 1.628 . . . . 0.0 111.662 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.5 m -131.65 144.21 50.86 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.301 1.441 . . . . 0.0 110.789 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 36.3 t -113.92 138.19 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.075 1.75 . . . . 0.0 108.017 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.0 m120 -104.8 127.44 52.6 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.47 1.108 . . . . 0.0 110.037 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -125.07 3.22 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.648 1.979 . . . . 0.0 113.323 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.1 tttt -50.33 -36.71 33.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.317 1.847 . . . . 0.0 114.674 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -115.41 10.95 15.91 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.585 1.554 . . . . 0.0 113.132 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.57 -40.05 50.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.78 154.71 9.4 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.63 1.11 . . . . 0.0 112.323 -168.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.63 171.94 14.41 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.455 1.102 . . . . 0.0 112.957 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 134.72 14.87 1.12 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.861 1.219 . . . . 0.0 115.81 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 103.51 103.68 2.82 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.595 1.569 . . . . 0.0 113.204 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.57 143.29 31.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.216 1.407 . . . . 0.0 110.52 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.6 m -136.07 156.8 48.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 111.938 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.4 tp -157.96 133.58 9.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.206 1.803 . . . . 0.0 108.756 -173.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 159.78 38.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.738 0.815 . . . . 0.0 112.427 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.0 mt -134.58 131.2 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.565 1.146 . . . . 0.0 109.481 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.59 107.4 14.2 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.28 1.432 . . . . 0.0 109.309 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -120.52 -173.74 15.01 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.122 1.344 . . . . 0.0 113.992 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.57 -21.66 45.67 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.78 2.987 . . . . 0.0 111.904 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.0 t -137.94 157.9 45.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.629 1.572 . . . . 0.0 109.096 158.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -71.95 117.47 13.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.987 -1.071 . . . . 0.0 111.638 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.05 149.05 43.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.79 140.5 29.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.194 0.598 . . . . 0.0 109.536 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 43.8 mt -131.84 143.53 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 110.111 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.8 t -140.34 163.08 33.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.806 1.242 . . . . 0.0 110.829 166.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -161.51 155.33 21.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.524 1.13 . . . . 0.0 112.658 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 81.5 m -137.19 114.72 11.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.61 1.564 . . . . 0.0 109.283 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.2 144.92 27.21 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.82 1.248 . . . . 0.0 112.226 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -123.07 147.76 46.37 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.411 1.484 . . . . 0.0 111.75 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -71.98 -12.59 61.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.714 0.806 . . . . 0.0 112.514 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.2 -7.0 49.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.861 1.664 . . . . 0.0 114.027 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.94 32.57 7.07 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.576 1.084 . . . . 0.0 113.99 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.3 p -141.08 161.31 38.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 111.292 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 30.0 m -132.3 133.14 43.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.343 1.457 . . . . 0.0 109.366 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -94.1 147.97 22.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.187 0.995 . . . . 0.0 110.459 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.0 t -130.72 142.84 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.736 1.614 . . . . 0.0 110.118 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 90.5 p -135.18 149.24 49.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.091 1.356 . . . . 0.0 111.783 167.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -151.51 155.26 38.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 4.6 mt -121.08 104.19 41.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.284 1.834 . . . . 0.0 110.344 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.52 164.09 16.6 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.731 2.954 . . . . 0.0 110.274 166.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -127.18 -20.51 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.4 153.25 32.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.797 1.239 . . . . 0.0 110.984 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.14 151.88 39.46 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.878 2.385 . . . . 0.0 112.63 -168.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.46 -151.67 23.67 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.471 1.51 . . . . 0.0 112.68 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.98 128.81 51.9 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.089 1.356 . . . . 0.0 110.672 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.14 127.4 55.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.339 1.856 . . . . 0.0 109.653 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 57.1 m -89.31 125.23 35.03 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.777 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.67 126.88 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.895 1.278 . . . . 0.0 108.977 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.38 129.35 55.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 109.594 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -130.66 129.92 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.685 1.194 . . . . 0.0 109.025 171.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.85 144.59 23.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.91 1.284 . . . . 0.0 111.845 -167.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.47 123.66 15.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.005 1.322 . . . . 0.0 109.933 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 52.55 56.91 6.99 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.623 1.569 . . . . 0.0 112.172 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 7.5 pt-20 59.35 8.47 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.62 2.768 . . . . 0.0 116.544 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -115.75 124.84 51.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.454 1.102 . . . . 0.0 110.899 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -61.84 145.89 51.31 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.431 -0.793 . . . . 0.0 111.704 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.2 m -68.8 149.94 97.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.254 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.37 131.33 40.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.073 2.515 . . . . 0.0 111.576 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.59 -14.57 61.03 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.223 1.392 . . . . 0.0 114.943 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.6 t -80.1 144.17 58.3 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 119.011 1.405 . . . . 0.0 111.411 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.08 140.64 67.05 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 120.01 1.039 . . . . 0.0 112.576 -0.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.36 175.57 6.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 110.541 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 27.8 m -135.3 125.73 26.68 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 110.739 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.49 132.16 48.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.023 1.329 . . . . 0.0 109.973 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.9 ttt85 -92.47 136.9 32.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 61.5 t -132.75 131.81 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.514 1.126 . . . . 0.0 110.759 -163.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 7.3 t -173.55 164.66 4.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.346 1.858 . . . . 0.0 111.217 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 143.18 -163.15 27.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.539 1.543 . . . . 0.0 113.682 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 15.7 t70 72.31 7.04 5.64 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 127.197 2.199 . . . . 0.0 114.114 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.32 1.848 . . . . 0.0 113.916 177.4 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.5 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.34 163.61 27.84 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.469 1.108 . . . . 0.0 112.878 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 44.6 tpp -155.06 143.25 20.24 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.245 1.418 . . . . 0.0 111.432 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -98.75 156.46 35.57 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.541 1.537 . . . . 0.0 112.29 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.85 173.09 14.07 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.617 2.878 . . . . 0.0 111.553 172.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.54 3.32 9.64 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.07 1.348 . . . . 0.0 114.234 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 -60.71 148.24 82.54 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.075 1.35 . . . . 0.0 112.085 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.07 155.91 63.79 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.548 2.832 . . . . 0.0 112.277 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1777 ' ' LEU . . . . . 0.666 HD13 ' H ' ' A' 1777 ' ' LEU . 0.0 OUTLIER -75.74 7.66 3.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.866 1.666 . . . . 0.0 115.255 -176.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 13.6 p -151.62 143.73 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.322 1.849 . . . . 0.0 110.318 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -81.76 151.42 30.61 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.533 1.063 . . . . 0.0 113.391 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 24.0 m -146.16 160.7 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.789 2.036 . . . . 0.0 110.191 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -64.61 -39.82 94.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.996 0.518 . . . . 0.0 112.331 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 76.52 -44.36 1.96 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 126.439 1.971 . . . . 0.0 115.529 169.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 98.2 mt -79.7 129.21 34.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.379 1.472 . . . . 0.0 111.763 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -79.5 -26.18 41.64 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.633 1.173 . . . . 0.0 112.78 174.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 30.2 m -65.16 -7.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.366 1.466 . . . . 0.0 113.99 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 3.7 t -64.55 -26.53 68.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.96 0.904 . . . . 0.0 112.328 168.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 2.3 t 90.02 161.57 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.057 2.543 . . . . 0.0 115.186 165.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 62.1 mt -131.44 164.16 26.35 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.962 2.505 . . . . 0.0 109.792 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -55.91 115.97 11.03 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.744 1.218 . . . . 0.0 110.975 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.94 151.54 50.66 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.822 2.348 . . . . 0.0 110.501 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.51 118.41 35.68 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.286 0.634 . . . . 0.0 110.195 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -150.63 122.34 8.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.687 1.595 . . . . 0.0 109.832 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.81 149.12 47.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.159 1.784 . . . . 0.0 110.088 -171.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.7 p -118.87 138.12 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.011 1.324 . . . . 0.0 109.689 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 51.1 mt -134.43 135.53 24.01 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.198 1.799 . . . . 0.0 108.42 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.91 31.21 0.44 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.488 3.458 . . . . 0.0 113.628 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.0 t80 -83.03 157.55 22.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.276 1.431 . . . . 0.0 110.833 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 90.5 m -129.62 126.35 38.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.314 1.446 . . . . 0.0 109.574 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 93.9 mt -87.58 134.53 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 110.389 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1800 ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' 1801 ' ' LYS . 29.0 ttpt -119.81 -147.48 0.4 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.77 1.628 . . . . 0.0 110.851 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1801 ' ' LYS . . . . . 0.443 ' H ' ' HG2' ' A' 1800 ' ' LYS . 8.0 tmtm? -73.5 123.11 23.28 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.573 -1.33 . . . . 0.0 110.201 171.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.2 -148.98 20.08 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.241 1.4 . . . . 0.0 112.16 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -156.97 145.79 19.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 110.772 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -129.03 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.596 1.558 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 44.6 p -144.75 -177.1 5.34 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.345 1.858 . . . . 0.0 109.998 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.84 37.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -154.49 133.15 12.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.319 1.447 . . . . 0.0 110.258 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.1 t -102.22 130.73 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.906 1.682 . . . . 0.0 108.458 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -106.14 125.53 51.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.404 1.481 . . . . 0.0 110.748 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 19.2 mtm -92.76 146.59 32.48 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.381 1.472 . . . . 0.0 110.447 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.68 -16.62 30.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.269 2.646 . . . . 0.0 113.488 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 51.7 p -73.96 -5.53 41.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.179 1.391 . . . . 0.0 113.929 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 98.48 -5.32 60.46 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.979 1.752 . . . . 0.0 114.177 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -73.81 159.55 32.74 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.5 1.12 . . . . 0.0 112.207 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.4 m -141.55 154.76 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.145 1.378 . . . . 0.0 111.771 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.19 166.65 32.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.351 1.86 . . . . 0.0 111.255 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -101.76 138.6 19.87 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 121.304 -0.873 . . . . 0.0 111.815 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -83.85 169.5 11.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.361 3.374 . . . . 0.0 111.672 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.3 m -108.62 131.69 54.63 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.611 1.564 . . . . 0.0 109.12 172.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.82 132.82 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.207 1.403 . . . . 0.0 109.126 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 84.8 m -135.39 127.87 30.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.49 1.516 . . . . 0.0 110.081 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.2 129.32 34.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.395 0.678 . . . . 0.0 110.861 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -82.52 -5.43 58.73 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 27.0 mmmt 73.24 3.86 4.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.145 2.578 . . . . 0.0 113.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -109.33 8.19 25.45 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.995 2.118 . . . . 0.0 112.967 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.2 20.42 42.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.72 1.152 . . . . 0.0 113.876 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 41.8 p -133.94 158.28 43.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.273 1.829 . . . . 0.0 109.966 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.97 146.73 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.472 1.109 . . . . 0.0 110.059 167.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.6 m -104.2 138.63 40.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.797 1.239 . . . . 0.0 108.449 167.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 27.3 t -126.47 134.81 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.991 1.317 . . . . 0.0 109.373 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -136.67 158.13 45.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.856 1.262 . . . . 0.0 113.277 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 10.3 t80 -156.42 135.42 11.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.314 1.846 . . . . 0.0 111.36 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.27 119.32 72.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.338 1.055 . . . . 0.0 110.579 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.97 145.39 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.53 2.82 . . . . 0.0 112.155 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.9 t -136.73 -14.52 1.64 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.81 152.35 45.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.995 1.718 . . . . 0.0 109.962 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.79 168.85 12.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.034 0.934 . . . . 0.0 112.116 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 105.15 -168.5 15.71 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.648 1.594 . . . . 0.0 113.916 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 39.7 tp -78.74 132.25 36.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.73 1.212 . . . . 0.0 110.613 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 47.5 m80 -127.17 166.37 17.82 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.796 1.638 . . . . 0.0 111.093 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -145.81 153.16 40.6 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.732 0.813 . . . . 0.0 111.356 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 65.4 ttp -128.28 117.21 21.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.568 1.547 . . . . 0.0 110.314 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.82 129.19 35.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.465 2.306 . . . . 0.0 109.411 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.5 mm -130.85 132.11 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 109.913 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 136.22 21.3 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -99.56 119.27 37.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.745 2.418 . . . . 0.0 109.699 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.16 36.14 15.01 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.808 1.243 . . . . 0.0 112.795 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.7 2.93 3.0 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.623 2.369 . . . . 0.0 113.93 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 68.8 mtm -104.37 131.65 51.49 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.617 1.567 . . . . 0.0 110.739 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -55.33 138.22 46.0 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.4 pt -72.47 154.01 91.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 166.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.56 129.33 30.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.237 1.958 . . . . 0.0 110.4 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.57 1.56 87.58 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.652 1.12 . . . . 0.0 115.453 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.1 t -76.03 145.89 78.02 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 119.771 1.785 . . . . 0.0 111.652 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.54 159.85 88.59 Favored 'Cis proline' 0 C--N 1.353 0.816 0 CA-C-N 119.845 0.98 . . . . 0.0 112.076 -6.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.92 148.47 22.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.874 1.27 . . . . 0.0 110.288 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -121.17 144.33 48.64 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.484 1.114 . . . . 0.0 110.586 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.6 p90 -163.54 164.78 24.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.152 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.5 t80 -110.7 143.99 40.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.045 0.938 . . . . 0.0 112.705 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.9 t -117.09 141.89 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.422 1.489 . . . . 0.0 109.32 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.7 t0 -157.22 165.36 36.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 0.0 111.463 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.19 148.43 47.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.581 1.152 . . . . 0.0 112.861 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.1 m -86.52 -16.47 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -109.58 -5.91 15.54 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -168.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 84.9 m -82.66 153.94 25.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.493 1.117 . . . . 0.0 112.878 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.62 -9.64 62.65 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.973 1.273 . . . . 0.0 115.238 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -65.38 159.27 24.48 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.69 1.245 . . . . 0.0 113.675 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.5 t -65.96 136.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.038 0.935 . . . . 0.0 109.083 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.4 t -156.49 145.53 20.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.53 1.132 . . . . 0.0 110.379 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.97 141.51 44.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.822 1.249 . . . . 0.0 111.86 -170.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.8 p90 -169.16 163.72 11.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 112.756 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.0 172.18 12.8 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.4 1.476 . . . . 0.0 112.784 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.94 -33.35 16.06 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.833 2.355 . . . . 0.0 112.681 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.3 -37.07 92.54 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.549 1.068 . . . . 0.0 114.321 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.85 -6.23 53.51 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.784 1.292 . . . . 0.0 113.272 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 53.9 m -97.35 -43.73 7.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.899 1.68 . . . . 0.0 110.777 170.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -152.86 124.54 7.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.041 1.737 . . . . 0.0 112.3 -164.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -127.65 -179.54 15.89 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.448 1.975 . . . . 0.0 112.315 166.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.9 t -142.59 139.77 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.821 1.649 . . . . 0.0 107.792 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.62 134.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 118.288 0.494 . . . . 0.0 112.125 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.4 m-80 67.93 -1.39 1.74 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.964 2.106 . . . . 0.0 114.752 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.45 137.17 19.56 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.949 1.3 . . . . 0.0 110.957 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.16 122.58 8.16 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.609 2.206 . . . . 0.0 110.299 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.15 144.03 34.47 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.4 1.48 . . . . 0.0 110.484 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.11 148.45 49.8 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.56 175.95 12.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.898 1.679 . . . . 0.0 112.011 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -132.36 145.55 51.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.095 1.358 . . . . 0.0 110.921 -171.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 28.6 t -117.47 138.0 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.13 1.772 . . . . 0.0 108.436 168.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -94.97 134.1 38.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.351 1.061 . . . . 0.0 111.423 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 72.3 p -131.13 3.67 4.36 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.164 1.785 . . . . 0.0 113.11 -171.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -55.99 -34.46 65.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.617 1.967 . . . . 0.0 115.615 -164.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.04 19.42 5.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.548 1.539 . . . . 0.0 112.357 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.69 -34.26 60.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -171.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.79 148.45 9.68 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.874 1.226 . . . . 0.0 112.737 -171.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.19 148.23 39.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.527 1.131 . . . . 0.0 112.165 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 172.01 -24.1 0.08 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.51 1.052 . . . . 0.0 115.121 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.81 110.14 1.15 Allowed Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.497 1.523 . . . . 0.0 112.643 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.44 126.76 32.58 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.609 1.564 . . . . 0.0 109.037 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 44.3 m -122.79 155.64 36.14 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.869 1.668 . . . . 0.0 111.875 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.6 tp -158.44 135.16 9.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.614 1.566 . . . . 0.0 109.131 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.57 159.0 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.995 0.918 . . . . 0.0 112.175 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -136.07 141.32 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.846 1.258 . . . . 0.0 109.661 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.24 161.7 28.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 109.882 170.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.87 31.47 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 118.875 -0.958 . . . . 0.0 114.317 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.57 -24.84 62.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.048 3.165 . . . . 0.0 112.717 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.1 t -143.42 160.87 39.77 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.311 1.444 . . . . 0.0 109.628 164.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.2 tptt -74.34 116.99 15.64 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.071 -1.018 . . . . 0.0 110.989 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.59 149.07 46.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.73 0.812 . . . . 0.0 111.738 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -85.79 140.82 30.14 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.644 0.778 . . . . 0.0 109.171 166.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.3 143.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.439 1.096 . . . . 0.0 110.402 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -140.63 164.97 28.74 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.871 1.268 . . . . 0.0 110.906 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.3 p -161.55 158.88 27.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.758 1.223 . . . . 0.0 112.555 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 50.4 m -144.42 119.14 9.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.989 1.316 . . . . 0.0 110.126 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.57 130.37 36.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.565 1.146 . . . . 0.0 110.938 171.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -109.77 145.57 36.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.883 1.673 . . . . 0.0 111.73 -176.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.02 -18.17 65.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.966 1.307 . . . . 0.0 113.237 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -69.62 -22.43 63.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.558 1.143 . . . . 0.0 113.636 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 103.41 43.54 1.84 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.271 0.939 . . . . 0.0 113.223 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 57.6 p -139.09 159.36 42.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.177 1.391 . . . . 0.0 110.398 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 36.4 t -115.38 125.63 53.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.174 1.39 . . . . 0.0 108.588 161.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.2 t -87.21 151.4 23.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.853 0.861 . . . . 0.0 110.293 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -133.03 143.12 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.827 1.651 . . . . 0.0 110.085 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.5 p -135.6 148.05 48.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.949 1.3 . . . . 0.0 111.694 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.2 p90 -150.39 153.17 35.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.9 mt -120.55 105.62 41.09 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.559 1.943 . . . . 0.0 109.869 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -82.67 176.87 7.39 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.847 3.031 . . . . 0.0 110.321 167.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -148.85 -30.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 69.3 mt -107.58 147.63 35.69 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 119.725 1.148 . . . . 0.0 110.767 167.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.6 155.17 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.128 2.552 . . . . 0.0 111.041 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.65 -159.09 25.8 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.442 1.496 . . . . 0.0 113.134 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.01 135.26 41.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.065 1.346 . . . . 0.0 111.929 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -118.87 142.49 47.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.718 1.607 . . . . 0.0 110.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -101.65 122.0 43.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.82 1.248 . . . . 0.0 110.356 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.91 120.89 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.775 1.63 . . . . 0.0 108.466 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.1 tt -103.69 131.36 50.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.478 1.511 . . . . 0.0 109.744 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 131.32 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.454 1.502 . . . . 0.0 108.098 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -152.99 142.9 22.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.104 1.362 . . . . 0.0 110.325 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.93 123.75 11.26 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.213 -0.93 . . . . 0.0 110.534 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 43.8 t-20 57.5 54.25 6.67 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.973 1.309 . . . . 0.0 111.443 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 9.4 pt-20 56.2 22.7 6.35 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.21 2.604 . . . . 0.0 115.975 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.4 129.78 39.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.558 1.143 . . . . 0.0 111.328 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.42 156.89 18.08 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.187 0.995 . . . . 0.0 112.482 169.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.7 m -87.83 156.68 52.52 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.272 0.629 . . . . 0.0 110.489 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.52 119.1 5.86 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.885 2.39 . . . . 0.0 110.203 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.94 -13.2 65.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.297 1.427 . . . . 0.0 116.564 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.5 p -81.5 151.36 68.59 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 119.921 1.861 . . . . 0.0 113.214 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 146.56 86.88 Favored 'Cis proline' 0 C--N 1.355 0.885 0 CA-C-N 119.076 0.706 . . . . 0.0 112.051 -6.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.64 159.31 15.05 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 110.955 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 48.4 m -114.71 121.17 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.817 0.847 . . . . 0.0 110.654 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -104.02 141.35 36.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.421 1.488 . . . . 0.0 111.623 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.56 141.02 41.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.548 1.139 . . . . 0.0 109.912 164.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.1 t -133.24 138.74 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.655 1.182 . . . . 0.0 109.562 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 11.8 p -132.7 169.99 15.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.677 1.191 . . . . 0.0 112.469 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.48 140.99 27.05 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.603 1.573 . . . . 0.0 113.129 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.7 t70 -86.69 -25.77 24.62 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.5 1.12 . . . . 0.0 113.047 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.949 1.699 . . . . 0.0 113.519 -179.874 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 112.196 -0.362 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.88 155.83 39.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.53 1.132 . . . . 0.0 112.813 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 96.7 mtp -85.52 146.24 27.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.211 1.405 . . . . 0.0 110.669 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . 72.43 153.19 0.15 Allowed Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 127.853 2.461 . . . . 0.0 112.316 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.34 161.77 44.59 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.072 2.515 . . . . 0.0 113.183 -170.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.21 6.19 4.63 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.503 1.521 . . . . 0.0 114.807 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -52.98 138.91 44.56 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 125.371 1.468 . . . . 0.0 110.728 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.24 130.73 21.31 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.393 2.729 . . . . 0.0 112.799 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 7.0 mp 74.46 -2.02 2.93 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 127.946 2.499 . . . . 0.0 113.752 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 17.2 t -108.33 148.85 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.118 1.767 . . . . 0.0 109.866 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 119.73 138.09 5.62 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.441 1.496 . . . . 0.0 112.309 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 10.1 p -153.33 147.9 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.669 1.188 . . . . 0.0 111.841 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -137.1 150.48 48.03 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.32 1.448 . . . . 0.0 112.27 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 117.08 159.03 11.35 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.818 1.675 . . . . 0.0 113.796 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 81.6 mt -88.89 -179.51 5.97 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.479 1.512 . . . . 0.0 111.966 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 46.5 t0 -147.3 164.45 33.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.861 1.664 . . . . 0.0 111.014 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.7 p -61.24 -21.57 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.116 1.366 . . . . 0.0 113.788 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.0 t -77.81 -8.62 58.28 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.544 1.538 . . . . 0.0 114.204 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 69.1 m -72.72 84.98 1.2 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.452 1.024 . . . . 0.0 113.695 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.3 147.69 39.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.475 1.51 . . . . 0.0 110.51 160.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.19 121.19 67.86 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.17 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.5 148.1 47.43 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.664 2.243 . . . . 0.0 110.424 173.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.36 135.66 33.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.468 0.651 . . . . 0.0 110.733 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -157.33 144.28 18.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.021 1.728 . . . . 0.0 110.531 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.36 149.87 21.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.455 1.502 . . . . 0.0 109.73 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -123.17 132.74 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.166 1.386 . . . . 0.0 109.489 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 74.0 mt -129.37 136.27 28.88 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.325 1.85 . . . . 0.0 108.735 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.0 72.24 6.27 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.256 3.304 . . . . 0.0 111.419 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 34.6 t80 -124.41 152.5 43.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.589 1.956 . . . . 0.0 109.338 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 34.6 m -127.25 125.62 41.28 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.424 1.09 . . . . 0.0 109.624 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.2 mt -75.08 135.6 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 110.378 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 21.4 pttp -128.84 -147.85 0.36 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.248 1.819 . . . . 0.0 110.923 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.11 126.74 29.02 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.537 -1.352 . . . . 0.0 110.418 165.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 124.65 -154.03 17.93 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.52 1.533 . . . . 0.0 112.183 -170.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -161.39 151.95 17.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 111.214 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.48 134.89 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.51 1.524 . . . . 0.0 111.847 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -147.52 158.85 44.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.561 1.544 . . . . 0.0 110.917 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -137.44 -175.85 14.08 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -153.39 143.71 22.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.341 1.856 . . . . 0.0 109.065 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 98.3 t -119.45 129.31 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.719 1.608 . . . . 0.0 108.008 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -113.5 130.08 56.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.356 1.462 . . . . 0.0 110.479 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 34.8 mtm -108.67 139.92 21.32 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.413 1.485 . . . . 0.0 111.875 -171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.37 -27.48 75.89 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 124.258 3.305 . . . . 0.0 115.54 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.8 p -75.08 4.87 6.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.353 1.461 . . . . 0.0 114.563 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.83 44.54 5.12 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 124.665 1.126 . . . . 0.0 113.088 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -153.24 165.07 36.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.522 1.529 . . . . 0.0 112.107 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.6 m -141.25 159.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.67 1.188 . . . . 0.0 112.632 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.05 175.55 13.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.063 2.145 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -121.91 143.9 39.75 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.123 -0.985 . . . . 0.0 112.204 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -86.25 171.74 7.56 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 111.877 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.2 m -106.91 130.56 54.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 109.031 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.88 132.88 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.163 1.385 . . . . 0.0 108.951 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -136.55 124.04 22.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.36 1.464 . . . . 0.0 109.975 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.1 126.41 30.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.54 0.736 . . . . 0.0 110.753 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.02 -6.33 57.39 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 73.68 1.09 3.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 113.537 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -102.85 4.6 37.9 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.086 2.155 . . . . 0.0 112.979 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.08 15.89 40.27 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.069 1.319 . . . . 0.0 114.341 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.0 p -130.69 155.94 45.76 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.163 1.785 . . . . 0.0 110.615 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -112.64 137.34 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.71 165.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.5 m -93.74 137.91 32.5 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.583 1.153 . . . . 0.0 108.424 167.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.2 t -125.5 133.43 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.469 1.508 . . . . 0.0 108.855 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -139.84 155.79 47.05 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 0.0 112.656 -176.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.3 t80 -151.05 134.55 16.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 111.547 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.86 122.72 74.45 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.575 1.15 . . . . 0.0 111.105 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.23 161.15 20.27 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.784 2.99 . . . . 0.0 111.938 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -149.81 -21.81 0.27 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -141.4 149.54 41.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.46 1.904 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.91 167.76 19.5 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.039 0.936 . . . . 0.0 112.98 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 122.58 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.59 1.567 . . . . 0.0 114.085 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tt -83.68 118.7 24.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.436 1.094 . . . . 0.0 109.417 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 28.3 m80 -111.38 158.43 19.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.524 1.53 . . . . 0.0 111.054 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -143.73 150.99 39.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.482 0.658 . . . . 0.0 112.337 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.8 ttm -132.14 139.2 48.35 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.782 2.033 . . . . 0.0 110.712 -164.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -112.19 137.37 50.37 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 109.635 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.3 mm -133.93 129.39 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.646 1.178 . . . . 0.0 109.683 174.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.87 137.66 36.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 19.9 t80 -103.83 124.91 49.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.499 1.92 . . . . 0.0 109.672 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 27.3 t70 48.29 46.51 20.11 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.779 1.232 . . . . 0.0 112.293 -177.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.306 0.3 OUTLIER 62.78 13.35 6.4 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 128.005 2.522 . . . . 0.0 116.543 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 58.9 ttm -114.74 130.41 56.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.529 1.532 . . . . 0.0 110.926 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -56.06 135.9 52.53 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.285 -0.885 . . . . 0.0 113.053 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.87 154.32 89.02 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.328 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.04 128.2 25.78 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.992 1.794 . . . . 0.0 109.403 170.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.35 -16.05 58.34 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.702 1.144 . . . . 0.0 114.098 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.1 t -82.41 146.98 55.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-N 119.803 1.802 . . . . 0.0 110.876 170.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.68 163.85 82.86 Favored 'Cis proline' 0 C--N 1.353 0.804 0 CA-C-N 120.333 1.155 . . . . 0.0 112.413 -6.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.5 159.26 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.17 1.788 . . . . 0.0 111.047 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -155.4 148.72 24.89 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 112.819 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 7.8 p90 -167.2 -179.4 4.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.968 1.707 . . . . 0.0 111.264 -167.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -120.48 142.39 49.32 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.779 -1.201 . . . . 0.0 113.405 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.1 t -111.73 134.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.144 1.778 . . . . 0.0 108.966 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -161.29 158.31 26.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.96 1.304 . . . . 0.0 112.923 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -75.48 122.15 23.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 112.124 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 32.7 m -79.79 -15.77 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 p30 -85.07 -14.69 46.45 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.719 1.208 . . . . 0.0 114.181 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.7 m -77.81 -17.22 57.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 85.16 -3.44 87.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 0.0 115.676 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -64.84 156.0 32.22 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 119.201 1.501 . . . . 0.0 112.962 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.5 t -68.19 131.82 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.2 t -152.92 161.1 42.97 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.507 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.84 142.8 36.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.358 1.463 . . . . 0.0 111.235 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 20.6 p90 -163.58 161.11 23.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.572 1.549 . . . . 0.0 112.161 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.67 176.97 15.63 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.863 1.22 . . . . 0.0 113.293 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.12 -37.94 5.49 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.045 2.496 . . . . 0.0 112.594 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.91 -32.54 73.69 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.588 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.23 -3.84 41.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.769 1.284 . . . . 0.0 113.426 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.7 m -110.35 -48.48 3.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.327 1.851 . . . . 0.0 111.109 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -138.54 145.96 41.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.101 1.76 . . . . 0.0 112.235 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.91 -179.27 21.15 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.574 1.083 . . . . 0.0 113.624 173.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.0 t -143.57 136.04 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.108 1.363 . . . . 0.0 108.598 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.3 m -56.46 137.34 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.2 m-80 68.06 -2.88 1.36 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.756 2.022 . . . . 0.0 114.663 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -100.9 136.99 19.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.039 1.336 . . . . 0.0 110.725 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.25 127.95 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.377 2.051 . . . . 0.0 110.124 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.12 146.55 36.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.613 1.565 . . . . 0.0 110.523 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.4 p -136.43 153.98 50.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -164.16 172.49 13.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.26 1.824 . . . . 0.0 111.351 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.7 m -122.75 142.42 50.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.161 1.384 . . . . 0.0 110.694 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.9 t -115.85 133.71 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.474 1.509 . . . . 0.0 108.417 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.73 132.85 36.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.381 1.072 . . . . 0.0 111.585 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 45.8 p -136.64 0.87 2.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.189 1.395 . . . . 0.0 114.108 -169.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -53.46 -37.86 63.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 115.119 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -117.01 9.92 13.82 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.396 1.479 . . . . 0.0 112.538 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.13 56.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.446 1.099 . . . . 0.0 113.504 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.36 -106.77 2.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.609 1.1 . . . . 0.0 112.247 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -161.45 155.12 21.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.523 1.929 . . . . 0.0 109.942 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 148.08 9.21 0.19 Allowed Glycine 0 N--CA 1.473 1.118 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.03 103.84 2.05 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 126.078 1.799 . . . . 0.0 112.479 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.72 132.85 33.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.984 1.713 . . . . 0.0 109.603 171.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.3 m -129.86 157.99 40.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.6 1.56 . . . . 0.0 112.134 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.1 tp -159.02 136.06 9.69 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.029 1.732 . . . . 0.0 109.184 -170.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.45 158.93 36.73 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 112.424 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.3 mt -137.51 139.04 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.89 1.276 . . . . 0.0 109.98 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.83 129.16 40.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.369 1.468 . . . . 0.0 109.944 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.35 -162.16 11.24 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 119.04 -0.866 . . . . 0.0 114.386 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.7 -24.72 69.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.042 3.162 . . . . 0.0 112.56 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.6 t -138.97 160.45 39.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.978 1.311 . . . . 0.0 109.627 162.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -71.75 112.34 7.77 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.134 -0.979 . . . . 0.0 110.689 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.64 148.77 50.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.694 0.798 . . . . 0.0 111.688 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.44 140.71 29.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.09 143.89 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.665 1.186 . . . . 0.0 110.259 -167.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.9 t -141.67 156.5 45.64 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.13 1.372 . . . . 0.0 111.144 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 48.9 t -145.35 136.97 25.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.211 1.405 . . . . 0.0 110.66 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 93.5 m -132.3 129.33 39.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.272 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.99 131.5 43.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 110.779 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.17 -131.23 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.85 0.86 . . . . 0.0 110.222 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -84.1 38.04 0.64 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.461 -1.399 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 20.7 t70 71.37 -20.44 0.23 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.813 2.845 . . . . 0.0 114.588 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . -76.77 -21.27 74.89 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.758 1.17 . . . . 0.0 114.194 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 31.8 p -147.5 157.61 43.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.788 1.635 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 74.2 m -115.54 136.7 52.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.115 1.766 . . . . 0.0 109.205 162.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -98.57 136.89 38.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.466 1.106 . . . . 0.0 110.493 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.5 t -111.43 142.48 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.93 1.692 . . . . 0.0 109.782 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 51.9 m -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.145 1.378 . . . . 0.0 110.833 168.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 9.6 p90 -148.38 154.29 39.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 8.8 mt -120.62 107.66 38.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.893 1.677 . . . . 0.0 110.763 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.64 175.03 9.18 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.036 3.157 . . . . 0.0 110.46 166.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.3 p -151.07 -30.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.4 mt -105.6 146.33 32.61 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.586 1.085 . . . . 0.0 110.533 167.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.86 154.53 48.46 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.911 2.407 . . . . 0.0 110.949 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.13 -158.6 24.0 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.796 1.188 . . . . 0.0 113.247 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -100.82 133.31 45.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.09 1.356 . . . . 0.0 112.492 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.83 126.07 50.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.999 1.72 . . . . 0.0 109.956 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 71.2 m -84.32 126.62 33.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.108 0.963 . . . . 0.0 110.582 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.73 124.99 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.6 1.56 . . . . 0.0 108.283 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -108.86 130.49 55.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.29 1.436 . . . . 0.0 109.811 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -132.58 128.79 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.417 1.087 . . . . 0.0 109.879 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.99 142.2 24.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.058 1.343 . . . . 0.0 111.718 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.65 121.36 16.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.809 1.244 . . . . 0.0 109.448 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.41 57.37 4.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.472 1.509 . . . . 0.0 112.159 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.285 8.5 pt-20 57.21 12.12 1.26 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.498 2.719 . . . . 0.0 116.329 -177.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -119.26 125.31 48.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.704 1.202 . . . . 0.0 110.671 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -64.72 147.39 53.17 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.457 -0.777 . . . . 0.0 111.894 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 21.8 m -69.11 152.47 96.71 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.044 168.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.99 128.69 23.66 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.254 1.969 . . . . 0.0 110.063 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.52 -14.74 64.74 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.989 1.28 . . . . 0.0 115.007 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.8 t -78.16 139.94 61.08 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.258 1.529 . . . . 0.0 111.295 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.41 135.55 40.83 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.383 0.816 . . . . 0.0 111.905 -3.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.3 170.9 12.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.0 1.72 . . . . 0.0 110.399 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 52.4 m -132.73 121.27 22.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.35 140.33 30.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.312 1.445 . . . . 0.0 110.872 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -100.89 122.52 43.6 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.732 0.813 . . . . 0.0 109.968 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.7 t -109.26 129.89 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.589 1.555 . . . . 0.0 110.373 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.5 p -100.68 155.96 17.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.676 1.19 . . . . 0.0 112.752 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.7 121.98 6.85 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.404 1.478 . . . . 0.0 111.183 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -151.86 4.23 0.41 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.823 1.249 . . . . 0.0 113.636 178.973 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.79 -26.0 64.07 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 54.4 mtm -139.73 161.68 36.96 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.685 1.594 . . . . 0.0 111.093 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -65.04 -44.17 69.99 Favored Pre-proline 0 CA--C 1.556 1.181 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.15 172.33 16.27 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.661 2.241 . . . . 0.0 112.297 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -67.17 1.64 1.98 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.354 1.862 . . . . 0.0 114.681 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -117.21 56.48 1.81 Allowed Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 126.831 2.052 . . . . 0.0 113.276 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.97 166.11 30.15 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.43 2.753 . . . . 0.0 111.786 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.63 33.66 0.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.686 1.594 . . . . 0.0 113.413 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 60.2 t -142.58 135.28 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 127.025 2.13 . . . . 0.0 109.082 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 166.78 174.76 36.35 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.657 1.123 . . . . 0.0 114.046 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 12.9 p -165.09 145.43 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 126.293 1.837 . . . . 0.0 110.21 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -68.5 128.2 35.76 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.826 0.851 . . . . 0.0 111.869 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -86.18 -15.83 63.92 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.722 1.154 . . . . 0.0 114.416 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.4 mt -91.17 153.79 19.79 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.685 1.194 . . . . 0.0 111.618 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 44.0 t0 -106.04 157.57 17.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.636 1.574 . . . . 0.0 111.052 167.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 58.3 t -141.38 132.49 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.74 1.616 . . . . 0.0 109.406 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 8.8 t -172.87 -38.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.894 2.078 . . . . 0.0 110.854 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 72.5 m -118.83 139.08 52.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.367 1.067 . . . . 0.0 111.982 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 5.7 mt -125.91 161.42 27.5 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.627 2.371 . . . . 0.0 110.149 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.38 117.49 16.88 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.605 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.67 112.54 3.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.546 2.164 . . . . 0.0 108.809 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.71 135.48 42.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.718 0.807 . . . . 0.0 111.686 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.75 166.07 27.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.508 1.923 . . . . 0.0 111.411 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 156.47 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.427 1.491 . . . . 0.0 111.038 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -121.67 135.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.326 1.45 . . . . 0.0 109.364 167.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 65.2 mt -132.02 136.94 29.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.368 1.867 . . . . 0.0 108.367 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.76 42.45 1.26 Allowed 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.46 3.44 . . . . 0.0 113.124 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -89.01 159.16 17.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.303 1.441 . . . . 0.0 111.546 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.5 m -127.04 128.1 45.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.396 1.478 . . . . 0.0 110.282 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 26.4 mt -93.8 130.67 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.617 1.167 . . . . 0.0 109.376 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -113.24 -75.23 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.635 1.174 . . . . 0.0 111.791 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.8 tttm -160.07 133.73 7.08 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.998 1.719 . . . . 0.0 110.951 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.6 -137.73 9.76 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.533 1.54 . . . . 0.0 110.945 -166.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -155.88 140.11 16.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.026 0.931 . . . . 0.0 111.727 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.9 tt -116.74 138.08 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.847 1.659 . . . . 0.0 110.696 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.0 p -144.1 177.96 8.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.19 1.796 . . . . 0.0 110.392 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.18 -172.27 37.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -156.41 143.83 19.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.62 1.568 . . . . 0.0 109.919 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 91.0 t -118.17 132.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.566 1.546 . . . . 0.0 108.674 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -108.76 137.14 47.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 112.166 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 8.3 mtm -103.0 142.5 24.68 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.059 1.743 . . . . 0.0 111.135 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.33 -27.21 66.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.052 3.168 . . . . 0.0 115.278 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.8 p -73.81 0.69 12.42 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.407 1.483 . . . . 0.0 114.37 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.71 69.22 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.892 1.71 . . . . 0.0 114.3 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -73.69 156.81 37.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.057 1.343 . . . . 0.0 112.153 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.0 m -139.95 152.59 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.594 1.557 . . . . 0.0 110.795 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.29 170.04 22.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.721 1.608 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -101.74 138.62 19.88 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.704 0.802 . . . . 0.0 111.556 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.36 162.53 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.946 3.098 . . . . 0.0 111.073 169.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 91.4 m -109.82 119.39 39.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.332 1.453 . . . . 0.0 108.997 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.73 132.01 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.957 1.303 . . . . 0.0 109.239 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.5 m -134.13 120.14 19.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.565 1.546 . . . . 0.0 109.376 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.37 131.64 37.05 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.718 0.807 . . . . 0.0 112.094 172.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.96 -3.55 58.96 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt 73.06 0.78 3.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.575 2.35 . . . . 0.0 113.875 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -109.78 8.44 24.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.802 2.041 . . . . 0.0 113.112 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.31 15.75 49.68 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.866 1.222 . . . . 0.0 114.352 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 45.1 p -131.14 161.03 33.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.216 1.806 . . . . 0.0 110.415 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 17.9 m -122.75 140.77 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 110.212 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 46.7 m -98.29 140.66 32.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.993 1.317 . . . . 0.0 108.432 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.4 t -127.56 134.84 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.546 1.139 . . . . 0.0 109.522 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -132.18 162.87 29.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.651 1.581 . . . . 0.0 111.984 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.1 t80 -157.14 140.4 15.55 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.513 1.525 . . . . 0.0 111.796 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.98 114.86 63.87 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.705 1.202 . . . . 0.0 110.807 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.68 158.33 28.29 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.593 2.862 . . . . 0.0 112.075 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 95.9 p -143.45 0.37 1.14 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -169.59 157.25 7.02 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.415 1.886 . . . . 0.0 110.554 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.87 170.94 15.62 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.324 1.05 . . . . 0.0 113.085 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.7 -177.79 16.39 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 125.884 1.707 . . . . 0.0 114.391 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.0 tp -86.93 112.38 21.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 110.155 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 45.2 m80 -105.71 171.69 7.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.002 1.721 . . . . 0.0 111.444 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.34 151.17 37.07 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.948 0.899 . . . . 0.0 111.339 172.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 31.4 ttm -119.19 129.98 55.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.059 1.744 . . . . 0.0 110.685 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.77 134.3 40.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.082 2.553 . . . . 0.0 109.392 165.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.0 mm -138.47 135.98 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.928 1.291 . . . . 0.0 108.703 168.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.71 142.15 24.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.993 0.917 . . . . 0.0 113.384 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.63 118.73 36.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.405 1.882 . . . . 0.0 109.611 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.14 34.23 10.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.62 1.168 . . . . 0.0 112.727 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 73.05 8.05 5.39 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.827 2.451 . . . . 0.0 115.11 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.98 128.68 46.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.375 1.47 . . . . 0.0 110.459 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 139.27 55.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.6 pt -73.66 150.29 88.71 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.88 169.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.21 -20.12 66.67 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.837 2.358 . . . . 0.0 113.959 -172.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.42 1.01 88.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.099 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.1 m -119.84 156.46 54.08 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 120.031 1.916 . . . . 0.0 113.347 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.35 169.29 74.4 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 119.098 0.714 . . . . 0.0 113.212 0.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 74.3 mt -129.71 150.12 51.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.375 1.87 . . . . 0.0 110.563 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.8 136.84 47.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.936 1.294 . . . . 0.0 110.164 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.4 p90 -154.17 149.26 26.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.386 1.074 . . . . 0.0 112.213 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.5 t80 -99.87 145.27 27.96 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.179 -0.951 . . . . 0.0 112.748 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.0 t -124.43 143.39 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.786 1.634 . . . . 0.0 109.233 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.9 t0 -151.64 167.8 26.98 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.966 1.306 . . . . 0.0 110.96 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.67 164.72 24.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.02 1.328 . . . . 0.0 112.787 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 34.1 m -73.52 -20.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.962 167.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -86.89 -6.74 58.69 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.849 1.259 . . . . 0.0 114.138 -171.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 29.4 p -64.14 145.57 55.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.267 1.027 . . . . 0.0 113.615 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -108.19 -21.15 7.85 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.156 1.36 . . . . 0.0 113.932 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -70.12 159.85 33.15 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.65 1.18 . . . . 0.0 113.999 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.3 t -64.59 135.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 109.061 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.9 t -156.71 163.12 39.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.773 1.229 . . . . 0.0 110.877 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.59 147.33 31.94 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.875 1.27 . . . . 0.0 112.38 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -169.08 160.34 9.79 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.758 1.623 . . . . 0.0 112.968 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 145.22 175.82 18.67 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.201 1.381 . . . . 0.0 113.576 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.46 -37.55 12.98 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.045 2.497 . . . . 0.0 112.218 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.9 75.88 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.215 0.912 . . . . 0.0 114.099 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.26 -11.09 60.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.576 1.15 . . . . 0.0 113.213 171.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.8 m -120.67 -43.52 2.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.718 1.607 . . . . 0.0 111.912 -170.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -142.84 154.56 44.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.715 2.006 . . . . 0.0 112.139 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.05 174.4 26.0 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.476 1.036 . . . . 0.0 113.699 172.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 38.4 t -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.919 1.288 . . . . 0.0 108.571 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.8 m -56.39 135.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.153 0.581 . . . . 0.0 112.52 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.7 m-80 66.45 3.5 2.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.938 2.095 . . . . 0.0 114.73 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 54.7 mttm -110.0 142.9 26.85 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.391 1.476 . . . . 0.0 110.948 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.33 119.87 6.22 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.576 2.184 . . . . 0.0 110.577 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -99.55 143.1 30.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.082 1.353 . . . . 0.0 110.082 172.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.9 p -133.49 152.99 51.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -165.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1886 ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.4 p90 -164.04 174.63 11.13 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.741 1.616 . . . . 0.0 112.175 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 80.7 m -126.69 142.83 51.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.579 1.552 . . . . 0.0 110.964 -170.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.8 t -116.48 133.15 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.963 1.705 . . . . 0.0 108.265 167.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.03 127.47 35.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.053 0.941 . . . . 0.0 111.222 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 51.5 p -133.13 0.44 3.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.076 1.35 . . . . 0.0 114.011 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.1 tptp -52.5 -39.12 60.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.699 1.6 . . . . 0.0 114.459 -173.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.37 6.66 20.54 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.385 1.474 . . . . 0.0 113.046 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.23 60.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.231 1.012 . . . . 0.0 113.622 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 77.72 -102.49 1.77 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.624 1.107 . . . . 0.0 112.164 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.92 157.28 23.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.247 1.819 . . . . 0.0 110.18 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.79 4.21 0.75 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.572 1.558 . . . . 0.0 115.146 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.01 103.67 1.89 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.544 1.545 . . . . 0.0 113.224 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.06 135.58 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.655 1.582 . . . . 0.0 109.266 168.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -138.76 165.3 27.34 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.079 1.352 . . . . 0.0 112.319 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -165.05 136.8 4.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.207 1.803 . . . . 0.0 109.699 -161.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.92 166.24 32.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.519 1.128 . . . . 0.0 112.004 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.66 131.76 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.651 1.18 . . . . 0.0 109.55 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.87 113.38 25.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 109.454 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.08 -174.95 13.93 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.128 1.347 . . . . 0.0 113.802 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.84 -23.81 47.36 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.853 3.035 . . . . 0.0 111.942 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -142.06 159.53 42.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 160.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.06 130.62 43.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.933 -1.105 . . . . 0.0 112.52 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.37 152.44 27.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.103 0.961 . . . . 0.0 110.981 164.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.21 139.3 30.63 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 165.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -132.8 138.76 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.558 1.143 . . . . 0.0 110.392 -167.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 68.6 m -134.74 158.27 44.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 111.008 170.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -152.87 153.61 33.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.387 1.075 . . . . 0.0 112.544 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.9 m -143.09 122.2 12.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.461 1.504 . . . . 0.0 110.373 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.68 129.51 36.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.415 1.086 . . . . 0.0 111.132 171.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -104.62 158.74 16.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.424 1.489 . . . . 0.0 112.602 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -70.92 -15.59 62.62 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.83 0.852 . . . . 0.0 112.114 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.47 -3.62 34.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.267 1.827 . . . . 0.0 114.551 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 86.99 27.3 29.0 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.207 0.908 . . . . 0.0 113.775 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.3 p -137.85 158.74 43.71 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 110.943 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 34.5 t -103.6 127.97 50.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.333 1.053 . . . . 0.0 108.819 159.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -88.15 152.36 22.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.681 0.793 . . . . 0.0 110.226 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1922 ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' 1886 ' ' PHE . 91.9 t -133.63 143.86 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.628 1.571 . . . . 0.0 109.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -135.97 147.64 48.12 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.019 1.328 . . . . 0.0 111.793 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -149.81 152.12 34.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.9 mt -117.54 102.0 52.16 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.693 1.997 . . . . 0.0 110.262 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.79 162.12 18.73 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.763 2.976 . . . . 0.0 110.412 170.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.9 m -124.25 -10.56 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -167.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -156.01 151.79 22.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.363 1.465 . . . . 0.0 110.347 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.33 140.69 24.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.665 2.244 . . . . 0.0 111.462 -173.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.63 -167.91 33.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.507 1.051 . . . . 0.0 113.591 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -96.0 124.3 39.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.331 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.67 121.33 38.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.75 1.62 . . . . 0.0 110.176 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.4 m -92.4 109.8 21.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.267 1.027 . . . . 0.0 110.989 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -81.49 131.99 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.765 1.626 . . . . 0.0 108.677 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.88 128.88 55.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.951 1.7 . . . . 0.0 108.987 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 48.9 t -128.28 130.02 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.19 0.996 . . . . 0.0 109.839 172.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.61 141.36 22.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.842 1.257 . . . . 0.0 111.961 -167.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.46 123.46 21.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.041 1.336 . . . . 0.0 109.457 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.79 57.72 5.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.347 1.459 . . . . 0.0 112.617 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.1 pt-20 57.84 11.02 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 128.134 2.574 . . . . 0.0 116.296 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -117.45 124.66 49.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.655 1.182 . . . . 0.0 110.597 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.73 143.6 57.27 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.463 -0.773 . . . . 0.0 111.29 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.8 m -70.11 151.83 95.92 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.718 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.54 132.8 45.14 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.535 2.157 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.44 -17.42 57.47 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.103 1.335 . . . . 0.0 114.751 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 32.7 t -75.68 141.29 72.21 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.289 1.544 . . . . 0.0 111.663 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.23 148.87 88.54 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.551 0.875 . . . . 0.0 112.339 -4.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -110.66 132.66 54.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 110.161 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 87.9 m -95.44 114.3 26.06 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.055 0.843 . . . . 0.0 111.251 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.3 138.31 33.17 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.037 1.335 . . . . 0.0 111.033 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -97.04 117.9 32.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.421 0.689 . . . . 0.0 110.887 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.8 t -93.34 137.5 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.399 1.48 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.0 p -115.58 155.84 26.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.564 1.546 . . . . 0.0 112.871 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.23 136.16 14.16 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.962 1.268 . . . . 0.0 112.119 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -90.53 -10.88 41.9 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.648 1.179 . . . . 0.0 113.464 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.714 2.005 . . . . 0.0 112.543 -177.434 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.05 -8.46 53.5 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -176.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -66.79 -15.61 63.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.117 1.767 . . . . 0.0 114.409 -176.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -141.75 152.81 63.71 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.691 1.597 . . . . 0.0 111.853 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.85 164.69 31.38 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.858 3.039 . . . . 0.0 112.105 178.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -74.0 146.39 43.83 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.171 0.988 . . . . 0.0 112.201 178.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -141.08 150.34 58.66 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.939 1.696 . . . . 0.0 110.752 178.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.02 149.87 59.6 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.461 2.774 . . . . 0.0 112.091 -175.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 97.8 mt -141.35 158.27 44.1 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.235 1.814 . . . . 0.0 110.427 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 84.8 t -101.45 136.03 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.124 1.37 . . . . 0.0 109.486 176.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 87.22 0.98 84.63 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.681 1.134 . . . . 0.0 115.317 175.37 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 35.6 m -86.69 153.08 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.987 1.315 . . . . 0.0 111.575 176.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 13.0 p30 -76.95 165.25 24.92 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.244 1.018 . . . . 0.0 113.559 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -163.12 171.57 38.91 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.491 1.519 . . . . 0.0 113.485 176.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.24 153.6 51.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.904 1.682 . . . . 0.0 111.325 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -162.82 171.08 17.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.714 2.005 . . . . 0.0 109.797 176.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 7.4 p -57.35 -21.36 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.321 1.448 . . . . 0.0 114.006 -176.378 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.0 t -62.64 -25.2 68.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.858 1.263 . . . . 0.0 112.923 173.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 41.5 m -75.58 109.56 9.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.009 0.924 . . . . 0.0 111.668 178.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 90.7 mt -85.68 146.05 27.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.66 1.184 . . . . 0.0 110.585 169.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -64.41 115.84 23.28 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.443 1.897 . . . . 0.0 110.073 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 151.46 64.59 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -171.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.82 122.89 41.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.199 0.6 . . . . 0.0 110.078 176.686 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -150.14 132.8 15.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.764 1.226 . . . . 0.0 110.966 174.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.01 157.73 45.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.33 2.252 . . . . 0.0 109.41 -175.303 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.9 p -135.3 134.14 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.654 1.182 . . . . 0.0 109.438 172.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.73 136.41 28.37 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.544 1.537 . . . . 0.0 109.284 -169.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.78 85.56 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.892 3.061 . . . . 0.0 110.319 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.4 t80 -139.98 152.53 46.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.697 1.999 . . . . 0.0 109.429 177.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -126.42 134.51 50.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.822 1.249 . . . . 0.0 109.471 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.5 mt -91.49 128.81 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.522 1.129 . . . . 0.0 109.345 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -99.52 -131.08 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.544 1.138 . . . . 0.0 109.821 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -83.01 -4.21 58.07 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.91 -152.65 17.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.801 1.667 . . . . 0.0 113.291 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.24 149.62 26.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.203 1.401 . . . . 0.0 110.631 -173.111 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.3 tt -128.8 136.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.542 1.537 . . . . 0.0 111.446 -175.296 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.1 p -149.25 167.64 25.48 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.169 1.788 . . . . 0.0 110.857 -175.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.39 -170.1 19.87 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -175.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.57 132.94 9.96 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.084 1.754 . . . . 0.0 109.589 177.401 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 40.2 t -112.33 138.99 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.61 1.564 . . . . 0.0 108.634 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.18 132.71 48.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.832 0.853 . . . . 0.0 111.153 -174.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.4 mtm -106.38 141.66 23.26 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.838 1.655 . . . . 0.0 111.95 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.12 -23.57 36.71 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.63 3.554 . . . . 0.0 115.757 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.0 t -68.92 -8.33 43.29 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.56 48.71 3.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.95 1.262 . . . . 0.0 112.429 177.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -156.87 163.36 39.27 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.131 1.773 . . . . 0.0 111.43 -171.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -139.0 161.71 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.541 1.136 . . . . 0.0 112.734 -171.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.08 169.48 24.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.695 1.998 . . . . 0.0 111.435 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.7 140.79 21.42 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.122 0.969 . . . . 0.0 111.308 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.38 175.24 7.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.209 3.273 . . . . 0.0 111.966 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -114.11 138.01 50.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.534 1.534 . . . . 0.0 109.008 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.76 131.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.783 1.233 . . . . 0.0 108.682 173.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.3 m -133.22 115.44 15.0 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.418 1.487 . . . . 0.0 109.092 -178.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.84 135.27 43.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 112.089 174.124 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.66 -13.5 34.12 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.3 mttp 66.49 7.04 4.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.326 2.25 . . . . 0.0 114.048 -177.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 9.47 43.25 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.082 2.153 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.84 11.9 57.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.356 1.455 . . . . 0.0 114.025 -174.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -130.13 157.31 42.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.062 1.745 . . . . 0.0 111.385 178.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -119.99 140.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.349 1.06 . . . . 0.0 109.949 164.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 51.7 m -94.16 138.5 32.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 170.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.6 t -126.72 133.04 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.688 1.595 . . . . 0.0 108.612 -175.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.07 157.23 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.553 1.141 . . . . 0.0 113.346 -170.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.0 t80 -158.31 137.83 11.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.874 1.669 . . . . 0.0 111.917 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.0 112.67 56.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.997 1.319 . . . . 0.0 110.785 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.11 149.04 28.09 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.685 2.923 . . . . 0.0 112.921 -174.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.1 p -139.21 -2.99 1.59 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 174.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -141.64 145.89 35.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.241 1.816 . . . . 0.0 109.484 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.74 169.53 15.15 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.976 0.911 . . . . 0.0 112.978 176.963 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 107.14 -173.19 18.77 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 124.992 1.282 . . . . 0.0 114.712 173.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 60.8 tp -77.71 128.16 33.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.96 1.304 . . . . 0.0 110.893 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -126.41 166.86 16.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.952 1.701 . . . . 0.0 111.175 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.49 153.54 51.71 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 112.312 156.537 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 43.7 ttm -112.54 121.8 45.86 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 109.875 169.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.77 136.22 38.99 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.106 1.363 . . . . 0.0 110.133 164.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.8 mm -133.88 135.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.709 1.203 . . . . 0.0 109.78 167.085 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.41 138.65 31.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.665 1.186 . . . . 0.0 112.966 175.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 46.4 t80 -102.87 123.81 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.53 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.08 45.75 22.86 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.766 1.227 . . . . 0.0 112.055 -176.048 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.28 4.6 p30 67.44 -2.05 1.39 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.864 2.866 . . . . 0.0 116.584 -177.065 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.2 mtt -100.67 134.27 43.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.069 1.347 . . . . 0.0 111.454 176.594 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 10.6 m170 -56.08 134.72 52.85 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.318 -0.864 . . . . 0.0 112.551 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.1 154.82 86.52 Favored Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 121.734 -0.603 . . . . 0.0 111.272 173.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -60.37 126.57 20.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.675 1.583 . . . . 0.0 108.587 165.231 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.98 45.53 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.565 1.078 . . . . 0.0 114.366 -173.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 20.7 t -82.09 142.15 47.56 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.181 1.491 . . . . 0.0 112.143 176.399 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.05 152.95 77.1 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.988 1.032 . . . . 0.0 111.864 -7.021 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.59 111.2 22.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.021 1.328 . . . . 0.0 109.109 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -102.27 139.4 37.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.331 1.052 . . . . 0.0 111.531 -176.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.5 p90 -164.35 160.11 20.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.174 0.989 . . . . 0.0 112.801 -176.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -102.75 130.98 49.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.338 1.055 . . . . 0.0 111.998 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.3 t -92.12 134.37 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.919 1.288 . . . . 0.0 109.726 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 21.0 t0 -144.1 162.35 36.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.579 1.952 . . . . 0.0 110.805 -169.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.83 154.02 26.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.387 1.075 . . . . 0.0 112.584 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -65.6 -29.21 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.309 -0.869 . . . . 0.0 112.054 168.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -92.24 -163.06 0.99 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.752 1.621 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.9 m 79.04 155.61 0.15 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.43 2.692 . . . . 0.0 113.352 173.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.35 -8.35 53.07 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 124.912 1.244 . . . . 0.0 115.521 -173.184 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.96 152.95 41.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 118.911 1.355 . . . . 0.0 113.871 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.2 t -64.88 143.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.181 0.992 . . . . 0.0 108.792 172.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -156.67 158.52 37.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.248 1.019 . . . . 0.0 110.795 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.92 141.81 33.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.194 1.398 . . . . 0.0 111.003 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.3 p90 -166.43 165.99 16.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.229 1.412 . . . . 0.0 112.796 -172.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 122.47 171.84 13.92 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.408 1.48 . . . . 0.0 112.466 -174.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.09 -33.68 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.914 2.409 . . . . 0.0 113.27 -168.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.61 86.68 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.144 0.884 . . . . 0.0 114.513 -169.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.65 -6.92 55.5 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.728 1.264 . . . . 0.0 113.785 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 -40.37 5.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.025 2.13 . . . . 0.0 111.723 176.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -153.43 142.44 21.26 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.039 1.336 . . . . 0.0 112.568 -171.058 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.57 -176.11 15.61 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.923 1.249 . . . . 0.0 112.672 174.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.0 p -153.38 136.14 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.734 1.214 . . . . 0.0 109.281 176.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.0 m -60.11 147.01 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -171.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 67.42 5.02 4.04 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.432 1.893 . . . . 0.0 114.574 173.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.9 mttp -120.61 149.72 50.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.179 1.792 . . . . 0.0 110.884 170.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.57 135.16 21.56 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.678 2.252 . . . . 0.0 110.848 175.189 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.29 146.92 36.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.798 1.639 . . . . 0.0 110.105 171.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.1 p -135.53 148.74 49.26 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -164.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -159.56 179.23 9.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.034 1.733 . . . . 0.0 111.265 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 52.6 m -132.87 144.87 50.48 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.316 1.446 . . . . 0.0 110.516 -170.46 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.6 t -122.53 127.75 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.876 1.67 . . . . 0.0 108.448 172.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -95.05 114.31 26.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.272 1.029 . . . . 0.0 110.554 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 25.2 p -120.54 -1.79 10.06 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.072 2.149 . . . . 0.0 113.423 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.64 -45.12 77.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.922 1.689 . . . . 0.0 114.562 -165.519 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.45 -15.85 38.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 113.534 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -82.46 -67.12 0.81 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.599 1.16 . . . . 0.0 111.058 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 64.99 16.02 61.28 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 165.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.5 146.58 22.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.585 1.693 . . . . 0.0 111.655 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 90.53 -170.96 35.9 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.58 1.562 . . . . 0.0 112.862 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -92.88 115.63 4.92 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 124.244 0.926 . . . . 0.0 111.525 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -77.74 123.24 26.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.346 1.059 . . . . 0.0 108.608 170.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 47.4 m -120.52 154.09 35.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.433 1.493 . . . . 0.0 112.104 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -157.66 133.83 9.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.865 1.666 . . . . 0.0 108.964 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 160.62 39.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.876 0.871 . . . . 0.0 112.147 177.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -135.04 134.34 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.794 1.238 . . . . 0.0 109.333 172.7 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.13 120.51 37.95 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.143 1.377 . . . . 0.0 109.051 171.412 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -132.57 179.93 16.82 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.659 1.124 . . . . 0.0 114.226 -176.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.05 -24.85 38.54 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.038 3.159 . . . . 0.0 111.923 174.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.5 t -134.73 157.81 45.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 108.683 156.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.99 120.64 19.85 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.843 -1.161 . . . . 0.0 112.132 -174.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.56 145.73 34.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.049 0.94 . . . . 0.0 111.202 168.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.62 148.84 25.3 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.336 0.654 . . . . 0.0 110.393 167.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -137.59 144.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.808 1.243 . . . . 0.0 110.235 -166.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 166.86 24.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.891 1.276 . . . . 0.0 111.259 167.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.0 p -155.97 153.46 29.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.939 1.295 . . . . 0.0 112.404 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 70.3 m -140.14 131.38 26.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.436 1.494 . . . . 0.0 110.331 -169.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.63 128.12 34.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.134 174.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -91.84 152.18 20.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.708 1.203 . . . . 0.0 111.657 176.065 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.51 -17.58 64.2 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.494 0.717 . . . . 0.0 112.322 173.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.8 -9.76 58.78 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.576 1.55 . . . . 0.0 113.702 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 9.66 57.94 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.16 1.362 . . . . 0.0 115.203 176.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.9 p -108.23 161.23 15.19 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.948 1.699 . . . . 0.0 111.524 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 83.5 m -102.65 124.86 48.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.954 1.302 . . . . 0.0 110.278 170.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.3 t -88.69 151.98 22.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.807 0.843 . . . . 0.0 110.582 166.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.3 t -130.94 144.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.174 1.79 . . . . 0.0 109.984 -177.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.5 p -135.65 147.66 48.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.615 1.166 . . . . 0.0 111.729 166.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -148.92 154.95 40.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.31 -0.869 . . . . 0.0 113.005 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.75 102.62 25.22 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.79 1.236 . . . . 0.0 110.456 -173.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.78 163.91 9.07 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.033 3.155 . . . . 0.0 111.3 175.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -127.12 -21.45 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.223 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.77 150.51 60.16 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.487 1.115 . . . . 0.0 110.755 173.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.9 145.73 32.2 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.849 2.366 . . . . 0.0 111.99 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.39 -167.54 32.46 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.837 1.208 . . . . 0.0 113.654 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.04 124.57 38.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.392 1.477 . . . . 0.0 112.098 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -116.51 128.21 55.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.855 1.662 . . . . 0.0 110.009 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.9 m -89.99 116.29 27.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.105 0.962 . . . . 0.0 110.705 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.59 124.67 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.698 1.599 . . . . 0.0 108.326 177.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.7 tt -108.53 127.48 53.97 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.455 1.502 . . . . 0.0 109.261 176.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -130.29 127.71 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.315 1.046 . . . . 0.0 109.497 173.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.75 144.6 24.41 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.066 1.347 . . . . 0.0 111.398 -167.522 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.29 125.98 13.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.509 1.123 . . . . 0.0 110.131 -177.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.1 52.37 11.84 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.576 1.15 . . . . 0.0 112.041 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 7.8 pt-20 58.84 12.68 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.322 2.649 . . . . 0.0 116.39 -177.45 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -119.49 127.35 52.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.453 1.101 . . . . 0.0 110.997 177.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -62.43 143.32 57.21 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.466 -0.772 . . . . 0.0 111.417 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.4 m -71.38 151.99 94.15 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.03 173.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -55.36 126.55 22.88 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.249 2.633 . . . . 0.0 111.19 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.92 62.17 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.367 1.46 . . . . 0.0 115.085 -175.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 36.4 t -78.06 141.69 63.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 119.356 1.578 . . . . 0.0 111.701 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 141.78 72.16 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.421 0.829 . . . . 0.0 112.27 -4.156 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -93.95 161.92 14.11 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.171 1.788 . . . . 0.0 110.617 176.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.7 m -119.97 116.0 24.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.675 0.79 . . . . 0.0 110.745 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.33 133.23 39.48 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.702 1.201 . . . . 0.0 111.084 172.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 111.75 23.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.898 0.879 . . . . 0.0 109.553 174.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.2 t -94.6 133.01 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.924 1.29 . . . . 0.0 110.05 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 78.7 p -108.37 165.69 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.915 1.286 . . . . 0.0 113.094 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.96 136.96 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.77 1.176 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -88.82 -18.31 27.93 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.78 1.232 . . . . 0.0 113.768 -175.456 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 24.9 t0 . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.652 2.381 . . . . 0.0 114.277 179.135 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.34 159.22 37.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.549 1.54 . . . . 0.0 112.121 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -75.25 163.75 27.17 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.322 1.449 . . . . 0.0 112.352 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -63.67 151.22 89.01 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.265 1.026 . . . . 0.0 112.282 174.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.04 -10.47 19.57 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.734 2.956 . . . . 0.0 113.81 -178.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.83 153.25 30.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.607 1.563 . . . . 0.0 110.191 -178.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.78 147.89 88.4 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.689 1.195 . . . . 0.0 112.419 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.61 154.11 72.16 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.697 2.931 . . . . 0.0 111.763 177.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 24.0 tp -79.89 59.26 3.11 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.308 1.443 . . . . 0.0 111.92 -174.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 84.7 t -75.99 131.25 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.284 1.433 . . . . 0.0 109.876 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 170.23 -178.96 42.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.856 1.217 . . . . 0.0 113.657 -179.438 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 21.4 m -143.53 154.16 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.851 1.661 . . . . 0.0 111.377 -179.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 63.6 t30 -164.29 162.15 22.27 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.295 1.838 . . . . 0.0 110.82 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -67.5 128.65 27.44 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.007 0.813 . . . . 0.0 111.111 173.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.96 145.85 26.61 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.57 1.148 . . . . 0.0 111.859 -174.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 37.5 t0 70.2 164.04 0.26 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.618 2.367 . . . . 0.0 112.692 -177.041 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 66.6 t -134.27 138.89 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.615 1.566 . . . . 0.0 109.726 -178.347 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.6 t -156.35 -40.45 0.08 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.405 1.482 . . . . 0.0 111.464 175.15 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 6.6 t -162.46 147.45 12.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.238 1.015 . . . . 0.0 112.245 168.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 54.1 mt -97.21 153.52 17.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.571 1.548 . . . . 0.0 110.144 168.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -45.65 110.75 1.21 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.392 1.877 . . . . 0.0 111.349 175.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 133.32 29.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.271 1.98 . . . . 0.0 108.801 172.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.99 123.67 45.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.587 0.755 . . . . 0.0 111.047 -174.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -157.2 141.78 16.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 110.928 177.103 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.72 147.6 51.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.267 1.827 . . . . 0.0 110.266 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -109.8 138.43 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.785 1.234 . . . . 0.0 109.963 172.084 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.8 mt -132.47 133.86 24.13 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.048 1.739 . . . . 0.0 108.686 -174.285 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.13 66.82 8.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.199 3.266 . . . . 0.0 111.211 177.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.8 t80 -115.68 153.81 30.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.895 1.678 . . . . 0.0 111.16 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 59.2 m -121.91 119.72 32.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.264 1.426 . . . . 0.0 109.429 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.46 127.01 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 109.295 174.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.17 -139.59 0.36 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.701 1.2 . . . . 0.0 110.67 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -75.27 -6.68 51.09 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.9 -148.42 8.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.781 1.658 . . . . 0.0 113.017 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -154.88 148.05 24.86 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 110.517 -173.683 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.49 136.03 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.286 1.434 . . . . 0.0 111.184 -178.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 54.9 p -146.14 -175.33 4.72 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.457 1.903 . . . . 0.0 109.894 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.88 -162.18 20.55 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 -177.491 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.37 144.75 17.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.289 1.836 . . . . 0.0 109.664 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 90.8 t -123.07 135.89 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.015 1.726 . . . . 0.0 108.223 173.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -120.72 139.59 52.85 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 112.056 -174.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.5 148.11 36.59 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.717 1.607 . . . . 0.0 111.481 -176.008 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.71 -28.75 67.96 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.115 3.21 . . . . 0.0 114.927 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.1 p -73.56 -2.78 24.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 114.496 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.35 -5.77 83.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.562 1.554 . . . . 0.0 113.9 -178.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -68.77 157.56 36.12 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.144 1.377 . . . . 0.0 112.052 173.1 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.9 m -140.76 156.36 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.165 1.386 . . . . 0.0 111.655 177.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.28 179.83 8.86 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.92 2.088 . . . . 0.0 110.267 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -127.36 144.76 51.92 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 121.146 -0.971 . . . . 0.0 111.915 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.83 166.14 13.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.146 3.231 . . . . 0.0 111.399 176.475 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.0 m -111.54 125.59 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.052 1.341 . . . . 0.0 108.96 173.479 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.14 132.47 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.788 1.235 . . . . 0.0 109.142 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 67.2 m -135.13 126.15 27.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.375 1.47 . . . . 0.0 109.744 178.15 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.84 139.01 41.49 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.954 0.901 . . . . 0.0 112.607 173.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -93.47 -4.96 50.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 71.14 -3.69 1.99 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.816 2.446 . . . . 0.0 114.225 -176.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.4 5.73 49.33 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.658 1.983 . . . . 0.0 113.264 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.43 14.75 55.17 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.964 1.269 . . . . 0.0 113.891 -174.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 63.7 p -129.69 161.59 30.28 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.293 1.837 . . . . 0.0 110.611 177.071 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 18.7 m -121.31 146.79 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.595 1.158 . . . . 0.0 109.689 166.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 80.8 m -105.77 135.69 46.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.402 1.081 . . . . 0.0 108.467 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 20.5 t -115.05 133.57 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.569 1.548 . . . . 0.0 108.95 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.55 154.07 47.41 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.55 1.54 . . . . 0.0 112.1 -174.66 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -153.9 136.19 14.9 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.714 1.606 . . . . 0.0 111.513 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.12 118.12 68.88 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.52 1.128 . . . . 0.0 110.88 177.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.46 144.98 23.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.508 2.805 . . . . 0.0 111.77 -176.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.4 p -135.02 -7.42 2.34 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 178.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -163.49 143.81 8.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.818 1.647 . . . . 0.0 110.218 -175.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -81.6 165.41 21.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.44 1.096 . . . . 0.0 113.239 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.68 -168.24 15.88 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.782 1.658 . . . . 0.0 114.377 178.011 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.0 130.19 37.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.197 1.799 . . . . 0.0 109.58 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 76.9 m80 -134.25 169.88 16.53 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.251 1.421 . . . . 0.0 112.007 -170.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.76 152.39 38.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 168.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.1 ttm -121.22 118.07 28.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.894 2.478 . . . . 0.0 109.837 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.34 137.75 32.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.428 1.491 . . . . 0.0 109.944 169.864 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.0 mm -135.65 135.17 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.573 1.149 . . . . 0.0 110.649 175.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.12 20.72 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.73 1.212 . . . . 0.0 113.131 -175.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -99.61 125.31 45.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.743 2.017 . . . . 0.0 109.901 174.126 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.4 34.05 14.3 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.734 1.214 . . . . 0.0 112.448 -174.587 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.1 t30 75.15 2.65 3.97 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.397 2.679 . . . . 0.0 114.746 -178.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.0 mtm -102.64 130.61 49.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 0.0 110.638 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -58.7 137.71 57.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.1 pt -71.45 152.46 94.01 Favored Pre-proline 0 N--CA 1.48 1.033 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.599 173.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.17 125.68 17.58 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.363 2.042 . . . . 0.0 110.936 -176.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.92 -8.63 76.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.144 1.354 . . . . 0.0 115.233 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.8 t -63.93 141.26 98.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 120.07 1.935 . . . . 0.0 111.941 175.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.59 161.45 76.15 Favored 'Cis proline' 0 C--N 1.354 0.837 0 CA-C-N 119.998 1.035 . . . . 0.0 113.492 0.016 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.1 mt -96.4 136.21 37.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.68 1.592 . . . . 0.0 110.004 172.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -109.25 141.96 40.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.372 1.069 . . . . 0.0 110.959 -177.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 34.0 p90 -153.85 174.13 14.99 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 113.212 -173.634 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.9 t80 -128.49 147.75 50.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 112.421 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 49.3 t -127.6 139.27 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.091 1.756 . . . . 0.0 109.16 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -153.38 160.41 42.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.459 1.504 . . . . 0.0 110.756 -174.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -76.38 139.79 41.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 111.485 177.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -66.04 -23.61 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 121.442 -0.786 . . . . 0.0 112.842 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 55.4 p30 -85.8 -3.66 58.96 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.469 1.508 . . . . 0.0 114.809 -176.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.1 m -64.48 137.48 57.89 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.04 0.936 . . . . 0.0 112.536 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.02 -12.95 54.63 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.939 1.257 . . . . 0.0 114.514 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -69.18 166.91 17.32 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 t -68.01 137.83 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 157.93 31.01 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.04 1.336 . . . . 0.0 110.335 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.07 143.35 44.6 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 111.823 -174.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.44 164.99 15.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.62 1.568 . . . . 0.0 112.813 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.57 173.8 13.42 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.229 1.395 . . . . 0.0 113.19 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.95 -32.99 12.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.666 -171.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.23 -38.32 91.74 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.641 1.109 . . . . 0.0 114.094 -172.806 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.75 -8.68 57.14 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.712 1.256 . . . . 0.0 113.35 176.069 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.8 m -96.96 -42.93 7.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.45 1.9 . . . . 0.0 110.881 174.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -155.55 127.42 7.49 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.34 1.856 . . . . 0.0 112.025 -164.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.58 -177.79 15.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.693 2.092 . . . . 0.0 112.165 168.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 87.2 t -145.6 142.71 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.833 2.053 . . . . 0.0 107.476 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.2 m -56.14 138.47 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 65.86 1.91 2.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.802 2.041 . . . . 0.0 114.887 175.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -106.74 139.43 20.36 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.411 1.484 . . . . 0.0 111.057 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.38 119.57 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.705 2.27 . . . . 0.0 110.314 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -101.96 134.54 45.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.179 1.392 . . . . 0.0 110.055 175.715 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 38.6 p -127.52 145.98 50.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -165.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -157.26 177.05 11.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 178.051 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.9 m -128.47 142.1 51.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 -169.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.08 131.66 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.679 1.591 . . . . 0.0 108.422 168.274 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -91.75 129.53 37.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.42 1.088 . . . . 0.0 111.024 -177.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -135.65 8.15 3.31 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.049 1.34 . . . . 0.0 113.606 -168.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.6 tptm -54.23 -37.0 64.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.307 1.843 . . . . 0.0 114.772 -168.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.12 20.13 5.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.695 1.598 . . . . 0.0 112.268 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.77 78.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.377 1.071 . . . . 0.0 113.854 -174.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.27 149.14 4.85 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.883 1.23 . . . . 0.0 112.365 -171.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.18 139.84 52.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.468 0.707 . . . . 0.0 111.815 -178.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.09 10.84 0.02 OUTLIER Glycine 0 CA--C 1.535 1.304 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.88 97.99 1.55 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.163 1.363 . . . . 0.0 112.819 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.47 127.25 31.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.817 1.247 . . . . 0.0 108.748 166.19 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 49.1 m -117.03 154.69 30.5 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 0.0 111.731 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 54.9 tp -159.57 132.49 6.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.605 1.562 . . . . 0.0 109.096 -172.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.92 159.65 36.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.062 0.945 . . . . 0.0 112.311 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.43 127.42 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.59 1.156 . . . . 0.0 109.9 175.363 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -105.6 168.01 9.38 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.897 1.679 . . . . 0.0 109.879 167.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 166.11 -161.16 34.79 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.008 -1.057 . . . . 0.0 113.717 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.1 -13.5 26.01 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.569 2.846 . . . . 0.0 112.435 176.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 9.5 t -155.08 168.25 27.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.396 1.879 . . . . 0.0 109.627 168.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -77.97 116.02 18.14 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.898 -1.126 . . . . 0.0 111.363 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -79.7 143.73 34.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.993 0.917 . . . . 0.0 110.802 166.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.64 146.73 23.54 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.236 0.615 . . . . 0.0 110.854 171.513 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.87 140.32 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.679 1.192 . . . . 0.0 110.856 -163.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -131.31 158.75 39.84 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.116 1.766 . . . . 0.0 110.628 167.31 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.9 p -151.55 153.65 34.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.165 0.986 . . . . 0.0 112.404 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.2 m -147.0 131.13 17.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.287 1.435 . . . . 0.0 110.812 -166.284 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 9.5 t0 -71.04 123.02 21.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.199 1.0 . . . . 0.0 110.986 169.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -80.96 -9.78 59.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 113.356 177.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 tt0 79.2 -25.12 0.19 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 129.005 2.922 . . . . 0.0 112.696 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.61 1.9 13.23 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.447 1.899 . . . . 0.0 114.15 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.86 21.17 19.32 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 125.216 1.389 . . . . 0.0 114.081 -177.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -133.78 150.4 51.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.095 1.358 . . . . 0.0 110.411 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 82.3 m -106.66 126.1 51.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.451 1.5 . . . . 0.0 109.339 170.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -84.33 150.71 25.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.819 0.848 . . . . 0.0 110.536 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.2 t -126.85 144.87 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.844 2.058 . . . . 0.0 108.828 177.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.1 t -137.35 136.59 38.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.38 1.472 . . . . 0.0 110.277 171.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -142.89 153.74 43.42 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 177.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.5 mt -120.13 104.72 43.31 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.953 1.701 . . . . 0.0 110.073 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.55 155.49 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.481 2.787 . . . . 0.0 110.021 169.361 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.2 m -116.73 -13.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.28 156.04 26.93 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.835 1.654 . . . . 0.0 110.458 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 153.52 49.32 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.005 2.47 . . . . 0.0 112.72 -170.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.64 -151.4 23.67 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.94 1.257 . . . . 0.0 113.47 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -120.91 125.37 47.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.339 1.456 . . . . 0.0 110.718 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -110.77 149.34 30.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.93 1.692 . . . . 0.0 110.778 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 66.6 m -113.27 114.25 26.43 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.556 1.142 . . . . 0.0 110.963 -177.574 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.44 123.41 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.288 1.835 . . . . 0.0 108.882 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.53 131.88 52.38 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.549 1.54 . . . . 0.0 109.479 173.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 50.6 t -133.46 131.9 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.394 1.478 . . . . 0.0 108.289 172.418 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.21 142.96 17.57 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.852 1.261 . . . . 0.0 110.765 -167.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.66 123.58 22.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.548 1.139 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 51.43 56.96 7.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.129 1.372 . . . . 0.0 112.492 176.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.307 8.0 pt-20 59.62 12.95 3.1 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.189 2.596 . . . . 0.0 116.321 -177.215 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -118.96 124.62 47.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.451 1.101 . . . . 0.0 111.188 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -61.59 155.52 22.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.149 0.98 . . . . 0.0 112.785 170.787 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.92 155.94 70.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 O-C-N 121.787 -0.571 . . . . 0.0 110.427 175.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -55.4 121.19 9.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.795 2.33 . . . . 0.0 110.448 172.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -13.04 67.22 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.177 1.37 . . . . 0.0 116.316 178.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 98.7 p -80.08 153.83 74.82 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 120.552 2.176 . . . . 0.0 113.212 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.95 158.34 99.05 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.222 0.758 . . . . 0.0 112.596 -4.697 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -112.96 138.21 50.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.335 1.454 . . . . 0.0 111.345 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 21.2 m -89.9 117.42 28.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.876 0.871 . . . . 0.0 110.712 177.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.76 127.5 44.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.281 1.432 . . . . 0.0 111.392 173.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.62 138.22 46.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.534 1.533 . . . . 0.0 110.608 172.083 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.1 t -138.15 138.8 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.646 1.178 . . . . 0.0 110.818 172.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 81.1 p -130.57 165.19 23.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.535 1.134 . . . . 0.0 112.672 174.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.64 144.19 22.05 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.941 1.734 . . . . 0.0 112.909 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.11 17.46 0.42 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.239 1.416 . . . . 0.0 112.707 178.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.239 1.815 . . . . 0.0 112.655 -176.887 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.97 164.27 36.98 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.698 1.599 . . . . 0.0 111.76 -179.085 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 77.1 mtm -73.28 148.08 43.92 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.23 1.012 . . . . 0.0 111.855 176.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -158.57 149.52 16.24 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 125.41 1.484 . . . . 0.0 111.708 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.26 170.78 18.06 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.832 3.021 . . . . 0.0 111.854 177.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -152.98 139.75 18.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.186 1.394 . . . . 0.0 109.934 173.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -75.11 150.3 85.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.825 0.85 . . . . 0.0 112.958 -174.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.63 171.19 18.66 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.435 2.756 . . . . 0.0 111.074 171.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -11.81 60.35 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 60.6 t -82.85 134.12 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.804 1.641 . . . . 0.0 110.021 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 79.83 -122.35 5.75 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.146 0.879 . . . . 0.0 112.25 175.38 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 96.5 t -59.58 135.63 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.66 1.184 . . . . 0.0 110.508 -179.077 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 8.0 p30 -156.93 153.35 27.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.186 1.394 . . . . 0.0 112.088 -176.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -83.43 166.23 43.57 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.706 1.146 . . . . 0.0 113.263 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.9 mt -69.69 155.58 40.3 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.181 0.993 . . . . 0.0 111.87 176.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.96 -14.83 61.53 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.757 1.223 . . . . 0.0 113.163 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 6.8 m -138.22 148.56 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.832 2.053 . . . . 0.0 111.287 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 8.9 t 174.84 -39.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 128.902 2.881 . . . . 0.0 110.482 -178.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 40.8 m -76.62 73.07 3.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.322 1.449 . . . . 0.0 111.694 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1788 ' ' LEU . . . . . 0.482 HD11 HG12 ' A' 1860 ' ' VAL . 20.9 tp -91.66 149.13 21.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.47 1.908 . . . . 0.0 110.866 177.138 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -53.13 110.91 2.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.689 1.196 . . . . 0.0 113.5 -168.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.02 135.79 28.23 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.19 1.927 . . . . 0.0 108.937 172.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -102.43 121.31 42.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.205 0.602 . . . . 0.0 109.839 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.67 124.53 9.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.828 1.251 . . . . 0.0 110.89 175.071 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -131.72 149.18 52.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.804 2.042 . . . . 0.0 109.558 -176.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 15.0 p -123.67 135.71 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.894 1.278 . . . . 0.0 110.069 176.21 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.94 138.18 31.27 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 125.885 1.674 . . . . 0.0 108.979 -174.389 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.48 59.56 7.2 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.582 3.521 . . . . 0.0 112.216 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 40.1 t80 -100.71 151.7 21.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.529 1.532 . . . . 0.0 111.017 174.426 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.1 m -124.53 126.79 46.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.149 1.379 . . . . 0.0 109.535 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.41 128.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.792 1.237 . . . . 0.0 110.691 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 41.0 tttm -99.08 -140.17 0.32 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.945 1.698 . . . . 0.0 111.707 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -82.51 -10.63 58.93 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -175.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.42 -143.01 6.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.056 1.789 . . . . 0.0 112.628 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.46 147.44 24.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.732 1.213 . . . . 0.0 110.924 -175.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.7 tt -118.54 133.76 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.684 1.593 . . . . 0.0 111.148 -178.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 29.1 p -150.31 170.84 18.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.197 1.799 . . . . 0.0 110.647 -174.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.47 -169.05 24.23 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 -176.356 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.77 141.86 21.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.395 1.878 . . . . 0.0 109.661 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.3 t -117.31 136.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.64 1.976 . . . . 0.0 108.12 173.324 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.57 132.2 56.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.252 1.021 . . . . 0.0 111.577 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -100.54 145.48 30.38 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.634 1.574 . . . . 0.0 111.235 -176.354 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.63 -16.89 23.74 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.673 2.916 . . . . 0.0 112.936 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 30.6 p -76.0 -2.06 28.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.369 1.467 . . . . 0.0 114.301 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.45 45.64 3.98 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.638 1.114 . . . . 0.0 113.63 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.48 170.09 18.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.282 1.433 . . . . 0.0 112.426 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.8 m -138.81 157.84 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.296 1.439 . . . . 0.0 112.159 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.6 177.6 11.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.899 2.08 . . . . 0.0 110.296 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -123.56 145.62 47.57 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 121.222 -0.924 . . . . 0.0 111.896 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -82.93 167.9 14.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.209 3.273 . . . . 0.0 111.342 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.84 126.62 53.24 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.125 1.37 . . . . 0.0 108.547 170.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.72 130.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.317 1.047 . . . . 0.0 108.848 175.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -121.12 128.39 52.5 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.799 1.64 . . . . 0.0 109.639 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.83 121.3 25.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.422 1.089 . . . . 0.0 110.346 173.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.11 -12.75 54.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 65.79 9.84 6.34 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.997 2.119 . . . . 0.0 114.149 -178.717 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -108.59 10.07 27.15 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.835 2.054 . . . . 0.0 112.808 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.8 15.06 62.0 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.79 1.186 . . . . 0.0 113.601 -172.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 64.2 p -132.78 160.26 37.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.544 1.938 . . . . 0.0 110.472 177.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.3 m -125.0 144.85 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.739 1.215 . . . . 0.0 109.636 166.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 85.9 m -106.96 135.55 48.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.208 1.003 . . . . 0.0 108.691 171.732 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.5 t -119.97 131.05 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.406 1.483 . . . . 0.0 108.846 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -130.9 156.44 45.05 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.404 . . . . 0.0 112.768 -174.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 9.1 t80 -153.93 137.19 15.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.667 1.587 . . . . 0.0 111.675 176.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.36 120.84 69.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.805 1.242 . . . . 0.0 111.023 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.02 155.88 26.32 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.757 2.971 . . . . 0.0 112.694 -172.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.1 p -140.66 -11.88 1.01 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -160.66 151.29 18.38 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.611 1.565 . . . . 0.0 110.55 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.02 170.44 16.68 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.893 1.277 . . . . 0.0 113.299 179.161 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.28 -172.11 14.07 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.428 1.49 . . . . 0.0 114.148 177.395 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.0 tp -82.32 134.56 35.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.636 1.175 . . . . 0.0 110.458 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 66.1 m80 -134.56 165.19 25.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 111.628 -172.653 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.15 153.49 37.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.438 1.095 . . . . 0.0 111.621 175.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.3 ttm -130.74 140.31 50.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.567 1.547 . . . . 0.0 110.889 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -107.73 131.1 54.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.425 1.49 . . . . 0.0 110.042 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.58 137.92 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.562 1.145 . . . . 0.0 109.852 167.574 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.41 144.01 37.91 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.638 1.175 . . . . 0.0 113.027 176.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -103.5 117.28 34.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.439 1.896 . . . . 0.0 109.679 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.56 30.97 9.24 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.663 1.185 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 65.8 m-80 79.09 4.56 2.32 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.662 2.785 . . . . 0.0 115.12 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.6 ttp -96.12 126.42 41.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.696 1.198 . . . . 0.0 110.206 166.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -59.11 139.12 57.21 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.172 -0.955 . . . . 0.0 113.086 -178.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.4 pt -73.76 149.85 88.26 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.375 173.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.34 -20.33 61.75 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 114.067 -171.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.77 -7.84 86.78 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 114.809 174.183 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.5 m -94.89 155.75 38.83 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.281 1.54 . . . . 0.0 113.078 177.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.22 161.48 94.61 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 118.707 0.574 . . . . 0.0 112.554 -1.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 85.0 mt -104.74 154.03 20.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.592 1.557 . . . . 0.0 110.129 172.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -145.99 139.38 26.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.663 1.185 . . . . 0.0 110.052 -177.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -163.4 166.13 23.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -177.344 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.9 t80 -110.16 141.52 42.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.025 0.93 . . . . 0.0 111.914 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1860 ' ' VAL . . . . . 0.482 HG12 HD11 ' A' 1788 ' ' LEU . 97.6 t -110.84 129.91 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.861 1.664 . . . . 0.0 109.085 -178.454 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.2 t0 -160.42 146.57 15.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.005 1.322 . . . . 0.0 111.841 -173.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 150.36 48.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 113.436 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.3 t -62.06 -44.38 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.289 1.036 . . . . 0.0 111.564 177.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.07 22.98 4.56 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.759 1.224 . . . . 0.0 113.407 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 31.4 p -62.39 -26.57 68.54 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 79.77 -46.81 3.18 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.997 1.761 . . . . 0.0 113.812 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -62.5 165.03 6.65 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.2 t -67.55 134.85 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.762 0.825 . . . . 0.0 109.308 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -160.33 167.7 26.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.953 1.301 . . . . 0.0 110.876 -174.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -148.03 146.31 28.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.879 1.271 . . . . 0.0 111.793 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.5 p90 -166.73 160.65 15.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.49 1.516 . . . . 0.0 113.041 -174.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.4 172.92 13.21 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.622 1.582 . . . . 0.0 112.747 -175.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.16 -32.34 6.87 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.189 2.593 . . . . 0.0 113.443 -170.591 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.06 77.07 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 0.0 114.287 -170.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.22 -2.32 37.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.678 1.239 . . . . 0.0 113.654 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.5 m -112.97 -41.47 3.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.841 2.056 . . . . 0.0 112.033 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -149.26 146.0 27.37 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.817 1.247 . . . . 0.0 112.843 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.72 179.2 21.3 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.116 1.341 . . . . 0.0 113.096 173.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.7 t -138.8 137.2 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.572 1.149 . . . . 0.0 108.661 174.404 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -55.7 141.6 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 66.2 m-80 65.9 4.95 3.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.698 1.999 . . . . 0.0 114.716 174.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -123.44 141.78 37.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.632 1.573 . . . . 0.0 110.766 176.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.15 135.9 25.91 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.554 2.17 . . . . 0.0 111.382 -174.029 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.28 147.14 39.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 110.262 173.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.0 p -136.72 150.85 48.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -165.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 56.0 p90 -162.29 -179.94 7.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.289 1.835 . . . . 0.0 111.507 176.528 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -129.69 143.64 50.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.37 1.468 . . . . 0.0 110.714 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 60.1 t -116.53 133.36 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.663 1.585 . . . . 0.0 108.393 170.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.33 132.92 37.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.483 1.113 . . . . 0.0 111.421 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.3 p -130.18 6.02 4.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.188 1.795 . . . . 0.0 112.89 -176.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -59.37 -20.65 56.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -165.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.63 31.83 1.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.197 1.399 . . . . 0.0 111.442 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.47 -37.34 65.81 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -175.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.63 153.22 9.04 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.513 1.054 . . . . 0.0 112.236 -168.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -76.78 165.01 25.31 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.745 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 160.01 -77.87 0.18 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.367 1.461 . . . . 0.0 111.457 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -176.07 114.67 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.496 1.046 . . . . 0.0 112.625 171.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.44 130.31 34.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.147 1.379 . . . . 0.0 109.32 174.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.9 m -128.27 155.91 43.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.516 1.526 . . . . 0.0 112.159 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 38.2 tp -155.11 135.45 13.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.41 1.884 . . . . 0.0 108.614 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.51 160.26 40.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.992 0.917 . . . . 0.0 112.097 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.9 mt -135.14 133.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.578 1.151 . . . . 0.0 109.614 174.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.82 110.11 13.9 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.301 1.44 . . . . 0.0 109.347 175.217 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.14 -169.73 12.75 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.918 1.247 . . . . 0.0 113.896 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.31 -18.76 38.97 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.657 2.905 . . . . 0.0 111.987 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.8 t -137.06 159.63 41.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.613 1.565 . . . . 0.0 109.211 159.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -76.86 114.52 15.72 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.85 -1.156 . . . . 0.0 111.216 -178.598 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -77.13 141.96 39.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.285 1.034 . . . . 0.0 111.547 174.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.51 146.68 26.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.004 0.521 . . . . 0.0 110.597 170.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.9 145.33 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.345 1.458 . . . . 0.0 110.277 -165.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 17.3 t -145.02 142.75 30.03 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.071 0.948 . . . . 0.0 110.695 164.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -140.44 153.86 46.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.34 1.056 . . . . 0.0 112.142 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 92.5 m -136.42 119.78 16.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.434 1.493 . . . . 0.0 109.875 -172.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -71.67 116.65 12.28 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.84 0.856 . . . . 0.0 109.774 166.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -81.24 -13.25 58.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.905 0.882 . . . . 0.0 112.844 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 70.86 -3.95 1.85 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.367 2.667 . . . . 0.0 114.072 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -87.71 2.0 52.28 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.986 1.714 . . . . 0.0 113.718 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 106.61 10.12 29.55 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.499 1.523 . . . . 0.0 114.754 -172.715 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 50.7 p -133.84 153.35 51.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.85 1.325 . . . . 0.0 112.375 173.279 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -112.46 129.69 56.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.885 1.674 . . . . 0.0 109.06 162.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.7 t -86.78 148.41 25.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 110.526 170.083 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.3 t -130.26 141.67 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.626 1.571 . . . . 0.0 110.074 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 98.2 p -136.36 148.88 48.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.57 1.548 . . . . 0.0 111.671 169.076 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.3 p90 -151.37 156.1 40.03 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 5.5 mt -122.0 107.4 35.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.742 1.617 . . . . 0.0 110.684 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.82 169.87 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.907 3.072 . . . . 0.0 110.452 167.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 10.8 p -135.01 -23.91 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.29 151.0 57.14 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.916 1.287 . . . . 0.0 110.495 175.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.19 153.91 41.24 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -168.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.23 -163.83 28.06 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.371 1.462 . . . . 0.0 112.534 -174.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.08 125.33 52.02 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.438 1.095 . . . . 0.0 111.338 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.26 129.68 55.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.787 2.035 . . . . 0.0 109.941 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.2 m -88.38 126.36 35.17 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.977 -1.077 . . . . 0.0 111.053 177.252 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.98 124.97 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 108.365 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -109.21 129.18 55.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.302 1.441 . . . . 0.0 109.708 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.0 t -131.94 129.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.434 1.094 . . . . 0.0 109.692 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.44 143.42 23.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.894 1.278 . . . . 0.0 111.721 -167.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.87 122.69 18.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.76 1.224 . . . . 0.0 109.587 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.2 t-20 55.04 56.94 6.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.197 1.399 . . . . 0.0 111.876 176.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 7.7 pt-20 58.82 8.43 0.95 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.653 2.781 . . . . 0.0 116.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.98 123.55 50.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.426 1.09 . . . . 0.0 110.884 177.522 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -63.34 145.24 55.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.549 -0.72 . . . . 0.0 111.742 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 11.3 m -72.5 157.67 88.66 Favored Pre-proline 0 N--CA 1.479 1.008 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.608 172.691 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -54.39 126.89 23.75 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 0.0 111.932 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.24 63.73 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.817 1.198 . . . . 0.0 115.375 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.7 t -75.59 140.14 71.44 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.437 1.618 . . . . 0.0 111.404 176.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.09 137.28 49.36 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 119.459 0.843 . . . . 0.0 112.101 -3.342 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -86.91 175.21 8.28 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.143 1.777 . . . . 0.0 110.725 174.176 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -136.78 119.66 16.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.765 0.826 . . . . 0.0 110.824 178.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.59 129.06 49.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.377 1.471 . . . . 0.0 110.806 174.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -91.13 125.03 35.79 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.955 -0.466 . . . . 0.0 110.557 173.87 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.6 t -107.09 129.2 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.525 1.53 . . . . 0.0 109.896 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.2 p -106.55 165.8 11.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.848 1.259 . . . . 0.0 112.538 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.37 144.09 29.04 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.751 1.167 . . . . 0.0 112.271 176.373 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.14 -13.62 59.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.572 1.149 . . . . 0.0 113.018 176.544 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.833 2.053 . . . . 0.0 112.473 -178.975 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -63.76 -18.11 63.73 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -173.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 49.0 ttp -72.4 -18.12 61.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.023 1.329 . . . . 0.0 113.367 176.438 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -64.37 140.93 98.08 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.883 0.873 . . . . 0.0 112.686 -177.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.43 163.34 29.92 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.786 2.99 . . . . 0.0 112.269 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -160.52 141.59 11.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.701 1.6 . . . . 0.0 109.921 177.308 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -157.82 131.53 4.85 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.081 1.352 . . . . 0.0 110.741 -179.453 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.19 157.38 29.96 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.454 2.769 . . . . 0.0 111.906 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 60.6 tp -161.55 136.26 7.19 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.69 1.596 . . . . 0.0 109.928 176.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 93.1 t -99.0 126.44 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.771 1.229 . . . . 0.0 109.411 175.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -96.27 148.75 19.1 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.947 1.261 . . . . 0.0 112.207 174.054 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 23.4 m -143.5 152.84 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.657 1.583 . . . . 0.0 110.972 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 10.3 p30 -107.17 165.96 10.98 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.296 1.438 . . . . 0.0 112.686 177.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -85.3 -112.13 0.72 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.496 1.522 . . . . 0.0 111.7 177.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.05 156.55 38.65 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.083 0.953 . . . . 0.0 111.516 174.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -74.18 65.97 1.21 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.294 1.438 . . . . 0.0 111.328 175.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 12.3 p -58.39 -32.71 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.526 1.531 . . . . 0.0 113.448 -172.384 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 1.7 t 60.22 -21.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 130.506 3.522 . . . . 0.0 117.49 171.31 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 50.1 m -79.07 72.15 5.59 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.178 1.391 . . . . 0.0 112.828 -173.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.71 136.26 55.25 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.284 -0.885 . . . . 0.0 110.39 167.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -60.51 117.81 28.24 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.627 1.571 . . . . 0.0 110.672 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.19 144.38 56.87 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.765 2.31 . . . . 0.0 109.746 178.371 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 34.0 t80 -109.92 129.32 55.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.444 0.697 . . . . 0.0 111.424 -174.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -155.79 145.61 21.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.462 1.505 . . . . 0.0 111.2 174.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.16 144.33 30.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.973 1.709 . . . . 0.0 110.008 -171.474 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.7 p -113.94 137.11 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 0.0 110.103 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.6 mt -133.71 135.41 24.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.924 1.689 . . . . 0.0 109.172 -172.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.39 96.13 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.731 2.954 . . . . 0.0 109.927 173.546 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 58.0 t80 -159.4 152.74 22.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.209 2.204 . . . . 0.0 108.523 -178.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.62 126.9 37.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.323 1.049 . . . . 0.0 109.868 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.6 mt -78.98 116.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.025 0.93 . . . . 0.0 109.71 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -98.68 -152.66 0.41 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.473 1.509 . . . . 0.0 110.882 172.697 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -70.93 122.23 19.58 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.635 -1.29 . . . . 0.0 111.03 171.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.0 -150.37 21.45 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.613 1.578 . . . . 0.0 111.986 -170.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -159.54 145.92 16.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 111.168 -175.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.7 tt -123.74 138.78 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.633 1.573 . . . . 0.0 110.965 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.3 p -146.51 170.77 16.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.95 1.7 . . . . 0.0 110.534 -177.789 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.51 -171.43 27.54 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -177.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -154.42 144.93 22.24 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.427 1.891 . . . . 0.0 109.637 176.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 74.3 t -120.3 132.58 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.929 1.692 . . . . 0.0 108.777 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -105.27 134.8 47.77 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.824 1.25 . . . . 0.0 111.713 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 9.4 mtm -101.82 140.11 20.92 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.697 1.599 . . . . 0.0 110.846 174.487 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -56.09 -30.13 77.54 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.084 3.189 . . . . 0.0 115.017 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.8 p -74.67 2.37 10.07 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.022 1.729 . . . . 0.0 114.375 178.224 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.28 62.94 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.716 1.627 . . . . 0.0 114.837 172.05 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -73.82 159.0 33.51 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.498 1.119 . . . . 0.0 111.898 175.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 19.3 m -139.65 150.83 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.491 1.516 . . . . 0.0 110.837 172.64 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.15 172.55 18.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.394 1.877 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -115.63 141.58 27.6 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.208 -0.933 . . . . 0.0 112.152 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.18 167.65 15.68 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.11 3.207 . . . . 0.0 111.317 174.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.04 130.32 55.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.044 1.338 . . . . 0.0 108.923 172.594 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.79 133.55 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.823 1.249 . . . . 0.0 109.437 177.109 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.8 m -133.41 127.63 33.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.605 1.562 . . . . 0.0 109.756 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.42 128.6 33.55 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.751 0.821 . . . . 0.0 110.625 172.008 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.48 -9.33 59.47 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.038 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.1 mttt 72.23 0.95 3.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.193 2.597 . . . . 0.0 114.088 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -97.41 3.7 50.87 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.682 1.993 . . . . 0.0 113.143 174.289 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.12 16.17 39.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.983 1.278 . . . . 0.0 114.426 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.7 p -127.96 156.65 42.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.206 1.802 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.5 m -112.74 144.94 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.809 0.844 . . . . 0.0 109.816 164.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 61.6 m -104.94 134.82 47.41 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.53 1.132 . . . . 0.0 108.435 166.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.6 t -114.04 135.78 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.561 1.544 . . . . 0.0 108.704 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -132.49 151.8 51.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 112.128 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 57.6 t80 -155.45 137.17 14.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.299 1.44 . . . . 0.0 112.306 -178.452 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -93.74 120.49 66.01 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.635 1.174 . . . . 0.0 111.109 177.024 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.65 150.52 24.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.664 2.909 . . . . 0.0 111.99 -178.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 87.6 p -122.95 -13.32 7.85 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -166.71 148.87 6.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.013 1.725 . . . . 0.0 110.206 -171.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.98 165.5 25.17 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.079 0.952 . . . . 0.0 113.348 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 128.62 179.5 15.95 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 125.484 1.516 . . . . 0.0 114.505 176.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.1 tp -85.9 107.65 17.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 110.402 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 25.8 m80 -100.48 169.79 8.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.686 1.594 . . . . 0.0 111.665 -176.601 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -141.59 149.13 40.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.897 0.879 . . . . 0.0 111.208 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.1 ttm -118.19 128.73 54.99 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.63 1.972 . . . . 0.0 110.018 -178.297 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.64 131.39 53.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.165 2.186 . . . . 0.0 109.385 173.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.9 mm -135.05 135.81 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.505 1.122 . . . . 0.0 110.466 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.04 139.73 26.29 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.21 123.97 47.73 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.89 2.076 . . . . 0.0 109.93 176.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 52.16 32.17 10.17 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.745 1.218 . . . . 0.0 112.535 -173.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.5 t30 75.56 6.15 4.0 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.076 2.55 . . . . 0.0 115.108 -178.427 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.8 mtm -104.41 132.66 50.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.739 1.616 . . . . 0.0 110.943 173.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.3 135.77 44.19 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.3 pt -75.82 154.54 85.13 Favored Pre-proline 0 N--CA 1.478 0.956 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.004 170.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.19 127.5 23.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.069 1.846 . . . . 0.0 109.302 170.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.58 -14.13 57.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.418 -175.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.8 t -82.78 143.2 46.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 119.812 1.806 . . . . 0.0 111.533 172.492 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.57 163.63 80.76 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.719 0.935 . . . . 0.0 112.28 -8.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.2 mt -113.27 156.6 23.04 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.157 1.783 . . . . 0.0 110.881 175.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -128.08 142.54 51.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.952 1.301 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 31.7 p90 -158.51 150.56 21.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.63 1.172 . . . . 0.0 112.056 -174.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 41.6 t80 -103.76 131.53 50.86 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.193 -0.942 . . . . 0.0 112.678 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.1 t -102.26 137.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.586 1.554 . . . . 0.0 108.852 176.741 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.63 160.68 31.94 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.638 1.175 . . . . 0.0 111.628 -169.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -75.45 117.43 17.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.007 0.923 . . . . 0.0 111.028 177.316 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.2 p -81.5 -23.63 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.025 0.93 . . . . 0.0 113.193 -168.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -83.36 -14.31 53.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.441 1.096 . . . . 0.0 113.547 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.4 m -72.77 156.66 38.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.72 1.208 . . . . 0.0 112.663 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.21 -14.77 68.23 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.467 1.032 . . . . 0.0 115.134 -173.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -64.51 154.63 35.37 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.793 1.296 . . . . 0.0 113.438 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 22.0 t -68.57 132.5 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.096 0.958 . . . . 0.0 109.38 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.8 t -154.1 146.72 24.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.461 1.105 . . . . 0.0 110.42 -176.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.44 141.96 51.77 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.746 1.219 . . . . 0.0 111.898 -172.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.0 p90 -168.07 164.8 13.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.314 1.446 . . . . 0.0 113.61 -175.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.07 172.18 12.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.653 1.597 . . . . 0.0 112.27 -176.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.4 -38.92 13.74 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.753 2.302 . . . . 0.0 112.422 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.57 89.62 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.799 -1.001 . . . . 0.0 115.14 -170.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -78.0 -3.59 42.82 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.444 1.622 . . . . 0.0 113.776 175.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.5 m -105.89 -61.46 1.5 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.172 1.789 . . . . 0.0 110.144 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -127.7 133.19 49.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.619 1.967 . . . . 0.0 111.502 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.02 177.02 16.83 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.166 1.365 . . . . 0.0 112.041 171.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 7.5 p -153.52 138.18 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.137 0.975 . . . . 0.0 109.451 176.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 29.3 m -60.68 152.93 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -170.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 34.1 m120 70.27 11.53 7.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.826 2.05 . . . . 0.0 114.738 166.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -147.03 156.97 47.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.524 1.529 . . . . 0.0 111.36 176.14 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.94 132.48 16.97 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.413 2.075 . . . . 0.0 111.586 -177.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.83 146.85 28.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.074 1.75 . . . . 0.0 109.784 167.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 40.1 p -132.19 149.13 52.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -164.181 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.23 177.24 11.26 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.84 1.656 . . . . 0.0 111.486 175.086 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -134.27 145.58 49.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.501 1.52 . . . . 0.0 110.336 -170.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.9 t -116.49 128.11 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.209 1.404 . . . . 0.0 108.221 168.848 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.33 131.41 35.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.719 177.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 53.7 p -134.01 12.11 3.94 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 112.812 -169.196 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.5 tptt -53.76 -40.41 66.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.21 1.804 . . . . 0.0 115.267 -162.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -110.54 1.88 18.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.076 1.35 . . . . 0.0 113.364 -178.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.8 -65.43 0.97 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.155 0.982 . . . . 0.0 111.127 178.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 69.97 0.99 30.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.795 1.878 . . . . 0.0 117.795 162.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -160.32 143.22 13.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.883 1.842 . . . . 0.0 111.731 -172.463 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 102.8 -173.7 22.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.868 1.699 . . . . 0.0 113.02 -177.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -94.83 114.66 4.89 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 124.231 0.92 . . . . 0.0 111.813 177.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.48 133.2 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.013 1.325 . . . . 0.0 108.751 168.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -140.2 161.53 37.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.46 1.504 . . . . 0.0 112.034 -168.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -166.35 139.34 3.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.617 1.567 . . . . 0.0 110.027 -162.37 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.85 163.26 34.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.902 1.281 . . . . 0.0 111.625 173.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 59.0 mt -136.43 134.0 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.298 1.039 . . . . 0.0 109.677 173.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.06 117.42 31.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.589 1.156 . . . . 0.0 109.519 170.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.58 179.26 16.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.928 1.251 . . . . 0.0 114.066 -177.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.27 -26.67 41.63 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.062 3.175 . . . . 0.0 111.753 172.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -137.51 154.87 49.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.57 1.548 . . . . 0.0 108.506 158.246 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.3 tttt -69.84 121.73 17.87 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.877 -1.139 . . . . 0.0 112.069 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.91 149.31 36.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 111.216 167.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -86.12 144.45 27.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.281 0.633 . . . . 0.0 109.647 166.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -133.69 139.49 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.797 1.239 . . . . 0.0 110.309 -167.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 72.8 m -135.17 157.21 47.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.689 1.596 . . . . 0.0 110.838 169.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -154.82 157.18 37.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.35 1.06 . . . . 0.0 112.484 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -143.48 125.72 15.55 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.125 1.37 . . . . 0.0 110.61 -171.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.77 131.6 40.93 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.944 1.297 . . . . 0.0 110.732 171.372 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -109.06 142.92 39.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.627 1.171 . . . . 0.0 111.723 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.43 -14.81 63.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.45 -11.69 60.78 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 113.905 177.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.78 36.08 5.66 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.914 1.245 . . . . 0.0 113.674 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.4 p -140.75 166.49 24.62 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.91 1.684 . . . . 0.0 110.424 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 76.3 m -120.53 129.79 53.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.685 1.594 . . . . 0.0 108.966 165.818 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.4 t -91.74 150.54 21.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.975 0.91 . . . . 0.0 110.808 172.257 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 77.6 t -134.97 141.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.686 1.594 . . . . 0.0 110.273 -176.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 53.0 m -132.67 140.37 48.12 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 110.552 172.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -145.18 148.23 33.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.134 -0.979 . . . . 0.0 113.19 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.2 tt -118.67 99.81 51.25 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.789 1.236 . . . . 0.0 110.006 -173.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -83.15 153.54 14.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.753 2.969 . . . . 0.0 111.279 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.0 m -116.54 -11.45 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -167.55 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.05 151.2 22.47 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.374 1.469 . . . . 0.0 110.537 177.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 142.99 28.29 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.918 2.412 . . . . 0.0 111.713 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.29 -165.0 32.7 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.518 1.056 . . . . 0.0 113.493 -176.133 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -99.44 124.43 44.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 112.327 -179.206 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -120.18 127.42 52.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.828 1.651 . . . . 0.0 110.431 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.8 m -92.06 114.46 27.01 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.951 -1.093 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.05 121.35 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.97 1.708 . . . . 0.0 108.777 177.349 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.91 134.92 45.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.778 1.631 . . . . 0.0 109.107 176.009 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 61.5 t -139.43 131.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.723 1.209 . . . . 0.0 109.126 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.2 tmmt? -154.73 143.39 20.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.911 1.285 . . . . 0.0 110.946 -165.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.82 121.06 10.86 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.552 1.141 . . . . 0.0 109.498 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.42 55.81 4.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.243 1.417 . . . . 0.0 111.599 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.0 pt-20 55.8 18.23 2.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.084 2.554 . . . . 0.0 115.94 -177.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -125.35 125.28 43.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.079 1.352 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.667 0.787 . . . . 0.0 112.499 171.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.7 m -74.39 155.53 87.67 Favored Pre-proline 0 N--CA 1.479 1.023 0 O-C-N 121.669 -0.644 . . . . 0.0 110.863 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -55.79 123.74 14.57 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.625 2.217 . . . . 0.0 110.343 172.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -15.42 63.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 178.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.1 p -79.52 151.76 74.9 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.177 1.988 . . . . 0.0 112.753 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.17 153.43 98.9 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.274 0.776 . . . . 0.0 112.9 -1.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -107.72 132.99 52.77 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.208 1.403 . . . . 0.0 110.49 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 58.6 m -88.86 108.93 19.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.374 0.67 . . . . 0.0 110.541 178.514 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.53 132.23 34.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.773 170.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.34 115.28 27.48 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 0.0 109.263 174.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -93.73 134.4 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.75 1.22 . . . . 0.0 109.894 177.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.6 p -111.01 166.89 10.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.165 1.386 . . . . 0.0 112.964 177.688 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.47 141.37 22.85 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.103 1.335 . . . . 0.0 112.137 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.28 -27.8 27.6 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.627 1.171 . . . . 0.0 113.225 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.571 1.548 . . . . 0.0 113.648 -179.55 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.523 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 60.95 -156.33 0.35 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.404 1.882 . . . . 0.0 112.866 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 24.6 ttt 74.22 -54.77 0.67 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 128.747 2.819 . . . . 0.0 112.833 177.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -89.44 148.77 41.19 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.224 1.41 . . . . 0.0 111.751 174.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.29 161.84 34.5 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.692 2.928 . . . . 0.0 111.716 176.413 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.68 136.04 40.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.805 0.842 . . . . 0.0 110.642 172.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -63.66 132.0 95.06 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.776 0.83 . . . . 0.0 111.741 -176.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.07 161.78 15.24 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.854 3.036 . . . . 0.0 113.189 169.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 96.2 mt -123.48 117.61 25.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.015 1.326 . . . . 0.0 109.168 172.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 41.2 t -144.13 -64.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.087 1.355 . . . . 0.0 110.007 -177.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 74.29 -165.66 54.77 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.282 0.944 . . . . 0.0 113.739 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 14.1 p -163.5 138.34 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.932 1.693 . . . . 0.0 110.389 177.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -89.51 135.51 33.56 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.529 1.132 . . . . 0.0 112.061 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -83.37 121.82 5.59 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.268 0.937 . . . . 0.0 111.33 175.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 86.4 mt -85.12 151.85 23.82 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.563 1.145 . . . . 0.0 111.726 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -79.57 130.27 35.23 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.127 0.971 . . . . 0.0 111.802 177.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 15.4 m -147.4 147.51 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.264 1.826 . . . . 0.0 110.177 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.2 t -176.87 -32.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.607 1.963 . . . . 0.0 112.129 -175.391 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 1.7 m -75.79 29.85 0.11 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.726 2.01 . . . . 0.0 115.387 -171.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 26.5 tp -75.28 148.06 39.71 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.275 2.23 . . . . 0.0 110.038 170.377 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -52.13 115.92 7.55 Favored Pre-proline 0 N--CA 1.479 0.993 0 CA-C-O 118.25 -0.881 . . . . 0.0 112.82 -165.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.28 138.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.373 2.049 . . . . 0.0 108.824 174.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 56.7 t80 -130.74 125.37 33.67 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 111.575 -171.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -157.43 139.42 14.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.771 1.629 . . . . 0.0 110.795 176.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.1 mm? -130.9 157.24 43.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.981 2.112 . . . . 0.0 110.0 -175.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.07 136.81 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.916 1.286 . . . . 0.0 109.901 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.1 mt -133.01 134.41 24.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.749 1.62 . . . . 0.0 109.038 -169.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.65 114.08 3.84 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.221 2.614 . . . . 0.0 109.795 173.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.7 t80 -175.24 148.45 0.97 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.389 1.876 . . . . 0.0 110.23 -171.008 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.2 m -128.6 128.29 43.93 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.72 1.208 . . . . 0.0 110.103 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.7 mt -89.76 135.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.672 1.189 . . . . 0.0 109.12 172.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.4 tptt -132.15 -58.36 0.95 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.105 0.962 . . . . 0.0 112.574 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.6 tttp -157.37 131.01 8.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.985 1.714 . . . . 0.0 110.55 179.347 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 121.14 -148.45 17.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 125.286 1.422 . . . . 0.0 111.485 -166.332 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.06 144.88 17.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -175.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.2 tt -121.52 136.2 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.779 1.632 . . . . 0.0 111.081 177.561 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 39.4 p -146.56 178.71 8.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.365 1.866 . . . . 0.0 110.259 -177.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.49 -168.46 30.6 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.319 0.887 . . . . 0.0 115.319 -179.179 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.96 146.39 23.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.87 1.668 . . . . 0.0 109.927 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 95.1 t -125.74 131.13 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.729 1.612 . . . . 0.0 108.327 173.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.7 mtm105 -119.66 138.33 53.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.651 1.18 . . . . 0.0 111.669 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 23.5 mtt -111.8 151.32 43.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.775 1.63 . . . . 0.0 111.764 -169.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -53.84 -38.76 85.81 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.093 3.195 . . . . 0.0 115.052 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -77.25 4.01 11.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -176.376 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.92 80.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.302 1.43 . . . . 0.0 114.155 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 152.01 44.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.15 1.38 . . . . 0.0 111.512 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.2 t -142.68 143.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.172 1.389 . . . . 0.0 109.981 -174.256 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.03 179.21 7.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.262 1.825 . . . . 0.0 110.984 177.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.66 143.98 43.24 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.928 0.891 . . . . 0.0 111.241 175.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.63 165.17 16.03 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.149 3.232 . . . . 0.0 111.41 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 89.9 m -106.41 124.09 49.06 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.222 1.409 . . . . 0.0 108.685 172.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.93 134.22 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.548 1.139 . . . . 0.0 109.213 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.1 m -135.41 122.63 21.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.495 1.518 . . . . 0.0 109.382 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.76 133.76 41.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.101 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.9 -12.08 45.8 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.5 mttm 69.79 6.91 5.96 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.333 2.253 . . . . 0.0 113.821 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.57 8.3 35.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.163 2.185 . . . . 0.0 112.804 179.319 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 94.22 14.42 51.35 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.169 1.366 . . . . 0.0 114.156 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.5 p -130.9 156.71 44.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.085 1.754 . . . . 0.0 110.774 176.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 30.0 m -119.22 138.87 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.291 1.036 . . . . 0.0 109.797 166.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 47.6 m -97.09 141.97 29.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.93 1.292 . . . . 0.0 108.604 171.027 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.1 t -126.59 132.19 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.045 1.338 . . . . 0.0 109.269 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.27 152.96 48.26 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.713 1.605 . . . . 0.0 111.693 -172.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 13.6 t80 -153.51 129.63 10.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.249 1.419 . . . . 0.0 111.327 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -79.76 121.43 82.35 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.102 0.961 . . . . 0.0 110.098 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.0 130.05 12.91 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 0.0 111.768 -170.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 74.2 m -126.0 -0.33 7.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -161.67 152.68 18.15 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.304 1.442 . . . . 0.0 111.021 -178.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -93.79 164.84 12.97 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.479 1.112 . . . . 0.0 112.683 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 102.28 -164.18 16.83 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.315 1.436 . . . . 0.0 113.9 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 26.4 tp -84.55 121.94 28.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.944 1.297 . . . . 0.0 110.95 -178.099 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 52.7 m80 -118.17 167.74 11.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.585 1.954 . . . . 0.0 111.316 -175.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -146.47 150.71 36.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.509 0.671 . . . . 0.0 112.571 167.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 10.6 ttm -119.91 131.89 55.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.655 2.382 . . . . 0.0 110.008 -174.616 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -102.05 139.3 37.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.812 1.645 . . . . 0.0 110.037 168.216 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -138.15 133.77 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.961 1.305 . . . . 0.0 109.268 173.519 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.64 138.55 23.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -102.41 119.35 38.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.025 2.13 . . . . 0.0 109.462 176.513 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 50.92 35.85 13.48 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.72 1.208 . . . . 0.0 112.829 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 6.7 t-20 82.71 -7.73 1.23 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.896 2.878 . . . . 0.0 114.69 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.0 mtp -94.11 129.49 40.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.831 1.252 . . . . 0.0 111.466 176.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.05 137.69 56.65 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.263 -0.898 . . . . 0.0 113.289 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.88 154.04 83.03 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.366 0.666 . . . . 0.0 111.501 176.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.63 135.53 57.24 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.479 2.119 . . . . 0.0 110.615 175.647 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 91.98 -13.95 65.61 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.646 1.117 . . . . 0.0 114.716 -175.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.1 m -96.52 158.7 33.31 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.463 1.631 . . . . 0.0 112.092 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.82 167.81 78.33 Favored 'Cis proline' 0 C--N 1.354 0.848 0 CA-C-N 119.827 0.974 . . . . 0.0 112.842 -2.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 98.8 mt -120.97 143.16 49.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.502 1.521 . . . . 0.0 110.994 -174.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -125.68 137.87 53.87 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.921 1.288 . . . . 0.0 110.374 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.99 152.04 24.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.565 1.146 . . . . 0.0 112.545 -166.079 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -103.91 148.28 26.35 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.291 -0.88 . . . . 0.0 112.945 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 25.5 t -129.73 137.42 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.311 1.444 . . . . 0.0 110.206 -177.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -165.81 145.21 6.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.746 1.618 . . . . 0.0 112.14 -163.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -71.22 133.97 46.53 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.433 -1.417 . . . . 0.0 113.237 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.8 p -63.74 -29.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -175.454 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.75 0.12 57.51 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.667 1.187 . . . . 0.0 113.775 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -66.69 140.15 57.88 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.216 -0.928 . . . . 0.0 111.919 -177.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.32 78.14 2.04 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.952 1.263 . . . . 0.0 112.334 -173.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -163.26 168.74 20.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.511 1.524 . . . . 0.0 113.795 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.4 p -67.37 146.2 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.749 0.819 . . . . 0.0 109.34 157.226 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.0 t -164.24 165.97 21.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.375 1.47 . . . . 0.0 110.637 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.69 147.78 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.54 1.136 . . . . 0.0 112.444 -176.096 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.6 p90 -166.02 160.11 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 112.623 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.65 170.49 12.1 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.347 1.451 . . . . 0.0 113.189 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.95 -30.86 32.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.241 2.628 . . . . 0.0 112.854 -170.754 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.9 -16.15 72.24 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 119.318 0.963 . . . . 0.0 114.703 -178.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.04 -13.75 59.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.939 1.369 . . . . 0.0 112.92 170.197 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 62.1 m -117.16 -38.97 3.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.43 1.892 . . . . 0.0 111.905 -166.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -147.35 159.64 43.45 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.903 2.081 . . . . 0.0 111.823 -171.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.2 175.92 33.77 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.313 0.959 . . . . 0.0 112.908 169.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 24.2 t -139.61 135.92 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 108.758 173.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.3 m -57.12 139.04 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 66.08 3.98 2.89 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.96 2.104 . . . . 0.0 114.926 173.139 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -119.43 144.63 36.98 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.697 1.599 . . . . 0.0 110.923 176.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.72 125.07 10.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 111.094 -174.268 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.95 146.73 27.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.298 1.439 . . . . 0.0 110.137 170.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 62.9 p -136.19 154.46 50.94 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -164.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1886 ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.3 p90 -164.09 172.07 14.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.229 1.812 . . . . 0.0 111.595 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.5 m -125.04 141.53 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.453 1.501 . . . . 0.0 110.565 -174.17 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.19 128.7 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.801 168.291 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -90.64 122.01 33.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 0.0 109.871 172.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 44.9 p -122.36 2.82 9.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.456 1.902 . . . . 0.0 113.251 -171.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 62.2 tttp -51.74 -37.37 50.85 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.861 1.664 . . . . 0.0 114.116 -176.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 1.52 31.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.308 1.443 . . . . 0.0 113.632 179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.22 -23.44 61.24 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.87 -91.64 1.42 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.712 1.149 . . . . 0.0 112.553 175.464 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.36 171.66 17.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.717 1.607 . . . . 0.0 112.231 -173.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 113.53 -166.89 12.19 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.929 1.728 . . . . 0.0 111.976 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -90.54 118.0 5.23 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 124.269 0.937 . . . . 0.0 112.262 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.45 128.67 34.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 108.484 164.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.9 m -127.78 157.98 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.372 1.469 . . . . 0.0 111.822 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.6 tp -159.6 133.73 7.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.598 1.559 . . . . 0.0 109.12 -169.22 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.91 162.52 38.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.293 1.037 . . . . 0.0 112.017 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.61 134.13 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.523 1.129 . . . . 0.0 109.751 175.075 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -114.67 159.19 20.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.634 1.573 . . . . 0.0 109.918 168.151 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.64 -163.39 35.99 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.416 -0.802 . . . . 0.0 113.572 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.29 -16.11 28.14 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.543 2.829 . . . . 0.0 112.716 177.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -152.49 160.15 43.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.064 1.746 . . . . 0.0 109.418 168.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -75.63 114.73 14.54 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.894 -1.129 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.18 148.04 44.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.902 0.881 . . . . 0.0 111.259 168.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.38 144.63 25.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.642 0.777 . . . . 0.0 109.967 170.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.48 144.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 110.719 -166.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.7 t -142.37 157.64 44.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.02 1.328 . . . . 0.0 110.713 166.848 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.8 p -155.65 154.92 32.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 112.764 -176.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.5 m -140.74 123.41 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.352 1.461 . . . . 0.0 110.246 -171.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -72.42 120.51 18.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 110.077 166.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.02 -10.31 57.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.769 0.827 . . . . 0.0 112.933 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 76.08 -28.37 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.583 2.753 . . . . 0.0 112.581 178.18 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -73.83 10.68 1.06 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.293 2.237 . . . . 0.0 114.68 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.51 16.99 32.51 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.234 1.397 . . . . 0.0 114.198 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 77.7 p -138.7 154.14 48.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.301 1.44 . . . . 0.0 111.325 175.651 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.0 m -119.49 134.28 55.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.001 1.721 . . . . 0.0 109.309 166.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.1 t -94.87 150.4 20.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 110.837 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1922 ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' A' 1886 ' ' PHE . 66.7 t -132.22 143.05 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.363 1.465 . . . . 0.0 110.405 -179.165 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 58.9 m -131.89 141.76 49.46 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.143 1.777 . . . . 0.0 110.748 171.315 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.7 p90 -147.01 152.36 38.47 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.81 102.82 49.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.852 2.061 . . . . 0.0 110.422 -178.055 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.77 160.08 16.29 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.683 2.922 . . . . 0.0 110.303 168.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 33.4 m -121.55 -10.12 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -168.49 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.77 152.72 24.66 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.267 1.427 . . . . 0.0 110.412 178.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.98 143.79 23.37 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.891 2.394 . . . . 0.0 111.729 -172.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 153.64 -172.09 32.43 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.07 1.319 . . . . 0.0 113.252 -174.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.83 129.3 37.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.006 1.322 . . . . 0.0 112.288 176.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -121.52 140.82 51.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.033 1.733 . . . . 0.0 110.341 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 72.2 m -106.49 113.39 26.87 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.997 1.319 . . . . 0.0 110.45 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -92.74 121.75 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.135 1.374 . . . . 0.0 108.514 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.2 tt -100.28 128.18 46.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.484 1.514 . . . . 0.0 109.362 175.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -129.71 130.61 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.232 1.013 . . . . 0.0 109.671 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.57 143.14 23.59 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.954 1.302 . . . . 0.0 112.087 -167.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.51 124.79 24.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 0.0 109.787 176.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 53.84 56.32 7.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.122 1.369 . . . . 0.0 112.033 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.301 8.2 pt-20 58.91 3.32 0.31 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 128.957 2.903 . . . . 0.0 116.809 -176.101 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -109.27 126.07 52.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.0 110.661 178.329 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m170 -62.0 144.13 55.56 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.221 -0.924 . . . . 0.0 111.716 172.424 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.3 m -70.32 152.11 95.64 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.445 172.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.49 127.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.665 2.243 . . . . 0.0 110.696 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.44 -13.07 67.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.147 1.356 . . . . 0.0 115.316 -176.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.1 t -75.1 141.36 74.38 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.335 1.567 . . . . 0.0 111.713 176.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.86 146.59 81.79 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 119.613 0.898 . . . . 0.0 112.385 -3.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -99.74 139.87 34.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.686 1.594 . . . . 0.0 111.155 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 5.9 m -98.91 108.0 20.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.894 0.878 . . . . 0.0 111.048 -176.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.64 126.13 45.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.29 175.12 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -93.21 115.13 27.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.304 0.641 . . . . 0.0 110.425 176.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.7 t -91.5 136.57 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.803 1.641 . . . . 0.0 110.461 -177.078 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 8.7 m -113.53 153.77 28.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.057 1.743 . . . . 0.0 111.094 -171.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.23 137.53 23.02 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.928 0.775 . . . . 0.0 111.802 172.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 39.1 t70 -76.99 -28.13 54.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.087 0.955 . . . . 0.0 113.315 -178.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.255 1.346 0 C-N-CA 126.436 1.894 . . . . 0.0 112.62 -176.815 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.52 -29.29 66.87 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.972 0.909 . . . . 0.0 113.145 178.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.2 ttt -104.55 148.26 26.7 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.893 1.677 . . . . 0.0 110.903 173.109 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -67.09 154.0 93.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.788 1.235 . . . . 0.0 112.612 175.199 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.28 167.35 26.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.708 2.938 . . . . 0.0 112.06 177.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.13 146.8 27.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.288 1.435 . . . . 0.0 110.4 -177.436 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -161.77 151.3 13.63 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.378 1.471 . . . . 0.0 112.287 -173.032 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.57 152.56 65.21 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.429 2.753 . . . . 0.0 111.702 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 15.7 tp -120.55 24.92 10.08 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.428 1.491 . . . . 0.0 111.909 -174.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 80.9 t -68.99 121.41 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.004 1.321 . . . . 0.0 110.542 -175.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -105.49 -142.47 11.19 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.676 1.608 . . . . 0.0 112.175 176.443 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 94.2 t -68.04 130.93 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.017 0.927 . . . . 0.0 109.481 173.664 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 33.2 m120 -79.94 -0.29 34.47 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -170.638 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 99.66 -176.69 28.85 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.759 1.647 . . . . 0.0 113.109 -176.456 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.1 mt -76.08 140.8 42.04 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.081 0.953 . . . . 0.0 112.039 -176.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 18.1 t0 -162.21 134.62 5.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.706 2.002 . . . . 0.0 109.218 178.528 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . 0.302 10.0 p 44.09 31.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.558 1.943 . . . . 0.0 114.465 -173.398 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.6 t -67.75 -32.26 72.74 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.876 1.27 . . . . 0.0 112.307 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 33.6 t -164.75 125.78 2.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.554 1.542 . . . . 0.0 110.026 172.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.72 137.06 32.75 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.956 1.302 . . . . 0.0 110.27 174.057 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -67.2 122.95 85.09 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.736 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.01 150.52 60.75 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.006 2.471 . . . . 0.0 110.86 179.526 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1791 ' ' PHE . . . . . 0.4 ' CE1' HD23 ' A' 1793 ' ' LEU . 20.4 t80 -107.0 128.51 54.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.381 0.672 . . . . 0.0 111.103 178.108 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -151.76 136.37 17.01 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.328 1.451 . . . . 0.0 110.723 173.046 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1793 ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' 1791 ' ' PHE . 0.4 OUTLIER -140.57 153.85 46.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.604 1.962 . . . . 0.0 109.724 -173.42 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -129.29 137.48 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.987 1.315 . . . . 0.0 110.363 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.47 137.55 29.26 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.166 1.787 . . . . 0.0 108.586 -173.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 52.39 4.28 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.417 3.411 . . . . 0.0 112.775 -178.117 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 44.2 t80 -95.68 150.05 20.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.262 1.425 . . . . 0.0 111.212 174.075 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 93.1 m -119.79 124.0 45.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.793 1.237 . . . . 0.0 109.897 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.3 mt -91.12 139.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.276 1.43 . . . . 0.0 109.74 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -148.69 -43.99 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -177.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 tttm -164.23 123.77 1.98 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.246 1.418 . . . . 0.0 111.601 178.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 123.74 -157.2 18.13 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.868 1.699 . . . . 0.0 111.764 -168.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -141.4 150.09 41.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.819 1.247 . . . . 0.0 111.457 -176.449 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.3 tt -127.68 135.24 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.718 1.607 . . . . 0.0 111.099 176.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.8 p -146.7 176.4 9.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.014 1.726 . . . . 0.0 109.953 176.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -164.99 -170.72 30.32 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 178.678 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -155.98 145.9 21.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.841 1.656 . . . . 0.0 110.194 -176.266 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 61.8 t -126.53 137.2 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.472 1.909 . . . . 0.0 108.944 178.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -116.63 131.36 56.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.666 1.586 . . . . 0.0 111.879 -173.277 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -102.42 148.25 35.19 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.804 1.641 . . . . 0.0 111.698 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.87 -28.6 68.69 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.283 3.322 . . . . 0.0 114.922 174.154 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 37.9 p -72.8 -5.95 41.52 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.492 1.517 . . . . 0.0 114.359 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.1 -5.09 81.59 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.473 1.511 . . . . 0.0 113.67 -175.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.68 159.18 32.64 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.347 1.073 . . . . 0.0 111.888 174.388 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.9 m -138.33 154.43 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.245 1.418 . . . . 0.0 111.384 174.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.55 171.6 19.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.396 1.879 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -117.19 141.44 28.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.651 0.781 . . . . 0.0 111.421 178.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -86.34 172.15 7.24 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.269 3.313 . . . . 0.0 111.93 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.5 m -103.01 130.69 50.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.925 1.29 . . . . 0.0 108.793 170.665 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.1 132.71 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 0.0 108.819 172.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.6 m -124.54 128.25 48.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.195 1.798 . . . . 0.0 109.746 -178.135 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.1 t0 -80.45 119.32 22.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.15 0.98 . . . . 0.0 110.276 171.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -81.73 -11.18 59.14 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.202 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.5 mmmt 72.48 -3.84 2.22 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 128.046 2.538 . . . . 0.0 114.007 -178.408 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -97.35 6.12 48.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.672 1.989 . . . . 0.0 113.41 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 89.52 16.02 57.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.722 1.153 . . . . 0.0 113.491 -172.101 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 48.5 p -130.86 159.55 37.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.611 1.965 . . . . 0.0 110.154 175.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -123.18 143.75 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.621 1.168 . . . . 0.0 109.928 168.107 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 24.1 m -104.74 139.86 38.92 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.729 1.212 . . . . 0.0 108.796 172.442 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 29.3 t -121.57 134.59 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.453 1.501 . . . . 0.0 108.664 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.78 149.22 50.38 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.078 1.351 . . . . 0.0 112.433 -173.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 29.8 t80 -150.83 131.1 13.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.418 1.487 . . . . 0.0 111.812 178.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.7 120.73 73.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.632 1.173 . . . . 0.0 110.825 176.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.06 146.17 20.02 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.71 2.94 . . . . 0.0 112.427 -170.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 84.3 p -128.4 -11.71 5.09 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 174.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -147.63 152.3 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.28 1.832 . . . . 0.0 110.487 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.45 168.17 12.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.368 1.067 . . . . 0.0 111.926 169.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.71 -173.45 14.74 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.463 1.506 . . . . 0.0 114.15 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.3 tp -82.06 114.83 20.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.695 1.198 . . . . 0.0 110.249 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 48.1 m80 -110.55 165.62 11.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 111.429 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.61 154.44 45.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.198 0.999 . . . . 0.0 111.103 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.5 ttm -138.35 137.78 37.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.846 1.658 . . . . 0.0 110.439 -171.018 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -121.21 121.1 37.05 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.509 1.924 . . . . 0.0 109.386 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -125.9 132.59 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.578 1.151 . . . . 0.0 110.158 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.41 136.55 26.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -172.034 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 11.6 t80 -106.13 125.16 50.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.455 1.902 . . . . 0.0 110.004 175.414 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 51.48 37.0 18.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.776 1.23 . . . . 0.0 112.569 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 57.0 t30 82.99 -9.42 1.09 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 129.081 2.952 . . . . 0.0 114.768 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 26.5 mmt -101.94 136.19 42.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.917 1.287 . . . . 0.0 111.819 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.22 136.42 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.218 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.59 152.65 91.67 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.178 175.484 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -57.41 124.34 15.9 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.085 2.523 . . . . 0.0 111.092 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 96.92 -11.28 66.12 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.933 1.254 . . . . 0.0 114.836 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.16 149.4 39.8 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 120.029 1.915 . . . . 0.0 111.099 173.268 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.15 162.1 92.74 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.778 1.314 . . . . 0.0 113.311 1.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.7 mt -113.42 157.15 22.28 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.179 1.792 . . . . 0.0 111.349 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.62 140.11 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.099 1.36 . . . . 0.0 109.458 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.55 163.46 17.01 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.389 1.075 . . . . 0.0 112.112 -169.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -104.29 135.11 46.37 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.188 -0.945 . . . . 0.0 113.028 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.1 t -103.17 139.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.335 1.454 . . . . 0.0 108.426 171.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.9 t0 -150.87 165.89 32.23 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.344 1.058 . . . . 0.0 111.875 -172.886 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -78.05 138.51 38.81 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.843 0.857 . . . . 0.0 111.536 174.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 94.8 t -72.24 -37.81 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.872 0.869 . . . . 0.0 112.643 -171.213 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -124.76 17.57 8.69 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -166.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 12.7 t -68.63 -26.73 65.49 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.0 -1.063 . . . . 0.0 113.125 178.116 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 101.39 -14.23 58.12 Favored Glycine 0 N--CA 1.476 1.34 0 C-N-CA 125.7 1.619 . . . . 0.0 115.782 166.25 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -66.47 158.57 29.2 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.001 1.4 . . . . 0.0 113.587 175.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 p -60.84 139.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.572 0.749 . . . . 0.0 110.137 169.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -161.54 172.23 16.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.243 1.417 . . . . 0.0 110.519 -178.215 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.72 144.58 24.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.542 1.137 . . . . 0.0 111.859 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.66 163.63 12.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.389 1.476 . . . . 0.0 113.156 -175.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.37 173.53 13.42 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.398 1.475 . . . . 0.0 112.717 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.66 -33.86 26.84 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.874 2.383 . . . . 0.0 112.418 -173.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.91 72.1 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.718 -1.046 . . . . 0.0 114.849 -173.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.83 -0.39 43.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.343 1.572 . . . . 0.0 113.854 174.076 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 55.4 m -108.64 -47.85 3.41 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 178.638 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -142.44 152.31 42.64 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.804 2.042 . . . . 0.0 112.255 -172.654 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -154.53 -176.07 26.4 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.474 1.035 . . . . 0.0 113.635 169.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.4 p -153.3 136.85 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.124 1.37 . . . . 0.0 108.889 177.053 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -58.8 145.23 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -170.881 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.6 m-80 68.79 1.57 3.14 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.734 2.014 . . . . 0.0 114.656 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -115.44 141.59 27.48 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.586 1.555 . . . . 0.0 110.597 176.101 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.1 136.81 30.3 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.661 2.24 . . . . 0.0 110.86 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.87 139.02 51.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.887 1.675 . . . . 0.0 110.182 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.2 p -131.84 147.69 52.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -165.13 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -157.68 174.98 14.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.635 1.574 . . . . 0.0 111.364 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.2 m -129.49 136.97 50.53 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.809 1.243 . . . . 0.0 110.812 -172.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.1 t -100.35 132.14 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.36 1.464 . . . . 0.0 107.811 167.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.53 130.46 49.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.789 1.236 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.0 p -135.28 11.27 3.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.293 1.837 . . . . 0.0 112.941 -170.063 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 58.5 tttp -52.37 -34.96 50.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.336 1.854 . . . . 0.0 115.546 -165.924 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.69 23.88 4.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.315 1.446 . . . . 0.0 111.934 175.006 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.66 -8.87 59.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.907 1.283 . . . . 0.0 114.433 -177.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 87.95 -122.16 6.18 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.669 1.128 . . . . 0.0 112.439 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.0 167.77 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.471 1.508 . . . . 0.0 112.254 -174.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 139.81 -162.69 26.27 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.625 1.583 . . . . 0.0 113.21 -178.671 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -84.58 109.6 3.27 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 124.082 0.848 . . . . 0.0 111.488 175.54 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 44.7 tp -85.15 134.46 34.17 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.612 1.165 . . . . 0.0 109.645 171.555 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.9 m -132.83 158.64 41.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.283 1.433 . . . . 0.0 112.338 -175.365 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.2 tp -161.08 134.87 6.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.393 1.877 . . . . 0.0 108.783 -169.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.08 157.3 34.31 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.978 0.911 . . . . 0.0 112.104 176.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -137.42 140.27 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.847 1.259 . . . . 0.0 109.625 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.02 143.56 50.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.639 1.576 . . . . 0.0 109.516 172.672 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.75 -162.99 23.03 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.99 -0.895 . . . . 0.0 114.982 -174.327 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -64.26 -26.86 64.05 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.126 3.217 . . . . 0.0 112.602 178.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -138.22 158.85 43.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.008 1.323 . . . . 0.0 109.253 161.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -74.6 112.78 11.13 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.895 -1.128 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.76 149.42 49.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.923 0.889 . . . . 0.0 112.123 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.3 139.89 30.09 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.523 0.729 . . . . 0.0 109.258 165.818 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.46 138.12 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.668 1.187 . . . . 0.0 110.469 -167.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -134.78 155.75 50.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 110.783 171.084 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.74 154.49 32.93 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.089 0.956 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 90.7 m -143.31 120.03 11.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.82 1.648 . . . . 0.0 109.906 -172.723 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -72.61 124.96 26.32 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.341 0.656 . . . . 0.0 110.109 170.188 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -86.28 -11.33 52.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -174.011 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 69.31 -3.3 1.61 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.27 2.628 . . . . 0.0 113.759 -175.254 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.49 8.29 39.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.446 1.898 . . . . 0.0 113.236 -177.437 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.43 18.28 36.44 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.097 1.332 . . . . 0.0 113.637 -172.19 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 54.1 p -142.64 157.03 45.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.673 1.589 . . . . 0.0 111.652 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 52.7 t -127.19 124.81 39.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.616 1.967 . . . . 0.0 109.009 169.585 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 146.64 25.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.235 1.014 . . . . 0.0 110.904 177.034 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.3 t -128.44 143.48 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.063 1.745 . . . . 0.0 109.778 -178.129 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.4 t -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.469 1.508 . . . . 0.0 110.728 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.0 p90 -144.95 153.58 41.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.185 -0.947 . . . . 0.0 113.491 175.255 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 3.2 mt -114.37 106.38 52.75 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.976 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.64 170.04 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.887 3.058 . . . . 0.0 110.703 167.152 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.5 p -148.52 -28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -173.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.05 146.18 33.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.541 1.064 . . . . 0.0 110.928 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 163.55 34.7 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.255 2.636 . . . . 0.0 111.159 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.93 -134.94 7.89 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 125.269 1.414 . . . . 0.0 111.02 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 2.2 p30 -143.91 145.36 32.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.009 0.909 . . . . 0.0 112.829 176.306 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -121.26 135.68 55.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.789 2.035 . . . . 0.0 109.872 -171.802 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -89.78 127.14 35.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.305 1.042 . . . . 0.0 110.509 174.364 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.4 120.67 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.66 1.584 . . . . 0.0 108.593 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -102.37 134.5 45.57 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 109.942 174.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.7 t -136.66 133.12 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.355 1.462 . . . . 0.0 108.384 171.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.39 141.69 19.57 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.015 1.326 . . . . 0.0 111.026 -170.302 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.37 125.38 18.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.662 1.185 . . . . 0.0 110.43 -178.557 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.76 54.3 10.09 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.056 1.343 . . . . 0.0 111.909 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.303 8.5 pt-20 57.97 15.72 3.3 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.233 2.613 . . . . 0.0 116.236 -177.933 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -121.99 129.81 52.77 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.577 1.151 . . . . 0.0 111.282 177.242 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -61.97 155.71 22.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.092 0.957 . . . . 0.0 112.722 170.556 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.2 m -83.14 156.4 66.7 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.272 0.629 . . . . 0.0 110.126 175.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.58 122.77 12.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.455 2.104 . . . . 0.0 110.276 176.237 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.39 -13.07 68.0 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.293 -1.281 . . . . 0.0 116.079 -179.135 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.4 p -80.92 152.02 71.26 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 120.262 2.031 . . . . 0.0 112.91 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.46 141.93 71.53 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.152 0.733 . . . . 0.0 111.948 -4.524 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.85 169.64 11.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.431 1.493 . . . . 0.0 110.669 176.221 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 37.4 m -132.81 117.43 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.647 0.779 . . . . 0.0 110.741 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.63 128.47 45.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.803 1.241 . . . . 0.0 110.94 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -88.85 131.67 35.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.195 0.452 . . . . 0.0 110.749 174.009 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -121.22 138.25 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.676 1.59 . . . . 0.0 109.788 -173.668 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -126.01 177.16 6.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.24 1.016 . . . . 0.0 112.801 -176.297 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.82 138.66 21.14 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.825 1.678 . . . . 0.0 112.51 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.94 -18.34 34.91 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.578 1.151 . . . . 0.0 113.558 -178.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.771 2.028 . . . . 0.0 112.544 -176.751 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.38 152.4 42.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.23 1.012 . . . . 0.0 112.628 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 28.4 ptm -77.7 -22.26 50.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.083 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -83.18 150.65 61.48 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.876 1.27 . . . . 0.0 112.41 -179.44 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.6 158.74 50.28 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.644 2.896 . . . . 0.0 111.58 175.379 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.17 -6.72 52.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.262 1.025 . . . . 0.0 113.489 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -134.43 133.99 22.08 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.368 1.867 . . . . 0.0 110.169 178.306 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.74 152.81 47.98 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.313 2.675 . . . . 0.0 111.711 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.43 11.96 19.98 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.007 1.323 . . . . 0.0 113.147 -178.64 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 10.9 p -57.15 143.49 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.445 1.898 . . . . 0.0 112.959 -175.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 100.84 -8.46 57.92 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.166 1.365 . . . . 0.0 115.366 173.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 33.0 m -77.0 145.22 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.873 1.337 . . . . 0.0 111.524 174.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -86.55 156.85 19.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.338 1.055 . . . . 0.0 113.214 177.09 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -90.76 -176.26 44.17 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.956 1.265 . . . . 0.0 112.335 167.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.4 mt -122.91 147.35 46.69 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.199 1.4 . . . . 0.0 110.824 175.422 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -93.53 8.5 40.49 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.285 1.434 . . . . 0.0 113.378 -174.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.8 p -57.43 -23.77 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.579 1.952 . . . . 0.0 115.213 -166.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.7 t -63.9 -33.91 76.77 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.29 1.036 . . . . 0.0 112.365 173.193 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 2.7 t 79.44 160.65 0.18 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.107 2.563 . . . . 0.0 114.436 174.104 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.1 tp -107.06 138.2 43.69 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.029 1.731 . . . . 0.0 109.121 173.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -61.8 121.9 67.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.949 0.9 . . . . 0.0 112.098 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.299 2.666 . . . . 0.0 111.506 -177.468 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.1 t80 -101.39 122.14 43.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.115 0.966 . . . . 0.0 109.635 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -148.63 131.29 15.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 110.581 171.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.23 153.84 43.23 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.381 1.872 . . . . 0.0 109.653 -170.592 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.62 137.81 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.825 1.25 . . . . 0.0 110.353 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.2 mt -131.7 136.32 28.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.303 1.841 . . . . 0.0 108.734 -172.609 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -77.75 69.58 7.3 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.558 3.505 . . . . 0.0 111.019 177.374 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -123.33 162.43 22.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.583 1.953 . . . . 0.0 110.307 175.156 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.8 m -139.28 130.0 26.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.906 1.282 . . . . 0.0 109.926 178.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 57.9 mt -82.17 118.2 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.18 0.992 . . . . 0.0 108.688 170.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -24.99 11.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -174.057 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -170.43 -24.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 178.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.79 -147.67 13.45 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.766 1.65 . . . . 0.0 113.087 -177.323 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.82 145.05 29.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 109.894 -176.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.74 132.61 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.279 1.432 . . . . 0.0 110.985 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -149.62 170.58 18.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.981 1.713 . . . . 0.0 110.465 -173.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.69 -167.29 20.1 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 116.301 1.281 . . . . 0.0 116.301 -175.448 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.52 142.59 22.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.13 1.772 . . . . 0.0 109.164 174.142 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.3 t -115.33 127.87 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.206 1.402 . . . . 0.0 108.379 172.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -109.69 122.53 47.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.915 1.686 . . . . 0.0 109.48 -175.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.3 mtt -93.77 150.8 39.26 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.278 1.431 . . . . 0.0 111.214 -173.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.24 -21.71 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.445 2.763 . . . . 0.0 112.774 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 14.0 m -72.84 -0.05 12.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.106 1.362 . . . . 0.0 114.47 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.15 42.96 6.45 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.698 1.142 . . . . 0.0 113.252 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -153.73 166.02 34.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.616 . . . . 0.0 111.931 -173.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 24.1 m -141.83 159.38 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.435 1.094 . . . . 0.0 113.144 -167.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.41 175.53 12.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.012 2.125 . . . . 0.0 110.617 174.168 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -112.39 143.45 28.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.113 -0.992 . . . . 0.0 112.31 -175.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.45 170.95 7.69 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.418 3.412 . . . . 0.0 111.767 173.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.3 m -115.27 128.49 56.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.564 1.546 . . . . 0.0 108.911 174.046 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.03 135.57 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.78 1.232 . . . . 0.0 109.395 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.1 m -134.29 126.79 30.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.532 1.533 . . . . 0.0 109.723 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.12 125.67 29.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.737 0.815 . . . . 0.0 110.651 172.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -82.19 -8.14 59.64 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.032 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 70.9 1.57 3.83 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.677 2.391 . . . . 0.0 113.674 -176.527 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.57 4.86 41.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.999 2.119 . . . . 0.0 113.039 -177.039 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.05 13.38 52.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.089 1.328 . . . . 0.0 114.112 -174.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 68.0 p -132.17 158.49 41.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.321 1.848 . . . . 0.0 110.999 178.302 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 22.3 m -115.31 141.07 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.253 1.021 . . . . 0.0 109.378 163.374 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 22.4 m -100.0 139.17 36.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.66 1.184 . . . . 0.0 108.444 169.92 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.99 133.82 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.38 1.472 . . . . 0.0 108.903 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -132.74 156.4 47.12 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.075 1.35 . . . . 0.0 112.267 -177.169 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.9 t80 -157.73 135.4 10.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.565 1.546 . . . . 0.0 111.625 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.86 124.53 76.87 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.188 0.995 . . . . 0.0 110.674 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -78.61 172.9 14.46 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.697 2.931 . . . . 0.0 111.73 -176.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -158.14 -39.3 0.07 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.779 0.832 . . . . 0.0 113.064 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -127.68 158.18 38.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.596 1.558 . . . . 0.0 110.767 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.23 174.99 10.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.238 1.015 . . . . 0.0 112.254 172.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.14 -177.66 22.47 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.156 1.36 . . . . 0.0 114.134 176.396 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 53.6 tp -73.93 117.69 16.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.327 1.051 . . . . 0.0 110.467 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 32.9 m80 -110.52 161.1 16.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.996 1.719 . . . . 0.0 110.71 178.013 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.2 150.09 33.11 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.7 -0.625 . . . . 0.0 112.401 175.372 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 30.8 ttm -128.82 139.26 52.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.139 1.776 . . . . 0.0 111.139 -168.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -108.7 137.14 47.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.194 1.798 . . . . 0.0 110.073 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.97 134.56 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.768 1.227 . . . . 0.0 110.43 175.934 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.92 138.94 36.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.586 1.154 . . . . 0.0 113.482 178.635 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 62.0 t80 -101.75 121.36 41.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.437 1.895 . . . . 0.0 109.334 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.38 32.33 13.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.836 1.254 . . . . 0.0 112.759 -175.297 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.5 m-80 73.87 7.28 4.9 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.798 2.439 . . . . 0.0 115.081 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.0 ttm -100.23 128.58 46.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.885 1.274 . . . . 0.0 110.269 166.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.17 136.59 57.28 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.46 -0.775 . . . . 0.0 112.762 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -74.81 156.74 86.32 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.76 174.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.08 -17.78 61.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.641 2.227 . . . . 0.0 113.204 175.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.92 7.61 65.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.643 1.116 . . . . 0.0 114.571 170.26 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 18.1 t -111.29 146.1 33.88 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 119.683 1.742 . . . . 0.0 111.678 178.111 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.37 169.45 72.81 Favored 'Cis proline' 0 C--N 1.351 0.668 0 CA-C-N 119.816 0.97 . . . . 0.0 111.76 -9.0 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.66 158.31 24.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.918 1.687 . . . . 0.0 110.654 171.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -148.41 152.18 36.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.334 -0.854 . . . . 0.0 111.894 171.332 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -165.97 154.28 10.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.914 1.286 . . . . 0.0 111.244 -175.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.3 t80 -94.67 129.39 41.57 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.483 -0.76 . . . . 0.0 112.301 177.568 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.6 t -95.1 134.25 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.989 1.316 . . . . 0.0 109.214 174.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -149.77 158.29 44.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.514 1.525 . . . . 0.0 110.146 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -67.65 160.49 27.84 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 63.4 t -65.09 -39.49 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.557 0.743 . . . . 0.0 111.046 179.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 p30 -90.46 155.73 18.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.238 1.015 . . . . 0.0 111.57 165.248 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 25.1 p -161.79 156.17 22.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.763 1.225 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -112.72 30.27 7.6 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 126.182 1.848 . . . . 0.0 113.094 178.502 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -165.19 162.84 20.25 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.342 1.457 . . . . 0.0 113.091 -165.361 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.3 p -66.75 140.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 0.0 110.015 167.282 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -156.58 162.48 39.89 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.874 1.27 . . . . 0.0 111.022 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.14 144.76 36.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.744 1.218 . . . . 0.0 112.042 -177.057 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 44.7 p90 -165.24 161.24 19.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.785 1.634 . . . . 0.0 112.527 -176.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.7 174.42 13.54 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.302 1.429 . . . . 0.0 113.369 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.17 -33.12 9.78 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.107 2.538 . . . . 0.0 113.447 -171.077 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.62 -36.69 88.43 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 119.523 1.056 . . . . 0.0 114.175 -171.211 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.16 -9.1 58.24 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.916 1.358 . . . . 0.0 113.215 176.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 29.1 m -98.45 -49.85 4.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.348 1.859 . . . . 0.0 111.089 177.211 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -143.11 146.03 33.39 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.511 1.924 . . . . 0.0 112.881 -174.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.16 178.61 21.28 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.485 1.517 . . . . 0.0 113.32 171.652 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.3 p -149.63 136.29 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.778 1.231 . . . . 0.0 109.37 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -58.21 144.01 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.1 m-80 67.8 7.44 5.73 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.737 2.015 . . . . 0.0 114.773 174.258 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 95.1 mttt -125.99 146.47 55.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.679 1.592 . . . . 0.0 110.877 174.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 135.68 25.72 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.78 2.32 . . . . 0.0 111.188 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.16 137.83 51.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 109.99 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.0 p -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -165.305 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -161.56 177.69 9.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.393 1.877 . . . . 0.0 111.26 178.25 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 45.6 m -130.82 142.01 50.37 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.669 1.187 . . . . 0.0 110.761 -170.625 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.3 t -112.82 128.46 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.194 1.398 . . . . 0.0 107.976 169.74 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m120 -94.27 126.07 39.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.664 1.186 . . . . 0.0 110.084 176.273 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.8 p -127.88 0.19 5.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.053 1.741 . . . . 0.0 113.57 -167.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 63.0 tttp -51.07 -38.69 53.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.134 1.774 . . . . 0.0 114.729 -171.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.47 9.58 18.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.517 1.527 . . . . 0.0 113.183 -178.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.33 62.79 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -172.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.73 147.23 5.88 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.908 1.242 . . . . 0.0 112.525 -172.055 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.84 148.29 36.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.252 1.021 . . . . 0.0 112.397 -177.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 177.22 -45.34 0.1 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.991 1.281 . . . . 0.0 113.715 175.214 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 165.03 106.45 0.19 Allowed Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.919 1.247 . . . . 0.0 112.729 171.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.92 130.32 34.91 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.076 1.35 . . . . 0.0 109.423 175.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.9 m -127.87 156.37 42.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.547 1.539 . . . . 0.0 112.159 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1900 ' ' LEU . . . . . 0.411 HD21 HG13 ' A' 1922 ' ' VAL . 38.5 tp -155.81 135.22 12.37 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.476 1.91 . . . . 0.0 108.663 -175.383 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -154.36 155.31 34.82 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.146 0.978 . . . . 0.0 112.031 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.6 mt -137.04 133.18 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.489 1.116 . . . . 0.0 110.374 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -115.85 160.85 19.62 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.261 1.824 . . . . 0.0 109.657 170.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.57 -163.35 34.62 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.047 -1.033 . . . . 0.0 114.695 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.73 -24.49 61.96 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.886 3.057 . . . . 0.0 112.278 175.109 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -140.79 159.65 41.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.431 1.492 . . . . 0.0 108.939 164.036 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 tptt -74.06 113.61 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.846 -1.158 . . . . 0.0 110.6 176.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.31 145.86 52.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 0.0 111.411 174.324 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.2 143.55 28.7 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 109.808 169.25 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 99.7 mt -128.78 144.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 110.887 -167.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 14.5 t -139.38 156.16 47.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 164.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 26.7 p -157.56 150.46 23.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.603 1.161 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.8 m -140.55 118.43 11.79 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 110.018 -169.63 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 14.0 t0 -67.43 118.38 10.69 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.785 0.834 . . . . 0.0 109.785 166.152 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -80.79 -13.37 59.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.69 0.796 . . . . 0.0 112.775 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 73.68 -7.96 1.48 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 128.5 2.72 . . . . 0.0 113.455 -179.272 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -88.6 8.43 28.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.478 1.911 . . . . 0.0 113.372 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.25 18.33 39.68 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.058 1.313 . . . . 0.0 113.694 -171.98 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.8 p -139.54 155.4 47.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.545 1.538 . . . . 0.0 111.181 176.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 43.5 t -124.33 128.9 49.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.532 1.933 . . . . 0.0 109.244 170.903 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.6 t -89.62 145.76 25.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.306 1.043 . . . . 0.0 110.643 174.453 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1922 ' ' VAL . . . . . 0.411 HG13 HD21 ' A' 1900 ' ' LEU . 84.1 t -126.83 143.3 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.933 1.693 . . . . 0.0 109.709 -177.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.8 t -138.3 141.32 39.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.603 1.561 . . . . 0.0 110.685 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -144.21 153.2 41.83 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.152 -0.967 . . . . 0.0 113.586 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 57.5 tp -119.35 103.09 47.51 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.705 1.602 . . . . 0.0 110.085 -176.207 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.71 172.72 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.85 3.034 . . . . 0.0 110.88 170.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.1 p -146.76 -30.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.8 mt -107.59 146.86 34.21 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.331 1.052 . . . . 0.0 110.902 167.633 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.78 160.69 43.17 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.142 2.561 . . . . 0.0 110.9 173.302 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 138.19 -132.61 5.91 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.444 1.021 . . . . 0.0 112.309 -175.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.84 135.94 30.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.133 1.373 . . . . 0.0 111.562 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.66 134.55 54.98 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.872 1.669 . . . . 0.0 110.423 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 31.9 m -91.54 121.32 33.13 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.22 126.04 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.93 1.692 . . . . 0.0 108.356 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.22 130.17 55.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.353 1.461 . . . . 0.0 109.298 175.346 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.9 t -132.11 130.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.33 1.052 . . . . 0.0 109.534 173.081 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.57 142.72 22.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.957 1.303 . . . . 0.0 111.804 -167.634 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.18 120.66 18.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.809 1.243 . . . . 0.0 109.733 178.302 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 54.57 58.18 5.11 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.358 1.463 . . . . 0.0 112.133 177.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 58.62 9.33 1.09 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.571 2.748 . . . . 0.0 116.542 -177.245 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -115.88 124.97 51.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.487 1.115 . . . . 0.0 110.801 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.87 145.69 54.52 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.379 -0.825 . . . . 0.0 111.984 172.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.6 m -72.26 156.87 90.13 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.142 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.64 125.75 18.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.697 2.932 . . . . 0.0 112.475 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.51 -12.42 63.13 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.919 1.247 . . . . 0.0 115.664 -179.061 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.6 t -74.67 142.02 76.72 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-N 119.449 1.625 . . . . 0.0 111.641 177.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.88 142.94 75.33 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.297 0.785 . . . . 0.0 112.24 -3.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -97.15 168.87 10.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.577 1.951 . . . . 0.0 110.803 175.801 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 90.0 m -126.51 122.03 34.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.962 0.905 . . . . 0.0 111.251 172.479 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.49 132.68 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.044 1.338 . . . . 0.0 110.874 173.004 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -84.53 124.43 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.307 0.643 . . . . 0.0 109.435 173.285 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.89 133.62 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.757 0.823 . . . . 0.0 110.304 -178.617 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.0 p -110.76 161.6 15.61 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.427 1.491 . . . . 0.0 112.686 -174.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.24 136.41 16.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.537 1.065 . . . . 0.0 110.95 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.52 -16.92 53.08 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.386 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.898 2.079 . . . . 0.0 112.488 -178.784 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 71.36 170.33 0.32 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.88 2.472 . . . . 0.0 113.761 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 28.7 ptm -78.9 -9.88 59.63 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -134.92 150.51 73.44 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.832 1.653 . . . . 0.0 111.632 -178.043 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.73 166.47 28.24 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.804 3.003 . . . . 0.0 112.362 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -157.37 157.13 33.49 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.761 1.624 . . . . 0.0 110.404 177.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -58.5 147.46 69.15 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.657 1.983 . . . . 0.0 112.999 -176.053 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.88 167.53 26.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.786 2.99 . . . . 0.0 111.357 173.315 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.3 36.84 0.19 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.667 1.587 . . . . 0.0 113.5 -175.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 92.2 t -83.07 138.07 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.377 1.871 . . . . 0.0 109.628 177.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -72.09 141.93 32.26 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.181 0.896 . . . . 0.0 113.308 -176.458 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 34.2 m -88.74 8.4 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 125.291 1.436 . . . . 0.0 113.675 -176.569 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 22.0 t30 -63.19 -26.12 68.66 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.971 1.308 . . . . 0.0 114.145 -177.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 85.37 -176.96 50.25 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.976 1.274 . . . . 0.0 113.374 -178.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.6 mt -72.18 128.01 34.35 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.611 1.164 . . . . 0.0 111.364 -177.593 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -87.79 -33.61 18.58 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 34.5 m -91.39 -8.47 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -169.132 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.7 t -86.12 -17.74 34.21 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 22.6 m -66.84 141.71 57.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -165.202 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 60.3 mt -81.66 144.67 31.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.662 1.185 . . . . 0.0 109.98 161.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.69 121.61 76.3 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.497 1.119 . . . . 0.0 110.676 -178.56 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.61 151.24 64.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.287 2.658 . . . . 0.0 111.632 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.4 t80 -106.79 121.97 45.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.896 0.878 . . . . 0.0 110.87 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.89 133.19 14.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.335 1.454 . . . . 0.0 110.367 170.724 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.75 134.74 25.46 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.379 1.471 . . . . 0.0 109.993 -167.702 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 11.2 p -103.72 139.94 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.931 1.292 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -134.89 137.9 28.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.584 1.953 . . . . 0.0 108.333 -177.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.02 23.76 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.236 3.291 . . . . 0.0 114.199 -178.339 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.1 t80 -72.75 153.15 41.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.563 1.145 . . . . 0.0 111.405 174.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 96.2 m -123.82 126.88 47.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.351 1.46 . . . . 0.0 110.225 -177.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.48 131.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.397 1.079 . . . . 0.0 109.642 172.483 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.46 -64.03 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.317 1.047 . . . . 0.0 112.71 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.97 124.62 4.35 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.543 1.537 . . . . 0.0 110.888 179.412 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.38 -144.6 16.58 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.567 1.556 . . . . 0.0 111.308 -166.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.09 143.8 17.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.515 1.126 . . . . 0.0 110.949 -176.469 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.4 tt -119.09 138.41 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.3 1.44 . . . . 0.0 111.257 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.16 166.01 30.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.884 1.674 . . . . 0.0 110.736 -178.818 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.17 -172.47 19.54 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 -177.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -151.18 138.76 19.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.231 1.812 . . . . 0.0 109.31 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 4.7 t -110.7 137.88 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.094 1.758 . . . . 0.0 108.218 174.578 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 53.1 mtp85 -129.18 118.62 22.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.769 1.627 . . . . 0.0 110.094 -171.837 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.8 mpp? -91.78 153.31 43.72 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.571 1.548 . . . . 0.0 111.265 -175.407 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.9 -19.2 46.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.385 2.723 . . . . 0.0 113.4 178.394 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 44.8 p -73.96 -8.49 56.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.381 1.473 . . . . 0.0 114.134 171.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.2 -4.95 81.25 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.512 1.53 . . . . 0.0 113.979 -174.573 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -68.48 160.02 30.58 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.531 1.166 . . . . 0.0 111.885 173.447 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.9 m -140.29 156.7 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.634 1.173 . . . . 0.0 112.427 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.54 -173.03 4.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.418 2.287 . . . . 0.0 110.059 178.494 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -130.79 143.86 51.09 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.843 -1.161 . . . . 0.0 111.395 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -84.74 167.07 11.54 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.945 3.097 . . . . 0.0 111.507 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.1 m -104.44 133.07 49.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.355 1.462 . . . . 0.0 108.726 170.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.13 135.19 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.157 0.983 . . . . 0.0 109.642 176.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -130.82 127.52 38.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.775 1.63 . . . . 0.0 109.389 178.016 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.31 127.96 33.74 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.261 0.624 . . . . 0.0 110.314 170.75 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -82.81 -5.58 59.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.177 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 69.91 4.62 4.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.59 2.356 . . . . 0.0 114.044 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.66 7.54 30.63 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.004 2.122 . . . . 0.0 112.795 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.56 20.18 41.88 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.853 1.216 . . . . 0.0 113.945 -175.822 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 36.9 p -135.77 160.13 39.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.231 1.812 . . . . 0.0 110.301 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.4 m -120.37 148.02 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.515 1.126 . . . . 0.0 110.17 168.881 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.2 m -111.36 133.72 53.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.523 1.129 . . . . 0.0 108.897 169.115 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.2 t -110.17 134.15 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.846 1.658 . . . . 0.0 108.587 176.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -134.19 152.24 51.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.265 1.426 . . . . 0.0 112.367 -169.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.7 t80 -159.52 133.92 7.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.448 1.499 . . . . 0.0 112.125 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.84 119.4 71.15 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.53 1.132 . . . . 0.0 110.563 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.03 139.81 19.55 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.501 2.801 . . . . 0.0 112.686 -170.358 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 52.2 m -123.02 -7.51 8.35 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 174.962 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -140.37 157.62 45.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.828 1.651 . . . . 0.0 110.68 -177.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.3 170.57 9.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.73 1.212 . . . . 0.0 111.688 168.445 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.66 -170.42 19.16 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.214 1.388 . . . . 0.0 113.781 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -83.53 119.29 24.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.432 1.093 . . . . 0.0 110.117 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 24.2 m80 -107.57 156.3 19.17 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.115 1.766 . . . . 0.0 111.759 -177.609 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -124.27 149.71 46.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.069 1.748 . . . . 0.0 109.059 175.062 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 15.7 tmm? -153.12 136.01 15.44 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 111.901 -175.026 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.5 1.92 . . . . 0.0 111.702 -172.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.4 mm -136.66 135.38 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.444 1.498 . . . . 0.0 110.803 175.235 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 142.83 30.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.211 1.004 . . . . 0.0 113.622 178.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.3 t80 -107.39 122.41 46.54 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.952 2.101 . . . . 0.0 110.208 177.812 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 52.12 32.17 10.07 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.528 1.131 . . . . 0.0 112.485 -172.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 20.3 t30 77.14 3.9 3.26 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.426 2.69 . . . . 0.0 115.149 -178.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.35 128.84 47.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.659 1.583 . . . . 0.0 110.809 174.11 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -59.14 137.3 58.01 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 113.582 -177.342 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.25 155.45 87.98 Favored Pre-proline 0 N--CA 1.48 1.034 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.459 172.429 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.42 -13.64 40.76 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.485 2.124 . . . . 0.0 113.762 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -89.45 9.32 77.45 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.008 1.29 . . . . 0.0 114.672 170.019 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 29.5 t -116.32 148.22 41.19 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.533 1.667 . . . . 0.0 111.698 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.02 165.87 77.93 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 119.931 1.011 . . . . 0.0 112.135 -6.333 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 65.5 mt -113.97 158.8 20.67 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.319 1.848 . . . . 0.0 110.92 172.198 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.79 146.97 19.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.766 1.226 . . . . 0.0 110.954 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 3.8 p90 -170.96 163.52 7.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.914 1.285 . . . . 0.0 111.784 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -98.45 138.61 35.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.246 -0.909 . . . . 0.0 112.967 177.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 45.0 t -111.75 135.54 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.701 1.6 . . . . 0.0 109.451 174.811 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -146.38 164.1 33.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.307 1.843 . . . . 0.0 111.715 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -80.71 155.32 26.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.633 0.773 . . . . 0.0 112.862 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 25.1 m -66.17 -16.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.344 -0.847 . . . . 0.0 112.309 165.535 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -74.49 -19.7 60.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.909 1.684 . . . . 0.0 114.194 178.298 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 92.6 m -62.41 130.61 46.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.859 1.264 . . . . 0.0 113.551 -170.123 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.31 -18.17 22.37 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.2 1.381 . . . . 0.0 114.12 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -68.45 160.3 30.0 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.294 1.047 . . . . 0.0 113.51 176.336 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 40.0 t -63.75 128.5 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.55 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 157.1 44.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.691 1.196 . . . . 0.0 110.596 -172.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.69 144.3 37.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 -176.77 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -166.83 172.24 10.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 0.0 112.375 -173.715 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 118.27 172.29 15.58 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.266 1.412 . . . . 0.0 112.622 -177.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.71 -35.01 17.42 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.789 2.326 . . . . 0.0 112.704 -170.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -64.14 -38.6 96.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.398 0.999 . . . . 0.0 114.668 -171.379 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -77.01 -7.16 55.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.055 1.428 . . . . 0.0 113.761 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.3 m -100.91 -40.27 7.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.385 1.874 . . . . 0.0 111.071 176.401 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -153.73 141.08 19.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.38 1.872 . . . . 0.0 112.189 -167.491 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -135.5 177.0 19.77 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.529 1.538 . . . . 0.0 112.17 173.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.0 t -141.86 135.67 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.132 0.973 . . . . 0.0 108.85 174.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.9 m -55.97 135.85 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.302 0.641 . . . . 0.0 112.576 -177.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 58.3 m-80 67.71 1.17 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.95 2.1 . . . . 0.0 114.89 174.537 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -121.22 143.46 37.37 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 125.468 1.507 . . . . 0.0 111.038 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.53 133.04 19.9 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.523 2.149 . . . . 0.0 111.309 -173.389 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -113.08 146.42 39.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.66 1.584 . . . . 0.0 110.116 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.7 p -137.12 145.33 43.72 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.385 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -154.46 175.38 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.266 1.426 . . . . 0.0 111.948 177.059 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 29.9 m -130.94 144.27 51.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.25 1.42 . . . . 0.0 110.759 -169.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.2 t -121.36 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.674 1.59 . . . . 0.0 108.704 170.105 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.54 124.38 43.26 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.56 1.144 . . . . 0.0 111.307 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 34.5 p -124.99 12.28 8.36 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.808 2.043 . . . . 0.0 112.318 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.29 -36.43 66.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.615 1.566 . . . . 0.0 114.564 -170.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.74 12.62 19.67 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.729 1.612 . . . . 0.0 112.741 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.95 60.83 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.507 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 -84.45 1.57 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.052 1.311 . . . . 0.0 111.91 178.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -159.56 148.4 17.86 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.434 1.493 . . . . 0.0 110.634 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 156.19 -152.46 23.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.392 1.473 . . . . 0.0 111.661 -174.203 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -147.68 144.97 13.1 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.81 1.195 . . . . 0.0 112.377 176.267 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.33 141.35 28.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.198 1.399 . . . . 0.0 111.12 176.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 12.3 t -125.69 160.13 30.5 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.961 1.705 . . . . 0.0 110.816 166.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.3 tp -163.06 136.23 5.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.928 1.691 . . . . 0.0 109.491 -162.708 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.41 160.84 35.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.36 1.064 . . . . 0.0 111.954 175.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.4 mt -132.87 137.83 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.723 1.209 . . . . 0.0 109.518 173.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -129.12 119.48 24.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.171 1.388 . . . . 0.0 109.517 174.034 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -136.88 -173.26 12.83 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.92 1.248 . . . . 0.0 113.911 -177.729 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.04 -21.07 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.958 3.105 . . . . 0.0 112.257 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -136.22 157.1 47.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.344 1.458 . . . . 0.0 109.0 158.716 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.0 tptt -76.03 122.48 24.28 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.796 -1.19 . . . . 0.0 111.862 -176.53 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.94 150.08 35.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.037 0.935 . . . . 0.0 112.082 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -86.19 142.81 28.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.798 0.839 . . . . 0.0 109.314 166.335 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.87 144.16 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.441 1.096 . . . . 0.0 110.626 -167.623 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.3 t -146.81 168.13 22.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.036 1.334 . . . . 0.0 111.461 168.011 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -161.32 158.48 27.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 112.965 -177.887 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.9 m -143.8 129.02 18.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.8 1.64 . . . . 0.0 110.446 -172.508 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.63 128.69 34.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.82 1.248 . . . . 0.0 111.09 170.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -98.72 149.73 22.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 111.732 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -67.48 -16.37 64.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.766 0.826 . . . . 0.0 112.661 174.293 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.13 -7.72 52.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.435 1.494 . . . . 0.0 113.85 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.17 27.06 19.68 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.783 1.182 . . . . 0.0 114.464 176.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.5 p -130.82 156.46 44.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.777 1.631 . . . . 0.0 110.589 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.1 m -106.89 128.0 53.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.626 1.171 . . . . 0.0 109.921 171.188 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.7 t -94.72 149.57 21.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.147 0.979 . . . . 0.0 110.375 169.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.4 t -131.36 144.56 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.097 1.759 . . . . 0.0 109.63 -176.496 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.7 p -135.51 149.95 49.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.893 1.277 . . . . 0.0 111.987 170.161 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.72 155.7 37.73 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 176.57 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.9 mt -122.72 106.65 34.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.641 1.976 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.09 170.17 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 124.065 3.177 . . . . 0.0 110.488 167.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -131.4 -20.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -170.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.93 151.28 48.72 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.701 1.201 . . . . 0.0 110.769 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.5 152.29 38.34 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.826 2.351 . . . . 0.0 112.366 -170.51 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.3 -152.46 24.34 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.502 1.049 . . . . 0.0 112.883 -177.199 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.32 130.33 56.67 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.829 1.652 . . . . 0.0 111.627 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -122.35 129.41 52.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.715 1.606 . . . . 0.0 110.015 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -86.7 127.76 34.98 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.09 -1.006 . . . . 0.0 111.159 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.15 121.8 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 108.666 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -98.1 134.79 40.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.107 1.363 . . . . 0.0 109.979 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 91.4 t -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.442 1.497 . . . . 0.0 108.416 171.808 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -151.6 133.98 15.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.818 1.247 . . . . 0.0 110.93 -172.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -133.42 133.63 42.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.825 1.25 . . . . 0.0 111.151 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.8 t-20 49.16 53.36 12.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.77 1.228 . . . . 0.0 112.406 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.31 8.8 pt-20 58.49 18.18 5.48 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.016 2.526 . . . . 0.0 116.305 -177.178 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -127.78 131.53 49.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.618 1.167 . . . . 0.0 111.88 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -63.02 157.03 23.0 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.268 -0.895 . . . . 0.0 112.486 168.169 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.8 m -88.52 155.13 51.2 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.499 0.72 . . . . 0.0 110.314 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.6 123.1 12.61 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.237 1.958 . . . . 0.0 110.051 175.251 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.48 -13.48 65.47 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.141 1.353 . . . . 0.0 115.633 -177.319 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 87.0 p -82.56 150.68 63.66 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.343 2.071 . . . . 0.0 112.87 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.91 140.96 67.21 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.218 0.757 . . . . 0.0 111.791 -4.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -86.84 170.17 11.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 110.406 175.593 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 35.0 m -132.65 117.92 18.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 176.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.7 134.25 38.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 111.641 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -86.75 113.86 22.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.271 1.028 . . . . 0.0 109.944 174.209 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.6 t -92.17 124.56 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.581 0.752 . . . . 0.0 110.173 178.064 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 82.9 m -92.44 142.83 27.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.657 1.983 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.61 17.26 11.13 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.046 1.308 . . . . 0.0 115.347 -176.32 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.5 t70 66.4 10.21 7.08 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.559 2.344 . . . . 0.0 113.659 -178.028 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.345 1.858 . . . . 0.0 114.1 -177.865 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.582 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -79.56 -18.46 51.7 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -177.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -74.81 166.79 23.04 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.604 1.561 . . . . 0.0 113.366 178.148 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -141.77 151.05 58.88 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.573 1.549 . . . . 0.0 111.361 178.054 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.95 157.03 43.24 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.708 2.939 . . . . 0.0 111.998 -179.027 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -83.43 121.42 27.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.941 0.897 . . . . 0.0 110.361 175.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -70.72 -44.46 16.34 Favored Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -176.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.44 151.78 33.57 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.121 1.88 . . . . 0.0 111.967 -173.09 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.35 36.43 0.3 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.718 1.607 . . . . 0.0 112.683 -176.143 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.6 p -75.14 140.11 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.117 1.367 . . . . 0.0 111.358 -176.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 84.88 3.65 87.77 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 172.258 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 28.2 m -72.68 159.71 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 118.841 1.32 . . . . 0.0 112.163 177.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 60.4 t30 -154.27 143.75 21.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.751 1.221 . . . . 0.0 111.761 179.232 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -91.29 -159.03 35.22 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.411 1.481 . . . . 0.0 113.126 177.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 91.2 mt -73.9 157.31 36.53 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.38 1.072 . . . . 0.0 111.758 176.015 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.09 -11.37 58.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.906 1.282 . . . . 0.0 114.458 -175.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 17.8 m -67.71 127.89 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.355 1.062 . . . . 0.0 111.837 -178.099 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.1 t -163.21 19.84 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.551 1.54 . . . . 0.0 112.612 -174.206 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 9.8 m -76.94 30.4 0.13 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.861 1.664 . . . . 0.0 114.537 -170.208 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.88 141.66 56.34 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.133 1.373 . . . . 0.0 111.466 176.796 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.6 ttm180 -57.32 116.08 12.63 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.852 1.661 . . . . 0.0 110.829 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.47 137.22 32.91 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.705 2.27 . . . . 0.0 109.334 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.8 t80 -102.81 121.61 42.83 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.506 0.669 . . . . 0.0 111.047 -176.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.66 138.72 21.19 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.657 1.583 . . . . 0.0 110.104 171.379 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.56 140.52 30.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.208 1.403 . . . . 0.0 109.83 -172.263 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 86.0 t -102.88 134.76 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 109.331 176.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.72 135.73 27.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.64 109.48 2.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.32 2.68 . . . . 0.0 109.876 173.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -174.51 149.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.275 2.23 . . . . 0.0 109.098 -172.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.0 m -126.96 124.43 39.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.16 0.984 . . . . 0.0 109.927 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.1 mt -87.01 120.94 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.692 1.197 . . . . 0.0 109.144 174.327 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.81 -101.86 0.4 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.825 1.25 . . . . 0.0 110.492 176.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 68.0 mttm -119.63 132.17 55.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.082 1.353 . . . . 0.0 111.249 174.233 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.04 -144.83 16.21 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.922 1.725 . . . . 0.0 111.186 -167.141 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -159.6 151.02 19.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.469 1.107 . . . . 0.0 111.082 -177.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.7 tt -141.25 130.98 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.098 1.359 . . . . 0.0 111.477 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 82.7 p -144.45 178.64 7.8 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.771 1.628 . . . . 0.0 110.382 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.53 -164.83 22.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -154.66 145.22 22.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.564 1.546 . . . . 0.0 110.113 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.4 t -128.66 134.24 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.954 1.701 . . . . 0.0 108.574 174.53 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -118.74 141.86 48.22 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.278 1.031 . . . . 0.0 112.158 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 1.5 mtm -103.04 147.36 34.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.036 1.734 . . . . 0.0 111.317 178.643 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.66 -26.88 67.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.007 3.138 . . . . 0.0 115.008 175.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.6 p -73.34 -3.6 28.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.983 1.713 . . . . 0.0 114.524 178.128 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.73 -4.36 75.63 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.508 1.528 . . . . 0.0 114.058 -179.64 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -69.04 152.58 45.04 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.732 1.213 . . . . 0.0 111.964 171.799 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 47.9 t -142.49 141.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.829 1.652 . . . . 0.0 109.673 -176.102 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -153.06 -179.7 7.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.077 1.751 . . . . 0.0 110.955 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -123.8 144.63 45.25 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.875 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.5 167.09 13.6 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.276 3.317 . . . . 0.0 111.513 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.3 m -110.86 127.13 55.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.482 1.513 . . . . 0.0 108.981 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -108.6 133.5 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 109.345 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 69.8 m -136.09 137.77 41.39 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.736 1.614 . . . . 0.0 109.494 177.366 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.6 129.47 34.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.287 0.635 . . . . 0.0 110.896 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -76.75 -8.11 56.67 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 71.49 13.01 6.51 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.895 2.478 . . . . 0.0 113.334 -179.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.62 9.88 10.92 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.074 2.15 . . . . 0.0 112.783 -176.763 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.63 12.7 59.17 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.043 1.306 . . . . 0.0 114.367 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.1 p -131.02 158.39 40.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.616 1.967 . . . . 0.0 109.991 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.9 m -111.99 151.7 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.939 0.896 . . . . 0.0 110.292 168.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 139.14 38.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 163.017 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.0 t -120.6 127.51 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.121 1.368 . . . . 0.0 108.466 173.921 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -130.49 153.35 48.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.504 1.521 . . . . 0.0 111.815 -166.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 43.5 t80 -159.67 137.0 9.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.748 1.219 . . . . 0.0 112.219 -174.428 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.13 119.85 69.25 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.532 1.133 . . . . 0.0 110.808 176.565 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.67 154.06 26.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.522 2.814 . . . . 0.0 111.608 -179.168 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 86.6 p -133.16 -9.78 2.96 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -168.88 145.52 3.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.479 1.512 . . . . 0.0 110.39 -168.22 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -76.41 167.63 21.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.286 1.034 . . . . 0.0 113.379 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 124.86 -178.25 16.58 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.537 1.541 . . . . 0.0 114.266 176.839 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.4 tp -82.17 127.17 32.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.008 1.323 . . . . 0.0 109.986 177.272 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.6 m80 -124.67 153.22 42.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.094 1.358 . . . . 0.0 111.655 -172.712 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.68 139.95 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.407 1.483 . . . . 0.0 109.882 178.363 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 20.3 ttm -118.51 133.37 55.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.353 1.861 . . . . 0.0 110.645 178.277 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -107.42 134.69 50.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.927 2.091 . . . . 0.0 109.753 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.1 mm -134.89 139.31 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.877 1.271 . . . . 0.0 110.996 176.002 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.8 135.07 20.55 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 113.518 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.9 t80 -99.62 123.12 43.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.061 1.744 . . . . 0.0 109.933 173.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 50.87 36.19 14.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.356 1.462 . . . . 0.0 112.829 -176.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.2 t30 79.3 0.05 2.29 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 128.305 2.642 . . . . 0.0 114.74 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -103.41 134.44 46.78 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.27 1.428 . . . . 0.0 111.007 175.594 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.7 m170 -54.14 136.95 41.61 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -76.33 154.46 84.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.989 166.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.57 -23.39 70.47 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.389 2.059 . . . . 0.0 113.28 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -81.07 3.85 74.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.39 0.995 . . . . 0.0 114.686 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.1 t -99.82 147.12 32.99 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.616 1.708 . . . . 0.0 111.8 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.14 170.12 71.17 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 CA-C-N 119.785 0.959 . . . . 0.0 111.498 -11.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.59 158.27 24.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.106 1.363 . . . . 0.0 110.846 169.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -148.03 139.94 24.0 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.589 1.156 . . . . 0.0 110.366 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -164.49 173.4 12.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 0.0 111.796 -173.38 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -114.67 135.78 53.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.985 0.914 . . . . 0.0 113.248 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 57.9 t -102.36 138.56 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.867 1.667 . . . . 0.0 108.973 174.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.5 t0 -160.99 166.5 28.17 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.915 1.286 . . . . 0.0 111.091 178.507 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.12 123.62 23.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.716 0.807 . . . . 0.0 111.267 174.048 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -70.98 -25.58 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.166 0.986 . . . . 0.0 113.361 -167.663 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -95.7 -2.79 47.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.198 1.399 . . . . 0.0 113.639 -177.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 4.3 t -69.81 150.36 46.94 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.184 -0.948 . . . . 0.0 113.501 -170.398 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -87.09 74.84 2.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.48 1.514 . . . . 0.0 113.278 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -169.96 166.87 9.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.007 2.123 . . . . 0.0 112.335 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -71.47 132.65 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.801 1.241 . . . . 0.0 109.605 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 81.9 p -138.69 164.12 30.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.939 1.296 . . . . 0.0 110.991 176.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.88 143.76 36.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.497 1.119 . . . . 0.0 111.274 171.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.7 p90 -169.36 164.6 10.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.773 1.629 . . . . 0.0 112.736 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.54 175.1 13.72 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.329 1.442 . . . . 0.0 112.695 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.94 -37.94 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.648 2.232 . . . . 0.0 112.374 -172.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.15 -36.95 93.54 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 119.534 1.061 . . . . 0.0 114.556 -171.106 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.59 -4.38 45.55 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.929 1.364 . . . . 0.0 113.648 176.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.3 m -104.9 -49.59 3.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.038 1.735 . . . . 0.0 110.506 176.5 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -142.49 131.86 23.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.5 1.92 . . . . 0.0 112.724 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -125.19 177.78 16.8 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.218 1.866 . . . . 0.0 112.431 171.117 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 46.3 t -142.05 134.6 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.654 1.182 . . . . 0.0 108.826 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.7 m -58.21 138.99 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 62.91 9.8 3.94 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.046 1.738 . . . . 0.0 114.635 176.915 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -120.89 141.3 32.32 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.79 129.37 15.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.578 2.185 . . . . 0.0 110.616 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.78 144.22 36.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.634 1.574 . . . . 0.0 110.185 174.229 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.0 p -135.6 147.33 48.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -166.774 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.69 178.06 10.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.632 1.573 . . . . 0.0 111.488 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.8 m -128.9 144.03 51.06 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.407 1.483 . . . . 0.0 110.768 -170.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 50.8 t -117.73 132.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.852 1.661 . . . . 0.0 108.158 169.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.48 129.57 38.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.932 0.893 . . . . 0.0 111.184 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -127.95 0.9 5.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.021 1.728 . . . . 0.0 113.349 -172.493 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.84 -41.78 62.06 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.042 1.737 . . . . 0.0 114.022 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.83 -3.89 34.44 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.27 1.428 . . . . 0.0 113.38 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.49 65.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.151 0.98 . . . . 0.0 113.611 -173.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.42 -88.62 1.11 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.744 1.164 . . . . 0.0 112.369 177.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.76 149.07 19.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.572 1.549 . . . . 0.0 110.954 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 163.54 -151.49 21.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.06 1.791 . . . . 0.0 111.519 -177.648 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -111.27 107.58 2.2 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.422 1.01 . . . . 0.0 111.402 172.378 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 55.6 tp -81.33 136.47 35.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.411 1.084 . . . . 0.0 109.864 172.077 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.2 m -136.67 156.18 48.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 0.0 111.768 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.0 tp -159.91 131.89 6.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 108.8 -168.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.23 34.59 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.786 0.834 . . . . 0.0 112.4 -179.287 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.39 137.43 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.016 1.326 . . . . 0.0 109.871 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -125.06 157.5 36.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.385 1.874 . . . . 0.0 109.807 171.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.71 -161.73 29.83 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.658 -178.057 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.4 -25.23 63.7 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.009 3.14 . . . . 0.0 112.68 177.646 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.4 t -140.45 159.95 41.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.041 1.336 . . . . 0.0 109.444 162.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.9 tptt -76.94 107.05 9.0 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.983 -1.073 . . . . 0.0 111.233 -178.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.81 147.01 53.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.024 0.93 . . . . 0.0 111.723 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.83 148.42 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.627 0.771 . . . . 0.0 110.674 168.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.0 mt -137.62 145.38 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.074 1.35 . . . . 0.0 110.181 -164.389 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -143.08 167.17 22.71 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.054 1.342 . . . . 0.0 111.016 166.447 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.8 156.03 28.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 0.0 112.594 -178.125 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 89.1 m -143.08 124.99 15.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.676 1.59 . . . . 0.0 109.922 -171.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 20.3 t0 -74.3 120.95 20.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.916 0.886 . . . . 0.0 109.839 170.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -83.48 -7.32 59.56 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.151 0.98 . . . . 0.0 113.455 -176.077 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 74.72 -17.51 0.48 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.07 2.948 . . . . 0.0 113.908 178.003 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -81.36 -3.88 54.05 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.853 1.661 . . . . 0.0 113.913 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 105.21 22.5 8.21 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.446 1.498 . . . . 0.0 114.07 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.9 p -138.94 154.63 48.34 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.613 172.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 93.9 m -115.04 131.56 56.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.858 1.663 . . . . 0.0 109.137 165.83 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -86.38 149.24 25.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.823 0.849 . . . . 0.0 110.304 168.42 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.5 t -127.01 142.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.426 1.89 . . . . 0.0 109.076 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 81.6 p -131.86 146.14 51.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.724 1.21 . . . . 0.0 111.442 167.334 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.44 157.05 42.96 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.077 -1.014 . . . . 0.0 113.118 175.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 43.4 tp -126.41 102.2 26.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.839 1.255 . . . . 0.0 110.492 -174.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.87 174.29 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.746 2.964 . . . . 0.0 110.61 170.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -148.44 -30.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.028 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.48 145.34 31.07 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.657 1.117 . . . . 0.0 110.776 167.764 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.56 164.81 31.67 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.273 2.649 . . . . 0.0 111.339 177.052 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.24 -124.48 3.93 Favored Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.909 1.242 . . . . 0.0 111.86 -175.784 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -147.76 144.78 28.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.359 1.464 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.18 143.22 51.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.445 1.898 . . . . 0.0 110.863 -172.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 60.4 m -96.1 123.7 39.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.717 1.207 . . . . 0.0 110.429 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.27 124.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.609 1.564 . . . . 0.0 108.464 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.98 131.87 54.65 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 109.908 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 42.6 t -133.58 127.85 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.465 1.106 . . . . 0.0 109.74 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.3 142.68 26.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.16 1.384 . . . . 0.0 111.397 -169.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.92 121.34 12.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.54 1.136 . . . . 0.0 110.025 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 59.59 56.08 3.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.584 1.554 . . . . 0.0 111.55 178.727 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.286 10.5 pt-20 54.19 23.59 4.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.796 2.438 . . . . 0.0 115.645 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -133.29 128.67 36.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.115 1.366 . . . . 0.0 110.432 177.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -65.01 148.04 52.38 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.448 -0.783 . . . . 0.0 112.022 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 15.2 m -70.21 152.43 95.68 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.879 168.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.22 128.01 24.94 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.683 2.255 . . . . 0.0 110.402 177.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.96 62.28 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.175 1.369 . . . . 0.0 115.045 -174.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.7 t -78.49 140.71 60.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.281 1.54 . . . . 0.0 111.5 175.411 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.71 137.39 49.97 Favored 'Cis proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.401 0.822 . . . . 0.0 111.963 -4.163 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -87.71 165.69 15.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.107 1.763 . . . . 0.0 110.66 175.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 88.7 m -123.84 119.22 29.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.885 0.874 . . . . 0.0 110.255 174.343 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.61 135.56 39.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.809 1.243 . . . . 0.0 110.921 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.6 tpt85 -80.2 141.41 35.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.818 0.847 . . . . 0.0 109.259 167.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.8 t -129.41 132.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.78 1.173 . . . . 0.0 110.926 176.306 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 27.6 p -111.49 159.55 17.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.251 1.42 . . . . 0.0 112.843 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.04 128.72 9.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.703 1.621 . . . . 0.0 112.57 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -102.09 -18.57 15.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.222 1.409 . . . . 0.0 113.42 176.645 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.331 1.852 . . . . 0.0 112.719 -173.609 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.69 150.59 45.8 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.277 1.031 . . . . 0.0 112.553 178.341 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -96.62 140.28 31.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.767 1.227 . . . . 0.0 111.628 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -87.15 147.28 42.2 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.413 1.085 . . . . 0.0 111.947 176.088 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.99 162.78 31.7 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.668 2.912 . . . . 0.0 111.716 176.336 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.53 166.14 17.47 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.779 1.232 . . . . 0.0 112.091 170.67 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -60.39 133.28 90.91 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.66 174.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.18 169.27 21.05 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.134 2.556 . . . . 0.0 111.357 173.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.76 12.69 1.98 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.689 1.196 . . . . 0.0 113.493 -176.276 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.0 p -51.46 126.61 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.949 1.3 . . . . 0.0 111.235 177.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 86.81 -14.09 57.28 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.084 1.326 . . . . 0.0 114.805 -173.252 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 36.4 t -101.7 -55.13 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.336 1.455 . . . . 0.0 109.75 175.129 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -94.48 -10.89 30.89 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 174.458 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -86.55 127.8 8.56 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.168 1.366 . . . . 0.0 111.651 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.6 mt -142.62 171.05 14.59 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.653 1.981 . . . . 0.0 110.722 -177.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 49.8 t0 -146.5 151.24 37.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.203 1.401 . . . . 0.0 111.412 174.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 31.3 m -148.43 13.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.853 2.061 . . . . 0.0 113.421 -168.022 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 1.7 t -87.3 -2.67 58.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.068 1.347 . . . . 0.0 114.236 -172.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 37.0 p -70.08 151.21 45.76 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -161.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.0 tp -91.29 135.41 33.82 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.533 1.933 . . . . 0.0 109.57 174.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -52.0 112.96 3.67 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.787 1.235 . . . . 0.0 112.313 -172.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.63 148.76 33.33 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.693 2.262 . . . . 0.0 110.811 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.48 122.49 32.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.182 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -148.45 147.13 28.8 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.904 1.282 . . . . 0.0 111.057 168.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.93 154.8 20.28 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.38 1.472 . . . . 0.0 110.503 -175.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 10.6 p -127.4 134.42 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.627 1.571 . . . . 0.0 109.615 172.533 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.0 mt -132.58 137.63 30.25 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.789 1.636 . . . . 0.0 109.334 -171.766 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.4 84.73 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.895 3.063 . . . . 0.0 110.883 177.343 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -134.16 151.16 51.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.509 1.923 . . . . 0.0 109.625 173.91 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 80.7 m -126.37 123.86 38.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 109.488 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.88 129.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.704 1.201 . . . . 0.0 109.904 178.573 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -105.69 -139.12 0.37 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.961 1.304 . . . . 0.0 110.643 175.797 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -75.94 -6.21 49.84 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -178.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.93 -149.18 10.58 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.922 1.725 . . . . 0.0 113.038 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.49 151.1 27.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.934 1.294 . . . . 0.0 111.033 -174.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.0 tt -127.35 135.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.59 1.556 . . . . 0.0 112.015 -175.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.3 p -147.92 162.66 38.85 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.814 1.645 . . . . 0.0 110.875 -176.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -147.19 -176.16 20.67 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 116.046 1.178 . . . . 0.0 116.046 -177.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -153.92 143.31 21.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.566 1.946 . . . . 0.0 109.119 173.327 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 24.9 t -117.61 133.2 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.727 1.611 . . . . 0.0 108.195 174.38 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -117.4 129.35 55.8 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.288 1.035 . . . . 0.0 110.813 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.9 mpp? -97.3 148.22 34.1 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.576 1.55 . . . . 0.0 111.506 -173.291 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 -21.01 29.91 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.462 2.774 . . . . 0.0 113.145 -179.161 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.2 p -79.22 1.02 26.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.379 1.471 . . . . 0.0 114.431 176.76 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.04 54.63 2.27 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.665 1.126 . . . . 0.0 113.296 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -156.61 166.33 33.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.961 1.704 . . . . 0.0 111.864 -177.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.8 m -141.63 158.13 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.798 1.239 . . . . 0.0 112.652 -173.326 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.88 173.46 16.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.474 2.31 . . . . 0.0 110.045 177.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -114.75 144.93 32.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 121.13 -0.981 . . . . 0.0 112.769 -179.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -86.56 174.8 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.837 3.691 . . . . 0.0 112.034 177.695 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 71.7 m -110.05 133.5 53.14 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.809 1.644 . . . . 0.0 108.806 171.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.83 140.75 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.989 1.316 . . . . 0.0 108.604 173.592 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 14.5 t -148.0 139.42 23.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.731 1.212 . . . . 0.0 111.005 177.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.01 138.38 32.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.651 1.18 . . . . 0.0 112.638 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -96.56 -9.54 29.23 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.064 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.76 -1.69 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.693 2.397 . . . . 0.0 115.02 173.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.79 3.33 55.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.602 1.961 . . . . 0.0 113.549 175.359 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 102.29 12.28 34.01 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.365 1.46 . . . . 0.0 114.399 -174.128 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 26.3 p -125.86 161.62 27.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.141 1.377 . . . . 0.0 111.824 174.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -121.79 144.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.734 1.214 . . . . 0.0 109.946 165.524 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 17.1 m -97.33 139.81 32.72 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.331 1.452 . . . . 0.0 109.037 170.788 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.1 t -127.23 136.84 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.69 1.596 . . . . 0.0 108.934 178.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -142.35 157.7 44.52 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.07 1.348 . . . . 0.0 112.684 -174.629 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -154.92 135.27 13.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.254 1.421 . . . . 0.0 111.88 172.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.16 120.58 72.5 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.9 1.28 . . . . 0.0 110.923 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.87 167.55 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.906 3.07 . . . . 0.0 112.281 -172.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 89.4 p -147.22 -26.32 0.39 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.877 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.92 150.09 45.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.175 1.79 . . . . 0.0 110.393 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.73 168.67 18.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.492 1.117 . . . . 0.0 113.135 178.477 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 121.44 -173.15 15.56 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 125.425 1.488 . . . . 0.0 114.071 178.09 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.8 tt -87.8 127.47 35.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.809 1.244 . . . . 0.0 109.747 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 65.3 m80 -127.66 164.16 22.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.943 1.697 . . . . 0.0 111.585 -172.29 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -146.35 154.15 41.33 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.777 0.799 . . . . 0.0 112.554 166.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.9 ttm -127.33 133.7 50.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.85 2.46 . . . . 0.0 109.763 -173.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -103.83 131.93 50.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.304 1.842 . . . . 0.0 109.354 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 27.8 mm -130.51 128.26 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.358 1.063 . . . . 0.0 109.783 175.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.52 137.39 37.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 48.2 t80 -103.9 124.07 48.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.836 2.054 . . . . 0.0 109.358 174.066 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.01 46.09 22.57 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.692 1.197 . . . . 0.0 112.344 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.301 0.2 OUTLIER 63.34 9.99 4.44 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.034 2.533 . . . . 0.0 116.56 -177.222 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.7 mtp -110.88 131.24 55.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.231 1.412 . . . . 0.0 110.931 173.349 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -55.91 134.11 51.86 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.433 -0.792 . . . . 0.0 112.813 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.8 pt -73.89 155.59 88.6 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.701 178.197 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -59.44 122.44 11.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.711 1.607 . . . . 0.0 108.395 163.288 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 113.78 -25.01 11.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.996 1.284 . . . . 0.0 113.021 -171.52 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.4 t -83.79 148.3 54.01 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 118.91 1.355 . . . . 0.0 111.341 174.794 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.06 155.85 97.27 Favored 'Cis proline' 0 C--N 1.351 0.698 0 CA-C-N 119.79 0.961 . . . . 0.0 111.674 -10.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.51 133.75 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 109.227 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -137.92 134.74 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 110.975 -170.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.5 178.85 7.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.309 1.043 . . . . 0.0 113.109 -171.062 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -116.8 143.53 45.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.517 1.127 . . . . 0.0 112.555 176.173 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 94.2 t -112.86 132.69 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.293 1.837 . . . . 0.0 109.416 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 29.3 t0 -159.46 152.0 21.39 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.235 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.07 134.86 39.94 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.18 -0.95 . . . . 0.0 112.622 -176.636 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.1 p -70.58 -19.95 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.4 0.68 . . . . 0.0 112.589 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -73.39 -20.61 60.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.889 1.276 . . . . 0.0 114.014 -178.186 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.0 m -73.92 148.61 42.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.384 1.073 . . . . 0.0 113.146 -173.731 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -92.46 -14.03 56.22 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.95 1.262 . . . . 0.0 114.703 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -65.03 160.78 20.16 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.553 1.176 . . . . 0.0 113.427 177.111 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.5 t -69.47 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.731 0.812 . . . . 0.0 109.363 177.044 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -161.22 161.53 30.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.301 1.441 . . . . 0.0 110.543 -175.661 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.73 147.83 32.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.511 1.124 . . . . 0.0 112.291 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.51 161.55 13.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.752 1.621 . . . . 0.0 112.941 -176.345 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.25 171.86 12.33 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.506 1.527 . . . . 0.0 113.09 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.29 -34.84 26.09 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.12 2.546 . . . . 0.0 112.616 -173.139 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.82 -21.99 73.5 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 119.036 0.835 . . . . 0.0 114.662 -177.431 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.89 -14.9 60.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.39 1.095 . . . . 0.0 113.168 172.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 16.9 m -117.15 -36.16 3.87 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.777 1.631 . . . . 0.0 111.926 -168.55 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -150.6 155.63 39.78 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.489 1.916 . . . . 0.0 111.963 -174.468 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -149.31 173.51 29.13 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 123.978 0.799 . . . . 0.0 113.176 171.351 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 54.6 t -135.32 132.01 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.654 1.182 . . . . 0.0 108.353 176.051 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -57.73 138.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.11 2.28 2.24 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.997 2.119 . . . . 0.0 114.62 176.651 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -117.64 141.28 28.7 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.026 1.73 . . . . 0.0 110.93 177.171 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.13 130.29 16.3 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.672 2.248 . . . . 0.0 111.099 -173.292 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.7 139.54 44.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.415 1.486 . . . . 0.0 110.06 173.34 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -131.02 152.61 50.15 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.5 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.1 175.12 12.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.541 1.536 . . . . 0.0 112.189 177.31 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 47.5 m -125.62 143.45 51.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.963 1.705 . . . . 0.0 110.625 -171.9 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.3 t -121.45 131.45 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.215 1.806 . . . . 0.0 108.362 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -89.13 132.31 34.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.391 1.077 . . . . 0.0 111.754 -178.332 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.6 p -130.74 1.31 4.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.754 . . . . 0.0 113.222 -176.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -52.0 -38.8 58.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.02 2.128 . . . . 0.0 115.445 -168.213 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -131.81 21.05 4.59 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.523 1.529 . . . . 0.0 111.926 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.95 69.43 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.729 1.212 . . . . 0.0 113.885 -174.587 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.51 149.88 6.37 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.685 1.136 . . . . 0.0 112.301 -169.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.67 163.96 27.28 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.08 0.952 . . . . 0.0 113.531 -177.766 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 161.85 -30.49 0.31 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.538 1.066 . . . . 0.0 114.705 175.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.73 101.15 0.35 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.579 1.562 . . . . 0.0 112.748 173.179 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.72 144.63 37.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.989 1.316 . . . . 0.0 110.457 175.421 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -147.44 158.34 43.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.974 1.31 . . . . 0.0 112.049 -173.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.7 tp -166.6 135.87 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.928 1.691 . . . . 0.0 109.495 -164.605 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.86 159.13 36.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.359 1.064 . . . . 0.0 111.923 175.312 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.35 128.67 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.662 1.185 . . . . 0.0 109.67 175.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -115.69 163.65 15.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.107 1.763 . . . . 0.0 110.039 171.771 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 178.91 -166.88 36.81 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.269 -0.894 . . . . 0.0 113.852 -179.309 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.75 -19.18 36.48 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.625 2.883 . . . . 0.0 112.268 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.0 t -142.88 158.16 43.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.831 1.653 . . . . 0.0 108.867 161.308 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 23.2 tptp -74.84 120.69 20.72 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.832 -1.167 . . . . 0.0 111.96 -175.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.2 147.33 34.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.002 0.921 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.01 147.68 23.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.057 0.943 . . . . 0.0 110.777 169.567 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 13.6 mt -137.08 145.98 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.882 1.273 . . . . 0.0 110.524 -161.466 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 78.5 p -143.79 161.98 37.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.1 1.36 . . . . 0.0 111.388 165.246 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.02 158.64 35.24 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.384 1.074 . . . . 0.0 112.738 -175.878 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.9 m -147.54 119.47 8.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.462 1.505 . . . . 0.0 110.097 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.69 129.7 35.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.658 1.183 . . . . 0.0 111.303 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -108.9 152.74 24.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.827 1.251 . . . . 0.0 112.127 -177.853 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -64.54 -26.31 68.36 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.855 1.262 . . . . 0.0 113.482 -174.21 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -83.13 8.08 14.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.241 1.416 . . . . 0.0 114.767 -178.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.53 27.73 8.94 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 168.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 23.4 p -139.88 135.14 32.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.324 1.05 . . . . 0.0 111.583 175.717 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 41.3 t -90.64 128.84 36.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 109.819 163.535 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -92.55 149.45 21.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.14 0.976 . . . . 0.0 110.212 169.77 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 61.9 t -132.43 144.09 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.761 1.624 . . . . 0.0 109.663 -178.098 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 19.7 t -138.19 142.38 40.02 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.601 1.561 . . . . 0.0 110.916 172.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.5 p90 -148.54 156.46 42.47 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.2 mt -121.31 107.25 37.25 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.828 1.651 . . . . 0.0 110.541 -179.314 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.35 164.27 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.7 2.933 . . . . 0.0 110.284 166.186 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.6 p -125.63 -21.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -170.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.9 pp -146.0 151.48 45.28 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.949 1.3 . . . . 0.0 110.31 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.48 153.28 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 112.534 -169.634 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.67 -165.51 28.38 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.8 1.19 . . . . 0.0 113.431 -177.59 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -93.13 124.87 37.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.159 1.384 . . . . 0.0 111.853 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -114.1 138.32 50.56 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.385 1.474 . . . . 0.0 110.627 178.272 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -102.64 114.7 29.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.483 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.51 125.46 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.196 1.398 . . . . 0.0 108.665 -179.275 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -104.63 132.26 51.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.578 1.551 . . . . 0.0 109.545 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.7 t -133.45 129.28 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.341 1.056 . . . . 0.0 109.565 172.391 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -154.54 144.45 21.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.98 1.312 . . . . 0.0 111.689 -165.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.92 122.15 11.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.833 1.253 . . . . 0.0 109.618 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.3 t-20 54.92 56.62 6.44 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.352 1.461 . . . . 0.0 111.635 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 60.62 1.46 0.41 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 129.149 2.98 . . . . 0.0 116.701 -177.522 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -106.46 125.92 51.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.532 1.133 . . . . 0.0 111.015 178.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.21 145.16 56.44 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 169.1 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 6.8 m -75.37 157.69 84.44 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.774 173.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.76 125.22 17.94 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.616 2.878 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.42 77.09 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.716 1.15 . . . . 0.0 115.544 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 33.0 t -77.03 139.91 65.97 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.349 1.575 . . . . 0.0 111.728 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.84 141.8 71.86 Favored 'Cis proline' 0 CA--C 1.539 0.773 0 CA-C-N 119.5 0.857 . . . . 0.0 111.953 -4.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 154.08 17.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 110.95 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 62.2 m -112.73 114.44 27.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.636 0.774 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.5 133.76 42.42 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 111.407 174.192 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -94.62 105.84 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.678 1.191 . . . . 0.0 109.863 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.4 t -91.09 137.68 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.245 1.018 . . . . 0.0 110.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 68.6 p -115.81 158.95 22.14 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.434 1.494 . . . . 0.0 112.942 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.53 137.66 19.24 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.896 1.236 . . . . 0.0 111.531 174.683 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.5 t70 -83.16 -16.86 45.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.391 1.076 . . . . 0.0 113.373 -179.015 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.872 2.069 . . . . 0.0 112.439 -178.076 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -63.37 -16.14 59.59 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -172.551 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.5 mtp -69.72 -17.27 63.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.715 1.206 . . . . 0.0 113.511 174.523 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -118.76 153.5 52.41 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.557 1.543 . . . . 0.0 112.329 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.75 172.68 15.83 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.769 2.979 . . . . 0.0 111.477 173.146 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.64 156.17 37.48 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.652 0.781 . . . . 0.0 112.663 173.326 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -56.52 120.65 37.92 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.852 1.261 . . . . 0.0 111.484 -178.615 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.81 151.41 28.01 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.36 2.707 . . . . 0.0 111.433 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 11.2 mp -86.78 -6.89 58.69 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.441 1.096 . . . . 0.0 113.094 -179.295 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 59.6 t -112.39 136.88 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.666 1.987 . . . . 0.0 109.752 -177.124 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -82.71 170.34 49.94 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.853 1.216 . . . . 0.0 114.503 -177.104 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 91.5 t -85.24 138.74 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.185 1.394 . . . . 0.0 110.535 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -119.33 143.55 47.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.609 1.564 . . . . 0.0 111.766 176.452 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 162.38 -175.69 38.8 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.117 1.341 . . . . 0.0 113.992 179.097 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.6 mt -73.65 151.61 40.74 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.353 1.061 . . . . 0.0 111.661 175.58 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 43.1 t0 -88.65 161.28 16.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.63 1.172 . . . . 0.0 111.344 170.597 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 33.8 m -65.07 -19.0 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.5 t -70.15 -17.59 63.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.109 1.364 . . . . 0.0 112.926 174.137 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 49.3 m -78.96 9.02 4.67 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.613 1.165 . . . . 0.0 114.101 179.45 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 82.1 mt -72.52 135.81 45.73 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.035 -1.041 . . . . 0.0 110.598 166.736 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -68.88 121.58 81.98 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.239 1.415 . . . . 0.0 110.51 -175.339 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.66 151.98 69.73 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.297 2.665 . . . . 0.0 111.723 -171.075 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.7 t80 -98.48 124.63 43.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.588 0.755 . . . . 0.0 110.306 176.869 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -153.16 133.35 13.44 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 110.913 173.389 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.11 156.37 44.32 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.456 1.902 . . . . 0.0 109.873 -170.783 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -130.98 138.57 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.083 1.353 . . . . 0.0 110.53 -178.451 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.86 136.41 27.67 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.243 1.817 . . . . 0.0 109.094 -174.953 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.18 114.38 3.97 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.168 2.579 . . . . 0.0 110.053 172.528 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 42.2 t80 -178.2 152.56 0.71 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.182 2.193 . . . . 0.0 109.333 -170.215 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 36.8 m -133.49 129.57 37.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.455 1.102 . . . . 0.0 110.218 178.719 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.0 mt -79.62 109.98 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.189 0.995 . . . . 0.0 109.056 171.761 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.73 -58.8 2.08 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -176.708 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -158.88 -12.32 0.07 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.482 2.031 . . . . 0.0 116.482 -167.1 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.02 -136.89 5.94 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.134 1.826 . . . . 0.0 112.226 176.089 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -154.31 145.64 22.98 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.147 1.379 . . . . 0.0 110.421 -176.053 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.8 tt -128.45 137.93 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.414 1.486 . . . . 0.0 111.438 -178.193 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.2 p -147.31 164.78 32.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.965 1.706 . . . . 0.0 110.587 -178.283 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -149.65 177.78 27.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 -177.069 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -150.62 137.3 18.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.993 1.717 . . . . 0.0 109.614 175.036 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.9 t -111.32 137.99 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.332 1.853 . . . . 0.0 108.506 174.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.88 133.67 54.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.969 1.308 . . . . 0.0 111.551 -173.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.02 149.61 38.79 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.837 1.655 . . . . 0.0 111.971 -173.946 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -54.66 -32.28 74.66 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.174 3.249 . . . . 0.0 114.668 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 38.1 m -71.42 -1.27 12.54 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.451 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.65 -1.53 83.84 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.545 1.545 . . . . 0.0 113.935 -176.976 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -74.83 161.61 29.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.596 1.558 . . . . 0.0 112.001 177.582 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.9 m -139.21 157.33 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.186 1.394 . . . . 0.0 111.831 176.438 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.6 170.42 21.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.41 1.884 . . . . 0.0 111.017 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -114.13 138.75 23.05 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.026 0.931 . . . . 0.0 111.391 178.591 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.62 175.55 2.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.497 3.465 . . . . 0.0 112.45 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.9 m -109.33 133.08 53.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.47 1.508 . . . . 0.0 109.373 173.813 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.93 134.47 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.051 1.34 . . . . 0.0 109.263 175.899 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -135.69 126.29 27.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.627 1.571 . . . . 0.0 109.999 179.243 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.69 129.52 34.55 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.744 0.818 . . . . 0.0 110.558 171.22 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.76 -5.0 59.09 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.997 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 65.37 22.46 11.99 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.331 1.853 . . . . 0.0 112.53 -175.878 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -134.77 15.44 3.62 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.383 1.873 . . . . 0.0 112.71 -171.437 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.37 11.11 72.72 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.768 1.175 . . . . 0.0 114.451 -179.058 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.1 p -130.86 154.06 48.45 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 110.958 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.1 m -113.76 138.21 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.313 1.045 . . . . 0.0 109.697 164.482 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.1 m -99.0 139.47 34.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.051 1.341 . . . . 0.0 108.531 170.093 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 36.2 t -126.08 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.288 1.435 . . . . 0.0 108.962 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -135.32 154.09 51.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.757 1.223 . . . . 0.0 112.823 -172.413 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 42.2 t80 -155.02 136.33 14.05 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.747 1.619 . . . . 0.0 112.054 177.707 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.55 117.39 67.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.799 1.239 . . . . 0.0 110.817 176.789 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.38 146.99 22.46 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.658 2.905 . . . . 0.0 112.704 -174.242 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 68.4 m -122.84 -2.75 8.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.68 1.192 . . . . 0.0 113.634 175.766 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 154.58 19.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.225 1.81 . . . . 0.0 111.166 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.62 172.02 12.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.519 1.128 . . . . 0.0 112.664 176.826 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.71 -175.92 16.8 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.047 1.308 . . . . 0.0 113.996 177.284 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -84.98 118.19 24.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.354 1.062 . . . . 0.0 110.186 -178.656 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 39.4 m80 -114.01 165.1 12.97 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.223 1.809 . . . . 0.0 111.779 -174.565 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.83 155.96 44.3 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.325 1.05 . . . . 0.0 111.551 173.134 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 29.2 ttm -142.28 124.16 15.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.583 1.553 . . . . 0.0 110.203 -171.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.93 126.34 46.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 109.841 176.253 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 41.0 mm -123.42 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.262 1.425 . . . . 0.0 110.285 176.395 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.32 139.77 23.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.422 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.8 t80 -106.18 124.95 50.38 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.337 2.255 . . . . 0.0 110.102 177.574 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 53.32 29.0 7.95 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.775 1.23 . . . . 0.0 112.461 -173.09 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 25.2 t30 77.41 4.87 3.13 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.573 2.749 . . . . 0.0 115.185 -178.224 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 59.8 ttm -103.32 134.04 47.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.346 1.458 . . . . 0.0 111.063 172.313 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.3 m170 -57.31 134.34 55.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.293 -0.879 . . . . 0.0 113.001 -178.549 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 42.0 pt -74.94 155.01 86.84 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.65 . . . . 0.0 111.568 176.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.12 125.86 19.33 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.374 2.049 . . . . 0.0 109.779 172.731 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.07 -16.7 56.99 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.618 1.104 . . . . 0.0 114.326 -173.243 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.5 t -81.76 146.65 56.82 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 119.043 1.422 . . . . 0.0 111.73 176.783 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.76 162.64 84.7 Favored 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 120.09 1.068 . . . . 0.0 112.302 -6.174 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.4 mt -95.64 155.3 16.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.038 1.335 . . . . 0.0 110.834 172.38 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -156.74 132.96 9.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.714 1.205 . . . . 0.0 109.977 -175.268 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.9 p90 -167.39 172.95 9.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.426 1.09 . . . . 0.0 112.526 -168.162 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 46.3 t80 -108.74 134.04 51.99 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.178 0.991 . . . . 0.0 113.035 176.308 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.3 t -96.31 133.38 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 109.494 172.938 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 45.5 t0 -143.97 173.89 11.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.811 2.045 . . . . 0.0 109.918 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -79.12 151.25 31.47 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.724 -1.235 . . . . 0.0 113.459 178.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 69.4 t -66.3 -47.64 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.229 1.411 . . . . 0.0 110.4 174.922 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -95.52 128.22 42.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 110.621 175.047 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 23.6 p -171.77 153.17 3.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.979 1.712 . . . . 0.0 112.192 -175.323 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -103.59 -19.33 12.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.114 1.34 . . . . 0.0 113.772 173.471 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -71.61 155.98 39.91 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.337 1.068 . . . . 0.0 113.379 177.782 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -68.39 137.58 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.095 0.958 . . . . 0.0 108.567 172.653 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.6 t -156.0 168.15 28.17 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.72 1.208 . . . . 0.0 110.972 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.22 147.36 30.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.823 1.249 . . . . 0.0 112.155 -177.603 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.7 p90 -167.21 164.41 15.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.052 1.741 . . . . 0.0 112.391 -175.842 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.39 173.72 13.44 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.201 1.381 . . . . 0.0 113.315 -179.203 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.37 -32.69 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.935 2.424 . . . . 0.0 113.194 -170.624 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.43 76.52 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 119.402 1.001 . . . . 0.0 114.333 -172.593 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.0 pp -78.09 -3.38 42.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.965 1.383 . . . . 0.0 113.374 174.818 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.2 m -107.01 -39.91 5.61 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.595 1.958 . . . . 0.0 111.891 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -149.94 150.51 31.96 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.501 1.92 . . . . 0.0 112.495 -169.817 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 177.07 28.92 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.015 0.817 . . . . 0.0 113.472 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 35.3 t -139.98 134.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.941 1.296 . . . . 0.0 107.901 174.787 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.2 m -56.31 134.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 122.901 0.48 . . . . 0.0 112.253 -177.821 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.9 m-80 69.48 -5.51 1.14 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.142 2.177 . . . . 0.0 114.616 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -97.87 138.45 21.0 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.865 1.266 . . . . 0.0 110.646 175.205 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.99 126.17 11.01 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.475 2.117 . . . . 0.0 110.289 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.58 144.11 36.72 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.463 1.505 . . . . 0.0 110.371 175.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 60.3 p -135.38 149.16 49.6 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -166.57 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.0 p90 -160.26 175.51 12.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.443 1.497 . . . . 0.0 111.682 177.234 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 30.5 m -129.68 139.48 51.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.04 1.336 . . . . 0.0 110.805 -169.024 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -110.44 133.94 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.024 1.73 . . . . 0.0 107.877 168.137 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.88 126.99 37.17 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.137 0.975 . . . . 0.0 111.02 178.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 78.6 p -127.09 3.13 6.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.065 1.746 . . . . 0.0 113.072 -172.777 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -52.99 -27.33 18.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.473 2.309 . . . . 0.0 116.382 -171.781 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.56 15.2 5.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.471 1.508 . . . . 0.0 112.191 176.483 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -79.23 -25.03 42.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.633 1.173 . . . . 0.0 113.494 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.09 -107.0 2.38 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.638 1.113 . . . . 0.0 112.101 178.649 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.94 152.99 23.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.234 1.813 . . . . 0.0 110.066 -174.998 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.55 8.26 0.11 Allowed Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 90.87 106.45 1.36 Allowed Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.463 1.506 . . . . 0.0 112.885 177.133 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 139.19 30.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.066 1.347 . . . . 0.0 109.762 170.396 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.0 m -130.77 159.35 37.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.569 1.548 . . . . 0.0 111.826 178.108 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.9 135.25 8.19 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.531 1.532 . . . . 0.0 109.409 -167.418 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 158.57 35.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.189 0.996 . . . . 0.0 112.194 178.664 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -138.24 136.04 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.758 1.223 . . . . 0.0 109.827 177.159 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -129.23 130.13 45.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.215 1.406 . . . . 0.0 110.21 176.075 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.84 -162.49 11.41 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.094 -176.259 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -62.33 -25.71 76.62 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.932 3.088 . . . . 0.0 112.388 174.324 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 21.1 t -137.2 153.8 50.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 109.112 161.202 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -74.07 119.54 18.42 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.876 -1.14 . . . . 0.0 110.837 177.006 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.33 151.7 44.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.002 0.921 . . . . 0.0 112.332 178.413 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.11 137.76 32.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 164.974 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.3 mt -132.99 138.9 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.479 1.112 . . . . 0.0 110.501 -169.307 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 74.1 m -132.03 157.53 43.89 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.848 1.659 . . . . 0.0 110.635 167.662 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -153.41 155.76 36.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.059 0.944 . . . . 0.0 112.766 177.617 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.6 m -143.54 119.22 10.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.33 1.452 . . . . 0.0 110.382 -170.902 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.11 134.47 38.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.633 1.173 . . . . 0.0 111.396 173.251 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -114.3 148.44 37.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.626 1.571 . . . . 0.0 111.913 -177.959 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.51 -12.81 61.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.838 0.855 . . . . 0.0 112.718 174.842 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.35 -5.77 44.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.791 1.637 . . . . 0.0 114.031 177.115 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 32.83 7.63 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.646 1.117 . . . . 0.0 113.723 -179.717 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.7 p -139.84 160.17 40.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.968 1.307 . . . . 0.0 111.363 176.797 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 46.5 t -114.66 127.22 55.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.246 1.419 . . . . 0.0 108.434 160.187 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.7 t -92.52 147.93 22.5 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.144 0.977 . . . . 0.0 110.759 174.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.6 t -124.83 142.11 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.883 1.673 . . . . 0.0 109.927 -178.176 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.4 m -131.06 140.43 50.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.523 1.529 . . . . 0.0 110.424 167.521 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 14.4 p90 -146.85 154.11 40.94 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 174.718 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.17 106.74 42.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.085 1.754 . . . . 0.0 110.514 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.31 176.41 7.36 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.926 3.084 . . . . 0.0 110.523 167.413 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.7 p -149.83 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.572 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.77 147.29 35.5 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.422 1.089 . . . . 0.0 110.434 166.693 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.21 156.07 46.66 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.897 2.398 . . . . 0.0 110.925 175.069 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.62 -161.19 23.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.77 1.176 . . . . 0.0 113.647 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.24 131.96 36.43 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.154 1.382 . . . . 0.0 112.682 -178.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.57 122.41 38.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.602 1.561 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.6 m -84.23 127.22 33.82 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.192 -0.942 . . . . 0.0 110.832 175.99 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.38 124.88 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.953 1.701 . . . . 0.0 108.33 178.881 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -105.01 130.68 53.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.401 1.48 . . . . 0.0 109.699 174.926 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.4 t -131.7 128.36 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.409 1.084 . . . . 0.0 109.779 172.284 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.9 147.08 29.35 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.233 1.413 . . . . 0.0 111.615 -170.358 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.47 121.93 11.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.94 1.296 . . . . 0.0 109.461 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 54.08 56.79 6.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.425 1.49 . . . . 0.0 112.123 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 8.4 pt-20 59.38 4.13 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.965 2.906 . . . . 0.0 116.711 -176.478 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.67 126.12 53.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.659 1.184 . . . . 0.0 111.022 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -65.02 146.9 54.41 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.234 -0.916 . . . . 0.0 111.787 169.907 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.2 m -72.09 153.47 92.61 Favored Pre-proline 0 N--CA 1.482 1.152 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.378 170.75 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -57.99 130.42 38.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.116 2.544 . . . . 0.0 110.65 175.223 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 90.71 -15.75 59.74 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.95 1.262 . . . . 0.0 114.929 -175.516 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.0 t -77.87 139.95 62.34 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.457 1.628 . . . . 0.0 111.457 175.629 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.45 135.92 42.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.373 0.812 . . . . 0.0 111.977 -3.807 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.44 172.92 10.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.825 1.65 . . . . 0.0 110.186 172.808 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 84.9 m -137.21 121.61 18.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 174.092 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.25 147.46 23.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.985 1.714 . . . . 0.0 111.571 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.47 113.0 25.7 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.343 1.057 . . . . 0.0 109.759 173.831 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.0 t -95.37 142.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.976 1.31 . . . . 0.0 110.115 177.29 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.4 t -128.3 170.61 12.86 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.305 1.042 . . . . 0.0 113.167 178.732 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -82.45 137.83 17.47 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.788 1.661 . . . . 0.0 113.091 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.06 -22.57 21.77 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.067 1.347 . . . . 0.0 112.803 174.987 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.255 1.347 0 C-N-CA 127.002 2.121 . . . . 0.0 112.425 -174.381 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.94 156.28 39.01 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.271 1.029 . . . . 0.0 112.813 178.843 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 54.1 ttm -73.71 -22.83 59.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.559 1.143 . . . . 0.0 113.161 179.316 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -149.03 154.64 39.79 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.998 1.719 . . . . 0.0 111.312 -178.444 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.34 160.1 47.79 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.577 2.851 . . . . 0.0 112.035 179.467 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.06 151.68 33.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.224 1.009 . . . . 0.0 112.39 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.27 148.52 97.89 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.437 1.095 . . . . 0.0 111.974 176.161 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.69 163.96 37.16 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.411 2.741 . . . . 0.0 110.903 170.569 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.39 37.94 0.35 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.347 1.459 . . . . 0.0 112.722 -173.806 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 12.0 p -168.78 143.11 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.69 2.396 . . . . 0.0 109.598 -174.744 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 72.64 20.11 79.45 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 123.597 0.617 . . . . 0.0 114.461 177.354 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 99.4 t -67.23 125.59 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.422 1.489 . . . . 0.0 110.437 -175.123 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.24 -18.93 58.79 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -174.892 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 86.98 -158.85 30.84 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.284 1.421 . . . . 0.0 112.901 -177.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.07 165.82 22.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.582 1.153 . . . . 0.0 112.061 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.33 -9.61 58.77 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.361 1.464 . . . . 0.0 114.845 -174.002 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.3 p -77.8 53.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.567 1.947 . . . . 0.0 112.408 -177.577 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.3 t -152.39 10.48 0.51 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.929 1.691 . . . . 0.0 113.353 -177.269 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 50.6 p -78.24 169.82 17.63 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.588 1.555 . . . . 0.0 114.407 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 74.9 mt -81.13 159.05 24.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.112 1.365 . . . . 0.0 111.036 165.399 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1789 ' ' ARG . . . . . 0.421 HH12 ' HA ' ' A' 1863 ' ' VAL . 8.7 tpp180 -55.03 118.85 18.97 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.251 1.42 . . . . 0.0 111.615 -174.316 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.19 126.64 13.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.443 2.095 . . . . 0.0 108.756 177.425 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 64.7 t80 -116.24 125.07 51.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.7 0.762 . . . . 0.0 111.833 -171.718 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.62 142.34 16.56 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.017 1.727 . . . . 0.0 110.524 174.124 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.39 148.36 47.78 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.867 1.667 . . . . 0.0 110.418 -173.209 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.1 p -112.54 137.59 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.105 1.362 . . . . 0.0 109.923 173.034 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.0 mt -134.68 135.58 23.77 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.93 1.692 . . . . 0.0 108.798 -173.348 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.77 113.84 3.88 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.273 2.649 . . . . 0.0 109.979 175.964 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.4 t80 -172.72 146.07 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.485 1.914 . . . . 0.0 109.689 -172.766 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.7 m -118.71 122.31 42.19 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.496 1.119 . . . . 0.0 109.269 176.19 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.77 116.42 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.73 0.812 . . . . 0.0 109.372 175.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.3 mttt -96.56 -143.23 0.28 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.37 1.468 . . . . 0.0 111.607 178.174 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -78.07 -9.79 59.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.59 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.82 -142.56 5.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.335 1.921 . . . . 0.0 113.086 177.178 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.94 150.05 25.47 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.015 1.326 . . . . 0.0 111.229 -172.484 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.14 136.88 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.791 1.636 . . . . 0.0 111.389 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.7 p -146.07 -178.08 5.94 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.207 1.803 . . . . 0.0 110.138 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.0 -165.07 31.81 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -179.437 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -147.87 149.29 31.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.773 2.029 . . . . 0.0 109.934 -179.881 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 62.0 t -122.23 132.25 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.689 1.595 . . . . 0.0 107.92 167.659 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -115.38 130.97 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.808 1.243 . . . . 0.0 111.133 -174.505 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -102.84 149.9 37.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.717 1.607 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.65 -32.95 85.65 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.349 3.366 . . . . 0.0 115.315 176.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.0 t -77.59 -1.68 31.99 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.2 -1.06 72.89 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.386 1.469 . . . . 0.0 114.079 -177.684 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -66.03 155.95 35.16 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 111.763 171.152 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.7 m -139.7 152.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.019 1.328 . . . . 0.0 111.334 175.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.97 175.02 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.556 1.942 . . . . 0.0 110.222 179.684 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -120.03 141.02 30.74 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 121.482 -0.761 . . . . 0.0 111.358 178.713 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.94 165.65 13.33 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.957 3.105 . . . . 0.0 111.341 177.236 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.7 m -104.82 125.5 50.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.009 1.324 . . . . 0.0 108.679 172.098 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.0 135.12 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 109.236 175.485 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 83.9 m -128.25 132.1 48.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.049 1.74 . . . . 0.0 109.935 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 18.0 t0 -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.241 1.016 . . . . 0.0 111.019 171.596 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.9 -14.74 43.93 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.088 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 62.8 tttt 72.71 -2.88 2.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 127.668 2.387 . . . . 0.0 113.967 178.267 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -96.98 5.34 50.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.005 2.122 . . . . 0.0 113.29 -178.138 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.12 12.78 54.52 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.144 1.354 . . . . 0.0 113.962 -174.19 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.6 p -127.46 159.32 34.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.173 1.789 . . . . 0.0 110.477 173.764 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.79 146.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.59 1.156 . . . . 0.0 109.623 166.275 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 27.0 m -105.04 137.06 43.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.111 0.965 . . . . 0.0 108.736 170.597 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.5 t -119.56 133.83 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.148 1.379 . . . . 0.0 109.167 178.619 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.76 150.76 51.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.628 1.571 . . . . 0.0 111.841 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.6 t80 -155.62 132.59 10.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.429 1.491 . . . . 0.0 111.384 178.431 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.36 120.7 74.75 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.246 1.019 . . . . 0.0 110.498 176.821 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.9 139.36 27.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.301 2.667 . . . . 0.0 112.138 -172.04 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -138.82 10.58 2.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.338 1.055 . . . . 0.0 113.815 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -161.83 154.26 19.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.226 1.81 . . . . 0.0 110.012 -178.269 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -101.27 160.18 14.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.612 1.165 . . . . 0.0 112.257 174.921 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.24 -163.39 12.25 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.555 1.55 . . . . 0.0 113.991 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -92.86 113.46 25.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.052 1.341 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.2 m80 -105.59 173.72 6.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.233 2.213 . . . . 0.0 111.933 -174.441 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.3 146.83 35.48 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.644 0.778 . . . . 0.0 112.071 171.364 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.2 ttm -116.7 134.97 54.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.051 2.14 . . . . 0.0 109.457 -179.899 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -126.62 119.7 27.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.712 2.005 . . . . 0.0 109.136 -174.273 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -131.45 136.77 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.051 0.941 . . . . 0.0 111.393 -171.39 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 134.86 21.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.486 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 27.3 t80 -101.49 125.1 48.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 110.185 176.366 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.8 36.38 14.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.858 1.263 . . . . 0.0 112.641 -176.229 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 45.0 m-80 83.02 -8.54 1.14 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.358 3.063 . . . . 0.0 114.658 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 62.3 mtt -100.95 134.71 43.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.22 1.408 . . . . 0.0 111.999 -178.469 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -54.0 135.85 42.28 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.189 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -76.89 155.23 83.01 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.272 173.109 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.09 131.96 41.93 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.153 1.902 . . . . 0.0 109.945 172.146 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.13 -9.17 76.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.432 -174.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.1 t -84.03 144.29 44.24 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 120.042 1.921 . . . . 0.0 111.422 170.721 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -79.38 164.1 83.25 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.816 0.97 . . . . 0.0 112.244 -7.439 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.6 mt -113.3 156.95 22.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.965 1.706 . . . . 0.0 110.697 174.512 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.59 143.46 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.711 1.204 . . . . 0.0 110.404 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -159.12 150.17 20.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.952 0.901 . . . . 0.0 112.489 -170.315 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -100.55 143.74 30.37 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.294 -0.879 . . . . 0.0 112.599 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 38.4 t -126.16 137.5 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.355 1.462 . . . . 0.0 109.438 178.98 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -161.48 158.54 26.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.81 -167.697 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -75.48 146.35 40.69 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.855 -1.153 . . . . 0.0 113.357 -173.443 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1863 ' ' VAL . . . . . 0.421 ' HA ' HH12 ' A' 1789 ' ' ARG . 18.0 m -70.6 -18.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.988 -1.07 . . . . 0.0 112.796 171.585 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 31.9 p30 -90.83 4.75 50.89 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.353 1.461 . . . . 0.0 114.244 178.97 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.1 p -62.66 151.41 38.27 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -166.342 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.91 40.73 2.42 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.382 1.944 . . . . 0.0 113.166 -177.424 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -153.89 167.33 30.06 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.24 1.416 . . . . 0.0 113.081 -176.21 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.2 t -73.05 134.76 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.113 0.965 . . . . 0.0 108.801 171.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.4 t -148.93 165.64 30.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.825 1.25 . . . . 0.0 110.905 -175.183 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.2 147.44 27.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.727 1.211 . . . . 0.0 111.861 -177.487 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 48.1 p90 -168.63 163.46 12.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.754 1.622 . . . . 0.0 112.597 -173.367 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.04 174.33 13.27 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.278 1.418 . . . . 0.0 113.032 -178.42 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.51 -35.12 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.908 2.405 . . . . 0.0 112.799 -172.308 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.73 -31.04 72.77 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.368 0.986 . . . . 0.0 114.537 -171.152 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.52 -3.99 49.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.814 1.307 . . . . 0.0 113.351 174.342 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -104.85 -51.74 3.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 110.69 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -141.56 145.12 34.71 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.093 1.757 . . . . 0.0 112.553 -176.864 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -140.4 178.38 19.99 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 124.767 1.175 . . . . 0.0 113.217 172.632 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 15.3 t -139.66 135.97 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.043 . . . . 0.0 108.884 175.941 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -55.57 139.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.3 m-80 67.96 -1.17 1.81 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.943 2.097 . . . . 0.0 115.039 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -116.39 141.99 28.77 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.226 1.41 . . . . 0.0 111.166 177.32 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.0 134.05 20.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.52 2.147 . . . . 0.0 111.126 -174.824 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -112.82 147.18 37.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.707 1.603 . . . . 0.0 110.306 173.653 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.3 p -136.52 152.28 50.34 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.114 0.966 . . . . 0.0 113.604 -167.188 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.9 p90 -161.86 176.56 10.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.097 1.759 . . . . 0.0 111.485 176.623 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 32.2 m -130.79 140.82 50.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.03 1.332 . . . . 0.0 110.862 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -109.96 132.51 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.723 1.609 . . . . 0.0 107.92 168.705 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.93 123.33 38.34 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.131 0.973 . . . . 0.0 110.634 179.516 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.5 p -126.63 1.58 6.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.445 1.498 . . . . 0.0 113.735 -168.236 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -52.91 -38.12 61.49 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.919 1.687 . . . . 0.0 113.777 -177.585 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -99.86 -1.22 37.99 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.643 1.577 . . . . 0.0 113.472 -179.272 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.55 -22.57 50.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -171.417 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.44 -105.53 2.39 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.218 0.913 . . . . 0.0 111.624 -177.057 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -158.37 148.91 20.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.825 -175.691 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.59 31.64 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.469 1.509 . . . . 0.0 112.667 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.73 103.26 2.89 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 124.063 0.84 . . . . 0.0 111.614 176.416 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.65 129.6 34.76 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.996 1.318 . . . . 0.0 108.935 170.442 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 26.9 m -133.55 158.84 42.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.266 1.426 . . . . 0.0 112.399 -175.99 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.8 tp -161.08 136.19 7.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.97 1.708 . . . . 0.0 109.123 -168.727 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.49 36.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.065 0.946 . . . . 0.0 112.299 177.615 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 48.8 mt -138.3 137.36 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.989 1.316 . . . . 0.0 109.675 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -127.37 143.06 51.28 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.42 1.488 . . . . 0.0 109.907 174.188 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -173.13 -162.13 24.65 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.895 -175.28 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.38 -22.81 59.35 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.223 3.282 . . . . 0.0 113.161 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.4 t -144.36 164.45 30.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.008 1.323 . . . . 0.0 109.829 165.647 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -68.7 107.63 3.07 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.845 178.053 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.478 0.711 . . . . 0.0 110.414 169.305 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -102.7 133.84 47.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.479 0.711 . . . . 0.0 109.717 176.605 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -128.15 144.86 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.709 1.204 . . . . 0.0 110.477 -159.137 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -141.57 164.07 31.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.773 1.229 . . . . 0.0 111.093 166.144 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -160.13 156.85 27.43 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.951 1.3 . . . . 0.0 112.206 -178.59 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 62.1 m -145.49 125.07 13.21 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 109.935 -172.465 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.15 134.72 38.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.09 0.956 . . . . 0.0 111.489 170.711 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -108.54 154.62 21.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.298 1.439 . . . . 0.0 112.342 -174.066 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -67.72 -22.02 65.27 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.568 1.147 . . . . 0.0 112.441 175.858 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.6 -4.83 50.8 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.716 1.606 . . . . 0.0 114.734 -176.884 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.98 35.46 6.74 Favored Glycine 0 N--CA 1.476 1.303 0 C-N-CA 124.23 0.919 . . . . 0.0 113.77 -179.414 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 72.9 p -139.46 165.38 27.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.746 1.618 . . . . 0.0 110.539 176.027 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.7 m -116.01 130.4 56.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.904 1.282 . . . . 0.0 109.14 161.529 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.7 t -89.53 149.57 22.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.968 0.907 . . . . 0.0 110.52 170.956 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 96.1 t -129.66 143.35 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.883 1.673 . . . . 0.0 109.842 -178.894 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.2 p -136.39 147.81 47.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.013 1.325 . . . . 0.0 111.84 167.957 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -151.92 152.79 33.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 175.668 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.2 mt -113.54 110.09 50.32 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.257 1.823 . . . . 0.0 110.427 176.401 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -83.1 175.86 8.05 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.918 3.079 . . . . 0.0 110.257 164.162 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -150.04 -31.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -173.932 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.94 147.19 34.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 119.481 1.037 . . . . 0.0 110.728 167.678 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.25 159.67 43.48 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.992 2.462 . . . . 0.0 111.088 175.475 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 127.77 -168.17 19.85 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.173 1.368 . . . . 0.0 112.822 -174.515 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.65 142.89 27.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.387 1.075 . . . . 0.0 113.101 178.167 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -127.13 135.14 50.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.007 1.723 . . . . 0.0 110.26 178.148 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -91.41 126.84 36.63 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.087 -1.008 . . . . 0.0 110.543 174.35 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.18 128.34 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.74 1.616 . . . . 0.0 108.229 178.757 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -111.8 131.82 55.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.383 1.473 . . . . 0.0 109.856 177.128 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.8 t -133.44 127.31 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.663 1.185 . . . . 0.0 109.893 174.192 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.15 144.32 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.148 1.379 . . . . 0.0 111.889 -169.518 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.62 121.21 11.79 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.916 1.286 . . . . 0.0 110.011 -179.226 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 56.38 55.96 6.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.33 1.452 . . . . 0.0 111.814 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.7 pt-20 56.9 14.65 1.95 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.333 2.653 . . . . 0.0 116.234 -177.84 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -123.81 129.03 50.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.661 1.184 . . . . 0.0 110.746 177.414 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -66.68 151.01 48.23 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.326 -0.859 . . . . 0.0 112.111 173.235 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 25.9 m -65.85 150.5 96.35 Favored Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.271 162.425 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.0 -16.69 45.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.269 1.98 . . . . 0.0 114.654 -164.213 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.77 -7.45 61.44 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.137 0.875 . . . . 0.0 115.253 172.525 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -84.69 143.07 40.26 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 118.88 1.34 . . . . 0.0 112.104 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.27 139.85 63.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 CA-C-N 119.2 0.75 . . . . 0.0 111.961 -4.016 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -91.38 165.2 13.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.992 1.717 . . . . 0.0 110.401 174.186 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.5 m -125.35 117.09 22.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.791 0.836 . . . . 0.0 110.223 174.639 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.57 158.7 15.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.735 1.214 . . . . 0.0 110.774 168.195 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -123.98 132.03 53.65 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.775 0.83 . . . . 0.0 110.483 169.363 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.6 t -113.35 131.28 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.437 1.495 . . . . 0.0 110.45 -171.875 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 32.1 p -106.45 167.41 9.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.098 1.359 . . . . 0.0 112.688 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.69 143.2 25.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.103 1.335 . . . . 0.0 112.058 174.247 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.81 -14.17 58.3 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.156 0.982 . . . . 0.0 113.177 176.442 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 25.6 m-20 . . . . . 0 C--O 1.255 1.353 0 C-N-CA 126.846 2.059 . . . . 0.0 112.269 176.832 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.0 160.58 31.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.407 1.083 . . . . 0.0 113.025 178.566 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -68.14 154.14 42.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.192 1.397 . . . . 0.0 112.228 178.851 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -152.77 153.78 30.55 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.375 1.47 . . . . 0.0 111.855 -179.29 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.52 -4.91 13.89 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.94 3.093 . . . . 0.0 113.889 -179.715 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.66 150.08 29.85 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.264 1.426 . . . . 0.0 111.654 -177.115 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -96.73 138.17 21.4 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.836 1.254 . . . . 0.0 111.133 -179.119 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.89 161.12 47.19 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.148 2.565 . . . . 0.0 111.709 170.618 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 68.5 tp -149.57 118.2 6.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.124 1.37 . . . . 0.0 110.226 -177.624 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 59.2 t -145.06 126.64 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.672 1.589 . . . . 0.0 108.895 176.756 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 76.71 -62.3 3.2 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.439 1.495 . . . . 0.0 113.623 175.799 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 23.3 m -144.37 157.5 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.104 2.162 . . . . 0.0 110.57 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -70.58 154.02 42.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.874 0.87 . . . . 0.0 113.017 175.621 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -126.13 170.98 17.93 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.389 1.471 . . . . 0.0 113.442 177.142 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.44 -159.97 0.77 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.464 1.506 . . . . 0.0 111.616 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 2.5 t0 -153.87 -178.24 6.93 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.035 1.734 . . . . 0.0 111.097 -177.107 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 6.3 p -62.0 -11.89 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.559 1.944 . . . . 0.0 114.685 -173.557 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.4 t -67.96 -12.2 60.27 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.622 1.969 . . . . 0.0 114.576 -179.38 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 5.2 t -71.59 -166.58 0.2 Allowed 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -171.511 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 51.5 mt -67.75 147.96 51.91 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.977 1.311 . . . . 0.0 111.711 170.72 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -56.95 118.15 21.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.445 1.898 . . . . 0.0 111.007 175.063 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.35 146.2 55.9 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.611 2.207 . . . . 0.0 109.46 172.596 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -131.14 133.24 45.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.74 0.781 . . . . 0.0 111.68 -175.333 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.51 146.98 10.33 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.593 1.957 . . . . 0.0 110.875 178.313 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.56 154.04 50.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.18 1.792 . . . . 0.0 110.546 -175.648 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.6 p -114.58 138.45 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.215 1.406 . . . . 0.0 109.624 170.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 46.5 mt -131.45 135.31 26.78 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.166 1.787 . . . . 0.0 108.395 -172.809 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.89 36.48 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.453 3.435 . . . . 0.0 112.909 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.17 152.11 27.9 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.846 1.258 . . . . 0.0 111.456 177.478 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -116.49 121.28 41.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.229 1.412 . . . . 0.0 109.925 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 78.8 mt -87.91 134.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.871 1.268 . . . . 0.0 110.013 175.84 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -117.91 -141.89 0.36 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.496 1.519 . . . . 0.0 110.542 174.713 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.75 127.18 32.67 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.707 -1.245 . . . . 0.0 110.904 171.412 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.11 -147.99 19.53 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 125.402 1.477 . . . . 0.0 111.723 -171.188 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.44 146.27 18.22 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.67 1.188 . . . . 0.0 111.242 -175.85 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -121.48 135.89 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.714 1.606 . . . . 0.0 111.217 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 47.0 p -146.85 177.69 8.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.399 1.88 . . . . 0.0 110.28 -177.827 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -163.18 -167.31 23.42 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.778 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.97 144.24 22.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.521 1.929 . . . . 0.0 109.549 175.689 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 96.2 t -121.72 134.98 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.897 1.679 . . . . 0.0 108.572 173.597 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -112.98 135.1 54.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.596 1.158 . . . . 0.0 111.832 -175.269 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.7 mpp? -108.04 142.89 26.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.707 1.603 . . . . 0.0 111.748 -175.736 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.46 -27.25 58.0 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.48 3.454 . . . . 0.0 115.819 174.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.3 t -71.93 -4.09 26.35 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.071 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.38 48.93 3.6 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.755 1.169 . . . . 0.0 112.383 177.8 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -153.31 163.67 39.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.084 1.754 . . . . 0.0 111.711 -172.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.37 157.84 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.87 1.268 . . . . 0.0 112.384 -173.425 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.07 176.47 12.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.265 2.226 . . . . 0.0 109.888 178.005 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -119.15 143.35 33.91 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 121.216 -0.928 . . . . 0.0 112.186 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -82.73 166.26 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.118 3.212 . . . . 0.0 111.388 174.872 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.8 m -110.58 122.52 47.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.05 1.34 . . . . 0.0 108.911 173.794 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.54 133.41 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.733 1.213 . . . . 0.0 109.351 177.422 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 52.4 m -120.93 130.24 53.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.557 1.943 . . . . 0.0 109.512 176.813 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.2 t0 -79.75 117.21 20.43 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.108 0.963 . . . . 0.0 110.15 170.583 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.52 -12.56 58.78 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.601 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 69.07 3.19 3.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.211 2.204 . . . . 0.0 114.21 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.78 9.2 35.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.823 2.049 . . . . 0.0 113.025 -175.563 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.08 11.97 60.74 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.931 1.253 . . . . 0.0 113.816 -173.295 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 56.3 p -131.73 164.69 25.42 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.462 1.905 . . . . 0.0 110.541 177.371 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.3 m -128.38 146.38 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.152 1.381 . . . . 0.0 109.821 168.224 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 32.6 m -105.84 139.37 40.51 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.315 1.046 . . . . 0.0 108.926 173.159 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.7 t -123.44 130.96 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.864 1.266 . . . . 0.0 109.249 179.135 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -128.08 157.49 40.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.329 1.451 . . . . 0.0 112.042 -176.08 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.5 t80 -155.15 138.2 15.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.498 1.519 . . . . 0.0 111.521 179.777 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.33 119.74 70.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.415 1.086 . . . . 0.0 110.762 177.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.6 135.08 14.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.172 2.581 . . . . 0.0 111.777 -173.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 80.9 p -127.09 -12.28 5.81 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 176.371 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -141.52 158.8 43.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.1 166.79 11.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.639 1.175 . . . . 0.0 112.059 169.593 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.97 -168.0 12.6 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.727 1.632 . . . . 0.0 113.992 179.489 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.9 tp -86.83 122.27 30.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.04 1.336 . . . . 0.0 110.299 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.0 m80 -117.78 168.86 10.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.07 1.748 . . . . 0.0 111.292 -174.949 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.8 148.52 33.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.894 . . . . 0.0 111.856 173.856 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.9 ttm -121.88 123.33 41.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.832 2.053 . . . . 0.0 110.125 -175.433 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -97.45 135.9 38.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.988 1.715 . . . . 0.0 109.809 169.605 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.1 mm -134.99 134.3 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.906 1.282 . . . . 0.0 109.95 176.393 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.7 139.09 27.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.361 1.065 . . . . 0.0 113.491 -176.976 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.3 t80 -102.53 122.16 43.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.809 2.044 . . . . 0.0 109.914 175.917 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 52.4 30.5 8.28 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.896 1.278 . . . . 0.0 112.739 -173.688 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 19.1 t30 79.46 2.63 2.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.658 2.783 . . . . 0.0 115.169 -179.263 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -99.74 130.61 45.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.167 1.387 . . . . 0.0 110.86 171.189 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -55.5 138.31 46.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -177.534 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.24 152.26 90.25 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.379 171.358 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.16 134.08 53.8 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.471 2.114 . . . . 0.0 110.952 -178.678 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.68 -7.63 75.92 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.966 1.27 . . . . 0.0 115.161 -178.146 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.2 t -76.55 144.86 74.47 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.77 1.785 . . . . 0.0 111.362 173.767 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.24 162.76 86.05 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.558 1.235 . . . . 0.0 114.107 1.69 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 84.4 mt -102.68 157.03 17.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.979 1.711 . . . . 0.0 110.632 171.174 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.68 141.47 49.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.069 1.347 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.54 155.69 28.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.66 1.184 . . . . 0.0 112.285 -171.463 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -112.13 135.94 52.15 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.11 -0.993 . . . . 0.0 113.191 179.533 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -118.43 142.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.529 1.532 . . . . 0.0 109.215 -178.196 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.25 165.8 35.32 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.6 1.16 . . . . 0.0 111.611 -175.768 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -77.02 128.15 33.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.427 1.091 . . . . 0.0 110.574 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 75.3 t -67.64 -31.89 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.604 -0.685 . . . . 0.0 112.248 -171.361 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -80.5 -14.19 58.46 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -178.001 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.0 t -70.33 139.24 51.99 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.239 -0.913 . . . . 0.0 112.758 -172.034 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.7 88.06 1.2 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.114 1.34 . . . . 0.0 113.129 -171.93 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -168.91 169.66 9.59 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.807 2.043 . . . . 0.0 112.533 174.177 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.5 p -66.57 142.95 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.875 0.87 . . . . 0.0 110.966 170.375 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -166.73 150.44 7.02 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.392 1.477 . . . . 0.0 110.711 178.972 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -123.71 145.89 48.66 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.228 1.411 . . . . 0.0 112.171 -176.308 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.6 p90 -167.6 163.87 14.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.82 1.648 . . . . 0.0 113.444 -179.962 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.8 172.59 13.05 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.461 1.505 . . . . 0.0 112.704 -178.359 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.82 -33.81 12.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.832 2.355 . . . . 0.0 112.693 -171.944 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.08 93.54 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.688 -1.062 . . . . 0.0 114.323 -171.342 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.09 -6.72 51.01 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.896 1.348 . . . . 0.0 113.381 176.552 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.9 m -99.77 -42.3 6.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.309 1.843 . . . . 0.0 110.943 173.504 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -155.4 126.38 7.07 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.026 1.73 . . . . 0.0 112.34 -165.239 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -130.63 -178.91 15.69 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.55 2.024 . . . . 0.0 112.794 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.4 t -141.19 139.52 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.864 1.666 . . . . 0.0 108.201 177.394 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -56.47 134.76 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.639 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 68.22 -0.91 1.98 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.349 2.26 . . . . 0.0 114.541 178.306 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.09 139.14 19.82 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.28 1.432 . . . . 0.0 110.951 176.502 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.37 123.93 9.06 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.519 2.146 . . . . 0.0 110.395 -178.513 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 142.7 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.509 1.524 . . . . 0.0 110.28 174.613 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 57.0 p -134.11 149.34 51.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -166.562 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.94 177.19 10.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.629 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 73.5 m -132.11 145.28 51.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.221 1.408 . . . . 0.0 110.497 -171.513 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 122.59 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 0.0 107.876 167.099 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -84.29 126.87 33.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.342 0.657 . . . . 0.0 109.924 173.542 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 4.1 p -133.77 12.11 4.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.418 1.887 . . . . 0.0 112.626 -172.038 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1891 ' ' LYS . . . . . 0.417 ' HE2' HG23 ' A' 1919 ' ' THR . 65.3 mttt -61.87 -35.48 78.44 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.442 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.56 11.36 12.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.258 1.823 . . . . 0.0 112.57 -176.854 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.1 -4.9 54.72 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.854 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 93.62 -127.84 9.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.736 1.16 . . . . 0.0 112.624 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -153.42 150.71 29.1 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.146 1.379 . . . . 0.0 110.901 -172.806 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 149.2 -158.55 27.7 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.763 1.649 . . . . 0.0 112.473 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.43 113.15 4.02 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.88 0.752 . . . . 0.0 111.315 174.097 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.39 125.18 32.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.887 1.275 . . . . 0.0 108.225 169.553 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 42.1 m -125.04 158.1 34.59 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.527 1.531 . . . . 0.0 112.397 -174.337 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -158.5 134.62 9.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.253 1.821 . . . . 0.0 108.979 -171.808 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.79 158.25 36.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.033 0.933 . . . . 0.0 112.145 177.899 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.68 134.55 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.561 1.144 . . . . 0.0 109.942 177.971 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -120.81 164.53 16.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.887 1.675 . . . . 0.0 109.94 168.942 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.01 29.7 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.251 -178.061 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.97 -22.82 62.27 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.894 3.062 . . . . 0.0 112.694 176.012 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.0 t -148.57 164.43 34.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.674 1.589 . . . . 0.0 109.517 164.663 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -73.17 113.63 10.45 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.926 -1.109 . . . . 0.0 111.081 177.55 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.01 149.51 48.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.796 0.838 . . . . 0.0 111.461 170.832 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.65 142.07 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.357 0.663 . . . . 0.0 109.648 168.751 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.2 mt -132.97 143.14 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.443 1.097 . . . . 0.0 110.456 -167.304 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.5 t -140.84 160.37 40.2 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.134 1.373 . . . . 0.0 110.62 167.376 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -158.5 156.47 30.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.594 1.158 . . . . 0.0 112.466 -177.217 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -140.24 123.7 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 110.385 -172.173 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.29 126.16 30.43 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.615 1.166 . . . . 0.0 110.417 168.812 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -100.61 151.33 21.74 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.078 1.351 . . . . 0.0 112.116 -178.45 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -67.47 -21.87 65.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.941 0.896 . . . . 0.0 112.703 179.008 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.33 -9.12 58.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.589 1.156 . . . . 0.0 113.557 172.629 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 98.28 10.5 51.14 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.176 1.369 . . . . 0.0 115.18 174.839 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1919 ' ' THR . . . . . 0.417 HG23 ' HE2' ' A' 1891 ' ' LYS . 82.3 p -100.88 161.91 13.27 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.132 1.466 . . . . 0.0 111.565 174.882 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.4 m -111.64 123.98 51.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.046 1.338 . . . . 0.0 109.685 166.755 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -92.39 151.07 20.44 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.014 0.926 . . . . 0.0 110.773 170.259 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.5 t -132.57 141.71 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.788 1.635 . . . . 0.0 110.652 -176.112 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.6 m -132.52 142.94 49.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.876 1.67 . . . . 0.0 110.854 168.654 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.15 152.37 37.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 174.326 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.4 mt -119.27 102.88 47.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.48 167.09 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.677 2.918 . . . . 0.0 110.251 168.498 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.4 m -136.54 -24.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.314 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 76.2 mt -116.91 149.63 44.44 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.772 1.229 . . . . 0.0 110.703 171.272 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 154.54 49.91 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.006 2.471 . . . . 0.0 110.922 174.832 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 140.45 -152.72 23.1 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.271 1.415 . . . . 0.0 113.031 -177.236 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -113.1 131.11 55.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.005 1.322 . . . . 0.0 111.082 178.73 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -113.47 144.96 41.93 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.787 1.635 . . . . 0.0 110.951 179.734 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.4 m -105.77 116.15 31.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.971 1.309 . . . . 0.0 110.257 178.784 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.53 120.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.872 1.669 . . . . 0.0 108.374 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -103.53 133.57 48.34 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.362 1.465 . . . . 0.0 109.55 174.593 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.6 t -135.57 133.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.301 1.44 . . . . 0.0 108.058 172.28 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.67 144.39 20.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.741 1.216 . . . . 0.0 111.037 -168.888 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 123.6 14.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.513 1.125 . . . . 0.0 110.363 -178.574 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.7 53.01 10.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.923 1.289 . . . . 0.0 111.767 178.294 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.19 13.08 2.14 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.392 2.677 . . . . 0.0 116.283 -176.554 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -117.39 128.26 54.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 0.0 110.922 176.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.26 152.28 25.31 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.704 0.802 . . . . 0.0 112.417 170.214 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 17.3 m -79.26 156.94 76.05 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.064 176.577 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.49 119.2 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.656 2.237 . . . . 0.0 110.776 174.981 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.43 65.38 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.312 1.434 . . . . 0.0 116.472 178.486 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.7 p -79.59 153.89 76.08 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 120.329 2.064 . . . . 0.0 113.238 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.77 153.36 99.12 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 119.154 0.733 . . . . 0.0 112.397 -5.076 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -106.37 143.51 34.39 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.44 1.496 . . . . 0.0 111.197 -177.505 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 54.0 m -95.09 117.34 30.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -100.9 132.87 46.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.055 1.342 . . . . 0.0 111.212 173.256 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 141.16 51.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.959 0.903 . . . . 0.0 110.065 166.12 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.4 138.9 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.484 1.113 . . . . 0.0 109.672 163.19 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 16.5 p -134.83 174.12 10.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.183 . . . . 0.0 112.124 178.145 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -68.27 152.87 52.73 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.404 1.478 . . . . 0.0 113.139 178.934 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.64 -9.08 59.25 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.63 1.172 . . . . 0.0 113.363 178.022 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.827 2.051 . . . . 0.0 113.093 178.713 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.67 158.32 35.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.313 1.045 . . . . 0.0 112.74 177.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 96.3 mtp -136.37 150.91 49.04 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.546 1.538 . . . . 0.0 111.412 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -73.15 152.66 90.52 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.22 1.008 . . . . 0.0 112.154 175.222 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.2 173.4 14.57 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.736 2.957 . . . . 0.0 111.624 175.577 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -78.09 -3.62 43.24 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.356 1.063 . . . . 0.0 113.281 175.759 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -148.62 55.42 2.09 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.637 1.575 . . . . 0.0 113.607 -173.147 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.68 148.64 53.4 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.264 2.643 . . . . 0.0 111.288 -178.715 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 82.1 mt -93.44 2.04 56.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.457 1.103 . . . . 0.0 113.486 -178.983 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 47.7 t -133.83 139.95 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.789 2.035 . . . . 0.0 109.205 -177.288 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -85.12 -147.18 8.89 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.112 1.339 . . . . 0.0 113.418 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 24.6 m -134.82 149.3 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.69 1.596 . . . . 0.0 111.061 178.468 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 31.2 m120 -148.39 169.63 19.75 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.791 1.637 . . . . 0.0 111.976 -174.051 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 100.82 162.63 27.87 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.412 1.482 . . . . 0.0 113.769 177.118 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.6 mt -137.03 165.66 25.49 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.786 2.034 . . . . 0.0 110.702 -178.816 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 45.1 t0 -70.15 151.77 45.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.453 0.701 . . . . 0.0 111.93 173.706 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 33.6 m 48.48 19.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 128.303 2.641 . . . . 0.0 115.933 -178.109 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.3 t -72.91 -13.79 61.34 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.433 1.493 . . . . 0.0 114.872 -170.143 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 18.7 p -71.7 161.47 30.93 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -174.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 34.2 mt -65.85 158.05 28.88 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.375 1.07 . . . . 0.0 111.288 166.558 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.26 114.61 6.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.519 1.127 . . . . 0.0 110.828 179.557 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.02 131.98 21.97 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.153 2.569 . . . . 0.0 110.56 -175.46 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.2 t80 -99.36 117.1 33.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.536 0.735 . . . . 0.0 111.079 -176.883 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -151.35 136.81 17.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 111.226 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.96 159.71 41.29 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.294 2.238 . . . . 0.0 110.115 -170.039 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -131.09 138.71 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.894 1.278 . . . . 0.0 110.271 177.742 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 53.8 mt -132.42 135.48 26.37 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.04 1.736 . . . . 0.0 108.832 -172.995 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.6 64.96 8.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.208 3.272 . . . . 0.0 111.813 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.51 147.34 35.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.706 1.602 . . . . 0.0 111.048 175.581 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 92.0 m -115.58 123.21 47.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.183 1.393 . . . . 0.0 109.61 178.164 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 74.5 mt -81.25 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.505 1.122 . . . . 0.0 110.326 177.863 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.2 -141.71 0.37 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.7 1.6 . . . . 0.0 110.8 178.282 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -80.11 123.79 28.19 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.752 -1.217 . . . . 0.0 110.871 170.673 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.96 -149.24 19.84 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.309 1.433 . . . . 0.0 112.199 -171.967 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -159.15 148.6 18.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.907 1.283 . . . . 0.0 111.132 -174.917 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.6 tt -120.92 136.12 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.59 1.556 . . . . 0.0 111.585 -179.436 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.7 p -148.46 -174.03 4.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.661 1.984 . . . . 0.0 110.197 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -178.09 -164.58 31.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.545 0.978 . . . . 0.0 115.545 -179.658 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -152.87 144.15 23.21 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.768 1.627 . . . . 0.0 110.24 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 85.8 t -121.0 137.15 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.504 1.921 . . . . 0.0 108.481 173.26 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -119.57 137.91 53.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.464 1.106 . . . . 0.0 112.448 -176.331 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.4 mtm -108.86 149.49 39.62 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.409 1.884 . . . . 0.0 111.999 -176.098 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.61 -40.0 55.62 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.965 3.776 . . . . 0.0 116.598 -177.601 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.7 t -74.61 0.85 13.67 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.957 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 95.83 -1.19 63.25 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.802 1.668 . . . . 0.0 114.064 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -67.99 153.36 43.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.971 1.308 . . . . 0.0 111.597 173.016 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.3 m -137.5 157.32 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.018 1.327 . . . . 0.0 111.551 -179.753 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.39 169.93 23.6 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.972 1.709 . . . . 0.0 111.263 -178.077 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -108.29 138.6 20.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.134 0.973 . . . . 0.0 111.068 178.206 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.95 165.09 17.58 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.187 3.258 . . . . 0.0 111.332 172.408 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.5 m -109.23 125.27 52.08 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.868 1.267 . . . . 0.0 108.972 173.804 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.31 138.43 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.792 1.237 . . . . 0.0 109.428 177.33 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 65.6 m -131.55 131.96 43.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.986 1.714 . . . . 0.0 110.322 -178.694 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -77.79 121.74 24.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 172.942 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -85.01 -13.3 50.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.608 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 73.87 -5.64 1.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.989 2.516 . . . . 0.0 114.075 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -91.79 3.49 55.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.229 1.812 . . . . 0.0 113.712 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.97 17.5 57.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.442 1.02 . . . . 0.0 113.368 -171.561 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.6 p -129.46 161.52 30.21 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.725 2.01 . . . . 0.0 109.88 176.051 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -123.21 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.203 1.001 . . . . 0.0 110.109 168.78 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 18.2 m -96.43 142.81 28.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.377 1.071 . . . . 0.0 108.598 170.576 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 12.7 t -127.87 134.47 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 109.301 178.487 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -132.38 154.89 49.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 -173.131 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.7 t80 -156.72 136.49 12.48 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.956 1.703 . . . . 0.0 111.722 178.465 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.02 118.02 69.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 110.812 176.496 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.93 135.49 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.401 2.734 . . . . 0.0 112.076 -174.167 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 69.6 m -131.83 4.42 4.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.344 1.058 . . . . 0.0 113.78 -178.861 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -162.35 144.75 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 110.156 -174.911 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.75 162.01 13.94 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.547 1.139 . . . . 0.0 112.45 177.034 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.1 -167.93 12.45 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.88 1.705 . . . . 0.0 113.633 -178.755 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 27.8 tp -78.76 126.35 30.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.672 1.189 . . . . 0.0 110.619 179.003 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.55 165.78 17.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.987 1.715 . . . . 0.0 111.257 -175.57 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.21 153.85 39.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.116 0.967 . . . . 0.0 111.817 176.927 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.9 ttm -131.67 131.99 43.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.125 -176.152 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -105.64 135.01 47.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.996 1.719 . . . . 0.0 109.546 169.108 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.2 133.58 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.437 1.095 . . . . 0.0 110.109 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 137.74 25.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.556 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.1 t80 -100.63 121.88 42.37 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.692 1.997 . . . . 0.0 109.861 175.171 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.9 34.71 14.07 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.542 1.137 . . . . 0.0 112.69 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.67 4.53 2.52 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.779 2.431 . . . . 0.0 114.083 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.9 mtm -107.1 129.82 54.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.615 1.566 . . . . 0.0 111.011 176.272 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -57.51 137.2 56.54 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -175.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.1 pt -79.49 156.08 75.97 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.721 175.61 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.88 131.15 38.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.251 1.967 . . . . 0.0 109.732 168.71 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.24 67.38 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.536 1.065 . . . . 0.0 114.138 -172.956 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.5 t -84.61 146.6 47.21 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 119.561 1.68 . . . . 0.0 110.952 168.658 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.35 158.8 82.57 Favored 'Cis proline' 0 C--N 1.351 0.694 0 CA-C-N 120.055 1.055 . . . . 0.0 112.032 -8.398 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.0 mt -103.61 153.56 20.47 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.79 1.236 . . . . 0.0 110.9 172.876 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -143.44 139.89 30.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.931 1.292 . . . . 0.0 109.525 -178.737 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 4.6 p90 -167.16 167.55 14.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.293 1.037 . . . . 0.0 112.223 -169.758 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.8 t80 -107.72 140.63 40.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.905 0.882 . . . . 0.0 112.564 178.495 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.4 t -109.7 139.41 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.616 1.566 . . . . 0.0 108.583 172.414 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.7 t0 -156.12 161.06 40.41 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.944 0.878 . . . . 0.0 113.074 -174.398 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -79.92 103.87 10.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.572 1.549 . . . . 0.0 110.783 177.91 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 29.9 m -65.02 -16.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.456 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -84.36 -14.58 49.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.664 1.186 . . . . 0.0 114.172 -178.307 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.5 m -73.72 157.32 36.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.241 1.016 . . . . 0.0 112.749 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.85 -14.9 68.85 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.499 1.047 . . . . 0.0 115.154 -173.274 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -67.84 155.22 39.84 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 118.679 1.24 . . . . 0.0 113.213 176.75 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 t -72.32 132.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.844 0.858 . . . . 0.0 109.089 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 6.3 t -150.5 162.67 40.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.773 1.229 . . . . 0.0 110.945 -175.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.65 147.99 32.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.535 1.134 . . . . 0.0 112.24 -174.449 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -168.14 163.22 13.3 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.787 1.635 . . . . 0.0 112.979 -174.843 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.92 175.05 13.62 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.264 1.411 . . . . 0.0 113.046 -179.557 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.02 -35.54 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.734 2.29 . . . . 0.0 112.88 -172.414 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.23 -34.09 87.08 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 119.478 1.035 . . . . 0.0 114.533 -171.384 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.13 -5.24 53.68 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.661 1.23 . . . . 0.0 113.51 175.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 48.4 m -103.8 -49.39 3.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.372 1.869 . . . . 0.0 110.884 177.61 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -139.6 142.88 37.07 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.484 1.914 . . . . 0.0 112.07 -178.36 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.9 171.28 21.79 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.707 1.146 . . . . 0.0 112.963 172.243 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.9 t -136.65 132.7 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.892 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 25.3 m -59.98 144.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.044 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.4 m-20 68.74 -3.91 1.31 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.597 1.959 . . . . 0.0 114.313 178.737 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.49 142.36 28.04 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.819 1.648 . . . . 0.0 111.269 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.5 125.84 11.02 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.704 2.27 . . . . 0.0 110.572 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -106.29 136.27 46.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.444 1.497 . . . . 0.0 110.167 175.0 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.3 p -129.53 148.77 51.46 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.922 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.84 177.68 10.56 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.686 1.594 . . . . 0.0 111.72 176.861 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.6 m -130.5 142.7 50.48 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.208 1.403 . . . . 0.0 111.028 -169.936 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.7 t -114.34 133.9 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.928 1.691 . . . . 0.0 108.208 169.265 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.15 127.07 40.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.452 1.101 . . . . 0.0 111.03 -179.505 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 57.8 p -131.53 7.04 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.587 1.555 . . . . 0.0 113.312 -170.501 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -54.54 -35.86 63.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.043 1.737 . . . . 0.0 114.788 -169.23 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -121.99 15.98 10.83 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.774 1.63 . . . . 0.0 112.572 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.29 -15.42 60.97 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.135 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.08 -125.01 6.66 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.377 0.989 . . . . 0.0 111.41 -176.156 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.51 151.52 30.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.006 1.322 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.39 -129.41 1.77 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.072 1.796 . . . . 0.0 110.57 -175.617 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -125.09 109.14 1.17 Allowed Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.372 0.986 . . . . 0.0 111.797 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.12 132.27 39.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.522 1.129 . . . . 0.0 108.875 170.738 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.7 t -140.06 158.91 43.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 0.0 111.847 -169.766 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 50.0 tp -166.99 136.28 2.85 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 109.472 -161.867 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.75 160.46 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.155 0.982 . . . . 0.0 112.226 176.625 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.99 137.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.945 1.298 . . . . 0.0 109.512 174.362 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.8 159.14 28.71 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.837 1.655 . . . . 0.0 109.727 170.726 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.44 -163.22 34.54 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.147 -0.971 . . . . 0.0 114.014 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.24 -11.7 23.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.638 2.892 . . . . 0.0 112.9 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 10.6 t -152.72 160.64 43.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.804 1.642 . . . . 0.0 109.938 169.595 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1907 ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 0.9 OUTLIER -76.75 109.07 10.23 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.958 -1.089 . . . . 0.0 111.616 -177.72 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.35 147.76 44.09 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.954 0.902 . . . . 0.0 111.51 169.153 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.035 0.934 . . . . 0.0 110.072 170.431 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.61 139.83 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.678 1.191 . . . . 0.0 110.668 -166.742 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -133.64 156.98 46.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.925 1.69 . . . . 0.0 110.828 169.042 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -152.72 155.56 37.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.29 1.036 . . . . 0.0 112.398 176.42 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.1 m -140.47 124.65 17.58 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.605 1.562 . . . . 0.0 110.353 -172.244 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.7 131.42 39.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 111.187 170.88 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -107.68 146.9 31.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.315 1.446 . . . . 0.0 111.822 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.0 tm0? -65.68 -21.68 66.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.471 1.108 . . . . 0.0 112.471 175.292 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -73.76 -5.32 40.04 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.705 1.602 . . . . 0.0 114.684 -179.973 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 33.25 6.65 Favored Glycine 0 N--CA 1.476 1.3 0 C-N-CA 124.474 1.035 . . . . 0.0 114.171 177.89 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.5 p -140.32 162.68 34.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.476 1.51 . . . . 0.0 110.902 176.748 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 98.3 m -111.81 130.47 55.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.828 1.251 . . . . 0.0 109.272 161.202 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -89.44 150.0 22.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.831 0.853 . . . . 0.0 110.471 169.258 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.7 t -130.25 144.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.134 1.774 . . . . 0.0 109.797 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.3 t -140.44 140.32 35.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.552 1.541 . . . . 0.0 110.78 172.113 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -146.77 154.16 41.06 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.2 mt -118.96 104.02 47.21 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.061 1.744 . . . . 0.0 110.629 -178.673 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.22 162.69 17.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.603 2.869 . . . . 0.0 110.336 166.326 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.0 p -127.59 -19.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.939 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.96 149.23 41.71 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.522 1.129 . . . . 0.0 110.614 174.567 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.28 153.03 40.16 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.887 2.391 . . . . 0.0 112.183 -169.524 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 151.1 -154.88 25.84 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.907 1.242 . . . . 0.0 112.598 -174.311 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -115.41 129.77 56.68 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.613 1.165 . . . . 0.0 110.682 178.351 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.45 134.52 55.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.889 1.675 . . . . 0.0 110.596 -176.805 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.1 m -93.2 125.96 38.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 110.85 178.916 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.58 129.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.4 1.48 . . . . 0.0 108.381 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.69 131.76 55.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.476 1.51 . . . . 0.0 109.65 176.633 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.9 t -133.89 130.87 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.108 174.59 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.6 tmmt? -153.69 144.75 22.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.212 1.405 . . . . 0.0 111.392 -165.321 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.16 119.98 11.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.762 1.225 . . . . 0.0 109.611 177.729 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 57.69 57.82 4.04 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 111.773 177.823 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.289 8.6 pt-20 58.16 15.16 3.12 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.179 2.592 . . . . 0.0 116.175 -179.236 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.54 131.56 52.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.679 1.192 . . . . 0.0 110.89 177.162 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -69.08 152.75 44.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.874 0.87 . . . . 0.0 112.456 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.1 m -67.9 152.36 96.44 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.707 163.386 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.23 -20.17 56.03 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.413 2.075 . . . . 0.0 114.846 -165.236 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.55 -7.11 62.01 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.124 0.869 . . . . 0.0 115.186 174.203 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 42.1 t -84.74 143.64 41.04 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 119.002 1.401 . . . . 0.0 112.193 -176.845 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.1 142.26 74.12 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 CA-C-N 119.158 0.735 . . . . 0.0 112.192 -3.856 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.07 170.48 9.5 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.318 1.847 . . . . 0.0 110.525 173.929 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 85.1 m -132.36 121.89 24.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.95 0.9 . . . . 0.0 110.63 173.02 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.65 138.01 36.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.561 1.545 . . . . 0.0 111.022 172.693 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 34.1 ttt85 -96.88 127.6 43.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.605 0.762 . . . . 0.0 110.032 173.545 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 96.1 t -114.86 130.22 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.863 1.265 . . . . 0.0 110.703 -171.02 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 39.5 p -110.08 163.44 13.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.123 1.369 . . . . 0.0 113.022 -179.197 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.16 141.21 22.97 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.445 1.498 . . . . 0.0 112.535 178.976 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -88.77 -10.94 46.44 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 176.96 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.255 1.371 0 C-N-CA 126.766 2.026 . . . . 0.0 112.639 -177.317 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.504 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.63 161.98 29.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.484 1.114 . . . . 0.0 112.992 178.192 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.11 164.14 30.9 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.177 1.791 . . . . 0.0 111.766 -179.584 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -81.88 137.05 47.11 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 123.887 0.875 . . . . 0.0 111.953 -179.828 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.72 173.19 14.92 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.778 2.986 . . . . 0.0 111.652 175.67 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -54.3 142.78 25.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.479 1.112 . . . . 0.0 113.134 -179.538 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -104.66 154.26 38.63 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.219 1.408 . . . . 0.0 112.709 -170.934 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.25 -167.25 0.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.997 3.131 . . . . 0.0 110.868 172.725 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 37.0 tp -71.49 76.13 0.78 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.088 1.355 . . . . 0.0 111.374 179.695 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 9.9 p -162.62 152.61 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.021 2.128 . . . . 0.0 109.998 -176.716 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -77.59 48.83 2.97 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.427 1.489 . . . . 0.0 114.044 -178.387 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 25.3 t 71.15 102.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 128.724 2.81 . . . . 0.0 110.447 -176.592 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 51.4 t30 -165.71 171.9 12.43 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.973 1.709 . . . . 0.0 110.704 -176.266 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -76.73 -177.15 44.24 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.346 0.974 . . . . 0.0 112.468 166.816 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 91.3 mt -70.84 155.61 40.58 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.731 0.812 . . . . 0.0 111.722 175.87 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 21.9 t0 -142.57 115.17 8.57 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.271 1.429 . . . . 0.0 109.798 175.506 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.0 p -175.35 152.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.309 1.844 . . . . 0.0 110.073 -166.085 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.9 t -154.59 -36.21 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.052 1.341 . . . . 0.0 112.595 177.655 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 74.1 p -157.16 162.67 39.36 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.46 1.104 . . . . 0.0 112.531 176.384 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 36.1 tp -129.38 148.37 51.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.945 1.698 . . . . 0.0 110.827 -166.14 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1789 ' ' ARG . . . . . 0.451 ' HB2' ' H ' ' A' 1861 ' ' ASP . 0.9 OUTLIER -41.66 108.57 0.6 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.239 1.816 . . . . 0.0 113.381 -168.666 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.56 100.03 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.635 2.224 . . . . 0.0 109.022 -178.964 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 37.4 t80 -89.42 130.89 35.7 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.752 0.787 . . . . 0.0 111.956 -174.753 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -158.04 160.62 37.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.24 1.816 . . . . 0.0 110.768 172.682 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.95 132.81 13.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.273 1.029 . . . . 0.0 110.572 -177.896 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 95.6 t -93.87 127.7 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.052 1.341 . . . . 0.0 109.023 169.51 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.93 135.37 26.96 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.171 1.788 . . . . 0.0 109.069 -173.944 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.66 110.69 2.95 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.543 2.829 . . . . 0.0 110.233 176.084 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 31.6 t80 -177.61 152.85 0.83 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.333 2.253 . . . . 0.0 109.291 -171.198 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 43.5 m -135.04 129.63 34.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.405 1.082 . . . . 0.0 110.052 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.1 mt -84.51 113.29 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 0.0 109.343 175.049 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -89.13 -66.96 0.87 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.738 0.815 . . . . 0.0 112.936 -179.536 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -157.03 -8.05 0.09 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.494 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.22 -138.4 4.39 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.751 1.644 . . . . 0.0 111.857 175.452 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -152.63 143.85 23.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.652 1.181 . . . . 0.0 110.665 -177.75 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.8 tt -126.25 134.91 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.649 1.58 . . . . 0.0 110.736 179.759 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 70.0 p -146.61 -179.66 6.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.894 1.678 . . . . 0.0 109.933 179.802 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.23 -166.21 33.16 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.549 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.93 137.77 18.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.512 1.525 . . . . 0.0 109.826 -179.734 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.2 t -107.54 133.96 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.892 1.677 . . . . 0.0 108.027 171.532 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -120.75 125.4 47.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.225 1.41 . . . . 0.0 110.468 -169.136 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.54 153.24 41.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.831 1.653 . . . . 0.0 111.373 -176.19 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.14 -23.48 29.0 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.177 2.585 . . . . 0.0 112.411 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.3 m -74.57 -1.16 20.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.681 1.592 . . . . 0.0 114.805 -178.416 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 85.87 49.49 4.28 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.518 1.056 . . . . 0.0 113.003 178.883 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.25 164.92 37.22 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.038 1.735 . . . . 0.0 111.743 -175.074 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.4 m -141.48 158.98 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.73 1.212 . . . . 0.0 112.97 -171.069 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.46 166.0 34.87 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.679 1.992 . . . . 0.0 111.219 178.451 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -100.31 137.65 20.04 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.781 0.833 . . . . 0.0 111.709 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.16 169.97 11.11 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.276 3.317 . . . . 0.0 111.646 170.57 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 72.3 m -113.48 129.74 56.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.292 1.437 . . . . 0.0 108.852 173.177 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.63 136.38 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.683 1.193 . . . . 0.0 109.36 176.545 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 61.7 m -139.18 132.81 30.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.142 1.377 . . . . 0.0 109.846 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.67 128.64 33.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.767 0.827 . . . . 0.0 110.824 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -82.91 -6.59 59.53 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.667 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.67 11.94 7.17 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.286 2.235 . . . . 0.0 113.882 -173.927 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.41 8.34 21.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.817 2.047 . . . . 0.0 112.872 -176.347 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.9 11.09 68.41 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.947 1.261 . . . . 0.0 113.711 -172.72 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 72.8 p -130.37 157.58 42.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.728 2.011 . . . . 0.0 110.362 178.477 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -109.72 153.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.086 0.954 . . . . 0.0 109.212 163.475 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.2 t -105.54 142.94 34.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.672 0.789 . . . . 0.0 109.449 162.981 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.6 t -119.56 132.44 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.401 1.48 . . . . 0.0 108.297 173.428 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -131.35 154.35 48.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.002 1.721 . . . . 0.0 111.497 -172.808 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.6 t80 -154.07 135.04 13.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.349 1.459 . . . . 0.0 111.814 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.79 115.82 65.29 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.684 1.194 . . . . 0.0 110.483 175.571 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.54 148.89 16.36 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.474 2.783 . . . . 0.0 112.258 -172.136 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 50.8 m -119.39 -21.6 7.39 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -167.08 156.65 10.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.95 1.7 . . . . 0.0 111.812 -175.151 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.78 169.6 17.38 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.83 1.252 . . . . 0.0 114.022 -174.888 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.74 -170.29 14.41 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.175 1.845 . . . . 0.0 114.036 177.927 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 32.6 tp -87.33 130.56 34.58 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.717 1.207 . . . . 0.0 110.612 177.382 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.5 m80 -128.71 167.61 16.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.034 1.734 . . . . 0.0 111.45 -173.164 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -144.67 159.01 43.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.977 0.911 . . . . 0.0 111.432 172.433 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 35.3 ttm -139.43 130.15 26.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.84 1.656 . . . . 0.0 110.023 -171.68 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.92 118.77 33.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.905 1.682 . . . . 0.0 109.197 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 38.4 mm -120.03 138.61 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.132 1.373 . . . . 0.0 110.637 -179.666 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 136.94 22.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.463 1.105 . . . . 0.0 113.625 -175.174 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.733 2.013 . . . . 0.0 110.014 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.36 36.2 15.81 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.834 1.254 . . . . 0.0 112.696 -177.438 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.6 t30 81.7 -1.0 1.59 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.706 2.802 . . . . 0.0 114.842 178.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 86.1 mtp -111.12 137.06 49.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.979 1.312 . . . . 0.0 111.697 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.6 m170 -57.97 136.85 57.15 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.042 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.19 155.85 86.01 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.588 175.434 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.71 129.08 29.23 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.094 1.863 . . . . 0.0 109.787 171.348 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.88 62.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.74 1.162 . . . . 0.0 113.981 -173.648 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.0 t -84.13 144.86 44.85 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 119.46 1.63 . . . . 0.0 111.31 173.349 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.19 164.17 80.76 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.24 1.121 . . . . 0.0 112.486 -5.795 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 81.0 mt -116.13 153.53 31.62 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.642 1.977 . . . . 0.0 110.788 -176.35 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.75 136.43 38.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.586 1.154 . . . . 0.0 110.66 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 30.1 p90 -155.95 151.37 26.9 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.064 0.945 . . . . 0.0 112.171 -169.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.8 t80 -102.79 149.44 24.48 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 0.0 112.049 175.4 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.2 t -125.95 135.87 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.604 1.562 . . . . 0.0 109.021 -178.566 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1861 ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' 1789 ' ' ARG . 3.5 p30 -157.86 152.24 24.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.177 1.791 . . . . 0.0 111.878 -174.794 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.75 138.75 58.15 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.38 -173.639 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 71.8 t -69.01 -33.07 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 121.308 -0.87 . . . . 0.0 112.101 -169.955 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -95.95 14.2 24.36 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.078 1.351 . . . . 0.0 113.785 -175.534 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 18.2 p -65.37 162.55 17.42 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -175.981 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.46 -20.94 25.77 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.784 1.183 . . . . 0.0 114.164 174.561 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -74.04 161.25 30.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.628 1.214 . . . . 0.0 113.726 179.474 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 19.1 t -75.38 125.12 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.923 1.289 . . . . 0.0 109.107 179.266 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 21.0 p -108.46 172.02 7.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.681 1.192 . . . . 0.0 111.711 -175.484 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.36 133.71 15.36 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.251 1.02 . . . . 0.0 110.195 160.222 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.5 p90 -161.89 161.97 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.238 1.415 . . . . 0.0 112.556 -177.148 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 127.25 173.84 13.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.393 1.473 . . . . 0.0 112.424 -174.195 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.73 -36.33 6.51 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.997 2.465 . . . . 0.0 113.205 -169.712 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.66 -32.12 80.49 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 118.741 0.7 . . . . 0.0 114.724 -168.131 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.93 -2.92 39.23 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.702 1.251 . . . . 0.0 113.818 178.213 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 70.7 m -118.49 -36.97 3.39 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.497 1.919 . . . . 0.0 112.238 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -142.73 146.14 34.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.382 1.473 . . . . 0.0 112.703 177.105 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 -179.16 22.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.514 1.054 . . . . 0.0 113.283 171.933 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.1 t -142.27 136.72 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.811 1.244 . . . . 0.0 108.491 175.403 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -55.82 135.62 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 122.799 0.44 . . . . 0.0 112.112 179.662 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.1 m-80 69.02 -4.33 1.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 114.97 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.71 139.14 20.61 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.512 1.125 . . . . 0.0 111.089 174.712 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.96 124.33 9.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.514 2.143 . . . . 0.0 110.229 178.418 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.24 146.44 34.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.332 1.453 . . . . 0.0 110.546 175.542 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 49.9 p -135.8 154.38 51.23 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -166.205 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -164.54 175.02 10.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.313 1.845 . . . . 0.0 111.772 177.243 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 91.9 m -130.68 144.85 51.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.639 1.576 . . . . 0.0 111.0 -169.233 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 72.6 t -124.61 126.48 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.951 2.1 . . . . 0.0 107.891 176.585 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.1 m120 -89.5 132.94 34.8 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.972 1.26 . . . . 0.0 111.406 177.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -128.34 -0.56 5.68 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.098 1.759 . . . . 0.0 113.494 -173.322 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -52.88 -39.6 62.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.927 1.691 . . . . 0.0 115.078 -169.446 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -114.61 11.15 16.91 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.537 1.535 . . . . 0.0 112.94 -179.02 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -173.39 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 151.9 8.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.739 1.161 . . . . 0.0 112.103 -168.417 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.34 143.27 50.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.557 0.743 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 179.93 -152.38 10.84 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.278 1.894 . . . . 0.0 111.813 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -93.8 101.28 2.73 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 123.955 0.788 . . . . 0.0 111.407 174.277 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.89 127.26 32.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.545 1.138 . . . . 0.0 108.84 170.686 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.1 m -129.25 156.25 44.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.239 1.416 . . . . 0.0 112.229 -176.71 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.0 tp -158.91 133.41 7.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.073 1.749 . . . . 0.0 108.517 -171.353 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.69 156.34 34.77 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.777 0.831 . . . . 0.0 112.065 179.082 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.7 mt -138.81 130.69 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.606 1.162 . . . . 0.0 109.682 177.728 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -116.73 162.56 17.49 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.171 1.788 . . . . 0.0 109.817 172.986 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.2 -160.52 32.83 Favored Glycine 0 CA--C 1.538 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 114.705 -179.163 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.95 -24.56 60.36 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.049 3.166 . . . . 0.0 112.415 176.279 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.3 t -140.25 159.99 40.96 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.291 1.437 . . . . 0.0 109.455 164.423 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 19.7 tptp -77.22 114.05 15.62 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.979 -1.075 . . . . 0.0 110.816 179.63 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.69 150.77 46.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.657 0.783 . . . . 0.0 112.15 178.599 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.16 139.38 30.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.766 0.826 . . . . 0.0 109.338 168.237 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -134.77 144.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.485 1.114 . . . . 0.0 110.54 -165.717 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -142.46 165.6 26.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.983 1.313 . . . . 0.0 111.156 166.625 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -160.16 157.48 28.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.78 1.232 . . . . 0.0 112.606 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.9 m -139.9 123.67 17.42 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.553 1.541 . . . . 0.0 110.053 -173.212 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -78.27 133.48 37.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.802 1.241 . . . . 0.0 111.2 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -114.12 145.55 41.48 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 111.694 -179.645 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -69.86 -13.09 62.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.83 0.852 . . . . 0.0 112.695 174.14 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.96 -3.18 24.31 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.811 1.645 . . . . 0.0 113.816 174.015 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.09 31.91 9.39 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.675 1.131 . . . . 0.0 113.877 176.962 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 61.7 p -138.95 158.62 43.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.047 1.339 . . . . 0.0 111.409 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 88.0 m -105.35 132.59 51.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.607 1.163 . . . . 0.0 109.021 155.818 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.8 148.44 22.12 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.054 0.942 . . . . 0.0 110.002 166.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 98.3 t -127.06 144.37 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.871 1.668 . . . . 0.0 110.122 -176.154 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -136.16 147.76 47.85 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 111.868 166.5 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.23 154.99 36.86 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 177.405 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 23.4 mt -120.73 107.55 38.19 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.662 1.985 . . . . 0.0 110.318 179.76 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.06 175.86 8.09 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.809 3.006 . . . . 0.0 110.337 166.179 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.4 p -148.98 -29.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -173.242 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.2 mt -107.56 146.71 33.89 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.723 1.147 . . . . 0.0 110.503 166.096 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.48 156.2 45.39 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.838 2.359 . . . . 0.0 110.96 176.075 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.98 -163.61 24.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.976 1.274 . . . . 0.0 113.358 -177.246 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.51 130.07 41.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.873 1.269 . . . . 0.0 112.413 178.946 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -115.03 139.45 49.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.7 m -99.27 119.94 38.73 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.699 1.2 . . . . 0.0 110.335 178.036 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.75 126.94 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.382 1.473 . . . . 0.0 108.401 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -110.74 131.93 54.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.623 1.569 . . . . 0.0 109.838 177.339 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.0 t -133.51 128.15 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.352 1.061 . . . . 0.0 109.762 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.4 143.16 23.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.108 1.363 . . . . 0.0 111.662 -168.102 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.7 119.26 11.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.514 1.126 . . . . 0.0 110.224 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 57.84 58.92 3.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.614 1.565 . . . . 0.0 111.762 179.036 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.283 10.1 pt-20 54.52 21.97 3.65 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.891 2.476 . . . . 0.0 115.764 -178.833 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -132.8 127.69 35.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.037 1.335 . . . . 0.0 110.439 177.167 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -66.16 152.34 45.0 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.784 0.834 . . . . 0.0 112.518 175.09 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.8 m -65.87 150.75 96.11 Favored Pre-proline 0 N--CA 1.485 1.302 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.132 162.818 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.74 -18.04 52.86 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.41 2.073 . . . . 0.0 114.893 -163.446 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.3 -6.58 58.71 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 173.937 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -82.03 143.33 49.26 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.038 1.419 . . . . 0.0 112.045 -176.647 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 145.51 82.31 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 119.183 0.744 . . . . 0.0 112.561 -3.231 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.62 166.13 11.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.385 1.874 . . . . 0.0 110.924 176.246 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 46.5 m -124.47 119.29 28.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.858 0.863 . . . . 0.0 110.766 177.762 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -101.46 135.29 43.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.868 1.267 . . . . 0.0 110.848 171.94 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -97.37 119.53 36.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.22 0.608 . . . . 0.0 110.059 173.184 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 78.5 t -104.5 131.03 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.37 1.468 . . . . 0.0 110.282 -175.611 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.6 p -103.27 163.57 12.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.933 1.293 . . . . 0.0 112.838 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.3 142.49 21.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.12 1.343 . . . . 0.0 112.475 177.289 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.0 t70 -81.27 -21.6 39.26 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.871 1.268 . . . . 0.0 112.904 175.573 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.584 1.954 . . . . 0.0 112.598 -176.705 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.444 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.1 151.59 44.32 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.203 1.001 . . . . 0.0 112.683 178.865 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 24.3 mmt -107.1 138.43 43.3 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.358 1.463 . . . . 0.0 111.615 178.891 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -88.29 150.73 47.57 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.618 1.167 . . . . 0.0 112.142 177.233 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.06 -13.91 17.07 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.78 2.987 . . . . 0.0 113.392 176.907 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -143.21 141.44 31.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.84 1.656 . . . . 0.0 109.42 178.434 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -118.05 153.47 51.25 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.284 1.434 . . . . 0.0 111.932 -170.549 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.57 165.04 30.64 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.725 2.95 . . . . 0.0 112.338 178.694 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -70.63 27.84 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.2 2.2 . . . . 0.0 116.224 -170.406 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 96.3 t -54.63 120.56 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.036 1.334 . . . . 0.0 109.974 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 101.07 -13.21 58.9 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.419 1.485 . . . . 0.0 114.753 -173.98 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 47.3 t -87.68 138.09 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.22 1.51 . . . . 0.0 109.309 172.13 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 64.1 t30 -153.19 153.05 31.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.871 1.269 . . . . 0.0 111.797 -178.289 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -80.37 -179.93 53.0 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.109 1.338 . . . . 0.0 113.751 178.582 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 88.0 mt -78.92 168.63 19.42 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.847 1.259 . . . . 0.0 112.413 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 47.3 t0 -153.85 168.52 26.05 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.378 1.871 . . . . 0.0 110.958 -178.107 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.6 p -156.93 143.33 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.328 1.451 . . . . 0.0 111.716 -172.535 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.5 t -153.75 -10.97 0.15 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -173.296 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 15.4 m -75.76 26.27 0.11 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.598 1.559 . . . . 0.0 114.072 177.799 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 25.4 tp -104.93 128.97 53.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.367 2.267 . . . . 0.0 110.03 -173.04 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -61.55 120.48 56.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.902 0.881 . . . . 0.0 111.389 -169.703 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 156.27 57.74 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.33 2.686 . . . . 0.0 111.612 -173.766 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -96.38 125.39 40.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.554 0.742 . . . . 0.0 109.943 176.603 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.13 131.37 13.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.172 1.389 . . . . 0.0 110.663 173.25 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.41 34.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.539 1.936 . . . . 0.0 109.471 -173.276 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -123.59 136.4 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.835 1.254 . . . . 0.0 110.42 179.486 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.4 mt -135.72 138.8 29.03 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 125.879 1.672 . . . . 0.0 109.092 -174.543 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.61 43.88 1.43 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.728 3.619 . . . . 0.0 113.134 177.706 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 88.5 t80 -87.09 157.51 19.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.316 1.446 . . . . 0.0 110.897 171.244 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 85.2 m -124.62 127.71 47.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.405 1.482 . . . . 0.0 110.128 -177.181 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.9 mt -88.17 128.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.503 1.121 . . . . 0.0 110.171 174.682 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -111.37 -146.96 0.41 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.926 1.691 . . . . 0.0 110.757 176.738 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -78.5 127.78 32.63 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.818 -1.176 . . . . 0.0 110.898 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 135.81 -148.33 19.6 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.443 1.497 . . . . 0.0 112.103 -170.804 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.71 148.58 19.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.677 1.191 . . . . 0.0 111.428 -174.994 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 11.8 tt -121.44 138.32 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.718 1.607 . . . . 0.0 111.398 179.214 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 45.2 p -144.54 -174.74 4.4 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.381 1.872 . . . . 0.0 110.317 -176.663 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.39 -169.31 38.34 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -152.92 136.76 16.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.894 1.677 . . . . 0.0 109.8 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 26.9 t -108.62 134.8 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.756 1.622 . . . . 0.0 108.343 171.656 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -119.93 138.87 53.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.43 1.092 . . . . 0.0 111.594 -172.196 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -109.32 144.14 29.17 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.825 1.65 . . . . 0.0 111.173 -176.157 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.37 -30.11 61.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.125 3.216 . . . . 0.0 114.836 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.7 m -69.49 -2.27 10.81 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.192 1.397 . . . . 0.0 114.402 178.535 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.22 -1.62 77.27 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.889 1.709 . . . . 0.0 113.829 -177.016 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -79.2 160.67 26.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.652 1.581 . . . . 0.0 111.963 179.732 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 36.0 m -141.55 157.51 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.152 1.381 . . . . 0.0 111.82 178.217 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.65 166.93 32.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.244 1.817 . . . . 0.0 111.415 -179.572 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.52 140.09 20.8 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 -179.836 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.47 174.98 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.625 3.55 . . . . 0.0 112.094 175.267 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.4 m -116.59 141.6 47.98 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 109.052 170.855 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.3 135.64 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.714 1.206 . . . . 0.0 109.272 174.541 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 54.5 m -140.06 128.08 22.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.277 1.431 . . . . 0.0 109.72 -178.691 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.17 137.52 40.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.908 0.883 . . . . 0.0 112.288 172.448 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -89.91 -8.73 51.15 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 69.43 3.1 4.01 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.636 2.374 . . . . 0.0 114.15 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.97 7.51 46.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.896 2.078 . . . . 0.0 112.821 178.849 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.43 16.81 51.96 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.942 1.258 . . . . 0.0 113.703 -173.36 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 37.7 p -132.68 159.69 38.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 178.859 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 31.5 m -121.51 147.26 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.674 1.19 . . . . 0.0 110.226 167.099 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 97.3 m -105.33 135.03 47.45 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.827 1.251 . . . . 0.0 108.752 169.131 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 65.1 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.413 1.885 . . . . 0.0 108.467 177.974 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -138.53 159.06 43.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.001 1.32 . . . . 0.0 113.131 -172.838 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.8 t80 -159.35 137.17 10.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.86 1.664 . . . . 0.0 111.883 174.94 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.35 115.91 65.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.09 1.356 . . . . 0.0 110.736 177.311 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.81 156.81 13.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.78 2.987 . . . . 0.0 112.769 -172.011 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 49.9 m -124.88 -24.6 4.06 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.682 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -145.77 148.61 33.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.421 1.489 . . . . 0.0 110.915 -177.351 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.82 162.89 27.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.547 1.139 . . . . 0.0 113.197 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 133.56 -177.37 19.08 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 125.282 1.42 . . . . 0.0 114.15 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.2 tt -88.26 123.55 32.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 109.115 175.588 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.45 159.05 32.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.219 1.407 . . . . 0.0 111.673 -172.235 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.18 154.79 50.31 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 111.649 172.291 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -137.69 123.96 20.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.222 1.809 . . . . 0.0 109.81 -172.312 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -95.16 129.52 42.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.748 2.019 . . . . 0.0 109.429 174.118 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.8 mm -127.64 136.82 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.739 1.216 . . . . 0.0 109.87 174.362 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -179.832 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -96.6 121.09 38.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.492 1.917 . . . . 0.0 109.886 173.634 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.47 35.03 10.24 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.965 1.306 . . . . 0.0 112.858 -174.969 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 47.9 t30 78.55 1.93 2.6 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.334 2.654 . . . . 0.0 114.787 -179.66 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -102.38 133.56 47.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.525 1.53 . . . . 0.0 111.435 174.188 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m170 -52.92 137.2 33.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.615 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.58 156.79 70.54 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.375 0.67 . . . . 0.0 111.204 169.425 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.53 130.87 35.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.034 1.823 . . . . 0.0 109.29 166.067 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.58 -2.27 67.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.245 0.926 . . . . 0.0 113.937 -172.963 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.4 t -93.24 145.12 29.45 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 118.939 1.369 . . . . 0.0 111.527 170.432 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.76 165.31 85.43 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.86 0.986 . . . . 0.0 111.606 -10.494 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.12 154.54 20.03 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.367 1.867 . . . . 0.0 110.068 173.725 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -158.23 135.12 9.81 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.177 0.991 . . . . 0.0 111.07 -174.575 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.1 p90 -167.23 173.43 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.746 1.218 . . . . 0.0 112.815 -167.551 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.8 t80 -107.13 141.69 37.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.945 0.898 . . . . 0.0 113.149 173.993 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 91.0 t -110.11 131.79 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.807 2.043 . . . . 0.0 109.157 179.046 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -152.02 151.2 30.84 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.355 1.462 . . . . 0.0 112.792 -172.833 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -69.99 149.23 47.94 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.235 -0.916 . . . . 0.0 112.751 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.9 m -71.54 -14.66 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -171.058 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.28 -126.1 0.18 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.463 1.505 . . . . 0.0 111.334 178.704 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 75.9 m 75.1 160.7 0.23 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.232 2.613 . . . . 0.0 114.398 171.848 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -102.27 -17.32 20.45 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.051 1.31 . . . . 0.0 114.652 178.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -71.82 155.62 40.21 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.685 1.242 . . . . 0.0 113.833 -179.509 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.7 t -68.01 143.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.604 1.162 . . . . 0.0 108.842 172.663 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.02 167.22 29.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.507 1.123 . . . . 0.0 110.984 -175.486 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -152.46 148.17 27.11 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.529 1.532 . . . . 0.0 111.441 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -165.51 161.14 18.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 112.392 -173.43 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.17 169.96 12.55 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.105 1.336 . . . . 0.0 113.56 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.08 -30.59 38.34 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.227 2.618 . . . . 0.0 113.092 -170.407 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.3 -17.38 72.23 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.429 1.013 . . . . 0.0 114.586 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 63.8 mt -76.04 -15.76 60.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.749 169.299 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 5.7 m -115.64 -39.46 3.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.029 1.732 . . . . 0.0 112.043 -165.711 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -151.4 150.36 30.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.086 1.754 . . . . 0.0 112.392 -172.434 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.83 176.87 29.19 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.235 1.398 . . . . 0.0 112.712 172.781 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.2 t -140.04 136.29 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.559 1.144 . . . . 0.0 108.342 175.442 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -57.12 137.12 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.272 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 65.32 3.79 2.42 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.833 2.053 . . . . 0.0 114.658 176.879 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -118.03 138.49 25.52 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.895 1.678 . . . . 0.0 110.401 177.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.08 131.97 17.48 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.363 2.042 . . . . 0.0 111.407 -171.077 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.2 148.24 33.22 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.479 1.512 . . . . 0.0 110.355 172.282 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 33.2 p -137.57 149.87 47.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -165.849 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.28 172.89 16.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.593 1.557 . . . . 0.0 111.85 176.59 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.9 m -123.35 141.39 52.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.738 1.615 . . . . 0.0 110.482 -173.657 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 59.2 t -113.71 139.6 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.272 1.829 . . . . 0.0 107.897 168.215 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.48 133.17 45.31 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.228 1.011 . . . . 0.0 111.738 177.947 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 68.3 p -125.58 1.02 7.57 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.469 1.907 . . . . 0.0 113.039 -177.317 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -49.97 -28.63 7.12 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.76 2.424 . . . . 0.0 117.122 -169.86 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -139.21 20.38 2.6 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.1 1.36 . . . . 0.0 112.031 176.678 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.46 44.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 113.474 -174.845 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.36 146.11 4.29 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.007 1.289 . . . . 0.0 112.297 -171.179 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.13 147.16 38.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.832 0.853 . . . . 0.0 112.005 -179.378 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . -175.79 -42.43 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.002 1.287 . . . . 0.0 113.543 176.513 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 162.03 102.17 0.17 Allowed Glycine 0 N--CA 1.47 0.943 0 C-N-CA 125.065 1.316 . . . . 0.0 112.594 170.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 33.2 tp -81.65 136.88 35.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.305 1.042 . . . . 0.0 110.117 176.577 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -129.97 157.44 42.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.346 1.458 . . . . 0.0 111.553 177.555 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 55.6 tp -160.68 132.35 5.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.457 1.503 . . . . 0.0 108.977 -169.589 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.43 162.72 37.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.877 0.871 . . . . 0.0 112.132 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.6 mt -136.59 132.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.872 1.269 . . . . 0.0 109.074 172.54 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -115.02 157.71 23.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.704 1.602 . . . . 0.0 109.744 169.219 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.6 -165.15 35.24 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.192 -0.943 . . . . 0.0 113.748 -177.714 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.62 -15.12 27.41 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.633 2.889 . . . . 0.0 112.422 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -147.1 160.38 42.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.997 1.719 . . . . 0.0 109.255 163.488 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 52.1 tptt -83.24 113.02 20.39 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.868 -1.145 . . . . 0.0 111.857 -174.973 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.94 150.27 44.29 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.182 0.993 . . . . 0.0 111.857 173.911 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.52 145.65 26.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.888 0.875 . . . . 0.0 110.691 169.611 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 20.1 mt -137.4 140.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.813 1.245 . . . . 0.0 110.505 -163.631 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.9 m -133.3 157.27 45.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.772 1.629 . . . . 0.0 110.675 168.442 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 31.8 p -156.46 156.89 34.54 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.233 -0.917 . . . . 0.0 113.104 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -144.14 124.82 14.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.704 1.602 . . . . 0.0 110.078 -171.032 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.24 144.92 32.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.569 1.147 . . . . 0.0 112.535 173.951 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -121.74 152.0 39.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.586 1.554 . . . . 0.0 112.062 -176.16 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -68.23 -18.41 64.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.818 1.247 . . . . 0.0 112.788 176.43 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -76.55 -2.79 34.18 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.86 1.664 . . . . 0.0 114.247 -178.427 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 89.77 33.92 8.76 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.385 0.993 . . . . 0.0 113.399 -178.563 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.2 p -139.88 163.63 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.354 1.461 . . . . 0.0 111.215 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.0 m -121.08 132.89 55.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.717 1.607 . . . . 0.0 108.841 161.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -92.02 147.51 22.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.857 0.863 . . . . 0.0 110.261 170.588 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 91.0 t -128.95 142.97 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.561 1.544 . . . . 0.0 109.83 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 86.2 p -132.99 147.5 52.28 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.227 1.411 . . . . 0.0 111.589 167.758 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -151.22 157.8 43.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 24.6 mt -124.93 108.4 28.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.903 1.681 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.02 168.95 15.05 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.781 2.987 . . . . 0.0 110.25 166.116 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.3 p -131.64 -20.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.434 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.7 150.73 51.44 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.556 1.142 . . . . 0.0 110.575 173.846 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.65 154.39 39.47 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.929 2.419 . . . . 0.0 112.573 -168.839 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.34 -144.68 12.19 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.683 1.135 . . . . 0.0 112.964 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -123.31 133.37 54.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.49 177.365 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -123.55 134.08 53.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 0.0 110.769 -174.911 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 74.7 m -100.06 110.32 22.62 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.996 1.318 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.35 126.77 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.419 1.488 . . . . 0.0 108.546 176.156 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -105.33 130.98 53.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.626 . . . . 0.0 109.665 174.378 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -131.11 128.55 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.433 1.093 . . . . 0.0 109.7 172.072 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.37 141.37 21.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.174 1.39 . . . . 0.0 111.502 -168.505 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.49 121.32 17.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.935 1.294 . . . . 0.0 109.968 -178.768 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 52.65 59.07 4.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.541 1.536 . . . . 0.0 112.0 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 7.7 pt-20 60.86 0.78 0.39 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 129.035 2.934 . . . . 0.0 116.867 -177.198 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -107.52 123.63 48.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.111 179.293 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.18 144.78 54.99 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.35 -0.844 . . . . 0.0 111.703 169.982 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.5 m -73.44 151.08 89.56 Favored Pre-proline 0 N--CA 1.48 1.041 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.038 171.976 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.52 129.67 35.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.129 2.553 . . . . 0.0 110.762 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.13 -15.24 63.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.04 1.305 . . . . 0.0 115.027 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 34.5 t -77.09 139.36 65.19 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.223 1.511 . . . . 0.0 111.346 176.148 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.79 147.55 81.3 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.648 0.91 . . . . 0.0 112.585 -3.098 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.24 133.77 45.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.837 1.655 . . . . 0.0 110.59 -178.887 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 24.6 m -97.67 108.66 21.43 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.552 0.741 . . . . 0.0 110.847 -177.08 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.34 132.84 37.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.014 1.326 . . . . 0.0 111.886 176.328 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 22.0 tpt85 -88.15 113.29 23.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.482 178.771 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.0 t -103.49 129.56 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.048 0.939 . . . . 0.0 110.758 -176.422 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 69.6 p -110.11 162.47 14.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.019 1.327 . . . . 0.0 112.977 -179.683 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.57 135.44 13.6 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.938 1.256 . . . . 0.0 112.345 178.003 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 -85.84 -23.53 27.1 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.577 1.151 . . . . 0.0 112.937 175.684 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.789 1.635 . . . . 0.0 113.796 -179.535 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.01 -28.81 64.68 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.209 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 15.2 tpt -162.1 138.51 7.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.001 1.721 . . . . 0.0 110.998 178.911 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -167.69 149.53 5.2 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.873 2.069 . . . . 0.0 110.748 177.419 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.18 140.12 30.44 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.269 2.646 . . . . 0.0 110.893 176.347 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -166.96 148.13 5.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.78 1.632 . . . . 0.0 110.28 -177.17 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -63.29 154.78 77.21 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.914 0.886 . . . . 0.0 113.144 177.656 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.36 145.39 53.57 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.991 2.461 . . . . 0.0 110.655 168.617 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 90.5 mt -116.7 15.48 15.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.287 1.435 . . . . 0.0 112.548 -177.376 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 59.2 t -68.2 135.97 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.538 1.535 . . . . 0.0 110.811 -176.588 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -171.4 -169.25 34.09 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.068 1.318 . . . . 0.0 113.639 178.728 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 26.1 t 81.27 134.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 128.515 2.726 . . . . 0.0 111.115 177.941 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 50.0 t30 -156.14 145.46 20.73 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.399 1.48 . . . . 0.0 111.396 179.525 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -79.04 137.65 19.57 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.583 1.087 . . . . 0.0 112.588 -179.669 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.9 mt -142.22 167.05 23.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.712 2.005 . . . . 0.0 110.535 -179.565 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 46.3 t0 -154.4 159.52 41.15 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.204 1.402 . . . . 0.0 111.874 179.084 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 61.7 t -91.8 133.46 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.788 1.635 . . . . 0.0 109.597 179.365 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 9.0 t -172.88 -35.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.56 1.544 . . . . 0.0 113.069 -175.437 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 14.8 m -67.85 139.91 56.55 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -162.046 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.24 144.27 40.49 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.254 1.022 . . . . 0.0 109.549 157.937 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 47.4 ttm-85 -67.28 117.9 51.04 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.817 1.647 . . . . 0.0 110.215 -175.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.2 151.11 60.48 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.212 2.608 . . . . 0.0 111.572 -171.463 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.4 t80 -101.16 119.5 38.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.938 0.895 . . . . 0.0 109.689 176.339 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -147.81 131.13 16.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.136 1.374 . . . . 0.0 110.398 172.38 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.78 148.31 35.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 109.756 -171.054 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -119.94 139.56 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.043 1.337 . . . . 0.0 110.56 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.3 mt -133.92 137.49 28.57 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.164 1.786 . . . . 0.0 108.465 -176.107 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.36 46.7 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.332 3.354 . . . . 0.0 112.861 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.2 t80 -91.41 155.05 18.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.362 1.465 . . . . 0.0 111.072 174.81 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.3 m -125.25 126.35 45.02 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.882 1.273 . . . . 0.0 109.831 177.866 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.3 mt -95.69 115.23 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 109.077 177.477 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.79 -55.52 4.05 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.627 0.771 . . . . 0.0 112.992 179.656 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -161.82 -35.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.852 1.261 . . . . 0.0 114.002 -171.536 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -72.53 164.9 54.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.226 1.393 . . . . 0.0 113.801 179.106 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -86.42 142.71 28.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.871 1.269 . . . . 0.0 112.212 -174.515 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.86 134.39 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.58 1.552 . . . . 0.0 110.459 174.591 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.1 p -145.68 173.03 12.43 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.998 1.719 . . . . 0.0 110.738 -175.082 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.72 -176.62 25.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 -177.658 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -151.43 137.72 18.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.938 1.695 . . . . 0.0 109.057 171.026 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.3 t -111.69 133.29 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.054 1.742 . . . . 0.0 108.131 174.179 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -109.28 129.96 55.5 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.237 1.415 . . . . 0.0 110.626 -176.625 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -96.21 151.79 38.4 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.621 1.568 . . . . 0.0 111.411 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.99 -24.85 45.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.294 2.663 . . . . 0.0 113.213 -179.093 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 20.3 m -73.91 -1.09 18.21 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.036 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.84 70.41 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.736 1.636 . . . . 0.0 114.624 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -71.75 163.76 27.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.221 1.408 . . . . 0.0 112.301 176.263 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.74 153.39 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.219 1.408 . . . . 0.0 111.873 175.647 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.43 166.55 31.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.852 2.061 . . . . 0.0 110.41 179.096 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.06 141.57 23.01 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.188 -0.945 . . . . 0.0 112.444 -177.823 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.24 172.64 8.29 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.67 3.58 . . . . 0.0 111.658 173.332 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.9 m -109.34 125.58 52.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.322 1.449 . . . . 0.0 108.899 172.942 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.02 129.46 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.407 1.083 . . . . 0.0 108.42 173.442 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.5 m -118.77 128.33 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.149 1.78 . . . . 0.0 109.674 -178.43 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.42 119.92 22.43 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.246 1.018 . . . . 0.0 110.465 170.615 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -84.67 -14.43 48.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.3 mttt 71.5 -3.36 2.15 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.788 2.435 . . . . 0.0 114.514 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -92.8 5.57 50.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.297 1.839 . . . . 0.0 113.319 178.515 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.63 19.02 46.03 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.694 1.14 . . . . 0.0 113.53 -172.504 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -131.98 162.0 31.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 109.966 175.216 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.1 m -126.1 147.13 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.226 . . . . 0.0 109.978 168.413 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 52.1 m -108.75 135.22 50.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.376 1.071 . . . . 0.0 108.568 171.328 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -117.63 131.49 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.309 1.444 . . . . 0.0 108.797 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.08 151.27 51.86 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.012 1.325 . . . . 0.0 112.504 -173.261 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.05 136.08 17.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.38 1.472 . . . . 0.0 111.764 176.825 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.86 115.62 64.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.764 1.225 . . . . 0.0 110.827 177.792 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.03 140.43 25.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.826 3.018 . . . . 0.0 112.918 -172.117 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.2 p -116.78 -8.45 11.37 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.705 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.29 157.48 22.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.044 1.738 . . . . 0.0 111.579 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.78 172.62 12.02 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.458 1.103 . . . . 0.0 112.377 174.058 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.95 -172.17 15.57 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.527 1.537 . . . . 0.0 113.62 178.778 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.83 130.9 35.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.502 1.121 . . . . 0.0 110.233 -178.581 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.5 m80 -128.89 162.08 28.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.913 1.685 . . . . 0.0 111.612 -173.786 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -141.98 159.5 42.11 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.28 1.032 . . . . 0.0 111.696 172.943 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.1 ttm -139.44 134.52 32.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 110.607 -171.8 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -110.24 136.16 49.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 109.922 172.691 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.0 mm -133.1 132.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.146 1.378 . . . . 0.0 109.951 178.118 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 138.19 28.32 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.972 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.8 t80 -102.47 121.03 41.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.478 2.311 . . . . 0.0 109.586 176.32 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.07 38.4 20.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.832 1.253 . . . . 0.0 112.551 -174.844 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 78.89 -9.0 1.57 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 128.906 2.883 . . . . 0.0 115.174 -178.392 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 67.7 mtm -95.53 129.82 42.58 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.208 1.403 . . . . 0.0 111.187 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -59.12 138.33 57.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.208 -0.933 . . . . 0.0 113.438 -177.309 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 33.4 pt -71.81 153.05 93.26 Favored Pre-proline 0 N--CA 1.48 1.044 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.044 169.645 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.65 -18.37 58.65 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.407 2.071 . . . . 0.0 113.9 -174.442 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.83 0.52 87.9 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.771 1.177 . . . . 0.0 114.685 171.485 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -97.2 142.6 24.78 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.652 1.726 . . . . 0.0 111.539 176.533 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.53 165.7 74.06 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.842 0.979 . . . . 0.0 112.854 -1.67 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 86.2 mt -112.93 159.54 18.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.22 1.808 . . . . 0.0 110.665 170.282 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -155.49 139.6 16.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.638 1.175 . . . . 0.0 110.137 -173.381 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.33 -175.69 3.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.906 1.282 . . . . 0.0 112.382 -170.429 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.4 t80 -124.02 141.58 51.92 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.89 1.276 . . . . 0.0 112.679 178.23 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 54.7 t -110.9 142.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.099 1.76 . . . . 0.0 109.434 176.724 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.03 169.39 21.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.801 2.04 . . . . 0.0 109.954 -171.607 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -77.32 143.57 38.71 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.513 -1.367 . . . . 0.0 111.187 170.981 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.7 m -61.94 -26.87 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -175.152 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.75 134.18 48.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.307 1.443 . . . . 0.0 110.045 166.814 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 7.6 t -164.66 156.56 15.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.934 1.694 . . . . 0.0 110.724 178.274 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.6 58.23 4.99 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.172 1.367 . . . . 0.0 113.525 -173.857 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -155.5 167.79 29.23 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.3 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.0 p -71.49 147.26 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.382 1.073 . . . . 0.0 109.582 159.436 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.5 t -160.02 167.96 26.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.087 1.355 . . . . 0.0 110.487 178.355 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.68 145.48 25.86 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 -179.119 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.6 p90 -168.74 166.77 11.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.786 1.634 . . . . 0.0 112.578 -173.757 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.89 174.63 13.7 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.3 1.428 . . . . 0.0 112.542 -177.279 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.17 -36.1 13.06 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.257 . . . . 0.0 112.87 -170.973 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.41 87.65 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.45 1.023 . . . . 0.0 114.589 -170.738 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.13 -2.08 39.08 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.912 1.356 . . . . 0.0 113.498 175.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.3 m -108.17 -51.39 2.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.28 1.832 . . . . 0.0 110.926 177.529 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -138.4 144.71 40.34 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.537 1.935 . . . . 0.0 112.522 -176.731 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.22 178.27 20.4 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.985 1.278 . . . . 0.0 112.912 171.718 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -141.67 138.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.852 1.261 . . . . 0.0 108.259 174.501 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -59.96 149.17 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.062 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 77.6 m-20 67.2 14.76 9.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.425 1.89 . . . . 0.0 114.382 169.838 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -145.56 152.84 50.34 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.874 1.67 . . . . 0.0 111.236 174.211 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.74 145.66 32.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.497 2.131 . . . . 0.0 112.145 -174.616 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -121.46 150.83 40.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.409 1.884 . . . . 0.0 110.043 170.621 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.8 p -137.71 149.97 46.93 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -165.487 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.07 175.96 12.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.78 1.632 . . . . 0.0 111.457 175.341 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.6 m -129.71 140.42 51.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.944 1.298 . . . . 0.0 110.727 -172.045 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.2 t -105.2 133.27 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.443 1.497 . . . . 0.0 107.906 168.217 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.43 126.69 46.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.703 1.201 . . . . 0.0 110.446 174.762 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.1 p -126.51 5.4 6.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.849 2.06 . . . . 0.0 113.066 -171.604 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.74 -37.5 51.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.241 1.817 . . . . 0.0 115.104 -170.241 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -116.36 9.73 14.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.403 1.481 . . . . 0.0 113.014 178.67 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.62 -10.94 59.71 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -171.097 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 86.37 -125.68 7.5 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.453 1.025 . . . . 0.0 112.446 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.02 149.5 28.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.387 1.475 . . . . 0.0 110.878 -173.901 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.84 -155.78 26.74 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.585 1.564 . . . . 0.0 112.736 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.1 108.14 3.38 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.127 0.87 . . . . 0.0 111.504 174.416 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.74 128.17 34.33 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 108.722 171.84 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.6 m -133.74 160.24 38.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.032 1.333 . . . . 0.0 112.854 -173.299 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 37.3 tp -158.46 138.53 12.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.491 1.916 . . . . 0.0 108.951 -171.569 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.15 157.19 35.54 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.071 0.948 . . . . 0.0 111.944 174.85 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.7 mt -138.35 140.29 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.875 1.27 . . . . 0.0 109.741 177.05 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.22 144.04 51.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.652 1.581 . . . . 0.0 109.877 173.723 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.34 -166.0 26.67 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.958 -175.242 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.58 -26.33 69.5 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.477 3.451 . . . . 0.0 112.843 178.436 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -141.72 156.26 45.61 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.986 1.314 . . . . 0.0 109.093 161.039 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -72.31 110.72 6.93 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.193 -0.942 . . . . 0.0 111.258 -177.739 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.88 148.38 51.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.0 111.372 172.229 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.33 146.34 27.77 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.818 0.447 . . . . 0.0 110.159 165.762 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.24 143.97 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.029 1.332 . . . . 0.0 109.856 -165.182 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.58 163.24 35.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.693 1.197 . . . . 0.0 111.418 168.946 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -161.34 152.43 18.5 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.991 1.317 . . . . 0.0 112.305 -178.606 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 95.1 m -137.96 121.92 17.79 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.637 1.575 . . . . 0.0 109.692 -175.914 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.55 119.3 15.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.452 0.701 . . . . 0.0 109.966 165.872 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.66 -16.79 50.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 112.656 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 10.3 tt0 72.71 -8.8 1.18 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 128.08 2.552 . . . . 0.0 113.072 -176.286 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.36 11.61 8.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.972 2.109 . . . . 0.0 113.494 -177.368 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.84 15.34 54.73 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.187 1.375 . . . . 0.0 113.605 -171.869 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 65.9 p -141.66 154.17 45.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.651 1.58 . . . . 0.0 111.754 177.419 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 35.3 m -120.87 131.24 54.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.662 1.585 . . . . 0.0 108.988 164.986 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.5 t -88.17 149.4 23.91 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.923 0.889 . . . . 0.0 110.838 173.125 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -132.58 143.14 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.632 1.573 . . . . 0.0 110.121 -177.229 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 92.8 p -137.28 150.32 47.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.876 1.27 . . . . 0.0 112.252 168.852 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -152.24 155.05 36.98 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.138 -0.976 . . . . 0.0 112.462 173.974 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.38 99.98 29.88 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.398 1.079 . . . . 0.0 109.998 -174.461 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -83.21 162.21 15.32 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.069 3.179 . . . . 0.0 111.083 176.41 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -133.77 -20.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -172.441 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.6 mt -118.65 147.32 41.86 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 124.849 1.259 . . . . 0.0 110.261 170.21 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 158.76 43.61 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.883 2.388 . . . . 0.0 111.019 176.385 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 128.08 -163.79 21.58 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.967 1.27 . . . . 0.0 113.213 -177.048 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.81 136.9 32.77 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 112.921 -178.957 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -124.78 129.98 51.51 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.743 1.617 . . . . 0.0 110.031 176.429 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.81 126.19 35.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 110.436 174.838 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.71 126.23 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.465 1.506 . . . . 0.0 108.047 178.643 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -108.94 131.84 54.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.474 1.509 . . . . 0.0 109.442 175.651 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.85 129.09 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.392 1.077 . . . . 0.0 109.383 172.739 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.78 143.39 26.34 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.225 1.41 . . . . 0.0 111.59 -168.36 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.83 122.18 12.34 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.597 1.159 . . . . 0.0 110.341 179.748 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 57.67 56.24 5.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.315 1.446 . . . . 0.0 111.732 -179.406 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 10.0 pt-20 54.78 22.34 4.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.903 2.481 . . . . 0.0 115.898 -179.113 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -132.84 131.39 40.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.071 1.348 . . . . 0.0 110.542 176.804 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.58 150.32 47.12 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.796 0.838 . . . . 0.0 112.299 174.788 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -67.69 156.29 89.37 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.103 167.833 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -52.28 -33.67 56.39 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.042 3.161 . . . . 0.0 116.378 -169.388 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.98 -3.21 59.17 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.6 t -84.12 143.02 41.87 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.983 1.392 . . . . 0.0 112.355 -177.316 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.26 138.14 54.17 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.062 0.701 . . . . 0.0 111.812 -4.449 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.48 168.3 12.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.862 1.665 . . . . 0.0 110.292 172.843 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 25.0 m -131.76 116.86 17.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 110.069 172.992 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -91.46 152.93 20.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.746 1.219 . . . . 0.0 110.785 170.113 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -108.87 129.08 55.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.516 0.726 . . . . 0.0 110.19 166.521 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.8 t -105.06 129.22 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.318 1.447 . . . . 0.0 110.135 179.242 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 86.9 m -95.99 152.56 18.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.0 1.72 . . . . 0.0 111.495 -178.897 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.27 133.35 12.18 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.871 1.224 . . . . 0.0 112.079 175.289 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.32 -25.6 39.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.751 1.22 . . . . 0.0 113.484 -177.157 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.48 1.912 . . . . 0.0 112.675 -176.206 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.94 157.64 37.03 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.289 1.036 . . . . 0.0 112.744 177.849 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.0 mmt -79.04 -22.76 44.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.111 0.964 . . . . 0.0 113.53 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -75.65 135.28 71.76 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.23 1.012 . . . . 0.0 112.241 -177.808 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.35 172.04 14.14 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.948 3.099 . . . . 0.0 111.707 176.017 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.03 149.38 21.31 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.46 1.504 . . . . 0.0 111.026 173.971 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -137.77 148.39 60.71 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 125.812 1.645 . . . . 0.0 111.486 -179.244 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.25 170.02 20.3 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.931 3.087 . . . . 0.0 111.734 175.436 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 61.7 tp -146.86 126.47 13.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.281 1.433 . . . . 0.0 109.101 172.672 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.5 p -168.3 154.9 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.176 1.39 . . . . 0.0 111.035 -169.424 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 86.31 -68.77 3.26 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.029 1.299 . . . . 0.0 113.154 171.054 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 13.1 p -165.16 146.25 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.212 1.405 . . . . 0.0 111.588 -173.596 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 3.9 p30 -161.69 159.38 27.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.658 1.983 . . . . 0.0 111.03 173.198 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -72.24 114.68 5.08 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 123.951 0.786 . . . . 0.0 112.554 -172.966 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.0 mt -143.46 151.07 39.9 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.331 1.852 . . . . 0.0 110.546 -176.967 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 32.0 t70 70.93 -52.79 0.68 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.354 2.662 . . . . 0.0 113.718 170.688 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1785 ' ' VAL . . . . . 0.469 ' HA ' HD21 ' A' 1864 ' ' ASN . 9.8 p -61.95 -24.59 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.591 1.556 . . . . 0.0 112.998 176.672 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 8.4 t -90.97 -11.69 38.21 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.176 1.79 . . . . 0.0 113.062 178.612 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 49.5 m -80.1 116.07 20.01 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.012 -1.055 . . . . 0.0 113.753 -166.037 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.01 149.77 35.85 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.324 1.05 . . . . 0.0 110.145 159.187 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -56.27 115.54 10.19 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.287 1.435 . . . . 0.0 110.362 177.445 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 133.41 27.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.117 1.878 . . . . 0.0 108.682 174.122 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.02 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 109.947 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.93 150.51 25.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.351 1.461 . . . . 0.0 111.652 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -159.62 151.57 20.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.856 1.662 . . . . 0.0 109.893 -177.123 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -123.81 134.5 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.005 1.322 . . . . 0.0 109.655 170.845 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.77 135.98 27.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.919 1.688 . . . . 0.0 109.215 -172.692 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.02 112.77 3.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.209 2.606 . . . . 0.0 110.208 173.873 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 46.8 t80 -174.94 147.6 0.98 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.026 2.13 . . . . 0.0 109.278 -171.683 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 52.5 m -125.63 127.0 45.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.574 1.15 . . . . 0.0 109.803 -178.993 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.82 113.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.731 0.812 . . . . 0.0 109.436 174.883 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -98.33 -158.53 0.68 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.213 1.405 . . . . 0.0 111.006 172.006 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tptt -68.5 120.36 14.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.603 -1.311 . . . . 0.0 111.091 173.104 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.64 -147.61 18.63 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.676 1.608 . . . . 0.0 111.867 -171.066 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.78 143.46 15.89 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.3 1.04 . . . . 0.0 111.496 -175.118 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.9 tt -128.95 136.44 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.731 1.612 . . . . 0.0 110.946 177.076 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.9 p -147.64 -178.37 6.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.337 1.855 . . . . 0.0 110.372 -176.765 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.52 -170.55 31.57 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 179.027 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -149.72 139.81 22.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.317 1.847 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 45.1 t -113.67 135.53 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.3 1.84 . . . . 0.0 108.178 170.647 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -119.02 138.15 53.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.166 1.387 . . . . 0.0 111.947 -178.386 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.5 mpp? -114.05 141.57 26.51 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.831 1.652 . . . . 0.0 111.399 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -25.13 78.77 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.126 3.217 . . . . 0.0 115.017 177.144 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.3 p -74.71 4.35 6.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.861 1.664 . . . . 0.0 114.655 -177.831 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.84 41.15 6.04 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 124.606 1.098 . . . . 0.0 113.293 172.961 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -148.67 163.89 35.94 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.63 1.572 . . . . 0.0 111.938 -175.058 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.5 161.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.011 1.324 . . . . 0.0 112.231 -174.207 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.02 -178.25 6.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.088 2.155 . . . . 0.0 110.22 178.051 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -127.04 146.23 56.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.065 -1.022 . . . . 0.0 111.419 176.581 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.33 166.18 14.23 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.207 3.271 . . . . 0.0 111.49 177.857 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.8 m -101.98 134.21 45.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 108.585 170.131 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.17 132.91 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.799 1.239 . . . . 0.0 109.013 175.019 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.7 m -138.6 122.32 17.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.243 1.417 . . . . 0.0 109.465 178.864 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -76.63 131.8 39.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.865 0.866 . . . . 0.0 111.73 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -83.44 1.68 40.44 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.041 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 69.51 16.86 8.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.624 1.97 . . . . 0.0 112.991 179.639 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -138.66 16.82 2.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.18 1.792 . . . . 0.0 113.015 -169.545 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.74 13.27 63.03 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.596 1.093 . . . . 0.0 115.132 177.184 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.9 p -129.44 155.94 44.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.835 1.654 . . . . 0.0 110.41 174.843 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.0 m -115.42 138.37 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.886 0.875 . . . . 0.0 110.202 167.192 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.4 m -96.03 136.43 36.49 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.731 1.212 . . . . 0.0 108.429 167.964 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 52.9 t -121.78 135.85 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.791 1.636 . . . . 0.0 108.399 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -140.63 159.33 42.44 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.562 1.145 . . . . 0.0 113.139 -175.839 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.0 t80 -154.59 134.25 12.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.942 1.697 . . . . 0.0 111.538 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.46 121.75 75.08 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.381 1.072 . . . . 0.0 111.205 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.44 156.68 32.65 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.741 2.96 . . . . 0.0 111.857 -176.558 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.1 t -140.75 -13.76 0.96 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.516 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -165.38 151.54 9.8 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 110.657 -176.531 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.02 168.45 20.07 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.427 1.091 . . . . 0.0 113.444 -177.602 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 125.04 -179.97 15.94 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.346 1.45 . . . . 0.0 114.157 176.723 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.0 tt -86.66 122.37 30.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.758 1.223 . . . . 0.0 109.821 179.771 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 26.2 m80 -116.99 160.82 20.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.698 1.599 . . . . 0.0 111.619 -173.113 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -142.78 144.21 32.5 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.978 1.311 . . . . 0.0 110.304 -178.557 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.5 ttm -135.39 141.02 45.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.827 1.251 . . . . 0.0 112.613 -176.386 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.09 139.57 35.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.737 1.615 . . . . 0.0 110.405 163.667 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.4 mm -127.84 131.61 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 109.272 163.63 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.31 134.69 23.06 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.106 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 13.7 t80 -98.03 122.83 41.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.573 1.949 . . . . 0.0 109.632 174.655 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.83 36.43 14.59 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.723 1.209 . . . . 0.0 112.824 -175.462 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 77.78 3.18 2.97 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 128.107 2.563 . . . . 0.0 114.614 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.0 mtm -105.64 130.21 53.72 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.583 1.553 . . . . 0.0 111.079 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.28 137.22 41.93 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.773 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 24.6 pt -77.05 156.18 82.25 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.228 171.024 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -59.82 128.53 27.14 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.111 1.874 . . . . 0.0 109.718 169.977 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.92 -16.9 57.99 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.784 1.183 . . . . 0.0 114.072 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.4 t -83.22 144.75 47.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 119.347 1.574 . . . . 0.0 110.664 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.43 160.24 93.94 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 120.209 1.11 . . . . 0.0 113.048 -2.638 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.97 154.07 22.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.661 1.984 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -156.4 134.41 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.039 0.936 . . . . 0.0 110.96 -173.025 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.08 -177.53 5.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 112.779 -172.486 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.4 t80 -122.4 137.44 54.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 177.253 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 90.4 t -100.75 134.59 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.644 1.577 . . . . 0.0 109.573 174.481 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 18.6 t0 -156.51 169.25 25.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.242 1.817 . . . . 0.0 110.301 -179.519 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -69.45 142.78 53.73 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.073 -1.017 . . . . 0.0 112.7 176.622 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 53.6 t -67.02 -36.14 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.207 1.003 . . . . 0.0 112.556 -172.245 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1864 ' ' ASN . . . . . 0.469 HD21 ' HA ' ' A' 1785 ' ' VAL . 45.8 p-10 -121.61 20.04 11.1 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.533 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 28.5 p -61.4 158.93 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.922 1.289 . . . . 0.0 114.413 -176.203 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -82.42 -29.65 35.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.331 0.967 . . . . 0.0 113.661 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -71.55 153.7 41.98 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.253 1.027 . . . . 0.0 112.583 173.472 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.8 t -70.17 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 3.3 t -155.0 164.11 39.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.591 1.157 . . . . 0.0 111.249 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.17 149.22 42.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 -175.966 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 4.2 p90 -161.93 158.62 25.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.643 1.577 . . . . 0.0 113.004 179.66 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.04 168.3 11.29 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.258 1.409 . . . . 0.0 113.572 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.48 -30.14 36.35 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.429 2.753 . . . . 0.0 113.153 -171.46 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.45 -13.58 71.12 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.078 0.847 . . . . 0.0 114.527 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 66.6 mt -79.03 -11.94 60.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.935 1.367 . . . . 0.0 112.807 168.603 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 10.3 m -120.6 -38.53 2.86 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.839 1.656 . . . . 0.0 112.466 -165.605 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -154.83 156.99 37.21 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.74 1.616 . . . . 0.0 112.366 -172.009 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.14 -176.84 28.71 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.108 0.861 . . . . 0.0 114.074 172.068 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.5 t -141.22 133.3 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.172 1.389 . . . . 0.0 108.255 177.741 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.9 m -56.63 137.44 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.876 0.47 . . . . 0.0 111.958 179.634 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.03 -2.18 1.86 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.691 1.996 . . . . 0.0 114.713 178.076 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -106.81 142.06 24.19 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.451 1.5 . . . . 0.0 110.791 175.793 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.4 126.53 11.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.382 2.054 . . . . 0.0 110.81 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -103.23 145.37 30.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.345 1.458 . . . . 0.0 110.282 172.422 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.4 p -135.9 153.51 51.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -165.626 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -165.6 173.45 10.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.226 1.81 . . . . 0.0 111.629 177.476 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 38.2 m -128.96 140.63 51.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.508 1.523 . . . . 0.0 110.781 -171.733 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.5 t -110.52 136.32 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.908 1.683 . . . . 0.0 108.335 168.198 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.39 126.0 38.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.681 1.193 . . . . 0.0 110.769 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 74.7 p -133.45 -1.31 3.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.909 1.283 . . . . 0.0 114.148 -167.53 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -54.59 -38.74 67.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.225 1.41 . . . . 0.0 114.684 -169.437 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -114.33 9.7 16.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.733 1.613 . . . . 0.0 112.759 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.83 67.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.329 1.052 . . . . 0.0 113.479 -175.116 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.13 153.11 6.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.833 1.206 . . . . 0.0 112.291 -169.554 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -70.13 160.94 31.14 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.655 0.782 . . . . 0.0 112.913 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.38 15.86 0.07 OUTLIER Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -176.419 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.44 96.0 1.5 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.531 1.539 . . . . 0.0 112.574 177.899 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.59 125.49 29.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.786 1.235 . . . . 0.0 108.527 167.543 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -116.34 154.96 29.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.98 1.712 . . . . 0.0 111.853 -179.465 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 59.7 tp -162.16 133.37 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 109.698 -170.034 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.84 161.68 34.52 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.655 1.182 . . . . 0.0 111.912 -179.523 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -137.99 132.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.612 1.165 . . . . 0.0 110.114 175.756 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -112.07 134.04 53.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.844 1.657 . . . . 0.0 109.323 170.458 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -164.96 -168.52 27.24 Favored Glycine 0 CA--C 1.537 1.435 0 O-C-N 121.353 -0.842 . . . . 0.0 114.909 -175.973 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.77 -23.35 55.82 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.929 3.086 . . . . 0.0 112.467 176.155 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -141.03 157.75 44.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.433 1.493 . . . . 0.0 109.441 165.377 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -69.29 111.36 5.15 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.042 -1.036 . . . . 0.0 110.424 174.454 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.06 146.18 51.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.553 0.741 . . . . 0.0 111.299 172.972 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.62 136.51 32.96 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.341 0.656 . . . . 0.0 109.368 169.394 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.9 mt -131.0 138.83 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.572 1.149 . . . . 0.0 110.456 -167.368 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.8 m -133.75 152.89 52.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.442 1.497 . . . . 0.0 110.661 169.75 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.6 p -150.88 153.18 34.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.829 0.852 . . . . 0.0 112.96 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 84.8 m -139.84 120.37 14.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.649 1.58 . . . . 0.0 110.107 -171.22 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.5 133.21 37.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.664 1.186 . . . . 0.0 111.332 172.189 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -110.75 145.89 37.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.697 1.599 . . . . 0.0 111.635 -178.685 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -69.25 -14.22 62.84 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.766 0.826 . . . . 0.0 112.736 174.524 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.78 -8.26 54.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.597 1.559 . . . . 0.0 113.913 174.999 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.98 31.68 7.19 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.466 1.031 . . . . 0.0 114.288 177.573 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.4 p -137.19 159.59 41.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.16 1.384 . . . . 0.0 110.966 175.665 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 49.6 t -112.86 126.21 55.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 108.667 160.697 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -93.23 145.39 24.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.921 0.889 . . . . 0.0 110.307 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 78.9 t -127.33 143.72 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.171 1.388 . . . . 0.0 110.138 -177.657 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.6 p -134.58 146.45 49.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.007 1.323 . . . . 0.0 111.552 167.096 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 26.1 p90 -148.21 151.38 35.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.576 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.8 mt -112.73 106.77 55.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.037 1.735 . . . . 0.0 110.512 179.021 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.64 174.44 10.41 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.795 2.997 . . . . 0.0 110.224 165.022 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -149.57 -31.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.214 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.44 148.69 35.82 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.33 0.968 . . . . 0.0 110.628 167.042 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.47 157.42 56.41 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 110.761 171.668 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.0 -159.7 23.1 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.667 1.127 . . . . 0.0 112.604 -175.667 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.35 129.86 56.15 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.187 0.995 . . . . 0.0 111.94 -174.805 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -116.88 127.69 54.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.528 1.931 . . . . 0.0 110.099 -177.588 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.5 m -97.23 114.42 26.15 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.635 1.174 . . . . 0.0 110.961 178.686 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -88.61 125.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.251 1.82 . . . . 0.0 108.776 178.355 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -101.16 131.37 47.15 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.357 1.463 . . . . 0.0 109.721 173.231 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 49.1 t -130.64 128.76 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 110.037 172.069 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -153.88 141.52 19.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.476 1.51 . . . . 0.0 111.071 -169.137 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.83 121.26 18.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.551 1.14 . . . . 0.0 109.545 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.84 59.57 4.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.24 1.416 . . . . 0.0 112.294 178.191 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.9 pt-20 59.14 11.97 2.28 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.279 2.632 . . . . 0.0 116.43 -178.431 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.41 123.35 41.88 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.48 1.112 . . . . 0.0 111.172 178.142 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -64.21 146.88 53.55 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.393 -0.817 . . . . 0.0 112.114 172.243 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 12.2 m -77.63 156.02 80.78 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.828 172.804 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -54.67 130.76 42.02 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.427 2.751 . . . . 0.0 112.086 177.397 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 85.75 -10.8 63.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.571 1.081 . . . . 0.0 115.554 -179.736 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -72.81 139.32 80.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 119.439 1.62 . . . . 0.0 111.344 176.717 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.89 149.06 80.23 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 CA-C-N 119.676 0.92 . . . . 0.0 112.768 -2.291 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -104.68 126.63 51.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 110.702 -177.199 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.8 m -94.73 110.95 22.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.599 0.759 . . . . 0.0 111.295 -175.791 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.86 129.55 45.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.917 1.687 . . . . 0.0 111.692 177.985 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -94.72 117.53 30.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.417 0.687 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 79.8 t -98.56 133.86 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.148 1.779 . . . . 0.0 110.643 -174.652 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 57.4 p -99.08 145.95 26.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.17 39.25 3.12 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.065 1.793 . . . . 0.0 113.831 -175.162 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -70.3 -28.4 65.16 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -168.133 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.253 1.238 0 C-N-CA 125.035 1.334 . . . . 0.0 113.659 -178.993 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.525 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.3 159.96 32.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.469 1.107 . . . . 0.0 112.921 178.248 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 14.8 tpt -70.88 145.62 50.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.38 1.072 . . . . 0.0 111.91 176.969 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -69.42 147.49 96.95 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.426 1.09 . . . . 0.0 112.639 179.317 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.15 162.88 33.63 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.771 2.981 . . . . 0.0 111.982 178.293 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.18 88.72 6.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.163 0.985 . . . . 0.0 110.223 175.369 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -72.68 147.37 89.25 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.26 1.024 . . . . 0.0 112.293 -177.859 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.69 173.58 14.25 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.019 3.146 . . . . 0.0 111.786 176.762 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -70.34 22.75 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.487 1.915 . . . . 0.0 114.899 175.853 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 86.3 t -133.78 144.44 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.918 2.487 . . . . 0.0 108.521 -174.879 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -66.37 107.94 2.19 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.198 0.904 . . . . 0.0 112.658 -175.457 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 99.1 t -68.32 137.16 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.859 1.264 . . . . 0.0 110.06 179.219 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -155.37 171.85 19.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.308 1.443 . . . . 0.0 112.337 -171.2 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 97.09 -111.16 4.19 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 124.731 1.158 . . . . 0.0 111.037 -175.604 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 67.7 mt -68.4 159.41 31.61 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.221 1.008 . . . . 0.0 112.038 177.549 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 37.4 t0 -154.93 159.7 40.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.083 1.353 . . . . 0.0 112.11 -176.373 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 32.7 m -68.93 -8.44 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.421 1.488 . . . . 0.0 114.575 -170.696 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 11.5 t -63.51 -32.22 73.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.148 1.379 . . . . 0.0 112.827 174.86 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 6.6 t 77.41 124.1 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.518 2.327 . . . . 0.0 114.62 164.068 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 46.6 mt -104.04 148.62 26.02 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.137 1.775 . . . . 0.0 111.482 176.512 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -64.36 118.54 48.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.871 1.268 . . . . 0.0 111.504 -179.627 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.0 152.55 57.31 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.115 2.543 . . . . 0.0 110.865 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 16.2 t80 -107.8 125.66 51.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.937 0.895 . . . . 0.0 110.302 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.56 130.06 13.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.531 1.532 . . . . 0.0 110.001 173.568 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 131.18 21.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.236 1.414 . . . . 0.0 110.054 -169.577 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 58.0 t -95.73 138.05 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.105 1.362 . . . . 0.0 109.598 -179.773 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.75 135.01 26.69 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.652 1.581 . . . . 0.0 108.784 -179.002 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -79.8 37.76 0.69 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.22 3.28 . . . . 0.0 113.141 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -85.79 152.38 23.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.221 1.408 . . . . 0.0 111.458 178.196 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.9 m -116.23 119.25 35.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.846 1.258 . . . . 0.0 109.733 177.184 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.29 127.69 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.211 1.004 . . . . 0.0 109.953 175.29 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -112.99 -154.92 0.55 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.569 1.547 . . . . 0.0 110.622 172.74 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -70.07 124.46 24.13 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.594 -1.316 . . . . 0.0 111.353 172.569 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.85 -148.76 20.5 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.789 1.661 . . . . 0.0 111.772 -170.514 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.18 146.27 18.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.307 1.043 . . . . 0.0 111.68 -175.944 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.18 135.74 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.97 1.708 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 32.7 p -146.23 177.08 9.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.154 1.781 . . . . 0.0 110.572 -175.218 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.76 -172.63 29.39 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.779 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.21 138.79 19.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.441 1.496 . . . . 0.0 109.762 173.71 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 13.3 t -108.51 132.59 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.14 1.776 . . . . 0.0 108.088 172.768 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -117.77 122.89 44.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.9 1.28 . . . . 0.0 110.124 -177.943 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.4 mtt -95.92 152.3 38.9 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.66 1.584 . . . . 0.0 111.461 -172.915 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.83 -20.7 34.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.28 2.654 . . . . 0.0 113.601 -177.259 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 58.4 p -78.44 -4.63 49.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 114.171 174.193 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.32 -3.82 64.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.575 1.56 . . . . 0.0 114.56 -178.946 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.47 159.54 33.08 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 118.506 1.153 . . . . 0.0 112.199 173.994 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.6 m -136.89 154.71 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.156 1.382 . . . . 0.0 111.519 175.077 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.17 172.63 17.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.234 1.813 . . . . 0.0 111.121 -179.193 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -109.7 139.47 21.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.981 0.913 . . . . 0.0 111.172 178.37 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -82.18 165.6 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.861 3.041 . . . . 0.0 110.82 170.34 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 97.4 m -107.86 123.36 48.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.102 1.361 . . . . 0.0 108.659 172.511 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.85 130.58 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.297 1.039 . . . . 0.0 108.677 175.485 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 97.4 m -128.27 130.53 48.02 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.495 1.518 . . . . 0.0 109.816 -177.901 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -76.16 130.77 38.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.823 1.249 . . . . 0.0 112.05 174.619 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -87.91 -15.74 35.82 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.345 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.4 mttt 70.07 4.19 4.71 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.736 2.414 . . . . 0.0 114.391 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -100.86 12.17 38.12 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.622 1.969 . . . . 0.0 112.849 -179.291 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.55 16.82 61.32 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.731 1.158 . . . . 0.0 113.38 -171.413 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -136.87 166.47 23.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.851 2.06 . . . . 0.0 110.178 179.993 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.0 m -131.37 164.97 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.222 1.409 . . . . 0.0 110.326 172.031 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.9 t -123.15 148.94 45.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.351 1.06 . . . . 0.0 110.073 166.478 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 32.4 t -123.42 128.51 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.502 1.521 . . . . 0.0 108.737 178.666 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -129.12 155.41 45.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.747 1.619 . . . . 0.0 111.836 -170.637 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.2 t80 -159.88 135.81 8.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.833 1.253 . . . . 0.0 112.297 -177.606 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.58 117.37 68.56 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.82 1.248 . . . . 0.0 110.694 175.771 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.03 145.76 22.39 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.482 2.788 . . . . 0.0 111.694 -174.87 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.8 p -131.17 -4.83 3.88 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 172.554 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -141.75 153.98 44.95 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.109 1.764 . . . . 0.0 110.316 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.23 173.32 8.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 111.757 166.43 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 104.6 -171.49 19.32 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.23 1.395 . . . . 0.0 114.002 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.33 124.27 30.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.971 1.308 . . . . 0.0 110.112 -177.882 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.9 m80 -120.57 163.13 18.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.427 1.891 . . . . 0.0 111.382 -176.051 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.25 155.56 39.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.126 0.971 . . . . 0.0 111.169 173.354 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.8 tmm? -148.85 132.68 17.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.166 0.986 . . . . 0.0 111.547 -160.686 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -111.08 141.96 43.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.738 2.015 . . . . 0.0 111.295 -174.831 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -133.86 134.33 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.858 1.263 . . . . 0.0 111.004 175.921 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.3 139.0 37.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.498 1.119 . . . . 0.0 113.331 176.629 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -99.7 120.94 40.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.362 1.865 . . . . 0.0 109.527 172.506 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 49.26 39.88 16.83 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.936 1.294 . . . . 0.0 112.853 -176.083 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 7.8 t-20 82.27 -13.65 0.83 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.03 2.932 . . . . 0.0 114.696 179.43 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.3 tpp -90.98 128.61 36.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.522 1.129 . . . . 0.0 111.561 177.029 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -57.68 136.22 56.82 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.38 -0.825 . . . . 0.0 113.164 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.3 pt -76.82 153.91 83.14 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.594 178.019 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -61.5 124.53 14.84 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.885 1.723 . . . . 0.0 108.617 166.121 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.4 -11.22 47.15 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.572 1.082 . . . . 0.0 114.681 -172.873 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.9 t -85.94 143.79 38.17 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.351 1.575 . . . . 0.0 111.319 169.587 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -82.85 171.83 51.23 Favored 'Cis proline' 0 C--N 1.352 0.738 0 CA-C-N 120.075 1.062 . . . . 0.0 112.505 -6.32 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.2 mt -113.99 160.82 18.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.459 1.904 . . . . 0.0 111.159 171.346 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -150.4 138.73 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.189 1.396 . . . . 0.0 109.99 -171.687 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 15.9 p90 -164.46 167.25 19.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.444 1.097 . . . . 0.0 112.398 -165.264 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.5 t80 -122.55 136.09 54.8 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.129 -0.982 . . . . 0.0 112.129 176.947 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 42.2 t -111.84 142.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.398 1.479 . . . . 0.0 109.675 -178.934 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 28.5 t0 -151.59 163.01 40.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.898 1.279 . . . . 0.0 111.52 -177.553 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -74.96 125.6 29.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.227 . . . . 0.0 111.152 178.319 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 31.4 m -78.92 -18.55 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -167.545 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -89.35 -4.63 58.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.792 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.7 m -72.73 150.51 42.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.962 0.905 . . . . 0.0 112.498 176.576 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.73 -14.62 60.96 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.604 1.097 . . . . 0.0 115.118 -174.369 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -66.56 158.14 30.52 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.7 1.25 . . . . 0.0 113.93 179.131 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 141.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.454 1.102 . . . . 0.0 110.888 173.422 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -158.1 152.89 25.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.358 1.463 . . . . 0.0 110.273 178.655 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.81 142.83 51.32 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.999 1.319 . . . . 0.0 111.754 -177.706 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.3 p90 -167.08 160.88 14.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.582 1.553 . . . . 0.0 113.519 -175.937 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.83 170.27 12.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.408 1.48 . . . . 0.0 112.539 -177.54 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.08 -33.29 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 113.324 -168.651 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.81 -33.78 86.83 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.455 1.025 . . . . 0.0 114.506 -171.567 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 1.5 pp -78.43 -0.61 29.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.832 1.316 . . . . 0.0 113.631 177.45 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.5 m -113.63 -46.09 3.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.698 1.999 . . . . 0.0 111.366 176.696 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1877 ' ' HIS . . . . . 0.555 ' CE1' HH22 ' A' 1951 ' ' ARG . 3.7 t-80 -137.88 122.37 18.42 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.314 1.845 . . . . 0.0 111.426 -174.075 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.5 170.94 16.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.28 1.419 . . . . 0.0 112.786 170.655 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 98.2 t -138.8 137.14 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.899 1.28 . . . . 0.0 108.239 174.203 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.7 m -55.3 136.54 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.585 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 61.0 m-80 67.32 0.31 2.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.969 2.108 . . . . 0.0 114.685 177.509 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -104.87 139.91 20.56 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.019 1.328 . . . . 0.0 110.977 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.9 118.66 5.74 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.59 2.193 . . . . 0.0 110.167 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.03 134.8 42.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.29 1.436 . . . . 0.0 110.205 176.544 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -128.31 148.16 50.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -164.729 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.63 -179.85 7.97 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.948 1.699 . . . . 0.0 111.673 176.704 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 60.2 m -135.03 146.65 49.19 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.228 1.411 . . . . 0.0 110.936 -168.096 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -116.86 129.89 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.687 1.595 . . . . 0.0 108.262 168.456 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.51 126.43 38.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.963 . . . . 0.0 110.325 176.079 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 40.6 p -132.06 4.15 4.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.708 1.603 . . . . 0.0 113.634 -167.147 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 52.2 tttp -55.22 -32.45 62.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.051 1.74 . . . . 0.0 115.61 -164.464 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.33 17.53 6.52 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.603 1.561 . . . . 0.0 112.42 178.407 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.28 58.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -176.557 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 151.44 12.21 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.186 1.374 . . . . 0.0 112.861 -175.643 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -72.94 145.65 46.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.159 0.983 . . . . 0.0 112.307 -177.218 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.7 -158.66 26.89 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.689 1.614 . . . . 0.0 112.501 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -82.98 98.39 2.04 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 175.43 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.17 126.55 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.707 1.203 . . . . 0.0 108.853 171.928 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.4 m -129.68 155.27 46.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.012 1.325 . . . . 0.0 112.133 -177.806 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.0 tp -158.95 132.61 7.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.162 1.785 . . . . 0.0 108.583 -171.108 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.64 160.41 39.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.853 0.861 . . . . 0.0 112.238 -179.313 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 58.4 mt -135.08 132.34 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.519 1.128 . . . . 0.0 109.645 174.379 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -114.76 105.98 13.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.013 1.325 . . . . 0.0 109.052 172.655 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -116.9 -178.84 17.85 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.024 1.297 . . . . 0.0 113.92 -178.639 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.2 -20.42 37.48 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.909 3.073 . . . . 0.0 111.811 170.744 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.2 t -137.43 157.77 45.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.877 1.671 . . . . 0.0 109.055 161.253 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.59 119.0 13.17 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.993 -1.067 . . . . 0.0 111.773 -176.866 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -80.13 144.33 33.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.166 170.14 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.86 140.92 29.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.479 0.712 . . . . 0.0 109.656 168.363 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.2 mt -132.91 139.24 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.79 1.236 . . . . 0.0 110.467 -167.67 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -130.32 155.96 45.48 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.652 168.544 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -152.65 154.07 34.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.102 0.961 . . . . 0.0 112.373 175.604 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.8 m -142.25 125.57 16.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.599 1.56 . . . . 0.0 109.985 -172.528 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.91 141.35 37.68 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 112.244 172.758 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -117.24 152.0 35.74 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.703 1.601 . . . . 0.0 112.031 -175.803 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -69.43 -18.54 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.926 1.29 . . . . 0.0 112.96 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.68 -13.44 60.62 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.128 1.371 . . . . 0.0 114.083 -179.503 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.74 34.73 4.84 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.786 1.184 . . . . 0.0 113.674 -175.773 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.7 p -138.34 164.3 29.65 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.266 1.426 . . . . 0.0 110.841 177.968 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 80.6 m -120.09 131.18 54.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.717 1.607 . . . . 0.0 109.033 164.369 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.6 t -90.18 150.15 22.12 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.161 0.984 . . . . 0.0 110.686 171.112 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 93.6 t -129.43 144.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.521 1.928 . . . . 0.0 109.592 -178.43 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 139.12 35.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.411 1.484 . . . . 0.0 110.707 171.074 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -144.63 153.24 41.55 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.587 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.7 mt -115.51 105.79 51.53 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.802 1.641 . . . . 0.0 110.816 179.636 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.0 169.71 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.645 2.897 . . . . 0.0 110.235 165.456 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -136.99 -20.13 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.81 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.39 152.06 59.57 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.632 1.173 . . . . 0.0 110.675 174.007 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.18 147.74 38.24 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.893 2.395 . . . . 0.0 111.904 -172.871 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.03 -155.68 26.33 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.675 1.131 . . . . 0.0 113.059 -174.896 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.26 126.41 53.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.07 1.348 . . . . 0.0 111.149 179.612 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.8 125.71 53.06 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.311 1.844 . . . . 0.0 109.93 -176.624 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 54.6 m -88.0 122.08 31.18 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.975 -1.078 . . . . 0.0 110.933 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.22 128.23 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.292 1.437 . . . . 0.0 108.626 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -112.23 131.07 55.7 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.367 1.467 . . . . 0.0 109.542 175.965 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.55 130.11 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.304 1.042 . . . . 0.0 109.67 172.898 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.93 144.02 23.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.061 1.344 . . . . 0.0 111.721 -168.552 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.11 122.64 14.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.697 1.199 . . . . 0.0 110.555 -177.882 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 57.0 44.62 22.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.134 1.374 . . . . 0.0 112.199 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.261 0.6 OUTLIER 77.98 -12.87 1.02 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.177 2.991 . . . . 0.0 114.736 -179.107 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -98.43 125.6 43.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.75 1.22 . . . . 0.0 111.384 -176.814 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -63.07 143.76 57.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.384 -0.823 . . . . 0.0 111.912 171.585 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.5 m -68.0 152.35 96.49 Favored Pre-proline 0 N--CA 1.48 1.036 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.57 171.417 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 126.96 22.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.781 2.321 . . . . 0.0 110.595 179.387 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.58 -15.01 64.23 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.193 1.378 . . . . 0.0 115.323 -176.118 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.5 t -76.62 140.98 68.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.304 1.552 . . . . 0.0 111.628 176.552 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.53 140.29 65.88 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.418 0.828 . . . . 0.0 112.161 -3.723 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.05 173.23 7.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.615 1.966 . . . . 0.0 110.779 175.51 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -131.02 122.32 26.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.845 0.858 . . . . 0.0 110.933 174.159 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.05 137.99 34.32 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.57 1.548 . . . . 0.0 110.535 169.429 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1951 ' ' ARG . . . . . 0.555 HH22 ' CE1' ' A' 1877 ' ' HIS . 0.0 OUTLIER -93.81 138.5 31.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.596 0.759 . . . . 0.0 109.474 169.756 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 139.59 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.456 1.502 . . . . 0.0 110.861 -178.402 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 1.1 p -124.04 163.2 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.931 1.693 . . . . 0.0 112.433 179.521 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.87 148.55 33.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.107 1.337 . . . . 0.0 112.249 172.269 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.17 -23.73 57.79 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.949 0.9 . . . . 0.0 112.898 174.323 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.477 1.911 . . . . 0.0 112.864 178.321 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.706 -0.557 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -156.73 163.84 38.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.724 1.609 . . . . 0.0 111.76 -179.068 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 77.4 mtm -74.2 -21.43 59.82 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.315 1.046 . . . . 0.0 113.619 -179.536 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -160.75 160.04 25.36 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 126.36 1.864 . . . . 0.0 111.341 -179.457 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.92 153.8 48.64 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.9 3.067 . . . . 0.0 113.308 174.455 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.19 -7.71 55.06 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.27 1.428 . . . . 0.0 113.209 174.762 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -62.66 137.75 96.61 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.441 1.096 . . . . 0.0 111.83 -179.433 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.52 165.08 32.5 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.821 3.014 . . . . 0.0 111.736 174.792 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -70.24 -5.07 24.98 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -173.21 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 5.2 p -67.86 -16.99 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 125.359 1.464 . . . . 0.0 113.694 -176.504 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -77.12 52.65 3.36 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.905 1.717 . . . . 0.0 114.451 -175.477 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 33.3 m -69.06 150.69 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.218 1.407 . . . . 0.0 111.99 177.482 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -77.14 -16.06 59.3 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.734 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -173.24 169.51 42.63 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.559 1.552 . . . . 0.0 113.244 178.645 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.8 149.66 36.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.035 0.934 . . . . 0.0 111.684 178.723 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 35.7 t70 -75.07 -21.02 59.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.255 1.022 . . . . 0.0 112.74 174.915 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.0 p -163.22 150.25 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.657 1.983 . . . . 0.0 110.602 -175.016 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 12.8 t -167.65 -35.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.66 1.984 . . . . 0.0 111.067 -178.503 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 24.2 p -73.24 146.38 45.5 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.605 1.162 . . . . 0.0 113.044 169.923 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 11.3 mt -137.08 153.68 50.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.531 1.932 . . . . 0.0 109.891 178.094 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1789 ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' 1789 ' ' ARG . 18.1 ttm-85 -58.72 119.52 37.76 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.233 1.013 . . . . 0.0 111.041 177.671 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.42 159.76 48.48 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.158 2.572 . . . . 0.0 110.431 176.496 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.46 134.26 17.83 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.642 0.734 . . . . 0.0 112.324 -172.533 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -163.98 145.81 9.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.817 2.047 . . . . 0.0 110.724 178.055 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 161.28 36.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.599 1.959 . . . . 0.0 110.831 -170.609 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -134.07 139.37 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.184 1.393 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 43.8 mt -136.59 138.2 25.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.314 1.846 . . . . 0.0 108.302 -170.801 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.11 31.93 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.505 3.47 . . . . 0.0 113.993 -177.052 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 27.6 t80 -79.65 155.03 28.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.47 1.108 . . . . 0.0 111.027 173.113 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.85 126.17 35.52 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.048 1.339 . . . . 0.0 109.534 176.76 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.5 mt -76.42 126.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.572 0.749 . . . . 0.0 110.49 177.24 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 67.1 mttm -116.48 -139.7 0.37 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.724 1.61 . . . . 0.0 110.516 172.71 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.76 124.44 27.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.657 -1.277 . . . . 0.0 111.188 171.689 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.4 -151.31 19.68 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.862 1.696 . . . . 0.0 111.805 -169.872 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.84 150.48 17.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.913 1.285 . . . . 0.0 111.178 -176.448 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.0 tt -122.51 133.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.353 1.461 . . . . 0.0 111.888 179.77 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 77.3 p -149.22 -178.05 6.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.082 1.753 . . . . 0.0 110.38 177.704 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.48 -164.4 27.9 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.341 0.897 . . . . 0.0 115.341 -179.323 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -157.47 139.49 14.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.616 1.566 . . . . 0.0 109.954 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 43.7 t -105.87 133.63 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.771 1.628 . . . . 0.0 108.266 171.435 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -121.44 135.46 55.05 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.847 1.659 . . . . 0.0 111.052 -174.677 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.2 mpp? -112.9 157.39 40.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.754 1.622 . . . . 0.0 112.562 -172.412 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -55.0 -37.15 93.9 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.243 3.295 . . . . 0.0 114.538 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.0 m -71.86 -5.22 32.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.14 1.376 . . . . 0.0 114.463 -176.098 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -2.2 84.83 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.343 1.449 . . . . 0.0 113.711 -170.951 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -64.96 152.38 43.41 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.265 1.426 . . . . 0.0 111.719 172.175 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.7 155.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.24 1.416 . . . . 0.0 111.537 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.47 164.46 37.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.791 1.636 . . . . 0.0 111.336 -179.841 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -102.36 134.2 20.12 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.675 0.79 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.98 161.21 20.91 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.721 2.948 . . . . 0.0 110.88 169.912 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.0 m -108.81 125.75 52.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.071 1.348 . . . . 0.0 108.986 174.13 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.7 137.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.905 1.282 . . . . 0.0 109.679 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 56.5 m -139.3 126.57 21.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.197 1.399 . . . . 0.0 110.049 176.477 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.9 126.83 31.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 172.533 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.2 -6.37 57.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.527 1.131 . . . . 0.0 114.032 -174.331 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.3 mmtm 77.99 -7.95 1.74 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.917 2.887 . . . . 0.0 113.831 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -92.58 2.53 56.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.406 1.882 . . . . 0.0 113.295 175.866 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.5 25.79 13.14 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.757 1.17 . . . . 0.0 114.141 -177.921 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 61.8 p -134.16 155.93 49.22 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.17 1.788 . . . . 0.0 109.706 174.179 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -115.17 138.67 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.196 0.998 . . . . 0.0 110.056 167.397 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 40.5 m -98.29 141.83 30.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.008 1.323 . . . . 0.0 108.588 168.867 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.3 t -125.66 134.41 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.4 1.48 . . . . 0.0 109.462 179.6 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -131.96 153.94 49.81 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 112.289 -174.787 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.65 134.34 10.9 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.857 1.663 . . . . 0.0 111.674 -177.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.69 123.67 68.87 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.343 1.057 . . . . 0.0 110.442 175.303 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.47 131.4 12.6 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.076 2.517 . . . . 0.0 111.6 -173.534 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -132.03 15.73 4.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.738 1.215 . . . . 0.0 112.406 179.22 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.93 162.26 20.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.569 1.948 . . . . 0.0 109.958 -175.224 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -111.79 170.93 7.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.924 1.29 . . . . 0.0 112.6 174.329 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 93.66 -161.79 25.11 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.182 1.372 . . . . 0.0 113.547 179.281 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.7 tp -81.58 114.93 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.591 1.156 . . . . 0.0 110.759 -177.816 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 6.4 m80 -103.3 168.34 9.23 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.077 1.751 . . . . 0.0 110.903 177.478 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.16 148.97 29.59 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.491 -0.756 . . . . 0.0 112.02 168.033 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 16.3 ttm -120.99 132.82 55.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.034 2.134 . . . . 0.0 110.264 -173.821 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -100.07 137.9 37.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.637 1.575 . . . . 0.0 109.893 166.891 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -133.95 133.95 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.907 1.283 . . . . 0.0 109.733 171.814 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 138.07 31.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.548 1.139 . . . . 0.0 112.681 -174.069 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.9 t80 -107.74 123.8 49.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.305 1.842 . . . . 0.0 110.063 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.19 35.35 16.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.551 1.14 . . . . 0.0 112.531 -176.128 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.8 t30 80.12 -0.68 2.03 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.671 2.788 . . . . 0.0 114.827 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.33 130.69 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.289 1.436 . . . . 0.0 110.907 178.319 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -56.23 135.13 53.52 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.258 -0.901 . . . . 0.0 113.111 -179.5 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.4 pt -71.6 155.2 92.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.254 172.755 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.6 -25.43 79.23 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.304 2.003 . . . . 0.0 113.648 -176.006 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -79.32 -3.66 88.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.17 0.891 . . . . 0.0 114.72 173.731 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 25.6 t -97.39 144.17 27.45 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.467 1.633 . . . . 0.0 111.824 178.773 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.21 161.01 85.33 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.677 0.92 . . . . 0.0 112.198 -4.563 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.33 144.67 37.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 109.85 170.959 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -126.48 137.2 53.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 109.682 179.152 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.01 146.2 21.52 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.678 0.791 . . . . 0.0 112.438 -169.299 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.1 t80 -99.62 139.43 35.28 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.397 -0.814 . . . . 0.0 112.433 179.694 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 41.1 t -122.83 142.51 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.852 1.661 . . . . 0.0 108.948 179.158 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 9.8 t0 -151.59 173.01 15.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.433 1.093 . . . . 0.0 111.679 -173.52 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -87.44 123.42 32.34 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.918 1.287 . . . . 0.0 111.288 178.2 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 35.4 m -72.09 -21.8 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -170.585 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -90.95 -8.76 48.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.75 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 87.6 m -78.75 -24.35 44.83 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -172.501 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 81.25 -7.29 60.96 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.175 1.369 . . . . 0.0 116.442 168.109 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -67.48 163.75 20.31 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.108 1.454 . . . . 0.0 113.484 176.282 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.4 t -64.88 133.26 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.704 0.801 . . . . 0.0 110.002 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -163.61 154.12 15.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.214 1.406 . . . . 0.0 109.855 -168.241 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.11 145.24 37.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.545 1.138 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.9 p90 -169.64 169.4 8.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.559 1.543 . . . . 0.0 113.092 -173.006 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.75 172.39 13.72 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.6 1.572 . . . . 0.0 112.175 -174.124 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.26 -32.63 12.52 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.774 2.316 . . . . 0.0 113.216 -170.308 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.03 -31.15 74.63 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 119.373 0.988 . . . . 0.0 114.873 -170.601 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.32 -0.37 36.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.925 1.362 . . . . 0.0 113.208 175.36 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 89.7 m -113.52 -48.4 2.94 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.657 1.983 . . . . 0.0 110.82 -178.933 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -137.76 149.07 46.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.089 1.756 . . . . 0.0 112.36 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.38 177.24 23.1 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 124.359 0.98 . . . . 0.0 113.116 170.123 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.6 t -139.1 133.42 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.454 1.102 . . . . 0.0 108.437 176.016 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -56.41 135.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 118.021 0.373 . . . . 0.0 111.986 -178.979 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.5 m-80 70.26 -8.92 0.8 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.381 2.273 . . . . 0.0 114.859 179.384 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.4 mttm -96.47 141.88 23.74 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.485 1.114 . . . . 0.0 111.078 174.011 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.22 123.64 8.92 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.509 2.14 . . . . 0.0 110.353 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.77 144.6 30.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.443 1.497 . . . . 0.0 110.472 174.525 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.1 p -135.49 145.52 47.21 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -166.364 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.36 178.99 9.68 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.735 1.614 . . . . 0.0 111.306 175.719 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 26.7 m -134.99 144.05 47.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 110.644 -169.658 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.8 t -116.53 131.32 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.571 1.548 . . . . 0.0 108.179 169.726 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.0 m120 -93.77 131.41 39.16 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.159 0.984 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.8 p -137.79 4.03 2.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.348 1.459 . . . . 0.0 113.765 -166.551 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 84.0 tttt -55.06 -33.66 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.77 1.628 . . . . 0.0 115.04 -168.361 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.87 16.63 9.38 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.741 1.617 . . . . 0.0 112.564 178.972 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.55 -39.57 70.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.368 1.067 . . . . 0.0 113.842 -174.062 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.71 145.22 4.85 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.908 1.242 . . . . 0.0 112.352 -171.084 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.94 148.98 45.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 112.185 -178.019 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 173.93 -27.36 0.08 OUTLIER Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.471 1.034 . . . . 0.0 114.973 176.667 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 142.56 102.05 0.43 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.884 1.707 . . . . 0.0 112.988 172.067 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.44 130.79 35.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.0 109.568 175.071 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.5 m -129.79 160.59 32.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.756 1.622 . . . . 0.0 112.273 -178.129 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.4 tp -160.48 136.68 8.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.762 1.625 . . . . 0.0 109.522 -169.264 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.33 156.9 33.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.392 1.077 . . . . 0.0 112.023 176.251 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 37.2 mt -139.64 134.78 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.96 143.25 51.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.485 1.514 . . . . 0.0 110.223 176.381 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.63 -161.83 20.77 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-O 118.81 -0.994 . . . . 0.0 114.694 -175.561 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -62.26 -26.16 77.19 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.044 3.163 . . . . 0.0 112.646 176.44 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -140.21 153.2 46.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.75 1.22 . . . . 0.0 109.618 161.352 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -71.68 123.37 22.4 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.995 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.7 152.99 37.4 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.313 1.045 . . . . 0.0 112.905 -178.054 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.16 134.1 33.56 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 163.829 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.9 mt -134.39 138.92 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.577 1.151 . . . . 0.0 110.231 -166.466 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 64.7 m -139.0 162.01 35.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.584 1.553 . . . . 0.0 111.247 172.592 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -155.27 156.47 35.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.378 1.071 . . . . 0.0 112.71 178.502 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.5 m -139.45 129.83 25.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.907 1.683 . . . . 0.0 110.248 -172.282 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -80.73 132.42 35.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.356 1.062 . . . . 0.0 111.264 174.141 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -110.13 148.62 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.077 1.351 . . . . 0.0 112.08 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -68.32 -21.3 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.507 1.123 . . . . 0.0 112.735 178.103 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.14 -6.83 48.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.556 1.543 . . . . 0.0 114.342 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.6 39.87 4.87 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.538 1.065 . . . . 0.0 113.266 -179.255 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.0 p -141.13 158.68 43.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.011 1.324 . . . . 0.0 111.304 177.23 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 63.9 m -107.22 125.19 50.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.391 1.476 . . . . 0.0 108.434 161.455 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.8 t -86.52 149.03 25.25 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.484 0.714 . . . . 0.0 110.393 167.704 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.4 t -130.31 142.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.842 1.657 . . . . 0.0 109.736 -177.54 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 84.1 p -136.12 147.22 47.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.849 1.26 . . . . 0.0 111.802 168.192 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.86 153.89 35.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.495 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.78 105.87 50.89 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.084 1.754 . . . . 0.0 110.282 179.333 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.83 173.79 11.7 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.618 2.879 . . . . 0.0 110.131 165.003 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.8 p -149.69 -29.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -172.814 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.54 144.83 30.32 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.402 1.001 . . . . 0.0 110.213 166.806 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.63 157.64 44.15 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.92 2.413 . . . . 0.0 111.013 177.303 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.32 -162.9 23.68 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.987 1.28 . . . . 0.0 113.204 -176.283 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.79 139.97 30.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.728 1.211 . . . . 0.0 112.844 179.739 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.49 131.67 50.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.757 1.623 . . . . 0.0 110.322 178.008 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.7 m -90.47 125.76 35.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.209 1.004 . . . . 0.0 110.684 174.757 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.99 120.91 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.735 1.614 . . . . 0.0 108.482 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -104.93 128.85 53.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.535 1.534 . . . . 0.0 109.808 178.709 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 58.2 t -130.92 128.52 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.574 1.15 . . . . 0.0 109.848 173.695 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.1 142.3 24.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.109 1.364 . . . . 0.0 111.666 -168.975 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.12 120.21 14.6 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.8 1.24 . . . . 0.0 109.679 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.1 t-20 54.93 58.98 4.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.602 1.561 . . . . 0.0 111.979 179.174 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 9.0 pt-20 57.11 13.56 1.65 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.418 2.687 . . . . 0.0 116.422 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -119.59 122.41 41.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.896 1.279 . . . . 0.0 110.671 177.655 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -63.94 142.69 58.31 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.618 0.767 . . . . 0.0 111.488 170.752 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.0 m -72.62 156.85 89.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.764 175.025 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.81 129.6 35.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.301 2.667 . . . . 0.0 111.963 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 86.27 -13.02 58.96 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.697 1.141 . . . . 0.0 115.142 -177.397 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.7 t -76.0 140.27 70.06 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.527 1.663 . . . . 0.0 111.491 176.121 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.48 136.02 43.04 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 -3.568 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -83.92 169.98 14.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.778 1.631 . . . . 0.0 110.532 173.889 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 28.4 m -131.12 116.73 18.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.552 0.741 . . . . 0.0 110.694 177.264 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.02 155.02 18.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.736 1.214 . . . . 0.0 111.082 169.279 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -116.48 125.64 52.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.291 1.037 . . . . 0.0 110.062 170.297 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 92.2 t -107.65 130.99 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.41 . . . . 0.0 110.526 -174.616 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.1 p -108.06 171.24 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.288 1.435 . . . . 0.0 112.739 178.921 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.59 154.62 44.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.372 1.463 . . . . 0.0 113.67 -178.576 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.28 -23.86 54.41 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.02 1.328 . . . . 0.0 113.241 179.035 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 125.809 1.644 . . . . 0.0 114.095 -179.678 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 6.1 mt . . . . . 0 N--CA 1.468 0.472 0 CA-C-O 121.301 0.572 . . . . 0.0 111.948 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -67.85 128.69 93.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.055 0.942 . . . . 0.0 110.578 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.0 167.69 25.6 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.522 2.815 . . . . 0.0 112.822 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -104.88 121.39 43.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 108.621 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -146.73 126.01 13.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.676 1.19 . . . . 0.0 110.299 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.26 159.63 41.84 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.433 1.893 . . . . 0.0 110.09 -170.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -133.11 139.49 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.116 1.366 . . . . 0.0 110.315 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.6 mt -133.48 135.2 24.77 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 109.118 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.96 109.67 2.74 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.364 2.709 . . . . 0.0 109.765 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 47.1 t80 -175.7 151.93 1.22 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.344 2.258 . . . . 0.0 108.956 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 41.5 m -134.67 125.89 28.0 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 110.576 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 37.5 mt -82.97 134.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.862 1.265 . . . . 0.0 109.389 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -131.77 -60.22 0.93 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 0.0 111.564 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.4 tptt -152.27 127.5 9.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.552 1.541 . . . . 0.0 110.388 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.95 -149.95 17.82 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.288 1.423 . . . . 0.0 111.648 -167.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.09 146.14 18.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.565 1.146 . . . . 0.0 111.089 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.5 tt -126.89 136.04 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.776 1.631 . . . . 0.0 111.043 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.9 p -148.58 173.16 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.398 1.879 . . . . 0.0 110.252 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.82 -170.69 24.71 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.65 137.96 15.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.593 1.557 . . . . 0.0 109.716 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 20.9 t -113.6 135.01 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 108.195 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -119.41 132.42 55.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.632 1.173 . . . . 0.0 111.457 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.08 142.52 25.21 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.842 1.657 . . . . 0.0 111.694 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.23 -32.96 82.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.149 3.232 . . . . 0.0 114.407 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -72.32 2.83 5.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.908 1.283 . . . . 0.0 114.34 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.35 4.75 65.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.634 1.588 . . . . 0.0 114.599 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.7 164.29 16.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.225 1.41 . . . . 0.0 111.91 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.4 m -137.91 152.83 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.603 1.561 . . . . 0.0 110.889 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.01 163.21 36.6 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.319 1.448 . . . . 0.0 111.624 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -105.97 139.17 19.98 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.169 0.988 . . . . 0.0 111.128 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.63 170.1 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.227 3.284 . . . . 0.0 111.771 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.7 m -109.5 135.71 50.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.41 1.484 . . . . 0.0 108.964 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.62 135.66 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.975 1.31 . . . . 0.0 109.252 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 53.0 m -137.98 127.3 24.63 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.323 1.449 . . . . 0.0 109.971 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -80.27 129.98 34.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.001 0.92 . . . . 0.0 111.154 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.7 -8.77 58.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 37.3 mtmm 63.97 14.3 8.33 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.532 2.333 . . . . 0.0 113.805 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.46 8.38 21.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.221 2.209 . . . . 0.0 112.503 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 12.52 57.07 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.22 1.39 . . . . 0.0 114.4 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.0 p -131.32 155.42 47.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.035 1.734 . . . . 0.0 111.202 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.3 m -112.99 139.47 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.058 0.943 . . . . 0.0 109.869 163.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 49.5 m -96.62 139.5 32.61 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.002 1.321 . . . . 0.0 108.523 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.6 t -124.92 134.82 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.475 1.51 . . . . 0.0 109.241 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -136.17 153.58 51.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 112.504 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.92 136.56 16.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.787 1.635 . . . . 0.0 111.576 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.63 123.46 70.86 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.643 1.177 . . . . 0.0 110.724 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.81 160.2 18.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.942 3.095 . . . . 0.0 112.574 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.9 p -152.34 -9.56 0.19 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.73 149.47 45.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.852 1.661 . . . . 0.0 110.075 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -91.6 166.25 12.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.176 0.991 . . . . 0.0 111.969 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.76 -171.06 13.8 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.148 1.356 . . . . 0.0 113.795 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.54 121.41 30.89 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.723 1.209 . . . . 0.0 109.825 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 70.2 m80 -119.85 165.32 14.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.134 1.774 . . . . 0.0 111.833 -172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.78 154.11 37.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.965 0.906 . . . . 0.0 111.975 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.3 ttm -134.94 127.4 30.52 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.904 2.082 . . . . 0.0 109.986 -168.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -97.4 135.6 39.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.617 1.567 . . . . 0.0 109.975 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.5 mm -132.95 130.55 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.932 1.293 . . . . 0.0 109.769 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.04 138.72 32.0 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.2 t80 -101.85 119.36 38.66 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 109.323 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.17 32.75 11.1 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.916 1.286 . . . . 0.0 112.903 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.5 m-80 74.95 7.22 4.28 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.957 2.503 . . . . 0.0 115.266 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.1 tpp -100.01 129.48 46.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.585 1.154 . . . . 0.0 110.573 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.79 136.7 56.97 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.373 -0.829 . . . . 0.0 113.067 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.7 pt -75.63 155.65 85.24 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.555 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -58.97 129.48 32.14 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.059 1.839 . . . . 0.0 109.485 169.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.06 62.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.499 1.047 . . . . 0.0 114.124 -174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -82.27 143.81 49.2 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.722 1.761 . . . . 0.0 111.209 171.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.0 155.68 91.58 Favored 'Cis proline' 0 C--N 1.351 0.684 0 CA-C-N 119.944 1.016 . . . . 0.0 112.117 -5.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.91 153.43 18.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.553 1.141 . . . . 0.0 110.548 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -150.0 135.07 17.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.693 1.197 . . . . 0.0 109.789 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.17 169.92 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.735 1.214 . . . . 0.0 112.324 -170.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 29.6 t80 -104.19 147.61 27.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.272 -0.892 . . . . 0.0 112.309 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 85.3 t -117.69 133.58 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.295 1.838 . . . . 0.0 108.893 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -151.1 163.04 39.71 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -169.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -80.0 87.63 5.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.226 1.411 . . . . 0.0 111.105 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 10.7 p -54.53 -27.59 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.242 1.417 . . . . 0.0 114.506 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -77.82 -16.99 57.91 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -75.9 161.97 28.52 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.749 1.219 . . . . 0.0 112.438 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.44 -9.82 78.39 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.9 1.238 . . . . 0.0 115.778 -169.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -66.63 147.72 52.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.169 1.485 . . . . 0.0 113.165 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 p -64.47 134.58 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.774 -0.579 . . . . 0.0 109.709 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.1 t -156.2 160.9 40.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.508 1.123 . . . . 0.0 111.057 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.93 142.92 33.04 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.06 161.05 19.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.526 1.531 . . . . 0.0 112.922 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 136.87 175.03 13.57 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.392 1.472 . . . . 0.0 113.046 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.31 -36.95 8.49 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.723 2.282 . . . . 0.0 112.944 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.18 -34.64 90.17 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.439 1.018 . . . . 0.0 114.608 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.59 -6.18 54.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.653 1.227 . . . . 0.0 113.561 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.0 m -104.7 -43.78 5.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.403 1.881 . . . . 0.0 111.166 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -147.31 142.76 27.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.582 1.953 . . . . 0.0 111.916 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -134.21 173.66 21.26 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.349 0.976 . . . . 0.0 113.052 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 28.0 t -138.69 133.3 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.348 1.059 . . . . 0.0 108.575 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.5 m -57.15 133.77 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.165 0.586 . . . . 0.0 112.442 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 23.1 m120 69.61 0.16 2.86 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.872 2.069 . . . . 0.0 114.192 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -103.14 138.66 19.61 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.212 1.405 . . . . 0.0 110.541 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.24 112.64 3.48 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.604 2.203 . . . . 0.0 109.866 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -96.39 133.1 41.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.132 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.7 p -127.04 153.63 45.7 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . 0.405 ' CZ ' HG11 ' A' 1922 ' ' VAL . 54.4 p90 -162.83 176.23 10.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.989 1.716 . . . . 0.0 111.415 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.7 m -126.82 142.63 51.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.24 1.416 . . . . 0.0 110.493 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.8 t -114.31 126.58 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 107.801 167.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -93.55 120.18 33.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.923 0.889 . . . . 0.0 110.378 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 20.2 p -119.76 15.45 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.97 2.108 . . . . 0.0 112.096 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -58.45 -30.97 67.36 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.029 1.732 . . . . 0.0 114.726 -164.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -131.69 20.28 4.66 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.993 1.717 . . . . 0.0 112.101 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -81.06 -9.5 59.82 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 90.98 -125.56 8.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.39 0.995 . . . . 0.0 112.623 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -154.03 151.5 29.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.335 1.454 . . . . 0.0 111.26 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 154.55 -156.21 26.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.821 1.677 . . . . 0.0 112.521 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.2 107.81 3.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.091 0.853 . . . . 0.0 111.218 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.54 126.53 32.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.884 1.274 . . . . 0.0 108.502 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -130.66 158.1 40.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.905 1.282 . . . . 0.0 112.607 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.6 tp -157.49 135.43 10.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.407 1.883 . . . . 0.0 108.728 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.63 161.39 39.9 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.949 0.9 . . . . 0.0 112.203 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.3 mt -134.87 135.65 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.589 1.156 . . . . 0.0 109.563 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.83 113.51 20.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.037 1.335 . . . . 0.0 109.316 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -129.44 -173.91 13.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.99 1.281 . . . . 0.0 113.912 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.97 -18.57 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.003 3.135 . . . . 0.0 112.32 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -142.57 157.32 44.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.772 1.629 . . . . 0.0 109.339 165.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . 0.432 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 1.0 OUTLIER -73.3 107.84 5.84 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.111 -0.993 . . . . 0.0 111.729 -175.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.49 145.81 48.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.867 0.867 . . . . 0.0 111.165 167.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.48 145.8 24.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.484 0.713 . . . . 0.0 110.457 168.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.0 mt -134.9 140.8 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.934 1.293 . . . . 0.0 110.316 -165.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 59.6 m -133.42 155.93 48.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.818 1.647 . . . . 0.0 110.713 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.4 p -153.23 153.97 33.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.482 1.113 . . . . 0.0 112.125 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.4 m -143.76 126.32 15.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.831 1.252 . . . . 0.0 110.748 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.66 131.17 39.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.968 1.307 . . . . 0.0 111.396 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -103.97 151.8 22.76 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.668 1.587 . . . . 0.0 111.852 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -68.18 -16.21 63.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.887 0.875 . . . . 0.0 113.184 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.22 -12.45 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 113.518 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.72 19.2 35.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.676 1.132 . . . . 0.0 114.139 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 80.4 p -114.2 165.36 12.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.958 1.703 . . . . 0.0 110.749 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.8 m -115.26 129.0 56.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.169 1.387 . . . . 0.0 109.916 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.1 t -87.0 151.7 23.04 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.842 0.857 . . . . 0.0 110.65 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' 1886 ' ' PHE . 89.6 t -132.21 144.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.136 1.774 . . . . 0.0 110.026 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.6 t -141.81 141.69 33.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.641 1.577 . . . . 0.0 110.924 171.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.2 p90 -147.19 155.0 41.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.1 mt -119.72 104.31 44.9 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.569 1.547 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.01 167.46 18.08 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.632 2.888 . . . . 0.0 110.36 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.4 p -132.29 -18.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -170.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.51 150.18 50.14 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.61 1.164 . . . . 0.0 110.404 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.29 142.57 27.17 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 111.552 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 158.61 -167.55 34.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.66 1.124 . . . . 0.0 113.331 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.33 126.8 40.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.215 1.406 . . . . 0.0 112.111 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -120.62 124.28 44.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.801 1.64 . . . . 0.0 109.922 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.9 m -87.64 121.08 29.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.116 -0.99 . . . . 0.0 110.851 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.51 127.88 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 108.522 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.46 130.54 55.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 38.2 t -133.22 130.56 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.289 1.036 . . . . 0.0 109.804 172.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.83 144.45 24.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 -167.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.08 124.76 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.892 1.277 . . . . 0.0 110.165 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 56.02 53.49 9.08 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.867 1.267 . . . . 0.0 111.676 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.94 3.42 0.32 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.988 2.915 . . . . 0.0 116.75 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -107.49 126.55 52.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.758 1.223 . . . . 0.0 110.718 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -63.89 147.29 52.28 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.238 -0.914 . . . . 0.0 111.949 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 9.9 m -68.85 152.84 96.57 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.672 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.99 130.29 30.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.165 1.91 . . . . 0.0 110.527 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.94 -15.93 61.63 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.005 1.288 . . . . 0.0 114.919 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.8 t -77.67 140.85 63.97 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 119.282 1.541 . . . . 0.0 111.465 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.72 137.87 52.75 Favored 'Cis proline' 0 C--N 1.352 0.727 0 CA-C-N 119.337 0.799 . . . . 0.0 112.077 -3.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -89.63 169.86 10.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.203 1.801 . . . . 0.0 110.555 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.6 m -129.12 115.95 18.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.698 0.799 . . . . 0.0 110.781 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.27 144.93 25.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.872 1.269 . . . . 0.0 110.656 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 17.8 ttt85 -108.82 121.52 45.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.832 0.853 . . . . 0.0 110.035 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.1 t -102.44 134.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.179 1.392 . . . . 0.0 110.648 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 48.4 p -114.88 169.64 8.93 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.252 1.421 . . . . 0.0 112.939 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.3 140.16 22.58 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.027 1.298 . . . . 0.0 112.612 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 CA--C 1.547 0.863 0 C-N-CA 124.38 1.072 . . . . 0.0 112.855 174.414 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 78.1 mt . . . . . 0 CA--C 1.538 0.514 0 CA-C-O 120.987 0.422 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -58.39 118.1 25.27 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.97 1.308 . . . . 0.0 110.991 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.08 152.68 45.99 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.024 2.483 . . . . 0.0 111.037 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.26 113.94 27.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.804 0.842 . . . . 0.0 109.71 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -146.81 125.23 12.34 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 109.99 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.16 153.48 50.45 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.482 1.913 . . . . 0.0 109.891 -173.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.8 p -129.2 136.77 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.029 1.332 . . . . 0.0 110.351 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.01 138.72 33.03 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.001 1.72 . . . . 0.0 109.074 -175.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.87 67.7 7.93 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 124.353 3.369 . . . . 0.0 111.698 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -113.82 150.73 33.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.146 1.778 . . . . 0.0 110.231 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 77.7 m -119.08 125.41 49.24 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.596 1.158 . . . . 0.0 109.751 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 81.1 mt -91.46 132.08 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.755 1.222 . . . . 0.0 109.876 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -114.35 -100.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.18 1.392 . . . . 0.0 110.746 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.4 mttp -133.69 139.35 46.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 111.089 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.4 -139.81 11.2 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.719 1.628 . . . . 0.0 110.801 -165.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.53 141.61 16.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.118 0.967 . . . . 0.0 111.36 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.68 135.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 0.0 110.711 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.3 p -145.77 174.58 11.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.112 1.765 . . . . 0.0 110.206 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.44 -170.96 24.64 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.3 140.14 16.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.843 1.657 . . . . 0.0 109.305 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.1 t -117.72 130.74 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.546 1.539 . . . . 0.0 108.343 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -117.99 128.36 54.71 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.001 1.32 . . . . 0.0 110.389 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 32.4 mtt -99.76 153.32 37.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.198 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -17.87 31.83 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.431 2.754 . . . . 0.0 112.831 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 35.3 p -72.76 -8.06 53.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.0 113.973 170.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.51 83.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.721 1.629 . . . . 0.0 113.777 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -72.52 159.54 33.76 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.599 1.16 . . . . 0.0 112.536 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 46.9 t -139.34 142.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.517 1.527 . . . . 0.0 110.169 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.88 171.15 16.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.885 1.674 . . . . 0.0 111.772 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -106.61 140.39 21.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.34 1.056 . . . . 0.0 111.264 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -86.65 174.0 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.549 3.499 . . . . 0.0 111.94 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 60.3 m -113.46 131.76 55.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.394 1.478 . . . . 0.0 108.982 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.01 133.31 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.839 1.256 . . . . 0.0 109.154 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 92.9 m -123.51 129.04 50.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.152 1.781 . . . . 0.0 109.789 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 59.5 t0 -81.78 118.61 23.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.309 1.044 . . . . 0.0 110.127 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -83.01 -10.54 58.71 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.8 mmmt 73.5 -10.44 1.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.269 2.628 . . . . 0.0 114.331 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -92.75 5.61 50.52 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.495 1.918 . . . . 0.0 113.691 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.89 15.82 53.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.802 1.191 . . . . 0.0 113.716 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 67.3 p -128.26 159.29 35.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.364 1.866 . . . . 0.0 110.286 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -121.79 143.01 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.494 1.118 . . . . 0.0 109.875 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 31.8 m -104.09 137.23 42.34 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.396 1.078 . . . . 0.0 108.618 170.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.3 t -124.92 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.184 1.394 . . . . 0.0 109.042 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -133.76 156.45 47.97 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.138 1.375 . . . . 0.0 112.826 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 22.9 t80 -155.61 135.76 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.828 1.651 . . . . 0.0 111.427 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.37 120.05 71.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.411 1.084 . . . . 0.0 110.776 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.33 139.99 21.49 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.349 2.699 . . . . 0.0 112.01 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.2 m -132.92 0.3 3.48 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -161.4 150.46 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.296 1.838 . . . . 0.0 109.686 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -86.09 173.06 10.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.857 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.09 -172.68 21.73 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.262 1.41 . . . . 0.0 114.098 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -78.0 125.84 29.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.618 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 51.2 m80 -123.09 163.05 21.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.075 1.75 . . . . 0.0 111.372 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.22 153.1 34.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.157 0.983 . . . . 0.0 111.862 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 28.0 ttm -137.36 135.25 36.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.956 1.702 . . . . 0.0 110.771 -167.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.11 134.3 51.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.443 1.897 . . . . 0.0 109.848 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.6 mm -133.97 130.59 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.171 1.388 . . . . 0.0 109.53 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 136.5 23.4 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -173.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.67 122.68 43.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.641 1.976 . . . . 0.0 109.784 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 51.82 31.28 8.03 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.876 1.27 . . . . 0.0 112.881 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 18.1 t30 77.62 5.09 3.01 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.279 2.631 . . . . 0.0 115.108 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 95.9 mtp -100.07 129.36 46.11 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.31 1.444 . . . . 0.0 110.772 170.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -56.77 137.15 55.05 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.6 pt -74.55 151.14 87.18 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.861 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.04 132.34 44.11 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.672 2.248 . . . . 0.0 110.243 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.91 -17.15 59.83 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.733 1.159 . . . . 0.0 113.905 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.9 t -85.53 147.77 47.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 119.164 1.482 . . . . 0.0 110.905 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.44 157.43 99.47 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.666 1.274 . . . . 0.0 113.251 -0.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 80.1 mt -101.38 157.87 16.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.67 1.588 . . . . 0.0 110.884 173.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -151.93 135.26 15.96 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.839 1.256 . . . . 0.0 110.154 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.2 p90 -165.51 167.2 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 111.98 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -108.52 141.09 40.93 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.126 -0.984 . . . . 0.0 112.928 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.9 t -111.56 139.93 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.815 1.646 . . . . 0.0 109.679 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -161.42 151.77 17.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.9 1.28 . . . . 0.0 112.22 -170.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -67.53 134.15 50.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.932 1.293 . . . . 0.0 112.152 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -68.41 -27.37 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.113 -0.992 . . . . 0.0 113.289 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.89 -21.33 44.11 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -170.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.6 t -67.22 147.03 53.57 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.484 -0.76 . . . . 0.0 112.964 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.9 -6.77 82.0 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.145 1.355 . . . . 0.0 115.103 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.29 166.85 11.36 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.09 1.445 . . . . 0.0 114.0 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.8 t -73.19 144.73 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.978 0.911 . . . . 0.0 108.832 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.0 t -159.74 148.25 17.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.03 1.332 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.61 144.83 50.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.62 1.168 . . . . 0.0 111.658 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.7 p90 -166.73 161.65 15.73 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.615 1.566 . . . . 0.0 112.745 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.02 175.36 13.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.324 1.44 . . . . 0.0 112.897 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 -36.48 9.66 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.721 2.28 . . . . 0.0 112.832 -171.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.96 90.75 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.378 0.99 . . . . 0.0 114.406 -171.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -78.77 -5.64 53.84 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.829 1.314 . . . . 0.0 113.615 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 32.3 m -104.89 -42.1 5.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.409 1.884 . . . . 0.0 111.25 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -151.14 143.39 24.11 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.772 2.029 . . . . 0.0 112.054 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -136.09 177.56 19.45 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.822 1.201 . . . . 0.0 113.212 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 25.5 t -142.96 135.19 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.905 1.282 . . . . 0.0 108.378 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.94 135.33 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 66.34 2.81 2.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.604 1.962 . . . . 0.0 114.382 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -100.01 142.3 24.36 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.907 1.283 . . . . 0.0 110.807 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.37 109.13 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.777 2.318 . . . . 0.0 109.853 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -93.6 133.0 37.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.003 1.321 . . . . 0.0 110.134 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.8 p -127.35 149.01 50.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -159.51 174.79 14.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.754 1.621 . . . . 0.0 111.664 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.8 m -126.51 145.14 50.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.347 1.459 . . . . 0.0 110.721 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 29.9 t -114.76 130.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.476 1.511 . . . . 0.0 108.128 167.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.02 132.77 36.29 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.226 1.011 . . . . 0.0 111.051 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.5 p -131.91 13.67 4.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.787 2.035 . . . . 0.0 112.449 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -50.61 -36.2 33.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.258 2.223 . . . . 0.0 115.268 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.27 24.83 3.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.647 1.579 . . . . 0.0 111.858 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.05 69.03 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.461 1.105 . . . . 0.0 113.619 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.66 150.74 5.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.827 1.203 . . . . 0.0 112.337 -169.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -73.82 149.27 41.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.744 0.783 . . . . 0.0 112.024 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.74 14.42 0.02 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.881 1.705 . . . . 0.0 114.905 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 92.85 100.63 1.46 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.535 1.541 . . . . 0.0 112.806 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.49 130.7 35.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.366 1.466 . . . . 0.0 109.415 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.3 m -126.96 158.4 36.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.64 1.576 . . . . 0.0 112.123 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.7 tp -160.72 135.45 7.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.788 1.635 . . . . 0.0 109.23 -169.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 161.57 38.1 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.043 0.937 . . . . 0.0 112.321 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -135.53 134.58 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.762 1.225 . . . . 0.0 109.547 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -116.73 115.7 26.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.001 1.32 . . . . 0.0 109.326 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -128.37 -177.64 14.97 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.978 1.275 . . . . 0.0 113.873 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.54 -22.65 44.32 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.001 3.134 . . . . 0.0 112.128 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -140.28 158.06 44.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.57 . . . . 0.0 109.069 161.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 118.51 11.98 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.093 -1.005 . . . . 0.0 111.915 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.09 142.63 33.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.207 1.003 . . . . 0.0 110.824 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.05 142.0 28.24 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.322 0.649 . . . . 0.0 110.082 171.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.8 mt -132.06 139.21 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.822 1.249 . . . . 0.0 110.471 -167.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.8 m -128.38 155.56 44.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.861 1.664 . . . . 0.0 110.393 167.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -151.46 156.23 40.19 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.156 0.982 . . . . 0.0 112.237 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.7 m -140.49 118.62 11.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.341 1.456 . . . . 0.0 109.697 -171.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.31 123.71 25.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.169 0.988 . . . . 0.0 110.779 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.55 -17.91 26.18 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 15.0 mm100 71.27 -10.34 0.8 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.344 2.658 . . . . 0.0 114.495 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.69 -14.04 61.48 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.313 1.445 . . . . 0.0 113.104 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 116.81 22.03 4.43 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.509 1.528 . . . . 0.0 114.17 -170.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.0 p -142.38 158.5 43.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.676 1.59 . . . . 0.0 111.111 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -126.23 135.45 51.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.632 1.973 . . . . 0.0 109.068 166.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 16.4 t -94.83 153.29 17.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.459 1.104 . . . . 0.0 111.343 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -132.11 145.03 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.316 1.846 . . . . 0.0 110.0 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.2 t -140.63 138.85 34.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.694 1.598 . . . . 0.0 110.752 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.99 154.5 42.62 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 26.4 mt -118.07 102.62 50.75 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.097 1.759 . . . . 0.0 110.415 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.68 160.67 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.546 2.83 . . . . 0.0 110.139 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.9 m -127.15 -7.77 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.72 151.18 22.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.176 1.39 . . . . 0.0 110.402 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.07 140.77 25.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.796 2.331 . . . . 0.0 111.691 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 157.8 -169.86 34.66 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.86 1.219 . . . . 0.0 113.087 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.82 135.3 35.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.889 1.276 . . . . 0.0 112.135 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.56 128.69 46.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.288 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.0 m -90.51 122.58 33.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.18 -0.95 . . . . 0.0 110.963 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.53 125.69 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.356 1.462 . . . . 0.0 108.621 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.09 130.42 55.48 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.424 1.49 . . . . 0.0 109.71 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 39.2 t -133.25 129.96 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.349 1.06 . . . . 0.0 109.753 172.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.48 142.26 22.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.145 1.378 . . . . 0.0 111.511 -168.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.5 122.17 19.75 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.817 1.247 . . . . 0.0 109.523 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.5 57.89 5.71 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.038 1.335 . . . . 0.0 112.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 8.2 pt-20 59.7 2.42 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.965 2.906 . . . . 0.0 116.819 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -107.5 123.54 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.567 1.147 . . . . 0.0 110.998 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.88 145.41 55.87 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.306 -0.871 . . . . 0.0 111.984 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.4 m -73.39 157.37 88.08 Favored Pre-proline 0 N--CA 1.48 1.065 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.64 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.04 125.82 20.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.63 2.887 . . . . 0.0 111.785 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.24 -11.36 67.84 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.705 1.145 . . . . 0.0 115.469 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.3 t -76.44 139.73 67.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.356 1.578 . . . . 0.0 111.579 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.07 136.84 47.06 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 CA-C-N 119.382 0.815 . . . . 0.0 111.969 -3.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -87.07 170.25 11.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.134 1.774 . . . . 0.0 110.662 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.1 m -128.92 117.76 21.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.748 0.819 . . . . 0.0 110.771 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.1 160.31 15.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.455 1.502 . . . . 0.0 110.954 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -127.62 126.22 41.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.553 1.141 . . . . 0.0 110.207 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.5 t -107.23 134.44 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 0.0 110.866 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 41.8 p -107.2 157.61 17.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.075 1.35 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -94.27 116.76 5.35 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.104 1.335 . . . . 0.0 112.349 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 N--CA 1.475 0.811 0 C-N-CA 124.73 1.212 . . . . 0.0 112.935 173.318 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 CA--C 1.534 0.359 0 CA-C-O 121.373 0.606 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -55.17 114.0 6.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.046 1.739 . . . . 0.0 111.302 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.3 142.54 50.26 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.566 2.177 . . . . 0.0 109.71 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 39.6 t80 -120.14 123.36 43.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.531 0.732 . . . . 0.0 111.457 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.3 135.88 13.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.92 1.688 . . . . 0.0 110.572 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.0 151.63 45.63 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.214 1.805 . . . . 0.0 110.317 -171.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.5 p -117.6 140.23 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.233 1.413 . . . . 0.0 110.318 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.7 mt -133.21 134.93 24.72 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.407 1.883 . . . . 0.0 108.367 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.37 38.75 0.75 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 124.33 3.353 . . . . 0.0 113.354 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.0 t80 -87.26 152.78 22.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.005 1.322 . . . . 0.0 111.415 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 94.2 m -122.94 127.46 48.93 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.419 1.488 . . . . 0.0 109.708 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.6 mt -75.61 136.24 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.457 1.103 . . . . 0.0 111.216 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.1 pttt -112.74 -148.97 0.44 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.497 1.919 . . . . 0.0 112.036 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -87.16 131.91 34.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.557 1.143 . . . . 0.0 111.102 167.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.52 -139.54 11.03 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.311 1.434 . . . . 0.0 111.884 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -156.68 145.01 19.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.567 1.147 . . . . 0.0 111.74 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.6 tt -117.81 137.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.987 1.715 . . . . 0.0 111.057 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 26.1 p -146.27 161.16 40.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.689 1.596 . . . . 0.0 110.799 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.86 20.05 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.0 138.98 18.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.7 1.6 . . . . 0.0 109.798 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 19.6 t -111.56 136.62 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.337 1.855 . . . . 0.0 108.053 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -121.11 125.02 46.18 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 110.882 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.05 148.25 34.12 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.84 1.656 . . . . 0.0 111.319 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.53 -20.2 31.49 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.481 2.787 . . . . 0.0 113.929 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.6 t -77.03 -4.08 42.38 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.91 51.06 2.53 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.596 1.093 . . . . 0.0 113.035 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.81 166.96 25.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.678 1.591 . . . . 0.0 111.849 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.9 m -139.41 159.49 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.671 1.188 . . . . 0.0 113.071 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.05 171.83 18.47 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.142 2.177 . . . . 0.0 110.545 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -107.26 137.98 19.76 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.822 0.849 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.97 168.11 13.91 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.939 3.092 . . . . 0.0 110.972 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.5 m -104.63 126.23 51.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.005 1.322 . . . . 0.0 108.83 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.31 137.67 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.962 1.305 . . . . 0.0 108.846 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 24.4 m -146.71 127.25 14.13 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 109.393 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.56 143.64 40.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 112.648 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -88.76 -3.09 58.85 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? 65.94 18.49 11.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.343 1.857 . . . . 0.0 112.978 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -128.2 15.53 6.72 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.529 1.932 . . . . 0.0 112.684 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 85.11 15.91 66.03 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.575 1.083 . . . . 0.0 114.094 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 30.2 p -135.19 158.14 45.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.281 1.833 . . . . 0.0 110.32 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -123.81 144.66 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.613 1.165 . . . . 0.0 110.497 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.1 m -103.71 140.16 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.118 1.367 . . . . 0.0 108.862 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 34.0 t -122.62 133.78 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.486 1.514 . . . . 0.0 108.833 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.45 153.77 50.54 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.574 1.55 . . . . 0.0 111.983 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 26.6 t80 -157.0 133.31 9.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.207 1.403 . . . . 0.0 111.826 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.43 119.04 71.23 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.374 1.07 . . . . 0.0 110.513 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.59 144.31 31.68 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.524 2.816 . . . . 0.0 112.114 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.7 p -129.07 -7.6 4.88 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -159.88 150.97 19.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.74 1.616 . . . . 0.0 110.698 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.31 170.8 14.22 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.649 1.18 . . . . 0.0 113.308 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.15 -171.09 13.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.099 1.809 . . . . 0.0 113.919 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.3 tp -85.21 133.72 34.17 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.753 1.221 . . . . 0.0 110.035 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -130.47 166.47 20.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.028 1.731 . . . . 0.0 111.37 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.67 157.32 45.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.447 1.099 . . . . 0.0 110.691 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.2 tmm? -146.56 135.02 21.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.013 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.31 137.71 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.832 2.053 . . . . 0.0 110.03 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.0 mm -135.03 132.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.133 1.373 . . . . 0.0 110.137 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 141.21 32.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.4 t80 -103.27 120.49 40.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.541 1.936 . . . . 0.0 109.965 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.26 32.39 8.15 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.716 1.206 . . . . 0.0 112.889 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.8 t30 81.47 0.69 1.6 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.728 2.811 . . . . 0.0 115.08 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 57.4 ttm -98.83 128.5 45.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.343 1.457 . . . . 0.0 110.957 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.27 137.42 52.26 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.38 154.17 81.84 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.26 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.51 129.58 33.21 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.514 2.143 . . . . 0.0 109.988 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.79 -16.92 59.65 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.812 1.196 . . . . 0.0 114.065 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.6 t -86.66 145.51 39.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 119.699 1.75 . . . . 0.0 111.244 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -82.8 165.31 70.91 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.076 1.063 . . . . 0.0 112.73 -4.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.63 156.88 25.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.286 1.834 . . . . 0.0 111.423 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -137.05 137.88 39.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.522 1.529 . . . . 0.0 109.71 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 27.0 p90 -158.5 155.89 29.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.284 1.034 . . . . 0.0 112.315 -169.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.0 t80 -106.01 148.17 28.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.878 0.871 . . . . 0.0 112.341 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 55.0 t -126.11 137.45 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.523 1.529 . . . . 0.0 108.979 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -150.35 158.43 44.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.599 1.16 . . . . 0.0 113.115 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.8 118.46 20.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.941 0.896 . . . . 0.0 111.748 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.6 p -62.9 -34.29 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.743 1.217 . . . . 0.0 114.017 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -88.24 -7.44 56.8 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 39.7 t -67.35 -34.04 76.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.292 1.037 . . . . 0.0 113.065 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 82.67 2.6 90.65 Favored Glycine 0 N--CA 1.476 1.319 0 C-N-CA 124.901 1.239 . . . . 0.0 115.325 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -64.03 163.26 12.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.622 1.569 . . . . 0.0 113.698 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.3 t -70.16 132.76 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.0 t -165.27 164.24 19.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.784 1.233 . . . . 0.0 110.963 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.32 143.9 44.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.433 1.493 . . . . 0.0 111.251 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.5 p90 -162.93 162.84 26.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.278 1.431 . . . . 0.0 112.782 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 125.89 173.59 13.66 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.443 1.497 . . . . 0.0 112.797 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.01 -34.99 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.793 2.329 . . . . 0.0 112.947 -170.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.82 -32.95 82.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.51 1.05 . . . . 0.0 114.786 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.33 -6.08 55.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.877 1.338 . . . . 0.0 113.526 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.2 m -105.0 -45.28 4.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.497 1.919 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -146.44 150.52 35.78 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.679 1.992 . . . . 0.0 112.132 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 179.86 22.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.293 0.949 . . . . 0.0 113.493 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 31.5 t -142.45 133.2 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 0.0 108.522 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.5 m -55.54 137.44 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.3 m-80 68.98 -4.92 1.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.072 2.149 . . . . 0.0 114.814 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -104.39 138.58 19.56 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.012 1.325 . . . . 0.0 110.771 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.93 127.13 12.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.368 2.045 . . . . 0.0 110.334 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.21 145.18 32.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.595 1.558 . . . . 0.0 110.368 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.6 p -135.11 151.07 50.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.909 0.884 . . . . 0.0 113.245 -167.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.5 p90 -162.01 176.26 10.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.945 1.698 . . . . 0.0 111.441 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 67.8 m -129.93 143.03 50.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.226 1.411 . . . . 0.0 110.275 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 49.0 t -115.4 135.15 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.689 1.596 . . . . 0.0 108.137 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.7 133.67 42.7 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.364 1.066 . . . . 0.0 111.136 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.7 p -134.61 14.57 3.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.778 1.631 . . . . 0.0 112.519 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.12 -34.78 70.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.645 1.578 . . . . 0.0 114.992 -163.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -129.39 21.51 5.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.691 1.596 . . . . 0.0 111.868 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.59 -39.14 70.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.482 1.113 . . . . 0.0 113.841 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.41 146.76 4.61 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.783 1.183 . . . . 0.0 112.01 -168.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.13 165.86 22.66 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 113.391 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.75 16.47 0.25 Allowed Glycine 0 N--CA 1.477 1.394 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.61 97.22 1.86 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.302 1.429 . . . . 0.0 113.126 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -80.14 127.22 32.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 108.952 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -120.08 159.49 24.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.775 1.63 . . . . 0.0 112.547 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -159.65 137.46 10.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.048 1.739 . . . . 0.0 109.437 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.13 159.51 36.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.442 1.097 . . . . 0.0 111.839 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.13 133.66 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.448 1.099 . . . . 0.0 109.813 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.52 132.68 53.98 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.182 1.393 . . . . 0.0 109.752 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.82 -165.6 15.11 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 119.089 -0.839 . . . . 0.0 114.412 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.31 -29.44 79.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.917 3.078 . . . . 0.0 111.996 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.2 t -129.83 150.43 51.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.851 1.26 . . . . 0.0 108.972 158.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -70.68 125.69 27.51 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.306 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.87 152.8 35.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.68 133.14 34.04 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 162.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.4 mt -133.07 143.13 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.823 1.249 . . . . 0.0 109.994 -166.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.7 t -143.42 158.99 43.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.931 1.293 . . . . 0.0 110.834 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -158.07 154.44 27.57 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.463 1.105 . . . . 0.0 112.436 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.7 m -135.84 120.06 17.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.302 1.441 . . . . 0.0 109.954 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.61 132.03 40.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.901 1.28 . . . . 0.0 110.913 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -109.82 138.77 45.72 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.156 1.382 . . . . 0.0 111.084 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -65.66 -17.85 64.9 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.863 0.865 . . . . 0.0 112.226 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.49 -12.44 57.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.048 1.739 . . . . 0.0 114.346 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.04 33.42 5.5 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.876 1.227 . . . . 0.0 114.486 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.8 p -140.55 164.24 30.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.596 1.558 . . . . 0.0 110.794 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.6 m -119.34 130.45 55.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 163.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -91.49 148.51 22.25 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 110.398 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.9 t -131.38 141.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.412 1.485 . . . . 0.0 110.606 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 49.8 m -133.43 143.46 48.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.947 1.699 . . . . 0.0 111.084 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.8 p90 -150.46 155.2 39.08 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.2 109.24 44.72 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.017 1.727 . . . . 0.0 110.67 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.86 174.68 10.03 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.712 2.941 . . . . 0.0 110.178 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -152.22 -31.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.32 146.17 31.96 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 119.319 0.963 . . . . 0.0 110.48 167.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.89 155.76 53.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.772 2.315 . . . . 0.0 110.703 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.02 -152.71 21.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.49 1.043 . . . . 0.0 112.926 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -114.37 129.75 56.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.634 1.173 . . . . 0.0 111.614 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.26 130.53 56.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 110.28 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.651 1.18 . . . . 0.0 110.798 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.34 124.3 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.416 1.886 . . . . 0.0 108.62 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.03 132.2 51.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.653 1.581 . . . . 0.0 109.58 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.3 t -133.36 131.87 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.417 1.487 . . . . 0.0 108.316 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.6 144.81 18.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.763 1.225 . . . . 0.0 110.714 -166.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.72 121.24 15.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.531 1.132 . . . . 0.0 109.591 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.2 t-20 52.64 57.72 6.11 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.059 1.344 . . . . 0.0 112.334 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.296 7.9 pt-20 59.36 11.72 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.302 2.641 . . . . 0.0 116.35 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.2 124.6 48.31 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.541 1.137 . . . . 0.0 111.218 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -61.1 154.58 22.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.058 0.943 . . . . 0.0 112.663 170.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.51 153.86 71.11 Favored Pre-proline 0 N--CA 1.479 0.984 0 O-C-N 121.845 -0.534 . . . . 0.0 110.269 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -57.15 123.14 13.13 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 110.457 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 97.33 -16.19 61.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.178 1.371 . . . . 0.0 115.956 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 89.8 p -79.56 152.98 75.94 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 120.321 2.06 . . . . 0.0 112.942 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.22 156.28 99.77 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 119.31 0.789 . . . . 0.0 112.675 -4.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -111.13 140.82 45.36 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.573 1.549 . . . . 0.0 111.001 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 43.8 m -95.25 115.43 27.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.509 0.724 . . . . 0.0 110.997 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.08 127.99 42.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.994 1.318 . . . . 0.0 110.664 169.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -96.0 125.21 40.39 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.187 0.595 . . . . 0.0 110.634 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.4 t -110.7 129.77 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.33 1.452 . . . . 0.0 110.897 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.7 p -97.73 148.77 23.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.702 1.201 . . . . 0.0 112.778 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.75 59.62 2.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.35 1.928 . . . . 0.0 112.782 -175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 CA--C 1.547 0.831 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.328 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 CA--C 1.537 0.459 0 CA-C-O 120.94 0.4 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -63.35 122.34 75.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.808 1.243 . . . . 0.0 110.357 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.27 140.2 52.53 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.932 2.421 . . . . 0.0 110.485 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.0 t80 -94.63 123.13 37.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.215 0.606 . . . . 0.0 110.255 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -147.42 136.12 21.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.191 1.396 . . . . 0.0 110.504 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.47 149.48 37.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.202 1.801 . . . . 0.0 109.533 -173.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.89 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.056 1.342 . . . . 0.0 110.164 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.83 136.12 27.17 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.774 1.629 . . . . 0.0 109.231 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.93 107.04 2.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.475 2.783 . . . . 0.0 109.693 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -172.95 152.3 2.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.758 2.423 . . . . 0.0 108.464 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.7 m -132.59 126.99 34.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.359 1.064 . . . . 0.0 109.783 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.85 117.63 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.229 1.011 . . . . 0.0 109.749 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 36.9 tptt -100.44 -146.06 0.34 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.214 1.406 . . . . 0.0 110.414 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.2 tttt -78.3 125.28 29.13 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.466 -1.396 . . . . 0.0 111.021 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 139.51 -150.4 21.34 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 125.462 1.506 . . . . 0.0 112.117 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -159.09 147.01 17.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.489 1.116 . . . . 0.0 111.412 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.33 136.78 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.876 1.67 . . . . 0.0 111.07 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.25 167.32 24.52 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.809 1.644 . . . . 0.0 111.004 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.74 -173.63 30.63 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.22 132.55 11.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.96 1.704 . . . . 0.0 109.648 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 86.2 t -103.33 134.43 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.708 1.603 . . . . 0.0 108.326 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.44 131.51 54.2 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.069 1.347 . . . . 0.0 110.972 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.8 mtt -106.23 149.24 37.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.634 1.574 . . . . 0.0 111.617 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -56.0 -28.18 67.79 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.073 3.182 . . . . 0.0 115.183 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 34.8 p -74.45 -6.15 46.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.542 1.537 . . . . 0.0 114.388 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.49 -5.5 82.52 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.535 1.54 . . . . 0.0 113.718 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -70.04 157.11 38.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.589 1.155 . . . . 0.0 112.128 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -142.06 155.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.275 1.43 . . . . 0.0 111.645 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.24 177.43 11.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.953 2.101 . . . . 0.0 110.149 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.43 143.17 33.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 120.974 -1.078 . . . . 0.0 112.254 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -83.97 169.18 11.81 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.417 3.411 . . . . 0.0 111.666 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.4 m -111.01 130.23 55.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.486 1.514 . . . . 0.0 109.03 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.35 137.32 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.945 1.298 . . . . 0.0 109.666 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -138.98 129.21 25.46 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.265 1.426 . . . . 0.0 110.002 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.11 129.04 34.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.949 0.899 . . . . 0.0 110.776 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -84.31 -9.14 58.72 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 66.3 mttm 65.71 10.24 6.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.469 2.308 . . . . 0.0 113.897 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.9 6.93 31.9 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.208 2.203 . . . . 0.0 112.632 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.95 11.82 58.45 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.314 1.435 . . . . 0.0 114.162 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.31 155.64 45.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.207 1.803 . . . . 0.0 111.044 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.5 m -111.14 142.12 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.986 0.914 . . . . 0.0 109.701 162.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 33.7 m -102.06 138.57 38.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.816 1.246 . . . . 0.0 108.465 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.8 t -123.6 134.41 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.196 1.398 . . . . 0.0 109.019 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.19 156.36 46.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.223 1.409 . . . . 0.0 112.715 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 32.6 t80 -155.35 135.41 12.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.718 1.607 . . . . 0.0 111.786 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.03 116.25 65.41 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.536 1.135 . . . . 0.0 110.59 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.46 148.01 29.31 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.47 2.78 . . . . 0.0 112.348 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 7.6 t -140.56 -2.59 1.37 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.166 0.987 . . . . 0.0 113.639 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -144.7 148.29 34.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.366 1.866 . . . . 0.0 109.501 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.15 168.31 12.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.02 0.928 . . . . 0.0 112.076 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.04 -172.48 18.96 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.686 1.136 . . . . 0.0 114.59 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.1 tp -79.86 110.74 15.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.564 1.546 . . . . 0.0 110.912 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 49.1 m80 -107.18 164.05 12.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.191 1.797 . . . . 0.0 112.214 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 142.46 42.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.217 1.407 . . . . 0.0 109.95 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.5 ttm -122.72 126.32 47.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.925 1.29 . . . . 0.0 111.196 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 t70 -87.77 133.86 33.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.801 1.641 . . . . 0.0 110.091 166.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 16.9 mm -134.15 139.63 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.309 1.443 . . . . 0.0 109.874 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.4 142.22 23.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.116 0.966 . . . . 0.0 113.585 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.0 t80 -98.52 118.79 36.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 109.505 172.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.46 34.36 12.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.999 1.32 . . . . 0.0 112.919 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 74.38 10.69 4.22 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.784 2.434 . . . . 0.0 115.073 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 6.0 tmm? -107.39 126.48 52.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.618 1.567 . . . . 0.0 110.197 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m170 -54.87 131.98 45.47 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.044 -1.035 . . . . 0.0 113.711 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.6 pt -71.43 154.41 93.48 Favored Pre-proline 0 N--CA 1.481 1.088 0 O-C-N 121.247 -0.908 . . . . 0.0 111.464 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.53 122.04 10.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.431 2.087 . . . . 0.0 109.627 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.39 43.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.692 1.139 . . . . 0.0 114.563 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.8 t -80.95 147.68 62.4 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.326 1.563 . . . . 0.0 112.173 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.64 164.02 82.65 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.286 1.138 . . . . 0.0 112.258 -7.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 50.8 mt -97.26 156.69 16.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.047 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -153.26 134.35 14.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.395 1.078 . . . . 0.0 110.012 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -167.02 160.59 14.23 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.164 0.986 . . . . 0.0 112.852 -170.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 58.4 t80 -96.44 134.42 39.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.945 0.898 . . . . 0.0 112.74 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.7 t -98.03 128.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.944 1.297 . . . . 0.0 109.966 173.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -132.61 173.51 11.25 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.373 2.269 . . . . 0.0 111.581 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -74.4 141.44 45.08 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.018 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 6.0 p -63.17 -27.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.343 1.057 . . . . 0.0 113.334 -170.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -132.45 134.95 45.71 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.292 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 26.5 p -169.71 164.05 10.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.011 1.724 . . . . 0.0 112.172 -174.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.31 -22.99 20.76 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.721 1.153 . . . . 0.0 114.38 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -73.16 158.54 35.08 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.378 1.089 . . . . 0.0 113.497 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.3 t -70.44 128.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.81 0.844 . . . . 0.0 108.956 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.9 t -147.01 158.15 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.983 1.313 . . . . 0.0 110.45 -175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.13 142.57 36.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.055 1.342 . . . . 0.0 111.513 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.5 p90 -165.69 160.69 17.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.529 1.532 . . . . 0.0 112.532 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.38 174.24 13.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.113 1.339 . . . . 0.0 113.294 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.52 -33.12 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.943 2.429 . . . . 0.0 113.088 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.63 70.62 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.481 1.037 . . . . 0.0 114.501 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.99 -6.64 57.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.028 1.414 . . . . 0.0 113.191 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 49.6 m -102.41 -40.29 6.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.532 1.933 . . . . 0.0 111.794 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.581 1.952 . . . . 0.0 112.338 -167.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -158.59 -175.3 29.36 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.708 0.671 . . . . 0.0 113.822 168.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.5 p -152.46 137.2 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.24 1.416 . . . . 0.0 108.67 174.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 30.1 m -56.74 140.95 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.3 m-80 72.04 -3.03 2.34 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.518 2.327 . . . . 0.0 114.86 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 41.4 mttm -103.59 143.6 26.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.507 1.123 . . . . 0.0 111.133 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.7 123.2 8.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.61 147.25 26.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.384 1.473 . . . . 0.0 110.273 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 70.0 p -137.05 150.85 48.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -168.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -161.38 175.53 12.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.794 1.638 . . . . 0.0 111.592 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.6 m -126.97 142.31 51.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.959 1.304 . . . . 0.0 110.752 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.9 t -117.58 130.22 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.695 1.598 . . . . 0.0 108.27 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -93.75 129.28 40.15 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.231 1.012 . . . . 0.0 111.158 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 56.8 p -136.0 0.52 2.64 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.039 1.336 . . . . 0.0 113.997 -166.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.12 -38.2 67.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.402 1.481 . . . . 0.0 114.727 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.84 9.15 17.53 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.763 1.625 . . . . 0.0 112.935 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.79 -38.42 67.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.9 145.29 5.03 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.93 1.253 . . . . 0.0 112.34 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.1 140.73 49.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.962 0.905 . . . . 0.0 112.014 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 176.1 19.35 0.02 OUTLIER Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.959 1.144 . . . . 0.0 115.959 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 88.62 97.45 0.99 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.191 1.377 . . . . 0.0 112.58 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.51 129.23 34.97 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.328 1.451 . . . . 0.0 109.017 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -124.03 159.66 29.38 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.666 1.586 . . . . 0.0 112.286 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.7 tp -160.34 136.09 8.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.052 1.741 . . . . 0.0 109.09 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.48 157.46 35.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.866 . . . . 0.0 112.331 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.9 mt -137.01 140.74 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.015 1.326 . . . . 0.0 110.006 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.8 159.09 36.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.23 1.812 . . . . 0.0 109.745 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.28 -160.34 28.03 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.862 -0.966 . . . . 0.0 114.595 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.45 -24.61 63.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.123 3.215 . . . . 0.0 112.649 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.1 t -146.81 160.39 42.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.365 1.466 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.01 118.5 16.05 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.986 -1.071 . . . . 0.0 111.59 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.0 149.98 40.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.01 0.924 . . . . 0.0 111.953 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.72 141.01 29.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.799 0.84 . . . . 0.0 109.572 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.4 140.65 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.68 1.192 . . . . 0.0 110.585 -166.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 58.6 m -134.84 157.39 46.93 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.719 1.608 . . . . 0.0 111.124 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 42.3 t -154.14 143.42 21.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.358 1.063 . . . . 0.0 111.778 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.4 m -137.27 126.25 24.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.669 1.587 . . . . 0.0 110.514 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.02 135.89 36.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.176 1.39 . . . . 0.0 111.664 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -113.65 148.26 36.62 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.654 1.581 . . . . 0.0 111.642 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -64.72 -18.62 65.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.331 1.053 . . . . 0.0 112.479 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.73 -8.36 34.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.046 1.738 . . . . 0.0 114.271 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.05 30.01 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.54 1.067 . . . . 0.0 114.032 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 41.6 p -138.4 143.79 39.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.939 1.295 . . . . 0.0 111.399 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.4 m -92.51 123.86 36.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.38 1.072 . . . . 0.0 109.035 161.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.79 139.93 30.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 109.902 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.6 t -117.25 144.44 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.966 1.707 . . . . 0.0 109.933 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 62.8 p -136.79 145.31 44.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.407 1.083 . . . . 0.0 111.77 165.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.3 p90 -151.44 152.94 33.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 12.4 mt -116.57 105.82 49.48 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.042 1.737 . . . . 0.0 110.755 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.74 162.23 16.39 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.79 2.993 . . . . 0.0 110.447 167.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.0 m -134.99 -20.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.62 149.04 47.31 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 110.371 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.31 154.55 51.29 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 111.107 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 135.08 -164.01 24.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.842 1.21 . . . . 0.0 113.592 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -92.18 130.53 37.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 112.368 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -117.3 132.35 56.63 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.601 1.561 . . . . 0.0 110.513 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.3 m -90.71 125.88 35.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.545 1.138 . . . . 0.0 110.551 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.88 127.12 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.535 1.534 . . . . 0.0 108.583 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.88 132.56 54.05 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.496 1.519 . . . . 0.0 109.75 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 67.2 t -132.79 130.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.684 1.594 . . . . 0.0 108.203 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.98 142.63 19.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.616 1.166 . . . . 0.0 111.08 -168.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.01 121.56 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.786 1.234 . . . . 0.0 109.641 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 53.87 56.1 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.103 1.361 . . . . 0.0 112.468 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.2 pt-20 58.25 13.67 2.46 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 128.085 2.554 . . . . 0.0 116.159 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -119.73 127.71 53.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.555 1.142 . . . . 0.0 111.262 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -63.62 159.94 17.85 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 113.006 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -83.3 159.09 62.71 Favored Pre-proline 0 N--CA 1.48 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.065 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.41 -27.44 49.09 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 115.931 -171.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -104.69 -6.04 41.2 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.311 1.284 . . . . 0.0 116.311 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 81.0 p -84.24 153.61 62.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 119.953 1.876 . . . . 0.0 113.416 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.73 148.0 90.76 Favored 'Cis proline' 0 C--N 1.354 0.827 0 CA-C-N 118.829 0.618 . . . . 0.0 112.112 -5.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.67 169.99 9.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.82 1.648 . . . . 0.0 110.724 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 60.9 m -133.22 121.35 22.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.671 0.788 . . . . 0.0 110.877 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.56 139.6 34.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.538 1.535 . . . . 0.0 111.082 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.97 110.88 23.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.677 0.791 . . . . 0.0 109.811 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.9 t -95.7 145.42 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.307 1.443 . . . . 0.0 109.884 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.6 t -128.51 175.11 8.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.262 1.025 . . . . 0.0 113.038 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.68 139.9 18.34 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.624 1.583 . . . . 0.0 112.692 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 CA--C 1.547 0.859 0 C-N-CA 124.693 1.197 . . . . 0.0 112.721 174.573 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 10.8 mt . . . . . 0 N--CA 1.47 0.538 0 CA-C-O 121.202 0.525 . . . . 0.0 112.218 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.23 117.87 25.49 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 110.634 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.35 157.01 50.23 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.321 2.68 . . . . 0.0 111.532 -173.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 19.6 t80 -110.47 125.12 52.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.701 0.801 . . . . 0.0 110.958 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -154.07 133.54 12.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.238 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.83 146.02 33.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.842 1.657 . . . . 0.0 109.794 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.3 p -111.52 139.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.063 1.345 . . . . 0.0 110.204 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.3 mt -131.06 134.84 26.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.953 1.701 . . . . 0.0 108.843 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.05 92.81 1.03 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.715 2.944 . . . . 0.0 109.759 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 68.8 t80 -151.89 154.28 35.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.16 1.784 . . . . 0.0 109.801 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 68.0 m -126.51 123.82 38.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.705 1.202 . . . . 0.0 109.65 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 91.6 mt -87.68 118.88 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.337 1.055 . . . . 0.0 109.147 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 99.6 mttt -98.08 -77.01 0.51 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.502 1.121 . . . . 0.0 113.232 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.35 -4.61 0.16 Allowed 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.23 -129.1 2.73 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.294 1.902 . . . . 0.0 111.938 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.39 148.61 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.829 1.252 . . . . 0.0 110.824 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -141.09 129.87 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.344 1.458 . . . . 0.0 111.722 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.46 168.4 22.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.007 1.723 . . . . 0.0 110.701 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -153.84 -171.45 20.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.18 138.18 18.16 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.74 1.616 . . . . 0.0 109.63 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.6 t -108.36 136.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.134 1.774 . . . . 0.0 107.892 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.23 121.27 35.47 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.111 1.364 . . . . 0.0 110.541 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 12.7 mtm -87.75 151.55 50.21 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.863 1.665 . . . . 0.0 111.028 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.46 -18.26 38.51 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.442 2.761 . . . . 0.0 113.207 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 36.0 p -73.06 -6.72 47.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.011 1.724 . . . . 0.0 114.22 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.76 -4.85 79.35 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.83 1.681 . . . . 0.0 113.898 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -69.93 158.55 35.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.596 1.159 . . . . 0.0 112.234 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.4 m -137.61 156.79 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 0.0 112.23 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.9 171.94 18.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.665 1.986 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.78 137.5 19.35 Favored Pre-proline 0 CA--C 1.546 0.813 0 O-C-N 121.288 -0.882 . . . . 0.0 111.051 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.52 163.31 19.18 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.837 3.025 . . . . 0.0 110.938 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 67.9 m -101.99 120.31 40.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.9 1.28 . . . . 0.0 108.578 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.04 131.41 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.351 1.06 . . . . 0.0 108.631 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -127.76 124.96 38.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 109.652 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.85 122.72 24.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.235 1.014 . . . . 0.0 110.83 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.7 -15.36 45.5 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 58.0 tttt 71.67 4.01 4.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.308 2.243 . . . . 0.0 114.241 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -113.83 15.29 18.66 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.88 2.072 . . . . 0.0 112.805 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.16 12.15 52.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.105 1.336 . . . . 0.0 114.636 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -131.39 160.57 34.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.018 1.727 . . . . 0.0 110.705 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.9 m -123.93 147.44 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.594 1.158 . . . . 0.0 109.566 164.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.2 m -107.38 136.48 47.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.144 0.978 . . . . 0.0 108.643 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 35.8 t -120.42 131.9 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.126 1.37 . . . . 0.0 109.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -133.1 155.63 48.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.435 1.494 . . . . 0.0 112.662 -169.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -158.29 136.86 11.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.338 1.455 . . . . 0.0 112.338 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.27 120.09 69.74 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.776 1.23 . . . . 0.0 110.996 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.72 159.77 28.08 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.713 2.942 . . . . 0.0 112.233 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 5.5 t -147.59 -11.77 0.4 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.37 149.02 20.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.819 1.648 . . . . 0.0 110.98 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.04 171.0 15.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.656 1.182 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.31 -175.14 15.56 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.535 1.541 . . . . 0.0 114.409 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.93 124.67 31.92 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 110.097 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 46.7 m80 -118.93 152.88 35.53 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.547 1.539 . . . . 0.0 112.193 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -117.3 148.14 41.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.091 1.756 . . . . 0.0 108.899 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.1 tmm? -143.89 130.19 19.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 111.407 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -118.13 139.7 50.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.45 1.9 . . . . 0.0 110.924 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -137.27 133.19 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.185 1.394 . . . . 0.0 110.57 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 140.69 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -103.05 119.85 39.59 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.589 1.956 . . . . 0.0 109.489 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.79 34.61 13.51 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.762 1.225 . . . . 0.0 112.835 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.7 m-80 72.76 9.16 5.57 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.698 2.399 . . . . 0.0 115.147 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.1 mtm -103.35 128.48 50.42 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.352 1.461 . . . . 0.0 110.158 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -57.37 136.61 56.6 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.247 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.9 pt -75.56 154.26 85.6 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.218 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -59.56 128.45 27.19 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.216 1.944 . . . . 0.0 109.791 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.09 -15.9 59.96 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.838 1.209 . . . . 0.0 114.014 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.2 t -84.89 143.48 40.34 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.687 1.744 . . . . 0.0 111.105 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.1 159.2 83.47 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.025 1.044 . . . . 0.0 112.664 -4.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 87.6 mt -107.21 161.51 14.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.427 1.891 . . . . 0.0 111.183 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.17 139.91 18.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.821 1.249 . . . . 0.0 110.03 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -166.31 174.78 8.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.58 1.152 . . . . 0.0 112.413 -170.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -122.79 131.73 53.9 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.223 1.009 . . . . 0.0 112.718 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 99.3 t -96.92 135.12 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.589 1.556 . . . . 0.0 109.059 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 19.8 t0 -154.98 166.76 32.58 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.943 1.297 . . . . 0.0 111.111 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -82.81 137.45 34.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.81 1.244 . . . . 0.0 112.064 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 7.7 p -67.61 -24.84 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.473 0.709 . . . . 0.0 112.331 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -88.9 25.54 1.77 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.01 1.724 . . . . 0.0 112.773 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.2 p -56.68 151.02 14.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.422 1.489 . . . . 0.0 114.212 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.94 28.52 11.97 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.14 1.829 . . . . 0.0 112.324 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -162.38 163.17 27.94 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.866 1.666 . . . . 0.0 112.556 -163.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 18.3 t -70.18 137.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.29 1.036 . . . . 0.0 109.82 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -147.26 158.7 44.05 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.756 1.222 . . . . 0.0 110.622 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.73 144.08 37.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.101 1.36 . . . . 0.0 111.52 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.3 p90 -168.34 164.83 12.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.403 1.481 . . . . 0.0 113.214 -173.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 126.16 170.75 13.03 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.614 1.578 . . . . 0.0 112.29 -175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -34.89 9.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.778 2.319 . . . . 0.0 113.222 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.08 76.41 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 119.348 0.976 . . . . 0.0 114.968 -169.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.01 -1.62 40.53 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.906 1.353 . . . . 0.0 113.813 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 51.6 m -118.05 -46.51 2.62 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.669 1.988 . . . . 0.0 111.726 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -138.01 148.2 44.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.503 1.521 . . . . 0.0 112.437 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -147.46 178.73 24.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.24 0.924 . . . . 0.0 113.52 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 19.1 t -139.53 136.97 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.914 1.286 . . . . 0.0 108.314 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -55.46 138.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 70.88 -3.29 2.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.547 2.339 . . . . 0.0 114.656 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.5 mttm -98.52 140.54 21.89 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.581 1.153 . . . . 0.0 111.144 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.89 109.77 2.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.647 2.232 . . . . 0.0 109.677 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -89.07 139.14 30.76 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.926 1.29 . . . . 0.0 110.168 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.0 p -130.83 151.25 51.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -166.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.28 175.95 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.276 1.83 . . . . 0.0 111.357 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.5 m -130.69 144.61 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.501 1.52 . . . . 0.0 110.898 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 31.1 t -117.59 135.77 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.584 1.554 . . . . 0.0 108.555 168.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.42 117.64 35.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.575 1.15 . . . . 0.0 110.632 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.8 p -117.05 14.4 14.97 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.289 1.836 . . . . 0.0 112.236 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 60.2 tttp -60.27 -28.39 68.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.421 1.488 . . . . 0.0 114.264 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -118.08 16.59 14.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.996 1.718 . . . . 0.0 112.754 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.71 -12.61 61.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.13 -103.34 2.48 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.718 1.151 . . . . 0.0 110.828 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.02 147.8 24.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.322 1.449 . . . . 0.0 110.432 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 164.36 -105.87 0.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.044 1.307 . . . . 0.0 111.061 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 167.27 144.36 4.1 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 124.773 1.177 . . . . 0.0 112.701 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 25.5 tp -92.39 137.97 31.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.666 1.186 . . . . 0.0 111.277 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.3 m -120.56 157.44 29.46 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.408 1.883 . . . . 0.0 110.74 169.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 53.4 tp -157.07 134.9 10.89 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.202 1.401 . . . . 0.0 109.721 -168.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.17 158.4 36.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.106 0.962 . . . . 0.0 112.324 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.1 mt -137.32 139.17 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.736 1.214 . . . . 0.0 109.986 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.17 131.34 47.13 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.439 1.496 . . . . 0.0 109.872 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -157.7 -162.7 11.89 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.891 -0.95 . . . . 0.0 114.625 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.79 -23.65 68.92 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.253 3.302 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.1 t -144.84 159.6 42.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.24 1.416 . . . . 0.0 109.433 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.11 111.54 5.84 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.095 -1.003 . . . . 0.0 111.019 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.65 148.31 50.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.863 0.865 . . . . 0.0 111.617 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.97 138.43 31.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.194 0.597 . . . . 0.0 109.416 166.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.2 mt -129.53 143.88 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.084 1.353 . . . . 0.0 109.906 -168.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.03 162.8 34.52 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 111.137 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.89 154.83 30.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.697 1.199 . . . . 0.0 112.485 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.3 m -136.94 123.36 20.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.61 1.564 . . . . 0.0 110.09 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.68 130.84 36.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.984 1.314 . . . . 0.0 111.239 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.91 149.14 27.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.463 1.505 . . . . 0.0 111.603 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -65.11 -20.0 66.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.539 1.136 . . . . 0.0 112.882 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.93 -7.87 53.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.203 1.401 . . . . 0.0 113.923 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.67 12.37 47.6 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.925 1.25 . . . . 0.0 114.869 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.0 p -108.61 154.88 21.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.099 1.359 . . . . 0.0 111.289 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 90.0 m -110.63 123.23 49.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 108.822 163.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -86.5 147.45 25.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.46 0.704 . . . . 0.0 110.161 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 90.3 t -128.36 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.977 1.711 . . . . 0.0 109.9 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.72 147.27 44.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 111.81 168.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -151.02 151.18 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -112.41 101.79 53.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.778 1.631 . . . . 0.0 110.575 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.27 161.13 29.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.303 2.669 . . . . 0.0 109.946 166.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.9 m -135.96 -21.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 89.9 mt -118.4 147.52 42.0 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.953 1.301 . . . . 0.0 110.21 170.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.08 154.12 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.734 2.29 . . . . 0.0 110.648 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 137.97 -158.54 24.75 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.706 1.146 . . . . 0.0 112.881 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -106.03 133.78 50.2 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.358 1.063 . . . . 0.0 111.727 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -121.0 125.27 46.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.98 1.712 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -87.6 127.17 35.27 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.965 -1.084 . . . . 0.0 110.848 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.43 120.74 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.545 1.538 . . . . 0.0 108.528 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -103.71 127.53 51.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -130.14 129.17 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.159 1.384 . . . . 0.0 109.036 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.37 136.56 22.43 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.353 -170.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 39.6 t80 -132.22 133.58 44.32 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.991 1.316 . . . . 0.0 110.933 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 48.99 53.73 12.08 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 112.547 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 8.4 pt-20 58.55 16.01 3.98 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 128.037 2.535 . . . . 0.0 116.413 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -125.15 130.33 51.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 111.292 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.3 m170 -62.15 141.35 58.21 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.481 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 8.3 m -71.25 150.86 94.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.35 -0.834 . . . . 0.0 109.872 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.83 130.37 39.5 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.38 2.72 . . . . 0.0 111.742 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.84 -15.14 58.4 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.279 1.419 . . . . 0.0 115.034 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 3.5 t -83.17 143.21 45.01 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 118.935 1.367 . . . . 0.0 111.488 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.9 138.11 51.94 Favored 'Cis proline' 0 C--N 1.357 0.996 0 CA-C-N 119.832 0.976 . . . . 0.0 112.72 0.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.0 173.8 8.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.809 1.643 . . . . 0.0 110.232 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.4 m -135.3 119.74 18.0 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.575 -0.703 . . . . 0.0 110.887 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.93 148.76 21.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 110.973 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -113.46 125.16 53.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.065 0.946 . . . . 0.0 110.21 172.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 83.9 t -111.5 132.46 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.297 1.439 . . . . 0.0 110.593 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 43.9 p -107.39 168.29 9.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.276 1.431 . . . . 0.0 112.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.64 149.57 33.52 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.049 1.309 . . . . 0.0 112.521 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.1 t70 . . . . . 0 CA--C 1.548 0.894 0 C-N-CA 124.629 1.172 . . . . 0.0 113.147 176.055 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 121.332 0.587 . . . . 0.0 111.456 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -56.81 116.02 11.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.06 1.744 . . . . 0.0 111.107 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.95 155.4 48.1 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.113 2.542 . . . . 0.0 110.947 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -105.28 124.38 49.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.345 0.658 . . . . 0.0 110.232 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -153.88 130.83 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 110.692 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.92 150.49 43.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.538 1.935 . . . . 0.0 109.565 -175.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -124.93 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.034 1.334 . . . . 0.0 110.31 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.49 138.57 27.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.117 1.767 . . . . 0.0 108.926 -172.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 47.41 2.37 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.655 3.57 . . . . 0.0 113.156 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 61.3 t80 -93.8 159.17 15.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.333 1.453 . . . . 0.0 110.559 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 49.2 m -135.16 127.29 29.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.919 1.288 . . . . 0.0 109.796 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 49.3 mt -75.56 131.46 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.244 1.018 . . . . 0.0 110.419 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' 1801 ' ' LYS . 9.3 tppt? -120.62 -145.48 0.36 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.426 1.49 . . . . 0.0 110.683 174.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' 1800 ' ' LYS . 1.5 tmtp? -77.17 122.49 25.09 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.548 -1.345 . . . . 0.0 110.749 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.41 -146.01 16.89 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.455 1.503 . . . . 0.0 112.07 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -158.87 145.35 17.0 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.758 1.223 . . . . 0.0 111.084 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.6 137.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.645 1.578 . . . . 0.0 111.122 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.5 p -148.4 168.56 22.3 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.937 1.695 . . . . 0.0 110.654 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.69 -176.47 26.98 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.73 134.71 13.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.293 1.437 . . . . 0.0 110.183 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 5.8 t -99.9 136.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.662 1.985 . . . . 0.0 108.024 171.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -121.53 126.3 48.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.828 1.251 . . . . 0.0 110.755 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -105.73 142.15 24.17 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.325 1.45 . . . . 0.0 112.09 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.61 -26.66 73.48 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.118 3.212 . . . . 0.0 115.022 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 23.3 p -73.84 1.19 11.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.257 1.423 . . . . 0.0 114.506 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.73 37.41 7.4 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.593 1.092 . . . . 0.0 113.46 173.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.21 169.32 17.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.408 1.483 . . . . 0.0 112.543 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.7 m -140.39 160.6 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.106 1.362 . . . . 0.0 112.43 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.32 169.19 24.78 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.494 1.918 . . . . 0.0 110.794 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -108.13 136.89 19.75 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.33 167.25 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.063 3.176 . . . . 0.0 111.406 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.9 m -105.13 130.85 53.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.566 1.546 . . . . 0.0 109.069 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 131.27 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.767 1.227 . . . . 0.0 108.976 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.9 m -133.22 122.21 23.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.251 1.42 . . . . 0.0 109.732 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.06 127.73 32.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.363 0.665 . . . . 0.0 110.407 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -82.31 -11.46 58.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 71.68 2.01 4.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 128.276 2.63 . . . . 0.0 114.055 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -94.38 3.57 55.01 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.564 1.946 . . . . 0.0 113.047 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.21 17.99 41.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.87 1.224 . . . . 0.0 113.93 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -131.06 155.63 46.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.47 1.908 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -112.51 143.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 109.532 163.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.8 m -104.23 135.17 46.2 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.624 1.17 . . . . 0.0 107.908 165.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.7 t -122.37 132.64 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.325 . . . . 0.0 108.838 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -135.02 160.54 38.0 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.086 1.354 . . . . 0.0 112.842 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.2 t80 -159.01 137.71 10.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.519 1.528 . . . . 0.0 111.936 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.41 119.08 71.26 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.665 1.186 . . . . 0.0 110.904 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.97 158.16 46.33 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.06 3.173 . . . . 0.0 112.432 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 8.4 t -135.86 -22.79 1.4 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -161.12 155.8 23.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.769 1.628 . . . . 0.0 109.952 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -72.05 166.43 22.26 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 126.1 178.38 15.28 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 125.906 1.717 . . . . 0.0 113.952 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -80.77 119.01 22.8 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.749 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 23.4 m80 -113.87 159.86 19.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.462 1.505 . . . . 0.0 110.892 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.46 155.72 40.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 111.517 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 3.2 tmm? -148.16 134.81 19.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.77 1.228 . . . . 0.0 111.303 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -103.04 138.45 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.85 1.66 . . . . 0.0 110.426 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.2 mm -127.63 136.56 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.339 1.456 . . . . 0.0 109.796 171.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.94 137.95 23.94 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -102.92 124.93 49.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 0.0 109.902 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.22 32.08 10.18 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.734 1.213 . . . . 0.0 112.462 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.1 t30 75.82 6.52 3.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 128.2 2.6 . . . . 0.0 115.17 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.17 131.13 53.04 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.769 1.628 . . . . 0.0 110.903 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.59 134.03 56.38 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.244 -0.91 . . . . 0.0 113.077 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.17 156.89 85.61 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 123.127 0.571 . . . . 0.0 112.046 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.25 126.37 21.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.274 1.983 . . . . 0.0 109.626 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.74 -16.57 57.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.666 1.127 . . . . 0.0 114.463 -172.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 21.2 t -86.03 148.37 47.74 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.37 1.585 . . . . 0.0 111.961 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -83.19 171.61 50.76 Favored 'Cis proline' 0 CA--C 1.54 0.783 0 CA-C-N 120.246 1.124 . . . . 0.0 112.485 -6.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.28 154.92 22.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.976 1.71 . . . . 0.0 111.662 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -145.36 140.92 28.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.441 1.497 . . . . 0.0 110.041 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -163.42 160.01 22.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.98 1.312 . . . . 0.0 112.04 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.8 t80 -100.15 135.21 41.93 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.058 -1.026 . . . . 0.0 112.396 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.1 t -103.99 141.05 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.961 1.704 . . . . 0.0 109.28 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 12.8 t0 -154.71 162.9 40.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.611 1.164 . . . . 0.0 111.683 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -81.77 148.06 29.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.57 1.148 . . . . 0.0 112.707 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 30.4 m -69.93 -17.65 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.9 p30 -80.51 -10.54 59.74 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.4 m -70.32 133.02 46.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.147 0.979 . . . . 0.0 112.584 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -101.75 -13.43 32.17 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 125.141 1.353 . . . . 0.0 114.773 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -68.59 164.45 21.38 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -63.46 138.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.355 1.062 . . . . 0.0 109.705 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.9 t -165.2 153.41 11.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.273 1.429 . . . . 0.0 110.022 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -129.8 145.16 51.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.34 . . . . 0.0 111.844 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -168.15 167.86 12.1 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.964 1.706 . . . . 0.0 112.864 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.07 169.37 13.28 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.508 1.528 . . . . 0.0 112.08 -172.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.04 -30.79 20.41 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.63 -33.98 77.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 119.255 0.934 . . . . 0.0 114.605 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.74 -4.33 45.72 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.169 1.485 . . . . 0.0 113.484 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.0 m -108.97 -41.25 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 111.973 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -149.48 152.37 35.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.131 1.772 . . . . 0.0 112.314 -172.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -152.01 177.14 30.02 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.847 0.737 . . . . 0.0 113.665 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 58.5 t -137.9 134.78 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.972 1.309 . . . . 0.0 108.192 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.6 m -55.58 137.51 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 55.5 m-80 68.92 2.21 3.46 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.011 2.124 . . . . 0.0 114.415 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.0 mttt -108.06 140.91 22.13 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.149 1.38 . . . . 0.0 111.087 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.04 124.22 9.9 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.462 2.108 . . . . 0.0 110.205 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.5 144.24 31.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.33 1.452 . . . . 0.0 110.291 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.6 p -133.87 149.59 51.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -166.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -160.18 178.28 9.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.812 1.645 . . . . 0.0 111.496 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 27.5 m -134.14 143.06 47.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.145 1.378 . . . . 0.0 110.565 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 22.7 t -115.14 130.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 108.137 168.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.83 129.83 36.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 111.08 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 69.6 p -137.1 1.01 2.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.103 1.361 . . . . 0.0 113.841 -166.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 82.4 tttt -55.89 -38.95 70.87 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.466 1.506 . . . . 0.0 114.992 -166.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -115.73 10.23 15.38 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.671 1.589 . . . . 0.0 112.667 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.4 67.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.15 151.37 8.07 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.672 1.13 . . . . 0.0 112.281 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.74 166.12 22.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 0.0 113.298 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 145.23 9.61 0.31 Allowed Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 102.0 96.95 2.32 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.484 1.516 . . . . 0.0 113.157 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.98 132.83 36.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.347 1.459 . . . . 0.0 109.251 169.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.5 t -134.98 165.78 24.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.366 1.467 . . . . 0.0 112.45 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 36.1 tp -166.86 137.36 3.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.738 2.015 . . . . 0.0 109.272 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.45 34.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.162 0.985 . . . . 0.0 112.16 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.6 mt -136.42 139.93 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.792 1.237 . . . . 0.0 110.264 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.58 145.74 51.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.717 1.607 . . . . 0.0 109.652 170.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.28 -165.48 25.74 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 119.091 -0.838 . . . . 0.0 114.841 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.47 -26.01 70.35 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.316 3.344 . . . . 0.0 112.657 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.3 t -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.962 1.305 . . . . 0.0 109.144 159.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.72 116.49 12.15 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.978 -1.076 . . . . 0.0 111.4 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -72.81 147.55 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.795 0.838 . . . . 0.0 111.903 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.17 143.66 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.677 0.791 . . . . 0.0 109.76 167.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.76 145.88 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.164 1.385 . . . . 0.0 110.826 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -142.74 164.72 29.34 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.045 162.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.5 p -161.78 155.72 21.82 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.939 1.296 . . . . 0.0 112.616 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 79.3 m -143.85 124.89 14.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.544 1.537 . . . . 0.0 110.437 -171.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.53 130.96 36.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.54 1.136 . . . . 0.0 111.216 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.43 147.87 32.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.471 1.508 . . . . 0.0 112.017 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.3 -15.47 63.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.0 0.92 . . . . 0.0 113.437 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -74.92 -6.58 49.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.103 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.62 33.08 7.68 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.476 1.036 . . . . 0.0 113.951 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.0 p -138.43 157.26 46.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.961 1.304 . . . . 0.0 111.268 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 39.2 t -105.24 124.13 49.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.572 1.149 . . . . 0.0 108.734 158.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -90.34 146.61 24.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.922 0.889 . . . . 0.0 110.282 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -129.38 143.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 95.3 p -136.31 149.68 48.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.811 1.244 . . . . 0.0 112.155 168.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.4 p90 -151.52 152.79 33.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.47 104.97 52.82 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.864 1.666 . . . . 0.0 110.649 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.25 164.98 14.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.839 3.026 . . . . 0.0 110.374 167.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -137.15 -20.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.7 mt -118.38 149.31 45.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.013 1.325 . . . . 0.0 110.327 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.57 155.67 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.966 2.444 . . . . 0.0 110.883 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.83 -162.38 23.82 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.738 1.161 . . . . 0.0 113.691 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -92.11 129.02 38.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.487 1.515 . . . . 0.0 112.671 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 130.05 55.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.485 1.514 . . . . 0.0 110.207 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -90.91 119.03 30.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.616 1.167 . . . . 0.0 110.52 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.42 123.22 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.304 1.842 . . . . 0.0 108.501 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -104.45 134.3 47.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.516 1.526 . . . . 0.0 109.391 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 83.8 t -133.95 133.47 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.312 1.445 . . . . 0.0 108.454 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.74 141.73 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.906 1.283 . . . . 0.0 111.071 -169.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.31 120.25 14.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.695 1.198 . . . . 0.0 109.974 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 52.48 58.42 5.41 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.445 1.498 . . . . 0.0 112.067 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 60.64 2.8 0.53 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.911 2.885 . . . . 0.0 116.684 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -107.27 127.1 53.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.473 1.109 . . . . 0.0 111.177 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -62.93 157.67 21.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.816 0.846 . . . . 0.0 112.392 167.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 32.6 m -87.73 155.75 53.16 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 0.0 110.498 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.53 121.59 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.834 2.356 . . . . 0.0 110.353 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.53 -13.73 66.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.373 1.464 . . . . 0.0 116.037 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.3 p -79.79 151.53 73.92 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 120.434 2.117 . . . . 0.0 113.028 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.35 149.75 94.62 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 119.107 0.717 . . . . 0.0 112.295 -4.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -102.44 156.1 17.82 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.84 1.656 . . . . 0.0 110.888 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 63.4 m -111.29 118.45 35.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.692 0.797 . . . . 0.0 111.047 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.18 133.17 37.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.036 1.334 . . . . 0.0 110.921 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.66 106.36 18.45 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.964 0.905 . . . . 0.0 109.738 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 90.4 t -90.98 145.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 0.0 109.875 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.7 t -137.25 174.26 10.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.049 0.939 . . . . 0.0 113.031 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.72 140.5 18.04 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.741 1.639 . . . . 0.0 112.914 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 . . . . . 0 CA--C 1.545 0.783 0 C-N-CA 124.048 0.939 . . . . 0.0 112.813 173.056 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . 0.494 HD11 HG12 ' A' 1860 ' ' VAL . 47.8 tp . . . . . 0 CA--C 1.537 0.448 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -47.62 111.06 1.53 Allowed Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.925 1.69 . . . . 0.0 112.326 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.44 155.28 45.72 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.021 2.48 . . . . 0.0 110.655 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.77 125.45 51.43 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.611 0.764 . . . . 0.0 110.514 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -151.46 128.33 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.782 1.633 . . . . 0.0 109.53 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.75 125.95 13.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 109.973 -167.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 96.7 t -93.23 137.92 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.911 1.284 . . . . 0.0 109.863 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.9 mt -131.25 136.2 28.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.651 1.58 . . . . 0.0 108.752 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.28 58.17 6.87 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.273 3.315 . . . . 0.0 111.896 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -107.45 158.56 17.09 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.878 1.671 . . . . 0.0 111.197 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.6 m -125.45 123.08 38.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.819 1.248 . . . . 0.0 109.576 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.45 128.37 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.758 1.223 . . . . 0.0 109.73 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.38 -143.12 0.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.065 1.346 . . . . 0.0 110.718 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -75.53 -10.63 59.62 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.43 168.99 50.68 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.354 1.454 . . . . 0.0 113.704 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 147.6 23.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.329 1.451 . . . . 0.0 111.699 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.49 131.52 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.292 1.437 . . . . 0.0 111.056 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 57.5 p -147.44 -168.82 3.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.546 1.938 . . . . 0.0 109.807 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.49 -155.76 9.12 Favored Glycine 0 N--CA 1.467 0.765 0 O-C-N 121.357 -0.839 . . . . 0.0 114.957 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.91 137.0 9.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.45 1.9 . . . . 0.0 108.964 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 6.7 t -108.5 135.22 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.949 1.699 . . . . 0.0 108.629 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -117.37 123.42 46.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.121 1.368 . . . . 0.0 110.554 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.0 mtm -96.85 147.56 33.1 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.827 1.651 . . . . 0.0 111.349 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.49 -18.79 25.62 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.643 2.895 . . . . 0.0 113.576 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -77.28 2.27 16.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.071 1.348 . . . . 0.0 114.338 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.17 48.29 3.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.678 1.133 . . . . 0.0 113.218 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -156.12 166.39 33.59 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.793 1.637 . . . . 0.0 111.872 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.38 161.48 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.446 1.098 . . . . 0.0 113.194 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.1 178.24 10.51 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.733 2.013 . . . . 0.0 111.006 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.91 140.72 25.14 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.385 1.074 . . . . 0.0 110.872 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.63 160.34 22.0 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.605 2.87 . . . . 0.0 111.003 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.8 m -104.39 120.73 41.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 108.692 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.62 131.35 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.194 0.998 . . . . 0.0 108.706 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.7 m -132.14 128.14 37.45 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.303 1.441 . . . . 0.0 109.221 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.43 134.37 42.37 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.275 0.63 . . . . 0.0 111.564 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -82.69 -13.52 56.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.0 ttpt 67.25 18.86 10.33 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.954 2.102 . . . . 0.0 113.356 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.43 17.38 8.95 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.824 2.049 . . . . 0.0 112.499 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.6 13.12 68.14 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.824 1.202 . . . . 0.0 114.014 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 62.7 p -136.9 164.65 27.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.911 2.085 . . . . 0.0 110.027 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.5 m -127.74 163.38 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.861 1.264 . . . . 0.0 110.115 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.1 t -120.69 147.19 45.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 110.098 164.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 39.0 t -120.01 128.09 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.523 1.529 . . . . 0.0 108.424 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.94 156.55 43.56 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.667 1.587 . . . . 0.0 111.829 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -163.93 133.4 3.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.069 1.348 . . . . 0.0 111.97 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -83.62 123.17 76.7 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.539 1.136 . . . . 0.0 110.483 175.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.24 174.49 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.632 2.888 . . . . 0.0 111.823 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -149.66 -40.24 0.14 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -137.55 154.89 49.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.315 1.446 . . . . 0.0 110.509 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.18 171.0 14.93 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.329 1.052 . . . . 0.0 113.624 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 118.08 -173.03 14.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.048 1.785 . . . . 0.0 113.943 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -85.19 131.78 34.38 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.977 1.311 . . . . 0.0 110.57 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 53.0 m80 -125.69 156.41 39.37 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.743 1.617 . . . . 0.0 111.47 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -134.31 146.49 50.03 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.352 1.461 . . . . 0.0 109.486 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 17.3 tmm? -151.1 132.41 14.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.627 0.771 . . . . 0.0 112.252 -168.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -106.03 148.52 27.65 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.873 1.669 . . . . 0.0 111.65 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 31.4 mm -133.63 135.42 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.406 1.082 . . . . 0.0 110.9 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.36 128.19 19.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.037 1.335 . . . . 0.0 113.085 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.37 126.58 45.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.873 2.069 . . . . 0.0 109.689 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.79 33.27 13.79 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.877 1.271 . . . . 0.0 112.539 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.4 t30 75.5 2.75 3.86 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.334 2.654 . . . . 0.0 114.795 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.26 132.77 50.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.177 1.391 . . . . 0.0 110.843 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -56.55 134.95 54.66 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.01 155.9 88.19 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.592 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.02 -19.67 69.65 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.503 2.136 . . . . 0.0 113.853 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -80.45 -3.5 89.99 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.32 0.964 . . . . 0.0 114.686 172.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 7.7 t -93.02 154.18 41.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 119.203 1.502 . . . . 0.0 111.887 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -82.36 163.01 75.8 Favored 'Cis proline' 0 C--N 1.352 0.726 0 CA-C-N 119.795 0.962 . . . . 0.0 111.591 -13.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 72.1 mt -111.52 156.63 21.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.634 1.574 . . . . 0.0 111.376 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -147.27 139.29 24.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.149 1.38 . . . . 0.0 109.416 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.2 p90 -162.68 162.19 26.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.889 0.876 . . . . 0.0 112.5 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 62.9 t80 -109.72 145.22 36.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.446 1.098 . . . . 0.0 113.004 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . 0.494 HG12 HD11 ' A' 1788 ' ' LEU . 69.4 t -121.95 141.02 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.311 1.844 . . . . 0.0 109.302 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -155.18 144.58 21.16 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.251 1.42 . . . . 0.0 112.989 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . 0.408 ' CD1' HD13 ' A' 1788 ' ' LEU . 49.9 m-85 -70.06 145.32 51.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 111.551 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 28.2 m -66.52 -19.4 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -91.11 0.56 57.51 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.342 1.457 . . . . 0.0 114.859 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 96.3 m -62.8 132.94 53.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.307 0.958 . . . . 0.0 112.247 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.87 -25.14 18.31 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.704 1.145 . . . . 0.0 113.887 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -68.5 159.71 31.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.22 1.008 . . . . 0.0 113.201 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.4 p -64.37 131.4 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.096 0.959 . . . . 0.0 111.272 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 53.4 p -136.36 164.78 27.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.166 1.786 . . . . 0.0 110.106 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -143.7 144.52 31.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.284 1.034 . . . . 0.0 111.671 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 38.9 p90 -166.49 167.27 15.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.684 1.593 . . . . 0.0 112.861 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.8 170.9 12.86 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.508 1.528 . . . . 0.0 112.454 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.74 -33.82 12.29 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.701 2.267 . . . . 0.0 113.142 -169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.5 -32.89 83.04 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.358 0.981 . . . . 0.0 114.609 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.82 -3.12 39.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.03 1.415 . . . . 0.0 113.771 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 77.5 m -113.31 -47.16 3.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.583 1.953 . . . . 0.0 111.863 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -138.58 143.38 39.35 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.684 1.594 . . . . 0.0 112.448 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.83 175.74 22.39 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.056 1.313 . . . . 0.0 113.026 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -139.62 134.67 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.452 1.101 . . . . 0.0 108.778 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.8 m -56.54 132.32 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 24.7 m120 69.35 1.65 3.37 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.112 2.165 . . . . 0.0 114.401 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -105.27 137.56 19.29 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.285 1.434 . . . . 0.0 110.433 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.47 121.94 7.88 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.417 2.078 . . . . 0.0 110.364 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 145.22 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.457 1.503 . . . . 0.0 110.393 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.5 p -136.22 149.17 48.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.6 p90 -160.74 176.29 11.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.96 1.704 . . . . 0.0 111.47 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.7 m -133.35 141.52 47.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.068 1.347 . . . . 0.0 110.851 -170.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.77 136.36 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.786 1.634 . . . . 0.0 108.014 168.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -104.13 123.0 46.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.421 1.089 . . . . 0.0 110.284 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.9 p -127.04 3.81 6.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.785 1.634 . . . . 0.0 113.636 -166.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.49 -36.92 36.02 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.856 2.062 . . . . 0.0 115.64 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -129.3 17.54 6.0 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.426 1.49 . . . . 0.0 112.423 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.7 -30.07 59.18 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.2 142.36 5.99 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.385 1.469 . . . . 0.0 113.156 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -72.9 152.95 41.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.668 1.187 . . . . 0.0 112.087 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.37 13.12 0.05 OUTLIER Glycine 0 N--CA 1.476 1.36 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 107.96 89.77 2.09 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-N 118.776 1.288 . . . . 0.0 112.728 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.14 126.62 31.08 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.802 1.241 . . . . 0.0 109.367 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -121.54 157.95 29.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.196 1.798 . . . . 0.0 112.166 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.3 tp -160.19 134.99 7.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.915 1.686 . . . . 0.0 109.343 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.82 158.1 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.384 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.55 138.03 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.859 1.263 . . . . 0.0 109.964 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.6 164.24 20.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.266 1.826 . . . . 0.0 109.731 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 169.96 -155.84 26.05 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.673 -1.071 . . . . 0.0 114.224 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.36 -21.92 60.53 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.866 3.044 . . . . 0.0 112.784 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 14.5 t -152.05 164.53 37.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.616 1.566 . . . . 0.0 109.708 166.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -72.45 112.58 8.63 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.991 -1.068 . . . . 0.0 111.153 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.43 148.17 48.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.762 0.825 . . . . 0.0 111.088 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.19 144.1 25.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.045 0.538 . . . . 0.0 110.27 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.7 mt -134.27 144.93 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.056 1.342 . . . . 0.0 110.074 -163.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.5 t -142.45 162.28 35.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.766 1.226 . . . . 0.0 110.922 166.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -159.32 158.83 33.09 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.645 1.178 . . . . 0.0 112.622 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 55.7 m -142.55 123.93 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.273 1.429 . . . . 0.0 110.162 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.09 132.4 37.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.887 1.275 . . . . 0.0 111.152 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -112.71 148.18 35.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.215 1.406 . . . . 0.0 111.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -70.54 -14.03 62.34 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.111 0.964 . . . . 0.0 112.877 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.45 -6.44 50.12 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.707 1.603 . . . . 0.0 114.125 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 35.81 6.21 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.555 1.074 . . . . 0.0 113.519 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.3 p -141.16 161.21 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.307 1.443 . . . . 0.0 111.172 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 66.0 m -115.39 128.3 55.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.032 1.333 . . . . 0.0 108.785 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -89.01 147.63 24.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.65 0.78 . . . . 0.0 110.296 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -129.38 143.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 110.127 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 77.6 p -136.82 148.02 46.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.916 1.286 . . . . 0.0 111.755 167.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 12.8 p90 -152.75 157.02 40.22 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.66 105.93 35.23 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.857 1.663 . . . . 0.0 110.081 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.92 167.26 20.41 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.543 2.829 . . . . 0.0 110.31 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 30.7 m -136.17 -25.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.3 mt -118.26 147.99 42.84 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.042 1.337 . . . . 0.0 110.395 170.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.36 156.11 45.98 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.924 2.416 . . . . 0.0 110.952 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.53 -149.1 20.55 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.55 1.072 . . . . 0.0 112.997 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -113.7 128.27 56.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.041 1.336 . . . . 0.0 111.24 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -112.31 139.74 47.61 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.371 1.468 . . . . 0.0 110.929 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.6 m -97.79 122.28 40.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.642 1.177 . . . . 0.0 110.496 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.34 127.91 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.482 1.513 . . . . 0.0 108.543 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.88 133.02 53.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.778 1.631 . . . . 0.0 109.861 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.4 t -133.9 132.41 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.504 1.521 . . . . 0.0 108.123 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -156.67 144.49 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.852 1.261 . . . . 0.0 110.786 -167.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.7 118.69 12.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 51.57 59.57 4.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.446 1.498 . . . . 0.0 112.179 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 59.39 12.05 2.5 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.036 2.534 . . . . 0.0 116.424 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -119.57 125.43 48.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.389 1.076 . . . . 0.0 111.133 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -60.63 155.45 18.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.099 0.96 . . . . 0.0 112.774 171.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.5 m -74.51 152.19 87.51 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 169.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.05 -12.33 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.506 2.138 . . . . 0.0 114.897 -167.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -102.22 -11.6 36.07 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 174.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 80.5 p -84.5 156.07 62.38 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 120.055 1.927 . . . . 0.0 113.6 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.49 151.21 96.77 Favored 'Cis proline' 0 C--N 1.352 0.763 0 CA-C-N 118.982 0.672 . . . . 0.0 112.472 -4.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -102.42 160.05 14.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.43 1.492 . . . . 0.0 110.825 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 44.3 m -119.71 116.62 26.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.747 0.819 . . . . 0.0 110.57 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.73 126.43 43.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.529 1.132 . . . . 0.0 111.222 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.34 114.41 21.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.163 0.985 . . . . 0.0 108.926 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.7 t -103.34 136.2 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.065 0.946 . . . . 0.0 110.402 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 34.0 p -121.83 171.59 8.79 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 112.589 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.95 145.66 30.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.936 1.255 . . . . 0.0 112.686 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 . . . . . 0 CA--C 1.548 0.889 0 C-N-CA 124.156 0.982 . . . . 0.0 112.863 174.125 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . 0.63 HD11 HG12 ' A' 1860 ' ' VAL . 22.0 tp . . . . . 0 CA--C 1.534 0.332 0 CA-C-O 120.727 0.298 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.3 120.28 46.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.311 1.044 . . . . 0.0 111.303 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.24 156.64 58.83 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.459 2.773 . . . . 0.0 110.922 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.1 t80 -108.12 127.72 54.06 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.656 0.782 . . . . 0.0 111.096 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.52 135.74 14.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.655 1.582 . . . . 0.0 110.785 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.39 152.48 41.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.518 1.927 . . . . 0.0 109.862 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.0 p -123.31 139.16 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.023 1.329 . . . . 0.0 110.469 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.24 137.49 29.42 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.271 1.828 . . . . 0.0 108.486 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -79.06 45.95 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.555 3.503 . . . . 0.0 112.999 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 29.2 t80 -91.15 153.49 20.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.135 1.374 . . . . 0.0 111.137 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.4 m -125.28 126.36 45.0 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.946 1.298 . . . . 0.0 109.746 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 95.2 mt -91.18 138.06 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.059 1.344 . . . . 0.0 109.917 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -149.74 95.96 2.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.501 1.12 . . . . 0.0 111.521 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 72.59 -31.74 0.23 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 128.539 2.736 . . . . 0.0 115.179 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.1 175.74 54.68 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.626 1.584 . . . . 0.0 113.443 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -111.45 141.68 44.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.235 1.414 . . . . 0.0 111.289 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -125.31 134.29 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.548 1.539 . . . . 0.0 110.602 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.18 170.64 17.97 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.183 1.793 . . . . 0.0 110.324 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -158.89 -167.48 19.67 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 115.884 1.114 . . . . 0.0 115.884 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.48 134.85 15.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.702 1.601 . . . . 0.0 109.264 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.0 t -104.53 131.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.694 1.598 . . . . 0.0 107.443 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -116.38 129.05 56.04 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.833 1.253 . . . . 0.0 110.657 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -97.02 150.68 37.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.71 1.604 . . . . 0.0 111.468 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.4 -20.56 27.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.507 2.804 . . . . 0.0 113.051 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -79.68 -0.54 34.44 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.945 1.698 . . . . 0.0 114.561 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.41 54.08 2.48 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.56 1.076 . . . . 0.0 113.161 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -155.62 167.04 31.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.064 1.746 . . . . 0.0 111.676 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.8 m -140.43 158.09 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.849 1.26 . . . . 0.0 112.58 -172.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.89 166.87 32.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.507 1.923 . . . . 0.0 110.892 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.01 137.73 20.16 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.2 -0.937 . . . . 0.0 111.588 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.77 163.96 20.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.958 3.105 . . . . 0.0 110.993 168.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.7 m -107.87 117.82 35.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.088 1.355 . . . . 0.0 108.852 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -97.64 133.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.43 1.092 . . . . 0.0 109.007 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -125.85 130.64 51.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.111 1.764 . . . . 0.0 109.901 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 17.5 t0 -75.52 122.23 23.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.169 0.988 . . . . 0.0 110.775 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -84.46 -15.4 46.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.7 tttt 71.39 0.22 3.37 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.614 2.366 . . . . 0.0 114.017 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.83 7.87 45.67 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.07 2.148 . . . . 0.0 113.023 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.83 15.12 55.39 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.983 1.278 . . . . 0.0 113.835 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.9 p -132.38 161.78 32.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.419 1.888 . . . . 0.0 110.3 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -125.4 145.24 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.787 1.235 . . . . 0.0 109.831 167.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.2 m -104.71 139.25 39.8 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.291 1.037 . . . . 0.0 108.564 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.7 t -124.14 129.49 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.912 1.285 . . . . 0.0 109.108 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -129.37 161.86 29.33 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -159.64 135.91 8.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 111.828 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.35 114.39 60.88 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.801 1.241 . . . . 0.0 110.602 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -83.97 165.82 13.21 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.723 2.949 . . . . 0.0 112.221 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.3 t -144.35 -1.5 0.92 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.92 152.02 3.49 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.509 1.924 . . . . 0.0 111.27 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.55 175.37 7.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.309 1.443 . . . . 0.0 114.49 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.86 -171.02 13.61 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 126.138 1.827 . . . . 0.0 113.985 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 59.3 tp -79.69 127.41 32.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.623 1.169 . . . . 0.0 110.454 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 55.0 m80 -125.69 168.99 12.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.809 1.644 . . . . 0.0 111.394 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -147.35 153.52 39.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.04 0.936 . . . . 0.0 111.77 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 22.1 ttm -124.34 133.71 53.37 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.117 1.767 . . . . 0.0 110.095 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -111.14 136.12 50.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.236 1.814 . . . . 0.0 109.829 169.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.1 mm -135.59 134.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.028 1.331 . . . . 0.0 110.451 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.03 140.42 36.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.366 1.066 . . . . 0.0 113.588 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.4 t80 -103.6 118.09 35.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.058 2.143 . . . . 0.0 109.256 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.81 31.92 11.41 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.826 1.25 . . . . 0.0 112.945 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.13 5.0 4.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.143 2.577 . . . . 0.0 115.171 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.8 ttp -95.4 127.94 41.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.595 1.158 . . . . 0.0 110.079 165.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.79 137.55 57.65 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.254 -0.904 . . . . 0.0 112.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -71.82 154.43 92.81 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.432 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.55 -17.86 61.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.582 2.188 . . . . 0.0 113.912 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -88.64 2.54 84.67 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.814 1.197 . . . . 0.0 114.88 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 31.5 t -101.94 142.62 24.97 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 119.822 1.811 . . . . 0.0 111.953 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.61 170.33 57.41 Favored 'Cis proline' 0 C--N 1.352 0.76 0 CA-C-N 119.816 0.97 . . . . 0.0 112.477 -3.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.2 mt -120.91 151.42 39.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.118 1.767 . . . . 0.0 110.38 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -132.67 144.73 50.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.73 1.212 . . . . 0.0 110.505 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 6.0 p90 -165.79 154.65 11.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.362 1.065 . . . . 0.0 112.304 -172.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 37.2 t80 -101.66 143.23 31.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 112.429 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . 0.63 HG12 HD11 ' A' 1788 ' ' LEU . 91.8 t -116.09 137.57 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.21 1.804 . . . . 0.0 109.413 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.0 t0 -159.6 147.64 17.3 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.857 1.263 . . . . 0.0 112.267 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -74.47 149.11 40.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 0.0 112.784 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 3.4 p -70.59 -22.33 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.507 -0.745 . . . . 0.0 112.83 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -82.67 -13.24 56.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.107 1.363 . . . . 0.0 114.174 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 82.9 m -58.98 134.49 57.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.535 1.134 . . . . 0.0 113.935 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.15 70.08 1.08 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.702 1.62 . . . . 0.0 111.772 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -162.6 168.58 21.55 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.652 1.581 . . . . 0.0 113.072 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.8 p -68.59 143.79 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.634 0.774 . . . . 0.0 110.074 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -163.52 159.51 22.08 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.692 1.597 . . . . 0.0 110.025 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -138.33 144.76 40.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.335 1.054 . . . . 0.0 112.358 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 45.0 p90 -167.67 165.44 14.32 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.683 1.593 . . . . 0.0 113.239 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.58 175.5 13.96 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.253 1.406 . . . . 0.0 112.977 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.56 -37.0 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.764 -171.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.06 91.34 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.538 1.063 . . . . 0.0 114.507 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.02 -6.51 52.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.704 1.252 . . . . 0.0 113.327 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 38.7 m -100.98 -54.73 2.73 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.222 1.809 . . . . 0.0 110.18 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -137.26 139.8 41.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.601 1.961 . . . . 0.0 112.375 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -129.97 172.84 20.01 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.058 1.313 . . . . 0.0 113.242 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 60.9 t -136.85 134.11 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.627 1.171 . . . . 0.0 108.948 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -56.95 139.23 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.0 m-80 66.16 2.24 2.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.86 2.064 . . . . 0.0 114.809 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.35 142.22 29.09 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.908 1.683 . . . . 0.0 111.096 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.79 119.21 5.95 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.637 2.224 . . . . 0.0 110.415 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -94.82 145.7 24.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.218 1.407 . . . . 0.0 109.996 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 76.0 p -136.18 151.57 49.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -168.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.7 p90 -162.87 176.16 10.49 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.461 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.9 m -134.05 138.34 45.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.707 1.203 . . . . 0.0 110.983 -169.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.4 t -102.09 134.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.186 1.394 . . . . 0.0 107.701 165.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -96.43 128.08 43.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.071 0.948 . . . . 0.0 109.824 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.1 p -129.39 7.46 5.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.379 1.872 . . . . 0.0 112.861 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -55.65 -32.17 62.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.91 1.684 . . . . 0.0 114.464 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.65 11.85 13.83 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.541 1.536 . . . . 0.0 113.063 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.03 -15.64 56.78 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.75 -128.75 8.62 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.344 0.973 . . . . 0.0 112.162 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -155.65 150.3 26.19 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.443 1.497 . . . . 0.0 110.723 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.3 -85.0 0.08 OUTLIER Glycine 0 N--CA 1.469 0.851 0 C-N-CA 125.482 1.515 . . . . 0.0 111.003 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -168.77 118.08 0.76 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.575 1.083 . . . . 0.0 112.222 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.14 138.2 32.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.439 1.096 . . . . 0.0 110.063 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.4 m -131.32 158.52 40.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.677 1.591 . . . . 0.0 111.547 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 43.2 tp -156.75 135.93 12.01 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.783 1.633 . . . . 0.0 108.893 -171.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.65 158.93 39.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.77 0.828 . . . . 0.0 112.346 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.0 mt -134.39 137.51 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 109.445 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.15 122.34 38.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.082 1.353 . . . . 0.0 109.379 172.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -139.1 -175.75 14.24 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.724 1.154 . . . . 0.0 114.08 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.5 -23.84 43.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.045 3.164 . . . . 0.0 112.112 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.3 t -136.59 152.23 50.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.506 1.522 . . . . 0.0 108.578 160.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.5 tptt -71.91 120.05 16.96 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.033 -1.042 . . . . 0.0 111.976 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.36 147.97 41.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.933 0.893 . . . . 0.0 111.681 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -89.81 142.85 27.3 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.505 0.722 . . . . 0.0 109.741 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.7 mt -135.11 143.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.587 1.155 . . . . 0.0 110.334 -167.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.2 t -143.19 158.22 43.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 110.838 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -158.74 157.31 31.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.442 1.097 . . . . 0.0 112.988 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 67.3 m -140.89 115.2 9.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.447 1.499 . . . . 0.0 109.868 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.85 136.92 36.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.026 1.331 . . . . 0.0 111.338 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -117.88 146.22 44.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.843 1.657 . . . . 0.0 111.986 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.86 -15.16 63.49 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.759 1.224 . . . . 0.0 112.496 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -70.87 -9.32 57.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.937 1.695 . . . . 0.0 114.159 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.88 33.73 7.22 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.266 0.936 . . . . 0.0 113.553 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.9 p -139.14 163.54 32.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.345 1.458 . . . . 0.0 110.931 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -130.88 125.64 34.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.453 1.501 . . . . 0.0 108.642 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -92.41 144.52 25.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.198 0.999 . . . . 0.0 110.589 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.9 t -126.62 141.7 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.542 1.537 . . . . 0.0 110.802 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 63.2 m -132.92 141.01 48.14 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.985 1.714 . . . . 0.0 110.795 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 10.6 p90 -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.56 104.56 49.45 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.375 1.87 . . . . 0.0 110.524 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.8 165.13 15.68 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.694 2.93 . . . . 0.0 110.199 166.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.0 p -127.77 -19.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.3 pp -146.84 152.06 43.48 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.188 0.995 . . . . 0.0 111.594 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -67.46 147.77 77.83 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.041 2.494 . . . . 0.0 112.838 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.21 -171.09 30.18 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.53 1.062 . . . . 0.0 113.708 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.92 134.64 34.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.956 1.302 . . . . 0.0 112.104 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.66 126.37 41.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.586 1.554 . . . . 0.0 109.842 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 62.6 m -88.37 124.33 33.82 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.987 -1.07 . . . . 0.0 110.708 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.0 128.31 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.512 1.525 . . . . 0.0 108.304 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.1 tt -112.31 130.34 55.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.426 1.49 . . . . 0.0 109.385 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 24.0 t -132.18 131.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.144 0.978 . . . . 0.0 109.577 173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.98 147.48 27.92 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.122 1.369 . . . . 0.0 111.683 -168.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.57 120.25 11.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 109.8 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.12 56.24 5.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.6 1.56 . . . . 0.0 111.824 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.4 pt-20 57.24 13.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.415 2.686 . . . . 0.0 116.322 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -120.23 127.09 52.11 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.732 1.213 . . . . 0.0 110.641 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -63.69 147.08 52.54 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.324 -0.86 . . . . 0.0 112.079 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -70.77 153.73 94.69 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.758 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.43 129.64 30.49 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.632 2.221 . . . . 0.0 110.887 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 91.95 -14.76 63.5 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.103 1.335 . . . . 0.0 114.949 -175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.8 t -78.42 142.63 62.84 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 119.433 1.617 . . . . 0.0 111.734 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.41 140.79 69.24 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.317 0.792 . . . . 0.0 111.989 -4.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -93.52 166.29 12.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.312 1.845 . . . . 0.0 110.689 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 51.3 m -124.44 113.99 18.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.816 0.847 . . . . 0.0 110.395 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.9 156.97 19.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.679 1.192 . . . . 0.0 110.953 167.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -120.9 126.55 50.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.184 0.993 . . . . 0.0 109.949 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.2 t -103.18 131.81 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.38 1.472 . . . . 0.0 109.793 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.2 p -108.99 162.1 14.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.73 1.212 . . . . 0.0 112.62 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.49 142.69 28.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.91 1.243 . . . . 0.0 112.089 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.3 t70 . . . . . 0 CA--C 1.549 0.926 0 C-N-CA 124.602 1.161 . . . . 0.0 113.52 -178.717 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 61.5 mt . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.03 0.443 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.22 115.34 10.3 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.551 1.54 . . . . 0.0 111.377 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.79 129.43 18.63 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.32 2.013 . . . . 0.0 108.852 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -114.83 128.88 56.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.616 0.766 . . . . 0.0 111.722 -171.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -157.67 142.72 16.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.817 1.647 . . . . 0.0 111.092 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.97 156.16 49.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.595 1.958 . . . . 0.0 110.141 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.5 p -122.35 137.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.904 1.282 . . . . 0.0 109.959 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 57.9 mt -131.64 133.48 24.31 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.999 1.72 . . . . 0.0 109.035 -172.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.94 112.1 3.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.266 2.644 . . . . 0.0 109.81 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.0 t80 -175.54 148.58 0.93 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.107 2.163 . . . . 0.0 109.177 -171.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.3 m -130.75 124.01 30.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.518 1.127 . . . . 0.0 109.234 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.7 mt -74.47 125.52 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.195 0.598 . . . . 0.0 110.265 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.6 mttp -110.42 -143.0 0.39 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.694 1.597 . . . . 0.0 110.513 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.46 120.29 19.82 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.651 -1.281 . . . . 0.0 110.883 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.98 -152.14 20.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.589 1.566 . . . . 0.0 112.303 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -160.31 147.47 16.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.956 1.302 . . . . 0.0 110.978 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.29 136.73 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.402 1.481 . . . . 0.0 111.207 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 25.2 p -149.58 174.31 12.67 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.573 1.949 . . . . 0.0 110.235 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -157.82 -166.33 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -152.34 142.3 22.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.234 1.813 . . . . 0.0 109.42 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.7 t -119.93 133.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.948 1.699 . . . . 0.0 108.673 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -109.97 132.89 53.75 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.665 1.186 . . . . 0.0 111.794 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -104.34 143.43 26.66 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.674 1.589 . . . . 0.0 111.219 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.08 -29.15 64.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.211 3.274 . . . . 0.0 114.994 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 6.1 m -69.94 -0.77 7.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.3 42.04 6.35 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.6 1.095 . . . . 0.0 112.839 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.59 162.65 39.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.809 1.644 . . . . 0.0 111.99 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.5 m -141.18 158.15 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.988 1.315 . . . . 0.0 112.204 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -151.53 179.1 8.66 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.018 2.127 . . . . 0.0 109.974 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.54 143.8 38.77 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 121.107 -0.996 . . . . 0.0 111.718 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -83.73 166.34 13.47 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.089 3.192 . . . . 0.0 111.405 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 77.5 m -107.21 130.58 54.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.4 1.48 . . . . 0.0 108.651 171.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.52 136.7 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.518 1.127 . . . . 0.0 109.443 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 63.0 m -133.26 124.26 27.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.659 1.584 . . . . 0.0 109.648 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.02 127.26 31.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.292 1.037 . . . . 0.0 111.076 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -87.52 -4.26 58.98 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -170.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 35.9 mmtm 71.57 -5.91 1.53 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.638 2.375 . . . . 0.0 114.538 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -98.21 2.79 48.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.715 2.006 . . . . 0.0 113.218 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.13 16.8 31.62 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.026 1.298 . . . . 0.0 114.457 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 65.1 p -128.75 157.39 41.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.016 1.726 . . . . 0.0 110.677 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -115.31 139.61 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.051 0.94 . . . . 0.0 109.633 163.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.1 m -96.7 138.05 34.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.659 1.184 . . . . 0.0 108.495 169.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 24.8 t -119.11 135.05 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.483 1.513 . . . . 0.0 109.052 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.1 152.77 51.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.558 1.543 . . . . 0.0 111.785 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -153.47 132.44 12.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.349 1.46 . . . . 0.0 110.914 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.43 117.89 70.0 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.236 1.014 . . . . 0.0 110.5 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.56 130.69 12.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.132 2.554 . . . . 0.0 111.823 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 78.2 p -118.7 -15.18 9.51 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -141.54 157.54 44.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.909 1.684 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -90.99 166.28 13.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.27 1.028 . . . . 0.0 112.004 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.24 -166.71 12.17 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.693 1.616 . . . . 0.0 114.079 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -91.77 122.28 34.18 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.338 1.455 . . . . 0.0 110.494 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.5 m80 -119.1 169.57 9.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 111.26 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.51 152.72 42.95 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 171.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 5.7 ttm -125.55 119.45 28.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.886 2.074 . . . . 0.0 109.928 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -95.86 138.4 33.57 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 109.967 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.6 mm -135.96 135.43 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.745 1.218 . . . . 0.0 110.577 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 141.1 32.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 113.329 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 20.6 t80 -103.14 120.26 40.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.153 1.781 . . . . 0.0 109.788 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.73 34.07 15.36 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.673 1.189 . . . . 0.0 112.701 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 73.29 5.35 5.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.92 2.488 . . . . 0.0 115.066 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -97.06 124.6 41.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.079 1.351 . . . . 0.0 109.921 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -57.51 136.11 56.68 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.265 -0.897 . . . . 0.0 112.938 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.3 pt -68.96 152.41 96.82 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.602 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.28 120.11 7.69 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.326 2.018 . . . . 0.0 109.748 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 90.86 7.57 66.11 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.664 -1.075 . . . . 0.0 115.5 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.2 t -74.16 142.11 78.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 120.283 2.041 . . . . 0.0 110.746 162.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -86.59 171.54 38.47 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 120.388 1.174 . . . . 0.0 113.205 -2.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.63 159.34 16.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.131 1.772 . . . . 0.0 110.62 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -133.47 138.86 46.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.614 1.166 . . . . 0.0 110.434 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -156.94 153.32 27.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.07 0.948 . . . . 0.0 112.863 -167.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 43.6 t80 -104.28 148.79 25.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.983 0.913 . . . . 0.0 112.916 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 32.2 t -132.41 139.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.613 1.565 . . . . 0.0 109.22 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.09 153.5 32.95 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.817 1.247 . . . . 0.0 113.023 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -75.69 125.99 30.14 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 111.35 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.0 p -68.72 -24.72 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.572 -0.705 . . . . 0.0 112.428 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.97 -26.02 63.9 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.996 1.318 . . . . 0.0 114.05 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 85.2 m -73.02 -24.61 60.75 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 74.44 7.19 78.14 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.697 1.141 . . . . 0.0 115.504 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -67.91 161.81 25.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.59 1.556 . . . . 0.0 113.629 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -68.26 127.43 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.7 t -156.21 162.78 40.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.41 1.084 . . . . 0.0 111.161 -167.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.4 147.01 31.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.082 1.353 . . . . 0.0 111.804 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.2 p90 -166.54 162.4 16.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.676 1.591 . . . . 0.0 112.355 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.97 173.34 13.26 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.3 1.428 . . . . 0.0 112.991 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.36 -32.56 15.84 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.989 2.46 . . . . 0.0 112.766 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.4 77.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.347 0.976 . . . . 0.0 114.498 -171.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.4 -2.93 44.01 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.865 1.332 . . . . 0.0 113.508 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -106.4 -40.41 5.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.709 2.003 . . . . 0.0 111.558 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -152.47 141.96 21.69 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.356 1.862 . . . . 0.0 111.92 -164.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.9 -179.91 23.35 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.032 1.301 . . . . 0.0 113.118 168.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 62.1 t -142.04 138.28 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.859 1.663 . . . . 0.0 107.831 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -54.91 134.52 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.3 m-80 69.18 -4.48 1.27 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.185 2.194 . . . . 0.0 114.644 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -95.51 137.25 22.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.598 1.159 . . . . 0.0 110.812 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.03 121.77 7.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.486 2.124 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.51 146.51 28.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.377 1.471 . . . . 0.0 110.319 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 73.2 p -138.92 151.2 46.73 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.09 174.43 13.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.0 1.72 . . . . 0.0 111.527 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.0 m -126.85 143.5 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.279 1.432 . . . . 0.0 110.769 -172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.4 t -117.12 134.69 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.017 1.727 . . . . 0.0 108.287 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.13 133.67 36.07 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.033 0.933 . . . . 0.0 111.811 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -134.8 0.87 2.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.433 1.493 . . . . 0.0 113.801 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -54.03 -40.14 66.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.313 1.845 . . . . 0.0 114.804 -167.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -119.92 12.07 11.95 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.708 1.603 . . . . 0.0 112.587 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.99 -35.94 69.61 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 82.37 145.11 5.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.947 1.261 . . . . 0.0 112.496 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.97 148.26 46.14 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.337 1.055 . . . . 0.0 112.142 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.69 -30.54 0.09 OUTLIER Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.51 1.052 . . . . 0.0 114.688 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 145.18 103.28 0.39 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.435 1.493 . . . . 0.0 112.662 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.38 131.49 35.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.232 1.413 . . . . 0.0 109.256 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 9.2 t -135.06 162.99 30.9 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.593 1.557 . . . . 0.0 112.211 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.9 tp -165.63 135.9 3.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.554 1.941 . . . . 0.0 109.205 -163.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.88 159.52 35.1 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.417 1.087 . . . . 0.0 111.956 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.45 135.83 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.523 1.129 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.3 136.23 53.96 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.108 1.363 . . . . 0.0 110.026 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -162.92 -165.02 19.29 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.509 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.98 -26.56 74.07 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.077 3.185 . . . . 0.0 112.514 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -135.87 156.53 48.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.735 1.214 . . . . 0.0 109.464 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -72.95 111.13 7.79 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.076 -1.015 . . . . 0.0 110.288 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.58 147.0 52.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.083 0.953 . . . . 0.0 111.96 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -84.94 135.07 34.21 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.5 mt -130.6 144.68 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 110.418 -166.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.7 t -145.18 165.02 29.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.824 1.25 . . . . 0.0 111.187 167.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -159.26 154.73 25.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.749 1.22 . . . . 0.0 112.528 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.6 m -138.97 125.09 20.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.524 1.53 . . . . 0.0 110.285 -172.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.11 128.79 35.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.715 1.206 . . . . 0.0 111.12 171.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -104.0 148.48 26.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.46 1.504 . . . . 0.0 111.686 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -68.18 -18.26 64.55 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.179 0.992 . . . . 0.0 113.556 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.02 -22.81 60.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.205 1.002 . . . . 0.0 113.695 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 104.52 45.62 1.41 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.287 0.946 . . . . 0.0 113.19 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -140.89 158.07 44.47 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.296 1.438 . . . . 0.0 110.005 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.5 m -107.92 127.36 53.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.638 1.175 . . . . 0.0 109.263 162.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -86.71 147.08 26.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.419 0.688 . . . . 0.0 109.955 166.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -127.98 144.2 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.67 1.588 . . . . 0.0 109.762 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.08 147.93 46.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.873 1.269 . . . . 0.0 111.98 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.9 p90 -151.88 154.25 35.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.15 107.69 43.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.231 1.812 . . . . 0.0 110.383 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -82.81 176.41 7.74 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.901 3.067 . . . . 0.0 110.333 167.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.2 p -151.45 -28.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 85.9 mt -107.58 147.03 34.54 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.53 1.059 . . . . 0.0 110.525 167.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.91 154.98 48.42 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.863 2.376 . . . . 0.0 110.824 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.89 -165.45 24.59 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.96 137.31 32.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.065 1.346 . . . . 0.0 112.506 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -125.36 125.87 44.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.849 1.66 . . . . 0.0 110.079 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 65.3 m -88.19 122.29 31.58 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.646 1.178 . . . . 0.0 110.643 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.69 123.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.437 1.495 . . . . 0.0 108.626 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.45 136.21 44.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.408 1.483 . . . . 0.0 109.318 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 98.4 t -140.32 127.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.173 1.389 . . . . 0.0 108.912 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.96 140.8 20.99 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.567 1.147 . . . . 0.0 111.331 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.4 121.04 14.28 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.465 1.106 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 49.8 t30 57.47 57.27 4.46 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.219 1.408 . . . . 0.0 111.581 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.0 pt-20 58.51 13.96 2.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.438 2.695 . . . . 0.0 116.372 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -124.83 125.9 44.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.382 1.073 . . . . 0.0 111.329 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -65.04 157.05 29.48 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.942 0.897 . . . . 0.0 112.547 169.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.1 m -75.81 152.65 84.93 Favored Pre-proline 0 N--CA 1.483 1.18 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.392 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.3 -13.01 37.97 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.08 1.853 . . . . 0.0 114.462 -166.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -100.24 -10.31 45.52 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.1 p -87.64 153.63 52.95 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 119.779 1.789 . . . . 0.0 113.148 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.11 141.09 68.21 Favored 'Cis proline' 0 C--N 1.352 0.732 0 CA-C-N 119.063 0.701 . . . . 0.0 112.107 -3.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -90.26 167.17 12.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.094 1.357 . . . . 0.0 110.281 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.2 m -128.35 112.15 14.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 110.048 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.76 150.23 23.71 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.383 1.073 . . . . 0.0 110.574 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -110.68 124.76 52.54 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.246 1.018 . . . . 0.0 109.78 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.4 t -107.5 135.05 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.922 1.289 . . . . 0.0 110.834 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.0 p -113.37 164.93 12.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.31 1.444 . . . . 0.0 112.561 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.93 143.15 29.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.007 1.289 . . . . 0.0 112.183 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 124.429 1.091 . . . . 0.0 113.362 -179.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 21.6 tp . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.326 0.584 . . . . 0.0 111.927 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.0 ttm-85 -59.06 120.04 43.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.931 1.692 . . . . 0.0 111.908 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.37 159.26 47.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.523 2.816 . . . . 0.0 112.02 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.8 t80 -112.16 123.03 49.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.777 1.231 . . . . 0.0 110.098 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.2 134.26 15.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.064 1.346 . . . . 0.0 110.514 170.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.9 140.81 31.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.686 1.594 . . . . 0.0 109.9 -170.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.1 p -107.67 138.93 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.715 1.206 . . . . 0.0 110.855 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.8 mt -134.08 134.99 23.52 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.348 1.859 . . . . 0.0 108.812 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.04 109.22 2.78 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.411 2.74 . . . . 0.0 110.1 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 48.4 t80 -175.2 151.62 1.31 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.999 2.12 . . . . 0.0 109.821 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 29.1 m -135.06 130.93 36.36 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.615 1.166 . . . . 0.0 110.057 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.98 122.35 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 109.437 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.64 -69.91 0.84 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.45 1.1 . . . . 0.0 112.322 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -158.79 127.14 5.24 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.782 1.633 . . . . 0.0 110.952 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.39 -139.54 11.04 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.51 1.528 . . . . 0.0 111.158 -166.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.09 142.29 17.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.366 1.066 . . . . 0.0 111.385 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.7 tt -121.65 135.49 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.785 1.634 . . . . 0.0 111.032 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.4 p -149.28 169.08 21.6 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.182 1.793 . . . . 0.0 110.596 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -162.07 -175.6 33.27 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 115.711 1.045 . . . . 0.0 115.711 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -153.21 143.35 22.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.654 1.582 . . . . 0.0 109.839 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.8 t -115.67 132.49 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.931 1.692 . . . . 0.0 108.101 171.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -119.03 137.47 53.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 110.898 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.8 mtt -110.56 146.67 34.83 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.463 1.505 . . . . 0.0 111.591 -169.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.63 -28.9 77.24 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.919 3.079 . . . . 0.0 114.944 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.5 p -74.51 0.58 14.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.046 1.738 . . . . 0.0 114.37 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.77 83.18 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.692 1.615 . . . . 0.0 113.947 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -72.96 159.11 34.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.742 1.617 . . . . 0.0 112.182 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.4 m -145.72 155.93 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.641 1.576 . . . . 0.0 111.074 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.68 166.5 26.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.442 1.497 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -100.06 137.63 20.13 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.175 0.99 . . . . 0.0 111.506 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.69 169.29 12.15 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.195 3.263 . . . . 0.0 111.827 171.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 86.9 m -110.24 119.75 40.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.667 1.587 . . . . 0.0 109.002 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.75 129.93 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.279 1.032 . . . . 0.0 109.026 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 35.0 m -125.99 116.13 20.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.861 1.664 . . . . 0.0 109.001 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.01 124.0 27.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.616 -0.678 . . . . 0.0 110.045 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.09 -10.24 59.75 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 72.97 -3.37 2.44 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.023 2.529 . . . . 0.0 113.864 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -93.86 1.19 56.45 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.665 1.986 . . . . 0.0 113.33 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.74 14.16 38.21 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.102 1.334 . . . . 0.0 114.472 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 76.1 p -128.37 157.12 41.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.407 1.883 . . . . 0.0 110.348 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -113.61 137.9 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.513 0.725 . . . . 0.0 109.59 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.5 m -102.29 128.88 48.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.649 1.179 . . . . 0.0 107.993 168.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.4 t -113.74 128.98 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.944 1.298 . . . . 0.0 108.95 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -126.53 154.4 43.88 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.231 1.812 . . . . 0.0 111.619 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.4 t80 -158.99 134.98 8.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.76 1.224 . . . . 0.0 112.275 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.91 119.96 70.66 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.562 1.145 . . . . 0.0 110.648 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.36 150.68 15.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.526 2.817 . . . . 0.0 111.798 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.4 m -132.2 -8.07 3.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -166.98 145.98 5.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.583 1.553 . . . . 0.0 110.325 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.56 170.66 16.17 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 0.0 113.523 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.84 178.77 17.88 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.484 1.516 . . . . 0.0 114.405 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 51.6 tp -75.98 103.21 5.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.191 1.397 . . . . 0.0 110.426 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -96.73 159.46 14.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 111.251 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.64 149.87 36.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 111.627 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 25.3 ttm -134.27 135.67 43.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.387 1.875 . . . . 0.0 110.645 -163.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -118.26 126.36 52.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.904 1.682 . . . . 0.0 109.763 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -127.94 130.13 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.818 1.247 . . . . 0.0 109.727 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 141.1 33.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.4 t80 -103.23 120.3 40.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.257 1.823 . . . . 0.0 109.5 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.15 32.6 10.8 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.766 1.226 . . . . 0.0 112.953 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 75.07 7.32 4.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.052 2.541 . . . . 0.0 115.195 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.4 mtp -99.19 128.03 45.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.921 1.288 . . . . 0.0 110.315 166.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -55.41 136.18 49.72 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.32 -0.862 . . . . 0.0 113.03 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.6 pt -73.12 150.63 90.05 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.883 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.39 131.62 39.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.532 2.155 . . . . 0.0 110.398 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.36 63.43 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.764 1.173 . . . . 0.0 114.51 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.33 150.24 44.35 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.59 1.695 . . . . 0.0 110.922 172.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.98 164.34 88.1 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 120.715 1.291 . . . . 0.0 113.317 -1.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.71 161.32 21.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.937 1.695 . . . . 0.0 111.322 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -157.86 148.99 21.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.391 1.077 . . . . 0.0 112.125 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -168.28 157.8 9.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.302 1.441 . . . . 0.0 111.885 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.4 t80 -95.04 128.69 42.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.056 -1.028 . . . . 0.0 112.685 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.4 t -93.13 135.13 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.501 1.52 . . . . 0.0 108.777 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.79 148.12 20.63 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.324 1.05 . . . . 0.0 112.717 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.34 144.47 51.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.105 1.362 . . . . 0.0 113.295 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.8 p -76.21 -28.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.208 1.003 . . . . 0.0 113.59 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -85.05 -19.48 31.87 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 73.1 m -67.27 149.16 50.76 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.325 1.05 . . . . 0.0 113.401 -173.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.53 -13.52 63.08 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.826 1.203 . . . . 0.0 114.831 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -64.23 153.39 38.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 118.713 1.257 . . . . 0.0 113.296 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.9 p -64.79 135.72 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.727 0.811 . . . . 0.0 110.001 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 9.6 t -154.64 157.27 37.91 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.729 1.212 . . . . 0.0 110.836 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.1 145.59 39.67 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.495 1.118 . . . . 0.0 111.975 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.5 p90 -165.91 165.16 18.35 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.91 1.684 . . . . 0.0 112.236 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.84 175.28 14.0 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.178 1.371 . . . . 0.0 113.123 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 -34.29 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.704 2.269 . . . . 0.0 113.057 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.65 -34.25 86.91 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.578 1.081 . . . . 0.0 114.444 -171.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.95 -4.67 48.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.797 1.299 . . . . 0.0 113.41 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.5 m -106.07 -47.74 3.77 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.446 1.898 . . . . 0.0 110.989 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -143.66 149.14 36.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.46 1.904 . . . . 0.0 112.341 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -145.43 178.27 23.29 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.451 1.024 . . . . 0.0 113.721 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 50.3 t -139.25 135.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 108.451 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.6 m -57.26 136.41 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.29 -0.72 2.07 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.168 2.187 . . . . 0.0 114.442 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -104.17 140.47 21.1 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.408 1.483 . . . . 0.0 110.881 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.54 120.19 6.57 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.613 2.209 . . . . 0.0 110.326 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.74 135.23 42.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.251 1.42 . . . . 0.0 110.155 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.6 p -129.41 147.24 51.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -165.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.46 175.8 13.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.628 1.571 . . . . 0.0 111.636 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.3 m -130.33 142.82 50.51 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.995 1.318 . . . . 0.0 110.839 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -113.04 132.82 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.862 1.665 . . . . 0.0 108.135 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.73 129.86 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.214 1.006 . . . . 0.0 110.393 173.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.7 p -132.92 2.29 3.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.42 1.488 . . . . 0.0 113.859 -166.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -50.22 -38.16 38.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.484 1.913 . . . . 0.0 115.346 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -128.88 20.47 5.96 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.439 1.496 . . . . 0.0 112.387 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.58 64.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.16 146.7 7.63 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.171 1.367 . . . . 0.0 113.039 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -75.88 148.06 38.58 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.423 1.089 . . . . 0.0 111.968 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.24 -30.1 0.17 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.692 1.139 . . . . 0.0 114.531 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.41 112.66 0.87 Allowed Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.511 1.529 . . . . 0.0 112.82 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.08 128.9 34.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.369 1.468 . . . . 0.0 109.209 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 37.2 m -126.95 156.04 42.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.996 1.718 . . . . 0.0 111.781 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.8 134.94 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.656 1.582 . . . . 0.0 109.103 -169.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.14 35.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.015 0.926 . . . . 0.0 112.275 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.24 139.31 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.874 1.27 . . . . 0.0 109.934 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.86 129.47 38.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.294 1.438 . . . . 0.0 110.095 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.52 -159.77 9.54 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.83 -0.984 . . . . 0.0 114.342 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.41 -23.08 71.56 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.101 3.201 . . . . 0.0 112.757 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.9 t -146.29 161.34 40.51 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.266 1.426 . . . . 0.0 109.542 163.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.74 113.63 8.02 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.002 -1.061 . . . . 0.0 111.078 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.15 147.9 49.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.73 0.812 . . . . 0.0 111.389 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.44 139.16 30.8 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.297 0.639 . . . . 0.0 109.532 168.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 28.7 mt -130.98 138.55 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.565 1.146 . . . . 0.0 110.325 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.5 m -129.79 152.65 49.05 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.737 1.615 . . . . 0.0 110.473 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -151.88 151.39 31.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.079 0.951 . . . . 0.0 112.332 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.5 m -140.9 116.44 10.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.205 1.402 . . . . 0.0 110.114 -169.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -72.26 135.63 46.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.161 0.985 . . . . 0.0 111.04 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -112.34 150.65 30.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.476 1.51 . . . . 0.0 111.863 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -72.75 -12.01 60.84 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.68 1.28 52.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.209 1.403 . . . . 0.0 114.553 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.53 30.9 8.68 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.523 1.059 . . . . 0.0 114.218 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 40.7 p -133.76 170.92 14.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.854 1.262 . . . . 0.0 111.703 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 53.5 t -130.57 130.85 44.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.496 1.919 . . . . 0.0 108.724 165.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.0 t -94.1 147.78 22.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.284 1.034 . . . . 0.0 110.935 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -126.97 143.57 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.81 1.644 . . . . 0.0 109.981 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -139.89 139.19 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.515 1.526 . . . . 0.0 110.603 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -144.91 151.74 39.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.7 mt -113.8 101.99 54.37 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.033 1.733 . . . . 0.0 110.288 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.46 164.8 23.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.442 2.762 . . . . 0.0 110.058 166.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.6 m -136.41 -22.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 92.1 mt -117.98 147.86 42.21 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.033 1.333 . . . . 0.0 110.234 170.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.96 155.39 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.656 2.238 . . . . 0.0 110.759 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.97 -165.65 23.41 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.684 1.135 . . . . 0.0 113.295 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.6 137.59 32.25 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.806 1.242 . . . . 0.0 112.973 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.74 124.8 40.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.797 1.639 . . . . 0.0 109.93 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -84.18 129.43 34.89 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.994 -1.066 . . . . 0.0 110.714 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.92 130.47 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.625 1.57 . . . . 0.0 108.127 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.8 tt -111.66 132.19 54.77 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.438 1.495 . . . . 0.0 109.613 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -134.46 128.12 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 172.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.5 141.09 23.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 111.433 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.09 121.75 15.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.43 1.092 . . . . 0.0 110.062 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.8 57.76 3.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.322 1.449 . . . . 0.0 111.496 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.1 pt-20 56.34 19.92 4.33 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.305 2.642 . . . . 0.0 116.172 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.48 128.65 37.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.719 1.207 . . . . 0.0 110.989 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.32 150.85 42.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.741 0.816 . . . . 0.0 112.237 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 7.9 m -67.12 154.19 93.13 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.039 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -52.68 -31.69 51.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.984 3.123 . . . . 0.0 116.29 -170.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.36 -4.6 59.53 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -84.33 143.29 41.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.153 1.477 . . . . 0.0 112.33 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.75 140.98 70.34 Favored 'Cis proline' 0 C--N 1.352 0.719 0 CA-C-N 119.106 0.717 . . . . 0.0 112.169 -4.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.35 172.86 8.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.193 1.797 . . . . 0.0 110.491 173.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.7 m -136.7 119.04 15.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.712 0.805 . . . . 0.0 110.567 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.91 158.57 16.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.214 1.406 . . . . 0.0 111.082 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -120.84 127.88 52.32 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.198 0.999 . . . . 0.0 110.287 169.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.8 t -107.17 132.74 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.759 -172.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 56.7 m -101.21 155.32 18.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.311 1.844 . . . . 0.0 111.612 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.55 138.35 23.05 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.709 1.147 . . . . 0.0 112.119 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.62 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -59.86 116.63 17.83 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.446 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.31 154.81 32.36 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.736 2.291 . . . . 0.0 111.025 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.3 t80 -100.9 128.97 46.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.236 0.541 . . . . 0.0 110.411 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -156.25 148.28 23.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.819 1.648 . . . . 0.0 110.836 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.09 152.89 17.57 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.126 1.37 . . . . 0.0 110.632 -174.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.3 p -125.8 133.15 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.201 1.4 . . . . 0.0 109.483 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 73.7 mt -132.15 135.33 26.31 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.901 1.68 . . . . 0.0 109.163 -167.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.57 112.74 3.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.995 2.463 . . . . 0.0 109.868 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.0 t80 -177.2 150.28 0.72 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.175 2.19 . . . . 0.0 109.435 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.4 m -132.1 128.72 38.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.381 1.072 . . . . 0.0 109.77 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.23 118.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.811 0.844 . . . . 0.0 109.834 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.0 pttt -90.95 -146.13 0.19 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.772 1.629 . . . . 0.0 112.393 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -72.84 -12.62 61.05 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.09 -149.04 19.67 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.86 1.695 . . . . 0.0 113.032 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.94 156.17 44.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 111.345 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.52 138.28 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 111.381 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.7 p -149.19 163.73 36.79 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.114 1.766 . . . . 0.0 110.76 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.56 -174.43 15.83 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.72 136.87 14.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.256 1.823 . . . . 0.0 108.915 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.01 134.19 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.748 1.619 . . . . 0.0 107.94 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -118.61 130.68 56.01 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.187 0.995 . . . . 0.0 111.207 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -96.52 152.23 38.49 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.069 1.748 . . . . 0.0 111.665 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.31 -21.89 26.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.378 2.719 . . . . 0.0 113.014 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.5 p -80.51 2.18 26.42 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.712 1.605 . . . . 0.0 114.5 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.36 54.15 2.62 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.515 1.055 . . . . 0.0 113.233 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -156.4 166.97 31.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.052 1.741 . . . . 0.0 111.681 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.6 159.25 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.587 1.155 . . . . 0.0 113.068 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.04 -178.65 7.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.802 2.441 . . . . 0.0 109.757 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.55 145.5 53.35 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 120.612 -1.305 . . . . 0.0 112.562 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.64 173.4 6.28 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.551 3.501 . . . . 0.0 111.696 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.0 m -108.75 136.18 48.75 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.524 1.53 . . . . 0.0 108.835 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.08 134.44 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.092 1.357 . . . . 0.0 109.187 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -136.11 121.83 19.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.539 1.535 . . . . 0.0 109.743 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.14 128.0 33.64 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.601 0.76 . . . . 0.0 110.617 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.63 -7.56 59.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 39.5 tttm 74.36 -5.24 2.13 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.437 2.695 . . . . 0.0 113.723 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -94.57 1.41 55.64 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.944 2.098 . . . . 0.0 113.329 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.2 16.37 32.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.108 1.337 . . . . 0.0 114.379 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.08 155.27 45.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.041 1.737 . . . . 0.0 110.608 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -113.6 135.95 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.98 0.912 . . . . 0.0 109.979 165.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.5 m -92.06 138.08 31.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.445 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.6 t -127.34 136.03 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.201 1.4 . . . . 0.0 109.026 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -141.58 155.02 45.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.811 1.244 . . . . 0.0 112.692 -174.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 31.6 t80 -154.41 133.17 12.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.522 1.529 . . . . 0.0 111.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -81.88 127.55 71.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.408 1.083 . . . . 0.0 111.214 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.09 175.03 10.79 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.835 3.024 . . . . 0.0 112.231 -173.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 19.0 t -162.89 -38.09 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.16 0.984 . . . . 0.0 113.227 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -135.0 150.78 50.39 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.828 1.651 . . . . 0.0 110.331 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -85.64 172.28 11.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 0.0 113.524 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.99 -170.49 13.34 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 126.121 1.819 . . . . 0.0 113.72 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.4 tp -81.32 131.02 35.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 110.43 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 59.5 m80 -128.69 163.5 24.97 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.065 1.746 . . . . 0.0 111.101 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -142.43 157.54 44.66 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.162 0.985 . . . . 0.0 111.266 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 67.0 ttp -141.16 123.87 16.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.388 1.075 . . . . 0.0 111.845 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -85.91 139.75 30.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.335 1.854 . . . . 0.0 110.373 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.17 128.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.295 1.438 . . . . 0.0 108.199 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 138.05 30.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -104.03 123.91 48.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.914 2.086 . . . . 0.0 110.336 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.91 34.34 13.38 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.47 1.108 . . . . 0.0 112.586 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 36.2 t30 78.66 2.3 2.56 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 128.519 2.727 . . . . 0.0 114.942 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.5 129.81 54.39 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.723 1.609 . . . . 0.0 111.035 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.06 139.09 35.91 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.85 147.43 97.86 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.925 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.62 120.25 7.59 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.532 2.155 . . . . 0.0 111.722 -165.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -8.96 72.37 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.338 1.447 . . . . 0.0 115.157 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 12.8 m -74.58 157.79 85.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 120.047 1.923 . . . . 0.0 112.359 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.87 161.48 91.45 Favored 'Cis proline' 0 C--N 1.355 0.881 0 CA-C-N 119.844 0.98 . . . . 0.0 113.999 5.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.47 162.11 13.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.885 1.674 . . . . 0.0 110.905 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -142.3 138.98 31.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.729 1.211 . . . . 0.0 110.503 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.47 167.74 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.751 1.221 . . . . 0.0 112.146 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 18.5 t80 -110.29 141.57 43.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.996 0.918 . . . . 0.0 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.4 t -112.04 138.08 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.946 1.698 . . . . 0.0 108.469 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t0 -156.4 151.62 26.51 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -75.61 95.89 3.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.283 1.433 . . . . 0.0 111.522 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 16.3 m -58.47 -23.1 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.293 1.437 . . . . 0.0 114.447 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.69 -13.68 44.74 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 97.9 m -75.92 156.67 34.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.211 1.004 . . . . 0.0 113.25 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.19 77.82 2.06 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.227 1.394 . . . . 0.0 112.35 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -163.9 154.71 15.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.099 1.759 . . . . 0.0 112.356 173.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.7 p -73.35 135.3 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.283 1.033 . . . . 0.0 110.434 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 5.9 t -152.78 171.37 18.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.572 1.149 . . . . 0.0 111.682 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -153.68 150.39 28.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.531 1.133 . . . . 0.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.68 164.81 6.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.052 1.741 . . . . 0.0 112.93 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.55 173.16 12.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.34 1.448 . . . . 0.0 113.167 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.55 -34.75 18.99 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.082 2.521 . . . . 0.0 112.762 -172.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.18 -33.5 85.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.895 0.77 . . . . 0.0 114.373 -172.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.22 0.13 38.03 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.744 1.272 . . . . 0.0 113.878 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.7 m -107.04 -38.85 5.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.414 1.886 . . . . 0.0 111.536 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -157.76 146.58 19.43 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.127 1.371 . . . . 0.0 112.993 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 -173.89 21.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.874 1.702 . . . . 0.0 112.852 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.7 p -150.89 138.61 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.981 1.312 . . . . 0.0 109.245 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.9 m -57.64 141.36 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 27.5 m120 69.53 -5.29 1.19 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.131 2.173 . . . . 0.0 114.728 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -102.18 144.29 28.3 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.338 1.455 . . . . 0.0 111.045 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.24 130.56 15.37 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.566 2.178 . . . . 0.0 110.625 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.91 147.05 32.78 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.548 . . . . 0.0 110.437 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.7 p -136.84 147.3 46.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -160.03 176.05 12.28 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.291 1.836 . . . . 0.0 110.936 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 82.8 m -134.01 136.75 44.28 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.152 0.981 . . . . 0.0 111.097 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 20.5 t -98.08 132.22 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.55 . . . . 0.0 107.752 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -98.66 116.74 31.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 109.753 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -121.3 8.69 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.685 1.994 . . . . 0.0 113.007 -166.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -52.75 -38.35 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.73 1.612 . . . . 0.0 113.786 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -92.39 -12.47 32.15 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.109 1.364 . . . . 0.0 113.637 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.23 68.32 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.168 0.987 . . . . 0.0 112.975 -172.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 76.76 -76.26 1.59 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.229 1.395 . . . . 0.0 113.848 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -163.46 150.15 12.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.395 1.878 . . . . 0.0 110.078 -171.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 133.39 -2.48 4.61 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.965 1.269 . . . . 0.0 115.085 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 99.81 117.66 4.04 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.73 1.634 . . . . 0.0 113.48 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 129.22 34.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.809 1.644 . . . . 0.0 109.247 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -121.4 153.05 38.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.411 1.485 . . . . 0.0 111.575 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.9 tp -159.83 134.8 7.96 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.356 1.462 . . . . 0.0 109.464 -170.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.29 161.3 37.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.338 1.055 . . . . 0.0 112.08 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.6 mt -137.4 132.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.622 1.169 . . . . 0.0 109.433 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -121.72 112.66 18.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.238 1.415 . . . . 0.0 109.684 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.26 12.92 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.23 -22.12 54.03 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.936 . . . . 0.0 111.998 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.4 t -135.29 157.86 45.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.237 1.415 . . . . 0.0 109.132 157.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -75.62 119.28 19.45 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.914 -1.116 . . . . 0.0 111.38 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.07 148.79 43.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.232 1.013 . . . . 0.0 111.7 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.67 139.91 32.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.235 0.614 . . . . 0.0 109.587 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.35 143.35 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.443 1.097 . . . . 0.0 110.362 -168.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.0 t -143.43 160.78 39.94 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.031 1.332 . . . . 0.0 110.846 167.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -157.42 155.28 30.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.334 1.054 . . . . 0.0 112.979 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -138.65 117.01 11.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.6 1.56 . . . . 0.0 110.198 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -74.83 136.37 41.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.077 1.351 . . . . 0.0 111.471 172.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -117.47 146.83 43.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.539 1.536 . . . . 0.0 112.016 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -68.16 -13.22 62.06 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.09 -5.1 45.01 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.652 1.581 . . . . 0.0 113.982 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.32 30.11 8.97 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.754 1.169 . . . . 0.0 113.858 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.2 p -137.44 165.0 27.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.299 1.44 . . . . 0.0 111.484 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -127.68 122.57 33.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.663 1.585 . . . . 0.0 108.796 164.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -87.51 145.87 26.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.959 0.903 . . . . 0.0 110.592 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.4 t -125.85 141.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.578 1.551 . . . . 0.0 110.321 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 67.3 m -130.96 140.71 50.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.884 1.673 . . . . 0.0 110.632 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -146.24 151.73 38.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.72 105.62 40.68 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.686 1.994 . . . . 0.0 110.494 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -86.62 160.3 9.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.043 3.162 . . . . 0.0 110.7 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -119.98 -21.82 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -169.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.52 149.32 36.83 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.857 1.263 . . . . 0.0 110.587 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.97 153.64 37.42 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.88 2.387 . . . . 0.0 112.432 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.67 -167.72 27.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.095 1.331 . . . . 0.0 113.393 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -91.08 128.56 36.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.013 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -118.77 127.35 53.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.678 1.591 . . . . 0.0 109.805 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.11 121.31 30.37 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.86 0.864 . . . . 0.0 110.448 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.27 127.21 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.19 1.396 . . . . 0.0 108.111 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.91 130.37 55.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.278 1.431 . . . . 0.0 109.5 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.1 t -132.99 129.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.276 1.03 . . . . 0.0 109.457 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 147.51 26.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 111.418 -166.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 2.2 t80 -140.9 126.14 18.55 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.794 1.238 . . . . 0.0 110.279 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.1 t-20 45.07 58.9 3.76 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.117 1.367 . . . . 0.0 113.245 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.311 7.9 pt-20 60.02 13.8 3.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.107 2.563 . . . . 0.0 116.596 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -125.65 128.46 47.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.48 1.112 . . . . 0.0 111.352 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.84 151.55 45.19 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.055 -1.028 . . . . 0.0 112.716 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 29.1 m -65.48 152.05 93.12 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.65 163.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.37 -20.04 66.03 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.476 2.117 . . . . 0.0 114.84 -167.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -94.46 -6.58 61.05 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -86.64 143.83 36.49 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 119.049 1.424 . . . . 0.0 112.33 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.74 141.29 71.33 Favored 'Cis proline' 0 C--N 1.354 0.819 0 CA-C-N 119.117 0.72 . . . . 0.0 112.064 -4.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -92.68 166.8 12.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.966 1.706 . . . . 0.0 110.041 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.7 m -131.75 119.71 21.68 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.536 0.734 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -103.16 137.53 41.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.949 1.3 . . . . 0.0 111.737 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -86.05 117.29 24.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.5 t -92.42 130.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.101 0.96 . . . . 0.0 109.207 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.1 m -105.13 159.92 15.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.756 1.623 . . . . 0.0 110.644 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.9 138.22 23.38 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.119 0.866 . . . . 0.0 111.969 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 N--CA 1.475 0.804 0 C-N-CA 125.221 1.408 . . . . 0.0 113.584 -174.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 30.0 tp . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -60.27 118.27 31.84 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.119 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.42 159.5 46.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.277 2.651 . . . . 0.0 111.318 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.01 123.23 36.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.429 0.692 . . . . 0.0 109.225 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.17 130.46 16.57 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.331 1.453 . . . . 0.0 109.956 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.39 141.53 27.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.266 1.426 . . . . 0.0 109.931 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -118.79 137.76 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.96 137.49 25.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.331 1.853 . . . . 0.0 108.738 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.48 37.99 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.386 3.39 . . . . 0.0 113.526 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.38 161.32 17.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.54 1.536 . . . . 0.0 110.499 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 87.6 m -133.42 130.2 38.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.019 1.327 . . . . 0.0 109.688 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 115.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.362 1.065 . . . . 0.0 110.304 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -92.94 -163.27 1.02 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.218 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.0 pttp -71.91 132.52 44.47 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.806 -1.184 . . . . 0.0 112.052 169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.53 -141.7 12.29 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.319 1.438 . . . . 0.0 111.631 -167.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.31 143.74 18.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.853 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.6 tt -134.68 136.48 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.292 1.837 . . . . 0.0 110.367 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 33.4 p -145.6 165.27 29.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.603 1.561 . . . . 0.0 110.849 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.65 176.46 29.22 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -151.94 138.17 18.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.128 1.771 . . . . 0.0 109.644 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.2 t -111.79 134.46 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.241 1.816 . . . . 0.0 108.651 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -113.7 123.16 49.23 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.862 1.665 . . . . 0.0 110.209 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.8 mtm -98.05 146.64 31.84 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.703 1.601 . . . . 0.0 111.466 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.28 -16.21 28.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.799 2.999 . . . . 0.0 113.144 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.7 p -74.42 0.28 15.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.806 1.642 . . . . 0.0 114.197 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.39 42.38 5.53 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.722 1.153 . . . . 0.0 113.538 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -152.66 169.26 23.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.392 1.477 . . . . 0.0 112.525 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.0 m -139.22 159.25 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.899 1.28 . . . . 0.0 112.848 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.8 171.26 19.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.078 2.151 . . . . 0.0 110.257 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -110.55 142.36 25.92 Favored Pre-proline 0 CA--C 1.547 0.831 0 O-C-N 121.103 -0.998 . . . . 0.0 112.344 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.22 175.87 3.91 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.57 3.513 . . . . 0.0 112.385 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.1 m -108.02 130.24 55.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.444 1.498 . . . . 0.0 108.963 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.84 131.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.149 1.379 . . . . 0.0 108.676 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.4 m -132.94 130.36 39.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.373 1.469 . . . . 0.0 110.05 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -82.45 126.46 32.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.164 0.586 . . . . 0.0 110.106 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -80.59 -7.6 59.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.2 mttp 71.77 7.4 5.9 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.592 2.357 . . . . 0.0 113.606 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.07 7.59 23.62 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.345 2.258 . . . . 0.0 112.597 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 19.35 35.55 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.974 1.274 . . . . 0.0 114.317 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.8 p -134.23 158.19 44.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.105 1.762 . . . . 0.0 110.267 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 27.2 m -116.13 148.1 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.568 1.147 . . . . 0.0 110.13 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 50.6 m -113.99 136.48 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 41.7 t -119.91 134.8 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.202 1.401 . . . . 0.0 108.925 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.21 154.96 50.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.896 1.279 . . . . 0.0 113.16 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.5 t80 -153.77 136.89 15.57 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.565 1.546 . . . . 0.0 111.927 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.2 117.26 67.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.023 1.329 . . . . 0.0 110.804 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.36 156.02 16.69 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.96 3.106 . . . . 0.0 112.656 -172.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.4 m -118.29 -18.39 9.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -163.66 155.12 16.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.665 1.586 . . . . 0.0 110.572 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -69.07 168.49 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.576 1.15 . . . . 0.0 113.531 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.06 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.598 1.571 . . . . 0.0 114.138 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.5 tp -79.09 129.61 34.64 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.744 1.218 . . . . 0.0 110.677 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.8 m80 -130.27 162.0 29.96 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.587 1.555 . . . . 0.0 111.373 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.71 156.15 41.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 111.786 172.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -138.92 126.85 22.31 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.112 1.765 . . . . 0.0 109.956 -168.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.46 122.4 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.335 1.454 . . . . 0.0 109.389 175.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 42.8 mm -120.89 135.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.129 1.372 . . . . 0.0 109.805 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.78 137.72 20.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.6 t80 -99.3 123.27 43.45 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.823 2.049 . . . . 0.0 109.857 175.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.15 33.42 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.785 1.234 . . . . 0.0 112.729 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 22.6 t30 75.77 5.94 3.89 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 128.123 2.569 . . . . 0.0 115.109 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.36 131.62 51.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.806 1.643 . . . . 0.0 110.884 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m170 -56.8 134.09 54.83 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.057 -1.027 . . . . 0.0 113.213 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.33 155.86 89.49 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.402 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.85 125.87 19.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.367 2.045 . . . . 0.0 109.761 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.69 53.54 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.725 1.155 . . . . 0.0 114.344 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.7 t -84.6 148.06 50.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.054 1.427 . . . . 0.0 111.919 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.38 159.99 94.35 Favored 'Cis proline' 0 C--N 1.352 0.72 0 CA-C-N 119.936 1.013 . . . . 0.0 112.062 -7.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.36 152.19 20.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.401 1.48 . . . . 0.0 110.523 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -151.43 134.41 15.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.469 1.108 . . . . 0.0 110.259 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.91 165.05 18.43 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.373 1.069 . . . . 0.0 112.504 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 44.2 t80 -103.19 139.76 38.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.168 0.987 . . . . 0.0 112.154 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 78.1 t -105.34 140.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.195 1.798 . . . . 0.0 109.24 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.4 t0 -156.41 149.12 23.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.087 1.355 . . . . 0.0 111.455 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.99 147.18 51.99 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.462 -0.774 . . . . 0.0 112.44 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 95.0 t -72.0 -29.04 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.071 0.948 . . . . 0.0 111.383 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -80.73 -7.7 59.44 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.6 m -58.52 137.44 57.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.481 1.113 . . . . 0.0 113.386 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.2 -19.87 40.8 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.951 1.263 . . . . 0.0 114.086 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.68 158.91 31.15 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.267 1.033 . . . . 0.0 113.457 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.9 p -62.49 138.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 110.176 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.0 t -159.67 156.68 28.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.17 1.388 . . . . 0.0 110.653 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.25 145.7 47.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.581 1.152 . . . . 0.0 112.65 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.3 p90 -168.17 157.1 9.18 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.881 1.673 . . . . 0.0 113.233 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 147.62 173.65 18.86 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.092 1.329 . . . . 0.0 113.985 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.82 -38.84 12.61 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.27 2.647 . . . . 0.0 112.468 -173.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.19 -18.46 74.91 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.017 0.826 . . . . 0.0 114.099 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 15.7 tp -82.25 -11.21 58.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.562 1.145 . . . . 0.0 112.55 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.1 m -116.59 -40.06 3.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.415 1.886 . . . . 0.0 111.776 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -136.25 169.84 16.99 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.956 2.502 . . . . 0.0 111.489 -172.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -168.29 173.2 43.06 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 121.046 -1.034 . . . . 0.0 113.215 164.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 64.7 t -136.9 130.65 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.728 1.211 . . . . 0.0 108.622 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.7 m -57.16 142.61 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.0 m-80 67.12 2.07 2.62 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.804 2.042 . . . . 0.0 114.606 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 93.7 mttt -118.79 141.6 30.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.791 1.636 . . . . 0.0 111.017 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.95 136.63 30.29 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.659 2.24 . . . . 0.0 110.853 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.74 146.48 42.77 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.1 p -135.58 150.37 49.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.124 0.97 . . . . 0.0 113.462 -164.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' 1922 ' ' VAL . 52.5 p90 -160.69 176.9 11.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.672 1.589 . . . . 0.0 111.661 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 39.7 m -130.19 143.89 51.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.232 1.413 . . . . 0.0 110.552 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.8 t -116.81 126.16 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 108.088 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.01 126.7 34.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.106 0.962 . . . . 0.0 110.696 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.3 p -134.32 4.49 3.44 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.092 1.357 . . . . 0.0 113.769 -167.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.2 tttp -54.96 -36.52 65.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.791 1.636 . . . . 0.0 114.789 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.19 14.17 10.49 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.815 1.646 . . . . 0.0 112.516 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -78.66 -11.53 59.98 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.93 -130.86 10.06 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.514 1.054 . . . . 0.0 112.267 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -160.95 161.55 31.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.037 1.735 . . . . 0.0 110.238 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 147.38 -14.28 1.43 Allowed Glycine 0 N--CA 1.475 1.29 0 C-N-CA 125.104 1.335 . . . . 0.0 115.284 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.45 105.73 0.92 Allowed Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.836 1.684 . . . . 0.0 112.482 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.02 125.98 32.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.11 1.364 . . . . 0.0 108.874 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.9 m -124.13 159.69 29.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.879 1.671 . . . . 0.0 112.118 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.7 tp -159.07 137.4 10.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.794 1.637 . . . . 0.0 109.404 -170.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.81 156.37 34.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.372 1.069 . . . . 0.0 111.935 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.75 135.52 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.534 1.134 . . . . 0.0 109.795 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.12 127.67 43.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.419 1.488 . . . . 0.0 109.787 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -153.15 -165.12 13.12 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.132 -0.816 . . . . 0.0 114.499 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.09 -24.15 66.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.087 3.191 . . . . 0.0 112.664 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.7 t -140.27 153.25 46.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.007 1.323 . . . . 0.0 109.739 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -72.56 117.17 13.91 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.167 -0.958 . . . . 0.0 111.049 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.81 153.16 37.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.481 1.112 . . . . 0.0 112.133 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.27 141.65 28.51 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 161.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.5 mt -138.37 138.54 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.758 1.223 . . . . 0.0 110.011 -163.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 65.1 m -137.98 158.1 45.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.515 1.526 . . . . 0.0 111.147 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.1 p -154.33 155.03 34.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 75.6 m -143.67 122.69 12.82 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.179 1.392 . . . . 0.0 110.66 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.94 113.61 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 165.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 27.6 p30 -83.53 -7.46 59.52 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 71.5 0.36 3.44 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -88.22 -11.09 47.66 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.326 1.45 . . . . 0.0 113.137 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 132.79 1.74 4.07 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.452 1.501 . . . . 0.0 115.661 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 64.4 p -137.27 156.66 48.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.231 1.516 . . . . 0.0 112.143 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 79.7 m -104.21 128.14 51.9 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.344 1.458 . . . . 0.0 109.115 165.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.8 t -91.48 151.89 20.59 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.126 0.97 . . . . 0.0 110.763 172.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' 1886 ' ' PHE . 84.1 t -132.33 144.54 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.765 1.626 . . . . 0.0 110.041 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 76.0 p -140.98 148.08 39.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.809 1.243 . . . . 0.0 112.236 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.9 p90 -152.51 156.72 39.95 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.16 -0.963 . . . . 0.0 113.212 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.15 106.18 43.53 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.117 1.367 . . . . 0.0 110.871 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -82.6 174.45 9.67 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.976 3.117 . . . . 0.0 110.884 168.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -150.24 -30.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.1 mt -105.99 146.96 33.93 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.502 1.046 . . . . 0.0 110.393 166.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.22 157.37 41.89 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.874 2.383 . . . . 0.0 110.946 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.85 -162.39 24.18 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.778 1.18 . . . . 0.0 113.621 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.49 125.92 35.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.187 1.395 . . . . 0.0 112.303 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -113.84 126.38 55.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.374 1.47 . . . . 0.0 109.203 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.2 m -89.45 127.7 35.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.147 0.979 . . . . 0.0 110.734 175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.9 128.11 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.841 1.257 . . . . 0.0 108.943 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.71 129.93 53.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.661 1.584 . . . . 0.0 109.361 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.0 t -130.19 132.44 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.536 1.134 . . . . 0.0 109.221 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.95 140.7 20.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.326 1.45 . . . . 0.0 111.357 -168.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 117.8 15.32 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.441 1.096 . . . . 0.0 110.017 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 50.7 t-20 56.61 63.6 1.91 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.686 1.594 . . . . 0.0 111.774 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.281 9.2 pt-20 55.63 18.68 2.91 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.234 2.613 . . . . 0.0 116.423 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -132.81 129.04 38.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.782 1.233 . . . . 0.0 110.922 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.4 m170 -64.17 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.917 0.887 . . . . 0.0 112.354 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.7 m -70.87 152.81 95.02 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.437 169.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.28 133.62 41.41 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.643 2.228 . . . . 0.0 111.224 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.58 63.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.899 1.237 . . . . 0.0 114.928 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.3 t -81.08 144.33 54.47 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.009 1.405 . . . . 0.0 111.68 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.43 140.34 64.32 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.014 1.041 . . . . 0.0 112.682 -1.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -95.05 175.81 6.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.595 1.958 . . . . 0.0 110.958 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -135.26 127.01 29.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.103 0.961 . . . . 0.0 110.687 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -106.69 140.55 39.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.684 . . . . 0.0 110.981 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.16 108.46 21.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.115 0.966 . . . . 0.0 110.178 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 87.8 t -90.84 143.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.917 1.287 . . . . 0.0 110.135 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.5 t -131.1 172.26 12.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.487 1.115 . . . . 0.0 112.767 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.42 142.8 26.39 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.746 1.641 . . . . 0.0 112.739 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 CA--C 1.549 0.913 0 C-N-CA 124.435 1.094 . . . . 0.0 113.198 177.674 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 N--CA 1.468 0.475 0 CA-C-O 120.935 0.398 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 121.64 68.6 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.852 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.27 156.18 51.04 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.144 2.563 . . . . 0.0 111.002 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.4 t80 -116.05 122.13 44.28 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.389 0.676 . . . . 0.0 110.966 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -148.69 151.87 35.67 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.743 1.617 . . . . 0.0 110.618 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 151.84 24.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.575 1.55 . . . . 0.0 109.949 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -125.95 133.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.927 1.291 . . . . 0.0 109.43 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.81 137.17 30.19 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.037 1.735 . . . . 0.0 108.673 -171.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.94 49.48 3.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.658 3.572 . . . . 0.0 112.827 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.3 t80 -93.91 153.0 18.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.463 1.505 . . . . 0.0 110.625 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 127.31 47.19 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.92 1.288 . . . . 0.0 110.217 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.6 mt -92.61 136.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.042 1.337 . . . . 0.0 109.203 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.9 tptt -129.04 -60.22 1.09 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.151 0.98 . . . . 0.0 112.49 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -159.15 131.06 6.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.316 1.846 . . . . 0.0 110.388 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.65 -146.82 16.54 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.292 1.425 . . . . 0.0 111.384 -166.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -157.7 144.84 18.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.577 1.151 . . . . 0.0 110.914 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.85 136.15 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.57 1.548 . . . . 0.0 110.864 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.8 p -148.0 174.4 11.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.165 1.786 . . . . 0.0 110.525 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.64 -171.31 27.53 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.83 146.07 23.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.571 1.949 . . . . 0.0 109.603 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 21.5 t -123.25 138.43 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.331 1.852 . . . . 0.0 108.351 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 68.7 mtm-85 -127.61 142.19 51.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.897 0.879 . . . . 0.0 112.037 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 5.3 mpp? -118.6 148.66 44.68 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.596 1.558 . . . . 0.0 111.936 -173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.01 -29.57 89.6 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.121 3.214 . . . . 0.0 114.886 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 12.5 m -72.93 3.32 5.44 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.88 42.14 6.47 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.556 1.074 . . . . 0.0 112.833 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -148.16 158.26 43.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.842 1.657 . . . . 0.0 111.854 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.9 m -143.21 162.52 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.108 1.363 . . . . 0.0 112.035 -171.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.58 -179.44 8.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.706 2.003 . . . . 0.0 110.923 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -128.96 147.73 65.99 Favored Pre-proline 0 CA--C 1.544 0.74 0 O-C-N 121.185 -0.947 . . . . 0.0 111.601 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -86.94 173.89 5.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.229 3.286 . . . . 0.0 112.191 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.0 m -110.39 135.47 51.05 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.458 1.503 . . . . 0.0 108.75 170.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.6 131.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.954 1.302 . . . . 0.0 108.693 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 89.4 m -132.66 126.85 33.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.475 1.51 . . . . 0.0 109.306 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.8 136.11 40.24 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.021 0.528 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -88.21 -12.69 43.06 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 56.7 tttt 70.63 6.07 5.67 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.219 2.208 . . . . 0.0 113.708 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -105.87 11.15 32.14 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.208 2.203 . . . . 0.0 112.751 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.78 16.15 52.56 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.889 1.233 . . . . 0.0 113.964 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 40.1 p -134.41 158.93 42.61 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 110.622 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.0 m -122.87 143.47 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.794 1.238 . . . . 0.0 110.084 168.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 35.0 m -98.47 138.09 36.2 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.351 1.46 . . . . 0.0 108.831 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 46.1 t -125.13 134.97 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.741 1.617 . . . . 0.0 108.824 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -140.8 156.58 46.12 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.894 1.277 . . . . 0.0 112.594 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 23.2 t80 -153.77 133.11 12.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.732 1.613 . . . . 0.0 111.216 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.19 119.83 73.78 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.4 1.08 . . . . 0.0 110.493 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.67 134.64 15.31 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.238 2.625 . . . . 0.0 111.691 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.2 m -131.73 8.06 4.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.558 1.143 . . . . 0.0 113.12 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -160.18 155.84 25.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.047 1.739 . . . . 0.0 109.912 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.63 175.95 6.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.315 1.046 . . . . 0.0 112.563 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 98.14 -170.4 24.79 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.297 1.427 . . . . 0.0 114.199 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 44.8 tp -76.87 121.85 24.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.924 1.289 . . . . 0.0 110.243 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 12.8 m80 -111.96 164.35 13.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.78 1.632 . . . . 0.0 110.863 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.56 149.79 35.22 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.669 -0.645 . . . . 0.0 111.954 162.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 42.4 ttm -121.36 139.82 52.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.614 1.966 . . . . 0.0 110.121 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.73 134.55 52.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.318 1.447 . . . . 0.0 109.808 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.39 136.42 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.811 1.644 . . . . 0.0 109.433 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 141.07 28.36 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.094 0.958 . . . . 0.0 113.53 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.4 t80 -107.3 122.5 46.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.389 2.276 . . . . 0.0 109.65 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 31.71 10.12 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.56 1.144 . . . . 0.0 112.432 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.0 t30 76.05 5.17 3.79 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.333 2.653 . . . . 0.0 115.071 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.6 mtm -102.44 132.27 48.57 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.526 1.531 . . . . 0.0 110.83 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 12.0 m170 -57.37 136.67 56.61 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 113.142 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 25.5 pt -77.45 153.06 81.52 Favored Pre-proline 0 N--CA 1.48 1.03 0 O-C-N 121.76 -0.588 . . . . 0.0 111.294 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.28 134.15 50.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.158 1.906 . . . . 0.0 109.671 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.4 -13.69 64.14 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.343 0.973 . . . . 0.0 113.973 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.15 146.7 31.77 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 119.11 1.455 . . . . 0.0 111.179 173.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.23 160.67 95.4 Favored 'Cis proline' 0 C--N 1.353 0.802 0 CA-C-N 120.688 1.282 . . . . 0.0 113.455 2.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 75.8 mt -112.06 133.68 54.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.786 2.034 . . . . 0.0 109.054 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -130.16 134.4 47.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.261 1.024 . . . . 0.0 110.575 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -163.12 162.67 25.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.05 0.94 . . . . 0.0 112.817 -175.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.6 t80 -106.57 144.58 33.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.267 1.027 . . . . 0.0 112.88 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 56.2 t -118.95 138.23 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.34 1.456 . . . . 0.0 110.124 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -155.54 147.95 23.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.361 1.064 . . . . 0.0 112.766 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -63.17 142.63 58.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.34 1.456 . . . . 0.0 112.94 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.7 p -67.27 -23.97 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.5 p30 -75.42 -17.06 60.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.7 m -68.21 143.35 55.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.919 0.888 . . . . 0.0 113.357 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -89.99 -17.14 54.73 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.865 1.221 . . . . 0.0 114.36 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -67.25 163.88 19.52 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.466 1.133 . . . . 0.0 113.283 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 4.5 t -66.53 136.94 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.535 1.134 . . . . 0.0 109.52 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 56.7 p -132.65 162.16 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.456 1.102 . . . . 0.0 110.682 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.55 142.21 28.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.358 1.063 . . . . 0.0 110.969 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.9 p90 -166.01 159.94 16.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.616 1.566 . . . . 0.0 112.362 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.74 170.84 12.69 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.329 1.443 . . . . 0.0 113.159 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.05 -32.77 33.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.29 2.66 . . . . 0.0 112.849 -171.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.75 -13.93 72.31 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.936 -0.924 . . . . 0.0 114.791 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.99 -12.64 60.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.128 1.464 . . . . 0.0 112.966 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 15.5 m -119.38 -38.42 3.02 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.684 1.593 . . . . 0.0 112.431 -165.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -156.11 155.03 31.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.61 -173.75 25.5 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.469 1.033 . . . . 0.0 113.033 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.9 p -150.74 136.45 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.647 1.179 . . . . 0.0 109.286 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.7 m -56.57 140.82 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.59 -4.45 1.65 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.396 2.278 . . . . 0.0 114.924 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.65 143.31 26.43 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.965 1.306 . . . . 0.0 110.867 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.54 127.59 11.89 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.461 2.107 . . . . 0.0 110.723 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.48 148.7 26.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.431 1.492 . . . . 0.0 110.361 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.6 p -137.25 155.07 49.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.1 0.96 . . . . 0.0 113.507 -167.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . 0.424 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.3 p90 -164.48 172.84 12.8 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.562 1.945 . . . . 0.0 111.404 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.1 m -128.01 144.23 51.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.691 1.596 . . . . 0.0 110.731 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 46.9 t -120.11 130.52 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.123 1.769 . . . . 0.0 108.454 171.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m120 -87.37 127.82 35.2 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.372 -0.83 . . . . 0.0 111.162 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 50.9 p -131.49 3.35 4.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.352 1.461 . . . . 0.0 113.36 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -55.93 -40.03 72.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.781 1.632 . . . . 0.0 114.328 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.34 4.64 22.8 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.523 1.529 . . . . 0.0 112.896 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.05 -25.92 59.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.349 1.06 . . . . 0.0 113.329 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 -92.47 1.46 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.766 1.174 . . . . 0.0 112.664 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -166.6 179.03 5.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.013 1.725 . . . . 0.0 111.863 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 116.52 5.76 15.96 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.998 1.285 . . . . 0.0 115.477 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.99 105.6 2.16 Favored Glycine 0 N--CA 1.47 0.961 0 C-N-CA 125.503 1.525 . . . . 0.0 113.079 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.23 132.1 34.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 109.179 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -128.26 161.02 30.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.69 1.596 . . . . 0.0 112.142 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.2 tp -159.08 136.55 10.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.699 1.599 . . . . 0.0 109.646 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.67 162.3 37.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.713 1.205 . . . . 0.0 111.776 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 41.2 mt -139.03 132.83 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.404 1.082 . . . . 0.0 109.935 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.29 163.76 14.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.769 1.627 . . . . 0.0 110.083 168.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 167.56 -158.49 31.39 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.179 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.72 -22.2 50.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.686 2.924 . . . . 0.0 112.435 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.3 t -147.11 158.54 43.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 109.499 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.63 112.05 9.35 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.977 -1.077 . . . . 0.0 110.595 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -66.47 150.72 48.53 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.119 0.968 . . . . 0.0 111.739 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.51 137.51 32.27 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.409 0.684 . . . . 0.0 109.315 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 35.1 mt -132.2 143.83 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.443 1.097 . . . . 0.0 110.428 -165.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.41 163.0 35.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 111.301 168.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -157.7 156.76 32.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 112.777 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -138.22 125.26 21.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.907 1.683 . . . . 0.0 110.069 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.34 128.92 33.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 110.862 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -107.98 151.94 25.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.292 1.437 . . . . 0.0 112.434 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -68.87 -16.81 63.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.05 0.94 . . . . 0.0 112.719 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.45 -6.39 48.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.724 1.61 . . . . 0.0 113.968 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.73 33.12 8.61 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.499 1.047 . . . . 0.0 113.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.8 p -136.74 156.77 48.07 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.815 1.246 . . . . 0.0 111.15 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.7 m -102.71 127.6 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.956 0.902 . . . . 0.0 108.903 157.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.8 t -92.21 145.83 24.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.746 0.818 . . . . 0.0 109.796 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' 1886 ' ' PHE . 86.8 t -130.38 143.69 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.129 1.372 . . . . 0.0 109.976 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.1 p -134.08 149.45 51.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.05 1.34 . . . . 0.0 111.919 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.89 152.82 33.07 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 18.8 mt -115.64 105.69 51.43 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.394 1.878 . . . . 0.0 110.207 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.71 170.63 15.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.573 2.849 . . . . 0.0 110.332 167.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -144.99 -28.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -172.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.93 147.89 36.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 110.394 166.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.97 156.22 52.38 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.83 2.353 . . . . 0.0 110.775 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.3 -167.84 23.65 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.98 1.276 . . . . 0.0 113.382 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.6 128.37 39.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.784 1.234 . . . . 0.0 112.262 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -112.47 140.5 47.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.46 1.904 . . . . 0.0 110.496 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.3 m -105.03 111.94 24.89 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.992 1.317 . . . . 0.0 110.229 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.03 122.27 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.023 1.329 . . . . 0.0 108.383 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.25 125.8 47.92 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.572 1.549 . . . . 0.0 109.231 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.1 t -126.71 129.38 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.27 1.028 . . . . 0.0 109.442 171.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.68 142.83 24.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.921 1.288 . . . . 0.0 111.943 -167.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.12 123.67 22.22 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 109.701 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.5 t-20 52.56 57.13 6.72 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.559 1.543 . . . . 0.0 112.541 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.1 pt-20 58.42 12.17 1.94 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.295 2.638 . . . . 0.0 116.286 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.97 125.28 49.04 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.629 1.172 . . . . 0.0 110.779 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.43 143.38 57.15 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.47 -0.769 . . . . 0.0 111.591 172.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.5 m -72.22 152.01 92.37 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.058 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -56.02 125.44 19.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.148 2.566 . . . . 0.0 111.115 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.73 64.33 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.458 1.504 . . . . 0.0 115.316 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 141.56 68.89 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.264 1.532 . . . . 0.0 111.804 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.69 145.54 79.63 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.587 0.888 . . . . 0.0 112.275 -3.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -96.55 139.4 32.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.585 1.554 . . . . 0.0 110.763 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -100.66 107.47 19.11 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.328 0.651 . . . . 0.0 110.63 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.51 125.17 45.22 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.652 1.181 . . . . 0.0 111.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -95.78 116.69 29.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.518 0.727 . . . . 0.0 110.685 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -99.43 133.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.045 1.738 . . . . 0.0 110.678 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 60.2 p -104.12 169.25 8.6 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.296 1.438 . . . . 0.0 112.959 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.83 142.03 25.07 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.946 1.26 . . . . 0.0 111.691 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 . . . . . 0 CA--C 1.549 0.935 0 C-N-CA 124.49 1.116 . . . . 0.0 113.781 -176.838 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 23.3 tp . . . . . 0 CA--C 1.538 0.502 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -66.42 119.06 59.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.918 -168.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.46 154.59 60.5 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.315 2.676 . . . . 0.0 111.715 -171.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.7 123.25 42.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.786 0.834 . . . . 0.0 110.194 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -153.18 130.2 11.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.446 1.498 . . . . 0.0 110.344 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.71 143.46 30.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.854 1.662 . . . . 0.0 109.83 -172.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.1 p -112.45 138.59 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.057 1.343 . . . . 0.0 110.571 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 70.8 mt -131.53 136.6 28.81 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.412 1.885 . . . . 0.0 108.71 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.66 45.47 1.96 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.503 3.469 . . . . 0.0 112.926 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 75.1 t80 -91.53 155.12 18.62 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.254 1.422 . . . . 0.0 111.462 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 95.7 m -125.43 125.86 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.549 1.54 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.7 134.25 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.346 1.058 . . . . 0.0 110.641 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -113.18 -141.78 0.38 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.845 1.658 . . . . 0.0 110.656 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.2 135.66 33.63 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.91 -1.119 . . . . 0.0 110.956 166.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 132.98 -145.26 17.29 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.511 1.529 . . . . 0.0 111.555 -167.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -158.6 151.47 22.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.464 1.106 . . . . 0.0 111.536 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.0 tt -124.64 135.23 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.763 1.625 . . . . 0.0 111.936 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.08 164.07 34.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.72 1.608 . . . . 0.0 110.978 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.72 -175.75 23.0 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.42 140.59 16.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.556 1.543 . . . . 0.0 110.02 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 16.3 t -111.47 132.91 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.814 1.646 . . . . 0.0 108.171 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.4 mtm105 -119.49 119.3 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.682 1.193 . . . . 0.0 110.226 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 11.3 mtt -95.53 149.24 35.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.781 1.632 . . . . 0.0 111.376 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.17 -20.59 28.2 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.4 2.733 . . . . 0.0 113.672 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.7 p -80.61 4.29 19.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.206 1.402 . . . . 0.0 114.387 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.06 45.11 4.88 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 124.485 1.04 . . . . 0.0 113.367 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.54 166.18 31.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.76 1.624 . . . . 0.0 112.021 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.59 161.37 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.224 1.01 . . . . 0.0 113.217 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.04 -179.26 7.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.063 2.145 . . . . 0.0 110.533 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -120.52 141.74 32.71 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 121.189 -0.944 . . . . 0.0 111.333 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.18 166.88 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.322 3.348 . . . . 0.0 111.343 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.8 m -106.91 128.02 53.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 108.915 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.9 130.43 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.611 1.165 . . . . 0.0 109.075 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 77.1 m -135.07 120.98 19.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.163 1.385 . . . . 0.0 109.321 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.58 141.77 41.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 112.218 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.63 -5.61 48.34 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.19 6.33 4.73 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.34 2.256 . . . . 0.0 113.515 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -107.2 9.51 30.2 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.805 2.042 . . . . 0.0 112.991 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.11 17.12 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.719 1.152 . . . . 0.0 113.608 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 34.9 p -134.86 159.77 40.34 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.316 1.846 . . . . 0.0 110.413 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.9 m -125.34 143.4 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.584 1.154 . . . . 0.0 110.076 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 96.3 m -104.56 135.92 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.432 1.093 . . . . 0.0 108.668 171.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 40.0 t -120.11 132.99 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.208 1.403 . . . . 0.0 108.744 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -133.14 159.17 40.91 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.035 1.334 . . . . 0.0 112.706 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.7 t80 -160.5 136.48 8.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.688 1.595 . . . . 0.0 111.66 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.12 112.03 51.67 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.749 1.219 . . . . 0.0 110.185 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.24 151.36 26.52 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.216 2.611 . . . . 0.0 112.209 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -116.16 -12.71 11.19 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -163.44 150.34 12.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.59 1.556 . . . . 0.0 110.884 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.79 172.48 12.1 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.7 1.2 . . . . 0.0 113.497 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.87 -178.58 17.63 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 125.542 1.544 . . . . 0.0 114.435 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.43 123.22 25.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.924 1.29 . . . . 0.0 110.088 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.7 m80 -117.7 157.07 27.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.314 1.446 . . . . 0.0 111.818 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -133.46 142.42 48.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.076 1.35 . . . . 0.0 109.317 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.7 tmm? -143.04 132.45 23.47 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.082 0.953 . . . . 0.0 111.753 -168.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -108.72 139.88 42.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.951 2.1 . . . . 0.0 111.455 -173.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.5 mm -139.32 131.05 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.187 1.395 . . . . 0.0 109.304 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.27 139.71 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.18 123.34 46.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.537 1.935 . . . . 0.0 109.912 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.91 30.95 7.78 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.719 1.208 . . . . 0.0 112.827 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.0 t30 80.59 6.16 1.54 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.53 2.732 . . . . 0.0 115.28 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 90.3 mtp -109.05 133.17 53.35 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.054 1.342 . . . . 0.0 111.119 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.24 138.05 55.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -72.84 153.7 91.15 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.273 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.26 123.89 14.89 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.036 2.491 . . . . 0.0 110.37 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.21 -11.22 61.89 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.376 -1.235 . . . . 0.0 114.903 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.3 m -102.2 154.59 37.28 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-N 119.999 1.9 . . . . 0.0 112.673 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.58 163.83 89.48 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.558 0.878 . . . . 0.0 113.272 0.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.22 151.91 24.8 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.82 1.648 . . . . 0.0 111.504 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.87 141.7 47.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.288 1.435 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.2 p90 -166.56 158.28 13.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.372 1.069 . . . . 0.0 112.072 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 38.2 t80 -96.36 130.19 43.53 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.433 0.693 . . . . 0.0 111.755 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 71.4 t -91.86 132.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.998 1.319 . . . . 0.0 108.681 172.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.1 t0 -146.51 163.7 34.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.498 1.519 . . . . 0.0 110.628 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.76 148.82 44.23 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.992 0.917 . . . . 0.0 112.543 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 89.7 t -67.05 -45.02 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.138 0.975 . . . . 0.0 110.631 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 6.4 p30 -93.64 141.66 28.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.924 0.89 . . . . 0.0 111.125 168.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.4 p -173.85 156.79 2.89 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.051 1.741 . . . . 0.0 112.235 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.42 -23.47 11.13 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.854 1.216 . . . . 0.0 113.595 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -73.59 156.9 37.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.424 1.089 . . . . 0.0 113.736 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.4 t -66.95 138.13 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.173 0.989 . . . . 0.0 108.473 170.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.0 t -153.49 166.77 31.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.038 0.935 . . . . 0.0 111.349 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.01 145.46 29.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.134 1.374 . . . . 0.0 111.665 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 47.2 p90 -166.15 162.4 17.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.629 1.572 . . . . 0.0 112.467 -175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.77 173.47 13.22 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.283 1.421 . . . . 0.0 113.014 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.72 -35.04 13.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.879 2.386 . . . . 0.0 112.751 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.38 -32.12 78.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.463 -171.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.34 -3.47 49.64 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.233 1.516 . . . . 0.0 113.478 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.6 m -108.17 -41.24 4.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.473 1.909 . . . . 0.0 111.676 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -151.09 152.55 33.58 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.244 1.818 . . . . 0.0 112.332 -170.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -153.19 -175.41 24.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.406 1.003 . . . . 0.0 113.393 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.8 p -153.6 137.36 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.07 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.8 m -58.57 142.12 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.0 m-80 68.28 7.33 5.86 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.558 1.943 . . . . 0.0 114.582 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -114.7 143.57 30.25 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.167 1.387 . . . . 0.0 110.924 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.48 127.94 13.06 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.604 2.202 . . . . 0.0 110.316 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.13 145.83 32.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.624 1.57 . . . . 0.0 110.273 173.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.2 p -135.69 152.23 50.97 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -167.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.9 173.83 13.97 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.985 1.714 . . . . 0.0 111.385 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 76.0 m -125.73 142.43 51.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.316 1.446 . . . . 0.0 110.464 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 48.1 t -115.9 128.16 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.837 1.655 . . . . 0.0 107.875 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.32 123.92 35.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.021 0.928 . . . . 0.0 110.932 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 54.5 p -125.99 10.25 7.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.408 1.883 . . . . 0.0 112.608 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.16 -40.06 76.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.52 1.528 . . . . 0.0 114.372 -165.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.39 5.42 21.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.648 1.579 . . . . 0.0 112.738 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.71 58.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.575 1.15 . . . . 0.0 113.693 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.33 -86.71 1.38 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.872 1.225 . . . . 0.0 112.772 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.6 -177.88 3.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.27 1.828 . . . . 0.0 111.627 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 119.38 9.52 8.54 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.815 1.198 . . . . 0.0 115.618 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.33 103.52 1.63 Allowed Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.533 1.54 . . . . 0.0 112.834 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 39.2 tp -84.66 141.35 30.67 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.319 1.447 . . . . 0.0 110.158 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.7 m -135.46 159.41 41.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.592 1.557 . . . . 0.0 112.155 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.5 tp -160.71 136.44 8.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.024 1.73 . . . . 0.0 109.338 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.36 159.17 35.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.74 137.24 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.884 1.274 . . . . 0.0 109.837 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.26 134.39 48.96 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.31 1.444 . . . . 0.0 109.979 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.5 -164.55 16.61 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.667 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.32 -24.48 64.81 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.18 3.253 . . . . 0.0 112.836 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.8 t -139.3 159.75 41.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.914 1.285 . . . . 0.0 109.6 162.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.25 110.57 5.98 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.088 -1.008 . . . . 0.0 110.704 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 145.18 54.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 0.0 111.144 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.46 137.13 32.79 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 36.5 mt -129.36 143.73 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.746 1.218 . . . . 0.0 110.131 -168.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.63 162.68 35.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 110.966 166.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -158.14 155.41 29.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.646 1.178 . . . . 0.0 112.228 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -142.38 125.18 16.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.385 1.474 . . . . 0.0 109.79 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.36 129.56 36.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.946 169.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.18 151.58 20.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.362 1.465 . . . . 0.0 111.808 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -71.14 -16.48 62.55 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.888 0.875 . . . . 0.0 113.281 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.06 -6.96 59.56 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.31 33.89 6.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.815 1.198 . . . . 0.0 114.445 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -127.94 174.09 9.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.331 1.452 . . . . 0.0 110.572 169.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.1 m -124.16 130.96 53.42 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.105 1.362 . . . . 0.0 109.963 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.6 t -93.88 149.13 21.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.277 1.031 . . . . 0.0 110.745 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.1 t -128.17 143.79 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.102 1.761 . . . . 0.0 109.742 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.1 p -136.14 148.1 48.04 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.78 168.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.28 153.78 36.74 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.5 107.33 43.12 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 110.375 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -85.79 173.07 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.114 3.209 . . . . 0.0 110.834 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.1 p -147.34 -28.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -173.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.06 148.67 37.92 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.249 1.019 . . . . 0.0 110.718 167.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.59 157.71 48.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.98 2.453 . . . . 0.0 110.845 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.16 -168.1 22.17 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.164 1.364 . . . . 0.0 113.484 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.66 132.77 34.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.956 1.302 . . . . 0.0 112.568 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 126.64 49.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.275 1.83 . . . . 0.0 109.816 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.1 m -86.8 124.33 32.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.529 1.132 . . . . 0.0 110.482 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.48 124.31 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.605 1.562 . . . . 0.0 108.402 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.6 tt -106.14 131.04 53.87 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.319 1.447 . . . . 0.0 109.831 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.8 t -133.07 127.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.552 1.141 . . . . 0.0 109.607 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.42 143.42 24.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.969 1.308 . . . . 0.0 111.547 -168.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.63 122.31 15.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.957 1.303 . . . . 0.0 109.641 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.68 56.26 6.96 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.199 1.399 . . . . 0.0 112.095 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.3 pt-20 59.42 3.74 0.43 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.85 2.86 . . . . 0.0 116.644 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -108.98 125.05 51.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.678 1.191 . . . . 0.0 110.87 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.62 145.87 54.86 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.279 -0.888 . . . . 0.0 111.809 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 16.3 m -70.39 152.7 95.45 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.091 170.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.42 128.32 27.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.007 2.471 . . . . 0.0 110.57 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.42 62.8 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.052 1.31 . . . . 0.0 115.082 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.3 t -77.61 139.99 63.5 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.392 1.596 . . . . 0.0 111.482 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.36 135.92 42.56 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.358 0.806 . . . . 0.0 111.857 -3.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -86.01 170.3 12.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.794 1.637 . . . . 0.0 110.378 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 45.7 m -131.45 117.38 18.75 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.549 0.74 . . . . 0.0 110.718 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.35 143.41 26.42 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.669 1.188 . . . . 0.0 110.722 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -104.22 119.37 38.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.931 0.492 . . . . 0.0 110.771 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.3 t -97.28 144.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.944 1.698 . . . . 0.0 109.237 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.5 t -132.82 175.65 9.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.038 0.935 . . . . 0.0 112.854 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.33 137.47 19.78 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.644 1.593 . . . . 0.0 112.367 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.0 t70 . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 124.336 1.054 . . . . 0.0 113.402 179.994 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.5 tp . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -44.5 110.07 0.97 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.5 1.52 . . . . 0.0 112.513 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.03 120.64 7.51 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.474 2.116 . . . . 0.0 108.297 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 53.6 t80 -101.01 130.33 46.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.617 0.723 . . . . 0.0 111.677 -172.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 2.1 p30 -160.38 150.11 17.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.769 1.628 . . . . 0.0 111.69 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.4 150.27 40.43 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.456 1.902 . . . . 0.0 110.044 -171.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 139.47 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.773 1.629 . . . . 0.0 110.316 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.3 139.04 30.36 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.886 1.675 . . . . 0.0 108.732 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.13 46.25 2.04 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.707 3.605 . . . . 0.0 112.934 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.15 160.78 14.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.917 1.687 . . . . 0.0 110.532 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 58.1 m -132.47 130.33 40.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.717 1.207 . . . . 0.0 109.41 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.7 mt -92.78 119.49 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.772 1.229 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 -161.98 0.86 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.442 1.497 . . . . 0.0 110.915 170.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -63.58 120.52 11.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.719 -1.238 . . . . 0.0 111.727 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.33 170.63 12.11 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.783 1.659 . . . . 0.0 112.868 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -98.3 143.83 28.36 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.35 1.06 . . . . 0.0 112.528 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 9.8 tt -146.84 129.36 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.807 1.643 . . . . 0.0 110.335 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 76.8 p -146.61 -177.85 5.86 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.174 1.79 . . . . 0.0 110.337 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -165.38 -171.38 31.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.26 141.12 21.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 109.783 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 92.7 t -111.02 136.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.202 1.801 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -118.06 129.49 55.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.943 1.297 . . . . 0.0 110.634 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 17.7 mtm -99.91 151.66 37.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.76 1.624 . . . . 0.0 111.52 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.81 -18.88 36.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.477 2.785 . . . . 0.0 113.021 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 25.8 p -74.85 -4.13 36.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.705 1.602 . . . . 0.0 114.177 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.53 79.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.757 1.646 . . . . 0.0 114.206 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -68.44 160.01 30.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.925 1.29 . . . . 0.0 112.616 173.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -137.49 156.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.207 1.403 . . . . 0.0 111.586 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.36 178.65 9.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.944 2.097 . . . . 0.0 110.095 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.31 142.13 31.86 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.039 -1.038 . . . . 0.0 111.788 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.91 166.98 12.98 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.059 3.173 . . . . 0.0 111.566 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.5 m -102.31 120.39 40.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.484 1.514 . . . . 0.0 108.883 174.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.6 137.97 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.993 1.317 . . . . 0.0 109.158 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 19.0 m -144.37 131.76 20.86 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.334 1.453 . . . . 0.0 110.082 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.43 129.3 34.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.782 0.833 . . . . 0.0 110.218 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -80.85 -4.63 55.43 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.7 mmmt 69.84 13.27 8.02 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.525 2.33 . . . . 0.0 113.365 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -126.59 13.88 7.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.699 2.0 . . . . 0.0 112.755 -173.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.5 13.54 59.71 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.828 1.204 . . . . 0.0 114.56 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 58.4 p -132.33 157.56 44.14 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.208 1.803 . . . . 0.0 110.28 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -114.51 148.1 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.509 1.123 . . . . 0.0 109.769 165.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.8 m -114.57 137.02 52.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.737 1.215 . . . . 0.0 108.256 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.15 130.48 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.875 1.27 . . . . 0.0 108.812 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -125.89 160.92 28.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.012 1.325 . . . . 0.0 112.546 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 16.5 t80 -157.08 134.22 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.104 1.362 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.56 117.27 68.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.664 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -80.99 162.98 20.57 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.592 2.861 . . . . 0.0 112.382 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.9 p -135.69 -20.14 1.57 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.27 155.26 44.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.0 110.987 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.93 174.12 11.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.516 1.126 . . . . 0.0 112.655 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 110.67 -170.86 14.2 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.838 1.685 . . . . 0.0 113.843 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.17 132.19 34.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.753 1.221 . . . . 0.0 110.766 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.0 m80 -129.84 170.72 13.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.687 1.995 . . . . 0.0 111.055 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.0 154.06 41.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.445 1.098 . . . . 0.0 111.424 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 2.3 ttm -138.66 123.73 19.03 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.352 1.461 . . . . 0.0 110.82 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -96.87 135.83 38.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.081 1.753 . . . . 0.0 110.305 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.85 137.44 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.208 1.403 . . . . 0.0 109.997 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.68 135.25 18.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -173.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -102.98 124.17 47.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.634 1.973 . . . . 0.0 109.558 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.34 40.38 22.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.902 1.281 . . . . 0.0 112.467 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.5 m120 76.36 -3.6 2.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.292 2.637 . . . . 0.0 114.845 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.8 mtm -103.45 134.18 47.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.472 1.509 . . . . 0.0 111.462 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.26 135.63 53.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.8 pt -73.9 157.48 87.13 Favored Pre-proline 0 N--CA 1.482 1.146 0 CA-C-O 118.698 -0.667 . . . . 0.0 111.505 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -57.97 125.81 19.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.635 2.224 . . . . 0.0 110.988 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.35 -9.94 71.62 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.991 1.281 . . . . 0.0 114.69 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.1 t -82.78 147.31 54.77 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.36 1.58 . . . . 0.0 111.667 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.4 164.76 69.02 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 120.126 1.081 . . . . 0.0 112.451 -4.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.37 156.64 17.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.703 1.601 . . . . 0.0 111.998 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -136.71 136.36 38.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 109.191 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.9 150.07 25.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 57.8 t80 -105.2 142.31 35.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.182 0.993 . . . . 0.0 112.199 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -124.83 138.33 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.692 1.597 . . . . 0.0 109.056 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 37.2 t0 -162.22 157.32 22.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.372 1.469 . . . . 0.0 111.581 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -82.73 146.19 29.16 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.963 -1.085 . . . . 0.0 113.188 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.1 t -62.63 -30.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.102 1.361 . . . . 0.0 112.281 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.22 -11.34 59.74 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.6 m -57.96 136.34 57.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.85 61.9 1.95 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.809 1.671 . . . . 0.0 112.575 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -158.56 166.67 31.56 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.228 1.411 . . . . 0.0 113.269 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 10.6 p -70.15 139.76 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.876 0.871 . . . . 0.0 110.089 166.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -156.41 167.64 29.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.23 145.98 31.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.39 1.076 . . . . 0.0 112.257 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.9 p90 -167.86 166.08 13.64 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.691 . . . . 0.0 112.882 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.03 172.02 13.03 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.7 1.619 . . . . 0.0 112.362 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.3 -34.84 12.08 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.859 2.372 . . . . 0.0 113.191 -169.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.14 -29.13 73.21 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.844 -0.976 . . . . 0.0 114.625 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.85 -0.13 42.1 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.21 1.505 . . . . 0.0 113.659 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 19.6 m -116.22 -42.21 3.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.051 2.141 . . . . 0.0 111.999 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -140.6 153.05 45.92 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.823 1.649 . . . . 0.0 112.604 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -155.09 -176.13 26.93 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.112 0.863 . . . . 0.0 113.436 167.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.8 p -151.6 137.98 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.92 1.288 . . . . 0.0 108.982 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -58.29 143.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 69.56 5.76 5.35 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.607 1.963 . . . . 0.0 114.776 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.6 mttm -117.41 147.49 40.74 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 111.194 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.25 138.65 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.62 2.214 . . . . 0.0 110.806 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -118.81 147.52 43.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.928 1.691 . . . . 0.0 110.3 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.6 p -135.52 152.45 51.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.088 0.955 . . . . 0.0 113.573 -166.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.67 176.53 10.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.093 1.757 . . . . 0.0 111.325 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 81.8 m -132.3 138.53 47.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.88 1.272 . . . . 0.0 110.68 -171.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.2 t -104.0 130.29 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.135 1.374 . . . . 0.0 107.6 167.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -97.3 123.8 41.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.561 1.144 . . . . 0.0 110.187 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 52.8 p -127.97 5.97 5.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.793 1.637 . . . . 0.0 113.397 -167.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -54.54 -33.92 60.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.629 1.572 . . . . 0.0 114.647 -171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.0 t70 -113.9 7.02 16.83 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.537 1.535 . . . . 0.0 113.259 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.41 -14.86 59.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.04 -97.98 2.19 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.493 1.044 . . . . 0.0 112.761 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.67 171.38 16.95 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.381 1.473 . . . . 0.0 112.515 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 125.46 -160.62 20.0 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.005 1.764 . . . . 0.0 112.771 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.98 115.25 4.73 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.257 0.932 . . . . 0.0 111.371 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.7 128.4 34.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.199 1.4 . . . . 0.0 108.88 171.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 34.4 m -129.9 158.54 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.508 1.523 . . . . 0.0 112.289 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -160.18 135.55 8.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.239 1.816 . . . . 0.0 108.909 -169.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.41 157.91 34.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.666 0.786 . . . . 0.0 112.497 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -136.29 140.39 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.132 1.373 . . . . 0.0 109.763 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.22 136.11 45.42 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.431 1.492 . . . . 0.0 109.38 171.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.29 -164.55 16.39 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.833 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.86 -27.19 67.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.077 3.185 . . . . 0.0 112.417 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.3 t -135.4 159.86 40.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.868 1.267 . . . . 0.0 109.352 159.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -75.76 109.51 9.42 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.042 -1.036 . . . . 0.0 110.871 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 147.27 52.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.724 0.809 . . . . 0.0 111.768 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.94 145.5 27.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.387 0.675 . . . . 0.0 110.083 166.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.94 140.21 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 110.203 -167.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 57.9 m -135.35 157.01 47.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.587 1.555 . . . . 0.0 110.776 167.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -156.16 156.7 34.66 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.094 0.957 . . . . 0.0 112.458 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.1 m -141.91 122.13 13.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.035 1.334 . . . . 0.0 110.406 -172.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.47 132.05 41.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.97 1.308 . . . . 0.0 111.065 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -112.76 146.4 38.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 111.75 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.45 -13.3 61.91 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.986 0.914 . . . . 0.0 113.312 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.77 -4.88 40.28 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.242 1.817 . . . . 0.0 114.219 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.25 31.55 9.61 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.58 1.086 . . . . 0.0 113.804 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.0 p -141.06 161.35 38.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.351 1.46 . . . . 0.0 111.357 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 78.9 m -112.85 128.23 56.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.719 1.207 . . . . 0.0 109.004 158.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.1 t -87.4 148.02 25.18 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 110.462 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -129.39 142.83 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.672 1.589 . . . . 0.0 110.214 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 69.6 p -136.45 145.75 45.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.922 1.289 . . . . 0.0 111.591 165.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.4 p90 -148.44 156.9 43.07 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.018 -1.051 . . . . 0.0 112.693 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.06 104.84 25.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.264 1.026 . . . . 0.0 110.666 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.17 172.13 9.8 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 124.226 3.284 . . . . 0.0 111.219 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.6 p -147.36 -29.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.28 147.91 36.11 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 119.515 1.052 . . . . 0.0 110.776 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.49 156.49 49.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.911 2.408 . . . . 0.0 110.696 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.96 -162.53 24.74 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.104 1.335 . . . . 0.0 113.003 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -104.03 125.85 50.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.344 1.058 . . . . 0.0 111.242 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -109.97 129.47 55.66 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.881 1.672 . . . . 0.0 110.023 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -88.23 127.19 35.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 110.611 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -106.64 127.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.63 1.572 . . . . 0.0 108.657 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.31 134.78 51.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 109.756 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.6 t -136.29 131.27 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.249 1.419 . . . . 0.0 108.546 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.12 143.22 22.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.865 1.266 . . . . 0.0 111.332 -170.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.77 124.67 15.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.849 1.259 . . . . 0.0 109.941 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 57.85 51.82 8.7 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 9.0 pt-20 55.57 17.24 2.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.149 2.579 . . . . 0.0 115.84 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -122.02 128.82 51.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.858 1.263 . . . . 0.0 110.725 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -65.18 156.24 32.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.132 0.973 . . . . 0.0 112.829 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.7 m -72.82 152.48 91.17 Favored Pre-proline 0 N--CA 1.48 1.029 0 O-C-N 121.545 -0.722 . . . . 0.0 109.247 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.94 -11.15 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.965 1.777 . . . . 0.0 114.657 -166.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -105.0 -7.48 38.22 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 85.1 p -85.89 156.4 58.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.143 1.971 . . . . 0.0 113.722 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.19 144.53 79.75 Favored 'Cis proline' 0 C--N 1.354 0.844 0 CA-C-N 118.968 0.667 . . . . 0.0 112.136 -5.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -95.71 167.93 10.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.362 1.465 . . . . 0.0 110.668 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 29.6 m -130.54 118.09 20.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.909 0.884 . . . . 0.0 110.23 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.72 127.29 44.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.354 . . . . 0.0 110.684 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -92.13 117.12 29.54 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.664 0.386 . . . . 0.0 110.353 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -102.81 140.82 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.087 1.755 . . . . 0.0 109.45 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.9 t -128.57 173.46 10.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 0.0 112.76 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.92 140.69 21.07 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.806 1.669 . . . . 0.0 112.193 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 25.1 t70 . . . . . 0 CA--C 1.549 0.93 0 C-N-CA 124.112 0.965 . . . . 0.0 113.464 177.982 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 48.3 mt . . . . . 0 N--CA 1.468 0.458 0 CA-C-O 121.272 0.558 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -60.12 117.49 24.28 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 110.837 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.29 152.74 44.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.821 2.347 . . . . 0.0 111.052 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -94.26 116.25 28.62 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 169.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -145.49 125.29 13.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.771 1.228 . . . . 0.0 110.184 168.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.92 147.02 39.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.304 1.842 . . . . 0.0 109.55 -174.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -122.32 136.94 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.967 1.307 . . . . 0.0 110.453 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.4 mt -135.15 136.15 24.16 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.893 1.677 . . . . 0.0 109.287 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.12 117.67 5.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.401 2.734 . . . . 0.0 110.167 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.6 t80 178.02 149.6 0.2 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.356 . . . . 0.0 109.315 -168.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 23.9 m -130.75 125.69 34.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.136 0.974 . . . . 0.0 110.336 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 31.8 mt -83.16 119.33 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.744 1.218 . . . . 0.0 108.954 171.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -122.68 -53.21 1.89 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.913 0.885 . . . . 0.0 113.189 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -160.18 121.74 3.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.313 1.445 . . . . 0.0 111.398 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.68 -146.7 18.61 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 125.735 1.636 . . . . 0.0 111.716 -169.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.6 146.94 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.711 1.204 . . . . 0.0 110.959 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 10.8 tt -130.58 136.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.523 1.529 . . . . 0.0 111.571 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 41.4 p -147.23 -177.99 5.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.611 1.964 . . . . 0.0 110.158 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.67 -166.99 34.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 115.324 0.889 . . . . 0.0 115.324 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.86 131.84 9.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.497 1.519 . . . . 0.0 110.306 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 18.3 t -101.6 136.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.367 1.467 . . . . 0.0 108.648 170.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -120.32 131.11 54.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.719 1.207 . . . . 0.0 111.222 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -105.78 148.33 36.27 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.798 1.639 . . . . 0.0 112.104 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.55 -39.79 55.21 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.8 3.667 . . . . 0.0 115.784 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 7.1 t -73.64 -1.4 18.74 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.44 60.8 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.707 1.622 . . . . 0.0 114.366 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -69.49 160.71 30.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.246 1.418 . . . . 0.0 112.169 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.5 m -139.41 155.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.334 1.454 . . . . 0.0 111.609 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.62 163.29 40.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.79 1.636 . . . . 0.0 111.37 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.63 137.02 21.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.567 0.747 . . . . 0.0 111.577 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.11 169.18 11.62 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.59 3.527 . . . . 0.0 111.924 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -110.55 139.08 46.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 108.995 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.24 132.24 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.668 1.187 . . . . 0.0 109.283 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -134.29 127.09 31.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.416 1.487 . . . . 0.0 109.74 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.08 127.17 31.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.458 0.703 . . . . 0.0 110.279 170.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -79.01 -3.49 45.35 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.2 mmtm 71.24 13.12 6.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.76 2.424 . . . . 0.0 113.13 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -126.63 11.09 7.27 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.825 2.05 . . . . 0.0 113.001 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.48 12.78 57.98 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.855 1.217 . . . . 0.0 114.821 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -128.38 154.32 46.12 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.064 1.746 . . . . 0.0 110.396 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.2 m -111.62 141.42 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.903 0.881 . . . . 0.0 109.894 165.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.0 m -103.43 133.61 48.2 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.604 1.162 . . . . 0.0 108.412 168.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 59.9 t -116.99 134.4 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.125 1.77 . . . . 0.0 108.649 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -139.2 159.2 42.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.636 1.174 . . . . 0.0 113.47 -172.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.2 t80 -158.47 135.84 10.11 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.019 1.727 . . . . 0.0 111.483 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.93 120.0 73.23 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 124.726 1.21 . . . . 0.0 110.846 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.33 148.03 23.5 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.706 2.937 . . . . 0.0 112.607 -170.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.0 p -142.25 5.41 1.66 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.664 1.186 . . . . 0.0 114.009 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -160.18 144.52 14.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.895 1.678 . . . . 0.0 110.056 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.86 163.51 13.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 0.0 112.196 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 114.45 -168.76 12.65 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 125.247 1.403 . . . . 0.0 113.665 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -86.21 122.26 29.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.9 m80 -118.61 161.58 19.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.966 1.707 . . . . 0.0 111.822 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.16 155.96 46.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 40.9 ttm -140.77 118.37 11.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.253 1.421 . . . . 0.0 111.156 -172.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -81.56 134.98 35.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.255 2.222 . . . . 0.0 109.832 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 19.9 mm -141.09 136.32 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.349 1.459 . . . . 0.0 108.714 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 136.84 16.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.9 t80 -97.21 121.98 39.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.741 2.016 . . . . 0.0 109.795 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.94 35.51 16.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.876 1.27 . . . . 0.0 112.775 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 76.69 4.22 3.47 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 127.983 2.513 . . . . 0.0 114.506 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.6 mtm -107.53 132.6 53.07 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.68 1.592 . . . . 0.0 110.952 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.24 139.07 55.75 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 39.9 pt -74.71 155.21 87.19 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.456 0.702 . . . . 0.0 110.902 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.58 119.78 7.21 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.932 2.421 . . . . 0.0 111.942 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.9 69.83 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.52 1.533 . . . . 0.0 115.128 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 38.8 m -80.79 154.69 73.3 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.758 1.779 . . . . 0.0 112.025 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.97 155.01 99.73 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.422 0.829 . . . . 0.0 112.538 -0.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.92 159.56 15.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.097 1.359 . . . . 0.0 110.86 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -159.08 133.9 8.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.315 1.046 . . . . 0.0 110.478 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.92 -179.48 5.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.032 1.333 . . . . 0.0 112.697 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -118.31 137.29 53.17 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.219 1.008 . . . . 0.0 113.353 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.0 t -108.95 138.04 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.25 1.82 . . . . 0.0 110.021 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.6 t0 -149.1 178.9 8.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.334 1.853 . . . . 0.0 109.509 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -77.85 143.07 38.11 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.693 -1.254 . . . . 0.0 111.304 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.9 m -65.47 -17.71 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -166.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -148.81 41.41 0.93 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.978 0.911 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 2.6 t -66.68 -28.58 68.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 106.09 -25.36 23.93 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.113 1.815 . . . . 0.0 115.019 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -72.42 160.49 32.25 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.909 1.354 . . . . 0.0 113.445 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.5 t -64.36 134.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.603 1.161 . . . . 0.0 109.678 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -161.47 150.09 15.79 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.59 1.156 . . . . 0.0 110.874 -173.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -118.96 147.05 44.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.836 1.254 . . . . 0.0 111.978 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.4 p90 -166.8 158.02 12.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.082 1.753 . . . . 0.0 112.818 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 141.19 170.3 12.16 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.309 1.433 . . . . 0.0 113.258 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 -33.19 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.942 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.92 82.04 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.263 0.938 . . . . 0.0 114.047 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.85 -5.99 54.94 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 118.645 1.222 . . . . 0.0 112.658 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.6 m -99.09 -45.56 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.073 1.749 . . . . 0.0 111.406 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -147.57 142.38 26.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.531 1.932 . . . . 0.0 111.987 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -137.31 170.4 23.61 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.373 0.987 . . . . 0.0 113.376 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 59.9 t -134.92 135.58 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.144 1.378 . . . . 0.0 107.963 173.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -55.85 133.84 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.199 0.6 . . . . 0.0 112.493 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.08 -0.19 2.19 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.094 2.158 . . . . 0.0 114.54 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.59 140.06 21.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.084 1.354 . . . . 0.0 110.973 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.45 120.96 7.06 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.636 2.224 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.61 133.89 48.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.331 1.452 . . . . 0.0 110.141 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.1 p -128.5 149.46 50.58 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.49 178.65 8.91 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.74 1.616 . . . . 0.0 111.728 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -130.79 145.14 51.89 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.129 1.372 . . . . 0.0 110.793 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.0 t -116.55 132.65 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.644 1.578 . . . . 0.0 108.288 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -94.25 128.67 40.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.31 1.044 . . . . 0.0 111.009 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 48.7 p -136.46 3.51 2.81 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.47 1.508 . . . . 0.0 113.792 -167.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -53.73 -40.23 65.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.422 1.489 . . . . 0.0 114.668 -169.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -107.43 5.87 27.69 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.505 1.522 . . . . 0.0 113.123 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.28 -19.11 61.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.07 -89.98 1.63 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.724 1.154 . . . . 0.0 112.497 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -165.04 173.06 11.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.286 1.434 . . . . 0.0 112.648 -169.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 121.09 -167.52 14.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.199 1.857 . . . . 0.0 112.73 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.64 106.55 3.2 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.935 0.779 . . . . 0.0 111.791 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.6 124.6 28.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.509 1.124 . . . . 0.0 108.586 168.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 46.1 m -124.07 158.04 33.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.782 1.633 . . . . 0.0 112.24 -173.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.46 137.22 10.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.857 1.663 . . . . 0.0 109.515 -172.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 160.57 37.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.354 1.061 . . . . 0.0 111.909 175.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.8 mt -135.53 132.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.499 1.12 . . . . 0.0 109.6 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.88 108.06 15.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.413 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -117.53 -178.16 17.5 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.124 1.345 . . . . 0.0 113.743 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.79 -26.1 52.83 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.797 2.998 . . . . 0.0 111.652 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 151.48 51.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.234 1.414 . . . . 0.0 108.646 155.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.18 122.25 20.72 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.957 -1.089 . . . . 0.0 112.0 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.88 154.27 41.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 112.12 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.88 139.62 30.27 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.354 0.662 . . . . 0.0 109.397 166.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 34.4 mt -133.85 143.61 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -166.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 10.8 t -142.58 161.64 37.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.31 1.444 . . . . 0.0 111.065 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -160.09 155.11 24.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.92 1.288 . . . . 0.0 112.687 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.0 m -141.65 127.32 19.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.375 1.47 . . . . 0.0 110.455 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.91 131.63 37.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.814 1.246 . . . . 0.0 111.264 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -111.13 151.06 28.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.129 1.371 . . . . 0.0 112.442 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -67.69 -19.68 65.19 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.49 1.116 . . . . 0.0 112.461 173.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.23 -5.71 37.76 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.811 1.644 . . . . 0.0 114.421 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.22 33.96 8.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.46 1.029 . . . . 0.0 113.235 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -141.28 161.37 38.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.518 1.527 . . . . 0.0 111.143 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.5 m -108.6 131.68 54.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.859 1.263 . . . . 0.0 108.913 158.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -91.09 149.89 21.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.939 0.895 . . . . 0.0 110.486 168.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 95.1 t -130.2 144.8 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.046 1.739 . . . . 0.0 109.973 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.1 t -140.35 141.05 35.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.486 1.514 . . . . 0.0 110.932 170.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -147.03 153.99 40.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.51 103.32 49.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.483 1.913 . . . . 0.0 110.256 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.12 161.99 17.94 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.647 2.898 . . . . 0.0 110.306 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.5 m -126.39 -10.06 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.48 151.63 22.82 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.207 1.403 . . . . 0.0 110.419 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.24 142.99 27.81 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.762 2.308 . . . . 0.0 111.649 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 155.4 -167.59 32.99 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.779 1.181 . . . . 0.0 113.299 -174.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -101.08 128.54 47.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.573 1.149 . . . . 0.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -120.15 123.23 42.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.65 1.58 . . . . 0.0 110.121 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 48.8 m -86.45 125.78 33.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.039 -1.038 . . . . 0.0 111.22 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 128.55 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.531 1.533 . . . . 0.0 108.614 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.23 129.95 55.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.301 1.44 . . . . 0.0 109.655 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.5 t -132.59 128.93 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.435 1.094 . . . . 0.0 109.757 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.39 143.68 24.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.269 1.428 . . . . 0.0 111.046 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.88 121.74 11.99 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.535 1.134 . . . . 0.0 109.721 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.77 55.28 5.56 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.034 1.333 . . . . 0.0 111.544 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.2 pt-20 58.26 13.19 2.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.396 2.678 . . . . 0.0 116.267 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.18 126.2 49.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.647 1.179 . . . . 0.0 110.909 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.57 146.15 54.28 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.803 170.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.5 m -71.19 152.76 94.51 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.152 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.96 129.59 35.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.005 2.47 . . . . 0.0 110.895 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.7 -17.69 57.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.169 1.366 . . . . 0.0 114.89 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 35.6 t -77.77 140.13 62.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.26 1.53 . . . . 0.0 111.542 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.0 135.42 40.07 Favored 'Cis proline' 0 C--N 1.352 0.735 0 CA-C-N 119.377 0.813 . . . . 0.0 111.717 -4.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.67 176.85 6.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.223 1.809 . . . . 0.0 110.492 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 95.4 m -137.35 123.25 20.13 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.94 0.896 . . . . 0.0 111.096 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.12 160.07 15.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.127 1.771 . . . . 0.0 110.711 167.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -122.13 126.31 48.09 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.788 0.835 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.5 t -106.19 141.01 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.21 1.804 . . . . 0.0 109.881 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -130.33 171.11 13.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 112.978 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.91 144.34 31.06 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.382 1.468 . . . . 0.0 112.557 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 . . . . . 0 CA--C 1.548 0.88 0 C-N-CA 124.231 1.012 . . . . 0.0 113.2 177.69 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.469 0.476 0 CA-C-O 121.049 0.452 . . . . 0.0 109.853 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -66.01 119.98 65.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 110.608 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.71 137.74 43.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.93 2.42 . . . . 0.0 110.197 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 27.4 t80 -105.63 129.91 53.77 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.535 0.734 . . . . 0.0 111.663 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -157.61 142.8 16.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.505 1.522 . . . . 0.0 111.2 171.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.42 151.02 45.93 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.164 1.786 . . . . 0.0 109.954 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.4 p -115.59 138.07 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 109.938 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.34 134.49 26.14 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.002 1.721 . . . . 0.0 108.713 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.51 100.02 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.385 2.724 . . . . 0.0 109.572 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -161.82 148.79 14.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.496 1.918 . . . . 0.0 109.164 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.5 m -124.28 125.93 45.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.122 . . . . 0.0 109.357 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 80.1 mt -86.01 126.0 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 0.0 109.933 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.29 -161.25 0.75 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.946 1.698 . . . . 0.0 111.658 172.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.97 126.46 29.55 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.897 -1.127 . . . . 0.0 111.509 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.39 -144.6 12.98 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.952 1.739 . . . . 0.0 111.476 -170.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.74 141.95 16.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.146 0.978 . . . . 0.0 111.752 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.4 tt -133.5 134.04 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.052 1.741 . . . . 0.0 110.607 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.25 166.5 27.78 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.85 1.66 . . . . 0.0 111.06 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.73 -175.34 24.13 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.99 140.68 18.99 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.683 1.993 . . . . 0.0 109.333 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.2 t -117.92 131.71 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.716 1.606 . . . . 0.0 108.19 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -113.92 125.34 53.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.479 1.112 . . . . 0.0 110.633 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 37.6 mtm -104.25 138.67 19.59 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.354 1.461 . . . . 0.0 111.473 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -56.42 -29.48 77.75 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.513 3.476 . . . . 0.0 116.098 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 9.0 p -77.67 8.13 4.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.152 1.381 . . . . 0.0 114.666 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.44 46.41 4.06 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.69 1.138 . . . . 0.0 113.168 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.54 162.42 41.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.646 1.578 . . . . 0.0 112.014 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.7 m -140.26 157.76 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.819 1.247 . . . . 0.0 112.396 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -149.32 178.16 9.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.1 2.16 . . . . 0.0 109.999 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.83 142.19 30.37 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.114 -0.991 . . . . 0.0 111.75 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -83.64 167.22 13.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.214 3.276 . . . . 0.0 111.547 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 64.3 m -104.3 116.48 32.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.314 1.446 . . . . 0.0 108.982 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.24 130.03 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.328 1.051 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -121.2 125.63 47.62 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.374 1.87 . . . . 0.0 109.491 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 63.2 t0 -82.47 116.93 22.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.26 1.024 . . . . 0.0 110.154 172.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.2 -14.0 54.24 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 67.47 4.0 3.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.022 2.129 . . . . 0.0 114.204 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -102.55 6.78 40.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.792 2.037 . . . . 0.0 113.146 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.69 9.16 63.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.087 1.327 . . . . 0.0 113.912 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.2 p -127.17 161.44 28.49 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.524 1.929 . . . . 0.0 110.558 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -120.69 144.48 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.961 0.904 . . . . 0.0 109.656 163.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.9 m -105.47 138.15 42.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.398 1.079 . . . . 0.0 108.144 170.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -125.52 127.58 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.162 0.985 . . . . 0.0 109.21 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -123.81 158.0 32.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.298 1.439 . . . . 0.0 112.229 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 15.3 t80 -157.35 134.36 10.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.147 1.379 . . . . 0.0 111.812 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.77 117.11 68.03 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 0.0 110.515 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.22 145.15 27.13 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.234 2.623 . . . . 0.0 112.258 -173.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.6 t -138.73 -10.96 1.35 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -139.49 153.21 47.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.404 1.882 . . . . 0.0 109.654 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -99.63 166.51 11.09 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.545 1.138 . . . . 0.0 112.556 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.01 -168.15 13.26 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.24 1.4 . . . . 0.0 114.217 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.1 tp -83.33 110.75 18.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.838 1.255 . . . . 0.0 110.91 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -105.73 170.96 7.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.341 1.856 . . . . 0.0 112.304 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.29 152.4 41.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.491 1.117 . . . . 0.0 111.49 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 13.6 ttm -122.21 127.67 50.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.034 1.734 . . . . 0.0 110.08 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.69 131.58 49.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.25 2.22 . . . . 0.0 109.2 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.2 mm -138.32 135.1 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.78 1.232 . . . . 0.0 109.193 174.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.49 140.0 27.21 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.864 0.866 . . . . 0.0 113.324 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -99.44 119.96 38.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.121 1.768 . . . . 0.0 109.179 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.22 34.83 12.08 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.927 1.291 . . . . 0.0 113.057 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.0 m-80 72.79 10.21 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.573 2.349 . . . . 0.0 115.133 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.7 mtt -104.65 130.36 52.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.133 1.373 . . . . 0.0 110.391 167.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.29 137.65 55.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.243 -0.911 . . . . 0.0 113.35 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.7 pt -74.17 153.88 88.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.986 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.29 126.5 20.25 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.565 2.177 . . . . 0.0 110.632 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.23 -18.2 54.52 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.14 1.353 . . . . 0.0 114.302 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 62.0 m -87.64 154.91 53.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.848 1.824 . . . . 0.0 112.564 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.22 158.11 98.95 Favored 'Cis proline' 0 C--N 1.354 0.838 0 CA-C-N 119.258 0.771 . . . . 0.0 112.241 -4.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.0 mt -103.53 157.71 16.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.985 1.314 . . . . 0.0 111.244 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -141.22 138.89 33.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 109.606 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.5 p90 -166.64 159.39 14.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.507 1.123 . . . . 0.0 111.977 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 35.3 t80 -101.24 139.56 36.75 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.145 -0.972 . . . . 0.0 112.656 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 50.5 t -107.83 132.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.154 1.381 . . . . 0.0 109.688 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -147.79 175.18 11.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.991 2.117 . . . . 0.0 111.454 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -84.71 145.02 28.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 0.0 112.792 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 17.1 m -69.49 -25.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.544 -0.722 . . . . 0.0 112.221 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -99.65 34.31 2.28 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.277 1.831 . . . . 0.0 111.691 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 14.9 p -53.36 141.99 22.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.982 1.713 . . . . 0.0 114.208 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.5 37.02 3.76 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 126.16 1.838 . . . . 0.0 112.255 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -166.93 156.52 10.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.619 1.568 . . . . 0.0 112.857 -167.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.1 p -61.1 141.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 110.126 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 163.18 36.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.91 0.884 . . . . 0.0 111.604 -173.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.43 145.18 31.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.379 1.472 . . . . 0.0 111.936 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.7 p90 -166.31 157.73 13.33 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.796 1.638 . . . . 0.0 112.722 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 146.2 175.77 19.5 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.485 1.04 . . . . 0.0 114.483 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.54 -43.49 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.203 2.602 . . . . 0.0 112.259 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.56 73.77 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.085 0.857 . . . . 0.0 113.641 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.57 -19.17 63.68 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.3 m -110.4 -49.73 3.03 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.06 1.744 . . . . 0.0 111.327 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -135.27 133.69 39.19 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.19 1.796 . . . . 0.0 112.035 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -119.38 167.37 13.31 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.593 1.092 . . . . 0.0 113.314 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.04 130.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 109.218 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 139.46 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.836 0.854 . . . . 0.0 111.966 -175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.83 6.12 4.4 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.674 1.99 . . . . 0.0 114.216 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 63.9 mttp -125.15 145.46 50.59 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.856 1.662 . . . . 0.0 111.06 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.01 133.58 21.78 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.606 2.204 . . . . 0.0 111.05 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -115.65 147.49 40.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.758 1.623 . . . . 0.0 110.179 173.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -166.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -160.76 176.17 11.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.769 1.628 . . . . 0.0 111.662 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.5 m -131.65 144.21 50.86 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.301 1.441 . . . . 0.0 110.789 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 36.3 t -113.92 138.19 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.075 1.75 . . . . 0.0 108.017 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -104.8 127.44 52.6 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.47 1.108 . . . . 0.0 110.037 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -125.07 3.22 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.648 1.979 . . . . 0.0 113.323 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.1 tttt -50.33 -36.71 33.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.317 1.847 . . . . 0.0 114.674 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -115.41 10.95 15.91 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.585 1.554 . . . . 0.0 113.132 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.57 -40.05 50.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.78 154.71 9.4 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.63 1.11 . . . . 0.0 112.323 -168.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.63 171.94 14.41 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.455 1.102 . . . . 0.0 112.957 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 134.72 14.87 1.12 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.861 1.219 . . . . 0.0 115.81 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 103.51 103.68 2.82 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.595 1.569 . . . . 0.0 113.204 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.57 143.29 31.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.216 1.407 . . . . 0.0 110.52 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.6 m -136.07 156.8 48.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 111.938 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.4 tp -157.96 133.58 9.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.206 1.803 . . . . 0.0 108.756 -173.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 159.78 38.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.738 0.815 . . . . 0.0 112.427 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.0 mt -134.58 131.2 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.565 1.146 . . . . 0.0 109.481 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.59 107.4 14.2 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.28 1.432 . . . . 0.0 109.309 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -120.52 -173.74 15.01 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.122 1.344 . . . . 0.0 113.992 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.57 -21.66 45.67 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.78 2.987 . . . . 0.0 111.904 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.0 t -137.94 157.9 45.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.629 1.572 . . . . 0.0 109.096 158.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -71.95 117.47 13.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.987 -1.071 . . . . 0.0 111.638 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.05 149.05 43.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.79 140.5 29.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.194 0.598 . . . . 0.0 109.536 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 43.8 mt -131.84 143.53 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 110.111 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.8 t -140.34 163.08 33.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.806 1.242 . . . . 0.0 110.829 166.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -161.51 155.33 21.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.524 1.13 . . . . 0.0 112.658 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 81.5 m -137.19 114.72 11.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.61 1.564 . . . . 0.0 109.283 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.2 144.92 27.21 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.82 1.248 . . . . 0.0 112.226 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -123.07 147.76 46.37 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.411 1.484 . . . . 0.0 111.75 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -71.98 -12.59 61.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.714 0.806 . . . . 0.0 112.514 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.2 -7.0 49.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.861 1.664 . . . . 0.0 114.027 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.94 32.57 7.07 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.576 1.084 . . . . 0.0 113.99 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.3 p -141.08 161.31 38.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 111.292 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 30.0 m -132.3 133.14 43.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.343 1.457 . . . . 0.0 109.366 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -94.1 147.97 22.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.187 0.995 . . . . 0.0 110.459 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.0 t -130.72 142.84 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.736 1.614 . . . . 0.0 110.118 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 90.5 p -135.18 149.24 49.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.091 1.356 . . . . 0.0 111.783 167.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -151.51 155.26 38.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 4.6 mt -121.08 104.19 41.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.284 1.834 . . . . 0.0 110.344 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.52 164.09 16.6 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.731 2.954 . . . . 0.0 110.274 166.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -127.18 -20.51 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.4 153.25 32.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.797 1.239 . . . . 0.0 110.984 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.14 151.88 39.46 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.878 2.385 . . . . 0.0 112.63 -168.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.46 -151.67 23.67 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.471 1.51 . . . . 0.0 112.68 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.98 128.81 51.9 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.089 1.356 . . . . 0.0 110.672 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.14 127.4 55.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.339 1.856 . . . . 0.0 109.653 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 57.1 m -89.31 125.23 35.03 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.777 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.67 126.88 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.895 1.278 . . . . 0.0 108.977 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.38 129.35 55.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 109.594 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -130.66 129.92 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.685 1.194 . . . . 0.0 109.025 171.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.85 144.59 23.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.91 1.284 . . . . 0.0 111.845 -167.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.47 123.66 15.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.005 1.322 . . . . 0.0 109.933 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 52.55 56.91 6.99 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.623 1.569 . . . . 0.0 112.172 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 7.5 pt-20 59.35 8.47 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.62 2.768 . . . . 0.0 116.544 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -115.75 124.84 51.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.454 1.102 . . . . 0.0 110.899 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -61.84 145.89 51.31 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.431 -0.793 . . . . 0.0 111.704 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.2 m -68.8 149.94 97.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.254 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.37 131.33 40.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.073 2.515 . . . . 0.0 111.576 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.59 -14.57 61.03 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.223 1.392 . . . . 0.0 114.943 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.6 t -80.1 144.17 58.3 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 119.011 1.405 . . . . 0.0 111.411 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.08 140.64 67.05 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 120.01 1.039 . . . . 0.0 112.576 -0.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.36 175.57 6.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 110.541 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 27.8 m -135.3 125.73 26.68 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 110.739 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.49 132.16 48.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.023 1.329 . . . . 0.0 109.973 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.9 ttt85 -92.47 136.9 32.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 61.5 t -132.75 131.81 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.514 1.126 . . . . 0.0 110.759 -163.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 7.3 t -173.55 164.66 4.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.346 1.858 . . . . 0.0 111.217 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 143.18 -163.15 27.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.539 1.543 . . . . 0.0 113.682 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 N--CA 1.48 1.063 0 C-N-CA 127.197 2.199 . . . . 0.0 114.114 176.279 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 62.1 mt . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -55.91 115.97 11.03 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.744 1.218 . . . . 0.0 110.975 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.94 151.54 50.66 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.822 2.348 . . . . 0.0 110.501 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.51 118.41 35.68 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.286 0.634 . . . . 0.0 110.195 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -150.63 122.34 8.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.687 1.595 . . . . 0.0 109.832 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.81 149.12 47.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.159 1.784 . . . . 0.0 110.088 -171.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.7 p -118.87 138.12 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.011 1.324 . . . . 0.0 109.689 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 51.1 mt -134.43 135.53 24.01 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.198 1.799 . . . . 0.0 108.42 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.91 31.21 0.44 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.488 3.458 . . . . 0.0 113.628 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.0 t80 -83.03 157.55 22.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.276 1.431 . . . . 0.0 110.833 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 90.5 m -129.62 126.35 38.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.314 1.446 . . . . 0.0 109.574 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 93.9 mt -87.58 134.53 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 110.389 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' 1801 ' ' LYS . 29.0 ttpt -119.81 -147.48 0.4 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.77 1.628 . . . . 0.0 110.851 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . 0.443 ' H ' ' HG2' ' A' 1800 ' ' LYS . 8.0 tmtm? -73.5 123.11 23.28 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.573 -1.33 . . . . 0.0 110.201 171.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.2 -148.98 20.08 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.241 1.4 . . . . 0.0 112.16 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -156.97 145.79 19.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 110.772 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -129.03 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.596 1.558 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 44.6 p -144.75 -177.1 5.34 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.345 1.858 . . . . 0.0 109.998 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.84 37.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -154.49 133.15 12.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.319 1.447 . . . . 0.0 110.258 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.1 t -102.22 130.73 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.906 1.682 . . . . 0.0 108.458 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -106.14 125.53 51.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.404 1.481 . . . . 0.0 110.748 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 19.2 mtm -92.76 146.59 32.48 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.381 1.472 . . . . 0.0 110.447 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.68 -16.62 30.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.269 2.646 . . . . 0.0 113.488 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 51.7 p -73.96 -5.53 41.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.179 1.391 . . . . 0.0 113.929 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 98.48 -5.32 60.46 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.979 1.752 . . . . 0.0 114.177 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -73.81 159.55 32.74 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.5 1.12 . . . . 0.0 112.207 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.4 m -141.55 154.76 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.145 1.378 . . . . 0.0 111.771 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.19 166.65 32.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.351 1.86 . . . . 0.0 111.255 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -101.76 138.6 19.87 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 121.304 -0.873 . . . . 0.0 111.815 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -83.85 169.5 11.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.361 3.374 . . . . 0.0 111.672 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.3 m -108.62 131.69 54.63 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.611 1.564 . . . . 0.0 109.12 172.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.82 132.82 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.207 1.403 . . . . 0.0 109.126 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 84.8 m -135.39 127.87 30.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.49 1.516 . . . . 0.0 110.081 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.2 129.32 34.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.395 0.678 . . . . 0.0 110.861 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -82.52 -5.43 58.73 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 27.0 mmmt 73.24 3.86 4.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.145 2.578 . . . . 0.0 113.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -109.33 8.19 25.45 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.995 2.118 . . . . 0.0 112.967 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.2 20.42 42.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.72 1.152 . . . . 0.0 113.876 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 41.8 p -133.94 158.28 43.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.273 1.829 . . . . 0.0 109.966 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.97 146.73 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.472 1.109 . . . . 0.0 110.059 167.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.6 m -104.2 138.63 40.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.797 1.239 . . . . 0.0 108.449 167.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 27.3 t -126.47 134.81 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.991 1.317 . . . . 0.0 109.373 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -136.67 158.13 45.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.856 1.262 . . . . 0.0 113.277 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 10.3 t80 -156.42 135.42 11.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.314 1.846 . . . . 0.0 111.36 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.27 119.32 72.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.338 1.055 . . . . 0.0 110.579 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.97 145.39 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.53 2.82 . . . . 0.0 112.155 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.9 t -136.73 -14.52 1.64 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.81 152.35 45.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.995 1.718 . . . . 0.0 109.962 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.79 168.85 12.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.034 0.934 . . . . 0.0 112.116 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 105.15 -168.5 15.71 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.648 1.594 . . . . 0.0 113.916 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 39.7 tp -78.74 132.25 36.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.73 1.212 . . . . 0.0 110.613 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 47.5 m80 -127.17 166.37 17.82 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.796 1.638 . . . . 0.0 111.093 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -145.81 153.16 40.6 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.732 0.813 . . . . 0.0 111.356 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 65.4 ttp -128.28 117.21 21.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.568 1.547 . . . . 0.0 110.314 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.82 129.19 35.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.465 2.306 . . . . 0.0 109.411 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.5 mm -130.85 132.11 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 109.913 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 136.22 21.3 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -99.56 119.27 37.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.745 2.418 . . . . 0.0 109.699 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.16 36.14 15.01 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.808 1.243 . . . . 0.0 112.795 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.7 2.93 3.0 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.623 2.369 . . . . 0.0 113.93 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 68.8 mtm -104.37 131.65 51.49 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.617 1.567 . . . . 0.0 110.739 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -55.33 138.22 46.0 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.4 pt -72.47 154.01 91.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 166.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.56 129.33 30.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.237 1.958 . . . . 0.0 110.4 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.57 1.56 87.58 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.652 1.12 . . . . 0.0 115.453 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.1 t -76.03 145.89 78.02 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 119.771 1.785 . . . . 0.0 111.652 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.54 159.85 88.59 Favored 'Cis proline' 0 C--N 1.353 0.816 0 CA-C-N 119.845 0.98 . . . . 0.0 112.076 -6.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.92 148.47 22.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.874 1.27 . . . . 0.0 110.288 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -121.17 144.33 48.64 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.484 1.114 . . . . 0.0 110.586 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.6 p90 -163.54 164.78 24.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.152 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.5 t80 -110.7 143.99 40.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.045 0.938 . . . . 0.0 112.705 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.9 t -117.09 141.89 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.422 1.489 . . . . 0.0 109.32 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.7 t0 -157.22 165.36 36.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 0.0 111.463 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.19 148.43 47.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.581 1.152 . . . . 0.0 112.861 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.1 m -86.52 -16.47 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -109.58 -5.91 15.54 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -168.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 84.9 m -82.66 153.94 25.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.493 1.117 . . . . 0.0 112.878 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.62 -9.64 62.65 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.973 1.273 . . . . 0.0 115.238 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -65.38 159.27 24.48 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.69 1.245 . . . . 0.0 113.675 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.5 t -65.96 136.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.038 0.935 . . . . 0.0 109.083 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.4 t -156.49 145.53 20.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.53 1.132 . . . . 0.0 110.379 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.97 141.51 44.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.822 1.249 . . . . 0.0 111.86 -170.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.8 p90 -169.16 163.72 11.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 112.756 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.0 172.18 12.8 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.4 1.476 . . . . 0.0 112.784 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.94 -33.35 16.06 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.833 2.355 . . . . 0.0 112.681 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.3 -37.07 92.54 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.549 1.068 . . . . 0.0 114.321 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.85 -6.23 53.51 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.784 1.292 . . . . 0.0 113.272 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 53.9 m -97.35 -43.73 7.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.899 1.68 . . . . 0.0 110.777 170.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -152.86 124.54 7.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.041 1.737 . . . . 0.0 112.3 -164.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -127.65 -179.54 15.89 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.448 1.975 . . . . 0.0 112.315 166.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.9 t -142.59 139.77 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.821 1.649 . . . . 0.0 107.792 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.62 134.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 118.288 0.494 . . . . 0.0 112.125 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.4 m-80 67.93 -1.39 1.74 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.964 2.106 . . . . 0.0 114.752 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.45 137.17 19.56 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.949 1.3 . . . . 0.0 110.957 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.16 122.58 8.16 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.609 2.206 . . . . 0.0 110.299 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.15 144.03 34.47 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.4 1.48 . . . . 0.0 110.484 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.11 148.45 49.8 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.56 175.95 12.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.898 1.679 . . . . 0.0 112.011 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -132.36 145.55 51.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.095 1.358 . . . . 0.0 110.921 -171.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 28.6 t -117.47 138.0 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.13 1.772 . . . . 0.0 108.436 168.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -94.97 134.1 38.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.351 1.061 . . . . 0.0 111.423 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 72.3 p -131.13 3.67 4.36 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.164 1.785 . . . . 0.0 113.11 -171.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -55.99 -34.46 65.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.617 1.967 . . . . 0.0 115.615 -164.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.04 19.42 5.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.548 1.539 . . . . 0.0 112.357 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.69 -34.26 60.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.79 148.45 9.68 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.874 1.226 . . . . 0.0 112.737 -171.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.19 148.23 39.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.527 1.131 . . . . 0.0 112.165 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 172.01 -24.1 0.08 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.51 1.052 . . . . 0.0 115.121 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.81 110.14 1.15 Allowed Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.497 1.523 . . . . 0.0 112.643 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.44 126.76 32.58 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.609 1.564 . . . . 0.0 109.037 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 44.3 m -122.79 155.64 36.14 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.869 1.668 . . . . 0.0 111.875 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.6 tp -158.44 135.16 9.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.614 1.566 . . . . 0.0 109.131 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.57 159.0 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.995 0.918 . . . . 0.0 112.175 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -136.07 141.32 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.846 1.258 . . . . 0.0 109.661 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.24 161.7 28.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 109.882 170.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.87 31.47 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 118.875 -0.958 . . . . 0.0 114.317 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.57 -24.84 62.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.048 3.165 . . . . 0.0 112.717 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.1 t -143.42 160.87 39.77 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.311 1.444 . . . . 0.0 109.628 164.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.2 tptt -74.34 116.99 15.64 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.071 -1.018 . . . . 0.0 110.989 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.59 149.07 46.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.73 0.812 . . . . 0.0 111.738 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -85.79 140.82 30.14 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.644 0.778 . . . . 0.0 109.171 166.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.3 143.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.439 1.096 . . . . 0.0 110.402 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -140.63 164.97 28.74 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.871 1.268 . . . . 0.0 110.906 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.3 p -161.55 158.88 27.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.758 1.223 . . . . 0.0 112.555 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 50.4 m -144.42 119.14 9.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.989 1.316 . . . . 0.0 110.126 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.57 130.37 36.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.565 1.146 . . . . 0.0 110.938 171.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -109.77 145.57 36.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.883 1.673 . . . . 0.0 111.73 -176.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.02 -18.17 65.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.966 1.307 . . . . 0.0 113.237 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -69.62 -22.43 63.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.558 1.143 . . . . 0.0 113.636 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 103.41 43.54 1.84 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.271 0.939 . . . . 0.0 113.223 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 57.6 p -139.09 159.36 42.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.177 1.391 . . . . 0.0 110.398 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 36.4 t -115.38 125.63 53.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.174 1.39 . . . . 0.0 108.588 161.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.2 t -87.21 151.4 23.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.853 0.861 . . . . 0.0 110.293 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -133.03 143.12 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.827 1.651 . . . . 0.0 110.085 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.5 p -135.6 148.05 48.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.949 1.3 . . . . 0.0 111.694 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.2 p90 -150.39 153.17 35.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.9 mt -120.55 105.62 41.09 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.559 1.943 . . . . 0.0 109.869 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -82.67 176.87 7.39 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.847 3.031 . . . . 0.0 110.321 167.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -148.85 -30.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 69.3 mt -107.58 147.63 35.69 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 119.725 1.148 . . . . 0.0 110.767 167.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.6 155.17 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.128 2.552 . . . . 0.0 111.041 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.65 -159.09 25.8 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.442 1.496 . . . . 0.0 113.134 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.01 135.26 41.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.065 1.346 . . . . 0.0 111.929 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -118.87 142.49 47.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.718 1.607 . . . . 0.0 110.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -101.65 122.0 43.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.82 1.248 . . . . 0.0 110.356 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.91 120.89 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.775 1.63 . . . . 0.0 108.466 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.1 tt -103.69 131.36 50.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.478 1.511 . . . . 0.0 109.744 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 131.32 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.454 1.502 . . . . 0.0 108.098 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -152.99 142.9 22.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.104 1.362 . . . . 0.0 110.325 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.93 123.75 11.26 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.213 -0.93 . . . . 0.0 110.534 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 43.8 t-20 57.5 54.25 6.67 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.973 1.309 . . . . 0.0 111.443 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 9.4 pt-20 56.2 22.7 6.35 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.21 2.604 . . . . 0.0 115.975 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.4 129.78 39.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.558 1.143 . . . . 0.0 111.328 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.42 156.89 18.08 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.187 0.995 . . . . 0.0 112.482 169.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.7 m -87.83 156.68 52.52 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.272 0.629 . . . . 0.0 110.489 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.52 119.1 5.86 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.885 2.39 . . . . 0.0 110.203 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.94 -13.2 65.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.297 1.427 . . . . 0.0 116.564 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.5 p -81.5 151.36 68.59 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 119.921 1.861 . . . . 0.0 113.214 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 146.56 86.88 Favored 'Cis proline' 0 C--N 1.355 0.885 0 CA-C-N 119.076 0.706 . . . . 0.0 112.051 -6.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.64 159.31 15.05 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 110.955 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 48.4 m -114.71 121.17 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.817 0.847 . . . . 0.0 110.654 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -104.02 141.35 36.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.421 1.488 . . . . 0.0 111.623 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.56 141.02 41.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.548 1.139 . . . . 0.0 109.912 164.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.1 t -133.24 138.74 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.655 1.182 . . . . 0.0 109.562 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 11.8 p -132.7 169.99 15.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.677 1.191 . . . . 0.0 112.469 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.48 140.99 27.05 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.603 1.573 . . . . 0.0 113.129 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.7 t70 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 124.5 1.12 . . . . 0.0 113.047 175.542 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 CA--C 1.537 0.444 0 CA-C-O 120.608 0.242 . . . . 0.0 110.51 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.19 121.19 67.86 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.17 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.5 148.1 47.43 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.664 2.243 . . . . 0.0 110.424 173.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.36 135.66 33.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.468 0.651 . . . . 0.0 110.733 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -157.33 144.28 18.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.021 1.728 . . . . 0.0 110.531 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.36 149.87 21.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.455 1.502 . . . . 0.0 109.73 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -123.17 132.74 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.166 1.386 . . . . 0.0 109.489 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 74.0 mt -129.37 136.27 28.88 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.325 1.85 . . . . 0.0 108.735 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.0 72.24 6.27 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.256 3.304 . . . . 0.0 111.419 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 34.6 t80 -124.41 152.5 43.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.589 1.956 . . . . 0.0 109.338 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 34.6 m -127.25 125.62 41.28 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.424 1.09 . . . . 0.0 109.624 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.2 mt -75.08 135.6 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 110.378 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 21.4 pttp -128.84 -147.85 0.36 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.248 1.819 . . . . 0.0 110.923 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.11 126.74 29.02 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.537 -1.352 . . . . 0.0 110.418 165.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 124.65 -154.03 17.93 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.52 1.533 . . . . 0.0 112.183 -170.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -161.39 151.95 17.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 111.214 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.48 134.89 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.51 1.524 . . . . 0.0 111.847 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -147.52 158.85 44.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.561 1.544 . . . . 0.0 110.917 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -137.44 -175.85 14.08 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -153.39 143.71 22.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.341 1.856 . . . . 0.0 109.065 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 98.3 t -119.45 129.31 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.719 1.608 . . . . 0.0 108.008 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -113.5 130.08 56.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.356 1.462 . . . . 0.0 110.479 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 34.8 mtm -108.67 139.92 21.32 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.413 1.485 . . . . 0.0 111.875 -171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.37 -27.48 75.89 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 124.258 3.305 . . . . 0.0 115.54 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.8 p -75.08 4.87 6.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.353 1.461 . . . . 0.0 114.563 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.83 44.54 5.12 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 124.665 1.126 . . . . 0.0 113.088 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -153.24 165.07 36.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.522 1.529 . . . . 0.0 112.107 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.6 m -141.25 159.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.67 1.188 . . . . 0.0 112.632 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.05 175.55 13.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.063 2.145 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -121.91 143.9 39.75 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.123 -0.985 . . . . 0.0 112.204 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -86.25 171.74 7.56 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 111.877 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.2 m -106.91 130.56 54.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 109.031 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.88 132.88 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.163 1.385 . . . . 0.0 108.951 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -136.55 124.04 22.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.36 1.464 . . . . 0.0 109.975 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.1 126.41 30.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.54 0.736 . . . . 0.0 110.753 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.02 -6.33 57.39 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 73.68 1.09 3.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 113.537 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -102.85 4.6 37.9 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.086 2.155 . . . . 0.0 112.979 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.08 15.89 40.27 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.069 1.319 . . . . 0.0 114.341 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.0 p -130.69 155.94 45.76 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.163 1.785 . . . . 0.0 110.615 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -112.64 137.34 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.71 165.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.5 m -93.74 137.91 32.5 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.583 1.153 . . . . 0.0 108.424 167.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.2 t -125.5 133.43 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.469 1.508 . . . . 0.0 108.855 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -139.84 155.79 47.05 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 0.0 112.656 -176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.3 t80 -151.05 134.55 16.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 111.547 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.86 122.72 74.45 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.575 1.15 . . . . 0.0 111.105 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.23 161.15 20.27 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.784 2.99 . . . . 0.0 111.938 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -149.81 -21.81 0.27 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -141.4 149.54 41.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.46 1.904 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.91 167.76 19.5 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.039 0.936 . . . . 0.0 112.98 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 122.58 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.59 1.567 . . . . 0.0 114.085 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tt -83.68 118.7 24.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.436 1.094 . . . . 0.0 109.417 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 28.3 m80 -111.38 158.43 19.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.524 1.53 . . . . 0.0 111.054 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -143.73 150.99 39.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.482 0.658 . . . . 0.0 112.337 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.8 ttm -132.14 139.2 48.35 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.782 2.033 . . . . 0.0 110.712 -164.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -112.19 137.37 50.37 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 109.635 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.3 mm -133.93 129.39 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.646 1.178 . . . . 0.0 109.683 174.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.87 137.66 36.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 19.9 t80 -103.83 124.91 49.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.499 1.92 . . . . 0.0 109.672 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 27.3 t70 48.29 46.51 20.11 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.779 1.232 . . . . 0.0 112.293 -177.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.306 0.3 OUTLIER 62.78 13.35 6.4 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 128.005 2.522 . . . . 0.0 116.543 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 58.9 ttm -114.74 130.41 56.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.529 1.532 . . . . 0.0 110.926 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -56.06 135.9 52.53 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.285 -0.885 . . . . 0.0 113.053 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.87 154.32 89.02 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.328 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.04 128.2 25.78 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.992 1.794 . . . . 0.0 109.403 170.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.35 -16.05 58.34 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.702 1.144 . . . . 0.0 114.098 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.1 t -82.41 146.98 55.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-N 119.803 1.802 . . . . 0.0 110.876 170.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.68 163.85 82.86 Favored 'Cis proline' 0 C--N 1.353 0.804 0 CA-C-N 120.333 1.155 . . . . 0.0 112.413 -6.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.5 159.26 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.17 1.788 . . . . 0.0 111.047 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -155.4 148.72 24.89 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 112.819 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 7.8 p90 -167.2 -179.4 4.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.968 1.707 . . . . 0.0 111.264 -167.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -120.48 142.39 49.32 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.779 -1.201 . . . . 0.0 113.405 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.1 t -111.73 134.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.144 1.778 . . . . 0.0 108.966 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -161.29 158.31 26.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.96 1.304 . . . . 0.0 112.923 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -75.48 122.15 23.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 112.124 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 32.7 m -79.79 -15.77 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 p30 -85.07 -14.69 46.45 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.719 1.208 . . . . 0.0 114.181 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.7 m -77.81 -17.22 57.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 85.16 -3.44 87.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 0.0 115.676 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -64.84 156.0 32.22 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 119.201 1.501 . . . . 0.0 112.962 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.5 t -68.19 131.82 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.2 t -152.92 161.1 42.97 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.507 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.84 142.8 36.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.358 1.463 . . . . 0.0 111.235 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 20.6 p90 -163.58 161.11 23.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.572 1.549 . . . . 0.0 112.161 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.67 176.97 15.63 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.863 1.22 . . . . 0.0 113.293 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.12 -37.94 5.49 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.045 2.496 . . . . 0.0 112.594 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.91 -32.54 73.69 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.588 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.23 -3.84 41.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.769 1.284 . . . . 0.0 113.426 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.7 m -110.35 -48.48 3.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.327 1.851 . . . . 0.0 111.109 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -138.54 145.96 41.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.101 1.76 . . . . 0.0 112.235 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.91 -179.27 21.15 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.574 1.083 . . . . 0.0 113.624 173.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.0 t -143.57 136.04 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.108 1.363 . . . . 0.0 108.598 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.3 m -56.46 137.34 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.2 m-80 68.06 -2.88 1.36 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.756 2.022 . . . . 0.0 114.663 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -100.9 136.99 19.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.039 1.336 . . . . 0.0 110.725 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.25 127.95 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.377 2.051 . . . . 0.0 110.124 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.12 146.55 36.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.613 1.565 . . . . 0.0 110.523 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.4 p -136.43 153.98 50.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -164.16 172.49 13.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.26 1.824 . . . . 0.0 111.351 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.7 m -122.75 142.42 50.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.161 1.384 . . . . 0.0 110.694 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.9 t -115.85 133.71 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.474 1.509 . . . . 0.0 108.417 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.73 132.85 36.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.381 1.072 . . . . 0.0 111.585 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 45.8 p -136.64 0.87 2.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.189 1.395 . . . . 0.0 114.108 -169.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -53.46 -37.86 63.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 115.119 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -117.01 9.92 13.82 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.396 1.479 . . . . 0.0 112.538 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.13 56.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.446 1.099 . . . . 0.0 113.504 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.36 -106.77 2.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.609 1.1 . . . . 0.0 112.247 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -161.45 155.12 21.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.523 1.929 . . . . 0.0 109.942 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 148.08 9.21 0.19 Allowed Glycine 0 N--CA 1.473 1.118 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.03 103.84 2.05 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 126.078 1.799 . . . . 0.0 112.479 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.72 132.85 33.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.984 1.713 . . . . 0.0 109.603 171.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.3 m -129.86 157.99 40.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.6 1.56 . . . . 0.0 112.134 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.1 tp -159.02 136.06 9.69 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.029 1.732 . . . . 0.0 109.184 -170.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.45 158.93 36.73 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 112.424 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.3 mt -137.51 139.04 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.89 1.276 . . . . 0.0 109.98 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.83 129.16 40.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.369 1.468 . . . . 0.0 109.944 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.35 -162.16 11.24 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 119.04 -0.866 . . . . 0.0 114.386 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.7 -24.72 69.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.042 3.162 . . . . 0.0 112.56 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.6 t -138.97 160.45 39.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.978 1.311 . . . . 0.0 109.627 162.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -71.75 112.34 7.77 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.134 -0.979 . . . . 0.0 110.689 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.64 148.77 50.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.694 0.798 . . . . 0.0 111.688 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.44 140.71 29.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.09 143.89 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.665 1.186 . . . . 0.0 110.259 -167.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.9 t -141.67 156.5 45.64 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.13 1.372 . . . . 0.0 111.144 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 48.9 t -145.35 136.97 25.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.211 1.405 . . . . 0.0 110.66 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 93.5 m -132.3 129.33 39.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.272 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.99 131.5 43.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 110.779 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.17 -131.23 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.85 0.86 . . . . 0.0 110.222 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -84.1 38.04 0.64 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.461 -1.399 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 20.7 t70 71.37 -20.44 0.23 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.813 2.845 . . . . 0.0 114.588 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . -76.77 -21.27 74.89 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.758 1.17 . . . . 0.0 114.194 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 31.8 p -147.5 157.61 43.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.788 1.635 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 74.2 m -115.54 136.7 52.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.115 1.766 . . . . 0.0 109.205 162.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -98.57 136.89 38.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.466 1.106 . . . . 0.0 110.493 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.5 t -111.43 142.48 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.93 1.692 . . . . 0.0 109.782 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 51.9 m -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.145 1.378 . . . . 0.0 110.833 168.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 9.6 p90 -148.38 154.29 39.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 8.8 mt -120.62 107.66 38.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.893 1.677 . . . . 0.0 110.763 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.64 175.03 9.18 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.036 3.157 . . . . 0.0 110.46 166.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.3 p -151.07 -30.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.4 mt -105.6 146.33 32.61 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.586 1.085 . . . . 0.0 110.533 167.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.86 154.53 48.46 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.911 2.407 . . . . 0.0 110.949 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.13 -158.6 24.0 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.796 1.188 . . . . 0.0 113.247 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -100.82 133.31 45.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.09 1.356 . . . . 0.0 112.492 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.83 126.07 50.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.999 1.72 . . . . 0.0 109.956 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 71.2 m -84.32 126.62 33.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.108 0.963 . . . . 0.0 110.582 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.73 124.99 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.6 1.56 . . . . 0.0 108.283 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -108.86 130.49 55.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.29 1.436 . . . . 0.0 109.811 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -132.58 128.79 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.417 1.087 . . . . 0.0 109.879 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.99 142.2 24.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.058 1.343 . . . . 0.0 111.718 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.65 121.36 16.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.809 1.244 . . . . 0.0 109.448 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.41 57.37 4.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.472 1.509 . . . . 0.0 112.159 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.285 8.5 pt-20 57.21 12.12 1.26 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.498 2.719 . . . . 0.0 116.329 -177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -119.26 125.31 48.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.704 1.202 . . . . 0.0 110.671 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -64.72 147.39 53.17 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.457 -0.777 . . . . 0.0 111.894 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 21.8 m -69.11 152.47 96.71 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.044 168.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.99 128.69 23.66 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.254 1.969 . . . . 0.0 110.063 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.52 -14.74 64.74 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.989 1.28 . . . . 0.0 115.007 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.8 t -78.16 139.94 61.08 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.258 1.529 . . . . 0.0 111.295 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.41 135.55 40.83 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.383 0.816 . . . . 0.0 111.905 -3.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.3 170.9 12.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.0 1.72 . . . . 0.0 110.399 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 52.4 m -132.73 121.27 22.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.35 140.33 30.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.312 1.445 . . . . 0.0 110.872 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -100.89 122.52 43.6 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.732 0.813 . . . . 0.0 109.968 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.7 t -109.26 129.89 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.589 1.555 . . . . 0.0 110.373 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.5 p -100.68 155.96 17.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.676 1.19 . . . . 0.0 112.752 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.7 121.98 6.85 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.404 1.478 . . . . 0.0 111.183 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 27.1 t70 . . . . . 0 CA--C 1.551 1.009 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.38 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 5.7 mt . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.38 117.49 16.88 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.605 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.67 112.54 3.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.546 2.164 . . . . 0.0 108.809 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.71 135.48 42.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.718 0.807 . . . . 0.0 111.686 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.75 166.07 27.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.508 1.923 . . . . 0.0 111.411 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 156.47 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.427 1.491 . . . . 0.0 111.038 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -121.67 135.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.326 1.45 . . . . 0.0 109.364 167.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 65.2 mt -132.02 136.94 29.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.368 1.867 . . . . 0.0 108.367 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.76 42.45 1.26 Allowed 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.46 3.44 . . . . 0.0 113.124 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -89.01 159.16 17.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.303 1.441 . . . . 0.0 111.546 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.5 m -127.04 128.1 45.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.396 1.478 . . . . 0.0 110.282 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 26.4 mt -93.8 130.67 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.617 1.167 . . . . 0.0 109.376 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -113.24 -75.23 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.635 1.174 . . . . 0.0 111.791 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.8 tttm -160.07 133.73 7.08 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.998 1.719 . . . . 0.0 110.951 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.6 -137.73 9.76 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.533 1.54 . . . . 0.0 110.945 -166.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -155.88 140.11 16.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.026 0.931 . . . . 0.0 111.727 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.9 tt -116.74 138.08 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.847 1.659 . . . . 0.0 110.696 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.0 p -144.1 177.96 8.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.19 1.796 . . . . 0.0 110.392 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.18 -172.27 37.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -156.41 143.83 19.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.62 1.568 . . . . 0.0 109.919 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 91.0 t -118.17 132.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.566 1.546 . . . . 0.0 108.674 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -108.76 137.14 47.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 112.166 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 8.3 mtm -103.0 142.5 24.68 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.059 1.743 . . . . 0.0 111.135 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.33 -27.21 66.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.052 3.168 . . . . 0.0 115.278 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.8 p -73.81 0.69 12.42 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.407 1.483 . . . . 0.0 114.37 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.71 69.22 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.892 1.71 . . . . 0.0 114.3 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -73.69 156.81 37.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.057 1.343 . . . . 0.0 112.153 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.0 m -139.95 152.59 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.594 1.557 . . . . 0.0 110.795 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.29 170.04 22.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.721 1.608 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -101.74 138.62 19.88 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.704 0.802 . . . . 0.0 111.556 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.36 162.53 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.946 3.098 . . . . 0.0 111.073 169.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 91.4 m -109.82 119.39 39.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.332 1.453 . . . . 0.0 108.997 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.73 132.01 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.957 1.303 . . . . 0.0 109.239 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.5 m -134.13 120.14 19.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.565 1.546 . . . . 0.0 109.376 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.37 131.64 37.05 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.718 0.807 . . . . 0.0 112.094 172.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.96 -3.55 58.96 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt 73.06 0.78 3.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.575 2.35 . . . . 0.0 113.875 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -109.78 8.44 24.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.802 2.041 . . . . 0.0 113.112 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.31 15.75 49.68 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.866 1.222 . . . . 0.0 114.352 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 45.1 p -131.14 161.03 33.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.216 1.806 . . . . 0.0 110.415 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 17.9 m -122.75 140.77 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 110.212 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 46.7 m -98.29 140.66 32.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.993 1.317 . . . . 0.0 108.432 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.4 t -127.56 134.84 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.546 1.139 . . . . 0.0 109.522 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -132.18 162.87 29.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.651 1.581 . . . . 0.0 111.984 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.1 t80 -157.14 140.4 15.55 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.513 1.525 . . . . 0.0 111.796 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.98 114.86 63.87 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.705 1.202 . . . . 0.0 110.807 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.68 158.33 28.29 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.593 2.862 . . . . 0.0 112.075 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 95.9 p -143.45 0.37 1.14 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -169.59 157.25 7.02 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.415 1.886 . . . . 0.0 110.554 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.87 170.94 15.62 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.324 1.05 . . . . 0.0 113.085 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.7 -177.79 16.39 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 125.884 1.707 . . . . 0.0 114.391 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.0 tp -86.93 112.38 21.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 110.155 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 45.2 m80 -105.71 171.69 7.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.002 1.721 . . . . 0.0 111.444 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.34 151.17 37.07 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.948 0.899 . . . . 0.0 111.339 172.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 31.4 ttm -119.19 129.98 55.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.059 1.744 . . . . 0.0 110.685 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.77 134.3 40.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.082 2.553 . . . . 0.0 109.392 165.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.0 mm -138.47 135.98 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.928 1.291 . . . . 0.0 108.703 168.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.71 142.15 24.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.993 0.917 . . . . 0.0 113.384 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.63 118.73 36.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.405 1.882 . . . . 0.0 109.611 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.14 34.23 10.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.62 1.168 . . . . 0.0 112.727 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 73.05 8.05 5.39 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.827 2.451 . . . . 0.0 115.11 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.98 128.68 46.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.375 1.47 . . . . 0.0 110.459 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 139.27 55.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.6 pt -73.66 150.29 88.71 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.88 169.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.21 -20.12 66.67 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.837 2.358 . . . . 0.0 113.959 -172.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.42 1.01 88.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.099 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.1 m -119.84 156.46 54.08 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 120.031 1.916 . . . . 0.0 113.347 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.35 169.29 74.4 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 119.098 0.714 . . . . 0.0 113.212 0.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 74.3 mt -129.71 150.12 51.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.375 1.87 . . . . 0.0 110.563 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.8 136.84 47.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.936 1.294 . . . . 0.0 110.164 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.4 p90 -154.17 149.26 26.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.386 1.074 . . . . 0.0 112.213 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.5 t80 -99.87 145.27 27.96 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.179 -0.951 . . . . 0.0 112.748 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.0 t -124.43 143.39 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.786 1.634 . . . . 0.0 109.233 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.9 t0 -151.64 167.8 26.98 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.966 1.306 . . . . 0.0 110.96 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.67 164.72 24.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.02 1.328 . . . . 0.0 112.787 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 34.1 m -73.52 -20.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.962 167.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -86.89 -6.74 58.69 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.849 1.259 . . . . 0.0 114.138 -171.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 29.4 p -64.14 145.57 55.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.267 1.027 . . . . 0.0 113.615 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -108.19 -21.15 7.85 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.156 1.36 . . . . 0.0 113.932 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -70.12 159.85 33.15 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.65 1.18 . . . . 0.0 113.999 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.3 t -64.59 135.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 109.061 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.9 t -156.71 163.12 39.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.773 1.229 . . . . 0.0 110.877 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.59 147.33 31.94 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.875 1.27 . . . . 0.0 112.38 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -169.08 160.34 9.79 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.758 1.623 . . . . 0.0 112.968 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 145.22 175.82 18.67 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.201 1.381 . . . . 0.0 113.576 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.46 -37.55 12.98 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.045 2.497 . . . . 0.0 112.218 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.9 75.88 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.215 0.912 . . . . 0.0 114.099 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.26 -11.09 60.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.576 1.15 . . . . 0.0 113.213 171.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.8 m -120.67 -43.52 2.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.718 1.607 . . . . 0.0 111.912 -170.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -142.84 154.56 44.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.715 2.006 . . . . 0.0 112.139 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.05 174.4 26.0 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.476 1.036 . . . . 0.0 113.699 172.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 38.4 t -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.919 1.288 . . . . 0.0 108.571 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.8 m -56.39 135.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.153 0.581 . . . . 0.0 112.52 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.7 m-80 66.45 3.5 2.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.938 2.095 . . . . 0.0 114.73 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 54.7 mttm -110.0 142.9 26.85 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.391 1.476 . . . . 0.0 110.948 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.33 119.87 6.22 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.576 2.184 . . . . 0.0 110.577 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -99.55 143.1 30.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.082 1.353 . . . . 0.0 110.082 172.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.9 p -133.49 152.99 51.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -165.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.4 p90 -164.04 174.63 11.13 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.741 1.616 . . . . 0.0 112.175 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 80.7 m -126.69 142.83 51.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.579 1.552 . . . . 0.0 110.964 -170.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.8 t -116.48 133.15 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.963 1.705 . . . . 0.0 108.265 167.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.03 127.47 35.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.053 0.941 . . . . 0.0 111.222 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 51.5 p -133.13 0.44 3.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.076 1.35 . . . . 0.0 114.011 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.1 tptp -52.5 -39.12 60.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.699 1.6 . . . . 0.0 114.459 -173.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.37 6.66 20.54 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.385 1.474 . . . . 0.0 113.046 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.23 60.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.231 1.012 . . . . 0.0 113.622 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 77.72 -102.49 1.77 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.624 1.107 . . . . 0.0 112.164 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.92 157.28 23.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.247 1.819 . . . . 0.0 110.18 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.79 4.21 0.75 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.572 1.558 . . . . 0.0 115.146 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.01 103.67 1.89 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.544 1.545 . . . . 0.0 113.224 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.06 135.58 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.655 1.582 . . . . 0.0 109.266 168.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -138.76 165.3 27.34 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.079 1.352 . . . . 0.0 112.319 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -165.05 136.8 4.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.207 1.803 . . . . 0.0 109.699 -161.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.92 166.24 32.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.519 1.128 . . . . 0.0 112.004 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.66 131.76 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.651 1.18 . . . . 0.0 109.55 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.87 113.38 25.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 109.454 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.08 -174.95 13.93 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.128 1.347 . . . . 0.0 113.802 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.84 -23.81 47.36 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.853 3.035 . . . . 0.0 111.942 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -142.06 159.53 42.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 160.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.06 130.62 43.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.933 -1.105 . . . . 0.0 112.52 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.37 152.44 27.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.103 0.961 . . . . 0.0 110.981 164.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.21 139.3 30.63 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 165.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -132.8 138.76 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.558 1.143 . . . . 0.0 110.392 -167.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 68.6 m -134.74 158.27 44.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 111.008 170.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -152.87 153.61 33.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.387 1.075 . . . . 0.0 112.544 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.9 m -143.09 122.2 12.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.461 1.504 . . . . 0.0 110.373 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.68 129.51 36.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.415 1.086 . . . . 0.0 111.132 171.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -104.62 158.74 16.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.424 1.489 . . . . 0.0 112.602 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -70.92 -15.59 62.62 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.83 0.852 . . . . 0.0 112.114 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.47 -3.62 34.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.267 1.827 . . . . 0.0 114.551 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 86.99 27.3 29.0 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.207 0.908 . . . . 0.0 113.775 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.3 p -137.85 158.74 43.71 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 110.943 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 34.5 t -103.6 127.97 50.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.333 1.053 . . . . 0.0 108.819 159.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -88.15 152.36 22.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.681 0.793 . . . . 0.0 110.226 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' 1886 ' ' PHE . 91.9 t -133.63 143.86 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.628 1.571 . . . . 0.0 109.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -135.97 147.64 48.12 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.019 1.328 . . . . 0.0 111.793 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -149.81 152.12 34.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.9 mt -117.54 102.0 52.16 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.693 1.997 . . . . 0.0 110.262 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.79 162.12 18.73 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.763 2.976 . . . . 0.0 110.412 170.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.9 m -124.25 -10.56 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -167.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -156.01 151.79 22.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.363 1.465 . . . . 0.0 110.347 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.33 140.69 24.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.665 2.244 . . . . 0.0 111.462 -173.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.63 -167.91 33.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.507 1.051 . . . . 0.0 113.591 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -96.0 124.3 39.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.331 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.67 121.33 38.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.75 1.62 . . . . 0.0 110.176 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.4 m -92.4 109.8 21.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.267 1.027 . . . . 0.0 110.989 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -81.49 131.99 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.765 1.626 . . . . 0.0 108.677 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.88 128.88 55.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.951 1.7 . . . . 0.0 108.987 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 48.9 t -128.28 130.02 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.19 0.996 . . . . 0.0 109.839 172.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.61 141.36 22.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.842 1.257 . . . . 0.0 111.961 -167.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.46 123.46 21.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.041 1.336 . . . . 0.0 109.457 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.79 57.72 5.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.347 1.459 . . . . 0.0 112.617 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.1 pt-20 57.84 11.02 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 128.134 2.574 . . . . 0.0 116.296 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -117.45 124.66 49.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.655 1.182 . . . . 0.0 110.597 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.73 143.6 57.27 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.463 -0.773 . . . . 0.0 111.29 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.8 m -70.11 151.83 95.92 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.718 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.54 132.8 45.14 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.535 2.157 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.44 -17.42 57.47 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.103 1.335 . . . . 0.0 114.751 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 32.7 t -75.68 141.29 72.21 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.289 1.544 . . . . 0.0 111.663 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.23 148.87 88.54 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.551 0.875 . . . . 0.0 112.339 -4.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -110.66 132.66 54.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 110.161 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 87.9 m -95.44 114.3 26.06 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.055 0.843 . . . . 0.0 111.251 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.3 138.31 33.17 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.037 1.335 . . . . 0.0 111.033 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -97.04 117.9 32.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.421 0.689 . . . . 0.0 110.887 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.8 t -93.34 137.5 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.399 1.48 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.0 p -115.58 155.84 26.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.564 1.546 . . . . 0.0 112.871 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.23 136.16 14.16 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.962 1.268 . . . . 0.0 112.119 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.3 t70 . . . . . 0 CA--C 1.549 0.905 0 C-N-CA 124.648 1.179 . . . . 0.0 113.464 178.473 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 CA--C 1.536 0.405 0 CA-C-O 121.476 0.655 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -64.41 115.84 23.28 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.443 1.897 . . . . 0.0 110.073 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 151.46 64.59 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -171.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.82 122.89 41.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.199 0.6 . . . . 0.0 110.078 176.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -150.14 132.8 15.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.764 1.226 . . . . 0.0 110.966 174.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.01 157.73 45.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.33 2.252 . . . . 0.0 109.41 -175.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.9 p -135.3 134.14 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.654 1.182 . . . . 0.0 109.438 172.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.73 136.41 28.37 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.544 1.537 . . . . 0.0 109.284 -169.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.78 85.56 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.892 3.061 . . . . 0.0 110.319 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.4 t80 -139.98 152.53 46.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.697 1.999 . . . . 0.0 109.429 177.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -126.42 134.51 50.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.822 1.249 . . . . 0.0 109.471 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.5 mt -91.49 128.81 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.522 1.129 . . . . 0.0 109.345 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -99.52 -131.08 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.544 1.138 . . . . 0.0 109.821 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -83.01 -4.21 58.07 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.91 -152.65 17.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.801 1.667 . . . . 0.0 113.291 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.24 149.62 26.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.203 1.401 . . . . 0.0 110.631 -173.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.3 tt -128.8 136.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.542 1.537 . . . . 0.0 111.446 -175.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.1 p -149.25 167.64 25.48 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.169 1.788 . . . . 0.0 110.857 -175.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.39 -170.1 19.87 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -175.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.57 132.94 9.96 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.084 1.754 . . . . 0.0 109.589 177.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 40.2 t -112.33 138.99 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.61 1.564 . . . . 0.0 108.634 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.18 132.71 48.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.832 0.853 . . . . 0.0 111.153 -174.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.4 mtm -106.38 141.66 23.26 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.838 1.655 . . . . 0.0 111.95 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.12 -23.57 36.71 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.63 3.554 . . . . 0.0 115.757 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.0 t -68.92 -8.33 43.29 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.56 48.71 3.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.95 1.262 . . . . 0.0 112.429 177.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -156.87 163.36 39.27 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.131 1.773 . . . . 0.0 111.43 -171.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -139.0 161.71 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.541 1.136 . . . . 0.0 112.734 -171.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.08 169.48 24.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.695 1.998 . . . . 0.0 111.435 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.7 140.79 21.42 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.122 0.969 . . . . 0.0 111.308 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.38 175.24 7.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.209 3.273 . . . . 0.0 111.966 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -114.11 138.01 50.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.534 1.534 . . . . 0.0 109.008 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.76 131.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.783 1.233 . . . . 0.0 108.682 173.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.3 m -133.22 115.44 15.0 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.418 1.487 . . . . 0.0 109.092 -178.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.84 135.27 43.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 112.089 174.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.66 -13.5 34.12 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.3 mttp 66.49 7.04 4.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.326 2.25 . . . . 0.0 114.048 -177.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 9.47 43.25 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.082 2.153 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.84 11.9 57.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.356 1.455 . . . . 0.0 114.025 -174.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -130.13 157.31 42.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.062 1.745 . . . . 0.0 111.385 178.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -119.99 140.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.349 1.06 . . . . 0.0 109.949 164.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 51.7 m -94.16 138.5 32.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 170.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.6 t -126.72 133.04 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.688 1.595 . . . . 0.0 108.612 -175.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.07 157.23 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.553 1.141 . . . . 0.0 113.346 -170.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.0 t80 -158.31 137.83 11.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.874 1.669 . . . . 0.0 111.917 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.0 112.67 56.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.997 1.319 . . . . 0.0 110.785 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.11 149.04 28.09 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.685 2.923 . . . . 0.0 112.921 -174.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.1 p -139.21 -2.99 1.59 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 174.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -141.64 145.89 35.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.241 1.816 . . . . 0.0 109.484 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.74 169.53 15.15 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.976 0.911 . . . . 0.0 112.978 176.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 107.14 -173.19 18.77 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 124.992 1.282 . . . . 0.0 114.712 173.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 60.8 tp -77.71 128.16 33.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.96 1.304 . . . . 0.0 110.893 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -126.41 166.86 16.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.952 1.701 . . . . 0.0 111.175 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.49 153.54 51.71 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 112.312 156.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 43.7 ttm -112.54 121.8 45.86 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 109.875 169.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.77 136.22 38.99 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.106 1.363 . . . . 0.0 110.133 164.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.8 mm -133.88 135.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.709 1.203 . . . . 0.0 109.78 167.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.41 138.65 31.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.665 1.186 . . . . 0.0 112.966 175.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 46.4 t80 -102.87 123.81 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.53 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.08 45.75 22.86 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.766 1.227 . . . . 0.0 112.055 -176.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.28 4.6 p30 67.44 -2.05 1.39 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.864 2.866 . . . . 0.0 116.584 -177.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.2 mtt -100.67 134.27 43.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.069 1.347 . . . . 0.0 111.454 176.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 10.6 m170 -56.08 134.72 52.85 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.318 -0.864 . . . . 0.0 112.551 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.1 154.82 86.52 Favored Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 121.734 -0.603 . . . . 0.0 111.272 173.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -60.37 126.57 20.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.675 1.583 . . . . 0.0 108.587 165.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.98 45.53 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.565 1.078 . . . . 0.0 114.366 -173.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 20.7 t -82.09 142.15 47.56 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.181 1.491 . . . . 0.0 112.143 176.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.05 152.95 77.1 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.988 1.032 . . . . 0.0 111.864 -7.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.59 111.2 22.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.021 1.328 . . . . 0.0 109.109 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -102.27 139.4 37.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.331 1.052 . . . . 0.0 111.531 -176.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.5 p90 -164.35 160.11 20.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.174 0.989 . . . . 0.0 112.801 -176.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -102.75 130.98 49.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.338 1.055 . . . . 0.0 111.998 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.3 t -92.12 134.37 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.919 1.288 . . . . 0.0 109.726 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 21.0 t0 -144.1 162.35 36.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.579 1.952 . . . . 0.0 110.805 -169.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.83 154.02 26.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.387 1.075 . . . . 0.0 112.584 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -65.6 -29.21 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.309 -0.869 . . . . 0.0 112.054 168.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -92.24 -163.06 0.99 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.752 1.621 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.9 m 79.04 155.61 0.15 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.43 2.692 . . . . 0.0 113.352 173.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.35 -8.35 53.07 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 124.912 1.244 . . . . 0.0 115.521 -173.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.96 152.95 41.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 118.911 1.355 . . . . 0.0 113.871 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.2 t -64.88 143.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.181 0.992 . . . . 0.0 108.792 172.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -156.67 158.52 37.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.248 1.019 . . . . 0.0 110.795 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.92 141.81 33.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.194 1.398 . . . . 0.0 111.003 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.3 p90 -166.43 165.99 16.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.229 1.412 . . . . 0.0 112.796 -172.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 122.47 171.84 13.92 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.408 1.48 . . . . 0.0 112.466 -174.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.09 -33.68 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.914 2.409 . . . . 0.0 113.27 -168.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.61 86.68 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.144 0.884 . . . . 0.0 114.513 -169.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.65 -6.92 55.5 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.728 1.264 . . . . 0.0 113.785 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 -40.37 5.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.025 2.13 . . . . 0.0 111.723 176.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -153.43 142.44 21.26 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.039 1.336 . . . . 0.0 112.568 -171.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.57 -176.11 15.61 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.923 1.249 . . . . 0.0 112.672 174.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.0 p -153.38 136.14 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.734 1.214 . . . . 0.0 109.281 176.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.0 m -60.11 147.01 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -171.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 67.42 5.02 4.04 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.432 1.893 . . . . 0.0 114.574 173.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.9 mttp -120.61 149.72 50.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.179 1.792 . . . . 0.0 110.884 170.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.57 135.16 21.56 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.678 2.252 . . . . 0.0 110.848 175.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.29 146.92 36.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.798 1.639 . . . . 0.0 110.105 171.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.1 p -135.53 148.74 49.26 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -164.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -159.56 179.23 9.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.034 1.733 . . . . 0.0 111.265 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 52.6 m -132.87 144.87 50.48 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.316 1.446 . . . . 0.0 110.516 -170.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.6 t -122.53 127.75 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.876 1.67 . . . . 0.0 108.448 172.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -95.05 114.31 26.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.272 1.029 . . . . 0.0 110.554 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 25.2 p -120.54 -1.79 10.06 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.072 2.149 . . . . 0.0 113.423 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.64 -45.12 77.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.922 1.689 . . . . 0.0 114.562 -165.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.45 -15.85 38.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 113.534 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -82.46 -67.12 0.81 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.599 1.16 . . . . 0.0 111.058 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 64.99 16.02 61.28 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 165.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.5 146.58 22.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.585 1.693 . . . . 0.0 111.655 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 90.53 -170.96 35.9 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.58 1.562 . . . . 0.0 112.862 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -92.88 115.63 4.92 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 124.244 0.926 . . . . 0.0 111.525 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -77.74 123.24 26.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.346 1.059 . . . . 0.0 108.608 170.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 47.4 m -120.52 154.09 35.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.433 1.493 . . . . 0.0 112.104 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -157.66 133.83 9.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.865 1.666 . . . . 0.0 108.964 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 160.62 39.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.876 0.871 . . . . 0.0 112.147 177.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -135.04 134.34 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.794 1.238 . . . . 0.0 109.333 172.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.13 120.51 37.95 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.143 1.377 . . . . 0.0 109.051 171.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -132.57 179.93 16.82 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.659 1.124 . . . . 0.0 114.226 -176.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.05 -24.85 38.54 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.038 3.159 . . . . 0.0 111.923 174.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.5 t -134.73 157.81 45.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 108.683 156.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.99 120.64 19.85 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.843 -1.161 . . . . 0.0 112.132 -174.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.56 145.73 34.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.049 0.94 . . . . 0.0 111.202 168.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.62 148.84 25.3 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.336 0.654 . . . . 0.0 110.393 167.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -137.59 144.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.808 1.243 . . . . 0.0 110.235 -166.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 166.86 24.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.891 1.276 . . . . 0.0 111.259 167.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.0 p -155.97 153.46 29.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.939 1.295 . . . . 0.0 112.404 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 70.3 m -140.14 131.38 26.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.436 1.494 . . . . 0.0 110.331 -169.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.63 128.12 34.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.134 174.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -91.84 152.18 20.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.708 1.203 . . . . 0.0 111.657 176.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.51 -17.58 64.2 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.494 0.717 . . . . 0.0 112.322 173.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.8 -9.76 58.78 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.576 1.55 . . . . 0.0 113.702 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 9.66 57.94 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.16 1.362 . . . . 0.0 115.203 176.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.9 p -108.23 161.23 15.19 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.948 1.699 . . . . 0.0 111.524 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 83.5 m -102.65 124.86 48.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.954 1.302 . . . . 0.0 110.278 170.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.3 t -88.69 151.98 22.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.807 0.843 . . . . 0.0 110.582 166.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.3 t -130.94 144.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.174 1.79 . . . . 0.0 109.984 -177.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.5 p -135.65 147.66 48.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.615 1.166 . . . . 0.0 111.729 166.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -148.92 154.95 40.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.31 -0.869 . . . . 0.0 113.005 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.75 102.62 25.22 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.79 1.236 . . . . 0.0 110.456 -173.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.78 163.91 9.07 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.033 3.155 . . . . 0.0 111.3 175.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -127.12 -21.45 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.77 150.51 60.16 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.487 1.115 . . . . 0.0 110.755 173.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.9 145.73 32.2 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.849 2.366 . . . . 0.0 111.99 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.39 -167.54 32.46 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.837 1.208 . . . . 0.0 113.654 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.04 124.57 38.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.392 1.477 . . . . 0.0 112.098 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -116.51 128.21 55.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.855 1.662 . . . . 0.0 110.009 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.9 m -89.99 116.29 27.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.105 0.962 . . . . 0.0 110.705 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.59 124.67 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.698 1.599 . . . . 0.0 108.326 177.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.7 tt -108.53 127.48 53.97 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.455 1.502 . . . . 0.0 109.261 176.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -130.29 127.71 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.315 1.046 . . . . 0.0 109.497 173.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.75 144.6 24.41 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.066 1.347 . . . . 0.0 111.398 -167.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.29 125.98 13.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.509 1.123 . . . . 0.0 110.131 -177.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.1 52.37 11.84 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.576 1.15 . . . . 0.0 112.041 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 7.8 pt-20 58.84 12.68 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.322 2.649 . . . . 0.0 116.39 -177.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -119.49 127.35 52.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.453 1.101 . . . . 0.0 110.997 177.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -62.43 143.32 57.21 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.466 -0.772 . . . . 0.0 111.417 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.4 m -71.38 151.99 94.15 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.03 173.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -55.36 126.55 22.88 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.249 2.633 . . . . 0.0 111.19 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.92 62.17 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.367 1.46 . . . . 0.0 115.085 -175.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 36.4 t -78.06 141.69 63.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 119.356 1.578 . . . . 0.0 111.701 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 141.78 72.16 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.421 0.829 . . . . 0.0 112.27 -4.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -93.95 161.92 14.11 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.171 1.788 . . . . 0.0 110.617 176.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.7 m -119.97 116.0 24.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.675 0.79 . . . . 0.0 110.745 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.33 133.23 39.48 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.702 1.201 . . . . 0.0 111.084 172.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 111.75 23.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.898 0.879 . . . . 0.0 109.553 174.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.2 t -94.6 133.01 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.924 1.29 . . . . 0.0 110.05 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 78.7 p -108.37 165.69 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.915 1.286 . . . . 0.0 113.094 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.96 136.96 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.77 1.176 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.3 t70 . . . . . 0 CA--C 1.547 0.85 0 C-N-CA 124.78 1.232 . . . . 0.0 113.768 -175.456 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 54.1 mt . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -45.65 110.75 1.21 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.392 1.877 . . . . 0.0 111.349 175.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 133.32 29.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.271 1.98 . . . . 0.0 108.801 172.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.99 123.67 45.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.587 0.755 . . . . 0.0 111.047 -174.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -157.2 141.78 16.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 110.928 177.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.72 147.6 51.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.267 1.827 . . . . 0.0 110.266 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -109.8 138.43 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.785 1.234 . . . . 0.0 109.963 172.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.8 mt -132.47 133.86 24.13 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.048 1.739 . . . . 0.0 108.686 -174.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.13 66.82 8.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.199 3.266 . . . . 0.0 111.211 177.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.8 t80 -115.68 153.81 30.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.895 1.678 . . . . 0.0 111.16 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 59.2 m -121.91 119.72 32.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.264 1.426 . . . . 0.0 109.429 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.46 127.01 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 109.295 174.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.17 -139.59 0.36 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.701 1.2 . . . . 0.0 110.67 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -75.27 -6.68 51.09 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.9 -148.42 8.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.781 1.658 . . . . 0.0 113.017 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -154.88 148.05 24.86 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 110.517 -173.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.49 136.03 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.286 1.434 . . . . 0.0 111.184 -178.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 54.9 p -146.14 -175.33 4.72 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.457 1.903 . . . . 0.0 109.894 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.88 -162.18 20.55 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 -177.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.37 144.75 17.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.289 1.836 . . . . 0.0 109.664 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 90.8 t -123.07 135.89 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.015 1.726 . . . . 0.0 108.223 173.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -120.72 139.59 52.85 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 112.056 -174.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.5 148.11 36.59 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.717 1.607 . . . . 0.0 111.481 -176.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.71 -28.75 67.96 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.115 3.21 . . . . 0.0 114.927 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.1 p -73.56 -2.78 24.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 114.496 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.35 -5.77 83.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.562 1.554 . . . . 0.0 113.9 -178.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -68.77 157.56 36.12 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.144 1.377 . . . . 0.0 112.052 173.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.9 m -140.76 156.36 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.165 1.386 . . . . 0.0 111.655 177.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.28 179.83 8.86 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.92 2.088 . . . . 0.0 110.267 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -127.36 144.76 51.92 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 121.146 -0.971 . . . . 0.0 111.915 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.83 166.14 13.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.146 3.231 . . . . 0.0 111.399 176.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.0 m -111.54 125.59 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.052 1.341 . . . . 0.0 108.96 173.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.14 132.47 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.788 1.235 . . . . 0.0 109.142 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 67.2 m -135.13 126.15 27.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.375 1.47 . . . . 0.0 109.744 178.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.84 139.01 41.49 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.954 0.901 . . . . 0.0 112.607 173.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -93.47 -4.96 50.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 71.14 -3.69 1.99 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.816 2.446 . . . . 0.0 114.225 -176.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.4 5.73 49.33 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.658 1.983 . . . . 0.0 113.264 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.43 14.75 55.17 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.964 1.269 . . . . 0.0 113.891 -174.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 63.7 p -129.69 161.59 30.28 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.293 1.837 . . . . 0.0 110.611 177.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 18.7 m -121.31 146.79 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.595 1.158 . . . . 0.0 109.689 166.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 80.8 m -105.77 135.69 46.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.402 1.081 . . . . 0.0 108.467 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 20.5 t -115.05 133.57 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.569 1.548 . . . . 0.0 108.95 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.55 154.07 47.41 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.55 1.54 . . . . 0.0 112.1 -174.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -153.9 136.19 14.9 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.714 1.606 . . . . 0.0 111.513 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.12 118.12 68.88 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.52 1.128 . . . . 0.0 110.88 177.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.46 144.98 23.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.508 2.805 . . . . 0.0 111.77 -176.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.4 p -135.02 -7.42 2.34 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 178.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -163.49 143.81 8.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.818 1.647 . . . . 0.0 110.218 -175.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -81.6 165.41 21.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.44 1.096 . . . . 0.0 113.239 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.68 -168.24 15.88 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.782 1.658 . . . . 0.0 114.377 178.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.0 130.19 37.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.197 1.799 . . . . 0.0 109.58 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 76.9 m80 -134.25 169.88 16.53 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.251 1.421 . . . . 0.0 112.007 -170.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.76 152.39 38.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 168.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.1 ttm -121.22 118.07 28.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.894 2.478 . . . . 0.0 109.837 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.34 137.75 32.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.428 1.491 . . . . 0.0 109.944 169.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.0 mm -135.65 135.17 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.573 1.149 . . . . 0.0 110.649 175.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.12 20.72 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.73 1.212 . . . . 0.0 113.131 -175.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -99.61 125.31 45.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.743 2.017 . . . . 0.0 109.901 174.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.4 34.05 14.3 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.734 1.214 . . . . 0.0 112.448 -174.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.1 t30 75.15 2.65 3.97 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.397 2.679 . . . . 0.0 114.746 -178.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.0 mtm -102.64 130.61 49.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 0.0 110.638 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -58.7 137.71 57.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.1 pt -71.45 152.46 94.01 Favored Pre-proline 0 N--CA 1.48 1.033 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.599 173.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.17 125.68 17.58 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.363 2.042 . . . . 0.0 110.936 -176.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.92 -8.63 76.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.144 1.354 . . . . 0.0 115.233 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.8 t -63.93 141.26 98.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 120.07 1.935 . . . . 0.0 111.941 175.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.59 161.45 76.15 Favored 'Cis proline' 0 C--N 1.354 0.837 0 CA-C-N 119.998 1.035 . . . . 0.0 113.492 0.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.1 mt -96.4 136.21 37.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.68 1.592 . . . . 0.0 110.004 172.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -109.25 141.96 40.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.372 1.069 . . . . 0.0 110.959 -177.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 34.0 p90 -153.85 174.13 14.99 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 113.212 -173.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.9 t80 -128.49 147.75 50.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 112.421 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 49.3 t -127.6 139.27 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.091 1.756 . . . . 0.0 109.16 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -153.38 160.41 42.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.459 1.504 . . . . 0.0 110.756 -174.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -76.38 139.79 41.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 111.485 177.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -66.04 -23.61 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 121.442 -0.786 . . . . 0.0 112.842 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 55.4 p30 -85.8 -3.66 58.96 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.469 1.508 . . . . 0.0 114.809 -176.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.1 m -64.48 137.48 57.89 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.04 0.936 . . . . 0.0 112.536 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.02 -12.95 54.63 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.939 1.257 . . . . 0.0 114.514 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -69.18 166.91 17.32 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 t -68.01 137.83 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 157.93 31.01 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.04 1.336 . . . . 0.0 110.335 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.07 143.35 44.6 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 111.823 -174.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.44 164.99 15.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.62 1.568 . . . . 0.0 112.813 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.57 173.8 13.42 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.229 1.395 . . . . 0.0 113.19 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.95 -32.99 12.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.666 -171.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.23 -38.32 91.74 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.641 1.109 . . . . 0.0 114.094 -172.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.75 -8.68 57.14 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.712 1.256 . . . . 0.0 113.35 176.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.8 m -96.96 -42.93 7.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.45 1.9 . . . . 0.0 110.881 174.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -155.55 127.42 7.49 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.34 1.856 . . . . 0.0 112.025 -164.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.58 -177.79 15.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.693 2.092 . . . . 0.0 112.165 168.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 87.2 t -145.6 142.71 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.833 2.053 . . . . 0.0 107.476 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.2 m -56.14 138.47 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 65.86 1.91 2.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.802 2.041 . . . . 0.0 114.887 175.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -106.74 139.43 20.36 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.411 1.484 . . . . 0.0 111.057 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.38 119.57 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.705 2.27 . . . . 0.0 110.314 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -101.96 134.54 45.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.179 1.392 . . . . 0.0 110.055 175.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 38.6 p -127.52 145.98 50.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -165.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -157.26 177.05 11.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 178.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.9 m -128.47 142.1 51.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 -169.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.08 131.66 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.679 1.591 . . . . 0.0 108.422 168.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -91.75 129.53 37.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.42 1.088 . . . . 0.0 111.024 -177.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -135.65 8.15 3.31 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.049 1.34 . . . . 0.0 113.606 -168.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.6 tptm -54.23 -37.0 64.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.307 1.843 . . . . 0.0 114.772 -168.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.12 20.13 5.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.695 1.598 . . . . 0.0 112.268 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.77 78.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.377 1.071 . . . . 0.0 113.854 -174.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.27 149.14 4.85 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.883 1.23 . . . . 0.0 112.365 -171.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.18 139.84 52.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.468 0.707 . . . . 0.0 111.815 -178.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.09 10.84 0.02 OUTLIER Glycine 0 CA--C 1.535 1.304 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.88 97.99 1.55 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.163 1.363 . . . . 0.0 112.819 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.47 127.25 31.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.817 1.247 . . . . 0.0 108.748 166.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 49.1 m -117.03 154.69 30.5 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 0.0 111.731 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 54.9 tp -159.57 132.49 6.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.605 1.562 . . . . 0.0 109.096 -172.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.92 159.65 36.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.062 0.945 . . . . 0.0 112.311 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.43 127.42 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.59 1.156 . . . . 0.0 109.9 175.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -105.6 168.01 9.38 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.897 1.679 . . . . 0.0 109.879 167.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 166.11 -161.16 34.79 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.008 -1.057 . . . . 0.0 113.717 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.1 -13.5 26.01 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.569 2.846 . . . . 0.0 112.435 176.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 9.5 t -155.08 168.25 27.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.396 1.879 . . . . 0.0 109.627 168.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -77.97 116.02 18.14 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.898 -1.126 . . . . 0.0 111.363 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -79.7 143.73 34.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.993 0.917 . . . . 0.0 110.802 166.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.64 146.73 23.54 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.236 0.615 . . . . 0.0 110.854 171.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.87 140.32 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.679 1.192 . . . . 0.0 110.856 -163.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -131.31 158.75 39.84 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.116 1.766 . . . . 0.0 110.628 167.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.9 p -151.55 153.65 34.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.165 0.986 . . . . 0.0 112.404 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.2 m -147.0 131.13 17.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.287 1.435 . . . . 0.0 110.812 -166.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 9.5 t0 -71.04 123.02 21.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.199 1.0 . . . . 0.0 110.986 169.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -80.96 -9.78 59.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 113.356 177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 tt0 79.2 -25.12 0.19 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 129.005 2.922 . . . . 0.0 112.696 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.61 1.9 13.23 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.447 1.899 . . . . 0.0 114.15 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.86 21.17 19.32 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 125.216 1.389 . . . . 0.0 114.081 -177.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -133.78 150.4 51.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.095 1.358 . . . . 0.0 110.411 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 82.3 m -106.66 126.1 51.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.451 1.5 . . . . 0.0 109.339 170.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -84.33 150.71 25.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.819 0.848 . . . . 0.0 110.536 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.2 t -126.85 144.87 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.844 2.058 . . . . 0.0 108.828 177.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.1 t -137.35 136.59 38.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.38 1.472 . . . . 0.0 110.277 171.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -142.89 153.74 43.42 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 177.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.5 mt -120.13 104.72 43.31 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.953 1.701 . . . . 0.0 110.073 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.55 155.49 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.481 2.787 . . . . 0.0 110.021 169.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.2 m -116.73 -13.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.28 156.04 26.93 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.835 1.654 . . . . 0.0 110.458 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 153.52 49.32 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.005 2.47 . . . . 0.0 112.72 -170.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.64 -151.4 23.67 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.94 1.257 . . . . 0.0 113.47 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -120.91 125.37 47.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.339 1.456 . . . . 0.0 110.718 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -110.77 149.34 30.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.93 1.692 . . . . 0.0 110.778 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 66.6 m -113.27 114.25 26.43 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.556 1.142 . . . . 0.0 110.963 -177.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.44 123.41 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.288 1.835 . . . . 0.0 108.882 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.53 131.88 52.38 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.549 1.54 . . . . 0.0 109.479 173.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 50.6 t -133.46 131.9 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.394 1.478 . . . . 0.0 108.289 172.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.21 142.96 17.57 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.852 1.261 . . . . 0.0 110.765 -167.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.66 123.58 22.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.548 1.139 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 51.43 56.96 7.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.129 1.372 . . . . 0.0 112.492 176.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.307 8.0 pt-20 59.62 12.95 3.1 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.189 2.596 . . . . 0.0 116.321 -177.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -118.96 124.62 47.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.451 1.101 . . . . 0.0 111.188 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -61.59 155.52 22.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.149 0.98 . . . . 0.0 112.785 170.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.92 155.94 70.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 O-C-N 121.787 -0.571 . . . . 0.0 110.427 175.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -55.4 121.19 9.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.795 2.33 . . . . 0.0 110.448 172.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -13.04 67.22 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.177 1.37 . . . . 0.0 116.316 178.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 98.7 p -80.08 153.83 74.82 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 120.552 2.176 . . . . 0.0 113.212 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.95 158.34 99.05 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.222 0.758 . . . . 0.0 112.596 -4.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -112.96 138.21 50.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.335 1.454 . . . . 0.0 111.345 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 21.2 m -89.9 117.42 28.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.876 0.871 . . . . 0.0 110.712 177.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.76 127.5 44.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.281 1.432 . . . . 0.0 111.392 173.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.62 138.22 46.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.534 1.533 . . . . 0.0 110.608 172.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.1 t -138.15 138.8 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.646 1.178 . . . . 0.0 110.818 172.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 81.1 p -130.57 165.19 23.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.535 1.134 . . . . 0.0 112.672 174.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.64 144.19 22.05 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.941 1.734 . . . . 0.0 112.909 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 CA--C 1.552 1.046 0 C-N-CA 125.239 1.416 . . . . 0.0 112.707 178.984 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . 0.482 HD11 HG12 ' A' 1860 ' ' VAL . 20.9 tp . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 110.866 -0.049 . . . . 0.0 110.866 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -53.13 110.91 2.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.689 1.196 . . . . 0.0 113.5 -168.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.02 135.79 28.23 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.19 1.927 . . . . 0.0 108.937 172.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -102.43 121.31 42.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.205 0.602 . . . . 0.0 109.839 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.67 124.53 9.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.828 1.251 . . . . 0.0 110.89 175.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -131.72 149.18 52.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.804 2.042 . . . . 0.0 109.558 -176.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 15.0 p -123.67 135.71 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.894 1.278 . . . . 0.0 110.069 176.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.94 138.18 31.27 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 125.885 1.674 . . . . 0.0 108.979 -174.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.48 59.56 7.2 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.582 3.521 . . . . 0.0 112.216 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 40.1 t80 -100.71 151.7 21.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.529 1.532 . . . . 0.0 111.017 174.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.1 m -124.53 126.79 46.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.149 1.379 . . . . 0.0 109.535 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.41 128.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.792 1.237 . . . . 0.0 110.691 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 41.0 tttm -99.08 -140.17 0.32 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.945 1.698 . . . . 0.0 111.707 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -82.51 -10.63 58.93 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -175.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.42 -143.01 6.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.056 1.789 . . . . 0.0 112.628 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.46 147.44 24.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.732 1.213 . . . . 0.0 110.924 -175.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.7 tt -118.54 133.76 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.684 1.593 . . . . 0.0 111.148 -178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 29.1 p -150.31 170.84 18.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.197 1.799 . . . . 0.0 110.647 -174.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.47 -169.05 24.23 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 -176.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.77 141.86 21.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.395 1.878 . . . . 0.0 109.661 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.3 t -117.31 136.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.64 1.976 . . . . 0.0 108.12 173.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.57 132.2 56.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.252 1.021 . . . . 0.0 111.577 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -100.54 145.48 30.38 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.634 1.574 . . . . 0.0 111.235 -176.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.63 -16.89 23.74 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.673 2.916 . . . . 0.0 112.936 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 30.6 p -76.0 -2.06 28.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.369 1.467 . . . . 0.0 114.301 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.45 45.64 3.98 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.638 1.114 . . . . 0.0 113.63 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.48 170.09 18.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.282 1.433 . . . . 0.0 112.426 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.8 m -138.81 157.84 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.296 1.439 . . . . 0.0 112.159 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.6 177.6 11.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.899 2.08 . . . . 0.0 110.296 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -123.56 145.62 47.57 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 121.222 -0.924 . . . . 0.0 111.896 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -82.93 167.9 14.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.209 3.273 . . . . 0.0 111.342 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.84 126.62 53.24 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.125 1.37 . . . . 0.0 108.547 170.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.72 130.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.317 1.047 . . . . 0.0 108.848 175.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -121.12 128.39 52.5 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.799 1.64 . . . . 0.0 109.639 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.83 121.3 25.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.422 1.089 . . . . 0.0 110.346 173.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.11 -12.75 54.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 65.79 9.84 6.34 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.997 2.119 . . . . 0.0 114.149 -178.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -108.59 10.07 27.15 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.835 2.054 . . . . 0.0 112.808 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.8 15.06 62.0 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.79 1.186 . . . . 0.0 113.601 -172.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 64.2 p -132.78 160.26 37.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.544 1.938 . . . . 0.0 110.472 177.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.3 m -125.0 144.85 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.739 1.215 . . . . 0.0 109.636 166.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 85.9 m -106.96 135.55 48.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.208 1.003 . . . . 0.0 108.691 171.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.5 t -119.97 131.05 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.406 1.483 . . . . 0.0 108.846 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -130.9 156.44 45.05 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.404 . . . . 0.0 112.768 -174.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 9.1 t80 -153.93 137.19 15.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.667 1.587 . . . . 0.0 111.675 176.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.36 120.84 69.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.805 1.242 . . . . 0.0 111.023 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.02 155.88 26.32 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.757 2.971 . . . . 0.0 112.694 -172.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.1 p -140.66 -11.88 1.01 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -160.66 151.29 18.38 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.611 1.565 . . . . 0.0 110.55 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.02 170.44 16.68 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.893 1.277 . . . . 0.0 113.299 179.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.28 -172.11 14.07 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.428 1.49 . . . . 0.0 114.148 177.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.0 tp -82.32 134.56 35.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.636 1.175 . . . . 0.0 110.458 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 66.1 m80 -134.56 165.19 25.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 111.628 -172.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.15 153.49 37.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.438 1.095 . . . . 0.0 111.621 175.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.3 ttm -130.74 140.31 50.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.567 1.547 . . . . 0.0 110.889 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -107.73 131.1 54.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.425 1.49 . . . . 0.0 110.042 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.58 137.92 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.562 1.145 . . . . 0.0 109.852 167.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.41 144.01 37.91 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.638 1.175 . . . . 0.0 113.027 176.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -103.5 117.28 34.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.439 1.896 . . . . 0.0 109.679 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.56 30.97 9.24 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.663 1.185 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 65.8 m-80 79.09 4.56 2.32 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.662 2.785 . . . . 0.0 115.12 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.6 ttp -96.12 126.42 41.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.696 1.198 . . . . 0.0 110.206 166.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -59.11 139.12 57.21 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.172 -0.955 . . . . 0.0 113.086 -178.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.4 pt -73.76 149.85 88.26 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.375 173.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.34 -20.33 61.75 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 114.067 -171.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.77 -7.84 86.78 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 114.809 174.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.5 m -94.89 155.75 38.83 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.281 1.54 . . . . 0.0 113.078 177.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.22 161.48 94.61 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 118.707 0.574 . . . . 0.0 112.554 -1.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 85.0 mt -104.74 154.03 20.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.592 1.557 . . . . 0.0 110.129 172.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -145.99 139.38 26.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.663 1.185 . . . . 0.0 110.052 -177.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -163.4 166.13 23.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -177.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.9 t80 -110.16 141.52 42.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.025 0.93 . . . . 0.0 111.914 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . 0.482 HG12 HD11 ' A' 1788 ' ' LEU . 97.6 t -110.84 129.91 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.861 1.664 . . . . 0.0 109.085 -178.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.2 t0 -160.42 146.57 15.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.005 1.322 . . . . 0.0 111.841 -173.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 150.36 48.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 113.436 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.3 t -62.06 -44.38 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.289 1.036 . . . . 0.0 111.564 177.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.07 22.98 4.56 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.759 1.224 . . . . 0.0 113.407 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 31.4 p -62.39 -26.57 68.54 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 79.77 -46.81 3.18 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.997 1.761 . . . . 0.0 113.812 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -62.5 165.03 6.65 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.2 t -67.55 134.85 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.762 0.825 . . . . 0.0 109.308 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -160.33 167.7 26.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.953 1.301 . . . . 0.0 110.876 -174.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -148.03 146.31 28.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.879 1.271 . . . . 0.0 111.793 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.5 p90 -166.73 160.65 15.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.49 1.516 . . . . 0.0 113.041 -174.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.4 172.92 13.21 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.622 1.582 . . . . 0.0 112.747 -175.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.16 -32.34 6.87 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.189 2.593 . . . . 0.0 113.443 -170.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.06 77.07 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 0.0 114.287 -170.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.22 -2.32 37.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.678 1.239 . . . . 0.0 113.654 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.5 m -112.97 -41.47 3.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.841 2.056 . . . . 0.0 112.033 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -149.26 146.0 27.37 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.817 1.247 . . . . 0.0 112.843 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.72 179.2 21.3 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.116 1.341 . . . . 0.0 113.096 173.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.7 t -138.8 137.2 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.572 1.149 . . . . 0.0 108.661 174.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -55.7 141.6 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 66.2 m-80 65.9 4.95 3.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.698 1.999 . . . . 0.0 114.716 174.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -123.44 141.78 37.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.632 1.573 . . . . 0.0 110.766 176.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.15 135.9 25.91 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.554 2.17 . . . . 0.0 111.382 -174.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.28 147.14 39.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 110.262 173.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.0 p -136.72 150.85 48.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -165.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 56.0 p90 -162.29 -179.94 7.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.289 1.835 . . . . 0.0 111.507 176.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -129.69 143.64 50.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.37 1.468 . . . . 0.0 110.714 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 60.1 t -116.53 133.36 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.663 1.585 . . . . 0.0 108.393 170.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.33 132.92 37.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.483 1.113 . . . . 0.0 111.421 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.3 p -130.18 6.02 4.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.188 1.795 . . . . 0.0 112.89 -176.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -59.37 -20.65 56.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -165.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.63 31.83 1.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.197 1.399 . . . . 0.0 111.442 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.47 -37.34 65.81 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -175.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.63 153.22 9.04 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.513 1.054 . . . . 0.0 112.236 -168.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -76.78 165.01 25.31 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 160.01 -77.87 0.18 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.367 1.461 . . . . 0.0 111.457 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -176.07 114.67 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.496 1.046 . . . . 0.0 112.625 171.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.44 130.31 34.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.147 1.379 . . . . 0.0 109.32 174.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.9 m -128.27 155.91 43.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.516 1.526 . . . . 0.0 112.159 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 38.2 tp -155.11 135.45 13.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.41 1.884 . . . . 0.0 108.614 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.51 160.26 40.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.992 0.917 . . . . 0.0 112.097 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.9 mt -135.14 133.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.578 1.151 . . . . 0.0 109.614 174.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.82 110.11 13.9 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.301 1.44 . . . . 0.0 109.347 175.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.14 -169.73 12.75 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.918 1.247 . . . . 0.0 113.896 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.31 -18.76 38.97 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.657 2.905 . . . . 0.0 111.987 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.8 t -137.06 159.63 41.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.613 1.565 . . . . 0.0 109.211 159.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -76.86 114.52 15.72 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.85 -1.156 . . . . 0.0 111.216 -178.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -77.13 141.96 39.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.285 1.034 . . . . 0.0 111.547 174.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.51 146.68 26.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.004 0.521 . . . . 0.0 110.597 170.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.9 145.33 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.345 1.458 . . . . 0.0 110.277 -165.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 17.3 t -145.02 142.75 30.03 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.071 0.948 . . . . 0.0 110.695 164.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -140.44 153.86 46.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.34 1.056 . . . . 0.0 112.142 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 92.5 m -136.42 119.78 16.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.434 1.493 . . . . 0.0 109.875 -172.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -71.67 116.65 12.28 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.84 0.856 . . . . 0.0 109.774 166.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -81.24 -13.25 58.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.905 0.882 . . . . 0.0 112.844 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 70.86 -3.95 1.85 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.367 2.667 . . . . 0.0 114.072 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -87.71 2.0 52.28 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.986 1.714 . . . . 0.0 113.718 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 106.61 10.12 29.55 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.499 1.523 . . . . 0.0 114.754 -172.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 50.7 p -133.84 153.35 51.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.85 1.325 . . . . 0.0 112.375 173.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -112.46 129.69 56.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.885 1.674 . . . . 0.0 109.06 162.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.7 t -86.78 148.41 25.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 110.526 170.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.3 t -130.26 141.67 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.626 1.571 . . . . 0.0 110.074 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 98.2 p -136.36 148.88 48.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.57 1.548 . . . . 0.0 111.671 169.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.3 p90 -151.37 156.1 40.03 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 5.5 mt -122.0 107.4 35.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.742 1.617 . . . . 0.0 110.684 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.82 169.87 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.907 3.072 . . . . 0.0 110.452 167.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 10.8 p -135.01 -23.91 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.29 151.0 57.14 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.916 1.287 . . . . 0.0 110.495 175.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.19 153.91 41.24 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -168.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.23 -163.83 28.06 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.371 1.462 . . . . 0.0 112.534 -174.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.08 125.33 52.02 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.438 1.095 . . . . 0.0 111.338 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.26 129.68 55.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.787 2.035 . . . . 0.0 109.941 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.2 m -88.38 126.36 35.17 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.977 -1.077 . . . . 0.0 111.053 177.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.98 124.97 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 108.365 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -109.21 129.18 55.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.302 1.441 . . . . 0.0 109.708 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.0 t -131.94 129.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.434 1.094 . . . . 0.0 109.692 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.44 143.42 23.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.894 1.278 . . . . 0.0 111.721 -167.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.87 122.69 18.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.76 1.224 . . . . 0.0 109.587 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.2 t-20 55.04 56.94 6.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.197 1.399 . . . . 0.0 111.876 176.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 7.7 pt-20 58.82 8.43 0.95 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.653 2.781 . . . . 0.0 116.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.98 123.55 50.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.426 1.09 . . . . 0.0 110.884 177.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -63.34 145.24 55.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.549 -0.72 . . . . 0.0 111.742 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 11.3 m -72.5 157.67 88.66 Favored Pre-proline 0 N--CA 1.479 1.008 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.608 172.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -54.39 126.89 23.75 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 0.0 111.932 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.24 63.73 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.817 1.198 . . . . 0.0 115.375 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.7 t -75.59 140.14 71.44 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.437 1.618 . . . . 0.0 111.404 176.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.09 137.28 49.36 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 119.459 0.843 . . . . 0.0 112.101 -3.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -86.91 175.21 8.28 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.143 1.777 . . . . 0.0 110.725 174.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -136.78 119.66 16.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.765 0.826 . . . . 0.0 110.824 178.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.59 129.06 49.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.377 1.471 . . . . 0.0 110.806 174.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -91.13 125.03 35.79 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.955 -0.466 . . . . 0.0 110.557 173.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.6 t -107.09 129.2 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.525 1.53 . . . . 0.0 109.896 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.2 p -106.55 165.8 11.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.848 1.259 . . . . 0.0 112.538 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.37 144.09 29.04 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.751 1.167 . . . . 0.0 112.271 176.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.8 t70 . . . . . 0 CA--C 1.55 0.977 0 C-N-CA 124.572 1.149 . . . . 0.0 113.018 176.544 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 CA--C 1.535 0.394 0 CA-C-O 121.314 0.578 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -60.51 117.81 28.24 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.627 1.571 . . . . 0.0 110.672 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.19 144.38 56.87 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.765 2.31 . . . . 0.0 109.746 178.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 34.0 t80 -109.92 129.32 55.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.444 0.697 . . . . 0.0 111.424 -174.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -155.79 145.61 21.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.462 1.505 . . . . 0.0 111.2 174.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.16 144.33 30.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.973 1.709 . . . . 0.0 110.008 -171.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.7 p -113.94 137.11 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 0.0 110.103 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.6 mt -133.71 135.41 24.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.924 1.689 . . . . 0.0 109.172 -172.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.39 96.13 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.731 2.954 . . . . 0.0 109.927 173.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 58.0 t80 -159.4 152.74 22.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.209 2.204 . . . . 0.0 108.523 -178.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.62 126.9 37.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.323 1.049 . . . . 0.0 109.868 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.6 mt -78.98 116.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.025 0.93 . . . . 0.0 109.71 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -98.68 -152.66 0.41 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.473 1.509 . . . . 0.0 110.882 172.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -70.93 122.23 19.58 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.635 -1.29 . . . . 0.0 111.03 171.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.0 -150.37 21.45 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.613 1.578 . . . . 0.0 111.986 -170.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -159.54 145.92 16.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 111.168 -175.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.7 tt -123.74 138.78 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.633 1.573 . . . . 0.0 110.965 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.3 p -146.51 170.77 16.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.95 1.7 . . . . 0.0 110.534 -177.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.51 -171.43 27.54 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -177.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -154.42 144.93 22.24 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.427 1.891 . . . . 0.0 109.637 176.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 74.3 t -120.3 132.58 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.929 1.692 . . . . 0.0 108.777 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -105.27 134.8 47.77 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.824 1.25 . . . . 0.0 111.713 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 9.4 mtm -101.82 140.11 20.92 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.697 1.599 . . . . 0.0 110.846 174.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -56.09 -30.13 77.54 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.084 3.189 . . . . 0.0 115.017 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.8 p -74.67 2.37 10.07 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.022 1.729 . . . . 0.0 114.375 178.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.28 62.94 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.716 1.627 . . . . 0.0 114.837 172.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -73.82 159.0 33.51 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.498 1.119 . . . . 0.0 111.898 175.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 19.3 m -139.65 150.83 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.491 1.516 . . . . 0.0 110.837 172.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.15 172.55 18.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.394 1.877 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -115.63 141.58 27.6 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.208 -0.933 . . . . 0.0 112.152 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.18 167.65 15.68 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.11 3.207 . . . . 0.0 111.317 174.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.04 130.32 55.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.044 1.338 . . . . 0.0 108.923 172.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.79 133.55 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.823 1.249 . . . . 0.0 109.437 177.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.8 m -133.41 127.63 33.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.605 1.562 . . . . 0.0 109.756 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.42 128.6 33.55 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.751 0.821 . . . . 0.0 110.625 172.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.48 -9.33 59.47 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.1 mttt 72.23 0.95 3.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.193 2.597 . . . . 0.0 114.088 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -97.41 3.7 50.87 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.682 1.993 . . . . 0.0 113.143 174.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.12 16.17 39.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.983 1.278 . . . . 0.0 114.426 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.7 p -127.96 156.65 42.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.206 1.802 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.5 m -112.74 144.94 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.809 0.844 . . . . 0.0 109.816 164.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 61.6 m -104.94 134.82 47.41 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.53 1.132 . . . . 0.0 108.435 166.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.6 t -114.04 135.78 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.561 1.544 . . . . 0.0 108.704 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -132.49 151.8 51.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 112.128 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 57.6 t80 -155.45 137.17 14.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.299 1.44 . . . . 0.0 112.306 -178.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -93.74 120.49 66.01 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.635 1.174 . . . . 0.0 111.109 177.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.65 150.52 24.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.664 2.909 . . . . 0.0 111.99 -178.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 87.6 p -122.95 -13.32 7.85 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -166.71 148.87 6.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.013 1.725 . . . . 0.0 110.206 -171.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.98 165.5 25.17 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.079 0.952 . . . . 0.0 113.348 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 128.62 179.5 15.95 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 125.484 1.516 . . . . 0.0 114.505 176.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.1 tp -85.9 107.65 17.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 110.402 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 25.8 m80 -100.48 169.79 8.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.686 1.594 . . . . 0.0 111.665 -176.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -141.59 149.13 40.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.897 0.879 . . . . 0.0 111.208 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.1 ttm -118.19 128.73 54.99 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.63 1.972 . . . . 0.0 110.018 -178.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.64 131.39 53.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.165 2.186 . . . . 0.0 109.385 173.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.9 mm -135.05 135.81 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.505 1.122 . . . . 0.0 110.466 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.04 139.73 26.29 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.21 123.97 47.73 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.89 2.076 . . . . 0.0 109.93 176.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 52.16 32.17 10.17 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.745 1.218 . . . . 0.0 112.535 -173.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.5 t30 75.56 6.15 4.0 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.076 2.55 . . . . 0.0 115.108 -178.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.8 mtm -104.41 132.66 50.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.739 1.616 . . . . 0.0 110.943 173.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.3 135.77 44.19 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.3 pt -75.82 154.54 85.13 Favored Pre-proline 0 N--CA 1.478 0.956 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.004 170.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.19 127.5 23.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.069 1.846 . . . . 0.0 109.302 170.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.58 -14.13 57.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.418 -175.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.8 t -82.78 143.2 46.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 119.812 1.806 . . . . 0.0 111.533 172.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.57 163.63 80.76 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.719 0.935 . . . . 0.0 112.28 -8.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.2 mt -113.27 156.6 23.04 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.157 1.783 . . . . 0.0 110.881 175.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -128.08 142.54 51.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.952 1.301 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 31.7 p90 -158.51 150.56 21.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.63 1.172 . . . . 0.0 112.056 -174.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 41.6 t80 -103.76 131.53 50.86 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.193 -0.942 . . . . 0.0 112.678 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.1 t -102.26 137.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.586 1.554 . . . . 0.0 108.852 176.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.63 160.68 31.94 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.638 1.175 . . . . 0.0 111.628 -169.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -75.45 117.43 17.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.007 0.923 . . . . 0.0 111.028 177.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.2 p -81.5 -23.63 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.025 0.93 . . . . 0.0 113.193 -168.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -83.36 -14.31 53.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.441 1.096 . . . . 0.0 113.547 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.4 m -72.77 156.66 38.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.72 1.208 . . . . 0.0 112.663 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.21 -14.77 68.23 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.467 1.032 . . . . 0.0 115.134 -173.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -64.51 154.63 35.37 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.793 1.296 . . . . 0.0 113.438 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 22.0 t -68.57 132.5 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.096 0.958 . . . . 0.0 109.38 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.8 t -154.1 146.72 24.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.461 1.105 . . . . 0.0 110.42 -176.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.44 141.96 51.77 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.746 1.219 . . . . 0.0 111.898 -172.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.0 p90 -168.07 164.8 13.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.314 1.446 . . . . 0.0 113.61 -175.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.07 172.18 12.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.653 1.597 . . . . 0.0 112.27 -176.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.4 -38.92 13.74 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.753 2.302 . . . . 0.0 112.422 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.57 89.62 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.799 -1.001 . . . . 0.0 115.14 -170.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -78.0 -3.59 42.82 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.444 1.622 . . . . 0.0 113.776 175.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.5 m -105.89 -61.46 1.5 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.172 1.789 . . . . 0.0 110.144 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -127.7 133.19 49.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.619 1.967 . . . . 0.0 111.502 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.02 177.02 16.83 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.166 1.365 . . . . 0.0 112.041 171.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 7.5 p -153.52 138.18 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.137 0.975 . . . . 0.0 109.451 176.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 29.3 m -60.68 152.93 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -170.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 34.1 m120 70.27 11.53 7.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.826 2.05 . . . . 0.0 114.738 166.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -147.03 156.97 47.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.524 1.529 . . . . 0.0 111.36 176.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.94 132.48 16.97 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.413 2.075 . . . . 0.0 111.586 -177.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.83 146.85 28.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.074 1.75 . . . . 0.0 109.784 167.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 40.1 p -132.19 149.13 52.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -164.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.23 177.24 11.26 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.84 1.656 . . . . 0.0 111.486 175.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -134.27 145.58 49.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.501 1.52 . . . . 0.0 110.336 -170.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.9 t -116.49 128.11 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.209 1.404 . . . . 0.0 108.221 168.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.33 131.41 35.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.719 177.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 53.7 p -134.01 12.11 3.94 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 112.812 -169.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.5 tptt -53.76 -40.41 66.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.21 1.804 . . . . 0.0 115.267 -162.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -110.54 1.88 18.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.076 1.35 . . . . 0.0 113.364 -178.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.8 -65.43 0.97 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.155 0.982 . . . . 0.0 111.127 178.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 69.97 0.99 30.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.795 1.878 . . . . 0.0 117.795 162.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -160.32 143.22 13.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.883 1.842 . . . . 0.0 111.731 -172.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 102.8 -173.7 22.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.868 1.699 . . . . 0.0 113.02 -177.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -94.83 114.66 4.89 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 124.231 0.92 . . . . 0.0 111.813 177.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.48 133.2 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.013 1.325 . . . . 0.0 108.751 168.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -140.2 161.53 37.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.46 1.504 . . . . 0.0 112.034 -168.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -166.35 139.34 3.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.617 1.567 . . . . 0.0 110.027 -162.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.85 163.26 34.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.902 1.281 . . . . 0.0 111.625 173.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 59.0 mt -136.43 134.0 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.298 1.039 . . . . 0.0 109.677 173.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.06 117.42 31.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.589 1.156 . . . . 0.0 109.519 170.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.58 179.26 16.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.928 1.251 . . . . 0.0 114.066 -177.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.27 -26.67 41.63 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.062 3.175 . . . . 0.0 111.753 172.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -137.51 154.87 49.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.57 1.548 . . . . 0.0 108.506 158.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.3 tttt -69.84 121.73 17.87 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.877 -1.139 . . . . 0.0 112.069 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.91 149.31 36.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 111.216 167.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -86.12 144.45 27.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.281 0.633 . . . . 0.0 109.647 166.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -133.69 139.49 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.797 1.239 . . . . 0.0 110.309 -167.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 72.8 m -135.17 157.21 47.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.689 1.596 . . . . 0.0 110.838 169.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -154.82 157.18 37.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.35 1.06 . . . . 0.0 112.484 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -143.48 125.72 15.55 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.125 1.37 . . . . 0.0 110.61 -171.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.77 131.6 40.93 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.944 1.297 . . . . 0.0 110.732 171.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -109.06 142.92 39.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.627 1.171 . . . . 0.0 111.723 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.43 -14.81 63.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.45 -11.69 60.78 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 113.905 177.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.78 36.08 5.66 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.914 1.245 . . . . 0.0 113.674 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.4 p -140.75 166.49 24.62 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.91 1.684 . . . . 0.0 110.424 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 76.3 m -120.53 129.79 53.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.685 1.594 . . . . 0.0 108.966 165.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.4 t -91.74 150.54 21.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.975 0.91 . . . . 0.0 110.808 172.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 77.6 t -134.97 141.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.686 1.594 . . . . 0.0 110.273 -176.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 53.0 m -132.67 140.37 48.12 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 110.552 172.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -145.18 148.23 33.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.134 -0.979 . . . . 0.0 113.19 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.2 tt -118.67 99.81 51.25 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.789 1.236 . . . . 0.0 110.006 -173.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -83.15 153.54 14.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.753 2.969 . . . . 0.0 111.279 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.0 m -116.54 -11.45 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -167.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.05 151.2 22.47 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.374 1.469 . . . . 0.0 110.537 177.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 142.99 28.29 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.918 2.412 . . . . 0.0 111.713 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.29 -165.0 32.7 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.518 1.056 . . . . 0.0 113.493 -176.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -99.44 124.43 44.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 112.327 -179.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -120.18 127.42 52.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.828 1.651 . . . . 0.0 110.431 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.8 m -92.06 114.46 27.01 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.951 -1.093 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.05 121.35 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.97 1.708 . . . . 0.0 108.777 177.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.91 134.92 45.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.778 1.631 . . . . 0.0 109.107 176.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 61.5 t -139.43 131.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.723 1.209 . . . . 0.0 109.126 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.2 tmmt? -154.73 143.39 20.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.911 1.285 . . . . 0.0 110.946 -165.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.82 121.06 10.86 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.552 1.141 . . . . 0.0 109.498 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.42 55.81 4.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.243 1.417 . . . . 0.0 111.599 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.0 pt-20 55.8 18.23 2.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.084 2.554 . . . . 0.0 115.94 -177.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -125.35 125.28 43.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.079 1.352 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.667 0.787 . . . . 0.0 112.499 171.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.7 m -74.39 155.53 87.67 Favored Pre-proline 0 N--CA 1.479 1.023 0 O-C-N 121.669 -0.644 . . . . 0.0 110.863 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -55.79 123.74 14.57 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.625 2.217 . . . . 0.0 110.343 172.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -15.42 63.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 178.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.1 p -79.52 151.76 74.9 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.177 1.988 . . . . 0.0 112.753 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.17 153.43 98.9 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.274 0.776 . . . . 0.0 112.9 -1.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -107.72 132.99 52.77 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.208 1.403 . . . . 0.0 110.49 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 58.6 m -88.86 108.93 19.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.374 0.67 . . . . 0.0 110.541 178.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.53 132.23 34.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.773 170.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.34 115.28 27.48 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 0.0 109.263 174.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -93.73 134.4 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.75 1.22 . . . . 0.0 109.894 177.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.6 p -111.01 166.89 10.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.165 1.386 . . . . 0.0 112.964 177.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.47 141.37 22.85 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.103 1.335 . . . . 0.0 112.137 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.0 t70 . . . . . 0 CA--C 1.546 0.809 0 C-N-CA 124.627 1.171 . . . . 0.0 113.225 179.876 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 26.5 tp . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -52.13 115.92 7.55 Favored Pre-proline 0 N--CA 1.479 0.993 0 CA-C-O 118.25 -0.881 . . . . 0.0 112.82 -165.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.28 138.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.373 2.049 . . . . 0.0 108.824 174.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 56.7 t80 -130.74 125.37 33.67 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 111.575 -171.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -157.43 139.42 14.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.771 1.629 . . . . 0.0 110.795 176.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.1 mm? -130.9 157.24 43.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.981 2.112 . . . . 0.0 110.0 -175.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.07 136.81 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.916 1.286 . . . . 0.0 109.901 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.1 mt -133.01 134.41 24.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.749 1.62 . . . . 0.0 109.038 -169.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.65 114.08 3.84 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.221 2.614 . . . . 0.0 109.795 173.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.7 t80 -175.24 148.45 0.97 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.389 1.876 . . . . 0.0 110.23 -171.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.2 m -128.6 128.29 43.93 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.72 1.208 . . . . 0.0 110.103 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.7 mt -89.76 135.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.672 1.189 . . . . 0.0 109.12 172.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.4 tptt -132.15 -58.36 0.95 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.105 0.962 . . . . 0.0 112.574 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.6 tttp -157.37 131.01 8.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.985 1.714 . . . . 0.0 110.55 179.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 121.14 -148.45 17.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 125.286 1.422 . . . . 0.0 111.485 -166.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.06 144.88 17.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -175.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.2 tt -121.52 136.2 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.779 1.632 . . . . 0.0 111.081 177.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 39.4 p -146.56 178.71 8.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.365 1.866 . . . . 0.0 110.259 -177.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.49 -168.46 30.6 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.319 0.887 . . . . 0.0 115.319 -179.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.96 146.39 23.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.87 1.668 . . . . 0.0 109.927 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 95.1 t -125.74 131.13 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.729 1.612 . . . . 0.0 108.327 173.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.7 mtm105 -119.66 138.33 53.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.651 1.18 . . . . 0.0 111.669 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 23.5 mtt -111.8 151.32 43.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.775 1.63 . . . . 0.0 111.764 -169.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -53.84 -38.76 85.81 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.093 3.195 . . . . 0.0 115.052 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -77.25 4.01 11.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -176.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.92 80.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.302 1.43 . . . . 0.0 114.155 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 152.01 44.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.15 1.38 . . . . 0.0 111.512 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.2 t -142.68 143.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.172 1.389 . . . . 0.0 109.981 -174.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.03 179.21 7.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.262 1.825 . . . . 0.0 110.984 177.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.66 143.98 43.24 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.928 0.891 . . . . 0.0 111.241 175.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.63 165.17 16.03 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.149 3.232 . . . . 0.0 111.41 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 89.9 m -106.41 124.09 49.06 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.222 1.409 . . . . 0.0 108.685 172.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.93 134.22 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.548 1.139 . . . . 0.0 109.213 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.1 m -135.41 122.63 21.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.495 1.518 . . . . 0.0 109.382 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.76 133.76 41.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.101 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.9 -12.08 45.8 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.5 mttm 69.79 6.91 5.96 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.333 2.253 . . . . 0.0 113.821 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.57 8.3 35.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.163 2.185 . . . . 0.0 112.804 179.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 94.22 14.42 51.35 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.169 1.366 . . . . 0.0 114.156 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.5 p -130.9 156.71 44.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.085 1.754 . . . . 0.0 110.774 176.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 30.0 m -119.22 138.87 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.291 1.036 . . . . 0.0 109.797 166.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 47.6 m -97.09 141.97 29.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.93 1.292 . . . . 0.0 108.604 171.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.1 t -126.59 132.19 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.045 1.338 . . . . 0.0 109.269 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.27 152.96 48.26 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.713 1.605 . . . . 0.0 111.693 -172.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 13.6 t80 -153.51 129.63 10.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.249 1.419 . . . . 0.0 111.327 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -79.76 121.43 82.35 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.102 0.961 . . . . 0.0 110.098 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.0 130.05 12.91 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 0.0 111.768 -170.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 74.2 m -126.0 -0.33 7.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -161.67 152.68 18.15 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.304 1.442 . . . . 0.0 111.021 -178.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -93.79 164.84 12.97 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.479 1.112 . . . . 0.0 112.683 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 102.28 -164.18 16.83 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.315 1.436 . . . . 0.0 113.9 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 26.4 tp -84.55 121.94 28.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.944 1.297 . . . . 0.0 110.95 -178.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 52.7 m80 -118.17 167.74 11.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.585 1.954 . . . . 0.0 111.316 -175.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -146.47 150.71 36.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.509 0.671 . . . . 0.0 112.571 167.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 10.6 ttm -119.91 131.89 55.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.655 2.382 . . . . 0.0 110.008 -174.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -102.05 139.3 37.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.812 1.645 . . . . 0.0 110.037 168.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -138.15 133.77 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.961 1.305 . . . . 0.0 109.268 173.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.64 138.55 23.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -102.41 119.35 38.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.025 2.13 . . . . 0.0 109.462 176.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 50.92 35.85 13.48 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.72 1.208 . . . . 0.0 112.829 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 6.7 t-20 82.71 -7.73 1.23 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.896 2.878 . . . . 0.0 114.69 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.0 mtp -94.11 129.49 40.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.831 1.252 . . . . 0.0 111.466 176.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.05 137.69 56.65 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.263 -0.898 . . . . 0.0 113.289 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.88 154.04 83.03 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.366 0.666 . . . . 0.0 111.501 176.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.63 135.53 57.24 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.479 2.119 . . . . 0.0 110.615 175.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 91.98 -13.95 65.61 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.646 1.117 . . . . 0.0 114.716 -175.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.1 m -96.52 158.7 33.31 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.463 1.631 . . . . 0.0 112.092 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.82 167.81 78.33 Favored 'Cis proline' 0 C--N 1.354 0.848 0 CA-C-N 119.827 0.974 . . . . 0.0 112.842 -2.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 98.8 mt -120.97 143.16 49.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.502 1.521 . . . . 0.0 110.994 -174.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -125.68 137.87 53.87 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.921 1.288 . . . . 0.0 110.374 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.99 152.04 24.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.565 1.146 . . . . 0.0 112.545 -166.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -103.91 148.28 26.35 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.291 -0.88 . . . . 0.0 112.945 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 25.5 t -129.73 137.42 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.311 1.444 . . . . 0.0 110.206 -177.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -165.81 145.21 6.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.746 1.618 . . . . 0.0 112.14 -163.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -71.22 133.97 46.53 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.433 -1.417 . . . . 0.0 113.237 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.8 p -63.74 -29.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -175.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.75 0.12 57.51 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.667 1.187 . . . . 0.0 113.775 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -66.69 140.15 57.88 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.216 -0.928 . . . . 0.0 111.919 -177.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.32 78.14 2.04 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.952 1.263 . . . . 0.0 112.334 -173.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -163.26 168.74 20.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.511 1.524 . . . . 0.0 113.795 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.4 p -67.37 146.2 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.749 0.819 . . . . 0.0 109.34 157.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.0 t -164.24 165.97 21.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.375 1.47 . . . . 0.0 110.637 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.69 147.78 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.54 1.136 . . . . 0.0 112.444 -176.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.6 p90 -166.02 160.11 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 112.623 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.65 170.49 12.1 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.347 1.451 . . . . 0.0 113.189 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.95 -30.86 32.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.241 2.628 . . . . 0.0 112.854 -170.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.9 -16.15 72.24 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 119.318 0.963 . . . . 0.0 114.703 -178.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.04 -13.75 59.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.939 1.369 . . . . 0.0 112.92 170.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 62.1 m -117.16 -38.97 3.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.43 1.892 . . . . 0.0 111.905 -166.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -147.35 159.64 43.45 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.903 2.081 . . . . 0.0 111.823 -171.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.2 175.92 33.77 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.313 0.959 . . . . 0.0 112.908 169.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 24.2 t -139.61 135.92 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 108.758 173.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.3 m -57.12 139.04 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 66.08 3.98 2.89 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.96 2.104 . . . . 0.0 114.926 173.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -119.43 144.63 36.98 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.697 1.599 . . . . 0.0 110.923 176.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.72 125.07 10.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 111.094 -174.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.95 146.73 27.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.298 1.439 . . . . 0.0 110.137 170.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 62.9 p -136.19 154.46 50.94 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -164.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.3 p90 -164.09 172.07 14.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.229 1.812 . . . . 0.0 111.595 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.5 m -125.04 141.53 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.453 1.501 . . . . 0.0 110.565 -174.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.19 128.7 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.801 168.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -90.64 122.01 33.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 0.0 109.871 172.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 44.9 p -122.36 2.82 9.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.456 1.902 . . . . 0.0 113.251 -171.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 62.2 tttp -51.74 -37.37 50.85 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.861 1.664 . . . . 0.0 114.116 -176.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 1.52 31.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.308 1.443 . . . . 0.0 113.632 179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.22 -23.44 61.24 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.87 -91.64 1.42 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.712 1.149 . . . . 0.0 112.553 175.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.36 171.66 17.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.717 1.607 . . . . 0.0 112.231 -173.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 113.53 -166.89 12.19 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.929 1.728 . . . . 0.0 111.976 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -90.54 118.0 5.23 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 124.269 0.937 . . . . 0.0 112.262 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.45 128.67 34.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 108.484 164.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.9 m -127.78 157.98 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.372 1.469 . . . . 0.0 111.822 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.6 tp -159.6 133.73 7.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.598 1.559 . . . . 0.0 109.12 -169.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.91 162.52 38.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.293 1.037 . . . . 0.0 112.017 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.61 134.13 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.523 1.129 . . . . 0.0 109.751 175.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -114.67 159.19 20.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.634 1.573 . . . . 0.0 109.918 168.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.64 -163.39 35.99 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.416 -0.802 . . . . 0.0 113.572 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.29 -16.11 28.14 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.543 2.829 . . . . 0.0 112.716 177.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -152.49 160.15 43.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.064 1.746 . . . . 0.0 109.418 168.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -75.63 114.73 14.54 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.894 -1.129 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.18 148.04 44.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.902 0.881 . . . . 0.0 111.259 168.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.38 144.63 25.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.642 0.777 . . . . 0.0 109.967 170.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.48 144.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 110.719 -166.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.7 t -142.37 157.64 44.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.02 1.328 . . . . 0.0 110.713 166.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.8 p -155.65 154.92 32.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 112.764 -176.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.5 m -140.74 123.41 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.352 1.461 . . . . 0.0 110.246 -171.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -72.42 120.51 18.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 110.077 166.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.02 -10.31 57.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.769 0.827 . . . . 0.0 112.933 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 76.08 -28.37 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.583 2.753 . . . . 0.0 112.581 178.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -73.83 10.68 1.06 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.293 2.237 . . . . 0.0 114.68 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.51 16.99 32.51 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.234 1.397 . . . . 0.0 114.198 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 77.7 p -138.7 154.14 48.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.301 1.44 . . . . 0.0 111.325 175.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.0 m -119.49 134.28 55.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.001 1.721 . . . . 0.0 109.309 166.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.1 t -94.87 150.4 20.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 110.837 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' A' 1886 ' ' PHE . 66.7 t -132.22 143.05 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.363 1.465 . . . . 0.0 110.405 -179.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 58.9 m -131.89 141.76 49.46 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.143 1.777 . . . . 0.0 110.748 171.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.7 p90 -147.01 152.36 38.47 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.81 102.82 49.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.852 2.061 . . . . 0.0 110.422 -178.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.77 160.08 16.29 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.683 2.922 . . . . 0.0 110.303 168.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 33.4 m -121.55 -10.12 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -168.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.77 152.72 24.66 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.267 1.427 . . . . 0.0 110.412 178.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.98 143.79 23.37 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.891 2.394 . . . . 0.0 111.729 -172.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 153.64 -172.09 32.43 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.07 1.319 . . . . 0.0 113.252 -174.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.83 129.3 37.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.006 1.322 . . . . 0.0 112.288 176.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -121.52 140.82 51.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.033 1.733 . . . . 0.0 110.341 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 72.2 m -106.49 113.39 26.87 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.997 1.319 . . . . 0.0 110.45 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -92.74 121.75 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.135 1.374 . . . . 0.0 108.514 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.2 tt -100.28 128.18 46.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.484 1.514 . . . . 0.0 109.362 175.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -129.71 130.61 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.232 1.013 . . . . 0.0 109.671 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.57 143.14 23.59 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.954 1.302 . . . . 0.0 112.087 -167.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.51 124.79 24.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 0.0 109.787 176.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 53.84 56.32 7.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.122 1.369 . . . . 0.0 112.033 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.301 8.2 pt-20 58.91 3.32 0.31 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 128.957 2.903 . . . . 0.0 116.809 -176.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -109.27 126.07 52.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.0 110.661 178.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m170 -62.0 144.13 55.56 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.221 -0.924 . . . . 0.0 111.716 172.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.3 m -70.32 152.11 95.64 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.445 172.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.49 127.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.665 2.243 . . . . 0.0 110.696 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.44 -13.07 67.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.147 1.356 . . . . 0.0 115.316 -176.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.1 t -75.1 141.36 74.38 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.335 1.567 . . . . 0.0 111.713 176.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.86 146.59 81.79 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 119.613 0.898 . . . . 0.0 112.385 -3.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -99.74 139.87 34.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.686 1.594 . . . . 0.0 111.155 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 5.9 m -98.91 108.0 20.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.894 0.878 . . . . 0.0 111.048 -176.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.64 126.13 45.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.29 175.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -93.21 115.13 27.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.304 0.641 . . . . 0.0 110.425 176.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.7 t -91.5 136.57 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.803 1.641 . . . . 0.0 110.461 -177.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 8.7 m -113.53 153.77 28.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.057 1.743 . . . . 0.0 111.094 -171.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.23 137.53 23.02 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.928 0.775 . . . . 0.0 111.802 172.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 39.1 t70 . . . . . 0 CA--C 1.546 0.822 0 C-N-CA 124.087 0.955 . . . . 0.0 113.315 -178.474 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.469 0.496 0 CA-C-O 120.876 0.37 . . . . 0.0 110.27 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -67.2 122.95 85.09 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.736 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.01 150.52 60.75 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.006 2.471 . . . . 0.0 110.86 179.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . 0.4 ' CE1' HD23 ' A' 1793 ' ' LEU . 20.4 t80 -107.0 128.51 54.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.381 0.672 . . . . 0.0 111.103 178.108 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -151.76 136.37 17.01 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.328 1.451 . . . . 0.0 110.723 173.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' 1791 ' ' PHE . 0.4 OUTLIER -140.57 153.85 46.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.604 1.962 . . . . 0.0 109.724 -173.42 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -129.29 137.48 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.987 1.315 . . . . 0.0 110.363 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.47 137.55 29.26 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.166 1.787 . . . . 0.0 108.586 -173.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 52.39 4.28 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.417 3.411 . . . . 0.0 112.775 -178.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 44.2 t80 -95.68 150.05 20.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.262 1.425 . . . . 0.0 111.212 174.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 93.1 m -119.79 124.0 45.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.793 1.237 . . . . 0.0 109.897 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.3 mt -91.12 139.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.276 1.43 . . . . 0.0 109.74 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -148.69 -43.99 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -177.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 tttm -164.23 123.77 1.98 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.246 1.418 . . . . 0.0 111.601 178.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 123.74 -157.2 18.13 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.868 1.699 . . . . 0.0 111.764 -168.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -141.4 150.09 41.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.819 1.247 . . . . 0.0 111.457 -176.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.3 tt -127.68 135.24 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.718 1.607 . . . . 0.0 111.099 176.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.8 p -146.7 176.4 9.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.014 1.726 . . . . 0.0 109.953 176.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -164.99 -170.72 30.32 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 178.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -155.98 145.9 21.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.841 1.656 . . . . 0.0 110.194 -176.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 61.8 t -126.53 137.2 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.472 1.909 . . . . 0.0 108.944 178.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -116.63 131.36 56.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.666 1.586 . . . . 0.0 111.879 -173.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -102.42 148.25 35.19 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.804 1.641 . . . . 0.0 111.698 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.87 -28.6 68.69 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.283 3.322 . . . . 0.0 114.922 174.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 37.9 p -72.8 -5.95 41.52 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.492 1.517 . . . . 0.0 114.359 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.1 -5.09 81.59 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.473 1.511 . . . . 0.0 113.67 -175.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.68 159.18 32.64 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.347 1.073 . . . . 0.0 111.888 174.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.9 m -138.33 154.43 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.245 1.418 . . . . 0.0 111.384 174.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.55 171.6 19.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.396 1.879 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -117.19 141.44 28.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.651 0.781 . . . . 0.0 111.421 178.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -86.34 172.15 7.24 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.269 3.313 . . . . 0.0 111.93 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.5 m -103.01 130.69 50.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.925 1.29 . . . . 0.0 108.793 170.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.1 132.71 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 0.0 108.819 172.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.6 m -124.54 128.25 48.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.195 1.798 . . . . 0.0 109.746 -178.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.1 t0 -80.45 119.32 22.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.15 0.98 . . . . 0.0 110.276 171.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -81.73 -11.18 59.14 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.5 mmmt 72.48 -3.84 2.22 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 128.046 2.538 . . . . 0.0 114.007 -178.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -97.35 6.12 48.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.672 1.989 . . . . 0.0 113.41 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 89.52 16.02 57.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.722 1.153 . . . . 0.0 113.491 -172.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 48.5 p -130.86 159.55 37.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.611 1.965 . . . . 0.0 110.154 175.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -123.18 143.75 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.621 1.168 . . . . 0.0 109.928 168.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 24.1 m -104.74 139.86 38.92 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.729 1.212 . . . . 0.0 108.796 172.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 29.3 t -121.57 134.59 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.453 1.501 . . . . 0.0 108.664 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.78 149.22 50.38 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.078 1.351 . . . . 0.0 112.433 -173.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 29.8 t80 -150.83 131.1 13.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.418 1.487 . . . . 0.0 111.812 178.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.7 120.73 73.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.632 1.173 . . . . 0.0 110.825 176.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.06 146.17 20.02 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.71 2.94 . . . . 0.0 112.427 -170.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 84.3 p -128.4 -11.71 5.09 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 174.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -147.63 152.3 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.28 1.832 . . . . 0.0 110.487 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.45 168.17 12.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.368 1.067 . . . . 0.0 111.926 169.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.71 -173.45 14.74 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.463 1.506 . . . . 0.0 114.15 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.3 tp -82.06 114.83 20.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.695 1.198 . . . . 0.0 110.249 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 48.1 m80 -110.55 165.62 11.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 111.429 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.61 154.44 45.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.198 0.999 . . . . 0.0 111.103 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.5 ttm -138.35 137.78 37.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.846 1.658 . . . . 0.0 110.439 -171.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -121.21 121.1 37.05 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.509 1.924 . . . . 0.0 109.386 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -125.9 132.59 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.578 1.151 . . . . 0.0 110.158 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.41 136.55 26.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -172.034 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 11.6 t80 -106.13 125.16 50.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.455 1.902 . . . . 0.0 110.004 175.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 51.48 37.0 18.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.776 1.23 . . . . 0.0 112.569 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 57.0 t30 82.99 -9.42 1.09 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 129.081 2.952 . . . . 0.0 114.768 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 26.5 mmt -101.94 136.19 42.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.917 1.287 . . . . 0.0 111.819 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.22 136.42 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.59 152.65 91.67 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.178 175.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -57.41 124.34 15.9 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.085 2.523 . . . . 0.0 111.092 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 96.92 -11.28 66.12 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.933 1.254 . . . . 0.0 114.836 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.16 149.4 39.8 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 120.029 1.915 . . . . 0.0 111.099 173.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.15 162.1 92.74 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.778 1.314 . . . . 0.0 113.311 1.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.7 mt -113.42 157.15 22.28 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.179 1.792 . . . . 0.0 111.349 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.62 140.11 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.099 1.36 . . . . 0.0 109.458 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.55 163.46 17.01 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.389 1.075 . . . . 0.0 112.112 -169.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -104.29 135.11 46.37 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.188 -0.945 . . . . 0.0 113.028 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.1 t -103.17 139.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.335 1.454 . . . . 0.0 108.426 171.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.9 t0 -150.87 165.89 32.23 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.344 1.058 . . . . 0.0 111.875 -172.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -78.05 138.51 38.81 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.843 0.857 . . . . 0.0 111.536 174.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 94.8 t -72.24 -37.81 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.872 0.869 . . . . 0.0 112.643 -171.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -124.76 17.57 8.69 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -166.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 12.7 t -68.63 -26.73 65.49 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.0 -1.063 . . . . 0.0 113.125 178.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 101.39 -14.23 58.12 Favored Glycine 0 N--CA 1.476 1.34 0 C-N-CA 125.7 1.619 . . . . 0.0 115.782 166.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -66.47 158.57 29.2 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.001 1.4 . . . . 0.0 113.587 175.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 p -60.84 139.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.572 0.749 . . . . 0.0 110.137 169.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -161.54 172.23 16.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.243 1.417 . . . . 0.0 110.519 -178.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.72 144.58 24.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.542 1.137 . . . . 0.0 111.859 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.66 163.63 12.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.389 1.476 . . . . 0.0 113.156 -175.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.37 173.53 13.42 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.398 1.475 . . . . 0.0 112.717 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.66 -33.86 26.84 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.874 2.383 . . . . 0.0 112.418 -173.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.91 72.1 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.718 -1.046 . . . . 0.0 114.849 -173.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.83 -0.39 43.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.343 1.572 . . . . 0.0 113.854 174.076 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 55.4 m -108.64 -47.85 3.41 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 178.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -142.44 152.31 42.64 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.804 2.042 . . . . 0.0 112.255 -172.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -154.53 -176.07 26.4 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.474 1.035 . . . . 0.0 113.635 169.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.4 p -153.3 136.85 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.124 1.37 . . . . 0.0 108.889 177.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -58.8 145.23 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -170.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.6 m-80 68.79 1.57 3.14 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.734 2.014 . . . . 0.0 114.656 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -115.44 141.59 27.48 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.586 1.555 . . . . 0.0 110.597 176.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.1 136.81 30.3 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.661 2.24 . . . . 0.0 110.86 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.87 139.02 51.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.887 1.675 . . . . 0.0 110.182 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.2 p -131.84 147.69 52.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -165.13 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -157.68 174.98 14.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.635 1.574 . . . . 0.0 111.364 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.2 m -129.49 136.97 50.53 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.809 1.243 . . . . 0.0 110.812 -172.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.1 t -100.35 132.14 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.36 1.464 . . . . 0.0 107.811 167.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.53 130.46 49.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.789 1.236 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.0 p -135.28 11.27 3.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.293 1.837 . . . . 0.0 112.941 -170.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 58.5 tttp -52.37 -34.96 50.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.336 1.854 . . . . 0.0 115.546 -165.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.69 23.88 4.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.315 1.446 . . . . 0.0 111.934 175.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.66 -8.87 59.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.907 1.283 . . . . 0.0 114.433 -177.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 87.95 -122.16 6.18 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.669 1.128 . . . . 0.0 112.439 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.0 167.77 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.471 1.508 . . . . 0.0 112.254 -174.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 139.81 -162.69 26.27 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.625 1.583 . . . . 0.0 113.21 -178.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -84.58 109.6 3.27 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 124.082 0.848 . . . . 0.0 111.488 175.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 44.7 tp -85.15 134.46 34.17 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.612 1.165 . . . . 0.0 109.645 171.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.9 m -132.83 158.64 41.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.283 1.433 . . . . 0.0 112.338 -175.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.2 tp -161.08 134.87 6.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.393 1.877 . . . . 0.0 108.783 -169.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.08 157.3 34.31 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.978 0.911 . . . . 0.0 112.104 176.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -137.42 140.27 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.847 1.259 . . . . 0.0 109.625 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.02 143.56 50.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.639 1.576 . . . . 0.0 109.516 172.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.75 -162.99 23.03 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.99 -0.895 . . . . 0.0 114.982 -174.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -64.26 -26.86 64.05 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.126 3.217 . . . . 0.0 112.602 178.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -138.22 158.85 43.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.008 1.323 . . . . 0.0 109.253 161.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -74.6 112.78 11.13 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.895 -1.128 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.76 149.42 49.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.923 0.889 . . . . 0.0 112.123 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.3 139.89 30.09 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.523 0.729 . . . . 0.0 109.258 165.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.46 138.12 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.668 1.187 . . . . 0.0 110.469 -167.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -134.78 155.75 50.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 110.783 171.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.74 154.49 32.93 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.089 0.956 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 90.7 m -143.31 120.03 11.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.82 1.648 . . . . 0.0 109.906 -172.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -72.61 124.96 26.32 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.341 0.656 . . . . 0.0 110.109 170.188 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -86.28 -11.33 52.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -174.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 69.31 -3.3 1.61 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.27 2.628 . . . . 0.0 113.759 -175.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.49 8.29 39.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.446 1.898 . . . . 0.0 113.236 -177.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.43 18.28 36.44 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.097 1.332 . . . . 0.0 113.637 -172.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 54.1 p -142.64 157.03 45.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.673 1.589 . . . . 0.0 111.652 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 52.7 t -127.19 124.81 39.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.616 1.967 . . . . 0.0 109.009 169.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 146.64 25.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.235 1.014 . . . . 0.0 110.904 177.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.3 t -128.44 143.48 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.063 1.745 . . . . 0.0 109.778 -178.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.4 t -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.469 1.508 . . . . 0.0 110.728 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.0 p90 -144.95 153.58 41.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.185 -0.947 . . . . 0.0 113.491 175.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 3.2 mt -114.37 106.38 52.75 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.976 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.64 170.04 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.887 3.058 . . . . 0.0 110.703 167.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.5 p -148.52 -28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -173.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.05 146.18 33.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.541 1.064 . . . . 0.0 110.928 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 163.55 34.7 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.255 2.636 . . . . 0.0 111.159 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.93 -134.94 7.89 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 125.269 1.414 . . . . 0.0 111.02 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 2.2 p30 -143.91 145.36 32.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.009 0.909 . . . . 0.0 112.829 176.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -121.26 135.68 55.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.789 2.035 . . . . 0.0 109.872 -171.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -89.78 127.14 35.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.305 1.042 . . . . 0.0 110.509 174.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.4 120.67 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.66 1.584 . . . . 0.0 108.593 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -102.37 134.5 45.57 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 109.942 174.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.7 t -136.66 133.12 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.355 1.462 . . . . 0.0 108.384 171.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.39 141.69 19.57 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.015 1.326 . . . . 0.0 111.026 -170.302 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.37 125.38 18.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.662 1.185 . . . . 0.0 110.43 -178.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.76 54.3 10.09 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.056 1.343 . . . . 0.0 111.909 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.303 8.5 pt-20 57.97 15.72 3.3 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.233 2.613 . . . . 0.0 116.236 -177.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -121.99 129.81 52.77 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.577 1.151 . . . . 0.0 111.282 177.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -61.97 155.71 22.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.092 0.957 . . . . 0.0 112.722 170.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.2 m -83.14 156.4 66.7 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.272 0.629 . . . . 0.0 110.126 175.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.58 122.77 12.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.455 2.104 . . . . 0.0 110.276 176.237 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.39 -13.07 68.0 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.293 -1.281 . . . . 0.0 116.079 -179.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.4 p -80.92 152.02 71.26 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 120.262 2.031 . . . . 0.0 112.91 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.46 141.93 71.53 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.152 0.733 . . . . 0.0 111.948 -4.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.85 169.64 11.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.431 1.493 . . . . 0.0 110.669 176.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 37.4 m -132.81 117.43 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.647 0.779 . . . . 0.0 110.741 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.63 128.47 45.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.803 1.241 . . . . 0.0 110.94 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -88.85 131.67 35.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.195 0.452 . . . . 0.0 110.749 174.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -121.22 138.25 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.676 1.59 . . . . 0.0 109.788 -173.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -126.01 177.16 6.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.24 1.016 . . . . 0.0 112.801 -176.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.82 138.66 21.14 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.825 1.678 . . . . 0.0 112.51 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 30.0 t70 . . . . . 0 CA--C 1.546 0.797 0 C-N-CA 124.578 1.151 . . . . 0.0 113.558 -178.7 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.1 tp . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -61.8 121.9 67.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.949 0.9 . . . . 0.0 112.098 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.299 2.666 . . . . 0.0 111.506 -177.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.1 t80 -101.39 122.14 43.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.115 0.966 . . . . 0.0 109.635 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -148.63 131.29 15.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 110.581 171.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.23 153.84 43.23 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.381 1.872 . . . . 0.0 109.653 -170.592 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.62 137.81 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.825 1.25 . . . . 0.0 110.353 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.2 mt -131.7 136.32 28.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.303 1.841 . . . . 0.0 108.734 -172.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -77.75 69.58 7.3 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.558 3.505 . . . . 0.0 111.019 177.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -123.33 162.43 22.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.583 1.953 . . . . 0.0 110.307 175.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.8 m -139.28 130.0 26.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.906 1.282 . . . . 0.0 109.926 178.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 57.9 mt -82.17 118.2 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.18 0.992 . . . . 0.0 108.688 170.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -24.99 11.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -174.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -170.43 -24.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 178.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.79 -147.67 13.45 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.766 1.65 . . . . 0.0 113.087 -177.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.82 145.05 29.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 109.894 -176.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.74 132.61 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.279 1.432 . . . . 0.0 110.985 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -149.62 170.58 18.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.981 1.713 . . . . 0.0 110.465 -173.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.69 -167.29 20.1 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 116.301 1.281 . . . . 0.0 116.301 -175.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.52 142.59 22.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.13 1.772 . . . . 0.0 109.164 174.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.3 t -115.33 127.87 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.206 1.402 . . . . 0.0 108.379 172.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -109.69 122.53 47.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.915 1.686 . . . . 0.0 109.48 -175.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.3 mtt -93.77 150.8 39.26 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.278 1.431 . . . . 0.0 111.214 -173.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.24 -21.71 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.445 2.763 . . . . 0.0 112.774 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 14.0 m -72.84 -0.05 12.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.106 1.362 . . . . 0.0 114.47 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.15 42.96 6.45 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.698 1.142 . . . . 0.0 113.252 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -153.73 166.02 34.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.616 . . . . 0.0 111.931 -173.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 24.1 m -141.83 159.38 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.435 1.094 . . . . 0.0 113.144 -167.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.41 175.53 12.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.012 2.125 . . . . 0.0 110.617 174.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -112.39 143.45 28.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.113 -0.992 . . . . 0.0 112.31 -175.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.45 170.95 7.69 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.418 3.412 . . . . 0.0 111.767 173.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.3 m -115.27 128.49 56.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.564 1.546 . . . . 0.0 108.911 174.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.03 135.57 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.78 1.232 . . . . 0.0 109.395 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.1 m -134.29 126.79 30.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.532 1.533 . . . . 0.0 109.723 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.12 125.67 29.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.737 0.815 . . . . 0.0 110.651 172.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -82.19 -8.14 59.64 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.032 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 70.9 1.57 3.83 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.677 2.391 . . . . 0.0 113.674 -176.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.57 4.86 41.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.999 2.119 . . . . 0.0 113.039 -177.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.05 13.38 52.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.089 1.328 . . . . 0.0 114.112 -174.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 68.0 p -132.17 158.49 41.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.321 1.848 . . . . 0.0 110.999 178.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 22.3 m -115.31 141.07 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.253 1.021 . . . . 0.0 109.378 163.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 22.4 m -100.0 139.17 36.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.66 1.184 . . . . 0.0 108.444 169.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.99 133.82 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.38 1.472 . . . . 0.0 108.903 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -132.74 156.4 47.12 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.075 1.35 . . . . 0.0 112.267 -177.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.9 t80 -157.73 135.4 10.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.565 1.546 . . . . 0.0 111.625 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.86 124.53 76.87 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.188 0.995 . . . . 0.0 110.674 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -78.61 172.9 14.46 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.697 2.931 . . . . 0.0 111.73 -176.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -158.14 -39.3 0.07 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.779 0.832 . . . . 0.0 113.064 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -127.68 158.18 38.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.596 1.558 . . . . 0.0 110.767 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.23 174.99 10.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.238 1.015 . . . . 0.0 112.254 172.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.14 -177.66 22.47 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.156 1.36 . . . . 0.0 114.134 176.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 53.6 tp -73.93 117.69 16.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.327 1.051 . . . . 0.0 110.467 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 32.9 m80 -110.52 161.1 16.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.996 1.719 . . . . 0.0 110.71 178.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.2 150.09 33.11 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.7 -0.625 . . . . 0.0 112.401 175.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 30.8 ttm -128.82 139.26 52.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.139 1.776 . . . . 0.0 111.139 -168.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -108.7 137.14 47.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.194 1.798 . . . . 0.0 110.073 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.97 134.56 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.768 1.227 . . . . 0.0 110.43 175.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.92 138.94 36.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.586 1.154 . . . . 0.0 113.482 178.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 62.0 t80 -101.75 121.36 41.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.437 1.895 . . . . 0.0 109.334 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.38 32.33 13.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.836 1.254 . . . . 0.0 112.759 -175.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.5 m-80 73.87 7.28 4.9 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.798 2.439 . . . . 0.0 115.081 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.0 ttm -100.23 128.58 46.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.885 1.274 . . . . 0.0 110.269 166.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.17 136.59 57.28 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.46 -0.775 . . . . 0.0 112.762 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -74.81 156.74 86.32 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.76 174.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.08 -17.78 61.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.641 2.227 . . . . 0.0 113.204 175.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.92 7.61 65.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.643 1.116 . . . . 0.0 114.571 170.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 18.1 t -111.29 146.1 33.88 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 119.683 1.742 . . . . 0.0 111.678 178.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.37 169.45 72.81 Favored 'Cis proline' 0 C--N 1.351 0.668 0 CA-C-N 119.816 0.97 . . . . 0.0 111.76 -9.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.66 158.31 24.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.918 1.687 . . . . 0.0 110.654 171.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -148.41 152.18 36.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.334 -0.854 . . . . 0.0 111.894 171.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -165.97 154.28 10.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.914 1.286 . . . . 0.0 111.244 -175.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.3 t80 -94.67 129.39 41.57 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.483 -0.76 . . . . 0.0 112.301 177.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.6 t -95.1 134.25 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.989 1.316 . . . . 0.0 109.214 174.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -149.77 158.29 44.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.514 1.525 . . . . 0.0 110.146 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -67.65 160.49 27.84 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 63.4 t -65.09 -39.49 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.557 0.743 . . . . 0.0 111.046 179.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 p30 -90.46 155.73 18.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.238 1.015 . . . . 0.0 111.57 165.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 25.1 p -161.79 156.17 22.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.763 1.225 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -112.72 30.27 7.6 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 126.182 1.848 . . . . 0.0 113.094 178.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -165.19 162.84 20.25 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.342 1.457 . . . . 0.0 113.091 -165.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.3 p -66.75 140.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 0.0 110.015 167.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -156.58 162.48 39.89 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.874 1.27 . . . . 0.0 111.022 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.14 144.76 36.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.744 1.218 . . . . 0.0 112.042 -177.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 44.7 p90 -165.24 161.24 19.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.785 1.634 . . . . 0.0 112.527 -176.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.7 174.42 13.54 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.302 1.429 . . . . 0.0 113.369 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.17 -33.12 9.78 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.107 2.538 . . . . 0.0 113.447 -171.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.62 -36.69 88.43 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 119.523 1.056 . . . . 0.0 114.175 -171.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.16 -9.1 58.24 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.916 1.358 . . . . 0.0 113.215 176.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 29.1 m -98.45 -49.85 4.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.348 1.859 . . . . 0.0 111.089 177.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -143.11 146.03 33.39 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.511 1.924 . . . . 0.0 112.881 -174.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.16 178.61 21.28 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.485 1.517 . . . . 0.0 113.32 171.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.3 p -149.63 136.29 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.778 1.231 . . . . 0.0 109.37 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -58.21 144.01 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.1 m-80 67.8 7.44 5.73 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.737 2.015 . . . . 0.0 114.773 174.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 95.1 mttt -125.99 146.47 55.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.679 1.592 . . . . 0.0 110.877 174.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 135.68 25.72 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.78 2.32 . . . . 0.0 111.188 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.16 137.83 51.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 109.99 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.0 p -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -165.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -161.56 177.69 9.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.393 1.877 . . . . 0.0 111.26 178.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 45.6 m -130.82 142.01 50.37 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.669 1.187 . . . . 0.0 110.761 -170.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.3 t -112.82 128.46 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.194 1.398 . . . . 0.0 107.976 169.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -94.27 126.07 39.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.664 1.186 . . . . 0.0 110.084 176.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.8 p -127.88 0.19 5.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.053 1.741 . . . . 0.0 113.57 -167.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 63.0 tttp -51.07 -38.69 53.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.134 1.774 . . . . 0.0 114.729 -171.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.47 9.58 18.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.517 1.527 . . . . 0.0 113.183 -178.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.33 62.79 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -172.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.73 147.23 5.88 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.908 1.242 . . . . 0.0 112.525 -172.055 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.84 148.29 36.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.252 1.021 . . . . 0.0 112.397 -177.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 177.22 -45.34 0.1 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.991 1.281 . . . . 0.0 113.715 175.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 165.03 106.45 0.19 Allowed Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.919 1.247 . . . . 0.0 112.729 171.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.92 130.32 34.91 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.076 1.35 . . . . 0.0 109.423 175.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.9 m -127.87 156.37 42.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.547 1.539 . . . . 0.0 112.159 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . 0.411 HD21 HG13 ' A' 1922 ' ' VAL . 38.5 tp -155.81 135.22 12.37 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.476 1.91 . . . . 0.0 108.663 -175.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -154.36 155.31 34.82 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.146 0.978 . . . . 0.0 112.031 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.6 mt -137.04 133.18 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.489 1.116 . . . . 0.0 110.374 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -115.85 160.85 19.62 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.261 1.824 . . . . 0.0 109.657 170.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.57 -163.35 34.62 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.047 -1.033 . . . . 0.0 114.695 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.73 -24.49 61.96 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.886 3.057 . . . . 0.0 112.278 175.109 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -140.79 159.65 41.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.431 1.492 . . . . 0.0 108.939 164.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 tptt -74.06 113.61 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.846 -1.158 . . . . 0.0 110.6 176.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.31 145.86 52.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 0.0 111.411 174.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.2 143.55 28.7 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 109.808 169.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 99.7 mt -128.78 144.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 110.887 -167.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 14.5 t -139.38 156.16 47.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 164.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 26.7 p -157.56 150.46 23.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.603 1.161 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.8 m -140.55 118.43 11.79 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 110.018 -169.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 14.0 t0 -67.43 118.38 10.69 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.785 0.834 . . . . 0.0 109.785 166.152 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -80.79 -13.37 59.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.69 0.796 . . . . 0.0 112.775 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 73.68 -7.96 1.48 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 128.5 2.72 . . . . 0.0 113.455 -179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -88.6 8.43 28.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.478 1.911 . . . . 0.0 113.372 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.25 18.33 39.68 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.058 1.313 . . . . 0.0 113.694 -171.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.8 p -139.54 155.4 47.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.545 1.538 . . . . 0.0 111.181 176.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 43.5 t -124.33 128.9 49.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.532 1.933 . . . . 0.0 109.244 170.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.6 t -89.62 145.76 25.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.306 1.043 . . . . 0.0 110.643 174.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . 0.411 HG13 HD21 ' A' 1900 ' ' LEU . 84.1 t -126.83 143.3 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.933 1.693 . . . . 0.0 109.709 -177.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.8 t -138.3 141.32 39.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.603 1.561 . . . . 0.0 110.685 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -144.21 153.2 41.83 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.152 -0.967 . . . . 0.0 113.586 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 57.5 tp -119.35 103.09 47.51 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.705 1.602 . . . . 0.0 110.085 -176.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.71 172.72 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.85 3.034 . . . . 0.0 110.88 170.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.1 p -146.76 -30.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.8 mt -107.59 146.86 34.21 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.331 1.052 . . . . 0.0 110.902 167.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.78 160.69 43.17 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.142 2.561 . . . . 0.0 110.9 173.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 138.19 -132.61 5.91 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.444 1.021 . . . . 0.0 112.309 -175.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.84 135.94 30.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.133 1.373 . . . . 0.0 111.562 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.66 134.55 54.98 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.872 1.669 . . . . 0.0 110.423 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 31.9 m -91.54 121.32 33.13 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.22 126.04 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.93 1.692 . . . . 0.0 108.356 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.22 130.17 55.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.353 1.461 . . . . 0.0 109.298 175.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.9 t -132.11 130.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.33 1.052 . . . . 0.0 109.534 173.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.57 142.72 22.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.957 1.303 . . . . 0.0 111.804 -167.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.18 120.66 18.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.809 1.243 . . . . 0.0 109.733 178.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 54.57 58.18 5.11 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.358 1.463 . . . . 0.0 112.133 177.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 58.62 9.33 1.09 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.571 2.748 . . . . 0.0 116.542 -177.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -115.88 124.97 51.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.487 1.115 . . . . 0.0 110.801 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.87 145.69 54.52 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.379 -0.825 . . . . 0.0 111.984 172.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.6 m -72.26 156.87 90.13 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.142 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.64 125.75 18.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.697 2.932 . . . . 0.0 112.475 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.51 -12.42 63.13 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.919 1.247 . . . . 0.0 115.664 -179.061 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.6 t -74.67 142.02 76.72 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-N 119.449 1.625 . . . . 0.0 111.641 177.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.88 142.94 75.33 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.297 0.785 . . . . 0.0 112.24 -3.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -97.15 168.87 10.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.577 1.951 . . . . 0.0 110.803 175.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 90.0 m -126.51 122.03 34.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.962 0.905 . . . . 0.0 111.251 172.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.49 132.68 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.044 1.338 . . . . 0.0 110.874 173.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -84.53 124.43 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.307 0.643 . . . . 0.0 109.435 173.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.89 133.62 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.757 0.823 . . . . 0.0 110.304 -178.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.0 p -110.76 161.6 15.61 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.427 1.491 . . . . 0.0 112.686 -174.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.24 136.41 16.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.537 1.065 . . . . 0.0 110.95 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 CA--C 1.547 0.85 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.386 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 60.3 mt . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.69 121.61 76.3 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.497 1.119 . . . . 0.0 110.676 -178.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.61 151.24 64.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.287 2.658 . . . . 0.0 111.632 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.4 t80 -106.79 121.97 45.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.896 0.878 . . . . 0.0 110.87 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.89 133.19 14.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.335 1.454 . . . . 0.0 110.367 170.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.75 134.74 25.46 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.379 1.471 . . . . 0.0 109.993 -167.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 11.2 p -103.72 139.94 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.931 1.292 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -134.89 137.9 28.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.584 1.953 . . . . 0.0 108.333 -177.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.02 23.76 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.236 3.291 . . . . 0.0 114.199 -178.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.1 t80 -72.75 153.15 41.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.563 1.145 . . . . 0.0 111.405 174.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 96.2 m -123.82 126.88 47.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.351 1.46 . . . . 0.0 110.225 -177.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.48 131.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.397 1.079 . . . . 0.0 109.642 172.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.46 -64.03 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.317 1.047 . . . . 0.0 112.71 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.97 124.62 4.35 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.543 1.537 . . . . 0.0 110.888 179.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.38 -144.6 16.58 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.567 1.556 . . . . 0.0 111.308 -166.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.09 143.8 17.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.515 1.126 . . . . 0.0 110.949 -176.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.4 tt -119.09 138.41 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.3 1.44 . . . . 0.0 111.257 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.16 166.01 30.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.884 1.674 . . . . 0.0 110.736 -178.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.17 -172.47 19.54 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 -177.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -151.18 138.76 19.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.231 1.812 . . . . 0.0 109.31 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 4.7 t -110.7 137.88 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.094 1.758 . . . . 0.0 108.218 174.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 53.1 mtp85 -129.18 118.62 22.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.769 1.627 . . . . 0.0 110.094 -171.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.8 mpp? -91.78 153.31 43.72 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.571 1.548 . . . . 0.0 111.265 -175.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.9 -19.2 46.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.385 2.723 . . . . 0.0 113.4 178.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 44.8 p -73.96 -8.49 56.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.381 1.473 . . . . 0.0 114.134 171.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.2 -4.95 81.25 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.512 1.53 . . . . 0.0 113.979 -174.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -68.48 160.02 30.58 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.531 1.166 . . . . 0.0 111.885 173.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.9 m -140.29 156.7 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.634 1.173 . . . . 0.0 112.427 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.54 -173.03 4.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.418 2.287 . . . . 0.0 110.059 178.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -130.79 143.86 51.09 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.843 -1.161 . . . . 0.0 111.395 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -84.74 167.07 11.54 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.945 3.097 . . . . 0.0 111.507 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.1 m -104.44 133.07 49.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.355 1.462 . . . . 0.0 108.726 170.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.13 135.19 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.157 0.983 . . . . 0.0 109.642 176.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -130.82 127.52 38.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.775 1.63 . . . . 0.0 109.389 178.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.31 127.96 33.74 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.261 0.624 . . . . 0.0 110.314 170.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -82.81 -5.58 59.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 69.91 4.62 4.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.59 2.356 . . . . 0.0 114.044 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.66 7.54 30.63 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.004 2.122 . . . . 0.0 112.795 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.56 20.18 41.88 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.853 1.216 . . . . 0.0 113.945 -175.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 36.9 p -135.77 160.13 39.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.231 1.812 . . . . 0.0 110.301 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.4 m -120.37 148.02 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.515 1.126 . . . . 0.0 110.17 168.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.2 m -111.36 133.72 53.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.523 1.129 . . . . 0.0 108.897 169.115 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.2 t -110.17 134.15 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.846 1.658 . . . . 0.0 108.587 176.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -134.19 152.24 51.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.265 1.426 . . . . 0.0 112.367 -169.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.7 t80 -159.52 133.92 7.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.448 1.499 . . . . 0.0 112.125 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.84 119.4 71.15 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.53 1.132 . . . . 0.0 110.563 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.03 139.81 19.55 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.501 2.801 . . . . 0.0 112.686 -170.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 52.2 m -123.02 -7.51 8.35 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 174.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -140.37 157.62 45.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.828 1.651 . . . . 0.0 110.68 -177.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.3 170.57 9.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.73 1.212 . . . . 0.0 111.688 168.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.66 -170.42 19.16 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.214 1.388 . . . . 0.0 113.781 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -83.53 119.29 24.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.432 1.093 . . . . 0.0 110.117 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 24.2 m80 -107.57 156.3 19.17 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.115 1.766 . . . . 0.0 111.759 -177.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -124.27 149.71 46.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.069 1.748 . . . . 0.0 109.059 175.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 15.7 tmm? -153.12 136.01 15.44 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 111.901 -175.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.5 1.92 . . . . 0.0 111.702 -172.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.4 mm -136.66 135.38 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.444 1.498 . . . . 0.0 110.803 175.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 142.83 30.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.211 1.004 . . . . 0.0 113.622 178.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.3 t80 -107.39 122.41 46.54 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.952 2.101 . . . . 0.0 110.208 177.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 52.12 32.17 10.07 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.528 1.131 . . . . 0.0 112.485 -172.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 20.3 t30 77.14 3.9 3.26 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.426 2.69 . . . . 0.0 115.149 -178.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.35 128.84 47.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.659 1.583 . . . . 0.0 110.809 174.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -59.14 137.3 58.01 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 113.582 -177.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.25 155.45 87.98 Favored Pre-proline 0 N--CA 1.48 1.034 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.459 172.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.42 -13.64 40.76 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.485 2.124 . . . . 0.0 113.762 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -89.45 9.32 77.45 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.008 1.29 . . . . 0.0 114.672 170.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 29.5 t -116.32 148.22 41.19 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.533 1.667 . . . . 0.0 111.698 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.02 165.87 77.93 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 119.931 1.011 . . . . 0.0 112.135 -6.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 65.5 mt -113.97 158.8 20.67 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.319 1.848 . . . . 0.0 110.92 172.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.79 146.97 19.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.766 1.226 . . . . 0.0 110.954 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 3.8 p90 -170.96 163.52 7.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.914 1.285 . . . . 0.0 111.784 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -98.45 138.61 35.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.246 -0.909 . . . . 0.0 112.967 177.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 45.0 t -111.75 135.54 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.701 1.6 . . . . 0.0 109.451 174.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -146.38 164.1 33.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.307 1.843 . . . . 0.0 111.715 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -80.71 155.32 26.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.633 0.773 . . . . 0.0 112.862 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 25.1 m -66.17 -16.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.344 -0.847 . . . . 0.0 112.309 165.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -74.49 -19.7 60.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.909 1.684 . . . . 0.0 114.194 178.298 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 92.6 m -62.41 130.61 46.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.859 1.264 . . . . 0.0 113.551 -170.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.31 -18.17 22.37 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.2 1.381 . . . . 0.0 114.12 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -68.45 160.3 30.0 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.294 1.047 . . . . 0.0 113.51 176.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 40.0 t -63.75 128.5 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 157.1 44.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.691 1.196 . . . . 0.0 110.596 -172.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.69 144.3 37.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 -176.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -166.83 172.24 10.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 0.0 112.375 -173.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 118.27 172.29 15.58 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.266 1.412 . . . . 0.0 112.622 -177.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.71 -35.01 17.42 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.789 2.326 . . . . 0.0 112.704 -170.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -64.14 -38.6 96.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.398 0.999 . . . . 0.0 114.668 -171.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -77.01 -7.16 55.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.055 1.428 . . . . 0.0 113.761 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.3 m -100.91 -40.27 7.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.385 1.874 . . . . 0.0 111.071 176.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -153.73 141.08 19.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.38 1.872 . . . . 0.0 112.189 -167.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -135.5 177.0 19.77 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.529 1.538 . . . . 0.0 112.17 173.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.0 t -141.86 135.67 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.132 0.973 . . . . 0.0 108.85 174.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.9 m -55.97 135.85 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.302 0.641 . . . . 0.0 112.576 -177.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 58.3 m-80 67.71 1.17 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.95 2.1 . . . . 0.0 114.89 174.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -121.22 143.46 37.37 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 125.468 1.507 . . . . 0.0 111.038 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.53 133.04 19.9 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.523 2.149 . . . . 0.0 111.309 -173.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -113.08 146.42 39.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.66 1.584 . . . . 0.0 110.116 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.7 p -137.12 145.33 43.72 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -154.46 175.38 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.266 1.426 . . . . 0.0 111.948 177.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 29.9 m -130.94 144.27 51.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.25 1.42 . . . . 0.0 110.759 -169.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.2 t -121.36 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.674 1.59 . . . . 0.0 108.704 170.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.54 124.38 43.26 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.56 1.144 . . . . 0.0 111.307 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 34.5 p -124.99 12.28 8.36 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.808 2.043 . . . . 0.0 112.318 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.29 -36.43 66.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.615 1.566 . . . . 0.0 114.564 -170.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.74 12.62 19.67 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.729 1.612 . . . . 0.0 112.741 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.95 60.83 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 -84.45 1.57 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.052 1.311 . . . . 0.0 111.91 178.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -159.56 148.4 17.86 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.434 1.493 . . . . 0.0 110.634 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 156.19 -152.46 23.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.392 1.473 . . . . 0.0 111.661 -174.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -147.68 144.97 13.1 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.81 1.195 . . . . 0.0 112.377 176.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.33 141.35 28.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.198 1.399 . . . . 0.0 111.12 176.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 12.3 t -125.69 160.13 30.5 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.961 1.705 . . . . 0.0 110.816 166.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.3 tp -163.06 136.23 5.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.928 1.691 . . . . 0.0 109.491 -162.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.41 160.84 35.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.36 1.064 . . . . 0.0 111.954 175.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.4 mt -132.87 137.83 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.723 1.209 . . . . 0.0 109.518 173.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -129.12 119.48 24.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.171 1.388 . . . . 0.0 109.517 174.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -136.88 -173.26 12.83 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.92 1.248 . . . . 0.0 113.911 -177.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.04 -21.07 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.958 3.105 . . . . 0.0 112.257 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -136.22 157.1 47.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.344 1.458 . . . . 0.0 109.0 158.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.0 tptt -76.03 122.48 24.28 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.796 -1.19 . . . . 0.0 111.862 -176.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.94 150.08 35.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.037 0.935 . . . . 0.0 112.082 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -86.19 142.81 28.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.798 0.839 . . . . 0.0 109.314 166.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.87 144.16 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.441 1.096 . . . . 0.0 110.626 -167.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.3 t -146.81 168.13 22.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.036 1.334 . . . . 0.0 111.461 168.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -161.32 158.48 27.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 112.965 -177.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.9 m -143.8 129.02 18.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.8 1.64 . . . . 0.0 110.446 -172.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.63 128.69 34.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.82 1.248 . . . . 0.0 111.09 170.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -98.72 149.73 22.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 111.732 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -67.48 -16.37 64.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.766 0.826 . . . . 0.0 112.661 174.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.13 -7.72 52.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.435 1.494 . . . . 0.0 113.85 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.17 27.06 19.68 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.783 1.182 . . . . 0.0 114.464 176.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.5 p -130.82 156.46 44.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.777 1.631 . . . . 0.0 110.589 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.1 m -106.89 128.0 53.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.626 1.171 . . . . 0.0 109.921 171.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.7 t -94.72 149.57 21.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.147 0.979 . . . . 0.0 110.375 169.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.4 t -131.36 144.56 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.097 1.759 . . . . 0.0 109.63 -176.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.7 p -135.51 149.95 49.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.893 1.277 . . . . 0.0 111.987 170.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.72 155.7 37.73 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 176.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.9 mt -122.72 106.65 34.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.641 1.976 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.09 170.17 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 124.065 3.177 . . . . 0.0 110.488 167.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -131.4 -20.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -170.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.93 151.28 48.72 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.701 1.201 . . . . 0.0 110.769 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.5 152.29 38.34 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.826 2.351 . . . . 0.0 112.366 -170.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.3 -152.46 24.34 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.502 1.049 . . . . 0.0 112.883 -177.199 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.32 130.33 56.67 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.829 1.652 . . . . 0.0 111.627 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -122.35 129.41 52.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.715 1.606 . . . . 0.0 110.015 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -86.7 127.76 34.98 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.09 -1.006 . . . . 0.0 111.159 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.15 121.8 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 108.666 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -98.1 134.79 40.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.107 1.363 . . . . 0.0 109.979 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 91.4 t -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.442 1.497 . . . . 0.0 108.416 171.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -151.6 133.98 15.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.818 1.247 . . . . 0.0 110.93 -172.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -133.42 133.63 42.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.825 1.25 . . . . 0.0 111.151 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.8 t-20 49.16 53.36 12.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.77 1.228 . . . . 0.0 112.406 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.31 8.8 pt-20 58.49 18.18 5.48 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.016 2.526 . . . . 0.0 116.305 -177.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -127.78 131.53 49.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.618 1.167 . . . . 0.0 111.88 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -63.02 157.03 23.0 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.268 -0.895 . . . . 0.0 112.486 168.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.8 m -88.52 155.13 51.2 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.499 0.72 . . . . 0.0 110.314 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.6 123.1 12.61 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.237 1.958 . . . . 0.0 110.051 175.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.48 -13.48 65.47 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.141 1.353 . . . . 0.0 115.633 -177.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 87.0 p -82.56 150.68 63.66 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.343 2.071 . . . . 0.0 112.87 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.91 140.96 67.21 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.218 0.757 . . . . 0.0 111.791 -4.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -86.84 170.17 11.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 110.406 175.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 35.0 m -132.65 117.92 18.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 176.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.7 134.25 38.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 111.641 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -86.75 113.86 22.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.271 1.028 . . . . 0.0 109.944 174.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.6 t -92.17 124.56 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.581 0.752 . . . . 0.0 110.173 178.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 82.9 m -92.44 142.83 27.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.657 1.983 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.61 17.26 11.13 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.046 1.308 . . . . 0.0 115.347 -176.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.5 t70 . . . . . 0 CA--C 1.553 1.092 0 C-N-CA 127.559 2.344 . . . . 0.0 113.659 -178.028 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 89.6 mt . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 121.393 0.616 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.6 ttm180 -57.32 116.08 12.63 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.852 1.661 . . . . 0.0 110.829 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.47 137.22 32.91 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.705 2.27 . . . . 0.0 109.334 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.8 t80 -102.81 121.61 42.83 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.506 0.669 . . . . 0.0 111.047 -176.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.66 138.72 21.19 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.657 1.583 . . . . 0.0 110.104 171.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.56 140.52 30.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.208 1.403 . . . . 0.0 109.83 -172.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 86.0 t -102.88 134.76 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 109.331 176.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.72 135.73 27.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.64 109.48 2.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.32 2.68 . . . . 0.0 109.876 173.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -174.51 149.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.275 2.23 . . . . 0.0 109.098 -172.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.0 m -126.96 124.43 39.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.16 0.984 . . . . 0.0 109.927 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.1 mt -87.01 120.94 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.692 1.197 . . . . 0.0 109.144 174.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.81 -101.86 0.4 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.825 1.25 . . . . 0.0 110.492 176.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 68.0 mttm -119.63 132.17 55.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.082 1.353 . . . . 0.0 111.249 174.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.04 -144.83 16.21 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.922 1.725 . . . . 0.0 111.186 -167.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -159.6 151.02 19.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.469 1.107 . . . . 0.0 111.082 -177.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.7 tt -141.25 130.98 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.098 1.359 . . . . 0.0 111.477 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 82.7 p -144.45 178.64 7.8 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.771 1.628 . . . . 0.0 110.382 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.53 -164.83 22.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -154.66 145.22 22.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.564 1.546 . . . . 0.0 110.113 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.4 t -128.66 134.24 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.954 1.701 . . . . 0.0 108.574 174.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -118.74 141.86 48.22 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.278 1.031 . . . . 0.0 112.158 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 1.5 mtm -103.04 147.36 34.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.036 1.734 . . . . 0.0 111.317 178.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.66 -26.88 67.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.007 3.138 . . . . 0.0 115.008 175.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.6 p -73.34 -3.6 28.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.983 1.713 . . . . 0.0 114.524 178.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.73 -4.36 75.63 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.508 1.528 . . . . 0.0 114.058 -179.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -69.04 152.58 45.04 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.732 1.213 . . . . 0.0 111.964 171.799 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 47.9 t -142.49 141.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.829 1.652 . . . . 0.0 109.673 -176.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -153.06 -179.7 7.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.077 1.751 . . . . 0.0 110.955 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -123.8 144.63 45.25 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.875 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.5 167.09 13.6 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.276 3.317 . . . . 0.0 111.513 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.3 m -110.86 127.13 55.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.482 1.513 . . . . 0.0 108.981 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -108.6 133.5 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 109.345 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 69.8 m -136.09 137.77 41.39 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.736 1.614 . . . . 0.0 109.494 177.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.6 129.47 34.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.287 0.635 . . . . 0.0 110.896 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -76.75 -8.11 56.67 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 71.49 13.01 6.51 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.895 2.478 . . . . 0.0 113.334 -179.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.62 9.88 10.92 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.074 2.15 . . . . 0.0 112.783 -176.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.63 12.7 59.17 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.043 1.306 . . . . 0.0 114.367 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.1 p -131.02 158.39 40.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.616 1.967 . . . . 0.0 109.991 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.9 m -111.99 151.7 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.939 0.896 . . . . 0.0 110.292 168.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 139.14 38.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 163.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.0 t -120.6 127.51 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.121 1.368 . . . . 0.0 108.466 173.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -130.49 153.35 48.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.504 1.521 . . . . 0.0 111.815 -166.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 43.5 t80 -159.67 137.0 9.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.748 1.219 . . . . 0.0 112.219 -174.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.13 119.85 69.25 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.532 1.133 . . . . 0.0 110.808 176.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.67 154.06 26.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.522 2.814 . . . . 0.0 111.608 -179.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 86.6 p -133.16 -9.78 2.96 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -168.88 145.52 3.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.479 1.512 . . . . 0.0 110.39 -168.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -76.41 167.63 21.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.286 1.034 . . . . 0.0 113.379 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 124.86 -178.25 16.58 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.537 1.541 . . . . 0.0 114.266 176.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.4 tp -82.17 127.17 32.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.008 1.323 . . . . 0.0 109.986 177.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.6 m80 -124.67 153.22 42.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.094 1.358 . . . . 0.0 111.655 -172.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.68 139.95 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.407 1.483 . . . . 0.0 109.882 178.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 20.3 ttm -118.51 133.37 55.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.353 1.861 . . . . 0.0 110.645 178.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -107.42 134.69 50.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.927 2.091 . . . . 0.0 109.753 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.1 mm -134.89 139.31 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.877 1.271 . . . . 0.0 110.996 176.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.8 135.07 20.55 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 113.518 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.9 t80 -99.62 123.12 43.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.061 1.744 . . . . 0.0 109.933 173.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 50.87 36.19 14.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.356 1.462 . . . . 0.0 112.829 -176.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.2 t30 79.3 0.05 2.29 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 128.305 2.642 . . . . 0.0 114.74 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -103.41 134.44 46.78 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.27 1.428 . . . . 0.0 111.007 175.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.7 m170 -54.14 136.95 41.61 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -76.33 154.46 84.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.989 166.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.57 -23.39 70.47 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.389 2.059 . . . . 0.0 113.28 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -81.07 3.85 74.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.39 0.995 . . . . 0.0 114.686 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.1 t -99.82 147.12 32.99 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.616 1.708 . . . . 0.0 111.8 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.14 170.12 71.17 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 CA-C-N 119.785 0.959 . . . . 0.0 111.498 -11.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.59 158.27 24.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.106 1.363 . . . . 0.0 110.846 169.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -148.03 139.94 24.0 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.589 1.156 . . . . 0.0 110.366 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -164.49 173.4 12.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 0.0 111.796 -173.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -114.67 135.78 53.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.985 0.914 . . . . 0.0 113.248 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 57.9 t -102.36 138.56 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.867 1.667 . . . . 0.0 108.973 174.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.5 t0 -160.99 166.5 28.17 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.915 1.286 . . . . 0.0 111.091 178.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.12 123.62 23.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.716 0.807 . . . . 0.0 111.267 174.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -70.98 -25.58 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.166 0.986 . . . . 0.0 113.361 -167.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -95.7 -2.79 47.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.198 1.399 . . . . 0.0 113.639 -177.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 4.3 t -69.81 150.36 46.94 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.184 -0.948 . . . . 0.0 113.501 -170.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -87.09 74.84 2.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.48 1.514 . . . . 0.0 113.278 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -169.96 166.87 9.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.007 2.123 . . . . 0.0 112.335 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -71.47 132.65 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.801 1.241 . . . . 0.0 109.605 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 81.9 p -138.69 164.12 30.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.939 1.296 . . . . 0.0 110.991 176.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.88 143.76 36.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.497 1.119 . . . . 0.0 111.274 171.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.7 p90 -169.36 164.6 10.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.773 1.629 . . . . 0.0 112.736 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.54 175.1 13.72 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.329 1.442 . . . . 0.0 112.695 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.94 -37.94 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.648 2.232 . . . . 0.0 112.374 -172.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.15 -36.95 93.54 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 119.534 1.061 . . . . 0.0 114.556 -171.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.59 -4.38 45.55 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.929 1.364 . . . . 0.0 113.648 176.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.3 m -104.9 -49.59 3.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.038 1.735 . . . . 0.0 110.506 176.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -142.49 131.86 23.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.5 1.92 . . . . 0.0 112.724 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -125.19 177.78 16.8 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.218 1.866 . . . . 0.0 112.431 171.117 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 46.3 t -142.05 134.6 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.654 1.182 . . . . 0.0 108.826 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.7 m -58.21 138.99 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 62.91 9.8 3.94 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.046 1.738 . . . . 0.0 114.635 176.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -120.89 141.3 32.32 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.79 129.37 15.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.578 2.185 . . . . 0.0 110.616 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.78 144.22 36.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.634 1.574 . . . . 0.0 110.185 174.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.0 p -135.6 147.33 48.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -166.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.69 178.06 10.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.632 1.573 . . . . 0.0 111.488 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.8 m -128.9 144.03 51.06 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.407 1.483 . . . . 0.0 110.768 -170.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 50.8 t -117.73 132.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.852 1.661 . . . . 0.0 108.158 169.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.48 129.57 38.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.932 0.893 . . . . 0.0 111.184 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -127.95 0.9 5.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.021 1.728 . . . . 0.0 113.349 -172.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.84 -41.78 62.06 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.042 1.737 . . . . 0.0 114.022 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.83 -3.89 34.44 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.27 1.428 . . . . 0.0 113.38 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.49 65.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.151 0.98 . . . . 0.0 113.611 -173.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.42 -88.62 1.11 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.744 1.164 . . . . 0.0 112.369 177.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.76 149.07 19.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.572 1.549 . . . . 0.0 110.954 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 163.54 -151.49 21.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.06 1.791 . . . . 0.0 111.519 -177.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -111.27 107.58 2.2 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.422 1.01 . . . . 0.0 111.402 172.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 55.6 tp -81.33 136.47 35.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.411 1.084 . . . . 0.0 109.864 172.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.2 m -136.67 156.18 48.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 0.0 111.768 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.0 tp -159.91 131.89 6.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 108.8 -168.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.23 34.59 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.786 0.834 . . . . 0.0 112.4 -179.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.39 137.43 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.016 1.326 . . . . 0.0 109.871 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -125.06 157.5 36.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.385 1.874 . . . . 0.0 109.807 171.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.71 -161.73 29.83 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.658 -178.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.4 -25.23 63.7 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.009 3.14 . . . . 0.0 112.68 177.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.4 t -140.45 159.95 41.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.041 1.336 . . . . 0.0 109.444 162.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.9 tptt -76.94 107.05 9.0 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.983 -1.073 . . . . 0.0 111.233 -178.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.81 147.01 53.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.024 0.93 . . . . 0.0 111.723 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.83 148.42 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.627 0.771 . . . . 0.0 110.674 168.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.0 mt -137.62 145.38 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.074 1.35 . . . . 0.0 110.181 -164.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -143.08 167.17 22.71 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.054 1.342 . . . . 0.0 111.016 166.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.8 156.03 28.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 0.0 112.594 -178.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 89.1 m -143.08 124.99 15.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.676 1.59 . . . . 0.0 109.922 -171.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 20.3 t0 -74.3 120.95 20.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.916 0.886 . . . . 0.0 109.839 170.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -83.48 -7.32 59.56 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.151 0.98 . . . . 0.0 113.455 -176.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 74.72 -17.51 0.48 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.07 2.948 . . . . 0.0 113.908 178.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -81.36 -3.88 54.05 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.853 1.661 . . . . 0.0 113.913 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 105.21 22.5 8.21 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.446 1.498 . . . . 0.0 114.07 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.9 p -138.94 154.63 48.34 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.613 172.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 93.9 m -115.04 131.56 56.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.858 1.663 . . . . 0.0 109.137 165.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -86.38 149.24 25.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.823 0.849 . . . . 0.0 110.304 168.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.5 t -127.01 142.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.426 1.89 . . . . 0.0 109.076 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 81.6 p -131.86 146.14 51.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.724 1.21 . . . . 0.0 111.442 167.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.44 157.05 42.96 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.077 -1.014 . . . . 0.0 113.118 175.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 43.4 tp -126.41 102.2 26.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.839 1.255 . . . . 0.0 110.492 -174.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.87 174.29 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.746 2.964 . . . . 0.0 110.61 170.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -148.44 -30.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.48 145.34 31.07 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.657 1.117 . . . . 0.0 110.776 167.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.56 164.81 31.67 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.273 2.649 . . . . 0.0 111.339 177.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.24 -124.48 3.93 Favored Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.909 1.242 . . . . 0.0 111.86 -175.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -147.76 144.78 28.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.359 1.464 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.18 143.22 51.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.445 1.898 . . . . 0.0 110.863 -172.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 60.4 m -96.1 123.7 39.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.717 1.207 . . . . 0.0 110.429 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.27 124.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.609 1.564 . . . . 0.0 108.464 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.98 131.87 54.65 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 109.908 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 42.6 t -133.58 127.85 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.465 1.106 . . . . 0.0 109.74 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.3 142.68 26.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.16 1.384 . . . . 0.0 111.397 -169.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.92 121.34 12.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.54 1.136 . . . . 0.0 110.025 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 59.59 56.08 3.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.584 1.554 . . . . 0.0 111.55 178.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.286 10.5 pt-20 54.19 23.59 4.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.796 2.438 . . . . 0.0 115.645 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -133.29 128.67 36.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.115 1.366 . . . . 0.0 110.432 177.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -65.01 148.04 52.38 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.448 -0.783 . . . . 0.0 112.022 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 15.2 m -70.21 152.43 95.68 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.879 168.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.22 128.01 24.94 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.683 2.255 . . . . 0.0 110.402 177.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.96 62.28 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.175 1.369 . . . . 0.0 115.045 -174.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.7 t -78.49 140.71 60.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.281 1.54 . . . . 0.0 111.5 175.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.71 137.39 49.97 Favored 'Cis proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.401 0.822 . . . . 0.0 111.963 -4.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -87.71 165.69 15.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.107 1.763 . . . . 0.0 110.66 175.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 88.7 m -123.84 119.22 29.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.885 0.874 . . . . 0.0 110.255 174.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.61 135.56 39.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.809 1.243 . . . . 0.0 110.921 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.6 tpt85 -80.2 141.41 35.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.818 0.847 . . . . 0.0 109.259 167.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.8 t -129.41 132.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.78 1.173 . . . . 0.0 110.926 176.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 27.6 p -111.49 159.55 17.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.251 1.42 . . . . 0.0 112.843 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.04 128.72 9.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.703 1.621 . . . . 0.0 112.57 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 125.222 1.409 . . . . 0.0 113.42 176.645 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -52.0 112.96 3.67 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.787 1.235 . . . . 0.0 112.313 -172.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.63 148.76 33.33 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.693 2.262 . . . . 0.0 110.811 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.48 122.49 32.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.182 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -148.45 147.13 28.8 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.904 1.282 . . . . 0.0 111.057 168.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.93 154.8 20.28 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.38 1.472 . . . . 0.0 110.503 -175.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 10.6 p -127.4 134.42 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.627 1.571 . . . . 0.0 109.615 172.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.0 mt -132.58 137.63 30.25 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.789 1.636 . . . . 0.0 109.334 -171.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.4 84.73 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.895 3.063 . . . . 0.0 110.883 177.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -134.16 151.16 51.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.509 1.923 . . . . 0.0 109.625 173.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 80.7 m -126.37 123.86 38.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 109.488 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.88 129.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.704 1.201 . . . . 0.0 109.904 178.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -105.69 -139.12 0.37 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.961 1.304 . . . . 0.0 110.643 175.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -75.94 -6.21 49.84 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -178.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.93 -149.18 10.58 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.922 1.725 . . . . 0.0 113.038 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.49 151.1 27.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.934 1.294 . . . . 0.0 111.033 -174.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.0 tt -127.35 135.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.59 1.556 . . . . 0.0 112.015 -175.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.3 p -147.92 162.66 38.85 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.814 1.645 . . . . 0.0 110.875 -176.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -147.19 -176.16 20.67 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 116.046 1.178 . . . . 0.0 116.046 -177.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -153.92 143.31 21.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.566 1.946 . . . . 0.0 109.119 173.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 24.9 t -117.61 133.2 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.727 1.611 . . . . 0.0 108.195 174.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -117.4 129.35 55.8 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.288 1.035 . . . . 0.0 110.813 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.9 mpp? -97.3 148.22 34.1 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.576 1.55 . . . . 0.0 111.506 -173.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 -21.01 29.91 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.462 2.774 . . . . 0.0 113.145 -179.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.2 p -79.22 1.02 26.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.379 1.471 . . . . 0.0 114.431 176.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.04 54.63 2.27 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.665 1.126 . . . . 0.0 113.296 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -156.61 166.33 33.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.961 1.704 . . . . 0.0 111.864 -177.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.8 m -141.63 158.13 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.798 1.239 . . . . 0.0 112.652 -173.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.88 173.46 16.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.474 2.31 . . . . 0.0 110.045 177.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -114.75 144.93 32.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 121.13 -0.981 . . . . 0.0 112.769 -179.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -86.56 174.8 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.837 3.691 . . . . 0.0 112.034 177.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 71.7 m -110.05 133.5 53.14 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.809 1.644 . . . . 0.0 108.806 171.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.83 140.75 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.989 1.316 . . . . 0.0 108.604 173.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 14.5 t -148.0 139.42 23.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.731 1.212 . . . . 0.0 111.005 177.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.01 138.38 32.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.651 1.18 . . . . 0.0 112.638 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -96.56 -9.54 29.23 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.064 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.76 -1.69 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.693 2.397 . . . . 0.0 115.02 173.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.79 3.33 55.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.602 1.961 . . . . 0.0 113.549 175.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 102.29 12.28 34.01 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.365 1.46 . . . . 0.0 114.399 -174.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 26.3 p -125.86 161.62 27.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.141 1.377 . . . . 0.0 111.824 174.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -121.79 144.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.734 1.214 . . . . 0.0 109.946 165.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 17.1 m -97.33 139.81 32.72 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.331 1.452 . . . . 0.0 109.037 170.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.1 t -127.23 136.84 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.69 1.596 . . . . 0.0 108.934 178.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -142.35 157.7 44.52 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.07 1.348 . . . . 0.0 112.684 -174.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -154.92 135.27 13.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.254 1.421 . . . . 0.0 111.88 172.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.16 120.58 72.5 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.9 1.28 . . . . 0.0 110.923 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.87 167.55 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.906 3.07 . . . . 0.0 112.281 -172.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 89.4 p -147.22 -26.32 0.39 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.92 150.09 45.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.175 1.79 . . . . 0.0 110.393 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.73 168.67 18.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.492 1.117 . . . . 0.0 113.135 178.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 121.44 -173.15 15.56 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 125.425 1.488 . . . . 0.0 114.071 178.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.8 tt -87.8 127.47 35.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.809 1.244 . . . . 0.0 109.747 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 65.3 m80 -127.66 164.16 22.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.943 1.697 . . . . 0.0 111.585 -172.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -146.35 154.15 41.33 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.777 0.799 . . . . 0.0 112.554 166.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.9 ttm -127.33 133.7 50.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.85 2.46 . . . . 0.0 109.763 -173.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -103.83 131.93 50.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.304 1.842 . . . . 0.0 109.354 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 27.8 mm -130.51 128.26 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.358 1.063 . . . . 0.0 109.783 175.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.52 137.39 37.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 48.2 t80 -103.9 124.07 48.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.836 2.054 . . . . 0.0 109.358 174.066 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.01 46.09 22.57 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.692 1.197 . . . . 0.0 112.344 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.301 0.2 OUTLIER 63.34 9.99 4.44 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.034 2.533 . . . . 0.0 116.56 -177.222 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.7 mtp -110.88 131.24 55.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.231 1.412 . . . . 0.0 110.931 173.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -55.91 134.11 51.86 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.433 -0.792 . . . . 0.0 112.813 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.8 pt -73.89 155.59 88.6 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.701 178.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -59.44 122.44 11.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.711 1.607 . . . . 0.0 108.395 163.288 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 113.78 -25.01 11.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.996 1.284 . . . . 0.0 113.021 -171.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.4 t -83.79 148.3 54.01 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 118.91 1.355 . . . . 0.0 111.341 174.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.06 155.85 97.27 Favored 'Cis proline' 0 C--N 1.351 0.698 0 CA-C-N 119.79 0.961 . . . . 0.0 111.674 -10.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.51 133.75 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 109.227 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -137.92 134.74 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 110.975 -170.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.5 178.85 7.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.309 1.043 . . . . 0.0 113.109 -171.062 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -116.8 143.53 45.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.517 1.127 . . . . 0.0 112.555 176.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 94.2 t -112.86 132.69 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.293 1.837 . . . . 0.0 109.416 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 29.3 t0 -159.46 152.0 21.39 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.07 134.86 39.94 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.18 -0.95 . . . . 0.0 112.622 -176.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.1 p -70.58 -19.95 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.4 0.68 . . . . 0.0 112.589 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -73.39 -20.61 60.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.889 1.276 . . . . 0.0 114.014 -178.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.0 m -73.92 148.61 42.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.384 1.073 . . . . 0.0 113.146 -173.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -92.46 -14.03 56.22 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.95 1.262 . . . . 0.0 114.703 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -65.03 160.78 20.16 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.553 1.176 . . . . 0.0 113.427 177.111 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.5 t -69.47 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.731 0.812 . . . . 0.0 109.363 177.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -161.22 161.53 30.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.301 1.441 . . . . 0.0 110.543 -175.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.73 147.83 32.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.511 1.124 . . . . 0.0 112.291 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.51 161.55 13.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.752 1.621 . . . . 0.0 112.941 -176.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.25 171.86 12.33 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.506 1.527 . . . . 0.0 113.09 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.29 -34.84 26.09 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.12 2.546 . . . . 0.0 112.616 -173.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.82 -21.99 73.5 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 119.036 0.835 . . . . 0.0 114.662 -177.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.89 -14.9 60.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.39 1.095 . . . . 0.0 113.168 172.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 16.9 m -117.15 -36.16 3.87 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.777 1.631 . . . . 0.0 111.926 -168.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -150.6 155.63 39.78 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.489 1.916 . . . . 0.0 111.963 -174.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -149.31 173.51 29.13 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 123.978 0.799 . . . . 0.0 113.176 171.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 54.6 t -135.32 132.01 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.654 1.182 . . . . 0.0 108.353 176.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -57.73 138.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.11 2.28 2.24 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.997 2.119 . . . . 0.0 114.62 176.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -117.64 141.28 28.7 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.026 1.73 . . . . 0.0 110.93 177.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.13 130.29 16.3 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.672 2.248 . . . . 0.0 111.099 -173.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.7 139.54 44.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.415 1.486 . . . . 0.0 110.06 173.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -131.02 152.61 50.15 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.1 175.12 12.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.541 1.536 . . . . 0.0 112.189 177.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 47.5 m -125.62 143.45 51.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.963 1.705 . . . . 0.0 110.625 -171.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.3 t -121.45 131.45 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.215 1.806 . . . . 0.0 108.362 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -89.13 132.31 34.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.391 1.077 . . . . 0.0 111.754 -178.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.6 p -130.74 1.31 4.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.754 . . . . 0.0 113.222 -176.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -52.0 -38.8 58.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.02 2.128 . . . . 0.0 115.445 -168.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -131.81 21.05 4.59 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.523 1.529 . . . . 0.0 111.926 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.95 69.43 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.729 1.212 . . . . 0.0 113.885 -174.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.51 149.88 6.37 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.685 1.136 . . . . 0.0 112.301 -169.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.67 163.96 27.28 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.08 0.952 . . . . 0.0 113.531 -177.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 161.85 -30.49 0.31 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.538 1.066 . . . . 0.0 114.705 175.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.73 101.15 0.35 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.579 1.562 . . . . 0.0 112.748 173.179 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.72 144.63 37.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.989 1.316 . . . . 0.0 110.457 175.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -147.44 158.34 43.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.974 1.31 . . . . 0.0 112.049 -173.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.7 tp -166.6 135.87 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.928 1.691 . . . . 0.0 109.495 -164.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.86 159.13 36.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.359 1.064 . . . . 0.0 111.923 175.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.35 128.67 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.662 1.185 . . . . 0.0 109.67 175.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -115.69 163.65 15.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.107 1.763 . . . . 0.0 110.039 171.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 178.91 -166.88 36.81 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.269 -0.894 . . . . 0.0 113.852 -179.309 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.75 -19.18 36.48 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.625 2.883 . . . . 0.0 112.268 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.0 t -142.88 158.16 43.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.831 1.653 . . . . 0.0 108.867 161.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 23.2 tptp -74.84 120.69 20.72 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.832 -1.167 . . . . 0.0 111.96 -175.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.2 147.33 34.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.002 0.921 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.01 147.68 23.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.057 0.943 . . . . 0.0 110.777 169.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 13.6 mt -137.08 145.98 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.882 1.273 . . . . 0.0 110.524 -161.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 78.5 p -143.79 161.98 37.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.1 1.36 . . . . 0.0 111.388 165.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.02 158.64 35.24 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.384 1.074 . . . . 0.0 112.738 -175.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.9 m -147.54 119.47 8.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.462 1.505 . . . . 0.0 110.097 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.69 129.7 35.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.658 1.183 . . . . 0.0 111.303 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -108.9 152.74 24.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.827 1.251 . . . . 0.0 112.127 -177.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -64.54 -26.31 68.36 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.855 1.262 . . . . 0.0 113.482 -174.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -83.13 8.08 14.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.241 1.416 . . . . 0.0 114.767 -178.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.53 27.73 8.94 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 168.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 23.4 p -139.88 135.14 32.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.324 1.05 . . . . 0.0 111.583 175.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 41.3 t -90.64 128.84 36.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 109.819 163.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -92.55 149.45 21.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.14 0.976 . . . . 0.0 110.212 169.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 61.9 t -132.43 144.09 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.761 1.624 . . . . 0.0 109.663 -178.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 19.7 t -138.19 142.38 40.02 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.601 1.561 . . . . 0.0 110.916 172.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.5 p90 -148.54 156.46 42.47 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.2 mt -121.31 107.25 37.25 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.828 1.651 . . . . 0.0 110.541 -179.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.35 164.27 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.7 2.933 . . . . 0.0 110.284 166.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.6 p -125.63 -21.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -170.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.9 pp -146.0 151.48 45.28 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.949 1.3 . . . . 0.0 110.31 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.48 153.28 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 112.534 -169.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.67 -165.51 28.38 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.8 1.19 . . . . 0.0 113.431 -177.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -93.13 124.87 37.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.159 1.384 . . . . 0.0 111.853 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -114.1 138.32 50.56 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.385 1.474 . . . . 0.0 110.627 178.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -102.64 114.7 29.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.483 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.51 125.46 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.196 1.398 . . . . 0.0 108.665 -179.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -104.63 132.26 51.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.578 1.551 . . . . 0.0 109.545 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.7 t -133.45 129.28 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.341 1.056 . . . . 0.0 109.565 172.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -154.54 144.45 21.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.98 1.312 . . . . 0.0 111.689 -165.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.92 122.15 11.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.833 1.253 . . . . 0.0 109.618 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.3 t-20 54.92 56.62 6.44 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.352 1.461 . . . . 0.0 111.635 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 60.62 1.46 0.41 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 129.149 2.98 . . . . 0.0 116.701 -177.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -106.46 125.92 51.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.532 1.133 . . . . 0.0 111.015 178.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.21 145.16 56.44 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 169.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 6.8 m -75.37 157.69 84.44 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.774 173.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.76 125.22 17.94 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.616 2.878 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.42 77.09 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.716 1.15 . . . . 0.0 115.544 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 33.0 t -77.03 139.91 65.97 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.349 1.575 . . . . 0.0 111.728 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.84 141.8 71.86 Favored 'Cis proline' 0 CA--C 1.539 0.773 0 CA-C-N 119.5 0.857 . . . . 0.0 111.953 -4.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 154.08 17.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 110.95 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 62.2 m -112.73 114.44 27.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.636 0.774 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.5 133.76 42.42 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 111.407 174.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -94.62 105.84 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.678 1.191 . . . . 0.0 109.863 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.4 t -91.09 137.68 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.245 1.018 . . . . 0.0 110.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 68.6 p -115.81 158.95 22.14 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.434 1.494 . . . . 0.0 112.942 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.53 137.66 19.24 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.896 1.236 . . . . 0.0 111.531 174.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.5 t70 . . . . . 0 CA--C 1.548 0.866 0 C-N-CA 124.391 1.076 . . . . 0.0 113.373 -179.015 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.29 0.567 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -68.88 121.58 81.98 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.239 1.415 . . . . 0.0 110.51 -175.339 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.66 151.98 69.73 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.297 2.665 . . . . 0.0 111.723 -171.075 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.7 t80 -98.48 124.63 43.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.588 0.755 . . . . 0.0 110.306 176.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -153.16 133.35 13.44 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 110.913 173.389 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.11 156.37 44.32 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.456 1.902 . . . . 0.0 109.873 -170.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -130.98 138.57 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.083 1.353 . . . . 0.0 110.53 -178.451 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.86 136.41 27.67 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.243 1.817 . . . . 0.0 109.094 -174.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.18 114.38 3.97 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.168 2.579 . . . . 0.0 110.053 172.528 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 42.2 t80 -178.2 152.56 0.71 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.182 2.193 . . . . 0.0 109.333 -170.215 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 36.8 m -133.49 129.57 37.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.455 1.102 . . . . 0.0 110.218 178.719 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.0 mt -79.62 109.98 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.189 0.995 . . . . 0.0 109.056 171.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.73 -58.8 2.08 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -176.708 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -158.88 -12.32 0.07 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.482 2.031 . . . . 0.0 116.482 -167.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.02 -136.89 5.94 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.134 1.826 . . . . 0.0 112.226 176.089 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -154.31 145.64 22.98 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.147 1.379 . . . . 0.0 110.421 -176.053 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.8 tt -128.45 137.93 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.414 1.486 . . . . 0.0 111.438 -178.193 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.2 p -147.31 164.78 32.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.965 1.706 . . . . 0.0 110.587 -178.283 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -149.65 177.78 27.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 -177.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -150.62 137.3 18.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.993 1.717 . . . . 0.0 109.614 175.036 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.9 t -111.32 137.99 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.332 1.853 . . . . 0.0 108.506 174.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.88 133.67 54.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.969 1.308 . . . . 0.0 111.551 -173.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.02 149.61 38.79 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.837 1.655 . . . . 0.0 111.971 -173.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -54.66 -32.28 74.66 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.174 3.249 . . . . 0.0 114.668 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 38.1 m -71.42 -1.27 12.54 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.451 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.65 -1.53 83.84 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.545 1.545 . . . . 0.0 113.935 -176.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -74.83 161.61 29.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.596 1.558 . . . . 0.0 112.001 177.582 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.9 m -139.21 157.33 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.186 1.394 . . . . 0.0 111.831 176.438 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.6 170.42 21.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.41 1.884 . . . . 0.0 111.017 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -114.13 138.75 23.05 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.026 0.931 . . . . 0.0 111.391 178.591 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.62 175.55 2.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.497 3.465 . . . . 0.0 112.45 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.9 m -109.33 133.08 53.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.47 1.508 . . . . 0.0 109.373 173.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.93 134.47 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.051 1.34 . . . . 0.0 109.263 175.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -135.69 126.29 27.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.627 1.571 . . . . 0.0 109.999 179.243 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.69 129.52 34.55 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.744 0.818 . . . . 0.0 110.558 171.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.76 -5.0 59.09 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 65.37 22.46 11.99 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.331 1.853 . . . . 0.0 112.53 -175.878 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -134.77 15.44 3.62 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.383 1.873 . . . . 0.0 112.71 -171.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.37 11.11 72.72 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.768 1.175 . . . . 0.0 114.451 -179.058 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.1 p -130.86 154.06 48.45 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 110.958 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.1 m -113.76 138.21 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.313 1.045 . . . . 0.0 109.697 164.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.1 m -99.0 139.47 34.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.051 1.341 . . . . 0.0 108.531 170.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 36.2 t -126.08 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.288 1.435 . . . . 0.0 108.962 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -135.32 154.09 51.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.757 1.223 . . . . 0.0 112.823 -172.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 42.2 t80 -155.02 136.33 14.05 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.747 1.619 . . . . 0.0 112.054 177.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.55 117.39 67.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.799 1.239 . . . . 0.0 110.817 176.789 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.38 146.99 22.46 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.658 2.905 . . . . 0.0 112.704 -174.242 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 68.4 m -122.84 -2.75 8.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.68 1.192 . . . . 0.0 113.634 175.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 154.58 19.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.225 1.81 . . . . 0.0 111.166 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.62 172.02 12.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.519 1.128 . . . . 0.0 112.664 176.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.71 -175.92 16.8 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.047 1.308 . . . . 0.0 113.996 177.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -84.98 118.19 24.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.354 1.062 . . . . 0.0 110.186 -178.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 39.4 m80 -114.01 165.1 12.97 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.223 1.809 . . . . 0.0 111.779 -174.565 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.83 155.96 44.3 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.325 1.05 . . . . 0.0 111.551 173.134 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 29.2 ttm -142.28 124.16 15.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.583 1.553 . . . . 0.0 110.203 -171.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.93 126.34 46.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 109.841 176.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 41.0 mm -123.42 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.262 1.425 . . . . 0.0 110.285 176.395 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.32 139.77 23.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.422 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.8 t80 -106.18 124.95 50.38 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.337 2.255 . . . . 0.0 110.102 177.574 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 53.32 29.0 7.95 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.775 1.23 . . . . 0.0 112.461 -173.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 25.2 t30 77.41 4.87 3.13 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.573 2.749 . . . . 0.0 115.185 -178.224 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 59.8 ttm -103.32 134.04 47.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.346 1.458 . . . . 0.0 111.063 172.313 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.3 m170 -57.31 134.34 55.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.293 -0.879 . . . . 0.0 113.001 -178.549 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 42.0 pt -74.94 155.01 86.84 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.65 . . . . 0.0 111.568 176.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.12 125.86 19.33 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.374 2.049 . . . . 0.0 109.779 172.731 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.07 -16.7 56.99 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.618 1.104 . . . . 0.0 114.326 -173.243 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.5 t -81.76 146.65 56.82 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 119.043 1.422 . . . . 0.0 111.73 176.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.76 162.64 84.7 Favored 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 120.09 1.068 . . . . 0.0 112.302 -6.174 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.4 mt -95.64 155.3 16.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.038 1.335 . . . . 0.0 110.834 172.38 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -156.74 132.96 9.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.714 1.205 . . . . 0.0 109.977 -175.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.9 p90 -167.39 172.95 9.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.426 1.09 . . . . 0.0 112.526 -168.162 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 46.3 t80 -108.74 134.04 51.99 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.178 0.991 . . . . 0.0 113.035 176.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.3 t -96.31 133.38 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 109.494 172.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 45.5 t0 -143.97 173.89 11.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.811 2.045 . . . . 0.0 109.918 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -79.12 151.25 31.47 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.724 -1.235 . . . . 0.0 113.459 178.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 69.4 t -66.3 -47.64 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.229 1.411 . . . . 0.0 110.4 174.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -95.52 128.22 42.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 110.621 175.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 23.6 p -171.77 153.17 3.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.979 1.712 . . . . 0.0 112.192 -175.323 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -103.59 -19.33 12.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.114 1.34 . . . . 0.0 113.772 173.471 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -71.61 155.98 39.91 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.337 1.068 . . . . 0.0 113.379 177.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -68.39 137.58 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.095 0.958 . . . . 0.0 108.567 172.653 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.6 t -156.0 168.15 28.17 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.72 1.208 . . . . 0.0 110.972 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.22 147.36 30.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.823 1.249 . . . . 0.0 112.155 -177.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.7 p90 -167.21 164.41 15.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.052 1.741 . . . . 0.0 112.391 -175.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.39 173.72 13.44 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.201 1.381 . . . . 0.0 113.315 -179.203 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.37 -32.69 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.935 2.424 . . . . 0.0 113.194 -170.624 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.43 76.52 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 119.402 1.001 . . . . 0.0 114.333 -172.593 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.0 pp -78.09 -3.38 42.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.965 1.383 . . . . 0.0 113.374 174.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.2 m -107.01 -39.91 5.61 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.595 1.958 . . . . 0.0 111.891 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -149.94 150.51 31.96 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.501 1.92 . . . . 0.0 112.495 -169.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 177.07 28.92 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.015 0.817 . . . . 0.0 113.472 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 35.3 t -139.98 134.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.941 1.296 . . . . 0.0 107.901 174.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.2 m -56.31 134.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 122.901 0.48 . . . . 0.0 112.253 -177.821 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.9 m-80 69.48 -5.51 1.14 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.142 2.177 . . . . 0.0 114.616 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -97.87 138.45 21.0 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.865 1.266 . . . . 0.0 110.646 175.205 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.99 126.17 11.01 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.475 2.117 . . . . 0.0 110.289 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.58 144.11 36.72 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.463 1.505 . . . . 0.0 110.371 175.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 60.3 p -135.38 149.16 49.6 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -166.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.0 p90 -160.26 175.51 12.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.443 1.497 . . . . 0.0 111.682 177.234 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 30.5 m -129.68 139.48 51.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.04 1.336 . . . . 0.0 110.805 -169.024 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -110.44 133.94 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.024 1.73 . . . . 0.0 107.877 168.137 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.88 126.99 37.17 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.137 0.975 . . . . 0.0 111.02 178.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 78.6 p -127.09 3.13 6.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.065 1.746 . . . . 0.0 113.072 -172.777 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -52.99 -27.33 18.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.473 2.309 . . . . 0.0 116.382 -171.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.56 15.2 5.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.471 1.508 . . . . 0.0 112.191 176.483 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -79.23 -25.03 42.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.633 1.173 . . . . 0.0 113.494 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.09 -107.0 2.38 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.638 1.113 . . . . 0.0 112.101 178.649 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.94 152.99 23.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.234 1.813 . . . . 0.0 110.066 -174.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.55 8.26 0.11 Allowed Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 90.87 106.45 1.36 Allowed Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.463 1.506 . . . . 0.0 112.885 177.133 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 139.19 30.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.066 1.347 . . . . 0.0 109.762 170.396 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.0 m -130.77 159.35 37.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.569 1.548 . . . . 0.0 111.826 178.108 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.9 135.25 8.19 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.531 1.532 . . . . 0.0 109.409 -167.418 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 158.57 35.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.189 0.996 . . . . 0.0 112.194 178.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -138.24 136.04 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.758 1.223 . . . . 0.0 109.827 177.159 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -129.23 130.13 45.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.215 1.406 . . . . 0.0 110.21 176.075 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.84 -162.49 11.41 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.094 -176.259 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -62.33 -25.71 76.62 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.932 3.088 . . . . 0.0 112.388 174.324 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 21.1 t -137.2 153.8 50.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 109.112 161.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -74.07 119.54 18.42 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.876 -1.14 . . . . 0.0 110.837 177.006 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.33 151.7 44.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.002 0.921 . . . . 0.0 112.332 178.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.11 137.76 32.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 164.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.3 mt -132.99 138.9 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.479 1.112 . . . . 0.0 110.501 -169.307 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 74.1 m -132.03 157.53 43.89 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.848 1.659 . . . . 0.0 110.635 167.662 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -153.41 155.76 36.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.059 0.944 . . . . 0.0 112.766 177.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.6 m -143.54 119.22 10.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.33 1.452 . . . . 0.0 110.382 -170.902 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.11 134.47 38.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.633 1.173 . . . . 0.0 111.396 173.251 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -114.3 148.44 37.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.626 1.571 . . . . 0.0 111.913 -177.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.51 -12.81 61.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.838 0.855 . . . . 0.0 112.718 174.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.35 -5.77 44.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.791 1.637 . . . . 0.0 114.031 177.115 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 32.83 7.63 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.646 1.117 . . . . 0.0 113.723 -179.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.7 p -139.84 160.17 40.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.968 1.307 . . . . 0.0 111.363 176.797 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 46.5 t -114.66 127.22 55.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.246 1.419 . . . . 0.0 108.434 160.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.7 t -92.52 147.93 22.5 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.144 0.977 . . . . 0.0 110.759 174.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.6 t -124.83 142.11 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.883 1.673 . . . . 0.0 109.927 -178.176 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.4 m -131.06 140.43 50.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.523 1.529 . . . . 0.0 110.424 167.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 14.4 p90 -146.85 154.11 40.94 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 174.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.17 106.74 42.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.085 1.754 . . . . 0.0 110.514 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.31 176.41 7.36 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.926 3.084 . . . . 0.0 110.523 167.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.7 p -149.83 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.572 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.77 147.29 35.5 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.422 1.089 . . . . 0.0 110.434 166.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.21 156.07 46.66 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.897 2.398 . . . . 0.0 110.925 175.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.62 -161.19 23.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.77 1.176 . . . . 0.0 113.647 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.24 131.96 36.43 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.154 1.382 . . . . 0.0 112.682 -178.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.57 122.41 38.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.602 1.561 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.6 m -84.23 127.22 33.82 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.192 -0.942 . . . . 0.0 110.832 175.99 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.38 124.88 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.953 1.701 . . . . 0.0 108.33 178.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -105.01 130.68 53.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.401 1.48 . . . . 0.0 109.699 174.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.4 t -131.7 128.36 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.409 1.084 . . . . 0.0 109.779 172.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.9 147.08 29.35 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.233 1.413 . . . . 0.0 111.615 -170.358 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.47 121.93 11.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.94 1.296 . . . . 0.0 109.461 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 54.08 56.79 6.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.425 1.49 . . . . 0.0 112.123 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 8.4 pt-20 59.38 4.13 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.965 2.906 . . . . 0.0 116.711 -176.478 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.67 126.12 53.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.659 1.184 . . . . 0.0 111.022 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -65.02 146.9 54.41 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.234 -0.916 . . . . 0.0 111.787 169.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.2 m -72.09 153.47 92.61 Favored Pre-proline 0 N--CA 1.482 1.152 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.378 170.75 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -57.99 130.42 38.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.116 2.544 . . . . 0.0 110.65 175.223 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 90.71 -15.75 59.74 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.95 1.262 . . . . 0.0 114.929 -175.516 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.0 t -77.87 139.95 62.34 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.457 1.628 . . . . 0.0 111.457 175.629 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.45 135.92 42.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.373 0.812 . . . . 0.0 111.977 -3.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.44 172.92 10.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.825 1.65 . . . . 0.0 110.186 172.808 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 84.9 m -137.21 121.61 18.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 174.092 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.25 147.46 23.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.985 1.714 . . . . 0.0 111.571 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.47 113.0 25.7 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.343 1.057 . . . . 0.0 109.759 173.831 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.0 t -95.37 142.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.976 1.31 . . . . 0.0 110.115 177.29 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.4 t -128.3 170.61 12.86 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.305 1.042 . . . . 0.0 113.167 178.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -82.45 137.83 17.47 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.788 1.661 . . . . 0.0 113.091 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 . . . . . 0 CA--C 1.548 0.867 0 C-N-CA 125.067 1.347 . . . . 0.0 112.803 174.987 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 74.9 mt . . . . . 0 CA--C 1.54 0.561 0 CA-C-O 121.021 0.438 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . 0.421 HH12 ' HA ' ' A' 1863 ' ' VAL . 8.7 tpp180 -55.03 118.85 18.97 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.251 1.42 . . . . 0.0 111.615 -174.316 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.19 126.64 13.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.443 2.095 . . . . 0.0 108.756 177.425 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 64.7 t80 -116.24 125.07 51.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.7 0.762 . . . . 0.0 111.833 -171.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.62 142.34 16.56 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.017 1.727 . . . . 0.0 110.524 174.124 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.39 148.36 47.78 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.867 1.667 . . . . 0.0 110.418 -173.209 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.1 p -112.54 137.59 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.105 1.362 . . . . 0.0 109.923 173.034 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.0 mt -134.68 135.58 23.77 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.93 1.692 . . . . 0.0 108.798 -173.348 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.77 113.84 3.88 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.273 2.649 . . . . 0.0 109.979 175.964 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.4 t80 -172.72 146.07 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.485 1.914 . . . . 0.0 109.689 -172.766 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.7 m -118.71 122.31 42.19 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.496 1.119 . . . . 0.0 109.269 176.19 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.77 116.42 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.73 0.812 . . . . 0.0 109.372 175.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.3 mttt -96.56 -143.23 0.28 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.37 1.468 . . . . 0.0 111.607 178.174 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -78.07 -9.79 59.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.59 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.82 -142.56 5.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.335 1.921 . . . . 0.0 113.086 177.178 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.94 150.05 25.47 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.015 1.326 . . . . 0.0 111.229 -172.484 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.14 136.88 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.791 1.636 . . . . 0.0 111.389 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.7 p -146.07 -178.08 5.94 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.207 1.803 . . . . 0.0 110.138 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.0 -165.07 31.81 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -179.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -147.87 149.29 31.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.773 2.029 . . . . 0.0 109.934 -179.881 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 62.0 t -122.23 132.25 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.689 1.595 . . . . 0.0 107.92 167.659 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -115.38 130.97 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.808 1.243 . . . . 0.0 111.133 -174.505 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -102.84 149.9 37.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.717 1.607 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.65 -32.95 85.65 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.349 3.366 . . . . 0.0 115.315 176.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.0 t -77.59 -1.68 31.99 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.2 -1.06 72.89 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.386 1.469 . . . . 0.0 114.079 -177.684 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -66.03 155.95 35.16 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 111.763 171.152 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.7 m -139.7 152.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.019 1.328 . . . . 0.0 111.334 175.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.97 175.02 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.556 1.942 . . . . 0.0 110.222 179.684 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -120.03 141.02 30.74 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 121.482 -0.761 . . . . 0.0 111.358 178.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.94 165.65 13.33 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.957 3.105 . . . . 0.0 111.341 177.236 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.7 m -104.82 125.5 50.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.009 1.324 . . . . 0.0 108.679 172.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.0 135.12 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 109.236 175.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 83.9 m -128.25 132.1 48.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.049 1.74 . . . . 0.0 109.935 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 18.0 t0 -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.241 1.016 . . . . 0.0 111.019 171.596 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.9 -14.74 43.93 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.088 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 62.8 tttt 72.71 -2.88 2.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 127.668 2.387 . . . . 0.0 113.967 178.267 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -96.98 5.34 50.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.005 2.122 . . . . 0.0 113.29 -178.138 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.12 12.78 54.52 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.144 1.354 . . . . 0.0 113.962 -174.19 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.6 p -127.46 159.32 34.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.173 1.789 . . . . 0.0 110.477 173.764 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.79 146.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.59 1.156 . . . . 0.0 109.623 166.275 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 27.0 m -105.04 137.06 43.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.111 0.965 . . . . 0.0 108.736 170.597 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.5 t -119.56 133.83 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.148 1.379 . . . . 0.0 109.167 178.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.76 150.76 51.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.628 1.571 . . . . 0.0 111.841 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.6 t80 -155.62 132.59 10.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.429 1.491 . . . . 0.0 111.384 178.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.36 120.7 74.75 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.246 1.019 . . . . 0.0 110.498 176.821 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.9 139.36 27.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.301 2.667 . . . . 0.0 112.138 -172.04 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -138.82 10.58 2.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.338 1.055 . . . . 0.0 113.815 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -161.83 154.26 19.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.226 1.81 . . . . 0.0 110.012 -178.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -101.27 160.18 14.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.612 1.165 . . . . 0.0 112.257 174.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.24 -163.39 12.25 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.555 1.55 . . . . 0.0 113.991 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -92.86 113.46 25.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.052 1.341 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.2 m80 -105.59 173.72 6.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.233 2.213 . . . . 0.0 111.933 -174.441 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.3 146.83 35.48 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.644 0.778 . . . . 0.0 112.071 171.364 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.2 ttm -116.7 134.97 54.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.051 2.14 . . . . 0.0 109.457 -179.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -126.62 119.7 27.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.712 2.005 . . . . 0.0 109.136 -174.273 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -131.45 136.77 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.051 0.941 . . . . 0.0 111.393 -171.39 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 134.86 21.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 27.3 t80 -101.49 125.1 48.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 110.185 176.366 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.8 36.38 14.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.858 1.263 . . . . 0.0 112.641 -176.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 45.0 m-80 83.02 -8.54 1.14 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.358 3.063 . . . . 0.0 114.658 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 62.3 mtt -100.95 134.71 43.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.22 1.408 . . . . 0.0 111.999 -178.469 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -54.0 135.85 42.28 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.189 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -76.89 155.23 83.01 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.272 173.109 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.09 131.96 41.93 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.153 1.902 . . . . 0.0 109.945 172.146 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.13 -9.17 76.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.432 -174.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.1 t -84.03 144.29 44.24 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 120.042 1.921 . . . . 0.0 111.422 170.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -79.38 164.1 83.25 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.816 0.97 . . . . 0.0 112.244 -7.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.6 mt -113.3 156.95 22.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.965 1.706 . . . . 0.0 110.697 174.512 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.59 143.46 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.711 1.204 . . . . 0.0 110.404 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -159.12 150.17 20.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.952 0.901 . . . . 0.0 112.489 -170.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -100.55 143.74 30.37 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.294 -0.879 . . . . 0.0 112.599 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 38.4 t -126.16 137.5 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.355 1.462 . . . . 0.0 109.438 178.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -161.48 158.54 26.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.81 -167.697 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -75.48 146.35 40.69 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.855 -1.153 . . . . 0.0 113.357 -173.443 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . 0.421 ' HA ' HH12 ' A' 1789 ' ' ARG . 18.0 m -70.6 -18.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.988 -1.07 . . . . 0.0 112.796 171.585 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 31.9 p30 -90.83 4.75 50.89 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.353 1.461 . . . . 0.0 114.244 178.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.1 p -62.66 151.41 38.27 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -166.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.91 40.73 2.42 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.382 1.944 . . . . 0.0 113.166 -177.424 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -153.89 167.33 30.06 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.24 1.416 . . . . 0.0 113.081 -176.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.2 t -73.05 134.76 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.113 0.965 . . . . 0.0 108.801 171.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.4 t -148.93 165.64 30.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.825 1.25 . . . . 0.0 110.905 -175.183 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.2 147.44 27.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.727 1.211 . . . . 0.0 111.861 -177.487 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 48.1 p90 -168.63 163.46 12.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.754 1.622 . . . . 0.0 112.597 -173.367 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.04 174.33 13.27 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.278 1.418 . . . . 0.0 113.032 -178.42 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.51 -35.12 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.908 2.405 . . . . 0.0 112.799 -172.308 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.73 -31.04 72.77 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.368 0.986 . . . . 0.0 114.537 -171.152 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.52 -3.99 49.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.814 1.307 . . . . 0.0 113.351 174.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -104.85 -51.74 3.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 110.69 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -141.56 145.12 34.71 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.093 1.757 . . . . 0.0 112.553 -176.864 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -140.4 178.38 19.99 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 124.767 1.175 . . . . 0.0 113.217 172.632 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 15.3 t -139.66 135.97 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.043 . . . . 0.0 108.884 175.941 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -55.57 139.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.3 m-80 67.96 -1.17 1.81 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.943 2.097 . . . . 0.0 115.039 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -116.39 141.99 28.77 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.226 1.41 . . . . 0.0 111.166 177.32 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.0 134.05 20.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.52 2.147 . . . . 0.0 111.126 -174.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -112.82 147.18 37.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.707 1.603 . . . . 0.0 110.306 173.653 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.3 p -136.52 152.28 50.34 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.114 0.966 . . . . 0.0 113.604 -167.188 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.9 p90 -161.86 176.56 10.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.097 1.759 . . . . 0.0 111.485 176.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 32.2 m -130.79 140.82 50.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.03 1.332 . . . . 0.0 110.862 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -109.96 132.51 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.723 1.609 . . . . 0.0 107.92 168.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.93 123.33 38.34 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.131 0.973 . . . . 0.0 110.634 179.516 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.5 p -126.63 1.58 6.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.445 1.498 . . . . 0.0 113.735 -168.236 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -52.91 -38.12 61.49 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.919 1.687 . . . . 0.0 113.777 -177.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -99.86 -1.22 37.99 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.643 1.577 . . . . 0.0 113.472 -179.272 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.55 -22.57 50.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -171.417 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.44 -105.53 2.39 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.218 0.913 . . . . 0.0 111.624 -177.057 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -158.37 148.91 20.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.825 -175.691 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.59 31.64 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.469 1.509 . . . . 0.0 112.667 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.73 103.26 2.89 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 124.063 0.84 . . . . 0.0 111.614 176.416 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.65 129.6 34.76 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.996 1.318 . . . . 0.0 108.935 170.442 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 26.9 m -133.55 158.84 42.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.266 1.426 . . . . 0.0 112.399 -175.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.8 tp -161.08 136.19 7.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.97 1.708 . . . . 0.0 109.123 -168.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.49 36.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.065 0.946 . . . . 0.0 112.299 177.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 48.8 mt -138.3 137.36 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.989 1.316 . . . . 0.0 109.675 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -127.37 143.06 51.28 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.42 1.488 . . . . 0.0 109.907 174.188 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -173.13 -162.13 24.65 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.895 -175.28 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.38 -22.81 59.35 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.223 3.282 . . . . 0.0 113.161 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.4 t -144.36 164.45 30.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.008 1.323 . . . . 0.0 109.829 165.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -68.7 107.63 3.07 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.845 178.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.478 0.711 . . . . 0.0 110.414 169.305 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -102.7 133.84 47.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.479 0.711 . . . . 0.0 109.717 176.605 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -128.15 144.86 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.709 1.204 . . . . 0.0 110.477 -159.137 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -141.57 164.07 31.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.773 1.229 . . . . 0.0 111.093 166.144 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -160.13 156.85 27.43 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.951 1.3 . . . . 0.0 112.206 -178.59 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 62.1 m -145.49 125.07 13.21 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 109.935 -172.465 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.15 134.72 38.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.09 0.956 . . . . 0.0 111.489 170.711 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -108.54 154.62 21.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.298 1.439 . . . . 0.0 112.342 -174.066 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -67.72 -22.02 65.27 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.568 1.147 . . . . 0.0 112.441 175.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.6 -4.83 50.8 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.716 1.606 . . . . 0.0 114.734 -176.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.98 35.46 6.74 Favored Glycine 0 N--CA 1.476 1.303 0 C-N-CA 124.23 0.919 . . . . 0.0 113.77 -179.414 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 72.9 p -139.46 165.38 27.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.746 1.618 . . . . 0.0 110.539 176.027 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.7 m -116.01 130.4 56.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.904 1.282 . . . . 0.0 109.14 161.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.7 t -89.53 149.57 22.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.968 0.907 . . . . 0.0 110.52 170.956 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 96.1 t -129.66 143.35 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.883 1.673 . . . . 0.0 109.842 -178.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.2 p -136.39 147.81 47.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.013 1.325 . . . . 0.0 111.84 167.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -151.92 152.79 33.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 175.668 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.2 mt -113.54 110.09 50.32 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.257 1.823 . . . . 0.0 110.427 176.401 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -83.1 175.86 8.05 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.918 3.079 . . . . 0.0 110.257 164.162 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -150.04 -31.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -173.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.94 147.19 34.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 119.481 1.037 . . . . 0.0 110.728 167.678 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.25 159.67 43.48 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.992 2.462 . . . . 0.0 111.088 175.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 127.77 -168.17 19.85 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.173 1.368 . . . . 0.0 112.822 -174.515 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.65 142.89 27.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.387 1.075 . . . . 0.0 113.101 178.167 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -127.13 135.14 50.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.007 1.723 . . . . 0.0 110.26 178.148 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -91.41 126.84 36.63 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.087 -1.008 . . . . 0.0 110.543 174.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.18 128.34 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.74 1.616 . . . . 0.0 108.229 178.757 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -111.8 131.82 55.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.383 1.473 . . . . 0.0 109.856 177.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.8 t -133.44 127.31 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.663 1.185 . . . . 0.0 109.893 174.192 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.15 144.32 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.148 1.379 . . . . 0.0 111.889 -169.518 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.62 121.21 11.79 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.916 1.286 . . . . 0.0 110.011 -179.226 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 56.38 55.96 6.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.33 1.452 . . . . 0.0 111.814 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.7 pt-20 56.9 14.65 1.95 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.333 2.653 . . . . 0.0 116.234 -177.84 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -123.81 129.03 50.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.661 1.184 . . . . 0.0 110.746 177.414 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -66.68 151.01 48.23 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.326 -0.859 . . . . 0.0 112.111 173.235 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 25.9 m -65.85 150.5 96.35 Favored Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.271 162.425 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.0 -16.69 45.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.269 1.98 . . . . 0.0 114.654 -164.213 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.77 -7.45 61.44 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.137 0.875 . . . . 0.0 115.253 172.525 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -84.69 143.07 40.26 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 118.88 1.34 . . . . 0.0 112.104 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.27 139.85 63.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 CA-C-N 119.2 0.75 . . . . 0.0 111.961 -4.016 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -91.38 165.2 13.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.992 1.717 . . . . 0.0 110.401 174.186 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.5 m -125.35 117.09 22.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.791 0.836 . . . . 0.0 110.223 174.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.57 158.7 15.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.735 1.214 . . . . 0.0 110.774 168.195 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -123.98 132.03 53.65 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.775 0.83 . . . . 0.0 110.483 169.363 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.6 t -113.35 131.28 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.437 1.495 . . . . 0.0 110.45 -171.875 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 32.1 p -106.45 167.41 9.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.098 1.359 . . . . 0.0 112.688 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.69 143.2 25.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.103 1.335 . . . . 0.0 112.058 174.247 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.8 t70 . . . . . 0 CA--C 1.55 0.954 0 C-N-CA 124.156 0.982 . . . . 0.0 113.177 176.442 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 51.5 mt . . . . . 0 CA--C 1.536 0.415 0 CA-C-O 121.683 0.754 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -56.95 118.15 21.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.445 1.898 . . . . 0.0 111.007 175.063 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.35 146.2 55.9 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.611 2.207 . . . . 0.0 109.46 172.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -131.14 133.24 45.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.74 0.781 . . . . 0.0 111.68 -175.333 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.51 146.98 10.33 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.593 1.957 . . . . 0.0 110.875 178.313 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.56 154.04 50.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.18 1.792 . . . . 0.0 110.546 -175.648 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.6 p -114.58 138.45 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.215 1.406 . . . . 0.0 109.624 170.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 46.5 mt -131.45 135.31 26.78 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.166 1.787 . . . . 0.0 108.395 -172.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.89 36.48 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.453 3.435 . . . . 0.0 112.909 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.17 152.11 27.9 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.846 1.258 . . . . 0.0 111.456 177.478 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -116.49 121.28 41.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.229 1.412 . . . . 0.0 109.925 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 78.8 mt -87.91 134.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.871 1.268 . . . . 0.0 110.013 175.84 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -117.91 -141.89 0.36 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.496 1.519 . . . . 0.0 110.542 174.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.75 127.18 32.67 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.707 -1.245 . . . . 0.0 110.904 171.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.11 -147.99 19.53 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 125.402 1.477 . . . . 0.0 111.723 -171.188 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.44 146.27 18.22 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.67 1.188 . . . . 0.0 111.242 -175.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -121.48 135.89 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.714 1.606 . . . . 0.0 111.217 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 47.0 p -146.85 177.69 8.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.399 1.88 . . . . 0.0 110.28 -177.827 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -163.18 -167.31 23.42 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.97 144.24 22.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.521 1.929 . . . . 0.0 109.549 175.689 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 96.2 t -121.72 134.98 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.897 1.679 . . . . 0.0 108.572 173.597 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -112.98 135.1 54.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.596 1.158 . . . . 0.0 111.832 -175.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.7 mpp? -108.04 142.89 26.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.707 1.603 . . . . 0.0 111.748 -175.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.46 -27.25 58.0 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.48 3.454 . . . . 0.0 115.819 174.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.3 t -71.93 -4.09 26.35 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.071 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.38 48.93 3.6 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.755 1.169 . . . . 0.0 112.383 177.8 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -153.31 163.67 39.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.084 1.754 . . . . 0.0 111.711 -172.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.37 157.84 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.87 1.268 . . . . 0.0 112.384 -173.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.07 176.47 12.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.265 2.226 . . . . 0.0 109.888 178.005 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -119.15 143.35 33.91 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 121.216 -0.928 . . . . 0.0 112.186 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -82.73 166.26 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.118 3.212 . . . . 0.0 111.388 174.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.8 m -110.58 122.52 47.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.05 1.34 . . . . 0.0 108.911 173.794 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.54 133.41 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.733 1.213 . . . . 0.0 109.351 177.422 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 52.4 m -120.93 130.24 53.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.557 1.943 . . . . 0.0 109.512 176.813 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.2 t0 -79.75 117.21 20.43 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.108 0.963 . . . . 0.0 110.15 170.583 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.52 -12.56 58.78 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.601 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 69.07 3.19 3.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.211 2.204 . . . . 0.0 114.21 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.78 9.2 35.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.823 2.049 . . . . 0.0 113.025 -175.563 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.08 11.97 60.74 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.931 1.253 . . . . 0.0 113.816 -173.295 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 56.3 p -131.73 164.69 25.42 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.462 1.905 . . . . 0.0 110.541 177.371 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.3 m -128.38 146.38 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.152 1.381 . . . . 0.0 109.821 168.224 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 32.6 m -105.84 139.37 40.51 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.315 1.046 . . . . 0.0 108.926 173.159 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.7 t -123.44 130.96 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.864 1.266 . . . . 0.0 109.249 179.135 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -128.08 157.49 40.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.329 1.451 . . . . 0.0 112.042 -176.08 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.5 t80 -155.15 138.2 15.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.498 1.519 . . . . 0.0 111.521 179.777 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.33 119.74 70.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.415 1.086 . . . . 0.0 110.762 177.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.6 135.08 14.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.172 2.581 . . . . 0.0 111.777 -173.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 80.9 p -127.09 -12.28 5.81 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 176.371 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -141.52 158.8 43.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.1 166.79 11.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.639 1.175 . . . . 0.0 112.059 169.593 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.97 -168.0 12.6 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.727 1.632 . . . . 0.0 113.992 179.489 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.9 tp -86.83 122.27 30.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.04 1.336 . . . . 0.0 110.299 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.0 m80 -117.78 168.86 10.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.07 1.748 . . . . 0.0 111.292 -174.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.8 148.52 33.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.894 . . . . 0.0 111.856 173.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.9 ttm -121.88 123.33 41.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.832 2.053 . . . . 0.0 110.125 -175.433 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -97.45 135.9 38.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.988 1.715 . . . . 0.0 109.809 169.605 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.1 mm -134.99 134.3 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.906 1.282 . . . . 0.0 109.95 176.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.7 139.09 27.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.361 1.065 . . . . 0.0 113.491 -176.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.3 t80 -102.53 122.16 43.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.809 2.044 . . . . 0.0 109.914 175.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 52.4 30.5 8.28 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.896 1.278 . . . . 0.0 112.739 -173.688 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 19.1 t30 79.46 2.63 2.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.658 2.783 . . . . 0.0 115.169 -179.263 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -99.74 130.61 45.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.167 1.387 . . . . 0.0 110.86 171.189 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -55.5 138.31 46.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -177.534 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.24 152.26 90.25 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.379 171.358 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.16 134.08 53.8 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.471 2.114 . . . . 0.0 110.952 -178.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.68 -7.63 75.92 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.966 1.27 . . . . 0.0 115.161 -178.146 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.2 t -76.55 144.86 74.47 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.77 1.785 . . . . 0.0 111.362 173.767 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.24 162.76 86.05 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.558 1.235 . . . . 0.0 114.107 1.69 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 84.4 mt -102.68 157.03 17.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.979 1.711 . . . . 0.0 110.632 171.174 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.68 141.47 49.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.069 1.347 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.54 155.69 28.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.66 1.184 . . . . 0.0 112.285 -171.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -112.13 135.94 52.15 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.11 -0.993 . . . . 0.0 113.191 179.533 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -118.43 142.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.529 1.532 . . . . 0.0 109.215 -178.196 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.25 165.8 35.32 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.6 1.16 . . . . 0.0 111.611 -175.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -77.02 128.15 33.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.427 1.091 . . . . 0.0 110.574 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 75.3 t -67.64 -31.89 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.604 -0.685 . . . . 0.0 112.248 -171.361 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -80.5 -14.19 58.46 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -178.001 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.0 t -70.33 139.24 51.99 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.239 -0.913 . . . . 0.0 112.758 -172.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.7 88.06 1.2 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.114 1.34 . . . . 0.0 113.129 -171.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -168.91 169.66 9.59 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.807 2.043 . . . . 0.0 112.533 174.177 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.5 p -66.57 142.95 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.875 0.87 . . . . 0.0 110.966 170.375 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -166.73 150.44 7.02 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.392 1.477 . . . . 0.0 110.711 178.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -123.71 145.89 48.66 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.228 1.411 . . . . 0.0 112.171 -176.308 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.6 p90 -167.6 163.87 14.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.82 1.648 . . . . 0.0 113.444 -179.962 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.8 172.59 13.05 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.461 1.505 . . . . 0.0 112.704 -178.359 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.82 -33.81 12.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.832 2.355 . . . . 0.0 112.693 -171.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.08 93.54 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.688 -1.062 . . . . 0.0 114.323 -171.342 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.09 -6.72 51.01 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.896 1.348 . . . . 0.0 113.381 176.552 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.9 m -99.77 -42.3 6.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.309 1.843 . . . . 0.0 110.943 173.504 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -155.4 126.38 7.07 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.026 1.73 . . . . 0.0 112.34 -165.239 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -130.63 -178.91 15.69 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.55 2.024 . . . . 0.0 112.794 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.4 t -141.19 139.52 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.864 1.666 . . . . 0.0 108.201 177.394 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -56.47 134.76 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.639 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 68.22 -0.91 1.98 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.349 2.26 . . . . 0.0 114.541 178.306 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.09 139.14 19.82 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.28 1.432 . . . . 0.0 110.951 176.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.37 123.93 9.06 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.519 2.146 . . . . 0.0 110.395 -178.513 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 142.7 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.509 1.524 . . . . 0.0 110.28 174.613 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 57.0 p -134.11 149.34 51.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -166.562 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.94 177.19 10.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.629 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 73.5 m -132.11 145.28 51.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.221 1.408 . . . . 0.0 110.497 -171.513 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 122.59 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 0.0 107.876 167.099 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -84.29 126.87 33.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.342 0.657 . . . . 0.0 109.924 173.542 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 4.1 p -133.77 12.11 4.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.418 1.887 . . . . 0.0 112.626 -172.038 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . 0.417 ' HE2' HG23 ' A' 1919 ' ' THR . 65.3 mttt -61.87 -35.48 78.44 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.56 11.36 12.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.258 1.823 . . . . 0.0 112.57 -176.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.1 -4.9 54.72 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 93.62 -127.84 9.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.736 1.16 . . . . 0.0 112.624 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -153.42 150.71 29.1 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.146 1.379 . . . . 0.0 110.901 -172.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 149.2 -158.55 27.7 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.763 1.649 . . . . 0.0 112.473 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.43 113.15 4.02 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.88 0.752 . . . . 0.0 111.315 174.097 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.39 125.18 32.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.887 1.275 . . . . 0.0 108.225 169.553 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 42.1 m -125.04 158.1 34.59 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.527 1.531 . . . . 0.0 112.397 -174.337 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -158.5 134.62 9.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.253 1.821 . . . . 0.0 108.979 -171.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.79 158.25 36.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.033 0.933 . . . . 0.0 112.145 177.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.68 134.55 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.561 1.144 . . . . 0.0 109.942 177.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -120.81 164.53 16.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.887 1.675 . . . . 0.0 109.94 168.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.01 29.7 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.251 -178.061 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.97 -22.82 62.27 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.894 3.062 . . . . 0.0 112.694 176.012 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.0 t -148.57 164.43 34.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.674 1.589 . . . . 0.0 109.517 164.663 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -73.17 113.63 10.45 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.926 -1.109 . . . . 0.0 111.081 177.55 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.01 149.51 48.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.796 0.838 . . . . 0.0 111.461 170.832 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.65 142.07 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.357 0.663 . . . . 0.0 109.648 168.751 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.2 mt -132.97 143.14 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.443 1.097 . . . . 0.0 110.456 -167.304 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.5 t -140.84 160.37 40.2 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.134 1.373 . . . . 0.0 110.62 167.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -158.5 156.47 30.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.594 1.158 . . . . 0.0 112.466 -177.217 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -140.24 123.7 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 110.385 -172.173 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.29 126.16 30.43 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.615 1.166 . . . . 0.0 110.417 168.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -100.61 151.33 21.74 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.078 1.351 . . . . 0.0 112.116 -178.45 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -67.47 -21.87 65.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.941 0.896 . . . . 0.0 112.703 179.008 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.33 -9.12 58.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.589 1.156 . . . . 0.0 113.557 172.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 98.28 10.5 51.14 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.176 1.369 . . . . 0.0 115.18 174.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . 0.417 HG23 ' HE2' ' A' 1891 ' ' LYS . 82.3 p -100.88 161.91 13.27 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.132 1.466 . . . . 0.0 111.565 174.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.4 m -111.64 123.98 51.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.046 1.338 . . . . 0.0 109.685 166.755 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -92.39 151.07 20.44 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.014 0.926 . . . . 0.0 110.773 170.259 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.5 t -132.57 141.71 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.788 1.635 . . . . 0.0 110.652 -176.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.6 m -132.52 142.94 49.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.876 1.67 . . . . 0.0 110.854 168.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.15 152.37 37.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 174.326 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.4 mt -119.27 102.88 47.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.48 167.09 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.677 2.918 . . . . 0.0 110.251 168.498 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.4 m -136.54 -24.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.314 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 76.2 mt -116.91 149.63 44.44 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.772 1.229 . . . . 0.0 110.703 171.272 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 154.54 49.91 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.006 2.471 . . . . 0.0 110.922 174.832 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 140.45 -152.72 23.1 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.271 1.415 . . . . 0.0 113.031 -177.236 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -113.1 131.11 55.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.005 1.322 . . . . 0.0 111.082 178.73 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -113.47 144.96 41.93 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.787 1.635 . . . . 0.0 110.951 179.734 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.4 m -105.77 116.15 31.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.971 1.309 . . . . 0.0 110.257 178.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.53 120.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.872 1.669 . . . . 0.0 108.374 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -103.53 133.57 48.34 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.362 1.465 . . . . 0.0 109.55 174.593 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.6 t -135.57 133.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.301 1.44 . . . . 0.0 108.058 172.28 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.67 144.39 20.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.741 1.216 . . . . 0.0 111.037 -168.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 123.6 14.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.513 1.125 . . . . 0.0 110.363 -178.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.7 53.01 10.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.923 1.289 . . . . 0.0 111.767 178.294 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.19 13.08 2.14 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.392 2.677 . . . . 0.0 116.283 -176.554 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -117.39 128.26 54.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 0.0 110.922 176.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.26 152.28 25.31 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.704 0.802 . . . . 0.0 112.417 170.214 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 17.3 m -79.26 156.94 76.05 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.064 176.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.49 119.2 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.656 2.237 . . . . 0.0 110.776 174.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.43 65.38 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.312 1.434 . . . . 0.0 116.472 178.486 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.7 p -79.59 153.89 76.08 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 120.329 2.064 . . . . 0.0 113.238 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.77 153.36 99.12 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 119.154 0.733 . . . . 0.0 112.397 -5.076 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -106.37 143.51 34.39 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.44 1.496 . . . . 0.0 111.197 -177.505 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 54.0 m -95.09 117.34 30.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -100.9 132.87 46.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.055 1.342 . . . . 0.0 111.212 173.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 141.16 51.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.959 0.903 . . . . 0.0 110.065 166.12 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.4 138.9 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.484 1.113 . . . . 0.0 109.672 163.19 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 16.5 p -134.83 174.12 10.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.183 . . . . 0.0 112.124 178.145 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -68.27 152.87 52.73 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.404 1.478 . . . . 0.0 113.139 178.934 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 CA--C 1.55 0.98 0 C-N-CA 124.63 1.172 . . . . 0.0 113.363 178.022 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 34.2 mt . . . . . 0 N--CA 1.471 0.576 0 CA-C-O 120.752 0.31 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.26 114.61 6.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.519 1.127 . . . . 0.0 110.828 179.557 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.02 131.98 21.97 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.153 2.569 . . . . 0.0 110.56 -175.46 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.2 t80 -99.36 117.1 33.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.536 0.735 . . . . 0.0 111.079 -176.883 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -151.35 136.81 17.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 111.226 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.96 159.71 41.29 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.294 2.238 . . . . 0.0 110.115 -170.039 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -131.09 138.71 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.894 1.278 . . . . 0.0 110.271 177.742 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 53.8 mt -132.42 135.48 26.37 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.04 1.736 . . . . 0.0 108.832 -172.995 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.6 64.96 8.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.208 3.272 . . . . 0.0 111.813 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.51 147.34 35.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.706 1.602 . . . . 0.0 111.048 175.581 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 92.0 m -115.58 123.21 47.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.183 1.393 . . . . 0.0 109.61 178.164 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 74.5 mt -81.25 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.505 1.122 . . . . 0.0 110.326 177.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.2 -141.71 0.37 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.7 1.6 . . . . 0.0 110.8 178.282 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -80.11 123.79 28.19 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.752 -1.217 . . . . 0.0 110.871 170.673 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.96 -149.24 19.84 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.309 1.433 . . . . 0.0 112.199 -171.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -159.15 148.6 18.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.907 1.283 . . . . 0.0 111.132 -174.917 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.6 tt -120.92 136.12 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.59 1.556 . . . . 0.0 111.585 -179.436 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.7 p -148.46 -174.03 4.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.661 1.984 . . . . 0.0 110.197 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -178.09 -164.58 31.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.545 0.978 . . . . 0.0 115.545 -179.658 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -152.87 144.15 23.21 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.768 1.627 . . . . 0.0 110.24 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 85.8 t -121.0 137.15 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.504 1.921 . . . . 0.0 108.481 173.26 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -119.57 137.91 53.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.464 1.106 . . . . 0.0 112.448 -176.331 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.4 mtm -108.86 149.49 39.62 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.409 1.884 . . . . 0.0 111.999 -176.098 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.61 -40.0 55.62 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.965 3.776 . . . . 0.0 116.598 -177.601 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.7 t -74.61 0.85 13.67 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 95.83 -1.19 63.25 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.802 1.668 . . . . 0.0 114.064 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -67.99 153.36 43.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.971 1.308 . . . . 0.0 111.597 173.016 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.3 m -137.5 157.32 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.018 1.327 . . . . 0.0 111.551 -179.753 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.39 169.93 23.6 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.972 1.709 . . . . 0.0 111.263 -178.077 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -108.29 138.6 20.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.134 0.973 . . . . 0.0 111.068 178.206 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.95 165.09 17.58 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.187 3.258 . . . . 0.0 111.332 172.408 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.5 m -109.23 125.27 52.08 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.868 1.267 . . . . 0.0 108.972 173.804 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.31 138.43 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.792 1.237 . . . . 0.0 109.428 177.33 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 65.6 m -131.55 131.96 43.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.986 1.714 . . . . 0.0 110.322 -178.694 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -77.79 121.74 24.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 172.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -85.01 -13.3 50.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 73.87 -5.64 1.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.989 2.516 . . . . 0.0 114.075 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -91.79 3.49 55.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.229 1.812 . . . . 0.0 113.712 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.97 17.5 57.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.442 1.02 . . . . 0.0 113.368 -171.561 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.6 p -129.46 161.52 30.21 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.725 2.01 . . . . 0.0 109.88 176.051 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -123.21 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.203 1.001 . . . . 0.0 110.109 168.78 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 18.2 m -96.43 142.81 28.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.377 1.071 . . . . 0.0 108.598 170.576 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 12.7 t -127.87 134.47 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 109.301 178.487 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -132.38 154.89 49.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 -173.131 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.7 t80 -156.72 136.49 12.48 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.956 1.703 . . . . 0.0 111.722 178.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.02 118.02 69.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 110.812 176.496 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.93 135.49 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.401 2.734 . . . . 0.0 112.076 -174.167 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 69.6 m -131.83 4.42 4.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.344 1.058 . . . . 0.0 113.78 -178.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -162.35 144.75 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 110.156 -174.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.75 162.01 13.94 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.547 1.139 . . . . 0.0 112.45 177.034 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.1 -167.93 12.45 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.88 1.705 . . . . 0.0 113.633 -178.755 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 27.8 tp -78.76 126.35 30.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.672 1.189 . . . . 0.0 110.619 179.003 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.55 165.78 17.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.987 1.715 . . . . 0.0 111.257 -175.57 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.21 153.85 39.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.116 0.967 . . . . 0.0 111.817 176.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.9 ttm -131.67 131.99 43.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.125 -176.152 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -105.64 135.01 47.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.996 1.719 . . . . 0.0 109.546 169.108 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.2 133.58 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.437 1.095 . . . . 0.0 110.109 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 137.74 25.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.556 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.1 t80 -100.63 121.88 42.37 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.692 1.997 . . . . 0.0 109.861 175.171 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.9 34.71 14.07 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.542 1.137 . . . . 0.0 112.69 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.67 4.53 2.52 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.779 2.431 . . . . 0.0 114.083 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.9 mtm -107.1 129.82 54.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.615 1.566 . . . . 0.0 111.011 176.272 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -57.51 137.2 56.54 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -175.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.1 pt -79.49 156.08 75.97 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.721 175.61 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.88 131.15 38.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.251 1.967 . . . . 0.0 109.732 168.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.24 67.38 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.536 1.065 . . . . 0.0 114.138 -172.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.5 t -84.61 146.6 47.21 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 119.561 1.68 . . . . 0.0 110.952 168.658 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.35 158.8 82.57 Favored 'Cis proline' 0 C--N 1.351 0.694 0 CA-C-N 120.055 1.055 . . . . 0.0 112.032 -8.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.0 mt -103.61 153.56 20.47 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.79 1.236 . . . . 0.0 110.9 172.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -143.44 139.89 30.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.931 1.292 . . . . 0.0 109.525 -178.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 4.6 p90 -167.16 167.55 14.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.293 1.037 . . . . 0.0 112.223 -169.758 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.8 t80 -107.72 140.63 40.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.905 0.882 . . . . 0.0 112.564 178.495 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.4 t -109.7 139.41 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.616 1.566 . . . . 0.0 108.583 172.414 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.7 t0 -156.12 161.06 40.41 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.944 0.878 . . . . 0.0 113.074 -174.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -79.92 103.87 10.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.572 1.549 . . . . 0.0 110.783 177.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 29.9 m -65.02 -16.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.456 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -84.36 -14.58 49.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.664 1.186 . . . . 0.0 114.172 -178.307 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.5 m -73.72 157.32 36.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.241 1.016 . . . . 0.0 112.749 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.85 -14.9 68.85 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.499 1.047 . . . . 0.0 115.154 -173.274 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -67.84 155.22 39.84 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 118.679 1.24 . . . . 0.0 113.213 176.75 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 t -72.32 132.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.844 0.858 . . . . 0.0 109.089 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 6.3 t -150.5 162.67 40.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.773 1.229 . . . . 0.0 110.945 -175.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.65 147.99 32.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.535 1.134 . . . . 0.0 112.24 -174.449 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -168.14 163.22 13.3 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.787 1.635 . . . . 0.0 112.979 -174.843 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.92 175.05 13.62 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.264 1.411 . . . . 0.0 113.046 -179.557 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.02 -35.54 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.734 2.29 . . . . 0.0 112.88 -172.414 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.23 -34.09 87.08 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 119.478 1.035 . . . . 0.0 114.533 -171.384 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.13 -5.24 53.68 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.661 1.23 . . . . 0.0 113.51 175.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 48.4 m -103.8 -49.39 3.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.372 1.869 . . . . 0.0 110.884 177.61 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -139.6 142.88 37.07 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.484 1.914 . . . . 0.0 112.07 -178.36 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.9 171.28 21.79 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.707 1.146 . . . . 0.0 112.963 172.243 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.9 t -136.65 132.7 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.892 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 25.3 m -59.98 144.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.044 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.4 m-20 68.74 -3.91 1.31 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.597 1.959 . . . . 0.0 114.313 178.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.49 142.36 28.04 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.819 1.648 . . . . 0.0 111.269 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.5 125.84 11.02 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.704 2.27 . . . . 0.0 110.572 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -106.29 136.27 46.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.444 1.497 . . . . 0.0 110.167 175.0 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.3 p -129.53 148.77 51.46 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.84 177.68 10.56 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.686 1.594 . . . . 0.0 111.72 176.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.6 m -130.5 142.7 50.48 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.208 1.403 . . . . 0.0 111.028 -169.936 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.7 t -114.34 133.9 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.928 1.691 . . . . 0.0 108.208 169.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.15 127.07 40.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.452 1.101 . . . . 0.0 111.03 -179.505 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 57.8 p -131.53 7.04 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.587 1.555 . . . . 0.0 113.312 -170.501 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -54.54 -35.86 63.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.043 1.737 . . . . 0.0 114.788 -169.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -121.99 15.98 10.83 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.774 1.63 . . . . 0.0 112.572 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.29 -15.42 60.97 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.08 -125.01 6.66 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.377 0.989 . . . . 0.0 111.41 -176.156 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.51 151.52 30.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.006 1.322 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.39 -129.41 1.77 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.072 1.796 . . . . 0.0 110.57 -175.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -125.09 109.14 1.17 Allowed Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.372 0.986 . . . . 0.0 111.797 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.12 132.27 39.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.522 1.129 . . . . 0.0 108.875 170.738 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.7 t -140.06 158.91 43.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 0.0 111.847 -169.766 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 50.0 tp -166.99 136.28 2.85 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 109.472 -161.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.75 160.46 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.155 0.982 . . . . 0.0 112.226 176.625 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.99 137.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.945 1.298 . . . . 0.0 109.512 174.362 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.8 159.14 28.71 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.837 1.655 . . . . 0.0 109.727 170.726 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.44 -163.22 34.54 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.147 -0.971 . . . . 0.0 114.014 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.24 -11.7 23.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.638 2.892 . . . . 0.0 112.9 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 10.6 t -152.72 160.64 43.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.804 1.642 . . . . 0.0 109.938 169.595 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 0.9 OUTLIER -76.75 109.07 10.23 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.958 -1.089 . . . . 0.0 111.616 -177.72 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.35 147.76 44.09 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.954 0.902 . . . . 0.0 111.51 169.153 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.035 0.934 . . . . 0.0 110.072 170.431 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.61 139.83 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.678 1.191 . . . . 0.0 110.668 -166.742 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -133.64 156.98 46.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.925 1.69 . . . . 0.0 110.828 169.042 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -152.72 155.56 37.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.29 1.036 . . . . 0.0 112.398 176.42 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.1 m -140.47 124.65 17.58 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.605 1.562 . . . . 0.0 110.353 -172.244 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.7 131.42 39.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 111.187 170.88 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -107.68 146.9 31.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.315 1.446 . . . . 0.0 111.822 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.0 tm0? -65.68 -21.68 66.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.471 1.108 . . . . 0.0 112.471 175.292 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -73.76 -5.32 40.04 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.705 1.602 . . . . 0.0 114.684 -179.973 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 33.25 6.65 Favored Glycine 0 N--CA 1.476 1.3 0 C-N-CA 124.474 1.035 . . . . 0.0 114.171 177.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.5 p -140.32 162.68 34.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.476 1.51 . . . . 0.0 110.902 176.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 98.3 m -111.81 130.47 55.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.828 1.251 . . . . 0.0 109.272 161.202 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -89.44 150.0 22.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.831 0.853 . . . . 0.0 110.471 169.258 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.7 t -130.25 144.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.134 1.774 . . . . 0.0 109.797 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.3 t -140.44 140.32 35.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.552 1.541 . . . . 0.0 110.78 172.113 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -146.77 154.16 41.06 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.2 mt -118.96 104.02 47.21 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.061 1.744 . . . . 0.0 110.629 -178.673 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.22 162.69 17.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.603 2.869 . . . . 0.0 110.336 166.326 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.0 p -127.59 -19.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.96 149.23 41.71 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.522 1.129 . . . . 0.0 110.614 174.567 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.28 153.03 40.16 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.887 2.391 . . . . 0.0 112.183 -169.524 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 151.1 -154.88 25.84 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.907 1.242 . . . . 0.0 112.598 -174.311 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -115.41 129.77 56.68 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.613 1.165 . . . . 0.0 110.682 178.351 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.45 134.52 55.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.889 1.675 . . . . 0.0 110.596 -176.805 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.1 m -93.2 125.96 38.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 110.85 178.916 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.58 129.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.4 1.48 . . . . 0.0 108.381 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.69 131.76 55.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.476 1.51 . . . . 0.0 109.65 176.633 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.9 t -133.89 130.87 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.108 174.59 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.6 tmmt? -153.69 144.75 22.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.212 1.405 . . . . 0.0 111.392 -165.321 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.16 119.98 11.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.762 1.225 . . . . 0.0 109.611 177.729 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 57.69 57.82 4.04 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 111.773 177.823 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.289 8.6 pt-20 58.16 15.16 3.12 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.179 2.592 . . . . 0.0 116.175 -179.236 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.54 131.56 52.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.679 1.192 . . . . 0.0 110.89 177.162 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -69.08 152.75 44.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.874 0.87 . . . . 0.0 112.456 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.1 m -67.9 152.36 96.44 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.707 163.386 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.23 -20.17 56.03 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.413 2.075 . . . . 0.0 114.846 -165.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.55 -7.11 62.01 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.124 0.869 . . . . 0.0 115.186 174.203 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 42.1 t -84.74 143.64 41.04 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 119.002 1.401 . . . . 0.0 112.193 -176.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.1 142.26 74.12 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 CA-C-N 119.158 0.735 . . . . 0.0 112.192 -3.856 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.07 170.48 9.5 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.318 1.847 . . . . 0.0 110.525 173.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 85.1 m -132.36 121.89 24.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.95 0.9 . . . . 0.0 110.63 173.02 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.65 138.01 36.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.561 1.545 . . . . 0.0 111.022 172.693 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 34.1 ttt85 -96.88 127.6 43.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.605 0.762 . . . . 0.0 110.032 173.545 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 96.1 t -114.86 130.22 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.863 1.265 . . . . 0.0 110.703 -171.02 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 39.5 p -110.08 163.44 13.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.123 1.369 . . . . 0.0 113.022 -179.197 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.16 141.21 22.97 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.445 1.498 . . . . 0.0 112.535 178.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 1.2 p-10 . . . . . 0 CA--C 1.548 0.877 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 176.96 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 36.1 tp . . . . . 0 CA--C 1.541 0.627 0 CA-C-O 119.685 -0.198 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . 0.451 ' HB2' ' H ' ' A' 1861 ' ' ASP . 0.9 OUTLIER -41.66 108.57 0.6 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.239 1.816 . . . . 0.0 113.381 -168.666 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.56 100.03 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.635 2.224 . . . . 0.0 109.022 -178.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 37.4 t80 -89.42 130.89 35.7 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.752 0.787 . . . . 0.0 111.956 -174.753 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -158.04 160.62 37.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.24 1.816 . . . . 0.0 110.768 172.682 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.95 132.81 13.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.273 1.029 . . . . 0.0 110.572 -177.896 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 95.6 t -93.87 127.7 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.052 1.341 . . . . 0.0 109.023 169.51 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.93 135.37 26.96 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.171 1.788 . . . . 0.0 109.069 -173.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.66 110.69 2.95 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.543 2.829 . . . . 0.0 110.233 176.084 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 31.6 t80 -177.61 152.85 0.83 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.333 2.253 . . . . 0.0 109.291 -171.198 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 43.5 m -135.04 129.63 34.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.405 1.082 . . . . 0.0 110.052 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.1 mt -84.51 113.29 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 0.0 109.343 175.049 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -89.13 -66.96 0.87 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.738 0.815 . . . . 0.0 112.936 -179.536 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -157.03 -8.05 0.09 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.494 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.22 -138.4 4.39 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.751 1.644 . . . . 0.0 111.857 175.452 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -152.63 143.85 23.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.652 1.181 . . . . 0.0 110.665 -177.75 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.8 tt -126.25 134.91 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.649 1.58 . . . . 0.0 110.736 179.759 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 70.0 p -146.61 -179.66 6.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.894 1.678 . . . . 0.0 109.933 179.802 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.23 -166.21 33.16 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.549 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.93 137.77 18.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.512 1.525 . . . . 0.0 109.826 -179.734 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.2 t -107.54 133.96 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.892 1.677 . . . . 0.0 108.027 171.532 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -120.75 125.4 47.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.225 1.41 . . . . 0.0 110.468 -169.136 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.54 153.24 41.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.831 1.653 . . . . 0.0 111.373 -176.19 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.14 -23.48 29.0 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.177 2.585 . . . . 0.0 112.411 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.3 m -74.57 -1.16 20.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.681 1.592 . . . . 0.0 114.805 -178.416 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 85.87 49.49 4.28 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.518 1.056 . . . . 0.0 113.003 178.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.25 164.92 37.22 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.038 1.735 . . . . 0.0 111.743 -175.074 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.4 m -141.48 158.98 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.73 1.212 . . . . 0.0 112.97 -171.069 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.46 166.0 34.87 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.679 1.992 . . . . 0.0 111.219 178.451 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -100.31 137.65 20.04 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.781 0.833 . . . . 0.0 111.709 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.16 169.97 11.11 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.276 3.317 . . . . 0.0 111.646 170.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 72.3 m -113.48 129.74 56.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.292 1.437 . . . . 0.0 108.852 173.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.63 136.38 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.683 1.193 . . . . 0.0 109.36 176.545 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 61.7 m -139.18 132.81 30.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.142 1.377 . . . . 0.0 109.846 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.67 128.64 33.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.767 0.827 . . . . 0.0 110.824 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -82.91 -6.59 59.53 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.67 11.94 7.17 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.286 2.235 . . . . 0.0 113.882 -173.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.41 8.34 21.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.817 2.047 . . . . 0.0 112.872 -176.347 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.9 11.09 68.41 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.947 1.261 . . . . 0.0 113.711 -172.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 72.8 p -130.37 157.58 42.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.728 2.011 . . . . 0.0 110.362 178.477 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -109.72 153.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.086 0.954 . . . . 0.0 109.212 163.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.2 t -105.54 142.94 34.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.672 0.789 . . . . 0.0 109.449 162.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.6 t -119.56 132.44 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.401 1.48 . . . . 0.0 108.297 173.428 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -131.35 154.35 48.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.002 1.721 . . . . 0.0 111.497 -172.808 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.6 t80 -154.07 135.04 13.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.349 1.459 . . . . 0.0 111.814 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.79 115.82 65.29 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.684 1.194 . . . . 0.0 110.483 175.571 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.54 148.89 16.36 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.474 2.783 . . . . 0.0 112.258 -172.136 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 50.8 m -119.39 -21.6 7.39 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -167.08 156.65 10.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.95 1.7 . . . . 0.0 111.812 -175.151 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.78 169.6 17.38 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.83 1.252 . . . . 0.0 114.022 -174.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.74 -170.29 14.41 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.175 1.845 . . . . 0.0 114.036 177.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 32.6 tp -87.33 130.56 34.58 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.717 1.207 . . . . 0.0 110.612 177.382 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.5 m80 -128.71 167.61 16.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.034 1.734 . . . . 0.0 111.45 -173.164 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -144.67 159.01 43.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.977 0.911 . . . . 0.0 111.432 172.433 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 35.3 ttm -139.43 130.15 26.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.84 1.656 . . . . 0.0 110.023 -171.68 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.92 118.77 33.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.905 1.682 . . . . 0.0 109.197 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 38.4 mm -120.03 138.61 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.132 1.373 . . . . 0.0 110.637 -179.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 136.94 22.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.463 1.105 . . . . 0.0 113.625 -175.174 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.733 2.013 . . . . 0.0 110.014 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.36 36.2 15.81 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.834 1.254 . . . . 0.0 112.696 -177.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.6 t30 81.7 -1.0 1.59 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.706 2.802 . . . . 0.0 114.842 178.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 86.1 mtp -111.12 137.06 49.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.979 1.312 . . . . 0.0 111.697 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.6 m170 -57.97 136.85 57.15 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.042 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.19 155.85 86.01 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.588 175.434 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.71 129.08 29.23 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.094 1.863 . . . . 0.0 109.787 171.348 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.88 62.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.74 1.162 . . . . 0.0 113.981 -173.648 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.0 t -84.13 144.86 44.85 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 119.46 1.63 . . . . 0.0 111.31 173.349 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.19 164.17 80.76 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.24 1.121 . . . . 0.0 112.486 -5.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 81.0 mt -116.13 153.53 31.62 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.642 1.977 . . . . 0.0 110.788 -176.35 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.75 136.43 38.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.586 1.154 . . . . 0.0 110.66 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 30.1 p90 -155.95 151.37 26.9 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.064 0.945 . . . . 0.0 112.171 -169.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.8 t80 -102.79 149.44 24.48 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 0.0 112.049 175.4 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.2 t -125.95 135.87 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.604 1.562 . . . . 0.0 109.021 -178.566 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' 1789 ' ' ARG . 3.5 p30 -157.86 152.24 24.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.177 1.791 . . . . 0.0 111.878 -174.794 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.75 138.75 58.15 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.38 -173.639 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 71.8 t -69.01 -33.07 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 121.308 -0.87 . . . . 0.0 112.101 -169.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -95.95 14.2 24.36 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.078 1.351 . . . . 0.0 113.785 -175.534 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 18.2 p -65.37 162.55 17.42 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -175.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.46 -20.94 25.77 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.784 1.183 . . . . 0.0 114.164 174.561 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -74.04 161.25 30.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.628 1.214 . . . . 0.0 113.726 179.474 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 19.1 t -75.38 125.12 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.923 1.289 . . . . 0.0 109.107 179.266 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 21.0 p -108.46 172.02 7.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.681 1.192 . . . . 0.0 111.711 -175.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.36 133.71 15.36 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.251 1.02 . . . . 0.0 110.195 160.222 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.5 p90 -161.89 161.97 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.238 1.415 . . . . 0.0 112.556 -177.148 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 127.25 173.84 13.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.393 1.473 . . . . 0.0 112.424 -174.195 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.73 -36.33 6.51 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.997 2.465 . . . . 0.0 113.205 -169.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.66 -32.12 80.49 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 118.741 0.7 . . . . 0.0 114.724 -168.131 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.93 -2.92 39.23 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.702 1.251 . . . . 0.0 113.818 178.213 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 70.7 m -118.49 -36.97 3.39 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.497 1.919 . . . . 0.0 112.238 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -142.73 146.14 34.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.382 1.473 . . . . 0.0 112.703 177.105 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 -179.16 22.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.514 1.054 . . . . 0.0 113.283 171.933 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.1 t -142.27 136.72 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.811 1.244 . . . . 0.0 108.491 175.403 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -55.82 135.62 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 122.799 0.44 . . . . 0.0 112.112 179.662 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.1 m-80 69.02 -4.33 1.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 114.97 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.71 139.14 20.61 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.512 1.125 . . . . 0.0 111.089 174.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.96 124.33 9.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.514 2.143 . . . . 0.0 110.229 178.418 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.24 146.44 34.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.332 1.453 . . . . 0.0 110.546 175.542 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 49.9 p -135.8 154.38 51.23 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -166.205 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -164.54 175.02 10.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.313 1.845 . . . . 0.0 111.772 177.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 91.9 m -130.68 144.85 51.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.639 1.576 . . . . 0.0 111.0 -169.233 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 72.6 t -124.61 126.48 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.951 2.1 . . . . 0.0 107.891 176.585 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.5 132.94 34.8 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.972 1.26 . . . . 0.0 111.406 177.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -128.34 -0.56 5.68 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.098 1.759 . . . . 0.0 113.494 -173.322 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -52.88 -39.6 62.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.927 1.691 . . . . 0.0 115.078 -169.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -114.61 11.15 16.91 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.537 1.535 . . . . 0.0 112.94 -179.02 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -173.39 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 151.9 8.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.739 1.161 . . . . 0.0 112.103 -168.417 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.34 143.27 50.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.557 0.743 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 179.93 -152.38 10.84 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.278 1.894 . . . . 0.0 111.813 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -93.8 101.28 2.73 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 123.955 0.788 . . . . 0.0 111.407 174.277 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.89 127.26 32.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.545 1.138 . . . . 0.0 108.84 170.686 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.1 m -129.25 156.25 44.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.239 1.416 . . . . 0.0 112.229 -176.71 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.0 tp -158.91 133.41 7.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.073 1.749 . . . . 0.0 108.517 -171.353 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.69 156.34 34.77 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.777 0.831 . . . . 0.0 112.065 179.082 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.7 mt -138.81 130.69 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.606 1.162 . . . . 0.0 109.682 177.728 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -116.73 162.56 17.49 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.171 1.788 . . . . 0.0 109.817 172.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.2 -160.52 32.83 Favored Glycine 0 CA--C 1.538 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 114.705 -179.163 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.95 -24.56 60.36 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.049 3.166 . . . . 0.0 112.415 176.279 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.3 t -140.25 159.99 40.96 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.291 1.437 . . . . 0.0 109.455 164.423 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 19.7 tptp -77.22 114.05 15.62 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.979 -1.075 . . . . 0.0 110.816 179.63 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.69 150.77 46.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.657 0.783 . . . . 0.0 112.15 178.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.16 139.38 30.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.766 0.826 . . . . 0.0 109.338 168.237 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -134.77 144.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.485 1.114 . . . . 0.0 110.54 -165.717 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -142.46 165.6 26.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.983 1.313 . . . . 0.0 111.156 166.625 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -160.16 157.48 28.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.78 1.232 . . . . 0.0 112.606 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.9 m -139.9 123.67 17.42 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.553 1.541 . . . . 0.0 110.053 -173.212 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -78.27 133.48 37.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.802 1.241 . . . . 0.0 111.2 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -114.12 145.55 41.48 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 111.694 -179.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -69.86 -13.09 62.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.83 0.852 . . . . 0.0 112.695 174.14 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.96 -3.18 24.31 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.811 1.645 . . . . 0.0 113.816 174.015 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.09 31.91 9.39 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.675 1.131 . . . . 0.0 113.877 176.962 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 61.7 p -138.95 158.62 43.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.047 1.339 . . . . 0.0 111.409 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 88.0 m -105.35 132.59 51.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.607 1.163 . . . . 0.0 109.021 155.818 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.8 148.44 22.12 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.054 0.942 . . . . 0.0 110.002 166.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 98.3 t -127.06 144.37 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.871 1.668 . . . . 0.0 110.122 -176.154 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -136.16 147.76 47.85 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 111.868 166.5 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.23 154.99 36.86 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 177.405 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 23.4 mt -120.73 107.55 38.19 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.662 1.985 . . . . 0.0 110.318 179.76 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.06 175.86 8.09 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.809 3.006 . . . . 0.0 110.337 166.179 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.4 p -148.98 -29.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -173.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.2 mt -107.56 146.71 33.89 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.723 1.147 . . . . 0.0 110.503 166.096 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.48 156.2 45.39 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.838 2.359 . . . . 0.0 110.96 176.075 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.98 -163.61 24.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.976 1.274 . . . . 0.0 113.358 -177.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.51 130.07 41.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.873 1.269 . . . . 0.0 112.413 178.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -115.03 139.45 49.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.7 m -99.27 119.94 38.73 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.699 1.2 . . . . 0.0 110.335 178.036 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.75 126.94 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.382 1.473 . . . . 0.0 108.401 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -110.74 131.93 54.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.623 1.569 . . . . 0.0 109.838 177.339 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.0 t -133.51 128.15 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.352 1.061 . . . . 0.0 109.762 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.4 143.16 23.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.108 1.363 . . . . 0.0 111.662 -168.102 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.7 119.26 11.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.514 1.126 . . . . 0.0 110.224 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 57.84 58.92 3.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.614 1.565 . . . . 0.0 111.762 179.036 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.283 10.1 pt-20 54.52 21.97 3.65 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.891 2.476 . . . . 0.0 115.764 -178.833 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -132.8 127.69 35.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.037 1.335 . . . . 0.0 110.439 177.167 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -66.16 152.34 45.0 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.784 0.834 . . . . 0.0 112.518 175.09 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.8 m -65.87 150.75 96.11 Favored Pre-proline 0 N--CA 1.485 1.302 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.132 162.818 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.74 -18.04 52.86 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.41 2.073 . . . . 0.0 114.893 -163.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.3 -6.58 58.71 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 173.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -82.03 143.33 49.26 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.038 1.419 . . . . 0.0 112.045 -176.647 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 145.51 82.31 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 119.183 0.744 . . . . 0.0 112.561 -3.231 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.62 166.13 11.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.385 1.874 . . . . 0.0 110.924 176.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 46.5 m -124.47 119.29 28.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.858 0.863 . . . . 0.0 110.766 177.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -101.46 135.29 43.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.868 1.267 . . . . 0.0 110.848 171.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -97.37 119.53 36.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.22 0.608 . . . . 0.0 110.059 173.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 78.5 t -104.5 131.03 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.37 1.468 . . . . 0.0 110.282 -175.611 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.6 p -103.27 163.57 12.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.933 1.293 . . . . 0.0 112.838 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.3 142.49 21.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.12 1.343 . . . . 0.0 112.475 177.289 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.0 t70 . . . . . 0 CA--C 1.548 0.89 0 C-N-CA 124.871 1.268 . . . . 0.0 112.904 175.573 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 25.4 tp . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -61.55 120.48 56.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.902 0.881 . . . . 0.0 111.389 -169.703 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 156.27 57.74 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.33 2.686 . . . . 0.0 111.612 -173.766 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -96.38 125.39 40.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.554 0.742 . . . . 0.0 109.943 176.603 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.13 131.37 13.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.172 1.389 . . . . 0.0 110.663 173.25 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.41 34.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.539 1.936 . . . . 0.0 109.471 -173.276 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -123.59 136.4 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.835 1.254 . . . . 0.0 110.42 179.486 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.4 mt -135.72 138.8 29.03 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 125.879 1.672 . . . . 0.0 109.092 -174.543 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.61 43.88 1.43 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.728 3.619 . . . . 0.0 113.134 177.706 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 88.5 t80 -87.09 157.51 19.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.316 1.446 . . . . 0.0 110.897 171.244 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 85.2 m -124.62 127.71 47.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.405 1.482 . . . . 0.0 110.128 -177.181 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.9 mt -88.17 128.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.503 1.121 . . . . 0.0 110.171 174.682 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -111.37 -146.96 0.41 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.926 1.691 . . . . 0.0 110.757 176.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -78.5 127.78 32.63 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.818 -1.176 . . . . 0.0 110.898 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 135.81 -148.33 19.6 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.443 1.497 . . . . 0.0 112.103 -170.804 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.71 148.58 19.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.677 1.191 . . . . 0.0 111.428 -174.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 11.8 tt -121.44 138.32 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.718 1.607 . . . . 0.0 111.398 179.214 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 45.2 p -144.54 -174.74 4.4 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.381 1.872 . . . . 0.0 110.317 -176.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.39 -169.31 38.34 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -152.92 136.76 16.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.894 1.677 . . . . 0.0 109.8 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 26.9 t -108.62 134.8 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.756 1.622 . . . . 0.0 108.343 171.656 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -119.93 138.87 53.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.43 1.092 . . . . 0.0 111.594 -172.196 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -109.32 144.14 29.17 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.825 1.65 . . . . 0.0 111.173 -176.157 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.37 -30.11 61.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.125 3.216 . . . . 0.0 114.836 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.7 m -69.49 -2.27 10.81 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.192 1.397 . . . . 0.0 114.402 178.535 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.22 -1.62 77.27 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.889 1.709 . . . . 0.0 113.829 -177.016 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -79.2 160.67 26.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.652 1.581 . . . . 0.0 111.963 179.732 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 36.0 m -141.55 157.51 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.152 1.381 . . . . 0.0 111.82 178.217 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.65 166.93 32.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.244 1.817 . . . . 0.0 111.415 -179.572 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.52 140.09 20.8 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 -179.836 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.47 174.98 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.625 3.55 . . . . 0.0 112.094 175.267 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.4 m -116.59 141.6 47.98 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 109.052 170.855 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.3 135.64 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.714 1.206 . . . . 0.0 109.272 174.541 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 54.5 m -140.06 128.08 22.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.277 1.431 . . . . 0.0 109.72 -178.691 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.17 137.52 40.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.908 0.883 . . . . 0.0 112.288 172.448 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -89.91 -8.73 51.15 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 69.43 3.1 4.01 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.636 2.374 . . . . 0.0 114.15 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.97 7.51 46.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.896 2.078 . . . . 0.0 112.821 178.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.43 16.81 51.96 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.942 1.258 . . . . 0.0 113.703 -173.36 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 37.7 p -132.68 159.69 38.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 178.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 31.5 m -121.51 147.26 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.674 1.19 . . . . 0.0 110.226 167.099 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 97.3 m -105.33 135.03 47.45 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.827 1.251 . . . . 0.0 108.752 169.131 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 65.1 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.413 1.885 . . . . 0.0 108.467 177.974 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -138.53 159.06 43.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.001 1.32 . . . . 0.0 113.131 -172.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.8 t80 -159.35 137.17 10.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.86 1.664 . . . . 0.0 111.883 174.94 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.35 115.91 65.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.09 1.356 . . . . 0.0 110.736 177.311 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.81 156.81 13.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.78 2.987 . . . . 0.0 112.769 -172.011 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 49.9 m -124.88 -24.6 4.06 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.682 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -145.77 148.61 33.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.421 1.489 . . . . 0.0 110.915 -177.351 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.82 162.89 27.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.547 1.139 . . . . 0.0 113.197 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 133.56 -177.37 19.08 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 125.282 1.42 . . . . 0.0 114.15 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.2 tt -88.26 123.55 32.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 109.115 175.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.45 159.05 32.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.219 1.407 . . . . 0.0 111.673 -172.235 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.18 154.79 50.31 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 111.649 172.291 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -137.69 123.96 20.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.222 1.809 . . . . 0.0 109.81 -172.312 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -95.16 129.52 42.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.748 2.019 . . . . 0.0 109.429 174.118 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.8 mm -127.64 136.82 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.739 1.216 . . . . 0.0 109.87 174.362 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -179.832 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -96.6 121.09 38.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.492 1.917 . . . . 0.0 109.886 173.634 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.47 35.03 10.24 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.965 1.306 . . . . 0.0 112.858 -174.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 47.9 t30 78.55 1.93 2.6 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.334 2.654 . . . . 0.0 114.787 -179.66 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -102.38 133.56 47.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.525 1.53 . . . . 0.0 111.435 174.188 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m170 -52.92 137.2 33.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.615 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.58 156.79 70.54 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.375 0.67 . . . . 0.0 111.204 169.425 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.53 130.87 35.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.034 1.823 . . . . 0.0 109.29 166.067 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.58 -2.27 67.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.245 0.926 . . . . 0.0 113.937 -172.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.4 t -93.24 145.12 29.45 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 118.939 1.369 . . . . 0.0 111.527 170.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.76 165.31 85.43 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.86 0.986 . . . . 0.0 111.606 -10.494 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.12 154.54 20.03 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.367 1.867 . . . . 0.0 110.068 173.725 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -158.23 135.12 9.81 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.177 0.991 . . . . 0.0 111.07 -174.575 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.1 p90 -167.23 173.43 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.746 1.218 . . . . 0.0 112.815 -167.551 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.8 t80 -107.13 141.69 37.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.945 0.898 . . . . 0.0 113.149 173.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 91.0 t -110.11 131.79 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.807 2.043 . . . . 0.0 109.157 179.046 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -152.02 151.2 30.84 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.355 1.462 . . . . 0.0 112.792 -172.833 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -69.99 149.23 47.94 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.235 -0.916 . . . . 0.0 112.751 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.9 m -71.54 -14.66 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -171.058 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.28 -126.1 0.18 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.463 1.505 . . . . 0.0 111.334 178.704 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 75.9 m 75.1 160.7 0.23 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.232 2.613 . . . . 0.0 114.398 171.848 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -102.27 -17.32 20.45 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.051 1.31 . . . . 0.0 114.652 178.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -71.82 155.62 40.21 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.685 1.242 . . . . 0.0 113.833 -179.509 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.7 t -68.01 143.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.604 1.162 . . . . 0.0 108.842 172.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.02 167.22 29.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.507 1.123 . . . . 0.0 110.984 -175.486 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -152.46 148.17 27.11 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.529 1.532 . . . . 0.0 111.441 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -165.51 161.14 18.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 112.392 -173.43 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.17 169.96 12.55 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.105 1.336 . . . . 0.0 113.56 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.08 -30.59 38.34 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.227 2.618 . . . . 0.0 113.092 -170.407 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.3 -17.38 72.23 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.429 1.013 . . . . 0.0 114.586 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 63.8 mt -76.04 -15.76 60.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.749 169.299 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 5.7 m -115.64 -39.46 3.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.029 1.732 . . . . 0.0 112.043 -165.711 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -151.4 150.36 30.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.086 1.754 . . . . 0.0 112.392 -172.434 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.83 176.87 29.19 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.235 1.398 . . . . 0.0 112.712 172.781 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.2 t -140.04 136.29 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.559 1.144 . . . . 0.0 108.342 175.442 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -57.12 137.12 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.272 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 65.32 3.79 2.42 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.833 2.053 . . . . 0.0 114.658 176.879 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -118.03 138.49 25.52 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.895 1.678 . . . . 0.0 110.401 177.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.08 131.97 17.48 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.363 2.042 . . . . 0.0 111.407 -171.077 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.2 148.24 33.22 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.479 1.512 . . . . 0.0 110.355 172.282 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 33.2 p -137.57 149.87 47.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -165.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.28 172.89 16.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.593 1.557 . . . . 0.0 111.85 176.59 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.9 m -123.35 141.39 52.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.738 1.615 . . . . 0.0 110.482 -173.657 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 59.2 t -113.71 139.6 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.272 1.829 . . . . 0.0 107.897 168.215 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.48 133.17 45.31 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.228 1.011 . . . . 0.0 111.738 177.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 68.3 p -125.58 1.02 7.57 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.469 1.907 . . . . 0.0 113.039 -177.317 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -49.97 -28.63 7.12 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.76 2.424 . . . . 0.0 117.122 -169.86 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -139.21 20.38 2.6 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.1 1.36 . . . . 0.0 112.031 176.678 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.46 44.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 113.474 -174.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.36 146.11 4.29 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.007 1.289 . . . . 0.0 112.297 -171.179 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.13 147.16 38.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.832 0.853 . . . . 0.0 112.005 -179.378 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . -175.79 -42.43 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.002 1.287 . . . . 0.0 113.543 176.513 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 162.03 102.17 0.17 Allowed Glycine 0 N--CA 1.47 0.943 0 C-N-CA 125.065 1.316 . . . . 0.0 112.594 170.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 33.2 tp -81.65 136.88 35.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.305 1.042 . . . . 0.0 110.117 176.577 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -129.97 157.44 42.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.346 1.458 . . . . 0.0 111.553 177.555 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 55.6 tp -160.68 132.35 5.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.457 1.503 . . . . 0.0 108.977 -169.589 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.43 162.72 37.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.877 0.871 . . . . 0.0 112.132 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.6 mt -136.59 132.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.872 1.269 . . . . 0.0 109.074 172.54 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -115.02 157.71 23.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.704 1.602 . . . . 0.0 109.744 169.219 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.6 -165.15 35.24 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.192 -0.943 . . . . 0.0 113.748 -177.714 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.62 -15.12 27.41 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.633 2.889 . . . . 0.0 112.422 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -147.1 160.38 42.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.997 1.719 . . . . 0.0 109.255 163.488 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 52.1 tptt -83.24 113.02 20.39 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.868 -1.145 . . . . 0.0 111.857 -174.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.94 150.27 44.29 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.182 0.993 . . . . 0.0 111.857 173.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.52 145.65 26.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.888 0.875 . . . . 0.0 110.691 169.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 20.1 mt -137.4 140.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.813 1.245 . . . . 0.0 110.505 -163.631 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.9 m -133.3 157.27 45.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.772 1.629 . . . . 0.0 110.675 168.442 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 31.8 p -156.46 156.89 34.54 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.233 -0.917 . . . . 0.0 113.104 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -144.14 124.82 14.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.704 1.602 . . . . 0.0 110.078 -171.032 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.24 144.92 32.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.569 1.147 . . . . 0.0 112.535 173.951 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -121.74 152.0 39.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.586 1.554 . . . . 0.0 112.062 -176.16 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -68.23 -18.41 64.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.818 1.247 . . . . 0.0 112.788 176.43 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -76.55 -2.79 34.18 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.86 1.664 . . . . 0.0 114.247 -178.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 89.77 33.92 8.76 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.385 0.993 . . . . 0.0 113.399 -178.563 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.2 p -139.88 163.63 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.354 1.461 . . . . 0.0 111.215 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.0 m -121.08 132.89 55.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.717 1.607 . . . . 0.0 108.841 161.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -92.02 147.51 22.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.857 0.863 . . . . 0.0 110.261 170.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 91.0 t -128.95 142.97 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.561 1.544 . . . . 0.0 109.83 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 86.2 p -132.99 147.5 52.28 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.227 1.411 . . . . 0.0 111.589 167.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -151.22 157.8 43.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 24.6 mt -124.93 108.4 28.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.903 1.681 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.02 168.95 15.05 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.781 2.987 . . . . 0.0 110.25 166.116 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.3 p -131.64 -20.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.434 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.7 150.73 51.44 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.556 1.142 . . . . 0.0 110.575 173.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.65 154.39 39.47 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.929 2.419 . . . . 0.0 112.573 -168.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.34 -144.68 12.19 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.683 1.135 . . . . 0.0 112.964 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -123.31 133.37 54.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.49 177.365 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -123.55 134.08 53.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 0.0 110.769 -174.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 74.7 m -100.06 110.32 22.62 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.996 1.318 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.35 126.77 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.419 1.488 . . . . 0.0 108.546 176.156 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -105.33 130.98 53.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.626 . . . . 0.0 109.665 174.378 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -131.11 128.55 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.433 1.093 . . . . 0.0 109.7 172.072 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.37 141.37 21.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.174 1.39 . . . . 0.0 111.502 -168.505 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.49 121.32 17.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.935 1.294 . . . . 0.0 109.968 -178.768 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 52.65 59.07 4.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.541 1.536 . . . . 0.0 112.0 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 7.7 pt-20 60.86 0.78 0.39 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 129.035 2.934 . . . . 0.0 116.867 -177.198 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -107.52 123.63 48.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.111 179.293 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.18 144.78 54.99 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.35 -0.844 . . . . 0.0 111.703 169.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.5 m -73.44 151.08 89.56 Favored Pre-proline 0 N--CA 1.48 1.041 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.038 171.976 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.52 129.67 35.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.129 2.553 . . . . 0.0 110.762 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.13 -15.24 63.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.04 1.305 . . . . 0.0 115.027 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 34.5 t -77.09 139.36 65.19 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.223 1.511 . . . . 0.0 111.346 176.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.79 147.55 81.3 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.648 0.91 . . . . 0.0 112.585 -3.098 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.24 133.77 45.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.837 1.655 . . . . 0.0 110.59 -178.887 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 24.6 m -97.67 108.66 21.43 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.552 0.741 . . . . 0.0 110.847 -177.08 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.34 132.84 37.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.014 1.326 . . . . 0.0 111.886 176.328 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 22.0 tpt85 -88.15 113.29 23.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.482 178.771 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.0 t -103.49 129.56 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.048 0.939 . . . . 0.0 110.758 -176.422 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 69.6 p -110.11 162.47 14.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.019 1.327 . . . . 0.0 112.977 -179.683 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.57 135.44 13.6 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.938 1.256 . . . . 0.0 112.345 178.003 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 . . . . . 0 CA--C 1.548 0.87 0 C-N-CA 124.577 1.151 . . . . 0.0 112.937 175.684 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 31.6 mt . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 47.4 ttm-85 -67.28 117.9 51.04 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.817 1.647 . . . . 0.0 110.215 -175.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.2 151.11 60.48 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.212 2.608 . . . . 0.0 111.572 -171.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.4 t80 -101.16 119.5 38.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.938 0.895 . . . . 0.0 109.689 176.339 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -147.81 131.13 16.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.136 1.374 . . . . 0.0 110.398 172.38 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.78 148.31 35.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 109.756 -171.054 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -119.94 139.56 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.043 1.337 . . . . 0.0 110.56 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.3 mt -133.92 137.49 28.57 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.164 1.786 . . . . 0.0 108.465 -176.107 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.36 46.7 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.332 3.354 . . . . 0.0 112.861 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.2 t80 -91.41 155.05 18.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.362 1.465 . . . . 0.0 111.072 174.81 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.3 m -125.25 126.35 45.02 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.882 1.273 . . . . 0.0 109.831 177.866 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.3 mt -95.69 115.23 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 109.077 177.477 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.79 -55.52 4.05 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.627 0.771 . . . . 0.0 112.992 179.656 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -161.82 -35.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.852 1.261 . . . . 0.0 114.002 -171.536 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -72.53 164.9 54.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.226 1.393 . . . . 0.0 113.801 179.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -86.42 142.71 28.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.871 1.269 . . . . 0.0 112.212 -174.515 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.86 134.39 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.58 1.552 . . . . 0.0 110.459 174.591 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.1 p -145.68 173.03 12.43 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.998 1.719 . . . . 0.0 110.738 -175.082 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.72 -176.62 25.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 -177.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -151.43 137.72 18.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.938 1.695 . . . . 0.0 109.057 171.026 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.3 t -111.69 133.29 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.054 1.742 . . . . 0.0 108.131 174.179 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -109.28 129.96 55.5 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.237 1.415 . . . . 0.0 110.626 -176.625 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -96.21 151.79 38.4 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.621 1.568 . . . . 0.0 111.411 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.99 -24.85 45.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.294 2.663 . . . . 0.0 113.213 -179.093 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 20.3 m -73.91 -1.09 18.21 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.84 70.41 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.736 1.636 . . . . 0.0 114.624 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -71.75 163.76 27.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.221 1.408 . . . . 0.0 112.301 176.263 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.74 153.39 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.219 1.408 . . . . 0.0 111.873 175.647 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.43 166.55 31.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.852 2.061 . . . . 0.0 110.41 179.096 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.06 141.57 23.01 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.188 -0.945 . . . . 0.0 112.444 -177.823 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.24 172.64 8.29 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.67 3.58 . . . . 0.0 111.658 173.332 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.9 m -109.34 125.58 52.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.322 1.449 . . . . 0.0 108.899 172.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.02 129.46 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.407 1.083 . . . . 0.0 108.42 173.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.5 m -118.77 128.33 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.149 1.78 . . . . 0.0 109.674 -178.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.42 119.92 22.43 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.246 1.018 . . . . 0.0 110.465 170.615 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -84.67 -14.43 48.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.3 mttt 71.5 -3.36 2.15 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.788 2.435 . . . . 0.0 114.514 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -92.8 5.57 50.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.297 1.839 . . . . 0.0 113.319 178.515 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.63 19.02 46.03 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.694 1.14 . . . . 0.0 113.53 -172.504 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -131.98 162.0 31.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 109.966 175.216 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.1 m -126.1 147.13 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.226 . . . . 0.0 109.978 168.413 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 52.1 m -108.75 135.22 50.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.376 1.071 . . . . 0.0 108.568 171.328 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -117.63 131.49 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.309 1.444 . . . . 0.0 108.797 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.08 151.27 51.86 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.012 1.325 . . . . 0.0 112.504 -173.261 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.05 136.08 17.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.38 1.472 . . . . 0.0 111.764 176.825 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.86 115.62 64.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.764 1.225 . . . . 0.0 110.827 177.792 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.03 140.43 25.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.826 3.018 . . . . 0.0 112.918 -172.117 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.2 p -116.78 -8.45 11.37 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.705 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.29 157.48 22.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.044 1.738 . . . . 0.0 111.579 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.78 172.62 12.02 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.458 1.103 . . . . 0.0 112.377 174.058 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.95 -172.17 15.57 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.527 1.537 . . . . 0.0 113.62 178.778 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.83 130.9 35.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.502 1.121 . . . . 0.0 110.233 -178.581 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.5 m80 -128.89 162.08 28.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.913 1.685 . . . . 0.0 111.612 -173.786 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -141.98 159.5 42.11 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.28 1.032 . . . . 0.0 111.696 172.943 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.1 ttm -139.44 134.52 32.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 110.607 -171.8 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -110.24 136.16 49.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 109.922 172.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.0 mm -133.1 132.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.146 1.378 . . . . 0.0 109.951 178.118 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 138.19 28.32 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.8 t80 -102.47 121.03 41.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.478 2.311 . . . . 0.0 109.586 176.32 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.07 38.4 20.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.832 1.253 . . . . 0.0 112.551 -174.844 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 78.89 -9.0 1.57 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 128.906 2.883 . . . . 0.0 115.174 -178.392 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 67.7 mtm -95.53 129.82 42.58 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.208 1.403 . . . . 0.0 111.187 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -59.12 138.33 57.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.208 -0.933 . . . . 0.0 113.438 -177.309 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 33.4 pt -71.81 153.05 93.26 Favored Pre-proline 0 N--CA 1.48 1.044 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.044 169.645 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.65 -18.37 58.65 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.407 2.071 . . . . 0.0 113.9 -174.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.83 0.52 87.9 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.771 1.177 . . . . 0.0 114.685 171.485 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -97.2 142.6 24.78 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.652 1.726 . . . . 0.0 111.539 176.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.53 165.7 74.06 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.842 0.979 . . . . 0.0 112.854 -1.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 86.2 mt -112.93 159.54 18.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.22 1.808 . . . . 0.0 110.665 170.282 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -155.49 139.6 16.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.638 1.175 . . . . 0.0 110.137 -173.381 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.33 -175.69 3.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.906 1.282 . . . . 0.0 112.382 -170.429 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.4 t80 -124.02 141.58 51.92 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.89 1.276 . . . . 0.0 112.679 178.23 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 54.7 t -110.9 142.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.099 1.76 . . . . 0.0 109.434 176.724 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.03 169.39 21.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.801 2.04 . . . . 0.0 109.954 -171.607 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -77.32 143.57 38.71 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.513 -1.367 . . . . 0.0 111.187 170.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.7 m -61.94 -26.87 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -175.152 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.75 134.18 48.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.307 1.443 . . . . 0.0 110.045 166.814 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 7.6 t -164.66 156.56 15.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.934 1.694 . . . . 0.0 110.724 178.274 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.6 58.23 4.99 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.172 1.367 . . . . 0.0 113.525 -173.857 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -155.5 167.79 29.23 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.3 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.0 p -71.49 147.26 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.382 1.073 . . . . 0.0 109.582 159.436 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.5 t -160.02 167.96 26.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.087 1.355 . . . . 0.0 110.487 178.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.68 145.48 25.86 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 -179.119 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.6 p90 -168.74 166.77 11.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.786 1.634 . . . . 0.0 112.578 -173.757 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.89 174.63 13.7 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.3 1.428 . . . . 0.0 112.542 -177.279 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.17 -36.1 13.06 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.257 . . . . 0.0 112.87 -170.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.41 87.65 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.45 1.023 . . . . 0.0 114.589 -170.738 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.13 -2.08 39.08 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.912 1.356 . . . . 0.0 113.498 175.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.3 m -108.17 -51.39 2.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.28 1.832 . . . . 0.0 110.926 177.529 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -138.4 144.71 40.34 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.537 1.935 . . . . 0.0 112.522 -176.731 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.22 178.27 20.4 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.985 1.278 . . . . 0.0 112.912 171.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -141.67 138.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.852 1.261 . . . . 0.0 108.259 174.501 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -59.96 149.17 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.062 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 77.6 m-20 67.2 14.76 9.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.425 1.89 . . . . 0.0 114.382 169.838 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -145.56 152.84 50.34 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.874 1.67 . . . . 0.0 111.236 174.211 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.74 145.66 32.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.497 2.131 . . . . 0.0 112.145 -174.616 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -121.46 150.83 40.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.409 1.884 . . . . 0.0 110.043 170.621 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.8 p -137.71 149.97 46.93 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -165.487 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.07 175.96 12.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.78 1.632 . . . . 0.0 111.457 175.341 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.6 m -129.71 140.42 51.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.944 1.298 . . . . 0.0 110.727 -172.045 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.2 t -105.2 133.27 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.443 1.497 . . . . 0.0 107.906 168.217 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.43 126.69 46.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.703 1.201 . . . . 0.0 110.446 174.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.1 p -126.51 5.4 6.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.849 2.06 . . . . 0.0 113.066 -171.604 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.74 -37.5 51.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.241 1.817 . . . . 0.0 115.104 -170.241 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -116.36 9.73 14.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.403 1.481 . . . . 0.0 113.014 178.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.62 -10.94 59.71 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -171.097 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 86.37 -125.68 7.5 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.453 1.025 . . . . 0.0 112.446 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.02 149.5 28.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.387 1.475 . . . . 0.0 110.878 -173.901 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.84 -155.78 26.74 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.585 1.564 . . . . 0.0 112.736 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.1 108.14 3.38 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.127 0.87 . . . . 0.0 111.504 174.416 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.74 128.17 34.33 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 108.722 171.84 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.6 m -133.74 160.24 38.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.032 1.333 . . . . 0.0 112.854 -173.299 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 37.3 tp -158.46 138.53 12.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.491 1.916 . . . . 0.0 108.951 -171.569 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.15 157.19 35.54 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.071 0.948 . . . . 0.0 111.944 174.85 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.7 mt -138.35 140.29 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.875 1.27 . . . . 0.0 109.741 177.05 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.22 144.04 51.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.652 1.581 . . . . 0.0 109.877 173.723 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.34 -166.0 26.67 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.958 -175.242 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.58 -26.33 69.5 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.477 3.451 . . . . 0.0 112.843 178.436 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -141.72 156.26 45.61 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.986 1.314 . . . . 0.0 109.093 161.039 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -72.31 110.72 6.93 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.193 -0.942 . . . . 0.0 111.258 -177.739 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.88 148.38 51.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.0 111.372 172.229 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.33 146.34 27.77 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.818 0.447 . . . . 0.0 110.159 165.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.24 143.97 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.029 1.332 . . . . 0.0 109.856 -165.182 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.58 163.24 35.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.693 1.197 . . . . 0.0 111.418 168.946 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -161.34 152.43 18.5 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.991 1.317 . . . . 0.0 112.305 -178.606 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 95.1 m -137.96 121.92 17.79 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.637 1.575 . . . . 0.0 109.692 -175.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.55 119.3 15.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.452 0.701 . . . . 0.0 109.966 165.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.66 -16.79 50.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 112.656 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 10.3 tt0 72.71 -8.8 1.18 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 128.08 2.552 . . . . 0.0 113.072 -176.286 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.36 11.61 8.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.972 2.109 . . . . 0.0 113.494 -177.368 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.84 15.34 54.73 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.187 1.375 . . . . 0.0 113.605 -171.869 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 65.9 p -141.66 154.17 45.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.651 1.58 . . . . 0.0 111.754 177.419 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 35.3 m -120.87 131.24 54.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.662 1.585 . . . . 0.0 108.988 164.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.5 t -88.17 149.4 23.91 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.923 0.889 . . . . 0.0 110.838 173.125 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -132.58 143.14 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.632 1.573 . . . . 0.0 110.121 -177.229 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 92.8 p -137.28 150.32 47.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.876 1.27 . . . . 0.0 112.252 168.852 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -152.24 155.05 36.98 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.138 -0.976 . . . . 0.0 112.462 173.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.38 99.98 29.88 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.398 1.079 . . . . 0.0 109.998 -174.461 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -83.21 162.21 15.32 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.069 3.179 . . . . 0.0 111.083 176.41 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -133.77 -20.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -172.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.6 mt -118.65 147.32 41.86 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 124.849 1.259 . . . . 0.0 110.261 170.21 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 158.76 43.61 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.883 2.388 . . . . 0.0 111.019 176.385 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 128.08 -163.79 21.58 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.967 1.27 . . . . 0.0 113.213 -177.048 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.81 136.9 32.77 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 112.921 -178.957 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -124.78 129.98 51.51 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.743 1.617 . . . . 0.0 110.031 176.429 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.81 126.19 35.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 110.436 174.838 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.71 126.23 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.465 1.506 . . . . 0.0 108.047 178.643 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -108.94 131.84 54.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.474 1.509 . . . . 0.0 109.442 175.651 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.85 129.09 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.392 1.077 . . . . 0.0 109.383 172.739 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.78 143.39 26.34 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.225 1.41 . . . . 0.0 111.59 -168.36 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.83 122.18 12.34 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.597 1.159 . . . . 0.0 110.341 179.748 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 57.67 56.24 5.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.315 1.446 . . . . 0.0 111.732 -179.406 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 10.0 pt-20 54.78 22.34 4.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.903 2.481 . . . . 0.0 115.898 -179.113 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -132.84 131.39 40.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.071 1.348 . . . . 0.0 110.542 176.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.58 150.32 47.12 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.796 0.838 . . . . 0.0 112.299 174.788 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -67.69 156.29 89.37 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.103 167.833 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -52.28 -33.67 56.39 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.042 3.161 . . . . 0.0 116.378 -169.388 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.98 -3.21 59.17 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.6 t -84.12 143.02 41.87 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.983 1.392 . . . . 0.0 112.355 -177.316 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.26 138.14 54.17 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.062 0.701 . . . . 0.0 111.812 -4.449 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.48 168.3 12.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.862 1.665 . . . . 0.0 110.292 172.843 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 25.0 m -131.76 116.86 17.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 110.069 172.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -91.46 152.93 20.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.746 1.219 . . . . 0.0 110.785 170.113 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -108.87 129.08 55.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.516 0.726 . . . . 0.0 110.19 166.521 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.8 t -105.06 129.22 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.318 1.447 . . . . 0.0 110.135 179.242 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 86.9 m -95.99 152.56 18.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.0 1.72 . . . . 0.0 111.495 -178.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.27 133.35 12.18 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.871 1.224 . . . . 0.0 112.079 175.289 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.2 t70 . . . . . 0 CA--C 1.546 0.799 0 C-N-CA 124.751 1.22 . . . . 0.0 113.484 -177.157 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.467 0.405 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -56.27 115.54 10.19 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.287 1.435 . . . . 0.0 110.362 177.445 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 133.41 27.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.117 1.878 . . . . 0.0 108.682 174.122 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.02 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 109.947 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.93 150.51 25.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.351 1.461 . . . . 0.0 111.652 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -159.62 151.57 20.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.856 1.662 . . . . 0.0 109.893 -177.123 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -123.81 134.5 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.005 1.322 . . . . 0.0 109.655 170.845 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.77 135.98 27.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.919 1.688 . . . . 0.0 109.215 -172.692 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.02 112.77 3.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.209 2.606 . . . . 0.0 110.208 173.873 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 46.8 t80 -174.94 147.6 0.98 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.026 2.13 . . . . 0.0 109.278 -171.683 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 52.5 m -125.63 127.0 45.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.574 1.15 . . . . 0.0 109.803 -178.993 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.82 113.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.731 0.812 . . . . 0.0 109.436 174.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -98.33 -158.53 0.68 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.213 1.405 . . . . 0.0 111.006 172.006 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tptt -68.5 120.36 14.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.603 -1.311 . . . . 0.0 111.091 173.104 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.64 -147.61 18.63 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.676 1.608 . . . . 0.0 111.867 -171.066 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.78 143.46 15.89 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.3 1.04 . . . . 0.0 111.496 -175.118 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.9 tt -128.95 136.44 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.731 1.612 . . . . 0.0 110.946 177.076 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.9 p -147.64 -178.37 6.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.337 1.855 . . . . 0.0 110.372 -176.765 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.52 -170.55 31.57 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 179.027 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -149.72 139.81 22.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.317 1.847 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 45.1 t -113.67 135.53 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.3 1.84 . . . . 0.0 108.178 170.647 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -119.02 138.15 53.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.166 1.387 . . . . 0.0 111.947 -178.386 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.5 mpp? -114.05 141.57 26.51 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.831 1.652 . . . . 0.0 111.399 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -25.13 78.77 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.126 3.217 . . . . 0.0 115.017 177.144 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.3 p -74.71 4.35 6.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.861 1.664 . . . . 0.0 114.655 -177.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.84 41.15 6.04 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 124.606 1.098 . . . . 0.0 113.293 172.961 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -148.67 163.89 35.94 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.63 1.572 . . . . 0.0 111.938 -175.058 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.5 161.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.011 1.324 . . . . 0.0 112.231 -174.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.02 -178.25 6.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.088 2.155 . . . . 0.0 110.22 178.051 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -127.04 146.23 56.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.065 -1.022 . . . . 0.0 111.419 176.581 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.33 166.18 14.23 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.207 3.271 . . . . 0.0 111.49 177.857 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.8 m -101.98 134.21 45.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 108.585 170.131 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.17 132.91 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.799 1.239 . . . . 0.0 109.013 175.019 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.7 m -138.6 122.32 17.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.243 1.417 . . . . 0.0 109.465 178.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -76.63 131.8 39.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.865 0.866 . . . . 0.0 111.73 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -83.44 1.68 40.44 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.041 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 69.51 16.86 8.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.624 1.97 . . . . 0.0 112.991 179.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -138.66 16.82 2.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.18 1.792 . . . . 0.0 113.015 -169.545 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.74 13.27 63.03 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.596 1.093 . . . . 0.0 115.132 177.184 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.9 p -129.44 155.94 44.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.835 1.654 . . . . 0.0 110.41 174.843 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.0 m -115.42 138.37 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.886 0.875 . . . . 0.0 110.202 167.192 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.4 m -96.03 136.43 36.49 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.731 1.212 . . . . 0.0 108.429 167.964 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 52.9 t -121.78 135.85 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.791 1.636 . . . . 0.0 108.399 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -140.63 159.33 42.44 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.562 1.145 . . . . 0.0 113.139 -175.839 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.0 t80 -154.59 134.25 12.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.942 1.697 . . . . 0.0 111.538 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.46 121.75 75.08 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.381 1.072 . . . . 0.0 111.205 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.44 156.68 32.65 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.741 2.96 . . . . 0.0 111.857 -176.558 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.1 t -140.75 -13.76 0.96 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.516 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -165.38 151.54 9.8 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 110.657 -176.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.02 168.45 20.07 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.427 1.091 . . . . 0.0 113.444 -177.602 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 125.04 -179.97 15.94 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.346 1.45 . . . . 0.0 114.157 176.723 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.0 tt -86.66 122.37 30.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.758 1.223 . . . . 0.0 109.821 179.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 26.2 m80 -116.99 160.82 20.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.698 1.599 . . . . 0.0 111.619 -173.113 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -142.78 144.21 32.5 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.978 1.311 . . . . 0.0 110.304 -178.557 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.5 ttm -135.39 141.02 45.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.827 1.251 . . . . 0.0 112.613 -176.386 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.09 139.57 35.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.737 1.615 . . . . 0.0 110.405 163.667 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.4 mm -127.84 131.61 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 109.272 163.63 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.31 134.69 23.06 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.106 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 13.7 t80 -98.03 122.83 41.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.573 1.949 . . . . 0.0 109.632 174.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.83 36.43 14.59 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.723 1.209 . . . . 0.0 112.824 -175.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 77.78 3.18 2.97 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 128.107 2.563 . . . . 0.0 114.614 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.0 mtm -105.64 130.21 53.72 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.583 1.553 . . . . 0.0 111.079 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.28 137.22 41.93 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.773 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 24.6 pt -77.05 156.18 82.25 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.228 171.024 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -59.82 128.53 27.14 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.111 1.874 . . . . 0.0 109.718 169.977 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.92 -16.9 57.99 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.784 1.183 . . . . 0.0 114.072 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.4 t -83.22 144.75 47.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 119.347 1.574 . . . . 0.0 110.664 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.43 160.24 93.94 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 120.209 1.11 . . . . 0.0 113.048 -2.638 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.97 154.07 22.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.661 1.984 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -156.4 134.41 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.039 0.936 . . . . 0.0 110.96 -173.025 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.08 -177.53 5.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 112.779 -172.486 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.4 t80 -122.4 137.44 54.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 177.253 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 90.4 t -100.75 134.59 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.644 1.577 . . . . 0.0 109.573 174.481 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 18.6 t0 -156.51 169.25 25.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.242 1.817 . . . . 0.0 110.301 -179.519 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -69.45 142.78 53.73 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.073 -1.017 . . . . 0.0 112.7 176.622 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 53.6 t -67.02 -36.14 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.207 1.003 . . . . 0.0 112.556 -172.245 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -121.61 20.04 11.1 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.533 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 28.5 p -61.4 158.93 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.922 1.289 . . . . 0.0 114.413 -176.203 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -82.42 -29.65 35.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.331 0.967 . . . . 0.0 113.661 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -71.55 153.7 41.98 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.253 1.027 . . . . 0.0 112.583 173.472 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.8 t -70.17 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 3.3 t -155.0 164.11 39.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.591 1.157 . . . . 0.0 111.249 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.17 149.22 42.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 -175.966 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 4.2 p90 -161.93 158.62 25.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.643 1.577 . . . . 0.0 113.004 179.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.04 168.3 11.29 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.258 1.409 . . . . 0.0 113.572 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.48 -30.14 36.35 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.429 2.753 . . . . 0.0 113.153 -171.46 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.45 -13.58 71.12 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.078 0.847 . . . . 0.0 114.527 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 66.6 mt -79.03 -11.94 60.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.935 1.367 . . . . 0.0 112.807 168.603 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 10.3 m -120.6 -38.53 2.86 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.839 1.656 . . . . 0.0 112.466 -165.605 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -154.83 156.99 37.21 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.74 1.616 . . . . 0.0 112.366 -172.009 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.14 -176.84 28.71 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.108 0.861 . . . . 0.0 114.074 172.068 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.5 t -141.22 133.3 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.172 1.389 . . . . 0.0 108.255 177.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.9 m -56.63 137.44 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.876 0.47 . . . . 0.0 111.958 179.634 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.03 -2.18 1.86 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.691 1.996 . . . . 0.0 114.713 178.076 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -106.81 142.06 24.19 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.451 1.5 . . . . 0.0 110.791 175.793 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.4 126.53 11.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.382 2.054 . . . . 0.0 110.81 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -103.23 145.37 30.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.345 1.458 . . . . 0.0 110.282 172.422 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.4 p -135.9 153.51 51.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -165.626 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -165.6 173.45 10.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.226 1.81 . . . . 0.0 111.629 177.476 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 38.2 m -128.96 140.63 51.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.508 1.523 . . . . 0.0 110.781 -171.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.5 t -110.52 136.32 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.908 1.683 . . . . 0.0 108.335 168.198 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.39 126.0 38.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.681 1.193 . . . . 0.0 110.769 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 74.7 p -133.45 -1.31 3.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.909 1.283 . . . . 0.0 114.148 -167.53 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -54.59 -38.74 67.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.225 1.41 . . . . 0.0 114.684 -169.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -114.33 9.7 16.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.733 1.613 . . . . 0.0 112.759 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.83 67.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.329 1.052 . . . . 0.0 113.479 -175.116 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.13 153.11 6.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.833 1.206 . . . . 0.0 112.291 -169.554 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -70.13 160.94 31.14 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.655 0.782 . . . . 0.0 112.913 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.38 15.86 0.07 OUTLIER Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -176.419 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.44 96.0 1.5 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.531 1.539 . . . . 0.0 112.574 177.899 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.59 125.49 29.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.786 1.235 . . . . 0.0 108.527 167.543 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -116.34 154.96 29.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.98 1.712 . . . . 0.0 111.853 -179.465 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 59.7 tp -162.16 133.37 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 109.698 -170.034 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.84 161.68 34.52 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.655 1.182 . . . . 0.0 111.912 -179.523 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -137.99 132.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.612 1.165 . . . . 0.0 110.114 175.756 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -112.07 134.04 53.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.844 1.657 . . . . 0.0 109.323 170.458 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -164.96 -168.52 27.24 Favored Glycine 0 CA--C 1.537 1.435 0 O-C-N 121.353 -0.842 . . . . 0.0 114.909 -175.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.77 -23.35 55.82 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.929 3.086 . . . . 0.0 112.467 176.155 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -141.03 157.75 44.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.433 1.493 . . . . 0.0 109.441 165.377 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -69.29 111.36 5.15 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.042 -1.036 . . . . 0.0 110.424 174.454 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.06 146.18 51.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.553 0.741 . . . . 0.0 111.299 172.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.62 136.51 32.96 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.341 0.656 . . . . 0.0 109.368 169.394 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.9 mt -131.0 138.83 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.572 1.149 . . . . 0.0 110.456 -167.368 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.8 m -133.75 152.89 52.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.442 1.497 . . . . 0.0 110.661 169.75 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.6 p -150.88 153.18 34.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.829 0.852 . . . . 0.0 112.96 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 84.8 m -139.84 120.37 14.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.649 1.58 . . . . 0.0 110.107 -171.22 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.5 133.21 37.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.664 1.186 . . . . 0.0 111.332 172.189 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -110.75 145.89 37.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.697 1.599 . . . . 0.0 111.635 -178.685 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -69.25 -14.22 62.84 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.766 0.826 . . . . 0.0 112.736 174.524 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.78 -8.26 54.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.597 1.559 . . . . 0.0 113.913 174.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.98 31.68 7.19 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.466 1.031 . . . . 0.0 114.288 177.573 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.4 p -137.19 159.59 41.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.16 1.384 . . . . 0.0 110.966 175.665 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 49.6 t -112.86 126.21 55.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 108.667 160.697 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -93.23 145.39 24.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.921 0.889 . . . . 0.0 110.307 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 78.9 t -127.33 143.72 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.171 1.388 . . . . 0.0 110.138 -177.657 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.6 p -134.58 146.45 49.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.007 1.323 . . . . 0.0 111.552 167.096 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 26.1 p90 -148.21 151.38 35.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.576 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.8 mt -112.73 106.77 55.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.037 1.735 . . . . 0.0 110.512 179.021 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.64 174.44 10.41 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.795 2.997 . . . . 0.0 110.224 165.022 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -149.57 -31.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.214 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.44 148.69 35.82 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.33 0.968 . . . . 0.0 110.628 167.042 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.47 157.42 56.41 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 110.761 171.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.0 -159.7 23.1 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.667 1.127 . . . . 0.0 112.604 -175.667 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.35 129.86 56.15 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.187 0.995 . . . . 0.0 111.94 -174.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -116.88 127.69 54.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.528 1.931 . . . . 0.0 110.099 -177.588 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.5 m -97.23 114.42 26.15 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.635 1.174 . . . . 0.0 110.961 178.686 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -88.61 125.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.251 1.82 . . . . 0.0 108.776 178.355 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -101.16 131.37 47.15 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.357 1.463 . . . . 0.0 109.721 173.231 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 49.1 t -130.64 128.76 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 110.037 172.069 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -153.88 141.52 19.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.476 1.51 . . . . 0.0 111.071 -169.137 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.83 121.26 18.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.551 1.14 . . . . 0.0 109.545 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.84 59.57 4.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.24 1.416 . . . . 0.0 112.294 178.191 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.9 pt-20 59.14 11.97 2.28 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.279 2.632 . . . . 0.0 116.43 -178.431 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.41 123.35 41.88 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.48 1.112 . . . . 0.0 111.172 178.142 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -64.21 146.88 53.55 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.393 -0.817 . . . . 0.0 112.114 172.243 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 12.2 m -77.63 156.02 80.78 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.828 172.804 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -54.67 130.76 42.02 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.427 2.751 . . . . 0.0 112.086 177.397 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 85.75 -10.8 63.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.571 1.081 . . . . 0.0 115.554 -179.736 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -72.81 139.32 80.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 119.439 1.62 . . . . 0.0 111.344 176.717 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.89 149.06 80.23 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 CA-C-N 119.676 0.92 . . . . 0.0 112.768 -2.291 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -104.68 126.63 51.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 110.702 -177.199 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.8 m -94.73 110.95 22.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.599 0.759 . . . . 0.0 111.295 -175.791 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.86 129.55 45.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.917 1.687 . . . . 0.0 111.692 177.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -94.72 117.53 30.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.417 0.687 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 79.8 t -98.56 133.86 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.148 1.779 . . . . 0.0 110.643 -174.652 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 57.4 p -99.08 145.95 26.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.17 39.25 3.12 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.065 1.793 . . . . 0.0 113.831 -175.162 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.2 t70 . . . . . 0 CA--C 1.546 0.827 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -168.133 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 46.6 mt . . . . . 0 N--CA 1.472 0.628 0 CA-C-O 121.223 0.535 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -64.36 118.54 48.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.871 1.268 . . . . 0.0 111.504 -179.627 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.0 152.55 57.31 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.115 2.543 . . . . 0.0 110.865 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 16.2 t80 -107.8 125.66 51.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.937 0.895 . . . . 0.0 110.302 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.56 130.06 13.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.531 1.532 . . . . 0.0 110.001 173.568 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 131.18 21.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.236 1.414 . . . . 0.0 110.054 -169.577 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 58.0 t -95.73 138.05 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.105 1.362 . . . . 0.0 109.598 -179.773 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.75 135.01 26.69 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.652 1.581 . . . . 0.0 108.784 -179.002 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -79.8 37.76 0.69 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.22 3.28 . . . . 0.0 113.141 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -85.79 152.38 23.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.221 1.408 . . . . 0.0 111.458 178.196 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.9 m -116.23 119.25 35.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.846 1.258 . . . . 0.0 109.733 177.184 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.29 127.69 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.211 1.004 . . . . 0.0 109.953 175.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -112.99 -154.92 0.55 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.569 1.547 . . . . 0.0 110.622 172.74 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -70.07 124.46 24.13 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.594 -1.316 . . . . 0.0 111.353 172.569 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.85 -148.76 20.5 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.789 1.661 . . . . 0.0 111.772 -170.514 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.18 146.27 18.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.307 1.043 . . . . 0.0 111.68 -175.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.18 135.74 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.97 1.708 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 32.7 p -146.23 177.08 9.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.154 1.781 . . . . 0.0 110.572 -175.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.76 -172.63 29.39 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.21 138.79 19.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.441 1.496 . . . . 0.0 109.762 173.71 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 13.3 t -108.51 132.59 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.14 1.776 . . . . 0.0 108.088 172.768 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -117.77 122.89 44.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.9 1.28 . . . . 0.0 110.124 -177.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.4 mtt -95.92 152.3 38.9 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.66 1.584 . . . . 0.0 111.461 -172.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.83 -20.7 34.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.28 2.654 . . . . 0.0 113.601 -177.259 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 58.4 p -78.44 -4.63 49.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 114.171 174.193 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.32 -3.82 64.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.575 1.56 . . . . 0.0 114.56 -178.946 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.47 159.54 33.08 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 118.506 1.153 . . . . 0.0 112.199 173.994 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.6 m -136.89 154.71 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.156 1.382 . . . . 0.0 111.519 175.077 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.17 172.63 17.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.234 1.813 . . . . 0.0 111.121 -179.193 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -109.7 139.47 21.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.981 0.913 . . . . 0.0 111.172 178.37 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -82.18 165.6 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.861 3.041 . . . . 0.0 110.82 170.34 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 97.4 m -107.86 123.36 48.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.102 1.361 . . . . 0.0 108.659 172.511 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.85 130.58 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.297 1.039 . . . . 0.0 108.677 175.485 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 97.4 m -128.27 130.53 48.02 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.495 1.518 . . . . 0.0 109.816 -177.901 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -76.16 130.77 38.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.823 1.249 . . . . 0.0 112.05 174.619 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -87.91 -15.74 35.82 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.345 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.4 mttt 70.07 4.19 4.71 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.736 2.414 . . . . 0.0 114.391 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -100.86 12.17 38.12 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.622 1.969 . . . . 0.0 112.849 -179.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.55 16.82 61.32 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.731 1.158 . . . . 0.0 113.38 -171.413 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -136.87 166.47 23.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.851 2.06 . . . . 0.0 110.178 179.993 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.0 m -131.37 164.97 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.222 1.409 . . . . 0.0 110.326 172.031 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.9 t -123.15 148.94 45.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.351 1.06 . . . . 0.0 110.073 166.478 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 32.4 t -123.42 128.51 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.502 1.521 . . . . 0.0 108.737 178.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -129.12 155.41 45.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.747 1.619 . . . . 0.0 111.836 -170.637 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.2 t80 -159.88 135.81 8.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.833 1.253 . . . . 0.0 112.297 -177.606 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.58 117.37 68.56 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.82 1.248 . . . . 0.0 110.694 175.771 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.03 145.76 22.39 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.482 2.788 . . . . 0.0 111.694 -174.87 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.8 p -131.17 -4.83 3.88 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 172.554 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -141.75 153.98 44.95 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.109 1.764 . . . . 0.0 110.316 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.23 173.32 8.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 111.757 166.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 104.6 -171.49 19.32 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.23 1.395 . . . . 0.0 114.002 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.33 124.27 30.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.971 1.308 . . . . 0.0 110.112 -177.882 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.9 m80 -120.57 163.13 18.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.427 1.891 . . . . 0.0 111.382 -176.051 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.25 155.56 39.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.126 0.971 . . . . 0.0 111.169 173.354 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.8 tmm? -148.85 132.68 17.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.166 0.986 . . . . 0.0 111.547 -160.686 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -111.08 141.96 43.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.738 2.015 . . . . 0.0 111.295 -174.831 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -133.86 134.33 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.858 1.263 . . . . 0.0 111.004 175.921 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.3 139.0 37.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.498 1.119 . . . . 0.0 113.331 176.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -99.7 120.94 40.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.362 1.865 . . . . 0.0 109.527 172.506 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 49.26 39.88 16.83 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.936 1.294 . . . . 0.0 112.853 -176.083 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 7.8 t-20 82.27 -13.65 0.83 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.03 2.932 . . . . 0.0 114.696 179.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.3 tpp -90.98 128.61 36.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.522 1.129 . . . . 0.0 111.561 177.029 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -57.68 136.22 56.82 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.38 -0.825 . . . . 0.0 113.164 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.3 pt -76.82 153.91 83.14 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.594 178.019 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -61.5 124.53 14.84 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.885 1.723 . . . . 0.0 108.617 166.121 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.4 -11.22 47.15 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.572 1.082 . . . . 0.0 114.681 -172.873 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.9 t -85.94 143.79 38.17 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.351 1.575 . . . . 0.0 111.319 169.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -82.85 171.83 51.23 Favored 'Cis proline' 0 C--N 1.352 0.738 0 CA-C-N 120.075 1.062 . . . . 0.0 112.505 -6.32 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.2 mt -113.99 160.82 18.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.459 1.904 . . . . 0.0 111.159 171.346 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -150.4 138.73 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.189 1.396 . . . . 0.0 109.99 -171.687 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 15.9 p90 -164.46 167.25 19.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.444 1.097 . . . . 0.0 112.398 -165.264 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.5 t80 -122.55 136.09 54.8 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.129 -0.982 . . . . 0.0 112.129 176.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 42.2 t -111.84 142.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.398 1.479 . . . . 0.0 109.675 -178.934 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 28.5 t0 -151.59 163.01 40.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.898 1.279 . . . . 0.0 111.52 -177.553 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -74.96 125.6 29.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.227 . . . . 0.0 111.152 178.319 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 31.4 m -78.92 -18.55 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -167.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -89.35 -4.63 58.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.792 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.7 m -72.73 150.51 42.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.962 0.905 . . . . 0.0 112.498 176.576 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.73 -14.62 60.96 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.604 1.097 . . . . 0.0 115.118 -174.369 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -66.56 158.14 30.52 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.7 1.25 . . . . 0.0 113.93 179.131 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 141.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.454 1.102 . . . . 0.0 110.888 173.422 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -158.1 152.89 25.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.358 1.463 . . . . 0.0 110.273 178.655 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.81 142.83 51.32 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.999 1.319 . . . . 0.0 111.754 -177.706 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.3 p90 -167.08 160.88 14.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.582 1.553 . . . . 0.0 113.519 -175.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.83 170.27 12.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.408 1.48 . . . . 0.0 112.539 -177.54 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.08 -33.29 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 113.324 -168.651 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.81 -33.78 86.83 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.455 1.025 . . . . 0.0 114.506 -171.567 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 1.5 pp -78.43 -0.61 29.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.832 1.316 . . . . 0.0 113.631 177.45 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.5 m -113.63 -46.09 3.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.698 1.999 . . . . 0.0 111.366 176.696 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . 0.555 ' CE1' HH22 ' A' 1951 ' ' ARG . 3.7 t-80 -137.88 122.37 18.42 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.314 1.845 . . . . 0.0 111.426 -174.075 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.5 170.94 16.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.28 1.419 . . . . 0.0 112.786 170.655 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 98.2 t -138.8 137.14 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.899 1.28 . . . . 0.0 108.239 174.203 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.7 m -55.3 136.54 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 61.0 m-80 67.32 0.31 2.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.969 2.108 . . . . 0.0 114.685 177.509 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -104.87 139.91 20.56 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.019 1.328 . . . . 0.0 110.977 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.9 118.66 5.74 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.59 2.193 . . . . 0.0 110.167 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.03 134.8 42.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.29 1.436 . . . . 0.0 110.205 176.544 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -128.31 148.16 50.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -164.729 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.63 -179.85 7.97 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.948 1.699 . . . . 0.0 111.673 176.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 60.2 m -135.03 146.65 49.19 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.228 1.411 . . . . 0.0 110.936 -168.096 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -116.86 129.89 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.687 1.595 . . . . 0.0 108.262 168.456 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.51 126.43 38.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.963 . . . . 0.0 110.325 176.079 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 40.6 p -132.06 4.15 4.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.708 1.603 . . . . 0.0 113.634 -167.147 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 52.2 tttp -55.22 -32.45 62.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.051 1.74 . . . . 0.0 115.61 -164.464 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.33 17.53 6.52 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.603 1.561 . . . . 0.0 112.42 178.407 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.28 58.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -176.557 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 151.44 12.21 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.186 1.374 . . . . 0.0 112.861 -175.643 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -72.94 145.65 46.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.159 0.983 . . . . 0.0 112.307 -177.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.7 -158.66 26.89 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.689 1.614 . . . . 0.0 112.501 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -82.98 98.39 2.04 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 175.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.17 126.55 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.707 1.203 . . . . 0.0 108.853 171.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.4 m -129.68 155.27 46.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.012 1.325 . . . . 0.0 112.133 -177.806 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.0 tp -158.95 132.61 7.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.162 1.785 . . . . 0.0 108.583 -171.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.64 160.41 39.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.853 0.861 . . . . 0.0 112.238 -179.313 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 58.4 mt -135.08 132.34 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.519 1.128 . . . . 0.0 109.645 174.379 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -114.76 105.98 13.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.013 1.325 . . . . 0.0 109.052 172.655 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -116.9 -178.84 17.85 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.024 1.297 . . . . 0.0 113.92 -178.639 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.2 -20.42 37.48 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.909 3.073 . . . . 0.0 111.811 170.744 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.2 t -137.43 157.77 45.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.877 1.671 . . . . 0.0 109.055 161.253 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.59 119.0 13.17 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.993 -1.067 . . . . 0.0 111.773 -176.866 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -80.13 144.33 33.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.166 170.14 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.86 140.92 29.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.479 0.712 . . . . 0.0 109.656 168.363 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.2 mt -132.91 139.24 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.79 1.236 . . . . 0.0 110.467 -167.67 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -130.32 155.96 45.48 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.652 168.544 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -152.65 154.07 34.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.102 0.961 . . . . 0.0 112.373 175.604 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.8 m -142.25 125.57 16.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.599 1.56 . . . . 0.0 109.985 -172.528 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.91 141.35 37.68 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 112.244 172.758 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -117.24 152.0 35.74 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.703 1.601 . . . . 0.0 112.031 -175.803 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -69.43 -18.54 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.926 1.29 . . . . 0.0 112.96 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.68 -13.44 60.62 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.128 1.371 . . . . 0.0 114.083 -179.503 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.74 34.73 4.84 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.786 1.184 . . . . 0.0 113.674 -175.773 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.7 p -138.34 164.3 29.65 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.266 1.426 . . . . 0.0 110.841 177.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 80.6 m -120.09 131.18 54.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.717 1.607 . . . . 0.0 109.033 164.369 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.6 t -90.18 150.15 22.12 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.161 0.984 . . . . 0.0 110.686 171.112 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 93.6 t -129.43 144.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.521 1.928 . . . . 0.0 109.592 -178.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 139.12 35.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.411 1.484 . . . . 0.0 110.707 171.074 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -144.63 153.24 41.55 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.7 mt -115.51 105.79 51.53 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.802 1.641 . . . . 0.0 110.816 179.636 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.0 169.71 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.645 2.897 . . . . 0.0 110.235 165.456 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -136.99 -20.13 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.39 152.06 59.57 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.632 1.173 . . . . 0.0 110.675 174.007 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.18 147.74 38.24 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.893 2.395 . . . . 0.0 111.904 -172.871 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.03 -155.68 26.33 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.675 1.131 . . . . 0.0 113.059 -174.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.26 126.41 53.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.07 1.348 . . . . 0.0 111.149 179.612 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.8 125.71 53.06 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.311 1.844 . . . . 0.0 109.93 -176.624 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 54.6 m -88.0 122.08 31.18 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.975 -1.078 . . . . 0.0 110.933 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.22 128.23 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.292 1.437 . . . . 0.0 108.626 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -112.23 131.07 55.7 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.367 1.467 . . . . 0.0 109.542 175.965 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.55 130.11 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.304 1.042 . . . . 0.0 109.67 172.898 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.93 144.02 23.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.061 1.344 . . . . 0.0 111.721 -168.552 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.11 122.64 14.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.697 1.199 . . . . 0.0 110.555 -177.882 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 57.0 44.62 22.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.134 1.374 . . . . 0.0 112.199 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.261 0.6 OUTLIER 77.98 -12.87 1.02 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.177 2.991 . . . . 0.0 114.736 -179.107 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -98.43 125.6 43.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.75 1.22 . . . . 0.0 111.384 -176.814 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -63.07 143.76 57.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.384 -0.823 . . . . 0.0 111.912 171.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.5 m -68.0 152.35 96.49 Favored Pre-proline 0 N--CA 1.48 1.036 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.57 171.417 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 126.96 22.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.781 2.321 . . . . 0.0 110.595 179.387 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.58 -15.01 64.23 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.193 1.378 . . . . 0.0 115.323 -176.118 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.5 t -76.62 140.98 68.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.304 1.552 . . . . 0.0 111.628 176.552 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.53 140.29 65.88 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.418 0.828 . . . . 0.0 112.161 -3.723 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.05 173.23 7.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.615 1.966 . . . . 0.0 110.779 175.51 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -131.02 122.32 26.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.845 0.858 . . . . 0.0 110.933 174.159 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.05 137.99 34.32 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.57 1.548 . . . . 0.0 110.535 169.429 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . 0.555 HH22 ' CE1' ' A' 1877 ' ' HIS . 0.0 OUTLIER -93.81 138.5 31.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.596 0.759 . . . . 0.0 109.474 169.756 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 139.59 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.456 1.502 . . . . 0.0 110.861 -178.402 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 1.1 p -124.04 163.2 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.931 1.693 . . . . 0.0 112.433 179.521 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.87 148.55 33.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.107 1.337 . . . . 0.0 112.249 172.269 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.8 t70 . . . . . 0 CA--C 1.549 0.916 0 C-N-CA 123.949 0.9 . . . . 0.0 112.898 174.323 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 11.3 mt . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A 1789 ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' 1789 ' ' ARG . 18.1 ttm-85 -58.72 119.52 37.76 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.233 1.013 . . . . 0.0 111.041 177.671 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.42 159.76 48.48 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.158 2.572 . . . . 0.0 110.431 176.496 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.46 134.26 17.83 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.642 0.734 . . . . 0.0 112.324 -172.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -163.98 145.81 9.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.817 2.047 . . . . 0.0 110.724 178.055 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 161.28 36.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.599 1.959 . . . . 0.0 110.831 -170.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -134.07 139.37 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.184 1.393 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 43.8 mt -136.59 138.2 25.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.314 1.846 . . . . 0.0 108.302 -170.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.11 31.93 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.505 3.47 . . . . 0.0 113.993 -177.052 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 27.6 t80 -79.65 155.03 28.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.47 1.108 . . . . 0.0 111.027 173.113 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.85 126.17 35.52 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.048 1.339 . . . . 0.0 109.534 176.76 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.5 mt -76.42 126.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.572 0.749 . . . . 0.0 110.49 177.24 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 67.1 mttm -116.48 -139.7 0.37 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.724 1.61 . . . . 0.0 110.516 172.71 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.76 124.44 27.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.657 -1.277 . . . . 0.0 111.188 171.689 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.4 -151.31 19.68 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.862 1.696 . . . . 0.0 111.805 -169.872 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.84 150.48 17.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.913 1.285 . . . . 0.0 111.178 -176.448 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.0 tt -122.51 133.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.353 1.461 . . . . 0.0 111.888 179.77 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1805 ' ' THR . . . . . . . . . . . . . 77.3 p -149.22 -178.05 6.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.082 1.753 . . . . 0.0 110.38 177.704 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.48 -164.4 27.9 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.341 0.897 . . . . 0.0 115.341 -179.323 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -157.47 139.49 14.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.616 1.566 . . . . 0.0 109.954 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 43.7 t -105.87 133.63 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.771 1.628 . . . . 0.0 108.266 171.435 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -121.44 135.46 55.05 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.847 1.659 . . . . 0.0 111.052 -174.677 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.2 mpp? -112.9 157.39 40.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.754 1.622 . . . . 0.0 112.562 -172.412 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -55.0 -37.15 93.9 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.243 3.295 . . . . 0.0 114.538 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.0 m -71.86 -5.22 32.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.14 1.376 . . . . 0.0 114.463 -176.098 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -2.2 84.83 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.343 1.449 . . . . 0.0 113.711 -170.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -64.96 152.38 43.41 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.265 1.426 . . . . 0.0 111.719 172.175 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.7 155.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.24 1.416 . . . . 0.0 111.537 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.47 164.46 37.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.791 1.636 . . . . 0.0 111.336 -179.841 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -102.36 134.2 20.12 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.675 0.79 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.98 161.21 20.91 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.721 2.948 . . . . 0.0 110.88 169.912 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.0 m -108.81 125.75 52.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.071 1.348 . . . . 0.0 108.986 174.13 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.7 137.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.905 1.282 . . . . 0.0 109.679 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1821 ' ' THR . . . . . . . . . . . . . 56.5 m -139.3 126.57 21.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.197 1.399 . . . . 0.0 110.049 176.477 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.9 126.83 31.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 172.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.2 -6.37 57.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.527 1.131 . . . . 0.0 114.032 -174.331 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.3 mmtm 77.99 -7.95 1.74 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.917 2.887 . . . . 0.0 113.831 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -92.58 2.53 56.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.406 1.882 . . . . 0.0 113.295 175.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.5 25.79 13.14 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.757 1.17 . . . . 0.0 114.141 -177.921 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1827 ' ' THR . . . . . . . . . . . . . 61.8 p -134.16 155.93 49.22 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.17 1.788 . . . . 0.0 109.706 174.179 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -115.17 138.67 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.196 0.998 . . . . 0.0 110.056 167.397 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1829 ' ' THR . . . . . . . . . . . . . 40.5 m -98.29 141.83 30.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.008 1.323 . . . . 0.0 108.588 168.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.3 t -125.66 134.41 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.4 1.48 . . . . 0.0 109.462 179.6 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -131.96 153.94 49.81 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 112.289 -174.787 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.65 134.34 10.9 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.857 1.663 . . . . 0.0 111.674 -177.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.69 123.67 68.87 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.343 1.057 . . . . 0.0 110.442 175.303 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.47 131.4 12.6 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.076 2.517 . . . . 0.0 111.6 -173.534 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -132.03 15.73 4.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.738 1.215 . . . . 0.0 112.406 179.22 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.93 162.26 20.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.569 1.948 . . . . 0.0 109.958 -175.224 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -111.79 170.93 7.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.924 1.29 . . . . 0.0 112.6 174.329 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 93.66 -161.79 25.11 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.182 1.372 . . . . 0.0 113.547 179.281 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.7 tp -81.58 114.93 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.591 1.156 . . . . 0.0 110.759 -177.816 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 6.4 m80 -103.3 168.34 9.23 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.077 1.751 . . . . 0.0 110.903 177.478 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.16 148.97 29.59 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.491 -0.756 . . . . 0.0 112.02 168.033 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1842 ' ' MET . . . . . . . . . . . . . 16.3 ttm -120.99 132.82 55.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.034 2.134 . . . . 0.0 110.264 -173.821 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -100.07 137.9 37.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.637 1.575 . . . . 0.0 109.893 166.891 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -133.95 133.95 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.907 1.283 . . . . 0.0 109.733 171.814 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 138.07 31.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.548 1.139 . . . . 0.0 112.681 -174.069 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.9 t80 -107.74 123.8 49.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.305 1.842 . . . . 0.0 110.063 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.19 35.35 16.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.551 1.14 . . . . 0.0 112.531 -176.128 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.8 t30 80.12 -0.68 2.03 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.671 2.788 . . . . 0.0 114.827 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.33 130.69 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.289 1.436 . . . . 0.0 110.907 178.319 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -56.23 135.13 53.52 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.258 -0.901 . . . . 0.0 113.111 -179.5 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.4 pt -71.6 155.2 92.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.254 172.755 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.6 -25.43 79.23 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.304 2.003 . . . . 0.0 113.648 -176.006 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -79.32 -3.66 88.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.17 0.891 . . . . 0.0 114.72 173.731 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1854 ' ' SER . . . . . . . . . . . . . 25.6 t -97.39 144.17 27.45 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.467 1.633 . . . . 0.0 111.824 178.773 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.21 161.01 85.33 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.677 0.92 . . . . 0.0 112.198 -4.563 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.33 144.67 37.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 109.85 170.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -126.48 137.2 53.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 109.682 179.152 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.01 146.2 21.52 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.678 0.791 . . . . 0.0 112.438 -169.299 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.1 t80 -99.62 139.43 35.28 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.397 -0.814 . . . . 0.0 112.433 179.694 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 41.1 t -122.83 142.51 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.852 1.661 . . . . 0.0 108.948 179.158 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 9.8 t0 -151.59 173.01 15.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.433 1.093 . . . . 0.0 111.679 -173.52 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -87.44 123.42 32.34 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.918 1.287 . . . . 0.0 111.288 178.2 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 35.4 m -72.09 -21.8 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -170.585 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.0 p30 -90.95 -8.76 48.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.75 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 87.6 m -78.75 -24.35 44.83 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -172.501 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 81.25 -7.29 60.96 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.175 1.369 . . . . 0.0 116.442 168.109 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -67.48 163.75 20.31 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.108 1.454 . . . . 0.0 113.484 176.282 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.4 t -64.88 133.26 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.704 0.801 . . . . 0.0 110.002 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -163.61 154.12 15.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.214 1.406 . . . . 0.0 109.855 -168.241 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.11 145.24 37.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.545 1.138 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.9 p90 -169.64 169.4 8.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.559 1.543 . . . . 0.0 113.092 -173.006 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.75 172.39 13.72 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.6 1.572 . . . . 0.0 112.175 -174.124 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.26 -32.63 12.52 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.774 2.316 . . . . 0.0 113.216 -170.308 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.03 -31.15 74.63 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 119.373 0.988 . . . . 0.0 114.873 -170.601 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.32 -0.37 36.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.925 1.362 . . . . 0.0 113.208 175.36 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1876 ' ' THR . . . . . . . . . . . . . 89.7 m -113.52 -48.4 2.94 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.657 1.983 . . . . 0.0 110.82 -178.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -137.76 149.07 46.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.089 1.756 . . . . 0.0 112.36 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.38 177.24 23.1 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 124.359 0.98 . . . . 0.0 113.116 170.123 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.6 t -139.1 133.42 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.454 1.102 . . . . 0.0 108.437 176.016 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -56.41 135.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 118.021 0.373 . . . . 0.0 111.986 -178.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.5 m-80 70.26 -8.92 0.8 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.381 2.273 . . . . 0.0 114.859 179.384 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.4 mttm -96.47 141.88 23.74 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.485 1.114 . . . . 0.0 111.078 174.011 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.22 123.64 8.92 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.509 2.14 . . . . 0.0 110.353 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.77 144.6 30.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.443 1.497 . . . . 0.0 110.472 174.525 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.1 p -135.49 145.52 47.21 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -166.364 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.36 178.99 9.68 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.735 1.614 . . . . 0.0 111.306 175.719 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1887 ' ' THR . . . . . . . . . . . . . 26.7 m -134.99 144.05 47.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 110.644 -169.658 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.8 t -116.53 131.32 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.571 1.548 . . . . 0.0 108.179 169.726 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.77 131.41 39.16 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.159 0.984 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.8 p -137.79 4.03 2.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.348 1.459 . . . . 0.0 113.765 -166.551 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 84.0 tttt -55.06 -33.66 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.77 1.628 . . . . 0.0 115.04 -168.361 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.87 16.63 9.38 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.741 1.617 . . . . 0.0 112.564 178.972 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.55 -39.57 70.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.368 1.067 . . . . 0.0 113.842 -174.062 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.71 145.22 4.85 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.908 1.242 . . . . 0.0 112.352 -171.084 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.94 148.98 45.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 112.185 -178.019 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 173.93 -27.36 0.08 OUTLIER Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.471 1.034 . . . . 0.0 114.973 176.667 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 142.56 102.05 0.43 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.884 1.707 . . . . 0.0 112.988 172.067 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.44 130.79 35.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.0 109.568 175.071 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.5 m -129.79 160.59 32.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.756 1.622 . . . . 0.0 112.273 -178.129 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.4 tp -160.48 136.68 8.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.762 1.625 . . . . 0.0 109.522 -169.264 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.33 156.9 33.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.392 1.077 . . . . 0.0 112.023 176.251 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 37.2 mt -139.64 134.78 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.96 143.25 51.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.485 1.514 . . . . 0.0 110.223 176.381 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.63 -161.83 20.77 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-O 118.81 -0.994 . . . . 0.0 114.694 -175.561 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -62.26 -26.16 77.19 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.044 3.163 . . . . 0.0 112.646 176.44 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -140.21 153.2 46.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.75 1.22 . . . . 0.0 109.618 161.352 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -71.68 123.37 22.4 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.995 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.7 152.99 37.4 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.313 1.045 . . . . 0.0 112.905 -178.054 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.16 134.1 33.56 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 163.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.9 mt -134.39 138.92 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.577 1.151 . . . . 0.0 110.231 -166.466 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1911 ' ' SER . . . . . . . . . . . . . 64.7 m -139.0 162.01 35.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.584 1.553 . . . . 0.0 111.247 172.592 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -155.27 156.47 35.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.378 1.071 . . . . 0.0 112.71 178.502 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.5 m -139.45 129.83 25.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.907 1.683 . . . . 0.0 110.248 -172.282 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -80.73 132.42 35.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.356 1.062 . . . . 0.0 111.264 174.141 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -110.13 148.62 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.077 1.351 . . . . 0.0 112.08 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -68.32 -21.3 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.507 1.123 . . . . 0.0 112.735 178.103 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.14 -6.83 48.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.556 1.543 . . . . 0.0 114.342 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.6 39.87 4.87 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.538 1.065 . . . . 0.0 113.266 -179.255 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.0 p -141.13 158.68 43.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.011 1.324 . . . . 0.0 111.304 177.23 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 63.9 m -107.22 125.19 50.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.391 1.476 . . . . 0.0 108.434 161.455 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.8 t -86.52 149.03 25.25 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.484 0.714 . . . . 0.0 110.393 167.704 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.4 t -130.31 142.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.842 1.657 . . . . 0.0 109.736 -177.54 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1923 ' ' SER . . . . . . . . . . . . . 84.1 p -136.12 147.22 47.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.849 1.26 . . . . 0.0 111.802 168.192 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.86 153.89 35.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.495 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.78 105.87 50.89 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.084 1.754 . . . . 0.0 110.282 179.333 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.83 173.79 11.7 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.618 2.879 . . . . 0.0 110.131 165.003 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.8 p -149.69 -29.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -172.814 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.54 144.83 30.32 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.402 1.001 . . . . 0.0 110.213 166.806 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.63 157.64 44.15 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.92 2.413 . . . . 0.0 111.013 177.303 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.32 -162.9 23.68 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.987 1.28 . . . . 0.0 113.204 -176.283 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.79 139.97 30.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.728 1.211 . . . . 0.0 112.844 179.739 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.49 131.67 50.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.757 1.623 . . . . 0.0 110.322 178.008 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.7 m -90.47 125.76 35.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.209 1.004 . . . . 0.0 110.684 174.757 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.99 120.91 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.735 1.614 . . . . 0.0 108.482 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -104.93 128.85 53.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.535 1.534 . . . . 0.0 109.808 178.709 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 58.2 t -130.92 128.52 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.574 1.15 . . . . 0.0 109.848 173.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.1 142.3 24.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.109 1.364 . . . . 0.0 111.666 -168.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.12 120.21 14.6 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.8 1.24 . . . . 0.0 109.679 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.1 t-20 54.93 58.98 4.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.602 1.561 . . . . 0.0 111.979 179.174 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 9.0 pt-20 57.11 13.56 1.65 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.418 2.687 . . . . 0.0 116.422 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -119.59 122.41 41.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.896 1.279 . . . . 0.0 110.671 177.655 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -63.94 142.69 58.31 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.618 0.767 . . . . 0.0 111.488 170.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.0 m -72.62 156.85 89.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.764 175.025 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.81 129.6 35.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.301 2.667 . . . . 0.0 111.963 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 86.27 -13.02 58.96 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.697 1.141 . . . . 0.0 115.142 -177.397 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.7 t -76.0 140.27 70.06 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.527 1.663 . . . . 0.0 111.491 176.121 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.48 136.02 43.04 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 -3.568 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -83.92 169.98 14.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.778 1.631 . . . . 0.0 110.532 173.889 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1949 ' ' THR . . . . . . . . . . . . . 28.4 m -131.12 116.73 18.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.552 0.741 . . . . 0.0 110.694 177.264 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.02 155.02 18.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.736 1.214 . . . . 0.0 111.082 169.279 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -116.48 125.64 52.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.291 1.037 . . . . 0.0 110.062 170.297 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 92.2 t -107.65 130.99 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.41 . . . . 0.0 110.526 -174.616 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.1 p -108.06 171.24 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.288 1.435 . . . . 0.0 112.739 178.921 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.59 154.62 44.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.372 1.463 . . . . 0.0 113.67 -178.576 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.9 t70 . . . . . 0 CA--C 1.547 0.834 0 C-N-CA 125.02 1.328 . . . . 0.0 113.241 179.035 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.563 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.02 -22.94 59.38 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 25.5 ptp -166.03 169.95 14.08 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.43 1.892 . . . . 0.0 112.011 -176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -64.88 153.08 89.24 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.435 1.094 . . . . 0.0 112.295 173.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.5 171.59 16.8 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.538 2.826 . . . . 0.0 111.741 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -78.6 37.3 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.686 1.594 . . . . 0.0 113.102 -176.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 30.8 ptt-85 -149.24 48.63 0.6 Allowed Pre-proline 0 CA--C 1.556 1.194 0 C-N-CA 126.741 2.016 . . . . 0.0 113.313 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -70.55 158.71 55.12 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 123.269 2.646 . . . . 0.0 111.915 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 57.1 tp -159.17 141.36 13.73 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.352 1.461 . . . . 0.0 110.33 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 82.1 t -110.9 135.3 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.504 1.522 . . . . 0.0 109.262 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -148.49 157.55 27.34 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.153 1.358 . . . . 0.0 112.971 176.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 96.9 t -98.44 124.37 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.001 1.32 . . . . 0.0 109.592 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -95.49 -15.61 22.8 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.442 1.097 . . . . 0.0 113.699 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -81.85 160.55 41.15 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.011 1.291 . . . . 0.0 113.185 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.0 163.46 13.3 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.747 1.219 . . . . 0.0 111.623 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 2.2 t0 -155.17 -176.05 5.74 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.071 1.348 . . . . 0.0 111.072 -175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 7.3 p -58.13 -20.35 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 125.576 1.55 . . . . 0.0 114.061 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.9 t -76.58 -27.51 55.86 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.134 1.373 . . . . 0.0 113.03 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 21.7 p -118.82 -14.8 9.46 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 114.633 1.346 . . . . 0.0 114.633 -171.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 6.1 mt -118.53 151.9 36.99 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.691 1.596 . . . . 0.0 111.948 172.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 58.0 ttp85 -67.85 128.69 93.41 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.055 0.942 . . . . 0.0 110.578 175.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -76.0 167.69 25.6 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 123.522 2.815 . . . . 0.0 112.822 -177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -104.88 121.39 43.6 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.221 1.408 . . . . 0.0 108.621 170.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -146.73 126.01 13.06 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.676 1.19 . . . . 0.0 110.299 171.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.26 159.63 41.84 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.433 1.893 . . . . 0.0 110.09 -170.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -133.11 139.49 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 125.116 1.366 . . . . 0.0 110.315 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.6 mt -133.48 135.2 24.77 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 125.872 1.669 . . . . 0.0 109.118 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.96 109.67 2.74 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.364 2.709 . . . . 0.0 109.765 172.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 47.1 t80 -175.7 151.93 1.22 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.344 2.258 . . . . 0.0 108.956 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 41.5 m -134.67 125.89 28.0 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.212 1.005 . . . . 0.0 110.576 -176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 37.5 mt -82.97 134.25 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.862 1.265 . . . . 0.0 109.389 170.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 7.2 tmtm? -131.77 -60.22 0.93 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.093 0.957 . . . . 0.0 111.564 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.4 tptt -152.27 127.5 9.85 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.552 1.541 . . . . 0.0 110.388 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.95 -149.95 17.82 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.288 1.423 . . . . 0.0 111.648 -167.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -158.09 146.14 18.63 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.565 1.146 . . . . 0.0 111.089 -175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.5 tt -126.89 136.04 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 125.776 1.631 . . . . 0.0 111.043 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.9 p -148.58 173.16 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.398 1.879 . . . . 0.0 110.252 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.82 -170.69 24.71 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 115.477 0.951 . . . . 0.0 115.477 -177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.65 137.96 15.77 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.593 1.557 . . . . 0.0 109.716 174.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 20.9 t -113.6 135.01 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.861 1.664 . . . . 0.0 108.195 173.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 41.8 mtm105 -119.41 132.42 55.82 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.632 1.173 . . . . 0.0 111.457 -174.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.08 142.52 25.21 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.842 1.657 . . . . 0.0 111.694 -170.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -55.23 -32.96 82.86 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.149 3.232 . . . . 0.0 114.407 173.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -72.32 2.83 5.42 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.908 1.283 . . . . 0.0 114.34 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.35 4.75 65.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.634 1.588 . . . . 0.0 114.599 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 47.0 mtpt -86.7 164.29 16.85 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.225 1.41 . . . . 0.0 111.91 -177.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.4 m -137.91 152.83 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.603 1.561 . . . . 0.0 110.889 173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.01 163.21 36.6 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.319 1.448 . . . . 0.0 111.624 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -105.97 139.17 19.98 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.169 0.988 . . . . 0.0 111.128 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -85.63 170.1 9.11 Favored 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 124.227 3.284 . . . . 0.0 111.771 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.7 m -109.5 135.71 50.07 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.41 1.484 . . . . 0.0 108.964 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 5.1 mp -120.62 135.66 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.975 1.31 . . . . 0.0 109.252 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 53.0 m -137.98 127.3 24.63 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.323 1.449 . . . . 0.0 109.971 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.1 t70 -80.27 129.98 34.88 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.001 0.92 . . . . 0.0 111.154 174.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.7 -8.77 58.73 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 37.3 mtmm 63.97 14.3 8.33 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.532 2.333 . . . . 0.0 113.805 -174.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -111.46 8.38 21.12 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 127.221 2.209 . . . . 0.0 112.503 178.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 12.52 57.07 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 125.22 1.39 . . . . 0.0 114.4 -176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.0 p -131.32 155.42 47.23 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 126.035 1.734 . . . . 0.0 111.202 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.3 m -112.99 139.47 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.058 0.943 . . . . 0.0 109.869 163.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 49.5 m -96.62 139.5 32.61 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.002 1.321 . . . . 0.0 108.523 169.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.6 t -124.92 134.82 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.475 1.51 . . . . 0.0 109.241 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.8 mtp180 -136.17 153.58 51.22 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.243 1.417 . . . . 0.0 112.504 -173.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.4 t80 -152.92 136.56 16.04 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.787 1.635 . . . . 0.0 111.576 176.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.63 123.46 70.86 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.643 1.177 . . . . 0.0 110.724 176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -81.81 160.2 18.79 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.942 3.095 . . . . 0.0 112.574 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.9 p -152.34 -9.56 0.19 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 172.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -138.73 149.47 45.09 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.852 1.661 . . . . 0.0 110.075 -178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -91.6 166.25 12.92 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.176 0.991 . . . . 0.0 111.969 169.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.76 -171.06 13.8 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 125.148 1.356 . . . . 0.0 113.795 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -88.54 121.41 30.89 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.723 1.209 . . . . 0.0 109.825 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 70.2 m80 -119.85 165.32 14.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.134 1.774 . . . . 0.0 111.833 -172.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -149.78 154.11 37.92 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.965 0.906 . . . . 0.0 111.975 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.3 ttm -134.94 127.4 30.52 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 126.904 2.082 . . . . 0.0 109.986 -168.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -97.4 135.6 39.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.617 1.567 . . . . 0.0 109.975 172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.5 mm -132.95 130.55 58.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.932 1.293 . . . . 0.0 109.769 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.04 138.72 32.0 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -177.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.2 t80 -101.85 119.36 38.66 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.655 1.982 . . . . 0.0 109.323 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.17 32.75 11.1 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 124.916 1.286 . . . . 0.0 112.903 -173.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.5 m-80 74.95 7.22 4.28 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 127.957 2.503 . . . . 0.0 115.266 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.1 tpp -100.01 129.48 46.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.585 1.154 . . . . 0.0 110.573 166.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.79 136.7 56.97 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 121.373 -0.829 . . . . 0.0 113.067 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.7 pt -75.63 155.65 85.24 Favored Pre-proline 0 N--CA 1.479 1.02 0 CA-C-O 118.814 -0.612 . . . . 0.0 111.555 175.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -58.97 129.48 32.14 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.059 1.839 . . . . 0.0 109.485 169.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.47 -15.06 62.69 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 124.499 1.047 . . . . 0.0 114.124 -174.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -82.27 143.81 49.2 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 119.722 1.761 . . . . 0.0 111.209 171.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.0 155.68 91.58 Favored 'Cis proline' 0 C--N 1.351 0.684 0 CA-C-N 119.944 1.016 . . . . 0.0 112.117 -5.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 82.5 mt -92.91 153.43 18.79 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.553 1.141 . . . . 0.0 110.548 169.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -150.0 135.07 17.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.693 1.197 . . . . 0.0 109.789 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -168.17 169.92 10.61 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.735 1.214 . . . . 0.0 112.324 -170.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 29.6 t80 -104.19 147.61 27.26 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.272 -0.892 . . . . 0.0 112.309 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 85.3 t -117.69 133.58 64.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.295 1.838 . . . . 0.0 108.893 176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -151.1 163.04 39.71 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -169.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -80.0 87.63 5.39 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.226 1.411 . . . . 0.0 111.105 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 10.7 p -54.53 -27.59 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.242 1.417 . . . . 0.0 114.506 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -77.82 -16.99 57.91 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 114.055 1.132 . . . . 0.0 114.055 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -75.9 161.97 28.52 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.749 1.219 . . . . 0.0 112.438 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.44 -9.82 78.39 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 124.9 1.238 . . . . 0.0 115.778 -169.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 55.2 p-80 -66.63 147.72 52.88 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 119.169 1.485 . . . . 0.0 113.165 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 p -64.47 134.58 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 O-C-N 121.774 -0.579 . . . . 0.0 109.709 169.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.1 t -156.2 160.9 40.25 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.508 1.123 . . . . 0.0 111.057 -168.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.93 142.92 33.04 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.696 1.198 . . . . 0.0 111.924 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.4 p90 -165.06 161.05 19.5 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.526 1.531 . . . . 0.0 112.922 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 136.87 175.03 13.57 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 125.392 1.472 . . . . 0.0 113.046 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.31 -36.95 8.49 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.723 2.282 . . . . 0.0 112.944 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.18 -34.64 90.17 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.439 1.018 . . . . 0.0 114.608 -170.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.59 -6.18 54.87 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 118.653 1.227 . . . . 0.0 113.561 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.0 m -104.7 -43.78 5.04 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.403 1.881 . . . . 0.0 111.166 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -147.31 142.76 27.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.582 1.953 . . . . 0.0 111.916 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -134.21 173.66 21.26 Favored Glycine 0 N--CA 1.471 1.019 0 C-N-CA 124.349 0.976 . . . . 0.0 113.052 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 28.0 t -138.69 133.3 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.348 1.059 . . . . 0.0 108.575 174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.5 m -57.15 133.77 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 123.165 0.586 . . . . 0.0 112.442 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 23.1 m120 69.61 0.16 2.86 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.872 2.069 . . . . 0.0 114.192 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -103.14 138.66 19.61 Favored Pre-proline 0 CA--C 1.548 0.865 0 C-N-CA 125.212 1.405 . . . . 0.0 110.541 176.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -72.24 112.64 3.48 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.604 2.203 . . . . 0.0 109.866 179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -96.39 133.1 41.21 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.142 1.377 . . . . 0.0 110.132 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.7 p -127.04 153.63 45.7 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -165.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . 0.405 ' CZ ' HG11 ' A' 1922 ' ' VAL . 54.4 p90 -162.83 176.23 10.45 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.989 1.716 . . . . 0.0 111.415 176.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.7 m -126.82 142.63 51.49 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.24 1.416 . . . . 0.0 110.493 -173.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.8 t -114.31 126.58 71.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.398 1.479 . . . . 0.0 107.801 167.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -93.55 120.18 33.51 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.923 0.889 . . . . 0.0 110.378 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 20.2 p -119.76 15.45 12.67 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.97 2.108 . . . . 0.0 112.096 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -58.45 -30.97 67.36 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.029 1.732 . . . . 0.0 114.726 -164.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -131.69 20.28 4.66 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.993 1.717 . . . . 0.0 112.101 177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -81.06 -9.5 59.82 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -169.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 90.98 -125.56 8.04 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.39 0.995 . . . . 0.0 112.623 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -154.03 151.5 29.41 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.335 1.454 . . . . 0.0 111.26 -172.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 154.55 -156.21 26.72 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.821 1.677 . . . . 0.0 112.521 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.2 107.81 3.52 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.091 0.853 . . . . 0.0 111.218 172.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.54 126.53 32.38 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.884 1.274 . . . . 0.0 108.502 171.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -130.66 158.1 40.97 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.905 1.282 . . . . 0.0 112.607 -174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.6 tp -157.49 135.43 10.84 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.407 1.883 . . . . 0.0 108.728 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.63 161.39 39.9 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.949 0.9 . . . . 0.0 112.203 177.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.3 mt -134.87 135.65 52.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 124.589 1.156 . . . . 0.0 109.563 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -120.83 113.51 20.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.037 1.335 . . . . 0.0 109.316 172.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -129.44 -173.91 13.55 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 124.99 1.281 . . . . 0.0 113.912 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -69.97 -18.57 35.95 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 124.003 3.135 . . . . 0.0 112.32 173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -142.57 157.32 44.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.772 1.629 . . . . 0.0 109.339 165.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . 0.432 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 1.0 OUTLIER -73.3 107.84 5.84 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.111 -0.993 . . . . 0.0 111.729 -175.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.49 145.81 48.95 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.867 0.867 . . . . 0.0 111.165 167.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -93.48 145.8 24.24 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.484 0.713 . . . . 0.0 110.457 168.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.0 mt -134.9 140.8 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.934 1.293 . . . . 0.0 110.316 -165.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 59.6 m -133.42 155.93 48.62 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.818 1.647 . . . . 0.0 110.713 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.4 p -153.23 153.97 33.75 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.482 1.113 . . . . 0.0 112.125 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.4 m -143.76 126.32 15.93 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.831 1.252 . . . . 0.0 110.748 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -75.66 131.17 39.74 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.968 1.307 . . . . 0.0 111.396 172.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -103.97 151.8 22.76 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.668 1.587 . . . . 0.0 111.852 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 52.4 mm-40 -68.18 -16.21 63.9 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.887 0.875 . . . . 0.0 113.184 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -72.22 -12.45 61.17 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.737 1.215 . . . . 0.0 113.518 173.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.72 19.2 35.25 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.676 1.132 . . . . 0.0 114.139 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 80.4 p -114.2 165.36 12.75 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.958 1.703 . . . . 0.0 110.749 174.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.8 m -115.26 129.0 56.5 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.169 1.387 . . . . 0.0 109.916 167.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.1 t -87.0 151.7 23.04 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.842 0.857 . . . . 0.0 110.65 168.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . 0.405 HG11 ' CZ ' ' A' 1886 ' ' PHE . 89.6 t -132.21 144.95 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.136 1.774 . . . . 0.0 110.026 -178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.6 t -141.81 141.69 33.15 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.641 1.577 . . . . 0.0 110.924 171.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.2 p90 -147.19 155.0 41.73 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 175.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.1 mt -119.72 104.31 44.9 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.569 1.547 . . . . 0.0 110.608 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -81.01 167.46 18.08 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.632 2.888 . . . . 0.0 110.36 167.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.4 p -132.29 -18.81 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -170.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -143.51 150.18 50.14 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.61 1.164 . . . . 0.0 110.404 173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.29 142.57 27.17 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.708 2.272 . . . . 0.0 111.552 -172.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 158.61 -167.55 34.66 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.66 1.124 . . . . 0.0 113.331 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -95.33 126.8 40.88 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.215 1.406 . . . . 0.0 112.111 177.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -120.62 124.28 44.88 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.801 1.64 . . . . 0.0 109.922 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.9 m -87.64 121.08 29.62 Favored 'General case' 0 CA--C 1.537 0.478 0 O-C-N 121.116 -0.99 . . . . 0.0 110.851 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -97.51 127.88 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.224 1.41 . . . . 0.0 108.522 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.46 130.54 55.68 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 38.2 t -133.22 130.56 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.289 1.036 . . . . 0.0 109.804 172.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.83 144.45 24.25 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.032 1.333 . . . . 0.0 111.871 -167.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -141.08 124.76 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.892 1.277 . . . . 0.0 110.165 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 56.02 53.49 9.08 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.867 1.267 . . . . 0.0 111.676 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.94 3.42 0.32 Allowed 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.988 2.915 . . . . 0.0 116.75 -175.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 20.2 mm100 -107.49 126.55 52.65 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.758 1.223 . . . . 0.0 110.718 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -63.89 147.29 52.28 Favored 'General case' 0 CA--C 1.546 0.8 0 O-C-N 121.238 -0.914 . . . . 0.0 111.949 171.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 9.9 m -68.85 152.84 96.57 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.387 -0.816 . . . . 0.0 109.672 168.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -61.99 130.29 30.37 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.165 1.91 . . . . 0.0 110.527 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.94 -15.93 61.63 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.005 1.288 . . . . 0.0 114.919 -174.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.8 t -77.67 140.85 63.97 Favored Pre-proline 0 CA--C 1.549 0.909 0 CA-C-N 119.282 1.541 . . . . 0.0 111.465 175.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.72 137.87 52.75 Favored 'Cis proline' 0 C--N 1.352 0.727 0 CA-C-N 119.337 0.799 . . . . 0.0 112.077 -3.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -89.63 169.86 10.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.203 1.801 . . . . 0.0 110.555 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.6 m -129.12 115.95 18.5 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.698 0.799 . . . . 0.0 110.781 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.27 144.93 25.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.872 1.269 . . . . 0.0 110.656 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 17.8 ttt85 -108.82 121.52 45.24 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.832 0.853 . . . . 0.0 110.035 172.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.1 t -102.44 134.37 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 125.179 1.392 . . . . 0.0 110.648 -173.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 48.4 p -114.88 169.64 8.93 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.252 1.421 . . . . 0.0 112.939 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.3 140.16 22.58 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.027 1.298 . . . . 0.0 112.612 177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.76 -23.81 41.98 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.38 1.072 . . . . 0.0 112.855 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.0 t70 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.801 2.04 . . . . 0.0 112.54 -175.911 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.35 -22.66 61.87 Favored 'General case' 0 CA--C 1.546 0.816 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -142.19 9.9 1.9 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 124.928 1.291 . . . . 0.0 114.483 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -158.06 149.18 16.47 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 125.287 1.435 . . . . 0.0 112.038 -176.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -78.63 171.58 16.5 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.137 3.224 . . . . 0.0 112.18 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -163.1 164.17 25.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.239 1.816 . . . . 0.0 110.86 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -64.33 140.09 97.87 Favored Pre-proline 0 CA--C 1.548 0.88 0 CA-C-O 118.889 -0.577 . . . . 0.0 111.747 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -74.99 174.99 11.83 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 123.738 2.959 . . . . 0.0 111.785 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 87.5 mt -76.84 67.66 2.92 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.176 1.391 . . . . 0.0 111.762 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 35.2 m -69.37 -10.68 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 125.681 1.592 . . . . 0.0 114.255 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 91.24 -145.43 17.77 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 124.866 1.222 . . . . 0.0 112.432 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 90.2 t -128.57 138.87 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.635 1.574 . . . . 0.0 109.578 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 53.6 t30 -139.38 38.42 2.07 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.611 1.564 . . . . 0.0 111.285 -177.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 85.6 -149.2 23.32 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.996 1.284 . . . . 0.0 111.077 -166.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.83 144.97 52.43 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.511 0.724 . . . . 0.0 111.076 175.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 32.4 t70 -72.51 -19.66 61.49 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.158 0.983 . . . . 0.0 113.196 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 18.1 m -142.61 153.45 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 127.178 2.191 . . . . 0.0 109.848 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 13.0 t -164.15 -45.01 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.913 1.285 . . . . 0.0 111.827 174.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 90.8 p -165.0 150.57 9.71 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 173.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 78.1 mt -90.46 158.95 16.8 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 126.072 1.749 . . . . 0.0 110.004 161.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -58.39 118.1 25.27 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 124.97 1.308 . . . . 0.0 110.991 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -74.08 152.68 45.99 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.024 2.483 . . . . 0.0 111.037 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -109.26 113.94 27.2 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.804 0.842 . . . . 0.0 109.71 174.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -146.81 125.23 12.34 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.168 1.387 . . . . 0.0 109.99 168.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -137.16 153.48 50.45 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 126.482 1.913 . . . . 0.0 109.891 -173.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.8 p -129.2 136.77 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.029 1.332 . . . . 0.0 110.351 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.01 138.72 33.03 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.001 1.72 . . . . 0.0 109.074 -175.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.87 67.7 7.93 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 124.353 3.369 . . . . 0.0 111.698 176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -113.82 150.73 33.08 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.146 1.778 . . . . 0.0 110.231 172.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 77.7 m -119.08 125.41 49.24 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.596 1.158 . . . . 0.0 109.751 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 81.1 mt -91.46 132.08 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.755 1.222 . . . . 0.0 109.876 177.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -114.35 -100.95 0.43 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.18 1.392 . . . . 0.0 110.746 177.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.4 mttp -133.69 139.35 46.37 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.02 1.728 . . . . 0.0 111.089 175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.4 -139.81 11.2 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.719 1.628 . . . . 0.0 110.801 -165.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.53 141.61 16.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.118 0.967 . . . . 0.0 111.36 -177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.1 tt -124.68 135.42 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.731 1.612 . . . . 0.0 110.711 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.3 p -145.77 174.58 11.1 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.112 1.765 . . . . 0.0 110.206 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.44 -170.96 24.64 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.3 140.14 16.18 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.843 1.657 . . . . 0.0 109.305 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.1 t -117.72 130.74 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.546 1.539 . . . . 0.0 108.343 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.0 mtm105 -117.99 128.36 54.71 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.001 1.32 . . . . 0.0 110.389 -174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 32.4 mtt -99.76 153.32 37.83 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.198 -170.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.95 -17.87 31.83 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 123.431 2.754 . . . . 0.0 112.831 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 35.3 p -72.76 -8.06 53.62 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.812 1.645 . . . . 0.0 113.973 170.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.51 83.2 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.721 1.629 . . . . 0.0 113.777 -174.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 62.5 mtpt -72.52 159.54 33.76 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.599 1.16 . . . . 0.0 112.536 176.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 46.9 t -139.34 142.79 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.517 1.527 . . . . 0.0 110.169 -173.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.88 171.15 16.77 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 125.885 1.674 . . . . 0.0 111.772 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -106.61 140.39 21.29 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.34 1.056 . . . . 0.0 111.264 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -86.65 174.0 5.97 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 124.549 3.499 . . . . 0.0 111.94 175.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 60.3 m -113.46 131.76 55.91 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.394 1.478 . . . . 0.0 108.982 172.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -113.01 133.31 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.839 1.256 . . . . 0.0 109.154 175.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 92.9 m -123.51 129.04 50.63 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.152 1.781 . . . . 0.0 109.789 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 59.5 t0 -81.78 118.61 23.01 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.309 1.044 . . . . 0.0 110.127 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -83.01 -10.54 58.71 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.8 mmmt 73.5 -10.44 1.05 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 128.269 2.628 . . . . 0.0 114.331 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -92.75 5.61 50.52 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.495 1.918 . . . . 0.0 113.691 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.89 15.82 53.19 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.802 1.191 . . . . 0.0 113.716 -173.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 67.3 p -128.26 159.29 35.68 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.364 1.866 . . . . 0.0 110.286 174.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -121.79 143.01 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.494 1.118 . . . . 0.0 109.875 167.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 31.8 m -104.09 137.23 42.34 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.396 1.078 . . . . 0.0 108.618 170.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.3 t -124.92 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 125.184 1.394 . . . . 0.0 109.042 -179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -133.76 156.45 47.97 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.138 1.375 . . . . 0.0 112.826 -172.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 22.9 t80 -155.61 135.76 13.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.828 1.651 . . . . 0.0 111.427 175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.37 120.05 71.93 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.411 1.084 . . . . 0.0 110.776 177.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -76.33 139.99 21.49 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 123.349 2.699 . . . . 0.0 112.01 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.2 m -132.92 0.3 3.48 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -161.4 150.46 16.23 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.296 1.838 . . . . 0.0 109.686 -177.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -86.09 173.06 10.12 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.634 1.173 . . . . 0.0 112.857 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.09 -172.68 21.73 Favored Glycine 0 N--CA 1.471 1.017 0 C-N-CA 125.262 1.41 . . . . 0.0 114.098 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -78.0 125.84 29.94 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.952 1.301 . . . . 0.0 110.618 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 51.2 m80 -123.09 163.05 21.26 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.075 1.75 . . . . 0.0 111.372 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -151.22 153.1 34.26 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.157 0.983 . . . . 0.0 111.862 175.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 28.0 ttm -137.36 135.25 36.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.956 1.702 . . . . 0.0 110.771 -167.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -108.11 134.3 51.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.443 1.897 . . . . 0.0 109.848 174.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.6 mm -133.97 130.59 55.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 125.171 1.388 . . . . 0.0 109.53 176.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.55 136.5 23.4 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -173.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.67 122.68 43.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.641 1.976 . . . . 0.0 109.784 175.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 51.82 31.28 8.03 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 124.876 1.27 . . . . 0.0 112.881 -173.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 18.1 t30 77.62 5.09 3.01 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 128.279 2.631 . . . . 0.0 115.108 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 95.9 mtp -100.07 129.36 46.11 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.31 1.444 . . . . 0.0 110.772 170.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -56.77 137.15 55.05 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.6 pt -74.55 151.14 87.18 Favored Pre-proline 0 N--CA 1.479 0.999 0 CA-C-O 118.842 -0.599 . . . . 0.0 110.861 173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -60.04 132.34 44.11 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.672 2.248 . . . . 0.0 110.243 176.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.91 -17.15 59.83 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.733 1.159 . . . . 0.0 113.905 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.9 t -85.53 147.77 47.55 Favored Pre-proline 0 CA--C 1.547 0.848 0 CA-C-N 119.164 1.482 . . . . 0.0 110.905 173.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -74.44 157.43 99.47 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 120.666 1.274 . . . . 0.0 113.251 -0.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 80.1 mt -101.38 157.87 16.48 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.67 1.588 . . . . 0.0 110.884 173.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -151.93 135.26 15.96 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.839 1.256 . . . . 0.0 110.154 -177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.2 p90 -165.51 167.2 17.7 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.043 1.337 . . . . 0.0 111.98 -172.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -108.52 141.09 40.93 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.126 -0.984 . . . . 0.0 112.928 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.9 t -111.56 139.93 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.815 1.646 . . . . 0.0 109.679 177.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -161.42 151.77 17.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.9 1.28 . . . . 0.0 112.22 -170.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -67.53 134.15 50.77 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.932 1.293 . . . . 0.0 112.152 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -68.41 -27.37 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 O-C-N 121.113 -0.992 . . . . 0.0 113.289 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -79.89 -21.33 44.11 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -170.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.6 t -67.22 147.03 53.57 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 121.484 -0.76 . . . . 0.0 112.964 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.9 -6.77 82.0 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.145 1.355 . . . . 0.0 115.103 -176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.29 166.85 11.36 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 119.09 1.445 . . . . 0.0 114.0 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.8 t -73.19 144.73 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.978 0.911 . . . . 0.0 108.832 171.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.0 t -159.74 148.25 17.47 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.03 1.332 . . . . 0.0 110.241 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.61 144.83 50.41 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.62 1.168 . . . . 0.0 111.658 177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.7 p90 -166.73 161.65 15.73 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.615 1.566 . . . . 0.0 112.745 -177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.02 175.36 13.81 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.324 1.44 . . . . 0.0 112.897 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.16 -36.48 9.66 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.721 2.28 . . . . 0.0 112.832 -171.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.4 -34.96 90.75 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 119.378 0.99 . . . . 0.0 114.406 -171.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -78.77 -5.64 53.84 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.829 1.314 . . . . 0.0 113.615 176.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 32.3 m -104.89 -42.1 5.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 126.409 1.884 . . . . 0.0 111.25 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -151.14 143.39 24.11 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.772 2.029 . . . . 0.0 112.054 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -136.09 177.56 19.45 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.822 1.201 . . . . 0.0 113.212 175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 25.5 t -142.96 135.19 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.905 1.282 . . . . 0.0 108.378 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.94 135.33 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -177.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 75.9 m-20 66.34 2.81 2.53 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.604 1.962 . . . . 0.0 114.382 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -100.01 142.3 24.36 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 124.907 1.283 . . . . 0.0 110.807 174.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -72.37 109.13 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.675 0 C-N-CA 122.777 2.318 . . . . 0.0 109.853 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -93.6 133.0 37.37 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.003 1.321 . . . . 0.0 110.134 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.8 p -127.35 149.01 50.25 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -164.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.3 p90 -159.51 174.79 14.12 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.754 1.621 . . . . 0.0 111.664 175.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.8 m -126.51 145.14 50.63 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.347 1.459 . . . . 0.0 110.721 -172.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 29.9 t -114.76 130.19 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.476 1.511 . . . . 0.0 108.128 167.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.02 132.77 36.29 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.226 1.011 . . . . 0.0 111.051 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.5 p -131.91 13.67 4.8 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.787 2.035 . . . . 0.0 112.449 -173.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -50.61 -36.2 33.94 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 127.258 2.223 . . . . 0.0 115.268 -166.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -134.27 24.83 3.84 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.647 1.579 . . . . 0.0 111.858 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -70.93 -43.05 69.03 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.461 1.105 . . . . 0.0 113.619 -174.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.66 150.74 5.23 Favored Glycine 0 CA--C 1.536 1.367 0 C-N-CA 124.827 1.203 . . . . 0.0 112.337 -169.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -73.82 149.27 41.75 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.744 0.783 . . . . 0.0 112.024 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.74 14.42 0.02 OUTLIER Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.881 1.705 . . . . 0.0 114.905 -178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 92.85 100.63 1.46 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.535 1.541 . . . . 0.0 112.806 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.49 130.7 35.03 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.366 1.466 . . . . 0.0 109.415 171.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.3 m -126.96 158.4 36.96 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.64 1.576 . . . . 0.0 112.123 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.7 tp -160.72 135.45 7.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.788 1.635 . . . . 0.0 109.23 -169.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 161.57 38.1 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.043 0.937 . . . . 0.0 112.321 178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -135.53 134.58 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.762 1.225 . . . . 0.0 109.547 173.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -116.73 115.7 26.13 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.001 1.32 . . . . 0.0 109.326 172.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -128.37 -177.64 14.97 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.978 1.275 . . . . 0.0 113.873 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.54 -22.65 44.32 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 124.001 3.134 . . . . 0.0 112.128 172.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -140.28 158.06 44.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.626 1.57 . . . . 0.0 109.069 161.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.96 118.51 11.98 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.093 -1.005 . . . . 0.0 111.915 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.09 142.63 33.12 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.207 1.003 . . . . 0.0 110.824 169.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.05 142.0 28.24 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.322 0.649 . . . . 0.0 110.082 171.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.8 mt -132.06 139.21 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 124.822 1.249 . . . . 0.0 110.471 -167.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.8 m -128.38 155.56 44.52 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.861 1.664 . . . . 0.0 110.393 167.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -151.46 156.23 40.19 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 124.156 0.982 . . . . 0.0 112.237 176.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.7 m -140.49 118.62 11.97 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.341 1.456 . . . . 0.0 109.697 -171.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.31 123.71 25.1 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.169 0.988 . . . . 0.0 110.779 169.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -90.55 -17.91 26.18 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 15.0 mm100 71.27 -10.34 0.8 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 128.344 2.658 . . . . 0.0 114.495 175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.0 t70 -72.69 -14.04 61.48 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.313 1.445 . . . . 0.0 113.104 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 116.81 22.03 4.43 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 125.509 1.528 . . . . 0.0 114.17 -170.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.0 p -142.38 158.5 43.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.676 1.59 . . . . 0.0 111.111 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -126.23 135.45 51.6 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.632 1.973 . . . . 0.0 109.068 166.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 16.4 t -94.83 153.29 17.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.459 1.104 . . . . 0.0 111.343 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -132.11 145.03 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.316 1.846 . . . . 0.0 110.0 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.2 t -140.63 138.85 34.68 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.694 1.598 . . . . 0.0 110.752 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -144.99 154.5 42.62 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 177.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 26.4 mt -118.07 102.62 50.75 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 126.097 1.759 . . . . 0.0 110.415 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -80.68 160.67 21.86 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.546 2.83 . . . . 0.0 110.139 167.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.9 m -127.15 -7.77 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 -168.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.72 151.18 22.96 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.176 1.39 . . . . 0.0 110.402 175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.07 140.77 25.65 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.796 2.331 . . . . 0.0 111.691 -173.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 157.8 -169.86 34.66 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.86 1.219 . . . . 0.0 113.087 -174.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -93.82 135.3 35.28 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.889 1.276 . . . . 0.0 112.135 176.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -127.56 128.69 46.04 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.58 1.552 . . . . 0.0 110.288 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.0 m -90.51 122.58 33.47 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.18 -0.95 . . . . 0.0 110.963 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -100.53 125.69 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 125.356 1.462 . . . . 0.0 108.621 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.09 130.42 55.48 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.424 1.49 . . . . 0.0 109.71 176.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 39.2 t -133.25 129.96 57.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 124.349 1.06 . . . . 0.0 109.753 172.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.48 142.26 22.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.145 1.378 . . . . 0.0 111.511 -168.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.5 122.17 19.75 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 124.817 1.247 . . . . 0.0 109.523 178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.5 57.89 5.71 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.038 1.335 . . . . 0.0 112.257 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 8.2 pt-20 59.7 2.42 0.36 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 128.965 2.906 . . . . 0.0 116.819 -176.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -107.5 123.54 48.58 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.567 1.147 . . . . 0.0 110.998 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.88 145.41 55.87 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.306 -0.871 . . . . 0.0 111.984 170.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.4 m -73.39 157.37 88.08 Favored Pre-proline 0 N--CA 1.48 1.065 0 CA-C-O 118.334 -0.841 . . . . 0.0 110.64 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -54.04 125.82 20.02 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.63 2.887 . . . . 0.0 111.785 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.24 -11.36 67.84 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.705 1.145 . . . . 0.0 115.469 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.3 t -76.44 139.73 67.98 Favored Pre-proline 0 CA--C 1.549 0.939 0 CA-C-N 119.356 1.578 . . . . 0.0 111.579 176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -75.07 136.84 47.06 Favored 'Cis proline' 0 CA--C 1.54 0.78 0 CA-C-N 119.382 0.815 . . . . 0.0 111.969 -3.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -87.07 170.25 11.7 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 126.134 1.774 . . . . 0.0 110.662 174.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.1 m -128.92 117.76 21.52 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.748 0.819 . . . . 0.0 110.771 175.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.1 160.31 15.27 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.455 1.502 . . . . 0.0 110.954 168.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -127.62 126.22 41.63 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.553 1.141 . . . . 0.0 110.207 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.5 t -107.23 134.44 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.834 1.653 . . . . 0.0 110.866 -170.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 41.8 p -107.2 157.61 17.75 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.075 1.35 . . . . 0.0 112.919 177.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -94.27 116.76 5.35 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.104 1.335 . . . . 0.0 112.349 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 -94.96 -30.05 14.33 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.73 1.212 . . . . 0.0 112.935 173.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 23.3 m-20 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 125.526 1.531 . . . . 0.0 113.305 179.661 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.654 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 70.96 -28.01 0.18 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 128.588 2.755 . . . . 0.0 115.248 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.19 176.72 12.12 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.375 2.27 . . . . 0.0 111.007 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -132.26 148.57 70.26 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 124.988 1.315 . . . . 0.0 111.706 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -78.0 -178.31 4.52 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 124.16 3.24 . . . . 0.0 111.79 177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -145.89 164.56 31.58 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.389 1.475 . . . . 0.0 111.475 176.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -58.59 123.69 68.49 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 124.557 1.143 . . . . 0.0 111.586 -175.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.32 174.85 12.15 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.681 2.921 . . . . 0.0 111.741 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.1 pp -68.93 8.39 0.54 Allowed 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 116.146 1.906 . . . . 0.0 116.146 -173.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 34.5 m -58.82 -11.12 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.131 1.772 . . . . 0.0 114.761 -174.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -74.87 -7.72 81.35 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 124.979 1.276 . . . . 0.0 114.97 172.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 28.4 m -62.56 153.67 6.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 CA-C-N 119.732 1.766 . . . . 0.0 112.249 172.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -63.51 144.76 56.73 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.347 1.059 . . . . 0.0 112.959 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 131.74 -179.61 16.98 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.831 1.681 . . . . 0.0 113.159 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.3 mt -73.7 142.3 46.37 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.223 1.009 . . . . 0.0 111.868 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 2.4 t70 -155.13 -171.87 3.97 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 125.969 1.708 . . . . 0.0 110.376 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 34.2 m -62.12 -24.95 36.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 O-C-N 120.643 -1.285 . . . . 0.0 113.446 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.5 t -73.26 -22.46 60.39 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.993 1.317 . . . . 0.0 112.82 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 3.7 m -83.4 -6.28 59.41 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.1 1.36 . . . . 0.0 113.425 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 86.7 mt -84.53 149.81 25.66 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.284 1.033 . . . . 0.0 111.903 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -55.17 114.0 6.4 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 126.046 1.739 . . . . 0.0 111.302 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -69.3 142.54 50.26 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.566 2.177 . . . . 0.0 109.71 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 39.6 t80 -120.14 123.36 43.13 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.531 0.732 . . . . 0.0 111.457 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -155.3 135.88 13.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.92 1.688 . . . . 0.0 110.572 175.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.0 151.63 45.63 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 126.214 1.805 . . . . 0.0 110.317 -171.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.5 p -117.6 140.23 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.233 1.413 . . . . 0.0 110.318 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.7 mt -133.21 134.93 24.72 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 126.407 1.883 . . . . 0.0 108.367 -174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -79.37 38.75 0.75 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 124.33 3.353 . . . . 0.0 113.354 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.0 t80 -87.26 152.78 22.01 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.005 1.322 . . . . 0.0 111.415 173.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 94.2 m -122.94 127.46 48.93 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.419 1.488 . . . . 0.0 109.708 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.6 mt -75.61 136.24 25.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.457 1.103 . . . . 0.0 111.216 178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.1 pttt -112.74 -148.97 0.44 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.497 1.919 . . . . 0.0 112.036 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 63.2 tttp -87.16 131.91 34.02 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.557 1.143 . . . . 0.0 111.102 167.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.52 -139.54 11.03 Favored Glycine 0 N--CA 1.475 1.251 0 C-N-CA 125.311 1.434 . . . . 0.0 111.884 -171.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -156.68 145.01 19.69 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.567 1.147 . . . . 0.0 111.74 -175.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.6 tt -117.81 137.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.987 1.715 . . . . 0.0 111.057 176.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 26.1 p -146.27 161.16 40.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.689 1.596 . . . . 0.0 110.799 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.96 -178.86 20.05 Favored Glycine 0 N--CA 1.467 0.714 0 N-CA-C 115.819 1.088 . . . . 0.0 115.819 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -153.0 138.98 18.13 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.7 1.6 . . . . 0.0 109.798 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 19.6 t -111.56 136.62 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 126.337 1.855 . . . . 0.0 108.053 171.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -121.11 125.02 46.18 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.886 1.274 . . . . 0.0 110.882 -173.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -97.05 148.25 34.12 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.84 1.656 . . . . 0.0 111.319 -176.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.53 -20.2 31.49 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.481 2.787 . . . . 0.0 113.929 -175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.6 t -77.03 -4.08 42.38 Favored 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.91 51.06 2.53 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 124.596 1.093 . . . . 0.0 113.035 177.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -147.81 166.96 25.99 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.678 1.591 . . . . 0.0 111.849 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.9 m -139.41 159.49 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 C-N-CA 124.671 1.188 . . . . 0.0 113.071 -171.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.05 171.83 18.47 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.142 2.177 . . . . 0.0 110.545 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -107.26 137.98 19.76 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.822 0.849 . . . . 0.0 111.162 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -82.97 168.11 13.91 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.939 3.092 . . . . 0.0 110.972 171.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.5 m -104.63 126.23 51.52 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.005 1.322 . . . . 0.0 108.83 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.2 mp -106.31 137.67 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.962 1.305 . . . . 0.0 108.846 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 24.4 m -146.71 127.25 14.13 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.205 1.402 . . . . 0.0 109.393 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -76.56 143.64 40.19 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.417 0.687 . . . . 0.0 112.648 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 75.3 m-80 -88.76 -3.09 58.85 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 178.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.7 tmtm? 65.94 18.49 11.08 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.343 1.857 . . . . 0.0 112.978 -178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -128.2 15.53 6.72 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.529 1.932 . . . . 0.0 112.684 -171.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 85.11 15.91 66.03 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 124.575 1.083 . . . . 0.0 114.094 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 30.2 p -135.19 158.14 45.11 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.281 1.833 . . . . 0.0 110.32 178.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -123.81 144.66 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.613 1.165 . . . . 0.0 110.497 170.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.1 m -103.71 140.16 37.97 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.118 1.367 . . . . 0.0 108.862 171.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 34.0 t -122.62 133.78 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.486 1.514 . . . . 0.0 108.833 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.45 153.77 50.54 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.574 1.55 . . . . 0.0 111.983 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 26.6 t80 -157.0 133.31 9.8 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.207 1.403 . . . . 0.0 111.826 178.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.43 119.04 71.23 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.374 1.07 . . . . 0.0 110.513 176.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.59 144.31 31.68 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.524 2.816 . . . . 0.0 112.114 -173.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.7 p -129.07 -7.6 4.88 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -159.88 150.97 19.38 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.74 1.616 . . . . 0.0 110.698 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.31 170.8 14.22 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.649 1.18 . . . . 0.0 113.308 177.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.15 -171.09 13.52 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.099 1.809 . . . . 0.0 113.919 178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.3 tp -85.21 133.72 34.17 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.753 1.221 . . . . 0.0 110.035 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 69.3 m80 -130.47 166.47 20.45 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.028 1.731 . . . . 0.0 111.37 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.67 157.32 45.22 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.447 1.099 . . . . 0.0 110.691 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.2 tmm? -146.56 135.02 21.98 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.533 1.133 . . . . 0.0 111.013 -172.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -120.31 137.71 54.11 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.832 2.053 . . . . 0.0 110.03 -171.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.0 mm -135.03 132.1 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.133 1.373 . . . . 0.0 110.137 177.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 141.21 32.03 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.4 t80 -103.27 120.49 40.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.541 1.936 . . . . 0.0 109.965 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.26 32.39 8.15 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 124.716 1.206 . . . . 0.0 112.889 -174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.8 t30 81.47 0.69 1.6 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.728 2.811 . . . . 0.0 115.08 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 57.4 ttm -98.83 128.5 45.05 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.343 1.457 . . . . 0.0 110.957 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.27 137.42 52.26 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -77.38 154.17 81.84 Favored Pre-proline 0 N--CA 1.479 0.98 0 CA-C-O 118.837 -0.601 . . . . 0.0 111.26 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -58.51 129.58 33.21 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.514 2.143 . . . . 0.0 109.988 171.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.79 -16.92 59.65 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.812 1.196 . . . . 0.0 114.065 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.6 t -86.66 145.51 39.36 Favored Pre-proline 0 CA--C 1.546 0.813 0 CA-C-N 119.699 1.75 . . . . 0.0 111.244 171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -82.8 165.31 70.91 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 120.076 1.063 . . . . 0.0 112.73 -4.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.1 mt -115.63 156.88 25.04 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.286 1.834 . . . . 0.0 111.423 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -137.05 137.88 39.83 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.522 1.529 . . . . 0.0 109.71 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 27.0 p90 -158.5 155.89 29.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.284 1.034 . . . . 0.0 112.315 -169.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.0 t80 -106.01 148.17 28.02 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.878 0.871 . . . . 0.0 112.341 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 55.0 t -126.11 137.45 57.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.523 1.529 . . . . 0.0 108.979 177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -150.35 158.43 44.15 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.599 1.16 . . . . 0.0 113.115 -171.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -77.8 118.46 20.16 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.941 0.896 . . . . 0.0 111.748 176.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.6 p -62.9 -34.29 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.743 1.217 . . . . 0.0 114.017 -170.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -88.24 -7.44 56.8 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 39.7 t -67.35 -34.04 76.49 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.292 1.037 . . . . 0.0 113.065 -176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 82.67 2.6 90.65 Favored Glycine 0 N--CA 1.476 1.319 0 C-N-CA 124.901 1.239 . . . . 0.0 115.325 171.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 37.4 p-80 -64.03 163.26 12.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 125.622 1.569 . . . . 0.0 113.698 175.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.3 t -70.16 132.76 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.0 t -165.27 164.24 19.97 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.784 1.233 . . . . 0.0 110.963 -174.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.32 143.9 44.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.433 1.493 . . . . 0.0 111.251 179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.5 p90 -162.93 162.84 26.39 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.278 1.431 . . . . 0.0 112.782 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 125.89 173.59 13.66 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.443 1.497 . . . . 0.0 112.797 -176.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.01 -34.99 9.63 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.793 2.329 . . . . 0.0 112.947 -170.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.82 -32.95 82.63 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-N 119.51 1.05 . . . . 0.0 114.786 -170.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -79.33 -6.08 55.95 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 118.877 1.338 . . . . 0.0 113.526 175.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.2 m -105.0 -45.28 4.58 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.497 1.919 . . . . 0.0 111.001 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -146.44 150.52 35.78 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.679 1.992 . . . . 0.0 112.132 -175.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 179.86 22.81 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 124.293 0.949 . . . . 0.0 113.493 171.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 31.5 t -142.45 133.2 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.867 1.267 . . . . 0.0 108.522 178.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.5 m -55.54 137.44 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.3 m-80 68.98 -4.92 1.11 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 127.072 2.149 . . . . 0.0 114.814 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 84.4 mttt -104.39 138.58 19.56 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.012 1.325 . . . . 0.0 110.771 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.93 127.13 12.57 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.368 2.045 . . . . 0.0 110.334 -179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.21 145.18 32.95 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.595 1.558 . . . . 0.0 110.368 175.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.6 p -135.11 151.07 50.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.909 0.884 . . . . 0.0 113.245 -167.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.5 p90 -162.01 176.26 10.93 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.945 1.698 . . . . 0.0 111.441 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 67.8 m -129.93 143.03 50.59 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.226 1.411 . . . . 0.0 110.275 -171.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 49.0 t -115.4 135.15 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 125.689 1.596 . . . . 0.0 108.137 169.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.7 133.67 42.7 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.364 1.066 . . . . 0.0 111.136 178.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.7 p -134.61 14.57 3.71 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.778 1.631 . . . . 0.0 112.519 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.6 tptt -58.12 -34.78 70.59 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.645 1.578 . . . . 0.0 114.992 -163.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -129.39 21.51 5.64 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.691 1.596 . . . . 0.0 111.868 177.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.59 -39.14 70.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.482 1.113 . . . . 0.0 113.841 -172.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.41 146.76 4.61 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.783 1.183 . . . . 0.0 112.01 -168.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.13 165.86 22.66 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.997 0.919 . . . . 0.0 113.391 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.75 16.47 0.25 Allowed Glycine 0 N--CA 1.477 1.394 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.61 97.22 1.86 Allowed Glycine 0 N--CA 1.47 0.903 0 C-N-CA 125.302 1.429 . . . . 0.0 113.126 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -80.14 127.22 32.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 108.952 169.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -120.08 159.49 24.71 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.775 1.63 . . . . 0.0 112.547 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -159.65 137.46 10.06 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 126.048 1.739 . . . . 0.0 109.437 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.13 159.51 36.29 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.442 1.097 . . . . 0.0 111.839 175.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.2 mt -139.13 133.66 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.448 1.099 . . . . 0.0 109.813 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -123.52 132.68 53.98 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.182 1.393 . . . . 0.0 109.752 173.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.82 -165.6 15.11 Favored Glycine 0 CA--C 1.537 1.43 0 CA-C-O 119.089 -0.839 . . . . 0.0 114.412 -174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -62.31 -29.44 79.84 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.917 3.078 . . . . 0.0 111.996 175.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.2 t -129.83 150.43 51.14 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.851 1.26 . . . . 0.0 108.972 158.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -70.68 125.69 27.51 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 121.114 -0.991 . . . . 0.0 110.306 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.87 152.8 35.28 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.251 1.021 . . . . 0.0 113.099 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -85.68 133.14 34.04 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 162.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.4 mt -133.07 143.13 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.823 1.249 . . . . 0.0 109.994 -166.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.7 t -143.42 158.99 43.2 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.931 1.293 . . . . 0.0 110.834 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -158.07 154.44 27.57 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.463 1.105 . . . . 0.0 112.436 -178.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.7 m -135.84 120.06 17.81 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.302 1.441 . . . . 0.0 109.954 -173.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 13.8 t70 -75.61 132.03 40.36 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.901 1.28 . . . . 0.0 110.913 170.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -109.82 138.77 45.72 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.156 1.382 . . . . 0.0 111.084 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -65.66 -17.85 64.9 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.863 0.865 . . . . 0.0 112.226 174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.49 -12.44 57.44 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.048 1.739 . . . . 0.0 114.346 173.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.04 33.42 5.5 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 124.876 1.227 . . . . 0.0 114.486 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.8 p -140.55 164.24 30.68 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.596 1.558 . . . . 0.0 110.794 175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.6 m -119.34 130.45 55.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.144 1.378 . . . . 0.0 109.442 163.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -91.49 148.51 22.25 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.82 0.848 . . . . 0.0 110.398 170.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.9 t -131.38 141.21 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.412 1.485 . . . . 0.0 110.606 -176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 49.8 m -133.43 143.46 48.89 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.947 1.699 . . . . 0.0 111.084 170.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.8 p90 -150.46 155.2 39.08 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.063 1.135 . . . . 0.0 114.063 173.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.4 mt -116.2 109.24 44.72 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.017 1.727 . . . . 0.0 110.67 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -81.86 174.68 10.03 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 123.712 2.941 . . . . 0.0 110.178 163.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -152.22 -31.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 -174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.8 mt -103.32 146.17 31.96 Favored Pre-proline 0 CA--C 1.543 0.709 0 CA-C-N 119.319 0.963 . . . . 0.0 110.48 167.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -72.89 155.76 53.08 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 122.772 2.315 . . . . 0.0 110.703 174.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.02 -152.71 21.16 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.49 1.043 . . . . 0.0 112.926 -176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -114.37 129.75 56.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.634 1.173 . . . . 0.0 111.614 -175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -116.26 130.53 56.83 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.326 1.85 . . . . 0.0 110.28 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -93.82 116.6 29.08 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.651 1.18 . . . . 0.0 110.798 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.34 124.3 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 126.416 1.886 . . . . 0.0 108.62 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.03 132.2 51.57 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.653 1.581 . . . . 0.0 109.58 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.3 t -133.36 131.87 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.417 1.487 . . . . 0.0 108.316 172.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.6 144.81 18.36 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.763 1.225 . . . . 0.0 110.714 -166.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.72 121.24 15.15 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.531 1.132 . . . . 0.0 109.591 -178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.2 t-20 52.64 57.72 6.11 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.059 1.344 . . . . 0.0 112.334 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.296 7.9 pt-20 59.36 11.72 2.33 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 128.302 2.641 . . . . 0.0 116.35 -177.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.2 124.6 48.31 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.541 1.137 . . . . 0.0 111.218 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -61.1 154.58 22.59 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.058 0.943 . . . . 0.0 112.663 170.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.51 153.86 71.11 Favored Pre-proline 0 N--CA 1.479 0.984 0 O-C-N 121.845 -0.534 . . . . 0.0 110.269 174.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -57.15 123.14 13.13 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.593 2.195 . . . . 0.0 110.457 174.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 97.33 -16.19 61.09 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.178 1.371 . . . . 0.0 115.956 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 89.8 p -79.56 152.98 75.94 Favored Pre-proline 0 CA--C 1.55 0.958 0 CA-C-N 120.321 2.06 . . . . 0.0 112.942 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.22 156.28 99.77 Favored 'Cis proline' 0 C--N 1.353 0.771 0 CA-C-N 119.31 0.789 . . . . 0.0 112.675 -4.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -111.13 140.82 45.36 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.573 1.549 . . . . 0.0 111.001 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 43.8 m -95.25 115.43 27.42 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.509 0.724 . . . . 0.0 110.997 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.08 127.99 42.58 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.994 1.318 . . . . 0.0 110.664 169.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.2 ttt85 -96.0 125.21 40.39 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.187 0.595 . . . . 0.0 110.634 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.4 t -110.7 129.77 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 125.33 1.452 . . . . 0.0 110.897 -172.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.7 p -97.73 148.77 23.02 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.702 1.201 . . . . 0.0 112.778 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.75 59.62 2.12 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.35 1.928 . . . . 0.0 112.782 -175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.6 t70 -70.41 -26.64 63.78 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -175.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 30.3 t70 . . . . . 0 C--O 1.254 1.293 0 C-N-CA 124.768 1.227 . . . . 0.0 113.48 177.372 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.61 164.26 26.23 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.444 1.098 . . . . 0.0 112.844 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 77.5 mtm -68.96 139.6 55.05 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.13 0.972 . . . . 0.0 111.633 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -165.06 156.59 13.09 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 125.822 1.649 . . . . 0.0 111.661 -174.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.19 173.1 13.52 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.699 2.932 . . . . 0.0 111.521 172.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -136.39 149.11 48.15 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.804 1.241 . . . . 0.0 111.945 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -79.0 146.24 67.46 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 124.302 1.041 . . . . 0.0 112.118 -177.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -75.19 167.89 25.88 Favored 'Trans proline' 0 CA--C 1.538 0.713 0 C-N-CA 123.667 2.911 . . . . 0.0 111.194 171.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 2.2 pt? -156.63 145.07 19.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.03 1.332 . . . . 0.0 111.842 176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 10.7 p -175.81 144.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 127.299 2.24 . . . . 0.0 109.557 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 71.21 28.88 69.32 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 123.47 0.557 . . . . 0.0 113.945 176.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 35.1 m -62.24 152.57 6.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.241 1.416 . . . . 0.0 113.03 -173.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 48.2 t30 -73.86 -11.39 60.35 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.674 1.19 . . . . 0.0 114.123 -177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -74.97 179.98 44.09 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.128 1.347 . . . . 0.0 114.075 179.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.1 mt -71.86 164.97 25.08 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.934 1.294 . . . . 0.0 112.709 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 34.7 t70 -154.44 -51.05 0.09 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.614 1.565 . . . . 0.0 111.149 177.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 20.3 m -134.14 149.13 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 125.531 1.532 . . . . 0.0 109.963 163.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.7 t -173.15 -34.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.559 1.944 . . . . 0.0 111.808 -176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 47.4 m -75.97 90.31 2.99 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.411 1.084 . . . . 0.0 112.169 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.67 140.18 55.45 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.815 0.846 . . . . 0.0 110.312 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.7 ttm-85 -63.35 122.34 75.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 124.808 1.243 . . . . 0.0 110.357 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -67.27 140.2 52.53 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.932 2.421 . . . . 0.0 110.485 -175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.0 t80 -94.63 123.13 37.88 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.215 0.606 . . . . 0.0 110.255 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -147.42 136.12 21.96 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.191 1.396 . . . . 0.0 110.504 172.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.47 149.48 37.62 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.202 1.801 . . . . 0.0 109.533 -173.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -126.89 136.66 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 125.056 1.342 . . . . 0.0 110.164 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.6 mt -132.83 136.12 27.17 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 125.774 1.629 . . . . 0.0 109.231 -173.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.93 107.04 2.13 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 123.475 2.783 . . . . 0.0 109.693 171.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -172.95 152.3 2.35 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 127.758 2.423 . . . . 0.0 108.464 -173.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.7 m -132.59 126.99 34.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.359 1.064 . . . . 0.0 109.783 -177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 40.8 mt -76.85 117.63 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.229 1.011 . . . . 0.0 109.749 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 36.9 tptt -100.44 -146.06 0.34 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.214 1.406 . . . . 0.0 110.414 172.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.2 tttt -78.3 125.28 29.13 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 120.466 -1.396 . . . . 0.0 111.021 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 139.51 -150.4 21.34 Favored Glycine 0 N--CA 1.473 1.165 0 C-N-CA 125.462 1.506 . . . . 0.0 112.117 -170.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -159.09 147.01 17.74 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.489 1.116 . . . . 0.0 111.412 -174.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.6 tt -125.33 136.78 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.876 1.67 . . . . 0.0 111.07 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.25 167.32 24.52 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.809 1.644 . . . . 0.0 111.004 -175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.74 -173.63 30.63 Favored Glycine 0 N--CA 1.467 0.703 0 N-CA-C 115.963 1.145 . . . . 0.0 115.963 -177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.22 132.55 11.93 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.96 1.704 . . . . 0.0 109.648 177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 86.2 t -103.33 134.43 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.708 1.603 . . . . 0.0 108.326 171.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -121.44 131.51 54.2 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 125.069 1.347 . . . . 0.0 110.972 -172.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.8 mtt -106.23 149.24 37.96 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.634 1.574 . . . . 0.0 111.617 -169.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -56.0 -28.18 67.79 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 124.073 3.182 . . . . 0.0 115.183 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 34.8 p -74.45 -6.15 46.62 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.542 1.537 . . . . 0.0 114.388 178.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.49 -5.5 82.52 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.535 1.54 . . . . 0.0 113.718 -174.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -70.04 157.11 38.13 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.589 1.155 . . . . 0.0 112.128 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -142.06 155.42 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.275 1.43 . . . . 0.0 111.645 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.24 177.43 11.29 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.953 2.101 . . . . 0.0 110.149 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.43 143.17 33.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 O-C-N 120.974 -1.078 . . . . 0.0 112.254 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -83.97 169.18 11.81 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.417 3.411 . . . . 0.0 111.666 175.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.4 m -111.01 130.23 55.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.486 1.514 . . . . 0.0 109.03 173.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.35 137.32 45.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.945 1.298 . . . . 0.0 109.666 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -138.98 129.21 25.46 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.265 1.426 . . . . 0.0 110.002 176.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -80.11 129.04 34.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.949 0.899 . . . . 0.0 110.776 172.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -84.31 -9.14 58.72 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -174.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 66.3 mttm 65.71 10.24 6.62 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 127.469 2.308 . . . . 0.0 113.897 -175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -105.9 6.93 31.9 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 127.208 2.203 . . . . 0.0 112.632 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.95 11.82 58.45 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 125.314 1.435 . . . . 0.0 114.162 -175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.31 155.64 45.3 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.207 1.803 . . . . 0.0 111.044 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.5 m -111.14 142.12 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.986 0.914 . . . . 0.0 109.701 162.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 33.7 m -102.06 138.57 38.84 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.816 1.246 . . . . 0.0 108.465 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.8 t -123.6 134.41 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 125.196 1.398 . . . . 0.0 109.019 177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -132.19 156.36 46.58 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.223 1.409 . . . . 0.0 112.715 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 32.6 t80 -155.35 135.41 12.97 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.718 1.607 . . . . 0.0 111.786 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.03 116.25 65.41 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 124.536 1.135 . . . . 0.0 110.59 175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.46 148.01 29.31 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.47 2.78 . . . . 0.0 112.348 -173.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 7.6 t -140.56 -2.59 1.37 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.166 0.987 . . . . 0.0 113.639 176.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -144.7 148.29 34.03 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.366 1.866 . . . . 0.0 109.501 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.15 168.31 12.88 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.02 0.928 . . . . 0.0 112.076 171.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.04 -172.48 18.96 Favored Glycine 0 N--CA 1.474 1.201 0 C-N-CA 124.686 1.136 . . . . 0.0 114.59 174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.1 tp -79.86 110.74 15.51 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.564 1.546 . . . . 0.0 110.912 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 49.1 m80 -107.18 164.05 12.5 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.191 1.797 . . . . 0.0 112.214 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -136.95 142.46 42.63 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.217 1.407 . . . . 0.0 109.95 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.5 ttm -122.72 126.32 47.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.925 1.29 . . . . 0.0 111.196 174.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 t70 -87.77 133.86 33.79 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.801 1.641 . . . . 0.0 110.091 166.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 16.9 mm -134.15 139.63 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 125.309 1.443 . . . . 0.0 109.874 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.4 142.22 23.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.116 0.966 . . . . 0.0 113.585 175.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.0 t80 -98.52 118.79 36.0 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.975 1.71 . . . . 0.0 109.505 172.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.46 34.36 12.01 Favored 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.999 1.32 . . . . 0.0 112.919 -174.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 74.38 10.69 4.22 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 127.784 2.434 . . . . 0.0 115.073 -178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 6.0 tmm? -107.39 126.48 52.53 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.618 1.567 . . . . 0.0 110.197 171.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m170 -54.87 131.98 45.47 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 121.044 -1.035 . . . . 0.0 113.711 -177.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.6 pt -71.43 154.41 93.48 Favored Pre-proline 0 N--CA 1.481 1.088 0 O-C-N 121.247 -0.908 . . . . 0.0 111.464 174.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.53 122.04 10.85 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 122.431 2.087 . . . . 0.0 109.627 171.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.97 -16.39 43.0 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.692 1.139 . . . . 0.0 114.563 -173.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.8 t -80.95 147.68 62.4 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-N 119.326 1.563 . . . . 0.0 112.173 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.64 164.02 82.65 Favored 'Cis proline' 0 CA--C 1.54 0.785 0 CA-C-N 120.286 1.138 . . . . 0.0 112.258 -7.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 50.8 mt -97.26 156.69 16.31 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.047 174.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -153.26 134.35 14.06 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.395 1.078 . . . . 0.0 110.012 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -167.02 160.59 14.23 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.164 0.986 . . . . 0.0 112.852 -170.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 58.4 t80 -96.44 134.42 39.64 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.945 0.898 . . . . 0.0 112.74 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.7 t -98.03 128.91 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.944 1.297 . . . . 0.0 109.966 173.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -132.61 173.51 11.25 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.373 2.269 . . . . 0.0 111.581 176.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -74.4 141.44 45.08 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.964 -1.085 . . . . 0.0 112.018 172.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 6.0 p -63.17 -27.7 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.343 1.057 . . . . 0.0 113.334 -170.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -132.45 134.95 45.71 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.723 1.609 . . . . 0.0 110.292 174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 26.5 p -169.71 164.05 10.01 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.011 1.724 . . . . 0.0 112.172 -174.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.31 -22.99 20.76 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.721 1.153 . . . . 0.0 114.38 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -73.16 158.54 35.08 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 118.378 1.089 . . . . 0.0 113.497 178.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.3 t -70.44 128.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 123.81 0.844 . . . . 0.0 108.956 176.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.9 t -147.01 158.15 43.84 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.983 1.313 . . . . 0.0 110.45 -175.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.13 142.57 36.01 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.055 1.342 . . . . 0.0 111.513 -177.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.5 p90 -165.69 160.69 17.58 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.529 1.532 . . . . 0.0 112.532 -175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.38 174.24 13.42 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.113 1.339 . . . . 0.0 113.294 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.52 -33.12 14.25 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.943 2.429 . . . . 0.0 113.088 -171.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.74 -32.63 70.62 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-N 119.481 1.037 . . . . 0.0 114.501 -172.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.99 -6.64 57.92 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.028 1.414 . . . . 0.0 113.191 174.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 49.6 m -102.41 -40.29 6.78 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.532 1.933 . . . . 0.0 111.794 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -151.55 154.43 36.47 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.581 1.952 . . . . 0.0 112.338 -167.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -158.59 -175.3 29.36 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.708 0.671 . . . . 0.0 113.822 168.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.5 p -152.46 137.2 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 125.24 1.416 . . . . 0.0 108.67 174.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 30.1 m -56.74 140.95 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.3 m-80 72.04 -3.03 2.34 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.518 2.327 . . . . 0.0 114.86 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 41.4 mttm -103.59 143.6 26.97 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.507 1.123 . . . . 0.0 111.133 171.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -72.7 123.2 8.83 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.555 2.17 . . . . 0.0 110.306 177.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.61 147.25 26.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.384 1.473 . . . . 0.0 110.273 173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 70.0 p -137.05 150.85 48.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -168.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -161.38 175.53 12.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.794 1.638 . . . . 0.0 111.592 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.6 m -126.97 142.31 51.58 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.959 1.304 . . . . 0.0 110.752 -171.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.9 t -117.58 130.22 72.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 125.695 1.598 . . . . 0.0 108.27 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -93.75 129.28 40.15 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.231 1.012 . . . . 0.0 111.158 -177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 56.8 p -136.0 0.52 2.64 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.039 1.336 . . . . 0.0 113.997 -166.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -55.12 -38.2 67.86 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.402 1.481 . . . . 0.0 114.727 -168.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -113.84 9.15 17.53 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.763 1.625 . . . . 0.0 112.935 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.79 -38.42 67.26 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.9 145.29 5.03 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.93 1.253 . . . . 0.0 112.34 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -72.1 140.73 49.06 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.962 0.905 . . . . 0.0 112.014 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 176.1 19.35 0.02 OUTLIER Glycine 0 CA--C 1.534 1.275 0 N-CA-C 115.959 1.144 . . . . 0.0 115.959 -178.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 88.62 97.45 0.99 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 125.191 1.377 . . . . 0.0 112.58 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.51 129.23 34.97 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.328 1.451 . . . . 0.0 109.017 170.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 29.0 m -124.03 159.66 29.38 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.666 1.586 . . . . 0.0 112.286 -178.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.7 tp -160.34 136.09 8.32 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.052 1.741 . . . . 0.0 109.09 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.48 157.46 35.5 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.864 0.866 . . . . 0.0 112.331 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.9 mt -137.01 140.74 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.015 1.326 . . . . 0.0 110.006 177.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -128.8 159.09 36.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.23 1.812 . . . . 0.0 109.745 170.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.28 -160.34 28.03 Favored Glycine 0 CA--C 1.539 1.589 0 CA-C-O 118.862 -0.966 . . . . 0.0 114.595 -177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -64.45 -24.61 63.79 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 124.123 3.215 . . . . 0.0 112.649 177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.1 t -146.81 160.39 42.33 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.365 1.466 . . . . 0.0 109.365 163.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.01 118.5 16.05 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 120.986 -1.071 . . . . 0.0 111.59 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.0 149.98 40.97 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.01 0.924 . . . . 0.0 111.953 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -91.72 141.01 29.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.799 0.84 . . . . 0.0 109.572 167.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.4 140.65 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.68 1.192 . . . . 0.0 110.585 -166.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 58.6 m -134.84 157.39 46.93 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.719 1.608 . . . . 0.0 111.124 167.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 42.3 t -154.14 143.42 21.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.358 1.063 . . . . 0.0 111.778 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.4 m -137.27 126.25 24.29 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.669 1.587 . . . . 0.0 110.514 -173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.02 135.89 36.47 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.176 1.39 . . . . 0.0 111.664 171.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -113.65 148.26 36.62 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.654 1.581 . . . . 0.0 111.642 178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -64.72 -18.62 65.18 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 124.331 1.053 . . . . 0.0 112.479 174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -67.73 -8.36 34.74 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 126.046 1.738 . . . . 0.0 114.271 173.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.05 30.01 10.8 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.54 1.067 . . . . 0.0 114.032 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 41.6 p -138.4 143.79 39.93 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.939 1.295 . . . . 0.0 111.399 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.4 m -92.51 123.86 36.12 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.38 1.072 . . . . 0.0 109.035 161.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.79 139.93 30.27 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.017 0.927 . . . . 0.0 109.902 171.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.6 t -117.25 144.44 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.966 1.707 . . . . 0.0 109.933 -175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 62.8 p -136.79 145.31 44.38 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.407 1.083 . . . . 0.0 111.77 165.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.3 p90 -151.44 152.94 33.73 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 12.4 mt -116.57 105.82 49.48 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 126.042 1.737 . . . . 0.0 110.755 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -82.74 162.23 16.39 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.79 2.993 . . . . 0.0 110.447 167.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.0 m -134.99 -20.36 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 115.693 1.738 . . . . 0.0 115.693 -173.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.0 mt -119.62 149.04 47.31 Favored Pre-proline 0 N--CA 1.476 0.855 0 C-N-CA 125.058 1.343 . . . . 0.0 110.371 168.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -73.31 154.55 51.29 Favored 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 123.086 2.524 . . . . 0.0 111.107 175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 135.08 -164.01 24.8 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.842 1.21 . . . . 0.0 113.592 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -92.18 130.53 37.87 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.893 1.277 . . . . 0.0 112.368 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -117.3 132.35 56.63 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.601 1.561 . . . . 0.0 110.513 177.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.3 m -90.71 125.88 35.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.545 1.138 . . . . 0.0 110.551 176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.88 127.12 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.535 1.534 . . . . 0.0 108.583 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -109.88 132.56 54.05 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.496 1.519 . . . . 0.0 109.75 175.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 67.2 t -132.79 130.9 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.684 1.594 . . . . 0.0 108.203 173.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.98 142.63 19.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.616 1.166 . . . . 0.0 111.08 -168.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.01 121.56 17.3 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.786 1.234 . . . . 0.0 109.641 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 53.87 56.1 7.57 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 125.103 1.361 . . . . 0.0 112.468 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.2 pt-20 58.25 13.67 2.46 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 128.085 2.554 . . . . 0.0 116.159 -176.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -119.73 127.71 53.09 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.555 1.142 . . . . 0.0 111.262 177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -63.62 159.94 17.85 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.601 1.16 . . . . 0.0 113.006 171.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -83.3 159.09 62.71 Favored Pre-proline 0 N--CA 1.48 1.073 0 CA-C-O 118.429 -0.796 . . . . 0.0 110.065 172.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -54.41 -27.44 49.09 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.534 2.823 . . . . 0.0 115.931 -171.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -104.69 -6.04 41.2 Favored Glycine 0 CA--C 1.532 1.113 0 N-CA-C 116.311 1.284 . . . . 0.0 116.311 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 81.0 p -84.24 153.61 62.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 CA-C-N 119.953 1.876 . . . . 0.0 113.416 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.73 148.0 90.76 Favored 'Cis proline' 0 C--N 1.354 0.827 0 CA-C-N 118.829 0.618 . . . . 0.0 112.112 -5.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -98.67 169.99 9.1 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.82 1.648 . . . . 0.0 110.724 176.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 60.9 m -133.22 121.35 22.37 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.671 0.788 . . . . 0.0 110.877 175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.56 139.6 34.04 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.538 1.535 . . . . 0.0 111.082 174.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -96.97 110.88 23.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.677 0.791 . . . . 0.0 109.811 175.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.9 t -95.7 145.42 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.307 1.443 . . . . 0.0 109.884 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.6 t -128.51 175.11 8.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.262 1.025 . . . . 0.0 113.038 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.68 139.9 18.34 Favored Glycine 0 CA--C 1.531 1.088 0 C-N-CA 125.624 1.583 . . . . 0.0 112.692 -177.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.7 t70 -81.02 -29.45 35.11 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.693 1.197 . . . . 0.0 112.721 174.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.1 t70 . . . . . 0 C--O 1.256 1.402 0 C-N-CA 125.736 1.614 . . . . 0.0 113.491 179.586 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.488 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.57 160.3 31.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.461 1.104 . . . . 0.0 112.937 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 15.4 tpt -158.36 139.03 12.81 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.812 1.645 . . . . 0.0 110.695 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -166.58 153.38 8.45 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 126.133 1.773 . . . . 0.0 111.514 -177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -73.6 159.62 45.64 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.666 2.91 . . . . 0.0 111.521 173.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -107.41 128.96 54.95 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.74 1.216 . . . . 0.0 110.933 178.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 78.7 ttt-85 -74.66 130.67 81.09 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.33 1.052 . . . . 0.0 111.02 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.79 151.84 36.51 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.273 2.649 . . . . 0.0 111.236 176.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 81.4 mt -90.18 10.62 23.84 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.423 1.089 . . . . 0.0 113.527 -177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.3 p -160.23 148.01 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 126.467 1.907 . . . . 0.0 110.65 -175.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -87.38 -156.87 30.44 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 124.998 1.285 . . . . 0.0 113.329 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 27.0 m -68.57 149.61 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.075 0 C-N-CA 124.309 1.043 . . . . 0.0 112.017 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 64.0 t30 -161.48 148.42 14.56 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.199 1.4 . . . . 0.0 111.813 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -86.78 175.56 47.1 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 125.207 1.384 . . . . 0.0 113.807 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 86.4 mt -101.68 153.14 20.04 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.39 1.476 . . . . 0.0 111.38 176.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -77.71 -30.02 51.59 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.935 0.894 . . . . 0.0 113.369 -177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 31.1 m -68.59 -15.13 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 -173.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 1.8 t -75.03 -16.51 60.59 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.716 1.206 . . . . 0.0 113.11 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 50.4 m -75.73 1.65 14.16 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 -175.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 10.8 mt -62.38 156.38 22.66 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.484 1.114 . . . . 0.0 112.218 169.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 48.2 ttp180 -59.23 117.87 25.49 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.081 0.952 . . . . 0.0 110.634 177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.35 157.01 50.23 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 123.321 2.68 . . . . 0.0 111.532 -173.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 19.6 t80 -110.47 125.12 52.95 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.701 0.801 . . . . 0.0 110.958 176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -154.07 133.54 12.77 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.644 1.578 . . . . 0.0 110.238 173.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.83 146.02 33.75 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.842 1.657 . . . . 0.0 109.794 -173.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.3 p -111.52 139.68 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.063 1.345 . . . . 0.0 110.204 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.3 mt -131.06 134.84 26.4 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.953 1.701 . . . . 0.0 108.843 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -76.05 92.81 1.03 Allowed 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.715 2.944 . . . . 0.0 109.759 174.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 68.8 t80 -151.89 154.28 35.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.16 1.784 . . . . 0.0 109.801 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 68.0 m -126.51 123.82 38.64 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.705 1.202 . . . . 0.0 109.65 -177.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 91.6 mt -87.68 118.88 34.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 124.337 1.055 . . . . 0.0 109.147 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 99.6 mttt -98.08 -77.01 0.51 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.502 1.121 . . . . 0.0 113.232 -172.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 26.2 pttm -154.35 -4.61 0.16 Allowed 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 -170.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.23 -129.1 2.73 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 126.294 1.902 . . . . 0.0 111.938 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -152.39 148.61 27.68 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.829 1.252 . . . . 0.0 110.824 -177.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -141.09 129.87 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.344 1.458 . . . . 0.0 111.722 -175.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.46 168.4 22.77 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 126.007 1.723 . . . . 0.0 110.701 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -153.84 -171.45 20.93 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 115.859 1.104 . . . . 0.0 115.859 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.18 138.18 18.16 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.74 1.616 . . . . 0.0 109.63 176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.6 t -108.36 136.43 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 126.134 1.774 . . . . 0.0 107.892 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -123.23 121.27 35.47 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 125.111 1.364 . . . . 0.0 110.541 -173.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 12.7 mtm -87.75 151.55 50.21 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.863 1.665 . . . . 0.0 111.028 178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.46 -18.26 38.51 Favored 'Trans proline' 0 CA--C 1.539 0.76 0 C-N-CA 123.442 2.761 . . . . 0.0 113.207 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 36.0 p -73.06 -6.72 47.46 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 126.011 1.724 . . . . 0.0 114.22 171.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.76 -4.85 79.35 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.83 1.681 . . . . 0.0 113.898 -176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -69.93 158.55 35.37 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.596 1.159 . . . . 0.0 112.234 173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.4 m -137.61 156.79 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.705 1.202 . . . . 0.0 112.23 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.9 171.94 18.85 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.665 1.986 . . . . 0.0 110.822 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -105.78 137.5 19.35 Favored Pre-proline 0 CA--C 1.546 0.813 0 O-C-N 121.288 -0.882 . . . . 0.0 111.051 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -81.52 163.31 19.18 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.837 3.025 . . . . 0.0 110.938 171.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 67.9 m -101.99 120.31 40.2 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.9 1.28 . . . . 0.0 108.578 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.04 131.41 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.351 1.06 . . . . 0.0 108.631 174.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -127.76 124.96 38.99 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.527 1.531 . . . . 0.0 109.652 -179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 19.5 t0 -75.85 122.72 24.52 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.235 1.014 . . . . 0.0 110.83 173.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -84.7 -15.36 45.5 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 58.0 tttt 71.67 4.01 4.88 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 127.308 2.243 . . . . 0.0 114.241 173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.5 t70 -113.83 15.29 18.66 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 126.88 2.072 . . . . 0.0 112.805 -175.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.16 12.15 52.74 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.105 1.336 . . . . 0.0 114.636 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -131.39 160.57 34.7 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.018 1.727 . . . . 0.0 110.705 173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.9 m -123.93 147.44 28.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.594 1.158 . . . . 0.0 109.566 164.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 67.2 m -107.38 136.48 47.11 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.144 0.978 . . . . 0.0 108.643 171.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 35.8 t -120.42 131.9 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 125.126 1.37 . . . . 0.0 109.103 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 76.2 mtm180 -133.1 155.63 48.9 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.435 1.494 . . . . 0.0 112.662 -169.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -158.29 136.86 11.09 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.338 1.455 . . . . 0.0 112.338 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.27 120.09 69.74 Favored Pre-proline 0 CA--C 1.552 1.04 0 C-N-CA 124.776 1.23 . . . . 0.0 110.996 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.72 159.77 28.08 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.713 2.942 . . . . 0.0 112.233 -176.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 5.5 t -147.59 -11.77 0.4 Allowed 'General case' 0 CA--C 1.551 0.983 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -158.37 149.02 20.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.819 1.648 . . . . 0.0 110.98 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.04 171.0 15.82 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.656 1.182 . . . . 0.0 113.685 -175.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 117.31 -175.14 15.56 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 125.535 1.541 . . . . 0.0 114.409 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.9 tt -84.93 124.67 31.92 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.203 1.401 . . . . 0.0 110.097 -177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 46.7 m80 -118.93 152.88 35.53 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.547 1.539 . . . . 0.0 112.193 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -117.3 148.14 41.96 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.091 1.756 . . . . 0.0 108.899 171.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.1 tmm? -143.89 130.19 19.82 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.241 1.016 . . . . 0.0 111.407 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -118.13 139.7 50.86 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.45 1.9 . . . . 0.0 110.924 -171.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -137.27 133.19 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 125.185 1.394 . . . . 0.0 110.57 177.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.96 140.69 36.38 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.5 t80 -103.05 119.85 39.59 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.589 1.956 . . . . 0.0 109.489 174.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.79 34.61 13.51 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.762 1.225 . . . . 0.0 112.835 -173.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.7 m-80 72.76 9.16 5.57 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.698 2.399 . . . . 0.0 115.147 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.1 mtm -103.35 128.48 50.42 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.352 1.461 . . . . 0.0 110.158 169.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -57.37 136.61 56.6 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 121.209 -0.932 . . . . 0.0 113.247 -177.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.9 pt -75.56 154.26 85.6 Favored Pre-proline 0 N--CA 1.48 1.074 0 CA-C-O 118.796 -0.621 . . . . 0.0 111.218 175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -59.56 128.45 27.19 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.216 1.944 . . . . 0.0 109.791 171.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.09 -15.9 59.96 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.838 1.209 . . . . 0.0 114.014 -173.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.2 t -84.89 143.48 40.34 Favored Pre-proline 0 CA--C 1.546 0.814 0 CA-C-N 119.687 1.744 . . . . 0.0 111.105 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.1 159.2 83.47 Favored 'Cis proline' 0 C--N 1.351 0.664 0 CA-C-N 120.025 1.044 . . . . 0.0 112.664 -4.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 87.6 mt -107.21 161.51 14.72 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.427 1.891 . . . . 0.0 111.183 174.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.17 139.91 18.04 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.821 1.249 . . . . 0.0 110.03 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 9.7 p90 -166.31 174.78 8.78 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.58 1.152 . . . . 0.0 112.413 -170.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.2 t80 -122.79 131.73 53.9 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.223 1.009 . . . . 0.0 112.718 178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 99.3 t -96.92 135.12 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 125.589 1.556 . . . . 0.0 109.059 176.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 19.8 t0 -154.98 166.76 32.58 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.943 1.297 . . . . 0.0 111.111 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -82.81 137.45 34.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.81 1.244 . . . . 0.0 112.064 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 7.7 p -67.61 -24.84 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.473 0.709 . . . . 0.0 112.331 175.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -88.9 25.54 1.77 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.01 1.724 . . . . 0.0 112.773 177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.2 p -56.68 151.02 14.7 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.422 1.489 . . . . 0.0 114.212 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.94 28.52 11.97 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 126.14 1.829 . . . . 0.0 112.324 172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -162.38 163.17 27.94 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.866 1.666 . . . . 0.0 112.556 -163.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 18.3 t -70.18 137.12 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 124.29 1.036 . . . . 0.0 109.82 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -147.26 158.7 44.05 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.756 1.222 . . . . 0.0 110.622 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.73 144.08 37.32 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.101 1.36 . . . . 0.0 111.52 -176.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.3 p90 -168.34 164.83 12.98 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.403 1.481 . . . . 0.0 113.214 -173.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 126.16 170.75 13.03 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 125.614 1.578 . . . . 0.0 112.29 -175.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.99 -34.89 9.83 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.778 2.319 . . . . 0.0 113.222 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.85 -30.08 76.41 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-N 119.348 0.976 . . . . 0.0 114.968 -169.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -80.01 -1.62 40.53 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 118.906 1.353 . . . . 0.0 113.813 176.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 51.6 m -118.05 -46.51 2.62 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.669 1.988 . . . . 0.0 111.726 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -138.01 148.2 44.92 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.503 1.521 . . . . 0.0 112.437 177.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -147.46 178.73 24.89 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.24 0.924 . . . . 0.0 113.52 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 19.1 t -139.53 136.97 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 124.914 1.286 . . . . 0.0 108.314 174.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -55.46 138.59 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.8 m-80 70.88 -3.29 2.03 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.547 2.339 . . . . 0.0 114.656 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.5 mttm -98.52 140.54 21.89 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 124.581 1.153 . . . . 0.0 111.144 173.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -72.89 109.77 2.88 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.647 2.232 . . . . 0.0 109.677 176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -89.07 139.14 30.76 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.926 1.29 . . . . 0.0 110.168 176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 42.0 p -130.83 151.25 51.46 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -166.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -163.28 175.95 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.276 1.83 . . . . 0.0 111.357 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.5 m -130.69 144.61 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.501 1.52 . . . . 0.0 110.898 -172.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 31.1 t -117.59 135.77 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.584 1.554 . . . . 0.0 108.555 168.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -102.42 117.64 35.15 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.575 1.15 . . . . 0.0 110.632 176.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.8 p -117.05 14.4 14.97 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.289 1.836 . . . . 0.0 112.236 176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 60.2 tttp -60.27 -28.39 68.03 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.421 1.488 . . . . 0.0 114.264 -169.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.5 t70 -118.08 16.59 14.14 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 125.996 1.718 . . . . 0.0 112.754 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.71 -12.61 61.09 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 -175.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.13 -103.34 2.48 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 124.718 1.151 . . . . 0.0 110.828 -176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -155.02 147.8 24.43 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.322 1.449 . . . . 0.0 110.432 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 164.36 -105.87 0.26 Allowed Glycine 0 CA--C 1.526 0.761 0 C-N-CA 125.044 1.307 . . . . 0.0 111.061 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 167.27 144.36 4.1 Favored Glycine 0 N--CA 1.468 0.82 0 C-N-CA 124.773 1.177 . . . . 0.0 112.701 176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 25.5 tp -92.39 137.97 31.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.666 1.186 . . . . 0.0 111.277 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.3 m -120.56 157.44 29.46 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.408 1.883 . . . . 0.0 110.74 169.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 53.4 tp -157.07 134.9 10.89 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.202 1.401 . . . . 0.0 109.721 -168.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.17 158.4 36.2 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.106 0.962 . . . . 0.0 112.324 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.1 mt -137.32 139.17 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.736 1.214 . . . . 0.0 109.986 177.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -129.17 131.34 47.13 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.439 1.496 . . . . 0.0 109.872 174.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -157.7 -162.7 11.89 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 118.891 -0.95 . . . . 0.0 114.625 -175.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -63.79 -23.65 68.92 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 124.253 3.302 . . . . 0.0 112.76 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.1 t -144.84 159.6 42.63 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.24 1.416 . . . . 0.0 109.433 163.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.11 111.54 5.84 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.095 -1.003 . . . . 0.0 111.019 178.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.65 148.31 50.63 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.863 0.865 . . . . 0.0 111.617 171.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -87.97 138.43 31.46 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.194 0.597 . . . . 0.0 109.416 166.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.2 mt -129.53 143.88 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.084 1.353 . . . . 0.0 109.906 -168.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.03 162.8 34.52 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.719 1.208 . . . . 0.0 111.137 168.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.6 p -156.89 154.83 30.41 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.697 1.199 . . . . 0.0 112.485 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.3 m -136.94 123.36 20.76 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.61 1.564 . . . . 0.0 110.09 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.68 130.84 36.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.984 1.314 . . . . 0.0 111.239 170.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -106.91 149.14 27.77 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.463 1.505 . . . . 0.0 111.603 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -65.11 -20.0 66.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.539 1.136 . . . . 0.0 112.882 177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.93 -7.87 53.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.203 1.401 . . . . 0.0 113.923 176.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.67 12.37 47.6 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 124.925 1.25 . . . . 0.0 114.869 177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.0 p -108.61 154.88 21.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.099 1.359 . . . . 0.0 111.289 175.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 90.0 m -110.63 123.23 49.59 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 108.822 163.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -86.5 147.45 25.97 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.46 0.704 . . . . 0.0 110.161 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 90.3 t -128.36 144.11 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 125.977 1.711 . . . . 0.0 109.9 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.72 147.27 44.63 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 111.81 168.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -151.02 151.18 31.69 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -112.41 101.79 53.0 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.778 1.631 . . . . 0.0 110.575 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -78.27 161.13 29.14 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.303 2.669 . . . . 0.0 109.946 166.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.9 m -135.96 -21.54 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 N-CA-C 115.455 1.65 . . . . 0.0 115.455 -173.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 89.9 mt -118.4 147.52 42.0 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 124.953 1.301 . . . . 0.0 110.21 170.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.08 154.12 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.734 2.29 . . . . 0.0 110.648 174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 137.97 -158.54 24.75 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.706 1.146 . . . . 0.0 112.881 -175.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -106.03 133.78 50.2 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.358 1.063 . . . . 0.0 111.727 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -121.0 125.27 46.92 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.98 1.712 . . . . 0.0 110.088 179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -87.6 127.17 35.27 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.965 -1.084 . . . . 0.0 110.848 175.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.43 120.74 56.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.545 1.538 . . . . 0.0 108.528 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -103.71 127.53 51.16 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.465 1.506 . . . . 0.0 109.56 176.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -130.14 129.17 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.159 1.384 . . . . 0.0 109.036 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.37 136.56 22.43 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.026 1.33 . . . . 0.0 111.353 -170.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 39.6 t80 -132.22 133.58 44.32 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.991 1.316 . . . . 0.0 110.933 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 48.99 53.73 12.08 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.63 1.172 . . . . 0.0 112.547 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 8.4 pt-20 58.55 16.01 3.98 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 128.037 2.535 . . . . 0.0 116.413 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -125.15 130.33 51.96 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.55 1.14 . . . . 0.0 111.292 176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.3 m170 -62.15 141.35 58.21 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 121.111 -0.993 . . . . 0.0 111.481 172.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 8.3 m -71.25 150.86 94.44 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.35 -0.834 . . . . 0.0 109.872 175.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.83 130.37 39.5 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.38 2.72 . . . . 0.0 111.742 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.84 -15.14 58.4 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.279 1.419 . . . . 0.0 115.034 -175.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 3.5 t -83.17 143.21 45.01 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 118.935 1.367 . . . . 0.0 111.488 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.9 138.11 51.94 Favored 'Cis proline' 0 C--N 1.357 0.996 0 CA-C-N 119.832 0.976 . . . . 0.0 112.72 0.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -90.0 173.8 8.01 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.809 1.643 . . . . 0.0 110.232 174.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.4 m -135.3 119.74 18.0 Favored 'General case' 0 N--CA 1.475 0.806 0 O-C-N 121.575 -0.703 . . . . 0.0 110.887 176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.93 148.76 21.74 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.628 1.571 . . . . 0.0 110.973 169.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 35.0 ttt85 -113.46 125.16 53.91 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.065 0.946 . . . . 0.0 110.21 172.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 83.9 t -111.5 132.46 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.297 1.439 . . . . 0.0 110.593 -171.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 43.9 p -107.39 168.29 9.34 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.276 1.431 . . . . 0.0 112.755 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.64 149.57 33.52 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.049 1.309 . . . . 0.0 112.521 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.1 t70 -75.8 -18.99 59.3 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.629 1.172 . . . . 0.0 113.147 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.253 1.242 0 C-N-CA 126.639 1.976 . . . . 0.0 112.673 -178.251 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.371 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.84 -36.17 67.4 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -77.69 -32.4 53.01 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.564 1.145 . . . . 0.0 112.915 -178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -166.88 152.55 7.53 Favored Pre-proline 0 CA--C 1.549 0.911 0 C-N-CA 126.563 1.945 . . . . 0.0 111.182 -176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -75.71 160.96 37.31 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.455 2.77 . . . . 0.0 111.708 176.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -67.52 -16.65 64.31 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.726 1.21 . . . . 0.0 112.837 173.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -59.94 122.27 64.6 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.372 1.469 . . . . 0.0 110.275 176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -76.49 157.38 36.54 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.714 2.943 . . . . 0.0 113.088 -169.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 30.2 tp -80.87 67.42 6.76 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.95 1.3 . . . . 0.0 111.119 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.6 p -160.17 150.1 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 126.391 1.876 . . . . 0.0 110.406 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 92.27 -147.25 18.6 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.855 1.217 . . . . 0.0 112.337 -176.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 27.8 m -135.78 150.6 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.521 1.528 . . . . 0.0 111.199 178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 11.5 p30 -93.5 162.42 13.97 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.861 1.264 . . . . 0.0 113.233 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 90.62 131.24 4.76 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.59 1.567 . . . . 0.0 113.303 175.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 94.8 mt -144.37 161.25 39.45 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 127.375 2.27 . . . . 0.0 109.764 176.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 33.5 t0 -158.16 165.54 34.68 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.493 1.117 . . . . 0.0 112.28 -177.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 22.7 m -73.52 6.04 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 125.826 1.65 . . . . 0.0 114.255 -175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.3 t -67.89 -11.93 59.67 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.838 1.655 . . . . 0.0 112.853 168.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 7.9 t -61.77 153.82 27.44 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.435 1.272 . . . . 0.0 114.435 -177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.8 mt -112.49 151.92 29.38 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.595 1.958 . . . . 0.0 111.456 -178.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -56.81 116.02 11.99 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 126.06 1.744 . . . . 0.0 111.107 173.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -73.95 155.4 48.1 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.113 2.542 . . . . 0.0 110.947 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.7 t80 -105.28 124.38 49.44 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.345 0.658 . . . . 0.0 110.232 174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -153.88 130.83 10.95 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.141 1.376 . . . . 0.0 110.692 171.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.92 150.49 43.22 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.538 1.935 . . . . 0.0 109.565 -175.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -124.93 136.63 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.034 1.334 . . . . 0.0 110.31 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.49 138.57 27.09 Favored Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 126.117 1.767 . . . . 0.0 108.926 -172.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -78.15 47.41 2.37 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 124.655 3.57 . . . . 0.0 113.156 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 61.3 t80 -93.8 159.17 15.32 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.333 1.453 . . . . 0.0 110.559 169.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 49.2 m -135.16 127.29 29.9 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.919 1.288 . . . . 0.0 109.796 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 49.3 mt -75.56 131.46 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.244 1.018 . . . . 0.0 110.419 174.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' 1801 ' ' LYS . 9.3 tppt? -120.62 -145.48 0.36 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.426 1.49 . . . . 0.0 110.683 174.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' 1800 ' ' LYS . 1.5 tmtp? -77.17 122.49 25.09 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.548 -1.345 . . . . 0.0 110.749 173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.41 -146.01 16.89 Favored Glycine 0 N--CA 1.472 1.081 0 C-N-CA 125.455 1.503 . . . . 0.0 112.07 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -158.87 145.35 17.0 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.758 1.223 . . . . 0.0 111.084 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.3 tt -128.6 137.05 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.645 1.578 . . . . 0.0 111.122 178.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.5 p -148.4 168.56 22.3 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.937 1.695 . . . . 0.0 110.654 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.69 -176.47 26.98 Favored Glycine 0 N--CA 1.466 0.686 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -154.73 134.71 13.01 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.293 1.437 . . . . 0.0 110.183 175.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 5.8 t -99.9 136.34 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 126.662 1.985 . . . . 0.0 108.024 171.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.8 mtm105 -121.53 126.3 48.87 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.828 1.251 . . . . 0.0 110.755 -177.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -105.73 142.15 24.17 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 125.325 1.45 . . . . 0.0 112.09 -173.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -57.61 -26.66 73.48 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.118 3.212 . . . . 0.0 115.022 175.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 23.3 p -73.84 1.19 11.11 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.257 1.423 . . . . 0.0 114.506 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.73 37.41 7.4 Favored Glycine 0 N--CA 1.472 1.085 0 C-N-CA 124.593 1.092 . . . . 0.0 113.46 173.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -142.21 169.32 17.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.408 1.483 . . . . 0.0 112.543 -177.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.7 m -140.39 160.6 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 125.106 1.362 . . . . 0.0 112.43 -175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.32 169.19 24.78 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.494 1.918 . . . . 0.0 110.794 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -108.13 136.89 19.75 Favored Pre-proline 0 CA--C 1.546 0.797 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -82.33 167.25 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.063 3.176 . . . . 0.0 111.406 172.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.9 m -105.13 130.85 53.21 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.566 1.546 . . . . 0.0 109.069 174.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.6 mp -113.09 131.27 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.767 1.227 . . . . 0.0 108.976 176.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.9 m -133.22 122.21 23.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.251 1.42 . . . . 0.0 109.732 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.4 t70 -81.06 127.73 32.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.363 0.665 . . . . 0.0 110.407 170.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -82.31 -11.46 58.6 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 71.68 2.01 4.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 128.276 2.63 . . . . 0.0 114.055 -176.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -94.38 3.57 55.01 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.564 1.946 . . . . 0.0 113.047 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.21 17.99 41.03 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.87 1.224 . . . . 0.0 113.93 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -131.06 155.63 46.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.47 1.908 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -112.51 143.16 22.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 109.532 163.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.8 m -104.23 135.17 46.2 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 124.624 1.17 . . . . 0.0 107.908 165.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.7 t -122.37 132.64 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 C-N-CA 125.014 1.325 . . . . 0.0 108.838 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -135.02 160.54 38.0 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.086 1.354 . . . . 0.0 112.842 -170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.2 t80 -159.01 137.71 10.97 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.519 1.528 . . . . 0.0 111.936 175.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.41 119.08 71.26 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.665 1.186 . . . . 0.0 110.904 177.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.97 158.16 46.33 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.06 3.173 . . . . 0.0 112.432 -173.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 8.4 t -135.86 -22.79 1.4 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -177.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -161.12 155.8 23.51 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.769 1.628 . . . . 0.0 109.952 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -72.05 166.43 22.26 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.847 1.054 . . . . 0.0 113.847 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 126.1 178.38 15.28 Favored Glycine 0 N--CA 1.473 1.161 0 C-N-CA 125.906 1.717 . . . . 0.0 113.952 178.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.6 tp -80.77 119.01 22.8 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.313 1.045 . . . . 0.0 109.749 175.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 23.4 m80 -113.87 159.86 19.39 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.462 1.505 . . . . 0.0 110.892 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -149.46 155.72 40.84 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 111.517 171.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 3.2 tmm? -148.16 134.81 19.86 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.77 1.228 . . . . 0.0 111.303 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -103.04 138.45 39.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.85 1.66 . . . . 0.0 110.426 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.2 mm -127.63 136.56 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 125.339 1.456 . . . . 0.0 109.796 171.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.94 137.95 23.94 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -102.92 124.93 49.35 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.709 2.004 . . . . 0.0 109.902 175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.22 32.08 10.18 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 124.734 1.213 . . . . 0.0 112.462 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.1 t30 75.82 6.52 3.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 128.2 2.6 . . . . 0.0 115.17 -178.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -105.17 131.13 53.04 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.769 1.628 . . . . 0.0 110.903 174.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.59 134.03 56.38 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.244 -0.91 . . . . 0.0 113.077 -177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -75.17 156.89 85.61 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 123.127 0.571 . . . . 0.0 112.046 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.25 126.37 21.28 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.274 1.983 . . . . 0.0 109.626 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.74 -16.57 57.46 Favored Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.666 1.127 . . . . 0.0 114.463 -172.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 21.2 t -86.03 148.37 47.74 Favored Pre-proline 0 N--CA 1.476 0.839 0 CA-C-N 119.37 1.585 . . . . 0.0 111.961 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -83.19 171.61 50.76 Favored 'Cis proline' 0 CA--C 1.54 0.783 0 CA-C-N 120.246 1.124 . . . . 0.0 112.485 -6.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 58.8 mt -110.28 154.92 22.78 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.976 1.71 . . . . 0.0 111.662 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -145.36 140.92 28.03 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.441 1.497 . . . . 0.0 110.041 176.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -163.42 160.01 22.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.98 1.312 . . . . 0.0 112.04 -177.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.8 t80 -100.15 135.21 41.93 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.058 -1.026 . . . . 0.0 112.396 176.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.1 t -103.99 141.05 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.961 1.704 . . . . 0.0 109.28 175.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 12.8 t0 -154.71 162.9 40.93 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.611 1.164 . . . . 0.0 111.683 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -81.77 148.06 29.1 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.57 1.148 . . . . 0.0 112.707 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 30.4 m -69.93 -17.65 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.9 p30 -80.51 -10.54 59.74 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.4 m -70.32 133.02 46.55 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.147 0.979 . . . . 0.0 112.584 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -101.75 -13.43 32.17 Favored Glycine 0 N--CA 1.476 1.335 0 C-N-CA 125.141 1.353 . . . . 0.0 114.773 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -68.59 164.45 21.38 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -63.46 138.91 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 124.355 1.062 . . . . 0.0 109.705 176.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.9 t -165.2 153.41 11.62 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.273 1.429 . . . . 0.0 110.022 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -129.8 145.16 51.58 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.051 1.34 . . . . 0.0 111.844 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -168.15 167.86 12.1 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.964 1.706 . . . . 0.0 112.864 -178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.07 169.37 13.28 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 125.508 1.528 . . . . 0.0 112.08 -172.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.04 -30.79 20.41 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.865 2.377 . . . . 0.0 113.589 -167.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.63 -33.98 77.51 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 119.255 0.934 . . . . 0.0 114.605 -171.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.74 -4.33 45.72 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 119.169 1.485 . . . . 0.0 113.484 175.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.0 m -108.97 -41.25 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.996 2.118 . . . . 0.0 111.973 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -149.48 152.37 35.52 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 126.131 1.772 . . . . 0.0 112.314 -172.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -152.01 177.14 30.02 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.847 0.737 . . . . 0.0 113.665 171.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 58.5 t -137.9 134.78 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 124.972 1.309 . . . . 0.0 108.192 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.6 m -55.58 137.51 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 55.5 m-80 68.92 2.21 3.46 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.011 2.124 . . . . 0.0 114.415 176.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.0 mttt -108.06 140.91 22.13 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.149 1.38 . . . . 0.0 111.087 174.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.04 124.22 9.9 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.462 2.108 . . . . 0.0 110.205 177.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.5 144.24 31.95 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.33 1.452 . . . . 0.0 110.291 174.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.6 p -133.87 149.59 51.34 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -166.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.3 p90 -160.18 178.28 9.81 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.812 1.645 . . . . 0.0 111.496 176.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 27.5 m -134.14 143.06 47.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.145 1.378 . . . . 0.0 110.565 -169.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 22.7 t -115.14 130.55 69.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 125.487 1.515 . . . . 0.0 108.137 168.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.83 129.83 36.15 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.992 0.917 . . . . 0.0 111.08 179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 69.6 p -137.1 1.01 2.42 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.103 1.361 . . . . 0.0 113.841 -166.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 82.4 tttt -55.89 -38.95 70.87 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.466 1.506 . . . . 0.0 114.992 -166.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -115.73 10.23 15.38 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.671 1.589 . . . . 0.0 112.667 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.66 -37.4 67.97 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 114.117 1.155 . . . . 0.0 114.117 -172.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.15 151.37 8.07 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 124.672 1.13 . . . . 0.0 112.281 -169.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -71.74 166.12 22.62 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.039 0.936 . . . . 0.0 113.298 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 145.23 9.61 0.31 Allowed Glycine 0 CA--C 1.536 1.354 0 N-CA-C 116.141 1.216 . . . . 0.0 116.141 -177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 102.0 96.95 2.32 Favored Glycine 0 N--CA 1.47 0.963 0 C-N-CA 125.484 1.516 . . . . 0.0 113.157 173.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.98 132.83 36.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.347 1.459 . . . . 0.0 109.251 169.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.5 t -134.98 165.78 24.56 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.366 1.467 . . . . 0.0 112.45 -178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 36.1 tp -166.86 137.36 3.15 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.738 2.015 . . . . 0.0 109.272 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.45 34.97 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.162 0.985 . . . . 0.0 112.16 175.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.6 mt -136.42 139.93 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 124.792 1.237 . . . . 0.0 110.264 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.58 145.74 51.95 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.717 1.607 . . . . 0.0 109.652 170.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.28 -165.48 25.74 Favored Glycine 0 CA--C 1.539 1.565 0 CA-C-O 119.091 -0.838 . . . . 0.0 114.841 -175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -63.47 -26.01 70.35 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.316 3.344 . . . . 0.0 112.657 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.3 t -140.36 158.92 43.29 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.962 1.305 . . . . 0.0 109.144 159.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 58.7 tptt -71.72 116.49 12.15 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 120.978 -1.076 . . . . 0.0 111.4 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -72.81 147.55 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.795 0.838 . . . . 0.0 111.903 174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.17 143.66 26.68 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.677 0.791 . . . . 0.0 109.76 167.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 90.4 mt -129.76 145.88 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 125.164 1.385 . . . . 0.0 110.826 -168.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -142.74 164.72 29.34 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.63 1.172 . . . . 0.0 111.045 162.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.5 p -161.78 155.72 21.82 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.939 1.296 . . . . 0.0 112.616 -178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 79.3 m -143.85 124.89 14.41 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.544 1.537 . . . . 0.0 110.437 -171.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.53 130.96 36.58 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.54 1.136 . . . . 0.0 111.216 171.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.43 147.87 32.1 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.471 1.508 . . . . 0.0 112.017 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -66.3 -15.47 63.26 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.0 0.92 . . . . 0.0 113.437 173.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -74.92 -6.58 49.99 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.986 1.714 . . . . 0.0 114.103 177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.62 33.08 7.68 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 124.476 1.036 . . . . 0.0 113.951 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.0 p -138.43 157.26 46.55 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.961 1.304 . . . . 0.0 111.268 177.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 39.2 t -105.24 124.13 49.02 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.572 1.149 . . . . 0.0 108.734 158.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -90.34 146.61 24.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.922 0.889 . . . . 0.0 110.282 171.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -129.38 143.46 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.739 1.616 . . . . 0.0 110.01 -173.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 95.3 p -136.31 149.68 48.53 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.811 1.244 . . . . 0.0 112.155 168.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.4 p90 -151.52 152.79 33.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 6.5 mt -115.47 104.97 52.82 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.864 1.666 . . . . 0.0 110.649 179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.25 164.98 14.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.839 3.026 . . . . 0.0 110.374 167.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -137.15 -20.12 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 -175.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.7 mt -118.38 149.31 45.73 Favored Pre-proline 0 CA--C 1.544 0.721 0 C-N-CA 125.013 1.325 . . . . 0.0 110.327 170.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -73.57 155.67 49.87 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.966 2.444 . . . . 0.0 110.883 175.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.83 -162.38 23.82 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 124.738 1.161 . . . . 0.0 113.691 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -92.11 129.02 38.16 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.487 1.515 . . . . 0.0 112.671 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -118.52 130.05 55.7 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.485 1.514 . . . . 0.0 110.207 176.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -90.91 119.03 30.78 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.616 1.167 . . . . 0.0 110.52 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -99.42 123.22 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 126.304 1.842 . . . . 0.0 108.501 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -104.45 134.3 47.87 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.516 1.526 . . . . 0.0 109.391 172.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 83.8 t -133.95 133.47 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 125.312 1.445 . . . . 0.0 108.454 173.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -155.74 141.73 18.2 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.906 1.283 . . . . 0.0 111.071 -169.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -139.31 120.25 14.48 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.695 1.198 . . . . 0.0 109.974 -178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 52.48 58.42 5.41 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.445 1.498 . . . . 0.0 112.067 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 60.64 2.8 0.53 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.911 2.885 . . . . 0.0 116.684 -177.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -107.27 127.1 53.24 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.473 1.109 . . . . 0.0 111.177 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -62.93 157.67 21.12 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.816 0.846 . . . . 0.0 112.392 167.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 32.6 m -87.73 155.75 53.16 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 123.35 0.66 . . . . 0.0 110.498 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -56.53 121.59 10.29 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.834 2.356 . . . . 0.0 110.353 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.53 -13.73 66.07 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.373 1.464 . . . . 0.0 116.037 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.3 p -79.79 151.53 73.92 Favored Pre-proline 0 CA--C 1.55 0.955 0 CA-C-N 120.434 2.117 . . . . 0.0 113.028 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -73.35 149.75 94.62 Favored 'Cis proline' 0 C--N 1.352 0.756 0 CA-C-N 119.107 0.717 . . . . 0.0 112.295 -4.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -102.44 156.1 17.82 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.84 1.656 . . . . 0.0 110.888 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 63.4 m -111.29 118.45 35.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.692 0.797 . . . . 0.0 111.047 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.18 133.17 37.98 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.036 1.334 . . . . 0.0 110.921 171.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.66 106.36 18.45 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.964 0.905 . . . . 0.0 109.738 178.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 90.4 t -90.98 145.87 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.407 1.083 . . . . 0.0 109.875 177.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 2.7 t -137.25 174.26 10.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.049 0.939 . . . . 0.0 113.031 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.72 140.5 18.04 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 125.741 1.639 . . . . 0.0 112.914 -177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -81.64 -33.81 31.17 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.048 0.939 . . . . 0.0 112.813 173.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--O 1.253 1.25 0 C-N-CA 125.831 1.652 . . . . 0.0 113.458 -177.735 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.33 162.91 28.8 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 124.43 1.092 . . . . 0.0 112.913 177.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.5 ptt? -68.15 -19.72 64.83 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -160.0 153.92 19.55 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 126.716 2.007 . . . . 0.0 110.833 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.62 164.77 34.05 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.452 2.768 . . . . 0.0 111.297 175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.71 -20.74 66.5 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.557 1.143 . . . . 0.0 113.553 -179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -126.51 76.68 73.7 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 126.077 1.751 . . . . 0.0 109.971 175.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -82.51 168.52 14.48 Favored 'Trans proline' 0 CA--C 1.537 0.636 0 C-N-CA 123.829 3.02 . . . . 0.0 111.832 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 78.2 mt -83.11 19.98 1.33 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 125.109 1.364 . . . . 0.0 113.626 -176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 84.3 t -60.92 136.42 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.77 1.628 . . . . 0.0 110.492 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 115.26 -146.0 18.77 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 125.389 1.471 . . . . 0.0 111.784 -173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 9.4 p -65.47 -25.42 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.27 1.028 . . . . 0.0 113.754 -174.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 1.8 t30 -73.66 -54.73 7.46 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.357 0.663 . . . . 0.0 112.314 -177.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 76.25 168.3 26.5 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.964 1.268 . . . . 0.0 113.19 -175.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.2 mt -80.23 137.91 36.73 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.177 0.991 . . . . 0.0 110.694 174.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 46.2 t0 -164.22 161.23 21.95 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.902 1.681 . . . . 0.0 111.286 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 75.3 t -96.68 127.59 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.598 1.559 . . . . 0.0 109.767 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.8 t -154.63 13.73 0.42 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.122 1.369 . . . . 0.0 113.099 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 61.1 m -81.2 114.76 20.23 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.56 -1.337 . . . . 0.0 111.997 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . 0.494 HD11 HG12 ' A' 1860 ' ' VAL . 47.8 tp -148.78 139.07 22.41 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.493 1.517 . . . . 0.0 110.193 -159.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -47.62 111.06 1.53 Allowed Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 125.925 1.69 . . . . 0.0 112.326 -176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -74.44 155.28 45.72 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.021 2.48 . . . . 0.0 110.655 174.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.6 t80 -107.77 125.45 51.43 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 123.611 0.764 . . . . 0.0 110.514 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -151.46 128.33 10.97 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.782 1.633 . . . . 0.0 109.53 172.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.75 125.95 13.84 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.769 1.228 . . . . 0.0 109.973 -167.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 96.7 t -93.23 137.92 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.911 1.284 . . . . 0.0 109.863 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.9 mt -131.25 136.2 28.35 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.651 1.58 . . . . 0.0 108.752 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -80.28 58.17 6.87 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 124.273 3.315 . . . . 0.0 111.896 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -107.45 158.56 17.09 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.878 1.671 . . . . 0.0 111.197 178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.6 m -125.45 123.08 38.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.819 1.248 . . . . 0.0 109.576 177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.6 mt -93.45 128.37 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.758 1.223 . . . . 0.0 109.73 178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -103.38 -143.12 0.36 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 125.065 1.346 . . . . 0.0 110.718 174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.7 pttp -75.53 -10.63 59.62 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.43 168.99 50.68 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.354 1.454 . . . . 0.0 113.704 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -96.06 147.6 23.55 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.329 1.451 . . . . 0.0 111.699 -176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.8 tt -140.49 131.52 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 125.292 1.437 . . . . 0.0 111.056 178.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 57.5 p -147.44 -168.82 3.16 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.546 1.938 . . . . 0.0 109.807 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.49 -155.76 9.12 Favored Glycine 0 N--CA 1.467 0.765 0 O-C-N 121.357 -0.839 . . . . 0.0 114.957 -177.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -159.91 137.0 9.43 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 126.45 1.9 . . . . 0.0 108.964 172.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 6.7 t -108.5 135.22 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.949 1.699 . . . . 0.0 108.629 171.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 87.5 mtm-85 -117.37 123.42 46.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.121 1.368 . . . . 0.0 110.554 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.0 mtm -96.85 147.56 33.1 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.827 1.651 . . . . 0.0 111.349 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.49 -18.79 25.62 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.643 2.895 . . . . 0.0 113.576 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -77.28 2.27 16.17 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.071 1.348 . . . . 0.0 114.338 176.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.17 48.29 3.6 Favored Glycine 0 N--CA 1.472 1.091 0 C-N-CA 124.678 1.133 . . . . 0.0 113.218 173.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -156.12 166.39 33.59 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.793 1.637 . . . . 0.0 111.872 -173.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.4 m -139.38 161.48 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.446 1.098 . . . . 0.0 113.194 -170.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.1 178.24 10.51 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.733 2.013 . . . . 0.0 111.006 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -113.91 140.72 25.14 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.385 1.074 . . . . 0.0 110.872 176.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.63 160.34 22.0 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.605 2.87 . . . . 0.0 111.003 174.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.8 m -104.39 120.73 41.88 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.077 1.351 . . . . 0.0 108.692 173.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.62 131.35 48.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 124.194 0.998 . . . . 0.0 108.706 177.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.7 m -132.14 128.14 37.45 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.303 1.441 . . . . 0.0 109.221 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -74.43 134.37 42.37 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.275 0.63 . . . . 0.0 111.564 173.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -82.69 -13.52 56.24 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.0 ttpt 67.25 18.86 10.33 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.954 2.102 . . . . 0.0 113.356 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -124.43 17.38 8.95 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 126.824 2.049 . . . . 0.0 112.499 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.6 13.12 68.14 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 124.824 1.202 . . . . 0.0 114.014 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 62.7 p -136.9 164.65 27.82 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.911 2.085 . . . . 0.0 110.027 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.5 m -127.74 163.38 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 124.861 1.264 . . . . 0.0 110.115 171.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.1 t -120.69 147.19 45.61 Favored 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 124.212 1.005 . . . . 0.0 110.098 164.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 39.0 t -120.01 128.09 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.523 1.529 . . . . 0.0 108.424 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.94 156.55 43.56 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 125.667 1.587 . . . . 0.0 111.829 -171.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.6 t80 -163.93 133.4 3.97 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.069 1.348 . . . . 0.0 111.97 -178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -83.62 123.17 76.7 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.539 1.136 . . . . 0.0 110.483 175.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.24 174.49 12.35 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 123.632 2.888 . . . . 0.0 111.823 -175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -149.66 -40.24 0.14 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -137.55 154.89 49.75 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.315 1.446 . . . . 0.0 110.509 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.18 171.0 14.93 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.329 1.052 . . . . 0.0 113.624 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 118.08 -173.03 14.65 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.048 1.785 . . . . 0.0 113.943 177.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -85.19 131.78 34.38 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.977 1.311 . . . . 0.0 110.57 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 53.0 m80 -125.69 156.41 39.37 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.743 1.617 . . . . 0.0 111.47 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -134.31 146.49 50.03 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.352 1.461 . . . . 0.0 109.486 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 17.3 tmm? -151.1 132.41 14.56 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.627 0.771 . . . . 0.0 112.252 -168.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -106.03 148.52 27.65 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.873 1.669 . . . . 0.0 111.65 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 31.4 mm -133.63 135.42 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.406 1.082 . . . . 0.0 110.9 168.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.36 128.19 19.39 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.037 1.335 . . . . 0.0 113.085 -175.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.3 t80 -99.37 126.58 45.27 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.873 2.069 . . . . 0.0 109.689 174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.4 t70 52.79 33.27 13.79 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.877 1.271 . . . . 0.0 112.539 -174.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.4 t30 75.5 2.75 3.86 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 128.334 2.654 . . . . 0.0 114.795 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.6 mtt -104.26 132.77 50.16 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.177 1.391 . . . . 0.0 110.843 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -56.55 134.95 54.66 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.8 pt -74.01 155.9 88.19 Favored Pre-proline 0 N--CA 1.481 1.1 0 CA-C-O 118.514 -0.755 . . . . 0.0 110.592 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.02 -19.67 69.65 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.503 2.136 . . . . 0.0 113.853 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -80.45 -3.5 89.99 Favored Glycine 0 CA--C 1.536 1.354 0 CA-C-N 119.32 0.964 . . . . 0.0 114.686 172.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 7.7 t -93.02 154.18 41.76 Favored Pre-proline 0 CA--C 1.551 0.994 0 CA-C-N 119.203 1.502 . . . . 0.0 111.887 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -82.36 163.01 75.8 Favored 'Cis proline' 0 C--N 1.352 0.726 0 CA-C-N 119.795 0.962 . . . . 0.0 111.591 -13.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 72.1 mt -111.52 156.63 21.43 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.634 1.574 . . . . 0.0 111.376 176.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -147.27 139.29 24.37 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.149 1.38 . . . . 0.0 109.416 -177.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.2 p90 -162.68 162.19 26.8 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.889 0.876 . . . . 0.0 112.5 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 62.9 t80 -109.72 145.22 36.95 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.446 1.098 . . . . 0.0 113.004 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . 0.494 HG12 HD11 ' A' 1788 ' ' LEU . 69.4 t -121.95 141.02 44.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 126.311 1.844 . . . . 0.0 109.302 -178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -155.18 144.58 21.16 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.251 1.42 . . . . 0.0 112.989 -175.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . 0.408 ' CD1' HD13 ' A' 1788 ' ' LEU . 49.9 m-85 -70.06 145.32 51.78 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 111.551 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 28.2 m -66.52 -19.4 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 113.661 0.985 . . . . 0.0 113.661 -174.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -91.11 0.56 57.51 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 125.342 1.457 . . . . 0.0 114.859 -178.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 96.3 m -62.8 132.94 53.89 Favored 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 119.307 0.958 . . . . 0.0 112.247 177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.87 -25.14 18.31 Favored Glycine 0 N--CA 1.475 1.245 0 C-N-CA 124.704 1.145 . . . . 0.0 113.887 178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -68.5 159.71 31.24 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.22 1.008 . . . . 0.0 113.201 175.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.4 p -64.37 131.4 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.096 0.959 . . . . 0.0 111.272 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 53.4 p -136.36 164.78 27.32 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 126.166 1.786 . . . . 0.0 110.106 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -143.7 144.52 31.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.284 1.034 . . . . 0.0 111.671 177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 38.9 p90 -166.49 167.27 15.77 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.684 1.593 . . . . 0.0 112.861 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.8 170.9 12.86 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 125.508 1.528 . . . . 0.0 112.454 -176.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.74 -33.82 12.29 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.701 2.267 . . . . 0.0 113.142 -169.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.5 -32.89 83.04 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-N 119.358 0.981 . . . . 0.0 114.609 -170.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 4.0 pp -77.82 -3.12 39.91 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 119.03 1.415 . . . . 0.0 113.771 176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 77.5 m -113.31 -47.16 3.03 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.583 1.953 . . . . 0.0 111.863 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.8 t-80 -138.58 143.38 39.35 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.684 1.594 . . . . 0.0 112.448 177.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.83 175.74 22.39 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 125.056 1.313 . . . . 0.0 113.026 173.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -139.62 134.67 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.452 1.101 . . . . 0.0 108.778 177.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.8 m -56.54 132.32 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 N-CA-C 112.36 0.504 . . . . 0.0 112.36 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 24.7 m120 69.35 1.65 3.37 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 127.112 2.165 . . . . 0.0 114.401 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -105.27 137.56 19.29 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.285 1.434 . . . . 0.0 110.433 176.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.47 121.94 7.88 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.417 2.078 . . . . 0.0 110.364 -177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 145.22 31.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.457 1.503 . . . . 0.0 110.393 175.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.5 p -136.22 149.17 48.43 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -166.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.6 p90 -160.74 176.29 11.67 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.96 1.704 . . . . 0.0 111.47 175.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.7 m -133.35 141.52 47.97 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.068 1.347 . . . . 0.0 110.851 -170.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.77 136.36 47.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.786 1.634 . . . . 0.0 108.014 168.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -104.13 123.0 46.47 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.421 1.089 . . . . 0.0 110.284 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.9 p -127.04 3.81 6.49 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 125.785 1.634 . . . . 0.0 113.636 -166.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -50.49 -36.92 36.02 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 126.856 2.062 . . . . 0.0 115.64 -166.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -129.3 17.54 6.0 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.426 1.49 . . . . 0.0 112.423 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.7 -30.07 59.18 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -176.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.2 142.36 5.99 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.385 1.469 . . . . 0.0 113.156 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -72.9 152.95 41.22 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.668 1.187 . . . . 0.0 112.087 -178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.37 13.12 0.05 OUTLIER Glycine 0 N--CA 1.476 1.36 0 N-CA-C 116.462 1.345 . . . . 0.0 116.462 -178.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 107.96 89.77 2.09 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-N 118.776 1.288 . . . . 0.0 112.728 175.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.14 126.62 31.08 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.802 1.241 . . . . 0.0 109.367 172.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.9 m -121.54 157.95 29.58 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.196 1.798 . . . . 0.0 112.166 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.3 tp -160.19 134.99 7.72 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.915 1.686 . . . . 0.0 109.343 -172.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.82 158.1 34.55 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.014 0.926 . . . . 0.0 112.384 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 45.3 mt -137.55 138.03 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.859 1.263 . . . . 0.0 109.964 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -125.6 164.24 20.99 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.266 1.826 . . . . 0.0 109.731 170.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 169.96 -155.84 26.05 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-O 118.673 -1.071 . . . . 0.0 114.224 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -65.36 -21.92 60.53 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 123.866 3.044 . . . . 0.0 112.784 176.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 14.5 t -152.05 164.53 37.03 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.616 1.566 . . . . 0.0 109.708 166.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -72.45 112.58 8.63 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 120.991 -1.068 . . . . 0.0 111.153 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.43 148.17 48.65 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.762 0.825 . . . . 0.0 111.088 168.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -92.19 144.1 25.76 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.045 0.538 . . . . 0.0 110.27 168.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.7 mt -134.27 144.93 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.056 1.342 . . . . 0.0 110.074 -163.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.5 t -142.45 162.28 35.87 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.766 1.226 . . . . 0.0 110.922 166.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -159.32 158.83 33.09 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.645 1.178 . . . . 0.0 112.622 -176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 55.7 m -142.55 123.93 14.77 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.273 1.429 . . . . 0.0 110.162 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 24.2 t70 -78.09 132.4 37.7 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.887 1.275 . . . . 0.0 111.152 170.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -112.71 148.18 35.25 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.215 1.406 . . . . 0.0 111.916 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -70.54 -14.03 62.34 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.111 0.964 . . . . 0.0 112.877 176.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -75.45 -6.44 50.12 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.707 1.603 . . . . 0.0 114.125 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 35.81 6.21 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.555 1.074 . . . . 0.0 113.519 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.3 p -141.16 161.21 38.4 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.307 1.443 . . . . 0.0 111.172 178.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 66.0 m -115.39 128.3 55.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.032 1.333 . . . . 0.0 108.785 161.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -89.01 147.63 24.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.65 0.78 . . . . 0.0 110.296 170.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.1 t -129.38 143.16 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.645 1.578 . . . . 0.0 110.127 -177.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 77.6 p -136.82 148.02 46.92 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.916 1.286 . . . . 0.0 111.755 167.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 12.8 p90 -152.75 157.02 40.22 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 19.0 mt -122.66 105.93 35.23 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 125.857 1.663 . . . . 0.0 110.081 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -79.92 167.26 20.41 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.543 2.829 . . . . 0.0 110.31 168.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 30.7 m -136.17 -25.05 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -173.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.3 mt -118.26 147.99 42.84 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 125.042 1.337 . . . . 0.0 110.395 170.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -74.36 156.11 45.98 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.924 2.416 . . . . 0.0 110.952 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.53 -149.1 20.55 Favored Glycine 0 CA--C 1.529 0.91 0 C-N-CA 124.55 1.072 . . . . 0.0 112.997 -177.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -113.7 128.27 56.36 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.041 1.336 . . . . 0.0 111.24 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -112.31 139.74 47.61 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.371 1.468 . . . . 0.0 110.929 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.6 m -97.79 122.28 40.7 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.642 1.177 . . . . 0.0 110.496 175.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.34 127.91 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.482 1.513 . . . . 0.0 108.543 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -110.88 133.02 53.71 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.778 1.631 . . . . 0.0 109.861 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.4 t -133.9 132.41 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.504 1.521 . . . . 0.0 108.123 171.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -156.67 144.49 19.33 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.852 1.261 . . . . 0.0 110.786 -167.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -139.7 118.69 12.57 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 51.57 59.57 4.48 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.446 1.498 . . . . 0.0 112.179 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.8 pt-20 59.39 12.05 2.5 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 128.036 2.534 . . . . 0.0 116.424 -178.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -119.57 125.43 48.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.389 1.076 . . . . 0.0 111.133 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -60.63 155.45 18.85 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.099 0.96 . . . . 0.0 112.774 171.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.5 m -74.51 152.19 87.51 Favored Pre-proline 0 N--CA 1.481 1.078 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 169.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.05 -12.33 34.95 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 122.506 2.138 . . . . 0.0 114.897 -167.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -102.22 -11.6 36.07 Favored Glycine 0 CA--C 1.535 1.323 0 N-CA-C 115.925 1.13 . . . . 0.0 115.925 174.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 80.5 p -84.5 156.07 62.38 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 120.055 1.927 . . . . 0.0 113.6 -172.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -73.49 151.21 96.77 Favored 'Cis proline' 0 C--N 1.352 0.763 0 CA-C-N 118.982 0.672 . . . . 0.0 112.472 -4.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -102.42 160.05 14.89 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.43 1.492 . . . . 0.0 110.825 177.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 44.3 m -119.71 116.62 26.32 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.747 0.819 . . . . 0.0 110.57 178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.73 126.43 43.06 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.529 1.132 . . . . 0.0 111.222 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -84.34 114.41 21.85 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.163 0.985 . . . . 0.0 108.926 174.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.7 t -103.34 136.2 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.065 0.946 . . . . 0.0 110.402 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 34.0 p -121.83 171.59 8.79 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.546 1.538 . . . . 0.0 112.589 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.95 145.66 30.05 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.936 1.255 . . . . 0.0 112.686 176.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.5 t70 -79.57 -21.16 45.44 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.156 0.982 . . . . 0.0 112.863 174.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.5 t70 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 125.867 1.667 . . . . 0.0 114.03 179.336 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -74.67 162.33 28.83 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 124.34 1.056 . . . . 0.0 113.03 178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -69.29 157.75 36.37 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.032 1.333 . . . . 0.0 112.655 174.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . 49.34 58.1 17.9 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 126.04 1.736 . . . . 0.0 113.759 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -70.59 161.99 44.1 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.793 2.995 . . . . 0.0 112.483 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -150.35 154.56 38.03 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.421 1.489 . . . . 0.0 110.522 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.05 147.03 57.17 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.228 1.411 . . . . 0.0 112.622 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -75.84 154.02 38.31 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.463 2.775 . . . . 0.0 111.458 178.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 83.1 mt -105.92 26.21 9.94 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.39 1.476 . . . . 0.0 111.959 179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 13.1 p -161.0 150.16 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 126.885 2.074 . . . . 0.0 110.318 -171.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 86.37 -152.16 25.13 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.582 1.087 . . . . 0.0 112.445 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 14.7 p -158.05 135.36 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.095 1.358 . . . . 0.0 110.802 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -97.17 -7.27 32.89 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 124.987 1.315 . . . . 0.0 113.87 -175.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -66.12 156.76 49.78 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.98 1.276 . . . . 0.0 113.537 -178.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 4.1 pp -154.9 166.23 34.18 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.783 1.633 . . . . 0.0 111.517 -174.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 31.0 t70 68.79 -43.81 0.51 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 128.563 2.745 . . . . 0.0 113.929 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.7 p -61.27 -24.26 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.775 1.63 . . . . 0.0 112.89 175.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.7 t -81.59 -16.47 51.48 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.66 1.584 . . . . 0.0 112.929 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -85.62 38.71 0.76 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.816 1.647 . . . . 0.0 111.725 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . 0.63 HD11 HG12 ' A' 1860 ' ' VAL . 22.0 tp -98.46 134.4 41.5 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.434 1.894 . . . . 0.0 111.241 -171.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.5 ttp85 -59.3 120.28 46.53 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 124.311 1.044 . . . . 0.0 111.303 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -71.24 156.64 58.83 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.459 2.773 . . . . 0.0 110.922 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.1 t80 -108.12 127.72 54.06 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.656 0.782 . . . . 0.0 111.096 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -154.52 135.74 14.0 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.655 1.582 . . . . 0.0 110.785 174.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.39 152.48 41.64 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.518 1.927 . . . . 0.0 109.862 -173.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.0 p -123.31 139.16 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.023 1.329 . . . . 0.0 110.469 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -133.24 137.49 29.42 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 126.271 1.828 . . . . 0.0 108.486 -174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -79.06 45.95 2.06 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 124.555 3.503 . . . . 0.0 112.999 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 29.2 t80 -91.15 153.49 20.0 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.135 1.374 . . . . 0.0 111.137 175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.4 m -125.28 126.36 45.0 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.946 1.298 . . . . 0.0 109.746 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 95.2 mt -91.18 138.06 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.059 1.344 . . . . 0.0 109.917 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -149.74 95.96 2.4 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.501 1.12 . . . . 0.0 111.521 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 72.59 -31.74 0.23 Allowed 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 128.539 2.736 . . . . 0.0 115.179 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -81.1 175.74 54.68 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.626 1.584 . . . . 0.0 113.443 178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -111.45 141.68 44.7 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.235 1.414 . . . . 0.0 111.289 -176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -125.31 134.29 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.548 1.539 . . . . 0.0 110.602 177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.18 170.64 17.97 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.183 1.793 . . . . 0.0 110.324 -175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -158.89 -167.48 19.67 Favored Glycine 0 N--CA 1.465 0.617 0 N-CA-C 115.884 1.114 . . . . 0.0 115.884 -176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -152.48 134.85 15.14 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.702 1.601 . . . . 0.0 109.264 175.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.0 t -104.53 131.4 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.694 1.598 . . . . 0.0 107.443 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -116.38 129.05 56.04 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 124.833 1.253 . . . . 0.0 110.657 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -97.02 150.68 37.1 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.71 1.604 . . . . 0.0 111.468 -174.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.4 -20.56 27.43 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.507 2.804 . . . . 0.0 113.051 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.2 p -79.68 -0.54 34.44 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.945 1.698 . . . . 0.0 114.561 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.41 54.08 2.48 Favored Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.56 1.076 . . . . 0.0 113.161 175.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -155.62 167.04 31.68 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.064 1.746 . . . . 0.0 111.676 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.8 m -140.43 158.09 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 124.849 1.26 . . . . 0.0 112.58 -172.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.89 166.87 32.15 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.507 1.923 . . . . 0.0 110.892 178.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.01 137.73 20.16 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.2 -0.937 . . . . 0.0 111.588 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -80.77 163.96 20.77 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.958 3.105 . . . . 0.0 110.993 168.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.7 m -107.87 117.82 35.11 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.088 1.355 . . . . 0.0 108.852 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -97.64 133.28 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.43 1.092 . . . . 0.0 109.007 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -125.85 130.64 51.77 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.111 1.764 . . . . 0.0 109.901 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 17.5 t0 -75.52 122.23 23.57 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.169 0.988 . . . . 0.0 110.775 169.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -84.46 -15.4 46.19 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.7 tttt 71.39 0.22 3.37 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 127.614 2.366 . . . . 0.0 114.017 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -97.83 7.87 45.67 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 127.07 2.148 . . . . 0.0 113.023 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.83 15.12 55.39 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 124.983 1.278 . . . . 0.0 113.835 -173.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.9 p -132.38 161.78 32.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.419 1.888 . . . . 0.0 110.3 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.7 m -125.4 145.24 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.787 1.235 . . . . 0.0 109.831 167.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.2 m -104.71 139.25 39.8 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.291 1.037 . . . . 0.0 108.564 171.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.7 t -124.14 129.49 74.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 124.912 1.285 . . . . 0.0 109.108 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 68.2 mtt85 -129.37 161.86 29.33 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.1 1.36 . . . . 0.0 112.496 -173.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.5 t80 -159.64 135.91 8.93 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.418 1.487 . . . . 0.0 111.828 178.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.35 114.39 60.88 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 124.801 1.241 . . . . 0.0 110.602 176.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -83.97 165.82 13.21 Favored 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.723 2.949 . . . . 0.0 112.221 -173.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.3 t -144.35 -1.5 0.92 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 114.475 1.287 . . . . 0.0 114.475 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -170.92 152.02 3.49 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 126.509 1.924 . . . . 0.0 111.27 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.55 175.37 7.31 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.309 1.443 . . . . 0.0 114.49 -172.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.86 -171.02 13.61 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 126.138 1.827 . . . . 0.0 113.985 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 59.3 tp -79.69 127.41 32.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.623 1.169 . . . . 0.0 110.454 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 55.0 m80 -125.69 168.99 12.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.809 1.644 . . . . 0.0 111.394 -176.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -147.35 153.52 39.77 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.04 0.936 . . . . 0.0 111.77 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 22.1 ttm -124.34 133.71 53.37 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.117 1.767 . . . . 0.0 110.095 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -111.14 136.12 50.65 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.236 1.814 . . . . 0.0 109.829 169.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.1 mm -135.59 134.45 51.76 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 125.028 1.331 . . . . 0.0 110.451 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.03 140.42 36.18 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.366 1.066 . . . . 0.0 113.588 179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 34.4 t80 -103.6 118.09 35.92 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 127.058 2.143 . . . . 0.0 109.256 174.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.81 31.92 11.41 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.826 1.25 . . . . 0.0 112.945 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 75.13 5.0 4.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.143 2.577 . . . . 0.0 115.171 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.8 ttp -95.4 127.94 41.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.595 1.158 . . . . 0.0 110.079 165.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -58.79 137.55 57.65 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.254 -0.904 . . . . 0.0 112.884 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -71.82 154.43 92.81 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-O 118.467 -0.778 . . . . 0.0 110.432 173.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -63.55 -17.86 61.83 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.582 2.188 . . . . 0.0 113.912 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -88.64 2.54 84.67 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.814 1.197 . . . . 0.0 114.88 172.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 31.5 t -101.94 142.62 24.97 Favored Pre-proline 0 CA--C 1.547 0.831 0 CA-C-N 119.822 1.811 . . . . 0.0 111.953 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -82.61 170.33 57.41 Favored 'Cis proline' 0 C--N 1.352 0.76 0 CA-C-N 119.816 0.97 . . . . 0.0 112.477 -3.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.2 mt -120.91 151.42 39.7 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.118 1.767 . . . . 0.0 110.38 172.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -132.67 144.73 50.53 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.73 1.212 . . . . 0.0 110.505 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 6.0 p90 -165.79 154.65 11.6 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.362 1.065 . . . . 0.0 112.304 -172.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 37.2 t80 -101.66 143.23 31.87 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.801 0.84 . . . . 0.0 112.429 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . 0.63 HG12 HD11 ' A' 1788 ' ' LEU . 91.8 t -116.09 137.57 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.21 1.804 . . . . 0.0 109.413 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.0 t0 -159.6 147.64 17.3 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.857 1.263 . . . . 0.0 112.267 -173.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -74.47 149.11 40.48 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.268 1.027 . . . . 0.0 112.784 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 3.4 p -70.59 -22.33 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 O-C-N 121.507 -0.745 . . . . 0.0 112.83 -176.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -82.67 -13.24 56.78 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.107 1.363 . . . . 0.0 114.174 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 82.9 m -58.98 134.49 57.02 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.535 1.134 . . . . 0.0 113.935 -171.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.15 70.08 1.08 Allowed Glycine 0 N--CA 1.469 0.847 0 C-N-CA 125.702 1.62 . . . . 0.0 111.772 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -162.6 168.58 21.55 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.652 1.581 . . . . 0.0 113.072 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.8 p -68.59 143.79 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 123.634 0.774 . . . . 0.0 110.074 164.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -163.52 159.51 22.08 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 125.692 1.597 . . . . 0.0 110.025 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -138.33 144.76 40.53 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.335 1.054 . . . . 0.0 112.358 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 45.0 p90 -167.67 165.44 14.32 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.683 1.593 . . . . 0.0 113.239 -175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.58 175.5 13.96 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.253 1.406 . . . . 0.0 112.977 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.56 -37.0 7.78 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.738 2.292 . . . . 0.0 112.764 -171.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.15 -36.06 91.34 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 119.538 1.063 . . . . 0.0 114.507 -170.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.02 -6.51 52.95 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.704 1.252 . . . . 0.0 113.327 176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 38.7 m -100.98 -54.73 2.73 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.222 1.809 . . . . 0.0 110.18 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -137.26 139.8 41.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.601 1.961 . . . . 0.0 112.375 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -129.97 172.84 20.01 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 125.058 1.313 . . . . 0.0 113.242 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 60.9 t -136.85 134.11 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.627 1.171 . . . . 0.0 108.948 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -56.95 139.23 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.0 m-80 66.16 2.24 2.25 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.86 2.064 . . . . 0.0 114.809 174.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 94.1 mttt -116.35 142.22 29.09 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.908 1.683 . . . . 0.0 111.096 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -72.79 119.21 5.95 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.637 2.224 . . . . 0.0 110.415 -177.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -94.82 145.7 24.7 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.218 1.407 . . . . 0.0 109.996 171.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 76.0 p -136.18 151.57 49.86 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -168.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.7 p90 -162.87 176.16 10.49 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.178 1.791 . . . . 0.0 111.461 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.9 m -134.05 138.34 45.26 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.707 1.203 . . . . 0.0 110.983 -169.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.4 t -102.09 134.97 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.186 1.394 . . . . 0.0 107.701 165.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -96.43 128.08 43.03 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.071 0.948 . . . . 0.0 109.824 170.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.1 p -129.39 7.46 5.37 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.379 1.872 . . . . 0.0 112.861 -171.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -55.65 -32.17 62.97 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.91 1.684 . . . . 0.0 114.464 -170.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.0 t70 -117.65 11.85 13.83 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.541 1.536 . . . . 0.0 113.063 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.03 -15.64 56.78 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 -174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.75 -128.75 8.62 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.344 0.973 . . . . 0.0 112.162 -179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -155.65 150.3 26.19 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.443 1.497 . . . . 0.0 110.723 -177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.3 -85.0 0.08 OUTLIER Glycine 0 N--CA 1.469 0.851 0 C-N-CA 125.482 1.515 . . . . 0.0 111.003 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -168.77 118.08 0.76 Allowed Glycine 0 N--CA 1.469 0.849 0 C-N-CA 124.575 1.083 . . . . 0.0 112.222 169.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.1 tt -85.14 138.2 32.54 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.439 1.096 . . . . 0.0 110.063 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.4 m -131.32 158.52 40.46 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.677 1.591 . . . . 0.0 111.547 178.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 43.2 tp -156.75 135.93 12.01 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.783 1.633 . . . . 0.0 108.893 -171.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.65 158.93 39.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.77 0.828 . . . . 0.0 112.346 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.0 mt -134.39 137.51 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 124.893 1.277 . . . . 0.0 109.445 173.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -123.15 122.34 38.18 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.082 1.353 . . . . 0.0 109.379 172.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -139.1 -175.75 14.24 Favored Glycine 0 CA--C 1.537 1.413 0 C-N-CA 124.724 1.154 . . . . 0.0 114.08 -176.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.5 -23.84 43.06 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 124.045 3.164 . . . . 0.0 112.112 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.3 t -136.59 152.23 50.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.506 1.522 . . . . 0.0 108.578 160.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.5 tptt -71.91 120.05 16.96 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 121.033 -1.042 . . . . 0.0 111.976 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -74.36 147.97 41.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.933 0.893 . . . . 0.0 111.681 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -89.81 142.85 27.3 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.505 0.722 . . . . 0.0 109.741 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.7 mt -135.11 143.88 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.587 1.155 . . . . 0.0 110.334 -167.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.2 t -143.19 158.22 43.81 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.018 1.327 . . . . 0.0 110.838 167.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -158.74 157.31 31.47 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.442 1.097 . . . . 0.0 112.988 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 67.3 m -140.89 115.2 9.33 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.447 1.499 . . . . 0.0 109.868 -175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -79.85 136.92 36.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.026 1.331 . . . . 0.0 111.338 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 61.4 m-20 -117.88 146.22 44.07 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.843 1.657 . . . . 0.0 111.986 -175.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -67.86 -15.16 63.49 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.759 1.224 . . . . 0.0 112.496 175.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -70.87 -9.32 57.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 125.937 1.695 . . . . 0.0 114.159 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 92.88 33.73 7.22 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 124.266 0.936 . . . . 0.0 113.553 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.9 p -139.14 163.54 32.16 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.345 1.458 . . . . 0.0 110.931 174.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -130.88 125.64 34.09 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.453 1.501 . . . . 0.0 108.642 164.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -92.41 144.52 25.28 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.198 0.999 . . . . 0.0 110.589 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.9 t -126.62 141.7 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.542 1.537 . . . . 0.0 110.802 -175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 63.2 m -132.92 141.01 48.14 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.985 1.714 . . . . 0.0 110.795 170.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 10.6 p90 -148.22 151.41 35.45 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 174.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 11.5 mt -117.56 104.56 49.45 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 126.375 1.87 . . . . 0.0 110.524 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -82.8 165.13 15.68 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.694 2.93 . . . . 0.0 110.199 166.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.0 p -127.77 -19.58 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 N-CA-C 115.1 1.519 . . . . 0.0 115.1 -170.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.3 pp -146.84 152.06 43.48 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 124.188 0.995 . . . . 0.0 111.594 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -67.46 147.77 77.83 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.041 2.494 . . . . 0.0 112.838 -174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.21 -171.09 30.18 Favored Glycine 0 N--CA 1.47 0.917 0 C-N-CA 124.53 1.062 . . . . 0.0 113.708 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.92 134.64 34.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.956 1.302 . . . . 0.0 112.104 176.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -127.66 126.37 41.85 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.586 1.554 . . . . 0.0 109.842 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 62.6 m -88.37 124.33 33.82 Favored 'General case' 0 N--CA 1.47 0.526 0 O-C-N 120.987 -1.07 . . . . 0.0 110.708 178.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.0 128.31 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 125.512 1.525 . . . . 0.0 108.304 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.1 tt -112.31 130.34 55.98 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 125.426 1.49 . . . . 0.0 109.385 175.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 24.0 t -132.18 131.03 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.144 0.978 . . . . 0.0 109.577 173.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.98 147.48 27.92 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.122 1.369 . . . . 0.0 111.683 -168.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -143.57 120.25 11.14 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 109.8 178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.5 t-20 57.12 56.24 5.39 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.6 1.56 . . . . 0.0 111.824 178.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.4 pt-20 57.24 13.38 1.66 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 128.415 2.686 . . . . 0.0 116.322 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -120.23 127.09 52.11 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.732 1.213 . . . . 0.0 110.641 177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -63.69 147.08 52.54 Favored 'General case' 0 CA--C 1.547 0.841 0 O-C-N 121.324 -0.86 . . . . 0.0 112.079 173.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -70.77 153.73 94.69 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 118.403 -0.808 . . . . 0.0 109.758 170.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -60.43 129.64 30.49 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 122.632 2.221 . . . . 0.0 110.887 179.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 91.95 -14.76 63.5 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.103 1.335 . . . . 0.0 114.949 -175.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.8 t -78.42 142.63 62.84 Favored Pre-proline 0 CA--C 1.549 0.924 0 CA-C-N 119.433 1.617 . . . . 0.0 111.734 176.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.41 140.79 69.24 Favored 'Cis proline' 0 C--N 1.353 0.799 0 CA-C-N 119.317 0.792 . . . . 0.0 111.989 -4.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -93.52 166.29 12.33 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.312 1.845 . . . . 0.0 110.689 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 51.3 m -124.44 113.99 18.88 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.816 0.847 . . . . 0.0 110.395 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.9 156.97 19.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.679 1.192 . . . . 0.0 110.953 167.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.2 ttt85 -120.9 126.55 50.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.184 0.993 . . . . 0.0 109.949 168.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.2 t -103.18 131.81 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 C-N-CA 125.38 1.472 . . . . 0.0 109.793 -177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.2 p -108.99 162.1 14.53 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.73 1.212 . . . . 0.0 112.62 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.49 142.69 28.37 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.91 1.243 . . . . 0.0 112.089 176.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 33.3 t70 -87.16 -10.71 52.01 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.602 1.161 . . . . 0.0 113.52 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.254 1.305 0 C-N-CA 126.617 1.967 . . . . 0.0 112.557 -177.564 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.579 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -75.92 -28.38 58.0 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 65.2 mtt -84.15 156.15 22.24 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.855 1.262 . . . . 0.0 112.107 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -67.26 150.0 98.13 Favored Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 124.304 1.042 . . . . 0.0 112.627 177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -74.65 170.56 20.04 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.8 3.0 . . . . 0.0 112.014 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -69.41 154.17 42.43 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.135 0.974 . . . . 0.0 112.168 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 61.5 ttm-85 -58.64 132.47 85.85 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 124.476 1.11 . . . . 0.0 111.49 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -72.89 164.74 34.72 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.464 2.776 . . . . 0.0 112.201 -178.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.6 pt? -70.76 20.52 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.875 2.07 . . . . 0.0 115.622 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 14.3 p -159.32 147.01 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.341 1.856 . . . . 0.0 110.848 -170.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -154.62 172.96 33.1 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.32 1.438 . . . . 0.0 113.293 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 85.0 t -76.56 128.82 37.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.494 1.118 . . . . 0.0 110.046 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -78.4 -14.04 59.57 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 88.66 31.45 12.98 Favored Glycine 0 N--CA 1.474 1.192 0 C-N-CA 124.874 1.226 . . . . 0.0 113.704 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 90.6 mt -65.27 144.83 56.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.821 1.249 . . . . 0.0 112.201 -178.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 27.4 t70 -137.06 22.75 3.04 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.293 1.437 . . . . 0.0 111.921 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 17.8 m -71.34 145.04 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.19 1.396 . . . . 0.0 111.765 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 9.5 t 179.42 -43.31 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.744 2.418 . . . . 0.0 110.503 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 74.9 m -80.73 86.05 6.0 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.394 1.077 . . . . 0.0 112.131 -179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 61.5 mt -72.34 153.32 41.55 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.115 1.366 . . . . 0.0 110.968 165.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -57.22 115.34 10.3 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 125.551 1.54 . . . . 0.0 111.377 -177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.79 129.43 18.63 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.32 2.013 . . . . 0.0 108.852 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 67.6 t80 -114.83 128.88 56.55 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.616 0.766 . . . . 0.0 111.722 -171.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -157.67 142.72 16.79 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.817 1.647 . . . . 0.0 111.092 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.97 156.16 49.51 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.595 1.958 . . . . 0.0 110.141 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.5 p -122.35 137.57 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.904 1.282 . . . . 0.0 109.959 173.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 57.9 mt -131.64 133.48 24.31 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.999 1.72 . . . . 0.0 109.035 -172.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.94 112.1 3.32 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.266 2.644 . . . . 0.0 109.81 173.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.0 t80 -175.54 148.58 0.93 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 127.107 2.163 . . . . 0.0 109.177 -171.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.3 m -130.75 124.01 30.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.518 1.127 . . . . 0.0 109.234 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 41.7 mt -74.47 125.52 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.195 0.598 . . . . 0.0 110.265 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.6 mttp -110.42 -143.0 0.39 Allowed 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 125.694 1.597 . . . . 0.0 110.513 176.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -74.46 120.29 19.82 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 120.651 -1.281 . . . . 0.0 110.883 170.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.98 -152.14 20.45 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.589 1.566 . . . . 0.0 112.303 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -160.31 147.47 16.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.956 1.302 . . . . 0.0 110.978 -174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -120.29 136.73 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.402 1.481 . . . . 0.0 111.207 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 25.2 p -149.58 174.31 12.67 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.573 1.949 . . . . 0.0 110.235 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -157.82 -166.33 16.97 Favored Glycine 0 N--CA 1.469 0.847 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -152.34 142.3 22.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.234 1.813 . . . . 0.0 109.42 174.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.7 t -119.93 133.78 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 125.948 1.699 . . . . 0.0 108.673 174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -109.97 132.89 53.75 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.665 1.186 . . . . 0.0 111.794 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.9 mpp? -104.34 143.43 26.66 Favored Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 125.674 1.589 . . . . 0.0 111.219 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -55.08 -29.15 64.03 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 124.211 3.274 . . . . 0.0 114.994 173.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 6.1 m -69.94 -0.77 7.97 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.3 42.04 6.35 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.6 1.095 . . . . 0.0 112.839 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -149.59 162.65 39.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.809 1.644 . . . . 0.0 111.99 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.5 m -141.18 158.15 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.988 1.315 . . . . 0.0 112.204 -174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -151.53 179.1 8.66 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 127.018 2.127 . . . . 0.0 109.974 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -121.54 143.8 38.77 Favored Pre-proline 0 CA--C 1.544 0.745 0 O-C-N 121.107 -0.996 . . . . 0.0 111.718 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -83.73 166.34 13.47 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.089 3.192 . . . . 0.0 111.405 176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 77.5 m -107.21 130.58 54.71 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 125.4 1.48 . . . . 0.0 108.651 171.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.52 136.7 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.518 1.127 . . . . 0.0 109.443 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 63.0 m -133.26 124.26 27.01 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.659 1.584 . . . . 0.0 109.648 177.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.4 t70 -79.02 127.26 31.76 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.292 1.037 . . . . 0.0 111.076 174.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -87.52 -4.26 58.98 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 -170.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 35.9 mmtm 71.57 -5.91 1.53 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.638 2.375 . . . . 0.0 114.538 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -98.21 2.79 48.73 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.715 2.006 . . . . 0.0 113.218 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.13 16.8 31.62 Favored Glycine 0 CA--C 1.535 1.307 0 C-N-CA 125.026 1.298 . . . . 0.0 114.457 -177.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 65.1 p -128.75 157.39 41.56 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.016 1.726 . . . . 0.0 110.677 174.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -115.31 139.61 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.051 0.94 . . . . 0.0 109.633 163.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.1 m -96.7 138.05 34.85 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.659 1.184 . . . . 0.0 108.495 169.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 24.8 t -119.11 135.05 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.483 1.513 . . . . 0.0 109.052 178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -133.1 152.77 51.93 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.558 1.543 . . . . 0.0 111.785 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -153.47 132.44 12.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.349 1.46 . . . . 0.0 110.914 177.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.43 117.89 70.0 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.236 1.014 . . . . 0.0 110.5 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.56 130.69 12.93 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.132 2.554 . . . . 0.0 111.823 -171.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 78.2 p -118.7 -15.18 9.51 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -141.54 157.54 44.99 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.909 1.684 . . . . 0.0 110.757 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -90.99 166.28 13.09 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.27 1.028 . . . . 0.0 112.004 168.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.24 -166.71 12.17 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.693 1.616 . . . . 0.0 114.079 177.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.9 tp -91.77 122.28 34.18 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.338 1.455 . . . . 0.0 110.494 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.5 m80 -119.1 169.57 9.81 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.437 1.895 . . . . 0.0 111.26 -172.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -142.51 152.72 42.95 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.871 0.868 . . . . 0.0 111.482 171.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 5.7 ttm -125.55 119.45 28.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.886 2.074 . . . . 0.0 109.928 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -95.86 138.4 33.57 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.737 1.615 . . . . 0.0 109.967 170.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.6 mm -135.96 135.43 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.745 1.218 . . . . 0.0 110.577 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.93 141.1 32.94 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 124.69 1.196 . . . . 0.0 113.329 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 20.6 t80 -103.14 120.26 40.37 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.153 1.781 . . . . 0.0 109.788 173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 52.73 34.07 15.36 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.673 1.189 . . . . 0.0 112.701 -174.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 69.8 m-80 73.29 5.35 5.04 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 127.92 2.488 . . . . 0.0 115.066 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.7 mtm -97.06 124.6 41.11 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.079 1.351 . . . . 0.0 109.921 168.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -57.51 136.11 56.68 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 121.265 -0.897 . . . . 0.0 112.938 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.3 pt -68.96 152.41 96.82 Favored Pre-proline 0 N--CA 1.478 0.973 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.602 176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -60.28 120.11 7.69 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.326 2.018 . . . . 0.0 109.748 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 90.86 7.57 66.11 Favored Glycine 0 CA--C 1.535 1.306 0 CA-C-O 118.664 -1.075 . . . . 0.0 115.5 -176.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.2 t -74.16 142.11 78.55 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-N 120.283 2.041 . . . . 0.0 110.746 162.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -86.59 171.54 38.47 Favored 'Cis proline' 0 CA--C 1.54 0.815 0 CA-C-N 120.388 1.174 . . . . 0.0 113.205 -2.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.1 mt -108.63 159.34 16.81 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.131 1.772 . . . . 0.0 110.62 168.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -133.47 138.86 46.37 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.614 1.166 . . . . 0.0 110.434 -179.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -156.94 153.32 27.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.07 0.948 . . . . 0.0 112.863 -167.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 43.6 t80 -104.28 148.79 25.95 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.983 0.913 . . . . 0.0 112.916 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 32.2 t -132.41 139.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.613 1.565 . . . . 0.0 109.22 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.09 153.5 32.95 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.817 1.247 . . . . 0.0 113.023 -171.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -75.69 125.99 30.14 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 121.613 -0.679 . . . . 0.0 111.35 175.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.0 p -68.72 -24.72 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 O-C-N 121.572 -0.705 . . . . 0.0 112.428 177.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -69.97 -26.02 63.9 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.996 1.318 . . . . 0.0 114.05 -176.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 85.2 m -73.02 -24.61 60.75 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -174.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 74.44 7.19 78.14 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.697 1.141 . . . . 0.0 115.504 172.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -67.91 161.81 25.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 125.59 1.556 . . . . 0.0 113.629 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.1 t -68.26 127.43 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 172.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.7 t -156.21 162.78 40.14 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.41 1.084 . . . . 0.0 111.161 -167.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.4 147.01 31.78 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.082 1.353 . . . . 0.0 111.804 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 46.2 p90 -166.54 162.4 16.66 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.676 1.591 . . . . 0.0 112.355 -174.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.97 173.34 13.26 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.3 1.428 . . . . 0.0 112.991 -178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.36 -32.56 15.84 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.989 2.46 . . . . 0.0 112.766 -172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.35 -33.4 77.5 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.347 0.976 . . . . 0.0 114.498 -171.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.4 -2.93 44.01 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 118.865 1.332 . . . . 0.0 113.508 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -106.4 -40.41 5.6 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 126.709 2.003 . . . . 0.0 111.558 176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -152.47 141.96 21.69 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.356 1.862 . . . . 0.0 111.92 -164.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.9 -179.91 23.35 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.032 1.301 . . . . 0.0 113.118 168.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 62.1 t -142.04 138.28 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 125.859 1.663 . . . . 0.0 107.831 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -54.91 134.52 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.3 m-80 69.18 -4.48 1.27 Allowed 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.185 2.194 . . . . 0.0 114.644 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -95.51 137.25 22.03 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 124.598 1.159 . . . . 0.0 110.812 176.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.03 121.77 7.56 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.486 2.124 . . . . 0.0 110.224 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.51 146.51 28.02 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.377 1.471 . . . . 0.0 110.319 175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 73.2 p -138.92 151.2 46.73 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -169.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.09 174.43 13.72 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.0 1.72 . . . . 0.0 111.527 177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.0 m -126.85 143.5 51.25 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.279 1.432 . . . . 0.0 110.769 -172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.4 t -117.12 134.69 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.017 1.727 . . . . 0.0 108.287 169.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.13 133.67 36.07 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.033 0.933 . . . . 0.0 111.811 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -134.8 0.87 2.99 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.433 1.493 . . . . 0.0 113.801 -171.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -54.03 -40.14 66.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.313 1.845 . . . . 0.0 114.804 -167.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -119.92 12.07 11.95 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.708 1.603 . . . . 0.0 112.587 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.99 -35.94 69.61 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 82.37 145.11 5.28 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 124.947 1.261 . . . . 0.0 112.496 -172.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.97 148.26 46.14 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.337 1.055 . . . . 0.0 112.142 -177.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.69 -30.54 0.09 OUTLIER Glycine 0 N--CA 1.474 1.213 0 C-N-CA 124.51 1.052 . . . . 0.0 114.688 176.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 145.18 103.28 0.39 Allowed Glycine 0 N--CA 1.47 0.957 0 C-N-CA 125.435 1.493 . . . . 0.0 112.662 171.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -81.38 131.49 35.29 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.232 1.413 . . . . 0.0 109.256 174.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 9.2 t -135.06 162.99 30.9 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.593 1.557 . . . . 0.0 112.211 -177.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.9 tp -165.63 135.9 3.6 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.554 1.941 . . . . 0.0 109.205 -163.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.88 159.52 35.1 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.417 1.087 . . . . 0.0 111.956 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.5 mt -137.45 135.83 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.523 1.129 . . . . 0.0 109.885 176.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.3 136.23 53.96 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.108 1.363 . . . . 0.0 110.026 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -162.92 -165.02 19.29 Favored Glycine 0 CA--C 1.538 1.506 0 CA-C-O 119.008 -0.885 . . . . 0.0 114.509 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -62.98 -26.56 74.07 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 124.077 3.185 . . . . 0.0 112.514 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.2 t -135.87 156.53 48.64 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.735 1.214 . . . . 0.0 109.464 160.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -72.95 111.13 7.79 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.076 -1.015 . . . . 0.0 110.288 177.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.58 147.0 52.57 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.083 0.953 . . . . 0.0 111.96 178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 33.1 mm-40 -84.94 135.07 34.21 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 170.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 40.5 mt -130.6 144.68 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 124.78 1.232 . . . . 0.0 110.418 -166.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.7 t -145.18 165.02 29.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.824 1.25 . . . . 0.0 111.187 167.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -159.26 154.73 25.75 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.749 1.22 . . . . 0.0 112.528 -177.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.6 m -138.97 125.09 20.06 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.524 1.53 . . . . 0.0 110.285 -172.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.7 t70 -76.11 128.79 35.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.715 1.206 . . . . 0.0 111.12 171.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -104.0 148.48 26.16 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.46 1.504 . . . . 0.0 111.686 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -68.18 -18.26 64.55 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.179 0.992 . . . . 0.0 113.556 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 24.9 t70 -73.02 -22.81 60.59 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.205 1.002 . . . . 0.0 113.695 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 104.52 45.62 1.41 Allowed Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.287 0.946 . . . . 0.0 113.19 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -140.89 158.07 44.47 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.296 1.438 . . . . 0.0 110.005 170.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 85.5 m -107.92 127.36 53.68 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.638 1.175 . . . . 0.0 109.263 162.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.0 t -86.71 147.08 26.02 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.419 0.688 . . . . 0.0 109.955 166.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -127.98 144.2 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 125.67 1.588 . . . . 0.0 109.762 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.2 p -137.08 147.93 46.41 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.873 1.269 . . . . 0.0 111.98 169.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.9 p90 -151.88 154.25 35.78 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 175.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 28.1 mt -118.15 107.69 43.26 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.231 1.812 . . . . 0.0 110.383 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -82.81 176.41 7.74 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.901 3.067 . . . . 0.0 110.333 167.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.2 p -151.45 -28.84 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -174.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 85.9 mt -107.58 147.03 34.54 Favored Pre-proline 0 CA--C 1.543 0.71 0 CA-C-N 119.53 1.059 . . . . 0.0 110.525 167.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -73.91 154.98 48.42 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.863 2.376 . . . . 0.0 110.824 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.89 -165.45 24.59 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -90.96 137.31 32.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.065 1.346 . . . . 0.0 112.506 178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.8 m-85 -125.36 125.87 44.12 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.849 1.66 . . . . 0.0 110.079 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 65.3 m -88.19 122.29 31.58 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.646 1.178 . . . . 0.0 110.643 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.69 123.48 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.437 1.495 . . . . 0.0 108.626 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.5 mp -104.45 136.21 44.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.408 1.483 . . . . 0.0 109.318 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 98.4 t -140.32 127.06 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 125.173 1.389 . . . . 0.0 108.912 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.96 140.8 20.99 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.567 1.147 . . . . 0.0 111.331 -169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.4 121.04 14.28 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.465 1.106 . . . . 0.0 110.155 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 49.8 t30 57.47 57.27 4.46 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.219 1.408 . . . . 0.0 111.581 176.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.0 pt-20 58.51 13.96 2.78 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 128.438 2.695 . . . . 0.0 116.372 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -124.83 125.9 44.73 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.382 1.073 . . . . 0.0 111.329 178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -65.04 157.05 29.48 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 123.942 0.897 . . . . 0.0 112.547 169.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.1 m -75.81 152.65 84.93 Favored Pre-proline 0 N--CA 1.483 1.18 0 CA-C-O 118.562 -0.732 . . . . 0.0 109.392 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -67.3 -13.01 37.97 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 122.08 1.853 . . . . 0.0 114.462 -166.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -100.24 -10.31 45.52 Favored Glycine 0 CA--C 1.532 1.111 0 N-CA-C 115.838 1.095 . . . . 0.0 115.838 174.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.1 p -87.64 153.63 52.95 Favored Pre-proline 0 CA--C 1.551 1.016 0 CA-C-N 119.779 1.789 . . . . 0.0 113.148 -174.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.11 141.09 68.21 Favored 'Cis proline' 0 C--N 1.352 0.732 0 CA-C-N 119.063 0.701 . . . . 0.0 112.107 -3.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -90.26 167.17 12.88 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.094 1.357 . . . . 0.0 110.281 174.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.2 m -128.35 112.15 14.12 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.504 0.722 . . . . 0.0 110.048 176.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.76 150.23 23.71 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.383 1.073 . . . . 0.0 110.574 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -110.68 124.76 52.54 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.246 1.018 . . . . 0.0 109.78 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.4 t -107.5 135.05 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.922 1.289 . . . . 0.0 110.834 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.0 p -113.37 164.93 12.96 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.31 1.444 . . . . 0.0 112.561 175.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.93 143.15 29.58 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.007 1.289 . . . . 0.0 112.183 175.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -84.47 -14.93 47.78 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.429 1.091 . . . . 0.0 113.362 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.253 1.283 0 C-N-CA 126.596 1.958 . . . . 0.0 112.524 -177.45 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.489 0 N-CA-C 111.728 -0.549 . . . . 0.0 111.728 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.25 163.47 28.06 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.462 1.105 . . . . 0.0 112.876 178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.6 ptt? -74.98 -15.23 60.68 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -70.02 151.6 96.07 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 124.881 1.272 . . . . 0.0 112.67 179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.87 160.64 47.28 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.675 2.917 . . . . 0.0 111.78 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -72.8 128.71 36.32 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.025 0.93 . . . . 0.0 111.737 -178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -104.14 137.93 19.37 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 125.606 1.562 . . . . 0.0 110.049 173.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -68.64 151.55 74.89 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.085 2.523 . . . . 0.0 111.598 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 82.4 mt -80.48 50.27 1.27 Allowed 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.294 1.437 . . . . 0.0 112.358 -174.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 9.1 p -169.6 -40.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.124 2.17 . . . . 0.0 111.635 -177.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -79.19 147.49 30.29 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.853 0.74 . . . . 0.0 111.608 170.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 27.2 m -141.54 140.03 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.812 1.245 . . . . 0.0 111.254 -179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -91.24 -10.67 40.73 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.802 1.241 . . . . 0.0 113.119 173.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -83.39 84.82 1.54 Allowed Glycine 0 C--N 1.342 0.902 0 C-N-CA 125.355 1.455 . . . . 0.0 110.812 176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 95.0 mt -129.63 163.18 26.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.282 1.833 . . . . 0.0 110.805 -177.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -155.65 160.91 40.79 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.246 1.418 . . . . 0.0 112.431 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 21.4 m -133.51 14.97 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 125.466 1.506 . . . . 0.0 113.361 -173.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.0 t -75.97 -27.82 57.64 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.159 0.984 . . . . 0.0 113.401 -173.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 30.2 m -79.18 35.24 0.26 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.633 1.573 . . . . 0.0 113.52 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 21.6 tp -73.13 141.57 47.48 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.478 1.511 . . . . 0.0 111.927 -176.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.0 ttm-85 -59.06 120.04 43.61 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 125.931 1.692 . . . . 0.0 111.908 -174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.37 159.26 47.06 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.523 2.816 . . . . 0.0 112.02 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 5.8 t80 -112.16 123.03 49.39 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.777 1.231 . . . . 0.0 110.098 177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.2 134.26 15.92 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.064 1.346 . . . . 0.0 110.514 170.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.9 140.81 31.33 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.686 1.594 . . . . 0.0 109.9 -170.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.1 p -107.67 138.93 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.715 1.206 . . . . 0.0 110.855 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.8 mt -134.08 134.99 23.52 Favored Pre-proline 0 CA--C 1.548 0.878 0 C-N-CA 126.348 1.859 . . . . 0.0 108.812 -173.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.04 109.22 2.78 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.411 2.74 . . . . 0.0 110.1 174.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 48.4 t80 -175.2 151.62 1.31 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.999 2.12 . . . . 0.0 109.821 -173.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 29.1 m -135.06 130.93 36.36 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.615 1.166 . . . . 0.0 110.057 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 60.3 mt -75.98 122.35 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.012 0.925 . . . . 0.0 109.437 171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -111.64 -69.91 0.84 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.45 1.1 . . . . 0.0 112.322 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -158.79 127.14 5.24 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.782 1.633 . . . . 0.0 110.952 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.39 -139.54 11.04 Favored Glycine 0 N--CA 1.472 1.071 0 C-N-CA 125.51 1.528 . . . . 0.0 111.158 -166.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -157.09 142.29 17.19 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.366 1.066 . . . . 0.0 111.385 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.7 tt -121.65 135.49 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.785 1.634 . . . . 0.0 111.032 176.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.4 p -149.28 169.08 21.6 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 126.182 1.793 . . . . 0.0 110.596 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -162.07 -175.6 33.27 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 115.711 1.045 . . . . 0.0 115.711 -177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -153.21 143.35 22.3 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.654 1.582 . . . . 0.0 109.839 177.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.8 t -115.67 132.49 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 125.931 1.692 . . . . 0.0 108.101 171.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -119.03 137.47 53.51 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.547 1.539 . . . . 0.0 110.898 -172.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.8 mtt -110.56 146.67 34.83 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 125.463 1.505 . . . . 0.0 111.591 -169.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -56.63 -28.9 77.24 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.919 3.079 . . . . 0.0 114.944 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.5 p -74.51 0.58 14.31 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.046 1.738 . . . . 0.0 114.37 178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -6.77 83.18 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 125.692 1.615 . . . . 0.0 113.947 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 39.1 mtpt -72.96 159.11 34.21 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.742 1.617 . . . . 0.0 112.182 175.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.4 m -145.72 155.93 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.641 1.576 . . . . 0.0 111.074 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.68 166.5 26.63 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.442 1.497 . . . . 0.0 111.888 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -100.06 137.63 20.13 Favored Pre-proline 0 CA--C 1.547 0.85 0 C-N-CA 124.175 0.99 . . . . 0.0 111.506 -177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -83.69 169.29 12.15 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 124.195 3.263 . . . . 0.0 111.827 171.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 86.9 m -110.24 119.75 40.26 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 125.667 1.587 . . . . 0.0 109.002 175.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.8 mp -96.75 129.93 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.279 1.032 . . . . 0.0 109.026 176.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 35.0 m -125.99 116.13 20.98 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.861 1.664 . . . . 0.0 109.001 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -79.01 124.0 27.84 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 121.616 -0.678 . . . . 0.0 110.045 171.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.09 -10.24 59.75 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -172.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 72.97 -3.37 2.44 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 128.023 2.529 . . . . 0.0 113.864 -177.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -93.86 1.19 56.45 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 126.665 1.986 . . . . 0.0 113.33 177.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.74 14.16 38.21 Favored Glycine 0 CA--C 1.536 1.366 0 C-N-CA 125.102 1.334 . . . . 0.0 114.472 -177.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 76.1 p -128.37 157.12 41.89 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.407 1.883 . . . . 0.0 110.348 175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -113.61 137.9 45.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.513 0.725 . . . . 0.0 109.59 165.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.5 m -102.29 128.88 48.65 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.649 1.179 . . . . 0.0 107.993 168.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.4 t -113.74 128.98 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 124.944 1.298 . . . . 0.0 108.95 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -126.53 154.4 43.88 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 126.231 1.812 . . . . 0.0 111.619 -167.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.4 t80 -158.99 134.98 8.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.76 1.224 . . . . 0.0 112.275 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.91 119.96 70.66 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 124.562 1.145 . . . . 0.0 110.648 175.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -82.36 150.68 15.32 Favored 'Trans proline' 0 CA--C 1.536 0.616 0 C-N-CA 123.526 2.817 . . . . 0.0 111.798 -175.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.4 m -132.2 -8.07 3.4 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -166.98 145.98 5.23 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.583 1.553 . . . . 0.0 110.325 -171.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.56 170.66 16.17 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.4 1.08 . . . . 0.0 113.523 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.84 178.77 17.88 Favored Glycine 0 N--CA 1.474 1.169 0 C-N-CA 125.484 1.516 . . . . 0.0 114.405 176.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 51.6 tp -75.98 103.21 5.94 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.191 1.397 . . . . 0.0 110.426 178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.9 m80 -96.73 159.46 14.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.77 1.228 . . . . 0.0 111.251 178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -144.64 149.87 36.45 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.79 0.836 . . . . 0.0 111.627 178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 25.3 ttm -134.27 135.67 43.03 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.387 1.875 . . . . 0.0 110.645 -163.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -118.26 126.36 52.0 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.904 1.682 . . . . 0.0 109.763 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -127.94 130.13 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 124.818 1.247 . . . . 0.0 109.727 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.83 141.1 33.1 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.4 t80 -103.23 120.3 40.47 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.257 1.823 . . . . 0.0 109.5 173.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.15 32.6 10.8 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 124.766 1.226 . . . . 0.0 112.953 -174.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.6 m-80 75.07 7.32 4.2 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 128.052 2.541 . . . . 0.0 115.195 -178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.4 mtp -99.19 128.03 45.25 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.921 1.288 . . . . 0.0 110.315 166.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -55.41 136.18 49.72 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.32 -0.862 . . . . 0.0 113.03 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.6 pt -73.12 150.63 90.05 Favored Pre-proline 0 N--CA 1.478 0.969 0 CA-C-O 118.803 -0.618 . . . . 0.0 110.883 174.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.39 131.62 39.41 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.532 2.155 . . . . 0.0 110.398 178.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.43 -15.36 63.43 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.764 1.173 . . . . 0.0 114.51 -172.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.33 150.24 44.35 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-N 119.59 1.695 . . . . 0.0 110.922 172.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.98 164.34 88.1 Favored 'Cis proline' 0 C--N 1.353 0.791 0 CA-C-N 120.715 1.291 . . . . 0.0 113.317 -1.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 97.7 mt -120.71 161.32 21.62 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.937 1.695 . . . . 0.0 111.322 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -157.86 148.99 21.24 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.391 1.077 . . . . 0.0 112.125 175.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -168.28 157.8 9.49 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.302 1.441 . . . . 0.0 111.885 -169.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.4 t80 -95.04 128.69 42.06 Favored 'General case' 0 CA--C 1.543 0.708 0 O-C-N 121.056 -1.028 . . . . 0.0 112.685 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.4 t -93.13 135.13 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.501 1.52 . . . . 0.0 108.777 172.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.1 t0 -157.79 148.12 20.63 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.324 1.05 . . . . 0.0 112.717 -173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -70.34 144.47 51.65 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.105 1.362 . . . . 0.0 113.295 -175.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 9.8 p -76.21 -28.05 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.208 1.003 . . . . 0.0 113.59 -175.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -85.05 -19.48 31.87 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -170.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 73.1 m -67.27 149.16 50.76 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.325 1.05 . . . . 0.0 113.401 -173.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.53 -13.52 63.08 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.826 1.203 . . . . 0.0 114.831 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -64.23 153.39 38.2 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 118.713 1.257 . . . . 0.0 113.296 177.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.9 p -64.79 135.72 27.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 123.727 0.811 . . . . 0.0 110.001 171.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 9.6 t -154.64 157.27 37.91 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.729 1.212 . . . . 0.0 110.836 -175.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.1 145.59 39.67 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.495 1.118 . . . . 0.0 111.975 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.5 p90 -165.91 165.16 18.35 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.91 1.684 . . . . 0.0 112.236 -174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 128.84 175.28 14.0 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.178 1.371 . . . . 0.0 113.123 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.24 -34.29 10.17 Favored 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.704 2.269 . . . . 0.0 113.057 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.65 -34.25 86.91 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-N 119.578 1.081 . . . . 0.0 114.444 -171.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.2 pp -77.95 -4.67 48.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.797 1.299 . . . . 0.0 113.41 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.5 m -106.07 -47.74 3.77 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.446 1.898 . . . . 0.0 110.989 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -143.66 149.14 36.83 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.46 1.904 . . . . 0.0 112.341 -175.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -145.43 178.27 23.29 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.451 1.024 . . . . 0.0 113.721 172.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 50.3 t -139.25 135.53 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.864 1.266 . . . . 0.0 108.451 174.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.6 m -57.26 136.41 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.29 -0.72 2.07 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 127.168 2.187 . . . . 0.0 114.442 178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -104.17 140.47 21.1 Favored Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 125.408 1.483 . . . . 0.0 110.881 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.54 120.19 6.57 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.613 2.209 . . . . 0.0 110.326 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.74 135.23 42.51 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.251 1.42 . . . . 0.0 110.155 175.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.6 p -129.41 147.24 51.21 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -165.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -158.46 175.8 13.23 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.628 1.571 . . . . 0.0 111.636 176.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 34.3 m -130.33 142.82 50.51 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.995 1.318 . . . . 0.0 110.839 -169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -113.04 132.82 60.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 125.862 1.665 . . . . 0.0 108.135 168.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.73 129.86 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.214 1.006 . . . . 0.0 110.393 173.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.7 p -132.92 2.29 3.65 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.42 1.488 . . . . 0.0 113.859 -166.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -50.22 -38.16 38.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.484 1.913 . . . . 0.0 115.346 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -128.88 20.47 5.96 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.439 1.496 . . . . 0.0 112.387 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -29.58 64.84 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.16 146.7 7.63 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 125.171 1.367 . . . . 0.0 113.039 -176.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -75.88 148.06 38.58 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.423 1.089 . . . . 0.0 111.968 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 168.24 -30.1 0.17 Allowed Glycine 0 N--CA 1.474 1.225 0 C-N-CA 124.692 1.139 . . . . 0.0 114.531 176.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.41 112.66 0.87 Allowed Glycine 0 N--CA 1.471 1.032 0 C-N-CA 125.511 1.529 . . . . 0.0 112.82 171.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.08 128.9 34.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.369 1.468 . . . . 0.0 109.209 174.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 37.2 m -126.95 156.04 42.15 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.996 1.718 . . . . 0.0 111.781 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.8 134.94 8.08 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.656 1.582 . . . . 0.0 109.103 -169.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.14 35.78 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.015 0.926 . . . . 0.0 112.275 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.1 mt -138.24 139.31 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.874 1.27 . . . . 0.0 109.934 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -132.86 129.47 38.47 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.294 1.438 . . . . 0.0 110.095 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.52 -159.77 9.54 Favored Glycine 0 CA--C 1.538 1.528 0 CA-C-O 118.83 -0.984 . . . . 0.0 114.342 -175.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.41 -23.08 71.56 Favored 'Trans proline' 0 C--N 1.353 0.81 0 C-N-CA 124.101 3.201 . . . . 0.0 112.757 175.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.9 t -146.29 161.34 40.51 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.266 1.426 . . . . 0.0 109.542 163.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -70.74 113.63 8.02 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.002 -1.061 . . . . 0.0 111.078 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.15 147.9 49.33 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.73 0.812 . . . . 0.0 111.389 170.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.44 139.16 30.8 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.297 0.639 . . . . 0.0 109.532 168.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 28.7 mt -130.98 138.55 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.565 1.146 . . . . 0.0 110.325 -167.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.5 m -129.79 152.65 49.05 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.737 1.615 . . . . 0.0 110.473 168.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -151.88 151.39 31.21 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.079 0.951 . . . . 0.0 112.332 176.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.5 m -140.9 116.44 10.17 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.205 1.402 . . . . 0.0 110.114 -169.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -72.26 135.63 46.07 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.161 0.985 . . . . 0.0 111.04 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -112.34 150.65 30.75 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.476 1.51 . . . . 0.0 111.863 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -72.75 -12.01 60.84 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -86.68 1.28 52.56 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.209 1.403 . . . . 0.0 114.553 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.53 30.9 8.68 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.523 1.059 . . . . 0.0 114.218 -179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 40.7 p -133.76 170.92 14.87 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.854 1.262 . . . . 0.0 111.703 174.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 53.5 t -130.57 130.85 44.58 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.496 1.919 . . . . 0.0 108.724 165.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.0 t -94.1 147.78 22.82 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.284 1.034 . . . . 0.0 110.935 175.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.8 t -126.97 143.57 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 125.81 1.644 . . . . 0.0 109.981 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -139.89 139.19 36.18 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.515 1.526 . . . . 0.0 110.603 170.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.6 p90 -144.91 151.74 39.15 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.7 mt -113.8 101.99 54.37 Favored Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 126.033 1.733 . . . . 0.0 110.288 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -79.46 164.8 23.61 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.442 2.762 . . . . 0.0 110.058 166.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 29.6 m -136.41 -22.53 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 115.453 1.649 . . . . 0.0 115.453 -173.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 92.1 mt -117.98 147.86 42.21 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 125.033 1.333 . . . . 0.0 110.234 170.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.96 155.39 53.0 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.656 2.238 . . . . 0.0 110.759 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.97 -165.65 23.41 Favored Glycine 0 N--CA 1.471 0.993 0 C-N-CA 124.684 1.135 . . . . 0.0 113.295 -175.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -91.6 137.59 32.25 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.806 1.242 . . . . 0.0 112.973 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -126.74 124.8 40.59 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 125.797 1.639 . . . . 0.0 109.93 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -84.18 129.43 34.89 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.994 -1.066 . . . . 0.0 110.714 174.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.92 130.47 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.625 1.57 . . . . 0.0 108.127 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.8 tt -111.66 132.19 54.77 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.438 1.495 . . . . 0.0 109.613 174.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -134.46 128.12 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.259 1.023 . . . . 0.0 109.801 172.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.5 141.09 23.44 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.487 1.515 . . . . 0.0 111.433 -169.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -140.09 121.75 15.31 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.43 1.092 . . . . 0.0 110.062 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.8 57.76 3.53 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.322 1.449 . . . . 0.0 111.496 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.1 pt-20 56.34 19.92 4.33 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 128.305 2.642 . . . . 0.0 116.172 -178.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.48 128.65 37.87 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.719 1.207 . . . . 0.0 110.989 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -63.32 150.85 42.34 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.741 0.816 . . . . 0.0 112.237 173.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 7.9 m -67.12 154.19 93.13 Favored Pre-proline 0 N--CA 1.481 1.103 0 CA-C-O 118.016 -0.992 . . . . 0.0 110.039 167.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 92.0 Cg_exo -52.68 -31.69 51.54 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.984 3.123 . . . . 0.0 116.29 -170.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.36 -4.6 59.53 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 115.734 1.054 . . . . 0.0 115.734 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -84.33 143.29 41.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.153 1.477 . . . . 0.0 112.33 -176.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.0 Cg_endo -74.75 140.98 70.34 Favored 'Cis proline' 0 C--N 1.352 0.719 0 CA-C-N 119.106 0.717 . . . . 0.0 112.169 -4.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -93.35 172.86 8.02 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.193 1.797 . . . . 0.0 110.491 173.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.7 m -136.7 119.04 15.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.712 0.805 . . . . 0.0 110.567 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -90.91 158.57 16.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.214 1.406 . . . . 0.0 111.082 169.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 41.0 ttt85 -120.84 127.88 52.32 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.198 0.999 . . . . 0.0 110.287 169.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.8 t -107.17 132.74 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.528 1.531 . . . . 0.0 110.759 -172.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 56.7 m -101.21 155.32 18.09 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.311 1.844 . . . . 0.0 111.612 -176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.55 138.35 23.05 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.709 1.147 . . . . 0.0 112.119 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 -82.65 -18.43 41.1 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 125.565 1.546 . . . . 0.0 113.773 178.82 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.361 -0.695 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -63.39 -19.04 64.33 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 115.072 1.508 . . . . 0.0 115.072 -173.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -82.9 -13.37 56.22 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 124.796 1.238 . . . . 0.0 113.797 177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -69.87 -48.58 21.72 Favored Pre-proline 0 CA--C 1.551 1.013 0 CA-C-O 117.218 -1.373 . . . . 0.0 114.602 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -74.86 154.64 43.35 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 122.525 2.15 . . . . 0.0 111.829 177.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.03 150.2 25.05 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.421 1.088 . . . . 0.0 111.539 175.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 67.6 ttt-85 -156.89 135.88 7.94 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.933 1.293 . . . . 0.0 111.375 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -77.02 175.84 10.88 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.951 3.101 . . . . 0.0 112.069 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -73.73 10.79 1.0 Allowed 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.791 1.636 . . . . 0.0 115.372 -179.304 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 83.3 t -60.79 139.18 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.811 1.645 . . . . 0.0 110.732 -178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 112.69 -5.73 26.08 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 124.969 1.271 . . . . 0.0 114.884 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 16.3 m -61.68 142.64 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 CA-C-N 118.647 1.224 . . . . 0.0 111.508 170.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 30.9 m120 -77.01 150.4 35.82 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.146 0.978 . . . . 0.0 113.257 -173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 76.39 -174.41 53.62 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 124.979 1.276 . . . . 0.0 114.257 175.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.1 mt -121.36 147.81 45.2 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.88 1.672 . . . . 0.0 110.393 174.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 41.0 t0 -81.4 158.36 24.66 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 124.178 0.991 . . . . 0.0 112.368 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 16.0 m -144.04 144.85 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 126.244 1.818 . . . . 0.0 110.507 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 12.9 t -177.57 -33.0 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 126.769 2.027 . . . . 0.0 111.96 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 15.3 m -58.77 142.99 48.56 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.968 1.307 . . . . 0.0 114.196 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 1.7 mt -161.04 166.41 28.22 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.161 2.184 . . . . 0.0 109.159 -178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -59.86 116.63 17.83 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.446 172.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.31 154.81 32.36 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.736 2.291 . . . . 0.0 111.025 178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.3 t80 -100.9 128.97 46.7 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.236 0.541 . . . . 0.0 110.411 172.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -156.25 148.28 23.18 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.819 1.648 . . . . 0.0 110.836 178.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -162.09 152.89 17.57 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.126 1.37 . . . . 0.0 110.632 -174.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.3 p -125.8 133.15 69.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.201 1.4 . . . . 0.0 109.483 169.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 73.7 mt -132.15 135.33 26.31 Favored Pre-proline 0 N--CA 1.475 0.816 0 C-N-CA 125.901 1.68 . . . . 0.0 109.163 -167.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.57 112.74 3.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.995 2.463 . . . . 0.0 109.868 176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.0 t80 -177.2 150.28 0.72 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.175 2.19 . . . . 0.0 109.435 -171.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 32.4 m -132.1 128.72 38.76 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.381 1.072 . . . . 0.0 109.77 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 47.9 mt -74.23 118.33 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.811 0.844 . . . . 0.0 109.834 173.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 63.0 pttt -90.95 -146.13 0.19 Allowed 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 125.772 1.629 . . . . 0.0 112.393 173.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -72.84 -12.62 61.05 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.09 -149.04 19.67 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 125.86 1.695 . . . . 0.0 113.032 178.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.94 156.17 44.84 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.668 1.587 . . . . 0.0 111.345 -177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.2 tt -127.52 138.28 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.608 1.563 . . . . 0.0 111.381 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.7 p -149.19 163.73 36.79 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.114 1.766 . . . . 0.0 110.76 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -143.56 -174.43 15.83 Favored Glycine 0 N--CA 1.469 0.873 0 N-CA-C 115.582 0.993 . . . . 0.0 115.582 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -154.72 136.87 14.76 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 126.256 1.823 . . . . 0.0 108.915 173.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.0 t -110.01 134.19 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 125.748 1.619 . . . . 0.0 107.94 175.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -118.61 130.68 56.01 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.187 0.995 . . . . 0.0 111.207 -177.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -96.52 152.23 38.49 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 126.069 1.748 . . . . 0.0 111.665 -174.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.31 -21.89 26.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.378 2.719 . . . . 0.0 113.014 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.5 p -80.51 2.18 26.42 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.712 1.605 . . . . 0.0 114.5 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 87.36 54.15 2.62 Favored Glycine 0 N--CA 1.471 1.018 0 C-N-CA 124.515 1.055 . . . . 0.0 113.233 173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -156.4 166.97 31.89 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 126.052 1.741 . . . . 0.0 111.681 -176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.6 159.25 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.587 1.155 . . . . 0.0 113.068 -172.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.04 -178.65 7.53 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 127.802 2.441 . . . . 0.0 109.757 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -126.55 145.5 53.35 Favored Pre-proline 0 CA--C 1.546 0.82 0 O-C-N 120.612 -1.305 . . . . 0.0 112.562 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -86.64 173.4 6.28 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.551 3.501 . . . . 0.0 111.696 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.0 m -108.75 136.18 48.75 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.524 1.53 . . . . 0.0 108.835 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -120.08 134.44 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 125.092 1.357 . . . . 0.0 109.187 174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.4 m -136.11 121.83 19.74 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.539 1.535 . . . . 0.0 109.743 178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.14 128.0 33.64 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.601 0.76 . . . . 0.0 110.617 172.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -82.63 -7.56 59.64 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -174.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 39.5 tttm 74.36 -5.24 2.13 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.437 2.695 . . . . 0.0 113.723 -178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.8 t70 -94.57 1.41 55.64 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.944 2.098 . . . . 0.0 113.329 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 98.2 16.37 32.77 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 125.108 1.337 . . . . 0.0 114.379 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.9 p -129.08 155.27 45.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.041 1.737 . . . . 0.0 110.608 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -113.6 135.95 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.98 0.912 . . . . 0.0 109.979 165.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.5 m -92.06 138.08 31.83 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.812 1.245 . . . . 0.0 108.445 168.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.6 t -127.34 136.03 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.201 1.4 . . . . 0.0 109.026 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -141.58 155.02 45.78 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.811 1.244 . . . . 0.0 112.692 -174.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 31.6 t80 -154.41 133.17 12.22 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.522 1.529 . . . . 0.0 111.702 174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -81.88 127.55 71.84 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.408 1.083 . . . . 0.0 111.214 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -80.09 175.03 10.79 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.835 3.024 . . . . 0.0 112.231 -173.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 19.0 t -162.89 -38.09 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.16 0.984 . . . . 0.0 113.227 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -135.0 150.78 50.39 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.828 1.651 . . . . 0.0 110.331 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -85.64 172.28 11.01 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.495 1.118 . . . . 0.0 113.524 179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.99 -170.49 13.34 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 126.121 1.819 . . . . 0.0 113.72 178.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.4 tp -81.32 131.02 35.27 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.585 1.154 . . . . 0.0 110.43 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 59.5 m80 -128.69 163.5 24.97 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.065 1.746 . . . . 0.0 111.101 -174.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -142.43 157.54 44.66 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.162 0.985 . . . . 0.0 111.266 174.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 67.0 ttp -141.16 123.87 16.08 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.388 1.075 . . . . 0.0 111.845 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -85.91 139.75 30.96 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.335 1.854 . . . . 0.0 110.373 169.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -139.17 128.98 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.295 1.438 . . . . 0.0 108.199 172.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.65 138.05 30.4 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -176.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -104.03 123.91 48.08 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.914 2.086 . . . . 0.0 110.336 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.91 34.34 13.38 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 124.47 1.108 . . . . 0.0 112.586 -175.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 36.2 t30 78.66 2.3 2.56 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 128.519 2.727 . . . . 0.0 114.942 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.7 mtm -106.5 129.81 54.39 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.723 1.609 . . . . 0.0 111.035 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -54.06 139.09 35.91 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.2 pt -68.85 147.43 97.86 Favored Pre-proline 0 N--CA 1.48 1.032 0 CA-C-O 118.769 -0.634 . . . . 0.0 109.925 169.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -63.62 120.25 7.59 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.532 2.155 . . . . 0.0 111.722 -165.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -8.96 72.37 Favored Glycine 0 CA--C 1.535 1.283 0 C-N-CA 125.338 1.447 . . . . 0.0 115.157 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 12.8 m -74.58 157.79 85.71 Favored Pre-proline 0 CA--C 1.55 0.97 0 CA-C-N 120.047 1.923 . . . . 0.0 112.359 170.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -71.87 161.48 91.45 Favored 'Cis proline' 0 C--N 1.355 0.881 0 CA-C-N 119.844 0.98 . . . . 0.0 113.999 5.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.1 mt -97.47 162.11 13.47 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.885 1.674 . . . . 0.0 110.905 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -142.3 138.98 31.71 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.729 1.211 . . . . 0.0 110.503 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.0 p90 -160.47 167.74 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.751 1.221 . . . . 0.0 112.146 -174.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 18.5 t80 -110.29 141.57 43.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.996 0.918 . . . . 0.0 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.4 t -112.04 138.08 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.946 1.698 . . . . 0.0 108.469 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.3 t0 -156.4 151.62 26.51 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.291 0.848 . . . . 0.0 113.291 -172.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -75.61 95.89 3.45 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.283 1.433 . . . . 0.0 111.522 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 16.3 m -58.47 -23.1 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.293 1.437 . . . . 0.0 114.447 -173.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 32.5 m120 -86.69 -13.68 44.74 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 97.9 m -75.92 156.67 34.02 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.211 1.004 . . . . 0.0 113.25 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.19 77.82 2.06 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.227 1.394 . . . . 0.0 112.35 -176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 27.8 p-80 -163.9 154.71 15.74 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 126.099 1.759 . . . . 0.0 112.356 173.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.7 p -73.35 135.3 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 124.283 1.033 . . . . 0.0 110.434 174.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 5.9 t -152.78 171.37 18.34 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.572 1.149 . . . . 0.0 111.682 -173.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -153.68 150.39 28.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.531 1.133 . . . . 0.0 112.514 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 3.0 p90 -171.68 164.81 6.69 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.052 1.741 . . . . 0.0 112.93 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.55 173.16 12.8 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.34 1.448 . . . . 0.0 113.167 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -68.55 -34.75 18.99 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 123.082 2.521 . . . . 0.0 112.762 -172.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.18 -33.5 85.42 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-N 118.895 0.77 . . . . 0.0 114.373 -172.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.2 pp -81.22 0.13 38.03 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 118.744 1.272 . . . . 0.0 113.878 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.7 m -107.04 -38.85 5.91 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.414 1.886 . . . . 0.0 111.536 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -157.76 146.58 19.43 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.127 1.371 . . . . 0.0 112.993 -169.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 -173.89 21.18 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 125.874 1.702 . . . . 0.0 112.852 172.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.7 p -150.89 138.61 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 124.981 1.312 . . . . 0.0 109.245 177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.9 m -57.64 141.36 14.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.274 0.842 . . . . 0.0 113.274 -170.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 27.5 m120 69.53 -5.29 1.19 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 127.131 2.173 . . . . 0.0 114.728 175.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -102.18 144.29 28.3 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 125.338 1.455 . . . . 0.0 111.045 171.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -73.24 130.56 15.37 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.566 2.178 . . . . 0.0 110.625 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.91 147.05 32.78 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.571 1.548 . . . . 0.0 110.437 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.7 p -136.84 147.3 46.46 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -165.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -160.03 176.05 12.28 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.291 1.836 . . . . 0.0 110.936 175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 82.8 m -134.01 136.75 44.28 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.152 0.981 . . . . 0.0 111.097 -170.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 20.5 t -98.08 132.22 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 125.576 1.55 . . . . 0.0 107.752 167.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -98.66 116.74 31.56 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 109.753 173.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -121.3 8.69 10.28 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.685 1.994 . . . . 0.0 113.007 -166.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 87.5 tttt -52.75 -38.35 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.73 1.612 . . . . 0.0 113.786 -175.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -92.39 -12.47 32.15 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.109 1.364 . . . . 0.0 113.637 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.33 -39.23 68.32 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.168 0.987 . . . . 0.0 112.975 -172.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 76.76 -76.26 1.59 Allowed Glycine 0 CA--C 1.531 1.08 0 C-N-CA 125.229 1.395 . . . . 0.0 113.848 171.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -163.46 150.15 12.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 126.395 1.878 . . . . 0.0 110.078 -171.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 133.39 -2.48 4.61 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.965 1.269 . . . . 0.0 115.085 -177.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 99.81 117.66 4.04 Favored Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.73 1.634 . . . . 0.0 113.48 169.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -79.22 129.22 34.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.809 1.644 . . . . 0.0 109.247 168.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -121.4 153.05 38.33 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 125.411 1.485 . . . . 0.0 111.575 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.9 tp -159.83 134.8 7.96 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.356 1.462 . . . . 0.0 109.464 -170.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.29 161.3 37.68 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.338 1.055 . . . . 0.0 112.08 177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.6 mt -137.4 132.81 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 124.622 1.169 . . . . 0.0 109.433 174.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -121.72 112.66 18.67 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.238 1.415 . . . . 0.0 109.684 175.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -126.42 -170.26 12.92 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.148 1.356 . . . . 0.0 113.441 178.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -66.23 -22.12 54.03 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.936 . . . . 0.0 111.998 171.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.4 t -135.29 157.86 45.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.237 1.415 . . . . 0.0 109.132 157.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -75.62 119.28 19.45 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.914 -1.116 . . . . 0.0 111.38 -178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.07 148.79 43.7 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.232 1.013 . . . . 0.0 111.7 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -83.67 139.91 32.49 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.235 0.614 . . . . 0.0 109.587 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 39.9 mt -133.35 143.35 39.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.443 1.097 . . . . 0.0 110.362 -168.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.0 t -143.43 160.78 39.94 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.031 1.332 . . . . 0.0 110.846 167.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -157.42 155.28 30.21 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.334 1.054 . . . . 0.0 112.979 -177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -138.65 117.01 11.95 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.6 1.56 . . . . 0.0 110.198 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -74.83 136.37 41.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.077 1.351 . . . . 0.0 111.471 172.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.0 m-20 -117.47 146.83 43.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.539 1.536 . . . . 0.0 112.016 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -68.16 -13.22 62.06 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.09 -5.1 45.01 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.652 1.581 . . . . 0.0 113.982 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.32 30.11 8.97 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 124.754 1.169 . . . . 0.0 113.858 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.2 p -137.44 165.0 27.3 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.299 1.44 . . . . 0.0 111.484 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 48.7 t -127.68 122.57 33.32 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.663 1.585 . . . . 0.0 108.796 164.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.3 t -87.51 145.87 26.05 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.959 0.903 . . . . 0.0 110.592 176.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.4 t -125.85 141.23 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.578 1.551 . . . . 0.0 110.321 -176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 67.3 m -130.96 140.71 50.19 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.884 1.673 . . . . 0.0 110.632 170.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.7 p90 -146.24 151.73 38.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 174.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 13.1 mt -120.72 105.62 40.68 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.686 1.994 . . . . 0.0 110.494 -178.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -86.62 160.3 9.3 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 124.043 3.162 . . . . 0.0 110.7 169.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -119.98 -21.82 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 114.981 1.475 . . . . 0.0 114.981 -169.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -146.52 149.32 36.83 Favored Pre-proline 0 CA--C 1.546 0.809 0 C-N-CA 124.857 1.263 . . . . 0.0 110.587 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.97 153.64 37.42 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 122.88 2.387 . . . . 0.0 112.432 -168.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.67 -167.72 27.55 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 125.095 1.331 . . . . 0.0 113.393 -176.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -91.08 128.56 36.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.013 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -118.77 127.35 53.46 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.678 1.591 . . . . 0.0 109.805 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.11 121.31 30.37 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.86 0.864 . . . . 0.0 110.448 177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.27 127.21 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.19 1.396 . . . . 0.0 108.111 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.91 130.37 55.54 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.278 1.431 . . . . 0.0 109.5 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.1 t -132.99 129.8 57.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.276 1.03 . . . . 0.0 109.457 172.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -151.92 147.51 26.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.665 1.186 . . . . 0.0 111.418 -166.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 2.2 t80 -140.9 126.14 18.55 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.794 1.238 . . . . 0.0 110.279 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.1 t-20 45.07 58.9 3.76 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.117 1.367 . . . . 0.0 113.245 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.311 7.9 pt-20 60.02 13.8 3.97 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 128.107 2.563 . . . . 0.0 116.596 -177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -125.65 128.46 47.88 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.48 1.112 . . . . 0.0 111.352 177.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.84 151.55 45.19 Favored 'General case' 0 CA--C 1.549 0.922 0 O-C-N 121.055 -1.028 . . . . 0.0 112.716 175.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 29.1 m -65.48 152.05 93.12 Favored Pre-proline 0 N--CA 1.485 1.29 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.65 163.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -64.37 -20.04 66.03 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.476 2.117 . . . . 0.0 114.84 -167.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -94.46 -6.58 61.05 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -86.64 143.83 36.49 Favored Pre-proline 0 CA--C 1.547 0.851 0 CA-C-N 119.049 1.424 . . . . 0.0 112.33 -176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -74.74 141.29 71.33 Favored 'Cis proline' 0 C--N 1.354 0.819 0 CA-C-N 119.117 0.72 . . . . 0.0 112.064 -4.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -92.68 166.8 12.29 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.966 1.706 . . . . 0.0 110.041 172.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 30.7 m -131.75 119.71 21.68 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.536 0.734 . . . . 0.0 110.517 177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -103.16 137.53 41.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.949 1.3 . . . . 0.0 111.737 176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -86.05 117.29 24.8 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.953 0.501 . . . . 0.0 110.058 168.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.5 t -92.42 130.22 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.101 0.96 . . . . 0.0 109.207 169.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.1 m -105.13 159.92 15.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.756 1.623 . . . . 0.0 110.644 -173.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.9 138.22 23.38 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 124.119 0.866 . . . . 0.0 111.969 172.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -89.39 -18.65 26.42 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.221 1.408 . . . . 0.0 113.584 -174.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.254 1.324 0 C-N-CA 126.61 1.964 . . . . 0.0 112.703 -175.657 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.541 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.16 155.68 39.39 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.268 1.027 . . . . 0.0 112.758 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.7 mmm -85.43 -12.38 52.13 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.505 1.122 . . . . 0.0 113.913 -178.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -68.89 144.72 96.13 Favored Pre-proline 0 CA--C 1.552 1.019 0 C-N-CA 124.345 1.058 . . . . 0.0 112.637 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.29 163.13 32.95 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.76 2.973 . . . . 0.0 111.96 178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -156.65 144.4 19.28 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.423 1.489 . . . . 0.0 110.139 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -135.72 145.27 52.38 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.502 1.521 . . . . 0.0 110.235 175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -76.24 146.0 27.93 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.354 2.703 . . . . 0.0 111.639 -176.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 29.0 tp -83.0 65.46 8.14 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.792 1.237 . . . . 0.0 110.974 -176.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 7.2 p -160.26 148.86 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.632 1.573 . . . . 0.0 111.138 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -144.7 -174.36 16.89 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.495 1.521 . . . . 0.0 113.32 176.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 99.7 t -62.23 134.69 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 124.505 1.122 . . . . 0.0 110.365 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 8.7 p30 -156.81 162.38 39.72 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.104 1.362 . . . . 0.0 112.551 -174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -172.75 -174.72 40.15 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.981 1.277 . . . . 0.0 113.835 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.5 mt -74.96 150.44 39.04 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.643 1.177 . . . . 0.0 111.998 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 34.0 t70 -74.01 -24.94 59.65 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.356 1.062 . . . . 0.0 112.895 177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.1 p -159.46 145.48 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 126.989 2.116 . . . . 0.0 109.407 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 12.3 t -169.2 -34.63 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.994 1.718 . . . . 0.0 111.902 -175.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 31.6 m -64.53 103.9 0.73 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.568 1.147 . . . . 0.0 111.841 175.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 30.0 tp -112.86 128.53 56.48 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.617 1.567 . . . . 0.0 109.745 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 46.6 ttp85 -60.27 118.27 31.84 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-O 118.196 -0.907 . . . . 0.0 111.119 -173.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -73.42 159.5 46.43 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.277 2.651 . . . . 0.0 111.318 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.1 t80 -93.01 123.23 36.11 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.429 0.692 . . . . 0.0 109.225 172.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.17 130.46 16.57 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.331 1.453 . . . . 0.0 109.956 169.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -146.39 141.53 27.28 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.266 1.426 . . . . 0.0 109.931 -172.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -118.79 137.76 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 125.474 1.51 . . . . 0.0 110.627 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 4.9 mp -135.96 137.49 25.3 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.331 1.853 . . . . 0.0 108.738 -175.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.48 37.99 0.68 Allowed 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.386 3.39 . . . . 0.0 113.526 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 86.1 t80 -87.38 161.32 17.96 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.54 1.536 . . . . 0.0 110.499 169.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 87.6 m -133.42 130.2 38.36 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.019 1.327 . . . . 0.0 109.688 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 72.2 mt -86.58 115.81 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.362 1.065 . . . . 0.0 110.304 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -92.94 -163.27 1.02 Allowed 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 125.943 1.697 . . . . 0.0 112.218 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.0 pttp -71.91 132.52 44.47 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 120.806 -1.184 . . . . 0.0 112.052 169.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.53 -141.7 12.29 Favored Glycine 0 N--CA 1.473 1.139 0 C-N-CA 125.319 1.438 . . . . 0.0 111.631 -167.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -157.31 143.74 18.0 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.149 0.98 . . . . 0.0 111.853 -175.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.6 tt -134.68 136.48 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 126.292 1.837 . . . . 0.0 110.367 177.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 33.4 p -145.6 165.27 29.17 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.603 1.561 . . . . 0.0 110.849 -175.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.65 176.46 29.22 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -151.94 138.17 18.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.128 1.771 . . . . 0.0 109.644 174.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 46.2 t -111.79 134.46 54.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 126.241 1.816 . . . . 0.0 108.651 175.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 37.2 mtp180 -113.7 123.16 49.23 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.862 1.665 . . . . 0.0 110.209 -174.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 31.8 mtm -98.05 146.64 31.84 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.703 1.601 . . . . 0.0 111.466 -176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.28 -16.21 28.13 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 123.799 2.999 . . . . 0.0 113.144 -177.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.7 p -74.42 0.28 15.06 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.806 1.642 . . . . 0.0 114.197 173.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.39 42.38 5.53 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.722 1.153 . . . . 0.0 113.538 173.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -152.66 169.26 23.14 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.392 1.477 . . . . 0.0 112.525 -174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 29.0 m -139.22 159.25 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.899 1.28 . . . . 0.0 112.848 -172.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.8 171.26 19.9 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.078 2.151 . . . . 0.0 110.257 175.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -110.55 142.36 25.92 Favored Pre-proline 0 CA--C 1.547 0.831 0 O-C-N 121.103 -0.998 . . . . 0.0 112.344 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -88.22 175.87 3.91 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.57 3.513 . . . . 0.0 112.385 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.1 m -108.02 130.24 55.08 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.444 1.498 . . . . 0.0 108.963 171.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -112.84 131.72 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.149 1.379 . . . . 0.0 108.676 175.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.4 m -132.94 130.36 39.49 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.373 1.469 . . . . 0.0 110.05 -179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.2 t70 -82.45 126.46 32.25 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.164 0.586 . . . . 0.0 110.106 167.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -80.59 -7.6 59.31 Favored 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.2 mttp 71.77 7.4 5.9 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.592 2.357 . . . . 0.0 113.606 176.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -110.07 7.59 23.62 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 127.345 2.258 . . . . 0.0 112.597 178.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.45 19.35 35.55 Favored Glycine 0 CA--C 1.537 1.448 0 C-N-CA 124.974 1.274 . . . . 0.0 114.317 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.8 p -134.23 158.19 44.34 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.105 1.762 . . . . 0.0 110.267 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 27.2 m -116.13 148.1 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.568 1.147 . . . . 0.0 110.13 167.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 50.6 m -113.99 136.48 52.86 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.753 1.221 . . . . 0.0 108.496 167.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 41.7 t -119.91 134.8 62.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 125.202 1.401 . . . . 0.0 108.925 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.21 154.96 50.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.896 1.279 . . . . 0.0 113.16 -174.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.5 t80 -153.77 136.89 15.57 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.565 1.546 . . . . 0.0 111.927 176.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.2 117.26 67.9 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 125.023 1.329 . . . . 0.0 110.804 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -82.36 156.02 16.69 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.96 3.106 . . . . 0.0 112.656 -172.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 55.4 m -118.29 -18.39 9.27 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 177.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -163.66 155.12 16.73 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.665 1.586 . . . . 0.0 110.572 -178.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -69.07 168.49 13.78 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.576 1.15 . . . . 0.0 113.531 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.06 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.137 0 C-N-CA 125.598 1.571 . . . . 0.0 114.138 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 48.5 tp -79.09 129.61 34.64 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.744 1.218 . . . . 0.0 110.677 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.8 m80 -130.27 162.0 29.96 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.587 1.555 . . . . 0.0 111.373 -175.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -148.71 156.15 41.98 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.927 0.891 . . . . 0.0 111.786 172.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -138.92 126.85 22.31 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.112 1.765 . . . . 0.0 109.956 -168.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -102.46 122.4 44.24 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.335 1.454 . . . . 0.0 109.389 175.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 42.8 mm -120.89 135.02 62.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 125.129 1.372 . . . . 0.0 109.805 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.78 137.72 20.29 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.6 t80 -99.3 123.27 43.45 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.823 2.049 . . . . 0.0 109.857 175.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.15 33.42 9.35 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.785 1.234 . . . . 0.0 112.729 -174.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 22.6 t30 75.77 5.94 3.89 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 128.123 2.569 . . . . 0.0 115.109 -178.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.36 131.62 51.5 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.806 1.643 . . . . 0.0 110.884 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m170 -56.8 134.09 54.83 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.057 -1.027 . . . . 0.0 113.213 -178.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.8 pt -73.33 155.86 89.49 Favored Pre-proline 0 N--CA 1.479 1.014 0 CA-C-O 118.691 -0.671 . . . . 0.0 111.402 174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.85 125.87 19.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.367 2.045 . . . . 0.0 109.761 172.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 102.1 -17.69 53.54 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.725 1.155 . . . . 0.0 114.344 -172.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.7 t -84.6 148.06 50.89 Favored Pre-proline 0 CA--C 1.547 0.862 0 CA-C-N 119.054 1.427 . . . . 0.0 111.919 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -77.38 159.99 94.35 Favored 'Cis proline' 0 C--N 1.352 0.72 0 CA-C-N 119.936 1.013 . . . . 0.0 112.062 -7.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 94.6 mt -100.36 152.19 20.62 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.401 1.48 . . . . 0.0 110.523 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -151.43 134.41 15.81 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.469 1.108 . . . . 0.0 110.259 -174.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.91 165.05 18.43 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.373 1.069 . . . . 0.0 112.504 -171.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 44.2 t80 -103.19 139.76 38.24 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.168 0.987 . . . . 0.0 112.154 175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 78.1 t -105.34 140.22 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 126.195 1.798 . . . . 0.0 109.24 177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.4 t0 -156.41 149.12 23.79 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.087 1.355 . . . . 0.0 111.455 -176.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.99 147.18 51.99 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.462 -0.774 . . . . 0.0 112.44 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 95.0 t -72.0 -29.04 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 124.071 0.948 . . . . 0.0 111.383 -175.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -80.73 -7.7 59.44 Favored 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 114.429 1.27 . . . . 0.0 114.429 -177.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.6 m -58.52 137.44 57.4 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.481 1.113 . . . . 0.0 113.386 -177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.2 -19.87 40.8 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.951 1.263 . . . . 0.0 114.086 178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.4 p-80 -67.68 158.91 31.15 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 118.267 1.033 . . . . 0.0 113.457 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.9 p -62.49 138.76 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.001 0.92 . . . . 0.0 110.176 169.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.0 t -159.67 156.68 28.24 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.17 1.388 . . . . 0.0 110.653 -176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.25 145.7 47.84 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.581 1.152 . . . . 0.0 112.65 -172.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.3 p90 -168.17 157.1 9.18 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.881 1.673 . . . . 0.0 113.233 -178.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 147.62 173.65 18.86 Favored Glycine 0 CA--C 1.537 1.453 0 C-N-CA 125.092 1.329 . . . . 0.0 113.985 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -67.82 -38.84 12.61 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.27 2.647 . . . . 0.0 112.468 -173.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.19 -18.46 74.91 Favored Glycine 0 CA--C 1.533 1.179 0 CA-C-N 119.017 0.826 . . . . 0.0 114.099 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 15.7 tp -82.25 -11.21 58.8 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.562 1.145 . . . . 0.0 112.55 175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.1 m -116.59 -40.06 3.25 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.415 1.886 . . . . 0.0 111.776 -174.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -136.25 169.84 16.99 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 127.956 2.502 . . . . 0.0 111.489 -172.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -168.29 173.2 43.06 Favored Glycine 0 CA--C 1.526 0.773 0 O-C-N 121.046 -1.034 . . . . 0.0 113.215 164.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 64.7 t -136.9 130.65 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.728 1.211 . . . . 0.0 108.622 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.7 m -57.16 142.61 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 N-CA-C 113.019 0.748 . . . . 0.0 113.019 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.0 m-80 67.12 2.07 2.62 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 126.804 2.042 . . . . 0.0 114.606 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 93.7 mttt -118.79 141.6 30.31 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.791 1.636 . . . . 0.0 111.017 176.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.95 136.63 30.29 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.659 2.24 . . . . 0.0 110.853 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.74 146.48 42.77 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 39.1 p -135.58 150.37 49.68 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.124 0.97 . . . . 0.0 113.462 -164.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' 1922 ' ' VAL . 52.5 p90 -160.69 176.9 11.01 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.672 1.589 . . . . 0.0 111.661 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 39.7 m -130.19 143.89 51.04 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.232 1.413 . . . . 0.0 110.552 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.8 t -116.81 126.16 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 108.088 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -87.01 126.7 34.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.106 0.962 . . . . 0.0 110.696 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 32.3 p -134.32 4.49 3.44 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 125.092 1.357 . . . . 0.0 113.769 -167.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.2 tttp -54.96 -36.52 65.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.791 1.636 . . . . 0.0 114.789 -169.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -122.19 14.17 10.49 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.815 1.646 . . . . 0.0 112.516 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -78.66 -11.53 59.98 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -175.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.93 -130.86 10.06 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.514 1.054 . . . . 0.0 112.267 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -160.95 161.55 31.66 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.037 1.735 . . . . 0.0 110.238 -175.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 147.38 -14.28 1.43 Allowed Glycine 0 N--CA 1.475 1.29 0 C-N-CA 125.104 1.335 . . . . 0.0 115.284 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.45 105.73 0.92 Allowed Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.836 1.684 . . . . 0.0 112.482 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.02 125.98 32.03 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.11 1.364 . . . . 0.0 108.874 172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 31.9 m -124.13 159.69 29.47 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.879 1.671 . . . . 0.0 112.118 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.7 tp -159.07 137.4 10.68 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.794 1.637 . . . . 0.0 109.404 -170.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.81 156.37 34.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.372 1.069 . . . . 0.0 111.935 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.75 135.52 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.534 1.134 . . . . 0.0 109.795 178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -128.12 127.67 43.45 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.419 1.488 . . . . 0.0 109.787 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -153.15 -165.12 13.12 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 119.132 -0.816 . . . . 0.0 114.499 -174.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.09 -24.15 66.61 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 124.087 3.191 . . . . 0.0 112.664 176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.7 t -140.27 153.25 46.45 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.007 1.323 . . . . 0.0 109.739 164.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -72.56 117.17 13.91 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.167 -0.958 . . . . 0.0 111.049 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.81 153.16 37.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.481 1.112 . . . . 0.0 112.133 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -90.27 141.65 28.51 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 161.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 26.5 mt -138.37 138.54 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.758 1.223 . . . . 0.0 110.011 -163.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 65.1 m -137.98 158.1 45.03 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.515 1.526 . . . . 0.0 111.147 172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.1 p -154.33 155.03 34.36 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.318 1.047 . . . . 0.0 112.27 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 75.6 m -143.67 122.69 12.82 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.179 1.392 . . . . 0.0 110.66 -168.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.5 t0 -80.94 113.61 19.26 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.129 0.972 . . . . 0.0 109.768 165.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 27.6 p30 -83.53 -7.46 59.52 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 114.045 1.128 . . . . 0.0 114.045 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 71.5 0.36 3.44 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 127.892 2.477 . . . . 0.0 114.171 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.7 t70 -88.22 -11.09 47.66 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.326 1.45 . . . . 0.0 113.137 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 132.79 1.74 4.07 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 125.452 1.501 . . . . 0.0 115.661 177.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 64.4 p -137.27 156.66 48.01 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 119.231 1.516 . . . . 0.0 112.143 177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 79.7 m -104.21 128.14 51.9 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.344 1.458 . . . . 0.0 109.115 165.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.8 t -91.48 151.89 20.59 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.126 0.97 . . . . 0.0 110.763 172.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' 1886 ' ' PHE . 84.1 t -132.33 144.54 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.765 1.626 . . . . 0.0 110.041 -176.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 76.0 p -140.98 148.08 39.76 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.809 1.243 . . . . 0.0 112.236 169.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.9 p90 -152.51 156.72 39.95 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 121.16 -0.963 . . . . 0.0 113.212 176.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.6 mt -119.15 106.18 43.53 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.117 1.367 . . . . 0.0 110.871 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -82.6 174.45 9.67 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.976 3.117 . . . . 0.0 110.884 168.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -150.24 -30.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.1 mt -105.99 146.96 33.93 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 119.502 1.046 . . . . 0.0 110.393 166.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.22 157.37 41.89 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.874 2.383 . . . . 0.0 110.946 175.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.85 -162.39 24.18 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 124.778 1.18 . . . . 0.0 113.621 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -89.49 125.92 35.38 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.187 1.395 . . . . 0.0 112.303 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -113.84 126.38 55.12 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.374 1.47 . . . . 0.0 109.203 173.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.2 m -89.45 127.7 35.87 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.147 0.979 . . . . 0.0 110.734 175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.9 128.11 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.841 1.257 . . . . 0.0 108.943 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -105.71 129.93 53.83 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.661 1.584 . . . . 0.0 109.361 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.0 t -130.19 132.44 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.536 1.134 . . . . 0.0 109.221 171.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -151.95 140.7 20.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.326 1.45 . . . . 0.0 111.357 -168.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -135.8 117.8 15.32 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.441 1.096 . . . . 0.0 110.017 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 50.7 t-20 56.61 63.6 1.91 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.686 1.594 . . . . 0.0 111.774 178.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.281 9.2 pt-20 55.63 18.68 2.91 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.234 2.613 . . . . 0.0 116.423 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -132.81 129.04 38.02 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.782 1.233 . . . . 0.0 110.922 177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.4 m170 -64.17 148.39 50.12 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.917 0.887 . . . . 0.0 112.354 175.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.7 m -70.87 152.81 95.02 Favored Pre-proline 0 N--CA 1.482 1.142 0 CA-C-O 118.349 -0.834 . . . . 0.0 109.437 169.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -63.28 133.62 41.41 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.643 2.228 . . . . 0.0 111.224 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.58 63.7 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.899 1.237 . . . . 0.0 114.928 -175.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.3 t -81.08 144.33 54.47 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.009 1.405 . . . . 0.0 111.68 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.43 140.34 64.32 Favored 'Cis proline' 0 C--N 1.354 0.829 0 CA-C-N 120.014 1.041 . . . . 0.0 112.682 -1.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -95.05 175.81 6.49 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.595 1.958 . . . . 0.0 110.958 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -135.26 127.01 29.17 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.103 0.961 . . . . 0.0 110.687 173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -106.69 140.55 39.37 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.911 1.684 . . . . 0.0 110.981 172.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -98.16 108.46 21.17 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.115 0.966 . . . . 0.0 110.178 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 87.8 t -90.84 143.46 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.917 1.287 . . . . 0.0 110.135 177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.5 t -131.1 172.26 12.3 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.487 1.115 . . . . 0.0 112.767 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.42 142.8 26.39 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 125.746 1.641 . . . . 0.0 112.739 -176.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.0 t70 -88.84 -17.67 29.23 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 124.435 1.094 . . . . 0.0 113.198 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 126.017 1.727 . . . . 0.0 114.386 -179.553 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 55.91 -117.9 1.17 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.404 1.481 . . . . 0.0 111.566 -178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -79.79 -15.76 56.81 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.625 1.17 . . . . 0.0 113.88 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -81.14 153.21 71.88 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.167 0.987 . . . . 0.0 111.896 177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.95 -10.6 23.12 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.665 2.91 . . . . 0.0 113.983 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -77.41 78.48 3.93 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.71 1.204 . . . . 0.0 110.703 176.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -78.35 135.74 61.18 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.088 1.355 . . . . 0.0 111.026 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 40.3 Cg_exo -59.37 162.68 14.03 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.757 2.971 . . . . 0.0 113.056 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 84.1 mt -79.68 54.22 1.76 Allowed 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.317 1.447 . . . . 0.0 112.743 -173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 32.7 m -76.55 -6.54 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 125.432 1.493 . . . . 0.0 114.35 -177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 89.16 -164.16 32.05 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.797 1.189 . . . . 0.0 113.432 -178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 20.6 m -145.19 156.87 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.667 1.587 . . . . 0.0 111.169 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 9.0 p30 -162.16 157.91 23.85 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 125.7 1.6 . . . . 0.0 112.439 -178.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -89.96 -162.65 38.53 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.371 1.462 . . . . 0.0 114.204 -177.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.5 mt -69.04 157.45 36.78 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.778 1.231 . . . . 0.0 112.174 177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 45.1 t0 -100.55 162.76 12.71 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.202 1.401 . . . . 0.0 111.165 175.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 34.0 m -59.82 -23.49 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -173.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.7 t -75.64 -18.05 59.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.451 1.5 . . . . 0.0 113.459 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 49.6 m -67.12 128.15 35.3 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 121.174 -0.954 . . . . 0.0 113.196 -172.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 76.3 mt -89.04 159.57 17.51 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.868 1.667 . . . . 0.0 111.038 171.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.53 121.64 68.6 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-O 118.312 -0.851 . . . . 0.0 110.852 177.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -73.27 156.18 51.04 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.144 2.563 . . . . 0.0 111.002 -178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 1.4 t80 -116.05 122.13 44.28 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.389 0.676 . . . . 0.0 110.966 174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -148.69 151.87 35.67 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.743 1.617 . . . . 0.0 110.618 170.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.61 151.84 24.67 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.575 1.55 . . . . 0.0 109.949 -176.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -125.95 133.63 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 124.927 1.291 . . . . 0.0 109.43 170.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.6 mt -130.81 137.17 30.19 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 126.037 1.735 . . . . 0.0 108.673 -171.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.94 49.48 3.16 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 124.658 3.572 . . . . 0.0 112.827 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.3 t80 -93.91 153.0 18.46 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.463 1.505 . . . . 0.0 110.625 171.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.5 m -124.59 127.31 47.19 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.92 1.288 . . . . 0.0 110.217 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.6 mt -92.61 136.33 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.042 1.337 . . . . 0.0 109.203 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.9 tptt -129.04 -60.22 1.09 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.151 0.98 . . . . 0.0 112.49 -178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 25.6 ttmm -159.15 131.06 6.46 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 126.316 1.846 . . . . 0.0 110.388 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 126.65 -146.82 16.54 Favored Glycine 0 N--CA 1.471 1.028 0 C-N-CA 125.292 1.425 . . . . 0.0 111.384 -166.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -157.7 144.84 18.24 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.577 1.151 . . . . 0.0 110.914 -176.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.4 tt -121.85 136.15 59.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.57 1.548 . . . . 0.0 110.864 177.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.8 p -148.0 174.4 11.94 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.165 1.786 . . . . 0.0 110.525 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.64 -171.31 27.53 Favored Glycine 0 N--CA 1.467 0.735 0 N-CA-C 116.118 1.207 . . . . 0.0 116.118 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -153.83 146.07 23.83 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.571 1.949 . . . . 0.0 109.603 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 21.5 t -123.25 138.43 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 126.331 1.852 . . . . 0.0 108.351 173.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 68.7 mtm-85 -127.61 142.19 51.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.897 0.879 . . . . 0.0 112.037 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 5.3 mpp? -118.6 148.66 44.68 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 125.596 1.558 . . . . 0.0 111.936 -173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.01 -29.57 89.6 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 124.121 3.214 . . . . 0.0 114.886 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 12.5 m -72.93 3.32 5.44 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 -173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.88 42.14 6.47 Favored Glycine 0 N--CA 1.472 1.056 0 C-N-CA 124.556 1.074 . . . . 0.0 112.833 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -148.16 158.26 43.97 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.842 1.657 . . . . 0.0 111.854 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.9 m -143.21 162.52 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 C-N-CA 125.108 1.363 . . . . 0.0 112.035 -171.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.58 -179.44 8.16 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 126.706 2.003 . . . . 0.0 110.923 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -128.96 147.73 65.99 Favored Pre-proline 0 CA--C 1.544 0.74 0 O-C-N 121.185 -0.947 . . . . 0.0 111.601 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -86.94 173.89 5.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 124.229 3.286 . . . . 0.0 112.191 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.0 m -110.39 135.47 51.05 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.458 1.503 . . . . 0.0 108.75 170.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -120.6 131.08 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.954 1.302 . . . . 0.0 108.693 174.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 89.4 m -132.66 126.85 33.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.475 1.51 . . . . 0.0 109.306 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.8 136.11 40.24 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.021 0.528 . . . . 0.0 111.817 172.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -88.21 -12.69 43.06 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 56.7 tttt 70.63 6.07 5.67 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 127.219 2.208 . . . . 0.0 113.708 178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -105.87 11.15 32.14 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 127.208 2.203 . . . . 0.0 112.751 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.78 16.15 52.56 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 124.889 1.233 . . . . 0.0 113.964 -174.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 40.1 p -134.41 158.93 42.61 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.014 1.726 . . . . 0.0 110.622 177.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.0 m -122.87 143.47 35.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 124.794 1.238 . . . . 0.0 110.084 168.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 35.0 m -98.47 138.09 36.2 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.351 1.46 . . . . 0.0 108.831 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 46.1 t -125.13 134.97 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.741 1.617 . . . . 0.0 108.824 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.1 mtp180 -140.8 156.58 46.12 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.894 1.277 . . . . 0.0 112.594 -173.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 23.2 t80 -153.77 133.11 12.74 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.732 1.613 . . . . 0.0 111.216 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.19 119.83 73.78 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.4 1.08 . . . . 0.0 110.493 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.67 134.64 15.31 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 123.238 2.625 . . . . 0.0 111.691 -174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 67.2 m -131.73 8.06 4.49 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.558 1.143 . . . . 0.0 113.12 178.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -160.18 155.84 25.66 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.047 1.739 . . . . 0.0 109.912 -176.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.63 175.95 6.47 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 124.315 1.046 . . . . 0.0 112.563 174.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 98.14 -170.4 24.79 Favored Glycine 0 CA--C 1.53 0.998 0 C-N-CA 125.297 1.427 . . . . 0.0 114.199 176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 44.8 tp -76.87 121.85 24.0 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.924 1.289 . . . . 0.0 110.243 177.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 12.8 m80 -111.96 164.35 13.22 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.78 1.632 . . . . 0.0 110.863 178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -145.56 149.79 35.22 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.669 -0.645 . . . . 0.0 111.954 162.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 42.4 ttm -121.36 139.82 52.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.614 1.966 . . . . 0.0 110.121 178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -110.73 134.55 52.38 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.318 1.447 . . . . 0.0 109.808 167.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 39.2 mm -123.39 136.42 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 125.811 1.644 . . . . 0.0 109.433 173.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.2 141.07 28.36 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.094 0.958 . . . . 0.0 113.53 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.4 t80 -107.3 122.5 46.69 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.389 2.276 . . . . 0.0 109.65 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 52.43 31.71 10.12 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.56 1.144 . . . . 0.0 112.432 -171.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.0 t30 76.05 5.17 3.79 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.333 2.653 . . . . 0.0 115.071 -178.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.6 mtm -102.44 132.27 48.57 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 125.526 1.531 . . . . 0.0 110.83 173.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 12.0 m170 -57.37 136.67 56.61 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 121.324 -0.86 . . . . 0.0 113.142 -176.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 25.5 pt -77.45 153.06 81.52 Favored Pre-proline 0 N--CA 1.48 1.03 0 O-C-N 121.76 -0.588 . . . . 0.0 111.294 173.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -61.28 134.15 50.47 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.158 1.906 . . . . 0.0 109.671 170.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.4 -13.69 64.14 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.343 0.973 . . . . 0.0 113.973 -174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -96.15 146.7 31.77 Favored Pre-proline 0 CA--C 1.547 0.828 0 CA-C-N 119.11 1.455 . . . . 0.0 111.179 173.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.23 160.67 95.4 Favored 'Cis proline' 0 C--N 1.353 0.802 0 CA-C-N 120.688 1.282 . . . . 0.0 113.455 2.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 75.8 mt -112.06 133.68 54.08 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.786 2.034 . . . . 0.0 109.054 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -130.16 134.4 47.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.261 1.024 . . . . 0.0 110.575 -175.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -163.12 162.67 25.78 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.05 0.94 . . . . 0.0 112.817 -175.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 23.6 t80 -106.57 144.58 33.03 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.267 1.027 . . . . 0.0 112.88 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 56.2 t -118.95 138.23 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 125.34 1.456 . . . . 0.0 110.124 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -155.54 147.95 23.85 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.361 1.064 . . . . 0.0 112.766 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -63.17 142.63 58.31 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.34 1.456 . . . . 0.0 112.94 -176.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.7 p -67.27 -23.97 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 10.5 p30 -75.42 -17.06 60.28 Favored 'General case' 0 CA--C 1.547 0.829 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 -174.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.7 m -68.21 143.35 55.36 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 123.919 0.888 . . . . 0.0 113.357 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -89.99 -17.14 54.73 Favored Glycine 0 N--CA 1.474 1.184 0 C-N-CA 124.865 1.221 . . . . 0.0 114.36 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -67.25 163.88 19.52 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 118.466 1.133 . . . . 0.0 113.283 173.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 4.5 t -66.53 136.94 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.535 1.134 . . . . 0.0 109.52 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 56.7 p -132.65 162.16 32.06 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.456 1.102 . . . . 0.0 110.682 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.55 142.21 28.94 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.358 1.063 . . . . 0.0 110.969 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.9 p90 -166.01 159.94 16.08 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.616 1.566 . . . . 0.0 112.362 -172.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.74 170.84 12.69 Favored Glycine 0 CA--C 1.537 1.433 0 C-N-CA 125.329 1.443 . . . . 0.0 113.159 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -67.05 -32.77 33.82 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 123.29 2.66 . . . . 0.0 112.849 -171.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.75 -13.93 72.31 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.936 -0.924 . . . . 0.0 114.791 -178.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 61.2 mt -78.99 -12.64 60.04 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 119.128 1.464 . . . . 0.0 112.966 168.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 15.5 m -119.38 -38.42 3.02 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.684 1.593 . . . . 0.0 112.431 -165.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -156.11 155.03 31.86 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.567 1.547 . . . . 0.0 112.258 -171.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.61 -173.75 25.5 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.469 1.033 . . . . 0.0 113.033 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.9 p -150.74 136.45 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.647 1.179 . . . . 0.0 109.286 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.7 m -56.57 140.82 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -171.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 62.1 m-80 70.59 -4.45 1.65 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 127.396 2.278 . . . . 0.0 114.924 175.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -104.65 143.31 26.43 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.965 1.306 . . . . 0.0 110.867 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -73.54 127.59 11.89 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.461 2.107 . . . . 0.0 110.723 -179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.48 148.7 26.91 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.431 1.492 . . . . 0.0 110.361 171.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.6 p -137.25 155.07 49.94 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.1 0.96 . . . . 0.0 113.507 -167.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . 0.424 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.3 p90 -164.48 172.84 12.8 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.562 1.945 . . . . 0.0 111.404 177.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.1 m -128.01 144.23 51.1 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.691 1.596 . . . . 0.0 110.731 -172.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 46.9 t -120.11 130.52 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.123 1.769 . . . . 0.0 108.454 171.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m120 -87.37 127.82 35.2 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.372 -0.83 . . . . 0.0 111.162 176.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 50.9 p -131.49 3.35 4.22 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 125.352 1.461 . . . . 0.0 113.36 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -55.93 -40.03 72.53 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.781 1.632 . . . . 0.0 114.328 -170.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -109.34 4.64 22.8 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.523 1.529 . . . . 0.0 112.896 178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.05 -25.92 59.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.349 1.06 . . . . 0.0 113.329 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 -92.47 1.46 Allowed Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.766 1.174 . . . . 0.0 112.664 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -166.6 179.03 5.67 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.013 1.725 . . . . 0.0 111.863 -170.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 116.52 5.76 15.96 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 124.998 1.285 . . . . 0.0 115.477 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.99 105.6 2.16 Favored Glycine 0 N--CA 1.47 0.961 0 C-N-CA 125.503 1.525 . . . . 0.0 113.079 175.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -84.23 132.1 34.68 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.791 1.636 . . . . 0.0 109.179 168.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -128.26 161.02 30.32 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.69 1.596 . . . . 0.0 112.142 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.2 tp -159.08 136.55 10.0 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.699 1.599 . . . . 0.0 109.646 -170.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.67 162.3 37.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.713 1.205 . . . . 0.0 111.776 176.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 41.2 mt -139.03 132.83 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.404 1.082 . . . . 0.0 109.935 175.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -114.29 163.76 14.83 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.769 1.627 . . . . 0.0 110.083 168.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 167.56 -158.49 31.39 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-O 118.76 -1.022 . . . . 0.0 114.179 -178.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.72 -22.2 50.43 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 123.686 2.924 . . . . 0.0 112.435 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.3 t -147.11 158.54 43.97 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.638 1.575 . . . . 0.0 109.499 168.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -73.63 112.05 9.35 Favored 'General case' 0 CA--C 1.543 0.69 0 O-C-N 120.977 -1.077 . . . . 0.0 110.595 174.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -66.47 150.72 48.53 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.119 0.968 . . . . 0.0 111.739 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.51 137.51 32.27 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.409 0.684 . . . . 0.0 109.315 167.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 35.1 mt -132.2 143.83 38.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 124.443 1.097 . . . . 0.0 110.428 -165.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.41 163.0 35.98 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.608 1.163 . . . . 0.0 111.301 168.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -157.7 156.76 32.27 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 112.777 -177.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -138.22 125.26 21.39 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.907 1.683 . . . . 0.0 110.069 -175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -79.34 128.92 33.94 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.95 1.3 . . . . 0.0 110.862 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.5 m-20 -107.98 151.94 25.14 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.292 1.437 . . . . 0.0 112.434 -176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -68.87 -16.81 63.87 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.05 0.94 . . . . 0.0 112.719 174.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -74.45 -6.39 48.03 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.724 1.61 . . . . 0.0 113.968 177.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.73 33.12 8.61 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.499 1.047 . . . . 0.0 113.566 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.8 p -136.74 156.77 48.07 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.815 1.246 . . . . 0.0 111.15 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.7 m -102.71 127.6 49.78 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.956 0.902 . . . . 0.0 108.903 157.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.8 t -92.21 145.83 24.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.746 0.818 . . . . 0.0 109.796 166.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . 0.424 HG11 ' CZ ' ' A' 1886 ' ' PHE . 86.8 t -130.38 143.69 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.129 1.372 . . . . 0.0 109.976 -175.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.1 p -134.08 149.45 51.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.05 1.34 . . . . 0.0 111.919 169.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 22.2 p90 -151.89 152.82 33.07 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 176.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 18.8 mt -115.64 105.69 51.43 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 126.394 1.878 . . . . 0.0 110.207 179.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.71 170.63 15.4 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.573 2.849 . . . . 0.0 110.332 167.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -144.99 -28.97 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -172.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.4 mt -108.93 147.89 36.79 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.298 1.039 . . . . 0.0 110.394 166.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -72.97 156.22 52.38 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.83 2.353 . . . . 0.0 110.775 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.3 -167.84 23.65 Favored Glycine 0 N--CA 1.471 1.013 0 C-N-CA 124.98 1.276 . . . . 0.0 113.382 -177.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -93.6 128.37 39.72 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.784 1.234 . . . . 0.0 112.262 179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -112.47 140.5 47.15 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.46 1.904 . . . . 0.0 110.496 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.3 m -105.03 111.94 24.89 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.992 1.317 . . . . 0.0 110.229 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -92.03 122.27 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.023 1.329 . . . . 0.0 108.383 178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 6.8 tt -101.25 125.8 47.92 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.572 1.549 . . . . 0.0 109.231 177.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.1 t -126.71 129.38 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.27 1.028 . . . . 0.0 109.442 171.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.68 142.83 24.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.921 1.288 . . . . 0.0 111.943 -167.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -136.12 123.67 22.22 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.993 1.317 . . . . 0.0 109.701 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.5 t-20 52.56 57.13 6.72 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.559 1.543 . . . . 0.0 112.541 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.1 pt-20 58.42 12.17 1.94 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.295 2.638 . . . . 0.0 116.286 -177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -118.97 125.28 49.04 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.629 1.172 . . . . 0.0 110.779 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.43 143.38 57.15 Favored 'General case' 0 CA--C 1.545 0.774 0 O-C-N 121.47 -0.769 . . . . 0.0 111.591 172.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 5.5 m -72.22 152.01 92.37 Favored Pre-proline 0 N--CA 1.479 0.995 0 CA-C-O 118.371 -0.823 . . . . 0.0 110.058 174.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -56.02 125.44 19.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.148 2.566 . . . . 0.0 111.115 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.77 -14.73 64.33 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.458 1.504 . . . . 0.0 115.316 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -76.72 141.56 68.89 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-N 119.264 1.532 . . . . 0.0 111.804 177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -77.69 145.54 79.63 Favored 'Cis proline' 0 C--N 1.352 0.729 0 CA-C-N 119.587 0.888 . . . . 0.0 112.275 -3.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -96.55 139.4 32.7 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.585 1.554 . . . . 0.0 110.763 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -100.66 107.47 19.11 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.328 0.651 . . . . 0.0 110.63 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.51 125.17 45.22 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.652 1.181 . . . . 0.0 111.127 175.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 25.4 ttt85 -95.78 116.69 29.26 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.518 0.727 . . . . 0.0 110.685 -179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -99.43 133.51 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 126.045 1.738 . . . . 0.0 110.678 -174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 60.2 p -104.12 169.25 8.6 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.296 1.438 . . . . 0.0 112.959 178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.83 142.03 25.07 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 124.946 1.26 . . . . 0.0 111.691 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.9 t70 -80.48 -11.51 59.67 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.49 1.116 . . . . 0.0 113.781 -176.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.252 1.202 0 C-N-CA 126.662 1.985 . . . . 0.0 112.577 -179.81 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.27 163.8 27.59 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.479 1.112 . . . . 0.0 112.862 177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.8 ttt -72.42 -31.3 65.39 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.162 0.985 . . . . 0.0 112.502 176.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -72.28 150.24 91.87 Favored Pre-proline 0 CA--C 1.551 1.009 0 C-N-CA 124.61 1.164 . . . . 0.0 112.128 175.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.28 171.58 17.76 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.638 2.892 . . . . 0.0 111.509 176.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -71.57 123.22 21.98 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.462 0.705 . . . . 0.0 110.57 174.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -79.91 145.95 62.8 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.063 0.945 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -74.99 162.04 37.81 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.657 2.904 . . . . 0.0 111.845 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 68.0 tp -115.52 131.16 57.02 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.181 1.392 . . . . 0.0 109.792 172.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 96.2 t -105.19 128.6 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.149 1.38 . . . . 0.0 108.396 170.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 74.03 -149.67 41.41 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 123.844 0.735 . . . . 0.0 112.357 -174.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 49.1 t -136.6 138.24 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.712 1.605 . . . . 0.0 108.842 178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -64.99 -28.61 69.63 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 87.97 -3.03 85.94 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.426 1.489 . . . . 0.0 115.189 173.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 90.5 mt -109.21 144.47 37.27 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.222 1.409 . . . . 0.0 111.115 176.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 39.3 t0 -160.22 149.36 17.41 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.211 1.804 . . . . 0.0 110.149 172.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . 0.276 1.1 p 50.7 15.09 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 C-N-CA 128.244 2.618 . . . . 0.0 115.461 -177.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.7 t -75.26 -12.02 60.19 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.884 1.674 . . . . 0.0 113.675 -174.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 74.0 p -73.98 75.31 1.69 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.114 1.366 . . . . 0.0 111.619 173.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 23.3 tp -91.09 129.43 37.09 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.499 1.519 . . . . 0.0 109.764 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 56.5 ttm-85 -66.42 119.06 59.55 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.918 -168.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -71.46 154.59 60.5 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.315 2.676 . . . . 0.0 111.715 -171.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.7 123.25 42.79 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.786 0.834 . . . . 0.0 110.194 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -153.18 130.2 11.06 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.446 1.498 . . . . 0.0 110.344 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.71 143.46 30.72 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.854 1.662 . . . . 0.0 109.83 -172.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.1 p -112.45 138.59 40.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.057 1.343 . . . . 0.0 110.571 177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 70.8 mt -131.53 136.6 28.81 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 126.412 1.885 . . . . 0.0 108.71 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -79.66 45.47 1.96 Allowed 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 124.503 3.469 . . . . 0.0 112.926 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 75.1 t80 -91.53 155.12 18.62 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.254 1.422 . . . . 0.0 111.462 174.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 95.7 m -125.43 125.86 44.04 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.549 1.54 . . . . 0.0 109.609 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 33.0 mt -78.7 134.25 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.346 1.058 . . . . 0.0 110.641 176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.1 mttt -113.18 -141.78 0.38 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.845 1.658 . . . . 0.0 110.656 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.2 135.66 33.63 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 120.91 -1.119 . . . . 0.0 110.956 166.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 132.98 -145.26 17.29 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.511 1.529 . . . . 0.0 111.555 -167.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -158.6 151.47 22.33 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.464 1.106 . . . . 0.0 111.536 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.0 tt -124.64 135.23 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.763 1.625 . . . . 0.0 111.936 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 27.8 p -147.08 164.07 34.25 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.72 1.608 . . . . 0.0 110.978 -177.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.72 -175.75 23.0 Favored Glycine 0 N--CA 1.469 0.871 0 N-CA-C 115.504 0.961 . . . . 0.0 115.504 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -156.42 140.59 16.48 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.556 1.543 . . . . 0.0 110.02 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 16.3 t -111.47 132.91 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.814 1.646 . . . . 0.0 108.171 174.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.4 mtm105 -119.49 119.3 33.45 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.682 1.193 . . . . 0.0 110.226 -177.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 11.3 mtt -95.53 149.24 35.84 Favored Pre-proline 0 CA--C 1.545 0.788 0 C-N-CA 125.781 1.632 . . . . 0.0 111.376 -173.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.17 -20.59 28.2 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 123.4 2.733 . . . . 0.0 113.672 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.7 p -80.61 4.29 19.08 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.206 1.402 . . . . 0.0 114.387 178.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.06 45.11 4.88 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 124.485 1.04 . . . . 0.0 113.367 173.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 22.1 ptmt -151.54 166.18 31.95 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.76 1.624 . . . . 0.0 112.021 -176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.59 161.37 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 C-N-CA 124.224 1.01 . . . . 0.0 113.217 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.04 -179.26 7.97 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.063 2.145 . . . . 0.0 110.533 176.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -120.52 141.74 32.71 Favored Pre-proline 0 CA--C 1.545 0.784 0 O-C-N 121.189 -0.944 . . . . 0.0 111.333 177.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -84.18 166.88 12.55 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 124.322 3.348 . . . . 0.0 111.343 175.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.8 m -106.91 128.02 53.94 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 108.915 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -108.9 130.43 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.611 1.165 . . . . 0.0 109.075 176.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 77.1 m -135.07 120.98 19.74 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.163 1.385 . . . . 0.0 109.321 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -76.58 141.77 41.0 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.227 0.611 . . . . 0.0 112.218 173.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -93.63 -5.61 48.34 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 67.19 6.33 4.73 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 127.34 2.256 . . . . 0.0 113.515 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -107.2 9.51 30.2 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.805 2.042 . . . . 0.0 112.991 -175.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.11 17.12 58.22 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.719 1.152 . . . . 0.0 113.608 -173.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 34.9 p -134.86 159.77 40.34 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.316 1.846 . . . . 0.0 110.413 178.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 21.9 m -125.34 143.4 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.584 1.154 . . . . 0.0 110.076 168.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 96.3 m -104.56 135.92 45.07 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.432 1.093 . . . . 0.0 108.668 171.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 40.0 t -120.11 132.99 68.3 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 125.208 1.403 . . . . 0.0 108.744 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -133.14 159.17 40.91 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.035 1.334 . . . . 0.0 112.706 -172.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.7 t80 -160.5 136.48 8.41 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.688 1.595 . . . . 0.0 111.66 176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.12 112.03 51.67 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.749 1.219 . . . . 0.0 110.185 175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.24 151.36 26.52 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.216 2.611 . . . . 0.0 112.209 -173.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -116.16 -12.71 11.19 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -163.44 150.34 12.37 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.59 1.556 . . . . 0.0 110.884 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.79 172.48 12.1 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.7 1.2 . . . . 0.0 113.497 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.87 -178.58 17.63 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 125.542 1.544 . . . . 0.0 114.435 175.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -75.43 123.22 25.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.924 1.29 . . . . 0.0 110.088 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.7 m80 -117.7 157.07 27.15 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.314 1.446 . . . . 0.0 111.818 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -133.46 142.42 48.27 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.076 1.35 . . . . 0.0 109.317 172.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.7 tmm? -143.04 132.45 23.47 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 124.082 0.953 . . . . 0.0 111.753 -168.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -108.72 139.88 42.9 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 126.951 2.1 . . . . 0.0 111.455 -173.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.5 mm -139.32 131.05 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.187 1.395 . . . . 0.0 109.304 170.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.27 139.71 30.31 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.18 123.34 46.53 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.537 1.935 . . . . 0.0 109.912 175.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.91 30.95 7.78 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.719 1.208 . . . . 0.0 112.827 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 23.0 t30 80.59 6.16 1.54 Allowed 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.53 2.732 . . . . 0.0 115.28 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 90.3 mtp -109.05 133.17 53.35 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.054 1.342 . . . . 0.0 111.119 172.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -57.24 138.05 55.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -72.84 153.7 91.15 Favored Pre-proline 0 N--CA 1.478 0.959 0 CA-C-O 118.93 -0.557 . . . . 0.0 111.273 176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -57.26 123.89 14.89 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.036 2.491 . . . . 0.0 110.37 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.21 -11.22 61.89 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 118.376 -1.235 . . . . 0.0 114.903 -176.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.3 m -102.2 154.59 37.28 Favored Pre-proline 0 N--CA 1.48 1.045 0 CA-C-N 119.999 1.9 . . . . 0.0 112.673 175.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.58 163.83 89.48 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.558 0.878 . . . . 0.0 113.272 0.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.0 mt -107.22 151.91 24.8 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.82 1.648 . . . . 0.0 111.504 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -133.87 141.7 47.5 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.288 1.435 . . . . 0.0 109.548 172.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.2 p90 -166.56 158.28 13.24 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.372 1.069 . . . . 0.0 112.072 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 38.2 t80 -96.36 130.19 43.53 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.433 0.693 . . . . 0.0 111.755 174.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 71.4 t -91.86 132.95 34.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.998 1.319 . . . . 0.0 108.681 172.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.1 t0 -146.51 163.7 34.89 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.498 1.519 . . . . 0.0 110.628 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -72.76 148.82 44.23 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.992 0.917 . . . . 0.0 112.543 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 89.7 t -67.05 -45.02 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.138 0.975 . . . . 0.0 110.631 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 6.4 p30 -93.64 141.66 28.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.924 0.89 . . . . 0.0 111.125 168.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.4 p -173.85 156.79 2.89 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.051 1.741 . . . . 0.0 112.235 -177.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.42 -23.47 11.13 Favored Glycine 0 N--CA 1.474 1.177 0 C-N-CA 124.854 1.216 . . . . 0.0 113.595 172.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.3 p-80 -73.59 156.9 37.59 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.424 1.089 . . . . 0.0 113.736 178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.4 t -66.95 138.13 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 124.173 0.989 . . . . 0.0 108.473 170.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.0 t -153.49 166.77 31.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.038 0.935 . . . . 0.0 111.349 -177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.01 145.46 29.73 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.134 1.374 . . . . 0.0 111.665 -178.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 47.2 p90 -166.15 162.4 17.61 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.629 1.572 . . . . 0.0 112.467 -175.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.77 173.47 13.22 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.283 1.421 . . . . 0.0 113.014 -178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -69.72 -35.04 13.49 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.879 2.386 . . . . 0.0 112.751 -171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.38 -32.12 78.61 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 118.898 -0.945 . . . . 0.0 114.463 -171.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -80.34 -3.47 49.64 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.233 1.516 . . . . 0.0 113.478 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.6 m -108.17 -41.24 4.96 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.473 1.909 . . . . 0.0 111.676 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -151.09 152.55 33.58 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.244 1.818 . . . . 0.0 112.332 -170.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -153.19 -175.41 24.57 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 124.406 1.003 . . . . 0.0 113.393 170.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.8 p -153.6 137.36 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.813 1.245 . . . . 0.0 109.07 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.8 m -58.57 142.12 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -170.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.0 m-80 68.28 7.33 5.86 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.558 1.943 . . . . 0.0 114.582 175.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -114.7 143.57 30.25 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.167 1.387 . . . . 0.0 110.924 173.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.48 127.94 13.06 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.604 2.202 . . . . 0.0 110.316 176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.13 145.83 32.03 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.624 1.57 . . . . 0.0 110.273 173.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 43.2 p -135.69 152.23 50.97 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 -167.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -161.9 173.83 13.97 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.985 1.714 . . . . 0.0 111.385 176.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 76.0 m -125.73 142.43 51.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.316 1.446 . . . . 0.0 110.464 -171.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 48.1 t -115.9 128.16 73.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.837 1.655 . . . . 0.0 107.875 170.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -91.32 123.92 35.12 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.021 0.928 . . . . 0.0 110.932 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 54.5 p -125.99 10.25 7.57 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.408 1.883 . . . . 0.0 112.608 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.16 -40.06 76.5 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.52 1.528 . . . . 0.0 114.372 -165.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -110.39 5.42 21.47 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.648 1.579 . . . . 0.0 112.738 178.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.84 -28.71 58.34 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.575 1.15 . . . . 0.0 113.693 -175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.33 -86.71 1.38 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.872 1.225 . . . . 0.0 112.772 176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -168.6 -177.88 3.27 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.27 1.828 . . . . 0.0 111.627 -169.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 119.38 9.52 8.54 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.815 1.198 . . . . 0.0 115.618 176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.33 103.52 1.63 Allowed Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.533 1.54 . . . . 0.0 112.834 175.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 39.2 tp -84.66 141.35 30.67 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.319 1.447 . . . . 0.0 110.158 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.7 m -135.46 159.41 41.67 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.592 1.557 . . . . 0.0 112.155 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.5 tp -160.71 136.44 8.16 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.024 1.73 . . . . 0.0 109.338 -169.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.36 159.17 35.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.164 0.986 . . . . 0.0 112.292 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 46.8 mt -137.74 137.24 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.884 1.274 . . . . 0.0 109.837 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.26 134.39 48.96 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.31 1.444 . . . . 0.0 109.979 174.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.5 -164.55 16.61 Favored Glycine 0 CA--C 1.539 1.55 0 CA-C-O 118.984 -0.898 . . . . 0.0 114.667 -175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.32 -24.48 64.81 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 124.18 3.253 . . . . 0.0 112.836 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.8 t -139.3 159.75 41.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.914 1.285 . . . . 0.0 109.6 162.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -71.25 110.57 5.98 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.088 -1.008 . . . . 0.0 110.704 177.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 145.18 54.7 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.419 0.688 . . . . 0.0 111.144 172.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -86.46 137.13 32.79 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 168.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 36.5 mt -129.36 143.73 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.746 1.218 . . . . 0.0 110.131 -168.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.3 t -143.63 162.68 35.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.624 1.17 . . . . 0.0 110.966 166.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -158.14 155.41 29.07 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.646 1.178 . . . . 0.0 112.228 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 88.6 m -142.38 125.18 16.0 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.385 1.474 . . . . 0.0 109.79 -170.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -76.36 129.56 36.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.766 0.826 . . . . 0.0 110.946 169.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -99.18 151.58 20.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.362 1.465 . . . . 0.0 111.808 -174.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -71.14 -16.48 62.55 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.888 0.875 . . . . 0.0 113.281 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -82.06 -6.96 59.56 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.31 33.89 6.65 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.815 1.198 . . . . 0.0 114.445 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -127.94 174.09 9.47 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.331 1.452 . . . . 0.0 110.572 169.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 96.1 m -124.16 130.96 53.42 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.105 1.362 . . . . 0.0 109.963 168.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.6 t -93.88 149.13 21.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.277 1.031 . . . . 0.0 110.745 171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.1 t -128.17 143.79 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 126.102 1.761 . . . . 0.0 109.742 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 78.1 p -136.14 148.1 48.04 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.878 1.271 . . . . 0.0 111.78 168.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -150.28 153.78 36.74 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 174.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.5 107.33 43.12 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.715 1.606 . . . . 0.0 110.375 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -85.79 173.07 7.4 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 124.114 3.209 . . . . 0.0 110.834 169.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.1 p -147.34 -28.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -173.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 83.0 mt -108.06 148.67 37.92 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 124.249 1.019 . . . . 0.0 110.718 167.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.59 157.71 48.34 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.98 2.453 . . . . 0.0 110.845 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.16 -168.1 22.17 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.164 1.364 . . . . 0.0 113.484 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -89.66 132.77 34.98 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.956 1.302 . . . . 0.0 112.568 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -121.49 126.64 49.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.275 1.83 . . . . 0.0 109.816 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.1 m -86.8 124.33 32.92 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.529 1.132 . . . . 0.0 110.482 176.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -103.48 124.31 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.605 1.562 . . . . 0.0 108.402 178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.6 tt -106.14 131.04 53.87 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 125.319 1.447 . . . . 0.0 109.831 175.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.8 t -133.07 127.99 55.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.552 1.141 . . . . 0.0 109.607 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -150.42 143.42 24.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.969 1.308 . . . . 0.0 111.547 -168.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -140.63 122.31 15.28 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.957 1.303 . . . . 0.0 109.641 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.68 56.26 6.96 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.199 1.399 . . . . 0.0 112.095 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.3 8.3 pt-20 59.42 3.74 0.43 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 128.85 2.86 . . . . 0.0 116.644 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -108.98 125.05 51.64 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.678 1.191 . . . . 0.0 110.87 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -63.62 145.87 54.86 Favored 'General case' 0 CA--C 1.546 0.792 0 O-C-N 121.279 -0.888 . . . . 0.0 111.809 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 16.3 m -70.39 152.7 95.45 Favored Pre-proline 0 N--CA 1.481 1.117 0 CA-C-O 118.389 -0.815 . . . . 0.0 110.091 170.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -58.42 128.32 27.98 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 123.007 2.471 . . . . 0.0 110.57 176.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.9 -15.42 62.8 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.052 1.31 . . . . 0.0 115.082 -175.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.3 t -77.61 139.99 63.5 Favored Pre-proline 0 CA--C 1.549 0.927 0 CA-C-N 119.392 1.596 . . . . 0.0 111.482 175.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.36 135.92 42.56 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.358 0.806 . . . . 0.0 111.857 -3.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -86.01 170.3 12.4 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.794 1.637 . . . . 0.0 110.378 173.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 45.7 m -131.45 117.38 18.75 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.549 0.74 . . . . 0.0 110.718 175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -94.35 143.41 26.42 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.669 1.188 . . . . 0.0 110.722 170.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 59.0 ttm-85 -104.22 119.37 38.81 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.931 0.492 . . . . 0.0 110.771 171.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.3 t -97.28 144.28 11.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.944 1.698 . . . . 0.0 109.237 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.5 t -132.82 175.65 9.16 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.038 0.935 . . . . 0.0 112.854 179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.33 137.47 19.78 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.644 1.593 . . . . 0.0 112.367 -179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.0 t70 -83.08 -23.77 32.99 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.336 1.054 . . . . 0.0 113.402 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.833 2.053 . . . . 0.0 112.456 -176.032 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.521 0 N-CA-C 112.236 -0.346 . . . . 0.0 112.236 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -80.46 -8.65 59.63 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 114.538 1.311 . . . . 0.0 114.538 -177.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -62.5 147.18 49.66 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.807 1.643 . . . . 0.0 112.853 -176.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -70.22 150.67 95.98 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 124.275 1.03 . . . . 0.0 112.652 178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.85 173.63 14.17 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.88 3.053 . . . . 0.0 111.854 176.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -76.62 6.43 5.91 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 125.049 1.34 . . . . 0.0 113.829 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -60.31 145.76 85.46 Favored Pre-proline 0 CA--C 1.549 0.942 0 C-N-CA 125.43 1.492 . . . . 0.0 112.45 -178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.85 153.36 68.59 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.563 2.842 . . . . 0.0 111.489 177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 80.1 mt -80.48 29.24 0.3 Allowed 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.421 1.488 . . . . 0.0 113.139 -176.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.6 p -169.25 153.52 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.598 2.359 . . . . 0.0 109.613 -170.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -68.42 145.17 43.71 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.657 0.646 . . . . 0.0 112.27 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 22.2 m -142.55 154.67 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.776 1.63 . . . . 0.0 111.234 -176.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 18.9 t-20 75.69 133.14 0.05 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 128.48 2.712 . . . . 0.0 113.014 -179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -82.81 121.2 5.37 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.351 0.976 . . . . 0.0 111.618 178.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 83.5 mt -83.01 152.59 25.34 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.567 1.147 . . . . 0.0 111.44 178.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 39.5 t0 -76.09 152.47 36.8 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.86 0.864 . . . . 0.0 112.087 175.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 9.3 p -172.64 139.4 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 126.915 2.086 . . . . 0.0 110.354 -176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 13.1 t -155.28 30.78 0.39 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.308 1.443 . . . . 0.0 112.381 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 16.3 m -63.7 149.22 47.14 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.323 1.049 . . . . 0.0 112.79 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.5 tp -84.29 136.93 33.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.857 1.263 . . . . 0.0 109.368 169.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -44.5 110.07 0.97 Allowed Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 125.5 1.52 . . . . 0.0 112.513 -172.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -69.03 120.64 7.51 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.474 2.116 . . . . 0.0 108.297 174.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 53.6 t80 -101.01 130.33 46.99 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 121.617 0.723 . . . . 0.0 111.677 -172.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 2.1 p30 -160.38 150.11 17.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.769 1.628 . . . . 0.0 111.69 171.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.4 150.27 40.43 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.456 1.902 . . . . 0.0 110.044 -171.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -119.51 139.47 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.773 1.629 . . . . 0.0 110.316 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 68.3 mt -135.3 139.04 30.36 Favored Pre-proline 0 CA--C 1.549 0.904 0 C-N-CA 125.886 1.675 . . . . 0.0 108.732 -177.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -78.13 46.25 2.04 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 124.707 3.605 . . . . 0.0 112.934 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 54.6 t80 -96.15 160.78 14.26 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.917 1.687 . . . . 0.0 110.532 171.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 58.1 m -132.47 130.33 40.36 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.717 1.207 . . . . 0.0 109.41 175.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 96.7 mt -92.78 119.49 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.772 1.229 . . . . 0.0 110.13 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.16 -161.98 0.86 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.442 1.497 . . . . 0.0 110.915 170.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.6 ttmt -63.58 120.52 11.91 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 120.719 -1.238 . . . . 0.0 111.727 174.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.33 170.63 12.11 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.783 1.659 . . . . 0.0 112.868 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -98.3 143.83 28.36 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.35 1.06 . . . . 0.0 112.528 -172.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 9.8 tt -146.84 129.36 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.807 1.643 . . . . 0.0 110.335 175.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 76.8 p -146.61 -177.85 5.86 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.174 1.79 . . . . 0.0 110.337 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -165.38 -171.38 31.53 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 115.558 0.983 . . . . 0.0 115.558 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -152.26 141.12 21.06 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.941 1.696 . . . . 0.0 109.783 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 92.7 t -111.02 136.42 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.202 1.801 . . . . 0.0 108.25 172.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.8 mtp180 -118.06 129.49 55.59 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.943 1.297 . . . . 0.0 110.634 -179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 17.7 mtm -99.91 151.66 37.56 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 125.76 1.624 . . . . 0.0 111.52 -176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -69.81 -18.88 36.5 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.477 2.785 . . . . 0.0 113.021 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 25.8 p -74.85 -4.13 36.01 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.705 1.602 . . . . 0.0 114.177 171.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.83 -6.53 79.54 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.757 1.646 . . . . 0.0 114.206 -178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.1 mtpt -68.44 160.01 30.53 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.925 1.29 . . . . 0.0 112.616 173.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -137.49 156.83 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.207 1.403 . . . . 0.0 111.586 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.36 178.65 9.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.944 2.097 . . . . 0.0 110.095 179.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -119.31 142.13 31.86 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.039 -1.038 . . . . 0.0 111.788 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -83.91 166.98 12.98 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 124.059 3.173 . . . . 0.0 111.566 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.5 m -102.31 120.39 40.41 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.484 1.514 . . . . 0.0 108.883 174.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.1 mp -99.6 137.97 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.993 1.317 . . . . 0.0 109.158 177.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 19.0 m -144.37 131.76 20.86 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.334 1.453 . . . . 0.0 110.082 176.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -83.43 129.3 34.98 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.782 0.833 . . . . 0.0 110.218 168.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -80.85 -4.63 55.43 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 -175.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 26.7 mmmt 69.84 13.27 8.02 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 127.525 2.33 . . . . 0.0 113.365 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -126.59 13.88 7.55 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 126.699 2.0 . . . . 0.0 112.755 -173.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.5 13.54 59.71 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.828 1.204 . . . . 0.0 114.56 -179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 58.4 p -132.33 157.56 44.14 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.208 1.803 . . . . 0.0 110.28 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.4 m -114.51 148.1 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.509 1.123 . . . . 0.0 109.769 165.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.8 m -114.57 137.02 52.39 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.737 1.215 . . . . 0.0 108.256 167.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.0 t -122.15 130.48 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 C-N-CA 124.875 1.27 . . . . 0.0 108.812 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -125.89 160.92 28.65 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 125.012 1.325 . . . . 0.0 112.546 -174.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 16.5 t80 -157.08 134.22 10.39 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.104 1.362 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.56 117.27 68.41 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 124.699 1.2 . . . . 0.0 110.664 176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -80.99 162.98 20.57 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.592 2.861 . . . . 0.0 112.382 -172.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.9 p -135.69 -20.14 1.57 Allowed 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 115.067 1.506 . . . . 0.0 115.067 171.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -143.27 155.26 44.44 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.737 1.615 . . . . 0.0 110.987 178.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.93 174.12 11.94 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.516 1.126 . . . . 0.0 112.655 174.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 110.67 -170.86 14.2 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.838 1.685 . . . . 0.0 113.843 177.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 22.9 tp -85.17 132.19 34.33 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.753 1.221 . . . . 0.0 110.766 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.0 m80 -129.84 170.72 13.54 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.687 1.995 . . . . 0.0 111.055 -174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -146.0 154.06 41.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.445 1.098 . . . . 0.0 111.424 173.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 2.3 ttm -138.66 123.73 19.03 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.352 1.461 . . . . 0.0 110.82 -173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -96.87 135.83 38.28 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.081 1.753 . . . . 0.0 110.305 174.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.7 mm -132.85 137.44 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.208 1.403 . . . . 0.0 109.997 171.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.68 135.25 18.44 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 -173.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 7.8 t80 -102.98 124.17 47.98 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.634 1.973 . . . . 0.0 109.558 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.9 t70 50.34 40.38 22.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 124.902 1.281 . . . . 0.0 112.467 -174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 28.5 m120 76.36 -3.6 2.51 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 128.292 2.637 . . . . 0.0 114.845 -179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.8 mtm -103.45 134.18 47.25 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.472 1.509 . . . . 0.0 111.462 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m170 -56.26 135.63 53.44 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 31.8 pt -73.9 157.48 87.13 Favored Pre-proline 0 N--CA 1.482 1.146 0 CA-C-O 118.698 -0.667 . . . . 0.0 111.505 174.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -57.97 125.81 19.73 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.635 2.224 . . . . 0.0 110.988 175.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.35 -9.94 71.62 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.991 1.281 . . . . 0.0 114.69 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.1 t -82.78 147.31 54.77 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.36 1.58 . . . . 0.0 111.667 175.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -83.4 164.76 69.02 Favored 'Cis proline' 0 C--N 1.353 0.803 0 CA-C-N 120.126 1.081 . . . . 0.0 112.451 -4.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.7 mt -103.37 156.64 17.59 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.703 1.601 . . . . 0.0 111.998 179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -136.71 136.36 38.95 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.366 1.466 . . . . 0.0 109.191 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 35.8 p90 -155.9 150.07 25.56 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -167.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 57.8 t80 -105.2 142.31 35.19 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.182 0.993 . . . . 0.0 112.199 177.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -124.83 138.33 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.692 1.597 . . . . 0.0 109.056 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 37.2 t0 -162.22 157.32 22.87 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.372 1.469 . . . . 0.0 111.581 -172.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -82.73 146.19 29.16 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 120.963 -1.085 . . . . 0.0 113.188 -177.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.1 t -62.63 -30.84 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 125.102 1.361 . . . . 0.0 112.281 178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -80.22 -11.34 59.74 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -175.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.6 m -57.96 136.34 57.07 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -173.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.85 61.9 1.95 Allowed Glycine 0 N--CA 1.469 0.878 0 C-N-CA 125.809 1.671 . . . . 0.0 112.575 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -158.56 166.67 31.56 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.228 1.411 . . . . 0.0 113.269 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 10.6 p -70.15 139.76 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.876 0.871 . . . . 0.0 110.089 166.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -156.41 167.64 29.8 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 125.464 1.506 . . . . 0.0 110.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.23 145.98 31.52 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.39 1.076 . . . . 0.0 112.257 -176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.9 p90 -167.86 166.08 13.64 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.929 1.691 . . . . 0.0 112.882 -177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.03 172.02 13.03 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 125.7 1.619 . . . . 0.0 112.362 -174.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.3 -34.84 12.08 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 122.859 2.372 . . . . 0.0 113.191 -169.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.14 -29.13 73.21 Favored Glycine 0 CA--C 1.53 1.002 0 CA-C-O 118.844 -0.976 . . . . 0.0 114.625 -170.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.1 pp -81.85 -0.13 42.1 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 119.21 1.505 . . . . 0.0 113.659 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 19.6 m -116.22 -42.21 3.07 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 127.051 2.141 . . . . 0.0 111.999 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -140.6 153.05 45.92 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.823 1.649 . . . . 0.0 112.604 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -155.09 -176.13 26.93 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.112 0.863 . . . . 0.0 113.436 167.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.8 p -151.6 137.98 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.92 1.288 . . . . 0.0 108.982 176.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.3 m -58.29 143.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 69.56 5.76 5.35 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.607 1.963 . . . . 0.0 114.776 174.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.6 mttm -117.41 147.49 40.74 Favored Pre-proline 0 N--CA 1.476 0.854 0 C-N-CA 124.862 1.265 . . . . 0.0 111.194 171.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -72.25 138.65 30.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.62 2.214 . . . . 0.0 110.806 175.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -118.81 147.52 43.83 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.928 1.691 . . . . 0.0 110.3 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.6 p -135.52 152.45 51.33 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.088 0.955 . . . . 0.0 113.573 -166.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -162.67 176.53 10.24 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 126.093 1.757 . . . . 0.0 111.325 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 81.8 m -132.3 138.53 47.86 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.88 1.272 . . . . 0.0 110.68 -171.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.2 t -104.0 130.29 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.135 1.374 . . . . 0.0 107.6 167.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -97.3 123.8 41.23 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.561 1.144 . . . . 0.0 110.187 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 52.8 p -127.97 5.97 5.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.793 1.637 . . . . 0.0 113.397 -167.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -54.54 -33.92 60.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.629 1.572 . . . . 0.0 114.647 -171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 24.0 t70 -113.9 7.02 16.83 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.537 1.535 . . . . 0.0 113.259 178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.41 -14.86 59.61 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.04 -97.98 2.19 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.493 1.044 . . . . 0.0 112.761 174.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -162.67 171.38 16.95 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.381 1.473 . . . . 0.0 112.515 -169.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 125.46 -160.62 20.0 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 126.005 1.764 . . . . 0.0 112.771 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -91.98 115.25 4.73 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.257 0.932 . . . . 0.0 111.371 175.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -85.7 128.4 34.77 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.199 1.4 . . . . 0.0 108.88 171.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 34.4 m -129.9 158.54 39.24 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.508 1.523 . . . . 0.0 112.289 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -160.18 135.55 8.12 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.239 1.816 . . . . 0.0 108.909 -169.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.41 157.91 34.89 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.666 0.786 . . . . 0.0 112.497 177.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -136.29 140.39 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.132 1.373 . . . . 0.0 109.763 176.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -133.22 136.11 45.42 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.431 1.492 . . . . 0.0 109.38 171.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -161.29 -164.55 16.39 Favored Glycine 0 CA--C 1.537 1.455 0 CA-C-O 119.107 -0.829 . . . . 0.0 114.833 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -63.86 -27.19 67.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 124.077 3.185 . . . . 0.0 112.417 177.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.3 t -135.4 159.86 40.26 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.868 1.267 . . . . 0.0 109.352 159.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -75.76 109.51 9.42 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.042 -1.036 . . . . 0.0 110.871 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.03 147.27 52.62 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.724 0.809 . . . . 0.0 111.768 174.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -85.94 145.5 27.11 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 123.387 0.675 . . . . 0.0 110.083 166.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.94 140.21 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.775 1.23 . . . . 0.0 110.203 -167.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 57.9 m -135.35 157.01 47.98 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.587 1.555 . . . . 0.0 110.776 167.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -156.16 156.7 34.66 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.094 0.957 . . . . 0.0 112.458 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.1 m -141.91 122.13 13.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.035 1.334 . . . . 0.0 110.406 -172.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.47 132.05 41.57 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.97 1.308 . . . . 0.0 111.065 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 66.6 m-20 -112.76 146.4 38.86 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.173 1.389 . . . . 0.0 111.75 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.45 -13.3 61.91 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.986 0.914 . . . . 0.0 113.312 172.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -74.77 -4.88 40.28 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.242 1.817 . . . . 0.0 114.219 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.25 31.55 9.61 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 124.58 1.086 . . . . 0.0 113.804 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 82.0 p -141.06 161.35 38.05 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.351 1.46 . . . . 0.0 111.357 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 78.9 m -112.85 128.23 56.4 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.719 1.207 . . . . 0.0 109.004 158.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.1 t -87.4 148.02 25.18 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.681 0.792 . . . . 0.0 110.462 170.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 85.4 t -129.39 142.83 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.672 1.589 . . . . 0.0 110.214 -178.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 69.6 p -136.45 145.75 45.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.922 1.289 . . . . 0.0 111.591 165.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.4 p90 -148.44 156.9 43.07 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.018 -1.051 . . . . 0.0 112.693 175.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -126.06 104.84 25.84 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 124.264 1.026 . . . . 0.0 110.666 -174.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -84.17 172.13 9.8 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 124.226 3.284 . . . . 0.0 111.219 173.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.6 p -147.36 -29.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -172.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 75.7 mt -107.28 147.91 36.11 Favored Pre-proline 0 CA--C 1.543 0.708 0 CA-C-N 119.515 1.052 . . . . 0.0 110.776 167.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -73.49 156.49 49.88 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 122.911 2.408 . . . . 0.0 110.696 173.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.96 -162.53 24.74 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.104 1.335 . . . . 0.0 113.003 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -104.03 125.85 50.7 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.344 1.058 . . . . 0.0 111.242 -177.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -109.97 129.47 55.66 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.881 1.672 . . . . 0.0 110.023 178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -88.23 127.19 35.45 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.398 1.079 . . . . 0.0 110.611 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -106.64 127.81 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.63 1.572 . . . . 0.0 108.657 179.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -109.31 134.78 51.37 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.82 1.648 . . . . 0.0 109.756 174.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.6 t -136.29 131.27 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.249 1.419 . . . . 0.0 108.546 172.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.12 143.22 22.3 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.865 1.266 . . . . 0.0 111.332 -170.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.77 124.67 15.17 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.849 1.259 . . . . 0.0 109.941 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 57.85 51.82 8.7 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.868 1.267 . . . . 0.0 111.683 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 9.0 pt-20 55.57 17.24 2.2 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 128.149 2.579 . . . . 0.0 115.84 -175.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -122.02 128.82 51.86 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.858 1.263 . . . . 0.0 110.725 179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -65.18 156.24 32.4 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.132 0.973 . . . . 0.0 112.829 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.7 m -72.82 152.48 91.17 Favored Pre-proline 0 N--CA 1.48 1.029 0 O-C-N 121.545 -0.722 . . . . 0.0 109.247 168.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -67.94 -11.15 31.13 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 121.965 1.777 . . . . 0.0 114.657 -166.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -105.0 -7.48 38.22 Favored Glycine 0 CA--C 1.534 1.26 0 N-CA-C 116.148 1.219 . . . . 0.0 116.148 173.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 85.1 p -85.89 156.4 58.11 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 120.143 1.971 . . . . 0.0 113.722 -174.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.19 144.53 79.75 Favored 'Cis proline' 0 C--N 1.354 0.844 0 CA-C-N 118.968 0.667 . . . . 0.0 112.136 -5.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -95.71 167.93 10.98 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.362 1.465 . . . . 0.0 110.668 175.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 29.6 m -130.54 118.09 20.56 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.909 0.884 . . . . 0.0 110.23 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.72 127.29 44.6 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.086 1.354 . . . . 0.0 110.684 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 39.6 ttt85 -92.13 117.12 29.54 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 122.664 0.386 . . . . 0.0 110.353 176.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -102.81 140.82 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.087 1.755 . . . . 0.0 109.45 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.9 t -128.57 173.46 10.24 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.164 0.986 . . . . 0.0 112.76 -178.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.92 140.69 21.07 Favored Glycine 0 CA--C 1.531 1.077 0 C-N-CA 125.806 1.669 . . . . 0.0 112.193 178.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 25.1 t70 -85.42 -8.74 58.24 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 124.112 0.965 . . . . 0.0 113.464 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 3.2 p-10 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 126.732 2.013 . . . . 0.0 113.118 -177.825 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.373 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.29 -43.67 69.93 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 117.806 0.803 . . . . 0.0 110.949 169.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? -79.8 168.07 19.76 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.15 1.78 . . . . 0.0 111.404 161.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -57.73 -50.36 88.58 Favored Pre-proline 0 CA--C 1.554 1.1 0 CA-C-O 117.24 -1.362 . . . . 0.0 114.518 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.7 172.57 15.52 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 122.82 2.347 . . . . 0.0 111.706 173.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -80.89 -13.45 58.91 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.612 0.765 . . . . 0.0 112.586 170.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 87.1 mtm-85 -79.93 137.49 53.8 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.281 1.433 . . . . 0.0 111.66 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.35 157.44 49.65 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 123.554 2.836 . . . . 0.0 111.473 177.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 90.7 mt -116.06 12.63 15.66 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.909 1.284 . . . . 0.0 113.387 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 78.0 t -121.44 132.9 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.126 1.771 . . . . 0.0 110.203 -174.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -105.04 166.44 14.63 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 125.6 1.571 . . . . 0.0 113.7 177.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 9.9 p -74.64 147.15 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.889 1.276 . . . . 0.0 111.855 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 45.2 p-10 -79.56 -9.24 59.59 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 84.42 7.92 84.05 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.339 1.447 . . . . 0.0 115.348 177.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 95.9 mt -117.29 158.44 24.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.534 1.534 . . . . 0.0 111.473 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 4.1 t0 -158.04 175.54 13.67 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.222 1.409 . . . . 0.0 110.778 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 23.7 m -60.94 -20.63 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.554 1.142 . . . . 0.0 113.775 -175.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.8 t -80.82 -15.3 56.76 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.276 1.83 . . . . 0.0 113.454 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 40.8 m -66.05 144.21 56.86 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.179 -0.951 . . . . 0.0 112.838 -176.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 48.3 mt -82.97 147.92 27.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.225 1.01 . . . . 0.0 111.172 171.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -60.12 117.49 24.28 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 126.005 1.722 . . . . 0.0 110.837 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.29 152.74 44.95 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.821 2.347 . . . . 0.0 111.052 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -94.26 116.25 28.62 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 169.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -145.49 125.29 13.43 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.771 1.228 . . . . 0.0 110.184 168.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.92 147.02 39.96 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.304 1.842 . . . . 0.0 109.55 -174.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -122.32 136.94 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.967 1.307 . . . . 0.0 110.453 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 71.4 mt -135.15 136.15 24.16 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 125.893 1.677 . . . . 0.0 109.287 -174.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -71.12 117.67 5.28 Favored 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.401 2.734 . . . . 0.0 110.167 173.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 43.6 t80 178.02 149.6 0.2 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.591 2.356 . . . . 0.0 109.315 -168.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 23.9 m -130.75 125.69 34.47 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.136 0.974 . . . . 0.0 110.336 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 31.8 mt -83.16 119.33 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.744 1.218 . . . . 0.0 108.954 171.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -122.68 -53.21 1.89 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.913 0.885 . . . . 0.0 113.189 -177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -160.18 121.74 3.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.313 1.445 . . . . 0.0 111.398 -179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.68 -146.7 18.61 Favored Glycine 0 N--CA 1.473 1.112 0 C-N-CA 125.735 1.636 . . . . 0.0 111.716 -169.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -158.6 146.94 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.711 1.204 . . . . 0.0 110.959 -175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 10.8 tt -130.58 136.51 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.523 1.529 . . . . 0.0 111.571 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 41.4 p -147.23 -177.99 5.98 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.611 1.964 . . . . 0.0 110.158 -176.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.67 -166.99 34.63 Favored Glycine 0 CA--C 1.528 0.862 0 N-CA-C 115.324 0.889 . . . . 0.0 115.324 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.86 131.84 9.93 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.497 1.519 . . . . 0.0 110.306 177.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 18.3 t -101.6 136.53 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.367 1.467 . . . . 0.0 108.648 170.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.7 mtp85 -120.32 131.11 54.73 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.719 1.207 . . . . 0.0 111.222 -173.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.3 mpp? -105.78 148.33 36.27 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.798 1.639 . . . . 0.0 112.104 -171.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -50.55 -39.79 55.21 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 124.8 3.667 . . . . 0.0 115.784 178.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 7.1 t -73.64 -1.4 18.74 Favored 'General case' 0 CA--C 1.553 1.087 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.85 -0.44 60.8 Favored Glycine 0 N--CA 1.475 1.258 0 C-N-CA 125.707 1.622 . . . . 0.0 114.366 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -69.49 160.71 30.92 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.246 1.418 . . . . 0.0 112.169 174.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.5 m -139.41 155.25 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 125.334 1.454 . . . . 0.0 111.609 176.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.62 163.29 40.13 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.79 1.636 . . . . 0.0 111.37 -178.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -97.63 137.02 21.01 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.567 0.747 . . . . 0.0 111.577 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -84.11 169.18 11.62 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 124.59 3.527 . . . . 0.0 111.924 174.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -110.55 139.08 46.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.733 1.613 . . . . 0.0 108.995 172.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.8 mp -127.24 132.24 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.668 1.187 . . . . 0.0 109.283 174.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -134.29 127.09 31.08 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.416 1.487 . . . . 0.0 109.74 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.08 127.17 31.9 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.458 0.703 . . . . 0.0 110.279 170.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -79.01 -3.49 45.35 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 -174.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.2 mmtm 71.24 13.12 6.75 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 127.76 2.424 . . . . 0.0 113.13 -178.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.7 t70 -126.63 11.09 7.27 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.825 2.05 . . . . 0.0 113.001 -173.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.48 12.78 57.98 Favored Glycine 0 CA--C 1.535 1.308 0 C-N-CA 124.855 1.217 . . . . 0.0 114.821 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.2 p -128.38 154.32 46.12 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.064 1.746 . . . . 0.0 110.396 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.2 m -111.62 141.42 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.903 0.881 . . . . 0.0 109.894 165.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 38.0 m -103.43 133.61 48.2 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.604 1.162 . . . . 0.0 108.412 168.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 59.9 t -116.99 134.4 60.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.125 1.77 . . . . 0.0 108.649 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -139.2 159.2 42.71 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.636 1.174 . . . . 0.0 113.47 -172.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.2 t80 -158.47 135.84 10.11 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.019 1.727 . . . . 0.0 111.483 174.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.93 120.0 73.23 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 124.726 1.21 . . . . 0.0 110.846 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -78.33 148.03 23.5 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 123.706 2.937 . . . . 0.0 112.607 -170.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.0 p -142.25 5.41 1.66 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.664 1.186 . . . . 0.0 114.009 177.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -160.18 144.52 14.44 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.895 1.678 . . . . 0.0 110.056 -173.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.86 163.51 13.31 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.734 1.214 . . . . 0.0 112.196 176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 114.45 -168.76 12.65 Favored Glycine 0 N--CA 1.472 1.096 0 C-N-CA 125.247 1.403 . . . . 0.0 113.665 -178.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -86.21 122.26 29.96 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.522 1.129 . . . . 0.0 110.085 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 64.9 m80 -118.61 161.58 19.82 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.966 1.707 . . . . 0.0 111.822 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -140.16 155.96 46.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.433 1.093 . . . . 0.0 111.425 173.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 40.9 ttm -140.77 118.37 11.59 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.253 1.421 . . . . 0.0 111.156 -172.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 8.9 t70 -81.56 134.98 35.57 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.255 2.222 . . . . 0.0 109.832 168.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 19.9 mm -141.09 136.32 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.349 1.459 . . . . 0.0 108.714 171.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.59 136.84 16.58 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 9.9 t80 -97.21 121.98 39.71 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.741 2.016 . . . . 0.0 109.795 174.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.9 t70 51.94 35.51 16.05 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.876 1.27 . . . . 0.0 112.775 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 76.69 4.22 3.47 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 127.983 2.513 . . . . 0.0 114.506 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.6 mtm -107.53 132.6 53.07 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.68 1.592 . . . . 0.0 110.952 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.24 139.07 55.75 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 39.9 pt -74.71 155.21 87.19 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 123.456 0.702 . . . . 0.0 110.902 171.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -59.58 119.78 7.21 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.932 2.421 . . . . 0.0 111.942 -175.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.29 -3.9 69.83 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 125.52 1.533 . . . . 0.0 115.128 179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 38.8 m -80.79 154.69 73.3 Favored Pre-proline 0 CA--C 1.55 0.944 0 CA-C-N 119.758 1.779 . . . . 0.0 112.025 169.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.97 155.01 99.73 Favored 'Cis proline' 0 C--N 1.354 0.817 0 CA-C-N 119.422 0.829 . . . . 0.0 112.538 -0.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 55.1 mt -92.92 159.56 15.29 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.097 1.359 . . . . 0.0 110.86 176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -159.08 133.9 8.11 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.315 1.046 . . . . 0.0 110.478 -174.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.92 -179.48 5.27 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.032 1.333 . . . . 0.0 112.697 -174.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -118.31 137.29 53.17 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.219 1.008 . . . . 0.0 113.353 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 60.0 t -108.95 138.04 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 126.25 1.82 . . . . 0.0 110.021 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 2.6 t0 -149.1 178.9 8.31 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 126.334 1.853 . . . . 0.0 109.509 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -77.85 143.07 38.11 Favored 'General case' 0 CA--C 1.546 0.794 0 O-C-N 120.693 -1.254 . . . . 0.0 111.304 173.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.9 m -65.47 -17.71 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 -166.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -148.81 41.41 0.93 Allowed 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 123.978 0.911 . . . . 0.0 112.431 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 2.6 t -66.68 -28.58 68.56 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.345 0.868 . . . . 0.0 113.345 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 106.09 -25.36 23.93 Favored Glycine 0 N--CA 1.473 1.141 0 C-N-CA 126.113 1.815 . . . . 0.0 115.019 169.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 25.2 p-80 -72.42 160.49 32.25 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-N 118.909 1.354 . . . . 0.0 113.445 175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.5 t -64.36 134.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 C-N-CA 124.603 1.161 . . . . 0.0 109.678 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -161.47 150.09 15.79 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.59 1.156 . . . . 0.0 110.874 -173.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -118.96 147.05 44.47 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.836 1.254 . . . . 0.0 111.978 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.4 p90 -166.8 158.02 12.48 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.082 1.753 . . . . 0.0 112.818 177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 141.19 170.3 12.16 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.309 1.433 . . . . 0.0 113.258 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.61 -33.19 17.66 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.144 2.563 . . . . 0.0 112.942 -170.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.18 -34.92 82.04 Favored Glycine 0 CA--C 1.526 0.776 0 CA-C-N 119.263 0.938 . . . . 0.0 114.047 -174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.85 -5.99 54.94 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 118.645 1.222 . . . . 0.0 112.658 175.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.6 m -99.09 -45.56 5.88 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.073 1.749 . . . . 0.0 111.406 175.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -147.57 142.38 26.8 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.531 1.932 . . . . 0.0 111.987 -170.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -137.31 170.4 23.61 Favored Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.373 0.987 . . . . 0.0 113.376 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 59.9 t -134.92 135.58 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.144 1.378 . . . . 0.0 107.963 173.073 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -55.85 133.84 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.199 0.6 . . . . 0.0 112.493 -177.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.8 m-80 68.08 -0.19 2.19 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 127.094 2.158 . . . . 0.0 114.54 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -100.59 140.06 21.1 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.084 1.354 . . . . 0.0 110.973 175.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.45 120.96 7.06 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.636 2.224 . . . . 0.0 110.227 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.61 133.89 48.7 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.331 1.452 . . . . 0.0 110.141 177.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.1 p -128.5 149.46 50.58 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.756 1.021 . . . . 0.0 113.756 -165.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.49 178.65 8.91 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.74 1.616 . . . . 0.0 111.728 178.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -130.79 145.14 51.89 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.129 1.372 . . . . 0.0 110.793 -169.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.0 t -116.55 132.65 65.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.644 1.578 . . . . 0.0 108.288 167.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -94.25 128.67 40.86 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.31 1.044 . . . . 0.0 111.009 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 48.7 p -136.46 3.51 2.81 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 125.47 1.508 . . . . 0.0 113.792 -167.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.0 tttt -53.73 -40.23 65.93 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.422 1.489 . . . . 0.0 114.668 -169.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -107.43 5.87 27.69 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 125.505 1.522 . . . . 0.0 113.123 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.28 -19.11 61.13 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 85.07 -89.98 1.63 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 124.724 1.154 . . . . 0.0 112.497 176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -165.04 173.06 11.92 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.286 1.434 . . . . 0.0 112.648 -169.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 121.09 -167.52 14.07 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 126.199 1.857 . . . . 0.0 112.73 -177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.64 106.55 3.2 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 123.935 0.779 . . . . 0.0 111.791 177.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -78.6 124.6 28.34 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.509 1.124 . . . . 0.0 108.586 168.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 46.1 m -124.07 158.04 33.13 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.782 1.633 . . . . 0.0 112.24 -173.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.6 tp -159.46 137.22 10.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.857 1.663 . . . . 0.0 109.515 -172.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 160.57 37.62 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.354 1.061 . . . . 0.0 111.909 175.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.8 mt -135.53 132.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.499 1.12 . . . . 0.0 109.6 174.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -115.88 108.06 15.81 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.182 1.393 . . . . 0.0 109.413 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -117.53 -178.16 17.5 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 125.124 1.345 . . . . 0.0 113.743 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.79 -26.1 52.83 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.797 2.998 . . . . 0.0 111.652 170.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 151.48 51.97 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.234 1.414 . . . . 0.0 108.646 155.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -72.18 122.25 20.72 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 120.957 -1.089 . . . . 0.0 112.0 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.88 154.27 41.35 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.443 1.097 . . . . 0.0 112.12 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -88.88 139.62 30.27 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.354 0.662 . . . . 0.0 109.397 166.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 34.4 mt -133.85 143.61 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.486 1.114 . . . . 0.0 110.435 -166.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 10.8 t -142.58 161.64 37.53 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.31 1.444 . . . . 0.0 111.065 168.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -160.09 155.11 24.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.92 1.288 . . . . 0.0 112.687 -177.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.0 m -141.65 127.32 19.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.375 1.47 . . . . 0.0 110.455 -171.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.6 t70 -77.91 131.63 37.56 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.814 1.246 . . . . 0.0 111.264 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -111.13 151.06 28.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.129 1.371 . . . . 0.0 112.442 -176.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -67.69 -19.68 65.19 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.49 1.116 . . . . 0.0 112.461 173.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.23 -5.71 37.76 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.811 1.644 . . . . 0.0 114.421 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 90.22 33.96 8.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.46 1.029 . . . . 0.0 113.235 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.9 p -141.28 161.37 38.05 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.518 1.527 . . . . 0.0 111.143 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.5 m -108.6 131.68 54.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.859 1.263 . . . . 0.0 108.913 158.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -91.09 149.89 21.63 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.939 0.895 . . . . 0.0 110.486 168.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 95.1 t -130.2 144.8 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 126.046 1.739 . . . . 0.0 109.973 -177.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.1 t -140.35 141.05 35.68 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.486 1.514 . . . . 0.0 110.932 170.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.6 p90 -147.03 153.99 40.67 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 31.0 mt -118.51 103.32 49.1 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 126.483 1.913 . . . . 0.0 110.256 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.12 161.99 17.94 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.647 2.898 . . . . 0.0 110.306 168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.5 m -126.39 -10.06 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -155.48 151.63 22.82 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.207 1.403 . . . . 0.0 110.419 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.24 142.99 27.81 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.762 2.308 . . . . 0.0 111.649 -172.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 155.4 -167.59 32.99 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.779 1.181 . . . . 0.0 113.299 -174.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -101.08 128.54 47.09 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.573 1.149 . . . . 0.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -120.15 123.23 42.81 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.65 1.58 . . . . 0.0 110.121 -176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 48.8 m -86.45 125.78 33.95 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.039 -1.038 . . . . 0.0 111.22 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.57 128.55 53.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.531 1.533 . . . . 0.0 108.614 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -110.23 129.95 55.63 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.301 1.44 . . . . 0.0 109.655 176.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.5 t -132.59 128.93 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.435 1.094 . . . . 0.0 109.757 172.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.39 143.68 24.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.269 1.428 . . . . 0.0 111.046 -168.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.88 121.74 11.99 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.535 1.134 . . . . 0.0 109.721 -178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.77 55.28 5.56 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.034 1.333 . . . . 0.0 111.544 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.295 8.2 pt-20 58.26 13.19 2.24 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 128.396 2.678 . . . . 0.0 116.267 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.18 126.2 49.08 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.647 1.179 . . . . 0.0 110.909 177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -63.57 146.15 54.28 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 121.505 -0.747 . . . . 0.0 111.803 170.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.5 m -71.19 152.76 94.51 Favored Pre-proline 0 N--CA 1.48 1.048 0 CA-C-O 118.484 -0.769 . . . . 0.0 110.152 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -56.96 129.59 35.33 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.005 2.47 . . . . 0.0 110.895 175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.7 -17.69 57.17 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.169 1.366 . . . . 0.0 114.89 -175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 35.6 t -77.77 140.13 62.94 Favored Pre-proline 0 CA--C 1.549 0.916 0 CA-C-N 119.26 1.53 . . . . 0.0 111.542 176.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.0 135.42 40.07 Favored 'Cis proline' 0 C--N 1.352 0.735 0 CA-C-N 119.377 0.813 . . . . 0.0 111.717 -4.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -88.67 176.85 6.93 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.223 1.809 . . . . 0.0 110.492 174.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 95.4 m -137.35 123.25 20.13 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.94 0.896 . . . . 0.0 111.096 172.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.12 160.07 15.01 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.127 1.771 . . . . 0.0 110.711 167.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -122.13 126.31 48.09 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.788 0.835 . . . . 0.0 110.921 172.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.5 t -106.19 141.01 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.21 1.804 . . . . 0.0 109.881 -174.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -130.33 171.11 13.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.567 1.147 . . . . 0.0 112.978 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.91 144.34 31.06 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.382 1.468 . . . . 0.0 112.557 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.88 -17.29 55.84 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.231 1.012 . . . . 0.0 113.2 177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.252 1.21 0 C-N-CA 126.786 2.035 . . . . 0.0 112.518 -179.086 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.63 162.98 28.6 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.396 1.078 . . . . 0.0 112.842 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.8 mtp -71.54 149.93 45.26 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.327 1.051 . . . . 0.0 112.218 178.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -70.44 152.7 95.41 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 124.404 1.082 . . . . 0.0 112.291 175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -72.07 168.27 24.46 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.758 2.972 . . . . 0.0 111.997 177.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.86 -179.43 7.13 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.356 1.462 . . . . 0.0 112.196 -176.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 6.3 tpp85 -156.69 136.29 8.35 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 125.009 1.324 . . . . 0.0 110.71 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -70.98 153.07 63.47 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.841 2.361 . . . . 0.0 111.058 178.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 9.9 mp 65.55 9.92 6.24 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 126.506 1.922 . . . . 0.0 113.949 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 9.8 p -64.98 -20.4 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 C-N-CA 125.237 1.415 . . . . 0.0 113.629 -179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 120.33 -171.76 14.73 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 125.751 1.644 . . . . 0.0 113.683 178.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 96.9 t -124.66 137.17 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 126.029 1.732 . . . . 0.0 109.177 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 30.0 m120 -69.96 127.76 33.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.823 0.849 . . . . 0.0 111.728 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 81.18 165.55 34.49 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.762 1.172 . . . . 0.0 113.516 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 95.1 mt -114.17 172.75 6.81 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.635 1.574 . . . . 0.0 111.551 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 45.3 t0 -150.65 161.73 42.03 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.876 1.67 . . . . 0.0 111.285 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 14.1 p -164.15 139.99 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.059 1.744 . . . . 0.0 110.928 -175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.5 t -158.21 26.72 0.25 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.554 1.542 . . . . 0.0 111.949 -174.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 18.6 m -80.68 149.15 29.88 Favored 'General case' 0 N--CA 1.473 0.686 0 O-C-N 120.699 -1.25 . . . . 0.0 113.635 -171.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.58 141.25 53.81 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 121.51 -0.744 . . . . 0.0 109.853 161.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 54.1 ttm-85 -66.01 119.98 65.7 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.854 1.261 . . . . 0.0 110.608 -174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.71 137.74 43.05 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 122.93 2.42 . . . . 0.0 110.197 -175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 27.4 t80 -105.63 129.91 53.77 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.535 0.734 . . . . 0.0 111.663 -174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -157.61 142.8 16.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.505 1.522 . . . . 0.0 111.2 171.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.42 151.02 45.93 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 126.164 1.786 . . . . 0.0 109.954 -176.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.4 p -115.59 138.07 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 125.297 1.439 . . . . 0.0 109.938 175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 60.6 mt -130.34 134.49 26.14 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.002 1.721 . . . . 0.0 108.713 -175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.51 100.02 1.28 Allowed 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.385 2.724 . . . . 0.0 109.572 173.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 62.9 t80 -161.82 148.79 14.14 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.496 1.918 . . . . 0.0 109.164 -176.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.5 m -124.28 125.93 45.2 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.506 1.122 . . . . 0.0 109.357 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 80.1 mt -86.01 126.0 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 124.191 0.996 . . . . 0.0 109.933 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -110.29 -161.25 0.75 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.946 1.698 . . . . 0.0 111.658 172.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.97 126.46 29.55 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 120.897 -1.127 . . . . 0.0 111.509 172.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.39 -144.6 12.98 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.952 1.739 . . . . 0.0 111.476 -170.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -157.74 141.95 16.08 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.146 0.978 . . . . 0.0 111.752 -176.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.4 tt -133.5 134.04 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.052 1.741 . . . . 0.0 110.607 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.2 p -148.25 166.5 27.78 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 125.85 1.66 . . . . 0.0 111.06 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.73 -175.34 24.13 Favored Glycine 0 N--CA 1.468 0.772 0 N-CA-C 116.49 1.356 . . . . 0.0 116.49 -175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -153.99 140.68 18.99 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.683 1.993 . . . . 0.0 109.333 177.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.2 t -117.92 131.71 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 125.716 1.606 . . . . 0.0 108.19 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 59.7 mtt180 -113.92 125.34 53.93 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.479 1.112 . . . . 0.0 110.633 -169.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 37.6 mtm -104.25 138.67 19.59 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 125.354 1.461 . . . . 0.0 111.473 -173.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -56.42 -29.48 77.75 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 124.513 3.476 . . . . 0.0 116.098 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 9.0 p -77.67 8.13 4.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.152 1.381 . . . . 0.0 114.666 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 90.44 46.41 4.06 Favored Glycine 0 N--CA 1.472 1.038 0 C-N-CA 124.69 1.138 . . . . 0.0 113.168 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -154.54 162.42 41.15 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.646 1.578 . . . . 0.0 112.014 -173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.7 m -140.26 157.76 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.819 1.247 . . . . 0.0 112.396 -174.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -149.32 178.16 9.02 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.1 2.16 . . . . 0.0 109.999 175.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -117.83 142.19 30.37 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.114 -0.991 . . . . 0.0 111.75 178.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -83.64 167.22 13.3 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.214 3.276 . . . . 0.0 111.547 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 64.3 m -104.3 116.48 32.24 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.314 1.446 . . . . 0.0 108.982 174.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.24 130.03 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 124.328 1.051 . . . . 0.0 108.869 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 87.4 m -121.2 125.63 47.62 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.374 1.87 . . . . 0.0 109.491 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 63.2 t0 -82.47 116.93 22.14 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.26 1.024 . . . . 0.0 110.154 172.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -83.2 -14.0 54.24 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 74.1 mmtt 67.47 4.0 3.59 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 127.022 2.129 . . . . 0.0 114.204 -177.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -102.55 6.78 40.06 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 126.792 2.037 . . . . 0.0 113.146 -175.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.69 9.16 63.07 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.087 1.327 . . . . 0.0 113.912 -173.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.2 p -127.17 161.44 28.49 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 126.524 1.929 . . . . 0.0 110.558 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.8 m -120.69 144.48 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 123.961 0.904 . . . . 0.0 109.656 163.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.9 m -105.47 138.15 42.13 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.398 1.079 . . . . 0.0 108.144 170.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -125.52 127.58 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.162 0.985 . . . . 0.0 109.21 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 58.1 mtp85 -123.81 158.0 32.79 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.298 1.439 . . . . 0.0 112.229 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 15.3 t80 -157.35 134.36 10.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.147 1.379 . . . . 0.0 111.812 177.191 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.77 117.11 68.03 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 124.549 1.139 . . . . 0.0 110.515 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -76.22 145.15 27.13 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.234 2.623 . . . . 0.0 112.258 -173.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.6 t -138.73 -10.96 1.35 Allowed 'General case' 0 CA--C 1.549 0.928 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -139.49 153.21 47.47 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.404 1.882 . . . . 0.0 109.654 -176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -99.63 166.51 11.09 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.545 1.138 . . . . 0.0 112.556 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.01 -168.15 13.26 Favored Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.24 1.4 . . . . 0.0 114.217 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 31.1 tp -83.33 110.75 18.38 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.838 1.255 . . . . 0.0 110.91 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 44.7 m80 -105.73 170.96 7.59 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.341 1.856 . . . . 0.0 112.304 -175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -143.29 152.4 41.62 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.491 1.117 . . . . 0.0 111.49 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 13.6 ttm -122.21 127.67 50.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.034 1.734 . . . . 0.0 110.08 178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -102.69 131.58 49.4 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 127.25 2.22 . . . . 0.0 109.2 173.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.2 mm -138.32 135.1 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.78 1.232 . . . . 0.0 109.193 174.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.49 140.0 27.21 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.864 0.866 . . . . 0.0 113.324 179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.7 t80 -99.44 119.96 38.85 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.121 1.768 . . . . 0.0 109.179 172.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.6 t70 51.22 34.83 12.08 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.927 1.291 . . . . 0.0 113.057 -174.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.0 m-80 72.79 10.21 5.5 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 127.573 2.349 . . . . 0.0 115.133 -178.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 63.7 mtt -104.65 130.36 52.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.133 1.373 . . . . 0.0 110.391 167.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -57.29 137.65 55.76 Favored 'General case' 0 N--CA 1.476 0.861 0 O-C-N 121.243 -0.911 . . . . 0.0 113.35 -178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.7 pt -74.17 153.88 88.42 Favored Pre-proline 0 N--CA 1.478 0.953 0 CA-C-O 118.889 -0.577 . . . . 0.0 110.986 173.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -60.29 126.5 20.25 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.565 2.177 . . . . 0.0 110.632 178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.23 -18.2 54.52 Favored Glycine 0 CA--C 1.53 1.007 0 C-N-CA 125.14 1.353 . . . . 0.0 114.302 -176.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 62.0 m -87.64 154.91 53.67 Favored Pre-proline 0 N--CA 1.476 0.868 0 CA-C-N 119.848 1.824 . . . . 0.0 112.564 177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -75.22 158.11 98.95 Favored 'Cis proline' 0 C--N 1.354 0.838 0 CA-C-N 119.258 0.771 . . . . 0.0 112.241 -4.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.0 mt -103.53 157.71 16.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.985 1.314 . . . . 0.0 111.244 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 38.1 tt0 -141.22 138.89 33.62 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.068 1.347 . . . . 0.0 109.606 -178.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 5.5 p90 -166.64 159.39 14.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.507 1.123 . . . . 0.0 111.977 -172.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 35.3 t80 -101.24 139.56 36.75 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 121.145 -0.972 . . . . 0.0 112.656 178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 50.5 t -107.83 132.32 55.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.154 1.381 . . . . 0.0 109.688 175.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -147.79 175.18 11.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.991 2.117 . . . . 0.0 111.454 -176.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -84.71 145.02 28.16 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.787 0.835 . . . . 0.0 112.792 177.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 17.1 m -69.49 -25.81 29.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 O-C-N 121.544 -0.722 . . . . 0.0 112.221 175.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 t-20 -99.65 34.31 2.28 Favored 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 126.277 1.831 . . . . 0.0 111.691 177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 14.9 p -53.36 141.99 22.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.982 1.713 . . . . 0.0 114.208 -176.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.5 37.02 3.76 Favored Glycine 0 N--CA 1.473 1.135 0 C-N-CA 126.16 1.838 . . . . 0.0 112.255 174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.3 p-80 -166.93 156.52 10.93 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.619 1.568 . . . . 0.0 112.857 -167.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 12.1 p -61.1 141.96 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.576 1.15 . . . . 0.0 110.126 169.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 163.18 36.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.91 0.884 . . . . 0.0 111.604 -173.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.43 145.18 31.02 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.379 1.472 . . . . 0.0 111.936 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 54.7 p90 -166.31 157.73 13.33 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.796 1.638 . . . . 0.0 112.722 -173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 146.2 175.77 19.5 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.485 1.04 . . . . 0.0 114.483 174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.54 -43.49 1.99 Allowed 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.203 2.602 . . . . 0.0 112.259 -174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.46 -24.56 73.77 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-N 119.085 0.857 . . . . 0.0 113.641 -178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 38.7 tp -69.57 -19.17 63.68 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.975 1.31 . . . . 0.0 112.501 173.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 45.3 m -110.4 -49.73 3.03 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.06 1.744 . . . . 0.0 111.327 -172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -135.27 133.69 39.19 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.19 1.796 . . . . 0.0 112.035 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -119.38 167.37 13.31 Favored Glycine 0 N--CA 1.472 1.092 0 C-N-CA 124.593 1.092 . . . . 0.0 113.314 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.04 130.3 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.958 1.303 . . . . 0.0 109.218 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 31.4 m -65.49 139.46 21.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 123.836 0.854 . . . . 0.0 111.966 -175.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.83 6.12 4.4 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.674 1.99 . . . . 0.0 114.216 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 63.9 mttp -125.15 145.46 50.59 Favored Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.856 1.662 . . . . 0.0 111.06 177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.01 133.58 21.78 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.606 2.204 . . . . 0.0 111.05 -177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -115.65 147.49 40.76 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.758 1.623 . . . . 0.0 110.179 173.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.63 150.51 49.66 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -166.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -160.76 176.17 11.79 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.769 1.628 . . . . 0.0 111.662 175.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.5 m -131.65 144.21 50.86 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.301 1.441 . . . . 0.0 110.789 -168.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 36.3 t -113.92 138.19 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 126.075 1.75 . . . . 0.0 108.017 168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -104.8 127.44 52.6 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.47 1.108 . . . . 0.0 110.037 170.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -125.07 3.22 7.97 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 126.648 1.979 . . . . 0.0 113.323 -171.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.1 tttt -50.33 -36.71 33.24 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.317 1.847 . . . . 0.0 114.674 -174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.5 t70 -115.41 10.95 15.91 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.585 1.554 . . . . 0.0 113.132 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.57 -40.05 50.82 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -173.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.78 154.71 9.4 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.63 1.11 . . . . 0.0 112.323 -168.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.63 171.94 14.41 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.455 1.102 . . . . 0.0 112.957 178.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 134.72 14.87 1.12 Allowed Glycine 0 CA--C 1.537 1.409 0 C-N-CA 124.861 1.219 . . . . 0.0 115.81 -177.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 103.51 103.68 2.82 Favored Glycine 0 N--CA 1.472 1.077 0 C-N-CA 125.595 1.569 . . . . 0.0 113.204 172.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 28.2 tp -82.57 143.29 31.15 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.216 1.407 . . . . 0.0 110.52 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 25.6 m -136.07 156.8 48.18 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.368 1.467 . . . . 0.0 111.938 175.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.4 tp -157.96 133.58 9.03 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.206 1.803 . . . . 0.0 108.756 -173.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 159.78 38.45 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.738 0.815 . . . . 0.0 112.427 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.0 mt -134.58 131.2 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.565 1.146 . . . . 0.0 109.481 174.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -117.59 107.4 14.2 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.28 1.432 . . . . 0.0 109.309 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -120.52 -173.74 15.01 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.122 1.344 . . . . 0.0 113.992 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -67.57 -21.66 45.67 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.78 2.987 . . . . 0.0 111.904 171.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.0 t -137.94 157.9 45.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.629 1.572 . . . . 0.0 109.096 158.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -71.95 117.47 13.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.987 -1.071 . . . . 0.0 111.638 -177.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.05 149.05 43.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.939 0.895 . . . . 0.0 111.468 171.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.79 140.5 29.65 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.194 0.598 . . . . 0.0 109.536 167.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 43.8 mt -131.84 143.53 40.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.843 1.257 . . . . 0.0 110.111 -169.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.8 t -140.34 163.08 33.73 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.806 1.242 . . . . 0.0 110.829 166.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.8 p -161.51 155.33 21.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.524 1.13 . . . . 0.0 112.658 -176.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 81.5 m -137.19 114.72 11.09 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.61 1.564 . . . . 0.0 109.283 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -86.2 144.92 27.21 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.82 1.248 . . . . 0.0 112.226 174.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -123.07 147.76 46.37 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.411 1.484 . . . . 0.0 111.75 -177.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -71.98 -12.59 61.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.714 0.806 . . . . 0.0 112.514 174.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.2 -7.0 49.55 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.861 1.664 . . . . 0.0 114.027 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.94 32.57 7.07 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.576 1.084 . . . . 0.0 113.99 178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.3 p -141.08 161.31 38.15 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 111.292 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 30.0 m -132.3 133.14 43.7 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.343 1.457 . . . . 0.0 109.366 165.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -94.1 147.97 22.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.187 0.995 . . . . 0.0 110.459 171.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.0 t -130.72 142.84 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.736 1.614 . . . . 0.0 110.118 -177.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 90.5 p -135.18 149.24 49.89 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.091 1.356 . . . . 0.0 111.783 167.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -151.51 155.26 38.15 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 4.6 mt -121.08 104.19 41.57 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 126.284 1.834 . . . . 0.0 110.344 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -82.52 164.09 16.6 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.731 2.954 . . . . 0.0 110.274 166.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -127.18 -20.51 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -168.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -151.4 153.25 32.14 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.797 1.239 . . . . 0.0 110.984 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.14 151.88 39.46 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.878 2.385 . . . . 0.0 112.63 -168.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.46 -151.67 23.67 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.471 1.51 . . . . 0.0 112.68 -176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -121.98 128.81 51.9 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.089 1.356 . . . . 0.0 110.672 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -114.14 127.4 55.89 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.339 1.856 . . . . 0.0 109.653 -176.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 57.1 m -89.31 125.23 35.03 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.198 -0.939 . . . . 0.0 110.777 178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.67 126.88 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.895 1.278 . . . . 0.0 108.977 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.0 tt -108.38 129.35 55.25 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.529 1.531 . . . . 0.0 109.594 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -130.66 129.92 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.685 1.194 . . . . 0.0 109.025 171.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.85 144.59 23.54 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.91 1.284 . . . . 0.0 111.845 -167.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -141.47 123.66 15.6 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.005 1.322 . . . . 0.0 109.933 -179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.6 t-20 52.55 56.91 6.99 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.623 1.569 . . . . 0.0 112.172 179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 7.5 pt-20 59.35 8.47 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 128.62 2.768 . . . . 0.0 116.544 -177.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -115.75 124.84 51.81 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.454 1.102 . . . . 0.0 110.899 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -61.84 145.89 51.31 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.431 -0.793 . . . . 0.0 111.704 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.2 m -68.8 149.94 97.77 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.254 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -59.37 131.33 40.23 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.073 2.515 . . . . 0.0 111.576 -175.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.59 -14.57 61.03 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.223 1.392 . . . . 0.0 114.943 -175.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 2.6 t -80.1 144.17 58.3 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 119.011 1.405 . . . . 0.0 111.411 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.08 140.64 67.05 Favored 'Cis proline' 0 C--N 1.352 0.762 0 CA-C-N 120.01 1.039 . . . . 0.0 112.576 -0.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -95.36 175.57 6.53 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 126.55 1.94 . . . . 0.0 110.541 176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 27.8 m -135.3 125.73 26.68 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.843 0.857 . . . . 0.0 110.739 175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.49 132.16 48.71 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.023 1.329 . . . . 0.0 109.973 168.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.9 ttt85 -92.47 136.9 32.82 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.103 0.561 . . . . 0.0 110.002 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 61.5 t -132.75 131.81 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.514 1.126 . . . . 0.0 110.759 -163.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 7.3 t -173.55 164.66 4.53 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 126.346 1.858 . . . . 0.0 111.217 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . 143.18 -163.15 27.49 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 125.539 1.543 . . . . 0.0 113.682 177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 15.7 t70 72.31 7.04 5.64 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 127.197 2.199 . . . . 0.0 114.114 176.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.5 t70 . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.32 1.848 . . . . 0.0 113.916 177.4 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.5 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.34 163.61 27.84 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.469 1.108 . . . . 0.0 112.878 177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 44.6 tpp -155.06 143.25 20.24 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.245 1.418 . . . . 0.0 111.432 179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -98.75 156.46 35.57 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.541 1.537 . . . . 0.0 112.29 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -72.85 173.09 14.07 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.617 2.878 . . . . 0.0 111.553 172.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.54 3.32 9.64 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.07 1.348 . . . . 0.0 114.234 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 35.0 mtp-105 -60.71 148.24 82.54 Favored Pre-proline 0 CA--C 1.549 0.93 0 C-N-CA 125.075 1.35 . . . . 0.0 112.085 177.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.07 155.91 63.79 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.548 2.832 . . . . 0.0 112.277 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . 0.666 HD13 ' H ' ' A' 1777 ' ' LEU . 0.0 OUTLIER -75.74 7.66 3.66 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.866 1.666 . . . . 0.0 115.255 -176.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 13.6 p -151.62 143.73 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 126.322 1.849 . . . . 0.0 110.318 -176.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -81.76 151.42 30.61 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.533 1.063 . . . . 0.0 113.391 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 24.0 m -146.16 160.7 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 126.789 2.036 . . . . 0.0 110.191 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -64.61 -39.82 94.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 122.996 0.518 . . . . 0.0 112.331 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 76.52 -44.36 1.96 Allowed Glycine 0 CA--C 1.535 1.307 0 C-N-CA 126.439 1.971 . . . . 0.0 115.529 169.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 98.2 mt -79.7 129.21 34.28 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.379 1.472 . . . . 0.0 111.763 -175.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -79.5 -26.18 41.64 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.633 1.173 . . . . 0.0 112.78 174.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 30.2 m -65.16 -7.39 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 125.366 1.466 . . . . 0.0 113.99 179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 3.7 t -64.55 -26.53 68.46 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.96 0.904 . . . . 0.0 112.328 168.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 2.3 t 90.02 161.57 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 128.057 2.543 . . . . 0.0 115.186 165.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 62.1 mt -131.44 164.16 26.35 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.962 2.505 . . . . 0.0 109.792 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 1.4 tpp180 -55.91 115.97 11.03 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 124.744 1.218 . . . . 0.0 110.975 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.94 151.54 50.66 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.822 2.348 . . . . 0.0 110.501 -178.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 4.8 t80 -111.51 118.41 35.68 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 123.286 0.634 . . . . 0.0 110.195 175.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -150.63 122.34 8.05 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.687 1.595 . . . . 0.0 109.832 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.81 149.12 47.57 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 126.159 1.784 . . . . 0.0 110.088 -171.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.7 p -118.87 138.12 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.011 1.324 . . . . 0.0 109.689 173.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 51.1 mt -134.43 135.53 24.01 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 126.198 1.799 . . . . 0.0 108.42 -170.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.91 31.21 0.44 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.488 3.458 . . . . 0.0 113.628 -179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.0 t80 -83.03 157.55 22.85 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.276 1.431 . . . . 0.0 110.833 172.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 90.5 m -129.62 126.35 38.24 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.314 1.446 . . . . 0.0 109.574 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 93.9 mt -87.58 134.53 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.815 0.846 . . . . 0.0 110.389 177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . 0.443 ' HG2' ' H ' ' A' 1801 ' ' LYS . 29.0 ttpt -119.81 -147.48 0.4 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 125.77 1.628 . . . . 0.0 110.851 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . 0.443 ' H ' ' HG2' ' A' 1800 ' ' LYS . 8.0 tmtm? -73.5 123.11 23.28 Favored 'General case' 0 N--CA 1.473 0.708 0 O-C-N 120.573 -1.33 . . . . 0.0 110.201 171.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.2 -148.98 20.08 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.241 1.4 . . . . 0.0 112.16 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -156.97 145.79 19.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.795 1.238 . . . . 0.0 110.772 -176.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -129.03 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.596 1.558 . . . . 0.0 110.816 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 44.6 p -144.75 -177.1 5.34 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 126.345 1.858 . . . . 0.0 109.998 -176.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -173.95 -170.84 37.78 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -154.49 133.15 12.13 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.319 1.447 . . . . 0.0 110.258 178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 39.1 t -102.22 130.73 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 125.906 1.682 . . . . 0.0 108.458 173.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 -106.14 125.53 51.11 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 125.404 1.481 . . . . 0.0 110.748 -177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 19.2 mtm -92.76 146.59 32.48 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 125.381 1.472 . . . . 0.0 110.447 175.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.68 -16.62 30.01 Favored 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 123.269 2.646 . . . . 0.0 113.488 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 51.7 p -73.96 -5.53 41.86 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.179 1.391 . . . . 0.0 113.929 171.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 98.48 -5.32 60.46 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.979 1.752 . . . . 0.0 114.177 -178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -73.81 159.55 32.74 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 124.5 1.12 . . . . 0.0 112.207 176.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.4 m -141.55 154.76 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 125.145 1.378 . . . . 0.0 111.771 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.19 166.65 32.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 126.351 1.86 . . . . 0.0 111.255 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -101.76 138.6 19.87 Favored Pre-proline 0 CA--C 1.548 0.898 0 O-C-N 121.304 -0.873 . . . . 0.0 111.815 -177.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -83.85 169.5 11.81 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 124.361 3.374 . . . . 0.0 111.672 172.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.3 m -108.62 131.69 54.63 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.611 1.564 . . . . 0.0 109.12 172.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -117.82 132.82 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 125.207 1.403 . . . . 0.0 109.126 176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 84.8 m -135.39 127.87 30.54 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 125.49 1.516 . . . . 0.0 110.081 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.2 129.32 34.33 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.395 0.678 . . . . 0.0 110.861 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -82.52 -5.43 58.73 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 -177.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 27.0 mmmt 73.24 3.86 4.73 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 128.145 2.578 . . . . 0.0 113.831 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -109.33 8.19 25.45 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.995 2.118 . . . . 0.0 112.967 -177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.2 20.42 42.28 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 124.72 1.152 . . . . 0.0 113.876 -175.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 41.8 p -133.94 158.28 43.89 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.273 1.829 . . . . 0.0 109.966 175.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.97 146.73 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.472 1.109 . . . . 0.0 110.059 167.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 54.6 m -104.2 138.63 40.4 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.797 1.239 . . . . 0.0 108.449 167.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 27.3 t -126.47 134.81 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 C-N-CA 124.991 1.317 . . . . 0.0 109.373 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.7 mtt85 -136.67 158.13 45.15 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.856 1.262 . . . . 0.0 113.277 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 10.3 t80 -156.42 135.42 11.93 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.314 1.846 . . . . 0.0 111.36 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.27 119.32 72.24 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 124.338 1.055 . . . . 0.0 110.579 176.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.97 145.39 35.7 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.53 2.82 . . . . 0.0 112.155 -173.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.9 t -136.73 -14.52 1.64 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -140.81 152.35 45.1 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.995 1.718 . . . . 0.0 109.962 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -88.79 168.85 12.12 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.034 0.934 . . . . 0.0 112.116 171.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 105.15 -168.5 15.71 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.648 1.594 . . . . 0.0 113.916 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 39.7 tp -78.74 132.25 36.87 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.73 1.212 . . . . 0.0 110.613 179.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 47.5 m80 -127.17 166.37 17.82 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.796 1.638 . . . . 0.0 111.093 -177.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -145.81 153.16 40.6 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.732 0.813 . . . . 0.0 111.356 168.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 65.4 ttp -128.28 117.21 21.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.568 1.547 . . . . 0.0 110.314 -176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.3 t70 -87.82 129.19 35.27 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.465 2.306 . . . . 0.0 109.411 174.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.5 mm -130.85 132.11 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.437 1.095 . . . . 0.0 109.913 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.02 136.22 21.3 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 114.19 1.182 . . . . 0.0 114.19 -175.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -99.56 119.27 37.79 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.745 2.418 . . . . 0.0 109.699 178.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.16 36.14 15.01 Favored 'General case' 0 CA--C 1.554 1.114 0 C-N-CA 124.808 1.243 . . . . 0.0 112.795 -174.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 77.7 2.93 3.0 Favored 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 127.623 2.369 . . . . 0.0 113.93 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 68.8 mtm -104.37 131.65 51.49 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.617 1.567 . . . . 0.0 110.739 175.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -55.33 138.22 46.0 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.4 pt -72.47 154.01 91.78 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.638 -0.696 . . . . 0.0 110.245 166.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -59.56 129.33 30.58 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.237 1.958 . . . . 0.0 110.4 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.57 1.56 87.58 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 124.652 1.12 . . . . 0.0 115.453 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.1 t -76.03 145.89 78.02 Favored Pre-proline 0 CA--C 1.551 1.01 0 CA-C-N 119.771 1.785 . . . . 0.0 111.652 168.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -79.54 159.85 88.59 Favored 'Cis proline' 0 C--N 1.353 0.816 0 CA-C-N 119.845 0.98 . . . . 0.0 112.076 -6.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 96.6 mt -95.92 148.47 22.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.874 1.27 . . . . 0.0 110.288 171.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -121.17 144.33 48.64 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.484 1.114 . . . . 0.0 110.586 178.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.6 p90 -163.54 164.78 24.14 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.678 1.191 . . . . 0.0 112.152 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.5 t80 -110.7 143.99 40.32 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.045 0.938 . . . . 0.0 112.705 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.9 t -117.09 141.89 33.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.422 1.489 . . . . 0.0 109.32 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.7 t0 -157.22 165.36 36.15 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.211 1.404 . . . . 0.0 111.463 -172.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -71.19 148.43 47.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.581 1.152 . . . . 0.0 112.861 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 26.1 m -86.52 -16.47 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 52.5 p-10 -109.58 -5.91 15.54 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -168.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 84.9 m -82.66 153.94 25.13 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.493 1.117 . . . . 0.0 112.878 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -91.62 -9.64 62.65 Favored Glycine 0 N--CA 1.474 1.208 0 C-N-CA 124.973 1.273 . . . . 0.0 115.238 -175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.9 p-80 -65.38 159.27 24.48 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 118.69 1.245 . . . . 0.0 113.675 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.5 t -65.96 136.29 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.038 0.935 . . . . 0.0 109.083 175.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 13.4 t -156.49 145.53 20.35 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.53 1.132 . . . . 0.0 110.379 -173.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -135.97 141.51 44.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.822 1.249 . . . . 0.0 111.86 -170.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.8 p90 -169.16 163.72 11.06 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.265 1.426 . . . . 0.0 112.756 -171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.0 172.18 12.8 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 125.4 1.476 . . . . 0.0 112.784 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -69.94 -33.35 16.06 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 122.833 2.355 . . . . 0.0 112.681 -172.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.3 -37.07 92.54 Favored Glycine 0 CA--C 1.528 0.893 0 CA-C-N 119.549 1.068 . . . . 0.0 114.321 -171.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.85 -6.23 53.51 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.784 1.292 . . . . 0.0 113.272 177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 53.9 m -97.35 -43.73 7.18 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 125.899 1.68 . . . . 0.0 110.777 170.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -152.86 124.54 7.8 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 126.041 1.737 . . . . 0.0 112.3 -164.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -127.65 -179.54 15.89 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 126.448 1.975 . . . . 0.0 112.315 166.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.9 t -142.59 139.77 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.821 1.649 . . . . 0.0 107.792 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -56.62 134.45 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 118.288 0.494 . . . . 0.0 112.125 -177.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.4 m-80 67.93 -1.39 1.74 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.964 2.106 . . . . 0.0 114.752 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.45 137.17 19.56 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.949 1.3 . . . . 0.0 110.957 175.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.16 122.58 8.16 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.609 2.206 . . . . 0.0 110.299 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -107.15 144.03 34.47 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.4 1.48 . . . . 0.0 110.484 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.9 p -135.11 148.45 49.8 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -160.56 175.95 12.14 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.898 1.679 . . . . 0.0 112.011 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -132.36 145.55 51.33 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.095 1.358 . . . . 0.0 110.921 -171.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 28.6 t -117.47 138.0 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 126.13 1.772 . . . . 0.0 108.436 168.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -94.97 134.1 38.0 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.351 1.061 . . . . 0.0 111.423 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 72.3 p -131.13 3.67 4.36 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.164 1.785 . . . . 0.0 113.11 -171.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -55.99 -34.46 65.79 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 126.617 1.967 . . . . 0.0 115.615 -164.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -130.04 19.42 5.46 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.548 1.539 . . . . 0.0 112.357 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.69 -34.26 60.41 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 114.535 1.309 . . . . 0.0 114.535 -171.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 84.79 148.45 9.68 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.874 1.226 . . . . 0.0 112.737 -171.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -75.19 148.23 39.73 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.527 1.131 . . . . 0.0 112.165 -177.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 172.01 -24.1 0.08 OUTLIER Glycine 0 CA--C 1.534 1.276 0 C-N-CA 124.51 1.052 . . . . 0.0 115.121 175.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 133.81 110.14 1.15 Allowed Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.497 1.523 . . . . 0.0 112.643 172.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -82.44 126.76 32.58 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.609 1.564 . . . . 0.0 109.037 174.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 44.3 m -122.79 155.64 36.14 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.869 1.668 . . . . 0.0 111.875 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.6 tp -158.44 135.16 9.62 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.614 1.566 . . . . 0.0 109.131 -169.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.57 159.0 36.65 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 123.995 0.918 . . . . 0.0 112.175 177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -136.07 141.32 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.846 1.258 . . . . 0.0 109.661 176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -128.24 161.7 28.74 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.155 1.782 . . . . 0.0 109.882 170.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.75 -159.87 31.47 Favored Glycine 0 CA--C 1.539 1.545 0 CA-C-O 118.875 -0.958 . . . . 0.0 114.317 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.57 -24.84 62.73 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.048 3.165 . . . . 0.0 112.717 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.1 t -143.42 160.87 39.77 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.311 1.444 . . . . 0.0 109.628 164.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.2 tptt -74.34 116.99 15.64 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 121.071 -1.018 . . . . 0.0 110.989 179.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.59 149.07 46.0 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.73 0.812 . . . . 0.0 111.738 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -85.79 140.82 30.14 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.644 0.778 . . . . 0.0 109.171 166.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 30.5 mt -134.3 143.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.439 1.096 . . . . 0.0 110.402 -168.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -140.63 164.97 28.74 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.871 1.268 . . . . 0.0 110.906 166.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.3 p -161.55 158.88 27.05 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.758 1.223 . . . . 0.0 112.555 -176.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 50.4 m -144.42 119.14 9.82 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.989 1.316 . . . . 0.0 110.126 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.57 130.37 36.83 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.565 1.146 . . . . 0.0 110.938 171.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -109.77 145.57 36.44 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.883 1.673 . . . . 0.0 111.73 -176.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.3 mp0 -67.02 -18.17 65.25 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.966 1.307 . . . . 0.0 113.237 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -69.62 -22.43 63.49 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.558 1.143 . . . . 0.0 113.636 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 103.41 43.54 1.84 Allowed Glycine 0 CA--C 1.531 1.082 0 C-N-CA 124.271 0.939 . . . . 0.0 113.223 -172.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 57.6 p -139.09 159.36 42.33 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.177 1.391 . . . . 0.0 110.398 170.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 36.4 t -115.38 125.63 53.41 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.174 1.39 . . . . 0.0 108.588 161.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.2 t -87.21 151.4 23.2 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.853 0.861 . . . . 0.0 110.293 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -133.03 143.12 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.827 1.651 . . . . 0.0 110.085 -177.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.5 p -135.6 148.05 48.89 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.949 1.3 . . . . 0.0 111.694 166.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.2 p90 -150.39 153.17 35.52 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 177.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.9 mt -120.55 105.62 41.09 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 126.559 1.943 . . . . 0.0 109.869 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -82.67 176.87 7.39 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.847 3.031 . . . . 0.0 110.321 167.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 11.8 p -148.85 -30.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 69.3 mt -107.58 147.63 35.69 Favored Pre-proline 0 N--CA 1.474 0.741 0 CA-C-N 119.725 1.148 . . . . 0.0 110.767 167.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.6 155.17 44.91 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.128 2.552 . . . . 0.0 111.041 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 139.65 -159.09 25.8 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 125.442 1.496 . . . . 0.0 113.134 -177.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -100.01 135.26 41.7 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.065 1.346 . . . . 0.0 111.929 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -118.87 142.49 47.7 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 125.718 1.607 . . . . 0.0 110.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -101.65 122.0 43.08 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.82 1.248 . . . . 0.0 110.356 177.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -103.91 120.89 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 125.775 1.63 . . . . 0.0 108.466 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.1 tt -103.69 131.36 50.93 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.478 1.511 . . . . 0.0 109.744 176.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.6 t -132.0 131.32 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.454 1.502 . . . . 0.0 108.098 171.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -152.99 142.9 22.18 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.104 1.362 . . . . 0.0 110.325 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -146.93 123.75 11.26 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 121.213 -0.93 . . . . 0.0 110.534 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 43.8 t-20 57.5 54.25 6.67 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.973 1.309 . . . . 0.0 111.443 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 9.4 pt-20 56.2 22.7 6.35 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 128.21 2.604 . . . . 0.0 115.975 -177.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -132.4 129.78 39.78 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.558 1.143 . . . . 0.0 111.328 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -61.42 156.89 18.08 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.187 0.995 . . . . 0.0 112.482 169.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.7 m -87.83 156.68 52.52 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.272 0.629 . . . . 0.0 110.489 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -54.52 119.1 5.86 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.885 2.39 . . . . 0.0 110.203 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.94 -13.2 65.31 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 125.297 1.427 . . . . 0.0 116.564 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.5 p -81.5 151.36 68.59 Favored Pre-proline 0 CA--C 1.551 0.989 0 CA-C-N 119.921 1.861 . . . . 0.0 113.214 -178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -72.54 146.56 86.88 Favored 'Cis proline' 0 C--N 1.355 0.885 0 CA-C-N 119.076 0.706 . . . . 0.0 112.051 -6.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -95.64 159.31 15.05 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.553 1.541 . . . . 0.0 110.955 179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 48.4 m -114.71 121.17 42.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.817 0.847 . . . . 0.0 110.654 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -104.02 141.35 36.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.421 1.488 . . . . 0.0 111.623 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.56 141.02 41.31 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.548 1.139 . . . . 0.0 109.912 164.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.1 t -133.24 138.74 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.655 1.182 . . . . 0.0 109.562 162.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 11.8 p -132.7 169.99 15.88 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.677 1.191 . . . . 0.0 112.469 178.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -75.48 140.99 27.05 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.603 1.573 . . . . 0.0 113.129 -176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.7 t70 -86.69 -25.77 24.62 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.5 1.12 . . . . 0.0 113.047 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--O 1.254 1.331 0 C-N-CA 125.949 1.699 . . . . 0.0 113.519 -179.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.589 0 N-CA-C 112.196 -0.362 . . . . 0.0 112.196 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.88 155.83 39.49 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.53 1.132 . . . . 0.0 112.813 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 96.7 mtp -85.52 146.24 27.01 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.211 1.405 . . . . 0.0 110.669 171.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . 72.43 153.19 0.15 Allowed Pre-proline 0 CA--C 1.56 1.347 0 C-N-CA 127.853 2.461 . . . . 0.0 112.316 -176.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.34 161.77 44.59 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 123.072 2.515 . . . . 0.0 113.183 -170.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -75.21 6.19 4.63 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.503 1.521 . . . . 0.0 114.807 -176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 27.0 tpt180 -52.98 138.91 44.56 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 125.371 1.468 . . . . 0.0 110.728 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.24 130.73 21.31 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 123.393 2.729 . . . . 0.0 112.799 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 7.0 mp 74.46 -2.02 2.93 Favored 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 127.946 2.499 . . . . 0.0 113.752 -177.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 17.2 t -108.33 148.85 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 126.118 1.767 . . . . 0.0 109.866 176.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 119.73 138.09 5.62 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.441 1.496 . . . . 0.0 112.309 -178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 10.1 p -153.33 147.9 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.669 1.188 . . . . 0.0 111.841 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -137.1 150.48 48.03 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.32 1.448 . . . . 0.0 112.27 -174.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 117.08 159.03 11.35 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.818 1.675 . . . . 0.0 113.796 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 81.6 mt -88.89 -179.51 5.97 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.479 1.512 . . . . 0.0 111.966 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 46.5 t0 -147.3 164.45 33.19 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.861 1.664 . . . . 0.0 111.014 176.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.7 p -61.24 -21.57 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.116 1.366 . . . . 0.0 113.788 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.0 t -77.81 -8.62 58.28 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.544 1.538 . . . . 0.0 114.204 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 69.1 m -72.72 84.98 1.2 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 119.452 1.024 . . . . 0.0 113.695 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 88.4 mt -75.3 147.69 39.97 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.475 1.51 . . . . 0.0 110.51 160.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.19 121.19 67.86 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.17 171.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.5 148.1 47.43 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 122.664 2.243 . . . . 0.0 110.424 173.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.4 t80 -91.36 135.66 33.66 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.468 0.651 . . . . 0.0 110.733 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -157.33 144.28 18.36 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.021 1.728 . . . . 0.0 110.531 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.36 149.87 21.16 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.455 1.502 . . . . 0.0 109.73 -176.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -123.17 132.74 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.166 1.386 . . . . 0.0 109.489 169.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 74.0 mt -129.37 136.27 28.88 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 126.325 1.85 . . . . 0.0 108.735 -170.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -78.0 72.24 6.27 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.256 3.304 . . . . 0.0 111.419 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 34.6 t80 -124.41 152.5 43.16 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.589 1.956 . . . . 0.0 109.338 171.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 34.6 m -127.25 125.62 41.28 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.424 1.09 . . . . 0.0 109.624 178.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.2 mt -75.08 135.6 26.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 123.79 0.836 . . . . 0.0 110.378 175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 21.4 pttp -128.84 -147.85 0.36 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 126.248 1.819 . . . . 0.0 110.923 179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.11 126.74 29.02 Favored 'General case' 0 CA--C 1.546 0.818 0 O-C-N 120.537 -1.352 . . . . 0.0 110.418 165.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 124.65 -154.03 17.93 Favored Glycine 0 N--CA 1.475 1.275 0 C-N-CA 125.52 1.533 . . . . 0.0 112.183 -170.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -161.39 151.95 17.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.86 1.264 . . . . 0.0 111.214 -174.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -128.48 134.89 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.51 1.524 . . . . 0.0 111.847 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -147.52 158.85 44.17 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 125.561 1.544 . . . . 0.0 110.917 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -137.44 -175.85 14.08 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 115.516 0.966 . . . . 0.0 115.516 -177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -153.39 143.71 22.38 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.341 1.856 . . . . 0.0 109.065 172.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 98.3 t -119.45 129.31 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.719 1.608 . . . . 0.0 108.008 173.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.1 mtm105 -113.5 130.08 56.41 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.356 1.462 . . . . 0.0 110.479 -173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 34.8 mtm -108.67 139.92 21.32 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.413 1.485 . . . . 0.0 111.875 -171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -57.37 -27.48 75.89 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 124.258 3.305 . . . . 0.0 115.54 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.8 p -75.08 4.87 6.01 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.353 1.461 . . . . 0.0 114.563 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.83 44.54 5.12 Favored Glycine 0 N--CA 1.472 1.087 0 C-N-CA 124.665 1.126 . . . . 0.0 113.088 171.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -153.24 165.07 36.86 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.522 1.529 . . . . 0.0 112.107 -172.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.6 m -141.25 159.1 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.67 1.188 . . . . 0.0 112.632 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.05 175.55 13.81 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 127.063 2.145 . . . . 0.0 110.145 176.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -121.91 143.9 39.75 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.123 -0.985 . . . . 0.0 112.204 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -86.25 171.74 7.56 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.494 3.463 . . . . 0.0 111.877 176.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.2 m -106.91 130.56 54.56 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.435 1.494 . . . . 0.0 109.031 172.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.88 132.88 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 125.163 1.385 . . . . 0.0 108.951 175.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -136.55 124.04 22.16 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.36 1.464 . . . . 0.0 109.975 178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.1 t70 -77.1 126.41 30.91 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.54 0.736 . . . . 0.0 110.753 172.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -80.02 -6.33 57.39 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 -174.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.0 mmtm 73.68 1.09 3.84 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 113.537 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -102.85 4.6 37.9 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 127.086 2.155 . . . . 0.0 112.979 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.08 15.89 40.27 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.069 1.319 . . . . 0.0 114.341 -176.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.0 p -130.69 155.94 45.76 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.163 1.785 . . . . 0.0 110.615 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -112.64 137.34 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.107 0.963 . . . . 0.0 109.71 165.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 20.5 m -93.74 137.91 32.5 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.583 1.153 . . . . 0.0 108.424 167.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.2 t -125.5 133.43 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 C-N-CA 125.469 1.508 . . . . 0.0 108.855 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -139.84 155.79 47.05 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.575 1.15 . . . . 0.0 112.656 -176.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.3 t80 -151.05 134.55 16.27 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.6 1.56 . . . . 0.0 111.547 178.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.86 122.72 74.45 Favored Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 124.575 1.15 . . . . 0.0 111.105 179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -81.23 161.15 20.27 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.784 2.99 . . . . 0.0 111.938 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -149.81 -21.81 0.27 Allowed 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -141.4 149.54 41.2 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.46 1.904 . . . . 0.0 109.551 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.91 167.76 19.5 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.039 0.936 . . . . 0.0 112.98 178.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 122.58 -178.28 16.39 Favored Glycine 0 N--CA 1.473 1.126 0 C-N-CA 125.59 1.567 . . . . 0.0 114.085 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.3 tt -83.68 118.7 24.05 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.436 1.094 . . . . 0.0 109.417 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 28.3 m80 -111.38 158.43 19.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.524 1.53 . . . . 0.0 111.054 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -143.73 150.99 39.46 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.482 0.658 . . . . 0.0 112.337 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.8 ttm -132.14 139.2 48.35 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.782 2.033 . . . . 0.0 110.712 -164.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -112.19 137.37 50.37 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.07 1.748 . . . . 0.0 109.635 170.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.3 mm -133.93 129.39 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.646 1.178 . . . . 0.0 109.683 174.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.87 137.66 36.75 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 19.9 t80 -103.83 124.91 49.79 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.499 1.92 . . . . 0.0 109.672 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 27.3 t70 48.29 46.51 20.11 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.779 1.232 . . . . 0.0 112.293 -177.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.306 0.3 OUTLIER 62.78 13.35 6.4 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 128.005 2.522 . . . . 0.0 116.543 -177.302 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 58.9 ttm -114.74 130.41 56.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.529 1.532 . . . . 0.0 110.926 172.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -56.06 135.9 52.53 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 121.285 -0.885 . . . . 0.0 113.053 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.2 pt -73.87 154.32 89.02 Favored Pre-proline 0 N--CA 1.48 1.038 0 CA-C-O 118.864 -0.589 . . . . 0.0 111.328 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -60.04 128.2 25.78 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.992 1.794 . . . . 0.0 109.403 170.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 100.35 -16.05 58.34 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.702 1.144 . . . . 0.0 114.098 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.1 t -82.41 146.98 55.22 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-N 119.803 1.802 . . . . 0.0 110.876 170.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.0 Cg_endo -79.68 163.85 82.86 Favored 'Cis proline' 0 C--N 1.353 0.804 0 CA-C-N 120.333 1.155 . . . . 0.0 112.413 -6.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.2 mt -120.5 159.26 25.54 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.17 1.788 . . . . 0.0 111.047 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -155.4 148.72 24.89 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.756 0.822 . . . . 0.0 112.819 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 7.8 p90 -167.2 -179.4 4.54 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.968 1.707 . . . . 0.0 111.264 -167.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.1 t80 -120.48 142.39 49.32 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.779 -1.201 . . . . 0.0 113.405 178.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 82.1 t -111.73 134.72 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.144 1.778 . . . . 0.0 108.966 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -161.29 158.31 26.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.96 1.304 . . . . 0.0 112.923 -174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -75.48 122.15 23.41 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.02 0.928 . . . . 0.0 112.124 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 32.7 m -79.79 -15.77 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 p30 -85.07 -14.69 46.45 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.719 1.208 . . . . 0.0 114.181 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.7 m -77.81 -17.22 57.68 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 -173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 85.16 -3.44 87.21 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.86 1.219 . . . . 0.0 115.676 172.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -64.84 156.0 32.22 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 119.201 1.501 . . . . 0.0 112.962 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 5.5 t -68.19 131.82 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 175.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.2 t -152.92 161.1 42.97 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.385 1.074 . . . . 0.0 111.507 -174.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.84 142.8 36.58 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.358 1.463 . . . . 0.0 111.235 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 20.6 p90 -163.58 161.11 23.7 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.572 1.549 . . . . 0.0 112.161 -178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.67 176.97 15.63 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 124.863 1.22 . . . . 0.0 113.293 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.12 -37.94 5.49 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.045 2.496 . . . . 0.0 112.594 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.91 -32.54 73.69 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-O 119.223 -0.765 . . . . 0.0 114.588 -169.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -77.23 -3.84 41.77 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 118.769 1.284 . . . . 0.0 113.426 175.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.7 m -110.35 -48.48 3.16 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.327 1.851 . . . . 0.0 111.109 -179.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -138.54 145.96 41.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.101 1.76 . . . . 0.0 112.235 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.91 -179.27 21.15 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 124.574 1.083 . . . . 0.0 113.624 173.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.0 t -143.57 136.04 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.108 1.363 . . . . 0.0 108.598 178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.3 m -56.46 137.34 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.2 m-80 68.06 -2.88 1.36 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.756 2.022 . . . . 0.0 114.663 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -100.9 136.99 19.66 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 125.039 1.336 . . . . 0.0 110.725 174.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -72.25 127.95 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.377 2.051 . . . . 0.0 110.124 177.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.12 146.55 36.62 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.613 1.565 . . . . 0.0 110.523 177.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 61.4 p -136.43 153.98 50.92 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -167.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.1 p90 -164.16 172.49 13.62 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.26 1.824 . . . . 0.0 111.351 177.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 87.7 m -122.75 142.42 50.74 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.161 1.384 . . . . 0.0 110.694 -170.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.9 t -115.85 133.71 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.474 1.509 . . . . 0.0 108.417 169.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.73 132.85 36.59 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.381 1.072 . . . . 0.0 111.585 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 45.8 p -136.64 0.87 2.52 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.189 1.395 . . . . 0.0 114.108 -169.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -53.46 -37.86 63.03 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.607 1.563 . . . . 0.0 115.119 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -117.01 9.92 13.82 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.396 1.479 . . . . 0.0 112.538 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.76 -25.13 56.23 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.446 1.099 . . . . 0.0 113.504 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.36 -106.77 2.36 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.609 1.1 . . . . 0.0 112.247 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -161.45 155.12 21.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.523 1.929 . . . . 0.0 109.942 -174.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 148.08 9.21 0.19 Allowed Glycine 0 N--CA 1.473 1.118 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 96.03 103.84 2.05 Favored Glycine 0 C--N 1.34 0.779 0 C-N-CA 126.078 1.799 . . . . 0.0 112.479 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -86.72 132.85 33.75 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.984 1.713 . . . . 0.0 109.603 171.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.3 m -129.86 157.99 40.71 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.6 1.56 . . . . 0.0 112.134 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.1 tp -159.02 136.06 9.69 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.029 1.732 . . . . 0.0 109.184 -170.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.45 158.93 36.73 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.022 0.929 . . . . 0.0 112.424 178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 49.3 mt -137.51 139.04 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.89 1.276 . . . . 0.0 109.98 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -131.83 129.16 40.1 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.369 1.468 . . . . 0.0 109.944 174.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -156.35 -162.16 11.24 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-O 119.04 -0.866 . . . . 0.0 114.386 -175.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -63.7 -24.72 69.0 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 124.042 3.162 . . . . 0.0 112.56 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.6 t -138.97 160.45 39.73 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.978 1.311 . . . . 0.0 109.627 162.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.3 tppt? -71.75 112.34 7.77 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.134 -0.979 . . . . 0.0 110.689 175.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.64 148.77 50.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.694 0.798 . . . . 0.0 111.688 172.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -87.44 140.71 29.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 166.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 23.5 mt -135.09 143.89 35.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.665 1.186 . . . . 0.0 110.259 -167.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 9.9 t -141.67 156.5 45.64 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.13 1.372 . . . . 0.0 111.144 168.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 48.9 t -145.35 136.97 25.31 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.211 1.405 . . . . 0.0 110.66 -178.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 93.5 m -132.3 129.33 39.4 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.781 1.632 . . . . 0.0 110.272 -172.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.99 131.5 43.77 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.399 1.08 . . . . 0.0 110.779 171.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -91.17 -131.23 0.1 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.85 0.86 . . . . 0.0 110.222 175.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -84.1 38.04 0.64 Allowed 'General case' 0 CA--C 1.55 0.944 0 O-C-N 120.461 -1.399 . . . . 0.0 111.855 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 20.7 t70 71.37 -20.44 0.23 Allowed 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 128.813 2.845 . . . . 0.0 114.588 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . -76.77 -21.27 74.89 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.758 1.17 . . . . 0.0 114.194 177.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 31.8 p -147.5 157.61 43.64 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.788 1.635 . . . . 0.0 111.463 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 74.2 m -115.54 136.7 52.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 126.115 1.766 . . . . 0.0 109.205 162.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -98.57 136.89 38.02 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.466 1.106 . . . . 0.0 110.493 173.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 94.5 t -111.43 142.48 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.93 1.692 . . . . 0.0 109.782 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 51.9 m -129.66 142.76 50.67 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.145 1.378 . . . . 0.0 110.833 168.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 9.6 p90 -148.38 154.29 39.74 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 8.8 mt -120.62 107.66 38.31 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 125.893 1.677 . . . . 0.0 110.763 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -82.64 175.03 9.18 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 124.036 3.157 . . . . 0.0 110.46 166.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.3 p -151.07 -30.27 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 -173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.4 mt -105.6 146.33 32.61 Favored Pre-proline 0 N--CA 1.474 0.732 0 CA-C-N 119.586 1.085 . . . . 0.0 110.533 167.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.86 154.53 48.46 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 122.911 2.407 . . . . 0.0 110.949 176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 136.13 -158.6 24.0 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.796 1.188 . . . . 0.0 113.247 -177.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -100.82 133.31 45.48 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.09 1.356 . . . . 0.0 112.492 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -119.83 126.07 50.09 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.999 1.72 . . . . 0.0 109.956 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 71.2 m -84.32 126.62 33.36 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.108 0.963 . . . . 0.0 110.582 173.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -105.73 124.99 61.14 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 125.6 1.56 . . . . 0.0 108.283 178.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -108.86 130.49 55.42 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.29 1.436 . . . . 0.0 109.811 177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -132.58 128.79 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.417 1.087 . . . . 0.0 109.879 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.99 142.2 24.13 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.058 1.343 . . . . 0.0 111.718 -169.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.65 121.36 16.38 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.809 1.244 . . . . 0.0 109.448 178.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.7 t-20 56.41 57.37 4.95 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.472 1.509 . . . . 0.0 112.159 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.285 8.5 pt-20 57.21 12.12 1.26 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 128.498 2.719 . . . . 0.0 116.329 -177.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -119.26 125.31 48.83 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.704 1.202 . . . . 0.0 110.671 177.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -64.72 147.39 53.17 Favored 'General case' 0 CA--C 1.546 0.811 0 O-C-N 121.457 -0.777 . . . . 0.0 111.894 171.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 21.8 m -69.11 152.47 96.71 Favored Pre-proline 0 N--CA 1.481 1.124 0 CA-C-O 118.458 -0.782 . . . . 0.0 110.044 168.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -62.99 128.69 23.66 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.254 1.969 . . . . 0.0 110.063 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.52 -14.74 64.74 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.989 1.28 . . . . 0.0 115.007 -174.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.8 t -78.16 139.94 61.08 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.258 1.529 . . . . 0.0 111.295 174.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.41 135.55 40.83 Favored 'Cis proline' 0 C--N 1.352 0.739 0 CA-C-N 119.383 0.816 . . . . 0.0 111.905 -3.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -85.3 170.9 12.34 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.0 1.72 . . . . 0.0 110.399 173.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 52.4 m -132.73 121.27 22.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.454 0.702 . . . . 0.0 110.893 174.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.35 140.33 30.38 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.312 1.445 . . . . 0.0 110.872 170.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.4 ttt85 -100.89 122.52 43.6 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.732 0.813 . . . . 0.0 109.968 171.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.7 t -109.26 129.89 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 125.589 1.555 . . . . 0.0 110.373 -174.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.5 p -100.68 155.96 17.59 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.676 1.19 . . . . 0.0 112.752 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -93.7 121.98 6.85 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 125.404 1.478 . . . . 0.0 111.183 174.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -151.86 4.23 0.41 Allowed 'General case' 0 CA--C 1.551 1.009 0 N-CA-C 114.219 1.192 . . . . 0.0 114.219 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 30.7 t70 . . . . . 0 C--O 1.253 1.275 0 C-N-CA 124.823 1.249 . . . . 0.0 113.636 178.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.543 0 N-CA-C 111.616 -0.593 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.79 -26.0 64.07 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 54.4 mtm -139.73 161.68 36.96 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.685 1.594 . . . . 0.0 111.093 174.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -65.04 -44.17 69.99 Favored Pre-proline 0 CA--C 1.556 1.181 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 -178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.15 172.33 16.27 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.661 2.241 . . . . 0.0 112.297 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -67.17 1.64 1.98 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 126.354 1.862 . . . . 0.0 114.681 -176.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -117.21 56.48 1.81 Allowed Pre-proline 0 CA--C 1.555 1.137 0 C-N-CA 126.831 2.052 . . . . 0.0 113.276 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -70.97 166.11 30.15 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.43 2.753 . . . . 0.0 111.786 -179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 69.4 mt -76.63 33.66 0.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.686 1.594 . . . . 0.0 113.413 -178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 60.2 t -142.58 135.28 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 127.025 2.13 . . . . 0.0 109.082 -174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 166.78 174.76 36.35 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.657 1.123 . . . . 0.0 114.046 178.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 12.9 p -165.09 145.43 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 126.293 1.837 . . . . 0.0 110.21 -179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -68.5 128.2 35.76 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.826 0.851 . . . . 0.0 111.869 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -86.18 -15.83 63.92 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.722 1.154 . . . . 0.0 114.416 178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.4 mt -91.17 153.79 19.79 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.685 1.194 . . . . 0.0 111.618 175.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 44.0 t0 -106.04 157.57 17.43 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.636 1.574 . . . . 0.0 111.052 167.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 58.3 t -141.38 132.49 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.74 1.616 . . . . 0.0 109.406 -178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 8.8 t -172.87 -38.83 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.894 2.078 . . . . 0.0 110.854 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 72.5 m -118.83 139.08 52.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.367 1.067 . . . . 0.0 111.982 169.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 5.7 mt -125.91 161.42 27.5 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.627 2.371 . . . . 0.0 110.149 -176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.38 117.49 16.88 Favored Pre-proline 0 CA--C 1.547 0.856 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.605 -178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.67 112.54 3.58 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.546 2.164 . . . . 0.0 108.809 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 38.5 t80 -100.71 135.48 42.09 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.718 0.807 . . . . 0.0 111.686 -176.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.3 p30 -161.75 166.07 27.11 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.508 1.923 . . . . 0.0 111.411 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -154.24 156.47 37.12 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.427 1.491 . . . . 0.0 111.038 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -121.67 135.18 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 125.326 1.45 . . . . 0.0 109.364 167.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 65.2 mt -132.02 136.94 29.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 126.368 1.867 . . . . 0.0 108.367 -170.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.76 42.45 1.26 Allowed 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 124.46 3.44 . . . . 0.0 113.124 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.7 t80 -89.01 159.16 17.74 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 125.303 1.441 . . . . 0.0 111.546 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 55.5 m -127.04 128.1 45.79 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.396 1.478 . . . . 0.0 110.282 -177.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 26.4 mt -93.8 130.67 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.617 1.167 . . . . 0.0 109.376 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -113.24 -75.23 0.6 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.635 1.174 . . . . 0.0 111.791 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.8 tttm -160.07 133.73 7.08 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.998 1.719 . . . . 0.0 110.951 -179.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 129.6 -137.73 9.76 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.533 1.54 . . . . 0.0 110.945 -166.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -155.88 140.11 16.58 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.026 0.931 . . . . 0.0 111.727 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.9 tt -116.74 138.08 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.847 1.659 . . . . 0.0 110.696 174.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.0 p -144.1 177.96 8.21 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.19 1.796 . . . . 0.0 110.392 -178.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.18 -172.27 37.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.055 0.782 . . . . 0.0 115.055 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -156.41 143.83 19.15 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.62 1.568 . . . . 0.0 109.919 177.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 91.0 t -118.17 132.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.566 1.546 . . . . 0.0 108.674 171.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 36.3 mtm180 -108.76 137.14 47.18 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 112.166 -177.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 8.3 mtm -103.0 142.5 24.68 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 126.059 1.743 . . . . 0.0 111.135 176.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -56.33 -27.21 66.13 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 124.052 3.168 . . . . 0.0 115.278 175.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.8 p -73.81 0.69 12.42 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.407 1.483 . . . . 0.0 114.37 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 94.9 -5.71 69.22 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.892 1.71 . . . . 0.0 114.3 176.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 3.1 mtpt -73.69 156.81 37.56 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.057 1.343 . . . . 0.0 112.153 175.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 28.0 m -139.95 152.59 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.594 1.557 . . . . 0.0 110.795 174.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.29 170.04 22.8 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.721 1.608 . . . . 0.0 111.107 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -101.74 138.62 19.88 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 123.704 0.802 . . . . 0.0 111.556 -177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -79.36 162.53 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.946 3.098 . . . . 0.0 111.073 169.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 91.4 m -109.82 119.39 39.2 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.332 1.453 . . . . 0.0 108.997 176.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.73 132.01 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 124.957 1.303 . . . . 0.0 109.239 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 93.5 m -134.13 120.14 19.75 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.565 1.546 . . . . 0.0 109.376 175.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -78.37 131.64 37.05 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.718 0.807 . . . . 0.0 112.094 172.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.96 -3.55 58.96 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -171.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 70.6 mmtt 73.06 0.78 3.8 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.575 2.35 . . . . 0.0 113.875 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -109.78 8.44 24.59 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.802 2.041 . . . . 0.0 113.112 -174.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.31 15.75 49.68 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 124.866 1.222 . . . . 0.0 114.352 -177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 45.1 p -131.14 161.03 33.03 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 126.216 1.806 . . . . 0.0 110.415 175.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 17.9 m -122.75 140.77 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.324 1.05 . . . . 0.0 110.212 168.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 46.7 m -98.29 140.66 32.24 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.993 1.317 . . . . 0.0 108.432 169.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 17.4 t -127.56 134.84 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.546 1.139 . . . . 0.0 109.522 177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -132.18 162.87 29.83 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.651 1.581 . . . . 0.0 111.984 -175.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.1 t80 -157.14 140.4 15.55 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.513 1.525 . . . . 0.0 111.796 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.98 114.86 63.87 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 124.705 1.202 . . . . 0.0 110.807 176.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -78.68 158.33 28.29 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.593 2.862 . . . . 0.0 112.075 -177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 95.9 p -143.45 0.37 1.14 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -169.59 157.25 7.02 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 126.415 1.886 . . . . 0.0 110.554 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.87 170.94 15.62 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.324 1.05 . . . . 0.0 113.085 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.7 -177.79 16.39 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 125.884 1.707 . . . . 0.0 114.391 176.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 28.0 tp -86.93 112.38 21.73 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.889 1.276 . . . . 0.0 110.155 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 45.2 m80 -105.71 171.69 7.2 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.002 1.721 . . . . 0.0 111.444 -176.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -146.34 151.17 37.07 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.948 0.899 . . . . 0.0 111.339 172.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 31.4 ttm -119.19 129.98 55.26 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.059 1.744 . . . . 0.0 110.685 -179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.77 134.3 40.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 128.082 2.553 . . . . 0.0 109.392 165.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 20.0 mm -138.47 135.98 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.928 1.291 . . . . 0.0 108.703 168.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.71 142.15 24.32 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.993 0.917 . . . . 0.0 113.384 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.63 118.73 36.8 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.405 1.882 . . . . 0.0 109.611 175.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 51.14 34.23 10.77 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 124.62 1.168 . . . . 0.0 112.727 -171.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 68.9 m-80 73.05 8.05 5.39 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 127.827 2.451 . . . . 0.0 115.11 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.98 128.68 46.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.375 1.47 . . . . 0.0 110.459 169.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 139.27 55.52 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -175.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.6 pt -73.66 150.29 88.71 Favored Pre-proline 0 N--CA 1.479 0.976 0 CA-C-O 118.579 -0.724 . . . . 0.0 109.88 169.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -64.21 -20.12 66.67 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.837 2.358 . . . . 0.0 113.959 -172.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.42 1.01 88.59 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.341 -1.255 . . . . 0.0 115.099 174.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.1 m -119.84 156.46 54.08 Favored Pre-proline 0 N--CA 1.476 0.864 0 CA-C-N 120.031 1.916 . . . . 0.0 113.347 -178.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.35 169.29 74.4 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 119.098 0.714 . . . . 0.0 113.212 0.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 74.3 mt -129.71 150.12 51.16 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.375 1.87 . . . . 0.0 110.563 -176.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -131.8 136.84 47.84 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.936 1.294 . . . . 0.0 110.164 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.4 p90 -154.17 149.26 26.87 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.386 1.074 . . . . 0.0 112.213 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.5 t80 -99.87 145.27 27.96 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.179 -0.951 . . . . 0.0 112.748 177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 48.0 t -124.43 143.39 37.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.786 1.634 . . . . 0.0 109.233 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 5.9 t0 -151.64 167.8 26.98 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.966 1.306 . . . . 0.0 110.96 178.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -78.67 164.72 24.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.02 1.328 . . . . 0.0 112.787 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 34.1 m -73.52 -20.28 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 120.935 -1.103 . . . . 0.0 112.962 167.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -86.89 -6.74 58.69 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.849 1.259 . . . . 0.0 114.138 -171.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 29.4 p -64.14 145.57 55.72 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.267 1.027 . . . . 0.0 113.615 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -108.19 -21.15 7.85 Favored Glycine 0 N--CA 1.476 1.318 0 C-N-CA 125.156 1.36 . . . . 0.0 113.932 174.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -70.12 159.85 33.15 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 124.65 1.18 . . . . 0.0 113.999 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 8.3 t -64.59 135.96 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 124.571 1.148 . . . . 0.0 109.061 174.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 10.9 t -156.71 163.12 39.64 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.773 1.229 . . . . 0.0 110.877 -177.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.59 147.33 31.94 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.875 1.27 . . . . 0.0 112.38 -173.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -169.08 160.34 9.79 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.758 1.623 . . . . 0.0 112.968 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 145.22 175.82 18.67 Favored Glycine 0 CA--C 1.537 1.438 0 C-N-CA 125.201 1.381 . . . . 0.0 113.576 178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.46 -37.55 12.98 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 123.045 2.497 . . . . 0.0 112.218 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.19 -21.9 75.88 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 124.215 0.912 . . . . 0.0 114.099 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 6.8 mt -73.26 -11.09 60.38 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.576 1.15 . . . . 0.0 113.213 171.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 24.8 m -120.67 -43.52 2.48 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.718 1.607 . . . . 0.0 111.912 -170.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -142.84 154.56 44.28 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.715 2.006 . . . . 0.0 112.139 -176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.05 174.4 26.0 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.476 1.036 . . . . 0.0 113.699 172.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 38.4 t -136.91 134.15 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.919 1.288 . . . . 0.0 108.571 175.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 26.8 m -56.39 135.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.153 0.581 . . . . 0.0 112.52 -178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.7 m-80 66.45 3.5 2.87 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 126.938 2.095 . . . . 0.0 114.73 176.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 54.7 mttm -110.0 142.9 26.85 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 125.391 1.476 . . . . 0.0 110.948 175.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -73.33 119.87 6.22 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.576 2.184 . . . . 0.0 110.577 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -99.55 143.1 30.18 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.082 1.353 . . . . 0.0 110.082 172.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.9 p -133.49 152.99 51.98 Favored 'General case' 0 N--CA 1.477 0.907 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -165.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.4 p90 -164.04 174.63 11.13 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.741 1.616 . . . . 0.0 112.175 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 80.7 m -126.69 142.83 51.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.579 1.552 . . . . 0.0 110.964 -170.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.8 t -116.48 133.15 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.963 1.705 . . . . 0.0 108.265 167.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.03 127.47 35.69 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.053 0.941 . . . . 0.0 111.222 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 51.5 p -133.13 0.44 3.43 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.076 1.35 . . . . 0.0 114.011 -170.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.1 tptp -52.5 -39.12 60.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.699 1.6 . . . . 0.0 114.459 -173.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.2 t70 -111.37 6.66 20.54 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.385 1.474 . . . . 0.0 113.046 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.41 -26.23 60.88 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.231 1.012 . . . . 0.0 113.622 -176.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 77.72 -102.49 1.77 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 124.624 1.107 . . . . 0.0 112.164 176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.92 157.28 23.59 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.247 1.819 . . . . 0.0 110.18 -174.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 143.79 4.21 0.75 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.572 1.558 . . . . 0.0 115.146 -177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 95.01 103.67 1.89 Allowed Glycine 0 CA--C 1.529 0.961 0 C-N-CA 125.544 1.545 . . . . 0.0 113.224 176.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -81.06 135.58 35.84 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.655 1.582 . . . . 0.0 109.266 168.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -138.76 165.3 27.34 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.079 1.352 . . . . 0.0 112.319 177.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -165.05 136.8 4.21 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.207 1.803 . . . . 0.0 109.699 -161.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.92 166.24 32.29 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.519 1.128 . . . . 0.0 112.004 176.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 53.9 mt -137.66 131.76 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.651 1.18 . . . . 0.0 109.55 172.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -111.87 113.38 25.67 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.003 1.321 . . . . 0.0 109.454 171.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.08 -174.95 13.93 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 125.128 1.347 . . . . 0.0 113.802 -179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.84 -23.81 47.36 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 123.853 3.035 . . . . 0.0 111.942 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -142.06 159.53 42.04 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.99 1.716 . . . . 0.0 108.593 160.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.06 130.62 43.49 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.933 -1.105 . . . . 0.0 112.52 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -81.37 152.44 27.48 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.103 0.961 . . . . 0.0 110.981 164.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -89.21 139.3 30.63 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 165.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -132.8 138.76 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.558 1.143 . . . . 0.0 110.392 -167.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 68.6 m -134.74 158.27 44.57 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.548 1.539 . . . . 0.0 111.008 170.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -152.87 153.61 33.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.387 1.075 . . . . 0.0 112.544 178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.9 m -143.09 122.2 12.89 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.461 1.504 . . . . 0.0 110.373 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -76.68 129.51 36.46 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.415 1.086 . . . . 0.0 111.132 171.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -104.62 158.74 16.29 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.424 1.489 . . . . 0.0 112.602 -175.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -70.92 -15.59 62.62 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 123.83 0.852 . . . . 0.0 112.114 169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -75.47 -3.62 34.97 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.267 1.827 . . . . 0.0 114.551 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 86.99 27.3 29.0 Favored Glycine 0 N--CA 1.474 1.185 0 C-N-CA 124.207 0.908 . . . . 0.0 113.775 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.3 p -137.85 158.74 43.71 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.439 1.496 . . . . 0.0 110.943 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 34.5 t -103.6 127.97 50.94 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.333 1.053 . . . . 0.0 108.819 159.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.0 t -88.15 152.36 22.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 123.681 0.793 . . . . 0.0 110.226 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' 1886 ' ' PHE . 91.9 t -133.63 143.86 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.628 1.571 . . . . 0.0 109.567 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -135.97 147.64 48.12 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.019 1.328 . . . . 0.0 111.793 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 21.6 p90 -149.81 152.12 34.66 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 176.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.9 mt -117.54 102.0 52.16 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 126.693 1.997 . . . . 0.0 110.262 -179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.79 162.12 18.73 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.763 2.976 . . . . 0.0 110.412 170.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.9 m -124.25 -10.56 6.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 115.443 1.646 . . . . 0.0 115.443 -167.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.6 pp -156.01 151.79 22.37 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.363 1.465 . . . . 0.0 110.347 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.33 140.69 24.87 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.665 2.244 . . . . 0.0 111.462 -173.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.63 -167.91 33.68 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.507 1.051 . . . . 0.0 113.591 -175.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -96.0 124.3 39.96 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.614 1.566 . . . . 0.0 112.331 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -120.67 121.33 38.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.75 1.62 . . . . 0.0 110.176 -177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.4 m -92.4 109.8 21.19 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.267 1.027 . . . . 0.0 110.989 -179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -81.49 131.99 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 125.765 1.626 . . . . 0.0 108.677 174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.6 tt -110.88 128.88 55.95 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.951 1.7 . . . . 0.0 108.987 174.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 48.9 t -128.28 130.02 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 124.19 0.996 . . . . 0.0 109.839 172.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.61 141.36 22.75 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.842 1.257 . . . . 0.0 111.961 -167.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -136.46 123.46 21.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.041 1.336 . . . . 0.0 109.457 177.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.9 t-20 53.79 57.72 5.78 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.347 1.459 . . . . 0.0 112.617 177.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 8.1 pt-20 57.84 11.02 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 128.134 2.574 . . . . 0.0 116.296 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -117.45 124.66 49.34 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.655 1.182 . . . . 0.0 110.597 177.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.2 m170 -62.73 143.6 57.27 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 121.463 -0.773 . . . . 0.0 111.29 170.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.8 m -70.11 151.83 95.92 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.524 -0.75 . . . . 0.0 109.718 171.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -60.54 132.8 45.14 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.535 2.157 . . . . 0.0 110.77 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 92.44 -17.42 57.47 Favored Glycine 0 CA--C 1.535 1.293 0 C-N-CA 125.103 1.335 . . . . 0.0 114.751 -174.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 32.7 t -75.68 141.29 72.21 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.289 1.544 . . . . 0.0 111.663 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -77.23 148.87 88.54 Favored 'Cis proline' 0 C--N 1.353 0.792 0 CA-C-N 119.551 0.875 . . . . 0.0 112.339 -4.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -110.66 132.66 54.0 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 110.161 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 87.9 m -95.44 114.3 26.06 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 119.055 0.843 . . . . 0.0 111.251 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.3 138.31 33.17 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.037 1.335 . . . . 0.0 111.033 171.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.6 ttt85 -97.04 117.9 32.24 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.421 0.689 . . . . 0.0 110.887 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.8 t -93.34 137.5 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 125.399 1.48 . . . . 0.0 110.2 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.0 p -115.58 155.84 26.88 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.564 1.546 . . . . 0.0 112.871 -178.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -85.23 136.16 14.16 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.962 1.268 . . . . 0.0 112.119 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.3 t70 -90.53 -10.88 41.9 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.648 1.179 . . . . 0.0 113.464 178.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.252 1.233 0 C-N-CA 126.714 2.005 . . . . 0.0 112.543 -177.434 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.538 0 N-CA-C 111.594 -0.603 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.05 -8.46 53.5 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -176.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -66.79 -15.61 63.7 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.117 1.767 . . . . 0.0 114.409 -176.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -141.75 152.81 63.71 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 125.691 1.597 . . . . 0.0 111.853 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.85 164.69 31.38 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 123.858 3.039 . . . . 0.0 112.105 178.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -74.0 146.39 43.83 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.171 0.988 . . . . 0.0 112.201 178.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -141.08 150.34 58.66 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.939 1.696 . . . . 0.0 110.752 178.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.02 149.87 59.6 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.461 2.774 . . . . 0.0 112.091 -175.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 97.8 mt -141.35 158.27 44.1 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.235 1.814 . . . . 0.0 110.427 178.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 84.8 t -101.45 136.03 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 C-N-CA 125.124 1.37 . . . . 0.0 109.486 176.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 87.22 0.98 84.63 Favored Glycine 0 CA--C 1.535 1.3 0 C-N-CA 124.681 1.134 . . . . 0.0 115.317 175.37 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 35.6 m -86.69 153.08 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.987 1.315 . . . . 0.0 111.575 176.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 13.0 p30 -76.95 165.25 24.92 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 124.244 1.018 . . . . 0.0 113.559 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -163.12 171.57 38.91 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.491 1.519 . . . . 0.0 113.485 176.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.0 mt -136.24 153.6 51.16 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 125.904 1.682 . . . . 0.0 111.325 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 32.3 t0 -162.82 171.08 17.25 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 126.714 2.005 . . . . 0.0 109.797 176.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 7.4 p -57.35 -21.36 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 125.321 1.448 . . . . 0.0 114.006 -176.378 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.0 t -62.64 -25.2 68.0 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.858 1.263 . . . . 0.0 112.923 173.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 41.5 m -75.58 109.56 9.25 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.009 0.924 . . . . 0.0 111.668 178.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 90.7 mt -85.68 146.05 27.01 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.66 1.184 . . . . 0.0 110.585 169.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -64.41 115.84 23.28 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.443 1.897 . . . . 0.0 110.073 -178.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.55 151.46 64.59 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -171.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.8 t80 -97.82 122.89 41.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.199 0.6 . . . . 0.0 110.078 176.686 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -150.14 132.8 15.85 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.764 1.226 . . . . 0.0 110.966 174.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -138.01 157.73 45.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 127.33 2.252 . . . . 0.0 109.41 -175.303 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.9 p -135.3 134.14 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.654 1.182 . . . . 0.0 109.438 172.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.0 mt -131.73 136.41 28.37 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.544 1.537 . . . . 0.0 109.284 -169.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.78 85.56 1.48 Allowed 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.892 3.061 . . . . 0.0 110.319 174.395 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 52.4 t80 -139.98 152.53 46.39 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.697 1.999 . . . . 0.0 109.429 177.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -126.42 134.51 50.98 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.822 1.249 . . . . 0.0 109.471 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.5 mt -91.49 128.81 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.522 1.129 . . . . 0.0 109.345 174.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -99.52 -131.08 0.23 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 124.544 1.138 . . . . 0.0 109.821 176.178 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -83.01 -4.21 58.07 Favored 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 176.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.91 -152.65 17.61 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.801 1.667 . . . . 0.0 113.291 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -155.24 149.62 26.1 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.203 1.401 . . . . 0.0 110.631 -173.111 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.3 tt -128.8 136.46 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.542 1.537 . . . . 0.0 111.446 -175.296 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.1 p -149.25 167.64 25.48 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.169 1.788 . . . . 0.0 110.857 -175.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -154.39 -170.1 19.87 Favored Glycine 0 N--CA 1.47 0.902 0 N-CA-C 116.382 1.313 . . . . 0.0 116.382 -175.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -156.57 132.94 9.96 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 126.084 1.754 . . . . 0.0 109.589 177.401 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 40.2 t -112.33 138.99 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.61 1.564 . . . . 0.0 108.634 173.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -128.18 132.71 48.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.832 0.853 . . . . 0.0 111.153 -174.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 27.4 mtm -106.38 141.66 23.26 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.838 1.655 . . . . 0.0 111.95 -170.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -55.12 -23.57 36.71 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 124.63 3.554 . . . . 0.0 115.757 175.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.0 t -68.92 -8.33 43.29 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 177.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.56 48.71 3.15 Favored Glycine 0 N--CA 1.472 1.064 0 C-N-CA 124.95 1.262 . . . . 0.0 112.429 177.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -156.87 163.36 39.27 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.131 1.773 . . . . 0.0 111.43 -171.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.2 m -139.0 161.71 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.541 1.136 . . . . 0.0 112.734 -171.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.08 169.48 24.01 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.695 1.998 . . . . 0.0 111.435 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.7 140.79 21.42 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.122 0.969 . . . . 0.0 111.308 179.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -84.38 175.24 7.37 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.209 3.273 . . . . 0.0 111.966 174.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.2 m -114.11 138.01 50.98 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.534 1.534 . . . . 0.0 109.008 171.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.76 131.44 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 124.783 1.233 . . . . 0.0 108.682 173.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.3 m -133.22 115.44 15.0 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.418 1.487 . . . . 0.0 109.092 -178.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.84 135.27 43.4 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.519 0.727 . . . . 0.0 112.089 174.124 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.66 -13.5 34.12 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -179.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.3 mttp 66.49 7.04 4.75 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 127.326 2.25 . . . . 0.0 114.048 -177.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -98.7 9.47 43.25 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 127.082 2.153 . . . . 0.0 112.582 176.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 93.84 11.9 57.31 Favored Glycine 0 CA--C 1.535 1.299 0 C-N-CA 125.356 1.455 . . . . 0.0 114.025 -174.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.5 p -130.13 157.31 42.76 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.062 1.745 . . . . 0.0 111.385 178.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 26.1 m -119.99 140.19 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.349 1.06 . . . . 0.0 109.949 164.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 51.7 m -94.16 138.5 32.13 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 125.248 1.419 . . . . 0.0 108.598 170.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 47.6 t -126.72 133.04 69.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 125.688 1.595 . . . . 0.0 108.612 -175.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -142.07 157.23 45.15 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.553 1.141 . . . . 0.0 113.346 -170.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.0 t80 -158.31 137.83 11.86 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.874 1.669 . . . . 0.0 111.917 175.02 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.0 112.67 56.01 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.997 1.319 . . . . 0.0 110.785 176.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.11 149.04 28.09 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.685 2.923 . . . . 0.0 112.921 -174.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.1 p -139.21 -2.99 1.59 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 174.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -141.64 145.89 35.52 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.241 1.816 . . . . 0.0 109.484 178.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.74 169.53 15.15 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.976 0.911 . . . . 0.0 112.978 176.963 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 107.14 -173.19 18.77 Favored Glycine 0 N--CA 1.474 1.22 0 C-N-CA 124.992 1.282 . . . . 0.0 114.712 173.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 60.8 tp -77.71 128.16 33.62 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.96 1.304 . . . . 0.0 110.893 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 42.3 m80 -126.41 166.86 16.41 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.952 1.701 . . . . 0.0 111.175 -177.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.49 153.54 51.71 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 121.449 0.642 . . . . 0.0 112.312 156.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 43.7 ttm -112.54 121.8 45.86 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.692 1.597 . . . . 0.0 109.875 169.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.77 136.22 38.99 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.106 1.363 . . . . 0.0 110.133 164.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.8 mm -133.88 135.9 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.709 1.203 . . . . 0.0 109.78 167.085 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.41 138.65 31.27 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.665 1.186 . . . . 0.0 112.966 175.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 46.4 t80 -102.87 123.81 47.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.787 2.035 . . . . 0.0 109.53 174.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t0 49.08 45.75 22.86 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.766 1.227 . . . . 0.0 112.055 -176.048 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.28 4.6 p30 67.44 -2.05 1.39 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 128.864 2.866 . . . . 0.0 116.584 -177.065 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.2 mtt -100.67 134.27 43.89 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.069 1.347 . . . . 0.0 111.454 176.594 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 10.6 m170 -56.08 134.72 52.85 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 121.318 -0.864 . . . . 0.0 112.551 -179.226 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.2 pt -75.1 154.82 86.52 Favored Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 121.734 -0.603 . . . . 0.0 111.272 173.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -60.37 126.57 20.38 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 121.675 1.583 . . . . 0.0 108.587 165.231 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.85 -13.98 45.53 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.565 1.078 . . . . 0.0 114.366 -173.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 20.7 t -82.09 142.15 47.56 Favored Pre-proline 0 CA--C 1.55 0.96 0 CA-C-N 119.181 1.491 . . . . 0.0 112.143 176.399 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.05 152.95 77.1 Favored 'Cis proline' 0 C--N 1.354 0.816 0 CA-C-N 119.988 1.032 . . . . 0.0 111.864 -7.021 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 48.9 mt -91.59 111.2 22.61 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.021 1.328 . . . . 0.0 109.109 178.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 37.1 mt-30 -102.27 139.4 37.93 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.331 1.052 . . . . 0.0 111.531 -176.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.5 p90 -164.35 160.11 20.48 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.174 0.989 . . . . 0.0 112.801 -176.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 49.2 t80 -102.75 130.98 49.88 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.338 1.055 . . . . 0.0 111.998 176.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 65.3 t -92.12 134.37 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.919 1.288 . . . . 0.0 109.726 174.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 21.0 t0 -144.1 162.35 36.49 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 126.579 1.952 . . . . 0.0 110.805 -169.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.83 154.02 26.11 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.387 1.075 . . . . 0.0 112.584 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.1 p -65.6 -29.21 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 O-C-N 121.309 -0.869 . . . . 0.0 112.054 168.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -92.24 -163.06 0.99 Allowed 'General case' 0 CA--C 1.557 1.236 0 C-N-CA 125.752 1.621 . . . . 0.0 111.906 -179.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 57.9 m 79.04 155.61 0.15 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.43 2.692 . . . . 0.0 113.352 173.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -99.35 -8.35 53.07 Favored Glycine 0 N--CA 1.474 1.231 0 C-N-CA 124.912 1.244 . . . . 0.0 115.521 -173.184 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -64.96 152.95 41.96 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 118.911 1.355 . . . . 0.0 113.871 -178.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.2 t -64.88 143.85 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 124.181 0.992 . . . . 0.0 108.792 172.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -156.67 158.52 37.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.248 1.019 . . . . 0.0 110.795 -175.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -141.92 141.81 33.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.194 1.398 . . . . 0.0 111.003 -179.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 50.3 p90 -166.43 165.99 16.73 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.229 1.412 . . . . 0.0 112.796 -172.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 122.47 171.84 13.92 Favored Glycine 0 CA--C 1.536 1.397 0 C-N-CA 125.408 1.48 . . . . 0.0 112.466 -174.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.09 -33.68 9.24 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.914 2.409 . . . . 0.0 113.27 -168.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.61 -33.61 86.68 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 119.144 0.884 . . . . 0.0 114.513 -169.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.65 -6.92 55.5 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.728 1.264 . . . . 0.0 113.785 177.542 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 54.5 m -105.14 -40.37 5.9 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 127.025 2.13 . . . . 0.0 111.723 176.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -153.43 142.44 21.26 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.039 1.336 . . . . 0.0 112.568 -171.058 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.57 -176.11 15.61 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.923 1.249 . . . . 0.0 112.672 174.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 8.0 p -153.38 136.14 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.734 1.214 . . . . 0.0 109.281 176.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.0 m -60.11 147.01 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 -171.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.5 m-20 67.42 5.02 4.04 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.432 1.893 . . . . 0.0 114.574 173.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.9 mttp -120.61 149.72 50.85 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 126.179 1.792 . . . . 0.0 110.884 170.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.57 135.16 21.56 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.678 2.252 . . . . 0.0 110.848 175.189 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.29 146.92 36.16 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.798 1.639 . . . . 0.0 110.105 171.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.1 p -135.53 148.74 49.26 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 113.701 1.001 . . . . 0.0 113.701 -164.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.4 p90 -159.56 179.23 9.08 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.034 1.733 . . . . 0.0 111.265 175.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 52.6 m -132.87 144.87 50.48 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.316 1.446 . . . . 0.0 110.516 -170.46 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 40.6 t -122.53 127.75 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.876 1.67 . . . . 0.0 108.448 172.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -95.05 114.31 26.1 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.272 1.029 . . . . 0.0 110.554 -179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 25.2 p -120.54 -1.79 10.06 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 127.072 2.149 . . . . 0.0 113.423 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.6 tttt -55.64 -45.12 77.66 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 125.922 1.689 . . . . 0.0 114.562 -165.519 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -86.45 -15.85 38.94 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.258 1.023 . . . . 0.0 113.534 -176.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -82.46 -67.12 0.81 Allowed 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.599 1.16 . . . . 0.0 111.058 177.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 64.99 16.02 61.28 Favored Glycine 0 CA--C 1.537 1.437 0 N-CA-C 116.815 1.486 . . . . 0.0 116.815 165.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -155.5 146.58 22.53 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 119.585 1.693 . . . . 0.0 111.655 -173.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 90.53 -170.96 35.9 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.58 1.562 . . . . 0.0 112.862 -172.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -92.88 115.63 4.92 Favored Glycine 0 N--CA 1.469 0.855 0 C-N-CA 124.244 0.926 . . . . 0.0 111.525 177.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -77.74 123.24 26.44 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.346 1.059 . . . . 0.0 108.608 170.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 47.4 m -120.52 154.09 35.78 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.433 1.493 . . . . 0.0 112.104 -175.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.1 tp -157.66 133.83 9.51 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.865 1.666 . . . . 0.0 108.964 -173.879 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.93 160.62 39.26 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.876 0.871 . . . . 0.0 112.147 177.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.4 mt -135.04 134.34 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.794 1.238 . . . . 0.0 109.333 172.7 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -118.13 120.51 37.95 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.143 1.377 . . . . 0.0 109.051 171.412 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -132.57 179.93 16.82 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.659 1.124 . . . . 0.0 114.226 -176.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -68.05 -24.85 38.54 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 124.038 3.159 . . . . 0.0 111.923 174.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 22.5 t -134.73 157.81 45.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.343 1.457 . . . . 0.0 108.683 156.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -73.99 120.64 19.85 Favored 'General case' 0 CA--C 1.544 0.737 0 O-C-N 120.843 -1.161 . . . . 0.0 112.132 -174.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.56 145.73 34.65 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.049 0.94 . . . . 0.0 111.202 168.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -86.62 148.84 25.3 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.336 0.654 . . . . 0.0 110.393 167.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -137.59 144.79 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.808 1.243 . . . . 0.0 110.235 -166.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -145.87 166.86 24.73 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.891 1.276 . . . . 0.0 111.259 167.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.0 p -155.97 153.46 29.59 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.939 1.295 . . . . 0.0 112.404 -177.259 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 70.3 m -140.14 131.38 26.58 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.436 1.494 . . . . 0.0 110.331 -169.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 32.4 m-20 -82.63 128.12 34.03 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.057 0.943 . . . . 0.0 111.134 174.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 -91.84 152.18 20.23 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.708 1.203 . . . . 0.0 111.657 176.065 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -68.51 -17.58 64.2 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.494 0.717 . . . . 0.0 112.322 173.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -71.8 -9.76 58.78 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.576 1.55 . . . . 0.0 113.702 171.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 9.66 57.94 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.16 1.362 . . . . 0.0 115.203 176.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.9 p -108.23 161.23 15.19 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.948 1.699 . . . . 0.0 111.524 178.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 83.5 m -102.65 124.86 48.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.954 1.302 . . . . 0.0 110.278 170.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.3 t -88.69 151.98 22.1 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.807 0.843 . . . . 0.0 110.582 166.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.3 t -130.94 144.15 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.174 1.79 . . . . 0.0 109.984 -177.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.5 p -135.65 147.66 48.68 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.615 1.166 . . . . 0.0 111.729 166.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -148.92 154.95 40.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.31 -0.869 . . . . 0.0 113.005 174.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.75 102.62 25.22 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 124.79 1.236 . . . . 0.0 110.456 -173.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -86.78 163.91 9.07 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.033 3.155 . . . . 0.0 111.3 175.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.5 p -127.12 -21.45 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 -169.223 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.3 pp -140.77 150.51 60.16 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 124.487 1.115 . . . . 0.0 110.755 173.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.9 145.73 32.2 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.849 2.366 . . . . 0.0 111.99 -173.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.39 -167.54 32.46 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.837 1.208 . . . . 0.0 113.654 -176.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.04 124.57 38.14 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.392 1.477 . . . . 0.0 112.098 177.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -116.51 128.21 55.24 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.855 1.662 . . . . 0.0 110.009 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.9 m -89.99 116.29 27.92 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.105 0.962 . . . . 0.0 110.705 179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -93.59 124.67 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 125.698 1.599 . . . . 0.0 108.326 177.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.7 tt -108.53 127.48 53.97 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.455 1.502 . . . . 0.0 109.261 176.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.3 t -130.29 127.71 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.315 1.046 . . . . 0.0 109.497 173.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.75 144.6 24.41 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.066 1.347 . . . . 0.0 111.398 -167.522 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.29 125.98 13.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.509 1.123 . . . . 0.0 110.131 -177.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.1 52.37 11.84 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.576 1.15 . . . . 0.0 112.041 -179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 7.8 pt-20 58.84 12.68 2.38 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 128.322 2.649 . . . . 0.0 116.39 -177.45 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 -119.49 127.35 52.96 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.453 1.101 . . . . 0.0 110.997 177.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m-70 -62.43 143.32 57.21 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 121.466 -0.772 . . . . 0.0 111.417 170.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.4 m -71.38 151.99 94.15 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 118.441 -0.79 . . . . 0.0 110.03 173.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -55.36 126.55 22.88 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.249 2.633 . . . . 0.0 111.19 176.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.28 -15.92 62.17 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 125.367 1.46 . . . . 0.0 115.085 -175.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 36.4 t -78.06 141.69 63.27 Favored Pre-proline 0 CA--C 1.549 0.905 0 CA-C-N 119.356 1.578 . . . . 0.0 111.701 176.673 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.54 141.78 72.16 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.421 0.829 . . . . 0.0 112.27 -4.156 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -93.95 161.92 14.11 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.171 1.788 . . . . 0.0 110.617 176.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 41.7 m -119.97 116.0 24.9 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.675 0.79 . . . . 0.0 110.745 178.362 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.33 133.23 39.48 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.702 1.201 . . . . 0.0 111.084 172.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.03 111.75 23.68 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.898 0.879 . . . . 0.0 109.553 174.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.2 t -94.6 133.01 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.924 1.29 . . . . 0.0 110.05 -179.77 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 78.7 p -108.37 165.69 11.32 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.915 1.286 . . . . 0.0 113.094 -178.338 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.96 136.96 17.9 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.77 1.176 . . . . 0.0 111.679 175.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.3 t70 -88.82 -18.31 27.93 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 124.78 1.232 . . . . 0.0 113.768 -175.456 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 24.9 t0 . . . . . 0 C--O 1.255 1.378 0 C-N-CA 127.652 2.381 . . . . 0.0 114.277 179.135 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.577 0 N-CA-C 111.9 -0.48 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.34 159.22 37.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.549 1.54 . . . . 0.0 112.121 -179.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.5 mpp? -75.25 163.75 27.17 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.322 1.449 . . . . 0.0 112.352 179.339 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -63.67 151.22 89.01 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.265 1.026 . . . . 0.0 112.282 174.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.04 -10.47 19.57 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.734 2.956 . . . . 0.0 113.81 -178.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -154.83 153.25 30.87 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.607 1.563 . . . . 0.0 110.191 -178.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.78 147.89 88.4 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.689 1.195 . . . . 0.0 112.419 -179.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -68.61 154.11 72.16 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.697 2.931 . . . . 0.0 111.763 177.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 24.0 tp -79.89 59.26 3.11 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.308 1.443 . . . . 0.0 111.92 -174.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 84.7 t -75.99 131.25 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.284 1.433 . . . . 0.0 109.876 177.293 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 170.23 -178.96 42.72 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.856 1.217 . . . . 0.0 113.657 -179.438 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 21.4 m -143.53 154.16 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.851 1.661 . . . . 0.0 111.377 -179.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 63.6 t30 -164.29 162.15 22.27 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.295 1.838 . . . . 0.0 110.82 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -67.5 128.65 27.44 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 124.007 0.813 . . . . 0.0 111.111 173.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 82.5 mt -98.96 145.85 26.61 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.57 1.148 . . . . 0.0 111.859 -174.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 37.5 t0 70.2 164.04 0.26 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 127.618 2.367 . . . . 0.0 112.692 -177.041 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 66.6 t -134.27 138.89 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 125.615 1.566 . . . . 0.0 109.726 -178.347 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.6 t -156.35 -40.45 0.08 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.405 1.482 . . . . 0.0 111.464 175.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 6.6 t -162.46 147.45 12.31 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.238 1.015 . . . . 0.0 112.245 168.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 54.1 mt -97.21 153.52 17.96 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.571 1.548 . . . . 0.0 110.144 168.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -45.65 110.75 1.21 Allowed Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 126.392 1.877 . . . . 0.0 111.349 175.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -67.62 133.32 29.43 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 122.271 1.98 . . . . 0.0 108.801 172.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 48.0 t80 -118.99 123.67 45.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.587 0.755 . . . . 0.0 111.047 -174.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -157.2 141.78 16.64 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.648 1.579 . . . . 0.0 110.928 177.103 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -133.72 147.6 51.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.267 1.827 . . . . 0.0 110.266 -173.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -109.8 138.43 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 124.785 1.234 . . . . 0.0 109.963 172.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 41.8 mt -132.47 133.86 24.13 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.048 1.739 . . . . 0.0 108.686 -174.285 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.13 66.82 8.74 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 124.199 3.266 . . . . 0.0 111.211 177.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.8 t80 -115.68 153.81 30.65 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.895 1.678 . . . . 0.0 111.16 178.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 59.2 m -121.91 119.72 32.37 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.264 1.426 . . . . 0.0 109.429 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 58.1 mt -85.46 127.01 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.999 0.919 . . . . 0.0 109.295 174.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 95.4 mttt -104.17 -139.59 0.36 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.701 1.2 . . . . 0.0 110.67 176.741 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 pttt -75.27 -6.68 51.09 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.9 -148.42 8.68 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 125.781 1.658 . . . . 0.0 113.017 178.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -154.88 148.05 24.86 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.095 1.358 . . . . 0.0 110.517 -173.683 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -130.49 136.03 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 125.286 1.434 . . . . 0.0 111.184 -178.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 54.9 p -146.14 -175.33 4.72 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.457 1.903 . . . . 0.0 109.894 -177.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.88 -162.18 20.55 Favored Glycine 0 N--CA 1.467 0.725 0 N-CA-C 115.36 0.904 . . . . 0.0 115.36 -177.491 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -158.37 144.75 17.29 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.289 1.836 . . . . 0.0 109.664 176.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 90.8 t -123.07 135.89 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 126.015 1.726 . . . . 0.0 108.223 173.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -120.72 139.59 52.85 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.434 1.093 . . . . 0.0 112.056 -174.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -107.5 148.11 36.59 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.717 1.607 . . . . 0.0 111.481 -176.008 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -55.71 -28.75 67.96 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 124.115 3.21 . . . . 0.0 114.927 174.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 13.1 p -73.56 -2.78 24.23 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.39 1.876 . . . . 0.0 114.496 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.35 -5.77 83.83 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.562 1.554 . . . . 0.0 113.9 -178.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -68.77 157.56 36.12 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.144 1.377 . . . . 0.0 112.052 173.1 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 33.9 m -140.76 156.36 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.165 1.386 . . . . 0.0 111.655 177.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.28 179.83 8.86 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.92 2.088 . . . . 0.0 110.267 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -127.36 144.76 51.92 Favored Pre-proline 0 CA--C 1.544 0.741 0 O-C-N 121.146 -0.971 . . . . 0.0 111.915 179.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.83 166.14 13.36 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 124.146 3.231 . . . . 0.0 111.399 176.475 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.0 m -111.54 125.59 54.08 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.052 1.341 . . . . 0.0 108.96 173.479 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.14 132.47 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.788 1.235 . . . . 0.0 109.142 178.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 67.2 m -135.13 126.15 27.75 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.375 1.47 . . . . 0.0 109.744 178.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -75.84 139.01 41.49 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.954 0.901 . . . . 0.0 112.607 173.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -93.47 -4.96 50.27 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 -174.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 71.14 -3.69 1.99 Allowed 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 127.816 2.446 . . . . 0.0 114.225 -176.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -97.4 5.73 49.33 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 126.658 1.983 . . . . 0.0 113.264 -177.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 92.43 14.75 55.17 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 124.964 1.269 . . . . 0.0 113.891 -174.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 63.7 p -129.69 161.59 30.28 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.293 1.837 . . . . 0.0 110.611 177.071 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 18.7 m -121.31 146.79 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 124.595 1.158 . . . . 0.0 109.689 166.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 80.8 m -105.77 135.69 46.73 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.402 1.081 . . . . 0.0 108.467 169.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 20.5 t -115.05 133.57 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.569 1.548 . . . . 0.0 108.95 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.1 mtt85 -129.55 154.07 47.41 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.55 1.54 . . . . 0.0 112.1 -174.66 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.2 t80 -153.9 136.19 14.9 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.714 1.606 . . . . 0.0 111.513 179.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.12 118.12 68.88 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 124.52 1.128 . . . . 0.0 110.88 177.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.46 144.98 23.23 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.508 2.805 . . . . 0.0 111.77 -176.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.4 p -135.02 -7.42 2.34 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 178.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 51.2 tt0 -163.49 143.81 8.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.818 1.647 . . . . 0.0 110.218 -175.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -81.6 165.41 21.12 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.44 1.096 . . . . 0.0 113.239 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 123.68 -168.24 15.88 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.782 1.658 . . . . 0.0 114.377 178.011 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 3.2 tt -92.0 130.19 37.8 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.197 1.799 . . . . 0.0 109.58 -179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 76.9 m80 -134.25 169.88 16.53 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.251 1.421 . . . . 0.0 112.007 -170.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -146.76 152.39 38.71 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 112.583 168.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.1 ttm -121.22 118.07 28.69 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.894 2.478 . . . . 0.0 109.837 -175.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -88.34 137.75 32.05 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.428 1.491 . . . . 0.0 109.944 169.864 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.0 mm -135.65 135.17 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 124.573 1.149 . . . . 0.0 110.649 175.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.91 131.12 20.72 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.73 1.212 . . . . 0.0 113.131 -175.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 43.9 t80 -99.61 125.31 45.4 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.743 2.017 . . . . 0.0 109.901 174.126 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 52.4 34.05 14.3 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 124.734 1.214 . . . . 0.0 112.448 -174.587 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.1 t30 75.15 2.65 3.97 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 128.397 2.679 . . . . 0.0 114.746 -178.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.0 mtm -102.64 130.61 49.59 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.418 1.487 . . . . 0.0 110.638 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -58.7 137.71 57.45 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -176.385 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.1 pt -71.45 152.46 94.01 Favored Pre-proline 0 N--CA 1.48 1.033 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.599 173.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -61.17 125.68 17.58 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.363 2.042 . . . . 0.0 110.936 -176.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.92 -8.63 76.21 Favored Glycine 0 CA--C 1.536 1.355 0 C-N-CA 125.144 1.354 . . . . 0.0 115.233 -177.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 47.8 t -63.93 141.26 98.0 Favored Pre-proline 0 CA--C 1.552 1.033 0 CA-C-N 120.07 1.935 . . . . 0.0 111.941 175.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -82.59 161.45 76.15 Favored 'Cis proline' 0 C--N 1.354 0.837 0 CA-C-N 119.998 1.035 . . . . 0.0 113.492 0.016 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.1 mt -96.4 136.21 37.21 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.68 1.592 . . . . 0.0 110.004 172.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -109.25 141.96 40.79 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.372 1.069 . . . . 0.0 110.959 -177.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 34.0 p90 -153.85 174.13 14.99 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.545 1.138 . . . . 0.0 113.212 -173.634 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 33.9 t80 -128.49 147.75 50.7 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.65 1.18 . . . . 0.0 112.421 177.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 49.3 t -127.6 139.27 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.091 1.756 . . . . 0.0 109.16 -178.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 41.6 t0 -153.38 160.41 42.64 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.459 1.504 . . . . 0.0 110.756 -174.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -76.38 139.79 41.1 Favored 'General case' 0 CA--C 1.542 0.645 0 O-C-N 121.295 -0.878 . . . . 0.0 111.485 177.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -66.04 -23.61 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 O-C-N 121.442 -0.786 . . . . 0.0 112.842 -177.26 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 55.4 p30 -85.8 -3.66 58.96 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.469 1.508 . . . . 0.0 114.809 -176.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 65.1 m -64.48 137.48 57.89 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.04 0.936 . . . . 0.0 112.536 179.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.02 -12.95 54.63 Favored Glycine 0 CA--C 1.534 1.219 0 C-N-CA 124.939 1.257 . . . . 0.0 114.514 178.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -69.18 166.91 17.32 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 178.401 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 t -68.01 137.83 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 169.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.47 157.93 31.01 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.04 1.336 . . . . 0.0 110.335 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -136.07 143.35 44.6 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.923 1.289 . . . . 0.0 111.823 -174.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -167.44 164.99 15.06 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.62 1.568 . . . . 0.0 112.813 -176.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.57 173.8 13.42 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 125.229 1.395 . . . . 0.0 113.19 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.95 -32.99 12.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.855 2.37 . . . . 0.0 112.666 -171.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.23 -38.32 91.74 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-N 119.641 1.109 . . . . 0.0 114.094 -172.806 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -74.75 -8.68 57.14 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.712 1.256 . . . . 0.0 113.35 176.069 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.8 m -96.96 -42.93 7.68 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.45 1.9 . . . . 0.0 110.881 174.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -155.55 127.42 7.49 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 126.34 1.856 . . . . 0.0 112.025 -164.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.58 -177.79 15.13 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.693 2.092 . . . . 0.0 112.165 168.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 87.2 t -145.6 142.71 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.833 2.053 . . . . 0.0 107.476 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.2 m -56.14 138.47 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 N-CA-C 112.671 0.619 . . . . 0.0 112.671 -176.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.4 m-80 65.86 1.91 2.0 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.802 2.041 . . . . 0.0 114.887 175.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -106.74 139.43 20.36 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 125.411 1.484 . . . . 0.0 111.057 174.667 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.38 119.57 6.22 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.705 2.27 . . . . 0.0 110.314 -179.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -101.96 134.54 45.01 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.179 1.392 . . . . 0.0 110.055 175.715 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 38.6 p -127.52 145.98 50.67 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -165.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.6 p90 -157.26 177.05 11.91 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.662 1.585 . . . . 0.0 111.443 178.051 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.9 m -128.47 142.1 51.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.063 1.345 . . . . 0.0 111.075 -169.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 44.6 t -117.08 131.66 69.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.679 1.591 . . . . 0.0 108.422 168.274 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -91.75 129.53 37.7 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.42 1.088 . . . . 0.0 111.024 -177.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.3 p -135.65 8.15 3.31 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.049 1.34 . . . . 0.0 113.606 -168.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 23.6 tptm -54.23 -37.0 64.12 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.307 1.843 . . . . 0.0 114.772 -168.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.3 t70 -129.12 20.13 5.87 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.695 1.598 . . . . 0.0 112.268 -178.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.77 78.72 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.377 1.071 . . . . 0.0 113.854 -174.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 79.27 149.14 4.85 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.883 1.23 . . . . 0.0 112.365 -171.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.18 139.84 52.42 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.468 0.707 . . . . 0.0 111.815 -178.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.09 10.84 0.02 OUTLIER Glycine 0 CA--C 1.535 1.304 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 -176.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.88 97.99 1.55 Allowed Glycine 0 CA--C 1.529 0.948 0 C-N-CA 125.163 1.363 . . . . 0.0 112.819 179.476 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.1 tm? -79.47 127.25 31.9 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.817 1.247 . . . . 0.0 108.748 166.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 49.1 m -117.03 154.69 30.5 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.81 1.644 . . . . 0.0 111.731 178.097 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 54.9 tp -159.57 132.49 6.84 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.605 1.562 . . . . 0.0 109.096 -172.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.92 159.65 36.77 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.062 0.945 . . . . 0.0 112.311 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 60.4 mt -135.43 127.42 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.59 1.156 . . . . 0.0 109.9 175.363 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -105.6 168.01 9.38 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.897 1.679 . . . . 0.0 109.879 167.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 166.11 -161.16 34.79 Favored Glycine 0 CA--C 1.533 1.202 0 O-C-N 121.008 -1.057 . . . . 0.0 113.717 -179.815 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.1 -13.5 26.01 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.569 2.846 . . . . 0.0 112.435 176.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 9.5 t -155.08 168.25 27.65 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.396 1.879 . . . . 0.0 109.627 168.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -77.97 116.02 18.14 Favored 'General case' 0 CA--C 1.545 0.777 0 O-C-N 120.898 -1.126 . . . . 0.0 111.363 179.524 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -79.7 143.73 34.31 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.993 0.917 . . . . 0.0 110.802 166.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -91.64 146.73 23.54 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.236 0.615 . . . . 0.0 110.854 171.513 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 17.9 mt -136.87 140.32 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.679 1.192 . . . . 0.0 110.856 -163.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -131.31 158.75 39.84 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.116 1.766 . . . . 0.0 110.628 167.31 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.9 p -151.55 153.65 34.96 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.165 0.986 . . . . 0.0 112.404 175.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.2 m -147.0 131.13 17.34 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.287 1.435 . . . . 0.0 110.812 -166.284 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 9.5 t0 -71.04 123.02 21.13 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.199 1.0 . . . . 0.0 110.986 169.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -80.96 -9.78 59.79 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.025 0.93 . . . . 0.0 113.356 177.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 45.9 tt0 79.2 -25.12 0.19 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 129.005 2.922 . . . . 0.0 112.696 179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -75.61 1.9 13.23 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.447 1.899 . . . . 0.0 114.15 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.86 21.17 19.32 Favored Glycine 0 N--CA 1.473 1.153 0 C-N-CA 125.216 1.389 . . . . 0.0 114.081 -177.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 73.2 p -133.78 150.4 51.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.095 1.358 . . . . 0.0 110.411 174.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 82.3 m -106.66 126.1 51.85 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.451 1.5 . . . . 0.0 109.339 170.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 23.2 t -84.33 150.71 25.21 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.819 0.848 . . . . 0.0 110.536 168.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 97.2 t -126.85 144.87 35.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 C-N-CA 126.844 2.058 . . . . 0.0 108.828 177.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.1 t -137.35 136.59 38.06 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.38 1.472 . . . . 0.0 110.277 171.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -142.89 153.74 43.42 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 177.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.5 mt -120.13 104.72 43.31 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.953 1.701 . . . . 0.0 110.073 -179.065 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -80.55 155.49 21.33 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.481 2.787 . . . . 0.0 110.021 169.361 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 35.2 m -116.73 -13.03 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -166.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.0 pp -158.28 156.04 26.93 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.835 1.654 . . . . 0.0 110.458 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.59 153.52 49.32 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.005 2.47 . . . . 0.0 112.72 -170.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.64 -151.4 23.67 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 124.94 1.257 . . . . 0.0 113.47 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -120.91 125.37 47.27 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.339 1.456 . . . . 0.0 110.718 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -110.77 149.34 30.66 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.93 1.692 . . . . 0.0 110.778 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 66.6 m -113.27 114.25 26.43 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.556 1.142 . . . . 0.0 110.963 -177.574 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -90.44 123.41 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 126.288 1.835 . . . . 0.0 108.882 -179.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.2 tt -105.53 131.88 52.38 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.549 1.54 . . . . 0.0 109.479 173.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 50.6 t -133.46 131.9 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.394 1.478 . . . . 0.0 108.289 172.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -157.21 142.96 17.57 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.852 1.261 . . . . 0.0 110.765 -167.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.66 123.58 22.69 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.548 1.139 . . . . 0.0 109.628 179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 10.8 t-20 51.43 56.96 7.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.129 1.372 . . . . 0.0 112.492 176.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.307 8.0 pt-20 59.62 12.95 3.1 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 128.189 2.596 . . . . 0.0 116.321 -177.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -118.96 124.62 47.49 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.451 1.101 . . . . 0.0 111.188 177.245 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -61.59 155.52 22.07 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.149 0.98 . . . . 0.0 112.785 170.787 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.4 m -81.92 155.94 70.08 Favored Pre-proline 0 N--CA 1.48 1.04 0 O-C-N 121.787 -0.571 . . . . 0.0 110.427 175.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -55.4 121.19 9.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.795 2.33 . . . . 0.0 110.448 172.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -13.04 67.22 Favored Glycine 0 CA--C 1.533 1.204 0 C-N-CA 125.177 1.37 . . . . 0.0 116.316 178.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 98.7 p -80.08 153.83 74.82 Favored Pre-proline 0 CA--C 1.549 0.938 0 CA-C-N 120.552 2.176 . . . . 0.0 113.212 -178.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -74.95 158.34 99.05 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.222 0.758 . . . . 0.0 112.596 -4.697 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -112.96 138.21 50.18 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.335 1.454 . . . . 0.0 111.345 -176.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 21.2 m -89.9 117.42 28.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.876 0.871 . . . . 0.0 110.712 177.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.76 127.5 44.7 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.281 1.432 . . . . 0.0 111.392 173.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.62 138.22 46.62 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.534 1.533 . . . . 0.0 110.608 172.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 98.1 t -138.15 138.8 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.244 0 C-N-CA 124.646 1.178 . . . . 0.0 110.818 172.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 81.1 p -130.57 165.19 23.28 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.535 1.134 . . . . 0.0 112.672 174.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.64 144.19 22.05 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.941 1.734 . . . . 0.0 112.909 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.2 t70 -155.11 17.46 0.42 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 125.239 1.416 . . . . 0.0 112.707 178.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.4 t70 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 126.239 1.815 . . . . 0.0 112.655 -176.887 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.555 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -157.97 164.27 36.98 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.698 1.599 . . . . 0.0 111.76 -179.085 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 77.1 mtm -73.28 148.08 43.92 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.23 1.012 . . . . 0.0 111.855 176.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -158.57 149.52 16.24 Favored Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 125.41 1.484 . . . . 0.0 111.708 178.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -78.26 170.78 18.06 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.832 3.021 . . . . 0.0 111.854 177.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -152.98 139.75 18.96 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.186 1.394 . . . . 0.0 109.934 173.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -75.11 150.3 85.48 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.825 0.85 . . . . 0.0 112.958 -174.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -74.63 171.19 18.66 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.435 2.756 . . . . 0.0 111.074 171.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -11.81 60.35 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 178.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 60.6 t -82.85 134.12 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 125.804 1.641 . . . . 0.0 110.021 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 79.83 -122.35 5.75 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 124.146 0.879 . . . . 0.0 112.25 175.38 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 96.5 t -59.58 135.63 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.66 1.184 . . . . 0.0 110.508 -179.077 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 8.0 p30 -156.93 153.35 27.98 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.186 1.394 . . . . 0.0 112.088 -176.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -83.43 166.23 43.57 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.706 1.146 . . . . 0.0 113.263 179.242 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.9 mt -69.69 155.58 40.3 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.181 0.993 . . . . 0.0 111.87 176.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 34.1 t70 -72.96 -14.83 61.53 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.757 1.223 . . . . 0.0 113.163 179.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 6.8 m -138.22 148.56 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.832 2.053 . . . . 0.0 111.287 -179.114 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 8.9 t 174.84 -39.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 128.902 2.881 . . . . 0.0 110.482 -178.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 40.8 m -76.62 73.07 3.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.322 1.449 . . . . 0.0 111.694 175.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . 0.482 HD11 HG12 ' A' 1860 ' ' VAL . 20.9 tp -91.66 149.13 21.79 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.47 1.908 . . . . 0.0 110.866 177.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 -53.13 110.91 2.24 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 124.689 1.196 . . . . 0.0 113.5 -168.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.02 135.79 28.23 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.19 1.927 . . . . 0.0 108.937 172.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -102.43 121.31 42.08 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.205 0.602 . . . . 0.0 109.839 -179.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.67 124.53 9.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.828 1.251 . . . . 0.0 110.89 175.071 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.2 mm? -131.72 149.18 52.56 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 126.804 2.042 . . . . 0.0 109.558 -176.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 15.0 p -123.67 135.71 62.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.894 1.278 . . . . 0.0 110.069 176.21 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 62.8 mt -132.94 138.18 31.27 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 125.885 1.674 . . . . 0.0 108.979 -174.389 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.48 59.56 7.2 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.582 3.521 . . . . 0.0 112.216 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 40.1 t80 -100.71 151.7 21.35 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.529 1.532 . . . . 0.0 111.017 174.426 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.1 m -124.53 126.79 46.41 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 125.149 1.379 . . . . 0.0 109.535 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 83.5 mt -88.41 128.85 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.792 1.237 . . . . 0.0 110.691 -177.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 41.0 tttm -99.08 -140.17 0.32 Allowed 'General case' 0 CA--C 1.556 1.192 0 C-N-CA 125.945 1.698 . . . . 0.0 111.707 177.239 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -82.51 -10.63 58.93 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.623 1.712 . . . . 0.0 115.623 -175.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.42 -143.01 6.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 126.056 1.789 . . . . 0.0 112.628 179.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -154.46 147.44 24.57 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.732 1.213 . . . . 0.0 110.924 -175.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 17.7 tt -118.54 133.76 64.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 125.684 1.593 . . . . 0.0 111.148 -178.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 29.1 p -150.31 170.84 18.06 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.197 1.799 . . . . 0.0 110.647 -174.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.47 -169.05 24.23 Favored Glycine 0 N--CA 1.468 0.789 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 -176.356 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -152.77 141.86 21.34 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.395 1.878 . . . . 0.0 109.661 177.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 57.3 t -117.31 136.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.64 1.976 . . . . 0.0 108.12 173.324 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -117.57 132.2 56.56 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.252 1.021 . . . . 0.0 111.577 -177.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -100.54 145.48 30.38 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 125.634 1.574 . . . . 0.0 111.235 -176.354 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -73.63 -16.89 23.74 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.673 2.916 . . . . 0.0 112.936 179.738 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 30.6 p -76.0 -2.06 28.72 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.369 1.467 . . . . 0.0 114.301 175.186 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.45 45.64 3.98 Favored Glycine 0 N--CA 1.472 1.041 0 C-N-CA 124.638 1.114 . . . . 0.0 113.63 175.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -147.48 170.09 18.15 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.282 1.433 . . . . 0.0 112.426 179.425 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.8 m -138.81 157.84 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 C-N-CA 125.296 1.439 . . . . 0.0 112.159 -174.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.6 177.6 11.03 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.899 2.08 . . . . 0.0 110.296 179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -123.56 145.62 47.57 Favored Pre-proline 0 CA--C 1.543 0.704 0 O-C-N 121.222 -0.924 . . . . 0.0 111.896 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -82.93 167.9 14.11 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 124.209 3.273 . . . . 0.0 111.342 176.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.84 126.62 53.24 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.125 1.37 . . . . 0.0 108.547 170.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.72 130.57 56.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.317 1.047 . . . . 0.0 108.848 175.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.3 m -121.12 128.39 52.5 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 125.799 1.64 . . . . 0.0 109.639 179.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 50.3 t0 -79.83 121.3 25.22 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.422 1.089 . . . . 0.0 110.346 173.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -84.11 -12.75 54.51 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 34.0 mmtp 65.79 9.84 6.34 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.997 2.119 . . . . 0.0 114.149 -178.717 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -108.59 10.07 27.15 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 126.835 2.054 . . . . 0.0 112.808 -176.705 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.8 15.06 62.0 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 124.79 1.186 . . . . 0.0 113.601 -172.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 64.2 p -132.78 160.26 37.39 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.544 1.938 . . . . 0.0 110.472 177.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.3 m -125.0 144.85 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.739 1.215 . . . . 0.0 109.636 166.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 85.9 m -106.96 135.55 48.34 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.208 1.003 . . . . 0.0 108.691 171.732 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.5 t -119.97 131.05 73.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 125.406 1.483 . . . . 0.0 108.846 -177.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 85.4 mtt85 -130.9 156.44 45.05 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.209 1.404 . . . . 0.0 112.768 -174.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 9.1 t80 -153.93 137.19 15.7 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.667 1.587 . . . . 0.0 111.675 176.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.36 120.84 69.02 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 124.805 1.242 . . . . 0.0 111.023 177.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -79.02 155.88 26.32 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.757 2.971 . . . . 0.0 112.694 -172.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 94.1 p -140.66 -11.88 1.01 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -160.66 151.29 18.38 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.611 1.565 . . . . 0.0 110.55 178.89 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -79.02 170.44 16.68 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.893 1.277 . . . . 0.0 113.299 179.161 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 116.28 -172.11 14.07 Favored Glycine 0 N--CA 1.473 1.103 0 C-N-CA 125.428 1.49 . . . . 0.0 114.148 177.395 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.0 tp -82.32 134.56 35.27 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.636 1.175 . . . . 0.0 110.458 177.444 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 66.1 m80 -134.56 165.19 25.78 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.622 1.569 . . . . 0.0 111.628 -172.653 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -149.15 153.49 37.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.438 1.095 . . . . 0.0 111.621 175.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 36.3 ttm -130.74 140.31 50.31 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.567 1.547 . . . . 0.0 110.889 179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -107.73 131.1 54.79 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.425 1.49 . . . . 0.0 110.042 167.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.58 137.92 51.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.562 1.145 . . . . 0.0 109.852 167.574 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.41 144.01 37.91 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.638 1.175 . . . . 0.0 113.027 176.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -103.5 117.28 34.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.439 1.896 . . . . 0.0 109.679 173.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.7 t70 52.56 30.97 9.24 Favored 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.663 1.185 . . . . 0.0 113.016 -175.402 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 65.8 m-80 79.09 4.56 2.32 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 128.662 2.785 . . . . 0.0 115.12 -178.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 64.6 ttp -96.12 126.42 41.34 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.696 1.198 . . . . 0.0 110.206 166.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -59.11 139.12 57.21 Favored 'General case' 0 N--CA 1.475 0.785 0 O-C-N 121.172 -0.955 . . . . 0.0 113.086 -178.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 32.4 pt -73.76 149.85 88.26 Favored Pre-proline 0 N--CA 1.479 1.01 0 CA-C-O 118.696 -0.669 . . . . 0.0 110.375 173.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.34 -20.33 61.75 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 114.067 -171.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.77 -7.84 86.78 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 114.809 174.183 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.5 m -94.89 155.75 38.83 Favored Pre-proline 0 CA--C 1.546 0.792 0 CA-C-N 119.281 1.54 . . . . 0.0 113.078 177.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -75.22 161.48 94.61 Favored 'Cis proline' 0 C--N 1.351 0.688 0 CA-C-N 118.707 0.574 . . . . 0.0 112.554 -1.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 85.0 mt -104.74 154.03 20.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.592 1.557 . . . . 0.0 110.129 172.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -145.99 139.38 26.11 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.663 1.185 . . . . 0.0 110.052 -177.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -163.4 166.13 23.2 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.387 1.075 . . . . 0.0 112.293 -177.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 28.9 t80 -110.16 141.52 42.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.025 0.93 . . . . 0.0 111.914 175.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . 0.482 HG12 HD11 ' A' 1788 ' ' LEU . 97.6 t -110.84 129.91 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 125.861 1.664 . . . . 0.0 109.085 -178.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 34.2 t0 -160.42 146.57 15.31 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.005 1.322 . . . . 0.0 111.841 -173.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -68.31 150.36 48.32 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.197 0.999 . . . . 0.0 113.436 -175.534 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 55.3 t -62.06 -44.38 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.289 1.036 . . . . 0.0 111.564 177.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -93.07 22.98 4.56 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.759 1.224 . . . . 0.0 113.407 -174.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 31.4 p -62.39 -26.57 68.54 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 115.161 1.541 . . . . 0.0 115.161 -174.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 79.77 -46.81 3.18 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 125.997 1.761 . . . . 0.0 113.812 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -62.5 165.03 6.65 Favored 'General case' 0 CA--C 1.552 1.031 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.2 t -67.55 134.85 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.762 0.825 . . . . 0.0 109.308 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -160.33 167.7 26.88 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.953 1.301 . . . . 0.0 110.876 -174.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -148.03 146.31 28.83 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.879 1.271 . . . . 0.0 111.793 -177.233 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.5 p90 -166.73 160.65 15.01 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.49 1.516 . . . . 0.0 113.041 -174.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.4 172.92 13.21 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.622 1.582 . . . . 0.0 112.747 -175.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.16 -32.34 6.87 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.189 2.593 . . . . 0.0 113.443 -170.591 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.9 -31.06 77.07 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-N 119.257 0.935 . . . . 0.0 114.287 -170.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.22 -2.32 37.18 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 118.678 1.239 . . . . 0.0 113.654 175.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 64.5 m -112.97 -41.47 3.74 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 126.841 2.056 . . . . 0.0 112.033 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -149.26 146.0 27.37 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.817 1.247 . . . . 0.0 112.843 -178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.72 179.2 21.3 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.116 1.341 . . . . 0.0 113.096 173.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.7 t -138.8 137.2 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.572 1.149 . . . . 0.0 108.661 174.404 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.4 m -55.7 141.6 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -177.581 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 66.2 m-80 65.9 4.95 3.19 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.698 1.999 . . . . 0.0 114.716 174.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 46.9 mtmt -123.44 141.78 37.15 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.632 1.573 . . . . 0.0 110.766 176.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.15 135.9 25.91 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.554 2.17 . . . . 0.0 111.382 -174.029 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.28 147.14 39.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.738 1.615 . . . . 0.0 110.262 173.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.0 p -136.72 150.85 48.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 -165.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 56.0 p90 -162.29 -179.94 7.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.289 1.835 . . . . 0.0 111.507 176.528 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 90.2 m -129.69 143.64 50.91 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.37 1.468 . . . . 0.0 110.714 -171.771 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 60.1 t -116.53 133.36 63.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.663 1.585 . . . . 0.0 108.393 170.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.33 132.92 37.1 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 124.483 1.113 . . . . 0.0 111.421 178.061 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 77.3 p -130.18 6.02 4.92 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.188 1.795 . . . . 0.0 112.89 -176.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 25.5 pttm -59.37 -20.65 56.4 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 -165.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -145.63 31.83 1.07 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.197 1.399 . . . . 0.0 111.442 171.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.47 -37.34 65.81 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.131 1.16 . . . . 0.0 114.131 -175.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.63 153.22 9.04 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.513 1.054 . . . . 0.0 112.236 -168.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -76.78 165.01 25.31 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -177.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 160.01 -77.87 0.18 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.367 1.461 . . . . 0.0 111.457 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -176.07 114.67 0.49 Allowed Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.496 1.046 . . . . 0.0 112.625 171.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.2 tm? -84.44 130.31 34.78 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.147 1.379 . . . . 0.0 109.32 174.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.9 m -128.27 155.91 43.84 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.516 1.526 . . . . 0.0 112.159 -178.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 38.2 tp -155.11 135.45 13.25 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.41 1.884 . . . . 0.0 108.614 -175.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.51 160.26 40.41 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.992 0.917 . . . . 0.0 112.097 177.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.9 mt -135.14 133.87 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.578 1.151 . . . . 0.0 109.614 174.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -124.82 110.11 13.9 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.301 1.44 . . . . 0.0 109.347 175.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.14 -169.73 12.75 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.918 1.247 . . . . 0.0 113.896 -178.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -69.31 -18.76 38.97 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.657 2.905 . . . . 0.0 111.987 173.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 15.8 t -137.06 159.63 41.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.613 1.565 . . . . 0.0 109.211 159.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -76.86 114.52 15.72 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 120.85 -1.156 . . . . 0.0 111.216 -178.598 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -77.13 141.96 39.93 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.285 1.034 . . . . 0.0 111.547 174.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -86.51 146.68 26.29 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.004 0.521 . . . . 0.0 110.597 170.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.9 145.33 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.345 1.458 . . . . 0.0 110.277 -165.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 17.3 t -145.02 142.75 30.03 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.071 0.948 . . . . 0.0 110.695 164.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -140.44 153.86 46.44 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.34 1.056 . . . . 0.0 112.142 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 92.5 m -136.42 119.78 16.85 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.434 1.493 . . . . 0.0 109.875 -172.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 31.9 t0 -71.67 116.65 12.28 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.84 0.856 . . . . 0.0 109.774 166.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -81.24 -13.25 58.72 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.905 0.882 . . . . 0.0 112.844 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 70.86 -3.95 1.85 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 128.367 2.667 . . . . 0.0 114.072 178.11 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -87.71 2.0 52.28 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.986 1.714 . . . . 0.0 113.718 177.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 106.61 10.12 29.55 Favored Glycine 0 CA--C 1.534 1.223 0 C-N-CA 125.499 1.523 . . . . 0.0 114.754 -172.715 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 50.7 p -133.84 153.35 51.8 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 118.85 1.325 . . . . 0.0 112.375 173.279 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.4 m -112.46 129.69 56.24 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.885 1.674 . . . . 0.0 109.06 162.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.7 t -86.78 148.41 25.42 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.855 0.862 . . . . 0.0 110.526 170.083 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.3 t -130.26 141.67 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 125.626 1.571 . . . . 0.0 110.074 -177.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 98.2 p -136.36 148.88 48.08 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.57 1.548 . . . . 0.0 111.671 169.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.3 p90 -151.37 156.1 40.03 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 175.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 5.5 mt -122.0 107.4 35.48 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.742 1.617 . . . . 0.0 110.684 -179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -82.82 169.87 13.02 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 123.907 3.072 . . . . 0.0 110.452 167.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 10.8 p -135.01 -23.91 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -170.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.2 pp -142.29 151.0 57.14 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 124.916 1.287 . . . . 0.0 110.495 175.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.19 153.91 41.24 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.67 2.247 . . . . 0.0 112.347 -168.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 145.23 -163.83 28.06 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 125.371 1.462 . . . . 0.0 112.534 -174.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -109.08 125.33 52.02 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.438 1.095 . . . . 0.0 111.338 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -110.26 129.68 55.69 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.787 2.035 . . . . 0.0 109.941 -177.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.2 m -88.38 126.36 35.17 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 120.977 -1.077 . . . . 0.0 111.053 177.252 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -102.98 124.97 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 125.313 1.445 . . . . 0.0 108.365 179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.8 tt -109.21 129.18 55.5 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.302 1.441 . . . . 0.0 109.708 177.675 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.0 t -131.94 129.28 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.434 1.094 . . . . 0.0 109.692 173.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -152.44 143.42 23.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.894 1.278 . . . . 0.0 111.721 -167.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.87 122.69 18.82 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.76 1.224 . . . . 0.0 109.587 177.45 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.2 t-20 55.04 56.94 6.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.197 1.399 . . . . 0.0 111.876 176.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.291 7.7 pt-20 58.82 8.43 0.95 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 128.653 2.781 . . . . 0.0 116.556 -176.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -113.98 123.55 50.0 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.426 1.09 . . . . 0.0 110.884 177.522 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -63.34 145.24 55.99 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.549 -0.72 . . . . 0.0 111.742 171.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 11.3 m -72.5 157.67 88.66 Favored Pre-proline 0 N--CA 1.479 1.008 0 CA-C-O 118.459 -0.781 . . . . 0.0 110.608 172.691 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -54.39 126.89 23.75 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 123.357 2.705 . . . . 0.0 111.932 178.147 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.54 -12.24 63.73 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.817 1.198 . . . . 0.0 115.375 -178.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 45.7 t -75.59 140.14 71.44 Favored Pre-proline 0 CA--C 1.55 0.974 0 CA-C-N 119.437 1.618 . . . . 0.0 111.404 176.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -75.09 137.28 49.36 Favored 'Cis proline' 0 CA--C 1.539 0.754 0 CA-C-N 119.459 0.843 . . . . 0.0 112.101 -3.342 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -86.91 175.21 8.28 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.143 1.777 . . . . 0.0 110.725 174.176 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 17.9 m -136.78 119.66 16.32 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.765 0.826 . . . . 0.0 110.824 178.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -102.59 129.06 49.04 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.377 1.471 . . . . 0.0 110.806 174.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -91.13 125.03 35.79 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.955 -0.466 . . . . 0.0 110.557 173.87 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.6 t -107.09 129.2 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.525 1.53 . . . . 0.0 109.896 -177.159 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.2 p -106.55 165.8 11.02 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.848 1.259 . . . . 0.0 112.538 178.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.37 144.09 29.04 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.751 1.167 . . . . 0.0 112.271 176.373 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 38.8 t70 -80.14 -13.62 59.12 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.572 1.149 . . . . 0.0 113.018 176.544 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.8 t70 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 126.833 2.053 . . . . 0.0 112.473 -178.975 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -63.76 -18.11 63.73 Favored 'General case' 0 CA--C 1.547 0.843 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -173.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 49.0 ttp -72.4 -18.12 61.75 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.023 1.329 . . . . 0.0 113.367 176.438 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -64.37 140.93 98.08 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 123.883 0.873 . . . . 0.0 112.686 -177.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -77.43 163.34 29.92 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.786 2.99 . . . . 0.0 112.269 -178.565 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -160.52 141.59 11.99 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.701 1.6 . . . . 0.0 109.921 177.308 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -157.82 131.53 4.85 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.081 1.352 . . . . 0.0 110.741 -179.453 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.19 157.38 29.96 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.454 2.769 . . . . 0.0 111.906 179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 60.6 tp -161.55 136.26 7.19 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.69 1.596 . . . . 0.0 109.928 176.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 93.1 t -99.0 126.44 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.771 1.229 . . . . 0.0 109.411 175.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -96.27 148.75 19.1 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.947 1.261 . . . . 0.0 112.207 174.054 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 23.4 m -143.5 152.84 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 125.657 1.583 . . . . 0.0 110.972 179.122 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 10.3 p30 -107.17 165.96 10.98 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.296 1.438 . . . . 0.0 112.686 177.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -85.3 -112.13 0.72 Allowed Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.496 1.522 . . . . 0.0 111.7 177.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.0 mt -73.05 156.55 38.65 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.083 0.953 . . . . 0.0 111.516 174.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 24.2 t0 -74.18 65.97 1.21 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.294 1.438 . . . . 0.0 111.328 175.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 12.3 p -58.39 -32.71 45.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 125.526 1.531 . . . . 0.0 113.448 -172.384 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 1.7 t 60.22 -21.83 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 130.506 3.522 . . . . 0.0 117.49 171.31 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 50.1 m -79.07 72.15 5.59 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.178 1.391 . . . . 0.0 112.828 -173.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.71 136.26 55.25 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.284 -0.885 . . . . 0.0 110.39 167.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -60.51 117.81 28.24 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 125.627 1.571 . . . . 0.0 110.672 179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.19 144.38 56.87 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.765 2.31 . . . . 0.0 109.746 178.371 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 34.0 t80 -109.92 129.32 55.67 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.444 0.697 . . . . 0.0 111.424 -174.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -155.79 145.61 21.29 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.462 1.505 . . . . 0.0 111.2 174.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.16 144.33 30.82 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 125.973 1.709 . . . . 0.0 110.008 -171.474 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.7 p -113.94 137.11 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.005 1.322 . . . . 0.0 110.103 174.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.6 mt -133.71 135.41 24.82 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.924 1.689 . . . . 0.0 109.172 -172.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -74.39 96.13 0.96 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.731 2.954 . . . . 0.0 109.927 173.546 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 58.0 t80 -159.4 152.74 22.41 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.209 2.204 . . . . 0.0 108.523 -178.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.62 126.9 37.83 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.323 1.049 . . . . 0.0 109.868 -177.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 46.6 mt -78.98 116.07 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 124.025 0.93 . . . . 0.0 109.71 175.055 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -98.68 -152.66 0.41 Allowed 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.473 1.509 . . . . 0.0 110.882 172.697 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tttp -70.93 122.23 19.58 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 120.635 -1.29 . . . . 0.0 111.03 171.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 140.0 -150.37 21.45 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.613 1.578 . . . . 0.0 111.986 -170.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -159.54 145.92 16.32 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.621 1.168 . . . . 0.0 111.168 -175.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.7 tt -123.74 138.78 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.633 1.573 . . . . 0.0 110.965 177.736 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 36.3 p -146.51 170.77 16.2 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.95 1.7 . . . . 0.0 110.534 -177.789 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.51 -171.43 27.54 Favored Glycine 0 N--CA 1.466 0.69 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 -177.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -154.42 144.93 22.24 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.427 1.891 . . . . 0.0 109.637 176.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 74.3 t -120.3 132.58 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.929 1.692 . . . . 0.0 108.777 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -105.27 134.8 47.77 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.824 1.25 . . . . 0.0 111.713 -177.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 9.4 mtm -101.82 140.11 20.92 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.697 1.599 . . . . 0.0 110.846 174.487 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -56.09 -30.13 77.54 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 124.084 3.189 . . . . 0.0 115.017 177.036 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.8 p -74.67 2.37 10.07 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.022 1.729 . . . . 0.0 114.375 178.224 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 97.24 -5.28 62.94 Favored Glycine 0 N--CA 1.473 1.138 0 C-N-CA 125.716 1.627 . . . . 0.0 114.837 172.05 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 4.6 mtpt -73.82 159.0 33.51 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.498 1.119 . . . . 0.0 111.898 175.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 19.3 m -139.65 150.83 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.491 1.516 . . . . 0.0 110.837 172.64 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -156.15 172.55 18.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.394 1.877 . . . . 0.0 110.051 179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -115.63 141.58 27.6 Favored Pre-proline 0 CA--C 1.545 0.774 0 O-C-N 121.208 -0.933 . . . . 0.0 112.152 -175.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -82.18 167.65 15.68 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 124.11 3.207 . . . . 0.0 111.317 174.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.8 m -108.04 130.32 55.08 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.044 1.338 . . . . 0.0 108.923 172.594 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -111.79 133.55 57.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.823 1.249 . . . . 0.0 109.437 177.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.8 m -133.41 127.63 33.82 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.605 1.562 . . . . 0.0 109.756 177.52 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.9 t70 -79.42 128.6 33.55 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.751 0.821 . . . . 0.0 110.625 172.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -82.48 -9.33 59.47 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -175.038 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.1 mttt 72.23 0.95 3.76 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 128.193 2.597 . . . . 0.0 114.088 -178.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -97.41 3.7 50.87 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.682 1.993 . . . . 0.0 113.143 174.289 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 96.12 16.17 39.12 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.983 1.278 . . . . 0.0 114.426 -177.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 75.7 p -127.96 156.65 42.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.206 1.802 . . . . 0.0 110.391 175.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 35.5 m -112.74 144.94 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.809 0.844 . . . . 0.0 109.816 164.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 61.6 m -104.94 134.82 47.41 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 124.53 1.132 . . . . 0.0 108.435 166.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.6 t -114.04 135.78 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 125.561 1.544 . . . . 0.0 108.704 175.447 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 72.2 mtp85 -132.49 151.8 51.77 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.232 1.413 . . . . 0.0 112.128 -176.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 57.6 t80 -155.45 137.17 14.32 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.299 1.44 . . . . 0.0 112.306 -178.452 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -93.74 120.49 66.01 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 124.635 1.174 . . . . 0.0 111.109 177.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.65 150.52 24.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.664 2.909 . . . . 0.0 111.99 -178.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 87.6 p -122.95 -13.32 7.85 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 174.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -166.71 148.87 6.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.013 1.725 . . . . 0.0 110.206 -171.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -74.98 165.5 25.17 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.079 0.952 . . . . 0.0 113.348 179.321 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 128.62 179.5 15.95 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 125.484 1.516 . . . . 0.0 114.505 176.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.1 tp -85.9 107.65 17.81 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.864 1.266 . . . . 0.0 110.402 179.687 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 25.8 m80 -100.48 169.79 8.83 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.686 1.594 . . . . 0.0 111.665 -176.601 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -141.59 149.13 40.33 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.897 0.879 . . . . 0.0 111.208 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 12.1 ttm -118.19 128.73 54.99 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 126.63 1.972 . . . . 0.0 110.018 -178.297 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -106.64 131.39 53.84 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 127.165 2.186 . . . . 0.0 109.385 173.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 21.9 mm -135.05 135.81 52.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.505 1.122 . . . . 0.0 110.466 177.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.04 139.73 26.29 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 179.011 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.7 t80 -103.21 123.97 47.73 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.89 2.076 . . . . 0.0 109.93 176.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 52.16 32.17 10.17 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 124.745 1.218 . . . . 0.0 112.535 -173.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 21.5 t30 75.56 6.15 4.0 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 128.076 2.55 . . . . 0.0 115.108 -178.427 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 70.8 mtm -104.41 132.66 50.41 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.739 1.616 . . . . 0.0 110.943 173.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.3 135.77 44.19 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -178.014 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.3 pt -75.82 154.54 85.13 Favored Pre-proline 0 N--CA 1.478 0.956 0 CA-C-O 118.746 -0.645 . . . . 0.0 111.004 170.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -60.19 127.5 23.29 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.069 1.846 . . . . 0.0 109.302 170.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.58 -14.13 57.89 Favored Glycine 0 CA--C 1.528 0.873 0 CA-C-O 118.719 -1.045 . . . . 0.0 114.418 -175.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.8 t -82.78 143.2 46.29 Favored Pre-proline 0 CA--C 1.55 0.945 0 CA-C-N 119.812 1.806 . . . . 0.0 111.533 172.492 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -80.57 163.63 80.76 Favored 'Cis proline' 0 CA--C 1.54 0.791 0 CA-C-N 119.719 0.935 . . . . 0.0 112.28 -8.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.2 mt -113.27 156.6 23.04 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.157 1.783 . . . . 0.0 110.881 175.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -128.08 142.54 51.18 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.952 1.301 . . . . 0.0 110.169 178.083 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 31.7 p90 -158.51 150.56 21.51 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.63 1.172 . . . . 0.0 112.056 -174.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 41.6 t80 -103.76 131.53 50.86 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.193 -0.942 . . . . 0.0 112.678 178.513 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.1 t -102.26 137.89 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 125.586 1.554 . . . . 0.0 108.852 176.741 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.9 t0 -160.63 160.68 31.94 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.638 1.175 . . . . 0.0 111.628 -169.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -75.45 117.43 17.23 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.007 0.923 . . . . 0.0 111.028 177.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.2 p -81.5 -23.63 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 124.025 0.93 . . . . 0.0 113.193 -168.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -83.36 -14.31 53.1 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.441 1.096 . . . . 0.0 113.547 -178.213 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 91.4 m -72.77 156.66 38.69 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.72 1.208 . . . . 0.0 112.663 -179.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -85.21 -14.77 68.23 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.467 1.032 . . . . 0.0 115.134 -173.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 24.1 p-80 -64.51 154.63 35.37 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 118.793 1.296 . . . . 0.0 113.438 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 22.0 t -68.57 132.5 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 124.096 0.958 . . . . 0.0 109.38 -179.437 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.8 t -154.1 146.72 24.15 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.461 1.105 . . . . 0.0 110.42 -176.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.44 141.96 51.77 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.746 1.219 . . . . 0.0 111.898 -172.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.0 p90 -168.07 164.8 13.6 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 125.314 1.446 . . . . 0.0 113.61 -175.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.07 172.18 12.92 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.653 1.597 . . . . 0.0 112.27 -176.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -67.4 -38.92 13.74 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.753 2.302 . . . . 0.0 112.422 -171.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.44 -34.57 89.62 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-O 118.799 -1.001 . . . . 0.0 115.14 -170.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -78.0 -3.59 42.82 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 119.444 1.622 . . . . 0.0 113.776 175.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.5 m -105.89 -61.46 1.5 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.172 1.789 . . . . 0.0 110.144 176.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -127.7 133.19 49.57 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 126.619 1.967 . . . . 0.0 111.502 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.02 177.02 16.83 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.166 1.365 . . . . 0.0 112.041 171.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 7.5 p -153.52 138.18 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.137 0.975 . . . . 0.0 109.451 176.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 29.3 m -60.68 152.93 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 -170.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 34.1 m120 70.27 11.53 7.5 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.826 2.05 . . . . 0.0 114.738 166.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -147.03 156.97 47.05 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.524 1.529 . . . . 0.0 111.36 176.14 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.94 132.48 16.97 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.413 2.075 . . . . 0.0 111.586 -177.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -104.83 146.85 28.42 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.074 1.75 . . . . 0.0 109.784 167.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 40.1 p -132.19 149.13 52.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -164.181 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.6 p90 -159.23 177.24 11.26 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.84 1.656 . . . . 0.0 111.486 175.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 31.8 m -134.27 145.58 49.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.501 1.52 . . . . 0.0 110.336 -170.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.9 t -116.49 128.11 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.209 1.404 . . . . 0.0 108.221 168.848 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -89.33 131.41 35.42 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.864 0.866 . . . . 0.0 110.719 177.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 53.7 p -134.01 12.11 3.94 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.867 1.667 . . . . 0.0 112.812 -169.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 53.5 tptt -53.76 -40.41 66.18 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.21 1.804 . . . . 0.0 115.267 -162.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.3 t70 -110.54 1.88 18.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.076 1.35 . . . . 0.0 113.364 -178.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.8 -65.43 0.97 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.155 0.982 . . . . 0.0 111.127 178.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 69.97 0.99 30.38 Favored Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.795 1.878 . . . . 0.0 117.795 162.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -160.32 143.22 13.42 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.883 1.842 . . . . 0.0 111.731 -172.463 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 102.8 -173.7 22.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 125.868 1.699 . . . . 0.0 113.02 -177.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -94.83 114.66 4.89 Favored Glycine 0 N--CA 1.469 0.838 0 C-N-CA 124.231 0.92 . . . . 0.0 111.813 177.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.48 133.2 37.46 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.013 1.325 . . . . 0.0 108.751 168.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -140.2 161.53 37.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.46 1.504 . . . . 0.0 112.034 -168.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 45.1 tp -166.35 139.34 3.95 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.617 1.567 . . . . 0.0 110.027 -162.37 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.85 163.26 34.57 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.902 1.281 . . . . 0.0 111.625 173.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 59.0 mt -136.43 134.0 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.298 1.039 . . . . 0.0 109.677 173.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.06 117.42 31.95 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.589 1.156 . . . . 0.0 109.519 170.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -127.58 179.26 16.54 Favored Glycine 0 CA--C 1.537 1.458 0 C-N-CA 124.928 1.251 . . . . 0.0 114.066 -177.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -67.27 -26.67 41.63 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 124.062 3.175 . . . . 0.0 111.753 172.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -137.51 154.87 49.79 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.57 1.548 . . . . 0.0 108.506 158.246 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 15.3 tttt -69.84 121.73 17.87 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.877 -1.139 . . . . 0.0 112.069 -174.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.91 149.31 36.07 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.943 0.897 . . . . 0.0 111.216 167.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 23.9 mm-40 -86.12 144.45 27.51 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.281 0.633 . . . . 0.0 109.647 166.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 29.8 mt -133.69 139.49 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.797 1.239 . . . . 0.0 110.309 -167.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 72.8 m -135.17 157.21 47.51 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.689 1.596 . . . . 0.0 110.838 169.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.4 p -154.82 157.18 37.5 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.35 1.06 . . . . 0.0 112.484 178.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -143.48 125.72 15.55 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.125 1.37 . . . . 0.0 110.61 -171.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.77 131.6 40.93 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.944 1.297 . . . . 0.0 110.732 171.372 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -109.06 142.92 39.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.627 1.171 . . . . 0.0 111.723 178.306 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -67.43 -14.81 63.26 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 175.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -72.45 -11.69 60.78 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.746 1.618 . . . . 0.0 113.905 177.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.78 36.08 5.66 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.914 1.245 . . . . 0.0 113.674 -177.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.4 p -140.75 166.49 24.62 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.91 1.684 . . . . 0.0 110.424 175.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 76.3 m -120.53 129.79 53.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.685 1.594 . . . . 0.0 108.966 165.818 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 15.4 t -91.74 150.54 21.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.975 0.91 . . . . 0.0 110.808 172.257 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 77.6 t -134.97 141.16 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.686 1.594 . . . . 0.0 110.273 -176.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 53.0 m -132.67 140.37 48.12 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.877 1.671 . . . . 0.0 110.552 172.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.0 p90 -145.18 148.23 33.33 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.134 -0.979 . . . . 0.0 113.19 172.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 2.2 tt -118.67 99.81 51.25 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 124.789 1.236 . . . . 0.0 110.006 -173.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -83.15 153.54 14.34 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.753 2.969 . . . . 0.0 111.279 176.582 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 34.0 m -116.54 -11.45 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -167.55 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.8 pp -155.05 151.2 22.47 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.374 1.469 . . . . 0.0 110.537 177.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -75.08 142.99 28.29 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.918 2.412 . . . . 0.0 111.713 -174.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 156.29 -165.0 32.7 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 124.518 1.056 . . . . 0.0 113.493 -176.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -99.44 124.43 44.58 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.74 1.616 . . . . 0.0 112.327 -179.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -120.18 127.42 52.45 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.828 1.651 . . . . 0.0 110.431 -178.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.8 m -92.06 114.46 27.01 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.951 -1.093 . . . . 0.0 110.991 179.728 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -90.05 121.35 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 125.97 1.708 . . . . 0.0 108.777 177.349 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.3 mp -102.91 134.92 45.52 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.778 1.631 . . . . 0.0 109.107 176.009 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 61.5 t -139.43 131.98 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.723 1.209 . . . . 0.0 109.126 177.396 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.2 tmmt? -154.73 143.39 20.71 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.911 1.285 . . . . 0.0 110.946 -165.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -144.82 121.06 10.86 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.552 1.141 . . . . 0.0 109.498 -179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.42 55.81 4.01 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.243 1.417 . . . . 0.0 111.599 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.287 9.0 pt-20 55.8 18.23 2.84 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 128.084 2.554 . . . . 0.0 115.94 -177.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -125.35 125.28 43.21 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.079 1.352 . . . . 0.0 110.254 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -66.26 149.57 50.14 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.667 0.787 . . . . 0.0 112.499 171.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 31.7 m -74.39 155.53 87.67 Favored Pre-proline 0 N--CA 1.479 1.023 0 O-C-N 121.669 -0.644 . . . . 0.0 110.863 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -55.79 123.74 14.57 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.625 2.217 . . . . 0.0 110.343 172.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 95.49 -15.42 63.25 Favored Glycine 0 CA--C 1.531 1.083 0 N-CA-C 116.354 1.302 . . . . 0.0 116.354 178.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 90.1 p -79.52 151.76 74.9 Favored Pre-proline 0 CA--C 1.55 0.963 0 CA-C-N 120.177 1.988 . . . . 0.0 112.753 -178.714 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.17 153.43 98.9 Favored 'Cis proline' 0 C--N 1.353 0.787 0 CA-C-N 119.274 0.776 . . . . 0.0 112.9 -1.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -107.72 132.99 52.77 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.208 1.403 . . . . 0.0 110.49 -179.394 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 58.6 m -88.86 108.93 19.8 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.374 0.67 . . . . 0.0 110.541 178.514 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -87.53 132.23 34.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.529 1.132 . . . . 0.0 110.773 170.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.34 115.28 27.48 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.512 0.725 . . . . 0.0 109.263 174.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.3 t -93.73 134.4 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.75 1.22 . . . . 0.0 109.894 177.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 44.6 p -111.01 166.89 10.68 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.165 1.386 . . . . 0.0 112.964 177.688 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.47 141.37 22.85 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.103 1.335 . . . . 0.0 112.137 175.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.0 t70 -84.28 -27.8 27.6 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.627 1.171 . . . . 0.0 113.225 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 34.0 t70 . . . . . 0 C--O 1.254 1.309 0 C-N-CA 125.571 1.548 . . . . 0.0 113.648 -179.55 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.523 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 60.95 -156.33 0.35 Allowed 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.404 1.882 . . . . 0.0 112.866 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 24.6 ttt 74.22 -54.77 0.67 Allowed 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 128.747 2.819 . . . . 0.0 112.833 177.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -89.44 148.77 41.19 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.224 1.41 . . . . 0.0 111.751 174.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.29 161.84 34.5 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.692 2.928 . . . . 0.0 111.716 176.413 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.68 136.04 40.4 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.805 0.842 . . . . 0.0 110.642 172.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 49.9 ttp180 -63.66 132.0 95.06 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.776 0.83 . . . . 0.0 111.741 -176.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.07 161.78 15.24 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.854 3.036 . . . . 0.0 113.189 169.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 96.2 mt -123.48 117.61 25.52 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.015 1.326 . . . . 0.0 109.168 172.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 41.2 t -144.13 -64.95 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 125.087 1.355 . . . . 0.0 110.007 -177.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 74.29 -165.66 54.77 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.282 0.944 . . . . 0.0 113.739 178.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 14.1 p -163.5 138.34 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.932 1.693 . . . . 0.0 110.389 177.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -89.51 135.51 33.56 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.529 1.132 . . . . 0.0 112.061 179.227 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -83.37 121.82 5.59 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.268 0.937 . . . . 0.0 111.33 175.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 86.4 mt -85.12 151.85 23.82 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.563 1.145 . . . . 0.0 111.726 -179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 24.8 t70 -79.57 130.27 35.23 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.127 0.971 . . . . 0.0 111.802 177.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 15.4 m -147.4 147.51 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.264 1.826 . . . . 0.0 110.177 176.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.2 t -176.87 -32.81 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.607 1.963 . . . . 0.0 112.129 -175.391 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 1.7 m -75.79 29.85 0.11 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 126.726 2.01 . . . . 0.0 115.387 -171.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 26.5 tp -75.28 148.06 39.71 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 127.275 2.23 . . . . 0.0 110.038 170.377 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -52.13 115.92 7.55 Favored Pre-proline 0 N--CA 1.479 0.993 0 CA-C-O 118.25 -0.881 . . . . 0.0 112.82 -165.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.28 138.82 40.3 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.373 2.049 . . . . 0.0 108.824 174.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 56.7 t80 -130.74 125.37 33.67 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.677 0.751 . . . . 0.0 111.575 -171.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -157.43 139.42 14.29 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.771 1.629 . . . . 0.0 110.795 176.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 1.1 mm? -130.9 157.24 43.46 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 126.981 2.112 . . . . 0.0 110.0 -175.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.07 136.81 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.916 1.286 . . . . 0.0 109.901 175.381 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 50.1 mt -133.01 134.41 24.39 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 125.749 1.62 . . . . 0.0 109.038 -169.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.65 114.08 3.84 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.221 2.614 . . . . 0.0 109.795 173.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.7 t80 -175.24 148.45 0.97 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.389 1.876 . . . . 0.0 110.23 -171.008 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 78.2 m -128.6 128.29 43.93 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.72 1.208 . . . . 0.0 110.103 -178.905 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.7 mt -89.76 135.26 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.672 1.189 . . . . 0.0 109.12 172.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 59.4 tptt -132.15 -58.36 0.95 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.105 0.962 . . . . 0.0 112.574 -178.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.6 tttp -157.37 131.01 8.0 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.985 1.714 . . . . 0.0 110.55 179.347 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 121.14 -148.45 17.45 Favored Glycine 0 N--CA 1.473 1.162 0 C-N-CA 125.286 1.422 . . . . 0.0 111.485 -166.332 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.06 144.88 17.79 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.545 1.138 . . . . 0.0 111.225 -175.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.2 tt -121.52 136.2 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.779 1.632 . . . . 0.0 111.081 177.561 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 39.4 p -146.56 178.71 8.08 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 126.365 1.866 . . . . 0.0 110.259 -177.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -168.49 -168.46 30.6 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 115.319 0.887 . . . . 0.0 115.319 -179.179 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -154.96 146.39 23.05 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.87 1.668 . . . . 0.0 109.927 -179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 95.1 t -125.74 131.13 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 125.729 1.612 . . . . 0.0 108.327 173.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 40.7 mtm105 -119.66 138.33 53.33 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.651 1.18 . . . . 0.0 111.669 -176.171 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 23.5 mtt -111.8 151.32 43.37 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 125.775 1.63 . . . . 0.0 111.764 -169.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -53.84 -38.76 85.81 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 124.093 3.195 . . . . 0.0 115.052 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 16.5 m -77.25 4.01 11.55 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -176.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.89 -0.92 80.07 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 125.302 1.43 . . . . 0.0 114.155 -178.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -70.69 152.01 44.3 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.15 1.38 . . . . 0.0 111.512 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 32.2 t -142.68 143.34 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 125.172 1.389 . . . . 0.0 109.981 -174.256 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -148.03 179.21 7.91 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.262 1.825 . . . . 0.0 110.984 177.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -123.66 143.98 43.24 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 123.928 0.891 . . . . 0.0 111.241 175.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -82.63 165.17 16.03 Favored 'Trans proline' 0 CA--C 1.538 0.685 0 C-N-CA 124.149 3.232 . . . . 0.0 111.41 177.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 89.9 m -106.41 124.09 49.06 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.222 1.409 . . . . 0.0 108.685 172.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.1 mp -102.93 134.22 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.548 1.139 . . . . 0.0 109.213 176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.1 m -135.41 122.63 21.62 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.495 1.518 . . . . 0.0 109.382 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -74.76 133.76 41.94 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.893 0.877 . . . . 0.0 112.101 173.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -87.9 -12.08 45.8 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 60.5 mttm 69.79 6.91 5.96 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 127.333 2.253 . . . . 0.0 113.821 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -104.57 8.3 35.34 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 127.163 2.185 . . . . 0.0 112.804 179.319 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 94.22 14.42 51.35 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.169 1.366 . . . . 0.0 114.156 -175.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.5 p -130.9 156.71 44.6 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.085 1.754 . . . . 0.0 110.774 176.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 30.0 m -119.22 138.87 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.291 1.036 . . . . 0.0 109.797 166.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 47.6 m -97.09 141.97 29.59 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.93 1.292 . . . . 0.0 108.604 171.027 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 23.1 t -126.59 132.19 70.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 125.045 1.338 . . . . 0.0 109.269 179.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -129.27 152.96 48.26 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.713 1.605 . . . . 0.0 111.693 -172.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 13.6 t80 -153.51 129.63 10.38 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.249 1.419 . . . . 0.0 111.327 177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -79.76 121.43 82.35 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.102 0.961 . . . . 0.0 110.098 175.11 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.0 130.05 12.91 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.117 2.545 . . . . 0.0 111.768 -170.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 74.2 m -126.0 -0.33 7.21 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -176.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -161.67 152.68 18.15 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.304 1.442 . . . . 0.0 111.021 -178.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -93.79 164.84 12.97 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.479 1.112 . . . . 0.0 112.683 178.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 102.28 -164.18 16.83 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.315 1.436 . . . . 0.0 113.9 178.026 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 26.4 tp -84.55 121.94 28.32 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.944 1.297 . . . . 0.0 110.95 -178.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 52.7 m80 -118.17 167.74 11.22 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.585 1.954 . . . . 0.0 111.316 -175.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 19.1 pt-20 -146.47 150.71 36.12 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.509 0.671 . . . . 0.0 112.571 167.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 10.6 ttm -119.91 131.89 55.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.655 2.382 . . . . 0.0 110.008 -174.616 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -102.05 139.3 37.85 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.812 1.645 . . . . 0.0 110.037 168.216 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.7 mm -138.15 133.77 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.961 1.305 . . . . 0.0 109.268 173.519 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.64 138.55 23.43 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.718 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 14.8 t80 -102.41 119.35 38.67 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.025 2.13 . . . . 0.0 109.462 176.513 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.0 t70 50.92 35.85 13.48 Favored 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 124.72 1.208 . . . . 0.0 112.829 -174.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 6.7 t-20 82.71 -7.73 1.23 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 128.896 2.878 . . . . 0.0 114.69 179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.0 mtp -94.11 129.49 40.65 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.831 1.252 . . . . 0.0 111.466 176.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -58.05 137.69 56.65 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.263 -0.898 . . . . 0.0 113.289 179.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 34.8 pt -76.88 154.04 83.03 Favored Pre-proline 0 N--CA 1.478 0.963 0 C-N-CA 123.366 0.666 . . . . 0.0 111.501 176.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -61.63 135.53 57.24 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.479 2.119 . . . . 0.0 110.615 175.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 91.98 -13.95 65.61 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.646 1.117 . . . . 0.0 114.716 -175.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 46.1 m -96.52 158.7 33.31 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-N 119.463 1.631 . . . . 0.0 112.092 173.388 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -73.82 167.81 78.33 Favored 'Cis proline' 0 C--N 1.354 0.848 0 CA-C-N 119.827 0.974 . . . . 0.0 112.842 -2.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 98.8 mt -120.97 143.16 49.15 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.502 1.521 . . . . 0.0 110.994 -174.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -125.68 137.87 53.87 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.921 1.288 . . . . 0.0 110.374 179.052 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.2 p90 -157.99 152.04 24.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.565 1.146 . . . . 0.0 112.545 -166.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -103.91 148.28 26.35 Favored 'General case' 0 CA--C 1.544 0.732 0 O-C-N 121.291 -0.88 . . . . 0.0 112.945 179.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 25.5 t -129.73 137.42 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.311 1.444 . . . . 0.0 110.206 -177.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 24.1 t70 -165.81 145.21 6.28 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.746 1.618 . . . . 0.0 112.14 -163.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -71.22 133.97 46.53 Favored 'General case' 0 N--CA 1.475 0.797 0 O-C-N 120.433 -1.417 . . . . 0.0 113.237 -178.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 5.8 p -63.74 -29.54 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -175.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 82.0 m-20 -91.75 0.12 57.51 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.667 1.187 . . . . 0.0 113.775 -177.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.5 t -66.69 140.15 57.88 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.216 -0.928 . . . . 0.0 111.919 -177.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.32 78.14 2.04 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 124.952 1.263 . . . . 0.0 112.334 -173.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -163.26 168.74 20.19 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.511 1.524 . . . . 0.0 113.795 175.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.4 p -67.37 146.2 13.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.749 0.819 . . . . 0.0 109.34 157.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.0 t -164.24 165.97 21.43 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.375 1.47 . . . . 0.0 110.637 -177.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.69 147.78 30.32 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.54 1.136 . . . . 0.0 112.444 -176.096 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 52.6 p90 -166.02 160.11 16.21 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.823 1.649 . . . . 0.0 112.623 -176.053 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.65 170.49 12.1 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.347 1.451 . . . . 0.0 113.189 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -67.95 -30.86 32.16 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.241 2.628 . . . . 0.0 112.854 -170.754 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.9 -16.15 72.24 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 119.318 0.963 . . . . 0.0 114.703 -178.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 69.6 mt -79.04 -13.75 59.58 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 118.939 1.369 . . . . 0.0 112.92 170.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 62.1 m -117.16 -38.97 3.27 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.43 1.892 . . . . 0.0 111.905 -166.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -147.35 159.64 43.45 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.903 2.081 . . . . 0.0 111.823 -171.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.2 175.92 33.77 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.313 0.959 . . . . 0.0 112.908 169.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 24.2 t -139.61 135.92 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.557 1.143 . . . . 0.0 108.758 173.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.3 m -57.12 139.04 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -176.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.8 m-80 66.08 3.98 2.89 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.96 2.104 . . . . 0.0 114.926 173.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 44.1 mtmt -119.43 144.63 36.98 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 125.697 1.599 . . . . 0.0 110.923 176.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -72.72 125.07 10.22 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.565 2.177 . . . . 0.0 111.094 -174.268 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.95 146.73 27.89 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 125.298 1.439 . . . . 0.0 110.137 170.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 62.9 p -136.19 154.46 50.94 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 113.874 1.064 . . . . 0.0 113.874 -164.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . 0.402 ' CZ ' HG11 ' A' 1922 ' ' VAL . 55.3 p90 -164.09 172.07 14.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.229 1.812 . . . . 0.0 111.595 177.333 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.5 m -125.04 141.53 52.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.453 1.501 . . . . 0.0 110.565 -174.17 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.2 t -110.19 128.7 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.801 168.291 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -90.64 122.01 33.05 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 0.0 109.871 172.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 44.9 p -122.36 2.82 9.73 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.456 1.902 . . . . 0.0 113.251 -171.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 62.2 tttp -51.74 -37.37 50.85 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.861 1.664 . . . . 0.0 114.116 -176.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 21.9 t70 -103.73 1.52 31.87 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.308 1.443 . . . . 0.0 113.632 179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.22 -23.44 61.24 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -175.62 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.87 -91.64 1.42 Allowed Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.712 1.149 . . . . 0.0 112.553 175.464 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -161.36 171.66 17.89 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.717 1.607 . . . . 0.0 112.231 -173.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 113.53 -166.89 12.19 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.929 1.728 . . . . 0.0 111.976 -169.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -90.54 118.0 5.23 Favored Glycine 0 N--CA 1.469 0.837 0 C-N-CA 124.269 0.937 . . . . 0.0 112.262 -179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.0 tm? -81.45 128.67 34.12 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.803 1.241 . . . . 0.0 108.484 164.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.9 m -127.78 157.98 38.93 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.372 1.469 . . . . 0.0 111.822 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.6 tp -159.6 133.73 7.52 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.598 1.559 . . . . 0.0 109.12 -169.22 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.91 162.52 38.3 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.293 1.037 . . . . 0.0 112.017 179.414 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 54.1 mt -135.61 134.13 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 124.523 1.129 . . . . 0.0 109.751 175.075 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -114.67 159.19 20.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.634 1.573 . . . . 0.0 109.918 168.151 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.64 -163.39 35.99 Favored Glycine 0 CA--C 1.535 1.324 0 O-C-N 121.416 -0.802 . . . . 0.0 113.572 -177.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -72.29 -16.11 28.14 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.543 2.829 . . . . 0.0 112.716 177.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -152.49 160.15 43.27 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.064 1.746 . . . . 0.0 109.418 168.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -75.63 114.73 14.54 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 120.894 -1.129 . . . . 0.0 111.568 -178.547 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.18 148.04 44.19 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 123.902 0.881 . . . . 0.0 111.259 168.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.38 144.63 25.38 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.642 0.777 . . . . 0.0 109.967 170.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.9 mt -135.48 144.08 34.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.531 1.132 . . . . 0.0 110.719 -166.702 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 12.7 t -142.37 157.64 44.57 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.02 1.328 . . . . 0.0 110.713 166.848 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.8 p -155.65 154.92 32.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.32 1.048 . . . . 0.0 112.764 -176.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.5 m -140.74 123.41 16.17 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.352 1.461 . . . . 0.0 110.246 -171.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 11.1 t0 -72.42 120.51 18.14 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.01 0.924 . . . . 0.0 110.077 166.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -84.02 -10.31 57.98 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.769 0.827 . . . . 0.0 112.933 179.832 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 76.08 -28.37 0.18 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 128.583 2.753 . . . . 0.0 112.581 178.18 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -73.83 10.68 1.06 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.293 2.237 . . . . 0.0 114.68 -179.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.51 16.99 32.51 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.234 1.397 . . . . 0.0 114.198 -178.226 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 77.7 p -138.7 154.14 48.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.301 1.44 . . . . 0.0 111.325 175.651 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 72.0 m -119.49 134.28 55.29 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.001 1.721 . . . . 0.0 109.309 166.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.1 t -94.87 150.4 20.22 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.241 1.016 . . . . 0.0 110.837 172.346 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . 0.402 HG11 ' CZ ' ' A' 1886 ' ' PHE . 66.7 t -132.22 143.05 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 125.363 1.465 . . . . 0.0 110.405 -179.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 58.9 m -131.89 141.76 49.46 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.143 1.777 . . . . 0.0 110.748 171.315 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.7 p90 -147.01 152.36 38.47 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 175.264 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 21.2 mt -118.81 102.82 49.12 Favored Pre-proline 0 CA--C 1.545 0.755 0 C-N-CA 126.852 2.061 . . . . 0.0 110.422 -178.055 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -82.77 160.08 16.29 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.683 2.922 . . . . 0.0 110.303 168.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 33.4 m -121.55 -10.12 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -168.49 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.5 pp -155.77 152.72 24.66 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 125.267 1.427 . . . . 0.0 110.412 178.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.98 143.79 23.37 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.891 2.394 . . . . 0.0 111.729 -172.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 153.64 -172.09 32.43 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 125.07 1.319 . . . . 0.0 113.252 -174.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -91.83 129.3 37.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.006 1.322 . . . . 0.0 112.288 176.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -121.52 140.82 51.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.033 1.733 . . . . 0.0 110.341 179.178 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 72.2 m -106.49 113.39 26.87 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 124.997 1.319 . . . . 0.0 110.45 -179.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -92.74 121.75 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.135 1.374 . . . . 0.0 108.514 178.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 7.2 tt -100.28 128.18 46.4 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.484 1.514 . . . . 0.0 109.362 175.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.8 t -129.71 130.61 66.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.232 1.013 . . . . 0.0 109.671 172.492 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.57 143.14 23.59 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.954 1.302 . . . . 0.0 112.087 -167.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.51 124.79 24.65 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.029 1.332 . . . . 0.0 109.787 176.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 15.0 t-20 53.84 56.32 7.3 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 125.122 1.369 . . . . 0.0 112.033 177.019 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.301 8.2 pt-20 58.91 3.32 0.31 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 128.957 2.903 . . . . 0.0 116.809 -176.101 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -109.27 126.07 52.95 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.67 1.188 . . . . 0.0 110.661 178.329 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.9 m170 -62.0 144.13 55.56 Favored 'General case' 0 CA--C 1.545 0.783 0 O-C-N 121.221 -0.924 . . . . 0.0 111.716 172.424 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.3 m -70.32 152.11 95.64 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-O 118.401 -0.809 . . . . 0.0 109.445 172.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -60.49 127.98 24.53 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.665 2.243 . . . . 0.0 110.696 -178.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.44 -13.07 67.99 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.147 1.356 . . . . 0.0 115.316 -176.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.1 t -75.1 141.36 74.38 Favored Pre-proline 0 CA--C 1.548 0.896 0 CA-C-N 119.335 1.567 . . . . 0.0 111.713 176.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.86 146.59 81.79 Favored 'Cis proline' 0 C--N 1.352 0.731 0 CA-C-N 119.613 0.898 . . . . 0.0 112.385 -3.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -99.74 139.87 34.77 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.686 1.594 . . . . 0.0 111.155 -178.063 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 5.9 m -98.91 108.0 20.57 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.894 0.878 . . . . 0.0 111.048 -176.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.64 126.13 45.6 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.426 1.09 . . . . 0.0 111.29 175.12 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 33.8 ttt85 -93.21 115.13 27.76 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.304 0.641 . . . . 0.0 110.425 176.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.7 t -91.5 136.57 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 125.803 1.641 . . . . 0.0 110.461 -177.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 8.7 m -113.53 153.77 28.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 126.057 1.743 . . . . 0.0 111.094 -171.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -74.23 137.53 23.02 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 123.928 0.775 . . . . 0.0 111.802 172.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 39.1 t70 -76.99 -28.13 54.97 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.087 0.955 . . . . 0.0 113.315 -178.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.255 1.346 0 C-N-CA 126.436 1.894 . . . . 0.0 112.62 -176.815 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.101 -0.8 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.52 -29.29 66.87 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.972 0.909 . . . . 0.0 113.145 178.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 27.2 ttt -104.55 148.26 26.7 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.893 1.677 . . . . 0.0 110.903 173.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -67.09 154.0 93.46 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.788 1.235 . . . . 0.0 112.612 175.199 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.28 167.35 26.48 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.708 2.938 . . . . 0.0 112.06 177.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -150.13 146.8 27.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.288 1.435 . . . . 0.0 110.4 -177.436 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -161.77 151.3 13.63 Favored Pre-proline 0 CA--C 1.546 0.827 0 C-N-CA 125.378 1.471 . . . . 0.0 112.287 -173.032 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.57 152.56 65.21 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.429 2.753 . . . . 0.0 111.702 179.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 15.7 tp -120.55 24.92 10.08 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.428 1.491 . . . . 0.0 111.909 -174.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 80.9 t -68.99 121.41 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 125.004 1.321 . . . . 0.0 110.542 -175.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -105.49 -142.47 11.19 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.676 1.608 . . . . 0.0 112.175 176.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 94.2 t -68.04 130.93 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 124.017 0.927 . . . . 0.0 109.481 173.664 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 33.2 m120 -79.94 -0.29 34.47 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 -170.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 99.66 -176.69 28.85 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.759 1.647 . . . . 0.0 113.109 -176.456 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.1 mt -76.08 140.8 42.04 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.081 0.953 . . . . 0.0 112.039 -176.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 18.1 t0 -162.21 134.62 5.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.706 2.002 . . . . 0.0 109.218 178.528 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . 0.302 10.0 p 44.09 31.89 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.558 1.943 . . . . 0.0 114.465 -173.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.6 t -67.75 -32.26 72.74 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.876 1.27 . . . . 0.0 112.307 -179.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 33.6 t -164.75 125.78 2.08 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.554 1.542 . . . . 0.0 110.026 172.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 16.0 mt -86.72 137.06 32.75 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.956 1.302 . . . . 0.0 110.27 174.057 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -67.2 122.95 85.09 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 123.978 0.911 . . . . 0.0 110.736 179.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -71.01 150.52 60.75 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.006 2.471 . . . . 0.0 110.86 179.526 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . 0.4 ' CE1' HD23 ' A' 1793 ' ' LEU . 20.4 t80 -107.0 128.51 54.42 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.381 0.672 . . . . 0.0 111.103 178.108 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -151.76 136.37 17.01 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.328 1.451 . . . . 0.0 110.723 173.046 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . 0.4 HD23 ' CE1' ' A' 1791 ' ' PHE . 0.4 OUTLIER -140.57 153.85 46.28 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.604 1.962 . . . . 0.0 109.724 -173.42 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.2 p -129.29 137.48 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.987 1.315 . . . . 0.0 110.363 179.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 79.5 mt -133.47 137.55 29.26 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 126.166 1.787 . . . . 0.0 108.586 -173.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -79.77 52.39 4.28 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.417 3.411 . . . . 0.0 112.775 -178.117 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 44.2 t80 -95.68 150.05 20.8 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.262 1.425 . . . . 0.0 111.212 174.075 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 93.1 m -119.79 124.0 45.07 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.793 1.237 . . . . 0.0 109.897 176.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 52.3 mt -91.12 139.43 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.276 1.43 . . . . 0.0 109.74 176.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -148.69 -43.99 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -177.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.9 tttm -164.23 123.77 1.98 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.246 1.418 . . . . 0.0 111.601 178.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 123.74 -157.2 18.13 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.868 1.699 . . . . 0.0 111.764 -168.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -141.4 150.09 41.91 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.819 1.247 . . . . 0.0 111.457 -176.449 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.3 tt -127.68 135.24 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.718 1.607 . . . . 0.0 111.099 176.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.8 p -146.7 176.4 9.88 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.014 1.726 . . . . 0.0 109.953 176.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -164.99 -170.72 30.32 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 115.244 0.858 . . . . 0.0 115.244 178.678 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -155.98 145.9 21.3 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.841 1.656 . . . . 0.0 110.194 -176.266 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 61.8 t -126.53 137.2 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 126.472 1.909 . . . . 0.0 108.944 178.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 51.9 mtt85 -116.63 131.36 56.97 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.666 1.586 . . . . 0.0 111.879 -173.277 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.1 mpp? -102.42 148.25 35.19 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.804 1.641 . . . . 0.0 111.698 -177.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -55.87 -28.6 68.69 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 124.283 3.322 . . . . 0.0 114.922 174.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 37.9 p -72.8 -5.95 41.52 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 125.492 1.517 . . . . 0.0 114.359 178.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.1 -5.09 81.59 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 125.473 1.511 . . . . 0.0 113.67 -175.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -68.68 159.18 32.64 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 118.347 1.073 . . . . 0.0 111.888 174.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 25.9 m -138.33 154.43 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 125.245 1.418 . . . . 0.0 111.384 174.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.55 171.6 19.17 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.396 1.879 . . . . 0.0 110.457 179.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -117.19 141.44 28.54 Favored Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 123.651 0.781 . . . . 0.0 111.421 178.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -86.34 172.15 7.24 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.269 3.313 . . . . 0.0 111.93 179.377 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 95.5 m -103.01 130.69 50.2 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.925 1.29 . . . . 0.0 108.793 170.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -109.1 132.71 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.514 1.126 . . . . 0.0 108.819 172.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 90.6 m -124.54 128.25 48.66 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.195 1.798 . . . . 0.0 109.746 -178.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.1 t0 -80.45 119.32 22.99 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.15 0.98 . . . . 0.0 110.276 171.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -81.73 -11.18 59.14 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -179.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.5 mmmt 72.48 -3.84 2.22 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 128.046 2.538 . . . . 0.0 114.007 -178.408 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -97.35 6.12 48.78 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.672 1.989 . . . . 0.0 113.41 -173.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 89.52 16.02 57.57 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.722 1.153 . . . . 0.0 113.491 -172.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 48.5 p -130.86 159.55 37.04 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.611 1.965 . . . . 0.0 110.154 175.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -123.18 143.75 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.621 1.168 . . . . 0.0 109.928 168.107 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 24.1 m -104.74 139.86 38.92 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.729 1.212 . . . . 0.0 108.796 172.442 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 29.3 t -121.57 134.59 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.453 1.501 . . . . 0.0 108.664 178.623 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -134.78 149.22 50.38 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.078 1.351 . . . . 0.0 112.433 -173.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 29.8 t80 -150.83 131.1 13.62 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.418 1.487 . . . . 0.0 111.812 178.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -85.7 120.73 73.12 Favored Pre-proline 0 CA--C 1.551 1.01 0 C-N-CA 124.632 1.173 . . . . 0.0 110.825 176.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.06 146.17 20.02 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.71 2.94 . . . . 0.0 112.427 -170.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 84.3 p -128.4 -11.71 5.09 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 174.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -147.63 152.3 37.65 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.28 1.832 . . . . 0.0 110.487 -177.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.45 168.17 12.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.368 1.067 . . . . 0.0 111.926 169.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.71 -173.45 14.74 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 125.463 1.506 . . . . 0.0 114.15 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 25.3 tp -82.06 114.83 20.88 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.695 1.198 . . . . 0.0 110.249 179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 48.1 m80 -110.55 165.62 11.66 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.835 1.654 . . . . 0.0 111.429 -176.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -141.61 154.44 45.41 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.198 0.999 . . . . 0.0 111.103 174.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.5 ttm -138.35 137.78 37.68 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.846 1.658 . . . . 0.0 110.439 -171.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -121.21 121.1 37.05 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.509 1.924 . . . . 0.0 109.386 -179.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -125.9 132.59 70.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.578 1.151 . . . . 0.0 110.158 179.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.41 136.55 26.28 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -172.034 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 11.6 t80 -106.13 125.16 50.66 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.455 1.902 . . . . 0.0 110.004 175.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 51.48 37.0 18.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 124.776 1.23 . . . . 0.0 112.569 -176.219 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 57.0 t30 82.99 -9.42 1.09 Allowed 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 129.081 2.952 . . . . 0.0 114.768 178.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 26.5 mmt -101.94 136.19 42.2 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 124.917 1.287 . . . . 0.0 111.819 179.897 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -56.22 136.42 52.95 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -178.218 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 38.5 pt -72.59 152.65 91.67 Favored Pre-proline 0 N--CA 1.48 1.04 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.178 175.484 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -57.41 124.34 15.9 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.085 2.523 . . . . 0.0 111.092 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 96.92 -11.28 66.12 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 124.933 1.254 . . . . 0.0 114.836 -174.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.16 149.4 39.8 Favored Pre-proline 0 CA--C 1.551 0.982 0 CA-C-N 120.029 1.915 . . . . 0.0 111.099 173.268 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -76.15 162.1 92.74 Favored 'Cis proline' 0 C--N 1.355 0.879 0 CA-C-N 120.778 1.314 . . . . 0.0 113.311 1.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 92.7 mt -113.42 157.15 22.28 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.179 1.792 . . . . 0.0 111.349 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -143.62 140.11 29.97 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.099 1.36 . . . . 0.0 109.458 176.563 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 8.9 p90 -166.55 163.46 17.01 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.389 1.075 . . . . 0.0 112.112 -169.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 30.3 t80 -104.29 135.11 46.37 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.188 -0.945 . . . . 0.0 113.028 179.26 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 47.1 t -103.17 139.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.335 1.454 . . . . 0.0 108.426 171.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 39.9 t0 -150.87 165.89 32.23 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.344 1.058 . . . . 0.0 111.875 -172.886 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -78.05 138.51 38.81 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.843 0.857 . . . . 0.0 111.536 174.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 94.8 t -72.24 -37.81 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.872 0.869 . . . . 0.0 112.643 -171.213 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -124.76 17.57 8.69 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 -166.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 12.7 t -68.63 -26.73 65.49 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 121.0 -1.063 . . . . 0.0 113.125 178.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 101.39 -14.23 58.12 Favored Glycine 0 N--CA 1.476 1.34 0 C-N-CA 125.7 1.619 . . . . 0.0 115.782 166.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -66.47 158.57 29.2 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-N 119.001 1.4 . . . . 0.0 113.587 175.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.6 p -60.84 139.93 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.572 0.749 . . . . 0.0 110.137 169.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.4 t -161.54 172.23 16.73 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.243 1.417 . . . . 0.0 110.519 -178.215 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.72 144.58 24.42 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.542 1.137 . . . . 0.0 111.859 -178.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 35.1 p90 -168.66 163.63 12.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.389 1.476 . . . . 0.0 113.156 -175.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.37 173.53 13.42 Favored Glycine 0 CA--C 1.534 1.263 0 C-N-CA 125.398 1.475 . . . . 0.0 112.717 -179.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.66 -33.86 26.84 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.874 2.383 . . . . 0.0 112.418 -173.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.23 -31.91 72.1 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 118.718 -1.046 . . . . 0.0 114.849 -173.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.83 -0.39 43.16 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.343 1.572 . . . . 0.0 113.854 174.076 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 55.4 m -108.64 -47.85 3.41 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 126.291 1.836 . . . . 0.0 111.298 178.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -142.44 152.31 42.64 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.804 2.042 . . . . 0.0 112.255 -172.654 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -154.53 -176.07 26.4 Favored Glycine 0 CA--C 1.528 0.879 0 C-N-CA 124.474 1.035 . . . . 0.0 113.635 169.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.4 p -153.3 136.85 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.124 1.37 . . . . 0.0 108.889 177.053 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 28.2 m -58.8 145.23 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -170.881 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 64.6 m-80 68.79 1.57 3.14 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.734 2.014 . . . . 0.0 114.656 176.146 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -115.44 141.59 27.48 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.586 1.555 . . . . 0.0 110.597 176.101 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -71.1 136.81 30.3 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.661 2.24 . . . . 0.0 110.86 -179.599 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -116.87 139.02 51.11 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.887 1.675 . . . . 0.0 110.182 176.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.2 p -131.84 147.69 52.5 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 -165.13 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -157.68 174.98 14.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.635 1.574 . . . . 0.0 111.364 176.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 85.2 m -129.49 136.97 50.53 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.809 1.243 . . . . 0.0 110.812 -172.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 42.1 t -100.35 132.14 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.36 1.464 . . . . 0.0 107.811 167.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -102.53 130.46 49.37 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.789 1.236 . . . . 0.0 110.741 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.0 p -135.28 11.27 3.53 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.293 1.837 . . . . 0.0 112.941 -170.063 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 58.5 tttp -52.37 -34.96 50.11 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 126.336 1.854 . . . . 0.0 115.546 -165.924 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -132.69 23.88 4.33 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.315 1.446 . . . . 0.0 111.934 175.006 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.66 -8.87 59.78 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.907 1.283 . . . . 0.0 114.433 -177.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 87.95 -122.16 6.18 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.669 1.128 . . . . 0.0 112.439 178.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -154.0 167.77 28.65 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.471 1.508 . . . . 0.0 112.254 -174.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 139.81 -162.69 26.27 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.625 1.583 . . . . 0.0 113.21 -178.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -84.58 109.6 3.27 Favored Glycine 0 N--CA 1.472 1.035 0 C-N-CA 124.082 0.848 . . . . 0.0 111.488 175.54 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 44.7 tp -85.15 134.46 34.17 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.612 1.165 . . . . 0.0 109.645 171.555 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.9 m -132.83 158.64 41.98 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.283 1.433 . . . . 0.0 112.338 -175.365 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.2 tp -161.08 134.87 6.79 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.393 1.877 . . . . 0.0 108.783 -169.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.08 157.3 34.31 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.978 0.911 . . . . 0.0 112.104 176.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 51.7 mt -137.42 140.27 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 C-N-CA 124.847 1.259 . . . . 0.0 109.625 176.532 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.02 143.56 50.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.639 1.576 . . . . 0.0 109.516 172.672 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.75 -162.99 23.03 Favored Glycine 0 CA--C 1.538 1.478 0 CA-C-O 118.99 -0.895 . . . . 0.0 114.982 -174.327 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -64.26 -26.86 64.05 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.126 3.217 . . . . 0.0 112.602 178.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.8 t -138.22 158.85 43.49 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.008 1.323 . . . . 0.0 109.253 161.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 57.3 tptt -74.6 112.78 11.13 Favored 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.895 -1.128 . . . . 0.0 111.145 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.76 149.42 49.03 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.923 0.889 . . . . 0.0 112.123 176.478 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -87.3 139.89 30.09 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.523 0.729 . . . . 0.0 109.258 165.818 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.46 138.12 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.668 1.187 . . . . 0.0 110.469 -167.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -134.78 155.75 50.05 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.887 1.675 . . . . 0.0 110.783 171.084 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.7 p -154.74 154.49 32.93 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.089 0.956 . . . . 0.0 112.744 176.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 90.7 m -143.31 120.03 11.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 125.82 1.648 . . . . 0.0 109.906 -172.723 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -72.61 124.96 26.32 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.341 0.656 . . . . 0.0 110.109 170.188 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -86.28 -11.33 52.54 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -174.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 69.31 -3.3 1.61 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 128.27 2.628 . . . . 0.0 113.759 -175.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -92.49 8.29 39.39 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 126.446 1.898 . . . . 0.0 113.236 -177.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 94.43 18.28 36.44 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.097 1.332 . . . . 0.0 113.637 -172.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 54.1 p -142.64 157.03 45.1 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.673 1.589 . . . . 0.0 111.652 179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 52.7 t -127.19 124.81 39.86 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.616 1.967 . . . . 0.0 109.009 169.585 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.9 t -87.29 146.64 25.86 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.235 1.014 . . . . 0.0 110.904 177.034 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.3 t -128.44 143.48 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 126.063 1.745 . . . . 0.0 109.778 -178.129 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 21.4 t -138.19 140.59 39.85 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.469 1.508 . . . . 0.0 110.728 171.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.0 p90 -144.95 153.58 41.67 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 121.185 -0.947 . . . . 0.0 113.491 175.255 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 3.2 mt -114.37 106.38 52.75 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 125.171 1.389 . . . . 0.0 110.976 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -80.64 170.04 16.16 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 123.887 3.058 . . . . 0.0 110.703 167.152 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.5 p -148.52 -28.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -173.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -110.05 146.18 33.63 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 119.541 1.064 . . . . 0.0 110.928 167.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.19 163.55 34.7 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.255 2.636 . . . . 0.0 111.159 176.026 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.93 -134.94 7.89 Favored Glycine 0 N--CA 1.468 0.776 0 C-N-CA 125.269 1.414 . . . . 0.0 111.02 -172.251 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 2.2 p30 -143.91 145.36 32.22 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 122.009 0.909 . . . . 0.0 112.829 176.306 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -121.26 135.68 55.08 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.789 2.035 . . . . 0.0 109.872 -171.802 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.3 m -89.78 127.14 35.91 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.305 1.042 . . . . 0.0 110.509 174.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.4 120.67 59.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.66 1.584 . . . . 0.0 108.593 -179.742 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -102.37 134.5 45.57 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 109.942 174.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 52.7 t -136.66 133.12 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.355 1.462 . . . . 0.0 108.384 171.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.39 141.69 19.57 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.015 1.326 . . . . 0.0 111.026 -170.302 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.37 125.38 18.45 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.662 1.185 . . . . 0.0 110.43 -178.557 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 53.76 54.3 10.09 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 125.056 1.343 . . . . 0.0 111.909 -179.649 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.303 8.5 pt-20 57.97 15.72 3.3 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.233 2.613 . . . . 0.0 116.236 -177.933 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -121.99 129.81 52.77 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.577 1.151 . . . . 0.0 111.282 177.242 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -61.97 155.71 22.99 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.092 0.957 . . . . 0.0 112.722 170.556 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 23.2 m -83.14 156.4 66.7 Favored Pre-proline 0 N--CA 1.479 0.981 0 C-N-CA 123.272 0.629 . . . . 0.0 110.126 175.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -58.58 122.77 12.21 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.455 2.104 . . . . 0.0 110.276 176.237 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.39 -13.07 68.0 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 118.293 -1.281 . . . . 0.0 116.079 -179.135 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 92.4 p -80.92 152.02 71.26 Favored Pre-proline 0 CA--C 1.551 0.983 0 CA-C-N 120.262 2.031 . . . . 0.0 112.91 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -71.46 141.93 71.53 Favored 'Cis proline' 0 C--N 1.353 0.772 0 CA-C-N 119.152 0.733 . . . . 0.0 111.948 -4.524 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.85 169.64 11.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.431 1.493 . . . . 0.0 110.669 176.221 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 37.4 m -132.81 117.43 17.76 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.647 0.779 . . . . 0.0 110.741 178.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.63 128.47 45.74 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.803 1.241 . . . . 0.0 110.94 175.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 37.0 ttm-85 -88.85 131.67 35.0 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.195 0.452 . . . . 0.0 110.749 174.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 84.3 t -121.22 138.25 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 125.676 1.59 . . . . 0.0 109.788 -173.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 4.8 t -126.01 177.16 6.51 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.24 1.016 . . . . 0.0 112.801 -176.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -78.82 138.66 21.14 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.825 1.678 . . . . 0.0 112.51 -178.849 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -84.94 -18.34 34.91 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.578 1.151 . . . . 0.0 113.558 -178.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.252 1.231 0 C-N-CA 126.771 2.028 . . . . 0.0 112.544 -176.751 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.38 152.4 42.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.23 1.012 . . . . 0.0 112.628 178.666 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 28.4 ptm -77.7 -22.26 50.72 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -83.18 150.65 61.48 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 124.876 1.27 . . . . 0.0 112.41 -179.44 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -72.6 158.74 50.28 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 123.644 2.896 . . . . 0.0 111.58 175.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.17 -6.72 52.56 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.262 1.025 . . . . 0.0 113.489 179.498 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 70.3 ttp85 -134.43 133.99 22.08 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 126.368 1.867 . . . . 0.0 110.169 178.306 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.74 152.81 47.98 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.313 2.675 . . . . 0.0 111.711 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 72.9 mt -90.43 11.96 19.98 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.007 1.323 . . . . 0.0 113.147 -178.64 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 10.9 p -57.15 143.49 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 126.445 1.898 . . . . 0.0 112.959 -175.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 100.84 -8.46 57.92 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.166 1.365 . . . . 0.0 115.366 173.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 33.0 m -77.0 145.22 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-N 118.873 1.337 . . . . 0.0 111.524 174.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -86.55 156.85 19.9 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.338 1.055 . . . . 0.0 113.214 177.09 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -90.76 -176.26 44.17 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 124.956 1.265 . . . . 0.0 112.335 167.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 96.4 mt -122.91 147.35 46.69 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.199 1.4 . . . . 0.0 110.824 175.422 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -93.53 8.5 40.49 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 125.285 1.434 . . . . 0.0 113.378 -174.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.8 p -57.43 -23.77 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.579 1.952 . . . . 0.0 115.213 -166.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.7 t -63.9 -33.91 76.77 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.29 1.036 . . . . 0.0 112.365 173.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 2.7 t 79.44 160.65 0.18 Allowed 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 128.107 2.563 . . . . 0.0 114.436 174.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 41.1 tp -107.06 138.2 43.69 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.029 1.731 . . . . 0.0 109.121 173.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -61.8 121.9 67.97 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.949 0.9 . . . . 0.0 112.098 -169.011 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.299 2.666 . . . . 0.0 111.506 -177.468 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.1 t80 -101.39 122.14 43.2 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.115 0.966 . . . . 0.0 109.635 175.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -148.63 131.29 15.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.806 1.242 . . . . 0.0 110.581 171.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.23 153.84 43.23 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.381 1.872 . . . . 0.0 109.653 -170.592 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -129.62 137.81 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.825 1.25 . . . . 0.0 110.353 179.558 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 63.2 mt -131.7 136.32 28.25 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.303 1.841 . . . . 0.0 108.734 -172.609 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -77.75 69.58 7.3 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 124.558 3.505 . . . . 0.0 111.019 177.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 45.3 t80 -123.33 162.43 22.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.583 1.953 . . . . 0.0 110.307 175.156 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.8 m -139.28 130.0 26.04 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.906 1.282 . . . . 0.0 109.926 178.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 57.9 mt -82.17 118.2 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.18 0.992 . . . . 0.0 108.688 170.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.59 -24.99 11.12 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.111 1.522 . . . . 0.0 115.111 -174.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 62.6 pttt -170.43 -24.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 115.218 1.562 . . . . 0.0 115.218 178.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -87.79 -147.67 13.45 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 125.766 1.65 . . . . 0.0 113.087 -177.323 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.82 145.05 29.75 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.358 1.463 . . . . 0.0 109.894 -176.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.6 tt -126.74 132.61 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.279 1.432 . . . . 0.0 110.985 -176.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 23.9 p -149.62 170.58 18.34 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.981 1.713 . . . . 0.0 110.465 -173.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -159.69 -167.29 20.1 Favored Glycine 0 N--CA 1.467 0.711 0 N-CA-C 116.301 1.281 . . . . 0.0 116.301 -175.448 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.52 142.59 22.27 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.13 1.772 . . . . 0.0 109.164 174.142 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.3 t -115.33 127.87 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.206 1.402 . . . . 0.0 108.379 172.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.1 mtm105 -109.69 122.53 47.67 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.915 1.686 . . . . 0.0 109.48 -175.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.3 mtt -93.77 150.8 39.26 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 125.278 1.431 . . . . 0.0 111.214 -173.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -69.24 -21.71 35.53 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.445 2.763 . . . . 0.0 112.774 179.613 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 14.0 m -72.84 -0.05 12.37 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.106 1.362 . . . . 0.0 114.47 178.101 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 86.15 42.96 6.45 Favored Glycine 0 N--CA 1.473 1.121 0 C-N-CA 124.698 1.142 . . . . 0.0 113.252 177.376 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -153.73 166.02 34.15 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.739 1.616 . . . . 0.0 111.931 -173.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 24.1 m -141.83 159.38 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 C-N-CA 124.435 1.094 . . . . 0.0 113.144 -167.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -161.41 175.53 12.1 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 127.012 2.125 . . . . 0.0 110.617 174.168 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -112.39 143.45 28.9 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 121.113 -0.992 . . . . 0.0 112.31 -175.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -86.45 170.95 7.69 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 124.418 3.412 . . . . 0.0 111.767 173.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.3 m -115.27 128.49 56.17 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.564 1.546 . . . . 0.0 108.911 174.046 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 2.9 mp -112.03 135.57 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.78 1.232 . . . . 0.0 109.395 177.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.1 m -134.29 126.79 30.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.532 1.533 . . . . 0.0 109.723 177.814 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.8 t70 -78.12 125.67 29.69 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.737 0.815 . . . . 0.0 110.651 172.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -82.19 -8.14 59.64 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 -173.032 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 71.3 mmtt 70.9 1.57 3.83 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 127.677 2.391 . . . . 0.0 113.674 -176.527 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 32.3 t70 -101.57 4.86 41.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.999 2.119 . . . . 0.0 113.039 -177.039 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.05 13.38 52.99 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.089 1.328 . . . . 0.0 114.112 -174.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 68.0 p -132.17 158.49 41.57 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.321 1.848 . . . . 0.0 110.999 178.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 22.3 m -115.31 141.07 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.253 1.021 . . . . 0.0 109.378 163.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 22.4 m -100.0 139.17 36.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.66 1.184 . . . . 0.0 108.444 169.92 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 19.0 t -120.99 133.82 66.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 125.38 1.472 . . . . 0.0 108.903 177.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -132.74 156.4 47.12 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.075 1.35 . . . . 0.0 112.267 -177.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.9 t80 -157.73 135.4 10.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.565 1.546 . . . . 0.0 111.625 -179.584 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -82.86 124.53 76.87 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.188 0.995 . . . . 0.0 110.674 176.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -78.61 172.9 14.46 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.697 2.931 . . . . 0.0 111.73 -176.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 20.9 t -158.14 -39.3 0.07 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.779 0.832 . . . . 0.0 113.064 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -127.68 158.18 38.29 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.596 1.558 . . . . 0.0 110.767 176.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.23 174.99 10.27 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 124.238 1.015 . . . . 0.0 112.254 172.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 106.14 -177.66 22.47 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 125.156 1.36 . . . . 0.0 114.134 176.396 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 53.6 tp -73.93 117.69 16.01 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.327 1.051 . . . . 0.0 110.467 178.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 32.9 m80 -110.52 161.1 16.03 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.996 1.719 . . . . 0.0 110.71 178.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -148.2 150.09 33.11 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 121.7 -0.625 . . . . 0.0 112.401 175.372 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 30.8 ttm -128.82 139.26 52.26 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.139 1.776 . . . . 0.0 111.139 -168.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -108.7 137.14 47.13 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.194 1.798 . . . . 0.0 110.073 170.763 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.1 mm -133.97 134.56 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.768 1.227 . . . . 0.0 110.43 175.934 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.92 138.94 36.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 124.586 1.154 . . . . 0.0 113.482 178.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 62.0 t80 -101.75 121.36 41.92 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.437 1.895 . . . . 0.0 109.334 172.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.38 32.33 13.63 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 124.836 1.254 . . . . 0.0 112.759 -175.297 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 70.5 m-80 73.87 7.28 4.9 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 127.798 2.439 . . . . 0.0 115.081 -178.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.0 ttm -100.23 128.58 46.27 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.885 1.274 . . . . 0.0 110.269 166.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -58.17 136.59 57.28 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.46 -0.775 . . . . 0.0 112.762 -179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.3 pt -74.81 156.74 86.32 Favored Pre-proline 0 N--CA 1.479 1.022 0 CA-C-O 118.691 -0.671 . . . . 0.0 110.76 174.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -64.08 -17.78 61.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.641 2.227 . . . . 0.0 113.204 175.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -82.92 7.61 65.79 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.643 1.116 . . . . 0.0 114.571 170.26 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 18.1 t -111.29 146.1 33.88 Favored Pre-proline 0 CA--C 1.548 0.878 0 CA-C-N 119.683 1.742 . . . . 0.0 111.678 178.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.37 169.45 72.81 Favored 'Cis proline' 0 C--N 1.351 0.668 0 CA-C-N 119.816 0.97 . . . . 0.0 111.76 -9.0 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.8 mt -117.66 158.31 24.9 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.918 1.687 . . . . 0.0 110.654 171.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -148.41 152.18 36.54 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.334 -0.854 . . . . 0.0 111.894 171.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.8 p90 -165.97 154.28 10.95 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.914 1.286 . . . . 0.0 111.244 -175.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.3 t80 -94.67 129.39 41.57 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.483 -0.76 . . . . 0.0 112.301 177.568 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 62.6 t -95.1 134.25 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 124.989 1.316 . . . . 0.0 109.214 174.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -149.77 158.29 44.03 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.514 1.525 . . . . 0.0 110.146 177.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -67.65 160.49 27.84 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -177.36 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 63.4 t -65.09 -39.49 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 123.557 0.743 . . . . 0.0 111.046 179.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.5 p30 -90.46 155.73 18.7 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.238 1.015 . . . . 0.0 111.57 165.248 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 25.1 p -161.79 156.17 22.41 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.763 1.225 . . . . 0.0 112.809 -179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -112.72 30.27 7.6 Favored Glycine 0 N--CA 1.474 1.19 0 C-N-CA 126.182 1.848 . . . . 0.0 113.094 178.502 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 6.9 p-80 -165.19 162.84 20.25 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 125.342 1.457 . . . . 0.0 113.091 -165.361 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 11.3 p -66.75 140.52 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 C-N-CA 124.082 0.953 . . . . 0.0 110.015 167.282 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -156.58 162.48 39.89 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.874 1.27 . . . . 0.0 111.022 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.14 144.76 36.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.744 1.218 . . . . 0.0 112.042 -177.057 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 44.7 p90 -165.24 161.24 19.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.785 1.634 . . . . 0.0 112.527 -176.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.7 174.42 13.54 Favored Glycine 0 CA--C 1.537 1.429 0 C-N-CA 125.302 1.429 . . . . 0.0 113.369 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.17 -33.12 9.78 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.107 2.538 . . . . 0.0 113.447 -171.077 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.62 -36.69 88.43 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 119.523 1.056 . . . . 0.0 114.175 -171.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.16 -9.1 58.24 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 118.916 1.358 . . . . 0.0 113.215 176.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 29.1 m -98.45 -49.85 4.51 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.348 1.859 . . . . 0.0 111.089 177.211 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -143.11 146.03 33.39 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 126.511 1.924 . . . . 0.0 112.881 -174.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -143.16 178.61 21.28 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.485 1.517 . . . . 0.0 113.32 171.652 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 12.3 p -149.63 136.29 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 124.778 1.231 . . . . 0.0 109.37 176.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.1 m -58.21 144.01 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -171.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 68.1 m-80 67.8 7.44 5.73 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.737 2.015 . . . . 0.0 114.773 174.258 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 95.1 mttt -125.99 146.47 55.69 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 125.679 1.592 . . . . 0.0 110.877 174.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 135.68 25.72 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.78 2.32 . . . . 0.0 111.188 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -114.16 137.83 51.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.945 1.698 . . . . 0.0 109.99 172.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 41.0 p -131.44 151.61 51.4 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -165.305 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.8 p90 -161.56 177.69 9.78 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.393 1.877 . . . . 0.0 111.26 178.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 45.6 m -130.82 142.01 50.37 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.669 1.187 . . . . 0.0 110.761 -170.625 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 38.3 t -112.82 128.46 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.194 1.398 . . . . 0.0 107.976 169.74 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -94.27 126.07 39.29 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.664 1.186 . . . . 0.0 110.084 176.273 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 41.8 p -127.88 0.19 5.99 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.053 1.741 . . . . 0.0 113.57 -167.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 63.0 tttp -51.07 -38.69 53.16 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 126.134 1.774 . . . . 0.0 114.729 -171.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 23.7 t70 -113.47 9.58 18.1 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.517 1.527 . . . . 0.0 113.183 -178.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.54 -38.33 62.79 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -172.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.73 147.23 5.88 Favored Glycine 0 CA--C 1.536 1.376 0 C-N-CA 124.908 1.242 . . . . 0.0 112.525 -172.055 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.84 148.29 36.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.252 1.021 . . . . 0.0 112.397 -177.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 177.22 -45.34 0.1 Allowed Glycine 0 N--CA 1.474 1.183 0 C-N-CA 124.991 1.281 . . . . 0.0 113.715 175.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 165.03 106.45 0.19 Allowed Glycine 0 N--CA 1.472 1.066 0 C-N-CA 124.919 1.247 . . . . 0.0 112.729 171.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.92 130.32 34.91 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.076 1.35 . . . . 0.0 109.423 175.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.9 m -127.87 156.37 42.67 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.547 1.539 . . . . 0.0 112.159 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . 0.411 HD21 HG13 ' A' 1922 ' ' VAL . 38.5 tp -155.81 135.22 12.37 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 126.476 1.91 . . . . 0.0 108.663 -175.383 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -154.36 155.31 34.82 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.146 0.978 . . . . 0.0 112.031 178.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.6 mt -137.04 133.18 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.489 1.116 . . . . 0.0 110.374 177.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -115.85 160.85 19.62 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.261 1.824 . . . . 0.0 109.657 170.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.57 -163.35 34.62 Favored Glycine 0 CA--C 1.537 1.428 0 O-C-N 121.047 -1.033 . . . . 0.0 114.695 -179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.73 -24.49 61.96 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 123.886 3.057 . . . . 0.0 112.278 175.109 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -140.79 159.65 41.74 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.431 1.492 . . . . 0.0 108.939 164.036 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.2 tptt -74.06 113.61 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 120.846 -1.158 . . . . 0.0 110.6 176.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.31 145.86 52.67 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.629 0.772 . . . . 0.0 111.411 174.324 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -85.2 143.55 28.7 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.09 0.556 . . . . 0.0 109.808 169.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 99.7 mt -128.78 144.21 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.687 1.195 . . . . 0.0 110.887 -167.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 14.5 t -139.38 156.16 47.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.292 1.437 . . . . 0.0 110.309 164.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 26.7 p -157.56 150.46 23.2 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 124.603 1.161 . . . . 0.0 112.301 179.694 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.8 m -140.55 118.43 11.79 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.242 1.417 . . . . 0.0 110.018 -169.63 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 14.0 t0 -67.43 118.38 10.69 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.785 0.834 . . . . 0.0 109.785 166.152 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -80.79 -13.37 59.03 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.69 0.796 . . . . 0.0 112.775 -179.737 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 73.68 -7.96 1.48 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 128.5 2.72 . . . . 0.0 113.455 -179.272 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -88.6 8.43 28.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.478 1.911 . . . . 0.0 113.372 -178.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.25 18.33 39.68 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 125.058 1.313 . . . . 0.0 113.694 -171.98 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 68.8 p -139.54 155.4 47.53 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.545 1.538 . . . . 0.0 111.181 176.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 43.5 t -124.33 128.9 49.8 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.532 1.933 . . . . 0.0 109.244 170.903 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.6 t -89.62 145.76 25.02 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.306 1.043 . . . . 0.0 110.643 174.453 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . 0.411 HG13 HD21 ' A' 1900 ' ' LEU . 84.1 t -126.83 143.3 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.933 1.693 . . . . 0.0 109.709 -177.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.8 t -138.3 141.32 39.8 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.603 1.561 . . . . 0.0 110.685 171.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.1 p90 -144.21 153.2 41.83 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.152 -0.967 . . . . 0.0 113.586 173.015 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 57.5 tp -119.35 103.09 47.51 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.705 1.602 . . . . 0.0 110.085 -176.207 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.71 172.72 10.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 123.85 3.034 . . . . 0.0 110.88 170.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.1 p -146.76 -30.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 -172.714 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.8 mt -107.59 146.86 34.21 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.331 1.052 . . . . 0.0 110.902 167.633 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.78 160.69 43.17 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.142 2.561 . . . . 0.0 110.9 173.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 138.19 -132.61 5.91 Favored Glycine 0 N--CA 1.468 0.832 0 C-N-CA 124.444 1.021 . . . . 0.0 112.309 -175.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.84 135.94 30.08 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.133 1.373 . . . . 0.0 111.562 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -121.66 134.55 54.98 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.872 1.669 . . . . 0.0 110.423 -172.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 31.9 m -91.54 121.32 33.13 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.912 0.885 . . . . 0.0 110.686 178.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -101.22 126.04 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 125.93 1.692 . . . . 0.0 108.356 179.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.2 tt -111.22 130.17 55.73 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.353 1.461 . . . . 0.0 109.298 175.346 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 21.9 t -132.11 130.42 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 124.33 1.052 . . . . 0.0 109.534 173.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -152.57 142.72 22.36 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.957 1.303 . . . . 0.0 111.804 -167.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.18 120.66 18.15 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.809 1.243 . . . . 0.0 109.733 178.302 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.0 t-20 54.57 58.18 5.11 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 125.358 1.463 . . . . 0.0 112.133 177.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 58.62 9.33 1.09 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 128.571 2.748 . . . . 0.0 116.542 -177.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -115.88 124.97 51.97 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.487 1.115 . . . . 0.0 110.801 177.278 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.87 145.69 54.52 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 121.379 -0.825 . . . . 0.0 111.984 172.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 3.6 m -72.26 156.87 90.13 Favored Pre-proline 0 N--CA 1.481 1.081 0 CA-C-O 118.353 -0.832 . . . . 0.0 110.142 172.397 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.64 125.75 18.89 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.697 2.932 . . . . 0.0 112.475 178.836 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 87.51 -12.42 63.13 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.919 1.247 . . . . 0.0 115.664 -179.061 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 47.6 t -74.67 142.02 76.72 Favored Pre-proline 0 CA--C 1.549 0.941 0 CA-C-N 119.449 1.625 . . . . 0.0 111.641 177.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -75.88 142.94 75.33 Favored 'Cis proline' 0 C--N 1.352 0.749 0 CA-C-N 119.297 0.785 . . . . 0.0 112.24 -3.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -97.15 168.87 10.18 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 126.577 1.951 . . . . 0.0 110.803 175.801 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 90.0 m -126.51 122.03 34.01 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.962 0.905 . . . . 0.0 111.251 172.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.49 132.68 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.044 1.338 . . . . 0.0 110.874 173.004 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.5 tpt85 -84.53 124.43 31.39 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.307 0.643 . . . . 0.0 109.435 173.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 75.6 t -110.89 133.62 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.757 0.823 . . . . 0.0 110.304 -178.617 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 37.0 p -110.76 161.6 15.61 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.427 1.491 . . . . 0.0 112.686 -174.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -81.24 136.41 16.11 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.537 1.065 . . . . 0.0 110.95 172.264 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 32.7 t70 -80.52 -16.92 53.08 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -177.386 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.252 1.229 0 C-N-CA 126.898 2.079 . . . . 0.0 112.488 -178.784 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 112.133 -0.387 . . . . 0.0 112.133 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . 71.36 170.33 0.32 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.88 2.472 . . . . 0.0 113.761 179.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 28.7 ptm -78.9 -9.88 59.63 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -178.536 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -134.92 150.51 73.44 Favored Pre-proline 0 CA--C 1.55 0.947 0 C-N-CA 125.832 1.653 . . . . 0.0 111.632 -178.043 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.73 166.47 28.24 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.804 3.003 . . . . 0.0 112.362 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -157.37 157.13 33.49 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.761 1.624 . . . . 0.0 110.404 177.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 68.8 mtt85 -58.5 147.46 69.15 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 126.657 1.983 . . . . 0.0 112.999 -176.053 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.88 167.53 26.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.786 2.99 . . . . 0.0 111.357 173.315 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 79.3 mt -77.3 36.84 0.19 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 125.667 1.587 . . . . 0.0 113.5 -175.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 92.2 t -83.07 138.07 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 126.377 1.871 . . . . 0.0 109.628 177.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -72.09 141.93 32.26 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 124.181 0.896 . . . . 0.0 113.308 -176.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 34.2 m -88.74 8.4 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 125.291 1.436 . . . . 0.0 113.675 -176.569 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 22.0 t30 -63.19 -26.12 68.66 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.971 1.308 . . . . 0.0 114.145 -177.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 85.37 -176.96 50.25 Favored Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.976 1.274 . . . . 0.0 113.374 -178.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.6 mt -72.18 128.01 34.35 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.611 1.164 . . . . 0.0 111.364 -177.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 33.0 t70 -87.79 -33.61 18.58 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 34.5 m -91.39 -8.47 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -169.132 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.7 t -86.12 -17.74 34.21 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -169.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 22.6 m -66.84 141.71 57.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -165.202 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 60.3 mt -81.66 144.67 31.02 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.662 1.185 . . . . 0.0 109.98 161.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 53.8 ttm-85 -65.69 121.61 76.3 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.497 1.119 . . . . 0.0 110.676 -178.56 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.61 151.24 64.08 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 123.287 2.658 . . . . 0.0 111.632 -174.347 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 12.4 t80 -106.79 121.97 45.46 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.896 0.878 . . . . 0.0 110.87 179.689 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.89 133.19 14.49 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.335 1.454 . . . . 0.0 110.367 170.724 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.75 134.74 25.46 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.379 1.471 . . . . 0.0 109.993 -167.702 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 11.2 p -103.72 139.94 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.931 1.292 . . . . 0.0 110.973 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 58.5 mt -134.89 137.9 28.34 Favored Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 126.584 1.953 . . . . 0.0 108.333 -177.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.02 23.76 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.091 0 C-N-CA 124.236 3.291 . . . . 0.0 114.199 -178.339 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 67.1 t80 -72.75 153.15 41.27 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.563 1.145 . . . . 0.0 111.405 174.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 96.2 m -123.82 126.88 47.22 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.351 1.46 . . . . 0.0 110.225 -177.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 35.0 mt -88.48 131.85 34.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.397 1.079 . . . . 0.0 109.642 172.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 87.7 tttt -125.46 -64.03 1.1 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.317 1.047 . . . . 0.0 112.71 -178.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -158.97 124.62 4.35 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.543 1.537 . . . . 0.0 110.888 179.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 133.38 -144.6 16.58 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.567 1.556 . . . . 0.0 111.308 -166.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.09 143.8 17.02 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.515 1.126 . . . . 0.0 110.949 -176.469 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.4 tt -119.09 138.41 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.3 1.44 . . . . 0.0 111.257 177.733 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 24.9 p -149.16 166.01 30.09 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.884 1.674 . . . . 0.0 110.736 -178.818 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -150.17 -172.47 19.54 Favored Glycine 0 N--CA 1.467 0.742 0 N-CA-C 115.891 1.116 . . . . 0.0 115.891 -177.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -151.18 138.76 19.62 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.231 1.812 . . . . 0.0 109.31 174.819 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 4.7 t -110.7 137.88 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 126.094 1.758 . . . . 0.0 108.218 174.578 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 53.1 mtp85 -129.18 118.62 22.7 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 125.769 1.627 . . . . 0.0 110.094 -171.837 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.8 mpp? -91.78 153.31 43.72 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.571 1.548 . . . . 0.0 111.265 -175.407 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.9 -19.2 46.62 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.385 2.723 . . . . 0.0 113.4 178.394 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 44.8 p -73.96 -8.49 56.3 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.381 1.473 . . . . 0.0 114.134 171.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.2 -4.95 81.25 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.512 1.53 . . . . 0.0 113.979 -174.573 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -68.48 160.02 30.58 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 118.531 1.166 . . . . 0.0 111.885 173.447 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.9 m -140.29 156.7 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.634 1.173 . . . . 0.0 112.427 179.769 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.54 -173.03 4.37 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.418 2.287 . . . . 0.0 110.059 178.494 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -130.79 143.86 51.09 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.843 -1.161 . . . . 0.0 111.395 176.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -84.74 167.07 11.54 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.945 3.097 . . . . 0.0 111.507 179.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 96.1 m -104.44 133.07 49.93 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.355 1.462 . . . . 0.0 108.726 170.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -112.13 135.19 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.157 0.983 . . . . 0.0 109.642 176.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 49.8 m -130.82 127.52 38.8 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.775 1.63 . . . . 0.0 109.389 178.016 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 11.7 t70 -82.31 127.96 33.74 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.261 0.624 . . . . 0.0 110.314 170.75 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -82.81 -5.58 59.02 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 -173.177 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 69.91 4.62 4.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 127.59 2.356 . . . . 0.0 114.044 -178.679 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -106.66 7.54 30.63 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 127.004 2.122 . . . . 0.0 112.795 -179.38 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.56 20.18 41.88 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 124.853 1.216 . . . . 0.0 113.945 -175.822 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 36.9 p -135.77 160.13 39.51 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 126.231 1.812 . . . . 0.0 110.301 178.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 32.4 m -120.37 148.02 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.515 1.126 . . . . 0.0 110.17 168.881 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 99.2 m -111.36 133.72 53.47 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.523 1.129 . . . . 0.0 108.897 169.115 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 42.2 t -110.17 134.15 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.846 1.658 . . . . 0.0 108.587 176.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -134.19 152.24 51.73 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.265 1.426 . . . . 0.0 112.367 -169.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.7 t80 -159.52 133.92 7.72 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.448 1.499 . . . . 0.0 112.125 177.241 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.84 119.4 71.15 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 124.53 1.132 . . . . 0.0 110.563 175.322 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -77.03 139.81 19.55 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.501 2.801 . . . . 0.0 112.686 -170.358 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 52.2 m -123.02 -7.51 8.35 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 174.962 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -140.37 157.62 45.26 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.828 1.651 . . . . 0.0 110.68 -177.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.3 170.57 9.0 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.73 1.212 . . . . 0.0 111.688 168.445 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 103.66 -170.42 19.16 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.214 1.388 . . . . 0.0 113.781 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.6 tt -83.53 119.29 24.53 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.432 1.093 . . . . 0.0 110.117 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 24.2 m80 -107.57 156.3 19.17 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 126.115 1.766 . . . . 0.0 111.759 -177.609 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -124.27 149.71 46.19 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.069 1.748 . . . . 0.0 109.059 175.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 15.7 tmm? -153.12 136.01 15.44 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 121.349 -0.844 . . . . 0.0 111.901 -175.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -119.84 143.38 47.93 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.5 1.92 . . . . 0.0 111.702 -172.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 26.4 mm -136.66 135.38 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 125.444 1.498 . . . . 0.0 110.803 175.235 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.29 142.83 30.69 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.211 1.004 . . . . 0.0 113.622 178.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.3 t80 -107.39 122.41 46.54 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.952 2.101 . . . . 0.0 110.208 177.812 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.4 t70 52.12 32.17 10.07 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.528 1.131 . . . . 0.0 112.485 -172.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 20.3 t30 77.14 3.9 3.26 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 128.426 2.69 . . . . 0.0 115.149 -178.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.35 128.84 47.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.659 1.583 . . . . 0.0 110.809 174.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -59.14 137.3 58.01 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 121.094 -1.004 . . . . 0.0 113.582 -177.342 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.6 pt -74.25 155.45 87.98 Favored Pre-proline 0 N--CA 1.48 1.034 0 CA-C-O 118.573 -0.727 . . . . 0.0 110.459 172.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -66.42 -13.64 40.76 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.485 2.124 . . . . 0.0 113.762 -179.337 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -89.45 9.32 77.45 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.008 1.29 . . . . 0.0 114.672 170.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 29.5 t -116.32 148.22 41.19 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 119.533 1.667 . . . . 0.0 111.698 178.599 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.02 165.87 77.93 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 119.931 1.011 . . . . 0.0 112.135 -6.333 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 65.5 mt -113.97 158.8 20.67 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.319 1.848 . . . . 0.0 110.92 172.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -157.79 146.97 19.67 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.766 1.226 . . . . 0.0 110.954 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 3.8 p90 -170.96 163.52 7.51 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.914 1.285 . . . . 0.0 111.784 -166.773 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -98.45 138.61 35.43 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.246 -0.909 . . . . 0.0 112.967 177.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 45.0 t -111.75 135.54 50.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 125.701 1.6 . . . . 0.0 109.451 174.811 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -146.38 164.1 33.49 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.307 1.843 . . . . 0.0 111.715 -175.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -80.71 155.32 26.81 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.633 0.773 . . . . 0.0 112.862 -179.197 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 25.1 m -66.17 -16.2 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 O-C-N 121.344 -0.847 . . . . 0.0 112.309 165.535 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -74.49 -19.7 60.28 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.909 1.684 . . . . 0.0 114.194 178.298 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 92.6 m -62.41 130.61 46.02 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.859 1.264 . . . . 0.0 113.551 -170.123 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -100.31 -18.17 22.37 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.2 1.381 . . . . 0.0 114.12 174.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -68.45 160.3 30.0 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.294 1.047 . . . . 0.0 113.51 176.336 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 40.0 t -63.75 128.5 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.55 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.5 t -144.2 157.1 44.49 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.691 1.196 . . . . 0.0 110.596 -172.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.69 144.3 37.5 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 -176.77 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 51.6 p90 -166.83 172.24 10.58 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.569 1.548 . . . . 0.0 112.375 -173.715 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 118.27 172.29 15.58 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 125.266 1.412 . . . . 0.0 112.622 -177.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.71 -35.01 17.42 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.789 2.326 . . . . 0.0 112.704 -170.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -64.14 -38.6 96.19 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.398 0.999 . . . . 0.0 114.668 -171.379 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.8 pp -77.01 -7.16 55.14 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 119.055 1.428 . . . . 0.0 113.761 177.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 26.3 m -100.91 -40.27 7.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 126.385 1.874 . . . . 0.0 111.071 176.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -153.73 141.08 19.65 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.38 1.872 . . . . 0.0 112.189 -167.491 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -135.5 177.0 19.77 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 125.529 1.538 . . . . 0.0 112.17 173.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 11.0 t -141.86 135.67 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.132 0.973 . . . . 0.0 108.85 174.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.9 m -55.97 135.85 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 123.302 0.641 . . . . 0.0 112.576 -177.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 58.3 m-80 67.71 1.17 2.52 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.95 2.1 . . . . 0.0 114.89 174.537 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 40.4 mtmt -121.22 143.46 37.37 Favored Pre-proline 0 N--CA 1.476 0.871 0 C-N-CA 125.468 1.507 . . . . 0.0 111.038 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -72.53 133.04 19.9 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 122.523 2.149 . . . . 0.0 111.309 -173.389 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -113.08 146.42 39.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.66 1.584 . . . . 0.0 110.116 172.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.7 p -137.12 145.33 43.72 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -165.385 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 52.1 p90 -154.46 175.38 13.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.266 1.426 . . . . 0.0 111.948 177.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 29.9 m -130.94 144.27 51.35 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.25 1.42 . . . . 0.0 110.759 -169.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.2 t -121.36 130.57 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.674 1.59 . . . . 0.0 108.704 170.105 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.54 124.38 43.26 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.56 1.144 . . . . 0.0 111.307 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 34.5 p -124.99 12.28 8.36 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 126.808 2.043 . . . . 0.0 112.318 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 29.2 tptp -55.29 -36.43 66.14 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.615 1.566 . . . . 0.0 114.564 -170.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.4 t70 -112.74 12.62 19.67 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 125.729 1.612 . . . . 0.0 112.741 -179.405 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -73.86 -12.95 60.83 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 114.291 1.219 . . . . 0.0 114.291 -177.507 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 -84.45 1.57 Allowed Glycine 0 CA--C 1.528 0.853 0 C-N-CA 125.052 1.311 . . . . 0.0 111.91 178.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -159.56 148.4 17.86 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.434 1.493 . . . . 0.0 110.634 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 156.19 -152.46 23.88 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.392 1.473 . . . . 0.0 111.661 -174.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -147.68 144.97 13.1 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 124.81 1.195 . . . . 0.0 112.377 176.267 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 38.7 tp -89.33 141.35 28.62 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.198 1.399 . . . . 0.0 111.12 176.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 12.3 t -125.69 160.13 30.5 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.961 1.705 . . . . 0.0 110.816 166.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 41.3 tp -163.06 136.23 5.7 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.928 1.691 . . . . 0.0 109.491 -162.708 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.41 160.84 35.34 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.36 1.064 . . . . 0.0 111.954 175.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.4 mt -132.87 137.83 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 C-N-CA 124.723 1.209 . . . . 0.0 109.518 173.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -129.12 119.48 24.22 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 125.171 1.388 . . . . 0.0 109.517 174.034 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -136.88 -173.26 12.83 Favored Glycine 0 CA--C 1.537 1.465 0 C-N-CA 124.92 1.248 . . . . 0.0 113.911 -177.729 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.04 -21.07 49.89 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.958 3.105 . . . . 0.0 112.257 173.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -136.22 157.1 47.62 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.344 1.458 . . . . 0.0 109.0 158.716 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.0 tptt -76.03 122.48 24.28 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 120.796 -1.19 . . . . 0.0 111.862 -176.53 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -76.94 150.08 35.96 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.037 0.935 . . . . 0.0 112.082 174.278 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 57.7 mm-40 -86.19 142.81 28.34 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.798 0.839 . . . . 0.0 109.314 166.335 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 21.5 mt -136.87 144.16 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 124.441 1.096 . . . . 0.0 110.626 -167.623 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.3 t -146.81 168.13 22.17 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.036 1.334 . . . . 0.0 111.461 168.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.4 p -161.32 158.48 27.1 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.985 1.314 . . . . 0.0 112.965 -177.887 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 80.9 m -143.8 129.02 18.78 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.8 1.64 . . . . 0.0 110.446 -172.508 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.3 t70 -82.63 128.69 34.57 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.82 1.248 . . . . 0.0 111.09 170.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -98.72 149.73 22.54 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.943 1.297 . . . . 0.0 111.732 178.515 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 56.1 mm-40 -67.48 -16.37 64.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.766 0.826 . . . . 0.0 112.661 174.293 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.13 -7.72 52.62 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.435 1.494 . . . . 0.0 113.85 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.17 27.06 19.68 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 124.783 1.182 . . . . 0.0 114.464 176.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 67.5 p -130.82 156.46 44.97 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.777 1.631 . . . . 0.0 110.589 176.728 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.1 m -106.89 128.0 53.91 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.626 1.171 . . . . 0.0 109.921 171.188 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 20.7 t -94.72 149.57 21.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.147 0.979 . . . . 0.0 110.375 169.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 86.4 t -131.36 144.56 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.097 1.759 . . . . 0.0 109.63 -176.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 89.7 p -135.51 149.95 49.64 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.893 1.277 . . . . 0.0 111.987 170.161 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 17.5 p90 -152.72 155.7 37.73 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 176.57 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.9 mt -122.72 106.65 34.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 126.641 1.976 . . . . 0.0 110.447 -179.762 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -85.09 170.17 9.77 Favored 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 124.065 3.177 . . . . 0.0 110.488 167.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -131.4 -20.41 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -170.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 4.1 pp -144.93 151.28 48.72 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 124.701 1.201 . . . . 0.0 110.769 176.774 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.5 152.29 38.34 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.826 2.351 . . . . 0.0 112.366 -170.51 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.3 -152.46 24.34 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.502 1.049 . . . . 0.0 112.883 -177.199 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -114.32 130.33 56.67 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.829 1.652 . . . . 0.0 111.627 177.772 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -122.35 129.41 52.1 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.715 1.606 . . . . 0.0 110.015 -176.482 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -86.7 127.76 34.98 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.09 -1.006 . . . . 0.0 111.159 178.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.15 121.8 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.945 1.698 . . . . 0.0 108.666 178.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.9 tt -98.1 134.79 40.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.107 1.363 . . . . 0.0 109.979 173.8 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 91.4 t -136.02 129.22 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.442 1.497 . . . . 0.0 108.416 171.808 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -151.6 133.98 15.34 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.818 1.247 . . . . 0.0 110.93 -172.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 51.4 t80 -133.42 133.63 42.59 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.825 1.25 . . . . 0.0 111.151 -179.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.8 t-20 49.16 53.36 12.75 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.77 1.228 . . . . 0.0 112.406 178.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.31 8.8 pt-20 58.49 18.18 5.48 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 128.016 2.526 . . . . 0.0 116.305 -177.178 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -127.78 131.53 49.6 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.618 1.167 . . . . 0.0 111.88 178.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -63.02 157.03 23.0 Favored 'General case' 0 CA--C 1.549 0.921 0 O-C-N 121.268 -0.895 . . . . 0.0 112.486 168.169 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 34.8 m -88.52 155.13 51.2 Favored Pre-proline 0 N--CA 1.48 1.042 0 C-N-CA 123.499 0.72 . . . . 0.0 110.314 176.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.6 123.1 12.61 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.237 1.958 . . . . 0.0 110.051 175.251 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.48 -13.48 65.47 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.141 1.353 . . . . 0.0 115.633 -177.319 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 87.0 p -82.56 150.68 63.66 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 120.343 2.071 . . . . 0.0 112.87 178.33 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.91 140.96 67.21 Favored 'Cis proline' 0 C--N 1.353 0.779 0 CA-C-N 119.218 0.757 . . . . 0.0 111.791 -4.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -86.84 170.17 11.91 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.165 1.386 . . . . 0.0 110.406 175.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 35.0 m -132.65 117.92 18.5 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.307 0.643 . . . . 0.0 110.543 176.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.7 134.25 38.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.968 1.307 . . . . 0.0 111.641 177.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 38.3 tpt85 -86.75 113.86 22.94 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 124.271 1.028 . . . . 0.0 109.944 174.209 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 93.6 t -92.17 124.56 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.581 0.752 . . . . 0.0 110.173 178.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 82.9 m -92.44 142.83 27.0 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.657 1.983 . . . . 0.0 110.478 -179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.61 17.26 11.13 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 125.046 1.308 . . . . 0.0 115.347 -176.32 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 26.5 t70 66.4 10.21 7.08 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 127.559 2.344 . . . . 0.0 113.659 -178.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.8 t70 . . . . . 0 C--O 1.253 1.259 0 C-N-CA 126.345 1.858 . . . . 0.0 114.1 -177.865 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.582 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -79.56 -18.46 51.7 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.263 1.208 . . . . 0.0 114.263 -177.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -74.81 166.79 23.04 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.604 1.561 . . . . 0.0 113.366 178.148 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -141.77 151.05 58.88 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 125.573 1.549 . . . . 0.0 111.361 178.054 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.95 157.03 43.24 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.708 2.939 . . . . 0.0 111.998 -179.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -83.43 121.42 27.16 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.941 0.897 . . . . 0.0 110.361 175.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -70.72 -44.46 16.34 Favored Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 -176.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -76.44 151.78 33.57 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.121 1.88 . . . . 0.0 111.967 -173.09 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 14.7 tp -79.35 36.43 0.3 Allowed 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.718 1.607 . . . . 0.0 112.683 -176.143 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.6 p -75.14 140.11 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.117 1.367 . . . . 0.0 111.358 -176.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 84.88 3.65 87.77 Favored Glycine 0 CA--C 1.534 1.257 0 N-CA-C 115.778 1.071 . . . . 0.0 115.778 172.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 28.2 m -72.68 159.71 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 118.841 1.32 . . . . 0.0 112.163 177.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 60.4 t30 -154.27 143.75 21.48 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 124.751 1.221 . . . . 0.0 111.761 179.232 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -91.29 -159.03 35.22 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.411 1.481 . . . . 0.0 113.126 177.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 91.2 mt -73.9 157.31 36.53 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 124.38 1.072 . . . . 0.0 111.758 176.015 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -82.09 -11.37 58.81 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.906 1.282 . . . . 0.0 114.458 -175.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 17.8 m -67.71 127.89 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.355 1.062 . . . . 0.0 111.837 -178.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.1 t -163.21 19.84 0.08 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.551 1.54 . . . . 0.0 112.612 -174.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 9.8 m -76.94 30.4 0.13 Allowed 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.861 1.664 . . . . 0.0 114.537 -170.208 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.88 141.66 56.34 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.133 1.373 . . . . 0.0 111.466 176.796 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 45.6 ttm180 -57.32 116.08 12.63 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 125.852 1.661 . . . . 0.0 110.829 176.526 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -70.47 137.22 32.91 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.705 2.27 . . . . 0.0 109.334 177.255 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.8 t80 -102.81 121.61 42.83 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.506 0.669 . . . . 0.0 111.047 -176.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -149.66 138.72 21.19 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.657 1.583 . . . . 0.0 110.104 171.379 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.56 140.52 30.27 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.208 1.403 . . . . 0.0 109.83 -172.263 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 86.0 t -102.88 134.76 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 109.331 176.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.72 135.73 27.91 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 108.885 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.64 109.48 2.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.32 2.68 . . . . 0.0 109.876 173.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -174.51 149.24 1.27 Allowed 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 127.275 2.23 . . . . 0.0 109.098 -172.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 56.0 m -126.96 124.43 39.45 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.16 0.984 . . . . 0.0 109.927 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.1 mt -87.01 120.94 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 124.692 1.197 . . . . 0.0 109.144 174.327 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -110.81 -101.86 0.4 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.825 1.25 . . . . 0.0 110.492 176.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 68.0 mttm -119.63 132.17 55.63 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.082 1.353 . . . . 0.0 111.249 174.233 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 138.04 -144.83 16.21 Favored Glycine 0 N--CA 1.472 1.094 0 C-N-CA 125.922 1.725 . . . . 0.0 111.186 -167.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -159.6 151.02 19.92 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.469 1.107 . . . . 0.0 111.082 -177.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.7 tt -141.25 130.98 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.098 1.359 . . . . 0.0 111.477 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 82.7 p -144.45 178.64 7.8 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 125.771 1.628 . . . . 0.0 110.382 -178.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.53 -164.83 22.85 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 114.912 0.725 . . . . 0.0 114.912 -179.596 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -154.66 145.22 22.25 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.564 1.546 . . . . 0.0 110.113 178.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 94.4 t -128.66 134.24 64.89 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 125.954 1.701 . . . . 0.0 108.574 174.53 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -118.74 141.86 48.22 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.278 1.031 . . . . 0.0 112.158 -178.006 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 1.5 mtm -103.04 147.36 34.01 Favored Pre-proline 0 CA--C 1.548 0.883 0 C-N-CA 126.036 1.734 . . . . 0.0 111.317 178.643 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -56.66 -26.88 67.54 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 124.007 3.138 . . . . 0.0 115.008 175.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.6 p -73.34 -3.6 28.14 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.983 1.713 . . . . 0.0 114.524 178.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.73 -4.36 75.63 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.508 1.528 . . . . 0.0 114.058 -179.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -69.04 152.58 45.04 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.732 1.213 . . . . 0.0 111.964 171.799 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 47.9 t -142.49 141.62 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 125.829 1.652 . . . . 0.0 109.673 -176.102 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -153.06 -179.7 7.92 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.077 1.751 . . . . 0.0 110.955 178.708 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -123.8 144.63 45.25 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.215 -0.928 . . . . 0.0 111.875 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.5 167.09 13.6 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 124.276 3.317 . . . . 0.0 111.513 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.3 m -110.86 127.13 55.32 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.482 1.513 . . . . 0.0 108.981 174.076 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.5 mp -108.6 133.5 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.8 1.24 . . . . 0.0 109.345 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 69.8 m -136.09 137.77 41.39 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.736 1.614 . . . . 0.0 109.494 177.366 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.6 129.47 34.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.287 0.635 . . . . 0.0 110.896 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -76.75 -8.11 56.67 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -178.506 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 71.49 13.01 6.51 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 127.895 2.478 . . . . 0.0 113.334 -179.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.3 t70 -120.62 9.88 10.92 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 127.074 2.15 . . . . 0.0 112.783 -176.763 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.63 12.7 59.17 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.043 1.306 . . . . 0.0 114.367 -177.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 81.1 p -131.02 158.39 40.44 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 126.616 1.967 . . . . 0.0 109.991 176.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.9 m -111.99 151.7 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 C-N-CA 123.939 0.896 . . . . 0.0 110.292 168.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 9.7 t -103.0 139.14 38.96 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.504 1.122 . . . . 0.0 108.681 163.017 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 33.0 t -120.6 127.51 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 125.121 1.368 . . . . 0.0 108.466 173.921 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -130.49 153.35 48.9 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.504 1.521 . . . . 0.0 111.815 -166.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 43.5 t80 -159.67 137.0 9.69 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.748 1.219 . . . . 0.0 112.219 -174.428 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -90.13 119.85 69.25 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.532 1.133 . . . . 0.0 110.808 176.565 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -78.67 154.06 26.77 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.522 2.814 . . . . 0.0 111.608 -179.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 86.6 p -133.16 -9.78 2.96 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.525 1.306 . . . . 0.0 114.525 174.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -168.88 145.52 3.6 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.479 1.512 . . . . 0.0 110.39 -168.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -76.41 167.63 21.5 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.286 1.034 . . . . 0.0 113.379 -179.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 124.86 -178.25 16.58 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 125.537 1.541 . . . . 0.0 114.266 176.839 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.4 tp -82.17 127.17 32.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.008 1.323 . . . . 0.0 109.986 177.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.6 m80 -124.67 153.22 42.63 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.094 1.358 . . . . 0.0 111.655 -172.712 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.68 139.95 51.99 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.407 1.483 . . . . 0.0 109.882 178.363 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 20.3 ttm -118.51 133.37 55.92 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.353 1.861 . . . . 0.0 110.645 178.277 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.8 t70 -107.42 134.69 50.09 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.927 2.091 . . . . 0.0 109.753 170.15 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 23.1 mm -134.89 139.31 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 124.877 1.271 . . . . 0.0 110.996 176.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.8 135.07 20.55 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.421 1.088 . . . . 0.0 113.518 -179.279 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 10.9 t80 -99.62 123.12 43.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.061 1.744 . . . . 0.0 109.933 173.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 50.87 36.19 14.14 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.356 1.462 . . . . 0.0 112.829 -176.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.2 t30 79.3 0.05 2.29 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 128.305 2.642 . . . . 0.0 114.74 179.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -103.41 134.44 46.78 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.27 1.428 . . . . 0.0 111.007 175.594 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.7 m170 -54.14 136.95 41.61 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 113.399 0.889 . . . . 0.0 113.399 177.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 30.4 pt -76.33 154.46 84.13 Favored Pre-proline 0 N--CA 1.48 1.042 0 CA-C-O 118.516 -0.754 . . . . 0.0 109.989 166.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -63.57 -23.39 70.47 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 122.389 2.059 . . . . 0.0 113.28 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -81.07 3.85 74.32 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 124.39 0.995 . . . . 0.0 114.686 173.312 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.1 t -99.82 147.12 32.99 Favored Pre-proline 0 CA--C 1.547 0.844 0 CA-C-N 119.616 1.708 . . . . 0.0 111.8 177.612 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.14 170.12 71.17 Favored 'Cis proline' 0 CA--C 1.539 0.76 0 CA-C-N 119.785 0.959 . . . . 0.0 111.498 -11.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 89.7 mt -117.59 158.27 24.9 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.106 1.363 . . . . 0.0 110.846 169.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -148.03 139.94 24.0 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.589 1.156 . . . . 0.0 110.366 -178.118 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.8 p90 -164.49 173.4 12.13 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.145 1.378 . . . . 0.0 111.796 -173.38 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 26.0 t80 -114.67 135.78 53.78 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.985 0.914 . . . . 0.0 113.248 178.616 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 57.9 t -102.36 138.56 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 125.867 1.667 . . . . 0.0 108.973 174.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.5 t0 -160.99 166.5 28.17 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.915 1.286 . . . . 0.0 111.091 178.507 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -72.12 123.62 23.26 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.716 0.807 . . . . 0.0 111.267 174.048 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 4.7 p -70.98 -25.58 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.166 0.986 . . . . 0.0 113.361 -167.663 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -95.7 -2.79 47.24 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.198 1.399 . . . . 0.0 113.639 -177.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 4.3 t -69.81 150.36 46.94 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.184 -0.948 . . . . 0.0 113.501 -170.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -87.09 74.84 2.25 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 125.48 1.514 . . . . 0.0 113.278 -172.435 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.7 p-80 -169.96 166.87 9.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 127.007 2.123 . . . . 0.0 112.335 173.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -71.47 132.65 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.801 1.241 . . . . 0.0 109.605 179.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 81.9 p -138.69 164.12 30.37 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.939 1.296 . . . . 0.0 110.991 176.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -139.88 143.76 36.87 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.497 1.119 . . . . 0.0 111.274 171.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.7 p90 -169.36 164.6 10.75 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.773 1.629 . . . . 0.0 112.736 -175.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 134.54 175.1 13.72 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 125.329 1.442 . . . . 0.0 112.695 -179.385 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -67.94 -37.94 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.648 2.232 . . . . 0.0 112.374 -172.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.15 -36.95 93.54 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-N 119.534 1.061 . . . . 0.0 114.556 -171.106 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.59 -4.38 45.55 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.929 1.364 . . . . 0.0 113.648 176.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.3 m -104.9 -49.59 3.46 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.038 1.735 . . . . 0.0 110.506 176.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -142.49 131.86 23.58 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 126.5 1.92 . . . . 0.0 112.724 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -125.19 177.78 16.8 Favored Glycine 0 CA--C 1.534 1.246 0 C-N-CA 126.218 1.866 . . . . 0.0 112.431 171.117 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 46.3 t -142.05 134.6 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.654 1.182 . . . . 0.0 108.826 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.7 m -58.21 138.99 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 67.4 m-80 62.91 9.8 3.94 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 126.046 1.738 . . . . 0.0 114.635 176.915 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -120.89 141.3 32.32 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 125.611 1.564 . . . . 0.0 110.328 172.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.79 129.37 15.38 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.578 2.185 . . . . 0.0 110.616 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.78 144.22 36.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.634 1.574 . . . . 0.0 110.185 174.229 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.0 p -135.6 147.33 48.63 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -166.774 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -157.69 178.06 10.69 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.632 1.573 . . . . 0.0 111.488 176.217 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 89.8 m -128.9 144.03 51.06 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.407 1.483 . . . . 0.0 110.768 -170.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 50.8 t -117.73 132.24 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.852 1.661 . . . . 0.0 108.158 169.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -92.48 129.57 38.38 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.932 0.893 . . . . 0.0 111.184 178.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 76.3 p -127.95 0.9 5.95 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.021 1.728 . . . . 0.0 113.349 -172.493 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 57.1 tptt -51.84 -41.78 62.06 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 126.042 1.737 . . . . 0.0 114.022 -174.215 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 26.0 t70 -98.83 -3.89 34.44 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.27 1.428 . . . . 0.0 113.38 -179.212 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.49 65.06 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.151 0.98 . . . . 0.0 113.611 -173.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.42 -88.62 1.11 Allowed Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.744 1.164 . . . . 0.0 112.369 177.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.76 149.07 19.71 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.572 1.549 . . . . 0.0 110.954 -174.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 163.54 -151.49 21.03 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.06 1.791 . . . . 0.0 111.519 -177.648 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -111.27 107.58 2.2 Favored Glycine 0 N--CA 1.47 0.902 0 C-N-CA 124.422 1.01 . . . . 0.0 111.402 172.378 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 55.6 tp -81.33 136.47 35.75 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.411 1.084 . . . . 0.0 109.864 172.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 35.2 m -136.67 156.18 48.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.369 1.468 . . . . 0.0 111.768 -179.726 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 51.0 tp -159.91 131.89 6.26 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.802 1.641 . . . . 0.0 108.8 -168.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.83 157.23 34.59 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.786 0.834 . . . . 0.0 112.4 -179.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 50.7 mt -138.39 137.43 43.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.016 1.326 . . . . 0.0 109.871 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -125.06 157.5 36.1 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.385 1.874 . . . . 0.0 109.807 171.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.71 -161.73 29.83 Favored Glycine 0 CA--C 1.539 1.562 0 CA-C-O 118.946 -0.919 . . . . 0.0 114.658 -178.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -64.4 -25.23 63.7 Favored 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 124.009 3.14 . . . . 0.0 112.68 177.646 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 19.4 t -140.45 159.95 41.06 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.041 1.336 . . . . 0.0 109.444 162.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.9 tptt -76.94 107.05 9.0 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 120.983 -1.073 . . . . 0.0 111.233 -178.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.81 147.01 53.14 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.024 0.93 . . . . 0.0 111.723 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -91.83 148.42 22.25 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.627 0.771 . . . . 0.0 110.674 168.881 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.0 mt -137.62 145.38 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.074 1.35 . . . . 0.0 110.181 -164.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.4 t -143.08 167.17 22.71 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.054 1.342 . . . . 0.0 111.016 166.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.8 156.03 28.98 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.779 1.232 . . . . 0.0 112.594 -178.125 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 89.1 m -143.08 124.99 15.14 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.676 1.59 . . . . 0.0 109.922 -171.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 20.3 t0 -74.3 120.95 20.57 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.916 0.886 . . . . 0.0 109.839 170.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -83.48 -7.32 59.56 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.151 0.98 . . . . 0.0 113.455 -176.077 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 74.72 -17.51 0.48 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 129.07 2.948 . . . . 0.0 113.908 178.003 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.4 t70 -81.36 -3.88 54.05 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 125.853 1.661 . . . . 0.0 113.913 -179.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 105.21 22.5 8.21 Favored Glycine 0 N--CA 1.474 1.186 0 C-N-CA 125.446 1.498 . . . . 0.0 114.07 -173.002 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.9 p -138.94 154.63 48.34 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.395 1.478 . . . . 0.0 110.613 172.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 93.9 m -115.04 131.56 56.89 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.858 1.663 . . . . 0.0 109.137 165.83 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -86.38 149.24 25.16 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 123.823 0.849 . . . . 0.0 110.304 168.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 84.5 t -127.01 142.62 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 C-N-CA 126.426 1.89 . . . . 0.0 109.076 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 81.6 p -131.86 146.14 51.95 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.724 1.21 . . . . 0.0 111.442 167.334 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.3 p90 -149.44 157.05 42.96 Favored 'General case' 0 N--CA 1.468 0.442 0 O-C-N 121.077 -1.014 . . . . 0.0 113.118 175.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 43.4 tp -126.41 102.2 26.87 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.839 1.255 . . . . 0.0 110.492 -174.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -80.87 174.29 11.14 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.746 2.964 . . . . 0.0 110.61 170.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -148.44 -30.82 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.028 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 82.2 mt -107.48 145.34 31.07 Favored Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 119.657 1.117 . . . . 0.0 110.776 167.764 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.56 164.81 31.67 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.273 2.649 . . . . 0.0 111.339 177.052 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.24 -124.48 3.93 Favored Glycine 0 N--CA 1.467 0.731 0 C-N-CA 124.909 1.242 . . . . 0.0 111.86 -175.784 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -147.76 144.78 28.49 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.359 1.464 . . . . 0.0 112.152 -179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -127.18 143.22 51.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.445 1.898 . . . . 0.0 110.863 -172.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 60.4 m -96.1 123.7 39.82 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.717 1.207 . . . . 0.0 110.429 176.274 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -107.27 124.4 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 125.609 1.564 . . . . 0.0 108.464 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.5 tt -108.98 131.87 54.65 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.461 1.505 . . . . 0.0 109.908 178.171 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 42.6 t -133.58 127.85 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.465 1.106 . . . . 0.0 109.74 171.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -148.3 142.68 26.28 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.16 1.384 . . . . 0.0 111.397 -169.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -142.92 121.34 12.38 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.54 1.136 . . . . 0.0 110.025 -179.936 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 59.59 56.08 3.8 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.584 1.554 . . . . 0.0 111.55 178.727 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.286 10.5 pt-20 54.19 23.59 4.33 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 127.796 2.438 . . . . 0.0 115.645 -178.511 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -133.29 128.67 36.29 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.115 1.366 . . . . 0.0 110.432 177.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -65.01 148.04 52.38 Favored 'General case' 0 CA--C 1.546 0.821 0 O-C-N 121.448 -0.783 . . . . 0.0 112.022 173.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 15.2 m -70.21 152.43 95.68 Favored Pre-proline 0 N--CA 1.482 1.127 0 CA-C-O 118.473 -0.775 . . . . 0.0 109.879 168.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -60.22 128.01 24.94 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.683 2.255 . . . . 0.0 110.402 177.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.87 -15.96 62.28 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.175 1.369 . . . . 0.0 115.045 -174.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.7 t -78.49 140.71 60.2 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 119.281 1.54 . . . . 0.0 111.5 175.411 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -74.71 137.39 49.97 Favored 'Cis proline' 0 CA--C 1.539 0.771 0 CA-C-N 119.401 0.822 . . . . 0.0 111.963 -4.163 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -87.71 165.69 15.19 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.107 1.763 . . . . 0.0 110.66 175.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 88.7 m -123.84 119.22 29.04 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.885 0.874 . . . . 0.0 110.255 174.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -97.61 135.56 39.25 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.809 1.243 . . . . 0.0 110.921 173.16 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 27.6 tpt85 -80.2 141.41 35.66 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.818 0.847 . . . . 0.0 109.259 167.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.8 t -129.41 132.19 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.78 1.173 . . . . 0.0 110.926 176.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 27.6 p -111.49 159.55 17.98 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.251 1.42 . . . . 0.0 112.843 -178.306 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.04 128.72 9.37 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.703 1.621 . . . . 0.0 112.57 -178.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -102.09 -18.57 15.52 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.222 1.409 . . . . 0.0 113.42 176.645 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.6 t70 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 126.331 1.852 . . . . 0.0 112.719 -173.609 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.544 0 N-CA-C 112.053 -0.419 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -70.69 150.59 45.8 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.277 1.031 . . . . 0.0 112.553 178.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.5 mmt -96.62 140.28 31.46 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.767 1.227 . . . . 0.0 111.628 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -87.15 147.28 42.2 Favored Pre-proline 0 CA--C 1.551 1.011 0 C-N-CA 124.413 1.085 . . . . 0.0 111.947 176.088 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -76.99 162.78 31.7 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 123.668 2.912 . . . . 0.0 111.716 176.336 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.53 166.14 17.47 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.779 1.232 . . . . 0.0 112.091 170.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -60.39 133.28 90.91 Favored Pre-proline 0 CA--C 1.55 0.949 0 CA-C-O 118.381 -0.819 . . . . 0.0 110.66 174.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.18 169.27 21.05 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 123.134 2.556 . . . . 0.0 111.357 173.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.76 12.69 1.98 Allowed 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.689 1.196 . . . . 0.0 113.493 -176.276 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.0 p -51.46 126.61 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.949 1.3 . . . . 0.0 111.235 177.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 86.81 -14.09 57.28 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 125.084 1.326 . . . . 0.0 114.805 -173.252 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 36.4 t -101.7 -55.13 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.336 1.455 . . . . 0.0 109.75 175.129 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -94.48 -10.89 30.89 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 174.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -86.55 127.8 8.56 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 125.168 1.366 . . . . 0.0 111.651 179.696 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.6 mt -142.62 171.05 14.59 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.653 1.981 . . . . 0.0 110.722 -177.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 49.8 t0 -146.5 151.24 37.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.203 1.401 . . . . 0.0 111.412 174.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 31.3 m -148.43 13.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 126.853 2.061 . . . . 0.0 113.421 -168.022 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 1.7 t -87.3 -2.67 58.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.068 1.347 . . . . 0.0 114.236 -172.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 37.0 p -70.08 151.21 45.76 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -161.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 35.0 tp -91.29 135.41 33.82 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.533 1.933 . . . . 0.0 109.57 174.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -52.0 112.96 3.67 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 124.787 1.235 . . . . 0.0 112.313 -172.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -75.63 148.76 33.33 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.693 2.262 . . . . 0.0 110.811 177.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -88.48 122.49 32.01 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 174.182 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -148.45 147.13 28.8 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.904 1.282 . . . . 0.0 111.057 168.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -161.93 154.8 20.28 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.38 1.472 . . . . 0.0 110.503 -175.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 10.6 p -127.4 134.42 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 125.627 1.571 . . . . 0.0 109.615 172.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 59.0 mt -132.58 137.63 30.25 Favored Pre-proline 0 N--CA 1.475 0.815 0 C-N-CA 125.789 1.636 . . . . 0.0 109.334 -171.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -75.4 84.73 1.67 Allowed 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 123.895 3.063 . . . . 0.0 110.883 177.343 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -134.16 151.16 51.21 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.509 1.923 . . . . 0.0 109.625 173.91 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 80.7 m -126.37 123.86 38.92 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.692 1.197 . . . . 0.0 109.488 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 68.5 mt -81.88 129.43 37.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.704 1.201 . . . . 0.0 109.904 178.573 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -105.69 -139.12 0.37 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.961 1.304 . . . . 0.0 110.643 175.797 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -75.94 -6.21 49.84 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -178.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -84.93 -149.18 10.58 Favored Glycine 0 CA--C 1.533 1.18 0 C-N-CA 125.922 1.725 . . . . 0.0 113.038 179.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -155.49 151.1 27.3 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.934 1.294 . . . . 0.0 111.033 -174.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 18.0 tt -127.35 135.48 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 125.59 1.556 . . . . 0.0 112.015 -175.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.3 p -147.92 162.66 38.85 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.814 1.645 . . . . 0.0 110.875 -176.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -147.19 -176.16 20.67 Favored Glycine 0 N--CA 1.468 0.819 0 N-CA-C 116.046 1.178 . . . . 0.0 116.046 -177.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -153.92 143.31 21.51 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.566 1.946 . . . . 0.0 109.119 173.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 24.9 t -117.61 133.2 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 125.727 1.611 . . . . 0.0 108.195 174.38 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 35.8 mtm-85 -117.4 129.35 55.8 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.288 1.035 . . . . 0.0 110.813 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 2.9 mpp? -97.3 148.22 34.1 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.576 1.55 . . . . 0.0 111.506 -173.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.65 -21.01 29.91 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.462 2.774 . . . . 0.0 113.145 -179.161 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 18.2 p -79.22 1.02 26.18 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.379 1.471 . . . . 0.0 114.431 176.76 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.04 54.63 2.27 Favored Glycine 0 N--CA 1.471 1.027 0 C-N-CA 124.665 1.126 . . . . 0.0 113.296 173.18 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -156.61 166.33 33.7 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.961 1.704 . . . . 0.0 111.864 -177.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.8 m -141.63 158.13 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.798 1.239 . . . . 0.0 112.652 -173.326 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.88 173.46 16.75 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.474 2.31 . . . . 0.0 110.045 177.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -114.75 144.93 32.86 Favored Pre-proline 0 CA--C 1.546 0.822 0 O-C-N 121.13 -0.981 . . . . 0.0 112.769 -179.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -86.56 174.8 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 124.837 3.691 . . . . 0.0 112.034 177.695 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 71.7 m -110.05 133.5 53.14 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.809 1.644 . . . . 0.0 108.806 171.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.6 mp -118.83 140.75 41.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 124.989 1.316 . . . . 0.0 108.604 173.592 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 14.5 t -148.0 139.42 23.61 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.731 1.212 . . . . 0.0 111.005 177.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -86.01 138.38 32.02 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.651 1.18 . . . . 0.0 112.638 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -96.56 -9.54 29.23 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.064 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.76 -1.69 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 127.693 2.397 . . . . 0.0 115.02 173.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -94.79 3.33 55.14 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 126.602 1.961 . . . . 0.0 113.549 175.359 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 102.29 12.28 34.01 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.365 1.46 . . . . 0.0 114.399 -174.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 26.3 p -125.86 161.62 27.02 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.141 1.377 . . . . 0.0 111.824 174.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -121.79 144.01 32.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.734 1.214 . . . . 0.0 109.946 165.524 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 17.1 m -97.33 139.81 32.72 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.331 1.452 . . . . 0.0 109.037 170.788 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 44.1 t -127.23 136.84 59.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.69 1.596 . . . . 0.0 108.934 178.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -142.35 157.7 44.52 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.07 1.348 . . . . 0.0 112.684 -174.629 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 5.9 t80 -154.92 135.27 13.27 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.254 1.421 . . . . 0.0 111.88 172.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.16 120.58 72.5 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.9 1.28 . . . . 0.0 110.923 178.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -82.87 167.55 14.43 Favored 'Trans proline' 0 CA--C 1.536 0.615 0 C-N-CA 123.906 3.07 . . . . 0.0 112.281 -172.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 89.4 p -147.22 -26.32 0.39 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.877 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -138.92 150.09 45.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.175 1.79 . . . . 0.0 110.393 -179.513 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.73 168.67 18.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.492 1.117 . . . . 0.0 113.135 178.477 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 121.44 -173.15 15.56 Favored Glycine 0 N--CA 1.474 1.23 0 C-N-CA 125.425 1.488 . . . . 0.0 114.071 178.09 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.8 tt -87.8 127.47 35.33 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.809 1.244 . . . . 0.0 109.747 178.219 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 65.3 m80 -127.66 164.16 22.67 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.943 1.697 . . . . 0.0 111.585 -172.29 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -146.35 154.15 41.33 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.777 0.799 . . . . 0.0 112.554 166.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 32.9 ttm -127.33 133.7 50.07 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.85 2.46 . . . . 0.0 109.763 -173.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -103.83 131.93 50.57 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.304 1.842 . . . . 0.0 109.354 174.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 27.8 mm -130.51 128.26 63.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.358 1.063 . . . . 0.0 109.783 175.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.52 137.39 37.04 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -177.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 48.2 t80 -103.9 124.07 48.3 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.836 2.054 . . . . 0.0 109.358 174.066 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.6 t0 49.01 46.09 22.57 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.692 1.197 . . . . 0.0 112.344 -176.188 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.301 0.2 OUTLIER 63.34 9.99 4.44 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 128.034 2.533 . . . . 0.0 116.56 -177.222 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 96.7 mtp -110.88 131.24 55.22 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.231 1.412 . . . . 0.0 110.931 173.349 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -55.91 134.11 51.86 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 121.433 -0.792 . . . . 0.0 112.813 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 27.8 pt -73.89 155.59 88.6 Favored Pre-proline 0 N--CA 1.478 0.955 0 CA-C-O 118.871 -0.585 . . . . 0.0 111.701 178.197 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -59.44 122.44 11.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 121.711 1.607 . . . . 0.0 108.395 163.288 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 113.78 -25.01 11.3 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 124.996 1.284 . . . . 0.0 113.021 -171.52 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 9.4 t -83.79 148.3 54.01 Favored Pre-proline 0 CA--C 1.55 0.953 0 CA-C-N 118.91 1.355 . . . . 0.0 111.341 174.794 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.06 155.85 97.27 Favored 'Cis proline' 0 C--N 1.351 0.698 0 CA-C-N 119.79 0.961 . . . . 0.0 111.674 -10.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 69.4 mt -106.51 133.75 50.72 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.702 1.601 . . . . 0.0 109.227 179.404 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -137.92 134.74 35.35 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.032 0.933 . . . . 0.0 110.975 -170.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.5 178.85 7.09 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.309 1.043 . . . . 0.0 113.109 -171.062 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 25.0 t80 -116.8 143.53 45.56 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.517 1.127 . . . . 0.0 112.555 176.173 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 94.2 t -112.86 132.69 60.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 126.293 1.837 . . . . 0.0 109.416 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 29.3 t0 -159.46 152.0 21.39 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.189 1.396 . . . . 0.0 112.006 -172.235 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -76.07 134.86 39.94 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.18 -0.95 . . . . 0.0 112.622 -176.636 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 2.1 p -70.58 -19.95 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 C-N-CA 123.4 0.68 . . . . 0.0 112.589 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -73.39 -20.61 60.71 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.889 1.276 . . . . 0.0 114.014 -178.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 90.0 m -73.92 148.61 42.06 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.384 1.073 . . . . 0.0 113.146 -173.731 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -92.46 -14.03 56.22 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.95 1.262 . . . . 0.0 114.703 -179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -65.03 160.78 20.16 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 118.553 1.176 . . . . 0.0 113.427 177.111 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.5 t -69.47 135.12 28.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 123.731 0.812 . . . . 0.0 109.363 177.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.7 t -161.22 161.53 30.87 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.301 1.441 . . . . 0.0 110.543 -175.661 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.73 147.83 32.34 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.511 1.124 . . . . 0.0 112.291 -174.369 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 16.4 p90 -167.51 161.55 13.88 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.752 1.621 . . . . 0.0 112.941 -176.345 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.25 171.86 12.33 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 125.506 1.527 . . . . 0.0 113.09 -178.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.29 -34.84 26.09 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 123.12 2.546 . . . . 0.0 112.616 -173.139 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -67.82 -21.99 73.5 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 119.036 0.835 . . . . 0.0 114.662 -177.431 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 23.9 mt -74.89 -14.9 60.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.39 1.095 . . . . 0.0 113.168 172.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 16.9 m -117.15 -36.16 3.87 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.777 1.631 . . . . 0.0 111.926 -168.55 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -150.6 155.63 39.78 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.489 1.916 . . . . 0.0 111.963 -174.468 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -149.31 173.51 29.13 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 123.978 0.799 . . . . 0.0 113.176 171.351 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 54.6 t -135.32 132.01 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.654 1.182 . . . . 0.0 108.353 176.051 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -57.73 138.13 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.9 m-80 66.11 2.28 2.24 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.997 2.119 . . . . 0.0 114.62 176.651 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 96.5 mttt -117.64 141.28 28.7 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 126.026 1.73 . . . . 0.0 110.93 177.171 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.13 130.29 16.3 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.672 2.248 . . . . 0.0 111.099 -173.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.7 139.54 44.62 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.415 1.486 . . . . 0.0 110.06 173.34 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -131.02 152.61 50.15 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.542 0.941 . . . . 0.0 113.542 -165.5 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.1 p90 -162.1 175.12 12.07 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.541 1.536 . . . . 0.0 112.189 177.31 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 47.5 m -125.62 143.45 51.02 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.963 1.705 . . . . 0.0 110.625 -171.9 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 41.3 t -121.45 131.45 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 126.215 1.806 . . . . 0.0 108.362 170.225 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 7.1 m-80 -89.13 132.31 34.87 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.391 1.077 . . . . 0.0 111.754 -178.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.6 p -130.74 1.31 4.4 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.084 1.754 . . . . 0.0 113.222 -176.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 86.7 tttt -52.0 -38.8 58.08 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.02 2.128 . . . . 0.0 115.445 -168.213 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.8 t70 -131.81 21.05 4.59 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.523 1.529 . . . . 0.0 111.926 179.305 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.62 -40.95 69.43 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.729 1.212 . . . . 0.0 113.885 -174.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.51 149.88 6.37 Favored Glycine 0 CA--C 1.537 1.452 0 C-N-CA 124.685 1.136 . . . . 0.0 112.301 -169.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.67 163.96 27.28 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.08 0.952 . . . . 0.0 113.531 -177.766 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 161.85 -30.49 0.31 Allowed Glycine 0 CA--C 1.536 1.347 0 C-N-CA 124.538 1.066 . . . . 0.0 114.705 175.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 143.73 101.15 0.35 Allowed Glycine 0 N--CA 1.471 0.991 0 C-N-CA 125.579 1.562 . . . . 0.0 112.748 173.179 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 51.3 tp -77.72 144.63 37.11 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.989 1.316 . . . . 0.0 110.457 175.421 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.6 t -147.44 158.34 43.94 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.974 1.31 . . . . 0.0 112.049 -173.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.7 tp -166.6 135.87 3.01 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.928 1.691 . . . . 0.0 109.495 -164.605 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.86 159.13 36.32 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.359 1.064 . . . . 0.0 111.923 175.312 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 39.4 mt -139.35 128.67 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 124.662 1.185 . . . . 0.0 109.67 175.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -115.69 163.65 15.5 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.107 1.763 . . . . 0.0 110.039 171.771 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 178.91 -166.88 36.81 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 121.269 -0.894 . . . . 0.0 113.852 -179.309 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -69.75 -19.18 36.48 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 123.625 2.883 . . . . 0.0 112.268 175.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.0 t -142.88 158.16 43.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.831 1.653 . . . . 0.0 108.867 161.308 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 23.2 tptp -74.84 120.69 20.72 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 120.832 -1.167 . . . . 0.0 111.96 -175.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -78.2 147.33 34.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.002 0.921 . . . . 0.0 111.53 169.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.01 147.68 23.76 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.057 0.943 . . . . 0.0 110.777 169.567 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 13.6 mt -137.08 145.98 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 124.882 1.273 . . . . 0.0 110.524 -161.466 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 78.5 p -143.79 161.98 37.21 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.1 1.36 . . . . 0.0 111.388 165.246 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.0 p -158.02 158.64 35.24 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.384 1.074 . . . . 0.0 112.738 -175.878 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 56.9 m -147.54 119.47 8.17 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 125.462 1.505 . . . . 0.0 110.097 -174.53 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 35.5 t70 -82.69 129.7 35.0 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.658 1.183 . . . . 0.0 111.303 172.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -108.9 152.74 24.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.827 1.251 . . . . 0.0 112.127 -177.853 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -64.54 -26.31 68.36 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.855 1.262 . . . . 0.0 113.482 -174.21 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -83.13 8.08 14.09 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.241 1.416 . . . . 0.0 114.767 -178.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 97.53 27.73 8.94 Favored Glycine 0 CA--C 1.532 1.116 0 N-CA-C 115.585 0.994 . . . . 0.0 115.585 168.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 23.4 p -139.88 135.14 32.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.324 1.05 . . . . 0.0 111.583 175.717 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 41.3 t -90.64 128.84 36.75 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.427 1.091 . . . . 0.0 109.819 163.535 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.0 t -92.55 149.45 21.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.14 0.976 . . . . 0.0 110.212 169.77 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 61.9 t -132.43 144.09 37.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.761 1.624 . . . . 0.0 109.663 -178.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 19.7 t -138.19 142.38 40.02 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.601 1.561 . . . . 0.0 110.916 172.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 18.5 p90 -148.54 156.46 42.47 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 177.832 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.2 mt -121.31 107.25 37.25 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.828 1.651 . . . . 0.0 110.541 -179.314 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.35 164.27 16.94 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.7 2.933 . . . . 0.0 110.284 166.186 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.6 p -125.63 -21.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -170.854 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.9 pp -146.0 151.48 45.28 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.949 1.3 . . . . 0.0 110.31 175.58 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.48 153.28 39.42 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 122.894 2.396 . . . . 0.0 112.534 -169.634 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 146.67 -165.51 28.38 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 124.8 1.19 . . . . 0.0 113.431 -177.59 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -93.13 124.87 37.41 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.159 1.384 . . . . 0.0 111.853 177.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -114.1 138.32 50.56 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.385 1.474 . . . . 0.0 110.627 178.272 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 68.8 m -102.64 114.7 29.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.908 1.283 . . . . 0.0 110.483 -177.588 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.51 125.46 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 125.196 1.398 . . . . 0.0 108.665 -179.275 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -104.63 132.26 51.09 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.578 1.551 . . . . 0.0 109.545 175.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 45.7 t -133.45 129.28 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.341 1.056 . . . . 0.0 109.565 172.391 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -154.54 144.45 21.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.98 1.312 . . . . 0.0 111.689 -165.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -144.92 122.15 11.52 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.833 1.253 . . . . 0.0 109.618 -179.02 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.3 t-20 54.92 56.62 6.44 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.352 1.461 . . . . 0.0 111.635 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.294 7.7 pt-20 60.62 1.46 0.41 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 129.149 2.98 . . . . 0.0 116.701 -177.522 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -106.46 125.92 51.6 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.532 1.133 . . . . 0.0 111.015 178.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.21 145.16 56.44 Favored 'General case' 0 CA--C 1.546 0.798 0 O-C-N 121.507 -0.745 . . . . 0.0 111.751 169.1 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 6.8 m -75.37 157.69 84.44 Favored Pre-proline 0 N--CA 1.481 1.085 0 CA-C-O 118.367 -0.825 . . . . 0.0 110.774 173.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -53.76 125.22 17.94 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.616 2.878 . . . . 0.0 112.004 177.698 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 89.42 -9.42 77.09 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.716 1.15 . . . . 0.0 115.544 -178.879 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 33.0 t -77.03 139.91 65.97 Favored Pre-proline 0 CA--C 1.549 0.93 0 CA-C-N 119.349 1.575 . . . . 0.0 111.728 176.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.84 141.8 71.86 Favored 'Cis proline' 0 CA--C 1.539 0.773 0 CA-C-N 119.5 0.857 . . . . 0.0 111.953 -4.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -95.15 154.08 17.35 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.417 1.887 . . . . 0.0 110.95 -179.469 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 62.2 m -112.73 114.44 27.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.636 0.774 . . . . 0.0 110.697 178.072 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.5 133.76 42.42 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.568 1.147 . . . . 0.0 111.407 174.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -94.62 105.84 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.678 1.191 . . . . 0.0 109.863 -178.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 95.4 t -91.09 137.68 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.245 1.018 . . . . 0.0 110.819 -177.54 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 68.6 p -115.81 158.95 22.14 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.434 1.494 . . . . 0.0 112.942 178.48 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.53 137.66 19.24 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.896 1.236 . . . . 0.0 111.531 174.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.5 t70 -83.16 -16.86 45.02 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 124.391 1.076 . . . . 0.0 113.373 -179.015 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 126.872 2.069 . . . . 0.0 112.439 -178.076 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.535 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -63.37 -16.14 59.59 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -172.551 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 97.5 mtp -69.72 -17.27 63.45 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.715 1.206 . . . . 0.0 113.511 174.523 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -118.76 153.5 52.41 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.557 1.543 . . . . 0.0 112.329 -179.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.75 172.68 15.83 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.769 2.979 . . . . 0.0 111.477 173.146 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -67.64 156.17 37.48 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.652 0.781 . . . . 0.0 112.663 173.326 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 2.0 tmm_? -56.52 120.65 37.92 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 124.852 1.261 . . . . 0.0 111.484 -178.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.81 151.41 28.01 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.36 2.707 . . . . 0.0 111.433 179.546 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 11.2 mp -86.78 -6.89 58.69 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.441 1.096 . . . . 0.0 113.094 -179.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 59.6 t -112.39 136.88 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 126.666 1.987 . . . . 0.0 109.752 -177.124 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -82.71 170.34 49.94 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.853 1.216 . . . . 0.0 114.503 -177.104 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 91.5 t -85.24 138.74 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 125.185 1.394 . . . . 0.0 110.535 -179.632 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -119.33 143.55 47.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.609 1.564 . . . . 0.0 111.766 176.452 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 162.38 -175.69 38.8 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.117 1.341 . . . . 0.0 113.992 179.097 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 93.6 mt -73.65 151.61 40.74 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.353 1.061 . . . . 0.0 111.661 175.58 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 43.1 t0 -88.65 161.28 16.95 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.63 1.172 . . . . 0.0 111.344 170.597 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 33.8 m -65.07 -19.0 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.5 t -70.15 -17.59 63.19 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.109 1.364 . . . . 0.0 112.926 174.137 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 49.3 m -78.96 9.02 4.67 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.613 1.165 . . . . 0.0 114.101 179.45 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 82.1 mt -72.52 135.81 45.73 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 121.035 -1.041 . . . . 0.0 110.598 166.736 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 -68.88 121.58 81.98 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 125.239 1.415 . . . . 0.0 110.51 -175.339 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.66 151.98 69.73 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.297 2.665 . . . . 0.0 111.723 -171.075 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 6.7 t80 -98.48 124.63 43.32 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.588 0.755 . . . . 0.0 110.306 176.869 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -153.16 133.35 13.44 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.917 1.287 . . . . 0.0 110.913 173.389 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.11 156.37 44.32 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.456 1.902 . . . . 0.0 109.873 -170.783 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -130.98 138.57 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.083 1.353 . . . . 0.0 110.53 -178.451 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 88.6 mt -132.86 136.41 27.67 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 126.243 1.817 . . . . 0.0 109.094 -174.953 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -72.18 114.38 3.97 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 123.168 2.579 . . . . 0.0 110.053 172.528 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 42.2 t80 -178.2 152.56 0.71 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.182 2.193 . . . . 0.0 109.333 -170.215 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 36.8 m -133.49 129.57 37.37 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.455 1.102 . . . . 0.0 110.218 178.719 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 53.0 mt -79.62 109.98 14.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 124.189 0.995 . . . . 0.0 109.056 171.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -94.73 -58.8 2.08 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -176.708 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -158.88 -12.32 0.07 Allowed 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 116.482 2.031 . . . . 0.0 116.482 -167.1 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -89.02 -136.89 5.94 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 126.134 1.826 . . . . 0.0 112.226 176.089 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -154.31 145.64 22.98 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.147 1.379 . . . . 0.0 110.421 -176.053 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 15.8 tt -128.45 137.93 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.414 1.486 . . . . 0.0 111.438 -178.193 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 28.2 p -147.31 164.78 32.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.965 1.706 . . . . 0.0 110.587 -178.283 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -149.65 177.78 27.59 Favored Glycine 0 CA--C 1.526 0.736 0 N-CA-C 115.883 1.113 . . . . 0.0 115.883 -177.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -150.62 137.3 18.96 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.993 1.717 . . . . 0.0 109.614 175.036 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 23.9 t -111.32 137.99 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.332 1.853 . . . . 0.0 108.506 174.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -122.88 133.67 54.41 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.969 1.308 . . . . 0.0 111.551 -173.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.4 mpp? -107.02 149.61 38.79 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.837 1.655 . . . . 0.0 111.971 -173.946 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -54.66 -32.28 74.66 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 124.174 3.249 . . . . 0.0 114.668 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 38.1 m -71.42 -1.27 12.54 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.451 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.65 -1.53 83.84 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 125.545 1.545 . . . . 0.0 113.935 -176.976 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.1 mtpt -74.83 161.61 29.41 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.596 1.558 . . . . 0.0 112.001 177.582 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.9 m -139.21 157.33 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 125.186 1.394 . . . . 0.0 111.831 176.438 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.6 170.42 21.54 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.41 1.884 . . . . 0.0 111.017 179.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -114.13 138.75 23.05 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.026 0.931 . . . . 0.0 111.391 178.591 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -90.62 175.55 2.63 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.497 3.465 . . . . 0.0 112.45 179.028 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 88.9 m -109.33 133.08 53.49 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.47 1.508 . . . . 0.0 109.373 173.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.93 134.47 60.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 125.051 1.34 . . . . 0.0 109.263 175.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 86.0 m -135.69 126.29 27.05 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.627 1.571 . . . . 0.0 109.999 179.243 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.69 129.52 34.55 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.744 0.818 . . . . 0.0 110.558 171.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -83.76 -5.0 59.09 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -173.997 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 4.4 tmtp? 65.37 22.46 11.99 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 126.331 1.853 . . . . 0.0 112.53 -175.878 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.6 t70 -134.77 15.44 3.62 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 126.383 1.873 . . . . 0.0 112.71 -171.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.37 11.11 72.72 Favored Glycine 0 CA--C 1.534 1.271 0 C-N-CA 124.768 1.175 . . . . 0.0 114.451 -179.058 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 71.1 p -130.86 154.06 48.45 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.087 1.755 . . . . 0.0 110.958 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.1 m -113.76 138.21 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.313 1.045 . . . . 0.0 109.697 164.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 43.1 m -99.0 139.47 34.6 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.051 1.341 . . . . 0.0 108.531 170.093 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 36.2 t -126.08 133.73 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 125.288 1.435 . . . . 0.0 108.962 179.71 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 64.8 mtp85 -135.32 154.09 51.64 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.757 1.223 . . . . 0.0 112.823 -172.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 42.2 t80 -155.02 136.33 14.05 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.747 1.619 . . . . 0.0 112.054 177.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.55 117.39 67.77 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.799 1.239 . . . . 0.0 110.817 176.789 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -78.38 146.99 22.46 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.658 2.905 . . . . 0.0 112.704 -174.242 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 68.4 m -122.84 -2.75 8.73 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.68 1.192 . . . . 0.0 113.634 175.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 154.58 19.81 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.225 1.81 . . . . 0.0 111.166 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.62 172.02 12.72 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.519 1.128 . . . . 0.0 112.664 176.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 113.71 -175.92 16.8 Favored Glycine 0 N--CA 1.474 1.193 0 C-N-CA 125.047 1.308 . . . . 0.0 113.996 177.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -84.98 118.19 24.42 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.354 1.062 . . . . 0.0 110.186 -178.656 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 39.4 m80 -114.01 165.1 12.97 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 126.223 1.809 . . . . 0.0 111.779 -174.565 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -143.83 155.96 44.3 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.325 1.05 . . . . 0.0 111.551 173.134 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 29.2 ttm -142.28 124.16 15.23 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.583 1.553 . . . . 0.0 110.203 -171.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -99.93 126.34 46.06 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.745 1.618 . . . . 0.0 109.841 176.253 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 41.0 mm -123.42 136.85 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.262 1.425 . . . . 0.0 110.285 176.395 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.32 139.77 23.53 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -178.422 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.8 t80 -106.18 124.95 50.38 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 127.337 2.255 . . . . 0.0 110.102 177.574 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 53.32 29.0 7.95 Favored 'General case' 0 CA--C 1.555 1.148 0 C-N-CA 124.775 1.23 . . . . 0.0 112.461 -173.09 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 25.2 t30 77.41 4.87 3.13 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 128.573 2.749 . . . . 0.0 115.185 -178.224 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 59.8 ttm -103.32 134.04 47.38 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.346 1.458 . . . . 0.0 111.063 172.313 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 7.3 m170 -57.31 134.34 55.9 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 121.293 -0.879 . . . . 0.0 113.001 -178.549 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 42.0 pt -74.94 155.01 86.84 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 123.324 0.65 . . . . 0.0 111.568 176.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.12 125.86 19.33 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.374 2.049 . . . . 0.0 109.779 172.731 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 101.07 -16.7 56.99 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.618 1.104 . . . . 0.0 114.326 -173.243 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 17.5 t -81.76 146.65 56.82 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 119.043 1.422 . . . . 0.0 111.73 176.783 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -79.76 162.64 84.7 Favored 'Cis proline' 0 C--N 1.351 0.704 0 CA-C-N 120.09 1.068 . . . . 0.0 112.302 -6.174 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 79.4 mt -95.64 155.3 16.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.038 1.335 . . . . 0.0 110.834 172.38 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -156.74 132.96 9.81 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.714 1.205 . . . . 0.0 109.977 -175.268 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.9 p90 -167.39 172.95 9.21 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 124.426 1.09 . . . . 0.0 112.526 -168.162 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 46.3 t80 -108.74 134.04 51.99 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.178 0.991 . . . . 0.0 113.035 176.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.3 t -96.31 133.38 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.394 1.478 . . . . 0.0 109.494 172.938 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 45.5 t0 -143.97 173.89 11.32 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.811 2.045 . . . . 0.0 109.918 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -79.12 151.25 31.47 Favored 'General case' 0 CA--C 1.544 0.726 0 O-C-N 120.724 -1.235 . . . . 0.0 113.459 178.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 69.4 t -66.3 -47.64 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.229 1.411 . . . . 0.0 110.4 174.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -95.52 128.22 42.2 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.467 1.107 . . . . 0.0 110.621 175.047 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 23.6 p -171.77 153.17 3.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.979 1.712 . . . . 0.0 112.192 -175.323 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -103.59 -19.33 12.35 Favored Glycine 0 CA--C 1.534 1.253 0 C-N-CA 125.114 1.34 . . . . 0.0 113.772 173.471 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 11.1 p-80 -71.61 155.98 39.91 Favored 'General case' 0 CA--C 1.55 0.945 0 CA-C-N 118.337 1.068 . . . . 0.0 113.379 177.782 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.3 t -68.39 137.58 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 124.095 0.958 . . . . 0.0 108.567 172.653 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 8.6 t -156.0 168.15 28.17 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.72 1.208 . . . . 0.0 110.972 -176.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -147.22 147.36 30.37 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.823 1.249 . . . . 0.0 112.155 -177.603 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.7 p90 -167.21 164.41 15.53 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.052 1.741 . . . . 0.0 112.391 -175.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.39 173.72 13.44 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 125.201 1.381 . . . . 0.0 113.315 -179.203 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.37 -32.69 15.59 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.935 2.424 . . . . 0.0 113.194 -170.624 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.01 -34.43 76.52 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 119.402 1.001 . . . . 0.0 114.333 -172.593 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.0 pp -78.09 -3.38 42.03 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 118.965 1.383 . . . . 0.0 113.374 174.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.2 m -107.01 -39.91 5.61 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 126.595 1.958 . . . . 0.0 111.891 178.314 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -149.94 150.51 31.96 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.501 1.92 . . . . 0.0 112.495 -169.817 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.64 177.07 28.92 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.015 0.817 . . . . 0.0 113.472 169.742 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 35.3 t -139.98 134.37 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.941 1.296 . . . . 0.0 107.901 174.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 32.2 m -56.31 134.64 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 122.901 0.48 . . . . 0.0 112.253 -177.821 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 50.9 m-80 69.48 -5.51 1.14 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 127.142 2.177 . . . . 0.0 114.616 -179.933 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -97.87 138.45 21.0 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 124.865 1.266 . . . . 0.0 110.646 175.205 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -72.99 126.17 11.01 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.475 2.117 . . . . 0.0 110.289 179.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -108.58 144.11 36.72 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.463 1.505 . . . . 0.0 110.371 175.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 60.3 p -135.38 149.16 49.6 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -166.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.0 p90 -160.26 175.51 12.78 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.443 1.497 . . . . 0.0 111.682 177.234 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 30.5 m -129.68 139.48 51.37 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.04 1.336 . . . . 0.0 110.805 -169.024 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -110.44 133.94 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 126.024 1.73 . . . . 0.0 107.877 168.137 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -91.88 126.99 37.17 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.137 0.975 . . . . 0.0 111.02 178.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 78.6 p -127.09 3.13 6.48 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.065 1.746 . . . . 0.0 113.072 -172.777 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 59.6 pttt -52.99 -27.33 18.65 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 127.473 2.309 . . . . 0.0 116.382 -171.781 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.8 t70 -130.56 15.2 5.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.471 1.508 . . . . 0.0 112.191 176.483 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -79.23 -25.03 42.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.633 1.173 . . . . 0.0 113.494 -178.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.09 -107.0 2.38 Favored Glycine 0 CA--C 1.53 0.981 0 C-N-CA 124.638 1.113 . . . . 0.0 112.101 178.649 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -158.94 152.99 23.54 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.234 1.813 . . . . 0.0 110.066 -174.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.55 8.26 0.11 Allowed Glycine 0 CA--C 1.535 1.291 0 N-CA-C 116.542 1.377 . . . . 0.0 116.542 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 90.87 106.45 1.36 Allowed Glycine 0 N--CA 1.471 1.031 0 C-N-CA 125.463 1.506 . . . . 0.0 112.885 177.133 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 139.19 30.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.066 1.347 . . . . 0.0 109.762 170.396 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 20.0 m -130.77 159.35 37.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.569 1.548 . . . . 0.0 111.826 178.108 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 52.3 tp -159.9 135.25 8.19 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.531 1.532 . . . . 0.0 109.409 -167.418 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.01 158.57 35.11 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.189 0.996 . . . . 0.0 112.194 178.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -138.24 136.04 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.758 1.223 . . . . 0.0 109.827 177.159 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -129.23 130.13 45.88 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 125.215 1.406 . . . . 0.0 110.21 176.075 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -155.84 -162.49 11.41 Favored Glycine 0 CA--C 1.538 1.5 0 CA-C-O 118.92 -0.934 . . . . 0.0 114.094 -176.259 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -62.33 -25.71 76.62 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.932 3.088 . . . . 0.0 112.388 174.324 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 21.1 t -137.2 153.8 50.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.139 1.376 . . . . 0.0 109.112 161.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -74.07 119.54 18.42 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.876 -1.14 . . . . 0.0 110.837 177.006 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.33 151.7 44.96 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.002 0.921 . . . . 0.0 112.332 178.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -85.11 137.76 32.83 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 164.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 33.3 mt -132.99 138.9 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.479 1.112 . . . . 0.0 110.501 -169.307 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 74.1 m -132.03 157.53 43.89 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.848 1.659 . . . . 0.0 110.635 167.662 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.0 p -153.41 155.76 36.96 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.059 0.944 . . . . 0.0 112.766 177.617 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.6 m -143.54 119.22 10.45 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.33 1.452 . . . . 0.0 110.382 -170.902 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.11 134.47 38.72 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.633 1.173 . . . . 0.0 111.396 173.251 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.6 m-20 -114.3 148.44 37.51 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.626 1.571 . . . . 0.0 111.913 -177.959 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -71.51 -12.81 61.57 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 123.838 0.855 . . . . 0.0 112.718 174.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -74.35 -5.77 44.19 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.791 1.637 . . . . 0.0 114.031 177.115 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.07 32.83 7.63 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.646 1.117 . . . . 0.0 113.723 -179.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 70.7 p -139.84 160.17 40.51 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.968 1.307 . . . . 0.0 111.363 176.797 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 46.5 t -114.66 127.22 55.65 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.246 1.419 . . . . 0.0 108.434 160.187 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 18.7 t -92.52 147.93 22.5 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.144 0.977 . . . . 0.0 110.759 174.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 88.6 t -124.83 142.11 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.883 1.673 . . . . 0.0 109.927 -178.176 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.4 m -131.06 140.43 50.05 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 125.523 1.529 . . . . 0.0 110.424 167.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 14.4 p90 -146.85 154.11 40.94 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.23 1.196 . . . . 0.0 114.23 174.718 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.0 mt -119.17 106.74 42.64 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 126.085 1.754 . . . . 0.0 110.514 -179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.31 176.41 7.36 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 123.926 3.084 . . . . 0.0 110.523 167.413 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.7 p -149.83 -27.74 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -173.572 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 91.6 mt -108.77 147.29 35.5 Favored Pre-proline 0 N--CA 1.475 0.802 0 C-N-CA 124.422 1.089 . . . . 0.0 110.434 166.693 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.21 156.07 46.66 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.897 2.398 . . . . 0.0 110.925 175.069 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 132.62 -161.19 23.98 Favored Glycine 0 N--CA 1.471 1.007 0 C-N-CA 124.77 1.176 . . . . 0.0 113.647 -178.841 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -91.24 131.96 36.43 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.154 1.382 . . . . 0.0 112.682 -178.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -123.57 122.41 38.11 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.602 1.561 . . . . 0.0 109.786 177.631 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 49.6 m -84.23 127.22 33.82 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 121.192 -0.942 . . . . 0.0 110.832 175.99 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -104.38 124.88 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 125.953 1.701 . . . . 0.0 108.33 178.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -105.01 130.68 53.16 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 125.401 1.48 . . . . 0.0 109.699 174.926 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.4 t -131.7 128.36 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.409 1.084 . . . . 0.0 109.779 172.284 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -147.9 147.08 29.35 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.233 1.413 . . . . 0.0 111.615 -170.358 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.47 121.93 11.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.94 1.296 . . . . 0.0 109.461 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 11.0 t-20 54.08 56.79 6.6 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.425 1.49 . . . . 0.0 112.123 179.281 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.299 8.4 pt-20 59.38 4.13 0.46 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 128.965 2.906 . . . . 0.0 116.711 -176.478 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 23.2 mm100 -109.67 126.12 53.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.659 1.184 . . . . 0.0 111.022 178.543 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -65.02 146.9 54.41 Favored 'General case' 0 CA--C 1.546 0.82 0 O-C-N 121.234 -0.916 . . . . 0.0 111.787 169.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 19.2 m -72.09 153.47 92.61 Favored Pre-proline 0 N--CA 1.482 1.152 0 CA-C-O 118.595 -0.717 . . . . 0.0 110.378 170.75 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -57.99 130.42 38.12 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.116 2.544 . . . . 0.0 110.65 175.223 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 90.71 -15.75 59.74 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 124.95 1.262 . . . . 0.0 114.929 -175.516 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.0 t -77.87 139.95 62.34 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.457 1.628 . . . . 0.0 111.457 175.629 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.45 135.92 42.57 Favored 'Cis proline' 0 C--N 1.353 0.789 0 CA-C-N 119.373 0.812 . . . . 0.0 111.977 -3.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -85.44 172.92 10.64 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.825 1.65 . . . . 0.0 110.186 172.808 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 84.9 m -137.21 121.61 18.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 174.092 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -95.25 147.46 23.45 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.985 1.714 . . . . 0.0 111.571 173.616 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -101.47 113.0 25.7 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.343 1.057 . . . . 0.0 109.759 173.831 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 91.0 t -95.37 142.56 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.976 1.31 . . . . 0.0 110.115 177.29 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 3.4 t -128.3 170.61 12.86 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.305 1.042 . . . . 0.0 113.167 178.732 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -82.45 137.83 17.47 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.788 1.661 . . . . 0.0 113.091 -174.628 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 35.4 t70 -90.06 -22.57 21.77 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 125.067 1.347 . . . . 0.0 112.803 174.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 C--O 1.255 1.347 0 C-N-CA 127.002 2.121 . . . . 0.0 112.425 -174.381 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.542 -0.623 . . . . 0.0 111.542 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.94 156.28 39.01 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.271 1.029 . . . . 0.0 112.813 178.843 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 54.1 ttm -73.71 -22.83 59.78 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.559 1.143 . . . . 0.0 113.161 179.316 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -149.03 154.64 39.79 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.998 1.719 . . . . 0.0 111.312 -178.444 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.34 160.1 47.79 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.577 2.851 . . . . 0.0 112.035 179.467 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -78.06 151.68 33.34 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.224 1.009 . . . . 0.0 112.39 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -65.27 148.52 97.89 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 124.437 1.095 . . . . 0.0 111.974 176.161 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.69 163.96 37.16 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.411 2.741 . . . . 0.0 110.903 170.569 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 3.0 mm? -79.39 37.94 0.35 Allowed 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.347 1.459 . . . . 0.0 112.722 -173.806 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 12.0 p -168.78 143.11 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.69 2.396 . . . . 0.0 109.598 -174.744 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 72.64 20.11 79.45 Favored Glycine 0 N--CA 1.475 1.279 0 C-N-CA 123.597 0.617 . . . . 0.0 114.461 177.354 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 99.4 t -67.23 125.59 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.422 1.489 . . . . 0.0 110.437 -175.123 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -76.24 -18.93 58.79 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -174.892 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 86.98 -158.85 30.84 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.284 1.421 . . . . 0.0 112.901 -177.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.07 165.82 22.97 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.582 1.153 . . . . 0.0 112.061 179.006 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.33 -9.61 58.77 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.361 1.464 . . . . 0.0 114.845 -174.002 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.3 p -77.8 53.5 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 126.567 1.947 . . . . 0.0 112.408 -177.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.3 t -152.39 10.48 0.51 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.929 1.691 . . . . 0.0 113.353 -177.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 50.6 p -78.24 169.82 17.63 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.588 1.555 . . . . 0.0 114.407 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 74.9 mt -81.13 159.05 24.78 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.112 1.365 . . . . 0.0 111.036 165.399 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . 0.421 HH12 ' HA ' ' A' 1863 ' ' VAL . 8.7 tpp180 -55.03 118.85 18.97 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 125.251 1.42 . . . . 0.0 111.615 -174.316 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.19 126.64 13.94 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.443 2.095 . . . . 0.0 108.756 177.425 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 64.7 t80 -116.24 125.07 51.72 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.7 0.762 . . . . 0.0 111.833 -171.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -157.62 142.34 16.56 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.017 1.727 . . . . 0.0 110.524 174.124 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -136.39 148.36 47.78 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.867 1.667 . . . . 0.0 110.418 -173.209 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.1 p -112.54 137.59 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.105 1.362 . . . . 0.0 109.923 173.034 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 55.0 mt -134.68 135.58 23.77 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 125.93 1.692 . . . . 0.0 108.798 -173.348 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.77 113.84 3.88 Favored 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 123.273 2.649 . . . . 0.0 109.979 175.964 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 36.4 t80 -172.72 146.07 1.59 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.485 1.914 . . . . 0.0 109.689 -172.766 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.7 m -118.71 122.31 42.19 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.496 1.119 . . . . 0.0 109.269 176.19 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.77 116.42 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.73 0.812 . . . . 0.0 109.372 175.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.3 mttt -96.56 -143.23 0.28 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.37 1.468 . . . . 0.0 111.607 178.174 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -78.07 -9.79 59.31 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -172.59 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -83.82 -142.56 5.17 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 126.335 1.921 . . . . 0.0 113.086 177.178 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -155.94 150.05 25.47 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.015 1.326 . . . . 0.0 111.229 -172.484 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.0 tt -130.14 136.88 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 C-N-CA 125.791 1.636 . . . . 0.0 111.389 -177.294 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 71.7 p -146.07 -178.08 5.94 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 126.207 1.803 . . . . 0.0 110.138 -179.303 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.0 -165.07 31.81 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 115.878 1.111 . . . . 0.0 115.878 -179.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -147.87 149.29 31.99 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.773 2.029 . . . . 0.0 109.934 -179.881 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 62.0 t -122.23 132.25 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.689 1.595 . . . . 0.0 107.92 167.659 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 74.8 mtm-85 -115.38 130.97 57.06 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.808 1.243 . . . . 0.0 111.133 -174.505 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.0 mpp? -102.84 149.9 37.24 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 125.717 1.607 . . . . 0.0 111.882 -173.162 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -55.65 -32.95 85.65 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 124.349 3.366 . . . . 0.0 115.315 176.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.0 t -77.59 -1.68 31.99 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 -178.048 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 92.2 -1.06 72.89 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.386 1.469 . . . . 0.0 114.079 -177.684 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 40.5 mtpt -66.03 155.95 35.16 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.102 1.361 . . . . 0.0 111.763 171.152 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 27.7 m -139.7 152.15 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.019 1.328 . . . . 0.0 111.334 175.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.97 175.02 14.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.556 1.942 . . . . 0.0 110.222 179.684 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -120.03 141.02 30.74 Favored Pre-proline 0 CA--C 1.545 0.763 0 O-C-N 121.482 -0.761 . . . . 0.0 111.358 178.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -83.94 165.65 13.33 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.957 3.105 . . . . 0.0 111.341 177.236 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 94.7 m -104.82 125.5 50.93 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.009 1.324 . . . . 0.0 108.679 172.098 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.4 mp -105.0 135.12 44.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.426 1.09 . . . . 0.0 109.236 175.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 83.9 m -128.25 132.1 48.75 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.049 1.74 . . . . 0.0 109.935 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 18.0 t0 -74.94 124.75 27.5 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.241 1.016 . . . . 0.0 111.019 171.596 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -85.9 -14.74 43.93 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.088 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 62.8 tttt 72.71 -2.88 2.53 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 127.668 2.387 . . . . 0.0 113.967 178.267 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.6 t70 -96.98 5.34 50.63 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 127.005 2.122 . . . . 0.0 113.29 -178.138 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.12 12.78 54.52 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 125.144 1.354 . . . . 0.0 113.962 -174.19 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 82.6 p -127.46 159.32 34.88 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.173 1.789 . . . . 0.0 110.477 173.764 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.9 m -118.79 146.13 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.59 1.156 . . . . 0.0 109.623 166.275 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 27.0 m -105.04 137.06 43.37 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.111 0.965 . . . . 0.0 108.736 170.597 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.5 t -119.56 133.83 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 125.148 1.379 . . . . 0.0 109.167 178.619 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -130.76 150.76 51.78 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 125.628 1.571 . . . . 0.0 111.841 -173.465 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 8.6 t80 -155.62 132.59 10.68 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.429 1.491 . . . . 0.0 111.384 178.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.36 120.7 74.75 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.246 1.019 . . . . 0.0 110.498 176.821 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -73.9 139.36 27.28 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.301 2.667 . . . . 0.0 112.138 -172.04 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 91.1 p -138.82 10.58 2.64 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.338 1.055 . . . . 0.0 113.815 -179.254 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -161.83 154.26 19.82 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 126.226 1.81 . . . . 0.0 110.012 -178.269 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -101.27 160.18 14.63 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.612 1.165 . . . . 0.0 112.257 174.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.24 -163.39 12.25 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 125.555 1.55 . . . . 0.0 113.991 179.33 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.7 tt -92.86 113.46 25.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 125.052 1.341 . . . . 0.0 110.471 -176.955 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 40.2 m80 -105.59 173.72 6.19 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.233 2.213 . . . . 0.0 111.933 -174.441 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -142.3 146.83 35.48 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.644 0.778 . . . . 0.0 112.071 171.364 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 9.2 ttm -116.7 134.97 54.17 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.051 2.14 . . . . 0.0 109.457 -179.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 11.0 t70 -126.62 119.7 27.7 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 126.712 2.005 . . . . 0.0 109.136 -174.273 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.2 mm -131.45 136.77 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.051 0.941 . . . . 0.0 111.393 -171.39 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.13 134.86 21.12 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -175.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 27.3 t80 -101.49 125.1 48.09 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.743 2.017 . . . . 0.0 110.185 176.366 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 25.2 t0 50.8 36.38 14.36 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 124.858 1.263 . . . . 0.0 112.641 -176.229 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 45.0 m-80 83.02 -8.54 1.14 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 129.358 3.063 . . . . 0.0 114.658 -179.489 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 62.3 mtt -100.95 134.71 43.53 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.22 1.408 . . . . 0.0 111.999 -178.469 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -54.0 135.85 42.28 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -179.189 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 29.5 pt -76.89 155.23 83.01 Favored Pre-proline 0 N--CA 1.48 1.052 0 CA-C-O 118.853 -0.594 . . . . 0.0 111.272 173.109 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -60.09 131.96 41.93 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.153 1.902 . . . . 0.0 109.945 172.146 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 92.13 -9.17 76.94 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.432 -174.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 32.1 t -84.03 144.29 44.24 Favored Pre-proline 0 CA--C 1.549 0.921 0 CA-C-N 120.042 1.921 . . . . 0.0 111.422 170.721 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -79.38 164.1 83.25 Favored 'Cis proline' 0 C--N 1.352 0.746 0 CA-C-N 119.816 0.97 . . . . 0.0 112.244 -7.439 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.6 mt -113.3 156.95 22.44 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.965 1.706 . . . . 0.0 110.697 174.512 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -130.59 143.46 50.77 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.711 1.204 . . . . 0.0 110.404 178.4 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 37.8 p90 -159.12 150.17 20.03 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.952 0.901 . . . . 0.0 112.489 -170.315 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.9 t80 -100.55 143.74 30.37 Favored 'General case' 0 CA--C 1.544 0.723 0 O-C-N 121.294 -0.879 . . . . 0.0 112.599 178.458 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 38.4 t -126.16 137.5 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 125.355 1.462 . . . . 0.0 109.438 178.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 22.4 t0 -161.48 158.54 26.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.81 -167.697 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -75.48 146.35 40.69 Favored 'General case' 0 CA--C 1.543 0.674 0 O-C-N 120.855 -1.153 . . . . 0.0 113.357 -173.443 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . 0.421 ' HA ' HH12 ' A' 1789 ' ' ARG . 18.0 m -70.6 -18.75 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 O-C-N 120.988 -1.07 . . . . 0.0 112.796 171.585 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 31.9 p30 -90.83 4.75 50.89 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 125.353 1.461 . . . . 0.0 114.244 178.97 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 24.1 p -62.66 151.41 38.27 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 -166.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -107.91 40.73 2.42 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 126.382 1.944 . . . . 0.0 113.166 -177.424 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -153.89 167.33 30.06 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.24 1.416 . . . . 0.0 113.081 -176.21 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 6.2 t -73.05 134.76 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.113 0.965 . . . . 0.0 108.801 171.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 7.4 t -148.93 165.64 30.97 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.825 1.25 . . . . 0.0 110.905 -175.183 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.2 147.44 27.71 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.727 1.211 . . . . 0.0 111.861 -177.487 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 48.1 p90 -168.63 163.46 12.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.754 1.622 . . . . 0.0 112.597 -173.367 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 137.04 174.33 13.27 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.278 1.418 . . . . 0.0 113.032 -178.42 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.51 -35.12 8.5 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.908 2.405 . . . . 0.0 112.799 -172.308 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.73 -31.04 72.77 Favored Glycine 0 CA--C 1.53 0.971 0 CA-C-N 119.368 0.986 . . . . 0.0 114.537 -171.152 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.7 pp -79.52 -3.99 49.3 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 118.814 1.307 . . . . 0.0 113.351 174.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 63.3 m -104.85 -51.74 3.0 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.47 1.908 . . . . 0.0 110.69 176.997 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.1 t-80 -141.56 145.12 34.71 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.093 1.757 . . . . 0.0 112.553 -176.864 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -140.4 178.38 19.99 Favored Glycine 0 N--CA 1.474 1.174 0 C-N-CA 124.767 1.175 . . . . 0.0 113.217 172.632 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 15.3 t -139.66 135.97 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.309 1.043 . . . . 0.0 108.884 175.941 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -55.57 139.75 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -178.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 65.3 m-80 67.96 -1.17 1.81 Allowed 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.943 2.097 . . . . 0.0 115.039 175.724 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -116.39 141.99 28.77 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 125.226 1.41 . . . . 0.0 111.166 177.32 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.0 134.05 20.81 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.52 2.147 . . . . 0.0 111.126 -174.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -112.82 147.18 37.47 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.707 1.603 . . . . 0.0 110.306 173.653 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.3 p -136.52 152.28 50.34 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.114 0.966 . . . . 0.0 113.604 -167.188 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.9 p90 -161.86 176.56 10.71 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.097 1.759 . . . . 0.0 111.485 176.623 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 32.2 m -130.79 140.82 50.32 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.03 1.332 . . . . 0.0 110.862 -170.742 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 39.1 t -109.96 132.51 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.723 1.609 . . . . 0.0 107.92 168.705 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -94.93 123.33 38.34 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.131 0.973 . . . . 0.0 110.634 179.516 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 71.5 p -126.63 1.58 6.82 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.445 1.498 . . . . 0.0 113.735 -168.236 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 88.5 tttt -52.91 -38.12 61.49 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.919 1.687 . . . . 0.0 113.777 -177.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -99.86 -1.22 37.99 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.643 1.577 . . . . 0.0 113.472 -179.272 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -77.55 -22.57 50.83 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 114.563 1.32 . . . . 0.0 114.563 -171.417 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.44 -105.53 2.39 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.218 0.913 . . . . 0.0 111.624 -177.057 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -158.37 148.91 20.27 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.557 1.543 . . . . 0.0 110.825 -175.691 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 159.8 -160.59 31.64 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.469 1.509 . . . . 0.0 112.667 -179.276 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -87.73 103.26 2.89 Favored Glycine 0 N--CA 1.469 0.858 0 C-N-CA 124.063 0.84 . . . . 0.0 111.614 176.416 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -81.65 129.6 34.76 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.996 1.318 . . . . 0.0 108.935 170.442 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 26.9 m -133.55 158.84 42.13 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.266 1.426 . . . . 0.0 112.399 -175.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.8 tp -161.08 136.19 7.61 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.97 1.708 . . . . 0.0 109.123 -168.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.13 158.49 36.43 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.065 0.946 . . . . 0.0 112.299 177.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 48.8 mt -138.3 137.36 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.989 1.316 . . . . 0.0 109.675 176.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -127.37 143.06 51.28 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.42 1.488 . . . . 0.0 109.907 174.188 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -173.13 -162.13 24.65 Favored Glycine 0 CA--C 1.54 1.619 0 CA-C-O 119.01 -0.883 . . . . 0.0 114.895 -175.28 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.38 -22.81 59.35 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 124.223 3.282 . . . . 0.0 113.161 179.723 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.4 t -144.36 164.45 30.77 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.008 1.323 . . . . 0.0 109.829 165.647 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -68.7 107.63 3.07 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.225 -0.922 . . . . 0.0 110.845 178.053 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -68.48 143.83 54.86 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.478 0.711 . . . . 0.0 110.414 169.305 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -102.7 133.84 47.07 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.479 0.711 . . . . 0.0 109.717 176.605 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -128.15 144.86 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.709 1.204 . . . . 0.0 110.477 -159.137 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -141.57 164.07 31.2 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.773 1.229 . . . . 0.0 111.093 166.144 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.8 p -160.13 156.85 27.43 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.951 1.3 . . . . 0.0 112.206 -178.59 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 62.1 m -145.49 125.07 13.21 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 109.935 -172.465 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -77.15 134.72 38.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.09 0.956 . . . . 0.0 111.489 170.711 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -108.54 154.62 21.67 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.298 1.439 . . . . 0.0 112.342 -174.066 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -67.72 -22.02 65.27 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.568 1.147 . . . . 0.0 112.441 175.858 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.8 t70 -78.6 -4.83 50.8 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.716 1.606 . . . . 0.0 114.734 -176.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.98 35.46 6.74 Favored Glycine 0 N--CA 1.476 1.303 0 C-N-CA 124.23 0.919 . . . . 0.0 113.77 -179.414 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 72.9 p -139.46 165.38 27.38 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.746 1.618 . . . . 0.0 110.539 176.027 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 84.7 m -116.01 130.4 56.8 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.904 1.282 . . . . 0.0 109.14 161.529 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.7 t -89.53 149.57 22.83 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 123.968 0.907 . . . . 0.0 110.52 170.956 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 96.1 t -129.66 143.35 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 125.883 1.673 . . . . 0.0 109.842 -178.894 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.2 p -136.39 147.81 47.51 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.013 1.325 . . . . 0.0 111.84 167.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.5 p90 -151.92 152.79 33.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 175.668 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 14.2 mt -113.54 110.09 50.32 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 126.257 1.823 . . . . 0.0 110.427 176.401 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -83.1 175.86 8.05 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.918 3.079 . . . . 0.0 110.257 164.162 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.7 p -150.04 -31.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 -173.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.5 mt -106.94 147.19 34.61 Favored Pre-proline 0 CA--C 1.544 0.725 0 CA-C-N 119.481 1.037 . . . . 0.0 110.728 167.678 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -74.25 159.67 43.48 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.992 2.462 . . . . 0.0 111.088 175.475 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 127.77 -168.17 19.85 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.173 1.368 . . . . 0.0 112.822 -174.515 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -91.65 142.89 27.12 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.387 1.075 . . . . 0.0 113.101 178.167 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -127.13 135.14 50.3 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 126.007 1.723 . . . . 0.0 110.26 178.148 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.9 m -91.41 126.84 36.63 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.087 -1.008 . . . . 0.0 110.543 174.35 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -106.18 128.34 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 125.74 1.616 . . . . 0.0 108.229 178.757 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -111.8 131.82 55.08 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.383 1.473 . . . . 0.0 109.856 177.128 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 57.8 t -133.44 127.31 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 124.663 1.185 . . . . 0.0 109.893 174.192 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.15 144.32 26.53 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 125.148 1.379 . . . . 0.0 111.889 -169.518 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.62 121.21 11.79 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.916 1.286 . . . . 0.0 110.011 -179.226 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 56.38 55.96 6.14 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.33 1.452 . . . . 0.0 111.814 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 8.7 pt-20 56.9 14.65 1.95 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 128.333 2.653 . . . . 0.0 116.234 -177.84 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -123.81 129.03 50.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.661 1.184 . . . . 0.0 110.746 177.414 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -66.68 151.01 48.23 Favored 'General case' 0 CA--C 1.548 0.873 0 O-C-N 121.326 -0.859 . . . . 0.0 112.111 173.235 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 25.9 m -65.85 150.5 96.35 Favored Pre-proline 0 N--CA 1.483 1.197 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.271 162.425 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.0 -16.69 45.55 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.269 1.98 . . . . 0.0 114.654 -164.213 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.77 -7.45 61.44 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 124.137 0.875 . . . . 0.0 115.253 172.525 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 43.4 t -84.69 143.07 40.26 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-N 118.88 1.34 . . . . 0.0 112.104 -177.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.27 139.85 63.96 Favored 'Cis proline' 0 C--N 1.351 0.695 0 CA-C-N 119.2 0.75 . . . . 0.0 111.961 -4.016 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -91.38 165.2 13.54 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.992 1.717 . . . . 0.0 110.401 174.186 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.5 m -125.35 117.09 22.99 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.791 0.836 . . . . 0.0 110.223 174.639 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.57 158.7 15.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.735 1.214 . . . . 0.0 110.774 168.195 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 40.4 ttt85 -123.98 132.03 53.65 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.775 0.83 . . . . 0.0 110.483 169.363 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 80.6 t -113.35 131.28 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 125.437 1.495 . . . . 0.0 110.45 -171.875 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 32.1 p -106.45 167.41 9.86 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.098 1.359 . . . . 0.0 112.688 179.889 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -79.69 143.2 25.39 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.103 1.335 . . . . 0.0 112.058 174.247 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.8 t70 -80.81 -14.17 58.3 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 124.156 0.982 . . . . 0.0 113.177 176.442 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 25.6 m-20 . . . . . 0 C--O 1.255 1.353 0 C-N-CA 126.846 2.059 . . . . 0.0 112.269 176.832 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 111.88 -0.488 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.0 160.58 31.86 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.407 1.083 . . . . 0.0 113.025 178.566 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -68.14 154.14 42.3 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.192 1.397 . . . . 0.0 112.228 178.851 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -152.77 153.78 30.55 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 125.375 1.47 . . . . 0.0 111.855 -179.29 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.52 -4.91 13.89 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.94 3.093 . . . . 0.0 113.889 -179.715 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -151.66 150.08 29.85 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.264 1.426 . . . . 0.0 111.654 -177.115 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 36.0 ttt-85 -96.73 138.17 21.4 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.836 1.254 . . . . 0.0 111.133 -179.119 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -70.89 161.12 47.19 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.148 2.565 . . . . 0.0 111.709 170.618 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 68.5 tp -149.57 118.2 6.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.124 1.37 . . . . 0.0 110.226 -177.624 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 59.2 t -145.06 126.64 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.672 1.589 . . . . 0.0 108.895 176.756 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 76.71 -62.3 3.2 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.439 1.495 . . . . 0.0 113.623 175.799 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 23.3 m -144.37 157.5 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 127.104 2.162 . . . . 0.0 110.57 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 6.3 p-10 -70.58 154.02 42.29 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.874 0.87 . . . . 0.0 113.017 175.621 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -126.13 170.98 17.93 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.389 1.471 . . . . 0.0 113.442 177.142 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 75.0 mt -98.44 -159.97 0.77 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.464 1.506 . . . . 0.0 111.616 -178.449 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 2.5 t0 -153.87 -178.24 6.93 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.035 1.734 . . . . 0.0 111.097 -177.107 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 6.3 p -62.0 -11.89 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.559 1.944 . . . . 0.0 114.685 -173.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 6.4 t -67.96 -12.2 60.27 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 126.622 1.969 . . . . 0.0 114.576 -179.38 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 5.2 t -71.59 -166.58 0.2 Allowed 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 115.44 1.644 . . . . 0.0 115.44 -171.511 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 51.5 mt -67.75 147.96 51.91 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.977 1.311 . . . . 0.0 111.711 170.72 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 41.9 ttm180 -56.95 118.15 21.96 Favored Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 126.445 1.898 . . . . 0.0 111.007 175.063 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -70.35 146.2 55.9 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.611 2.207 . . . . 0.0 109.46 172.596 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -131.14 133.24 45.4 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.74 0.781 . . . . 0.0 111.68 -175.333 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -163.51 146.98 10.33 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.593 1.957 . . . . 0.0 110.875 178.313 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.56 154.04 50.81 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 126.18 1.792 . . . . 0.0 110.546 -175.648 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.6 p -114.58 138.45 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.215 1.406 . . . . 0.0 109.624 170.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 46.5 mt -131.45 135.31 26.78 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.166 1.787 . . . . 0.0 108.395 -172.809 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.89 36.48 0.62 Allowed 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.453 3.435 . . . . 0.0 112.909 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.17 152.11 27.9 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.846 1.258 . . . . 0.0 111.456 177.478 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 86.9 m -116.49 121.28 41.37 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.229 1.412 . . . . 0.0 109.925 -179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 78.8 mt -87.91 134.13 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.871 1.268 . . . . 0.0 110.013 175.84 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -117.91 -141.89 0.36 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.496 1.519 . . . . 0.0 110.542 174.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -81.75 127.18 32.67 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 120.707 -1.245 . . . . 0.0 110.904 171.412 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 137.11 -147.99 19.53 Favored Glycine 0 N--CA 1.473 1.122 0 C-N-CA 125.402 1.477 . . . . 0.0 111.723 -171.188 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -158.44 146.27 18.22 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.67 1.188 . . . . 0.0 111.242 -175.85 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.1 tt -121.48 135.89 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 125.714 1.606 . . . . 0.0 111.217 178.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 47.0 p -146.85 177.69 8.92 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 126.399 1.88 . . . . 0.0 110.28 -177.827 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -163.18 -167.31 23.42 Favored Glycine 0 N--CA 1.468 0.8 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 -178.778 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -153.97 144.24 22.17 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.521 1.929 . . . . 0.0 109.549 175.689 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 96.2 t -121.72 134.98 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 125.897 1.679 . . . . 0.0 108.572 173.597 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -112.98 135.1 54.13 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.596 1.158 . . . . 0.0 111.832 -175.269 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.7 mpp? -108.04 142.89 26.25 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 125.707 1.603 . . . . 0.0 111.748 -175.736 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -55.46 -27.25 58.0 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 124.48 3.454 . . . . 0.0 115.819 174.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 5.3 t -71.93 -4.09 26.35 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.071 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 89.38 48.93 3.6 Favored Glycine 0 N--CA 1.471 1.02 0 C-N-CA 124.755 1.169 . . . . 0.0 112.383 177.8 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -153.31 163.67 39.49 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.084 1.754 . . . . 0.0 111.711 -172.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 35.4 m -140.37 157.84 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.87 1.268 . . . . 0.0 112.384 -173.425 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.07 176.47 12.19 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 127.265 2.226 . . . . 0.0 109.888 178.005 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -119.15 143.35 33.91 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 121.216 -0.928 . . . . 0.0 112.186 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -82.73 166.26 15.34 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.118 3.212 . . . . 0.0 111.388 174.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 98.8 m -110.58 122.52 47.96 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.05 1.34 . . . . 0.0 108.911 173.794 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.8 mp -101.54 133.41 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.733 1.213 . . . . 0.0 109.351 177.422 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 52.4 m -120.93 130.24 53.79 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.557 1.943 . . . . 0.0 109.512 176.813 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 61.2 t0 -79.75 117.21 20.43 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.108 0.963 . . . . 0.0 110.15 170.583 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -81.52 -12.56 58.78 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 -178.601 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 69.07 3.19 3.94 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 127.211 2.204 . . . . 0.0 114.21 179.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.78 9.2 35.01 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.823 2.049 . . . . 0.0 113.025 -175.563 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.08 11.97 60.74 Favored Glycine 0 CA--C 1.536 1.401 0 C-N-CA 124.931 1.253 . . . . 0.0 113.816 -173.295 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 56.3 p -131.73 164.69 25.42 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 126.462 1.905 . . . . 0.0 110.541 177.371 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.3 m -128.38 146.38 33.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.152 1.381 . . . . 0.0 109.821 168.224 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 32.6 m -105.84 139.37 40.51 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.315 1.046 . . . . 0.0 108.926 173.159 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.7 t -123.44 130.96 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.864 1.266 . . . . 0.0 109.249 179.135 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.2 mtt85 -128.08 157.49 40.57 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.329 1.451 . . . . 0.0 112.042 -176.08 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 1.5 t80 -155.15 138.2 15.54 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.498 1.519 . . . . 0.0 111.521 179.777 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.33 119.74 70.97 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.415 1.086 . . . . 0.0 110.762 177.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.6 135.08 14.27 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.172 2.581 . . . . 0.0 111.777 -173.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 80.9 p -127.09 -12.28 5.81 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 176.371 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -141.52 158.8 43.39 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.062 1.745 . . . . 0.0 110.46 -178.615 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -97.1 166.79 11.42 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.639 1.175 . . . . 0.0 112.059 169.593 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 111.97 -168.0 12.6 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 125.727 1.632 . . . . 0.0 113.992 179.489 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.9 tp -86.83 122.27 30.48 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.04 1.336 . . . . 0.0 110.299 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.0 m80 -117.78 168.86 10.08 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.07 1.748 . . . . 0.0 111.292 -174.949 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -145.8 148.52 33.02 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.936 0.894 . . . . 0.0 111.856 173.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 11.9 ttm -121.88 123.33 41.48 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 126.832 2.053 . . . . 0.0 110.125 -175.433 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -97.45 135.9 38.65 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.988 1.715 . . . . 0.0 109.809 169.605 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.1 mm -134.99 134.3 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.906 1.282 . . . . 0.0 109.95 176.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.7 139.09 27.71 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.361 1.065 . . . . 0.0 113.491 -176.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 16.3 t80 -102.53 122.16 43.81 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.809 2.044 . . . . 0.0 109.914 175.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 52.4 30.5 8.28 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.896 1.278 . . . . 0.0 112.739 -173.688 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 19.1 t30 79.46 2.63 2.25 Favored 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 128.658 2.783 . . . . 0.0 115.169 -179.263 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -99.74 130.61 45.97 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 125.167 1.387 . . . . 0.0 110.86 171.189 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -55.5 138.31 46.71 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -177.534 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 23.9 pt -73.24 152.26 90.25 Favored Pre-proline 0 N--CA 1.479 0.991 0 CA-C-O 118.697 -0.668 . . . . 0.0 110.379 171.358 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -60.16 134.08 53.8 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.471 2.114 . . . . 0.0 110.952 -178.678 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 85.68 -7.63 75.92 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.966 1.27 . . . . 0.0 115.161 -178.146 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 3.2 t -76.55 144.86 74.47 Favored Pre-proline 0 CA--C 1.552 1.047 0 CA-C-N 119.77 1.785 . . . . 0.0 111.362 173.767 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.24 162.76 86.05 Favored 'Cis proline' 0 C--N 1.355 0.877 0 CA-C-N 120.558 1.235 . . . . 0.0 114.107 1.69 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 84.4 mt -102.68 157.03 17.23 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.979 1.711 . . . . 0.0 110.632 171.174 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -131.68 141.47 49.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.069 1.347 . . . . 0.0 110.568 -179.44 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 36.3 p90 -158.54 155.69 28.85 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.66 1.184 . . . . 0.0 112.285 -171.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 31.3 t80 -112.13 135.94 52.15 Favored 'General case' 0 N--CA 1.477 0.877 0 O-C-N 121.11 -0.993 . . . . 0.0 113.191 179.533 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 34.1 t -118.43 142.64 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.529 1.532 . . . . 0.0 109.215 -178.196 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 36.5 t0 -156.25 165.8 35.32 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.6 1.16 . . . . 0.0 111.611 -175.768 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -77.02 128.15 33.97 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.427 1.091 . . . . 0.0 110.574 176.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 75.3 t -67.64 -31.89 54.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 O-C-N 121.604 -0.685 . . . . 0.0 112.248 -171.361 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -80.5 -14.19 58.46 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 -178.001 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 8.0 t -70.33 139.24 51.99 Favored 'General case' 0 CA--C 1.547 0.827 0 O-C-N 121.239 -0.913 . . . . 0.0 112.758 -172.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -93.7 88.06 1.2 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.114 1.34 . . . . 0.0 113.129 -171.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -168.91 169.66 9.59 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.807 2.043 . . . . 0.0 112.533 174.177 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.5 p -66.57 142.95 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 123.875 0.87 . . . . 0.0 110.966 170.375 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.1 t -166.73 150.44 7.02 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 125.392 1.477 . . . . 0.0 110.711 178.972 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -123.71 145.89 48.66 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.228 1.411 . . . . 0.0 112.171 -176.308 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.6 p90 -167.6 163.87 14.59 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.82 1.648 . . . . 0.0 113.444 -179.962 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 132.8 172.59 13.05 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.461 1.505 . . . . 0.0 112.704 -178.359 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.82 -33.81 12.03 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.832 2.355 . . . . 0.0 112.693 -171.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.19 -38.08 93.54 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 118.688 -1.062 . . . . 0.0 114.323 -171.342 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.6 pp -75.09 -6.72 51.01 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.896 1.348 . . . . 0.0 113.381 176.552 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 35.9 m -99.77 -42.3 6.9 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.309 1.843 . . . . 0.0 110.943 173.504 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 7.9 t-80 -155.4 126.38 7.07 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.026 1.73 . . . . 0.0 112.34 -165.239 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -130.63 -178.91 15.69 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.55 2.024 . . . . 0.0 112.794 168.184 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 85.4 t -141.19 139.52 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 125.864 1.666 . . . . 0.0 108.201 177.394 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -56.47 134.76 20.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -177.639 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 51.9 m-80 68.22 -0.91 1.98 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 127.349 2.26 . . . . 0.0 114.541 178.306 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -105.09 139.14 19.82 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.28 1.432 . . . . 0.0 110.951 176.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -73.37 123.93 9.06 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.519 2.146 . . . . 0.0 110.395 -178.513 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -105.49 142.7 34.78 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.509 1.524 . . . . 0.0 110.28 174.613 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 57.0 p -134.11 149.34 51.09 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -166.562 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 53.8 p90 -161.94 177.19 10.03 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.81 1.644 . . . . 0.0 111.629 177.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 73.5 m -132.11 145.28 51.29 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.221 1.408 . . . . 0.0 110.497 -171.513 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 17.5 t -117.65 122.59 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.102 1.361 . . . . 0.0 107.876 167.099 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -84.29 126.87 33.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.342 0.657 . . . . 0.0 109.924 173.542 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 4.1 p -133.77 12.11 4.02 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.418 1.887 . . . . 0.0 112.626 -172.038 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . 0.417 ' HE2' HG23 ' A' 1919 ' ' THR . 65.3 mttt -61.87 -35.48 78.44 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -167.442 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.1 t70 -118.56 11.36 12.85 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.258 1.823 . . . . 0.0 112.57 -176.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.1 -4.9 54.72 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.854 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 93.62 -127.84 9.21 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.736 1.16 . . . . 0.0 112.624 178.716 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -153.42 150.71 29.1 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.146 1.379 . . . . 0.0 110.901 -172.806 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 149.2 -158.55 27.7 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 125.763 1.649 . . . . 0.0 112.473 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.43 113.15 4.02 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 123.88 0.752 . . . . 0.0 111.315 174.097 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -84.39 125.18 32.09 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.887 1.275 . . . . 0.0 108.225 169.553 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 42.1 m -125.04 158.1 34.59 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.527 1.531 . . . . 0.0 112.397 -174.337 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 46.8 tp -158.5 134.62 9.18 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.253 1.821 . . . . 0.0 108.979 -171.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.79 158.25 36.48 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.033 0.933 . . . . 0.0 112.145 177.899 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.4 mt -137.68 134.55 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 124.561 1.144 . . . . 0.0 109.942 177.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -120.81 164.53 16.48 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.887 1.675 . . . . 0.0 109.94 168.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 170.21 -158.01 29.7 Favored Glycine 0 CA--C 1.539 1.548 0 CA-C-O 118.694 -1.059 . . . . 0.0 114.251 -178.061 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -64.97 -22.82 62.27 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.894 3.062 . . . . 0.0 112.694 176.012 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 16.0 t -148.57 164.43 34.28 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.674 1.589 . . . . 0.0 109.517 164.663 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -73.17 113.63 10.45 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 120.926 -1.109 . . . . 0.0 111.081 177.55 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.01 149.51 48.71 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.796 0.838 . . . . 0.0 111.461 170.832 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.65 142.07 27.99 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.357 0.663 . . . . 0.0 109.648 168.751 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 22.2 mt -132.97 143.14 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 C-N-CA 124.443 1.097 . . . . 0.0 110.456 -167.304 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 11.5 t -140.84 160.37 40.2 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.134 1.373 . . . . 0.0 110.62 167.376 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.6 p -158.5 156.47 30.32 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.594 1.158 . . . . 0.0 112.466 -177.217 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 59.3 m -140.24 123.7 17.03 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.104 1.362 . . . . 0.0 110.385 -172.173 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.29 126.16 30.43 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.615 1.166 . . . . 0.0 110.417 168.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -100.61 151.33 21.74 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.078 1.351 . . . . 0.0 112.116 -178.45 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -67.47 -21.87 65.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.941 0.896 . . . . 0.0 112.703 179.008 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.33 -9.12 58.08 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 124.589 1.156 . . . . 0.0 113.557 172.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 98.28 10.5 51.14 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 125.176 1.369 . . . . 0.0 115.18 174.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . 0.417 HG23 ' HE2' ' A' 1891 ' ' LYS . 82.3 p -100.88 161.91 13.27 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 119.132 1.466 . . . . 0.0 111.565 174.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 73.4 m -111.64 123.98 51.36 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.046 1.338 . . . . 0.0 109.685 166.755 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.5 t -92.39 151.07 20.44 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.014 0.926 . . . . 0.0 110.773 170.259 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.5 t -132.57 141.71 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.788 1.635 . . . . 0.0 110.652 -176.112 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 50.6 m -132.52 142.94 49.42 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.876 1.67 . . . . 0.0 110.854 168.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 13.4 p90 -148.15 152.37 37.17 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 174.326 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 22.4 mt -119.27 102.88 47.97 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.744 2.018 . . . . 0.0 110.013 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -81.48 167.09 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 123.677 2.918 . . . . 0.0 110.251 168.498 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 31.4 m -136.54 -24.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 -173.314 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 76.2 mt -116.91 149.63 44.44 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 124.772 1.229 . . . . 0.0 110.703 171.272 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -73.58 154.54 49.91 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.006 2.471 . . . . 0.0 110.922 174.832 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 140.45 -152.72 23.1 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.271 1.415 . . . . 0.0 113.031 -177.236 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -113.1 131.11 55.94 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.005 1.322 . . . . 0.0 111.082 178.73 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -113.47 144.96 41.93 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.787 1.635 . . . . 0.0 110.951 179.734 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 69.4 m -105.77 116.15 31.46 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.971 1.309 . . . . 0.0 110.257 178.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.53 120.52 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.872 1.669 . . . . 0.0 108.374 -179.518 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 10.3 tt -103.53 133.57 48.34 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 125.362 1.465 . . . . 0.0 109.55 174.593 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.6 t -135.57 133.81 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 125.301 1.44 . . . . 0.0 108.058 172.28 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.67 144.39 20.43 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.741 1.216 . . . . 0.0 111.037 -168.888 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.06 123.6 14.97 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.513 1.125 . . . . 0.0 110.363 -178.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.9 t-20 55.7 53.01 10.05 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.923 1.289 . . . . 0.0 111.767 178.294 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.298 8.1 pt-20 58.19 13.08 2.14 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 128.392 2.677 . . . . 0.0 116.283 -176.554 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -117.39 128.26 54.85 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 0.0 110.922 176.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -60.26 152.28 25.31 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.704 0.802 . . . . 0.0 112.417 170.214 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 17.3 m -79.26 156.94 76.05 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-O 118.744 -0.646 . . . . 0.0 110.064 176.577 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -55.49 119.2 6.17 Favored 'Trans proline' 0 CA--C 1.535 0.553 0 C-N-CA 122.656 2.237 . . . . 0.0 110.776 174.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 96.62 -13.43 65.38 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.312 1.434 . . . . 0.0 116.472 178.486 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 93.7 p -79.59 153.89 76.08 Favored Pre-proline 0 CA--C 1.549 0.935 0 CA-C-N 120.329 2.064 . . . . 0.0 113.238 -176.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.77 153.36 99.12 Favored 'Cis proline' 0 C--N 1.354 0.83 0 CA-C-N 119.154 0.733 . . . . 0.0 112.397 -5.076 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -106.37 143.51 34.39 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.44 1.496 . . . . 0.0 111.197 -177.505 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 54.0 m -95.09 117.34 30.02 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.844 0.858 . . . . 0.0 110.376 176.551 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -100.9 132.87 46.09 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.055 1.342 . . . . 0.0 111.212 173.256 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.67 141.16 51.64 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.959 0.903 . . . . 0.0 110.065 166.12 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 94.9 t -134.4 138.9 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.484 1.113 . . . . 0.0 109.672 163.19 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 16.5 p -134.83 174.12 10.94 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.656 1.183 . . . . 0.0 112.124 178.145 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -68.27 152.87 52.73 Favored Glycine 0 CA--C 1.532 1.145 0 C-N-CA 125.404 1.478 . . . . 0.0 113.139 178.934 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 -78.64 -9.08 59.25 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 124.63 1.172 . . . . 0.0 113.363 178.022 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 2.9 p-10 . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.827 2.051 . . . . 0.0 113.093 178.713 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.559 -0.616 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -69.67 158.32 35.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.313 1.045 . . . . 0.0 112.74 177.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 96.3 mtp -136.37 150.91 49.04 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.546 1.538 . . . . 0.0 111.412 -179.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -73.15 152.66 90.52 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.22 1.008 . . . . 0.0 112.154 175.222 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.2 173.4 14.57 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 123.736 2.957 . . . . 0.0 111.624 175.577 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -78.09 -3.62 43.24 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.356 1.063 . . . . 0.0 113.281 175.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -148.62 55.42 2.09 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 125.637 1.575 . . . . 0.0 113.607 -173.147 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.68 148.64 53.4 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 123.264 2.643 . . . . 0.0 111.288 -178.715 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 82.1 mt -93.44 2.04 56.62 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.457 1.103 . . . . 0.0 113.486 -178.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 47.7 t -133.83 139.95 47.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 126.789 2.035 . . . . 0.0 109.205 -177.288 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -85.12 -147.18 8.89 Favored Glycine 0 CA--C 1.535 1.294 0 C-N-CA 125.112 1.339 . . . . 0.0 113.418 179.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 24.6 m -134.82 149.3 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.69 1.596 . . . . 0.0 111.061 178.468 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 31.2 m120 -148.39 169.63 19.75 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.791 1.637 . . . . 0.0 111.976 -174.051 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 100.82 162.63 27.87 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.412 1.482 . . . . 0.0 113.769 177.118 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.6 mt -137.03 165.66 25.49 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.786 2.034 . . . . 0.0 110.702 -178.816 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 45.1 t0 -70.15 151.77 45.04 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.453 0.701 . . . . 0.0 111.93 173.706 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 33.6 m 48.48 19.54 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 128.303 2.641 . . . . 0.0 115.933 -178.109 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 4.3 t -72.91 -13.79 61.34 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.433 1.493 . . . . 0.0 114.872 -170.143 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 18.7 p -71.7 161.47 30.93 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -174.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 34.2 mt -65.85 158.05 28.88 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.375 1.07 . . . . 0.0 111.288 166.558 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.1 tmm_? -54.26 114.61 6.88 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.519 1.127 . . . . 0.0 110.828 179.557 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -70.02 131.98 21.97 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.153 2.569 . . . . 0.0 110.56 -175.46 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 11.2 t80 -99.36 117.1 33.03 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.536 0.735 . . . . 0.0 111.079 -176.883 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -151.35 136.81 17.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 111.226 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -137.96 159.71 41.29 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.294 2.238 . . . . 0.0 110.115 -170.039 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.9 p -131.09 138.71 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.894 1.278 . . . . 0.0 110.271 177.742 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 53.8 mt -132.42 135.48 26.37 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 126.04 1.736 . . . . 0.0 108.832 -172.995 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.6 64.96 8.91 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 124.208 3.272 . . . . 0.0 111.813 -179.977 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 63.0 t80 -111.51 147.34 35.55 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.706 1.602 . . . . 0.0 111.048 175.581 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 92.0 m -115.58 123.21 47.88 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.183 1.393 . . . . 0.0 109.61 178.164 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 74.5 mt -81.25 131.78 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.505 1.122 . . . . 0.0 110.326 177.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 96.4 mttt -117.2 -141.71 0.37 Allowed 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.7 1.6 . . . . 0.0 110.8 178.282 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 29.3 tptp -80.11 123.79 28.19 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.752 -1.217 . . . . 0.0 110.871 170.673 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 134.96 -149.24 19.84 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 125.309 1.433 . . . . 0.0 112.199 -171.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -159.15 148.6 18.69 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.907 1.283 . . . . 0.0 111.132 -174.917 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 19.6 tt -120.92 136.12 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.59 1.556 . . . . 0.0 111.585 -179.436 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 38.7 p -148.46 -174.03 4.49 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 126.661 1.984 . . . . 0.0 110.197 -176.938 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -178.09 -164.58 31.52 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 115.545 0.978 . . . . 0.0 115.545 -179.658 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -152.87 144.15 23.21 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 125.768 1.627 . . . . 0.0 110.24 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 85.8 t -121.0 137.15 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.504 1.921 . . . . 0.0 108.481 173.26 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -119.57 137.91 53.54 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.464 1.106 . . . . 0.0 112.448 -176.331 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 24.4 mtm -108.86 149.49 39.62 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.409 1.884 . . . . 0.0 111.999 -176.098 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -50.61 -40.0 55.62 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 124.965 3.776 . . . . 0.0 116.598 -177.601 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 4.7 t -74.61 0.85 13.67 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -177.957 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 95.83 -1.19 63.25 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.802 1.668 . . . . 0.0 114.064 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -67.99 153.36 43.9 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.971 1.308 . . . . 0.0 111.597 173.016 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 31.3 m -137.5 157.32 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.018 1.327 . . . . 0.0 111.551 -179.753 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.39 169.93 23.6 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.972 1.709 . . . . 0.0 111.263 -178.077 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -108.29 138.6 20.22 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 124.134 0.973 . . . . 0.0 111.068 178.206 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -81.95 165.09 17.58 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.187 3.258 . . . . 0.0 111.332 172.408 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.5 m -109.23 125.27 52.08 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.868 1.267 . . . . 0.0 108.972 173.804 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.31 138.43 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.792 1.237 . . . . 0.0 109.428 177.33 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 65.6 m -131.55 131.96 43.76 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.986 1.714 . . . . 0.0 110.322 -178.694 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 57.9 t0 -77.79 121.74 24.47 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 172.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -85.01 -13.3 50.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -179.608 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 24.9 mmmt 73.87 -5.64 1.98 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 127.989 2.516 . . . . 0.0 114.075 -175.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -91.79 3.49 55.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.229 1.812 . . . . 0.0 113.712 -177.604 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.97 17.5 57.74 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.442 1.02 . . . . 0.0 113.368 -171.561 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.6 p -129.46 161.52 30.21 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.725 2.01 . . . . 0.0 109.88 176.051 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.5 m -123.21 139.99 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.203 1.001 . . . . 0.0 110.109 168.78 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 18.2 m -96.43 142.81 28.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.377 1.071 . . . . 0.0 108.598 170.576 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 12.7 t -127.87 134.47 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.855 1.262 . . . . 0.0 109.301 178.487 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 62.5 mtp85 -132.38 154.89 49.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.165 1.386 . . . . 0.0 112.469 -173.131 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 37.7 t80 -156.72 136.49 12.48 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.956 1.703 . . . . 0.0 111.722 178.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.02 118.02 69.73 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.393 1.077 . . . . 0.0 110.812 176.496 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.93 135.49 15.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.401 2.734 . . . . 0.0 112.076 -174.167 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 69.6 m -131.83 4.42 4.18 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.344 1.058 . . . . 0.0 113.78 -178.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -162.35 144.75 11.08 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.653 1.581 . . . . 0.0 110.156 -174.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -94.75 162.01 13.94 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.547 1.139 . . . . 0.0 112.45 177.034 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 115.1 -167.93 12.45 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 125.88 1.705 . . . . 0.0 113.633 -178.755 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 27.8 tp -78.76 126.35 30.6 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.672 1.189 . . . . 0.0 110.619 179.003 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.7 m80 -125.55 165.78 17.87 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.987 1.715 . . . . 0.0 111.257 -175.57 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -148.21 153.85 39.31 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.116 0.967 . . . . 0.0 111.817 176.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.9 ttm -131.67 131.99 43.59 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.693 1.997 . . . . 0.0 110.125 -176.152 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -105.64 135.01 47.83 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.996 1.719 . . . . 0.0 109.546 169.108 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.5 mm -131.2 133.58 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.437 1.095 . . . . 0.0 110.109 175.253 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 137.74 25.72 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -174.556 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.1 t80 -100.63 121.88 42.37 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.692 1.997 . . . . 0.0 109.861 175.171 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 51.9 34.71 14.07 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 124.542 1.137 . . . . 0.0 112.69 -175.397 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 78.67 4.53 2.52 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.779 2.431 . . . . 0.0 114.083 179.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.9 mtm -107.1 129.82 54.77 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.615 1.566 . . . . 0.0 111.011 176.272 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -57.51 137.2 56.54 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 -175.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.1 pt -79.49 156.08 75.97 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.721 175.61 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -59.88 131.15 38.09 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.251 1.967 . . . . 0.0 109.732 168.71 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 95.86 -12.24 67.38 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.536 1.065 . . . . 0.0 114.138 -172.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 22.5 t -84.61 146.6 47.21 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 119.561 1.68 . . . . 0.0 110.952 168.658 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -81.35 158.8 82.57 Favored 'Cis proline' 0 C--N 1.351 0.694 0 CA-C-N 120.055 1.055 . . . . 0.0 112.032 -8.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 93.0 mt -103.61 153.56 20.47 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.79 1.236 . . . . 0.0 110.9 172.876 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -143.44 139.89 30.13 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.931 1.292 . . . . 0.0 109.525 -178.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 4.6 p90 -167.16 167.55 14.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.293 1.037 . . . . 0.0 112.223 -169.758 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 16.8 t80 -107.72 140.63 40.48 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.905 0.882 . . . . 0.0 112.564 178.495 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 61.4 t -109.7 139.41 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.616 1.566 . . . . 0.0 108.583 172.414 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 35.7 t0 -156.12 161.06 40.41 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.944 0.878 . . . . 0.0 113.074 -174.398 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -79.92 103.87 10.11 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.572 1.549 . . . . 0.0 110.783 177.91 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 29.9 m -65.02 -16.87 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.456 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -84.36 -14.58 49.16 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.664 1.186 . . . . 0.0 114.172 -178.307 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.5 m -73.72 157.32 36.72 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.241 1.016 . . . . 0.0 112.749 -178.746 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.85 -14.9 68.85 Favored Glycine 0 CA--C 1.533 1.209 0 C-N-CA 124.499 1.047 . . . . 0.0 115.154 -173.274 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -67.84 155.22 39.84 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 118.679 1.24 . . . . 0.0 113.213 176.75 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 7.2 t -72.32 132.62 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 123.844 0.858 . . . . 0.0 109.089 177.728 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 6.3 t -150.5 162.67 40.16 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.773 1.229 . . . . 0.0 110.945 -175.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -145.65 147.99 32.59 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.535 1.134 . . . . 0.0 112.24 -174.449 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 29.6 p90 -168.14 163.22 13.3 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.787 1.635 . . . . 0.0 112.979 -174.843 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 135.92 175.05 13.62 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.264 1.411 . . . . 0.0 113.046 -179.557 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.02 -35.54 8.82 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.734 2.29 . . . . 0.0 112.88 -172.414 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.23 -34.09 87.08 Favored Glycine 0 CA--C 1.53 0.972 0 CA-C-N 119.478 1.035 . . . . 0.0 114.533 -171.384 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.4 pp -79.13 -5.24 53.68 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 118.661 1.23 . . . . 0.0 113.51 175.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 48.4 m -103.8 -49.39 3.67 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.372 1.869 . . . . 0.0 110.884 177.61 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -139.6 142.88 37.07 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.484 1.914 . . . . 0.0 112.07 -178.36 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -132.9 171.28 21.79 Favored Glycine 0 CA--C 1.53 1.001 0 C-N-CA 124.707 1.146 . . . . 0.0 112.963 172.243 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.9 t -136.65 132.7 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 172.892 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 25.3 m -59.98 144.62 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.044 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 71.4 m-20 68.74 -3.91 1.31 Allowed 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.597 1.959 . . . . 0.0 114.313 178.737 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 97.1 mttt -114.49 142.36 28.04 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 125.819 1.648 . . . . 0.0 111.269 179.388 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -72.5 125.84 11.02 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.704 2.27 . . . . 0.0 110.572 -179.331 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -106.29 136.27 46.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.444 1.497 . . . . 0.0 110.167 175.0 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 36.3 p -129.53 148.77 51.46 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -164.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.2 p90 -159.84 177.68 10.56 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.686 1.594 . . . . 0.0 111.72 176.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 86.6 m -130.5 142.7 50.48 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.208 1.403 . . . . 0.0 111.028 -169.936 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 25.7 t -114.34 133.9 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.928 1.691 . . . . 0.0 108.208 169.265 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -95.15 127.07 40.91 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.452 1.101 . . . . 0.0 111.03 -179.505 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 57.8 p -131.53 7.04 4.47 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.587 1.555 . . . . 0.0 113.312 -170.501 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -54.54 -35.86 63.67 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.043 1.737 . . . . 0.0 114.788 -169.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 28.9 t70 -121.99 15.98 10.83 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.774 1.63 . . . . 0.0 112.572 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -74.29 -15.42 60.97 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -174.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.08 -125.01 6.66 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.377 0.989 . . . . 0.0 111.41 -176.156 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -152.51 151.52 30.81 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.006 1.322 . . . . 0.0 110.903 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 171.39 -129.41 1.77 Allowed Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.072 1.796 . . . . 0.0 110.57 -175.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -125.09 109.14 1.17 Allowed Glycine 0 N--CA 1.47 0.91 0 C-N-CA 124.372 0.986 . . . . 0.0 111.797 170.55 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.12 132.27 39.93 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.522 1.129 . . . . 0.0 108.875 170.738 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 8.7 t -140.06 158.91 43.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.299 1.44 . . . . 0.0 111.847 -169.766 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 50.0 tp -166.99 136.28 2.85 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 109.472 -161.867 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.75 160.46 37.89 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.155 0.982 . . . . 0.0 112.226 176.625 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 52.3 mt -135.99 137.93 48.1 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.945 1.298 . . . . 0.0 109.512 174.362 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -122.8 159.14 28.71 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.837 1.655 . . . . 0.0 109.727 170.726 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 173.44 -163.22 34.54 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 121.147 -0.971 . . . . 0.0 114.014 -177.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.24 -11.7 23.03 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.638 2.892 . . . . 0.0 112.9 179.19 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 10.6 t -152.72 160.64 43.14 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.804 1.642 . . . . 0.0 109.938 169.595 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . 0.429 ' HA ' ' HE3' ' A' 1907 ' ' LYS . 0.9 OUTLIER -76.75 109.07 10.23 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 120.958 -1.089 . . . . 0.0 111.616 -177.72 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -73.35 147.76 44.09 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.954 0.902 . . . . 0.0 111.51 169.153 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.035 0.934 . . . . 0.0 110.072 170.431 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 19.2 mt -134.61 139.83 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.678 1.191 . . . . 0.0 110.668 -166.742 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.0 m -133.64 156.98 46.91 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.925 1.69 . . . . 0.0 110.828 169.042 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -152.72 155.56 37.46 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.29 1.036 . . . . 0.0 112.398 176.42 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 87.1 m -140.47 124.65 17.58 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.605 1.562 . . . . 0.0 110.353 -172.244 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 19.4 t70 -75.7 131.42 39.86 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.807 1.243 . . . . 0.0 111.187 170.88 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 68.7 m-20 -107.68 146.9 31.43 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.315 1.446 . . . . 0.0 111.822 179.573 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 26.0 tm0? -65.68 -21.68 66.56 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.471 1.108 . . . . 0.0 112.471 175.292 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.6 t70 -73.76 -5.32 40.04 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.705 1.602 . . . . 0.0 114.684 -179.973 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.16 33.25 6.65 Favored Glycine 0 N--CA 1.476 1.3 0 C-N-CA 124.474 1.035 . . . . 0.0 114.171 177.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 74.5 p -140.32 162.68 34.72 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.476 1.51 . . . . 0.0 110.902 176.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 98.3 m -111.81 130.47 55.8 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.828 1.251 . . . . 0.0 109.272 161.202 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -89.44 150.0 22.7 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.831 0.853 . . . . 0.0 110.471 169.258 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 89.7 t -130.25 144.75 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.134 1.774 . . . . 0.0 109.797 -178.291 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 22.3 t -140.44 140.32 35.38 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.552 1.541 . . . . 0.0 110.78 172.113 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.7 p90 -146.77 154.16 41.06 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 177.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.2 mt -118.96 104.02 47.21 Favored Pre-proline 0 CA--C 1.545 0.753 0 C-N-CA 126.061 1.744 . . . . 0.0 110.629 -178.673 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -82.22 162.69 17.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 123.603 2.869 . . . . 0.0 110.336 166.326 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.0 p -127.59 -19.74 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -168.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -144.96 149.23 41.71 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 124.522 1.129 . . . . 0.0 110.614 174.567 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.28 153.03 40.16 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.887 2.391 . . . . 0.0 112.183 -169.524 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 151.1 -154.88 25.84 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 124.907 1.242 . . . . 0.0 112.598 -174.311 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -115.41 129.77 56.68 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.613 1.165 . . . . 0.0 110.682 178.351 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -119.45 134.52 55.18 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.889 1.675 . . . . 0.0 110.596 -176.805 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 43.1 m -93.2 125.96 38.07 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.561 1.144 . . . . 0.0 110.85 178.916 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.58 129.59 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 125.4 1.48 . . . . 0.0 108.381 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -112.69 131.76 55.5 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 125.476 1.51 . . . . 0.0 109.65 176.633 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 46.9 t -133.89 130.87 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 124.43 1.092 . . . . 0.0 110.108 174.59 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 4.6 tmmt? -153.69 144.75 22.84 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.212 1.405 . . . . 0.0 111.392 -165.321 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -142.16 119.98 11.93 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.762 1.225 . . . . 0.0 109.611 177.729 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.4 t-20 57.69 57.82 4.04 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.273 1.429 . . . . 0.0 111.773 177.823 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.289 8.6 pt-20 58.16 15.16 3.12 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.179 2.592 . . . . 0.0 116.175 -179.236 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -125.54 131.56 52.75 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.679 1.192 . . . . 0.0 110.89 177.162 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -69.08 152.75 44.8 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 123.874 0.87 . . . . 0.0 112.456 174.565 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 20.1 m -67.9 152.36 96.44 Favored Pre-proline 0 N--CA 1.483 1.217 0 CA-C-O 118.072 -0.966 . . . . 0.0 109.707 163.386 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -66.23 -20.17 56.03 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.413 2.075 . . . . 0.0 114.846 -165.236 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -93.55 -7.11 62.01 Favored Glycine 0 CA--C 1.536 1.385 0 C-N-CA 124.124 0.869 . . . . 0.0 115.186 174.203 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 42.1 t -84.74 143.64 41.04 Favored Pre-proline 0 CA--C 1.548 0.881 0 CA-C-N 119.002 1.401 . . . . 0.0 112.193 -176.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -75.1 142.26 74.12 Favored 'Cis proline' 0 CA--C 1.539 0.731 0 CA-C-N 119.158 0.735 . . . . 0.0 112.192 -3.856 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -94.07 170.48 9.5 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.318 1.847 . . . . 0.0 110.525 173.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 85.1 m -132.36 121.89 24.21 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.95 0.9 . . . . 0.0 110.63 173.02 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -98.65 138.01 36.45 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.561 1.545 . . . . 0.0 111.022 172.693 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 34.1 ttt85 -96.88 127.6 43.02 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.605 0.762 . . . . 0.0 110.032 173.545 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 96.1 t -114.86 130.22 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 124.863 1.265 . . . . 0.0 110.703 -171.02 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 39.5 p -110.08 163.44 13.59 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.123 1.369 . . . . 0.0 113.022 -179.197 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.16 141.21 22.97 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.445 1.498 . . . . 0.0 112.535 178.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -88.77 -10.94 46.44 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 114.019 1.118 . . . . 0.0 114.019 176.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.2 t70 . . . . . 0 C--O 1.255 1.371 0 C-N-CA 126.766 2.026 . . . . 0.0 112.639 -177.317 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.504 0 N-CA-C 111.533 -0.627 . . . . 0.0 111.533 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.63 161.98 29.71 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.484 1.114 . . . . 0.0 112.992 178.192 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.11 164.14 30.9 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.177 1.791 . . . . 0.0 111.766 -179.584 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -81.88 137.05 47.11 Favored Pre-proline 0 CA--C 1.55 0.956 0 C-N-CA 123.887 0.875 . . . . 0.0 111.953 -179.828 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -75.72 173.19 14.92 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.778 2.986 . . . . 0.0 111.652 175.67 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -54.3 142.78 25.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.479 1.112 . . . . 0.0 113.134 -179.538 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -104.66 154.26 38.63 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 125.219 1.408 . . . . 0.0 112.709 -170.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -75.25 -167.25 0.41 Allowed 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.997 3.131 . . . . 0.0 110.868 172.725 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 37.0 tp -71.49 76.13 0.78 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.088 1.355 . . . . 0.0 111.374 179.695 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 9.9 p -162.62 152.61 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 127.021 2.128 . . . . 0.0 109.998 -176.716 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -77.59 48.83 2.97 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.427 1.489 . . . . 0.0 114.044 -178.387 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 25.3 t 71.15 102.7 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 128.724 2.81 . . . . 0.0 110.447 -176.592 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 51.4 t30 -165.71 171.9 12.43 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.973 1.709 . . . . 0.0 110.704 -176.266 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -76.73 -177.15 44.24 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.346 0.974 . . . . 0.0 112.468 166.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 91.3 mt -70.84 155.61 40.58 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.731 0.812 . . . . 0.0 111.722 175.87 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 21.9 t0 -142.57 115.17 8.57 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.271 1.429 . . . . 0.0 109.798 175.506 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 8.0 p -175.35 152.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 126.309 1.844 . . . . 0.0 110.073 -166.085 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 14.9 t -154.59 -36.21 0.09 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.052 1.341 . . . . 0.0 112.595 177.655 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 74.1 p -157.16 162.67 39.36 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.46 1.104 . . . . 0.0 112.531 176.384 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 36.1 tp -129.38 148.37 51.3 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.945 1.698 . . . . 0.0 110.827 -166.14 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . 0.451 ' HB2' ' H ' ' A' 1861 ' ' ASP . 0.9 OUTLIER -41.66 108.57 0.6 Allowed Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 126.239 1.816 . . . . 0.0 113.381 -168.666 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.56 100.03 1.33 Allowed 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.635 2.224 . . . . 0.0 109.022 -178.964 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 37.4 t80 -89.42 130.89 35.7 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.752 0.787 . . . . 0.0 111.956 -174.753 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 3.4 p30 -158.04 160.62 37.61 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.24 1.816 . . . . 0.0 110.768 172.682 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -152.95 132.81 13.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.273 1.029 . . . . 0.0 110.572 -177.896 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 95.6 t -93.87 127.7 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 125.052 1.341 . . . . 0.0 109.023 169.51 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.5 mt -125.93 135.37 26.96 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 126.171 1.788 . . . . 0.0 109.069 -173.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -71.66 110.69 2.95 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 123.543 2.829 . . . . 0.0 110.233 176.084 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 31.6 t80 -177.61 152.85 0.83 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 127.333 2.253 . . . . 0.0 109.291 -171.198 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 43.5 m -135.04 129.63 34.37 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 124.405 1.082 . . . . 0.0 110.052 178.421 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.1 mt -84.51 113.29 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.211 1.004 . . . . 0.0 109.343 175.049 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -89.13 -66.96 0.87 Allowed 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.738 0.815 . . . . 0.0 112.936 -179.536 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 22.9 ptmt -157.03 -8.05 0.09 Allowed 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.494 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -85.22 -138.4 4.39 Favored Glycine 0 CA--C 1.531 1.043 0 C-N-CA 125.751 1.644 . . . . 0.0 111.857 175.452 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -152.63 143.85 23.19 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.652 1.181 . . . . 0.0 110.665 -177.75 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 16.8 tt -126.25 134.91 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.649 1.58 . . . . 0.0 110.736 179.759 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 70.0 p -146.61 -179.66 6.93 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.894 1.678 . . . . 0.0 109.933 179.802 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -176.23 -166.21 33.16 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 178.549 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -150.93 137.77 18.99 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.512 1.525 . . . . 0.0 109.826 -179.734 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 58.2 t -107.54 133.96 50.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.892 1.677 . . . . 0.0 108.027 171.532 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -120.75 125.4 47.51 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.225 1.41 . . . . 0.0 110.468 -169.136 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -93.54 153.24 41.32 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.831 1.653 . . . . 0.0 111.373 -176.19 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.14 -23.48 29.0 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 123.177 2.585 . . . . 0.0 112.411 177.365 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 15.3 m -74.57 -1.16 20.26 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.681 1.592 . . . . 0.0 114.805 -178.416 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 85.87 49.49 4.28 Favored Glycine 0 N--CA 1.472 1.099 0 C-N-CA 124.518 1.056 . . . . 0.0 113.003 178.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -153.25 164.92 37.22 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 126.038 1.735 . . . . 0.0 111.743 -175.074 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.4 m -141.48 158.98 22.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.73 1.212 . . . . 0.0 112.97 -171.069 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.46 166.0 34.87 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.679 1.992 . . . . 0.0 111.219 178.451 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -100.31 137.65 20.04 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.781 0.833 . . . . 0.0 111.709 -179.581 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -84.16 169.97 11.11 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 124.276 3.317 . . . . 0.0 111.646 170.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 72.3 m -113.48 129.74 56.48 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.292 1.437 . . . . 0.0 108.852 173.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -114.63 136.38 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.683 1.193 . . . . 0.0 109.36 176.545 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 61.7 m -139.18 132.81 30.5 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.142 1.377 . . . . 0.0 109.846 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.67 128.64 33.74 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.767 0.827 . . . . 0.0 110.824 173.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -82.91 -6.59 59.53 Favored 'General case' 0 CA--C 1.546 0.802 0 N-CA-C 114.118 1.155 . . . . 0.0 114.118 -174.667 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 2.5 mptp? 64.67 11.94 7.17 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 127.286 2.235 . . . . 0.0 113.882 -173.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -111.41 8.34 21.2 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 126.817 2.047 . . . . 0.0 112.872 -176.347 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 87.9 11.09 68.41 Favored Glycine 0 CA--C 1.537 1.408 0 C-N-CA 124.947 1.261 . . . . 0.0 113.711 -172.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 72.8 p -130.37 157.58 42.18 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 126.728 2.011 . . . . 0.0 110.362 178.477 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.5 m -109.72 153.18 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.086 0.954 . . . . 0.0 109.212 163.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.2 t -105.54 142.94 34.42 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.672 0.789 . . . . 0.0 109.449 162.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 38.6 t -119.56 132.44 69.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 125.401 1.48 . . . . 0.0 108.297 173.428 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 73.5 mtp85 -131.35 154.35 48.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.002 1.721 . . . . 0.0 111.497 -172.808 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 35.6 t80 -154.07 135.04 13.83 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.349 1.459 . . . . 0.0 111.814 -178.229 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -91.79 115.82 65.29 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 124.684 1.194 . . . . 0.0 110.483 175.571 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.54 148.89 16.36 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.474 2.783 . . . . 0.0 112.258 -172.136 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 50.8 m -119.39 -21.6 7.39 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 179.894 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -167.08 156.65 10.76 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.95 1.7 . . . . 0.0 111.812 -175.151 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -80.78 169.6 17.38 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 124.83 1.252 . . . . 0.0 114.022 -174.888 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 120.74 -170.29 14.41 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 126.175 1.845 . . . . 0.0 114.036 177.927 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 32.6 tp -87.33 130.56 34.58 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.717 1.207 . . . . 0.0 110.612 177.382 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 62.5 m80 -128.71 167.61 16.99 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.034 1.734 . . . . 0.0 111.45 -173.164 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -144.67 159.01 43.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.977 0.911 . . . . 0.0 111.432 172.433 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 35.3 ttm -139.43 130.15 26.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.84 1.656 . . . . 0.0 110.023 -171.68 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -115.92 118.77 33.89 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.905 1.682 . . . . 0.0 109.197 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 38.4 mm -120.03 138.61 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 125.132 1.373 . . . . 0.0 110.637 -179.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.38 136.94 22.77 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.463 1.105 . . . . 0.0 113.625 -175.174 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 21.8 t80 -106.23 125.51 51.08 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.733 2.013 . . . . 0.0 110.014 176.429 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.36 36.2 15.81 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.834 1.254 . . . . 0.0 112.696 -177.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 54.6 t30 81.7 -1.0 1.59 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.706 2.802 . . . . 0.0 114.842 178.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 86.1 mtp -111.12 137.06 49.26 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.979 1.312 . . . . 0.0 111.697 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.6 m170 -57.97 136.85 57.15 Favored 'General case' 0 CA--C 1.546 0.799 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.042 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 36.4 pt -75.19 155.85 86.01 Favored Pre-proline 0 N--CA 1.481 1.091 0 CA-C-O 118.827 -0.606 . . . . 0.0 111.588 175.434 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -59.71 129.08 29.23 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.094 1.863 . . . . 0.0 109.787 171.348 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 97.52 -14.88 62.83 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.74 1.162 . . . . 0.0 113.981 -173.648 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 19.0 t -84.13 144.86 44.85 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 119.46 1.63 . . . . 0.0 111.31 173.349 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -80.19 164.17 80.76 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 120.24 1.121 . . . . 0.0 112.486 -5.795 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 81.0 mt -116.13 153.53 31.62 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.642 1.977 . . . . 0.0 110.788 -176.35 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -136.75 136.43 38.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.586 1.154 . . . . 0.0 110.66 -179.066 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 30.1 p90 -155.95 151.37 26.9 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.064 0.945 . . . . 0.0 112.171 -169.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 27.8 t80 -102.79 149.44 24.48 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.694 0.797 . . . . 0.0 112.049 175.4 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 58.2 t -125.95 135.87 62.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 125.604 1.562 . . . . 0.0 109.021 -178.566 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . 0.451 ' H ' ' HB2' ' A' 1789 ' ' ARG . 3.5 p30 -157.86 152.24 24.69 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.177 1.791 . . . . 0.0 111.878 -174.794 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -65.75 138.75 58.15 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.063 0.945 . . . . 0.0 112.38 -173.639 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 71.8 t -69.01 -33.07 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 O-C-N 121.308 -0.87 . . . . 0.0 112.101 -169.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -95.95 14.2 24.36 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 125.078 1.351 . . . . 0.0 113.785 -175.534 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 18.2 p -65.37 162.55 17.42 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -175.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -95.46 -20.94 25.77 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.784 1.183 . . . . 0.0 114.164 174.561 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 16.9 p-80 -74.04 161.25 30.25 Favored 'General case' 0 CA--C 1.549 0.914 0 CA-C-N 118.628 1.214 . . . . 0.0 113.726 179.474 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 19.1 t -75.38 125.12 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.923 1.289 . . . . 0.0 109.107 179.266 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 21.0 p -108.46 172.02 7.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.681 1.192 . . . . 0.0 111.711 -175.484 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -151.36 133.71 15.36 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.251 1.02 . . . . 0.0 110.195 160.222 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 49.5 p90 -161.89 161.97 29.04 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 125.238 1.415 . . . . 0.0 112.556 -177.148 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 127.25 173.84 13.61 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 125.393 1.473 . . . . 0.0 112.424 -174.195 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.73 -36.33 6.51 Favored 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 122.997 2.465 . . . . 0.0 113.205 -169.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.66 -32.12 80.49 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-N 118.741 0.7 . . . . 0.0 114.724 -168.131 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 3.8 pp -77.93 -2.92 39.23 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 118.702 1.251 . . . . 0.0 113.818 178.213 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 70.7 m -118.49 -36.97 3.39 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 126.497 1.919 . . . . 0.0 112.238 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -142.73 146.14 34.03 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.382 1.473 . . . . 0.0 112.703 177.105 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -146.1 -179.16 22.09 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.514 1.054 . . . . 0.0 113.283 171.933 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 13.1 t -142.27 136.72 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.811 1.244 . . . . 0.0 108.491 175.403 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -55.82 135.62 18.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 122.799 0.44 . . . . 0.0 112.112 179.662 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 57.1 m-80 69.02 -4.33 1.27 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.061 2.144 . . . . 0.0 114.97 178.159 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 53.7 mttm -99.71 139.14 20.61 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.512 1.125 . . . . 0.0 111.089 174.712 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -72.96 124.33 9.55 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.514 2.143 . . . . 0.0 110.229 178.418 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -109.24 146.44 34.22 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.332 1.453 . . . . 0.0 110.546 175.542 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 49.9 p -135.8 154.38 51.23 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.707 1.003 . . . . 0.0 113.707 -166.205 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.7 p90 -164.54 175.02 10.23 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 126.313 1.845 . . . . 0.0 111.772 177.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 91.9 m -130.68 144.85 51.71 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.639 1.576 . . . . 0.0 111.0 -169.233 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 72.6 t -124.61 126.48 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 126.951 2.1 . . . . 0.0 107.891 176.585 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -89.5 132.94 34.8 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 119.972 1.26 . . . . 0.0 111.406 177.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 46.2 p -128.34 -0.56 5.68 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.098 1.759 . . . . 0.0 113.494 -173.322 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -52.88 -39.6 62.8 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.927 1.691 . . . . 0.0 115.078 -169.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.9 t70 -114.61 11.15 16.91 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 125.537 1.535 . . . . 0.0 112.94 -179.02 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.54 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 -173.39 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.94 151.9 8.25 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.739 1.161 . . . . 0.0 112.103 -168.417 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -71.34 143.27 50.3 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.557 0.743 . . . . 0.0 112.292 -176.708 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 179.93 -152.38 10.84 Favored Glycine 0 CA--C 1.531 1.063 0 C-N-CA 126.278 1.894 . . . . 0.0 111.813 -179.909 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -93.8 101.28 2.73 Favored Glycine 0 N--CA 1.469 0.896 0 C-N-CA 123.955 0.788 . . . . 0.0 111.407 174.277 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.89 127.26 32.03 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.545 1.138 . . . . 0.0 108.84 170.686 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 38.1 m -129.25 156.25 44.28 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.239 1.416 . . . . 0.0 112.229 -176.71 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 47.0 tp -158.91 133.41 7.96 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.073 1.749 . . . . 0.0 108.517 -171.353 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -155.69 156.34 34.77 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.777 0.831 . . . . 0.0 112.065 179.082 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 43.7 mt -138.81 130.69 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.606 1.162 . . . . 0.0 109.682 177.728 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -116.73 162.56 17.49 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.171 1.788 . . . . 0.0 109.817 172.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 171.2 -160.52 32.83 Favored Glycine 0 CA--C 1.538 1.512 0 O-C-N 121.119 -0.988 . . . . 0.0 114.705 -179.163 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -64.95 -24.56 60.36 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 124.049 3.166 . . . . 0.0 112.415 176.279 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 13.3 t -140.25 159.99 40.96 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.291 1.437 . . . . 0.0 109.455 164.423 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 19.7 tptp -77.22 114.05 15.62 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.979 -1.075 . . . . 0.0 110.816 179.63 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -69.69 150.77 46.62 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.657 0.783 . . . . 0.0 112.15 178.599 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -91.16 139.38 30.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.766 0.826 . . . . 0.0 109.338 168.237 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 32.7 mt -134.77 144.01 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.485 1.114 . . . . 0.0 110.54 -165.717 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.5 t -142.46 165.6 26.97 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.983 1.313 . . . . 0.0 111.156 166.625 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.2 p -160.16 157.48 28.45 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.78 1.232 . . . . 0.0 112.606 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 86.9 m -139.9 123.67 17.42 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.553 1.541 . . . . 0.0 110.053 -173.212 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 21.4 t70 -78.27 133.48 37.67 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.802 1.241 . . . . 0.0 111.2 171.608 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 63.9 m-20 -114.12 145.55 41.48 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.598 1.559 . . . . 0.0 111.694 -179.645 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -69.86 -13.09 62.09 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.83 0.852 . . . . 0.0 112.695 174.14 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.96 -3.18 24.31 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.811 1.645 . . . . 0.0 113.816 174.015 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.09 31.91 9.39 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.675 1.131 . . . . 0.0 113.877 176.962 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 61.7 p -138.95 158.62 43.87 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.047 1.339 . . . . 0.0 111.409 178.587 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 88.0 m -105.35 132.59 51.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.607 1.163 . . . . 0.0 109.021 155.818 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.9 t -93.8 148.44 22.12 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.054 0.942 . . . . 0.0 110.002 166.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 98.3 t -127.06 144.37 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.871 1.668 . . . . 0.0 110.122 -176.154 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 88.4 p -136.16 147.76 47.85 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.9 1.28 . . . . 0.0 111.868 166.5 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.23 154.99 36.86 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 114.265 1.209 . . . . 0.0 114.265 177.405 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 23.4 mt -120.73 107.55 38.19 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.662 1.985 . . . . 0.0 110.318 179.76 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -83.06 175.86 8.09 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.809 3.006 . . . . 0.0 110.337 166.179 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 12.4 p -148.98 -29.55 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -173.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 79.2 mt -107.56 146.71 33.89 Favored Pre-proline 0 CA--C 1.544 0.722 0 CA-C-N 119.723 1.147 . . . . 0.0 110.503 166.096 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.48 156.2 45.39 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.838 2.359 . . . . 0.0 110.96 176.075 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 134.98 -163.61 24.79 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.976 1.274 . . . . 0.0 113.358 -177.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -94.51 130.07 41.06 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.873 1.269 . . . . 0.0 112.413 178.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -115.03 139.45 49.85 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.195 1.798 . . . . 0.0 110.778 177.904 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 59.7 m -99.27 119.94 38.73 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.699 1.2 . . . . 0.0 110.335 178.036 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.6 mp -101.75 126.94 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.382 1.473 . . . . 0.0 108.401 -179.373 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.7 tt -110.74 131.93 54.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.623 1.569 . . . . 0.0 109.838 177.339 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 40.0 t -133.51 128.15 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 C-N-CA 124.352 1.061 . . . . 0.0 109.762 172.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.4 143.16 23.74 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.108 1.363 . . . . 0.0 111.662 -168.102 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -141.7 119.26 11.66 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.514 1.126 . . . . 0.0 110.224 -179.828 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.9 t-20 57.84 58.92 3.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.614 1.565 . . . . 0.0 111.762 179.036 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.283 10.1 pt-20 54.52 21.97 3.65 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.891 2.476 . . . . 0.0 115.764 -178.833 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -132.8 127.69 35.12 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.037 1.335 . . . . 0.0 110.439 177.167 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -66.16 152.34 45.0 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.784 0.834 . . . . 0.0 112.518 175.09 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 14.8 m -65.87 150.75 96.11 Favored Pre-proline 0 N--CA 1.485 1.302 0 CA-C-O 118.185 -0.912 . . . . 0.0 109.132 162.818 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -66.74 -18.04 52.86 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.41 2.073 . . . . 0.0 114.893 -163.446 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.3 -6.58 58.71 Favored Glycine 0 CA--C 1.535 1.309 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 173.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.0 t -82.03 143.33 49.26 Favored Pre-proline 0 CA--C 1.548 0.889 0 CA-C-N 119.038 1.419 . . . . 0.0 112.045 -176.647 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 145.51 82.31 Favored 'Cis proline' 0 C--N 1.353 0.788 0 CA-C-N 119.183 0.744 . . . . 0.0 112.561 -3.231 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.62 166.13 11.65 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.385 1.874 . . . . 0.0 110.924 176.246 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 46.5 m -124.47 119.29 28.71 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.858 0.863 . . . . 0.0 110.766 177.762 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -101.46 135.29 43.2 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.868 1.267 . . . . 0.0 110.848 171.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 23.1 ttt85 -97.37 119.53 36.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.22 0.608 . . . . 0.0 110.059 173.184 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 78.5 t -104.5 131.03 54.41 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.37 1.468 . . . . 0.0 110.282 -175.611 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 52.6 p -103.27 163.57 12.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.933 1.293 . . . . 0.0 112.838 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -83.3 142.49 21.29 Favored Glycine 0 CA--C 1.533 1.176 0 C-N-CA 125.12 1.343 . . . . 0.0 112.475 177.289 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.0 t70 -81.27 -21.6 39.26 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 124.871 1.268 . . . . 0.0 112.904 175.573 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.1 t70 . . . . . 0 C--O 1.254 1.321 0 C-N-CA 126.584 1.954 . . . . 0.0 112.598 -176.705 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.444 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.1 151.59 44.32 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.203 1.001 . . . . 0.0 112.683 178.865 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 24.3 mmt -107.1 138.43 43.3 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.358 1.463 . . . . 0.0 111.615 178.891 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -88.29 150.73 47.57 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.618 1.167 . . . . 0.0 112.142 177.233 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -77.06 -13.91 17.07 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.78 2.987 . . . . 0.0 113.392 176.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -143.21 141.44 31.1 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.84 1.656 . . . . 0.0 109.42 178.434 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 23.7 mmt85 -118.05 153.47 51.25 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 125.284 1.434 . . . . 0.0 111.932 -170.549 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.57 165.04 30.64 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.725 2.95 . . . . 0.0 112.338 178.694 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -70.63 27.84 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.2 2.2 . . . . 0.0 116.224 -170.406 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 96.3 t -54.63 120.56 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.036 1.334 . . . . 0.0 109.974 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 101.07 -13.21 58.9 Favored Glycine 0 CA--C 1.535 1.324 0 C-N-CA 125.419 1.485 . . . . 0.0 114.753 -173.98 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 47.3 t -87.68 138.09 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 119.22 1.51 . . . . 0.0 109.309 172.13 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 64.1 t30 -153.19 153.05 31.97 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.871 1.269 . . . . 0.0 111.797 -178.289 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -80.37 -179.93 53.0 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.109 1.338 . . . . 0.0 113.751 178.582 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 88.0 mt -78.92 168.63 19.42 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.847 1.259 . . . . 0.0 112.413 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 47.3 t0 -153.85 168.52 26.05 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.378 1.871 . . . . 0.0 110.958 -178.107 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 13.6 p -156.93 143.33 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 C-N-CA 125.328 1.451 . . . . 0.0 111.716 -172.535 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 5.5 t -153.75 -10.97 0.15 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.121 1.526 . . . . 0.0 115.121 -173.296 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 15.4 m -75.76 26.27 0.11 Allowed 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.598 1.559 . . . . 0.0 114.072 177.799 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 25.4 tp -104.93 128.97 53.39 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 127.367 2.267 . . . . 0.0 110.03 -173.04 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 43.0 ttm-85 -61.55 120.48 56.33 Favored Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 123.902 0.881 . . . . 0.0 111.389 -169.703 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 156.27 57.74 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 123.33 2.686 . . . . 0.0 111.612 -173.766 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.0 t80 -96.38 125.39 40.85 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.554 0.742 . . . . 0.0 109.943 176.603 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -151.13 131.37 13.59 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.172 1.389 . . . . 0.0 110.663 173.25 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.38 146.41 34.9 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.539 1.936 . . . . 0.0 109.471 -173.276 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.5 p -123.59 136.4 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.835 1.254 . . . . 0.0 110.42 179.486 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 61.4 mt -135.72 138.8 29.03 Favored Pre-proline 0 N--CA 1.476 0.831 0 C-N-CA 125.879 1.672 . . . . 0.0 109.092 -174.543 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.61 43.88 1.43 Allowed 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 124.728 3.619 . . . . 0.0 113.134 177.706 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 88.5 t80 -87.09 157.51 19.39 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.316 1.446 . . . . 0.0 110.897 171.244 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 85.2 m -124.62 127.71 47.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.405 1.482 . . . . 0.0 110.128 -177.181 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 38.9 mt -88.17 128.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.503 1.121 . . . . 0.0 110.171 174.682 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -111.37 -146.96 0.41 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.926 1.691 . . . . 0.0 110.757 176.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 87.2 tttt -78.5 127.78 32.63 Favored 'General case' 0 CA--C 1.546 0.815 0 O-C-N 120.818 -1.176 . . . . 0.0 110.898 169.283 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 135.81 -148.33 19.6 Favored Glycine 0 N--CA 1.473 1.13 0 C-N-CA 125.443 1.497 . . . . 0.0 112.103 -170.804 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.71 148.58 19.44 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.677 1.191 . . . . 0.0 111.428 -174.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 11.8 tt -121.44 138.32 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 125.718 1.607 . . . . 0.0 111.398 179.214 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 45.2 p -144.54 -174.74 4.4 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 126.381 1.872 . . . . 0.0 110.317 -176.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -177.39 -169.31 38.34 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 115.351 0.9 . . . . 0.0 115.351 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -152.92 136.76 16.19 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.894 1.677 . . . . 0.0 109.8 174.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 26.9 t -108.62 134.8 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.756 1.622 . . . . 0.0 108.343 171.656 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 76.4 mtp85 -119.93 138.87 53.19 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.43 1.092 . . . . 0.0 111.594 -172.196 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -109.32 144.14 29.17 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 125.825 1.65 . . . . 0.0 111.173 -176.157 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -54.37 -30.11 61.53 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 124.125 3.216 . . . . 0.0 114.836 174.177 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 8.7 m -69.49 -2.27 10.81 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.192 1.397 . . . . 0.0 114.402 178.535 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 91.22 -1.62 77.27 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.889 1.709 . . . . 0.0 113.829 -177.016 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -79.2 160.67 26.82 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.652 1.581 . . . . 0.0 111.963 179.732 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 36.0 m -141.55 157.51 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 125.152 1.381 . . . . 0.0 111.82 178.217 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -155.65 166.93 32.02 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.244 1.817 . . . . 0.0 111.415 -179.572 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -102.52 140.09 20.8 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.836 0.854 . . . . 0.0 111.663 -179.836 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -86.47 174.98 5.65 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 124.625 3.55 . . . . 0.0 112.094 175.267 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 99.4 m -116.59 141.6 47.98 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.798 1.639 . . . . 0.0 109.052 170.855 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -129.3 135.64 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.714 1.206 . . . . 0.0 109.272 174.541 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 54.5 m -140.06 128.08 22.21 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.277 1.431 . . . . 0.0 109.72 -178.691 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -76.17 137.52 40.11 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.908 0.883 . . . . 0.0 112.288 172.448 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -89.91 -8.73 51.15 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.9 mttt 69.43 3.1 4.01 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 127.636 2.374 . . . . 0.0 114.15 -178.496 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.97 7.51 46.22 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.896 2.078 . . . . 0.0 112.821 178.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 91.43 16.81 51.96 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.942 1.258 . . . . 0.0 113.703 -173.36 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 37.7 p -132.68 159.69 38.89 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.16 1.784 . . . . 0.0 110.766 178.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 31.5 m -121.51 147.26 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 124.674 1.19 . . . . 0.0 110.226 167.099 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 97.3 m -105.33 135.03 47.45 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.827 1.251 . . . . 0.0 108.752 169.131 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 65.1 t -115.73 136.1 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 126.413 1.885 . . . . 0.0 108.467 177.974 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -138.53 159.06 43.04 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.001 1.32 . . . . 0.0 113.131 -172.838 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 19.8 t80 -159.35 137.17 10.17 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.86 1.664 . . . . 0.0 111.883 174.94 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -92.35 115.91 65.56 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 125.09 1.356 . . . . 0.0 110.736 177.311 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -83.81 156.81 13.71 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.78 2.987 . . . . 0.0 112.769 -172.011 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 49.9 m -124.88 -24.6 4.06 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 175.682 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -145.77 148.61 33.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.421 1.489 . . . . 0.0 110.915 -177.351 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -75.82 162.89 27.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.547 1.139 . . . . 0.0 113.197 177.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 133.56 -177.37 19.08 Favored Glycine 0 N--CA 1.474 1.171 0 C-N-CA 125.282 1.42 . . . . 0.0 114.15 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.2 tt -88.26 123.55 32.98 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.79 1.236 . . . . 0.0 109.115 175.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 77.2 m80 -125.45 159.05 32.88 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.219 1.407 . . . . 0.0 111.673 -172.235 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -133.18 154.79 50.31 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.566 1.147 . . . . 0.0 111.649 172.291 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 27.2 ttm -137.69 123.96 20.56 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 126.222 1.809 . . . . 0.0 109.81 -172.312 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 10.7 t70 -95.16 129.52 42.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.748 2.019 . . . . 0.0 109.429 174.118 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 29.8 mm -127.64 136.82 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 124.739 1.216 . . . . 0.0 109.87 174.362 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.08 139.13 21.09 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -179.832 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 18.0 t80 -96.6 121.09 38.05 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.492 1.917 . . . . 0.0 109.886 173.634 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.47 35.03 10.24 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 124.965 1.306 . . . . 0.0 112.858 -174.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 47.9 t30 78.55 1.93 2.6 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 128.334 2.654 . . . . 0.0 114.787 -179.66 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 60.2 ttm -102.38 133.56 47.11 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.525 1.53 . . . . 0.0 111.435 174.188 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 1.6 m170 -52.92 137.2 33.02 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 -179.615 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.2 pt -81.58 156.79 70.54 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.375 0.67 . . . . 0.0 111.204 169.425 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -60.53 130.87 35.34 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.034 1.823 . . . . 0.0 109.29 166.067 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 94.58 -2.27 67.19 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.245 0.926 . . . . 0.0 113.937 -172.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 8.4 t -93.24 145.12 29.45 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-N 118.939 1.369 . . . . 0.0 111.527 170.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -76.76 165.31 85.43 Favored 'Cis proline' 0 CA--C 1.541 0.852 0 CA-C-N 119.86 0.986 . . . . 0.0 111.606 -10.494 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 83.0 mt -105.12 154.54 20.03 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.367 1.867 . . . . 0.0 110.068 173.725 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -158.23 135.12 9.81 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.177 0.991 . . . . 0.0 111.07 -174.575 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.1 p90 -167.23 173.43 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.746 1.218 . . . . 0.0 112.815 -167.551 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 34.8 t80 -107.13 141.69 37.99 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.945 0.898 . . . . 0.0 113.149 173.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 91.0 t -110.11 131.79 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 126.807 2.043 . . . . 0.0 109.157 179.046 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -152.02 151.2 30.84 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.355 1.462 . . . . 0.0 112.792 -172.833 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -69.99 149.23 47.94 Favored 'General case' 0 N--CA 1.472 0.633 0 O-C-N 121.235 -0.916 . . . . 0.0 112.751 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.9 m -71.54 -14.66 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -171.058 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.28 -126.1 0.18 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.463 1.505 . . . . 0.0 111.334 178.704 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 75.9 m 75.1 160.7 0.23 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 128.232 2.613 . . . . 0.0 114.398 171.848 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -102.27 -17.32 20.45 Favored Glycine 0 N--CA 1.475 1.236 0 C-N-CA 125.051 1.31 . . . . 0.0 114.652 178.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -71.82 155.62 40.21 Favored 'General case' 0 CA--C 1.548 0.901 0 CA-C-N 118.685 1.242 . . . . 0.0 113.833 -179.509 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.7 t -68.01 143.22 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.604 1.162 . . . . 0.0 108.842 172.663 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 14.8 t -159.02 167.22 29.88 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.507 1.123 . . . . 0.0 110.984 -175.486 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -152.46 148.17 27.11 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.529 1.532 . . . . 0.0 111.441 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 41.3 p90 -165.51 161.14 18.42 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.799 1.64 . . . . 0.0 112.392 -173.43 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.17 169.96 12.55 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 125.105 1.336 . . . . 0.0 113.56 178.863 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.08 -30.59 38.34 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.227 2.618 . . . . 0.0 113.092 -170.407 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -69.3 -17.38 72.23 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-N 119.429 1.013 . . . . 0.0 114.586 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 63.8 mt -76.04 -15.76 60.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.042 1.421 . . . . 0.0 112.749 169.299 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 5.7 m -115.64 -39.46 3.53 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.029 1.732 . . . . 0.0 112.043 -165.711 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -151.4 150.36 30.36 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 126.086 1.754 . . . . 0.0 112.392 -172.434 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -150.83 176.87 29.19 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 125.235 1.398 . . . . 0.0 112.712 172.781 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 21.2 t -140.04 136.29 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 124.559 1.144 . . . . 0.0 108.342 175.442 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 34.0 m -57.12 137.12 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -178.272 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 60.3 m-80 65.32 3.79 2.42 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.833 2.053 . . . . 0.0 114.658 176.879 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 60.0 mtpt -118.03 138.49 25.52 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.895 1.678 . . . . 0.0 110.401 177.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.08 131.97 17.48 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.363 2.042 . . . . 0.0 111.407 -171.077 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -111.2 148.24 33.22 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.479 1.512 . . . . 0.0 110.355 172.282 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 33.2 p -137.57 149.87 47.03 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -165.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -160.28 172.89 16.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.593 1.557 . . . . 0.0 111.85 176.59 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 84.9 m -123.35 141.39 52.04 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.738 1.615 . . . . 0.0 110.482 -173.657 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 59.2 t -113.71 139.6 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.272 1.829 . . . . 0.0 107.897 168.215 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -100.48 133.17 45.31 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.228 1.011 . . . . 0.0 111.738 177.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 68.3 p -125.58 1.02 7.57 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.469 1.907 . . . . 0.0 113.039 -177.317 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 19.5 pttp -49.97 -28.63 7.12 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 127.76 2.424 . . . . 0.0 117.122 -169.86 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 27.5 t70 -139.21 20.38 2.6 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.1 1.36 . . . . 0.0 112.031 176.678 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -76.79 -41.46 44.48 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.567 1.147 . . . . 0.0 113.474 -174.845 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 80.36 146.11 4.29 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 125.007 1.289 . . . . 0.0 112.297 -171.179 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -76.13 147.16 38.74 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.832 0.853 . . . . 0.0 112.005 -179.378 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . -175.79 -42.43 0.05 OUTLIER Glycine 0 CA--C 1.531 1.063 0 C-N-CA 125.002 1.287 . . . . 0.0 113.543 176.513 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 162.03 102.17 0.17 Allowed Glycine 0 N--CA 1.47 0.943 0 C-N-CA 125.065 1.316 . . . . 0.0 112.594 170.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 33.2 tp -81.65 136.88 35.51 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.305 1.042 . . . . 0.0 110.117 176.577 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 24.0 m -129.97 157.44 42.32 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.346 1.458 . . . . 0.0 111.553 177.555 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 55.6 tp -160.68 132.35 5.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.457 1.503 . . . . 0.0 108.977 -169.589 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -158.43 162.72 37.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.877 0.871 . . . . 0.0 112.132 -179.421 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 56.6 mt -136.59 132.87 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.872 1.269 . . . . 0.0 109.074 172.54 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -115.02 157.71 23.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.704 1.602 . . . . 0.0 109.744 169.219 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . 176.6 -165.15 35.24 Favored Glycine 0 CA--C 1.536 1.359 0 O-C-N 121.192 -0.943 . . . . 0.0 113.748 -177.714 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -72.62 -15.12 27.41 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.633 2.889 . . . . 0.0 112.422 177.463 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 12.6 t -147.1 160.38 42.48 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.997 1.719 . . . . 0.0 109.255 163.488 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 52.1 tptt -83.24 113.02 20.39 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 120.868 -1.145 . . . . 0.0 111.857 -174.973 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -71.94 150.27 44.29 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.182 0.993 . . . . 0.0 111.857 173.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -97.52 145.65 26.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.888 0.875 . . . . 0.0 110.691 169.611 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 20.1 mt -137.4 140.84 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.813 1.245 . . . . 0.0 110.505 -163.631 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.9 m -133.3 157.27 45.88 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.772 1.629 . . . . 0.0 110.675 168.442 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 31.8 p -156.46 156.89 34.54 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.233 -0.917 . . . . 0.0 113.104 178.908 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.4 m -144.14 124.82 14.11 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.704 1.602 . . . . 0.0 110.078 -171.032 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -80.24 144.92 32.51 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.569 1.147 . . . . 0.0 112.535 173.951 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 64.3 m-20 -121.74 152.0 39.91 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.586 1.554 . . . . 0.0 112.062 -176.16 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 14.6 mp0 -68.23 -18.41 64.56 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.818 1.247 . . . . 0.0 112.788 176.43 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 30.2 t70 -76.55 -2.79 34.18 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.86 1.664 . . . . 0.0 114.247 -178.427 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 89.77 33.92 8.76 Favored Glycine 0 N--CA 1.472 1.093 0 C-N-CA 124.385 0.993 . . . . 0.0 113.399 -178.563 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.2 p -139.88 163.63 32.14 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.354 1.461 . . . . 0.0 111.215 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 75.0 m -121.08 132.89 55.15 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.717 1.607 . . . . 0.0 108.841 161.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.5 t -92.02 147.51 22.9 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 123.857 0.863 . . . . 0.0 110.261 170.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 91.0 t -128.95 142.97 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.561 1.544 . . . . 0.0 109.83 -179.441 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 86.2 p -132.99 147.5 52.28 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.227 1.411 . . . . 0.0 111.589 167.758 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 19.4 p90 -151.22 157.8 43.09 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 178.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 24.6 mt -124.93 108.4 28.09 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.903 1.681 . . . . 0.0 110.531 -179.481 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -82.02 168.95 15.05 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.781 2.987 . . . . 0.0 110.25 166.116 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 8.3 p -131.64 -20.59 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 -169.434 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -143.7 150.73 51.44 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.556 1.142 . . . . 0.0 110.575 173.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.65 154.39 39.47 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.929 2.419 . . . . 0.0 112.573 -168.839 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 150.34 -144.68 12.19 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.683 1.135 . . . . 0.0 112.964 -175.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -123.31 133.37 54.16 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.648 1.579 . . . . 0.0 111.49 177.365 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -123.55 134.08 53.89 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 125.44 1.496 . . . . 0.0 110.769 -174.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 74.7 m -100.06 110.32 22.62 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.996 1.318 . . . . 0.0 110.8 -178.102 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.2 mp -86.35 126.77 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.419 1.488 . . . . 0.0 108.546 176.156 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -105.33 130.98 53.33 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.764 1.626 . . . . 0.0 109.665 174.378 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 47.6 t -131.11 128.55 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.433 1.093 . . . . 0.0 109.7 172.072 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.37 141.37 21.2 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.174 1.39 . . . . 0.0 111.502 -168.505 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -137.49 121.32 17.56 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.935 1.294 . . . . 0.0 109.968 -178.768 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.5 t-20 52.65 59.07 4.74 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.541 1.536 . . . . 0.0 112.0 -179.853 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.304 7.7 pt-20 60.86 0.78 0.39 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 129.035 2.934 . . . . 0.0 116.867 -177.198 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 22.7 mm100 -107.52 123.63 48.71 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.549 1.14 . . . . 0.0 111.111 179.293 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -62.18 144.78 54.99 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.35 -0.844 . . . . 0.0 111.703 169.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 10.5 m -73.44 151.08 89.56 Favored Pre-proline 0 N--CA 1.48 1.041 0 CA-C-O 118.69 -0.671 . . . . 0.0 110.038 171.976 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -57.52 129.67 35.0 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.129 2.553 . . . . 0.0 110.762 175.341 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.13 -15.24 63.61 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.04 1.305 . . . . 0.0 115.027 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 34.5 t -77.09 139.36 65.19 Favored Pre-proline 0 CA--C 1.549 0.922 0 CA-C-N 119.223 1.511 . . . . 0.0 111.346 176.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -78.79 147.55 81.3 Favored 'Cis proline' 0 CA--C 1.539 0.755 0 CA-C-N 119.648 0.91 . . . . 0.0 112.585 -3.098 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -101.24 133.77 45.3 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.837 1.655 . . . . 0.0 110.59 -178.887 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 24.6 m -97.67 108.66 21.43 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.552 0.741 . . . . 0.0 110.847 -177.08 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -93.34 132.84 37.18 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.014 1.326 . . . . 0.0 111.886 176.328 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 22.0 tpt85 -88.15 113.29 23.63 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.076 1.35 . . . . 0.0 110.482 178.771 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 97.0 t -103.49 129.56 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 C-N-CA 124.048 0.939 . . . . 0.0 110.758 -176.422 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 69.6 p -110.11 162.47 14.54 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 125.019 1.327 . . . . 0.0 112.977 -179.683 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -84.57 135.44 13.6 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.938 1.256 . . . . 0.0 112.345 178.003 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.1 t70 -85.84 -23.53 27.1 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.577 1.151 . . . . 0.0 112.937 175.684 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.7 t70 . . . . . 0 C--O 1.255 1.354 0 C-N-CA 125.789 1.635 . . . . 0.0 113.796 -179.535 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.687 -0.565 . . . . 0.0 111.687 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -71.01 -28.81 64.68 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -177.209 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 15.2 tpt -162.1 138.51 7.89 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.001 1.721 . . . . 0.0 110.998 178.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -167.69 149.53 5.2 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 126.873 2.069 . . . . 0.0 110.748 177.419 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.18 140.12 30.44 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 123.269 2.646 . . . . 0.0 110.893 176.347 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -166.96 148.13 5.87 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.78 1.632 . . . . 0.0 110.28 -177.17 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -63.29 154.78 77.21 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.914 0.886 . . . . 0.0 113.144 177.656 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.36 145.39 53.57 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.991 2.461 . . . . 0.0 110.655 168.617 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 90.5 mt -116.7 15.48 15.43 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.287 1.435 . . . . 0.0 112.548 -177.376 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 59.2 t -68.2 135.97 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 125.538 1.535 . . . . 0.0 110.811 -176.588 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -171.4 -169.25 34.09 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.068 1.318 . . . . 0.0 113.639 178.728 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 26.1 t 81.27 134.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 128.515 2.726 . . . . 0.0 111.115 177.941 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 50.0 t30 -156.14 145.46 20.73 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.399 1.48 . . . . 0.0 111.396 179.525 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -79.04 137.65 19.57 Favored Glycine 0 CA--C 1.532 1.144 0 C-N-CA 124.583 1.087 . . . . 0.0 112.588 -179.669 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.9 mt -142.22 167.05 23.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.712 2.005 . . . . 0.0 110.535 -179.565 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 46.3 t0 -154.4 159.52 41.15 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.204 1.402 . . . . 0.0 111.874 179.084 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 61.7 t -91.8 133.46 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 125.788 1.635 . . . . 0.0 109.597 179.365 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 9.0 t -172.88 -35.49 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.56 1.544 . . . . 0.0 113.069 -175.437 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 14.8 m -67.85 139.91 56.55 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 -162.046 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 31.6 mt -76.24 144.27 40.49 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.254 1.022 . . . . 0.0 109.549 157.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 47.4 ttm-85 -67.28 117.9 51.04 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 125.817 1.647 . . . . 0.0 110.215 -175.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -71.2 151.11 60.48 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.212 2.608 . . . . 0.0 111.572 -171.463 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.4 t80 -101.16 119.5 38.84 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.938 0.895 . . . . 0.0 109.689 176.339 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -147.81 131.13 16.55 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.136 1.374 . . . . 0.0 110.398 172.38 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.78 148.31 35.43 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.071 1.748 . . . . 0.0 109.756 -171.054 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 12.4 p -119.94 139.56 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.043 1.337 . . . . 0.0 110.56 -179.82 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 56.3 mt -133.92 137.49 28.57 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 126.164 1.786 . . . . 0.0 108.465 -176.107 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -79.36 46.7 2.28 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.332 3.354 . . . . 0.0 112.861 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 37.2 t80 -91.41 155.05 18.75 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.362 1.465 . . . . 0.0 111.072 174.81 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 89.3 m -125.25 126.35 45.02 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.882 1.273 . . . . 0.0 109.831 177.866 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 84.3 mt -95.69 115.23 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 124.573 1.149 . . . . 0.0 109.077 177.477 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 88.4 tttt -84.79 -55.52 4.05 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.627 0.771 . . . . 0.0 112.992 179.656 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 86.9 tttt -161.82 -35.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.852 1.261 . . . . 0.0 114.002 -171.536 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . -72.53 164.9 54.6 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.226 1.393 . . . . 0.0 113.801 179.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -86.42 142.71 28.22 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.871 1.269 . . . . 0.0 112.212 -174.515 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.86 134.39 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 125.58 1.552 . . . . 0.0 110.459 174.591 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 31.1 p -145.68 173.03 12.43 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.998 1.719 . . . . 0.0 110.738 -175.082 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -152.72 -176.62 25.48 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 115.651 1.02 . . . . 0.0 115.651 -177.658 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -151.43 137.72 18.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.938 1.695 . . . . 0.0 109.057 171.026 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 53.3 t -111.69 133.29 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 126.054 1.742 . . . . 0.0 108.131 174.179 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 43.5 mtp180 -109.28 129.96 55.5 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 125.237 1.415 . . . . 0.0 110.626 -176.625 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 3.2 mpp? -96.21 151.79 38.4 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 125.621 1.568 . . . . 0.0 111.411 -176.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -66.99 -24.85 45.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.294 2.663 . . . . 0.0 113.213 -179.093 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 20.3 m -73.91 -1.09 18.21 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 172.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 93.27 -1.84 70.41 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.736 1.636 . . . . 0.0 114.624 179.759 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 38.6 mtpt -71.75 163.76 27.21 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.221 1.408 . . . . 0.0 112.301 176.263 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 30.7 m -139.74 153.39 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.219 1.408 . . . . 0.0 111.873 175.647 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -158.43 166.55 31.95 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.852 2.061 . . . . 0.0 110.41 179.096 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -106.06 141.57 23.01 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.188 -0.945 . . . . 0.0 112.444 -177.823 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -85.24 172.64 8.29 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 124.67 3.58 . . . . 0.0 111.658 173.332 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 90.9 m -109.34 125.58 52.49 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.322 1.449 . . . . 0.0 108.899 172.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.2 mp -102.02 129.46 53.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.407 1.083 . . . . 0.0 108.42 173.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 85.5 m -118.77 128.33 54.38 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.149 1.78 . . . . 0.0 109.674 -178.43 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 37.9 t0 -78.42 119.92 22.43 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.246 1.018 . . . . 0.0 110.465 170.615 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -84.67 -14.43 48.54 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 178.243 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.3 mttt 71.5 -3.36 2.15 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 127.788 2.435 . . . . 0.0 114.514 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -92.8 5.57 50.73 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 126.297 1.839 . . . . 0.0 113.319 178.515 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 90.63 19.02 46.03 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 124.694 1.14 . . . . 0.0 113.53 -172.504 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -131.98 162.0 31.78 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 126.519 1.928 . . . . 0.0 109.966 175.216 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.1 m -126.1 147.13 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 124.766 1.226 . . . . 0.0 109.978 168.413 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 52.1 m -108.75 135.22 50.34 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.376 1.071 . . . . 0.0 108.568 171.328 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 22.0 t -117.63 131.49 70.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.309 1.444 . . . . 0.0 108.797 -179.993 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.08 151.27 51.86 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.012 1.325 . . . . 0.0 112.504 -173.261 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 20.7 t80 -151.05 136.08 17.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.38 1.472 . . . . 0.0 111.764 176.825 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -89.86 115.62 64.35 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 124.764 1.225 . . . . 0.0 110.827 177.792 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.03 140.43 25.37 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 123.826 3.018 . . . . 0.0 112.918 -172.117 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 88.2 p -116.78 -8.45 11.37 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.705 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -162.29 157.48 22.89 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.044 1.738 . . . . 0.0 111.579 179.487 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -83.78 172.62 12.02 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.458 1.103 . . . . 0.0 112.377 174.058 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 109.95 -172.17 15.57 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 125.527 1.537 . . . . 0.0 113.62 178.778 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -82.83 130.9 35.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.502 1.121 . . . . 0.0 110.233 -178.581 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 56.5 m80 -128.89 162.08 28.36 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.913 1.685 . . . . 0.0 111.612 -173.786 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -141.98 159.5 42.11 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.28 1.032 . . . . 0.0 111.696 172.943 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.1 ttm -139.44 134.52 32.48 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.963 1.705 . . . . 0.0 110.607 -171.8 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -110.24 136.16 49.87 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.211 1.804 . . . . 0.0 109.922 172.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 30.0 mm -133.1 132.1 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 125.146 1.378 . . . . 0.0 109.951 178.118 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.94 138.19 28.32 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 114.241 1.2 . . . . 0.0 114.241 -176.972 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 26.8 t80 -102.47 121.03 41.53 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 127.478 2.311 . . . . 0.0 109.586 176.32 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 51.07 38.4 20.59 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 124.832 1.253 . . . . 0.0 112.551 -174.844 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . 0.256 0.0 OUTLIER 78.89 -9.0 1.57 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 128.906 2.883 . . . . 0.0 115.174 -178.392 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 67.7 mtm -95.53 129.82 42.58 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.208 1.403 . . . . 0.0 111.187 178.926 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 6.9 m-70 -59.12 138.33 57.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.208 -0.933 . . . . 0.0 113.438 -177.309 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 33.4 pt -71.81 153.05 93.26 Favored Pre-proline 0 N--CA 1.48 1.044 0 CA-C-O 118.426 -0.797 . . . . 0.0 110.044 169.645 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -65.65 -18.37 58.65 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.407 2.071 . . . . 0.0 113.9 -174.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -85.83 0.52 87.9 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 124.771 1.177 . . . . 0.0 114.685 171.485 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 30.0 t -97.2 142.6 24.78 Favored Pre-proline 0 CA--C 1.547 0.835 0 CA-C-N 119.652 1.726 . . . . 0.0 111.539 176.533 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -81.53 165.7 74.06 Favored 'Cis proline' 0 C--N 1.352 0.733 0 CA-C-N 119.842 0.979 . . . . 0.0 112.854 -1.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 86.2 mt -112.93 159.54 18.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.22 1.808 . . . . 0.0 110.665 170.282 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -155.49 139.6 16.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.638 1.175 . . . . 0.0 110.137 -173.381 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 2.0 p90 -167.33 -175.69 3.0 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.906 1.282 . . . . 0.0 112.382 -170.429 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 40.4 t80 -124.02 141.58 51.92 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.89 1.276 . . . . 0.0 112.679 178.23 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 54.7 t -110.9 142.38 23.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.099 1.76 . . . . 0.0 109.434 176.724 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 26.2 t0 -150.03 169.39 21.33 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.801 2.04 . . . . 0.0 109.954 -171.607 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -77.32 143.57 38.71 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 120.513 -1.367 . . . . 0.0 111.187 170.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 27.7 m -61.94 -26.87 41.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -175.152 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -128.75 134.18 48.34 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.307 1.443 . . . . 0.0 110.045 166.814 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 7.6 t -164.66 156.56 15.86 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.934 1.694 . . . . 0.0 110.724 178.274 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -84.6 58.23 4.99 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.172 1.367 . . . . 0.0 113.525 -173.857 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -155.5 167.79 29.23 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -179.3 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 14.0 p -71.49 147.26 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 C-N-CA 124.382 1.073 . . . . 0.0 109.582 159.436 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 12.5 t -160.02 167.96 26.7 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.087 1.355 . . . . 0.0 110.487 178.355 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -150.68 145.48 25.86 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.566 1.146 . . . . 0.0 111.845 -179.119 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.6 p90 -168.74 166.77 11.51 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.786 1.634 . . . . 0.0 112.578 -173.757 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 131.89 174.63 13.7 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 125.3 1.428 . . . . 0.0 112.542 -177.279 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.17 -36.1 13.06 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.685 2.257 . . . . 0.0 112.87 -170.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -66.48 -34.41 87.65 Favored Glycine 0 CA--C 1.531 1.055 0 CA-C-N 119.45 1.023 . . . . 0.0 114.589 -170.738 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.13 -2.08 39.08 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 118.912 1.356 . . . . 0.0 113.498 175.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 31.3 m -108.17 -51.39 2.9 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.28 1.832 . . . . 0.0 110.926 177.529 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -138.4 144.71 40.34 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.537 1.935 . . . . 0.0 112.522 -176.731 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -141.22 178.27 20.4 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.985 1.278 . . . . 0.0 112.912 171.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 41.2 t -141.67 138.13 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.852 1.261 . . . . 0.0 108.259 174.501 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.9 m -59.96 149.17 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -179.062 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 77.6 m-20 67.2 14.76 9.86 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 126.425 1.89 . . . . 0.0 114.382 169.838 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -145.56 152.84 50.34 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 125.874 1.67 . . . . 0.0 111.236 174.211 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.74 145.66 32.82 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.497 2.131 . . . . 0.0 112.145 -174.616 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -121.46 150.83 40.99 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.409 1.884 . . . . 0.0 110.043 170.621 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 34.8 p -137.71 149.97 46.93 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -165.487 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.9 p90 -159.07 175.96 12.86 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.78 1.632 . . . . 0.0 111.457 175.341 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 88.6 m -129.71 140.42 51.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.944 1.298 . . . . 0.0 110.727 -172.045 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 34.2 t -105.2 133.27 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 125.443 1.497 . . . . 0.0 107.906 168.217 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -100.43 126.69 46.85 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.703 1.201 . . . . 0.0 110.446 174.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 42.1 p -126.51 5.4 6.87 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.849 2.06 . . . . 0.0 113.066 -171.604 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 61.2 tttp -51.74 -37.5 51.39 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.241 1.817 . . . . 0.0 115.104 -170.241 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 25.7 t70 -116.36 9.73 14.52 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 125.403 1.481 . . . . 0.0 113.014 178.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -80.62 -10.94 59.71 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.941 1.46 . . . . 0.0 114.941 -171.097 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 86.37 -125.68 7.5 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.453 1.025 . . . . 0.0 112.446 179.059 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -153.02 149.5 28.22 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.387 1.475 . . . . 0.0 110.878 -173.901 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 157.84 -155.78 26.74 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.585 1.564 . . . . 0.0 112.736 -178.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -88.1 108.14 3.38 Favored Glycine 0 N--CA 1.469 0.883 0 C-N-CA 124.127 0.87 . . . . 0.0 111.504 174.416 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.74 128.17 34.33 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.201 1.4 . . . . 0.0 108.722 171.84 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.6 m -133.74 160.24 38.18 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.032 1.333 . . . . 0.0 112.854 -173.299 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 37.3 tp -158.46 138.53 12.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.491 1.916 . . . . 0.0 108.951 -171.569 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.15 157.19 35.54 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.071 0.948 . . . . 0.0 111.944 174.85 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 47.7 mt -138.35 140.29 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 124.875 1.27 . . . . 0.0 109.741 177.05 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -131.22 144.04 51.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.652 1.581 . . . . 0.0 109.877 173.723 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -168.34 -166.0 26.67 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-O 118.976 -0.902 . . . . 0.0 114.958 -175.242 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.58 -26.33 69.5 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 124.477 3.451 . . . . 0.0 112.843 178.436 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 23.1 t -141.72 156.26 45.61 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.986 1.314 . . . . 0.0 109.093 161.039 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 56.4 tptt -72.31 110.72 6.93 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.193 -0.942 . . . . 0.0 111.258 -177.739 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -67.88 148.38 51.22 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.853 0.861 . . . . 0.0 111.372 172.229 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -84.33 146.34 27.77 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.818 0.447 . . . . 0.0 110.159 165.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.0 mt -136.24 143.97 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 125.029 1.332 . . . . 0.0 109.856 -165.182 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 8.6 t -145.58 163.24 35.41 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.693 1.197 . . . . 0.0 111.418 168.946 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 27.5 p -161.34 152.43 18.5 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.991 1.317 . . . . 0.0 112.305 -178.606 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 95.1 m -137.96 121.92 17.79 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.637 1.575 . . . . 0.0 109.692 -175.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 12.3 t0 -71.55 119.3 15.52 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.452 0.701 . . . . 0.0 109.966 165.872 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -81.66 -16.79 50.24 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.345 0.658 . . . . 0.0 112.656 179.797 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 10.3 tt0 72.71 -8.8 1.18 Allowed 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 128.08 2.552 . . . . 0.0 113.072 -176.286 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 29.6 t70 -84.36 11.61 8.17 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.972 2.109 . . . . 0.0 113.494 -177.368 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 91.84 15.34 54.73 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.187 1.375 . . . . 0.0 113.605 -171.869 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 65.9 p -141.66 154.17 45.18 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.651 1.58 . . . . 0.0 111.754 177.419 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 35.3 m -120.87 131.24 54.29 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.662 1.585 . . . . 0.0 108.988 164.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 19.5 t -88.17 149.4 23.91 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.923 0.889 . . . . 0.0 110.838 173.125 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 87.7 t -132.58 143.14 40.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 125.632 1.573 . . . . 0.0 110.121 -177.229 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 92.8 p -137.28 150.32 47.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 124.876 1.27 . . . . 0.0 112.252 168.852 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 15.9 p90 -152.24 155.05 36.98 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.138 -0.976 . . . . 0.0 112.462 173.974 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 1.7 tt -126.38 99.98 29.88 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 124.398 1.079 . . . . 0.0 109.998 -174.461 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -83.21 162.21 15.32 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 124.069 3.179 . . . . 0.0 111.083 176.41 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 27.8 m -133.77 -20.42 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -172.441 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 78.6 mt -118.65 147.32 41.86 Favored Pre-proline 0 N--CA 1.474 0.755 0 C-N-CA 124.849 1.259 . . . . 0.0 110.261 170.21 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 158.76 43.61 Favored 'Trans proline' 0 CA--C 1.537 0.641 0 C-N-CA 122.883 2.388 . . . . 0.0 111.019 176.385 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 128.08 -163.79 21.58 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 124.967 1.27 . . . . 0.0 113.213 -177.048 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -89.81 136.9 32.77 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 124.828 1.251 . . . . 0.0 112.921 -178.957 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -124.78 129.98 51.51 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 125.743 1.617 . . . . 0.0 110.031 176.429 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 70.3 m -88.81 126.19 35.24 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.903 0.881 . . . . 0.0 110.436 174.838 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.7 mp -106.71 126.23 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.465 1.506 . . . . 0.0 108.047 178.643 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.4 tt -108.94 131.84 54.65 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 125.474 1.509 . . . . 0.0 109.442 175.651 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.85 129.09 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.392 1.077 . . . . 0.0 109.383 172.739 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -148.78 143.39 26.34 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.225 1.41 . . . . 0.0 111.59 -168.36 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -143.83 122.18 12.34 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 124.597 1.159 . . . . 0.0 110.341 179.748 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.7 t-20 57.67 56.24 5.01 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.315 1.446 . . . . 0.0 111.732 -179.406 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.29 10.0 pt-20 54.78 22.34 4.11 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 127.903 2.481 . . . . 0.0 115.898 -179.113 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -132.84 131.39 40.95 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.071 1.348 . . . . 0.0 110.542 176.804 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -64.58 150.32 47.12 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.796 0.838 . . . . 0.0 112.299 174.788 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.7 m -67.69 156.29 89.37 Favored Pre-proline 0 N--CA 1.482 1.151 0 CA-C-O 118.004 -0.998 . . . . 0.0 110.103 167.833 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -52.28 -33.67 56.39 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 124.042 3.161 . . . . 0.0 116.378 -169.388 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . -96.98 -3.21 59.17 Favored Glycine 0 CA--C 1.533 1.163 0 N-CA-C 115.756 1.062 . . . . 0.0 115.756 179.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 41.6 t -84.12 143.02 41.87 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-N 118.983 1.392 . . . . 0.0 112.355 -177.316 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.26 138.14 54.17 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.062 0.701 . . . . 0.0 111.812 -4.449 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -89.48 168.3 12.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 125.862 1.665 . . . . 0.0 110.292 172.843 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 25.0 m -131.76 116.86 17.82 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.589 0.756 . . . . 0.0 110.069 172.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -91.46 152.93 20.16 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.746 1.219 . . . . 0.0 110.785 170.113 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -108.87 129.08 55.4 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.516 0.726 . . . . 0.0 110.19 166.521 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 86.8 t -105.06 129.22 58.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.318 1.447 . . . . 0.0 110.135 179.242 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 86.9 m -95.99 152.56 18.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.0 1.72 . . . . 0.0 111.495 -178.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -80.27 133.35 12.18 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.871 1.224 . . . . 0.0 112.079 175.289 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 37.2 t70 -80.32 -25.6 39.21 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.751 1.22 . . . . 0.0 113.484 -177.157 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.7 t70 . . . . . 0 C--O 1.254 1.34 0 C-N-CA 126.48 1.912 . . . . 0.0 112.675 -176.206 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.537 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -72.94 157.64 37.03 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.289 1.036 . . . . 0.0 112.744 177.849 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 26.0 mmt -79.04 -22.76 44.92 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.111 0.964 . . . . 0.0 113.53 -179.414 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -75.65 135.28 71.76 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 124.23 1.012 . . . . 0.0 112.241 -177.808 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.35 172.04 14.14 Favored 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 123.948 3.099 . . . . 0.0 111.707 176.017 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -158.03 149.38 21.31 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.46 1.504 . . . . 0.0 111.026 173.971 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -137.77 148.39 60.71 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 125.812 1.645 . . . . 0.0 111.486 -179.244 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -77.25 170.02 20.3 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.931 3.087 . . . . 0.0 111.734 175.436 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 61.7 tp -146.86 126.47 13.33 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.281 1.433 . . . . 0.0 109.101 172.672 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 11.5 p -168.3 154.9 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.176 1.39 . . . . 0.0 111.035 -169.424 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . 86.31 -68.77 3.26 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.029 1.299 . . . . 0.0 113.154 171.054 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 13.1 p -165.16 146.25 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 125.212 1.405 . . . . 0.0 111.588 -173.596 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 3.9 p30 -161.69 159.38 27.3 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.658 1.983 . . . . 0.0 111.03 173.198 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -72.24 114.68 5.08 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 123.951 0.786 . . . . 0.0 112.554 -172.966 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 97.0 mt -143.46 151.07 39.9 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.331 1.852 . . . . 0.0 110.546 -176.967 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 32.0 t70 70.93 -52.79 0.68 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 128.354 2.662 . . . . 0.0 113.718 170.688 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . 0.469 ' HA ' HD21 ' A' 1864 ' ' ASN . 9.8 p -61.95 -24.59 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 125.591 1.556 . . . . 0.0 112.998 176.672 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 8.4 t -90.97 -11.69 38.21 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.176 1.79 . . . . 0.0 113.062 178.612 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 49.5 m -80.1 116.07 20.01 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.012 -1.055 . . . . 0.0 113.753 -166.037 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 92.2 mt -77.01 149.77 35.85 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.324 1.05 . . . . 0.0 110.145 159.187 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -56.27 115.54 10.19 Favored Pre-proline 0 CA--C 1.542 0.654 0 C-N-CA 125.287 1.435 . . . . 0.0 110.362 177.445 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.72 133.41 27.48 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.117 1.878 . . . . 0.0 108.682 174.122 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 2.9 t80 -87.02 128.04 35.09 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 109.947 -179.796 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.93 150.51 25.97 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.351 1.461 . . . . 0.0 111.652 -179.306 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -159.62 151.57 20.57 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.856 1.662 . . . . 0.0 109.893 -177.123 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 14.7 p -123.81 134.5 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.005 1.322 . . . . 0.0 109.655 170.845 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 66.7 mt -131.77 135.98 27.66 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 125.919 1.688 . . . . 0.0 109.215 -172.692 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -71.02 112.77 3.38 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 123.209 2.606 . . . . 0.0 110.208 173.873 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 46.8 t80 -174.94 147.6 0.98 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.026 2.13 . . . . 0.0 109.278 -171.683 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 52.5 m -125.63 127.0 45.62 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.574 1.15 . . . . 0.0 109.803 -178.993 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 55.6 mt -82.82 113.74 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.731 0.812 . . . . 0.0 109.436 174.883 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -98.33 -158.53 0.68 Allowed 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.213 1.405 . . . . 0.0 111.006 172.006 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 60.7 tptt -68.5 120.36 14.43 Favored 'General case' 0 CA--C 1.547 0.862 0 O-C-N 120.603 -1.311 . . . . 0.0 111.091 173.104 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 146.64 -147.61 18.63 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.676 1.608 . . . . 0.0 111.867 -171.066 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -158.78 143.46 15.89 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.3 1.04 . . . . 0.0 111.496 -175.118 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.9 tt -128.95 136.44 59.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.731 1.612 . . . . 0.0 110.946 177.076 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 40.9 p -147.64 -178.37 6.22 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.337 1.855 . . . . 0.0 110.372 -176.765 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -166.52 -170.55 31.57 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 115.26 0.864 . . . . 0.0 115.26 179.027 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -149.72 139.81 22.08 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.317 1.847 . . . . 0.0 109.151 178.264 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 45.1 t -113.67 135.53 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 126.3 1.84 . . . . 0.0 108.178 170.647 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -119.02 138.15 53.03 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.166 1.387 . . . . 0.0 111.947 -178.386 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.5 mpp? -114.05 141.57 26.51 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 125.831 1.652 . . . . 0.0 111.399 -178.875 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -59.99 -25.13 78.77 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.126 3.217 . . . . 0.0 115.017 177.144 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.3 p -74.71 4.35 6.42 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.861 1.664 . . . . 0.0 114.655 -177.831 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.84 41.15 6.04 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 124.606 1.098 . . . . 0.0 113.293 172.961 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -148.67 163.89 35.94 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.63 1.572 . . . . 0.0 111.938 -175.058 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.5 161.28 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 125.011 1.324 . . . . 0.0 112.231 -174.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -154.02 -178.25 6.96 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 127.088 2.155 . . . . 0.0 110.22 178.051 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -127.04 146.23 56.93 Favored Pre-proline 0 CA--C 1.543 0.696 0 O-C-N 121.065 -1.022 . . . . 0.0 111.419 176.581 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -83.33 166.18 14.23 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.207 3.271 . . . . 0.0 111.49 177.857 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 93.8 m -101.98 134.21 45.55 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.319 1.448 . . . . 0.0 108.585 170.131 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 4.7 mp -119.17 132.91 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.799 1.239 . . . . 0.0 109.013 175.019 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 59.7 m -138.6 122.32 17.55 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.243 1.417 . . . . 0.0 109.465 178.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -76.63 131.8 39.07 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.865 0.866 . . . . 0.0 111.73 171.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -83.44 1.68 40.44 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 114.151 1.167 . . . . 0.0 114.151 -173.041 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 69.7 mmtt 69.51 16.86 8.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 126.624 1.97 . . . . 0.0 112.991 179.639 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 28.2 t70 -138.66 16.82 2.7 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 126.18 1.792 . . . . 0.0 113.015 -169.545 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 88.74 13.27 63.03 Favored Glycine 0 CA--C 1.535 1.298 0 C-N-CA 124.596 1.093 . . . . 0.0 115.132 177.184 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 77.9 p -129.44 155.94 44.89 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.835 1.654 . . . . 0.0 110.41 174.843 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 34.0 m -115.42 138.37 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.886 0.875 . . . . 0.0 110.202 167.192 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 36.4 m -96.03 136.43 36.49 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.731 1.212 . . . . 0.0 108.429 167.964 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 52.9 t -121.78 135.85 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 125.791 1.636 . . . . 0.0 108.399 178.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -140.63 159.33 42.44 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.562 1.145 . . . . 0.0 113.139 -175.839 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 33.0 t80 -154.59 134.25 12.82 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.942 1.697 . . . . 0.0 111.538 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -84.46 121.75 75.08 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 124.381 1.072 . . . . 0.0 111.205 179.207 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -77.44 156.68 32.65 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.741 2.96 . . . . 0.0 111.857 -176.558 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 6.1 t -140.75 -13.76 0.96 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 176.516 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -165.38 151.54 9.8 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.348 1.859 . . . . 0.0 110.657 -176.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -77.02 168.45 20.07 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.427 1.091 . . . . 0.0 113.444 -177.602 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 125.04 -179.97 15.94 Favored Glycine 0 N--CA 1.474 1.168 0 C-N-CA 125.346 1.45 . . . . 0.0 114.157 176.723 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 2.0 tt -86.66 122.37 30.48 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.758 1.223 . . . . 0.0 109.821 179.771 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 26.2 m80 -116.99 160.82 20.36 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.698 1.599 . . . . 0.0 111.619 -173.113 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -142.78 144.21 32.5 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.978 1.311 . . . . 0.0 110.304 -178.557 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 26.5 ttm -135.39 141.02 45.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.827 1.251 . . . . 0.0 112.613 -176.386 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.09 139.57 35.57 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.737 1.615 . . . . 0.0 110.405 163.667 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 24.4 mm -127.84 131.61 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.702 1.201 . . . . 0.0 109.272 163.63 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.31 134.69 23.06 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 -176.106 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 13.7 t80 -98.03 122.83 41.63 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.573 1.949 . . . . 0.0 109.632 174.655 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.1 t70 50.83 36.43 14.59 Favored 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.723 1.209 . . . . 0.0 112.824 -175.462 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 52.7 t30 77.78 3.18 2.97 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 128.107 2.563 . . . . 0.0 114.614 179.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.0 mtm -105.64 130.21 53.72 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.583 1.553 . . . . 0.0 111.079 176.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -54.28 137.22 41.93 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -178.773 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 24.6 pt -77.05 156.18 82.25 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-O 118.893 -0.575 . . . . 0.0 111.228 171.024 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -59.82 128.53 27.14 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.111 1.874 . . . . 0.0 109.718 169.977 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 99.92 -16.9 57.99 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.784 1.183 . . . . 0.0 114.072 -174.426 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 28.4 t -83.22 144.75 47.43 Favored Pre-proline 0 CA--C 1.548 0.902 0 CA-C-N 119.347 1.574 . . . . 0.0 110.664 170.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.43 160.24 93.94 Favored 'Cis proline' 0 C--N 1.352 0.744 0 CA-C-N 120.209 1.11 . . . . 0.0 113.048 -2.638 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 66.5 mt -108.97 154.07 22.69 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.661 1.984 . . . . 0.0 110.288 179.193 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -156.4 134.41 11.19 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.039 0.936 . . . . 0.0 110.96 -173.025 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 1.3 p90 -164.08 -177.53 5.07 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.623 1.169 . . . . 0.0 112.779 -172.486 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.4 t80 -122.4 137.44 54.86 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.67 1.188 . . . . 0.0 113.189 177.253 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 90.4 t -100.75 134.59 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.644 1.577 . . . . 0.0 109.573 174.481 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 18.6 t0 -156.51 169.25 25.08 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.242 1.817 . . . . 0.0 110.301 -179.519 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -69.45 142.78 53.73 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.073 -1.017 . . . . 0.0 112.7 176.622 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 53.6 t -67.02 -36.14 76.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 124.207 1.003 . . . . 0.0 112.556 -172.245 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . 0.469 HD21 ' HA ' ' A' 1785 ' ' VAL . 45.8 p-10 -121.61 20.04 11.1 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.533 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 28.5 p -61.4 158.93 13.55 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.922 1.289 . . . . 0.0 114.413 -176.203 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -82.42 -29.65 35.86 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.331 0.967 . . . . 0.0 113.661 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -71.55 153.7 41.98 Favored 'General case' 0 CA--C 1.549 0.942 0 CA-C-N 118.253 1.027 . . . . 0.0 112.583 173.472 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 3.8 t -70.17 131.18 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.823 0.849 . . . . 0.0 109.269 179.505 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 3.3 t -155.0 164.11 39.37 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.591 1.157 . . . . 0.0 111.249 -178.391 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.17 149.22 42.71 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.618 1.167 . . . . 0.0 112.337 -175.966 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 4.2 p90 -161.93 158.62 25.55 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.643 1.577 . . . . 0.0 113.004 179.66 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 140.04 168.3 11.29 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.258 1.409 . . . . 0.0 113.572 179.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -67.48 -30.14 36.35 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.429 2.753 . . . . 0.0 113.153 -171.46 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -70.45 -13.58 71.12 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.078 0.847 . . . . 0.0 114.527 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 66.6 mt -79.03 -11.94 60.01 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 118.935 1.367 . . . . 0.0 112.807 168.603 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 10.3 m -120.6 -38.53 2.86 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.839 1.656 . . . . 0.0 112.466 -165.605 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -154.83 156.99 37.21 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.74 1.616 . . . . 0.0 112.366 -172.009 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -156.14 -176.84 28.71 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 124.108 0.861 . . . . 0.0 114.074 172.068 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 22.5 t -141.22 133.3 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.172 1.389 . . . . 0.0 108.255 177.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 27.9 m -56.63 137.44 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 122.876 0.47 . . . . 0.0 111.958 179.634 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 59.6 m-80 69.03 -2.18 1.86 Allowed 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 126.691 1.996 . . . . 0.0 114.713 178.076 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -106.81 142.06 24.19 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.451 1.5 . . . . 0.0 110.791 175.793 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -73.4 126.53 11.06 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.382 2.054 . . . . 0.0 110.81 -179.928 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -103.23 145.37 30.04 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.345 1.458 . . . . 0.0 110.282 172.422 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 45.4 p -135.9 153.51 51.43 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -165.626 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.2 p90 -165.6 173.45 10.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.226 1.81 . . . . 0.0 111.629 177.476 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 38.2 m -128.96 140.63 51.57 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.508 1.523 . . . . 0.0 110.781 -171.733 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 23.5 t -110.52 136.32 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.908 1.683 . . . . 0.0 108.335 168.198 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -93.39 126.0 38.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.681 1.193 . . . . 0.0 110.769 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 74.7 p -133.45 -1.31 3.17 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.909 1.283 . . . . 0.0 114.148 -167.53 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -54.59 -38.74 67.08 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 125.225 1.41 . . . . 0.0 114.684 -169.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 30.5 t70 -114.33 9.7 16.97 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.733 1.613 . . . . 0.0 112.759 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.6 -42.83 67.21 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.329 1.052 . . . . 0.0 113.479 -175.116 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 78.13 153.11 6.25 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.833 1.206 . . . . 0.0 112.291 -169.554 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -70.13 160.94 31.14 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.655 0.782 . . . . 0.0 112.913 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 151.38 15.86 0.07 OUTLIER Glycine 0 CA--C 1.534 1.272 0 N-CA-C 116.134 1.214 . . . . 0.0 116.134 -176.419 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 93.44 96.0 1.5 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 125.531 1.539 . . . . 0.0 112.574 177.899 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -79.59 125.49 29.67 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.786 1.235 . . . . 0.0 108.527 167.543 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 50.5 m -116.34 154.96 29.29 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.98 1.712 . . . . 0.0 111.853 -179.465 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 59.7 tp -162.16 133.37 5.16 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.19 1.396 . . . . 0.0 109.698 -170.034 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -159.84 161.68 34.52 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.655 1.182 . . . . 0.0 111.912 -179.523 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 57.7 mt -137.99 132.23 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.612 1.165 . . . . 0.0 110.114 175.756 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -112.07 134.04 53.86 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.844 1.657 . . . . 0.0 109.323 170.458 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -164.96 -168.52 27.24 Favored Glycine 0 CA--C 1.537 1.435 0 O-C-N 121.353 -0.842 . . . . 0.0 114.909 -175.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.77 -23.35 55.82 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.929 3.086 . . . . 0.0 112.467 176.155 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.5 t -141.03 157.75 44.89 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.433 1.493 . . . . 0.0 109.441 165.377 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 2.9 tpmt? -69.29 111.36 5.15 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 121.042 -1.036 . . . . 0.0 110.424 174.454 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -70.06 146.18 51.15 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.553 0.741 . . . . 0.0 111.299 172.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -88.62 136.51 32.96 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.341 0.656 . . . . 0.0 109.368 169.394 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 25.9 mt -131.0 138.83 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.572 1.149 . . . . 0.0 110.456 -167.368 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 67.8 m -133.75 152.89 52.0 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.442 1.497 . . . . 0.0 110.661 169.75 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 28.6 p -150.88 153.18 34.83 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.829 0.852 . . . . 0.0 112.96 179.219 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 84.8 m -139.84 120.37 14.13 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.649 1.58 . . . . 0.0 110.107 -171.22 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.7 t70 -78.5 133.21 37.43 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.664 1.186 . . . . 0.0 111.332 172.189 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 67.3 m-20 -110.75 145.89 37.28 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.697 1.599 . . . . 0.0 111.635 -178.685 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -69.25 -14.22 62.84 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 123.766 0.826 . . . . 0.0 112.736 174.524 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 31.9 t70 -72.78 -8.26 54.59 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.597 1.559 . . . . 0.0 113.913 174.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 95.98 31.68 7.19 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.466 1.031 . . . . 0.0 114.288 177.573 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 75.4 p -137.19 159.59 41.46 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.16 1.384 . . . . 0.0 110.966 175.665 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 49.6 t -112.86 126.21 55.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.659 1.184 . . . . 0.0 108.667 160.697 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.2 t -93.23 145.39 24.47 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.921 0.889 . . . . 0.0 110.307 173.864 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 78.9 t -127.33 143.72 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 C-N-CA 125.171 1.388 . . . . 0.0 110.138 -177.657 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 74.6 p -134.58 146.45 49.63 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.007 1.323 . . . . 0.0 111.552 167.096 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 26.1 p90 -148.21 151.38 35.4 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 176.576 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 20.8 mt -112.73 106.77 55.26 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 126.037 1.735 . . . . 0.0 110.512 179.021 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -81.64 174.44 10.41 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.795 2.997 . . . . 0.0 110.224 165.022 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 14.8 p -149.57 -31.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -173.214 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.44 148.69 35.82 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 119.33 0.968 . . . . 0.0 110.628 167.042 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -71.47 157.42 56.41 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.751 2.301 . . . . 0.0 110.761 171.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.0 -159.7 23.1 Favored Glycine 0 N--CA 1.47 0.92 0 C-N-CA 124.667 1.127 . . . . 0.0 112.604 -175.667 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -112.35 129.86 56.15 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.187 0.995 . . . . 0.0 111.94 -174.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -116.88 127.69 54.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.528 1.931 . . . . 0.0 110.099 -177.588 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 58.5 m -97.23 114.42 26.15 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.635 1.174 . . . . 0.0 110.961 178.686 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.3 mp -88.61 125.77 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 C-N-CA 126.251 1.82 . . . . 0.0 108.776 178.355 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -101.16 131.37 47.15 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.357 1.463 . . . . 0.0 109.721 173.231 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 49.1 t -130.64 128.76 63.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.253 1.021 . . . . 0.0 110.037 172.069 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -153.88 141.52 19.92 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.476 1.51 . . . . 0.0 111.071 -169.137 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.83 121.26 18.19 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.551 1.14 . . . . 0.0 109.545 -179.829 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 12.0 t-20 53.84 59.57 4.2 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.24 1.416 . . . . 0.0 112.294 178.191 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.297 7.9 pt-20 59.14 11.97 2.28 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 128.279 2.632 . . . . 0.0 116.43 -178.431 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -121.41 123.35 41.88 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.48 1.112 . . . . 0.0 111.172 178.142 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -64.21 146.88 53.55 Favored 'General case' 0 CA--C 1.545 0.751 0 O-C-N 121.393 -0.817 . . . . 0.0 112.114 172.243 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 12.2 m -77.63 156.02 80.78 Favored Pre-proline 0 N--CA 1.479 0.998 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.828 172.804 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -54.67 130.76 42.02 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 123.427 2.751 . . . . 0.0 112.086 177.397 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 85.75 -10.8 63.76 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.571 1.081 . . . . 0.0 115.554 -179.736 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 39.1 t -72.81 139.32 80.21 Favored Pre-proline 0 CA--C 1.548 0.9 0 CA-C-N 119.439 1.62 . . . . 0.0 111.344 176.717 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -79.89 149.06 80.23 Favored 'Cis proline' 0 CA--C 1.54 0.811 0 CA-C-N 119.676 0.92 . . . . 0.0 112.768 -2.291 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -104.68 126.63 51.95 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.664 1.586 . . . . 0.0 110.702 -177.199 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 23.8 m -94.73 110.95 22.75 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.599 0.759 . . . . 0.0 111.295 -175.791 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -99.86 129.55 45.96 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.917 1.687 . . . . 0.0 111.692 177.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 26.9 ttt85 -94.72 117.53 30.27 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.417 0.687 . . . . 0.0 111.436 -179.672 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 79.8 t -98.56 133.86 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 126.148 1.779 . . . . 0.0 110.643 -174.652 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 57.4 p -99.08 145.95 26.6 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.127 1.371 . . . . 0.0 112.383 179.467 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -90.17 39.25 3.12 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.065 1.793 . . . . 0.0 113.831 -175.162 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 29.2 t70 -70.3 -28.4 65.16 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -168.133 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--O 1.253 1.238 0 C-N-CA 125.035 1.334 . . . . 0.0 113.659 -178.993 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.525 0 N-CA-C 111.664 -0.575 . . . . 0.0 111.664 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -73.3 159.96 32.59 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.469 1.107 . . . . 0.0 112.921 178.248 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 14.8 tpt -70.88 145.62 50.1 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.38 1.072 . . . . 0.0 111.91 176.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -69.42 147.49 96.95 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.426 1.09 . . . . 0.0 112.639 179.317 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.15 162.88 33.63 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.771 2.981 . . . . 0.0 111.982 178.293 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.18 88.72 6.47 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.163 0.985 . . . . 0.0 110.223 175.369 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -72.68 147.37 89.25 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.26 1.024 . . . . 0.0 112.293 -177.859 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.69 173.58 14.25 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 124.019 3.146 . . . . 0.0 111.786 176.762 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 2.0 pt? -70.34 22.75 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 126.487 1.915 . . . . 0.0 114.899 175.853 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 86.3 t -133.78 144.44 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 127.918 2.487 . . . . 0.0 108.521 -174.879 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -66.37 107.94 2.19 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.198 0.904 . . . . 0.0 112.658 -175.457 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 99.1 t -68.32 137.16 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.859 1.264 . . . . 0.0 110.06 179.219 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 9.6 p30 -155.37 171.85 19.18 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.308 1.443 . . . . 0.0 112.337 -171.2 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . 97.09 -111.16 4.19 Favored Glycine 0 N--CA 1.47 0.926 0 C-N-CA 124.731 1.158 . . . . 0.0 111.037 -175.604 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 67.7 mt -68.4 159.41 31.61 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.221 1.008 . . . . 0.0 112.038 177.549 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 37.4 t0 -154.93 159.7 40.62 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.083 1.353 . . . . 0.0 112.11 -176.373 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . . . . . . . . . 32.7 m -68.93 -8.44 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 125.421 1.488 . . . . 0.0 114.575 -170.696 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 11.5 t -63.51 -32.22 73.61 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.148 1.379 . . . . 0.0 112.827 174.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 6.6 t 77.41 124.1 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.518 2.327 . . . . 0.0 114.62 164.068 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 46.6 mt -104.04 148.62 26.02 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 126.137 1.775 . . . . 0.0 111.482 176.512 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . . . . . . . . . 34.7 ttp180 -64.36 118.54 48.1 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 124.871 1.268 . . . . 0.0 111.504 -179.627 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -72.0 152.55 57.31 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 123.115 2.543 . . . . 0.0 110.865 -178.748 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 16.2 t80 -107.8 125.66 51.7 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.937 0.895 . . . . 0.0 110.302 179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -150.56 130.06 13.0 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.531 1.532 . . . . 0.0 110.001 173.568 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 131.18 21.51 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.236 1.414 . . . . 0.0 110.054 -169.577 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 58.0 t -95.73 138.05 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 125.105 1.362 . . . . 0.0 109.598 -179.773 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 32.8 mt -130.75 135.01 26.69 Favored Pre-proline 0 CA--C 1.546 0.817 0 C-N-CA 125.652 1.581 . . . . 0.0 108.784 -179.002 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -79.8 37.76 0.69 Allowed 'Trans proline' 0 CA--C 1.547 1.162 0 C-N-CA 124.22 3.28 . . . . 0.0 113.141 -179.118 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 57.3 t80 -85.79 152.38 23.08 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.221 1.408 . . . . 0.0 111.458 178.196 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 88.9 m -116.23 119.25 35.16 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.846 1.258 . . . . 0.0 109.733 177.184 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 89.9 mt -85.29 127.69 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 124.211 1.004 . . . . 0.0 109.953 175.29 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 56.3 mtpt -112.99 -154.92 0.55 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.569 1.547 . . . . 0.0 110.622 172.74 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -70.07 124.46 24.13 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 120.594 -1.316 . . . . 0.0 111.353 172.569 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 141.85 -148.76 20.5 Favored Glycine 0 N--CA 1.473 1.134 0 C-N-CA 125.789 1.661 . . . . 0.0 111.772 -170.514 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -158.18 146.27 18.59 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.307 1.043 . . . . 0.0 111.68 -175.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 20.5 tt -129.18 135.74 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 125.97 1.708 . . . . 0.0 110.792 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 32.7 p -146.23 177.08 9.27 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.154 1.781 . . . . 0.0 110.572 -175.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -161.76 -172.63 29.39 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 115.679 1.032 . . . . 0.0 115.679 -176.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -151.21 138.79 19.61 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.441 1.496 . . . . 0.0 109.762 173.71 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 13.3 t -108.51 132.59 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.14 1.776 . . . . 0.0 108.088 172.768 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 45.8 mtm105 -117.77 122.89 44.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.9 1.28 . . . . 0.0 110.124 -177.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 14.4 mtt -95.92 152.3 38.9 Favored Pre-proline 0 N--CA 1.474 0.764 0 C-N-CA 125.66 1.584 . . . . 0.0 111.461 -172.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -69.83 -20.7 34.17 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.28 2.654 . . . . 0.0 113.601 -177.259 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 58.4 p -78.44 -4.63 49.35 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.915 1.286 . . . . 0.0 114.171 174.193 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 96.32 -3.82 64.15 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.575 1.56 . . . . 0.0 114.56 -178.946 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.47 159.54 33.08 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 118.506 1.153 . . . . 0.0 112.199 173.994 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.6 m -136.89 154.71 31.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 125.156 1.382 . . . . 0.0 111.519 175.077 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -159.17 172.63 17.73 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.234 1.813 . . . . 0.0 111.121 -179.193 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -109.7 139.47 21.26 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 123.981 0.913 . . . . 0.0 111.172 178.37 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -82.18 165.6 16.83 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.861 3.041 . . . . 0.0 110.82 170.34 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 97.4 m -107.86 123.36 48.47 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 125.102 1.361 . . . . 0.0 108.659 172.511 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.85 130.58 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.297 1.039 . . . . 0.0 108.677 175.485 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 97.4 m -128.27 130.53 48.02 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.495 1.518 . . . . 0.0 109.816 -177.901 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -76.16 130.77 38.76 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.823 1.249 . . . . 0.0 112.05 174.619 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -87.91 -15.74 35.82 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 112.889 0.7 . . . . 0.0 112.889 176.345 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 94.4 mttt 70.07 4.19 4.71 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 127.736 2.414 . . . . 0.0 114.391 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 29.1 t70 -100.86 12.17 38.12 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 126.622 1.969 . . . . 0.0 112.849 -179.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 86.55 16.82 61.32 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.731 1.158 . . . . 0.0 113.38 -171.413 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 43.5 p -136.87 166.47 23.54 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.851 2.06 . . . . 0.0 110.178 179.993 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 24.0 m -131.37 164.97 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 125.222 1.409 . . . . 0.0 110.326 172.031 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 14.9 t -123.15 148.94 45.2 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.351 1.06 . . . . 0.0 110.073 166.478 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 32.4 t -123.42 128.51 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 125.502 1.521 . . . . 0.0 108.737 178.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -129.12 155.41 45.52 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 125.747 1.619 . . . . 0.0 111.836 -170.637 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 27.2 t80 -159.88 135.81 8.61 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.833 1.253 . . . . 0.0 112.297 -177.606 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -86.58 117.37 68.56 Favored Pre-proline 0 CA--C 1.55 0.951 0 C-N-CA 124.82 1.248 . . . . 0.0 110.694 175.771 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.03 145.76 22.39 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.482 2.788 . . . . 0.0 111.694 -174.87 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 99.8 p -131.17 -4.83 3.88 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 172.554 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -141.75 153.98 44.95 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 126.109 1.764 . . . . 0.0 110.316 -179.295 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -89.23 173.32 8.47 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.098 0.959 . . . . 0.0 111.757 166.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 104.6 -171.49 19.32 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 125.23 1.395 . . . . 0.0 114.002 177.671 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 1.5 tt -83.33 124.27 30.45 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.971 1.308 . . . . 0.0 110.112 -177.882 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 54.9 m80 -120.57 163.13 18.46 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.427 1.891 . . . . 0.0 111.382 -176.051 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -150.25 155.56 39.94 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.126 0.971 . . . . 0.0 111.169 173.354 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 14.8 tmm? -148.85 132.68 17.01 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.166 0.986 . . . . 0.0 111.547 -160.686 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -111.08 141.96 43.87 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.738 2.015 . . . . 0.0 111.295 -174.831 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 28.1 mm -133.86 134.33 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 124.858 1.263 . . . . 0.0 111.004 175.921 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.3 139.0 37.2 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.498 1.119 . . . . 0.0 113.331 176.629 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 15.2 t80 -99.7 120.94 40.5 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.362 1.865 . . . . 0.0 109.527 172.506 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.2 t70 49.26 39.88 16.83 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.936 1.294 . . . . 0.0 112.853 -176.083 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 7.8 t-20 82.27 -13.65 0.83 Allowed 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 129.03 2.932 . . . . 0.0 114.696 179.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 47.3 tpp -90.98 128.61 36.87 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.522 1.129 . . . . 0.0 111.561 177.029 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -57.68 136.22 56.82 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.38 -0.825 . . . . 0.0 113.164 -179.636 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 28.3 pt -76.82 153.91 83.14 Favored Pre-proline 0 N--CA 1.479 0.981 0 CA-C-O 118.951 -0.547 . . . . 0.0 111.594 178.019 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -61.5 124.53 14.84 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 121.885 1.723 . . . . 0.0 108.617 166.121 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . 105.4 -11.22 47.15 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 124.572 1.082 . . . . 0.0 114.681 -172.873 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 26.9 t -85.94 143.79 38.17 Favored Pre-proline 0 CA--C 1.548 0.903 0 CA-C-N 119.351 1.575 . . . . 0.0 111.319 169.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -82.85 171.83 51.23 Favored 'Cis proline' 0 C--N 1.352 0.738 0 CA-C-N 120.075 1.062 . . . . 0.0 112.505 -6.32 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 71.2 mt -113.99 160.82 18.42 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.459 1.904 . . . . 0.0 111.159 171.346 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -150.4 138.73 20.41 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.189 1.396 . . . . 0.0 109.99 -171.687 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 15.9 p90 -164.46 167.25 19.73 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.444 1.097 . . . . 0.0 112.398 -165.264 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 39.5 t80 -122.55 136.09 54.8 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.129 -0.982 . . . . 0.0 112.129 176.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 42.2 t -111.84 142.55 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 125.398 1.479 . . . . 0.0 109.675 -178.934 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 28.5 t0 -151.59 163.01 40.0 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.898 1.279 . . . . 0.0 111.52 -177.553 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -74.96 125.6 29.23 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.766 1.227 . . . . 0.0 111.152 178.319 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 31.4 m -78.92 -18.55 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -167.545 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -89.35 -4.63 58.0 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -178.792 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 95.7 m -72.73 150.51 42.8 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.962 0.905 . . . . 0.0 112.498 176.576 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . -88.73 -14.62 60.96 Favored Glycine 0 N--CA 1.475 1.237 0 C-N-CA 124.604 1.097 . . . . 0.0 115.118 -174.369 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -66.56 158.14 30.52 Favored 'General case' 0 CA--C 1.55 0.969 0 CA-C-N 118.7 1.25 . . . . 0.0 113.93 179.131 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 9.8 p -62.93 141.59 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 124.454 1.102 . . . . 0.0 110.888 173.422 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 15.2 t -158.1 152.89 25.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.358 1.463 . . . . 0.0 110.273 178.655 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -125.81 142.83 51.32 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.999 1.319 . . . . 0.0 111.754 -177.706 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 55.3 p90 -167.08 160.88 14.38 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.582 1.553 . . . . 0.0 113.519 -175.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 133.83 170.27 12.3 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.408 1.48 . . . . 0.0 112.539 -177.54 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.08 -33.29 15.66 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.953 2.435 . . . . 0.0 113.324 -168.651 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -65.81 -33.78 86.83 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 119.455 1.025 . . . . 0.0 114.506 -171.567 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 1.5 pp -78.43 -0.61 29.93 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 118.832 1.316 . . . . 0.0 113.631 177.45 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 28.5 m -113.63 -46.09 3.07 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.698 1.999 . . . . 0.0 111.366 176.696 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . 0.555 ' CE1' HH22 ' A' 1951 ' ' ARG . 3.7 t-80 -137.88 122.37 18.42 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.314 1.845 . . . . 0.0 111.426 -174.075 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -124.5 170.94 16.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.28 1.419 . . . . 0.0 112.786 170.655 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 98.2 t -138.8 137.14 43.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.899 1.28 . . . . 0.0 108.239 174.203 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 33.7 m -55.3 136.54 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 61.0 m-80 67.32 0.31 2.07 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.969 2.108 . . . . 0.0 114.685 177.509 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 87.5 mttt -104.87 139.91 20.56 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.019 1.328 . . . . 0.0 110.977 175.207 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -71.9 118.66 5.74 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.59 2.193 . . . . 0.0 110.167 179.425 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -100.03 134.8 42.42 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.29 1.436 . . . . 0.0 110.205 176.544 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 35.3 p -128.31 148.16 50.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -164.729 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 54.4 p90 -160.63 -179.85 7.97 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.948 1.699 . . . . 0.0 111.673 176.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 60.2 m -135.03 146.65 49.19 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.228 1.411 . . . . 0.0 110.936 -168.096 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 21.6 t -116.86 129.89 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.687 1.595 . . . . 0.0 108.262 168.456 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -93.51 126.43 38.66 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.106 0.963 . . . . 0.0 110.325 176.079 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 40.6 p -132.06 4.15 4.09 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 125.708 1.603 . . . . 0.0 113.634 -167.147 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 52.2 tttp -55.22 -32.45 62.27 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.051 1.74 . . . . 0.0 115.61 -164.464 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 31.0 t70 -128.33 17.53 6.52 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 125.603 1.561 . . . . 0.0 112.42 178.407 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -75.2 -25.28 58.08 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.147 1.165 . . . . 0.0 114.147 -176.557 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 83.9 151.44 12.21 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.186 1.374 . . . . 0.0 112.861 -175.643 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -72.94 145.65 46.64 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.159 0.983 . . . . 0.0 112.307 -177.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 174.7 -158.66 26.89 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.689 1.614 . . . . 0.0 112.501 178.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . -82.98 98.39 2.04 Favored Glycine 0 N--CA 1.469 0.84 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 175.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.5 tm? -80.17 126.55 31.25 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.707 1.203 . . . . 0.0 108.853 171.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 36.4 m -129.68 155.27 46.14 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.012 1.325 . . . . 0.0 112.133 -177.806 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 48.0 tp -158.95 132.61 7.45 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 126.162 1.785 . . . . 0.0 108.583 -171.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -156.64 160.41 39.36 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.853 0.861 . . . . 0.0 112.238 -179.313 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 58.4 mt -135.08 132.34 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 124.519 1.128 . . . . 0.0 109.645 174.379 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -114.76 105.98 13.66 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.013 1.325 . . . . 0.0 109.052 172.655 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -116.9 -178.84 17.85 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.024 1.297 . . . . 0.0 113.92 -178.639 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.2 -20.42 37.48 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 123.909 3.073 . . . . 0.0 111.811 170.744 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 20.2 t -137.43 157.77 45.85 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.877 1.671 . . . . 0.0 109.055 161.253 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -69.59 119.0 13.17 Favored 'General case' 0 CA--C 1.545 0.75 0 O-C-N 120.993 -1.067 . . . . 0.0 111.773 -176.866 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -80.13 144.33 33.14 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.872 0.869 . . . . 0.0 111.166 170.14 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -90.86 140.92 29.36 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.479 0.712 . . . . 0.0 109.656 168.363 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.2 mt -132.91 139.24 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 124.79 1.236 . . . . 0.0 110.467 -167.67 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 75.2 m -130.32 155.96 45.48 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.937 1.695 . . . . 0.0 110.652 168.544 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 30.3 p -152.65 154.07 34.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.102 0.961 . . . . 0.0 112.373 175.604 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 91.8 m -142.25 125.57 16.56 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.599 1.56 . . . . 0.0 109.985 -172.528 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.91 141.35 37.68 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.183 0.993 . . . . 0.0 112.244 172.758 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 65.9 m-20 -117.24 152.0 35.74 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.703 1.601 . . . . 0.0 112.031 -175.803 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 24.1 mp0 -69.43 -18.54 63.75 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.926 1.29 . . . . 0.0 112.96 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.68 -13.44 60.62 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.128 1.371 . . . . 0.0 114.083 -179.503 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 99.74 34.73 4.84 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.786 1.184 . . . . 0.0 113.674 -175.773 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 71.7 p -138.34 164.3 29.65 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.266 1.426 . . . . 0.0 110.841 177.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 80.6 m -120.09 131.18 54.98 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.717 1.607 . . . . 0.0 109.033 164.369 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 22.6 t -90.18 150.15 22.12 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.161 0.984 . . . . 0.0 110.686 171.112 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 93.6 t -129.43 144.15 38.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.521 1.928 . . . . 0.0 109.592 -178.43 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 23.3 t -140.03 139.12 35.91 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.411 1.484 . . . . 0.0 110.707 171.074 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.0 p90 -144.63 153.24 41.55 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.061 1.134 . . . . 0.0 114.061 176.587 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 17.7 mt -115.51 105.79 51.53 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.802 1.641 . . . . 0.0 110.816 179.636 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -81.0 169.71 16.0 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.645 2.897 . . . . 0.0 110.235 165.456 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 7.9 p -136.99 -20.13 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 3.7 pp -142.39 152.06 59.57 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.632 1.173 . . . . 0.0 110.675 174.007 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -74.18 147.74 38.24 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.893 2.395 . . . . 0.0 111.904 -172.871 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 154.03 -155.68 26.33 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.675 1.131 . . . . 0.0 113.059 -174.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -116.26 126.41 53.54 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.07 1.348 . . . . 0.0 111.149 179.612 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -115.8 125.71 53.06 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.311 1.844 . . . . 0.0 109.93 -176.624 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 54.6 m -88.0 122.08 31.18 Favored 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.975 -1.078 . . . . 0.0 110.933 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.5 mp -98.22 128.23 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 125.292 1.437 . . . . 0.0 108.626 179.873 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 9.3 tt -112.23 131.07 55.7 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.367 1.467 . . . . 0.0 109.542 175.965 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 22.5 t -133.55 130.11 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.304 1.042 . . . . 0.0 109.67 172.898 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -151.93 144.02 23.87 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.061 1.344 . . . . 0.0 111.721 -168.552 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -142.11 122.64 14.13 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.697 1.199 . . . . 0.0 110.555 -177.882 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 13.7 t-20 57.0 44.62 22.56 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.134 1.374 . . . . 0.0 112.199 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.261 0.6 OUTLIER 77.98 -12.87 1.02 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 129.177 2.991 . . . . 0.0 114.736 -179.107 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -98.43 125.6 43.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.75 1.22 . . . . 0.0 111.384 -176.814 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -63.07 143.76 57.5 Favored 'General case' 0 CA--C 1.544 0.739 0 O-C-N 121.384 -0.823 . . . . 0.0 111.912 171.585 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 4.5 m -68.0 152.35 96.49 Favored Pre-proline 0 N--CA 1.48 1.036 0 CA-C-O 118.348 -0.834 . . . . 0.0 109.57 171.417 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -59.5 126.96 22.13 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.781 2.321 . . . . 0.0 110.595 179.387 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 94.58 -15.01 64.23 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 125.193 1.378 . . . . 0.0 115.323 -176.118 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 46.5 t -76.62 140.98 68.45 Favored Pre-proline 0 CA--C 1.549 0.937 0 CA-C-N 119.304 1.552 . . . . 0.0 111.628 176.552 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -75.53 140.29 65.88 Favored 'Cis proline' 0 CA--C 1.539 0.75 0 CA-C-N 119.418 0.828 . . . . 0.0 112.161 -3.723 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -93.05 173.23 7.84 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.615 1.966 . . . . 0.0 110.779 175.51 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 57.9 m -131.02 122.32 26.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.845 0.858 . . . . 0.0 110.933 174.159 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -96.05 137.99 34.32 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.57 1.548 . . . . 0.0 110.535 169.429 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . 0.555 HH22 ' CE1' ' A' 1877 ' ' HIS . 0.0 OUTLIER -93.81 138.5 31.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.596 0.759 . . . . 0.0 109.474 169.756 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 85.0 t -124.46 139.59 50.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.456 1.502 . . . . 0.0 110.861 -178.402 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 1.1 p -124.04 163.2 21.91 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.931 1.693 . . . . 0.0 112.433 179.521 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -77.87 148.55 33.49 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 125.107 1.337 . . . . 0.0 112.249 172.269 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 36.8 t70 -75.17 -23.73 57.79 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.949 0.9 . . . . 0.0 112.898 174.323 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 32.9 t70 . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.477 1.911 . . . . 0.0 112.864 178.321 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.548 0 N-CA-C 111.706 -0.557 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' -2' ' ' ALA . . . . . . . . . . . . . . . -156.73 163.84 38.81 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.724 1.609 . . . . 0.0 111.76 -179.068 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' -1' ' ' MET . . . . . . . . . . . . . 77.4 mtm -74.2 -21.43 59.82 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.315 1.046 . . . . 0.0 113.619 -179.536 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1772 ' ' ALA . . . . . . . . . . . . . . . -160.75 160.04 25.36 Favored Pre-proline 0 CA--C 1.551 0.992 0 C-N-CA 126.36 1.864 . . . . 0.0 111.341 -179.457 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1773 ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.92 153.8 48.64 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.9 3.067 . . . . 0.0 113.308 174.455 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1774 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.19 -7.71 55.06 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.27 1.428 . . . . 0.0 113.209 174.762 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A 1775 ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? -62.66 137.75 96.61 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.441 1.096 . . . . 0.0 111.83 -179.433 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1776 ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -74.52 165.08 32.5 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 123.821 3.014 . . . . 0.0 111.736 174.792 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1777 ' ' LEU . . . . . . . . . . . . . 1.7 pt? -70.24 -5.07 24.98 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 115.899 1.815 . . . . 0.0 115.899 -173.21 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1778 ' ' VAL . . . . . . . . . . . . . 5.2 p -67.86 -16.99 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 125.359 1.464 . . . . 0.0 113.694 -176.504 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1779 ' ' GLY . . . . . . . . . . . . . . . -77.12 52.65 3.36 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 125.905 1.717 . . . . 0.0 114.451 -175.477 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1780 ' ' VAL . . . . . . . . . . . . . 33.3 m -69.06 150.69 10.52 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.218 1.407 . . . . 0.0 111.99 177.482 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1781 ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -77.14 -16.06 59.3 Favored 'General case' 0 CA--C 1.547 0.838 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -179.734 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1782 ' ' GLY . . . . . . . . . . . . . . . -173.24 169.51 42.63 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.559 1.552 . . . . 0.0 113.244 178.645 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1783 ' ' LEU . . . . . . . . . . . . . 88.9 mt -76.8 149.66 36.22 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.035 0.934 . . . . 0.0 111.684 178.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1784 ' ' ASP . . . . . . . . . . . . . 35.7 t70 -75.07 -21.02 59.24 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.255 1.022 . . . . 0.0 112.74 174.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1785 ' ' VAL . . . . . 0.461 HG23 HD21 ' A' 1864 ' ' ASN . 13.0 p -163.22 150.25 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 126.657 1.983 . . . . 0.0 110.602 -175.016 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A 1786 ' ' THR . . . . . . . . . . . . . 12.8 t -167.65 -35.96 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 126.66 1.984 . . . . 0.0 111.067 -178.503 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1787 ' ' SER . . . . . . . . . . . . . 24.2 p -73.24 146.38 45.5 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.605 1.162 . . . . 0.0 113.044 169.923 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1788 ' ' LEU . . . . . . . . . . . . . 11.3 mt -137.08 153.68 50.51 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 126.531 1.932 . . . . 0.0 109.891 178.094 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1789 ' ' ARG . . . . . 0.44 HH11 ' HG3' ' A' 1789 ' ' ARG . 18.1 ttm-85 -58.72 119.52 37.76 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.233 1.013 . . . . 0.0 111.041 177.671 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A 1790 ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.42 159.76 48.48 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.158 2.572 . . . . 0.0 110.431 176.496 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1791 ' ' PHE . . . . . . . . . . . . . 90.9 t80 -149.46 134.26 17.83 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.642 0.734 . . . . 0.0 112.324 -172.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1792 ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -163.98 145.81 9.04 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.817 2.047 . . . . 0.0 110.724 178.055 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1793 ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 161.28 36.26 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 126.599 1.959 . . . . 0.0 110.831 -170.609 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A 1794 ' ' VAL . . . . . . . . . . . . . 13.2 p -134.07 139.37 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.184 1.393 . . . . 0.0 110.038 176.262 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1795 ' ' ILE . . . . . . . . . . . . . 43.8 mt -136.59 138.2 25.91 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 126.314 1.846 . . . . 0.0 108.302 -170.801 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1796 ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.11 31.93 0.42 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.505 3.47 . . . . 0.0 113.993 -177.052 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1797 ' ' PHE . . . . . . . . . . . . . 27.6 t80 -79.65 155.03 28.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.47 1.108 . . . . 0.0 111.027 173.113 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1798 ' ' THR . . . . . . . . . . . . . 44.9 m -130.85 126.17 35.52 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.048 1.339 . . . . 0.0 109.534 176.76 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1799 ' ' ILE . . . . . . . . . . . . . 51.5 mt -76.42 126.26 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.572 0.749 . . . . 0.0 110.49 177.24 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1800 ' ' LYS . . . . . . . . . . . . . 67.1 mttm -116.48 -139.7 0.37 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.724 1.61 . . . . 0.0 110.516 172.71 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1801 ' ' LYS . . . . . . . . . . . . . 64.6 mttp -75.76 124.44 27.29 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.657 -1.277 . . . . 0.0 111.188 171.689 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1802 ' ' GLY . . . . . . . . . . . . . . . 131.4 -151.31 19.68 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.862 1.696 . . . . 0.0 111.805 -169.872 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1803 ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.84 150.48 17.27 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.913 1.285 . . . . 0.0 111.178 -176.448 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1804 ' ' ILE . . . . . . . . . . . . . 14.0 tt -122.51 133.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 125.353 1.461 . . . . 0.0 111.888 179.77 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1805 ' ' THR . . . . . . . . . . . . . 77.3 p -149.22 -178.05 6.18 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.082 1.753 . . . . 0.0 110.38 177.704 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1806 ' ' GLY . . . . . . . . . . . . . . . -172.48 -164.4 27.9 Favored Glycine 0 CA--C 1.526 0.768 0 N-CA-C 115.341 0.897 . . . . 0.0 115.341 -179.323 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1807 ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -157.47 139.49 14.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.616 1.566 . . . . 0.0 109.954 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1808 ' ' VAL . . . . . . . . . . . . . 43.7 t -105.87 133.63 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.771 1.628 . . . . 0.0 108.266 171.435 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1809 ' ' ARG . . . . . . . . . . . . . 42.3 mtm105 -121.44 135.46 55.05 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.847 1.659 . . . . 0.0 111.052 -174.677 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1810 ' ' MET . . . . . . . . . . . . . 4.2 mpp? -112.9 157.39 40.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 125.754 1.622 . . . . 0.0 112.562 -172.412 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1811 ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -55.0 -37.15 93.9 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 124.243 3.295 . . . . 0.0 114.538 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1812 ' ' SER . . . . . . . . . . . . . 11.0 m -71.86 -5.22 32.87 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.14 1.376 . . . . 0.0 114.463 -176.098 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1813 ' ' GLY . . . . . . . . . . . . . . . 88.37 -2.2 84.83 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.343 1.449 . . . . 0.0 113.711 -170.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1814 ' ' LYS . . . . . . . . . . . . . 48.2 mtpt -64.96 152.38 43.41 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.265 1.426 . . . . 0.0 111.719 172.175 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1815 ' ' VAL . . . . . . . . . . . . . 34.3 m -141.7 155.79 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 125.24 1.416 . . . . 0.0 111.537 178.77 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1816 ' ' ALA . . . . . . . . . . . . . . . -157.47 164.46 37.4 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.791 1.636 . . . . 0.0 111.336 -179.841 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1817 ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -102.36 134.2 20.12 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.675 0.79 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1818 ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -80.98 161.21 20.91 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.721 2.948 . . . . 0.0 110.88 169.912 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1819 ' ' THR . . . . . . . . . . . . . 92.0 m -108.81 125.75 52.3 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.071 1.348 . . . . 0.0 108.986 174.13 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1820 ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.7 137.41 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.905 1.282 . . . . 0.0 109.679 179.786 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1821 ' ' THR . . . . . . . . . . . . . 56.5 m -139.3 126.57 21.38 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.197 1.399 . . . . 0.0 110.049 176.477 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1822 ' ' ASP . . . . . . . . . . . . . 9.9 t70 -77.9 126.83 31.44 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.862 0.865 . . . . 0.0 110.623 172.533 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1823 ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -80.2 -6.37 57.69 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.527 1.131 . . . . 0.0 114.032 -174.331 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1824 ' ' LYS . . . . . . . . . . . . . 40.3 mmtm 77.99 -7.95 1.74 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 128.917 2.887 . . . . 0.0 113.831 178.665 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1825 ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -92.58 2.53 56.65 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 126.406 1.882 . . . . 0.0 113.295 175.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1826 ' ' GLY . . . . . . . . . . . . . . . 95.5 25.79 13.14 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.757 1.17 . . . . 0.0 114.141 -177.921 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1827 ' ' THR . . . . . . . . . . . . . 61.8 p -134.16 155.93 49.22 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.17 1.788 . . . . 0.0 109.706 174.179 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1828 ' ' VAL . . . . . . . . . . . . . 33.8 m -115.17 138.67 44.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 124.196 0.998 . . . . 0.0 110.056 167.397 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1829 ' ' THR . . . . . . . . . . . . . 40.5 m -98.29 141.83 30.69 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.008 1.323 . . . . 0.0 108.588 168.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1830 ' ' VAL . . . . . . . . . . . . . 21.3 t -125.66 134.41 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 125.4 1.48 . . . . 0.0 109.462 179.6 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1831 ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -131.96 153.94 49.81 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.268 1.427 . . . . 0.0 112.289 -174.787 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1832 ' ' TYR . . . . . . . . . . . . . 11.5 t80 -156.65 134.34 10.9 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.857 1.663 . . . . 0.0 111.674 -177.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1833 ' ' ALA . . . . . . . . . . . . . . . -87.69 123.67 68.87 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.343 1.057 . . . . 0.0 110.442 175.303 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1834 ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.47 131.4 12.6 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.076 2.517 . . . . 0.0 111.6 -173.534 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1835 ' ' SER . . . . . . . . . . . . . 71.2 m -132.03 15.73 4.69 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.738 1.215 . . . . 0.0 112.406 179.22 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1836 ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -164.93 162.26 20.55 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 126.569 1.948 . . . . 0.0 109.958 -175.224 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1837 ' ' ALA . . . . . . . . . . . . . . . -111.79 170.93 7.8 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.924 1.29 . . . . 0.0 112.6 174.329 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1838 ' ' GLY . . . . . . . . . . . . . . . 93.66 -161.79 25.11 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.182 1.372 . . . . 0.0 113.547 179.281 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1839 ' ' LEU . . . . . . . . . . . . . 21.7 tp -81.58 114.93 20.61 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.591 1.156 . . . . 0.0 110.759 -177.816 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1840 ' ' HIS . . . . . . . . . . . . . 6.4 m80 -103.3 168.34 9.23 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 126.077 1.751 . . . . 0.0 110.903 177.478 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1841 ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.16 148.97 29.59 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.491 -0.756 . . . . 0.0 112.02 168.033 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1842 ' ' MET . . . . . . . . . . . . . 16.3 ttm -120.99 132.82 55.14 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 127.034 2.134 . . . . 0.0 110.264 -173.821 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1843 ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -100.07 137.9 37.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.637 1.575 . . . . 0.0 109.893 166.891 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1844 ' ' ILE . . . . . . . . . . . . . 25.2 mm -133.95 133.95 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.907 1.283 . . . . 0.0 109.733 171.814 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1845 ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.85 138.07 31.88 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.548 1.139 . . . . 0.0 112.681 -174.069 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A 1846 ' ' TYR . . . . . . . . . . . . . 24.9 t80 -107.74 123.8 49.07 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.305 1.842 . . . . 0.0 110.063 175.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1847 ' ' ASP . . . . . . . . . . . . . 26.3 t70 52.19 35.35 16.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 124.551 1.14 . . . . 0.0 112.531 -176.128 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1848 ' ' ASN . . . . . . . . . . . . . 53.8 t30 80.12 -0.68 2.03 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 128.671 2.788 . . . . 0.0 114.827 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1849 ' ' MET . . . . . . . . . . . . . 69.2 mtm -104.33 130.69 52.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.289 1.436 . . . . 0.0 110.907 178.319 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1850 ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -56.23 135.13 53.52 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 121.258 -0.901 . . . . 0.0 113.111 -179.5 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1851 ' ' ILE . . . . . . . . . . . . . 26.4 pt -71.6 155.2 92.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.254 172.755 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1852 ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.6 -25.43 79.23 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.304 2.003 . . . . 0.0 113.648 -176.006 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1853 ' ' GLY . . . . . . . . . . . . . . . -79.32 -3.66 88.67 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.17 0.891 . . . . 0.0 114.72 173.731 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1854 ' ' SER . . . . . . . . . . . . . 25.6 t -97.39 144.17 27.45 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 119.467 1.633 . . . . 0.0 111.824 178.773 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1855 ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -80.21 161.01 85.33 Favored 'Cis proline' 0 C--N 1.352 0.722 0 CA-C-N 119.677 0.92 . . . . 0.0 112.198 -4.563 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1856 ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.33 144.67 37.2 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 125.488 1.515 . . . . 0.0 109.85 170.959 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1857 ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -126.48 137.2 53.36 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.486 1.114 . . . . 0.0 109.682 179.152 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1858 ' ' PHE . . . . . . . . . . . . . 39.3 p90 -156.01 146.2 21.52 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.678 0.791 . . . . 0.0 112.438 -169.299 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1859 ' ' TYR . . . . . . . . . . . . . 36.1 t80 -99.62 139.43 35.28 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 121.397 -0.814 . . . . 0.0 112.433 179.694 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1860 ' ' VAL . . . . . . . . . . . . . 41.1 t -122.83 142.51 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 125.852 1.661 . . . . 0.0 108.948 179.158 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1861 ' ' ASP . . . . . . . . . . . . . 9.8 t0 -151.59 173.01 15.16 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.433 1.093 . . . . 0.0 111.679 -173.52 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1862 ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -87.44 123.42 32.34 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.918 1.287 . . . . 0.0 111.288 178.2 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1863 ' ' VAL . . . . . . . . . . . . . 35.4 m -72.09 -21.8 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 -170.585 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1864 ' ' ASN . . . . . 0.461 HD21 HG23 ' A' 1785 ' ' VAL . 17.0 p30 -90.95 -8.76 48.37 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -172.75 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A 1865 ' ' CYS . . . . . . . . . . . . . 87.6 m -78.75 -24.35 44.83 Favored 'General case' 0 CA--C 1.547 0.845 0 N-CA-C 114.409 1.263 . . . . 0.0 114.409 -172.501 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1866 ' ' GLY . . . . . . . . . . . . . . . 81.25 -7.29 60.96 Favored Glycine 0 CA--C 1.536 1.399 0 C-N-CA 125.175 1.369 . . . . 0.0 116.442 168.109 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1867 ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -67.48 163.75 20.31 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 119.108 1.454 . . . . 0.0 113.484 176.282 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1868 ' ' VAL . . . . . . . . . . . . . 2.4 t -64.88 133.26 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.704 0.801 . . . . 0.0 110.002 -179.478 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1869 ' ' THR . . . . . . . . . . . . . 11.4 t -163.61 154.12 15.79 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.214 1.406 . . . . 0.0 109.855 -168.241 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1870 ' ' ALA . . . . . . . . . . . . . . . -140.11 145.24 37.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.545 1.138 . . . . 0.0 112.082 -173.934 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1871 ' ' TYR . . . . . . . . . . . . . 53.9 p90 -169.64 169.4 8.64 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.559 1.543 . . . . 0.0 113.092 -173.006 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1872 ' ' GLY . . . . . . . . . . . . . . . 123.75 172.39 13.72 Favored Glycine 0 CA--C 1.536 1.359 0 C-N-CA 125.6 1.572 . . . . 0.0 112.175 -174.124 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1873 ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.26 -32.63 12.52 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.774 2.316 . . . . 0.0 113.216 -170.308 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1874 ' ' GLY . . . . . . . . . . . . . . . -68.03 -31.15 74.63 Favored Glycine 0 CA--C 1.531 1.044 0 CA-C-N 119.373 0.988 . . . . 0.0 114.873 -170.601 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1875 ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.32 -0.37 36.43 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 118.925 1.362 . . . . 0.0 113.208 175.36 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1876 ' ' THR . . . . . . . . . . . . . 89.7 m -113.52 -48.4 2.94 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.657 1.983 . . . . 0.0 110.82 -178.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1877 ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -137.76 149.07 46.13 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.089 1.756 . . . . 0.0 112.36 179.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1878 ' ' GLY . . . . . . . . . . . . . . . -144.38 177.24 23.1 Favored Glycine 0 N--CA 1.47 0.922 0 C-N-CA 124.359 0.98 . . . . 0.0 113.116 170.123 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1879 ' ' VAL . . . . . . . . . . . . . 39.6 t -139.1 133.42 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.454 1.102 . . . . 0.0 108.437 176.016 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1880 ' ' VAL . . . . . . . . . . . . . 35.7 m -56.41 135.86 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 118.021 0.373 . . . . 0.0 111.986 -178.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1881 ' ' ASN . . . . . . . . . . . . . 53.5 m-80 70.26 -8.92 0.8 Allowed 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 127.381 2.273 . . . . 0.0 114.859 179.384 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1882 ' ' LYS . . . . . . . . . . . . . 59.4 mttm -96.47 141.88 23.74 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 124.485 1.114 . . . . 0.0 111.078 174.011 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1883 ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -73.22 123.64 8.92 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.509 2.14 . . . . 0.0 110.353 178.141 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1884 ' ' ALA . . . . . . . . . . . . . . . -102.77 144.6 30.91 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.443 1.497 . . . . 0.0 110.472 174.525 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1885 ' ' THR . . . . . . . . . . . . . 37.1 p -135.49 145.52 47.21 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -166.364 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1886 ' ' PHE . . . . . . . . . . . . . 55.0 p90 -157.36 178.99 9.68 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.735 1.614 . . . . 0.0 111.306 175.719 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1887 ' ' THR . . . . . . . . . . . . . 26.7 m -134.99 144.05 47.16 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.052 1.341 . . . . 0.0 110.644 -169.658 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1888 ' ' VAL . . . . . . . . . . . . . 26.8 t -116.53 131.32 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 125.571 1.548 . . . . 0.0 108.179 169.726 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1889 ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -93.77 131.41 39.16 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.159 0.984 . . . . 0.0 111.109 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1890 ' ' THR . . . . . . . . . . . . . 58.8 p -137.79 4.03 2.53 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.348 1.459 . . . . 0.0 113.765 -166.551 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1891 ' ' LYS . . . . . . . . . . . . . 84.0 tttt -55.06 -33.66 62.93 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.77 1.628 . . . . 0.0 115.04 -168.361 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1892 ' ' ASP . . . . . . . . . . . . . 29.0 t70 -123.87 16.63 9.38 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.741 1.617 . . . . 0.0 112.564 178.972 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1893 ' ' ALA . . . . . . . . . . . . . . . -71.55 -39.57 70.58 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.368 1.067 . . . . 0.0 113.842 -174.062 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1894 ' ' GLY . . . . . . . . . . . . . . . 81.71 145.22 4.85 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.908 1.242 . . . . 0.0 112.352 -171.084 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1895 ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.94 148.98 45.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.367 1.067 . . . . 0.0 112.185 -178.019 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1896 ' ' GLY . . . . . . . . . . . . . . . 173.93 -27.36 0.08 OUTLIER Glycine 0 N--CA 1.473 1.162 0 C-N-CA 124.471 1.034 . . . . 0.0 114.973 176.667 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1897 ' ' GLY . . . . . . . . . . . . . . . 142.56 102.05 0.43 Allowed Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.884 1.707 . . . . 0.0 112.988 172.067 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1898 ' ' LEU . . . . . . . . . . . . . 3.4 tm? -83.44 130.79 35.04 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.329 1.452 . . . . 0.0 109.568 175.071 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1899 ' ' SER . . . . . . . . . . . . . 27.5 m -129.79 160.59 32.98 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.756 1.622 . . . . 0.0 112.273 -178.129 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1900 ' ' LEU . . . . . . . . . . . . . 49.4 tp -160.48 136.68 8.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.762 1.625 . . . . 0.0 109.522 -169.264 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1901 ' ' ALA . . . . . . . . . . . . . . . -157.33 156.9 33.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.392 1.077 . . . . 0.0 112.023 176.251 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1902 ' ' ILE . . . . . . . . . . . . . 37.2 mt -139.64 134.78 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 124.699 1.199 . . . . 0.0 109.523 177.084 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1903 ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -126.96 143.25 51.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.485 1.514 . . . . 0.0 110.223 176.381 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1904 ' ' GLY . . . . . . . . . . . . . . . -169.63 -161.83 20.77 Favored Glycine 0 CA--C 1.538 1.51 0 CA-C-O 118.81 -0.994 . . . . 0.0 114.694 -175.561 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1905 ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -62.26 -26.16 77.19 Favored 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 124.044 3.163 . . . . 0.0 112.646 176.44 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1906 ' ' SER . . . . . . . . . . . . . 18.9 t -140.21 153.2 46.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.75 1.22 . . . . 0.0 109.618 161.352 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1907 ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -71.68 123.37 22.4 Favored 'General case' 0 CA--C 1.545 0.752 0 O-C-N 121.229 -0.92 . . . . 0.0 110.995 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1908 ' ' ALA . . . . . . . . . . . . . . . -75.7 152.99 37.4 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.313 1.045 . . . . 0.0 112.905 -178.054 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1909 ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.16 134.1 33.56 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 163.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1910 ' ' ILE . . . . . . . . . . . . . 27.9 mt -134.39 138.92 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.577 1.151 . . . . 0.0 110.231 -166.466 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1911 ' ' SER . . . . . . . . . . . . . 64.7 m -139.0 162.01 35.96 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.584 1.553 . . . . 0.0 111.247 172.592 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1912 ' ' CYS . . . . . . . . . . . . . 29.7 p -155.27 156.47 35.62 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.378 1.071 . . . . 0.0 112.71 178.502 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1913 ' ' THR . . . . . . . . . . . . . 85.5 m -139.45 129.83 25.53 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.907 1.683 . . . . 0.0 110.248 -172.282 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1914 ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -80.73 132.42 35.54 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.356 1.062 . . . . 0.0 111.264 174.141 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1915 ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -110.13 148.62 31.41 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.077 1.351 . . . . 0.0 112.08 179.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1916 ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -68.32 -21.3 64.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.507 1.123 . . . . 0.0 112.735 178.103 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1917 ' ' ASP . . . . . . . . . . . . . 32.0 t70 -73.14 -6.83 48.31 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.556 1.543 . . . . 0.0 114.342 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1918 ' ' GLY . . . . . . . . . . . . . . . 93.6 39.87 4.87 Favored Glycine 0 N--CA 1.473 1.113 0 C-N-CA 124.538 1.065 . . . . 0.0 113.266 -179.255 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1919 ' ' THR . . . . . . . . . . . . . 81.0 p -141.13 158.68 43.58 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.011 1.324 . . . . 0.0 111.304 177.23 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1920 ' ' CYS . . . . . . . . . . . . . 63.9 m -107.22 125.19 50.81 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.391 1.476 . . . . 0.0 108.434 161.455 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1921 ' ' SER . . . . . . . . . . . . . 21.8 t -86.52 149.03 25.25 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.484 0.714 . . . . 0.0 110.393 167.704 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1922 ' ' VAL . . . . . . . . . . . . . 99.4 t -130.31 142.6 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 125.842 1.657 . . . . 0.0 109.736 -177.54 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1923 ' ' SER . . . . . . . . . . . . . 84.1 p -136.12 147.22 47.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.849 1.26 . . . . 0.0 111.802 168.192 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1924 ' ' TYR . . . . . . . . . . . . . 16.1 p90 -151.86 153.89 35.07 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 177.495 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1925 ' ' LEU . . . . . . . . . . . . . 27.9 mt -115.78 105.87 50.89 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 126.084 1.754 . . . . 0.0 110.282 179.333 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1926 ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.83 173.79 11.7 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.618 2.879 . . . . 0.0 110.131 165.003 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1927 ' ' VAL . . . . . . . . . . . . . 13.8 p -149.69 -29.41 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 -172.814 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1928 ' ' LEU . . . . . . . . . . . . . 87.6 mt -108.54 144.83 30.32 Favored Pre-proline 0 CA--C 1.544 0.749 0 CA-C-N 119.402 1.001 . . . . 0.0 110.213 166.806 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1929 ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.63 157.64 44.15 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 122.92 2.413 . . . . 0.0 111.013 177.303 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1930 ' ' GLY . . . . . . . . . . . . . . . 131.32 -162.9 23.68 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.987 1.28 . . . . 0.0 113.204 -176.283 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1931 ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -90.79 139.97 30.24 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.728 1.211 . . . . 0.0 112.844 179.739 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1932 ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -127.49 131.67 50.09 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.757 1.623 . . . . 0.0 110.322 178.008 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1933 ' ' SER . . . . . . . . . . . . . 67.7 m -90.47 125.76 35.68 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.209 1.004 . . . . 0.0 110.684 174.757 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1934 ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.99 120.91 59.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.735 1.614 . . . . 0.0 108.482 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1935 ' ' LEU . . . . . . . . . . . . . 8.2 tt -104.93 128.85 53.35 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 125.535 1.534 . . . . 0.0 109.808 178.709 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1936 ' ' VAL . . . . . . . . . . . . . 58.2 t -130.92 128.52 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 124.574 1.15 . . . . 0.0 109.848 173.695 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1937 ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -150.1 142.3 24.12 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.109 1.364 . . . . 0.0 111.666 -168.975 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A 1938 ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -139.12 120.21 14.6 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.8 1.24 . . . . 0.0 109.679 179.486 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A 1939 ' ' ASN . . . . . . . . . . . . . 14.1 t-20 54.93 58.98 4.32 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.602 1.561 . . . . 0.0 111.979 179.174 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1940 ' ' GLU . . . . . . . . . . . . 0.293 9.0 pt-20 57.11 13.56 1.65 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 128.418 2.687 . . . . 0.0 116.422 -178.034 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A 1941 ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -119.59 122.41 41.52 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.896 1.279 . . . . 0.0 110.671 177.655 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1942 ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -63.94 142.69 58.31 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.618 0.767 . . . . 0.0 111.488 170.752 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1943 ' ' VAL . . . . . . . . . . . . . 13.0 m -72.62 156.85 89.76 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.453 -0.784 . . . . 0.0 110.764 175.025 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1944 ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -54.81 129.6 35.99 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.301 2.667 . . . . 0.0 111.963 177.727 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1945 ' ' GLY . . . . . . . . . . . . . . . 86.27 -13.02 58.96 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.697 1.141 . . . . 0.0 115.142 -177.397 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1946 ' ' SER . . . . . . . . . . . . . 40.7 t -76.0 140.27 70.06 Favored Pre-proline 0 CA--C 1.549 0.926 0 CA-C-N 119.527 1.663 . . . . 0.0 111.491 176.121 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1947 ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.48 136.02 43.04 Favored 'Cis proline' 0 C--N 1.352 0.751 0 CA-C-N 119.519 0.864 . . . . 0.0 111.768 -3.568 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1948 ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -83.92 169.98 14.49 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.778 1.631 . . . . 0.0 110.532 173.889 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1949 ' ' THR . . . . . . . . . . . . . 28.4 m -131.12 116.73 18.11 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.552 0.741 . . . . 0.0 110.694 177.264 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1950 ' ' ALA . . . . . . . . . . . . . . . -92.02 155.02 18.4 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.736 1.214 . . . . 0.0 111.082 169.279 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1951 ' ' ARG . . . . . . . . . . . . . 51.2 ttt85 -116.48 125.64 52.24 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.291 1.037 . . . . 0.0 110.062 170.297 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1952 ' ' VAL . . . . . . . . . . . . . 92.2 t -107.65 130.99 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 125.224 1.41 . . . . 0.0 110.526 -174.616 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1953 ' ' THR . . . . . . . . . . . . . 40.1 p -108.06 171.24 7.52 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.288 1.435 . . . . 0.0 112.739 178.921 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1954 ' ' GLY . . . . . . . . . . . . . . . -76.59 154.62 44.08 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.372 1.463 . . . . 0.0 113.67 -178.576 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1955 ' ' ASP . . . . . . . . . . . . . 34.9 t70 -76.28 -23.86 54.41 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.02 1.328 . . . . 0.0 113.241 179.035 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A 1956 ' ' ASP . . . . . . . . . . . . . 33.9 t70 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 125.809 1.644 . . . . 0.0 114.095 -179.678 . . . . . . . . 0 0 . 1 stop_ save_